FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Peetz, D
   Baird, M
   Banerjee, R
   Bartkiw, T
   Campbell, S
   Charlesworth, S
   Coles, A
   Cooper, R
   Foster, J
   Galea, N
   de la Harpe, B
   Leighton, C
   Lynch, B
   Pike, K
   Pyman, A
   Ramia, I
   Ressia, S
   Samani, MN
   Southey, K
   Strachan, G
   To, M
   Troup, C
   Walsworth, S
   Werth, S
   Weststar, J
AF Peetz, David
   Baird, Marian
   Banerjee, Rupa
   Bartkiw, Tim
   Campbell, Shelagh
   Charlesworth, Sara
   Coles, Amanda
   Cooper, Rae
   Foster, Jason
   Galea, Natalie
   de la Harpe, Barbara
   Leighton, Catherine
   Lynch, Bernadette
   Pike, Kelly
   Pyman, Amanda
   Ramia, Ioana
   Ressia, Susan
   Samani, Mojan Naisani
   Southey, Kim
   Strachan, Glenda
   To, March
   Troup, Carolyn
   Walsworth, Scott
   Werth, Shalene
   Weststar, Johanna
TI Sustained knowledge work and thinking time amongst academics: gender and
   working from home during the COVID-19 pandemic
SO LABOUR & INDUSTRY-A JOURNAL OF THE SOCIAL AND ECONOMIC RELATIONS OF WORK
LA English
DT Article
DE Knowledge work; working from home; remote working; gender; universities
ID WOMEN; MOTHERS; CARE; DISCRIMINATION; INTERFERENCE; FLEXIBILITY
AB The COVID-19 pandemic triggered a migration of workforces to work from home. A key issue for academics was the implications for the ability to carve out 'thinking time' to engage in what we term sustained knowledge work, the type of work essential for producing research. We administered an employee survey to academics from seven Australian and seven Canadian Universities, receiving over 3000 responses. We report on both quantitative and qualitative findings from the survey, with a particular emphasis on the latter. The two countries displayed broadly similar patterns in responses, but these patterns were gendered in specific ways. We distinguished between episodic and sustained knowledge work and found the shift of the location for sustained knowledge work from the workplace to the home affected academics unevenly, with disproportionate negative impacts on women. There are implications for all knowledge workers: while gendered, domestic norms continue to exist, the sustained knowledge work that is critical to career advancement can become especially problematic for women knowledge workers.
C1 [Peetz, David; Ressia, Susan] Griffith Univ, Dept Employment Relat & HR, Brisbane, Qld, Australia.
   [Baird, Marian; Cooper, Rae] Univ Sydney, Work & Org Studies, Sydney, NSW, Australia.
   [Banerjee, Rupa; Bartkiw, Tim] Ryerson Univ, Dept HR Management & Org Behav, Toronto, ON, Canada.
   [Campbell, Shelagh] Univ Regina, Fac Business Adm, Regina, SK, Canada.
   [Charlesworth, Sara] RMIT Univ, Ctr People Org & Work, Melbourne, Vic, Australia.
   [Coles, Amanda] Deakin Univ, Dept Management, Geelong, Vic, Australia.
   [Foster, Jason] Athabasca Univ, Human Resources & Lab Relat, Athabasca, AB, Canada.
   [Galea, Natalie] Univ Melbourne, Fac Architecture Bldg & Planning, Melbourne, Vic, Australia.
   [de la Harpe, Barbara] Univ Southern Queensland, Fac Business Educ Law & Arts, Toowoomba, Qld, Australia.
   [Leighton, Catherine; To, March] Univ Western Australia, Perth, WA, Australia.
   [Lynch, Bernadette; Southey, Kim; Werth, Shalene] Univ Southern Queensland, Sch Business, Toowoomba, Qld, Australia.
   [Pike, Kelly] York Univ, Toronto, ON, Canada.
   [Pyman, Amanda] Deakin Univ, Deakin Business Sch, Geelong, Vic, Australia.
   [Ramia, Ioana] Australian Educ Res Org, Melbourne, Vic, Australia.
   [Samani, Mojan Naisani] McMaster Univ, Hamilton, ON, Canada.
   [Strachan, Glenda; Troup, Carolyn] Griffith Univ, Ctr Work Org & Wellbeing, Brisbane, Qld, Australia.
   [Walsworth, Scott] Univ Saskatchewan, Edwards Sch Business, Saskatoon, SK, Canada.
   [Weststar, Johanna] Univ Western Ontario, DAN Dept Management & Org Studies, London, ON, Canada.
RP Peetz, D (corresponding author), Griffith Univ, Dept Employment Relat & HR, Brisbane, Qld, Australia.
EM d.peetz@griffith.edu.au
OI Peetz, David/0000-0003-3722-3163; Galea, Natalie/0000-0002-9684-6953
FU University Staff Survey
FX This project (the COVID-19 Home-working of University Staff Survey, or
   CHUSS) was financially supported by a number of the universities whose
   staff were surveyed, and involved all the researchers shown in the
   author list plus the two listed in the acknowledgements section. Note
   that since the project was completed some researchers have moved
   institutions. Results for participating universities were provided to
   them but the anonymity of respondents, and of the funding universities,
   has been maintained. Funding universities had no influence over the
   final version of the paper or any draft.
CR Adisa T., 2021, J WORK-APPL MANAG, V13, P241, DOI [10.1108/JWAM-07-2020-0036, DOI 10.1108/JWAM-07-2020-0036]
   Alvesson M, 2001, HUM RELAT, V54, P863, DOI 10.1177/0018726701547004
   Andersen J. P., 2020, eLife, V9, DOI 10.7554/eLife.58807
   Armstrong P., 2004, CARING CARING WOMEN, P5
   Avent-Holt D, 2019, SOCIOL COMPASS, V13, DOI 10.1111/soc4.12655
   BAGILHOLE B, 1993, BRIT J SOCIOL EDUC, V14, P261, DOI 10.1080/0142569930140303
   Barber BM, 2021, J FINANC, V76, P1655, DOI 10.1111/jofi.13028
   Braverman Harry, 1974, LABOR MONOPOLY CAPIT
   Carreri, 2020, ITALIAN SOCIOLOGICAL, V10, P821
   Charalampous M, 2019, EUR J WORK ORGAN PSY, V28, P51, DOI 10.1080/1359432X.2018.1541886
   Cooklin AR, 2016, SOC SCI MED, V155, P24, DOI 10.1016/j.socscimed.2016.02.036
   Corbin J., 1998, BASICS QUALITATIVE R
   Crabtree SA, 2019, SAGE OPEN, V9, DOI 10.1177/2158244019876285
   Craig L, 2020, J SOCIOL, V56, P684, DOI 10.1177/1440783320942413
   Craig L, 2021, GENDER WORK ORGAN, V28, P66, DOI 10.1111/gwao.12497
   Craig L, 2011, AM SOCIOL REV, V76, P834, DOI 10.1177/0003122411427673
   Davenport T., 2005, THINKING LIVING GET
   Deryugina T., 2021, W28360 NAT BUR EC RE, DOI [10.3386/w28360, DOI 10.3386/W28360]
   Feng ZY, 2020, GEND MANAG, V35, P719, DOI 10.1108/GM-07-2020-0202
   Folbre N, 2012, BRIT J IND RELAT, V50, P597, DOI 10.1111/bjir.12000
   FRENKEL S, 1995, WORK EMPLOY SOC, V9, P773, DOI 10.1177/095001709594008
   Fuller S, 2018, SOC FORCES, V96, P1443, DOI 10.1093/sf/sox087
   Garrido-Vasquez, 2020, OSF PREPRINTS, DOI [10.31219/osf.io/ek6aq, DOI 10.31219/OSF.IO/EK6AQ]
   Guarino CM, 2017, RES HIGH EDUC, V58, P672, DOI 10.1007/s11162-017-9454-2
   Guy B, 2020, GENDER WORK ORGAN, V27, P887, DOI 10.1111/gwao.12493
   Hjalmsdottir A, 2021, GENDER WORK ORGAN, V28, P268, DOI 10.1111/gwao.12552
   Huppatz K, 2019, GENDER WORK ORGAN, V26, P772, DOI 10.1111/gwao.12314
   Krukowski RA, 2021, J WOMENS HEALTH, V30, P341, DOI 10.1089/jwh.2020.8710
   Mallett O, 2020, GEND MANAG, V35, P657, DOI 10.1108/GM-06-2020-0173
   Massey D, 2002, T I BRIT GEOGR, V27, P259, DOI 10.1111/1475-5661.00054
   Mazmanian M, 2013, ORGAN SCI, V24, P1337, DOI 10.1287/orsc.1120.0806
   McDonald P., 2021, WOMEN WORK CARE COVI
   Moulier Boutang Y., 2011, COGNITIVE CAPITALISM
   Oleschuk M, 2020, CAN REV SOCIOL, V57, P502, DOI 10.1111/cars.12295
   Palvalin M, 2019, EMPL RELAT, V41, P209, DOI 10.1108/ER-04-2017-0091
   Parlak S, 2021, GENDER WORK ORGAN, V28, P461, DOI 10.1111/gwao.12655
   Pereira MD, 2021, GENDER WORK ORGAN, V28, P498, DOI 10.1111/gwao.12618
   Pocock B, 2005, GENDER WORK ORGAN, V12, P32, DOI 10.1111/j.1468-0432.2005.00261.x
   Pocock B, 2017, WORK OCCUPATION, V44, P23, DOI 10.1177/0730888415619218
   Reid A, 2003, BRIT J SOCIOL EDUC, V24, P559, DOI 10.1080/0142569032000127134
   Ruppanner L, 2014, WORK OCCUPATION, V41, P210, DOI 10.1177/0730888413500679
   Schimanski Lesley A, 2018, F1000Res, V7, P1605, DOI 10.12688/f1000research.16493.1
   Skinner N, 2011, J IND RELAT, V53, P65, DOI 10.1177/0022185610390297
   Smith, 1990, CONCEPTUAL PRACTICES
   Smith C, 1998, ECON IND DEMOCRACY, V19, P551, DOI 10.1177/0143831X98194002
   Squazzoni F., 2020, SSRN ELECT J, DOI [10.2139/ssrn.3712813, DOI 10.2139/SSRN.3712813]
   Taras D., 2016, INT COMP EMPLOYMENT, P81
   Tilly C., 1998, DURABLE INEQUALITY
   United Nations, 2020, POLICY BRIEF IMPACT POLICY BRIEF IMPACT
   Vartiainen M, 2007, LECT NOTES ARTIF INT, V4562, P194
   Verloo M., 2007, MULTIPLE MEANINGS GE, P21
   Vincent-Lamarre P, 2020, NATURE INDEX    0519
   Waizenegger L, 2020, EUR J INFORM SYST, V29, P429, DOI 10.1080/0960085X.2020.1800417
   Warhurst C., 2008, SERVICE WORK CRITICA, P91
   Wilson JZ, 2010, GENDER EDUC, V22, P535, DOI 10.1080/09540250903354404
   Young M, 2018, J MARRIAGE FAM, V80, P99, DOI 10.1111/jomf.12435
NR 56
TC 0
Z9 0
U1 3
U2 3
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1030-1763
EI 2325-5676
J9 LABOUR IND
JI Labour Ind.
PD JAN 2
PY 2022
VL 32
IS 1
SI SI
BP 72
EP 92
DI 10.1080/10301763.2022.2034092
EA MAR 2022
PG 21
WC Industrial Relations & Labor
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA ZX9FD
UT WOS:000770376700001
DA 2022-04-20
ER

PT J
AU Dindar, M
   Suorsa, A
   Hermes, J
   Karppinen, P
   Naykki, P
AF Dindar, Muhterem
   Suorsa, Anna
   Hermes, Jan
   Karppinen, Pasi
   Naykki, Piia
TI Comparing technology acceptance of K-12 teachers with and without prior
   experience of learning management systems: A Covid-19 pandemic study
SO JOURNAL OF COMPUTER ASSISTED LEARNING
LA English
DT Article; Early Access
DE Covid-19; K-12 education; online education; technology acceptance; UTAUT
ID USER ACCEPTANCE; INFORMATION-TECHNOLOGY; INTERACTIVE WHITEBOARDS;
   BEHAVIORAL INTENTIONS; CONTENT KNOWLEDGE; SCHOOL TEACHERS; ADOPTION;
   STUDENTS; MODEL; PRESERVICE
AB Covid-19 pandemic has caused a massive transformation in K-12 settings towards online education. It is important to explore the factors that facilitate online teaching technology adoption of teachers during the pandemic. The aim of this study was to compare Learning Management System (LMS) acceptance of Finnish K-12 teachers who have been using a specific LMS as part of their regular teaching before the Covid-19 pandemic (experienced group) and teachers who started using it for emergency remote teaching during the pandemic (inexperienced group). Based on the Unified Theory of Acceptance and Use of Technology framework, a self-report questionnaire was administered to 196 teachers (n(experienced) = 127; n(inexperienced) = 69). Our findings showed no difference between the two groups of teachers in terms of performance expectancy, effort expectancy, LMS self-efficacy and satisfaction. However, the experienced group had higher behavioural intention to use LMS in the future, reported receiving higher online teaching support and displayed higher online teaching self-efficacy in terms of student engagement, classroom management, instructional strategies and ICT skills. For the experienced group, the most significant predictor of satisfaction with LMS was performance expectancy whereas for the inexperienced group, it was the effort expectancy. In terms of behavioural intention to use LMS in the future, the most significant predictor was the performance expectancy for both groups. Further, support was also a significant predictor of behavioural intention for the inexperienced group. Overall, our findings indicate that teachers should not be regarded as a unified profile when managing technology adoption in schools.
C1 [Dindar, Muhterem] Univ Oulu, Fac Educ, Learning & Educ Technol Res Unit, FI-90014 Oulu, Finland.
   [Suorsa, Anna] Univ Oulu, Fac Humanities, Hist Culture & Commun Studies, Oulu, Finland.
   [Hermes, Jan] Univ Oulu, Oulu Business Sch, Dept Mkt Management & Int Studies, Oulu, Finland.
   [Hermes, Jan] Nicholas Copernicus Univ, Fac Econ Sci & Management, Dept Org Behav & Mkt, Torun, Poland.
   [Karppinen, Pasi] Univ Oulu, Fac Informat Technol & Elect Engn, Oulu Adv Res Serv & Informat Syst, Oulu, Finland.
   [Naykki, Piia] Univ Jyvaskyla, Fac Educ & Psychol, Jyvaskyla, Finland.
RP Dindar, M (corresponding author), Univ Oulu, Fac Educ, Learning & Educ Technol Res Unit, FI-90014 Oulu, Finland.
EM muhterem.dindar@oulu.fi; anna.suorsa@oulu.fi; jan.hermes@oulu.fi;
   pasi.karppinen@oulu.fi; piia.t.naykki@jyu.fi
OI Karppinen, Pasi/0000-0002-7800-8243; Naykki, Piia/0000-0002-2931-704X;
   Dindar, Muhterem/0000-0002-4094-5274; Hermes, Jan/0000-0002-6822-8269
FU University of Oulu; Academy of FinlandAcademy of Finland
FX University of Oulu; Academy of Finland
CR Akar SGM, 2019, EDUC INF TECHNOL, V24, P3415, DOI 10.1007/s10639-019-09933-z
   Al-Samarraie H, 2018, STUD HIGH EDUC, V43, P2003, DOI 10.1080/03075079.2017.1298088
   Alsabawy AY, 2013, COMPUT EDUC, V69, P431, DOI 10.1016/j.compedu.2013.07.035
   Barbour M.K., 2020, UNDERSTANDING PANDEM
   Barton EA, 2020, ETR&D-EDUC TECH RES, V68, P89, DOI 10.1007/s11423-019-09671-6
   Baydas O, 2017, INTERACT LEARN ENVIR, V25, P930, DOI 10.1080/10494820.2016.1232277
   Beaunoyer E, 2020, COMPUT HUM BEHAV, V111, DOI 10.1016/j.chb.2020.106424
   Blau I, 2017, EDUC INF TECHNOL, V22, P769, DOI 10.1007/s10639-015-9456-7
   Chang CT, 2017, COMPUT EDUC, V111, P128, DOI 10.1016/j.compedu.2017.04.010
   Chao CM, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01652
   Chen HR, 2012, EVAL PROGRAM PLANN, V35, P398, DOI 10.1016/j.evalprogplan.2011.11.007
   Chen YH, 2014, COMPUT HUM BEHAV, V32, P79, DOI 10.1016/j.chb.2013.11.011
   Chiu TKF, 2017, BRIT J EDUC TECHNOL, V48, P524, DOI 10.1111/bjet.12432
   DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982
   DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008
   del Barrio-Garcia S, 2015, EDUC TECHNOL SOC, V18, P129
   Ertmer PA, 1999, ETR&D-EDUC TECH RES, V47, P47, DOI 10.1007/BF02299597
   Ertmer PA, 2012, COMPUT EDUC, V59, P423, DOI 10.1016/j.compedu.2012.02.001
   Fishbein D., 1975, BELIEF ATTITUDE INTE
   Fraillon J., 2014, PREPARING LIFEIN DIG, DOI [10.1007/978-3-319-14222-7, DOI 10.1007/978-3-319-14222-7]
   Garone A, 2019, BRIT J EDUC TECHNOL, V50, P2466, DOI 10.1111/bjet.12867
   Hakkinen P, 2017, TEACH TEACH, V23, P25, DOI 10.1080/13540602.2016.1203772
   Han J, 2020, ROBOTICS, V9, DOI 10.3390/robotics9020034
   Hauge TE, 2015, INT J LEADERSH EDUC, V18, P340, DOI 10.1080/13603124.2014.963689
   Hong JC, 2020, INTERACT LEARN ENVIR, DOI 10.1080/10494820.2020.1752740
   Hu PJH, 2003, INFORM MANAGE-AMSTER, V41, P227, DOI 10.1016/S0378-7206(03)00050-8
   Hung MC, 2011, COMPUT EDUC, V57, P1530, DOI 10.1016/j.compedu.2011.02.001
   Jin CH, 2014, COMPUT HUM BEHAV, V41, P471, DOI 10.1016/j.chb.2014.09.056
   Johnson MP, 2014, DECIS SUPPORT SYST, V57, P444, DOI 10.1016/j.dss.2012.10.049
   Joo YJ, 2018, COMPUT EDUC, V122, P260, DOI 10.1016/j.compedu.2018.01.003
   Joo YJ, 2016, ETR&D-EDUC TECH RES, V64, P611, DOI 10.1007/s11423-016-9436-7
   KEIL M, 1995, DECIS SUPPORT SYST, V13, P75, DOI 10.1016/0167-9236(94)E0032-M
   Kemp A, 2019, BRIT J EDUC TECHNOL, V50, P2394, DOI 10.1111/bjet.12833
   Khechine H, 2020, BRIT J EDUC TECHNOL, V51, P2306, DOI 10.1111/bjet.12905
   Khlaif ZN, 2021, TECHNOL PEDAGOG EDUC, V30, P95, DOI 10.1080/1475939X.2020.1851752
   Kintu MJ, 2017, INT J EDUC TECHNOL H, V14, DOI 10.1186/s41239-017-0043-4
   Kirschner P., 2003, Technology, Pedagogy and Education, V12, P5, DOI 10.1080/14759390300200143
   Klapproth Florian., 2020, J PEDAGOGICAL RES, V4, P444, DOI [10.33902/JPR.2020062805, DOI 10.33902/JPR.2020062805]
   Kyriacou C, 2001, EDUC REV, V53, P27, DOI 10.1080/00131910120033628
   Liao CC, 2009, INT J INFORM MANAGE, V29, P309, DOI 10.1016/j.ijinfomgt.2009.03.004
   Liu F, 2017, ETR&D-EDUC TECH RES, V65, P795, DOI 10.1007/s11423-016-9487-9
   Long TT, 2019, BRIT J EDUC TECHNOL, V50, P2028, DOI 10.1111/bjet.12703
   Maity S, 2021, REV EDUC-US, V9, P405, DOI 10.1002/rev3.3250
   Marek MW, 2021, INT J DIST EDUC, V19, P40, DOI 10.4018/IJDET.20210101.oa3
   Miranda HP, 2012, BRIT J EDUC TECHNOL, V43, P652, DOI 10.1111/j.1467-8535.2011.01228.x
   Mishra P, 2006, TEACH COLL REC, V108, P1017, DOI 10.1111/j.1467-9620.2006.00684.x
   Mohammadi H, 2015, COMPUT HUM BEHAV, V45, P359, DOI 10.1016/j.chb.2014.07.044
   Jurado MDM, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/1021408
   OECD, 2015, STUDENTS COMPUTERS L, DOI [10.1787/9789264239555-en, DOI 10.1787/9789264239555-EN]
   Patricia Aguilera-Hermida A, 2020, Int J Educ Res Open, V1, P100011, DOI 10.1016/j.ijedro.2020.100011
   Perrotta D, 2021, STUD HIGH EDUC, V46, P30, DOI 10.1080/03075079.2020.1859679
   Petko D, 2015, COMPUT EDUC, V84, P49, DOI 10.1016/j.compedu.2014.12.019
   Pozon-Lopez I, 2020, INTERACT LEARN ENVIR, V28, P1003, DOI 10.1080/10494820.2019.1636074
   Punch K.F., 1996, RES EDUC-UK, V56, P63, DOI [10.1177/003452379605600105, DOI 10.1177/003452379605600105]
   Putwain DW, 2019, EDUC PSYCHOL-UK, V39, P51, DOI 10.1080/01443410.2018.1500681
   Pynoo B, 2011, COMPUT HUM BEHAV, V27, P568, DOI 10.1016/j.chb.2010.10.005
   Richmond G, 2020, J TEACH EDUC, V71, P375, DOI 10.1177/0022487120938888
   Robinia Kristi A, 2008, THESIS W MICHIGAN U
   Rogers E.M., 2010, DIFFUSION INNOVATION, V4th ed .
   Scherer R, 2019, EDUC RES REV-NETH, V27, P90, DOI 10.1016/j.edurev.2019.03.001
   Scherer R, 2019, COMPUT EDUC, V128, P13, DOI 10.1016/j.compedu.2018.09.009
   Siddiq F, 2016, COMPUT EDUC, V92-93, P1, DOI 10.1016/j.compedu.2015.10.006
   Straub ET, 2009, REV EDUC RES, V79, P625, DOI 10.3102/0034654308325896
   Sumak B, 2017, COMPUT HUM BEHAV, V72, P733, DOI 10.1016/j.chb.2016.09.006
   Sumak B, 2016, COMPUT HUM BEHAV, V64, P602, DOI 10.1016/j.chb.2016.07.037
   Tawafak RM, 2018, IEEE ACCESS, V6, P66481, DOI 10.1109/ACCESS.2018.2877760
   Teo T, 2019, INTERACT LEARN ENVIR, V27, P530, DOI 10.1080/10494820.2018.1489290
   Teo T, 2014, COMPUT EDUC, V75, P127, DOI 10.1016/j.compedu.2014.01.014
   Teo T, 2011, COMPUT EDUC, V57, P1645, DOI 10.1016/j.compedu.2011.03.002
   Tondeur J, 2020, ETR&D-EDUC TECH RES, V68, P319, DOI 10.1007/s11423-019-09692-1
   Ursavas OF, 2019, BRIT J EDUC TECHNOL, V50, P2501, DOI 10.1111/bjet.12834
   Valtonen T, 2021, COMPUT HUM BEHAV, V116, DOI 10.1016/j.chb.2020.106643
   Valtonen T, 2017, EDUC INF TECHNOL, V22, P2055, DOI 10.1007/s10639-016-9529-2
   Vanderlinde R, 2010, COMPUT EDUC, V55, P541, DOI 10.1016/j.compedu.2010.02.016
   Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540
   Venkatesh V, 2012, MIS QUART, V36, P157
   Voogt J, 2017, TECHNOL PEDAGOG EDUC, V26, P69, DOI 10.1080/1475939X.2016.1174730
   Wong GKW, 2016, ETR&D-EDUC TECH RES, V64, P313, DOI 10.1007/s11423-016-9426-9
NR 78
TC 2
Z9 2
U1 16
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0266-4909
EI 1365-2729
J9 J COMPUT ASSIST LEAR
JI J. Comput. Assist. Learn.
DI 10.1111/jcal.12552
EA AUG 2021
PG 13
WC Education & Educational Research
WE Social Science Citation Index (SSCI)
SC Education & Educational Research
GA UB9LY
UT WOS:000686160200001
PM 34548732
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Risling, T
   Carlberg, C
   Kassam, I
   Moss, T
   Janssen, P
   Iduye, S
   Strudwick, G
AF Risling, Tracie
   Carlberg, Courtney
   Kassam, Iman
   Moss, Tyler
   Janssen, Patricia
   Iduye, Steve
   Strudwick, Gillian
TI Supporting population mental health and wellness during the COVID-19
   pandemic in Canada: protocol for a sequential mixed-method study
SO BMJ OPEN
LA English
DT Article
DE digital health; mental health; COVID-19; nursing informatics;
   psychiatry; population mental health; co-design
AB Introduction The global COVID-19 pandemic has reported to have a negative impact on the mental health and well-being of individuals around the world. Mental health system infrastructure, primarily developed to support individuals through in-person care, struggled to meet rising demand for services even prior to COVID-19. With public health guidelines requiring the use of physical distancing during the pandemic, digital mental health supports may be one way to address the needs of the population. Despite this, barriers exist in promoting and supporting access to existing and emerging digital resources. Text messaging may address some of these barriers, extending the potential reach of these digital interventions across divides that may separate some vulnerable or disadvantaged groups from essential mental health supports. Building on an existing knowledge synthesis project identifying key digital resources for improved mental health, this research will establish low-tech connections to assess need and better match access to services for those who need it most. The aim of this study is to codesign a customised two-way texting service to explore need and better align access to mental health supports for Canadians located in Saskatchewan during the COVID-19 pandemic. Methods and analysis This study will be completed in Saskatchewan, Canada. For this project, the RE-AIM (reach, effectiveness, adoption, implementation, maintenance) framework will be used to support three phases of a sequential mixed-method study. An advisory committee of Saskatchewan residents will guide this work with the study team. A 10-week service will be launched to connect individuals with appropriately suited digital mental health interventions through the use of text messaging. In phase 1, implementation and prototyping will be conducted with collaborative codesign for key elements related to features of an enrolment survey and initial messaging content. Phase 2 will focus on advancing the effectiveness of the service using quantitative user data. In phase 3, an embedding approach will be used to integrate both qualitative and quantitative data collected to understand the overall acceptability, satisfaction and perceived benefit of the text messaging service. Thematic analysis and descriptive statistics will be used as analytic methods. Ethics and dissemination This study has received approval from the Research Ethics Board at the University of Saskatchewan. A knowledge dissemination plan has been developed that includes traditional academic approaches such as conference presentations, and academic publications, as well as mainstream approaches such as social media, radio and dissemination through the advisory committee.
C1 [Risling, Tracie; Carlberg, Courtney; Moss, Tyler; Iduye, Steve] Univ Saskatchewan, Coll Nursing, Saskatoon, SK, Canada.
   [Kassam, Iman; Strudwick, Gillian] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada.
   [Janssen, Patricia] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.
   [Strudwick, Gillian] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
RP Strudwick, G (corresponding author), Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada.; Strudwick, G (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
EM gillian.strudwick@camh.ca
FU Canadian Institutes of Health Research, Operating Grant: COVID-19 Mental
   Health & Substance Use Service Needs and DeliveryCanadian Institutes of
   Health Research (CIHR); Saskatchewan Health Research Foundation
FX This study is funded by the Canadian Institutes of Health Research,
   Operating Grant: COVID--19 Mental Health & Substance Use Service Needs
   and Delivery and the Saskatchewan Health Research Foundation. The grant
   numbers are not applicable.
CR [Anonymous], 2020, ALZHEIMERS DEMENT, V16, P391, DOI 10.1002/alz.12068
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Brewer LC, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/14512
   Canadian Mental Health Association, 2021, COVID 19 MENT HLTH H
   Canadian Mental Health Association University of British Columbia Maru/Matchbox Mental Health Foundation & the Agenda Collaborative, 2020, COVID 19 EFF MENT HL
   Centre for Addiction and Mental Health, 2020, MENT HLTH CAN COVID
   Centre for Addiction and Mental Health, 2020, DIG COVID 19 MENT HL
   Chang T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-936
   Clarke PN, 2009, NURS SCI QUART, V22, P339, DOI 10.1177/0894318409344769
   Creswell J.W., 2017, DESIGNING CONDUCTING, V3rd
   Daly Z, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113631
   Estacio EV, 2019, J HEALTH PSYCHOL, V24, P1668, DOI 10.1177/1359105317695429
   Ferreira B, 2017, ICEIS: PROCEEDINGS OF THE 19TH INTERNATIONAL CONFERENCE ON ENTERPRISE INFORMATION SYSTEMS - VOL 2, P64, DOI 10.5220/0006311600640075
   Fetters MD, 2013, HEALTH SERV RES, V48, P2134, DOI 10.1111/1475-6773.12117
   Figueroa CA, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00523
   Glasgow RE, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00064
   Hall AK, 2015, ANNU REV PUBL HEALTH, V36, P393, DOI 10.1146/annurev-publhealth-031914-122855
   Harden SM, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00071
   Hyun C, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/15098
   Johnson RB, 2007, J MIX METHOD RES, V1, P112, DOI 10.1177/1558689806298224
   Keyes CLM, 2002, J HEALTH SOC BEHAV, V43, P207, DOI 10.2307/3090197
   Kruse G, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/11498
   Lester R, 2019, J CLIN TUBER OTH MYC, V16, DOI 10.1016/j.jctube.2019.100108
   Manganello Jennifer, 2017, J Public Health Manag Pract, V23, P380, DOI 10.1097/PHH.0000000000000366
   Marko-Holguin M, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/11833
   Martinez-Martin N, 2020, JMIR MENT HEALTH, V7, DOI 10.2196/23776
   Mental Health Commission of Canada, 2014, E MENT HLTH CAN TRAN
   Moreno C, 2020, LANCET PSYCHIAT, V7, P813, DOI 10.1016/S2215-0366(20)30307-2
   Munro Sarah, 2017, JMIR Public Health Surveill, V3, pe7, DOI 10.2196/publichealth.6949
   Prayaga RB, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.8930
   Rathbone AL, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7740
   Robillard R, 2021, CAN J PSYCHIAT, V66, P815, DOI 10.1177/0706743720986786
   Simon K., 2020, DIGITAL 2020 GLOBAL
   Strudwick G, 2021, JMIR MENT HEALTH, V8, DOI 10.2196/26550
   Vodopivec-Jamsek V, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007457.pub2
   WHO, 2020, WHO2019NCOVMENTALHLT
   World Health Organization, 2020, UNL INF TECHN DEF CO
   Yoshida Y, 2020, J AM MED INFORM ASSN, V27, P946, DOI 10.1093/jamia/ocaa041
   Zhang WQ, 2013, MED CARE, V51, pe51, DOI 10.1097/MLR.0b013e31824642fd
NR 39
TC 0
Z9 0
U1 3
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD NOV
PY 2021
VL 11
IS 11
AR e052259
DI 10.1136/bmjopen-2021-052259
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC General & Internal Medicine
GA XA9VD
UT WOS:000720985600008
PM 34794993
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Felix, HC
   Andersen, JA
   Willis, DE
   Malhis, JR
   Selig, JP
   McElfish, PA
AF Felix, Holly C.
   Andersen, Jennifer A.
   Willis, Don E.
   Malhis, Joseph R.
   Selig, James P.
   McElfish, Pearl A.
TI Control of type 2 diabetes mellitus during the COVID-19 pandemic
SO PRIMARY CARE DIABETES
LA English
DT Article
DE Type 2 diabetes mellitus; Diabetes control; Diabetes self-care
   behaviors; COVID-19 pandemic
ID SELF-MANAGEMENT; DISEASES
AB Aims: Type 2 Diabetes Mellitus (T2DM) is a prevalent chronic condition that can lead to significant complications if not well controlled. The COVID-19 pandemic created disruptions in daily life; however, it is unknown whether the pandemic's disruptions affected the ability for adults with T2DM to control their condition. This study aims to fill the knowledge gap with the experiences of adults with T2DM in Arkansas, U.S. during the COVID-19 pandemic. Methods: This study analyzed cross-sectional, observational survey data collected from adults (>18 years) who live, work, or receive healthcare in Arkansas; self-reported a diagnosis of T2DM; and completed the diabetes module of the Impact of COVID-19 online survey (n = 131) fielded in July-August 2020. Descriptive statistics were used to characterize the sample and survey responses, and multivariate regression was used to identify demographics, self-care behaviors, and access issues associated with uncontrolled T2DM (HbA1c > 9% or 74.9 mmol/mol) or with an increase in HbA1c. Results: 28.2% reported an increase in their HbA1c since the pandemic began, and 18.2% had uncontrolled T2DM. Educational level, eating healthily, and weight gain were negatively associated with uncontrolled T2DM. Eating less healthily and having difficulty accessing diabetes related medication were positively associated with an increase in HbA1c. Conclusions: Adults with T2DM in Arkansas were reasonably able to maintain control of their T2DM during the five months post the first case of COVD-19 diagnosed in the state. However, T2DM self-management interventions targeting those with lower educational levels that are focused on eating habits and/or that improve access to diabetes medication should be considered for future public health emergencies. (c) 2021 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
C1 [Felix, Holly C.; Selig, James P.] Univ Arkansas Med Sci, Fay W Boozman Coll Publ Hlth, 4301 West Markham, Little Rock, AR 72205 USA.
   [Andersen, Jennifer A.; Willis, Don E.; McElfish, Pearl A.] Univ Arkansas Med Sci Northwest, Coll Med, Div Community Hlth & Res, 1125 N Coll Ave, Fayetteville, AR 72703 USA.
   [Malhis, Joseph R.] Univ Arkansas Med Sci Northwest, Coll Med, 1125 N Coll Ave, Fayetteville, AR 72703 USA.
RP McElfish, PA (corresponding author), Univ Arkansas Med Sci Northwest, Coll Med, Div Community Hlth & Res, 1125 N Coll Ave, Fayetteville, AR 72703 USA.
EM pamelfish@uams.edu
RI Andersen, Jennifer/ABA-9656-2020; Willis, Don/AAF-5959-2021
OI Willis, Don/0000-0001-9612-489X; Felix, Holly C./0000-0002-7375-4095;
   Selig, James/0000-0002-8964-1829; Andersen, Jennifer/0000-0001-6809-892X
FU UAMS Translational Research Institute; NIH's National Center for
   Advancing Translational Sciences [1U54TR001629-01A1]
FX This work was supported by UAMS Translational Research Institute funding
   from NIH's National Center for Advancing Translational Sciences [grant
   number 1U54TR001629-01A1].
CR Albright A, 2011, DIABETES MANAGEMENT, V1, P369, DOI DOI 10.2217/DMT.11.31
   Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014
   Appel S.J., J NURSE PRACT, DOI [10.1016/j.nurpra.2020.12.021,2021/02/15, DOI 10.1016/J.NURPRA.2020.12.021,2021/02/15]
   Banerjee M, 2020, DIABETES METAB SYND, V14, P351, DOI 10.1016/j.dsx.2020.04.013
   Baruah M, 2014, J SOC HLTH DIABETES, V2, P67, DOI [10.4103/2321-0656.130788, DOI 10.4103/2321-0656.130788]
   Basu S, 2019, MED CARE, V57, P592, DOI 10.1097/MLR.0000000000001147
   Bhandari S, 2020, INT J DIABETES DEV C, V40, P340, DOI 10.1007/s13410-020-00868-7
   Bos-Touwen I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126400
   Brown A, 2017, DIABETES OBES METAB, V19, P1655, DOI 10.1111/dom.13009
   Centers for Disease Control and Prevention, 2020, NAT DIAB STAT RRP 20
   Centers for Disease Control and Prevention, 2019 BRFSS QUEST
   Dunton GF, 2020, PREV MED REP, V20, DOI 10.1016/j.pmedr.2020.101241
   Fonseca VA, 2009, DIABETES CARE, V32, P1632, DOI 10.2337/dc09-0670
   Heerman WJ, 2017, CONTEMP CLIN TRIALS, V62, P50, DOI 10.1016/j.cct.2017.08.006
   Milionis C, 2020, J DIABETES METAB DIS, V19, P2035, DOI 10.1007/s40200-020-00592-3
   Miller AC, 2008, PREHOSPITAL DISASTER, V23, P185, DOI 10.1017/S1049023X00005835
   Mukona DM, 2020, DIABETES METAB SYND, V14, P1575, DOI 10.1016/j.dsx.2020.08.022
   National Center for Chronic Disease Prevention and Health Promotion, 2015, CTR DIS CONTROL PREV
   Nelson DE, 2003, AM J PUBLIC HEALTH, V93, P1335, DOI 10.2105/AJPH.93.8.1335
   Nussbaumer-Streit B, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013574
   Pak A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00241
   PUN SP, 2009, J NURS HEALTHC CHRON, V1, P4, DOI [DOI 10.1111/J.1365-2702.2008.01000.X, 10.1111/j.1365-2702.2008.01000.x]
   Quinn LM, 2021, DIABETIC MED, V38, DOI 10.1111/dme.14469
   Rouleau L, 2021, J MANAGE STUD, V58, P243, DOI 10.1111/joms.12649
   Sacks LJ, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108296
   Senteio CR, 2021, J RACIAL ETHN HEALTH, V8, P704, DOI 10.1007/s40615-020-00830-7
   Shen W, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092712
   Toolkit P, COVID 19 PROTOCOLS
   Wicaksana AL, 2020, DIABETES METAB SYND, V14, P1109, DOI 10.1016/j.dsx.2020.06.070
   Wolfson JA, 2020, PUBLIC HEALTH NUTR, V23, P2384, DOI 10.1017/S1368980019003549
   Xue T., 2020, BLOOD GLUCOSE LEVELS, DOI 10.1101/2020.03.31.20048579
NR 31
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1751-9918
EI 1878-0210
J9 PRIM CARE DIABETES
JI Prim. Care Diabetes
PD OCT
PY 2021
VL 15
IS 5
BP 786
EP 792
DI 10.1016/j.pcd.2021.06.012
EA SEP 2021
PG 7
WC Endocrinology & Metabolism; Primary Health Care
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; General & Internal Medicine
GA US8OR
UT WOS:000697686000006
PM 34246614
OA Green Published, Bronze, Green Accepted
DA 2022-04-20
ER

PT J
AU Idoiaga, N
   Berasategi, N
   Eiguren, A
   Picaza, M
AF Idoiaga, Nahia
   Berasategi, Naiara
   Eiguren, Amaia
   Picaza, Maitane
TI Exploring Children's Social and Emotional Representations of the
   COVID-19 Pandemic
SO FRONTIERS IN PSYCHOLOGY
LA English
DT Article
DE COVID-19; children; emotions; pandemic; social representation
ID ILLNESS; RISK; HEALTH; PERCEPTIONS; KNOWLEDGE
AB COVID-19, a new emerging infectious disease (EID), has spread throughout the world, including Europe. Spain, in particular, has witnessed a significant outbreak of the pandemic. All classes have been canceled, and the government has declared a state of emergency, ordering the lockdown and confinement of the entire population. All children in the country have been confined to their homes since March 13 and are not allowed to leave at any time. This population is thus facing the harshest restrictions. Given the vulnerable situation of children, the aim of this research is to understand how they represent and emotionally cope with the COVID-19 crisis. A free association exercise elicited by the word "coronavirus" was completed by 228 children (age range: 3-12 years) from the North of Spain. To analyze the content, we employed the Reinert method with Iramuteq software for lexical analysis. The results revealed that children represent the COVID-19 as an enemy that is being fought by the doctors. Children are afraid and worried about catching the virus, but mainly because they think they can infect their grandparents, and this makes them feel guilty. Moreover, the lockdown situation has produced conflicting emotions in the children. On the one hand, they are scared, nervous, lonely, sad, bored, and angry, but they also feel safe, calm, and happy with their families. These results indicate the need for governments to also consider children in their management of the current situation by placing greater emphasis on social and inclusive policies to help alleviate the possible effects that they may suffer as a consequence of the pandemic and the lockdown. In short, there is a need to address the psychological, educational, social, health, and well-being needs of children.
C1 [Idoiaga, Nahia] Univ Basque Country UPV EHU, Dept Evolutionary & Educ Psychol, Bilbao, Spain.
   [Berasategi, Naiara; Eiguren, Amaia; Picaza, Maitane] Univ Basque Country UPV EHU, Dept Didact & Sch Org, Bilbao, Spain.
RP Idoiaga, N (corresponding author), Univ Basque Country UPV EHU, Dept Evolutionary & Educ Psychol, Bilbao, Spain.
EM nahia.idoiaga@ehu.eus
RI Mondragon, Nahia Idoiaga/AAD-5903-2021; sancho, Naiara
   Berasategi/ABH-3654-2020; Mondragon, Nahia Idoiaga/L-1754-2017
OI Mondragon, Nahia Idoiaga/0000-0003-0345-8570; Mondragon, Nahia
   Idoiaga/0000-0003-0345-8570; Eiguren Munitis, Amaia/0000-0001-5960-9994
CR BANKS W, 1990, OUTLOOK AGR, V19, P43, DOI 10.1177/003072709001900109
   Berger L., 1995, PESSOAS IDOSAS ABORD
   Bibace R., 1980, NEW DIR CHILD ADOLES, P34
   Brooks, 2005, HDB RESILIENCE CHILD
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   Cagnin Elaise Regina Gonçalves, 2004, Rev. esc. enferm. USP, V38, P51
   Cai JH, 2020, CLIN INFECT DIS, V71, P1547, DOI 10.1093/cid/ciaa198
   Camargo BV, 2009, SPAN J PSYCHOL, V12, P565, DOI 10.1017/S1138741600001931
   Carson D K, 1992, Child Health Care, V21, P103, DOI 10.1207/s15326888chc2102_6
   Cava MA, 2005, PUBLIC HEALTH NURS, V22, P398, DOI 10.1111/j.0737-1209.2005.220504.x
   Coyne LW, 2021, BEHAV ANAL PRACT, V14, P1092, DOI 10.1007/s40617-020-00435-w
   Dalton L, 2020, LANCET CHILD ADOLESC, V4, P346, DOI 10.1016/S2352-4642(20)30097-3
   Eiguren A., 2020, EXPLORING SOCIAL EMO
   Fasanelli R., 1995, PAPERS SOCIAL REPRES, V4, P15
   GALLI I, 1987, SOC SCI INFORM, V26, P535, DOI 10.1177/053901887026003004
   Garcia C., 2020, PSICOLOGOS INSISTEN
   Gillis A J, 1990, J Pediatr Nurs, V5, P78
   Goodwin R, 2004, J HEALTH PSYCHOL, V9, P381, DOI 10.1177/1359105304042348
   Granda G., 2020, ESPANA UNICO PAIS EU
   Grechyna D, 2020, HLTH THREATS ASS CHI, P1, DOI [10.2139/ssrn.3567670, DOI 10.2139/SSRN.3567670]
   Griffiths, 2020, J CONCURRENT DISORDE, V2, P58, DOI [10.1177/2333721420966081, DOI 10.54127/WCIC8036]
   Hamzelou J, 2020, NEW SCI
   HERGENRATHER JR, 1991, DEV PSYCHOL, V27, P952, DOI 10.1037/0012-1649.27.6.952
   Hoijer B, 2010, PUBLIC UNDERST SCI, V19, P717, DOI 10.1177/0963662509348863
   Howes C, 2000, SOC DEV, V9, P191, DOI 10.1111/1467-9507.00119
   Mondragon NI, 2017, J HEALTH PSYCHOL, V22, P951, DOI 10.1177/1359105315620294
   Jiao WY, 2020, J PEDIATR-US, V221, P264, DOI 10.1016/j.jpeds.2020.03.013
   Jiloha RC, 2020, EPIDEMIOLOGY INTERNA, V5, P7, DOI DOI 10.24321/2455.7048.202002
   Joffe H, 2002, SOC SCI MED, V54, P955, DOI 10.1016/S0277-9536(01)00068-5
   Joffe H, 2003, J HEALTH PSYCHOL, V8, P616, DOI 10.1177/13591053030085011
   Joffe H, 2003, BRIT J SOC PSYCHOL, V42, P55, DOI 10.1348/014466603763276126
   Joffe H, 2004, J HEALTH PSYCHOL, V9, P517, DOI 10.1177/1359105304044036
   Joffe H, 2011, PUBLIC UNDERST SCI, V20, P446, DOI 10.1177/0963662510391604
   Kalampalikis N., 2005, METHODES TUDE REPRES, P147
   Klein O, 2003, BRIT J SOC PSYCHOL, V42, P571, DOI 10.1348/014466603322595284
   Koopman HM, 2004, PATIENT EDUC COUNS, V55, P363, DOI 10.1016/j.pec.2004.02.020
   KURY SP, 1995, CLIN PEDIATR, V34, P178, DOI 10.1177/000992289503400401
   Lahlou S., 1996, JAPANESE J EXPT SOCI, V35, P278, DOI [DOI 10.2130/JJESP.35.278, 10.2130/jjesp.35.278]
   Lahlou S., 2001, PAPERS SOCIAL REPRES, V20, P1
   Leon M., 2020, PAIS
   Merino J. C., 2020, VANGUARDIA
   Mondragon NI, 2017, SCI COMMUN, V39, P101, DOI 10.1177/1075547016688908
   Moscovici S., 1961, PSYCHANALYSE SON IMA
   Moscovici S., 1984, SOCIAL REPRESENTATIO, P3
   Moscovici S., 2000, SOCIAL REPRESENTATIO
   Moss-Morris R., 1995, PHYS OCCUPATIONAL TH, V14, P95, DOI [10.1080/j006v14n03_05, DOI 10.1080/J006V14N03_05]
   Myant KA, 2005, J HEALTH PSYCHOL, V10, P805, DOI 10.1177/1359105305057315
   Pavone P., 2020, INFECT DIS TROPICAL, V6, DOI [10.32113/idtm_20203_594, DOI 10.32113/idtm_20203_594]
   Pettoello-Mantovani M, 2019, J PEDIATR-US, V205, P298, DOI 10.1016/j.jpeds.2018.10.069
   Piko BF, 2006, HEALTH EDUC RES, V21, P643, DOI 10.1093/her/cyl034
   Ratinaud, 2012, ACT 11 JOURN INT AN, P687
   Reinert M., 1996, ALCESTE VERSION 3 0
   Reinert M., 1990, BMS-B SOCIOL METHOD, V26, P25, DOI [10.1177/075910639002600103, DOI 10.1177/075910639002600103]
   Reinert M., 1983, CAHIERS ANAL DONNEES, V8, P187
   Sanchez P., 2020, PRES GOV EXTR COUNC
   Sanchez P., 2020, APPEARANCE PRESIDENT
   Schonhardt-Bailey, 2013, DELIBERATING AM MONE
   Sherlaw W, 2013, SOCIOL HEALTH ILL, V35, P332, DOI 10.1111/j.1467-9566.2012.01525.x
   Simeonsson R. J., 1993, READINGS PEDIAT PSYC, P173
   Smith N, 2013, PUBLIC UNDERST SCI, V22, P16, DOI 10.1177/0963662512440913
   The Spanish Children's Rights Coalition, 2020, COM DER NIN NNUU ADV
   TONUCCI Francesco, 2020, PAIS
   United Nations Educational Scientific and Cultural Organization, 2020, COVID 19 ED DISR RES
   Vacik H W, 2001, J Pediatr Nurs, V16, P429, DOI 10.1053/jpdn.2001.27883
   Vidal M., 2020, PAIS
   Wagner W., 2005, EVERYDAY DISCOURSE C
   Wagner-Egger P, 2011, PUBLIC UNDERST SCI, V20, P461, DOI 10.1177/0963662510393605
   Wang GH, 2020, LANCET, V395, P945, DOI 10.1016/S0140-6736(20)30547-X
   Washer P, 2006, SOC SCI MED, V62, P457, DOI 10.1016/j.socscimed.2005.06.001
   Washer P., 2010, EMERGING INFECT DIS
   Weaver MS, 2020, J PAIN SYMPTOM MANAG, V60, pE8, DOI 10.1016/j.jpainsymman.2020.03.020
   Wentzel K.R., 2007, HDB SOCIALIZATION TH, P382
NR 72
TC 33
Z9 33
U1 10
U2 20
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-1078
J9 FRONT PSYCHOL
JI Front. Psychol.
PD AUG 12
PY 2020
VL 11
AR 1952
DI 10.3389/fpsyg.2020.01952
PG 9
WC Psychology, Multidisciplinary
WE Social Science Citation Index (SSCI)
SC Psychology
GA NI4QX
UT WOS:000565339500001
PM 32922334
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Nguyen, V
   Nguyen, MQ
   Le, NT
   Nguyen, TNH
   Huynh, G
AF Van Tap Nguyen
   Minh Quan Nguyen
   Ngoc Thi Le
   Thi Ngoc Han Nguyen
   Giao Huynh
TI Predictors of Intention to Get a COVID-19 Vaccine of Health Science
   Students: A Cross-Sectional Study
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19 vaccine; health science; student; intention; Vietnam
ID CHI MINH CITY; KNOWLEDGE
AB Background: Vaccination is one of the interventions that can be employed to control coronavirus disease (COVID-19). The aim of this study is to identify factors that affect vaccination intention among health science students, by using the health belief model (HBM) as a theoretical framework. Methods: This study was undertaken in April 2021 using a convenience sample strategy among health science students in Tra Vinh University, which is a university in South Vietnam. Participants were required to complete the self-report questionnaire. All data were calculated by using STATA 14 software, to determine the factors associated with COVID-19 vaccine acceptance, a multivariable logistic regression analysis was performed, along with odds ratio (OR) and 95% confidence interval (95% CI). Results: A total of 412 eligible participants were taken part in the study, with a questionnaire response rate of 48.2%, reporting that 77.7% of participants intended to receive a COVID-19 vaccination when available. An overall score of knowledge was 7.8 +/- 1.5 (range 0-10), a positive attitude toward vaccination including perceived susceptibility and severity (3.1 +/- 0.7), perceived benefits (3.1 +/- 0.7) and cues to action (4.0 +/- 0.6). Determinants of willingness to get a COVID-19 vaccination included their field of education, knowledge and factors in HBM model including perceived susceptibility and severity, perceived benefits and cues to action (all p < 0.05). In contrast, perceived barriers had a negative association with the probability of vaccine acceptance (p < 0.05). The study did indicate a number of participants not willing to receive a vaccination due to, mainly, safety (67.4%), development issues (58.7%) and side effects (79.3%). Conclusion: The theoretical framework recognized factors that influence vaccine accep-tance. These are considered evidence for the development of planning strategies to optimize the vaccination uptake and offer success in vaccination campaigns for both health science students and the general population.
C1 [Van Tap Nguyen] Tra Vinh Univ, Fac Med, Tra Vinh City, Tra Vinh Provin, Vietnam.
   [Minh Quan Nguyen] Thu Duc Dist Hosp, Dept Sci Res, 29 Phu Chau St, Ho Chi Minh City, Vietnam.
   [Ngoc Thi Le] Hanoi Univ Publ Hlth, Hlth Management Training Inst, Hanoi, Vietnam.
   [Thi Ngoc Han Nguyen] Univ Med Ctr Ho Chi Minh City, Infect Control Dept, Ho Chi Minh City, Vietnam.
   [Giao Huynh] Univ Med & Pharm Ho Chi Minh City, Fac Publ Hlth, Ho Chi Minh City, Vietnam.
RP Nguyen, MQ (corresponding author), Thu Duc Dist Hosp, Dept Sci Res, 29 Phu Chau St, Ho Chi Minh City, Vietnam.
EM minhquanbvtd@gmail.com
OI , Han Thi Ngoc Nguyen/0000-0002-1986-0647; Nguyen, Van
   Tap/0000-0001-6722-1383; HUYNH, GIAO/0000-0002-6882-1097
CR CDC, VAR VIR CAUS COVID 1
   Centers for Disease Control and Prevention (CDC), PEOPL CERT MED COND
   Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y
   FDA, KNOW YOUR TREATM OPT
   Frediansyah A, 2021, CLIN EPIDEMIOL GLOB, V9, P90, DOI 10.1016/j.cegh.2020.07.006
   Huynh G, 2021, RISK MANAG HEALTHC P, V14, P2517, DOI 10.2147/RMHP.S301645
   Huynh G, 2021, INFECT DRUG RESIST, V14, P1773, DOI 10.2147/IDR.S308446
   Huynh G, 2021, ASIAN PAC J TROP MED, V14, P159, DOI 10.4103/1995-7645.312513
   Huynh G, 2020, RISK MANAG HEALTHC P, V13, P1571, DOI 10.2147/RMHP.S268876
   Goruntla N, ASIAN PAC J TROP MED, V14, P2517, DOI [10.2147/RMHP.S301645, DOI 10.2147/RMHP.S301645]
   Haldane V, 2021, NAT MED, V27, P964, DOI 10.1038/s41591-021-01381-y
   Harapan H, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00381
   Harapan H, 2020, J INFECT PUBLIC HEAL, V13, P667, DOI 10.1016/j.jiph.2020.03.019
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Kanyike AM, 2021, TROP MED HEALTH, V49, DOI 10.1186/s41182-021-00331-1
   Lucia VC, 2021, J PUBLIC HEALTH-UK, V43, P445, DOI 10.1093/pubmed/fdaa230
   MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036
   Mascarenhas AK, 2021, J DENT EDUC, V85, P1504, DOI 10.1002/jdd.12632
   Nguyen KH, 2021, MMWR-MORBID MORTAL W, V70, P217, DOI 10.15585/mmwr.mm7006e3
   Olliaro P, 2021, LANCET MICROBE, V2, pE279, DOI 10.1016/S2666-5247(21)00069-0
   Patelarou E, 2021, NURS EDUC TODAY, V104, DOI 10.1016/j.nedt.2021.105010
   Saied SM, 2021, J MED VIROL, V93, P4280, DOI 10.1002/jmv.26910
   Tran TT., 2020, MEDPHARMRES, V2020, P27, DOI [10.32895/UMP.MPR.4.4.5, DOI 10.32895/UMP.MPR.4.4.5]
   Wagner AL, NARRA J, V1, P42, DOI [10.52225/ narraj.v1i2.42, DOI 10.52225/NARRAJ.V1I2.42]
   WHO, 2012, WORLD MALARIA REPORT 2012, P1
   World Health Organization, WHO COR COVID 19 DAS
   World Health Organization, COR
   World Health Organization, VIET NAM SIT
   Yusuf Fauzi, 2021, F1000Res, V10, P301, DOI 10.12688/f1000research.52216.1
NR 29
TC 2
Z9 2
U1 3
U2 3
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 4023
EP 4030
DI 10.2147/RMHP.S328665
PG 8
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA WB2ZK
UT WOS:000703445500006
PM 34594141
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Zaidi, A
   Elmasaad, A
   Alobaidli, H
   Sayed, R
   Al-Ali, D
   Al-Kuwari, D
   Al-Kubaisi, S
   Mekki, Y
   Emara, MM
   Daher-Nashif, S
AF Zaidi, Amine
   Elmasaad, Amal
   Alobaidli, Hend
   Sayed, Rana
   Al-Ali, Dana
   Al-Kuwari, Dana
   Al-Kubaisi, Shaikha
   Mekki, Yosra
   Emara, Mohamed M.
   Daher-Nashif, Suhad
TI Attitudes and Intentions toward COVID-19 Vaccination among Health
   Professions Students and Faculty in Qatar
SO VACCINES
LA English
DT Article
DE COVID-19 vaccination; attitudes towards vaccine; vaccine hesitancy;
   sociodemographic factors; knowledge; health professions students and
   faculty; Middle East
AB A population's desire to take the COVID-19 vaccine is an important predictor of a country's future pandemic management. This cross-sectional study examines the impact of psychological and sociodemographic factors on attitudes toward and intentions to take the COVID-19 vaccine among students and faculty at four colleges of health professions and sciences at Qatar University. The data were collected through an online survey using Google Forms. The survey was distributed through various online platforms. Data analysis was conducted using Stata 16. Of the 364 participants, 9.89% expressed a high mistrust of vaccine safety, and 21.7% were uncertain about their levels of trust; 28% expressed strong worries about unforeseen side effects, whereas 54.95% expressed moderate worries. Furthermore, 7.69% expressed strong concerns and 39.84% showed moderate concerns about commercial profiteering. Approximately 13% of the participants expressed a strong preference towards natural immunity, whilst 45.33% appeared to believe that natural immunity might be better than a vaccine. Importantly, 68.13% of the participants intended to receive the COVID-19 vaccine once it became available, compared to 17.03% who were uncertain and 14.83% who were unwilling to be vaccinated. Our findings differ from the data on vaccine hesitancy among the general population of Qatar. We argue that this gap is due to scientific knowledge and domain of education. Furthermore, although knowledge and awareness may affect vaccine attitudes, mental health and sociodemographic factors play a role in shaping attitudes towards vaccines.
C1 [Zaidi, Amine; Elmasaad, Amal; Alobaidli, Hend; Sayed, Rana; Al-Ali, Dana; Al-Kuwari, Dana; Al-Kubaisi, Shaikha; Mekki, Yosra; Emara, Mohamed M.] Qatar Univ, Coll Med, Basic Med Sci Dept, QU Hlth, Doha 2713, Qatar.
   [Emara, Mohamed M.] Qatar Univ, Biomed & Pharmaceut Res Unit, QU Hlth, Doha 2713, Qatar.
   [Daher-Nashif, Suhad] Qatar Univ, Coll Med, Populat Med Dept, QU Hlth, Doha 2713, Qatar.
RP Daher-Nashif, S (corresponding author), Qatar Univ, Coll Med, Populat Med Dept, QU Hlth, Doha 2713, Qatar.
EM az1708239@student.qu.edu.qa; ae1800819@student.qu.edu.qa;
   ha1704865@student.qu.edu.qa; rs1703961@student.qu.edu.qa;
   da1802872@student.qu.edu.qa; da1701937@student.qu.edu.qa;
   sa1601106@student.qu.edu.qa; ym1707134@student.qu.edu.qa;
   memara@qu.edu.qa; snashif@qu.edu.qa
RI Daher-Nashif, Suhad/AAL-7765-2020
OI Daher-Nashif, Suhad/0000-0002-8767-4619; Elmasaad,
   Amal/0000-0002-1858-8370
FU College of Medicine-QU Health, Qatar University
FX This publication was funded by the College of Medicine-QU Health, Qatar
   University.
CR Al Halabi CK, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10902-w
   Al-Mohaithef M, 2020, J MULTIDISCIP HEALTH, V13, P1657, DOI 10.2147/JMDH.S276771
   [Anonymous], 2020, COR VACC CLIN TRIAL
   [Anonymous], 2021, 5 THINGS YOU CAN BUI
   Barello S, 2020, EUR J EPIDEMIOL, V35, P781, DOI 10.1007/s10654-020-00670-z
   Catching A., 2020, EPIDEMIOLOGY, DOI [10.1038/s41598-021-94960-5, DOI 10.1101/2020.08.12.20173047, 10.1101/2020.08.12.20173047]
   Daher-Nashif S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17031059
   de Figueiredo A, 2020, LANCET, V396, P898, DOI 10.1016/S0140-6736(20)31558-0
   Dube E, 2014, VACCINE, V32, P6649, DOI 10.1016/j.vaccine.2014.09.039
   Freeman Daniel, 2020, Psychol Med, P1, DOI [10.1017/S0033291721002609, 10.1017/S0033291720005188]
   Galle F, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9060638
   Ayhan SG, 2021, INT J GYNECOL OBSTET, V154, P291, DOI 10.1002/ijgo.13713
   Khaled SM, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050471
   Largent EA, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.33324
   Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9
   Lee SA, 2020, DEATH STUD, DOI [10.1080/07481187.2020.1748481, 10.1080/07481187.2020.1853885]
   Lucia VC, 2021, J PUBLIC HEALTH-UK, V43, P445, DOI 10.1093/pubmed/fdaa230
   MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036
   Malik A.A., 2020, ECLINICALMEDICINE, V26, P100495, DOI [10.1016/j.eclinm.2020.100495, DOI 10.1016/J.ECLINM.2020.100495]
   Martin LR, 2017, ANN BEHAV MED, V51, P652, DOI 10.1007/s12160-017-9888-y
   Mjrby LM, 2020, J FAM MED PRIM CARE, V9, P2079, DOI 10.4103/jfmpc.jfmpc_1061_19
   Murphy J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20226-9
   Paul E, 2021, LANCET REG HEALTH-EU, V1, DOI 10.1016/j.lanepe.2020.100012
   Qunaibi E, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050446
   Ritchie H., CORONAVIRUS PANDEMIC
   Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020160
   Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010042
   Schwarzinger M, 2021, LANCET PUBLIC HEALTH, V6, pE210, DOI 10.1016/S2468-2667(21)00012-8
   Shaban RZ, 2020, AM J INFECT CONTROL, V48, P1445, DOI 10.1016/j.ajic.2020.08.032
   Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6
   Soares P, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030300
   Widge AT, 2021, NEW ENGL J MED, V384, P80, DOI 10.1056/NEJMc2032195
NR 32
TC 1
Z9 1
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD NOV
PY 2021
VL 9
IS 11
AR 1275
DI 10.3390/vaccines9111275
PG 23
WC Immunology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Immunology; Research & Experimental Medicine
GA XI3MF
UT WOS:000726019500001
PM 34835206
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU van Eijk, LE
   Binkhorst, M
   Bourgonje, AR
   Offringa, AK
   Mulder, DJ
   Bos, EM
   Kolundzic, N
   Abdulle, AE
   van der Voort, PHJ
   Rikkert, MGMO
   van der Hoeven, JG
   den Dunnen, WFA
   Hillebrands, JL
   van Goor, H
AF van Eijk, Larissa E.
   Binkhorst, Mathijs
   Bourgonje, Arno R.
   Offringa, Annette K.
   Mulder, Douwe J.
   Bos, Eelke M.
   Kolundzic, Nikola
   Abdulle, Amaal E.
   van der Voort, Peter H. J.
   Olde Rikkert, Marcel G. M.
   van der Hoeven, Johannes G.
   den Dunnen, Wilfred F. A.
   Hillebrands, Jan-Luuk
   van Goor, Harry
TI COVID-19: immunopathology, pathophysiological mechanisms, and treatment
   options
SO JOURNAL OF PATHOLOGY
LA English
DT Review
DE coronavirus disease 2019 (COVID-19); severe acute respiratory syndrome
   coronavirus 2 (SARS-CoV-2); acute respiratory distress syndrome (ARDS);
   pathology; immunopathology; pathophysiology; diffuse alveolar damage
   (DAD); treatment; angiotensin-converting enzyme 2 (ACE2); autoimmunity
ID SARS-COV-2 INFECTION; THROMBOCYTOPENIC PURPURA; CALCINEURIN INHIBITOR;
   COMPLEMENT ACTIVATION; CELL INFECTION; HUMAN BRAIN; VIRAL-RNA; SARS-COV;
   ACE2; CORONAVIRUS
AB Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread globally despite the worldwide implementation of preventive measures to combat the disease. Although most COVID-19 cases are characterised by a mild, self-limiting disease course, a considerable subset of patients develop a more severe condition, varying from pneumonia and acute respiratory distress syndrome (ARDS) to multi-organ failure (MOF). Progression of COVID-19 is thought to occur as a result of a complex interplay between multiple pathophysiological mechanisms, all of which may orchestrate SARS-CoV-2 infection and contribute to organ-specific tissue damage. In this respect, dissecting currently available knowledge of COVID-19 immunopathogenesis is crucially important, not only to improve our understanding of its pathophysiology but also to fuel the rationale of both novel and repurposed treatment modalities. Various immune-mediated pathways during SARS-CoV-2 infection are relevant in this context, which relate to innate immunity, adaptive immunity, and autoimmunity. Pathological findings in tissue specimens of patients with COVID-19 provide valuable information with regard to our understanding of pathophysiology as well as the development of evidence-based treatment regimens. This review provides an updated overview of the main pathological changes observed in COVID-19 within the most commonly affected organ systems, with special emphasis on immunopathology. Current management strategies for COVID-19 include supportive care and the use of repurposed or symptomatic drugs, such as dexamethasone, remdesivir, and anticoagulants. Ultimately, prevention is key to combat COVID-19, and this requires appropriate measures to attenuate its spread and, above all, the development and implementation of effective vaccines. (c) 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.
C1 [van Eijk, Larissa E.; den Dunnen, Wilfred F. A.; Hillebrands, Jan-Luuk; van Goor, Harry] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Pathol, Groningen, Netherlands.
   [Binkhorst, Mathijs] Radboud Univ Nijmegen, Dept Paediat, Subdiv Neonatol, Med Ctr,Amalia Childrens Hosp, Nijmegen, Netherlands.
   [Bourgonje, Arno R.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.
   [Offringa, Annette K.] Netherlands Org Appl Sci Res, Microbiol & Syst Biol, Zeist, Netherlands.
   [Mulder, Douwe J.; Abdulle, Amaal E.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Vasc Med, Groningen, Netherlands.
   [Bos, Eelke M.] Erasmus Univ, Med Ctr, Dept Neurosurg, Rotterdam, Netherlands.
   [Kolundzic, Nikola] Kings Coll London, Fac Life Sci & Med, Sch Life Course Sci, Stem Cell Lab,Dept Women & Childrens Hlth, London, England.
   [Kolundzic, Nikola] Guys Hosp, Assisted Concept Unit, London, England.
   [van der Voort, Peter H. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, Groningen, Netherlands.
   [Olde Rikkert, Marcel G. M.] Radboud Univ Nijmegen, Dept Geriatr Med, Med Ctr, Nijmegen, Netherlands.
   [van der Hoeven, Johannes G.] Radboud Univ Nijmegen, Dept Intens Care Med, Med Ctr, Nijmegen, Netherlands.
RP van Goor, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Pathol, Groningen, Netherlands.
EM h.van.goor@umcg.nl
RI ; Olde Rikkert, Marcel/H-8078-2014
OI Offringa, Annette/0000-0003-1332-2466; Mulder,
   Douwe/0000-0003-3715-6474; van der Voort, Peter HJ/0000-0002-3486-2843;
   van Eijk, Larissa/0000-0003-4280-0164; Olde Rikkert,
   Marcel/0000-0003-1397-1677; Kolundzic, Nikola/0000-0002-6480-2729;
   Bourgonje, Arno/0000-0001-5754-3821; Bos, Eelke/0000-0003-3647-6740
CR Abella BS, 2021, JAMA INTERN MED, V181, P195, DOI 10.1001/jamainternmed.2020.6319
   Abrams JY, 2020, J PEDIATR-US, V226, P45, DOI 10.1016/j.jpeds.2020.08.003
   Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Agarwal A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3939
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Angelopoulou A, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109858
   Angus DC, 2020, JAMA-J AM MED ASSOC, V324, P1317, DOI 10.1001/jama.2020.17022
   [Anonymous], BBC
   [Anonymous], CABLE NEWS NETWORK C
   ANONYMOUS, 2020, LANCET RHEUMATOL, V2, pE577, DOI DOI 10.1016/S2665-9913(20)30310-6
   Ashford JW, 2021, AM J MED, V134, P153, DOI 10.1016/j.amjmed.2020.10.003
   Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389
   Barnes BJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20200652
   Basso C, 2020, EUR HEART J, V41, P3827, DOI 10.1093/eurheartj/ehaa664
   Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Bhadelia N, 2021, BIORXIV, V2021, DOI [10.1101/2021.01.21.21249176, 10.1101/2021.01.21.212, DOI 10.1101/2021.01.21.212]
   Bilinska K, 2020, ACS CHEM NEUROSCI, V11, P1555, DOI 10.1021/acschemneuro.0c00210
   Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026
   Bomhof G, 2020, BRIT J HAEMATOL, V190, pE61, DOI 10.1111/bjh.16850
   Borczuk AC, 2021, CURR OPIN PULM MED, V27, P184, DOI 10.1097/MCP.0000000000000761
   Borczuk AC, 2020, MODERN PATHOL, V33, P2156, DOI 10.1038/s41379-020-00661-1
   Bourgonje AR, 2020, J PATHOL, V251, P228, DOI 10.1002/path.5471
   Bowles L, 2020, NEW ENGL J MED, V383, P288, DOI 10.1056/NEJMc2013656
   Bradley BT, 2020, LANCET, V396, P320, DOI 10.1016/S0140-6736(20)31305-2
   Braun F, 2020, LANCET, V396, P597, DOI 10.1016/S0140-6736(20)31759-1
   Briguglio M, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00146
   Bryant A., 2021, IVERMECTIN PREVENTIO, DOI [10.31219/osf.io/k37ft, DOI 10.31219/OSF.IO/K37FT]
   Buijsers B, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102969
   Calomeni E, 2020, KIDNEY INT, V98, P233, DOI 10.1016/j.kint.2020.05.003
   Caly Leon, 2020, Antiviral Res, V178, P104787, DOI 10.1016/j.antiviral.2020.104787
   Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985
   Carbajo-Lozoya J, 2012, VIRUS RES, V165, P112, DOI 10.1016/j.virusres.2012.02.002
   Suri HC, 2020, EXPERT REV RESP MED, V14, P1071, DOI 10.1080/17476348.2020.1801427
   Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5
   Carter MJ, 2020, NAT MED, V26, P1701, DOI 10.1038/s41591-020-1054-6
   Casciola-Rosen Livia, 2020, medRxiv, DOI 10.1101/2020.10.13.20211664
   Casta?eda-Sabogal A., 2021, OUTCOMES IVERMECTIN, DOI [10.1101/2021.01.26.21250420, DOI 10.1101/2021.01.26.21250420]
   Cavagna L, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8070977
   Cervera R, 2018, J AUTOIMMUN, V92, P1, DOI 10.1016/j.jaut.2018.05.007
   Chai KL, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD013600.pub2, 10.1002/14651858.CD013600.pub3]
   Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849
   Chen Y, 2020, HUMAN KIDNEY IS TARG, DOI [10.1101/2020.03.04.20031120, DOI 10.1101/2020.03.04.20031120]
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Cheung KS, 2020, GASTROENTEROLOGY, V159, P81, DOI 10.1053/j.gastro.2020.03.065
   Colmenero I, 2020, BRIT J DERMATOL, V183, P729, DOI 10.1111/bjd.19327
   Consiglio CR, 2020, CELL, V183, P968, DOI 10.1016/j.cell.2020.09.016
   Creel-Bulos C, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2010459
   Cruces P, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03197-7
   Curtis N, 2020, LANCET, V395, P1545, DOI 10.1016/S0140-6736(20)31025-4
   Damsky W, 2020, J AM ACAD DERMATOL, V83, pE269, DOI 10.1016/j.jaad.2020.06.052
   Davoudi-Monfared E, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01061-20
   de Queiroz TM, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01154
   de Wilde AH, 2011, J GEN VIROL, V92, P2542, DOI 10.1099/vir.0.034983-0
   Debisarun P.A., 2020, EFFECT INFLUENZA VAC, DOI [10.1101/2020.10.14.20212498, https://doi.org/10.1101/2020.10.14.20212498, DOI 10.1101/2020.10.14.20212498]
   Derosa L, 2020, NAT CANCER, V1, P946, DOI 10.1038/s43018-020-00122-3
   Deshmukh V, 2021, J CLIN PATHOL, V74, P76, DOI 10.1136/jclinpath-2020-206995
   Devreese KMJ, 2020, J THROMB HAEMOST, V18, P2191, DOI 10.1111/jth.14994
   Diurno F, 2020, EUR REV MED PHARMACO, V24, P4040, DOI 10.26355/eurrev_202004_20875
   Dolhnikoff M, 2020, LANCET CHILD ADOLESC, V4, P790, DOI 10.1016/S2352-4642(20)30257-1
   Dorward DA, 2021, AM J RESP CRIT CARE, V203, P192, DOI 10.1164/rccm.202008-3265OC
   dos Santos WG, 2020, BIOMED PHARMACOTHER, V129, DOI 10.1016/j.biopha.2020.110493
   Droesch C, 2020, JAMA DERMATOL, V156, P1022, DOI 10.1001/jamadermatol.2020.2800
   Duarte-Neto AN, 2020, HISTOPATHOLOGY, V77, P186, DOI 10.1111/his.14160
   Duffy L, 2016, IMMUNOTARGETS THER, V5, P69, DOI 10.2147/ITT.S89795
   Elli S, 2020, BIORXIV, DOI 10.1101/2020.02.29.971093
   Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283
   Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345
   Farkash EA, 2020, J AM SOC NEPHROL, V31, P1683, DOI 10.1681/ASN.2020040432
   Farrugia M, 2017, INT J INFLAMM, V2017, DOI 10.1155/2017/8391230
   Feldmann M, 2020, LANCET, V395, P1407, DOI 10.1016/S0140-6736(20)30858-8
   Fenizia C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18933-4
   Fox SE, 2020, LANCET RESP MED, V8, P681, DOI 10.1016/S2213-2600(20)30243-5
   Freeman EE, 2020, J AM ACAD DERMATOL, V83, P1118, DOI 10.1016/j.jaad.2020.06.1016
   Furtado RHM, 2020, LANCET, V396, P959, DOI 10.1016/S0140-6736(20)31862-6
   Ge XN, 2007, J PHARMACOL SCI, V105, P168, DOI 10.1254/jphs.FP0070858
   Giamarellos-Bourboulis EJ, 2020, CELL, V183, P315, DOI 10.1016/j.cell.2020.08.051
   Giannini S, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010219
   Gil MR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.17539
   Golmai P, 2020, J AM SOC NEPHROL, V31, P1944, DOI 10.1681/ASN.2020050683
   Gordon A.C., 2021, INTERLEUKIN 6 RECEPT, DOI [10.1101/2021.01.07.21249390, DOI 10.1101/2021.01.07.21249390]
   Gottlieb RL, 2021, JAMA-J AM MED ASSOC, V325, P632, DOI 10.1001/jama.2021.0202
   Gozzo L, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01307
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015
   Gruber Conor, 2020, medRxiv, DOI 10.1101/2020.07.04.20142752
   Gu JY, 2020, GASTROENTEROLOGY, V158, P1518, DOI 10.1053/j.gastro.2020.02.054
   Guan G W, 2020, Zhonghua Gan Zang Bing Za Zhi, V28, P100, DOI 10.3760/cma.j.issn.1007-3418.2020.02.002
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hamming I, 2007, J PATHOL, V212, P1, DOI 10.1002/path.2162
   Heidary F, 2020, J ANTIBIOT, V73, P593, DOI 10.1038/s41429-020-0336-z
   Helal MA, 2022, J BIOMOL STRUCT DYN, V40, P1109, DOI 10.1080/07391102.2020.1822208
   Heurich A, 2014, J VIROL, V88, P1293, DOI 10.1128/JVI.02202-13
   Hewitt J, 2020, LANCET PUBLIC HEALTH, V5, pE444, DOI 10.1016/S2468-2667(20)30146-8
   Hill A., 2021, METAANALYSIS RANDOMI, DOI [10.21203/rs.3.rs-148845/v1, DOI 10.21203/RS.3.RS-148845/V1]
   Hindilerden F, 2020, THROMB RES, V195, P136, DOI 10.1016/j.thromres.2020.07.005
   Hoeven, 2020, COVID 19 COMPREHENSI, DOI [10.20944/preprints202007.0108.v1, DOI 10.20944/PREPRINTS202007.0108.V1]
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Hoffmann M, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.00754-20
   Holter JC, 2020, P NATL ACAD SCI USA, V117, P25018, DOI 10.1073/pnas.2010540117
   Horby P, 2020, NEW ENGL J MED, V383, P2030, DOI 10.1056/NEJMoa2022926
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Horby PW, 2020, LANCET, V396, P1345, DOI 10.1016/S0140-6736(20)32013-4
   Hu HD, 2021, EUR HEART J, V42, P206, DOI 10.1093/eurheartj/ehaa190
   Hu M, 2020, HIGHLY PATHOGENIC CO, DOI 10.1101/2020.03.29.20041962
   Huang C., 2020, FAVIPIRAVIR VERSUS A, DOI [10.1101/2020.03.17.20037432, DOI 10.1101/2020.03.17.20037432]
   Huang YH, 2020, BRAIN BEHAV IMMUN, V87, P149, DOI 10.1016/j.bbi.2020.05.012
   Huet T, 2020, LANCET RHEUMATOL, V2, pE393, DOI 10.1016/S2665-9913(20)30164-8
   Iadecola C, 2020, CELL, V183, P16, DOI 10.1016/j.cell.2020.08.028
   Inciardi RM, 2020, EUR HEART J, V41, P1821, DOI 10.1093/eurheartj/ehaa388
   Jang IA, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111741
   Jin X, 2020, GUT, V69, P1002, DOI 10.1136/gutjnl-2020-320926
   Kalra A, 2020, CIRC-CARDIOVASC QUAL, V13, DOI 10.1161/CIRCOUTCOMES.120.007115
   Kaneko Naoki, 2020, Cell, V183, P143, DOI [10.2139/ssrn.3652322, 10.1016/j.cell.2020.08.025]
   Kanitakis J, 2020, J AM ACAD DERMATOL, V83, P870, DOI 10.1016/j.jaad.2020.05.145
   Kantonen J, 2020, BRAIN PATHOL, V30, P1012, DOI 10.1111/bpa.12889
   Kemmner S, 2020, KIDNEY INT, V98, P507, DOI 10.1016/j.kint.2020.05.024
   Kesici S, 2020, EUR HEART J, V41, P3021, DOI 10.1093/eurheartj/ehaa515
   Khalil A, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100446
   Kielian M, 2020, SCIENCE, V370, P765, DOI 10.1126/science.abf0732
   Kim DH, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020575
   Kissling S, 2020, KIDNEY INT, V98, P228, DOI 10.1016/j.kint.2020.04.006
   Konno Y, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108185
   Kory Pierre, 2021, Am J Ther, V28, pe299, DOI 10.1097/MJT.0000000000001377
   Kory P, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000724
   Kudose S, 2020, J AM SOC NEPHROL, V31, P1959, DOI 10.1681/ASN.2020060802
   Kumar N.D., 2020, RESVERATROL PTEROSTI
   Kurche JS, 2012, J IMMUNOL, V188, P585, DOI 10.4049/jimmunol.1102550
   Lagana SM, 2020, MODERN PATHOL, V33, P2147, DOI 10.1038/s41379-020-00649-x
   Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200
   Lamers MM, 2020, SCIENCE, V369, P50, DOI 10.1126/science.abc1669
   Lammers AJJ, 2020, INT J INFECT DIS, V101, P283, DOI 10.1016/j.ijid.2020.09.1460
   Lamontagne F, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3379
   Larsen CP, 2020, KIDNEY INT REP, V5, P935, DOI 10.1016/j.ekir.2020.04.002
   Laurence J, 2020, CLIN IMMUNOL, V219, DOI 10.1016/j.clim.2020.108555
   Lee WS, 2020, NAT MICROBIOL, V5, P1185, DOI 10.1038/s41564-020-00789-5
   Lei XB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17665-9
   Leisman DE, 2020, LANCET RESP MED, V8, P1233, DOI 10.1016/S2213-2600(20)30404-5
   Li Diangeng, 2020, JAMA Netw Open, V3, pe208292, DOI 10.1001/jamanetworkopen.2020.8292
   Li YY, 2020, J MED VIROL, V92, P1491, DOI 10.1002/jmv.25973
   Lian NF, 2020, LUNG, V198, P323, DOI 10.1007/s00408-020-00321-w
   Lindner D, 2020, JAMA CARDIOL, V5, P1281, DOI 10.1001/jamacardio.2020.3551
   Liu J, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0156-0
   Logunov DY, 2021, LANCET, V397, P671, DOI 10.1016/S0140-6736(21)00234-8
   Lopes da Silva Rodrigo, 2011, Hematol Oncol Stem Cell Ther, V4, P51
   Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007
   Mahmoud IS, 2020, BIOCHIMIE, V175, P93, DOI 10.1016/j.biochi.2020.05.012
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Mao R, 2020, LANCET GASTROENTEROL, V5, P426, DOI 10.1016/S2468-1253(20)30076-5
   Marcec R, 2021, POSTGRAD MED J, V97, P143, DOI 10.1136/postgradmedj-2020-138903
   Mariette X, 2021, LANCET RESP MED, V9, P295, DOI 10.1016/S2213-2600(20)30556-7
   Marin-Hernandez D, 2021, J MED VIROL, V93, P64, DOI 10.1002/jmv.26120
   Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871
   Matschke J, 2020, LANCET NEUROL, V19, P919, DOI 10.1016/S1474-4422(20)30308-2
   McGonagle D, 2020, LANCET RHEUMATOL, V2, pE437, DOI 10.1016/S2665-9913(20)30121-1
   McMillan Philip, 2020, MOJ Immunol, V7, P17
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134
   Mercante G, 2020, JAMA OTOLARYNGOL, V146, P723, DOI 10.1001/jamaoto.2020.1155
   Middleton EA, 2020, BLOOD, V136, P1169, DOI 10.1182/blood.2020007008
   Miller SE, 2020, KIDNEY INT, V98, P231, DOI 10.1016/j.kint.2020.05.004
   Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x
   Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038
   Momekov G, 2020, BIOTECHNOL BIOTEC EQ, V34, P469, DOI 10.1080/13102818.2020.1775118
   Monk PD, 2021, LANCET RESP MED, V9, P196, DOI 10.1016/S2213-2600(20)30511-7
   Monteil V, 2020, CELL, V181, P905, DOI 10.1016/j.cell.2020.04.004
   Moon Chang, 2020, Nat Rev Immunol, V20, P277, DOI 10.1038/s41577-020-0304-7
   Morbini P, 2020, JAMA OTOLARYNGOL, V146, P972, DOI 10.1001/jamaoto.2020.2366
   Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062
   Morris SB, 2020, MMWR-MORBID MORTAL W, V69, P1450, DOI 10.15585/mmwr.mm6940e1
   Mueller AL, 2020, AGING-US, V12, P9959, DOI 10.18632/aging.103344
   Munster VJ, 2020, NATURE, V585, P268, DOI 10.1038/s41586-020-2324-7
   Nadim MK, 2020, NAT REV NEPHROL, V16, P747, DOI 10.1038/s41581-020-00356-5
   Nakazawa D, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102942
   Nan J, 2020, J GERIATR CARDIOL, V17, P221, DOI 10.11909/j.issn.1671-5411.2020.04.010
   Narula S, 2020, LANCET, V396, P968, DOI 10.1016/S0140-6736(20)31964-4
   National Institutes of Health (NIH), 2021, JANSS INV COVID 19 V
   Nederlands Tijdschrift voor Geneeskunde (NTVG), BCG VOORK COV 19 BIJ
   Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08
   Ng Kevin W, 2020, Science, V370, P1339, DOI 10.1126/science.abe1107
   Nguyen AA, 2020, CLIN IMMUNOL, V216, DOI 10.1016/j.clim.2020.108459
   Nicin L, 2020, EUR HEART J, V41, P1804, DOI 10.1093/eurheartj/ehaa311
   Nienhold R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18854-2
   Noris M, 2020, KIDNEY INT, V98, P314, DOI 10.1016/j.kint.2020.05.013
   Novavax, NOV COVID 19 VACC DE
   Oldenburg CE, 2020, LANCET, V396, P936, DOI 10.1016/S0140-6736(20)31863-8
   Omarjee L, 2020, CLIN IMMUNOL, V216, DOI 10.1016/j.clim.2020.108464
   Onabajo OO, 2020, NAT GENET, V52, P1283, DOI 10.1038/s41588-020-00731-9
   Paniz-Mondolfi A, 2020, J MED VIROL, V92, P699, DOI 10.1002/jmv.25915
   Patel SK., 2020, PLASMA ACE2 ACTIVITY, DOI [10.1101/2020.10.06.20207514, DOI 10.1101/2020.10.06.20207514]
   Paterson RW, 2020, BRAIN, V143, P3104, DOI 10.1093/brain/awaa240
   Patrick, 2020, COGNITIVE DEFICITS P, DOI 10.1101/2020.10.20.20215863
   Pavel A, 2020, LANCET NEUROL, V19, P719, DOI 10.1016/S1474-4422(20)30269-6
   Peleg Y, 2020, KIDNEY INT REP, V5, P940, DOI 10.1016/j.ekir.2020.04.017
   Pellegrini L, 2020, CELL STEM CELL, V27, P951, DOI 10.1016/j.stem.2020.10.001
   Pfefferle S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002331
   Nguyen-Contant P, 2020, MBIO, V11, DOI 10.1128/mBio.01991-20
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Polak SB, 2020, MODERN PATHOL, V33, P2128, DOI 10.1038/s41379-020-0603-3
   Jeronimo CMP, 2021, CLIN INFECT DIS, V72, pE373, DOI 10.1093/cid/ciaa1177
   Prinz N, 2011, BLOOD, V118, P2322, DOI 10.1182/blood-2011-01-330639
   Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2013400, 10.1056/NEJMc2011400]
   Puntmann VO, 2020, JAMA CARDIOL, V5, P1265, DOI 10.1001/jamacardio.2020.3557
   Qiu L, 2020, CLIN INFECT DIS, V71, P813, DOI 10.1093/cid/ciaa375
   Rajpal S, 2021, JAMA CARDIOL, V6, P116, DOI 10.1001/jamacardio.2020.4916
   Ramamoorthy S, 2016, RHEUM DIS CLIN N AM, V42, P15, DOI 10.1016/j.rdc.2015.08.002
   Regeneron, 2020, REGN COV2 IND DAT MO
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richardson P, 2020, LANCET, V395, pE30, DOI 10.1016/S0140-6736(20)30304-4
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Robinson PC, 2020, LANCET RHEUMATOL, V2, pE653, DOI 10.1016/S2665-9913(20)30309-X
   Rubin R, 2020, JAMA-J AM MED ASSOC, V323, P2114, DOI 10.1001/jama.2020.7456
   Sama IE, 2020, EUR HEART J, V41, P1810, DOI 10.1093/eurheartj/ehaa373
   Santoriello D, 2020, J AM SOC NEPHROL, V31, P2158, DOI 10.1681/ASN.2020050744
   Schaefer IM, 2020, MODERN PATHOL, V33, P2104, DOI 10.1038/s41379-020-0595-z
   Schogler A, 2015, EUR RESPIR J, V45, P428, DOI 10.1183/09031936.00102014
   Schrezenmeier E, 2020, NAT REV RHEUMATOL, V16, P155, DOI 10.1038/s41584-020-0372-x
   Schurink B, 2020, LANCET MICROBE, V1, pE290, DOI 10.1016/S2666-5247(20)30144-0
   Scorzolini L, 2020, CLIN INFECT DIS, V71, P2298, DOI 10.1093/cid/ciaa445
   Seif F, 2020, INT ARCH ALLERGY IMM, V181, P467, DOI 10.1159/000508247
   Self WH, 2020, JAMA-J AM MED ASSOC, V324, P2165, DOI 10.1001/jama.2020.22240
   Shannon A, 2020, bioRxiv, DOI 10.1101/2020.05.15.098731
   Sharma P, 2020, J AM SOC NEPHROL, V31, P1948, DOI 10.1681/ASN.2020050699
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Simonovich VA, 2021, NEW ENGL J MED, V384, P619, DOI 10.1056/NEJMoa2031304
   Solomon IH, 2020, NEW ENGL J MED, V383, P989, DOI 10.1056/NEJMc2019373
   Stapley, 2020, ROBUST SARS COV 2 SP, DOI [10.1101/2020.11.01.362319., DOI 10.1101/2020.11.01.362319]
   Stebbing J, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe4724
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003
   Su S, 2020, THER ADV GASTROENTER, V13, DOI 10.1177/1756284820934626
   Sulzer D, 2020, NPJ PARKINSONS DIS, V6, DOI 10.1038/s41531-020-00123-0
   Sun SH, 2020, CELL HOST MICROBE, V28, P124, DOI 10.1016/j.chom.2020.05.020
   Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6
   Sward P, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02942-2
   Szkudelska K, 2009, EUR J CLIN INVEST, V39, P899, DOI 10.1111/j.1365-2362.2009.02188.x
   Takahashi Takehiro, 2020, medRxiv, DOI 10.1101/2020.06.06.20123414
   Tanaka Y, 2013, VIRUSES-BASEL, V5, P1250, DOI 10.3390/v5051250
   Tardif J-C., 2021, EFFICACY COLCHICINE, DOI [10.1101/2021.01.26.21250494, https://doi.org/10.1101/2021.01.26.21250494, DOI 10.1101/2021.01.26.21250494, 10.1101/2021.01.26.21250494v1, DOI 10.1101/2021.01.26.21250494V1]
   Tavazzi G, 2020, EUR J HEART FAIL, V22, P911, DOI 10.1002/ejhf.1828
   The Human Protein Atlas , TISS EXPR ACE2 EP
   Tian SF, 2020, MODERN PATHOL, V33, P1007, DOI 10.1038/s41379-020-0536-x
   Tian WM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19706-9
   Tillett RL, 2021, LANCET INFECT DIS, V21, P52, DOI 10.1016/S1473-3099(20)30764-7
   Tomazini BM, 2020, JAMA-J AM MED ASSOC, V324, P1307, DOI 10.1001/jama.2020.17021
   Tome CML, 2013, MOL NEUROBIOL, V47, P561, DOI 10.1007/s12035-012-8267-8
   Tong S, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106114
   Treon SP, 2020, BLOOD, V135, P1912, DOI 10.1182/blood.2020006288
   Tschope C, 2021, NAT REV CARDIOL, V18, P169, DOI 10.1038/s41569-020-00435-x
   Ungaro RC, 2021, GUT, V70, P725, DOI 10.1136/gutjnl-2020-322539
   Urwyler P, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02072
   Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760
   van de Veerdonk F.L., 2020, SYSTEMS APPROACH INF, DOI [10.1101/2020.05.23.20110916, DOI 10.1101/2020.05.23.20110916]
   van de Veerdonk FL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.17708
   van de Veerdonk FL, 2020, ELIFE, V9, DOI 10.7554/eLife.57555
   van der Made CI, 2020, JAMA-J AM MED ASSOC, V324, P663, DOI 10.1001/jama.2020.13719
   van der Voort PHJ, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04696
   van Zelst CM, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000792
   Vankadari N, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105998
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Velavan TP, 2020, INT J INFECT DIS, V95, P304, DOI 10.1016/j.ijid.2020.04.061
   Virhammar J, 2020, NEUROLOGY, V95, P445, DOI 10.1212/WNL.0000000000010250
   Vivanti AJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17436-6
   Vogel-Gonz?lez M., 2020, LOW ZINC LEVELS CLIN, DOI [10.1101/2020.10.07.20208645, DOI 10.1101/2020.10.07.20208645]
   Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1
   Wajnberg A, 2020, SCIENCE, V370, P1227, DOI 10.1126/science.abd7728
   Wang EY, 2021, NATURE, V595, P283, DOI [10.1038/s41586-021-03631-y, 10.1101/2020.12.10.20247205]
   Wang ZP, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040920
   Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369
   Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4
   Woodruff M.C., 2020, CLIN IDENTIFIABLE AU, DOI [10.21.20216192, DOI 10.1101/2020.10.21.20216192, 10.1 101/2020.10.21.20216192]
   Woodruff MC, 2020, NAT IMMUNOL, V21, P1506, DOI 10.1038/s41590-020-00814-z
   World Health Organization, 2020, COVID 19 LANDSC EXP
   World Health Organization, 2021, DRAFT LANDSC TRACK
   World Health Organization, 2021, WEEKLY EPIDEMIOLOGIC
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Wu YJ, 2020, LANCET GASTROENTEROL, V5, P434, DOI 10.1016/S2468-1253(20)30083-2
   Wu Y, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.139051
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xia HJ, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108234
   Xiao F, 2020, GASTROENTEROLOGY, V158, P1831, DOI 10.1053/j.gastro.2020.02.055
   Yan, 2020, SPECIFIC ACE2 EXPRES, DOI 10.1101/2020.02.03.931766
   Yan J, 2020, MOL HUM REPROD, V26, P367, DOI 10.1093/molehr/gaaa030
   Yan Y, 2020, JAMA OPHTHALMOL, V138, P1201, DOI 10.1001/jamaophthalmol.2020.3962
   Yang LJ, 2020, LANCET GASTROENTEROL, V5, P629, DOI 10.1016/S2468-1253(20)30132-1
   Yang M, 2020, EUR UROL FOCUS, V6, P1124, DOI 10.1016/j.euf.2020.05.009
   Yao X H, 2020, Zhonghua Bing Li Xue Za Zhi, V49, P411, DOI 10.3760/cma.j.cn112151-20200312-00193
   Zang RC, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc3582
   Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1
   Zhang H, 2020, GUT, V69, P1010, DOI 10.1136/gutjnl-2020-320953
   Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570
   Zhang X, 2008, INFLAMM RES, V57, P524, DOI 10.1007/s00011-008-8007-8
   Zhang XN, 2020, NATURE, V583, P437, DOI 10.1038/s41586-020-2355-0
   Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575
   Zhavoronkov A, 2020, AGING-US, V12, P6492, DOI 10.18632/aging.102988
   Zhou J, 2020, NAT MED, V26, P1077, DOI 10.1038/s41591-020-0912-6
   Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035
   Zoufaly A, 2020, LANCET RESP MED, V8, P1154, DOI 10.1016/S2213-2600(20)30418-5
   Zulfiqar AA, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2010472
   Zuo Y, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abd3876
   Zuo Y, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138999
NR 301
TC 16
Z9 17
U1 6
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
EI 1096-9896
J9 J PATHOL
JI J. Pathol.
PD JUL
PY 2021
VL 254
IS 4
BP 307
EP 331
DI 10.1002/path.5642
EA MAR 2021
PG 25
WC Oncology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pathology
GA SN6TC
UT WOS:000632472500001
PM 33586189
OA Green Published, Green Submitted, hybrid
DA 2022-04-20
ER

PT J
AU Chen, YX
   Chen, M
   Huang, B
   Wu, C
   Shi, WJ
AF Chen, Yixiang
   Chen, Min
   Huang, Bo
   Wu, Chao
   Shi, Wenjia
TI Modeling the Spatiotemporal Association Between COVID-19 Transmission
   and Population Mobility Using Geographically and Temporally Weighted
   Regression
SO GEOHEALTH
LA English
DT Article
DE COVID-19; heterogeneity; population movement; time; space
ID MOUTH-DISEASE; CHINA; DETERMINANTS; FEVER; FOOT; HAND
AB The ongoing Coronavirus Disease 2019 (COVID-19) has posed a serious threat to human public health and global economy. Population mobility is an important factor that drives the spread of COVID-19. This study aimed to quantitatively evaluate the impact of population flow on the spread of COVID-19 from a spatiotemporal perspective. To this end, a case study was carried out in Hubei Province, which was once the most affected area of COVID-19 outbreak in Mainland China. The geographically and temporally weighted regression (GTWR) model was applied to model the spatiotemporal association between COVID-19 epidemic and population mobility. Two patterns of population flows, including the population inflow from Wuhan and intra-city population movement, were considered to construct explanatory variables. Results indicate that the GTWR model can reveal the spatial-temporal-varying relationships between COVID-19 and population mobility. Moreover, the association between COVID-19 case counts and population movements presented three stages of temporal variation characteristics due to the virus incubation period and implementation of strict lockdown measures. In the spatial dimension, evident geographical disparities were observed across Hubei Province. These findings can provide policymakers useful knowledge about the impact of population movement on the spatio-temporal transmission of COVID-19. Thus, targeted interventions, if necessary in certain time periods, can be implemented to restrict population flow in cities with high transmission risk.
C1 [Chen, Yixiang; Chen, Min; Wu, Chao; Shi, Wenjia] Nanjing Univ Posts & Telecommun, Sch Geog & Biol Informat, Nanjing, Peoples R China.
   [Chen, Yixiang; Wu, Chao] Smart Hlth Big Data Anal & Locat Serv Engn Lab Ji, Nanjing, Peoples R China.
   [Huang, Bo] Chinese Univ Hong Kong, Dept Geog & Resource Management, Hong Kong, Peoples R China.
RP Wu, C (corresponding author), Nanjing Univ Posts & Telecommun, Sch Geog & Biol Informat, Nanjing, Peoples R China.; Wu, C (corresponding author), Smart Hlth Big Data Anal & Locat Serv Engn Lab Ji, Nanjing, Peoples R China.
EM chaowu@njupt.edu.cn
RI Huang, Bo/H-9874-2014
OI Huang, Bo/0000-0002-5063-3522
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [41901326]; Natural Science Foundation of
   Jiangsu ProvinceNatural Science Foundation of Jiangsu Province
   [BK20190742]; Natural Science Research of Jiangsu Higher Education
   Institutions of China [19KJB170009]; Open Foundation of Smart Health Big
   Data Analysis and Location Services Engineering Lab of Jiangsu Province
   [SHEL221003]
FX This study was funded by the National Natural Science Foundation of
   China (No.41901326), the Natural Science Foundation of Jiangsu Province
   (No. BK20190742) and the Natural Science Research of Jiangsu Higher
   Education Institutions of China (No. 19KJB170009). This work was also
   funded by the Open Foundation of Smart Health Big Data Analysis and
   Location Services Engineering Lab of Jiangsu Province (No. SHEL221003).
CR Andersen LM, 2021, SCI TOTAL ENVIRON, V754, DOI 10.1016/j.scitotenv.2020.142396
   Brunsdon C, 1996, GEOGR ANAL, V28, P281, DOI 10.1111/j.1538-4632.1996.tb00936.x
   Chen SM, 2020, LANCET, V395, P764, DOI 10.1016/S0140-6736(20)30421-9
   Franch-Pardo I, 2020, SCI TOTAL ENVIRON, V739, DOI 10.1016/j.scitotenv.2020.140033
   Ge L, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111062
   He QQ, 2018, REMOTE SENS ENVIRON, V206, P72, DOI 10.1016/j.rse.2017.12.018
   Hong ZM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35721-9
   Huang B, 2010, INT J GEOGR INF SCI, V24, P383, DOI 10.1080/13658810802672469
   Jia JSS, 2020, NATURE, V582, P389, DOI [10.1038/s41586-020-2284-y, 10.1109/LGRS.2020.3028443]
   Kraemer MUG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41192-3
   Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Liu H., 2020, MEDRXIV, DOI [10.1101/2020.04.02.20050781, DOI 10.1101/2020.04.02.20050781]
   Ma XL, 2018, COMPUT ENVIRON URBAN, V70, P113, DOI 10.1016/j.compenvurbsys.2018.03.001
   Merler S, 2010, PROCEDIA COMPUT SCI, V1, P2231, DOI 10.1016/j.procs.2010.04.250
   Mollalo A, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138884
   O'Sullivan D, 2003, GEOGR ANAL, V35, P272, DOI 10.1111/j.1538-4632.2003.tb01114.x
   Pan JH, 2019, CITIES, V94, P55, DOI 10.1016/j.cities.2019.05.022
   Ren HY, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121518
   Sannigrahi S, 2020, SUSTAIN CITIES SOC, V62, DOI 10.1016/j.scs.2020.102418
   Song C, 2019, SCI TOTAL ENVIRON, V648, P550, DOI 10.1016/j.scitotenv.2018.08.114
   Sun FN, 2020, ANN EPIDEMIOL, V52, P54, DOI 10.1016/j.annepidem.2020.07.014
   Tao R, 2020, COMPUT ENVIRON URBAN, V83, DOI 10.1016/j.compenvurbsys.2020.101519
   Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105
   Wu C, 2019, INT J GEOGR INF SCI, V33, P489, DOI 10.1080/13658816.2018.1545158
   Yang CW, 2020, INT J DIGIT EARTH, V13, P1186, DOI 10.1080/17538947.2020.1809723
   Yang ZF, 2020, J THORAC DIS, V12, P165, DOI 10.21037/jtd.2020.02.64
   Zhang WL, 2020, CITIES, V99, DOI 10.1016/j.cities.2020.102640
NR 28
TC 5
Z9 5
U1 33
U2 52
PU AMER GEOPHYSICAL UNION
PI WASHINGTON
PA 2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA
SN 2471-1403
J9 GEOHEALTH
JI GeoHealth
PD MAY
PY 2021
VL 5
IS 5
AR e2021GH000402
DI 10.1029/2021GH000402
PG 13
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA SH8AN
UT WOS:000654354800004
PM 34027263
OA Green Published
DA 2022-04-20
ER

PT J
AU Gauer, S
   Germann, B
AF Gauer, Sandra
   Germann, Barbara
TI Managing COVID-19 in workplaces - a theoretical framework for integral
   employees' health
SO JOURNAL OF CORPORATE REAL ESTATE
LA English
DT Article
DE Framework; Covid-19; Employees' health; Organization development; Stress
   reduction; Change management
ID COMMUNICATION; STRESS; WORK
AB Purpose The purpose of this paper is to develop a framework on how to deal with stressors emerging from the COVID-19 outbreak. The theoretical framework aims to explain pandemic-related stressors and potential ways to prevent them, considering a wide range of interacting factors at individual, team and organizational levels to ensure their employees' health. Design/methodology/approach The authors drew on an integrative literature review to identify pandemic-related stressors influenceable by the organization and gathered solution approaches to counteract them. Popular psychological stress theories served as a theoretical base for the framework. Findings The authors based the framework on an integration of the transactional stress theory (Lazarus and Folkman, 1984) and the job demands resources model (Schaufeli and Bakker, 2004), focusing on their respective theoretical strengths. The final framework offers a solid orientation for scholars regarding the introduction of holistic and strategic measures in coping with pandemic-related stressors. A section describing possibilities for practitioners' use of the framework has been integrated. Originality/value To the best of the authors' knowledge, this study is the first to offer a framework on how to handle COVID-19-related stressors in the workplace by implementing teamwide and companywide measures.
C1 [Gauer, Sandra; Germann, Barbara] Gauer Consulting, Bern, Switzerland.
RP Gauer, S (corresponding author), Gauer Consulting, Bern, Switzerland.
EM info@gauer-consulting.com
CR B?Deker, 2003, GESUNDHEITLICHER KON
   Bauerle A, 2020, J PUBLIC HEALTH-UK, V42, P672, DOI 10.1093/pubmed/fdaa106
   Bakker AB, 2021, CAN PSYCHOL, V62, P73, DOI 10.1037/cap0000262
   Bamberg, 1991, PSYCHISCHER STRESS A, P1
   Bartsch S, 2021, J SERV MANAGE, V32, P71, DOI 10.1108/JOSM-05-2020-0160
   Breuer C, 2020, HUM RELAT, V73, P3, DOI 10.1177/0018726718818721
   Bull M, 2012, FACILITIES, V30, P135, DOI 10.1108/02632771211202842
   Burnes B, 2012, HUM RELAT, V65, P1395, DOI 10.1177/0018726712450058
   Cavanaugh MA, 2000, J APPL PSYCHOL, V85, P65, DOI 10.1037/0021-9010.85.1.65
   Chen SQ, 2020, PSYCHOL TRAUMA-US, V12, pS51, DOI 10.1037/tra0000685
   Cloots, 2020, ZUKUNFT ARBEIT PERSP
   Collins C, 2021, GENDER WORK ORGAN, V28, P101, DOI 10.1111/gwao.12506
   Del Boca, 2020, 8403 CESIFO U MUN IF
   Diab-Bahman R, 2020, INT J SOCIOL SOC POL, V40, P909, DOI 10.1108/IJSSP-07-2020-0262
   Einola K, 2019, HUM RELAT, V72, P1891, DOI 10.1177/0018726718812130
   Erzen E, 2018, INT J SOC PSYCHIATR, V64, P427, DOI 10.1177/0020764018776349
   Feng ZY, 2020, GEND MANAG, V35, P719, DOI 10.1108/GM-07-2020-0202
   Franke F., 2015, TRENDS PSYCHOL FUHRU, P253
   Franken, 2016, FUHREN ARBEITSWELT Z
   Giorgi G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17217857
   Hacker, 1998, BELASTUNG BEANSPRUCH
   He J, 2021, INT J CONTEMP HOSP M, V33, P346, DOI 10.1108/IJCHM-04-2020-0300
   J?Ger, 2007, Z MED PSYCHOL, V16, P41
   Kaluza G., 2018, STRESSBEWALTIGUNG TR
   Kauffeld, 2016, NACHHALTIGE PERSONAL
   Killgore WDS, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113117
   Kniffin KM, 2021, AM PSYCHOL, V76, P63, DOI 10.1037/amp0000716
   Lautsch BA, 2009, HUM RELAT, V62, P795, DOI 10.1177/0018726709104543
   Lazarus RS, 1984, STRESS APPRAISAL COP
   Parker LD, 2020, ACCOUNT AUDIT ACCOUN, V33, P1943, DOI 10.1108/AAAJ-06-2020-4609
   Perrewe P.L., 1995, OCCUPATIONAL STRESS, P15
   Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213
   Robinson B., 2020, WHAT STUDIES REVEAL
   Schaufeli W.B., 2014, BRIDGING OCCUPATIONA, P43, DOI DOI 10.1007/978-94-007-5640-3_4
   Schaufeli WB, 2004, J ORGAN BEHAV, V25, P293, DOI 10.1002/job.248
   Schuler, 2004, ENZYKLOPADIE PSYCH 3, P1007
   Schwarzer, 2000, STRESS ANGST HANDLUN
   Shin Y, 2004, J MANAGE, V30, P725, DOI 10.1016/j.jm.2004.03.002
   Shumate M, 2004, HUM RELAT, V57, P55, DOI 10.1177/0018726704042714
   Sunday Agba, 2020, J ED SOCIAL RES, V10, P119, DOI [10.36941/jesr-2020-0093, DOI 10.36941/JESR-2020-0093]
   Torraco R.J., 2005, HUMAN RESOURCE DEV R, V4, P356, DOI [https://doi.org/10.1177/1534484305278283, DOI 10.1177/1534484305278283, 10.1177/1534484305278283]
   Trougakos JP, 2020, J APPL PSYCHOL, V105, P1234, DOI 10.1037/apl0000739
   Vaziri H, 2020, J APPL PSYCHOL, V105, P1073, DOI 10.1037/apl0000819
   Vinkers CH, 2020, EUR NEUROPSYCHOPHARM, V35, P12, DOI 10.1016/j.euroneuro.2020.05.003
   Wang B, 2021, APPL PSYCHOL-INT REV, V70, P16, DOI 10.1111/apps.12290
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072459
   World Health Organization, 2020, ROLL UPD COR DIS COV
   World Health Organization, 2021, WHO COR DIS COVID 19
   Yildirim TM, 2021, GENDER WORK ORGAN, V28, P243, DOI 10.1111/gwao.12529
NR 49
TC 0
Z9 0
U1 1
U2 3
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1463-001X
EI 1479-1048
J9 J CORP REAL ESTATE
JI J. Corp. Real Estate
PD APR 5
PY 2022
VL 24
IS 2
SI SI
BP 93
EP 107
DI 10.1108/JCRE-10-2020-0045
EA AUG 2021
PG 15
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA 0E5TI
UT WOS:000688452900001
OA Bronze
DA 2022-04-20
ER

PT J
AU Saeed, B
AF Saeed, Bassam
TI Impact of COVID-19 Pandemic on Management of Pediatric Kidney Transplant
   Recipients
SO EXPERIMENTAL AND CLINICAL TRANSPLANTATION
LA English
DT Review
DE Coronavirus disease 2019; Pediatric nephrology; Renal transplantation;
   Severe acute respiratory syndrome coronavirus 2
ID CORONAVIRUS
AB Children appear to be less commonly and less severely affected by COVID-19 than adults, accounting for 1% to 5% of all COVID-19 cases. The COVID-19 pande mic has challenged pediatric kidney transplant programs to provide safe and consistent care during this difficult and unprecedented time. So far during this pandemic, best practices being delivered to pediatric kidney transplant patients are based on available information from published literature and expert opinions. The key areas of pediatric kidney transplant care that may be affected by the COVID-19 pandemic include transplant activity, outpatient clinic activity, monitoring, multidisciplinary care, medications (immunosuppression and others), patient/family education/support, school and employment, and care of pediatric kidney transplant patients who are COVID-19 positive. It has been presumed that children with chronic kidney disease and/or those who take immunosuppressants may be at increased risk for complications from COVID-19 infection; however, available evidence has now suggested that immunosuppressed children with kidney transplant are not at increased risk of severe COVID-19 disease. Clinicians should remain aware that transplant recipients may present with atypical symptoms. In addition, because evidence-based reports to support specific adjustments to immunosuppressive medications in relation to COVID-19 are not yet available, decisions on reduction or discontinuation of immunosuppression should be on a case-by-case basis for kidney transplant recipients who are COVID-19 positive. Reports to support evidence-based management of pediatric kidney transplant patients during the COVID-19 pandemic are lacking; therefore, expert opinion and available knowledge and experience remain subject to biases.
C1 [Saeed, Bassam] Farah Assoc Child Kidney Dis Syria, Damascus, Syria.
RP Saeed, B (corresponding author), POB 8292, Damascus, Syria.
EM bmsaeed2000@yahoo.com
CR Arthur, 2021, BIOPHARMA REPORTER, P2021
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4
   Bush R, 2020, AM J TRANSPLANT, V20, P2942, DOI 10.1111/ajt.16003
   CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI 10.15585/mmwr.mm6915e4
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   European Society of Hypertension, 2020, STAT EUR SOC HYP ESH
   Fernandez-Ruiz M, 2020, AM J TRANSPLANT, V20, P1849, DOI 10.1111/ajt.15929
   Government of Canada,, COR DIS 2019 COVID 1
   Guillen E, 2020, AM J TRANSPLANT, V20, P1875, DOI 10.1111/ajt.15874
   Lamontagne F, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3379
   Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073
   Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270
   Maggiore U, 2020, NEPHROL DIAL TRANSPL, V35, P899, DOI 10.1093/ndt/gfaa130
   Marlais M, 2020, LANCET CHILD ADOLESC, V4, pE17, DOI 10.1016/S2352-4642(20)30145-0
   Minotti C, 2020, J INFECTION, V81, pE61, DOI 10.1016/j.jinf.2020.04.026
   Ogimi C, 2017, J INFECT DIS, V216, P203, DOI 10.1093/infdis/jix264
   Piechotta V, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013600.pub2
   Ray S, NEW VARIANTS CORONAV
   Teoh Chia Wei, 2020, Can J Kidney Health Dis, V7, p2054358120967845, DOI 10.1177/2054358120967845
   Viner RM, 2021, JAMA PEDIATR, V175, P143, DOI 10.1001/jamapediatrics.2020.4573
   Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X
   Willicombe M, 2020, J AM SOC NEPHROL, V31, P1145, DOI 10.1681/ASN.2020030348
   Worldometer, COVID 19 COR PAND
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
NR 25
TC 1
Z9 1
U1 0
U2 0
PU BASKENT UNIV
PI ANKARA
PA TASKENT CADDESI NO 77, KAT 4, BAHCELIEVLER, ANKARA, 06490, TURKEY
SN 1304-0855
EI 2146-8427
J9 EXP CLIN TRANSPLANT
JI Exp. Clin. Transplant.
PD SEP
PY 2021
VL 19
IS 9
BP 894
EP 898
DI 10.6002/ect.2021.0275
PG 5
WC Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Transplantation
GA UK5RK
UT WOS:000692026600002
PM 34313581
DA 2022-04-20
ER

PT J
AU Abadi, RSS
   Ghaderi, Z
   Hall, CM
   Soltaninasab, M
   Qezelbash, AH
AF Shahabi Sorman Abadi, Rasoul
   Ghaderi, Zahed
   Hall, C. Michael
   Soltaninasab, Maryam
   Hossein Qezelbash, Amir
TI COVID-19 and the travel behavior of xenophobic tourists
SO JOURNAL OF POLICY RESEARCH IN TOURISM LEISURE AND EVENTS
LA English
DT Article; Early Access
DE Xenophobia; tourist behavior; COVID-19 pandemic; risk perception; untact
   tourism; pull-and-push factor; l
ID RISK PERCEPTION; SARS; HEALTH; STIGMA; FEAR; TERRORISM; KNOWLEDGE;
   VALIDITY; EPIDEMIC; DISEASE
AB The COVID-19 pandemic led to a dramatic loss of human lives worldwide and presented an unprecedented challenge to public health, tourism and community relations. Previous research on the relationship between xenophobia and travel behavior is limited, especially in the context of concerns over potential contagion. Therefore, this study examined the relationship between xenophobia and travel behavior during the COVID-19 pandemic in a sample of 489 Iranian travelers participated in survey conducted online. The results demonstrated that xenophobia positively correlates with the fear of COVID-19, travel risk perception, untact tourism, and travel precautions, although it is negatively correlated with the intention to undertake outbound and domestic travel. The relationships between push and pull factors to xenophobia were found insignificant. Interestingly, a significant difference between genders in the relationship between travel risk perception and xenophobia was identified. The study presents significant theoretical and practical implications and offers new avenues for future research.
C1 [Shahabi Sorman Abadi, Rasoul] Univ Tehran, Tourism Mkt, Fac Management, Tehran, Iran.
   [Ghaderi, Zahed] Kharazmi Univ, Sch Management, Tehran, Iran.
   [Ghaderi, Zahed] SilkRd Int Univ Tourism, Samarkand, Uzbekistan.
   [Hall, C. Michael] Univ Canterbury, Dept Management Mkt & Entrepreneurship, Christchurch, New Zealand.
   [Hall, C. Michael] Lund Univ, Dept Serv Management & Serv Studies, Helsingborg, Sweden.
   [Hall, C. Michael] Univ Oulu, Geog Res Unit, Oulu, Finland.
   [Hall, C. Michael] Linnaeus Univ, Sch Business & Econ, Kalmar, Sweden.
   [Soltaninasab, Maryam] Univ Semnan, Tourism Management, Semnan, Iran.
   [Hossein Qezelbash, Amir] Univ Florence, Dept Econ & Management, Design Sustainable Tourism Syst, Via Delle Pandette, Italy.
RP Abadi, RSS (corresponding author), Univ Tehran, Tourism Mkt, Fac Management, Tehran, Iran.
EM rasoulshahabi@ut.ac.ir
RI ; Hall, Colin Michael/C-1439-2010
OI Qezelbash, Amir Hossein/0000-0003-2349-2610; Hall, Colin
   Michael/0000-0002-7734-4587; Shahabi Sorman Abadi,
   RASOUL/0000-0002-9661-225X
CR Adeleke BO, 2008, IFE PSYCHOLOGIA, V16
   [Anonymous], 2020, WASH POST
   Antara M., 2018, J TOURISM HOSPITALIT, V6, P112
   Aschauer W., 2018, REV TURISMO DESENVOL, V2, P863
   Bae SY, 2021, CURR ISSUES TOUR, V24, P1017, DOI 10.1080/13683500.2020.1798895
   Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI DOI 10.1007/BF02723327
   Barclay D., 1995, TECHNOLOGY STUDIES, V2, P285, DOI DOI 10.1017/CBO9781107415324.004
   Beirman D, 2016, J POLICY RES TOUR LE, V8, P98, DOI 10.1080/19407963.2015.1083339
   Bieber F, 2018, ETHNOPOLITICS, V17, P519, DOI 10.1080/17449057.2018.1532633
   Biran A, 2014, ANN TOURISM RES, V47, P1, DOI 10.1016/j.annals.2014.03.004
   Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283
   Burger CJSC, 2001, TOURISM MANAGE, V22, P403, DOI 10.1016/S0261-5177(00)00068-6
   Cavlek N, 2002, ANN TOURISM RES, V29, P478, DOI 10.1016/S0160-7383(01)00067-6
   Centers for Disease Control and Prevention, 2020, REDUCING STIGMA CDC
   Chien PM, 2018, ANN TOURISM RES, V72, P177, DOI 10.1016/j.annals.2018.03.004
   Chien PM, 2017, J TRAVEL RES, V56, P744, DOI 10.1177/0047287516665479
   Chien PM, 2012, J TRAVEL RES, V51, P451, DOI 10.1177/0047287511426336
   Chin W.W., 2010, HDB PARTIAL LEAST SQ, P655, DOI DOI 10.1007/978-3-540-32827-8_29
   Chin WW, 1998, QUANT METH SER, P295
   Chua BL, 2021, J SUSTAIN TOUR, V29, P879, DOI 10.1080/09669582.2020.1849236
   Crompton J. L., 1979, Annals of Tourism Research, V6, P408, DOI 10.1016/0160-7383(79)90004-5
   Devakumar D, 2020, J ROY SOC MED, V113, P234, DOI 10.1177/0141076820925434
   Dias A, 2021, J POLICY RES TOUR LE, DOI 10.1080/19407963.2021.1892124
   Su DN, 2020, CURR ISSUES TOUR, V23, P572, DOI 10.1080/13683500.2018.1553152
   Dolnicar S., 2005, J VACAT MARK, V11, P197, DOI [10.1177/1356766705055706, DOI 10.1177/1356766705055706]
   Dowling G.R, 1986, PSYCHOL MARKET, V3, P193, DOI DOI 10.1002/mar.4220030307
   Dzhambov AM, 2021, ENVIRON RES, V196, DOI 10.1016/j.envres.2020.110420
   Farmaki A, 2017, TOURISM MANAGE, V59, P528, DOI 10.1016/j.tourman.2016.09.012
   Faulkner J, 2004, GROUP PROCESS INTERG, V7, P333, DOI 10.1177/1368430204046142
   Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878
   Floyd MF, 2004, ANN TOURISM RES, V31, P1051, DOI 10.1016/j.annals.2004.03.011
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Fuchs G., 2006, Journal of Hospitality & Leisure Marketing, V14, P83, DOI 10.1300/J150v14n02_06
   Garau-Vadell JB, 2018, J DESTIN MARK MANAGE, V7, P68, DOI 10.1016/j.jdmm.2016.08.008
   Gefen D., 2000, COMMUN ASSOC INF SYS, V4, P7, DOI [DOI 10.17705/1CAIS.00407, 10.17705/1CAIS.00407]
   Gefen D, 2005, COMMUN ASSOC INF SYS, V16, P91, DOI 10.17705/1CAIS.01605
   GEISSER S, 1974, BIOMETRIKA, V61, P101, DOI 10.2307/2334290
   Ghaderi Z, 2021, J HOSP TOUR INSIGHTS, DOI 10.1108/JHTI-10-2020-0199
   Ghaderi Z, 2015, ASPEC TOUR, V69, P109
   Glover TD, 2015, ANN TOURISM RES, V50, P159, DOI 10.1016/j.annals.2014.10.001
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Gustafson PE, 1998, RISK ANAL, V18, P805, DOI 10.1023/B:RIAN.0000005926.03250.c0
   Hair JF, 2012, J ACAD MARKET SCI, V40, P414, DOI 10.1007/s11747-011-0261-6
   Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202
   Hall CM, 2021, ECONOMIES, V9, DOI 10.3390/economies9020046
   Hall CM, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13031585
   Hall CM, 2020, TOURISM GEOGR, V22, P577, DOI 10.1080/14616688.2020.1759131
   Hall CM, 2011, TOUR REV, V66, P118, DOI 10.1108/16605371111127288
   Han H, 2020, INT J ENV RES PUB HE, V17, DOI [10.3390/ijerph17186485, 10.3390/ijerph17186485/]
   Hem L. E., 2002, Journal of Travel & Tourism Marketing, V13, P1, DOI 10.1300/J073v13n04_01
   Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8
   Henseler J, 2014, ORGAN RES METHODS, V17, P182, DOI 10.1177/1094428114526928
   Henseler J, 2009, ADV INT MARKETING, V20, P277, DOI 10.1108/S1474-7979(2009)0000020014
   Hjerm M, 1998, ACTA SOCIOL, V41, P335, DOI 10.1177/000169939804100403
   Horng JS, 2012, TOURISM MANAGE, V33, P815, DOI 10.1016/j.tourman.2011.09.004
   JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101
   Jonas A, 2011, J TRAVEL RES, V50, P87, DOI 10.1177/0047287509355323
   Josiam B. M., 1999, Journal of Vacation Marketing, V5, P167, DOI 10.1177/135676679900500205
   Khan MJ, 2017, INT J HEALTHCARE MAN, V10, P115, DOI 10.1080/20479700.2017.1304345
   Khuong M.N., 2014, INT J TRADE EC FINAN, V5, P490, DOI 10.7763/IJTEF.2014.V5.421
   Kim HS, 2016, PSYCHOL SCI, V27, P935, DOI 10.1177/0956797616642596
   Kim MJ, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18084111
   Kim MJ, 2022, CURR ISSUES TOUR, V25, P21, DOI 10.1080/13683500.2021.1883558
   Klenosky D. B., 2002, Journal of Travel Research, V40, P385, DOI 10.1177/0047287502040004005
   Kock F, 2020, ANN TOURISM RES, V85, DOI 10.1016/j.annals.2020.103053
   Kock F, 2019, J TRAVEL RES, V58, P427, DOI 10.1177/0047287518755504
   Kock F, 2019, ANN TOURISM RES, V74, P155, DOI 10.1016/j.annals.2018.11.005
   Kwok AOJ, 2021, CURR ISSUES TOUR, V24, P1935, DOI 10.1080/13683500.2020.1798896
   Laver SM, 2001, J TRAVEL MED, V8, P298, DOI 10.2310/7060.2001.23975
   Lee KJ, 2017, J TRAVEL RES, V56, P381, DOI 10.1177/0047287516643184
   Lee S, 2005, SOC SCI MED, V61, P2038, DOI 10.1016/j.socscimed.2005.04.010
   Lee SM, 2020, SERV BUS, V14, P1, DOI 10.1007/s11628-019-00408-2
   Lindberg K, 1997, ANN TOURISM RES, V24, P90, DOI 10.1016/S0160-7383(96)00033-3
   Litvin S. W., 2004, International Journal of Tourism Research, V6, P29, DOI 10.1002/jtr.468
   Livengood JS, 2004, J LEISURE RES, V36, P183, DOI 10.1080/00222216.2004.11950019
   McKercher B, 2004, ANN TOURISM RES, V31, P716, DOI 10.1016/j.annals.2003.11.002
   Moosa IA, 2021, J POLICY RES TOUR LE, V13, P419, DOI 10.1080/19407963.2020.1859519
   Muragu MM, 2021, J POLICY RES TOUR LE, DOI [10.1017/S0022215121003558, 10.1080/19407963.2021.1903020]
   Nakayachi K, 2015, J RISK RES, V18, P156, DOI 10.1080/13669877.2013.875936
   Napper LE, 2012, AIDS BEHAV, V16, P1075, DOI 10.1007/s10461-011-0003-2
   Neuburger L, 2021, CURR ISSUES TOUR, V24, P1003, DOI 10.1080/13683500.2020.1803807
   Novelli M, 2018, ANN TOURISM RES, V70, P76, DOI 10.1016/j.annals.2018.03.006
   Pearce P. L., 2005, Journal of Travel Research, V43, P226, DOI 10.1177/0047287504272020
   Pennycook G, 2020, PSYCHOL SCI, V31, P770, DOI 10.1177/0956797620939054
   Person B, 2004, EMERG INFECT DIS, V10, P358, DOI 10.3201/eid1002.030750
   PHILIPP SF, 1994, ANN TOURISM RES, V21, P479, DOI 10.1016/0160-7383(94)90115-5
   Prati G, 2016, RISK ANAL, V36, P2000, DOI 10.1111/risa.12537
   Rauhaus B.M., 2020, ADM THEORY PRAXIS, V42, P364, DOI [DOI 10.1080/10841806.2020.1782128, 10.1080/10841806.2020.1782128]
   Reisinger Y., 2005, Journal of Travel Research, V43, P212, DOI 10.1177/0047287504272017
   Ritchie BW, 2017, J TRAVEL TOUR MARK, V34, P274, DOI 10.1080/10548408.2016.1156616
   Rittichainuwat BN, 2009, TOURISM MANAGE, V30, P410, DOI 10.1016/j.tourman.2008.08.001
   Rohrmann B., 2000, CROSS CULTURAL RISK, P11, DOI DOI 10.1007/978-1-4757-4891-8_1
   Ronkko M, 2013, ORGAN RES METHODS, V16, P425, DOI 10.1177/1094428112474693
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403
   Roy G., 2020, TOUR RECREAT RES, P288
   Salazar NB, 2022, TOURISM GEOGR, V24, P141, DOI 10.1080/14616688.2020.1801827
   Schaller M, 2011, CURR DIR PSYCHOL SCI, V20, P99, DOI 10.1177/0963721411402596
   Seabra C, 2013, TOURISM MANAGE, V36, P502, DOI 10.1016/j.tourman.2012.09.008
   Seyfi S, 2020, TOURISM GEOGR, DOI 10.1080/14616688.2020.1833972
   Shen SY, 2009, J TRAVEL TOUR MARK, V26, P722, DOI 10.1080/10548400903284610
   Siu JYM, 2008, QUAL HEALTH RES, V18, P729, DOI 10.1177/1049732308318372
   Sjoberg L, 1998, RISK ANAL, V18, P85, DOI 10.1111/j.1539-6924.1998.tb00918.x
   Sonmez SF, 1998, ANN TOURISM RES, V25, P112, DOI 10.1016/S0160-7383(97)00072-8
   STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x
   Tung VWS, 2019, J TRAVEL RES, V58, P837, DOI 10.1177/0047287518778150
   Umukoro G.M., 2020, INT J HUMANITIES INN, V3, P115
   UNWTO, 2020, TOURISM BACK 1990 LE
   UNWTO, 2021, GLOBAL TOURISM CRISI
   Valls A, 2018, INFORM MANAGE-AMSTER, V55, P145, DOI 10.1016/j.im.2017.05.002
   van der Veer K, 2013, QUAL QUANT, V47, P1429, DOI 10.1007/s11135-011-9599-6
   Weaver DB, 2013, TOURISM MANAGE, V37, P165, DOI 10.1016/j.tourman.2013.01.017
   Wen J, 2020, ANATOLIA, V31, P331, DOI 10.1080/13032917.2020.1730621
   WHO, 2021, CURRENT COVID 19 SIT
   WHO, 2020, WHO SARS COV 2 VARIA
   Yakushko K, 2009, COUNS PSYCHOL, V37, P36, DOI 10.1177/0011000008316034
   Yang ECL, 2017, TOURISM MANAGE, V58, P89, DOI 10.1016/j.tourman.2016.10.011
   Yang HY, 2009, J POLICY RES TOUR LE, V1, P37, DOI 10.1080/19407960902738313
   Yang I., 2020, TOUR ANAL, V25, P2
   You XinRan, 2000, International Journal of Hospitality & Tourism Administration, V1, P1, DOI 10.1300/J149v01n02_01
   Zenker S, 2020, TOURISM MANAGE, V81, DOI 10.1016/j.tourman.2020.104164
   Zhang RY, 2020, P NATL ACAD SCI USA, V117, P14857, DOI 10.1073/pnas.2009637117
NR 121
TC 3
Z9 3
U1 2
U2 13
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1940-7963
EI 1940-7971
J9 J POLICY RES TOUR LE
JI J. Policy Res. Tour. Leis. Events
DI 10.1080/19407963.2021.1943415
EA JUN 2021
PG 23
WC Hospitality, Leisure, Sport & Tourism
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA SX0KY
UT WOS:000664902200001
DA 2022-04-20
ER

PT J
AU Sharma, N
   Sharma, G
   Joshi, M
   Sharma, S
AF Sharma, Neeraj
   Sharma, Garima
   Joshi, Mahesh
   Sharma, Sharad
TI Lessons from leveraging technology in auditing during COVID-19: an
   emerging economy perspective
SO MANAGERIAL AUDITING JOURNAL
LA English
DT Article; Early Access
DE COVID 19; Audit quality; Technology; Emerging economy; Semi-structured
   Interviews
ID INFORMATION-TECHNOLOGY; EARNINGS MANAGEMENT
AB Purpose - This study aims to examine the challenges posed by COVID-19 restrictions for audit processes in India and explore the perceptions of the profession on how technology was leveraged to conduct audits during this period. The opinions of auditors on future changes in post-COVID-19 audit practices and processes are also explored.
   Design/methodology/approach - Semi-structured interviews were conducted with senior auditors working in various audit firms in major business centers in India and subjected to content and thematic analysis using the institutional theory perspective.
   Findings - The auditing profession used technology to respond to COVID-19-imposed disruptions of established audit process and practices while maintaining the legitimacy of audit reports. The findings indicate that auditors now seem to strongly support the integration of emerging technologies into their auditing practices post-COVID to ensure data accuracy and transparency. The interviewees displayed keen interest in continuing remote and in-person audits to maintain audit quality in the future. The experience of COVID-19 appears to have forced the auditing profession to overcome their reluctance to adopt technologies that were previously used by only Big 4 and large audit companies.
   Practical implications - The results will be of particular interest to various stakeholders concerned with aspects of the acceptance of technology-assisted audit reports such as legitimacy, required infrastructure, cost involvement and resistance to change. The findings will also assist professional bodies and policymakers in both developed and developing economies in devising useful strategies to promote technology-aided auditing during and after COVID-19. Limitations posed by inadequate infrastructure and resistance to changes must be overcomed before implementation of technology-aided audits.
   Originality/value - As COVID-19 pandemic is a recent phenomenon, to the best of the authors' knowledge, this study is one of the first few studies that have examined the use of technology to facilitate audits during the COVID-19 period, more specifically from a developing economy perspective.
C1 [Sharma, Neeraj] Mukraj Insights & Consultancy, Dept Market Res, Jabalpur, India.
   [Sharma, Garima] Victoria Univ, Dept Business, Melbourne, Vic, Australia.
   [Joshi, Mahesh; Sharma, Sharad] RMIT Univ, Sch Accounting Informat Syst & Supply Chain, Melbourne, Vic, Australia.
RP Joshi, M (corresponding author), RMIT Univ, Sch Accounting Informat Syst & Supply Chain, Melbourne, Vic, Australia.
EM mahesh.joshi@rmit.edu.au
CR ACCA, 2020, IMP COV 19 AUD ASS C
   ACCOUNTANCY AGE, 2020, INV TECHN WILL HELP
   Ahn PD, 2021, ACCOUNT AUDIT ACCOUN, V34, P1320, DOI 10.1108/AAAJ-08-2020-4829
   AICPA, 2021, AUD PAND YOU ASK WE
   AICPA Staff, 2014, REIM AUD WIR WORLD
   Albitar K, 2021, INT J ACCOUNT INF MA, V29, P169, DOI 10.1108/IJAIM-08-2020-0128
   Alles MG, 2015, ACCOUNT HORIZ, V29, P439, DOI 10.2308/acch-51067
   Appelbaum D., 2020, CPA J, V90, P14
   AUASB, 2020, COR COV 19 GUID
   Beechem O, 2021, IT USAGE AUDITING IM
   Braun V, 2021, QUAL RES PSYCHOL, V18, P328, DOI 10.1080/14780887.2020.1769238
   CAANZ, 2020, FINANCIAL REPORTING
   Castka P, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12114740
   Council F.R, 2020, GUIDANCE AUDIT ISSUE
   Creswell J.W, 2014, RES DESIGN QUALITATI, V4th
   Cruz J.E, 2020, USE TECHNOLOGY RISK, P67
   De Santis F, 2021, MEDITARI ACCOUNT RES, V29, P1088, DOI 10.1108/MEDAR-03-2020-0838
   Decorte M., 2021, ARMED FORCES COMP, V66, P48
   DIMAGGIO PJ, 1983, AM SOCIOL REV, V48, P147, DOI 10.2307/2095101
   Dowling C, 2014, CONTEMP ACCOUNT RES, V31, P230, DOI 10.1111/1911-3846.12010
   Durst S, 2021, J RISK FINANC MANAG, V14, DOI 10.3390/jrfm14010010
   Earley CE, 2015, BUS HORIZONS, V58, P493, DOI 10.1016/j.bushor.2015.05.002
   Eichengreen B, 2010, SERVICE SECTOR INDIA
   FRC, 2020, ID ASS RISKS MAT MIS
   Ghosh S, 2011, MANAG AUDIT J, V26, P350, DOI 10.1108/02686901111124666
   Goodell JW, 2020, FINANC RES LETT, V35, DOI 10.1016/j.frl.2020.101512
   Houqe MN, 2017, INT J AUDIT, V21, P177, DOI 10.1111/ijau.12087
   ICAEW, 2020, REG AR QUAL ASS MON
   ICAEW, 2017, UNDERSTANDING IMPACT
   ICAI, 2020, IMP COR FIN REP AUD
   IFAC, 2020, SUMM COVID 19 AUD CO
   INDIA TODAY, 2019, INDIA TODAY
   Jacob J, 2019, ACCOUNT HORIZ, V33, P43, DOI 10.2308/acch-52347
   Janvrin D, 2008, ACCOUNT HORIZ, V22, P1, DOI 10.2308/acch.2008.22.1.1
   Kotb A, 2011, INT J AUDIT, V15, P150, DOI 10.1111/j.1099-1123.2011.00427.x
   KPMG, 2014, LEV DAT AN CONT AUD
   KPMG, 2020, FINANCIAL REPORTING
   Krieger F, 2021, INT J ACCOUNT INF SY, V41, DOI 10.1016/j.accinf.2021.100511
   Layak S., 2009, BUSINESS TODAY, V22, P54
   Levy H.B., 2020, CPA J, V90, P26
   Liao T.F., 2004, SAGE ENCY SOCIAL SCI
   Lillis, 1999, ACCOUNT FINANC, V39, P79, DOI [10.1111/1467-629X.00018, DOI 10.1111/1467-629X.00018]
   Lowe DJ, 2018, J INF SYST, V32, P87, DOI 10.2308/isys-51794
   Nagar N, 2021, J INT ACCOUNT AUDIT, V42, DOI 10.1016/j.intaccaudtax.2021.100376
   Nezhyva M, 2020, VISNIK KIEV NATL U T, V3, P123
   PCAOB, 2020, SPOTL STAFF OBS REM
   Perumpral SE, 2009, ADV ACCOUNT, V25, P106, DOI 10.1016/j.adiac.2009.02.003
   Rakipi R, 2021, J INT ACCOUNT AUDIT, V42, DOI 10.1016/j.intaccaudtax.2020.100357
   Sastararuji D, 2021, CLOUD ACCOUNTING ADO
   Schmitz J., 2020, BLACK
   Scott WR, 2008, THEOR SOC, V37, P427, DOI 10.1007/s11186-008-9067-z
   Scott WR, 2014, MANAGEMENT, V17, P136, DOI 10.3917/mana.172.0136
   Seol I, 2017, J APPL ACCOUNT RES, V18, P341, DOI 10.1108/JAAR-09-2014-0100
   Sinha S., 2020, PARADIGM, V24, P208
   Slater J., 2021, INDIAS DEVASTATING O
   Soares ALV, 2021, TOUR REV, V76, P669, DOI 10.1108/TR-05-2019-0153
   Tarek M, 2017, INT J ACCOUNT INF MA, V25, P237, DOI 10.1108/IJAIM-03-2016-0022
   Teeter RA, 2010, J EMERG TECHNOL ACCO, V7, P73, DOI 10.2308/jeta.2010.7.1.73
   Tysiac K., 2020, J ACCOUNTANCY
   Vasarhelyi MA, 2015, ACCOUNT HORIZ, V29, P381, DOI 10.2308/acch-51071
   Vasarhelyi MA, 2014, MANAG AUDIT J, V29, P350, DOI 10.1108/MAJ-06-2013-0881
   Witte A., 2020, TECHNOLOGY BASED AUD
NR 62
TC 0
Z9 0
U1 2
U2 2
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0268-6902
EI 1758-7735
J9 MANAG AUDIT J
JI Manag. Audit. J.
DI 10.1108/MAJ-07-2021-3267
EA MAR 2022
PG 17
WC Business, Finance; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA ZZ9VX
UT WOS:000773612200001
OA Bronze
DA 2022-04-20
ER

PT C
AU Dostal, P
   Jankova, Z
AF Dostal, Petr
   Jankova, Zuzana
BE Soliman, KS
TI COVID-19 Threats Evaluation of Countries via Fuzzy Interface Systems
SO EDUCATION EXCELLENCE AND INNOVATION MANAGEMENT: A 2025 VISION TO SUSTAIN
   ECONOMIC DEVELOPMENT DURING GLOBAL CHALLENGES
LA English
DT Proceedings Paper
CT 35th International-Business-Information-Management-Association
   Conference (IBIMA)
CY APR 01-02, 2020
CL Seville, SPAIN
SP Int Business Informat Management Assoc
DE 2019-Ncov; ANFIS; Coronavirus; COVID-19; Coronavirus Disease 2019;
   Evaluation; Fuzzy Logic; Soft Computing
ID ACUTE RESPIRATORY SYNDROME; CORONAVIRUS; OUTBREAK; BATS; SARS
AB The paper deals with the evaluation of a new type of coronavirus, called WHO as COVID-19, by means of soft computing. Specifically, the fuzzy logic supported by neural networks is chosen, which serves to create a knowledge base of rules on the basis of which the model is evaluated. For analysis, European countries have been selected, to which the coronavirus has spread from the Wuhan epicenter in China, where a further outbreak of infection has subsequently emerged. Input variables such as area, population, density and tourism are chosen for the model. The output of the model is a normalized number of infected persons. Based on the output of the fuzzy model, we can say whether the country is high, medium and low threats country.
C1 [Dostal, Petr; Jankova, Zuzana] Brno Univ Technol, Fac Business & Management, Inst Informat, Kolejni 2906-4, Brno 61200, Czech Republic.
RP Dostal, P (corresponding author), Brno Univ Technol, Fac Business & Management, Inst Informat, Kolejni 2906-4, Brno 61200, Czech Republic.
EM dostal@fbm.vutbr.cz; Zuzana.Jankova@vutbr.cz
FU Internal Grant Agency at Brno University of Technology [FP-J-20-6246]
FX This paper was supported by project No. FP-J-20-6246 'The Use of
   Artificial Intelligence in Business IV' from the Internal Grant Agency
   at Brno University of Technology.
CR Ahmad A, 2009, TROP MED INT HEALTH, V14, P36, DOI 10.1111/j.1365-3156.2008.02146.x
   [Anonymous], 2020, LANCET
   Arkhipov M., 2008, P INT C COMP SCI ITS
   GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257
   Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Jankova Z, 2019, EDUCATION EXCELLENCE AND INNOVATION MANAGEMENT THROUGH VISION 2020, P2610
   Mathur N, 2016, MED ENG PHYS, V38, P1083, DOI 10.1016/j.medengphy.2016.07.003
   Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172
   Pan XC, 2020, MICROBES INFECT, V22, P86, DOI 10.1016/j.micinf.2020.02.004
   Pang XH, 2003, JAMA-J AM MED ASSOC, V290, P3215, DOI 10.1001/jama.290.24.3215
   Parashar UD, 2004, INT J EPIDEMIOL, V33, P628, DOI 10.1093/ije/dyh198
   Sahin M, 2017, MATH COMPUT APPL, V22, DOI 10.3390/mca22040043
   Salleh MNM, 2017, LECT NOTES COMPUT SC, V10387, P527, DOI 10.1007/978-3-319-61845-6_52
   Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979
   Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666
   Wang LF, 2006, EMERG INFECT DIS, V12, P1834
   WHO, 2020, NOVEL CORONAVIRUS CH
   World Health Organisation, 2020, NOV COR 2019 NCOV SI
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Yilmaz N. A. S., 2003, THESIS MIDDLE E TU, P34
NR 21
TC 0
Z9 0
U1 0
U2 0
PU INT BUSINESS INFORMATION MANAGEMENT ASSOC-IBIMA
PI NORRISTOWN
PA 34 E GERMANTOWN PIKE, NO. 327, NORRISTOWN, PA 19401 USA
BN 978-0-9998551-4-0
PY 2020
BP 10652
EP 10662
PG 11
WC Business; Green & Sustainable Science & Technology; Economics;
   Management
WE Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Business & Economics; Science & Technology - Other Topics
GA BR6JR
UT WOS:000661489801047
DA 2022-04-20
ER

PT J
AU Amicarelli, V
   Bux, C
AF Amicarelli, Vera
   Bux, Christian
TI Food waste in Italian households during the Covid-19 pandemic: a
   self-reporting approach
SO FOOD SECURITY
LA English
DT Article
DE Food waste; Food diaries; Food waste behavior; Sustainability; COVID-19
   pandemic
ID QUANTIFICATION; CHALLENGES; BEHAVIOR; METHODOLOGY; GENERATION;
   PREVENTION; LOSSES
AB Food waste prevention and reduction are an economic, social and environmental concern included among the 17 Sustainable Development Goals (SDGs) within Agenda 2030 for Sustainable Development. The third target under SDG 12 (Target 12.3) on Responsible Production and Consumption aims to halve food waste by 2030 at retail and consumer levels, considering that more than half of its quantity is generated by final consumers, both indoor and outdoor. However, the Covid-19 pandemic outbreak at the beginning of 2020 imposed several food consumption behaviors and lifestyle changes: food service facilities (e.g., restaurants, pubs, cafes, hotels, resorts) have been closed roughly all over the world, generating a sharp domestic consumption and an expected increase in household waste. The authors conducted an explorative research through the food diary approach. The purpose of this paper is to have a better understanding of household food consumption and wastage trends during Covid-19 pandemic testing, as well as food diary methodology strengths and weaknesses. Food diaries, even with their intrinsic limitations and biases, represent a valuable technique to obtain detailed qualitative and quantitative knowledge on daily food consumption and consumers' behavior. Through the limited but significant results achieved, the authors highlight the logistics of the methodology and the food waste generation trends among a small sample of Italian families during the Covid-19 pandemic. Further, healthier work-life balances, adequate time management and smart food delivery seem to be good opportunities for food waste reduction in households.
C1 [Amicarelli, Vera; Bux, Christian] Univ Bari Aldo Moro, Dept Econ Management & Business Law, Bari, Italy.
RP Bux, C (corresponding author), Univ Bari Aldo Moro, Dept Econ Management & Business Law, Bari, Italy.
EM vera.amicarelli@uniba.it; christian.bux@uniba.it
RI Bux, Christian/ABA-8983-2020; Amicarelli, Vera/AAZ-3147-2020
OI Bux, Christian/0000-0001-7360-4989; Amicarelli, Vera/0000-0003-0115-1356
CR Amicarelli V., 2019, P 5 SCI INT C ENV CR
   Amicarelli V, 2021, BRIT FOOD J, V123, P67, DOI 10.1108/BFJ-03-2020-0241
   [Anonymous], 2017, GLOB IN FOOD LOSS WA
   Aschemann-Witzel J, 2015, SUSTAINABILITY-BASEL, V7, P6457, DOI 10.3390/su7066457
   Barrett CB, 2010, SCIENCE, V327, P825, DOI 10.1126/science.1182768
   Beretta C, 2013, WASTE MANAGE, V33, P764, DOI 10.1016/j.wasman.2012.11.007
   Boschini M, 2020, J CLEAN PROD, V246, DOI 10.1016/j.jclepro.2019.118994
   Boschini M, 2018, J CLEAN PROD, V182, P1024, DOI 10.1016/j.jclepro.2018.02.040
   Brunner P.H., 2017, HDB MAT FLOW ANAL EN
   Caldeira C, 2019, RESOUR CONSERV RECY, V149, P479, DOI 10.1016/j.resconrec.2019.06.011
   Coldiretti, 2020, COR BALZ NELL PROD A
   Corrado S, 2019, GLOB FOOD SECUR-AGR, V20, P93, DOI 10.1016/j.gfs.2019.01.002
   Delley M, 2018, BRIT FOOD J, V120, P1504, DOI 10.1108/BFJ-09-2017-0486
   Downe-Wamboldt B, 1992, Health Care Women Int, V13, P313
   Elimelech E, 2019, WASTE MANAGE, V95, P259, DOI 10.1016/j.wasman.2019.06.015
   Elliott H, 1997, SOCIOLOGICAL RES ONL, V2, P2, DOI DOI 10.5153/SR0.38
   European Commission, 2010, PREP STUD FOOD WAST
   European Commission, 2020, **DROPPED REF**
   European Commission, 2018, EN DIG TRANSF HLTH C
   European Commission, 2015, CLOS LOOP EU ACT PLA
   Eurostat, 2020, MON FRAM CIRC EC IND
   Fanelli R.M., 2016, 52 SIDEA ANN C ROM V
   FAO, 2011, GLOBAL FOOD LOSSES F
   FAO, 2020, COVID 19 TIM 9 TIPS
   FAO, 2018, STATE FOOD SECURITY
   FAO, 2020, NOV COR COVID 19 Q A
   FAO, 2018, WORLD FOOD AGR STAT
   FAO, 2020, NUTR FACT
   Farina, 2015, FOOD RECOVERY WASTE
   Fiore Mariantonietta, 2017, International Journal of Globalisation and Small Business, V9, P185
   FLW Protocol, 2016, GUID FLW QUANT METH
   Food and Agriculture Organization of the United Nations (FAO), 2019, STAT FOOD AGR MOV FO
   FUSIONS, 2016, ESTIMATES EUROPEAN F
   FUSIONS, 2016, MARK BAS INSTR OTH S
   FUSIONS, 2014, REP REV FOOD WAST RE
   Galanakis CM, 2020, FOODS, V9, DOI 10.3390/foods9040523
   Giordano C, 2018, BRIT FOOD J, V120, P2885, DOI 10.1108/BFJ-02-2018-0081
   Governo Italiano, 2020, IORESTOACASA MIS CON
   Gustavsson J., 2011, GLOBAL FOOD LOSSES F
   Hoj S.B., 2011, THESIS
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Ilakovac B, 2020, WASTE MANAGE, V102, P231, DOI 10.1016/j.wasman.2019.10.042
   International Food Policy Research Institute, 2019, 2019 GLOB FOOD POL R
   Ismea, 2020, LATT DER BOV
   Istat, 2020, IND PREZZ CONS ANN 2
   Istat, 2011, IT 150 ANN SOMM STAT, P867
   Istat, 2020, PREZZ CONS
   Jacelon CS, 2005, QUAL HEALTH RES, V15, P991, DOI 10.1177/1049732305278603
   Jorissen J, 2015, SUSTAINABILITY-BASEL, V7, P2695, DOI 10.3390/su7032695
   Jribi S, 2020, ENVIRON DEV SUSTAIN, V22, P3939, DOI 10.1007/s10668-020-00740-y
   Kasavan S, 2019, WASTE MANAGE, V91, P72, DOI 10.1016/j.wasman.2019.04.055
   Katajajuuri JM, 2014, J CLEAN PROD, V73, P322, DOI 10.1016/j.jclepro.2013.12.057
   Kedah Z., 2015, MALAYSIAN MANAGEMENT, P50
   Kremer S, 2016, CONSUMPTION LIFE CYC
   Laguna L, 2020, FOOD QUAL PREFER, V86, DOI 10.1016/j.foodqual.2020.104028
   Lanfranchi M, 2016, BRIT FOOD J, V118, P3059, DOI 10.1108/BFJ-01-2016-0001
   Langley J, 2010, WASTE MANAGE RES, V28, P220, DOI 10.1177/0734242X08095348
   Leverenz D, 2019, RESOUR CONSERV RECY, V150, DOI 10.1016/j.resconrec.2019.104417
   Lindstrom LS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005588
   Mc Carthy U, 2018, TRENDS FOOD SCI TECH, V77, P11, DOI 10.1016/j.tifs.2018.05.002
   Mikami A, 2012, J COOKERY SCI JAPAN, V45, P3
   Ministero dello Sviluppo Economico, 2020, OSS PREZZ TAR PAN FL
   Ministero dello Sviluppo Economico, 2020, BEN SERV LARG CONS
   MOller H, 2014, REPORT REV FOOD WAST
   Monier V, 2010, PREPARATORY STUDY FO
   National Geographic, 2020, NATL GEOGRAPHIC
   National Sustainable Agriculture Coalition, 2020, MIT IMM HARMF IMP CO
   Nations United, 2015, TRANSF OUR WORLD 203
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Nielsen, 2020, INS LARG CONS DISTR
   Nielsen, 2020, COR SPES QUAR
   Park C. H., 2003, INT J RETAIL DISTRIB, V31, P16, DOI DOI 10.1108/09590550310457818
   Patrinley JR, 2020, J MED SYST, V44, DOI 10.1007/s10916-020-01595-6
   Perez-Fuentes MD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235305
   Philippidis G, 2019, RESOUR CONSERV RECY, V146, P514, DOI 10.1016/j.resconrec.2019.04.016
   Quested T, 2009, HOUSEHOLD FOOD DRINK
   Quested TE, 2020, J CLEAN PROD, V262, DOI 10.1016/j.jclepro.2020.121263
   Reid L, 2011, GEOFORUM, V42, P720, DOI 10.1016/j.geoforum.2011.04.011
   Richter B, 2017, RESOUR CONSERV RECY, V125, P181, DOI 10.1016/j.resconrec.2017.06.006
   Roversi S., 2020, FOOD EARTH TOOLBOX U
   Russell SV, 2017, RESOUR CONSERV RECY, V125, P107, DOI 10.1016/j.resconrec.2017.06.007
   Salhofer S, 2008, WASTE MANAGE, V28, P245, DOI 10.1016/j.wasman.2007.02.026
   Savarelli E, 2019, J CONSUMER MARKETING, V37, P148, DOI [10.1108/JCM-10-2018-2890, DOI 10.1108/JCM-10-2018-2890]
   Schanes K, 2018, J CLEAN PROD, V182, P978, DOI 10.1016/j.jclepro.2018.02.030
   Schneider F, 2019, WASTE MANAGE, V86, P106, DOI 10.1016/j.wasman.2019.01.020
   Schott ABS, 2015, RESOUR CONSERV RECY, V101, P132, DOI 10.1016/j.resconrec.2015.05.004
   Secondi L, 2015, FOOD POLICY, V56, P25, DOI 10.1016/j.foodpol.2015.07.007
   Sharp V, 2010, WASTE MANAGE RES, V28, P269, DOI 10.1177/0734242X10361508
   Sheble L, 2009, APPL SOCIAL RES METH, P211
   Silvennoinen K, 2014, BRIT FOOD J, V116, P1058, DOI 10.1108/BFJ-12-2012-0311
   Thamagasorn M, 2019, J CLEAN PROD, V228, P845, DOI 10.1016/j.jclepro.2019.04.312
   United Nations, 2020, OB
   van Dooren C, 2019, WASTE MANAGE, V94, P153, DOI 10.1016/j.wasman.2019.05.025
   van Herpen E, 2019, WASTE MANAGE, V88, P71, DOI 10.1016/j.wasman.2019.03.013
   WHO, 2020, 139 WHO
   World Economic Forum, 2020, HER COVID 19 CREAT F
   WRAP, 2014, HOUS FOOD DRINK WAST
   Yetkin Ozbuk RM, 2020, J CLEAN PROD, V244, DOI 10.1016/j.jclepro.2019.118628
   Zaghdaoui H., 2017, 20 WORLD C INT FED A
NR 99
TC 26
Z9 27
U1 23
U2 38
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1876-4517
EI 1876-4525
J9 FOOD SECUR
JI Food Secur.
PD FEB
PY 2021
VL 13
IS 1
BP 25
EP 37
DI 10.1007/s12571-020-01121-z
EA NOV 2020
PG 13
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Food Science & Technology
GA QD1AE
UT WOS:000586363000001
PM 33173548
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Kumari, G
   Eguruze, ES
AF Kumari, Gaitri
   Eguruze, Ebikinei Stanley
TI Positive Deviance Traits and Social Entrepreneurship for Women
   Empowerment Amid COVID-19
SO IIM KOZHIKODE SOCIETY & MANAGEMENT REVIEW
LA English
DT Article
DE COVID-19; pandemic; social entrepreneurship; positive deviance; women
   empowerment; India
ID CREDIT
AB Purpose: The threat of the COVID-19 pandemic persists despite concerted global efforts to contain it. So also is its impact on social entrepreneurs. One of the main questions being, what is the extent to which small businesses overcome the imminent economic recession amid the threat of COVID-19? Many small businesses have already closed operations due to the countrywide lockdown in India and the resultant cash flow constraints. The government has introduced loan guarantee schemes as a way of support, but it is not sufficient for operational expenses. This study examines the survival traits of positive deviance and social entrepreneurial roles that may be pertinent to women's empowerment, concerning the challenges that have emerged from the pandemic.
   Methodology: Case study methodology was adopted, engaging Rosenblatt's Transactional Theory to collect qualitative data, which are part of the narratives based on the experiences of a focus group within the social entrepreneurial venture, called Pipal Tree, while a descriptive approach was deployed to isolate and analyze the relevant survival traits, that is, leadership, multidimensional resourcefulness, altruism, innovation, norm-violation and labelling/stigmatization.
   Findings: The findings revealed that every trait-that is, leadership, multidimensional resourcefulness, altruism, innovation, norm-violation, and labelling/stigmatization-could potentially play an important role and contribute towards the sustainability of social entrepreneurs to empower women amidst the pandemic. The paper observed that ultimately this insight might be relevant to social entrepreneurs, managers and policymakers in developing effective survival strategies during the COVID-19 pandemic.
   Originality values: This is a conceptualization and empirically based study that engaged in primary data collection, analysis and interpretation supported with literature evidence. As well as insights on the literature and methodology development, its unique contributions also include conceptualizing the phenomenon and strategy development. Additionally, it promotes diversity and inclusivity, as well as highlighting inequality.
   Social implication/Practical values: This study can serve as a guide towards addressing social issues relating to global social entrepreneurship policy-making. As such, it would be a powerful tool for women empowerment, policymakers, not-for-profit organizations, civil society and social entrepreneurs in the post-COVID-19 global environment.
   Theoretical contributions: This study has added the literature to the existing theory relating to social deviance, social entrepreneurship and women empowerment, thereby advancing knowledge. Highlighting issues about how humanity responds to this strange new threat from the COVID-19 pandemic is critical to saving lives. The new knowledge gained will often equip social entrepreneurs to capture new ways of survival (innovative ways) in complex and new challenges to cope with post-COVID-19 socio-economic circumstances. These benefits gained may be beneficial not only in Jharkhand India but nationally as well as globally. The authors also made an addition to the definition of positive deviance.
   Practical contributions: The study contributes towards enabling social entrepreneurs to cope in uncertain situations, which is critical to survival most challenging or crises and not just in entrepreneurship-so in critical decisionmaking, problem-solving, diversity management, gender equity, human rights advancement through women empowerment, business setting and expansion, in helping weakness into strengths and ensuring a level playing ground and inclusivity. Women empowerment can be a positive strength in policy formulation and implementation processes. These kinds reflections from the perspective of women are significant, relevant and valuable in a post-pandemic environment across the Jharkhand India region and are transferable elsewhere across the globe.
C1 [Kumari, Gaitri] Usha Martin Univ, Ranchi, Bihar, India.
   [Eguruze, Ebikinei Stanley] Amer Univ Leaders AUL, London, England.
RP Kumari, G (corresponding author), 2 D Shreedham Enclave, Ranchi 834002, Jharkhand, India.
EM gaitri11@gmail.com
OI Kumari, Gaitri/0000-0002-3381-3265
CR Abu-Saifan S, 2012, TECHNOL INNOV MANAG, P22, DOI 10.22215/timreview523
   [Anonymous], 2020, HINDUSTAN TIMES
   Ashton R., 2011, BE SOCIAL ENTREPRENE
   Bauman R., 1986, STORY PERFORMANCE EV
   Bayeh E., 2016, PAC SCI REV B, V2, P37, DOI [DOI 10.1016/J.PSRB.2016.09.013, 10.1016/j.psrb.2016.09.013]
   BENYEHUDA N, 1990, DEVIANT BEHAV, V11, P221, DOI 10.1080/01639625.1990.9967846
   Berkowitz, 1970, ALTRUISM HELP BEHAV, P1
   Bertaux N, 2007, J DEV ENTREP, V12, P467, DOI 10.1142/S1084946707000757
   Bornstein D., 2010, SOCIAL ENTREPRENEURS
   Broehl W.G., 1978, VILLAGE ENTREPRENEUR
   BUFFALO MD, 1971, SOC PROBL, V19, P101
   Chase S. E., 2011, SAGE HDB QUALITATIVE, V4, P421
   Chavda, 2013, INT J ADV RES COMPUT, V1, P28
   Cialdini R.B., 1982, DEV PROSOC BEHAV, P339, DOI [DOI 10.1016/B978-0-12-234980-5.50018-3, 10.1016/B978-0-12-234980-5.50018-3]
   College I., 1998, FREE INQUIRY CREATIV, V2691, P23
   de Haan, 2008, I PATHWAYS EQUITY AD, P103
   Dewey John, 1934, ART EXPERIENCE
   DODGE DL, 1985, DEVIANT BEHAV, V6, P17, DOI 10.1080/01639625.1985.9967657
   Dolby N, 1996, SOURCES FINANCING NE
   Doob A.N, 1968, DEVIANCY PSYCHOL BEI
   Drayton W, 2002, CALIF MANAGE REV, V44, P120, DOI 10.2307/41166136
   Ewald K, 1981, THESIS OHIO STATE U
   Goetz AM, 1996, WORLD DEV, V24, P45, DOI 10.1016/0305-750X(95)00124-U
   Goffman Erving, 1961, ASYLUMS ESSAYS CONDI
   GOODE E, 1991, DEVIANT BEHAV, V12, P289, DOI 10.1080/01639625.1991.9967880
   Government of Orissa, 2004, OR HUM DEV REP
   Grusec J.E., 1981, ALTRUISM HELP BEHAV, P65
   Guba, 1995, NATURALISTIC INQUIRY
   Gubrium J.F., 2009, ANAL NARRATIVE REALI
   Handy F, 2011, ENTREP REGION DEV, V23, P405, DOI 10.1080/08985626.2011.580166
   Haugh HM, 2016, J BUS ETHICS, V133, P643, DOI 10.1007/s10551-014-2449-4
   Jones E., 2012, Gender and Development, V20, P13, DOI 10.1080/13552074.2012.663640
   Jumani U., 1993, DEALING POVERTY SELF
   Kabeer N, 2001, WORLD DEV, V29, P63, DOI 10.1016/S0305-750X(00)00081-4
   Kabeer N., 2005, GEND DEV, V13, P13, DOI [10.1080/13552070512331332273, DOI 10.1080/13552070512331332273]
   KATZ J, 1972, SOC PROBL, V20, P188
   Kumar, 2016, ANVESHANA, V6, P32
   Leeds R., 1963, MERRILL PALMER QUART, V9, P229
   Lemert E.M., 1951, SOCIAL PATHOLOGY
   Luckenbill D, 1981, ORG DEVIANCE
   Mair J, 2006, J WORLD BUS, V41, P36, DOI 10.1016/j.jwb.2005.09.002
   Mair J., 2009, OP169E U NAV IESE BU
   Mansuri G, 2004, WORLD BANK RES OBSER, V19, P1, DOI 10.1093/wbro/lkh012
   Mayoux L., 2002, DEV B, V57, P76
   McFarlane P.T., 1975, DEVIANCE ACTION REAC
   Merton RK, 1938, AM SOCIOL REV, V3, P672, DOI 10.2307/2084686
   Mosedale S., 2005, J INT DEV, V17, P243, DOI 10.1002/jid.1212
   NORLAND S, 1976, SOCIOL SOC RES, V61, P83
   Patton M.Q., 2002, QUALITATIVE RES EVAL, V3rd
   Rahman A, 2013, GLOBAL J HUMAN SOCIA, V13
   Riessman C., 2008, NARRATIVE METHODS HU
   Rogers E.M., 2010, DIFFUSION INNOVATION, V4th ed .
   Rose K., 1992, WOMEN ARE LEADERS SE
   Rosenblatt L., 1995, LIT EXPLORATION, V5th ed.
   SAGARIN E, 1985, DEVIANT BEHAV, V6, P169, DOI 10.1080/01639625.1985.9967668
   Schumpeter J.A., 1934, THEORY EC DEV INQUIR
   Schumpeter J.A, 2013, CAPITALISM SOCIALISM
   Schumpeter J.A, 2004, THEORY EC DEV, P117
   Seelos C., 2005, BUS HORIZONS, V48, P241, DOI DOI 10.1016/J.BUSHOR.2004.11.006
   Siddiqui A.R, 2020, WILL OUTBREAK COVID
   Singh S, 2009, JHARKHAND SOCIAL DEV
   Sitaram, 2002, DEV PRACTICE, V12, P575, DOI DOI 10.1080/0961452022000017597
   Sorokin P.A., 1950, ALTRUISTIC LOVE
   Sorokin P.A, 2016, RECONSTRUCTION HUMAN
   Sorokin P.A, 1948, RECONSTRUCTION HUMAN
   Sternin, 2010, POWER POSITIVE DEVIA
   Sternin, 2003, CHANGE CHAMPIONS FIE, P20
   Sternin J, 2005, HARVARD BUS REV, P1
   Subramaniam M, 2012, INT SOCIOL, V27, P72, DOI 10.1177/0268580911423044
   Svenkerud, 2018, J DEV COMMUNICATION, V29, P54
   Terry R.M., 1975, EXAMINING DEVIANCE E
   Tiedeman G., 1975, CREATION DEVIANCE
   Vasi IB, 2009, INTRODUCTION TO SOCIAL ENTREPRENEURSHIP: VOICES, PRECONDITIONS, CONTEXTS, P155
   Wilkins L.T., 1965, SOCIAL DEVIANCE
   Winslow R.W., 1970, SOC TRANSITION SOCIA
   Worsham EL, 2012, ACAD MANAG LEARN EDU, V11, P442, DOI 10.5465/amle.2011.0024
   Yin R.K., 1994, CASE STUDY RES DESIG, V2nd ed.
NR 77
TC 0
Z9 0
U1 3
U2 7
PU SAGE PUBLICATIONS INDIA  PVT LTD
PI NEW DELHI
PA B-1-I-1 MOHAN CO-OPERATIVE INDUSTRIAL AREA, MATHURA RD, POST BAG NO 7,
   NEW DELHI 110 044, INDIA
SN 2277-9752
EI 2321-029X
J9 IIM KOZHIKODE SOC MA
JI IIM Kozhikode Soc. Manag. Rev.
PD JAN
PY 2022
VL 11
IS 1
BP 109
EP 125
DI 10.1177/22779752211030697
EA AUG 2021
PG 17
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA YC2OV
UT WOS:000687658700001
OA hybrid
DA 2022-04-20
ER

PT J
AU Iqbal, S
   Bilal, AR
   Nurunnabi, M
   Iqbal, W
   Alfakhri, Y
   Iqbal, N
AF Iqbal, Sajid
   Bilal, Ahmad Raza
   Nurunnabi, Mohammad
   Iqbal, Wasim
   Alfakhri, Yazeed
   Iqbal, Nadeem
TI It is time to control the worst: testing COVID-19 outbreak, energy
   consumption and CO2 emission
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE COVID-19 outbreak; Energy consumption; CO2 emission; Renewable energy;
   Energy transition
ID UNIT-ROOT TESTS; CARBON EMISSIONS; PRICE; COINTEGRATION; EFFICIENCY;
   GROWTH; OIL
AB During the COVID-19 outbreak, managing energy consumption and CO2 emission remained a serious problem. The previous literature rarely solved this real-time issue, and there is a lack of public research proposing an effective way forward on it. However, the study examines the impact of the COVID-19 outbreak on energy consumption and CO2 emission. The design of the study is quantitative, and the data is acquired from different online databases. The model of the study is inferred by using panel unit root test and ARDL test. The robustness of study findings was checked through panel quantile regression. The findings highlighted that the COVID-19 outbreak is negatively significant with energy consumption and CO2 emission. The study suggested revising the energy consumption patterns by developing and implementing the national action plan for energy consumption and environmental protection. The study also contributed in knowledge by suggesting the novel insight into CO2 emission and energy consumption patterns during COVID-19 pandemic and recommended to consider renewable energy transition methods as an opportunity for the society. For a more effective management of energy consumption and environmental pollution, country-specific measures are suggested to be taken, and the national government should support the concerned public departments, ministries and private organizations on it. To the best of our study, this is one of the pioneer studies studying this novel link and suggesting the way forward on recent topicality.
C1 [Iqbal, Sajid] Univ Management & Technol, KUBEAC, Sialkot 51310, Pakistan.
   [Bilal, Ahmad Raza] Sohar Univ, Sch Business, Sohar 311, Oman.
   [Nurunnabi, Mohammad] Prince Sultan Univ, Coll Business Adm, Riyadh, Saudi Arabia.
   [Iqbal, Wasim; Alfakhri, Yazeed] Shenzhen Univ, Coll Management, Dept Management Sci, Shenzhen, Peoples R China.
   [Iqbal, Nadeem] Ghazi Univ, Dept Business Adm, Dera Ghazi Khan, Pakistan.
RP Iqbal, W (corresponding author), Shenzhen Univ, Coll Management, Dept Management Sci, Shenzhen, Peoples R China.
EM sajidiqbal.edu@gmail.com; abilal@su.edu.om; mnurunnabi@psu.edu.sa;
   wasimiqbal@stumail.ysu.edu.cn; yalfakhri@psu.edu.sa;
   drnadeemiqbal1@gmail.com
RI Bilal, Ahmad Raza/AAH-1537-2019; IQBAL, SAJID/ABE-2262-2020; Iqbal,
   Nadeem/AAN-3196-2021
OI Bilal, Ahmad Raza/0000-0001-9471-7093; IQBAL, SAJID/0000-0001-7729-8464;
   
CR Al Asbahi AAMH, 2019, ENERGY REP, V5, P704, DOI 10.1016/j.egyr.2019.06.009
   Arango-Miranda R, 2018, ENERGIES, V11, DOI 10.3390/en11102668
   Ataguba JE, 2020, APPL HEALTH ECON HEA, P1
   Baker S. R., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts)
   Baloch ZA, 2020, ENVIRON SCI POLLUT R, V27, P34337, DOI 10.1007/s11356-020-09578-3
   Burkle FM, 2020, PREHOSP DISASTER MED, V35, P237, DOI 10.1017/S1049023X20000424
   Chohan UW, 2020, SSRN ELECT J, DOI [10.2139/ssrn.3557738, DOI 10.2139/SSRN.3557738]
   Choi I, 2001, J INT MONEY FINANC, V20, P249, DOI 10.1016/S0261-5606(00)00048-6
   Ciaschini M, 2013, EC POLICY ENERGY ENV, P129, DOI [10.3280/EFE2013-002008, DOI 10.3280/EFE2013-002008]
   Coccia M, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138474
   Colenda CC, 2020, ACAD MED, V95, P1143, DOI 10.1097/ACM.0000000000003418
   Connors E, 2020, AUST FINANC REV
   Correia S, 2020, PUBLIC HLTH INTERVEN, P1, DOI [10.2139/ssrn.3561560, DOI 10.2139/SSRN.3561560]
   Das K., 2020, SSRN ELECT J, DOI [10.2139/ssrn.3580341, DOI 10.2139/SSRN.3580341]
   Department of Economic and Social Affairs, 2020, SOC IMP COVID 19
   Disemadi HS, 2020, J INOV EKON, V3, DOI DOI 10.22219/JIK0.V5I3.11790
   Dong K., 2015, ENERGY EC, V51, P445, DOI [10.1016/j.ecolind.2015.09.013, DOI 10.1016/J.ECOLIND.2015.09.013]
   ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6
   Goodell JW, 2020, FINANC RES LETT, V35, DOI 10.1016/j.frl.2020.101512
   Gugler K, 2013, ENERG ECON, V40, P702, DOI 10.1016/j.eneco.2013.08.022
   Halkos GE, 2019, ECON ANAL POLICY, V63, P234, DOI 10.1016/j.eap.2019.06.001
   Hou YM, 2019, PROCESSES, V7, DOI 10.3390/pr7060325
   IEA IEA, 2017, ENERG POLICY, DOI [10.1016/0301-4215(73)90024-4, DOI 10.1016/0301-4215(73)90024-4]
   Igwe PA, 2020, CORONAVIRUS LOOMING
   Iqbal N, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138916
   Iqbal W, 2020, J CLEAN PROD, V255, DOI 10.1016/j.jclepro.2020.120187
   Iqbal W, 2019, PROCESSES, V7, DOI 10.3390/pr7120902
   Iqbal W, 2019, PROCESSES, V7, DOI 10.3390/pr7040196
   van de Ven DJ, 2017, ENERG ECON, V62, P204, DOI 10.1016/j.eneco.2016.12.009
   JOHANSEN S, 1990, OXFORD B ECON STAT, V52, P169, DOI 10.1111/j.1468-0084.1990.mp52002003.x
   Khokhar M, 2020, PROBL EKOROZWOJU, V15
   Lamarche C, 2010, J ECONOMETRICS, V157, P396, DOI 10.1016/j.jeconom.2010.03.042
   Levin A, 2002, J ECONOMETRICS, V108, P1, DOI 10.1016/S0304-4076(01)00098-7
   Lin BQ, 2019, J CLEAN PROD, V219, P981, DOI 10.1016/j.jclepro.2019.02.112
   Liu W, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072304
   Malamud C, 2020, COVID 19 LATIN AM PO
   Mirza FM, 2017, RENEW SUST ENERG REV, V72, P1233, DOI 10.1016/j.rser.2016.10.081
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Noy I, 2020, GLOB POLICY, V11, P413, DOI 10.1111/1758-5899.12851
   oncu TS, 2020, EC POLIT WKLY, V55, P10
   Parth K, 2020, INT J ADV SCI TECHNO, V29, P2182
   Pegels A, 2010, ENERG POLICY, V38, P4945, DOI 10.1016/j.enpol.2010.03.077
   Pesaran M.H., 1998, EC SOC MONOGR, V31, P371
   Pesaran MH, 2007, J APPL ECONOMET, V22, P265, DOI 10.1002/jae.951
   Pesaran MH, 2001, J APPL ECONOMET, V16, P289, DOI 10.1002/jae.616
   Solangi YA, 2019, 2018 IEEE 5 INT C EN
   Solangi YA, 2020, PROCESSES, V8, DOI 10.3390/pr8070825
   Solangi YA, 2019, J CLEAN PROD, V236, DOI 10.1016/j.jclepro.2019.117655
   Thomas, 2020, EC POLIT WKLY, V55, P15
   Trotta G, 2018, ENERG POLICY, V114, P529, DOI 10.1016/j.enpol.2017.12.042
   VIVALDI C, 2020, ONCOLOGIST 1003, DOI DOI 10.1002/ONCO.13538
   Wang CY, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13020036
   Wang MG, 2016, APPL ENERG, V175, P109, DOI 10.1016/j.apenergy.2016.05.013
   Wang Y, 2020, SUSTAIN CITIES SOC, V52, DOI 10.1016/j.scs.2019.101861
   Wren-Lewis S, 2020, EC EFFECTS PANDEMIC, V2
   Yasmeen H, 2019, ENERGY REP, V5, P688, DOI 10.1016/j.egyr.2019.06.006
   Zameer H, 2018, RENEW SUST ENERG REV, V82, P886, DOI 10.1016/j.rser.2017.09.089
   Zheng JL, 2019, ENERG ECON, V81, P25, DOI 10.1016/j.eneco.2019.03.003
NR 60
TC 33
Z9 34
U1 9
U2 15
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD APR
PY 2021
VL 28
IS 15
BP 19008
EP 19020
DI 10.1007/s11356-020-11462-z
EA NOV 2020
PG 13
WC Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology
GA RI6VU
UT WOS:000589022300005
PM 33184786
OA Green Published, Bronze
DA 2022-04-20
ER

PT C
AU Strulak-Wojcikiewicz, R
   Bohdan, A
AF Strulak-Wojcikiewicz, Roma
   Bohdan, Adriana
BE Watrobski, J
   Salabun, W
   Toro, C
   Zanni-Merk, C
   Howlett, RJ
   Jain, LC
TI The concept of an e-platform cooperation model in the field of 3D
   printing during the COVID-19 pandemic
SO KNOWLEDGE-BASED AND INTELLIGENT INFORMATION & ENGINEERING SYSTEMS (KSE
   2021)
SE Procedia Computer Science
LA English
DT Proceedings Paper
CT 25th KES International Conference on Knowledge-Based and Intelligent
   Information & Engineering Systems (KES)
CY SEP 08-10, 2021
CL Szczecin, POLAND
SP KES Int
DE e-platforms; management; crowdsourcing; Covid-19 pandemic; additive
   manufacturing
ID FRAMEWORK; BUSINESS; INNOVATION
AB The COVID-19 pandemic has caused unprecedented public health and economic crises around the world. The protection of human health and life has become the most important challenge. Disrupted supply chains resulted in shortages in the supply of essential medical equipment and personal protective equipment. The quick response to this situation was the use of 3D printers for the production of this type of article, especially for the medical service. The initial experience presented in this article (the review of solutions and initiatives based on cooperation in the field of 3D printing during the first wave of the pandemic) showed the challenges faced by organizations engaged in 3D printing during the pandemic. The performed identification and compilation of the difficulties that occurred during cooperation in crisis conditions allowed the author of this article to present an original proposal to minimize the most important of these problems. The main purpose of the article is to present the concept of a cooperation model based on an internet platform in the field of 3D printing during the COVID-19 pandemic, which will allow to increase the efficiency of management of activities necessary in crisis conditions. (C) 2021 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0) Peer-review under responsibility of the scientific committee of KES International.
C1 [Strulak-Wojcikiewicz, Roma; Bohdan, Adriana] Maritime Univ Szczecin, H Pobotsego 11 St, PL-70507 Szczecin, Poland.
RP Strulak-Wojcikiewicz, R (corresponding author), Maritime Univ Szczecin, H Pobotsego 11 St, PL-70507 Szczecin, Poland.
EM r.strulak@am.szczecin.pl
RI ; Strulak-Wojcikiewicz, Roma/O-8082-2019
OI Bohdan, Adriana/0000-0003-2695-0808; Strulak-Wojcikiewicz,
   Roma/0000-0002-9702-7554
FU Ministry of Science and Higher Education of PolandMinistry of Science
   and Higher Education, Poland
FX This research was funded by the Ministry of Science and Higher Education
   of Poland.
CR Adamkiewicz A, 2019, ARCH THERMODYN, V40, P229, DOI 10.24425/ather.2019.130003
   Afuah A, 2012, ACAD MANAGE REV, V37, P355, DOI 10.5465/amr.2010.0146
   Arshad M., 2020, INF TECHNOL ELECT EN, V9, P23
   Balic K., 2019, INT MULT SCI GEOCONF, V19, P557
   Bernardo T, 2021, JMIR PUBLIC HLTH SUR, V7, DOI 10.2196/25935
   Blackhurst J, 2011, J BUS LOGIST, V32, P374, DOI 10.1111/j.0000-0000.2011.01032.x
   Buchal R., 2019, P CAN ENG ED ASS CEE
   Cadnum Jennifer L, 2020, Pathog Immun, V5, P52, DOI 10.20411/pai.v5i1.372
   Caligiuri P, 2020, J INT BUS STUD, V51, P697, DOI 10.1057/s41267-020-00335-9
   Callaghan CW, 2015, BRIT MED BULL, V115, P67, DOI 10.1093/bmb/ldv035
   Carroll N, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102186
   Choong YYC, 2020, NAT REV MATER, V5, P637, DOI 10.1038/s41578-020-00234-3
   Christensen I, 2019, J INNOV KNOWL, V4, P240, DOI 10.1016/j.jik.2018.03.008
   Davis JG, 2011, IEEE INTERNET COMPUT, V15, P92, DOI 10.1109/MIC.2011.61
   Donthu N, 2020, J BUS RES, V117, P284, DOI 10.1016/j.jbusres.2020.06.008
   Dwivedi YK, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102211
   EC, 2020, COR RESP
   Ernst NA, 2015, 2015 10TH JOINT MEETING OF THE EUROPEAN SOFTWARE ENGINEERING CONFERENCE AND THE ACM SIGSOFT SYMPOSIUM ON THE FOUNDATIONS OF SOFTWARE ENGINEERING (ESEC/FSE 2015) PROCEEDINGS, P50, DOI 10.1145/2786805.2786848
   Farrugia G, 2020, MAYO CLIN PROC, V95, P1574, DOI 10.1016/j.mayocp.2020.05.024
   Frazer John Scott, 2020, Journal of Medical Engineering & Technology, V44, DOI 10.1080/03091902.2020.1757772
   Garg PK, 2020, J SURG ONCOL, V122, P1262, DOI 10.1002/jso.26156
   Geiger D., 2011, CROWDSOURCING INFORM
   Gibb F, 2006, INT J INFORM MANAGE, V26, P128, DOI 10.1016/j.ijinfomgt.2005.11.008
   Gonzales-Zamora Jose A, 2020, Infez Med, V28, P135
   Hirth M., 2011, 2011 5 INT C INN MOB, P322
   Howe J, 2006, WIRED MAGAZINE, V14, P1, DOI DOI 10.1086/599595
   Hughes L, 2019, INT J INFORM MANAGE, V49, P114, DOI 10.1016/j.ijinfomgt.2019.02.005
   Ilyas S, 2020, SCI TOTAL ENVIRON, V749, DOI 10.1016/j.scitotenv.2020.141652
   Imbrie-Moore AM, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8030225
   Jeppesen LB, 2010, ORGAN SCI, V21, P1016, DOI 10.1287/orsc.1090.0491
   Kaul P, 2021, J SURG ONCOL, V123, P1204, DOI 10.1002/jso.26417
   Krolikowski T., 2020, EUROPEAN RES STUDIES, V23, P569
   Kudyba S, 2020, INFORM SYST MANAGE, V37, P284, DOI 10.1080/10580530.2020.1818903
   Leonardi PM, 2021, J MANAGE STUD, V58, P247, DOI 10.1111/joms.12648
   Lowenthal P., 2020, J TECHNOLOGY TEACHER, V28, P383
   Mackenzie D., 2020, REUS N95 MASKS
   Manero A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134634
   Mueller T, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10124135
   Mukaino M, 2020, AM J PHYS MED REHAB, V99, P478, DOI 10.1097/PHM.0000000000001441
   Nikonczuk Piotr, 2021, Sustainable Design and Manufacturing 2020. Proceedings of the 7th International Conference on Sustainable Design and Manufacturing (KES-SDM 2020). Smart Innovation, Systems and Technologies (SIST 200), P555, DOI 10.1007/978-981-15-8131-1_49
   Nikonczuk P, 2018, EKSPLOAT NIEZAWODN, V20, P387, DOI 10.17531/ein.2018.3.6
   Pan SL, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102196
   Papadopoulos T, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102192
   Papadopoulos T, 2017, J CLEAN PROD, V142, P1108, DOI 10.1016/j.jclepro.2016.03.059
   Silva ALP, 2020, SCI TOTAL ENVIRON, V742, DOI 10.1016/j.scitotenv.2020.140565
   Peltier RE, 2020, INFECT CONT HOSP EP, V41, P1446, DOI 10.1017/ice.2020.332
   Rayna T, 2015, J ENG TECHNOL MANAGE, V37, P90, DOI 10.1016/j.jengtecman.2015.07.002
   Ringel M., 2015, MOST INNOVATIVE COMP
   Ringel M., 2018, INNOVATION 2018 MOST
   Rowan NJ, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138532
   Rusinko C, 2020, INFORM SYST MANAGE, V37, P332, DOI 10.1080/10580530.2020.1820637
   Rysavy MDT, 2020, J LIBR ADM, V60, P532, DOI 10.1080/01930826.2020.1760569
   Sabahat M, 2020, PAK J MED SCI, V36, P1412, DOI 10.12669/pjms.36.6.3342
   Saini V, 2020, GUT PATHOG, V12, DOI 10.1186/s13099-020-00367-4
   Sarkis J, 2020, RESOUR CONSERV RECY, V159, DOI 10.1016/j.resconrec.2020.104894
   Senyo PK, 2019, INT J INFORM MANAGE, V47, P52, DOI 10.1016/j.ijinfomgt.2019.01.002
   Silva ALP, 2021, CHEM ENG J, V405, DOI 10.1016/j.cej.2020.126683
   Storey D. J, 2016, UNDERSTANDING SMALL
   Tarfaoui M, 2020, MATERIALS, V13, DOI 10.3390/ma13153339
   Tomasz Krolikowski, 2019, Sustainable Design and Manufacturing 2019. Proceedings of the 6th International Conference on Sustainable Design and Manufacturing (KES-SDM 19). Smart Innovation, Systems and Technologies (SIST 155), P485, DOI 10.1007/978-981-13-9271-9_40
   Wagner Natalia, 2020, Procedia Computer Science, V176, P2536, DOI 10.1016/j.procs.2020.09.319
   Wagner N., 2020, CSR CONT POLAND INST, V2020, P237, DOI DOI 10.1007/978-3-030-42277-6_17
   WASP, 2020, IT WASP PIV PROD 3D
   Zhu JJ, 2017, J PROD INNOVAT MANAG, V34, P598, DOI 10.1111/jpim.12400
   2020, NUTRI H ASP TRAD ETH, P1
NR 65
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-0509
J9 PROCEDIA COMPUT SCI
PY 2021
VL 192
BP 4083
EP 4092
DI 10.1016/j.procs.2021.09.183
PG 10
WC Automation & Control Systems; Computer Science, Artificial Intelligence;
   Computer Science, Information Systems; Computer Science, Theory &
   Methods; Engineering, Electrical & Electronic; Mathematics, Applied
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Automation & Control Systems; Computer Science; Engineering; Mathematics
GA BS4LU
UT WOS:000720289004015
PM 34630758
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Alabi, MO
   Ngwenyama, O
AF Alabi, Michael Omotayo
   Ngwenyama, Ojelanki
TI Food security and disruptions of the global food supply chains during
   COVID-19: building smarter food supply chains for post COVID-19 era
SO BRITISH FOOD JOURNAL
LA English
DT Review; Early Access
DE Food security; Global food supply chain; E-commerce; Post-COVID-19; Food
   insecurity; Food and beverage industry; Agri-food; Industry 4; 0
ID INSECURITY
AB Purpose The COVID-19 pandemic has revealed the fragility of the complex global food supply chains (GFSCs) which has drastically affected the essential flow of food from the farms and producers to the final consumers. The COVID-19 outbreak has served as a great lesson for the food businesses and companies to re-strategize toward the post-COVID-19 era. This paper examines the impact of COVID-19 pandemic on food security and global food supply chains using the two countries (Canada and the United States) in North America as the case studies and provides appropriate strategy or framework to build smarter and resilience food supply chains for post-COVID-19 era. Design/methodology/approach This paper is a general review of the impacts of COVID-19 pandemic on food security and disruptions of the GFSCs. This paper conducted a comprehensive literature review to have a complete understanding of the study, identify the research problem and missing gaps in literature and to formulate appropriate research questions. This study uses two countries from North America (Canada and the US) as case studies by analyzing the available open data from Statistics Canada and some recent studies conducted on food insecurity in the US. Finally, based on the findings, a proposed approach or framework was presented. Findings The findings from this study establishes that COVID-19 pandemic has greater impacts on the food security and GFSC due to disruption of the food supply chain leading to increase food insecurity in Canada and the US. The findings clearly show how the COVID-19 pandemic has disrupted the GFSC in the following ways - poor economy, shortage of farm worker, limitation to food accessibility, restriction in the transportation of farm commodities, changes in demand of consumers, shutdown of food production facilities, uncertainty of food quality and safety, food trade policies restriction, delays in transportation of food products, etc. The main findings of this study show that food and beverages sector needs to re-strategize, re-shape and re-design their food supply chains with post-COVID-19 resilience approach in mind. As a result, this study presents a proposed approach or framework to build a smarter and resilience GFSCs in the post-COVID-19 era. The findings in this study highlights the way the proposed framework provide solutions to the identified problems created by the COVID-19 pandemic in affecting the GFSC. Originality/value The contribution of this study towards the existing body of knowledge in food security and GFSC is in the form of a proposed approach or framework for building smarter and resilience GFSC that would assist the key players in the food industry to respond better and faster to the ongoing COVID-19 pandemic, including post-COVID-19 era.
C1 [Alabi, Michael Omotayo; Ngwenyama, Ojelanki] Ryerson Univ, Ted Rogers Sch Management, Inst Innovat & Technol Management, Toronto, ON, Canada.
RP Alabi, MO (corresponding author), Ryerson Univ, Ted Rogers Sch Management, Inst Innovat & Technol Management, Toronto, ON, Canada.
EM micalabs@gmail.com
CR Abdullah D, 2021, SYSTEMATIC REV PHARM, V12, P142
   Acharya S, 2021, IMPORTANCE END TO EN
   Aday S, 2020, FOOD QUAL SAF-OXFORD, V4, P167, DOI 10.1093/fqsafe/fyaa024
   Alicke K., 2020, SUPPLY CHAIN RECOVER
   Almena A, 2019, ENRGY PROCED, V161, P182, DOI 10.1016/j.egypro.2019.02.080
   Barman A., 2021, CURRENT RES BEHAV SC, V2, P100017, DOI [10.1016/j.crbeha.2021.100017, DOI 10.1016/J.CRBEHA.2021.100017]
   Basnayake H, 2020, COVID 19 BUSINESS CO
   Bauer L., 2020, COVID 19 CRISIS HAS
   Chenarides L, 2021, APPL ECON PERSPECT P, V43, P270, DOI 10.1002/aepp.13085
   Chin CF, 2020, J AGRIC FOOD SYST CO, V9, P161, DOI 10.5304/jafscd.2020.094.031
   CIPS, 2020, GLOBAL SUPPLY CHAINS
   Claudine S., 2018, P HAMB INT C LOG HIC, V25, P37
   Coleman-Jensen A., 2020, Economic Research Report - Economic Research Service, USDA
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   Deaton BJ, 2020, CAN J AGR ECON, V68, P143, DOI 10.1111/cjag.12227
   FAO, 2003, TRADE REFORMS FOOD S
   FAO, 2020, FAO BIG DAT TOOL COV
   FAO (Food and Agriculture Organization) (2020b), ADJ BUS MOD SUST AGR
   Ferkoun M., 2015, CLOUD COMPUTING HELP
   Fitzpatrick KM, 2021, J HUNGER ENVIRON NUT, V16, P1, DOI 10.1080/19320248.2020.1830221
   Food and Agricultural Organization, 2008, INTR BAS CONC FOOD S
   FoodSafetyCan, 2020, FOOD INS RIS CAN
   Gartner, 2020, GARTNER IDENTIFIES T
   Gundersen C, 2021, APPL ECON PERSPECT P, V43, P153, DOI 10.1002/aepp.13100
   Hobbs JE, 2020, CAN J AGR ECON, V68, P171, DOI 10.1111/cjag.12237
   Holland K.L., 2020, CANADAS FOOD SECURIT
   Jagt R., 2020, SO NOW WHAT
   Kilpatrick J., 2020, COVID 19 MANAGING SU
   Kochan C, 2014, ANN CSCMP ED C, DOI [10.13140/2.1.4274.7841, DOI 10.13140/2.1.4274.7841]
   Laborde D, 2020, SCIENCE, V369, P500, DOI 10.1126/science.abc4765
   Lauren B.N., 2020, PREDICTORS HOUSEHOLD, DOI [10.1101/2020.06.10.20122275, DOI 10.1101/2020.06.10.20122275]
   Lee J, 2020, COVID 19 SHATTERED S
   Lin J., 2020, HERES GLOBAL SUPPLY
   Mardones FO, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.578508
   McDermott J., 2020, COVID 19 GLOBAL FOOD, DOI [10.2499/p15738coll2.133762, DOI 10.2499/P15738COLL2.133762_03, DOI 10.2499/P15738COLL2.133762]
   Mulay A, 2013, DECENTRALIZE IMPROVE
   Mussell A, 2020, INDEPENDENT AGR FOOD
   Nasereldin Y.A., 2021, OPEN J BUSINESS MANA, V9, P184
   Niles MT, 2020, NUTRIENTS, V12, DOI 10.3390/nu12072096
   OECD, 2020, FOOD SUPPL CHAINS CO
   Owens MR, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092515
   Payne K, 2019, ARTIF INTELL
   Picard S, 2020, ARE YOU READY E COMM
   Polsky JY, 2020, HEALTH REP, V31, P3, DOI 10.25318/82-003-x202001200001-eng
   PROOF, 2021, HOUSEHOLD FOOD INSEC
   Reardon T, 2020, 17 COVID 19 MAY DISR
   Reliefweb, 2020, NEW RES COVID 19 EC
   Reza M.N.H., 2021, IMPLICATIONS IND 4 0, DOI [10.12688/f1000research.73138.1, DOI 10.12688/F1000RESEARCH.73138.1]
   SGInnovate, 2021, SUPPL CHAIN DIG TRAN
   StatCan, 2020, FOOD INS COVID 19 PA
   Stoitsis G., 2020, IMPACT COVID 19 GLOB
   Tarasuk V., 2020, HOUSEHOLD FOOD INSEC
   Terblanche I, 2021, BUILDING RESILIENCE
   Tetrapak, 2020, CISC VIS NETW IND GL
   Wolfson JA, 2020, AM J PUBLIC HEALTH, V110, P1763, DOI 10.2105/AJPH.2020.305953
   Wolfson JA, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061648
   Workie Endashaw, 2020, Curr Res Environ Sustain, V2, P100014, DOI 10.1016/j.crsust.2020.100014
   World Health Organization, 2020, 2019 NOV COR 2019 NC
   Zhang Y, 2020, E COMMERCE SUPPLY CH
   Zoltners A.A., 2004, SALES FORCE DESIGN S, DOI [10.1057/9780230514928_4, DOI 10.1057/9780230514928_4]
NR 60
TC 0
Z9 0
U1 5
U2 5
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0007-070X
EI 1758-4108
J9 BRIT FOOD J
JI Br. Food J.
DI 10.1108/BFJ-03-2021-0333
EA MAR 2022
PG 19
WC Agricultural Economics & Policy; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Food Science & Technology
GA ZY2LT
UT WOS:000772421500001
OA Bronze
DA 2022-04-20
ER

PT J
AU Bargaoanu, A
   Corbu, N
   Buturoiu, R
   Durach, F
AF Bargaoanu, Alina
   Corbu, Nicoleta
   Buturoiu, Raluca
   Durach, Flavia
TI Managing the COVID-19 pandemic: predictors of trust in institutions in
   Romania
SO KYBERNETES
LA English
DT Article; Early Access
DE Trust in institutions; Predictors of trust; COVID-19 pandemic; Fake news
   incidence
ID POLITICAL TRUST; SOCIAL MEDIA; NEWS MEDIA; FAKE NEWS; UNCERTAINTY;
   DYNAMICS; PARTICIPATION; MOBILIZATION; INFORMATION; CONSUMPTION
AB Purpose The paper discusses the predictors of trust in the institutions and people involved in crisis management at the beginning of the COVID-19 pandemic in Romania. Trust in institutions might be a key factor in the way countries affected by the COVID-19 pandemic deal with the crisis as people might be more willing to accept the restrictions and rules imposed if they trust the key institutions and people involved in managing the pandemic. The paper provides recommendations for key stakeholders to increase trust in people and institutions in times of crisis. Design/methodology/approach The authors draw evidence from a national online panel survey (N = 1,160) to investigate the main predictors of trust in this context. Findings The main results indicate that trust in institutions is positively correlated with news consumption and personal discussions about the pandemic, perceived incidence of COVID-19 fake news, belief in conspiracy theories and uncertainty about the future of the country. Originality/value To the best of the knowledge, this study is one of the few papers investigating the predictors of trust in the institutions and people involved in managing the current pandemic in a country in the Central and Eastern European region.
C1 [Bargaoanu, Alina; Corbu, Nicoleta; Buturoiu, Raluca; Durach, Flavia] Scoala Natl Studii Polit & Adm, Fac Comunicare & Relatii Publ, Bucharest, Romania.
RP Buturoiu, R (corresponding author), Scoala Natl Studii Polit & Adm, Fac Comunicare & Relatii Publ, Bucharest, Romania.
EM alina.bargaoanu@comunicare.ro; nicoleta.corbu@comunicare.ro;
   raluca.buturoiu@comunicare.ro; flavia.durach@comunicare.ro
OI Durach, Flavia/0000-0002-4405-8605; Buturoiu, Raluca/0000-0001-9841-0929
CR Achimescu V., 2020, PATHWAY DISTRUSTING
   Alper S, ANTECEDENTS CONSEQUE
   Amat F., 2020, PANDEMICS MEET DEMOC
   Amsalem E, 2021, COMMUN RES, V48, P619, DOI 10.1177/0093650219866357
   [Anonymous], 2020, ROMANIA INSIDER
   Arnold C, 2012, EUR INTEGR ONLINE PA, V16, DOI 10.1695/2012008
   Avery JM, 2009, INT J PRESS/POLIT, V14, P410, DOI 10.1177/1940161209336224
   Baekgaard M., 2020, J BEHAV PUBLIC ADM J BEHAV PUBLIC ADM, V3, P1
   Bargaoanu A, 2020, ROM J COMMUN PUB REL, V22, P125
   Bargaoanu A, 2018, ROM J EUR AFF, V18, P24
   Bierwiaczonek K, 2020, APPL PSYCHOL-HLTH WE, V12, P1270, DOI 10.1111/aphw.12223
   Boggild T, 2021, AM POLIT SCI REV, V115, P269, DOI 10.1017/S0003055420000805
   Bol D, 2021, EUR J POLIT RES, V60, P497, DOI 10.1111/1475-6765.12401
   Boukes M, 2017, J MEDIA PSYCHOL-GER, V29, P137, DOI 10.1027/1864-1105/a000224
   Bunker D, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102201
   Carpini MXD, 2004, ANNU REV POLIT SCI, V7, P315, DOI 10.1146/annurev.polisci.7.121003.091630
   Ceron A, 2015, J COMPUT-MEDIAT COMM, V20, P487, DOI 10.1111/jcc4.12129
   Chaffee S.H., 1986, INTERMEDIA INTERPERS, V3rd ed, P62
   Chater N, 2020, NAT HUM BEHAV, V4, P439, DOI 10.1038/s41562-020-0865-2
   Chatterjee S., 2012, REGRESSION ANAL EXAM, V5
   Choi E, 2016, JPN J POLIT SCI, V17, P410, DOI 10.1017/S1468109916000165
   Cinelli Matteo, 2020, Sci Rep, V10, P16598, DOI 10.1038/s41598-020-73510-5
   Corbu N, 2020, COMMUNICATIONS-GER, V45, P694, DOI 10.1515/commun-2019-0152
   De Vries C.E., 2020, CRISIS SIGNALING ITA
   Devine D, 2021, POLIT STUD REV, V19, P274, DOI 10.1177/1478929920948684
   Douglas KM, 2019, POLIT PSYCHOL, V40, P3, DOI 10.1111/pops.12568
   Echeverria M, 2020, COMMUN SOC-SPAIN, V33, P119, DOI 10.15581/003.33.2.119-135
   Edelman, 2020, ED TRUST BAR 2020
   Einstein K, 2015, POLIT BEHAV, V37, P679, DOI 10.1007/s11109-014-9287-z
   Ejaz W, 2020, DATA BRIEF, V32, DOI 10.1016/j.dib.2020.106091
   Esaiasson P, 2021, EUR J POLIT RES, V60, P748, DOI 10.1111/1475-6765.12419
   European Social Survey, 2014, ESS4 MAIN INT SUPPL ESS4 MAIN INT SUPPL
   European Union Data Portal, 2018, FLASH EUR 464 FAK NE FLASH EUR 464 FAK NE
   Fox CR, 2002, ORGAN BEHAV HUM DEC, V88, P476, DOI 10.1006/obhd.2001.2990
   Freund R.J., 2006, REGRESSION ANAL
   Godefroidt A, 2017, DEMOCRATIZATION, V24, P906, DOI 10.1080/13510347.2016.1248416
   Gustafson A, 2020, PUBLIC UNDERST SCI, V29, P614, DOI 10.1177/0963662520942122
   Hameleers M., 2020, HARVARD KENNEDY SCH, V1
   Hetherington MJ, 2008, J POLIT, V70, P498, DOI 10.1017/S0022381608080468
   Hupcey JE, 2001, J ADV NURS, V36, P282, DOI 10.1046/j.1365-2648.2001.01970.x
   Imhoff R, 2018, PERS SOC PSYCHOL B, V44, P1364, DOI 10.1177/0146167218768779
   Invernizzi G.M., 2019, TRUST NOBODY VOTERS, DOI [10.2139/ssrn.3507190, DOI 10.2139/SSRN.3507190]
   Jensen JD, 2008, HUM COMMUN RES, V34, P347, DOI 10.1111/j.1468-2958.2008.00324.x
   JOHNSON BB, 1995, RISK ANAL, V15, P485, DOI 10.1111/j.1539-6924.1995.tb00341.x
   Jolley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089177
   Jones K., 2020, COVID 19 HAS IMPACTE
   Jordan PJ, 2020, AUST J MANAGE, V45, P3, DOI 10.1177/0312896219871976
   Kampen, 2002, IDENTITY VS PERFORMA
   Kantar, 2020, COVID 19 BAR CONS AT
   Keele L, 2007, AM J POLIT SCI, V51, P241, DOI 10.1111/j.1540-5907.2007.00248.x
   Keren G, 1999, ACTA PSYCHOL, V103, P149, DOI 10.1016/S0001-6918(99)00034-7
   Kleinfeld Rachel, 2020, DO AUTHORITARIAN DEM
   Kwak N, 2005, COMMUN RES, V32, P87, DOI 10.1177/0093650204271400
   Lazer DMJ, 2018, SCIENCE, V359, P1094, DOI 10.1126/science.aao2998
   Lecheler S, 2013, COMMUNICATIONS-GER, V38, P189, DOI 10.1515/commun-2013-0011
   Li XQ, 2017, ASIAN J COMMUN, V27, P65, DOI 10.1080/01292986.2016.1248454
   Lu HY, 2020, SOC INDIC RES, V149, P167, DOI 10.1007/s11205-019-02247-0
   Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546
   Lynas M, 2020, COVID TOP 10 CURRENT
   Ministry of Health, 2020, BUL INF BUL INF
   Mishler W, 2005, COMP POLIT STUD, V38, P1050, DOI 10.1177/0010414005278419
   Mishler W, 2001, COMP POLIT STUD, V34, P30, DOI 10.1177/0010414001034001002
   MUELLER JE, 1970, AM POLIT SCI REV, V64, P18, DOI 10.2307/1955610
   Newman N., 2019, REUTERS I DIGITAL NE
   Norris Pippa., 2000, VIRTUOUS CIRCLE POLI
   Oleksy T, 2021, PERS INDIV DIFFER, V168, DOI 10.1016/j.paid.2020.110289
   Oliver AL, 2001, HUM RELAT, V54, P1045, DOI 10.1177/0018726701548003
   Pring-Mill D., 2019, SOCIAL MEDIA PLATFOR
   Pummerer L, 2022, SOC PSYCHOL PERS SCI, V13, P49, DOI 10.1177/19485506211000217
   Radu R, 2020, SOC MEDIA SOC, V6, DOI 10.1177/2056305120948190
   Rojas H, 2009, J COMPUT-MEDIAT COMM, V14, P902, DOI 10.1111/j.1083-6101.2009.01475.x
   Schraff D, 2021, EUR J POLIT RES, V60, P1007, DOI 10.1111/1475-6765.12425
   Sibley CG, 2020, AM PSYCHOL, V75, P618, DOI 10.1037/amp0000662
   Sirotnikova M.G., 2020, TRUST DEMOCRACY FRAG
   Spence PR, 2016, COMMUN Q, V64, P55, DOI 10.1080/01463373.2015.1100644
   Steinbruner John., 2002, CYBERNETIC THEORY DE
   Stromback J, 2016, INT J PRESS/POLIT, V21, P88, DOI 10.1177/1940161215613059
   Sztompka P., 1998, POLISH POLITICAL SCI, V29
   Tardaguila C., 2020, Coronavirus: fact-checkers from 30 countries are fighting 3 waves of misinformation
   van der Bles AM, 2020, P NATL ACAD SCI USA, V117, P7672, DOI 10.1073/pnas.1913678117
   van der Bles AM, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.181870
   Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559
   Walsh JP, 2020, INT J CULTURAL STUD, V23, P840, DOI 10.1177/1367877920912257
   Ward PR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164096
   Weaver, 1973, ANN M INT COMM ASS M
   Weaver D.H., 1991, AGENDA SETTING
   Wiederhold BK, 2020, CYBERPSYCH BEH SOC N, V23, P197, DOI 10.1089/cyber.2020.29180.bkw
   World Health Organisation, INF INF
   Yang K.C., 2020, PREVALENCE LOW CREDI
   Yang Q, 2010, ASIAN POLIT POLICY, V2, P415, DOI 10.1111/j.1943-0787.2010.01201.x
   Zhang L., 2020, HEALTHCARE, V8
NR 91
TC 0
Z9 0
U1 2
U2 7
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0368-492X
EI 1758-7883
J9 KYBERNETES
JI Kybernetes
DI 10.1108/K-12-2020-0913
EA JUN 2021
PG 18
WC Computer Science, Cybernetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science
GA TD7PP
UT WOS:000669514300001
OA Bronze
DA 2022-04-20
ER

PT J
AU Li, ZY
   Zhang, XX
   Yang, KL
   Singer, R
   Cui, R
AF Li, Zhiyong
   Zhang, Xiaoxuan
   Yang, Kailu
   Singer, Russ
   Cui, Rui
TI Urban and rural tourism under COVID-19 in China: research on the
   recovery measures and tourism development
SO TOURISM REVIEW
LA English
DT Article
DE Urban tourism; Rural tourism; COVID-19; China; Stakeholders
ID MANAGEMENT; IMPACTS; ROLES; MEDIA; SARS
AB Purpose - COVID-19 has severely affected urban and rural tourism in China, which has been extensively reported in the newspapers. This paper aims to discuss the impact of COVID-19 on urban and rural tourism at each critical juncture of the COVID-19 pandemic, as well as the studies, measures and attitudes of various stakeholders toward urban and rural tourism and their future development.
   Design/methodology/approach - This paper collects Chinese news reports as the research object and uses ROST Content Mining 6.0 and Gephi software to analyze and visualize the data for high-frequency words and analyzed the discourse of stakeholders within the newspaper text.
   Findings - This study found that prior to February 20, 2020, the Chinese Government mainly focused on pandemic prevention. From February 21 to April 3 (before The Qingming Festival), resumption of work and production became the theme. From April 4 to May 1 (before May Day), a time-sharing reservation system was widely implemented and the differentiation between urban and rural tourism became more prominent. After May 1, rural tourism attracted greater attention.
   Originality/value - This paper uses discourse analysis to understand the impact of COVID-19 on urban and rural tourism from the perspective of time nodes and the relationship between various stakeholders and predicts the development trends within urban and rural tourism. This paper enriches and expands tourism management knowledge in the face of major crises, providing valuable advice for managers and investors and makes suggestions for the development of urban and rural tourism.
C1 [Li, Zhiyong; Zhang, Xiaoxuan; Yang, Kailu; Cui, Rui] Sichuan Univ, Sch Tourism, Chengdu, Peoples R China.
   [Singer, Russ] KPMG Consulting, Amstelveen, Netherlands.
RP Cui, R (corresponding author), Sichuan Univ, Sch Tourism, Chengdu, Peoples R China.
EM cuiruiscu@163.com
FU Sichuan Province Science and Technology Plan Project [2019YFS0078];
   Sichuan universitySichuan University [2019hhs-13]
FX The authors would like to thank the seven reviewers for their helpful
   and constructive comments and suggestions for the paper.Funding: This
   work was supported by a grant from the Sichuan Province Science and
   Technology Plan Project (to LI Zhiyong) (No. 2019YFS0078), from Sichuan
   university (to LI Zhiyong) (No. 2019hhs-13).
CR Al-Saad S, 2017, TOURISM, V65, P361
   Ateljevic I, 2020, TOURISM GEOGR, V22, P467, DOI 10.1080/14616688.2020.1759134
   Bramwell, 1994, J SUSTAIN TOUR, V2, P1, DOI [https://doi.org/10.1080/09669589409510679, DOI 10.1080/09669589409510679]
   Bratman GN, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax0903
   Brouder P, 2020, TOURISM GEOGR, V22, P484, DOI 10.1080/14616688.2020.1760928
   Campiranon K, 2014, J TRAVEL TOUR MARK, V31, P313, DOI 10.1080/10548408.2013.877414
   Cheer JM, 2020, TOURISM GEOGR, V22, P514, DOI 10.1080/14616688.2020.1765016
   Chen C., 1996, GEOGRAPHY GEOINFORMA, V01, P61
   Chen HL, 2022, CURR ISSUES TOUR, V25, P198, DOI 10.1080/13683500.2020.1763269
   Chen X., 2020, ANN TOURISM RES, V83, P102913, DOI [10.1016/j.annals.2020.102913, DOI 10.1016/j.annals.2020.102913]
   Chen Y., 2020, TOURISM TRIBUNE, V08, P11, DOI [10.19765/j.cnki.1002-5006.2020.08.006, DOI 10.19765/J.CNKI.1002-5006.2020.08.006]
   Cheng G., 2020, ISSUES AGR EC, V04, P4
   Cheng MM, 2022, J SUSTAIN TOUR, V30, P1122, DOI 10.1080/09669582.2020.1802469
   CNKI, 2000, DAT INTR INF
   Ctrip, 2020, MID NAT DAY HOL TOUR
   Dai B., 2020, FRONTIERS, P46
   Dang S., 2020, INFORM MAGAZINE
   Durocher J., 1994, Cornell Hotel and Restaurant Administration Quarterly, V35, P66, DOI 10.1177/001088049403500220
   Edelheim J, 2020, TOURISM GEOGR, V22, P547, DOI 10.1080/14616688.2020.1760927
   Everingham P, 2020, TOURISM GEOGR, V22, P555, DOI 10.1080/14616688.2020.1762119
   Farmaki A, 2021, TOURISM MANAGE, V83, DOI 10.1016/j.tourman.2020.104210
   Figueres-Esteban M, 2016, SAFETY SCI, V89, P72, DOI 10.1016/j.ssci.2016.05.009
   Hu A., 2009, TOURISM TRIBUNE, V10, P9
   Iovino F, 2019, EUROMED ACAD BUS CON, P419
   Jiricka-Purrer A, 2020, J OUTDOOR REC TOUR, V31, DOI 10.1016/j.jort.2020.100329
   Kuo HI, 2008, TOURISM MANAGE, V29, P917, DOI 10.1016/j.tourman.2007.10.006
   Leslie D., 2006, J TRAVEL TOUR MARK, V19, P35, DOI DOI 10.1300/J073V19N02_04
   Li S.Y., 2020, CURR DEV NUTR, V4, P47, DOI [10.1093/cdn/nzaa040_047, DOI 10.1093/CDN/NZAA040_047]
   Liu BJ, 2016, TOURISM MANAGE, V55, P310, DOI 10.1016/j.tourman.2016.02.021
   Mansfeld Y., 1999, Journal of Travel Research, V38, P30, DOI 10.1177/004728759903800107
   Mao CK, 2010, TOURISM MANAGE, V31, P855, DOI 10.1016/j.tourman.2009.09.003
   Melly D, 2021, TOUR REV, V76, P88, DOI 10.1108/TR-07-2019-0312
   Ming Z., 2020, ACAD EXPLORATION, V3, P124
   Montanari A, 2010, ROME RIV SCI TURISMO, V1, P381
   Nanni A, 2021, ANN TOURISM RES, V86, DOI 10.1016/j.annals.2020.102942
   Niewiadomski P, 2020, TOURISM GEOGR, V22, P651, DOI 10.1080/14616688.2020.1757749
   Nilsson PA, 2002, ANN TOURISM RES, V29, P7, DOI 10.1016/S0160-7383(00)00081-5
   OECD, 1994, TOUR POL INT TOUR
   Panisson A, 2020, ARXIV PREPRINT ARXIV
   Rassy D, 2013, HEALTH ECON, V22, P824, DOI 10.1002/hec.2862
   Reddy MV, 2020, ANN TOURISM RES, V84, DOI 10.1016/j.annals.2020.102940
   Ritchie BW, 2019, ANN TOURISM RES, V79, DOI 10.1016/j.annals.2019.102812
   Roxas FMY, 2020, J HOSP TOUR MANAG, V45, P387, DOI 10.1016/j.jhtm.2020.09.005
   Schmidt A, 2013, GLOBAL ENVIRON CHANG, V23, P1233, DOI 10.1016/j.gloenvcha.2013.07.020
   Schweinsberg S, 2017, TOURISM MANAGE, V62, P241, DOI 10.1016/j.tourman.2017.04.011
   Schwitzer G, 2005, PLOS MED, V2, P576, DOI 10.1371/journal.pmed.0020215
   Sigala M, 2020, J BUS RES, V117, P312, DOI 10.1016/j.jbusres.2020.06.015
   Su BR, 2011, TOURISM MANAGE, V32, P1438, DOI 10.1016/j.tourman.2010.12.005
   Tomassini L, 2020, TOURISM GEOGR, V22, P713, DOI 10.1080/14616688.2020.1757747
   Tujia, 2020, 2020 NOV GOLD WEEK B
   United Nations World Tourism Organisation (UNWTO), 2019, URBAN TOURISM
   UNWTO, 2020, UNWTO STAT NOV COR O
   Wang Y. C., 2006, TOURISM TRIBUNE, V21, P6
   Wen J, 2021, TOUR REV, V76, P74, DOI 10.1108/TR-03-2020-0110
   Westcott B, 2020, CORONAVIRUS PANDEMIC
   Worldmeter, 2020, COVID 19 COR PAND
   Xu D., 2020, MOD URBAN RES, V1, P113
   Yang X., 2020, SOCIAL SCI, V01, P132
   Yu M, 2020, CURR ISSUES TOUR, DOI 10.1080/13683500.2020.1733497
   Zeng ZJ, 2020, TOURISM GEOGR, V22, P724, DOI 10.1080/14616688.2020.1762118
   Zhang YQ, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00742-y
   Zheng Y, 2020, ANATOLIA, V31, P337, DOI 10.1080/13032917.2020.1747208
   Zhu HL, 2020, IEICE ELECTRON EXPR, V17, DOI 10.1587/elex.17.20200001
NR 63
TC 22
Z9 22
U1 84
U2 146
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1660-5373
EI 1759-8451
J9 TOUR REV
JI Tour. Rev.
PD JUL 27
PY 2021
VL 76
IS 4
BP 718
EP 736
DI 10.1108/TR-08-2020-0357
EA JAN 2021
PG 19
WC Hospitality, Leisure, Sport & Tourism
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics
GA TT7MK
UT WOS:000613630300003
OA Bronze
DA 2022-04-20
ER

PT J
AU Vlados, C
AF Vlados, Charis
TI Designing Integrated Business Training Programs Focused on the
   Unemployed in the Post-COVID-19 Era
SO TEM JOURNAL-TECHNOLOGY EDUCATION MANAGEMENT INFORMATICS
LA English
DT Article
DE Training program; Unemployment; Post-COVID-19 era; Stra.Tech.Man
   approach; Modern management; Human resource development; Innovation;
   Knowledge development
ID HUMAN-RESOURCE MANAGEMENT; PERFORMANCE
AB Human resource development and continuous training are a precondition for organizational and socio-economic resilience and development. It is also vital to build integrated training programs, especially for the unemployed nowadays, considering the major challenges caused by the COVID-19 pandemic crisis in various labor markets internationally. This article aims to distinguish fundamental theoretical and practical dimensions of structuring business training programs and supporting learning and innovation after investigating critical trends of conceptual readjustment of modern management theory. A significant conclusion is that a business training program has to synthesize the organization's strategic, technological, and managerial potential and goals (Stra.Tech.Man approach), valorizing the basic principles of integrated planning, organizing, implementing, and controlling. A novel training program framework is suggested, attributing particular weight to developing structured mechanisms for training unemployed population groups at the local level.
C1 [Vlados, Charis] Democritus Univ Thrace, Dept Econ, POB 69100, Komotini, Greece.
   [Vlados, Charis] Univ Nicosia, Sch Business, 46 Makedonitissas Ave,POB 24005, CY-2417 Nicosia, Cyprus.
RP Vlados, C (corresponding author), Democritus Univ Thrace, Dept Econ, POB 69100, Komotini, Greece.
EM cvlados@econ.duth.gr
RI Vlados, Charis/AAI-3252-2021
OI Vlados, Charis/0000-0003-2509-6961
CR Andrikopoulos A, 2013, TRANSPORT RES A-POL, V47, P141, DOI 10.1016/j.tra.2012.10.016
   Bernardino G, 2020, EUR J TRAIN DEV, V44, P531, DOI 10.1108/EJTD-10-2019-0177
   Byrd MY, 2021, ADV DEV HUM RESOUR, V23, P3, DOI 10.1177/1523422320973957
   Carson M., 2006, BUS HORIZONS, V49, P395, DOI DOI 10.1016/J.BUSHOR.2006.01.004
   Dahl J, 2014, IND MARKET MANAG, V43, P272, DOI 10.1016/j.indmarman.2013.12.002
   Denby S., 2010, IND COMMER TRAIN, V42, P147, DOI [10.1108/00197851011038132, DOI 10.1108/00197851011038132]
   Donaires OS, 2019, SYST RES BEHAV SCI, V36, P66, DOI 10.1002/sres.2534
   Guest DE, 2011, HUM RESOUR MANAG J, V21, P3, DOI 10.1111/j.1748-8583.2010.00164.x
   HAMEL G, 1989, HARVARD BUS REV, V67, P133
   Hitt M.A., 2012, STRATEG MANAG
   Homburg C, 2014, J MARKETING, V78, P58, DOI 10.1509/jm.12.0529
   International Labour Organization (ILO), 2020, ILO MON COVID 19 WOR
   LAUDICINA PA, 2016, GLOBALIZATION ISLAND, P26
   Lee S, 2021, IEEE T INTELL TRANSP, V22, P1001, DOI [10.1109/TITS.2019.2961928, 10.1007/s41027-020-00249-y]
   Lengnick-Hall CA, 2011, HUM RESOUR MANAGE R, V21, P243, DOI 10.1016/j.hrmr.2010.07.001
   Lutchman, 2016, PROJECT EXECUTION PR
   Machado C, 2018, MANAGE IND ENG, P173, DOI 10.1007/978-3-319-66864-2_8
   McKelvey B, 2011, SAGE HDB COMPLEXITY
   Morduch, 2020, PRINCIPLES EC
   Nakano T., 2018, JAPANESE MANAGEMENT
   Nonaka I, 1995, KNOWLEDGE CREATING C
   Norton, 2008, EXECUTION PREMIUM LI
   Peneder M, 2017, CAMB J ECON, V41, P829, DOI 10.1093/cje/bew025
   Porter M.E., 1996, HARVARD BUS REV, P61
   Schumpeter J.A., 1934, THEORY EC DEV INQUIR
   Schwab K., 2016, 4 IND REVOLUTION
   Sharma S., 2018, TOTAL QUALITY MANAGE
   Sheehan M, 2014, INT SMALL BUS J, V32, P545, DOI 10.1177/0266242612465454
   Snyder H, 2019, J BUS RES, V104, P333, DOI 10.1016/j.jbusres.2019.07.039
   Spender, 2015, INT ENCY SOCIAL BEHA, V15, P675
   Stalker, 2011, SOCIOLOGY ORG STRUCT, V14
   Strikwerda E., 2013, WAGES RELIEF CITIES, V4
   Ting SC, 2011, EDUC ADMIN QUART, V47, P353, DOI 10.1177/0013161X10387589
   Tolstyakova OV, 2020, ENTREP SUSTAIN ISS, V8, P370, DOI 10.9770/jesi.2020.8.2(22)
   Vlados C, 2019, J STRATEGY MANAG, V12, P347, DOI 10.1108/JSMA-02-2019-0026
   Williamson P, 2021, MANAGE ORGAN REV, V17, P29, DOI 10.1017/mor.2020.80
   Womack J.P., 1990, MACHINE CHANGED WORL
   Zeleny M, 2010, HUM SYST MANAGE, V29, P191, DOI 10.3233/HSM-2010-0725
NR 38
TC 0
Z9 0
U1 4
U2 6
PU ASSOC INFORMATION COMMUNICATION TECHNOLOGY EDUCATION & SCIENCE
PI NOVI PAZAR
PA HILMA ROZAJCA 15, NOVI PAZAR, 36300, SERBIA
SN 2217-8309
EI 2217-8333
J9 TEM J
JI TEM J.
PD MAY
PY 2021
VL 10
IS 2
BP 645
EP 655
DI 10.18421/TEM102-20
PG 11
WC Computer Science, Information Systems
WE Emerging Sources Citation Index (ESCI)
SC Computer Science
GA SL8QL
UT WOS:000657179100020
OA gold
DA 2022-04-20
ER

PT J
AU Zhang, D
   Fang, B
   Yang, L
   Cai, YY
AF Zhang, Di
   Fang, Bing
   Yang, Ling
   Cai, Yuyang
TI Disinformation of text mining online about tobacco and the COVID-19
   discussed on Sina Weibo
SO TOBACCO INDUCED DISEASES
LA English
DT Article
DE tobacco; COVID-19; text; mining; disinformation; new; media
AB INTRODUCTION During the COVID-19 pandemic, various types of disinformation have emerged from the media. This study focuses on the online disinformation about tobacco and the COVID-19 on the Sina Weibo, the Chinese largest new media microblog platform. METHODS The related posts from the beginning of the epidemic in December 2019 to 19 January 2021 were searched. Text mining technology was applied on these posts to identify content on 'smoking can prevent COVID-19'. Descriptive research was used to analyze the dataset. RESULTS Among the 912 original posts, 508 informative posts were selected after artificial recognition, including 112 posts of spreading disinformation and 396 which dispel the disinformation. Of the disinformation posts, 74% (83/112) cited the results of scientific research, and 17% (19/112) mentioned that smog from burning Asian wormwood could prevent COVID-19. By analyzing the public's comments on these 112 disinformation posts, it was suggested that about 12% of the comments were in support, and 88% of the posts were opposed or invalid. The proportion of supportive comments on pseudo-scientific information was higher than on plain disinformation, 21% and 9%, respectively. CONCLUSIONS The disinformation of promoting smoking as a way to prevent COVID-19 has the typical feature of using pseudo-scientific arguments to package disinformation, making it very difficult for readers without professional knowledge to identify. Such actions harm both tobacco control and COVID-19 prevention.
C1 [Zhang, Di; Yang, Ling] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Geriatr, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.
   [Fang, Bing] Shanghai Univ, Sch Management, Dept Informat Management, Shanghai, Peoples R China.
   [Yang, Ling] Tibet Univ, Sch Med, Lhasa, Peoples R China.
   [Cai, Yuyang] Shanghai Jiao Tong Univ, Sch Med, Sch Publ Hlth, Shanghai 200025, Peoples R China.
   [Cai, Yuyang] Shanghai Jiao Tong Univ, China Inst Urban Governance, Shanghai, Peoples R China.
RP Yang, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Geriatr, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.; Cai, YY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Sch Publ Hlth, Shanghai 200025, Peoples R China.
EM yangling01@xinhuamed.com.cn; caiyuyang@sjtu.edu.cn
OI CAI, YUYANG/0000-0003-1500-8518
FU Shanghai Jiao Tong University Technology Promotion Fund [ZT202003];
   Humanity and Social Science Youth Foundation of the Ministry of
   Education of China [18YJC860006]
FX This study was supported by Shanghai Jiao Tong University Technology
   Promotion Fund (Grant Number: ZT202003) and Humanity and Social Science
   Youth Foundation of the Ministry of Education of China (Grant Number:
   18YJC860006).
CR [Anonymous], 2020, LANCET INFECT DIS, V20, P261, DOI 10.1016/S1473-3099(20)30072-4
   Jin X, 2018, CHINAS NATUROPATHY, V26, P45
   The Lancet, 2020, Lancet, V395, P537, DOI 10.1016/S0140-6736(20)30379-2
   World Health Organization, WHO COR COVID 19 DAS
   Yang G, 2011, TOBACCO CONTROL FUTU
NR 5
TC 0
Z9 0
U1 9
U2 9
PU EUROPEAN PUBLISHING
PI HERAKLION
PA SCIENCE & TECHNOLGY PARK CRETE, (STEP-C), N PLASTIRA 100, VASSILIKA
   VOUTWN, HERAKLION, CRETE 00000, GREECE
SN 1617-9625
J9 TOB INDUC DIS
JI Tob. Induc. Dis.
PD OCT
PY 2021
VL 19
AR 83
DI 10.18332/tid/142776
PG 3
WC Substance Abuse; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Substance Abuse; Public, Environmental & Occupational Health
GA WM6AD
UT WOS:000711165100001
PM 34720798
OA gold, Green Published
DA 2022-04-20
ER

PT C
AU Zhou, XY
   Mulay, A
   Ferrara, E
   Zafarani, R
AF Zhou, Xinyi
   Mulay, Apurva
   Ferrara, Emilio
   Zafarani, Reza
GP ASSOC COMP MACHINERY
TI ReCOVery: A Multimodal Repository for COVID-19 News Credibility Research
SO CIKM '20: PROCEEDINGS OF THE 29TH ACM INTERNATIONAL CONFERENCE ON
   INFORMATION & KNOWLEDGE MANAGEMENT
LA English
DT Proceedings Paper
CT 29th ACM International Conference on Information and Knowledge
   Management (CIKM)
CY OCT 19-23, 2020
CL ELECTR NETWORK
SP Assoc Comp Machinery, ACM SIGIR, ACM SIGWEB
DE Repository; COVID-19; coronavirus; pandemic; infodemic; information
   credibility; fake news; multimodal; social media
AB First identified in Wuhan, China, in December 2019, the outbreak of COVID-19 has been declared as a global emergency in January, and a pandemic in March 2020 by the World Health Organization (WHO). Along with this pandemic, we are also experiencing an "infodemic" of information with low credibility such as fake news and conspiracies. In this work, we present ReCOVery, a repository designed and constructed to facilitate research on combating such information regarding COVID-19. We first broadly search and investigate similar to 2,000 news publishers, from which 60 are identified with extreme [high or low] levels of credibility. By inheriting the credibility of the media on which they were published, a total of 2,029 news articles on coronavirus, published from January to May 2020, are collected in the repository, along with 140,820 tweets that reveal how these news articles have spread on the Twitter social network. The repository provides multimodal information of news articles on coronavirus, including textual, visual, temporal, and network information. The way that news credibility is obtained allows a trade-off between dataset scalability and label accuracy. Extensive experiments are conducted to present data statistics and distributions, as well as to provide baseline performances for predicting news credibility so that future methods can be compared. Our repository is available at http://coronavirus-fakenews.com.
C1 [Zhou, Xinyi; Mulay, Apurva; Zafarani, Reza] Syracuse Univ, EECS Dept, Data Lab, Syracuse, NY 13244 USA.
   [Ferrara, Emilio] Univ Southern Calif, Informat Sci Inst, Los Angeles, CA USA.
RP Zhou, XY (corresponding author), Syracuse Univ, EECS Dept, Data Lab, Syracuse, NY 13244 USA.
EM zhouxinyi@data.syr.edu; asmulay@syr.edu; emiliofe@usc.edu;
   reza@data.syr.edu
FU Defense Advanced Research Projects Agency (DARPA)United States
   Department of DefenseDefense Advanced Research Projects Agency (DARPA)
   [W911NF-17-C-0094]
FX Emilio Ferrara is supported by the Defense Advanced Research Projects
   Agency (DARPA, grant number W911NF-17-C-0094).
CR Baly R., 2018, ARXIV PREPRINT ARXIV, P3528, DOI [10.18653/v1/D18-1389, DOI 10.18653/V1/D18-1389]
   Chen Emily, 2020, JMIR Public Health Surveill, V6, pe19273, DOI 10.2196/19273
   Cui L., 2020, COAID COVID 19 HEALT
   Dai Enyan, 2020, P 14 INT AAAI C WEB, V14, P853
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Ferrara E, 2019, COMMUN ACM, V62, P82, DOI 10.1145/3299768
   Guo HL, 2020, ADV FUNCT MATER, V30, DOI 10.1002/adfm.202000024
   Ji YF, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P13
   Kim Y., 2014, P 2014 C EMP METH NA, DOI 10.3115/v1/D14-1181
   Mitra Tanushree., 2015, P 9 INT AAAI C WEB S, P258
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Norregaard J., 2019, P INT AAAI C WEB SOC, V13, P630
   Pennebaker J. W., 2015, DEV PSYCHOMETRIC PRO
   Shu K., 2018, ARXIV PREPRINT ARXIV
   Sitaula Niraj, 2020, DISINFORMATION MISIN
   Thorne James, 2018, P ACL, V1, P809, DOI 10.18653/v1/N18-1074
   Wang WY, 2017, PROCEEDINGS OF THE 55TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2017), VOL 2, P422, DOI 10.18653/v1/P17-2067
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
   Xu B, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0448-0
   Zafarani R, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P3207, DOI 10.1145/3292500.3332287
   Zafarani Reza, 2014, SOCIAL MEDIA MINING
   Zhang JW, 2020, PROC INT CONF DATA, P1826, DOI 10.1109/ICDE48307.2020.00180
   Zhou X., 2020, DIGITAL THREATS RES, V1
   Zhou Xinyi, 2020, COMPUT SURVEYS
NR 24
TC 4
Z9 4
U1 0
U2 0
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1601 Broadway, 10th Floor, NEW YORK, NY, UNITED STATES
BN 978-1-4503-6859-9
PY 2020
BP 3205
EP 3212
DI 10.1145/3340531.3412880
PG 8
WC Computer Science, Information Systems; Computer Science, Theory &
   Methods
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science
GA BS6LW
UT WOS:000749561303024
OA Green Submitted
DA 2022-04-20
ER

PT J
AU Fassas, A
   Bellos, S
   Kladakis, G
AF Fassas, Athanasios
   Bellos, Sotirios
   Kladakis, George
TI Corporate liquidity, supply chain and cost issues awareness within the
   Covid-19 context: evidence from us management reports' textual analysis
SO CORPORATE GOVERNANCE-THE INTERNATIONAL JOURNAL OF BUSINESS IN SOCIETY
LA English
DT Article
DE Textual analysis; Coronavirus; COVID-19; Pandemic; Corporate
   disclosures; SEC filings; G30; G34; G39
AB Purpose
   The purpose of this study is to assess the management responses and intentions of 3,279 US firms from all industries, before and after the coronavirus outbreak, to identify the level of managerial concern about specific financial issues and potential economic costs of the COVID-19 pandemic.
   Design/methodology/approach
   This paper uses textual analysis of official management reports to search for specific single words in five domains related to corporate finance and governance. This paper focuses on the relative frequency of single words using a weighting scheme that adjusts for document length and for the inverse document frequency. This paper then uses t-tests to investigate the univariate differences across groups of reports before and after the US stock market crash in February 2020.
   Findings
   The applied textual and empirical analysis provides evidence that firms' primary concerns relate to the disruption in supply chains, liquidity need and coronavirus-led recession. This paper also shows that the main cost reduction measure they are considering is salary reduction, rather than workforce reduction. This paper also shows evidence that firm managers are rather swift to provide coronavirus-related information in the US Securities and Exchange Commission (SEC) corporate filings.
   Practical implications
   The findings provide a primary view of the directions, on which US firms will move in the near future, and thus, they can be used as tools for the formulation of appropriate government policies in the corresponding sectors, which could mitigate the economic risks related to the pandemic. At the business level, the disseminated knowledge can assist firms either in the same sector or in similar/related sectors to "locate" themselves within the map of the pandemic and to adjust or align correspondingly their strategies and decisions as they will have a view of the bigger picture.
   Originality/value
   The empirical analysis divulges US firms' management primary concerns after the COVID-19 outbreak, and thus, offers insights to the processes taking place in the US business community and the formulating new corporate and economic reality.
C1 [Fassas, Athanasios] Univ Thessaly, Volos, Greece.
   [Bellos, Sotirios] Univ York Europe Campus, CITY Coll, Thessaloniki, Greece.
   [Bellos, Sotirios] South East European Res Ctr, Thessaloniki, Greece.
   [Kladakis, George] Univ Sheffield, Management Sch, Sheffield, S Yorkshire, England.
RP Fassas, A (corresponding author), Univ Thessaly, Volos, Greece.
EM afassas@uth.gr; sbellos@citycollege.sheffield.eu;
   gkladakis1@sheffield.ac.uk
RI Fassas, Athanasios P./AAS-8514-2020; Bellos, Sotirios/AAZ-2409-2020
OI Fassas, Athanasios P./0000-0002-4566-2257; Bellos,
   Sotirios/0000-0003-1973-2335; Kladakis, George/0000-0003-2502-2401
CR Alexer D., 2020, 202012 WP FED RES BA
   Arezki R., 2020, EC TIME COVID 19
   Bacha S, 2019, CORP GOV-INT J BUS S, V20, P201, DOI 10.1108/CG-02-2019-0060
   Baldwin R., 2020, MITIGATING COVID EC
   Banerjee, 2020, COVID 19 CORPORATE S
   Barnett T., 2002, AIDS 21 CENTURY DIS
   Bartik A.W., 2020, TARGETING IMPACT PAY
   Brown SV, 2011, J ACCOUNT RES, V49, P309, DOI 10.1111/j.1475-679X.2010.00396.x
   Bueno G, 2018, CORP GOV-INT J BUS S, V18, P886, DOI 10.1108/CG-09-2017-0205
   Chakraborty B, 2020, J FINANC REPORT ACCO, V18, P757, DOI 10.1108/JFRA-02-2020-0047
   Chen MK, 2013, AM ECON REV, V103, P690, DOI 10.1257/aer.103.2.690
   Chiu TT, 2018, CONTEMP ACCOUNT RES, V35, P2191, DOI 10.1111/1911-3846.12362
   Cuadrado-Ballesteros B, 2016, MANAGE DECIS, V54, P1669, DOI 10.1108/MD-10-2015-0454
   Anh DLT, 2021, J ECON STUD, V48, P836, DOI 10.1108/JES-06-2020-0312
   Davies S, 2020, ECON AFFA, V40, P131, DOI 10.1111/ecaf.12415
   Davis AK, 2015, REV ACCOUNT STUD, V20, P639, DOI 10.1007/s11142-014-9309-4
   de Villiers C, 2021, J MANAG GOV, V25, P7, DOI 10.1007/s10997-020-09530-0
   Ding Wenzhi., 2020, CORPORATE IMMUNITY C
   Duffie D, 2001, ECONOMETRICA, V69, P633, DOI 10.1111/1468-0262.00208
   Easley D, 2009, REV FINANC STUD, V22, P1817, DOI 10.1093/rfs/hhn100
   Espitia A., 2020, VOX CEPR POLICY PORT, V9
   Evenett SJ, 2019, J INT BUS POLICY, V2, P9, DOI 10.1057/s42214-019-00021-0
   Farrell F, 2020, BECKER FRIEDMAN I EC, P2020
   Froud J., 2011, GREAT COMPLACENCE FI
   Gonz?lez A, 2020, PETERSON I INT EC, V23
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Gray RS, 2020, CAN J AGR ECON, V68, P239, DOI 10.1111/cjag.12235
   Hassan MK, 2019, CORP GOV-INT J BUS S, V19, P270, DOI 10.1108/CG-05-2018-0182
   Hassan OAG, 2019, INT J ACCOUNT, V54, DOI 10.1142/S1094406019500069
   Healy PM, 2001, J ACCOUNT ECON, V31, P405, DOI 10.1016/S0165-4101(01)00018-0
   Hendren N., 2020, W27431 MAT BUR EC RE
   Henry E, 2016, ACCOUNT REV, V91, P153, DOI 10.2308/accr-51161
   Jain A, 2015, SOC RESPONSIB J, V11, P2, DOI 10.1108/SRJ-10-2012-0136
   Javorcik B., 2020, COVID 19 TRADE POLIC, P111
   Jurafsky D., 2009, PART OF SPEECH TAGGI
   Karapandza R, 2016, J BANK FINANC, V71, P50, DOI 10.1016/j.jbankfin.2016.04.025
   Kearney C, 2014, INT REV FINANC ANAL, V33, P171, DOI 10.1016/j.irfa.2014.02.006
   Kerr W.A, 2009, J INT LAW TRADE POLI, V10, P1, DOI DOI 10.22004/AG.EC0N.48788
   Kerr WA, 2020, CAN J AGR ECON, V68, P225, DOI 10.1111/cjag.12230
   Kravet T, 2013, REV ACCOUNT STUD, V18, P1088, DOI 10.1007/s11142-013-9228-9
   Lamontagne E, 2010, CURR OPIN HIV AIDS, V5, P249, DOI 10.1097/COH.0b013e3283384a3c
   Larue B, 2020, CAN J AGR ECON, V68, P231, DOI 10.1111/cjag.12233
   Lo K, 2017, J ACCOUNT ECON, V63, P1, DOI 10.1016/j.jacceco.2016.09.002
   Loughran T, 2016, J ACCOUNT RES, V54, P1187, DOI 10.1111/1475-679X.12123
   Loughran T, 2011, J FINANC, V66, P35, DOI 10.1111/j.1540-6261.2010.01625.x
   Lyocsa S, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101707
   McNeill W.H., 1998, PLAGUES PEOPLES 1976
   McQuinn J., 2020, SME LIQUIDITY NEEDS
   Morris RD, 2018, ACCOUNT RES J, V31, P423, DOI 10.1108/ARJ-10-2015-0126
   Nerantzidis M, 2018, CORP GOV-INT J BUS S, V18, P773, DOI 10.1108/CG-10-2018-302
   Nerantzidis M, 2017, CORP GOV-INT J BUS S, V17, P365, DOI 10.1108/CG-07-2016-0145
   Ramelli S, 2020, REV CORP FINANC STUD, V9, P622, DOI 10.1093/rcfs/cfaa012
   Rizwan MS, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101682
   Routledge BR, 2009, REV ECON DYNAM, V12, P543, DOI 10.1016/j.red.2008.10.002
   SALTON G, 1988, INFORM PROCESS MANAG, V24, P513, DOI 10.1016/0306-4573(88)90021-0
   Sengupta P, 1998, ACCOUNT REV, V73, P459
   Shama R., 2011, FOOD EXPORT RESTRICT, P1
   Sharfuddin S., 2020, COMMONWEALTH J INT A, V109, P247
   Singh SK, 2021, INT J HUM RESOUR MAN, V32, P1707, DOI 10.1080/09585192.2018.1547778
   Szmrecsanyi B, 2003, J ENGL LINGUIST, V31, P295, DOI DOI 10.1177/0075424203257830
   Tahoun A., 2020, FIRM LEVEL EXPOSURE, DOI 10.36687/inetwp119
   Tayan B., 2020, ROCK CTR CORPORATE G, VCGRP85
   van Hoek R, 2020, INT J OPER PROD MAN, V40, P341, DOI 10.1108/IJOPM-03-2020-0165
   Wang LQ, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12155978
   Wang V.X, 2020, EAR C CALLS ANN REP
   Wang ZH, 2018, CORP SOC RESP ENV MA, V25, P66, DOI 10.1002/csr.1440
   Wojcik D, 2020, TIJDSCHR ECON SOC GE, V111, P387, DOI 10.1111/tesg.12434
   Zhang YM, 2020, CHINA AGR ECON REV, V12, P387, DOI 10.1108/CAER-04-2020-0063
   Zobel J., 1998, SIGIR Forum, V32, P18
NR 69
TC 1
Z9 1
U1 5
U2 17
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1472-0701
EI 1758-6054
J9 CORP GOV-INT J BUS S
JI Corp. Gov.-Int. J. Bus. Soc.
PD SEP 22
PY 2021
VL 21
IS 6
SI SI
BP 1155
EP 1171
DI 10.1108/CG-09-2020-0399
EA APR 2021
PG 17
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA US4PQ
UT WOS:000637817900001
OA Bronze
DA 2022-04-20
ER

PT J
AU Tan, R
   Yu, T
   Luo, KY
   Teng, F
   Liu, YL
   Luo, J
   Hu, DY
AF Tan, Rong
   Yu, Ting
   Luo, Kaiyan
   Teng, Fen
   Liu, Yilan
   Luo, Jian
   Hu, Deying
TI Experiences of clinical first-line nurses treating patients with
   COVID-19: A qualitative study
SO JOURNAL OF NURSING MANAGEMENT
LA English
DT Article
DE COVID-19; first-line nurses; public health emergency; qualitative study;
   work experience
ID HEALTH-CARE WORKERS; CORONAVIRUS; INFLUENZA; OUTBREAK; CHINA
AB Aim To explore the work experience of clinical first-line nurses treating patients with coronavirus disease 2019 (COVID-19). Background COVID-19 has been listed as an international public health emergency. Clinical first-line nurses are at a high risk of infection, and they face a lack of experience and inadequate preparation for COVID-19, leading to physical and psychological disorders. Methods A qualitative study was conducted from January to February 2020 at a COVID-19-designated hospital in Wuhan, China. Thirty nurses were selected for the study using a purposive sampling method. Data were collected by semi-structured interviews and analysed using content analysis. Results Two main categories were defined in the study from the perspective of nurses: negative experiences during clinical first-line work and positive impacts of clinical first-line work. Under the first category, two subcategories were included: psychological experiences of clinical first-line work and difficulties faced during clinical first-line work. The analysis further yielded two subcategories for the second category: the needs of clinical first-line work and the impact of clinical first-line work on professional attitudes. Conclusions The results demonstrate that success depends upon strengthening emergency training and knowledge of infectious diseases for nurses, providing adequate protective equipment and improving the emergency response plans of hospitals for public health emergencies. Implications for Nursing Management It is believed that our findings will guide hospital managers to make improvements in personal, administrative and institutional areas and that they will provide a reference and inspiration for nurses with regard to public health emergencies in the future.
C1 [Tan, Rong; Luo, Kaiyan] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Orthoped, Wuhan, Peoples R China.
   [Yu, Ting] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Nursing, Wuhan, Peoples R China.
   [Teng, Fen] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Nursing, Wuhan, Peoples R China.
   [Liu, Yilan; Luo, Jian; Hu, Deying] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Nursing, 1277 Jiefang Dadao, Wuhan 430022, Hubei, Peoples R China.
RP Hu, DY (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Nursing, 1277 Jiefang Dadao, Wuhan 430022, Hubei, Peoples R China.
EM hudeying2006@126.com
OI Tan, Rong/0000-0002-5124-1600
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [71673100]
FX This study was supported by the National Natural Science Foundation of
   China (grant number: 71673100).
CR [Anonymous], 2020, ANN HEADQ NOV COR PN
   Baric RS., 2020, SEVERE ACUTE RESP SY, P2020, DOI [10.1101/2020.02.07.937862, DOI 10.1101/2020.02.07.937862]
   Barnett M, 2005, J CLIN NURS, V14, P805, DOI 10.1111/j.1365-2702.2005.01125.x
   Butsashvili M, 2007, J INFECT DEV COUNTR, V1, P329, DOI 10.3855/jidc.373
   Chen GQ, 2015, J SENSORS, V2015, DOI 10.1155/2015/964730
   Chersich MF, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00574-3
   Chinese Economic Network, 2020, USD 16 5 BILL EP PRE
   Damery S, 2010, J MED ETHICS, V36, P12, DOI 10.1136/jme.2009.032821
   Feng ZH, 2020, J INFECTION, V80, P605, DOI 10.1016/j.jinf.2020.02.011
   Heidegger Martin, 2010, BEING TIME
   Holloway I, 2010, QUALITATIVE RES NURS
   Lee W, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3936-1
   Li JY, 2020, MICROBES INFECT, V22, P80, DOI 10.1016/j.micinf.2020.02.002
   Li Z., 2012, NURSING RES METHODS
   Lippi G, 2020, DIAGNOSIS, V7, P79, DOI 10.1515/dx-2020-0015
   Liu HP, 2009, J CLIN NURS, V18, P2880, DOI 10.1111/j.1365-2702.2009.02857.x
   Liu S, 2020, LANCET PSYCHIAT, V7, pE17, DOI 10.1016/S2215-0366(20)30077-8
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]
   Martins JT, 2009, REV LAT-AM ENFERM, V17, P52, DOI 10.1590/S0104-11692009000100009
   [苗琪琪 Miao Qiqi], 2018, [中华护理杂志, Chinese Journal of Nursing], V53, P720
   Molayaghobi NS, 2019, J NURS MANAGE, V27, P1091, DOI 10.1111/jonm.12777
   Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929
   Nagesh S, 2020, J GLOB HEALTH, V10, DOI [10.7189/jogh.10.010345, 10.7189/jogh-10-010345]
   National Health Commission of the People's Republic of China, 2020, LAT SIT NOV COR EP
   Refrande SM, 2019, REV BRAS ENFERM, V72, P111, DOI 10.1590/0034-7167-2018-0221
   Samur M, 2019, J NURS MANAGE, V27, P1400, DOI 10.1111/jonm.12821
   Selgelid MJ, 2009, PUBLIC HEALTH, V123, P255, DOI 10.1016/j.puhe.2008.12.005
   Tan ZH, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010357
   Tang H. Y., 2018, J NURSING SCI, V15, P87, DOI [10.3870/j.issn.1001-4152.2018.15.087, DOI 10.3870/J.ISSN.1001-4152.2018.15.087]
   To KKW, 2013, J THORAC DIS, V5, pS103, DOI 10.3978/j.issn.2072-1439.2013.06.02
   World Health Organization (WHO), 2020, COVID 19 STRAT UPD
   Wuhan Municipal Health Commission, 2020, UT HOSP BEDS DES HOS
   Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8
   Xu M, 2020, CHIN NURS RES, V34, P1
   Ye X. Y., 2020, MODERN CLIN NURSING, V19, P1
   [张华 Zhang Hua], 2014, [护理学杂志, Journal of Nursing Science], V29, P13
   张黎明, 2003, [中华护理杂志, Chinese Journal of Nursing], V38, P402
NR 37
TC 44
Z9 44
U1 6
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0966-0429
EI 1365-2834
J9 J NURS MANAGE
JI J. Nurs. Manag.
PD SEP
PY 2020
VL 28
IS 6
BP 1381
EP 1390
DI 10.1111/jonm.13095
EA AUG 2020
PG 10
WC Management; Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Business & Economics; Nursing
GA NK6MG
UT WOS:000558809500001
PM 32657465
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Geldres-Weiss, VV
   Massa, NP
   Monreal-Perez, J
AF Geldres-Weiss, Valeska V.
   Massa, Nathaniel P.
   Monreal-Perez, Joaquin
TI Export Promotion Agencies' Lived Turmoil, Response and Strategies in
   COVID-19 Times
SO SUSTAINABILITY
LA English
DT Article
DE Export Promotion Agencies; exports; internationalisation; SME; COVID-19;
   crisis; uncertainty; South America; in-depth interviews; narratives
ID INNOVATION PROCESS; RISK-MANAGEMENT; VALUE CREATION; FIRMS; KNOWLEDGE;
   BUSINESS; ENTREPRENEURSHIP; ECONOMIES; SMES; OPPORTUNITIES
AB This paper explores Export Promotion Agencies' (EPAs') lived turmoil amid the COVID-19 crisis. It investigates: the EPAs' perspective on pandemic impact on exporting SMEs; the pandemic impact on EPAs, their operations and response strategies; and EPAs' perception and expectations post-COVID. The research draws on in-depth interviews with three countries' EPA managers (Chile, Ecuador, Peru); five elite informants engaged operationally and strategically. A narrative approach inquiring on human experience is adopted, enabling rich insights on complex dynamics and contextual realities 'from the inside'. Notwithstanding heavy regional impact, no research exists on South America; especially EPAs' role in COVID times. The methodology provides intimate first-hand knowledge on idiosyncratic circumstances shrouded in uncertainty; unprecedented challenges faced at ground zero, addressed in unconventional ways. Country-specific complexities compounded pandemic impact. EPAs were compelled to rediscover their purpose, devising novel responses to help exporting SMEs. Notwithstanding reduced budgets and layoffs, the EPAs persevered, innovating resource-light solutions to pragmatically surmount turmoil; effectively serving their mission amid uncertainty and adversity. In/formal emergent trust-based cooperation strategies proved crucial. Also accentuated was production and consumption environmental sustainability. Detailed front-line perspectives provide valuable insight and important lessons on complex challenges endured and effective EPA action. Post-COVID perspectives, best practice and policy support recommendations are forthcoming.
C1 [Geldres-Weiss, Valeska V.] Univ La Frontera, Fac Law & Business, Dept Management & Econ, Temuco 4811230, Chile.
   [Massa, Nathaniel P.] Univ Malta, Fac Econ Management & Accountancy, Dept Management, MSD 2080, Msida, Malta.
   [Monreal-Perez, Joaquin] Campus Univ Espinardo, Fac Econ & Business, Dept Business Management & Finances, Murcia 30100, Spain.
RP Geldres-Weiss, VV (corresponding author), Univ La Frontera, Fac Law & Business, Dept Management & Econ, Temuco 4811230, Chile.
EM valeska.geldres@ufrontera.cl; nathaniel.massa@um.edu.mt; jomonreal@um.es
RI Geldres-Weiss, Valeska V./C-8673-2015; Monreal-Perez,
   Joaquin/L-1781-2014
OI Geldres-Weiss, Valeska V./0000-0002-4963-0789; Monreal-Perez,
   Joaquin/0000-0002-9471-9643
FU Chilean National Research Agency and Development ANID [ANID-COVID0364]
FX This research was funded by Chilean National Research Agency and
   Development ANID, grant for Rapid Resource Allocation for Research
   Projects on Coronavirus (COVID-19), grant number ANID-COVID0364
   [Concurso Asignacion Rapida].
CR Aguinis H, 2019, STRATEGIC MANAGE J, V40, P1291, DOI 10.1002/smj.3015
   [Anonymous], 2020, LANCET, V396, P1463, DOI 10.1016/S0140-6736(20)32328-X
   Arfaoui M, 2017, EUR J MANAG BUS ECON, V26, P278, DOI 10.1108/EJMBE-10-2017-016
   Arthur S, 2003, QUALITATIVE RES PRAC
   Berry H, 2014, STRATEGIC MANAGE J, V35, P869, DOI 10.1002/smj.2140
   Bodwell W, 2010, TECHNOL FORECAST SOC, V77, P193, DOI 10.1016/j.techfore.2009.07.004
   Bolano-Ortiz TR, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208661
   BOYACIGILLER NA, 1991, ACAD MANAGE REV, V16, P262, DOI 10.2307/258862
   Brinkmann, 2018, DOING INTERVIEWS
   Buckley PJ., 1996, INT BUS REV, V5, P223
   Cao LJ, 2021, CHINA AGR ECON REV, V13, P1, DOI 10.1108/CAER-05-2020-0079
   Castro-Gonzales S, 2016, ECON SYST, V40, P373, DOI 10.1016/j.ecosys.2015.10.003
   Catanzaro A, 2021, SMALL BUS ECON, V57, P1479, DOI 10.1007/s11187-020-00358-4
   Coviello NE, 2004, J BUS VENTURING, V19, P485, DOI 10.1016/j.jbusvent.2003.06.001
   Creswell J.W., 1998, QUAL INQ
   Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2
   De P., 2020, ARTNET WORKING PAPER, V198
   Destri AML, 2018, EUR J MANAG BUS ECON, V27, P155, DOI 10.1108/EJMBE-09-2017-0016
   Dias A, 2017, EUR J MANAG BUS ECON, V26, P2, DOI 10.1108/EJMBE-07-2017-001
   Dias GC, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13116049
   Dominguez N, 2018, J INT ENTREP, V16, P58, DOI 10.1007/s10843-017-0219-y
   Donthu N, 2020, J BUS RES, V117, P284, DOI 10.1016/j.jbusres.2020.06.008
   Economic Commission for Latin America and the Caribbean (ECLAC), REP EC IMP COR DIS C
   Economic Commission on Latin America and the Caribbean (ECLAC), 2020, PREL OV EC LAT AM CA
   Eggers F, 2020, J BUS RES, V116, P199, DOI 10.1016/j.jbusres.2020.05.025
   Eisenhardt KM, 2007, ACAD MANAGE J, V50, P25, DOI 10.5465/AMJ.2007.24160888
   European Trade Promotion Organisation Association (ETPOA), COVID 19 SURV
   Fernandes N, WP1240E IESE
   Freixanet J, 2021, EUR J INT MANAG, V16, P118, DOI 10.1504/EJIM.2021.116703
   Freixanet J, 2018, J EAST-WEST BUS, V24, P287, DOI 10.1080/10669868.2018.1467840
   Gao SS, 2013, INT SMALL BUS J, V31, P677, DOI 10.1177/0266242611431094
   Garcia-Rodriguez FJ, 2017, EUR J MANAG BUS ECON, V26, P163, DOI 10.1108/EJMBE-07-2017-010
   Geldres-Weiss VV, 2016, J BUS RES, V69, P5076, DOI 10.1016/j.jbusres.2016.04.083
   Ghauri P., 2010, RES METHODS BUSINESS
   Glavic P, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12166500
   Goddard W., 2004, RES METHODOLOGY INTR
   Harvey WS, 2011, QUAL RES, V11, P431, DOI 10.1177/1468794111404329
   Heredia Jorge, 2019, Journal of Technology Management & Innovation, V14, P54
   Hilmola OP, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208315
   Hosein R, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13052870
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Huarng KH, 2019, EUR J MANAG BUS ECON, V28, P110, DOI 10.1108/EJMBE-07-2019-140
   IMF (International Monetary Fund), WORLD EC OUTL UPD JU
   International Labour Organization (ILO), PREP FUT WORK WE WAN
   International Monetary Fund (IMF), COVID 19 LAT AM HIGH
   International Monetary Fund (IMF), REG EC OUTL W HEM PA
   International Trade Center (ITC), SME COMP OUTL 2020 C
   Ivanov D, 2020, INT J PROD RES, V58, P2904, DOI 10.1080/00207543.2020.1750727
   Jones MV, 2014, ENTREP THEORY PRACT, V38, P45, DOI 10.1111/etap.12060
   Kamasak R, 2017, EUR J MANAG BUS ECON, V26, P252, DOI 10.1108/EJMBE-07-2017-015
   Kang J, 2021, MARK INTELL PLAN, V39, P454, DOI 10.1108/MIP-05-2020-0217
   Kantur D, 2012, J MANAGE ORGAN, V18, P762
   Lamb P, 2011, J INT BUS STUD, V42, P672, DOI 10.1057/jibs.2011.8
   Leonidou LC, 2015, HANDBOOK OF RESEARCH ON INTERNATIONAL ENTREPRENEURSHIP STRATEGY: IMPROVING SME PERFORMANCE GLOBALLY, P233
   Lincoln Y.S., 1986, NEW DIRECTIONS PROGR, V1986, P73, DOI [10.1002/(ISSN)1551-2371, DOI 10.1002/EV.1427, https://doi.org/10.1002/ev.1427]
   Malca O, 2020, SMALL BUS ECON, V55, P831, DOI 10.1007/s11187-019-00185-2
   Suarez-Ortega SM, 2016, EUR J MANAG BUS ECON, V25, P22, DOI 10.1016/j.redee.2015.10.002
   Marschan-Piekkari R., 2004, HDB QUALITATIVE RES, P5, DOI [10.4337/9781781954331, DOI 10.4337/9781781954331.00013]
   Mintzberg H., 2005, STRATEGY SAFARI GUID
   Moen T., 2006, INT J QUAL METH, V5, P56, DOI [https://doi.org/10.1177/160940690600500405, DOI 10.1177/160940690600500405]
   Mohiuddin H, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13042222
   Monreal-Perez J, 2020, BRQ-BUS RES Q, V23, DOI 10.1177/2340944420901045
   Monreal-Purez, 2018, J PROMOTION MANAGEME, V24, P660, DOI [10.1080/10496491.2018.1405519, DOI 10.1080/10496491.2018.1405519]
   Moon SG, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9030415
   Navarro-Galera A, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9030432
   Neuman WL, 2003, SOCIAL RES METHODS Q
   Oberg C, 2019, EUR J MANAG BUS ECON, V28, P174, DOI 10.1108/EJMBE-11-2018-0116
   Organisation for Economic Co-Operation and Development (OECD), PROM PROD INCL GROWT
   Organisation for Economic Co-Operation and Development (OECD), COVID 19 INT TRAD IS
   Organisation for Economic Co-operation and Development (OECD), TACKL COR COVID 19 K
   Ortiz B, 2017, EUR J MANAG BUS ECON, V26, P48, DOI 10.1108/EJMBE-07-2017-004
   Perez JAH, 2019, TECHNOVATION, V79, P35, DOI 10.1016/j.technovation.2018.02.012
   Petrunenko I, 2020, BALT J ECON STUD, V6, P107, DOI 10.30525/2256-0742/2020-6-3-107-113
   Rehman FU, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13105408
   Ribeiro-Soriano D, 2017, ENTREP REGION DEV, V29, P1, DOI 10.1080/08985626.2016.1255438
   Rico P, 2019, EUR J MANAG BUS ECON, V28, P158, DOI 10.1108/EJMBE-07-2018-0077
   Diaz CAR, 2017, EUR J MANAG BUS ECON, V26, P180, DOI 10.1108/EJMBE-07-2017-011
   Rodriguez V, 2017, EUR J MANAG BUS ECON, V26, P220, DOI 10.1108/EJMBE-07-2017-013
   Rokosz K, 2020, COVID 19 PANDEMIC DI
   Saunders M., 2012, RES METHODS BUSINESS
   Scheibelhofer E, 2008, INT J SOC RES METHOD, V11, P403, DOI 10.1080/13645570701401370
   Snape D., 2003, QUALITATIVE RES PRAC
   Stake R.E, 1995, ART CASE STUDY RES
   Tsuji M, 2018, EUR J MANAG BUS ECON, V27, P198, DOI 10.1108/EJMBE-02-2018-0030
   Van Biesebroeck J, 2016, ECON POLICY, V31, P653, DOI 10.1093/epolic/eiw014
   Vendrell-Herrero F, 2017, J WORLD BUS, V52, P489, DOI 10.1016/j.jwb.2016.08.007
   Verma S, 2020, J BUS RES, V118, P253, DOI 10.1016/j.jbusres.2020.06.057
   Wang YG, 2020, J BUS RES, V116, P214, DOI 10.1016/j.jbusres.2020.05.029
   Weick KE, 2005, ORGAN SCI, V16, P409, DOI 10.1287/orsc.1050.0133
   WEICK KE, 1988, J MANAGE STUD, V25, P305, DOI 10.1111/j.1467-6486.1988.tb00039.x
   Willis R, 2019, QUAL RES, V19, P471, DOI 10.1177/1468794118787711
   Wipulanusat W, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13116024
   WRIGHT LL, 1996, HDB INT MANAGEMENT R, P63
   WTO, 2020, WORLD TRAD STAT REV
   Zoratto L., 2018, POLICY RES WORKING P
NR 95
TC 0
Z9 0
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD NOV
PY 2021
VL 13
IS 21
AR 12056
DI 10.3390/su132112056
PG 24
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA XJ7CP
UT WOS:000726941400001
OA gold
DA 2022-04-20
ER

PT J
AU Moradzadeh, R
   Nazari, J
   Shamsi, M
   Amini, S
AF Moradzadeh, Rahmatollah
   Nazari, Javad
   Shamsi, Mohsen
   Amini, Saeed
TI Knowledge, Attitudes, and Practices Toward Coronavirus Disease 2019 in
   the Central Area of Iran: A Population-Based Study
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE knowledge; attitudes; practices; COVID-19; Iran
AB Background: The spread of the coronavirus disease 2019 (COVID-19) pandemic has imposed high threats on global health, life and work style, and social and economic development. The current study aimed to extract knowledge, attitudes, and practices related to COVID-19 among the general population in the central area of Iran.
   Method: A cross-sectional study was conducted in Arak City between April and May 2020. Stratified random sampling was applied to select the study participants. Phone interview was applied to collect the data. Data were collected using a questionnaire that was constructed and validated in this study. The questionnaire included demographic variables and items about knowledge, attitudes, and practices toward COVID-19. Descriptive and inferential analyses were conducted in STATA software.
   Results: In total, 544 participants completed the questionnaire; 76% of the participants accounted COVID-19 as a high threat 1 month from the onset of COVID-19. From the maximum attainable scores of 1, 6, and 6, for COVID-19-related knowledge, attitudes, and practices, means of 0.77 (0.13), 4.97 (0.63), and 5.35 (0.70) were obtained, respectively. Females had a higher practice score (5.4 +/- 0.6). The participants with a family history of heart and respiratory diseases had significantly higher attitude and practice scores. SMS from the Ministry of Health had a significant impact on knowledge, attitude, and practice scores (p < 0.05).
   Conclusion: Higher attention should be given to increase the knowledge, attitudes, and practices of men and the housewife group. COVID-19 preventive messaging from the Ministry of Health was among the most influential methods of increasing knowledge that attracted public attention.
C1 [Moradzadeh, Rahmatollah] Arak Univ Med Sci, Sch Hlth, Dept Epidemiol, Arak, Iran.
   [Nazari, Javad] Arak Univ Med Sci, Sch Med, Dept Pediat, Arak, Iran.
   [Shamsi, Mohsen] Arak Univ Med Sci, Fac Hlth, Dept Hlth Educ & Hlth Promot, Arak, Iran.
   [Amini, Saeed] Arak Univ Med Sci, Sch Hlth, Dept Hlth Management, Arak, Iran.
RP Amini, S (corresponding author), Arak Univ Med Sci, Sch Hlth, Dept Hlth Management, Arak, Iran.
EM sa_536@yahoo.com
RI Nazari, Javad/ABE-6348-2021; shamsi, mohsen/N-1363-2017
FU Arak University of Medical Sciences
FX This study was financially supported by Arak University of Medical
   Sciences.
CR Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217
   Almutairi KM, 2015, FAM COMMUNITY HEALTH, V38, P332, DOI 10.1097/FCH.0000000000000082
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Beier ME, 2003, J PERS SOC PSYCHOL, V84, P439, DOI 10.1037/0022-3514.84.2.439
   Chen Yan, 2020, Zhonghua Yufang Yixue Zazhi, V54, P367, DOI [10.3760/cma.j.cn112150-20200205-00069, 10.3760/cma.j.cn112150.20200205.00069]
   Dilucca M, 2020, BIORXIV, V9, P1, DOI [10.1101/2020.05.08.084236, DOI 10.1101/2020.05.08.084236]
   Kazemi-Karyani A, 2020, J EDUC HEALTH PROMOT, V9, DOI 10.4103/jehp.jehp_483_20
   Koolivand A, 2020, Ethics Med Public Health, V14, P100549, DOI 10.1016/j.jemep.2020.100549
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Ministry of Health and Medical Education Public Relations and Information Center, 2020, DEATH 2 PAT NEW COR
   Moradzadeh R, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000783
   Moradzadeh R, 2020, J GASTROINTEST CANC, V51, P159, DOI 10.1007/s12029-019-00227-8
   Nazari J, 2020, OPEN PUB HLTH J, V13, P529, DOI [10.2174/1874944502013010529, DOI 10.2174/1874944502013010529]
   News and Information Center of the Ministry of Health and Medical Education, INT HLTH SYST SIB IM
   Nooh HZ, 2021, J PUBLIC HEALTH-HEID, V29, P1107, DOI 10.1007/s10389-020-01209-y
   Person B, 2004, EMERG INFECT DIS, V10, P358, DOI 10.3201/eid1002.030750
   Rahman A, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/8223
   Tao N., 2003, J ANHUI I ED, V21, P78
   The World Health Organization, 2020, 2019 NCOV OUTBR IS E
   World Health Organization (WHO), 2020, COVID 19 STRAT UPD
   Yap J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-442
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 22
TC 6
Z9 6
U1 1
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD DEC 8
PY 2020
VL 8
AR 599007
DI 10.3389/fpubh.2020.599007
PG 7
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA PH8IF
UT WOS:000600648400001
PM 33364226
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Al-Hasan, A
   Yim, D
   Khuntia, J
AF Al-Hasan, Abrar
   Yim, Dobin
   Khuntia, Jiban
TI Citizens' Adherence to COVID-19 Mitigation Recommendations by the
   Government: A 3-Country Comparative Evaluation Using Web-Based
   Cross-Sectional Survey Data
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE COVID-19; adherence; social distancing; government perception;
   information sources; social media; knowledge
ID PROTECTION MOTIVATION THEORY; HEALTH BELIEF MODEL; INTENTION; IMPACT
AB Background: Social distancing is an effective preventative policy for the coronavirus disease (COVID-19) that is enforced by governments worldwide. However, significant variations are observed in following the policy across individuals and countries. Arguably, differences in citizens' adherence actions will be influenced by their perceptions about government's plans and the information available to guide their behaviors-more so in the digital age in the realm of mass influence of social media on citizens. Insights into the underlying factors and dynamics involved with citizens' adherence process will inform the policy makers to follow appropriate communication and messaging approaches to influence citizens' willingness to adhere to the recommendations.
   Objective: The aim of this study is a comparative evaluation of citizens' adherence process to COVID-19-relevant recommendations by the government. The focus is on how three different countries' (United States, Kuwait, and South Korea) citizens, randomly sampled, respond to governments'pandemic guidance efforts. We draw insights into two categories of perceived government roles in managing the pandemic: (1) citizens' perceptions of government's role in responding to the pandemic and (2) citizens' perceptions of government's business reopening efforts. Undoubtedly, the internet and social media have burgeoned, with differing effects on shaping individuals' views and assessments of the COVID-19 situation; we argue and test for the effects of information sources, social media use, and knowledge on the adherence actions.
   Methods: We randomly sampled web-based survey data collected by a global firm in May 2020 from citizens of the United States, Kuwait, and South Korea. A nonlinear ordered probit regression, controlling for several counterfactuals, was used for analysis. The focal estimated effects of the study were compared across countries using the weighted distance between the parameter estimates.
   Results: The total sample size was 482 respondents, of which 207 (43%) lived in the United States, 181 (38%) lived in Kuwait, and 94 (20%) lived in South Korea. The ordered probit estimation results suggest that overall, perception of government response efforts positively influenced self-adherence (P<.001) and others'adherence (P<.001) to social distancing and sheltering. Perception of government business reopening efforts positively influenced others' adherence (P<.001). A higher intensity of general health information source for COVID-19 had a positive effect on self-adherence (P=.003). A higher intensity of social media source use for COVID-19 positively influenced others' adherence (P=.002). A higher intensity of knowledge on COVID-19 positively influenced self-adherence (P=.008) and negatively influenced others' adherence (P<.001). There were country-level variations-broadly, the United States and Kuwait had better effects than South Korea.
   Conclusions: As the COVID-19 global pandemic continues to grow and governmental restrictions are ongoing, it is critical to understand people's frustration to reduce panic and promote social distancing to facilitate the control of the pandemic. This study finds that the government plays a central role in terms of adherence to restrictions. Governments need to enhance their efforts on publicizing information on the pandemic, as well as employ strategies for improved communication management to citizens through social media as well as mainstream information sources.
C1 [Al-Hasan, Abrar] Kuwait Univ, Coll Business Adm, Alshadadiya Univ City, Kuwait.
   [Yim, Dobin] Loyola Univ Maryland, Baltimore, MD USA.
   [Khuntia, Jiban] Univ Colorado, Denver, CO 80202 USA.
RP Al-Hasan, A (corresponding author), Kuwait Univ, Coll Business Adm, Informat Syst & Operat Management Dept, Alshadadiya Univ City 13055, Kuwait.
EM abrar.alhasan@ku.edu.kw
OI Al-Hasan, Abrar/0000-0002-1662-6417; Yim, Dobin/0000-0002-9360-8343
CR AKBARIALIABAD H, 2020, J MED INTERNET RES, DOI DOI 10.2196/18932
   Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9
   Aronson E, 2010, SOZIALPSYCHOLOGIE
   Baron RS, 1996, J PERS SOC PSYCHOL, V71, P915, DOI 10.1037/0022-3514.71.5.915
   Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160
   Brooks JT, 2020, JAMA-J AM MED ASSOC, V324, P635, DOI 10.1001/jama.2020.13107
   Centola D, 2011, SCIENCE, V334, P1269, DOI 10.1126/science.1207055
   Christakis NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012948
   Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015
   Eysenbach G, 2020, J MED INTERNET RES, V22, DOI 10.2196/21820
   Farooq A, 2020, J MED INTERNET RES, V22, DOI 10.2196/19128
   Fisher D, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01533-w
   Floyd DL, 2000, J APPL SOC PSYCHOL, V30, P407, DOI 10.1111/j.1559-1816.2000.tb02323.x
   Gesser-Edelsburg A, 2020, J MED INTERNET RES, V22, DOI 10.2196/19370
   Guest JL, 2020, JMIR PUBLIC HLTH SUR, V6, P4, DOI 10.2196/19043
   Guidry JPD, 2019, EMERG INFECT DIS, V25, P179, DOI 10.3201/eid2501.180824
   Hassani L, 2014, ASIAN PAC J CANCER P, V15, P1227, DOI 10.7314/APJCP.2014.15.3.1227
   Hernandez-Garcia I, 2020, JMIR PUBLIC HLTH SUR, V6, P110, DOI 10.2196/18717
   Igielnik R, 2020, MOST AM SAY THEY REG
   James G., BBC
   Kouzy R, 2020, CUREUS, V12, DOI 10.7759/cureus.7255
   Larson HJ, 2020, NATURE, V580, P306, DOI 10.1038/d41586-020-00920-w
   Li CL, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.10.2000199
   Liao QY, 2020, J MED INTERNET RES, V22, DOI 10.2196/18796
   Liu Q, 2020, J MED INTERNET RES, V22, DOI 10.2196/19118
   Lucas T., 2006, SOC INFLUENCE, V1, P58
   Macdonell Karen, 2013, J Addict Res Ther, V4, P154
   MAI GZ, 2020, SWARM EVOL COMPUT, V57
   Matthes J, 2020, COMPUT HUM BEHAV, V105, DOI 10.1016/j.chb.2019.106217
   Milne S, 2000, J APPL SOC PSYCHOL, V30, P106, DOI 10.1111/j.1559-1816.2000.tb02308.x
   Monat A, 1991, STRESS COPING ANTHOL, P231
   Mukhtar S, 2020, BRAIN BEHAV IMMUN, V87, P28, DOI 10.1016/j.bbi.2020.04.012
   Qazi A, 2020, J MED VIROL, V92, P849, DOI 10.1002/jmv.25840
   Raamkumar AS, 2020, J MED INTERNET RES, V22, DOI 10.2196/19334
   ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803
   Saey TH, SCI NEWS
   Seymour B, 2015, AM J PUBLIC HEALTH, V105, P517, DOI 10.2105/AJPH.2014.302437
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   TANGCHAROENSATHIEN, 2020, J MED INTERNET RES, V22, DOI DOI 10.2196/19659
   Torous John, 2020, JMIR Ment Health, V7, pe18848, DOI 10.2196/18848
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   Vora D, 2019, J INT BUS STUD, V50, P499, DOI 10.1057/s41267-018-0191-3
   Wada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035069
   Xiao Han, 2016, Glob Health Res Policy, V1, P15, DOI 10.1186/s41256-016-0015-6
   Xiao H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003246
   Yan YQ, 2014, ADDICT BEHAV, V39, P181, DOI 10.1016/j.addbeh.2013.09.027
NR 46
TC 49
Z9 49
U1 4
U2 21
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD AUG 11
PY 2020
VL 22
IS 8
AR e20634
DI 10.2196/20634
PG 11
WC Health Care Sciences & Services; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Medical Informatics
GA NW5MP
UT WOS:000575056300009
PM 32716896
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU AlOmar, RS
   AlShamlan, NA
   AlAmer, NA
   Aldulijan, F
   AlMuhaidib, S
   Almukhadhib, O
   Algarni, SA
   Alshaibani, A
   Darwish, M
   Al Shammari, M
AF AlOmar, Reem S.
   AlShamlan, Nouf A.
   AlAmer, Naheel A.
   Aldulijan, Fajar
   AlMuhaidib, Seereen
   Almukhadhib, Omar
   Algarni, Saad A.
   Alshaibani, Askar
   Darwish, Magdy
   Al Shammari, Malak
TI What are the barriers and facilitators of volunteering among healthcare
   students during the COVID-19 pandemic? A Saudi-based cross-sectional
   study
SO BMJ OPEN
LA English
DT Article
DE public health; COVID-19; health services administration & management
ID MEDICAL-STUDENTS; NURSING-STUDENTS; STAFF; WILLINGNESS
AB Objectives The objectives of this study were to assess the volunteering of undergraduate health students and interns in the Ministry of Health (MOH) services in the Kingdom of Saudi Arabia (KSA) during the COVID-19 pandemic, its motivational factors and barriers, as well as their risk perception of COVID-19. Design A cross-sectional study. Participants From 12 to 21 May 2020, an online survey was sent to all undergraduate health students and interns in the KSA. This included questions on demographics, volunteering status, risk perception of COVID-19, as well as motivations and barriers towards volunteering. Results In a convenience sample of 6016 students and interns across KSA, 1824 (30.31%) have volunteered with the MOH services during the COVID-19 pandemic. Volunteering was more likely among older participants, from the College of Medicine, those with self-perceived at risk of COVID-19 infection and those with self-perceived healthy participants. Females, those who did not think that students had moral duties to volunteer, those who were at risk of seasonal influenza and those with self-perceived at risk of hospitalisation from COVID-19 were less likely to volunteer. Patriotism, gaining experience, assisting when able and religious rewards all were reported as major motivators to volunteer. Non-volunteering participants reported that lack of interest, protocol and knowledge, as well as issues related to their personal health and transportation were the main barriers to volunteering. Conclusions About one-third of undergraduate health students and interns volunteered during the first 2 months of the COVID-19 pandemic in KSA. Moral values were the most important motivations among volunteers. Efforts to encourage heath students and interns to volunteer and providing those with appropriate educational programmes are recommended.
C1 [AlOmar, Reem S.; Darwish, Magdy; Al Shammari, Malak] Imam Abdulrahman Bin Faisal Univ, Coll Med, Dept Family & Community Med, Dammam, Saudi Arabia.
   [AlShamlan, Nouf A.; AlAmer, Naheel A.] Imam Abdulrahman Bin Faisal Univ, Dept Family & Community Med, Dammam, Saudi Arabia.
   [Aldulijan, Fajar; AlMuhaidib, Seereen; Almukhadhib, Omar; Algarni, Saad A.; Alshaibani, Askar] Imam Abdulrahman Bin Faisal Univ, King Fahd Hosp Univ, Al Khobar, Saudi Arabia.
RP AlOmar, RS (corresponding author), Imam Abdulrahman Bin Faisal Univ, Coll Med, Dept Family & Community Med, Dammam, Saudi Arabia.
EM rsomar@iau.edu.sa
RI AlShamlan, Nouf Adel/AFQ-4643-2022; AlOmar, Reem S/H-2922-2017; Alamer,
   Naheel/AGL-1330-2022; Shammari, Malak Al/AAG-4532-2021; darwish,
   magdy/E-9107-2015
OI AlShamlan, Nouf Adel/0000-0002-8049-237X; AlOmar, Reem
   S/0000-0003-4899-7965; Alamer, Naheel/0000-0003-2700-5197; Shammari,
   Malak Al/0000-0002-7434-7432; darwish, magdy/0000-0002-2803-8524
CR Al-Hunaishi W, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030547
   Al-Tawfiq JA, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105968
   Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934
   Chang Jinghui, 2020, Nan Fang Yi Ke Da Xue Xue Bao, V40, P171, DOI 10.12122/j.issn.1673-4254.2020.02.06
   Dyson SE, 2017, NURSE EDUC PRACT, V23, P15, DOI 10.1016/j.nepr.2017.01.004
   GAS, 2020, SAUD WOM AR PARTN SU
   Gouda P, 2020, DISASTER MED PUBLIC, V14, P308, DOI 10.1017/dmp.2019.81
   Harapan H, 2020, J INFECT PUBLIC HEAL, V13, P667, DOI 10.1016/j.jiph.2020.03.019
   Herman B, 2007, EMERG INFECT DIS, V13, P1781, DOI 10.3201/eid1311.070279
   Li XX, 2020, BRAIN BEHAV IMMUN, V87, P140, DOI 10.1016/j.bbi.2020.05.008
   Menon A, 2020, ACAD MED, V95, P1149, DOI 10.1097/ACM.0000000000003478
   Miller DG, 2020, ANN INTERN MED, V173, P145, DOI 10.7326/M20-1281
   Niebuur J, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6077-2
   O'Byrne L, 2020, J MED ETHICS, V46, P623, DOI 10.1136/medethics-2020-106353
   Rasmussen S, 2020, LANCET, V395, pE79, DOI 10.1016/S0140-6736(20)30923-5
   Rosychuk RJ, 2008, INFLUENZA OTHER RESP, V2, P71, DOI 10.1111/j.1750-2659.2008.00042.x
   Rovers J, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0618-0
   SCFHS, 2018, REAL SAUD HLTH WORKF
   Shi ML, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020218
   Soled D, 2020, ACAD MED, V95, P1384, DOI 10.1097/ACM.0000000000003401
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Vahidi M, 2020, INT J HEALTH POLICY, V9, P464, DOI 10.34172/ijhpm.2020.82
   Wang SD, 2020, POSTGRAD MED J, V96, P728, DOI 10.1136/postgradmedj-2020-137763
   Whelan A, 2020, GUIDANCE MED STUDENT
   Yonge O, 2010, PUBLIC HEALTH NURS, V27, P174, DOI 10.1111/j.1525-1446.2010.00839.x
NR 25
TC 9
Z9 9
U1 3
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD FEB
PY 2021
VL 11
IS 2
AR e042910
DI 10.1136/bmjopen-2020-042910
PG 9
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC General & Internal Medicine
GA ZZ9WW
UT WOS:000773614800003
PM 33602709
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU de las Heras-pedrosa, C
   Jambrino-Maldonado, C
   Rando-Cueto, D
   Iglesias-Sanchez, PP
AF de las Heras-pedrosa, Carlos
   Jambrino-Maldonado, Carmen
   Rando-Cueto, Dolores
   Iglesias-Sanchez, Patricia P.
TI COVID-19 Study on Scientific Articles in Health Communication: A Science
   Mapping Analysis in Web of Science
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE health communication; COVID-19; coronavirus; bibliometric analysis
ID SENTIMENT ANALYSIS; KNOWLEDGE; STUDENTS
AB The COVID-19 pandemic continues to cause a collapse in the health systems and econo-mies of many countries around the world, after 2 years of struggle and with the number of cases still growing exponentially. Health communication has become as essential and necessary for control of the pandemic as epidemiology. This bibliometric analysis identifies existing contributions, jointly studying health communication and the pandemic in scientific journals indexed. A systematic search of the Web of Science was performed, using keywords related to COVID-19 and health communication. Data extracted included the type of study, journal, number of citations, number of authors, country of publication, and study content. As the number of scientific investigations has grown, it is necessary to delve into the areas in which the most impactful publications have been generated. The results show that the scientific community has been quick to react by generating an extraordinary volume of publications. This review provides a comprehensive mapping of contributions to date, showing how research approaches have evolved in parallel with the pandemic. In 2020, concepts related to mental health, mass communication, misinformation and communication risk were more used. In 2021, vaccination, infodemic, risk perception, social distancing and telemedicine were the most prevalent keywords. By highlighting the main topics, authors, manuscripts and journals since the origin of COVID-19, the authors hope to disseminate information that can help researchers to identify subsisting knowledge gaps and a number of future research opportunities.
C1 [de las Heras-pedrosa, Carlos; Rando-Cueto, Dolores] Univ Malaga, Fac Commun Sci, Malaga 29016, Spain.
   [Jambrino-Maldonado, Carmen; Iglesias-Sanchez, Patricia P.] Univ Malaga, Fac Commerce & Management, Malaga 29016, Spain.
RP Jambrino-Maldonado, C (corresponding author), Univ Malaga, Fac Commerce & Management, Malaga 29016, Spain.
EM cheras@uma.es; mcjambrino@uma.es; lrandocueto@uma.es;
   patricia.iglesias@uma.es
RI Cueto, Dolores Rando/ABF-5897-2021; Jambrino-Maldonado,
   Carmen/H-6297-2017; de las Heras-Pedrosa, Carlos/M-4492-2015
OI Cueto, Dolores Rando/0000-0002-8512-5034; Jambrino-Maldonado,
   Carmen/0000-0001-8444-0967; de las Heras-Pedrosa,
   Carlos/0000-0002-2738-4177; Iglesias Sanchez,
   Patricia/0000-0002-5591-2248
FU Programa Operativo FEDER Andalucia 2014-2020 [UMA18-FEDERJA-148];
   Universidad de Malaga/CBUA
FX This research was funded by Programa Operativo FEDER Andalucia
   2014-2020, grant number UMA18-FEDERJA-148' and the APC was funded by
   Universidad de Malaga/CBUA.
CR Al-Dmour H, 2020, J MED INTERNET RES, V22, DOI 10.2196/19996
   An L, 2021, J MED INTERNET RES, V23, DOI 10.2196/25042
   Arvai J., 2013, EFFECTIVE RISK COMMU
   Tran BX, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103577
   Basch CH, 2020, J COMMUN HEALTH, V45, P1089, DOI 10.1007/s10900-020-00913-w
   Basch CH, 2020, DISASTER MED PUBLIC, V14, P635, DOI 10.1017/dmp.2020.151
   Bleakley A, 2022, ANN BEHAV MED, V56, P347, DOI 10.1093/abm/kaab091
   Borah P, 2021, J HEALTH COMMUN, V26, P523, DOI 10.1080/10810730.2021.1966687
   Chen CM, 2017, J DATA INFO SCI, V2, P1, DOI 10.1515/jdis-2017-0006
   Chen CM, 2020, MULTILINGUA, V39, P597, DOI 10.1515/multi-2020-0092
   Chou WYS, 2020, HEALTH COMMUN, V35, P1718, DOI 10.1080/10410236.2020.1838096
   Conrow E.H., 2004, INSIGHT, V6, P44, DOI [10.1002/inst.20046244, DOI 10.1002/INST.20046244]
   Costa-Sanchez C., 2022, TOTAL JOURNALISM MOD, P137
   Costa-Sanchez C, 2020, PROF INFORM, V29, DOI 10.3145/epi.2020.may.04
   Crowley JP, 2021, HEALTH COMMUN, V36, P32, DOI 10.1080/10410236.2020.1847452
   De Felice F, 2020, IN VIVO, V34, P1613, DOI 10.21873/invivo.11951
   de las Heras-Pedrosa C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155542
   de las Heras-Pedrosa C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134859
   ElHawary Hassan, 2020, Infect Dis (Auckl), V13, p1178633720962935, DOI 10.1177/1178633720962935
   European Commission,, COR COMM UNV EU VACC
   Fernandez Beltran F., 2020, REV CIENTIFICA ESTRA, V20, P381, DOI [10.6035/2174-0992.2020.20.16, DOI 10.6035/2174-0992.2020.20.16]
   Fernandez-Diaz E, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165663
   Frewer L, 2004, TOXICOL LETT, V149, P391, DOI 10.1016/j.toxlet.2003.12.049
   Fridman I, 2020, JMIR PUBLIC HLTH SUR, V6, P398, DOI 10.2196/22060
   Garrett L, 2020, LANCET, V395, P942, DOI 10.1016/S0140-6736(20)30600-0
   Garrick B.J., 1991, ANAL COMMUNICATION P
   Gharzai LA, 2020, JAMA ONCOL, V6, P1424, DOI 10.1001/jamaoncol.2020.2980
   Gollust SE, 2020, J HEALTH POLIT POLIC, V45, P967, DOI 10.1215/03616878-8641506
   Graffigna G, 2021, MILBANK Q, V99, P369, DOI 10.1111/1468-0009.12506
   Graffigna G, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.567101
   Green MS, 2007, NATO SECUR SCI SER A, P177, DOI 10.1007/978-1-4020-5808-0_15
   Han XH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082788
   Head KJ, 2020, SCI COMMUN, V42, P698, DOI 10.1177/1075547020960463
   Hornik R, 2021, HEALTH COMMUN, V36, P6, DOI 10.1080/10410236.2020.1847437
   Le HT, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.589437
   Hwang J, 2020, J HEALTH COMMUN, V25, P727, DOI 10.1080/10810730.2020.1840675
   Iglesias-Sanchez PP, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165918
   Ike JD, 2020, J HEALTH COMMUN, V25, P990, DOI 10.1080/10810730.2020.1867257
   Jang IC, 2020, MULTILINGUA, V39, P541, DOI 10.1515/multi-2020-0097
   Jiang XY, 2021, SOC MEDIA SOC, V7, DOI 10.1177/20563051211048413
   Jimenez T, 2020, SSM-POPUL HLTH, V11, DOI 10.1016/j.ssmph.2020.100615
   Kelly BJ, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06023-9
   Kowalski RM, 2021, HEALTH COMMUN, V36, P15, DOI 10.1080/10410236.2020.1847448
   Kreps G.L., 1984, HEALTH COMMUN
   Kupferschmidt K, 2020, SCIENCE, V367, P963, DOI 10.1126/science.367.6481.963
   Latkin CA, 2020, J HEALTH COMMUN, V25, P764, DOI 10.1080/10810730.2020.1865487
   Li XJ, 2020, J MED INTERNET RES, V22, DOI 10.2196/19684
   Liem A, 2021, PUBLIC HEALTH, V197, P28, DOI 10.1016/j.puhe.2021.05.029
   Liu Q, 2020, J MED INTERNET RES, V22, DOI 10.2196/19118
   Lundgren R.E., 2013, RISK COMMUNICATION H, V4th ed
   Lyu JC, 2012, PUBLIC RELAT REV, V38, P799, DOI 10.1016/j.pubrev.2012.07.006
   Maal M, 2019, INT J DISASTER RESIL, V10, P379, DOI 10.1108/IJDRBE-06-2014-0044
   Martinez-Lopez FJ, 2018, EUR J MARKETING, V52, P439, DOI 10.1108/EJM-11-2017-0853
   Masiello MM, 2020, J HEALTH COMMUN, V25, P753, DOI 10.1080/10810730.2020.1868629
   McCormack LA, 2021, PUBLIC HEALTH REP, V136, P107, DOI 10.1177/0033354920970182
   Motta M, 2021, SOC SCI MED, V272, DOI 10.1016/j.socscimed.2020.113642
   Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898
   Noar SM, 2020, HEALTH COMMUN, V35, P1735, DOI 10.1080/10410236.2020.1838093
   Oh SH, 2021, HEALTH COMMUN, V36, P972, DOI 10.1080/10410236.2020.1724639
   Okuhara T, 2020, PATIENT EDUC COUNS, V103, P2588, DOI 10.1016/j.pec.2020.08.016
   Olivares-Delgado F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17238876
   Pavlic J, 2021, J RES INTERACT MARK, DOI 10.1108/JRIM-02-2021-0041
   Pfeffer J., 1978, EXTERNAL CONTROL ORG
   Piryani R, 2017, INFORM PROCESS MANAG, V53, P122, DOI 10.1016/j.ipm.2016.07.001
   Ratzan S., 2020, COVID 19 URGENT CALL, P1, DOI [10.31478/202003a, DOI 10.31478/202003A]
   Renaud L., 2007, OBSERVATORIO-OBS, V1, P215
   Resnicow K, 2021, J MED INTERNET RES, V23, DOI 10.2196/23488
   Rios S., 2021, PFIZER PRONOSTICA QU
   Sanchez-Nunez P, 2020, SOC SCI-BASEL, V9, DOI 10.3390/socsci9030023
   Sanchez-Nunez P, 2020, IEEE ACCESS, V8, P134563, DOI 10.1109/ACCESS.2020.3009482
   Sharf B.F., 1984, J CONTIN ED PROF HLT, V4, P129, DOI [10.1002/chp.4760040320, DOI 10.1002/CHP.4760040320]
   Sigala M, 2020, J BUS RES, V117, P312, DOI 10.1016/j.jbusres.2020.06.015
   Southwell BG, 2020, HEALTH COMMUN, V35, P1707, DOI 10.1080/10410236.2020.1837462
   Stolow JA, 2020, HEALTH EDUC BEHAV, V47, P531, DOI 10.1177/1090198120935073
   Tomczyk S, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01821
   Torres-Salinas D, 2020, PROF INFORM, V29, DOI 10.3145/epi.2020.mar.15
   van Eck NJ, 2014, J INFORMETR, V8, P802, DOI 10.1016/j.joi.2014.07.006
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
   Verma S, 2020, J BUS RES, V118, P253, DOI 10.1016/j.jbusres.2020.06.057
   White SJ, 2021, PATIENT EDUC COUNS, V104, P217, DOI 10.1016/j.pec.2020.12.025
   World Health Organization,, UPD WHO SAGE ROADM P
   Young D.G., 2020, INT J COMMUN-US, V14, P17
   Zhang LW, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197213
NR 83
TC 0
Z9 0
U1 7
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD FEB
PY 2022
VL 19
IS 3
AR 1705
DI 10.3390/ijerph19031705
PG 29
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA ZF4JP
UT WOS:000759536300001
PM 35162726
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Jeong, M
   Kim, K
   Ma, FR
   DiPietro, R
AF Jeong, Miyoung
   Kim, Kawon
   Ma, Forest
   DiPietro, Robin
TI Key factors driving customers' restaurant dining behavior during the
   COVID-19 pandemic
SO INTERNATIONAL JOURNAL OF CONTEMPORARY HOSPITALITY MANAGEMENT
LA English
DT Article
DE Willingness to pay; Perceived trust; Restaurant attributes; COVID-19;
   Pandemic; Dining behavior
ID WILLINGNESS-TO-PAY; PERCEIVED RISK; PHYSICAL-ENVIRONMENT; CONSUMERS;
   SATISFACTION; LOYALTY; TRUST; TECHNOLOGY; ROLES; FOOD
AB Purpose This study aims to identify key factors that affected US respondents' dining behavior at restaurants during the midst of the COVID-19 pandemic. Design/methodology/approach Due to the lack of a prior framework or model to test customers' perceptions of dining-out behavior during this unprecedented time, this study used a mixed-methods approach, conducting two focus group discussions to generate potential restaurant attributes, followed by a US-based survey using an online panel. Using structural equation modeling, this study tested eight developed propositions. Findings The findings of this study indicated that the three key factors (i.e. restaurant dining environment, communication and hygiene and contactless features) made customers feel comfortable dining in the restaurant during the pandemic. Out of these three factors, only the restaurant dining environment and communication and hygiene were essential predictors for customers' perceived trust toward the restaurant, leading to their willingness to pay more. This study used two moderators, customers' perceived risk and support for restaurants to examine how they affected customers' perceived trust and willingness to pay, respectively. Practical implications This study provides both theoretical and practical implications to the current body of knowledge in customers' dining-out behavior and the development of operational strategies for restaurants to accommodate customers' changing dining-out behavior due to the COVID-19 pandemic. To develop a holistic conceptual framework, this study incorporates two COVID-19-focused measurement items, perceived risk and support of the restaurant, to identify their moderating roles in the relationships among the five proposed measurement items. This study provides restaurant operators with insights into the altered dining-out behavior of their customers due to the COVID-19 pandemic and prepares them for the post pandemic environment. Originality/value During the unprecedented pandemic situation, few customers are willing to dine in restaurants. As local and national governments lifted the mandated COVID-19 protocols, restaurants opened their business slowly to cater to customers in compliance with the centers for disease control's health and safety regulations. It is of utmost importance for restaurant operators to accommodate their customers' needs when they dine in the middle of the COVID-19 pandemic. There is a paucity of research that has examined customers' comfort level when dining in restaurants and customers' preferred dining environment during the pandemic.
C1 [Jeong, Miyoung; Kim, Kawon; Ma, Forest; DiPietro, Robin] Univ South Carolina, Sch Hotel Restaurant & Tourism Management, Columbia, SC 29208 USA.
RP Jeong, M (corresponding author), Univ South Carolina, Sch Hotel Restaurant & Tourism Management, Columbia, SC 29208 USA.
EM jeongm@mailbox.sc.edu; kkim01@mailbox.sc.edu; xiaom@email.sc.edu;
   rdipietr@mailbox.sc.edu
OI Ma, Forest/0000-0001-7670-6219
CR Ahn JA, 2018, INT J HOSP MANAG, V74, P109, DOI 10.1016/j.ijhm.2018.02.020
   Alphonce R, 2014, FOOD POLICY, V49, P160, DOI 10.1016/j.foodpol.2014.06.009
   ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411
   Andrews JC, 1998, J MARKETING, V62, P62, DOI 10.2307/1252287
   Avery, 2020, RESTAURANT REVOLUTIO
   BITNER MJ, 1992, J MARKETING, V56, P57, DOI 10.2307/1252042
   Cavusoglu M, 2019, J HOSP TOUR TECHNOL, V10, P45, DOI [10.1108/jhtt-12-2017-0141, 10.1108/JHTT-12-2017-0141]
   Centers for Disease Control and Prevention, 2020, CONS REST BARS
   Chang H, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2020.102854
   Chang S, 2021, NATURE, V589, P82, DOI 10.1038/s41586-020-2923-3
   Chen C. F., 2006, Information Technology and Tourism, V8, P197, DOI 10.3727/109830506778690849
   Choi J, 2019, J ENVIRON HEALTH, V82, P16
   Chung N, 2009, BEHAV INFORM TECHNOL, V28, P549, DOI 10.1080/01449290802506562
   Crutchfield, 2003, J SERV RES-US, V5, P316, DOI DOI 10.1177/1094670503005004004
   Douglas A. C., 2007, Journal of Foodservice Business Research, V10, P101, DOI 10.1300/J369v10n01_06
   Ellen T., 2014, Journal of Foodservice Business Research, V17, P85, DOI 10.1080/15378020.2014.902642
   Faasse K, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.551004
   Failla, 2020, COVID 19 IMPACT FOOD
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Frash RE, 2015, J HOSP MARKET MANAG, V24, P411, DOI 10.1080/19368623.2014.911715
   Freeman T, 2006, J ADV NURS, V56, P491, DOI 10.1111/j.1365-2648.2006.04043.x
   Friend, 2020, FOOD WINE
   Gu JC, 2009, EXPERT SYST APPL, V36, P11605, DOI 10.1016/j.eswa.2009.03.024
   Han H, 2013, INT J HOSP MANAG, V32, P59, DOI 10.1016/j.ijhm.2012.04.004
   Han H, 2009, J HOSP TOUR RES, V33, P487, DOI 10.1177/1096348009344212
   Hao F, 2021, INT J CONTEMP HOSP M, DOI 10.1108/IJCHM-05-2021-0559
   Hong IB, 2015, INT J INFORM MANAGE, V35, P322, DOI 10.1016/j.ijinfomgt.2015.01.003
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Iacobucci D, 2015, J CONSUM PSYCHOL, V25, P690, DOI 10.1016/j.jcps.2015.06.014
   Jiang YY, 2020, INT J CONTEMP HOSP M, V32, P2563, DOI 10.1108/IJCHM-03-2020-0237
   Jin N, 2016, J HOSP MARKET MANAG, V25, P523, DOI 10.1080/19368623.2015.1063469
   Kim, 2020, PEOPLE ARE BEING URG
   Kim M, 2021, INT J CONTEMP HOSP M, V33, P4373, DOI 10.1108/IJCHM-03-2021-0306
   Kim SeongSeop [Kim S. S. S.], 2005, Asia Pacific Journal of Tourism Research, V10, P369, DOI 10.1080/10941660500363694
   Kim TJ, 2021, INT J CONTEMP HOSP M, V33, P893, DOI 10.1108/IJCHM-08-2020-0822
   Kim W. G., 2006, Journal of Hospitality & Tourism Research, V30, P143, DOI 10.1177/1096348005285086
   Kim WG, 2009, INT J HOSP MANAG, V28, P144, DOI 10.1016/j.ijhm.2008.06.010
   KITZINGER J, 1994, SOCIOL HEALTH ILL, V16, P103, DOI 10.1111/1467-9566.ep11347023
   Krystallis A, 2005, BRIT FOOD J, V107, P320, DOI 10.1108/00070700510596901
   Lai IKW, 2015, CORNELL HOSP Q, V56, P118, DOI 10.1177/1938965514556149
   McCarthy M, 2006, BRIT FOOD J, V108, P875, DOI 10.1108/00070700610702127
   McKnight DH, 2002, INFORM SYST RES, V13, P334, DOI 10.1287/isre.13.3.334.81
   Naumov N, 2021, ANATOLIA, V32, P144, DOI 10.1080/13032917.2020.1771742
   NCR, 2020, NCR
   Nguyen N, 2002, INT J SERV IND MANAG, V13, P242, DOI 10.1108/09564230210431965
   Ojiako U, 2009, BUS PROCESS MANAG J, V15, P816, DOI 10.1108/14637150910987955
   Park Haeik, 2016, Journal of Foodservice Business Research, V19, P474, DOI 10.1080/15378020.2016.1189740
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Rosenbaum MS, 2007, J BUS RES, V60, P206, DOI 10.1016/j.jbusres.2006.09.026
   Ruggless, 2021, PRICKLY PANDEMIC CON
   Sanchez-Canizares SM, 2021, CURR ISSUES TOUR, V24, P970, DOI 10.1080/13683500.2020.1829571
   Sanpellegrino, 2020, SPELLEGRINO LAUNCH
   SLOVIC P, 1981, P ROY SOC LOND A MAT, V376, P17, DOI 10.1098/rspa.1981.0073
   Stashevsky S., 2002, QUALITATIVE MARKET R, V5, P291, DOI DOI 10.1108/13522750210443245
   Susskind AM, 2016, SERV SCI, V8, P203, DOI 10.1287/serv.2016.0132
   Taylor, 2020, RESTAURANTSCOVID 19
   Taylor S, 2020, INT J HOSP MANAG, V91, DOI 10.1016/j.ijhm.2020.102692
   Tombs A., 2003, MARKET THEOR, V3, P447
   VCUHealth, 2020, COMP COVID 19 H1N1 O
   Yang M, 2021, INT J CONTEMP HOSP M, V33, P1230, DOI 10.1108/IJCHM-08-2020-0920
   Yang Y, 2020, INT J CONTEMP HOSP M, V13, P3809, DOI 10.1108/IJCHM-06-2020-0504
NR 61
TC 1
Z9 1
U1 20
U2 20
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0959-6119
EI 1757-1049
J9 INT J CONTEMP HOSP M
JI Int. J. Contemp. Hosp. Manag.
PD JAN 21
PY 2022
VL 34
IS 2
BP 836
EP 858
DI 10.1108/IJCHM-07-2021-0831
EA DEC 2021
PG 23
WC Hospitality, Leisure, Sport & Tourism; Management
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics; Business & Economics
GA YN5DO
UT WOS:000730715100001
DA 2022-04-20
ER

PT J
AU Atkinson, L
   Kite, C
   McGregor, G
   James, T
   Clark, CCT
   Randeva, HS
   Kyrou, I
AF Atkinson, Lou
   Kite, Chris
   McGregor, Gordon
   James, Tamsin
   Clark, Cain C. T.
   Randeva, Harpal S.
   Kyrou, Ioannis
TI Uncertainty, Anxiety and Isolation: Experiencing the COVID-19 Pandemic
   and Lockdown as a Woman with Polycystic Ovary Syndrome (PCOS)
SO JOURNAL OF PERSONALIZED MEDICINE
LA English
DT Article
DE polycystic ovary syndrome; PCOS; COVID-19; lockdown; lived experience;
   mental health; qualitative study
ID DIAGNOSTIC-CRITERIA; WOMEN; PATHOPHYSIOLOGY; MANAGEMENT; PHYSICIANS;
   KNOWLEDGE
AB Background: The COVID-19 pandemic and the related lockdown measures presented a significant risk to physical and mental wellbeing in affected populations. Women with polycystic ovary syndrome (PCOS) are predisposed to several cardio-metabolic risk factors which increase the susceptibility to severe COVID-19 and also exhibit increased likelihood of impaired mental health wellbeing. Therefore, these women who usually receive care from multiple primary and specialist healthcare services may be disproportionately impacted by this pandemic and the related restrictions. This study aimed to explore the lived experience of the first UK national lockdown as a woman with PCOS. Methods: As part of a larger cross-sectional study, 12 women with PCOS living in the UK during the first national COVID-19 lockdown were recruited to a qualitative study. Telephone interviews were conducted in June/July of 2020, and data collected were subjected to thematic analysis. Results: Five themes were identified. "My PCOS Journey " describes participants' experiences of diagnosis, treatment and ongoing management of their PCOS. "Living Through Lockdown " describes the overall experience and impact of the lockdown on all aspects of participants' lives. "Self-care and Managing Symptoms " describe multiple challenges to living well with PCOS during the lockdown, including lack of access to supplies and services, and disruption to weight management. "Healthcare on Hold " describes the uncertainty and anxiety associated with delays in accessing specialised healthcare for a range of PCOS aspects, including fertility treatment. "Exacerbating Existing Issues " captures the worsening of pre-existing mental health issues, and an increase in health anxiety and feelings of isolation. Conclusion: For the women with PCOS in this study, the COVID-19 pandemic and the first national lockdown was mostly experienced as adding to the pre-existing challenges of living with their condition. The mental health impact experienced by the study participants was increased due to lack of access to their normal support strategies, limitations on healthcare services and uncertainty about their risk of COVID-19.</p>
C1 [Atkinson, Lou; James, Tamsin] Aston Univ, Sch Psychol, Coll Hlth & Life Sci, Birmingham B4 7ET, W Midlands, England.
   [Atkinson, Lou; Kite, Chris; Clark, Cain C. T.; Randeva, Harpal S.; Kyrou, Ioannis] Univ Hosp Coventry & Warwickshire NHS Trust, Warwickshire Inst Study Diabet Endocrinol & Metab, Coventry CV2 2DX, W Midlands, England.
   [Kite, Chris] Univ Chester, Univ Ctr Shrewsbury, Ctr Act Living, Shrewsbury SY3 8HQ, Salop, England.
   [Kite, Chris; McGregor, Gordon; Kyrou, Ioannis] Coventry Univ, Res Inst Hlth & Wellbeing, Ctr Sport Exercise & Life Sci, Coventry CV1 5FB, W Midlands, England.
   [McGregor, Gordon] Univ Hosp Coventry & Warwickshire NHS Trust, Dept Cardiopulm Rehabil, Ctr Exercise & Hlth, Coventry CV2 2DX, W Midlands, England.
   [McGregor, Gordon] Univ Warwick, Warwick Med Sch, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England.
   [Clark, Cain C. T.] Coventry Univ, Ctr Intelligent Healthcare, Coventry CV1 5FB, W Midlands, England.
   [Randeva, Harpal S.; Kyrou, Ioannis] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.
   [Kyrou, Ioannis] Aston Univ, Aston Med Sch, Coll Hlth & Life Sci, Birmingham B4 7ET, W Midlands, England.
RP Atkinson, L (corresponding author), Aston Univ, Sch Psychol, Coll Hlth & Life Sci, Birmingham B4 7ET, W Midlands, England.; Atkinson, L; Randeva, HS; Kyrou, I (corresponding author), Univ Hosp Coventry & Warwickshire NHS Trust, Warwickshire Inst Study Diabet Endocrinol & Metab, Coventry CV2 2DX, W Midlands, England.; Kyrou, I (corresponding author), Coventry Univ, Res Inst Hlth & Wellbeing, Ctr Sport Exercise & Life Sci, Coventry CV1 5FB, W Midlands, England.; Randeva, HS; Kyrou, I (corresponding author), Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.; Kyrou, I (corresponding author), Aston Univ, Aston Med Sch, Coll Hlth & Life Sci, Birmingham B4 7ET, W Midlands, England.
RI Clark, Cain Craig Truman/I-4480-2019; McGregor, Gordon/AAP-1917-2020
OI Clark, Cain Craig Truman/0000-0002-6610-4617; McGregor,
   Gordon/0000-0001-8963-9107; Atkinson, Lou/0000-0003-1613-3791; Kite,
   Chris/0000-0003-1342-274X
FU General Charities of the City of Coventry
FX All authors acknowledge and thank all the participants of this study,
   Verity (the UK PCOS charity) and the PCOS support groups on Facebook for
   their valuable support to this study. I.K. and H.S.R. also acknowledge
   and thank the General Charities of the City of Coventry for their
   support. This paper is also dedicated to all of the healthcare
   professionals fighting against COVID-19 globally.
CR Bohn MK, 2020, PHYSIOLOGY, V35, P288, DOI 10.1152/physiol.00019.2020
   Booth A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247461
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Burton A., 2020, IMPACT COVID 19 PAND, DOI [10.1101/2020.12.01.20241067, DOI 10.1101/2020.12.01.20241067]
   Caristia S, 2020, EPIDEMIOL PREV, V44, P60, DOI 10.19191/EP20.5-6.S2.104
   Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004
   Crete J, 2011, J HOLIST NURS, V29, P256, DOI 10.1177/0898010111398660
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   Damone AL, 2019, PSYCHOL MED, V49, P1510, DOI 10.1017/S0033291718002076
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Dokras A, 2017, FERTIL STERIL, V107, P1380, DOI 10.1016/j.fertnstert.2017.04.011
   Du Pengqiang, 2021, Can J Infect Dis Med Microbiol, V2021, P6660930, DOI 10.1155/2021/6660930
   Du YB, 2021, NUTR METAB CARDIOVAS, V31, P745, DOI 10.1016/j.numecd.2020.12.009
   Gibson-Helm M, 2018, SEMIN REPROD MED, V36, P19, DOI 10.1055/s-0038-1667155
   Gillard S, 2021, SOC PSYCH PSYCH EPID, V56, P1447, DOI 10.1007/s00127-021-02051-7
   Girum T, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00285-w
   Grannell A, 2020, CLIN OBES, V10, DOI 10.1111/cob.12406
   Griffin T., 2021, P ANN GEN M UK SOC B
   Groarke JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239698
   Hadjiconstantinou M, 2017, ENDOCR CONNECT, V6, P323, DOI 10.1530/EC-17-0053
   Hamer M, 2020, P NATL ACAD SCI USA, V117, P21011, DOI 10.1073/pnas.2011086117
   Hillman SC, 2020, BRIT J GEN PRACT, V70, pE322, DOI 10.3399/bjgp20X708881
   Institute, 2021, FUT WORK COVID 19
   Kahal H, 2020, SLEEP BREATH, V24, P339, DOI 10.1007/s11325-019-01835-1
   Kakoly NS, 2018, HUM REPROD UPDATE, V24, P455, DOI 10.1093/humupd/dmy007
   Kite Chris, 2021, Front Glob Womens Health, V2, P649104, DOI 10.3389/fgwh.2021.649104
   Kitzinger C, 2002, SOC SCI MED, V54, P349, DOI 10.1016/S0277-9536(01)00034-X
   Kyritsi EM, 2017, CLIN ENDOCRINOL, V86, P1, DOI 10.1111/cen.13245
   Kyrou I, 2015, ENDOCRINOLOGY DIABET, P99, DOI DOI 10.1007/978-1-4471-2789-5_13
   Kyrou I, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01697-5
   Lim S, 2019, BMC ENDOCR DISORD, V19, DOI 10.1186/s12902-019-0434-8
   Moin AM, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.638621
   Moreno C, 2020, LANCET PSYCHIAT, V7, P813, DOI 10.1016/S2215-0366(20)30307-2
   Musselwhite K, 2007, INT J NURS STUD, V44, P1064, DOI 10.1016/j.ijnurstu.2006.05.014
   Nussbaumer-Streit B, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013574
   Osuchowski MF, 2021, LANCET RESP MED, V9, P622, DOI 10.1016/S2213-2600(21)00218-6
   Pfaff KA, 2014, INT J NURS STUD, V51, P1142, DOI 10.1016/j.ijnurstu.2014.01.001
   Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775
   Schlesinger S, 2021, DIABETOLOGIA, V64, P1480, DOI 10.1007/s00125-021-05458-8
   Shah H, 2021, ACTA DIABETOL, V58, P831, DOI 10.1007/s00592-020-01636-z
   Snyder BS, 2006, JOGNN-J OBST GYN NEO, V35, P385, DOI 10.1111/J.1552-6909.2006.00047.x
   Subramanian A, 2021, EUR J ENDOCRINOL, V184, P637, DOI 10.1530/EJE-20-1163
   Tay CT, 2019, FERTIL STERIL, V112, P353, DOI 10.1016/j.fertnstert.2019.03.027
   Teede HJ, 2018, HUM REPROD, V33, P1602, DOI 10.1093/humrep/dey256
   Tippett A, 2021, J HEALTH PSYCHOL, DOI 10.1177/1359105321999711
   Tomlinson J, 2017, J ADV NURS, V73, P2318, DOI 10.1111/jan.13300
   Willaing I., 2021, DIABETOLOGY, V2, P1, DOI [10.3390/diabetology2010001, DOI 10.3390/DIABETOLOGY2010001]
   Williams Simon N, 2020, BMJ Open, V10, pe039334, DOI 10.1136/bmjopen-2020-039334
   Wingert A, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-044684
   Wood SJ, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18147575
NR 50
TC 0
Z9 0
U1 4
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-4426
J9 J PERS MED
JI J. Pers. Med.
PD OCT
PY 2021
VL 11
IS 10
AR 952
DI 10.3390/jpm11100952
PG 15
WC Health Care Sciences & Services; Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services; General & Internal Medicine
GA WP0YT
UT WOS:000712868600001
PM 34683093
OA Green Published, Green Accepted, gold
DA 2022-04-20
ER

PT J
AU Shamseer, L
   Bourgeault, I
   Grunfeld, E
   Moore, A
   Peer, N
   Straus, SE
   Tricco, AC
AF Shamseer, Larissa
   Bourgeault, Ivy
   Grunfeld, Eva
   Moore, Ainsley
   Peer, Nazia
   Straus, Sharon E.
   Tricco, Andrea C.
TI Will COVID-19 result in a giant step backwards for women in academic
   science
SO JOURNAL OF CLINICAL EPIDEMIOLOGY
LA English
DT Article
DE Women; COVID-19; Gender; Intersectionality; Productivity; Academic
   reward; Early career
ID GENDER; MEDICINE
AB COVID-19 has disproportionately placed women in academic science on the frontlines of domestic and clinical care compared to men. As a result, women in science are publishing less and potentially acquiring less funding during COVID-19 than compared to before. This widens the pre-existing gap between men and women in prevailing, publication-based measures of productivity used to determine academic career progression. Early career women and those with intersectional identities associated with greater inequities, are facing unique challenges during this time. We argue that women will fall further behind unless academic reward systems adjust how and what they evaluate. We propose several strategies that academic institutions, funders, journals, and men in academic science can take. (c) 2021 Elsevier Inc. All rights reserved.
C1 [Shamseer, Larissa; Peer, Nazia; Straus, Sharon E.; Tricco, Andrea C.] Unity Hlth Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Knowledge Translat Program, 209 Victoria St,East Bldg, Toronto, ON M5B 1W8, Canada.
   [Bourgeault, Ivy] Univ Ottawa, Sch Sociol & Anthropol, 120 Univ Private,Social Sci Bldg, Ottawa, ON K1N 6N5, Canada.
   [Grunfeld, Eva] Univ Toronto, Dept Family & Community Med, 500 Univ Ave, Toronto, ON M5G 1V7, Canada.
   [Moore, Ainsley] McMaster Univ, Dept Family Med, 100 Main St West, Hamilton, ON L8P 1H6, Canada.
   [Straus, Sharon E.] Univ Toronto, Dept Geriatr Med, 6 Queens Pk Crescent West, Toronto, ON M5S 3H2, Canada.
   [Tricco, Andrea C.] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, 155 Coll St, Toronto, ON M5T 3M7, Canada.
   [Tricco, Andrea C.] Univ Toronto, Inst Hlth Management & Evaluat, 155 Coll St, Toronto, ON M5T 3M7, Canada.
   [Tricco, Andrea C.] Queens Univ, Queens Collaborat Hlth Care Qual, JBI Ctr Excellence, 99 Univ Ave, Kingston, ON K7L 3N6, Canada.
RP Shamseer, L (corresponding author), Unity Hlth Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Knowledge Translat Program, 209 Victoria St,East Bldg, Toronto, ON M5B 1W8, Canada.
EM Larissa.shamseer@unityhealth.to
RI ; Shamseer, Larissa/E-9645-2017
OI moore, ainsley/0000-0003-3542-4519; Shamseer,
   Larissa/0000-0003-3690-3378
FU University of Ottawa through the Research Chair in Gender, Diversity and
   the Professions; Status of Women Canada, ON, Empowering Women Leaders in
   Health; Ontario Institute for Cancer research; Giblon Chair in family
   medicine research; Tier 1 Canada Research Chair in Knowledge
   Translation; Tier 2 Canada Research Chair in Knowledge Synthesis
FX Ivy Bourgeault is funded from the University of Ottawa through the
   Research Chair in Gender, Diversity and the Professions and from Status
   of Women Canada, ON 16255, Empowering Women Leaders in Health. Eva
   Grunfeld is funded by a physician scientist award from the Ontario
   Institute for Cancer research and by the Giblon Chair in family medicine
   research. Sharon Straus is funded by a Tier 1 Canada Research Chair in
   Knowledge Translation. Andrea Tricco is funded by a Tier 2 Canada
   Research Chair in Knowledge Synthesis.
CR Aguinis H, 2021, BUS HORIZONS, V64, P149, DOI 10.1016/j.bushor.2020.09.001
   Andersen JP, 2020, ELIFE, V9, DOI 10.7554/eLife.58807
   [Anonymous], 2019, LANCET, V393, P493, DOI 10.1016/S0140-6736(19)30239-9
   [Anonymous], 2020, COVID 19 IMPACT RES
   [Anonymous], 2020, COVID 19 IMPACTS WOM
   [Anonymous], Diversity, Equity, and Inclusion: Accredication Information and Other Resources for Institutional and Program Leaders and Staff Members; Diversity, Equity, and Inclusion Officers; and Residents and Fellows
   [Anonymous], 2020, COVID 50 50
   Bell ML, 2021, AM J PUBLIC HEALTH, V111, P159, DOI 10.2105/AJPH.2020.305975
   Brierley L, 2021, 431090 BIORXIV
   Burns KEA, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002935
   C4DISC, COAL DIV INCL SCHOL
   Cardel MI, 2020, ANN AM THORAC SOC, V17, P1366, DOI 10.1513/AnnalsATS.202006-589IP
   Carneiro Clarissa F D, 2020, Res Integr Peer Rev, V5, P16, DOI 10.1186/s41073-020-00101-3
   Charbonneau L., 2019, MOST U REPORT HAVING
   Clark J, 2017, LANCET, V390, P2423, DOI 10.1016/S0140-6736(17)32903-3
   Clifford T, 2020, CIHR
   Crenshaw K., 1991, STANFORD LAW REV, V43, P1241, DOI [DOI 10.2307/1229039, 10.2307/1229039]
   Director-General UNESCO, 2017, CRACK COD GIRLS WOM, P1
   Gewin Virginia, 2020, Nature, V583, P867, DOI 10.1038/d41586-020-02183-x
   Ginther DK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205929
   Glauser W, 2018, CAN MED ASSOC J, V190, pE479, DOI 10.1503/cmaj.109-5567
   Helmer M, 2017, ELIFE, V6, DOI 10.7554/eLife.21718
   Horton J, 2021, GLOBE MAIL
   Imperial College London, CAR BREAKS FLEX WORK
   Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V312, P483, DOI 10.1001/jama.2014.6932
   Jagsi R, 2018, ANN INTERN MED, V169, P128, DOI 10.7326/M17-2676
   King MM, 2017, SOCIUS, V3, P1, DOI DOI 10.1177/2378023117738903
   Kirkham JJ, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-041849
   Mason M., 2013, DO BABIES MATTER GEN
   MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56
   Misra J., 2011, ACADEME, V97, P22
   Moreira da Silva Jorge., 2019, OECD DEV MATTERS
   Moutinho S, 2021, SCIENCE
   Murray D, 2018, 400515 BIORXIV
   Pinho-Gomes Ana-Catarina, 2020, BMJ Glob Health, V5, DOI 10.1136/bmjgh-2020-002922
   Rice DB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2081
   Schiebinger L., 2008, DUAL CAREER ACAD COU
   Schiffer VMMM, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100652
   Sheather J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n28
   Spagnolo PA, 2020, ANN INTERN MED, V173, P385, DOI 10.7326/M20-1941
   Squazzoni F, 2020, ELSEVIER J PANDEMIC, DOI [10.2139/ssrn.3712813, DOI 10.2139/SSRN.3712813]
   Sugimoto CR, 2019, LANCET, V393, P550, DOI 10.1016/S0140-6736(18)32995-7
   Sugimoto CR, 2013, NATURE, V504, P211, DOI 10.1038/504211a
   Symonds MRE, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000127
   Tannenbaum C, 2020, 355206 BIORXIV, V2020, DOI 10.26.355206
   Tiesmaki M, 2020, SUPPORTING HLTH RES
   Tricco AC, 2021, CAN MED ASSOC J, V193, pE244, DOI 10.1503/cmaj.200951
   UN Secretary-General, 2020, POL BRIEF IMP COIVD
   Van Leeuwen T, 2019, MODELS PARENTING ITS
   Vincent-Lamarre P, 2020, NATURE INDEX    0519
   Vincent-Lamarre P., 2020, MONITORING WOMENS SC
   Wellcome, CORONAVIRUS INFORM G
   WHO Director-General, 2020, WHO DIR GEN OP REM M
   Witteman HO, 2019, LANCET, V393, P531, DOI 10.1016/S0140-6736(18)32611-4
   World Health Organisation, 2019, HUM RESOUR HLTH OBS, V24, P1
NR 55
TC 6
Z9 6
U1 1
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0895-4356
EI 1878-5921
J9 J CLIN EPIDEMIOL
JI J. Clin. Epidemiol.
PD JUN
PY 2021
VL 134
BP 160
EP 166
DI 10.1016/j.jclinepi.2021.03.004
EA MAY 2021
PG 7
WC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA SF3SI
UT WOS:000652678700015
PM 33705957
OA Bronze
DA 2022-04-20
ER

PT J
AU Khademian, F
   Aslani, A
   Ravangard, R
   Bastani, P
   Nami, M
   Jafari, P
AF Khademian, Fatemeh
   Aslani, Azam
   Ravangard, Ramin
   Bastani, Peivand
   Nami, Mohammad
   Jafari, Peyman
TI Efficacy of a web application for stress management among Iranian
   college students during COVID-19 outbreak: a study protocol for
   randomized controlled trials
SO TRIALS
LA English
DT Article
DE Randomized controlled trial; Telemedicine; Stress; COVID-19; Mobile
   health; College student
ID MENTAL-DISORDERS; PREVALENCE
AB Background: The prevalence of mental health disorders is increasing globally, and the prevalence of COVID-19 has made it worse. Evidence has indicated a major mental health burden and elevated anxiety associated with the new coronavirus outbreak in the general population. This study aims to evaluate an evidence-based web application (Naranj) for stress management among Iranian college students.
   Methods and design: This study aims to present a protocol related to a randomized controlled trial among Iranian college students. The study will be conducted on 100 students from two colleges of Shiraz University of Medical Sciences in Iran. The participants will be randomly assigned to the intervention and control groups. The intervention group participants will be provided with a web application, whereas the control group ones will be provided with an app unrelated to stress management. The primary outcome for this study will be the Perceived Stress Scale, and the two groups will be compared with respect to stress level and sleep quality.
   Discussion: A web application will be developed according to psychological theories and will be scientifically approved for managing college students' stress and improving their sleep quality during the COVID-19 outbreak.
C1 [Khademian, Fatemeh] Shiraz Univ Med Sci, Sch Management & Med Informat Sci, Dept Hlth Informat Management, Student Res Comm, Shiraz, Iran.
   [Aslani, Azam] Natl Agcy Strateg Res Med Educ, Tehran, Iran.
   [Aslani, Azam; Bastani, Peivand] Shiraz Univ Med Sci, Sch Management & Informat Sci, Hlth Human Resources Res Ctr, Shiraz, Iran.
   [Ravangard, Ramin] Shiraz Univ Med Sci, Sch Management & Med Informat Sci, Hlth Human Resources Res Ctr, Almas Bldg,Alley 29,Qasrodasht Ave, Shiraz, Iran.
   [Nami, Mohammad] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Neurosci, Shiraz, Iran.
   [Nami, Mohammad] Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Neurosci Ctr, City Knowledge 084301103, Panama City, Panama.
   [Nami, Mohammad] Inst Cognit Sci Studies, Dept Cognit Neurosci, Tehran, Iran.
   [Jafari, Peyman] Shiraz Univ Med Sci, Dept Biostat, Fac Med, Shiraz, Iran.
RP Ravangard, R (corresponding author), Shiraz Univ Med Sci, Sch Management & Med Informat Sci, Hlth Human Resources Res Ctr, Almas Bldg,Alley 29,Qasrodasht Ave, Shiraz, Iran.
EM ra_ravangard@yahoo.com
RI Jafari, Peyman/B-1914-2012; Bastani, Peivand/AAE-1769-2022; Nami,
   Mohammad/AAL-6280-2021
OI Jafari, Peyman/0000-0002-6766-1343; Bastani,
   Peivand/0000-0002-0412-0267; Nami, Mohammad/0000-0003-1410-5340;
   khademian, fatemeh/0000-0001-5648-8939
FU Shiraz University of Medical Sciences [98-01-07-19451]
FX This article was extracted from the Ph.D. dissertation written by
   Fatemeh Khademian and was financially supported by Shiraz University of
   Medical Sciences (grant No 98-01-07-19451). The authors would like to
   thank Ms. A. Keivanshekouh at the Research Improvement Center of Shiraz
   University of Medical Sciences for improving the use of English in the
   manuscript.
CR ADAIR JG, 1984, J APPL PSYCHOL, V69, P334, DOI 10.1037/0021-9010.69.2.334
   Afrisham R, 2019, INT J ENDOCRINOL MET, V17, DOI 10.5812/ijem.67400
   Alotaibi AD, 2020, J FAM COMMUNITY MED, V27, P23, DOI 10.4103/jfcm.JFCM_132_19
   Anthes E, 2016, NATURE, V532, P20, DOI 10.1038/532020a
   Borjalilu S, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.17767
   Dehghani A., 2019, IRAN J PSYCHIAT, V14, P137, DOI DOI 10.18502/IJPS.V14I2.993
   Farsi A., 2008, RAZI J MED SCI, V15, P31
   Fawzy M, 2017, PSYCHIAT RES, V255, P186, DOI 10.1016/j.psychres.2017.05.027
   Furer P, 1997, Depress Anxiety, V6, P78, DOI 10.1002/(SICI)1520-6394(1997)6:2<78::AID-DA4>3.0.CO;2-1
   Grist R, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7332
   Guo KJ, 2016, CHANGING ORGANIZATION: AGENCY THEORY IN A CROSS-CULTURAL CONTEXT, P21
   Harrer M, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9293
   Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954
   Huberty J, 2020, JMIR CANCER, V6, DOI 10.2196/16926
   Islamoska S, 2021, AGING MENT HEALTH, V25, P1151, DOI 10.1080/13607863.2020.1742656
   Khademian F, 2020, COMMUNITY DENT HLTH, V37, P125, DOI 10.1922/CDH_4642Rezaee07
   KHademian Fatemeh, 2020, Invest. educ. enferm, V38, pe08, DOI 10.17533/udea.iee.v38n1e08
   Kulkarni SH, 2020, STUD INDIAN PLACE NA, V40, P185
   Lee SA, 2020, DEATH STUD, DOI [10.1080/07481187.2020.1748481, 10.1080/07481187.2020.1853885]
   Lian Z, 2020, J AM COLL HEALTH, V68, P176, DOI 10.1080/07448481.2018.1538147
   Masaki K, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0243-5
   Metrics IfH Evaluation, 2017, GLOB BURD DIS COLL N
   Noorbala Ahmad Ali, 2018, Iran J Psychiatry, V13, P94
   Noorbala AA, 2017, ARCH IRAN MED, V20, P128, DOI 0172003/AIM.003
   Pitt A, 2018, ACT LEARN HIGH EDUC, V19, P61, DOI 10.1177/1469787417731194
   Polinski KJ, 2020, ARTHRIT CARE RES, V72, P1766, DOI 10.1002/acr.24085
   Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066
   Ramani S, 2020, CURR PROTEIN PEPT SC, V21, P611, DOI 10.2174/1389203721666200214111816
   Rodriguez-Rey R, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01540
   Roser M, 2020, BURDEN DIS
   Salehi F, 2019, STUD HEALTH TECHNOL, V261, P303, DOI 10.3233/978-1-61499-975-1-303
   Segal J, 2018, STRESS SYMPTOMS SIGN
   Sepahvand T, 2009, J PSYCHOL ED, V38, P27
   Shaheen A, 2020, MEDICINAL PLANTS OF SOUTH ASIA: NOVEL SOURCES FOR DRUG DISCOVERY, P1, DOI 10.1016/B978-0-08-102659-5.00001-X
   Silverman AL, 2019, CARDIOL REV, V27, P202, DOI 10.1097/CRD.0000000000000228
   Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038
   Su TP, 2007, J PSYCHIATR RES, V41, P119, DOI 10.1016/j.jpsychires.2005.12.006
   Tariq S, 2020, J PAK MED ASSOC, V70, P162, DOI 10.5455/JPMA.2153
   Wang CY, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01168
   WHO, 2020, 168 WHO
   World Health Assembly, 2012, GLOB BURD MENT DIS N
   World Health Organization, 2001, WORLD HLTH REP 2001
   World Health Organization, 2008, MHGAP MENT HLTH GAP
NR 43
TC 6
Z9 6
U1 5
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1745-6215
J9 TRIALS
JI Trials
PD DEC 14
PY 2020
VL 21
IS 1
AR 1023
DI 10.1186/s13063-020-04949-0
PG 7
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Research & Experimental Medicine
GA PG5ND
UT WOS:000599780600002
PM 33317615
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Nikooghadam, M
   Ghazikhani, A
   Saeedi, M
AF Nikooghadam, Morteza
   Ghazikhani, Adel
   Saeedi, Mohammad
TI COVID-19 Prediction Classifier Model Using Hybrid Algorithms in Data
   Mining
SO INTERNATIONAL JOURNAL OF PEDIATRICS-MASHHAD
LA English
DT Article
DE Accuracy; Covid-19; Classifier model; Data mining; Hybrid data mining
AB Increase of stored data in medical databases needs allocative tools to get access to data, data mining, discover knowledge and efficient use of data. Medical and treatment fields are two examples of data mining tools to analyze massive data and predictive modelling. In medical sciences, prediction and precise-quick detection of multiple diseases has to reduced exprense and also save people's lives. Group based methods (Ensemble Methods) are approaches that use hybrid models to recover classification. Coronavirus (COVID-19) has killed many people around the world so far, and this could be a good reason to present a new model for diagnosing the disease using data mining algorithms. This research presents a hybrid model of basic data mining and hybrid algorithms according to information in medical and laboratory records of patients suffering Covid-19 in Emam-Reza (AS) hospital in Mashhad, Iran, to diagnose the sickness. The proposed method uses Ensemble base (hybrid) classifiers, where the general model can be used to provide diagnoses with higher precision rather than classifiers. To execute the proposed model, data mining tools including Rapid Miner 9.7 and Python 3.7 were used. This study used stacking classifiers composed of basic algorithms including simple baze, decision tree, K- nearest neighborhood backup vector machine for basic section and uses chaos jungle algorithm in stack section that has gained 86.5% accuracy for diagnosis of Covid-19.
C1 [Nikooghadam, Morteza; Ghazikhani, Adel; Saeedi, Mohammad] Imam Reza Int Univ, Dept Comp Engn & Informat Technol, Mashhad, Razavi Khorasan, Iran.
RP Nikooghadam, M (corresponding author), Imam Reza Int Univ, Dept Comp Engn & Informat Technol, Mashhad, Razavi Khorasan, Iran.
EM Morteza.nikooghadam@gmail.com
RI Saeedi, Mohammad/AFQ-1644-2022
FU Imam Reza International University, Mashhad, Iran [552379]
FX This paper is derived from the MS dissertation of Mohammad Saeedi. The
   authors would like to acknowledge the University Research Management,
   for assisting this project at Imam Reza International University,
   Mashhad, Iran (ID-number: 552379).
CR AlMansour N, 2017, PROCEEDINGS OF THE 2017 INTELLIGENT SYSTEMS CONFERENCE (INTELLISYS), P430, DOI 10.1109/IntelliSys.2017.8324330
   AlMoammar A, 2019, ADV INTELL SYST, V868, P1070, DOI 10.1007/978-3-030-01054-6_74
   Altman, CLASSIFICATION EVALU
   [Anonymous], 2005, WHO STAT 2 M INT HLT
   Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Barstugan M., 2020, ARXIV PREPRINT ARXIV
   Bashir S, 2014, 2014 INTERNATIONAL CONFERENCE ON INFORMATION SOCIETY (I-SOCIETY 2014), P259, DOI 10.1109/i-Society.2014.7009056
   Bousquet J, 2007, ALLERGY, V62, P216, DOI 10.1111/j.1398-9995.2007.01307.x
   Chaurasia V., 2013, CARRIBBEAN J SCI TEC, V1, P208
   Chen M, 2017, IEEE ACCESS, V5, P8869, DOI 10.1109/ACCESS.2017.2694446
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Dash M., 1997, Intelligent Data Analysis, V1
   DRUCKER H, 1994, NEURAL COMPUT, V6, P1289, DOI 10.1162/neco.1994.6.6.1289
   Elshazly HI, 2014, I C ENG TECHNOL
   Eom JH, 2008, EXPERT SYST APPL, V34, P2465, DOI 10.1016/j.eswa.2007.04.015
   Fayyad U, 1997, FUTURE GENER COMP SY, V13, P99, DOI 10.1016/S0167-739X(97)00015-0
   Frias-Blanco I., 2016, P 31 ANN ACM S APPL, DOI [10.1145/2851613.2851655, DOI 10.1145/2851613.2851655]
   Garcia, 2018, ENSEMBLE CLASSIFIERS, P31, DOI DOI 10.1002/9781119421566.CH3
   Garcia S, 2015, INTEL SYST REF LIBR, V72, P1, DOI 10.1007/978-3-319-10247-4
   Han XY, 2020, CLIN INFECT DIS, V71, P723, DOI 10.1093/cid/ciaa271
   Islam S., 2018, CLASSIFICATION CHRON
   Kar S.K., 2020, COPING MENTAL HLTH C, P199, DOI 10.1007/978-981-15-4814-7_16
   Khanday Akib Mohi Ud Din, 2020, Int J Inf Technol, P1, DOI 10.1007/s41870-020-00495-9
   Lakshmi, 2018, INT J SCI RES COMPUT, V3, P25
   Muhammad L J, 2020, SN Comput Sci, V1, P206, DOI 10.1007/s42979-020-00216-w
   Narin A, 2021, PATTERN ANAL APPL, V24, P1207, DOI 10.1007/s10044-021-00984-y
   Nikam Sagar S., 2015, Oriental Journal of Computer Science and Technology, V8, P13
   Oza NC, 2005, IEEE SYS MAN CYBERN, P2340
   Riana D., 2020, JURNAL PILAR NUSA MA, V16, P71, DOI DOI 10.33480/PILAR.V16I1.1293
   Ruta D., 2005, Information Fusion, V6, P63, DOI 10.1016/j.inffus.2004.04.008
   Sahu B., 2018, OPEN BIOINF J, V11, P117, DOI [10.2174/1875036201811010117, DOI 10.2174/1875036201811010117]
   Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005
   Shirayeh BH, 2020, INT J PEDIATR-MASSHA, V8, P12619, DOI [10.22038/IJP.2020.53054.4203, 10.22038/ijp.2020.53054.4203]
   Urbanowicz RJ, 2018, J BIOMED INFORM, V85, P189, DOI 10.1016/j.jbi.2018.07.014
   Visa S., 2011, MAICS, V710, P120
   Wang S, 2021, EUR RADIOL, V31, P6096, DOI [10.1079/9781789246070.0001, 10.1007/s00330-021-07715-1]
   Wong TT, 2015, PATTERN RECOGN, V48, P2839, DOI 10.1016/j.patcog.2015.03.009
   Yu H., 2020, COPING STYLE SOCIAL, DOI [10.2139/ssrn.3556633, DOI 10.21203/RS.3.RS-20397/V2]
   Zhang Y, 2020, CHEST, V157, pE99, DOI 10.1016/j.chest.2020.02.014
NR 39
TC 0
Z9 0
U1 0
U2 4
PU MASHHAD UNIV MED SCIENCES
PI MASHHAD
PA VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 -
   445, MASHHAD, 00000, IRAN
SN 2345-5047
EI 2345-5055
J9 INT J PEDIATR-MASSHA
JI Int. J. Pediatr.-Masshad
PD JAN
PY 2021
VL 9
IS 1
BP 12723
EP 12737
DI 10.22038/ijp.2020.54272.4290
PG 15
WC Pediatrics
WE Emerging Sources Citation Index (ESCI)
SC Pediatrics
GA PR5VO
UT WOS:000607304200003
DA 2022-04-20
ER

PT J
AU Arpaci, I
   Alshehabi, S
   Mahariq, I
   Topcu, AE
AF Arpaci, Ibrahim
   Alshehabi, Shadi
   Mahariq, Ibrahim
   Topcu, Ahmet E.
TI An Evolutionary Clustering Analysis of Social Media Content and Global
   Infection Rates During the COVID-19 Pandemic
SO JOURNAL OF INFORMATION & KNOWLEDGE MANAGEMENT
LA English
DT Article
DE COVID-19; evolutionary clustering; social media; Twitter
ID IMPACT
AB This study investigates the impact of global infection rates on social media posts during the COVID-19 pandemic. The study analysed over 179 million tweets posted between March 22 and April 13, 2020 and the global COVID-19 infection rates using evolutionary clustering analysis. Results showed six clusters constructed for each term type, including three-level n-grams (unigrams, bigrams and trigrams). The frequent occurrences of unigrams ("COVID-19", "virus", "government", "people", etc.), bigrams ("COVID 19", "COVID-19 cases", "times share", etc.) and trigrams (COVID 19 crisis, things help stop and trying times share) were identified. The results demonstrated that the unigram trends on Twitter were up to about two times and 54 times more common than the bigram terms and trigram terms, respectively. Unigrams like "home" or "need" also became important as these terms reflected the main concerns of people during this period. Taken together, the present findings confirm that many tweets were used to broadcast peoples prevalent topics of interest during the COVID-19 pandemic. Furthermore, the results indicate that the number of COVID-19 infections had a significant effect on all clusters, being strong on 86% of clusters and moderate on 16% of clusters. The downward slope in global infection rates reflected the start of the trending of "social distancing" and "stay at home". These findings suggest that infection rates have had a significant impact on social media posting during the COVID-19 pandemic.
C1 [Arpaci, Ibrahim] Tokat Gaziosmanpasa Univ, Dept Comp Educ & Instruct Technol, TR-60250 Tokat, Turkey.
   [Alshehabi, Shadi] Turkish Aeronaut Assoc Univ, Dept Comp Engn, TR-06790 Ankara, Turkey.
   [Mahariq, Ibrahim; Topcu, Ahmet E.] Amer Univ Middle East, Coll Engn & Technol, Egaila, Kuwait.
RP Arpaci, I (corresponding author), Tokat Gaziosmanpasa Univ, Dept Comp Educ & Instruct Technol, TR-60250 Tokat, Turkey.
EM ibrahim.arpaci@gop.edu.tr; shadialshehabi@gmail.com;
   ibmahariq@gmail.com; ahmet.topcu@aum.edu.kw
RI Mahariq, Ibrahim/F-4460-2014; ARPACI, Ibrahim/AAC-2389-2019
OI Mahariq, Ibrahim/0000-0002-7222-3014; ARPACI,
   Ibrahim/0000-0001-6513-4569; Al Shehabi, Shadi/0000-0003-0545-9104
CR Ahmed W, 2020, J MED INTERNET RES, V22, DOI 10.2196/19458
   Arpaci I, 2022, DEATH STUD, V46, P553, DOI 10.1080/07481187.2020.1848945
   Arpaci I, 2020, CMC-COMPUT MATER CON, V65, P193, DOI 10.32604/cmc.2020.011489
   Banda JM., 2020, TWITTER DATASET 40 M
   Ben-Hur A, 2001, ADV NEUR IN, V13, P367
   Boslaugh S, 2012, STAT NUTSHELL DESKTO
   Burnap P, 2014, SOC NETW ANAL MIN, V4, DOI 10.1007/s13278-014-0206-4
   Guo JW, 2020, PUBLIC HEALTH NURS, V37, P934, DOI 10.1111/phn.12809
   Hassan N., 2020, INT J INTELL ENG SYS, V13, P291, DOI DOI 10.22266/IJIES2020.0229.27
   Islam MS, 2020, AM J TROP MED HYG, V103, P1621, DOI 10.4269/ajtmh.20-0812
   Kaufhold MA, 2020, INFORM PROCESS MANAG, V57, DOI 10.1016/j.ipm.2019.102132
   Kayes A., 2020, AUTOMATED MEASUREMEN, DOI 10.20944/preprints202004.0057.v1
   KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325
   Li HM, 2018, J CONTING CRISIS MAN, V26, P16, DOI 10.1111/1468-5973.12194
   Li Jiawei, 2020, JMIR Public Health Surveill, V6, pe18700, DOI 10.2196/18700
   Mingoti SA, 2006, EUR J OPER RES, V174, P1742, DOI 10.1016/j.ejor.2005.03.039
   Nayar KR, 2020, SOCIAL MEDIA MESSAGE SOCIAL MEDIA MESSAGE
   Qin L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072365
   Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777]
   Shah K, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/5098598
   Sharma A, 2020, J BUS RES, V117, P443, DOI 10.1016/j.jbusres.2020.05.035
   Tao ZY, 2020, J MED INTERNET RES, V22, DOI 10.2196/19981
   Tasnim S., 2020, J PREVENTIVE MED PUB, V53, P171, DOI [10.31235/osf.io/uf3zn, DOI 10.3961/JPMPH.20.094, 10.3961/jpmph.20.094]
   Valdez D, 2020, J MED INTERNET RES, V22, DOI 10.2196/21418
   Wilson ME, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa015
   Winters-Hilt S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S18
   Zaki M.J., 2014, DATA MINING ANAL FUN
   Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X
NR 28
TC 0
Z9 0
U1 5
U2 7
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0219-6492
EI 1793-6926
J9 J INF KNOWL MANAG
JI J. Inf. Knowl. Manag.
PD SEP
PY 2021
VL 20
IS 03
AR 2150038
DI 10.1142/S0219649221500386
PG 18
WC Information Science & Library Science
WE Emerging Sources Citation Index (ESCI)
SC Information Science & Library Science
GA TE3FZ
UT WOS:000669900900013
DA 2022-04-20
ER

PT J
AU Adesina, E
   Oyero, O
   Amodu, L
   Amoo, E
   Oyesomi, K
   Adeyeye, B
   Yartey, D
AF Adesina, Evaristus
   Oyero, Olusola
   Amodu, Lanre
   Amoo, Emmanuel
   Oyesomi, Kehinde
   Adeyeye, Babatunde
   Yartey, Darlynton
TI Health belief model and behavioural practice of urban poor towards
   COVID-19 in Nigeria
SO HELIYON
LA English
DT Article
DE Behaviour; Covid-19; Health belief model; Practice; Urban poor; Nigeria
ID DISGUST SENSITIVITY; SEX-DIFFERENCES; INTERVENTIONS; RISK
AB Poor adherence to promoting health behaviours is a significant challenge for prevention and management of infectious respiratory diseases. Non-pharmaceutical Interventions (NPIs) remain a proven behavioural practice for reducing the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) currently ravaging the world. Studies on Covid-19 have primarily focused on epidemiology, virology, and potential drug treatments to the neglect of behavioural practice of low-income settings. This study examines the extent health belief model predicts the behavior of 405 urban poor residents of Ogun State, which recorded the first index case in Nigeria, towards adoption Covid-19 NPIs. A cross-sectional study was conducted to find out the relationship between study participant characteristics, HBM constructs and unhealthy behavior. Study constructs were assessed on a four point Likert scale and were mean aggregated such that higher scores indicated stronger feelings about a construct. Findings shows that urban poor in the age group 30-40 years were more likely to feel susceptible to contracting Covid-19 (mean score: 2.59 and std. dev. 0.54), they also had a higher perception of the benefit of Covid-19 preventive behaviours than participants in other age groups (mean score: 2.95 and std. dev. 0.71). Also, the most prevalent unhealthy behaviour amongst urban poor residents was the indiscriminate use of facemasks as shown by almost half (47.6%) of participants who agreed that they use facemasks all the time even when alone. The study concludes that though urban poor residents feel threatened by Covid-19, nexus of factors such as low financial earnings, inadequate knowledge, and limited access to basic medical needs hamper the effective adoption of NPIs.
C1 [Adesina, Evaristus; Oyero, Olusola; Amodu, Lanre; Oyesomi, Kehinde; Adeyeye, Babatunde; Yartey, Darlynton] Covenant Univ, Dept Mass Commun, Ota, Nigeria.
   [Amoo, Emmanuel] Covenant Univ, Dept Demog & Social Stat, Ota, Nigeria.
RP Adesina, E (corresponding author), Covenant Univ, Dept Mass Commun, Ota, Nigeria.
EM evaristus.adesina@covenantuniversity.edu.ng
OI Adesina, Evaristus/0000-0003-4017-3291
FU Covenant University Centre for Research, Innovation, and Discovery
FX This work was supported by the Covenant University Centre for Research,
   Innovation, and Discovery.
CR Adekola PO, 2019, ENVIRON DEV SUSTAIN, V21, P2165, DOI 10.1007/s10668-018-0130-2
   Adesina Evaristus, 2021, WSEAS Transactions on Environment and Development, V17, P28, DOI 10.37394/232015.2021.17.3
   Adesina Evaristus, 2020, ScientificWorldJournal, V2020, P4969687, DOI 10.1155/2020/4969687
   Adesina E, 2020, DATA BRIEF, V30, DOI 10.1016/j.dib.2020.105507
   Adeyeye, 2018, 32 INT BUS INF MAN A
   Adeyeye B, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13073929
   Aledort JE, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-208
   [Anonymous], 1974, Health Education Monograph, V2, P324
   Armitage CJ, 2000, PSYCHOL HEALTH, V15, P173, DOI 10.1080/08870440008400299
   Blavos AA, 2014, J STUD AFF RES PRACT, V51, P420, DOI 10.1515/jsarp-2014-0042
   Brook Robert D., 2020, FLATTENING CURVE COV
   Carpenter CJ, 2010, HEALTH COMMUN, V25, P661, DOI 10.1080/10410236.2010.521906
   Chen MF, 2011, J COMMUN HEALTH NURS, V28, P29, DOI 10.1080/07370016.2011.539087
   Chen Xuyu, 2020, Int J Environ Res Public Health, V17, DOI 10.3390/ijerph17082893
   Chinedu, 2014, J DEMOGRAP SOCITU ST, P57
   Chung C., 2012, AHRCAC93 UN RIGHT FO
   Cook PA, 2001, PUBLIC HEALTH, V115, P54, DOI 10.1016/S0033-3506(01)00414-0
   Costa MF, 2020, REV SAUDE PUBL, V54, DOI 10.11606/s1518-8787.2020054002494
   Cummings K M, 1980, J Behav Med, V3, P123
   Davies NG, 2020, LANCET PUBLIC HEALTH, V5, pE375, DOI 10.1016/S2468-2667(20)30133-X
   Devaux, 2020, EFFECTIVENESS NONPHA, DOI DOI 10.1101/2020.04.06.20054197
   Dolnicar S., 2011, 3 GOOD REASONS NOT U
   Ellingson L.A., 1997, J SEX EDUC THER, V22, P19, DOI 10.1080/01614576.1997.11074189
   Eme Okechukwu I., 1851, J POL DEV STUD, V289, P1
   Ferebee, 2000, FACTORS INFLUENCE WH
   Fessler DMT, 2005, EVOL HUM BEHAV, V26, P344, DOI 10.1016/j.evolhumbehav.2004.12.001
   Fessler DMT, 2003, EVOL HUM BEHAV, V24, P406, DOI 10.1016/S1090-5138(03)00054-0
   Glanz K, 2010, ANNU REV PUBL HEALTH, V31, P399, DOI 10.1146/annurev.publhealth.012809.103604
   ILO, 2013, DOMESTIC WORKERS WOR
   IRC, 2020, CONF COVID CAS MOR D
   JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101
   Jones CJ, 2014, HEALTH PSYCHOL REV, V8, P253, DOI 10.1080/17437199.2013.802623
   Lau JTF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-18
   Lee AJ, 2015, EVOL HUM BEHAV, V36, P249, DOI 10.1016/j.evolhumbehav.2014.12.001
   Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857
   Lone SA, 2020, EMERG MICROBES INFEC, V9, P1300, DOI 10.1080/22221751.2020.1775132
   Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644
   Miller Carolyn, 2015, OXFAM EBOLA RESPONSE
   Mirzaei A, 2021, J EDUC HEALTH PROMOT, V10, DOI 10.4103/jehp.jehp_747_20
   Montanaro EA, 2014, HEALTH PSYCHOL, V33, P1251, DOI 10.1037/a0033969
   Montano DE, 2002, HLTH BEHAV HLTH ED T, P67
   NCDC, 2020, COV 19 CAS NIG
   Ngonghala CN, 2020, MATH BIOSCI, V325, DOI 10.1016/j.mbs.2020.108364
   Oaten M, 2009, PSYCHOL BULL, V135, P303, DOI 10.1037/a0014823
   Ogoina D, 2020, AM J TROP MED HYG, V103, P33, DOI 10.4269/ajtmh.20-0433
   OGS, 2020, OG STAT GOV POUL
   Olatunji BO, 2012, ASSESSMENT, V19, P205, DOI 10.1177/1073191111432881
   Pawlowski B, 2008, EVOL PSYCHOL-US, V6, P29, DOI 10.1177/147470490800600104
   Price, 2016, EXAMINING CONSTRUCTS
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403
   ROSENSTOCK IM, 1966, MILBANK FUND Q, V44, P94, DOI 10.2307/3348967
   ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203
   Sim SW, 2014, SINGAP MED J, V55, P160
   Somik, 2020, COVID 19 URBAN POOR
   Taylor M, 2009, RISK MANAG HEALTHC P, V2, P9, DOI 10.2147/RMHP.S4810
   Tola HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155147
   Tybur JM, 2011, PERS INDIV DIFFER, V51, P343, DOI 10.1016/j.paid.2011.04.003
   Wahba, 2017, J HIGH I PUBLIC HLTH, V47, P13, DOI DOI 10.21608/JHIPH.2017.19973
   Wang C, 2009, PREV MED, V48, P197, DOI 10.1016/j.ypmed.2008.11.008
   WHO, 2019, GLOB INFL PROGR NONP
   World Health Organization, 2019, NONPH PUBL HLTH MEAS
   World Health Organization, 2020, ADV US MASKS CONT CO, DOI [10.1093/jiaa077, DOI 10.1093/JIAA077]
   Yap J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-442
   Yartey Darlynton, COGENT SOCIAL SCI, V6
   Yep G A, 1993, J Am Coll Health, V41, P199
   Zotor, 2015, CENTRAL AFRICAN J PU, V1, P1, DOI [10.11648/j.cajph.20150101.11., DOI 10.11648/J.CAJPH.20150101.11]
NR 66
TC 1
Z9 1
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
EI 2405-8440
J9 HELIYON
JI Heliyon
PD SEP
PY 2021
VL 7
IS 9
AR e08037
DI 10.1016/j.heliyon.2021.e08037
EA SEP 2021
PG 8
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA WC7NY
UT WOS:000704442300021
PM 34568608
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Hand, MW
   Alexander, C
   Lyman, B
   Parchment, J
   Joseph, ML
   Chipps, E
AF Hand, Mikel W.
   Alexander, Catherine
   Lyman, Bret
   Parchment, Joy
   Joseph, M. Lindell
   Chipps, Esther
TI Filling the Knowledge Gap for Nurse Leaders: Next Steps Following
   COVID-19
SO NURSE LEADER
LA English
DT Article
AB The purpose of this article is to share gaps in knowledge and research related to pandemic management identified by nurse leaders during the COVID-19 pandemic.As part of a larger Delphi study, nurse leaders responded to an open-ended question about gaps in research they saw as important following the pandemic.Responses were analyzed using directed content analysis. Results are presented as 4 supercategories: Organizational leadership preparedness, adaptive leadership in crisis, innovations in care delivery, and health, well-being, and resilience.
C1 [Hand, Mikel W.] Univ Southern Indiana, Coll Nursing & Hlth Profess, Nursing, Evansville, IN 47712 USA.
   [Alexander, Catherine] San Francisco VA Med Ctr, San Francisco, CA USA.
   [Lyman, Bret] Brigham Young Univ, Coll Nursing, Provo, UT 84602 USA.
   [Parchment, Joy] Univ Cent Florida, Coll Nursing, Orlando, FL 32816 USA.
   [Joseph, M. Lindell] Univ Iowa, CNL Program, Hlth Syst Adm Program, Iowa City, IA USA.
   [Chipps, Esther] Ohio State Univ, Wexner Med Ctr, Clin Nursing, Columbus, OH 43210 USA.
   [Chipps, Esther] Ohio State Univ, Wexner Med Ctr, Coll Nursing, Columbus, OH 43210 USA.
RP Hand, MW (corresponding author), Univ Southern Indiana, Coll Nursing & Hlth Profess, Nursing, Evansville, IN 47712 USA.
EM mwhand@usi.edu
RI Hand, Mikel W/J-6710-2019
OI Hand, Mikel W/0000-0002-5271-3438
FU American Organization for Nursing Leadership Foundation for Nursing
   Leadership Research and Education
FX The authors would like to thank the American Organization for Nursing
   Leadership Foundation for Nursing Leadership Research and Education for
   funding this study. The authors also would like to thank the board
   members of the Association for Leadership Science in Nursing and the
   American Organization for Nursing Leadership Foundation for their
   support of this work.
CR Assarroudi A, 2018, J RES NURS, V23, P42, DOI 10.1177/1744987117741667
   Auerbach A, 2020, J HOSP MED, V15, P483, DOI 10.12788/jhm.3476
   Cariaso-Sugay John, 2021, Nurs Adm Q, V45, P142, DOI 10.1097/NAQ.0000000000000468
   Chipps EM, 2021, J NURS ADMIN, V51, P430, DOI 10.1097/NNA.0000000000001042
   Freysteinson WM, 2021, J NURS MANAGE, V29, P1535, DOI 10.1111/jonm.13310
   Heifetz R.A., 1994, LEADERSHIP EASY ANSW
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Institute of Medicine, 2021, FUT NURS 2020 2030 C
   Lefebre Nancy, 2020, Nurs Leadersh (Tor Ont), V33, P51, DOI 10.12927/cjnl.2021.26420
   Loh TP, 2020, CLIN CHEM LAB MED, V58, P1441, DOI 10.1515/cclm-2020-0710
   Losty Lyn Stankiewicz, 2021, Nurs Adm Q, V45, P118, DOI 10.1097/NAQ.0000000000000456
   Majers JS, 2020, NURSE LEAD, V18, P471, DOI 10.1016/j.mnl.2020.06.006
   Montoya Lorraine, 2020, Nurs Leadersh (Tor Ont), V33, P35, DOI 10.12927/cjnl.2021.26422
   Pearson MM, 2020, J NURS ADMIN, V50, P142, DOI 10.1097/NNA.0000000000000858
   Raso R, 2021, J NURS ADMIN, V51, P257, DOI 10.1097/NNA.0000000000001010
   Stamps DC, 2021, NURSE LEAD, V19, P159, DOI 10.1016/j.mnl.2020.07.011
   Veenema Tener Goodwin, 2017, Nurs Adm Q, V41, P151, DOI 10.1097/NAQ.0000000000000224
   Veenema TG, 2016, J NURS SCHOLARSHIP, V48, P187, DOI 10.1111/jnu.12198
   Wahlster S, 2021, CHEST, V159, P619, DOI 10.1016/j.chest.2020.09.070
   Zhao FQ, 2020, INT J NURS STUD, V110, DOI 10.1016/j.ijnurstu.2020.103725
NR 20
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1541-4612
EI 1541-4620
J9 NURSE LEAD
JI Nurse Lead.
PD DEC
PY 2021
VL 19
IS 6
BP 616
EP 621
DI 10.1016/j.mnl.2021.07.005
EA NOV 2021
PG 6
WC Nursing
WE Emerging Sources Citation Index (ESCI)
SC Nursing
GA ZA3JJ
UT WOS:000756063900014
PM 34335118
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Bratianu, C
AF Bratianu, Constantin
TI Toward understanding the complexity of the COVID-19 crisis: a grounded
   theory approach
SO MANAGEMENT & MARKETING-CHALLENGES FOR THE KNOWLEDGE SOCIETY
LA English
DT Article
DE COVID-19 pandemic; grounded theory; health system crisis; economic
   crisis; people's behavior; qualitative research; codification
ID STRATEGIES; IMPACT
AB The purpose of this paper is to investigate the complexity of the COVID-19 crisis by using the grounded theory approach. It is a new approach based on a data set constituted from published papers, reports delivered by official organizations or research institutes, working papers, and public information in media. Each of these documents presents data, information, knowledge, and ideas, usually from a single perspective. The present research uses the method of grounded theory and constructs an integrated model of analysis that explores the complexity of the global crisis induced by COVID-19. For the present research, the data were extracted from published papers focused on different aspects of the COVID-19 pandemic induced economic crisis. That means a meta-analysis of the initial quantitative data but performed from a semantic perspective. The findings show that COVID-19 induced economic crisis is a complex phenomenon that is influenced directly and indirectly by the health system crisis, governmental policies, and behavior of people. The integrated model we got can be used as a tool in a further investigation for a deeper understanding of the complexity of COVID-19. The originality of this paper comes from creating a meta-analysis with the grounded theory of different aspects investigated in a series of papers and constructing a dynamic model capable of approaching the complexity of this Black Swan phenomenon.
C1 [Bratianu, Constantin] Bucharest Univ Econ Studies, Bucharest, Romania.
RP Bratianu, C (corresponding author), Bucharest Univ Econ Studies, Bucharest, Romania.
EM constantin.bratianu@gmail.com
RI Bratianu, Constantin/L-3402-2018
OI Bratianu, Constantin/0000-0002-1029-7384
CR Ariely Dan, 2011, UPSIDE IRRATIONALITY
   Aum S., 2020, COVID EC VETTED REAL, P143
   Baldwin R., 2020, MITIGATING COVID EC
   Baron J., 2000, THINKING DECIDING
   Bird RJ, 2003, CHAOS LIFE COMPLEXIT, DOI DOI 10.7312/BIRD12662
   Black CV, 2020, RENAISSANCE FUTURITIES: SCIENCE, ART, INVENTION, P1
   Blake C., 2008, ART DECISIONS MANAGE
   Boroditsky L, 2000, COGNITION, V75, P1, DOI 10.1016/S0010-0277(99)00073-6
   Bratianu C., 2015, J DYNAMICS KNOWLEDGE, V3, P409
   Bratianu C, 2020, AMFITEATRU ECON, V22, P639, DOI 10.24818/EA/2020/55/639
   Bratianu C, 2020, MANAG MARK, V15, P154, DOI 10.2478/mmcks-2020-0010
   Bratianu C, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12041348
   Bratianu C, 2020, KYBERNETES, V49, P6, DOI 10.1108/K-02-2019-0122
   Bratianu C, 2019, SYSTEMS-BASEL, V7, DOI 10.3390/systems7020020
   Bratianu C, 2014, PROC INT CONF INTELL, P83
   Bratianu C, 2011, PROCEEDINGS OF THE 3RD EUROPEAN CONFERENCE ON INTELLECTUAL CAPITAL, P94
   Bryman A., 2007, BUSINESS RES METHODS, V2nd ed.
   Burt R., 2005, BROKERAGE CLOSURE IN
   Casasanto D, 2012, COGN LINGUIST, V23, P643, DOI 10.1515/cog-2012-0020
   Chang R, 2020, EC POLICY INCENTIVES
   Corbin J., 2015, BASICS QUALITATIVE R
   Delaporte I., 2020, COVID EC CTR EC POLI, V14, P200
   Dima AM, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10061706
   Dima AM, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11133506
   Frankfort-Nachmias C., 2000, RES METHODS SOCIAL S
   Cegarra-Navarro JG, 2019, J ORGAN CHANGE MANAG, V32, P67, DOI 10.1108/JOCM-04-2018-0107
   Galeotti A., 2020, EC PANDEMIC CASE COV
   Gharajedaghi J, 2006, SYSTEMS THINKING MAN
   Glaser BG, 2017, DISCOVERY GROUNDED T
   Glasser B. G., 1967, DISCOVERY GROUNDED T
   Gleick J., 2008, CHAOS MAKING NEW SCI
   Gourinchas P.-O., 2020, MITIGATING COVID EC, P31
   Greenberg N, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1211
   Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020
   Handa P., 2019, KNOWLEDGE ASSETS KNO
   Hasanat M.V., 2000, ASIAN J MULTIDISCIPL, V3, P85
   Ho CSH, 2020, ANN ACAD MED SINGAP, V49, P155
   Jackson M.C., 2019, CRITICAL SYSTEMS THI
   Kahneman D., 2011, THINKING
   Kostin KB, 2018, STRATEG MANAG, V23, P11, DOI 10.5937/StraMan1801011K
   Lakoff G., 1980, METAPHORS WE LIVE
   Lakoff G., 1999, PHILOS FLESH EMBODIE
   Lin P.Z., 2020, VETTED REAL TIME PAP, V14, P85
   Maxwell, 2013, QUALITATIVE RES DESI
   Mey N.D., 2020, SHIFTS LOW TOUCH EC
   Moustakas, 1990, HEURISTIC RES DESIGN
   Nadim S.S., 2020, SHORT TERM PRE UNPUB, P1
   Reeves M., 2020, HARVARD BUSINESS REV
   Remenyi D., 2014, GROUNDED THEORY
   Senge P. M., 1990, 5 DISCIPLINE ART PRA
   Shaw P, 2000, COMPLEXITY MANAGEMEN
   Solnit R., 2020, GUARDIAN
   Spinelli A, 2020, BRIT J SURG, V107, P785, DOI 10.1002/bjs.11627
   Stacey, 2001, COMPLEX RESPONSIVE P
   Sutherland S., 2013, IRRATIONALITY ENEMY
   Taleb N., 2008, BLACK SWAN IMPACT HI
   Vatamanescu EM, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11092510
   Wagner III W.E., 2017, USING IBM SPSS STAT
   World Health Organization, 2020, 177 WHO
   World Health Organization, 2020, 2019 NOV COR 2019 NC
   Zhong N., 2020, CORONAVIRUS PREVENTI
NR 61
TC 18
Z9 18
U1 9
U2 16
PU SCIENDO
PI WARSAW
PA BOGUMILA ZUGA 32A, WARSAW, MAZOVIA, POLAND
SN 1842-0206
EI 2069-8887
J9 MANAG MARK
JI Manag. Mark.
PD OCT
PY 2020
VL 15
SU 1
BP 410
EP 423
DI 10.2478/mmcks-2020-0024
PG 14
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA OH5NR
UT WOS:000582631600001
OA gold
DA 2022-04-20
ER

PT J
AU Pomara, C
   Volti, GL
   Cappello, F
AF Pomara, Cristoforo
   Volti, Giovanni Li
   Cappello, Francesco
TI COVID-19 Deaths: Are We Sure It Is Pneumonia? Please, Autopsy, Autopsy,
   Autopsy!
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Editorial Material
DE COVID-19; infectious diseases; autopsy; diagnosis
ID CLINICAL DIAGNOSES; EBOLA-VIRUS
AB The current outbreak of COVID-19 severe respiratory disease, which started in Wuhan, China, is an ongoing challenge, and a major threat to public health that requires surveillance, prompt diagnosis, and research efforts to understand this emergent pathogen and to develop an effective response. Due to the scientific community's efforts, there is an increasing body of published studies describing the virus' biology, its transmission and diagnosis, its clinical features, its radiological findings, and the development of candidate therapeutics and vaccines. Despite the decline in postmortem examination rate, autopsy remains the gold standard to determine why and how death happens. Defining the pathophysiology of death is not only limited to forensic considerations; it may also provide useful clinical and epidemiologic insights. Selective approaches to postmortem diagnosis, such as limited postmortem sampling over full autopsy, can also be useful in the control of disease outbreaks and provide valuable knowledge for managing appropriate control measures. In this scenario, we strongly recommend performing full autopsies on patients who died with suspected or confirmed COVID-19 infection, particularly in the presence of several comorbidities. Only by working with a complete set of histological samples obtained through autopsy can one ascertain the exact cause(s) of death, optimize clinical management, and assist clinicians in pointing out a timely and effective treatment to reduce mortality. Death can teach us not only about the disease, it might also help with its prevention and, above all, treatment.
C1 [Pomara, Cristoforo] Univ Catania, Dept Med Surg Sci & Adv Technol GF Ingrassia, I-95100 Catania, Italy.
   [Pomara, Cristoforo] Univ Hosp Policlin Vittorio, Med Legal Unit, I-95100 Catania, Italy.
   [Volti, Giovanni Li] Univ Catania, Dept Biomed & Biotechnol Sci, I-95100 Catania, Italy.
   [Cappello, Francesco] Univ Palermo, Dept Biomed Neurosci & Adv Diagnost, I-90100 Palermo, Italy.
   [Cappello, Francesco] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA.
RP Pomara, C (corresponding author), Univ Catania, Dept Med Surg Sci & Adv Technol GF Ingrassia, I-95100 Catania, Italy.; Pomara, C (corresponding author), Univ Hosp Policlin Vittorio, Med Legal Unit, I-95100 Catania, Italy.; Volti, GL (corresponding author), Univ Catania, Dept Biomed & Biotechnol Sci, I-95100 Catania, Italy.; Cappello, F (corresponding author), Univ Palermo, Dept Biomed Neurosci & Adv Diagnost, I-90100 Palermo, Italy.; Cappello, F (corresponding author), Temple Univ, Dept Biol, Philadelphia, PA 19122 USA.
EM cristoforo.pomara@unict.it; livolti@unict.it;
   francesco.cappello@unipa.it
RI Pomara, Cristoforo/AAX-1029-2020; Volti, Giovanni Li/A-2435-2008
OI Volti, Giovanni Li/0000-0002-8678-2183
CR Castillo P, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002171
   De Cock KM, 2019, NEW ENGL J MED, V381, P1889, DOI 10.1056/NEJMp1909017
   Kreuels B., 2015, N ENGL J MED, V372
   Kreuels B, 2014, NEW ENGL J MED, V371, P2394, DOI 10.1056/NEJMoa1411677
   Letko M, 2020, NAT MICROBIOL, V5, P562, DOI 10.1038/s41564-020-0688-y
   Ossei P.P.S., 2019, FORENSIC SCI INT REP, V1
   Petrosillo N, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1169-4
   Roosen J, 2000, MAYO CLIN PROC, V75, P562, DOI 10.4065/75.6.562
   SARODE VR, 1993, HUM PATHOL, V24, P194, DOI 10.1016/0046-8177(93)90300-6
   Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y
   Tejerina EE, 2018, HUM PATHOL, V76, P85, DOI 10.1016/j.humpath.2018.02.025
   Tian S, 2020, J THORAC ONCOL
   Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306
   Vetter P, 2016, J INFECT DIS, V214, pS177, DOI 10.1093/infdis/jiw254
NR 14
TC 48
Z9 49
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD MAY
PY 2020
VL 9
IS 5
AR 1259
DI 10.3390/jcm9051259
PG 3
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA LY0OO
UT WOS:000540223800016
PM 32357503
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Kumric, M
   Kurir, TT
   Martinovic, D
   Zivkovic, PM
   Bozic, J
AF Kumric, Marko
   Kurir, Tina Ticinovic
   Martinovic, Dinko
   Zivkovic, Piero Marin
   Bozic, Josko
TI Impact of the COVID-19 pandemic on inflammatory bowel disease patients:
   A review of the current evidence
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Review
DE COVID-19; SARS-CoV-2; Inflammatory bowel disease; Crohn's disease;
   Ulcerative colitis
ID TUMOR-NECROSIS-FACTOR; OPPORTUNISTIC INFECTIONS;
   INTERNATIONAL-ORGANIZATION; CROHNS-DISEASE; FACTOR-ALPHA; MANAGEMENT;
   CORONAVIRUS; SARS; STRATEGIES; RECEPTOR
AB Since the initial coronavirus disease 2019 (COVID-19) outbreak in China in December 2019, the infection has now become the biggest medical issue of modern medicine. Two major contributors that amplified the impact of the disease and subsequently increased the burden on health care systems were high mortality among patients with multiple co-morbidities and overcapacity of intensive care units. Within the gastroenterology-related community, particular concern was raised with respect to patients with inflammatory bowel disease (IBD), as those patients are prone to opportunistic infections mainly owing to their immunosuppressive-based therapies. Hence, we sought to summarize current knowledge regarding COVID-19 infection in patients with IBD. Overall, it seems that IBD is not a comorbidity that poses an increased risk for COVID-19 acquisition, except in patients treated with 5-aminosalicylates. Furthermore, outcomes of the infected patients are largely dependent on therapeutic modality by which they are treated, as some worsen the clinical course of COVID-19 infection, whereas others seem to dampen the detrimental effects of COVID-19. Finally, we discussed the present and the future impact of COVID-19 pandemic and concomitantly increased health care burden on IBD-management.
C1 [Kumric, Marko; Kurir, Tina Ticinovic; Martinovic, Dinko; Bozic, Josko] Univ Split, Dept Pathophysiol, Sch Med, Soltanska 2, Split 21000, Croatia.
   [Kurir, Tina Ticinovic] Univ Hosp Split, Dept Endocrinol, Split 21000, Croatia.
   [Zivkovic, Piero Marin] Univ Hosp Split, Dept Gastroenterol, Split 21000, Croatia.
RP Bozic, J (corresponding author), Univ Split, Dept Pathophysiol, Sch Med, Soltanska 2, Split 21000, Croatia.
EM josko.bozic@mefst.hr
RI Kumrić, Marko/ABA-5467-2021
OI Kumrić, Marko/0000-0002-9696-3359; Martinovic, Dinko/0000-0003-2060-5130
CR Abreu MT, 2020, J CROHNS COLITIS, V14, pS767, DOI 10.1093/ecco-jcc/jjaa116
   Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994
   Allez M, 2020, J CROHNS COLITIS, V14, pS774, DOI 10.1093/ecco-jcc/jjaa150
   Allocca M, 2020, CLIN GASTROENTEROL H, V18, P1882, DOI 10.1016/j.cgh.2020.04.028
   Armstrong RA, 2020, ANAESTHESIA, V75, P1340, DOI 10.1111/anae.15201
   Ashton JJ, 2019, CLIN NUTR, V38, P80, DOI 10.1016/j.clnu.2018.01.020
   Ashton JJ, 2018, ARCH DIS CHILD, V103, P307, DOI 10.1136/archdischild-2017-313955
   Bai XY, 2020, J CROHNS COLITIS, V14, P1494, DOI 10.1093/ecco-jcc/jjaa064
   Batlle D, 2020, CLIN SCI, V134, P543, DOI 10.1042/CS20200163
   Beddok A, 2020, RADIOTHER ONCOL, V150, P12, DOI 10.1016/j.radonc.2020.05.043
   Bedoui Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205023
   Bezzio C, 2021, GUT, V70, P623, DOI 10.1136/gutjnl-2020-321760
   Bilato C, 2020, G ITAL CARDIOL, V21, P408, DOI 10.1714/3359.33322
   BLEYER WA, 1978, CANCER-AM CANCER SOC, V41, P36, DOI 10.1002/1097-0142(197801)41:1<36::AID-CNCR2820410108>3.0.CO;2-I
   Bonovas S, 2016, CLIN GASTROENTEROL H, V14, P1385, DOI 10.1016/j.cgh.2016.04.039
   Brenner EJ, 2020, GASTROENTEROLOGY, V159, P481, DOI 10.1053/j.gastro.2020.05.032
   Brnic D, 2020, WORLD J GASTROENTERO, V26, P4866, DOI 10.3748/wjg.v26.i32.4866
   Centers for Disease Control and Prevention, DISC TRANSM BAS PREC
   Cerniello FM, 2017, HYPERTENSION, V70, P982, DOI 10.1161/HYPERTENSIONAHA.117.09789
   Chen C, 2020, Zhonghua Shao Shang Za Zhi, V36, P471, DOI 10.3760/cma.j.cn501120-20200224-00088
   Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005
   D'Amico F, 2020, CLIN GASTROENTEROL H, V18, P2689, DOI 10.1016/j.cgh.2020.08.003
   D'Amico F, 2020, GASTROENTEROLOGY, V159, P14, DOI 10.1053/j.gastro.2020.04.059
   D'Amico F, 2020, CLIN GASTROENTEROL H, V18, P1663, DOI 10.1016/j.cgh.2020.04.001
   DE LK, 2020, J CROHNS COLITIS, V14, pS807
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Dolinger MT, 2020, J PEDIATR GASTR NUTR, V71, P153, DOI 10.1097/MPG.0000000000002809
   Dotan I, 2020, J CROHNS COLITIS, V14, pS785, DOI 10.1093/ecco-jcc/jjaa147
   Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090
   Duricova D, 2014, J CROHNS COLITIS, V8, P1351, DOI 10.1016/j.crohns.2014.05.006
   Effenberger M, 2020, GUT, V69, P1543, DOI 10.1136/gutjnl-2020-321388
   Fiorino G, 2020, J CROHNS COLITIS, V14, P1037, DOI 10.1093/ecco-jcc/jjaa023
   Ford AC, 2013, AM J GASTROENTEROL, V108, P1268, DOI 10.1038/ajg.2013.138
   Fung M, 2021, CLIN INFECT DIS, V72, P340, DOI 10.1093/cid/ciaa863
   Gajendran M, 2020, ANN GASTROENTEROL, V33, P591, DOI 10.20524/aog.2020.0547
   Garg M, 2020, GUT, V69, P841, DOI 10.1136/gutjnl-2019-318512
   Garg M, 2015, J RENIN-ANGIO-ALDO S, V16, P559, DOI 10.1177/1470320314521086
   Gibson PG, 2020, MED J AUSTRALIA, V213, P54, DOI 10.5694/mja2.50674
   Gower-Rousseau C, 2021, GASTROENTEROLOGY, V160, P473, DOI 10.1053/j.gastro.2020.05.013
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Gu JY, 2020, GASTROENTEROLOGY, V158, P1518, DOI 10.1053/j.gastro.2020.02.054
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hanauer SB, 2010, NAT REV GASTRO HEPAT, V7, P63, DOI 10.1038/nrgastro.2009.238
   Harmer D, 2002, FEBS LETT, V532, P107, DOI 10.1016/S0014-5793(02)03640-2
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ibrahim A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010015
   Ibrahim IM, 2020, J INFECTION, V80, P554, DOI 10.1016/j.jinf.2020.02.026
   Jablaoui A, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00021
   Kaneko H, 1999, LAB INVEST, V79, P379
   Kappelman MD, 2020, SECURE IBD DATABASE
   Kennedy NA, 2020, GUT, V69, P984, DOI 10.1136/gutjnl-2020-321244
   Khajah MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150861
   Kochar B, 2020, GASTROENTEROLOGY, V158, P2104, DOI 10.1053/j.gastro.2020.02.032
   Kucharzik Torsten, 2014, Viszeralmedizin, V30, P326, DOI 10.1159/000366463
   Leung WK, 2003, GASTROENTEROLOGY, V125, P1011, DOI [10.1053/S0016-5085(03)01215-0, 10.1016/j.gastro.2003.08.001]
   Lewin S, 2020, J CROHNS COLITIS, V14, pS780, DOI 10.1093/ecco-jcc/jjaa140
   Lukin DJ, 2020, GASTROENTEROLOGY, V159, P1541, DOI 10.1053/j.gastro.2020.05.066
   Luthra P, 2015, ALIMENT PHARM THER, V41, P1227, DOI 10.1111/apt.13215
   Macaluso FS, 2020, DIGEST LIVER DIS, V52, P1222, DOI 10.1016/j.dld.2020.09.002
   Magro F, 2020, J CROHNS COLITIS, V14, pS798, DOI 10.1093/ecco-jcc/jjaa160
   Mao R, 2020, LANCET GASTROENTEROL, V5, P426, DOI 10.1016/S2468-1253(20)30076-5
   Arranz EM, 2020, INFLAMM BOWEL DIS, V26, P1149, DOI 10.1093/ibd/izaa142
   Mazzola G, 2017, J INFECTION, V74, P433, DOI 10.1016/j.jinf.2017.02.009
   Monteleone G, 2020, J CROHNS COLITIS, V14, P1334, DOI 10.1093/ecco-jcc/jjaa061
   Murdaca G, 2015, EXPERT OPIN DRUG SAF, V14, P571, DOI 10.1517/14740338.2015.1009036
   Neurath MF, 2020, GUT, V69, P1335, DOI 10.1136/gutjnl-2020-321269
   Ng SC, 2020, J CROHNS COLITIS, V14, pS791, DOI 10.1093/ecco-jcc/jjaa128
   Pak A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00241
   Parasa S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.11335
   Perrotta C, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/456895
   Rahier JF, 2014, J CROHNS COLITIS, V8, P443, DOI 10.1016/j.crohns.2013.12.013
   Reuken PA, 2020, ALIMENT PHARM THER, V52, P1748, DOI 10.1111/apt.16087
   Ricciuto A, 2018, ARCH DIS CHILD, V103, P319, DOI 10.1136/archdischild-2017-313060
   Rubin DT, 2020, GASTROENTEROLOGY, V159, P6, DOI 10.1053/j.gastro.2020.04.002
   Saibeni S, 2020, UNITED EUR GASTROENT, V8, P1228, DOI 10.1177/2050640620964132
   Sarkar S, 2021, J MED VIROL, V93, P1538, DOI 10.1002/jmv.26483
   Sebastian, 2020, UNITED EUROPEAN GAST
   Siegel CA, 2021, GUT, V70, P635, DOI 10.1136/gutjnl-2020-324000
   Singh S, 2020, GASTROENTEROLOGY, V159, P1575, DOI 10.1053/j.gastro.2020.06.003
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   Taxonera C, 2020, ALIMENT PHARM THER, V52, P1750, DOI 10.1111/apt.16117
   Taxonera C, 2020, ALIMENT PHARM THER, V52, P276, DOI 10.1111/apt.15804
   Tlayjeh H, 2020, J INFECT PUBLIC HEAL, V13, P1652, DOI 10.1016/j.jiph.2020.09.008
   van Paassen J, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03400-9
   Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200
   Vijayanand P, 2004, CLIN MED, V4, P152, DOI 10.7861/clinmedicine.4-2-152
   Vrdoljak J, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113429
   Waljee AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158017
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   WHO, COR DIS 2019 COVID 1
   Williams Chadwick, 2011, Therap Adv Gastroenterol, V4, P237, DOI 10.1177/1756283X11405250
   Windsor Joseph W, 2019, Curr Gastroenterol Rep, V21, P40, DOI 10.1007/s11894-019-0705-6
   Wong E, 2016, SCI REP-UK, V6, DOI 10.1038/srep35598
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Wysocki J, 2010, HYPERTENSION, V55, P90, DOI 10.1161/HYPERTENSIONAHA.109.138420
   Xiao F, 2020, GASTROENTEROLOGY, V158, P1831, DOI 10.1053/j.gastro.2020.02.055
   Zabana Y, 2019, J CROHNS COLITIS, V13, P828, DOI 10.1093/ecco-jcc/jjz013
   Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9
   Zhang LQ, 1996, NATURE, V383, P768, DOI 10.1038/383768a0
NR 102
TC 2
Z9 2
U1 0
U2 2
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD JUL 7
PY 2021
VL 27
IS 25
BP 3748
EP 3761
DI 10.3748/wjg.v27.i25.3748
PG 14
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA TN5LJ
UT WOS:000676275500004
PM 34321841
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Ferreira, CM
   Sa, MJ
   Martins, JG
   Serpa, S
AF Ferreira, Carlos Miguel
   Sa, Maria Jose
   Martins, Jose Garrucho
   Serpa, Sandro
TI The COVID-19 Contagion-Pandemic Dyad: A View from Social Sciences
SO SOCIETIES
LA English
DT Article
DE COVID-19; social sciences; inequality; pandemic; contagion; social
   distancing
ID HEALTH; WILL
AB The objective of this concept paper focuses on the relevance of the analytical potential of Social Sciences for understanding the multiple implications and challenges posed by the COVID-19 contagion-pandemic dyad. This pandemic is generating a global threat with a high number of deaths and infected individuals, triggering enormous pressure on health systems. Most countries have put in place a set of procedures based on social distancing, as well as (preventive) isolation from possible infected and transmitters of the disease. This crisis has profound implications and raises issues for which the contribution of Social Sciences does not seem to be sufficiently mobilised. The contribution of Social Sciences is paramount, in terms of their knowledge and skills, to the knowledge of these problematic realities and to act in an informed way on these crises. Social Sciences are a scientific project focused on interdisciplinarity, theoretical and methodological plurality. This discussion is developed from the systems of relationships between social phenomena in the coordinates of time and place, and in the socio-historical contexts in which they are integrated. A pandemic is a complex phenomenon as it is always a point of articulation between natural and social determinations. The space of the discourse on the COVID-19 pandemic can be understood as the expression of a coalition of discourses, i.e., the interaction of various discourses, combined in re-interpretative modalities of certain realities and social phenomena. The circumstantial coalitions of interests, which shape the different discursive records and actions produced by different agents of distinct social spaces, enable the acknowledgement and legitimation of this pandemic threat and danger, and the promotion of its public management.
C1 [Ferreira, Carlos Miguel; Martins, Jose Garrucho; Serpa, Sandro] ISCTE Univ Inst Lisbon, Interdisciplinary Ctr Social Sci CICS NOVA, P-1649026 Lisbon, Portugal.
   [Ferreira, Carlos Miguel] Estoril Higher Inst Tourism & Hotel Studies, P-2765273 Estoril, Portugal.
   [Sa, Maria Jose] CIPES Ctr Res Higher Educ Policies, P-4450137 Matosinhos, Portugal.
   [Serpa, Sandro] Univ Azores, Fac Social & Human Sci, Dept Sociol, P-9500321 Ponta Delgada, Portugal.
   [Serpa, Sandro] Univ Azores, Interdisciplinary Ctr Childhood & Adolescence NIC, P-9500321 Ponta Delgada, Portugal.
RP Serpa, S (corresponding author), ISCTE Univ Inst Lisbon, Interdisciplinary Ctr Social Sci CICS NOVA, P-1649026 Lisbon, Portugal.; Serpa, S (corresponding author), Univ Azores, Fac Social & Human Sci, Dept Sociol, P-9500321 Ponta Delgada, Portugal.; Serpa, S (corresponding author), Univ Azores, Interdisciplinary Ctr Childhood & Adolescence NIC, P-9500321 Ponta Delgada, Portugal.
EM carlos.miguel.ferreira@iscte-iul.pt; mjsa@cipes.up.pt;
   jj.garruchomartins@gmail.com; sandro.nf.serpa@uac.pt
RI Serpa, Sandro/T-5007-2017; de Sá, Maria José Sampaio/L-4285-2019
OI Serpa, Sandro/0000-0003-4286-4440; de Sá, Maria José
   Sampaio/0000-0003-0991-3669; , Carlos Miguel
   Ferreira/0000-0001-9232-6929
FU University of Azores, Interdisciplinary Centre of Social
   Sciences-CICS.UAc/CICS.NOVA.UAc [UID/SOC/04647/2020]; FCT/MEC;
   FEDEREuropean Commission
FX University of Azores, Interdisciplinary Centre of Social
   Sciences-CICS.UAc/CICS.NOVA.UAc, UID/SOC/04647/2020, with the financial
   support of FCT/MEC through national funds and when applicable
   co-financed by FEDER under the PT2020 Partnership Agreement.
CR Ahmed F, 2020, LANCET PUBLIC HEALTH, V5, pE240, DOI 10.1016/S2468-2667(20)30085-2
   Almeida J.F., 1994, INTRO SOCIOLOGIA
   Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5
   Aristovnik A., 2020, BIBLIOMETRIC ANAL CO, DOI [10.20944/preprints202006.0299.v3, DOI 10.20944/PREPRINTS202006.0299.V3]
   Barreneche, 2020, SOC REGISTER, V4, P19, DOI [10.14746/sr.2020.4.2.02, DOI 10.14746/SR.2020.4.2.02]
   Beck Ulrich, 2008, WORLD RISK
   Bikbov B., 2020, COMMUNICATION COVID, DOI [10.31235/osf.io/ea9jm, DOI 10.31235/OSF.IO/EA9JM]
   Bonnet F., VERY THOUGHT WHAT CR
   Borges M.M., 2017, REFLEXOS TECNOLOGIA, P179
   Borraz O., 2020, QUEST CE QUUNE CRISE
   Bourdelais P., 1989, SOC SCI HLTH, V7, P7
   Carapinheiro G, 2011, SOCIOL LINE REV ASS, V3, P57
   Cardoso G., 2010, QUE SIGNIFICA OPEN S
   Carvalho L.M., 2000, NOS ATRAVES ESCRITA
   Correia T., 2020, ENTREVISTA TIAGO COR
   Costa A.F., 1992, SOCIOLOGIA SOCIOLOGY
   Costa A.F., 2020, ENTREVISTA ANTONIO F
   Coste F., 2011, REV SCI HUMAINES, V21, DOI [10.4000/traces.5126, DOI 10.4000/TRACES.5126]
   Dobry M., 2009, SOCIOLOGIE CRISES PO
   DOLLFUS O, 1994, ESPACE MONDE
   Douglas M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1557
   Dubar C., 2006, SOCIO LOGOS, V1, DOI [10.4000/socio-logos.20, DOI 10.4000/SOCIO-LOGOS.20]
   Elias N., 2008, INTRODUCAO SOCIOLOGI
   Elias N, 1991, SOC INDIVIDUALS
   Erol S., 2020, SSRN ELECT J, P1, DOI [10.2139/ssrn.3583181, DOI 10.2139/SSRN.3583181]
   FASSIN D, 1996, ESPACE POLITIQUE SAN
   Fassin D, 2015, M S-MED SCI, V31, P463, DOI 10.1051/medsci/20153105001
   Ferguson SJ, 2016, TEACH SOCIOL, V44, P163, DOI 10.1177/0092055X16651478
   Ferreira C.M., 2020, CONTAGIONS SOCIAL SU, DOI [10.20944/preprints202003.0324.v1, DOI 10.20944/PREPRINTS202003.0324.V1]
   Ferreira CM, 2017, SOCIETIES, V7, DOI 10.3390/soc7040030
   Flick U., 2005, METODOS QUALITATIVOS
   Fressoz J.-B., 2020, VIRUS POLITIQUEMENT
   Gaudilliere J.-P., 2020, VIRUSES HUMANS KNOWL
   Gellert G. A., 2020, ONLINE J HLTH ETHICS, V16, DOI [10.18785/ojhe.1601.03, DOI 10.18785/OJHE.1601.03]
   Gilbert C., 1992, POWER EXTREME SITUAT
   Goffman E, 1963, STIGMA NOTES MANIPUL
   Grace D, 2011, ECOHEALTH, V8, P55, DOI 10.1007/s10393-010-0357-3
   Greiff, 2020, SCI KNOWLEDGE TRUST, DOI [10.31234/osf.io/tmu8f, DOI 10.31234/OSF.IO/TMU8F]
   Grubert E., 2020, ROLE SOCIALLY EQUITA
   Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1
   Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352
   Houdart S., 2011, HUMAN NONHUMAN COMME
   IMF, 2020, WORLD EC OUTL APR 20
   Instituto de Higiene e Medicina Tropical, 2020, DOSS OR DISP PAND CO
   Jared D., 2000, INEQUALITY SOC ESSAI
   Jarynowski A., 2020, SOC REGIST, V4, P7, DOI DOI 10.14746/sr.2020.4.3.01
   Kakodkar P, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7560
   Kirksey SE, 2010, CULT ANTHROPOL, V25, P545, DOI 10.1111/j.1548-1360.2010.01069.x
   Kupferschmidt K, 2020, SCIENCE, V368, P218, DOI 10.1126/science.368.6488.218
   Lagadec P., 1988, STATES EMERGENCY TEC
   Lakoff A, 2008, CULT ANTHROPOL, V23, P399, DOI 10.1111/j.1548-1360.2008.00013.x
   Lakoff A, 2007, PUBLIC CULTURE, V19, P247, DOI 10.1215/08992363-2006-035
   Lalanda-Goncalves R., 2014, P 3 INT C MUSSI NETW
   Leandro M., 2011, SOC REV FAC LET U PO, V11, P215
   Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0
   Ludovic J., 2020, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.20.261099, DOI 10.2471/BLT.20.261099]
   Lunn P.D, 2020, MOTIVATING SOCIAL DI, DOI [10.31234/osf.io/x4agb, DOI 10.31234/OSF.IO/X4AGB]
   Mardellat V., 2020, IS IT IMMORAL CHOOSE
   Mateus A., 2020, EC CRISIS COVID 19 F
   Mendes J., 2015, SOC ANAL, V214, P2182
   Mills C.Wright., 1959, SOCIOLOGICAL IMAGINA
   Minard A., 2011, TRACES, V21, P217, DOI [10.4000/traces.5227, DOI 10.4000/TRACES.5227]
   MOGI R., 2020, INFLUENCE SOCIAL EC, DOI [10.31235/osf.io/sb8xn, DOI 10.31235/OSF.IO/SB8XN]
   Mohammadi M, 2022, J PUBLIC HEALTH-HEID, V30, P167, DOI 10.1007/s10389-020-01258-3
   Morrison A, 2017, EDUC STUD-AESA, V53, P233, DOI 10.1080/00131946.2017.1297301
   Musinguzi G, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/7895
   Nelson W., 2020, SOCIOLOGICAL PSYCHOL, DOI [10.31234/osf.io/s5jkh, DOI 10.31234/OSF.IO/S5JKH]
   Nentwich M., 2005, Information Communication & Society, V8, P542, DOI 10.1080/13691180500418451
   Nunes JA, 2009, REV CRIT CIENC SOC, P143, DOI 10.4000/rccs.1588
   OECD, 2020, COR WORLD EC RISK
   Oksanen A., 2020, REGULATION TRUST SOC, DOI [10.2139/ssrn.3569845, DOI 10.2139/SSRN.3569845]
   Older M., 2011, THESIS
   Peretti-Watel P., 2020, RESSOUR SCI EC SOC
   Pires R., 2020, ENTREVISTA RUI PENA
   Portuguese Sociological Associati, 2020, OLH SOC CRIS COVID 1
   Poulain M., 2005, SOC INT FACE SARS SA, V6, P905
   Rodriguez CP, 2020, INT MULTIDISCIP J SO, V9, P107, DOI 10.17583/rimcis.2020.5386
   Ramos A.G., 1981, NEW SCI ORG NEW SCI
   Reher M., 2020, COVID 19 PANDEMIC AG, DOI [10.31235/osf.io/bfvxt, DOI 10.31235/OSF.IO/BFVXT]
   Revet S., 2020, COVID 19 NATURAL DIS
   Richardson ET, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002571
   Rosenfeld DL, 2020, POLITICIZING COVID 1, DOI [10.31234/osf.io/k23cv, DOI 10.31234/OSF.IO/K23CV]
   Rossman J., CORONAVIRUS CAN HERD
   Sa M.J., 2020, SCI INS EDUC FRONT, V5, P525, DOI [10.15354/sief.20.ar039, DOI 10.15354/SIEF.20.AR039]
   Santoro P., CORONAVIRUS SOC FREN
   Santos B.S., 2020, CRUEL PEDAGOGIA DO V
   Schiariti V, 2020, DEV MED CHILD NEUROL, DOI 10.1111/dmcn.14549
   Serpa S, 2020, SOCIETIES, V10, DOI 10.3390/soc10010004
   Sethuraju N, 2013, SAGE OPEN, V3, DOI 10.1177/2158244013496182
   Shuja KH, 2020, PSYCHIAT DANUB, V32, P32, DOI 10.24869/psyd.2020.32
   Silva A.S., 1986, METODOLOGIA CIENCIAS, P9
   Teixeira R.R., 1998, INTERFACE, V2, P77
   Teuton J, 2018, SOCIAL ISOLATION LON
   Timmons S., 2020, J BEHAV PUBLIC ADM, V3, P1, DOI 10.30636/jbpa.31.147
   Torny D., 2012, RESEAUX DECOUVERTE, V30, P45, DOI [10.3917/res.171.0045, DOI 10.3917/RES.171.0045]
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X
   Bezerra ACV, 2020, CIENC SAUDE COLETIVA, V25, P2411, DOI 10.1590/1413-81232020256.1.10792020
   Vilaca O., CE QUE EPIDEMIES NOU
   von Braun J, 2020, SCIENCE, V368, P214, DOI 10.1126/science.abc2255
   WHO, 2020, OR SARS COV 2
   Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020
   Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548
   Ye ZW, 2020, INT J BIOL SCI, V16, P1686, DOI 10.7150/ijbs.45472
   Yu J., 2020, OPEN ACCESS I NEWS M
   Zylberman P., 2012, TRIB SANTE, V1, P35, DOI [10.3917/seve.034.0035, DOI 10.3917/SEVE.034.0035]
NR 106
TC 10
Z9 10
U1 5
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-4698
J9 SOCIETIES
JI Societies
PD DEC
PY 2020
VL 10
IS 4
AR 77
DI 10.3390/soc10040077
PG 19
WC Sociology
WE Emerging Sources Citation Index (ESCI)
SC Sociology
GA PJ3CE
UT WOS:000601649600001
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Ebekozien, A
   Aigbavboa, C
AF Ebekozien, Andrew
   Aigbavboa, Clinton
TI COVID-19 recovery for the Nigerian construction sites: The role of the
   fourth industrial revolution technologies
SO SUSTAINABLE CITIES AND SOCIETY
LA English
DT Article
DE Construction firm; Construction site; Covid-19; Fourth industrial
   revolution technologies; Nigeria
ID BLOCKCHAIN
AB Fourth industrial revolution (4IR) technologies have been proved as successful platforms to communicate and visualise construction projects within team meetings. These techniques possibly can enhance compliance with Covid-19 rules on sites. How far concerning Nigerian construction contractors in the use of 4IR technologies are yet to receive in-depth studies. Therefore, this paper offers a collective insight into the issues affecting construction firms from Covid-19 regarding lockdown rules and the role of 4IR technologies. Given the unexplored nature of the problem, a virtual face-to-face type of qualitative research method was employed. Twelve semistructured interviews from selected construction firms and consultant experts were engaged and collated data analysed via a thematic approach. Findings group the 4IR technologies into smart construction site, simulation and modelling, and digitisation and virtualisation in Nigeria?s context, and majority of the 4IR technologies can be useful to enhance Covid-19 compliance. Reluctant to adopt, high implementation cost, inadequate knowledge management, resistance to change, among others emerged as the factors hindering 4IR technologies usage. Findings will strengthen and provide a rich insight into the impact of Covid-19 on construction sites and contribute towards informing key stakeholders to create an enabling environment for the implementation of 4IR technologies on site.
C1 [Ebekozien, Andrew] Univ Sains Malaysia, Sch Housing Bldg & Planning, George Town, Malaysia.
   [Ebekozien, Andrew] Bekos Energy Serv Nigeria Ltd, Ikorodu, Nigeria.
   [Ebekozien, Andrew] Quant Surveying Consultancy Firm, Bowen Partnership, Benin, Nigeria.
   [Aigbavboa, Clinton] Univ Johannesburg, Dept Construct Management & Quant Surveying, Johannesburg, South Africa.
RP Ebekozien, A (corresponding author), Univ Sains Malaysia, Sch Housing Bldg & Planning, George Town, Malaysia.
EM ebekoandy45@yahoo.com
RI Aigbavboa, Clinton/AAS-6493-2020
OI Aigbavboa, Clinton/0000-0003-2866-3706
FU Bekos Energy Services Limited, Nigeria [SR/02/2020/005]
FX This work was supported by Bekos Energy Services Limited, Nigeria
   (SR/02/2020/005). Special thanks to the anonymous reviewers for
   providing constructive comments to enhance the quality of this paper.
   Also, thanks to the participants for their cooperation and valuable
   responses, which form the basis of this study.
CR Ahmed I, 2021, SUSTAIN CITIES SOC, V65, DOI 10.1016/j.scs.2020.102571
   Ajibade P., 2020, BANKS BANK SYSTEMS, V15, P187, DOI [10.21511/bbs.15(2).2020.17, DOI 10.21511/BBS.15(2).2020.17]
   [Anonymous], 2020, THE GUARDIAN
   Ayentimi DT, 2019, TECHNOL ANAL STRATEG, V31, P641, DOI 10.1080/09537325.2018.1542129
   Bisong A., 2020, IMPACT COVID 19 REMI
   Black B., 2020, **DROPPED REF**
   Bogue R, 2018, IND ROBOT, V45, P1, DOI 10.1108/IR-11-2017-0194
   Bong CL, 2020, ANESTH ANALG, V131, P86, DOI 10.1213/ANE.0000000000004846
   Centres for Disease Control and Prevention, 2021, COVID 19 8 THINGS KN
   Chamola V, 2020, IEEE ACCESS, V8, P90225, DOI 10.1109/ACCESS.2020.2992341
   Coombs C, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102182
   Corbin J., 2015, BASICS QUALITATIVE R
   Creswell J.W., 2009, RES DESIGN QUALITATI, DOI [10.2307/1523157., DOI 10.2307/1523157]
   Denzin K.N., 2017, HDB QUALITATIVE RES, V5th
   Dwivedi YK, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102211
   Ebekozien A., 2019, THESIS U SAINS MALAY
   Ebekozien A, 2020, J CONTEMP AFR STUD, V38, P348, DOI 10.1080/02589001.2020.1758304
   Ebekozien A, 2020, J HUM BEHAV SOC ENVI, V30, P918, DOI 10.1080/10911359.2020.1772164
   Ebekozien A, 2020, PROP MANAG, V38, P325, DOI 10.1108/PM-08-2019-0048
   Ebekozien A, 2019, HABITAT INT, V87, P27, DOI 10.1016/j.habitatint.2019.03.009
   Ezeokoli O. F., 2020, ARCH CURRENT RES INT, V20, P69, DOI [10.9734/ACRI/2020/v201430191, DOI 10.9734/ACRI/2020/V20I430191]
   Garcia D, 2013, J ORGAN CHANGE MANAG, V26, P423, DOI 10.1108/09534811311328416
   Gbadamosi AQ, 2020, PROG DISASTER SCI, V8, DOI 10.1016/j.pdisas.2020.100130
   Goulding JS, 2015, ARCHIT ENG DES MANAG, V11, P163, DOI 10.1080/17452007.2014.891501
   Gruber T, 2008, QUAL MARK RES, V11, P256, DOI 10.1108/13522750810879002
   Hirschi A, 2018, CAREER DEV Q, V66, P192, DOI 10.1002/cdq.12142
   Jallow H, 2021, SMART SUSTAIN BUILT, V10, P581, DOI 10.1108/SASBE-05-2020-0068
   Josephs L., 2020, 1 MASS AIR SHIPMENT
   Kabiru J. M., 2020, INT J SCI ENG SCI, V4, P34
   Kajander J.-K., 2016, NORDIC CONSTR INNOV
   Kim K, 2020, KSCE J CIV ENG, V24, P2561, DOI 10.1007/s12205-020-0188-x
   Laing T, 2020, EXTRACT IND SOC, V7, P580, DOI 10.1016/j.exis.2020.04.003
   Lemieux VL, 2016, REC MANAG J, V26, P110, DOI 10.1108/RMJ-12-2015-0042
   Li B, 2021, SUSTAIN CITIES SOC, V66, DOI 10.1016/j.scs.2020.102685
   Loayza V.N., 2020, COSTS TRADE OFFS FIG
   Madueke O., 2020, J PUBLIC ADM SOCIAL, V5, P43
   Manda MI, 2019, PROCEEDINGS OF THE 12TH INTERNATIONAL CONFERENCE ON THEORY AND PRACTICE OF ELECTRONIC GOVERNANCE (ICEGOV2019), P244, DOI 10.1145/3326365.3326398
   Nkosi T., 2020, P INT C IND ENG OP M
   Omobowale AO, 2020, INT J SOCIOL SOC POL, V40, P1041, DOI 10.1108/IJSSP-05-2020-0150
   Owoseni A, 2020, INFORM TECHNOL DEV, V26, P762, DOI 10.1080/02681102.2020.1727825
   Papadopoulou T, 2020, HIGH EDUC PEDAGOG, V5, P182, DOI 10.1080/23752696.2020.1816844
   PWC, 2020, 5 ACT CAN HELP MIT R
   Rotatori D, 2021, HUM RESOUR DEV INT, V24, P92, DOI 10.1080/13678868.2020.1767453
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Roxby P., 2020, BBC NEWS
   Saunders M., 2019, RES METHODS BUSINESS, V8
   Shakor P, 2020, AUTOMAT CONSTR, V110, DOI 10.1016/j.autcon.2019.102964
   Smith P, 2014, PROCD SOC BEHV, V119, P475, DOI 10.1016/j.sbspro.2014.03.053
   Stysko-Kunkowska M., 2014, INTERVIEWS QUALITATI
   Sun CJ, 2020, SUSTAIN CITIES SOC, V62, DOI 10.1016/j.scs.2020.102390
   Sutherland E, 2020, POLITIKON-UK, V47, P233, DOI 10.1080/02589346.2019.1696003
   Tahmasebinia F, 2020, CONSTR INNOV-ENGL, V20, P379, DOI 10.1108/CI-10-2019-0103
   Tajeddini K, 2009, J INT ENTREP, V7, P1, DOI 10.1007/s10843-008-0028-4
   Teddlie C, 2010, HDB MIXED METHODS SO
   Thurlow J., 2020, 63 INT FOOD POL RES
   Oesterreich TD, 2016, COMPUT IND, V83, P121, DOI 10.1016/j.compind.2016.09.006
   Tjahjono B, 2017, PROCEDIA MANUF, V13, P1175, DOI 10.1016/j.promfg.2017.09.191
   Wang JG, 2021, SUSTAIN CITIES SOC, V64, DOI 10.1016/j.scs.2020.102511
   Weber B., 2016, INFRASTRUCTURE ASSET
   Woetzel J., 2015, JUNE REPORT MCKINSE
   World Bank, 2020, COVID 19 EMERGENCY P
   World Economic Forum, 2020, 900000000 NIG LIV EX
   World Health Organisation, 2020, OV PUBL HLTH SOC MEA
   Worldometers, 2021, COVID 19 CORONAVIRUS
NR 64
TC 31
Z9 31
U1 11
U2 29
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2210-6707
EI 2210-6715
J9 SUSTAIN CITIES SOC
JI Sust. Cities Soc.
PD JUN
PY 2021
VL 69
AR 102803
DI 10.1016/j.scs.2021.102803
EA MAR 2021
PG 10
WC Construction & Building Technology; Green & Sustainable Science &
   Technology; Energy & Fuels
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Construction & Building Technology; Science & Technology - Other Topics;
   Energy & Fuels
GA SD5IC
UT WOS:000651405200005
DA 2022-04-20
ER

PT J
AU Sasangohar, F
   Moats, J
   Mehta, R
   Peres, SC
AF Sasangohar, Farzan
   Moats, Jason
   Mehta, Ranjana
   Peres, S. Camille
TI Disaster Ergonomics: Human Factors in COVID-19 Pandemic Emergency
   Management
SO HUMAN FACTORS
LA English
DT Article
DE emergency response; pandemic; disasters; training; communication
ID PERSONAL PROTECTIVE EQUIPMENT; TEAM PERFORMANCE; PREPAREDNESS; LESSONS;
   DISEASE
AB Objective We aimed to identify opportunities for application of human factors knowledge base to mitigate disaster management (DM) challenges associated with the unique characteristics of the COVID-19 pandemic. Background The role of DM is to minimize and prevent further spread of the contagion over an extended period of time. This requires addressing large-scale logistics, coordination, and specialized training needs. However, DM-related challenges during the pandemic response and recovery are significantly different than with other kinds of disasters. Method An expert review was conducted to document issues relevant to human factors and ergonomics (HFE) in DM. Results The response to the COVID-19 crisis has presented complex and unique challenges to DM and public health practitioners. Compared to other disasters and previous pandemics, the COVID-19 outbreak has had an unprecedented scale, magnitude, and propagation rate. The high technical complexity of response and DM coupled with lack of mental model and expertise to respond to such a unique disaster has seriously challenged the response work systems. Recent research has investigated the role of HFE in modeling DM systems' characteristics to improve resilience, accelerating emergency management expertise, developing agile training methods to facilitate dynamically changing response, improving communication and coordination among system elements, mitigating occupational hazards including guidelines for the design of personal protective equipment, and improving procedures to enhance efficiency and effectiveness of response efforts. Conclusion This short review highlights the potential for the field's contribution to proactive and resilient DM for the ongoing and future pandemics.
C1 [Sasangohar, Farzan; Mehta, Ranjana] Texas A&M Univ, Dept Ind & Syst Engn, College Stn, TX 77843 USA.
   [Sasangohar, Farzan] Houston Methodist Hosp, Ctr Outcomes Res, Houston, TX 77030 USA.
   [Sasangohar, Farzan] Houston Methodist Hosp, Dept Surg, Houston, TX 77030 USA.
   [Moats, Jason] Texas A&M Engn Extens Serv TEEX, Testing & Innovat Ctr TT&IC, College Stn, TX USA.
   [Peres, S. Camille] Texas A&M Univ, Dept Environm & Occupat Hlth, College Stn, TX 77843 USA.
   [Peres, S. Camille] Texas A&M Univ, Human Syst Engn, Mary Kay OConnor Proc Safety Ctr, College Stn, TX 77843 USA.
RP Sasangohar, F (corresponding author), Texas A&M Univ, Ind & Syst Engn, 3131 TAMU, College Stn, TX 77843 USA.
EM sasangohar@tamu.edu
RI ; Peres, S. Camille/C-2494-2018
OI Mehta, Ranjana/0000-0002-8254-8365; Sasangohar,
   Farzan/0000-0001-9962-5470; Peres, S. Camille/0000-0002-3679-9171
FU National Science FoundationNational Science Foundation (NSF) [1724676,
   1760479, 1937053]; (advanced robotics for next-generation emergency
   responders)
FX The work is partially supported by the National Science Foundation under
   grant numbers: 1724676 (Human-team-machine interaction in emergency
   response), 1760479 (Human-robotic interactions during Harvey recovery
   operations), and 1937053 (Learning environments with advanced robotics
   for next-generation emergency responders). We would like to thank Jacob
   Kolman for his editorial support.
CR Au S. Y. Z, 2009, P 4 INT S HUM BEH FI, P443
   Badiru Adedeji B., 2013, HDB EMERGENCY RESPON
   Baers JH, 2018, ERGON DES, V26, P24, DOI 10.1177/1064804617744694
   BagenstosSamuel R., 2020, SSRN ELECT J, V130, DOI [10.2139/ssrn.3559926, DOI 10.2139/SSRN.3559926]
   Aguilera MVC, 2016, J LOSS PREVENT PROC, V41, P18, DOI 10.1016/j.jlp.2016.02.018
   Chacon P. S., 2019, EXP AI GAM ATL GA
   Christensen L, 2020, DISASTER MED PUBLIC, V14, P514, DOI 10.1017/dmp.2020.56
   Crichton M, 2001, J HAZARD MATER, V88, P255, DOI 10.1016/S0304-3894(01)00270-9
   Drews FA, 2019, CLIN INFECT DIS, V69, pS199, DOI 10.1093/cid/ciz520
   Drews FA, 2019, HUM FACTORS, V61, P693, DOI 10.1177/0018720819833214
   Edmond MB, 2014, JAMA-J AM MED ASSOC, V312, P2495, DOI 10.1001/jama.2014.15497
   Ericsson KA, 2008, ACAD EMERG MED, V15, P988, DOI 10.1111/j.1553-2712.2008.00227.x
   Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802
   Gates B, 2020, NEW ENGL J MED, V382, P1677, DOI 10.1056/NEJMp2003762
   Gomes JO, 2014, APPL ERGON, V45, P780, DOI 10.1016/j.apergo.2013.10.009
   Gostin LO, 2020, HASTINGS CENT REP, V50, P8, DOI 10.1002/hast.1090
   Guastello SJ, 2010, HUM FACTORS, V52, P162, DOI 10.1177/0018720809359003
   Gurses Ayse P, 2020, J Patient Saf Risk Manag, V25, P49, DOI 10.1177/2516043520917764
   Hegde S, 2020, J COGN ENG DECIS MAK, V14, P75, DOI 10.1177/1555343419877719
   Herlihey TA, 2016, INFECT CONT HOSP EP, V37, P1022, DOI 10.1017/ice.2016.124
   Hochmitz I, 2011, HUM FACTORS, V53, P489, DOI 10.1177/0018720811412777
   Hollnagel E., 2015, SAFETY 1 SAFETY 2 WH
   Hsiao HW, 2014, HUM FACTORS, V56, P873, DOI 10.1177/0018720813516359
   Ji YP, 2020, LANCET GLOB HEALTH, V8, pE480, DOI 10.1016/S2214-109X(20)30068-1
   Jipp M, 2016, HUM FACTORS, V58, P92, DOI 10.1177/0018720815604441
   Kalet Adina L, 2020, WMJ, V119, P6
   McNeese NJ, 2018, HUM FACTORS, V60, P262, DOI 10.1177/0018720817743223
   Nuamah J. K., 2020, DESIGN HLTH, P201
   Nuamah JK, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00287
   Owen C, 2014, HUMAN FACTORS CHALLENGES IN EMERGENCY MANAGEMENT: ENHANCING INDIVIDUAL AND TEAM PERFORMANCE IN FIRE AND EMERGENCY SERVICES, P1
   Patterson MD, 2016, J COGN ENG DECIS MAK, V10, P36, DOI 10.1177/1555343416629520
   Porpiglia F, 2020, BJU INT, V125, pE15, DOI 10.1111/bju.15076
   Prytz Erik G., 2019, Proceedings of the Human Factors and Ergonomics Society Annual Meeting, V63, P640, DOI 10.1177/1071181319631323
   Rao A. H., 2020, CLIN ENG HDB, P839
   Rozman T., 2020, HDB RES ROLE HUMAN F, P368
   Salehi H, 2019, AM J INFECT CONTROL, V47, P595, DOI 10.1016/j.ajic.2018.10.008
   Salmon P, 2011, DISASTER PREV MANAG, V20, P140, DOI 10.1108/09653561111126085
   Sasangohar F, 2020, ANESTH ANALG, V131, P106, DOI 10.1213/ANE.0000000000004866
   Son C, 2020, APPL ERGON, V87, DOI 10.1016/j.apergo.2020.103114
   Son C, 2020, ERGONOMICS, V63, P643, DOI 10.1080/00140139.2020.1752820
   Son C, 2020, APPL ERGON, V84, DOI 10.1016/j.apergo.2019.103031
   Taha S, 2014, BRIT J HEALTH PSYCH, V19, P592, DOI 10.1111/bjhp.12058
   Williams G., 2019, THESIS
   Wisher, 1992, P HUM FACT SOC ANN M, V36, P1171, DOI [10.1518/107118192786749676, DOI 10.1518/107118192786749676]
   Yamnill S., 2001, HUM RESOUR DEV Q, V12, P195, DOI [10.1002/hrdq.7, DOI 10.1002/HRDQ.7]
   Young R, 2020, KNOWING REMOVE PPE I
NR 46
TC 13
Z9 13
U1 19
U2 33
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0018-7208
EI 1547-8181
J9 HUM FACTORS
JI Hum. Factors
PD NOV
PY 2020
VL 62
IS 7
BP 1061
EP 1068
AR 0018720820939428
DI 10.1177/0018720820939428
EA JUL 2020
PG 8
WC Behavioral Sciences; Engineering, Industrial; Ergonomics; Psychology,
   Applied; Psychology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Behavioral Sciences; Engineering; Psychology
GA OG3BR
UT WOS:000549730000001
PM 32648781
OA Bronze
DA 2022-04-20
ER

PT J
AU Ajmal, MM
   Khan, M
   Shad, MK
   AlKatheeri, H
   Jabeen, F
AF Ajmal, Mian M.
   Khan, Mehmood
   Shad, Muhammad Kashif
   AlKatheeri, Haseena
   Jabeen, Fauzia
TI Empirical examination of societal, financial and technology-related
   challenges amid COVID-19 in service supply chains: evidence from
   emerging market
SO INTERNATIONAL JOURNAL OF LOGISTICS MANAGEMENT
LA English
DT Article; Early Access
DE COVID-19; Pandemic; Financial; Societal; Technological; Challenges;
   Services; Supply chain; Emerging market
ID BUSINESS; PERFORMANCE; VALIDATION; MANAGEMENT; INDUSTRY
AB Purpose This paper reports an empirical examination of the societal, financial and technology-related challenges amid the ongoing pandemic (COVID-19) in the service supply chain network. Design/methodology/approach A combination of qualitative approach (for items generation pertinent to the constructs involved) and quantitative approach (self-administered questionnaires from the top and middle management of the sampled companies) was used for data collection. In total, 272 complete responses were received and analyzed through structural equation modeling. Findings The results provided empirical evidence that social and physical distancing, travel restrictions, work from home and lockdown practices have two conflicting effects: On one hand, these practices have contributed to the reduction of economic activities, including the low economic outlook, low productivity, high unemployment, poverty, fall in customer demands, dissatisfaction and mental health, that ultimately impacts rise financial and societal issues. On the other hand, the results revealed an insignificant influence of COVID-19 on creating technology-related challenges in the service sector. It shows that the organizations are doing well in combating the technology-related challenges amidst the current pandemic. Research limitations/implications Findings of the inquiry recommend implications for the services industry to harmonize a comprehensive strategy and revisit the global norms in sustainable supply chain management activities that have been the backdrop in their operations for a long time. Practical implications Findings of the inquiry recommend implications for the services industry to harmonize a comprehensive strategy and revisit the global norms in supply chain management activities that have been the backdrop in their operations for a long time. Originality/value Prior studies in the context of the COVID-19 outbreak and its implications have given more attention to the exploratory and theoretical discussion than to empirical evidence. This paper contributes to filling this knowledge gap by empirically exploring the societal, financial and technology-related challenges created by COVID-19. The analysis in this paper covers three dimensions of the PEST model, namely economic, societal and technological factors. This study also helps in laying out a platform for investigating the PEST (political, economic, social and technological) model for guiding the services industry in strategic decision-making in a new era due to COVID-19.
C1 [Ajmal, Mian M.; Khan, Mehmood; Jabeen, Fauzia] Abu Dhabi Univ, Coll Business, Abu Dhabi, U Arab Emirates.
   [Shad, Muhammad Kashif] Univ Teknol Petronas, Management & Humanities Dept, Seri Iskandar, Perak, Malaysia.
   [AlKatheeri, Haseena] Zayed Univ, Dubai, U Arab Emirates.
RP Jabeen, F (corresponding author), Abu Dhabi Univ, Coll Business, Abu Dhabi, U Arab Emirates.
EM fauzia.jabeen@adu.ac.ae
OI Ajmal, Mian/0000-0001-9534-7629
CR Abdel-Basset M, 2021, TECHNOL FORECAST SOC, V163, DOI 10.1016/j.techfore.2020.120431
   Aboal D, 2016, ECON INNOV NEW TECH, V25, P435, DOI 10.1080/10438599.2015.1073478
   Abodunrin O., 2020, INT J ARTS LANGUAGES, V4, P13
   Alonazi WB, 2020, PSYCHOL RES BEHAV MA, V13, P749, DOI 10.2147/PRBM.S263656
   Arao R.M., 2020, EC IMPACT COVID 19 O, P1, DOI [10.22617/BRF200096, DOI 10.22617/BRF200096]
   Asahi K, 2021, J GLOB HEALTH, V11, DOI [10.7189/jogh.10.05002, 10.7189/jogh.11.05002]
   Baldwin R., 2020, EC TIME COVID 19, P59
   Baldwin R., 2020, MITIGATING COVID EC
   Barua S., 2021, J DEV AREAS PROJECT, V55, P435, DOI [10.1353/jda.2021.0073, DOI 10.1353/JDA.2021.0073]
   Belhadi A, 2021, TECHNOL FORECAST SOC, V163, DOI 10.1016/j.techfore.2020.120447
   Bofinger P, 2020, MITIGATING COVID EC, P167
   Bradley SW, 2011, J MANAGE STUD, V48, P1071, DOI 10.1111/j.1467-6486.2009.00906.x
   Brem A, 2021, TECHNOL FORECAST SOC, V163, DOI 10.1016/j.techfore.2020.120451
   Buheji M. etal, 2020, AM J EC, V10, P213, DOI [10.5923/j.economics.20201004.02, DOI 10.5923/J.ECONOMICS.20201004.02]
   Buil-Gil D, 2021, EUR SOC, V23, pS47, DOI 10.1080/14616696.2020.1804973
   Carlsson-Szlezak P., 2020, HARVARD BUS REV
   Cepal N., 2020, EFFECTS CORONAVIRUS
   Chhabra A, 2021, WORLDW HOSP TOUR THE, V13, P660, DOI 10.1108/WHATT-05-2021-0078
   Chudik A., 2020, EC CONSEQUENCES COVI
   Cichosz M, 2020, INT J LOGIST MANAG, V31, P209, DOI 10.1108/IJLM-08-2019-0229
   Cohen J., 2013, APPL MULTIPLE REGRES
   Craighead CW, 2020, DECISION SCI, V51, P838, DOI 10.1111/deci.12468
   Deshmukh S. G., 2020, INT J GLOB BUS COMPE, DOI [10.1007/s42943-020-00009-1, DOI 10.1007/S42943-020-00009-1]
   Fernandes N., 2020, EC EFFECTS CORONAVIR, DOI [10.2139/ssrn.3557504, 10.2139/SSRN.3557504]
   Grace D, 2020, J RETAIL CONSUM SERV, V52, DOI 10.1016/j.jretconser.2019.101908
   Hair J.F., 2017, INT J MULTIVAR DATA, V1, P107, DOI DOI 10.1504/IJMDA.2017.10008574
   Hair JF, 2014, EUR BUS REV, V26, P106, DOI 10.1108/EBR-10-2013-0128
   Haleem Abid, 2020, Curr Med Res Pract, V10, P78, DOI 10.1016/j.cmrp.2020.03.011
   Heidenreich S., 2020, AMS REV, V10, P279
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Ivanov D, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03640-6
   Jackson K.J., 2020, GLOBAL EC EFFECTS CO
   Jiang P, 2021, APPL ENERG, V285, DOI 10.1016/j.apenergy.2021.116441
   Joreskog K.G., 1993, LISREL8 STRUCTURAL E
   Kabadayi S, 2020, J SERV MARK, V34, P809, DOI 10.1108/JSM-03-2020-0090
   KAISER HF, 1974, EDUC PSYCHOL MEAS, V34, P111, DOI 10.1177/001316447403400115
   Kaur P, 2021, INT J CONTEMP HOSP M, V33, P1129, DOI 10.1108/IJCHM-05-2020-0477
   Kaur P, 2016, COMPUT HUM BEHAV, V59, P358, DOI 10.1016/j.chb.2016.02.039
   Kaushal V, 2021, INT J HOSP MANAG, V92, DOI 10.1016/j.ijhm.2020.102707
   Kazancoglu Y., 2020, SUSTAINABLE OPERATIO, V1, P1, DOI [10.1016/j.susoc.2020.06.001, DOI 10.1016/J.SUSOC.2020.06.001]
   Khanra S, 2021, J HOSP TOUR MANAG, V46, P26, DOI 10.1016/j.jhtm.2020.11.004
   Kim J., 2014, EUROPEAN ACAD RES, VII, P6478
   Kniffin KM, 2021, AM PSYCHOL, V76, P63, DOI 10.1037/amp0000716
   Kumar A., 2021, ACAD MARKETING STUDI, V25, P22
   Laato S, 2020, J RETAIL CONSUM SERV, V57, DOI 10.1016/j.jretconser.2020.102224
   Lambert H, 2020, LANCET PLANET HEALTH, V4, pE312, DOI 10.1016/S2542-5196(20)30168-6
   Liu YP, 2020, ASIAN BUS MANAG, V19, P277, DOI 10.1057/s41291-020-00119-x
   Maher CS, 2020, PUBLIC ADMIN REV, V80, P644, DOI 10.1111/puar.13238
   Majumdar A, 2020, SUSTAIN PROD CONSUMP, V24, P150, DOI 10.1016/j.spc.2020.07.001
   Malhotra N. K., 2003, J MARK MANAG, V27, P1208, DOI DOI 10.1016/S0167-4870(02)00151-4
   Mbunge E, 2021, HUM BEHAV EMERG TECH, V3, P25, DOI 10.1002/hbe2.237
   McKinsey Company, 2020, COR IMP SERV ORG WEA
   Meninno R., 2020, EC TIME COVID 19
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Obrenovic B, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12155981
   Parveen M., 2020, CHALLENGE, V63, P349, DOI [10.1080/05775132.2020.1822659, DOI 10.1080/05775132.2020.1822659]
   Paul SK, 2021, INT J PHYS DISTR LOG, V51, P104, DOI 10.1108/IJPDLM-04-2020-0127
   Rajesh R, 2021, J MANUF SYST, V60, P903, DOI 10.1016/j.jmsy.2020.10.010
   Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066
   Rodela T.T., 2020, SOCARXIV
   Rosliza A, 2018, INT J PUBLIC HLTH CL, V5, P1
   Santacroce L, 2020, INT J OCCUP ENV MED, V11, P151, DOI 10.34172/ijoem.2020.1984
   Sarkis J, 2021, INT J OPER PROD MAN, V41, P63, DOI 10.1108/IJOPM-08-2020-0568
   Sekaran U., 2003, RES METHODS BUSINESS, V4th edn.
   Shad MK, 2019, J CLEAN PROD, V208, P415, DOI 10.1016/j.jclepro.2018.10.120
   Shakibaei S, 2021, SUSTAIN CITIES SOC, V65, DOI 10.1016/j.scs.2020.102619
   Shamim A, 2017, J CONSUM MARK, V34, P591, DOI 10.1108/JCM-01-2016-1664
   Sharma J, 2021, J AGRIBUS DEV EMERG, V11, P452, DOI 10.1108/JADEE-09-2020-0194
   Sharma R, 2021, INT J HOSP MANAG, V96, DOI 10.1016/j.ijhm.2021.102977
   Sigala M, 2020, J BUS RES, V117, P312, DOI 10.1016/j.jbusres.2020.06.015
   Sparato J., 2020, 2 YEARS DIGITAL TRAN
   Straka W, 2021, REMOTE SENS-BASEL, V13, DOI 10.3390/rs13010005
   Suau-Sanchez P, 2020, J TRANSP GEOGR, V86, DOI 10.1016/j.jtrangeo.2020.102749
   Talwar M, 2021, J RETAIL CONSUM SERV, V58, DOI 10.1016/j.jretconser.2020.102341
   Talwar S, 2021, PSYCHOL MARKET, V38, P2142, DOI 10.1002/mar.21550
   Talwar S, 2021, INT J PROD RES, V59, P3509, DOI 10.1080/00207543.2020.1868599
   Tandon A, 2021, TECHNOL FORECAST SOC, V166, DOI 10.1016/j.techfore.2021.120649
   Thakur V, 2021, J CLEAN PROD, V287, DOI 10.1016/j.jclepro.2020.125562
   Tonnessen O, 2021, TECHNOL FORECAST SOC, V170, DOI 10.1016/j.techfore.2021.120866
   Tuzovic S, 2021, J SERV MANAGE, V32, P145, DOI 10.1108/JOSM-05-2020-0140
   UNWTO, 2020, INT TOUR COVID 19
   Varona L, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244920
   Verma S, 2020, J BUS RES, V118, P253, DOI 10.1016/j.jbusres.2020.06.057
   Vo T.D., 2021, INT J SOCIAL SCI EC, V7, P1
   Watanabe EAD, 2020, BRIT FOOD J, V122, P1170, DOI 10.1108/BFJ-05-2019-0363
   Weder di Mauro, 2020, EC TIME COVID 19, P53
   Wren-Lewis S, 2020, EC TIME COVID 19, DOI 10.1126/sciadv.abb6914
   Yacoub L, 2021, INT J CONTEMP HOSP M, V33, P929, DOI 10.1108/IJCHM-08-2020-0814
   Yan Y, 2021, COMPLEX INTELL SYST, DOI 10.1007/s40747-021-00290-4
   Yezli S, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101692
NR 90
TC 0
Z9 0
U1 12
U2 12
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0957-4093
EI 1758-6550
J9 INT J LOGIST MANAG
JI Int. J. Logist. Manag.
DI 10.1108/IJLM-04-2021-0220
EA OCT 2021
PG 26
WC Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA WL8ZY
UT WOS:000710688400001
OA Bronze
DA 2022-04-20
ER

PT J
AU Xia, JL
   Zeng, Y
   Tan, ZH
   Chen, T
   Hu, WL
   Shuai, SL
   Cao, DL
   Zeng, X
AF Xia, Jiliang
   Zeng, Ying
   Tan, Zhenghong
   Chen, Ting
   Hu, Weilan
   Shuai, Shulei
   Cao, Deliang
   Zeng, Xi
TI Differences in SARS-CoV-2 viral RNA re-positivity in discharged COVID-19
   patients
SO AIDS REVIEWS
LA English
DT Article
DE SARS-CoV-2; COVID-19; Polymerase chain reaction re-positivity;
   Re-infection; Re-activation
ID REACTIVATION; REINFECTION
AB The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly infectious RNA coronavirus responsible for the pandemic of the coronavirus disease 2019 (COVID-19). Recent advances in virology, epidemiology, diagnosis, and clinical management of COVID-19 have contributed to the control and prevention of this disease, but re-positivity of SARS-CoV-2 in recovered COVID-19 patients has brought a new challenge for this worldwide anti-viral battle. Reverse transcription polymerase chain reaction (RT-PCR) tests of the SARS-CoV-2 pathogen is widely used in clinical diagnosis, but a positive RT-PCR result may be multifactorial, including false positive, SARS-CoV-2 RNA fragment shedding, reinfection of SARS-CoV-2, or re-activation of COVID-19. Re-infection of SARS-CoV-2 or re-activation of COVID-19 is an indicator of live viral carriers and isolation/treatment is needed, but SARS-CoV-2 RNA fragment shedding is not. SARS-CoV-2 RNA is recently reported to integrate into the host genome, but the far-reaching outcome is currently unclear. Therefore, it is critical for appropriate manipulation and prevention of COVID-19 to distinguish these causal factors of SARS-CoV-2 re-positivity. In this review article, we updated the current knowledge of SARS-CoV-2 re-positivity in discharged COVID-19 patients with a focus on re-infection and re-activation. We proposed a hypothetical flowchart for handling of the SARS-CoV-2 re-positive cases.
C1 [Xia, Jiliang; Zeng, Ying; Tan, Zhenghong; Chen, Ting; Hu, Weilan; Shuai, Shulei; Cao, Deliang; Zeng, Xi] Univ South China, Canc Res Inst, Hunan Prov Key Lab Canc Cellular & Mol Pathol, Hengyang, Hunan, Peoples R China.
   [Zeng, Ying] Univ South China, Sch Nursing, Hengyang, Hunan, Peoples R China.
RP Cao, DL; Zeng, X (corresponding author), Univ South China, Canc Res Inst, Hunan Prov Key Lab Canc Cellular & Mol Pathol, Hengyang, Hunan, Peoples R China.
EM dcao@usc.edu.cn; zx397@126.com
OI Zeng, Xi/0000-0001-6835-9691
CR AlFehaidi A, 2021, J INFECTION, V82, P422, DOI 10.1016/j.jinf.2020.10.019
   Alonso FOM, 2021, J MED VIROL, V93, P655, DOI 10.1002/jmv.26432
   Arteaga-Livias K, 2021, TRAVEL MED INFECT DI, V39, DOI 10.1016/j.tmaid.2020.101947
   Bentivegna E, 2021, J MED VIROL, V93, P97, DOI 10.1002/jmv.26160
   Bongiovanni M, 2021, J MED VIROL, V93, P4058, DOI 10.1002/jmv.26565
   Bonifacio LP, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0619-2020
   Bordon J, 2020, U LOUISVILLE J RESPI, V4, P1
   Braunstein GD, 2021, J OCCUP ENVIRON MED, V63, pE159, DOI 10.1097/JOM.0000000000002138
   Chae KJ, 2020, EUR J RADIOL, V129, DOI 10.1016/j.ejrad.2020.109122
   Chen M, 2020, J MED VIROL, V92, P2146, DOI 10.1002/jmv.26002
   Coppola A, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00531
   Ramirez JD, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030282
   Deng GT, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02902-w
   Duggan NM, 2021, AM J EMERG MED, V39, DOI 10.1016/j.ajem.2020.06.079
   Fehdi MA, 2020, PAN AFR MED J, V35, DOI [10.11604/pamj.supp.2020.35.2.23326, 10.11604/pamj.2020.35.2.23326]
   Fels JM, 2021, GENOMIC SURVEILLANCE, V2021
   Fernandes AC, 2021, REV SOC BRAS MED TRO, V54, DOI 10.1590/0037-8682-0002-2021
   Fintelman-Rodrigues N, 2021, EMERG INFECT DIS, V27, P1446, DOI 10.3201/eid2705.204912
   Gao GS, 2021, INFECTION, V49, P57, DOI 10.1007/s15010-020-01485-6
   Gao ZR, 2020, INFECT GENET EVOL, V85, DOI 10.1016/j.meegid.2020.104494
   Garvey MI, 2021, J INFECT, V2021
   Goldman Jason D, 2020, medRxiv, DOI 10.1101/2020.09.22.20192443
   Gousseff M, 2020, J INFECTION, V81, P821, DOI 10.1016/j.jinf.2020.06.073
   Griffin DO, 2021, AIDS REV, V23, P40, DOI 10.24875/AIDSRev.200001261
   Gupta V., 2020, CLIN INFECT DIS, V73, pe2823, DOI [10.1093/cid/ciaa1451, DOI 10.1093/cid/ciaa1451]
   Hanif M, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.11176
   Harcourt J, 2020, EMERG INFECT DIS, V26, P1266, DOI 10.3201/eid2606.200516
   Harrington D, 2021, CLIN INFECT DIS, V73, P1946, DOI 10.1093/cid/ciab014
   Kang YJ, 2020, DISASTER MED PUBLIC, V14, P762, DOI 10.1017/dmp.2020.168
   Kapoor Rajan, 2021, SN Compr Clin Med, V3, P670, DOI 10.1007/s42399-021-00790-x
   KIM AY, 2020, CLIN INFECT DIS, DOI DOI 10.1093/CID/CIAA1541
   Kulkarni Onkar, 2021, Clin Infect Dis, DOI 10.1093/cid/ciab136
   Lafaie L, 2020, J AM GERIATR SOC, V68, P2179, DOI 10.1111/jgs.16728
   Larson D., 2021, CLIN INFECT DIS, V73, pe2827, DOI DOI 10.1093/cid/ciaa1436
   Lee JS, 2021, CLIN INFECT DIS, V73, pE3002, DOI 10.1093/cid/ciaa1421
   Loconsole D, 2020, INFECTION, V48, P965, DOI 10.1007/s15010-020-01444-1
   Nainu F, 2020, HUM VACC IMMUNOTHER, V16, P3061, DOI 10.1080/21645515.2020.1830683
   Ngo BT, 2021, EXPERT OPIN INV DRUG, V30, P505, DOI 10.1080/13543784.2021.1901883
   Ozaras R, 2020, NEW MICROB NEW INFEC, V38, DOI 10.1016/j.nmni.2020.100774
   Patrocinio de Jesus Rita, 2020, SN Compr Clin Med, V2, P2402, DOI 10.1007/s42399-020-00548-x
   Plante JA, 2021, CELL HOST MICROBE, V29, P508, DOI 10.1016/j.chom.2021.02.020
   Prado-Vivar B, 2020, LANCET INFECT DIS, V21, pE142, DOI 10.1016/S1473-3099(20)30910-5
   Rahman B, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2111
   Randolph HE, 2020, IMMUNITY, V52, P737, DOI 10.1016/j.immuni.2020.04.012
   Ravioli S, 2020, J INFECTION, V81, pE72, DOI 10.1016/j.jinf.2020.05.008
   Roy S, 2021, CUREUS J MED SCIENCE, V13, DOI 10.7759/cureus.14033
   Selhorst P., 2021, CLIN INFECT DIS, V73, P2985, DOI DOI 10.1093/CID/CIAA1850
   Sharma R, 2020, AM J CASE REP, V21, DOI 10.12659/AJCR.927154
   Tillett RL, 2021, LANCET INFECT DIS, V21, P52, DOI 10.1016/S1473-3099(20)30764-7
   To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149
   Tomassini S, 2021, J INFECTION, V82, P325, DOI 10.1016/j.jinf.2020.08.011
   Torres DD, 2021, J MED VIROL, V93, P1857, DOI 10.1002/jmv.26637
   Ul-Haq Zia, 2020, J Ayub Med Coll Abbottabad, V32(Suppl 1), pS704
   Takeda CFV, 2020, AM J TROP MED HYG, V103, P1993, DOI 10.4269/ajtmh.20-0893
   Van Elslande J, 2021, CLIN INFECT DIS, V73, P354, DOI 10.1093/cid/ciaa1330
   Vetter P, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2021.02.010
   Wang JX, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021865
   Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839
   Xiao AT, 2020, J MED VIROL, V92, P1755, DOI 10.1002/jmv.25855
   Xie CJ, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101668
   Yadav SP, 2021, IDCASES, V23, DOI 10.1016/j.idcr.2020.e01018
   Ye GM, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.001
   Yoo SY, 2020, PEDIATR INT, V62, P879, DOI 10.1111/ped.14312
   Younuskunju S., 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa1846, DOI 10.1093/CID/CIAA1846]
   Zhang Liguo, 2020, bioRxiv, DOI 10.1101/2020.12.12.422516
   Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344
   Zhou XX, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05231-z
NR 67
TC 0
Z9 0
U1 6
U2 6
PU PERMANYER PUBL
PI BARCELONA
PA MALLORCA, 310, BARCELONA, 08037, SPAIN
SN 1139-6121
EI 1698-6997
J9 AIDS REV
JI Aids Rev.
PD JUL-SEP
PY 2021
VL 23
IS 3
BP 153
EP 163
DI 10.24875/AIDSRev.21000023
PG 11
WC Immunology; Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Infectious Diseases
GA XU3YO
UT WOS:000734204900005
PM 34082440
OA Bronze
DA 2022-04-20
ER

PT J
AU Iddris, F
   Mensah, PO
   Asiedu, R
   Mensah, HK
AF Iddris, Faisal
   Mensah, Philip Opoku
   Asiedu, Richard
   Mensah, Henry Kofi
TI Student innovation capability in virtual team projects: lessons learnt
   from COVID-19 pandemic era
SO INTERNATIONAL JOURNAL OF INNOVATION SCIENCE
LA English
DT Article; Early Access
DE Culture; Virtual teams; Knowledge management; Communication; Innovation
   capability; Propensity to innovate
ID KNOWLEDGE-BASED THEORY; DYNAMIC CAPABILITIES; ABSORPTIVE-CAPACITY;
   MANAGEMENT; COMMUNICATION; PERFORMANCE; CULTURE; QUALITY; ORGANIZATIONS;
   RELIABILITY
AB Purpose The purpose of this study was to examine students' innovation capability in virtual team projects from the COVID-19 pandemic era. Design/methodology/approach The researchers conducted an empirical study and the data were collected from a total of 308 participants engaging in virtual team projects. A structural equation modeling (SEM) was used to assess the relationship of the conceptual framework. Findings The findings showed that virtual team culture positively influenced propensity to innovate. Also, knowledge management and communication influenced propensity to innovate through the mediation of support for innovation. Practical implications Developing a strategy for propensity to innovate in any organization demands that project team members should be able to seamlessly communicate. Developing knowledge management, communication and support for innovation strategy in a virtual team may prepare an organization for permanently different post-pandemic events and the future turbulent business environment. Originality/value This study highlights innovation capability for the propensity to innovate, a topic that is not widely researched, especially in the context of virtual teams.
C1 [Iddris, Faisal] Akenten Appiah Menka Univ Skills Training & Entre, Dept Management Studies, Kumasi, Ghana.
   [Mensah, Philip Opoku; Mensah, Henry Kofi] Kwame Nkrumah Univ Sci & Technol, Dept Human Resource & Org Dev, Kumasi, Ghana.
   [Asiedu, Richard] Univ Malaysia Sarawak, Fac Sci Technol Engn & Math, Kota Samarahan, Malaysia.
RP Iddris, F (corresponding author), Akenten Appiah Menka Univ Skills Training & Entre, Dept Management Studies, Kumasi, Ghana.
EM faisal.iddris@hh.se
CR Abou El-Seoud MS, 2014, INT J EMERG TECHNOL, V9, P20, DOI 10.3991/ijet.v9i4.3465
   Adams R, 2006, INT J MANAG REV, V8, P21, DOI 10.1111/j.1468-2370.2006.00119.x
   Ahmed P.K., 1998, EUR J INNOV MANAG, V1, P30, DOI DOI 10.1108/14601069810199131
   Alavi M, 2002, J AM SOC INF SCI TEC, V53, P1029, DOI 10.1002/asi.10107
   Aljanabi ARA, 2022, EUR J INNOV MANAG, V25, P73, DOI 10.1108/EJIM-04-2020-0146
   Amabile TM, 1998, HARVARD BUS REV, V76, P76
   Arif I., 2016, J FINANCE EC RES, V1, DOI [10.20547/jfer1601104, DOI 10.20547/JFER1601104]
   Assensoh-Kodua A., 2019, PROBLEMS PERSPECTIVE, V17, P143
   Bell BS, 2002, GROUP ORGAN MANAGE, V27, P14, DOI 10.1177/1059601102027001003
   Bello-Pintado A, 2021, EUR J INNOV MANAG, V24, P756, DOI 10.1108/EJIM-10-2019-0300
   Berglund A., 2009, P ASME DES ENG TECHN, DOI [10.1115/DETC2009-87628, DOI 10.1115/DETC2009-87628]
   Calantone RJ, 2002, IND MARKET MANAG, V31, P515, DOI 10.1016/S0019-8501(01)00203-6
   Chamakiotis P, 2020, INT J INFORM MANAGE, V50, P182, DOI 10.1016/j.ijinfomgt.2019.04.015
   Chen AL, 2013, PROCEDIA COMPUT SCI, V17, P1194, DOI 10.1016/j.procs.2013.05.152
   Cheng CCJ, 2016, J ENG TECHNOL MANAGE, V41, P79, DOI 10.1016/j.jengtecman.2016.07.002
   Cleary Y., 2019, J TECH WRIT COMMUN, V49, P309, DOI [10.1177/0047281618775908, DOI 10.1177/0047281618775908]
   COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553
   Creswell J.W., 2017, RES DESIGN QUALITATI
   Damanpour F, 2006, BRIT J MANAGE, V17, P215, DOI 10.1111/j.1467-8551.2006.00498.x
   Darroch J., 2005, Journal of Knowledge Management, V9, P101, DOI 10.1108/13673270510602809
   Davenport T., 1998, WORKING KNOWLEDGE OR
   Dibble R, 2019, J TEACH INT BUS, V30, P33, DOI 10.1080/08975930.2019.1627980
   Dobni CB, 2008, EUR J INNOV MANAG, V11, P539, DOI 10.1108/14601060810911156
   Duarte V, 2011, EUR J INNOV MANAG, V14, P435, DOI 10.1108/14601061111174907
   Easterby-Smith M., 2015, MANAGEMENT BUSINESS
   Ebner W, 2009, R&D MANAGE, V39, P342, DOI 10.1111/j.1467-9310.2009.00564.x
   Edelson R, 2019, ASTROPHYS J, V870, DOI 10.3847/1538-4357/aaf3b4
   Erdogan B, 2006, ACAD MANAGE J, V49, P395
   Erez M, 2013, ACAD MANAG LEARN EDU, V12, P16, DOI 10.5465/amle.2012.0200
   Faccin K, 2019, J KNOWL MANAG, V23, P439, DOI 10.1108/JKM-04-2018-0233
   Ganguly A, 2019, J KNOWL MANAG, V23, P1105, DOI 10.1108/JKM-03-2018-0190
   Gaskin J., 2019, AMOS PLUGIN
   Gaskin J., 2020, AMOS PLUGIN
   Geldhof GJ, 2014, PSYCHOL METHODS, V19, P72, DOI 10.1037/a0032138
   Genco N., 2010, ASEE ANN C EXPOSITIO
   Goos JACM, 2014, BRIT J CANCER, V111, P749, DOI 10.1038/bjc.2014.354
   Grant RM, 1996, STRATEGIC MANAGE J, V17, P109, DOI 10.1002/smj.4250171110
   Gressgard L.J., 2011, TEAM PERFORM MANAG
   Gressgard LJ, 2011, TEAM PERFORM MANAG, V17, P102, DOI 10.1108/13527591111114738
   Griffith TL, 2003, MIS QUART, V27, P265
   Hair J.F.Jr., 2010, MULTIVARIATE DATA AN, V7th ed.
   Hair JF, 2019, EUR BUS REV, V31, P2, DOI 10.1108/EBR-11-2018-0203
   Hair JF, 2013, LONG RANGE PLANN, V46, P1, DOI 10.1016/j.lrp.2013.01.001
   Hayes AF, 2018, COMMUN MONOGR, V85, P4, DOI 10.1080/03637751.2017.1352100
   Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8
   Hertel G., 2004, EUR J WORK ORGAN PSY, V13, P1, DOI DOI 10.1080/13594320344000228
   Hormiga E., 2013, MANAGE DECIS
   Hosseini MR, 2013, INT J PROJ MANAG, V31, P1101, DOI 10.1016/j.ijproman.2013.01.001
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Iddris F, 2016, INT J INOV SCI, V8, P331, DOI 10.1108/IJIS-07-2016-0015
   Jadhav V., 2016, QUAL REP
   Jahid J., 2016, INNOVATION CAPABILIT
   Jaya G.N.M., 2019, INT J SCI ENG RES, V10
   Kayworth T., 2000, EUROPEAN MANAGEMENT, V18, P183, DOI DOI 10.1016/S0263-2373(99)00090-0
   Kershaw T.C., 2015, P ASME DES ENG TECHN, DOI [10.1115/DETC2015-47650, DOI 10.1115/DETC2015-47650]
   Khaksar SMS, 2020, KNOWL MAN RES PRACT, DOI 10.1080/14778238.2020.1794992
   Kivimaki M, 2000, R&D MANAGE, V30, P33, DOI 10.1111/1467-9310.00155
   Klass D., 2009, 23 ANZAM C 2009 SUST
   Kline P, 2016, Q J ECON, V131, P1795, DOI 10.1093/qje/qjw027
   Kline RB, 2010, PRINCIPLES PRACTICE
   Kratzer J., 2004, CREAT INNOV MANAG, V13, DOI [DOI 10.1111/J.1467-8691.2004.00294.X, 10.1111/j.1467-8691.2004.00294.x]
   Kremp E., 2004, KNOWLEDGE MANAGEMENT
   Laforet S, 2011, INT J ENTREP BEHAV R, V17, P380, DOI 10.1108/13552551111139638
   Lawson B., 2001, INT J INNOV MANAG, V5, P377, DOI DOI 10.1142/S1363919601000427
   Le PB, 2019, J KNOWL MANAG, V23, P527, DOI 10.1108/JKM-09-2018-0568
   Lee JN, 2001, INFORM MANAGE, V38, P323, DOI 10.1016/S0378-7206(00)00074-4
   Lee JC, 2016, COMPUT HUM BEHAV, V54, P462, DOI 10.1016/j.chb.2015.08.030
   Lei J., 2020, SOLID STATE TECHNOL, V63, P2279
   Li J., 2020, REV CERCET INTERV SO, V69, DOI [10.33788/rcis.69.14, DOI 10.33788/RCIS.69.14]
   Liao SH, 2007, J INF SCI, V33, P340, DOI 10.1177/0165551506070739
   Lim, 2016, MASTER VALIDITY TOOL
   Lin HF, 2007, INT J MANPOWER, V28, P315, DOI 10.1108/01437720710755272
   Lin YN, 2014, J BUS RES, V67, P407, DOI 10.1016/j.jbusres.2012.12.019
   Linke A, 2011, J COMMUN MANAG, V15, P332, DOI 10.1108/13632541111183361
   Luxton S, 2015, J ADVERTISING, V44, P37, DOI 10.1080/00913367.2014.934938
   Machado A.deB., 2019, J INFORM SYSTEMS ENG, V4, pem86
   Malhotra N. K., 2011, MARKETING RES APPL O
   Mangiarotti G, 2012, INT J TECHNOL MANAGE, V58, P261, DOI 10.1504/IJTM.2012.046618
   Martin P, 2017, STUD HIGH EDUC, V42, P1229, DOI 10.1080/03075079.2015.1087993
   Martins E.C., 2003, EUR J INNOV MANAG, V6, P64, DOI DOI 10.1108/14601060310456337
   Maskey R, 2018, ASIAN J SHIPPING LOG, V34, P91, DOI 10.1016/j.ajsl.2018.06.006
   Maznevski ML, 2000, ORGAN SCI, V11, P473, DOI 10.1287/orsc.11.5.473.15200
   Memon M. A., 2020, J APPL STRUCTURAL EQ, V4, P1, DOI 10.47263/ jasem.4(2)01
   Mendoza-Silva A, 2021, EUR J INNOV MANAG, V24, P707, DOI 10.1108/EJIM-09-2019-0263
   Migdadi MM, 2021, J BUS IND MARK, V36, P111, DOI 10.1108/JBIM-12-2019-0504
   Moenaert RK, 2000, J PROD INNOVAT MANAG, V17, P360, DOI 10.1016/S0737-6782(00)00048-5
   Mothe C, 2015, APPL ECON, V47, P3040, DOI 10.1080/00036846.2015.1011320
   Nickerson JA, 2004, ORGAN SCI, V15, P617, DOI 10.1287/orsc.1040.0093
   Nulty DD, 2008, ASSESS EVAL HIGH EDU, V33, P301, DOI 10.1080/02602930701293231
   Obeidat BY, 2016, MANAG RES REV, V39, P1214, DOI 10.1108/MRR-09-2015-0214
   Ode E, 2020, J INNOV KNOWL, V5, P209, DOI 10.1016/j.jik.2019.08.002
   OECD/Eurostat, 2005, COMMUNITIES, DOI [10.1787/9789264013100-en, DOI 10.1787/9789264013100-EN]
   Olson-Buchanan JB, 2007, EDUC TRAIN, V49, P408, DOI 10.1108/00400910710762968
   Paiola M, 2020, IND MARKET MANAG, V89, P245, DOI 10.1016/j.indmarman.2020.03.009
   Pallant JF, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1157-8
   Pandey SC, 2018, KYBERNETES, V47, P222, DOI 10.1108/K-01-2017-0041
   Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452
   PRAHALAD CK, 1994, STRATEGIC MANAGE J, V15, P5, DOI 10.1002/smj.4250151002
   Quintane E, 2011, J KNOWL MANAG, V15, P928, DOI 10.1108/13673271111179299
   Raykov T, 2004, BEHAV THER, V35, P299, DOI 10.1016/S0005-7894(04)80041-8
   Robert LP, 2009, J MANAGE INFORM SYST, V26, P241, DOI 10.2753/MIS0742-1222260210
   Rogbeer S, 2014, J INT MANAG, V20, P464, DOI 10.1016/j.intman.2014.09.003
   Safeng Z., 2013, INT J SCI RES PUBLIC, V425
   SALEH SD, 1993, IEEE T ENG MANAGE, V40, P14, DOI 10.1109/17.206645
   Saunders M., 2016, RES METHODS BUSINESS
   Saunila M, 2020, J INNOV KNOWL, V5, P260, DOI 10.1016/j.jik.2019.11.002
   Scott CPR, 2015, LEADING GLOBAL TEAMS: TRANSLATING MULTIDISCIPLINARY SCIENCE TO PRACTICE, P13, DOI 10.1007/978-1-4939-2050-1_2
   SIEGEL SM, 1978, J APPL PSYCHOL, V63, P553, DOI 10.1037/0021-9010.63.5.553
   Spender JC, 1996, STRATEGIC MANAGE J, V17, P5, DOI 10.1002/smj.4250171103
   Tabachnick B.G., 1996, USING MULTIVARIATE S
   Tan CK, 2019, KYBERNETES, V48, P2065, DOI 10.1108/K-01-2018-0031
   Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z
   Valls V, 2016, J OCCUP ORGAN PSYCH, V89, P751, DOI 10.1111/joop.12152
   Velinov E., 2019, DEALING STUDENTSAVER, DOI [10.2991/essd-19.2019.80, DOI 10.2991/ESSD-19.2019.80]
   Weilin S., 2017, PRESENT SITUATION CO, DOI [10.2991/snce-17.2017.112, DOI 10.2991/SNCE-17.2017.112]
   Wiig KM, 1997, EXPERT SYST APPL, V13, P1, DOI 10.1016/S0957-4174(97)00018-3
   Xia YL, 2019, J METEOROL RES-PRC, V33, P159, DOI 10.1007/s13351-019-8172-4
   Yang WG, 2020, J MANAGE PSYCHOL, V35, P129, DOI 10.1108/JMP-04-2018-0171
   Yin J., 2019, J KNOWL MANAG
   Yu QM, 2008, J RARE EARTH, V26, P783, DOI 10.1016/S1002-0721(09)60005-3
   Yuan FR, 2010, ACAD MANAGE J, V53, P323, DOI 10.5465/AMJ.2010.49388995
   Zakaria N., 2004, CREATIVITY INNOVATIO, V13, P15, DOI [10.1111/j.1467-8691.2004.00290.x, DOI 10.1111/J.1467-8691.2004.00290.X]
   Zaltman G.R., 1973, INNOVATIONS ORG
   Zhang Y., 2017, INNOVATION ABILITY I, DOI [10.1117/12.2269942, DOI 10.1117/12.2269942]
NR 124
TC 0
Z9 0
U1 0
U2 0
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1757-2223
EI 1757-2231
J9 INT J INOV SCI
JI Int. J. Innov. Sci.
DI 10.1108/IJIS-08-2021-0149
EA MAR 2022
PG 22
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA ZT5YK
UT WOS:000769231400001
DA 2022-04-20
ER

PT J
AU Djalante, R
   Shaw, R
   DeWit, A
AF Djalante, Riyanti
   Shaw, Rajib
   DeWit, Andrew
TI Building resilience against biological hazards and pandemics: COVID-19
   and its implications for the Sendai Framework
SO PROGRESS IN DISASTER SCIENCE
LA English
DT Article
DE Sendai Framework for Disaster Risk Reduction (SFDRR); COVID-19;
   Health-emergency disaster risk management (Health-EDRM); Resilience;
   Disaster; Pandemic
AB 2020 has become the year of coping with COVID-19. This year was to be the "super year" for sustainability, a year of strengthening global actions to accelerate the transformations required for achieving the 2030 agenda. We argue that 2020 can and must be a year of both. Thus we call for more utilisation of the health-emergency disaster risk management (Health-EDRM) framework to complement current responses to COVID-19 and the patent risk of similar phenomena in the future. To make our case, we examine current responses to COVID-19 and their implications for the SFDRR. We argue that current mechanisms and strategies for disaster resilience, as outlined in the SFDRR, can enhance responses to epidemics or global pandemics such as COVID-19. In this regard, we make several general and DRR-specific recommendations. These recommendations concern knowledge and science provision in understanding disaster and health-related emergency risks, the extension of disaster risk governance to manage both disaster risks and potential health-emergencies, particularly for humanitarian coordination aspects; and the strengthening of community-level preparedness and response. (C) 2020 The Author(s). Published by Elsevier Ltd.
C1 [Djalante, Riyanti] United Nations Univ, Inst Adv Study Sustainabil UNU IAS, Tokyo, Japan.
   [Djalante, Riyanti; Shaw, Rajib] Integrated Res Disaster Risk IRDR, Tokyo, Japan.
   [Shaw, Rajib] Keio Univ, Grad Sch Media & Governance, Tokyo, Japan.
   [DeWit, Andrew] Rikkyo Univ, Sch Econ Policy Studies, Tokyo, Japan.
RP Shaw, R (corresponding author), Keio Univ, Grad Sch Media & Governance, Tokyo, Japan.
EM djalante@unu.edu; shaw@sfc.keio.ac.jp; dewit@rikkyo.ac.jp
OI Shaw, Rajib/0000-0003-3153-1800
CR ADB, 2020, COVID 19 COR ADBS RE
   AHA Center, 2020, US
   Aitsi-Selmi A, 2016, PREHOSP DISASTER MED, V31, P74, DOI 10.1017/S1049023X15005531
   Aitsi-Selmi A, 2015, INT J DISAST RISK SC, V6, P164, DOI 10.1007/s13753-015-0050-9
   Allen KM, 2006, DISASTERS, V30, P81, DOI 10.1111/j.1467-9523.2006.00308.x
   ASEAN, 2020, ASEAN HLTH SECT EFF
   ASEAN, 2020, ASEAN ON VIS ON ID C
   Banwell N, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030538
   Chan EYY, 2017, LANCET, V390, pE35, DOI 10.1016/S0140-6736(17)31670-7
   di Floristella AP, 2016, PAC REV, V29, P283, DOI 10.1080/09512748.2015.1013498
   EU, 2016, EU INT POL CRIS RESP
   EU, 2015, SEND FRAM DIS RISK R
   EU, 2020, COR RESP
   EU, 2015, EUR UN SUPP SEND FRA
   Garschagen M., 2016, WORLD RISK REPORT 20
   Government of Canada, 2020, GOV CAN TAK ACT COVI
   Government of Indonesia, 2020, IND SETS AS 70 MILL
   Government of Indonesia, 2020, COVID19 GO ID
   Government of Japan, 2020, INF REL COVID 19
   Government of the United Kingdom, 2020, SUPP THOS AFF COV 19
   Government of the United States of America, 2020, GOV RESP COR COVID 1
   Ho MC, 2008, RISK ANAL, V28, P635, DOI 10.1111/j.1539-6924.2008.01040.x
   Hoegh-Guldberg O., 2018, GLOBAL WARMING 1 5 C, DOI DOI 10.1093/AJE/KWP410
   Hua J, 2020, INT J ENV RES PUBLIC
   IFRC, 2020, COVID19 IFRC UNICEF
   IMF, 2020, IMF MAK AV 50 BILL H
   Lamichhane S, 2016, ENHANCING SAARC DISA
   Lo STT, 2017, INT J DISAST RISK SC, V8, P145, DOI 10.1007/s13753-017-0122-0
   McConnell, 2007, J CONTING CRISIS MAN, V15, P50, DOI DOI 10.1111/J.1468-5973.2007.00504.X
   Melinda and Gates Foundation, 2020, COVID 19
   Murthy Padmaja, 2000, STRATEGIC ANAL, V23, P1781
   P?rtner H-O, IPCC 2018 GLOBAL WAR
   Pescaroli G, 2018, RISK ANAL, V38, P2245, DOI 10.1111/risa.13128
   Petz D., 2014, BROOKINGSLSE PROJECT
   Poljansek K., 2017, SCI DISASTER RISK MA
   Scherer CW, 2003, RISK ANAL, V23, P261, DOI 10.1111/1539-6924.00306
   Shaw R, 2012, COMM ENV DISAST RISK, V10, P1
   Shaw R., 2020, PUBLIC HLTH DISASTER
   Sterbenz JPG, 2014, TELECOMMUN SYST, V56, P17, DOI 10.1007/s11235-013-9816-9
   UN, 2020, GLOB GOALS
   UN, 2020, UN REL EM FUNDS HELP
   UNDRR, 2000, 2019 GLOB ASS REP GA
   UNDRR, 2020, UNDRR URG DIS MAN AG
   UNISDR, 2015, 3 WORLD C DIS RISK R
   United Nations (UN), 2015, TRANSF OUR WORLD 203
   WB, 2020, WORLD BANK GROUP INC
   WHO, 2019, HLTH EM DIS RISK MAN
   WHO, 2020, COVID 19 RESP FUND
   WHO-A, 2020, COR COVID 19
   World Health Organization (WHO), 2020, OP PLANN GUID SUPP C
NR 50
TC 81
Z9 84
U1 5
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2590-0617
J9 PROG DISASTER SCI
JI Prog. Disaster Sci.
PD APR
PY 2020
VL 6
AR 100080
DI 10.1016/j.pdisas.2020.100080
PG 7
WC Environmental Sciences; Environmental Studies; Geosciences,
   Multidisciplinary; Public, Environmental & Occupational Health;
   Meteorology & Atmospheric Sciences
WE Emerging Sources Citation Index (ESCI)
SC Environmental Sciences & Ecology; Geology; Public, Environmental &
   Occupational Health; Meteorology & Atmospheric Sciences
GA VK7JG
UT WOS:000748948200011
PM 34171009
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Chopra, N
   Pereira, C
   Prata, A
   Lamba, W
   Sockalingam, S
AF Chopra, Nitin
   Pereira, Cheryl
   Prata, Alysha
   Lamba, Wiplove
   Sockalingam, Sanjeev
TI Building Substance Use Disorder Management Capacity During COVID-19:
   Outcomes From a Tele-mentoring Program for Community-based Healthcare
   Professionals
SO CANADIAN JOURNAL OF ADDICTION
LA English
DT Article
DE addictions care; continuing education; COVID-19; mental health;
   tele-mentoring
ID NATIONAL EPIDEMIOLOGIC SURVEY; PROJECT ECHO; ALCOHOL
AB Objectives: The limited access to addiction services pre-COVID-19 and the increase in substance use disorder support required during COVID has led to a heightened need for virtual addictions care capacity building interventions. We describe the evaluation of Project Extension for Community Healthcare Outcomes (TM)-Ontario Addiction Medicine and Psychosocial Interventions (ECHO-AMPI), a Canadian virtual tele-mentoring program focused on building capacity in community-based addiction care during COVID-19. Methods: We used Moore's multi-level evaluation framework for continuing education. Participants rated their satisfaction on a five-point Likert scale. A pre-post 10-item scale was used to measure self-efficacy. Participants used a binary scale to self-report post-participation whether ECHO changed their practice. Participants also responded to an open-text question around how participation in ECHO has impacted challenges experienced during the pandemic. Results: Seventy-nine healthcare professionals from 62 organizations across Ontario participated in ECHO-AMPI. Mean satisfaction ratings were high (>4.27/5), and a 12% improvement in participants' addictions care mean self-efficacy scores was observed (P < 0.001). Post-ECHO participation, 77% of participants reported practice change. Analysis of open-text responses highlighted participants felt ECHO fostered an open and supportive community, improved knowledge and skills via the acquisition of new resources, enhanced participants' interaction with their clients, and reduced professional isolation. Conclusions: ECHO-AMPI demonstrated the ability to engage providers and build addictions care capacity during COVID-19, specifically by improving learning outcomes and supporting practice change. Our data also suggests that this virtual tele-mentoring model can provide a supportive community of practice for addictions care providers during COVID-19.
C1 [Chopra, Nitin; Prata, Alysha] Ctr Addict & Mental Hlth, 100 Stokes St, Toronto, ON, Canada.
   [Pereira, Cheryl] Ctr Addict & Mental Hlth, ECHO Ontario Mental Hlth, Virtual Mental Hlth & Outreach, Toronto, ON, Canada.
   [Lamba, Wiplove] Ontario Shores Mental Hlth Sci, Whitby, ON, Canada.
   [Chopra, Nitin; Lamba, Wiplove; Sockalingam, Sanjeev] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON, Canada.
   [Sockalingam, Sanjeev] Ctr Addict & Mental Hlth, Educ, Toronto, ON, Canada.
RP Chopra, N (corresponding author), Ctr Addict & Mental Hlth, 100 Stokes St, Toronto, ON, Canada.
EM nitin.chopra@camh.ca
FU Ontario Ministry of Health and Long-Term CareMinistry of Health and
   Long-Term Care, Ontario
FX This initiative was funded by the Ontario Ministry of Health and
   Long-Term Care.
CR Ahmed MZ, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102092
   Canadian Centre on Substance Use and Addiction, 2020, IMP COVID 19 PAND PE
   Dunlop A, 2020, HARM REDUCT J, V17, DOI 10.1186/s12954-020-00370-7
   Erlingsson C, 2017, AFR J EMERG MED, V7, P93, DOI 10.1016/j.afjem.2017.08.001
   Faherty LJ, 2020, J GEN INTERN MED, V35, P899, DOI 10.1007/s11606-019-05599-y
   Grant BF, 2016, JAMA PSYCHIAT, V73, P39, DOI 10.1001/jamapsychiatry.2015.2132
   Grant BF, 2015, JAMA PSYCHIAT, V72, P757, DOI 10.1001/jamapsychiatry.2015.0584
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Komaromy M, 2017, PSYCHIAT SERV, V68, P873, DOI 10.1176/appi.ps.201600471
   Lau JTF, 2005, EMERG INFECT DIS, V11, P417
   Moore DE, 2009, J CONTIN EDUC HEALTH, V29, P1, DOI 10.1002/chp.20001
   Rolland B, 2020, JMIR PUBLIC HLTH SUR, V6, P435, DOI 10.2196/19630
   Shi L, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.14053
   Sockalingam S, 2020, J CONTIN EDUC HEALTH, V40, P211, DOI 10.1097/CEH.0000000000000311
   Sockalingam S, 2018, ACAD PSYCHIATR, V42, P451, DOI 10.1007/s40596-017-0735-z
   Volkow ND, 2020, ANN INTERN MED, V173, P61, DOI 10.7326/M20-1212
   Zhou C, 2016, ACAD MED, V91, P1439, DOI 10.1097/ACM.0000000000001328
NR 17
TC 1
Z9 1
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2368-4720
EI 2368-4739
J9 CAN J ADDICT
JI CAN. J. ADDICT.
PD JUN
PY 2021
VL 12
IS 2
BP 19
EP 23
DI 10.1097/CXA.0000000000000114
PG 5
WC Substance Abuse
WE Emerging Sources Citation Index (ESCI)
SC Substance Abuse
GA WI6ZS
UT WOS:000708507600003
DA 2022-04-20
ER

PT J
AU Asefa, A
   Qanche, Q
   Hailemariam, S
   Dhuguma, T
   Nigussie, T
AF Asefa, Adane
   Qanche, Qaro
   Hailemariam, Shewangizaw
   Dhuguma, Tadesse
   Nigussie, Tadesse
TI Risk Perception Towards COVID-19 and Its Associated Factors Among
   Waiters in Selected Towns of Southwest Ethiopia
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE risk perception; COVID-19; coronavirus; waiters
ID BEHAVIOR
AB Background: Waiters working in hotels, pensions, restaurants, and cafeteria are more susceptible to COVID-19 and easily transmit the virus to others because they interact with almost all individuals who enter those establishments. However, information regarding their risk perception is scarce; hence, this study aimed to assess risk perception regarding COVID-19 and its associated factors among waiters working in the selected towns of southwest Ethiopia.
   Methods: A cross-sectional study was conducted from June 1 to 15, 2020. The interviewad-ministered structured questionnaire was used to collect data. Data were entered into Epi data manager version 4.0.2 and exported to SPSS version 24 for analysis. Multiple linear regression analysis was done to identify factors associated with risk perception. A p-value of less than 0.05 was used as a level of significance.
   Results: A total of 416 waiters were interviewed, with a 98.6% response rate. The mean age of respondents was 27.26 (SD=8.35) years. More than half (53.4%) agreed that COVID-19 causes more deaths than other respiratory diseases. Regarding overall risk perception, two hundred twenty-two (53.4%) participants had high-risk perceptions concerning COVID-19. Risk perception was associated with age (beta= 0.10; 95% CI: 0.02, 0.18), knowledge of COVID-19 (beta=0.50, 95% CI: 0.23, 0.76) and preventive behaviors (beta=0.62; 95% CI: 0.33, 0.90).
   Conclusion: A higher level of risk perception was found regarding the COVID-19. Proper risk communication to promote protective behaviors is very essential since waiters are more at risk to be infected with COVID-19 and their infection with the virus has important public health implications.
C1 [Asefa, Adane; Qanche, Qaro; Nigussie, Tadesse] Mizan Tepi Univ, Coll Hlth Sci, Dept Publ Hlth, Mizan Aman, Ethiopia.
   [Hailemariam, Shewangizaw] Mizan Tepi Univ, Coll Hlth Sci, Dept Midwifery, Mizan Aman, Ethiopia.
   [Dhuguma, Tadesse] Mizan Tepi Univ, Coll Hlth Sci, Dept Med Lab, Mizan Aman, Ethiopia.
RP Asefa, A (corresponding author), Mizan Tepi Univ, Coll Hlth Sci, Dept Publ Hlth, Mizan Aman, Ethiopia.
EM adane779@gmail.com
RI Qanche, Qaro/ABE-7172-2021
OI Qanche, Qaro/0000-0002-8051-2529; Asefa, Adane/0000-0001-9374-978X;
   Nigussie, Tadesse/0000-0003-3123-5809; Duguma,
   Tadesse/0000-0001-7372-7145
FU MizanTepi University
FX We would like to express our heartfelt gratitude to MizanTepi University
   for supporting this research project. We also extend our thanks to our
   data collectors and study participants for their magnificent
   contributions to this work.
CR Abdulkareem SA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226483
   Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136
   Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7
   Brug J, 2009, INT J BEHAV MED, V16, P3, DOI 10.1007/s12529-008-9000-x
   Carter SE, 2017, J HEALTH COMMUN, V22, P31, DOI 10.1080/10810730.2016.1222034
   Chan EYY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113869
   Ding YN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237626
   Dionne G, 2007, J RISK UNCERTAINTY, V35, P237, DOI 10.1007/s11166-007-9023-8
   Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193
   FMOH, 2020, NAT COMPR COVID 19 M
   Glanz K., 2002, HLTH BEHAV HLTH ED T, P1
   Hauck Grace, 2020, CORONAVIRUS UPDATES
   Herrera-Diestra JL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225576
   Honarvar B, 2020, INT J PUBLIC HEALTH, V65, P731, DOI 10.1007/s00038-020-01406-2
   Huynh TLD, 2020, DATA BRIEF, V30, DOI 10.1016/j.dib.2020.105530
   Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296
   Ioannidis JPA, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109890
   Lan FY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233588
   Leppin A, 2009, INT J BEHAV MED, V16, P7, DOI 10.1007/s12529-008-9002-8
   Massaro E, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.052817
   Multnomah County Health Department, 2020, COVID19 CLEAN SAN GU
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Huynh TLD, 2020, ECON BULL, V40, P758
   Vandeweerd V, 2020, COVID 19 OVERVIEW IN, P1
   WHO, 2020, 1 CAS COV 19 CONF ET
   WHO, 2020, Q COR COVID 19
   WHO-World Health Organization, 2020, OP CONS COVID 19 MAN
   Wolff K, 2019, ANN TOURISM RES, V79, DOI 10.1016/j.annals.2019.102759
   Zhong Y, 2020, NURS OUTLOOK, P1, DOI [10.1016/j.outlook.20 20.08.00520., DOI 10.1016/J.OUTLOOK.20.08.005]
NR 29
TC 10
Z9 10
U1 3
U2 5
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2020
VL 13
BP 2601
EP 2610
DI 10.2147/RMHP.S276257
PG 10
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA OU9IV
UT WOS:000591837700001
PM 33223860
OA Green Published
DA 2022-04-20
ER

PT J
AU Ilesanmi, OS
   Afolabi, AA
   Akande, A
   Raji, T
   Mohammed, A
AF Ilesanmi, O. S.
   Afolabi, A. A.
   Akande, A.
   Raji, T.
   Mohammed, A.
TI Infection prevention and control during COVID-19 pandemic: realities
   from health care workers in a north central state in Nigeria
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Coronavirus; COVID-19; health care workers; infection prevention and
   control; Nigeria
ID OLDER-ADULTS; OUTBREAK; CRISIS; CHINA
AB Health care workers (HCWs) are vulnerable to the risk of infections and could become vectors of onward transmission of coronavirus disease 2019 (COVID-19). Little is known about the factors which could contribute to increased COVID-19 infection among HCWs in Nigeria. We aimed at assessing the causes of COVID-19 infection among HCWs. We used a qualitative study design to conduct in-depth interview among 16 frontline HCWs participating in the COVID-19 response in Kwara State, Nigeria. Colaizzi's phenomenological method was used in the qualitative analysis of data. We found that HCWs were aware of their vulnerability to the COVID-19 infection, and the reasons attributed included poor knowledge of IPC measures for COVID-19, inadequate supply of personal protective equipment (PPE), poor political will and inadequate health facilities (HFs) management support. Improved political will and better involvement of HFs management teams in infection prevention and control (IPC) systems are needed to reduce the risk for COVID-19 infection among HCWs. We recommend scale-up training on IPC measures particularly hand washing and use of PPE as well as the development of effective points of care risk assessment with a high index of suspicion in HFs.
C1 [Ilesanmi, O. S.; Afolabi, A. A.] Univ Ibadan, Dept Community Med, Ibadan, Oyo State, Nigeria.
   [Ilesanmi, O. S.; Akande, A.] Univ Coll Hosp, Dept Community Med, Ibadan, Oyo State, Nigeria.
   [Raji, T.; Mohammed, A.] Africa Ctr Dis Control & Prevent, Addis Ababa, Ethiopia.
RP Ilesanmi, OS (corresponding author), Univ Ibadan, Dept Community Med, Ibadan, Oyo State, Nigeria.; Ilesanmi, OS (corresponding author), Univ Coll Hosp, Dept Community Med, Ibadan, Oyo State, Nigeria.
EM ileolasteve@yahoo.co.uk
RI Ilesanmi, Olayinka/AAF-8628-2021
OI Ilesanmi, Olayinka/0000-0003-0827-6442
CR Abdullahi K. A., 2020, ASIAN J TROPICAL MED, V13, P1
   Annan AA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4474-6
   Bazeyo W, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.404.6159
   Bookey-Bassett S, 2017, J ADV NURS, V73, P71, DOI 10.1111/jan.13162
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Bukhari Q, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155399
   Chang D, 2020, LANCET RESP MED, V8, pE13, DOI 10.1016/S2213-2600(20)30066-7
   Colaizzi P., 1978, PSYCHOL RES PHENOMEN
   Elkholy AA, 2020, J INFECT PUBLIC HEAL, V13, P418, DOI 10.1016/j.jiph.2019.04.011
   Euro News, EURO NEWS
   Ilesanmi O, 2020, PEERJ, V8, DOI 10.7717/peerj.10038
   Kebe NNMK, 2020, BMC FAM PRACT, V21, DOI 10.1186/s12875-019-1076-7
   Kim KH, 2017, J HOSP INFECT, V95, P207, DOI 10.1016/j.jhin.2016.10.008
   Lee SM, 2018, COMPR PSYCHIAT, V87, P123, DOI 10.1016/j.comppsych.2018.10.003
   Li L, 2020, LANCET RESP MED, V8, pE23, DOI 10.1016/S2213-2600(20)30125-9
   Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7
   Marjanovic Z, 2007, INT J NURS STUD, V44, P991, DOI 10.1016/j.ijnurstu.2006.02.012
   Maunder R, 2003, CAN MED ASSOC J, V168, P1245
   Nigerian Centre for Disease Control (NCDC), 2019, 2018 NCDC ANN REP
   Ong MS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-72
   Ong MS, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.035972
   Ptaff KA, 2014, INT NURSING STUDIES, V51, P1141
   Ripples Nigeria, RIPPLES NIGERIA
   Schwartz J, 2020, CLIN INFECT DIS, V71, P858, DOI 10.1093/cid/ciaa255
   Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002
   World Health Organization, 2011, COR COMP INF PREV CO
   World Health Organization, 2016, PERS PROT EQ US FIL
   Yang Y, 2020, LANCET PSYCHIAT, V7, pE19, DOI 10.1016/S2215-0366(20)30079-1
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 29
TC 6
Z9 6
U1 2
U2 3
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD JAN 7
PY 2021
VL 149
AR e15
DI 10.1017/S0950268821000017
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Infectious Diseases
GA PS9AI
UT WOS:000608214200001
PM 33407965
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Lo, IT
   Lin, CY
   Cheng, MT
AF Lo, I-Tien
   Lin, Ching-Yuan
   Cheng, Ming-Tai
TI A COVID-19 Lockdown Tabletop Exercise in New Taipei City, Taiwan
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article; Early Access
DE COVID-19; lockdown; public health; tabletop exercise
AB Objectives: This exercise aimed to validate New Taipei City's strategic plan for a city lockdown in response to coronavirus disease (COVID-19). The main goal of all solutions was the principle of "reducing citizen activity and strengthening government control." Methods: We created a suitable exercise, creating 15 hypothetical situations for 3 stages. All participating units designed and proposed policy plans and execution protocols according to each situation. Results: In the course of the exercise, many existing policies and execution protocols were validated. These addressed (1) situations occurring in Stage 1, when the epidemic was spreading to the point of lockdown preparations; (2) approaches to curb the continued spread of the epidemic in Stage 2; and (3) returning to work after the epidemic was controlled and lockdown lifted in Stage 3. Twenty response units participated in the exercise. Although favorable outcomes were obtained, the evaluators provided comments suggesting further improvements. Conclusions: Our exercise demonstrated a successful example to help policy-making and revision in a large city of over 4 million people during the COVID-19 pandemic. It also enhanced participants' subject knowledge and familiarity with the implementation of a city lockdown. For locations intending to go into lockdown, similar tabletop exercises are an effective verification option.
C1 [Lo, I-Tien; Lin, Ching-Yuan] Natl Taiwan Univ Sci & Technol, Dept Architecture, Taipei, Taiwan.
   [Lo, I-Tien] New Taipei City Govt, Disaster Management Off, New Taipei, Taiwan.
   [Cheng, Ming-Tai] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan.
   [Cheng, Ming-Tai] Minist Hlth & Welf, Taipei Reg Emergency Med Operat Ctr, Taipei, Taiwan.
RP Cheng, MT (corresponding author), Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan.; Cheng, MT (corresponding author), Minist Hlth & Welf, Taipei Reg Emergency Med Operat Ctr, Taipei, Taiwan.
EM jengmt1976@gmail.com
OI CHENG, MING-TAI/0000-0003-2781-340X; Lo, ITien/0000-0003-2935-5721
CR Bonney J., 2019, PREHOSP DISASTER MED, V34, pS147
   Chandra A, 2015, DISASTER MED PUBLIC, V9, P484, DOI 10.1017/dmp.2015.99
   Dobbs M, 2020, EUR J RISK REGUL, V11, P240, DOI 10.1017/err.2020.39
   Evans CA, 2019, NURS EDUC PERSPECT, V40, P62, DOI 10.1097/01.NEP.0000000000000308
   Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017
   Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037
   Mukho[adhyay L., 2020, ARXIV200403126
   Ryan BJ, 2020, DISASTER MED PUBLIC, V14, P623, DOI 10.1017/dmp.2020.109
   Sarpy SA, 2005, J PUBLIC HEALTH MAN, pS75
   Savoia E, 2009, DISASTER MED PUBLIC, V3, P104, DOI 10.1097/DMP.0b013e3181a539bc
   Taiwan Centers for Disease Control, 2020, TAIW TIM ID 1 IMP CA
   Taiwan Centers for Disease Control, 2020, CENTR EP COMM CTR AN
   Taylor JL, 2005, BIOSECUR BIOTERROR, V3, P61, DOI 10.1089/bsp.2005.3.61
   Wendelboe AM., 2020, TABLETOP EXERCISE PR, DOI [10.5055/jem.2020.0464, DOI 10.5055/JEM.2020.0464]
   Worldometers, 2021, COVID 19 COR PAND
NR 15
TC 0
Z9 0
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
AR PII S1935789321000355
DI 10.1017/dmp.2021.35
EA FEB 2021
PG 7
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA ZB9II
UT WOS:000757146500001
PM 33588961
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Tamuzi, JL
   Ayele, BT
   Shumba, CS
   Adetokunboh, OO
   Uwimana-Nicol, J
   Haile, ZT
   Inugu, J
   Nyasulu, PS
AF Tamuzi, Jacques L.
   Ayele, Birhanu T.
   Shumba, Constance S.
   Adetokunboh, Olatunji O.
   Uwimana-Nicol, Jeannine
   Haile, Zelalem T.
   Inugu, Joseph
   Nyasulu, Peter S.
TI Implications of COVID-19 in high burden countries for HIV/TB: A
   systematic review of evidence
SO BMC INFECTIOUS DISEASES
LA English
DT Review
DE COVID-19; SARS-CoV; MERS-CoV; SARS-CoV-2; HIV; TB; Co-infection
ID RESPIRATORY SYNDROME CORONAVIRUS; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY
   TUBERCULOSIS; PHARMACOKINETICS; INFECTION; SAFETY; SARS
AB BackgroundThe triple burden of COVID-19, tuberculosis and human immunodeficiency virus is one of the major global health challenges of the twenty-first century. In high burden HIV/TB countries, the spread of COVID-19 among people living with HIV is a well-founded concern. A thorough understanding of HIV/TB and COVID-19 pandemics is important as the three diseases interact. This may clarify HIV/TB/COVID-19 as a newly related field. However, several gaps remain in the knowledge of the burden of COVID-19 on patients with TB and HIV. This study was conducted to review different studies on SARS-CoV, MERS-CoV or COVID-19 associated with HIV/TB co-infection or only TB, to understand the interactions between HIV, TB and COVID-19 and its implications on the burden of the COVID-19 among HIV/TB co-infected or TB patients, screening algorithm and clinical management.MethodsWe conducted an electronic search of potentially eligible studies published in English in the Cochrane Controlled Register of Trials, PubMed, Medrxiv, Google scholar and Clinical Trials Registry databases. We included case studies, case series and observational studies published between January, 2002 and July, 2020 in which SARS-CoV, MERS-CoV and COVID-19 co-infected to HIV/TB or TB in adults. We screened titles, abstracts and full articles for eligibility. Descriptive and meta-analysis were done and results have been presented in graphs and tables.ResultsAfter removing 95 duplicates, 58 out of 437 articles were assessed for eligibility, of which 14 studies were included for descriptive analysis and seven studies were included in the meta-analysis. Compared to the descriptive analysis, the meta-analysis showed strong evidence that current TB exposure was high-risk COVID-19 group (OR 1.67, 95% CI 1.06-2.65, P=0.03). The pooled of COVID-19/TB severity rate increased from OR 4.50 (95% CI 1.12-18.10, P=0.03), the recovery rate was high among COVID-19 compared to COVID-19/TB irrespective of HIV status (OR 2.23, 95% CI 1.83-2.74, P<0.001) and the mortality was reduced among non-TB group (P<0.001).ConclusionIn summary, TB was a risk factor for COVID-19 both in terms of severity and mortality irrespective of HIV status. Structured diagnostic algorithms and clinical management are suggested to improve COVID-19/HIV/TB or COVID-19/TB co-infections outcomes.
C1 [Tamuzi, Jacques L.; Ayele, Birhanu T.; Adetokunboh, Olatunji O.; Nyasulu, Peter S.] Stellenbosch Univ, Fac Med & Hlth Sci, Div Epidemiol & Biostat, Cape Town, South Africa.
   [Shumba, Constance S.] Aga Khan Univ, Dept Populat Hlth, Nairobi, Kenya.
   [Shumba, Constance S.] Aga Khan Univ, Sch Nursing & Midwifery, Nairobi, Kenya.
   [Adetokunboh, Olatunji O.] Stellenbosch Univ, DSI NRF Ctr Excellence Epidemiol Modelling & Anal, Stellenbosch, South Africa.
   [Uwimana-Nicol, Jeannine] Univ Rwanda, Coll Med & Hlth Sci, Sch Publ Hlth, Kigali, Rwanda.
   [Haile, Zelalem T.] Ohio Univ, Heritage Coll Osteopath Med, Dept Social Med, Dublin, OH USA.
   [Inugu, Joseph] Cent Michigan Univ, Dept Publ Hlth, Sch Hlth Sci, Mt Pleasant, MI 48859 USA.
   [Nyasulu, Peter S.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Div Epidemiol, Johannesburg, South Africa.
RP Nyasulu, PS (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, Div Epidemiol & Biostat, Cape Town, South Africa.; Nyasulu, PS (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Div Epidemiol, Johannesburg, South Africa.
EM pnyasulu@sun.ac.za
RI ; Adetokunboh, Olatunji/O-7224-2018
OI Nyasulu, Peter/0000-0003-2757-0663; Haile, Zelalem/0000-0002-2912-8564;
   Shumba, Constance/0000-0001-7787-9998; Adetokunboh,
   Olatunji/0000-0002-4608-3951
FU National Research Foundation (NRF)
FX National Research Foundation (NRF) incentive funding to enhance research
   development. NRF did not have a role in the design of the study and
   collection, analysis, and interpretation of data and in writing the
   manuscript.
CR Acosta EP, 2007, ANTIMICROB AGENTS CH, V51, P3104, DOI 10.1128/AAC.00341-07
   Ahmed A, 2016, ORAL DIS, V22, P53, DOI 10.1111/odi.12390
   Alfaraj SH, 2017, INTERVIROLOGY, V60, P53, DOI 10.1159/000477908
   Alhazzani W, 2020, CRIT CARE MED, V48, pE440, DOI [10.1097/CCM.0000000000004363, 10.1007/s00134-020-06022-5]
   [Anonymous], 2020, GLOB RES COR DIS COV
   [Anonymous], 2020, CORONAVIRUS DIS 2019
   [Anonymous], 2016, AUT REAL TIM DNA AMP
   [Anonymous], 2018, LAT TUB INF UPD CONS
   [Anonymous], 2017, HIV CONTINUUM CARE U
   [Anonymous], 2014, USAID REP TWIN EP HI
   [Anonymous], 2020, COR DIS 2019 COVID 1
   [Anonymous], 2009, TB HIV FACTS 2009
   [Anonymous], 2014, REV MAN REVMAN VERS
   [Anonymous], 2019, GLOB HIV AIDS STAT 2
   Baden LR, 2020, NEW ENGL J MED, V382, P1851, DOI 10.1056/NEJMe2005477
   Cattamanchi A, 2012, PLOS ONE, V7
   CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI 10.15585/mmwr.mm6915e4
   Chen TL, 2020, J GERONTOL A-BIOL, V20, P1
   Colson P, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105923
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   Cutler T, 2020, AM J RESP CRIT CARE, V202, P748, DOI 10.1164/rccm.202003-0828IM
   Davies Mary-Ann, 2020, medRxiv, DOI 10.1101/2020.07.02.20145185
   del Amo J, 2020, ANN INTERN MED, V173, P536, DOI 10.7326/M20-3689
   Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10
   Dirlikov E, 2015, ANN INTERN MED, V163, P52, DOI 10.7326/M14-2210
   Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020
   Esmail H, 2018, ANNU REV IMMUNOL, V36, P603, DOI 10.1146/annurev-immunol-042617-053420
   Faqihi F, 2020, RESPIR MED CASE REP, V31, DOI 10.1016/j.rmcr.2020.101146
   Ford N, 2020, J INT AIDS SOC, DOI [10.1002/:jia2.25489, DOI 10.1002/:JIA2.25489]
   Geldmacher C, 2012, CURR OPIN HIV AIDS, V7, P268, DOI 10.1097/COH.0b013e3283524e32
   Gralinski LE, 2015, J PATHOL, V235, P185, DOI 10.1002/path.4454
   Gupta RK, 2015, AIDS, V29, P1987, DOI 10.1097/QAD.0000000000000802
   He GQ, 2020, J MED VIROL, V92, P1802, DOI 10.1002/jmv.25943
   Hong KH, 2020, ANN LAB MED, V40, P351, DOI 10.3343/alm.2020.40.5.351
   Jiang HB, 2020, LANCET HIV, V7, pE308, DOI 10.1016/S2352-3018(20)30105-3
   Juurlink DN, 2020, CAN MED ASSOC J, V192, pE450, DOI 10.1503/cmaj.200528
   Kalyesubula R, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/562790
   Karanja J., 2016, J DRUG METAB TOXICOL, V7
   Karla SL, 2020, PREVIOUS ACTIVE TUBE
   Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685
   Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006
   Lin QY, 2018, STAT METHODS MED RES, V27, P1968, DOI 10.1177/0962280217746442
   Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616
   Liu C, 2020, INT J TUBERC LUNG D, DOI [10.5588/ijld.20.0163, DOI 10.5588/IJLD.20.0163]
   Liu W, 2006, EMERG INFECT DIS, V12, P707, DOI 10.3201/eid1204.050264
   Liu YJ, 2020, ARTECH HSE MOB COMM, P1
   Low JGH, 2004, CLIN INFECT DIS, V38, pE123, DOI 10.1086/421396
   Marquez B, 2011, CURR DRUG TARGETS, V12, P600, DOI 10.2174/138945011795378504
   Motta I, 2020, PULMONOLOGY, V26, P233, DOI 10.1016/j.pulmoe.2020.05.002
   OE Cnar, 2020, TRANSFUS APHER SCI, DOI [10.1016/j.transci.2020.102821:102821, DOI 10.1016/J.TRANSCI.2020.102821:102821]
   Ogimi C, 2019, J PEDIAT INF DIS SOC, V8, P21, DOI 10.1093/jpids/pix093
   Ogimi C, 2017, CLIN INFECT DIS, V64, P1532, DOI 10.1093/cid/cix160
   Piatek AS, 2013, GLOB HEALTH-SCI PRAC, V1, P18, DOI 10.9745/GHSP-D-12-00004
   Savarino A, 2005, J CLIN VIROL, V34, P170, DOI 10.1016/j.jcv.2005.03.005
   Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6
   Shiau S, 2020, AIDS BEHAV, V24, P2244, DOI 10.1007/s10461-020-02871-9
   Singh A, 2020, RES SQUARE, DOI DOI 10.21203/RS.3.RS-22464/V1
   Soriano V, 2020, AIDS REV, V22, P57, DOI 10.24875/AIDSRev.M20000031
   Sousa M, 2008, J ANTIMICROB CHEMOTH, V62, P872, DOI 10.1093/jac/dkn330
   Stochino C, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01708-2020
   Strydom N, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002773
   Suurmond R, 2017, RES SYNTH METHODS, V8, P537, DOI 10.1002/jrsm.1260
   Swaminathan S, 2008, J BIOSCIENCES, V33, P527, DOI 10.1007/s12038-008-0071-2
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Tham SM, 2020, EMERG INFECT DIS, V26, P2763, DOI 10.3201/eid2611.202752
   Tobaiqy M, 2020, THERAPEUTIC MANAGEME, DOI DOI 10.1016/J.INFPIP.2020.100061
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wells GA, NEWCASTLE OTTAWA SCA
   Wong ATY, 2004, AIDS, V18, P829, DOI 10.1097/00002030-200403260-00021
   Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237
   Zhang H, EFFICACY SAFETY NINT
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
   [张应涛 Zhang Yingtao], 2020, [中华流行病学杂志, Chinese Journal of Epidemiology], V41, P1999
NR 75
TC 21
Z9 21
U1 5
U2 11
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD OCT 9
PY 2020
VL 20
IS 1
AR 744
DI 10.1186/s12879-020-05450-4
PG 18
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA OB6DH
UT WOS:000578559000005
PM 33036570
OA Green Submitted, Green Published, gold
DA 2022-04-20
ER

PT J
AU Rosen, K
   Patel, M
   Lawrence, C
   Mooney, B
AF Rosen, Kelsey
   Patel, Monika
   Lawrence, Cecelia
   Mooney, Brianne
TI Delivering Telerehabilitation to COVID-19 Inpatients: A Retrospective
   Chart Review Suggests it is a Viable Option
SO HSS JOURNAL
LA English
DT Editorial Material
DE coronavirus; COVID-19; telehealth; telerehabilitation; physical therapy;
   inpatient; rehabilitation
AB Background Guidelines for physical therapy management of patients hospitalized with COVID-19 recommend limiting physical therapists' contact with patients when possible. Telehealth has been viewed as "electronic personal protective equipment" during the COVID-19 pandemic; although telerehabilitation has been shown to be effective with outpatients, it is unknown whether it is a viable option for hospitalized patients. Purpose Our facility developed an algorithm for the use of a physical therapy telerehabilitation program for inpatients with COVID-19. We sought to investigate the safety and viability of the program. Methods We conducted a retrospective chart review of patients admitted with a diagnosis of COVID-19 who received either telerehabilitation only or a combination of telerehabilitation and in-person rehabilitation. Based on the algorithm, COVID-19 inpatients were selected to receive telerehabilitation if they could ambulate independently, could use technology, had stable vital signs, required minimal supplemental oxygen, and were cognitively intact. We analyzed data of inpatients who received telerehabilitation only, which included patient education, therapeutic exercises, and breathing techniques. Results Of 33 COVID-19 inpatients who received telerehabilitation, in-person rehabilitation, or a combination of the two, 12 patients received telerehabilitation only (age range, 33 to 65 years; all but one male). They demonstrated independence with their individualized home exercise programs in one to two sessions, did not require an in-person rehabilitation consultation, did not require increased oxygen, experienced no exacerbation of symptoms, and were discharged home. Conclusions Inpatient telerehabilitation appears to be a viable option for selected hospitalized patients with COVID-19 and may be a safe way of delivering inpatient rehabilitation to isolated or at-risk populations. At our hospital, the use of inpatient telerehabilitation reduced staff exposure while providing important education and services to patients. To our knowledge, no studies have investigated the use of telerehabilitation for hospitalized patients, including those with COVID-19. Our findings suggest that this innovative approach warrants further study.
C1 [Rosen, Kelsey; Patel, Monika; Lawrence, Cecelia; Mooney, Brianne] Hosp Special Surg, Rehabil Dept, 535 70th St, New York, NY 10021 USA.
RP Rosen, K (corresponding author), Hosp Special Surg, Rehabil Dept, 535 70th St, New York, NY 10021 USA.
EM rosenk@hss.edu
CR Agostini M, 2015, J TELEMED TELECARE, V21, P202, DOI 10.1177/1357633X15572201
   Al Amer Hamad S, 2018, BMC Res Notes, V11, P356, DOI 10.1186/s13104-018-3464-9
   Anesi GL., UPTODATE
   [Anonymous], 2006, ENERGY CONSERVATION
   BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012
   Calton B, 2020, J PAIN SYMPTOM MANAG, V60, pE12, DOI 10.1016/j.jpainsymman.2020.03.019
   Caputo ND, 2020, ACAD EMERG MED, V27, P375, DOI 10.1111/acem.13994
   Ceravolo MG, 2020, EUR J PHYS REHAB MED, V56, P347, DOI 10.23736/S1973-9087.20.06329-7
   Chou E, 2020, EMERG MED J, V37, P335, DOI 10.1136/emermed-2020-209645
   Cottrell MA, 2017, CLIN REHABIL, V31, P625, DOI 10.1177/0269215516645148
   Fisher C, 2019, HSS J, V15, P226, DOI 10.1007/s11420-019-09714-x
   Hall C, 2017, ENERGY CONSERVATION
   Hanlon Peter, 2017, J Med Internet Res, V19, pe172, DOI 10.2196/jmir.6688
   Hillegass E., 2016, ESSENTIALS CARDIOPUL, V4
   Hillegass E., 2020, POSTACUTE COVID 19 E
   Hirschmann MT, 2020, KNEE SURG SPORT TR A, V28, P1690, DOI 10.1007/s00167-020-06022-4
   Kendrick K R, 2000, J Emerg Nurs, V26, P216
   Kim Dong-Hyun, 2016, J Phys Ther Sci, V28, P2785
   Mann DM, 2020, J AM MED INFORM ASSN, V27, P1132, DOI 10.1093/jamia/ocaa072
   Middleton A, 2020, PHYS THER, V100, P1278, DOI 10.1093/ptj/pzaa089
   Richmond T, 2017, INT J TELEREHABILITA, V9, P63, DOI 10.5195/ijt.2017.6232
   Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623
   Thomas P, 2020, J PHYSIOTHER, V66, P73, DOI 10.1016/j.jphys.2020.03.011
   Toya K, 2016, J PHYS THER SCI, V28, P685, DOI 10.1589/jpts.28.685
   Wilson J., 2004, NZ J PHYSIOTHER, V33, P95
   Yu PM, 2020, AM J PHYS MED REHAB, V99, P468, DOI 10.1097/PHM.0000000000001445
   Zhao HM, 2020, CHINESE MED J-PEKING, V133, P1595, DOI 10.1097/CM9.0000000000000848
NR 27
TC 11
Z9 11
U1 6
U2 6
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1556-3316
EI 1556-3324
J9 HSS J
JI HSS J.
PD NOV
PY 2020
VL 16
IS 1_SUPPL
SU 1_
SI SI
BP 64
EP 70
DI 10.1007/s11420-020-09774-4
PG 7
WC Orthopedics; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Orthopedics; Surgery
GA VK8DA
UT WOS:000755972100011
PM 32837409
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Yamin, M
   Sen, AAA
   AlKubaisy, ZM
   Almarzouki, R
AF Yamin, Mohammad
   Sen, Adnan Ahmed Abi
   AlKubaisy, Zenah Mahmoud
   Almarzouki, Rahaf
TI A Novel Technique for Early Detection of COVID-19
SO CMC-COMPUTERS MATERIALS & CONTINUA
LA English
DT Article
DE COVID-19; classification; feature selection; dimensionality reduction;
   chest CT; deep learning; deep convolutional neural network; AIRRCNN
ID CHEST-X-RAY; ARTIFICIAL-INTELLIGENCE
AB COVID-19 is a global pandemic disease, which results from a dangerous coronavirus attack, and spreads aggressively through close contacts with infected people and artifacts. So far, there is not any prescribed line of treatment for COVID-19 patients. Measures to control the disease are very limited, partly due to the lack of knowledge about technologies which could be effectively used for early detection and control the disease. Early detection of positive cases is critical in preventing further spread, achieving the herd immunity, and saving lives. Unfortunately, so far we do not have effective toolkits to diagnose very early detection of the disease. Recent research findings have suggested that radiology images, such as X-rays, contain significant information to detect the presence of COVID-19 virus in early stages. However, to detect the presence of the disease in in very early stages from the X-ray images by the naked eye is not possible. Artificial Intelligence (AI) techniques, machine learning in particular, are known to be very helpful in accurately diagnosing many diseases from radiology images. This paper proposes an automatic technique to classify COVID-19 patients from their computerized tomography (CT) scan images. The technique is known as Advanced Inception based Recurrent Residual Convolution Neural Network (AIRRCNN), which uses machine learning techniques for classifying data. We focus on the Advanced Inception based Recurrent Residual Convolution Neural Network, because we do not find it being used in the literature. Also, we conduct principal component analysis, which is used for dimensional deduction. Experimental results of our method have demonstrated an accuracy of about 99%, which is regarded to be very efficient.
C1 [Yamin, Mohammad; AlKubaisy, Zenah Mahmoud; Almarzouki, Rahaf] King Abdulaziz Univ, Fac Econ & Adm, Dept Management Informat Syst, Jeddah 21589, Saudi Arabia.
   [Sen, Adnan Ahmed Abi] Islamic Univ Madinah, Fac Comp & Informat Syst, Al Medina, Saudi Arabia.
RP Yamin, M (corresponding author), King Abdulaziz Univ, Fac Econ & Adm, Dept Management Informat Syst, Jeddah 21589, Saudi Arabia.
EM myamin@kau.edu.sa
RI Yamin, Mohammad/N-3003-2019; Yamin, Mohammad/AAS-2929-2021
OI Yamin, Mohammad/0000-0002-3778-3366; 
FU Deanship of Scientific Research (DSR) at King Abdulaziz University,
   Jeddah [GCV19-49-1441]
FX This project was funded by the Deanship of Scientific Research (DSR) at
   King Abdulaziz University, Jeddah, under Grant No. GCV19-49-1441. The
   authors, therefore, acknowledge with thanks DSR for technical and
   financial support.
CR Abualigah LMQ., 2019, FEATURE SELECTION EN, DOI 10.1007/978-3-030-10674-4
   Al-Falluji RA, 2021, CMC-COMPUT MATER CON, V66, P1301, DOI 10.32604/cmc.2020.013232
   Arnal J., 2020, APPL SCI, V10, P1
   Bardak T, 2017, J POLYTECH, V20, P979, DOI 10.2339/politeknik.369132
   Block J., 2020, COVID 19 PUTS SPOTLI
   Butt C, 2020, APPL INTELL, DOI 10.1007/s10489-020-01714-3
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1007/s00330-019-06574-1, 10.1148/radiol.2020200230]
   Deng X, 2020, CMES-COMP MODEL ENG, V125, P579, DOI 10.32604/cmes.2020.011920
   Elleboudy N. A., 2016, EGYPTIAN J FORENSIC, V6, P235, DOI DOI 10.1016/J
   Huang C., 2020, LANCET, V3, P11
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ioffe S., 2015, ARXIV PREPRINT ARXIV, P448
   Jiang XG, 2020, CMC-COMPUT MATER CON, V63, P537, DOI 10.32604/cmc.2020.010691
   Langkvist M, 2014, PATTERN RECOGN LETT, V42, P11, DOI 10.1016/j.patrec.2014.01.008
   Lin M., 2013, ARXIV13124400
   Lin M, 2020, BMJ STEL, V2, P1
   Mallapaty S., 2021, NATURE NEWS
   Mohammed MA, 2021, CMC-COMPUT MATER CON, V66, P3289, DOI 10.32604/cmc.2021.012874
   Mueller J. M., 2019, 2019 IEEE INT S TECH, P1, DOI DOI 10.1109/ISTAS48451.2019.8938010
   Narin A., 2020, ARXIV200310849
   Naude W., 2020, IZA DISCUSSION PAPER
   Rajan K., 2009, STAT ANAL DATA MIN, V1, P361, DOI [DOI 10.1002/SAM, DOI 10.1002/SAM.10031]
   Shi F., LARGE SCALE SCREENIN
   Shi W., 2021, ANN TRANSL MED, V9, P2
   Siddiqui SY, 2021, CMC-COMPUT MATER CON, V66, P1719, DOI 10.32604/cmc.2020.012585
   Silverman K., 2020, TACKLING COVID 19 RE
   Song Y., 2020, MEDRXIV, V5, P871
   Soto-Hidalgo J. M., 2019, FUZZY SET SYSTEMS, V8, P453
   Sreeharsha V., 2020, WALL STREET J
   SZEGEDY C, 2016, PROC CVPR IEEE, P2818, DOI DOI 10.1109/CVPR.2016.308
   Tang ZY, 2021, PHYS MED BIOL, V66, DOI 10.1088/1361-6560/abbf9e
   Wang S., 2020, DEEP LEARNING ALGORI, V6, P334
   Wang S., 2020, DEEP LEARNING ALGORI, V4, P34
   Wang S, 2021, EUR RADIOL, V31, P6096, DOI [10.1079/9781789246070.0001, 10.1007/s00330-021-07715-1]
   World Health Organization, 2020, GLOB SIT WHO COR DIS
   Xu XW, 2020, ENGINEERING-PRC, V6, P1122, DOI 10.1016/j.eng.2020.04.010
   Yamin Mohammad, 2020, Int J Inf Technol, V12, P311, DOI 10.1007/s41870-020-00466-0
   Yu PP, 2020, CMC-COMPUT MATER CON, V65, P743, DOI 10.32604/cmc.2020.011391
   Zhao J., 2020, ARXIV200313865V1
   Zheng C., 2020, DEEP LEARNING BASED, V4, P21
NR 41
TC 5
Z9 5
U1 3
U2 5
PU TECH SCIENCE PRESS
PI HENDERSON
PA 871 CORONADO CENTER DR, SUTE 200, HENDERSON, NV 89052 USA
SN 1546-2218
EI 1546-2226
J9 CMC-COMPUT MATER CON
JI CMC-Comput. Mat. Contin.
PY 2021
VL 68
IS 2
BP 2283
EP 2298
DI 10.32604/cmc.2021.017433
PG 16
WC Computer Science, Information Systems; Materials Science,
   Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science; Materials Science
GA RN3EP
UT WOS:000640234500009
OA gold
DA 2022-04-20
ER

PT J
AU Han, XH
   Wang, JL
   Zhang, M
   Wang, XJ
AF Han, Xuehua
   Wang, Juanle
   Zhang, Min
   Wang, Xiaojie
TI Using Social Media to Mine and Analyze Public Opinion Related to
   COVID-19 in China
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE coronavirus; COVID-19; social media; public opinion; China; resource
   allocation
ID ANALYTICS; TWITTER
AB The outbreak of Corona Virus Disease 2019 (COVID-19) is a grave global public health emergency. Nowadays, social media has become the main channel through which the public can obtain information and express their opinions and feelings. This study explored public opinion in the early stages of COVID-19 in China by analyzing Sina-Weibo (a Twitter-like microblogging system in China) texts in terms of space, time, and content. Temporal changes within one-hour intervals and the spatial distribution of COVID-19-related Weibo texts were analyzed. Based on the latent Dirichlet allocation model and the random forest algorithm, a topic extraction and classification model was developed to hierarchically identify seven COVID-19-relevant topics and 13 sub-topics from Weibo texts. The results indicate that the number of Weibo texts varied over time for different topics and sub-topics corresponding with the different developmental stages of the event. The spatial distribution of COVID-19-relevant Weibo was mainly concentrated in Wuhan, Beijing-Tianjin-Hebei, the Yangtze River Delta, the Pearl River Delta, and the Chengdu-Chongqing urban agglomeration. There is a synchronization between frequent daily discussions on Weibo and the trend of the COVID-19 outbreak in the real world. Public response is very sensitive to the epidemic and significant social events, especially in urban agglomerations with convenient transportation and a large population. The timely dissemination and updating of epidemic-related information and the popularization of such information by the government can contribute to stabilizing public sentiments. However, the surge of public demand and the hysteresis of social support demonstrated that the allocation of medical resources was under enormous pressure in the early stage of the epidemic. It is suggested that the government should strengthen the response in terms of public opinion and epidemic prevention and exert control in key epidemic areas, urban agglomerations, and transboundary areas at the province level. In controlling the crisis, accurate response countermeasures should be formulated following public help demands. The findings can help government and emergency agencies to better understand the public opinion and sentiments towards COVID-19, to accelerate emergency responses, and to support post-disaster management.
C1 [Han, Xuehua; Wang, Juanle; Zhang, Min; Wang, Xiaojie] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing 100101, Peoples R China.
   [Han, Xuehua; Zhang, Min] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing 100049, Peoples R China.
   [Wang, Juanle] Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing 210023, Peoples R China.
   [Wang, Xiaojie] Shandong Univ Technol, Sch Civil & Architectural Engn, Zibo 255049, Peoples R China.
RP Wang, JL (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing 100101, Peoples R China.; Wang, JL (corresponding author), Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing 210023, Peoples R China.
EM hanxh@lreis.ac.cn; wangjl@igsnrr.ac.cn; zhangmin@lreis.ac.cn;
   wxj@lreis.ac.cn
RI , Juanle/R-8881-2016
OI , Juanle/0000-0002-5641-0813; HAN, XUEHUA/0000-0002-0819-4917
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [41421001]; Construction Project of China
   Knowledge Center for Engineering Sciences and Technology
   [CKCEST-2019-3-6]; 13th Five-year Informatization Plan of Chinese
   Academy of Sciences
FX This research was funded by the National Natural Science Foundation of
   China (No. 41421001); Construction Project of China Knowledge Center for
   Engineering Sciences and Technology (No. CKCEST-2019-3-6) and the 13th
   Five-year Informatization Plan of Chinese Academy of Sciences
   (No.XXH13505-07).
CR Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Cao XD, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020250
   CCTV Network, WHAT IS REAS WUH CLO
   Chae J, 2014, COMPUT GRAPH-UK, V38, P51, DOI 10.1016/j.cag.2013.10.008
   Dahal B, 2019, SOC NETW ANAL MIN, V9, DOI 10.1007/s13278-019-0568-8
   Goodchild MF, 2010, INT J DIGIT EARTH, V3, P231, DOI 10.1080/17538941003759255
   Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101
   Gruebner O, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102275
   Han XH, 2019, ISPRS INT J GEO-INF, V8, DOI 10.3390/ijgi8040185
   Jung SM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020523
   Miller HJ, 2015, GEOJOURNAL, V80, P449, DOI 10.1007/s10708-014-9602-6
   Myers J.L., 2003, RES DESIGN STAT ANAL, V2nd
   National Health Commission of the People's Republic of China, LAT SIT NEW COR PNEU
   National Health Commission of the People's Republic of China, ANN NAT HLTH COMM PR
   Okabe A, 2009, INT J GEOGR INF SCI, V23, P7, DOI 10.1080/13658810802475491
   Piskorski J., 2013, MULTISOURCE MULTILIN, V11, P23, DOI DOI 10.1007/978-3-642-28569-1_2
   Qiang L, 2014, PROCEEDINGS OF 2014 IEEE WORKSHOP ON ADVANCED RESEARCH AND TECHNOLOGY IN INDUSTRY APPLICATIONS (WARTIA), P464, DOI 10.1109/WARTIA.2014.6976296
   Saffari Amir, 2009, 2009 IEEE 12th International Conference on Computer Vision Workshops, ICCV Workshops, P1393, DOI 10.1109/ICCVW.2009.5457447
   Salles T, 2018, INFORM SYST, V77, P1, DOI 10.1016/j.is.2018.05.006
   Sina Finance, GUARD ALL 2 MOUNT HO
   Steiger E, 2016, INT J GEOGR INF SCI, V30, P1694, DOI 10.1080/13658816.2015.1099658
   WANG YD, 2016, SUSTAINABILITY-BASEL, V8, DOI DOI 10.3390/SU8010025
   Wang ZY, 2018, INT J GEOGR INF SCI, V32, P49, DOI 10.1080/13658816.2017.1367003
   Wang ZY, 2016, NAT HAZARDS, V83, P523, DOI 10.1007/s11069-016-2329-6
   WHO,, WHO CHAR COVID 19 PA
   World Health Organization (WHO), WHO STAT CAS COVID 1
   Ye XY, 2016, ISPRS INT J GEO-INF, V5, DOI 10.3390/ijgi5090156
   Zong Q., 2017, J INF RESOUR MANAG, V7, P13
   Zou L, 2019, INT J DIGIT EARTH, V12, P1300, DOI 10.1080/17538947.2018.1545878
NR 30
TC 84
Z9 89
U1 108
U2 214
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD APR
PY 2020
VL 17
IS 8
AR 2788
DI 10.3390/ijerph17082788
PG 22
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA LR5OL
UT WOS:000535744100173
PM 32316647
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Etafa, W
   Gadisa, G
   Jabessa, S
   Takele, T
AF Etafa, Werku
   Gadisa, Gosa
   Jabessa, Shibiru
   Takele, Tagay
TI Healthcare workers' compliance and its potential determinants to prevent
   COVID-19 in public hospitals in Western Ethiopia
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Healthcare workers; COVID-19; Prevention; Infection control; Compliance;
   Barriers; Determinants
ID KNOWLEDGE
AB Background: Globally, Coronavirus disease-19 has created unprecedented challenges to public health. Healthcare workers (HCWs) are at risk of COVID-19 because of their profession. There are limited studies conducted in Ethiopia among HCWs regarding their compliance with COVID-19 preventive measures. Therefore, this study intended to assess HCWs' compliance with measures to prevent COVID-19, and its potential determinants in public hospitals in Western Ethiopia.
   Methods: A self-administered, multicenter hospital-based cross-sectional survey was proposed to 422 randomly selected HCWs working in seven public hospitals in Western Ethiopia identified as COVID-19 referral centers. Data were entered into Epi Data version 3.1 and analyzed using SPSS version 24. Binary logistic regression was used to identify potential determinants of outcome variables at p-value < 0.05.
   Results: Out of 422 completed questionnaires, the overall HCWs' compliance with COVID-19 prevention is 22% (n = 404). In multivariate regression analysis, factors such as spending most of caring time at bedside (AOR = 1.94, 95%CI, 1.06-3.55), receiving training on infection prevention/COVID-19 (AOR = 1.86, 95%CI, 1.04-3.33), reading materials on COVID-19 (AOR = 2.04, 95%CI, 1.14-3.63) and having support from hospital management (AOR = 2.09, 95%CI, 1.20-3.64) were found to be significantly associated with COVID-19 preventive measures. Furthermore, inadequate supplies of appropriate personal protective equipment (83.2%), insufficient supportive medications (78.5%), and lack of provision of adequate ventilation (77.7%) were the barriers to COVID-19 prevention most frequently mentioned by participants.
   Conclusion: Our findings highlight HCWs poor compliance with COVID-19 preventive measures. Providing information and refreshing training to improve the level of healthcare workers' adherence with COVID-19 prevention is as imperative as increasing staff commitment to supply resources necessary to protect HCWs and to reduce healthcare-associated infections transmission of SARS-COV-2.
C1 [Etafa, Werku] Wollega Univ, Inst Hlth Sci, Nekemte, Ethiopia.
   [Gadisa, Gosa; Jabessa, Shibiru; Takele, Tagay] Wollega Univ, Coll Nat & Computat Sci, Nekemte, Ethiopia.
RP Etafa, W (corresponding author), Wollega Univ, Inst Hlth Sci, Nekemte, Ethiopia.
EM witafay@gmail.com
RI Ebi, Werku Etafa/Q-2742-2019
OI Ebi, Werku Etafa/0000-0001-9576-8888
FU Wollega University
FX The cost of data collection for this research was funded by Wollega
   University.
CR Adams JG, 2020, JAMA-J AM MED ASSOC, V323, P1439, DOI 10.1001/jama.2020.3972
   Asemahagn MA, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00254-3
   CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI 10.15585/mmwr.mm6915e4
   Centers for Disease Control and prevention, US PERS PROT EQ
   COVID-19 Treatment Guidelines Panel, COR DIS 2019 COVID 1
   Ehrlich H, 2020, AM J EMERG MED, V38, P1527, DOI 10.1016/j.ajem.2020.04.024
   Haile TG, 2017, J ENVIRON PUBLIC HEA, V2017, DOI 10.1155/2017/2050635
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Houghton C., 2020, COCHRANE DB SYST REV, V4, pCD013582, DOI DOI 10.1002/14651858.CD013582
   Iversen K, 2020, LANCET INFECT DIS, V20, P1401, DOI 10.1016/S1473-3099(20)30589-2
   Kassie BA, 2020, ADV PUBLIC HLTH, V2020, DOI 10.1155/2020/7526037
   Kibret S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243022
   Legido-Quigley H, 2020, LANCET PUBLIC HEALTH, V5, pE251, DOI 10.1016/S2468-2667(20)30060-8
   Matakanye H, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16244977
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Shaukat N, 2020, INT J EMERG MED, V13, DOI 10.1186/s12245-020-00299-5
   Tan NC, 2006, ASIA-PAC J PUBLIC HE, V18, P49, DOI 10.1177/10105395060180030901
   World Health Organization, AFR 1 CAS COVID 19 C
   World Health Organization, 2020, 57 WHO
   World Health Organization, COR VIR DIS COVID 19
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zinatsa F, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3083-0
NR 25
TC 3
Z9 3
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAY 19
PY 2021
VL 21
IS 1
AR 454
DI 10.1186/s12879-021-06149-w
PG 8
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA SN5WP
UT WOS:000658359900004
PM 34011263
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Sahu, AK
   Mathew, R
   Aggarwal, P
   Nayer, J
   Bhoi, S
   Satapathy, S
   Ekka, M
AF Sahu, Ankit Kumar
   Mathew, Roshan
   Aggarwal, Praveen
   Nayer, Jamshed
   Bhoi, Sanjeev
   Satapathy, Swayamjeet
   Ekka, Meera
TI Clinical determinants of severe COVID-19 disease - A systematic review
   and meta-analysis
SO JOURNAL OF GLOBAL INFECTIOUS DISEASES
LA English
DT Review
DE Clinical determinants; clinical predictors; COVID-19; meta-analysis;
   severe disease
ID FEATURES; OUTCOMES; PNEUMONIA
AB Background: A systematic review and meta-analysis of available studies was performed to investigate the clinical characteristics that can predict COVID-19 disease severity. Materials and Methods: Databases including PubMed, Embase, and Web of Science were searched from December 31, 2019, to May 24, 2020. Random-effects meta-analysis was used for summarizing the Pooled odds ratio (pOR) of individual clinical characteristics to describe their association with severe COVID-19 disease. Results: A total of 3895 articles were identified, and finally, 22 studies comprising 4380 patients were included. Severe disease was more common in males than females (pOR: 1.36, 95% confidence interval [CI]: 1.08-1.70). Clinical features that were associated with significantly higher odds of severe disease were abdominal pain (pOR: 6.58, 95% CI: 1.56-27.67), breathlessness (pOR: 3.94, 95% CI: 2.55-6.07), and hemoptysis (pOR: 3.35, 95% CI: 1.05-10.74). pOR was highest for chronic obstructive pulmonary disease (pOR: 2.92, 95% CI: 1.70-5.02), followed by obesity (pOR: 2.84, 95% CI: 1.19-6.77), malignancy (pOR: 2.38, 95% CI: 1.25-4.52), diabetes (pOR: 2.29, 95% CI: 1.56-3.39), hypertension (pOR: 1.72, 95% CI: 1.23-2.42), cardiovascular disease (pOR: 1.61, 95% CI: 1.31-1.98) and chronic kidney disease (pOR: 1.46, 95% CI: 1.06-2.02), for predicting severe COVID-19. Conclusion: Our analysis describes the association of specific symptoms and comorbidities with severe COVID-19 disease. Knowledge of these clinical determinants will assist the clinicians in the risk-stratification of these patients for better triage and clinical management.
C1 [Sahu, Ankit Kumar; Mathew, Roshan; Aggarwal, Praveen; Nayer, Jamshed; Bhoi, Sanjeev; Ekka, Meera] All India Inst Med Sci, Dept Emergency Med, New Delhi, India.
   [Satapathy, Swayamjeet] Post Grad Inst Med Educ & Res, Dept Nucl Med, Chandigarh, India.
RP Nayer, J (corresponding author), All India Inst Med Sci, Dept Emergency Med, New Delhi, India.
EM jamshednayer@gmail.com
RI Sahu, Ankit Kumar/AAR-9646-2020
OI Sahu, Ankit Kumar/0000-0002-3232-9308; Satapathy,
   Swayamjeet/0000-0001-5318-6644
CR Aggarwal S, 2020, DIAGNOSIS, V7, P91, DOI 10.1515/dx-2020-0046
   Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2
   Colaneri M, 2020, EUROSURVEILLANCE, V25, P8, DOI 10.2807/1560-7917.ES.2020.25.16.2000460
   Downes MJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011458
   Ferguson J, 2020, EMERG INFECT DIS, V26, P1679, DOI 10.3201/eid2608.201776
   Gao Y, 2020, J MED VIROL, V92, P791, DOI 10.1002/jmv.25770
   Hong KS, 2020, YONSEI MED J, V61, P431, DOI 10.3349/ymj.2020.61.5.431
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ihle-Hansen H, 2020, TIDSSKR NORSKE LAEGE, V140, P662, DOI 10.4045/tidsskr.20.0301
   Itelman Edward, 2020, Isr Med Assoc J, V22, P271
   Lagi F, 2020, EUROSURVEILLANCE, V25, P6, DOI 10.2807/1560-7917.ES.2020.25.17.2000556
   Li KH, 2020, INVEST RADIOL, V55, P327, DOI 10.1097/RLI.0000000000000672
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Liu W, 2020, CHINESE MED J-PEKING, V133, P1032, DOI 10.1097/CM9.0000000000000775
   Liu YX, 2020, SCI CHINA LIFE SCI, V63, P364, DOI 10.1007/s11427-020-1643-8
   Novel Coronavirus, 2020, NCOV SIT REP, V61
   Peng Y D, 2020, Zhonghua Xin Xue Guan Bing Za Zhi, V48, P450, DOI 10.3760/cma.j.cn112148-20200220-00105
   Tian SJ, 2020, J INFECTION, V80, P401, DOI 10.1016/j.jinf.2020.02.018
   WANG D, 2020, JAMA-J AM MED ASSOC, DOI [DOI 10.1001/JAMA.2020.1585, 10.1001/jama.2020.1585]
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xu YH, 2020, J INFECTION, V80, P394, DOI 10.1016/j.jinf.2020.02.017
   Yang J, 2020, INT J INFECT DIS, DOI 10.1016/j.ijid.2020.03.01732173574
   Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204
   Zhang H, 2020, DIGESTIVE SYSTEM IS, P1, DOI [10.1101/2020.01.30.927806v1, DOI 10.1101/2020.01.30.927806, 10.1101/2020.01.30.927806]
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
   Zhao XY, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05010-w
NR 27
TC 3
Z9 3
U1 2
U2 2
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 0974-777X
EI 0974-8245
J9 J GLOB INFECT DIS
JI J. Glob. Insect. Dis.
PD JAN-MAR
PY 2021
VL 13
IS 1
BP 13
EP +
DI 10.4103/jgid.jgid_136_20
PG 16
WC Infectious Diseases
WE Emerging Sources Citation Index (ESCI)
SC Infectious Diseases
GA QQ6KG
UT WOS:000624631300004
PM 33911447
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Barone, MTU
   Ngongo, B
   Harnik, SB
   de Oliveira, LX
   Vegh, D
   de Luca, PV
   Pedrosa, HC
   Giraudo, F
   Cardona-Hernandez, R
   Chaudhury, N
   Menna-Barreto, L
AF Ugliara Barone, Mark Thomaz
   Ngongo, Belinda
   Harnik, Simone Bega
   de Oliveira, Lucas Xavier
   Vegh, Daniel
   de Luca, Patricia Vieira
   Pedrosa, Hermelinda Cordeiro
   Giraudo, Franco
   Cardona-Hernandez, Roque
   Chaudhury, Nayanjeet
   Menna-Barreto, Luiz
TI COVID-19 associated with diabetes and other noncommunicable diseases led
   to a global health crisis
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Review
DE COVID-19; Coronavirus; Diabetes; Global health; Noncommunicable
   diseases; Health systems
ID BLOOD-GLUCOSE CONTROL; GLYCEMIC CONTROL; LOCKDOWN; OUTCOMES; ADULTS;
   TYPE-1; MORTALITY; PEOPLE; IMPACT; RISK
AB COVID-19 has gravely threatened high-risk populations, such as people with diabetes and other noncommunicable diseases, leading to disproportionate hospitalizations and deaths worldwide. It is well documented from previous outbreaks that diabetes increases the risk for poor outcomes due to SARS infection. In the present review, we bring evidence that the country and global level health crisis caused by COVID-19 could have been avoided or extremely minimized if measures to protect high-risk populations were implemented timely. In addition to general lockdowns, testing, tracing, isolation and hygiene measures, other specific interventions for diabetes and comorbidities management were shown crucial to allow the continuation of care services during the pandemic. These interventions included: teleconsultation, digital remote education andmonitoring, e-prescriptions, medicine delivery options, mobile clinics, and home point-of-care tests. In conclusion, we recommend prompt actions to protect the most vulnerable groups, valuing knowledge and experiences from previous outbreaks and lessons learned during the COVID-19 pandemic, in order to shield communities, health systems and the global economy. (C) 2020 Elsevier B.V. All rights reserved.
C1 [Ugliara Barone, Mark Thomaz; de Oliveira, Lucas Xavier; Vegh, Daniel] Int Diabet Federat IDF, 166 Chaussee Hulpe, B-1170 Brussels, Belgium.
   [Ugliara Barone, Mark Thomaz; de Oliveira, Lucas Xavier] ADJ Diabet Brasil ADJ, Rua Padre Antonio Tomas 213, BR-05003010 Sao Paulo, SP, Brazil.
   [Ugliara Barone, Mark Thomaz; de Luca, Patricia Vieira] Forum Intersetorial Combate DCNTs Brasil ForumDCN, Rua Padre Antonio Tomas 213, BR-05003010 Sao Paulo, SP, Brazil.
   [Ugliara Barone, Mark Thomaz; Pedrosa, Hermelinda Cordeiro] Soc Brasileira Diabet SBD, Rua Afonso Braz 579,Salas 72-74, BR-04511011 Sao Paulo, SP, Brazil.
   [Ngongo, Belinda] Pan African Women Hlth PAWH, POB 95535, ZA-2051 Grant Pk, South Africa.
   [Harnik, Simone Bega] Univ Sao Paulo, Inst Matemat & Estatist, Dept Estatist, Rua Matao 1010, BR-05508090 Sao Paulo, SP, Brazil.
   [de Oliveira, Lucas Xavier] Univ Sao Paulo LEAD EE USP, Liga Enfermagem Atencao Diabet Escola Enfermagem, Av Dr Eneas Carvalho Aguiar 419, BR-05403000 Sao Paulo, SP, Brazil.
   [Vegh, Daniel] Semmelweis Univ, Dept Prosthodont, Fac Dent, Budapest, Hungary.
   [de Luca, Patricia Vieira] Assoc Brasileira Hipercolesterolemia Familiar AHF, Rua Machado Bittencourt 190, BR-04044000 Sao Paulo, Brazil.
   [Pedrosa, Hermelinda Cordeiro] Reg Taguatinga Hosp, Endocrinol Unit, Res Ctr, Secretary Hlth, Brasilia, DF, Brazil.
   [Giraudo, Franco] Univ Chile, Inst Maternal & Child Res IDIMI, Sch Med, Santiago, Chile.
   [Giraudo, Franco] Juvenile Diabet Fdn Chile FDJ, Santiago, Chile.
   [Cardona-Hernandez, Roque] Hosp St Joan Deu, Div Pediat Endocrinol, Barcelona, Spain.
   [Chaudhury, Nayanjeet] Publ Hlth Inst, 555 12th St,Suite 215, Oakland, CA 94607 USA.
   [Chaudhury, Nayanjeet] Ramaiah Int Ctr Publ Hlth Innovat, MSRIT Post, Bangalore 560097, Karnataka, India.
   [Menna-Barreto, Luiz] Univ Sao Paulo EACH USP, Grp Multidisciplinar Desenvolvimento & Ritmos Bio, Escola Artes Ciencias & eHumanidades, Rua Arlindo Bettio 1000, BR-03828000 Sao Paulo, SP, Brazil.
RP Barone, MTU (corresponding author), Rua Padre Antonio Tomas 213, BR-05003010 Sao Paulo, SP, Brazil.
EM mark.barone@alumni.usp.br; mark.barone@alumni.usp.br
RI Végh, Dániel/F-5207-2017; Végh, Dániel/ABE-1150-2021
OI Végh, Dániel/0000-0002-2836-6747; Chaudhury,
   Nayanjeet/0000-0002-8793-4679; Cardona-Hernandez,
   Roque/0000-0002-7067-1657
CR Alromaihi D, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108298
   Andrikopoulos S, 2020, DIABETES RES CLIN PR, V165, DOI 10.1016/j.diabres.2020.108246
   [Anonymous], 2020, PEDIATR DIABETES, V21, P413, DOI 10.1111/pedi.13013
   [Anonymous], 2020, DIABETES RES CLIN PR, V166
   Apicella M, 2020, LANCET DIABETES ENDO, V8, P782, DOI 10.1016/S2213-8587(20)30238-2
   Barone MTU, 2020, SLEEP SCI, V13, P191, DOI 10.5935/1984-0063.20200038
   Barron E, 2020, LANCET DIABETES ENDO, V8, P813, DOI 10.1016/S2213-8587(20)30272-2
   Belkhadir J, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108277
   Bergman M, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108215
   Bhandari Sudhir, 2020, J Assoc Physicians India, V68, P13
   Bhowmik B, 2020, J DIABETOL, V11, P137, DOI [10.4103/JOD.JOD_51_20, DOI 10.4103/JOD.JOD_51_20]
   Bode Bruce, 2020, J Diabetes Sci Technol, V14, P813, DOI 10.1177/1932296820924469
   Bonora BM, 2020, DIABETES THER, V11, P1369, DOI 10.1007/s13300-020-00829-7
   Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885
   Bornstein SR, 2020, LANCET DIABETES ENDO, V8, P546, DOI 10.1016/S2213-8587(20)30152-2
   Brazilian Ministry of Health, 2020, BRAZ MIN HLTH SPEC E
   Caballero AE, 2020, J DIABETES COMPLICAT, V34, DOI 10.1016/j.jdiacomp.2020.107671
   Capaldo B, 2020, DIABETES CARE, V43, pE88, DOI 10.2337/dc20-1127
   Ceriello A, 2020, DIABETES RES CLIN PR, V167, DOI 10.1016/j.diabres.2020.108383
   Chan JWM, 2003, THORAX, V58, P686, DOI 10.1136/thorax.58.8.686
   de Almeida-Pititto B, 2020, DIABETOL METAB SYNDR, V12, DOI 10.1186/s13098-020-00586-4
   Sales-Peres SHD, 2020, OBES RES CLIN PRACT, V14, P389, DOI 10.1016/j.orcp.2020.07.007
   Ebekozien OA, 2020, DIABETES CARE, V43, pE83, DOI 10.2337/dc20-1088
   Fernandez E, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108348
   Fung A, 2020, J CLIN TRANSL ENDOCR, V22, DOI 10.1016/j.jcte.2020.100238
   Gamble Anissa, 2020, JMIR Diabetes, V5, pe19581, DOI 10.2196/19581
   Gentile S, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108137
   Ghosh A, 2020, DIABETES METAB SYND, V14, P273, DOI 10.1016/j.dsx.2020.04.001
   Graham RL, 2013, NAT REV MICROBIOL, V11, P836, DOI 10.1038/nrmicro3143
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Holman N, 2020, LANCET DIABETES ENDO, V8, P823, DOI 10.1016/S2213-8587(20)30271-0
   Hwang Y, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108278
   Jeong IK, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108303
   Kamrath C, 2020, JAMA-J AM MED ASSOC, V324, P801, DOI 10.1001/jama.2020.13445
   Kanc K, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108285
   Khader MA, 2020, DIABETES METAB SYND, V14, P1579, DOI 10.1016/j.dsx.2020.08.011
   Kim MK, 2020, DIABETES METAB J, V44, P602, DOI 10.4093/dmj.2020.0146
   Klatman EL, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108275
   Kluge HHP, 2020, LANCET, V395, P1678, DOI 10.1016/S0140-6736(20)31067-9
   Krispin R, Coronavirus: the 2019 novel coronavirus COVID-19 (2019-nCoV) Dataset. R package version 0.3.0
   Liu SP, 2020, DIABETES RES CLIN PR, V167, DOI 10.1016/j.diabres.2020.108338
   Ma RCW, 2020, DIABETIC MED, V37, P723, DOI 10.1111/dme.14300
   Parra-Bracamonte GM, 2020, ANN EPIDEMIOL, V52, P93, DOI 10.1016/j.annepidem.2020.08.005
   Merzon E, 2021, DIABETES-METAB RES, V37, DOI 10.1002/dmrr.3398
   Mesa A, 2020, DIABETES RES CLIN PR, V167, DOI 10.1016/j.diabres.2020.108354
   Noh J, 2020, DIABETES METAB J, V44, P372, DOI 10.4093/dmj.2020.0138
   Nouri S, 2020, NEJM CATAL INNOV CAR, P1, DOI [10.1056/CAT.20.0123, DOI 10.1056/CAT.20.0123]
   Odeh R, 2020, DIABETES RES CLIN PR, V168, DOI 10.1016/j.diabres.2020.108393
   Pan American Health Organization, 2020, FACT SHEET HAV DIAB
   Pititto BD, 2020, REV SAUDE PUBL, V54, DOI 10.11606/s1518-8787.2020054002577
   Rabbone I, 2020, DIABETES CARE, V43, P2870, DOI 10.2337/dc20-1321
   Ranscombe P, 2020, LANCET DIABETES ENDO, V8, P571, DOI 10.1016/S2213-8587(20)30181-9
   Rezende LFM, 2020, REV SAUDE PUBL, V54, DOI 10.11606/s1518-8787.2020054002596
   Hernandez-Galdamez DR, 2020, ARCH MED RES, V51, P683, DOI 10.1016/j.arcmed.2020.07.003
   Sacks LJ, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108296
   SARS- CoV- 2 Surveillance Group, 2020, CHAR SARS COV 2 PAT
   Soares DA, 2020, REV SAUDE PUBL, V54, DOI 10.11606/s1518-8787.2020054002953
   Subbarao K, 2020, CELL HOST MICROBE, V27, P692, DOI 10.1016/j.chom.2020.04.019
   Teles Milena, 2020, J Diabetes Sci Technol, V14, P797, DOI 10.1177/1932296820930033
   Thakur JS, 2020, INT J NONCOMMUN DIS, V5, P29, DOI 10.4103/jncd.jncd_35_20
   Tornese G, 2020, DIABETES TECHNOL THE, V22, P462, DOI 10.1089/dia.2020.0169
   Barone MTU, 2020, DIABETES METAB SYND, V14, P1973, DOI 10.1016/j.dsx.2020.10.005
   Barone MTU, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108301
   Barone MTU, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108304
   United Nations Population Division, WPP2019 WORLD POP PR
   Verma A, 2020, DIABETES METAB SYND, V14, P1213, DOI 10.1016/j.dsx.2020.07.016
   Wake DJ, 2020, EUR J ENDOCRINOL, V183, pG67, DOI 10.1530/EJE-20-0377
   Wang AH, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108118
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   WHO, 2012, WORLD MALARIA REPORT 2012, P1
   World Health Organization, 2020, ENS PEOPL CTR DIAB C
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yang JK, 2006, DIABETIC MED, V23, P623, DOI 10.1111/j.1464-5491.2006.01861.x
   Zhu LH, 2020, CELL METAB, V31, P1068, DOI 10.1016/j.cmet.2020.04.021
NR 74
TC 6
Z9 6
U1 2
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD JAN
PY 2021
VL 171
AR 108587
DI 10.1016/j.diabres.2020.108587
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA QE1RN
UT WOS:000615988000014
PM 33307134
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Dost, B
   Koksal, E
   Terzi, O
   Bilgin, S
   Ustun, YB
   Arslan, HN
AF Dost, Burhan
   Koksal, Ersin
   Terzi, Ozlem
   Bilgin, Sezgin
   Ustun, Yasemin Burcu
   Arslan, Hatice Nilden
TI Attitudes of Anesthesiology Specialists and Residents Toward Patients
   Infected with the Novel Coronavirus (COVID-19): A National Survey Study
SO SURGICAL INFECTIONS
LA English
DT Article
DE anesthesiology; intensive care; COVID-19
AB Background: The novel coronavirus (COVID-19) emerged in Wuhan, China, in December 2019. This study aims to evaluate the knowledge of anesthesiology specialists and residents in Turkey about COVID-19 and their attitudes toward the strategies and application methods to be used for a suspected/confirmed COVID-19 case that needs to be operated on or followed up in an intensive care unit, as well as to raise awareness about this issue.
   Methods: This descriptive study comprised anesthesiology specialists and residents working in various health institutions in Turkey. The data used in this study were obtained online between March 13, 2020 and March 25, 2020 through the website SurveyMonkey (SurveyMonkey, San Mateo, CA) by using a survey form. We contacted members of the Turkish Anaesthesiology and Reanimation Society through the social media platforms Twitter, LinkedIn, and WhatsApp, as well as through their e-mail addresses and invited them to participate in the study. Those who agreed to participate responded to the aforementioned survey. We used SPSS 22.0 (IBM, Armonk, NY) to analyze the survey data statistically.
   Results: A total of 346 anesthesiology specialists and residents participated in the study. Although the majority of the participants exhibited the correct attitudes toward airway management, research assistants with little professional experience were observed to be undecided or had the tendency to make incorrect decisions.
   Conclusions: The COVID-19 pandemic is spreading rapidly worldwide. The incidence of COVID-19 cases is increasing daily, and this disease can cause patient death. Anesthesiology specialists and residents who perform emergency operations on these patients in settings other than intensive care units should follow simple and easy-to-understand algorithms to ensure safety. The provision of theoretical and practical training to healthcare providers before they meet patients will help ensure patient-healthcare provider safety and prevent panic, which can cause distress among healthcare providers.
C1 [Dost, Burhan; Koksal, Ersin; Bilgin, Sezgin; Ustun, Yasemin Burcu] Ondokuz Mayis Univ, Fac Med, Dept Anaesthesiol & Reanimat, Samsun, Turkey.
   [Terzi, Ozlem; Arslan, Hatice Nilden] Ondokuz Mayis Univ, Fac Med, Dept Publ Hlth, Samsun, Turkey.
RP Dost, B (corresponding author), Ondokuz Mayis Univ, Fac Med, Dept Anaesthesiol & Reanimat, Samsun, Turkey.
EM burhandost@hotmail.com
RI dost, burhan/AAS-4788-2020
OI dost, burhan/0000-0002-4562-1172; /0000-0002-2628-7543
CR Centers for Disease Control and prevention, 2020, INT INF PREV CONTR R
   Chen QN, 2020, LANCET PSYCHIAT, V7, pE15, DOI 10.1016/S2215-0366(20)30078-X
   Chen XD, 2020, ANESTHESIOLOGY, V132, P1307, DOI 10.1097/ALN.0000000000003301
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang LS, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2841-7
   onler E, 2010, THESIS
   Peng PWH, 2020, BRIT J ANAESTH, V124, P497, DOI 10.1016/j.bja.2020.02.008
   Ronco C, 2020, LANCET RESP MED, V8, P240, DOI 10.1016/S2213-2600(20)30060-6
   Saunders-Hastings P, 2017, EPIDEMICS-NETH, V20, P1, DOI 10.1016/j.epidem.2017.04.003
   Turkish Society of Anesthesiology and Reanimation. The Airway Management Guidance, AIRW MAN GUID
   Visentin LM, 2009, CAN J EMERG MED, V11, P44
   Wax RS, 2020, CAN J ANESTH, V67, P568, DOI 10.1007/s12630-020-01591-x
   Wiyor HD, 2020, DISASTER MED PUBLIC, V14, P273, DOI 10.1017/dmp.2019.52
   World Health Organization, NOV COR 2019 NCOV SI
   World Health Organization, NOV COR VIR 2019 NCO
   World Health Organization, SUMM PROB SARS CAS O
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 17
TC 34
Z9 34
U1 4
U2 18
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-2964
EI 1557-8674
J9 SURG INFECT
JI Surg. Infect.
PD MAY 1
PY 2020
VL 21
IS 4
BP 350
EP 356
DI 10.1089/sur.2020.097
EA APR 2020
PG 7
WC Infectious Diseases; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases; Surgery
GA LJ2YR
UT WOS:000525003200001
PM 32275463
DA 2022-04-20
ER

PT J
AU Qiu, MY
   Sha, J
   Utomo, S
AF Qiu, Mengyuan
   Sha, Ji
   Utomo, Sulistyo
TI Listening to Forests: Comparing the Perceived Restorative
   Characteristics of Natural Soundscapes before and after the COVID-19
   Pandemic
SO SUSTAINABILITY
LA English
DT Article
DE natural soundscape; mental restoration; health and well-being;
   sustainability; COVID-19
AB Natural sounds are known to contribute to health and well-being. However, few studies have investigated what makes a natural sound renew and re-energize people, especially in the face of significant stressors caused by the Corona Virus Disease 2019 (COVID-19). This study examined the interactive mechanism towards the perceived restorative characteristics of natural soundscapes: fascination, being-away, compatibility, and extent. Two groups of data were collected in Burleigh Heads National Park, Australia, before the outbreak of COVID-19 (n = 526) and in October 2020 (n = 371). The objective measures of L-Aeq confirmed that the acoustic environment of Burleigh Heads National Park are quiet and peaceful for attention restoration. The results of the subject evaluation revealed that participants from the post-COVID-19 group reported higher stress levels, while there was a greater mental restoration through water sounds. There are significant differences between the pre- and post-COVID-19 groups with respect to the relationships among the perceived restorative characteristics of natural soundscapes. The direct effects of extent and fascination, as well as the mediating effects of fascination, were more significant among the post-COVID-19 group than the pre-COVID-19 group. However, the effects of being-away on compatibility were less significant in the post-COVID-19 group. This study reduces the gap that exists on the research of environment-people-health-wellbeing nexus. Knowledge about natural soundscapes encourages administrations to consider it as a guideline for the planning and management of natural resources, especially during the COVID-19 pandemic.
C1 [Qiu, Mengyuan] Nanjing Forestry Univ, Coll Econ & Management, Nanjing 210037, Peoples R China.
   [Sha, Ji] Jiangsu Vocat Inst Commerce, Nanjing 211168, Peoples R China.
   [Sha, Ji; Utomo, Sulistyo] Griffith Univ, Griffith Business Sch, Gold Coast Campus, Gold Coast, Qld 4222, Australia.
RP Sha, J (corresponding author), Jiangsu Vocat Inst Commerce, Nanjing 211168, Peoples R China.; Sha, J (corresponding author), Griffith Univ, Griffith Business Sch, Gold Coast Campus, Gold Coast, Qld 4222, Australia.
EM qiumengyuan@njfu.edu.cn; shaji@griffith-edu.org; Utomo@griffith-edu.org
OI Qiu, Mengyuan/0000-0002-3951-2789; Sha, Ji/0000-0001-5482-488X
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [41901174]; Universities' Philosophy and
   Social Science Researches in Jiangsu Province [2019SJA0112, 2015SJB283]
FX This research was funded by the National Natural Science Foundation of
   China, grant number 41901174 and Universities' Philosophy and Social
   Science Researches in Jiangsu Province, grant number 2019SJA0112 and
   2015SJB283.
CR Aletta F, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112392
   Benfield J.A., 2014, ECOPSYCHOLOGY, V6, P183, DOI DOI 10.1089/ECO.2014.0028
   Benocci R, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20020412
   Brambilla G, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12197899
   Brzoska P, 2020, LAND-BASEL, V9, DOI 10.3390/land9050150
   Chin W.W., 2010, HDB PARTIAL LEAST SQ, P655, DOI DOI 10.1007/978-3-540-32827-8_29
   Deng X, 2020, LAND-BASEL, V9, DOI 10.3390/land9100360
   Erfanian M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16193533
   Ferraro DM, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2020.1811
   Fiorillo A, 2020, EUR PSYCHIAT, V63, DOI 10.1192/j.eurpsy.2020.35
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Franco LS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080864
   Galinsky E., 2005, OVERWORK AM WAY WE W, P69
   Gascon M, 2015, INT J ENV RES PUB HE, V12, P4354, DOI 10.3390/ijerph120404354
   Getzner M, 2020, FORESTS, V11, DOI 10.3390/f11030326
   Giustino V, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12114356
   Grahn P, 2010, LANDSCAPE URBAN PLAN, V94, P264, DOI 10.1016/j.landurbplan.2009.10.012
   Hair JF, 2012, J ACAD MARKET SCI, V40, P414, DOI 10.1007/s11747-011-0261-6
   Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202
   Han KT, 2018, J LEISURE RES, V49, P151, DOI 10.1080/00222216.2018.1505159
   Hartig T, 2001, ENVIRON BEHAV, V33, P590, DOI 10.1177/00139160121973142
   Hartig T, 2003, J ENVIRON PSYCHOL, V23, P109, DOI 10.1016/S0272-4944(02)00109-3
   Havnen A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186461
   Henseler J, 2016, IND MANAGE DATA SYST, V116, P2, DOI 10.1108/IMDS-09-2015-0382
   Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8
   Herranz-Pascual K., 2010, P INTERNOISE, P2904, DOI DOI 10.1121/1.4897313
   Herranz-Pascual K, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16071284
   Herzog TR, 2003, J ENVIRON PSYCHOL, V23, P159, DOI 10.1016/S0272-4944(02)00113-5
   International Association for Standardization, 2018, 129132 ISOTS
   KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2
   Kock N, 2014, INT J E-COLLAB, V10, P1, DOI 10.4018/ijec.2014010101
   Kuper R, 2017, URBAN FOR URBAN GREE, V28, P118, DOI 10.1016/j.ufug.2017.10.002
   Laumann K, 2003, J ENVIRON PSYCHOL, V23, P125, DOI 10.1016/S0272-4944(02)00110-X
   Lehto XY, 2019, J HOSP TOUR RES, V43, P935, DOI 10.1177/1096348019849684
   Lehto XY, 2013, J TRAVEL RES, V52, P325, DOI 10.1177/0047287512461567
   Liu CR, 2017, TOURISM MANAGE, V63, P255, DOI 10.1016/j.tourman.2017.06.023
   Medvedev O, 2015, APPL ACOUST, V96, P20, DOI 10.1016/j.apacoust.2015.03.004
   Min Z, 2020, ASIA PAC J TOUR RES, V25, P131, DOI 10.1080/10941665.2019.1683046
   Mitchell AM, 2008, RES NURS HEALTH, V31, P576, DOI 10.1002/nur.20284
   Newman KP, 2016, J CONSUM PSYCHOL, V26, P535, DOI 10.1016/j.jcps.2016.02.005
   Ni MY, 2020, JMIR MENT HEALTH, V7, DOI 10.2196/19009
   Ohe Y, 2017, TOURISM MANAGE, V62, P322, DOI 10.1016/j.tourman.2017.04.010
   Pals R, 2009, J ENVIRON PSYCHOL, V29, P441, DOI 10.1016/j.jenvp.2009.08.005
   Pasini M, 2014, PROCD SOC BEHV, V159, P293, DOI 10.1016/j.sbspro.2014.12.375
   Payne S.R., 2008, J ACOUST SOC AM, V123, P3809, DOI [10.1121/1.2935525, DOI 10.1121/1.2935525]
   Payne SR, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02224
   Payne SR, 2013, APPL ACOUST, V74, P255, DOI 10.1016/j.apacoust.2011.11.005
   Pheasant R, 2008, J ACOUST SOC AM, V123, P1446, DOI 10.1121/1.2831735
   Pilcher EJ, 2009, ENVIRON MANAGE, V43, P425, DOI 10.1007/s00267-008-9224-1
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Qiu MY, 2018, J TRAVEL TOUR MARK, V35, P869, DOI 10.1080/10548408.2018.1445064
   Ratcliffe E, 2013, J ENVIRON PSYCHOL, V36, P221, DOI 10.1016/j.jenvp.2013.08.004
   Reinartz W, 2009, INT J RES MARK, V26, P332, DOI 10.1016/j.ijresmar.2009.08.001
   Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478
   Schafer R.M., 1993, SOUNDSCAPE OUR SONIC, P12
   Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338
   Schwaiger, 2011, SCHMALENBACH BUSINES, V63, P34, DOI DOI 10.1007/BF03396886
   Shen SY, 2019, TOUR MANAG PERSPECT, V30, P98, DOI 10.1016/j.tmp.2019.02.006
   Shu S, 2018, J ENVIRON PSYCHOL, V60, P72, DOI 10.1016/j.jenvp.2018.10.011
   Sobel M.E., 1982, SOCIOLOGICAL METHODO, V13, P290, DOI DOI 10.2307/270723
   Stevenson MP, 2018, J TOXICOL ENV HEAL B, V21, P227, DOI 10.1080/10937404.2018.1505571
   ULRICH RS, 1984, SCIENCE, V224, P420, DOI 10.1126/science.6143402
   Voorhees CM, 2016, J ACAD MARKET SCI, V44, P119, DOI 10.1007/s11747-015-0455-4
   Xie J, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12176751
   Yang W, 2005, J URBAN DES, V10, P61, DOI 10.1080/13574800500062395
   Zhang Y., 2014, NEW ARCHIT, V5, P18
   Zheng CH, 2020, TOURISM GEOGR, V22, P105, DOI 10.1080/14616688.2019.1618903
   Zhu X, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072271
NR 68
TC 6
Z9 6
U1 19
U2 34
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD JAN
PY 2021
VL 13
IS 1
AR 293
DI 10.3390/su13010293
PG 20
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA PQ3HP
UT WOS:000606438700001
OA gold
DA 2022-04-20
ER

PT J
AU Prakash, L
   Dhar, SA
   Mushtaq, M
AF Prakash, Lakshmanan
   Dhar, Shabir Ahmed
   Mushtaq, Muzaffar
TI COVID-19 in the operating room: a review of evolving safety protocols
SO PATIENT SAFETY IN SURGERY
LA English
DT Review
DE COVID-19; Coronavirus; Surgeon; Health care workers; Protection;
   Orthopaedic surgery
ID CORONAVIRUS; WUHAN; REPLICATION
AB Background The COVID-19 pandemic has already infected more than 3 million people across the world. As the healthworkers man the frontlines, the best practices model is continuously evolving as literature concerning the Coronavirus develops. Methods A systematic review of the available literature was performed using the keyword terms "COVID-19", "Coronavirus", "surgeon", "health-care workers", "protection" and "Orthopaedic Surgery". All peer-reviewed articles we could find were considered. Randomized controlled trials (RCTs), prospective trials and retrospective studies, as well as reviews and case reports, were included in this systematic review. Results Even though surgical specialties including orthopedics are on the relative sidelines of the management of this pandemic but best practices models are inevitably developed for surgical specialties. The algorithm of postpone, delay, and operate only when life-threatening conditions exist is going to be useful up to a point. Conclusion The surgical staff needs to keep abreast of the latest literature concerning safety measures to be taken during surgical procedures. Review articles can go some distance in helping in this educational process. This knowledge must evolve as new information comes to light.
C1 [Prakash, Lakshmanan] Inst Special Orthopaed, Palakkad, Kerala, India.
   [Dhar, Shabir Ahmed; Mushtaq, Muzaffar] Skims MC Bemina, Srinagar, Kashmir, India.
RP Dhar, SA (corresponding author), Skims MC Bemina, Srinagar, Kashmir, India.
EM shabirdhar@yahoo.co.in
CR American College of Surgeons, 2020, COVID 19 CONS OPT SU
   Amodeo G, 2018, J PAIN RES, V11, P1297, DOI 10.2147/JPR.S158230
   [Anonymous], 2020, MAN PAT URG ORTH CON
   [Anonymous], 2020, COR COVID 19
   [Anonymous], 2020, NEUROSURGEON DIES CO
   Awad ME, 2020, J AM ACAD ORTHOP SUR, V28, P451, DOI 10.5435/JAAOS-D-20-00227
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Cai J, 2020, EMERG INFECT DIS, V26, P1343, DOI 10.3201/eid2606.200412
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Cheney C, 2020, CORONA VIRUS FOLLOW
   Chien JY, 2006, RESPIROLOGY, V11, P715, DOI 10.1111/j.1440-1843.2006.00942.x
   Chow TT, 2004, J HOSP INFECT, V56, P85, DOI 10.1016/j.jhin.2003.09.020
   Coccolini F, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00302-7
   Cohen S.L., 2020, J MINIM INVASIVE GYN
   FEHR AR, 2015, METHOD MOL BIOL, V1282, DOI [10.1007/978-1-4939-2438-7_1, DOI 10.1007/978-1-4939-2438-7_1]
   Firstenberg MS, 2020, PATIENT SAF SURG, V14, DOI 10.1186/s13037-020-00243-9
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guo XD, 2020, J BONE JOINT SURG AM, V102, P847, DOI 10.2106/JBJS.20.00417
   Hirschmann MT, 2020, KNEE SURG SPORT TR A, V28, P1690, DOI 10.1007/s00167-020-06022-4
   Howard RA, 2020, AM J INFECT CONTROL, V48, P153, DOI 10.1016/j.ajic.2019.08.009
   Jain VK, 2020, TROP DOCT, V50, P108, DOI 10.1177/0049475520921616
   Law HKW, 2005, BLOOD, V106, P2366, DOI 10.1182/blood-2004-10-4166
   Lei SQ, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100331
   Lockhart SL, 2020, CAN J ANESTH, V67, P1005, DOI 10.1007/s12630-020-01673-w
   Massey PA, 2020, J AM ACAD ORTHOP SUR, V28, P436, DOI 10.5435/JAAOS-D-20-00360
   Morgan C, 2020, BRIT J HOSP MED, V81, DOI 10.12968/hmed.2020.0137
   NHS England, 2020, CLIN GUID MAN TRAUM
   Nogler M, 2003, J BONE JOINT SURG BR, V85B, P436, DOI 10.1302/0301-620X.85B3.12451
   Nogler M, 2001, EUR SPINE J, V10, P274, DOI 10.1007/s005860100310
   Peng PWH, 2020, BRIT J ANAESTH, V124, P497, DOI 10.1016/j.bja.2020.02.008
   Perry JL, 2016, NASATM2016218224
   Pryor A., 2020, SAGES EAES RECOMMEND
   Raphael T, 2020, BLOOMBERG OPINION
   Rodrigues-Pinto R, 2020, J BONE JOINT SURG AM, V102, P946, DOI 10.2106/JBJS.20.00454
   Stahel PF, 2020, PATIENT SAF SURG, V14, DOI 10.1186/s13037-020-00235-9
   Ti LK, 2020, CAN J ANESTH, V67, P756, DOI 10.1007/s12630-020-01617-4
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wong J, 2020, CAN J ANESTH, V67, P732, DOI 10.1007/s12630-020-01620-9
   YEH HC, 1995, AEROSOL SCI TECH, V22, P151, DOI 10.1080/02786829408959736
   Zheng MH, 2020, ANN SURG, V272, pE5, DOI 10.1097/SLA.0000000000003924
   Zhou J, 2014, J INFECT DIS, V209, P1331, DOI 10.1093/infdis/jit504
NR 42
TC 10
Z9 10
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1754-9493
J9 PATIENT SAF SURG
JI Patient Saf. Surg.
PD JUL 20
PY 2020
VL 14
IS 1
AR 30
DI 10.1186/s13037-020-00254-6
PG 8
WC Surgery
WE Emerging Sources Citation Index (ESCI)
SC Surgery
GA MP8CL
UT WOS:000552427500001
PM 32695225
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Pinto, CAS
AF Schettini Pinto, Carlos Alberto
TI Knowledge management as a support for supply chain logistics planning in
   pandemic cases
SO BRAZILIAN JOURNAL OF OPERATIONS & PRODUCTION MANAGEMENT
LA English
DT Article
DE Knowledge management; Supply chain management; Logistics; Pandemic
AB Goal: This study presents how the knowledge management can be an excellent ally to logistics for planning the supply chain in actions in cases of pandemic.
   Design/Methodology/Approach: The present study was based on a bibliographic review sought in the main existing databases. From there, it was possible to obtain subsidies to support the proposal of this work.
   Results: The results showed that a correct application of knowledge management can assist in logistical planning in a very effective way, reducing gaps and shortages, providing very effective actions to mitigate the main obstacles that a pandemic can generate.
   Limitations of the investigation: The most important limitation in this study was the fact that the COVID-19 pandemic is still very active and logistics operations do not yet have effective and consolidated data to bring even more reliable results.
   Practical implications: According to the conclusions obtained, governmental organizations, at their three levels (municipal, state and federal) should focus on creating public policies that mitigate the problems of supplying of the various matrices of inputs and products.
   Originality/Value: The main contribution of the research lies in the opportunity to present a management component to assist the logistical demands that occur in a pandemic environment.
C1 [Schettini Pinto, Carlos Alberto] Getulio Vargas Fdn, Postgrad Course Logist & Supply Chain Management, Rio De Janeiro, Brazil.
RP Pinto, CAS (corresponding author), Getulio Vargas Fdn, Postgrad Course Logist & Supply Chain Management, Rio De Janeiro, Brazil.
EM schettini.buco@gmail.com
RI Pinto, Carlos Alberto Schettini/AAT-8125-2021
OI Pinto, Carlos Alberto Schettini/0000-0001-6674-289X
CR Al-ghamdi HAK, 2015, PROCEDIA COMPUT SCI, V65, P406, DOI 10.1016/j.procs.2015.09.102
   [Anonymous], 2020, FORTUNE
   Araz OM, 2020, DECISION SCI, V51, P1316, DOI 10.1111/deci.12443
   Bowersox J.C., 2014, GESTAO LOGISTICA CAD
   Brasil Agencia Nacional de Transportes Aquaticos, 2020, IN IMP COR
   Calvo Mora A., 2015, INT J PROJ MANAG, V33, P1638, DOI [10.1016/j.ijproman.2015.01.010, DOI 10.1016/J.IJPROMAN.2015.01.010]
   Carvalho F.C.A., 2012, GESTAO CONHECIMENTO
   Chang CLH, 2015, J KNOWL MANAG, V19, P433, DOI 10.1108/JKM-08-2014-0353
   Choo C. W., 2006, ORG CONHECIMENTO COM
   Costa N., 2020, GEOEDUC         0317
   Dalkir K., 2011, KNOWLEDGE MANAGEMENT
   Dolgui A, 2019, INT J PROD RES, pNIL_1, DOI 10.1080/00207543.2019.1627438
   Dolgui A, 2018, INT J PROD RES, V56, P414, DOI 10.1080/00207543.2017.1387680
   Garvey MD, 2015, EUR J OPER RES, V243, P618, DOI 10.1016/j.ejor.2014.10.034
   Gnimpieba DR, 2015, PROCEDIA COMPUT SCI, V56, P550, DOI 10.1016/j.procs.2015.07.251
   Ilie-Zudor E, 2014, PROC CIRP, V25, P337, DOI 10.1016/j.procir.2014.10.047
   Ivanov D, 2020, INT J PROD RES, V58, P3252, DOI 10.1080/00207543.2019.1634850
   Ivanov D, 2014, INT J PROD RES, V52, P2154, DOI 10.1080/00207543.2013.858836
   Jakobsone A, 2017, PROCEDIA COMPUT SCI, V104, P160, DOI 10.1016/j.procs.2017.01.095
   Johansson T, 2013, PROCD SOC BEHV, V74, P295, DOI 10.1016/j.sbspro.2013.03.018
   Krumina I, 2015, PROCD SOC BEHV, V213, P781, DOI 10.1016/j.sbspro.2015.11.475
   Li YH, 2020, INT J PROD ECON, V228, DOI 10.1016/j.ijpe.2020.107693
   MACHADO NETO N. R., 1998, SEM GER INF SET PUBL, V4
   Mejía Trejo Juan, 2016, Contad. Adm, V61, P456, DOI 10.1016/j.cya.2015.11.011
   Meyer MH, 1996, SLOAN MANAGE REV, V37, P43
   Mylonakou-Keke I, 2012, PROCD SOC BEHV, V69, P169, DOI 10.1016/j.sbspro.2012.11.396
   Rodriguez-Enriquez CA, 2016, ELECTRON COMMER R A, V19, P1, DOI 10.1016/j.elerap.2016.06.004
   Tachizawa EM, 2015, SUPPLY CHAIN MANAG, V20, P237, DOI 10.1108/SCM-03-2014-0108
   Terzieva M, 2014, PROC TECH, V16, P1086, DOI 10.1016/j.protcy.2014.10.123
   United Nations, 2020, UM COVID 19 DAT
   Witkowski K, 2017, PROCEDIA ENGINEER, V182, P763, DOI 10.1016/j.proeng.2017.03.197
   Zhou CH, 2020, GEOGR SUSTAIN, V1, P77, DOI 10.1016/j.geosus.2020.03.005
NR 32
TC 3
Z9 3
U1 12
U2 14
PU ASSOC BRASILEIRA ENGENHARIA PRODUCAO-ABEPRO
PI SAO PAULO
PA AV PROF ALMEIDA PRADO 531, 1O ANDAR, SALA 102, SAO PAULO, 05508-900,
   BRAZIL
SN 2237-8960
J9 BRAZ J OPER PROD MAN
JI Braz. J. Oper. Prod. Manag.
PD SEP
PY 2020
VL 17
IS 3
SI SI
AR e2020970
DI 10.14488/BJOPM.2020.033
PG 11
WC Operations Research & Management Science
WE Emerging Sources Citation Index (ESCI)
SC Operations Research & Management Science
GA OM4YM
UT WOS:000586032300006
OA gold
DA 2022-04-20
ER

PT J
AU Brown, C
   Wilkins, K
   Craig-Neil, A
   Upshaw, T
   Pinto, AD
AF Brown, Chloe
   Wilkins, Katie
   Craig-Neil, Amy
   Upshaw, Tara
   Pinto, Andrew David
TI Reducing Inequities During the COVID-19 Pandemic: A Rapid Review and
   Synthesis of Public Health Recommendations
SO PUBLIC HEALTH REVIEWS
LA English
DT Review
DE public health; social determinants of health; SARS-CoV-2; health equity;
   COVID-19; prevention
ID MENTAL-HEALTH; CHALLENGES; INFECTION; CARE; EPIDEMIC; OUTBREAK; DISEASE;
   IMPACT; SPREAD
AB Objectives: Efforts to contain the COVID-19 pandemic should take into account worsening health inequities. While many public health experts have commented on inequities, no analysis has yet synthesized recommendations into a guideline for practitioners. The objective of this rapid review was to identify the areas of greatest concern and synthesize recommendations.Methods: We conducted a rapid systematic review (PROSPERO: CRD42020178131). We searched Ovid MEDLINE, Embase, PsycINFO, CINAHL and Cochrane Central Register of Controlled Trials databases from December 1, 2019 to April 27, 2020. We included English language peer-reviewed commentaries, editorials, and opinion pieces that addressed the social determinants of health in the context of COVID-19.Results: 338 articles met our criteria. Authors represented 81 countries. Income, housing, mental health, age and occupation were the most discussed social determinants of health. We categorized recommendations into primordial, primary, secondary and tertiary prevention that spoke to the social determinants of COVID-19 and equity.Conclusion: These recommendations can assist efforts to contain COVID-19 and reduce health inequities during the pandemic. Using these recommendations, public health practitioners could support a more equitable pandemic response.
C1 [Brown, Chloe; Wilkins, Katie; Craig-Neil, Amy; Upshaw, Tara; Pinto, Andrew David] Unity Hlth Toronto, Li Ka Shing Knowledge Inst, Upstream Lab, MAP Ctr Urban Hlth Solut, Toronto, ON, Canada.
   [Brown, Chloe; Wilkins, Katie] Univ Toronto, Undergraduate Med Educ, Fac Med, Toronto, ON, Canada.
   [Pinto, Andrew David] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
   [Pinto, Andrew David] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Pinto, Andrew David] Univ Toronto, Dept Family & Community Med, Fac Med, Toronto, ON, Canada.
   [Pinto, Andrew David] St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada.
RP Pinto, AD (corresponding author), Unity Hlth Toronto, Li Ka Shing Knowledge Inst, Upstream Lab, MAP Ctr Urban Hlth Solut, Toronto, ON, Canada.; Pinto, AD (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.; Pinto, AD (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Pinto, AD (corresponding author), Univ Toronto, Dept Family & Community Med, Fac Med, Toronto, ON, Canada.; Pinto, AD (corresponding author), St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada.
EM andrew.pinto@utoronto.ca
FU Early Researcher Award from the Government of Ontario; University of
   Toronto COVID-19 Student Engagement Award; Canada Graduate Scholarship
   from the Canadian Institutes for Health ResearchCanadian Institutes of
   Health Research (CIHR); Canadian Institutes for Health ResearchCanadian
   Institutes of Health Research (CIHR); Innovation Funds from the Academic
   Health Science Centre Alternative Funding Plan; Department of Family and
   Community Medicine, Faculty of Medicine, University of Toronto;
   Department of Family and Community Medicine, St. Michael's Hospital; Li
   Ka Shing Knowledge Institute, St. Michael's Hospital; Physicians'
   Services Incorporated Foundation; Associate Director for Clinical
   Research at the University of Toronto Practice-Based Research Network
   (UTOPIAN); Department of Family and Community Medicine, University of
   TorontoUniversity of Toronto
FX This project was supported in part by an Early Researcher Award from the
   Government of Ontario, held by AP, and a University of Toronto COVID-19
   Student Engagement Award, which supported TU and CB. TU was also
   supported by a Canada Graduate Scholarship from the Canadian Institutes
   for Health Research. AC-N was supported by the Canadian Institutes for
   Health Research. KW was supported from the Innovation Funds from the
   Academic Health Science Centre Alternative Funding Plan. AP is supported
   as a Clinician-Scientist by the Department of Family and Community
   Medicine, Faculty of Medicine, University of Toronto, the Department of
   Family and Community Medicine, St. Michael's Hospital, and the Li Ka
   Shing Knowledge Institute, St. Michael's Hospital, by a fellowship from
   the Physicians' Services Incorporated Foundation and as the Associate
   Director for Clinical Research at the University of Toronto
   Practice-Based Research Network (UTOPIAN). Funding for publication has
   been made possible through the Department of Family and Community
   Medicine, University of Toronto and the Department of Family and
   Community Medicine, St. Michael's Hospital. The study sponsors had no
   role in study design; collection, analysis, and interpretation of data;
   writing the report; and the decision to submit the report for
   publication.
CR Ademuyiwa AO, 2020, ANN SURG, V272, pE9, DOI 10.1097/SLA.0000000000003964
   Agoramoorthy G, 2020, INFECT CONT HOSP EP, V41, P1114, DOI 10.1017/ice.2020.140
   Agyeman AA., 2020, J MED VIROL, P1
   Ahonsi B, 2020, AFR J REPROD HEALTH, V24, P22, DOI 10.29063/ajrh2020/v24i1.3
   Akiyama MJ, 2020, NEW ENGL J MED, V382, P2075, DOI 10.1056/NEJMp2005687
   Al-Quteimat OM, 2021, RES SOC ADMIN PHARM, V17, P480, DOI 10.1016/j.sapharm.2020.03.018
   Alexander GC, 2020, ANN INTERN MED, V173, P57, DOI 10.7326/M20-1141
   American Medical Association, 2020, COVID 19 HLTH EQ
   [Anonymous], 2020, LANCET, V395, P1168, DOI 10.1016/S0140-6736(20)30823-0
   [Anonymous], 2020, ALZHEIMERS DEMENT, V16, P587, DOI 10.1002/alz.12093
   Armitage R, 2020, LANCET GLOB HEALTH, V8, pE644, DOI 10.1016/S2214-109X(20)30116-9
   Armitage R, 2020, LANCET PUBLIC HEALTH, V5, pE257, DOI 10.1016/S2468-2667(20)30076-1
   Ayalon L, 2021, J GERONTOL B-PSYCHOL, V76, pE49, DOI 10.1093/geronb/gbaa051
   Azar KMJ, 2020, HEALTH AFFAIR, V39, P1253, DOI 10.1377/hlthaff.2020.00598
   Azim D, 2020, INFECT CONT HOSP EP, V41, P989, DOI 10.1017/ice.2020.127
   Bachireddy C, 2020, JAMA-J AM MED ASSOC, V323, P2009, DOI 10.1001/jama.2020.4272
   Barazzoni R, 2020, CLIN NUTR, V39, P1631, DOI 10.1016/j.clnu.2020.03.022
   Bayefsky MJ, 2020, NEW ENGL J MED, V382, pE47, DOI 10.1056/NEJMp2008006
   Becker WC, 2020, ANN INTERN MED, V173, P59, DOI 10.7326/M20-1210
   Berger ZD, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1141
   Berkowitz SA, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2021209
   Bhopal RS, 2020, PUBLIC HEALTH, V182, P161, DOI 10.1016/j.puhe.2020.04.010
   Bradbury-Jones C, 2020, J CLIN NURS, V29, P2047, DOI 10.1111/jocn.15296
   Buss PM, 2020, CAD SAUDE PUBLICA, V36, DOI 10.1590/0102-311X00066920
   Calton B, 2020, J PAIN SYMPTOM MANAG, V60, pE12, DOI 10.1016/j.jpainsymman.2020.03.019
   Carrico AW, 2020, AIDS BEHAV, V24, P3020, DOI 10.1007/s10461-020-02854-w
   Carta Mauro Giovanni, 2020, Open Respir Med J, V14, P8, DOI 10.2174/1874306402014010008
   Castillo B., 2020, VIRULENT GREED NATL, V9
   Chen JT, 2021, J PUBLIC HEALTH MAN, V27, pS43, DOI 10.1097/PHH.0000000000001263
   Cowling BJ, 2020, J INFECT DIS, V221, P1749, DOI 10.1093/infdis/jiaa123
   Cullen W, 2020, QJM-INT J MED, V113, P311, DOI 10.1093/qjmed/hcaa110
   de Lusignan S, 2020, LANCET INFECT DIS, V20, P1034, DOI 10.1016/S1473-3099(20)30371-6
   DePierro J, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.113024
   Dietz W, 2020, OBESITY, V28, P1005, DOI 10.1002/oby.22818
   Donovan D., AFMC PRIM POP HLTH
   Douglas M., 2020, BMJ
   Drain PK, 2020, ECLINICALMEDICINE, V22, DOI 10.1016/j.eclinm.2020.100342
   Druss BG, 2020, JAMA PSYCHIAT, V77, P891, DOI 10.1001/jamapsychiatry.2020.0894
   Duong MT, 2020, J AM GERIATR SOC, V68, P1170, DOI 10.1111/jgs.16495
   Fakari FR, 2020, ARCH ACAD EMERG MED, V8
   Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X
   Ferrante L, 2020, SCIENCE, V368, P251, DOI 10.1126/science.abc0073
   Fiorillo A, 2020, EUR PSYCHIAT, V63, DOI 10.1192/j.eurpsy.2020.35
   Flint AJ., 2020, INT PSYCHOGERIATRICS
   Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562
   Gamio L., 2020, NEW YORK TIMES 0315
   Gardner W, 2020, J AGING SOC POLICY, V32, P310, DOI 10.1080/08959420.2020.1750543
   Garritty C, 2021, J CLIN EPIDEMIOL, V130, P13, DOI 10.1016/j.jclinepi.2020.10.007
   Gaur S, 2020, INFECT CONT HOSP EP, V41, P729, DOI 10.1017/ice.2020.98
   Ghebreyesus TA, 2020, LANCET, V395, P762, DOI 10.1016/S0140-6736(20)30420-7
   Goldschmidt K, 2020, J PEDIATR NURS, V53, P88, DOI 10.1016/j.pedn.2020.04.013
   Gostin LO, 2020, JAMA-J AM MED ASSOC, V323, P1547, DOI 10.1001/jama.2020.4335
   Gupta Naveen, 2020, Med J Armed Forces India, V76, P132, DOI 10.1016/j.mjafi.2020.04.001
   Han SD, 2020, J AM GERIATR SOC, V68, P1386, DOI 10.1111/jgs.16496
   Hargreaves J, 2020, LANCET HIV, V7, pE309, DOI 10.1016/S2352-3018(20)30110-7
   Hargreaves S, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1213
   Hastie CE, 2020, DIABETES METAB SYND, V14, P561, DOI 10.1016/j.dsx.2020.04.050
   Hedima EW, 2021, RES SOC ADMIN PHARM, V17, P1964, DOI 10.1016/j.sapharm.2020.04.013
   Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1
   Humphreys KL, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-0982
   Ivers LC, 2020, AM J TROP MED HYG, V102, P1149, DOI 10.4269/ajtmh.20-0260
   Jenkins WD, 2021, J RURAL HEALTH, V37, P172, DOI 10.1111/jrh.12442
   Joanna Briggs Institute, 2017, CHECKL TEXT OP, P5
   John N, 2020, DEV WORLD BIOETH, V20, P65, DOI 10.1111/dewb.12261
   Jones, 2020, WASH POST
   Jung SJ, 2020, YONSEI MED J, V61, P271, DOI 10.3349/ymj.2020.61.4.271
   Kar SK., 2020, ASIAN J PSYCHIATR, P51
   Kavoor AR, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102051
   Keating D, 2020, WASHINGTON POST
   Khoury R, 2020, INT PSYCHOGERIATR, V32, P1177, DOI 10.1017/S104161022000068X
   Koh D, 2020, OCCUP MED-OXFORD, V70, P3, DOI 10.1093/occmed/kqaa036
   Lai CC, 2020, J MICROBIOL IMMUNOL, V53, P444, DOI 10.1016/j.jmii.2020.04.008
   Lau LS, 2020, NAT MED, V26, P647, DOI 10.1038/s41591-020-0851-2
   Lee K, 2009, GLOB INST, P1
   Liem A, 2020, LANCET PSYCHIAT, V7, pE20, DOI 10.1016/S2215-0366(20)30076-6
   Liu JJ, 2020, LANCET CHILD ADOLESC, V4, P347, DOI 10.1016/S2352-4642(20)30096-1
   Lopez MM, 2020, AM J PUBLIC HEALTH, V110, P958, DOI 10.2105/AJPH.2020.305704
   Louis-Jean J, 2020, J COMMUN HEALTH, V45, P437, DOI 10.1007/s10900-020-00825-9
   Mahmood S, 2020, JMIR PUBLIC HLTH SUR, V6, P226, DOI 10.2196/18980
   Malta M, 2020, ECLINICALMEDICINE, V20, DOI 10.1016/j.eclinm.2020.100289
   Markus HS, 2020, INT J STROKE, V15, P361, DOI 10.1177/1747493020923472
   Marziali ME., 2020, AIDS BEHAV, P1
   Mather TPS, 2020, LANCET GLOB HEALTH, V8, pE773, DOI 10.1016/S2214-109X(20)30131-5
   Mazumder H, 2020, J GERONTOL SOC WORK, V63, P257, DOI 10.1080/01634372.2020.1746723
   Merchant RM, 2020, JAMA-J AM MED ASSOC, V323, P2011, DOI 10.1001/jama.2020.4469
   Meyer JP, 2020, LANCET INFECT DIS, V20, P646, DOI 10.1016/S1473-3099(20)30295-4
   Mohamed K, 2020, INFECT CONT HOSP EP, V41, P1245, DOI 10.1017/ice.2020.162
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   Monjur MR, 2020, INFECT CONT HOSP EP, V41, P1116, DOI 10.1017/ice.2020.147
   Monteith LL, 2021, J RURAL HEALTH, V37, P179, DOI 10.1111/jrh.12448
   Montenovo L., 2020, NBER WORK PAP, P1689
   Mosites E, 2020, MMWR-MORBID MORTAL W, V69, P521, DOI 10.15585/mmwr.mm6917e1
   Mukhtar S, 2021, RES SOC ADMIN PHARM, V17, P2052, DOI 10.1016/j.sapharm.2020.04.011
   National Collaborating Centre for Determinants of Health, 2020, EQ INF RESP COVID 19
   Nicol GE, 2020, J CLIN PSYCHIAT, V81, DOI 10.4088/JCP.20com13373
   Nicol GE, 2020, J AM GERIATR SOC, V68, P922, DOI 10.1111/jgs.16443
   Nkengasong JN, 2020, LANCET, V395, P841, DOI 10.1016/S0140-6736(20)30464-5
   O'Neill D, 2020, Ir Med J, V113, P50
   Page KR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2005953
   Paintsil E, 2020, J CLIN INVEST, V130, P2741, DOI 10.1172/JCI138493
   Palipana D, 2020, EMERG MED AUSTRALAS, V32, P692, DOI 10.1111/1742-6723.13525
   Pan American Health Organization, 2020, PROM HLTH EQ GEND ET
   Pandve Harshal T, 2014, J Family Med Prim Care, V3, P309
   Parmet WE, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2004211
   Patel L, 2021, J RURAL HEALTH, V37, P175, DOI 10.1111/jrh.12447
   Patrick K, 2020, CAN MED ASSOC J, V192, pE516, DOI 10.1503/cmaj.200606
   Pineda VS, 2020, J URBAN HEALTH, V97, P336, DOI 10.1007/s11524-020-00437-7
   Quaresima V, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012488
   Neto MLR, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112939
   Shalev D, 2020, GEN HOSP PSYCHIAT, V64, P68, DOI 10.1016/j.genhosppsych.2020.03.009
   Sharma S, 2020, AM J TRANSPLANT, V20, P1954, DOI 10.1111/ajt.15931
   Shiau S, 2020, AIDS BEHAV, V24, P2244, DOI 10.1007/s10461-020-02871-9
   Smith JA, 2020, HEALTH PROMOT J AUST, V31, P158, DOI 10.1002/hpja.333
   Sodhi M, 2021, J RURAL HEALTH, V37, P158, DOI 10.1111/jrh.12445
   Sood A, 2021, J RURAL HEALTH, V37, P165, DOI 10.1111/jrh.12444
   Steinman MA, 2020, JAMA INTERN MED, V180, P819, DOI 10.1001/jamainternmed.2020.1661
   Sun YK, 2020, AM J ADDICTION, V29, P174, DOI 10.1111/ajad.13031
   Tandon PN, 2020, INDIAN J MED RES, V151, P121, DOI 10.4103/ijmr.IJMR_664_20
   The Centre for Disease Control and Prevention, 2020, CDC COVID 19 RESP HL
   The Centre for Disease Control and Prevention, 2017, PREV PICT AM
   Tobolowsky FA, 2020, MMWR-MORBID MORTAL W, V69, P523, DOI 10.15585/mmwr.mm6917e2
   Tsai J, 2020, LANCET PUBLIC HEALTH, V5, pE186, DOI 10.1016/S2468-2667(20)30053-0
   Tseng TG, 2020, J GERONTOL A-BIOL, V75, pE128, DOI 10.1093/gerona/glaa081
   Upshaw TL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248336
   Usher K, 2020, INT J MENT HEALTH NU, V29, P315, DOI 10.1111/inm.12726
   van der Werf S, 2020, VIROLOGIE, V24, pE12, DOI 10.1684/vir.2020.0826
   van Gelder N, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100348
   Vessey JA, 2020, J PEDIATR NURS, V52, DOI 10.1016/j.pedn.2020.03.014
   Volkow ND, 2020, ANN INTERN MED, V173, P61, DOI 10.7326/M20-1212
   Walensky RP, 2020, JAMA-J AM MED ASSOC, V323, P1889, DOI 10.1001/jama.2020.6572
   Walter-McCabe HA, 2020, SOC WORK PUBLIC HLTH, V35, P69, DOI 10.1080/19371918.2020.1751533
   Wang HL, 2020, LANCET, V395, P1190, DOI 10.1016/S0140-6736(20)30755-8
   Wang ZC, 2020, NAT MED, V26, P458, DOI 10.1038/s41591-020-0823-6
   Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2
   Whaibeh Emile, 2020, Curr Treat Options Psychiatry, V7, P198, DOI 10.1007/s40501-020-00210-2
   World Health Organization Commission on the Social Determinants of Health (CSDH), 2008, CLOSING GAP GENERATI
   Wurcel AG, 2020, CLIN INFECT DIS, V71, P891, DOI 10.1093/cid/ciaa346
   Yamey G, 2020, LANCET, V395, P1405, DOI 10.1016/S0140-6736(20)30763-7
   Yang H, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1362
   Yip PSF, 2020, CRISIS, V41, P153, DOI [10.1007/s42379-020-00069-z, 10.1027/0227-5910/a000710]
   Young HM, 2020, J GERONTOL NURS, V46, P4, DOI 10.3928/00989134-20200403-01
   Zavaleta C, 2020, NATURE, V580, P185, DOI 10.1038/d41586-020-01032-1
   Zhu YH, 2020, NEUROSCI BULL, V36, P299, DOI 10.1007/s12264-020-00476-9
   Zimmerman S, 2020, J AM MED DIR ASSOC, V21, P572, DOI 10.1016/j.jamda.2020.03.024
NR 144
TC 0
Z9 0
U1 2
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2107-6952
J9 PUBLIC HEALTH REV
JI Public Health Rev.
PD JAN 17
PY 2022
VL 42
AR 1604031
DI 10.3389/phrs.2021.1604031
PG 11
WC Public, Environmental & Occupational Health
WE Emerging Sources Citation Index (ESCI)
SC Public, Environmental & Occupational Health
GA ZH6CX
UT WOS:000761025600001
PM 35140994
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Shiina, A
   Niitsu, T
   Kobori, O
   Idemoto, K
   Hashimoto, T
   Sasaki, T
   Igarashi, Y
   Shimizu, E
   Nakazato, M
   Hashimoto, K
   Iyo, M
AF Shiina, Akihiro
   Niitsu, Tomihisa
   Kobori, Osamu
   Idemoto, Keita
   Hashimoto, Tasuku
   Sasaki, Tsuyoshi
   Igarashi, Yoshito
   Shimizu, Eiji
   Nakazato, Michiko
   Hashimoto, Kenji
   Iyo, Masaomi
TI Perception of and anxiety about COVID-19 infection and risk behaviors
   for spreading infection: an international comparison
SO ANNALS OF GENERAL PSYCHIATRY
LA English
DT Article
DE COVID-19; Anxiety; Precautionary behaviors; International comparison;
   Questionnaire survey
AB Background To control the spread of the new SARS-CoV-2 infection's disease (COVID-19), appropriate precautionary behaviors by the public should be promoted. There are international differences in public cognitive and behavioral pattern, attitudes toward information sources, and anxiety about COVID-19. Information about these differences could increase understanding of the patterns of epidemic-related anxiety and behavior, and would help optimize future policies for preventing the next wave of the epidemic. Methods To examine between-country differences in perception, attitude, and precautionary behaviors toward COVID-19, we conducted a cross-sectional study using an online questionnaire survey. Participants were adults who had been registered in Cross Marketing Group Inc. and living in the UK, Spain, or Japan. A total of 8,000 people stratified by age were recruited on a first-come, first-serve basis. Knowledge of and anxiety about COVID-19, the frequency of access and perceived credibility of several information sources, and the frequency of each precautionary behavior were examined on March 27-28, 2020, in Japan and April 17-21, 2020, in the UK and Spain. Results Knowledge, anxiety, and the frequency of precautionary behaviors were higher in the UK and Spain than in Japan. Participants with infected acquaintances were more concerned about COVID-19. However, participants in the UK rarely wore a medical mask. Participants in the UK and Spain were more eager to obtain information about COVID-19 than those in Japan. Participants in Spain tended not to trust official information and to believe specialists' comments instead. Conclusion The rapidity of the spread of COVID-19, cultural background, and recent political situations seemed to contribute to the international differences here.
C1 [Shiina, Akihiro; Igarashi, Yoshito; Hashimoto, Kenji; Iyo, Masaomi] Chiba Univ, Ctr Forens Mental Hlth, Chuo Ku, Inohana 1-8-1, Chiba 2608670, Japan.
   [Niitsu, Tomihisa; Idemoto, Keita; Sasaki, Tsuyoshi; Iyo, Masaomi] Chiba Univ, Dept Psychiat, Grad Sch Med, Chiba, Japan.
   [Kobori, Osamu] Int Univ Hlth & Welf, Dept Psychol, Akasaka, Japan.
   [Hashimoto, Tasuku; Nakazato, Michiko] Int Univ Hlth & Welf, Sch Med, Dept Psychiat, Narita, Japan.
   [Shimizu, Eiji] Chiba Univ, Grad Sch Med, Dept Cognit Behav Physiol, Chiba, Japan.
RP Shiina, A (corresponding author), Chiba Univ, Ctr Forens Mental Hlth, Chuo Ku, Inohana 1-8-1, Chiba 2608670, Japan.
EM shiina-akihiro@faculty.chiba-u.jp
RI Hashimoto, Kenji/I-5800-2015; Shiina, Akihiro/E-8450-2011
OI Hashimoto, Kenji/0000-0002-8892-0439; Shiina,
   Akihiro/0000-0003-0158-3941
FU Japan's Ministry of Education, Culture, Sport, Science and Technology
   [MECSST]; Japan Society for the Promotion of Science [JSPS]
   KAKENHIMinistry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for
   Scientific Research (KAKENHI) [JP19K08066]
FX This study was conducted with a management grant provided by Japan's
   Ministry of Education, Culture, Sport, Science and Technology [MECSST]
   to Chiba University Graduate School of Medicine and by a grant from the
   Japan Society for the Promotion of Science [JSPS] KAKENHI [to T.N., no.
   JP19K08066]. The MECSST and JSPS had no role in or control over the
   execution of this study.
CR [Anonymous], 2020, BBC
   [Anonymous], 2020, THE JAPAN TIMES
   [Anonymous], 2020, KYODO NEWS
   [Anonymous], Ministry of Internal Affairs and Communications State of Prefectures and Municipalities (System of Social and Demographic Statistics)
   [Anonymous], 2020, YOUGOV
   [Anonymous], 2015, DIMSDRIVE
   [Anonymous], 2020, WORLD EC FORUM
   [Anonymous], 2020, EXPRESS STAR
   [Anonymous], 2020, SCIENCEMAG
   [Anonymous], OECD DATA
   [Anonymous], 2020, INDEPENDENT
   Boulos MKN, 2020, INT J HEALTH GEOGR, V19, DOI 10.1186/s12942-020-00202-8
   Bults M, 2015, DISASTER MED PUBLIC, V9, P207, DOI 10.1017/dmp.2014.160
   Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193
   Freeman D, 2022, PSYCHOL MED, V52, P251, DOI 10.1017/S0033291720001890
   Harper CA, 2021, INT J MENT HEALTH AD, V19, P1875, DOI 10.1007/s11469-020-00281-5
   He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5
   Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032
   Li YK, 2020, CURR MED SCI, V40, P295, DOI 10.1007/s11596-020-2176-2
   Morishima Mika, 2011, J Hum Ergol (Tokyo), V40, P151
   Sakai T, 2001, CONDUCT QUESTIONNAIR
   Shigemura J, 2020, PSYCHIAT CLIN NEUROS, V74, P281, DOI 10.1111/pcn.12988
   Shiina Akihiro, 2020, Brain Behav Immun Health, V6, P100101, DOI 10.1016/j.bbih.2020.100101
   Stutt ROJH, 2020, P ROY SOC A-MATH PHY, V476, DOI 10.1098/rspa.2020.0376
   World Health Organization, 2020, RISK ASSESSMENT MANA
   World Health Organization, 2020, 66 WHO
   Zanin GM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093024
NR 27
TC 5
Z9 5
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1744-859X
J9 ANN GEN PSYCHIATR
JI Ann. Gen. Psychiatr.
PD FEB 18
PY 2021
VL 20
IS 1
AR 13
DI 10.1186/s12991-021-00334-6
PG 11
WC Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Psychiatry
GA QL2PR
UT WOS:000620923800001
PM 33602250
OA Green Published, Green Submitted, gold
DA 2022-04-20
ER

PT J
AU Dionne-Odom, J
   Klipstein, S
AF Dionne-Odom, Jodie
   Klipstein, Sigal
TI The Impact of Epidemiology on Fertility and Prenatal Care During the
   COVID-19 Pandemic
SO AMERICAN JOURNAL OF EPIDEMIOLOGY
LA English
DT Editorial Material
DE conception; COVID-19; inclusion in trials; lactation; pregnancy;
   vertical transmission
ID INFLUENZA
AB The emergence of the novel coronavirus disease 2019 (COVID-19) presented the field of reproductive medicine with many challenges due to an absence of data to guide clinical decision-making and inform patient counseling and management in the early days of the pandemic. Epidemiological studies rapidly filled key gaps in our understanding of the susceptibility of reproductive-aged women to the virus, transmission dynamics during pregnancy and lactation, and the effect of infection during the prenatal, pregnancy, and postpartum periods. This data guided the development of clinical guidelines written by the American Society for Reproductive Medicine as patients and clinicians navigated reproductive decisions during a time of uncertainty. We present a review of epidemiologic studies published between March and December 2020 that have directly informed prenatal and fertility care during the COVID-19 pandemic. Despite a significant increase in our knowledge base over the past year, many questions remain about the impact of COVID-19 on conception, pregnancy, fetal development, and lactation. In the future, a commitment toward inclusion of pregnant persons and those attempting pregnancy in the design of observational and interventional trials is necessary to gain earlier insights about outcomes and assist providers and patients in making data-driven decisions.
C1 [Dionne-Odom, Jodie; Klipstein, Sigal] Univ Alabama Birmingham, Div Infect Dis, 703 19th St S, Birmingham, AL 35294 USA.
RP Dionne-Odom, J (corresponding author), Univ Alabama Birmingham, Div Infect Dis, 703 19th St S, Birmingham, AL 35294 USA.
EM jdionne@uabmc.edu
FU Eunice Kennedy Shriver National Institute of Child Health and Human
   DevelopmentUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [1K23HD090993,
   R01HD101545]
FX This work was supported by The Eunice Kennedy Shriver National Institute
   of Child Health and Human Development (awards 1K23HD090993 and
   R01HD101545 to J.D.).
CR Afshar Y, 2020, OBSTET GYNECOL, V136, P1117, DOI 10.1097/AOG.0000000000004178
   Allotey J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3320
   Amer Coll Obstetricians Gynecologi, 2015, OBSTET GYNECOL, V126, pE100, DOI 10.1097/AOG.0000000000001150
   American Society of Reproductive Medicine, PAT MAN CLIN REC COV
   [Anonymous], 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04243-3
   [Anonymous], NTR
   Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389
   Chambers Christina D, 2020, medRxiv, DOI 10.1101/2020.06.12.20127944
   Edlow AG, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.30455
   Gallup Poll Survey, WILL GET COVID19 VAC
   He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5
   Jaffe E, 2020, VACCINE, V38, P6922, DOI 10.1016/j.vaccine.2020.08.059
   Kotlyar AM, 2021, AM J OBSTET GYNECOL, V224, P35, DOI 10.1016/j.ajog.2020.07.049
   Krubiner CB, 2021, VACCINE, V39, P85, DOI 10.1016/j.vaccine.2019.01.011
   LaCourse SM, 2020, CLIN INFECT DIS, V71, P879, DOI 10.1093/cid/ciaa444
   Merrill RM, 2009, MED SCI MONITOR, V15, pPH92
   National Center for Health Statistics, 2018, MMWR-MORBID MORTAL W, V67, P1330
   Pew Research, US PUBL NOW DIV WHET
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Rasmussen SA, 2021, OBSTET GYNECOL, V137, P408, DOI 10.1097/AOG.0000000000004290
   Rasmussen SA, 2012, AM J OBSTET GYNECOL, V207, pS3, DOI 10.1016/j.ajog.2012.06.068
   Report to the Secretary of Health and Human Services, TASK FORC RES SPEC P
   Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2098, DOI 10.1001/jama.2020.7681
   Salvatore CM, 2020, LANCET CHILD ADOLESC, V4, P721, DOI 10.1016/S2352-4642(20)30235-2
   Smith DD, 2020, AM J PERINAT, V37, P792, DOI 10.1055/s-0040-1712103
   Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2
   Sutton D, 2020, NEW ENGL J MED, V382, P2163, DOI 10.1056/NEJMc2009316
   Szablewski CM, 2020, MMWR-MORBID MORTAL W, V69, P1023, DOI 10.15585/mmwr.mm6931e1
   To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149
   University of California San Francisco, UCSF ASPIRE
   WebMD, WEBMD POLL MOR ACC C
   Woodworth KR, 2020, MMWR-MORBID MORTAL W, V69, P1635, DOI 10.15585/mmwr.mm6944e2
   Zambrano LD, 2020, MMWR-MORBID MORTAL W, V69, P1641, DOI 10.15585/mmwr.mm6944e3
NR 33
TC 0
Z9 0
U1 3
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0002-9262
EI 1476-6256
J9 AM J EPIDEMIOL
JI Am. J. Epidemiol.
PD MAY
PY 2021
VL 190
IS 5
BP 701
EP 706
DI 10.1093/aje/kwab026
EA FEB 2021
PG 6
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA TB2BU
UT WOS:000667749900002
PM 33564827
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Radulescu, A
   Williams, C
   Cavanagh, K
AF Radulescu, Anca
   Williams, Cassandra
   Cavanagh, Kieran
TI Management strategies in a SEIR-type model of COVID 19 community spread
SO SCIENTIFIC REPORTS
LA English
DT Article
AB The 2019 Novel Corona virus infection (COVID 19) is an ongoing public health emergency of international focus. Significant gaps persist in our knowledge of COVID 19 epidemiology, transmission dynamics, investigation tools and management, despite (or possibly because of) the fact that the outbreak is an unprecedented global threat. On the positive side, enough is currently known about the epidemic process to permit the construction of mathematical predictive models. In our work, we adapt a traditional SEIR epidemic model to the specific dynamic compartments and epidemic parameters of COVID 19, as it spreads in an age-heterogeneous community. We analyze management strategies of the epidemic course (as they were implemented through lockdown and reopening procedures in many of the US states and countries worldwide); however, to more clearly illustrate ideas, we focus on the example of a small scale college town community, with the timeline of control measures introduced in the state of New York. We generate predictions, and assess the efficiency of these control measures (closures, mobility restrictions, social distancing), in a sustainability context.
C1 [Radulescu, Anca; Williams, Cassandra; Cavanagh, Kieran] SUNY Coll New Paltz, Dept Math, New Paltz, NY 12561 USA.
   [Cavanagh, Kieran] SUNY Coll New Paltz, Dept Mech Engn, New Paltz, NY 12561 USA.
RP Radulescu, A (corresponding author), SUNY Coll New Paltz, Dept Math, New Paltz, NY 12561 USA.
EM radulesa@newpaltz.edu
OI Radulescu, Anca/0000-0002-2681-7233
CR Aguilar J. B., 2020, INVESTIGATING IMPACT
   Carcione JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00230
   Centers for Disease Control and Prevention, CLIN QUEST COVID 19
   Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9
   Edridge A.W., 2020, HUMAN CORONAVIRUS RE, DOI [10.1101/2020.05.11.20086439, DOI 10.1101/2020.05.11.20086439]
   Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x
   European Centre for Disease Prevention and Control, IMM RESP IMM SARS CO
   European Centre for Disease Prevention and Control, TRANSM COVID 19
   Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936
   Ganyani T, 2020, EUROSURVEILLANCE, V25, P12, DOI 10.2807/1560-7917.ES.2020.25.17.2000257
   Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7
   Github, EP CALC
   Glasziou P., 2020, J ASS MED MICROBIOL, V5, P223, DOI [DOI 10.3138/JAMMI-2020-0030, 10.1101/2020.05.10.20097543]
   Guggemos, 2020, NATURE          0401, V581, DOI [10.1038/s41586-020-2196-x, DOI 10.1038/s41586-020-2196-x]
   Huang L.-S., 2020, TAKING ACCOUNT ASYMP
   Jang S, 2020, EMERG INFECT DIS, V26, P1917, DOI 10.3201/eid2608.200633
   Kellam P, 2020, J GEN VIROL, V101, P791, DOI 10.1099/jgv.0.001439
   L'Huillier AG, 2020, SHEDDING INFECT SARS, V2020, DOI [10.1101/2020.04.27.20076778, DOI 10.1101/2020.04.27.20076778]
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Liu WB, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00461-20
   Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021
   Long Q.-X., 2020, NAT MED, P1, DOI [10.1038/s41591-020-0897-1, DOI 10.1038/S41591-020-0897-1]
   Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073
   Luo L., 2020, LANCET
   New York State Government, GOV CUOM ISS GUID ES
   Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841
   RadioFreeEurope, COR VS CHURCH ORTH T
   Riccardo F., 2020, EPIDEMIOLOGICAL CHAR
   Subbarao K, 2020, CELL HOST MICROBE, V27, P692, DOI 10.1016/j.chom.2020.04.019
   Texas Medical Association, COVID 19 RES
   Tong ZD, 2020, EMERG INFECT DIS, V26, P1052, DOI 10.3201/eid2605.200198
   Wang HW, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0148-0
   WHO World Health Organization, TRANSM SARS COV 2 IM
   Williams C., COVID 19 SEIR MOD
   Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1
   World Health Organization, SOL CLIN TRIAL COVID
   Wu A, 2020, PUBLICATIONS, V8, DOI 10.3390/publications8020022
   Xiao AT, 2020, J INFECTION, V81, P174, DOI 10.1016/j.jinf.2020.03.012
   Yu P, 2020, J INFECT DIS, V221, P1757, DOI 10.1093/infdis/jiaa077
   Zeng H, 2020, JAMA-J AM MED ASSOC, V323, P1848, DOI 10.1001/jama.2020.4861
   Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344
NR 41
TC 33
Z9 33
U1 6
U2 14
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 4
PY 2020
VL 10
IS 1
AR 21256
DI 10.1038/s41598-020-77628-4
PG 16
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA PT8JE
UT WOS:000608856300020
PM 33277553
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Ali, I
   Golgeci, I
   Arslan, A
AF Ali, Imran
   Golgeci, Ismail
   Arslan, Ahmad
TI Achieving resilience through knowledge management practices and risk
   management culture in agri-food supply chains
SO SUPPLY CHAIN MANAGEMENT-AN INTERNATIONAL JOURNAL
LA English
DT Article; Early Access
DE Supply chain resilience; Knowledge management; Risk management culture;
   Agri-food supply chains; Empirical
ID DYNAMIC CAPABILITIES; ABSORPTIVE-CAPACITY; ENTREPRENEURIAL THEORY;
   MITIGATION STRATEGIES; METHOD VARIANCE; CO-CREATION; PERFORMANCE;
   DISRUPTIONS; PERSPECTIVE; INNOVATION
AB Purpose Given the increasingly turbulent business landscape and unprecedented incidents (e.g. Covid-19), firms must achieve supply chain resilience (SCRes) as a dynamic capability to bounce back from adversities and ensure continuity of operations. The purpose of this study is to integrate the three interrelated [knowledge management, risk management culture (RMC) and resilience] but often separately discussed concepts to advance the understanding of their intertwined influence on SCRes in the agri-food supply chains. Design/methodology/approach This study uses a cross-sectional survey approach where quantitative data is collected from 349 participants from the Australian agri-food supply chains to test the proposed hypotheses. Findings Exposure to supply chain risks triggers the deployment of specific knowledge management practices in the agri-food supply chains. Further, the analysis on serial mediation suggests that firms' knowledge management practices work sequentially (knowledge acquisition, assimilation and application) and develop a RMC to achieve SCRes amid supply chain risks. Practical implications The findings of this study inform practitioners and policymakers who seek to understand the key mechanisms that facilitate the development of SCRes when facing supply chain risks, particularly in the Australian agri-food supply chains. Social implications The growth of the food industry through more resilient food supply chains could ensure sustained food supply and more employment opportunities. Originality/value Using dynamic capability theory, the authors devise a novel empirical model that explicates how knowledge management practices and RMC instigate the dynamic capability of SCRes amid supply chain risks facing agri-food supply chains.
C1 [Ali, Imran] Cent Queensland Univ, Sch Business & Law, Melbourne Campus, Melbourne, Vic, Australia.
   [Golgeci, Ismail] Aarhus Univ, Sch Business & Social Sci, Dept Business Dev & Technol, Herning, Denmark.
   [Arslan, Ahmad] Oulun Yliopisto, Dept Mkt Management & Int Business, Oulu, Finland.
RP Golgeci, I (corresponding author), Aarhus Univ, Sch Business & Social Sci, Dept Business Dev & Technol, Herning, Denmark.
EM i.golgeci@btech.au.dk
RI Ali, Imran/O-5404-2019
OI Ali, Imran/0000-0002-8912-5760
CR Aarikka-Stenroos L, 2012, IND MARKET MANAG, V41, P15, DOI 10.1016/j.indmarman.2011.11.008
   Aitken J, 2016, INT J LOGIST MANAG, V27, P188, DOI 10.1108/IJLM-03-2014-0047
   Ali I, 2021, IEEE T ENG MANAGE, DOI 10.1109/TEM.2021.3088518
   Ali I, 2021, PROD PLAN CONTROL, DOI 10.1080/09537287.2021.1988177
   Ali I, 2021, SUPPLY CHAIN MANAG, V26, P1, DOI 10.1108/SCM-03-2020-0124
   Ali I, 2019, INT J PHYS DISTR LOG, V49, P793, DOI 10.1108/IJPDLM-02-2019-0038
   Ali I, 2018, INT J LOGIST MANAG, V29, P922, DOI 10.1108/IJLM-06-2017-0147
   Ali I, 2017, PROD PLAN CONTROL, V28, P1236, DOI 10.1080/09537287.2017.1362487
   Ambulkar S, 2016, INT J PROD RES, V54, P1398, DOI 10.1080/00207543.2015.1070972
   Ambulkar S, 2015, J OPER MANAG, V33-34, P111, DOI 10.1016/j.jom.2014.11.002
   Andersson, 2020, TRANSNATIONAL CORPOR, V27, P127, DOI DOI 10.18356/99B1410F-EN
   ARMSTRONG JS, 1977, J MARKETING RES, V14, P396, DOI 10.2307/3150783
   Ates A, 2011, INT J PROD RES, V49, P5601, DOI 10.1080/00207543.2011.563825
   Bag S, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03790-7
   Bakshi N., 2007, RISK MANAGEMENT DECI
   Barbosa MW, 2021, GLOB FOOD SECUR-AGR, V28, DOI 10.1016/j.gfs.2021.100517
   Behzadi G., 2017, OMEGA-J DEATH DYING, V79
   Brandon-Jones E, 2014, J SUPPLY CHAIN MANAG, V50, P55, DOI 10.1111/jscm.12050
   Cantor DE, 2014, INT J LOGIST MANAG, V25, P202, DOI 10.1108/IJLM-10-2012-0111
   Cao M, 2010, INT J PROD RES, V48, P6613, DOI 10.1080/00207540903349039
   Chaudhuri A, 2020, INT J LOGIST MANAG, V31, P77, DOI 10.1108/IJLM-11-2018-0289
   Chen J, 2013, INT J PROD RES, V51, P2186, DOI 10.1080/00207543.2012.727490
   Chowdhury MMH, 2016, SUPPLY CHAIN MANAG, V21, P709, DOI 10.1108/SCM-12-2015-0463
   Christopher M., 2004, INT J LOGIST MANAG, V15, P1, DOI [10.1108/09574090410700275, DOI 10.1108/09574090410700275]
   Christopher M, 2011, SUPPLY CHAIN MANAG, V16, P67, DOI 10.1108/13598541111115338
   CHURCHILL GA, 1979, J MARKETING RES, V16, P64, DOI 10.2307/3150876
   Colicchia C, 2012, SUPPLY CHAIN MANAG, V17, P403, DOI 10.1108/13598541211246558
   Craighead CW, 2011, IEEE T ENG MANAGE, V58, P578, DOI 10.1109/TEM.2011.2136437
   Darroch J., 2003, Journal of Knowledge Management, V7, P41, DOI 10.1108/13673270310505377
   Ding MJ, 2014, INT J LOGIST MANAG, V25, P85, DOI 10.1108/IJLM-07-2012-0057
   Do H, 2018, HUM RESOUR MANAGE-US, V57, P1271, DOI 10.1002/hrm.21903
   Donaldson L., 2001, CONTINGENCY THEORY O
   DRAZIN R, 1986, ADMIN SCI QUART, V30, P514
   Dubey R, 2021, INT J PROD RES, V59, P110, DOI 10.1080/00207543.2019.1582820
   Dubey R, 2019, IEEE T ENG MANAGE, V66, P8, DOI 10.1109/TEM.2017.2723042
   Enkel E, 2017, TECHNOVATION, V60-61, P29, DOI 10.1016/j.technovation.2016.08.002
   Ferraris A, 2017, J KNOWL MANAG, V21, P540, DOI 10.1108/JKM-09-2016-0411
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Glover J, 2020, J BUS RES, V121, P33, DOI 10.1016/j.jbusres.2020.06.066
   Golgeci I, 2020, IND MARKET MANAG, V84, P63, DOI 10.1016/j.indmarman.2019.05.006
   Golgeci I, 2013, SUPPLY CHAIN MANAG, V18, P604, DOI 10.1108/SCM-10-2012-0331
   Grant RM, 1996, STRATEGIC MANAGE J, V17, P109, DOI 10.1002/smj.4250171110
   Hair J.F., 2010, MULTIVARIATE DATA AN, V7th
   Handfield R, 2020, SUPPLY CHAIN MANAG, V25, P803, DOI 10.1108/SCM-11-2019-0423
   Harman H.H., 1976, MODERN FACTOR ANAL
   Helfat CE, 2009, STRATEG ORGAN, V7, P91, DOI 10.1177/1476127008100133
   Ho W, 2015, INT J PROD RES, V53, P5031, DOI 10.1080/00207543.2015.1030467
   Hobbs JE, 2020, CAN J AGR ECON, V68, P171, DOI 10.1111/cjag.12237
   HOFER CW, 1975, ACAD MANAGE J, V18, P784, DOI 10.2307/255379
   Hora M, 2013, J OPER MANAG, V31, P52, DOI 10.1016/j.jom.2012.06.004
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Huertas-Valdivia I, 2018, INT J CONTEMP HOSP M, V30, P217, DOI 10.1108/IJCHM-09-2016-0538
   Hult GTM, 2007, STRATEG MANAGE J, V28, P1035, DOI 10.1002/smj.627
   Hult GTM, 2010, DECISION SCI, V41, P435, DOI 10.1111/j.1540-5915.2010.00276.x
   J?ttner U., 2003, INT J LOGIST-RES APP, V6, P197, DOI [10.1080/13675560310001627016, DOI 10.1080/13675560310001627016]
   Jain V, 2017, INT J PROD RES, V55, P6779, DOI 10.1080/00207543.2017.1349947
   Jansen JJP, 2005, ACAD MANAGE J, V48, P999, DOI 10.5465/AMJ.2005.19573106
   Kaufman A, 2000, STRATEGIC MANAGE J, V21, P649, DOI 10.1002/(SICI)1097-0266(200006)21:6<649::AID-SMJ108>3.0.CO;2-U
   Kleindorfer PR, 2005, PROD OPER MANAG, V14, P53, DOI 10.1111/j.1937-5956.2005.tb00009.x
   Kumar A., 2019, MANAGEMENT SCI LETT, V9, P217, DOI 10.5267/j.msl.2018.12.001
   Kumar P, 2021, INT J LOGIST-RES APP, DOI 10.1080/13675567.2021.1908524
   Kumar S, 2020, P I MECH ENG O-J RIS, V234, P246, DOI 10.1177/1748006X19886718
   Kumar V, 2018, SUPPLY CHAIN MANAG, V23, P461, DOI 10.1108/SCM-10-2017-0319
   Leat P, 2013, SUPPLY CHAIN MANAG, V18, P219, DOI 10.1108/13598541311318845
   Li SH, 2006, OMEGA-INT J MANAGE S, V34, P107, DOI 10.1016/j.omega.2004.08.002
   Liu CL, 2018, TRANSPORT RES A-POL, V110, P202, DOI 10.1016/j.tra.2017.02.004
   Lopez C, 2019, J BUS RES, V103, P495, DOI 10.1016/j.jbusres.2017.09.050
   MADOW WG, 1953, ANN MATH STAT, V24, P101, DOI 10.1214/aoms/1177729087
   Manuj I, 2008, J BUS LOGIST, V29, P133, DOI 10.1002/j.2158-1592.2008.tb00072.x
   Manuj I, 2008, INT J PHYS DISTR LOG, V38, P192, DOI 10.1108/09600030810866986
   Mason-Jones R., 1998, OPERATIONS MANAGEMEN, V24, P17
   Massingham P, 2010, J KNOWL MANAG, V14, P464, DOI 10.1108/13673271011050166
   McEvily SK, 2002, STRATEGIC MANAGE J, V23, P285, DOI 10.1002/smj.223
   Mentzer J.T., 1997, J BUS LOGIST, V18, P199
   Moazzam M, 2018, PROD PLAN CONTROL, V29, P1258, DOI 10.1080/09537287.2018.1522847
   Nunnally J.C., 1978, PSYCHOMETRIC THEORY
   Pettit TJ, 2013, J BUS LOGIST, V34, P46, DOI 10.1111/jbl.12009
   PILLING BK, 1994, J BUS RES, V30, P237, DOI 10.1016/0148-2963(94)90054-X
   Pitelis CN, 2010, IND CORP CHANGE, V19, P1247, DOI 10.1093/icc/dtq030
   Ponomarov S.Y., 2012, THESIS U TENNESSEE K
   Ponomarov SY, 2009, INT J LOGIST MANAG, V20, P124, DOI 10.1108/09574090910954873
   Rao S, 2009, INT J LOGIST MANAG, V20, P97, DOI 10.1108/09574090910954864
   Revilla E, 2017, INT J OPER PROD MAN, V37, P557, DOI 10.1108/IJOPM-03-2016-0129
   Ritchie B, 2007, INT J OPER PROD MAN, V27, P303, DOI 10.1108/01443570710725563
   Rodriguez E., 2009, P 2009 ENT RISK MAN
   Roeschmann A.Z., 2014, RISK MANAGEMENT INSU, V17, P277
   Sande JB, 2018, INT J RES MARK, V35, P185, DOI 10.1016/j.ijresmar.2018.01.005
   Schilke O, 2018, ACAD MANAG ANN, V12, P390, DOI 10.5465/annals.2016.0014
   Scholten K, 2014, SUPPLY CHAIN MANAG, V19, P211, DOI 10.1108/SCM-06-2013-0191
   Schweiger SA, 2019, STRATEGIC MANAGE J, V40, P1822, DOI 10.1002/smj.3042
   Sheffi Y, 2005, MIT SLOAN MANAGE REV, V47, P41
   Siddh MM, 2017, IND MANAGE DATA SYST, V117, P2015, DOI 10.1108/IMDS-10-2016-0427
   Talluri S, 2013, J BUS LOGIST, V34, P253, DOI 10.1111/jbl.12025
   Teece DJ, 2007, STRATEGIC MANAGE J, V28, P1319, DOI 10.1002/smj.640
   Teece DJ, 2014, J INT BUS STUD, V45, P8, DOI 10.1057/jibs.2013.54
   Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z
   Teller J, 2013, INT J PROJ MANAG, V31, P817, DOI 10.1016/j.ijproman.2012.11.012
   Tse YK, 2021, J BUS RES, V122, P822, DOI 10.1016/j.jbusres.2020.07.003
   Tse YK, 2019, J BUS RES, V97, P291, DOI 10.1016/j.jbusres.2018.01.029
   Umar M, 2017, SAGE OPEN, V7, DOI 10.1177/2158244017717570
   Upton R., 2000, SUPPLY CHAIN MANAG, V5, P187, DOI DOI 10.1108/13598540010347307
   USDA, 2021, AG FOOD SECT EC USDA
   Wagner S. M., 2006, Journal of Purchasing and Supply Management, V12, P301, DOI 10.1016/j.pursup.2007.01.004
   Wagner SM, 2008, J BUS LOGIST, V29, P307, DOI 10.1002/j.2158-1592.2008.tb00081.x
   Wang E, 2007, INT J PROD RES, V45, P2419, DOI 10.1080/00207540601020437
   Wang XJ, 2017, PROD PLAN CONTROL, V28, P1023, DOI 10.1080/09537287.2017.1329562
   Williams LJ, 2010, ORGAN RES METHODS, V13, P477, DOI 10.1177/1094428110366036
   World Bank, 2021, AGR FOR FISH VAL ADD
   Xie XM, 2018, J BUS RES, V88, P289, DOI 10.1016/j.jbusres.2018.01.019
   Yeniyurt S, 2005, INT BUS REV, V14, P1, DOI 10.1016/j.ibusrev.2004.10.002
   Zahra SA, 2002, ACAD MANAGE REV, V27, P185, DOI 10.2307/4134351
   Zhang M, 2015, INT J OPER PROD MAN, V35, P1275, DOI 10.1108/IJOPM-03-2015-0120
   Zhao XF, 2021, INT J PROD ECON, V231, DOI 10.1016/j.ijpe.2020.107832
   Zhong R, 2017, IND MANAGE DATA SYST, V117, P2085, DOI 10.1108/IMDS-09-2016-0391
   Zsidisin G. A., 2004, International Journal of Physical Distribution & Logistics Management, V34, P397, DOI 10.1108/09600030410545445
   Zsidisin G.A., 2005, SUPPLY CHAIN MANAGEM, V9, P46
   Zsidisin GA, 2005, INT J PROD RES, V43, P3401, DOI [10.1080/00207540500095613, 10.1080/0020754000095613]
   Zsidisin GA., 2003, J SUPPLY CHAIN MANAG, V39, P14, DOI DOI 10.1111/JSCM.2003.39.ISSUE-1
   Zsidisin GA, 2010, J BUS LOGIST, V31, P1, DOI 10.1002/j.2158-1592.2010.tb00140.x
NR 119
TC 1
Z9 1
U1 30
U2 30
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1359-8546
EI 1758-6852
J9 SUPPLY CHAIN MANAG
JI Supply Chain Manag.
DI 10.1108/SCM-02-2021-0059
EA DEC 2021
PG 16
WC Business; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA XZ6ZB
UT WOS:000737797100001
OA Green Accepted
DA 2022-04-20
ER

PT J
AU Khan, MN
   Ashraf, MA
   Seinen, D
   Khan, KU
   Laar, RA
AF Khan, Muhammad Naeem
   Ashraf, Muhammad Azeem
   Seinen, Donald
   Khan, Kashif Ullah
   Laar, Rizwan Ahmed
TI Social Media for Knowledge Acquisition and Dissemination: The Impact of
   the COVID-19 Pandemic on Collaborative Learning Driven Social Media
   Adoption
SO FRONTIERS IN PSYCHOLOGY
LA English
DT Article
DE collaborative learning; COVID-19; electronic-learning; social
   networking; student community; TAM
ID TECHNOLOGY ACCEPTANCE MODEL; PARTIAL LEAST-SQUARES; HIGHER-EDUCATION;
   USER ACCEPTANCE; PERCEIVED EASE; INFORMATION-TECHNOLOGY; COGNITIVE
   ABSORPTION; RESEARCH AGENDA; STUDENTS; USAGE
AB During the COVID-19 outbreak, educational institutions were closed, and students worldwide were confined to their homes. In an educational environment, students depend on collaborative learning (CL) to improve their learning performance. This study aimed to increase the understanding of social media adoption among students during the COVID-19 pandemic for the purpose of CL. Social media provides a learning platform that enables students to easily communicate with their peers and subject specialists, and is conducive to students' CL. This study addresses the key concept of CL during the COVID-19 pandemic by assessing social media use among students in higher education. The relationship between social media use and students' performance is crucial to understanding the role of social media during a pandemic. This study is based on constructivism theory and the technology acceptance model. Structural equation modeling was used to analyze the conceptual model using SmartPLS. The research findings indicate that social media plays an important role during the pandemic because it provides opportunities for students to enhance CL under the aforementioned situations. This study makes noteworthy theoretical and practical contributions.
C1 [Khan, Muhammad Naeem] Nanjing Univ, Sch Social & Behav Sci, Nanjing, Peoples R China.
   [Ashraf, Muhammad Azeem] Hunan Univ, Res Inst Educ Sci, Changsha, Peoples R China.
   [Seinen, Donald] Nanjing Univ, Sch Informat Management, Nanjing, Peoples R China.
   [Khan, Kashif Ullah] Ghulam Ishaq Khan Inst Engn Sci & Technol, Sch Management Sci, Swabi, Pakistan.
   [Laar, Rizwan Ahmed] Nanjing Normal Univ, Sch Sports Sci & Phys Educ, Nanjing, Peoples R China.
RP Ashraf, MA (corresponding author), Hunan Univ, Res Inst Educ Sci, Changsha, Peoples R China.
EM azeem20037@gmail.com
RI Ashraf, Muhammad Azeem/I-4114-2017; Khan, Kashif Ullah/AAK-4421-2020
OI Ashraf, Muhammad Azeem/0000-0003-0133-4056; Khan, Kashif
   Ullah/0000-0002-0604-3103; Khan, Muhammad Naeem/0000-0001-6212-8737
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [71950410624]
FX The authors disclose receipt of the following financial support for the
   research, authorship, and/or publication of this article: this study was
   funded by the National Natural Science Foundation of China (Grant No.:
   71950410624).
CR Abi-Rafeh J, 2020, J PLAST RECONSTR AES, V73, P1580, DOI 10.1016/j.bjps.2020.05.085
   Abi-Rafeh J, 2019, PRS-GLOB OPEN, V7, DOI 10.1097/GOX.0000000000002319
   Adnan, 2020, J PEDAGOGICAL SOCIOL, V1, P45, DOI [10.33902/jpsp.2020261309, DOI 10.33902/JPSP.2020261309]
   Agarwal R, 2000, MIS QUART, V24, P665, DOI 10.2307/3250951
   Al-Bahrani A, 2015, INT REV ECON EDUC, V19, P36, DOI 10.1016/j.iree.2015.06.001
   Al-Rahmi WM, 2020, INTERACT LEARN ENVIR, DOI 10.1080/10494820.2020.1728342
   Al-Rahmi WM, 2018, COMPUT EDUC, V121, P59, DOI 10.1016/j.compedu.2018.02.010
   Al-Shihi H, 2018, EDUC INF TECHNOL, V23, P1805, DOI 10.1007/s10639-018-9691-9
   Alamri MM, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12166471
   Alenazy WM, 2019, IEEE ACCESS, V7, P71550, DOI 10.1109/ACCESS.2019.2920242
   Almaiah MA, 2020, EDUC INF TECHNOL, V25, P5261, DOI 10.1007/s10639-020-10219-y
   Almaiah MA, 2019, EDUC INF TECHNOL, V24, P885, DOI 10.1007/s10639-018-9810-7
   Almaiah MA, 2016, J COMPUT EDUC, V3, P453, DOI 10.1007/s40692-016-0074-1
   Althunibat A, 2015, COMPUT HUM BEHAV, V52, P65, DOI 10.1016/j.chb.2015.05.046
   Ansari JAN, 2020, SMART LEARN ENVIRON, V7, DOI 10.1186/s40561-020-00118-7
   Arshad M, 2018, INT REV RES OPEN DIS, V19, P243
   Sanchez RA, 2014, COMPUT EDUC, V70, P138, DOI 10.1016/j.compedu.2013.08.012
   Bai J, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.568492
   Becker JM, 2015, MARKET LETT, V26, P643, DOI 10.1007/s11002-014-9299-9
   Benitez J, 2020, INFORM MANAGE-AMSTER, V57, DOI 10.1016/j.im.2019.05.003
   Berger P, 2017, TEACH TEACH EDUC, V67, P410, DOI 10.1016/j.tate.2017.07.009
   Berkani L, 2020, SOFTWARE PRACT EXPER, V50, P1498, DOI 10.1002/spe.2828
   Bernard R.M., 2000, J DISTANCE ED, V21, P260, DOI DOI 10.1080/0158791000210205
   Bhattacherjee A, 2001, MIS QUART, V25, P351, DOI 10.2307/3250921
   Brown J. S., 1989, EDUC RESEARCHER, V18, P32, DOI [10.3102/0013189X018001032, DOI 10.3102/0013189X018001032]
   Cao YX, 2011, HORIZON, V19, P297, DOI 10.1108/10748121111179420
   Chan AKM, 2020, ANAESTHESIA, V75, P1579, DOI 10.1111/anae.15057
   Chandra C.P., 2015, IBUSS MANAG, V3, P423
   Cheng YM, 2012, INTERNET RES, V22, P361, DOI 10.1108/10662241211235699
   Chin WW, 2003, INFORM SYST RES, V14, P189, DOI 10.1287/isre.14.2.189.16018
   DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008
   DeLone WH, 2003, J MANAGE INFORM SYST, V19, P9, DOI 10.1080/07421222.2003.11045748
   Dijkstra TK, 2015, MIS QUART, V39, P297, DOI 10.25300/MISQ/2015/39.2.02
   Dwivedi YK, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102211
   Ebner M., 2009, J RES INNOVATIVE TEA, V2, P91
   Esam N. M., 2016, RES HUB, V2, P16
   Fishbein M., 1975, BELIEF ATTITUDE INTE
   Forkosh-Baruch A, 2012, INTERNET HIGH EDUC, V15, P58, DOI 10.1016/j.iheduc.2011.08.003
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Golub J., 1988, FOCUS COLLABORATIVE
   Greenhow C, 2020, INFORM LEARN SCI, V121, P341, DOI 10.1108/ILS-04-2020-0134
   Gunasagaran Sujatavani, 2019, IOP Conference Series: Materials Science and Engineering, V636, DOI 10.1088/1757-899X/636/1/012015
   Hair J, 2017, IND MANAGE DATA SYST, V117, P442, DOI 10.1108/IMDS-04-2016-0130
   Hair JF, 2019, EUR J MARKETING, V53, P566, DOI 10.1108/EJM-10-2018-0665
   Henseler J., 2016, PARTIAL LEAST SQUARE, P19
   Holmes R, 2020, IS COVID 19 SOCIAL M
   Islam AKMN, 2020, TECHNOL FORECAST SOC, V159, DOI 10.1016/j.techfore.2020.120201
   Kannan VR, 2005, OMEGA-INT J MANAGE S, V33, P153, DOI 10.1016/j.omega.2004.03.012
   Karasneh R, 2021, RES SOC ADMIN PHARM, V17, P1897, DOI 10.1016/j.sapharm.2020.04.027
   Khan S, 2020, J MED VIROL, V92, P824, DOI 10.1002/jmv.25814
   Khan TM, 2021, INT J PHARM PRACT, V29, P90, DOI 10.1111/ijpp.12659
   Koenig-Lewis N, 2015, SERV IND J, V35, P537, DOI 10.1080/02642069.2015.1043278
   Koh E, 2012, COMPUT EDUC, V59, P481, DOI 10.1016/j.compedu.2012.02.002
   Krishnamurthy S, 2020, J BUS RES, V117, P1, DOI 10.1016/j.jbusres.2020.05.034
   Ku HY, 2013, COMPUT HUM BEHAV, V29, P922, DOI 10.1016/j.chb.2012.12.019
   Laato S, 2020, MULTIMODAL TECHNOLOG, V4, DOI 10.3390/mti4020029
   Lee MKO, 2005, INFORM MANAGE-AMSTER, V42, P1095, DOI 10.1016/j.im.2003.10.007
   Li CH, 2020, ACAD RADIOL, V27, P872, DOI 10.1016/j.acra.2020.04.028
   Liao YW, 2015, COMPUT HUM BEHAV, V43, P313, DOI 10.1016/j.chb.2014.10.028
   Lin Meng-Hsien, 2019, Front Psychol, V10, P2664, DOI 10.3389/fpsyg.2019.02664
   Liu CC, 2011, COMPUT EDUC, V57, P1544, DOI 10.1016/j.compedu.2011.02.002
   Luo MM, 2020, COMPUT EDUC, V154, DOI 10.1016/j.compedu.2020.103920
   Madhav N., 2017, PANDEMICS RISKS IMPA, V9
   MASON CH, 1991, J MARKETING RES, V28, P268, DOI 10.2307/3172863
   Mazer JP, 2007, COMMUN EDUC, V56, P1, DOI 10.1080/03634520601009710
   Mazman SG, 2010, COMPUT EDUC, V55, P444, DOI 10.1016/j.compedu.2010.02.008
   McMurtrie B., 2020, CHRON HIGHER EDUC, V66
   Merle P, 2016, J RES INTERACT MARK, V10, P124, DOI 10.1108/JRIM-01-2015-0008
   Molinillo S, 2018, COMPUT EDUC, V123, P41, DOI 10.1016/j.compedu.2018.04.012
   Paul R., 2005, MINIATURE GUIDE PRAC
   Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Pulido CM, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00135
   Qi C, 2019, J EDUC COMPUT RES, V57, P385, DOI 10.1177/0735633117751604
   Rahman S, 2020, HIGH EDUC Q, V74, P304, DOI 10.1111/hequ.12228
   Ramsha J., 2020, DAWN
   Rau PLP, 2008, COMPUT HUM BEHAV, V24, P2757, DOI 10.1016/j.chb.2008.04.001
   Rauniar R, 2014, J ENTERP INF MANAG, V27, P6, DOI 10.1108/JEIM-04-2012-0011
   Reid D., 2010, EDMEDIA INNOVATE LEA, P1117
   Pinho JCMR, 2011, J RES INTERACT MARK, V5, P116, DOI 10.1108/17505931111187767
   Saade R, 2005, INFORM MANAGE-AMSTER, V42, P317, DOI 10.1016/j.im.2003.12.013
   Sarstedt M., 2016, PRIMER PARTIAL LEAST
   Sarwar B, 2019, J EDUC COMPUT RES, V57, P246, DOI 10.1177/0735633117748415
   Sobaih AE, 2016, COMPUT HUM BEHAV, V58, P296, DOI 10.1016/j.chb.2016.01.002
   Sugimoto C., 2015, 1 MONDAY, V20, DOI [10.5210/fm.v20i3.5387, DOI 10.5210/FM.V20I3.5387]
   Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1
   Tam M., 2000, ED TECHNOLOGY SOC, V3, P50
   Tess PA, 2013, COMPUT HUM BEHAV, V29, pA60, DOI 10.1016/j.chb.2012.12.032
   United Nations Educational Scientific and Cultural Organization (UNESCO), 2020, COVID 19 ED DISR RES
   Valaei N, 2017, J BUS RES, V70, P224, DOI 10.1016/j.jbusres.2016.08.016
   van der Heijden H, 2004, MIS QUART, V28, P695, DOI 10.2307/25148660
   van der Heijden H, 2003, EUR J INFORM SYST, V12, P41, DOI 10.1057/palgrave.ejis.3000445
   van Riel ACR, 2017, IND MANAGE DATA SYST, V117, P459, DOI 10.1108/IMDS-07-2016-0286
   Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926
   Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540
   Venkatesh V, 2000, INFORM SYST RES, V11, P342, DOI 10.1287/isre.11.4.342.11872
   Venkatesh V, 2008, DECISION SCI, V39, P273, DOI 10.1111/j.1540-5915.2008.00192.x
   Venkatesh V, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102197
   Vordos N, 2020, SAFETY SCI, V130, DOI 10.1016/j.ssci.2020.104870
   Vygotsky L.S., 1978, MIND SOC DEV HIGHER
   Wang QY, 2010, COMPUT EDUC, V55, P1270, DOI 10.1016/j.compedu.2010.05.023
   Williams DL, 2012, J PUBLIC AFF, V12, P127, DOI 10.1002/pa.1414
   World Health Organization, 2021, WHO COR COVID 19 DAS
   Wu JH, 2007, COMPUT HUM BEHAV, V23, P162, DOI 10.1016/j.chb.2004.04.003
NR 104
TC 3
Z9 3
U1 8
U2 12
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-1078
J9 FRONT PSYCHOL
JI Front. Psychol.
PD MAY 31
PY 2021
VL 12
AR 648253
DI 10.3389/fpsyg.2021.648253
PG 13
WC Psychology, Multidisciplinary
WE Social Science Citation Index (SSCI)
SC Psychology
GA SR5PP
UT WOS:000661094500001
PM 34135814
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Tay, KH
   Ooi, CC
   Bin Mahmood, MI
   Aw, LP
   Chan, LP
   Ng, DCE
   Tan, BS
AF Tay, Kiang Hiong
   Ooi, Chin Chin
   Bin Mahmood, Muhammad Illyyas
   Aw, Lian Ping
   Chan, Lai Peng
   Ng, David Chee Eng
   Tan, Bien Soo
TI Reconfiguring the radiology leadership team for crisis management during
   the COVID-19 pandemic in a large tertiary hospital in Singapore
SO EUROPEAN RADIOLOGY
LA English
DT Article
DE COVID-19; Coronavirus; Disease outbreaks; Radiology; Leadership;
   Pandemics
AB The coronavirus 2019 (COVID-19) outbreak poses a serious public health risk. To date, the disease has affected almost all countries in the world. The enormous scale of the outbreak and the relative lack of knowledge and information regarding a new virus, as well as the unpredictability of events, make it challenging for leadership teams to respond. This paper shares how we have reconfigured our radiology leadership team into a smaller disease outbreak task force (DOTF) to respond and coordinate all related efforts during this ongoing COVID-19 pandemic. The DOTF format is modelled after the military with domain groups looking at manpower, intelligence, operations, and logistics matters on a daily basis so that timely decisions can be made and action plans executed promptly. In managing the DOTF, discipline, flexibility, and teamwork are key principles, and these are built upon a strong foundation of focus on infection prevention and control, and patient and staff safety as well as staff well-being. The DOTF has positioned us well to confront the many challenges to date. We believe it will also help us navigate the complex issues that will arise with future surges in cases and in formulating strategies to manage exit from the present and future lockdowns.
C1 [Tay, Kiang Hiong; Tan, Bien Soo] Singapore Gen Hosp, Dept Vasc & Intervent Radiol, Div Radiol Sci, Block 2 Level 1,Outram Rd, Singapore 169608, Singapore.
   [Tay, Kiang Hiong; Ooi, Chin Chin; Chan, Lai Peng; Ng, David Chee Eng; Tan, Bien Soo] Duke NUS Med Sch, 8 Coll Rd, Singapore 169857, Singapore.
   [Ooi, Chin Chin; Bin Mahmood, Muhammad Illyyas; Aw, Lian Ping] Singapore Gen Hosp, Div Radiol Sci, Radiog Unit, Outram Rd, Singapore 169608, Singapore.
   [Chan, Lai Peng] Singapore Gen Hosp, Dept Nucl Med & Mol Imaging, Div Radiol Sci, Outram Rd, Singapore 169608, Singapore.
   [Ng, David Chee Eng] Singapore Gen Hosp, Dept Diagnost Radiol, Div Radiol Sci, Outram Rd, Singapore 169608, Singapore.
RP Tay, KH (corresponding author), Singapore Gen Hosp, Dept Vasc & Intervent Radiol, Div Radiol Sci, Block 2 Level 1,Outram Rd, Singapore 169608, Singapore.; Tay, KH (corresponding author), Duke NUS Med Sch, 8 Coll Rd, Singapore 169857, Singapore.
EM tay.kiang.hiong@singhealth.com.sg
OI Chan, Lai Peng/0000-0002-3971-3476
CR Chen RC, 2020, EUR RADIOL, V30, P4964, DOI 10.1007/s00330-020-06862-1
   Chen RC, 2020, J AM COLL RADIOL, V17, P739, DOI 10.1016/j.jacr.2020.04.019
   Cheng LTE, 2020, AM J ROENTGENOL, V214, P1206, DOI 10.2214/AJR.20.22927
   Da Zhuang K, 2020, CARDIOVASC INTER RAD, V43, P665, DOI 10.1007/s00270-020-02440-6
   Gogna A, 2014, AM J ROENTGENOL, V203, P746, DOI 10.2214/AJR.14.13062
   Gutzeit A, 2020, EUR RADIOL, V30, P3609, DOI 10.1007/s00330-020-06841-6
   Kim H, 2020, EUR RADIOL, V30, P3266, DOI 10.1007/s00330-020-06748-2
   Koh D, 2018, OCCUP ENVIRON MED, V75, pA14
   Lexa Frank James, 2009, J Am Coll Radiol, V6, P671, DOI 10.1016/j.jacr.2009.06.023
   Lexa Frank James, 2009, J Am Coll Radiol, V6, P521, DOI 10.1016/j.jacr.2009.03.012
   Mossa-Basha M, 2020, RADIOLOGY, V296, pE106, DOI 10.1148/radiol.2020200988
   Revel MP, 2020, EUR RADIOL, V30, P4903, DOI 10.1007/s00330-020-06865-y
   Singapore Ministry of Health (MOH), DAIL SIT REP
   Singapore Ministry of Health (MOH), 2004, MOH PAND READ RESP P
   Tan Bien Peng, 2020, Radiol Cardiothorac Imaging, V2, pe200140, DOI 10.1148/ryct.2020200140
   Too CW, 2020, CARDIOVASC INTER RAD, V43, P827, DOI 10.1007/s00270-020-02483-9
   Tsou IYY, 2020, CLIN RADIOL, V75, P415, DOI 10.1016/j.crad.2020.03.028
   VanVactor Jerry D, 2010, J Bus Contin Emer Plan, V4, P97
   Wong JEL, 2020, JAMA-J AM MED ASSOC, V323, P1243, DOI 10.1001/jama.2020.2467
NR 19
TC 6
Z9 6
U1 2
U2 8
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0938-7994
EI 1432-1084
J9 EUR RADIOL
JI Eur. Radiol.
PD JAN
PY 2021
VL 31
IS 1
BP 468
EP 474
DI 10.1007/s00330-020-07116-w
EA AUG 2020
PG 7
WC Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Radiology, Nuclear Medicine & Medical Imaging
GA PI7EM
UT WOS:000559630300001
PM 32780206
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Dobrucali, E
   Sadikoglu, E
   Demirkesen, S
   Zhang, CY
   Tezel, A
AF Dobrucali, Esra
   Sadikoglu, Emel
   Demirkesen, Sevilay
   Zhang, Chengyi
   Tezel, Algan
TI Exploring the Impact of COVID-19 on the United States Construction
   Industry: Challenges and Opportunities
SO IEEE TRANSACTIONS ON ENGINEERING MANAGEMENT
LA English
DT Article; Early Access
DE COVID-19; Construction industry; Pandemics; Industries; Companies;
   Interviews; Uncertainty; Challenges; construction; COVID-19;
   oppor-tunities; pandemic; principal component analysis (PCA)
AB The construction industry is one of the leading industries in the economy of any country. However, the industry is vulnerable to changes and uncertainties, either external or internal, due to its fragmented and dynamic nature. Coronavirus disease (COVID-19), which first emerged in Wuhan, China in 2019, is considered a pandemic by the World Health Organization (WHO). COVID-19 has quickly spread all over the world resulting in significant social and economic consequences. The main objective of the study is to determine the challenges and opportunities due to the pandemic in the construction industry and to categorize them. Through a review of the existing literature and interviews with construction experts, the challenges and opportunities arising from the COVID-19 pandemic were listed. A questionnaire survey was designed to evaluate them. The principal component analysis (PCA) was utilized to group the identified challenges and opportunities. PCA was conducted with SPSS Version 25.0 software. The most critical challenges of the pandemic were determined as "the requirement of COVID-19 protocols," "restriction on movement and travel," "additional safety equipment use," where the most important opportunities were found as "hygiene programs," "use of technological tools effectively," and "BIM-enabled construction." The research contributes to the body of knowledge in terms of making construction practitioners beware of the main challenges and opportunities along with leading them to act toward change and uncertainty. This study further provides general guidelines and implications for practitioners and policymakers in case of similar outbreaks.
C1 [Dobrucali, Esra] Sakarya Univ, Dept Civil Engn, TR-54050 Sakarya, Turkey.
   [Sadikoglu, Emel; Demirkesen, Sevilay] Gebze Tech Univ, Dept Civil Engn, TR-41400 Gebze, Turkey.
   [Zhang, Chengyi] Univ Wyoming, Dept Civil & Architectural Engn, Laramie, WY 82071 USA.
   [Tezel, Algan] Aston Univ, Dept Construct Management & Engn, Birmingham B4 7ET, W Midlands, England.
RP Demirkesen, S (corresponding author), Gebze Tech Univ, Dept Civil Engn, TR-41400 Gebze, Turkey.
EM eeken@sakarya.edu.tr; esadikoglu@gtu.edu.tr; demirkesen@gtu.edu.tr;
   chengyi.zhang@uwyo.edu; a.tezel@aston.ac.uk
OI Tezel, Algan/0000-0003-3903-6126
CR Abowitz DA, 2010, J CONSTR ENG M, V136, P108, DOI 10.1061/(ASCE)CO.1943-7862.0000026
   AECOM, 2020, LAYING FDN NEW FUT O
   Alsharef A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041559
   Amoah C, 2021, J FACIL MANAG, V19, P111, DOI 10.1108/JFM-08-2020-0061
   [Anonymous], 2015, GLOBAL FORECAST CONS
   Anwar S., 2020, KARDAN J EC MANAGE S, V3, P68
   Araya F, 2021, SAFETY SCI, V133, DOI 10.1016/j.ssci.2020.105022
   Associated General Contractors of America, 2020, 2020 WORKF SURV RES
   Biorck J., 2020, CONSTRUCTION CAN EME
   Biswas A., 2021, J PHYS C SER, V1797
   Bohannon E. G., 2020, EFFECTS COVID 19 COM
   Bsisu K. A. D., 2020, INT J ENG RES TECH, V13, P828
   Bureau of Economic Analysis (BEA), 2021, VAL ADD IND PERC GRO
   Centers for Disease Control and Prevention (CDC), 2022, CDC MUS COVID 19 TIM
   Choi S. D., 2021, IND SYST ENG REV, V9, P56
   D'Alessandro Daniela, 2020, Acta Biomed, V91, P61, DOI 10.23750/abm.v91i9-S.10115
   Denny-Smith G, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13020988
   Ebekozien A, 2021, INT J CONSTR MANAG, DOI 10.1080/15623599.2021.1973184
   Ebekozien A, 2021, SUSTAIN CITIES SOC, V69, DOI 10.1016/j.scs.2021.102803
   Emmett T., 2020, COVID 19 IMPACT AUST
   Fairlie R, 2020, J ECON MANAGE STRAT, V29, P727, DOI 10.1111/jems.12400
   Fernandes N., 2020, SSRN ELECT J
   Gamil Y., 2020, MEDITERRANEAN J SOCI, V11, P122, DOI 10.36941/mjss-2020-0047
   Hair JF., 2009, MULTIVARIATE DATA AN
   Hollingsworth J., 2020, PROFESSIONAL SAF, V65, P32
   International Labour Organization (ILO), 2021, IMP COVID 19 CONSTR
   Iqbal M, 2021, BRAZ J OPER PROD MAN, V18, DOI 10.14488/BJOPM.2021.034
   Jallow H, 2021, SMART SUSTAIN BUILT, V10, P581, DOI 10.1108/SASBE-05-2020-0068
   Jeon J., 2021, J MANAGE ENG, V38
   Jones K., 2020, SHOULD ALL CONSTRUCT
   Kabiru J. M., 2020, INT J SCI ENG SCI, V4, P34
   King S. S., 2021, IOP Conference Series: Earth and Environmental Science, V682, DOI 10.1088/1755-1315/682/1/012047
   Kleinbaum D.G., 2013, APPL REGRESSION ANAL
   Lan FY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233588
   Litwin M., 1995, MEASURE SURVEY RELIA
   Majumder S., 2021, LECT NOTES DATA ENG, V60, P115
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Markus KA, 2012, STRUCT EQU MODELING, V19, P509, DOI 10.1080/10705511.2012.687667
   Megahed NA, 2020, SUSTAIN CITIES SOC, V61, DOI 10.1016/j.scs.2020.102350
   Minnullina A., 2020, IOP Conference Series: Materials Science and Engineering, V918, DOI 10.1088/1757-899X/918/1/012200
   Occupational Health and Safety Administration (OSHA), 2021, COVID 19 GUID CONSTR
   Ogunnusi M, 2020, INT J REAL ESTATE ST, V14
   Ogunnusi M, 2022, J ENG DES TECHNOL, V20, P299, DOI 10.1108/JEDT-05-2021-0286
   Our World in Data, 2022, CAS FAT RAT VS TOT C
   Pamidimukkala A., 2021, PROJ LEADERSH SOC, V2, DOI DOI 10.1016/J.PLAS.2021.100018
   Pasco R., 2020, COVID19 AUSTIN TEXAS
   Quezon E. T., 2021, GLOB J ENG TECHNOL A, V6, P74
   Rajabi S., 2020, INT J IND SYST ENG, V14, P1053
   Raoufi M, 2021, PUBLIC WORKS MANAG P, V26, P47, DOI 10.1177/1087724X20969164
   Rehman MSU, 2021, J ENG DES TECHNOL, DOI 10.1108/JEDT-12-2020-0481
   Salami BA, 2021, INT J CONSTR MANAG, DOI 10.1080/15623599.2021.1963561
   Schwab O., 2018, FUTURE SCENARIOS IMP
   Scott V., 2020, REBUILDING CUSTOMER
   Sihombing L. B., 2020, P IPMA RES C
   Stiles S, 2021, HUM FACTOR ERGON MAN, V31, P425, DOI 10.1002/hfm.20882
   Stoller JK, 2020, BMJ LEAD, V4, P77, DOI 10.1136/leader-2020-000244
   Stride M., 2020, COV0118 IMP COR BUS
   Tabachnick B.G., 2007, USING MULTIVARIATE S, P481
   Thompson B., 2004, EXPLORATORY CONFIRMA
   Turner Construction Company, 2022, TURN BUILD COST IND
   U.S. Bureau of Labor Statistics, 2022, EMPL HOURS EARN CURR
   United States Census Bureau, 2022, CONSTR SPEND
   Verikios G, 2020, SOCIO-ECON PLAN SCI, V71, DOI 10.1016/j.seps.2020.100898
   Whiting -Turner, 2020, IMP INF OUR CLIENTS
   Worldometer, 2022, REP CAS DEATHS COUNT
NR 65
TC 0
Z9 0
U1 4
U2 4
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0018-9391
EI 1558-0040
J9 IEEE T ENG MANAGE
JI IEEE Trans. Eng. Manage.
DI 10.1109/TEM.2022.3155055
EA MAR 2022
PG 13
WC Business; Engineering, Industrial; Management
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Business & Economics; Engineering
GA ZZ4IY
UT WOS:000773235900001
DA 2022-04-20
ER

PT J
AU Lou, NM
   Montreuil, T
   Feldman, LS
   Fried, GM
   Lavoie-Tremblay, M
   Bhanji, F
   Kennedy, H
   Kaneva, P
   Drouin, S
   Harley, JM
AF Lou, Nigel Mantou
   Montreuil, Tina
   Feldman, Liane S.
   Fried, Gerald M.
   Lavoie-Tremblay, Melanie
   Bhanji, Farhan
   Kennedy, Heather
   Kaneva, Pepa
   Drouin, Susan
   Harley, Jason M.
TI Evaluations of Healthcare Providers' Perceived Support From Personal,
   Hospital, and System Resources: Implications for Well-Being and
   Management in Healthcare in Montreal, Quebec, During COVID-19
SO EVALUATION & THE HEALTH PROFESSIONS
LA English
DT Article
DE healthcare provider; support; stress; resources; COVID-19
ID BURNOUT; PHYSICIANS; STRESSORS; VALIDITY; WORKERS
AB Increased stressful experiences are pervasive among healthcare providers (HCPs) during the COVID-19 pandemic. Identifying resources that help mitigate stress is critical to maintaining HCPs' well-being. However, to our knowledge, no instrument has systematically examined how different levels of resources help HCPs cope with stress during COVID-19. This cross-sectional study involved 119 HCPs (64 nurses and 55 physicians) and evaluated the perceived availability, utilization, and helpfulness of a list of personal, hospital, and healthcare system resources. Participants also reported on their level of burnout, psychological distress, and intentions to quit. Results revealed that HCPs perceived the most useful personal resource to be family support; the most useful hospital resources were a safe environment, personal protective equipment, and support from colleagues; the most useful system resources were job protection, and clear communication and information about COVID. Moreover, HCPs who perceived having more available hospital resources also reported lower levels of psychological distress symptoms, burnout, and intentions to quit. Finally, although training and counseling services were perceived as useful to reduce stress, training was not perceived as widely available, and counseling services, though reported as being available, were underutilized. This instrument helps identify resources that support HCPs, providing implications for healthcare management.
C1 [Lou, Nigel Mantou; Montreuil, Tina; Harley, Jason M.] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada.
   [Montreuil, Tina; Kennedy, Heather; Harley, Jason M.] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada.
   [Montreuil, Tina] McGill Univ, Dept Psychiat, Montreal, PQ, Canada.
   [Feldman, Liane S.; Fried, Gerald M.; Harley, Jason M.] McGill Univ, Dept Surg, Fac Med & Hlth Sci, Montreal, PQ, Canada.
   [Feldman, Liane S.; Kaneva, Pepa] McGill Univ, Steinberg Bernstein Ctr Minimally Invas Surg, Montreal, PQ, Canada.
   [Fried, Gerald M.; Bhanji, Farhan; Harley, Jason M.] McGill Univ, Steinberg Ctr Simulat & Interact Learning, Montreal, PQ, Canada.
   [Fried, Gerald M.; Bhanji, Farhan; Harley, Jason M.] Inst Hlth Sci Educ, Montreal, PQ, Canada.
   [Lavoie-Tremblay, Melanie; Bhanji, Farhan] McGill Univ, Dept Pediat, Fac Med & Hlth Sci, Montreal, PQ, Canada.
   [Drouin, Susan] McGill Univ, Ingram Sch Nursing, Montreal, PQ, Canada.
RP Harley, JM (corresponding author), McGill Univ, Dept Surg, Fac Med & Hlth Sci, Montreal Gen Hosp, 1650 Cedar Ave,R1-112, Montreal, PQ H3G 1A4, Canada.
EM jason.harley@mcgill.ca
RI Lou, Nigel Mantou/ABI-4983-2020
OI Lou, Nigel Mantou/0000-0003-1363-833X; Fried, Gerald/0000-0001-6434-0555
FU McGill Interdisciplinary Initiative in Infection and Immunity (MI4)
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: This project
   was supported by the McGill Interdisciplinary Initiative in Infection
   and Immunity (MI4).
CR Beneria A, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02427-4
   Chan AOM, 2004, OCCUP MED-OXFORD, V54, P190, DOI 10.1093/occmed/kqh027
   Coffey S., 2007, CAN J COMMUN MENT HL, V25, P89, DOI [10.7870/, DOI 10.7870/]
   Dzau VJ, 2020, NEW ENGL J MED, V383, P513, DOI 10.1056/NEJMp2011027
   Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657
   Hu YY, 2012, ARCH SURG-CHICAGO, V147, P212, DOI 10.1001/archsurg.2011.312
   Kennedy H., J CONTIN EDUC HEALTH
   Krishnamoorthy Y, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113382
   Lee SH, 2005, GEN HOSP PSYCHIAT, V27, P352, DOI 10.1016/j.genhosppsych.2005.04.007
   ODRISCOLL MP, 1994, J ORGAN BEHAV, V15, P141, DOI 10.1002/job.4030150204
   Panagioti M, 2017, JAMA INTERN MED, V177, P195, DOI 10.1001/jamainternmed.2016.7674
   Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]
   Riley MR, 2018, STRESS HEALTH, V34, P187, DOI 10.1002/smi.2762
   Rubin Barry, 2021, CMAJ Open, V9, pE10, DOI 10.9778/cmajo.20200057
   Shapiro J, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2024834
   Spinelli WM, 2016, EVAL HEALTH PROF, V39, P282, DOI 10.1177/0163278716637900
   Talaee N, 2022, J PUBLIC HEALTH-HEID, V30, P531, DOI 10.1007/s10389-020-01313-z
   Thrush CR, 2021, EVAL HEALTH PROF, V44, P400, DOI 10.1177/0163278720934165
   Von Rueden Kathryn T, 2010, J Trauma Nurs, V17, P191, DOI 10.1097/JTN.0b013e3181ff2607
   Wang CY, 2019, EVAL HEALTH PROF, V42, P233, DOI 10.1177/0163278717729732
NR 20
TC 4
Z9 4
U1 2
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0163-2787
EI 1552-3918
J9 EVAL HEALTH PROF
JI Eval. Health Prof.
PD SEP
PY 2021
VL 44
IS 3
BP 319
EP 322
AR 01632787211012742
DI 10.1177/01632787211012742
EA APR 2021
PG 4
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA TS5GW
UT WOS:000647246000001
PM 33902348
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Taher, J
   Mighton, C
   Chowdhary, S
   Casalino, S
   Frangione, E
   Arnoldo, S
   Bearss, E
   Binnie, A
   Bombard, Y
   Borgundvaag, B
   Chertkow, H
   Clausen, M
   Devine, L
   Faghfoury, H
   Friedman, SM
   Gingras, AC
   Khan, Z
   Mazzulli, T
   McGeer, A
   McLeod, SL
   Pugh, TJ
   Richardson, D
   Simpson, J
   Stern, S
   Strug, L
   Taher, A
   Lerner-Ellis, J
AF Taher, Jennifer
   Mighton, Chloe
   Chowdhary, Sunakshi
   Casalino, Selina
   Frangione, Erika
   Arnoldo, Saranya
   Bearss, Erin
   Binnie, Alexandra
   Bombard, Yvonne
   Borgundvaag, Bjug
   Chertkow, Howard
   Clausen, Marc
   Devine, Luke
   Faghfoury, Hanna
   Friedman, Steven Marc
   Gingras, Anne-Claude
   Khan, Zeeshan
   Mazzulli, Tony
   McGeer, Allison
   McLeod, Shelley L.
   Pugh, Trevor J.
   Richardson, David
   Simpson, Jared
   Stern, Seth
   Strug, Lisa
   Taher, Ahmed
   Lerner-Ellis, Jordan
TI Implementation of serological and molecular tools to inform COVID-19
   patient management: protocol for the GENCOV prospective cohort study
SO BMJ OPEN
LA English
DT Article
DE COVID-19; genetics; immunology; molecular diagnostics
ID SECONDARY FINDINGS; GENOME; GENETICS; SUSCEPTIBILITY; ASSOCIATION;
   SARS-COV-2; SELECTION; VIEWS
AB Introduction There is considerable variability in symptoms and severity of COVID-19 among patients infected by the SARS-CoV-2 virus. Linking host and virus genome sequence information to antibody response and biological information may identify patient or viral characteristics associated with poor and favourable outcomes. This study aims to (1) identify characteristics of the antibody response that result in maintained immune response and better outcomes, (2) determine the impact of genetic differences on infection severity and immune response, (3) determine the impact of viral lineage on antibody response and patient outcomes and (4) evaluate patient-reported outcomes of receiving host genome, antibody and viral lineage results. Methods and analysis A prospective, observational cohort study is being conducted among adult patients with COVID-19 in the Greater Toronto Area. Blood samples are collected at baseline (during infection) and 1, 6 and 12 months after diagnosis. Serial antibody titres, isotype, antigen target and viral neutralisation will be assessed. Clinical data will be collected from chart reviews and patient surveys. Host genomes and T-cell and B-cell receptors will be sequenced. Viral genomes will be sequenced to identify viral lineage. Regression models will be used to test associations between antibody response, physiological response, genetic markers and patient outcomes. Pathogenic genomic variants related to disease severity, or negative outcomes will be identified and genome wide association will be conducted. Immune repertoire diversity during infection will be correlated with severity of COVID-19 symptoms and human leucocyte antigen-type associated with SARS-CoV-2 infection. Participants can learn their genome sequencing, antibody and viral sequencing results; patient-reported outcomes of receiving this information will be assessed through surveys and qualitative interviews. Ethics and dissemination This study was approved by Clinical Trials Ontario Streamlined Ethics Review System (CTO Project ID: 3302) and the research ethics boards at participating hospitals. Study findings will be disseminated through peer-reviewed publications, conference presentations and end-users.
C1 [Taher, Jennifer; Arnoldo, Saranya; Mazzulli, Tony; Lerner-Ellis, Jordan] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.
   [Taher, Jennifer; Mighton, Chloe; Chowdhary, Sunakshi; Casalino, Selina; Frangione, Erika; Gingras, Anne-Claude; Lerner-Ellis, Jordan] Mt Sinai Hosp, Pathol & Lab Med, Sinai Hlth, Toronto, ON, Canada.
   [Mighton, Chloe; Chowdhary, Sunakshi; Casalino, Selina; Frangione, Erika; Gingras, Anne-Claude; McGeer, Allison; Lerner-Ellis, Jordan] Sinai Hlth, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada.
   [Mighton, Chloe; Bombard, Yvonne; Friedman, Steven Marc] St Michaels Hosp, Unity Hlth Toronto, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Bombard, Yvonne] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
   [Binnie, Alexandra; Richardson, David] William Osler Hlth Syst, Brampton, ON, Canada.
   [Bearss, Erin] Mt Sinai Hosp, Mt Sinai Acad Family Hlth Team, Sinai Hlth, Toronto, ON, Canada.
   [Bearss, Erin; Borgundvaag, Bjug] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada.
   [Borgundvaag, Bjug] Mt Sinai Hosp, Dept Emergency Med, Sinai Hlth, Toronto, ON, Canada.
   [Chertkow, Howard] Baycrest Hlth Sci, Toronto, ON, Canada.
   [Devine, Luke] Mt Sinai Hosp, Div Gen Internal Med, Sinai Hlth, Toronto, ON, Canada.
   [Devine, Luke] Univ Toronto, Fac Med, Toronto, ON, Canada.
   [Faghfoury, Hanna] Univ Hlth Network, Fred Litwin & Family Ctr Genet Med, Toronto, ON, Canada.
   [Faghfoury, Hanna] Mt Sinai Hosp, Toronto, ON, Canada.
   [Friedman, Steven Marc; Taher, Ahmed] Univ Hlth Network, Emergency Med, Toronto, ON, Canada.
   [Gingras, Anne-Claude] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.
   [Khan, Zeeshan; Taher, Ahmed] Mackenzie Hlth, Richmond Hill, ON, Canada.
   [Mazzulli, Tony; McGeer, Allison] Mt Sinai Hosp, Dept Microbiol, Sinai Hlth, Toronto, ON, Canada.
   [McLeod, Shelley L.] Sinai Hlth Syst, Schwartz Reisman Emergency Med Inst, Toronto, ON, Canada.
   [Pugh, Trevor J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.
   [Pugh, Trevor J.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.
   [Simpson, Jared] Ontario Inst Canc Res, Toronto, ON, Canada.
   [Simpson, Jared] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada.
   [Strug, Lisa] Hosp Sick Children, Ctr Appl Genom, Toronto, ON, Canada.
   [Strug, Lisa] Univ Toronto, Dept Stat Sci, Toronto, ON, Canada.
   [Taher, Ahmed] Univ Toronto, Div Emergency Med, Toronto, ON, Canada.
RP Taher, J; Lerner-Ellis, J (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Taher, J; Lerner-Ellis, J (corresponding author), Mt Sinai Hosp, Pathol & Lab Med, Sinai Hlth, Toronto, ON, Canada.; Lerner-Ellis, J (corresponding author), Sinai Hlth, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada.
EM Jennifer.Taher@sinaihealth.ca; jordan.lerner-ellis@sinaihealth.ca
RI Gingras, Anne-Claude/E-9982-2010; Pugh, Trevor/Y-2535-2019
OI Gingras, Anne-Claude/0000-0002-6090-4437; Pugh,
   Trevor/0000-0002-8073-5888; Binnie, Alexandra/0000-0003-2969-8177;
   Bombard, Yvonne/0000-0002-9516-4539; Strug, Lisa/0000-0003-0503-9740
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [VR4-172753]
FX This work was supported by the Canadian Institutes of Health Research
   (Funding Reference Number VR4-172753).
CR Abe KT, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.142362
   Allers K, 2015, CURR OPIN VIROL, V14, P24, DOI 10.1016/j.coviro.2015.06.007
   Baskurt Z, 2020, BIOINFORMATICS, V36, P1283, DOI 10.1093/bioinformatics/btz716
   Bombard Y, 2020, GENET MED, V22, P727, DOI 10.1038/s41436-019-0702-z
   Bombard Y, 2018, EUR J HUM GENET, V26, P984, DOI 10.1038/s41431-018-0144-0
   Bombard Y, 2014, EUR J HUM GENET, V22, P1248, DOI 10.1038/ejhg.2014.22
   Bombard Y, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2175
   Covid 19 Host Genetics Initiative, 2020, EUR J HUM GENET, V28, P715, DOI 10.1038/s41431-020-0636-6
   COVID-19 Host Genetics Initiative, 2020, PHEN DEF AN 27 APR 2
   Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985
   Duggal P, 2013, ANN INTERN MED, V158, P235, DOI 10.7326/0003-4819-158-4-201302190-00003
   Dumonteil E, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13020227
   Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283
   Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3
   Global Alliance for Genomics and Health, 2021, POL CLIN ACT GEN RES
   Hart MR, 2019, GENET MED, V21, P1100, DOI 10.1038/s41436-018-0308-x
   Haun J, 2012, J HEALTH COMMUN, V17, P141, DOI 10.1080/10810730.2012.712615
   Henry BM, 2020, CLIN CHEM LAB MED, V58, P1135, DOI 10.1515/cclm-2020-0272
   Ikitimur H, 2021, J MED VIROL, V93, P357, DOI 10.1002/jmv.26106
   Initiative C-HG, 2020, AN PLAN AUG 2020 VER
   International Federation of Clinical Chemistry and Laboratory Medicine, 2020, IFCC INF GUID COVID
   ISARIC4C, 2020, ISARIC COR CLIN CHAR
   Isho B, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe5511
   Johnson JA, 1998, QUAL LIFE RES, V7, P155, DOI 10.1023/A:1008809610703
   Johnston B., 2020, COVID 19 ARTIC V3 IL
   Kaphingst KA, 2012, CLIN GENET, V82, P408, DOI 10.1111/j.1399-0004.2012.01909.x
   Lebo MS, 2018, GENET MED, V20, P294, DOI 10.1038/gim.2017.80
   Lerner-Ellis J, 2015, J MED GENET, V52, P438, DOI 10.1136/jmedgenet-2014-102933
   Li M, 2019, J GENET COUNS, V28, P477, DOI 10.1007/s10897-018-0286-9
   Lin Marie, 2003, BMC Med Genet, V4, P9, DOI 10.1186/1471-2350-4-9
   Lin YC, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00818-2
   Linderman MD, 2016, J PERS MED, V6, DOI 10.3390/jpm6020014
   Lippi G, 2020, CLIN CHEM LAB MED, V58, P1131, DOI [10.1515/cclm-2020-1761, 10.1515/cclm-2020-0198]
   LoPresti M, 2020, AM J HUM GENET, V107, P381, DOI 10.1016/j.ajhg.2020.08.007
   MacDonald KS, 2000, J INFECT DIS, V181, P1581, DOI 10.1086/315472
   Mackley MP, 2017, GENET MED, V19, P283, DOI 10.1038/gim.2016.109
   Middleton A, 2016, EUR J HUM GENET, V24, P21, DOI 10.1038/ejhg.2015.58
   Mighton C, 2021, J MED GENET, DOI 10.1136/jmedgenet-2021-107738
   Mighton C, 2020, EUR J HUM GENET, V28, P1178, DOI 10.1038/s41431-020-0640-x
   Miller DT, 2021, GENET MED, V23, P1391, DOI 10.1038/s41436-021-01171-4
   Mulder DT, 2018, BLOOD ADV, V2, P3506, DOI 10.1182/bloodadvances.2017014639
   O'Cathain A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4587
   OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105
   Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y
   Ratmann, 2021, TRANSMISSION SARS CO
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Robinson JO, 2019, GENET MED, V21, P2781, DOI 10.1038/s41436-019-0565-3
   Sanderson SC, 2016, EUR J HUM GENET, V24, P14, DOI 10.1038/ejhg.2015.118
   Sanderson SC, 2005, PUBLIC UNDERST SCI, V14, P213, DOI 10.1177/0963662505050993
   Schulert GS, 2016, J INFECT DIS, V213, P1180, DOI 10.1093/infdis/jiv550
   Sette A, 2021, CELL, V184, P861, DOI 10.1016/j.cell.2021.01.007
   Shi YF, 2020, CELL DEATH DIFFER, V27, P1451, DOI 10.1038/s41418-020-0530-3
   Shickh S, 2021, J MED GENET, V58, P275, DOI 10.1136/jmedgenet-2020-106936
   Stadlbauer Daniel, 2020, Curr Protoc Microbiol, V57, pe100, DOI 10.1002/cpmc.100
   Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x
   Stergachis AB, 2020, NAT MED, V26, P991, DOI 10.1038/s41591-020-0953-x
   Thorne S., 2008, INTERPRETIVE DESCRIP
   To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1
   van Dorp L, 2020, INFECT GENET EVOL, V83, DOI 10.1016/j.meegid.2020.104351
   Winter AK, 2020, LANCET INFECT DIS, V20, P758, DOI 10.1016/S1473-3099(20)30322-4
   Wu F., 2020, NEUTRALIZING ANTIBOD, DOI [10.1101/2020.03.30.20047365v1, DOI 10.1101/2020.03.30.20047365, 10.1101/2020.03.30.20047365]
   Yousefzadegan S, 2020, AM J TROP MED HYG, V102, P1203, DOI 10.4269/ajtmh.20-0240
   Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
   Zoltick ES, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0619-9
NR 65
TC 0
Z9 0
U1 4
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD SEP
PY 2021
VL 11
IS 9
AR e052842
DI 10.1136/bmjopen-2021-052842
PG 12
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA WA8YE
UT WOS:000703167900006
PM 34593505
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Oldoni, E
   van Gool, A
   Bermejo, LG
   Scherer, A
   Mayrhofer, MT
   Florindi, F
   Demotes, J
   Kubiak, C
   Fauvel, AC
   Bietrix, F
   Ussi, A
   Andreu, AL
AF Oldoni, Emanuela
   van Gool, Alain
   Bermejo, Laura Garcia
   Scherer, Andreas
   Mayrhofer, Michaela Th
   Florindi, Francesco
   Demotes, Jacques
   Kubiak, Christine
   Fauvel, Anne-Charlotte
   Bietrix, Florence
   Ussi, Anton
   Andreu, Antonio L.
TI Biomarker Research and Development for Coronavirus Disease 2019
   (COVID-19): European Medical Research Infrastructures Call for Global
   Coordination
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE COVID-19; biomarkers; European Research Infrastructures; SARS-CoV-2
   pandemic
AB An effective response to the coronavirus disease 2019 (COVID-19) pandemic requires a better understanding of the biology of the infection and the identification of validated biomarker profiles that would increase the availability, accuracy, and speed of COVID-19 testing. Here, we describe the strategic objectives and action lines of the European Affiance of Medical Research Infrastructures (AMRI), established to improve the research process and tackle challenges related to diagnostic tests and biomarker development. Recommendations include: the creation of a European taskforce for validation of novel diagnostic products, the definition and promotion of criteria for COVID-19 samples biobanking, the identification and validation of biomarkers as clinical endpoints for clinical trials, and the definition of immune biomarker signatures at different stages of the disease. An effective management of the COVID-19 pandemic is possible only if there is a high level of knowledge and coordination between the public and private sectors within a robust quality framework.
C1 [Oldoni, Emanuela; Fauvel, Anne-Charlotte; Bietrix, Florence; Ussi, Anton; Andreu, Antonio L.] European Infrastruct Translat Med EATRIS, Amsterdam, Netherlands.
   [van Gool, Alain] Radboud Univ Nijmegen, Dept Lab Med, Med Ctr, Nijmegen, Netherlands.
   [Bermejo, Laura Garcia] Inst Ramon y Cajal Invest Sanitaria IRYCIS, Dept Pathol, Madrid, Spain.
   [Scherer, Andreas] Inst Mol Med Finland FIMM, Helsinki, Finland.
   [Mayrhofer, Michaela Th; Florindi, Francesco] Biobanking & BioMol Resources Res Infrastruct Eur, Graz, Austria.
   [Demotes, Jacques; Kubiak, Christine] European Clin Res Infrastruct Network ECRIN, Paris, France.
RP Andreu, AL (corresponding author), EATRIS, De Boelelaan 1118, NL-1081 HZ Amsterdam, Netherlands.
EM toniandreu@eatris.eu
RI Scherer, Andreas/ABD-8660-2020
OI van Gool, Alain/0000-0003-0010-5286; Scherer,
   Andreas/0000-0002-4254-7122; Ussi, Anton/0000-0001-7342-7062; OLDONI,
   EMANUELA/0000-0002-9105-2601
CR [Anonymous], CORONAVIRUS COVID 19
   Azkur AK, 2020, ALLERGY, V75, P1564, DOI 10.1111/all.14364
   Babady, 2020, AM SOC MICROBIOL, V11, P722
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Favaloro EJ, 2020, SEMIN THROMB HEMOST, V46, P379, DOI 10.1055/s-0040-1709498
   Frater JL, 2020, INT J LAB HEMATOL, V42, P11, DOI 10.1111/ijlh.13229
   Holub P, 2020, EUR J HUM GENET, V28, P728, DOI 10.1038/s41431-020-0634-8
   Kellner MJ, 2019, NAT PROTOC, V14, P2986, DOI 10.1038/s41596-019-0210-2
   Krammer F, 2020, SCIENCE, V368, P1060, DOI 10.1126/science.abc1227
   Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z
   Lu RF, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082826
   Madjid M, 2020, JAMA CARDIOL, V5, P831, DOI 10.1001/jamacardio.2020.1286
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Palmer K, 2020, AGING CLIN EXP RES, V32, P1189, DOI 10.1007/s40520-020-01601-4
   Randolph HE, 2020, IMMUNITY, V52, P737, DOI 10.1016/j.immuni.2020.04.012
   Rodriguez-Morales Alfonso J, 2020, Travel Med Infect Dis, V34, P101623, DOI 10.1016/j.tmaid.2020.101623
   Salehi S, 2020, J THORAC IMAG, V35, pW87, DOI 10.1097/RTI.0000000000000534
   Sanyaolu Adekunle, 2020, SN Compr Clin Med, V2, P1069, DOI 10.1007/s42399-020-00363-4
   Shen MZ, 2020, J PHARM ANAL, V10, P97, DOI 10.1016/j.jpha.2020.02.010
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Tang YW, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00512-20
   van Gool AJ, 2017, NAT REV DRUG DISCOV, V16, P587, DOI 10.1038/nrd.2017.72
   Venter M, 2020, J CLIN PATHOL, V73, P370, DOI 10.1136/jclinpath-2020-206685
   Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Weissleder R, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abc1931
   Winter AK, 2020, LANCET INFECT DIS, V20, P758, DOI 10.1016/S1473-3099(20)30322-4
   Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3
   World Health Organization, 2020, LAB TEST COR DIS 201
   Wu F, 2020, ACUTE KIDNEY INJURY, DOI [10.1101/2020.04.06.20055194, DOI 10.1101/2020.04.06.20055194]
   Xiao SY, 2020, J MED VIROL, V92, P464, DOI 10.1002/jmv.25702
   Yousefi, 2020, J LIFE SCI BIOMED, V10, P1, DOI DOI 10.29252/SCIL.2020.JLSB1
NR 32
TC 0
Z9 0
U1 2
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAY 15
PY 2021
VL 72
IS 10
BP 1838
EP 1842
DI 10.1093/cid/ciaa1250
PG 5
WC Immunology; Infectious Diseases; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Infectious Diseases; Microbiology
GA SS1QP
UT WOS:000661516500070
PM 33091118
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Dascalu, S
AF Dascalu, Stefan
TI The Successes and Failures of the Initial COVID-19 Pandemic Response in
   Romania
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Review
DE Romania; COVID-19; coronavirus; pandemic; epidemic; public health;
   diaspora; sociocultural
ID HEALTH
AB In the context of the COVID-19 pandemic, countries around the world varied in the strength and timeliness of their responses. In Romania, specific challenges were faced with regards to managing the spread and limiting the impact of the disease, ranging from healthcare infrastructure to demographic and sociocultural aspects. As the country has a sizeable diaspora, major difficulties were faced when large numbers of individuals from highly affected areas returned to Romania. However, the fast implementation of control measures successfully averted a surge in the number of COVID-19 cases. This delayed the overburdening of an already challenged healthcare system during the initial phases of the epidemic. Furthermore, early control was facilitated by the exploitation of communication channels that penetrated all layers of society, from ordinary citizens to governmental authorities and high-ranking religious figures. The management of the COVID-19 crisis in Romania illustrates the importance of a fast initial response which takes into account the role played by sociocultural aspects in the context of an epidemic. As the challenges faced by Romania are not unique, these results could inform future public health strategies worldwide.
C1 [Dascalu, Stefan] Univ Oxford, Dept Zool, Oxford, England.
   [Dascalu, Stefan] Pirbright Inst, Avian Influenza Grp, Woking, Surrey, England.
RP Dascalu, S (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Dascalu, S (corresponding author), Pirbright Inst, Avian Influenza Grp, Woking, Surrey, England.
EM stefan.dascalu@dtc.ox.ac.uk
OI Dascalu, Stefan/0000-0003-2715-749X
FU Biotechnology and Biological Sciences Research Council (BBSRC)UK
   Research & Innovation (UKRI)Biotechnology and Biological Sciences
   Research Council (BBSRC) [BB/M011224/1]
FX This work was funded by the Biotechnology and Biological Sciences
   Research Council (BBSRC), grant number BB/M011224/1. The article
   processing charge was covered by the Frontiers Coronavirus Knowledge
   Hub.
CR [Anonymous], 2020, HOTNEWS RO
   [Anonymous], 2020, FORBES RO
   [Anonymous], 2020, ROMANIA INSIDER
   [Anonymous], 2020, ZIARE
   [Anonymous], 2020, DIGI24
   [Anonymous], 2020, STIRILEPROTV RO
   Dascalu S, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00098
   Eurostat, IND POV SOC EXCL STA
   Frieden TR, 2020, EMERG INFECT DIS, V26, P1061, DOI 10.3201/eid2606.200495
   Istrate T., 2020, LIBERTATEA
   Kluge HHP, 2020, LANCET, V395, P1237, DOI 10.1016/S0140-6736(20)30791-1
   Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218
   Liem A, 2020, LANCET PSYCHIAT, V7, pE20, DOI 10.1016/S2215-0366(20)30076-6
   Mutler A., 2020, RADIO FREE EUROPE
   Neagu A., 2019, HOTNEWS RO
   OECD, 2019, TAL ABR REV ROM EM
   Pew Research Center, 2020, E W EUR DIFF IMP REL
   Pora A., 2020, RADIO FREE EUROPE
   Rdulescu A., 2020, RADIO FREE EUROPEAN
   Romanian Ministry of Internal Affairs, 2016, REP LESS LEARN COL N
   Romanian National Centre for the Surveillance and Control of Communicable Diseases (CNSCBT), 2020, WEEKL EV CONF COVID
   Romanian National Centre for the Surveillance and Control of Communicable Diseases (CNSCBT), 2020, PREV CONTR SUSP INF
   Schitea R., 2020, ANAL 1 100 COVID 19
   The Chancellery of the Holy Synod of the Romanian Orthodox Church, 2020, NEW MEASURES REGARDI
   Ungureanu MI, 2017, LANCET, V390, P2139, DOI 10.1016/S0140-6736(17)32811-8
   Vladescu C, 2016, HEALT SYST TRANSIT, V18, P1
   WHO, GLOB HLTH EXP DAT
   World Health Organization, 2020, COR DIS 2019 COVID 1
   Worldmeters, 2020, COR CAS
NR 29
TC 23
Z9 23
U1 2
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD JUL 10
PY 2020
VL 8
AR 344
DI 10.3389/fpubh.2020.00344
PG 6
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA MU6OC
UT WOS:000555789500001
PM 32766201
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Baskaran, S
   Nallaluthan, K
   Kunjuraman, V
AF Baskaran, Shathees
   Nallaluthan, Kesavan
   Kunjuraman, Velan
TI Perception and Readiness towards Indian Ayurvedic Medicine Acceptance to
   Combat COVID-19 Outbreak: A Multigroup Analysis in PLS Path Modelling
SO INTERNATIONAL JOURNAL OF AYURVEDIC MEDICINE
LA English
DT Article
DE Ayurvedic; COVID-19; Belief; Perception; Attitude; Satisfaction
ID ALTERNATIVE MEDICINE; COMPLEMENTARY; ISSUES; CLASSIFICATION;
   SATISFACTION; KNOWLEDGE; ATTITUDE; SYSTEM; FIT
AB Introduction-COVID-19 has come to us as a danger without a cure. Ayurvedic Medicine is seen to have the potential to be an alternative solution in curing COVID-19. Hence, the research aims to empirically investigate the adoption of Ayurvedic Medicine as an alternative cure for COVID-19 among the users and non-users. Methods-The research employed a quantitative research approach using a survey involving adults aged more than 18 years old. A convenient sampling method was chosen for this research. The collected data was analyzed by employing PLS-SEM and PLS-SEM MGA. Results - The results indicated that there is no significant difference between users and non-users of Ayurvedic medicine. All hypotheses formulated investigating Ayurvedic medicine beliefs, attitude, perception, and satisfaction in considering it as a Potential Alternative for COVID-19 were retained. Conclusion - This study has provided new insights in understanding the possibilities of using Ayurvedic medicine in curing COVID-19 and welcoming the medical practitioners of clinical research to identify the technical properties of Ayurvedic Medicine to be considered as an alternative for COVID-19 and many other existing and future diseases. The novelty of this study is two-fold. First, this is a pioneer study attempting to understand the public's view in considering Ayurvedic medicine as an alternative in combating COVID-19. Second, the conceptual model presented in this study to bridge the critical knowledge gap of the Ayurvedic Medicine phenomenon is neither formulated nor tested empirically in previous studies, locally or perhaps globally, therefore stands out as an original incremental contribution in avurvedic medicines perception.
C1 [Baskaran, Shathees] Univ Teknol Malaysia, Azman Hashim Int Business Sch, Johor Baharu, Malaysia.
   [Nallaluthan, Kesavan] Univ Pendidikan Sultan Idris, Fac Management & Econ, Tanjong Malim, Perak, Malaysia.
   [Kunjuraman, Velan] Univ Malaysia Kelantan, Fac Hospitality Tourism & Wellness, Kota Baharu, Kelantan, Malaysia.
RP Baskaran, S (corresponding author), Univ Teknol Malaysia, Azman Hashim Int Business Sch, T-08,Level 03-10-02, Johor Baharu 81310, Johor, Malaysia.
EM shathees@utm.my
CR Abrams LS., 2010, QUAL SOC WORK, V9, P536, DOI DOI 10.1177/1473325010367821
   Aktepe A, 2015, COMPUT IND ENG, V86, P95, DOI 10.1016/j.cie.2014.09.031
   Armstrong G. M., 2018, MARKETING INTRO
   Ary D, 2002, INTRO RES, V6th
   Ashraf M, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2503-y
   Atif A, 2012, 23 AUSTR C INF SYST
   Ben-Arye E, 2012, J ALTERN COMPLEM MED, V18, P824, DOI 10.1089/acm.2011.0327
   Berger R., 2013, AYURVEDA MADE MODERN
   Bhalerao MS, 2013, NATL MED J INDIA, V26, P75
   Borg R, 2007, ED RES INTRO
   Burton D., 2000, RES TRAINING SOCIAL
   Chin WW, 2003, INFORM SYST RES, V14, P189, DOI 10.1287/isre.14.2.189.16018
   Chin WW, 1998, MIS QUART, V22, pVII
   Chopra I, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-14
   Choudhry FR, 2016, NEUROPSYCH DIS TREAT, V12, P2807, DOI 10.2147/NDT.S111543
   Cohen, 1988, STAT POWER ANAL BEHA, DOI DOI 10.1016/C2013-0-10517-X
   Colley FC, 1978, J MALAYSIAN BRANCH R, V51, P77
   Cooper DR., 2006, BUSINESS RES METHODS
   Couper MP, 2000, PUBLIC OPIN QUART, V64, P464, DOI 10.1086/318641
   Creswell J.W, 2014, RES DESIGN QUALITATI, V4th
   Dillman D, 2011, MAIL INTERNET SURVEY
   Dow HD, 2011, HOME HLTH CARE MAN P, V23, P176, DOI 10.1177/1084822310390876
   Engler S., 2003, SCI RELIG CLASSICAL, V50
   Etikan I, 2016, AM J THEORETICAL APP, V5, P1, DOI 10.11648/j.ajtas.20160501.11
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Fowler F., 2002, SURV RES METHODS-GER
   Fraenkel J. R., 2006, DESIGN EVALUATE RES
   Gallinger Z, 2014, CAN J GASTROENTEROL, V28, P45, DOI 10.1155/2014/632627
   Gawde Suchita R, 2013, Perspect Clin Res, V4, P175, DOI 10.4103/2229-3485.115380
   Ghauri R, 1995, RES METHODS BUSINESS
   Gudergan SP, 2008, J BUS RES, V61, P1238, DOI 10.1016/j.jbusres.2008.01.012
   Gupta B, 2014, 42 ESID U MANCH
   Hair J.F., 2021, PRIMER PARTIAL LEAST
   Hair J.F., 2014, PRIMER PARTIAL LEAST
   Hair J.F.Jr., 2010, MULTIVARIATE DATA AN, V7th ed.
   Henseler J, 2016, IND MANAGE DATA SYST, V116, P2, DOI 10.1108/IMDS-09-2015-0382
   Henseler J, 2013, COMPUTATION STAT, V28, P565, DOI 10.1007/s00180-012-0317-1
   Jaiswal Yogini S, 2017, J Tradit Complement Med, V7, P50, DOI 10.1016/j.jtcme.2016.02.002
   Johnson B, 2008, ED RES QUANTITATIVE
   Khalid K., 2012, INT J RES MANAGEMENT, V2, P15
   Kline R., 1998, PRINCIPLES PRACTICE
   Koch A., 2006, Z MED ETHIK, V52, P169
   Kooij DTAM, 2017, J APPL PSYCHOL, V102, P971, DOI 10.1037/apl0000194
   Kritikaa SR, 2018, INT J PURE APPL MATH, V119, P3587
   Lind DA, 2008, STAT TECHNIQUES BUSI, V13th
   Lowhorn GL, 2007, AC BUS WORLD INT C N
   Maddux J. E., 1995, SELF EFFICACY ADAPTA, P37, DOI DOI 10.1007/978-1-4419-6868-5_2
   Malhotra N.K., 2007, MARKETING RES APPL O
   Mankar NN, 2015, J EVOL MED DENT SCI-, V4, P223
   Marta-Pedroso C, 2007, ECOL ECON, V62, P388, DOI 10.1016/j.ecolecon.2007.02.005
   Mehrotra R, 2004, NATL MED J INDIA, V17, P243
   Mishra LC, 2001, ALTERN THER HEALTH M, V7, P36
   Narahari SR, 2016, CURR SCI INDIA, V111, P302, DOI 10.18520/cs/v111/i2/302-317
   Neuman W. L, 2004, SOCIAL RES METHODS Q
   Nilashi M, 2020, J INFECT PUBLIC HEAL, V13, P893, DOI 10.1016/j.jiph.2020.05.009
   Panchal GS, 2014, J CLIN EXPT RES, V2, P115
   Patwardhan B, 2016, J AYURVEDA INTEGR ME, V7, P73, DOI 10.1016/j.jaim.2016.07.002
   Patwardhan B, 2016, J AYURVEDA INTEGR ME, V7, P1, DOI 10.1016/j.jaim.2016.05.001
   Philips CA, 2019, J CLIN TRANSL HEPATO, V7, P263, DOI 10.14218/JCTH.2019.00024
   Porter SR, 2003, PUBLIC OPIN QUART, V67, P579, DOI 10.1086/378964
   Posada E., 2017, ENV SCI INDIAN J, V13, P144
   Rastogi S, 2020, J AYURVEDA INTEGR ME
   Roscoe, 1975, FUNDAMENTAL RES STAT
   ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203
   Roy V, 2015, INDIAN J PHARMACOL, V47, P137, DOI 10.4103/0253-7613.153418
   Salmon MH, 2007, INTRO LOGIC CRITICAL, V5th
   Saunders M., 2007, RES METHODS BUSINESS
   Sekaran U., 2006, RES METHODS BUSINESS
   Snider J., 2010, ED WEEK, V29, P20
   Sreena Raj, 2011, Research in Plant Biology, V1, P1
   Sumathipala K, 2012, CHRONIC ILLN, V8, P31, DOI 10.1177/1742395311423848
   Tabish SA, 2008, INT J HEALTH SCI-IJH, V2, P3
   Thambirasa S., 2015, AM J MARKETING RES, V1, P158
   Thatte U M, 1993, J Postgrad Med, V39, P179
   Vygotsky L, 2012, THOUGHT AND LANGUAGE, P1
   Wynn SG, 2007, VET HERBAL MED
   Yi Y, 2020, INT J BIOL SCI, V16, P1753, DOI 10.7150/ijbs.45134
   Yoshida Y, 2016, NAGOYA J MED SCI, V78, P99
NR 78
TC 0
Z9 0
U1 2
U2 2
PU AYURVEDA SAHITI PRABHA
PI ANDHRA PRADESH
PA 1-2-288-23, SBH COLONY, HYDERABAD, ANDHRA PRADESH, 500 029, INDIA
SN 0976-5921
J9 INT J AYURVEDIC MED
JI Int. J. Ayurvedic Med.
PD APR-JUN
PY 2021
VL 12
IS 2
BP 318
EP 331
PG 14
WC Medicine, Research & Experimental
WE Emerging Sources Citation Index (ESCI)
SC Research & Experimental Medicine
GA TD5TH
UT WOS:000669388600026
DA 2022-04-20
ER

PT J
AU Donatella, P
   Haraldsson, M
   Tagesson, T
AF Donatella, Pierre
   Haraldsson, Mattias
   Tagesson, Torbjorn
TI Reporting on COVID-19-or not? Annual report disclosure of the pandemic
   as a subsequent event
SO JOURNAL OF PUBLIC BUDGETING ACCOUNTING & FINANCIAL MANAGEMENT
LA English
DT Article
DE Annual report; Crisis; COVID-19; Disclosure; Public sector accounting;
   Subsequent event
ID LOCAL-GOVERNMENTS; SECTOR; TRANSPARENCY; DETERMINANTS; UNCERTAINTY;
   STANDARDS; RESPONSES
AB Purpose This paper focuses on the extent to which Swedish municipalities identified and communicated risks due to the COVID-19 outbreak early on. The purpose of this paper is to explore to what extent the situational factors of the COVID-19 pandemic influenced the likelihood of municipalities disclosing COVID-19 information as a subsequent event in the annual reports of 2019. Design/methodology/approach Logistic regression models were used to estimate COVID-19 disclosure as a subsequent event. Data were handpicked from annual reports, audit reports and meeting minutes, or were retrieved from publicly available sources. Findings Regression results indicate that municipalities issuing their annual report in a later stage of the pandemic, in regions with a higher number of confirmed COVID-19 cases, were more likely to disclose COVID-19 information as a subsequent event. However, the municipal factors used to capture the risk of a severe impact of the COVID-19 outbreak were not of major importance. In line with previous research, this study shows that political and institutional factors have explanatory power in predicting and explaining accounting disclosure choices. Originality/value This paper contributes to research on accounting disclosures in urgent crises and on the specific topic of subsequent events in the public sector. Few studies address subsequent events in a corporate setting and, to the best of the authors' knowledge, none do so in the context of the public sector. This paper also offers insight into how explanatory factors, previously tested under normal conditions and circumstances, influence disclosure choices in an early stage of a health crisis characterized by uncertainty regarding both occurrence and consequences.
C1 [Donatella, Pierre] Univ Gothenburg, Sch Publ Adm, Gothenburg, Sweden.
   [Haraldsson, Mattias] Lund Univ, Sch Econ & Management, Lund, Sweden.
   [Tagesson, Torbjorn] Linkoping Univ, Dept Management & Engn, Campus Valla, Linkoping, Sweden.
RP Donatella, P (corresponding author), Univ Gothenburg, Sch Publ Adm, Gothenburg, Sweden.
EM pierre.donatella@spa.gu.se
CR Ahrens T, 2020, J PUBLIC BUDGET ACC, V32, P813, DOI 10.1108/JPBAFM-07-2020-0098
   Munoz LA, 2015, LEX LOCALIS, V13, P129, DOI 10.4335/13.2.129-160
   Allegrini V, 2018, INT J PUBLIC SECT MA, V31, P583, DOI 10.1108/IJPSM-08-2017-0216
   Argento D, 2020, J PUBLIC BUDGET ACC, V32, P875, DOI 10.1108/JPBAFM-07-2020-0093
   Argento D, 2018, PUBLIC ADMIN DEVELOP, V38, P39, DOI 10.1002/pad.1819
   Auer, 2016, HDB INT CRISIS COMMU, P236, DOI [10.1002/9781118516812.ch22, DOI 10.1002/9781118516812.CH22]
   Auer C, 2016, HDB INT CRISIS COMMU, P236, DOI [10.1002/9781118516812.ch22, DOI 10.1002/9781118516812.CH22]
   Avery EJ, 2016, J CONTING CRISIS MAN, V24, P73, DOI 10.1111/1468-5973.12109
   Barbera C, 2017, PUBLIC ADMIN, V95, P670, DOI 10.1111/padm.12350
   Bouckaert G, 2020, PUBLIC ADMIN REV, V80, P765, DOI 10.1111/puar.13242
   Carpenter VL, 2001, ACCOUNT ORG SOC, V26, P565, DOI 10.1016/S0361-3682(00)00038-6
   Christiaens J., 1999, FINANC ACCOUNT MANAG, V15, P21, DOI [10.1111/1468-0408.00072, DOI 10.1111/1468-0408.00072]
   Collin SO, 2017, FINANC ACCOUNT MANAG, V33, P391, DOI 10.1111/faam.12130
   Czerney K, 2020, ACCOUNT REV, V95, P97, DOI 10.2308/accr-52662
   DIMAGGIO PJ, 1983, AM SOCIOL REV, V48, P147, DOI 10.2307/2095101
   Donatella P, 2021, FINANC ACCOUNT MANAG, DOI 10.1111/faam.12278
   Donatella P, 2020, J PUBLIC BUDGET ACC, V32, P247, DOI 10.1108/JPBAFM-03-2019-0048
   Donatella P, 2021, J MANAG GOV, V25, P509, DOI 10.1007/s10997-020-09521-1
   Ellwood S, 2016, PUBLIC MONEY MANAGE, V36, P231, DOI 10.1080/09540962.2016.1140974
   Falkman P, 2008, SCAND J MANAG, V24, P271, DOI 10.1016/j.scaman.2008.02.004
   FAR, 2020, UPPL HAND EFT BAL GR
   Ghosh D, 2009, ACCOUNT ORG SOC, V34, P188, DOI 10.1016/j.aos.2008.07.001
   Gomes PS, 2015, INT J PUBLIC ADMIN, V38, P268, DOI 10.1080/01900692.2015.1001237
   Granberg M, 2021, PUBLIC MONEY MANAGE, V41, P223, DOI 10.1080/09540962.2020.1866842
   Haraldsson M, 2014, J ACCOUNT ORGAN CHAN, V10, P288, DOI 10.1108/JAOC-10-2012-0096
   Hsieh CC, 2019, ACCOUNT ORG SOC, V74, P41, DOI 10.1016/j.aos.2018.08.001
   Huang YH, 2009, PUBLIC RELAT REV, V35, P7, DOI 10.1016/j.pubrev.2008.09.020
   IFAC, 2020, FINANCIAL REPORTING
   IPSASB, 2020, COVID 19 REL IPSASB
   Johansen W., 2009, INT J STRATEGIC COMM, V3, P102, DOI DOI 10.1080/15531180902805460
   Jorge S, 2021, J PUBLIC BUDGET ACC, V33, P114, DOI 10.1108/JPBAFM-08-2019-0125
   KPMG, 2020, HANT EFF COV 19 AR R
   Kuhlmann S, 2021, INT REV ADM SCI, V87, P556, DOI 10.1177/0020852320979359
   Lee TH, 2017, PUBLIC RELAT INQ, V6, P233, DOI 10.1177/2046147X17694937
   Lindgren A., 2016, SEACROW ISLAND
   Mann B, 2019, ACCOUNT EUR, V16, P195, DOI 10.1080/17449480.2019.1632467
   MEYER JW, 1977, AM J SOCIOL, V83, P340, DOI 10.1086/226550
   MEZIAS SJ, 1990, ADMIN SCI QUART, V35, P431, DOI 10.2307/2393312
   Michels J, 2017, J ACCOUNT RES, V55, P3, DOI 10.1111/1475-679X.12128
   OLIVER C, 1991, ACAD MANAGE REV, V16, P145, DOI 10.2307/258610
   Oulasvirta L, 2021, PUBLIC MONEY MANAGE, V41, P436, DOI 10.1080/09540962.2021.1881235
   Oulasvirta L, 2014, CRIT PERSPECT ACCOUN, V25, P272, DOI 10.1016/j.cpa.2012.12.001
   Polzer T, 2022, ACCOUNT FORUM, V46, P57, DOI 10.1080/01559982.2021.1920277
   Bolivar MPR, 2016, LOCAL GOV STUD, V42, P29, DOI 10.1080/03003930.2015.1061506
   Bolivar MPR, 2013, INT PUBLIC MANAG J, V16, P557, DOI 10.1080/10967494.2013.849169
   Roux-Dufort C., 2016, HDB INT CRISIS COMMU, V43, P24
   Singh H., 2020, SA UPPLYSER ARSREDOV
   Tagesson T, 2015, PUBLIC MONEY MANAGE, V35, P273, DOI 10.1080/09540962.2015.1047270
   Tagesson T, 2015, PUBLIC SECTOR ACCOUNTING, P1
   Tagesson T, 2013, J MANAG GOV, V17, P217, DOI 10.1007/s10997-011-9174-5
   Tagesson T, 2011, FINANC ACCOUNT MANAG, V27, P272, DOI 10.1111/j.1468-0408.2011.00525.x
   Tommasetti A., 2017, INT J BUSINESS MANAG, V12, P119, DOI [10.5539/ijbm.v12n12p119, DOI 10.5539/IJBM.V12N12P119]
NR 52
TC 0
Z9 0
U1 1
U2 1
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1096-3367
EI 1945-1814
J9 J PUBLIC BUDGET ACC
JI J. Public Budg. Account. Financ. Manage.
PY 2022
VL 34
IS 6
BP 117
EP 136
DI 10.1108/JPBAFM-04-2021-0074
EA NOV 2021
PG 20
WC Business, Finance; Public Administration
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics; Public Administration
GA YO0AQ
UT WOS:000721110500001
OA Green Submitted, hybrid
DA 2022-04-20
ER

PT J
AU Anser, MK
   Sharif, M
   Khan, MA
   Nassani, AA
   Zaman, K
   Abro, MMQ
   Kabbani, A
AF Anser, Muhammad Khalid
   Sharif, Muhammad
   Khan, Muhammad Azhar
   Nassani, Abdelmohsen A.
   Zaman, Khalid
   Abro, Muhammad Moinuddin Qazi
   Kabbani, Ahmad
TI Demographic, psychological, and environmental factors affecting
   student's health during the COVID-19 pandemic: on the rocks
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE COVID-19; Environmental pollution; Student&#8217; s health; Knowledge;
   Ignorance; Healthcare expenditures; Government support
AB The novel coronavirus (COVID-19) is spreading exponentially, increasing fear, depression, and other mental health disorders in the general public. Pakistan's economy is suffered mainly by the novel coronavirus. The massive healthcare expenditures bring inadequacy to manage COVID-19. The study explored the effects of coronavirus fear among the students who remain in their homes due to educational institutions' closure. The study results show that female students mostly fear the coronavirus pandemic compared to their male counterparts that negatively impact their health. The "age" of the students and "household size" positively impact students' health, while the student's existing "healthcare profile" is not competitive enough to escape from the deadly coronavirus. The "knowledge" for the coronavirus pandemic and its prevention guidelines is the only solution to contain coronavirus. Simultaneously, "ignorance" is the foremost factor that could be more dangerous to spread coronavirus among the students; besides the COVID-19 pandemic, students and general public health mainly suffered from environmental pollution. The current epidemic also exacerbated environmental concerns among students isolated in their homes, and their outdoor activities are primarily limited. Hence, the student's quality of life is exposed mainly to environmental pollution over time. The "healthcare expenditures" and "government support" both are not competitive enough to control novel coronavirus. Thus, it required more sustainable strategic policies and national unity to controlled coronavirus with firm conviction and provincial synchronization.
C1 [Anser, Muhammad Khalid] Xian Univ Architecture & Technol, Sch Publ Adm, Xian 710000, Peoples R China.
   [Sharif, Muhammad] Quaid I Azam Univ, Sch Econ, Islamabad, Pakistan.
   [Khan, Muhammad Azhar; Zaman, Khalid] Univ Haripur, Dept Econ, Haripur, Khyber Pakhtunk, Pakistan.
   [Nassani, Abdelmohsen A.; Abro, Muhammad Moinuddin Qazi] King Saud Univ, Dept Management, Coll Business Adm, POB 71115, Riyadh 11587, Saudi Arabia.
   [Kabbani, Ahmad] Aleppo Univ, Dept Management, Aleppo, Syria.
RP Nassani, AA (corresponding author), King Saud Univ, Dept Management, Coll Business Adm, POB 71115, Riyadh 11587, Saudi Arabia.
EM Nassani@ksu.edu.sa; khalid_zaman786@yahoo.com; mqazi@ksu.edu.sa
RI Nassani, Abdelmohsen A./AAG-9442-2021; KABBANI, AHMAD/AAS-8524-2021
OI Nassani, Abdelmohsen A./0000-0001-9658-8299; KABBANI,
   AHMAD/0000-0002-3479-3438; Sharif, Muhammad/0000-0003-4305-5362
FU King Saud University, Riyadh, Saudi ArabiaKing Saud University
   [RSP2021/87]
FX Researchers Supporting Project number (RSP2021/87), King Saud
   University, Riyadh, Saudi Arabia.
CR Agarwal A, 2020, INDIAN J MED RES, V151, P177, DOI 10.4103/ijmr.IJMR_518_20
   Alsafi Z, 2020, INT J SURG, V78, P64, DOI 10.1016/j.ijsu.2020.03.083
   [Anonymous], TRIBUNE EXPRESS
   [Anonymous], 2020, THE HARVARD GAZETTE
   Awan U, 2020, IND INNOVATION INFRA, DOI [10.1007/978-3-319-71059-4_64-1, DOI 10.1007/978-3-319-71059-4_64-1]
   Awan U., 2020, HDB ENV MAT MANAGEME
   Billauer, 2020, ITSELF
   Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934
   Goswami M., 2020, INT J RES PHARM SCI, V11, P43, DOI [10.26452/ijrps.v11iSPL1.2112, DOI 10.26452/IJRPS.V11ISPL1.2112]
   Greenberg N, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1211
   Grover S., 2020, EPIDEMIOL INT, V5, P14, DOI [10.24321/2455.7048.202004, DOI 10.24321/2455.7048.202004]
   Hua JL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072309
   Hyder, 2020, POLICING UNCERTAIN T, V3
   Hyder, 2020, IMPACT COVID 19 MENT, V3
   Javed A., 2020, POLICY REV EC IMPACT
   Javed B, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00158
   Kurian NK, 2020, NOVEL CORONAVIRUS CO
   Lee, 2020, PROGR MICROBES MOL B, V3, P1
   Liang LL, 2020, PSYCHIAT QUART, V91, P841, DOI 10.1007/s11126-020-09744-3
   Malik YS, 2020, EMERGING CORONAVIRUS
   Morgan, 2020, CLEARING HOUSE J ED, V93, P135, DOI [10.1080/00098655.2020.1751480, DOI 10.1080/00098655.2020.1751480]
   NCSL, 2020, PUBL ED RESP COR COV
   OECD, 2020, QUAL ED ALL COV 19
   Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066
   Reich J., 2020, REMOTE LEARNING GUID
   Rose S, 2020, JAMA-J AM MED ASSOC, V323, P2131, DOI 10.1001/jama.2020.5227
   Rothstein, 2020, J MED ETHICS, V48, P1, DOI DOI 10.2139/SSRN.3544331
   Sahu P, 2020, CUREUS, V12, DOI 10.7759/cureus.7541
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Stein RA, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13488
   Strielkowski W., 2020, COVID 19 PANDEMIC DI, P2020040290, DOI DOI 1020944/PREPRINTS2020040290V1
   Sun LT, 2020, NAT MATER, V19, P687, DOI 10.1038/s41563-020-0678-8
   The World Bank, 2020, WORLD BANK ED COVID
   Thurackal BJ, 2020, OUTBREAK NOVEL CORON
   Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048
   Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X
   Wall, 2021, IND INNOVATION INFRA, DOI [10.1007/978-3-319-71059-4_86-1, DOI 10.1007/978-3-319-71059-4_86-1]
   Wall, 2020, RESPONSIBLE CONSUMPT, DOI [10.1007/978-3-319-95726-5_18, DOI 10.1007/978-3-319-95726-5_18]
   World Economic Forum, 2020, 3 WAYS COR PAND COUL
   Wu Mengting, 2020, Gen Psychiatr, V33, pe100250, DOI 10.1136/gpsych-2020-100250
   Zhang, 2020, 4 INT C CULT ED EC D, P1222, DOI [DOI 10.2991/ASSEHR.K.200316.266, 10.2991/assehr.k.200316.266]
NR 41
TC 2
Z9 2
U1 3
U2 6
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD JUN
PY 2021
VL 28
IS 24
BP 31596
EP 31606
DI 10.1007/s11356-021-12991-x
EA FEB 2021
PG 11
WC Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology
GA TB2VK
UT WOS:000619737500001
PM 33608786
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Resnicow, K
   Bacon, E
   Yang, P
   Hawley, S
   Van Horn, ML
   An, L
AF Resnicow, Ken
   Bacon, Elizabeth
   Yang, Penny
   Hawley, Sarah
   Van Horn, M. Lee
   An, Lawrence
TI Novel Predictors of COVID-19 Protective Behaviors Among US Adults:
   Cross-sectional Survey
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE COVID-19; protective behavior; psychological predictors; reactance;
   conspiracy beliefs; public health; health communication; communication;
   protection; behavior; psychology
ID PSYCHOLOGICAL REACTANCE; CONSPIRACY BELIEFS; HIV/AIDS
AB Background: A central component of the public health strategy to control the COVID-19 pandemic involves encouraging mask wearing and social distancing to protect individuals from acquiring and transmitting the virus.
   Objective: This study aims to understand the psychological factors that drive adoption or rejection of these protective behaviors, which can inform public health interventions to control the pandemic.
   Methods: We conducted an online survey of a representative sample of 1074 US adults and assessed three novel potential predictors of COVID-19 behaviors: trait reactance, COVID-19 conspiracy beliefs, and COVID-19 apocalypse beliefs. Key outcomes (dependent variables) included an index of COVID-19 protective behaviors, the number of trips taken from the home, and COVID-19 knowledge.
   Results: In bivariate analyses, all three predictors were significantly correlated in the hypothesized direction with the three COVID-19 outcomes. Specifically, each predictor was negatively (P<.01) correlated with the COVID-19 protective behaviors index and COVID-19 knowledge score, and positively correlated with trips taken from home per week (more of which was considered higher risk). COVID-19 protective behaviors and COVID-19 knowledge were significantly lower in the top median compared to the bottom median for all three predictors. In general, these findings remained significant after adjusting for all novel predictors plus age, gender, income, education, race, political party, and religiosity. Self-identified Republicans (vs other political affiliations) reported the highest values for each of the novel predictors.
   Conclusions: This study can inform the development of health communication interventions to encourage the adoption of COVID-19 protective behaviors. Interestingly, we found that higher scores of all three novel predictors were associated with lower COVID-19 knowledge, suggesting that lack of an accurate understanding of the virus may be driving some of these attitudes; although, it is also possible that these attributes may interfere with one's willingness or ability to seek and absorb accurate health information. These individuals may be particularly immune to accepting new information and yielding their beliefs. Health communication professionals may apply lessons learned from countering similar beliefs around climate change and vaccine hesitancy. Messages designed for individuals prone to reactance may be more effective if they minimize controlling language and emphasize the individual's independence in adopting these behavioral recommendations. Messaging for those who possess conspiracy beliefs should similarly not assume that providing evidence contrary to these beliefs will alone alter behavior. Other communication techniques such as rolling with resistance, a strategy used in motivational interviewing, may be helpful. Messaging for those with apocalyptic beliefs may require using religious leaders as the message source and using scripture that would support the adoption of COVID-19 protection behaviors.
C1 [Resnicow, Ken; Bacon, Elizabeth; Yang, Penny; Hawley, Sarah; An, Lawrence] Univ Michigan, Ctr Hlth Commun Res, Rogel Canc Ctr, Ann Arbor, MI 48109 USA.
   [Resnicow, Ken] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, 109 Observ St,Room 3867 SPH I, Ann Arbor, MI 48109 USA.
   [Hawley, Sarah; An, Lawrence] Univ Michigan, Sch Med, Div Gen Med, Ann Arbor, MI 48109 USA.
   [Hawley, Sarah] VA Ann Arbor Healthcare Syst, VA Ctr Clin Management Res, Ann Arbor, MI USA.
   [Van Horn, M. Lee] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.
RP Resnicow, K (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, 109 Observ St,Room 3867 SPH I, Ann Arbor, MI 48109 USA.
EM kresnic@umich.edu
OI Yang, Penny/0000-0002-2330-2330; Bacon, Elizabeth/0000-0001-9029-8004;
   Resnicow, Ken/0000-0003-1416-9627
FU National Cancer Institute GrantUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Cancer Institute (NCI) [P30CA046592-29-S4]; Google Focus awardGoogle
   Incorporated; Cancer Center Shared Resource: Center for Health
   Communications Research
FX This study was supported by the National Cancer Institute Grant
   P30CA046592-29-S4 (including Cancer Center Shared Resource: Center for
   Health Communications Research) and a Google Focus award (to LA).
CR [Anonymous], DYNATA
   [Anonymous], 2017, IBM SPSS SOFTW
   Ball P, 2020, NATURE, V581, P371, DOI 10.1038/d41586-020-01452-z
   Biddlestone M, 2020, BRIT J SOC PSYCHOL, V59, P663, DOI 10.1111/bjso.12397
   Bogart LM, 2005, JAIDS-J ACQ IMM DEF, V38, P213, DOI 10.1097/00126334-200502010-00014
   Bogart LM, 2003, J NATL MED ASSOC, V95, P1057
   Brehm S. S., 1981, PSYCHOL REACTANCE TH
   Brenan M, 2020, GALLUP 0812
   Brors G, 2020, EUR J CARDIOVASC NUR, V19, P458, DOI 10.1177/1474515120941307
   Centers for Disease Control and Prevention (CDC), 2020, OLD AD
   Chan EYY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113869
   Chong YY, 2020, INT J NURS STUD, V108, DOI 10.1016/j.ijnurstu.2020.103644
   Donnell AJ, 2001, J SOC PSYCHOL, V141, P679, DOI 10.1080/00224540109600581
   Feinberg M, 2011, PSYCHOL SCI, V22, P34, DOI 10.1177/0956797610391911
   Freeman D, 2022, PSYCHOL MED, V52, P251, DOI 10.1017/S0033291720001890
   Funk C., 2020, INTENT GET COVID 19
   Geldsetzer P, 2020, J MED INTERNET RES, V22, DOI 10.2196/18790
   Georgiou N, 2020, PERS INDIV DIFFER, V166, DOI 10.1016/j.paid.2020.110201
   HONG SM, 1989, PSYCHOL REP, V64, P1323, DOI 10.2466/pr0.1989.64.3c.1323
   HONG SM, 1994, J SOC PSYCHOL, V134, P223, DOI 10.1080/00224545.1994.9711385
   Howard MC, 2020, BRIT J HEALTH PSYCH, V25, P912, DOI 10.1111/bjhp.12453
   Jonason PK, 2006, PSYCHOL REP, V98, P569, DOI 10.2466/PRO.98.2.569-579
   Ko NY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124282
   McGeeney, 2015, COVERAGE ERROR INTER
   Miller W.R., 2013, MOTIVATIONAL INTERVI, V3rd ed
   Patten E, 2015, WHOS LEFT OUT WEB ON
   Resnicow K, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-19
   Saad L., 2020, GALLUP
   Sadaf A, 2013, VACCINE, V31, P4293, DOI 10.1016/j.vaccine.2013.07.013
   Sallam M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144915
   Shen LJ, 2005, J PERS ASSESS, V85, P74, DOI 10.1207/s15327752jpa8501_07
   Tyminski R, 2020, J ANAL PSYCHOL, V65, P27, DOI 10.1111/1468-5922.12572
   van Prooijen JW, 2018, PERSPECT PSYCHOL SCI, V13, P770, DOI 10.1177/1745691618774270
   Vansteenkiste M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-23
NR 34
TC 5
Z9 5
U1 5
U2 15
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD APR 20
PY 2021
VL 23
IS 4
AR e23488
DI 10.2196/23488
PG 11
WC Health Care Sciences & Services; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Medical Informatics
GA RQ2QD
UT WOS:000642263900003
PM 33835930
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Pham, T
   Lai, P
   Nguyen, V
   Nguyen, H
AF Thach Pham
   Phuong Lai
   Vinh Nguyen
   Hai Nguyen
TI Online learning amid Covid-19 pandemic: students' experience and
   satisfaction
SO JOURNAL OF E-LEARNING AND KNOWLEDGE SOCIETY
LA English
DT Article
DE Satisfaction; Course Content; Interaction; Online Pedagogy; Vietnam;
   Covid-19
ID LEARNERS PERCEPTIONS; SELF-EFFICACY; OUTCOMES
AB The outbreak of COVID-19 Pandemic forced most higher education institutions around the globe to move their teaching and learning to online mode. This had huge impact on the students, especially for those who had not been used to being online for learning before. This mixed methods study utilized correlation, factor analysis and multiple regression techniques to identify significant predictors of students' satisfaction with online learning in a higher education institution in Vietnam amid COVID-19 Pandemic. The study results show that learners' interaction with content, peers and instructors correlated to and predicted student satisfaction. The study also indicated that although students valued the chance to be online for learning during the historic time, they viewed that interaction was limited and instructors should improve online teaching pedagogy. These findings provide learners, teachers and curriculum developers with new insights into learner interaction and its relation to course contents, teaching pedagogy and learning satisfaction in an Asian context.
C1 [Thach Pham] Hanoi Univ, Board Trustees, Hanoi, Vietnam.
   [Phuong Lai] Hanoi Univ, Fac Management, Hanoi, Vietnam.
   [Vinh Nguyen] Hanoi Univ, English Studies Dept, Hanoi, Vietnam.
   [Hai Nguyen] Hanoi Univ, Fac English Specif Purpose, Hanoi, Vietnam.
RP Pham, T (corresponding author), Hanoi Univ, Board Trustees, Hanoi, Vietnam.
EM thachpn@hanu.edu.vn
OI Nguyen, Vinh/0000-0002-2281-916X
CR Abraham LB, 2008, COMPUT ASSIST LANG L, V21, P199, DOI 10.1080/09588220802090246
   Bich T, 2020, GIAO DUC DAI HOC XOA
   Chen W.S., 2016, UNIVERSAL J ED RES, V4, P1667, DOI [10.13189/ujer.2016.040719, DOI 10.13189/UJER.2016.040719]
   Cox S., 2015, TEACHING ENGLISH 2 Y, V42, P376
   DeVellis, 2003, SCALE DEV THEORY APP
   Eneau J, 2012, RECALL, V24, P3, DOI 10.1017/S0958344011000267
   Gameel BG, 2017, AM J DISTANCE EDUC, V31, P98, DOI 10.1080/08923647.2017.1300462
   Ghadirian H, 2018, TECHNOL PEDAGOG EDUC, V27, P85, DOI 10.1080/1475939X.2017.1380695
   Goh CF, 2017, J E-LEARN KNOWL SOC, V13, P117, DOI 10.20368/1971-8829/1298
   Gomez-Rey P, 2017, INT REV RES OPEN DIS, V18, P234
   Hair J.F., 2011, ESSENTIALS BUSINESS
   Joseph C., 2020, J APPL LEARNING TEAC, V3
   Kang M, 2013, J COMPUT ASSIST LEAR, V29, P292, DOI 10.1111/jcal.12005
   Kim M, 2017, LINGUIST RES, V34, P97, DOI 10.17250/khisli.34..201709.005
   Kuo YC, 2014, INTERNET HIGH EDUC, V20, P35, DOI 10.1016/j.iheduc.2013.10.001
   Le Q. X, 2013, THESIS U NOTTINGHAM
   Lee JW, 2002, RES NURS HEALTH, V25, P295, DOI 10.1002/nur.10041
   Loh CYR., 2017, J ED SOCIAL POLICY, V7, P194
   Loi N.V., 2016, LANGUAGE LEARNER AUT
   Lowenthal P., 2020, J TECHNOLOGY TEACHER, V28, P383
   Marzban A, 2011, PROCEDIA COMPUT SCI, V3, DOI 10.1016/j.procs.2010.12.003
   MOET, 2020, INFORM COMMUNICATION, V02
   Moore, 1989, AM J DISTANCE ED, V3, P1, DOI [10.1080/08923648909526659, DOI 10.1080/08923648909526659]
   Mukhtar K, 2020, PAK J MED SCI, V36, pS27, DOI 10.12669/pjms.36.COVID19-S4.2785
   Nagar S., 2020, UGC CARE J, V19, P272
   Pallant J., 2011, SPSS SURVIVAL MANUAL, DOI 10.1046/j.1365-2648.2001.2027c.x
   Saldaa, 2020, QUALITATIVE DATA ANA
   Shen DM, 2013, INTERNET HIGH EDUC, V19, P10, DOI 10.1016/j.iheduc.2013.04.001
   Spathis P., 2020, ACM SIGC ED WORKSH
   Teddlie C., 2009, FDN MIXED METHODS RE
   Thao N. T. P., 2020, TAP CH KHOA HOC DAI, V15, P18
   Wang R., 2007, ANN C AM ASS PUBL OP
   Yukselir C, 2016, J EFFIC RESPONSIB ED, V9, P23, DOI 10.7160/eriesj.2016.090104
   Zaili N., 2019, J INFORM SYSTEM TECH, V4, P73
NR 34
TC 1
Z9 1
U1 9
U2 9
PU SOC ITALIANA E-LEARNING
PI ROME
PA VIA ORAZIO RAIMONDO 18, ROME, 00173, ITALY
SN 1826-6223
EI 1971-8829
J9 J E-LEARN KNOWL SOC
JI J. E-Learn. Knowl. Soc.
PD JUL
PY 2021
VL 17
IS 1
BP 39
EP 48
DI 10.20368/1971-8829/1135293
PG 10
WC Education & Educational Research
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research
GA XL2FU
UT WOS:000727965900005
DA 2022-04-20
ER

PT J
AU Kaba, A
AF Kaba, Abdoulaye
TI Assessing an academic library performance before and during the COVID-19
   pandemic: a case study in UAE
SO PERFORMANCE MEASUREMENT AND METRICS
LA English
DT Article
DE Assessment; Performance; Pandemic; COVID-19; Coronavirus; Academic
   library; UAE
ID ROLES
AB Purpose The purpose of this case study is to assess and compare the performance of an academic library, in the United Arab Emirates (UAE), before and during the coronavirus disease 2019 (COVID-19) pandemic. Design/methodology/approach The study is based on data collected from the library management system, usage reports of online databases, and monthly reports and archives to evaluate and assess library performance in managerial activities, collection development, collection treatment, collection circulation, usage of digital resources, quality control, reference services and information literacy activities. Frequency distributions and non-parametric tests were used in identifying differences and testing hypotheses. Findings The study found that library performance before the COVID-19 pandemic outperformed library performance during the pandemic in collection development, collection treatment, collection circulation, access and use of digital resources, quality control and information literacy. On the other hand, the library demonstrated higher performance in managerial activities and reference services during the COVID-19 pandemic than that of before the pandemic period. Interestingly, the analysis of the Wilcoxon signed-ranks test revealed statistically no significant difference in the library performance before and during the COVID-19 pandemic. The results supported all the eight hypotheses stated in this study. Research limitations/implications This is a case study based on data collected from an academic library in the UAE before and during the COVID-19 pandemic. The findings may not be generalized and may differ if more data are analyzed from many academic libraries. Practical implications COVID-19 pandemic is a turning point for library managers to increase the number of digital resources and services, to ensure that library staff are equipped with essential and up-to-date information and communication technology (ICT) skills and knowledge, to ensure that library users are equipped with essential and up-to-date information literacy skills and knowledge. These will enable them to satisfy users' information needs and ensure library operation in disasters and crisis periods. Originality/value This is one of the few studies conducted in the Gulf Cooperation Council (GCC) countries to evaluate library performance before and during COVID-19 pandemic. The findings of the study could be an important reference in understanding how libraries responded to COVID-19 pandemic in the Middle East. The results of the study may contribute to the provision of digital resources and services during the pandemic and disasters in the UAE and the Arab world.
C1 [Kaba, Abdoulaye] Al Ain Univ, Al Ain, U Arab Emirates.
RP Kaba, A (corresponding author), Al Ain Univ, Al Ain, U Arab Emirates.
EM kaba_abdoulaye@yahoo.com
CR Alajmi BM, 2021, PUBLIC LIBR Q, V40, P540, DOI 10.1080/01616846.2020.1827618
   Chisita Collence Takaingenhamo, 2020, Library Hi Tech News, V37, P11, DOI 10.1108/LHTN-03-2020-0022
   Crawford J., 2020, J APPL LEARN TEACH, V3, P1, DOI DOI 10.37074/JALT.2020.3.1.7
   Disaster Information Management Research Center, 2020, DIS INF SPEC PROGR
   Featherstone RM, 2008, J MED LIBR ASSOC, V96, P343, DOI 10.3163/1536-5050.96.4.009
   Guo YJ, 2021, LIBR HI TECH, V39, P533, DOI 10.1108/LHT-04-2020-0098
   Hendal BA, 2020, DIGIT LIBR PERSPECT, V36, P429, DOI 10.1108/DLP-04-2020-0023
   Kosciejew M, 2021, GLOB KNOWL MEM COMMU, V70, P304, DOI 10.1108/GKMC-04-2020-0041
   McGuire Lisa, 2007, Medical Reference Services Quarterly, V26, P1, DOI 10.1300/J115v26n04_01
   Meek GE, 2007, J MOD APPL STAT METH, V6, P91, DOI 10.22237/jmasm/1177992540
   Mehta D, 2020, DIGIT LIBR PERSPECT, V36, P351, DOI 10.1108/DLP-05-2020-0030
   Ministry of Education U.A.E., 2020, ED MIN ANN EARL 4 WE
   Ministry of Education U.A.E., 2020, SCH BREAK COVID 19 O
   Oyelude A.A., 2020, LIB HI TECH NEWS, V37, P5, DOI [10.1108/lhtn-05-2020-0049, DOI 10.1108/LHTN-05-2020-0049]
   Pokorna L, 2020, DIGIT LIBR PERSPECT, V36, P389, DOI 10.1108/DLP-05-2020-0026
   Risley C, 2020, J LIBR ADM, V60, P653, DOI 10.1080/01930826.2020.1773716
   Suman R, 2020, J CLIN EXP HEPATOL, V10, P386, DOI 10.1016/j.jceh.2020.04.020
   Taheri SM, 2013, STAT PAP, V54, P457, DOI 10.1007/s00362-012-0443-4
   Tammaro AM., 2020, INT INF LIBR REV, V52, P216, DOI DOI 10.1080/10572317.2020.1785172
   Wang T, 2020, PUBLIC LIBR Q, V39, P283, DOI 10.1080/01616846.2020.1764325
NR 20
TC 1
Z9 1
U1 8
U2 8
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1467-8047
EI 1758-6925
J9 PERFORM MEAS METR
JI Perform. Meas. Metr.
PD NOV 15
PY 2021
VL 22
IS 3
BP 187
EP 199
DI 10.1108/PMM-01-2021-0003
EA NOV 2021
PG 13
WC Information Science & Library Science
WE Emerging Sources Citation Index (ESCI)
SC Information Science & Library Science
GA WZ7AU
UT WOS:000717190200001
OA Bronze
DA 2022-04-20
ER

PT C
AU Wang, D
   Huang, LX
   Li, P
AF Wang, Dong
   Huang, Lixin
   Li, Ping
BE Sun, Y
   Thomas, P
   Bie, R
   Cheng, X
TI Risk Taker or Driver: An Empirical Analysis of US Financial Markets
   during the COVID-19 Pandemic
SO 2020 INTERNATIONAL CONFERENCE ON IDENTIFICATION, INFORMATION AND
   KNOWLEDGE IN THE INTERNET OF THINGS (IIKI2020)
SE Procedia Computer Science
LA English
DT Proceedings Paper
CT International Conference on Identification, Information and Knowledge in
   the Internet of Things (IIKI)
CY NOV 27-29, 2020
CL Zhuhai, PEOPLES R CHINA
DE COVID-19 Pandemic; risk spillover; connectedness index; US stock market
ID IMPULSE-RESPONSE ANALYSIS; SPILLOVERS; RETURN
AB This paper studies the dynamic risk spillovers between ten major sectors of US stock market during the global COVID-19 pandemic based on the DYCI (Diebold-Yilmaz Connectedness Index) framework. We find that the pairwise directional connectedness between Finance and Utility, Technology and Utility, and Consumer Discretionary were larger than other pairs. These results show that COVID-19 pandemic brought huge shocks to US economy. We also fmd that the sectors that require inperson contact and were banned in some degree during the pandemic took the greatest impact during the pandemic. But the risk did drop down as the COVID-19 was somehow controlled by the US government.
C1 [Wang, Dong; Li, Ping] Beihang Univ, Sch Econ & Management, Beijing 100191, Peoples R China.
   [Huang, Lixin] Princeton Int Sch Math & Sci, Princeton, NJ 08540 USA.
   [Li, Ping] Beihang Univ, Key Lab Complex Syst Anal Management & Decis, Minist Educ, Beijing 100191, Peoples R China.
RP Li, P (corresponding author), Beihang Univ, Sch Econ & Management, Beijing 100191, Peoples R China.; Li, P (corresponding author), Beihang Univ, Key Lab Complex Syst Anal Management & Decis, Minist Educ, Beijing 100191, Peoples R China.
EM liping124@buaa.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [72033001, 71571008]; Open Fund of Hubei
   Cultural Industry Economy Research Center [HBCIR2018Z001]
FX This paper is supported by the National Natural Science Foundation of
   China (No. 72033001 & 71571008) and Open Fund of Hubei Cultural Industry
   Economy Research Center (No. HBCIR2018Z001).
CR Diebold F. X., 2015, FINANCIAL MACROECONO
   Diebold FX, 2016, J FINANC ECONOMET, V14, P81, DOI 10.1093/jjfinec/nbv021
   Diebold FX, 2014, J ECONOMETRICS, V182, P119, DOI 10.1016/j.jeconom.2014.04.012
   Diebold FX, 2012, INT J FORECASTING, V28, P57, DOI 10.1016/j.ijforecast.2011.02.006
   Diebold FX, 2009, ECON J, V119, P158, DOI 10.1111/j.1468-0297.2008.02208.x
   GARMAN MB, 1980, J BUS, V53, P67, DOI 10.1086/296072
   Greenwood-Nimmo M, 2016, J FINANC MARK, V31, P43, DOI 10.1016/j.finmar.2016.05.001
   Koop G, 1996, J ECONOMETRICS, V74, P119, DOI 10.1016/0304-4076(95)01753-4
   Pesaran HH, 1998, ECON LETT, V58, P17, DOI 10.1016/S0165-1765(97)00214-0
   Sun YC, 2018, PERS UBIQUIT COMPUT, V22, P575, DOI 10.1007/s00779-018-1121-x
   Wang Dong, 2020, SSRN ELECT J
NR 11
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-0509
J9 PROCEDIA COMPUT SCI
PY 2021
VL 187
BP 554
EP 558
DI 10.1016/j.procs.2021.04.099
PG 5
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Computer Science, Theory & Methods; Engineering, Electrical &
   Electronic; Telecommunications
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science; Engineering; Telecommunications
GA BS0DU
UT WOS:000681301200087
OA gold
DA 2022-04-20
ER

PT J
AU Khan, R
   Saha, S
   Gimpaya, N
   Bansal, R
   Scaffidi, MA
   Razak, F
   Verma, AA
   Grover, SC
AF Khan, Rishad
   Saha, Sudipta
   Gimpaya, Nikko
   Bansal, Rishi
   Scaffidi, Michael A.
   Razak, Fahad
   Verma, Amol A.
   Grover, Samir C.
TI Outcomes for upper gastrointestinal bleeding during the first wave of
   the COVID-19 pandemic in the Toronto area
SO JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article; Early Access
DE COVID-19; endoscopy; gastrointestinal hemorrhage
ID RISK; VALIDATION; PREDICTORS; ENDOSCOPY; MORTALITY
AB Background and Aim Changes to endoscopy service availability during the COVID-19 pandemic may have affected management of upper gastrointestinal bleeding (UGIB). The aim of this study was to describe the impact of the pandemic on UGIB outcomes in the Toronto area in Canada. Methods We described all adults admitted to general medicine wards or intensive care units at six hospitals in Toronto and Mississauga, Canada, with UGIB during the first wave of the COVID-19 pandemic (March 1 to June 30, 2020) and compared them with a historical cohort (March 1 to June 30, 2018 and 2019). We compared clinical outcomes (in-hospital mortality, length of stay, 30-day readmission, intensive care utilization, receipt of endoscopy, persistent bleeding, receipt of second endoscopy, and need for angiographic or surgical intervention) using multivariable regression models, controlling for demographics, comorbidities, and severity of clinical presentation. Results There were 82.5 and 215.5 admissions per month for UGIB during the COVID-19 and control periods, respectively. There were no baseline differences between groups for demographic characteristics, comorbidities, or severity of bleeding. Patients in the COVID-19 group did not have significantly different unadjusted (3.9% vs 4.2%, P = 0.983) or adjusted mortality (adjusted odds ratio [OR] = 0.64, 95% confidence interval [CI] = 0.25-1.48, P = 0.322). Patients in COVID-19 group were less likely to receive endoscopy for UGIB in the unadjusted (61.8% vs 71.0%, P = 0.003) and adjusted (adjusted OR = 0.64, 95% CI = 0.49-0.84, P < 0.01) models. There were no differences between groups for other secondary outcomes. Conclusions While patients admitted for UGIB during the first wave of the pandemic were less likely to receive endoscopy, this had no impact on mortality or any secondary outcomes.
C1 [Khan, Rishad; Razak, Fahad; Verma, Amol A.; Grover, Samir C.] Univ Toronto, Dept Med, Toronto, ON, Canada.
   [Saha, Sudipta; Razak, Fahad; Verma, Amol A.; Grover, Samir C.] Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Gimpaya, Nikko; Bansal, Rishi; Scaffidi, Michael A.; Grover, Samir C.] St Michaels Hosp, Div Gastroenterol, Toronto, ON, Canada.
   [Razak, Fahad; Verma, Amol A.] St Michaels Hosp, Div Gen Internal Med, Toronto, ON, Canada.
RP Grover, SC (corresponding author), St Michaels Hosp, 16-046 Cardinal Carter Wing,30 Bond St, Toronto, ON M5B 1W8, Canada.
EM samir.grover@utoronto.ca
OI Bansal, Rishi/0000-0003-4381-7945; Gimpaya, Nikko/0000-0003-1015-4372;
   Khan, Rishad/0000-0002-5090-7685; Scaffidi, Michael/0000-0003-2068-6655
FU St. Michael's Hospital Foundation Association Innovation Fund Award
   [SMH-20-034]
FX This study was supported by St. Michael's Hospital Foundation
   Association Innovation Fund Award (SMH-20-034).
CR Aguila EJT., 2020, GASTROENTEROLOGY
   Annadurai V, 2021, DIGEST DIS, V39, P663, DOI 10.1159/000515431
   Armellini E, 2020, DIGEST LIVER DIS, V52, P695, DOI 10.1016/j.dld.2020.05.015
   Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574
   Button LA, 2011, ALIMENT PHARM THER, V33, P64, DOI 10.1111/j.1365-2036.2010.04495.x
   Castro EC, 2020, GASTROINTEST ENDOSC, V92, P440, DOI 10.1016/j.gie.2020.03.3854
   CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5
   Crespo J, 2021, J GASTROEN HEPATOL, V36, P1627, DOI 10.1111/jgh.15340
   De Filippo O, 2020, NEW ENGL J MED, V383, P88, DOI 10.1056/NEJMc2009166
   del Olmo JA, 2000, J HEPATOL, V32, P19
   Duan Z., 2021, GASTROENT RES PRACT, V6, P1
   El-Tawil AM, 2012, WORLD J GASTROENTERO, V18, P1154, DOI 10.3748/wjg.v18.i11.1154
   Hearnshaw SA, 2011, GUT, V60, P1327, DOI 10.1136/gut.2010.228437
   Jeffery MM, 2020, JAMA INTERN MED, V180, P1328, DOI 10.1001/jamainternmed.2020.3288
   Kim J, 2020, GASTROENTEROLOGY, V159, P1155, DOI 10.1053/j.gastro.2020.05.031
   Lahiff C, 2012, EUR J GASTROEN HEPAT, V24, P149, DOI 10.1097/MEG.0b013e32834e37d6
   Laine L, 2010, AM J GASTROENTEROL, V105, P540, DOI 10.1038/ajg.2009.702
   Lau LHS, 2020, GASTROENTEROLOGY, V159, P1979, DOI 10.1053/j.gastro.2020.07.042
   Lui TKL, 2021, ENDOSC INT OPEN, V09, pE284, DOI 10.1055/a-1333-1337
   Lui TKL, 2020, GASTROENTEROLOGY, V159, P1164, DOI 10.1053/j.gastro.2020.05.037
   Parasa S, 2020, GASTROENTEROLOGY, V159, P1579, DOI 10.1053/j.gastro.2020.06.009
   Park C., 2020, GLOBAL SHORTAGE PERS
   Repici A, 2020, GASTROENTEROLOGY, V159, P363, DOI 10.1053/j.gastro.2020.04.003
   Roberts SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049507
   Rockall TA, 1996, GUT, V38, P316, DOI 10.1136/gut.38.3.316
   Sagami R, 2021, AM J GASTROENTEROL, V116, P202, DOI 10.14309/ajg.0000000000000983
   Schmiderer A, 2020, ENDOSCOPY, V52, P1036, DOI 10.1055/a-1178-4656
   Sethi A., 2020, CLIN GASTROENTEROL H
   Tavabie OD, 2021, FRONTLINE GASTROENTE, V12, P279, DOI 10.1136/flgastro-2020-101592
   Verma AA., 2017, CMAJ OPEN, V5, pE842, DOI [10.9778/cmajo.20170097, DOI 10.9778/CMAJO.20170097]
   Verma AA, 2021, J AM MED INFORM ASSN, V28, P578, DOI 10.1093/jamia/ocaa225
   Vreeburg EM, 1999, GUT, V44, P331, DOI 10.1136/gut.44.3.331
   World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd
NR 33
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0815-9319
EI 1440-1746
J9 J GASTROEN HEPATOL
JI J. Gastroenterol. Hepatol.
DI 10.1111/jgh.15804
EA FEB 2022
PG 5
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA ZJ1PD
UT WOS:000762083300001
PM 35174540
DA 2022-04-20
ER

PT J
AU Kumar, A
   Narayan, RK
   Kulandhasamy, M
   Prasoon, P
   Kumari, C
   Kumar, S
   Pareek, V
   Sesham, K
   Shekhawat, PS
   Kant, K
   Kumar, S
AF Kumar, Ashutosh
   Narayan, Ravi K.
   Kulandhasamy, Maheswari
   Prasoon, Pranav
   Kumari, Chiman
   Kumar, Sujeet
   Pareek, Vikas
   Sesham, Kishore
   Shekhawat, Prakash S.
   Kant, Kamla
   Kumar, Santosh
TI COVID-19 pandemic: insights into molecular mechanisms leading to
   sex-based differences in patient outcomes
SO EXPERT REVIEWS IN MOLECULAR MEDICINE
LA English
DT Review
DE COVID-19; epigenetic mechanisms; evolution; genetics; SARS-CoV-2; sex;
   sex hormones
ID PLASMACYTOID DENDRITIC CELLS; IFN-ALPHA PRODUCTION; MEDIATED RESPONSE;
   IMMUNE-RESPONSES; ESTROGEN; EXPRESSION; SUSCEPTIBILITY; PATHOGENESIS
AB Recent epidemiological studies analysing sex-disaggregated patient data of coronavirus disease 2019 (COVID-19) across the world revealed a distinct sex bias in the disease morbidity as well as the mortality - both being higher for the men. Similar antecedents have been known for the previous viral infections, including from coronaviruses, such as severe acute respiratory syndrome (SARS) and middle-east respiratory syndrome (MERS). A sound understanding of molecular mechanisms leading to the biological sex bias in the survival outcomes of the patients in relation to COVID-19 will act as an essential requisite for developing a sex-differentiated approach for therapeutic management of this disease. Recent studies which have explored molecular mechanism(s) behind sex-based differences in COVID-19 pathogenesis are scarce; however, existing evidence, for other respiratory viral infections, viz. SARS, MERS and influenza, provides important clues in this regard. In attempt to consolidate the available knowledge on this issue, we conducted a systematic review of the existing empirical knowledge and recent experimental studies following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The qualitative analysis of the collected data unravelled multiple molecular mechanisms, such as evolutionary and genetic/epigenetic factors, sex-linkage of viral host cell entry receptor and immune response genes, sex hormone and gut microbiome-mediated immune-modulation, as the possible key reasons for the sex-based differences in patient outcomes in COVID-19.
C1 [Kumar, Ashutosh; Narayan, Ravi K.; Kulandhasamy, Maheswari; Prasoon, Pranav; Kumari, Chiman; Kumar, Sujeet; Pareek, Vikas; Sesham, Kishore; Shekhawat, Prakash S.; Kant, Kamla; Kumar, Santosh] Etiol Elus Disorders Res Network EEDRN, New Delhi, India.
   [Kumar, Ashutosh; Narayan, Ravi K.] All India Inst Med Sci AIIMS, Dept Anat, Patna, Bihar, India.
   [Kulandhasamy, Maheswari] Maulana Azad Med Coll MAMC, Dept Biochem, New Delhi, India.
   [Prasoon, Pranav] Univ Pittsburgh, Sch Med, Pittsburgh Ctr Pain Res, Pittsburgh, PA USA.
   [Kumari, Chiman] Postgrad Inst Med Educ & Res PGIMER, Dept Anat, Chandigarh, India.
   [Kumar, Sujeet] Amity Univ, Amity Inst Biotechnol, Ctr Prote & Drug Discovery, Mumbai, Maharashtra, India.
   [Pareek, Vikas] Indian Inst Technol, Ctr Cognit & Brain Sci, Gandhinagar, Gujarat, India.
   [Sesham, Kishore] All India Inst Med Sci AIIMS, Dept Anat, Mangalagiri, Andhra Pradesh, India.
   [Shekhawat, Prakash S.] Nil Ratan Sircar Med Coll & Hosp NRSMCH, Dept Hematol, Kolkata, India.
   [Kant, Kamla] All India Inst Med Sci AIIMS, Dept Microbiol, Bathinda, India.
   [Kumar, Santosh] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA.
RP Kumar, A (corresponding author), Etiol Elus Disorders Res Network EEDRN, New Delhi, India.; Kumar, A (corresponding author), All India Inst Med Sci AIIMS, Dept Anat, Patna, Bihar, India.
EM drashutoshkumar@aiimspatna.org
RI Kumar, Ashutosh/AAA-1035-2021; Prasoon, Pranav/AAE-4642-2022; Sesham,
   Kishore/AAG-6962-2022; NARAYAN, RAVI KANT/Y-7912-2019
OI Kumar, Ashutosh/0000-0003-1589-9568; Prasoon,
   Pranav/0000-0002-5035-3619; Sesham, Kishore/0000-0002-6196-5565;
   NARAYAN, RAVI KANT/0000-0003-2510-6744; Shekhawat, Prakash
   Singh/0000-0002-8164-3045
CR Alqahtani JS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233147
   [Anonymous], DATASET GLOBAL HLTH
   [Anonymous], SARS COV 2 RELATED P
   Baker JM, 2017, MATURITAS, V103, P45, DOI 10.1016/j.maturitas.2017.06.025
   Baratchian M., 2020, NO EVIDENCE ANDROGEN NO EVIDENCE ANDROGEN
   Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585
   Benetti E, 2020, EUR J HUM GENET, V28, P1602, DOI 10.1038/s41431-020-0691-z
   Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088
   Bhopal SS, 2020, LANCET, V396, P532, DOI 10.1016/S0140-6736(20)31748-7
   Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026
   Bukowska A, 2017, EXP BIOL MED, V242, P1412, DOI 10.1177/1535370217718808
   Bunders MJ, 2020, IMMUNITY, V53, P487, DOI 10.1016/j.immuni.2020.08.003
   Cao YN, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0147-1
   Maya WDC, 2020, REPROD BIOMED ONLINE, V40, P763, DOI [10.1016/j.rbmo.2020.04.0091472-6483, 10.1016/j.rbmo.2020.04.009]
   Cayan S, 2020, AGING MALE, V23, P1493, DOI 10.1080/13685538.2020.1807930
   Chang JJ, 2013, J INFECT DIS, V208, P830, DOI 10.1093/infdis/jit262
   Channappanavar R, 2017, J IMMUNOL, V198, P4046, DOI 10.4049/jimmunol.1601896
   Chu H, 2020, CLIN INFECT DIS, V71, P1400, DOI 10.1093/cid/ciaa410
   Coperchini F, 2020, CYTOKINE GROWTH F R, V53, P25, DOI 10.1016/j.cytogfr.2020.05.003
   Dehingia N, 2021, LANCET GLOB HEALTH, V9, pE14, DOI 10.1016/S2214-109X(20)30464-2
   Deshmukh V, 2021, J CLIN PATHOL, V74, P76, DOI 10.1136/jclinpath-2020-206995
   Dhar D, 2020, VIRUS RES, V285, DOI 10.1016/j.virusres.2020.198018
   Dhar SK, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06155
   Feng Y, 2017, J IMMUNOL, V199, P2106, DOI 10.4049/jimmunol.1700730
   Fink AL, 2018, P NATL ACAD SCI USA, V115, P12477, DOI 10.1073/pnas.1805268115
   Flanagan KL, 2017, ANNU REV CELL DEV BI, V33, P577, DOI 10.1146/annurev-cellbio-100616-060718
   Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111
   Fuseini H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02740
   Fuseini H, 2018, J IMMUNOL, V201, P1843, DOI 10.4049/jimmunol.1800293
   Gadi N, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02147
   Gause WC, 2020, NAT REV IMMUNOL, V20, P603, DOI 10.1038/s41577-020-0301-x
   Ghazizadeh Z., 2020, ANDROGEN REGULATES S ANDROGEN REGULATES S
   Glowacka I, 2010, J VIROL, V84, P1198, DOI 10.1128/JVI.01248-09
   Griesbeck M, 2015, J IMMUNOL, V195, P5327, DOI 10.4049/jimmunol.1501684
   Haagmans BL, 2004, NAT MED, V10, P290, DOI 10.1038/nm1001
   Haitao T, 2020, MAYO CLIN PROC, V95, P2189, DOI 10.1016/j.mayocp.2020.07.024
   Hall OJ, 2017, MUCOSAL IMMUNOL, V10, P1097, DOI 10.1038/mi.2017.35
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Hou Y, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01673-z
   Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152
   Karnam G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002710
   Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90
   Kucharzik T, 1998, CLIN EXP IMMUNOL, V111, P152
   Kumar A, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.110271
   Kumar A, 2020, MED HYPOTHESES, V145, DOI 10.1016/j.mehy.2020.110320
   Kumar S., 2020, INDIAN J PALLIAT CAR, V26, P89
   Laffont S, 2017, J EXP MED, V214, P1581, DOI 10.1084/jem.20161807
   Li SW, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050678
   Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460
   Mantlo E, 2020, ANTIVIR RES, V179, DOI 10.1016/j.antiviral.2020.104811
   Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004
   Mohamad NV, 2019, AGING MALE, V22, P129, DOI 10.1080/13685538.2018.1482487
   Mohamed MS, 2021, ENDOCRINE, V71, P3, DOI 10.1007/s12020-020-02536-6
   Montopoli M, 2020, ANN ONCOL, V31, P1040, DOI 10.1016/j.annonc.2020.04.479
   Nasiri MJ, 2020, FRONT MED-LAUSANNE, DOI DOI 10.3389/fmed.2020.00459
   Newcomb DC, 2015, J ALLERGY CLIN IMMUN, V136, P1025, DOI 10.1016/j.jaci.2015.05.046
   Peckham H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19741-6
   Peters MC, 2020, AM J RESP CRIT CARE, V202, P83, DOI 10.1164/rccm.202003-0821OC
   Pociask DA, 2013, AM J PATHOL, V182, P1286, DOI 10.1016/j.ajpath.2012.12.007
   Pontecorvi G, 2020, ACTA PHYSIOL, V230, DOI 10.1111/apha.13538
   Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4
   Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x
   Samuel RM, 2020, CELL STEM CELL, V27, P876, DOI 10.1016/j.stem.2020.11.009
   Sankaran-Walters S, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-10
   Scheuplein VA, 2015, J VIROL, V89, P3859, DOI 10.1128/JVI.03607-14
   Schurz H, 2019, HUM GENOMICS, V13, DOI 10.1186/s40246-018-0185-z
   Scully EP, 2020, NAT REV IMMUNOL, V20, P442, DOI 10.1038/s41577-020-0348-8
   Seillet C, 2012, BLOOD, V119, P454, DOI 10.1182/blood-2011-08-371831
   Shen QY, 2020, J CELL MOL MED, V24, P9472, DOI 10.1111/jcmm.15541
   Shin JH, 2019, RES MICROBIOL, V170, P192, DOI 10.1016/j.resmic.2019.03.003
   Singla V, 2020, 2020 IEEE INT INSTR, P1, DOI DOI 10.1109/I2MTC43012.2020.9128506
   Stopsack KH, 2020, CANCER DISCOV, V10, P779, DOI 10.1158/2159-8290.CD-20-0451
   Tadount F, 2020, VACCINE, V38, P444, DOI 10.1016/j.vaccine.2019.10.091
   Takahashi T, 2020, NATURE, V588, DOI 10.1038/s41586-020-2700-3
   Taneja V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01931
   Tukiainen T, 2017, NATURE, V550, P244, DOI 10.1038/nature24265
   Ubeda F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13849
   van der Made CI, 2020, JAMA-J AM MED ASSOC, V324, P663, DOI 10.1001/jama.2020.13719
   van Zyl-Smit RN, 2020, LANCET RESP MED, V8, P664, DOI 10.1016/S2213-2600(20)30239-3
   Viveiros A, 2021, AM J PHYSIOL-HEART C, V320, pH296, DOI 10.1152/ajpheart.00755.2020
   Wang ZP, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040920
   Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4
   World Health Organization, 2020, SMOK COVID 19
   Xu J, 2006, BIOL REPROD, V74, P410, DOI 10.1095/biolreprod.105.044776
   Xu KJ, 2020, CLIN INFECT DIS, V71, P799, DOI 10.1093/cid/ciaa351
   Yanez ND, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09826-8
   Zhang J, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02571-x
   Zhao Jing-min, 2003, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V17, P217
   Zheng SF, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1443
   Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017
   Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035
   Ziegler SM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01224
   Zipeto D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.576745
   Zuk M, 2010, SEX HORMONES AND IMMUNITY TO INFECTION, P1, DOI 10.1007/978-3-642-02155-8_1
NR 94
TC 4
Z9 4
U1 1
U2 4
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1462-3994
J9 EXPERT REV MOL MED
JI Expert Rev. Mol. Med.
PD AUG 3
PY 2021
VL 23
AR e7
DI 10.1017/erm.2021.9
PG 12
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA TU9PF
UT WOS:000681361000001
PM 34340720
OA Green Published
DA 2022-04-20
ER

PT J
AU Bag, S
   Dhamija, P
   Luthra, S
   Huisingh, D
AF Bag, Surajit
   Dhamija, Pavitra
   Luthra, Sunil
   Huisingh, Donald
TI How big data analytics can help manufacturing companies strengthen
   supply chain resilience in the context of the COVID-19 pandemic
SO INTERNATIONAL JOURNAL OF LOGISTICS MANAGEMENT
LA English
DT Article; Early Access
DE Supply chain resilience; Purchasing and supply capabilities; COVID-19;
   Pandemic uncertainties; Risks; RBV theory
ID RESOURCE-BASED THEORY; RISK-MANAGEMENT; ARTIFICIAL-INTELLIGENCE;
   BLOCKCHAIN TECHNOLOGY; OPERATIONS MANAGEMENT; DYNAMIC CAPABILITY;
   PERFORMANCE; LOGISTICS; IMPACT; OPTIMIZATION
AB Purpose In this paper, the authors emphasize that COVID-19 pandemic is a serious pandemic as it continues to cause deaths and long-term health effects, followed by the most prolonged crisis in the 21st century and has disrupted supply chains globally. This study questions "can technological inputs such as big data analytics help to restore strength and resilience to supply chains post COVID-19 pandemic?"; toward which authors identified risks associated with purchasing and supply chain management by using a hypothetical model to achieve supply chain resilience through big data analytics. Design/methodology/approach The hypothetical model is tested by using the partial least squares structural equation modeling (PLS-SEM) technique on the primary data collected from the manufacturing industries. Findings It is found that big data analytics tools can be used to help to restore and to increase resilience to supply chains. Internal risk management capabilities were developed during the COVID-19 pandemic that increased the company's external risk management capabilities. Practical implications The findings provide valuable insights in ways to achieve improved competitive advantage and to build internal and external capabilities and competencies for developing more resilient and viable supply chains. Originality/value To the best of authors' knowledge, the model is unique and this work advances literature on supply chain resilience.
C1 [Bag, Surajit] Univ Johannesburg, Dept Transport & Supply Chain Management, Johannesburg, South Africa.
   [Dhamija, Pavitra] Fortune Inst Int Business FHB, New Delhi, India.
   [Dhamija, Pavitra] Univ Johannesburg, Fac Engn & Built Environm, Ctr Excellence, Johannesburg, South Africa.
   [Luthra, Sunil] Ch Ranbir Singh State Inst Engn & Technol, Dept Mech Engn, Jhajjar, India.
   [Huisingh, Donald] Univ Tennessee, Coll Business Adm, Knoxville, TN USA.
RP Luthra, S (corresponding author), Ch Ranbir Singh State Inst Engn & Technol, Dept Mech Engn, Jhajjar, India.
EM sunilluthra1977@gmail.com
OI Luthra, Sunil/0000-0001-7571-1331; BAG, SURAJIT/0000-0002-2344-9551
CR Antony J, 2021, PROD PLAN CONTROL, V32, P889, DOI 10.1080/09537287.2020.1776410
   Aragon-Correa JA, 2003, ACAD MANAGE REV, V28, P71
   ARMSTRONG JS, 1977, J MARKETING RES, V14, P396, DOI 10.2307/3150783
   Bag Surajit, 2018, International Journal of Logistics Systems and Management, V30, P113
   Bag S, 2021, TECHNOL FORECAST SOC, V163, DOI 10.1016/j.techfore.2020.120420
   Bag S, 2020, RESOUR CONSERV RECY, V152, DOI 10.1016/j.resconrec.2019.104502
   Bag S, 2018, GLOB BUS REV, V19, pS176, DOI 10.1177/0972150918760051
   Bala PK, 2012, J MODEL MANAG, V7, P23, DOI 10.1108/17465661211208794
   Baryannis G, 2019, INT J PROD RES, V57, P2179, DOI 10.1080/00207543.2018.1530476
   Basole RC, 2014, DECISION SCI, V45, P753, DOI 10.1111/deci.12099
   Bell JE, 2010, J BUS LOGIST, V31, P157, DOI 10.1002/j.2158-1592.2010.tb00146.x
   Ben-Ammar O, 2019, INT J PROD ECON, V218, P106, DOI 10.1016/j.ijpe.2019.05.003
   Birkel HS, 2019, SUPPLY CHAIN MANAG, V24, P39, DOI 10.1108/SCM-03-2018-0142
   Bode C, 2011, ACAD MANAGE J, V54, P833, DOI 10.5465/AMJ.2011.64870145
   Bostrom M, 2015, J CLEAN PROD, V107, P1, DOI 10.1016/j.jclepro.2014.11.050
   Brandon-Jones A, 2018, INT J OPER PROD MAN, V38, P446, DOI 10.1108/IJOPM-10-2015-0656
   Brandon-Jones E, 2014, J SUPPLY CHAIN MANAG, V50, P55, DOI 10.1111/jscm.12050
   Brinch M, 2018, INT J LOGIST MANAG, V29, P555, DOI 10.1108/IJLM-05-2017-0115
   Calatayud A, 2019, SUPPLY CHAIN MANAG, V24, P22, DOI 10.1108/SCM-03-2018-0136
   CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016
   Chae B, 2014, DECIS SUPPORT SYST, V59, P119, DOI 10.1016/j.dss.2013.10.012
   Chiarini A, 2020, PROD PLAN CONTROL, V31, P1385, DOI 10.1080/09537287.2019.1710304
   Cole R, 2019, SUPPLY CHAIN MANAG, V24, P469, DOI 10.1108/SCM-09-2018-0309
   Colicchia C, 2019, SUPPLY CHAIN MANAG, V24, P5, DOI 10.1108/SCM-01-2018-0003
   Collins CJ, 2021, INT J HUM RESOUR MAN, V32, P331, DOI 10.1080/09585192.2019.1711442
   Cousins PD, 2019, INT J OPER PROD MAN, V39, P767, DOI 10.1108/IJOPM-11-2018-0676
   Craighead CW, 2020, DECISION SCI, V51, P838, DOI 10.1111/deci.12468
   Dash S.R., 2013, INT J SUPPLY CHAIN M, V2, P55
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Dolgui A, 2020, INT J PROD RES, V58, P4138, DOI 10.1080/00207543.2020.1774679
   Dolgui A, 2019, INT J PROD RES, pNIL_1, DOI 10.1080/00207543.2019.1627438
   Fahimnia Behnam, 2019, Decision Sciences, V50, P1127, DOI 10.1111/deci.12369
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Fortune, 2020, 94 FORT 1000 AR SEEI
   Giannakis Mihalis, 2016, International Journal of Production Economics, V171, P455, DOI 10.1016/j.ijpe.2015.06.032
   Goldbeck N, 2020, TRANSPORT RES E-LOG, V133, DOI 10.1016/j.tre.2019.101830
   Golgeci I, 2020, IND MARKET MANAG, V84, P63, DOI 10.1016/j.indmarman.2019.05.006
   Grover P, 2022, ANN OPER RES, V308, P177, DOI 10.1007/s10479-020-03683-9
   Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202
   Hallikas Jukka, 2016, International Journal of Production Economics, V171, P487, DOI 10.1016/j.ijpe.2015.09.013
   Hitt MA, 2016, J OPER MANAG, V41, P107, DOI 10.1016/j.jom.2015.11.004
   Hitt MA, 2016, J OPER MANAG, V41, P77, DOI 10.1016/j.jom.2015.11.002
   Hosseini S, 2020, INT J PROD RES, V58, P3284, DOI 10.1080/00207543.2019.1661538
   Hult GTM, 2010, DECISION SCI, V41, P435, DOI 10.1111/j.1540-5915.2010.00276.x
   Ivanov D, 2021, PROD PLAN CONTROL, V32, P775, DOI 10.1080/09537287.2020.1768450
   Ivanov D, 2020, INT J PROD RES, V58, P2904, DOI 10.1080/00207543.2020.1750727
   Ivanov D, 2019, IFAC PAPERSONLINE, V52, P337, DOI 10.1016/j.ifacol.2019.11.138
   Ivanov D, 2020, INT J PROD RES, V58, P3252, DOI 10.1080/00207543.2019.1634850
   Jabbour ABLD, 2020, PROD PLAN CONTROL, V31, P841, DOI 10.1080/09537287.2019.1695926
   Kamble SS, 2020, INT J PROD ECON, V219, P179, DOI 10.1016/j.ijpe.2019.05.022
   Kang S, 2008, J COMPUT INFORM SYST, V48, P25
   Kirilmaz O, 2017, J PURCH SUPPLY MANAG, V23, P54, DOI 10.1016/j.pursup.2016.04.002
   Koberg E, 2019, J CLEAN PROD, V207, P1084, DOI 10.1016/j.jclepro.2018.10.033
   Kock N., 2020, WARPPLS USER MANUAL
   Kock N, 2012, J ASSOC INF SYST, V13, P546, DOI 10.17705/1jais.00302
   Lai YY, 2018, INT J LOGIST MANAG, V29, P676, DOI 10.1108/IJLM-06-2017-0153
   Lavrakas P. J., 2008, ENCY SURVEY RES METH, DOI [10.4135/9781412963947, DOI 10.4135/9781412963947]
   Lawson B, 2019, INT J OPER PROD MAN, V39, P1076, DOI 10.1108/IJOPM-04-2018-0225
   Liu G, 2019, INT J OPER PROD MAN, V39, P1122, DOI 10.1108/IJOPM-09-2018-0578
   Mahapatra SK, 2012, J OPER MANAG, V30, P406, DOI 10.1016/j.jom.2012.03.004
   Min H, 2010, INT J LOGIST-RES APP, V13, P13, DOI 10.1080/13675560902736537
   Neirotti P, 2017, INFORM MANAGE-AMSTER, V54, P139, DOI 10.1016/j.im.2016.05.004
   Nkengasong JN, 2020, LANCET, V395, P841, DOI 10.1016/S0140-6736(20)30464-5
   Nunes LJR, 2020, RENEW SUST ENERG REV, V120, DOI 10.1016/j.rser.2019.109658
   Papadopoulos T, 2017, J CLEAN PROD, V142, P1108, DOI 10.1016/j.jclepro.2016.03.059
   Paulraj A, 2011, J SUPPLY CHAIN MANAG, V47, P19, DOI 10.1111/j.1745-493X.2010.03212.x
   Pettit TJ, 2019, J BUS LOGIST, V40, P56, DOI 10.1111/jbl.12202
   Queiroz MM, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03685-7
   Queiroz MM, 2018, INT J LOGIST MANAG, V29, P767, DOI 10.1108/IJLM-05-2017-0116
   Ritvanen V., 2008, PURCHASING SUPPLY MA
   Saberi S, 2019, INT J PROD RES, V57, P2117, DOI 10.1080/00207543.2018.1533261
   Sande JB, 2018, INT J RES MARK, V35, P185, DOI 10.1016/j.ijresmar.2018.01.005
   Sanders NR, 2019, J BUS LOGIST, V40, P229, DOI 10.1111/jbl.12224
   Sarkis J, 2020, RESOUR CONSERV RECY, V159, DOI 10.1016/j.resconrec.2020.104894
   Schauerte R, 2021, J CULT ECON, V45, P263, DOI 10.1007/s10824-020-09389-x
   Schoenherr Tobias, 2008, Journal of Purchasing and Supply Management, V14, P100, DOI 10.1016/j.pursup.2008.01.008
   Scholten K, 2019, INT J OPER PROD MAN, V40, P1, DOI 10.1108/IJOPM-01-2020-789
   Scuotto V, 2017, PROD PLAN CONTROL, V28, P1378, DOI 10.1080/09537287.2017.1375149
   Sedera D, 2016, INFORM MANAGE-AMSTER, V53, P366, DOI 10.1016/j.im.2016.01.001
   Shan SQ, 2019, TECHNOL ANAL STRATEG, V31, P406, DOI 10.1080/09537325.2018.1516866
   Shekarian M, 2020, INT J PROD ECON, V220, DOI 10.1016/j.ijpe.2019.07.011
   Sivarajah U, 2017, J BUS RES, V70, P263, DOI 10.1016/j.jbusres.2016.08.001
   Snacken R, 1999, EMERG INFECT DIS, V5, P195, DOI 10.3201/eid0502.990202
   Sogaard B, 2019, SUPPLY CHAIN MANAG, V24, P147, DOI 10.1108/SCM-03-2018-0087
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Time Magazine Special Edition, 2020, TIME MAGAZINE
   Trkman P, 2009, INT J PROD ECON, V119, P247, DOI 10.1016/j.ijpe.2009.03.002
   Tseng ML, 2019, RESOUR CONSERV RECY, V141, P145, DOI 10.1016/j.resconrec.2018.10.009
   TUMPA TJ, 2019, J CLEAN PROD, V228, P1552, DOI DOI 10.1016/J.JCLEPRO.2019
   Vidal E, 2018, STRATEGIC MANAGE J, V39, P131, DOI 10.1002/smj.2701
   Wagner S. M., 2006, Journal of Purchasing and Supply Management, V12, P301, DOI 10.1016/j.pursup.2007.01.004
   Wamba SF, 2018, INT J LOGIST MANAG, V29, P478, DOI 10.1108/IJLM-02-2018-0026
   Wang G, 2016, INT J PROD ECON, V176, P98, DOI 10.1016/j.ijpe.2016.03.014
   Wang YL, 2019, SUPPLY CHAIN MANAG, V24, P62, DOI 10.1108/SCM-03-2018-0148
   Whitten GD, 2012, INT J OPER PROD MAN, V32, P28, DOI 10.1108/01443571211195727
   Wong LW, 2020, INT J INFORM MANAGE, V52, DOI 10.1016/j.ijinfomgt.2019.08.005
   World Economic Forum-WEF, 2020, CHIN CAN REB GLOB SU
   World Economic Forum-WEF, 2020, WHAT DISR CAN TEACH
   Wu F, 2006, IND MARKET MANAG, V35, P493, DOI 10.1016/j.indmarman.2005.05.003
   Xue Y., 2006, J TECHNOLOGY MANAGEM, V1, P27, DOI DOI 10.1108/17468770610642740
   Yu KDS, 2020, PROC INTEGR OPTIM, V4, P183, DOI 10.1007/s41660-020-00113-y
   Zsidisin GA., 2003, J PURCHASING SUPPLY, V9, P217, DOI 10.1016/j.purs
NR 102
TC 0
Z9 0
U1 47
U2 68
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0957-4093
EI 1758-6550
J9 INT J LOGIST MANAG
JI Int. J. Logist. Manag.
DI 10.1108/IJLM-02-2021-0095
EA AUG 2021
PG 24
WC Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA TX9GY
UT WOS:000683395100001
OA Bronze
DA 2022-04-20
ER

PT J
AU Torres, C
   Ogbu-Nwobodo, L
   Alsan, M
   Stanford, FC
   Banerjee, A
   Breza, E
   Chandrasekhar, AG
   Eichmeyer, S
   Karnani, M
   Loisel, T
   Goldsmith-Pinkham, P
   Olken, BA
   Vautrey, PL
   Warner, E
   Duflo, E
AF Torres, Carlos
   Ogbu-Nwobodo, Lucy
   Alsan, Marcella
   Stanford, Fatima Cody
   Banerjee, Abhijit
   Breza, Emily
   Chandrasekhar, Arun G.
   Eichmeyer, Sarah
   Karnani, Mohit
   Loisel, Tristan
   Goldsmith-Pinkham, Paul
   Olken, Benjamin A.
   Vautrey, Pierre-Luc
   Warner, Erica
   Duflo, Esther
CA COVID 19 Working Grp
TI Effect of Physician-Delivered COVID-19 Public Health Messages and
   Messages Acknowledging Racial Inequity on Black and White Adults'
   Knowledge, Beliefs, and Practices Related to COVID-19 A Randomized
   Clinical Trial
SO JAMA NETWORK OPEN
LA English
DT Article
AB IMPORTANCE Social distancing is critical to the control of COVID-19, which has disproportionately affected the Black community. Physician-delivered messages may increase adherence to these behaviors.
   OBJECTIVES To determine whether messages delivered by physicians improve COVID-19 knowledge and preventive behaviors and to assess the differential effectiveness of messages tailored to the Black community.
   DESIGN, SETTING, AND PARTICIPANTS This randomized clinical trial of self-identified White and Black adults with less than a college education was conducted from August 7 to September 6, 2020. Of 44 743 volunteers screened, 30 174were eligible, 5534 did not consent or failed attention checks, and 4163 left the survey before randomization. The final sample had 20 460 individuals (participation rate, 68%). Participants were randomly assigned to receive video messages on COVID-19 or other health topics.
   INTERVENTIONS Participants saw video messages delivered either by a Black or a White study physician. In the control groups, participants saw 3 placebo videos with generic health topics. In the treatment group, they saw 3 videos on COVID-19, recorded by several physicians of varied age, gender, and race. Video 1 discussed common symptoms. Video 2 highlighted case numbers; in one group, the unequal burden of the disease by race was discussed. Video 3 described US Centers for Disease Control and Prevention social distancing guidelines. Participants in both the control and intervention groups were also randomly assigned to see 1 of 2 American Medical Association statements, one on structural racism and the other on drug price transparency.
   MAIN OUTCOMES AND MEASURES Knowledge, beliefs, and practices related to COVID-19, demand for information, willingness to pay for masks, and self-reported behavior.
   RESULTS Overall, 18 223 participants (9168 Black; 9055 White) completed the survey (9980 [55.9%] women, mean [SD] age, 40.2 [17.8] years). Overall, 6303 Black participants (34.6%) and 7842 White participants (43.0%) were assigned to the intervention group, and 1576 Black participants (8.6%) and 1968 White participants (10.8%) were assigned to the control group. Compared with the control group, the intervention group had smaller gaps in COVID-19 knowledge (incidence rate ratio [IRR], 0.89 [95% CI, 0.87-0.91]) and greater demand for COVID-19 information (IRR, 1.05 [95% CI, 1.01-1.11]), willingness to pay for a mask (difference, $0.50 [95% CI, $0.15-$0.85]). Self-reported safety behavior improved, although the difference was not statistically significant (IRR, 0.96 [95% CI, 0.92-1.01]; P =.08). Effects did not differ by race (F = 0.0112; P > .99) or in different intervention groups (F = 0.324; P > .99).
   CONCLUSIONS AND RELEVANCE In this study, a physician messaging campaign was effective in increasing COVID-19 knowledge, information-seeking, and self-reported protective behaviors among diverse groups. Studies implemented at scale are needed to confirm clinical importance.
C1 [Torres, Carlos; Ogbu-Nwobodo, Lucy; Stanford, Fatima Cody; Warner, Erica] Harvard Med Sch, Boston, MA 02115 USA.
   [Torres, Carlos] Massachusetts Gen Hosp Children, Dept Pediatrics General Pediat, Boston, MA USA.
   [Ogbu-Nwobodo, Lucy; Warner, Erica] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.
   [Ogbu-Nwobodo, Lucy] McLean Hosp, Dept Psychiat, Belmont, MA USA.
   [Alsan, Marcella] Harvard Kennedy Sch Govt, Cambridge, MA USA.
   [Stanford, Fatima Cody] Massachusetts Gen Hosp, Dept Pediatrics Endocrinol, Dept Med Neuroendocrine Unit, Boston, MA 02114 USA.
   [Banerjee, Abhijit; Karnani, Mohit; Olken, Benjamin A.; Vautrey, Pierre-Luc; Duflo, Esther] MIT, Dept Econ, Cambridge, MA USA.
   [Breza, Emily] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA.
   [Chandrasekhar, Arun G.] Stanford Univ, Dept Econ, Stanford, CA 94305 USA.
   [Eichmeyer, Sarah] Ludwig Maximilian Univ Munich, Dept Econ, Munich, Germany.
   [Loisel, Tristan] Paris Sch Econ, Paris, France.
   [Goldsmith-Pinkham, Paul] Yale Sch Management, New Haven, CT USA.
   [Warner, Erica] Massachusetts Gen Hosp, Clin Translat Epidemiol Unit, Boston, MA 02114 USA.
   [Duflo, Esther] MIT, Dept Econ, 77 Massachusetts Ave,Bldg E52-544, Cambridge, MA 02139 USA.
RP Duflo, E (corresponding author), MIT, Dept Econ, 77 Massachusetts Ave,Bldg E52-544, Cambridge, MA 02139 USA.
EM eduflo@mit.edu
OI Breza, Emily/0000-0002-4745-4689
FU National Science FoundationNational Science Foundation (NSF) [2029880];
   Executive Committee on Research at Massachusetts General Hospital;
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P30 DK040561, L30
   DK118710]; Massachusetts General Physicians Organization at
   Massachusetts General Hospital
FX Thisworkwas supported by grant 2029880 from the National Science
   Foundation to Drs Alsan and Duflo, the Physician/Scientist Development
   Award from the Executive Committee on Research at Massachusetts General
   Hospital to Dr Stanford, grant P30 DK040561from the National Institutes
   of Health to Dr Stanford, grant L30 DK118710 from the National
   Institutes of Health to Dr Stanford, and the Clinician-Teacher
   Development Award from the Massachusetts General Physicians Organization
   at Massachusetts General Hospital to Dr Torres.
CR Alsan M, 2021, ANN INTERN MED, V174, P484, DOI 10.7326/M20-6141
   American Medical Association, 2020, AMA BOARD TRUST PLED
   American Medical Association, 2019, AMA APPL CONGR ACT P
   Hainmueller J, 2012, POLIT ANAL, V20, P25, DOI 10.1093/pan/mpr025
   McDonnell Nieto del Rio G, NY TIMES
   US Census Bureau, 2019, 2018 POP EST AG SEX
   US Centers for Disease Control and Prevention, RISK COVID 19 INF HO
   Wertenbroch K, 2002, J MARKETING RES, V39, P228, DOI 10.1509/jmkr.39.2.228.19086
   Zhao J, PREPRINT
NR 9
TC 5
Z9 5
U1 2
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2574-3805
J9 JAMA NETW OPEN
JI JAMA Netw. Open
PD JUL 14
PY 2021
VL 4
IS 7
AR e2117115
DI 10.1001/jamanetworkopen.2021.17115
PG 13
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC General & Internal Medicine
GA TI7IN
UT WOS:000672973700008
PM 34259846
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ang, V
   Shar, LK
AF Ang, Vincent
   Shar, Lwin Khin
TI COVID-19 One Year on - Security and Privacy Review of Contact Tracing
   Mobile Apps
SO IEEE PERVASIVE COMPUTING
LA English
DT Article
DE COVID-19; Cryptography; Codes; Privacy; Pandemics; Databases; Government
AB The ongoing Coronavirus Disease 2019 (COVID-19) pandemic has caused 3.8 million deaths since December 2019. At the current vaccination pace, this global pandemic could persist for several years. Throughout the world, contact tracing (CT) apps were developed, which play a significant role in mitigating the spread of COVID-19. This work examines the current state of security and privacy landscape of mobile CT apps. Our work is the first attempt, to our knowledge, which provides a comprehensive analysis of 70 CT apps used worldwide as of the year Q1 2021. Among other findings, we observed that 80% of them may have handled sensitive data without adequate protection, 70% of them used weak cryptographic algorithms, and 35% of them embedded data trackers. We also observed key developments in app privacy protection and security assurance initiatives. Our findings provide useful insights into the design and deployment of more secure and privacy-preserving CT apps moving forward.
C1 [Ang, Vincent] Singapore Management Univ, Singapore 188065, Singapore.
   [Shar, Lwin Khin] Singapore Management Univ, Sch Comp & Informat Syst, Singapore 188065, Singapore.
RP Ang, V (corresponding author), Singapore Management Univ, Singapore 188065, Singapore.
EM weiyang.ang.2019@mais.smu.edu.sg; lkshar@smu.edu.sg
OI Shar, Lwin Khin/0000-0001-5130-0407; Ang, Vincent/0000-0002-3087-9111
CR Ahmed N, 2020, IEEE ACCESS, V8, P134577, DOI 10.1109/ACCESS.2020.3010226
   Amnesty International, 2020, BAHR KUW NORW CONT T
   [Anonymous], 2020, CHANNEL NEWS ASIA
   Binns R, 2018, WEBSCI'18: PROCEEDINGS OF THE 10TH ACM CONFERENCE ON WEB SCIENCE, P23, DOI 10.1145/3201064.3201089
   Blog A. D, 2021, NEW SAFETY SECTION G
   Dave P, 2020, NEW CONTACT TRACING
   Guo X., 2020, ARXIVABS200503599
   Gvili Y., 2020, IACR CRYPTOL EPRINT, V2020, P428
   Henley, 2021, GUARDIAN 0420
   Liang F, 2020, SOC MEDIA SOC, V6, DOI 10.1177/2056305120947657
   Loohuis K, 2021, DATA THOUSANDS DUTCH
   NIST National Vulnerability Database (NVD), 2020, CVE202012717 NIST NA
   Ranasinghe D. C., 2020, EMPIRICAL ASSESSMENT
   Raywood D, 2020, NHS CONTACT TRACING
   Ryan-Mosley T., 2020, MIT TECHNOLOGY REV C
   Saroha A, 2021, THEHINDU 0208
   Sato M, 2020, TECHNOL REV
   Starks T, 2020, EARLY COVID 19 TRACK
   Statista, 2021, MOBILE OPERATING SYS
   Vijayan J, 2019, RES SHOW SQLITE CAN
   Wang L, 2021, EMPIR SOFTW ENG, V26, DOI 10.1007/s10664-021-09974-4
   Whittaker Z, 2020, AUSTR SPY AGENCIES C
   WHO, 2020, NOV COR 2019 NCOV SI
   Zastrow Mark, 2020, Nature, DOI 10.1038/d41586-020-00740-y
NR 24
TC 0
Z9 0
U1 1
U2 1
PU IEEE COMPUTER SOC
PI LOS ALAMITOS
PA 10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA
SN 1536-1268
EI 1558-2590
J9 IEEE PERVAS COMPUT
JI IEEE Pervasive Comput.
PD OCT
PY 2021
VL 20
IS 4
BP 61
EP 70
DI 10.1109/MPRV.2021.3115478
PG 10
WC Computer Science, Information Systems; Engineering, Electrical &
   Electronic; Telecommunications
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science; Engineering; Telecommunications
GA XL4UE
UT WOS:000728139300015
DA 2022-04-20
ER

PT J
AU Houben-Wilke, S
   Delbressine, JM
   Vaes, AW
   Goertz, YMJ
   Meys, R
   Machado, FVC
   Van Herck, M
   Burtin, C
   Posthuma, R
   Franssen, FM
   van Loon, NHP
   Hajian, B
   Vijlbrief, H
   Spies, Y
   van't Hul, A
   Janssen, DJA
   Spruit, MA
AF Houben-Wilke, Sarah
   Delbressine, Jeannet M.
   Vaes, Anouk W.
   Goertz, Yvonne M. J.
   Meys, Roy
   Machado, Felipe V. C.
   Van Herck, Maarten
   Burtin, Chris
   Posthuma, Rein
   Franssen, Frits M. E.
   van Loon, Nicole H. P.
   Hajian, Bita
   Vijlbrief, Herman
   Spies, Yvonne
   Hul, Alex van 't
   Janssen, Daisy J. A.
   Spruit, Martijn A.
TI Understanding and Being Understood: Information and Care Needs of 2113
   Patients With Confirmed or Suspected COVID-19
SO JOURNAL OF PATIENT EXPERIENCE
LA English
DT Article
DE COVID-19; corona; unmet needs; information needs; long-term symptoms;
   social support
ID MODEL
AB To become a proactive and informed partner in postacute coronavirus disease 2019 (COVID-19) management, patients need to have the knowledge, skills, and confidence to self-manage COVID-19-related health challenges. Due to several restrictions and consequently social isolation, online platforms and forums where people can share information and experiences became more popular and influential. Therefore, this study aimed to identify perceived information needs and care needs of members of 2 Facebook groups for patients with COVID-19 and persistent complaints in the Netherlands and Belgium and patients with COVID-19 who registered at a website of the Lung Foundation Netherlands. Besides demographics and clinical characteristics, the degree of satisfaction with care during and after the infection as well as satisfaction with available information were assessed. Open text fields revealed specific information needs which were summarized. Patients with confirmed or suspected COVID-19 perceive various unmet needs varying from specific information needs (eg, information about permanent lung damage) to general needs (eg, being heard and understood). These data lead to several recommendations to improve care for patients with COVID-19 and justify further development of online platforms specifically addressing these unmet needs.
C1 [Houben-Wilke, Sarah; Delbressine, Jeannet M.; Vaes, Anouk W.; Goertz, Yvonne M. J.; Meys, Roy; Machado, Felipe V. C.; Van Herck, Maarten; Posthuma, Rein; Franssen, Frits M. E.; van Loon, Nicole H. P.; Hajian, Bita; Janssen, Daisy J. A.; Spruit, Martijn A.] Ciro, Dept Res & Dev, NL-6085NM Horn, Netherlands.
   [Goertz, Yvonne M. J.; Meys, Roy; Machado, Felipe V. C.; Van Herck, Maarten; Posthuma, Rein; Franssen, Frits M. E.; Hajian, Bita; Spruit, Martijn A.] Nutrim Sch Nutr & Translat Res Metab, Maastricht, Netherlands.
   [Goertz, Yvonne M. J.; Meys, Roy; Machado, Felipe V. C.; Van Herck, Maarten; Posthuma, Rein; Franssen, Frits M. E.; Hajian, Bita; Spruit, Martijn A.] Maastricht Univ Med Ctr MUMC, Dept Resp Med, Maastricht, Netherlands.
   [Van Herck, Maarten; Burtin, Chris] Hasselt Univ, Fac Rehabil Sci, BIOMED Biomed Res Inst, REVAL Rehabil Res Ctr, Diepenbeek, Belgium.
   [van Loon, Nicole H. P.] Maastricht Univ Med Ctr MUMC, Dept Internal Med, Maastricht, Netherlands.
   [Vijlbrief, Herman; Spies, Yvonne] Lung Fdn Netherlands, Amersfoort, Netherlands.
   [Hul, Alex van 't] Radboud Univ Nijmegen Med Ctr, Dept Pulm Dis, Nijmegen, Netherlands.
   [Janssen, Daisy J. A.] Maastricht Univ, Dept Hlth Serv Res, Care & Publ Hlth Res Inst, Fac Hlth Med & Life Sci, Maastricht, Netherlands.
RP Houben-Wilke, S (corresponding author), Ciro, Dept Res & Dev, NL-6085NM Horn, Netherlands.
EM sarahwilke@ciro-horn.nl
RI Machado, Felipe/AAA-7851-2020; Delbressine, Jeannet/AAE-2339-2022;
   Janssen, Daisy J.A./AAW-2248-2021
OI Janssen, Daisy J.A./0000-0002-1827-9869; Machado,
   Felipe/0000-0003-1910-7695
FU Lung Foundation Netherlands [4.1.16.085, 5.1.18.232]; EU-grant ZonMw
   ERACoSysMed [90030355]
FX The research team acknowledges the valuable input from the patient
   representatives to develop the survey, and the technical support by
   ASolutions' Martijn Briejers and Oscar Wagemakers. The scientific work
   of YMJG is financially supported by Lung Foundation Netherlands grant
   4.1.16.085, RM is financially supported by Lung Foundation Netherlands
   grant 5.1.18.232, and FVCM is financially supported by EU-grant ZonMw
   ERACoSysMed 90030355.
CR Abrams EM, 2020, J ALLER CL IMM-PRACT, V8, P2474, DOI 10.1016/j.jaip.2020.07.003
   Abrams EM, 2020, J ALLER CL IMM-PRACT, V8, P1791, DOI 10.1016/j.jaip.2020.04.012
   [Anonymous], 2020, PNEUMONIA UNKNOWN CA
   [Anonymous], 2020, COR PAT MET LANGD KL
   Bardel A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211532
   Cappuccio A, 2018, ERJ OPEN RES, V4, DOI 10.1183/23120541.00155-2017
   Chin J, 2011, J HEALTH COMMUN, V16, P222, DOI 10.1080/10810730.2011.604702
   Clarke MA, 2016, HEALTH INFORM J, V22, P992, DOI 10.1177/1460458215602939
   Cook NS, 2019, ERJ OPEN RES, V5, DOI 10.1183/23120541.00128-2018
   Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6
   Goertz YMJ, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00542-2020
   Graham B, 2019, EMERG MED J, V36, P355, DOI 10.1136/emermed-2018-208156
   Greenhalgh T, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b49
   Gutenbrunner C, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2713
   Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x
   Houben-Wilke S, 2017, EXPERT REV RESP MED, V11, P919, DOI 10.1080/17476348.2017.1392242
   Ladds E, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-06001-y
   Larson CO, 1996, INT J QUAL HEALTH C, V8, P447, DOI 10.1093/intqhc/8.5.447
   Meyer MA, 2020, J PATIENT EXPERIENCE, V7, P657, DOI 10.1177/2374373520959486
   Meys R, 2020, J CLIN MED, V9, DOI 10.3390/jcm9123993
   Public Facebook Group, 2020, COR ERV LANGD KLACHT
   Russo G, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11051315
   Ryan P, 2009, NURS OUTLOOK, V57, P217, DOI 10.1016/j.outlook.2008.10.004
   Spruit MA, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02197-2020
   Tongue John R, 2005, Instr Course Lect, V54, P3
   Vaes AW, 2020, J CLIN MED, V9, DOI 10.3390/jcm9092946
   Zhang L, 2015, PROCEDIA MANUF, V3, P200, DOI 10.1016/j.promfg.2015.07.129
NR 27
TC 4
Z9 4
U1 2
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2374-3743
EI 2374-3735
J9 J PATIENT EXPERIENCE
JI J. Patient Experience
PD MAR 5
PY 2021
VL 8
AR 2374373521997222
DI 10.1177/2374373521997222
PG 9
WC Health Care Sciences & Services
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services
GA SA2SJ
UT WOS:000649149900001
PM 34179387
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Lababidi, HMS
   Alzoraigi, U
   Almarshed, AA
   AlHarbi, W
   AlAmar, M
   Arab, AA
   Mukahal, MA
   AlAsmari, FA
   Mzahim, BY
   AlHarastani, HAM
   Alammi, SS
   AlAwad, YI
AF Lababidi, Hani M. S.
   Alzoraigi, Usamah
   Almarshed, Abdullah Abdulaziz
   AlHarbi, Waleed
   AlAmar, Mohamad
   Arab, Amer A.
   Mukahal, Mahmoud A.
   AlAsmari, Faisal A.
   Mzahim, Bandar Y.
   AlHarastani, Husam A. M.
   Alammi, Salem S.
   AlAwad, Yousef, I
TI Simulation-based training programme and preparedness testing for
   COVID-19 using system integration methodology
SO BMJ SIMULATION & TECHNOLOGY ENHANCED LEARNING
LA English
DT Article
DE simulation based Education; quality improvement; disaster simulation;
   emergency department; COVID-19
ID DISEASE
AB Background COVID-19 pandemic is presenting serious challenges to the world's healthcare systems. The high communicability of the COVID-19 necessitates robust medical preparedness and vigilance.
   Objective To report on the simulation-based training and test preparedness activities to prepare healthcare workers (HCWs) for effective and safe handling of patients with COVID-19.
   Methodology Two activities were conducted: simulation-based training to all HCWs and a full-scale unannounced simulation-based disaster exercise at King Fahad Medical City (KFMC). The online module was designed to enhance the knowledge on COVID-19. This module was available to all KFMC staff. The five hands-on practical part of the course was available to frontliner HCWs. The unannounced undercover simulated patients' full-scale COVID-19 simulation-based disaster exercise took place in the emergency department over 3 hours. Six scenarios were executed to test the existing plan in providing care of suspected COVID-19 cases.
   Results 2620 HCWs took the online module, 17 courses were conducted and 337 frontliner HCWs were trained. 94% of learners were satisfied and recommended the activity to others. The overall compliance rate of the full-scale COVID-19 disaster drill with infection control guidelines was 90%. Post-drill debriefing sessions recommended reinforcing PPE training, ensuring availability of different sizes of PPEs and developing an algorithm to transfer patients to designated quarantine areas.
   Conclusion Simulation-based training and preparedness testing activities are vital in identifying gaps to apply corrective actions immediately. In the presence of a highly hazardous contagious disease like COVID-19, such exercises are a necessity to any healthcare institution.
C1 [Lababidi, Hani M. S.] King Fahad Med City, Crit Care Adm, POB 59046, Riyadh 11525, Saudi Arabia.
   [Lababidi, Hani M. S.; Alzoraigi, Usamah; Almarshed, Abdullah Abdulaziz; AlHarbi, Waleed; AlAmar, Mohamad; Arab, Amer A.] King Fahad Med City, CRESENT, Riyadh, Saudi Arabia.
   [Mukahal, Mahmoud A.; AlAsmari, Faisal A.] King Fahad Med City, Infect Control Dept, Riyadh, Saudi Arabia.
   [Mzahim, Bandar Y.; AlHarastani, Husam A. M.; Alammi, Salem S.; AlAwad, Yousef, I] King Fahad Med City, Disaster Management Dept, Riyadh, Saudi Arabia.
RP Lababidi, HMS (corresponding author), King Fahad Med City, Crit Care Adm, POB 59046, Riyadh 11525, Saudi Arabia.
EM hanilab@hotmail.com
RI Alasmari, Faisal/AGW-9536-2022
CR Abualenain JT, 2018, J INFECT PUBLIC HEAL, V11, P796, DOI 10.1016/j.jiph.2018.05.002
   Almoziny S., 2018, ADV SIMUL, V3, pA2
   Azizalrahman A, 2018, P SAUDI HLTH SIMULAT, V3, P6
   Cao YB, 2020, ACAD EMERG MED, V27, P309, DOI 10.1111/acem.13951
   Cardenosa N, 2010, CLIN MICROBIOL INFEC, V16, P1365, DOI [10.1111/j.1469-0691.2010.03144.x, 10.1111/j.1469-0691.2009.03144.x]
   Dunn WF, 2013, COMPREHENSIVE TXB HE, P121
   Foote MMK, 2017, MMWR-MORBID MORTAL W, V66, P945, DOI 10.15585/mmwr.mm6636a2
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Hammerschmidt J, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4347-z
   Hsu SM, 2015, HEALTH SECUR, V13, P339, DOI 10.1089/hs.2015.0022
   Huh S, 2020, J EDUC EVAL HEALTH P, V17, DOI 10.3352/jeehp.2020.17.10
   International Councils of Nurses, HIGH PROP HEALTHC WO
   Jernigan DB, 2020, MMWR-MORBID MORTAL W, V69, P216, DOI 10.15585/mmwr.mm6908e1
   Klein Kelly R, 2004, Prehosp Disaster Med, V19, P256
   Lababidi H., 2018, P SAUDI HLTH SIMULAT, V3, P6
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Lee MH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229911
   McFadden KL, 2015, HEALTH CARE MANAGE R, V40, P24, DOI 10.1097/HMR.0000000000000006
   Murray Michael, 2004, CJEM, V6, P421
   Phrampus PE, 2016, SIMUL HEALTHC, V11, P82, DOI 10.1097/SIH.0000000000000137
   Ran L, 2020, CLIN INFECT DIS, V71, P2218, DOI 10.1093/cid/ciaa287
   Saudi MOH, PREV COVID 19 AR
   Schwartz J., 2020, CLIN INFECT DIS, V71, P858, DOI [DOI 10.1093/cid/ciaa255, 10.1093/cid/ciaa255]
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Spina S, 2020, LANCET, V395, pE49, DOI 10.1016/S0140-6736(20)30493-1
   Su Alice, 2020, LOS ANGELES TIMES
   Wang P, 2020, CLIN CHEM, V66, P644, DOI 10.1093/clinchem/hvaa080
NR 27
TC 8
Z9 9
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2056-6697
J9 BMJ SIMUL TECHNOL EN
JI BMJ Simul. Technol. Enhanc. Learn.
PD MAY
PY 2021
VL 7
IS 3
BP 126
EP 133
DI 10.1136/bmjstel-2020-000626
PG 8
WC Health Care Sciences & Services
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services
GA SB9TG
UT WOS:000650326800002
OA Green Published
DA 2022-04-20
ER

PT J
AU Ozdemir, S
   Ng, S
   Chaudhry, I
   Finkelstein, EA
AF Ozdemir, Semra
   Ng, Sean
   Chaudhry, Isha
   Finkelstein, Eric Andrew
TI Adoption of Preventive Behaviour Strategies and Public Perceptions About
   COVID-19 in Singapore
SO INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT
LA English
DT Article
DE COVID-19; Coronavirus; Preventive Behaviour Uptake; Public Perceptions;
   SARS-CoV-2; Singapore
ID KNOWLEDGE; INFLUENZA; OUTBREAK
AB Background: The unprecedented severity of coronavirus disease 2019 (COVID-19) constitutes a serious public health concern. However, adoption of COVID-19-related preventive behaviours remain relatively unknown. This study investigated predictors of preventive behaviours. Methods: An analytical sample of 897 Singaporean adults who were quota sampled based on age, gender, and ethnicity were recruited through a web-enabled survey. Outcomes were adoption of, or increased frequency of preventive behaviours (avoiding social events; avoiding public transport; reducing time spent shopping and eating out; wearing a mask in public; avoiding hospitals/clinics; keeping children out of school, washing hands/using sanitisers; keeping surroundings clean; avoiding touching public surfaces; working from/studying at home). Public perceptions regarding COVID-19 (chances of getting COVID-19; perceived likelihood of COVID-19-related intensive care unit (ICU) admission; government trust; self-efficacy; perceived appropriateness of COVID-19 behaviours; response efficacy), anxiety, and demographic characteristics (age; ethnicity; marital status; education; chronic conditions; current living arrangements) were investigated as predictors of preventive behaviours adopted during COVID-19 in binomial and ordered logistic regressions. Results: Though adoption of preventive behaviours among Singaporeans varied, it was, overall, high, and consistent with government recommendations. Nearly a quarter reported moderate to severe anxiety (General Anxiety Disorder 7-item - GAD-7 scores). Respondents who perceived higher COVID-19 risks, had higher government trust, higher self-efficacy, and perceived that others acted appropriately reported increased adoption/frequency of preventive measures. The strongest indicator of behavioural change was response efficacy. Respondents who were older, highly educated, anxious and married reported higher adoption/frequency of preventive measures. Conclusion: To successfully influence appropriate preventive behaviours, public health messages should highlight response efficacy, increase self-efficacy, and promote trust in governmental response. Focus should be on demographic segments with low adoptions, such as younger individuals and those with low education.
C1 [Ozdemir, Semra; Ng, Sean; Chaudhry, Isha; Finkelstein, Eric Andrew] Duke NUS Med Sch, Lien Ctr Palliat Care, Signature Programme Hlth Serv & Syst Res, Singapore, Singapore.
RP Ozdemir, S (corresponding author), Duke NUS Med Sch, Lien Ctr Palliat Care, Signature Programme Hlth Serv & Syst Res, Singapore, Singapore.
EM semra.ozdemir@duke-nus.edu.sg
OI Ozdemir, Semra/0000-0001-7556-1601; Ng, Sean/0000-0001-8406-2388;
   Chaudhry, Isha/0000-0002-9728-7399
FU Lien Centre for Palliative Care (LCPC Research), Duke-NUS Medical School
   [N-911-000-030-091]
FX This project is funded by Lien Centre for Palliative Care (LCPC Research
   N-911-000-030-091), Duke-NUS Medical School.
CR Abdulkareem SA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226483
   Aguero F, 2011, PREV MED, V53, P203, DOI 10.1016/j.ypmed.2011.06.018
   Ahmad M, 2020, ENVIRON RES, V190, DOI 10.1016/j.envres.2020.109995
   Ahmad T, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101607
   Ang J., 2020, STRAITS TIMES
   Ang P, 2020, THE ONLINE CITIZEN
   Bacon AM, 2020, BRIT J HEALTH PSYCH, V25, P839, DOI 10.1111/bjhp.12423
   Barnett DJ, 2005, PLOS MED, V2, P1235, DOI 10.1371/journal.pmed.0020359
   Barr M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-117
   Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5
   Carlson M, 2008, ASIAN J POLIT SCI, V16, P219, DOI 10.1080/02185370802504076
   Chee K., 2020, STRAITS TIMES 0206
   Cheong D, 2020, STRAIT TIMES 0403
   Chng S, 2019, TRANSP RES INTERDISC, V2, DOI [10.1016/j.trip.2019.100030, DOI 10.1016/J.TRIP.2019.100030]
   Clark Cory, 2020, Glob Transit, V2, P76, DOI 10.1016/j.glt.2020.06.003
   Davis MDM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1756-8
   Deurenberg-Yap M, 2005, HEALTH PROMOT INT, V20, P320, DOI 10.1093/heapro/dai010
   Eaton Jw, 2020, PERCEPTIONS BEHAV RE, P1
   Goh T, 2020, STRAITS TIMES 0131
   Government of Singapore, 2020, CLAR MIS RUM REG COV
   Government of Singapore, CIRC BREAK EXT TIGHT
   Government of Singapore, 2020, UPD COVID 19 COR DIS
   Government of Singapore, CORR CLAR REG FALS P
   Harper CA, 2021, INT J MENT HEALTH AD, V19, P1875, DOI 10.1007/s11469-020-00281-5
   Iau J., 2020, STRAITS TIMES 0420
   Imhoff R, 2020, SOC PSYCHOL PERS SCI, V11, P1110, DOI 10.1177/1948550620934692
   Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233744
   Khafaie Morteza Abdullatif, 2020, Osong Public Health Res Perspect, V11, P74, DOI 10.24171/j.phrp.2020.11.2.03
   Khalik S, 2020, STRAITS TIMES 0201
   Kurohi R., 2020, ASIAONE
   Lee M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17092977
   Leung K, 2020, LANCET, V395, P1382, DOI 10.1016/S0140-6736(20)30746-7
   Li SY, 2020, J MED INTERNET RES, V22, DOI 10.2196/19782
   Ling S, 2020, THE ONLINE CITIZEN
   Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021
   Lythgoe MP, 2020, TRENDS PHARMACOL SCI, V41, P363, DOI 10.1016/j.tips.2020.03.006
   Niu ZM, 2020, J MED INTERNET RES, V22, DOI 10.2196/19995
   ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803
   Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651
   Rudan I, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010335
   Sadique MZ, 2007, EMERG INFECT DIS, V13, P1307, DOI 10.3201/eid1309.070372
   Seale H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235112
   Sharifirad Gholamreza, 2014, J Educ Health Promot, V3, P7, DOI 10.4103/2277-9531.127556
   Sim SW, 2014, SINGAP MED J, V55, P160
   Singapore Department of Statistics, POP TRENDS 2019
   Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Stephenson N, 2014, SOC SCI MED, V102, P10, DOI 10.1016/j.socscimed.2013.11.031
   The Straits Times, 2020, STRAITS TIMES 0327
   Truman BI, 2009, AM J PUBLIC HEALTH, V99, pS278, DOI 10.2105/AJPH.2008.154054
   Vaughan E, 2009, AM J PUBLIC HEALTH, V99, pS324, DOI 10.2105/AJPH.2009.162537
   Wei AC., 2020, STRAITS TIMES 0509
   Wei T.T., 2020, STRAITS TIMES
   Worldometer, 2020, COVID 19 CORONAVIRUS
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yi Y, 2020, INT J BIOL SCI, V16, P1753, DOI 10.7150/ijbs.45134
   Yildirim M, 2022, DEATH STUD, V46, P979, DOI 10.1080/07481187.2020.1793434
   Zahraei SM, 2016, ADV INTELL SYST, V426, P135, DOI 10.1007/978-3-319-29643-2_10
   Zhai YD, 2017, INT J COMP SOCIOL, V58, P120, DOI 10.1177/0020715217694078
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 60
TC 13
Z9 13
U1 5
U2 10
PU KERMAN UNIV MEDICAL SCIENCES
PI KERMAN
PA JAHAD BLVD, KERMAN, 7619813159, IRAN
EI 2322-5939
J9 INT J HEALTH POLICY
JI Int. J. Health Policy Manag.
PD MAY
PY 2022
VL 11
IS 5
BP 579
EP 591
DI 10.34172/ijhpm.2020.199
EA OCT 2020
PG 13
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA ZX6WK
UT WOS:000720033400001
PM 33105971
OA gold
DA 2022-04-20
ER

PT J
AU Mezghani, T
   Ben Hamadou, F
   Abbes, MB
AF Mezghani, Taicir
   Ben Hamadou, Fatma
   Abbes, Mouna Boujelbene
TI The dynamic network connectedness and hedging strategies across stock
   markets and commodities: COVID-19 pandemic effect
SO ASIA-PACIFIC JOURNAL OF BUSINESS ADMINISTRATION
LA English
DT Article
DE Network connectedness; Stock markets; Commodity markets; 2014 oil price
   drop; COVID-19 pandemic; Hedging strategy
ID CRUDE-OIL; SAFE HAVEN; VOLATILITY SPILLOVERS; PORTFOLIO MANAGEMENT;
   FINANCIAL CRISIS; PRECIOUS-METAL; TIME-SERIES; GOLD; RISK; PRICE
AB Purpose The aim of this study was to investigate the dynamic network connectedness between stock markets and commodity futures and its implications on hedging strategies. Specifically, the authors studied the impact of the 2014 oil price drop and coronavirus disease 2019 (COVID-19) pandemic on risk spillovers and portfolio allocation among stock markets (United States (SP500), China (SSEC), Japan (Nikkei 225), France (CAC40) and Germany (DAX)) and commodities (oil and gold). Design/methodology/approach In this study, the authors used the Baba, Engle, Kraft and Kroner-generalized autoregressive conditional heteroskedasticity (BEKK-GARCH) model to estimate shock transmission among the five financial markets and the two commodities. The authors rely on Diebold and Yilmaz (2014, 2015) methodology to construct network-associated measures. Findings Relying on the BEKK-GARCH, the authors found that the recent health crisis of COVID-19 intensified the volatility spillovers among stock markets and commodities. Using the dynamic network connectedness, the authors showed that at the 2014 oil price drop and the COVID-19 pandemic shock, the Nikkei225 moderated the transmission of volatility to the majority of markets. During the COVID-19 pandemic, the commodity markets are a net receiver of volatility shocks from stock markets. In addition, the SP500 stock market dominates the network connectedness dynamic during the COVID-19 pandemic, while DAX index is the weakest risk transmitter. Regarding the portfolio allocation and hedging strategies, the study showed that the oil market is the most vulnerable and risky as it was heavily affected by the two crises. The results show that gold is a hedging tool during turmoil periods. Originality/value This study contributes to knowledge in this area by improving our understanding of the influence of fluctuations in oil prices on the dynamics of the volatility connection between stock markets and commodities during the COVID-19 pandemic shock. The study's findings provide more implications regarding portfolio management and hedging strategies that could help investors optimize their portfolios.
C1 [Mezghani, Taicir; Ben Hamadou, Fatma; Abbes, Mouna Boujelbene] Univ Sfax, Fac Econ & Management Sfax, Sfax, Tunisia.
RP Mezghani, T (corresponding author), Univ Sfax, Fac Econ & Management Sfax, Sfax, Tunisia.
EM taicir.mezghani@yahoo.fr
RI Mezghani, Taicir/AAG-5384-2019
OI Mezghani, Taicir/0000-0002-4751-1508; Ben Hamadou,
   Fatma/0000-0003-3320-3931
CR Abbes MB, 2013, INT J MANAG FINANC A, V5, P138, DOI 10.1504/IJMFA.2013.053209
   Abdelhedi M, 2020, INT J EMERG MARK, V15, P262, DOI 10.1108/IJOEM-07-2017-0244
   Akhtaruzzaman M, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101604
   Al-Awadhi AM, 2020, J BEHAV EXP FINANC, V27, DOI 10.1016/j.jbef.2020.100326
   Allen F, 2000, J POLIT ECON, V108, P1, DOI 10.1086/262109
   Aloui D., 2020, SSRN ELECT J, P1, DOI [10.2139/ssrn.3587740, DOI 10.2139/SSRN.3587740]
   An SF, 2018, PHYSICA A, V503, P1241, DOI 10.1016/j.physa.2018.08.063
   Arouri ME, 2012, ENERG ECON, V34, P611, DOI 10.1016/j.eneco.2011.08.009
   Askari M, 2018, PHYSICA A, V501, P164, DOI 10.1016/j.physa.2018.02.153
   Azimli A, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101648
   Baur DG, 2010, FINAN REV, V45, P217, DOI 10.1111/j.1540-6288.2010.00244.x
   Baur DG, 2010, J BANK FINANC, V34, P1886, DOI 10.1016/j.jbankfin.2009.12.008
   Bialkowski J, 2015, INT REV FINANC ANAL, V41, P329, DOI 10.1016/j.irfa.2014.07.001
   Billio M, 2012, J FINANC ECON, V104, P535, DOI 10.1016/j.jfineco.2011.12.010
   Bredin D, 2015, INT REV FINANC ANAL, V41, P320, DOI 10.1016/j.irfa.2015.01.010
   Chakrabarti P, 2021, APPL ECON, V53, P2930, DOI 10.1080/00036846.2020.1870654
   Chang CL, 2011, ENERG ECON, V33, P912, DOI 10.1016/j.eneco.2011.01.009
   CHEN NF, 1986, J BUS, V59, P383, DOI 10.1086/296344
   Chen P, 2015, ENERG POLICY, V87, P284, DOI 10.1016/j.enpol.2015.09.024
   Choudhry T, 2015, INT REV FINANC ANAL, V41, P247, DOI 10.1016/j.irfa.2015.03.011
   Cimini R, 2015, FINANC RES LETT, V14, P160, DOI 10.1016/j.frl.2015.05.003
   Ciner C, 2013, INT REV FINANC ANAL, V29, P202, DOI 10.1016/j.irfa.2012.12.001
   Conlon T, 2020, FINANC RES LETT, V35, DOI 10.1016/j.frl.2020.101607
   Corbet S, 2020, FINANC RES LETT, V35, DOI 10.1016/j.frl.2020.101554
   Dastkhan H, 2018, PHYSICA A, V492, P324, DOI 10.1016/j.physa.2017.09.089
   Diebold FX, 2014, J ECONOMETRICS, V182, P119, DOI 10.1016/j.jeconom.2014.04.012
   Diebold FX, 2012, INT J FORECASTING, V28, P57, DOI 10.1016/j.ijforecast.2011.02.006
   DIEBOLD FX, 2015, J ECON LIT, V53, P1021
   ENGLE RF, 1995, ECONOMET THEOR, V11, P122, DOI 10.1017/S0266466600009063
   Fantazzini D, 2016, ENERG POLICY, V96, P383, DOI 10.1016/j.enpol.2016.06.020
   Ghazali MF, 2020, SINGAP ECON REV, V65, P275, DOI 10.1142/S021759081950036X
   Gil-Alana LA, 2017, RESOUR POLICY, V53, P117, DOI 10.1016/j.resourpol.2017.06.006
   Goodell JW, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101625
   Goodell JW, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101578
   Guesmi K, 2018, ENERG J, V39, P97, DOI 10.5547/01956574.39.SI2.kgue
   Hamilton, 2014, ECONBROWER BLOG ENTR, V14
   Hammoudeh S, 2008, ENERG ECON, V30, P606, DOI 10.1016/j.eneco.2007.09.004
   He X, 2020, ENERG ENVIRON-UK, V31, P1416, DOI 10.1177/0958305X20907081
   Huynh TLD, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03680-y
   Jacomy M, 2009, GEPHI OPEN SOURCE SO, DOI DOI 10.1136/QSHC.2004.010033
   Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679
   Ji Q, 2018, ENERG ECON, V75, P14, DOI 10.1016/j.eneco.2018.08.015
   Joy M, 2011, FINANC RES LETT, V8, P120, DOI 10.1016/j.frl.2011.01.001
   Junttila J, 2018, J INT FINANC MARK I, V56, P255, DOI 10.1016/j.intfin.2018.01.002
   Kang SH, 2017, ENERG ECON, V62, P19, DOI 10.1016/j.eneco.2016.12.011
   Kilian L, 2014, J APPL ECONOMET, V29, P454, DOI 10.1002/jae.2322
   Kroner KF, 1998, REV FINANC STUD, V11, P817, DOI 10.1093/rfs/11.4.817
   Ku YHH, 2007, APPL ECON LETT, V14, P503, DOI 10.1080/13504850500447331
   Kumar D, 2014, IIMB MANAG REV, V26, P5, DOI 10.1016/j.iimb.2013.12.002
   Lau MCK, 2017, INT REV FINANC ANAL, V52, P316, DOI 10.1016/j.irfa.2017.04.001
   Li SL, 2017, J COMMOD MARK, V7, P1, DOI 10.1016/j.jcomm.2017.05.003
   Liu XY, 2017, PHYSICA A, V479, P265, DOI 10.1016/j.physa.2017.03.016
   Luo JW, 2018, ENERG ECON, V76, P424, DOI 10.1016/j.eneco.2018.10.031
   Maghyereh AI, 2017, ENERG ECON, V68, P440, DOI 10.1016/j.eneco.2017.10.025
   Majapa M, 2016, PHYSICA A, V445, P35, DOI 10.1016/j.physa.2015.10.108
   Majdoub J, 2014, N AM J ECON FINANC, V29, P452, DOI 10.1016/j.najef.2014.06.011
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   Mensi W, 2018, FINANC RES LETT, V25, P230, DOI 10.1016/j.frl.2017.10.032
   Mensi W, 2017, N AM J ECON FINANC, V41, P133, DOI 10.1016/j.najef.2017.03.006
   Mensi W, 2015, ECON MODEL, V51, P340, DOI 10.1016/j.econmod.2015.08.005
   Mezghani T, 2018, INT J ISLAMIC MIDDLE, V11, P157, DOI 10.1108/IMEFM-08-2017-0227
   Minoiu C, 2013, J FINANC STABIL, V9, DOI 10.1016/j.jfs.2013.03.001
   Narayan, 2020, ASIAN EC LETT, V1, P17654, DOI [10.46557/001c.17654, DOI 10.46557/001C.17654]
   Narayan P.K., 2020, ENERGY RES LETT, V1, P13176, DOI [10.46557/001c.13176, 10.46557/ 001c.13176, DOI 10.46557/001C.13176]
   Narayan P.K., 2020, ASIAN EC LETT, V1, DOI [10.46557/001c. 17389, DOI 10.46557/001C.17389, 10.46557/001c.17389]
   Olson E, 2017, RES INT BUS FINANC, V42, P1274, DOI 10.1016/j.ribaf.2017.07.064
   Reboredo JC, 2013, J BANK FINANC, V37, P2665, DOI 10.1016/j.jbankfin.2013.03.020
   Salisu AA, 2020, INT REV ECON FINANC, V69, P280, DOI 10.1016/j.iref.2020.06.023
   Schell D, 2020, J BEHAV EXP FINANC, V27, DOI 10.1016/j.jbef.2020.100349
   Shahzad SJH, 2020, ECON MODEL, V87, P212, DOI 10.1016/j.econmod.2019.07.023
   Sharif A, 2020, INT REV FINANC ANAL, V70, DOI 10.1016/j.irfa.2020.101496
   Stocker M., 2015, GREAT PLUNGE OIL PRI, DOI [DOI 10.2139/SSRN.2624398, 10.2139/ssrn.2624398]
   Tiwari AK, 2020, ENERG ECON, V85, DOI 10.1016/j.eneco.2019.104529
   Tsiotas D, 2018, PHYSICA A, V505, P280, DOI 10.1016/j.physa.2018.03.055
   Wang J, 2020, CHAOS SOLITON FRACT, V136, DOI 10.1016/j.chaos.2020.109896
   World Health Organization, 2020, DIR GEN REM MED BRIE
   Xi X, 2018, PHYSICA A, V490, P1309, DOI 10.1016/j.physa.2017.08.114
   Yarovaya L, 2020, SSRN ELECT J, DOI [10.2139/ssrn.3602973, DOI 10.2139/SSRN.3602973]
   Yu JW, 2018, PHYSICA A, V490, P1335, DOI 10.1016/j.physa.2017.08.046
   Zhang CG, 2014, ENERG POLICY, V66, P32, DOI 10.1016/j.enpol.2013.09.067
   Zhang DY, 2020, INT REV FINANC ANAL, V68, DOI 10.1016/j.irfa.2018.08.003
   Zhang DY, 2017, ENERG ECON, V62, P323, DOI 10.1016/j.eneco.2017.01.009
   Zhang WT, 2020, ENERGIES, V13, DOI 10.3390/en13030727
   Zhao LF, 2018, PHYSICA A, V506, P1104, DOI 10.1016/j.physa.2018.05.039
NR 84
TC 1
Z9 1
U1 3
U2 5
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1757-4323
EI 1757-4331
J9 ASIA-PAC J BUS ADM
JI Asia-Pac. J. Bus. Adm.
PD OCT 18
PY 2021
VL 13
IS 4
BP 520
EP 552
DI 10.1108/APJBA-01-2021-0036
EA JUL 2021
PG 33
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA WJ3ES
UT WOS:000674995100001
OA Bronze
DA 2022-04-20
ER

PT J
AU Estrada, ADB
   Parra, JC
   Carracedo, EF
   Miguez, AM
   Martinez, AR
   Rubio, EM
   Rubio-Rivas, M
   Agudo, P
   Fernandez, FA
   Perez, VE
   Martinez, MLT
   Vieitez, AC
   Fontan, PMP
   Bustamante, M
   Freire, SJ
   Oriol-Bermudez, I
   Artero, A
   Sierra, JO
   Manrique, MA
   Carrasco-Sanchez, HFJ
   Vento, VC
   Garcia, GMG
   Cubero-Morais, P
   Casas-Rojo, JM
   Nunez-Cortes, JM
AF Bendala Estrada, Alejandro David
   Calderon Parra, Jorge
   Fernandez Carracedo, Eduardo
   Muino Miguez, Antonio
   Ramos Martinez, Antonio
   Munez Rubio, Elena
   Rubio-Rivas, Manuel
   Agudo, Paloma
   Arnalich Fernandez, Francisco
   Estrada Perez, Vicente
   Taboada Martinez, Maria Luisa
   Crestelo Vieitez, Anxela
   Pesqueira Fontan, Paula Maria
   Bustamante, Marta
   Freire, Santiago J.
   Oriol-Bermudez, Isabel
   Artero, Arturo
   Olalla Sierra, Julian
   Areses Manrique, Maria
   Javier Carrasco-Sanchez, H. Francisco
   Carolina Vento, Vanessa
   Garcia Garcia, Gema Maria
   Cubero-Morais, Pablo
   Casas-Rojo, Jose-Manuel
   Millan Nunez-Cortes, Jesus
TI Inadequate use of antibiotics in the covid-19 era: effectiveness of
   antibiotic therapy
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE COVID-19; SARS-CoV-2; Antibiotics; Survival; Macrolides; Azithromycin
ID BACTERIAL COINFECTION; INFLUENZA; INFECTION; ADULTS; SARS-COV-2;
   GUIDELINE; PNEUMONIA; VIRUS
AB Background Since December 2019, the COVID-19 pandemic has changed the concept of medicine. This work aims to analyze the use of antibiotics in patients admitted to the hospital due to SARS-CoV-2 infection. Methods This work analyzes the use and effectiveness of antibiotics in hospitalized patients with COVID-19 based on data from the SEMI-COVID-19 registry, an initiative to generate knowledge about this disease using data from electronic medical records. Our primary endpoint was all-cause in-hospital mortality according to antibiotic use. The secondary endpoint was the effect of macrolides on mortality. Results Of 13,932 patients, antibiotics were used in 12,238. The overall death rate was 20.7% and higher among those taking antibiotics (87.8%). Higher mortality was observed with use of all antibiotics (OR 1.40, 95% CI 1.21-1.62; p < .001) except macrolides, which had a higher survival rate (OR 0.70, 95% CI 0.64-0.76; p < .001). The decision to start antibiotics was influenced by presence of increased inflammatory markers and any kind of infiltrate on an x-ray. Patients receiving antibiotics required respiratory support and were transferred to intensive care units more often. Conclusions Bacterial co-infection was uncommon among COVID-19 patients, yet use of antibiotics was high. There is insufficient evidence to support widespread use of empiric antibiotics in these patients. Most may not require empiric treatment and if they do, there is promising evidence regarding azithromycin as a potential COVID-19 treatment.
C1 [Bendala Estrada, Alejandro David; Fernandez Carracedo, Eduardo; Muino Miguez, Antonio; Millan Nunez-Cortes, Jesus] Gregorio Maranon Gen Univ Hosp, Internal Med Dept, Madrid, Spain.
   [Calderon Parra, Jorge; Ramos Martinez, Antonio; Munez Rubio, Elena] Puerta Hierro Majadahonda Univ Hosp, Internal Med Dept, Madrid, Spain.
   [Rubio-Rivas, Manuel] Bellvitge Univ Hosp IDIBELL, Internal Med Dept, Barcelona, Spain.
   [Agudo, Paloma] 12 Octubre Univ Hosp, Internal Med Dept, Madrid, Spain.
   [Arnalich Fernandez, Francisco] La Paz Univ Hosp, Internal Med Dept, Madrid, Spain.
   [Estrada Perez, Vicente] San Carlos Clin Hosp, Internal Med Dept, Madrid, Spain.
   [Taboada Martinez, Maria Luisa] Cabuenes Univ Hosp, Internal Med Dept, Gijon, Asturias, Spain.
   [Crestelo Vieitez, Anxela] Royo Villanova Hosp, Internal Med Dept, Zaragoza, Spain.
   [Pesqueira Fontan, Paula Maria] Santiago Clin Hosp, Internal Med Dept, Santiago De Compostela, A Coruna, Spain.
   [Bustamante, Marta] La Princesa Univ Hosp, Internal Med Dept, Madrid, Spain.
   [Freire, Santiago J.] A Coruna Univ Hosp, Internal Med Dept, La Coruna, Spain.
   [Oriol-Bermudez, Isabel] Moises Broggi Hosp, Internal Med Dept, Infect Dis, Barcelona, Spain.
   [Artero, Arturo] Dr Peset Univ Hosp, Internal Med Dept, Valencia, Spain.
   [Olalla Sierra, Julian] Costa del Sol Hosp, Internal Med Dept, Malaga, Spain.
   [Areses Manrique, Maria] Santa Marina Hosp, Internal Med Dept, Bilbao, Spain.
   [Javier Carrasco-Sanchez, H. Francisco] Juan Ramon Jimenez Univ Hosp, Internal Med Dept, Huelva, Spain.
   [Carolina Vento, Vanessa] Henares Hosp, Internal Med Dept, Madrid, Spain.
   [Garcia Garcia, Gema Maria] Badajoz Univ Hosp Complex, Internal Med Dept, Badajoz, Spain.
   [Cubero-Morais, Pablo] Rio Hortega Univ Hosp, Internal Med Dept, Reg Hlth Management Castilla & Leon SACYL, Valladolid, Spain.
   [Casas-Rojo, Jose-Manuel] Infanta Cristina Univ Hosp, Internal Med Dept, Madrid, Spain.
RP Estrada, ADB (corresponding author), Gregorio Maranon Gen Univ Hosp, Internal Med Dept, Madrid, Spain.
EM alejandro.bendala@gmail.com
RI Sánchez, Francisco Javier Carrasco/T-9558-2019; Calderon-Parra,
   Jorge/AGJ-4075-2022; Ramos-Martinez, Antonio/G-5535-2016
OI Sánchez, Francisco Javier Carrasco/0000-0002-9275-7056; Calderon-Parra,
   Jorge/0000-0002-0369-9369; Bendala Estrada,
   Alejandro/0000-0002-7705-2656; Fernandez Carracedo,
   Eduardo/0000-0001-6105-6647; Casas Rojo, Jose
   Manuel/0000-0002-6649-4301; Oriol, Isabel/0000-0001-5542-7878;
   Ramos-Martinez, Antonio/0000-0002-4840-9425
CR Abelenda-Alonso G, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa066
   Alhazzani W, 2020, CRIT CARE MED, V48, pE440, DOI [10.1097/CCM.0000000000004363, 10.1007/s00134-020-06022-5]
   [Anonymous], 2021, SIT COVID 19 ESP
   [Anonymous], 2020, COR DIS 2019 COVID 1
   Argenziano Michael G, 2020, medRxiv, DOI 10.1101/2020.04.20.20072116
   Baron SA, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105944
   Bengoechea JA, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012560
   Beovic B, 2020, J ANTIMICROB CHEMOTH, V75, P3386, DOI 10.1093/jac/dkaa326
   Bezerra PGM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018928
   Bordi L, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.8.2000170
   Boryczka S, 2020, CIPROFLOXACIN MOXIFL, DOI [10.2139/ssrn.3562475, DOI 10.2139/SSRN.3562475]
   Casas-Rojo JM, 2020, REV CLIN ESP, V220, P480, DOI 10.1016/j.rce.2020.07.003
   Castro MC, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-049089
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Cilloniz C, 2012, J INFECTION, V65, P223, DOI 10.1016/j.jinf.2012.04.009
   Crotty MP, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002332
   Tran DH, 2019, J ANTIBIOT, V72, P759, DOI 10.1038/s41429-019-0204-x
   Deng JC, 2013, INFLUENZA OTHER RESP, V7, P24, DOI 10.1111/irv.12174
   Du YZ, 2020, AM J RESP CRIT CARE, V201, P1372, DOI 10.1164/rccm.202003-0543OC
   Feldman C, 2012, SEMIN RESP CRIT CARE, V33, P232, DOI 10.1055/s-0032-1315635
   Garcia-Vidal C, 2021, CLIN MICROBIOL INFEC, V27, P83, DOI 10.1016/j.cmi.2020.07.041
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hendaus MA, 2021, J BIOMOL STRUCT DYN, V39, P4185, DOI 10.1080/07391102.2020.1772110
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huttner BD, 2020, CLIN MICROBIOL INFEC, V26, P808, DOI 10.1016/j.cmi.2020.04.024
   Jia LL, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00338
   Johansson N, 2011, SCAND J INFECT DIS, V43, P609, DOI 10.3109/00365548.2011.570785
   Karampela I, 2020, ARCH MED RES, V51, P741, DOI 10.1016/j.arcmed.2020.06.004
   Katsurada N, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2858-y
   Kim D, 2020, JAMA-J AM MED ASSOC, V323, P2085, DOI 10.1001/jama.2020.6266
   Klein EY, 2016, INFLUENZA OTHER RESP, V10, P394, DOI 10.1111/irv.12398
   [Anonymous], 2010, Can Commun Dis Rep, V36, P1, DOI [10.14745/ccdr.v36i00a05, 10.14745/ccdr.v36i00as3, 10.14745/ccdr.v36i00as2]
   Langford BJ, 2020, CLIN MICROBIOL INFEC, V26, P1622, DOI 10.1016/j.cmi.2020.07.016
   Lee MS, 2018, INFECT CHEMOTHER, V50, P160, DOI 10.3947/ic.2018.50.2.160
   Liang WH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00562-2020
   Mayi BS, 2021, J MICROBIOL BIOL EDU, V22, DOI 10.1128/jmbe.v22i1.2285
   Metlay JP, 2019, AM J RESP CRIT CARE, V200, pE45, DOI 10.1164/rccm.201908-1581ST
   Min JY, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/649570
   Mirzaei R, 2020, IUBMB LIFE, V72, P2097, DOI 10.1002/iub.2356
   Morris DE, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01041
   Nhan, 2018, J ANTIVIR ANTIRETROV, V10, P6, DOI DOI 10.4172/1948-5964.1000173
   Novy E, 2020, ANAESTH CRIT CARE PA, V39, P387, DOI 10.1016/j.accpm.2020.04.005
   Ohe M, 2020, BIOSCI TRENDS, V14, P159, DOI 10.5582/bst.2020.03058
   Pal RK, 2020, J FAM MED PRIM CARE, V9, P5827, DOI 10.4103/jfmpc.jfmpc_1860_20
   Pani A, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106053
   Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097
   Quah J, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3366-4
   Quinton LJ, 2018, PHYSIOL REV, V98, P1417, DOI 10.1152/physrev.00032.2017
   Rawson TM, 2020, NAT REV MICROBIOL, V18, P409, DOI 10.1038/s41579-020-0395-y
   Rawson TM, 2020, J ANTIMICROB CHEMOTH, V75, P1681, DOI 10.1093/jac/dkaa194
   Rawson TM, 2020, CLIN INFECT DIS, V71, P2459, DOI 10.1093/cid/ciaa530
   Rice TW, 2012, CRIT CARE MED, V40, P1487, DOI 10.1097/CCM.0b013e3182416f23
   Richter Sara, 2004, Current Drug Targets - Infectious Disorders, V4, P111, DOI 10.2174/1568005043340920
   Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6
   Sehgal K, 2021, INFECT DRUG RESIST, V14, P1645, DOI 10.2147/IDR.S305349
   Sharland M, 2018, LANCET INFECT DIS, V18, P18, DOI 10.1016/S1473-3099(17)30724-7
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Smith AM, 2014, CURR TOP MICROBIOL, V385, P327, DOI 10.1007/82_2014_394
   Suleyman G, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.12270
   Touret F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70143-6
   van Duin D, 2016, INFECT DIS CLIN N AM, V30, P377, DOI 10.1016/j.idc.2016.02.004
   Wang ZL, 2020, CLIN INFECT DIS, V71, P769, DOI 10.1093/cid/ciaa272
   Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481
   Weston S, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00203-20
   World Health Organization, COR DIS COVID 19 SIT
   World Health Organization, 2020, CLIN MAN COVID 19 IN
   Wu J, 2020, CLIN INFECT DIS, V71, P706, DOI 10.1093/cid/ciaa199
   Yamada M, 1999, Ryoikibetsu Shokogun Shirizu, P83
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zahariadis George, 2006, Can Respir J, V13, P17
   Zhang JN, 2020, LANCET RESP MED, V8, pE11, DOI 10.1016/S2213-2600(20)30071-0
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 74
TC 2
Z9 2
U1 4
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD NOV 8
PY 2021
VL 21
IS 1
AR 1144
DI 10.1186/s12879-021-06821-1
PG 23
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA WT3MD
UT WOS:000715771300004
PM 34749645
OA gold, Green Published, Green Submitted
DA 2022-04-20
ER

PT J
AU Zeneli, A
   Altini, M
   Bragagni, M
   Gentili, N
   Prati, S
   Golinucci, M
   Rustignoli, M
   Montalti, S
AF Zeneli, A.
   Altini, M.
   Bragagni, M.
   Gentili, N.
   Prati, S.
   Golinucci, M.
   Rustignoli, M.
   Montalti, S.
TI Mitigating strategies and nursing response for cancer care management
   during the COVID-19 pandemic: an Italian experience
SO INTERNATIONAL NURSING REVIEW
LA English
DT Article
DE Cancer Patients; COVID-19 Pandemic; Health Policy; Mitigating
   Strategies; Nursing Policy; Nursing Response; Nursing Triage; Social
   Distancing
ID OUTBREAK
AB Aim: To describe our response to the COVID-19 emergency in a cancer centre to enable other nursing organizations to determine which elements could be useful to manage a surge of patients in their own setting.
   Background: The COVID-19 pandemic represents one of the most challenging healthcare scenarios faced to date. Managing cancer care in such a complex situation requires a coordinated emergency action plan to guarantee the continuity of cancer treatments for patients by providing healthcare procedures for patients, caregivers and healthcare professionals in a safe environment.
   Procedures: We describe the main strategies and role of nurses in implementating such procedures.
   Results: Nurses at our hospital were actively involved in COVID-19 response defined by the emergency action plan that positively contributed to correct social distancing and to the prevention of the spread of the virus.
   Implications for nursing and health policies: Lessons learned from the response to phase I of COVID-19 have several implications for future nursing and health policies in which nurses play an active role through their involvement in the frontline of such events. Key policies include a coordinated emergency action plan permitting duty of care within the context of a pandemic, and care pathway revision. This requires the rapid implementation of strategies and policies for a nursing response to the new care scenarios: personnel redistribution, nursing workflow revision, acquisition of new skills and knowledge, effective communication strategies, infection control policies, risk assessment and surveillance programmes, and continuous supplying of personal protective equipment. Finally, within a pandemic context, clear nursing policies reinforcing the role of nurses as patient and caregiver educators are needed to promote infection prevention behaviour in the general population.
C1 [Zeneli, A.; Altini, M.; Bragagni, M.; Gentili, N.; Prati, S.; Golinucci, M.; Rustignoli, M.; Montalti, S.] IRCCS, Ist Sci Romagnolo Studio & Cura Tumori IRST, Meldola, Italy.
RP Zeneli, A (corresponding author), IRCCS, Ist Sci Romagnolo Studio & Cura Tumori IRST, Meldola, Italy.
EM anita.zeneli@irst.emr.it
RI Gentili, Nicola/J-2236-2016; Zeneli, Anita/ABC-8887-2020; Altini,
   Mattia/AAC-9635-2022
OI Gentili, Nicola/0000-0002-0066-9172; Zeneli, Anita/0000-0002-8556-378X;
   Altini, Mattia/0000-0002-1809-184X; prati, sabrina/0000-0003-0849-1775;
   Montalti, Sandra/0000-0002-3765-4855
CR Allegra A, 2020, CANCERS, V12, DOI 10.3390/cancers12061581
   [Anonymous], 2020, LANCET RESP MED, V8, P321, DOI 10.1016/S2213-2600(20)30128-4
   Armocida B, 2020, LANCET PUBLIC HEALTH, V5, pE253, DOI 10.1016/S2468-2667(20)30074-8
   Carinci F, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m799
   Catton H, 2020, INT NURS REV, V67, P4, DOI 10.1111/inr.12578
   CDC, 2020, Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19)
   CDC, 2020, CLIN CAR GUID HEALTH
   Cheng HY, 2020, J FORMOS MED ASSOC, V119, P771, DOI 10.1016/j.jfma.2020.03.007
   Chughtai AA, 2020, INT J NURS STUD, V105, DOI 10.1016/j.ijnurstu.2020.103567
   Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114
   Fang YQ, 2020, J MED VIROL, V92, P645, DOI 10.1002/jmv.25750
   Fathizadeh Hadis, 2020, Infez Med, V28, P185
   FNOPI, 2020, MAN DEONT PAND COVID
   Jazieh AR, 2020, JCO GLOB ONCOL, V6, P471, DOI 10.1200/GO.20.00064
   Ministero della Salute, 2020, RACC TEST PAZ ONC ON
   Ministero della Salute, 2020, COV 19 RIP CONT PROV
   Nagesh S, 2020, J GLOB HEALTH, V10, DOI [10.7189/jogh.10.010345, 10.7189/jogh-10-010345]
   Paterson C, 2020, SEMIN ONCOL NURS, V36, DOI 10.1016/j.soncn.2020.151028
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Rockwell KL, 2020, AM J MANAG CARE, V26, P147, DOI 10.37765/ajmc.2020.42784
   Thompson R, 2020, LANCET INFECT DIS, V20, P280, DOI 10.1016/S1473-3099(20)30068-2
   Ueda M, 2020, J NATL COMPR CANC NE, V18, P366, DOI 10.6004/jnccn.2020.7560
   Volpato S, 2020, J GERONTOL A-BIOL, V75, pE126, DOI 10.1093/gerona/glaa087
   Wall B.M., 2010, NURSES FRONT LINE DI
   Wang HP, 2020, LANCET ONCOL, V21, pE181, DOI 10.1016/S1470-2045(20)30149-2
   World Health Organization, 2020, COUNTR TECHN GUID CO
   World Health Organization, 2020, COMMUNICATION 0311
   World Health Organization, 2020, 2019 NOV COR 2019 NC
   Xia Y, 2020, LANCET ONCOL, V21, pE180, DOI 10.1016/S1470-2045(20)30150-9
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 30
TC 3
Z9 3
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-8132
EI 1466-7657
J9 INT NURS REV
JI Int. Nurs. Rev.
PD DEC
PY 2020
VL 67
IS 4
BP 543
EP 553
DI 10.1111/inr.12625
EA OCT 2020
PG 11
WC Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing
GA PR5MR
UT WOS:000574165100001
PM 33006169
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Azab, MA
   Azzam, AY
   Salem, AE
   Reda, A
   Hassanein, SF
   Sabra, M
   Gadelmoula, IS
AF Azab, Mohammed A.
   Azzam, Ahmed Y.
   Salem, Ahmed E.
   Reda, Ahmed
   Hassanein, Sherif F.
   Sabra, Mohamed
   Gadelmoula, Islam S.
TI Neurological problems in the context of COVID-19 infection in Egypt. A
   multicenter retrospective analysis
SO INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT
LA English
DT Article
DE COVID-19; Egypt; Multicenter; Neurological complication; SARS-CoV-2
ID OPTIC NEURITIS; CORONAVIRUS; ENCEPHALITIS
AB Background: COVID-19 infection has spread so fast in both low- and high-income countries. In December 2019, an outbreak of a respiratory disease occurred in China, and later, it involved different countries. Acute neurological insults are more likely to occur in severely infected patients.
   Methods: We tried to evaluate patients with selective criteria including, the age of participants 18 and older with a confirmed diagnosis of SARS-CoV-2, and developed neurological complications post COVID-19 infection. An overall data of 1500 patients were collected from neurological and primary health care departments. About 970 of them had neurological problems. Patients-related data were gathered and assembled from the patients' records at participating hospitals from the Ministry of Health and university hospitals.
   Results: We presented the results according to several variables including, regional distribution, reasons of presentation, neurological complications, follow-ups, and survival outcome.
   Conclusions: To our knowledge, we conducted the first retrospective analysis for neurological problems related to COVID-19 infection in Egypt. COVID-19 patients present with a variety of central and peripheral neurological symptoms, the pathogenic mechanisms of which have not been explained. Robust investigations of the neurological presentations of COVID-19 infection should be recruited for better understanding of the possible association. Moreover, further explaining the pathophysiologic mechanisms will help in designing proper treatment plans.
C1 [Azab, Mohammed A.] Cairo Univ, Dept Neurosurg, Fac Med, Cairo, Egypt.
   [Azab, Mohammed A.] Boise State Univ, Dept Biochem & Mol Biol, Boise, ID USA.
   [Azzam, Ahmed Y.] October 6 Univ, Fac Med, Giza, Egypt.
   [Salem, Ahmed E.] Johns Hopkins Univ Hosp, Baltimore, MD USA.
   [Azab, Mohammed A.; Reda, Ahmed; Hassanein, Sherif F.] Cairo Univ, Fac Med, Cairo, Egypt.
   [Sabra, Mohamed] Rhode Isl Hosp, Cardiovasc Res Ctr, Providence, RI 02903 USA.
   [Gadelmoula, Islam S.] Egyptian Minist Hlth & Populat Hosp, Dept Neurol, Cairo, Egypt.
RP Azab, MA (corresponding author), Cairo Univ, Fac Med, Cairo, Egypt.
EM mohammedazab@u.boisestate.edu
RI Azzam, Ahmed Y./ABB-1522-2020
OI Azzam, Ahmed Y./0000-0002-4256-0159
CR Alberti P, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000741
   Arnaud S, 2020, CLIN NEUROPHYSIOL, V131, P1652, DOI 10.1016/j.clinph.2020.05.003
   ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   Ashrafi F, 2020, NEUROL SCI, V41, P1985, DOI 10.1007/s10072-020-04521-3
   Azab MA, 2021, INTERDISCIP NEUROSUR, V25, DOI 10.1016/j.inat.2021.101132
   Baig AM, 2020, ACS CHEM NEUROSCI, V11, P995, DOI 10.1021/acschemneuro.0c00122
   Balcer LJ, 2006, NEW ENGL J MED, V354, P1273, DOI 10.1056/NEJMcp053247
   Benito-Pascual B, 2020, OCUL IMMUNOL INFLAMM, V28, P922, DOI 10.1080/09273948.2020.1792512
   Beyrouti R, 2020, J NEUROL NEUROSUR PS, V91, P889, DOI 10.1136/jnnp-2020-323586
   Bigaut K, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000785
   Caress JB, 2020, MUSCLE NERVE, V62, P485, DOI 10.1002/mus.27024
   Fara MG, 2020, J THROMB HAEMOST, V18, P2031, DOI 10.1111/jth.14938
   Franceschi AM, 2020, AM J NEURORADIOL, V41, P1632, DOI 10.3174/ajnr.A6655
   Garnero M, 2020, J NEUROL SCI, V418, DOI 10.1016/j.jns.2020.117114
   Germano A, 2020, WORLD NEUROSURG, V139, pE812, DOI 10.1016/j.wneu.2020.04.181
   Ghannam M, 2020, J NEUROL, V267, P3135, DOI 10.1007/s00415-020-09990-2
   Giwa A L, 2020, Pediatr Emerg Med Pract, V17, P1
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Han H, 2020, CLIN CHEM LAB MED, V58, P1116, DOI 10.1515/cclm-2020-0188
   Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Kantonen J, 2020, BRAIN PATHOL, V30, P1012, DOI 10.1111/bpa.12889
   Khurana M.S., FREE NEUROPATHOL, V2
   Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728
   Li YN, 2020, STROKE VASC NEUROL, V5, P279, DOI 10.1136/svn-2020-000431
   Li Z, 2021, ENVIRON SCI POLLUT R, V28, P20939, DOI 10.1007/s11356-021-13233-w
   Lu L, 2020, EPILEPSIA, V61, pE49, DOI 10.1111/epi.16524
   Manji H, 2020, J NEUROL NEUROSUR PS, V91, P568, DOI 10.1136/jnnp-2020-323414
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Matschke J, 2020, LANCET NEUROL, V19, P919, DOI 10.1016/S1474-4422(20)30308-2
   Molina-Gil J, 2021, HEADACHE, V61, P560, DOI 10.1111/head.14075
   Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062
   Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08
   Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787
   Paniz-Mondolfi A, 2020, J MED VIROL, V92, P699, DOI 10.1002/jmv.25915
   Poyiadji N, 2020, RADIOLOGY, V296, pE119, DOI 10.1148/radiol.2020201187
   Rahimi K, 2020, NEUROL SCI, V41, P3149, DOI 10.1007/s10072-020-04693-y
   Remmelink M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03218-5
   Roed H, 2005, J NEUROIMMUNOL, V162, P165, DOI 10.1016/j.jneuroim.2005.02.002
   Sawalha K, 2020, J INVEST MED HIGH IM, V8, DOI 10.1177/2324709620976018
   Schurink B, 2020, LANCET MICROBE, V1, pE290, DOI 10.1016/S2666-5247(20)30144-0
   Shellhaas RA, 2020, NEUROLOGY, V94, P855, DOI 10.1212/WNL.0000000000009496
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Vehapoglu A, 2015, CASE REP NEUROL MED, V2015, DOI 10.1155/2015/131780
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
   von Weyhern CH, 2020, LANCET, V395, pE109, DOI 10.1016/S0140-6736(20)31282-4
   [王科雯 Wang Kewen], 2020, [测绘通报, Bulletin of Surveying and Mapping], P1
   WHO China, 2020, REP WHO CHIN JOINT M, DOI DOI 10.1186/S40249-020-00650-1
   Wu YS, 2020, BRAIN BEHAV IMMUN, V87, P18, DOI 10.1016/j.bbi.2020.03.031
   Yaghi S, 2020, STROKE, V51, P2002, DOI 10.1161/STROKEAHA.120.030335
   Yousufuddin M, 2019, AGING-US, V11, P2542, DOI 10.18632/aging.101931
   Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575
   Zhou SW, 2020, J NEURO-OPHTHALMOL, V40, P398, DOI 10.1097/WNO.0000000000001049
NR 53
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2214-7519
J9 INTERDISCIP NEUROSUR
JI Interdiscip. Neurosurg.
PD DEC
PY 2021
VL 26
AR 101345
DI 10.1016/j.inat.2021.101345
EA AUG 2021
PG 7
WC Clinical Neurology
WE Emerging Sources Citation Index (ESCI)
SC Neurosciences & Neurology
GA WJ5UI
UT WOS:000709109700005
PM 34426783
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU O'Leary, L
   Erikainen, S
   Peltonen, LM
   Ahmed, W
   Thelwall, M
   O'Connor, S
AF O'Leary, Lisa
   Erikainen, Sonja
   Peltonen, Laura-Maria
   Ahmed, Wasim
   Thelwall, Mike
   O'Connor, Siobhan
TI Exploring nurses' online perspectives and social networks during a
   global pandemic COVID-19
SO PUBLIC HEALTH NURSING
LA English
DT Article; Early Access
DE communicable diseases; coronavirus; COVID-19; infectious disease;
   nursing; pandemics; social media; Twitter
AB Objectives Examine the online interactions, social networks, and perspectives of nursing actors on COVID-19 from conversations on Twitter to understand how the profession responded to this global pandemic. Design Mixed methods. Sample Ten-thousand five-hundred and seventy-four tweets by 2790 individuals and organizations. Measurements NodeXL software was used for social network analysis to produce a network visualization. The betweenness centrality algorithm identified key users who were influential in COVID-19 related conversations on Twitter. Inductive content analysis enabled exploration of tweet content. A communicative figurations framework guided the study. Results Nursing actors formed different social groupings, and communicated with one another across groups. Tweets covered four themes; (1) outbreak and clinical management of the infectious disease, (2) education and information sharing, (3) social, economic, and political context, and (4) working together and supporting each other. Conclusion In addition to spreading knowledge, nurses tried to reach out through social media to political and healthcare leaders to advocate for improvements needed to address COVID-19. However, they primarily conversed within their own professional community. Action is needed to better understand how social media is and can be used by nurses for health communication, and to improve their preparedness to be influential on social media beyond the nursing community.
C1 [O'Leary, Lisa] Edinburgh Napier Univ, Sch Hlth & Social Care, Edinburgh, Midlothian, Scotland.
   [Erikainen, Sonja] Univ Edinburgh, Usher Inst, Ctr Biomed Self & Soc, Edinburgh, Midlothian, Scotland.
   [Peltonen, Laura-Maria] Univ Turku, Dept Nursing Sci, Turku, Finland.
   [Ahmed, Wasim] Univ Stirling, Business Sch, Stirling, Scotland.
   [Thelwall, Mike] Univ Wolverhampton, Fac Sci & Engn, Wolverhampton, England.
   [O'Connor, Siobhan] Natl Univ Ireland Galway, Sch Nursing & Midwifery, Moyola Bldg, Galway, Ireland.
RP O'Connor, S (corresponding author), Natl Univ Ireland Galway, Sch Nursing & Midwifery, Moyola Bldg, Galway, Ireland.
EM s.oconnor@nuigalway.ie
RI Thelwall, Mike/C-1449-2013; O'Connor, Siobhan/D-8140-2015
OI Thelwall, Mike/0000-0001-6065-205X; Peltonen,
   Laura-Maria/0000-0001-5740-6480; O'Connor, Siobhan/0000-0001-8579-1718
CR Ahmed W, 2019, ONLINE INFORM REV, V43, P149, DOI 10.1108/OIR-03-2018-0093
   Atique S, 2020, J ADV NURS, V76, P2462, DOI 10.1111/jan.14417
   Basch CH, 2021, JMIR PUBLIC HLTH SUR, V7, DOI 10.2196/26392
   Booth RG, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1190
   Bowen P., 2017, INT J QUANTITATIVE Q, V5, P10
   Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111
   Corley A, 2010, INT J NURS STUD, V47, P577, DOI 10.1016/j.ijnurstu.2009.11.015
   Corner J., 2018, MEDIA THEORY, V2, P79
   Dewart G, 2020, NURS EDUC TODAY, V92, DOI 10.1016/j.nedt.2020.104471
   Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x
   Erdem H, 2021, INT J INFECT DIS, V102, P239, DOI 10.1016/j.ijid.2020.10.064
   Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34
   Fernandez R, 2020, INT J NURS STUD, V111, DOI 10.1016/j.ijnurstu.2020.103637
   Gabarron E, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.32193
   Gennaro S, 2020, J NURS SCHOLARSHIP, V52, P231, DOI 10.1111/jnu.12556
   Gilroy R., 2020, NURS TIMES
   Halberg N, 2021, J ADV NURS, V77, P2429, DOI 10.1111/jan.14811
   Hannaford L, 2021, NURS EDUC TODAY, V99, DOI 10.1016/j.nedt.2021.104784
   Hasebrink U, 2017, CONVERGENCE-US, V23, P362, DOI 10.1177/1354856517700384
   Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3
   Hoernke K, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-046199
   Hu DY, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100424
   Jaffe S, 2021, LANCET, V397, P362, DOI 10.1016/S0140-6736(21)00182-3
   Jensen EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180080
   Jun J, 2020, WORLDV EVID-BASED NU, V17, P182, DOI 10.1111/wvn.12439
   Kates J, 2021, PUBLIC HEALTH NURS, V38, P459, DOI 10.1111/phn.12827
   Khubchandani J, 2021, J COMMUN HEALTH, V46, P270, DOI 10.1007/s10900-020-00958-x
   Lee JJ, 2020, J MED INTERNET RES, V22, DOI 10.2196/22205
   Lincoln Y.S., 1985, NATURALISTIC INQUIRY
   Liu YE, 2020, PUBLIC HEALTH NURS, V37, P757, DOI 10.1111/phn.12768
   Lutkenhaus RO, 2019, DIGIT HEALTH, V5, DOI 10.1177/2055207618821521
   Mackay MT, 2014, NURSE EDUC PRACT, V14, P281, DOI 10.1016/j.nepr.2013.08.005
   Mboussou F, 2019, Epidemiol Infect, V147, pe299, DOI 10.1017/S0950268819001912
   McCabe C., 2013, COMMUNICATION SKILLS, V2nd ed.
   Mutsvairo B, 2019, MAPPING THE DIGITAL DIVIDE IN AFRICA: A MEDIATED ANALYSIS, P13, DOI 10.5117/9789462986855_CH01
   Niknam F, 2021, HEALTH POLICY TECHN, V10, P165, DOI 10.1016/j.hlpt.2020.10.016
   Noble Helen, 2015, Evid Based Nurs, V18, P34, DOI 10.1136/eb-2015-102054
   O'Connor S, 2021, NURSE EDUC PRACT, V50, DOI 10.1016/j.nepr.2020.102934
   Oleribe OO, 2019, INT J GEN MED, V12, P395, DOI 10.2147/IJGM.S223882
   Ozga D, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8040578
   Palaganas EC, 2017, QUAL REP, V22, P426
   Parker JM, 2017, Int J Nurs Sci, V4, P196, DOI 10.1016/j.ijnss.2017.01.002
   Paterson J., 1976, HUMANISTIC NURSING
   Peplau H., 1991, INTERPERSONAL RELATI
   Probst YC, 2019, NUTR DIET, V76, P414, DOI 10.1111/1747-0080.12488
   Riddell J, 2017, WEST J EMERG MED, V18, P281, DOI 10.5811/westjem.2016.11.31299
   Suominen H, 2015, JMIR MED INF, V3, DOI 10.2196/medinform.4321
   Le TT, 2020, NAT REV DRUG DISCOV, V19, P305, DOI 10.1038/d41573-020-00073-5
   Townsend L., 2016, SOCIAL MEDIA RES GUI
   van Manen AS, 2021, INT J NURS STUD, V113, DOI 10.1016/j.ijnurstu.2020.103776
   Vessey JA, 2020, J PEDIATR NURS, V52, DOI 10.1016/j.pedn.2020.03.014
   Wagg AJ, 2018, INT J NURS STUD, V82, P68, DOI 10.1016/j.ijnurstu.2018.03.010
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   WHITE DR, 1994, SOC NETWORKS, V16, P335, DOI 10.1016/0378-8733(94)90015-9
   WHO, 2021, COVID 19 WEEKL EP UP
   Wood E, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-044139
   World Health Organization, 2020, RAT US PERS PROT EQ
NR 57
TC 2
Z9 2
U1 11
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0737-1209
EI 1525-1446
J9 PUBLIC HEALTH NURS
JI Public Health Nurs.
DI 10.1111/phn.12994
EA OCT 2021
PG 15
WC Public, Environmental & Occupational Health; Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Nursing
GA WK8YS
UT WOS:000710007100001
PM 34687078
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Mester, A
   Benedek, I
   Rat, N
   Tolescu, C
   Polexa, SA
   Benedek, T
AF Mester, Andras
   Benedek, Imre
   Rat, Nora
   Tolescu, Cosmin
   Polexa, Stefania Alexandra
   Benedek, Theodora
TI Imaging Cardiovascular Inflammation in the COVID-19 Era
SO DIAGNOSTICS
LA English
DT Review
DE COVID-19; cardiac magnetic resonance; inflammation; multimodal imaging;
   myocardial injury; artificial intelligence
ID MAGNETIC-RESONANCE; MYOCARDIAL-INFARCTION; COMPLICATIONS; HEART
AB Cardiac complications are among the most frequent extrapulmonary manifestations of COVID-19 and are associated with high mortality rates. Moreover, positive SARS-CoV-2 patients with underlying cardiovascular disease are more likely to require intensive care and are at higher risk of death. The underlying mechanism for myocardial injury is multifaceted, in which the severe inflammatory response causes myocardial inflammation, coronary plaque destabilization, acute thrombotic events, and ischemia. Cardiac magnetic resonance (CMR) imaging is the non-invasive method of choice for identifying myocardial injury, and it is able to differentiate between underlying causes in various and often challenging clinical scenarios. Multimodal imaging protocols that incorporate CMR and computed tomography provide a complex evaluation for both respiratory and cardiovascular complications of SARS-CoV2 infection. This, in relation to biological evaluation of systemic inflammation, can guide appropriate therapeutic management in every stage of the disease. The use of artificial intelligence can further improve the diagnostic accuracy of these imaging techniques, thus enabling risk stratification and evaluation of prognosis. The present manuscript aims to review the current knowledge on the possible modalities for imaging COVID-related myocardial inflammation or post-COVID coronary inflammation and atherosclerosis.
C1 [Mester, Andras; Benedek, Imre; Rat, Nora; Benedek, Theodora] George Emil Palade Univ Med Pharm Sci & Technol T, Dept Cardiol, Targu Mures 540142, Romania.
   [Tolescu, Cosmin; Polexa, Stefania Alexandra] Emergency Clin Cty Hosp Targu Mures, Cardiol Clin, Targu Mures 540142, Romania.
RP Rat, N (corresponding author), George Emil Palade Univ Med Pharm Sci & Technol T, Dept Cardiol, Targu Mures 540142, Romania.
EM andras.mester@yahoo.com; imrebenedek@yahoo.com; ratnora@gmail.com;
   tolescu.cosmin@yahoo.com; polexa.stefania@gmail.com;
   theodora.benedek@gmail.com
RI RAT, NORA/AAX-9920-2021
OI MESTER, ANDRAS/0000-0001-9509-1192
CR Agricola E, 2020, JACC-CARDIOVASC IMAG, V13, P1792, DOI 10.1016/j.jcmg.2020.05.017
   Akhmerov A, 2020, CIRC RES, V126, P1443, DOI 10.1161/CIRCRESAHA.120.317055
   Albert CL, 2020, CIRCULATION, V142, P1865, DOI 10.1161/CIRCULATIONAHA.120.050097
   Anghel L, 2019, J CARDIOVASC EMERG, V5, P25, DOI 10.2478/jce-2019-0005
   Antonopoulos AS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2658
   Babapoor-Farrokhran S, 2020, LIFE SCI, V253, DOI 10.1016/j.lfs.2020.117723
   Baldi E, 2020, NEW ENGL J MED, V383, P496, DOI 10.1056/NEJMc2010418
   Bangalore S, 2020, NEW ENGL J MED, V382, P2478, DOI 10.1056/NEJMc2009020
   Basso C, 2020, EUR HEART J, V41, P3827, DOI 10.1093/eurheartj/ehaa664
   Bearse M, 2021, MODERN PATHOL, V34, P1345, DOI 10.1038/s41379-021-00790-1
   Bonow RO, 2020, JAMA CARDIOL, V5, P751, DOI 10.1001/jamacardio.2020.1105
   Boukhris M, 2020, CAN J CARDIOL, V36, P1068, DOI 10.1016/j.cjca.2020.05.018
   Bowles L, 2020, NEW ENGL J MED, V383, P288, DOI 10.1056/NEJMc2013656
   Braiteh N, 2020, AM HEART J, V226, P147, DOI 10.1016/j.ahj.2020.05.009
   Caballeros Lam Meylin, 2020, Rev Esp Cardiol (Engl Ed), V73, P863, DOI 10.1016/j.rec.2020.06.018
   Cantador E, 2020, J THROMB THROMBOLYS, V50, P543, DOI 10.1007/s11239-020-02176-7
   Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5
   Cau Riccardo, 2020, SN Compr Clin Med, V2, P845, DOI 10.1007/s42399-020-00344-7
   Chen JY, 2020, J MED INTERNET RES, V22, DOI 10.2196/21476
   Chen XH, 2020, CLIN INFECT DIS, V71, P1937, DOI 10.1093/cid/ciaa449
   Cheng H, 2020, J MED VIROL, V92, P726, DOI 10.1002/jmv.25785
   Citro R, 2021, TRENDS CARDIOVAS MED, V31, P8, DOI 10.1016/j.tcm.2020.10.001
   Cosyns B, 2020, EUR HEART J-CARD IMG, V21, P709, DOI 10.1093/ehjci/jeaa136
   Datta PK, 2020, THERANOSTICS, V10, P7448, DOI 10.7150/thno.48076
   De Rosa S, 2020, EUR HEART J, V41, P2083, DOI 10.1093/eurheartj/ehaa409
   El-Shabrawy M, 2021, EGYPT J BRONCHOL, V15, DOI 10.1186/s43168-021-00054-1
   Elnabawi YA, 2019, CARDIOVASC RES, V115, P721, DOI 10.1093/cvr/cvz009
   Erdogan G, 2020, J CARDIOVASC EMERG, V6, P7, DOI 10.2478/jce-2020-0002
   Esenwa C, 2020, AM J NEURORADIOL, V41, P1993, DOI 10.3174/ajnr.A6752
   Esposito A, 2021, EUR RADIOL, V31, P4031, DOI 10.1007/s00330-020-07622-x
   Esposito A, 2020, JACC-CARDIOVASC IMAG, V13, P2462, DOI 10.1016/j.jcmg.2020.06.003
   Garcia S, 2020, J AM COLL CARDIOL, V75, P2871, DOI 10.1016/j.jacc.2020.04.011
   Gauchotte G, 2021, INT J LEGAL MED, V135, P577, DOI 10.1007/s00414-020-02500-z
   Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015
   Ghio S, 2020, INTERN EMERG MED, V15, P1457, DOI 10.1007/s11739-020-02493-y
   Gravinay P, 2021, EUR HEART J-CARD IMG, V22, P133, DOI 10.1093/ehjci/jeaa169
   Guagliumi G, 2020, CIRCULATION, V142, P804, DOI 10.1161/CIRCULATIONAHA.120.049294
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Gupta A, 2020, NAT MED, V26, P1017, DOI 10.1038/s41591-020-0968-3
   Guzik TJ, 2020, CARDIOVASC RES, V116, P1666, DOI 10.1093/cvr/cvaa106
   Haaf P, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0308-4
   Han YC, 2020, J CARDIOVASC MAGN R, V22, DOI 10.1186/s12968-020-00628-w
   Hansson GK, 2015, J INTERN MED, V278, P483, DOI 10.1111/joim.12406
   Harari R, 2021, CATHETER CARDIO INTE, V97, pE661, DOI 10.1002/ccd.28992
   Harzallah I, 2020, J THROMB HAEMOST, V18, P2064, DOI 10.1111/jth.14867
   Held C, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005077
   Hemingway H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000286
   Huang L, 2020, JACC-CARDIOVASC IMAG, V13, P2330, DOI 10.1016/j.jcmg.2020.05.004
   Inciardi RM, 2020, EUR HEART J, V41, P1821, DOI 10.1093/eurheartj/ehaa388
   Jabri A, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.14780
   Jamthikar A, 2019, CARDIOVASC DIAGN THE, V9, P420, DOI 10.21037/cdt.2019.09.03
   Jenab Y, 2020, CLIN CASE REP, V8, P2414, DOI 10.1002/ccr3.3112
   John K, 2021, MONALDI ARCH CHEST D, V91, DOI 10.4081/monaldi.2021.1710
   Kagiyama N, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012788
   Kang M, 2021, J KOREAN MED SCI, V36, DOI 10.3346/jkms.2021.36.e46
   Kang Y, 2020, HEART, V106, P1132, DOI 10.1136/heartjnl-2020-317056
   Kariyanna Pramod Theetha, 2020, Am J Med Case Rep, V8, P350
   Kelle S, 2020, J CARDIOVASC MAGN R, V22, DOI 10.1186/s12968-020-00656-6
   Kim HW, 2020, ARTERIOSCL THROM VAS, V40, P2569, DOI 10.1161/ATVBAHA.120.312470
   Kirresh A, 2021, CARDIOVASC REVASCULA, V28, P82, DOI 10.1016/j.carrev.2020.07.032
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Knight DS, 2020, CIRCULATION, V142, P1120, DOI 10.1161/CIRCULATIONAHA.120.049252
   Knuuti J, 2020, EUR HEART J, V41, P407, DOI 10.1093/eurheartj/ehz425
   Kotecha T, 2021, EUR HEART J, V42, P1866, DOI 10.1093/eurheartj/ehab075
   Krittanawong C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72685-1
   Kwenandar F, 2020, IJC HEART VASC, V29, DOI 10.1016/j.ijcha.2020.100557
   Li Z, 2020, EUR RADIOL, V30, P6828, DOI 10.1007/s00330-020-07042-x
   Libby P, 2020, EUR HEART J, V41, P3038, DOI 10.1093/eurheartj/ehaa623
   Lindner D, 2020, JAMA CARDIOL, V5, P1281, DOI 10.1001/jamacardio.2020.3551
   Lippi G, 2020, PROG CARDIOVASC DIS, V63, P390, DOI 10.1016/j.pcad.2020.03.001
   Liu PP, 2020, CIRCULATION, V142, P68, DOI 10.1161/CIRCULATIONAHA.120.047549
   Liu T, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012421
   Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024
   Luetkens JA, 2020, CIRC-CARDIOVASC IMAG, V13, DOI 10.1161/CIRCIMAGING.120.010897
   Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007
   Manfrini, 2021, J CARDIOVASC COMPUT
   Manka R, 2020, J HEART LUNG TRANSPL, V39, P730, DOI 10.1016/j.healun.2020.04.025
   MCGONAGLE D, 2020, LANCET RHEUMATOL, V2, DOI DOI 10.1016/S2665-9913(20)30121-1
   Metzler B, 2020, EUR HEART J, V41, P1852, DOI 10.1093/eurheartj/ehaa314
   Middeldorp S, 2020, J THROMB HAEMOST, V18, P1995, DOI 10.1111/jth.14888
   Mohamud AY, 2020, AM J NEURORADIOL, V41, P1677, DOI 10.3174/ajnr.A6674
   Moriarty PM, 2020, CURR ATHEROSCLER REP, V22, DOI 10.1007/s11883-020-00867-3
   Nakao Masahiko, 2021, J Cardiol Cases, V23, P87, DOI 10.1016/j.jccase.2020.09.012
   Ng MY, 2020, JACC-CARDIOVASC IMAG, V13, P2476, DOI 10.1016/j.jcmg.2020.08.012
   Ojha V, 2021, J THORAC IMAG, V36, P73, DOI 10.1097/RTI.0000000000000574
   Opincariu D, 2020, INT J CARDIOVAS IMAG, V36, P2403, DOI 10.1007/s10554-020-01926-1
   Oudit GY, 2009, EUR J CLIN INVEST, V39, P618, DOI 10.1111/j.1365-2362.2009.02153.x
   Ozturk T, 2020, COMPUT BIOL MED, V121, DOI 10.1016/j.compbiomed.2020.103792
   Pontone G, 2020, JACC-CARDIOVASC IMAG, V13, P1854, DOI 10.1016/j.jcmg.2020.04.012
   Puntmann VO, 2020, JAMA CARDIOL, V5, P1265, DOI 10.1001/jamacardio.2020.3557
   Ragab D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01446
   Rajpal S, 2021, JAMA CARDIOL, V6, P116, DOI 10.1001/jamacardio.2020.4916
   Rizzo P, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0791-5
   Rudski L, 2020, J AM COLL CARDIOL, V76, P1345, DOI 10.1016/j.jacc.2020.06.080
   Rusnak J, 2017, CURR PHARM BIOTECHNO, V18, P456, DOI 10.2174/1389201018666170630120805
   Scoccia A, 2021, ATHEROSCLEROSIS, V328, P136, DOI 10.1016/j.atherosclerosis.2021.03.041
   Shah RM, 2021, CURR PROB CARDIOLOGY, V46, DOI 10.1016/j.cpcardiol.2020.100763
   Sharma Kamal, 2021, SN Compr Clin Med, V3, P62, DOI 10.1007/s42399-021-00743-4
   Sheth AR, 2020, MED HYPOTHESES, V143, DOI 10.1016/j.mehy.2020.110125
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Singh S, 2020, SERV IND J, V40, P491, DOI [10.1007/s42399-020-00557-w, 10.1080/02642069.2020.1731477]
   Skulstad H, 2020, EUR HEART J-CARD IMG, V21, P592, DOI 10.1093/ehjci/jeaa072
   Stefanini GG, 2020, CIRCULATION, V141, P2113, DOI 10.1161/CIRCULATIONAHA.120.047525
   Suri JS, 2020, COMPUT BIOL MED, V124, DOI 10.1016/j.compbiomed.2020.103960
   Tibaut M, 2019, HEART LUNG CIRC, V28, P667, DOI 10.1016/j.hlc.2018.06.1057
   Vaishya R, 2020, DIABETES METAB SYND, V14, P337, DOI 10.1016/j.dsx.2020.04.012
   Verhagen SN, 2011, ATHEROSCLEROSIS, V214, P3, DOI 10.1016/j.atherosclerosis.2010.05.034
   Violi F, 2020, THROMB HAEMOSTASIS, V120, P949, DOI 10.1055/s-0040-1710317
   Wang H, 2021, J CARDIOVASC MAGN R, V23, DOI 10.1186/s12968-021-00710-x
   Wang KM, 2020, CIRCULATION, V142, P426, DOI 10.1161/CIRCULATIONAHA.120.047049
   Warnke, 2020, CARDIOVASC MED
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   Xiong TY, 2020, EUR HEART J, V41, P1798, DOI 10.1093/eurheartj/ehaa231
   Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zoghbi WA, 2020, JACC-CARDIOVASC IMAG, V13, P1615, DOI 10.1016/j.jcmg.2020.06.001
NR 116
TC 0
Z9 0
U1 4
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-4418
J9 DIAGNOSTICS
JI Diagnostics
PD JUN
PY 2021
VL 11
IS 6
AR 1114
DI 10.3390/diagnostics11061114
PG 16
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA SX9LR
UT WOS:000665518800001
PM 34207266
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU El-Malky, AM
   Albalawi, HJ
   Alotaibi, TA
   Alamoudi, AI
   Aldhafeeri, DA
   Alshammari, KA
   Alshammari, AA
   Al-khalaf, TI
   El Shaer, F
AF El-Malky, Ahmed M.
   Albalawi, Haya J.
   Alotaibi, Talal A.
   Alamoudi, Abdullah, I
   Aldhafeeri, Dhari A.
   Alshammari, Khlood A.
   Alshammari, Afnan A.
   Al-khalaf, Turki, I
   El Shaer, Fayez
TI Social stigma associated with COVID-19 infection in Saudi Arabia: A
   population based study
SO MEDICAL SCIENCE
LA English
DT Article
DE COVID-19; anxiety; Saudi Arabia; psycho-behavioral
ID TRAIT ANXIETY INVENTORY; DEPRESSION
AB Background: Saudi Arabia is one of the nations impacted by the epidemic of COVID-19. Objectives: To address psycho-behavioral problems to the pandemic of COVID-19 in the whole population of Saudi Arabia, namely: 1) obstacles to infection control measures against COVID infections; 2) adverse responses to COVID-19; and 3) fear among the general population in Saudi Arabia. Methods: An electronic population based cross sectional survey using a validated electronic questionnaire was performed between 23 July and 1 August 2020. Among the whole estimated target population of COVID-19 patients in Saudi Arabia. Using multi-stage random sampling technique all over the governorates. The six-item variant of the State-Trait-Anxiety-Stock (STAS-6) was used to measure rates of anxiety. Estimated target population of 67,000 Covid-19 patients according to last national report of MOH. A multi stage sampling from different affected governorates. Sample size was calculated using Steven Sampthon formula to be 2230 patient. Sample was collected from MOH electronic registries approved by the ethical committee of KSUMC # (78/82/KSUMC/IRB-COVID-3792). Results: A total of 1,800 full replies have been received. Almost 60 percent reported having trouble wearing a face mask to guard against COVID infection. The mean and standard deviation (SD) for the overall avoidance obstacle value was 35.8 (SD +/- 7.1; scale 18 to 68) out of a maximum 72. Male respondents [odds ratio (OR) = 1.25; 95 % confidence interval (CI) 1.03 to 1.51] and many respondents who regarded their health condition as poor / fair (OR = 1.49; 95 % CI 1.31 to 1.82) were indicators of Strong obstacles to avoidance. Negative feelings such as anxiety (74.6%), accompanied by sadness (43.4%) and stigma (23.0%) correlated with SARS-CoV-2 infection has been identified. The addressing groups that their wellbeing was viewed as poor / fair (OR = 2.19; 95 % CI 1.57 to 3.04) and a higher risk was recorded to get more depressive feelings. Anxiety rating results showed 68.0 per cent (95 per cent CI 65.8 to 65.8 per cent). (70.1) mild to extreme anxiety recorded. Participants who see their well-being as poor / fair (OR = 3.46; 95% CI 12.22 to 5.40) and who were female (OR = 1.91; 95 % CI 1.55 to 2.36) were female; predictors with mild to extreme fear. Conclusion: Psycho behavioral measures are expected to promote the management and monitoring of the epidemic of COVID-19.
C1 [El-Malky, Ahmed M.] Minist Higher Educ, Acad Sci Res, Theodor Bilharz Res Inst, Publ Hlth & Community Med Dept, Cairo, Egypt.
   [El-Malky, Ahmed M.] King Saud Univ Med City, Morbid & Mortal Review Unit, Riyadh, Saudi Arabia.
   [El-Malky, Ahmed M.] King Saud Univ, Coll Med, Evidence Based Healthcare & Knowledge Translat, Riyadh, Saudi Arabia.
   [Albalawi, Haya J.] Tabuk Univ, Coll Med, Tabuk, Saudi Arabia.
   [Alotaibi, Talal A.] Univ Hail, Coll Pharm, Clin Pharm Dept, Hail, Saudi Arabia.
   [Alamoudi, Abdullah, I] King Fahad Hosp, Al Khobar, Saudi Arabia.
   [Aldhafeeri, Dhari A.; Al-khalaf, Turki, I] Jordan Univ Sci & Technol, Irbid, Jordan.
   [Aldhafeeri, Dhari A.] Jordanian Royal Med Serv, Amman, Saudi Arabia.
   [Alshammari, Khlood A.] Taibah Univ, Coll Med, Medina, Saudi Arabia.
   [Alshammari, Afnan A.] Imam Abdulrahman Bin Faisal Univ Dammam, Coll Appl Med Sci, Resp Care Dept, Jubail Ind City, Saudi Arabia.
   [El Shaer, Fayez] King Saud Univ Med City, Cardiol Dept, Riyadh, Saudi Arabia.
RP El-Malky, AM (corresponding author), Minist Higher Educ, Acad Sci Res, Theodor Bilharz Res Inst, Publ Hlth & Community Med Dept, Cairo, Egypt.; El-Malky, AM (corresponding author), King Saud Univ Med City, Morbid & Mortal Review Unit, Riyadh, Saudi Arabia.; El-Malky, AM (corresponding author), King Saud Univ, Coll Med, Evidence Based Healthcare & Knowledge Translat, Riyadh, Saudi Arabia.
EM aelmalky@ksu.edu.sa; hayaalbalawi9@gmail.com; taotiabi@gmail.com;
   Abdullah10014@hotmail.com; Alshbel@outlook.com; k-freedom@hotmail.com;
   kitkatm2009@gmail.com; Turki.khalaf93@gmail.com; felshaer@ksu.edu.sa
CR Betsch C., 2020, NATUREHUMAN BEHAV, V5, P425
   CDC, 2020, CLOTH FAC COV WEAR C
   Duan L, 2020, LANCET PSYCHIAT, V7, P300, DOI 10.1016/S2215-0366(20)30073-0
   Fana Thanduxolo Elford, 2019, Tuberc Res Treat, V2019, P8978021, DOI 10.1155/2019/8978021
   Flahault A, 2020, LANCET, V395, P947, DOI 10.1016/S0140-6736(20)30521-3
   Hou WK, 2015, J AFFECT DISORDERS, V186, P74, DOI 10.1016/j.jad.2015.07.005
   Jiang SB, 2020, EMERG MICROBES INFEC, V9, P275, DOI 10.1080/22221751.2020.1723441
   Kamen C, 2015, AJAR-AFR J AIDS RES, V14, P67, DOI 10.2989/16085906.2015.1016987
   KNIGHT RG, 1983, BRIT J CLIN PSYCHOL, V22, P245, DOI 10.1111/j.2044-8260.1983.tb00610.x
   Leung CC, 2020, LANCET, V395, P945, DOI 10.1016/S0140-6736(20)30520-1
   Leung N. H., 2020, NAT MED, V5, P425
   Lewnard J. A., SCI ETHICAL BASIS SO
   Mao R, 2020, LANCET GASTROENTEROL, V5, P426, DOI 10.1016/S2468-1253(20)30076-5
   MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x
   Muwahed J., 2020, ABC NEWS        0314
   Popoola J., 2020, FACULTY OPINIONS POS
   Prem K, EFFECT CONTROL STRAT
   Valizadeh L, 2017, GASTROENTEROL NURS, V40, P143, DOI 10.1097/SGA.0000000000000223
   WHO, 2020, ADV US MASKS COMM HO
   World Health Organisation, 2020, ADV US MASKS CONT CO
   Wuhan Johnson M., 2019, MAT METHODS, V2020, P10
   Yamanobe S, 2019, J JAPAN SOC CIVIL EN, V75, P80
NR 22
TC 4
Z9 4
U1 0
U2 3
PU DISCOVERY PUBLICATION
PI TAMILNADU
PA KANYAKUMARI DISTRICT, TAMILNADU, 00000, INDIA
SN 2321-7359
EI 2321-7367
J9 MED SCI
JI Med. Sci.
PD SEP-OCT
PY 2020
VL 24
IS 105
BP 3427
EP 3437
PG 11
WC Medicine, Research & Experimental
WE Emerging Sources Citation Index (ESCI)
SC Research & Experimental Medicine
GA PN1PO
UT WOS:000604259000061
DA 2022-04-20
ER

PT J
AU Zrnic, M
   Kilibarda, N
   Brdar, I
   Vujic, M
   Stojanovic, D
AF Zrnic, Milos
   Kilibarda, Natasa
   Brdar, Ivana
   Vujic, Milan
   Stojanovic, Djordje
TI FOOD SAFETY AND EATING HABITS DURING PANDEMIC COVID-19 IN THE REPUBLIC
   OF SERBIA
SO EKONOMIKA POLJOPRIVREDA-ECONOMICS OF AGRICULTURE
LA English
DT Article
DE food; food safety; eating habits; COVID-19; Serbia
ID KNOWLEDGE; BEHAVIOR
AB Food safety is of paramount importance at all times, especially in exceptional circumstances, such as pandemic COVID-19, given the fact that coronavirus is spreading rapidly and little is known about coronavirus. Protections have been strengthened in all fields, including food safety. In order to best protect ourselves and others, it's necessary to handle food properly, especially if children, pregnant women, the elderly and the ill ones are in the immediate vicinity. The paper will examine food safety and eating habits during pandemic COVID-19, with focus on recommended guidelines for safe food preparation, food storage, together with the prescribed measures of the Government of the Republic of Serbia. (C) 2021 EA. All rights reserved.
C1 [Zrnic, Milos; Kilibarda, Natasa; Brdar, Ivana] Univ Singidunum, Danijelova 32, Belgrade, Serbia.
   [Zrnic, Milos; Stojanovic, Djordje] Acad Appl Studies, Coll Hotel Management, Kneza Viseslava 70, Belgrade, Serbia.
   [Vujic, Milan] Coll Hotel Management Belgrade, Acad Appl Studies, Kneza Viseslava 70, Belgrade, Serbia.
RP Zrnic, M (corresponding author), Univ Singidunum, Danijelova 32, Belgrade, Serbia.; Zrnic, M (corresponding author), Acad Appl Studies, Coll Hotel Management, Kneza Viseslava 70, Belgrade, Serbia.
EM milos.zrnic@vhs.edu.rs; nkilibarda@singidunum.ac.rs;
   ibrdar@singidunum.ac.rs; milan.vujic@vhs.edu.rs;
   djordje.stojanovic@vhs.edu.rs
OI Kilibarda, Natasa/0000-0002-2967-3749
CR Al Thani M, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5400-2
   [Anonymous], 2020, LANCET INFECT DIS, V20, P261, DOI 10.1016/S1473-3099(20)30072-4
   [Anonymous], Food and coronavirus (COVID-19): what you need to know.
   Associacao Brasileira de Nutrologia [Brazilian Association of Clinical Nutrition], 2020, GUID HLTH EAT TIM CO
   Ben Hassen T, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12176973
   Borchgrevink CP, 2013, J ENVIRON HEALTH, V75, P18
   do Nascimento IB, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040941
   Borovcanin D., 2020, Meat Technology, V61, P82, DOI 10.18485/meattech.2020.61.1.8
   Chaloner-Larsson G., 1999, WHOVSQ9701
   Chang L, 2020, TRANSFUS MED REV, V34, P75, DOI 10.1016/j.tmrv.2020.02.003
   Chenarides L, 2021, AGRIBUSINESS, V37, P44, DOI 10.1002/agr.21679
   Chodkiewicz J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134677
   Di Renzo L, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02399-5
   Duda-Chodak A, 2020, TRENDS FOOD SCI TECH, V105, P145, DOI 10.1016/j.tifs.2020.08.020
   European Food Safety Authority, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5500
   FAO, 2020, Q A COVID 19 PAND IM
   Food and Agriculture Organization of the United Nations [FAO] and World Health Organization [WHO], 2020, COVID 19 FOOD SAF GU, P1
   Gil MI, 2009, INT J FOOD MICROBIOL, V134, P37, DOI 10.1016/j.ijfoodmicro.2009.05.021
   Gold N. A., 2018, STATPEARLS
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Guzek D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165770
   Harapan H, 2020, J INFECT PUBLIC HEAL, V13, P667, DOI 10.1016/j.jiph.2020.03.019
   Jay LS, 1999, J FOOD PROTECT, V62, P921, DOI 10.4315/0362-028X-62.8.921
   Jernigan DH., AM IS DRINKING ITS W
   Jin HJ, 2014, FOOD POLICY, V44, P95, DOI 10.1016/j.foodpol.2013.10.007
   Jribi S, 2020, ENVIRON DEV SUSTAIN, V22, P3939, DOI 10.1007/s10668-020-00740-y
   Katri J., 2020, INT J HYG ENVIR HEAL
   Kaul Dinesh, 2020, Curr Med Res Pract, V10, P54, DOI 10.1016/j.cmrp.2020.04.001
   Kilibarda N., 2019, ZERO HUNGER, P1, DOI [10.1007/978-3-319-69626-3_107-1, DOI 10.1007/978-3-319-69626-3_107-1]
   Kumar S, 2017, AM J TROP MED HYG, V97, P447, DOI 10.4269/ajtmh.16-0445
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Manning L, 2018, WORLDW HOSP TOUR THE, V10, P284, DOI 10.1108/WHATT-02-2018-0008
   Micallef J.V., COVID 19 PANDEMIC IS
   Milan B. T., 2013, CONSUMERS FOOD SAFET, P11
   Min S, 2020, J INTEGR AGR, V19, P2926, DOI 10.1016/S2095-3119(20)63388-3
   Moynihan AB, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00369
   Naserghandi A, 2020, NEW MICROB NEW INFEC, V35, DOI 10.1016/j.nmni.2020.100678
   Petrosillo N, 2020, CLIN MICROBIOL INFEC, V26, P729, DOI 10.1016/j.cmi.2020.03.026
   Qiao GH, 2012, FOOD CONTROL, V26, P378, DOI 10.1016/j.foodcont.2012.01.045
   Quevedo-leon R, 2020, SCI AGROPEC, V11, P257, DOI 10.17268/sci.agropecu.2020.02.14
   Rossi EM, 2018, J FOOD SAFETY, V38, DOI 10.1111/jfs.12417
   Scarmozzino F, 2020, FOODS, V9, DOI 10.3390/foods9050675
   Sun PF, 2020, J MED VIROL, V92, P612, DOI 10.1002/jmv.25735
   WHO, 2012, WORLD MALARIA REPORT 2012, P1
   Worsfold D., 1997, British Food Journal, V99, P97, DOI 10.1108/00070709710168932
   Yilmaz C, 2020, FOOD RES INT, V128, DOI 10.1016/j.foodres.2019.108744
   Yuan JJ, 2020, ECOSYST HEALTH SUST, V6, DOI 10.1080/20964129.2020.1741325
NR 47
TC 0
Z9 0
U1 1
U2 1
PU BALKAN SCIENTIFIC ASSOC AGRARIAN ECONOMISTS
PI BELGRADE
PA VOLGINA 15, PO BOX 93, BELGRADE, 11060, SERBIA
SN 0352-3462
J9 EKON POLJOPR
JI Ekon. Poljopr.
PY 2021
VL 68
IS 4
BP 895
EP 910
DI 10.5937/ekoPolj2104895Z
PG 16
WC Agricultural Economics & Policy
WE Emerging Sources Citation Index (ESCI)
SC Agriculture
GA YX8EU
UT WOS:000754330300003
OA gold
DA 2022-04-20
ER

PT J
AU Monteleone, PAA
   Nakano, M
   Lazar, V
   Gomes, AP
   de Martin, H
   Bonetti, TCS
AF Monteleone, Pedro A. A.
   Nakano, Mayra
   Lazar, Victor
   Gomes, Alecsandra P.
   de Martin, Hamilton
   Bonetti, Tatiana C. S.
TI A review of initial data on pregnancy during the COVID-19 outbreak:
   implications for assisted reproductive treatments
SO JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA
LA English
DT Review
DE COVID-19; SARS-CoV-2; pregnancy; assisted reproduction
ID CORONAVIRUS; WUHAN
AB The current outbreak of the novel 2019 coronavirus disease (COVID-19) started in China in December 2019 and has since spread to several other countries. On March 25, 2020, a total of 375,498 cases had been confirmed globally with 2,201 cases in Brazil, showing the urgency of reacting to this international public health emergency. While in most cases, mild symptoms are observed, in some cases the infection leads to serious pulmonary disease. As a result, the possible consequences of the COVID-19 outbreak for pregnant women and its potential effects on the management of assisted reproductive treatments, demand attention. In this review, we summarize the latest research progress related to COVID-19 epidemiology and the reported data of pregnant women, and discuss the current evidence of COVID-19 infections during pregnancy and its potential consequences for assisted reproductive treatments. Reported data suggest that symptoms in pregnant women are similar to those in other people, and that there is no evidence for higher maternal or fetal risks. However, considering the initial data and lack of comprehensive knowledge on the pathogenesis of SARS-CoV-2 during pregnancy, human reproduction societies have recommended postponing the embryo transfers and do not initiate new treatment cycles. New evidence must be considered carefully in order to adjust these recommendations accordingly at any time and to guide assisted reproductive treatments.
C1 [Monteleone, Pedro A. A.; Nakano, Mayra; Lazar, Victor; Gomes, Alecsandra P.; de Martin, Hamilton; Bonetti, Tatiana C. S.] Univ Sao Paulo FMUSP, Fac Med, Ctr Reprod Humana Monteleone, Sao Paulo, Brazil.
   [Monteleone, Pedro A. A.; Nakano, Mayra; de Martin, Hamilton] Univ Sao Paulo FMUSP, Disciplina Ginecol, Dept Obstet & Ginecol, Fac Med, Sao Paulo, Brazil.
   [Bonetti, Tatiana C. S.] Univ Fed Sao Paulo, Dept Ginecol, EPM, UNIFESP, Sao Paulo, Brazil.
RP Bonetti, TCS (corresponding author), Ctr Reprod Humana Monteleone, Sao Paulo, SP, Brazil.; Bonetti, TCS (corresponding author), Univ Fed Sao Paulo, Lab Ginecol Mol, Dept Ginecol, Escola Paulista Med, Sao Paulo, SP, Brazil.
EM cientifico@monteleone.med.br
RI Lazar, Vladimir/AAQ-2086-2020; Bonetti, Tatiana Carvalho de
   Souza/AAX-2706-2021
OI Bonetti, Tatiana Carvalho de Souza/0000-0002-5193-700X
CR American Society for Reproductive Medicine (ASRM), 2020, PAT MAN CLIN REC COR
   ASRM-American Society for Reproductive Medicine, 2020, COVID 19 SUGG MAN PA
   BRASIL-Ministerio da Saude. Secretaria de Atencao Primaria a Saude. Departamento de Acoes Programaticas Estrategicas. Coordenacao-Geral de Ciclos da Vida. Coordenacao de Saude das Mulheres, 2020, SEIMS0014128689 MIN
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen DJ, 2020, INT J GYNECOL OBSTET, V149, P130, DOI 10.1002/ijgo.13146
   Chen S, 2020, ZHONGHUA BING LI XUE, V49, P418, DOI DOI 10.3760/cma.j.cn112151-20200225-00138
   Chen W, EARLY CONTAINMENT ST, V395, P809, DOI [10.1016/S0140-6736(20)30360-3, DOI 10.1016/S0140-6736(20)30360-3]
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   ESHRE-European Society of Human Reproduction and Embryology, 2020, COR COV 19 ESHRE STA
   European Centre for Disease Prevention and Control, 2020, COR DIS
   Fakari FR, 2020, ARCH ACAD EMERG MED, V8
   Fan C, 2020, PERINATAL TRANSMISSI
   Goodnight William H, 2005, Crit Care Med, V33, pS390, DOI 10.1097/01.CCM.0000182483.24836.66
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   IFFS-International Federation Fertility Societies, 2020, UPD RES REL COR PAND
   Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152
   Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0
   Khan S, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00187-20
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Liang H, 2020, ACTA OBSTET GYN SCAN, V99, P439, DOI 10.1111/aogs.13836
   Liu DH, 2020, AM J ROENTGENOL, V215, P127, DOI 10.2214/AJR.20.23072
   Liu J, 2020, J MED VIROL, V92, P491, DOI 10.1002/jmv.25709
   Liu Yangli, 2020, J Infect, DOI 10.1016/j.jinf.2020.02.028
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Niud Y, 2020, LANCET GLOB HEALTH, V8, pE452, DOI 10.1016/S2214-109X(20)30085-1
   Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, ZHONGHUA LIU XING BI, V41, P145, DOI DOI 10.3760/CMA.J.ISSN.0254-6450.2020.02.003
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   SBRA-Sociedade Brasileira de Reproducao Assistida, 2020, REPR ASS COV 19
   SBRH-Sociedade Brasileira de Reproducao Humana, 2020, COVID 19 AC PAC SUBM
   Schwartz DA, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020194
   Spiteri G, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.9.2000178
   Sun PF, 2020, J MED VIROL, V92, P548, DOI 10.1002/jmv.25722
   Wang SS, 2020, CLIN INFECT DIS, V71, P853, DOI 10.1093/cid/ciaa225
   Wang XT, 2020, CLIN INFECT DIS, V71, P844, DOI 10.1093/cid/ciaa200
   Wen R, 2020, J MICROBIOL IMMUNOL, V53, P499, DOI 10.1016/j.jmii.2020.03.004
   WHO, 2020, NOV COR COVID 19 SIT
   WHO China, 2020, REP WHO CHIN JOINT M, DOI DOI 10.1186/S40249-020-00650-1
   Wong SF, 2004, AM J OBSTET GYNECOL, V191, P292, DOI 10.1016/j.ajog.2003.11.019
   World Health Organization, 2020, WHO COR DIS COVID 19
   World Health Organization, 2018, PRET BIRTH
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhang L, 2020, Zhonghua Fu Chan Ke Za Zhi, V55, P166, DOI 10.3760/cma.j.cn112141-20200218-00111
   Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu HP, 2020, TRANSL PEDIATR, V9, P51, DOI 10.21037/tp.2020.02.06
NR 50
TC 25
Z9 26
U1 0
U2 9
PU SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA
PI RIBEIRAO
PA SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA, RIBEIRAO, 00000, BRAZIL
SN 1517-5693
EI 1518-0557
J9 J BRAS REPROD ASSIST
JI J. Bras. Reprod. Assist.
PD APR-JUN
PY 2020
VL 24
IS 2
BP 219
EP 225
DI 10.5935/1518-0557.20200030
PG 7
WC Obstetrics & Gynecology
WE Emerging Sources Citation Index (ESCI)
SC Obstetrics & Gynecology
GA LD0XA
UT WOS:000525755600020
PM 32301600
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Alshahrani, SM
   Dehom, S
   Almutairi, D
   Alnasser, BS
   Alsaif, B
   Alabdrabalnabi, AA
   Bin Rahmah, A
   Alshahrani, MS
   El-Metwally, A
   Al-Khateeb, BF
   Othman, F
   Alam, MM
AF Alshahrani, Saeed Mastour
   Dehom, Salem
   Almutairi, Diaa
   Alnasser, Badr Saud
   Alsaif, Bandar
   Alabdrabalnabi, Ahmed A.
   Bin Rahmah, Abdullah
   Alshahrani, Mastour Safar
   El-Metwally, Ashraf
   Al-Khateeb, Badr F.
   Othman, Fatmah
   Mahtab Alam, Mohammad
TI Acceptability of COVID-19 vaccination in Saudi Arabia: A cross-sectional
   study using a web-based survey
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT Article
DE COVID-19; vaccine; acceptance; hesitancy; questionnaire; Saudi Arabia
AB The success of COVID-19 vaccination depends on individual's vaccine acceptance. There has been misinformation on the media that doubts its effectiveness, safety, and long-term risk. Such controversy could affect the acceptance toward the uptake of the COVID-19 vaccine. The objective of this study was to assess the factors influencing the acceptance and hesitancy toward the COVID-19 vaccine in Saudi Arabia. A cross-sectional study was conducted. An online survey was conducted with four parameters: Demographics, medical history, knowledge and information sources about COVID-19 and vaccine, and hesitancy/acceptance of vaccinations. Bivariate analysis between several survey items and the acceptance of COVID-19 vaccine was conducted using Chi-square test. Logistic regression was used to assess to what degree each variable affects the acceptance and the hesitancy toward the COVID-19 vaccine. Approximately 64% show a desire to accept the vaccine while 18.3% were extremely hesitant to take the vaccine. Non-demographic factors that were associated with the acceptance toward the COVID-19 vaccine were the source of health information about COVID-19 (OR:1.63; 95% CI:1.07-2.47), perception toward whether the vaccine is effective on other variants of the virus (OR:7.24; 95% CI:4.58-11.45), previous uptake of the influenza vaccine (OR:1.62; 95% CI:1.07-2.47), and potential mandatory of vaccination in order to travel internationally (OR:16.52; 95% CI:10.23-26.68). This study provides an insight into factors - other than the sociodemographic - influencing the acceptance of the COVID-19 vaccine in Saudi Arabia. The government should address the COVID-19-related misinformation and rumors to increase acceptance of COVID-19 vaccination.
C1 [Alshahrani, Saeed Mastour; Mahtab Alam, Mohammad] King Khalid Univ, Coll Appl Med Sci, Abha 96061421, Saudi Arabia.
   [Dehom, Salem] Loma Linda Univ, Sch Nursing, Dept Grad Studies, Loma Linda, CA 92350 USA.
   [Almutairi, Diaa] Prince Sultan Mil Coll Hlth Sci, Dept Oral Hlth, Dhahran, Saudi Arabia.
   [Almutairi, Diaa] Queen Mary Univ London, Sch Med & Dent, London, England.
   [Alnasser, Badr Saud] Univ Hail, Coll Publ Hlth & Hlth Informat, Dept Hlth Management, Hail, Saudi Arabia.
   [Alsaif, Bandar] Univ Hail, Dept Publ Hlth, Hail, Saudi Arabia.
   [Alabdrabalnabi, Ahmed A.] Saudi Elect Univ, Coll Hlth Sci, Dept Publ Hlth, Dammam, Saudi Arabia.
   [Bin Rahmah, Abdullah] King Saud Univ, Coll Dent, Riyadh, Saudi Arabia.
   [Bin Rahmah, Abdullah] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England.
   [Alshahrani, Mastour Safar] Minist Hlth, Dent Dept, Khamis Mushayt, Saudi Arabia.
   [El-Metwally, Ashraf; Al-Khateeb, Badr F.] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Publ Hlth & Hlth Informat, Riyadh, Saudi Arabia.
   [Al-Khateeb, Badr F.] King Abdul Aziz Med City, Dept Family Med, Riyadh, Saudi Arabia.
   [Othman, Fatmah] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Appl Med Sci, Riyadh, Saudi Arabia.
RP Alshahrani, SM (corresponding author), King Khalid Univ, Coll Appl Med Sci, Abha 96061421, Saudi Arabia.
EM smsalshahrani@kku.edu.sa
RI Alshahrani, Saeed Mastour/AAL-2795-2020; Library, COAMS/ABD-3174-2021;
   Alsaif, Bandar/AAP-6225-2021
OI Alshahrani, Saeed Mastour/0000-0003-2714-7785; Alsaif,
   Bandar/0000-0002-1501-7396; Al-khateeb, Badr/0000-0001-9824-7148;
   Othman, Fatmah/0000-0002-6846-4632
CR Al-Mohaithef M, 2020, J MULTIDISCIP HEALTH, V13, P1657, DOI 10.2147/JMDH.S276771
   Almaghaslah D, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9040330
   [Anonymous], BBC NEWS
   Bell S, 2020, VACCINE, V38, P7789, DOI 10.1016/j.vaccine.2020.10.027
   Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107
   Ceri, 2021, ARXIV PREPRINT ARXIV
   COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408
   Cordina M, 2021, PHARM PRACT-GRANADA, V19, DOI [10.18549/PharmPract.2021.1.2317, 10.18549/pharmpract.2021.1.2317]
   Ditekemena JD, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020153
   Fagerland MW, 2012, STATA J, V12, P447, DOI 10.1177/1536867X1201200307
   Fridman A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250123
   Gagneux-Brunon A, 2021, J HOSP INFECT, V108, P168, DOI [10.1016/j.jhin.2020.11.0200195-6701, 10.1016/j.jhin.2020.11.020]
   General Authority for statistics, 2019, B IND HOUS ICT ACC U
   Grech Victor, 2020, Early Hum Dev, P105213, DOI 10.1016/j.earlhumdev.2020.105213
   HANLEY JA, 1989, CRIT REV DIAGN IMAG, V29, P307
   Harapan H, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00381
   Johns Hopkins Coronavirus Resource Center, COVID 19 MAP
   Kaur SP, 2020, VIRUS RES, V288, DOI 10.1016/j.virusres.2020.198114
   Khan YH, 2020, AM J TROP MED HYG, V103, P603, DOI 10.4269/ajtmh.20-0654
   Kose S, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13917
   Kreps S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25594
   Ladnyi, SMALLPOX ITS ERADICA, P302
   Lemeshow S. A., 2005, ENCY BIOSTATISTICS, V2, P2870
   Liu P., 2020, ACCEPTANCE PREFERENC, DOI [10.1101/2020.04.09.20060103, DOI 10.1101/2020.04.09.20060103]
   Loomba S, 2021, NAT HUM BEHAV, V5, P337, DOI 10.1038/s41562-021-01056-1
   Machida M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030210
   Magadmi R, 2020, RES SQUARE, DOI [10.21203/rs.3.rs-48955/v1, DOI 10.21203/RS.3.RS-48955/V1]
   Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n158
   MANSFIELD ER, 1982, AM STAT, V36, P158, DOI 10.2307/2683167
   McGill COVID19 Vaccine Tracker Team, COVID19 VACC TRACK
   Pennings S, 2021, J MED ETHICS, V47, P709, DOI 10.1136/medethics-2020-107076
   Reuters, REUTERS
   ROBERTS G, 1987, BIOMETRIKA, V74, P1
   Ryan TP, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118439241
   Sadler GR, 2010, NURS HEALTH SCI, V12, P369, DOI 10.1111/j.1442-2018.2010.00541.x
   Saied SM, 2021, J MED VIROL, V93, P4280, DOI 10.1002/jmv.26910
   Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020160
   Saudi Arabia Ministry of Health, COVID 19 DASHB
   Saudi Press Agency, SFDA APPR REG PFIZ B
   Saudi Press Agency, COVID 19 FOLL UP COM
   Saudi Press Agency, MOH ANN START REG TA
   Saudi Press Agency, MOH REG TAK COVID 19
   Saudi Press Agency, HRH CROWN PRINC REC
   Saudi Press Agency, MIN HLHT REASS PUBL
   Saudi Press Agency, HLTH MIN LAUNCH VACC
   Saudi Press Agency, MIN HLTH SDAIA LAUNC
   Tanne JH, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4799
   UPTON GJG, 1992, J ROY STAT SOC A STA, V155, P395, DOI 10.2307/2982890
   von Tigerstrom BJ, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa127
   Voo TC, 2020, J INFECT DIS, V222, P715, DOI 10.1093/infdis/jiaa352
   Wang JH, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030482
   Wilson SL, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-004206
   Wise J, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4857
   World Health Organization, 2008, INT HLTH REG 2005
   World Health Organization, 2021, STAT 6 M INT HLTH RE, V15
   Yen MY, 2020, J MICROBIOL IMMUNOL, V53, P377, DOI 10.1016/j.jmii.2020.03.011
NR 56
TC 4
Z9 4
U1 3
U2 6
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PD OCT 3
PY 2021
VL 17
IS 10
BP 3338
EP 3347
DI 10.1080/21645515.2021.1936869
EA JUL 2021
PG 10
WC Biotechnology & Applied Microbiology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Immunology
GA UW4JW
UT WOS:000670810600001
PM 34236290
OA Bronze
DA 2022-04-20
ER

PT J
AU Tesfaye, ZT
   Yismaw, MB
   Negash, Z
   Ayele, AG
AF Tesfaye, Zelalem Tilahun
   Yismaw, Malede Berihun
   Negash, Zenebe
   Ayele, Akeberegn Gorems
TI COVID-19-Related Knowledge, Attitude and Practice Among Hospital and
   Community Pharmacists in Addis Ababa, Ethiopia
SO INTEGRATED PHARMACY RESEARCH AND PRACTICE
LA English
DT Article
DE novel coronavirus; global pandemic; SARS-CoV-2; viral pneumonia;
   physical distancing
ID CORONAVIRUS; LOPINAVIR/RITONAVIR; INFECTION
AB Purpose: This study was launched to assess COVID-19-related knowledge, attitude and practice among hospital and community pharmacists in Addis Ababa, Ethiopia.
   Methods: Self-administered questionnaire was distributed to pharmacists working in hospitals and community pharmacies by physically delivering the questionnaire to study subjects. Data collected were entered into and analyzed by IBM SPSS Statistics (R) Version 25. Binary logistic analysis was used to determine the association between independent and outcome variables.
   Results: All 295 participants who completed the survey stated that they had heard about COVID-19. Almost all of the participants were aware of the causative agent, the clinical manifestations and the ways of transmission of COVID-19. Most participants (92.2%) identified elderly individuals as one of the high-risk groups for severe complications and death while 89.5% identified supportive therapy and life support as recommended management options to date. More than half (53.2%) of the respondents were found to have adequate knowledge about COVID-19. Among respondents, 89.8% had a positive attitude on the importance of following WHO recommendations in reducing the transmission of COVID-19. Only 9.8% had confidence in the capacity of healthcare facilities in the country to properly handle potential COVID-19 pandemic. Inadequate protective measures were taken to protect the staff from COVID-19 in the institutions of 70.2% of the participants. Among the WHO recommended prevention measures, hand washing was exercised by 97.3% of the study participants.
   Conclusion: The study findings confirmed that there is a high level of knowledge on each specific aspect of COVID-19 among the study participants. However, only about half of the participants had adequate knowledge about the disease. The pharmacists showed a predominantly positive attitude towards the importance of WHO recommendations and predominantly negative attitude towards the country's capacity to deal with the pandemic. The practice related to COVID-19 was inadequate at institutional level. Nevertheless, most of the pharmacists individually exercised self-protective measures against COVID-19. All stakeholders should work on ensuring the adequate supply of materials and services that aid in controlling the pandemic.
C1 [Tesfaye, Zelalem Tilahun; Yismaw, Malede Berihun; Negash, Zenebe; Ayele, Akeberegn Gorems] Addis Ababa Univ, Coll Hlth Sci, Sch Pharm, Dept Pharmacol & Clin Pharm, Zambia St,POB 9086, Addis Ababa, Ethiopia.
RP Tesfaye, ZT (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Sch Pharm, Dept Pharmacol & Clin Pharm, Zambia St,POB 9086, Addis Ababa, Ethiopia.
EM zelalem11@yahoo.com
OI Tesfaye, Zelalem Tilahun/0000-0002-9841-8901
CR [Anonymous], 2020, CORONAVIRUS DIS COVI
   [Anonymous], 2020, 1 CASE COVID 19 CONF
   Bandari DK, 2020, NOVEL CORONAVIRUS CO, V6, DOI DOI 10.1101/2020.03.09.20033381
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Bhattacharya M, 2020, J MED VIROL, V92, P618, DOI 10.1002/jmv.25736
   Cooper J, 2000, CAN PHARM J, P133
   COVID, 2020, COVID 19 PREPAREDNES
   de Wilde AH, 2018, CURR TOP MICROBIOL, V419, P1, DOI 10.1007/82_2017_25
   del Rio C, 2020, JAMA-J AM MED ASSOC, V323, P1339, DOI 10.1001/jama.2020.3072
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Jiang F, 2020, J GEN INTERN MED, V35, P1545, DOI 10.1007/s11606-020-05762-w
   Jin YF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040372
   Liu S, 2020, INT J CLIN PHARM-NET, V42, P299, DOI 10.1007/s11096-020-01017-0
   Mullen E, 2009, J AM PHARM ASSOC, V49, P722, DOI 10.1331/JAPhA.2009.09539
   Nemati M, 2020, ARCH CLIN INFECT DIS, V15, DOI 10.5812/archcid.102848
   Nkengasong JN, 2020, LANCET, V395, P841, DOI 10.1016/S0140-6736(20)30464-5
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Tian XL, 2020, EMERG MICROBES INFEC, V9, P382, DOI 10.1080/22221751.2020.1729069
   Voo TC, 2010, SINGAP MED J, V51, P275
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Yasri S, 2020, ASIAN PAC J TROP MED, V13, P137, DOI 10.4103/1995-7645.277815
   Zeng YM, 2020, CHINESE MED J-PEKING, V133, P1132, DOI 10.1097/CM9.0000000000000790
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 25
TC 18
Z9 18
U1 0
U2 4
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 2230-5254
J9 INTEGR PHARM RES PRA
JI Integr. Pharm. Res. Pract.
PY 2020
VL 9
BP 105
EP 112
DI 10.2147/IPRP.S261275
PG 8
WC Pharmacology & Pharmacy
WE Emerging Sources Citation Index (ESCI)
SC Pharmacology & Pharmacy
GA NH3QV
UT WOS:000564589100001
PM 32904494
OA Green Published
DA 2022-04-20
ER

PT J
AU Hundal, GS
   Thiyagarajan, S
   Alduraibi, M
   Laux, CM
   Furterer, SL
   Cudney, EA
   Antony, J
AF Hundal, Gaganpreet Singh
   Thiyagarajan, Senthilkumar
   Alduraibi, Manal
   Laux, Chad Matthew
   Furterer, Sandra L.
   Cudney, Elizabeth A.
   Antony, Jiju
TI Lean Six Sigma as an organizational resilience mechanism in health care
   during the era of COVID-19
SO INTERNATIONAL JOURNAL OF LEAN SIX SIGMA
LA English
DT Article
DE Lean six sigma; Health care; Organizational resilience; COVID-19; Supply
   chain resilience
AB Purpose
   The purpose of this study was to investigate how Lean Six Sigma (LSS) may help mitigate the impact of COVID-19 within health care environments. The goals of this study were to understand the current knowledge of LSS and COVID-19 through a systematic review of the current literature, identify the gap in the current knowledge of LSS in COVID-19 mitigation within health care environments and define the principles of LSS, within organizational resilience that support a health care organization's ability to mitigate the impact of COVID-19.
   Design/methodology/approach
   A narrative literature review was conducted to identify relevant research. A total of 21 subject matter experts (SMEs) meeting the inclusion criteria were approached through a guided interview process. Content analysis was conducted to describe how LSS principles contribute to supporting health care organizations operating in the era of COVID-19.
   Findings
   Study results report that personal safety is the primary subject, followed by supporting dimensions of process redesign, and telemedicine. LSS topics that directly relate to COVID-19 are in four thematic areas: tools, applications, benefits and challenges. Particular areas of application, techniques, challenges and benefits are identified and discussed that could be applied proactively and reactively, to organizational and supply chain resilience to recover from COVID-19.
   Research limitations/implications
   There were a number of limitations to the generalizability of this work. The sample size was small and purposeful, thus, external validity of the study results are not determined. The SMEs in this study have not implemented the practices noted in the results at the time of the study, and knowledge of results is limited to the study aims.
   Originality/value
   This study of LSS principles and COVID-19 has implications for practitioners and offers specific guidance for areas of health care adoption of LSS techniques and tools that benefit patient safety, challenges for the user to be mindful of and potential benefits in resilience of operations in the era of COVID-19.
C1 [Hundal, Gaganpreet Singh; Thiyagarajan, Senthilkumar; Alduraibi, Manal; Laux, Chad Matthew] Purdue Univ, Dept Comp & Informat Technol, W Lafayette, IN 47907 USA.
   [Furterer, Sandra L.] Univ Dayton, Dept Engn Management Syst & Technol, Dayton, OH 45469 USA.
   [Cudney, Elizabeth A.] Maryville Univ, John E Simon Sch Business, St Louis, MO USA.
   [Antony, Jiju] Heriot Watt Univ, Sch Management & Languages, Edinburgh, Midlothian, Scotland.
RP Hundal, GS (corresponding author), Purdue Univ, Dept Comp & Informat Technol, W Lafayette, IN 47907 USA.
EM ghundal@purdue.edu; sthiyaga@purdue.edu; maldurai@purdue.edu;
   claux@purdue.edu; sfurterer1@udayton.edu; ecudney@maryville.edu;
   J.Antony@hw.ac.uk
RI Laux, Chad/AAN-4145-2021
OI Laux, Chad/0000-0001-7445-2446; Alduraibi, Manal/0000-0001-7186-0233
CR Altay N., 2009, INT J SERV SCI, V2, P142, DOI DOI 10.1504/IJSSCI.2009.024937
   Altay N, 2006, EUR J OPER RES, V175, P475, DOI 10.1016/j.ejor.2005.05.016
   Ambulkar S, 2015, J OPER MANAG, V33-34, P111, DOI 10.1016/j.jom.2014.11.002
   Andersson R, 2020, TQM J, V32, P1021, DOI [10.1108/tqm-04-2019-0120, DOI 10.1108/TQM-04-2019-0120]
   Antony J, 2019, INT J QUAL RELIAB MA, V36, P1370, DOI 10.1108/IJQRM-12-2018-0346
   Antony J, 2018, INT J QUAL RELIAB MA, V35, P1075, DOI 10.1108/IJQRM-02-2017-0027
   Bal A, 2017, INT J HEALTHCARE MAN, V10, P196, DOI 10.1080/20479700.2017.1304323
   Beck Michael J, 2016, Hosp Pract (1995), V44, P252
   Bhamra R, 2011, INT J PROD RES, V49, P5375, DOI 10.1080/00207543.2011.563826
   Birkie SE, 2016, J MANUF TECHNOL MANA, V27, P185, DOI 10.1108/JMTM-07-2015-0054
   Brandon-Jones E, 2014, J SUPPLY CHAIN MANAG, V50, P55, DOI 10.1111/jscm.12050
   Carboneau Clark, 2010, J Healthc Qual, V32, P61, DOI 10.1111/j.1945-1474.2009.00074.x
   Castilla-Polo F, 2017, J INTELLECT CAP, V18, P506, DOI 10.1108/JIC-11-2016-0123
   Chowdhury MMH, 2017, INT J PROD ECON, V188, P185, DOI 10.1016/j.ijpe.2017.03.020
   Christopher M., 2004, CRITICAL EYE     JUN, V7, P24
   Costa LBM, 2016, PROD PLAN CONTROL, V27, P823, DOI 10.1080/09537287.2016.1143131
   Deblois S, 2016, INT J HEALTH CARE Q, V29, P192, DOI 10.1108/IJHCQA-05-2014-0058
   Downe-Wamboldt B, 1992, Health Care Women Int, V13, P313
   Eldridge NE, 2006, J GEN INTERN MED, V21, pS35, DOI 10.1111/j.1525-1497.2006.00361.x
   Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x
   Elstad EA, 2010, J ADV NURS, V66, P2460, DOI 10.1111/j.1365-2648.2010.05422.x
   Furterer SL, 2018, QUAL ENG, V30, P389, DOI 10.1080/08982112.2018.1464657
   Galletta, 2013, MASTERING SEMISTRUCT, V18
   Gates B, 2020, NEW ENGL J MED, V382, P1677, DOI 10.1056/NEJMp2003762
   Golan Maureen S., 2020, Environment Systems & Decisions, V40, DOI 10.1007/s10669-020-09777-w
   Halcomb E, 2020, J NURS MANAGE, V28, P1553, DOI 10.1111/jonm.13108
   Henrique DB, 2020, TOTAL QUAL MANAG BUS, V31, P429, DOI 10.1080/14783363.2018.1429259
   Hina-Syeda H, 2013, OCHSNER J, V13, P310
   Hoerl RW, 2010, INT J LEAN SIX SIG, V1, P30, DOI 10.1108/20401461011033149
   Honda A.C., 2018, QUALITY MANAGEMENT J, V25, DOI [10.1080/10686967.2018.1436349, https://doi.org/10.1080/10686967.2018.1436349, DOI 10.1080/10686967.2018.1436349]
   Hruschka D., 2004, FIELD METHOD, V16, P307, DOI [10.1177/1525822X04266540, DOI 10.1177/1525822X04266540]
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Hynes William, 2020, Environment Systems & Decisions, V40, DOI 10.1007/s10669-020-09776-x
   Isfahani HM, 2019, INT J LEAN SIX SIG, V10, P161, DOI 10.1108/IJLSS-05-2017-0051
   Ivanov D, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03640-6
   Jnanesh N.A., 2019, INT J PRODUCT PERFOR, V63
   Kallio H, 2016, J ADV NURS, V72, P2954, DOI 10.1111/jan.13031
   Keenan Jesse M., 2020, Environment Systems & Decisions, V40, DOI 10.1007/s10669-020-09773-0
   Krippendorff K., 2018, CONTENT ANAL INTRO I
   Krueger RA, 1988, FOCUS GROUPS PRACTIC
   Laureani A, 2013, LEADERSH HEALTH SERV, V26, P322, DOI 10.1108/LHS-01-2012-0002
   Laux, 2020, INT J SUPPLY CHAIN O, V4, P171, DOI DOI 10.1504/IJSCOR.2020.10031125
   Laux C, 2017, INT J PRODUCT PERFOR, V66, P662, DOI 10.1108/IJPPM-09-2016-0194
   Leite H., 2020, TQM J, V33, P247, DOI DOI 10.1108/TQM-05-2020-0111
   Linkov Igor, 2018, Environment Systems & Decisions, V38, P170, DOI 10.1007/s10669-018-9686-5
   Linkov I, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10020440
   Locke T, 2020, UK COVID 19 DAILY 40
   Madu CN, 2014, INT J QUAL RELIAB MA, V31, P1052, DOI 10.1108/IJQRM-08-2013-0136
   Marchese D, 2018, SCI TOTAL ENVIRON, V613, P1275, DOI 10.1016/j.scitotenv.2017.09.086
   Marley KA, 2013, OPER MANAGE RES, V6, P44, DOI 10.1007/s12063-013-0077-2
   Marsi F, 2020, INDEPENDENT
   Mason SE, 2015, SURG-J R COLL SURG E, V13, P91, DOI 10.1016/j.surge.2014.08.002
   Mayring P, 2008, QUALITATIVE CONTENT
   Mayring P., 2000, FORUM QUALITATIVE SO, V1, DOI 10.17169/fqs-1.2.1089
   McFadden K.L., 2015, QUAL MANAG J, V22, P37, DOI DOI 10.1080/10686967.2015.11918449
   Mensah P, 2014, PROCEDIA COMPUT SCI, V43, P101, DOI 10.1016/j.procs.2014.12.014
   Montella E, 2017, J EVAL CLIN PRACT, V23, P530, DOI 10.1111/jep.12662
   Munoz A, 2015, INT J PROD RES, V53, P6736, DOI 10.1080/00207543.2015.1057296
   Pal R, 2014, INT J PROD ECON, V147, P410, DOI 10.1016/j.ijpe.2013.02.031
   Ponomarov SY, 2009, INT J LOGIST MANAG, V20, P124, DOI 10.1108/09574090910954873
   Potter WJ, 1999, J APPL COMMUN RES, V27, P258, DOI 10.1080/00909889909365539
   Regattieri A., 2018, TQM J, V30, P717
   Rodgers Bryan A., 2019, TQM Journal, V31, P641, DOI 10.1108/TQM-03-2019-0089
   Scaria J., 2013, LEADERSHIP HLTH SERV, V26, P253, DOI [10.1108/LHS-02-2012-0004, DOI 10.1108/LHS-02-2012-0004]
   Sodhi HS, 2020, WORLD J SCI TECHNOL, V17, P311, DOI 10.1108/WJSTSD-03-2020-0025
   Trakulsunti Y, 2018, LEADERSH HEALTH SERV, V31, P426, DOI 10.1108/LHS-09-2017-0055
   Trump BD, 2020, HEALTH SECUR, V18, P250, DOI 10.1089/hs.2020.0057
   Womack D.T., 1997, J OPER RES SOC, V48, P1148
   Yazan B, 2015, QUAL REP, V20, P134
NR 69
TC 11
Z9 11
U1 12
U2 38
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2040-4166
EI 2040-4174
J9 INT J LEAN SIX SIG
JI Int. J. Lean Six Sigma
PD SEP 1
PY 2021
VL 12
IS 4
SI SI
BP 762
EP 783
DI 10.1108/IJLSS-11-2020-0204
EA JAN 2021
PG 22
WC Engineering, Industrial; Management
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Engineering; Business & Economics
GA UK7UY
UT WOS:000614181700001
DA 2022-04-20
ER

PT J
AU Fernandez, AM
AF Martin Fernandez, Almudena
TI Role of the information systems and e-health in the COVID-19 pandemic. A
   call to action
SO REVISTA ESPANOLA DE SALUD PUBLICA
LA Spanish
DT Article
DE COVID-19; Pandemic; Information management; Digital health; Health
   information systems
AB In March 2020, the World Health Organization declared the 2019 coronavirus disease (COVID-19) outbreak a pandemic, with the coronavirus disease spreading worryingly fast. In this context, information systems, digital health (electronic health, mobile health), the Internet of things, play a key role, since they can contribute to fight against COVID-19 by introducing smarter solutions to achieve a rapid control in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the disease. However, these technologies need a solid regulatory framework that contributes to their implementation and integration in health systems, and to improve the national response in public health. In this context, coordination between administrations and the standardization and interoperability of information are necessary. Now is the time to establish the legal and knowledge bases so that everything that has been learned and advanced is integrated into health systems, promoting safe and evidence-based use.
C1 [Martin Fernandez, Almudena] Minist Sanidad, Subdirecc Gen Informac Sanitaria, Paseo Prado 18-20, Madrid 28014, Spain.
RP Fernandez, AM (corresponding author), Minist Sanidad, Subdirecc Gen Informac Sanitaria, Paseo Prado 18-20, Madrid 28014, Spain.
EM amartinf@mscbs.es
CR Adly AS, 2020, J MED INTERNET RES, V22, DOI 10.2196/19104
   Agerfalk PJ, 2020, EUR J INFORM SYST, V29, P203, DOI 10.1080/0960085X.2020.1771968
   [Anonymous], 2010, TELEMEDICINE OPPORTU, V2nd
   [Anonymous], 2020, TRACK MOB DEV FIGHT
   [Anonymous], 2020, COVID 19 DASHB CTR S
   European Commission, 2012, DIGITAL AGENDA EUROP
   Jimenez-Planet V, 2020, GUIA COVID 19 GUIA I
   Kakaes K, 2020, RASTREO CONTACTOS UN
   Ohannessian R, 2020, JMIR PUBLIC HLTH SUR, V6, P121, DOI 10.2196/18810
   ONeill PH, 2020, ASI FUNCIONARA APP G
   Shachar C, 2020, JAMA-J AM MED ASSOC, V323, P2375, DOI 10.1001/jama.2020.7943
   Ting DSW, 2020, NAT MED, V26, P459, DOI 10.1038/s41591-020-0824-5
   World Health Organisation (WHO), 2015, ATL EHEALTH COUNTR P
   World Health Organization, 2011, MHEALTH NEW HORIZONS
NR 15
TC 0
Z9 0
U1 1
U2 7
PU MINISTERIO DE SANIDAD Y CONSUMO
PI MADRID
PA PASEO DEL PRADO 18-20, MADRID, 28071, SPAIN
SN 1135-5727
EI 2173-9110
J9 REV ESP SALUD PUBLIC
JI Rev. Esp. Salud Publica
PD JAN 21
PY 2021
VL 95
AR e202101006
PG 15
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA PU5CY
UT WOS:000609323500001
DA 2022-04-20
ER

PT J
AU Patriti, A
   Baiocchi, GL
   Catena, F
   Marini, P
   Catarci, M
AF Patriti, Alberto
   Baiocchi, Gian Luca
   Catena, Fausto
   Marini, Pierluigi
   Catarci, Marco
CA ACOI
TI Emergency general surgery in Italy during the COVID-19 outbreak: first
   survey from the real life
SO WORLD JOURNAL OF EMERGENCY SURGERY
LA English
DT Article
DE Coronavirus; COVID-19; Epidemic; Pandemic; Emergency surgery;
   Laparoscopy; Management; Resources; Surgery
AB Background COVID-19 pandemic has rapidly spread in Italy in late February 2020. Almost all surgical services have been reorganized, with the aim of maintaining an adequate therapeutic path, especially for surgical emergencies. The knowledge of how surgeons dealing with emergency surgery have reacted to the epidemic in the real life can be useful while drafting clinical recommendations. Methods Surgeons from multiple Italian regions were invited answering to an online survey in order to make a snapshot of their current behaviors towards COVID-19-positive patients bearing urgent surgical diseases. Questions about institutional rules and personal approach for patient treatment and to limit epidemic spread were included in a 37-item questionnaire. Results Seventy-one questionnaires from institutions dealing with emergency surgery were accepted. Participating surgeons were equally subdivided from a geographical point of view, with a large proportion of public (97.2%) and non-academical (91.5%) centers. In 80.3% of cases, the hospitals treated COVID-19 patients; in 69.1% of centers, a change in work plan was necessary, and 33.8% of teams had almost a surgeon infected or in preventive quarantine. The vast majority of surgeons operated only on urgent cases (73.9%), but the number of interventions significantly dropped. Up to 40% of non-traumatic abdominal emergency cases had an unusual delayed treatment. The laparoscopic approach was used in 69.6% of interventions on COVID-19 patients. Strategies to protect health care workers against COVID-19 infection and to identify asymptomatic infected surgeons were suboptimal with respect to the WHO recommendations in 70.4% and 90.2% of centers, respectively. Advanced personal protective equipment for operating room workers was adopted for all surgeries in only 12.7% of centers. Discussion This survey confirms that the COVID-19 outbreak is dramatically changing the practice of emergency surgery centers in Italy. Despite the reduction in number, urgent cases were on average more challenging owing to diagnostic delay. Recommendations from the International Scientific Societies are frequently not complied concerning the use of laparoscopic approach, the availability of personal protective equipment in the operating rooms, and the testing of both asymptomatic physicians and patients scheduled for surgery. A further evaluation of the short-term results of these attitudes is warranted to modulate international recommendations.
C1 [Patriti, Alberto] Osped San Salvatore, Dept Surg, Azienda Osped Marche Nord, Piazzale Cinelli 1, Pesaro Fano, Italy.
   [Baiocchi, Gian Luca] Univ Brescia, Dept Clin & Expt Sci, Brescia, Italy.
   [Catena, Fausto] AOU Parma, Emergency Surg Unit, Parma, Italy.
   [Marini, Pierluigi] Azienda Osped San Camillo Forlanini, Gen Surg Unit, Rome, Italy.
   [Catarci, Marco] ASUR Marche AV5, Gen Surg Unit, Osped C&G Mazzoni, Ascoli Piceno, Italy.
RP Patriti, A (corresponding author), Osped San Salvatore, Dept Surg, Azienda Osped Marche Nord, Piazzale Cinelli 1, Pesaro Fano, Italy.
EM alberto.patriti@ospedalimarchenord.it
RI Catarci, Marco/AAG-3920-2020; Clementi, Marco/P-8582-2016
OI Catarci, Marco/0000-0002-6338-0114; Clementi, Marco/0000-0002-9652-5148;
   BAIOCCHI, Gian Luca/0000-0003-2402-2178; Di Venere,
   Beatrice/0000-0003-2170-8721; Scuderi, Vincenzo/0000-0002-0490-7780;
   Patriti, Alberto/0000-0003-2414-268X
CR Aminian A, 2020, ANN SURG, V272, pE27, DOI 10.1097/SLA.0000000000003925
   [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9
   [Anonymous], 2020, INFECT PREVENTION CO
   Brindle M, 2020, ANN SURG, DOI [10.1097/SLA.0000000000003923., DOI 10.1097/SLA.0000000000003923.E]
   Catena F, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-0293-7
   Centers for Disease Control and Prevention, COR DIS 2019 COVID 1
   Lee IK, 2020, J HOSP INFECT, V105, P102, DOI 10.1016/j.jhin.2020.02.022
   NHS, 2020, CLIN GUID MAN NONC P
   Patriti A, 2020, UPDATES SURG, V72, P309, DOI 10.1007/s13304-020-00779-6
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Spinelli A, 2020, BRIT J SURG, V107, P785, DOI 10.1002/bjs.11627
   Tao K X, 2020, Zhonghua Wai Ke Za Zhi, V58, P170, DOI 10.3760/cma.j.issn.0529-5815.2020.03.003
   Ti LK, 2020, CAN J ANESTH, V67, P756, DOI 10.1007/s12630-020-01617-4
   Wong J, 2020, CAN J ANESTH, V67, P732, DOI 10.1007/s12630-020-01620-9
   Zheng M, 2020, ANN SURG
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 16
TC 48
Z9 49
U1 1
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1749-7922
J9 WORLD J EMERG SURG
JI World J. Emerg. Surg.
PD MAY 24
PY 2020
VL 15
IS 1
AR 36
DI 10.1186/s13017-020-00314-3
PG 7
WC Emergency Medicine; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Emergency Medicine; Surgery
GA LU4HA
UT WOS:000537716900001
PM 32448333
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Noreen, K
   Zil-e-Rubab
   Umar, M
   Rehman, R
   Baig, M
   Baig, F
AF Noreen, Khola
   Zil-e-Rubab
   Umar, Muhammad
   Rehman, Rehana
   Baig, Mukhtiar
   Baig, Fizzah
TI Knowledge, attitudes, and practices against the growing threat of
   COVID-19 among medical students of Pakistan
SO PLOS ONE
LA English
DT Article
ID ACUTE RESPIRATORY SYNDROME; UNIVERSITY-STUDENTS; EPIDEMIC; PREVENTION;
   RESPONSES; OUTBREAK; CHINESE
AB Background
   On account of the COVID-19 pandemic, many changes have been implicated in university medical students. We are cognizant that pandemic can be controlled with dedicated contributions from all involved in the healthcare profession. Therefore, it is important to know the pandemic and application of knowledge by the medical students to formulate a further line of management in Pakistan.
   Objective
   We aimed toinvestigate the knowledge, attitudes, and practices (KAP) regarding COVID-19 and its impact on medical students of Pakistan.
   Methods
   A cross-sectional survey was conducted in June 2020 by a validated self-administered questionnaire. The survey instrument was tailored from a published questionnaire comprised of questions on demographics (6), knowledge (14), attitudes (4), and practices (6).
   Results
   Of the 1474 medical students in the study, 576(39.1%) were males, and 898(60.1%) were females. Two-thirds of the participants 1057(71.7%) had adequate knowledge, and almost all the students had positive attitudes (1363(92.5%), and good practices 1406(95.4%) to COVID-19. Two-thirds of the medical students 1023(69%) believed that the COVID-19 outbreak had affected their social, mental, and psychological well-being. One-quarter of the medical students 391(26%) become more religious, 597(40%) realized the importance of life, and 1140(77%) became careless because of the pandemic. The female medical students were 2.545 times (p < .001) and 4.414 times (p < .001) more likely to have positive attitudes and good practices toward COVID-19 as compared to males.
   Conclusion
   Medical students, especially females and senior year scholars, were well-versed with desired levels of knowledge, attitudes, and preventive measures toward COVID-19. Most of them recognized COVID 19, is shaping their social, mental, and psychological well-being and encroaching on the healthcare system and economy. The information acquired by the KAP study may help to devise effective preventive strategies for future events.
C1 [Noreen, Khola] Rawalpindi Med Univ, Dept Community Med, Rawalpindi, Pakistan.
   [Zil-e-Rubab; Baig, Fizzah] Ziauddin Univ, Ziauddin Med Coll, Karachi, Pakistan.
   [Umar, Muhammad] Rawalpindi Med Univ, Rawalpindi, Pakistan.
   [Rehman, Rehana] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan.
   [Baig, Mukhtiar] King Abdulaziz Univ, Fac Med, Dept Clin Biochem, Jeddah, Saudi Arabia.
RP Noreen, K (corresponding author), Rawalpindi Med Univ, Dept Community Med, Rawalpindi, Pakistan.
EM khauladr@gmail.com
RI Noreen, Khaula/ABF-6152-2021
CR Ahmad T, 2020, PAK J MED SCI, V36, pS73, DOI 10.12669/pjms.36.COVID19-S4.2638
   Ajilore K, 2017, HEALTH EDUC J, V76, P648, DOI 10.1177/0017896917710969
   Akan H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-413
   Al-Hazmi A, 2018, SAUDI J BIOL SCI, V25, P572, DOI 10.1016/j.sjbs.2016.01.032
   Alkot M., 2016, International Journal of Medical Science and Public Health, V5, P952
   Alzoubi H, 2020, J PURE APPL MICROBIO, V14, P17, DOI 10.22207/JPAM.14.1.04
   Baig M, 2020, PREDICTORS MISCONCEP, DOI [10.1101/2020.05.22.20110627, DOI 10.1101/2020.05.22.20110627]
   Chen Wei, 2020, Zhonghua Yufang Yixue Zazhi, V54, P239, DOI [10.3760/cma.j.issn.0253.9624.2020.03.003, 10.3760/cma.j.issn.0253-9624.2020.03.003]
   CSSE J, 2020, COR COVID 19 GLOB CA
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Heung Y Y Jenny, 2005, Nurse Educ Today, V25, P112, DOI 10.1016/j.nedt.2004.11.003
   Hui DS, 2017, CLIN CHEST MED, V38, P71, DOI 10.1016/j.ccm.2016.11.007
   Hussain I, 2021, J COMMUN HEALTH, V46, P441, DOI 10.1007/s10900-020-00879-9
   Hymowitz MB, 2006, ARCH DERMATOL, V142, P523, DOI 10.1001/archderm.142.4.523
   Jairoun A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6878-y
   Lau JTF, 2009, J INFECTION, V59, P122, DOI 10.1016/j.jinf.2009.06.004
   Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864
   Leung GM, 2005, CLIN INFECT DIS, V40, P1713, DOI 10.1086/429923
   Organization WH, 2020, COR DIS COVID 19 ADV, DOI [10.1093/cid/ciaa255, DOI 10.1093/CID/CIAA255]
   Park JH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-222
   Plaster AN, 2018, J COMMUN HEALTH, V43, P647, DOI 10.1007/s10900-017-0463-z
   Ritchie, 2020, CORONAVIRUS PANDEMIC
   Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651
   Schwartz J, 2020, CLIN INFECT DIS, V71, P858, DOI 10.1093/cid/ciaa255
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Tang CSK, 2004, PREV MED, V39, P1187, DOI 10.1016/j.ypmed.2004.04.032
   Tariq Saba, 2020, Disaster Med Public Health Prep, P1, DOI 10.1017/dmp.2020.408
   Velavan TP, 2020, TROP MED INT HEALTH, V25, P278, DOI 10.1111/tmi.13383
   Waris A, 2020, NEW MICROB NEW INFEC, V35, DOI 10.1016/j.nmni.2020.100681
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 33
TC 21
Z9 21
U1 2
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 11
PY 2020
VL 15
IS 12
AR e0243696
DI 10.1371/journal.pone.0243696
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics
GA PH0WM
UT WOS:000600144200049
PM 33306712
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Lee, DJ
   Daliyot, D
   Wang, R
   Lockwood, J
   Das, P
   Zimlichman, E
   Lee, JM
AF Lee, Daniel J.
   Daliyot, Daniella
   Wang, Ri
   Lockwood, Joel
   Das, Paul
   Zimlichman, Eyal
   Lee, John M.
TI Comparative Study of Chemosensory Dysfunction in COVID-19 in 2
   Geographically Distinct Regions
SO ENT-EAR NOSE & THROAT JOURNAL
LA English
DT Article; Early Access
DE anosmia; dysgeusia; epidemiology; COVID-19; population health
ID DYSGEUSIA; ANOSMIA
AB Objective: To directly compare the prevalence of chemosensory dysfunction (smell and taste) in geographically distinct regions with the same questionnaires. Methods: A cross-sectional study was performed to evaluate the self-reported symptoms among adults (older than 18 years) who underwent COVID-19 testing at an ambulatory assessment center in Canada and at a hospital in Israel between March 16, 2020, and August 19, 2020. The primary outcome was the prevalence of self-reported chemosensory dysfunction (anosmia/hypomsia and dysgeusia/ageusia). Subgroup analysis was performed to evaluate the prevalence of chemosensory deficits among the outpatients. Results: We identified a total of 350 COVID-19-positive patients (138 Canadians and 212 Israelis). The overall prevalence of chemosensory dysfunction was 47.1%. There was a higher proportion of chemosensory deficits among Canadians compared to Israelis (66.7% vs 34.4%, P < .01). A subgroup analysis for outpatients (never hospitalized) still identified a higher prevalence of chemosensory dysfunction among Canadians compared to Israelis (68.2% vs 36.1%, P < 0.01). A majority of patients recovered their sense of smell after 4 weeks of symptom onset. Conclusion: Although the prevalence of chemosensory deficit in COVID-19 was found to be similar to previously published reports, the prevalence can vary significantly across different geographical regions. Therefore, it is important to obtain regionally specific data so that the symptom of anosmia/dysgeusia can be used as a guide for screening for the clinical diagnosis of COVID-19.
C1 [Lee, Daniel J.; Lee, John M.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Unity Hlth Toronto, St Michaels Hosp, Toronto, ON, Canada.
   [Daliyot, Daniella; Zimlichman, Eyal] Sheba Med Ctr, Cent Management, Ramat Gan, Israel.
   [Wang, Ri] St Michaels Hosp, Li Ka Shing Knowledge Inst, Unity Hlth, MAP Ctr Urban Hlth Solut, Toronto, ON, Canada.
   [Lockwood, Joel] St Michaels Hosp, Unity Hlth Toronto, Dept Emergency Med, Toronto, ON, Canada.
   [Das, Paul] St Michaels Hosp, Unity Hlth Toronto, Dept Family & Community Med, Toronto, ON, Canada.
   [Lee, John M.] St Michaels Hosp, Unity Hlth Toronto, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
RP Lee, JM (corresponding author), Univ Toronto, Dept Otolaryngol Head & Neck Surg, Unity Hlth Toronto, St Michaels Hosp, Toronto, ON, Canada.; Lee, JM (corresponding author), St Michaels Hosp, 30 Bond St,8 Cardinal Carter Wing, Toronto, ON M5B 1W8, Canada.
EM john.lee@unityhealth.to
OI Lee, Daniel/0000-0003-4057-2858
FU Dunin Foundation
FX The author(s) disclosed receipt of the financial support for the
   research, authorship, and/or publication of this article: The Dunin
   Foundation.
CR Agyeman AA, 2020, MAYO CLIN PROC, V95, P1621, DOI 10.1016/j.mayocp.2020.05.030
   [Anonymous], 2020, AAO HNS AN HYP DYSG
   Asselta R, 2020, AGING-US, V12, P10087, DOI 10.18632/aging.103415
   Beckers, 2020, PREVALENCE RECOVERY
   Borsetto D, 2020, RHINOLOGY, V58, P430, DOI 10.4193/Rhin20.185
   Candau J, 2004, WATER SCI TECHNOL, V49, P11, DOI 10.2166/wst.2004.0522
   Cao YN, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0147-1
   Carignan A, 2020, CAN MED ASSOC J, V192, pE702, DOI 10.1503/cmaj.200869
   ENTUK, 2020, LOSS SENS SMELL MARK
   Fearon JD, 2003, J ECON GROWTH, V8, P195, DOI 10.1023/A:1024419522867
   Ferdenzi C, 2017, CHEM SENSES, V41, P37, DOI 10.1093/chemse/bjw098
   Ferdenzi C, 2013, CHEM SENSES, V38, P175, DOI 10.1093/chemse/bjs083
   Hopkins C, 2020, RHINOLOGY, V58, P295, DOI 10.4193/Rhin20.116
   Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043
   Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1
   Lee DJ, 2020, CAN J EMERG MED, V22, P595, DOI 10.1017/cem.2020.420
   Levinson R, 2020, INFECT DIS-NOR, V52, P600, DOI 10.1080/23744235.2020.1772992
   Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012
   Moein ST, 2020, INT FORUM ALLERGY RH, V10, P944, DOI 10.1002/alr.22587
   Parma V, 2020, CHEM SENSES, V45, P609, DOI 10.1093/chemse/bjaa041
   Rocke J, 2020, CLIN OTOLARYNGOL, V45, P914, DOI 10.1111/coa.13620
   Shoer S., 2020, WHO SHOULD WE TEST C, DOI 10.1101% 252F2020.05.18
   Spinato G, 2020, JAMA-J AM MED ASSOC, V323, P2089, DOI 10.1001/jama.2020.6771
   Strafella C, 2020, GENES-BASEL, V11, DOI 10.3390/genes11070741
   Tong JY, 2020, OTOLARYNG HEAD NECK, V163, P3, DOI 10.1177/0194599820926473
   Vaira LA, 2020, LARYNGOSCOPE, V130, P1787, DOI 10.1002/lary.28692
   von Bartheld CS, 2020, ACS CHEM NEUROSCI, V11, P2944, DOI 10.1021/acschemneuro.0c00460
   Vroegop AV, 2020, B-ENT, V16, P81, DOI 10.5152/B-ENT.2020.20127
   Yan CRH, 2020, INT FORUM ALLERGY RH, V10, P821, DOI 10.1002/alr.22592
   Yan CG, 2021, IEEE T PATTERN ANAL, V43, P1445, DOI 10.1109/TPAMI.2020.2975798
NR 30
TC 1
Z9 1
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-5613
EI 1942-7522
J9 ENT-EAR NOSE THROAT
JI ENT-Ear Nose Throat J.
AR 01455613211000170
DI 10.1177/01455613211000170
EA MAR 2021
PG 6
WC Otorhinolaryngology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Otorhinolaryngology
GA TT9ZT
UT WOS:000680702500001
PM 33729897
OA gold
DA 2022-04-20
ER

PT J
AU Changizi, N
   Raeisi, A
   Barekati, H
   Habibollahi, A
   Sajadi, HS
   Emami-Afshar, N
   Radpooyan, L
AF Changizi, Nasrin
   Raeisi, Alireza
   Barekati, Hamed
   Habibollahi, Abbas
   Sajadi, Haniye Sadat
   Emami-Afshar, Nezhat
   Radpooyan, Laleh
TI Provision of Critical Maternity Care during the Coronavirus Disease 2019
   (COVID-19) Pandemic in the Islamic Republic of Iran
SO ARCHIVES OF IRANIAN MEDICINE
LA English
DT Article
DE COVID-19; Disease outbreaks; Epidemics; Maternal health services;
   Mortality; Pregnancy
AB Reducing maternal mortality is one of the Sustainable Development Goals. Although there is no vigorous evidence that pregnant women are in the high-risk groups in response to coronavirus disease 2019 (COVID-19), it is crucial to respond to the pandemic through providing required action plans for confirmed or suspected pregnant women cases while maintaining routine functions. Iran's response and preparedness measures to COVID-19 aimed to meet the essential needs required to protect pregnant women and their families. Establishing a national maternal health network, relying on mechanisms for timely reporting, monitoring, and following-up, preparing guidelines and protocols required for COVID-19 management in pregnant women though a multidisciplinary team working approach, and embedding the precautions of reducing transmission in maternity care were the main measures taken to cope with COVID-19 in pregnancy. Iran's experience in providing maternity care during the COVID-19 can guide other countries affected by COVID-19. However, it should be adapted to local health-care facilities, as well as in response to any further updates on COVID-19.
C1 [Changizi, Nasrin] Univ Tehran Med Sci, Maternal Fetal & Neonatal Res Ctr, Tehran, Iran.
   [Changizi, Nasrin; Emami-Afshar, Nezhat; Radpooyan, Laleh] Minist Hlth & Med Educ, Maternal Hlth Dept, Populat Family & Sch Hlth Off, Hlth, Tehran, Iran.
   [Raeisi, Alireza] Shiraz Univ Med Sci, Tehran, Iran.
   [Raeisi, Alireza] Minist Hlth & Med Educ, Hlth, Tehran, Iran.
   [Barekati, Hamed] Minist Hlth & Med Educ, Populat Family & Sch Hlth Off, Hlth, Tehran, Iran.
   [Habibollahi, Abbas] Minist Hlth & Med Educ, Neonatal Hlth Dept, Populat Family & Sch Hlth Off, Hlth, Tehran, Iran.
   [Sajadi, Haniye Sadat] Univ Tehran Med Sci, Univ Res & Dev Ctr, Knowledge Utilizat Res Ctr, Tehran, Iran.
RP Sajadi, HS (corresponding author), Univ Tehran Med Sci, Univ Res & Dev Ctr, Knowledge Utilizat Res Ctr, Tehran, Iran.
EM h.sajjadi@tums.ac.ir
RI Raeisi, Alireza/AAQ-5779-2021
OI Changizi, Nasrin/0000-0003-3808-6594
CR Arab-Mazar Z, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101630
   Luo YW, 2020, LANCET INFECT DIS, V20, P513, DOI 10.1016/S1473-3099(20)30191-2
   Raeisi A, 2020, ARCH IRAN MED, V23, P216, DOI 10.34172/aim.2020.01
   World Health Organization, OP GUID MAINT ESS HL
   World Health Organization (WHO), 2020, REP WHO CHIN JOINT M
   World Health Organization (WHO), 2020, COVID 19 STRAT UPD
NR 6
TC 0
Z9 0
U1 5
U2 7
PU ACAD MEDICAL SCIENCES I R IRAN
PI TEHRAN
PA PO BOX 19395-5655, TEHRAN, 00000, IRAN
SN 1029-2977
EI 1735-3947
J9 ARCH IRAN MED
JI Arch. Iran. Med.
PD AUG
PY 2020
VL 23
IS 8
BP 557
EP 560
DI 10.34172/aim.2020.59
PG 4
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA NT3ST
UT WOS:000572865700009
PM 32894968
OA hybrid
DA 2022-04-20
ER

PT J
AU Ko, NY
   Lu, WH
   Chen, YL
   Li, DJ
   Chang, YP
   Wang, PW
   Yen, CF
AF Ko, Nai-Ying
   Lu, Wei-Hsin
   Chen, Yi-Lung
   Li, Dian-Jeng
   Chang, Yu-Ping
   Wang, Peng-Wei
   Yen, Cheng-Fang
TI Cognitive, Affective, and Behavioral Constructs of COVID-19 Health
   Beliefs: A Comparison Between Sexual Minority and Heterosexual
   Individuals in Taiwan
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; health belief; LGBT; pandemic; sexual minority
ID BISEXUAL MEN; GAY; ANXIETY
AB This online survey study aimed to compare the cognitive, affective, and behavioral constructs of health beliefs related to coronavirus disease 2019 (COVID-19) between sexual minority and heterosexual individuals in Taiwan. In total, 533 sexual minority and 1421 heterosexual participants were recruited through a Facebook advertisement. The constructs pertaining to cognition (perceived relative susceptibility to COVID-19, perceived COVID-19 severity, having sufficient knowledge and information on COVID-19, and confidence in coping with COVID-19), affect (worry toward COVID-19), and behavior (adoption of health-protective behaviors) in relation to health beliefs about COVID-19 were compared between sexual minority and heterosexual participants. The results indicated that sexual minority participants had lower perceived susceptibility to COVID-19, greater self-confidence in coping with COVID-19, and lower worry about COVID-19 and were less likely to maintain good indoor ventilation and disinfect their household than heterosexual individuals. Sexual orientation is the modifying factor for the Health Belief Model in the COVID-19 pandemic and should be taken into consideration when medical professionals establish prevention programs for COVID-19.
C1 [Ko, Nai-Ying] Natl Cheng Kung Univ, Coll Med, Dept Nursing, Tainan 70101, Taiwan.
   [Lu, Wei-Hsin] Ditmanson Med Fdn, Dept Psychiat, Chia Yi Christian Hosp, Chiayi 60002, Taiwan.
   [Lu, Wei-Hsin] Chia Nan Univ Pharm & Sci, Dept Senior Citizen Serv Management, Tainan 71710, Taiwan.
   [Chen, Yi-Lung] Asia Univ, Dept Healthcare Adm, Taichung 41354, Taiwan.
   [Chen, Yi-Lung] Asia Univ, Dept Psychol, Taichung 41354, Taiwan.
   [Li, Dian-Jeng] Kaohsiung Municipal Kai Syuan Psychiat Hosp, Dept Addict Sci, Kaohsiung 80276, Taiwan.
   [Li, Dian-Jeng; Wang, Peng-Wei; Yen, Cheng-Fang] Kaohsiung Med Univ, Dept Psychiat, Sch Med, Kaohsiung 80708, Taiwan.
   [Li, Dian-Jeng; Wang, Peng-Wei; Yen, Cheng-Fang] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung 80708, Taiwan.
   [Chang, Yu-Ping] State Univ New York Univ Buffalo, Sch Nursing, New York, NY 14214 USA.
   [Wang, Peng-Wei; Yen, Cheng-Fang] Kaohsiung Med Univ Hosp, Dept Psychiat, Kaohsiung 80708, Taiwan.
RP Wang, PW; Yen, CF (corresponding author), Kaohsiung Med Univ, Dept Psychiat, Sch Med, Kaohsiung 80708, Taiwan.; Wang, PW; Yen, CF (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung 80708, Taiwan.; Wang, PW; Yen, CF (corresponding author), Kaohsiung Med Univ Hosp, Dept Psychiat, Kaohsiung 80708, Taiwan.
EM nyko@mail.ncku.edu.tw; wiiseen@gmail.com; elong@asia.edu.tw;
   u108800004@kmu.edu.tw; yc73@buffalo.edu; wistar.huang@gmail.com;
   chfaye@cc.kmu.edu.tw
RI Li, Dian‐Jeng/T-7571-2019; Ko, Monica/AAE-2253-2021; Chen,
   Kuan-Lin/AAC-5430-2021
OI Li, Dian‐Jeng/0000-0002-6036-045X; Chang, Yu-Ping/0000-0003-2328-6876;
   Lu, Wei-hsin/0000-0002-6294-8820; Chen, Yi-Lung/0000-0003-2934-5814; Ko,
   Nai-Ying/0000-0002-3007-2537; Yen, Cheng-Fang/0000-0003-1156-4939
CR [Anonymous], 2015, STAND QUEST RISK PER
   Asmundson GJG, 2020, J ANXIETY DISORD, V71, DOI 10.1016/j.janxdis.2020.102211
   Asmundson GJG, 2012, J ANXIETY DISORD, V26, P246, DOI 10.1016/j.janxdis.2011.11.009
   Eaton LA, 2020, J BEHAV MED, V43, P341, DOI 10.1007/s10865-020-00157-y
   Ellingson L.A., 1997, J SEX EDUC THER, V22, P19, DOI 10.1080/01614576.1997.11074189
   Geldsetzer P, 2020, J MED INTERNET RES, V22, DOI 10.2196/18790
   Gilles I, 2011, EUR J EPIDEMIOL, V26, P203, DOI 10.1007/s10654-011-9577-2
   Glanz Karen, 2015, HLTH BEHAV THEORY RE, V5th
   Hatzenbuehler ML, 2009, PSYCHOL BULL, V135, P707, DOI 10.1037/a0016441
   Hu HF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213015
   JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101
   Kouzy R, 2020, CUREUS, V12, DOI 10.7759/cureus.7255
   Lei L, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924609
   Li DJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113870
   Li DJ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16224476
   Liao QY, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-169
   Logie CH, 2018, AIDS CARE, V30, P33, DOI 10.1080/09540121.2018.1468011
   Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674
   National Research Council, 2011, HLTH LESB GAY BISEX
   Ramo Danielle E, 2014, Internet Interv, V1, P58
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403
   ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203
   Taha SA, 2013, J HEALTH COMMUN, V18, P278, DOI 10.1080/10810730.2012.727960
   Wang CC, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16234634
   Wang CC, 2019, COMPR PSYCHIAT, V90, P14, DOI 10.1016/j.comppsych.2018.12.015
   Wang CC, 2018, NEUROPSYCH DIS TREAT, V14, P1309, DOI 10.2147/NDT.S164579
   Wang PW, 2019, SUICIDE LIFE-THREAT, V49, P466, DOI 10.1111/sltb.12451
   Whitaker C, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7071
   WHO, 2020, WHO DIR GEN OP REM M
   World Health Organization, SUMM PROB SARS CAS O
NR 30
TC 17
Z9 18
U1 10
U2 30
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUN
PY 2020
VL 17
IS 12
AR 4282
DI 10.3390/ijerph17124282
PG 10
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA ML4KX
UT WOS:000549438000001
PM 32549345
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Yang, M
   Wang, HM
   Li, Z
   Zhang, Q
   Liu, X
   He, MX
   Gao, S
AF Yang, Mi
   Wang, Hongming
   Li, Zhi
   Zhang, Qiang
   Liu, Xin
   He, Manxi
   Gao, Shan
TI Prevention and Control of COVID-19 Infection in a Chinese Mental Health
   Center
SO FRONTIERS IN MEDICINE
LA English
DT Article
DE the 2019 novel coronavirus disease (COVID-19); outbreak; mental health
   center; nosocomial infection; prevention and control practice
ID PNEUMONIA
AB Faced with the rapid spread of the novel coronavirus disease (COVID-19), a global public health threat, psychiatric hospitals are under huge pressure to prevent and control nosocomial infection. The current research analyzed the COVID-19 infection control practices in a regional mental health center in China and addressed how this type of medical institutions could enhance their ability to prevent and control hospital transmission of major respiratory diseases and general management of nosocomial infection risks. Firstly, hospital-related risks of COVID-19 were analyzed, and targeted prevention and control measures were then established. Pre- and post-intervention theoretical knowledge of nosocomial infection control, hand hygiene compliance and accuracy, use of personal protective equipment, and disinfection and sterilization effectiveness were evaluated and compared. All the indexes displayed significant improvements following the implementation of the prevention and control measures. Up to the submission of this paper, the mental health center had obtained no suspected or confirmed case of COVID-19 infection due to hospital transmission. The findings provide empirical evidence for the effectiveness of the COVID-19 preventive strategies and have important implications for integrated and characterized infection control in mental health centers during a major epidemic. The establishment of the transitional isolation ward and air fumigation using traditional Chinese medicine for patients and staff are preventive measures worthy of further discussion and dissemination.
C1 [Yang, Mi; Wang, Hongming; Zhang, Qiang; Liu, Xin; He, Manxi] Chengdu Mental Hlth Ctr, Chengdu, Peoples R China.
   [Yang, Mi; Wang, Hongming; Zhang, Qiang; Liu, Xin; He, Manxi] Fourth Peoples Hosp Chengdu, Chengdu, Peoples R China.
   [Yang, Mi; Wang, Hongming; Zhang, Qiang; Liu, Xin; He, Manxi; Gao, Shan] Univ Elect Sci & Technol China, Clin Hosp, MOE Key Lab NeuroInformat, Chengdu Brain Sci Inst, Chengdu, Peoples R China.
   [Li, Zhi] Sichuan Univ, Coll Elect & Informat Engn, Chengdu, Peoples R China.
   [Gao, Shan] Univ Elect Sci & Technol China, Sch Foreign Languages, Chengdu, Peoples R China.
RP He, MX (corresponding author), Chengdu Mental Hlth Ctr, Chengdu, Peoples R China.; He, MX (corresponding author), Fourth Peoples Hosp Chengdu, Chengdu, Peoples R China.; He, MX; Gao, S (corresponding author), Univ Elect Sci & Technol China, Clin Hosp, MOE Key Lab NeuroInformat, Chengdu Brain Sci Inst, Chengdu, Peoples R China.; Gao, S (corresponding author), Univ Elect Sci & Technol China, Sch Foreign Languages, Chengdu, Peoples R China.
EM 2357622298@qq.com; gaoshan@uestc.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [61806042, 31600880]; Special Research
   Project for the novel coronavirus pneumonia - Chengdu Science and
   Technology Bureau [2020-YF05-00171-SN]; Science and Technology
   Department of Sichuan Province [2018sz0236]
FX This study was supported by the National Natural Science Foundation of
   China (grant numbers 61806042, 31600880); the Special Research Project
   for the novel coronavirus pneumonia funded by the Chengdu Science and
   Technology Bureau (grant number 2020-YF05-00171-SN); and the Science and
   Technology Department of Sichuan Province (grant number 2018sz0236).
CR Alolayyan, 2013, INT J SERVICES OPERA, V15, P482, DOI DOI 10.1504/IJSOM.2013.054904
   [Anonymous], 2020, REC PRESCR PREV RESP
   [Anonymous], 2017, 354282017 GBT GEN AD
   [Anonymous], 2020, TECHN GUID NOV COR I
   [Anonymous], 2009, 3112009 WST MIN HLTH
   Chen XJ, 2020, LANCET INFECT DIS, V20, P397, DOI 10.1016/S1473-3099(20)30110-9
   Guerra LM, 2013, REV EPIDEMIOL CONTRO, V3, P62, DOI 10.17058/reci.v3i2.2959
   Haas JP, 2007, J HOSP INFECT, V66, P6, DOI 10.1016/j.jhin.2006.11.013
   He YL, 2020, LANCET HAEMATOL, V7, pE359, DOI 10.1016/S2352-3026(20)30104-6
   Huang Z-L, 2011, AM J INFECT CONTROL, V39, pE74, DOI [10.1016/j.ajic.2011.04.141, DOI 10.1016/J.AJIC.2011.04.141]
   Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021
   Lu D, 2020, J HOSP INFECT, V104, P454, DOI 10.1016/j.jhin.2020.02.018
   McAleer M, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13030046
   Randle J, 2006, J HOSP INFECT, V64, P205, DOI 10.1016/j.jhin.2006.06.008
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   WHO, 2020, WHO CHARACTERIZES CO
   WHO, 2009, WHO GUID HAND HYG HL
   Wong J, 2020, CAN J ANESTH, V67, P732, DOI 10.1007/s12630-020-01620-9
   [吴安华 Wu Anhua], 2020, [中国感染控制杂志, Chinese Journal of Infection Control], V19, P99
   Zhu YH, 2020, NEUROSCI BULL, V36, P299, DOI 10.1007/s12264-020-00476-9
NR 20
TC 7
Z9 7
U1 4
U2 17
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-858X
J9 FRONT MED-LAUSANNE
JI Front. Med.
PD JUL 3
PY 2020
VL 7
AR 356
DI 10.3389/fmed.2020.00356
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC General & Internal Medicine
GA MR8BY
UT WOS:000553817200001
PM 32719805
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Minagorre, PJA
   Pinto, EV
   Fernandez, JMR
   Rodriguez-Fernandez, R
   Ronco, MV
   Escosa-Garcia, L
   Jorge, JIM
   Garcia, JJG
AF Alcala Minagorre, Pedro J.
   Villalobos Pinto, Enrique
   Ramos Fernandez, Jose Miguel
   Rodriguez-Fernandez, Rosa
   Vazquez Ronco, Miguel
   Escosa-Garcia, Luis
   Montiano Jorge, Juan Ignacio
   Garcia Garcia, Juan Jose
CA Soc Espanola Pediat Hosp SEPHO
TI Changes from COVID-19. A perspective from internal pediatric medicine
SO ANALES DE PEDIATRIA
LA Spanish
DT Article
DE COVID-19; SARS-CoV-2; Hospital medicine; Pediatric hospitals; Internal
   pediatric medicine
ID PROTECTIVE EQUIPMENT; MANAGEMENT; TIME
AB SARS-CoV-2 pandemic dimension has affected the Hospital Pediatrics Medicine assistance in our country. New challenges generated by COVID-19 require a series of proactive measures, based on existing scientific knowledge and standards of good practice, that allow the Pediatric Hospital services readiness and operability. Hospital Internal Pediatrics, as responsible of integral care of the hospitalized child, plays a leading role in the new hospital model emerging from this crisis. This review analyzes the impact of the current SARS-CoV-2 epidemic on pediatric care, and perspective of new COVID-19 outbreaks in coexistence with other viral infections. Changes secondary to pandemic involved in Hospital Pediatric units, how to prepare for future epidemics, also the involvement of pediatric units in adult care and the possible opportunities for improvement need to be revised. Assistance of patients with chronic complex conditions in epidemic circumstances, safety aspects, opportunities for teaching and ethical considerations are reviewed. The Spanish Society of Hospital Pediatrics Medicine offers with this article a series of resources for Internal Pediatric Medicine practitioners responsible to face next challenges in pediatric hospitalization units. (C) 2020 Asociacion Espanola de Pediatria. Published by Elsevier Espana, S.L.U.
C1 [Alcala Minagorre, Pedro J.] Hosp Gen Univ Alicante, Unidad Hospitalizac Pediat, Alicante, Spain.
   [Villalobos Pinto, Enrique] Hosp Nino Jesus, Serv Pediat, Madrid, Spain.
   [Ramos Fernandez, Jose Miguel] Hosp Reg Univ Materno Infantil Malaga, Serv Pediat, Malaga, Spain.
   [Rodriguez-Fernandez, Rosa] Hosp Gregorio Maranon, Secc Pediat Hosp, Madrid, Spain.
   [Vazquez Ronco, Miguel] Hosp Univ Cruces, Secc Pediat Hosp, Baracaldo, Bizkaia, Spain.
   [Escosa-Garcia, Luis] Hosp Univ La Paz, Serv Pediat Hosp Enfermedades Infecciosas & Trop, Madrid, Spain.
   [Montiano Jorge, Juan Ignacio] Hosp Univ Araba, Serv Pediat, Vitoria, Spain.
   [Garcia Garcia, Juan Jose] Hosp St Joan De Deu, Esplugues Llobregat, Unidad Hospitalizac Pediat, Barcelona, Spain.
RP Minagorre, PJA (corresponding author), Hosp Gen Univ Alicante, Unidad Hospitalizac Pediat, Alicante, Spain.
EM alcala_ped@gva.es
RI Garcia-Garcia, Juan José/J-5295-2014; Escosa-Garcia, Luis/AFZ-2323-2022;
   Ramos-Fernández, José Miguel/T-8508-2019
OI Garcia-Garcia, Juan José/0000-0002-3483-528X; Ramos-Fernández, José
   Miguel/0000-0001-9769-603X; Alcala Minagorre, Pedro
   J/0000-0003-4737-5638
CR Ahmed H, 2020, LANCET INFECT DIS, VS1473, P30226
   Anderson ML, 2020, J HOSP MED, V15, P287, DOI 10.12788/jhm.3431
   Arora VM, 2020, J HOSP MED, V15, P290, DOI 10.12788/jhm.3434
   Beigi RH, 2009, EMERG HLTH THREATS J, V2, pe214
   Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4
   Calve C, 2020, PEDIATR BANC, V92
   Cavallo JJ, 2020, JAMA HLTH FORUM, P1
   Chang YT, 2020, KAOHSIUNG J MED SCI, V36, P296, DOI 10.1002/kjm2.12228
   Chopra V, 2020, ANN INTERN MED, V172, P621, DOI 10.7326/M20-0907
   Comision Central de Etica de la OMC, 2011, CODIGO DEONTOLOGIA M
   Comision de Deontologia y Etica del Consejo Andaluz de Cotegios de Medicos, 2020, INF OBT ETH DEONT ET
   Cram P, 2020, J HOSP MED, V15, P314, DOI 10.12788/jhm.3426
   De Montalvo Jaasketainen F, 2020, INFORME ASPECTOS BIO
   European Centre for Disease Prevention and Control, 2020, CHECKL HOSP PREP REC
   Farias JA, 2010, INTENS CARE MED, V36, P1015, DOI 10.1007/s00134-010-1853-1
   Garcia-Alegria J, 2020, REV CLIN ESP, V220, P439, DOI 10.1016/j.rce.2020.05.010
   Garg M, 2020, J HOSP MED, V15, P305, DOI 10.12788/jhm.3427
   Grupo de Trabajo de Bioetica de la SEMICYUC, 2020, REC ET TOM DEC SIT E
   Jenkins A, 2020, J HOSP MED, V15, P311, DOI 10.12788/jhm.3432
   Lavilledieu D, 2020, J INFECT PUBLIC HEAL, V13, P167, DOI 10.1016/j.jiph.2019.07.007
   Lazzerini M, 2020, LANCET CHILD ADOLESC, V4, pE10, DOI 10.1016/S2352-4642(20)30108-5
   Lopez Reboiro ML, 2020, REV CLIN ESP, DOI [10.1016/j.rce.2020.04.013., DOI 10.1016/J.RCE.2020.04.013]
   Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270
   Meier KA, 2020, J HOSP MED, V15, P308, DOI 10.12788/jhm.3435
   Moore KA, 2020, FUTURE COVID 19 PAND
   Munoz-Quiles C, 2016, PEDIATR INFECT DIS J, V35, P275, DOI 10.1097/INF.0000000000000993
   Munro APS, 2020, ARCH DIS CHILD, V105, P618, DOI 10.1136/archdischild-2020-319474
   Philips K, 2020, J PEDIAT, DOI [10.1016/j.jpeds.7070.04.060, DOI 10.1016/J.JPEDS.7070.04.060]
   Saez M, 2020, SCI TOTAL ENVIRON, V727, DOI 10.1016/j.scitotenv.2020.138761
   Shekerdemian LS, 2020, JAMA PEDIATR, V174, P868, DOI 10.1001/jamapediatrics.2020.1948
   Steuart R, 2020, J HOSP MED, V15, P295, DOI 10.12788/jhm.3429
   The Children's Hospital Association United States, 2020, COORD HOSP CAR CHILD
   Varghese L, 2018, J PEDIAT INF DIS SOC, V7, P151, DOI 10.1093/jpids/pix027
   WHO, 2020, 139 WHO
   World Health Organization, 2020, RAT US PERS PROT EQ
   World Health Organization, 2016, GUID MAN ETH ISS INF
   World Health Organization, 2020, HOSP READ CHECKL COV
   Wu Q, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-0961
   Zhang JC, 2020, J HOSP MED, V15, P292, DOI 10.12788/jhm.3437
   Zhang JJ, 2020, SCIENCE, V368, P1481, DOI 10.1126/science.abb8001
NR 40
TC 0
Z9 0
U1 1
U2 2
PU EDICIONES DOYMA S A
PI BARCELONA
PA TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN
SN 1695-4033
EI 1696-4608
J9 AN PEDIATR
JI An. Pediatr.
PD NOV
PY 2020
VL 93
IS 5
DI 10.1016/j.anpedi.2020.06.004
PG 8
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA OR9US
UT WOS:000589811800001
PM 32646797
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Gurumurthy, B
   Das, SK
   Hiremath, R
   Shetty, S
   Hiremath, A
   Gowda, T
AF Gurumurthy, Balasubramanian
   Das, Sudha Kiran
   Hiremath, Rudresh
   Shetty, Sachin
   Hiremath, Aniketh
   Gowda, Thasmai
TI Spectrum of atypical pulmonary manifestations of COVID-19 on computed
   tomography
SO EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE
LA English
DT Article
DE COVID-19 pneumonia; Atypical CT features; Pulmonary cysts; Bull's eye;
   target sign; Halo sign; Hilar lymphadenopathy; Necrotizing pneumonia
ID REVERSED-HALO; CT FEATURES; PNEUMOMEDIASTINUM; PNEUMONIA; SIGN
AB Background: The typical CT manifestations of COVID-19 pneumonia include ground-glass opacity (GGO) with or without consolidation and superimposed interlobular septal thickening. These are often rounded in morphology and frequently bilateral, multilobar, posterior, peripheral, and basilar in distribution. The various atypical CT features of COVID-19 are seldom described in the literature. The study aims to enumerate the atypical pulmonary CT features in patients with COVID-19 pneumonia in correlation with the disease severity.
   Results: A total of 298 confirmed cases of COVID-19 pneumonia with positive reverse transcription polymerase chain reaction (RT-PCR) who underwent chest CT scans were retrospectively evaluated. The cohort included 234 (78.5%) men and 64 (21.5%) women and the mean age was 53.48 +/- 15.74 years. The most common presenting symptoms were fever [n = 197 (66.1%)] and cough [n = 139 (46.6%)]. Out of 298 cases of COVID-19 pneumonia, 218 cases (73.1%) showed typical CT features while 63 cases (21.1%) showed atypical CT features with concurrent classical findings and the remaining 17 cases (5.8%) were normal. Among the atypical CT features, the most common was pulmonary cysts [n = 27 (9%)]. The other features in the order of frequency included pleural effusion [n = 17 (5.7%)], nodules [n = 13 (4.3%)], bull's eye/target sign[n = 4 (1.3%)], cavitation [n = 3 (1.0%)], spontaneous pneumothorax [n = 2 (0.6%)], hilar lymphadenopathy [n = 2 (0.6%)], spontaneous pneumo-mediastinum with subcutaneous emphysema [n = 1 (0.3%)], Halo sign [n = 1 (0.3%)], empyema [n = 1 (0.3%)] and necrotizing pneumonia with abscess [n = 1 (0.3%)].
   Conclusion: CT imaging features of COVID-19 pneumonia while in a vast majority of cases is classical, atypical diverse patterns are also encountered. A comprehensive knowledge of various atypical presentations on imaging plays an important role in the early diagnosis and management of COVID-19.
C1 [Gurumurthy, Balasubramanian; Das, Sudha Kiran; Hiremath, Rudresh; Shetty, Sachin; Hiremath, Aniketh; Gowda, Thasmai] JSS Hosp, JSS Acad Higher Educ & Res, Dept Radiol, Mysore 570004, Karnataka, India.
RP Gurumurthy, B (corresponding author), JSS Hosp, JSS Acad Higher Educ & Res, Dept Radiol, Mysore 570004, Karnataka, India.
EM gurumurthyb@jssuni.edu.in
OI Shetty, Sachin P/0000-0002-0002-4665; Murthy, Guru/0000-0002-2200-5625
CR Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   Ali A, 2020, CORRELATION CHEST CT, DOI [10.1101/2020.10.15.20213058, DOI 10.1101/2020.10.15.20213058]
   Aujayeb Avinash, 2020, Radiol Cardiothorac Imaging, V2, pe200330, DOI 10.1148/ryct.2020200330
   Brogna B, 2020, HEART LUNG, V49, P864, DOI 10.1016/j.hrtlng.2020.06.005
   Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5
   Chen JQ, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021240
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen Y, 2021, ANN PALLIAT MED, V10, P5786, DOI 10.21037/apm-20-452
   Chu CM, 2004, EUR RESPIR J, V23, P802, DOI 10.1183/09031936.04.00096404
   Chung M, 2020, RADIOLOGY, V295, P202, DOI 10.1148/radiol.2020200230
   de Farias LDG, 2020, EINSTEIN-SAO PAULO, V18, DOI [10.31744/einstein_journal/2020AI5742, 10.31744/einstein_journal/2020ai5742]
   Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712
   Hu QJ, 2020, EUR J RADIOL, V128, DOI 10.1016/j.ejrad.2020.109017
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Kong Weifang, 2020, Radiol Cardiothorac Imaging, V2, pe200028, DOI 10.1148/ryct.2020200028
   Koo HJ, 2018, RADIOGRAPHICS, V38, P719, DOI 10.1148/rg.2018170048
   Liu KF, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020175
   MANGETE EDO, 1993, ARCH DIS CHILD, V69, P587, DOI 10.1136/adc.69.5.587
   McLaren TA, 2020, CLIN IMAG, V68, P191, DOI 10.1016/j.clinimag.2020.07.024
   Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134
   Muheim M, 2020, BMJ CASE REP, V13, DOI 10.1136/bcr-2020-237967
   Ng Ming-Yen, 2020, Radiol Cardiothorac Imaging, V2, pe200034, DOI 10.1148/ryct.2020200034
   Ooi S Y, 2017, Med J Malaysia, V72, P367
   Poerio A, 2020, KOREAN J RADIOL, V21, P1161, DOI 10.3348/kjr.2020.0687
   PRIMACK SL, 1994, RADIOLOGY, V190, P513, DOI 10.1148/radiology.190.2.8284408
   Revzin MV, 2020, RADIOGRAPHICS, V40, P1574, DOI 10.1148/rg.2020200149
   Sahni Sonu, 2013, N Am J Med Sci, V5, P460, DOI 10.4103/1947-2714.117296
   Selvaraj V, 2020, BMJ CASE REP, V13, DOI 10.1136/bcr-2020-237245
   Shaghaghi S, 2021, CLIN IMAG, V69, P72, DOI 10.1016/j.clinimag.2020.06.038
   Shan S, 2020, REV INST MED TROP SP, V62, DOI [10.1590/S1678-9946202062076, 10.1590/s1678-9946202062076]
   Shi H, 2020, LANCET INFECT DIS, DOI [DOI 10.1016/S1473-3099(20)30086-4, 10.1016/S1473-3099(20)30086-4]
   Simpson Scott, 2020, J Thorac Imaging, V35, P219, DOI [10.1148/ryct.2020200152, 10.1097/RTI.0000000000000524]
   Sun RH, 2020, KOREAN J RADIOL, V21, P541, DOI 10.3348/kjr.2020.0180
   Valette X, 2020, LANCET INFECT DIS, V20, P1230, DOI [10.1016/S1473-3099(20)30310-9, 10.1016/S1473-3099(20)30310-8]
   Wang WY, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa062
   Wintermark M, 2001, CHEST, V120, P543, DOI 10.1378/chest.120.2.543
   Wu Yan, 2020, Radiol Cardiothorac Imaging, V2, pe200031, DOI 10.1148/ryct.2020200031
   Xiong Y, 2020, INVEST RADIOL, V55, P332, DOI 10.1097/RLI.0000000000000674
   Xu ZF, 2020, DIAGN INTERV RADIOL, V26, P380, DOI 10.5152/dir.2020.20181
   Yadav R, 2020, CLEV CLIN J MED, V87, P469, DOI 10.3949/ccjm.87a.ccc032
   Yao X H, 2020, Zhonghua Bing Li Xue Za Zhi, V49, P411, DOI 10.3760/cma.j.cn112151-20200312-00193
   Ye Z, 2020, EUR RADIOL, V30, P4381, DOI 10.1007/s00330-020-06801-0
   Zeng JH, 2020, INFECTION, V48, P773, DOI 10.1007/s15010-020-01424-5
   Zhang YB, 2020, J ASIAN NAT PROD RES, V22, P1121, DOI 10.1080/10286020.2020.1731799
   Zhou CY, 2020, LANCET INFECT DIS, V20, P510, DOI 10.1016/S1473-3099(20)30156-0
   Zhou ZM, 2020, EUR RADIOL, V30, P4398, DOI 10.1007/s00330-020-06816-7
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 47
TC 5
Z9 5
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
EI 2090-4762
J9 EGYPT J RADIOL NUC M
JI Egypt. J. Radiol. Nucl. Med.
PD MAR 4
PY 2021
VL 52
IS 1
AR 72
DI 10.1186/s43055-021-00448-7
PG 13
WC Radiology, Nuclear Medicine & Medical Imaging
WE Emerging Sources Citation Index (ESCI)
SC Radiology, Nuclear Medicine & Medical Imaging
GA QT4JK
UT WOS:000626554800001
OA gold
DA 2022-04-20
ER

PT J
AU Millan, NM
   Morano, J
   Florez, L
   Carugno, J
   Medina, CA
AF Millan, N. M.
   Morano, J.
   Florez, L.
   Carugno, J.
   Medina, C. A.
TI Management of tubal ectopic pregnancy with methotrexate in the setting
   of symptomatic Coronavirus disease 2019 (COVID-19): A case report
SO FACTS VIEWS AND VISION IN OBGYN
LA English
DT Article
DE Methotrexate; ectopic pregnancy; coronavirus
ID CLINICAL CHARACTERISTICS; EXPECTANT MANAGEMENT; PNEUMONITIS
AB Background: Coronavirus Disease 2019 (COVID-19) represents a complex therapeutic challenge. As the pandemic progresses, patients are presenting with ectopic pregnancies (EPs) and symptomatic COVID-19.
   Objective: We present the management of a patient with multiple medical comorbidities and tubal EP in the setting of severe symptomatic COVID-19 infection where all management options were precluded.
   Methods: Case report with literature review of management of tubal EP in the setting of severe symptomatic COVID-19 infection.
   Result: After careful consideration of options, the patient underwent successful medical management with methotrexate while receiving supportive care for COVID-19.
   Conclusions: Methotrexate proved to be the safest therapeutic option in this patient. Management of patients with severe COVID-19 and gynaecologic emergencies should be individualised and carefully reviewed with evolving knowledge of COVID-19.
C1 [Millan, N. M.; Morano, J.; Florez, L.; Carugno, J.; Medina, C. A.] Univ Miami, Jackson Mem Hosp, Dept Obstet Gynecol & Reprod Sci, Hlth Syst, Miami, FL USA.
RP Millan, NM (corresponding author), Holtz Childrens Hosp, Suite 4070,1611 NW 12th Ave, Miami, FL 33136 USA.
EM Nicole.millan@jhsmiami.org
CR American College of Obstetricians and Gynecologists' Committee on Practice BulletinsGynecology, 2018, Obstet Gynecol, V131, pe91, DOI 10.1097/AOG.0000000000002560
   Beguin C, 2019, FACTS VIEWS VIS OBGY, V11, P329
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   COOPER JAD, 1986, AM REV RESPIR DIS, V133, P321
   COVIDsurg Collaborative, 2020, LANCET, V396, P27, DOI 10.1016/S0140-6736(20)31182-X
   GOLDEN MR, 1995, J RHEUMATOL, V22, P1043
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   Guan Wei-Jie, 2020, N Engl J Med, V382, P1861, DOI 10.1056/NEJMc2005203
   Hamed HO, 2012, INT J GYNECOL OBSTET, V116, P67, DOI 10.1016/j.ijgo.2011.08.009
   Hansen KA, 2020, OBSTET GYNECOL, V136, P288, DOI 10.1097/AOG.0000000000003995
   Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4
   Huang G, 2020, EMERG INFECT DIS, V26, P1839, DOI 10.3201/eid2608.201160
   JUNIOR JE, 2020, REV BRAS GINECOL OBS, V42, P849
   Jurkovic D, 2017, ULTRASOUND OBST GYN, V49, P171, DOI 10.1002/uog.17329
   Kim YJ, 2009, EXPERT OPIN DRUG SAF, V8, P451, DOI 10.1517/14740330903066734
   Kim YJ, 2009, TOXICOLOGY, V256, P183, DOI 10.1016/j.tox.2008.11.016
   KORHONEN J, 1994, FERTIL STERIL, V61, P632
   Lynch JP, 1997, AM J RESP CRIT CARE, V155, P395, DOI 10.1164/ajrccm.155.2.9032171
   Ohbayashi M, 2010, J TOXICOL SCI, V35, P653, DOI 10.2131/jts.35.653
   Pfeifer S, 2013, FERTIL STERIL, V100, P638, DOI 10.1016/j.fertnstert.2013.06.013
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Saridogan E, 2020, FACTS VIEWS VIS OBGY, V12, P1
   STCLAIR EW, 1985, ARCH INTERN MED, V145, P2035, DOI 10.1001/archinte.145.11.2035
   van Mello NM, 2013, HUM REPROD, V28, P60, DOI 10.1093/humrep/des373
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yang C, 2017, REPROD BIOMED ONLINE, V34, P383, DOI 10.1016/j.rbmo.2017.01.004
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 28
TC 0
Z9 0
U1 0
U2 0
PU UNIVERSA PRESS
PI WETTEREN
PA RUE HOENDER 24, WETTEREN, 9230, BELGIUM
SN 2032-0418
J9 FACTS VIEWS VIS OBGY
JI Facts Views Vis. ObGyn
PD SEP
PY 2021
VL 13
IS 3
BP 277
EP 281
DI 10.52054/FVVO.13.3.030
PG 5
WC Obstetrics & Gynecology
WE Emerging Sources Citation Index (ESCI)
SC Obstetrics & Gynecology
GA WE7YR
UT WOS:000705837100011
PM 34555882
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Meghana, A
   Aparna, Y
   Chandra, SM
   Sanjeev, S
AF Meghana, Aruru
   Aparna, Yerramilli
   Chandra, Sekar M.
   Sanjeev, Sharma
TI Emergency preparedness and response (EP&R) by pharmacy professionals in
   India: Lessons from the COVID-19 pandemic and the way forward
SO RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY
LA English
DT Article
DE COVID-19; Pharmacists; Pharmacy professionals; India; Emergency
   preparedness and response; Disaster management
AB The COVID-19 pandemic highlights the importance of Emergency Preparedness & Response (EP&R) education, training, capacity building and infrastructure development in India. During the pandemic, pharmacy professionals (PPs) in India have continued to provide medications, supplies and services. India's public-private healthcare system is complex and of variable quality. Lacunae in pharmacy education, training, and lack of resolution around pharmacist roles present challenges in providing health services to patients. Such lack of differentiation creates challenges around role specifications and appropriate placement of PPs in patient care and on EP&R task forces or representation at the policy level. This study aimed to gain rapid insights from PPs in India regarding their roles and preparedness for the COVID-19 pandemic. An online survey comprising 20 questions regarding EP&R and Operations management was developed using the Qualtrics (R) survey software and administered to a sample of PPs. Survey results indicate that PPs were actively involved in essential pharmacy services despite minimal EP&R training. Based on lessons learned during COVID-19, lacunae in knowledge, training and regulations were identified and recommendations are provided to broaden PP roles and enable them to be better prepared and actively engaged in EP&R for future emergencies.
C1 [Meghana, Aruru] Univ Pittsburgh, Sch Pharm, Program Evaluat & Res Unit PERU, Pittsburgh, PA 15260 USA.
   [Aparna, Yerramilli] Osmania Univ, Dept Pharm Practice, Sri Venkateshwara Coll Pharm, Hyderabad 500081, Andhra Pradesh, India.
   [Chandra, Sekar M.] Univ Findlay, Coll Pharm, Findlay, OH 45840 USA.
   [Sanjeev, Sharma] Apollo Hosp Enterprises Ltd, Pharmacovigilance Ctr, Delhi 110076, India.
RP Meghana, A (corresponding author), Univ Pittsburgh, Sch Pharm, Program Evaluat & Res Unit PERU, Pittsburgh, PA 15260 USA.
EM meghana.aruru@pitt.edu; aparnayerramilli@gmail.com; sekar@findlay.edu;
   sanjeevsham.cp@gmail.com
OI Desai, Meghana/0000-0001-9054-1844; YERRAMILLI,
   APARNA/0000-0003-0362-6239
CR Alan E, 2020, J AM COLL CLIN PHARM, V3, P564, DOI 10.1002/jac5.1253
   Amariles P, 2021, RES SOC ADMIN PHARM, V17, P2036, DOI 10.1016/j.sapharm.2020.03.013
   [Anonymous], Pharmacist advocacy groups call for new action to enhance COVID-19 patient care
   [Anonymous], TRACKING INDIAS CORO
   [Anonymous], REGISTRATION PHARMAC
   [Anonymous], 2020, FIP HLTH ADVISORY CO, V2020, P1
   [Anonymous], HLTH CARE CLOSED POI
   [Anonymous], 2019, E NATL HLTH PROFILE
   [Anonymous], DOCTORS COME ATTACK
   [Anonymous], INDIAS CORONAVIRUS L
   [Anonymous], STRATEGIC NATL STOCK
   [Anonymous], EC TIMES
   Aruru M, 2021, RES SOC ADMIN PHARM, V17, P1967, DOI 10.1016/j.sapharm.2020.04.002
   Basak SC, 2009, PHARM WORLD SCI, V31, P612, DOI 10.1007/s11096-009-9307-y
   CDC, 2013, COLLABORATIVE PRACTI
   Chokshi M, 2016, J PERINATOL, V36, pS9, DOI 10.1038/jp.2016.184
   Indian Council of Medical Research, 2020, PRELIMINARY STAKEHOL, P2020
   Indian council of medical research, RECOMMENDATION EMPIR
   Kasthuri A, 2018, INDIAN J COMMUN MED, V43, P141, DOI 10.4103/ijcm.IJCM_194_18
   Mohanan M, 2016, HEALTH AFFAIR, V35, P1753, DOI 10.1377/hlthaff.2016.0676
   MoHFW, HOME
   National Disaster Response Force, MINISTRY HOME AFFAIR
   Varma N, 2018, SUPPLY CHAINS INDIA, V2018
   Warriors Corona, SAY PHARMACISTS GADK
   WHO, 2018, DENSITY PHYS TOTAL N
   Yang L, 2020, RES SOC ADM PHARM, DOI [10.1016/j.sapharm.2020.03, DOI 10.1016/J.SAPHARM.2020.03]
NR 26
TC 13
Z9 13
U1 1
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1551-7411
EI 1934-8150
J9 RES SOC ADMIN PHARM
JI Res. Soc. Adm. Pharm.
PD JAN
PY 2021
VL 17
IS 1
BP 2018
EP 2022
DI 10.1016/j.sapharm.2020.04.028
PG 5
WC Public, Environmental & Occupational Health; Pharmacology & Pharmacy
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Pharmacology & Pharmacy
GA QD2JC
UT WOS:000615350400039
PM 32362583
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Syed, MH
   Wheatcroft, M
   Marcuzzi, D
   Hennessey, H
   Qadura, M
AF Syed, Muzammil H.
   Wheatcroft, Mark
   Marcuzzi, Danny
   Hennessey, Hooman
   Qadura, Mohammad
TI Management of a Mycotic Aneurysm in a Patient with COVID-19: A Case
   Report
SO MEDICINA-LITHUANIA
LA English
DT Article
DE mycotic aneurysm; COVID-19; endovascular stents; rifampin; Klebsiella
   pneumoniae; endoleak; follow-up studies; SARS-CoV-2
ID AORTIC-ANEURYSMS; ENDOVASCULAR REPAIR; EXPERIENCE; ARTERIES; GRAFT
AB The aim of this paper is to share our experience in managing a patient with Klebsiella pneumoniae mycotic abdominal aortic aneurysm who was also infected with COVID-19. A 69-year-old male was transferred to our hospital for the management of an infra-renal mycotic abdominal aortic aneurysm. During his hospital course, the patient contracted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). He was intubated due to respiratory distress. Over a short period, his mycotic aneurysm increased in size from 2.5 cm to 3.9 cm. An emergency repair of his expanding aneurysm was achieved using our previously described protocol of coating endovascular stents with rifampin. The patient was managed with a rifampin-coated endovascular stent graft without any major complications. Postoperatively, the patient did not demonstrate any neurological deficits nor any vascular compromise. He remained afebrile during his postoperative course and was extubated sometime thereafter. He was then transferred to the ward for additional monitoring prior to his discharge to a rehab hospital while being on long-term antibiotics. During his hospital stay, he was monitored with serial ultrasounds to ensure the absence of abscess formation, aortic aneurysm growth or graft endoleak. At 6 weeks after stent graft placement, he underwent a CT scan, which showed a patent stent graft, with a residual sac size of 2.5 cm without any evidence of abscess or endoleak. Over a follow-up period of 180 days, the patient remained asymptomatic while remaining on long-term antibiotics. Thus, in patients whose surgical risk is prohibitive, endovascular stent grafts can be used as a bridge to definitive surgical management.
C1 [Syed, Muzammil H.; Wheatcroft, Mark; Qadura, Mohammad] St Michaels Hosp, Div Vasc Surg, Toronto, ON M5B 1W8, Canada.
   [Wheatcroft, Mark; Qadura, Mohammad] Univ Toronto, Dept Surg, Toronto, ON M5B 1W8, Canada.
   [Marcuzzi, Danny] St Michaels Hosp, Dept Diagnost Imaging, Toronto, ON M5B 1W8, Canada.
   [Hennessey, Hooman] Northern Ontario Sch Med, Div Vasc & Intervent Radiol, Hlth Sci North, Sudbury, ON M5B 1W8, Canada.
   [Qadura, Mohammad] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada.
RP Qadura, M (corresponding author), St Michaels Hosp, Div Vasc Surg, Toronto, ON M5B 1W8, Canada.; Qadura, M (corresponding author), Univ Toronto, Dept Surg, Toronto, ON M5B 1W8, Canada.; Qadura, M (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada.
EM muzammil.syed@mail.utoronto.ca; mark.wheatcroft@unityhealth.to;
   Danny.Marcuzzi@unityhealth.to; hhennessey@nosm.ca;
   mohammad.qadura@utoronto.ca
CR AVRAMOVIC JR, 1991, AUST NZ J SURG, V61, P436, DOI 10.1111/j.1445-2197.1991.tb00258.x
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Hennessey H, 2019, J VASC SURG, V69, P242, DOI 10.1016/j.jvs.2017.10.069
   Hsu RB, 2004, J VASC SURG, V40, P30, DOI 10.1016/j.jvs.2004.03.020
   Kan CD, 2007, J VASC SURG, V46, P906, DOI 10.1016/j.jvs.2007.07.025
   Lew WK, 2009, ANN VASC SURG, V23, P81, DOI 10.1016/j.avsg.2008.08.008
   MCDOUGAL EG, 1986, J VASC SURG, V4, P5, DOI 10.1067/mva.1986.avs0040005
   Muller BT, 2001, J VASC SURG, V33, P106, DOI 10.1067/mva.2001.110356
   Osler W, 1885, BRIT MED J, V1, P577
   Puppala S, 2020, CLIN RADIOL, V75, DOI 10.1016/j.crad.2020.05.019
   Shahi N, 2016, VASC ENDOVASC SURG, V50, P373, DOI 10.1177/1538574416655894
   Sorelius K, 2019, EUR J VASC ENDOVASC, V57, P239, DOI 10.1016/j.ejvs.2018.08.052
   Sorelius K, 2016, CIRCULATION, V134, P1822, DOI 10.1161/CIRCULATIONAHA.116.024021
   Sorelius K, 2014, CIRCULATION, V130, P2136, DOI 10.1161/CIRCULATIONAHA.114.009481
   Sorelius K, 2009, J VASC SURG, V50, P269, DOI 10.1016/j.jvs.2009.01.001
   Weis-Muller BT, 2011, ANN VASC SURG, V25, P1020, DOI 10.1016/j.avsg.2011.03.009
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Young RM, 1999, AM J SURG, V178, P136, DOI 10.1016/S0002-9610(99)00146-4
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 19
TC 2
Z9 2
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1010-660X
EI 1648-9144
J9 MEDICINA-LITHUANIA
JI Med. Lith.
PD JUN
PY 2021
VL 57
IS 6
AR 620
DI 10.3390/medicina57060620
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA SZ3RY
UT WOS:000666487800001
PM 34198541
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Turatto, F
   Mazzalai, E
   Pagano, F
   Migliara, G
   Villari, P
   De Vito, C
AF Turatto, Federica
   Mazzalai, Elena
   Pagano, Federica
   Migliara, Giuseppe
   Villari, Paolo
   De Vito, Corrado
TI A Systematic Review and Bibliometric Analysis of the Scientific
   Literature on the Early Phase of COVID-19 in Italy
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Review
DE coronavirus; COVID-19; Italy; bibliometric analysis; public health;
   systematic review
AB Background: Studying the scientific literature about COVID-19 and Italy, one of the first countries to be hit by the pandemic, allows an investigation into how knowledge develops during a public health emergency. Methods: A systematic review of the literature was conducted to identify articles published on the topic between January and April 2020. Articles were classified according to type of study. Co-occurrence of terms, and geographic and temporal trends were analyzed. Results: Of the 238 articles included in the systematic review, the majority (37%) focused on hospital and clinical management of COVID-19, while 23.9% were commentaries. Epidemiological studies constituted 45.5% of the articles published by authors with non-Italian affiliations. Conclusion: The scientific articles on COVID-19 in Italy were varied in type of study, though with limited international impact. The lockdown and the pressure placed on hospitals during the first wave of the pandemic mainly resulted in publications on disease management and commentaries.
C1 [Turatto, Federica; Mazzalai, Elena; Pagano, Federica; Migliara, Giuseppe; Villari, Paolo; De Vito, Corrado] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy.
RP Turatto, F (corresponding author), Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy.
EM federica.turatto@uniroma1.it
CR Andersen J. P., 2020, eLife, V9, DOI 10.7554/eLife.58807
   Belli S, 2020, SCIENTOMETRICS, V124, P2661, DOI 10.1007/s11192-020-03590-7
   Chahrour M, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7357
   De Felice F, 2020, IN VIVO, V34, P1613, DOI 10.21873/invivo.11951
   Fan JC, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00477
   Gale RP, 2020, BRIT J HAEMATOL, V190, P358, DOI 10.1111/bjh.16905
   Hamidah I., 2020, INDONESIAN J SCI TEC, V5, P209, DOI [10.17509/ijost.v5i2.24522, DOI 10.17509/IJOST.V5I2.24522]
   Horbach SPJM, 2020, QUANT SCI STUD, V1, P1056, DOI 10.1162/qss_a_00076
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   ISTAT, 2021, POP RES 1 GENN
   Kambhampati Srinivas B S, 2020, J Clin Orthop Trauma, V11, pS304, DOI 10.1016/j.jcot.2020.04.030
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007]
   Lou J, 2020, EUR REV MED PHARMACO, V24, P3411, DOI 10.26355/eurrev_202003_20712
   Mao XJ, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020137
   Memon AR, 2020, J PAK MED ASSOC, V70, pS166, DOI 10.5455/JPMA.39
   Ministero della Salute Istituto Superiore di SanituSS, 2020, PEV RISP COVID 19 EV
   Nowakowska J, 2020, BIOMED PHARMACOTHER, V129, DOI 10.1016/j.biopha.2020.110451
   Odone Anna, 2020, Acta Biomed, V91, P34, DOI 10.23750/abm.v91i9-S.10121
   Presidenza del Consiglio dei Ministri, 2020, DECR PRES CONS MIN 9
   Protezione Civile, 2020, COVID 19 SIT IT
   Rohrig B, 2009, DTSCH ARZTEBL INT, V106, P262, DOI 10.3238/arztebl.2009.0262
   Shamsi A, 2020, J DIABETES METAB DIS, V19, P1845, DOI 10.1007/s40200-020-00606-0
   Song PP, 2020, BIOSCI TRENDS, V14, P1, DOI 10.5582/bst.2020.01056
   Wallin JA, 2005, BASIC CLIN PHARMACOL, V97, P261, DOI 10.1111/j.1742-7843.2005.pto_139.x
   WHO, 2021, STAT 2 M INT HLTH RE
   World Health Organization, 2020, WHO COR DIS COVID 19
   World Health Organization, 2020, IT WHO COR DIS COVID
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Yu YT, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-4235
   Zhai F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113766
   Zhang L, 2020, SCIENTOMETRICS, V124, P747, DOI 10.1007/s11192-020-03531-4
   Zyoud SH, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05293-z
   Zyoud SH, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1600-5
NR 33
TC 1
Z9 1
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD JUN 22
PY 2021
VL 9
AR 666669
DI 10.3389/fpubh.2021.666669
PG 10
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA TE2WR
UT WOS:000669876700001
PM 34239853
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Yang, Y
   Luo, K
   Jiang, Y
   Yu, Q
   Huang, X
   Wang, J
   Liu, NH
   Huang, P
AF Yang, Y.
   Luo, K.
   Jiang, Y.
   Yu, Q.
   Huang, X.
   Wang, J.
   Liu, Nanhai
   Huang, Pan
TI The Impact of Frailty on COVID-19 Outcomes: A Systematic Review and
   Meta-Analysis of 16 Cohort Studies
SO JOURNAL OF NUTRITION HEALTH & AGING
LA English
DT Review
DE COVID-19; frailty; Meta-analysis; SARS-COV-2
AB Background Frail patients are increasingly vulnerable to stress, which is mainly manifested by a reduced physiologic reserve in metabolic and immune systems and neuromuscular system. Several studies found a significant association of frailty with COVID-19 severity to support the evidence for the application of frailty assessment. However, there were contradictory results in other studies. Thus we conducted a systematic review and meta-analysis to synthesize the current studies to investigate impact of frailty on COVID-19 outcomes and provide evidence-based decisions in clinical practice. Objective We aimed to synthesize the current studies to investigate impact of frailty on COVID-19 outcomes and provide evidence-based decisions in clinical practice. Design A systematic review and Meta-analysis of 16 cohort studies. Participants Patients with COVID-19. Methods A systematic retrieving for potential literature was conducted in several public electronic databases, including Medline(OvidSP), EMBASE, Pubmed and Chinese databases(China National Knowledge Infrastructure, Wanfang and Weipu) on August 1, 2020. The literature research was updated on October 26, 2020. Newcastle Ottawa Scale for cohort studies was used for quality assessment. RevMan (Version 5.3) and Stata 14.0 were used to synthesize the pooled effects. Results According to the predefined inclusion and exclusion criteria, sixteen studies of 4324 patients were included in the final analysis. Frailty was significantly associated with increased risk of all-cause mortality among patients with COVID-19, with pooled adjusted odds ratios of 1.81 (95% confidence intervals:1.48,2.21, I2=87.0%, P<0.001). The result was consistent in stratified analysis to according to age, patient source, definitions of frailty, study quality, and adjustment method. Frailty was significant associated with an increased risk of COVID-19 severity, admission to intensive care unit, application of invasive mechanical ventilation, long-length stay. Conclusions In this meta-analysis, we found frailty was significantly associated with an increased risk of clinical adverse events (all- cause mortality, COVID-19 severity, admission to the intensive care unit, application of invasive mechanical ventilation, long-length stay). Given the epidemic of COVID-19 and shortage of medical resources, paying more attention to screening frailty would contribute to disease management and resource allocation among patients with COVID-19.
C1 [Yang, Y.] Fifth Peoples Hosp Chengdu, Dept Neurol, Chengdu, Peoples R China.
   [Luo, K.; Jiang, Y.; Huang, X.; Wang, J.] Jinggangshan Univ, Dept Med, Jian, Jiangxi, Peoples R China.
   [Yu, Q.] Gannan Med Univ, Coll Nursing, Ganzhou, Jiangxi, Peoples R China.
   [Liu, Nanhai] Gannan Med Univ, Dept Neurol, Affiliated Hosp 1, Ganzhou, Jiangxi, Peoples R China.
   [Huang, Pan] Wenzhou Med Univ, Coll Nursing, Wenzhou, Zhejiang, Peoples R China.
RP Liu, NH (corresponding author), Gannan Med Univ, Dept Neurol, Affiliated Hosp 1, Ganzhou, Jiangxi, Peoples R China.; Huang, P (corresponding author), Wenzhou Med Univ, Coll Nursing, Wenzhou, Zhejiang, Peoples R China.
EM 13970781916@163.com; gnyxywthp@163.com
FU science and technology research project of Jiangxi Provincial Department
   of Education [GJJ150960]; production study research project of Gannan
   Medical University [cp201407]; "Xinglin scholar" subject talent research
   plan of Chengdu University of traditional Chinese Medicine [YYZX2019004]
FX Funding source from science and technology research project of Jiangxi
   Provincial Department of Education (GJJ150960), production study
   research project of Gannan Medical University (cp201407) and "Xinglin
   scholar" subject talent research plan of Chengdu University of
   traditional Chinese Medicine(YYZX2019004).
CR Ahmed J, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.9424
   Aw D, 2020, AGE AGEING, V49, P915, DOI 10.1093/ageing/afaa184
   Bellelli G, 2020, INTENS CARE MED, V46, P1634, DOI 10.1007/s00134-020-06087-2
   Brenner EJ, 2020, GASTROENTEROLOGY, V159, P481, DOI 10.1053/j.gastro.2020.05.032
   Brill SE, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01665-z
   Brook RD, 2020, CIRC-CARDIOVASC QUAL, V13, P382, DOI 10.1161/CIRCOUTCOMES.120.006815
   Burns GP, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000621
   Chinnadurai R, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01803-5
   CRAPO RO, 1988, EUR RESPIR J, V1, P573
   Darvall JN, 2020, BRIT J ANAESTH, V125, P730, DOI 10.1016/j.bja.2020.07.049
   De Smet R, 2020, J AM MED DIR ASSOC, V21, P928, DOI 10.1016/j.jamda.2020.06.008
   Dent E, 2019, J NUTR HEALTH AGING, V23, P771, DOI 10.1007/s12603-019-1273-z
   Dent E, 2019, LANCET, V394, P1376, DOI 10.1016/S0140-6736(19)31785-4
   Doglietto F, 2020, JAMA SURG, V155, P691, DOI 10.1001/jamasurg.2020.2713
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Fiorentino M, 2020, PALLIATIVE MED, V34, P1228, DOI 10.1177/0269216320940566
   Gilbert T, 2018, LANCET, V391, P1775, DOI 10.1016/S0140-6736(18)30668-8
   Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020
   Guo T, 2020, GERONTOLOGY, V66, P467, DOI 10.1159/000508734
   Hagg S, 2020, J AM MED DIR ASSOC, V21, P1555, DOI 10.1016/j.jamda.2020.08.014
   Han SA, 2020, DISASTER MED PUBLIC, V14, pE35, DOI 10.1017/dmp.2020.232
   Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D
   Hewitt J, 2020, LANCET PUBLIC HEALTH, V5, pE444, DOI 10.1016/S2468-2667(20)30146-8
   Hewitt J, 2018, AGE AGEING, V47, P793, DOI 10.1093/ageing/afy110
   Hoek RAS, 2020, TRANSPL INT, V33, P1099, DOI 10.1111/tri.13662
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Houghton JSM, 2020, ANN SURG, V272, P266, DOI 10.1097/SLA.0000000000003642
   Jiang, 2020, DIGEST LIVER DIS
   Knights H, 2020, CLIN MED, V20, pE148, DOI 10.7861/clinmed.2020-0303
   Knopp P, 2020, EUR GERIATR MED, V11, P1089, DOI 10.1007/s41999-020-00373-4
   Kojima G, 2017, J EPIDEMIOL, V27, P347, DOI 10.1016/j.je.2016.09.008
   Kojima G, 2015, J AM MED DIR ASSOC, V16, P1027, DOI 10.1016/j.jamda.2015.06.018
   Kojima G, 2015, J AM MED DIR ASSOC, V16, P940, DOI 10.1016/j.jamda.2015.06.025
   Kundi H, 2020, J INFECTION, V81, P944, DOI 10.1016/j.jinf.2020.09.029
   Kusumastuti S, 2018, EUR J INTERN MED, V57, P7, DOI 10.1016/j.ejim.2018.06.019
   Labenz C, 2020, J INVEST MED, V68, P1199, DOI 10.1136/jim-2020-001410
   Liang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033
   Liu PP, 2020, CIRCULATION, V142, P68, DOI 10.1161/CIRCULATIONAHA.120.047549
   Cunha AIL, 2019, AGEING RES REV, V56, DOI 10.1016/j.arr.2019.100960
   Ma Y, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01761-0
   Maguire D, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02524-4
   Maltese G, 2020, J CLIN MED, V9, DOI 10.3390/jcm9072106
   Marengoni A, 2020, AGE AGEING, V49, P923, DOI 10.1093/ageing/afaa189
   Miles A, 2020, EUR GERIATR MED, V11, P851, DOI 10.1007/s41999-020-00354-7
   Muscedere J, 2017, INTENS CARE MED, V43, P1105, DOI 10.1007/s00134-017-4867-0
   Owen RK, 2021, AGE AGEING, V50, P307, DOI 10.1093/ageing/afaa167
   Pansarasa O, 2019, AGEING RES REV, V54, DOI 10.1016/j.arr.2019.100935
   Pareek M, 2020, LANCET, V395, P1421, DOI 10.1016/S0140-6736(20)30922-3
   Potere N, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03022-1
   Pourbaix A, 2020, CLIN INFECT DIS, V71, P1106, DOI 10.1093/cid/ciaa001
   Qin JJ, 2020, HYPERTENSION, V76, P1104, DOI 10.1161/HYPERTENSIONAHA.120.15528
   Rawle Mark James, 2020, Aging Med (Milton), V3, P237, DOI 10.1002/agm2.12126
   Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051
   Severin R, 2020, AM J MED, V133, P1025, DOI 10.1016/j.amjmed.2020.04.003
   Shen HQ, 2019, ORG LETT, V21, P2712, DOI 10.1021/acs.orglett.9b00687
   Shi SM, 2020, J AM MED DIR ASSOC, V21, P1378, DOI 10.1016/j.jamda.2020.08.027
   Soysal P, 2016, AGEING RES REV, V31, P1, DOI 10.1016/j.arr.2016.08.006
   Steinmeyer Z, 2020, GERIATRICS-BASEL, V5, DOI 10.3390/geriatrics5040065
   Strandberg TE, 2007, LANCET, V369, P1328, DOI 10.1016/S0140-6736(12)62167-9
   Tandon P, 2016, AM J GASTROENTEROL, V111, P1759, DOI 10.1038/ajg.2016.303
   Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200
   Velavan TP, 2020, TROP MED INT HEALTH, V25, P278, DOI 10.1111/tmi.13383
   Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654
   Woolford SJ, 2020, AGING CLIN EXP RES, V32, P1897, DOI 10.1007/s40520-020-01653-6
   Xu LZ, 2020, AGING-US, V12, P12410, DOI 10.18632/aging.103383
   Yang XH, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03065-4
   Yang XianQin, 2018, Journal of Food Research, V7, P1, DOI 10.5539/jfr.v7n4p1
   Zhang Y, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4673
   Zhao MM, 2020, AGING-US, V12, P10070, DOI 10.18632/aging.103298
   Zhou JH, 2016, MATURITAS, V94, P70, DOI 10.1016/j.maturitas.2016.09.003
   Zhu YJ, 2020, SCI TOTAL ENVIRON, V727, DOI 10.1016/j.scitotenv.2020.138704
NR 71
TC 8
Z9 8
U1 4
U2 7
PU SPRINGER FRANCE
PI PARIS
PA 22 RUE DE PALESTRO, PARIS, 75002, FRANCE
SN 1279-7707
EI 1760-4788
J9 J NUTR HEALTH AGING
JI J. Nutr. Health Aging
PD MAY
PY 2021
VL 25
IS 5
BP 702
EP 709
DI 10.1007/s12603-021-1611-9
EA MAR 2021
PG 8
WC Geriatrics & Gerontology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Nutrition & Dietetics
GA RX2UV
UT WOS:000625619800001
PM 33949641
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Gusar, I
   Konjevoda, S
   Babic, G
   Hnatesen, D
   Cebohin, M
   Orlandini, R
   Dzelalija, B
AF Gusar, Ivana
   Konjevoda, Suzana
   Babic, Grozdana
   Hnatesen, Dijana
   Cebohin, Maja
   Orlandini, Rahela
   Dzelalija, Boris
TI Pre-Vaccination COVID-19 Vaccine Literacy in a Croatian Adult
   Population: A Cross-Sectional Study
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; vaccine literacy; vaccination; pandemic; general population
ID HEALTH LITERACY; COMMUNICATION; KNOWLEDGE
AB Despite world-level efforts and the endeavors of scientists and medical professionals in suppressing the COVID-19 pandemic, inadequate levels of vaccine literacy of the general population can represent a grave obstacle. The aim of this study was to evaluate COVID-19 vaccine literacy in the Croatian adult general population before vaccination began. The specific objectives were to test differences regarding socio-demographic characteristics and to examine perceptions and attitudes about vaccination against COVID-19 considering the level of VL against COVID-19. A cross-sectional study with a translated and psychometrically tested questionnaire was conducted in 1227 participants before the start of vaccination, from 15 to 31 January 2021. The results show a medium level of vaccine literacy (M = 2.37, SD = 0.54) and a significant difference between functional and interactive-critical vaccine literacy (p < 0.001). The level of vaccine literacy grew with the level of education (p = 0.031) and reduced with age (p < 0.001). Participants who were employed, had chronic diseases, took medicine, or consumed alcohol daily had a lower level of vaccine literacy. There is room for progress in the COVID-19 VL level for the adult population in Croatia, especially at the interactive-critical VL, which could have an important role in people accepting the vaccine against the COVID-19 disease. A satisfactory level of vaccine literacy in the population is necessary because it can contribute to the fight against the pandemic.
C1 [Gusar, Ivana; Konjevoda, Suzana; Babic, Grozdana; Dzelalija, Boris] Univ Zadar, Dept Hlth Studies, Zadar 23000, Croatia.
   [Gusar, Ivana; Hnatesen, Dijana; Cebohin, Maja] Josip Juraj Strossmayer Univ Osijek, Fac Med, Osijek 31000, Croatia.
   [Konjevoda, Suzana; Dzelalija, Boris] Gen Hosp Zadar, Zadar 23000, Croatia.
   [Hnatesen, Dijana] Univ Hosp Osijek, Clin Dept Pain Management, Osijek 31000, Croatia.
   [Hnatesen, Dijana; Cebohin, Maja] Josip Juraj Strossmayer Univ Osijek, Fac Dent Med & Hlth Osijek, Nursing Inst Prof Radivoje Radi, Osijek 31000, Croatia.
   [Cebohin, Maja] Med Sch Osijek, Osijek 31000, Croatia.
   [Orlandini, Rahela] Univ Split, Dept Hlth Studies, Split 21000, Croatia.
   [Orlandini, Rahela; Dzelalija, Boris] Univ Split, Sch Med, Split 21000, Croatia.
RP Konjevoda, S (corresponding author), Univ Zadar, Dept Hlth Studies, Zadar 23000, Croatia.; Konjevoda, S (corresponding author), Gen Hosp Zadar, Zadar 23000, Croatia.
EM igusar@unizd.hr; skonjevod@unizd.hr; grozdana.babic@gmail.com;
   hnatesen.dijana@kbco.hr; maja.cebohin@skole.hr;
   rahela.orlandini@ozs.unist.hr; bdzelalija@unizd.hr
OI Hnatesen, Dijana/0000-0001-9036-3232; Cebohin, Maja/0000-0002-1197-0104;
   Gusar, Ivana/0000-0002-4829-1543
CR Aharon AA, 2017, PATIENT EDUC COUNS, V100, P768, DOI 10.1016/j.pec.2016.11.016
   Alharbi BA, 2020, J FAM MED PRIM CARE, V9, P1684, DOI 10.4103/jfmpc.jfmpc_1060_19
   [Anonymous], **NON-TRADITIONAL**
   Ashkenazi S, 2020, VACCINE, V38, P7292, DOI 10.1016/j.vaccine.2020.09.044
   Bauer A, 2021, WIEN KLIN WOCHENSCHR, V133, P703, DOI 10.1007/s00508-020-01777-9
   Biasio LR, 2020, ANN IG MED PREV COMU, V32, P205, DOI 10.7416/ai.2020.2344
   Biasio LR, 2019, HUM VACC IMMUNOTHER, V15, P2552, DOI 10.1080/21645515.2019.1609850
   Dakin, 2020, DISPARITIES COVID 19, P1, DOI [10.1101/2020.06.03.20121814, DOI 10.1101/2020.06.03.20121814]
   Espanha R, 2016, PROCEDIA COMPUT SCI, V100, P1033, DOI 10.1016/j.procs.2016.09.277
   Gao L, 2018, AGE AGEING, V47, P220, DOI 10.1093/ageing/afx158
   Khoshravesh S., 2018, J ED COMMUNITY HLTH, V5, P19, DOI [10.21859/jech.5.1.19, DOI 10.21859/JECH.5.1.19]
   Lazcano-Ponce E, 2020, SALUD PUBLICA MEXICO, V62, P331, DOI 10.21149/11408
   Levin-Zamir D, 2020, J HEALTH COMMUN, V25, P816, DOI 10.1080/10810730.2021.1884773
   Lorini C, 2018, HUM VACC IMMUNOTHER, V14, P478, DOI 10.1080/21645515.2017.1392423
   Marazziti D, 2020, PSYCHOL TRAUMA-US, V12, P531, DOI 10.1037/tra0000687
   Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259
   Pattanayak, 2017, J GERIATR MENT HLTH, V4, P4, DOI [DOI 10.4103/jgmh.jgmh_34_16, 10.4103/jgmh.jgmh_34_16, DOI 10.4103/JGMH.JGMH_34_16]
   Petersen RS, 2019, REV LAT-AM ENFERM, V27, DOI 10.1590/1518-8345.2943.3170
   Puri N, 2020, HUM VACC IMMUNOTHER, V16, P2586, DOI 10.1080/21645515.2020.1780846
   Ratzan S. C., 2000, NATL LIB MED CURRENT, VCBM 2000-1, pv
   Regmi PR, 2016, NEPAL J EPIDEMIOL, V6, P640, DOI 10.3126/nje.v6i4.17258
   Roozenbeek J, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.201199
   Soares P, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030300
   Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80
   Spring H, 2020, HEALTH INFO LIBR J, V37, P171, DOI 10.1111/hir.12322
   Svendsen IW, 2021, INT J PUBLIC HEALTH, V66, DOI 10.3389/ijph.2021.598083
   Vanderpool RC, 2020, AM J PUBLIC HEALTH, V110, pS284, DOI 10.2105/AJPH.2020.305906
   Zarcadoolas C, 2005, HEALTH PROMOT INT, V20, P195, DOI 10.1093/heapro/dah609
NR 28
TC 4
Z9 4
U1 7
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUL
PY 2021
VL 18
IS 13
AR 7073
DI 10.3390/ijerph18137073
PG 10
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA TG1KH
UT WOS:000671169700001
PM 34281009
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Bruynseels, K
AF Bruynseels, Koen
TI Responsible innovation in synthetic biology in response to COVID-19: the
   role of data positionality
SO ETHICS AND INFORMATION TECHNOLOGY
LA English
DT Article
DE Positionality; Synthetic biology; Responsible innovation; Data
   frictions; Knowledge commons; Pandemic; COVID-19
ID SCIENCE; SOCIETY
AB Synthetic biology, as an engineering approach to biological systems, has the potential to disruptively innovate the development of vaccines, therapeutics, and diagnostics. Data accessibility and differences in data-usage capabilities are important factors in shaping this innovation landscape. In this paper, the data that underpin synthetic biology responses to the COVID-19 pandemic are analyzed as positional information goods-goods whose value depends on exclusivity. The positionality of biological data impacts the ability to guide innovations toward societally preferred goals. From both an ethical and economic point of view, positionality can lead to suboptimal as well as beneficial situations. When aiming for responsible innovation (i.e. embedding societal deliberation in the innovation process), it is important to consider hurdles and facilitators in data access and use. Central governance and knowledge commons provide routes to mitigate the negative effects of data positionality.
C1 [Bruynseels, Koen] Delft Univ Technol, Technol Policy & Management, Dept Philosophy, Jaffalaan 5, NL-2628 BX Delft, Netherlands.
RP Bruynseels, K (corresponding author), Delft Univ Technol, Technol Policy & Management, Dept Philosophy, Jaffalaan 5, NL-2628 BX Delft, Netherlands.
EM K.R.C.Bruynseels@tudelft.nl
CR Aanensen DM, 2020, LANCET MICROBE, V1, pE99, DOI 10.1016/S2666-5247(20)30054-9
   [Anonymous], 2020, BIOBRICKS TM PUBLIC
   [Anonymous], 2020, GENBANK SARS COV 2
   [Anonymous], 2019, SYNTH BIOL INV REP 2
   Bates J, 2018, J DOC, V74, P412, DOI 10.1108/JD-05-2017-0080
   Begley S, 2020, STAT NEWS
   Bogner A, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01884
   Bogner P, 2006, NATURE, V442, P981, DOI 10.1038/442981a
   Boyle James, 2008, PUBLIC DOMAIN ENCLOS
   Braun R, 2020, J RESPONSIBLE INNOV, V7, P680, DOI 10.1080/23299460.2020.1789387
   Broughton JP, 2020, NAT BIOTECHNOL, V38, P870, DOI 10.1038/s41587-020-0513-4
   Bruynseels K, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00031
   Burgelman JC, 2019, FRONT BIG DATA, V2, DOI 10.3389/fdata.2019.00043
   Burget M, 2017, SCI ENG ETHICS, V23, P1, DOI 10.1007/s11948-016-9782-1
   Butler, 2013, NATURE NEWS, V493, DOI [10.1038/nature.2012.12108, DOI 10.1038/NATURE.2012.12108]
   CEPI, 2020, COAL EP PREP INN
   Chadwick Ruth, 2004, Res Publica, V10, P123, DOI 10.1023/B:RESP.0000034637.15364.11
   Cole P, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a020891
   Covid 19 Host Genetics Initiative, 2020, EUR J HUM GENET, V28, P715, DOI 10.1038/s41431-020-0636-6
   Douglas Conor M W, 2013, Syst Synth Biol, V7, P139, DOI 10.1007/s11693-013-9119-1
   Edwards P., 2010, VAST MACHINE COMPUTE
   European Commission, 2014, ROM DECL RESP RES IN
   Frank R., 2011, DARWIN EC LIBERTY CO
   FRANK RH, 1985, AM ECON REV, V75, P101
   Freemont PS, 2019, EMERG TOP LIFE SCI, V3, P651, DOI 10.1042/ETLS20190040
   Gouglas D, 2018, LANCET GLOB HEALTH, V6, pE1386, DOI 10.1016/S2214-109X(18)30346-2
   GRCIDP, 2018, DAT SHAR W AFR EB PU
   Hardy BJ, 2008, NAT REV GENET, V9, pS19, DOI 10.1038/nrg2441
   Hirsch Fred., 1976, SOCIAL LIMITS GROWTH
   holmes e, 2020, INITIAL GENOME RELEA
   Jensen AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5022
   Kritikos, 2020, 10 TECHNOLOGIES FIGH
   Ledford H, 2020, NATURE, V582, P172, DOI 10.1038/d41586-020-01524-0
   Leslie D, 2020, HARVARD DATA SCI REV, DOI [10.2139/ssrn.3652970, DOI 10.2139/SSRN.3652970]
   Levin Nadine, 2016, Bull Sci Technol Soc, V36, P128
   Lezaun J, 2015, SCI TECHNOL HUM VAL, V40, P3, DOI 10.1177/0162243914542349
   Liddicoat J, 2019, EUR J HUM GENET, V27, P997, DOI 10.1038/s41431-019-0368-7
   Macnaghten P, 2016, ESSAYS BIOCHEM, V60, P347, DOI 10.1042/EBC20160048
   Manders-Huits N, 2008, FUTURE OF IDENTITY IN THE INFORMATION SOCIETY, P77
   Marcandalli J, 2019, CELL, V176, P1420, DOI 10.1016/j.cell.2019.01.046
   National Health Commission of the People's Republic of China (NHC), 2020, TIM CHIN REL INF COV
   OECD, 2020, WHY OP SCI IS CRIT C
   Olena A., 2020, SCIENTIST
   Owen R., 2013, RESPONSIBLE INNOVATI, P27, DOI DOI 10.1002/9781118551424.CH2
   Owen R, 2012, SCI PUBL POLICY, V39, P751, DOI 10.1093/scipol/scs093
   Pagano U, 1999, POLITICS EC POWER, P116
   Peeri NC, 2020, INT J EPIDEMIOL, V49, P717, DOI 10.1093/ije/dyaa033
   Piller C, 2020, SCIENCE, V368, P1167, DOI 10.1126/science.368.6496.1167
   Prainsack B, 2019, BIG DATA SOC, V6, DOI 10.1177/2053951719829773
   Quah D, 2003, CEPDP0563563 LOND SC
   Raimbault B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161522
   RDA COVID-19 Working Group, 2020, REC GUID DAT SHAR, DOI [10.15497/rda00052, DOI 10.15497/RDA00052]
   Sachsenmeier P, 2016, ENGINEERING, V2, P225, DOI 10.1016/J.ENG.2016.02.015
   Sedyaningsih ER, 2008, ANN ACAD MED SINGAP, V37, P482
   Shin MD, 2020, NAT NANOTECHNOL, V15, P646, DOI 10.1038/s41565-020-0737-y
   Silva HP, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0362-5
   Stilgoe J, 2013, RES POLICY, V42, P1568, DOI 10.1016/j.respol.2013.05.008
   Strandburg KJ, 2017, KNOWLEDGE COMMONS FR
   Le TT, 2020, NAT REV DRUG DISCOV, V19, P305, DOI 10.1038/d41573-020-00073-5
   Torrance AW, 2017, GOVERNING MED KNOWLE, P192
   UK Biobank, 2020, UK BIOB MAK HLTH DAT
   Urquiza-Garcia U, 2019, SYN BIOL, V4, DOI 10.1093/synbio/ysz016
   van den Hoven J, 2012, EUR PHYS J-SPEC TOP, V214, P153, DOI 10.1140/epjst/e2012-01691-2
   Vatiero M, 2009, QUADERNI DIPARTIMENT, V575
   Vaught J, 2020, BIOPRESERV BIOBANK, V18, P153, DOI 10.1089/bio.2020.29069.jjv
   Vinatzer BA, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00106
   von Schomberg Rene., 2012, TECHNIKFOLGEN ABSCHA, P39, DOI [10.1007/978-3-531-93468-6_2, DOI 10.1007/978-3-531-93468-6_2]
   Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a
   Zhuang L, 2020, METAB ENG, V60, P37, DOI 10.1016/j.ymben.2020.03.009
   Zinnbauer D, 2018, INFORM WANTS BE EXPE, DOI [10.2139/ssrn.3125074, DOI 10.2139/SSRN.3125074]
NR 70
TC 1
Z9 1
U1 2
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-1957
EI 1572-8439
J9 ETHICS INF TECHNOL
JI Ethics Inf. Technol.
PD NOV
PY 2021
VL 23
IS SUPPL 1
SU 1
BP 117
EP 125
DI 10.1007/s10676-020-09565-9
EA OCT 2020
PG 9
WC Ethics; Information Science & Library Science; Philosophy
WE Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)
SC Social Sciences - Other Topics; Information Science & Library Science;
   Philosophy
GA XK3BS
UT WOS:000584050500001
PM 33132748
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Teran, F
   Burns, KM
   Narasimhan, M
   Goffi, A
   Mohabir, P
   Horowitz, JM
   Yuriditsky, E
   Nagdev, A
   Panebianco, N
   Chin, EJ
   Gottlieb, M
   Koenig, S
   Arntfield, R
AF Teran, Felipe
   Burns, Katharine M.
   Narasimhan, Mangala
   Goffi, Alberto
   Mohabir, Paul
   Horowitz, James M.
   Yuriditsky, Eugene
   Nagdev, Arun
   Panebianco, Nova
   Chin, Eric J.
   Gottlieb, Michael
   Koenig, Seth
   Arntfield, Robert
TI Critical Care Transesophageal Echocardiography in Patients during the
   COVID-19 Pandemic
SO JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
LA English
DT Review
DE COVID-19; Novel coronavirus; SARS-CoV-2; Acute respiratory syndrome
   associated with COVID-19; Transesophageal echocardiography;
   Point-of-care ultrasound
ID INTRAAORTIC BALLOON PUMP; LIFE-SUPPORT; RESUSCITATION; GUIDELINES;
   MANAGEMENT
AB Background: The COVID-19 pandemic has placed an extraordinary strain on healthcare systems across North America. Defining the optimal approach for managing a critically ill COVID-19 patient is rapidly changing. Goaldirected transesophageal echocardiography (TEE) is frequently used by physicians caring for intubated critically ill patients as a reliable imaging modality that is well suited to answer questions at bedside.
   Methods: A multidisciplinary (intensive care, critical care cardiology, and emergency medicine) group of experts in point-of-care echocardiography and TEE from the United States and Canada convened to review the available evidence, share experiences, and produce a consensus statement aiming to provide clinicians with a framework to maximize the safety of patients and healthcare providers when considering focused point-of-care TEE in critically ill patients during the COVID-19 pandemic.
   Results: Although transthoracic echocardiography can provide the information needed in most patients, there are specific scenarios in which TEE represents the modality of choice. TEE provides acute care clinicians with a goal-directed framework to guide clinical care and represents an ideal modality to evaluate hemodynamic instability during prone ventilation, perform serial evaluations of the lungs, support cardiac arrest resuscitation, and guide veno-venous ECMO cannulation. To aid other clinicians in performing TEE during the COVID-19 pandemic, we describe a set of principles and practical aspects for performing examinations with a focus on the logistics, personnel, and equipment required before, during, and after an examination.
   Conclusions: In the right clinical scenario, TEE is a tool that can provide the information needed to deliver the best and safest possible care for the critically ill patients.
C1 [Teran, Felipe; Panebianco, Nova] Univ Penn, Div Emergency Ultrasound, Dept Emergency Med, Philadelphia, PA 19104 USA.
   [Teran, Felipe] Univ Penn, Ctr Resuscitat Sci, Philadelphia, PA 19104 USA.
   [Burns, Katharine M.] Advocate Christ Med Ctr, Dept Emergency Med, Oak Lawn, IL USA.
   [Burns, Katharine M.] Univ Illinois, Chicago, IL USA.
   [Narasimhan, Mangala] Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Med, Div Pulm Crit Care & Sleep Med, New Hyde Pk, NY USA.
   [Goffi, Alberto] Unity Hlth Toronto, Li Ka Shing Knowledge Inst, Dept Crit Care Med, St Michaels Hosp, Toronto, ON, Canada.
   [Goffi, Alberto] Univ Toronto, Dept Med, Toronto, ON, Canada.
   [Goffi, Alberto] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada.
   [Mohabir, Paul] Stanford Univ, Dept Med, Sch Med, Div Pulm Allergy & Crit Care Med, Stanford, CA 94305 USA.
   [Horowitz, James M.; Yuriditsky, Eugene] NYU, Dept Med, Langone Med Ctr, Leon H Charney Div Cardiol, 550 1St Ave, New York, NY 10016 USA.
   [Nagdev, Arun] Highland Gen Hosp, Dept Emergency Med, Div Emergency Ultrasound, Oakland, CA USA.
   [Chin, Eric J.] Brooke Army Med Ctr, Dept Emergency Med, Ft Sam Houston, TX 78234 USA.
   [Gottlieb, Michael] Rush Univ, Med Ctr, Dept Emergency Med, Chicago, IL USA.
   [Koenig, Seth] Albert Einstein Coll Med, Dept Med, Div Pulm, Bronx, NY USA.
   [Arntfield, Robert] Western Univ, Crit Care Trauma Ctr, Schulich Sch Med & Dent, Victoria Hosp,Dept Med,Div Crit Care Med, London, ON, Canada.
RP Teran, F (corresponding author), Div Emergency Ultrasound, Dept Emergency Med, Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.; Teran, F (corresponding author), Ctr Resuscitat Sci, Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.
EM felipeteran@gmail.com
RI Goffi, Alberto/AAE-2817-2020
OI Goffi, Alberto/0000-0002-9658-3903; Teran, Felipe/0000-0003-1137-0800;
   Yuriditsky, Eugene/0000-0003-2263-9297; Gottlieb,
   Michael/0000-0003-3276-8375
CR Alhazzani W, 2020, CRIT CARE MED, V48, pE440, DOI [10.1097/CCM.0000000000004363, 10.1007/s00134-020-06022-5]
   Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326
   Arntfield R, 2020, J INTENSIVE CARE MED
   Arntfield R, 2015, CRIT ULTRASOUND J, V7, DOI 10.1186/s13089-015-0027-3
   Banfi C, 2016, J THORAC DIS, V8, P3762, DOI 10.21037/jtd.2016.12.88
   Catena E, 2019, RESUSCITATION, V138, P8, DOI 10.1016/j.resuscitation.2019.02.027
   Cavalcanti AB, 2017, JAMA-J AM MED ASSOC, V318, P1335, DOI 10.1001/jama.2017.14171
   Cavayas YA, 2016, CAN J ANESTH, V63, P1266, DOI 10.1007/s12630-016-0702-2
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Cianchi G, 2019, ASAIO J, V65, P414, DOI 10.1097/MAT.0000000000000826
   Couper K., 2020, COVID 19 INFECT RISK
   Cronin B, 2017, J CARDIOTHOR VASC AN, V31, P178, DOI 10.1053/j.jvca.2016.07.012
   Danzi GB, 2020, EUR HEART J, V41, P1858, DOI 10.1093/eurheartj/ehaa254
   Dessap AM, 2011, INTENS CARE MED, V37, P430, DOI 10.1007/s00134-010-2114-z
   Doufle G., 2015, CRITICAL CARE, V19, P1
   Fair J, 2016, AM J EMERG MED, V34, P1637, DOI 10.1016/j.ajem.2016.06.038
   Fair J, 2019, ANN EMERG MED, V73, P610, DOI 10.1016/j.annemergmed.2019.01.018
   Gralnek IM, 2020, ENDOSCOPY, V52, P483, DOI 10.1055/a-1155-6229
   Grasselli G, JAMA
   Griffee MJ, 2020, J CARDIOTHOR VASC AN, V34, P698, DOI 10.1053/j.jvca.2019.10.024
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guarracino F, 2011, INTENS CARE MED, V37, P380, DOI 10.1007/s00134-010-2119-7
   Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103
   Hendren NS, CIRCULATION
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Johnston ER, 2019, GASTROINTEST ENDOSC, V89, P818, DOI 10.1016/j.gie.2018.10.034
   Kirkpatrick JN, 2020, J AM COLL CARDIOL, V75, P3078, DOI [10.1016/j.echo.2020.04.001, 10.1016/j.jacc.2020.04.002]
   Kleinman ME, 2018, CIRCULATION, V137, pE7, DOI 10.1161/CIR.0000000000000539
   Klopman MA, 2011, ANESTH ANALG, V113, P40, DOI 10.1213/ANE.0b013e3182140b9a
   Lerner RP, 2020, AM J EMERG MED, V38, DOI 10.1016/j.ajem.2019.12.027
   Long B, AM J EMERG MED
   Lui RN, 2020, J GASTROEN HEPATOL, V35, P749, DOI 10.1111/jgh.15053
   Mayo PH, 2015, CHEST, V148, P1323, DOI 10.1378/chest.15-0260
   Miller Scott D, 2020, Proc (Bayl Univ Med Cent), V33, P85, DOI 10.1080/08998280.2019.1673920
   Narasimhan M, 2014, CHEST, V145, P135, DOI 10.1378/chest.12-2442
   Nicoara A, 2020, J AM SOC ECHOCARDIOG
   Nishioka T, 1996, AM J CARDIOL, V77, P105, DOI 10.1016/S0002-9149(97)89148-5
   Nolan JP, 2015, RESUSCITATION, V89, pA1, DOI 10.1016/j.resuscitation.2015.01.027
   Platts DG, 2012, J AM SOC ECHOCARDIOG, V25, P131, DOI 10.1016/j.echo.2011.11.009
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Soetikno R, GASTROINTEST ENDOSC
   Spencer KT, 2013, J AM SOC ECHOCARDIOG, V26, P567, DOI 10.1016/j.echo.2013.04.001
   Teran F, 2019, RESUSCITATION, V137, P140, DOI 10.1016/j.resuscitation.2019.02.013
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Vieillard-Baron A, 2013, INTENS CARE MED, V39, P1836, DOI 10.1007/s00134-013-3045-2
   VIGNON P, 1994, CHEST, V106, P1829, DOI 10.1378/chest.106.6.1829
   Vignon P, 2017, INTENS CARE MED, V43, P1048, DOI 10.1007/s00134-017-4716-1
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Weber DJ., GUIDELINE DISINFECTI
   Xie Yuanliang, 2020, Radiol Cardiothorac Imaging, V2, pe200067, DOI 10.1148/ryct.2020200067
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
NR 51
TC 12
Z9 12
U1 2
U2 6
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0894-7317
J9 J AM SOC ECHOCARDIOG
JI J. Am. Soc. Echocardiogr.
PD AUG
PY 2020
VL 33
IS 8
BP 1040
EP 1047
DI 10.1016/j.echo.2020.05.022
PG 8
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA MW0CR
UT WOS:000556715600013
PM 32600742
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Si, MY
   Su, XY
   Jiang, Y
   Wang, WJ
   Gu, XF
   Ma, L
   Li, J
   Zhang, SK
   Ren, ZF
   Liu, YL
   Qiao, YL
AF Si, Ming-Yu
   Su, Xiao-You
   Jiang, Yu
   Wang, Wen-Jun
   Gu, Xiao-Fen
   Ma, Li
   Li, Jing
   Zhang, Shao-Kai
   Ren, Ze-Fang
   Liu, Yuan-Li
   Qiao, You-Lin
TI Prevalence and Predictors of PTSD During the Initial Stage of COVID-19
   Epidemic among Female College Students in China
SO INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING
LA English
DT Article
DE COVID-19; female college students; China; posttraumatic stress disorder;
   PTSD
ID FAMILY-MEMBERS; MENTAL-HEALTH; MULTIDIMENSIONAL SCALE;
   GENDER-DIFFERENCES; IMPACT; SYMPTOMS; ADOLESCENTS; DEPRESSION;
   SURVIVORS; ANXIETY
AB Background College students are vulnerable and may experience high stress due to COVID-19, especially girls. This study aims to identify posttraumatic stress disorder (PTSD) and related factors among the target population during the initial phases of the COVID-19 pandemic. Methods In the initial phase of COVID-19 epidemic (February 23 to March 5, 2020), 2205 female college students from six provinces in mainland China were enrolled in this study and completed the online survey about the cognitive status of COVID-19, including the Impact of Event Scale-6, the Multidimensional Perceived Social Support Scale and a self-developed 10-item Perceived threat scale. Univariate and multivariate logistic regression were performed using SPSS software to explore the determinants of PTSD symptoms. Results PTSD symptoms were prevalent in female college students, and 34.20% met the cut-off for PTSD. Self-reported fair or poor health (AOR = 1.78, 95% CI: 1.22-2.59), high concern about COVID-19 (AOR = 1.66, 95% CI: 1.35-2.03), beliefs that "COVID-19 can cause a global outbreak" (AOR = 1.26, 95% CI: 1.02-1.56), the perception of "risk of infection" (AOR = 2.46, 95% CI: 2.16-2.81), beliefs that "closed management" and "COVID-19 as a public health emergency of international concern" would have an impact, and the fear of "impact on life planning" were all positively associated with PTSD (AOR = 1.37, 1.22, and 1.29, respectively); however, perceived social support from family (AOR = 0.81, 95% CI: 0.70-0.93) was negatively associated with PTSD. Among the significant variables at the bivariate level, multivariate logistic regression revealed that the greatest protector for PTSD was the high knowledge score (AOR = 0.73, 95% CI: 0.60-0.90), while had confirmed cases among relatives and friends (AOR = 7.70, 95% CI: 1.28-46.25) was the strongest predictor of PTSD. Conclusions In summary, PTSD symptoms were prevalent among female college students in China during the COVID-19 epidemic. Targeting vulnerable populations to improve their knowledge about COVID-19 and create an atmosphere of social support would be beneficial. Moreover, the joint efforts from family, school administrators, and policymakers are essential to improve the mental health of the female students during the COVID-19 epidemic.
C1 [Si, Ming-Yu; Su, Xiao-You; Jiang, Yu; Qiao, You-Lin] Chinese Acad Med Sci & Peking Union Med Coll, Sch Populat Med & Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China.
   [Wang, Wen-Jun] Jining Med Univ, Sch Nursing, Jining, Peoples R China.
   [Gu, Xiao-Fen] Xinjiang Med Univ, Affiliated Tumor Hosp, Urumqi, Peoples R China.
   [Ma, Li] Dalian Med Univ, Publ Hlth Sch, Dalian, Peoples R China.
   [Li, Jing] Sichuan Univ, West China Hosp 4, West China Sch Publ Hlth, Chengdu, Peoples R China.
   [Zhang, Shao-Kai] Zhengzhou Univ, Henan Canc Hosp, Affiliate Canc Hosp, Zhengzhou, Peoples R China.
   [Ren, Ze-Fang] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Peoples R China.
   [Liu, Yuan-Li] Chinese Acad Med Sci & Peking Union Med Coll, Sch Hlth Policy & Management, Beijing, Peoples R China.
   [Qiao, You-Lin] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Canc Epidemiol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China.
RP Su, XY; Jiang, Y (corresponding author), 9 DongDanSanTiao, Dongcheng, Peoples R China.; Qiao, YL (corresponding author), 17 South Panjiayuan, Chaoyang 100021, Peoples R China.
EM suxiaoyou@hotmail.com; jiangyu@pumc.edu.cn; qiaoy@cicams.ac.cn
OI Si, Mingyu/0000-0002-8372-9301
FU Asian Regional Special Cooperation Fund of National Health Commission of
   the People's Republic of China [BLXM01]; Innovation Fund for Medical
   Sciences - Chinese Academy of Medical Sciences [2020-I2M-2-015,
   2019-I2M-2-005]
FX Asian Regional Special Cooperation Fund of National Health Commission of
   the People's Republic of China (BLXM01) and Innovation Fund for Medical
   Sciences sponsored by Chinese Academy of Medical Sciences
   (2020-I2M-2-015, 2019-I2M-2-005).
CR Andrikopoulos S, 2020, DIABETES RES CLIN PR, V165, DOI 10.1016/j.diabres.2020.108246
   [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461
   Backstrom J, 2013, J ADV NURS, V69, P384, DOI 10.1111/j.1365-2648.2012.06017.x
   Bigalke JA, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00333-4
   Bond S, 2017, BURNS, V43, P592, DOI 10.1016/j.burns.2016.09.025
   Bryant RA, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0976-x
   Charak R, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.25547
   Chi XL, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00803
   Chou KL, 2000, PERS INDIV DIFFER, V28, P299, DOI 10.1016/S0191-8869(99)00098-7
   Dias MC, 2020, FISC STUD, V41, P371, DOI 10.1111/1475-5890.12233
   Du LP, 2017, EUR J PREV CARDIOL, V24, P962, DOI 10.1177/2047487317695628
   Extance A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1174
   Farhood L, 2018, ARCH WOMEN MENT HLTH, V21, P725, DOI 10.1007/s00737-018-0849-7
   Gallotti R, 2020, NAT HUM BEHAV, V4, DOI 10.1038/s41562-020-00994-6
   Garza K, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0830-6
   Gonzalez-Sanguino C, 2020, BRAIN BEHAV IMMUN, V87, P172, DOI 10.1016/j.bbi.2020.05.040
   Huckins JF, 2020, J MED INTERNET RES, V22, DOI 10.2196/20185
   Khan AH, 2020, J AFFECT DISORDERS, V277, P121, DOI 10.1016/j.jad.2020.07.135
   Li SH, 2017, LANCET PSYCHIAT, V4, P73, DOI 10.1016/S2215-0366(16)30358-3
   Liu CH, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113172
   Liu NQ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112921
   Liu Zhao-rui, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P594
   Luo M, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113190
   Ministry of Education of the People's Republic of China, MOE PART LEAD GROUP
   National Health Commission of the People's Republic of China, DAIL BRIEF NOV COR C
   Needham DM, 2017, AM J RESP CRIT CARE, V196, P1122, DOI 10.1164/rccm.201702-0372OC
   Oram S, 2017, LANCET PSYCHIAT, V4, P159, DOI 10.1016/S2215-0366(16)30261-9
   Palmer K, 2020, AGING CLIN EXP RES, V32, P1189, DOI 10.1007/s40520-020-01601-4
   Paparrigopoulos T, 2006, J PSYCHOSOM RES, V61, P719, DOI 10.1016/j.jpsychores.2006.05.013
   Patel MP, 2020, INDIAN J NEPHROL, V30, P188, DOI 10.4103/ijn.IJN_216_20
   Post LM, 2011, J ANXIETY DISORD, V25, P1123, DOI 10.1016/j.janxdis.2011.08.003
   Riecher-Rossler A, 2017, LANCET PSYCHIAT, V4, P8, DOI 10.1016/S2215-0366(16)30348-0
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   Sun Y, 2010, J CHILD ADOL PS NURS, V23, P173, DOI 10.1111/j.1744-6171.2010.00238.x
   Sundara DC, 2011, J BURN CARE RES, V32, P349, DOI 10.1097/BCR.0b013e318217f6cb
   Tang WJ, 2020, J AFFECT DISORDERS, V274, P1, DOI 10.1016/j.jad.2020.05.009
   Thoresen S, 2010, SOC PSYCH PSYCH EPID, V45, P405, DOI 10.1007/s00127-009-0073-x
   Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048
   Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   Wathelet M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25591
   WHO, 2020, WHO CHARACTERIZES CO
   Williams FMK, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2922
   Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001
   Yao ZJ, 2014, CLIN NEUROPHYSIOL, V125, P2232, DOI 10.1016/j.clinph.2014.03.006
   Zhan Siyan, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35 Suppl, P95
   ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17
NR 47
TC 0
Z9 0
U1 9
U2 9
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0046-9580
EI 1945-7243
J9 INQUIRY-J HEALTH CAR
JI Inquiry-J. Health Care Organ. Provis. Financ.
PD DEC 22
PY 2021
VL 58
AR 00469580211059953
DI 10.1177/00469580211059953
PG 12
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA XZ8JP
UT WOS:000737893700001
PM 34933595
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Alsyouf, A
   Masa'deh, R
   Albugami, M
   Al-Bsheish, M
   Lutfi, A
   Alsubahi, N
AF Alsyouf, Adi
   Masa'deh, Ra'ed
   Albugami, Moteb
   Al-Bsheish, Mohammad
   Lutfi, Abdalwali
   Alsubahi, Nizar
TI Risk of Fear and Anxiety in Utilising Health App Surveillance Due to
   COVID-19: Gender Differences Analysis
SO RISKS
LA English
DT Article
DE COVID-19 pandemic; TAM; mHealth; anxiety; event-related fear; Saudi
   Arabia
ID USER ACCEPTANCE; TECHNOLOGY ACCEPTANCE; INFORMATION-TECHNOLOGY; PLS-SEM;
   MODEL; BEHAVIOR; ADOPTION; MANAGEMENT; EXTENSION; ATTITUDES
AB Although technology trends and acceptance have been considered crucial topics, limited research has examined stress-specific factors such as health anxiety in the context of the COVID-19 pandemic based on people's attitudes toward a mobile health app using the Technology Acceptance Model (TAM). Accordingly, this study primarily highlights the psychological determinants stemming from the COVID-19 pandemic that affect the usage of a mobile health app. The study followed a cross-sectional design and adopted a snowball sampling technique to collect the data. The findings showed a significant association between perceived usefulness, perceived ease of use, and event-related fear and Tabaud App intention. The relationships between Tabaud App intention and COVID-19 anxiety on Tabaud App usage were also revealed. The study found a significant association between perceived ease of use and perceived usefulness. Additionally, the multi-group analysis showed that only two paths related to Tabaud App intention, perceived ease of use and perceived usefulness, differed significantly between males and females. Additionally, women experienced anxiety disorders more than men. The study contributes to the previous knowledge on the field by examining the psychological determinants resulting from the COVID-19 pandemic that influence using a mobile health app, namely, event-related fear and COVID-19 anxiety. The study results may help governments, health policymakers, and health organisations in Saudi Arabia contain the spread of the COVID-19 pandemic.
C1 [Alsyouf, Adi; Alsubahi, Nizar] King Abdulaziz Univ, Fac Business Rabigh, Coll Business COB, Dept Managing Hlth Serv & Hosp, POB 344, Jeddah 21991, Saudi Arabia.
   [Masa'deh, Ra'ed] Univ Jordan, Sch Business, Dept Management Informat Syst, Amman 11942, Jordan.
   [Albugami, Moteb] King Abdulaziz Univ, Coll Business COB Rabigh, Dept Management Informat Syst, POB 344, Jeddah 21991, Saudi Arabia.
   [Al-Bsheish, Mohammad] Batterjee Med Coll BMC, Dept Healthcare Adm, POB 6231, Jeddah 21442, Saudi Arabia.
   [Lutfi, Abdalwali] King Faisal Univ, Coll Business Adm, Dept Accounting, Al Hasa 31982, Saudi Arabia.
RP Masa'deh, R (corresponding author), Univ Jordan, Sch Business, Dept Management Informat Syst, Amman 11942, Jordan.
EM oal@kau.edu.sa; r.masadeh@ju.edu.jo; maalbugami@kau.edu.sa;
   mohammed.ghandour@bmc.edu.sa; aalkhassawneh@kfu.edu.sa;
   Nalsubahi@kau.edu.sa
RI Lutfi, Abdalwali/ABI-8321-2020; AL-Bsheish, Mohammad/AAD-6995-2021;
   Alsyouf, Adi/B-6544-2019; Masa'deh, Ra'ed/J-4574-2016
OI Lutfi, Abdalwali/0000-0002-3928-7497; AL-Bsheish,
   Mohammad/0000-0003-2698-8101; Alsyouf, Adi/0000-0002-4672-8991;
   Masa'deh, Ra'ed/0000-0002-9070-3732
CR Al-Bsheish M, 2021, INQUIRY-J HEALTH CAR, V58, DOI 10.1177/00469580211031382
   Al-Dmour H, 2020, J MED INTERNET RES, V22, DOI 10.2196/19996
   Al-Okaily M., 2020, HUMANITIES SOCIAL SC, V8, P840, DOI [10.18510/hssr.2020.8483, DOI 10.18510/HSSR.2020.8483]
   Al-Okaily M, 2020, TECHNOL SOC, V63, DOI 10.1016/j.techsoc.2020.101367
   Al-Okaily M, 2020, DATA BRIEF, V32, DOI 10.1016/j.dib.2020.106176
   Al-Syouf Adi., 2017, THESIS U UTARA MALAY
   Alam MZ, 2020, INT J INFORM MANAGE, V50, P128, DOI 10.1016/j.ijinfomgt.2019.04.016
   Alkhamees AA, 2020, COMPR PSYCHIAT, V102, DOI 10.1016/j.comppsych.2020.152192
   Alshira'h AF, 2020, ECONOMIES, V8, DOI 10.3390/economies8040088
   Alshira'h AF, 2021, EUROMED J BUS, V16, P431, DOI 10.1108/EMJB-01-2020-0004
   Alshirah M., 2021, ACCOUNTING, V7, P645, DOI [10.5267/j.ac.2020.12.013, DOI 10.5267/J.AC.2020.12.013]
   Alsyouf Adi, 2018, International Journal of Electronic Healthcare, V10, P24
   Alsyouf A., 2021, INT J MANAG, V12, P1049, DOI [10.34218/IJM.12.3.2021.096, DOI 10.34218/IJM.12.3.2021.096]
   Alsyouf A., 2020, SOLID STATE TECHNOL, V63, P2474
   [Anonymous], 2020, MOH APPS SMARTPH
   Asmundson GJG, 2020, J ANXIETY DISORD, V71, DOI 10.1016/j.janxdis.2020.102211
   Baptista G, 2016, COMPUT HUM BEHAV, V63, P480, DOI 10.1016/j.chb.2016.05.074
   Binyamin SS, 2021, HEALTH INFORM J, V27, DOI 10.1177/1460458220976737
   Boudreaux ED, 2010, ANN BEHAV MED, V40, P350, DOI 10.1007/s12160-010-9227-z
   Brown RJ, 2020, CLIN PSYCHOL-SCI PR, V27, DOI 10.1111/cpsp.12299
   Byrne B.M, 2012, STRUCTURAL EQUATION, DOI DOI 10.4324/9781315757421
   Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934
   Chen XY, 2019, BEHAV INFORM TECHNOL, V38, P120, DOI 10.1080/0144929X.2018.1515985
   Chin W.W., 2010, HDB PARTIAL LEAST SQ, P655, DOI DOI 10.1007/978-3-540-32827-8_29
   DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982
   DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008
   Dawson CH, 2017, ERGONOMICS, V60, P1621, DOI 10.1080/00140139.2017.1316018
   Deng ZH, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.9316
   Dodd RH, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18030866
   Fan F, 2011, J TRAUMA STRESS, V24, P44, DOI 10.1002/jts.20599
   Fessler DMT, 2004, ORGAN BEHAV HUM DEC, V95, P107, DOI 10.1016/j.obhdp.2004.06.006
   Finucane ML, 2000, J BEHAV DECIS MAKING, V13, P1, DOI 10.1002/(SICI)1099-0771(200001/03)13:1<1::AID-BDM333>3.0.CO;2-S
   Galasso V, 2020, P NATL ACAD SCI USA, V117, P27285, DOI 10.1073/pnas.2012520117
   Gaygisiz Ummugulsum, 2012, J Infect Public Health, V5, P9, DOI 10.1016/j.jiph.2011.09.008
   Gefen D, 2011, MIS QUART, V35, pIII
   Grogan SC, 1997, APPETITE, V28, P19, DOI 10.1006/appe.1996.0067
   Hair J.F., 2010, MULTIVARIATE DATA AN, V7th
   Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202
   Hair JF, 2014, EUR BUS REV, V26, P106, DOI 10.1108/EBR-10-2013-0128
   Hair JF, 2013, LONG RANGE PLANN, V46, P1, DOI 10.1016/j.lrp.2013.01.001
   Henseler J, 2010, HDB PARTIAL LEAST SQ, P713, DOI DOI 10.1007/978-3-540-32827-8_31
   Henseler J., 2012, CHALLENGES INTERFACE, P495, DOI [https://doi.org/10.1007/978-3-642-24466-7_50, DOI 10.1007/978-3-642-24466-7_50]
   HILL RJ, 1977, CONTEMP SOCIOL, V6, P244, DOI 10.2307/2065853
   Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1
   Hsu HH, 2017, CIN-COMPUT INFORM NU, V35, P315, DOI 10.1097/CIN.0000000000000313
   Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954
   Hwang Y, 2016, INFORM DEV, V32, P1266, DOI 10.1177/0266666915593621
   Jalloh MF, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000471
   JOHNSON EJ, 1983, J PERS SOC PSYCHOL, V45, P20, DOI 10.1037/0022-3514.45.1.20
   Jungmann SM, 2020, J ANXIETY DISORD, V73, DOI 10.1016/j.janxdis.2020.102239
   Keil M, 2000, MIS QUART, V24, P299, DOI 10.2307/3250940
   Kendler KS, 2001, AM J PSYCHIAT, V158, P587, DOI 10.1176/appi.ajp.158.4.587
   Khassawneh AbdAlwaliLutfi., 2014, INT J MARKETING TECH, V4, P240
   Kirchmeyer C, 2002, J APPL PSYCHOL, V87, P929, DOI 10.1037//0021-9010.87.5.929
   Kissi J, 2020, HEALTH INFORM J, V26, P1866, DOI 10.1177/1460458219892162
   Konrad AM, 2000, PSYCHOL BULL, V126, P593, DOI 10.1037/0033-2909.126.4.593
   KREJCIE RV, 1970, EDUC PSYCHOL MEAS, V30, P607, DOI 10.1177/001316447003000308
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Lau JTF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-139
   Lei L, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924609
   Lerner JS, 2003, PSYCHOL SCI, V14, P144, DOI 10.1111/1467-9280.01433
   Lerner JS, 2000, COGNITION EMOTION, V14, P473, DOI 10.1080/026999300402763
   Li JD, 2019, APPL ERGON, V75, P162, DOI 10.1016/j.apergo.2018.10.006
   Liu NQ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112921
   Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267
   Lutfi A., 2020, J OPEN INNOV TECHNOL, V6, P91, DOI [10.3390/joitmc6030091, DOI 10.3390/JOITMC6030091]
   Lutfi A.A., 2017, J ADV RES BUS MANAG, V6, P24
   Lutfi A.A., 2016, INT J EC FINANC ISSU, V6, P240
   Lutfi A, 2020, GLOB BUS REV, DOI 10.1177/0972150920965079
   Mathieson K., 2001, Data Base for Advances in Information Systems, V32, P86
   Mayes Jonathan., 2016, J GLOBAL HLTH, V6, P36
   McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006
   McLean CP, 2009, CLIN PSYCHOL REV, V29, P496, DOI 10.1016/j.cpr.2009.05.003
   Minton H.L., 1980, DIFFERENTIAL PSYCHOL
   Moreno C, 2020, LANCET PSYCHIAT, V7, P813, DOI 10.1016/S2215-0366(20)30307-2
   Ni MY, 2020, JMIR MENT HEALTH, V7, DOI 10.2196/19009
   Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213
   Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066
   Rathnayake S, 2020, COLLEGIAN, V27, P288, DOI 10.1016/j.colegn.2019.09.001
   Rosenbaum L, 2020, NEW ENGL J MED, V382, P1873, DOI 10.1056/NEJMp2005492
   Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083
   Rzymski P, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9040382
   Sadowski A, 2021, J BIG DATA-GER, V8, DOI 10.1186/s40537-021-00474-2
   Salloum Said A., 2018, International Journal of Electronic Business, V14, P371
   Sarstedt M, 2014, LONG RANGE PLANN, V47, P132, DOI 10.1016/j.lrp.2014.02.008
   Saudi Data and Artificial Intelligence Authority, 2020, TAB 2020
   Sezgin E, 2018, INFORM DEV, V34, P182, DOI 10.1177/0266666916684180
   Shi QJ, 2020, SOC SCI MED, V255, DOI 10.1016/j.socscimed.2020.113036
   Shi Yudong, 2020, Brain Behav Immun Health, V4, P100064, DOI 10.1016/j.bbih.2020.100064
   Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x
   Smith J., 2019, Gender and Development, V27, P355, DOI 10.1080/13552074.2019.1615288
   Sun SF, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-021-00663-x
   Tao D, 2020, COMPUT HUM BEHAV, V104, DOI 10.1016/j.chb.2019.09.023
   Tao D, 2020, HEALTH INFORM J, V26, P1347, DOI 10.1177/1460458219879337
   Tao D, 2018, CIN-COMPUT INFORM NU, V36, P530, DOI 10.1097/CIN.0000000000000467
   Tausczik Y, 2012, HEALTH COMMUN, V27, P179, DOI 10.1080/10410236.2011.571759
   TAYLOR S, 1995, INFORM SYST RES, V6, P144, DOI 10.1287/isre.6.2.144
   Teng ZW, 2020, J AFFECT DISORDERS, V275, P247, DOI 10.1016/j.jad.2020.06.032
   Ting H., 2020, ASIAN J BUSINESS RES, V10, P1, DOI DOI 10.14707/AJBR.200087
   Tsai TH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227270
   Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926
   Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540
   Venkatesh V, 2000, MIS QUART, V24, P115, DOI 10.2307/3250981
   Venkatesh V, 2000, ORGAN BEHAV HUM DEC, V83, P33, DOI 10.1006/obhd.2000.2896
   Venkatesh V, 2012, MIS QUART, V36, P157
   Venkatesh V, 2011, INFORM SYST J, V21, P527, DOI [10.1111/J.1365-2575.2011.00373.x, 10.1111/j.1365-2575.2011.00373.x]
   Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   Wheaton MG, 2012, COGNITIVE THER RES, V36, P210, DOI 10.1007/s10608-011-9353-3
   Williams PG, 2004, COGNITIVE THER RES, V28, P629, DOI 10.1023/B:COTR.0000045569.25096.44
   WRIGHT WF, 1992, ORGAN BEHAV HUM DEC, V52, P276, DOI 10.1016/0749-5978(92)90039-A
   Yang C, 2018, RISK ANAL, V38, P2535, DOI 10.1111/risa.12973
   Yuen A. H. K., 2002, Journal of Technology and Teacher Education, V10, P365
   Zhang XF, 2017, INFORM HEALTH SOC CA, V42, P194, DOI 10.1080/17538157.2016.1200053
   Zhang YF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072381
   Zhu ZX, 2018, INFORM HEALTH SOC CA, V43, P22, DOI 10.1080/17538157.2016.1255631
NR 116
TC 4
Z9 4
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9091
J9 RISKS
JI Risks
PD OCT
PY 2021
VL 9
IS 10
AR 179
DI 10.3390/risks9100179
PG 19
WC Business, Finance
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA WM6PY
UT WOS:000711206500001
OA gold
DA 2022-04-20
ER

PT J
AU Sanchez-Betancourt, A
   Sibaja-Alvarez, P
   Gonzalez-Cole, M
   Mendez-Barboza, I
   Ledezma-Cruz, C
   Vargas-Paez, P
AF Sanchez-Betancourt, Alfredo
   Sibaja-Alvarez, Pablo
   Gonzalez-Cole, Milagros
   Mendez-Barboza, Ivannia
   Ledezma-Cruz, Crishtna
   Vargas-Paez, Priscilla
TI First surgical experience with a COVID-19 positive patient in Costa
   Rica: case report, staff safety protocol and brief review of literature
SO SURGICAL CASE REPORTS
LA English
DT Review
DE Case report; COVID-19; Global health
AB Background The safe management of patients with COVID-19 has been a challenge during the current pandemic, leading to healthcare workers being disproportionately affected by the virus. In Costa Rica, 20% of all infections and 27% of all ICU cases during the initial weeks of the outbreak were healthcare workers. The existing recommendations and protocols on how to care for an infected patient that requires acute surgical management have been applied successfully in various scenarios. We look to describe the first case of a COVID-19 patient that required surgical management in Costa Rica and present a summary of the protection measures utilized in a tertiary care hospital. Materials and methods A review of literature utilizing Embase, Medline Complete and Google Scholar was performed. A surgical case report using the SCARE statement guidelines was drafted and a brief summary of the 54 items contained in the hospital's COVID-19 surgical protocol is described. Case presentation We present the case of a 29 year old obese male who had acute appendicitis with perforation that contracted SARS-CoV-2 and became symptomatic at home on pod#3, who later required multiple surgeries to address an infected abdominal hematoma both while having an active COVID-19 infection and afterwards. Conclusions Safety measures for both staff and patients are of the utmost importance during the current coronavirus pandemic. Limitations in the availability of personal protection equipment as well a lack of knowledge and experience with handling surgical patients with this condition have led to various safety and attention protocols being drafted. The successful management of this patient is the first experience in Costa Rica on how to properly address staff safety during a surgical procedure. None of the workers involved in care of this patient were diagnosed with SARS-CoV-2.
C1 [Sanchez-Betancourt, Alfredo; Gonzalez-Cole, Milagros] Ctr & Invest Clin Oriente, San Jose, Costa Rica.
   [Sibaja-Alvarez, Pablo; Mendez-Barboza, Ivannia; Ledezma-Cruz, Crishtna; Vargas-Paez, Priscilla] Hosp Mexico, Caja Costarricense Seguro Social, San Jose, Costa Rica.
RP Sanchez-Betancourt, A (corresponding author), Ctr & Invest Clin Oriente, San Jose, Costa Rica.
EM asanchezbet@gmail.com
OI Sanchez Betancourt, Alfredo/0000-0001-7222-1310
CR Aminian A, 2020, ANN SURG, V23, P121
   [Anonymous], 2020, MEDIDAS HIGIENE COVI
   [Anonymous], 2020, NIC IN COULD SEE COV
   Bhangu A, 2020, BRIT J SURG, V90, pe32
   Chaves LF, 2020, MATH MODEL NAT PHENO, V15, DOI 10.1051/mmnp/2020019
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chirico F, 2020, INFECT CONT HOSP EP, V41, P1117, DOI 10.1017/ice.2020.148
   Coccolini F, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00307-2
   Cordero, 2020, CAJA DEBERA REPROGRA
   Ehrlich H, 2020, AM J EMERG MED, V10, P1
   Godderis L, 2020, OCCUP MED CHIC ILL
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]
   Marquez-GutierrezdeVelasco J, 2020, REV MEXANESTESIOL, V43, P121
   Morales HF, 2020, REV MED COSTA RICA, P85
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Roth S, 2020, ADB BRIEFS, DOI [10.22617/brf200128- 2, DOI 10.22617/BRF200128-2, 10.22617/BRF200128-2]
   Ti LK, 2020, CAN J ANESTH, V67, P756, DOI 10.1007/s12630-020-01617-4
   Wax RS, 2020, CAN J ANESTH, V67, P568, DOI 10.1007/s12630-020-01591-x
   Wong J, 2020, CAN J ANESTH, V67, P732, DOI 10.1007/s12630-020-01620-9
   World Health Organization, WHO DIR GEN OP REM M
   Zhou H, 2020, CURR BIOL, V30, P2196, DOI 10.1016/j.cub.2020.05.023
   ZHOU P, 2020, NATURE          0203, pNIL1, DOI DOI 10.1038/s41586-020-2012-7
NR 22
TC 0
Z9 0
U1 1
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 2198-7793
J9 SURG CASE REP
JI SURG. CASE REP.
PD NOV 6
PY 2020
VL 6
IS 1
AR 281
DI 10.1186/s40792-020-01054-x
PG 6
WC Surgery
WE Emerging Sources Citation Index (ESCI)
SC Surgery
GA OO0YU
UT WOS:000587115100001
PM 33159457
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU de Watteville, A
   Genton, L
   Barcelos, GK
   Pugin, J
   Pichard, C
   Heidegger, CP
AF de Watteville, Aude
   Genton, Laurence
   Barcelos, Gleicy Keli
   Pugin, Jerome
   Pichard, Claude
   Heidegger, Claudia Paula
TI Easy-to-prescribe nutrition support in the intensive care in the era of
   COVID-19
SO CLINICAL NUTRITION ESPEN
LA English
DT Article
DE COVID-19; Nutrition therapy; Critical illness; Pandemic; ICU;
   Questionnaire
ID CRITICALLY-ILL PATIENTS; MORTALITY
AB Background & aims: COVID-19 pandemic had resulted in a massive increase in the number of patients admitted to intensive care units (ICUs). This created significant organizational challenges including numerous non-specialist ICU caregivers who came to work in the ICU. In this context, pragmatic protocols were essential to simplify nutritional care. We aimed at providing a simple and easy-to-prescribe nutritional protocol and evaluated its usefulness with questionnaires sent to physicians involved in the care of ICU COVID-19 patients.
   Methods: A simplified nutrition protocol was distributed to all physicians (n = 122) of the ICU medical team during COVID-19 pandemic. Clinical dieticians estimated energy targets for acute and post-acute phases at patient's admission and suggested adaptations of nutrition therapy. More complex situations were discussed with clinical nutrition doctors and, if required, a clinical evaluation was performed. To further facilitate the procedure, a chart with prescription aids was also distributed to the whole medical ICU team. At the end of the current pandemic wave, a 13-item questionnaire was emailed to the ICU medical team to obtain their opinion on the suggested nutritional therapy.
   Results: Answers were received from 81/122 medical doctors (MDs) (66% response rate), from intensive care physicians (41%), anaesthesiologists (53%) and MDs from other specialties (6%). Thirty-two percent of MDs felt that their knowledge of nutrition management was insufficient and 45% of the physicians surveyed did not face nutrition management in their daily practice prior to the pandemic. The initially proposed nutritional protocol, the chart with prescription aids and the suggested nutritional proposals were considered as useful to very useful by the majority of physicians surveyed (89.9, 90.7 and 92.1% respectively). The protocol was followed by 92% of MDs, and almost all participants (95%) were convinced that adaptations of nutritional therapy had beneficial effects on patients' outcomes.
   Conclusions: Nutritional therapy in critically ill COVID-19 patients is a challenge and the implementation of this specific pandemic simplified nutritional protocol was assessed as useful by a great majority of physicians. Pragmatic and simplified protocols are useful for ensuring the quality of nutritional therapy and could be used in future studies to assess its actual impact on the clinical outcomes of COVID-19 patients. (c) 2020 Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.
C1 [de Watteville, Aude; Genton, Laurence; Pichard, Claude] Geneva Univ Hosp, Dept Med, Nutr Unit, Geneva, Switzerland.
   [de Watteville, Aude; Pugin, Jerome; Heidegger, Claudia Paula] Geneva Univ Hosp, Dept Acute Med, Div Intens Care, Geneva, Switzerland.
   [Barcelos, Gleicy Keli] Geneva Univ Hosp, Dept Acute Med, Div Anesthesiol, Geneva, Switzerland.
RP Heidegger, CP (corresponding author), Geneva Univ Hosp Hug, Div Intens Care, Dept Acute Med DMA, Geneva, Switzerland.
EM claudia.heidegger@hcuge.ch
OI de Watteville, Aude/0000-0003-3078-5227
CR Ali NA, 2008, AM J RESP CRIT CARE, V178, P261, DOI 10.1164/rccm.200712-1829OC
   Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326
   Arkin N, 2020, CLIN NUTR, V39, P2327, DOI 10.1016/j.clnu.2020.05.007
   Barazzoni R, 2020, CLIN NUTR, V39, P1631, DOI 10.1016/j.clnu.2020.03.022
   Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500
   Bordeje Laguna L, 2020, ALGORITMO TRATAMIENT
   Caccialanza R, 2020, NUTRITION, V74, DOI 10.1016/j.nut.2020.110835
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Cintoni M, 2020, EUR J CLIN NUTR, V74, P846, DOI 10.1038/s41430-020-0625-4
   Combes A, 2003, CRIT CARE MED, V31, P1373, DOI 10.1097/01.CCM.0000065188.87029.C3
   Graf S, 2017, CLIN NUTR, V36, P224, DOI 10.1016/j.clnu.2015.11.007
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Hartl WH, 2014, NUTRITION, V30, P261, DOI 10.1016/j.nut.2013.07.019
   Heidegger CP, 2013, LANCET, V381, P385, DOI 10.1016/S0140-6736(12)61351-8
   Laviano A, 2020, NUTRITION, V74, DOI 10.1016/j.nut.2020.110834
   Li L, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00661-z
   Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481
   Sharma K, 2019, NUTR CLIN PRACT, V34, P12, DOI 10.1002/ncp.10232
   Singer P, 2019, CLIN NUTR, V38, P48, DOI 10.1016/j.clnu.2018.08.037
   Wang ZW, 2020, BIOSCI TRENDS, V14, P64, DOI 10.5582/bst.2020.01030
   Wieske L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0937-2
NR 21
TC 3
Z9 3
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2405-4577
J9 CLIN NUTR ESPEN
JI Clin. Nutr. ESPEN
PD OCT
PY 2020
VL 39
BP 74
EP 78
DI 10.1016/j.clnesp.2020.07.015
PG 5
WC Nutrition & Dietetics
WE Emerging Sources Citation Index (ESCI)
SC Nutrition & Dietetics
GA NJ0PY
UT WOS:000565747500009
PM 32859332
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Al-Khalifa, KS
   AlSheikh, R
   Alsahafi, YA
   Alkhalifa, A
   Sadaf, S
   Al-Moumen, SA
   Muazen, YY
   Shetty, AC
AF Al-Khalifa, Khalifa S.
   AlSheikh, Rasha
   Alsahafi, Yaser A.
   Alkhalifa, Atheer
   Sadaf, Shazia
   Al-Moumen, Saud A.
   Muazen, Yasmeen Y.
   Shetty, Ashwin C.
TI Dental Care in the Arab Countries During the COVID-19 Pandemic: An
   Infodemiological Study
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19; Twitter; pandemic; oral health; dentistry; social media;
   tweet; Arab
ID ORAL-HEALTH LITERACY; COMMUNICATION; KNOWLEDGE; PAIN
AB Background: Twitter is a powerful platform which could be used to reflect on the demand and supply of dental services during a pandemic. The aim of this study was to examine the nature and dissemination of COVID-19 information related to dentistry on Twitter platform Arabic database during the COVID-19 pandemic.
   Methodology: One hundred and fifty independent searches with a combination of keywords for both COVID-19 and dentistry from a preselected Arabic keyword were carried out for the period from the 2nd of March (first confirmed cases of COVID-19) to the 6th of July 2020. Tweets were filtered to remove duplicate and unrelated tweets. The suitable tweets were 1,150. After calibration, two examiners coded the tweets following two main themes: COVID-19 and oral health-related information. Tweets were then compared with COVID-19 daily events in the Arab countries as reported by the World Health Organization (WHO). Descriptive analysis was performed to present the overview of the findings using Microsoft Excel.
   Results: The most retweeted information was the help with urgent consultation or emergency dental treatment during COVID-19 tweeted by a dentist. There were 673 retweets and 1,116 likes of this tweet. The most common tweets related to oral health were needs of dental treatment (n=462, 39.5%) of which, toothaches or wisdom tooth problems constituted 48% of the related tweets.
   Conclusion: Based on the results of this study, it is obvious that social media users reacted to the COVID-19 threat to dental practices. Twitter as one of the social media platforms served as a connection between dental health professionals and patients.
C1 [Al-Khalifa, Khalifa S.] Imam Abdulrahman Bin Faisal Univ, Coll Dent, Dept Prevent Dent Sci, Dammam, Saudi Arabia.
   [AlSheikh, Rasha] Imam Abdulrahman Bin Faisal Univ, Coll Dent, Dept Restorat Dent Sci, Dammam, Saudi Arabia.
   [Alsahafi, Yaser A.] Taibah Univ, Coll Dent, Dept Prevent Dent Sci, Al Madinah Al Munawwarah, Saudi Arabia.
   [Alkhalifa, Atheer] King Abdulaziz City Sci & Technol KACST, Natl Ctr Artificial Intelligence & Big Data, Riyadh, Saudi Arabia.
   [Sadaf, Shazia] Imam Abdulrahman Bin Faisal Univ, Coll Dent, Dept Dent Educ, Dammam, Saudi Arabia.
   [Al-Moumen, Saud A.] Minist Hlth, Dent Dept, Dammam, Saudi Arabia.
   [Muazen, Yasmeen Y.] Imam Abdulrahman Bin Faisal Univ, Coll Dent, Dent Internship Program, Dammam, Saudi Arabia.
   [Shetty, Ashwin C.] Imam Abdulrahman Bin Faisal Univ, Coll Dent, Vice Deanship Postgrad Studies & Sci Res, Dammam, Saudi Arabia.
RP Al-Khalifa, KS (corresponding author), Imam Abdulrahman Bin Faisal Univ, Coll Dent, Dept Prevent Dent Sci, Dammam, Saudi Arabia.
EM kalkhalifa@iau.edu.sa
RI alsheikh, rasha/AFP-7526-2022; Shetty, Ashwin/AAY-2963-2021
OI alsheikh, rasha/0000-0003-2910-5511; Al-Khalifa,
   Khalifa/0000-0001-8160-9288
CR Abd-Alrazaq A, 2020, J MED INTERNET RES, V22, DOI 10.2196/19016
   Ahlwardt K, 2014, J AM DENT ASSOC, V145, P737, DOI 10.14219/jada.2014.30
   Al-Khalifa KS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237630
   Alqurashi S, 2020, ARXIV2004043152
   Ather A, 2020, J ENDODONT, V46, P584, DOI 10.1016/j.joen.2020.03.008
   Baskaradoss JK, 2016, J AM DENT ASSOC, V147, P867, DOI 10.1016/j.adaj.2016.05.011
   Clement R, 2020, HARDWAREX, V8, DOI 10.1016/j.ohx.2020.e00122
   Dar-Odeh N, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093151
   Donelle Lorie, 2012, Online J Issues Nurs, V17, P4
   El Tantawi M, 2018, J MED INTERNET RES, V20, DOI 10.2196/10781
   European Centre for Disease Prevention and Control, COVID 19 SIT UPD WOR
   Haouari F, 2020, ARXIV200405861
   Hawkins CM, 2014, J AM COLL RADIOL, V11, P387, DOI 10.1016/j.jacr.2013.07.015
   Heaivilin N, 2011, J DENT RES, V90, P1047, DOI 10.1177/0022034511415273
   Izzetti R, 2020, J DENT RES, V99, P1030, DOI 10.1177/0022034520920580
   Karasneh R, 2021, RES SOC ADMIN PHARM, V17, P1897, DOI 10.1016/j.sapharm.2020.04.027
   Kouzy R, 2020, CUREUS, V12, DOI 10.7759/cureus.7255
   Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0
   Mccallum ML, 2013, BIODIVERS CONSERV, V22, P1355, DOI 10.1007/s10531-013-0476-6
   Mishra V, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.18033
   Mollema L, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3863
   Paakkari L, 2020, LANCET PUBLIC HEALTH, V5, pE249, DOI 10.1016/S2468-2667(20)30086-4
   Park HW, 2020, J MED INTERNET RES, V22, DOI 10.2196/18897
   Programme UNDP, MON COVID 19 AR STAT
   Sabbahi DA, 2009, COMMUNITY DENT ORAL, V37, P451, DOI 10.1111/j.1600-0528.2009.00490.x
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Singh L, 2020, ARXIV200313907V1
   Tao ZY, 2020, J MED INTERNET RES, V22, DOI 10.2196/19981
   Tasnim S., 2020, J PREVENTIVE MED PUB, V53, P171, DOI [10.31235/osf.io/uf3zn, DOI 10.3961/JPMPH.20.094, 10.3961/jpmph.20.094]
   Watts GD, 2018, MED PRIN PRACT, V27, P227, DOI 10.1159/000487904
   Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020
   Winters M, 2018, EMERG INFECT DIS, V24, P336, DOI 10.3201/eid2402.171028
NR 32
TC 1
Z9 1
U1 1
U2 2
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 2153
EP 2162
DI 10.2147/RMHP.S310023
PG 10
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA SJ7JD
UT WOS:000655705900001
PM 34079402
OA Green Published
DA 2022-04-20
ER

PT J
AU Vigano, C
   Mulinacci, G
   Palermo, A
   Barisani, D
   Pirola, L
   Fichera, M
   Invernizzi, P
   Massironi, S
AF Vigano, Chiara
   Mulinacci, Giacomo
   Palermo, Andrea
   Barisani, Donatella
   Pirola, Lorena
   Fichera, Maria
   Invernizzi, Pietro
   Massironi, Sara
TI Impact of COVID-19 on inflammatory bowel disease practice and
   perspectives for the future
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Review
DE Inflammatory bowel disease; Ulcerative colitis; Crohn disease; COVID-19;
   SARS-CoV-2; Autoimmunity
ID MAINTENANCE THERAPY; FECAL CALPROTECTIN; IMMUNE-RESPONSE; IBD;
   EXPRESSION; CORONAVIRUS; INVOLVEMENT; DEPRESSION; INFECTION; ANXIETY
AB Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); since its first description in December 2019, it has rapidly spread to a global pandemic. Specific concerns have been raised concerning patients with inflammatory bowel diseases (IBD), which are chronic autoimmune inflammatory disorders of the gut that frequently require immunosuppressive and biological therapies to control their activity. Accumulating evidence has so far demonstrated that patients with IBD are not at increased risk of contracting severe acute respiratory syndrome coronavirus 2 infection. As for the general population, the identified risk factors for severe COVID-19 course among IBD patients have been established to be advanced age and the presence of comorbidities. Treatment with high-dose corticosteroids has also been associated with an increased risk of death in IBD patients with COVID-19. Information on COVID-19 is constantly evolving, with data growing at a rapid pace. This will guarantee better knowledge and stronger evidence to help physicians in the choice of the best therapeutic approach for each patient, concurrently controlling for the risk of IBD disease under treatment and the risk of COVID-19 adverse outcomes and balancing the two. Moreover, the impact of the enormous number of severe respiratory patients on healthcare systems and facilities has led to an unprecedented redeployment of healthcare resources, significantly impacting the care of patients with chronic diseases. In this newly changed environment, the primary aim is to avoid harm whilst still providing adequate management. Telemedicine has been applied and is strongly encouraged for patients without the necessity of infusion therapy and whose conditions are stable. The severe acute respiratory syndrome coronavirus 2 pandemic has already revolutionized the management of patients with chronic immune-mediated diseases such as IBD. Direct and indirect effects of the COVID-19 pandemic will be present for some time. This is the reason why continuous research, rapid solutions and constantly updated guidelines are of utmost importance. The aim of the present review is, therefore, to point out what has been learned so far as well as to pinpoint the unanswered questions and perspectives for the future.
C1 [Vigano, Chiara; Mulinacci, Giacomo; Palermo, Andrea; Pirola, Lorena; Fichera, Maria; Invernizzi, Pietro; Massironi, Sara] Univ Milano Bicocca, Div Gastroenterol, Via GB Pergolesi 33, I-20900 Monza, Italy.
   [Vigano, Chiara; Mulinacci, Giacomo; Palermo, Andrea; Pirola, Lorena; Fichera, Maria; Invernizzi, Pietro; Massironi, Sara] Univ Milano Bicocca, Ctr Autoimmune Liver Dis, Dept Med & Surg, Via GB Pergolesi 33, I-20900 Monza, Italy.
   [Vigano, Chiara; Mulinacci, Giacomo; Palermo, Andrea; Pirola, Lorena; Fichera, Maria; Invernizzi, Pietro; Massironi, Sara] San Gerardo Hosp, European Ref Network Hepatol Dis, I-20900 Monza, Italy.
   [Barisani, Donatella] Univ Milano Bicocca, Sch Med & Surg, I-20900 Monza, Italy.
RP Vigano, C (corresponding author), Univ Milano Bicocca, Div Gastroenterol, Via GB Pergolesi 33, I-20900 Monza, Italy.; Vigano, C (corresponding author), Univ Milano Bicocca, Ctr Autoimmune Liver Dis, Dept Med & Surg, Via GB Pergolesi 33, I-20900 Monza, Italy.
EM c.vigano@asst-monza.it
RI Invernizzi, Pietro/AAB-8367-2022
OI Invernizzi, Pietro/0000-0003-3262-1998
CR Agrawal M, 2021, GUT, V70, P1037, DOI 10.1136/gutjnl-2020-321798
   Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   Allez M, 2020, J CROHNS COLITIS, V14, pS774, DOI 10.1093/ecco-jcc/jjaa150
   Allocca M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113533
   Allocca M, 2020, CLIN GASTROENTEROL H, V18, P2134, DOI 10.1016/j.cgh.2020.04.071
   Antonelli E, 2019, J CLIN GASTROENTEROL, V53, P635, DOI 10.1097/MCG.0000000000001250
   Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332
   Attauabi M, 2021, J CROHNS COLITIS, V15, P540, DOI 10.1093/ecco-jcc/jjaa205
   Berte R, 2021, J CROHNS COLITIS, V15, P864, DOI 10.1093/ecco-jcc/jjaa237
   Bezzio C, 2020, GUT, V69, P1213, DOI 10.1136/gutjnl-2020-321411
   Bozkurt HS, 2020, INT J IMMUNOPATH PH, V34, DOI 10.1177/2058738420961304
   Bozkurt HS, 2020, EUR J INFLAMM, V18, DOI 10.1177/2058739220942626
   Brenner EJ, 2020, GASTROENTEROLOGY, V159, P481, DOI 10.1053/j.gastro.2020.05.032
   Brodmerkel C, 2013, J DRUGS DERMATOL, V12, P1122
   BSG, BSG EXP CONS ADV MAN
   Burke KE, 2021, INFLAMM BOWEL DIS, V27, P155, DOI 10.1093/ibd/izaa278
   Caldera F, 2020, INFLAMM BOWEL DIS, V26, P593, DOI 10.1093/ibd/izz164
   Chen JR, 2021, GASTROENTEROLOGY, V160, P2223, DOI 10.1053/j.gastro.2020.05.087
   Chen LJ, 2020, AM J GASTROENTEROL, V115, P790, DOI 10.14309/ajg.0000000000000610
   Cheung KS, 2020, GASTROENTEROLOGY, V159, P81, DOI 10.1053/j.gastro.2020.03.065
   Coperchini F, 2020, CYTOKINE GROWTH F R, V53, P25, DOI 10.1016/j.cytogfr.2020.05.003
   D'Amico F, 2020, CLIN GASTROENTEROL H, V18, P2689, DOI 10.1016/j.cgh.2020.08.003
   D'Amico F, 2020, LANCET GASTROENTEROL, V5, P631, DOI 10.1016/S2468-1253(20)30151-5
   D'Amico F, 2020, ALIMENT PHARM THER, V51, P689, DOI 10.1111/apt.15662
   Derikx LAAP, 2021, J CROHNS COLITIS, V15, P529, DOI 10.1093/ecco-jcc/jjaa215
   Dubey S, 2020, DIABETES METAB SYND, V14, P779, DOI 10.1016/j.dsx.2020.05.035
   Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432
   Fiorino G, 2020, J CROHNS COLITIS, V14, P1037, DOI 10.1093/ecco-jcc/jjaa023
   Galvez Julio, 2014, ISRN Inflamm, V2014, P928461, DOI 10.1155/2014/928461
   Garg M, 2020, GUT, V69, P841, DOI 10.1136/gutjnl-2019-318512
   Gianfrancesco M, 2020, ANN RHEUM DIS, V79, P859, DOI 10.1136/annrheumdis-2020-217871
   Gomez J, 2020, GENE, V762, DOI 10.1016/j.gene.2020.145102
   Graff LA, 2009, INFLAMM BOWEL DIS, V15, P1105, DOI 10.1002/ibd.20873
   Gubatan J, 2020, GASTROENTEROLOGY, V159, P1141, DOI 10.1053/j.gastro.2020.05.009
   Han CQ, 2020, AM J GASTROENTEROL, V115, P916, DOI 10.14309/ajg.0000000000000664
   Heida A, 2017, CLIN GASTROENTEROL H, V15, P1742, DOI 10.1016/j.cgh.2017.06.007
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Hou WQ, 2014, J VIROL, V88, P8479, DOI 10.1128/JVI.00724-14
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Iacucci M, 2020, LANCET GASTROENTEROL, V5, P598, DOI 10.1016/S2468-1253(20)30119-9
   Kennedy NA, 2020, GUT, V69, P984, DOI 10.1136/gutjnl-2020-321244
   Khan N, 2020, GASTROENTEROLOGY, V159, P1545, DOI 10.1053/j.gastro.2020.05.065
   Kirchgesner J, 2018, GASTROENTEROLOGY, V155, P337, DOI 10.1053/j.gastro.2018.04.012
   Lees CW, 2020, GASTROENTEROLOGY, V159, P805, DOI 10.1053/j.gastro.2020.05.063
   Lin JF, 2014, INFLAMM BOWEL DIS, V20, P1407, DOI 10.1097/MIB.0000000000000057
   Lukin DJ, 2020, GASTROENTEROLOGY, V159, P1541, DOI 10.1053/j.gastro.2020.05.066
   Magro F, 2020, J CROHNS COLITIS, V14, pS798, DOI 10.1093/ecco-jcc/jjaa160
   Mamula P, 2007, CLIN GASTROENTEROL H, V5, P851, DOI 10.1016/j.cgh.2007.02.035
   Mao R, 2020, LANCET GASTROENTEROL, V5, P426, DOI 10.1016/S2468-1253(20)30076-5
   Melmed GY, 2010, AM J GASTROENTEROL, V105, P148, DOI 10.1038/ajg.2009.523
   Neuendorf R, 2016, J PSYCHOSOM RES, V87, P70, DOI 10.1016/j.jpsychores.2016.06.001
   Ng SC, 2020, J CROHNS COLITIS, V14, pS791, DOI 10.1093/ecco-jcc/jjaa128
   Nowak JK, 2020, GASTROENTEROLOGY, V159, P1151, DOI 10.1053/j.gastro.2020.05.030
   Pacha O, 2020, NAT REV IMMUNOL, V20, P345, DOI 10.1038/s41577-020-0328-z
   Papamichael K, 2016, J CROHNS COLITIS, V10, P371, DOI 10.1093/ecco-jcc/jjv206
   Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143
   Perrier C, 2013, IMMUNOLOGY, V138, P47, DOI 10.1111/imm.12014
   Rodriguez-Lago I, 2020, GASTROENTEROLOGY, V159, P781, DOI 10.1053/j.gastro.2020.04.043
   Rubin DT, 2020, GASTROENTEROLOGY, V159, P350, DOI 10.1053/j.gastro.2020.04.012
   Rubin DT, 2020, GASTROENTEROLOGY, V159, P6, DOI 10.1053/j.gastro.2020.04.002
   Sajadinejad MS, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/106502
   Sandborn WJ, 2013, NEW ENGL J MED, V369, P711, DOI 10.1056/NEJMoa1215739
   Satsangi J., 2020, MAINTENANCE THERAPY
   Scaldaferri F, 2020, UNITED EUR GASTROENT, V8, P775, DOI 10.1177/2050640620929133
   SECURE-IBD Database.,, COR IBD REP DAT
   Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y
   Siegel CA, 2021, GUT, V70, P635, DOI 10.1136/gutjnl-2020-324000
   Singh S, 2020, GASTROENTEROLOGY, V159, P1575, DOI 10.1053/j.gastro.2020.06.003
   Spalinger MR, 2020, IDENTIFICATION NOVEL
   Srivastava A, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.564741
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   Suarez-Farinas M, 2021, GASTROENTEROLOGY, V160, P287, DOI 10.1053/j.gastro.2020.09.029
   Szymczak WA, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01369-20
   Taxonera C, 2020, ALIMENT PHARM THER, V52, P276, DOI 10.1111/apt.15804
   Tinsley A, 2019, INFLAMM BOWEL DIS, V25, P369, DOI 10.1093/ibd/izy243
   Ungaro RC, 2021, GASTROENTEROLOGY, V160, P1447, DOI 10.1053/j.gastro.2020.12.042
   Ungaro RC, 2021, GUT, V70, P725, DOI 10.1136/gutjnl-2020-322539
   Van Assche G, 2012, GUT, V61, P229, DOI 10.1136/gutjnl-2011-300755
   Vigano C, 2020, INFLAMM BOWEL DIS, V26, pE138, DOI 10.1093/ibd/izaa244
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Wisniewski A, 2020, UNITED EUR GASTROENT, V8, P303, DOI 10.1177/2050640619889763
   Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3
   World Health Organization (WHO), 2020, WHO COR COVID 19 DAS
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Wu YJ, 2020, LANCET GASTROENTEROL, V5, P434, DOI 10.1016/S2468-1253(20)30083-2
   Xie XZ, 2020, RADIOLOGY, V296, pE41, DOI 10.1148/radiol.2020200343
   Xu Z, 2020, EXUBERANT ELEVATION, DOI 10.1101/2020.02.11.20021493
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Yeoh YK, 2021, GUT, V70, P698, DOI 10.1136/gutjnl-2020-323020
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zheng SF, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1443
   Zingone F, 2020, LANCET GASTROENTEROL, V5, P525, DOI 10.1016/S2468-1253(20)30085-6
   Zipeto D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.576745
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
   Zuo T, 2020, GASTROENTEROLOGY, V159, P944, DOI 10.1053/j.gastro.2020.05.048
NR 95
TC 1
Z9 1
U1 1
U2 2
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD SEP 7
PY 2021
VL 27
IS 33
BP 5520
EP 5535
DI 10.3748/wjg.v27.i33.5520
PG 16
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA UY7YX
UT WOS:000701735900005
PM 34588749
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU McGurk, MD
   Pirkle, CM
   Beckelman, T
   Lee, J
   Inoue, K
   Yang, A
   Hansen-Smith, H
   Sentell, T
AF McGurk, Meghan D.
   Pirkle, Catherine M.
   Beckelman, Toby
   Lee, Jessica
   Inoue, Katherine
   Yang, Alyssa
   Hansen-Smith, Heidi
   Sentell, Tetine
TI Reinventing health promotion for healthy default beverage laws in the
   face of COVID-19
SO GLOBAL HEALTH PROMOTION
LA English
DT Editorial Material
DE childhood obesity; children's meals; restaurants; policy; COVID-19;
   sugar-sweetened beverages
AB Shortly after a healthy default beverage (HDB) law took effect in Hawai'i, requiring restaurants that serve children's meals to offer healthy beverages with the meals, the COVID-19 pandemic struck. Efforts to contain the virus resulted in changes to restaurants' operations and disrupted HDB implementation efforts. Economic repercussions from containment efforts have exacerbated food insecurity, limited access to healthy foods, and created obstacles to chronic disease management. Promoting healthy default options is critical at a time when engaging in healthy behaviors is difficult, but important, to both prevent and manage chronic disease and decrease COVID-19 risk. This commentary discusses COVID-19's impact on restaurant operations and healthy eating, and the resulting challenges and opportunities for this promising health promotion intervention.
C1 [McGurk, Meghan D.; Pirkle, Catherine M.; Sentell, Tetine] Univ Hawaii Manoa, 1960 East West Rd,Biomed D210, Honolulu, HI 96822 USA.
   [Beckelman, Toby; Lee, Jessica; Inoue, Katherine; Yang, Alyssa; Hansen-Smith, Heidi] Hawaii State Dept Hlth, Honolulu, HI USA.
RP McGurk, MD (corresponding author), Univ Hawaii Manoa, 1960 East West Rd,Biomed D210, Honolulu, HI 96822 USA.
EM mcgurkm@hawaii.edu
OI McGurk, Meghan/0000-0003-0960-1147
FU Chronic Disease Prevention and Health Promotion Division of the Hawai'i
   State Department of Health (HDOH)
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: This project
   was supported through a contract with the Chronic Disease Prevention and
   Health Promotion Division of the Hawai'i State Department of Health
   (HDOH). HDOH employees with knowledge of HDB law implementation and
   enforcement participated in the drafting, revision, and submission of
   this manuscript. The contents of this commentary are the sole
   responsibility of the authors and do not necessarily reflect the
   official views of HDOH.
CR [Anonymous], 2020, 3 SUPPLEMENTARY PROC
   Anzman-Frasca S, 2017, J NUTR EDUC BEHAV, V49, P285, DOI 10.1016/j.jneb.2016.11.009
   Anzman-Frasca S, 2015, OBESITY, V23, P1055, DOI 10.1002/oby.21061
   Backholer K, 2016, PUBLIC HEALTH NUTR, V19, P3057, DOI 10.1017/S1368980016003086
   Beckelman T, 2020, J NUTR EDUC BEHAV, V52, P330, DOI 10.1016/j.jneb.2019.11.016
   Centers for Disease Control (CDC), 2020, REPORT NO CS317670
   Choi, 2017, ARE FAST FOOD RESTAU
   Chudasama YV, 2020, DIABETES METAB SYND, V14, P965, DOI 10.1016/j.dsx.2020.06.042
   Cohn S., 2020, CNBC
   Dave JM, 2017, HEALTH EQUITY, V1, P28, DOI 10.1089/heq.2016.0009
   Department of Labor and Industrial Relations [Internet], 2020, HAWAI IS UNEMPLOYMEN
   Emami A, 2020, ARCH ACAD EMERG MED, V8, DOI 10.22037/aaem.v8i1.600
   Hennessy, 2018, QSR MAGAZINE INTERNE
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Marzilli T., 2020, QSR MAGAZINE INTERNE
   National Restaurant Association, 2020, COVID 19 REOPENING G
   National Restaurant Association, 2020, RESTAURANT TECH IMPR
   National Restaurant Association [Internet], 2020, COVID 19 UPDATE REST
   Oches, 2020, QSR MAGAZINE INTERNE
   Office of the Mayor, 2020, MAYOR LONDON BREED A
   Park B., 2020, ANGELES TIMES INTERN
   Peters John, 2016, J Assoc Consum Res, V1, P92, DOI 10.1086/684364
   Pirkle, 2020, FOOD INSECURITY HAWA
   Popper N., 2020, NEW YORK TIMES INTER
   Powell LM, 2013, JAMA PEDIATR, V167, P14, DOI 10.1001/jamapediatrics.2013.417
   Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222
   Sanchez-Vaznaugh EV, 2019, AM J PREV MED, V57, P338, DOI 10.1016/j.amepre.2019.04.023
   Seattle City Council, 2020, ORDINANCE, P1
   Sentell T., 2020, HONOLULU STAR ADVERT
   Shapiro, 2020, WASHINGTON POST INTE
   Stupplebeen DA, 2019, PREV CHRONIC DIS, V16, DOI 10.5888/pcd16.180311
   World Health Organization, 2020, OBESITY OVERWEIGHT I
   Yang YT, 2019, PREV MED, V123, P160, DOI 10.1016/j.ypmed.2019.03.031
NR 33
TC 0
Z9 0
U1 1
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1757-9759
EI 1757-9767
J9 GLOB HEALTH PROMOT
JI Glob. Health Promot.
PD MAR
PY 2021
VL 28
IS 1
SI SI
BP 79
EP 83
AR 1757975920986696
DI 10.1177/1757975920986696
EA JAN 2021
PG 5
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA RR7QW
UT WOS:000618475100001
PM 33482708
OA Bronze
DA 2022-04-20
ER

PT J
AU Nguyen, HTT
   Dinh, DX
   Nguyen, VM
AF Nguyen, Huong Thi Thanh
   Dinh, Dai Xuan
   Nguyen, Van Minh
TI Knowledge, attitude and practices of community pharmacists regarding
   COVID-19: A paper-based survey in Vietnam
SO PLOS ONE
LA English
DT Article
AB Objective To survey the knowledge, attitude, and practices of Vietnamese pharmacists regarding the COVID-19 pandemic. Method This cross-sectional, paper-based study was conducted from June to August 2020. A validated questionnaire (Cronbach's alpha = 0.84) was used to interview 1,023 pharmacists in nine provinces of Vietnam. Analysis of covariance was employed to identify factors associated with the knowledge of pharmacists. The best model was chosen by using the Bayesian Model Averaging method in R software version 4.0.4. Results The mean knowledge score was 12.02 +/- 1.64 (range: 6-15), which indicated that 93.4% of pharmacists had good knowledge of COVID-19. There was no difference in the average score between males and females (p > 0.05). The multivariate linear regression model revealed that the knowledge was significantly associated with pharmacists' age, education level, and residence (p < 0.001). About attitude and practices, pharmacists daily sought and updated information on the COVID-19 pandemic through mass media and the internet (social network and online newspapers). Nearly 48% of them conceded that they communicated with customers when at least one person did not wear a face mask at the time of the COVID-19 outbreak. At medicine outlets, many measures were applied to protect pharmacists and customers, such as equipping pharmacists with face masks and hand sanitizers (95.0%), using glass shields (83.0%), and maintaining at least one-meter distance between two people (85.2%). Conclusion The pharmacists' knowledge of COVID-19 transmission, symptoms, and prevention was good. Many useful measures against the spread of this perilous virus were applied in medicine outlets. However, pharmacists should restrict forgetting to wear face masks in communication with medicine purchasers. The government and health agencies should have practical remedies to reduce the significant differences in the COVID-19 knowledge of pharmacists among provinces and education-level groups.
C1 [Nguyen, Huong Thi Thanh; Dinh, Dai Xuan] Hanoi Univ Pharm, Dept Pharmaceut Management & PharmacoEcon, Hanoi, Vietnam.
   [Nguyen, Van Minh] Hanoi Univ Publ Hlth, Ctr Populat Hlth Sci, Hanoi, Vietnam.
RP Dinh, DX (corresponding author), Hanoi Univ Pharm, Dept Pharmaceut Management & PharmacoEcon, Hanoi, Vietnam.
EM dinhxuandai.224@gmail.com
OI Xuan Dinh, Dai/0000-0001-6387-2496; Nguyen, Huong/0000-0003-2191-6408
CR Al Mazrouei N, 2021, INT J PHARM PRACT, V29, P137, DOI 10.1093/ijpp/riaa003
   Alan E, 2020, J AM COLL CLIN PHARM, V3, P564, DOI 10.1002/jac5.1253
   Alrasheedy AA, 2021, RISK MANAG HEALTHC P, V14, P729, DOI 10.2147/RMHP.S292354
   Basheti IA, 2021, RES SOC ADMIN PHARM, V17, P514, DOI 10.1016/j.sapharm.2020.04.020
   Cacodcar JA., 2020, INT J COMMUNITY MED, V7, P5081, DOI [10.18203/2394-6040.ijcmph20205188, DOI 10.18203/2394-6040.IJCMPH20205188]
   Cadogan CA, 2021, RES SOC ADMIN PHARM, V17, P2032, DOI 10.1016/j.sapharm.2020.03.015
   Col U, 2020, RES SOC ADMIN PHARM, P583, DOI [DOI 10.1016/j.sapharm.2020.02.003, 10.1016/j.sapharm.2020.02.003]
   Erku DA, 2021, RES SOC ADMIN PHARM, V17, P1954, DOI 10.1016/j.sapharm.2020.04.032
   Gohel KH, 2021, CLIN EPIDEMIOL GLOB, V9, P104, DOI 10.1016/j.cegh.2020.07.008
   Goode JVR, 2020, J AM PHARM ASSOC, V60, pE19, DOI 10.1016/j.japh.2020.08.017
   Hamza MS, 2021, J COMMUN HEALTH, V46, P139, DOI 10.1007/s10900-020-00859-z
   Handicap International, 2009, KNOWLEDGE ATTITUDES
   Hussain I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241467
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Jalil MA, 2020, DISASTER MED PUBLIC, V14, P782, DOI 10.1017/dmp.2020.186
   Jarab AS, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13696
   Kara E, 2020, TURK J PHARM SCI, V17, P242, DOI 10.4274/tjps.galenos.2020.72325
   Karasneh R, 2021, RES SOC ADMIN PHARM, V17, P1897, DOI 10.1016/j.sapharm.2020.04.027
   Khan Z, 2020, DRUGS THER PERSPECT, V36, P215, DOI 10.1007/s40267-020-00717-x
   Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0
   Li HB, 2021, RES SOC ADMIN PHARM, V17, P1813, DOI 10.1016/j.sapharm.2020.04.003
   Dinh L, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa047
   Muhammad K, 2021, DISASTER MED PUBLIC, DOI 10.1017/dmp.2021.54
   Nguyen THD, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101651
   Quan NHK., 2021, ASIAN J HUMANIT SOC, V9, P19, DOI 10.24203/ajhss.v9i1.6531
   Shrestha S, 2020, SAGE OPEN MED, V8, DOI 10.1177/2050312120974513
   Strand MA, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.200317
   Tan SL, 2020, AM J HEALTH-SYST PH, V77, P1096, DOI 10.1093/ajhp/zxaa120
   Tesfaye ZT, 2020, INTEGR PHARM RES PRA, V9, P105, DOI 10.2147/IPRP.S261275
   Thunstrom L, 2020, J BENEFIT-COST ANAL, V11, P179, DOI 10.1017/bca.2020.12
   Vietnam Ministry of Health, 2021, INF COV 19 VIR INF COV 19 VIR
   World Health Organization, COV 19 VACC COV 19 VACC
   World Health Organization, 2020, RAT US PERS PROT EQU RAT US PERS PROT EQU
   World Health Organization, COR DIS COV 19 WEEKL COR DIS COV 19 WEEKL
   World Health Organization, Q AS COV 19 REL HLTH Q AS COV 19 REL HLTH
   World Health Organization, COR OV SYMPT PREV COR OV SYMPT PREV
   Yimenu DK, 2020, SAGE OPEN MED, V8, DOI 10.1177/2050312120973498
   Zeenny RM, 2020, J PHARM POLICY PRACT, V13, DOI 10.1186/s40545-020-00266-8
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 39
TC 2
Z9 2
U1 3
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 29
PY 2021
VL 16
IS 7
AR e0255420
DI 10.1371/journal.pone.0255420
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA UA6CQ
UT WOS:000685248200097
PM 34324597
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Kharel, R
   Baird, J
   Vaishnav, H
   Chillara, N
   Lee, JA
   Genisca, A
   Hayward, A
   Uzevski, V
   Elbenni, A
   Levine, AC
   Aluisio, AR
AF Kharel, Ramu
   Baird, Janette
   Vaishnav, Himanshu
   Chillara, Nidhi
   Lee, J. Austin
   Genisca, Alicia
   Hayward, Alison
   Uzevski, Vlatko
   Elbenni, Asmaa
   Levine, Adam C.
   Aluisio, Adam R.
TI Development and assessment of novel virtual COVID-19 trainer-of trainers
   course implemented by an academic-humanitarian partnership
SO GLOBAL HEALTH ACTION
LA English
DT Article
DE COVID-19; education; public health; virtual education; global health
AB Background In response to the coronavirus disease (COVID-19) pandemic, Project HOPE (R), an international humanitarian organization, partnered with Brown University to develop and deploy a virtual training-of-trainers (TOT) program to provide practical knowledge to healthcare stakeholders. This study is designed to evaluate this TOT program. Objective The goal of this study is to assess the effectiveness of this educational intervention in enhancing knowledge on COVID-19 concepts and to present relative change in score of each competency domains of the training. Methods The training was created by interdisciplinary faculty from Brown University and delivered virtually. Training included eight COVID-19 specific modules on infection prevention and control, screening and triage, diagnosis and management, stabilization and resuscitation, surge capacity, surveillance, and risk communication and community education. The assessment of knowledge attainment in each of the course competency domain was conducted using 10 question pre-and post-test evaluations. Paired t-test were used to compare interval knowledge scores in the overall cohort and stratified by WHO regions. TOT dissemination data was collected from in-country partners by Project Hope. Results Over the period of 7 months, 4,291 personnel completed the TOT training in 55 countries, including all WHO regions. Pre-test and post-test were completed by 1,198 and 706 primary training participants, respectively. The mean scores on the pre-test and post-test were 68.45% and 81.4%, respectively. The mean change in score was 11.72%, with P value <0.0005. All WHO regions had a statistically significant improvement in their score in post-test. The training was disseminated to 97,809 health workers through local secondary training. Conclusion Innovative educational tools resulted in improvement in knowledge related to the COVID-19 pandemic, significantly increasing the average score on knowledge assessment testing. Academic - humanitarian partnerships can serve to implement and disseminate effective education rapidly across the globe.
C1 [Kharel, Ramu; Lee, J. Austin] Brown Univ, Warren Alpert Med Sch, Div Global Emergency Med, Providence, RI 02903 USA.
   [Baird, Janette; Genisca, Alicia; Aluisio, Adam R.] Brown Univ, Warren Alpert Med Sch, Dept Emergency Med & Pediat, Providence, RI 02903 USA.
   [Vaishnav, Himanshu; Elbenni, Asmaa] Brown Univ, Dept Emergency Med, Providence, RI 02903 USA.
   [Chillara, Nidhi] Ben Gurion Univ Negev, Med Sch Int Hlth, Beer Sheva, Israel.
   [Hayward, Alison; Levine, Adam C.] Brown Univ, Warren Alpert Med Sch, Dept Emergency Med, Providence, RI 02903 USA.
   [Uzevski, Vlatko] Project HOPE, Millwood, VA USA.
RP Kharel, R (corresponding author), Brown Univ, Dept Emergency Med, Alpert Med Sch, 55 Claverick St,Room 274, Providence, RI 02903 USA.
EM ramu_kharel@brown.edu
RI Aluisio, Adam/AGU-9179-2022
OI Kharel, Ramu/0000-0003-3498-3722; Hayward, Alison
   S./0000-0003-1607-1842; Genisca, Alicia/0000-0001-7679-1126; Lee,
   John/0000-0002-0252-3716
FU Project HOPE(R)
FX The program development and implementation were funded by Project HOPE
   (R). This paper and analysis were not funded.
CR Agrawal N, 2016, NURS EDUC TODAY, V36, P293, DOI 10.1016/j.nedt.2015.07.022
   Aluisio AR, 2020, GLOBAL HEALTH ACTION, V13, DOI 10.1080/16549716.2020.1797296
   [Anonymous], WHO CORONAVIRUS DIS
   Arce JSS, 2021, NAT MED, V27, P1385, DOI 10.1038/s41591-021-01454-y
   Babcock C, 2012, ACAD MED, V87, P1609, DOI 10.1097/ACM.0b013e31826db6a2
   Babcock C, 2010, DISASTER MED PUBLIC, V4, P169, DOI 10.1001/dmphp.4.2.169
   Crystal I-T., NOVEL CORONAVIRUS 20
   Kola L, 2021, LANCET PSYCHIAT, V8, P535, DOI 10.1016/S2215-0366(21)00025-0
   Mormina M, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0420-3
   Pascarella G, 2020, J INTERN MED, V288, P192, DOI 10.1111/joim.13091
   Sa Maria Jose, 2019, J ED SOCIAL RES, V9, P35, DOI DOI 10.2478/JESR-2019-0011
   Santomauro DF, 2021, LANCET, V398, P1700, DOI 10.1016/S0140-6736(21)02143-7
   Verspoor Karin, 2021, Yearb Med Inform, V30, P176, DOI 10.1055/s-0041-1726503
   Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839
   Wilcha Robyn-Jenia, 2020, JMIR Med Educ, V6, pe20963, DOI 10.2196/20963
NR 15
TC 0
Z9 0
U1 17
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 1654-9880
J9 GLOBAL HEALTH ACTION
JI Glob. Health Action
PD DEC 31
PY 2022
VL 15
IS 1
AR 2010391
DI 10.1080/16549716.2021.2010391
PG 6
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA YE0UB
UT WOS:000740846500001
PM 35006037
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Seddighi, H
AF Seddighi, Hamed
TI Trust in Humanitarian Aid From the Earthquake in 2017 to COVID-19 in
   Iran: A Policy Analysis
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article
DE COVID-19; disasters; humanitarian aid; trust
AB The earthquake of November 2017, the great flood of April 2019, and the COVID-19 outbreak in 2020 are 3 major emergencies in Iran during the last 3 years. A common issue in all of these crises seems to be the issue of "trust." Official authorities, including the Iranian President, ministers, and the judiciary system, tried to gain people's trust by either changing policies or developing new ones. In August 2019, the new law on crisis management in Iran went into effect and the issue of public donation has been considered, too. Also, in their response to the COVID-19 outbreak, Iranian officials ordered all sectors to cooperate with the Ministry of Health and provide it with all necessary facilities. Therefore, it seems that new policies are still needed to overcome mistrust in Iran at times of emergency. Developing a policy on donation management was the first step, and there are several factors that could have contributed to the perception of the mistrust and failure in emergency missions. Mistrust can be the result of different causes, including but not limited to lack of knowledge on capabilities and efficiencies of humanitarian organizations, engagement of a wide range of organizations from different categories, extension of mistrust of an organization to other emergency organizations in the area or all of operation, lack of unity in emergency response, and poor public relations.
C1 [Seddighi, Hamed] Univ Social Welf & Rehabil Sci, Student Res Comm, Tehran, Iran.
RP Seddighi, H (corresponding author), Univ Social Welf & Rehabil Sci, Kodakyar Ave,Daneshjo Blvd, Evin 1985713871, Iran.
EM Hseddighi@gmail.com
RI Seddighi, Hamed/AAV-2922-2020; Seddighi, Hamed/AAV-4923-2020
OI Seddighi, Hamed/0000-0002-6214-4830
CR [Anonymous], 2018, J HOSP PALLIAT NURS, V20, pE1
   [Anonymous], 2019, FRANCE24
   Bacchi C., 2009, ANAL POLICY
   Euronews, 2019, IR BANS NON CROWDF A
   IFRC, 2019, EM APP IR FLOOD
   Iranian Government, 2020, TRUST IS PRINC US
   Iranian Government, 2020, SOM WORR INFL SOC TH
   Iranian Labour News Agency (ILNA), 2020, DAM SOC TRUST INC LA
   Iranian Parliament Special Committee, 2019, EV HUM RESP KERM EAR
   Iranian Students' News Agency (ISNA), 2020, RAB TRUST IS MOST IM
   Iranian Students' News Agency (ISNA), 2019, 15 PEOPL DIED FLU LA
   Khamenei A, 2020, I KHAM ADV PEOPL COR
   Nissen E, 2019, J GEOPHYS RES-SOL EA, V124, P2124, DOI 10.1029/2018JB016221
   Parliament Islamic Consultative Assembly (ICAI), 2019, NAT CRIS MAN LAW
   Tatham P, 2010, INT J PROD ECON, V126, P35, DOI 10.1016/j.ijpe.2009.10.006
   Tolooei Z, 2019, 16439 ISL PARL RES C
   World Health Organization (WHO), 2020, COVID 19 STRAT UPD
   Zamani S., 2019, SHAHRVAND, V1662, P15
   2019, CJEM, V21
   2019, CJEM, V21
   2019, CJEM, V21
NR 21
TC 11
Z9 11
U1 1
U2 7
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD OCT
PY 2020
VL 14
IS 5
BP E7
EP E10
AR PII S1935789320000543
DI 10.1017/dmp.2020.54
PG 4
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA PI7CI
UT WOS:000601244100004
PM 32216858
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Fan, GH
   Yang, ZC
   Lin, QY
   Zhao, S
   Yang, L
   He, DH
AF Fan, Guihong
   Yang, Zhichun
   Lin, Qianying
   Zhao, Shi
   Yang, Lin
   He, Daihai
TI Decreased Case Fatality Rate of COVID-19 in the Second Wave: A study in
   53 countries or regions
SO TRANSBOUNDARY AND EMERGING DISEASES
LA English
DT Article
DE case fatality rate; COVID-19; influenza
AB The raw case fatality rate (CFR, the reported number of COVID-19 deaths divided by the total number of cases) is an important indicator to quantify the severity or treatment efficacy. In many countries, the pandemic had experienced two waves to date. To our knowledge, no studies have compared the CFR between the two waves. In this work, we reported the CFR of 53 countries or regions with the highest COVID-19 death tolls. Of them, 43 had lower CFR estimates in the ongoing second wave than in the first wave. We discussed the possible reasons. Also, we compared the two-wave pattern of COVID-19 with those of influenza. Influenza activities in the pre-pandemic era provided an indicator for seasonality of climate in a country. The sharp drop in influenza activities in 2020 could an indicator of the effects of social distancing.
C1 [Fan, Guihong] Columbus State Univ, Math Dept, Columbus, GA USA.
   [Yang, Zhichun] Chongqing Normal Univ, Sch Math Coll, Chongqing, Peoples R China.
   [Lin, Qianying] Univ Michigan, Michigan Inst Data Sci, Ann Arbor, MI 48109 USA.
   [Zhao, Shi] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China.
   [Zhao, Shi] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.
   [Yang, Lin] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Peoples R China.
   [He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Peoples R China.
RP He, DH (corresponding author), Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Peoples R China.
EM daihai.he@polyu.edu.hk
RI He, Daihai/AAT-8735-2021; Zhao, Shi/AAW-6992-2021; Lin,
   Qianying/ABD-8415-2021; Yang, Lin/F-9601-2014
OI Zhao, Shi/0000-0001-8722-6149; Yang, Lin/0000-0002-5964-3233; Fan,
   Guihong/0000-0002-1601-4947; He, Daihai/0000-0003-3253-654X
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [11971081]; Science and Technology Research
   Program of Chongqing Municipal Education Commission [KJZD-M202000501];
   General Research Fund of Research Grants Council of Hong Kong
   [15205119]; Alibaba (China) Co. Ltd.
FX ZY was supported by National Natural Science Foundation of China under
   Grant 11971081, Science and Technology Research Program of Chongqing
   Municipal Education Commission, KJZD-M202000501. DH was supported by
   General Research Fund (15205119) of Research Grants Council of Hong Kong
   and Alibaba (China) Co. Ltd. Collaborative Research project. The funding
   agencies had no role in the design and conduct of the study; collection,
   management, analysis and interpretation of the data; preparation, review
   or approval of the manuscript; or decision to submit the manuscript for
   publication.
CR Bedford T, 2015, NATURE, V523, P217, DOI 10.1038/nature14460
   Ran JJ, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa133
   Ran JJ, 2020, J INFECTION, V81, pE9, DOI 10.1016/j.jinf.2020.07.011
   Ran JJ, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01253-2020
   Yang S, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.66
NR 5
TC 52
Z9 52
U1 10
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1865-1674
EI 1865-1682
J9 TRANSBOUND EMERG DIS
JI Transbound. Emerg. Dis.
PD MAR
PY 2021
VL 68
IS 2
BP 213
EP 215
DI 10.1111/tbed.13819
EA SEP 2020
PG 3
WC Infectious Diseases; Veterinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases; Veterinary Sciences
GA RT6KB
UT WOS:000569932500001
PM 32892500
OA Bronze
DA 2022-04-20
ER

PT J
AU Al-Quteimat, O
   Siddiqui, M
   Hussein, L
   Al Emleh, H
   Shamieh, IE
AF Al-Quteimat, Osama
   Siddiqui, Mohammad
   Hussein, Lana
   Al Emleh, Haytham
   Shamieh, Imad El Dine
TI Analysis of Pharmacist Interventions in Adult COVID-19 Patients Admitted
   to a Tertiary Care Hospital
SO JOURNAL OF PHARMACY PRACTICE
LA English
DT Article; Early Access
DE COVID-19; pharmacist; inpatient; clinical pharmacy; hospital pharmacy;
   pharmacist interventions
AB Background: Pharmacists are integral members of the multidisciplinary healthcare team who, with their skills, knowledge, and training, are well positioned to prevent, identify, and manage medication-related issues. Many published articles related to COVID-19 management have highlighted the important role of the pharmacists in assuring the safe, effective, and cost-effective use of medications. During such challenging times of COVID-19 pandemic that resulted in a high demand on medical resources and healthcare providers, pharmacists are well positioned to contribute and add more efforts to the healthcare system to achieve best use of the available resources including medications and providing high quality pharmaceutical care to help the patients and support the healthcare providers. Methods: This is a retrospective chart review included all admitted adult patients with confirmed COVID-19 diagnosis from 1 March 2020 till 30 June 2020. The documented clinical pharmacist interventions were extracted from the EMR and reviewed by multiple clinical pharmacists to identify type, number, frequency, outcome, and physician's acceptance rate of documented interventions. Results: A total of 484 pharmacist interventions included in the final analysis. Antimicrobial stewardship interventions were the most reported (149, 30.8%) and antibiotics were the most reported class of medication, constituting 31.1% of the total interventions. "Optimized therapy" was the most commonly reported outcome (58.8%). Overall, 50.8% (246) of the interventions were rated as having "moderate" clinical significance using the clinical significance scoring tool. The physicians' acceptance rate was 94.7%. Conclusion: Pharmacist interventions are associated with improved communication and medication use in admitted adult patients with COVID-19. Clinical pharmacists can play a crucial role in optimizing medication use in patients with COVID-19 through prevention, identification, and resolving existing or potential drug-related problems.
C1 [Al-Quteimat, Osama; Siddiqui, Mohammad; Hussein, Lana; Al Emleh, Haytham; Shamieh, Imad El Dine] Cleveland Clin Abu Dhabi, Pharm Dept, Abu Dhabi, U Arab Emirates.
RP Al-Quteimat, O (corresponding author), Cleveland Clin Abu Dhabi, Pharm Dept, Abu Dhabi, U Arab Emirates.
EM Alquteo@clevelandclinicabudhabi.ae
CR Alan E, 2020, J AM COLL CLIN PHARM, V3, P564, DOI 10.1002/jac5.1253
   [Anonymous], 2020, STAND PRACT CLIN PHA
   Cheong MWL., 2020, J AM COLL CLIN PHARM, V3, P860
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Dodds LJ, 2014, EUR J HOSP PHARM-S P, V21, P95, DOI 10.1136/ejhpharm-2013-000385
   Faqeer N, 2021, J ONCOL PHARM PRACT, V27, P897, DOI 10.1177/1078155220943277
   Graabaek T, 2013, BASIC CLIN PHARMACOL, V112, P359, DOI 10.1111/bcpt.12062
   Gunterus Alicia, 2016, Ment Health Clin, V6, P242, DOI 10.9740/mhc.2016.09.242
   International Pharmaceutical Federation (FIP), 2020, COVID 19 PAND GUID P
   Salameh LK, 2019, J PHARM HEALTH SERV, V10, P149, DOI 10.1111/jphs.12261
   Siddiqui MA, 2020, AM J HEALTH-SYST PH, V77, P1191, DOI 10.1093/ajhp/zxaa133
   Stevens MP, 2020, INFECT CONT HOSP EP, V41, P744, DOI 10.1017/ice.2020.69
   U.S. Food and Drug Administration, DRUG SAF COMM FDA CA
NR 13
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0897-1900
EI 1531-1937
J9 J PHARM PRACT
JI J. Pharm. Pract.
AR 08971900211065536
DI 10.1177/08971900211065536
EA JAN 2022
PG 7
WC Pharmacology & Pharmacy
WE Emerging Sources Citation Index (ESCI)
SC Pharmacology & Pharmacy
GA YP5FG
UT WOS:000748647600001
PM 35001748
DA 2022-04-20
ER

PT J
AU Pandey, NN
   Sharma, S
AF Pandey, Niraj Nirmal
   Sharma, Sanjiv
TI Conducting and critically appraising a high-quality systematic review
   and Meta-analysis pertaining to COVID-19
SO CURRENT MEDICAL RESEARCH AND OPINION
LA English
DT Review
DE Systematic review; meta-analysis; COVID-19; research methodology
ID BIAS
AB With constantly emerging new information regarding the epidemiology, pathogenesis, diagnosis and management of Coronavirus Disease 2019 (COVID-19), reviewing literature related to it has become increasingly complicated and resource-intensive. In the setting of this global pandemic, clinical decisions are being guided by the results of multiple pertinent studies; however, it has been observed that these studies are often heterogenous in design and population characteristics and results of initial trials may not be replicated in subsequent studies. The resulting clinical conundrum can be resolved by high-quality systematic review and meta-analysis with a robust and reliable methodology, encapsulating and critically appraising all the available literature relevant to the clinical scenario under scrutiny. It can condense the large volume of scientific information available and can also identify the cause of differences in the degree of effect under consideration across different studies. It can identify optimal diagnostic algorithms, assess efficacy of treatment strategies, and analyze inherent factors influencing the efficacy of treatment for COVID-19. The current review aims to provide a basic guide to plan and conduct a high-quality systematic review and meta-analysis pertaining to COVID-19, describing the main steps and addressing the pitfalls commonly encountered at each step. Knowledge of the basic steps would also allow the reader to critically appraise published systematic review and meta-analysis and the quality of evidence provided therein.
C1 [Pandey, Niraj Nirmal; Sharma, Sanjiv] All India Inst Med Sci, Dept Cardiovasc Radiol & Endovasc Intervent, New Delhi 110029, India.
RP Pandey, NN (corresponding author), All India Inst Med Sci, Dept Cardiovasc Radiol & Endovasc Intervent, New Delhi 110029, India.
EM nirajpandey2403@gmail.com
OI Pandey, Niraj/0000-0001-6786-8304
CR Ahn E, 2018, KOREAN J ANESTHESIOL, V71, P103, DOI 10.4097/kjae.2018.71.2.103
   American Psychological Association, 2020, PUBL MAN AM PSYCH AS, V7th
   Baumeister RF, 2013, PORTABLE MENTOR: EXPERT GUIDE TO A SUCCESSFUL CAREER IN PSYCHOLOGY, SECOND EDITION, P119, DOI 10.1007/978-1-4614-3994-3_8
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Beller E, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0740-7
   BEM DJ, 1995, PSYCHOL BULL, V118, P172, DOI 10.1037/0033-2909.118.2.172
   Borenstein M., 2009, INTRO META ANAL
   Bushman BJ, 2001, PERS SOC PSYCHOL B, V27, P1123, DOI 10.1177/0146167201279005
   Bushman BJ, 1994, HDB RES SYNTHESIS, P193
   Cooper H, 2003, PSYCHOL BULL, V129, P3, DOI 10.1037//0033-2909.129.1.3
   Cooper H., 2010, RES SYNTHESIS META A, V4th
   Crocetti E, 2016, EMERG ADULTHOOD, V4, P3, DOI 10.1177/2167696815617076
   Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966
   Dijkers M, 2013, KT UPDATE, P1
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1
   Fanelli D, 2013, P NATL ACAD SCI USA, V110, P15031, DOI 10.1073/pnas.1302997110
   Garg AX, 2008, CLIN J AM SOC NEPHRO, V3, P253, DOI 10.2215/CJN.01430307
   HEDGES LV, 1980, PSYCHOL BULL, V88, P359, DOI 10.1037/0033-2909.88.2.359
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928
   Hunt M., 1997, SCI TAKES STOCK STOR
   Ioannidis JPA, 2016, MILBANK Q, V94, P485, DOI 10.1111/1468-0009.12210
   Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218
   Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124
   Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749
   Joober R, 2012, J PSYCHIATR NEUROSCI, V37, P149, DOI 10.1503/jpn.120065
   Kellum JA, 2000, CRIT CARE MED, V28, P3067, DOI 10.1097/00003246-200008000-00065
   Kline R. B., 2013, SIGNIFICANCE TESTING
   Leary, 1997, REV GEN PSYCHOL, V1, P311, DOI [DOI 10.1037/1089-2680.1.3.311, 10.1037/1089-2680.1.3.311]
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007]
   Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3
   Marshall IJ, 2016, J AM MED INFORM ASSN, V23, P193, DOI 10.1093/jamia/ocv044
   Michelson JD, 2014, AM J INFECT CONTROL, V42, P333, DOI 10.1016/j.ajic.2013.09.007
   O'Mara-Eves A, 2015, SYST REV, V4, DOI 10.1186/2046-4053-4-5
   Olofsson H, 2017, RES SYNTH METHODS, V8, P275, DOI 10.1002/jrsm.1237
   Oxman A, 2013, HDB GRADING QUALITY
   Pfeiffer T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018362
   Pillemer DB, 1984, SUMMING SCI REV RES
   Rothstein H.R., 2009, HDB RES SYNTHESIS ME
   Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168
   Shokraneh F, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1601
   Siddaway AP, 2019, ANNU REV PSYCHOL, V70, P747, DOI 10.1146/annurev-psych-010418-102803
   Singh S, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2017.20
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Tsafnat G, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-74
   Uman LS, 2011, J CAN ACAD CHILD ADO, V20, P57
   Valentine J. C., 2009, HDB RES SYNTHESIS ME, P129
   West SL., 2010, COMP EFFECTIVENESS R
   Wilson D. B., 2001, PRACTICAL METAANALYS
NR 50
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0300-7995
EI 1473-4877
J9 CURR MED RES OPIN
JI Curr. Med. Res. Opin.
PD FEB 1
PY 2022
VL 38
IS 2
BP 317
EP 325
DI 10.1080/03007995.2021.2015160
EA DEC 2021
PG 9
WC Medicine, General & Internal; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC General & Internal Medicine; Research & Experimental Medicine
GA YQ5MO
UT WOS:000730109400001
PM 34870545
DA 2022-04-20
ER

PT J
AU Ul Haq, MI
   Shafiq, F
   Sheikh, H
AF Ul Haq, Muhammad Irfan
   Shafiq, Faraz
   Sheikh, Haris
TI Potential Barriers amongst Health Care Professionals of Pakistan in
   managing COVID-19 patients
SO PAKISTAN JOURNAL OF MEDICAL SCIENCES
LA English
DT Article
DE Pakistan; COVID 19; Health Personnel; Attitude
ID MENTAL-HEALTH
AB Objectives: To evaluate basic knowledge of Health Care Professionals (HCPs) of Pakistan in managing COVID 19 patients. It includes information regarding infection control measures, administrative and professional support. This was followed by evaluation of psychological factor that can act as a barrier in effective management of these patients.
   Methods: The survey was conducted on line using Google Form. After approval from hospital ethical committee survey link was disseminated to HCPs using social media.
   Results: Four hundred fifteen HCPs were participated. Most of them were younger than 30 years and majority of them were postgraduate trainees. Results showed gaps in the knowledge about basic infection control measure like donning/doffing and understanding about high-risk procedures. On job training, professional and administrative support is compromising. Many of HCPs are anxious nowadays, having symptoms related to burn out with logical reasons behind. Even with all those hurdles they are committed and ready to volunteer themselves.
   Conclusion: The HCPs of Pakistan needs urgent attention for providing them Formal training regarding infection control measure. Administrative and professional support is required from institutions and scientific societies. Online teaching modules and webinar is a suitable option. The symptoms of burn out are significant and would increase with passage of time. This needs to be supported by occupational health committees.
C1 [Ul Haq, Muhammad Irfan; Shafiq, Faraz; Sheikh, Haris] Aga Khan Univ, Dept Anaesthesiol, Stadium Rd, Karachi, Pakistan.
RP Shafiq, F (corresponding author), Aga Khan Univ, Dept Anaesthesiol, Stadium Rd, Karachi, Pakistan.
EM faraz.shafiq@aku.edu
OI Sheikh, Haris/0000-0003-4399-073X
CR Adams JG, 2020, JAMA-J AM MED ASSOC, V323, P1439, DOI 10.1001/jama.2020.3972
   Cook TM, 2020, ANAESTHESIA, V75, P785, DOI 10.1111/anae.15054
   Kang LJ, 2020, LANCET PSYCHIAT, V7, pE14, DOI 10.1016/S2215-0366(20)30047-X
   Li W, 2020, INT J BIOL SCI, V16, P1732, DOI 10.7150/ijbs.45120
   Mukhtar S, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102069
   Peng PWH, 2020, BRIT J ANAESTH, V124, P497, DOI 10.1016/j.bja.2020.02.008
   Ripp J, 2020, ACAD MED, V95, P1136, DOI 10.1097/ACM.0000000000003414
   Wong J, 2020, CAN J ANESTH, V67, P732, DOI 10.1007/s12630-020-01620-9
   World Health Organization, NOV COR 2019 NCOV TE
   World Health Organization, NOV COR 2019 NCOV SI
NR 10
TC 0
Z9 0
U1 0
U2 4
PU PROFESSIONAL MEDICAL PUBLICATIONS
PI SADDAR
PA PANORAMA CENTRE, RM 522, 5TH FLOOR, BLDG 2, RAJA GHAZANFAR ALI RD, PO
   BOX 8766, SADDAR, KARACHI 00000, PAKISTAN
SN 1682-024X
J9 PAK J MED SCI
JI Pak. J. Med. Sci.
PD MAY
PY 2020
VL 36
IS 4
SU S
SI SI
BP S17
EP S21
DI 10.12669/pjms.36.COVID19-S4.2753
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA MS7ML
UT WOS:000554459400005
PM 32582308
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Janmohamed, K
   Soale, AN
   Forastiere, L
   Tang, WM
   Sha, YJ
   Demant, J
   Airoldi, E
   Kumar, N
AF Janmohamed, Kamila
   Soale, Abdul-Nasah
   Forastiere, Laura
   Tang, Weiming
   Sha, Yongjie
   Demant, Jakob
   Airoldi, Edoardo
   Kumar, Navin
TI Intersection of the Web-Based Vaping Narrative With COVID-19: Topic
   Modeling Study
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE vaping; COVID-19; topic modeling; web-based narrative; modeling; trend;
   narrative; social media; internet; web-based health information
ID PUBLIC-HEALTH; CIGARETTES; TEXT; MISINFORMATION; PREVALENCE
AB Background: The COVID-19 outbreak was designated a global pandemic on March 11, 2020. The relationship between vaping and contracting COVID-19 is unclear, and information on the internet is conflicting. There is some scientific evidence that vaping cannabidiol (CBD), an active ingredient in cannabis that is obtained from the hemp plant, or other substances is associated with more severe manifestations of COVID-19. However, there is also inaccurate information that vaping can aid COVID-19 treatment, as well as expert opinion that CBD, possibly administered through vaping, can mitigate COVID-19 symptoms. Thus, it is necessary to study the spread of inaccurate information to better understand how to promote scientific knowledge and curb inaccurate information, which is critical to the health of vapers. Inaccurate information about vaping and COVID-19 may affect COVID-19 treatment outcomes.
   Objective: Using structural topic modeling, we aimed to map temporal trends in the web-based vaping narrative (a large data set comprising web-based vaping chatter from several sources) to indicate how the narrative changed from before to during the COVID-19 pandemic.
   Methods: We obtained data using a textual query that scanned a data pool of approximately 200,000 different domains (4,027,172 documents and 361,100,284 words) such as public internet forums, blogs, and social media, from August 1, 2019, to April 21, 2020. We then used structural topic modeling to understand changes in word prevalence and semantic structures within topics around vaping before and after December 31, 2019, when COVID-19 was reported to the World Health Organization.
   Results: Broadly, the web-based vaping narrative can be organized into the following groups or archetypes: harms from vaping; Vaping Regulation; Vaping as Harm Reduction or Treatment; and Vaping Lifestyle. Three archetypes were observed prior to the emergence of COVID-19; however, four archetypes were identified post-COVID-19 (Vaping as Harm Reduction or Treatment was the additional archetype). A topic related to CBD product preference emerged after COVID-19 was first reported, which may be related to the use of CBD by vapers as a COVID-19 treatment.
   Conclusions: Our main finding is the emergence of a vape-administered CBD treatment narrative around COVID-19 when comparing the web-based vaping narratives before and during the COVID-19 pandemic. These results are key to understanding how vapers respond to inaccurate information about COVID-19, optimizing treatment of vapers who contract COVID-19, and possibly minimizing instances of inaccurate information. The findings have implications for the management of COVID-19 among vapers and the monitoring of web-based content pertinent to tobacco to develop targeted interventions to manage COVID-19 among vapers.
C1 [Janmohamed, Kamila; Forastiere, Laura; Kumar, Navin] Yale Univ, Dept Sociol, Human Nat Lab, 17 Hillhouse Ave, New Haven, CT 06511 USA.
   [Soale, Abdul-Nasah; Airoldi, Edoardo] Temple Univ, Fox Sch Business, Dept Stat Sci, Philadelphia, PA USA.
   [Forastiere, Laura] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT USA.
   [Tang, Weiming; Sha, Yongjie] Univ North Carolina Chapel Hill, UNC Project China, Guangzhou, Peoples R China.
   [Tang, Weiming] Southern Med Univ Dermatol Hosp, Guangzhou, Peoples R China.
   [Tang, Weiming] Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC USA.
   [Demant, Jakob] Univ Copenhagen, Copenhagen, Denmark.
RP Kumar, N (corresponding author), Yale Univ, Dept Sociol, Human Nat Lab, 17 Hillhouse Ave, New Haven, CT 06511 USA.
EM navin.kumar@yale.edu
RI ; Demant, Jakob/G-7347-2015
OI Forastiere, Laura/0000-0003-3721-9826; Kumar, Navin/0000-0003-4502-069X;
   Janmohamed, Kamila/0000-0003-4858-6701; Tang,
   Weiming/0000-0002-9026-707X; Airoldi, Edoardo/0000-0002-3512-0542;
   Soale, Abdul-Nasah/0000-0003-2093-7645; Demant,
   Jakob/0000-0003-3333-224X
FU Foundation for a Smoke-Free World [DOI 10.17605/OSF.IO/XBVF2]
FX This study was funded by The Foundation for a Smoke-Free World. The
   funding body had no role in the design, analysis, or interpretation of
   the data in the study. This study was preregistered on the Open Science
   Framework (DOI 10.17605/OSF.IO/XBVF2).
CR Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007
   Barnett PA, 2009, J SOC DISTRESS HOMEL, V18, P57, DOI 10.1179/105307809805365235
   Benoit K., 2018, J OPEN SOURCE SOFTW, V3, DOI [10.21105/joss.00774, DOI 10.21105/JOSS.00774]
   Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826
   Brown JD, 2021, RES SOC ADMIN PHARM, V17, P2053, DOI 10.1016/j.sapharm.2020.03.020
   Chadi N, 2020, PAED CHILD HEALT-CAN, V25, P337, DOI 10.1093/pch/pxz137
   DiMaggio P, 2013, POETICS, V41, P570, DOI 10.1016/j.poetic.2013.08.004
   Esposito G, 2020, BRIT J PHARMACOL, V177, P4967, DOI 10.1111/bph.15157
   Evans MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087908
   Farrell J, 2016, P NATL ACAD SCI USA, V113, P92, DOI 10.1073/pnas.1509433112
   Feinerer I, 2008, J STAT SOFTW, V25, P1
   Forsyth SR, 2010, NICOTINE TOB RES, V12, P810, DOI 10.1093/ntr/ntq101
   Freeman B, 2012, TOB CONTROL, V21, P139, DOI 10.1136/tobaccocontrol-2011-050193
   Furlow B, 2019, LANCET RESP MED, V7, P932, DOI 10.1016/S2213-2600(19)30329-7
   Gilpin DF, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1206-8
   Glantz Stanton A, 2020, REDUCE YOUR RISK SER
   Grimmer J, 2013, POLIT ANAL, V21, P267, DOI 10.1093/pan/mps028
   Guarino S, 2018, IEEE INT C SEMANT CO, P269, DOI 10.1109/ICSC.2018.00048
   Hooper RW, 2020, ANN INTERN MED, V172, P57, DOI 10.7326/M19-2908
   Huang J, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4265
   Huang JD, 2014, TOB CONTROL, V23, P26, DOI 10.1136/tobaccocontrol-2014-051551
   Kostygina G, 2016, TOB CONTROL, V25, pi75, DOI 10.1136/tobaccocontrol-2016-053094
   Kovalchuk O, 2020, SEARCH PREVENTATIVE
   Krippendorff K., 2018, CONTENT ANAL INTRO I
   Lawrence K., 2020, E CIGARETTE IND CRIS, DOI [10.4135/9781529728613, DOI 10.4135/9781529728613]
   Lewis T., 2020, SCI AM
   Madison MC, 2019, J CLIN INVEST, V129, P4290, DOI 10.1172/JCI128531
   Majmundar A, 2020, NICOTINE TOB RES, V22, P1667, DOI 10.1093/ntr/ntaa064
   McAlinden KD, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01645-2020
   Mohr JW, 2013, POETICS, V41, P545, DOI 10.1016/j.poetic.2013.10.001
   Muller K., DPLYR GRAMMAR DATA M
   Munksgaard R, 2016, INT J DRUG POLICY, V35, P77, DOI 10.1016/j.drugpo.2016.04.021
   Nikolenko SI, 2017, J INF SCI, V43, P88, DOI 10.1177/0165551515617393
   Nordheim LV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161485
   Pennycook G, 2020, PSYCHOL SCI, V31, P770, DOI 10.1177/0956797620939054
   Pennycook G, 2019, P NATL ACAD SCI USA, V116, P2521, DOI 10.1073/pnas.1806781116
   Reasoner JJ, 2020, OCHSNER J, V20, P2, DOI 10.31486/toj.20.0012
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Rinker TW, TEXTCLEAN TEXT CLEAN
   Roberts ME, 2019, J STAT SOFTW, V91, P1, DOI 10.18637/jss.v091.i02
   Roberts ME, 2016, J AM STAT ASSOC, V111, P988, DOI 10.1080/01621459.2016.1141684
   Roberts ME, 2014, AM J POLIT SCI, V58, P1064, DOI 10.1111/ajps.12103
   SAAL FE, 1980, PSYCHOL BULL, V88, P413, DOI 10.1037/0033-2909.88.2.413
   Swire-Thompson B, 2020, ANNU REV PUBL HEALTH, V41, P433, DOI 10.1146/annurev-publhealth-040119-094127
   Tvinnereim E, 2015, NAT CLIM CHANGE, V5, P744, DOI [10.1038/nclimate2663, 10.1038/NCLIMATE2663]
   U.S. Food and Drug Administration, FRAUD COR DIS 2019 C
   Volkow ND, 2020, ANN INTERN MED, V173, P61, DOI 10.7326/M20-1212
   Wallach H. M., 2009, P 26 ANN INT C MACH, P1105
   Winickoff J, SMOKING E CIGARETTE
   World Health Organization, TIM WHOS RESP COVID
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yamin CK, 2010, ANN INTERN MED, V153, P607, DOI 10.7326/0003-4819-153-9-201011020-00011
NR 52
TC 6
Z9 6
U1 4
U2 10
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD OCT 30
PY 2020
VL 22
IS 10
AR e21743
DI 10.2196/21743
PG 14
WC Health Care Sciences & Services; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Medical Informatics
GA OL5LC
UT WOS:000585380300012
PM 33001829
OA gold, Green Submitted, Green Published
DA 2022-04-20
ER

PT J
AU Ismail, Z
   Salabei, JK
   Stanger, G
   Asnake, ZT
   Frimer, L
   Smock, A
AF Ismail, Zeeshan
   Salabei, Joshua K.
   Stanger, Greg
   Asnake, Zekarias T.
   Frimer, Leora
   Smock, Andrew
TI Third-Degree Heart Block Associated With Saddle Pulmonary Embolism: A
   Rare Sequelae of COVID-19-Induced Hypercoagulable State
SO CUREUS
LA English
DT Article
DE covid 19; hypercoagulable state; third degree atrioventricular block;
   pulmonary emboli; saddle embolus
AB The pathophysiology of coronavirus disease 2019 (COVID-19) involves multi-organ dysfunction, particularly involving the respiratory, cardiovascular and hematological systems. This dysfunction is partly due to systemic inflammation causing a wide array of pathological sequelae thus posing a significant challenge to management despite the advances in treatment made thus far. In this report, we present a COVID-19 patient who developed a transient complete heart block and was temporarily paced as a complication of a saddle pulmonary embolus (PE). The mechanism of complete heart block is unclear, may be related to strain, ischemia, or vagal response. We believe that this is a unique sequence of events in a COVID-19 patient and, to our knowledge, is the first of its kind to be reported.
C1 [Ismail, Zeeshan; Salabei, Joshua K.; Stanger, Greg; Asnake, Zekarias T.; Frimer, Leora; Smock, Andrew] Univ Cent Florida, Sch Med, Hosp Corp Amer HCA,Internal Med, Grad Med Educ Consortium,North Florida Reg Med Ct, Gainesville, FL 32611 USA.
RP Ismail, Z (corresponding author), Univ Cent Florida, Sch Med, Hosp Corp Amer HCA,Internal Med, Grad Med Educ Consortium,North Florida Reg Med Ct, Gainesville, FL 32611 USA.
EM zeeshan.ismail@hcahealthcare.com
CR Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Begbie M, 2000, THROMB HAEMOSTASIS, V84, P216
   Bilaloglu S, 2020, JAMA-J AM MED ASSOC, V324, P799, DOI 10.1001/jama.2020.13372
   Elias Jorge, 2004, Arq. Bras. Cardiol., V83, P434, DOI 10.1590/S0066-782X2004001700010
   Hubloue I, 1996, Eur J Emerg Med, V3, P199, DOI 10.1097/00063110-199609000-00012
   Kosuge M, 2007, AM J CARDIOL, V99, P817, DOI 10.1016/j.amjcard.2006.10.043
   Libby P, 2020, EUR HEART J, V41, P3038, DOI 10.1093/eurheartj/ehaa623
   Lowenstein CJ, 2020, CIRCULATION, V142, P1609, DOI 10.1161/CIRCULATIONAHA.120.050354
   Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007
   Marti J, 2005, REV ESP CARDIOL, V58, P230, DOI 10.1157/13071899
   Salabei JK, 2021, HEART LUNG, V50, P357, DOI 10.1016/j.hrtlng.2021.01.011
   Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
NR 13
TC 1
Z9 1
U1 2
U2 3
PU CUREUS INC
PI PALO ALTO
PA PO BOX 61002, PALO ALTO, CA 94306 USA
EI 2168-8184
J9 CUREUS
JI Cureus
PD JUL 7
PY 2021
VL 13
IS 7
AR e16246
DI 10.7759/cureus.16246
PG 6
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA TM6AK
UT WOS:000675632400024
PM 34381643
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Nabipour, M
   Ulku, MA
AF Nabipour, Mohammad
   Ulku, M. Ali
TI On Deploying Blockchain Technologies in Supply Chain Strategies and the
   COVID-19 Pandemic: A Systematic Literature Review and Research Outlook
SO SUSTAINABILITY
LA English
DT Review
DE blockchain; COVID-19 pandemic; digitalization; visibility; transparency;
   smart contracts; sustainability; supply chain management; literature
   review
ID MANAGEMENT; ECONOMY; EQUIPMENT; IMPACT
AB The emergence of a new pandemic, known as COVID-19, has touched various sections of the supply chain (SC). Since then, numerous studies have been conducted on the issue, but the need for a holistic review study that highlights the gaps and limits of previous research, as well as opportunities and agendas for future studies, is palpable. Through a systematic literature review on blockchain technology (BCT) deployment in supply-chain management (SCM) concerning the COVID-19 pandemic, this research seeks to add to the content of previous studies and to enlighten the path for future studies. Relevant papers were found using a variety of resources (Scopus, Google Scholar, Web of Science, and ProQuest). Seventy-two articles were systematically selected, considering the PRISMA procedure, and were thoroughly analyzed based on BCT, methodologies, industrial sectors, geographical, and sustainability context. According to our findings, there is a significant lack of empirical and quantitative methodologies in the literature. The majority of studies did not take specific industries into account. Furthermore, the articles focusing on the sustainability context are few, particularly regarding social and environmental issues. In addition, most of the reviewed papers did not consider the geographical context. The results indicate that the deployment of BCT in several sectors is not uniform, and this utilization is reliant on their services during the COVID-19 pandemic. Furthermore, the concentration of research on the impacts of the BCT on SCM differs according to the conditions of various countries in terms of the consequences of the COVID-19 pandemic. The findings also show that there is a direct relationship between the deployment of BCT and sustainability factors, such as economic and waste issues, under the circumstances surrounding COVID-19. Finally, this study offers research opportunities and agendas to help academics and other stakeholders to gain a better knowledge of the present literature, recognize aspects that necessitate more exploration, and drive prospective studies.
C1 [Nabipour, Mohammad] Univ Shomal, Dept Civil Engn, Amol 4616184596, Iran.
   [Ulku, M. Ali] Dalhousie Univ, Rowe Sch Business, Ctr Res Sustainable Supply Chain Analyt, Halifax, NS B3H 4R2, Canada.
RP Nabipour, M (corresponding author), Univ Shomal, Dept Civil Engn, Amol 4616184596, Iran.
EM mhd.nabipour@shomal.ac.ir; ulku@dal.ca
OI Ulku, M. Ali/0000-0002-8495-3364; NABIPOUR, MOHAMMAD/0000-0002-5557-252X
FU CRSSCA-Centre for Research in Sustainable Supply Chain Analytics,
   Dalhousie University, Canada [49100-20003-SCR]
FX This research was partially funded by the CRSSCA-Centre for Research in
   Sustainable Supply Chain Analytics, Dalhousie University, Canada. Grant
   number: CRSSCA#49100-20003-SCR.
CR Acioli C, 2021, INT J PRODUCT PERFOR, V70, P988, DOI 10.1108/IJPPM-03-2020-0137
   Agarwal N., 2020, CONTINUITY RESILIENC, V2, P97
   Ahmad RW, 2021, IEEE ACCESS, V9, P44905, DOI 10.1109/ACCESS.2021.3066503
   Akhigbe BI, 2021, BIG DATA COGN COMPUT, V5, DOI 10.3390/bdcc5010010
   Amankwah-Amoah J, 2020, J CLEAN PROD, V271, DOI 10.1016/j.jclepro.2020.123000
   [Anonymous], 2020, GLOB EN REV 2020 REP
   [Anonymous], 2020, INT MAP PROD IMP COV
   Babich V, 2020, M&SOM-MANUF SERV OP, V22, P223, DOI 10.1287/msom.2018.0752
   Bager SL, 2020, BUS STRATEG ENVIRON, V29, P3555, DOI 10.1002/bse.2596
   Bahn RA, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13063223
   Bai CA, 2019, BUS STRATEG ENVIRON, DOI 10.1002/bse.2431
   Bakalis S, 2020, CURR RES FOOD SCI, V3, P166, DOI 10.1016/j.crfs.2020.05.003
   Bamakan SMH, 2021, J CLEAN PROD, V302, DOI 10.1016/j.jclepro.2021.127021
   Baumers M, 2019, J OPER MANAG, V65, P794, DOI 10.1002/joom.1053
   Bekrar A, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13052895
   Betcheva L, 2021, M&SOM-MANUF SERV OP, V23, P1333, DOI 10.1287/msom.2020.0920
   Bocek Thomas, 2017, 2017 IFIP/IEEE Symposium on Integrated Network and Service Management (IM), P772, DOI 10.23919/INM.2017.7987376
   Bryman A., 2016, SOCIAL RES METHODS
   Bumblauskas D, 2020, INT J INFORM MANAGE, V52, DOI 10.1016/j.ijinfomgt.2019.09.004
   Butt Javaid, 2020, Designs, V4, DOI 10.3390/designs4020013
   Cai YJ, 2021, DECISION SCI, V52, P866, DOI 10.1111/deci.12475
   Carter CR, 2015, J SUPPLY CHAIN MANAG, V51, P89, DOI 10.1111/jscm.12073
   Casey M.J., 2017, HARV BUS REV, V13, P1
   Chadha SS, 2021, INT J PROD RES, DOI 10.1080/00207543.2021.1946613
   Chamola V, 2020, IEEE ACCESS, V8, P90225, DOI 10.1109/ACCESS.2020.2992341
   Chang SE, 2019, TECHNOL FORECAST SOC, V144, P1, DOI 10.1016/j.techfore.2019.03.015
   Choi TM, 2021, ANN OPER RES, DOI 10.1007/s10479-021-03973-w
   Choi TM, 2021, TRANSPORT RES E-LOG, V145, DOI 10.1016/j.tre.2020.102190
   Choi TM, 2020, TRANSPORT RES E-LOG, V140, DOI 10.1016/j.tre.2020.101961
   Chowdhury P, 2021, TRANSPORT RES E-LOG, V148, DOI 10.1016/j.tre.2021.102271
   Collomb A., 2016, DIGIWORLD EC J, V103, P93
   Cordeiro MC, 2021, INT J LOGIST-RES APP, DOI 10.1080/13675567.2021.1902487
   Currie B.A., 2021, BIG DATA ANAL SUPPLY, V1st ed., P109
   de Sousa Jabbour A.B.L., 2020, MODERN SUPPLY CHAIN, DOI DOI 10.1108/MSCRA-05-2020-0011
   Di Vaio A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12124851
   Dolgui A., 2020, INT J PROD RES, V58, P1285, DOI DOI 10.1080/00207543.2019.1627439
   Dolgui A, 2020, INT J PROD ECON, V229, DOI 10.1016/j.ijpe.2020.107886
   Dutta P, 2020, TRANSPORT RES E-LOG, V142, DOI 10.1016/j.tre.2020.102067
   Etemadi N, 2021, INFORMATION, V12, DOI 10.3390/info12020070
   Fasan M, 2021, BUS STRATEG ENVIRON, V30, P2702, DOI 10.1002/bse.2772
   Feng Tian, 2016, 2016 13th International Conference on Service Systems and Service Management (ICSSSM), P1, DOI 10.1109/ICSSSM.2016.7538424
   Finkenstadt DJ, 2021, J PURCH SUPPLY MANAG, V27, DOI 10.1016/j.pursup.2021.100689
   Flynn B, 2021, J SUPPLY CHAIN MANAG, V57, P3, DOI 10.1111/jscm.12254
   Francisco K, 2018, LOGISTICS-BASEL, V2, DOI 10.3390/logistics2010002
   Frohlich MT, 2001, J OPER MANAG, V19, P185, DOI 10.1016/S0272-6963(00)00055-3
   Fusco A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197167
   Goel R.K., CESIFO WORKING PAPER
   Golan Maureen S., 2020, Environment Systems & Decisions, V40, DOI 10.1007/s10669-020-09777-w
   Grashuis J, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12135369
   Guan DB, 2020, NAT HUM BEHAV, V4, P577, DOI 10.1038/s41562-020-0896-8
   Gunessee S, 2020, INT J OPER PROD MAN, V40, P1201, DOI 10.1108/IJOPM-07-2019-0530
   Guo H, 2020, FRONT BUS RES CHINA, V14, DOI 10.1186/s11782-020-00087-1
   Gurbuz Ismail Bulent, 2020, IEEE Engineering Management Review, V48, P139, DOI 10.1109/EMR.2020.3014693
   Gurtu A, 2019, INT J PHYS DISTR LOG, V49, P881, DOI 10.1108/IJPDLM-11-2018-0371
   Hamma-Adama M., 2021, J SCI RES REP, V27, P20, DOI DOI 10.9734/JSRR/2021/V27I230356
   Hinge G., 2020, INTEGRATED RISK PAND, DOI [10.1007/978-981-15-7679-9_15, DOI 10.1007/978-981-15-7679-9_15]
   Hudecheck M., 2020, MIT SLOAN MANAGE REV
   Iftekhar A, 2020, J FOOD QUALITY, V2020, DOI 10.1155/2020/5385207
   Ivanov Dmitry, 2020, International Journal of Integrated Supply Management, V13, P90
   Ivanov D, 2021, INT J LOGIST MANAG, DOI 10.1108/IJLM-11-2020-0448
   Ivanov D, 2021, PROD PLAN CONTROL, V32, P775, DOI 10.1080/09537287.2020.1768450
   Ivanov D, 2020, INT J PROD RES, V58, P2904, DOI 10.1080/00207543.2020.1750727
   Kalla Anshuman, 2020, IEEE Engineering Management Review, V48, P85, DOI 10.1109/EMR.2020.3014052
   Karmaker CL, 2021, SUSTAIN PROD CONSUMP, V26, P411, DOI 10.1016/j.spc.2020.09.019
   Kazancoglu Y, 2021, J ENTERP INF MANAG, DOI 10.1108/JEIM-12-2020-0521
   Kemp D, 2021, BUS STRATEG ENVIRON, V30, P122, DOI 10.1002/bse.2613
   Khan SAR, 2021, BUS STRATEG ENVIRON, V30, P4001, DOI 10.1002/bse.2853
   Kovacs G, 2021, J SUPPLY CHAIN MANAG, V57, P41, DOI 10.1111/jscm.12253
   Kumar A, 2021, J HUMANIT LOGIST SUP, V11, P1, DOI 10.1108/JHLSCM-06-2020-0050
   Kumar P, 2021, INT J LOGIST-RES APP, DOI 10.1080/13675567.2021.1908524
   Kumar S., 2020, P INT C IND ENG OP M
   Kumar S, 2020, DIABETES METAB SYND, V14, P1283, DOI 10.1016/j.dsx.2020.07.010
   Lin WJ, 2020, IEEE ACCESS, V8, P143920, DOI 10.1109/ACCESS.2020.3014522
   Lin X, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18030912
   Liu Y, 2020, INT J PROD ECON, V229, DOI 10.1016/j.ijpe.2020.107889
   Lohmer J, 2020, INT J PROD ECON, V228, DOI 10.1016/j.ijpe.2020.107882
   Mansfield-Devine Steve, 2017, Computer Fraud & Security, V2017, P14, DOI 10.1016/S1361-3723(17)30042-8
   Memon SU, 2021, FOODS, V10, DOI 10.3390/foods10051069
   Michelman P, 2017, MIT SLOAN MANAGE REV, V58, P17
   Montecchi M, 2021, INT J PROD ECON, V238, DOI 10.1016/j.ijpe.2021.108152
   Nakasumi M, 2017, CONF BUS INFORM, V1, P140, DOI 10.1109/CBI.2017.56
   Nandi S, 2021, IND MANAGE DATA SYST, V121, P333, DOI 10.1108/IMDS-09-2020-0560
   Nandi S, 2021, SUSTAIN PROD CONSUMP, V27, P10, DOI 10.1016/j.spc.2020.10.019
   Narayanamurthy G, 2021, INT J PROD ECON, V234, DOI 10.1016/j.ijpe.2021.108075
   Omar IA, 2021, IEEE ACCESS, V9, P37397, DOI 10.1109/ACCESS.2021.3062471
   Panday A., 2020, LIVEMINT
   Papadopoulos T, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102192
   Paul SK, 2021, INT J PHYS DISTR LOG, V51, P104, DOI 10.1108/IJPDLM-04-2020-0127
   Pillai S.V., 2020, J SUPPLY CHAIN MANAG, V9, P1
   Platt M, 2021, JMIR PUBLIC HLTH SUR, V7, DOI 10.2196/26460
   Quayson Matthew, 2020, IEEE Engineering Management Review, V48, P104, DOI 10.1109/EMR.2020.3006259
   Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141
   Rodriguez-Espindola O, 2020, INT J PROD RES, V58, P4610, DOI 10.1080/00207543.2020.1761565
   Roeck D, 2020, INT J PROD RES, V58, P2124, DOI 10.1080/00207543.2019.1657247
   Rowan NJ, 2020, SCI TOTAL ENVIRON, V748, DOI 10.1016/j.scitotenv.2020.141362
   Saberi S, 2019, INT J PROD RES, V57, P2117, DOI 10.1080/00207543.2018.1533261
   Sarkis J, 2021, INT J OPER PROD MAN, V41, P63, DOI 10.1108/IJOPM-08-2020-0568
   Saunders M., 2009, RES METHODS BUSINESS
   Sharma A, 2020, J BUS RES, V117, P443, DOI 10.1016/j.jbusres.2020.05.035
   Sharma M, 2021, J ENTERP INF MANAG, V34, P1844, DOI 10.1108/JEIM-07-2020-0286
   Shashi, 2020, BUS STRATEG ENVIRON, V29, P1215, DOI 10.1002/bse.2428
   Siriwardhana Yushan, 2020, IEEE Engineering Management Review, V48, P72, DOI 10.1109/EMR.2020.3017451
   Sodhi MS, 2021, J SUPPLY CHAIN MANAG, V57, P7, DOI 10.1111/jscm.12255
   Sodhi MS, 2016, J OPER MANAG, V45, P101, DOI 10.1016/j.jom.2016.05.010
   Starr CW, 2021, J PROP INVEST FINANC, V39, P157, DOI 10.1108/JPIF-08-2020-0090
   Sufian AT, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11083568
   Szymkowski S., 2020, ROADSHOW
   Tasnim Z., 2020, EUR J BUS MANAG, V12, P73, DOI DOI 10.7176/EJBM/12-17-08
   Tranfield D, 2003, BRIT J MANAGE, V14, P207, DOI 10.1111/1467-8551.00375
   Ulku M.A., 2021, ENCY UN SUSTAINABLE, P1123, DOI [10.1007/978-3-319-71059-4_117-1, DOI 10.1007/978-3-319-71059-4_117-1]
   Ulku MA, 2018, INT J PROD ECON, V203, P124, DOI 10.1016/j.ijpe.2018.05.016
   van Engelenburg S, 2019, J INTELL INF SYST, V52, P595, DOI 10.1007/s10844-017-0478-z
   van Hoek R, 2020, INT J OPER PROD MAN, V40, P341, DOI 10.1108/IJOPM-03-2020-0165
   van Hoek R, 2019, INT J OPER PROD MAN, V39, P829, DOI 10.1108/IJOPM-01-2019-0022
   Wamba SF, 2020, INT J INFORM MANAGE, V52, DOI 10.1016/j.ijinfomgt.2019.102064
   Wang J, 2017, FRONT ENG MANAG, V4, P67, DOI 10.15302/J-FEM-2017006
   Wang YL, 2019, SUPPLY CHAIN MANAG, V24, P62, DOI 10.1108/SCM-03-2018-0148
   Wong CWY, 2018, BUS STRATEG ENVIRON, V27, P375, DOI 10.1002/bse.2004
   Worku A, 2021, J AGRIBUS DEV EMERG, DOI 10.1108/JADEE-06-2021-0147
   Wright Aaron, 2015, DECENTRALIZED BLOCKC, DOI 10.2139/ssrn.2580664
   Xu JY, 2021, J CLEAN PROD, V282, DOI 10.1016/j.jclepro.2020.124540
   Yadav S, 2021, ENVIRON SCI POLLUT R, V28, P16633, DOI 10.1007/s11356-020-11676-1
   Yang J, 2021, INT J PROD RES, V59, P1573, DOI 10.1080/00207543.2020.1856958
   Yeganeh H, 2021, CRIT PERSPECT INT BU, V17, P188, DOI 10.1108/cpoib-05-2020-0066
   Yousif M, 2021, FUTURE INTERNET, V13, DOI 10.3390/fi13050105
   Yu Z, 2021, OPER MANAGE RES, DOI 10.1007/s12063-021-00179-y
   Zhang FQ, 2020, PROD OPER MANAG, V29, P2219, DOI 10.1111/poms.13231
   Zouari D, 2021, INT J PHYS DISTR LOG, V51, P149, DOI 10.1108/IJPDLM-01-2020-0038
NR 128
TC 0
Z9 0
U1 25
U2 25
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD OCT
PY 2021
VL 13
IS 19
AR 10566
DI 10.3390/su131910566
PG 32
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA WG7VI
UT WOS:000707202400001
OA gold
DA 2022-04-20
ER

PT J
AU Habets, MAW
   Sturkenboom, HN
   Tio, RA
   Belfroid, E
   Hoogervorst-Schilp, J
   Siebelink, HJ
   Jansen, CW
   Smits, PC
AF Habets, M. A. W.
   Sturkenboom, H. N.
   Tio, R. A.
   Belfroid, E.
   Hoogervorst-Schilp, J.
   Siebelink, H. J.
   Jansen, C. W.
   Smits, P. C.
TI How often and to what extent do admitted COVID-19 patients have signs of
   cardiac injury?
SO NETHERLANDS HEART JOURNAL
LA English
DT Article
DE COVID-19; Myocardial injury; Cardiac troponin
ID PROGNOSIS
AB Background COVID-19 can cause myocardial injury in a significant proportion of patients admitted to the hospital and seems to be associated with worse prognosis. The aim of this review was to study how often and to what extent COVID-19 causes myocardial injury and whether this is an important contributor to outcome with implications for management. Methods A literature search was performed in Medline and Embase. Myocardial injury was defined as elevated cardiac troponin (cTn) levels with at least one value > 99th percentile of the upper reference limit. The primary outcome measure was mortality, whereas secondary outcome measures were intensive care unit (ICU) admission and length of hospital stay. Results Four studies and one review were included. The presence of myocardial injury varied between 9.6 and 46.3%. Myocardial injury was associated with a higher mortality rate (risk ratio (RR) 5.54, 95% confidence interval (CI) 3.48-8.80) and more ICU admissions (RR 3.78, 95% CI 2.07-6.89). The results regarding length of hospital stay were inconclusive. Conclusion Patients with myocardial injury might be classified as high-risk patients, with probably a higher mortality rate and a larger need for ICU admission. cTn levels can be used in risk stratification models and can indicate which patients potentially benefit from early medication administration. We recommend measuring cTn levels in all COVID-19 patients admitted to the hospital or who deteriorate during admission.
C1 [Habets, M. A. W.; Sturkenboom, H. N.; Tio, R. A.] Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands.
   [Belfroid, E.; Hoogervorst-Schilp, J.] Dutch Assoc Med Specialists, Knowledge Inst Med Specialists, Utrecht, Netherlands.
   [Siebelink, H. J.] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands.
   [Jansen, C. W.] Netherlands Soc Cardiol, Utrecht, Netherlands.
   [Smits, P. C.] Maasstad Hosp, Dept Cardiol, Rotterdam, Netherlands.
   [Smits, P. C.] Netherlands Heart Registrat, Utrecht, Netherlands.
RP Habets, MAW (corresponding author), Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands.
EM margot.habets@catharinaziekenhuis.nl
FU Quality Funds Foundation of Dutch Medical Specialists
FX This work was supported by the Quality Funds Foundation of Dutch Medical
   Specialists (Stichting Kwaliteitsgelden Medisch Specialisten).
CR Barman HA, 2021, CORONARY ARTERY DIS, V32, P359, DOI 10.1097/MCA.0000000000000914
   Bonow RO, 2020, JAMA-J AM MED ASSOC, V324, P1131, DOI 10.1001/jama.2020.15088
   Chacko B, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.05.016
   Deng Q, 2020, INT J CARDIOL, V311, P116, DOI 10.1016/j.ijcard.2020.03.087
   Gao C, 2020, CRIT CARE MED, V48, P451, DOI 10.1097/CCM.0000000000004207
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010
   Hayden JA, 2013, ANN INTERN MED, V158, P280, DOI 10.7326/0003-4819-158-4-201302190-00009
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Kuno T, 2020, AM HEART J, V226, P24, DOI 10.1016/j.ahj.2020.05.005
   Landesberg G, 2012, EUR HEART J, V33, P895, DOI 10.1093/eurheartj/ehr351
   Libby P, 2020, JACC-BASIC TRANSL SC, V5, P537, DOI 10.1016/j.jacbts.2020.04.001
   Lindner D, 2020, JAMA CARDIOL, V5, P1281, DOI 10.1001/jamacardio.2020.3551
   Lorente-Ros A, 2020, CARDIOL J, V27, P489, DOI 10.5603/CJ.a2020.0089
   Meyer P, 2020, JAMA CARDIOL, V5, P1198, DOI 10.1001/jamacardio.2020.2453
   Nishiga M, 2020, NAT REV CARDIOL, V17, P543, DOI 10.1038/s41569-020-0413-9
   Park KC, 2017, CARDIOVASC RES, V113, P1708, DOI 10.1093/cvr/cvx183
   Puntmann VO, 2020, JAMA CARDIOL, V5, P1265, DOI 10.1001/jamacardio.2020.3557
   Santoso A, 2021, AM J EMERG MED, V44, P352, DOI 10.1016/j.ajem.2020.04.052
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Stawicki SP, 2020, J GLOB INFECT DIS, V12, P47, DOI 10.4103/jgid.jgid_86_20
   Szekely Y, 2020, CIRCULATION, V142, P342, DOI 10.1161/CIRCULATIONAHA.120.047971
   Vasile VC, 2010, AM J MED, V123, P1049, DOI 10.1016/j.amjmed.2010.06.021
   Velavan TP, 2020, INT J INFECT DIS, V95, P304, DOI 10.1016/j.ijid.2020.04.061
   Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]
   Wei JF, 2020, HEART, V106, P1154, DOI 10.1136/heartjnl-2020-317007
   Yu YT, 2020, PEERJ, V8, DOI 10.7717/peerj.9885
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 28
TC 4
Z9 4
U1 0
U2 0
PU BOHN STAFLEU VAN LOGHUM BV
PI HOUTEN
PA POSTBUS 246, 3990 GA HOUTEN, NETHERLANDS
SN 1568-5888
EI 1876-6250
J9 NETH HEART J
JI Neth. Heart J.
PD MAY
PY 2021
VL 29
IS SUPPL 1
SU 1
SI SI
BP 5
EP 12
DI 10.1007/s12471-021-01571-w
EA APR 2021
PG 8
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA RQ4SL
UT WOS:000640758600005
PM 33860908
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Lazaridis, C
   Vlachogiannis, NI
   Bakogiannis, C
   Spyridopoulos, I
   Stamatelopoulos, K
   Kanakakis, I
   Vassilikos, V
   Stellos, K
AF Lazaridis, Charalampos
   Vlachogiannis, Nikolaos, I
   Bakogiannis, Constantinos
   Spyridopoulos, Ioakim
   Stamatelopoulos, Kimon
   Kanakakis, Ioannis
   Vassilikos, Vassilios
   Stellos, Konstantinos
TI Involvement of cardiovascular system as the critical point in
   coronavirus disease 2019 (COVID-19) prognosis and recovery
SO HELLENIC JOURNAL OF CARDIOLOGY
LA English
DT Review
DE COVID-19; SARS-CoV-2; Pandemic; Cardiovascular comorbidities;
   Cardiovascular complications
ID RENIN-ANGIOTENSIN SYSTEM; CONVERTING ENZYME 2; KAWASAKI-LIKE DISEASE;
   VIRAL MYOCARDITIS; ESC GUIDELINES; SARS-COV-2; RECEPTOR; HEART; ACE2;
   INFECTION
AB The novel coronavirus disease 2019 (COVID-19) pandemic has already caused more than 300,000 deaths worldwide. Several studies have elucidated the central role of cardiovascular complications in the disease course. Herein, we provide a concise review of current knowledge regarding the involvement of cardiovascular system in the pathogenesis and prognosis of COVID-19. We summarize data from 21 studies involving in total more than 21,000 patients from Asia, Europe, and the USA indicating that severe disease is associated with the presence of myocardial injury, heart failure, and arrhythmias. Additionally, we present the clinical and laboratory differences between recovered and deceased patients highlighting the importance of cardiac manifestations. For the infected patients, underlying cardiovascular comorbidities and particularly existing cardiovascular disease seem to predispose to the development of cardiovascular complications, which are in turn associated with higher mortality rates. We provide mechanistic insights into the underlying mechanisms including direct myocardial damage by the virus and the consequences of the hyperinflammatory syndrome developed later in the disease course. Finally, we summarize current knowledge on therapeutic modalities and recommendations by scientific societies and experts regarding the cardiovascular management of patients with COVID-19. (C) 2020 Hellenic Society of Cardiology. Publishing services by Elsevier B.V.
C1 [Lazaridis, Charalampos; Vlachogiannis, Nikolaos, I; Spyridopoulos, Ioakim; Stellos, Konstantinos] Newcastle Tyne Hosp NHS Fdn Trust, Freeman Hosp, Dept Cardiol, Newcastle Upon Tyne, Tyne & Wear, England.
   [Lazaridis, Charalampos; Bakogiannis, Constantinos; Vassilikos, Vassilios] Aristotle Univ Thessaloniki, Hippokrate Univ Hosp, Sch Med, Cardiol Dept 3, Thessaloniki, Greece.
   [Lazaridis, Charalampos; Vlachogiannis, Nikolaos, I; Stamatelopoulos, Kimon; Stellos, Konstantinos] Newcastle Univ, Fac Med Sci, Biosci Inst, Vasc Biol & Med Theme, Newcastle Upon Tyne, Tyne & Wear, England.
   [Spyridopoulos, Ioakim] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Vasc Biol & Med Theme, Newcastle Upon Tyne, Tyne & Wear, England.
   [Stamatelopoulos, Kimon; Kanakakis, Ioannis] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece.
RP Stellos, K (corresponding author), Newcastle Univ, Fac Med Sci, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.; Stellos, K (corresponding author), Newcastle Hosp NHS Fdn Trust, Int Ctr Life, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
EM konstantinos.stellos@ncl.ac.uk
RI Stellos, Konstantinos/ABH-1523-2021
OI Spyridopoulos, Ioakim/0000-0002-2750-2444; Stellos,
   Konstantinos/0000-0002-0194-0825; Bakogiannis,
   Constantinos/0000-0002-1132-9835; Vlachogiannis,
   Nikolaos/0000-0001-7878-8078
FU European Research Council (ERC) under the European Union's Horizon 2020
   research and innovation programEuropean Research Council (ERC) [759248];
   DFGGerman Research Foundation (DFG)European Commission [SFB834,
   75732319]; Hellenic Society of Cardiology
FX Dr. K. Stellos is supported by grants from the European Research Council
   (ERC) under the European Union's Horizon 2020 research and innovation
   program (grant agreement No 759248) and the DFG (SFB834 project number
   75732319). Dr. C. Lazaridis is supported by a scholarship from the
   Hellenic Society of Cardiology.
CR Adler Y, 2015, EUR HEART J, V36, P2873, DOI 10.1093/eurheartj/ehv479
   Alifano M, 2020, BIOCHIMIE, V174, P30, DOI 10.1016/j.biochi.2020.04.008
   American College of Cardiology A, 2020, COVID 19 CLIN GUIDAN
   Ammirati E, 2018, CIRCULATION, V138, P1088, DOI 10.1161/CIRCULATIONAHA.118.035319
   [Anonymous], [No title captured]
   Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326
   ASCIERTO PA, 2020, J IMMUNOTHER CANCER, V8, DOI DOI 10.1136/JITC-2020-000878
   Atefi G, 2011, FASEB J, V25, P2500, DOI 10.1096/fj.11-183236
   Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Badorff C, 2004, MED MICROBIOL IMMUN, V193, P121, DOI 10.1007/s00430-003-0189-7
   Bonow RO, 2020, JAMA CARDIOL, V5, P751, DOI 10.1001/jamacardio.2020.1105
   Caforio ALP, 2013, EUR HEART J, V34, P2636, DOI 10.1093/eurheartj/eht210
   Cavusoglu Y, 2019, HELL J CARDIOL, V60, P117, DOI 10.1016/j.hjc.2018.03.006
   Chen D, 2020, MEDRXIV, V29, DOI [10.1101/2020.02.27.20028530v1, DOI 10.1101/2020.02.27.20028530V1]
   Chen L, 2020, CARDIOVASC RES, V116, P1097, DOI 10.1093/cvr/cvaa078
   Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   Choy EH, 2020, NAT REV RHEUMATOL, V16, P335, DOI 10.1038/s41584-020-0419-z
   COLSON P, 2020, INT J ANTIMICROB AG, V55, DOI [10.1016/j.ijantimicag.2020.105932, DOI 10.1016/J.IJANTIMICAG.2020.105932]
   Corrales-Medina VF, 2012, CIRCULATION, V125, P773, DOI 10.1161/CIRCULATIONAHA.111.040766
   Critchley JA, 2018, DIABETES CARE, V41, P2127, DOI 10.2337/dc18-0287
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   Danser AHJ, 2020, HYPERTENSION, V75, P1382, DOI 10.1161/HYPERTENSIONAHA.120.15082
   Deftereos SG, 2020, HELL J CARDIOL, V61, P42, DOI 10.1016/j.hjc.2020.03.002
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Dong M, 2011, INT J CARDIOL, V147, P479, DOI 10.1016/j.ijcard.2011.01.035
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1
   Doyen D, 2020, LANCET, V395, P1516, DOI 10.1016/S0140-6736(20)30912-0
   Du Toit A, 2020, NAT REV MICROBIOL, V18, P123, DOI 10.1038/s41579-020-0332-0
   Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283
   ESC Council on Hypertension, 2020, POSITION STATEMENT E
   Esler M, 2020, J HYPERTENS, V38, P781, DOI 10.1097/HJH.0000000000002450
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Felker GM, 2000, J AM COLL CARDIOL, V36, P227, DOI 10.1016/S0735-1097(00)00690-2
   FERRO G, 1995, CIRCULATION, V92, P342, DOI 10.1161/01.CIR.92.3.342
   Freeman EJ, 1996, HYPERTENSION, V28, P104, DOI 10.1161/01.HYP.28.1.104
   Fu LW, 2020, J INFECTION, V80, P656, DOI 10.1016/j.jinf.2020.03.041
   Fung G, 2016, CIRC RES, V118, P496, DOI 10.1161/CIRCRESAHA.115.306573
   Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757
   Gao L, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01352-w
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gembardt F, 2005, PEPTIDES, V26, P1270, DOI 10.1016/j.peptides.2005.01.009
   Giudicessi JR, 2020, MAYO CLIN PROC, V95, P1213, DOI 10.1016/j.mayocp.2020.03.024
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   Greek National Organization of Public Health, 2020, DAILY REPORT
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020
   Guo C., 2020, BIORXIV PREPRINT, DOI [10.1101/2020.04.08.029769, DOI 10.1101/2020.04.08.029769]
   Guo JY, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016219
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Han H, 2020, J MED VIROL, V92, P819, DOI 10.1002/jmv.25809
   Han YL, 2020, CIRCULATION, V141, pE810, DOI 10.1161/CIRCULATIONAHA.120.047011
   Hansson GK, 2015, J INTERN MED, V278, P483, DOI 10.1111/joim.12406
   HFSA/ACC/AHA Statement Addresses Concerns Re, 2020, USING RAAS ANTAGONIS
   Hoffmann M, 2020, NOVEL CORONAVIRUS 20, P1, DOI [10.1016/j.cell.2020.02.052, 10.1101/2020.01.31.929042, DOI 10.1101/2020.01.31.929042]
   Hu HD, 2021, EUR HEART J, V42, P206, DOI 10.1093/eurheartj/ehaa190
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang R, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008280
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Iacobucci G, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1106
   Inciardi RM, 2020, JAMA CARDIOL, V5, P819, DOI 10.1001/jamacardio.2020.1096
   Jaffe AS., 2018, GLOB HEART, V40, P237, DOI 10.5603/KP.2018.0203
   Jiang F, 2014, NAT REV CARDIOL, V11, P413, DOI 10.1038/nrcardio.2014.59
   Johnson HC, 2020, EUROSURVEILLANCE, V25, P8, DOI 10.2807/1560-7917.ES.2020.25.9.2000202
   Joseph Norman, 2020, SYSTEMIC RISK PANDEM
   Koutsoukis A, 2019, HELL J CARDIOL, V60, P211, DOI 10.1016/j.hjc.2019.01.001
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Kuhl U, 2005, CIRCULATION, V112, P1965, DOI 10.1161/CIRCULATIONAHA.105.548156
   Kumar A, 1996, J EXP MED, V183, P949, DOI 10.1084/jem.183.3.949
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105946
   Lakkireddy DR, 2020, CIRCULATION, V141, pE823, DOI 10.1161/CIRCULATIONAHA.120.047063
   Lechien JR, 2020, J INTERN MED, V288, P335, DOI 10.1111/joim.13089
   Leroy EM, 2020, ONE HEALTH-AMSTERDAM, V10, DOI 10.1016/j.onehlt.2020.100133
   Li KH, 2020, INVEST RADIOL, V55, P327, DOI 10.1097/RLI.0000000000000672
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Li XC, 2017, PHARMACOL RES, V125, P21, DOI 10.1016/j.phrs.2017.06.005
   Libby P, 2020, JACC-BASIC TRANSL SC, V5, P537, DOI 10.1016/j.jacbts.2020.04.001
   Lippi G, 2020, EUR J INTERN MED, V75, P107, DOI 10.1016/j.ejim.2020.03.014
   Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022
   Liu Q, 2016, CELL MOL IMMUNOL, V13, P3, DOI 10.1038/cmi.2015.74
   Liu YW, 2020, J AM STAT ASSOC, DOI 10.1080/01621459.2020.1831926
   Liu YW, 2020, J INFECTION, V81, pE6, DOI 10.1016/j.jinf.2020.04.002
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Magagnoli J, 2020, MED-CAMBRIDGE, V1, P114, DOI [10.1016/j.medj.2020.06.001, 10.1101/2020.04.16.20065920]
   Marques-Da-Silva C, 2011, BRIT J PHARMACOL, V163, P912, DOI 10.1111/j.1476-5381.2011.01254.x
   Matsuyama S, 2020, P NATL ACAD SCI USA, V117, P7001, DOI 10.1073/pnas.2002589117
   Maude SL, 2014, CANCER J, V20, P119, DOI 10.1097/PPO.0000000000000035
   McCollum LT, 2012, PEPTIDES, V34, P380, DOI 10.1016/j.peptides.2012.01.020
   Mehra MR, 2020, NEW ENGL J MED, V18382, pE102
   Mehta Puja, 2020, Lancet, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4
   Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P9122, DOI 10.1073/pnas.2004064117
   Molina JM, 2020, MED MALADIES INFECT, V50, P384, DOI 10.1016/j.medmal.2020.03.006
   Monteil V, 2020, CELL, V181, P905, DOI 10.1016/j.cell.2020.04.004
   Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993
   Musher DM, 2019, NEW ENGL J MED, V380, P171, DOI 10.1056/NEJMra1808137
   Nicin L, 2020, EUR HEART J, V41, P1804, DOI 10.1093/eurheartj/ehaa311
   Nikolaou M, 2018, HELL J CARDIOL, V59, P60, DOI 10.1016/j.hjc.2017.08.003
   Oakes JM, 2018, AM J PHYSIOL-REG I, V315, pR895, DOI 10.1152/ajpregu.00099.2018
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227
   Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9
   Owens Ben, 2020, HEALTH SERV J
   Pan XF, 2020, LANCET INFECT DIS, V20, P410, DOI 10.1016/S1473-3099(20)30114-6
   Patel AB, 2020, JAMA-J AM MED ASSOC, V323, P1769, DOI 10.1001/jama.2020.4812
   Patel VB, 2016, CIRC RES, V118, P1313, DOI 10.1161/CIRCRESAHA.116.307708
   Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2013400, 10.1056/NEJMc2011400]
   Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248
   Qiu CF, 2020, J MED VIROL, V92, P2027, DOI 10.1002/jmv.25975
   Reynolds HR, 2020, NEW ENGL J MED, V382, P2441, DOI 10.1056/NEJMoa2008975
   Richardson S., 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.7681, 10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775]
   Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623
   Romani-Perez M, 2015, ENDOCRINOLOGY, V156, P3559, DOI 10.1210/en.2014-1685
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Sama IE, 2020, EUR HEART J, V41, P1810, DOI 10.1093/eurheartj/ehaa373
   Sampaio WO, 2007, HYPERTENSION, V50, P1093, DOI 10.1161/HYPERTENSIONAHA.106.084848
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Severino A, 2012, GEN PHYSIOL BIOPHYS, V31, P439, DOI 10.4149/gpb_2012_047
   Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y
   Shauer A, 2013, ISR MED ASSOC J, V15, P180
   Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005
   Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015
   Shi SB, 2020, EUR HEART J, V41, P2070, DOI 10.1093/eurheartj/ehaa408
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Skulstad H, 2020, EUR HEART J-CARD IMG, V21, P592, DOI 10.1093/ehjci/jeaa072
   South AM, 2020, AM J PHYSIOL-HEART C, V318, pH1084, DOI 10.1152/ajpheart.00217.2020
   Spiteri G, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.9.2000178
   SUFFREDINI AF, 1989, NEW ENGL J MED, V321, P280, DOI 10.1056/NEJM198908033210503
   Tam CCF, 2020, CIRC-CARDIOVASC QUAL, V13, DOI 10.1161/CIRCOUTCOMES.120.006631
   Tignanelli CJ, 2020, LANCET RESP MED, V8, pE30, DOI 10.1016/S2213-2600(20)30153-3
   To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149
   Touyz RM, 2000, PHARMACOL REV, V52, P639
   U.S. Food and Drug Administration, 2020, REQUEST EMERGENCY US
   Vardavas CI, 2020, TOB INDUC DIS, V18, DOI 10.18332/tid/119324
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Verdecchia P, 2020, EUR J INTERN MED, V76, P14, DOI 10.1016/j.ejim.2020.04.037
   Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X
   VERNY C, 1992, PRESSE MED, V21, P800
   Vieillard-Baron A, 2014, INTENS CARE MED, V40, P1560, DOI 10.1007/s00134-014-3367-8
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Viner RM, 2020, LANCET, V395, P1741, DOI 10.1016/S0140-6736(20)31129-6
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang QM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz7086
   Wang W, 2015, SEMIN ARTHRITIS RHEU, V44, P405, DOI 10.1016/j.semarthrit.2014.07.007
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Wei JF, 2020, HEART, V106, P1154, DOI 10.1136/heartjnl-2020-317007
   Wolrd Health Organization, NOVEL CORONAVIRUS 20
   World Health Organization, 2020, SUMMARY PROBABLE SAR
   World Health Organization, CORONAVIRUS DIS COVI
   World Health Organization, 2016, MIDDL E RESP SYNDR C
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xiao Y., 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa270, DOI 10.1093/CID/CIAA270]
   Xu PY, 2020, ANN HEMATOL, V99, P1205, DOI 10.1007/s00277-020-04019-0
   Xu X, 2020, EUR J NUCL MED MOL I, V47, P1275, DOI 10.1007/s00259-020-04735-9
   Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yang X., 2020, Lancet Respir. Med, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Yeo C, 2020, LANCET GASTROENTEROL, V5, P335, DOI 10.1016/S2468-1253(20)30048-0
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zeng J, 2020, INFECTION 0410, DOI [10.20944/preprints202003.0180.v1, DOI 10.1007/S15010-020-01424-5, 10.1007/s15010-020-01424-5]
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
   Zhang P, 2020, CIRC RES, V126, P1671, DOI 10.1161/CIRCRESAHA.120.317134
   Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
   Zimmermann P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00302
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 181
TC 25
Z9 25
U1 0
U2 0
PU HELLENIC CARDIOLOGICAL SOC
PI ATHENS
PA 6 POTAMIANOU ST, ATHENS, 11528, GREECE
SN 1109-9666
EI 2241-5955
J9 HELL J CARDIOL
JI Hell. J. Cardiol.
PD NOV-DEC
PY 2020
VL 61
IS 6
BP 381
EP 395
DI 10.1016/j.hjc.2020.05.004
PG 15
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA RB1PP
UT WOS:000631888600005
PM 32534109
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Fan, E
   Beitler, JR
   Brochard, L
   Calfee, CS
   Ferguson, ND
   Slutsky, AS
   Brodie, D
AF Fan, Eddy
   Beitler, Jeremy R.
   Brochard, Laurent
   Calfee, Carolyn S.
   Ferguson, Niall D.
   Slutsky, Arthur S.
   Brodie, Daniel
TI COVID-19-associated acute respiratory distress syndrome: is a different
   approach to management warranted?
SO LANCET RESPIRATORY MEDICINE
LA English
DT Article
ID ACUTE LUNG INJURY; END-EXPIRATORY PRESSURE; LOWER TIDAL VOLUMES;
   MECHANICAL VENTILATION; SUBPHENOTYPES; CARE; EPIDEMIOLOGY; REDUCTION;
   OUTCOMES
AB The COVID-19 pandemic has seen a surge of patients with acute respiratory distress syndrome (ARDS) in intensive care units across the globe. As experience of managing patients with COVID-19-associated ARDS has grown, so too have efforts to classify patients according to respiratory system mechanics, with a view to optimising ventilatory management. Personalised lung-protective mechanical ventilation reduces mortality and has become the mainstay of treatment in ARDS. In this Viewpoint, we address ventilatory strategies in the context of recent discussions on phenotypic heterogeneity in patients with COVID-19-associated ARDS. Although early reports suggested that COVID-19-associated ARDS has distinctive features that set it apart from historical ARDS, emerging evidence indicates that the respiratory system mechanics of patients with ARDS, with or without COVID-19, are broadly similar. In the absence of evidence to support a shift away from the current paradigm of ventilatory management, we strongly recommend adherence to evidence-based management, informed by bedside physiology, as resources permit.
C1 [Fan, Eddy; Brochard, Laurent; Ferguson, Niall D.; Slutsky, Arthur S.] Univ Toronto, Dept Med, Interdept Div Crit Care Med, Toronto, ON, Canada.
   [Fan, Eddy; Ferguson, Niall D.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
   [Fan, Eddy; Ferguson, Niall D.] Univ Hlth Network & Sinai Hlth Syst, Dept Med, Toronto, ON, Canada.
   [Beitler, Jeremy R.; Brodie, Daniel] New York Presbyterian Med Ctr, Ctr Acute Resp Failure, New York, NY USA.
   [Beitler, Jeremy R.; Brodie, Daniel] Columbia Univ Coll Phys & Surg, Dept Med, Div Pulm Allergy & Crit Care Med, New York, NY USA.
   [Brochard, Laurent; Slutsky, Arthur S.] Unity Hlth Toronto, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Calfee, Carolyn S.] Univ Calif San Francisco, Dept Med, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA 94143 USA.
RP Fan, E (corresponding author), Univ Toronto, Interdept Div Crit Care Med, Toronto, ON M5G 2N2, Canada.
EM eddy.fan@uhn.ca
RI Ferguson, Niall/D-7619-2019; Slutsky, Arthur/M-3325-2019
OI Ferguson, Niall/0000-0002-6213-5264; 
FU NHLBI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [R21 HL145506, R35 HL140026, K23 HL133489] Funding
   Source: Medline
CR Abrams D, 2019, LANCET RESP MED
   Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639
   Angus DC, 2020, JAMA-J AM MED ASSOC, V323, P1895, DOI 10.1001/jama.2020.4984
   Bellani G, 2017, AM J RESP CRIT CARE, V195, P67, DOI 10.1164/rccm.201606-1306OC
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500
   Bos LDJ, 2020, ANN AM THORAC SOC, V17, P1161, DOI 10.1513/AnnalsATS.202004-376RL
   Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218
   Brochard L, 2017, AM J RESP CRIT CARE, V195, P438, DOI 10.1164/rccm.201605-1081CP
   Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801
   Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9
   Chen L, 2020, AM J RESP CRIT CARE, V201, P178, DOI 10.1164/rccm.201902-0334OC
   Cook DJ, 2020, JAMA-J AM MED ASSOC, V323, P1559, DOI 10.1001/jama.2020.5775
   Coppo A, 2020, LANCET RESP MED, V8, P765, DOI 10.1016/S2213-2600(20)30268-X
   Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2
   DANTZKER DR, 1980, CHEST, V77, P636, DOI 10.1378/chest.77.5.636
   Delucchi K, 2018, THORAX, V73, P439, DOI 10.1136/thoraxjnl-2017-211090
   Elharrar X, 2020, JAMA-J AM MED ASSOC, V323, P2336, DOI 10.1001/jama.2020.8255
   Famous KR, 2017, AM J RESP CRIT CARE, V195, P331, DOI 10.1164/rccm.201603-0645OC
   Fan E, 2018, JAMA-J AM MED ASSOC, V319, P698, DOI 10.1001/jama.2017.21907
   Fan E, 2017, AM J RESP CRIT CARE, V195, P1253, DOI 10.1164/rccm.201703-0548ST
   Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2
   Gattinoni L, 2020, AM J RESP CRIT CARE, V201, P1299, DOI 10.1164/rccm.202003-0817LE
   Grasselli G, 2020, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2020.5394., DOI 10.1001/JAMA.2020.5394.]
   Griffiths MJD, 2019, BMJ OPEN RESPIR RES, V6, DOI 10.1136/bmjresp-2019-000420
   Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103
   Hager DN, 2005, AM J RESP CRIT CARE, V172, P1241, DOI 10.1164/rccm.200501-048CP
   Haudebourg AF, 2020, AM J RESP CRIT CARE, V202, P287, DOI 10.1164/rccm.202004-1226LE
   Hoegl S, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13648
   Lellouche F, 2020, CHEST, V158, P45, DOI 10.1016/j.chest.2020.02.033
   Lyazidi A, 2010, INTENS CARE MED, V36, P2074, DOI 10.1007/s00134-010-2044-9
   Marini JJ, 2020, JAMA-J AM MED ASSOC, V323, P2329, DOI 10.1001/jama.2020.6825
   Morales-Quinteros L, 2019, INTENS CARE MED EXP, V7, DOI 10.1186/s40635-019-0239-0
   Munshi L, 2017, ANN AM THORAC SOC, V14, pS280, DOI 10.1513/AnnalsATS.201704-343OT
   Neto AS, 2012, JAMA-J AM MED ASSOC, V308, P1651, DOI 10.1001/jama.2012.13730
   Nin N, 2017, INTENS CARE MED, V43, P200, DOI 10.1007/s00134-016-4611-1
   Pan C, 2020, AM J RESP CRIT CARE, V201, P1294, DOI 10.1164/rccm.202003-0527LE
   Papazian L, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0540-9
   Phua J, 2020, LANCET RESP MED, V8, P506, DOI 10.1016/S2213-2600(20)30161-2
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Reddy K, 2020, LANCET RESP MED, V8, P631, DOI 10.1016/S2213-2600(20)30124-7
   Rochwerg B, 2020, CRITICAL CARE EXPLOR, V2
   Sahetya SK, 2017, AM J RESP CRIT CARE, V195, P1429, DOI 10.1164/rccm.201610-2035CI
   Sartini C, 2020, JAMA-J AM MED ASSOC, V323, P2338, DOI 10.1001/jama.2020.7861
   Schaller T, 2020, JAMA-J AM MED ASSOC, V323, P2518, DOI 10.1001/jama.2020.8907
   Schenck EJ, 2020, ANN AM THORAC SOC, V17, P1158, DOI 10.1513/AnnalsATS.202005-427RL
   Singer BD, 2020, AM J RESP CELL MOL, V63, P132, DOI 10.1165/rcmb.2020-0151LE
   SUTER PM, 1975, NEW ENGL J MED, V292, P284, DOI 10.1056/NEJM197502062920604
   Tobin MJ, 2020, AM J RESP CRIT CARE, V201, P1319, DOI 10.1164/rccm.202004-1076ED
   Tonelli R, 2020, AM J RESP CRIT CARE, V202, P558, DOI 10.1164/rccm.201912-2512OC
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   Wunsch H, 2020, AM J RESP CRIT CARE, V202, P1, DOI 10.1164/rccm.202004-1385ED
   Yoshida T, 2017, AM J RESP CRIT CARE, V195, P985, DOI 10.1164/rccm.201604-0748CP
   Ziehr DR, 2020, AM J RESP CRIT CARE, V201, P1560, DOI 10.1164/rccm.202004-1163LE
NR 54
TC 194
Z9 197
U1 5
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2213-2600
J9 LANCET RESP MED
JI Lancet Resp. Med.
PD AUG
PY 2020
VL 8
IS 8
BP 816
EP 821
DI 10.1016/S2213-2600(20)30304-0
PG 6
WC Critical Care Medicine; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Respiratory System
GA MZ1FJ
UT WOS:000558867100021
PM 32645311
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Saddik, B
   Hussein, A
   Sharif-Askari, FS
   Kheder, W
   Temsah, MH
   Koutaich, RA
   Haddad, ES
   Al-Roub, NM
   Marhoon, FA
   Hamid, Q
   Halwani, R
AF Saddik, Basema
   Hussein, Amal
   Sharif-Askari, Fatemeh Saheb
   Kheder, Waad
   Temsah, Mohamad-Hani
   Koutaich, Rim Adnan
   Haddad, Enad Sami
   Al-Roub, Nora Marwan
   Marhoon, Fatema Adel
   Hamid, Qutayba
   Halwani, Rabih
TI Increased Levels of Anxiety Among Medical and Non-Medical University
   Students During the COVID-19 Pandemic in the United Arab Emirates
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19; anxiety; medical students; GAD-7; United Arab Emirates
ID EAST RESPIRATORY SYNDROME; HEALTH-CARE; EPIDEMIC; STRESS
AB Introduction: The COVID-19 pandemic is likely to increase anxiety levels within the community and in particular medical students who are already considered psychologically vulnerable groups. Since the COVID-19 outbreak, no study has yet estimated the effect of this pandemic on university students in the UAE or its impact on the psychological well-being of medical students.
   Methods and Materials: We surveyed 1485 medical (comprising medical and dental) and non-medical university students across 4 emirates within the UAE. We used an online platform to assess knowledge, sources of information, changes in hygienic behavior, perceptions of fear and worry and anxiety levels using the generalized anxiety disorder 7 (GAD-7) scale. The GAD-7 score was measured at three time points: during hospital visits for medical/dental students, before the introduction of online learning and after online learning for all students.
   Results: The majority of students demonstrated high levels of knowledge and utilized reliable sources of information. Non-medical students exercised higher compliance with social restrictions, while medical students practiced better hand hygiene. Almost half of students reported anxiety levels ranging from mild to severe with females reporting higher anxiety scores during hospital visits (OR=2.02, 95% CI, 1.41 to 2.91) and medical students reporting lower anxiety levels in comparison to dental students (OR=0.61, 95% CI, 0.45 to 0.84). Medical students reported higher levels of anxiety during their clinical rotations which decreased with the introduction of online learning, yet, non-medical students' anxiety levels increased with online learning.
   Conclusion: This study provides important information on the initial response and anxiety levels in university students across the UAE during the COVID-19 pandemic. The findings from our study can be used to support the development of effective screening strategies and interventions to build psychological resilience among university students during the COVID-19 pandemic or any other public health emergencies in the future.
C1 [Saddik, Basema; Hussein, Amal] Univ Sharjah, Coll Med, Dept Family & Community Med, Sharjah, U Arab Emirates.
   [Saddik, Basema; Sharif-Askari, Fatemeh Saheb; Hamid, Qutayba; Halwani, Rabih] Univ Sharjah, Coll Med, Sharjah Inst Med Res, Sharjah, U Arab Emirates.
   [Kheder, Waad] Univ Sharjah, Coll Dent Med, Sharjah, U Arab Emirates.
   [Temsah, Mohamad-Hani] King Saud Univ, Fac Med, Dept Pediat, Prince Abdullah Ben Khaled Celiac Dis Res Chair, Riyadh, Saudi Arabia.
   [Koutaich, Rim Adnan; Haddad, Enad Sami; Al-Roub, Nora Marwan; Marhoon, Fatema Adel; Hamid, Qutayba; Halwani, Rabih] Univ Sharjah, Coll Med, Dept Clin Sci, Sharjah, U Arab Emirates.
RP Halwani, R (corresponding author), Univ Sharjah, Coll Med, Sharjah Inst Med Res, Sharjah, U Arab Emirates.; Halwani, R (corresponding author), Univ Sharjah, Coll Med, Dept Clin Sci, Sharjah, U Arab Emirates.
EM rhalwani@sharjah.ac.ae
RI Hussein, Amal/ABC-1428-2021; Temsah, Mohamad-Hani/AAJ-9703-2020
OI Hussein, Amal/0000-0002-0708-8119; Saddik, Basema/0000-0002-4682-5927
FU Clinical Epidemiology Research group operational grant [150389];
   University of Sharjah, UAE [CoV19-0301, CoV19-0307, 2001090275,
   2001090278]; Prince Abdullah Ben Khalid Celiac Disease Research Chair,
   under the Vice Deanship of Research Chairs, King Saud University,
   Riyadh, Kingdom of Saudi Arabia
FX This research has been financially supported by Clinical Epidemiology
   Research group operational grant (Grant code: 150389); COVID-19 research
   grant (CoV19-0301) to BS, University of Sharjah, UAE; COVID-19 research
   grant (CoV19-0307), Seed grant (Grant code: 2001090275); and
   collaborative research grant (Grant code: 2001090278) to RH, University
   of Sharjah, UAE; and by Prince Abdullah Ben Khalid Celiac Disease
   Research Chair, under the Vice Deanship of Research Chairs, King Saud
   University, Riyadh, Kingdom of Saudi Arabia.
CR Aboalshamat K, 2015, MED TEACH, V37, pS75, DOI 10.3109/0142159X.2015.1006612
   Abouammoh N, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02039-y
   Ahmad FA, 2017, J DENT EDUC, V81, P534, DOI 10.21815/JDE.016.026
   Ahmed MA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082821
   Al Saadi T, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-017-1012-2
   Al-Rabiaah A, 2020, J INFECT PUBLIC HEAL, V13, P687, DOI 10.1016/j.jiph.2020.01.005
   Alahmadi AM, 2019, J HLTH INFORM DEV CT, V13
   Albarrak AI, 2019, J INFECT PUBLIC HEAL, DOI [10.1016/j.jiph.2019.06.02929., DOI 10.1016/J.JIPH.2019.06.02929]
   Alghobain M, 2017, EMERG MED INT, V2017, DOI 10.1155/2017/6978256
   Bao YP, 2020, LANCET, V395, pE37, DOI 10.1016/S0140-6736(20)30309-3
   Bueno-Notivol J, 2020, INT J CLIN HLTH PSYC, DOI [10.1016/j.ijchp.2020.07., DOI 10.1016/J.IJCHP.2020.07]
   Chao M, 2020, J ANXIETY DISORD, V74, DOI 10.1016/j.janxdis.2020.102248
   Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562
   Geldsetzer P, 2020, J MED INTERNET RES, V22, DOI 10.2196/18790
   Goulia P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-322
   Gritsenko V, 2021, INT J MENT HEALTH AD, V19, P2362, DOI 10.1007/s11469-020-00330-z
   Harper CA, 2021, INT J MENT HEALTH AD, V19, P1875, DOI 10.1007/s11469-020-00281-5
   IBM, 2017, IBM SPSS STAT WINDOW
   Islam MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238162
   Karasneh R, 2020, RES SOC ADMIN PHARM, DOI [10.1016/j. sapharm.2020.04.02730., DOI 10.1016/J.SAPHARM.2020.04.02730]
   Khan MU, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1281
   Kim S, 2018, INT J ENV RES PUBLIC, V15
   Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004
   Liu NQ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112921
   Lu W, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112936
   Maunder RG, 2006, EMERG INFECT DIS, V12, P1924
   Mertens G, 2020, J ANXIETY DISORD, V74, DOI 10.1016/j.janxdis.2020.102258
   Murphy RJ, 2009, J DENT EDUC, V73, P328
   Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757
   Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213
   Quek TTC, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16152735
   Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066
   Rastegar KA, 2020, MED EDUC, V54, P762, DOI DOI 10.1111/MEDU.1420628
   Roberto Alice, 2011, Acta Med Port, V24 Suppl 2, P279
   Ryan BJ, 2020, DISASTER MED PUBLIC, V14, P623, DOI 10.1017/dmp.2020.109
   Sarfaraz S, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8030232
   Savitsky B, 2020, NURSE EDUC PRACT, V46, DOI 10.1016/j.nepr.2020.102809
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Sundarasen S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176206
   Trivate T, 2019, BMC MED EDUC, V19, DOI 10.1186/s12909-019-1871-9
   Wang C, 2020, INT J ENV RES PUBLIC, V17
   Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028
   Wong JGWS, 2004, MED TEACH, V26, P657, DOI 10.1080/01421590400006572
   Wong TW, 2007, STRESS HEALTH, V23, P31, DOI 10.1002/smi.1116
   World Health Organization, COR DIS COVID 19 OUT
   Yang S, 2017, AM J INFECT CONTROL, V45, pE53, DOI 10.1016/j.ajic.2017.02.013
   Zettler I., 2020, PSYARXIV
NR 47
TC 50
Z9 50
U1 4
U2 12
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2020
VL 13
BP 2395
EP 2406
DI 10.2147/RMHP.S273333
PG 12
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA OP8JV
UT WOS:000588337500001
PM 33177898
OA Green Published, gold, Green Submitted
DA 2022-04-20
ER

PT J
AU Curryer, C
   Russo, PL
   Kiernan, M
   Wares, KD
   Cert, KSG
   Mitchell, BG
AF Curryer, Cassie
   Russo, Philip L.
   Kiernan, Martin
   Wares, Karen D.
   Cert (Nurs), Kate Smith Grad
   Mitchell, Brett G.
TI Environmental hygiene, knowledge and cleaning practice: a
   phenomenological study of nurses and midwives during COVID-19
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Article
DE Infection prevention and control; Compliance; Shared patient equipment;
   Hospital design; Evidence-based learning; Organisational contexts
ID HEALTH-CARE WORKERS; INFECTION-CONTROL; ATTITUDES; HOSPITALS
AB Background: Environmental cleanliness is a fundamental tenet in nursing and midwifery but often overshadowed in practice. This study explored nurses' and midwives' knowledge and experiences of infection prevention and control (IPC) processes and cleaning, and perceptions about workplace risk-management during COVID-19. Methods: Six registered and enrolled nurses (one with dual midwife qualifications) were recruited. In-depth telephone interviews were analyzed using Colaizzi's phenomenological method. Results: Four major themes were identified: Striving towards environmental cleanliness; Knowledge and learning feeds good practice; There's always doubt in the back of your mind; and COVID has cracked it wide open. These articulate the nurses' and midwives' experiences and knowledge of IPC, particularly during COVID-19. Discussion: The findings emphasize the dynamic, interdependent nature of clinical (time, staff knowledge and compliance, work processes, hospital design) and organizational contexts and environmental cleanliness, which must be constantly maintained. COVID-19 opened up critical insights regarding poor past practices and lack of IPC compliance. Conclusions: COVID-19 has highlighted the criticality of environmental cleanliness within clinical and community settings. Evidence-based, experiential learning is important for nurses and midwives at all career stages, but provides only one solution. Clinician-led hospital design may also reduce the spread of infection; thus, promoting better patient care. (c) 2021 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
C1 [Curryer, Cassie; Kiernan, Martin; Wares, Karen D.; Cert (Nurs), Kate Smith Grad; Mitchell, Brett G.] Univ Newcastle, Sch Nursing & Midwifery, BE Bldg,10 Chittaway Rd, Ourimbah, NSW 2258, Australia.
   [Russo, Philip L.] Cabrini Inst, Dept Nursing Res, Malvern, Vic, Australia.
   [Russo, Philip L.] Monash Univ, Nursing & Midwifery, Frankston, Vic, Australia.
   [Wares, Karen D.] Univ West London, Richard Wells Res Ctr, Brentford, England.
   [Mitchell, Brett G.] Avondale Coll Higher Educ, Sch Nursing, Wahroonga, NSW, Australia.
RP Mitchell, BG (corresponding author), Univ Newcastle, Sch Nursing & Midwifery, BE Bldg,10 Chittaway Rd, Ourimbah, NSW 2258, Australia.
EM brett.mitchell@newcastle.edu.au
OI Mitchell, Brett/0000-0003-4220-8291
CR Adams V, 2021, AM J INFECT CONTROL, V49, P721, DOI 10.1016/j.ajic.2020.10.021
   Brown B, 2008, SOC SCI MED, V67, P1047, DOI 10.1016/j.socscimed.2008.06.016
   Colaizzi P., 1978, PSYCHOL RES PHENOMEN
   Dancer SJ, 2020, INFECT DIS HEALTH, V25, P223, DOI 10.1016/j.idh.2020.08.005
   Deyneko A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1535-x
   Emmanuel U, 2020, J ENVIRON HEALTH SCI, V18, P1699, DOI 10.1007/s40201-020-00580-y
   Fryk JJ, 2021, INFECT DIS HEALTH, V26, P95, DOI 10.1016/j.idh.2020.10.002
   Hall L, 2020, ANTIMICROB RESIST IN, V9, DOI 10.1186/s13756-020-0694-0
   Henderson J, 2020, COLLEGIAN, V27, P11, DOI 10.1016/j.colegn.2019.05.004
   Hou YC, 2020, J EMERG NURS, V46, P848, DOI 10.1016/j.jen.2020.07.008
   Houghton C, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013582
   Kang HS, 2018, INT J NURS PRACT, V24, DOI 10.1111/ijn.12664
   Meyer J, 2021, AM J INFECT CONTROL, V49, P40, DOI 10.1016/j.ajic.2020.06.187
   Mitchell BG, 2021, INFECT DIS HEALTH, V26, P55, DOI 10.1016/j.idh.2020.09.002
   Mitchell BG, 2019, LANCET INFECT DIS, V19, P410, DOI 10.1016/S1473-3099(18)30714-X
   Mitchell BG, 2017, INFECT DIS HEALTH, V22, P195, DOI 10.1016/j.idh.2017.08.001
   Moore D, 2005, AM J INFECT CONTROL, V33, P88, DOI 10.1016/j.ajic.2004.11.003
   Nasiri A, 2019, AM J INFECT CONTROL, V47, P827, DOI 10.1016/j.ajic.2018.11.022
   Park SH, 2020, INFECT CHEMOTHER, V52, P165, DOI 10.3947/ic.2020.52.2.165
   Pink S, 2020, HERD-HEALTH ENV RES, V13, P243, DOI 10.1177/1937586719900954
   Prin M, 2020, CAN J ANESTH, V67, P789, DOI 10.1007/s12630-020-01651-2
   Seibert DJ, 2014, AM J INFECT CONTROL, V42, P405, DOI 10.1016/j.ajic.2013.10.008
   Semret M, 2016, AM J INFECT CONTROL, V44, P1582, DOI 10.1016/j.ajic.2016.04.234
   Van Manen M., 1990, RES LIVED EXPERIENCE
   Walton H, 2020, EMERG MED J, V37, P768, DOI 10.1136/emermed-2020-210220
   Welsh CA, 2012, AM J INFECT CONTROL, V40, P29, DOI 10.1016/j.ajic.2011.02.017
   White NM, 2020, CLIN INFECT DIS, V70, P2461, DOI 10.1093/cid/ciz717
   Zimmerman PAP, 2020, NURSE EDUC PRACT, V44, DOI 10.1016/j.nepr.2020.102746
NR 28
TC 0
Z9 0
U1 2
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-6553
EI 1527-3296
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD SEP
PY 2021
VL 49
IS 9
BP 1123
EP 1128
DI 10.1016/j.ajic.2021.04.080
EA AUG 2021
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Infectious Diseases
GA UH1BD
UT WOS:000689673200006
PM 33915230
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Farmani, R
   Dalton, J
   Charalambous, B
   Lawson, E
   Bunney, S
   Cotterill, S
AF Farmani, R.
   Dalton, Joe
   Charalambous, Bambos
   Lawson, Elizabeth
   Bunney, Sarah
   Cotterill, Sarah
TI Intermittent water supply systems and their resilience to COVID-19: IWA
   IWS SG survey
SO AQUA-WATER INFRASTRUCTURE ECOSYSTEMS AND SOCIETY
LA English
DT Article
DE conversion; COVID-19; equity; intermittent water supply systems;
   resilience; SDGs
AB There is limited information about the current state of intermittent water supply (IWS) systems at the global level. A survey was carried out by the Intermittent Water Supply Specialist Group of the International Water Association (IWA IWS SG) to better understand the current state of these systems and challenges that water companies may have faced under COVID-19 pandemic and to capture successful management strategies applied by water utilities. The survey consisted of three parts: (1) general information about IWS systems, (2) current state of IWS and (3) resilience of IWS under COVID-19 conditions, as well as some questions about potential interventions in order to improve system performance in general and under future uncertain conditions. The survey responses were evaluated based on the Safe & SuRe resilience framework, assessing measures of mitigation, adaptation, coping and learning, and exploring organisational and operational responses of IWS utilities. Infrastructure capacity and water resources availability were identified as the main causes of intermittency in most water distribution systems, while intermittent electricity was considered as the main external cause. Participants indicated that some risk assessment process was in place; however, COVID-19 has surpassed any provisions made to address the risks. Lessons learnt highlighted the importance of financial resources, e-infrastructure for efficient system operation and communication with consumers, and the critical role of international knowledge transfer and the sharing of best practice guidelines for improving resilience and transitioning towards continuous water supply.
C1 [Farmani, R.; Lawson, Elizabeth] Univ Exeter, Ctr Water Syst, Exeter, Devon, England.
   [Dalton, Joe] HydrOptimise, MAZ Business Dev, Amwaj, Bahrain.
   [Charalambous, Bambos] Hydrocontrol Ltd, POB 71044, Limassol, Cyprus.
   [Bunney, Sarah] Imperial Coll, London, England.
   [Cotterill, Sarah] Univ Coll Dublin, Sch Civil Engn, Dublin, Ireland.
RP Farmani, R (corresponding author), Univ Exeter, Ctr Water Syst, Exeter, Devon, England.
EM r.farmani@exeter.ac.uk
RI Farmani, Raziyeh/D-3457-2012
OI Farmani, Raziyeh/0000-0001-8148-0488
FU Royal Academy of Engineering Industrial Fellowship; UKRI Engineering &
   Physical Sciences Research Council's Industrial Doctorate Centre STREAM
   [EP/L015412/1]
FX The authors would like to thank all participants for agreeing to take
   part in this research, IWA's IWS SG members for their support and IWA
   for facilitating the survey. Support was available from: a Royal Academy
   of Engineering Industrial Fellowship to support R. Farmani's involvement
   and the UKRI Engineering & Physical Sciences Research Council's
   Industrial Doctorate Centre STREAM [EP/L015412/1] to resource E.
   Lawson's
CR Abolnga H, 2020, GLOBAL WATER FORUM
   Bivins AW, 2017, ENVIRON SCI TECHNOL, V51, P7542, DOI 10.1021/acs.est.7b01014
   Burt Z, 2018, WORLD DEV, V109, P121, DOI 10.1016/j.worlddev.2018.04.011
   Butler D, 2017, GLOB CHALL, V1, P63, DOI 10.1002/gch2.1010
   Charalambous B., 2017, DEALING COMPLEX INTE
   Cotterill S, 2020, WATER ENVIRON J, V34, P715, DOI 10.1111/wej.12649
   Ercumen A, 2014, ENVIRON HEALTH PERSP, V122, P651, DOI 10.1289/ehp.1306912
   Galaitsi SE, 2016, WATER-SUI, V8, DOI 10.3390/w8070274
   Gullotta A., 2020, WATER RESOURCES PLAN
   ILO, 2016, UPGR WAT SAN SYST IN
   Klingel P, 2012, WATER SCI TECH-W SUP, V12, P504, DOI 10.2166/ws.2012.023
   Kumpel E, 2016, ENVIRON SCI TECHNOL, V50, P542, DOI 10.1021/acs.est.5b03973
   Meng F, 2018, WATER RES, V143, P376, DOI 10.1016/j.watres.2018.06.048
   Neal MJ, 2020, WATER INT, V45, P435, DOI 10.1080/02508060.2020.1773648
   Simukonda K, 2018, WATER PRACT TECHNOL, V13, P335, DOI 10.2166/wpt.2018.046
   Simukonda K, 2018, URBAN WATER J, V15, P488, DOI 10.1080/1573062X.2018.1483522
   Taylor DDJ, 2019, WATER RESOUR RES, V55, P5217, DOI 10.1029/2018WR024124
   Totsuka N., 2004, P 30 WEDC INT C, P505
   UK Cabinet Office, 2013, RES SOC INFR COMM BU
   UN, 2020, SDG6 GLOB ACC FRAM
   UN MDG Monitor, 2017, MDG 7 ENS ENV SUST
   UN-Water, 2016, WAT SAN INT 2030 AG
   United Nations, 2020, SUST DEV OUTL 2020 A
   Vairavamoorthy K, 2008, PHYS CHEM EARTH, V33, P330, DOI 10.1016/j.pce.2008.02.008
   Walton B, 2020, UTILITIES DEV COUNTR
   WHO/UNICEF, 2019, PROGR DRINKING WATER
   WHO-UNICEF, 2000, GLOB WAT SUPPL SAN A
NR 27
TC 2
Z9 2
U1 3
U2 6
PU IWA PUBLISHING
PI LONDON
PA ALLIANCE HOUSE, 12 CAXTON ST, LONDON SW1H0QS, ENGLAND
SN 2709-8028
EI 2709-8036
J9 AQUA-UK
JI AQUA
PD JUN
PY 2021
VL 70
IS 4
SI SI
BP 507
EP 520
DI 10.2166/aqua.2021.009
EA APR 2021
PG 14
WC Engineering, Civil; Water Resources
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Water Resources
GA SW0WM
UT WOS:000655015800001
OA hybrid
DA 2022-04-20
ER

PT J
AU Liu, M
   Chen, Y
   Shi, D
   Yan, TW
AF Liu, Mei
   Chen, You
   Shi, Dan
   Yan, Tingwu
TI The Public's Risk Information Seeking and Avoidance in China During
   Early Stages of the COVID-19 Outbreak
SO FRONTIERS IN PSYCHOLOGY
LA English
DT Article
DE information seeking; information avoidance; COVID-19; emerging risk;
   risk perception
AB This study uses the Planned Risk Information Seeking Model (PRISM) to estimate the public's information seeking and avoidance intentions during the COVID-19 outbreak based on an online sample of 1031 Chinese adults and provides support for the applicability of PRISM framework in the situation of a novel high-level risk. The results indicate that information seeking is primarily directed by informational subjective norms (ISN) and perceived seeking control (PSC), while the main predictors of information avoidance include ISN and attitude toward seeking. Because ISN are the strongest predictor of both information seeking and avoidance, the way the public copes with COVID-19 information may be strongly affected by individuals' social environment. Furthermore, a significant relationship between risk perception and affective risk response is identified. Our results also indicate that people who perceive greater knowledge of COVID-19 are more likely to report greater knowledge insufficiency, which results in less information avoidance.
C1 [Liu, Mei; Chen, You; Shi, Dan] Huazhong Agr Univ, Dept Business Adm, Coll Econ & Management, Wuhan, Peoples R China.
   [Yan, Tingwu] Huazhong Agr Univ, Dept Agr Econ & Management, Coll Econ & Management, Wuhan, Peoples R China.
RP Yan, TW (corresponding author), Huazhong Agr Univ, Dept Agr Econ & Management, Coll Econ & Management, Wuhan, Peoples R China.
EM yantw@mail.hzau.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [71603095]; Fundamental Research Funds for
   the Central Universities in China [2662016PY079]
FX This work was supported by the National Natural Science Foundation of
   China (Grant No. 71603095) and the Fundamental Research Funds for the
   Central Universities in China (Grant No. 2662016PY079).
CR Afifi WA, 2004, COMMUN THEOR, V14, P167, DOI 10.1093/ct/14.2.167
   Ajzen I, 2005, HANDBOOK OF ATTITUDES, P173
   Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Babrow AS, 2001, J COMMUN, V51, P553, DOI 10.1111/j.1460-2466.2001.tb02896.x
   Barbour JB, 2012, J HEALTH COMMUN, V17, P212, DOI 10.1080/10810730.2011.585691
   Brashers DE, 2002, HUM COMMUN RES, V28, P258, DOI 10.1093/hcr/28.2.258
   Brashers DE, 2000, COMMUN MONOGR, V67, P63, DOI 10.1080/03637750009376495
   Case DO, 2005, J MED LIBR ASSOC, V93, P353
   Dunwoody S., 2015, SAGE HDB RISK COMMUN, P102
   Eagly A.H., 1993, PSYCHOL ATTITUDES
   Eastin MS, 2015, HUM COMMUN RES, V41, P603, DOI 10.1111/hcre.12062
   Frijda N.H., 2004, FEELINGS EMOTIONS AM, P158, DOI [10.1017/CBO9780511806582.010, DOI 10.1080/14733140701561846]
   Griffin R.J., 1999, ANN CONVENTION INT C
   Griffin R. J., 2012, COMMUNICATION YB, V36, P323, DOI DOI 10.1080/23808985.2013.11679138
   Griffin RJ, 1999, ENVIRON RES, V80, pS230, DOI 10.1006/enrs.1998.3940
   Griffin RJ, 2004, MEDIA PSYCHOL, V6, P23, DOI 10.1207/s1532785xmep0601_2
   Griffin RJ, 2008, SCI COMMUN, V29, P285, DOI 10.1177/1075547007312309
   Hao XJ, 2020, NATURE, V584, P420, DOI 10.1038/s41586-020-2554-8
   Ho SS, 2014, SCI COMMUN, V36, P270, DOI 10.1177/1075547013520238
   Hovick SR, 2014, HEALTH COMMUN, V29, P656, DOI 10.1080/10410236.2012.763204
   Hovick SR, 2014, J HEALTH COMMUN, V19, P511, DOI 10.1080/10810730.2013.821556
   Howell JL, 2016, HEALTH PSYCHOL, V35, P816, DOI 10.1037/hea0000330
   Hubner AY, 2020, RISK ANAL, V40, P1212, DOI 10.1111/risa.13456
   International Monetary Fund, 2021, WORLD EC OUTLOOK UPD
   JOHNSON JD, 1993, HUM COMMUN RES, V19, P343, DOI 10.1111/j.1468-2958.1993.tb00305.x
   Kahlor LA, 2007, MEDIA PSYCHOL, V10, P414, DOI 10.1080/15213260701532971
   Kahlor LA, 2019, INT J DISAST RISK RE, V37, DOI 10.1016/j.ijdrr.2019.101147
   Kahlor L, 2010, HEALTH COMMUN, V25, P345, DOI 10.1080/10410231003775172
   KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x
   Lambert SD, 2007, QUAL HEALTH RES, V17, P1006, DOI 10.1177/1049732307305199
   Lep Z, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01846
   Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267
   Siebenhaar KU, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.567905
   Sweeny K, 2012, SELF IDENTITY, V11, P185, DOI 10.1080/15298868.2010.520902
   Sweeny K, 2010, REV GEN PSYCHOL, V14, P340, DOI 10.1037/a0021288
   Turner MM, 2006, HUM COMMUN RES, V32, P130, DOI 10.1111/j.1468-2958.2006.00006.x
   Viswanath K., 1996, COMMUNICATION YB, V19, P187, DOI [DOI 10.1080/23808985.1996.11678931, 10.1080/23808985.1996.11678931]
   Willoughby JF, 2016, J HEALTH COMMUN, V21, P696, DOI 10.1080/10810730.2016.1153764
   WINKLEBY MA, 1994, AM J PUBLIC HEALTH, V84, P767, DOI 10.2105/AJPH.84.5.767
   WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276
   WITTE K, 1994, COMMUN MONOGR, V61, P113, DOI 10.1080/03637759409376328
   World Health Organization, 2021, WHO CORONAVIRUS DASH
   World health organization (WHO), 2020, CORONAVIRUS
   Yang JZ, 2019, RISK ANAL, V39, P1708, DOI 10.1111/risa.13282
   Yang ZJ, 2014, J COMMUN, V64, P20, DOI 10.1111/jcom.12071
   Yang ZJ, 2013, SCI COMMUN, V35, P189, DOI 10.1177/1075547012441873
   Yang ZJ, 2012, RISK ANAL, V32, P1703, DOI 10.1111/j.1539-6924.2012.01799.x
   Yang ZJ, 2011, COMMUN RES, V38, P856, DOI 10.1177/0093650210380411
   Yang ZJ, 2010, HEALTH COMMUN, V25, P423, DOI 10.1080/10410236.2010.483338
   Yang ZJ, 2010, PATIENT EDUC COUNS, V79, P231, DOI 10.1016/j.pec.2009.08.010
   Zillmann D, 1985, SELECTIVE EXPOSURE C, P157
NR 52
TC 1
Z9 1
U1 26
U2 40
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-1078
J9 FRONT PSYCHOL
JI Front. Psychol.
PD MAR 12
PY 2021
VL 12
AR 649180
DI 10.3389/fpsyg.2021.649180
PG 12
WC Psychology, Multidisciplinary
WE Social Science Citation Index (SSCI)
SC Psychology
GA RC5RP
UT WOS:000632858500001
PM 33776873
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Natoli, S
   Carpenedo, R
   Chine, E
   Vannicola, F
   Leonardis, F
   Dauri, M
AF Natoli, S.
   Carpenedo, R.
   Chine, E.
   Vannicola, F.
   Leonardis, F.
   Dauri, M.
TI Should we be concerned when COVID-19-positive patients take opioids to
   control their pain? Insights from a pharmacological point of view
SO EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
LA English
DT Article
DE COVID-19; Opioids; Drug-drug interaction; CYP450 system
ID PHARMACOKINETIC DRUG-INTERACTIONS; RESPIRATORY-DISTRESS-SYNDROME;
   CONTROLLED-RELEASE OXYCODONE; CLINICAL-EVIDENCE; COVID-19; TAPENTADOL;
   MORPHINE; IMMUNE; METHADONE; RECEPTOR
AB OBJECTIVE: The purpose of this narrative review is to discuss the available information regarding the currently utilized COVID-19 therapies (and the evidence level supporting them) and opioids for chronic pain with a focus on warnings of potential interactions between these two therapeutic approaches.
   MATERIALS AND METHODS: Papers were retrieved from a PubMed search, using different combinations of keywords [e.g., pain treatment AND COVID-19 AND drug-drug interaction (DDI)], without limitations in terms of publication date and language.
   RESULTS: Remdesivir is an inhibitor of CYP3A4 and may increase the plasma concentration of CYP3A4 substrates (e.g., fentanyl). Dexamethasone is an inducer of CYP3A4 and glycoprotein P, thus coadministration with drugs metabolized by this isoform will lead to their increased clearance. Dexamethasone may cause hypokalemia, thus potentiating the risk of ventricular arrhythmias if it is given with opioids able to prolong the QT interval, such as oxycodone and methadone. Finally, the existing differences among opioids with regard to their impact on immune responses should also be taken into account with only tapentadol and hydromorphone appearing neutral on both cytokine production and immune parameters.
   CONCLUSIONS: Clinicians should keep in mind the frequent DDIs with drugs extensively metabolized by the CYP450 system and prefer opioids undergoing a limited hepatic metabolism. Identification and management of DDIs and dissemination of the related knowledge should be a major goal in the delivery of chronic care to ensure optimized patient outcomes and facilitate updating recommendations for COVID-19 therapy in frail populations, namely comorbid, poly-medicated patients or individuals suffering from substance use disorder.
C1 [Natoli, S.; Carpenedo, R.; Chine, E.] Polyclin Tor Vergata, Unit Pain Therapy, Rome, Italy.
   [Natoli, S.; Vannicola, F.; Dauri, M.] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy.
   [Leonardis, F.] Univ Roma Tor Vergata, Dept Surg, Rome, Italy.
RP Natoli, S (corresponding author), Polyclin Tor Vergata, Unit Pain Therapy, Rome, Italy.; Natoli, S (corresponding author), Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy.
EM silvia.natoli@uniroma2.it
RI Carpenedo, Roberta/AAA-1664-2022
OI LEONARDIS, Francesca/0000-0003-2523-5706; Carpenedo,
   Roberta/0000-0002-6653-510X
FU Grunenthal Italia s.r.l.
FX This work was supported by Grunenthal Italia s.r.l.
CR Abubakar AR, 2020, INFECT DRUG RESIST, V13, P4673, DOI 10.2147/IDR.S289037
   Al Rihani SB, 2020, ARCH PHARM PHARM RE, V2, DOI [10.33552/APPR.2020.02.000546, DOI 10.33552/APPR.2020.02.000546, 10.33552/ APPR.2020.02.000546]
   Angus DC, 2020, JAMA-J AM MED ASSOC, V324, P1317, DOI 10.1001/jama.2020.17022
   Armstrong SC, 2003, PSYCHOSOMATICS, V44, P167, DOI 10.1176/appi.psy.44.2.167
   Attal N, 2021, PAIN REP, V6, DOI 10.1097/PR9.0000000000000884
   Auyeung TW, 2005, J INFECTION, V51, P98, DOI 10.1016/j.jinf.2004.09.008
   Ayanga D, 2016, EXPERT OPIN PHARMACO, V17, P2307, DOI 10.1080/14656566.2016.1244529
   Bailey PL., 1994, INTRAVENOUS OPIOID A, P353
   Baron R, 2016, PAIN PRACT, V16, P580, DOI 10.1111/papr.12308
   Beigel JH, 2020, NEW ENGL J MED, V383, P994, DOI 10.1056/NEJMc2022236
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Brandariz-Nunez D, 2020, MED CLIN-BARCELONA, V155, P281, DOI [10.1016/j.medcli.2020.06.026, 10.1016/j.medcle.2020.06.012]
   Bruton L, 2018, PHARMACOLOGICAL BASI
   Butler SM, 2020, JAMA-J AM MED ASSOC, V323, P2450, DOI 10.1001/jama.2020.8484
   Chen SH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015375
   Choy KT, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104786
   Chugh SS, 2008, AM J MED, V121, P66, DOI 10.1016/j.amjmed.2007.10.009
   Clauw DJ, 2020, PAIN, V161, P1694, DOI 10.1097/j.pain.0000000000001950
   Coaccioli S, 2013, CLIN TER, V164, pE97, DOI 10.7417/CT.2013.1539
   Coluzzi F, 2020, MINERVA ANESTESIOL, V86, P797, DOI 10.23736/S0375-9393.20.14666-2
   Cowan A, 2005, BUPRENORPHINE THE UN, P3
   de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117
   Doyle HH, 2018, PHYSIOL BEHAV, V187, P32, DOI 10.1016/j.physbeh.2017.11.030
   Eap CB, 2002, CLIN PHARMACOKINET, V41, P1153, DOI 10.2165/00003088-200241140-00003
   Edwards RJ, 2003, DRUG METAB DISPOS, V31, P282, DOI 10.1124/dmd.31.3.282
   El-Tallawy SN, 2020, PAIN THER, V9, P453, DOI 10.1007/s40122-020-00190-4
   Farooq M, 2016, DRUG METAB DISPOS, V44, P750, DOI 10.1124/dmd.115.069229
   Feng XQ, 2017, J PAIN RES, V10, P1225, DOI 10.2147/JPR.S138698
   Flaherty GT, 2020, TROP DIS TRAVEL MED, V6, DOI 10.1186/s40794-020-00118-y
   Franchi S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02914
   Franchi S, 2017, ANESTH ANALG, V124, P986, DOI 10.1213/ANE.0000000000001669
   Friedman H, 2003, CLIN MICROBIOL REV, V16, P209, DOI 10.1128/CMR.16.2.209-219.2003
   Gaveriaux-Ruff C, 1998, P NATL ACAD SCI USA, V95, P6326, DOI 10.1073/pnas.95.11.6326
   Ghosh A, 2020, J PSYCHOSOM RES, V135, DOI 10.1016/j.jpsychores.2020.110159
   Gohler K, 2013, INT J CLIN PHARM TH, V51, P338, DOI 10.5414/CP201722
   Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301
   Gordon CJ, 2020, J BIOL CHEM, V295, P4773, DOI 10.1074/jbc.AC120.013056
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Guitton J, 1997, BIOCHEM PHARMACOL, V53, P1613, DOI 10.1016/S0006-2952(96)00893-3
   Haider A, 2020, ANN PALLIAT MED, V9, P579, DOI 10.21037/apm.2020.02.01
   Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450
   Hodge C, 2020, J ANTIMICROB CHEMOTH, V75, P3417, DOI 10.1093/jac/dkaa340
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Jeronimo CMP, 2020, CLIN INFECT DIS, V72, P373, DOI DOI 10.1093/CID/CIAA1177
   Klivinyi C, 2018, KOREAN J PAIN, V31, P3, DOI 10.3344/kjp.2018.31.1.3
   Kosciuczuk U, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e1554
   Lamontagne F, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3379
   Lane HC, 2021, NEW ENGL J MED, V384, P755, DOI 10.1056/NEJMe2024638
   Lemaitre F, 2020, FUND CLIN PHARMACOL, V34, P530, DOI 10.1111/fcp.12586
   Maciorowski D, 2020, SLAS DISCOV, V25, P1108, DOI 10.1177/2472555220958385
   McCance-Katz EF, 2010, AM J ADDICTION, V19, P4, DOI 10.1111/j.1521-0391.2009.00005.x
   McCrea JB, 2003, CLIN PHARMACOL THER, V74, P17, DOI 10.1016/S0009-9236(03)00066-3
   McPherson ML, 2019, J PAIN SYMPTOM MANAG, V57, P635, DOI 10.1016/j.jpainsymman.2018.12.001
   Mercadante S, 2018, EXPERT REV ANTICANC, V18, P445, DOI 10.1080/14737140.2018.1443813
   Moura C, 2009, J PHARM PHARM SCI, V12, P266, DOI 10.18433/J35C7Z
   Nicholas M, 2019, PAIN, V160, P28, DOI 10.1097/j.pain.0000000000001390
   Ninkovic J, 2013, AMINO ACIDS, V45, P9, DOI 10.1007/s00726-011-1163-0
   Noreen S, 2021, EUR J PHARMACOL, V894, DOI 10.1016/j.ejphar.2021.173854
   Olkkola KT, 2013, TRENDS PHARMACOL SCI, V34, P206, DOI 10.1016/j.tips.2013.02.001
   Panella L, 2019, J PAIN RES, V12, P1561, DOI 10.2147/JPR.S190158
   Parris WCV, 1998, J PAIN SYMPTOM MANAG, V16, P205, DOI 10.1016/S0885-3924(98)00064-5
   Pasternak GW, 2013, PHARMACOL REV, V65, P1257, DOI 10.1124/pr.112.007138
   Plein LM, 2018, BRIT J PHARMACOL, V175, P2717, DOI 10.1111/bph.13750
   Polati E, 2019, J PAIN RES, V12, P1569, DOI 10.2147/JPR.S190154
   Poti Francesco, 2020, Acta Biomed, V91, P118, DOI 10.23750/abm.v91i2.9639
   Raffa RB, 2012, EXPERT OPIN PHARMACO, V13, P1397, DOI 10.1517/14656566.2012.682150
   Rebold N, 2021, INFECT DIS THER, V10, P93, DOI 10.1007/s40121-021-00399-6
   Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234
   Roth SH, 2000, ARCH INTERN MED, V160, P853, DOI 10.1001/archinte.160.6.853
   Roy S, 2006, J NEUROIMMUNE PHARM, V1, P77, DOI 10.1007/s11481-005-9009-8
   Roy S, 2011, J NEUROIMMUNE PHARM, V6, P442, DOI 10.1007/s11481-011-9292-5
   Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2
   Sacerdote P, 2012, CURR PHARM DESIGN, V18, P6034, DOI 10.2174/138161212803582496
   Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019
   Scott LJ, 2000, DRUGS, V60, P139, DOI 10.2165/00003495-200060010-00008
   Shanthanna H, 2020, ANAESTHESIA, V75, P935, DOI 10.1111/anae.15076
   Shi YF, 2020, CELL DEATH DIFFER, V27, P1451, DOI 10.1038/s41418-020-0530-3
   Siegel D, 2017, J MED CHEM, V60, P1648, DOI 10.1021/acs.jmedchem.6b01594
   Siemieniuk RAC, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2980
   Silva MV, 2020, MEDRXIV PREPRINT, DOI [10.5935/0103-507X.20200063, DOI 10.1101/2020.06.24.20139303]
   Tateishi T, 1996, ANESTH ANALG, V82, P167
   Tomazini BM, 2020, JAMA-J AM MED ASSOC, V324, P1307, DOI 10.1001/jama.2020.17021
   Treede RD, 2019, PAIN, V160, P19, DOI 10.1097/j.pain.0000000000001384
   Trescot AM, 2008, PAIN PHYSICIAN, V11, pS133
   Vallejo Ricardo, 2004, Am J Ther, V11, P354, DOI 10.1097/01.mjt.0000132250.95650.85
   van Hecke O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170653
   Vazzana M, 2015, BIOMED PHARMACOTHER, V70, P234, DOI 10.1016/j.biopha.2015.01.022
   Villar J, 2020, LANCET RESP MED, V8, P267, DOI 10.1016/S2213-2600(19)30417-5
   Vittori A, 2020, ANESTH ANALG, V131, P117, DOI 10.1213/ANE.0000000000004914
   Wahawisan Joy, 2011, Ann Pharmacother, V45, pe34, DOI 10.1345/aph.1P759
   Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184
   Williams John, 2008, Rev Pain, V1, P2, DOI 10.1177/204946370800100202
   Yin WC, 2020, SCIENCE, V368, P1499, DOI 10.1126/science.abc1560
   Young B, 2021, LANCET INFECT DIS, V21, P20, DOI 10.1016/S1473-3099(20)30911-7
   Zis P, 2017, CLIN INTERV AGING, V12, P709, DOI 10.2147/CIA.S113576
NR 97
TC 0
Z9 0
U1 1
U2 1
PU VERDUCI PUBLISHER
PI ROME
PA VIA GREGORIO VII, ROME, 186-00165, ITALY
SN 1128-3602
J9 EUR REV MED PHARMACO
JI Eur. Rev. Med. Pharmacol. Sci.
PY 2021
VL 25
IS 14
BP 4854
EP 4868
DI 10.26355/eurrev_202107_26399
PG 15
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA TT2EI
UT WOS:000680162900027
PM 34337735
DA 2022-04-20
ER

PT J
AU Talasaz, AH
   Sadeghipour, P
   Aghakouchakzadeh, M
   Dreyfus, I
   Kakavand, H
   Ariannejad, H
   Gupta, A
   Madhavan, MV
   Van Tassell, BW
   Jimenez, D
   Monreal, M
   Vaduganathan, M
   Fanikos, J
   Dixon, DL
   Piazza, G
   Parikh, SA
   Bhatt, DL
   Lip, GYH
   Stone, GW
   Krumholz, HM
   Libby, P
   Goldhaber, SZ
   Bikdeli, B
AF Talasaz, Azita H.
   Sadeghipour, Parham
   Aghakouchakzadeh, Maryam
   Dreyfus, Isaac
   Kakavand, Hessam
   Ariannejad, Hamid
   Gupta, Aakriti
   Madhavan, Mahesh, V
   Van Tassell, Benjamin W.
   Jimenez, David
   Monreal, Manuel
   Vaduganathan, Muthiah
   Fanikos, John
   Dixon, Dave L.
   Piazza, Gregory
   Parikh, Sahil A.
   Bhatt, Deepak L.
   Lip, Gregory Y. H.
   Stone, Gregg W.
   Krumholz, Harlan M.
   Libby, Peter
   Goldhaber, Samuel Z.
   Bikdeli, Behnood
TI Investigating Lipid-Modulating Agents for Prevention or Treatment of
   COVID-19 JACC State-of-the-Art Review
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Review
DE COVID-19; fibrate; niacin; omega-3; statin; lipid-modulating agent
ID OMEGA-3-FATTY-ACIDS SUPPLEMENTATION; LUNG INJURY; HIGH-RISK; THERAPY;
   NIACIN; INFLAMMATION; METAANALYSIS; CORONAVIRUS; PLACEBO; FOCUS
AB Coronavirus disease-2019 (COVID-19) is associated with systemic inflammation, endothelial activation, and multiorgan manifestations. Lipid-modulating agents may be useful in treating patients with COVID-19. These agents may inhibit viral entry by lipid raft disruption or ameliorate the inflammatory response and endothelial activation. In addition, dyslipidemia with lower high-density lipoprotein cholesterol and higher triglyceride levels portend worse outcomes in patients with COVID-19. Upon a systematic search, 40 randomized controlled trials (RCTs) with lipid-modulating agents were identified, including 17 statin trials, 14 omega-3 fatty acids RCTs, 3 fibrate RCTs, 5 niacin RCTs, and 1 dalcetrapib RCT for the management or prevention of COVID-19. From these 40 RCTs, only 2 have reported preliminary results, and most others are ongoing. This paper summarizes the ongoing or completed RCTs of lipid-modulating agents in COVID-19 and the implications of these trials for patient management.
C1 [Talasaz, Azita H.; Aghakouchakzadeh, Maryam; Kakavand, Hessam] Univ Tehran Med Sci, Dept Clin Pharm, Fac Pharm, Tehran, Iran.
   [Talasaz, Azita H.; Ariannejad, Hamid] Univ Tehran Med Sci, Tehran Heart Ctr, Tehran, Iran.
   [Talasaz, Azita H.; Van Tassell, Benjamin W.; Dixon, Dave L.] Virginia Commonwealth Univ, Sch Pharm, Dept Pharmacotherapy & Outcome Sci, Richmond, VA USA.
   [Sadeghipour, Parham] Iran Univ Med Sci, Cardiovasc Intervent Res Ctr, Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran.
   [Dreyfus, Isaac; Gupta, Aakriti; Madhavan, Mahesh, V; Parikh, Sahil A.] Columbia Univ Irving Med Ctr, NewYork Presbyterian Hosp, New York, NY USA.
   [Gupta, Aakriti; Madhavan, Mahesh, V; Parikh, Sahil A.; Stone, Gregg W.; Bikdeli, Behnood] Cardiovasc Res Fdn, Clin Trials Ctr, New York, NY USA.
   [Gupta, Aakriti; Krumholz, Harlan M.; Bikdeli, Behnood] Yale Sch Med, Ctr Outcomes Res & Evaluat CORE, New Haven, CT USA.
   [Van Tassell, Benjamin W.; Dixon, Dave L.] Virginia Commonwealth Univ, Pauley Heart Ctr, Div Cardiol, Dept Internal Med,Sch Pharm, Richmond, VA USA.
   [Jimenez, David] Univ Alcala, Resp Dept, Hosp Ramon y Cajal, Inst Ramon y Cajal Invest Sanitaria,Ctr Invest Bi, Madrid, Spain.
   [Jimenez, David] Univ Alcala, Dept Med, Inst Ramon y Cajal Invest Sanitaria, Ctr Invest Biomed Red Enfermedades Resp, Madrid, Spain.
   [Monreal, Manuel] Univ Catolica San Antonio Murcia, Dept Internal Med, Hosp Univ Germans Trials & Pujol, Barcelona, Spain.
   [Vaduganathan, Muthiah; Piazza, Gregory; Bhatt, Deepak L.; Libby, Peter; Goldhaber, Samuel Z.; Bikdeli, Behnood] Harvard Med Sch, Div Cardiovasc Med Div, Brigham & Womens Hosp, Boston, MA 02115 USA.
   [Fanikos, John] Harvard Med Sch, Dept Pharm, Brigham & Womens Hosp, Boston, MA 02115 USA.
   [Lip, Gregory Y. H.] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England.
   [Lip, Gregory Y. H.] Aalborg Univ, Dept Clin Med, Aalborg, Denmark.
   [Stone, Gregg W.] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA.
   [Krumholz, Harlan M.] Yale Sch Publ Hlth, Dept Hlth Policy & Adm, New Haven, CT USA.
   [Krumholz, Harlan M.] Yale Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT USA.
RP Bikdeli, B (corresponding author), Brigham & Womens Hosp, Cardiovasc Med Div, 75 Francis St,Shapiro 5,Suite 5156, Boston, MA 02115 USA.
EM bbikdeli@bwh.harvard.edu
OI Kakavand, Hessam/0000-0001-6719-4856
FU National Institutes of Health/National Heart, Lung, and Blood
   InstituteUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [T32 HL 007854]; NovartisNovartis; Swedish Orphan
   Biovitrum; Serpin Pharma; Sanofi; BayerBayer AG; American Regent;
   AmgenAmgen; AstraZenecaAstraZeneca; Bayer AGBayer AG; Baxter Healthcare;
   Boehringer IngelheimBoehringer Ingelheim; Lexicon Pharmaceuticals;
   Relypsa; Galmed; National Institutes of HealthUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA;
   BSC; Bristol Myers Squibb/Pfizer Alliance; Portola; JanssenJohnson &
   JohnsonJohnson & Johnson USAJanssen Biotech Inc; Abbott VascularAbbott
   Laboratories; Boston ScientificBoston Scientific; SurModics; TriReme;
   Veryan Medical; Edwards; Daiichi-SankyoDaiichi Sankyo Company Limited;
   CSL Behring; Ferring PharmaceuticalsFerring Pharmaceuticals;
   AbbottAbbott Laboratories; Afimmune; Bristol Myers SquibbBristol-Myers
   Squibb; Cardax; ChiesiChiesi Pharmaceuticals Inc; Ethicon; EisaiEisai Co
   Ltd; Forest Laboratories; HLS Therapeutics; Idorsia; Ironwood; Ischemix;
   Lexicon; LillyEli Lilly; MedtronicMedtronic; MyoKardia; PhaseBio; PLx
   Pharma; RegeneronRegeneron; Medicines Company; Olatec Therapeutics;
   ROVI; Cytokinetics; Amarin; Fractyl; Owkin; PfizerPfizer; RocheRoche
   Holding; Synaptic; National Heart, Lung, and Blood InstituteUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI);
   Thrombosis Research Institute
FX Dr Gupta received payment from the Arnold & Porter Law Firm for work
   related to the Sanofi clopidogrel litigation and from the Ben C. Martin
   Law Firm for work related to an inferior vena cava filter liti-gation;
   received consulting fees from Edward Lifesciences; and holds equity in
   the health care telecardiology startup Heartbeat Health. Dr Madhavan was
   supported by a grant from the National Institutes of Health/National
   Heart, Lung, and Blood Institute to Columbia Uni-versity Irving Medical
   Center (T32 HL 007854) . Dr Van Tassell has received research support
   from Novartis, Swedish Orphan Biovitrum, Olatec Therapeutics, and Serpin
   Pharma; and is a consultant of R-Pharm and Serpin Pharma. Dr Jimenez has
   served as an advisor or consultant for Bayer HealthCare Pharmaceuticals,
   Boehringer Ingel-heim, Bristol Myers Squibb, Daiichi-Sankyo, Leo Pharma,
   Pfizer, ROVI, and Sanofi; has served as a speaker or a member of a
   speaker bureau for Bayer HealthCare Pharmaceuticals, Boehringer
   Ingelheim, Bristol Myers Squibb, Daiichi-Sankyo, Leo Pharma, ROVI, and
   Sanofi; and has received grants for clinical research from
   Daiichi-Sankyo, Sanofi, and ROVI. Dr Monreal has served as an advisor or
   consultant for Sanofi, Leo Pharma, and Daiichi-Sankyo; and has received
   a nonrestricted educational grant by Sanofi and Bayer to sponsor the
   Computerized Registry of Patients with Venous Thromboembolism. Dr
   Vaduganathan has received research grant support or served on advisory
   boards for American Regent, Amgen, AstraZeneca, Bayer AG, Baxter
   Healthcare, Boehringer Ingelheim, Cytokinetics, Lexicon Pharmaceuticals,
   and Relypsa; participates in speaker engagements with Novartis and Roche
   Diagnostics; and participates on clinical endpoint committees for
   studies sponsored by Galmed, Novartis, and the National Institutes of
   Health. Dr Fanikos has served as a consul-tant for Portola, Inc and
   Pfizer, Inc. Dr Piazza has received researchgrant support from BSC,
   Bayer, Bristol Myers Squibb/Pfizer Alliance, Portola, Amgen, and
   Janssen; and has received consulting fees from Amgen, Pfizer, and BSC.
   Dr Parikh has served as a noncompensated advisor to Abbott Vascular,
   Boston Scientific, Cardiovascular Systems Inc, Cordis, Janssen,
   Medtronic, and Philips; receives institutional research support from
   Abbott Vascular, Boston Scientific, SurModics, TriReme, and Veryan
   Medical; and is a consultant to Abiomed, Inari Medical, Penumbra, and
   Terumo. Dr Bhatt has served on the advisory board for Cardax,
   CellProthera, Cereno Scientific, Elsevier Practice Update Cardiology,
   Janssen, Level Ex, Medscape Cardiology, Myo-Kardia, Novo Nordisk,
   PhaseBio, PLx Pharma, and Regado Bio-sciences; has served on the Board
   of Directors for the Boston VA Research Institute, Society of
   Cardiovascular Patient Care, and ToBeSoft; serves as Chair of the
   American Heart Association Quality Oversight Committee; has served on
   the data monitoring committees for Baim Institute for Clinical Research
   (formerly Harvard Clinical Research Institute, the PORTICO trial, funded
   by St. Jude Medical, now Abbott) , Cleveland Clinic (including for the
   ExCEED trial, funded by Edwards) , Contego Medical (Chair, PERFORMANCE
   2) , Duke Clinical Research Institute, Mayo Clinic, Mount Sinai School
   of Med-icine (for the ENVISAGE trial, funded by Daiichi-Sankyo) ,
   Population Health Research Institute; has received honoraria from the
   American College of Cardiology (Senior Associate Editor, Clinical Trials
   and News, ACC.; org; Vice-Chair, ACC Accreditation Committee) , Baim
   Institute for Clinical Research (formerly Harvard Clinical Research
   Institute; RE-DUAL PCI clinical trial steering committee funded by
   Boehringer Ingelheim; AEGIS-II executive committee funded by CSL
   Behring) , Belvoir Publications (Editor in Chief, Harvard Heart Letter)
   , Canadian Medical and Surgical Knowledge Translation Research Group
   (clinical trial steering committees) , Duke Clinical Research Institute
   (clinical trial steering committees, including for the PRO-NOUNCE trial,
   funded by Ferring Pharmaceuticals) , HMP Global (Editor in Chief,
   Journal of Invasive Cardiology) , Journal of the American College of
   Cardiology (Guest Editor; Associate Editor) , K2P (Co-Chair,
   interdisciplinary curriculum) , Level Ex, Medtelligence/ReachMD (CME
   steering committees) , MJH Life Sciences, Population Health Research
   Institute (for the COMPASS operations committee, publications committee,
   steering committee, and USA national co-leader, funded by Bayer) , Slack
   Publications (Chief Medical Editor, Cardiology Today's Intervention) ,
   Society of Cardiovascular Patient Care (Secretary/Treasurer) , WebMD
   (CME steering committees) ; other, Clinical Cardiology (Deputy Editor) ,
   NCDR-ACTION Registry Steering Committee (Chair) , VA CART Research and
   Publications Committee (Chair) ; has received research funding from
   Abbott, Afimmune, Amarin, Amgen, AstraZeneca, Bayer, Boehringer
   Ingel-heim, Bristol Myers Squibb, Cardax, Chiesi, CSL Behring, Eisai,
   Ethi-con, Ferring Pharmaceuticals, Forest Laboratories, Fractyl, HLS
   Therapeutics, Idorsia, Ironwood, Ischemix, Janssen, Lexicon, Lilly,
   Medtronic, MyoKardia, Novo Nordisk, Owkin, Pfizer, PhaseBio, PLx Pharma,
   Regeneron, Roche, Sanofi, Synaptic, and The Medicines Company; has
   received royalties from Elsevier (Editor, Cardiovascu-lar Intervention:
   A Companion to Braunwald's Heart Disease) ; has been a site
   co-investigator, Abbott, Biotronik, Boston Scientific, CSI, St. Jude
   Medical (now Abbott) , and Svelte; has been a trustee for the American
   College of Cardiology; and has received unfunded research from FlowCo,
   Merck, and Takeda. Dr Lip is a consultant and speaker for BMS/Pfizer,
   Boehringer Ingelheim, and Daiichi-Sankyo (no fees are received
   personally) . Dr Stone has received speaker or other honoraria from
   Cook, Terumo, and Orchestra Biomed; has been a consultant to Valfix,
   TherOx, Vascular Dynamics, Robocath, Heart-Flow, Gore, Ablative
   Solutions, Miracor, Neovasc, V-Wave, Abiomed, Ancora, MAIA
   Pharmaceuticals, Vectorious, Reva, Matrizyme, and CardioMech; and has
   equity/options from Ancora, Cagent, Applied Therapeutics, BioStar family
   of funds, SpectraWave, Orchestra Bio-me d, Aria, Cardiac Success, Med
   Focus family of funds, and Valfix. Dr Krumholz has received personal
   fees from UnitedHealth, IBM Watson Health, Element Science, Aetna,
   Facebook, Siegfried & Jensen Law Firm, Arnold & Porter Law Firm, Ben C.
   Martin Law Firm, and theNational Center for Cardiovascular Diseases
   (Beijing, China) ; has ownership in Hugo Health and Refactor Health; has
   contracts from the U.S. Centers for Medicare & Medicaid Services; and
   has received grants from Medtronic, the U.S. Food and Drug
   Administration, Johnson & Johnson, and the Shenzhen Center for Health
   Information, outside the submitted work.; Dr Libby is an unpaid
   consultant to, or involved in clinical trials for Amgen, AstraZeneca,
   Beren, Esperion Therapeutics, Ionis Pharmaceuticals, Kowa
   Pharmaceuticals, Novar-tis, Pfizer, Sanofi-Regeneron, and XBiotech, Inc;
   and is a member of the scientific advisory board for Amgen, Corvidia
   Therapeutics, CSL Behring, DalCor Pharmaceuticals, Genentech, Kowa
   Pharmaceuticals, Olatec Therapeutics, PlaqueTec, Kancera, Medimmune,
   Novartis, Novo Nordisk, and XBiotech, Inc. Dr Libby is on the Board of
   Directors of XBiotech, Inc; and has a financial interest in XBiotech, a
   company developing therapeutic human antibodies. Dr Libby's interests
   were reviewed and are managed by Brigham and Women's Hospital and
   Partners HealthCare in accordance with their conflict of interest
   policies. Dr Libby's laboratory has received research funding in thelast
   2 years from Novartis. Dr Goldhaber has received research sup-port from
   Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Boston Scientific,
   Daiichi-Sankyo, Janssen, the National Heart, Lung, and Blood Institute,
   and the Thrombosis Research Institute; and has received consulting fees
   from Bayer, Agile, Boston Scientific, and Boehringer Ingelheim. Dr
   Bikdeli is a consulting expert, on behalf of the plaintiff, for
   litigation related to 2 specific brand models of infe-rior vena cava
   filters. All other authors have reported that they have no relationships
   relevant to the contents of this paper to disclose.
CR Adhyaru BB, 2018, NAT REV CARDIOL, V15, P757, DOI 10.1038/s41569-018-0098-5
   Ambrosy AP, 2021, AM HEART J, V235, P54, DOI 10.1016/j.ahj.2021.01.018
   Arnardottir H, 2021, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.624657
   Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628
   Bhatt DL, 2019, NEW ENGL J MED, V380, P11, DOI 10.1056/NEJMoa1812792
   Bhatt DL, 2020, NATL LIP ASS VIRT SC
   Bikdeli B, 2021, AM COLL CARD SCI SES
   Bikdeli B, 2020, THROMB RES, V196, P382, DOI 10.1016/j.thromres.2020.09.027
   Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
   Bikdeli B, 2012, CIRC-CARDIOVASC QUAL, V5, P580, DOI 10.1161/CIRCOUTCOMES.111.964072
   Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579
   Buschard K, 2020, MED HYPOTHESES, V143, DOI 10.1016/j.mehy.2020.110127
   Calfee CS, 2018, LANCET RESP MED, V6, P691, DOI 10.1016/S2213-2600(18)30177-2
   Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3
   Chen YQ, 2020, CURR MED RES OPIN, V36, P941, DOI 10.1080/03007995.2020.1747416
   Darwesh AM, 2021, PHARMACOL THERAPEUT, V219, DOI 10.1016/j.pharmthera.2020.107703
   Davies SP, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.660490
   DeDiego ML, 2014, J VIROL, V88, P913, DOI 10.1128/JVI.02576-13
   Deftereos SG, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.13136
   Dequin PF, 2020, JAMA-J AM MED ASSOC, V324, P1298, DOI 10.1001/jama.2020.16761
   Duvall MG, 2016, EUR J PHARMACOL, V785, P144, DOI 10.1016/j.ejphar.2015.11.001
   Everhart A, 2021, HEALTH SERV RES, V56, P919, DOI 10.1111/1475-6773.13630
   Feng Y, 2018, EUR REV MED PHARMACO, V22, P3190, DOI 10.26355/eurrev_201805_15080
   Ghati N, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04840-y
   Goligher EC, 2021, THERAPEUTIC ANTICOAG
   Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002
   Guo HC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170123
   Gupta A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21553-1
   Hilgendorff A, 2003, INT J CLIN PHARM TH, V41, P397
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   HPS3 TIMI55-REVEAl Collaborative, 2017, NEW ENGL J MED, V377, P1217, DOI 10.1056/NEJMoa1706444
   Huber Reed, 2020, Skin Therapy Lett, V25, P7
   Kalstad AA, 2021, CIRCULATION, V143, P528, DOI 10.1161/CIRCULATIONAHA.120.052209
   Kanagarantam P, 2020, PREV CARD COMP COVID
   Krisko TI, 2016, PRINCIPLES PHARM PAT
   Lan SH, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106103
   Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955
   Lee C, 2021, ARCH PHARM RES, V44, P99, DOI 10.1007/s12272-020-01301-7
   Lee HY, 2021, ARTERIOSCL THROM VAS, V41, pE175, DOI 10.1161/ATVBAHA.120.315551
   Lerner D, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04905-y
   Libby P, 2020, EUR HEART J, V41, P3038, DOI 10.1093/eurheartj/ehaa623
   Lombardi M, 2021, EUR HEART J-CARD PHA, V7, pE69, DOI 10.1093/ehjcvp/pvab008
   Lopes MI, 2021, RMD OPEN, V7, DOI 10.1136/rmdopen-2020-001455
   Lopez-Medina E, 2021, JAMA-J AM MED ASSOC, V325, P1426, DOI 10.1001/jama.2021.3071
   Mach F, 2018, EUR HEART J, V39, P2526, DOI 10.1093/eurheartj/ehy182
   Masana L, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86747-5
   McAuley DF, 2014, NEW ENGL J MED, V371, P1695, DOI 10.1056/NEJMoa1403285
   Mechanick JI, 2020, J AM COLL CARDIOL, V76, P2024, DOI 10.1016/j.jacc.2020.07.069
   Mehmel M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061616
   Mehrbod P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/872370
   Merx MW, 2006, CURR OPIN CRIT CARE, V12, P309, DOI 10.1097/01.ccx.0000235207.00322.96
   NAGAI A, 1994, EXP LUNG RES, V20, P263, DOI 10.3109/01902149409064387
   Oesterle A, 2017, CIRC RES, V120, P229, DOI 10.1161/CIRCRESAHA.116.308537
   Pandit AK, 2016, ACTA NEUROL SCAND, V134, P22, DOI 10.1111/ane.12540
   Parihar SP, 2019, NAT REV IMMUNOL, V19, P104, DOI 10.1038/s41577-018-0094-3
   Pontes-Arruda A, 2008, JPEN-PARENTER ENTER, V32, P596, DOI 10.1177/0148607108324203
   Ramakrishnan S, 2021, LANCET RESP MED, V9, P763, DOI 10.1016/S2213-2600(21)00160-0
   REMAP-CAP, 2020, RAND EMB MULT FACT A
   Rogero MM, 2020, FREE RADICAL BIO MED, V156, P190, DOI 10.1016/j.freeradbiomed.2020.07.005
   Sadeghipour P, 2021, JAMA-J AM MED ASSOC, V325, P1620, DOI 10.1001/jama.2021.4152
   Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797
   Self WH, 2020, JAMA-J AM MED ASSOC, V324, P2165, DOI 10.1001/jama.2020.22240
   SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132
   Sheahan T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000240
   Sorokin AV, 2020, FASEB J, V34, P9843, DOI 10.1096/fj.202001451
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   Stone JH, 2020, NEW ENGL J MED, V383, P2333, DOI 10.1056/NEJMoa2028836
   Sun F, 2015, BRIT J PHARMACOL, V172, P3779, DOI 10.1111/bph.13166
   Sviridov D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.574508
   Talasaz AH, 2021, J AM COLL CARDIOL, V77, P1903, DOI 10.1016/j.jacc.2021.02.035
   Talasaz AH, 2021, CARDIOVASC DRUG THER, V35, P249, DOI 10.1007/s10557-020-07037-2
   Tomazini BM, 2020, JAMA-J AM MED ASSOC, V324, P1307, DOI 10.1001/jama.2020.17021
   Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520
   Wood FA, 2020, NEW ENGL J MED, V383, P2182, DOI 10.1056/NEJMc2031173
   Yuan S, 2015, MBIO, V6, DOI 10.1128/mBio.01120-15
NR 75
TC 5
Z9 5
U1 7
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0735-1097
EI 1558-3597
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD OCT 19
PY 2021
VL 78
IS 16
BP 1635
EP 1654
DI 10.1016/j.jacc.2021.08.021
EA OCT 2021
PG 20
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA WG7TG
UT WOS:000707196900011
PM 34649702
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Wang, CL
   Li, GY
   Han, PH
   Osen, O
   Zhang, HX
AF Wang, Chunlin
   Li, Guoyuan
   Han, Peihua
   Osen, Ottar
   Zhang, Houxiang
TI Impacts of COVID-19 on Ship Behaviours in Port Area: An AIS Data-Based
   Pattern Recognition Approach
SO IEEE TRANSACTIONS ON INTELLIGENT TRANSPORTATION SYSTEMS
LA English
DT Article; Early Access
DE Marine vehicles; Artificial intelligence; Seaports; COVID-19; Feature
   extraction; Statistical analysis; Pandemics; COVID-19; PD-DBSCAN;
   dynamic time warping; significance test; statistical analysis; AIS data
AB The advent of the COVID-19 pandemic disrupted global commercial activities and the tourism industry heavily. Impacts on maritime transportation were huge, as seaborne trade represents over 80% of global merchandise trade. Investigating how COVID-19 has affected ship behaviours is significant for economic condition evaluation, port management. This paper develops an analysis method to mine knowledge from raw Automation Identification System (AIS) data. First, berths are identified by improved density-based spatial clustering of applications with noise by Pythagoras distance (PD-DBSCAN). Data features, such as ship deadweight, arrival time, dwelling time, ship types, etc., can then be extracted using information matching and statistical analysis. Next, the dynamic time warping method is employed to analyse abnormal ship behaviour patterns and quantify the impacts of COVID-19. After that, a significance test is employed to determine an impact threshold through year-on-year analysis on ship flow, daily throughout and berthing time of quays. Finally, statistical analysis is used for the short-term impact analysis. This research examines a case study based on four-year AIS data in the Oslo port area. The results show that the proposed method can identify abnormal patterns caused by COVID-19 and estimate its impacts. Passenger ships are influenced heavily compared with cargo ships. The variation of passenger ships' flow is over 90% during 2020, larger than the average variation before 2020. The discovered knowledge could be used for future decision-making and preplanning in the next health crisis.
C1 [Wang, Chunlin; Li, Guoyuan; Han, Peihua; Zhang, Houxiang] Norwegian Univ Sci & Technol, Dept Ocean Operat & Civil Engn, N-6009 Alesund, Norway.
   [Osen, Ottar] Norwegian Univ Sci & Technol, Dept ICT & Nat Sci, N-6009 Alesund, Norway.
RP Li, GY; Zhang, HX (corresponding author), Norwegian Univ Sci & Technol, Dept Ocean Operat & Civil Engn, N-6009 Alesund, Norway.
EM chunliw@ntnu.no; guoyuan.li@ntnu.no; peihua.han@ntnu.no;
   ottar.osen@ntnu.no; hozh@ntnu.no
RI ; Li, Guoyuan/H-5911-2018
OI Han, Peihua/0000-0002-2990-5896; Li, Guoyuan/0000-0001-7553-0899
FU IKTPLUSS Project "Remote Control Centre for Autonomous Ship Support"
   from Research Council of Norway [309323]; Centre for Research Based
   Innovation "SFI Marine Operation in Virtual Environment (SFI-MOVE)" from
   Research Council of Norway [237929]; Chinese Scholarship Council through
   the Norwegian University of Science and Technology
FX This work was supported in part by IKTPLUSS Project "Remote Control
   Centre for Autonomous Ship Support" under Project 309323 and in part by
   Centre for Research Based Innovation "SFI Marine Operation in Virtual
   Environment (SFI-MOVE)" under Project 237929 from Research Council of
   Norway. The work of Chunlin Wang was supported by the Chinese
   Scholarship Council through the Norwegian University of Science and
   Technology.
CR Cannata A, 2012, ADV DATA MINING KNOW, DOI DOI 10.5772/49941
   Chambers M., 2018, 2 BUR TRANSP STAT OF
   Choi HR, 2018, MATH PROBL ENG, V2018, DOI 10.1155/2018/2404089
   Depellegrin D, 2020, SCI TOTAL ENVIRON, V740, DOI 10.1016/j.scitotenv.2020.140123
   Ding H, 2008, PROC VLDB ENDOW, V1, P1542
   Du YM, 2020, IEEE ACCESS, V8, P64646, DOI 10.1109/ACCESS.2020.2984677
   Arguedas VF, 2018, IEEE T INTELL TRANSP, V19, P722, DOI 10.1109/TITS.2017.2699635
   Fuller JA, 2021, MMWR-MORBID MORTAL W, V70, P58, DOI 10.15585/mmwr.mm7002e4
   Gao M, 2020, OCEAN ENG, V205, DOI 10.1016/j.oceaneng.2020.106919
   Hua-Zhi H, 2008, THESIS U PLYMOUTH PL
   Ito Hirohito, 2020, Transp Res Interdiscip Perspect, V5, P100136, DOI 10.1016/j.trip.2020.100136
   Jia H, 2019, INT J SHIP TRANS LOG, V11, P25, DOI 10.1504/IJSTL.2019.10017649
   Jishuang Zhu, 2020, Journal of Physics: Conference Series, V1624, DOI 10.1088/1742-6596/1624/3/032050
   Lazaro F, 2019, CEAS SPACE J, V11, P55, DOI 10.1007/s12567-018-0214-8
   Li LB, 2018, J NAVIGATION, V71, P664, DOI 10.1017/S0373463317000807
   Liang Shen, 2020, Journal of Computational Methods in Sciences and Engineering, V20, P13, DOI 10.3233/JCM-193574
   Liu DY, 2019, IEEE T VIS COMPUT GR, V25, P1, DOI 10.1109/TVCG.2018.2865018
   March D, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22423-6
   Menhat M, 2021, OCEAN COAST MANAGE, V209, DOI 10.1016/j.ocecoaman.2021.105638
   Millefiori LM, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON BIG DATA (BIG DATA), P1627, DOI 10.1109/BigData.2016.7840774
   Pamuji G. C., 2020, IOP Conference Series: Materials Science and Engineering, V879, DOI 10.1088/1757-899X/879/1/012057
   Safar J., 2017, ANTENNAS PROPAGATION, P1
   Schubert E, 2017, ACM T DATABASE SYST, V42, DOI 10.1145/3068335
   Sheng K, 2018, J NAVIGATION, V71, P100, DOI 10.1017/S0373463317000546
   Shi JH, 2020, J MAR SCI ENG, V8, DOI 10.3390/jmse8090682
   Verschuur J, 2021, NAT HUM BEHAV, V5, P305, DOI 10.1038/s41562-021-01060-5
   Wang J, 2017, J NAVIGATION, V70, P1383, DOI 10.1017/S0373463317000406
   Wang ZH, 2020, ISPRS INT J GEO-INF, V9, DOI 10.3390/ijgi9060351
   Wen YQ, 2020, APPL OCEAN RES, V96, DOI 10.1016/j.apor.2019.102049
   Yang D, 2019, TRANSPORT REV, V39, P755, DOI 10.1080/01441647.2019.1649315
   Zhang LY, 2019, TRANSPORT RES E-LOG, V129, P287, DOI 10.1016/j.tre.2017.07.011
   Zheng HL, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13031089
NR 32
TC 0
Z9 0
U1 9
U2 9
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 1524-9050
EI 1558-0016
J9 IEEE T INTELL TRANSP
JI IEEE Trans. Intell. Transp. Syst.
DI 10.1109/TITS.2022.3147377
EA FEB 2022
PG 12
WC Engineering, Civil; Engineering, Electrical & Electronic; Transportation
   Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Transportation
GA YX7SJ
UT WOS:000754297800001
DA 2022-04-20
ER

PT J
AU Yang, R
   Du, GM
   Duan, ZW
   Du, MJ
   Miao, X
   Tang, YH
AF Yang, Rui
   Du, Guoming
   Duan, Ziwei
   Du, Mengjin
   Miao, Xin
   Tang, Yanhong
TI Knowledge System Analysis on Emergency Management of Public Health
   Emergencies
SO SUSTAINABILITY
LA English
DT Review
DE emergency management; public health emergencies; knowledge system;
   CiteSpace
ID SCIENCE; TRENDS; RESILIENCE; LESSONS; POINTS; DOMAIN; CHINA; RISK
AB The Coronavirus Disease 2019 (COVID-19) infectious pneumonia pandemic highlights the importance of emergency management of public health emergencies (EMPHE). This paper addresses the challenge of building a knowledge system for EMPHE research that may contribute to understand the spatial and temporal characteristics of knowledge distribution, research status, cutting-edge research and development trends, and helps to identify promising research topics and guide research and practice of EMPHE. Based on the Web of Science, this paper retrieves 1467 articles about EMPHE published from 2010 to date. Then, based on high-frequency keywords, we use CiteSpace to analyze their knowledge co-occurrence network, clustering network and knowledge evolution. Furthermore, we summarize the features and gaps in EMPHE research, providing references for future research directions. Based on the above analysis, this work constructs a knowledge system about EMPHE research, providing a comprehensive visual summary of the existing research in the field of EMPHE, with the aim to guide future research and practice.
C1 [Yang, Rui; Miao, Xin] Harbin Inst Technol, Sch Management, Harbin 150001, Peoples R China.
   [Du, Guoming; Tang, Yanhong] Northeast Agr Univ, Sch Publ Adm & Law, Harbin 150030, Peoples R China.
   [Duan, Ziwei] Harbin Inst Technol, Sch Humanities Social Sci & Law, Harbin 15001, Peoples R China.
   [Du, Mengjin] Northeastern Univ, Sch Business Adm, Shenyang 110000, Peoples R China.
RP Tang, YH (corresponding author), Northeast Agr Univ, Sch Publ Adm & Law, Harbin 150030, Peoples R China.
EM 18b910068@stu.hit.edu.cn; nmgdgm@126.com; 19s116040@stu.hit.edu.cn;
   20160672@stu.neu.edu.cn; miaoxin@hit.edu.cn; tangyanhong@neau.edu.cn
FU Humanities and Social Science Foundation of Ministry of Education
   [15YJC630116]
FX This work is supported by the Humanities and Social Science Foundation
   of Ministry of Education (Grant No. 15YJC630116).
CR Ajrawat K., 2018, P 2018 SYST INF ENG
   An RP, 2019, AM J HEALTH BEHAV, V43, P1186, DOI 10.5993/AJHB.43.6.15
   An XY, 2011, SCIENTOMETRICS, V88, P133, DOI 10.1007/s11192-011-0374-1
   Archambault E, 2009, J AM SOC INF SCI TEC, V60, P1320, DOI 10.1002/asi.21062
   Ronda-Pupo GA, 2012, STRATEGIC MANAGE J, V33, P162, DOI 10.1002/smj.948
   Asghar H, 2014, J INFECT DIS, V210, pS294, DOI 10.1093/infdis/jiu384
   Boston-Fleischhauer C, 2008, J NURS ADMIN, V38, P84, DOI 10.1097/01.NNA.0000295637.03216.26
   Ramirez LJC, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11113121
   CAMBROSIO A, 1993, SCIENTOMETRICS, V27, P119, DOI 10.1007/BF02016546
   Chan EYY, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16020228
   Chen CM, 2006, J AM SOC INF SCI TEC, V57, P359, DOI 10.1002/asi.20317
   Chen CM, 2004, P NATL ACAD SCI USA, V101, P5303, DOI 10.1073/pnas.0307513100
   Chen J, 2019, J INTELL FUZZY SYST, V37, P3655, DOI 10.3233/JIFS-182737
   Chen JF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010049
   Chen S.Y., 2012, P 5 INT C BUS INT FI
   Cho CH, 2007, ACCOUNT ORG SOC, V32, P639, DOI 10.1016/j.aos.2006.09.009
   Clauson K.A., 2018, BLOCKCHAIN HEALTHCAR, V1, P1, DOI [10.30953/bhty.v1.20, DOI 10.30953/BHTY.V1.20]
   Cochi SL, 2014, J INFECT DIS, V210, pS540, DOI 10.1093/infdis/jiu345
   Corrales-Garay D, 2019, GOV INFORM Q, V36, P77, DOI 10.1016/j.giq.2018.10.008
   Darko A, 2019, BUILD ENVIRON, V149, P501, DOI 10.1016/j.buildenv.2018.12.059
   Davis MV, 2007, PUBLIC HEALTH REP, V122, P17, DOI 10.1177/003335490712200103
   de Jong M, 2015, J CLEAN PROD, V109, P25, DOI 10.1016/j.jclepro.2015.02.004
   Dehdarirad T, 2014, SCIENTOMETRICS, V101, P273, DOI 10.1007/s11192-014-1327-2
   Ding Y, 2001, INFORM PROCESS MANAG, V37, P817, DOI 10.1016/S0306-4573(00)00051-0
   Duan W, 2013, IEEE T SYST MAN CY-S, V43, P1028, DOI 10.1109/TSMC.2013.2256855
   Dufty N, 2012, AUST J EMERG MANAG, V27, P40
   Edmunds KL, 2016, B WORLD HEALTH ORGAN, V94, P424, DOI 10.2471/BLT.15.163931
   Ferguson A, 2020, MAR POLLUT BULL, V150, DOI 10.1016/j.marpolbul.2019.110746
   Gao W.Y., 2020, INT J LAB MED, V41, P641
   Gillespie A, 2016, GLOB HEALTH-SCI PRAC, V4, P626, DOI 10.9745/GHSP-D-16-00226
   Glenn S., 2009, INTEGR ENV ASSESS, V5, P357, DOI [10.1002/ieam.5630050223, DOI 10.1002/IEAM.5630050223]
   GULLAND A, 2016, BMJ-BRIT MED J, V352, DOI DOI 10.1136/BMJ.I657
   Harding N, 2020, ENTROPY-SWITZ, V22, DOI 10.3390/e22020133
   He F, 2018, J CLEAN PROD, V174, P502, DOI 10.1016/j.jclepro.2017.10.314
   Hope K, 2010, AUST J EMERG MANAG, V25, P39
   Hou JH, 2018, SCIENTOMETRICS, V115, P869, DOI 10.1007/s11192-018-2695-9
   Hu GQ, 2006, J PUBLIC HEALTH-HEID, V14, P43, DOI 10.1007/s10389-005-0008-2
   Hu JX, 2018, IRAN J PUBLIC HEALTH, V47, P156
   Jamal T, 2020, J TOUR FUTURES, V6, P181, DOI 10.1108/JTF-02-2020-0014
   Josang Audun, 2002, P 15 BLED EL COMM C, V5, P2502
   Khan Y, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6250-7
   Khot Wasim Yunus, 2020, J Assoc Physicians India, V68, P67
   Lei JQ, 2020, RADIOLOGY, V295, P18, DOI 10.1148/radiol.2020200236
   Li CS, 2019, INT J PHYS DISTR LOG, V50, P80, DOI 10.1108/IJPDLM-02-2019-0041
   Liu YJ, 2020, ARTECH HSE MOB COMM, P1
   Lurie N, 2013, NEW ENGL J MED, V368, P1251, DOI 10.1056/NEJMsb1209510
   Mosoiu D, 2020, AM J THER, V27, pE204, DOI 10.1097/MJT.0000000000001067
   Mou J., 2009, J ELECTRON COMMER RE, V20, P219
   Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757
   Qu T.J., 2019, CHIN J PUBLIC HLTH M, V35, P433, DOI 10.19568/j.cnki.23-1318.2019.04.001
   Rayner G, 2019, INT J MENT HEALTH NU, V28, P40, DOI 10.1111/inm.12550
   Reeder B, 2011, J BIOMED INFORM, V44, P978, DOI 10.1016/j.jbi.2011.07.004
   Richards P., 2016, EBOLA PEOPLES SCI HE, P1
   Sarker MNI, 2020, POL J ENVIRON STUD, V29, P1825, DOI 10.15244/pjoes/109527
   Schnall A, 2017, AM J PUBLIC HEALTH, V107, pS186, DOI [10.2105/AJPH.2017.303948, 10.2105/ajph.2017.303948]
   Schneider JW, 2004, J AM SOC INF SCI TEC, V55, P363, DOI 10.1002/asi.10383
   [Anonymous], 2016, BMJ, V354, pi4086, DOI [10.1136/bmj.g7647, 10.1136/bmj.i4086]
   Shi YL, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11133716
   Shrivastava S. R. B. L., 2015, Asian Pacific Journal of Tropical Disease, V5, P253, DOI 10.1016/S2222-1808(14)60779-9
   SMALL H, 1974, SCI STUD, V4, P17, DOI 10.1177/030631277400400102
   Tang YH, 2013, J CLEAN PROD, V57, P228, DOI 10.1016/j.jclepro.2013.06.018
   Vaiciulyte S, 2019, INT J DISAST RISK RE, V40, DOI 10.1016/j.ijdrr.2019.101272
   van der Vegt GS, 2015, ACAD MANAGE J, V58, P971, DOI 10.5465/amj.2015.4004
   Wang F, 2018, J RISK RES, V21, P809, DOI 10.1080/13669877.2016.1247377
   Wang WE, 2020, J MED VIROL, V92, P441, DOI 10.1002/jmv.25689
   Wen J, 2020, ANATOLIA, V31, P331, DOI 10.1080/13032917.2020.1730621
   Whalen M, 2018, J EMERG NURS, V44, P446, DOI 10.1016/j.jen.2018.02.002
   Wingfield T, 2020, LANCET RESP MED, V8, P536, DOI 10.1016/S2213-2600(20)30151-X
   Xu J., 2018, RES LIB SCI, V11, P26, DOI 10.15941/j.cnki.issn1001-0424.2018.11.005
   YANG H, 2019, SUSTAINABILITY-BASEL, V11, DOI DOI 10.3390/SU11184908
   Yao Q, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-26
   [张勤 ZHANG Qin], 2007, [管理科学学报, Journal of Management Sciences in China], V10, P65
   Zhang W, 2015, QUAL QUANT, V49, P1023, DOI 10.1007/s11135-014-0032-9
   Zhang Z, 2019, MULTIMED TOOLS APPL, V78, P29643, DOI 10.1007/s11042-018-6061-y
   Zheng KY, 2019, MED SCI MONITOR, V25, P8940, DOI 10.12659/MSM.917742
   ZHONG WQ, 2013, RES J APPL SCI ENG T, V6, P3289
   Zhu J, 2017, SCIENTOMETRICS, V110, P893, DOI 10.1007/s11192-016-2187-8
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zong QJ, 2013, SCIENTOMETRICS, V94, P781, DOI 10.1007/s11192-012-0799-1
   Zuo J, 2014, RENEW SUST ENERG REV, V30, P271, DOI 10.1016/j.rser.2013.10.021
NR 80
TC 7
Z9 7
U1 35
U2 65
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD JUN
PY 2020
VL 12
IS 11
AR 4410
DI 10.3390/su12114410
PG 18
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA MC6JX
UT WOS:000543391800073
OA gold
DA 2022-04-20
ER

PT J
AU Faulks, B
   Song, YH
   Waiganjo, M
   Obrenovic, B
   Godinic, D
AF Faulks, Baira
   Song, Yinghua
   Waiganjo, Moses
   Obrenovic, Bojan
   Godinic, Danijela
TI Impact of Empowering Leadership, Innovative Work, and Organizational
   Learning Readiness on Sustainable Economic Performance: An Empirical
   Study of Companies in Russia during the COVID-19 Pandemic
SO SUSTAINABILITY
LA English
DT Article
DE empowering leadership; sustainable economic performance; COVID-19
   pandemic; company performance during COVID-19; innovative work behavior;
   organizational readiness to learn
ID TRANSFORMATIONAL LEADERSHIP; SUPPLY CHAINS; COMMITMENT; BEHAVIOR;
   CREATIVITY; MANAGEMENT; METAANALYSIS; PERCEPTIONS; FIT
AB The COVID-19 pandemic shocked the global economy, with numerous companies suffering losses and shutting down. However, some companies proved to be resilient, being able to sustain their economic performance despite the pandemic. The study aims to explain the sustainable economic performance of companies during the COVID-19 pandemic. The relationships between empowering leadership, innovative work behavior, organizational readiness to change, and sustainable economic performance were assessed. The data were collected via an online questionnaire from January 2021 to March 2021, during the height of the COVID-19 pandemic in Russia. The respondents were Russian companies' employees holding management positions, competent to objectively assess organizational circumstances during the COVID-19 pandemic. A sample of 337 was used in the analysis. Confirmatory factor analysis (CFA) with maximum likelihood estimation was conducted using SPSS AMOS. The structural model was tested with standardized parameter estimates, standard errors, and p-values calculated. The findings of the study suggest that innovative work behavior and organizational readiness to learn have a direct influence on sustainable economic performance. The findings also suggest that empowering leadership impacts innovative work behavior but not sustainable economic performance. The mediation analysis indicates that innovative work behavior is a mediator between empowering leadership and sustainable economic performance, whereas organizational readiness to learn is not a moderator. The study adds to the leadership and sustainability body of knowledge and contributes to the research on the COVID-19 pandemic in the organizational context.
C1 [Faulks, Baira; Song, Yinghua] Wuhan Univ Technol, Sch Management, Wuhan 430070, Peoples R China.
   [Waiganjo, Moses] Namibia Univ Sci & Technol NUST, Business Management Dept, Windhoek 51434, Namibia.
   [Obrenovic, Bojan] Jiangsu Univ, Sch Management, Zhenjiang 212013, Jiangsu, Peoples R China.
   [Godinic, Danijela] Univ Zagreb, Fac Humanities & Social Sci, Zagreb 10000, Croatia.
RP Faulks, B (corresponding author), Wuhan Univ Technol, Sch Management, Wuhan 430070, Peoples R China.
EM faulksbaira@bk.ru; song6688c@163.com; mwaiganjo@nust.na;
   bojan@inovatus-usluge.hr; danijela.godinic5@gmail.com
RI , Bojan/ABF-5818-2021
OI , Bojan/0000-0001-6072-4367; Godinic, Danijela/0000-0002-7150-675X
CR Abrahamson E, 2000, HARVARD BUS REV, V78, P75
   Abrell-Vogel C, 2014, J ORGAN CHANGE MANAG, V27, P900, DOI 10.1108/JOCM-07-2012-0111
   Afsar B., 2017, AC MAN P AC MAN NEW, P14644, DOI [10.5465/ambpp.2014.14644abstract, DOI 10.5465/AMBPP.2014.14644ABSTRACT]
   Ahmad N.H., 2018, P AS AC MAN INT C SH, P5
   Alheet A., 2021, MANAG SCI LETT, V11, P239, DOI [10.5267/j.msl.2020.8.010, DOI 10.5267/J.MSL.2020.8.010]
   Belso-Martinez JA, 2020, J SMALL BUS MANAGE, V58, P73, DOI 10.1080/00472778.2019.1659673
   Argote L., 2013, CREATING RETAINING T, V2nd ed.
   Argyris C., 1999, ORG LEARNING
   Armeanu DS, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10010004
   Arnold JA, 2000, J ORGAN BEHAV, V21, P249, DOI 10.1002/(SICI)1099-1379(200005)21:3<249::AID-JOB10>3.0.CO;2-#
   Astuti J.P., 2020, J IND ENG MANAGEMENT, V1, P153
   Bak H, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.559160
   Begum S, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208620
   Ben Youssef A, 2018, TECHNOL FORECAST SOC, V129, P232, DOI 10.1016/j.techfore.2017.11.003
   Bilal Afsar, 2016, Journal of Human Resources in Hospitality & Tourism, V15, P252, DOI 10.1080/15332845.2016.1147936
   Bilan Y, 2020, INZ EKON, V31, P93, DOI 10.5755/j01.ee.31.1.24045
   Bratianu C., 2015, ORG KNOWLEDGE DYNAMI
   Bratianu C, 2013, KNOWL MAN RES PRACT, V11, P133, DOI 10.1057/kmrp.2013.11
   Breitzman A., ANAL SMALL BUSINESS
   Byrne B.M, 2012, STRUCTURAL EQUATION, DOI DOI 10.4324/9781315757421
   Cai D, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01304
   Choi SB, 2016, PERS REV, V45, P459, DOI 10.1108/PR-03-2014-0058
   Christopher M, 2011, INT J PHYS DISTR LOG, V41, P63, DOI 10.1108/09600031111101439
   Chung S, 2018, PERS SOC PSYCHOL B, V44, P63, DOI 10.1177/0146167217733069
   Dasgupta P, 2001, HUMAN WELL BEING NAT
   de Jong J, 2010, CREAT INNOV MANAG, V19, P23, DOI 10.1111/j.1467-8691.2010.00547.x
   de Jong JPJ, 2007, EUR J INNOV MANAG, V10, P41, DOI 10.1108/14601060710720546
   De Jong JeroenP.J., 2008, EIM BUSINESS POLICY, V8, P1
   De Marco CE, 2020, TECHNOL FORECAST SOC, V152, DOI 10.1016/j.techfore.2019.119843
   Dieppe A., 2020, POLICY RES WORKING
   Eltayeb TK, 2011, RESOUR CONSERV RECY, V55, P495, DOI 10.1016/j.resconrec.2010.09.003
   Farhadi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048903
   Farr J.L., 1990, INNOVATION CREATIVIT
   Fischer C.F., 1995, AUTHENTIC ASSESSMENT
   Flamholtz E., 2021, INT REV ENTREP, V19, P225
   Ford RC., 1995, ACAD MANAGEMENT PROS, V9, P21
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Garvin D., 2000, LEARNING ACTION GUID
   Garvin DA, 2008, HARVARD BUS REV, V86, P109
   Geissdoerfer M, 2017, J CLEAN PROD, V143, P757, DOI 10.1016/j.jclepro.2016.12.048
   Gherardi S., SOC FDN ORG LEARN
   GOULDNER AW, 1960, AM SOCIOL REV, V25, P161, DOI 10.2307/2092623
   Grama-Vigouroux S, 2020, J BUS RES, V119, P230, DOI 10.1016/j.jbusres.2019.08.016
   Grobman L., 2020, MAJOR DECISIONS
   Gursoy D, 2020, J HOSP MARKET MANAG, V29, P527, DOI 10.1080/19368623.2020.1788231
   Hair JF, 2013, LONG RANGE PLANN, V46, P1, DOI 10.1016/j.lrp.2013.01.001
   Hameed A.O., 2015, J SUSTAIN SCI MANAG, V10, P42
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   International Monetary Fund(IMF), POL RESP COVID 19
   Janssen O, 2000, J OCCUP ORGAN PSYCH, V73, P287, DOI 10.1348/096317900167038
   Jansson J, 2017, BUS STRATEG ENVIRON, V26, P69, DOI 10.1002/bse.1901
   Javed B., 2017, J MANAGE ORGAN, V23, P472, DOI [10.1017/jmo.2017.17, DOI 10.1017/JMO.2017.17]
   Jiang WP, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9091567
   Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6
   Jokisaari M, 2013, J VOCAT BEHAV, V82, P96, DOI 10.1016/j.jvb.2013.01.002
   Jung KB, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12062340
   Kanter R. M., 1983, HUM RESOUR MANAGE-US, V22, P9
   Kawamorita H., 2020, J ENTREPRENEURSHIP B, V8, P77
   Knezovic E, 2021, EMPL RELAT, V43, P398, DOI 10.1108/ER-03-2020-0124
   Koch P., INNOVATION PUBLIC SE
   Kristof-Brown AL, 2014, J ORGAN BEHAV, V35, P969, DOI 10.1002/job.1942
   Kulmaganbetova A, 2020, ENTREP SUSTAIN ISS, V8, P1286, DOI 10.9770/jesi.2020.8.2(76)
   Kuzma E, 2020, J CLEAN PROD, V259, DOI 10.1016/j.jclepro.2020.120745
   LaMarsh J., 2005, CHIEF LEARN OFF, V4, P46
   Lee K, 2017, J ORGAN CHANGE MANAG, V30, P501, DOI 10.1108/JOCM-08-2015-0139
   Li H, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11061594
   Liu XM, 2020, MANAGE DECIS, V58, P2681, DOI 10.1108/MD-02-2019-0281
   Luscher LS, 2008, ACAD MANAGE J, V51, P221, DOI 10.5465/AMJ.2008.31767217
   MARCH JG, 1981, ADMIN SCI QUART, V26, P563, DOI 10.2307/2392340
   McTernan WP, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040382
   Mei L, 2019, TECHNOL FORECAST SOC, V144, P118, DOI 10.1016/j.techfore.2019.04.010
   Meyer JP, 2002, J VOCAT BEHAV, V61, P20, DOI 10.1006/jvbe.2001.1842
   Mutonyi BR, 2020, INT J PUBLIV LEADERS, V16, P175, DOI 10.1108/IJPL-07-2019-0045
   Nadia ZBH., 2014, INT STRATEGIC MANAGE, V2, P31
   Nelson S., 2008, IMPACT LMX NURSES PE
   Nishitani K, 2020, SUSTAIN PROD CONSUMP, V21, P156, DOI 10.1016/j.spc.2019.12.002
   Nor-Aishah H, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12083100
   Novitasari D., 2020, ASIA PAC MANAG BUS A, V9, P37
   Obrenovic B, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12155981
   Olafsen AH, 2021, J WORKPLACE LEARN, V33, P180, DOI 10.1108/JWL-05-2020-0093
   ORGAN DW, 1989, J APPL PSYCHOL, V74, P157, DOI 10.1037/0021-9010.74.1.157
   Pearce D.W., 1993, WARFORD WORLD END
   Perry-Smith JE, 2003, ACAD MANAGE REV, V28, P89
   Pettit TJ, 2019, J BUS LOGIST, V40, P56, DOI 10.1111/jbl.12202
   Poole M.S., 2004, HDB ORG CHANGE INNOV
   Purwanto A., 2021, INT J SOC MANAG STUD, V2, P1, DOI 10.5555/ijosmas.v2i1.4
   Rae D., 2017, INT J WORK INNOV, V2, P76, DOI [10.1504/IJWI.2017.080725, DOI 10.1504/IJWI.2017.080725]
   Rahi S., 2020, P 52 INT SCI C EC SO, P16
   Rank J, 2007, HUM PERFORM, V20, P363
   Rao P, 2005, INT J OPER PROD MAN, V25, P898, DOI 10.1108/01443570510613956
   Razumovskaia E., 2020, J OPEN INNOVAT TECHN, V6, P1, DOI [DOI 10.3390/JOITMC6040160, 10.3390/joitmc6040160]
   Redelinghuys K, 2020, S AFR J BUS MANAG, V51, DOI 10.4102/sajbm.v51i1.1837
   Ritter T, 2020, IND MARKET MANAG, V88, P214, DOI 10.1016/j.indmarman.2020.05.014
   ROBSON KA, 1993, TAXON, V42, P17, DOI 10.2307/1223299
   Roos J., 2020, INT J MANAG APPL RES, V7, P1, DOI [10.18646/2056.71.20-001, DOI 10.18646/2056.71.20-001]
   SCOTT SG, 1994, PROCEEDINGS OF THE IEEE 1994 INTERNATIONAL ENGINEERING MANAGEMENT CONFERENCE, P48, DOI 10.1109/IEMC.1994.379952
   Senge P., 1999, CHALLENGES SUSTAININ
   Senge PM., 1990, 5 DISCIPLINE
   Seo Jung Kyu, 2020, [Journal of the Korea Society Industrial Information System, 한국산업정보학회논문지], V25, P103, DOI 10.9723/jksiis.2020.25.5.103
   Shlosberg M., 2010, SELF REINVENTING ORG
   Singh M, 2012, J PERS PSYCHOL, V11, P127, DOI 10.1027/1866-5888/a000065
   Soto-Acosta P, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8040342
   Spreitzer GM, 1996, ACAD MANAGE J, V39, P483, DOI 10.2307/256789
   Srivastava A, 2006, ACAD MANAGE J, V49, P1239, DOI 10.5465/AMJ.2006.23478718
   Tang GY, 2020, J ORGAN BEHAV, V41, P551, DOI 10.1002/job.2449
   Teplov R, 2019, INT J INNOV MANAG, V23, DOI 10.1142/S1363919619500026
   The World Bank, GLOB EC OUTL COVID 1
   Tian GX, 2020, SOC BEHAV PERSONAL, V48, DOI 10.2224/sbp.9320
   Tiwana A, 2005, J MANAGE INFORM SYST, V22, P13, DOI 10.1080/07421222.2003.11045836
   To ML, 2015, LEADERSHIP QUART, V26, P543, DOI 10.1016/j.leaqua.2015.05.005
   Tuckey MR, 2012, J OCCUP HEALTH PSYCH, V17, P15, DOI 10.1037/a0025942
   Ugoani J., 2020, INT J EC BUS ADM, V6, P78
   Usman M., 2020, INT BUSINESS ED J, V13, P95, DOI [10.37134/ibej.vol13.1.8.2020, DOI 10.37134/IBEJ.VOL13.1.8.2020]
   Vecchio RP, 2010, LEADERSHIP QUART, V21, P530, DOI 10.1016/j.leaqua.2010.03.014
   Vu KM, 2011, TELECOMMUN POLICY, V35, P357, DOI 10.1016/j.telpol.2011.02.008
   Vu M.H., 2020, TECH ROM J APPL SCI, V2, P20, DOI DOI 10.47577/TECHNIUM.V2I7.1653
   Wanberg CR, 2000, J APPL PSYCHOL, V85, P373, DOI 10.1037//0021-9010.85.3.373
   [王辉 WANG Hui], 2008, [心理学报, Acta Psychologica Sinica], V40, P1297
   Wang ZM, 2005, INT J MANPOWER, V26, P481, DOI 10.1108/01437720510625403
   Weiner B.J., 2020, HDB IMPLEMENTATION S
   West M., 1992, INNOVATION CREATIVIT
   West P, 2000, INT J OPER PROD MAN, V20, P1236, DOI 10.1108/01443570010343762
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   Wiek A, 2014, RES EVALUAT, V23, P117, DOI 10.1093/reseval/rvt031
   Wulandari R.D., 2020, PROBL PERSPECT MANAG, V18, P1, DOI [10.21511/ppm.18(3).2020.01, DOI 10.21511/PPM.18(3).2020.01]
   Xerri MJ, 2013, INT J HUM RESOUR MAN, V24, P3163, DOI 10.1080/09585192.2013.775033
   Xie J, 2019, BUS STRATEG ENVIRON, V28, P286, DOI 10.1002/bse.2224
   Xue YJ, 2011, J KNOWL MANAG, V15, P299, DOI 10.1108/13673271111119709
   Yang TA, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010072
   Yusliza MY, 2020, J CLEAN PROD, V249, DOI 10.1016/j.jclepro.2019.119334
   Zhang T., 2018, APPL INTELL, P1, DOI DOI 10.1007/S10479-018-3084-8
   Zhao CH, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10082607
   Zhen Z, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13020720
   Zhou J, 2001, ACAD MANAGE J, V44, P682, DOI 10.2307/3069410
NR 134
TC 2
Z9 2
U1 12
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD NOV
PY 2021
VL 13
IS 22
AR 12465
DI 10.3390/su132212465
PG 27
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA XF6XJ
UT WOS:000724212300001
OA gold
DA 2022-04-20
ER

PT J
AU Agarwal, V
   Sharma, S
   Gupta, L
   Misra, DP
   Davalbhakta, S
   Agarwal, V
   Goel, A
   Aggarwal, S
AF Agarwal, Vishwesh
   Sharma, Supriya
   Gupta, Latika
   Misra, Durga Prasanna
   Davalbhakta, Samira
   Agarwal, Vikas
   Goel, Ashish
   Aggarwal, Shelley
TI COVID-19 and Psychological Disaster Preparedness - An Unmet Need
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article
DE awareness; epidemic; knowledge; psychological preparedness; psychology;
   risk
AB Objective:
   The coronavirus disease (COVID-19) pandemic is a disaster of unprecedented proportions with global repercussions. Psychological preparedness, the primed cognitive awareness and anticipation of dealing with emotional responses in an adverse situation, has assumed a compelling relevance during a health disaster of this magnitude.
   Methods:
   An anonymized eSurvey was conducted in India to assess psychological preparedness toward the ongoing pandemic with a focus on knowledge, management of own and others' emotional response, and anticipatory coping mechanisms among the survey population. An adapted version of the qualitative Psychological Preparedness for Natural Disaster Scale validated by the World Health Organization was widely circulated over the Internet and various social media platforms for assessment. Results are expressed as median +/- standard deviation. Descriptive statistics were used and figures downloaded from surveymonkey.com.
   Results:
   Of the 1120 respondents (M:F 1.7:1, age 35 years +/- 14.1), most expressed a high level of perceived knowledge and confidence of managing COVID-19, such as awareness of the symptoms of the illness (95.1%), actions needed (94.4%), hospital to report to (88.9%), and emergency contact number (89.1%). A majority (95%) monitored regularly the news bulletins and scientific journals regarding COVID-19. However, nearly one-third (29.2%) could not assess their likelihood of developing COVID-19, and 17.5% were unaware of the difference between a mild and severe infection. Twenty-three percent (23.3%) were unfamiliar with the materials needed in an acute illness situation.
   Conclusion:
   Psychological disaster preparedness is reasonable, although lacking in specific domains. Timely but focused interventions can be a cost-efficient administrative exercise, which federal agencies may prioritize working on.
C1 [Agarwal, Vishwesh] Mahatma Gandhi Mission Med Coll, Navi Mumbai, India.
   [Sharma, Supriya; Gupta, Latika; Misra, Durga Prasanna; Aggarwal, Shelley] Sanjay Gandhi Post Grad Inst Med Sci, Lucknow, Uttar Pradesh, India.
   [Davalbhakta, Samira] Byramjee Jeejeebhoy Govt Med Coll, Pune, Maharashtra, India.
   [Davalbhakta, Samira] Sassoon Gen Hosp, Pune, Maharashtra, India.
   [Goel, Ashish] Univ Coll Med Sci, Delhi, India.
   [Agarwal, Vikas] Stanford Univ, Sch Med, Stanford, CA USA.
RP Gupta, L (corresponding author), SGPGIMS, Dept Clin Immunol & Rheumatol, C Block, Lucknow 226014, Uttar Pradesh, India.
EM drlatikagupta@gmail.com
RI Agarwal, Vishwesh/ABB-2415-2020; Davalbhakta, Samira/AAX-5095-2020
OI Agarwal, Vishwesh/0000-0002-0986-8354; Gupta, Latika/0000-0003-2753-2990
CR De Sousa A, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102128
   Donaldson SE, 2019, UNDERSTANDING SECURITY ISSUES, P87, DOI 10.1515/9781501506505-009
   Expert Panel on Gastrointestinal Imaging, 2019, J AM COLL RADIOL, V16, pS141, DOI [10.1016/j.jacr.2019.02.015, DOI 10.3390/ijerph16162964]
   EYSENBACH G, 2004, J MED INTERNET RES, V6, P3
   Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562
   Indian Council of Medical Research, 2019, ICMR GUID COMM ETH R
   Kar N., 2006, INT J DISASTER MED, V4, P169, DOI [10.1080/15031430701875551, DOI 10.1080/15031430701875551]
   Malkina-Pykh I, 2013, INTEGRATED MODEL PSY
   Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017
   Power EA, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0023
   The Lancet Psychiatry, 2020, MENT HLTH COVID 19 C
   Wikipedia, 2019, CONT VAL
   Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548
   Zulch H, PSYCHOL PREPAREDNESS
NR 14
TC 15
Z9 15
U1 2
U2 3
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD JUN
PY 2020
VL 14
IS 3
BP 387
EP 390
AR PII S1935789320002190
DI 10.1017/dmp.2020.219
PG 4
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA OP8NT
UT WOS:000588347800041
PM 32580799
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Marques, G
   Agarwal, D
   Diez, ID
AF Marques, Goncalo
   Agarwal, Deevyankar
   de la Torre Diez, Isabel
TI Automated medical diagnosis of COVID-19 through EfficientNet
   convolutional neural network
SO APPLIED SOFT COMPUTING
LA English
DT Article
DE Automated decision support system; Convolutional Neural Network (CNN);
   COVID-19; Deep learning; Machine learning
ID RECOGNITION
AB COVID-19 infection was reported in December 2019 at Wuhan, China. This virus critically affects several countries such as the USA, Brazil, India and Italy. Numerous research units are working at their higher level of effort to develop novel methods to prevent and control this pandemic scenario. The main objective of this paper is to propose a medical decision support system using the implementation of a convolutional neural network (CNN). This CNN has been developed using EfficientNet architecture. To the best of the authors' knowledge, there is no similar study that proposes an automated method for COVID-19 diagnosis using EfficientNet. Therefore, the main contribution is to present the results of a CNN developed using EfficientNet and 10-fold stratified cross-validation. This paper presents two main experiments. First, the binary classification results using images from COVID-19 patients and normal patients are shown. Second, the multi-class results using images from COVID-19, pneumonia and normal patients are discussed. The results show average accuracy values for binary and multi-class of 99.62% and 96.70%, respectively. On the one hand, the proposed CNN model using EfficientNet presents an average recall value of 99.63% and 96.69% concerning binary and multi-class, respectively. On the other hand, 99.64% is the average precision value reported by binary classification, and 97.54% is presented in multi-class. Finally, the average F1-score for multi-class is 97.11%, and 99.62% is presented for binary classification. In conclusion, the proposed architecture can provide an automated medical diagnostics system to support healthcare specialists for enhanced decision making during this pandemic scenario. (C) 2020 Elsevier B.V. All rights reserved.
C1 [Marques, Goncalo; Agarwal, Deevyankar; de la Torre Diez, Isabel] Univ Valladolid, Dept Signal Theory & Commun & Telemat Engn, Paseo de Belen 15, Valladolid 47011, Spain.
RP Marques, G (corresponding author), Univ Valladolid, Dept Signal Theory & Commun & Telemat Engn, Paseo de Belen 15, Valladolid 47011, Spain.
EM goncalosantosmarques@gmail.com; deevyankar.agarwal@hct.edu.om;
   isator@tel.uva.es
RI Marques, Goncalo/N-1805-2018; Agarwal, Deevyankar/AAP-9083-2021
OI Marques, Goncalo/0000-0001-5834-6571; Agarwal,
   Deevyankar/0000-0001-8083-7342
FU European CommissionEuropean CommissionEuropean Commission Joint Research
   Centre; Ministry of Industry, Energy and Tourism [AAL-20125036]
FX This research has been partially supported by European Commission and
   the Ministry of Industry, Energy and Tourism under the project
   AAL-20125036 named "Wetake Care: ICT-based Solution for (Self-)
   Management of Daily Living''.
CR Ahuja S, 2021, APPL INTELL, V51, P571, DOI 10.1007/s10489-020-01826-w
   Al Kasab S., 2020, OPTIMIZING USE TELEN, DOI DOI 10.1089/TMJ.2020
   Ali MNY, 2019, INT J AMBIENT COMPUT, V10, P92, DOI 10.4018/IJACI.2019070106
   Alimadadi A, 2020, PHYSIOL GENOMICS, V52, P200, DOI 10.1152/physiolgenomics.00029.2020
   [Anonymous], 2020, EFFICIENTNET IMPROVI
   [Anonymous], 2020, CHEST XRAY IMAGES PN
   Apostolopoulos ID, 2020, PHYS ENG SCI MED, V43, P635, DOI 10.1007/s13246-020-00865-4
   Araujo FHD, 2016, INT J MED INFORM, V94, P1, DOI 10.1016/j.ijmedinf.2016.06.007
   Buslaev A, 2020, INFORMATION, V11, DOI 10.3390/info11020125
   Buzaev Igor Vyacheslavovich, 2016, Chronic Dis Transl Med, V2, P166, DOI 10.1016/j.cdtm.2016.09.007
   Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3
   Rangel JC, 2018, APPL SOFT COMPUT, V65, P603, DOI 10.1016/j.asoc.2018.02.005
   Cohen J. P., 2020, J MACH LEARN BIOMED
   Das DK, 2019, APPL SOFT COMPUT, V83, DOI 10.1016/j.asoc.2019.105642
   Debnath Shubham, 2020, Bioelectron Med, V6, P14, DOI 10.1186/s42234-020-00050-8
   Dong C, 2016, LECT NOTES COMPUT SC, V9906, P391, DOI 10.1007/978-3-319-46475-6_25
   Doshi A, 2020, J HOSP MED, V15, P302, DOI 10.12788/jhm.3419
   Drew DA, 2020, SCIENCE, V368, P1362, DOI 10.1126/science.abc0473
   Duong LT, 2020, COMPUT ELECTRON AGR, V171, DOI 10.1016/j.compag.2020.105326
   Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7
   Harapan H, 2020, J INFECT PUBLIC HEAL, V13, P667, DOI 10.1016/j.jiph.2020.03.019
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Kansagra AP, 2020, NEW ENGL J MED, V383, P400, DOI 10.1056/NEJMc2014816
   Karthik R, 2020, APPL SOFT COMPUT, V86, DOI 10.1016/j.asoc.2019.105933
   Konar D., 2020, RES SQUARE, DOI DOI 10.21203/RS.3.RS-34596/V1
   Lawrence S, 1997, IEEE T NEURAL NETWOR, V8, P98, DOI 10.1109/72.554195
   Lee D, 2020, WORLD DEV, V135, DOI 10.1016/j.worlddev.2020.105057
   Lescure FX, 2020, LANCET INFECT DIS, V20, P697, DOI 10.1016/S1473-3099(20)30200-0
   Li ZY, 2020, BRAIN BEHAV IMMUN, V88, P916, DOI 10.1016/j.bbi.2020.03.007
   Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024
   Luo L, 2019, INT J HEALTH PLAN M, V34, pE1236, DOI 10.1002/hpm.2769
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Muralidharan N, 2021, J BIOMOL STRUCT DYN, V39, P2673, DOI 10.1080/07391102.2020.1752802
   Nour M, 2020, APPL SOFT COMPUT, V97, DOI 10.1016/j.asoc.2020.106580
   Omboni S, 2020, TELEMED E-HEALTH, V26, P973, DOI 10.1089/tmj.2020.0106
   Ostaszewski M, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0477-8
   Ozturk T, 2020, COMPUT BIOL MED, V121, DOI 10.1016/j.compbiomed.2020.103792
   Panwar H, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.109944
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   RODRIGUEZMORALE.AJ, 2020, TRAVEL MED INFECT DI, V35, DOI DOI 10.1016/J.TMAID.2020.101613
   Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083
   Shi F, 2021, IEEE REV BIOMED ENG, V14, P4, DOI 10.1109/RBME.2020.2987975
   Rao ASRS, 2020, INFECT CONT HOSP EP, V41, P826, DOI 10.1017/ice.2020.61
   Tan MX, 2019, PR MACH LEARN RES, V97
   Tashiro A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12135250
   Tavanaei A, 2019, NEURAL NETWORKS, V111, P47, DOI 10.1016/j.neunet.2018.12.002
   Topol EJ, 2019, NAT MED, V25, P44, DOI 10.1038/s41591-018-0300-7
   Toraman S, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110122
   Tukiainen M, IMAGEDATAAUGMENTOR
   Vaid S, 2020, INT ORTHOP, V44, P1539, DOI 10.1007/s00264-020-04609-7
   Vaishya R, 2020, DIABETES METAB SYND, V14, P337, DOI 10.1016/j.dsx.2020.04.012
   Wang C, 2020, APPL SOFT COMPUT, V91, DOI 10.1016/j.asoc.2020.106253
   Wang Y, 2020, APPL SOFT COMPUT, V92, DOI 10.1016/j.asoc.2020.106302
   Xiaoyu Ji, 2019, Intelligent Computing Theories and Application. 15th International Conference, ICIC 2019. Proceedings: Lecture Notes in Computer Science (LNCS 11643), P653, DOI 10.1007/978-3-030-26763-6_63
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
NR 55
TC 56
Z9 56
U1 13
U2 39
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1568-4946
EI 1872-9681
J9 APPL SOFT COMPUT
JI Appl. Soft. Comput.
PD NOV
PY 2020
VL 96
AR 106691
DI 10.1016/j.asoc.2020.106691
PG 11
WC Computer Science, Artificial Intelligence; Computer Science,
   Interdisciplinary Applications
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science
GA OH7GI
UT WOS:000582762000093
PM 33519327
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Vanhaecht, K
   Seys, D
   Bruyneel, L
   Cox, B
   Kaesemans, G
   Cloet, M
   Van den Broeck, K
   Cools, O
   De Witte, A
   Lowet, K
   Hellings, J
   Bilsen, J
   Lemmens, G
   Claes, S
AF Vanhaecht, Kris
   Seys, Deborah
   Bruyneel, Luk
   Cox, Bianca
   Kaesemans, Gorik
   Cloet, Margot
   Van den Broeck, Kris
   Cools, Olivia
   De Witte, Andy
   Lowet, Koen
   Hellings, Johan
   Bilsen, Johan
   Lemmens, Gilbert
   Claes, Stephan
TI COVID-19 is having a destructive impact on health-care workers' mental
   well-being
SO INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE
LA English
DT Article
DE professions; workforce and workload; COVID-19; mental health; corona;
   pandemic
ID PSYCHOLOGICAL IMPACT; MEDICAL STAFF; CHINA
AB Background: The coronavirus disease 2019 (COVID-19) may aggravate workplace conditions that impact health-care workers' mental health. However, it can also place other stresses on workers outside of their work. This study determines the effect of COVID-19 on symptoms of negative and positive mental health and the workforce's experience with various sources of support. Effect modification by demographic variables was also studied.
   Methods: A cross-sectional survey study, conducted between 2 April and 4 May 2020 (two waves), led to a convenience sample of 4509 health-care workers in Flanders (Belgium), including paramedics (40.6%), nurses (33.4%), doctors (13.4%) and management staff (12.2%). About three in four were employed in university and acute hospitals (29.6%), primary care practices (25.7%), residential care centers (21.3%) or care sites for disabled and mental health care. In each of the two waves, participants were asked how frequently (on a scale of 0-10) they experienced positive and negative mental health symptoms during normal circumstances and during last week, referred to as before and during COVID-19, respectively. These symptoms were stress, hypervigilance, fatigue, difficulty sleeping, unable to relax, fear, irregular lifestyle, flashback, difficulty concentrating, feeling unhappy and dejected, failing to recognize their own emotional response, doubting knowledge and skills and feeling uncomfortable within the team. Associations between COVID-19 and mental health symptoms were estimated by cumulative logit models and reported as odds ratios. The needed support was our secondary outcome and was reported as the degree to which health-care workers relied on sources of support and how they experienced them.
   Results: All symptoms were significantly more pronounced during versus before COVID-19. For hypervigilance, there was a 12-fold odds (odds ratio 12.24, 95% confidence interval 11.11-13.49) during versus before COVID-19. Positive professional symptoms such as the feeling that one can make a difference were less frequently experienced. The association between COVID-19 and mental health was generally strongest for the age group 30-49 years, females, nurses and residential care centers. Health-care workers reported to rely on support from relatives and peers. A considerable proportion, respectively, 18 and 27%, reported the need for professional guidance from psychologists and more support from their leadership.
   Conclusions: The toll of the crisis has been heavy on health-care workers. Those who carry leadership positions at an organizational or system level should take this opportunity to develop targeted strategies to mitigate key stressors of health-care workers' mental well-being.
C1 [Vanhaecht, Kris; Seys, Deborah; Bruyneel, Luk; Cox, Bianca] KU Leuven Univ Leuven, Leuven Inst Healthcare Policy, Kapucijnenvoer 35, B-3000 Leuven, Belgium.
   [Kaesemans, Gorik; Cloet, Margot] Zorgnet Icuro, Brussels, Belgium.
   [Van den Broeck, Kris] Univ Antwerp, Dept Primary Care, Doornstr 331, B-2610 Antwerp, Belgium.
   [Cools, Olivia] KARUS Vzw, Melle, Belgium.
   [De Witte, Andy] GZA Hosp, Doctors4Doctors, Antwerp, Belgium.
   [Lowet, Koen] Flemish Assoc Clin Psychologists, Brussels, Belgium.
   [Hellings, Johan] Hasselt Univ, Fac Med & Life Sci, Martelarenlaan 42, BE-3500 Hasselt, Belgium.
   [Bilsen, Johan] VUB, Mental Hlth & Wellbeing Res Grp, Laarbeeklaan 103, B-1050 Brussels, Belgium.
   [Lemmens, Gilbert] Univ Ghent, Fac Med & Hlth Sci, De Pintelaan 185, B-9000 Ghent, Belgium.
   [Claes, Stephan] KU Leuven Univ Leuven, Dept Adult Psychiat, Herestr 49, B-3000 Leuven, Belgium.
RP Vanhaecht, K (corresponding author), KU Leuven Univ Leuven, Leuven Inst Healthcare Policy, Kapucijnenvoer 35, B-3000 Leuven, Belgium.
EM Kris.vanhaecht@kuleuven.be
RI Seys, Deborah/N-6149-2019; Van den Broeck, Kris/AAD-5886-2019
OI Seys, Deborah/0000-0003-4966-3879; Van den Broeck,
   Kris/0000-0002-5566-6868
CR [Anonymous], 2020, ZORGSAMEN CONSORTIUM
   [Anonymous], 2020, SCIENSANO
   Babore A, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113366
   Balasubramanian A, 2020, HEAD NECK-J SCI SPEC, V42, P1638, DOI 10.1002/hed.26291
   Cai HZ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924171
   Chen QN, 2020, LANCET PSYCHIAT, V7, pE15, DOI 10.1016/S2215-0366(20)30078-X
   Dewey C, 2020, ANN INTERN MED, V172, P752, DOI 10.7326/M20-1033
   Dong ZQ, 2020, EUR PSYCHIAT, V63, DOI [10.1192/j.eurpsy.2020.59, 10.1145/3416315.3416316]
   Evanoff BA, 2020, J MED INTERNET RES, V22, DOI 10.2196/21366
   Fukuti P, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e1963
   Hou TY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233831
   Huang L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237303
   John Hopkins University & Medicine, 2020, MORT AN
   Kang LJ, 2020, BRAIN BEHAV IMMUN, V87, P11, DOI 10.1016/j.bbi.2020.03.028
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Liang YM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186550
   Muller AE, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113441
   Ning XJ, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02838-z
   Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017
   Scott SD., 2010, AHRQ HLTH CARE INNOV
   Seys D, 2013, INT J NURS STUD, V50, P678, DOI 10.1016/j.ijnurstu.2012.07.006
   Shanafelt T, 2020, JAMA-J AM MED ASSOC, V323, P2133, DOI 10.1001/jama.2020.5893
   Shapiro J, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2024834
   Shechter A, 2020, GEN HOSP PSYCHIAT, V66, P1, DOI 10.1016/j.genhosppsych.2020.06.007
   Si MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00724-0
   Song LL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145059
   Spoorthy MS, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102119
   Tan BYQ, 2020, ANN INTERN MED, V173, P317, DOI 10.7326/M20-1083
   Tannenbaum SI, 2021, BMJ QUAL SAF, V30, P59, DOI 10.1136/bmjqs-2020-011447
   Thomas C., 2020, I PUBLIC POLICY RES
   Van Gerven E, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011403
   Vanhaecht K, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029923
   Walton M, 2020, EUR HEART J-ACUTE CA, V9, P241, DOI 10.1177/2048872620922795
   Wang LQ, 2020, J PSYCHIATR RES, V129, P198, DOI 10.1016/j.jpsychires.2020.07.008
   Wu AW, 2020, ANN INTERN MED, V172, P822, DOI 10.7326/M20-1236
   Zhang WR, 2020, PSYCHOTHER PSYCHOSOM, V89, P242, DOI 10.1159/000507639
NR 36
TC 25
Z9 25
U1 1
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1353-4505
EI 1464-3677
J9 INT J QUAL HEALTH C
JI Int. J. Qual. Health Care
PD JAN
PY 2021
VL 33
IS 1
AR mzaa158
DI 10.1093/intqhc/mzaa158
PG 6
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA RZ9TY
UT WOS:000648943600047
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Alrasheedy, AA
   Abdulsalim, S
   Farooqui, M
   Alsahali, S
   Godman, B
AF Alrasheedy, Alian A.
   Abdulsalim, Suhaj
   Farooqui, Maryam
   Alsahali, Saud
   Godman, Brian
TI Knowledge, Attitude and Practice About Coronavirus Disease (COVID-19)
   Pandemic and Its Psychological Impact on Students and Their Studies: A
   Cross-Sectional Study Among Pharmacy Students in Saudi Arabia
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE coronavirus; COVID-19; mental health; pharmacy; Saudi Arabia
ID MENTAL-HEALTH; PRECAUTIONARY MEASURES; UNIVERSITY-STUDENTS;
   TRANSMISSION; PREPAREDNESS; OUTBREAK
AB Background: Individuals' knowledge, attitude and practice towards preventive and precautionary measures of COVID-19 are essential to control the spread of the disease. Consequently, the aims of the study were to evaluate knowledge, attitude and practice of pharmacy students towards the pandemic and to assess its psychological impact on them to provide future guidance.
   Methods: A cross-sectional, questionnaire-based study was conducted via a web-based survey in May 2020. All pharmacy students enrolled at Unaizah College of Pharmacy, Qassim University, were invited to take part in the study.
   Results: A total of 232 out of 460 students took part in the study, giving a response rate of 50.43%. The mean total knowledge score was 9.87 +/- 2.04 (maximum attainable score, 12). The majority of the participants (n=163; 70.3%) believed COVID-19 is a health threat to their community in the early months of the pandemic. Moreover, the majority (93%) also believed that the lockdown at the beginning of the pandemic was necessary to contain the pandemic. Encouragingly, 86.6% reported that they did not go to any crowded places during the pandemic with more female students avoiding crowded places compared to male students (91.6% versus 78.7%, respectively, P = 0.005). The majority (91%) also reported that they were following the strategies recommended by the authorities to prevent the spread of the virus. Encouragingly, 54.3% reported that the pandemic either had no effect or just a limited effect on their studies. However, 38.5% reported that they always felt or frequently felt nervous or anxious during the pandemic.
   Conclusion: The study showed that pharmacy students had good knowledge as well as positive attitudes and good practices towards COVID-19 and the preventive measures. However, during the early months, the pandemic did have a negative psychological impact on a number of students. Consequently, proactive psychological and social support services to the students should be considered during the current and future pandemics. In addition, it is important to consider and proactively address key issues that could cause stress and anxiety among students when shifting to distance learning and assessments.
C1 [Alrasheedy, Alian A.] Qassim Univ, Coll Pharm, Dept Pharm Practice, Buraydah 51452, Qassim, Saudi Arabia.
   [Abdulsalim, Suhaj; Farooqui, Maryam; Alsahali, Saud] Qassim Univ, Unaizah Coll Pharm, Dept Pharm Practice, Unaizah, Qassim, Saudi Arabia.
   [Godman, Brian] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.
   [Godman, Brian] Sefako Makgatho Hlth Sci Univ, Sch Pharm, Pretoria, South Africa.
   [Godman, Brian] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia.
RP Alrasheedy, AA (corresponding author), Qassim Univ, Coll Pharm, Dept Pharm Practice, Buraydah 51452, Qassim, Saudi Arabia.
EM aarshiedy@qu.edu.sa
RI Alrasheedy, Alian A./Z-3228-2019
OI Alrasheedy, Alian A./0000-0003-3617-7425; Godman,
   Brian/0000-0001-6539-6972
CR Abubakar AR, 2020, INFECT DRUG RESIST, V13, P4673, DOI 10.2147/IDR.S289037
   Afriyie DK, 2020, J INFECT DEV COUNTR, V14, P838, DOI 10.3855/jidc.12909
   Akudjedu Theophilus N, 2020, BJR Open, V2, P20200023, DOI 10.1259/bjro.20200023
   Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217
   Alahdal H, 2020, J INFECT PUBLIC HEAL, V13, P1446, DOI 10.1016/j.jiph.2020.06.015
   Algaissi AA, 2020, J INFECT PUBLIC HEAL, V13, P834, DOI 10.1016/j.jiph.2020.04.016
   Alghamdi SM, 2020, J FAM COMMUNITY MED, V27, P208, DOI 10.4103/jfcm.JFCM_295_20
   AlHumaid J, 2020, PSYCHOL TRAUMA-US, V12, P505, DOI 10.1037/tra0000623
   Alkhamees AA, 2020, COMPR PSYCHIAT, V102, DOI 10.1016/j.comppsych.2020.152192
   Almutairi AF, 2020, RISK MANAG HEALTHC P, V13, P753, DOI 10.2147/RMHP.S257287
   Alshammari TM, 2020, SAUDI PHARM J, V28, P898, DOI 10.1016/j.jsps.2020.05.005
   Alumran A, 2020, J MULTIDISCIP HEALTH, V13, P615, DOI 10.2147/JMDH.S261643
   Alzoubi H, 2020, J PURE APPL MICROBIO, V14, P17, DOI 10.22207/JPAM.14.1.04
   Aucejo EM, 2020, J PUBLIC ECON, V191, DOI 10.1016/j.jpubeco.2020.104271
   Auerbach RP, 2018, J ABNORM PSYCHOL, V127, P623, DOI 10.1037/abn0000362
   Aylie NS, 2020, PSYCHOL RES BEHAV MA, V13, P813, DOI 10.2147/PRBM.S275593
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Bates BR, 2020, J COMMUN HEALTH, V45, P1158, DOI 10.1007/s10900-020-00916-7
   Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572
   Burhamah W, 2020, J AFFECT DISORDERS, V277, P977, DOI 10.1016/j.jad.2020.09.014
   Cadogan CA, 2021, RES SOC ADMIN PHARM, V17, P2032, DOI 10.1016/j.sapharm.2020.03.015
   Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934
   Castaldelli-Maia JM, 2019, INT REV PSYCHIATR, V31, P603, DOI 10.1080/09540261.2019.1669335
   Cheng Kar Keung, 2020, Lancet, DOI 10.1016/S0140-6736(20)30918-1
   Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9
   Col U, 2020, RES SOC ADMIN PHARM, P583, DOI [DOI 10.1016/j.sapharm.2020.02.003, 10.1016/j.sapharm.2020.02.003]
   Courtemanche C, 2020, HEALTH AFFAIR, V39, P1237, DOI 10.1377/hlthaff.2020.00608
   Day M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1165
   Deng SQ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020575
   Dubey S, 2020, DIABETES METAB SYND, V14, P779, DOI 10.1016/j.dsx.2020.05.035
   Dyer O, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4057
   Elshami W, 2021, RADIOGRAPHY, V27, P360, DOI 10.1016/j.radi.2020.09.016
   Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X
   Gara K.H., 2020, J DR NTR U HLTH SCI, V9, P107, DOI [10.4103/JDRNTRUHS.JDRNTRUHS_75_20, DOI 10.4103/JDRNTRUHS.JDRNTRUHS_75_20]
   Godman B, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.585832
   Gonzalez-Sanguino C, 2020, BRAIN BEHAV IMMUN, V87, P172, DOI 10.1016/j.bbi.2020.05.040
   Hamza MS, 2021, J COMMUN HEALTH, V46, P139, DOI 10.1007/s10900-020-00859-z
   Hassounah M, 2020, J MED INTERNET RES, V22, DOI 10.2196/19338
   Hedima EW, 2021, RES SOC ADMIN PHARM, V17, P1964, DOI 10.1016/j.sapharm.2020.04.013
   Huff HV, 2020, CLIN INFECT DIS, V71, P2752, DOI 10.1093/cid/ciaa654
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Ibrahim AK, 2013, J PSYCHIATR RES, V47, P391, DOI 10.1016/j.jpsychires.2012.11.015
   Kapasia N, 2020, CHILD YOUTH SERV REV, V116, DOI 10.1016/j.childyouth.2020.105194
   Kasemy ZA, 2020, J EPIDEMIOL GLOB HEA, V10, P378, DOI 10.2991/jegh.k.200909.001
   Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233744
   Kecojevic A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239696
   Khan AH, 2020, J AFFECT DISORDERS, V277, P121, DOI 10.1016/j.jad.2020.07.135
   Khasawneh AI, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00253
   Khojah HMJ, 2020, SAUDI PHARM J, V28, P1402, DOI 10.1016/j.jsps.2020.09.004
   Klompas M, 2020, JAMA-J AM MED ASSOC, V324, P441, DOI 10.1001/jama.2020.12458
   Kluge HHP, 2020, LANCET, V395, P1678, DOI 10.1016/S0140-6736(20)31067-9
   Lan FY, 2021, OCCUP ENVIRON MED, V78, P237, DOI 10.1136/oemed-2020-106774
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Liang MM, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101751
   Liang SW, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.02231
   Lim S, 2020, J HOSP INFECT, V106, P206, DOI 10.1016/j.jhin.2020.06.017
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Livingston E, 2020, JAMA-J AM MED ASSOC, V323, P1912, DOI 10.1001/jama.2020.5317
   Lyons Z, 2020, AUSTRALAS PSYCHIATRY, V28, P649, DOI 10.1177/1039856220947945
   Lyu W, 2020, HEALTH AFFAIR, V39, P1419, DOI 10.1377/hlthaff.2020.00818
   Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m477
   McCracken LM, 2020, EUR PSYCHIAT, V63, DOI 10.1192/j.eurpsy.2020.81
   McMahon DE, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008412
   Meo SA, 2020, PAK J MED SCI, V36, pS43, DOI 10.12669/pjms.36.COVID19-S4.2809
   Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180
   Modi PD, 2020, CUREUS, V12, DOI 10.7759/cureus.7514
   Naseer A, 2020, J MATER RES TECHNOL, V9, P9093, DOI 10.1016/j.jmrt.2020.06.013
   Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020
   Nurunnabi M, 2021, J MICROBIOL IMMUNOL, V54, P127, DOI 10.1016/j.jmii.2020.07.023
   Nussbaumer-Streit B, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013574
   Obied DA, 2020, J INFECT DEV COUNTR, V14, P699, DOI 10.3855/jidc.13203
   Ogunleye OO, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01205
   Pal R, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108344
   Palmer K, 2020, AGING CLIN EXP RES, V32, P1189, DOI 10.1007/s40520-020-01601-4
   Peng YL, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09392-z
   Pradhan D, 2020, ARCH MED RES, V51, P363, DOI 10.1016/j.arcmed.2020.04.020
   Rainford LA, 2021, RADIOGRAPHY, V27, P464, DOI 10.1016/j.radi.2020.10.015
   Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066
   Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1
   Sahu P, 2020, CUREUS, V12, DOI 10.7759/cureus.7541
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Sefah IA, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.588106
   Serafini G, 2020, QJM-INT J MED, V113, P529, DOI 10.1093/qjmed/hcaa201
   Sharma D, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.589669
   Shawaqfeh MS, 2020, J MED EDUC CURRIC DE, V7, DOI 10.1177/2382120520963039
   Shi Yudong, 2020, Brain Behav Immun Health, V4, P100064, DOI 10.1016/j.bbih.2020.100064
   Singh JP, 2020, J HEALTH MANAG, V22, P281, DOI 10.1177/0972063420935669
   Son C, 2020, J MED INTERNET RES, V22, DOI 10.2196/21279
   Sundarasen S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176206
   Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd
   Tee ML, 2020, J AFFECT DISORDERS, V277, P379, DOI 10.1016/j.jad.2020.08.043
   THAI PQ, 2021, CLIN INFECT DIS, V72, pE334, DOI DOI 10.1093/CID/CIAA1130
   Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212
   Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048
   Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151
   Wang XM, 2020, J MED INTERNET RES, V22, DOI 10.2196/22817
   WHO Eastern Mediterranean Office (EMRO), COVID 19 SITUA TION
   Wong RSY, 2020, SN COMPR CLIN MED, V2, P1983
   WORLD HEALT H ORGANIZATION, 2020, COVID 19 STRAT PREP
   World health organization (WHO), 2020, CORONAVIRUS
   World Health Organization (WHO), 2020, COVID 19 PUBL HLTH E
   Wu HL, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100329
   Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 104
TC 13
Z9 13
U1 3
U2 7
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 729
EP 741
DI 10.2147/RMHP.S292354
PG 13
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA QM6AP
UT WOS:000621860100001
PM 33654441
OA gold, Green Accepted, Green Published
DA 2022-04-20
ER

PT J
AU Silesh, M
   Demisse, TL
   Taye, BT
   Desta, K
   Kitaw, TM
   Mekuria, AD
   Tafesse, TT
   Fenta, B
AF Silesh, Mulualem
   Demisse, Tesfanesh Lemma
   Taye, Birhan Tsegaw
   Desta, Kelem
   Kitaw, Tebabere Moltot
   Mekuria, Abinet Dagnaw
   Tafesse, Tiwabwork Tekalign
   Fenta, Belete
TI Compliance with COVID-19 Preventive Measures and Associated Factors
   Among Women Attending Antenatal Care at Public Health Facilities of
   Debre Berhan Town, Ethiopia
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE antenatal care; compliance; COVID-19; Ethiopia
ID CORONA VIRUS-DISEASE; PREGNANT-WOMEN; KNOWLEDGE; ATTITUDE
AB Background: Coronavirus disease-2019 (COVID-19) is a highly contagious and cause for the death of many people worldwide. Due to physiological immunosuppressive state and mechanical alteration, pregnant women are at a higher risk of severe illness and adverse maternal and fetal outcomes from COVID-19 than non-pregnant women. Compliance with the preventive measures is essential to control COVID-19 related consequences. Therefore, this study aimed to assess compliance with COVID-19 preventive measures among pregnant women attending antenatal care at public facilities of Debre Berhan town, Ethiopia. Methods: A facility-based cross-sectional study was conducted from May 1 to 30, 2021 among 402 pregnant mothers. Data were collected via a face-to-face interviewer-administered questionnaire. Then, entered into Epi-Data version 4.6 and exported to SPSS version 25 for data analysis. In multivariable logistic regression analysis, variables with p < 0.05 were declared as statistically significant and the strength of statistical association was measured by adjusted odds ratio (AOR) and 95% confidence interval (CI). Results: Of the total 396 participants, 222 (56.1%) of women had a good compliance with COVID-19 preventive measures. Maternal age (25-34 years) [AOR: 1.926; 95% CI (1.084, 3.421)] and (>= 35 years) [AOR: 3.018; 95% CI (1.53, 5.952)], husband educational status [AOR: 3.68; 95% CI (1.55, 8.737)], had current chronic disease [AOR: 2.516; 95% CI (1.297, 4.883)], and knowledge [AOR: 5.484; 95% CI (3.057, 9.838)] were significant predictors to have good compliance with COVID-19 preventive measures. Conclusion: Although COVID-19 is a global and national agenda, compliance towards its preventive measures was not sufficient enough. Therefore, scale-up the community aware-ness via media campaign is crucial which will eventually improve compliance. Furthermore, those women who had no pre-existing chronic diseases and those in the young age group should be given special consideration.
C1 [Silesh, Mulualem; Demisse, Tesfanesh Lemma; Taye, Birhan Tsegaw; Desta, Kelem; Kitaw, Tebabere Moltot] Debre Berhan Univ, Coll Hlth Sci, Dept Midwifery, Debre Berhan, Ethiopia.
   [Mekuria, Abinet Dagnaw] Debre Berhan Univ, Coll Hlth Sci, Dept Publ Hlth, Debre Berhan, Ethiopia.
   [Tafesse, Tiwabwork Tekalign] Wolaita Sodo Univ, Coll Hlth Sci, Sch Nursing, Wolaita Sodo, Ethiopia.
   [Fenta, Belete] Jimma Univ, Fac Hlth Sci, Sch Midwifery, Jimma, Ethiopia.
RP Silesh, M (corresponding author), Debre Berhan Univ, Coll Hlth Sci, Dept Midwifery, Debre Berhan, Ethiopia.
EM sileshmulualem22@gmail.com
RI Moltot, Tebabere/AAB-6486-2022
OI Tafesse, Tiwabwork/0000-0002-4200-4216; Lemma,
   Tesfanesh/0000-0003-3038-5821; Mekuria, Abinet/0000-0002-3892-1572;
   Taye, Birhan Tsegaw/0000-0003-2174-3797; Silesh,
   Mulualem/0000-0002-1943-041X
CR Abdo R, 2016, J WOMENS HLTH CARE, V5, DOI DOI 10.4172/2167-0420.1000324
   Allotey J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3320
   Anikwe CC, 2020, INT J GYNECOL OBSTET, V151, P197, DOI 10.1002/ijgo.13293
   Apanga PA, 2021, TROP MED INT HEALTH, V26, P656, DOI 10.1111/tmi.13566
   Ayele AD, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-021-03877-4
   Azene ZN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244265
   Bante A, 2021, PATIENT PREFER ADHER, V15, P237, DOI 10.2147/PPA.S293647
   Belete ZW, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250145
   Besho M, 2021, INT J GEN MED, V14, P3563, DOI 10.2147/IJGM.S295490
   Cao Y, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-043560
   Centers for Disease Control and Prevention, 2021, PREGN REC PREGN PEOP
   Chandrashekarappa, 2020, INT J REPROD CONTRAC, V9, P3622, DOI [10.18203/2320-1770.ijrcog20203830, DOI 10.18203/2320-1770.IJRCOG20203830]
   Chi JH, 2021, ARCH GYNECOL OBSTET, V303, P337, DOI 10.1007/s00404-020-05889-5
   Chmielewska B, 2021, LANCET GLOB HEALTH, V9, pE759, DOI 10.1016/S2214-109X(21)00079-6
   Dashraath P, 2020, AM J OBSTET GYNECOL, V222, P521, DOI 10.1016/j.ajog.2020.03.021
   Degu A, 2021, INT J WOMENS HEALTH, V13, P61, DOI 10.2147/IJWH.S285552
   Diriba K, 2020, EUR J MED RES, V25, DOI 10.1186/s40001-020-00439-w
   Dule A, 2021, BRAIN BEHAV, V11, DOI 10.1002/brb3.2045
   Elsenbruch S, 2007, HUM REPROD, V22, P869, DOI 10.1093/humrep/del432
   Etafa W, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06149-w
   Fikadu Y, 2021, INT J WOMENS HEALTH, V13, P39, DOI 10.2147/IJWH.S291507
   Gajbhiye RK, 2021, INT J GYNECOL OBSTET, V155, P48, DOI 10.1002/ijgo.13793
   Haft JW, 2020, ANN THORAC SURG, V110, P697, DOI [10.1016/j.jtcvs.2020.04.011, 10.1016/j.athoracsur.2020.04.003]
   Hoque AM., 2021, EUR J MED HEAL SCI, V3, P50, DOI DOI 10.24018/EJMED.2021.3.1.654
   James JL, 2006, HUM REPROD UPDATE, V12, P137, DOI 10.1093/humupd/dmi043
   Kamal D, 2020, J MAR MED SOC, V22, P66, DOI 10.4103/jmms.jmms_81_20
   Kumbeni MT, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253446
   Liang H, 2020, ACTA OBSTET GYN SCAN, V99, P439, DOI 10.1111/aogs.13836
   Liu H, 2020, J REPROD IMMUNOL, V139, DOI 10.1016/j.jri.2020.103122
   Margallo Lucio N, 2020, S D Med, V73, P262
   Mariam TGMW, 2021, INT J WOMENS HEALTH, V13, P95, DOI 10.2147/IJWH.S286088
   Martinez-Portilla RJ, 2021, AM J OBSTET GYNECOL, V224, P328, DOI 10.1016/j.ajog.2020.11.013
   Molgora S, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.567155
   Nwafor JI, 2020, INT J GYNECOL OBSTET, V150, P121, DOI 10.1002/ijgo.13186
   Panahi L, 2020, ARCH ACAD EMERG MED, V8
   Rhoda D, 2020, INT J NURSING MIDWIF, V6, P29
   Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623
   Shigute Z, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010369
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wei SQ, 2021, CAN MED ASSOC J, V193, pE540, DOI 10.1503/cmaj.202604
   WHO, 2020, NOV COR 2019 NCOV SI
   WHO, 2020, COR DIS COVID 19 PRE
   WHO, 2020, UPD WHO ADV INT TRAF
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017
   Yehualashet SS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246006
   Yesse M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257058
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 48
TC 0
Z9 0
U1 0
U2 0
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 4561
EP 4569
DI 10.2147/RMHP.S330932
PG 9
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA WX5OW
UT WOS:000718646200001
PM 34795541
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Ma, J
   Zhang, L
   Wang, G
   Li, Y
   Liu, XB
AF Ma, Jun
   Zhang, Lin
   Wang, Gang
   Li, Yi
   Liu, Xuebing
TI CHALLENGES TO THE MANAGEMENT OF PSYCHIATRIC HOSPITALS CAUSED BY THE
   CONTINUED POSITIVE ANTIBODIES OF PATIENTS WITH SCHIZOPHRENIA AFTER
   COVID-19: TWO CASE REPORTS
SO ASEAN JOURNAL OF PSYCHIATRY
LA English
DT Review
DE SARS-CoV-2 Antibody; IgM; IgG; COVID-19; Schizophrenia
ID IGM
AB In the context of the global pandemic of COVID-19, with the epidemic epicenter located in the Wuhan City, China, patients with severe mental illness have also been deeply affected by the epidemic. In this paper, two patients with schizophrenia who recovered from COVID-19 were reported. Because of the long-term positive results of the SARS-CoV-2 serum antibody IgM test, they had to undergo medical isolation and social restrictions for a long time. After the situation was effectively identified by the medical staff and they were eliminated as a potential virus carrier and released from the medical isolation center. Since psychiatrists often lack systematic knowledge of infectious diseases, the authors hope that this paper can provide a reference to avoid unnecessary wastage of medical resources and prevent placing serious mental burden on such patients in the future.
C1 [Ma, Jun; Zhang, Lin; Wang, Gang; Li, Yi; Liu, Xuebing] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan Mental Hlth Ctr, Wuhan, Peoples R China.
RP Li, Y (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan Mental Hlth Ctr, Wuhan, Peoples R China.
EM psylee@163.com
FU Wuhan Health Commission [WX19Y12]
FX This study was funded by the Wuhan Health Commission (WX19Y12, J.M., PI)
CR Azkur AK, 2020, ALLERGY, V75, P1564, DOI 10.1111/all.14364
   Druss BG, 2020, JAMA PSYCHIAT, V77, P891, DOI 10.1001/jamapsychiatry.2020.0894
   Esbin MN, 2020, RNA, V26, P771, DOI 10.1261/rna.076232.120
   General Office of National Health Commission of People's Republic of China OoNAoTCM, 2020, CHINA MED, V15, P801, DOI DOI 10.3760/J.ISSN.1673-4777.2020.06.001
   GIOUDPAQUET M, 1987, ANN RHEUM DIS, V46, P65, DOI 10.1136/ard.46.1.65
   Ingegnoli F, 2013, DIS MARKERS, V2013, P727, DOI 10.1155/2013/726598
   Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1
   Ma J, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-00959-3
   Nishiura H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020330
   Ota Toshiyuki, 2003, Rinsho Byori, V51, P649
   Shu HQ, 2020, VIROL SIN, V35, P744, DOI 10.1007/s12250-020-00268-5
   Wang GuangRong, 2020, Chinese Journal of Virology, V36, P570
   Wang Q, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212893
   West CP, 2020, MAYO CLIN PROC, V95, P1127, DOI 10.1016/j.mayocp.2020.04.004
   Winichakoon P, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00297-20
   Xiang F, 2020, CLIN INFECT DIS, V71, P1930, DOI 10.1093/cid/ciaa461
   Xiang YT, 2020, JAMA PSYCHIAT, V77, P989, DOI 10.1001/jamapsychiatry.2020.1057
   Xiao AT, 2020, J MED VIROL, V92, P1755, DOI 10.1002/jmv.25855
   ZHAO J, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa344, DOI 10.1093/CID/CIAA344]
   Zhong L, 2020, SCI CHINA LIFE SCI, V63, P777, DOI 10.1007/s11427-020-1688-9
NR 20
TC 0
Z9 0
U1 1
U2 5
PU ASEAN FEDERATION PSYCHIATRY & MENTAL HEALTH
PI KUALA LUMPUR
PA ASEAN FEDERATION PSYCHIATRY & MENTAL HEALTH, KUALA LUMPUR, 00000,
   MALAYSIA
SN 2231-7791
EI 2231-7805
J9 ASEAN J PSYCHIATR
JI ASEAN J. Psychiatr.
PD AUG
PY 2021
VL 22
IS 6
PG 6
WC Psychiatry
WE Emerging Sources Citation Index (ESCI)
SC Psychiatry
GA UO5WJ
UT WOS:000694765500004
DA 2022-04-20
ER

PT J
AU Angelini, V
   Villanacci, A
   Belotti, A
   Castagnoli, F
   Frittoli, B
   Corvino, A
   Brunetti, A
   Grazioli, L
AF Angelini, Valentina
   Villanacci, Alberta
   Belotti, Angelo
   Castagnoli, Francesca
   Frittoli, Barbara
   Corvino, Antonio
   Brunetti, Arturo
   Grazioli, Luigi
TI Incidental whole-body MRI evidence of COVID-19 in an asymptomatic
   patient in a high prevalence region
SO EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE
LA English
DT Article
DE COVID-19; Whole-body MRI; Incidental findings; Chest CT
ID CHEST CT
AB Background: The purpose of this case report is to emphasize the importance of curing any clinical radiological elements in this historical period, especially in the area of endemic to coronavirus disease 19 (COVID-19) such as Lombardy and to stress the importance of the management of the asymptomatic patient, their crucial role in the spread of contagion.
   Case presentation: We reported the case of incidental diagnosis of interstitial pneumonia by first finding on whole-body MR (WB-MR) in the patient affected by multiple myeloma (MM), with a negative respiratory symptoms at the time and with previous (1 month before) negative chest X-ray. The patient was promptly subjected to chest CT, which confirmed the suspicion of interstitial COVID-19 pneumonia and, in hospitalization, performed nasopharyngeal swabs for real-time polymerase chain reaction (RNA-PCR), with a doubtful outcome. Once the bacterial nature of the alterations was serologically and radiologically excluded, the patient was definitively diagnosed with COVID-19 and appropriately treated in hospitalization.
   Conclusion: The clinical choices must, therefore, to make use of all the diagnostic tools available and full knowledge of the limitation of each of them.
C1 [Angelini, Valentina; Brunetti, Arturo] Univ Napoli Federico II, Dipartimento Oncoematol Diagnost Immagini & Morfo, Via Pansini 5, I-80133 Naples, Italy.
   [Villanacci, Alberta; Belotti, Angelo; Frittoli, Barbara; Grazioli, Luigi] ASST Spedali Civili Brescia, Dipartimento Radiol 1, Piazzale Spedali Civili 1, Brescia, Italy.
   [Castagnoli, Francesca] Univ Brescia, Dipartimento Radiol, Brescia, Italy.
   [Corvino, Antonio] Univ Naples Parthenope, Motor Sci & Wellness Dept, Via F Acton 38, I-80133 Naples, Italy.
RP Angelini, V (corresponding author), Univ Napoli Federico II, Dipartimento Oncoematol Diagnost Immagini & Morfo, Via Pansini 5, I-80133 Naples, Italy.
EM va.angelini90@gmail.com
RI Frittoli, Barbara/AAW-3710-2021; Brunetti, Arturo/AAE-5261-2019
OI Brunetti, Arturo/0000-0001-7057-3494; Angelini,
   Valentina/0000-0001-6335-7961
CR Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   Booth TC, 2010, BRIT J RADIOL, V83, P456, DOI 10.1259/bjr/15877332
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1007/s00330-019-06574-1, 10.1148/radiol.2020200230]
   Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432
   Hegenscheid K, 2013, EUR RADIOL, V23, P816, DOI 10.1007/s00330-012-2636-6
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jefferson AL, 2010, CIRCULATION, V122, P690, DOI 10.1161/CIRCULATIONAHA.109.905091
   Jiang F, 2020, J GEN INTERN MED, V35, P1545, DOI 10.1007/s11606-020-05762-w
   Kim H, 2020, EUR RADIOL, V30, P3266, DOI 10.1007/s00330-020-06748-2
   Mao L, 2020, JAMA NEUROL, P1, DOI [10.1001/jamaneurol.2020.1127, 10.2139/ssrn.3544840, 10.1101/ 2020.02.22.20026500, DOI 10.1101/2020.02.22.20026500]
   Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370
   Qiu C, 2010, NEUROLOGY, V75, P2221, DOI 10.1212/WNL.0b013e3182020349
   Song FX, 2020, RADIOLOGY, V295, P210, DOI [10.1148/radiol.2020200274, 10.1148/radiol.2020209021]
   Turkbey EB, 2010, JACC-CARDIOVASC IMAG, V3, P266, DOI 10.1016/j.jcmg.2009.10.012
   Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wei S., 2020, ZHONGHUA JIE HE HE H, V43, P203, DOI [10.3760/cmaj.issn.1001-0939.2020.03.013, DOI 10.3760/CMA.J.ISSN.1001-0939.2020.0005]
   WHO, 2020, NOV COR 2019 NCOV SI
   Wu J, 2020, INVEST RADIOL, V55, P257, DOI 10.1097/RLI.0000000000000670
   Ye Z, 2020, EUR RADIOL, V30, P4381, DOI 10.1007/s00330-020-06801-0
   Zhao W, 2020, AM J ROENTGENOL, V214, P1072, DOI 10.2214/AJR.20.22976
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 24
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
EI 2090-4762
J9 EGYPT J RADIOL NUC M
JI Egypt. J. Radiol. Nucl. Med.
PD SEP 9
PY 2020
VL 51
IS 1
AR 182
DI 10.1186/s43055-020-00288-x
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
WE Emerging Sources Citation Index (ESCI)
SC Radiology, Nuclear Medicine & Medical Imaging
GA NS2CR
UT WOS:000572073200001
OA gold
DA 2022-04-20
ER

PT J
AU Simoni-Wastila, L
   Wallem, A
   Fleming, SP
   Le, TT
   Kepczynska, P
   Yang, JN
   Qato, DM
AF Simoni-Wastila, Linda
   Wallem, Alexandra
   Fleming, Sean P.
   Le, Tham T.
   Kepczynska, Paulina
   Yang, Jeanne
   Qato, Danya M.
TI Staffing and Protective Equipment Access Mitigated COVID-19 Penetration
   and Spread in US Nursing Homes During the Third Surge
SO JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION
LA English
DT Article
DE COVID-19; nursing home; long-term care
AB Objectives: During the last quarter of 2020-despite improved distribution of personal protective equipment (PPE) and knowledge of COVID-19 management-nursing homes experienced the greatest increases in cases and deaths since the pandemic's beginning. We sought to update COVID-19 estimates of cases, hospitalization, and mortality and to evaluate the association of potentially modifiable facility-level infection control factors on odds and magnitude of COVID-19 cases, hospitalizations, and deaths in nursing homes during the third surge of the pandemic. Design: Cross-sectional analysis. Setting and Participants: Facility-level data from 13,156 US nursing home facilities. Methods: Two series of multivariable logistic regression and generalized linear models to examine the association of infection control factors (personal protective equipment and staffing) on incidence and magnitude, respectively, of confirmed COVID-19 cases, hospitalizations, and deaths in nursing home residents reported in the last quarter of 2020. Results: Nursing homes experienced steep increases in COVID-19 cases, hospitalizations, and deaths during the final quarter of 2020. Four-fifths (80.51%; n =10,592) of facilities reported at least 1 COVID-19 case, 49.44% (n = 6504) reported at least 1 hospitalization, and 49.76% (n = 6546) reported at least 1 death during this third surge. N95 mask shortages were associated with increased odds of at least 1 COVID-19 case [odds ratio (OR) 1.21, 95% confidence interval (CI) 1.05-1.40] and hospitalization (1.26, 95% CI 1.13-1.40), as well as larger numbers of hospitalizations (1.11, 95% CI 1.02-1.20). Nursing aide shortages were associated with lower odds of at least 1 COVID-19 death (1.23, 95% CI 1.12-1.34) and higher hos-pitalizations (1.09, 95% CI 1.01-1.17). The number of nursing hours per resident per day was largely insignificant across all outcomes. Of note, smaller (<50-bed) and midsized (50-to 150-bed) facilities had lower odds yet higher magnitude of all COVID outcomes. Bed occupancy rates >75% increased odds of experiencing a COVID-19 case (1.48, 95% CI 1.35-1.62) or death (1.25, 95% CI 1.17-1.34). Conclusions and Implications: Adequate staffing and PPE-along with reduced occupancy and smaller facilities-mitigate incidence and magnitude of COVID-19 cases and sequelae. Addressing shortcomings in these factors is critical to the prevention of infections and adverse health consequences of a next surge among vulnerable nursing home residents. (c) 2021 AMDA -The Society for Post-Acute and Long-Term Care Medicine.
C1 [Simoni-Wastila, Linda; Wallem, Alexandra; Fleming, Sean P.; Le, Tham T.; Kepczynska, Paulina; Yang, Jeanne; Qato, Danya M.] Univ Maryland, Sch Pharm, Saratoga Bldg,12th Floor,220 N Arch St, Baltimore, MD 21201 USA.
   [Simoni-Wastila, Linda; Fleming, Sean P.; Qato, Danya M.] Peter Lamy Ctr Drug Therapy & Aging, Baltimore, MD USA.
   [Qato, Danya M.] Univ Maryland, Sch Med, Saratoga Bldg,12th Floor,220 N Arch St, Baltimore, MD 21201 USA.
RP Qato, DM (corresponding author), Univ Maryland, Sch Pharm, Saratoga Bldg,12th Floor,220 N Arch St, Baltimore, MD 21201 USA.; Qato, DM (corresponding author), Univ Maryland, Sch Med, Saratoga Bldg,12th Floor,220 N Arch St, Baltimore, MD 21201 USA.
EM dqato@rx.umaryland.edu
FU NCATS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1 TR003098] Funding Source: Medline;
   NIA NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)
   [T32 AG000262, RF1 AG060939] Funding Source: Medline
CR Abrams HR, 2020, J AM GERIATR SOC, V68, P1653, DOI 10.1111/jgs.16661
   [Anonymous], New York Times COVID-19 data
   [Anonymous], IMMUNIZATION INFECT
   [Anonymous], Long-Term Care: Facts on Care in the US. LTCFocus
   [Anonymous], 2020, LOW NURSING HOME WAG
   [Anonymous], 2021, COR COVID 19 DEATHS
   Brown KA, 2021, JAMA INTERN MED, V181, P229, DOI 10.1001/jamainternmed.2020.6466
   Centers for Disease Control and Prevention, INT CLIN GUID MAN PA, P2021
   Centers for Disease Control and Prevention, TRENDS NUMB COVID 19
   Centers for Disease Control and Prevention, 2004, CURR RES TABL EST
   Centers for Medicare & Medicaid Services, NURS HOM COMP MDS QU, P2021
   Centers for Medicare & Medicaid Services, 2021, COVID 19 NURS HOM DA
   Cerullo M, 2020, COVID 19 AGAIN TEARI
   Chen AT, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.1555
   Dean A, 2020, HEALTH AFFAIR, V39, P1993, DOI 10.1377/hlthaff.2020.01011
   Food and Drug Administration, FACT SHEET REC CAR E
   Fulop T, 2009, CLIN INFECT DIS, V48, P443, DOI 10.1086/596475
   Gorges RJ, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.37431
   Harrington Charlene, 2020, Policy Polit Nurs Pract, V21, P174, DOI 10.1177/1527154420938707
   Harrington C, 2020, HEALTH SERV INSIGHTS, V13, DOI 10.1177/1178632920934785
   He MY, 2020, J AM MED DIR ASSOC, V21, P905, DOI 10.1016/j.jamda.2020.06.016
   Hewitt J, 2020, LANCET PUBLIC HEALTH, V5, pE444, DOI 10.1016/S2468-2667(20)30146-8
   Kosar CM, 2021, HEALTH AFFAIR, V40, P655, DOI 10.1377/hlthaff.2020.02191
   Lepore M, 2020, IMPACTS MINIMUM WAGE
   Li Y, 2020, J AM GERIATR SOC, V68, P2454, DOI 10.1111/jgs.16847
   Li Y, 2020, J AM GERIATR SOC, V68, P1899, DOI 10.1111/jgs.16689
   Mehta HB, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.6315
   National Institutes of Health, 2021, COR DIS 2019 COVID 1
   Ochieng N, 2021, FACTORS ASS COVID 19
   Office of Inspector General U.S. Department of Health & Human Services., 2021, COVID 19 HAD DEV IMP
   Perrotta F, 2020, AGING CLIN EXP RES, V32, P1599, DOI 10.1007/s40520-020-01631-y
   Stockman F, 2020, THEYRE DEATH PITS VI
   Travers J, 2015, GERIATR NURS, V36, P355, DOI 10.1016/j.gerinurse.2015.05.001
   Travers JL, J AM MED DIR ASSOC, V22, P2
   U.S. Government Accountability Office, COVID 19 NURS HOM MO
   Unruh MA, 2020, J AM MED DIR ASSOC, V21, P1001, DOI 10.1016/j.jamda.2020.06.019
   US Census Bureau, 2020, COUNT POP TOT 2010 2
   Zanettini C, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050427
NR 38
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1525-8610
EI 1538-9375
J9 J AM MED DIR ASSOC
JI J. Am. Med. Dir. Assoc.
PD DEC
PY 2021
VL 22
IS 12
BP 2504
EP 2510
DI 10.1016/j.jamda.2021.09.0301525-8610
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA XC6OI
UT WOS:000722129900016
PM 34678266
DA 2022-04-20
ER

PT J
AU Gupta, PK
   Kumar, A
   Joshi, S
AF Gupta, Puneet Kumar
   Kumar, Aishwarya
   Joshi, Sudhanshu
TI A review of knowledge, attitude, and practice towards COVID-19 with
   future directions and open challenges
SO JOURNAL OF PUBLIC AFFAIRS
LA English
DT Review
ID MEDICAL-STUDENTS
AB In most of the affected country's ignorance of Knowledge, Attitude, and Practice (KAP) towards COVID-19 leads to several issues. The aim of the present study is to review and discuss the KAP to fight the COVID-19 crisis in respect of stakeholders namely, general populations, health workers, and students. A comprehensive search of the literature associated with KAP towards COVID-19 is made using various keywords through PubMed, Web of Science, and Scopus and based on the results; a brief review is done by assessing the various aspects like country, sample size, and so forth. A detailed structure is provided with the KAP towards COVID-19 to overwhelm the significant impact of the explosion. Though, various studies appear in the literature as a result of sufficient element of knowledge, positive attitude, and necessary practice, yet there are various challenges in front of the authority bodies as this pandemic becoming critical day by day. Incessant progress in the KAP has contributed well in the fight against the pandemic and we believe that providing proper information to related COVID-19 would help in tackling this disease, especially, when authorities started talking with COVID-19 for a long period or until a vaccine developed.
C1 [Gupta, Puneet Kumar; Kumar, Aishwarya] ICFAI Univ, ICFAI Business Sch, Dehra Dun, Uttarakhand, India.
   [Joshi, Sudhanshu] Doon Univ, Sch Management, Operat & Supply Chain Management Area, Dehra Dun 248012, Uttarakhand, India.
RP Joshi, S (corresponding author), Doon Univ, Sch Management, Operat & Supply Chain Management Area, Dehra Dun 248012, Uttarakhand, India.
EM sudhanshujoshi@doonuniversity.ac.in
RI Kumar, Aishwarya/AFR-7670-2022; Joshi, Sudhanshu/L-2284-2019; Gupta,
   Puneet Kumar/AAA-1148-2020
OI Kumar, Aishwarya/0000-0001-6894-4540; Joshi,
   Sudhanshu/0000-0003-4748-5001; Gupta, Puneet Kumar/0000-0002-3458-5655
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Asraf Hussain, 2020, Asian Journal of Medical Sciences, V11, P6, DOI 10.3126/ajms.v11i3.28485
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160
   Byanaku A., 2020, KNOWLEDGE ATTITUDES, DOI 10.1101/2020.04.26.20080820v2
   China National Health Comission, 2020, CHIN NAT HLTH COM RE
   Erfani A, 2020, B WORLD HEALTH ORGAN, V76, P648, DOI DOI 10.2471/BLT.20.256651
   Geldsetzer P, 2020, J MED INTERNET RES, V22, DOI 10.2196/18790
   Kamate SK, 2020, DENT MED PROBL, V57, P11, DOI 10.17219/dmp/119743
   Kangwana, 2020, COVID 19 RELATED KNO
   Maheshwari S, 2020, J ACUTE DIS, V9, P100, DOI 10.4103/2221-6189.283886
   Naser A. Y., 2020, KNOWLEDGE PRACTICES, DOI [10.1101/2020.04.13.20063560, DOI 10.1101/2020.04.13.20063560]
   Nemati M, 2020, ARCH CLIN INFECT DIS, V15, DOI 10.5812/archcid.102848
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Pandey B., 2020, J PATAN ACAD HLTH SC, V7, P13
   Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757
   Rios-Gonzalez C. M., 2020, KNOWLEDGE ATTITUDES, DOI [10.1590/SciELOPreprints.149, DOI 10.1590/SCIELOPREPRINTS.149]
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   World Health Organization, 2020, COR DIS COV 19 OUTBR
   Zegarra-Valdivia J, 2020, KNOWLEDGE PERCEPTION
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zheng Z, 2020, KNOWLEDGE ATTITUDE P
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 24
TC 3
Z9 3
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1472-3891
EI 1479-1854
J9 J PUBLIC AFF
JI J. Public Aff.
PD NOV
PY 2021
VL 21
IS 4
AR e2555
DI 10.1002/pa.2555
EA NOV 2020
PG 7
WC Public Administration
WE Emerging Sources Citation Index (ESCI)
SC Public Administration
GA XK5VL
UT WOS:000592630100001
DA 2022-04-20
ER

PT J
AU Sindhusen, P
AF Sindhusen, Pendhamma
TI Vitamin D and COVID-19: A Physiological Perspective
SO BIOMEDICAL RESEARCH AND THERAPY
LA English
DT Review
DE 1.25-dihydroxyvitamin D; Angiotensin Converting Enzyme 2; COVID-19;
   Renin-Angiotensin System; SARS-CoV-2; T-cell Differentiation; Vitamin D
ID RESPIRATORY-TRACT INFECTION; D DEFICIENCY; D-RECEPTOR; EPITHELIAL-CELLS;
   CYTOKINES; CATHELICIDINS; INFLAMMATION; ASSOCIATION; CHEMOKINES;
   EXPRESSION
AB Known for its ability to enhance the performance of the immune system, preclude microbial infections, and reduce susceptibility to influenza, Vitamin D (or 1,25- dihydroxyvitamin D (1,25(OH)(2)D) as the active form) has garnered a positive reputation in the management of COVID-19 for some time. Its deficiency is statistically correlated with infection of the disease, as well as disease severity and fatalities. There have been suggestions that Vitamin D supplements could either prevent the contraction of SARS- CoV-2, the coronavirus which causes the disease or alleviate the symptoms of the disease. Indeed, data have established a relationship between Vitamin D supplementation and the severity of respiratory illnesses, with some assays indicating optimistic results in COVID-19 patients who were supplemented with the vitamin. Accordingly, a great deal of research and efforts have been put into investigating the physiological mechanisms in the human body attributable to the vitamin's reputation against the coronavirus. Combined with what was already discovered before the advent of SARS-CoV-2, a great amount of knowledge has consequently now been unveiled. Via regulation of various pathways, 1,25(OH)(2)D promotes the production of antimicrobial peptides, autophagy, as well as integrity and impermeability of cellular junctions against pathogens. Moreover, it mitigates the consequences of SARS-CoV-2 infection, such as cytokine storm (through immunomodulation of T cell differentiation pathways) and lung injury (through stimulation of the Angiotensin-Converting Enzyme 2 (ACE2) and manipulation of the Renin-Angiotensin System (RAS)). Nevertheless, Vitamin D deficiency still plagues the global population across all age groups, possibly contributing to the heightened global exposure to the coronavirus. With the COVID-19 pandemic inexorably raging on with no prospect of termination observable in the foreseeable future, this review article provides a concise yet thorough insight into the vast knowledge which could illuminate the significance of Vitamin D amidst the current predicament experienced by mankind, as well as instigate further curiosity and ignite further investigations into the role of vitamins, such as Vitamin D, as a safeguard against SARS-CoV-2.
C1 [Sindhusen, Pendhamma] Pathumwan Demonstrat Sch, Bangkok, Thailand.
RP Sindhusen, P (corresponding author), Pathumwan Demonstrat Sch, Bangkok, Thailand.
EM realpendhammas@gmail.com
OI Sindhusen, Pendhamma/0000-0002-5310-436X
CR Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0
   Abdel-Mohsen MA, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010172
   Adams JS, 2014, J STEROID BIOCHEM, V144, P22, DOI 10.1016/j.jsbmb.2013.12.009
   Adorini L, 2003, ANN NY ACAD SCI, V987, P258, DOI 10.1111/j.1749-6632.2003.tb06057.x
   Ahmad A, 2021, VITAMIN D LEVELS 19
   Ali N, 2020, J INFECT PUBLIC HEAL, V13, P1373, DOI 10.1016/j.jiph.2020.06.021
   Alijotas-Reig J, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102569
   Aranow C, 2011, J INVEST MED, V59, P881, DOI 10.2310/JIM.0b013e31821b8755
   Aygun H, 2020, N-S ARCH PHARMACOL, V393, P1157, DOI 10.1007/s00210-020-01911-4
   Barlow PG, 2014, FUTURE MICROBIOL, V9, P55, DOI 10.2217/fmb.13.135
   Barlow PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025333
   Berger A, 2000, BRIT MED J, V321, P424, DOI 10.1136/bmj.321.7258.424
   Bhalla V, 2020, HIST PERSPECTIVE ACE, DOI [10.1038/s41371- 020-00459-3, DOI 10.1038/S41371-020-00459-3]
   Bilezikian JP, 2020, EUR J ENDOCRINOL, V183, pR133, DOI 10.1530/EJE-20-0665
   Bivona G, 2018, CENT EUR J IMMUNOL, V43, P331, DOI 10.5114/ceji.2018.80053
   Bivona G, 2017, ANN CLIN LAB SCI, V47, P508
   Bodnar LM, 2009, J NUTR, V139, P1157, DOI 10.3945/jn.108.103168
   Bonaventura A, 2021, NAT REV IMMUNOL, V21, P319, DOI 10.1038/s41577-021-00536-9
   Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175
   Cantorna MT, 2015, NUTRIENTS, V7, P3011, DOI 10.3390/nu7043011
   Cantorna MT, 2000, J NUTR, V130, P2648, DOI 10.1093/jn/130.11.2648
   Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x
   Chen HL, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2018.1540904
   Chen LQ, 2004, J IMMUNOL, V172, P2059, DOI 10.4049/jimmunol.172.4.2059
   Choi Y, 2018, NAT REV MICROBIOL, V16, P340, DOI 10.1038/s41579-018-0003-6
   Cron RQ, 2021, LANCET RHEUMATOL, V3, pE236, DOI 10.1016/S2665-9913(21)00011-4
   Dandona P, 2007, J HUM HYPERTENS, V21, P20, DOI 10.1038/sj.jhh.1002101
   Daneshkhah A, 2020, POSSIBLE ROLE VITAMI, DOI [10.1101/2020.04.08.20058578, DOI 10.1101/2020.04.08.20058578]
   Dankers W, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00697
   De Smet D., 2020, VITAMIN D DEFICIENCY
   Elizondo RA, 2014, INVEST OPHTH VIS SCI, V55, P5245, DOI 10.1167/iovs.13-13553
   Fajgenbaum DC, 2020, NEW ENGL J MED, V383, P2255, DOI 10.1056/NEJMra2026131
   Fountain JH, 2021, PHYSL RENIN ANGIOTEN
   Fujita H, 2008, MOL BIOL CELL, V19, P1912, DOI 10.1091/mbc.E07-09-0973
   Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180
   Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015
   Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560
   Goldsmith JR, 2015, HEALTHCARE-BASEL, V3, P219, DOI 10.3390/healthcare3020219
   Gunville Cameron F., 2013, Inflammation & Allergy Drug Targets, V12, P239
   Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090
   Hansdottir S, 2010, J IMMUNOL, V184, P965, DOI 10.4049/jimmunol.0902840
   Hazlett L, 2011, CELL TISSUE RES, V343, P175, DOI 10.1007/s00441-010-1022-4
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Hojyo S, 2020, INFLAMM REGEN, V40, DOI 10.1186/s41232-020-00146-3
   Hovsepian S, 2011, J HEALTH POPUL NUTR, V29, P149
   Hu B, 2021, NAT REV MICROBIOL, V19, P141, DOI 10.1038/s41579-020-00459-7
   Ilie PC, 2020, AGING CLIN EXP RES, V32, P1195, DOI 10.1007/s40520-020-01570-8
   Infante M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092185
   Kang SW, 2012, J IMMUNOL, V188, P5276, DOI 10.4049/jimmunol.1101211
   Kidd Parris, 2003, Altern Med Rev, V8, P223
   Kim J, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1035-2
   Kong J, 2008, AM J PHYSIOL-GASTR L, V294, pG208, DOI 10.1152/ajpgi.00398.2007
   Laaksi I, 2007, AM J CLIN NUTR, V86, P714, DOI 10.1093/ajcn/86.3.714
   Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933
   Luckheeram RV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/925135
   Mahdavi AM, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2119
   Manaseki-Holland S, 2012, LANCET, V379, P1419, DOI 10.1016/S0140-6736(11)61650-4
   Mao JR, 2019, ADV EXP MED BIOL, V1209, P55, DOI 10.1007/978-981-15-0606-2_5
   Martens PJ, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051248
   Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583
   McCall B., 2020, VITAMIN D DEFICIENCY
   McLachlan CS, 2020, CLIN HYPERTENS, V26, DOI 10.1186/s40885-020-00147-x
   Meftahi GH, 2020, INFLAMM RES, V69, P825, DOI 10.1007/s00011-020-01372-8
   Meltzer DO, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19722
   Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925
   MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145
   Murai IH, 2021, JAMA-J AM MED ASSOC, V325, P1053, DOI 10.1001/jama.2020.26848
   Murphy AM, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0023-z
   Nikniaz L, 2021, PHARM SCI-IRAN, V27, pS1, DOI 10.34172/PS.2021.13
   PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8
   Prietl B, 2013, NUTRIENTS, V5, P2502, DOI 10.3390/nu5072502
   Ramanathan B, 2002, MICROBES INFECT, V4, P361, DOI 10.1016/S1286-4579(02)01549-6
   Rodriguez M, 2009, AIDS RES HUM RETROV, V25, P9, DOI 10.1089/aid.2008.0183
   Sabetta JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011088
   Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100
   Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206
   Shah K, 2021, QJM-INT J MED, V114, P175, DOI 10.1093/qjmed/hcab009
   [Anonymous], 2016, BMJ, V354, pi4086, DOI [10.1136/bmj.g7647, 10.1136/bmj.i4086]
   Shi YY, 2016, MOL MED REP, V13, P1186, DOI 10.3892/mmr.2015.4685
   Shimabukuro-Vornhagen A, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0343-9
   Silhol F, 2020, HYPERTENS RES, V43, P854, DOI 10.1038/s41440-020-0476-3
   Silva R, 2005, Int J Biomed Sci, V1, P46
   Sloka S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-56
   Sousa FH, 2017, PEPTIDES, V95, P76, DOI 10.1016/j.peptides.2017.07.013
   Stio M, 2016, SCAND J GASTROENTERO, V51, P1193, DOI 10.1080/00365521.2016.1185463
   Tang L, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.570993
   Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6
   Tripathi S, 2013, J GEN VIROL, V94, P40, DOI 10.1099/vir.0.045013-0
   van Eden W, 2002, ANN RHEUM DIS, V61, P25
   Vardhana SA, 2020, J EXP MED, V217, DOI 10.1084/jem.20200678
   Wang JR, 2008, J BIOL CHEM, V283, P25596, DOI 10.1074/jbc.M801716200
   Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909
   Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x
   Xu J, 2017, MOL MED REP, V16, P7432, DOI 10.3892/mmr.2017.7546
   Y-guo Z., 2013, TISSUE BARRIERS, V1
   Yim S, 2007, J CYST FIBROS, V6, P403, DOI 10.1016/j.jcf.2007.03.003
   Youssef DA, 2011, DERM-ENDOCRINOL, V3, P220, DOI 10.4161/derm.3.4.15027
   Zhang BN, 2019, BIOMED ENVIRON SCI, V32, P419, DOI 10.3967/bes2019.057
   Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e
   Zhang YC, 2004, INFECT IMMUN, V72, P4410, DOI 10.1128/IAI.72.8.4410-4415.2004
   Zhang YG, 2015, SCI REP-UK, V5, DOI 10.1038/srep10642
NR 101
TC 0
Z9 0
U1 0
U2 0
PU BIOMEDPRESS
PI HO CHI MINH
PA BIOMEDPRESS, HO CHI MINH, 00000, VIETNAM
SN 2198-4093
J9 BIOMED RES THER
JI Biomed. Res. Ther.
PY 2021
VL 8
IS 5
BP 4358
EP 4366
DI 10.15419/bmrat.v8i5.674
PG 9
WC Medicine, Research & Experimental
WE Emerging Sources Citation Index (ESCI)
SC Research & Experimental Medicine
GA YV1IW
UT WOS:000752487500002
OA gold
DA 2022-04-20
ER

PT J
AU Musa, S
AF Musa, Sherief
TI Hepatic and gastrointestinal involvement in coronavirus disease 2019
   (COVID-19): What do we know till now?
SO ARAB JOURNAL OF GASTROENTEROLOGY
LA English
DT Review
DE SARS-Cov-2; COVID-19; Liver; Gastrointestinal tract; Endoscopy
ID ENTERIC INVOLVEMENT; TRANSMISSION; INFECTION; SARS
AB Since December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19), has posed a serious threat to global health and is currently causing a major pandemic. While patients typically present with fever and a respiratory illness, mounting evidence indicates that patients might also report extra-pulmonary manifestations, including those affecting the liver and gastrointestinal tract. This involvement may have important implications to the disease management, transmission, and prognosis, especially in patients with pre-existing hepatic or digestive co-morbidities.
   In this review, the characteristics and possible explanations of hepatic and gastrointestinal involvement caused by SARS-CoV-2 infection are summarized, adding to our knowledge of the spectrum of COVID-19. In addition, preventive measures implemented in endoscopy departments to prevent further dissemination of SARS-CoV-2 infection are proposed. (C) 2020 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved.
C1 [Musa, Sherief] Cairo Univ, Fac Med, Endem Hepatogastroenterol Dept, Cairo, Egypt.
RP Musa, S (corresponding author), Cairo Univ, Fac Med, Endem Hepatogastroenterol Dept, Cairo, Egypt.
EM sheriefmusa@cu.edu.eg
OI Musa, Sherief/0000-0001-9386-6812
CR Alsaad KO, 2018, HISTOPATHOLOGY, V72, P516, DOI 10.1111/his.13379
   An P, PROTECTION 318 INFLA
   [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9
   Bangash MN, 2020, LANCET GASTROENTEROL, V5, P529, DOI 10.1016/S2468-1253(20)30084-4
   Budden KF, 2017, NAT REV MICROBIOL, V15, P55, DOI 10.1038/nrmicro.2016.142
   Cai QX, 2020, ALLERGY, V75, P1742, DOI 10.1111/all.14309
   Calderwood AH, 2018, GASTROINTEST ENDOSC, V87, P1167, DOI 10.1016/j.gie.2017.12.009
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chau TN, 2004, HEPATOLOGY, V39, P302, DOI 10.1002/hep.20111
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chien JY, 2006, RESPIROLOGY, V11, P715, DOI 10.1111/j.1440-1843.2006.00942.x
   Chinse Society of IBD, 2020, CHIN J DIG, V40, pE001
   Chu H, 2016, J INFECT DIS, V213, P904, DOI 10.1093/infdis/jiv380
   Collins JP., 2020, MEDRXIV
   del Rio C, 2020, JAMA-J AM MED ASSOC, V323, P1039, DOI 10.1001/jama.2020.1490
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   ESGE and ESGENA, 2020, ESGE ESGENA POSITION
   European Centre for Disease Prevention and Control (ECDC), 2020, PERS PROT EQ PPE NEE
   Fan ZY, 2020, CLIN GASTROENTEROL H, V18, P1561, DOI 10.1016/j.cgh.2020.04.002
   Gao Z., 2003, CHIN J CLIN HEPATOL, V6, P342
   Geller C, 2012, VIRUSES-BASEL, V4, P3044, DOI 10.3390/v4113044
   Gori A, 2020, AM J TRANSPLANT, V20, P1939, DOI 10.1111/ajt.15853
   Gu JY, 2020, GASTROENTEROLOGY, V158, P1518, DOI 10.1053/j.gastro.2020.02.054
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hoffmann M, 2020, NOVEL CORONAVIRUS 20, P1, DOI [10.1016/j.cell.2020.02.052, 10.1101/2020.01.31.929042, DOI 10.1101/2020.01.31.929042]
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ianiro G, 2020, LANCET GASTROENTEROL, DOI [10.1016/S2468 1253(20)30082-0, DOI 10.1016/S24681253(20)30082-0]
   Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633
   Kumar D, 2003, AM J TRANSPLANT, V3, P977, DOI 10.1034/j.1600-6143.2003.00197.x
   Leung WK, 2003, GASTROENTEROLOGY, V125, P1011, DOI [10.1053/S0016-5085(03)01215-0, 10.1016/j.gastro.2003.08.001]
   Li L, 2020, RISK FACTORS RELATED, DOI [10.1101/2020.02.28.20028514, DOI 10.1101/2020.02.28.20028514]
   Liang WC, 2020, GUT, V69, P1141, DOI 10.1136/gutjnl-2020-320832
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   LIU J, 2020, LONGITUDINAL CHARACT, DOI [10.1016/j.ebiom.2020.102763, DOI 10.1101/2020.02.16.20023671]
   LIU Q, 2020, J FORENSIC MED, V36, DOI DOI 10.1007/S11274-019-2794-7
   Mao R, 2020, LANCET GASTROENTEROL, V5, P426, DOI 10.1016/S2468-1253(20)30076-5
   Michaels MG, 2020, AM J TRANSPLANT, V20, P1768, DOI 10.1111/ajt.15832
   Pan L, AM J GASTROENTEROLOG
   Repici A, 2020, GASTROINTEST ENDOSC, V92, P192, DOI 10.1016/j.gie.2020.03.019
   Shi HP, 2019, IEEE INT CONF ELECTR, P81, DOI 10.1109/ICEIEC.2019.8784578
   Strnad P, 2017, NAT REV GASTRO HEPAT, V14, P55, DOI 10.1038/nrgastro.2016.168
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022
   Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11
   Tse F, 2020, COVID 19 ADVICE CANA
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wang D, 2020, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2020.1585, DOI 10.1001/JAMA.2020.1585]
   Wei XS, LANCET RESP ME UNPUB
   Wu YJ, 2020, LANCET GASTROENTEROL, V5, P434, DOI 10.1016/S2468-1253(20)30083-2
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xiao F, 2020, GASTROENTEROLOGY, V158, P1831, DOI 10.1053/j.gastro.2020.02.055
   Xiao Y, 2020, LANCET GASTROENTEROL, V5, P528, DOI 10.1016/S2468-1253(20)30080-7
   Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yan, 2020, SPECIFIC ACE2 EXPRES, DOI 10.1101/2020.02.03.931766
   Yang J, 2020, INT J INFECT DIS, DOI 10.1016/j.ijid.2020.03.01732173574
   Yang R, 2020, CLIN CHARACTERISTICS, DOI [10.1101/2020.02.27.20029009, DOI 10.1101/2020.02.27.20029009]
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Yeo C, 2020, LANCET GASTROENTEROL, V5, P335, DOI 10.1016/S2468-1253(20)30048-0
   Zhang B., 2020, CLIN CHARACTERISTICS, DOI [10.1101/2020.02.26.20028191, DOI 10.1101/2020.02.26.20028191]
   Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1
   Zhang H, 2020, DIGESTIVE SYSTEM IS, P1, DOI [10.1101/2020.01.30.927806v1, DOI 10.1101/2020.01.30.927806, 10.1101/2020.01.30.927806]
   Zhang Y, SUGGESTIONS INFECT P
NR 64
TC 72
Z9 82
U1 2
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1687-1979
EI 2090-2387
J9 ARAB J GASTROENTEROL
JI Arab J. Gastroenterol.
PD MAR
PY 2020
VL 21
IS 1
BP 3
EP 8
DI 10.1016/j.ajg.2020.03.002
PG 6
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA LI3AP
UT WOS:000529355200002
PM 32253172
OA Green Published
DA 2022-04-20
ER

PT J
AU Jahanbakhsh, M
   Bagherian, H
   Tavakoli, N
   Ehteshami, A
   Sattari, M
   Isfahani, SSN
   Jangi, M
AF Jahanbakhsh, Maryam
   Bagherian, Hossein
   Tavakoli, Nahid
   Ehteshami, Asghar
   Sattari, Mohammad
   Isfahani, Sakineh Saghaeian Nejad
   Jangi, Majid
TI The role of virtual social networks in shaping people's attitudes toward
   COVID-19 in Iran
SO JOURNAL OF EDUCATION AND HEALTH PROMOTION
LA English
DT Article
DE Attitude; COVID-19; virtual social network
ID MEDIA USE
AB BACKGROUND: The widespread occurrence of COVID-19 has caused people to seek information from various sources such as virtual social networks, which can positively or negatively affect one's mental status. In this article, we present the role of virtual social networks in shaping people's attitudes toward COVID-19 in Iran. MATERIALS AND METHODS: This is an applied descriptive study, in which 1010 users of virtual social networks were surveyed through an electronic questionnaire. Data were analyzed with SPSS, Excel, and Rapid Miner software. The FP-growth technique was used to investigate the concurrence of choices in multiple-choice questions, and the Mann-Whitney and the Kruskal-Wallis tests were used to determine the correlation of the mean of each dimension with demographic data. Moreover, the Wilcoxon signed-rank, the Shapiro-Wilk, and the Kolmogorov-Smirnov tests were used. RESULTS: Virtual social networks use increased significantly (40%) after the COVID-19 outbreak. According to users, the greatest psychological impact of virtual social networks was the induction of anxiety (46.43%) and the most common use was to learn about COVID-19 prevention and treatment (69.3%). Based on the findings, there were no significant differences between the "awareness," "behavior intention," and "attitude and trust" and the users' marital status, age group, educational degree, and gender. CONCLUSION: Although social networks have enriched the public knowledge, they increased the individuals' anxiety mostly because of controversial news and disperse of misinformation which in turn misled the users. The social networks play an important role in directing the behavioral inclinations. Accordingly, it is recommended that the authorities in healthcare system establish authentic and formal webpage in these social networks to manage controversial and voluminous information.
C1 [Jahanbakhsh, Maryam; Bagherian, Hossein; Tavakoli, Nahid; Ehteshami, Asghar; Sattari, Mohammad; Isfahani, Sakineh Saghaeian Nejad; Jangi, Majid] Isfahan Univ Med Sci, Hlth Informat Technol Res Ctr, Esfahan, Iran.
RP Jangi, M (corresponding author), Isfahan Univ Med Sci, Hlth Informat Technol Res Ctr, Sch Management & Informat, Salamat Blvd, Esfahan, Iran.
EM jangim@mng.mui.ac.ir
FU Isfahan University of Medical Sciences [198243]; Code of Ethics
   [IR.MUI.RESEARCH.REC.1398.781]
FX This article is part of a research project supported by the Isfahan
   University of Medical Sciences (Grant No.198243 and Code of Ethics
   IR.MUI.RESEARCH.REC.1398.781).
CR Abdizadeh R, 2017, SOCIOLING STUD, V38, P43
   Alanzi T, 2019, INT J TELEMED APPL, V2019, DOI 10.1155/2019/6323962
   Amedie J., 2015, IMPACT SOCIAL MEDIA
   [Anonymous], 2019, MIGRATION TELEGRAM W
   Asik B, 2019, DIGITAL WORLD
   Behrman JR, 2003, 03007 SOC SCI RES NE
   Cellini N, 2020, J SLEEP RES, V29, DOI 10.1111/jsr.13074
   Clement J., DAILY SOCIAL MEDIA U
   Deng ZH, 2017, INT J MED INFORM, V105, P98, DOI 10.1016/j.ijmedinf.2017.05.014
   Grabner-Krauter S., 2015, FORUM SOC ECON, V44, P48, DOI [10.1080/07360932.2013.781517, DOI 10.1080/07360932.2013.781517]
   Houston VJ, 2006, ROLE SOCIAL NETWORKS
   Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954
   Keles B, 2020, INT J ADOLESC YOUTH, V25, P79, DOI 10.1080/02673843.2019.1590851
   KhabarOnline News Agency, MAN HOURS DAY AR IR
   Levula A, 2018, COMMUNITY MENT HLT J, V54, P842, DOI 10.1007/s10597-017-0195-7
   Musial K, 2013, WORLD WIDE WEB, V16, P31, DOI 10.1007/s11280-011-0155-z
   Nyhan B, 2012, J ADOLESCENT HEALTH, V51, P302, DOI 10.1016/j.jadohealth.2012.02.014
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Perrin A., 2015, PEW RES CENT, V125, P52, DOI DOI 10.4236/CN.2015.74015
   Rasoulzadeh Aghdam S, 2012, SOCIOLING STUD, V16, P49
   Salanitri D, 2015, LECT NOTES COMPUT SC, V9169, P49, DOI 10.1007/978-3-319-20901-2_5
   Sherchan W, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2501654.2501661
   Smailhodzic E, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1691-0
   Smith D., 2011, J COMMUN HEALTHC, V4, P200, DOI 10.1179/1753807611Y.0000000010
   Tavousi M, 2019, J ED COMMUNITY HLTH, V6, P103
   Tripathi M, 2018, VIROL IMMUNOL J, V2
   Vannucci A, 2017, J AFFECT DISORDERS, V207, P163, DOI 10.1016/j.jad.2016.08.040
   Villanti AC, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7303
   Vosner HB, 2016, COMPUT HUM BEHAV, V55, P230, DOI 10.1016/j.chb.2015.09.014
   Wiederhold BK, 2020, CYBERPSYCH BEH SOC N, V23, P275, DOI 10.1089/cyber.2020.29181.bkw
NR 30
TC 0
Z9 0
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 2277-9531
EI 2319-6440
J9 J EDUC HEALTH PROMOT
JI J. Educ. Health Promot.
PD JAN-DEC
PY 2021
VL 10
IS 1
DI 10.4103/jehp.jehp_642_20
PG 7
WC Education, Scientific Disciplines; Public, Environmental & Occupational
   Health
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research; Public, Environmental & Occupational
   Health
GA RI6RA
UT WOS:000637034300008
PM 34084837
DA 2022-04-20
ER

PT J
AU Kim, S
   Capasso, A
   Cook, SH
   Ali, SH
   Jones, AM
   Foreman, J
   DiClemente, RJ
   Tozan, Y
AF Kim, Sooyoung
   Capasso, Ariadna
   Cook, Stephanie H.
   Ali, Shahmir H.
   Jones, Abbey M.
   Foreman, Joshua
   DiClemente, Ralph J.
   Tozan, Yesim
TI Impact of COVID-19-related knowledge on protective behaviors: The
   moderating role of primary sources of information
SO PLOS ONE
LA English
DT Article
ID TRENDS
AB This study assessed the modifying role of primary source of COVID-19 information in the association between knowledge and protective behaviors related to COVID-19 among adults living in the United States (US). Data was collected from 6,518 US adults through an online cross-sectional self-administered survey via social media platforms in April 2020. Linear regression was performed on COVID-19 knowledge and behavior scores, adjusted for sociodemographic factors. An interaction term between knowledge score and primary information source was included to observe effect modification by primary information source. Higher levels of knowledge were associated with increased self-reported engagement with protective behaviors against COVID-19. The primary information source significantly moderated the association between knowledge and behavior, and analyses of simple slopes revealed significant differences by primary information source. This study shows the important role of COVID-19 information sources in affecting people's engagement in recommended protective behaviors. Governments and health agencies should monitor the use of various information sources to effectively engage the public and translate knowledge into behavior change during an evolving public health crisis like COVID-19.
C1 [Kim, Sooyoung; Tozan, Yesim] NYU, Sch Global Publ Hlth, Dept Publ Hlth Policy & Management, New York, NY 10012 USA.
   [Capasso, Ariadna; Cook, Stephanie H.; Ali, Shahmir H.; Foreman, Joshua; DiClemente, Ralph J.] NYU, Dept Social & Behav Sci, Sch Global Publ Hlth, New York, NY USA.
   [Cook, Stephanie H.] NYU, Dept Biostat, Sch Global Publ Hlth, New York, NY USA.
   [Jones, Abbey M.] NYU, Dept Epidemiol, Sch Global Publ Hlth, New York, NY USA.
   [Tozan, Yesim] NYU, Global & Environm Publ Hlth Program, Sch Global Publ Hlth, New York, NY 10012 USA.
RP Tozan, Y (corresponding author), NYU, Sch Global Publ Hlth, Dept Publ Hlth Policy & Management, New York, NY 10012 USA.; Tozan, Y (corresponding author), NYU, Global & Environm Publ Hlth Program, Sch Global Publ Hlth, New York, NY 10012 USA.
EM tozan@nyu.edu
RI Ali, Shahmir H/G-4495-2018
OI Ali, Shahmir H/0000-0002-0360-3507; Cook, Stephanie/0000-0003-4505-0813;
   Tozan, Yesim/0000-0001-8997-8897; Capasso, Ariadna/0000-0001-5462-7800
CR Ali SH, 2020, JMIR PUBLIC HLTH SUR, V6, P154, DOI 10.2196/21071
   Ali SH, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-01011-0
   Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5
   [Anonymous], 2020, DIS OUTBREAK NE 0208
   Chernozhukov V, 2021, J ECONOMETRICS, V220, P23, DOI 10.1016/j.jeconom.2020.09.003
   Dooling K, 2021, MMWR-MORBID MORTAL W, V69, P1657, DOI 10.15585/mmwr.mm695152e2
   Dutta-Bergman MJ, 2004, HEALTH COMMUN, V16, P273, DOI 10.1207/S15327027HC1603_1
   Dzisi Emmanuel Komla Junior, 2020, Transp Res Interdiscip Perspect, V7, P100191, DOI 10.1016/j.trip.2020.100191
   Gambino C, 2014, ENGLISH SPEAKING ABI
   Hou ZY, 2020, J MED INTERNET RES, V22, DOI 10.2196/21143
   Howard J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014564118
   Hua F, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00481
   Hulin C, 2001, J CONSUM PSYCHOL, V10, P55
   Islam AKMN, 2020, TECHNOL FORECAST SOC, V159, DOI 10.1016/j.techfore.2020.120201
   Jansen J., 2011, PART 3 TECHNOLOGY RE, V2011
   Kim K.-S., 2011, P AM SOC INFORM SCI, V48, P1, DOI [10.1002/meet.2011.14504801283, DOI 10.1002/MEET.2011.14504801283]
   Lee M, 2020, BMC PUBLIC HEALTH
   Maher CA, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2952
   Michie S, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4171
   Nielsen R., 2020, NAVIGATING INFODEMIC
   Painter M, 2021, J ECON BEHAV ORGAN, V185, P688, DOI 10.1016/j.jebo.2021.03.019
   Park M, 2017, CYBERPSYCH BEH SOC N, V20, P278, DOI 10.1089/cyber.2016.0698
   Park S, 2021, J GEN INTERN MED, V36, P3088, DOI 10.1007/s11606-021-07080-1
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405
   Smith A., 2018, SOCIAL MEDIA USE 201
   U.S. Census Bureau, QUICK FACTS 2019
   Van Dyke ME, 2020, MMWR-MORBID MORTAL W, V69, P1777, DOI 10.15585/mmwr.mm6947e2
   Wee EG., 2020, INT J BIOMEDICAL CLI, V5, P236
   WHO, 2020, INF PREV CONTR HLTH
   World Health Organization, 2020, INF MAN INF
   World Health Organization Regional Office for Europe, 2020, SURV TOOL GUID RAP S
   Yaqub O, 2014, SOC SCI MED, V112, P1, DOI 10.1016/j.socscimed.2014.04.018
   Zajenkowski M, 2020, PERS INDIV DIFFER, V166, DOI 10.1016/j.paid.2020.110199
NR 33
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 29
PY 2021
VL 16
IS 11
AR e0260643
DI 10.1371/journal.pone.0260643
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA YU5IH
UT WOS:000752076100110
PM 34843590
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Maulana, N
AF Maulana, Noveri
TI Research Trends in Marketing Science Before COVID-19 Outbreak: A
   Literature Review
SO MANAGEMENT & MARKETING-CHALLENGES FOR THE KNOWLEDGE SOCIETY
LA English
DT Review
DE Research Trends; Research Comparison; Marketing Research; Literature
   Review; Journal Review; COVID-19 Research
ID FUTURE; METHODOLOGY
AB The research trends after COVID-19 pandemic will be changing and more challenging. This study is aimed to review the trends of marketing research in the first semester of 2020. There are three parts of this analysis. First, review was made to summarize the trend of research domain and model. Second, the trend of data collection method is also synthesized. Third, trends of data analysis method are being categorized. Result shows that before COVID-19 outbreak, research model in marketing studies was dominated by Literature Review articles (systematic, integrative, and meta-analysis), and also Experimental Studies on various consumer behaviour topics. In term of data collection methods, Purposive Sampling and Amazon Mechanical Turk (MTurk) are two approaches that popularly used by the researchers. On the trend of data analysis method, ANOVA, Regression, and Qualitative Analysis are three popular methods which used among the studies. Future research agendas after the pandemic are also discussed in this study.
C1 [Maulana, Noveri] Univ Indonesia, PPM Sch Management, Jakarta, Indonesia.
   [Maulana, Noveri] Univ Indonesia, Postgrad Program Management, Jakarta, Indonesia.
RP Maulana, N (corresponding author), Univ Indonesia, PPM Sch Management, Jakarta, Indonesia.; Maulana, N (corresponding author), Univ Indonesia, Postgrad Program Management, Jakarta, Indonesia.
EM noverimaulana@gmail.com
RI Maulana, Noveri/ABE-9609-2020
OI Maulana, Noveri/0000-0003-3753-9854
CR Agoston S, 2012, PROCEEDINGS OF THE 4TH EUROPEAN CONFERENCE ON INTELLECTUAL CAPITAL, P1
   Anson IG, 2018, RES POLITICS, V5, DOI 10.1177/2053168018785483
   Anwar M., 2020, INDOASIAN J MULTIDIS INDOASIAN J MULTIDIS, V3, P1
   Appel G, 2020, J ACAD MARKET SCI, V48, P79, DOI 10.1007/s11747-019-00695-1
   Bastani Peivand, 2020, J Med Internet Res, DOI 10.2196/18932
   Bratianu C, 2020, MANAG MARK, V15, P154, DOI 10.2478/mmcks-2020-0010
   BRUNK ME, 1958, J FARM ECON, V40, P1237, DOI 10.2307/1234999
   Carlsson-Szlezak P., 2020, HARVARD BUSINESS REV, V12
   Chabowski BR, 2011, J ACAD MARKET SCI, V39, P55, DOI 10.1007/s11747-010-0212-7
   Chang CT, 2020, J ACAD MARKET SCI, V48, P203, DOI 10.1007/s11747-019-00675-5
   Craven M., 2020, COVID 19 BRIEFING NO
   Dahlstrom R, 2008, J MARKET THEORY PRAC, V16, P139, DOI 10.2753/MTP1069-6679160204
   Davis J, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-511
   de Caro F, 2020, KNEE SURG SPORT TR A, V28, P1699, DOI 10.1007/s00167-020-06031-3
   Feng H, 2020, J ACAD MARKET SCI, V48, P246, DOI 10.1007/s11747-019-00686-2
   Franceschini F, 2015, SCIENTOMETRICS, V103, P1083, DOI 10.1007/s11192-015-1583-9
   Hilken T, 2020, J ACAD MARKET SCI, V48, P143, DOI 10.1007/s11747-019-00688-0
   Hulland J, 2020, J ACAD MARKET SCI, V48, P351, DOI 10.1007/s11747-020-00721-7
   Hunt NC, 2019, J INF SYST, V33, P43, DOI 10.2308/isys-52021
   Johnston WJ, 2018, J ACAD MARKET SCI, V46, P674, DOI 10.1007/s11747-017-0564-3
   Kariippanon K, 2020, MARKETING THEOR, V20, P123, DOI 10.1177/1470593119870215
   Kees J, 2017, J ADVERTISING, V46, P141, DOI 10.1080/00913367.2016.1269304
   Li X, 2020, J MARKETING RES, V57, P78, DOI 10.1177/0022243719881448
   Li YY, 2020, J MARKETING RES, V57, P1, DOI 10.1177/0022243719881113
   Maxwell J. A., 2015, INT ENCY SOCIAL BEHA, V2, P685, DOI [10.1016/B978-0-08-097086-8.10558-6, DOI 10.1016/B978-0-08-097086-8.10558-6]
   Merig?, 2020, J PROMOTION MANAGEME, V26, P674, DOI DOI 10.1080/10496491.2020.1729315
   Miles, 2002, QUALITATIVE RES COMP, P36, DOI [10.4135/9781412986274.n2, DOI 10.4135/9781412986274.N2]
   Palmatier RW, 2018, J ACAD MARKET SCI, V46, P1, DOI 10.1007/s11747-017-0563-4
   Reich T, 2020, J MARKETING, V84, P52, DOI 10.1177/0022242919882428
   Robinson TD, 2020, MARKETING THEOR, V20, P3, DOI 10.1177/1470593119870226
   Rodas MA, 2020, J CONSUM RES, V46, P1093, DOI 10.1093/jcr/ucz041
   Sekaran U., 2011, BUSINESS RES METHODS
   Shaddy F, 2020, J MARKETING RES, V57, P118, DOI 10.1177/0022243719871946
   Sheehan D, 2020, J CONSUM RES, V46, P1076, DOI 10.1093/jcr/ucz037
   Snyder H, 2019, J BUS RES, V104, P333, DOI 10.1016/j.jbusres.2019.07.039
   Sorescu A, 2017, J ACAD MARKET SCI, V45, P186, DOI 10.1007/s11747-017-0516-y
   Stojanovski J., 2014, LIB DIG AG LIDA P
   Yang ZL, 2006, INT BUS REV, V15, P601, DOI 10.1016/j.ibusrev.2006.08.003
   Yip J, 2020, MARKETING THEOR, V20, P103, DOI 10.1177/1470593119856654
   Zeithaml VA, 2020, J MARKETING, V84, P32, DOI 10.1177/0022242919888477
NR 40
TC 6
Z9 6
U1 7
U2 14
PU SCIENDO
PI WARSAW
PA BOGUMILA ZUGA 32A, WARSAW, MAZOVIA, POLAND
SN 1842-0206
EI 2069-8887
J9 MANAG MARK
JI Manag. Mark.
PD OCT
PY 2020
VL 15
SU 1
BP 514
EP 533
DI 10.2478/mmcks-2020-0030
PG 20
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA OH5NR
UT WOS:000582631600007
OA gold
DA 2022-04-20
ER

PT J
AU Chan, AKM
   Nickson, CP
   Rudolph, JW
   Lee, A
   Joynt, GM
AF Chan, A. K. M.
   Nickson, C. P.
   Rudolph, J. W.
   Lee, A.
   Joynt, G. M.
TI Social media for rapid knowledge dissemination: early experience from
   the COVID-19 pandemic
SO ANAESTHESIA
LA English
DT Editorial Material
DE airway management; COVID-19; dissemination; infographic; Twitter
ID ACUTE RESPIRATORY SYNDROME; SARS
C1 [Chan, A. K. M.] Prince Wales Hosp, Dept Anaesthesia & Intens Care, Shatin, Hong Kong, Peoples R China.
   [Nickson, C. P.] Monash Univ, Sch Publ Hlth & Preventat Med, Melbourne, Vic, Australia.
   [Rudolph, J. W.] Harvard Med Sch, Ctr Med Simulat, Boston, MA 02115 USA.
   [Lee, A.; Joynt, G. M.] Chinese Univ Hong Kong, Dept Anaesthesia & Intens Care, Shatin, Hong Kong, Peoples R China.
RP Chan, AKM (corresponding author), Prince Wales Hosp, Dept Anaesthesia & Intens Care, Shatin, Hong Kong, Peoples R China.
EM chan.albert.km@cuhk.edu.hk
RI Lee, Anna/B-2773-2009; Joynt, Gavin M/C-7606-2009; Nickson,
   Christopher/AAD-9853-2022
OI Lee, Anna/0000-0003-2864-0045; Joynt, Gavin M/0000-0002-5823-3435;
   Nickson, Christopher/0000-0002-6968-3087; Chan,
   Albert/0000-0002-4166-161X
CR Brownson RC, 2018, J PUBLIC HEALTH MAN, V24, P102, DOI 10.1097/PHH.0000000000000673
   Carlisle JB, 2017, ANAESTHESIA, V72, P944, DOI 10.1111/anae.13938
   Chan-Yeung M, 2004, INT J OCCUP ENV HEAL, V10, P421, DOI 10.1179/oeh.2004.10.4.421
   Fowler RA, 2004, AM J RESP CRIT CARE, V169, P1198, DOI 10.1164/rccm.200305-715OC
   Griffith J, 2003, AM J ROENTGENOL, V180, P1736, DOI 10.2214/ajr.180.6.1801736
   Hong Kong Legislative Council, 2004, REP SEL COMM INQ HAN
   Johannsson H, 2020, ANAESTHESIA, V75, P155, DOI 10.1111/anae.14780
   Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797
   Martin LJ., 2019, HLTH PROFES ED, V5, P48, DOI [10.1016/j.hpe.2018.03.005, DOI 10.1016/J.HPE.2018.03.005]
   Ng FK, 2020, ANAESTHESIA, V75, P227, DOI 10.1111/anae.14747
   Nickson CP, 2017, ICU MANAGEMENT PRACT, V17
   Pariser Eli, 2012, FILTER BUBBLE NEW PE
   Rogers EM., 2010, DIFFUSION INNOVATION, P576
   Thoma B, 2018, CAN J EMERG MED, V20, P300, DOI 10.1017/cem.2017.394
   World Health Organization, SUMM PROB SARS CAS O
   World Health Organization (WHO), 2020, COVID 19 STRAT UPD
   Wu Z., 2020, J AM MED ASS
   Young PJ, 2013, CRIT CARE RESUSC, V15, P257
NR 18
TC 140
Z9 144
U1 4
U2 31
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0003-2409
EI 1365-2044
J9 ANAESTHESIA
JI Anaesthesia
PD DEC
PY 2020
VL 75
IS 12
BP 1579
EP 1582
DI 10.1111/anae.15057
EA MAR 2020
PG 4
WC Anesthesiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anesthesiology
GA OY6XD
UT WOS:000522497500001
PM 32227594
OA Green Published
DA 2022-04-20
ER

PT J
AU Singh, AK
   Agrawal, B
   Sharma, A
   Sharma, P
AF Singh, Ashish Kumar
   Agrawal, Bharti
   Sharma, Anukriti
   Sharma, Prayas
TI COVID-19: Assessment of knowledge and awareness in Indian society
SO JOURNAL OF PUBLIC AFFAIRS
LA English
DT Article
ID ACCOMMODATION; EMPLOYEES
AB COVID-19, which was initiated regionally at Wuhan of China, has become a global pandemic by infecting people of almost all the world. Human civilizations are facing threat for their survival and livelihood. No country are getting any substantial relief and solution from this pandemic rather to convince their citizens to make aware and taking precaution by changing their living style. In view of this, this study attempted to assess the awareness, threat, symptoms and its prevention among people of India about the COVID-19. A total of 522 responses from all over India were received. The respondents have adequate awareness for COVID-19 outbreak and its preventive measures, out of total, 98% (513) answered that the virus spreads from one person to another, 95% (494) answered that the disease is caused by a virus. Peoples understand the importance of social distancing and other preventive measures prescribed by the government with good attitude for coronavirus. Peoples are following trusted sources for corona information, having confidence to defeat disease but showed their concern for corona threat, are aware about the virus, its common symptoms and prevention, govt. testing and medical facilities. Principal component analysis was used to identify the latent dimensions regarding people's preventive measures and was found that they are majorly adopting three methods, that is, lockdown, naturopathy and social distancing. This study will help government and peoples to understand and handle this coronavirus pandemic effectively and in prevention of COVID-19, which is crucial for the awareness of society in coming time.
C1 [Singh, Ashish Kumar] Raj Kumar Goel Inst Technol, Dept Management Studies, Ghaziabad, India.
   [Agrawal, Bharti] Shri Vaishnav Inst Management, Dept Comp Sci, Indore, Madhya Pradesh, India.
   [Sharma, Anukriti; Sharma, Prayas] Univ Petr & Energy Studies, Sch Business, Dehra Dun, Uttarakhand, India.
RP Sharma, P (corresponding author), Univ Petr & Energy Studies, Sch Business, Dehra Dun, Uttarakhand, India.
EM prayassharma02@gmail.com
RI SINGH, ASHISH/ABC-4711-2020; Sharma, Prayas/D-5101-2014
OI SINGH, ASHISH/0000-0002-5398-2947; Sharma, Prayas/0000-0002-4828-1177
CR Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5
   Baldridge DC, 2001, ACAD MANAGE REV, V26, P85, DOI 10.2307/259396
   Balser DB, 2007, ADMIN SOC, V39, P656, DOI 10.1177/0095399707303639
   Balser DB, 2008, EMPLOY RESPONSIB RIG, V20, P13, DOI 10.1007/s10672-007-9062-y
   Cleveland JN, 1997, HUM RESOUR MANAGE R, V7, P77, DOI 10.1016/S1053-4822(97)90006-1
   Colella A, 2001, ACAD MANAGE REV, V26, P100, DOI 10.5465/AMR.2001.4011984
   Cronbach L.J, 1984, ESSENTIALS PSYCHOL T
   Ebrahim SH, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1066
   Hair J, 1995, MULTIVAR DATA ANAL, P373
   Hair J.F.Jr., 2010, MULTIVARIATE DATA AN, V7th ed.
   KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575
   KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   McCloskey B, 2020, LANCET, V395, P1096, DOI 10.1016/S0140-6736(20)30681-4
   Pett M. A., 2003, MAKING SENSE FACTOR
   Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083
   Sharma P, 2020, J PUBLIC AFF, V20, DOI 10.1002/pa.2222
   Sharma S., 1996, APPL MULTIVARIATE TE, V1st ed.
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Stone DL, 1996, ACAD MANAGE REV, V21, P352, DOI 10.2307/258666
   Tabachnick B., 2007, USING MULTIVARIATE S, V5
   Takian A, 2020, LANCET, V395, P1035, DOI 10.1016/S0140-6736(20)30668-1
   WHO, 2020, 70 WHO
   World Health Organization (WHO), 2020, 137 WHO, P46
   World Health Organization (WHO), 2020, ROLLING UPDATES CORO
NR 25
TC 7
Z9 7
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1472-3891
EI 1479-1854
J9 J PUBLIC AFF
JI J. Public Aff.
PD NOV
PY 2020
VL 20
IS 4
AR e2354
DI 10.1002/pa.2354
EA AUG 2020
PG 9
WC Public Administration
WE Emerging Sources Citation Index (ESCI)
SC Public Administration
GA PA5XJ
UT WOS:000563273100001
PM 32904779
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Floyd, L
   Stauss, M
   Storrar, J
   Vanalia, P
   France, A
   Dhaygude, A
AF Floyd, Lauren
   Stauss, Madelena
   Storrar, Joshua
   Vanalia, Parthvi
   France, Anna
   Dhaygude, Ajay
TI Using CPAP in COVID-19 patients outside of the intensive care setting: a
   comparison of survival and outcomes between dialysis and non-dialysis
   dependent patients
SO BMC NEPHROLOGY
LA English
DT Article
DE CPAP; COVID-19; Dialysis; Anticoagulation
ID FLUID BALANCE; HEMODIALYSIS; CHECK
AB Background: SARS-CoV-2 (COVID-19) is a novel coronavirus associated with high mortality rates. The use of Continuous Positive Airway Pressure (CPAP) has been recognised as a management option for severe COVID-19 (NHS, Specialty guides for patient management during the coronavirus pandemic Guidance for the role and use of non-invasive respiratory support in adult patients with coronavirus (confirmed or suspected), ). We offered ward-based CPAP to COVID-19, dialysis patients not suitable for escalation to ICU. The aim of the study was to evaluate the use of CPAP for COVID-19 dialysis patients compared to non-dialysis COVID-19 patients outside of the intensive care setting. We further aimed to investigate factors associated with improved outcomes.
   Methods: Data was collected from a single centre (Royal Preston Hospital, UK), from March to June 2020. Treatment outcomes were compared for dialysis and non-dialysis dependent patients who received CPAP with limitations on their escalation and resuscitation status. Kaplan-Meier survival curves and Cox regression models were used to compare outcomes. The primary study outcome was 30 day mortality. Confounders including length of admission, systemic anticoagulation and ultrafiltration volumes on dialysis were also analysed.
   Results: Over the study period, 40 dialysis patients tested positive for COVID-19, with 30 requiring hospital admission. 93% (n = 28) required supplementary oxygen and 12% (n = 9) required CPAP on the ward. These patients were compared to a serial selection of 14 non-dialysis patients treated with CPAP during the same period. Results showed a significant difference in 30 day survival rates between the two groups: 88.9% in the dialysis group vs. 21.4% in the non-dialysis group. Statistical modelling showed that anticoagulation was also an important factor and correlated with better outcomes.
   Conclusion: This is to the best of our knowledge, the largest series of COVID-19 dialysis patients treated with CPAP in a ward-based setting. In general, dialysis dependent patients have multiple co-morbidities including cardiovascular disease and diabetes mellitus making them vulnerable to COVID-19 and not always suitable for treatment in ICU. We showed a significantly lower 30 day mortality rate with the use of CPAP in the dialysis group (11.1%) compared to the non-dialysis group (78.6%). Despite a small sample size, we believe this study provides impetus for further work clarifying the role of CPAP in treating COVID-19 dialysis dependent patients.
C1 [Floyd, Lauren; Stauss, Madelena; Storrar, Joshua; Vanalia, Parthvi; Dhaygude, Ajay] Lancashire Teaching Hosp NHS Fdn Trust, Royal Preston Hosp, Dept Nephrol, Preston, Lancs, England.
   [France, Anna] Univ Cent Lancashire, Preston, Lancs, England.
RP Floyd, L (corresponding author), Lancashire Teaching Hosp NHS Fdn Trust, Royal Preston Hosp, Dept Nephrol, Preston, Lancs, England.
EM lauren.floyd@doctors.org.uk
OI Floyd, Lauren/0000-0002-0756-3151; France, Anna/0000-0002-6227-9401
CR Acheampong A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0970-1
   Alberici F, 2020, KIDNEY INT REP, V5, P580, DOI 10.1016/j.ekir.2020.04.001
   Besen Bruno Adler Maccagnan Pinheiro, 2015, World J Crit Care Med, V4, P116, DOI 10.5492/wjccm.v4.i2.116
   Care Quality Commission, 2016, INSP FRAM NHS AC HOS
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Coggon D, 2020, OCCUP MED-OXFORD, V70, P461, DOI 10.1093/occmed/kqaa150
   Elli S, 2020, BIORXIV, DOI 10.1101/2020.02.29.971093
   Esposito P, 2020, HEMODIAL INT, V24, P423, DOI 10.1111/hdi.12837
   Fisher Molly, 2020, Kidney360, V1, P755, DOI 10.34067/KID.0003672020
   Fu D, 2020, NEPHRON, V144, P245, DOI 10.1159/000507261
   Gallieni Maurizio, 2020, Kidney360, V1, P403, DOI 10.34067/KID.0001782020
   GILLUM DM, 1986, CLIN NEPHROL, V25, P249
   Goicoechea M, 2020, KIDNEY INT, V98, P27, DOI 10.1016/j.kint.2020.04.031
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Hens N, 2020, EUR HEART J-ACUTE CA, V9, P204, DOI 10.1177/2048872620924922
   Iannaccone G, 2020, CARDIORENAL MED, V10, P277, DOI 10.1159/000509483
   Jung HY, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061688
   Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208
   Kliger AS, 2020, KIDNEY INT, V98, P12, DOI 10.1016/j.kint.2020.04.007
   Kuroki Y, 2020, CEN CASE REP, V9, P404, DOI 10.1007/s13730-020-00495-5
   Ma Y, 2020, COVID 19 HEMODIALYSI, DOI [10.1101/2020.02.24.20027201, DOI 10.1101/2020.02.24.20027201]
   Manini, 2020, G ITAL NEFROL ORGANO, V37, P2
   NHS, 2020, SPEC GUID PAT MAN CO, P19
   Oranger M, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01692-2020
   Pisani A, 2020, NEPHRON, V144, P383, DOI 10.1159/000508638
   Rabb H, 2020, J CLIN INVEST, V130, P2749, DOI 10.1172/JCI138871
   Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051
   Sablerolles RSG, 2021, LANCET HEALTH LONGEV, V2, pE163, DOI 10.1016/S2666-7568(21)00006-4
   Schiffl H, 2002, NEW ENGL J MED, V346, P305, DOI 10.1056/NEJMoa010877
   Sirvent JM, 2015, AM J EMERG MED, V33, P186, DOI 10.1016/j.ajem.2014.11.016
   Tang B, 2020, KIDNEY MED, V2, P354, DOI 10.1016/j.xkme.2020.03.001
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Thachil J, 2020, J THROMB HAEMOST, V18, P1020, DOI 10.1111/jth.14821
   UK Renal Registry, 2020, COVID 19 SURV REP RE
   Valeri AM, 2020, J AM SOC NEPHROL, V31, P1409, DOI 10.1681/ASN.2020040470
   Wang R, 2020, AM J KIDNEY DIS, V76, P141, DOI 10.1053/j.ajkd.2020.03.009
   Williams T., 2021, COVID 19 MED RISK AS
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
   Xiong F, 2020, J AM SOC NEPHROL, V31, P1387, DOI 10.1681/ASN.2020030354
NR 39
TC 1
Z9 1
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2369
J9 BMC NEPHROL
JI BMC Nephrol.
PD APR 21
PY 2021
VL 22
IS 1
AR 144
DI 10.1186/s12882-021-02341-x
PG 9
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA RS4ZQ
UT WOS:000643789600001
PM 33882842
OA Green Accepted, gold, Green Published
DA 2022-04-20
ER

PT J
AU Yang, SY
   Chen, YJ
   Zhou, LS
   Huang, YT
   Dai, JH
AF Yang, Siyu
   Chen, Yijing
   Zhou, Leshan
   Huang, Yuting
   Dai, Jiahui
TI Willingness to Adopt mHealth Among Chinese Parents During the COVID-19
   Outbreak: Cross-sectional Questionnaire Study
SO JMIR MHEALTH AND UHEALTH
LA English
DT Article
DE mHealth; parents; child health at home; COVID-19
ID MOBILE HEALTH; ADOLESCENTS; INFORMATION; EDUCATION; INTENTION; SERVICES;
   SUPPORT; CARE
AB Background: Parental involvement in mobile health (mHealth) to consult with medical professionals appears to be prevalent in China with the rapid development of the internet. More parents with busy jobs have chosen to use mHealth. During the ongoing COVID-19 outbreak, mHealth can assist with health promotion, directions for medication use, and disease diagnosis via online chat and video consultation without contacting others. To our knowledge, no studies have been performed to explore the role of mHealth in parents' attitudes toward child health care at home during the COVID-19 outbreak.
   Objective: This study aims to identify the associated factors of willingness to adopt mHealth among Chinese parents during the COVID-19 outbreak and to explore the correlation between the frequency of adopting mHealth and parents' attitudes toward child health care at home.
   Methods: Chinese parents were asked to complete an online survey from January 25 to February 15, 2020. The questionnaire comprised of two parts with a total of 16 items, including parents' demographic variables and attitudes toward child health care at home. By multivariate logistic regression, we explored factors associated with parents' willingness to adopt mHealth during the COVID-19 outbreak. Pearson chi-square tests were used to reveal the correlation between the frequency of adopting mHealth and parents' attitudes toward child health care at home.
   Results: A total of 254 parents enrolled, and 202 (79.5%) parents were willing to adopt mHealth during the COVID-19 outbreak. Parents' age (26-35 years: adjusted odds ratio [AOR] 8.114, 95% CI 1.471-44.764), parents' interest in the COVID-19 pandemic (moderate: AOR 8.753, 95% CI 2.009-38.127; high: AOR 22.194, 95% CI 5.509-89.411), the source that recommended mHealth (medical health providers: AOR 4.257, 95% CI 1.439-12.596), the presence of chronic disease in their children (yes: AOR 20.844, 95% CI 4.600-94.443), parents' duration of daily internet use (4-6 hours: AOR 6.487, 95% CI 1.870-22.495; >6 hours: AOR 8.766, 95% CI 1.883-40.804), and adoption of mHealth before the COVID-19 outbreak (yes: AOR 3.413, 95% CI 1.234-9.444) were significantly correlated with the parents' willingness to adopt mHealth during the COVID-19 outbreak. The frequency of mHealth use among parents was correlated with their behaviors in regard to handwashing (chi(2)(6) =18.967, P=.004), mask wearing (chi(2)(6) =45.364, P<.001), frequency of leaving the home (chi(2)(6) =16.767, P=.01), room disinfection and ventilation (chi(2)(6) =19.515, P=.003), temperature checking (chi(2)(6) =17.47, P=. 007), and mental health care of children (chi(2 )(6)=63.810, P<.001) during the COVID-19 pandemic.
   Conclusions: We found various objective factors that were associated with parents' willingness to adopt mHealth during the COVID-19 outbreak. Overall, parents' willingness to adopt mHealth was high. The frequency of mHealth use among parents was correlated with their attitudes toward child health care at home. The option of mHealth to patients at home during the COVID-19 outbreak would be beneficial for education and improvement in self-management of child health care at home.
C1 [Yang, Siyu] Huazhong Univ Sci & Technol, Tongji Med Coll, Nursing Dept, Tongji Hosp, Wuhan, Peoples R China.
   [Chen, Yijing] Huazhong Univ Sci & Technol, Wuhan Mental Hlth Ctr, Tongji Med Coll, Wuhan, Peoples R China.
   [Zhou, Leshan; Huang, Yuting] Cent South Univ, Xiangya Nursing Sch, 172 Tongzipo Rd, Changsha, Peoples R China.
   [Dai, Jiahui] Univ Sydney, Fac Med & Hlth, Sydney Sch Publ Hlth, Sydney, NSW, Australia.
RP Zhou, LS (corresponding author), Cent South Univ, Xiangya Nursing Sch, 172 Tongzipo Rd, Changsha, Peoples R China.
EM leshanzhou@csu.edu.cn
OI CHEN, YIJING/0000-0002-9732-6183; Huang, Yuting/0000-0002-9779-6492
FU Hunan Women Theory and Practice Research Project [19YB11]
FX This study is funded by a research grant from Hunan Women Theory and
   Practice Research Project (19YB11).
CR Abelson JS, 2017, AM J SURG, V214, P616, DOI 10.1016/j.amjsurg.2017.06.009
   Ajzen I, 2005, HANDBOOK OF ATTITUDES, P173
   Alberts NM, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/14884
   [Anonymous], 2020, CHINESE MED J-PEKING, V133, P1087, DOI 10.1097/CM9.0000000000000819
   Cajita MI, 2017, J CARDIOVASC NURS, V32, pE1, DOI 10.1097/JCN.0000000000000401
   Chen Xuyu, 2020, Int J Environ Res Public Health, V17, DOI 10.3390/ijerph17082893
   Chib A, 2015, J HEALTH COMMUN, V20, P4, DOI 10.1080/10810730.2013.864735
   Chiu NC, 2020, J MED INTERNET RES, V22, DOI 10.2196/21257
   Dai MM, 2017, TELEMED E-HEALTH, V23, P822, DOI 10.1089/tmj.2016.0254
   Fiks AG, 2018, TELEMED E-HEALTH, V24, P236, DOI 10.1089/tmj.2017.0075
   Garavand A, 2019, METHOD INFORM MED, V58, P131, DOI 10.1055/s-0040-1701607
   Hether HJ, 2014, J HEALTH COMMUN, V19, P1424, DOI 10.1080/10810730.2014.894596
   Hollander JE, 2020, NEW ENGL J MED, V382, P1679, DOI 10.1056/NEJMp2003539
   Huckins JF, 2020, J MED INTERNET RES, V22, DOI 10.2196/20185
   Illiger K, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3799
   James DCS, 2018, HEALTH EDUC BEHAV, V45, P315, DOI 10.1177/1090198117714020
   James DCS, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160210
   Jemere AT, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-021766
   Kelvin AA, 2020, LANCET INFECT DIS, V20, P633, DOI 10.1016/S1473-3099(20)30236-X
   Kichloo Asim, 2020, Fam Med Community Health, V8, DOI 10.1136/fmch-2020-000530
   Liu JJ, 2020, LANCET CHILD ADOLESC, V4, P347, DOI 10.1016/S2352-4642(20)30096-1
   Liu S, 2020, LANCET PSYCHIAT, V7, pE17, DOI 10.1016/S2215-0366(20)30077-8
   Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073
   Mann DM, 2020, J AM MED INFORM ASSN, V27, P1132, DOI 10.1093/jamia/ocaa072
   Mathieson K, 2017, J HEALTH CARE POOR U, V28, P1522, DOI 10.1353/hpu.2017.0131
   Mitsutake S, 2012, J MED INTERNET RES, V14, P406, DOI 10.2196/jmir.1927
   Nicholas DB, 2012, SOC WORK HEALTH CARE, V51, P815, DOI 10.1080/00981389.2012.699507
   Nijland N, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1603
   Olson CA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2334
   Phichitchaisopa N, 2013, EXCLI J, V12, P413
   Piette JD, 2010, TELEMED J E-HEALTH, V16, P1030, DOI 10.1089/tmj.2010.0074
   Qian WJ, 2019, J MED INTERNET RES, V21, DOI 10.2196/12340
   Quaosar GMAA, 2018, TELEMED E-HEALTH, V24, P309, DOI 10.1089/tmj.2017.0111
   Robb M, 2014, ON LINE J NURSING IN, V18, DOI [10.17645/mac.v7i2.1871, DOI 10.17645/MAC.V7I2.1871]
   Ruton H, 2018, HEALTH POLICY PLANN, V33, P920, DOI 10.1093/heapol/czy066
   Sankar J, 2020, INDIAN J PEDIATR, V87, P433, DOI 10.1007/s12098-020-03292-1
   Scott BK, 2020, TELEMED E-HEALTH, V26, P1226, DOI 10.1089/tmj.2020.0140
   She JT, 2020, J MED VIROL, V92, P747, DOI 10.1002/jmv.25807
   Shibuta T, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2016-000322
   Shigekawa E, 2018, HEALTH AFFAIR, V37, P1975, DOI 10.1377/hlthaff.2018.05132
   Ting DSW, 2020, NAT MED, V26, P459, DOI 10.1038/s41591-020-0824-5
   To T, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01704-2020
   Tubaishat A, 2016, NURS EDUC TODAY, V42, P47, DOI 10.1016/j.nedt.2016.04.003
   Vaala SE, 2018, J AM MED INFORM ASSN, V25, P135, DOI 10.1093/jamia/ocx051
   van der Vaart R, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1840
   Ye Jiancheng, 2020, JMIR Pediatr Parent, V3, pe19867, DOI 10.2196/19867
   Zhao Y, 2018, INT J INFORM MANAGE, V43, P342, DOI 10.1016/j.ijinfomgt.2017.08.006
NR 47
TC 1
Z9 1
U1 14
U2 23
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 2291-5222
J9 JMIR MHEALTH UHEALTH
JI JMIR mHealth uHealth
PD JAN 27
PY 2021
VL 9
IS 1
AR e23155
DI 10.2196/23155
PG 12
WC Health Care Sciences & Services; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Medical Informatics
GA QG6QH
UT WOS:000617708100001
PM 33406052
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Neykova, KK
   Milanova, M
   Ignatov, PN
AF Neykova, Konstantsa Krassimirova
   Milanova, Milena
   Ignatov, Peter Nikolaev
TI Myasthenia gravis and covid-19 in pregnancy: a review of the literature
   and case series report
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Review; Early Access
DE Myasthenia gravis; pregnancy; COVID-19 infection
ID LOW-DOSE ASPIRIN; MANAGEMENT; CORTICOSTEROIDS; PRECONCEPTION; EXPOSURE;
   SAFETY; BIRTH; SEX
AB Objectives The aim of our study was to investigate the interrelations of symptoms, clinical outcomes and treatment regimens in pregnant women, diagnosed with myasthenia gravis and superimposed COVID-19 infection. Methods We conducted an observational retrospective study between August, 2020 and July, 2021. Five patients with preexisting MG and superimposed COVID- infection were included in our study. We investigated the duration of MG, the antibody patient status, any present comorbidities, MG baseline treatment and MG severity class prior to the COVID-19 infection, MG severity class and treatment during the COVID-infection, and last but not least, the maternal and fetal clinical outcome. Results None of the participants were hospitalized as they were treated under quarantine at their homes. The most frequently reported complaints were anosmia, headache and fever, which were observed in 3 out of 5 patients. The MG severity was evaluated twice - before and after the quarantine period. Progression to a more advanced stage was found in 2 of our 5 patients. Three of the patients did not require any changes in the prescribed baseline MG treatment. In 2 patients the pyridostigmine dosage had to be increased. One patient received azithromycin and 4 patients were given LMWH (nadroparin) as specific anti-COVID measures. All patients fully recovered and gave birth to healthy newborns. Conclusion To our knowledge, this is the first study on pregnant MG patients with superimposed COVID-19 infection. Based on our observations in this study it would seem that the coexistence of MG and COVID-19 infection in pregnancy does not elicit exacerbation in neither of those conditions. Further research is needed to confirm or challenge these findings, especially with the prospects of new virus variants emerging in the future.
C1 [Neykova, Konstantsa Krassimirova] Maichin Dom State Univ Hosp, Sofia, Bulgaria.
   [Milanova, Milena] State Univ Hosp Treatment Neurol & Psychiat Disor, MBALNP Sv Naum EAD, Sofia, Bulgaria.
   [Ignatov, Peter Nikolaev] Orthogyn Med Ctr, Sofia, Bulgaria.
   [Ignatov, Peter Nikolaev] II SAGBAL Sheinovo, Sofia, Bulgaria.
RP Neykova, KK (corresponding author), Maichin Dom State Univ Hosp, Sofia, Bulgaria.
EM neykovaconstantsa@yahoo.com
OI Ignatov, Peter/0000-0003-1656-5316
CR Ahrens KA, 2016, OBSTET GYNECOL, V127, P689, DOI 10.1097/AOG.0000000000001301
   Aksoy E, 2020, CASE REP INFECT DIS, V2020, DOI 10.1155/2020/8845844
   Almeida C, 2010, EUR J ANAESTH, V27, P985, DOI 10.1097/EJA.0b013e32833e263f
   [Anonymous], 2019, WHO OFFICIAL UPDATES
   Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0
   Bansal R, 2018, INDIAN J PHARMACOL, V50, P302, DOI 10.4103/ijp.IJP_452_17
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Camelo AE, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.01053
   Carr AS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-46
   Chow JH, 2021, ANESTH ANALG, V132, P930, DOI 10.1213/ANE.0000000000005292
   Cosma S, 2021, AM J OBSTET GYNECOL, V224, DOI [10.1016/j.ajog.2020.10.005, 10.1016/j.ajog.2020.10.OO5]
   Cozzani E, 2019, GIORN ITAL DERMAT V, V154, P299, DOI 10.23736/S0392-0488.18.06212-0
   D'Souza R, 2020, ACTA OBSTET GYN SCAN, V99, P1110, DOI 10.1111/aogs.13962
   da Costa GM, 2020, J SENS STUD, V35, DOI 10.1111/joss.12602
   Djelmis J, 2002, EUR J OBSTET GYN R B, V104, P21, DOI 10.1016/S0301-2115(02)00051-9
   Ducci RD, 2017, NEUROMUSCULAR DISORD, V27, P352, DOI 10.1016/j.nmd.2017.01.021
   Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2
   Ferrazzi E, 2020, BJOG-INT J OBSTET GY, V127, P1116, DOI 10.1111/1471-0528.16278
   Ferrero S, 2005, EUR J OBSTET GYN R B, V121, P129, DOI 10.1016/j.ejogrb.2005.01.002
   Ferrero Simone, 2008, Expert Rev Neurother, V8, P979, DOI 10.1586/14737175.8.6.979
   Furtado RHM, 2020, LANCET, V396, P959, DOI 10.1016/S0140-6736(20)31862-6
   Gately R, 2017, NEPHROLOGY, V22, P32, DOI 10.1111/nep.12938
   GAUDIER FL, 1988, SURG GYNECOL OBSTET, V167, P533
   Ghasemi M, 2020, WJOG, V9, P1
   Gilhus NE, 2016, NEW ENGL J MED, V375, P2570, DOI 10.1056/NEJMra1602678
   Gur C, 2004, REPROD TOXICOL, V18, P93, DOI 10.1016/j.reprotox.2003.10.007
   Hammad I, 2020, CLIN PERINATOL, V47, P733, DOI 10.1016/j.clp.2020.08.003
   Hassoun M, 2020, NEOREVIEWS, V11, P200, DOI [10.1542/neo.11-4-e200, DOI 10.1542/NEO.11-4-E200]
   Henderson JT, 2014, ANN INTERN MED, V160, P695, DOI 10.7326/M13-2844
   Hoff JM, 2007, EUR J NEUROL, V14, P38, DOI 10.1111/j.1468-1331.2006.01538.x
   Hoff JM, 2015, J CHILD ORTHOP, V9, P433, DOI 10.1007/s11832-015-0690-8
   Jaretzki A 3rd, 2000, Ann Thorac Surg, V70, P327
   Jimenez-Lozano I, 2021, J CLIN PHARM THER, V46, P1062, DOI 10.1111/jcpt.13394
   Leker RR, 2000, EUR J NEUROL, V7, P203, DOI 10.1046/j.1468-1331.2000.00042.x
   Li Y, 2010, INTERNAL MED, V49, P611, DOI 10.2169/internalmedicine.49.2737
   Mehta Puja, 2020, Lancet, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Norwood F, 2014, J NEUROL NEUROSUR PS, V85, P538, DOI 10.1136/jnnp-2013-305572
   Oertelt-Prigione S, 2012, AUTOIMMUN REV, V11, pA479, DOI 10.1016/j.autrev.2011.11.022
   Ozcan John, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-208323
   Park-Wyllie L, 2000, TERATOLOGY, V62, P385, DOI 10.1002/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z
   Rottenstreich A, 2021, ARCH GYNECOL OBSTET, V303, P1401, DOI 10.1007/s00404-020-05854-2
   Sanders DB, 2016, NEUROLOGY, V87, P419, DOI 10.1212/WNL.0000000000002790
   Schinzel H, 2006, TRANSFUSION, V46, P624, DOI 10.1111/j.1537-2995.2006.00755.x
   Shimabukuro TT, 2021, OBSTET GYNECOL SURV, V76, P729, DOI [10.1056/NEJMx210016, 10.1056/NEJMoa2104983, 10.1097/01.ogx.0000802676.57373.17]
   Thai TN, 2020, PHARMACOEPIDEM DR S, V29, P716, DOI 10.1002/pds.5017
   University of Oxford, 2021, REC RAND EV COVID 19
   Vukojevic Z., 2010, CURR TOP NEUROL PSYC, V18, P40
   WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184
   World Health Organization, 2020, CLIN MAN COVID 19 IN
NR 49
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
DI 10.1080/14767058.2021.1973418
EA SEP 2021
PG 9
WC Obstetrics & Gynecology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Obstetrics & Gynecology
GA UW1DL
UT WOS:000699905600001
PM 34582289
DA 2022-04-20
ER

PT J
AU Yan, XC
   Wang, JJ
   Yao, JW
   Estill, J
   Wu, SY
   Lu, J
   Liang, BP
   Li, HM
   Tao, SX
   Bai, HL
   Liu, HL
   Chen, YL
AF Yan, Xuanchen
   Wang, Jianjian
   Yao, Jingwen
   Estill, Janne
   Wu, Shouyuan
   Lu, Jie
   Liang, Baoping
   Li, Hongmin
   Tao, Shengxin
   Bai, Huanli
   Liu, Hongliang
   Chen, Yaolong
CA COVID-19 Evidence Recommendations
TI A cross-sectional study of the epidemic situation on COVID-19 in Gansu
   Province, China - a big data analysis of the national health information
   platform
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Corona virus disease 2019 (COVID-19); Gansu Province National Health
   Information Platform; Big data
AB BackgroundIn December 2019, a pneumonia caused by SARS-CoV-2 emerged in Wuhan, China and has rapidly spread around the world since then. This study is to explore the patient characteristics and transmission chains of COVID-19 in the population of Gansu province, and support decision-making.MethodsWe collected data from Gansu Province National Health Information Platform. A cross-sectional study was conducted, including patients with COVID-19 confirmed between January 23 and February 6, 2020, and analyzed the gender and age of the patients. We also described the incubation period, consultation time and sources of infection in the cases, and calculated the secondary cases that occurred within Gansu for each imported case.ResultsWe found thirty-six (53.7%) of the patients were women and thirty-one (46.3%) men, and the median ages were 40 (IQR 31-53) years. Twenty-eight (41.8%) of the 67 cases had a history of direct exposure in Wuhan. Twenty-five (52.2%) cases came from ten families, and we found no clear reports of modes of transmission other than family clusters. The largest number of secondary cases linked to a single source was nine.ConclusionMore women than men were diagnosed with COVID-19 in Gansu Province. Although the age range of confirmed cases of COVID-19 in Gansu Province covered almost all age groups, most patients with confirmed COVID-19 tend to be middle aged persons. The most common suspected mode of transmission was through family cluster. Gansu and other settings worldwide should continue to strengthen the utilization of big data in epidemic control.
C1 [Yan, Xuanchen; Yao, Jingwen; Lu, Jie; Liang, Baoping; Li, Hongmin; Tao, Shengxin; Bai, Huanli; Liu, Hongliang] Hlth Commiss Gansu Prov, Hlth Stat Informat Ctr, Lanzhou, Peoples R China.
   [Wang, Jianjian; Wu, Shouyuan; Chen, Yaolong] Lanzhou Univ, Sch Publ Hlth, Lanzhou, Peoples R China.
   [Wang, Jianjian; Chen, Yaolong] WHO Collaborating Ctr Guideline Implementat & Kno, Lanzhou, Peoples R China.
   [Wang, Jianjian; Chen, Yaolong] Lanzhou Univ, Key Lab Evidence Based Med & Knowledge Translat G, Lanzhou, Peoples R China.
   [Estill, Janne] Univ Geneva, Inst Global Hlth, Geneva, Switzerland.
   [Estill, Janne] Univ Bern, Inst Math Stat & Actuarial Sci, Bern, Switzerland.
RP Yao, JW (corresponding author), Hlth Commiss Gansu Prov, Hlth Stat Informat Ctr, Lanzhou, Peoples R China.; Chen, YL (corresponding author), Lanzhou Univ, Sch Publ Hlth, Lanzhou, Peoples R China.; Chen, YL (corresponding author), WHO Collaborating Ctr Guideline Implementat & Kno, Lanzhou, Peoples R China.; Chen, YL (corresponding author), Lanzhou Univ, Key Lab Evidence Based Med & Knowledge Translat G, Lanzhou, Peoples R China.
EM 1527658556@qq.com; chenyaolong@izu.edu.cn
OI Chen, Yaolong/0000-0002-9841-5233
FU "Research on Decision Support for Epidemic Surveillance, Prevention and
   Control and Emergency Management Based on Health and Medical Big Data"
   [GSWSKY2020-34]
FX This study was supported by "Research on Decision Support for Epidemic
   Surveillance, Prevention and Control and Emergency Management Based on
   Health and Medical Big Data" (grant number GSWSKY2020-34), to (Health
   Commission of Gansu Province). The funding is mainly used for the
   construction of Gansu Province National Health Information Platform, and
   it was also used to pay for data engineers of this platform. But it
   didn't affect design, data collection, analysis, interpretation and
   writing of this study.
CR [Anonymous], 2020, CCTV NETWORK
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Gartner, BIG DATA
   Health Commission of Chongqing, EP SIT COVID 19 CHON
   Health Commission of Gansu Province, NO NEW CAS CONF GANS
   Health Commission of Shaanxi Province, 23 NEW CAS COVID 19
   Huang, 2017, CHINA DIGITAL MED, V12, P24, DOI [10.3969/j.issn.1673-7571.2017.05.008, DOI 10.3969/J.ISSN.1673-7571.2017.05.008]
   Jaillon S, 2019, CLIN REV ALLERG IMMU, V56, P308, DOI 10.1007/s12016-017-8648-x
   Jamison DC, 2003, CURR PROTOC BIOI FEB, DOI [10.1002/0471250953.bi0902s00, DOI 10.1002/0471250953.BI0902S00]
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   [孟润堂 Meng Runtang], 2015, [中国全科医学, Chinese General Practice], V18, P4388
   Mooney SJ, 2018, ANNU REV PUBL HEALTH, V39, P95, DOI 10.1146/annurev-publhealth-040617-014208
   National Health Commission of the People's Republic of China, DIAGN TREATM COVID 1
   National Health Commission of the People's Republic of China, 2020, NAT HLTH COMM PRESS
   National Health Commission of the People's Republic of China, UPD EP SIT COVID 19
   Ni AP, 2003, CHIN J LAB MED, V26, P410, DOI [10.3760/j:issn:1009-9158.2003.07.028, DOI 10.3760/J:ISSN:1009-9158.2003.07.028]
   Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181
   Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P139, DOI 10.3760/cma.j.issn.0254-6450.2020.02.002
   The State Council of the People's Republic of China, ACT PLAN BIG DAT DEV
   The State Council of the People's Republic of China, PEOPLES REPUBLIC CHI
   WHO, WHO DIR GEN REM MED
   World Health Organisation (WHO), NOV COR CHIN
   World Health Organization, NAM COR DIS COVID 19
   Wuhan Municipal Health Commission, REP WUH MUN HLTH COM
   Xu Z, 2020, EXUBERANT ELEVATION, DOI 10.1101/2020.02.11.20021493
   Zhang LX, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5910
   ZHOU P, 2020, NATURE, V579, P270, DOI DOI 10.1038/S41586-020-2012-7
NR 27
TC 0
Z9 0
U1 4
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD FEB 5
PY 2021
VL 21
IS 1
AR 146
DI 10.1186/s12879-020-05743-8
PG 7
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA QG2VE
UT WOS:000617447300001
PM 33546618
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Yakunin, K
   Mukhamediev, RI
   Zaitseva, E
   Levashenko, V
   Yelis, M
   Symagulov, A
   Kuchin, Y
   Muhamedijeva, E
   Aubakirov, M
   Gopejenko, V
AF Yakunin, Kirill
   Mukhamediev, Ravil I.
   Zaitseva, Elena
   Levashenko, Vitaly
   Yelis, Marina
   Symagulov, Adilkhan
   Kuchin, Yan
   Muhamedijeva, Elena
   Aubakirov, Margulan
   Gopejenko, Viktors
TI Mass Media as a Mirror of the COVID-19 Pandemic
SO COMPUTATION
LA English
DT Article
DE COVID-19; topic modeling; BigARTM; latent Dirichlet analysis; mass media
   analysis
ID NEWS
AB The media plays an important role in disseminating facts and knowledge to the public at critical times, and the COVID-19 pandemic is a good example of such a period. This research is devoted to performing a comparative analysis of the representation of topics connected with the pandemic in the internet media of Kazakhstan and the Russian Federation. The main goal of the research is to propose a method that would make it possible to analyze the correlation between mass media dynamic indicators and the World Health Organization COVID-19 data. In order to solve the task, three approaches related to the representation of mass media dynamics in numerical form-automatically obtained topics, average sentiment, and dynamic indicators-were proposed and applied according to a manually selected list of search queries. The results of the analysis indicate similarities and differences in the ways in which the epidemiological situation is reflected in publications in Russia and in Kazakhstan. In particular, the publication activity in both countries correlates with the absolute indicators, such as the daily number of new infections, and the daily number of deaths. However, mass media tend to ignore the positive rate of confirmed cases and the virus reproduction rate. If we consider strictness of quarantine measures, mass media in Russia show a rather high correlation, while in Kazakhstan, the correlation is much lower. Analysis of search queries revealed that in Kazakhstan the problem of fake news and disinformation is more acute during periods of deterioration of the epidemiological situation, when the level of crime and poverty increase. The novelty of this work is the proposal and implementation of a method that allows the performing of a comparative analysis of objective COVID-19 statistics and several mass media indicators. In addition, it is the first time that such a comparative analysis, between different countries, has been performed on a corpus in a language other than English.
C1 [Yakunin, Kirill; Mukhamediev, Ravil I.; Yelis, Marina; Symagulov, Adilkhan; Kuchin, Yan; Muhamedijeva, Elena] Inst Informat & Computat Technol MES RK, Pushkin St 125, Alma Ata 050010, Kazakhstan.
   [Yakunin, Kirill; Mukhamediev, Ravil I.; Yelis, Marina; Symagulov, Adilkhan; Kuchin, Yan] Satbayev Univ, Inst Automat & Informat Technol, Satpayev St,22A, Alma Ata 050013, Kazakhstan.
   [Yakunin, Kirill] Almaty Management Univ, Sch Engn Management, Rozybakiev St 227, Alma Ata 050060, Kazakhstan.
   [Zaitseva, Elena; Levashenko, Vitaly] Univ Zilina, Fac Management Sci & Informat, Univ 8215-1, Zilina 01026, Slovakia.
   [Aubakirov, Margulan] Maharishi Int Univ, Dept Informat Technol, 1000 N 4th St, Fairfield, IA 52557 USA.
   [Gopejenko, Viktors] Ventspils Univ Appl Sci, Int Radio Astron Ctr, Inzhenieru St 101, LV-3601 Ventspils, Latvia.
   [Gopejenko, Viktors] ISMA Univ, Dept Nat Sci & Comp Technol, Lomonosov St 1, LV-1011 Riga, Latvia.
RP Mukhamediev, RI; Yelis, M; Kuchin, Y (corresponding author), Inst Informat & Computat Technol MES RK, Pushkin St 125, Alma Ata 050010, Kazakhstan.; Mukhamediev, RI; Yelis, M; Kuchin, Y (corresponding author), Satbayev Univ, Inst Automat & Informat Technol, Satpayev St,22A, Alma Ata 050013, Kazakhstan.; Zaitseva, E (corresponding author), Univ Zilina, Fac Management Sci & Informat, Univ 8215-1, Zilina 01026, Slovakia.
EM Yakunin.k@mail.ru; ravil.muhamedyev@gmail.com;
   elena.zaitseva@fri.uniza.sk; vitaly@kifri.fri.uniza.sk;
   k.marina92@gmail.com; a.symagulov@satbayev.university; ykuchin@mail.ru;
   muhamedijeva@gmail.com; margulan.aubakir@gmail.com;
   viktors.gopejenko@isma.lv
RI Aubakirov, Margulan/AAD-8102-2021; Zaitseva, Elena/F-9778-2017
OI Zaitseva, Elena/0000-0002-9087-0311; Kuchin, Yan/0000-0002-5271-9071;
   Symagulov, Adilkhan/0000-0001-9974-3215; Aubakirov,
   Margulan/0000-0002-9187-1500; Yakunin, Kirill/0000-0002-7378-9212
CR Abdulaziz M, 2021, INT J ADV COMPUT SC, V12, P626
   Angelov, 2020, ARXIV200809470
   Apuke OD, 2021, TELEMAT INFORM, V56, DOI 10.1016/j.tele.2020.101475
   Arroyo-Marioli F, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244474
   Aslam F, 2020, HUM SOC SCI COMMUN, V7, DOI 10.1057/s41599-020-0523-3
   Atun R, 2015, LANCET, V386, P721, DOI 10.1016/S0140-6736(14)62254-6
   Baldwin R., 2020, VOX CEPR POLICY PORT, P2
   Bandari R., 2012, ICWSM, V12, P26
   Barakhnin VB, 2019, BIZN INFORM, V13, P60, DOI 10.17323/1998-0663.2019.4.60.72
   Battineni G., 2020, APPL COMPUTING INFOR
   Bialecki A., 2012, P SIGIR 2012 WORKSH, V4, P17
   Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993
   Bushman B., 2012, ENCY HUMAN BEHAV, P571
   Bushman B.J., 2017, MEDIA INFLUENCE BEHA
   Campedelli GM, 2021, AM J CRIM JUSTICE, V46, P704, DOI 10.1007/s12103-020-09578-6
   Casero-Ripolles A, 2020, PROF INFORM, V29, DOI 10.3145/epi.2020.mar.23
   Chakraborty Arunava Kumar, 2021, Proceedings of Research and Applications in Artificial Intelligence. RAAI 2020. Advances in Intelligent Systems and Computing (AISC 1355), P75, DOI 10.1007/978-981-16-1543-6_7
   Chintalapudi N, 2021, INFECT DIS REP, V13, P329, DOI 10.3390/idr13020032
   Choudhary V., 2020, AUT AUT RES J, VXI, P398
   Daniel JE, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P948
   Divya M. S., 2013, COMPUSOFT, V2, P171
   Don W., 2015, INT ENCY SOCIAL BEHA, V3, P29
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Draganescu O., 2019, EIRP P, V13
   Fernandes N., 2020, SSRN ELECT J
   Gabrielyan D, 2020, 3RD INTERNATIONAL CONFERENCE ON ADVANCED RESEARCH METHODS AND ANALYTICS (CARMA 2020), P9, DOI 10.4995/CARMA2020.2020.11322
   Galanti T, 2021, J OCCUP ENVIRON MED, V63, pE426, DOI 10.1097/JOM.0000000000002236
   Gao JL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231924
   Ghasiya P, 2021, IEEE ACCESS, V9, P36645, DOI 10.1109/ACCESS.2021.3062875
   Giri SP, 2021, PERS INDIV DIFFER, V180, DOI 10.1016/j.paid.2021.110962
   Gupta Akash, 2021, Front Digit Health, V3, P686720, DOI 10.3389/fdgth.2021.686720
   Haleem Abid, 2020, Curr Med Res Pract, V10, P78, DOI 10.1016/j.cmrp.2020.03.011
   Hamidein Z, 2020, BASIC CLIN NEUROSCI, V11, P171, DOI 10.32598/bcn.11.covid19.809.2
   Jelodar H, 2019, MULTIMED TOOLS APPL, V78, P15169, DOI 10.1007/s11042-018-6894-4
   Jo W, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00425
   Kirill Y, 2020, PROCEDIA COMPUT SCI, V178, P205, DOI 10.1016/j.procs.2020.11.022
   Ko H, 2019, COGN SYST RES, V55, P77, DOI 10.1016/j.cogsys.2018.12.018
   Krasnov F, 2019, MACH LEARN KNOW EXTR, V1, DOI 10.3390/make1010025
   Kuchler Theresa, 2022, J Urban Econ, V127, P103314, DOI 10.1016/j.jue.2020.103314
   Lee JB, 2020, AM J SPEECH-LANG PAT, V29, P393, DOI [10.1044/2019_AJSLP-CAC48-18-0220, 10.1093/bioinformatics/btz682]
   Leombroni M, 2021, J FINANC ECON, V141, P860, DOI 10.1016/j.jfineco.2021.04.036
   Liu Yinhan, 2019, ARXIV190711692
   Luo F, 2020, WWW'20: COMPANION PROCEEDINGS OF THE WEB CONFERENCE 2020, P194, DOI 10.1145/3366424.3383539
   Miller D., 1998, INTRO MEDIA, P65
   Mimno D., 2011, P C EMP METH NAT LAN, P262
   Mukhamediev R.I., SIMPLIFIED SCIENTOME, V2021, P5541, DOI [10.3390/app11125541, DOI 10.3390/APP11125541]
   Mukhamediev RI, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12121945
   Mutanga MB, 2022, AFR J SCI TECHNOL IN, V14, P163, DOI 10.1080/20421338.2020.1817262
   Orlov E.M., 2010, BASIC RES, V10, P70
   Panch T, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.020303
   [Пархоменко П.А. Parhomenko P.A.], 2017, [Труды Института системного программирования РАН, Trudy Instituta sistemnogo programmirovaniya RAN], V29, P161, DOI 10.15514/ISPRAS-2017-29(2)-6
   Policy Research Information Service and Management, 2020, SOCIOECONOMIC IMPACT
   Ridhwan K.M., 2021, INT J INF MANAG DATA, V1, DOI [10.1016/j.jjimei.2021.100021, DOI 10.1016/J.JJIMEI.2021.100021]
   Segalovich I, 2003, MLMTA'03: INTERNATIONAL CONFERENCE ON MACHINE LEARNING; MODELS, TECHNOLOGIES AND APPLICATIONS, P273
   Song XY, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247086
   Sun KY, 2020, LANCET DIGIT HEALTH, V2, pE201, DOI 10.1016/S2589-7500(20)30026-1
   Tandoc EC, 2019, JOURNAL PRACT, V13, P178, DOI 10.1080/17512786.2017.1423237
   Tao G, 2020, IEEE INT CONF INF VI, P734, DOI 10.1109/IV51561.2020.00129
   Tasnim Samia, 2020, J Prev Med Public Health, V53, P171, DOI 10.3961/jpmph.20.094
   Tatar A, 2012, 2012 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), P106, DOI 10.1109/ASONAM.2012.28
   Tsao SF, 2021, LANCET DIGIT HEALTH, V3, pE175, DOI 10.1016/S2589-7500(20)30315-0
   [Воронцов Константин Вячеславович Vorontsov K.V.], 2012, [Компьютерные исследования и моделирование, Computer Research and Modeling, Komp'yuternye issledovaniya i modelirovanie], V4, P693
   Vorontsov K, 2015, COMM COM INF SC, V542, P370, DOI 10.1007/978-3-319-26123-2_36
   Xue J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239441
   Yakunin K. O., 2021, 2021 IEEE International Conference on Smart Information Systems and Technologies (SIST), DOI 10.1109/SIST50301.2021.9465884
   Yakunin K, 2021, DATA, V6, DOI 10.3390/data6030031
NR 66
TC 0
Z9 0
U1 4
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2079-3197
J9 COMPUTATION
JI Computation
PD DEC
PY 2021
VL 9
IS 12
AR 140
DI 10.3390/computation9120140
PG 23
WC Mathematics, Interdisciplinary Applications
WE Emerging Sources Citation Index (ESCI)
SC Mathematics
GA XW4TO
UT WOS:000735613900001
OA gold
DA 2022-04-20
ER

PT J
AU Vanhaecht, K
   Seys, D
   Bruyneel, L
   Cox, B
   Kaesemans, G
   Cloet, M
   Van den Broeck, K
   Cools, O
   De Witte, A
   Lowet, K
   Hellings, J
   Bilsen, J
   Lemmens, G
   Claes, S
AF Vanhaecht, Kris
   Seys, Deborah
   Bruyneel, Luk
   Cox, Bianca
   Kaesemans, Gorik
   Cloet, Margot
   Van den Broeck, Kris
   Cools, Olivia
   De Witte, Andy
   Lowet, Koen
   Hellings, Johan
   Bilsen, Johan
   Lemmens, Gilbert
   Claes, Stephan
TI COVID-19 is having a destructive impact on health-care workers' mental
   well-being
SO INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE
LA English
DT Article
DE professions; workforce and workload; COVID-19; mental health; corona;
   pandemic
ID MEDICAL STAFF; CHINA
AB Background The coronavirus disease 2019 (COVID-19) may aggravate workplace conditions that impact health-care workers' mental health. However, it can also place other stresses on workers outside of their work. This study determines the effect of COVID-19 on symptoms of negative and positive mental health and the workforce's experience with various sources of support. Effect modification by demographic variables was also studied. Methods A cross-sectional survey study, conducted between 2 April and 4 May 2020 (two waves), led to a convenience sample of 4509 health-care workers in Flanders (Belgium), including paramedics (40.6%), nurses (33.4%), doctors (13.4%) and management staff (12.2%). About three in four were employed in university and acute hospitals (29.6%), primary care practices (25.7%), residential care centers (21.3%) or care sites for disabled and mental health care. In each of the two waves, participants were asked how frequently (on a scale of 0-10) they experienced positive and negative mental health symptoms during normal circumstances and during last week, referred to as before and during COVID-19, respectively. These symptoms were stress, hypervigilance, fatigue, difficulty sleeping, unable to relax, fear, irregular lifestyle, flashback, difficulty concentrating, feeling unhappy and dejected, failing to recognize their own emotional response, doubting knowledge and skills and feeling uncomfortable within the team. Associations between COVID-19 and mental health symptoms were estimated by cumulative logit models and reported as odds ratios. The needed support was our secondary outcome and was reported as the degree to which health-care workers relied on sources of support and how they experienced them. Results All symptoms were significantly more pronounced during versus before COVID-19. For hypervigilance, there was a 12-fold odds (odds ratio 12.24, 95% confidence interval 11.11-13.49) during versus before COVID-19. Positive professional symptoms such as the feeling that one can make a difference were less frequently experienced. The association between COVID-19 and mental health was generally strongest for the age group 30-49 years, females, nurses and residential care centers. Health-care workers reported to rely on support from relatives and peers. A considerable proportion, respectively, 18 and 27%, reported the need for professional guidance from psychologists and more support from their leadership. Conclusions The toll of the crisis has been heavy on health-care workers. Those who carry leadership positions at an organizational or system level should take this opportunity to develop targeted strategies to mitigate key stressors of health-care workers' mental well-being.
C1 [Vanhaecht, Kris; Seys, Deborah; Bruyneel, Luk; Cox, Bianca] Univ Leuven, KU Leuven, Leuven Inst Healthcare Policy, Kapucijnenvoer 35, B-3000 Leuven, Belgium.
   [Kaesemans, Gorik; Cloet, Margot] Zorgnet Icuro, Brussels, Belgium.
   [Van den Broeck, Kris] Univ Antwerp, Dept Primary Care, Doornstr 331, B-2610 Antwerp, Belgium.
   [Cools, Olivia] KARUS Vzw, Melle, Belgium.
   [De Witte, Andy] GZA Hosp, Doctors4Doctors, Antwerp, Belgium.
   [Lowet, Koen] Flemish Assoc Clin Psychologists, Brussels, Belgium.
   [Hellings, Johan] Hasselt Univ, Fac Med & Life Sci, Martelarenlaan 42, BE-3500 Hasselt, Belgium.
   [Bilsen, Johan] VUB, Mental Hlth & Wellbeing Res Grp, Laarbeeklaan 103, B-1050 Brussels, Belgium.
   [Lemmens, Gilbert] Univ Ghent, Fac Med & Hlth Sci, Pintelaan 185, B-9000 Ghent, Belgium.
   [Claes, Stephan] Univ Leuven, KU Leuven, Dept Adult Psychiat, Herestr 49, B-3000 Leuven, Belgium.
RP Vanhaecht, K (corresponding author), Univ Leuven, KU Leuven, Leuven Inst Healthcare Policy, Kapucijnenvoer 35, B-3000 Leuven, Belgium.
EM Kris.vanhaecht@kuleuven.be
CR Babore A, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113366
   Balasubramanian A, 2020, HEAD NECK-J SCI SPEC, V42, P1638, DOI 10.1002/hed.26291
   Cai HZ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924171
   Chen QN, 2020, LANCET PSYCHIAT, V7, pE15, DOI 10.1016/S2215-0366(20)30078-X
   Dewey C, 2020, ANN INTERN MED, V172, P752, DOI 10.7326/M20-1033
   Dong ZQ, 2020, EUR PSYCHIAT, V63, DOI [10.1192/j.eurpsy.2020.59, 10.1145/3416315.3416316]
   Evanoff BA, 2020, J MED INTERNET RES, V22, DOI 10.2196/21366
   Fukuti P, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e1963
   Hou TY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233831
   Huang L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237303
   John Hopkins University Medicine,, MORT AN 2020
   Kang LJ, 2020, BRAIN BEHAV IMMUN, V87, P11, DOI 10.1016/j.bbi.2020.03.028
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Liang YM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186550
   Muller AE, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113441
   Ning XJ, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02838-z
   Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017
   Scott SD., 2010, AHRQ HLTH CARE INNOV
   Seys D, 2013, INT J NURS STUD, V50, P678, DOI 10.1016/j.ijnurstu.2012.07.006
   Shanafelt T, 2020, JAMA-J AM MED ASSOC, V323, P2133, DOI 10.1001/jama.2020.5893
   Shapiro J, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2024834
   Shechter A, 2020, GEN HOSP PSYCHIAT, V66, P1, DOI 10.1016/j.genhosppsych.2020.06.007
   Si MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00724-0
   Song LL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145059
   Spoorthy MS, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102119
   Tan BYQ, 2020, ANN INTERN MED, V173, P317, DOI 10.7326/M20-1083
   Tannenbaum SI, 2021, BMJ QUAL SAF, V30, P59, DOI 10.1136/bmjqs-2020-011447
   Thomas C., 2020, I PUBLIC POLICY RES
   Van Gerven E, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011403
   Vanhaecht K, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029923
   Walton M, 2020, EUR HEART J-ACUTE CA, V9, P241, DOI 10.1177/2048872620922795
   Wang LQ, 2020, J PSYCHIATR RES, V129, P198, DOI 10.1016/j.jpsychires.2020.07.008
   Wu AW, 2020, ANN INTERN MED, V172, P822, DOI 10.7326/M20-1236
   Zhang WR, 2020, PSYCHOTHER PSYCHOSOM, V89, P242, DOI 10.1159/000507639
NR 34
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1353-4505
EI 1464-3677
J9 INT J QUAL HEALTH C
JI Int. J. Qual. Health Care
PD FEB 20
PY 2021
VL 33
IS 1
AR mzaa158
DI 10.1093/intqhc/mzaa158
PG 6
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA ZO1HQ
UT WOS:000765478500035
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Bassendine, MF
   Bridge, SH
   McCaughan, GW
   Gorrell, MD
AF Bassendine, Margaret F.
   Bridge, Simon H.
   McCaughan, Geoffrey W.
   Gorrell, Mark D.
TI COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in
   disease severity?
SO JOURNAL OF DIABETES
LA English
DT Review
DE case fatality; COVID-19; dipeptidyl-peptidase IV inhibitors; metabolic
   syndrome; SARS-CoV-2
ID RESPIRATORY SYNDROME SARS; TYPE-2 DIABETES-MELLITUS; FATTY
   LIVER-DISEASE; ADENOSINE-DEAMINASE; MERS-COV; CORONAVIRUS RECEPTOR;
   TISSUE DISTRIBUTION; SPIKE GLYCOPROTEIN; RECENT INSIGHTS; CELL ENTRY
AB The coronavirus disease 2019 (COVID-19) pandemic is caused by a novel betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), similar to SARS-CoV and Middle East respiratory syndrome (MERS-CoV), which cause acute respiratory distress syndrome and case fatalities. COVID-19 disease severity is worse in older obese patients with comorbidities such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Cell binding and entry of betacoronaviruses is via their surface spike glycoprotein; SARS-CoV binds to the metalloprotease angiotensin-converting enzyme 2 (ACE2), MERS-CoV utilizes dipeptidyl peptidase 4 (DPP4), and recent modeling of the structure of SARS-CoV-2 spike glycoprotein predicts that it can interact with human DPP4 in addition to ACE2. DPP4 is a ubiquitous membrane-bound aminopeptidase that circulates in plasma; it is multifunctional with roles in nutrition, metabolism, and immune and endocrine systems. DPP4 activity differentially regulates glucose homeostasis and inflammation via its enzymatic activity and nonenzymatic immunomodulatory effects. The importance of DPP4 for the medical community has been highlighted by the approval of DPP4 inhibitors, or gliptins, for the treatment of type 2 diabetes mellitus. This review discusses the dysregulation of DPP4 in COVID-19 comorbid conditions; DPP4 activity is higher in older individuals and increased plasma DPP4 is a predictor of the onset of metabolic syndrome. DPP4 upregulation may be a determinant of COVID-19 disease severity, which creates interest regarding the use of gliptins in management of COVID-19. Also, knowledge of the chemistry and biology of DPP4 could be utilized to develop novel therapies to block viral entry of some betacoronaviruses, potentially including SARS-CoV-2.
C1 [Bassendine, Margaret F.; Bridge, Simon H.] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England.
   [Bridge, Simon H.] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne, Tyne & Wear, England.
   [McCaughan, Geoffrey W.; Gorrell, Mark D.] Centenary Inst, Sydney, NSW, Australia.
   [McCaughan, Geoffrey W.; Gorrell, Mark D.] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia.
RP Bassendine, MF (corresponding author), Newcastle Univ, Translat & Clin Res Inst, Med Sch, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM margaret.bassendine@ncl.ac.uk; simon.bridge@northumbria.ac.uk;
   g.mccaughan@centenary.usyd.edu.au; m.gorrell@centenary.usyd.edu.au
RI Gorrell, Mark Douglas/H-7231-2019; Gorrell, Mark/AAX-6394-2021
OI Gorrell, Mark Douglas/0000-0002-0528-2604; Bridge,
   Simon/0000-0002-6212-3255
FU National Medical Research CouncilUK Research & Innovation (UKRI)Medical
   Research Council UK (MRC); Northumbria University; Action Medical
   Research
FX National Medical Research Council; Northumbria University; Action
   Medical Research
CR Abbott CA, 1999, EUR J BIOCHEM, V266, P798, DOI 10.1046/j.1432-1327.1999.00902.x
   Aemaimanan P, 2009, J PERIODONTOL, V80, P1809, DOI 10.1902/jop.2009.090233
   [Anonymous], 2019, VIRUSES BASEL, DOI DOI 10.3390/v11030280
   Antonioli L, 2019, IMMUNOL LETT, V205, P9, DOI 10.1016/j.imlet.2018.04.006
   Badawi A, 2016, INT J INFECT DIS, V49, P129, DOI 10.1016/j.ijid.2016.06.015
   Baumeier C, 2017, MOL METAB, V6, P1254, DOI 10.1016/j.molmet.2017.07.016
   Baumeier C, 2017, DIABETES, V66, P25, DOI 10.2337/db15-1716
   Beraldo JI, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081940
   Birnbaum Y, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2016-000227
   Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594
   Chen GH, 2020, J MED VIROL, V92, P3743, DOI 10.1002/jmv.25670
   Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]
   Cook SJ, 2018, IMMUNOL CELL BIOL, V96, P1131, DOI 10.1111/imcb.12186
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Earnest JT, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006546
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Fujihara K, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006122
   Gallwitz B, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00389
   Ghorpade DS, 2018, NATURE, V555, P673, DOI 10.1038/nature26138
   Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10
   Gorrell MD, 2005, CLIN SCI, V108, P277, DOI 10.1042/CS20040302
   Gorrell MD, 2001, SCAND J IMMUNOL, V54, P249, DOI 10.1046/j.1365-3083.2001.00984.x
   Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Itou M, 2013, WORLD J GASTROENTERO, V19, P2298, DOI 10.3748/wjg.v19.i15.2298
   Jiang L, 2014, ARTHRITIS RHEUMATOL, V66, P1121, DOI 10.1002/art.38353
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kagal Urmila Anil, 2017, Int J Appl Basic Med Res, V7, P26, DOI 10.4103/2229-516X.198516
   Kim KM, 2017, GENE DEV, V31, P1529, DOI 10.1101/gad.302570.117
   Kim YI, 2020, CELL HOST MICROBE, V27, P704, DOI 10.1016/j.chom.2020.03.023
   Kirby M, 2010, CLIN SCI, V118, P31, DOI 10.1042/CS20090047
   Kirino Y, 2012, ENDOCR J, V59, P949, DOI 10.1507/endocrj.EJ12-0158
   Kleine-Weber H, 2020, EMERG MICROBES INFEC, V9, P155, DOI 10.1080/22221751.2020.1713705
   Kushwaha RN, 2014, CURR MED CHEM, V21, P4013, DOI 10.2174/0929867321666140915143309
   Lam TTY, 2020, NATURE, V583, P282, DOI 10.1038/s41586-020-2169-0
   Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707
   Letko Michael, 2020, bioRxiv, DOI 10.1101/2020.01.22.915660
   Letko M, 2018, CELL REP, V24, P1730, DOI 10.1016/j.celrep.2018.07.045
   Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9
   Li XX, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00449
   Makdissi A, 2012, J CLIN ENDOCR METAB, V97, P3333, DOI 10.1210/jc.2012-1544
   Mandl JN, 2015, CELL, V160, P20, DOI 10.1016/j.cell.2014.12.003
   Mehta Puja, 2020, Lancet, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Meyerholz DK, 2016, AM J PATHOL, V186, P78, DOI 10.1016/j.ajpath.2015.09.014
   Nistala R, 2017, AM J PHYSIOL-RENAL, V312, pF661, DOI 10.1152/ajprenal.00316.2016
   Noels H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00058
   Oh MD, 2016, NEW ENGL J MED, V375, P1303, DOI 10.1056/NEJMc1511695
   Pang ZD, 2014, P NATL ACAD SCI USA, V111, pE1256, DOI 10.1073/pnas.1322009111
   Park YJ, 2019, NAT STRUCT MOL BIOL, V26, P1151, DOI 10.1038/s41594-019-0334-7
   Peck KM, 2017, J VIROL, V91, DOI 10.1128/JVI.00534-17
   Qi FR, 2020, BIOCHEM BIOPH RES CO, V526, P135, DOI 10.1016/j.bbrc.2020.03.044
   Ragab D, 2013, CYTOKINE, V63, P105, DOI 10.1016/j.cyto.2013.04.016
   Rainczuk A, 2014, INT J CANCER, V134, P530, DOI 10.1002/ijc.28393
   Raj VS, 2014, J VIROL, V88, P1834, DOI 10.1128/JVI.02935-13
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Rodriguez-Morales Alfonso J, 2020, Travel Med Infect Dis, V34, P101623, DOI 10.1016/j.tmaid.2020.101623
   Romacho T, 2020, AM J PHYSIOL-ENDOC M, V318, pE590, DOI 10.1152/ajpendo.00323.2019
   Saussenthaler S, 2019, J NUTR BIOCHEM, V63, P109, DOI 10.1016/j.jnutbio.2018.09.025
   Schuppan D, 2010, LIVER INT, V30, P795, DOI 10.1111/j.1478-3231.2010.02264.x
   Seys LJM, 2018, CLIN INFECT DIS, V66, P45, DOI 10.1093/cid/cix741
   Sharma PK, 2015, IMMUNOLOGY, V145, P443, DOI 10.1111/imm.12461
   Simmons G, 2013, ANTIVIR RES, V100, P605, DOI 10.1016/j.antiviral.2013.09.028
   Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831
   Smith RE, 1998, AIDS RES HUM RETROV, V14, P851, DOI 10.1089/aid.1998.14.851
   Stengel A, 2014, PEPTIDES, V61, P75, DOI 10.1016/j.peptides.2014.09.006
   Tacelli M, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11040121
   Tang SM, 2017, COMPUT MATH METHOD M, V2017, DOI 10.1155/2017/5285810
   To KF, 2004, J PATHOL, V203, P740, DOI 10.1002/path.1597
   Tomovic K, 2019, MED RES REV, V39, P404, DOI 10.1002/med.21513
   Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760
   Vankadari N, 2020, EMERG MICROBES INFEC, V9, P601, DOI 10.1080/22221751.2020.1739565
   Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036
   Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000
   Wang TB, 2020, LANCET, V395, pE52, DOI 10.1016/S0140-6736(20)30558-4
   Widagdo W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01290-6
   Williams KH, 2015, J DIABETES, V7, P809, DOI 10.1111/1753-0407.12237
   Wolke C, 2017, EXP BIOL MED, V242, P554, DOI 10.1177/1535370216684040
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092222
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017
   Yu DMT, 2011, SCAND J IMMUNOL, V73, P102, DOI 10.1111/j.1365-3083.2010.02488.x
   Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071
   Zheng TP, 2017, METABOLISM, V73, P125, DOI 10.1016/j.metabol.2017.04.012
   Zhong JX, 2015, CIRC RES, V116, P1491, DOI 10.1161/CIRCRESAHA.116.305665
   Zhong JX, 2013, DIABETES, V62, P149, DOI 10.2337/db12-0230
   Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2
   Zhou Y, 2015, ANTIVIR RES, V116, P76, DOI 10.1016/j.antiviral.2015.01.011
NR 88
TC 60
Z9 63
U1 7
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1753-0393
EI 1753-0407
J9 J DIABETES
JI J. Diabetes
PD SEP
PY 2020
VL 12
IS 9
BP 649
EP 658
DI 10.1111/1753-0407.13052
EA MAY 2020
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA MV4ZA
UT WOS:000535605300001
PM 32394639
OA Green Published, Green Accepted
DA 2022-04-20
ER

PT J
AU Rahman, MA
   Khudri, MM
   Kamran, M
   Butt, P
AF Rahman, Md Arafat
   Khudri, Md Mohsan
   Kamran, Muhammad
   Butt, Pakeezah
TI A note on the relationship between COVID-19 and stock market return:
   evidence from South Asia
SO INTERNATIONAL JOURNAL OF ISLAMIC AND MIDDLE EASTERN FINANCE AND
   MANAGEMENT
LA English
DT Article; Early Access
DE COVID-19; Cross-sectional dependence; Stock markets; Causality; South
   Asia
ID UNIT-ROOT TESTS; ENERGY-CONSUMPTION; PANEL-DATA; EVENT
AB Purpose The transformation of coronavirus disease (COVID-19) from a regional health crisis in a Chinese city to a global pandemic has caused severe damage not only to the natural and economic lives of human beings but also to the financial markets. The rapidly pervading and daunting consequences of COVID-19 spread have plummeted the stock markets to their lowest levels in many decades especially in South Asia. This concern motivates us to investigate the stock markets' response to the COVID-19 pandemic in four South Asian countries: Bangladesh, India, Pakistan and Sri Lanka. This study aims to investigate the causal impact of the number of confirmed COVID-19 cases on stock market returns using panel data of the countries stated above. Design/methodology/approach This study collects and analyzes the daily data on COVID-19 spread and stock market return over the period May 28, 2020 to October 01, 2020. Using Dumitrescu and Hurlin panel Granger non-causality test, the empirical results demonstrate that the COVID-19 spread measured through its daily confirmed cases in a country significantly induces stock market return. This paper cross-validates the results using the pairwise Granger causality test. Findings The empirical results suggest unidirectional causality from COVID-19 to stock market returns, indicating that the spread of COVID-19 has a dominant short-term influence on the stock movements. To the best of the knowledge, this study provides the first empirical insights into the impact of COVID-19 on the stock markets of selected South Asian countries taking the cross-sectional dependence into account. The results are also in line with the findings of other existing literature on COVID-19. Moreover, the results are robust across the two tests used in this study. Originality/value The findings are equally insightful to the fund managers and investors in South Asian countries. Taking into account the possible impact of COVID-19 on stock markets' returns, investors can design their optimal portfolios more effectively. This study has another important implication in the sense that the impact of COVID-19 on the stock markets of South Asian countries may have spillover effects on other developing or even developed countries.
C1 [Rahman, Md Arafat] Macquarie Univ, Dept Econ, N Ryde, Australia.
   [Khudri, Md Mohsan] Univ Memphis, Fogelman Coll Business & Econ, Dept Econ, Memphis, TN USA.
   [Kamran, Muhammad; Butt, Pakeezah] Edith Cowan Univ, Sch Business & Law, Joondalup, Australia.
RP Rahman, MA (corresponding author), Macquarie Univ, Dept Econ, N Ryde, Australia.
EM arafat.rahman@hdr.mq.edu.au
RI Khudri, Md Mohsan/T-3660-2017
OI Khudri, Md Mohsan/0000-0003-4960-2259; , MUHAMMAD
   KAMRAN/0000-0002-3122-6681
CR Adrian T, 2019, J FINANC, V74, P1931, DOI 10.1111/jofi.12776
   Al-Awadhi AM, 2020, J BEHAV EXP FINANC, V27, DOI 10.1016/j.jbef.2020.100326
   Alber, 2020, EFFECT CORONAVIRUS S, DOI [10.2139/ssrn.3578080, DOI 10.2139/SSRN.3578080]
   Alfaro L., 2020, AGGREGATE FIRM LEVEL
   Ashraf, 2020, RES INT BUS FINANC, P101249, DOI 10.1016/j.ribaf.2020.101249
   Ashraf BN, 2020, J BEHAV EXP FINANC, V27, DOI 10.1016/j.jbef.2020.100371
   Asian Development Bank, 2020, ACC FIN INCL S E DIG
   Baker SR, 2020, REV ASSET PRICING ST, V10, P742, DOI 10.1093/rapstu/raaa008
   Bateman, 2020, BBC NEWS
   Baubeau P, 2021, ECON HIST REV, V74, P223, DOI 10.1111/ehr.12972
   Ben Jebli M, 2015, AFR DEV REV, V27, P288, DOI 10.1111/1467-8268.12147
   Ben-Rephael A, 2017, J FINANC INTERMED, V31, P30, DOI 10.1016/j.jfi.2017.05.002
   BREUSCH TS, 1980, REV ECON STUD, V47, P239, DOI 10.2307/2297111
   Brueckner Markus., 2020, SSRN ELECT J, DOI [10.2139/ssrn.3624676, DOI 10.2139/SSRN.3624676]
   Buheji M. etal, 2020, AM J EC, V10, P213, DOI [10.5923/j.economics.20201004.02, DOI 10.5923/J.ECONOMICS.20201004.02]
   Carlsson-Szlezak P., 2020, HARVARD BUS REV
   Chalise H.N., 2020, ARCH PSYCHIAT MENTAL, V4, P46, DOI DOI 10.29328/JOURNAL.APMH.1001018
   Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757
   Cho JW, 2016, J BANK FINANC, V62, P191, DOI 10.1016/j.jbankfin.2014.09.003
   Chulia H, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101515
   Dumitrescu EI, 2012, ECON MODEL, V29, P1450, DOI 10.1016/j.econmod.2012.02.014
   Dunford D., 2020, BBC NEWS 0407
   Edmans A, 2007, J FINANC, V62, P1967, DOI 10.1111/j.1540-6261.2007.01262.x
   Gangopadhyay P., 2010, J INSUR ISS, V33, P132
   Gates B, 2020, NEW ENGL J MED, V382, P1677, DOI 10.1056/NEJMp2003762
   Goodell JW, 2020, FINANC RES LETT, V35, DOI 10.1016/j.frl.2020.101512
   Gunay S., 2020, NEW FORM FINANCIAL C
   Harjoto MA, 2021, APPL ECON LETT, V28, P795, DOI 10.1080/13504851.2020.1781767
   Hassan M.K., 2021, GLOB FINANC J, P100643, DOI [10.1016/J.GFJ.2021.100643, DOI 10.1016/J.GFJ.2021.100643, 10.1016/j.gfj.2021.100643]
   He PL, 2020, EMERG MARK FINANC TR, V56, P2198, DOI 10.1080/1540496X.2020.1785865
   He Q, 2020, ECON POLIT STUD-EPS, V8, P275, DOI 10.1080/20954816.2020.1757570
   Hevia C., 2020, COVID 19 DEV EC, V1, P25
   Heyden KJ, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101745
   Hirshleifer D, 2003, J FINANC, V58, P1009, DOI 10.1111/1540-6261.00556
   Horton R, 2020, LANCET, V395, P1410, DOI 10.1016/S0140-6736(20)31017-5
   Im KS, 2003, J ECONOMETRICS, V115, P53, DOI 10.1016/S0304-4076(03)00092-7
   Kaplanski G, 2010, J FINANC ECON, V95, P174, DOI 10.1016/j.jfineco.2009.10.002
   Kelly, 2020, INVESTMENT IMPLICATI
   Kinateder H, 2021, FINANC RES LETT, V43, DOI 10.1016/j.frl.2021.101951
   Kowalewski O, 2020, J COMMOD MARK, V20, DOI 10.1016/j.jcomm.2020.100124
   Lepori GM, 2016, J EMPIR FINANC, V35, P25, DOI 10.1016/j.jempfin.2015.10.008
   Levin A, 2002, J ECONOMETRICS, V108, P1, DOI 10.1016/S0304-4076(01)00098-7
   Liu HY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082800
   Maddala GS, 1999, OXFORD B ECON STAT, V61, P631, DOI 10.1111/1468-0084.61.s1.13
   Mckee M, 2020, NAT MED, V26, P640, DOI 10.1038/s41591-020-0863-y
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Okorie DI, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101640
   Onali E., 2020, COVID 19 STOCK MARKE, DOI 10.2139/ssrn.3571453
   Pandey DK, 2021, INT REV ECON FINANC, V71, P467, DOI 10.1016/j.iref.2020.09.014
   Papadamou S, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101852
   Pesaran MH, 2007, J APPL ECONOMET, V22, P265, DOI 10.1002/jae.951
   Pesaran MH, 2021, EMPIR ECON, V60, P13, DOI 10.1007/s00181-020-01875-7
   Ramelli S, 2020, REV CORP FINANC STUD, V9, P622, DOI 10.1093/rcfs/cfaa012
   Saud S, 2020, J CLEAN PROD, V250, DOI 10.1016/j.jclepro.2019.119518
   Sharma GD, 2020, J PUBLIC AFF, V20, DOI 10.1002/pa.2195
   Le TPTD, 2021, J ASIAN FINANC ECON, V8, P759, DOI 10.13106/jafeb.2021.vol8.no2.0759
   Topcu M, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101691
   Tugcu CT, 2018, ECONOMICS AND ECONOMETRICS OF THE ENERGY-GROWTH NEXUS, P255, DOI 10.1016/B978-0-12-812746-9.00008-0
   Tugcu CT, 2016, RENEW SUST ENERG REV, V65, P610, DOI 10.1016/j.rser.2016.07.016
   van Hoek R, 2020, INT J OPER PROD MAN, V40, P341, DOI 10.1108/IJOPM-03-2020-0165
   Wang CY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16256-y
   Wang W., 2020, SSRN ELECT J, DOI DOI 10.2139/SSRN.3588021
   World Bank, 2008, GLOBAL ECONOMIC PROSPECTS: TECHNOLOGY DIFFUSION IN THE DEVELOPING WORLD, P1, DOI 10.1596/978-0-8213-7365-1
   Worldometer, 2020, AG SEX EX COND COV 1
   Yarovaya L., 2020, SEARCHING SAFE HAVEN
   Zhang DY, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101528
NR 66
TC 3
Z9 3
U1 4
U2 6
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1753-8394
EI 1753-8408
J9 INT J ISLAMIC MIDDLE
JI Int.J. Islamic Middle Eastern Finance Manag.
DI 10.1108/IMEFM-03-2021-0124
EA AUG 2021
PG 13
WC Business, Finance; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA UJ4XN
UT WOS:000691290000001
OA Bronze, Green Submitted
DA 2022-04-20
ER

PT J
AU Dang, HA
   Lanjouw, P
   Vrijburg, E
AF Dang, Hai-Anh
   Lanjouw, Peter
   Vrijburg, Elise
TI Poverty in India in the face of Covid-19: Diagnosis and prospects*
SO REVIEW OF DEVELOPMENT ECONOMICS
LA English
DT Article
DE Covid-19; India; poverty; poverty dynamics; synthetic panels;
   vulnerability
AB India has been hard-hit by the Covid-19 pandemic. The virus has exacted a heavy toll in terms of lives lost and deteriorating health outcomes. The economic consequences of the pandemic have been similarly grim. In this paper we attempt an initial, interim, assessment of the impacts of the crisis on poverty. We review the growing literature that considers emerging poverty impacts, noting that there remain significant knowledge gaps due to limited evidence on current welfare outcomes. We analyze pre-Covid survey data to examine the incidence of chronic poverty and downward mobility during a period of rapid economic growth and declining poverty. A profile of poverty during such a period might offer a plausible, partial, window on population groups currently at risk. We suggest that, notwithstanding the severe initial impacts of the crisis on poverty, there are grounds for expecting further consequences going forward. As the virus has spread out of the relatively affluent cities, and as economic stagnation persists, rural areas, with historically higher rates of chronic poverty and vulnerability, may see particularly sharp increases in poverty. While recent vaccination developments offer some grounds for optimism, there remains an urgent need to identify, implement and amplify effective policy alleviation measures.
C1 [Dang, Hai-Anh] World Bank, Dev Data Grp, 1818 H St NW, Washington, DC 20433 USA.
   [Lanjouw, Peter; Vrijburg, Elise] Vrije Univ, Dept Econ, Amsterdam, Netherlands.
RP Lanjouw, P (corresponding author), Vrije Univ Amsterdam, Sch Business & Econ, Dept Econ, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.
EM p.f.lanjouw@vu.nl
OI Lanjouw, Peter/0000-0002-4150-7890
FU Oxford Policy Management
FX Oxford Policy Management
CR Agarwal V, 2021, INDIAS MIGRANTS FLEE
   Agrawal P, 2020, BIHARS MIGRANTS RETU
   Akoijam B.S., 2017, INT J MIG BORDER STU, V3, P328, DOI DOI 10.1504/IJMBS.2017.086963
   [Anonymous], 2021, INDIAN EXPRESS
   [Anonymous], 2021, ECONOMIST
   [Anonymous], 2020, HINDUSTAN TIMES
   Ashwini D, 2020, 607 GLO
   Azim Premji University,, 2021, IMP COVID 19 LIV INF
   Azim Premji University, COVID19 AN IMP REL M
   Azim Premji University,, 2021, REV EMPL LIV IND COV
   Barcellos SH, 2014, AM ECON J-APPL ECON, V6, P157, DOI 10.1257/app.6.1.157
   Basole A., 2020, 202001 CSE
   Beyer RCM, 2021, WORLD DEV, V140, DOI 10.1016/j.worlddev.2020.105287
   Ceballos F, 2020, WORLD DEV, V136, DOI 10.1016/j.worlddev.2020.105069
   Centre for Monitoring Indian Economy, 2020, UNH REC
   Chatterjee M, 2016, FOR PUBL PRIV PARTN, P30
   Chaudhuri S, 2003, ASSESSING VULNERABIL
   Chishti S, 2020, EXPLAINED MANY MIGRA
   Dang HAH, 2017, REV INCOME WEALTH, V63, P633, DOI 10.1111/roiw.12237
   Datt G, 2011, WORLD BANK ECON REV, V25, P157, DOI 10.1093/wber/lhr002
   Dhanaraj S., 2014, 2014003 WIDER
   Elbers C, 2021, NOTE SYNTHETIC PANEL
   Express News Service, 2020, EXPL WHAT AR CONT ZO
   Express Web Desk, 2020, COR MAY 19 HIGHL REC
   Ganguly S, 2020, INDIAS CORONAVIRUS P
   Gangwar HS, 2021, INT J INFECT DIS, V105, P424, DOI 10.1016/j.ijid.2021.02.070
   Garces-Urzainqui D, 2021, REV DEV ECON, V25, P1803, DOI 10.1111/rode.12832
   Gettleman J., 2020, INDIA DAY 1 WORLDS L
   Ghosh D, 2017, ADV FINANC ACCOUNT E, P99, DOI 10.4018/978-1-5225-2364-2.ch006
   Global Hunger Index, 2010, CHALL HUNG FOC CRIS
   GN Thejesh, 2020, NONVIRUS DEATHS
   Gu?rin I., 2020, COVID 19 CRISIS INDI
   Herault N, 2019, J ECON INEQUAL, V17, P51, DOI 10.1007/s10888-019-09408-8
   Home Secretary, 2020, DO 40 10 2020 DM 1 A
   IMS Institute for Healthcare Informatics, 2013, UNDERSTANDING HLTH
   International Labour Organisation, 2018, WOM MEN INF EC STAT
   Iyer M., 2020, MIGRATION INDIA IMPA
   Jamkhandikar S., 2021, COVID 19 SPREADS RUR
   John Hopkins University Center for Systems Science and Engineering, 2021, COVID 19 DASHB CTR S
   LaForgia G, 2012, DIR DEV, P1, DOI 10.1596/978-0-8213-9618-6
   Lanjouw, 2018, 2018175 WIDER UNU
   Maggo, 2020, IMPACT COVID 19 SMAL
   Menon S., 2020, CORONAVIRUS IS INDIA
   Michiels S., 2020, 20009 CEB
   Ministry of Home Affairs, 2020, 4032020DMIA MIN HOM
   Ministry of Labour Employment, 2015, NAT CLASS OCC 2015 C, V1
   Ministry of Panchayati Raj, BACKW REG GRANT FUND
   Ministry of Statistics Programme Implementation, 2015, 56368104 NSS MIN STA
   Naik M., 2021, PANDEMICS 2 WAVE RAG
   Narayanan A., 2015, INDIAN J LABOUR EC, V58, P119, DOI [10.1007/s41027-015-0009-9, DOI 10.1007/S41027-015-0009-9]
   National Commision for Enterprises in the Unorganised Sector (NCEUS), 2007, REP COND WORK PROM L
   National Commission for Enterprises in the Unorganised Sector,, 2009, CHALL EMPL IND INF E, V1
   Oster E., 2006, 12743 NBER
   Our World in Data, 2021, DAIL NEW CONF COV 19
   Our World in Data, 2021, CUM CONF COVID 19 CA
   Our World in Data, 2021, DAIL TESTS 1000 PEOP
   OxCGRT, REL NUMB COVID 19 CA
   Pais J., 2020, SSER MONOGRAPH
   Pandya A.A., 2010, MUSLIM INDIANS STRUG
   Post Sachar Evaluation Committee, 2014, POSTS EV COMM REP
   Raghunathan M.N, 2020, FIGHTING GENDER INEQ
   Ravallion M, 2012, WORLD BANK RES OBSER, V27, P1, DOI 10.1093/wbro/lkr009
   Sengupta Sohini., 2020, INT J COMMUNITY SOCI, V2, P152
   Seth A., 2020, POSTLOCKDOWN STATE L
   Sharma M, 2020, JOB WAGE LOSSES INFO
   Singh B.B., 2021, 207 ZEF
   Singh S, 2020, T INDIAN I METALS, V73, P2747, DOI 10.1007/s12666-020-02070-z
   Sinha A., 2021, 2 WAVE COVID HITS RU
   Sinha S, 2020, POLICY RES WORKING P
   Srivastava R., 2020, UNDERSTANDING CIRCUL
   Subramanian S., 2020, INDIAS LOCKDOWN INTE
   Sumarto S, 2000, WORLD BANK POLICY RE
   Tikkanen R, 2020, INT HLTH CARE SYSTEM
   Unni J, 2003, DEV CHANGE, V34, P127, DOI 10.1111/1467-7660.00299
   Vijayamba R., 2020, IMPACT COVID 19 PAND
   WHO, 2020, NOV COR 2019 NCOV SI
   World Economic Forum, 2020, GLOBAL GENDER GAP RE
   Yeung, 2021, INDIAS 2 WAVE IS RAV
NR 78
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1363-6669
EI 1467-9361
J9 REV DEV ECON
JI Rev. Dev. Econ.
PD NOV
PY 2021
VL 25
IS 4
BP 1816
EP 1837
DI 10.1111/rode.12833
EA OCT 2021
PG 22
WC Development Studies; Economics
WE Social Science Citation Index (SSCI)
SC Development Studies; Business & Economics
GA WV5NC
UT WOS:000702710600001
PM 34908902
OA Green Published
DA 2022-04-20
ER

PT J
AU Cherri, S
   Noventa, S
   Fanelli, M
   Calandra, G
   Prochilo, T
   Bna, C
   Savelli, G
   Zaniboni, A
AF Cherri, Sara
   Noventa, Silvia
   Fanelli, Martina
   Calandra, Giulio
   Prochilo, Tiziana
   Bna, Claudio
   Savelli, Giordano
   Zaniboni, Alberto
TI Drug-Related Pneumonitis in Cancer Treatment during the COVID-19 Era
SO CANCERS
LA English
DT Review
DE lung toxicity; interstitial lung disease; pneumonitis; cancer treatment;
   target therapy; chemotherapy; immunotherapy; COVID-19
ID INTERSTITIAL LUNG-DISEASE; RENAL-CELL CARCINOMA; BLEOMYCIN-INDUCED
   PNEUMONITIS; IMMUNE CHECKPOINT INHIBITORS; PULMONARY TOXICITY;
   DOUBLE-BLIND; TARGETED THERAPIES; PHASE-II; CHEMOTHERAPY; TRASTUZUMAB
AB Simple Summary
   Interstitial lung disease is a group of diseases characterized by chronic lung inflammation that can be related to oncological treatments, such as traditional chemotherapy drugs and the newest targeted therapies and immunotherapies. Awareness about this potentially fatal adverse event is paramount in patient management and to make a conscious therapeutic choice. It represents a differential diagnostic challenge, especially in the context of the COVID-19 pandemic. Our aim is to describe the incidence and characteristics of this adverse event across oncological treatment groups and to promote greater knowledge about this important toxicity.
   Interstitial lung disease is recognized as a group of diseases with a different etiopathogenesis characterized by chronic lung inflammation with the accumulation of inflammatory cells, lymphocytes and macrophages, and the consequent release of proinflammatory cytokines. Various degrees of pulmonary fibrosis can be associated with this inflammatory condition. Interstitial lung disease related to oncological drugs is a relevant problem in clinical practice. The etiopathogenetic mechanisms underlying this adverse event are not completely known but can be partly explained by the mechanism of action of the drug involved. Therefore, knowledge of the relevance of this potentially fatal adverse event supported by the reported safety data of pivotal studies becomes fundamental in the management of patients. The prompt diagnosis of drug-related pneumonia and the consequent differential diagnosis with other forms of pneumonia allow a rapid suspension of treatment and the establishment of an immunosuppressive treatment if necessary. In the context of the health emergency related to SARS CoV2 infection and COVID-19-related interstitial lung disease, such knowledge holds decisive relevance in the conscious choice of cancer treatments. Our intent was to describe the oncological drugs most correlated with this adverse event by reporting, where possible, the percentages of insurgency in pivotal studies to provide an overview and therefore promote greater awareness of this important toxicity related to oncological treatment.
C1 [Cherri, Sara; Noventa, Silvia; Prochilo, Tiziana; Zaniboni, Alberto] Fdn Poliambulanza, Dept Oncol, Unit Med Oncol, I-25124 Brescia, Italy.
   [Fanelli, Martina] Univ Hosp Modena, Med Oncol Unit, I-41124 Modena, Italy.
   [Calandra, Giulio; Bna, Claudio] Fdn Poliambulanza, Dept Diagnost Imaging, Unit Radiol, I-25124 Brescia, Italy.
   [Savelli, Giordano] Fdn Poliambulanza, Nucl Med Dept, I-25124 Brescia, Italy.
RP Prochilo, T (corresponding author), Fdn Poliambulanza, Dept Oncol, Unit Med Oncol, I-25124 Brescia, Italy.
EM sara.cherri@poliambulanza.it; silvia.noventa@poliambulanza.it;
   martinafun89@gmail.com; giulio.calandra@poliambulanza.it;
   tiziana.prochilo@poliambulanza.it; claudio.bna@poliambulanza.it;
   giordano.savelli@poliambulanza.it; alberto.zaniboni@poliambulanza.it
RI ; Savelli, Giordano/G-6449-2018
OI NOVENTA, SILVIA/0000-0001-7423-6065; Savelli,
   Giordano/0000-0002-4898-7647; Cherri, Sara/0000-0001-7062-8723
CR Abid SH, 2001, CURR OPIN ONCOL, V13, P242, DOI 10.1097/00001622-200107000-00006
   Akinleye A, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0779-5
   Alvarez RH, 2018, ONCOLOGIST, V23, P660, DOI 10.1634/theoncologist.2017-0343
   Andre F, 2019, NEW ENGL J MED, V380, P1929, DOI 10.1056/NEJMoa1813904
   Antonia SJ, 2018, NEW ENGL J MED, V379, P2342, DOI 10.1056/NEJMoa1809697
   Arora R, 2019, CURR ONCOL, V26, pE700, DOI 10.3747/co.26.5399
   Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185
   BAKER WJ, 1990, CANCER, V65, P2217, DOI 10.1002/1097-0142(19900515)65:10<2217::AID-CNCR2820651009>3.0.CO;2-R
   Barber NA, 2011, TARGET ONCOL, V6, P235, DOI 10.1007/s11523-011-0199-0
   Barlesi F, 2004, FUND CLIN PHARMACOL, V18, P85, DOI 10.1046/j.0767-3981.2003.00206.x
   Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653
   Basu S, 2011, MOL IMAGING BIOL, V13, P1051, DOI 10.1007/s11307-010-0459-x
   Bedi S, 2018, SAUDI PHARM J, V26, P755, DOI 10.1016/j.jsps.2018.04.010
   Bellmunt J, 2008, ANN ONCOL, V19, P1387, DOI 10.1093/annonc/mdn066
   Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683
   Bielopolski D, 2017, J CHEMOTHERAPY, V29, P113, DOI 10.1179/1973947815Y.0000000029
   Blank CU, 2015, INT IMMUNOL, V27, P3, DOI 10.1093/intimm/dxu076
   Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643
   Boyle HJ, 2012, EUR RESPIR J, V40, P1300, DOI 10.1183/09031936.00048212
   Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627
   Brahmer JR, 2018, J CLIN ONCOL, V36, P1714, DOI 10.1200/JCO.2017.77.6385
   Buchler T, 2007, HAEMATOLOGICA, V92, pE120, DOI 10.3324/haematol.11856
   Burtness B, 2019, LANCET, V394, P1915, DOI 10.1016/S0140-6736(19)32591-7
   Chan A, 2016, LANCET ONCOL, V17, P367, DOI 10.1016/S1470-2045(15)00551-3
   Chua W, 2009, CLIN COLORECTAL CANC, V8, P118, DOI 10.3816/CCC.2009.n.019
   Cohen EEW, 2019, LANCET, V393, P156, DOI 10.1016/S0140-6736(18)31999-8
   Costa R, 2017, CASE REP ONCOL, V10, P524, DOI 10.1159/000477340
   Crequit P, 2015, J THORAC ONCOL, V10, P1148, DOI 10.1097/JTO.0000000000000577
   D'Elia Tommaso, 2014, Inflammation & Allergy Drug Targets, V13, P25
   Dabydeen DA, 2012, EUR J CANCER, V48, P1519, DOI 10.1016/j.ejca.2012.03.012
   Delanoy N, 2015, INT J GYNECOL CANCER, V25, P1593, DOI 10.1097/IGC.0000000000000530
   Ding PN, 2017, J THORAC ONCOL, V12, P633, DOI 10.1016/j.jtho.2016.11.2236
   Distefano G, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10040244
   Duzgun SA, 2020, INSIGHTS IMAGING, V11, DOI 10.1186/s13244-020-00933-z
   Eggermont AMM, 2018, NEW ENGL J MED, V378, P1789, DOI 10.1056/NEJMoa1802357
   EMA, PROD INF IP
   EMA, PRESCR INF EV
   Endoh H, 2021, CLIN LUNG CANCER, V22, P218, DOI 10.1016/j.cllc.2020.05.002
   Erickson BJ, 2017, RADIOGRAPHICS, V37, P505, DOI 10.1148/rg.2017160130
   FDA, 2019, HIGHL PRESCR INF ALP
   Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252
   Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421
   Fragoulis GE, 2019, RHEUMATOLOGY, V58, P1900, DOI 10.1093/rheumatology/kez337
   Friedman CF, 2016, JAMA ONCOL, V2, P1346, DOI 10.1001/jamaoncol.2016.1051
   Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5
   Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005
   Gong CC, 2021, ONCOLOGIST, V26, pE580, DOI 10.1002/onco.13594
   Gurjal A, 1999, LUNG CANCER-J IASLC, V26, P109, DOI 10.1016/S0169-5002(99)00081-1
   Hackshaw MD, 2020, BREAST CANCER RES TR, V183, P23, DOI 10.1007/s10549-020-05754-8
   Hardy D, 2010, J THORAC ONCOL, V5, P90, DOI 10.1097/JTO.0b013e3181c0a128
   Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7
   Hoag JB, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-113
   Hochstrasser A, 2012, CHEMOTHERAPY, V58, P84, DOI 10.1159/000336131
   Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466
   Hurvitz SA, 2013, J CLIN ONCOL, V31, P1157, DOI 10.1200/JCO.2012.44.9694
   Hwang HJ, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000018131
   Ide S, 2017, INTERNAL MED, V56, P79, DOI 10.2169/internalmedicine.56.7380
   Ideguchi Hideharu, 2014, Case Rep Pulmonol, V2014, P209732, DOI 10.1155/2014/209732
   Imokawa S, 2000, EUR RESPIR J, V15, P373, DOI 10.1034/j.1399-3003.2000.15b25.x
   Jacobs C, 2002, CLIN ONCOL-UK, V14, P262, DOI 10.1053/clon.2002.0071
   Kalchiem-Dekel O, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120476
   Kaufman HL, 2016, LANCET ONCOL, V17, P1374, DOI 10.1016/S1470-2045(16)30364-3
   Khunger M, 2017, CHEST, V152, P271, DOI 10.1016/j.chest.2017.04.177
   Kim Robert, 2008, Ther Adv Respir Dis, V2, P319, DOI 10.1177/1753465808096948
   Knudsen L, 2018, AM J RESP CELL MOL, V59, P757, DOI 10.1165/rcmb.2018-0044OC
   Koschel D, 2009, EUR RESPIR J, V33, P931, DOI 10.1183/09031936.00004808
   Kouroussis C, 2004, LUNG CANCER, V44, P363, DOI 10.1016/j.lungcan.2003.12.004
   Koyama N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198886
   Larkin J, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]
   Lee LYW, 2020, LANCET, V395, P1919, DOI 10.1016/S0140-6736(20)31173-9
   Lindell KO, 2018, CURR PULMONOL REP, V7, P126, DOI 10.1007/s13665-018-0211-6
   LINETTE DC, 1992, ANN PHARMACOTHER, V26, P481, DOI 10.1177/106002809202600404
   Long GV, 2015, LANCET, V386, P444, DOI 10.1016/S0140-6736(15)60898-4
   Maldonado F, 2007, MAYO CLIN PROC, V82, P771
   Malik YS, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9070519
   Michielin O, 2004, LANCET ONCOL, V5, P322, DOI 10.1016/S1470-2045(04)01471-8
   Mizuno R, 2012, JPN J CLIN ONCOL, V42, P442, DOI 10.1093/jjco/hys033
   Modi S, 2020, NEW ENGL J MED, V382, P610, DOI 10.1056/NEJMoa1914510
   Morelon E, 2001, TRANSPLANTATION, V72, P787, DOI 10.1097/00007890-200109150-00008
   Moskovitz M, 2015, CASE REP ONCOL MED, V2015, DOI 10.1155/2015/341064
   Motzer RJ, 2018, NEW ENGL J MED, V378, P1277, DOI 10.1056/NEJMoa1712126
   Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665
   Motzer RJ, 2019, NEW ENGL J MED, V380, P1103, DOI 10.1056/NEJMoa1816047
   Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219
   Murthy RK, 2020, NEW ENGL J MED, V382, P597, DOI 10.1056/NEJMoa1914609
   Myung HJ, 2010, GUT LIVER, V4, P543, DOI 10.5009/gnl.2010.4.4.543
   Nagata S, 2010, J INFECT CHEMOTHER, V16, P340, DOI 10.1007/s10156-010-0058-4
   Necchi A, 2017, CLIN GENITOURIN CANC, V15, P213, DOI 10.1016/j.clgc.2016.08.021
   Ng TL, 2020, J THORAC ONCOL, V15, P1190, DOI 10.1016/j.jtho.2020.02.011
   Nishino M, 2019, RADIOLOGY, V290, P9, DOI 10.1148/radiol.2018181349
   Nishino Mizuki, 2017, JCO Precis Oncol, V1, DOI 10.1200/PO.17.00026
   Nishino M, 2017, RADIOGRAPHICS, V37, P1371, DOI 10.1148/rg.2017170015
   Nozawa M, 2015, INT J CLIN ONCOL, V20, P790, DOI 10.1007/s10147-014-0764-5
   O'Sullivan JM, 2003, ANN ONCOL, V14, P91, DOI 10.1093/annonc/mdg020
   Ochoa Roberto, 2012, J Med Case Rep, V6, P413, DOI 10.1186/1752-1947-6-413
   Ohnishi K, 2006, LEUKEMIA, V20, P1162, DOI 10.1038/sj.leu.2404207
   Okada N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70743-2
   Okuno SH, 1997, AM J CLIN ONCOL-CANC, V20, P282, DOI 10.1097/00000421-199706000-00015
   Ostoros G, 2006, INT J GYNECOL CANCER, V16, P391, DOI 10.1111/j.1525-1438.2006.00222.x
   Ozaki Y, 2019, NEW ENGL J MED, V380, P2382, DOI 10.1056/NEJMc1903943
   Ozawa Y, 2018, ANTICANCER RES, V38, P5937, DOI 10.21873/anticanres.12939
   Pavel ME, 2011, LANCET, V378, P2005, DOI 10.1016/S0140-6736(11)61742-X
   Paz-Ares L, 2018, NEW ENGL J MED, V379, P2040, DOI 10.1056/NEJMoa1810865
   Paz-Ares L, 2019, LANCET, V394, P1929, DOI 10.1016/S0140-6736(19)32222-6
   Pellegrino B, 2018, CLIN LUNG CANCER, V19, pE151, DOI 10.1016/j.cllc.2017.10.008
   Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306
   Postow MA, 2018, NEW ENGL J MED, V378, P158, DOI [10.1056/NEJMc1801663, 10.1056/NEJMra1703481]
   Qi WX, 2015, J CHEMOTHERAPY, V27, P40, DOI 10.1179/1973947814Y.0000000189
   Razzouk-Cadet M, 2019, CLIN NUCL MED, V44, P806, DOI 10.1097/RLU.0000000000002707
   Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774
   Ribas A, 2015, LANCET ONCOL, V16, P908, DOI 10.1016/S1470-2045(15)00083-2
   Rini BI, 2019, NEW ENGL J MED, V380, P1116, DOI 10.1056/NEJMoa1816714
   Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X
   Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093
   Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082
   Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690
   Rosenberg JE, 2019, J CLIN ONCOL, V37, P2592, DOI 10.1200/JCO.19.01140
   Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4
   Roychowdhury DF, 2002, INVEST NEW DRUG, V20, P311, DOI 10.1023/A:1016214032272
   Saemann MD, 2009, AM J TRANSPLANT, V9, P2655, DOI 10.1111/j.1600-6143.2009.02832.x
   Sakai F, 2012, INT J CLIN ONCOL, V17, P542, DOI 10.1007/s10147-012-0489-2
   Schmid P, 2018, NEW ENGL J MED, V379, P2108, DOI 10.1056/NEJMoa1809615
   Sekimoto Y, 2016, RESPIROL CASE REP, V4, DOI 10.1002/rcr2.151
   Sharma P, 2017, LANCET ONCOL, V18, P312, DOI 10.1016/S1470-2045(17)30065-7
   Singavi AK, 2019, J ONCOL PRACT, V15, P556, DOI 10.1200/JOP.19.00180
   Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137
   Su Q, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00108
   Sugano T, 2020, THORAC CANCER, V11, P1052, DOI 10.1111/1759-7714.13364
   Sugaya A, 2017, MOL CLIN ONCOL, V6, P229, DOI 10.3892/mco.2016.1113
   Suzuki H, 2011, J CHEMOTHERAPY, V23, P367, DOI 10.1179/joc.2011.23.6.367
   Swain SM, 2013, LANCET ONCOL, V14, P461, DOI 10.1016/S1470-2045(13)70130-X
   Takano T, 2004, LUNG CANCER, V45, P93, DOI 10.1016/j.lungcan.2004.01.010
   Tamiya A, 2012, ANTICANCER RES, V32, P1103
   Tamura K, 2019, LANCET ONCOL, V20, P816, DOI 10.1016/S1470-2045(19)30097-X
   Thomas AL, 2000, EUR J CANCER, V36, P2329, DOI 10.1016/S0959-8049(00)00341-5
   Till BG, 2012, LEUKEMIA LYMPHOMA, V53, P1019, DOI 10.3109/10428194.2011.654341
   Torrisi JM, 2011, RADIOLOGY, V258, P41, DOI 10.1148/radiol.10092129
   TWOHIG KJ, 1990, CLIN CHEST MED, V11, P31
   Uribe CF, 2019, J NUCL MED, V60, P451, DOI 10.2967/jnumed.118.223495
   Vacchi C, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020407
   van Diessen J, 2019, RADIOTHER ONCOL, V131, P166, DOI 10.1016/j.radonc.2018.09.019
   VANBARNEVELD PWC, 1984, AM REV RESPIR DIS, V130, P1078
   Wang HP, 2020, THORAC CANCER, V11, P191, DOI 10.1111/1759-7714.13240
   Waters Michael J, 2014, World J Oncol, V5, P232, DOI 10.14740/wjon845w
   Watkins J, 2011, CLIN COLORECTAL CANC, V10, P198, DOI 10.1016/j.clcc.2011.03.019
   Weber J, 2017, NEW ENGL J MED, V377, P1824, DOI 10.1056/NEJMoa1709030
   Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6
   Willemsen AECAB, 2019, TARGET ONCOL, V14, P441, DOI 10.1007/s11523-019-00656-2
   Yanagitani Noriko, 2008, Gan To Kagaku Ryoho, V35, P1619
   Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290
   Yoneda KY, 2017, CLIN LUNG CANCER, V18, P472, DOI 10.1016/j.cllc.2017.03.004
   Yoshii N, 2011, ANTI-CANCER DRUG, V22, P563, DOI 10.1097/CAD.0b013e3283473f28
NR 152
TC 0
Z9 0
U1 1
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6694
J9 CANCERS
JI Cancers
PD MAR
PY 2021
VL 13
IS 5
AR 1052
DI 10.3390/cancers13051052
PG 24
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA QV4TP
UT WOS:000627966400001
PM 33801385
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Li, HB
   Zheng, SQ
   Li, D
   Jiang, DC
   Liu, F
   Guo, W
   Zhao, ZY
   Zhou, YF
   Liu, JT
   Zhao, RS
AF Li, Huibo
   Zheng, Siqian
   Li, Da
   Jiang, Dechun
   Liu, Fang
   Guo, Wei
   Zhao, Zhenying
   Zhou, Yanfei
   Liu, Jingting
   Zhao, Rongsheng
TI The Establishment and Practice of Pharmacy Care Service Based on
   Internet Social Media: Telemedicine in Response to the COVID-19 Pandemic
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE COVID-19; medication therapy management (MTM); remote pharmacy service;
   innovative service model; telepharmacy
ID TELEPHARMACY; CHINA
AB Objective: For patients with chronic diseases requiring long-term use of medications who are quarantined at home, the management of medication therapy during the COVID-19 pandemic is a problem that pharmacists urgently need to discuss and solve. The study aims to establish and launch a telepharmacy framework to implement pharmaceutical care during the COVID-19 pandemic.
   Methods: To establish a remote pharmacy service model based on a medication consultation service platform under the official account of the "Beijing Pharmacists Association" on the social software WeChat app, obtain the medication consultation records from February 28 to April 27, 2020, during the worst period of the epidemic in China, and to perform a statistical analysis of the information about the patients seeking consultation, consultation process, content and follow-up results.
   Results: The medication consultation service system and telepharmacy service model based on social software were established in February 2020. The "Cloud Pharmacy Care" platform had 1,432 views and 66 followers and completed 39 counseling cases in 2 months. Counseling was available for patients of all ages. Of the 39 cases, 82.05% of patients were young and middle-aged. During the COVID-19 pandemic, the long-term medication usage problems of patients with chronic disease were effectively addressed using "Cloud Pharmacy Care". In the consultation, 35 cases (89.7%) were related to the use of medicines or health products, and 4 cases (10.3%) involved disease state management and the use of supplements. The top five drug-related issues included the selection of medications, the dosage and usage of drugs, medications for special populations, medication therapy management of chronic diseases, and adverse drug reactions. All consultations were completed within 4 h, with a positive review rate of 97.4%.
   Conclusion: During the COVID-19 pandemic, a remote pharmacy service "Cloud Pharmacy Care" based on the social software WeChat app was quickly constructed and applied to solve the medication-related problems of patients and the public during home quarantining. The significance of the study lies in the timely and interactive consultation model helps to carry out medication therapy management for chronically ill patients and improves patients' medication compliance, improves medical quality, and plays a positive role in promoting the popularization of safe medication knowledge.
C1 [Li, Huibo; Zheng, Siqian; Liu, Fang; Zhao, Rongsheng] Peking Univ Third Hosp, Dept Pharm, Beijing, Peoples R China.
   [Li, Huibo; Zheng, Siqian; Liu, Fang; Zhao, Rongsheng] Peking Univ, Inst Drug Evaluat, Hlth Sci Ctr, Beijing, Peoples R China.
   [Li, Da; Zhou, Yanfei] Raffles Hosp Beijing, Dept Pharm, Beijing, Peoples R China.
   [Li, Da; Jiang, Dechun; Liu, Jingting] Beijing Pharmacists Assoc, Beijing, Peoples R China.
   [Jiang, Dechun] Capital Med Univ, Beijing Shijitan Hosp, Dept Pharm, Beijing, Peoples R China.
   [Guo, Wei] Capital Med Univ, Beijing Anding Hosp, Natl Clin Res Ctr Mental Disorders, Beijing, Peoples R China.
   [Guo, Wei] Capital Med Univ, Dept Pharm, Beijing Key Lab Mental Disorders, Beijing, Peoples R China.
   [Guo, Wei] Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Beijing, Peoples R China.
   [Zhao, Zhenying] Tianjin Union Med Ctr, Dept Pharm, Tianjin, Peoples R China.
RP Zhao, RS (corresponding author), Peking Univ Third Hosp, Dept Pharm, Beijing, Peoples R China.; Zhao, RS (corresponding author), Peking Univ, Inst Drug Evaluat, Hlth Sci Ctr, Beijing, Peoples R China.
EM zhaorongsheng@bjmu.edu.cn
FU National Science and Technology Major Special Project for New Drug
   Development funding [2018ZX09201016]
FX This study was supported by the National Science and Technology Major
   Special Project for New Drug Development funding (No. 2018ZX09201016).
   In addition, my organization, the Third Hospital of Peking University,
   will also cover the editing and publishing costs of this manuscript.
CR Alexander Emily, 2017, Am J Health Syst Pharm, V74, pe236, DOI 10.2146/ajhp170039
   [Anonymous], 2020, Am J Health Syst Pharm, V77, P113, DOI 10.1093/ajhp/zxz271
   Anthony B, 2021, INT J HEALTHCARE MAN, V14, P280, DOI 10.1080/20479700.2020.1870354
   Anthony B, 2020, J MED SYST, V44, DOI 10.1007/s10916-020-01596-5
   Baldoni S, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55070327
   Benetoli A, 2017, INT J CLIN PHARM-NET, V39, P364, DOI 10.1007/s11096-017-0444-4
   Bokolo AJ, 2021, IRISH J MED SCI, V190, P1, DOI 10.1007/s11845-020-02299-z
   Chinese Pharmacists Association Chinese Pharmaceutical Association Hospital Pharmacy Professional Committee, 2020, CONS PHARM PROV EXP
   Currie K, 2016, J HOSP INFECT, V93, P121, DOI 10.1016/j.jhin.2015.12.011
   Currie K, 2016, J HOSP INFECT, V92, P253, DOI 10.1016/j.jhin.2015.10.018
   Feng W, 2020, Beijing Da Xue Xue Bao Yi Xue Ban, V52, P302
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Greenhalgh T, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1182
   Hedima EW, 2021, HEALTH POLICY TECHN, V10, P23, DOI 10.1016/j.hlpt.2020.10.013
   Hollander JE, 2020, NEW ENGL J MED, V382, P1679, DOI 10.1056/NEJMp2003539
   Ibrahim OM, 2020, J TELEMED TELECARE, DOI 10.1177/1357633X20964347
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037
   Le T, 2020, J PHARM PRACT, V33, P176, DOI 10.1177/0897190018791060
   Li HB, 2021, RES SOC ADMIN PHARM, V17, P1813, DOI 10.1016/j.sapharm.2020.04.003
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Morillo-Verdugo R, 2020, FARM HOSP, V44, P174, DOI 10.7399/fh.11515
   Patel A, 2020, MMWR-MORBID MORTAL W, V69, P140, DOI 10.15585/mmwr.mm6905e1
   Pathak S, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.200012
   Shokri T, 2020, FACIAL PLAST SURG AE, V22, P155, DOI 10.1089/fpsam.2020.0163
   Smith AC, 2020, J TELEMED TELECARE, V26, P309, DOI 10.1177/1357633X20916567
   Toney Blake, 2015, Hosp Pharm, V50, P644, DOI 10.1310/hpj5007-644
   Wang Yaogang, 2017, JMIR Med Inform, V5, pe22, DOI 10.2196/medinform.6799
   WHO, 2020, INF PREV CONTR HLTH
   Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020
   Win AZ, 2017, RES SOC ADMIN PHARM, V13, P882, DOI 10.1016/j.sapharm.2015.06.002
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yang Y, 2020, LANCET PSYCHIAT, V7, pE19, DOI 10.1016/S2215-0366(20)30079-1
   Zhou XY, 2020, TELEMED E-HEALTH, V26, P377, DOI 10.1089/tmj.2020.0068
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 36
TC 1
Z9 1
U1 5
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD OCT 1
PY 2021
VL 12
AR 707442
DI 10.3389/fphar.2021.707442
PG 9
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA WH3RI
UT WOS:000707599000001
PM 34658854
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Kutieshat, R
   Farmanesh, P
AF Kutieshat, Ruba
   Farmanesh, Panteha
TI The Impact of New Human Resource Management Practices on Innovation
   Performance during the COVID 19 Crisis: A New Perception on Enhancing
   the Educational Sector
SO SUSTAINABILITY
LA English
DT Article
DE COVID-19 crisis; new human resource management practices (NHRM);
   innovation performance (IP); organizational innovation (OI); innovative
   work behavior (IWB); sustainability
ID WORK BEHAVIOR; TECHNOLOGY; HRM; DETERMINANTS; RETHINKING; KNOWLEDGE;
   POLICY; ONLINE
AB The study aims to investigate the impact of New Human Resource Management Practices (NHRM) on innovation performance mediating by organizational innovation and innovative work behavior in the educational sector during the COVID-19 pandemic. However, experiential proof to determine this relationship is inadequate. Consequently, quantitative statistical tools were implemented in the study. Using data gathered from 450 employees in the Ministry of Education in Amman-Jordan who participated in the online survey the present results indicate that there is a significant positive relationship linking NHRM practices and innovation performance. Additionally, a mediating role of organizational innovation and innovative work behavior was found. Moreover, the results identified that the relation increases more by organizational innovation mediator. Therefore, based on the results, boosting NHRM practices in the Ministry of Education will reinforce managerial implementation, fostering innovative performance. During the COVID 19 pandemic, the cruel challenges obliged the educational sector to use organizational strategies to achieve innovation within the crucial and unpredictable period, which needs practical, swifter technological practices, making it unbeatable, creative, and motivational competitive. Therefore, applying NHRM can present solutions, resolve problems, and enhance innovation among employees during the response time of a crisis. Form, execution and improved environmental sustainability within organizations that rely on permanent innovation are associated with HR practices.
C1 [Kutieshat, Ruba] Girne Amer Univ, Business Dept, Karmi 10, TR-99428 Kyrenia, Northern Cyprus, Turkey.
   [Farmanesh, Panteha] Girne Amer Univ, Ctr Management Res, Karmi 10, TR-99428 Kyrenia, Northern Cyprus, Turkey.
RP Kutieshat, R (corresponding author), Girne Amer Univ, Business Dept, Karmi 10, TR-99428 Kyrenia, Northern Cyprus, Turkey.
EM ruba968@yahoo.com; pantehafarmanesh@gau.edu.tr
OI Farmanesh, Panteha/0000-0001-6630-4435
CR Adam J. K., 2020, J MULTIDISCIPLINARY, V4, P63
   Al-Harazneh YM, 2021, J GLOB INF MANAG, V29, P118, DOI 10.4018/JGIM.2021030107
   Al-Hyari H.S.A., 2020, P C 4 INT ED VAL S I
   Al-Jaafreh S.J.A., CASE STUDY E LEARNIN
   Al-Salman S, 2021, ONLINE LEARN, V25, P286, DOI 10.24059/olj.v25i1.2470
   Alsoud AR, 2021, J THEOR APPL EL COMM, V16, P1404, DOI 10.3390/jtaer16050079
   Alzoubi R.H., 2020, INT J FINANC RES, V11, P384, DOI [10.5430/ijfr.v11n4p384, DOI 10.5430/IJFR.V11N4P384]
   Awa HO, 2015, J SCI TECHNOL POLICY, V6, P76, DOI 10.1108/JSTPM-04-2014-0012
   Bebell D, 2010, J RES TECHNOL EDUC, V43, P29, DOI 10.1080/15391523.2010.10782560
   Boris P., 2008, ANN WORLD BANK C DEV
   Bos-Nehles A, 2017, PERS REV, V46, P1228, DOI 10.1108/PR-09-2016-0257
   Bryman A, 2008, SOCIAL RES METHODS, V3rd
   Bryman A., 2011, BUSINESS RES METHODS, V3rd
   Burbules NC, 2020, GEOGR SUSTAIN, V1, P93, DOI 10.1016/j.geosus.2020.05.001
   Butterick M, 2021, HUM RESOUR MANAG J, V31, P847, DOI 10.1111/1748-8583.12344
   Castro MVD, 2020, REGE-REV GEST, V27, P229, DOI 10.1108/REGE-10-2018-0102
   Christa U., 2021, UNCERTAIN SUPPLY CHA, V9, P151, DOI [10.5267/j.uscm.2020.10.006, DOI 10.5267/J.USCM.2020.10.006]
   Collier J.E., 2007, MARKETING THEOR, V7, P163, DOI DOI 10.1177/1470593107076865
   Crossan MM, 2010, J MANAGE STUD, V47, P1154, DOI [10.1111/J.1467-6486.2009.00880.X, 10.1111/j.1467-6486.2009.00880.x]
   De Jong JeroenP.J., 2008, EIM BUSINESS POLICY, V8, P1
   Demo G., 2020, REV ADM UNIMEP, V18, P138
   Dorenbosch L., 2005, JOB INNOVATION, V14, P129, DOI [10.1111/j.1476-8691.2005.00333.x, DOI 10.1111/J.1476-8691.2005.00333.X]
   Ebersberger B, 2021, J BUS RES, V124, P126, DOI 10.1016/j.jbusres.2020.11.051
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Grimshaw D, 2009, HUM RELAT, V62, P1521, DOI 10.1177/0018726709336498
   Guderian CC, 2021, R&D MANAGE, V51, P223, DOI 10.1111/radm.12447
   Hair J.F., 2021, PRIMER PARTIAL LEAST
   Hair JF, 2019, EUR J MARKETING, V53, P566, DOI 10.1108/EJM-10-2018-0665
   Hair JF, 2019, EUR BUS REV, V31, P2, DOI 10.1108/EBR-11-2018-0203
   Hamilton JD, 2009, BROOKINGS PAP ECO AC, P215
   Henseler J, 2016, IND MANAGE DATA SYST, V116, P2, DOI 10.1108/IMDS-09-2015-0382
   Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8
   Jackson, 1987, ACADEMY MANAGEMENT E, V1, P207, DOI [DOI 10.5465/AME.1987.4275740, 10.5465/ame.1987.4275740]
   Janssen O, 2003, J OCCUP ORGAN PSYCH, V76, P347, DOI 10.1348/096317903769647210
   Kelana BWY, 2015, ADV SCI LETT, V21, P1501, DOI 10.1166/asl.2015.6086
   Kleysen RF., 2001, J INTELL CAPITAL, V2, P284, DOI DOI 10.1108/EUM0000000005660
   Kock N, 2012, J ASSOC INF SYST, V13, P546, DOI 10.17705/1jais.00302
   Laursen K, 2003, CAMB J ECON, V27, P243, DOI 10.1093/cje/27.2.243
   Lin SY, 2022, SUSTAINABILITY-BASEL, V14, DOI 10.3390/su14041949
   Lundvall B.A., 2008, HIGH ED DEV, V8, P201, DOI [10.1596/978-0-8213-7123-7, DOI 10.1596/978-0-8213-7123-7]
   Maymone MBC, 2018, J INVEST DERMATOL, V138, P1456, DOI 10.1016/j.jid.2018.02.032
   Menon S., 2015, IOSR J RES METHOD ED, V5, P12, DOI [10.9790/7388-05621214, DOI 10.9790/7388-05621214]
   Moohammad A.Y., 2014, BUS MANAG DYN, V4, P01
   Nedumaran G., 2021, ZENITH INT J MULTIDI, V11, P18
   Nesterova K., 2021, P ART INT GREEN THIN, P93
   Novitasari D., 2020, SOLID STATE TECHNOL, V63, P2927
   Nulty DD, 2008, ASSESS EVAL HIGH EDU, V33, P301, DOI 10.1080/02602930701293231
   Nutsubidze N., 2021, REV SOCIOECON PERSPE, V6, P1, DOI [10.19275/RSEP103, DOI 10.19275/RSEP103]
   Odoardi C., 2010, BPA APPL PSYCHOL B, V3, P261
   Ozcan S, 2009, MANAGE SCI, V55, P604, DOI 10.1287/mnsc.1080.0954
   Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452
   Prange C, 2017, INT BUS REV, V26, P1114, DOI 10.1016/j.ibusrev.2017.04.004
   Ratten V, 2020, J ENTERP COMMUNITIES, V14, P753, DOI 10.1108/JEC-06-2020-0121
   Rigdon EE, 2012, LONG RANGE PLANN, V45, P341, DOI 10.1016/j.lrp.2012.09.010
   Rungtusanatham M, 2014, J OPER MANAG, V32, P99, DOI 10.1016/j.jom.2014.01.002
   Santangelo GD, 2011, IND INNOV, V18, P611, DOI 10.1080/13662716.2011.591977
   Sanz-Valle R, 2018, MANAGE DECIS, V56, P1417, DOI 10.1108/MD-04-2017-0404
   SCOTT SG, 1994, ACAD MANAGE J, V37, P580, DOI 10.2307/256701
   Sekaran U., 2016, RES METHODS BUSINESS, V7th Edition
   Shahzad K, 2016, UTIL POLICY, V41, P107, DOI 10.1016/j.jup.2016.06.011
   Sinacore J.M., 1993, EVAL PRACT, V14, P167, DOI [10.1177/109821409301400208, DOI 10.1177/109821409301400208]
   Snieska V, 2020, TRANSFORM BUS ECON, V19, P38
   Tai F.-M., 2014, IBUSINESS, V6, P117, DOI DOI 10.4236/IB.2014.63013
   Tawalbeh M, 2001, BRIT J EDUC TECHNOL, V32, P133, DOI 10.1111/1467-8535.00184
   Thornhill S, 2006, J BUS VENTURING, V21, P687, DOI 10.1016/j.jbusvent.2005.06.001
   Venkatesh V, 2000, INFORM SYST RES, V11, P342, DOI 10.1287/isre.11.4.342.11872
   Waheed Abdul, 2020, International Journal of Information Technology and Management, V19, P181
   Waheed A., 2016, 2016 JOINT INT INF T, DOI [10.2991/jimec-16.2016.29, DOI 10.2991/JIMEC-16.2016.29]
   Waheed A, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11030621
   Waheed A, 2017, FRONT ARTIF INTEL AP, V296, P573, DOI 10.3233/978-1-61499-785-6-573
   Waheed A, 2017, FRONT ARTIF INTEL AP, V296, P228, DOI 10.3233/978-1-61499-785-6-228
NR 71
TC 0
Z9 0
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD MAR
PY 2022
VL 14
IS 5
AR 2872
DI 10.3390/su14052872
PG 21
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA ZR4WF
UT WOS:000767784500001
OA gold
DA 2022-04-20
ER

PT J
AU Peng, SX
   Lai, X
   Du, YK
   Li, YT
   Tian, KM
   Gan, Y
AF Peng, Songxu
   Lai, Xin
   Du, Yukai
   Li, Yuting
   Tian, Kunming
   Gan, Yong
TI Prevalence and Associated Factors for Depressive Symptomatology in
   Chinese Adults During COVID-19 Epidemic
SO FRONTIERS IN PSYCHOLOGY
LA English
DT Article
DE epidemic; COVID-19; risk factors; prevalence; depression symptoms
ID MENTAL-HEALTH; RISK-FACTORS; SYMPTOMS; POPULATION; DISORDER; SCALE;
   SUPPORT; ANXIETY; LONG
AB Background: The coronavirus disease 2019 (COVID-19) has been rapidly transmitted worldwide, which contributed to various psychological problems (such as fear, depression, and anxiety) among the general population in China. The purpose of this study is to investigate the prevalence and associated factors of depressive symptoms among Chinese adults.
   Methods: A cross-sectional study of Chinese adults was conducted during 17-29 February 2020. Symptoms of depression were assessed using the Center for Epidemiologic Studies Depression scale (CES-D).
   Results: A total of 3,399 respondents were included in the analysis. It was observed that 14.2% (481/3,399) of the participants were screened positive for depressive symptoms. In a multivariate logistic regression analysis, older age (OR = 0.98; 95% CI, 0.97-0.99), smoking (OR = 1.57; 95% CI, 1.10-2.26), self-rated health (good: OR = 0.49; 95% CI, 0.37-0.66; fairly: OR = 0.60; 95% CI, 0.45-0.80), having greater support scores (OR = 0.95; 95% CI, 0.94-0.96), knowledge about the main symptom of COVID-19 (very clearly: OR = 0.58; 95% CI, 0.42-0.79; relatively clearly: OR = 0.59; 95% CI, 0.44-0.79), and staying in Wuhan within 3 months before the outbreak of epidemic (OR = 1.78; 95% CI, 1.34-2.38) were associated with depressive symptoms.
   Conclusion: A considerable proportion of the general population in China had depressive symptoms during the COVID-19 epidemic. Routine screening and targeted interventions for depression are needed among high-risk depressed individuals during the COVID-19 epidemic.
C1 [Peng, Songxu; Lai, Xin] Cent South Univ, Xiangya Sch Publ Hlth, Dept Maternal & Child Hlth, Changsha, Peoples R China.
   [Du, Yukai] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Maternal & Child Hlth, Wuhan, Peoples R China.
   [Li, Yuting] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Canc Ctr, Wuhan, Peoples R China.
   [Tian, Kunming] Zunyi Med Univ, Sch Publ Hlth, Dept Prevent Med, Zunyi, Guizhou, Peoples R China.
   [Tian, Kunming] Huazhong Univ Sci & Technol, Tongji Med Coll, Inst Reprod Hlth, Wuhan, Peoples R China.
   [Gan, Yong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Social Med & Hlth Management, Wuhan, Peoples R China.
RP Tian, KM (corresponding author), Zunyi Med Univ, Sch Publ Hlth, Dept Prevent Med, Zunyi, Guizhou, Peoples R China.; Tian, KM (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Inst Reprod Hlth, Wuhan, Peoples R China.; Gan, Y (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Social Med & Hlth Management, Wuhan, Peoples R China.
EM non-standstill@163.com; scswj2008@163.com
FU Guizhou Province Science and Technology Support Project [(2020)4Y165]
FX This study was approved by the Guizhou Province Science and Technology
   Support Project [(2020)4Y165].
CR Arias-de la Torre J, 2018, J AFFECT DISORDERS, V239, P203, DOI 10.1016/j.jad.2018.06.051
   Cheng ST, 2005, INT J GERIATR PSYCH, V20, P465, DOI 10.1002/gps.1314
   Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985
   Dozeman E, 2011, INT J GERIATR PSYCH, V26, P239, DOI 10.1002/gps.2519
   Ettman CK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19686
   Goularte JF, 2021, J PSYCHIATR RES, V132, P32, DOI 10.1016/j.jpsychires.2020.09.021
   Hammen C, 2018, ANNU REV CLIN PSYCHO, V14, P1, DOI [10.1146/annurev-clinpsy-050817-084811, 10.1146/annurev-clinpsy-050817084811]
   Holden L, 2019, J AFFECT DISORDERS, V245, P771, DOI 10.1016/j.jad.2018.11.076
   Hu HW, 2018, J AFFECT DISORDERS, V237, P104, DOI 10.1016/j.jad.2018.04.076
   Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954
   Jiang LJ, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00315
   Karagiannidis C, 2020, LANCET RESP MED, V8, P853, DOI 10.1016/S2213-2600(20)30316-7
   Keita MM, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1280-8
   Kozela M, 2016, EUR J PREV CARDIOL, V23, P1839, DOI 10.1177/2047487316649493
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Lei L, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924609
   Liu J, 2015, J AFFECT DISORDERS, V179, P74, DOI 10.1016/j.jad.2015.03.009
   Loomba RS, 2021, ANN MED, V53, P151, DOI 10.1080/07853890.2020.1840620
   Lopez E, 2018, J AFFECT DISORDERS, V225, P117, DOI 10.1016/j.jad.2017.08.031
   Mak IWC, 2009, GEN HOSP PSYCHIAT, V31, P318, DOI 10.1016/j.genhosppsych.2009.03.001
   Maske UE, 2016, J AFFECT DISORDERS, V190, P167, DOI 10.1016/j.jad.2015.10.006
   Meo SA, 2020, EUR REV MED PHARMACO, V24, P2012, DOI 10.26355/eurrev_202002_20379
   Naicker K, 2013, J ADOLESCENT HEALTH, V52, P533, DOI 10.1016/j.jadohealth.2012.12.016
   Nelson Benjamin W, 2020, PLoS One, V15, pe0241990, DOI 10.1371/journal.pone.0241990
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Pasco JA, 2008, BRIT J PSYCHIAT, V193, P322, DOI 10.1192/bjp.bp.107.046706
   Peng M, 2020, J AFFECT DISORDERS, V275, P119, DOI 10.1016/j.jad.2020.06.035
   Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rodriguez-Rey R, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01540
   Rotenstein LS, 2016, JAMA-J AM MED ASSOC, V316, P2214, DOI 10.1001/jama.2016.17324
   Rousou E, 2016, BMC NURS, V15, DOI 10.1186/s12912-016-0134-x
   Salari N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00589-w
   Shi L, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.14053
   Tadesse DB, 2020, EMERG MICROBES INFEC, V9, P1372, DOI 10.1080/22221751.2020.1775499
   Tan WQ, 2020, BRAIN BEHAV IMMUN, V87, P84, DOI 10.1016/j.bbi.2020.04.055
   Tang YJ, 2020, EMERG MICROBES INFEC, V9, P1453, DOI 10.1080/22221751.2020.1785337
   The National Health Commission of China, 2020, UPD NOV COR OUTBR FE
   van der Velden PG, 2020, J AFFECT DISORDERS, V277, P540, DOI 10.1016/j.jad.2020.08.026
   Vilagut G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155431
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Whooley MA, 2013, ANNU REV CLIN PSYCHO, V9, P327, DOI 10.1146/annurev-clinpsy-050212-185526
   Wu J, 2020, WIRELESS NETW-GER, P1, DOI [10.1038/s41591-020-0822-7, 10.1007/978-3-030-29844-9]
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Ye ZJ, 2017, EUR J ONCOL NURS, V27, P36, DOI 10.1016/j.ejon.2017.01.004
   Zhang J, 2020, J CLIN NURS, V29, P4020, DOI 10.1111/jocn.15425
   Zhang YS, 2019, J AFFECT DISORDERS, V252, P92, DOI 10.1016/j.jad.2019.01.049
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17
NR 49
TC 1
Z9 1
U1 1
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-1078
J9 FRONT PSYCHOL
JI Front. Psychol.
PD DEC 23
PY 2020
VL 11
AR 616723
DI 10.3389/fpsyg.2020.616723
PG 8
WC Psychology, Multidisciplinary
WE Social Science Citation Index (SSCI)
SC Psychology
GA PO1MU
UT WOS:000604935700001
PM 33424729
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Jian, S
   Qian, Z
   Cao, X
AF Jian, Song
   Qian, Zhang
   Cao, Xiong
TI CONSTRUCTION AND PRACTICE ABOUT THE FINE MANAGEMENT OF CANCER PATIENTS
   DURING THE EPIDEMIC OF COVID-19
SO ACTA MEDICA MEDITERRANEA
LA English
DT Article
DE novel coronavirus; tumours; fine management
AB Purpose: This paper explored the construction and practice of the fine management of cancer patients during the Covid-19 outbreak.
   Methods: To establish the medical groups for the fine management of cancer patients during the Covid-19 outbreak, 6 doctors and 6 backbone nurses were selected from the oncology department since January 28th, 2020. And then the medical needs of cancer patients were obtained through telephone follow-up network. Next, the medical group was further divided and the we-media was used for the fine management of cancer patients based on patients needs. When the we-media failed to solve problems in some special or emergent situations, a pattern combining hospitals, communities with patients was used to provide continuous medical care for cancer patients.
   Results: The medical group effectively completed the information collection registration of 198 cancer patients through the telephone follow-up network. The current needs of 198 patients were ranked from high to low, and they were: knowledge of diseases, psychological support, PICC maintenance, complication treatment, medication use instructions, rehabilitation exercise instructions and diet combination methods, respectively. Based on patients' needs, the medical group has carried out the fine management for 198 patients through the following activities: 16 live broadcast, 4 recorded videos, 27 group activities targeted at patients, 48 one-to-one telephone counselling, 1 disease brochure, 1 nutritional diet recipe and 1 list for self-monitoring patients' diseases. During the epidemic outbreak, no death or infection cases were found.
   Conclusion: The fine management effectively helped meet the urgent needs of cancer patients who sought medical service and treatment during the epidemic outbreak.
C1 [Jian, Song; Cao, Xiong] Jingzhou Vocat & Tech Coll, Sch Nursing, Jingzhou 434020, Hubei, Peoples R China.
   [Qian, Zhang] Jingzhou Cent Hosp, Oncol Dept, Jingzhou 434020, Hubei, Peoples R China.
RP Cao, X (corresponding author), Jingzhou Vocat & Tech Coll, Sch Nursing, Jingzhou 434020, Hubei, Peoples R China.
EM 654546433@qq.com
CR [Anonymous], TRAFFIC CONTROL DOWN
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Han Ding, 2020, MED J CHINAS PEOPLES, P1
   Hu Sheng, 2017, CHINAS NURSING ED, V14, P655
   National Health Commission of the People's Republic of China, 2020, NOV COR PNEUM DIAGN, V6th
   Wang, 2019, NURSING STUDY, V33, P803
   Wang, CHINESE J LUNG CANC, P1
   Xue He, 2019, J CHINESE MODERN DOC, V57, P134
   Yao YY, 2021, J BIOCHEM MOL TOXIC, V35, DOI 10.1002/jbt.22626
   Yi Deng, 2019, MED INFORM, V32, P72
NR 10
TC 0
Z9 0
U1 4
U2 4
PU CARBONE EDITORE
PI PALERMO
PA VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY
SN 0393-6384
EI 2283-9720
J9 ACTA MEDICA MEDITERR
JI Acta Medica Mediterr.
PY 2021
VL 37
IS 5
BP 2607
EP 2611
DI 10.19193/0393-6384_2021_5_402
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA UZ4LO
UT WOS:000702178700037
DA 2022-04-20
ER

PT J
AU Pollak, F
   Konecny, M
   Sceulovs, D
AF Pollak, Frantisek
   Konecny, Michal
   Sceulovs, Deniss
TI Innovations in the Management of E-Commerce: Analysis of Customer
   Interactions during the COVID-19 Pandemic
SO SUSTAINABILITY
LA English
DT Article
DE innovation; management; e-shop; social network; facebook; pandemic;
   e-consumer behavior; Czech Republic; Latvia; regional development
ID BEHAVIOR; ENTERPRISES; SERVICES; LATVIA; SMES
AB In the days leading to the outbreak of the COVID-19 pandemic, open innovations in the form of the deployment of digital marketing tools in the management portfolio were an option; in a time of forced closing of economies, they suddenly became a necessity. The aim of the comprehensive research, in which the presented study is prepared, is to describe the changes in e-consumer behavior that occurred in the market during the COVID-19 pandemic. The presented study examines the seasonal and regional specifics that characterize the markets of Central and Eastern Europe. In a sample of almost 14,000,000 Facebook users, the user interactions with ten selected representatives of the e-commerce sector were recorded daily during the 2020/2021 Christmas season lasting 49 days. By analyzing the nature and timing of interactions, it was possible to identify the geographical specifics of e-consumer behavior, as well as basic seasonality indicators based on a comparison with the reference period of the first half of 2020. The synthesis of the findings provided a knowledge base for compiling a preliminary version of the model of the COVID-19 pandemic impact on e-consumer behavior. In terms of changes in e-consumer behavior, it can be stated that the step change in e-behavior patterns caused by the pandemic merges with pre-pandemic behavior patterns. In general, it can be stated that the evolutionary process of the transition from offline to online the COVID-19 pandemic appears to be a significant acceleration factor of inevitable changes.
C1 [Pollak, Frantisek; Konecny, Michal] Inst Technol & Business Ceske Budejovice, Fac Corp Strategy, Nemanicka 436-7, Eske Budejovice 37010, Czech Republic.
   [Sceulovs, Deniss] Riga Tech Univ, Fac Engn Econ & Management, Kalnciema St 6,Room 408, LV-1048 Riga, Latvia.
RP Pollak, F (corresponding author), Inst Technol & Business Ceske Budejovice, Fac Corp Strategy, Nemanicka 436-7, Eske Budejovice 37010, Czech Republic.
EM frantisek.pollak@mail.vstecb.cz; michal.konecny@mail.vstecb.cz;
   deniss.sceulovs@rtu.lv
RI Konecny, Michal/AAE-5990-2022; Pollak, Frantisek/A-8330-2014
OI Konecny, Michal/0000-0001-7926-257X; Pollak,
   Frantisek/0000-0001-6346-8629
FU Slovak Republic scientific grant agency VEGA [1/0140/21]
FX This research was funded by the Slovak Republic scientific grant agency
   VEGA, grant number 1/0140/21.
CR Al-Adwan AS, 2019, J THEOR APPL EL COMM, V14, P15, DOI 10.4067/S0718-18762019000200103
   Barroso RMR, 2019, TECHNOL ECON DEV ECO, V25, P496, DOI 10.3846/tede.2019.9386
   Batraga A, 2018, ECON SCI RURAL DEV, P329, DOI 10.22616/ESRD.2018.102
   Bormane S, 2018, PROC CBU, V6, P62, DOI 10.12955/cbup.v6.1134
   Braojos J, 2019, INFORM MANAGE-AMSTER, V56, P155, DOI 10.1016/j.im.2018.04.006
   Bumanis N, 2017, ENG RUR DEVELOP, P82, DOI 10.22616/ERDev2017.16.N015
   Casno K, 2019, EUR INTEGR STUD, P90, DOI 10.5755/j01.eis.0.13.23495
   Dunska M, 2018, MARK MANAG INNOV, P276, DOI 10.21272/mmi.2018.3-25
   Eremina Y., 2019, J OPEN INNOV-TECHNOL, V5, DOI [10.3390/joitmc5030054, DOI 10.3390/JOITMC5030054]
   Gaitniece E, 2017, NEW CHALLENGES OF ECONOMIC AND BUSINESS DEVELOPMENT - 2017: DIGITAL ECONOMY, P215
   Glopal, SELL ONL LATV SELL ONL LATV
   Gudele I, 2020, EUR INTEGR STUD, P207, DOI 10.5755/j01.eis.1.14.26385
   Gudele I, 2017, ICERI PROC, P8934
   Gudele I, 2015, Nordic View to Sustainable Rural Development, P496
   Guseva N, 2013, MARK-TRZ, V25, P8
   Hambalikova K., JAK KORONAVIRUS ZMEN JAK KORONAVIRUS ZMEN
   Hamm P, 2012, AM SOCIOL REV, V77, P295, DOI 10.1177/0003122412441354
   Kirk CP, 2020, J BUS RES, V117, P124, DOI 10.1016/j.jbusres.2020.05.028
   Kristapsone S, 2017, NEW CHALLENGES OF ECONOMIC AND BUSINESS DEVELOPMENT - 2017: DIGITAL ECONOMY, P277
   Lee M., 2018, J OPEN INNOV TECHNOL, V4, P21, DOI [10.3390/JOITMC4030021, DOI 10.3390/JOITMC4030021, 10.3390/joitmc4030021]
   Linina I, 2019, ECON SCI RURAL DEV, V51, P298, DOI 10.22616/ESRD.2019.089
   Lu YB, 2010, ELECTRON COMMER R A, V9, P346, DOI 10.1016/j.elerap.2009.07.003
   Lv JJ, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12187459
   Meijere S, 2017, ECON SCI RURAL DEV, P110
   Mishler W, 1997, J POLIT, V59, P418, DOI 10.2307/2998171
   Mokhtar SSS, 2020, POL J MANAG STUD, V22, P310, DOI 10.17512/pjms.2020.22.1.20
   Muangmee C, 2021, J THEOR APPL EL COMM, V16, P1297, DOI 10.3390/jtaer16050073
   Nambisan S, 2017, MIS QUART, V41, P223, DOI 10.25300/MISQ/2017/41:1.03
   Nosratabadi S, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11061663
   Ozola I, 2019, ICERI PROC, P9303
   Pilik M, 2017, ECON ANN-XXI, V165, P119, DOI 10.21003/ea.V165-24
   Pollak F., 2021, SHS WEB C, V90, DOI [10.1051/shsconf/20219001016, DOI 10.1051/SHSCONF/20219001016]
   Pollak F., 2021, INTELLIGENT PROCESSI
   Pollak F., 2021, SHS WEB C, V90, DOI DOI 10.1051/SHSCONF/20219001015
   Pollak F, 2021, MANAG MARK, V16, P134, DOI 10.2478/mmcks-2021-0009
   Pollak F, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13073999
   Pollak F, 2016, MARK-TRZ, V28, P79
   Radionova-Girsa E, 2018, NEW CHALLENGES OF ECONOMIC AND BUSINESS DEVELOPMENT - 2018: PRODUCTIVITY AND ECONOMIC GROWTH, P532
   Rivza B, 2020, COMP ECON RES, V23, P7, DOI 10.18778/1508-2008.23.17
   Sceulovs D, 2011, 2011 INTERNATIONAL CONFERENCE ON SOCIAL SCIENCES AND SOCIETY (ICSSS 2011), VOL 1, P357
   Szopinski T, 2017, INTERNET RES, V27, P199, DOI 10.1108/IntR-01-2015-0011
   Tambovceva T, 2018, INT J ENVIRON TECHNO, V21, P238, DOI 10.1504/IJETM.2018.100578
   Van de Walle S, 2018, INFORM POLITY, V23, P399, DOI 10.3233/IP-170069
   Yun J.J., 2020, J OPEN INNOVATION TE, V6, P131
   Yun JJ, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9050811
   Zankova K., NAKUPY DOBE KORONAVI NAKUPY DOBE KORONAVI
NR 46
TC 4
Z9 4
U1 23
U2 31
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD JUL
PY 2021
VL 13
IS 14
AR 7986
DI 10.3390/su13147986
PG 22
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA TO6WC
UT WOS:000677048100001
OA gold
DA 2022-04-20
ER

PT J
AU Gkiotsalitis, K
   Cats, O
AF Gkiotsalitis, Konstantinos
   Cats, Oded
TI Public transport planning adaption under the COVID-19 pandemic crisis:
   literature review of research needs and directions
SO TRANSPORT REVIEWS
LA English
DT Review
DE COVID-19; social distancing; ridership; public transport planning;
   capacity management
ID TRANSIT-NETWORK DESIGN; BUS ROUTE; FREQUENCY ALLOCATION; VEHICLE
   OVERTAKING; CONTROL STRATEGIES; HOLDING CONTROL; OPTIMIZATION;
   SYNCHRONIZATION; MODEL; ROBUSTNESS
AB The COVID-19 pandemic crisis has greatly impacted public transport ridership and service provision across the world. As many countries start to navigate their return to normality, new public transport planning requirements are devised. These measures imply a major reduction in service capacity compared to the pre-COVID-19 era. At the time of writing, there is a severe lack of knowledge regarding the potential impact of the pandemic on public transport operations and models that can support the service planning given these new challenges. In this literature review, we systematically review and synthesise the literature on the impacts of COVID on public transport to identify the need to adjust planning measures, and, on the other hand, the existing methods for public transport planning at the strategic, tactical and operational level. We identify intervention measures that can support public transport service providers in planning their services in the post-shutdown phase and their respective modelling development requirements. This can support the transition from the initial ad-hoc planning practices to a more evidence-based decision making.
C1 [Gkiotsalitis, Konstantinos] Univ Twente, Dept Civil Engn, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.
   [Cats, Oded] Delft Univ Technol, Dept Transport & Planning, Delft, Netherlands.
RP Gkiotsalitis, K (corresponding author), Univ Twente, Dept Civil Engn, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.
EM k.gkiotsalitis@utwente.nl
OI Gkiotsalitis, Konstantinos/0000-0002-3009-1527
CR Altazin E, 2017, TRANSPORT RES C-EMER, V79, P73, DOI 10.1016/j.trc.2017.03.012
   Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5
   [Anonymous], 2020, THE GUARDIAN
   Arbex RO, 2015, TRANSPORT RES B-METH, V81, P355, DOI 10.1016/j.trb.2015.06.014
   Bagloee SA, 2011, TRANSPORT RES B-METH, V45, P1787, DOI 10.1016/j.trb.2011.07.005
   Bahl Prateek, 2020, J Infect Dis, DOI 10.1093/infdis/jiaa189
   Bartholdi JJ, 2012, TRANSPORT RES B-METH, V46, P481, DOI 10.1016/j.trb.2011.11.001
   Beck MJ, 2020, TRANSPORT POLICY, V99, P95, DOI 10.1016/j.tranpol.2020.08.004
   Bucsky Peter, 2020, Transp Res Interdiscip Perspect, V8, P100141, DOI 10.1016/j.trip.2020.100141
   Munoz JC, 2013, TRANSPORT RES C-EMER, V28, P101, DOI 10.1016/j.trc.2012.12.010
   Cassel KD, 2020, AM J MENS HEALTH, V14, DOI 10.1177/1557988319893886
   Cats O, 2016, J TRANSP GEOGR, V51, P236, DOI 10.1016/j.jtrangeo.2016.01.011
   Cats O, 2020, PHYSICA A, V549, DOI 10.1016/j.physa.2020.124317
   Cats O, 2019, TRANSPORT RES REC, V2673, P574, DOI 10.1177/0361198118822292
   Ceder A, 2002, J URBAN PLAN D-ASCE, V128, P225, DOI 10.1061/(ASCE)0733-9488(2002)128:4(225)
   Ceder A, 2001, TRANSPORT RES REC, P28
   CEDER A, 1984, TRANSPORT RES A-POL, V18, P439, DOI 10.1016/0191-2607(84)90019-0
   Ceder A, 2001, TRANSPORT RES A-POL, V35, P913, DOI 10.1016/S0965-8564(00)00032-X
   Ceder A., 1989, TRANSPORT RES REC, V1221, P8
   Ceder A., 2016, PUBLIC TRANSIT PLANN
   Cevallos F, 2006, TRANSPORT RES REC, P74
   Chen JT, 2015, LECT NOTES COMPUT SC, V9237, P83, DOI 10.1007/978-3-319-22482-4_10
   Chivers C, 2020, COVID 19 IS AFFECTIN
   Chong C., 2020, STRAITSTIMES
   Cipriani V, 2012, EUR J HUM GENET, V20, P1, DOI 10.1038/ejhg.2011.118
   Cortes CE, 2011, TRANSPORT RES A-POL, V45, P419, DOI 10.1016/j.tra.2011.02.002
   Currie G., 2009, TRANSP RES BOARD 88
   Daduna J.R., 1995, COMPUTER AIDED TRANS, V430, P39, DOI DOI 10.1007/978-3-642-57762-8_4
   de Haas Mathijs, 2020, Transp Res Interdiscip Perspect, V6, P100150, DOI 10.1016/j.trip.2020.100150
   de Palma A, 2001, TRANSPORT RES B-METH, V35, P789, DOI 10.1016/S0191-2615(00)00023-0
   Delgado F, 2012, TRANSPORT RES B-METH, V46, P1202, DOI 10.1016/j.trb.2012.04.005
   Delgado F, 2009, TRANSPORT RES REC, P59, DOI 10.3141/2090-07
   dell'Olio L, 2012, TRANSPORTATION, V39, P449, DOI 10.1007/s11116-011-9332-2
   Delle Site P, 1998, TRANSPORT RES A-POL, V32, P19, DOI 10.1016/S0965-8564(97)00016-5
   Di Carlo P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235943
   Du Toit A, 2020, NAT REV MICROBIOL, V18, P3, DOI 10.1038/s41579-019-0305-3
   Dzisi Emmanuel Komla Junior, 2020, Transp Res Interdiscip Perspect, V7, P100191, DOI 10.1016/j.trip.2020.100191
   Eberlein XJ, 2001, TRANSPORT SCI, V35, P1, DOI 10.1287/trsc.35.1.1.10143
   Eranki A., 2004, MODEL CREATE BUS TIM
   Fu JM, 2013, INT CONF INFO SCI, P35
   Fu LP, 2003, TRANSPORT RES REC, P48, DOI 10.3141/1857-06
   Furth P.G., 1987, TRANSPORT RES REC, V1108, P42
   Furth P.G., 1981, TRANSPORT RES REC, V818, P1
   Gavriilidou A, 2019, TRANSPORTMETRICA A, V15, P215, DOI 10.1080/23249935.2018.1458757
   Ghaemi N, 2017, PUBLIC TRANSPORT, V9, P343, DOI 10.1007/s12469-017-0157-z
   Gkiotsalitis K, 2020, TRANSPORT RES C-EMER, V110, P143, DOI 10.1016/j.trc.2019.11.009
   Gkiotsalitis K, 2019, TRANSPORT RES E-LOG, V128, P30, DOI 10.1016/j.tre.2019.05.016
   Gkiotsalitis K, 2019, TRANSPORT RES C-EMER, V98, P14, DOI 10.1016/j.trc.2018.11.007
   Gkiotsalitis K, 2018, TRANSPORT RES C-EMER, V88, P187, DOI 10.1016/j.trc.2018.01.026
   Gkiotsalitis K., 2020, OPTIMAL FREQUENCY SE
   Gkiotsalitis K., 2006, APPL ADV TECHNOLOGY, P737
   Gkiotsalitis K., 2019, IEEE T INTELL TRANSP
   Gkiotsalitis K, 2021, TRANSPORTMETRICA A, V17, P492, DOI 10.1080/23249935.2020.1798554
   Gkiotsalitis K, 2019, TRANSPORT RES REC, V2673, P611, DOI 10.1177/0361198119834549
   Gkiotsalitis K, 2019, TRANSPORTMETRICA B, V7, P1258, DOI 10.1080/21680566.2019.1606743
   Gray RS, 2020, CAN J AGR ECON, V68, P239, DOI 10.1111/cjag.12235
   Greenhalgh T, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1435
   Hernandez A. T., 2020, WHAT WE KNOW WHAT WE
   Hernandez D, 2015, TRANSPORT RES B-METH, V78, P83, DOI 10.1016/j.trb.2015.04.011
   Hickman MD, 2001, TRANSPORT SCI, V35, P215, DOI 10.1287/trsc.35.3.215.10150
   Ibarra-Rojas OJ, 2015, TRANSPORT RES B-METH, V77, P38, DOI 10.1016/j.trb.2015.03.002
   Ibarra-Rojas OJ, 2012, TRANSPORT RES B-METH, V46, P599, DOI 10.1016/j.trb.2012.01.006
   Iliopoulou C, 2019, PUBLIC TRANSPORT, V11, P487, DOI 10.1007/s12469-019-00211-2
   Islam N, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2743
   Jamili A, 2015, TRANSPORT RES C-EMER, V61, P63, DOI 10.1016/j.trc.2015.09.013
   JARVIS CI, 2020, BMC MED, V18, DOI [10.1186/s12916-020-01597-8, DOI 10.1186/S12916-020-01597-8]
   Javid B, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1442
   Jeffords S., 2020, TRANSIT RIDERSHIP RE
   Jenelius E, 2015, TRANSPORTMETRICA A, V11, P819, DOI 10.1080/23249935.2015.1087232
   Jiang F, 2020, J GEN INTERN MED, V35, P1545, DOI 10.1007/s11606-020-05762-w
   Jones NR, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3223
   Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0
   Li Z, 2013, REV PAC BASIN FINANC, V16, DOI 10.1142/S0219091513500069
   McDaniels T, 2008, GLOBAL ENVIRON CHANG, V18, P310, DOI 10.1016/j.gloenvcha.2008.03.001
   Morawska L, 2020, CLIN INFECT DIS, V71, P2311, DOI 10.1093/cid/ciaa939
   Muller S.A., 2020, EPIDEMIOLOGY
   Musselwhite C, 2020, J TRANSP HEALTH, V16, DOI 10.1016/j.jth.2020.100853
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Oded Cats, 2020, VIRUS SPREADING PUBL
   Pawar Digvijay S, 2020, Transp Res Interdiscip Perspect, V7, P100203, DOI 10.1016/j.trip.2020.100203
   Potter S, 2003, HB TRANSPORT, V4, P247
   Puong A, 2008, LECT NOTES ECON MATH, V600, P319
   Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213
   Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V33, DOI 10.1016/j.tmaid.2020.101578
   Rubensson I, 2020, J TRANSP GEOGR, V89, DOI 10.1016/j.jtrangeo.2020.102890
   Saez D, 2012, TRANSPORTMETRICA, V8, P61, DOI 10.1080/18128601003615535
   Sanchez-Martinez GE, 2016, TRANSPORT RES B-METH, V83, P1, DOI 10.1016/j.trb.2015.11.013
   Schultz K, 2020, NEW YORK TIMES
   Severo M., MEDRXIV2020091820195, DOI [10.1101/2020.09.18.20195776, DOI 10.1101/2020.09.18.20195776]
   Shelat S., 2020, WORKING PAPER
   Shen J, 2020, ENVIRON POLLUT, V266, DOI 10.1016/j.envpol.2020.115291
   Shen Y, 2020, JAMA INTERN MED, V180, P1665, DOI 10.1001/jamainternmed.2020.5225
   Shrivastava P, 2009, EUR TRANSP
   Sun A., 2005, J INTELL TRANSP SYST, V9, P91, DOI DOI 10.1080/15472450590934642
   Sun AC, 2008, LECT NOTES ECON MATH, V600, P339
   Szeto WY, 2011, EUR J OPER RES, V209, P141, DOI 10.1016/j.ejor.2010.08.020
   Tan C., 2020, CORONAVIRUS REDUCED
   Teixeira A, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05306
   TfL, 2020, CHECK LAT TRAV INF F
   Tirachini A, 2020, J PUBLIC TRANSPORT, V22, P1, DOI 10.5038/2375-091.22.1.1
   Troko J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-16
   UITP, 2020, PUBL TRANSP AUTH COV
   UITP, 2020, COVID 19 PAND RES PU
   Vansteenwegen P, 2006, EUR J OPER RES, V173, P337, DOI 10.1016/j.ejor.2004.12.013
   Verbas IO, 2013, TRANSPORT RES REC, P50, DOI 10.3141/2334-06
   Verbas IO, 2015, TRANSPORT RES B-METH, V81, P577, DOI 10.1016/j.trb.2015.06.018
   Verbas IO, 2015, PUBLIC TRANSPORT, V7, P1, DOI 10.1007/s12469-013-0084-6
   Vuorinen V, 2020, SAFETY SCI, V130, DOI 10.1016/j.ssci.2020.104866
   Wagner A., 2020, COVID 19 OUTBREAK IM
   Wang XR, 2017, PHYSICA A, V474, P19, DOI 10.1016/j.physa.2017.01.072
   WANG Y, 2015, IEEE T INTELL TRANSP, V16, P3337, DOI DOI 10.1109/TITS.2015.2445920
   Wang YY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-34
   WMATA, 2020, CUST SHOULD WEAR CLO
   Wong RCW, 2008, TRANSPORT SCI, V42, P57, DOI 10.1287/trsc.1070.0200
   Wu WT, 2019, TRANSPORT RES E-LOG, V130, P61, DOI 10.1016/j.tre.2019.08.012
   Wu WT, 2017, TRANSPORT RES B-METH, V104, P175, DOI 10.1016/j.trb.2017.06.019
   Xu SQ, 2020, LANCET, V395, P1321, DOI 10.1016/S0140-6736(20)30845-X
   Xuan YG, 2011, TRANSPORT RES B-METH, V45, P1831, DOI 10.1016/j.trb.2011.07.009
   Yang X, 2020, J HAZARD MATER, V397, DOI 10.1016/j.jhazmat.2020.122609
   Yap M, 2019, TRANSPORT RES C-EMER, V98, P433, DOI 10.1016/j.trc.2018.12.013
   Yu B, 2012, TRANSPORT RES C-EMER, V22, P58, DOI 10.1016/j.trc.2011.12.003
   Yu B, 2010, J TRANSP ENG-ASCE, V136, P576, DOI 10.1061/(ASCE)TE.1943-5436.0000119
   Zhang D, 2011, INT PROC COMPUT SCI, V7, P6
   Zheng RZ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101626
   Zolfaghari S., 2004, INT J TRANSPORT MANA, V2, P99, DOI DOI 10.1016/J.IJTM.2005.02.001
NR 125
TC 51
Z9 51
U1 34
U2 53
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0144-1647
EI 1464-5327
J9 TRANSPORT REV
JI Transp. Rev.
PD MAY 4
PY 2021
VL 41
IS 3
BP 374
EP 392
DI 10.1080/01441647.2020.1857886
EA DEC 2020
PG 19
WC Transportation
WE Social Science Citation Index (SSCI)
SC Transportation
GA RU1IY
UT WOS:000597010200001
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Dang, HAH
   Trinh, TA
AF Dang, Hai-Anh H.
   Trong-Anh Trinh
TI Does the COVID-19 lockdown improve global air quality? New
   cross-national evidence on its unintended consequences
SO JOURNAL OF ENVIRONMENTAL ECONOMICS AND MANAGEMENT
LA English
DT Article
DE COVID-19; Air pollution; Mobility restriction; RDD
ID REGRESSION-DISCONTINUITY; TRADE GOOD; ENVIRONMENT; POLLUTION
AB Despite a growing literature on the impacts of the COVID-19 pandemic, scant evidence currently exists on its impacts on air quality. We offer an early assessment with cross-national evidence on the causal impacts of COVID-19 on air pollution. We assemble a rich database consisting of daily, sub-national level data of air quality for 164 countries before and after the COVID-19 lockdowns and we analyze it using a Regression Discontinuity Design approach. We find the global concentration of NO2 and PM2.5 to decrease by 5 percent and 4 percent, respectively, using data-driven optimal bandwidth selection. These results are consistent across measures of air quality and data sources and robust to various model specifications and placebo tests. We also find that mobility restrictions following the lockdowns are a possible explanation for improved air quality. (C) 2020 Published by Elsevier Inc.
C1 [Dang, Hai-Anh H.; Trong-Anh Trinh] World Bank, Dev Data Grp, Data Prod & Methods Unit, 1818 H St NW, Washington, DC 20433 USA.
   [Dang, Hai-Anh H.] Indiana Univ, IZA, GLO, Bloomington, IN 47405 USA.
   [Dang, Hai-Anh H.] Vietnam Acad Social Sci, Hanoi, Vietnam.
RP Dang, HAH (corresponding author), World Bank, Dev Data Grp, Data Prod & Methods Unit, 1818 H St NW, Washington, DC 20433 USA.
EM hdang@worldbank.org; tronganh.trinh@rmit.edu.au
RI Dang, Hai-Anh/AAW-5169-2021
OI Dang, Hai-Anh/0000-0003-4913-5291
FU UK Department of International Development through a through a Knowledge
   for Change (KCP) grant for the World Development Report 2021 "Data for
   Better Lives"; World Bank Young Fellows Program in Forced Displacement
FX We would like to thank the editor Nicholas Rivers, two anonymous
   reviewer, Dean Jolliffe, and Paolo Verme for helpful discussions on
   earlier versions. Dang would also like to thank the UK Department of
   International Development for additional funding assistance through a
   Knowledge for Change (KCP) grant for the World Development Report 2021
   "Data for Better Lives". Trinh acknowledges support from the World Bank
   Young Fellows Program in Forced Displacement.
CR Acemoglu D, 2019, J POLIT ECON, V127, P47, DOI 10.1086/700936
   Achakulwisut P, 2019, LANCET PLANET HEALTH, V3, pE166, DOI 10.1016/S2542-5196(19)30046-4
   Akesson J., 2020, FATALISM BELIEFS BEH
   Anderson ML, 2014, AM ECON REV, V104, P2763, DOI 10.1257/aer.104.9.2763
   Antweiler W, 2001, AM ECON REV, V91, P877, DOI 10.1257/aer.91.4.877
   Auffhammer M, 2011, AM ECON REV, V101, P2687, DOI 10.1257/aer.101.6.2687
   Baker SD, 2020, REV ASSET PRICING ST, V10, P1, DOI 10.1093/rapstu/raz001
   Barreca AI, 2011, Q J ECON, V126, P2117, DOI 10.1093/qje/qjr042
   Brodeur A, 2021, J ECON SURV, V35, P1007, DOI 10.1111/joes.12423
   Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8
   Calonico S, 2014, ECONOMETRICA, V82, P2295, DOI 10.3982/ECTA11757
   Chen K, 2020, LANCET PLANET HEALTH, V4, pE210, DOI 10.1016/S2542-5196(20)30107-8
   Chen Y, 2012, AM ECON J-ECON POLIC, V4, P58, DOI 10.1257/pol.4.1.58
   Cicala S., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts), DOI 10.3386/w27135
   Cole M., 2020, IZA DISCUSSION PAPER
   Dang HAH, 2021, WORLD DEV, V140, DOI 10.1016/j.worlddev.2020.105296
   Davis LW, 2008, J POLIT ECON, V116, P38, DOI 10.1086/529398
   Dutheil F, 2020, ENVIRON POLLUT, V263, DOI 10.1016/j.envpol.2020.114466
   Fairlie RobertW, 2020, W27246 NAT BUR EC RE
   Frankel JA, 2005, REV ECON STAT, V87, P85, DOI 10.1162/0034653053327577
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8
   Gelman A, 2019, J BUS ECON STAT, V37, P447, DOI 10.1080/07350015.2017.1366909
   Gorodnichenko Y, 2017, REV ECON STAT, V99, P402, DOI 10.1162/REST_a_00599
   Hahn JY, 2001, ECONOMETRICA, V69, P201, DOI 10.1111/1468-0262.00183
   Hale T, 2020, VARIATION GOVT RESPO
   Hausman C, 2018, ANNU REV RESOUR ECON, V10, P533, DOI 10.1146/annurev-resource-121517-033306
   He GJ, 2020, NAT SUSTAIN, V3, DOI 10.1038/s41893-020-0581-y
   Imbens G, 2012, REV ECON STUD, V79, P933, DOI 10.1093/restud/rdr043
   Lee DS, 2010, J ECON LIT, V48, P281, DOI 10.1257/jel.48.2.281
   Lenzen M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235654
   Li ZG, 2015, ECON LETT, V128, P72, DOI 10.1016/j.econlet.2015.01.014
   Liu C, 2019, NEW ENGL J MED, V381, P705, DOI 10.1056/NEJMoa1817364
   Managi S, 2009, J ENVIRON ECON MANAG, V58, P346, DOI 10.1016/j.jeem.2009.04.008
   Pestel, 2020, IZA DISCUSSION PAPER
   Tarui, 2020, 202016 U HAW MAN DEP
   Tobias A, 2020, SCI TOTAL ENVIRON, V726, DOI 10.1016/j.scitotenv.2020.138540
   Venter ZS, 2020, P NATL ACAD SCI USA, V117, P18984, DOI 10.1073/pnas.2006853117
   Viard VB, 2015, J PUBLIC ECON, V125, P98, DOI 10.1016/j.jpubeco.2015.02.003
   Zambrano-Monserrate MA, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138813
   Zhang S., 2020, DID COVID 19 IMPROVE
NR 40
TC 17
Z9 18
U1 38
U2 56
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0095-0696
EI 1096-0449
J9 J ENVIRON ECON MANAG
JI J.Environ.Econ.Manage.
PD JAN
PY 2021
VL 105
AR 102401
DI 10.1016/j.jeem.2020.102401
PG 25
WC Business; Economics; Environmental Studies
WE Social Science Citation Index (SSCI)
SC Business & Economics; Environmental Sciences & Ecology
GA PR2SA
UT WOS:000607089900009
OA Bronze
DA 2022-04-20
ER

PT J
AU Aldhmadi, BK
   Itumalla, R
   Kumar, R
   Perera, B
AF Aldhmadi, Badr K.
   Itumalla, Ramaiah
   Kumar, Rakesh
   Perera, Bilesha
TI Feelings, Behavioral Actions and Depressive Symptoms Related to COVID-19
   among Undergraduates in Hail, Saudi Arabia
SO HEALTHCARE
LA English
DT Article
DE COVID-19; depressive symptomatology; feelings; behavioral acts;
   undergraduates
ID KNOWLEDGE; STUDENTS; IMPACT; SCALE
AB The severe acute respiratory syndrome coronavirus 2 (COVID-19) outbreak has had a profound psychological impact on university undergraduates. Feelings, behavioral actions, and depressive symptoms related to COVID-19 in undergraduates in Hail, Saudi Arabia, were assessed using an online survey. Eighteen feelings and six behavioral acts were assessed. The Center for Epidemiological Studies Depression Scale was used to measure depressive symptomatology. Descriptive statistics and logistic regression techniques were used. The mean age of the participants (n = 418) was 20.2 years (standard deviation (SD) = 1.8 years), and 52.9% (n = 221) were males. Elevated levels of depressive symptoms were reported by 47.1% of male and 51.3% of female participants. Social isolation, loss of interest, obsessive monitoring of symptoms, concentration difficulties, recurrent negative thoughts, and worries about health services emerged as vital negative feelings related to COVID-19 that were expressed by the participants. Younger age (odds ratio (OR) = 0.636, 95% confidence interval (95% CI) = 0.428-0.946) and coming from the middle-income category (OR = 0.388, 95% CI = 0.151-0.994) were found to be protective factors against developing depressive symptoms. Frequent cleaning of hands, wearing masks when going out, and adherence to social distancing rules were practiced by 71.5% (95% CI = 67.2-75.8%), 78.7% (95% CI = (74.4-82.5%) and 66.0% (95% CI = (61.3-70.5%) of the participants, respectively. These behavioral acts were not associated with the development of depressive symptoms. Although the practice of COVID-19 precautionary measures by the participants was satisfactory, nearly half of the participants reported depressive symptoms. Innovative educational strategies are needed to curb concentration difficulties and social isolation experienced by undergraduates during outbreaks such as COVID-19.
C1 [Aldhmadi, Badr K.; Itumalla, Ramaiah; Kumar, Rakesh; Perera, Bilesha] Univ Hail, Coll Publ Hlth & Hlth Informat, Dept Hlth Management, POB 2440, Hail, Saudi Arabia.
RP Aldhmadi, BK (corresponding author), Univ Hail, Coll Publ Hlth & Hlth Informat, Dept Hlth Management, POB 2440, Hail, Saudi Arabia.
EM b.aldhmadi@uoh.edu.sa; r.itumalla@uoh.edu.sa; ra.kumar@uoh.edu.sa;
   bileshap@gmail.com
OI Itumalla, Dr. Ramaiah/0000-0002-6090-9641; Aldhmadi,
   Badr/0000-0002-3012-5766
FU Scientific Research Deanship, University of Hail, Saudi Arabia
   [COVID-1930]
FX This research was funded by the Scientific Research Deanship, University
   of Hail, Saudi Arabia (Project Number COVID-1930).
CR Abdulrahim H., 2020, ASIAN J DIS ED, V15, P291
   Al-Kumaim NH, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13052546
   Al-Otaibi ST, 2020, SAUDI MED J, V41, P1285, DOI 10.15537/smj.2020.12.25459
   Algaissi AA, 2020, J INFECT PUBLIC HEAL, V13, P834, DOI 10.1016/j.jiph.2020.04.016
   Alghamdi AA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250026
   Alqurshi A, 2020, SAUDI PHARM J, V28, P1075, DOI 10.1016/j.jsps.2020.07.008
   Atique S, 2020, INFECT DIS HEALTH, V25, P219, DOI 10.1016/j.idh.2020.04.001
   Blake H, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17092997
   Blustein DL, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103436
   Browning MHEM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245327
   Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934
   Elmer T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236337
   Essau CA, 2013, CHILD PSYCHIAT HUM D, V44, P123, DOI 10.1007/s10578-012-0314-1
   Ghubash R, 2000, INT J SOC PSYCHIATR, V46, P241, DOI 10.1177/002076400004600402
   Grubic N, 2020, INT J SOC PSYCHIATR, V66, P517, DOI 10.1177/0020764020925108
   Guner R, 2020, TURK J MED SCI, V50, P571, DOI 10.3906/sag-2004-146
   Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3
   Irfan F., 2019, J NAT SCI MED, V2, P237, DOI [10.4103/JNSM.JNSM_68_18, DOI 10.4103/JNSM.JNSM_68_18]
   Islam MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238162
   Jones HE, 2021, J URBAN HEALTH, V98, P187, DOI 10.1007/s11524-020-00506-x
   Kadam AB, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa057
   Lambert H, 2020, LANCET PLANET HEALTH, V4, pE312, DOI 10.1016/S2542-5196(20)30168-6
   Lee J, 2021, INNOV HIGH EDUC, V46, P519, DOI 10.1007/s10755-021-09552-y
   Mofijur M, 2021, SUSTAIN PROD CONSUMP, V26, P343, DOI 10.1016/j.spc.2020.10.016
   Naser AY, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1730
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Orso D, 2020, EUR J EMERG MED, V27, P327, DOI 10.1097/MEJ.0000000000000713
   Parikhani AB, 2021, CURR MICROBIOL, V78, P1099, DOI 10.1007/s00284-021-02396-x
   Patias N.D., 2021, TRENDS PSYCHOL, V29, P414, DOI [10.1007/s43076-021-00069-z, DOI 10.1007/S43076-021-00069-Z]
   Porter C., 2021, BMJ OPEN, V11, pe049653, DOI [10.1136/BMJOPEN-2021-049653, DOI 10.1136/bmjopen-2021-049653]
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rodriguez-Besteiro S, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18083908
   Tanveer M., 2020, J ENTREP ED, V23, P1
   Wang XM, 2020, J MED INTERNET RES, V22, DOI 10.2196/22817
   Wang ZH, 2020, J AFFECT DISORDERS, V275, P188, DOI 10.1016/j.jad.2020.06.034
   World Health Organization, COR DIS COVID 19 OUT
   Worldometer, 2021, COR UPD
   Zhao B, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9040433
NR 38
TC 0
Z9 0
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9032
J9 HEALTHCARE-BASEL
JI Healthcare
PD OCT
PY 2021
VL 9
IS 10
AR 1280
DI 10.3390/healthcare9101280
PG 10
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA WM8ZE
UT WOS:000711366600001
PM 34682960
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Perillat, L
   Baigrie, BS
AF Perillat, Lucie
   Baigrie, Brian S.
TI COVID-19 and the generation of novel scientific knowledge: Research
   questions and study designs
SO JOURNAL OF EVALUATION IN CLINICAL PRACTICE
LA English
DT Article
DE epistemology; evidence&#8208; based medicine; medical research;
   philosophy of medicine
ID CLINICAL-TRIALS; PNEUMONIA; PATIENT; ETHICS
AB Rationale, aims, and objectives One of the sectors challenged by the COVID-19 pandemic is medical research. COVID-19 originates from a novel coronavirus (SARS-CoV-2) and the scientific community is faced with the daunting task of creating a novel model for this pandemic or, in other words, creating novel science. This paper is the first part of a series of two papers that explore the intricate relationship between the different challenges that have hindered biomedical research and the generation of scientific knowledge during the COVID-19 pandemic.
   Methods During the early stages of the pandemic, research conducted on hydroxychloroquine (HCQ) was chaotic and sparked several heated debates with respect to the scientific methods used and the quality of knowledge generated. Research on HCQ is used as a case study in both papers. The authors explored biomedical databases, peer-reviewed journals, pre-print servers, and media articles to identify relevant literature on HCQ and COVID-19, and examined philosophical perspectives on medical research in the context of this pandemic and previous global health challenges.
   Results This paper demonstrates that a lack of prioritization among research questions and therapeutics was responsible for the duplication of clinical trials and the dispersion of precious resources. Study designs, aimed at minimising biases and increasing objectivity, were, instead, the subject of fruitless oppositions. The duplication of research works, combined with poor-quality research, has greatly contributed to slowing down the creation of novel scientific knowledge.
   Conclusions The COVID-19 pandemic presented challenges in terms of (1) finding and prioritising relevant research questions and (2) choosing study designs that are appropriate for a time of emergency.
C1 [Perillat, Lucie] Univ Toronto, Fac Arts & Sci, 100 St George St, Toronto, ON M5S 3G3, Canada.
   [Baigrie, Brian S.] Univ Toronto, Inst Hist & Philosophy Sci & Technol, Toronto, ON, Canada.
   [Baigrie, Brian S.] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
RP Perillat, L (corresponding author), Univ Toronto, Fac Arts & Sci, 100 St George St, Toronto, ON M5S 3G3, Canada.
EM lucie.perillat@mail.utoronto.ca
OI Perillat, Lucie/0000-0002-5124-8570
CR 4CE 4CE, 2020, CONSORTIUM CLIN CHAR
   Abramowitz S., 2018, DATA SHARING PUBLIC, P124
   Adaptive Platform Trials Coalition, 2019, Nat Rev Drug Discov, V18, P797, DOI 10.1038/s41573-019-0034-3
   Adebamowo C, 2014, LANCET, V384, P1423, DOI 10.1016/S0140-6736(14)61734-7
   Ahmad I, 2020, DOXYCYCLINE HYDROXYC, DOI [DOI 10.1101/2020.05.18.20066902, 10.1101/2020.05.18.20066902]
   Alexander PE, 2020, J CLIN EPIDEMIOL, V123, P120, DOI 10.1016/j.jclinepi.2020.04.016
   Angus DC, 2020, JAMA-J AM MED ASSOC, V324, P1317, DOI 10.1001/jama.2020.17022
   Angus DC, 2020, ANN AM THORAC SOC, V17, P879, DOI 10.1513/AnnalsATS.202003-192SD
   Angus DC, 2020, JAMA-J AM MED ASSOC, V323, P1895, DOI 10.1001/jama.2020.4984
   Angus DC, 2015, JAMA-J AM MED ASSOC, V314, P767, DOI 10.1001/jama.2015.7762
   [Anonymous], 2020, UN NEWS
   Arshad S, 2020, INT J INFECT DIS, V97, P396, DOI 10.1016/j.ijid.2020.06.099
   Baigrie B, 2020, J EVAL CLIN PRACT, V26, P1341, DOI 10.1111/jep.13474
   Bansal P, 2021, ANN MED, V53, P117, DOI 10.1080/07853890.2020.1839959
   Barbosa J, 2020, NAT NEUROSCI, V23, P1016, DOI 10.1038/s41593-020-0644-4
   Bedford J, 2019, NATURE, V575, P130, DOI 10.1038/s41586-019-1717-y
   Borba MGS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8857
   Brat GA., 2020, INT ELECT HLTH RECOR, DOI [10.1101/.20059691, DOI 10.1101/.20059691]
   Caplan AL, 2020, J CLIN INVEST, V130, P2752, DOI 10.1172/JCI139562
   CAPTIC CAPTIC, 2020, REMAP CAP TRIAL
   Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9
   Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902
   Chen CP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242763
   Chen Jun, 2020, Zhejiang Da Xue Xue Bao Yi Xue Ban, V49, P215, DOI 10.3785/j.issn.1008-9292.2020.03.03
   Chen L., 2020, EFFICACY SAFETY CHLO, DOI [10.1101/.20136093, DOI 10.1101/.20136093]
   Chowdhury MDS, 2020, ACAD EMERG MED, V27, P493, DOI 10.1111/acem.14005
   Cochrane Response Cochrane Response, 2020, TARGETED UPDATE SAFE, P1
   Cook DJ, 2020, JAMA-J AM MED ASSOC, V323, P1559, DOI 10.1001/jama.2020.5775
   Cosgriff CV, 2020, LANCET DIGIT HEALTH, V2, pE224, DOI 10.1016/S2589-7500(20)30082-0
   COVID-19 CP COVID-19 CP, 2020, COVID 19 COLLABORATI
   Cummings J., 2006, ADULTS AMBIVALENT RI
   Das S, 2017, CONTEMP CLIN TRIALS, V62, P168, DOI 10.1016/j.cct.2017.09.002
   Davido B, 2020, HYDROXYCHLOROQUINE P, DOI [10.1101/2020.05.05.20088757, DOI 10.1101/2020.05.05.20088757]
   de Novales FJM, 2020, EARLY HYDROXYCHLOROQ, DOI [10.20944/preprints202005.0057.v1, 10.20944/preprints202005.0057.v2, DOI 10.20944/PREPRINTS202005.0057.V1]
   Dean NE, 2020, NEW ENGL J MED, V382, P1366, DOI 10.1056/NEJMsb1905390
   Edwards KM, 2020, ANNU REV VIROL, V7, P475, DOI 10.1146/annurev-virology-013120-013123
   El Emam K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1139
   Faico-Filho KS., 2020, EFFECT HYDROXYCHLORO, DOI [10.1101/2020.06.16.20133066, DOI 10.1101/2020.06.16.20133066]
   (FDA) FaDA, 2020, COR COVID 19 UPD FDA
   FDA FDA, 2020, HYDR FACT SHEET HLTH
   Feuer W., 2020, WHO RESUMES CORONAVI
   Funck-Brentano Christian, 2020, Lancet, DOI 10.1016/S0140-6736(20)31174-0
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gautret P, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101663
   Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410
   Glasziou PP, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1847
   Global Citizen Global Citizen, 2020, ASK EXP WHY AR THER
   Goozner M, 2012, J NATL CANCER I, V104, P1347, DOI 10.1093/jnci/djs404
   Hey Spencer Phillips, 2015, Clin Trials, V12, P102, DOI 10.1177/1740774514563583
   Horby P., 2020, RECOVERY TRIAL RANDO
   Horby P, 2020, NEW ENGL J MED, V383, P2030, DOI 10.1056/NEJMoa2022926
   Huang Mingxing, 2020, Natl Sci Rev, V7, P1428, DOI 10.1093/nsr/nwaa113
   INSERM INSERM, 2020, SCI SANT COVID 19 ES
   Ip A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237693
   Kalil AC, 2020, JAMA-J AM MED ASSOC, V323, P1897, DOI 10.1001/jama.2020.4742
   Keusch G, 2017, INTEGRATING CLIN RES
   Kim AHJ, 2020, ANN INTERN MED, V172, P819, DOI 10.7326/M20-1223
   Kim MS, 2020, TREATMENT RESPONSE H
   Komorowski M, 2020, LANCET DIGIT HEALTH, V2, pE345, DOI 10.1016/S2589-7500(20)30132-1
   Lecronier M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03117-9
   Lemaitre, 2020, HYDROXYCHLOROQUINE A, DOI [10.1101/2020.06.16.20132597., DOI 10.1101/2020.06.16.20132597, 10.1101/2020.06.16.20132597]
   London AJ, 2020, SCIENCE, V368, P476, DOI 10.1126/science.abc1731
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Lurie N, 2013, NEW ENGL J MED, V368, P1251, DOI 10.1056/NEJMsb1209510
   Magagnoli J, 2020, MED-CAMBRIDGE, V1, P114, DOI [10.1016/j.medj.2020.06.001, 10.1101/2020.04.16.20065920]
   Mahevas M, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1844, 10.1136/bmj.m2328]
   Mallat J., 2020, HYDROXYCHLOROQUINE I
   Meagher KM, 2020, MAYO CLIN PROC, V95, P1119, DOI 10.1016/j.mayocp.2020.04.019
   Mehra MR, 2020, LANCET, V395, P1820, DOI [10.1016/S0140-6736(20)31180-6, 10.1016/S0140-6736(20)31324-6]
   Meyer N, 2020, MONDE
   Million M, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101738
   Ministre de la Sante et des Solidarites Ministre de la Sante et des Solidarites, 2020, AV HAUT CONS SANT PU
   Mitja O, 2021, CLIN INFECT DIS, V73, pE4073, DOI 10.1093/cid/ciaa1009
   Molina JM, 2020, MED MALADIES INFECT, V50, P384, DOI 10.1016/j.medmal.2020.03.006
   Muller MP, 2004, EMERG INFECT DIS, V10, P389
   NIH NIH, 2018, TRIAL INNOVATION NET
   Paccoud O, 2021, CLIN INFECT DIS, V73, pE4064, DOI 10.1093/cid/ciaa791
   Perillat L, 2021, J EVAL CLIN PRACT, V27, P694, DOI 10.1111/jep.13550
   Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021
   Raoult D., 2020, MEDECIN PEUT DOIT RE
   RECOVERY RECOVERY, 2020, DEF DER BAS CHAR OUT
   RECOVERY RECOVERY, 2020, STAT ANAL PLAN RECOV
   RECOVERY RECOVERY, 2020, RANDOMISED EVALUATIO
   RECOVERY RECOVERY, 2020, STATEMENT CHIEF INVE
   REMAP-CAP REMAP-CAP, 2020, REMAP CAP RANDOMIZED
   REMAP-CAP REMAP-CAP, 2019, REMAP CAP APPENDIX C
   REMAP-CAP REMAP-CAP, 2019, REMAP CAP CORE PROTO
   REMAP-CAP REMAP-CAP, PANDEMIC PREPAREDNES
   REMAP-CAP REMAP-CAP, 2020, DOMAIN SPECIFIC APPE
   Rojek AM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0760-x
   Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630
   Sacristan JA, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/1471-2288-15-4
   Sattui SE, 2020, EXPERT REV CLIN IMMU, V16, P659, DOI 10.1080/1744666X.2020.1792778
   Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012
   Singh S., 2020, OUTCOMES HYDROXYCHLO
   Skipper CP, 2020, ANN INTERN MED, V173, P623, DOI 10.7326/M20-4207
   SMART IRB SMART IRB, SMART IRB NATL IRB R
   Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459
   Smith MJ, 2020, AM J PUBLIC HEALTH, V110, P947, DOI 10.2105/AJPH.2020.305686
   Suranagi UD, 2020, REV CURRENT EVIDENCE, DOI [10.1101/2020.04.16.20068205, DOI 10.1101/2020.04.16.20068205]
   Tang W, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1849
   Tansey CM, 2010, CAN MED ASSOC J, V182, P1533, DOI 10.1503/cmaj.090976
   U.S. Department of Health and Human Services Food and Drug Administration  Center for Drug Evaluation and Research (CDER)  Center for Biologics Evaluation and Research (CBER) U.S. Department of Health and Human Services Food and Drug Administration  Center for Drug Evaluation and Research (CDER)  Center for Biologics Evaluation and Research (CBER), 2019, ADAPTIVE DESIGNS CLI
   UPMC UPMC, 2020, LED GLOB EFF FAST TR
   Upshur NE., 2019, OXFORD HDB PUBLIC HL, P796
   Waston J., 2020, OPEN LETT MR MEHRA S
   Watson J.A., 2020, LONGISH POST PUBLICA
   WHO, 2020, WHO R D BLUEPRINT IN
   WHO WHO, 2016, GUIDANCE MANAGING ET
   WHO WHO, 2020, COVID 19 LIVING RES
   WHO WHO, 2015, WHO CONSULTATION DAT
   WHO WHO, 2020, ETHICAL STANDARDS RE
   WHO WHO, 2016, R D BLUEPRINT ACTION
   Wilder-Smith A, 2020, LANCET INFECT DIS, V20, pE102, DOI 10.1016/S1473-3099(20)30129-8
   Wittich CM, 2012, MAYO CLIN PROC, V87, P982, DOI 10.1016/j.mayocp.2012.04.017
   World Health Organisation, 2020, COORD GLOB RES ROADM
   World Health Organization, 2020, COR DIS COVID 19 HYD
   World Health Organization, 2020, WHO R D BLUEPRINT NO
   Xu XN, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00251-x
   Yan D., 2020, EFFICACY HYDROXYCHLO, DOI 10.1101/2020.03.22.20040758
   Yu B, 2020, HYDROXYCHLOROQUINE A, DOI [10.1101/2020.04.27.20073379, DOI 10.1101/2020.04.27.20073379]
NR 123
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1356-1294
EI 1365-2753
J9 J EVAL CLIN PRACT
JI J. Eval. Clin. Pract.
PD JUN
PY 2021
VL 27
IS 3
BP 694
EP 707
DI 10.1111/jep.13550
EA FEB 2021
PG 14
WC Health Care Sciences & Services; Medical Informatics; Medicine, General
   & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services; Medical Informatics; General & Internal
   Medicine
GA SH9GG
UT WOS:000618052200001
PM 33590660
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Salem, A
   Elamir, H
   Alfoudri, H
   Shamsah, M
   Abdelraheem, S
   Abdo, I
   Galal, M
   Ali, L
AF Salem, Ahmed
   Elamir, Hossam
   Alfoudri, Huda
   Shamsah, Mohammed
   Abdelraheem, Shams
   Abdo, Ibtissam
   Galal, Mohammad
   Ali, Lamiaa
TI Improving management of hospitalised patients with COVID-19: algorithms
   and tools for implementation and measurement
SO BMJ OPEN QUALITY
LA English
DT Article
DE clinical practice guidelines; critical care; decision support; clinical;
   performance measures; quality improvement
ID QUALITY IMPROVEMENT; GUIDELINES; PATHWAYS
AB Background The COVID-19 pandemic represents an unprecedented challenge to healthcare systems and nations across the world. Particularly challenging are the lack of agreed-upon management guidelines and variations in practice. Our hospital is a large, secondary-care government hospital in Kuwait, which has increased its capacity by approximately 28% to manage the care of patients with COVID-19. The surge in capacity has necessitated the redeployment of staff who are not well-trained to manage such conditions. There was a great need to develop a tool to help redeployed staff in decision-making for patients with COVID-19, a tool which could also be used for training.
   Methods Based on the best available clinical knowledge and best practices, an eight member multidisciplinary group of clinical and quality experts undertook the development of a clinical algorithm-based toolkit to guide training and practice for the management of patients with COVID-19. The team followed Horabin and Lewis' seven-step approach in developing the algorithms and a five-step method in writing them. Moreover, we applied Rosenfeld et al's five points to each algorithm.
   Results A set of seven clinical algorithms and one illustrative layout diagram were developed. The algorithms were augmented with documentation forms, data-collection online forms and spreadsheets and an indicators' reference sheet to guide implementation and performance measurement. The final version underwent several revisions and amendments prior to approval.
   Conclusions A large volume of published literature on the topic of COVID-19 pandemic was translated into a user-friendly, algorithm-based toolkit for the management of patients with COVID-19. This toolkit can be used for training and decision-making to improve the quality of care provided to patients with COVID-19.
C1 [Salem, Ahmed] Minist Hlth, Anaesthesia & Intens Care Dept, Sabah Al Ahmad Urol Ctr, Sabah, Kuwait.
   [Salem, Ahmed] Banha Univ, Fac Med, Anaesthesia & Intens Care Dept, Banha, Egypt.
   [Elamir, Hossam; Abdo, Ibtissam; Galal, Mohammad; Ali, Lamiaa] Minist Hlth, Qual & Accreditat Directorate, Safat, Kuwait.
   [Alfoudri, Huda; Shamsah, Mohammed] Minist Hlth, Anaesthesia Crit Care & Pain Management Dept, Adan Hosp, Hadiya, Kuwait.
   [Abdelraheem, Shams] Manchester Univ NHS Fdn Trust, Crit Care Dept, Manchester, Lancs, England.
   [Ali, Lamiaa] Fayoum Univ, Publ Hlth Dept, Fac Med, Al Fayyum, Egypt.
RP Elamir, H (corresponding author), Minist Hlth, Qual & Accreditat Directorate, Safat, Kuwait.
EM dr_hossam_elamir@hotmail.com
RI Elamir, Hossam/D-9537-2018
OI Elamir, Hossam/0000-0002-5573-4023
CR [Anonymous], 2020, COVID 19 TREATMENT G
   [Anonymous], 2020, THERAPEUTICS
   Atallah B, 2020, EUR HEART J-CARD PHA, V6, P260, DOI 10.1093/ehjcvp/pvaa036
   Barnes GD, 2020, J THROMB THROMBOLYS, V50, P72, DOI 10.1007/s11239-020-02138-z
   Camporota L, 2020, VENTILATE COVID 19
   de AMG., 2020, RESP SUPPORT
   de Ruijter A, 2016, SAFETY SCI, V88, P211, DOI 10.1016/j.ssci.2016.03.001
   Djulbegovic B, 2018, J EVAL CLIN PRACT, V24, P1247, DOI 10.1111/jep.12895
   Ferguson NM, 2020, IMPACT NONPHARMACEUT, DOI DOI 10.25561/77482
   Galluccio F, 2020, CLIN RHEUMATOL, V39, P2077, DOI 10.1007/s10067-020-05179-0
   Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2
   GEP B., 1987, EMPIRICAL MODEL BUIL, V1st ed
   Grant MJ, 2009, HEALTH INFO LIBR J, V26, P91, DOI 10.1111/j.1471-1842.2009.00848.x
   GREEN G, 1978, CLIN PEDIATR, V17, P457, DOI 10.1177/000992287801700512
   GREENFIELD S, 1978, WESTERN J MED, V129, P230
   Hajjar L., 2020, HAEMODYNAMIC MANAGEM
   Hasan A, 2020, CUREUS, V12, DOI 10.7759/cureus.7485
   Hasanin A, 2020, J ANESTH, V34, P758, DOI 10.1007/s00540-020-02801-y
   Horabin IS., 1980, ALGORITHMS, V2nd
   Kirkpatrick, 2006, EVALUATING TRAINING
   KOMAROFF AL, 1982, AM J PUBLIC HEALTH, V72, P10, DOI 10.2105/AJPH.72.1.10
   Legg P, 2017, ANN ROY COLL SURG, V99, P280, DOI 10.1308/rcsann.2016.0276
   Leung K, 2020, LANCET, V395, P1382, DOI 10.1016/S0140-6736(20)30746-7
   Long B., 2020, COVID 19 OXYGEN ESCA
   MARGOLIS CZ, 1983, JAMA-J AM MED ASSOC, V249, P627, DOI 10.1001/jama.249.5.627
   Marino PL., 2014, MARINOS ICU BOOK, P487
   Martin GP, 2017, SOCIOL HEALTH ILL, V39, P1314, DOI 10.1111/1467-9566.12585
   Mozena JP., 1996, CLIN GUIDELINE DEV A
   NHS England and NHS Improvement, 2020, CLIN GUID MAN CRIT C CLIN GUID MAN CRIT C
   Ogrinc G, 2015, AM J CRIT CARE, V24, P466, DOI 10.4037/ajcc2015455
   Rosenfeld RM, 2013, OTOLARYNG HEAD NECK, V148, P1, DOI 10.1177/0194599812468849
   Schoel L, 2018, J SURG RES, V230, P131, DOI 10.1016/j.jss.2018.04.043
   Sochet AA, 2018, PEDIATR CRIT CARE ME, V19, pE72, DOI 10.1097/PCC.0000000000001396
   Staines A, 2020, INT J QUAL HEALTH C, V33, P1, DOI [10.1093/intqhc/mzaa050, DOI 10.1093/INTQHC/MZAA050]
   Teoule P, 2020, CANCERS, V12, DOI 10.3390/cancers12020434
   The Public Authority for Civil Information, 2019, POP STAT STAT SERV S POP STAT STAT SERV S
   Vieillard-Baron A., 2020, 5 MINUTES ECHO EXAM
   WHO, 2020, NOV COR 2019 NCOV SI
   Yousuf B, 2020, INTENS CARE MED, V46, P1663, DOI 10.1007/s00134-020-06115-1
NR 39
TC 1
Z9 1
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
EI 2399-6641
J9 BMJ OPEN QUAL
JI BMJ Open Qual.
PD DEC
PY 2020
VL 9
IS 4
AR e001130
DI 10.1136/bmjoq-2020-001130
PG 9
WC Health Care Sciences & Services; Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services; General & Internal Medicine
GA TI1NO
UT WOS:000672550100037
PM 33199287
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Tortorella, G
   Narayanamurthy, G
   Staines, J
AF Tortorella, Guilherme
   Narayanamurthy, Gopalakrishnan
   Staines, Jo
TI COVID-19 Implications on the Relationship between Organizational
   Learning and Performance
SO KNOWLEDGE MANAGEMENT RESEARCH & PRACTICE
LA English
DT Article
DE COVID-19; pandemic; organisational learning; social learning theory;
   transactive memory system theory; service sector; operational
   performance
AB This research examines the implications of COVID-19 on the relationship between organisational learning and operational performance in service organisations. By using social learning theory and transactive memory system theory, we developed competing hypotheses on how organisational learning and COVID-19 outbreak interact with each other to explain 10 their impact on operational performance. To test our hypotheses, we surveyed 106 employees of service organisations who have been remotely working during COVID-19 outbreak. The collected data were analysed through multivariate data techniques. We specifically measured operational performance to assess the organisation's performance as they were the ones immediately affected by the outbreak of COVID-19, which then is expected to have a lagged 15 impact on financial performance. Through exploratory factor analysis, we identified two bundles of COVID-19 work implications, namely home office work environment and social distancing. Results confirmed that home office work environment positively mediates the relationship between organisational learning and operational performance of service organisations. Our research adds to theory, since we evidenced that individuals' behaviours and work environment reciprocally influence each other, even when individuals are actually apart from the usual work environment, asobserved during the pandemic.
C1 [Tortorella, Guilherme; Staines, Jo] Univ Melbourne, Melbourne, Vic, Australia.
   [Tortorella, Guilherme] Univ Fed Santa Catarina, Florianopolis, SC, Brazil.
   [Narayanamurthy, Gopalakrishnan] Univ Liverpool, Liverpool, Merseyside, England.
RP Tortorella, G (corresponding author), Campus Trindade 476, Florianopolis, SC, Brazil.
EM gtortorella@bol.com.br
OI Tortorella, Guilherme/0000-0003-2396-4665; Staines,
   Jo-Anne/0000-0001-6638-8827
CR Ammirato S, 2021, KNOWL MAN RES PRACT, V19, P415, DOI 10.1080/14778238.2020.1801364
   Anderson EG, 2014, ORGAN SCI, V25, P356, DOI 10.1287/orsc.2013.0854
   ARMSTRONG JS, 1977, J MARKETING RES, V14, P396, DOI 10.2307/3150783
   Bachrach DG, 2019, J APPL PSYCHOL, V104, P464, DOI 10.1037/apl0000329
   Balakrishnan V, 2016, TELEMAT INFORM, V33, P808, DOI 10.1016/j.tele.2015.12.004
   Bandura A., 1971, SOCIAL LEARNING THEO
   Berinato S, 2014, HARVARD BUS REV, V92, P28
   Craighead CW, 2020, DECISION SCI, V51, P838, DOI 10.1111/deci.12468
   Davies J, 2013, PROD OPER MANAG, V22, P1494, DOI 10.1111/poms.12052
   Desai V, 2010, IND CORP CHANGE, V19, P713, DOI 10.1093/icc/dtp048
   Edmondson AC, 2001, ADMIN SCI QUART, V46, P685, DOI 10.2307/3094828
   Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272
   Finch JF, 1997, J RES PERS, V31, P439, DOI 10.1006/jrpe.1997.2194
   Fitzsimmons J., 2008, SERVICE MANAGEMENT O, P4
   Fornell C., 1981, J MARK RES, V18, DOI 10.1177/002224378101800104
   Fuchs C., 2020, OPEN ACCESS J GLOBAL, V18, DOI [10.31269/triplec.v18i1.1167, DOI 10.31269/TRIPLEC.V18I1.1167]
   Gil AJ, 2016, KNOWL MAN RES PRACT, V14, P60, DOI 10.1057/kmrp.2014.12
   Golden TD, 2006, J ORGAN BEHAV, V27, P319, DOI 10.1002/job.369
   Graves Laura M., 2020, IEEE Engineering Management Review, V48, P166, DOI 10.1109/EMR.2020.2990386
   GRUSEC JE, 1992, DEV PSYCHOL, V28, P776, DOI 10.1037/0012-1649.28.5.776
   Hair J.F.Jr., 2010, MULTIVARIATE DATA AN, V7th ed.
   Hara N, 2009, INFORM SCI KNOWL MAN, V13, P1
   Harter J.K., 2020, GALLUP
   Harvey J., 2018, HARVARD BUSINESS SCH
   Heraty N., 2004, HUM RESOUR MANAGE R, V14, P449
   Hill EJ, 2003, J VOCAT BEHAV, V63, P220, DOI 10.1016/S0001-8791(03)00042-3
   Hollingshead AB, 2001, J PERS SOC PSYCHOL, V81, P1080, DOI 10.1037//0022-3514.81.6.1080
   Huysman M., 2000, ACCOUNTING MANAGEMEN, V10, DOI [10.1016/S0959-8022(99)00018-1, DOI 10.1016/S0959-8022(99)00018-1]
   IBISWorld, 2020, COR UPD IND FAST FAC
   Kontoghiorghes C., 2005, HUM RESOUR DEV Q, V16, P185, DOI DOI 10.1002/HRDQ.1133
   Lewis K, 2011, ORGAN SCI, V22, P1254, DOI 10.1287/orsc.1110.0647
   Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0
   Malhotra N., 2006, MARKETING RES APPL A
   Marsick VJ, 2013, ADV DEV HUM RESOUR, V15, P127, DOI 10.1177/1523422313475984
   Meyers L. S., 2006, APPL MULTIVARIATE RE
   Muro M, 2008, J ENVIRON PLANN MAN, V51, P325, DOI 10.1080/09640560801977190
   Narayanamurthy G, 2021, INT J PROD ECON, V234, DOI 10.1016/j.ijpe.2021.108075
   Naughton M., 2020, HARVARD BUS REV
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Obayi R, 2017, INT J OPER PROD MAN, V37, P343, DOI 10.1108/IJOPM-12-2015-0775
   Ortenblad A, 2002, INT J MANAG REV, V4, P87, DOI 10.1111/1468-2370.00078
   Paul K, 2020, GUARDIAN
   Pinho C, 2020, INFORM MANAGE-AMSTER, V57, DOI 10.1016/j.im.2019.103208
   PODSAKOFF PM, 1986, J MANAGE, V12, P531, DOI 10.1177/014920638601200408
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213
   Rao RD, 2006, EUR MANAG REV, V3, P77, DOI 10.1057/palgrave.emr.1500057
   Ren YQ, 2006, MANAGE SCI, V52, P671, DOI 10.1287/mnsc.1050.0496
   Rossini M, 2019, INT J ADV MANUF TECH, V102, P3963, DOI 10.1007/s00170-019-03441-7
   Salmador MP, 2013, KNOWL MAN RES PRACT, V11, P374, DOI 10.1057/kmrp.2012.33
   Sanghvi A., 2020, REIMAGINING OFFICE W
   Santa M, 2016, KNOWL MAN RES PRACT, V14, P106, DOI 10.1057/kmrp.2014.22
   SEBRAE, 2010, CRIT CLASS MAN CO BR
   Senge PM., 1990, 5 DISCIPLINE
   Shah R, 2003, J OPER MANAG, V21, P129, DOI 10.1016/S0272-6963(02)00108-0
   SMITH T, 1983, J ROY STAT SOC A STA, V146
   Snethen G, 2008, AGGRESS VIOLENT BEH, V13, P346, DOI 10.1016/j.avb.2008.05.003
   Song JH, 2009, HUM RESOUR DEV Q, V20, P147, DOI 10.1002/hrdq.20013
   Staats BR, 2012, PROD OPER MANAG, V21, P619, DOI 10.1111/j.1937-5956.2011.01254.x
   Tabachnick B.G., 2007, USING MULTIVARIATE S, V5th
   Tortorella Guilherme Luz, 2017, TQM Journal, V29, P610, DOI 10.1108/TQM-11-2016-0102
   Tortorella G, 2021, J SERV THEOR PRACT, V31, P203, DOI 10.1108/JSTP-07-2020-0182
   Tortorella G, 2015, LEARN ORGAN, V22, P229, DOI 10.1108/TLO-02-2015-0008
   Tortorella GL, 2020, INT J PROD ECON, V219, P284, DOI 10.1016/j.ijpe.2019.06.023
   Tortorella GL, 2020, INT J PROD RES, V58, P3650, DOI 10.1080/00207543.2019.1633028
   Tortorella GL, 2018, INT J OPER PROD MAN, V38, P1205, DOI 10.1108/IJOPM-08-2016-0453
   Tortorella GL, 2015, INT J PROD RES, V53, P3989, DOI 10.1080/00207543.2014.980462
   Tortorella GL, 2014, INT J PROD RES, V52, P4623, DOI 10.1080/00207543.2014.881577
   Tovstiga N, 2021, KNOWL MAN RES PRACT, V19, P427, DOI 10.1080/14778238.2020.1806749
   von Gaudecker H., 2020, IZA DISCUSSION PAPER, V13158
   Waizenegger L, 2020, EUR J INFORM SYST, V29, P429, DOI 10.1080/0960085X.2020.1800417
   Watkins, 2003, ADV DEV HUMAN RESOUR, V5, P132, DOI [10.1177/1523422303005002002, DOI 10.1177/1523422303005002002]
   Watkins, 2015, INFORMAL INCIDENTAL
   Wegner D.M., 1987, THEORIES GROUP BEHAV, P185, DOI DOI 10.1007/978-1-4612-4634-3_9
   Wong A., 2006, Asia Pacific Journal of Management, V23, P299, DOI 10.1007/s10490-006-9000-9
   Yang B., 2004, HUM RESOUR DEV Q, V15, P31, DOI DOI 10.1002/HRDQ.1086
   ZHANG SX, 2020, PSYCHIAT RES, V288, DOI DOI 10.1016/J.PSYCHRES.2020.112958
NR 77
TC 4
Z9 4
U1 16
U2 31
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1477-8238
EI 1477-8246
J9 KNOWL MAN RES PRACT
JI Knowl. Manag. Res. Pract.
PD OCT 2
PY 2021
VL 19
IS 4
BP 551
EP 564
DI 10.1080/14778238.2021.1909430
EA APR 2021
PG 14
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA XR8BJ
UT WOS:000639690100001
DA 2022-04-20
ER

PT J
AU Rossmann, K
   Wegner, H
   Stark, H
   Grossmann, G
   Jansen, A
   Frangoulidis, D
AF Rossmann, Katalyn
   Wegner, Heike
   Stark, Hans
   Grossmann, Gerd
   Jansen, Andreas
   Frangoulidis, Dimitrios
TI COVID-19 Pandemic & Bureaucracy: The Crisis Inside the Crisis
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE COVID-19; Cynefin framework; crisis; innovation; layperson training;
   evaluation matrix; public health dashboard; Bundeswehr
AB The Medical Intelligence and Information (MI2) Unit of the German Armed Forces (Bundeswehr) is experienced in crisis support in military missions since several years. It gained additional experiences during the current coronavirus 2019 (COVID-19) pandemic on different levels of the response to crisis and was requested to share the findings and expertise with the overloaded civil public health agencies inside Germany. Since the beginning of the pandemic, the unit is constantly developing new products for crisis communication, knowledge sharing techniques in new databases, dashboards for leadership, and training for laypersons in contact tracing. Hence, trying to innovate in crisis since the first severe acute respiratory syndrome coronavirus (SARS-CoV)-2-disease wave. During the second wave, the unit was requested to evaluate the outbreak management of different national civil public health agencies in southern Germany, and to support the development of dashboards in a comprehensive public health approach as a necessary start toward digitalization.
C1 [Rossmann, Katalyn; Grossmann, Gerd; Frangoulidis, Dimitrios] Med Intelligence & Informat MI2, Bundeswehr Med Serv Headquarters 6 2, Munich, Germany.
   [Wegner, Heike; Stark, Hans] Bundeswehr Ctr Software Expertise BwCSE, Euskirchen, Germany.
   [Jansen, Andreas] Robert Koch Inst, Fed Informat Ctr Int Hlth Protect, Berlin, Germany.
RP Rossmann, K; Frangoulidis, D (corresponding author), Med Intelligence & Informat MI2, Bundeswehr Med Serv Headquarters 6 2, Munich, Germany.
EM katalynrossmann@bundeswehr.org; dimitriosfrangoulidis@bundeswehr.org
FU Bundeswehr MI2
FX We would like to thank all members of the different public health
   agencies and other partners for their open-minded co-operation and
   patience despite their exhaustionwe learned a lot, our superiors for
   their trust in our innovations, all comrades and members of the
   Bundeswehr MI2-unit in Munich for their constant, engaged, cordial, and
   professional teamwork in this pandemic crisis, our spouses who supported
   and still support our children in homeschooling while we are oscillating
   between all these public health agencies day-to-day and afterward
   disappearing into our home-office cubicles, and last but not the least
   Diana Rieck for her excellent and patient support in English grammar and
   spelling.
CR Aitken T, 2020, J INFECTION, V81, P353, DOI 10.1016/j.jinf.2020.05.001
   Allal-Cherif O, 2021, J BUS RES, V133, P354, DOI 10.1016/j.jbusres.2021.05.008
   Bian Q, 2021, INT J DISAST RISK RE, V60, DOI 10.1016/j.ijdrr.2021.102281
   Boulos MKN, 2020, INT J HEALTH GEOGR, V19, DOI 10.1186/s12942-020-00202-8
   Cameron E, 2019, GLOBAL HLTH SECURITY
   Chang CL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093161
   Coccia M., GLOBAL ENCY PUBLIC A, P2021, DOI [10.1007/978-3-319-31816-5_3969-1, DOI 10.1007/978-3-319-31816-5_3969-1]
   Coccia M, 2021, ENVIRON RES, V199, DOI 10.1016/j.envres.2021.111339
   Coccia M, 2020, ENVIRON RES, V191, DOI 10.1016/j.envres.2020.110155
   Kaiser M, 2021, HEALTH RES POLICY SY, V19, DOI 10.1186/s12961-021-00702-4
   Kalgotra P, 2021, J BUS RES, V134, P540, DOI 10.1016/j.jbusres.2021.06.002
   Kurtz CF, 2003, IBM SYST J, V42, P462, DOI 10.1147/sj.423.0462
   Lu N, 2020, AM J INFECT CONTROL, V48, P851, DOI 10.1016/j.ajic.2020.04.021
   Pang J., 2020, ARXIV201102883CS
   Snowden D, 1999, CYNEFIN SENSE TIME P
   Snowden D., 1999, LIBERATING KNOWLEDGE
   Weber M., 1922, RATIONALISM MODERN S, P73
   World Health Organization, 2008, WORLD HLTH REPORT 20
NR 18
TC 0
Z9 0
U1 5
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD OCT 7
PY 2021
VL 9
AR 665323
DI 10.3389/fpubh.2021.665323
PG 6
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA WK2NC
UT WOS:000709566800001
PM 34692616
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Bui, HTT
   Duong, DM
   Pham, TQ
   Mirzoev, T
   Bui, ATM
   La, QN
AF Ha Thi Thu Bui
   Duc Minh Duong
   Thanh Quoc Pham
   Mirzoev, Tolib
   Anh Thi My Bui
   Quang Ngoc La
TI COVID-19 Stressors on Migrant Workers in Vietnam: Cumulative Risk
   Consideration
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; Vietnam; migrant workers; cumulative risk assessment (CRA);
   industrial zones
AB This study explored the impact of COVID-19 on migrant workers in Vietnam, using a cumulative risk assessment (CRA) framework which comprises four domains (workplace, environment, individual and community). A cross-sectional study was conducted. Data were collected in 2020 through a self-administered questionnaire with 445 domestic migrant workers in two industrial zones in two northern provinces (Bac Ninh and Ninh Binh) in Vietnam. The majority of migrant workers were female (65.2%), aged between 18 and 29 years old (66.8%), and had high school or higher education level qualifications. Most migrant workers had good knowledge about preventive measures (>90%) and correct practices on COVID-19 prevention (81.1%). Three health risk behaviors were reported: 10% of participants smoked, 25% consumed alcohol and 23.1% were engaged in online gaming. In terms of workplace, occupational working conditions were good. Noise was the most commonly reported hazard (29%). Regarding environment, about two-thirds of migrant workers lived in a small house (<36 m(2)). Most participants (80.4%) lived with their families. About community domain, many reported low salary or losing their job during January-July, 2020. Most migrants received information about COVID-19. The migrant workers suffered from poor health and low occupational safety, fear of job loss and income cut, poor housing and living conditions and limited access to public services. The holistic approach to address stressors is recommended to improve health and safety of migrant workers.
C1 [Ha Thi Thu Bui; Duc Minh Duong] Hanoi Univ Publ Hlth, Fac Social & Behav Sci, Duc Thang Ward, 1A Duc Thang Rd, Hanoi 119000, Vietnam.
   [Thanh Quoc Pham; Quang Ngoc La] Hanoi Univ Publ Hlth, Fac Fundamental Sci, Duc Thang Ward, 1A Duc Thang Rd, Hanoi 119000, Vietnam.
   [Mirzoev, Tolib] Leeds Inst Hlth Sci, Nuffield Ctr Int Hlth & Dev, 6 Clarendon Way,Woodhouse, Leeds LS2 9NL, W Yorkshire, England.
   [Anh Thi My Bui] Hanoi Univ Publ Hlth, Hlth Management Training Inst, Duc Thang Ward, 1A Duc Thang Rd, Hanoi 119000, Vietnam.
   [Mirzoev, Tolib] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1H 9SH, England.
RP Duong, DM (corresponding author), Hanoi Univ Publ Hlth, Fac Social & Behav Sci, Duc Thang Ward, 1A Duc Thang Rd, Hanoi 119000, Vietnam.
EM bth@huph.edu.vn; dmd@huph.edu.vn; pqt@huph.edu.vn;
   tolib.mirzoev@lshtm.ac.uk; btma@huph.edu.vn; lnq@huph.edu.vn
OI Pham, Thanh/0000-0002-5526-1510; Myanh, Bui/0000-0003-1678-6397; Duong,
   Duc/0000-0002-4415-5229; Mirzoev, Tolib/0000-0003-2959-9187
FU World Health OrganizationWorld Health Organization
FX This study was supported by the World Health Organization.
CR Alahmad B, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002995
   Tran BX, 2020, SAFETY SCI, V129, DOI 10.1016/j.ssci.2020.104811
   Tran BX, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16245085
   Tran BX, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16091642
   Tran BX, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3983-z
   Bhopal R, 2020, BMJ-BRIT MED J, V369, pM1673, DOI [10.1136/bmj.m1673, DOI 10.1136/BMJ.M1673]
   Ha BTT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093125
   Corburn J, 2020, J URBAN HEALTH, V97, P348, DOI 10.1007/s11524-020-00438-6
   Dang H.-A, 2020, TURNING VIETNAMS COV
   Douglas M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1557
   Fox MA, 2018, ENVIRON INT, V115, P230, DOI 10.1016/j.envint.2018.03.026
   General Statistics Office and UNFPA, 2016, 2015 NAT INT MIGR SU
   Greenaway C, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa113
   Nhu HV, 2020, J COMMUN HEALTH, V45, P1263, DOI 10.1007/s10900-020-00919-4
   Institute for Policy and Strategies for Agriculture and Rural Development, 2020, RAP ASS IMP COVID 19
   International Labor Organization, 2020, COVID 19 LAB MARK VI
   International Labor Organization, 2020, 20202021 INT LAB ORG
   International Labour Organization (ILO), 2020, COVID 19 VIETN UNPR
   International Labour Organization (ILO), 2018, **NON-TRADITIONAL**, V2nd ed.
   International Organization for Migration, 2020, VIETNAM
   International Organization for Migration, 2020, WORLD MIGRATION REPO
   Kham T. V., 2015, VNU J SOC SCI HUMANI, V1, P277
   Kluge HHP, 2020, LANCET, V395, P1237, DOI 10.1016/S0140-6736(20)30791-1
   Vu LTH, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0172-6
   Anh LTK, 2013, GLOBAL HEALTH ACTION, V6, P122, DOI 10.3402/gha.v5i0.9334
   Lin YL, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00236
   Long G.T, 2013, SOCIAL PROTECTION MI
   Nguyen LT, 2012, J ADOLESCENT HEALTH, V50, pS61, DOI 10.1016/j.jadohealth.2011.12.004
   Pham L.T.L, 2012, REPROD HEALTH, V9, P1
   Thanh N.T, 2018, ASIAN SOC SCI, V14, P115, DOI [10.5539/ass.v14n12p115, DOI 10.5539/ASS.V14N12P115]
   Do TTT, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5641-0
   UNFPA, 2020, ETH GROUP VIETN AN K
   UNICEF, 2020, RAP ASS SOC EC IMP C
   UNICEF, 2020, IMP COVID 19 MIGR TH
   UNICEF, 2020, RAP ASS ROUT SERV HL
   Vietnam Ministry of Health, 2020, INF WEBS PAND COVID
   Vietnam Ministry of Health, 2021, COVID 19 TIM
   Watson MF, 2020, FAM PROCESS, V59, P832, DOI 10.1111/famp.12572
   WHO, 2020, WPRO INT ROL COMM EN
   Wilkinson A, 2020, ENVIRON URBAN, V32, P503, DOI 10.1177/0956247820922843
   World Health Organization, 2018, RISK COMM COMM ENG R
   World Health Organization, 2017, WHO COMM ENG FRAM QU
NR 42
TC 0
Z9 0
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD AUG
PY 2021
VL 18
IS 16
AR 8757
DI 10.3390/ijerph18168757
PG 15
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA UI3AH
UT WOS:000690484100001
PM 34444521
OA Green Accepted, Green Published, gold
DA 2022-04-20
ER

PT J
AU Benlidayi, IC
   Kurtaran, B
   Tirasci, E
   Guzel, R
AF Coskun Benlidayi, Ilke
   Kurtaran, Behice
   Tirasci, Emre
   Guzel, Rengin
TI Coronavirus disease 2019 (COVID-19) in a patient with ankylosing
   spondylitis treated with secukinumab: a case-based review
SO RHEUMATOLOGY INTERNATIONAL
LA English
DT Review
DE Ankylosing spondylitis; Biological drugs; COVID-19; Interleukin-17;
   Rheumatic diseases; Secukinumab; Spondyloarthritis
ID ARTHRITIS
AB Severe acute respiratory syndrome coranovirus-2 (SARS-CoV-2) infection has become an important health-care issue worldwide. The coronavirus disease 2019 (COVID-19) has also raised concerns among patients with inflammatory rheumatic conditions and their treating physicians. There are emerging data regarding the potential risks of SARS-CoV-2 for this particular patient group. However, less is known with regard to the course of COVID-19 among patients receiving IL-17 inhibitors. The aim of the current article is to review the growing body of knowledge on the course/management of COVID-19 in patients with inflammatory rheumatic diseases by presenting a SARS-CoV-2 infected case with ankylosing spondylitis under secukinumab therapy. A 61-year old patient with ankylosing spondylitis who was on secukinumab therapy for 5 months admitted with newly onset fever and gastrointestinal complaints. After being hospitalized, she developed respiratory manifestations with focal pulmonary ground-glass opacities and multiple nodular densities in both lungs. The patient was tested positive for SARS-CoV-2 infection. Substantial clinical improvement was obtained following a management plan, which included tocilizumab, hydroxychloroquine, prednisolone and enoxaparin sodium. PubMed/MEDLINE and Scopus databases were searched by using relevant keywords and their combinations. The literature search revealed four articles reporting the clinical course of COVID-19 in seven rheumatic patients on secukinumab. The clinical course of SARS-CoV-2 infection was mild in most of these patients, while one of them experienced severe COVID-19. Interleukin-17 has been related to the hyperinflammatory state in COVID-19 and IL-17 inhibitors were presented as promising targets for the prevention of aberrant inflammation and acute respiratory distress in COVID-19. However, this hypothesis still remains to be proved. Further studies are warranted in order to test the benefits and risks of IL-inhibitors in SARS-CoV-2 infected individuals.
C1 [Coskun Benlidayi, Ilke; Tirasci, Emre; Guzel, Rengin] Cukurova Univ, Fac Med, Dept Phys Med & Rehabil, Adana, Turkey.
   [Kurtaran, Behice] Cukurova Univ, Fac Med, Dept Infect Dis, Adana, Turkey.
RP Benlidayi, IC (corresponding author), Cukurova Univ, Fac Med, Dept Phys Med & Rehabil, Adana, Turkey.
EM icbenlidayi@hotmail.com; behicekurtaran@gmail.com;
   emre_tirasci@hotmail.com; renginguzel@gmail.com
RI Sarpel, Tunay/D-9438-2018; Guzel, Rengin/K-6570-2013
OI Sarpel, Tunay/0000-0001-6517-5969; Guzel, Rengin/0000-0002-3064-5868;
   Tirasci, Emre/0000-0002-3131-9298
CR [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   Askanase AD, 2020, LUPUS SCI MED, V7, DOI 10.1136/lupus-2020-000396
   Balestri R, 2020, J EUR ACAD DERMATOL, V34, pE357, DOI 10.1111/jdv.16571
   Benucci M, 2020, JOINT BONE SPINE, V87, P195, DOI 10.1016/j.jbspin.2020.03.013
   Cafarotti S, 2020, J THORAC ONCOL, V15, pE101, DOI 10.1016/j.jtho.2020.04.015
   Ceribelli A, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102442
   Cron RQ, 2020, J RHEUMATOL, V47, P639, DOI 10.3899/jrheum.200334
   Di Lernia V, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13580
   Duret PM, 2020, ANN RHEUM DIS, V79, P1250, DOI 10.1136/annrheumdis-2020-217362
   Emmi G, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102575
   Favalli EG, 2021, ANN RHEUM DIS, V80, DOI 10.1136/annrheumdis-2020-217615
   Favalli EG, 2020, J RHEUMATOL, V47, P1296, DOI 10.3899/jrheum.200507
   Favalli EG, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102523
   Galluzzo M, 2020, EXPERT OPIN BIOL TH, V20, P173, DOI 10.1080/14712598.2020.1708897
   Gasparyan AY, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e176
   Gasparyan AY, 2011, RHEUMATOL INT, V31, P1409, DOI 10.1007/s00296-011-1999-3
   Georgiev T, 2020, RHEUMATOL INT, V40, P825, DOI 10.1007/s00296-020-04570-z
   Gianfrancesco MA, 2020, LANCET RHEUMATOL, V2, pE250, DOI 10.1016/S2665-9913(20)30095-3
   Gupta L, 2021, ANN RHEUM DIS, V80, DOI 10.1136/annrheumdis-2020-217509
   Haberman R, 2020, NEW ENGL J MED, V383, P85, DOI 10.1056/NEJMc2009567
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Liu YX, 2020, NATL SCI REV, V7, P1003, DOI 10.1093/nsr/nwaa037
   Lu CY, 2020, ANN RHEUM DIS, V79, P737, DOI 10.1136/annrheumdis-2020-217460
   Matucci-Cerinic M, 2020, ANN RHEUM DIS, V79, P724, DOI 10.1136/annrheumdis-2020-217407
   McInnes IB, 2020, ANN RHEUM DIS, V79, P551, DOI 10.1136/annrheumdis-2020-217494
   Megna M, 2020, MED HYPOTHESES, V140, DOI 10.1016/j.mehy.2020.109749
   Messina F, 2020, J EUR ACAD DERMATOL, V34, pE254, DOI 10.1111/jdv.16468
   Mikuls TR, 2020, ARTHRITIS RHEUMATOL, V72, P1241, DOI 10.1002/art.41301
   Misra DP, 2020, CLIN RHEUMATOL, V39, P2055, DOI 10.1007/s10067-020-05073-9
   Monti S, 2020, ANN RHEUM DIS, V79, P667, DOI 10.1136/annrheumdis-2020-217424
   Muir R, 2016, AM J RESP CRIT CARE, V193, P407, DOI 10.1164/rccm.201410-1782OC
   Nasonov EL, 2020, RHEUMATOL SCI PRACT, V58, P123, DOI [10.14412/1995-4484-2020-123-132, DOI 10.14412/1995-4484-2020-123-132]
   Pacha O, 2020, NAT REV IMMUNOL, V20, P345, DOI 10.1038/s41577-020-0328-z
   Pan L, 2020, AM J GASTROENTEROL, V115, P766, DOI 10.14309/ajg.0000000000000620
   Pope JE, 2020, CURR TREAT OPT RHEUM, V6, P71, DOI 10.1007/s40674-020-00145-y
   Raucci F, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102572
   Rosenbaum JT, 2020, ANN RHEUM DIS, V79, P1663, DOI 10.1136/annrheumdis-2020-217941
   Rozzo G, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13680
   Schett G, 2020, NAT REV IMMUNOL, V20, P271, DOI 10.1038/s41577-020-0312-7
   Serrato VA, 2013, CLIN RHEUMATOL, V32, pS21, DOI 10.1007/s10067-010-1415-5
   Sharmeen S, 2020, SEMIN ARTHRITIS RHEU, V50, P680, DOI 10.1016/j.semarthrit.2020.05.010
   Song J, 2020, RHEUMATOL INT, V40, P991, DOI 10.1007/s00296-020-04584-7
   Tufan A, 2020, TURK J MED SCI, V50, P620, DOI 10.3906/sag-2004-168
   Wu DD, 2020, J MICROBIOL IMMUNOL, V53, P368, DOI 10.1016/j.jmii.2020.03.005
   XU X, 2020, EFFECTIVE TREATMENT, DOI [10.1073/pnas.2005615117, DOI 10.1073/PNAS.2005615117]
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yang LJ, 2020, LANCET GASTROENTEROL, V5, P629, DOI 10.1016/S2468-1253(20)30132-1
   Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237
NR 48
TC 18
Z9 18
U1 0
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0172-8172
EI 1437-160X
J9 RHEUMATOL INT
JI Rheumatol. Int.
PD OCT
PY 2020
VL 40
IS 10
BP 1707
EP 1716
DI 10.1007/s00296-020-04635-z
EA JUN 2020
PG 10
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA NF2MU
UT WOS:000543625000001
PM 32591970
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Diaz-Guio, DA
   Diaz-Guio, Y
   Pinzon-Rodas, V
   Diaz-Gomez, AS
   Guarin-Medina, JA
   Chaparro-Zuniga, Y
   Ricardo-Zapata, A
   Rodriguez-Morales, AJ
AF Andres Diaz-Guio, Diego
   Diaz-Guio, Yimmy
   Pinzon-Rodas, Valentina
   Sofia Diaz-Gomez, Ana
   Guarin-Medina, Jorge Andres
   Chaparro-Zuniga, Yesid
   Ricardo-Zapata, Alejandra
   Rodriguez-Morales, Alfonso J.
TI COVID-19: Biosafety in the Intensive Care Unit
SO CURRENT TROPICAL MEDICINE REPORTS
LA English
DT Review
DE COVID-19; SARS-CoV-2; Cooperative behavior; Personal protective
   equipment; Biosafety; Critical care unit; Education; Medical
ID RISK; CORONAVIRUS; GUIDELINES; INFECTION
AB Purpose of Review COVID-19 is a new, highly transmissible disease to which healthcare workers (HCWs) are exposed, especially in the intensive care unit (ICU). Information related to protection mechanisms is heterogeneous, and the infected HCWs' number is increasing. This review intends to summarize the current knowledge and practices to protect ICU personnel during the patient management process in the context of the current pandemic. Recent Findings The transmission mechanisms of SARS-CoV-2 are mainly respiratory droplets, aerosols, and contact. The virus can last for a few hours suspended in the air and be viable on surfaces for several days. Some procedures carried out in the ICU can generate aerosols. The shortage of respirators, such as the N95, has generated an increase in the demand for other protective equipment in critical care settings. The probability of transmission depends on the characteristics of the pathogen, the availability of quality personal protective equipment, and the human factors associated with the performance of health workers. It is necessary to have knowledge of the virus and availability of the best possible personal protection equipment, develop skills for handling equipment, and develop non-technical skills during all intensive care process; this can be achieved through structured training.
C1 [Andres Diaz-Guio, Diego; Diaz-Guio, Yimmy; Pinzon-Rodas, Valentina; Sofia Diaz-Gomez, Ana; Ricardo-Zapata, Alejandra] Ctr Simulac Clin VitalCare, Educ & Simulat Res Grp EdSIMc, 16N St 14-50, Armenia, Colombia.
   [Andres Diaz-Guio, Diego; Diaz-Guio, Yimmy] Hosp Univ San Juan de Dios, Crit Care Dept, Armenia, Colombia.
   [Andres Diaz-Guio, Diego] Univ Caldas, Arts & Humanities Fac, Doctoral Program Educ, Manizales, Colombia.
   [Guarin-Medina, Jorge Andres] Westkustenklinikum, Crit Care Dept, Heide, Schleswig Holst, Germany.
   [Chaparro-Zuniga, Yesid] Hosp Univ Santa Clara, Internal Med Dept, Bogota, Colombia.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Fdn Univ Autonoma Amer, Fac Med, Sede Pereira, Grp Invest Biomed, Pereira, Colombia.
RP Diaz-Guio, DA (corresponding author), Ctr Simulac Clin VitalCare, Educ & Simulat Res Grp EdSIMc, 16N St 14-50, Armenia, Colombia.; Diaz-Guio, DA (corresponding author), Hosp Univ San Juan de Dios, Crit Care Dept, Armenia, Colombia.; Diaz-Guio, DA (corresponding author), Univ Caldas, Arts & Humanities Fac, Doctoral Program Educ, Manizales, Colombia.
EM andres.diaz@vitalcare.co
RI Rodriguez-Morales, Alfonso J./R-9765-2016
OI Rodriguez-Morales, Alfonso J./0000-0001-9773-2192; Diaz-Guio, Diego
   Andres/0000-0003-4940-9870
CR Alhazzani W, 2020, CRIT CARE MED, V48, pE440, DOI [10.1097/CCM.0000000000004363, 10.1007/s00134-020-06022-5]
   Diaz-Guio DA, 2020, TRAVEL MED INFECT DI, V38, DOI 10.1016/j.tmaid.2020.101746
   Bartoszko JJ, 2020, INFLUENZA OTHER RESP, V14, P365, DOI 10.1111/irv.12745
   Bourouiba L, 2020, JAMA-J AM MED ASSOC, V323, P1837, DOI 10.1001/jama.2020.4756
   Canelli R, 2020, NEW ENGL J MED, V382, P1957, DOI 10.1056/NEJMc2007589
   Cheng ZKJ, 2020, INFECTION, V48, P155, DOI 10.1007/s15010-020-01401-y
   Cheung JCH, 2020, LANCET RESP MED, V8, pE19, DOI 10.1016/S2213-2600(20)30084-9
   Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30
   Cook TM, 2020, ANAESTHESIA, V75, P785, DOI 10.1111/anae.15054
   Couper K, 2020, RESUSCITATION, V151, P59, DOI 10.1016/j.resuscitation.2020.04.022
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Diaz-Guio D, 2020, SIMUL CLIN, V2, P6
   Diaz-Guio Diego Andres, 2020, Infez Med, V28, P111
   Díaz-Guio Diego Andrés, 2019, Rev. colomb. anestesiol., V47, P113, DOI 10.1097/cj9.0000000000000107
   Diaz-Guio Y, 2018, ACTA COLOMB CUID INT, V18, P190, DOI [10.1016/j.acci.2018.04.003, DOI 10.1016/J.ACCI.2018.04.003]
   Ecdc, 2020, PERS PROT EQ PPE NEE
   European Centre for Disease Prevention and Control, 2014, SAF US PERS PROT EQ
   Goh KJ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02916-4
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Hines SE, 2019, HEALTH SECUR, V17, P384, DOI 10.1089/hs.2019.0039
   Houghton C, 2020, COCHRANE DATABASE SY, V4
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   ILCOR, 2020, COVID 19 PRACT GUID
   Jessop ZM, 2020, BRIT J SURG, V107, P1262, DOI 10.1002/bjs.11750
   Liu W, 2009, TROP MED INT HEALTH, V14, P52, DOI 10.1111/j.1365-3156.2009.02255.x
   Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021
   Livingston E, 2020, JAMA
   Matava CT, 2020, CAN J ANESTH, V67, P902, DOI 10.1007/s12630-020-01649-w
   Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063
   Morawska L, 2020, CLIN INFECT DIS, V71, P2311, DOI 10.1093/cid/ciaa939
   Mumma JM, 2018, CLIN INFECT DIS, V66, P950, DOI 10.1093/cid/cix957
   Nates JL, 2016, CRIT CARE MED, V44, P1553, DOI 10.1097/CCM.0000000000001856
   NHS, 2020, COVID 19 INF PREV CO
   Escalera-Antezana JP, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101702
   Pagliano P, 2020, INFEZ MED, V2, P185
   Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]
   Pawar S, 2018, BMJ SIMUL TECHNOL EN, V4, P87, DOI 10.1136/bmjstel-2017-000225
   Pisano M, 2020, NEJM CATALYST, V1, P1, DOI [10.1056/CAT.20.0080, DOI 10.1056/CAT.20.0080]
   Pompeii LA, 2020, JAMA-J AM MED ASSOC, V323, P1849, DOI 10.1001/jama.2020.4806
   Reader T, 2006, BRIT J ANAESTH, V96, P551, DOI 10.1093/bja/ael067
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Rodriguez-Morales Alfonso J, 2020, Travel Med Infect Dis, V34, P101623, DOI 10.1016/j.tmaid.2020.101623
   Sorbello M, 2020, ANAESTHESIA, V75, P724, DOI 10.1111/anae.15049
   Takhar A, 2020, EUR ARCH OTO-RHINO-L, V277, P2173, DOI 10.1007/s00405-020-05993-x
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Verbeek JH, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD011621.pub5, 10.1002/14651858.CD011621.pub4]
   Wei JJ, 2016, AM J INFECT CONTROL, V44, pS102, DOI 10.1016/j.ajic.2016.06.003
   Wilson NM, 2020, ANAESTHESIA, V75, P1086, DOI 10.1111/anae.15093
   World Health Organization, 2020, CLEAN DIS ENV SURF C
   World Health Organization, 2020, TRANSM SARS COV 2 IM
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yaacoub S, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002650
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 55
TC 3
Z9 3
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
EI 2196-3045
J9 CURR TROP MED REP
JI Curr. Trop. Med. Rep.
PD DEC
PY 2020
VL 7
IS 4
BP 104
EP 111
DI 10.1007/s40475-020-00208-z
EA AUG 2020
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
WE Emerging Sources Citation Index (ESCI)
SC Infectious Diseases; Parasitology; Tropical Medicine
GA PA5SK
UT WOS:000565958300001
PM 32868986
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Jang, S
   Lee, H
AF Jang, Sunjoo
   Lee, Haeyoung
TI Changes in Core Competencies among Korean University Students Due to
   Remote Learning during the COVID-19 Pandemic
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE core competencies; remote learning; online learning; academic
   performance; problem solving; university students; South Korea; COVID-19
AB This study aimed to determine the academic performance and learning skills of students who studied through remote teaching methods during the coronavirus disease 2019 (COVID-19) pandemic. It was conducted in February 2021 with 398 university students in South Korea. Data were collected through online surveys. Generalized estimating equations (GEEs) with an autoregressive correlation structure were employed to distinguish differences in core competencies, academic performance, satisfaction, and usefulness of teaching methods before 2019 and after the COVID-19 pandemic. The findings revealed that the overall core competencies of participants were significantly lower in 2020 than before the COVID-19 pandemic. Furthermore, knowledge construction, responsibility practice, and socialization were significantly low during the COVID-19 pandemic, whereas information management and identity value did not show a significant difference. However, problem-solving was higher during the COVID-19 pandemic. Enhancing the core competencies of university students is integral in the new learning environment of the post-COVID-19 era. It is necessary to devise approaches that improve the effectiveness of remote teaching methods and simultaneously augment student satisfaction.
C1 [Jang, Sunjoo; Lee, Haeyoung] Chung Ang Univ, Red Cross Coll Nursing, Seoul 06974, South Korea.
RP Lee, H (corresponding author), Chung Ang Univ, Red Cross Coll Nursing, Seoul 06974, South Korea.
EM icedcoffee@cau.ac.kr; im0202@cau.ac.kr
OI Lee, Haeyoung/0000-0001-6024-0039; Jang, Sun Joo/0000-0002-7655-1744
CR Alghamdi AA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250026
   Baek Jongnam, 2020, [Journal of the Korea Convergence Society, 한국융합학회논문지], V11, P349, DOI 10.15207/JKCS.2020.11.6.349
   Baek Jongnam, 2020, [Journal of Digital Convergence, 디지털융복합연구], V18, P539, DOI 10.14400/JDC.2020.18.11.539
   Baek P. G., 2013, KOREAN J GEN ED, V7, P349
   Daniels LM, 2021, SOC PSYCHOL EDUC, V24, P299, DOI 10.1007/s11218-021-09612-3
   den Brok P, 2006, EDUC RES EVAL, V12, P3, DOI 10.1080/13803610500392053
   Frey BB., 2018, SAGE ENCY ED RES MEA, DOI [10.4135/9781506326139, DOI 10.4135/9781506326139]
   Goodwin B, 2013, EDUC LEADERSHIP, V70, P80
   Hamdan KM, 2021, INT J EDUC MANAG, V35, P713, DOI 10.1108/IJEM-11-2020-0513
   Hur J., 2020, 202003 KOR ED DEV I
   Im S, 2019, J NURS EDUC, V58, P354, DOI 10.3928/01484834-20190521-06
   JIN Misug, 2013, [Korean journal of sociology of education, 교육사회학연구], V23, P105
   JIN Misug, 2011, [The Journal of Educational Administration, 교육행정학연구], V29, P461
   Jo Il-Hyun, 2014, 교육과학연구, V45, P77
   Kang Minsoo, 2020, [Journal of Korea Academia-Industrial cooperation Society, 한국산학기술학회논문지], V21, P236, DOI 10.5762/KAIS.2020.21.4.236
   Kang M, 2010, J RES TECHNOL EDUC, V43, P157, DOI 10.1080/15391523.2010.10782567
   KANGMYUNGHEE, 2014, 평생학습사회, V10, P61
   Kantar LD, 2014, NURS EDUC TODAY, V34, P789, DOI 10.1016/j.nedt.2013.08.013
   Kim ME, 2020, J LEARN CENT CURRIC, V20, P519, DOI [10.22251/jlcci.2020.20.17.519, DOI 10.22251/JLCCI.2020.20.17.519]
   Korean Disease Control and Prevention Agency, COVID 19 INC
   Kumar S, 2021, J CLIN DIAGN RES, V15, DOI 10.7860/JCDR/2021/46195.14578
   Lee H, 2021, INT J MENT HEALTH NU, V30, P1263, DOI 10.1111/inm.12885
   Lee Jang-ik, 2012, [Journal ofAgricultural Education and Human Resource Development, 농업교육과 인적자원개발], V44, P73
   Lee Kyung A, 2021, [Journal of the Korea Convergence Society, 한국융합학회논문지], V12, P239, DOI 10.15207/JKCS.2021.12.5.239
   Lee Mi-Kyoung, 2017, [Journal of Korean Academy of Psychiatric and Mental Health Nursing, 정신간호학회지], V26, P196
   OECD, 2005, DEF SEL KEY COMP EXC
   OECD, 2003, DEF SEL COMP THEOR C
   Organisation for Economic Co-Operation and Development-OECD (Ed, 2005, DEFINITION SELECTION
   Park Ju Young, 2020, [The Journal of Korean Academic Society of Nursing Education, 한국간호교육학회지], V26, P185, DOI 10.5977/jkasne.2020.26.2.185
   Park Sanghoon, 2020, [The Journal of Learner-Centered Curriculum and Instruction, 학습자중심교과교육연구], V20, P911, DOI 10.22251/jlcci.2020.20.21.911
   Presti CR, 2016, J NURS EDUC, V55, P252, DOI 10.3928/01484834-20160414-03
   Senko C, 2017, J EDUC PSYCHOL, V109, P574, DOI 10.1037/edu0000160
   Sim Y.K., 2014, KOREAN J TECHNOL ED, V14, P49
   Taylor-Pashow KML, 2019, SOLVENT EXTR ION EXC, V37, P1, DOI 10.1080/07366299.2019.1592924
   Usher K, 2017, INT J NURS STUD, V71, P89, DOI 10.1016/j.ijnurstu.2017.03.006
   World Health Organization, 2020, COVID 19 PAND
   Yi Yeom Eun, 2019, [Asia-pacific Journal of Multimedia Services Convergent with Art, Humanities, and Sociology, 예술인문사회 융합 멀티미디어 논문지], V9, P209, DOI 10.21742/AJMAHS.2019.01.22
   송충진, 2014, [Asian Journal of Education, 아시아교육연구], V15, P171
NR 38
TC 1
Z9 1
U1 6
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUL
PY 2021
VL 18
IS 14
AR 7476
DI 10.3390/ijerph18147476
PG 11
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA TO3EH
UT WOS:000676799000001
PM 34299922
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ng, A
   Fong, B
   Lo, MF
AF Ng, Artie
   Fong, Ben
   Lo, Man Fung
TI Dynamic knowledge management in response to the pandemic outbreak: an
   interinstitutional risk-based approach to sustainability
SO KNOWLEDGE MANAGEMENT RESEARCH & PRACTICE
LA English
DT Article
DE Risk management; pandemic outbreak; Hong Kong; sustainability; dynamic
   knowledge; management; Interinstitutional
AB The coronavirus pandemic (COVID-19) represents an unprecedented challenge for the survival of various organisations around the world. The resilience of an organisation depends predominantly on its ability to respond in a timely manner by leveraging optimal decisions, as supported by dynamic knowledge management in assessing rapidly evolving external uncertainties while evaluating real options. Such a capability can be enhanced by a risk-based approach through collaboration among organisations under public health policy directives to implement concerted control measures in a responsive manner. An integrative framework is developed to illustrate an underlying system that embraces dynamic knowledge management to mitigate limitations in the conventional approach based on a single organisation's perspective. The case of Hong Kong, a highly populated city in Asia, is illustrated to explore the interinstitutional dynamics of knowledge transfer to external stakeholders in protecting public health under an exposed system. Implications for postpandemic management system development for institutional sustainability are articulated.
C1 [Ng, Artie] Hong Kong Polytech Univ, Sch Profess Educ & Execut Dev, Hong Kong, Peoples R China.
   [Fong, Ben] Hong Kong Polytech Univ, Coll Profess & Continuing Educ, Hong Kong, Peoples R China.
   [Lo, Man Fung] Educ Univ Hong Kong, Dept Math & Informat Technol, Hong Kong, Peoples R China.
RP Ng, A (corresponding author), Hong Kong Polytech Univ, Sch Profess Educ & Execut Dev, Hong Kong, Peoples R China.
EM artie.ng@speed-polyu.edu.hk
RI LO, Man Fung/ABD-7936-2020; Ng, Artie/B-4386-2010
OI LO, Man Fung/0000-0002-0358-0309; Fong, Ben/0000-0003-0909-0674; Ng,
   Artie/0000-0002-1388-5835
FU Institutional Development Scheme, Research Grants Council of the Hong
   Kong Special Administrative Region, China [UGC/IDS24/18]
FX This work was supported by the Institutional Development Scheme,
   Research Grants Council of the Hong Kong Special Administrative Region,
   China [Project Reference No.: UGC/IDS24/18].
CR Akhavan P, 2018, J KNOWL MANAG, V22, P413, DOI 10.1108/JKM-06-2017-0242
   Alhawari S, 2012, INT J INFORM MANAGE, V32, P50, DOI 10.1016/j.ijinfomgt.2011.07.002
   Aziz, 2019, MANAG SCI LETT, V9, P585, DOI [10.5267/j.msl.2019.1.004, DOI 10.5267/J.MSL.2019.1.004]
   Centers for Disease Control and Prevention, 2021, SIM DIFF FLU COVID 1
   Centre for Health Protection, 2020, PREPAREDNESS RESPONS
   Committee of Sponsoring Organisations of the Treadway Commission (COSO) & World Business Council for Sustainable Development (WBCSD), 2018, ENTERPRISE RISK MANA
   Deloitte, 2015, COSO APPR INT CONTR
   Durst S, 2018, J KNOWL MANAG, V24, P717, DOI 10.1108/JKM-12-2017-0558
   Edmondson AC, 2020, DONT HIDE BAD NEWS T
   Filho, 2019, GOOD HLTH WELL BEING, P1
   Fong B., 2016, ELECT J KNOWLEDGE MA, V14, P166
   Gates B, 2020, NEW ENGL J MED, V382, P1677, DOI 10.1056/NEJMp2003762
   Government of Hong Kong SAR, 2020, FREQUENTLY ASKED QUE
   Government of Hong Kong SAR, 2020, DET 24 MEAS
   Government of Hong Kong SAR, 2020, TOG WE FIGHT VIR
   Government of Hong Kong SAR, 2020, SUSP WUH VIR CAS HK
   Hong Kong Laureate Forum, 2020, HLTH COMM
   Hung LS, 2003, J ROY SOC MED, V96, P374, DOI 10.1258/jrsm.96.8.374
   Castaneda DI, 2018, J KNOWL MANAG, V22, P299, DOI 10.1108/JKM-01-2017-0041
   Lai TST, 2010, CLIN MED, V10, P50
   Law S, 2020, INT J INFECT DIS, V94, P156, DOI 10.1016/j.ijid.2020.03.059
   Mason RB, 2007, MANAGE DECIS, V45, P10, DOI 10.1108/00251740710718935
   Massaro M, 2015, J KNOWL MANAG, V19, P530, DOI 10.1108/JKM-11-2014-0466
   McCloskey B, 2020, LANCET, V395, P1256, DOI 10.1016/S0140-6736(20)30794-7
   Morens DM, 2009, J INFECT DIS, V200, P1018, DOI 10.1086/644537
   Nair A, 2014, MANAG DECIS ECON, V35, P555, DOI 10.1002/mde.2641
   Ng Artie W, 2009, International Journal of Learning and Intellectual Capital, V6, P170, DOI 10.1504/IJLIC.2009.021726
   OMER H, 1994, AM J COMMUN PSYCHOL, V22, P273, DOI 10.1007/BF02506866
   Osman M, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13030452
   Pereira V, 2019, J KNOWL MANAG, V23, P1708, DOI 10.1108/JKM-06-2018-0391
   Research Fund Secretariat ,, 2020, FHBS HLTH MED RES FU
   Rodriguez E, 2014, INT J KNOWL MANAG, V10, P43, DOI 10.4018/ijkm.2014040104
   Slywotzky AJ, 2005, HARVARD BUS REV, V83, P78
   Stirling AC, 2009, ECOL SOC, V14
   Tang B, 2020, INFECT DIS MODEL, V5, P248, DOI 10.1016/j.idm.2020.02.001
   Wang FS, 2020, LANCET, V395, P391, DOI 10.1016/S0140-6736(20)30300-7
   Wong SCY, 2020, J HOSP INFECT, V105, P119, DOI 10.1016/j.jhin.2020.03.036
   Wong SYS, 2020, CAN MED ASSOC J, V192, pE511, DOI 10.1503/cmaj.200563
   World Health Organization, 2018, CHECKL PAND INFL RIS
   World Health Organization, 2017, PAND INFL RISK MAN W
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
NR 41
TC 1
Z9 1
U1 5
U2 18
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1477-8238
EI 1477-8246
J9 KNOWL MAN RES PRACT
JI Knowl. Manag. Res. Pract.
PD OCT 2
PY 2021
VL 19
IS 4
BP 536
EP 544
DI 10.1080/14778238.2021.1919574
EA MAY 2021
PG 9
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA XR8BJ
UT WOS:000646312000001
DA 2022-04-20
ER

PT J
AU Lemieux, AJ
   Michaud, AAD
   Damasse, J
   Morin-Major, JK
   Nguyen, TN
   Lesage, A
   Crocker, AG
AF Lemieux, Ashley J.
   Dumais Michaud, Audrey-Anne
   Damasse, Jean
   Morin-Major, Julie-Katia
   Nguyen, To Nhu
   Lesage, Alain
   Crocker, Anne G.
TI Management of COVID-19 for Persons with Mental Illness in Secure Units:
   A Rapid International Review to Inform Practice in Quebec
SO VICTIMS & OFFENDERS
LA English
DT Review
DE Mental illness; secure unit; prison; psychiatric institution; forensic;
   COVID-19; Pandemic; Alternatives to incarceration; Early release
   mechanisms; Prison reform
ID HEALTH-CARE; CORONAVIRUS; CHALLENGES; EPIDEMIC
AB Most countries have implemented guidelines and policies in response to COVID-19 that have had a direct impact on institutionalized or incarcerated persons with mental health problems. Although these strategies are essential to protect these vulnerable persons from the pandemic, they can also have significant consequences on recovery, well-being, as well as rights and freedoms. Accordingly, we conducted a rapid review to identify strategies, challenges and recommendations for dealing with the COVID-19 outbreak in secure settings for persons with mental illness. While most available publications are not empirical in nature, this knowledge synthesis can nevertheless guide managers of psychiatric and forensic psychiatric institutions, and correctional facilities in dealing with the COVID-19 pandemic.
C1 [Lemieux, Ashley J.; Dumais Michaud, Audrey-Anne; Crocker, Anne G.] Inst Natl Psychiat Legale Philippe Pinel, Montreal, PQ, Canada.
   [Dumais Michaud, Audrey-Anne] Univ Quebec Outaouais, Dept Social Work, St Jerome, PQ, Canada.
   [Damasse, Jean; Morin-Major, Julie-Katia; Nguyen, To Nhu; Lesage, Alain] Ctr Integre Univ Sante & Serv Sociaux CIUSSS Est, Montreal, PQ, Canada.
   [Lesage, Alain; Crocker, Anne G.] Univ Montreal, Dept Psychiat & Addict, Montreal, PQ, Canada.
   [Crocker, Anne G.] Univ Montreal, Sch Criminol, Montreal, PQ, Canada.
RP Lemieux, AJ (corresponding author), Inst Natl Psychiat Legale Philippe Pinel UETMI SM, Unite Evaluat Technol & Modes Intervent Sante Men, 10 905 Blvd Henri Bourassa Est, Montreal, PQ H1C 1H1, Canada.
EM ashley.lemieux.pinel@ssss.gouv.qc.ca
OI lesage, alain/0000-0002-4226-4683
CR Akiyama MJ, 2020, NEW ENGL J MED, V382, P2075, DOI 10.1056/NEJMp2005687
   Arango C, 2020, BIOL PSYCHIAT, V88, pE33, DOI 10.1016/j.biopsych.2020.04.003
   Association des jeunes psychiatres et des jeunes addictologues, 2020, REC PSYCH LEG EP COV
   Beach C, 2013, PSYCHIAT SERV, V64, P437, DOI 10.1176/appi.ps.201200170
   Bojdani E, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113069
   Boland X, 2021, INT J PSYCHIAT CLIN, V25, P132, DOI 10.1080/13651501.2020.1801755
   Brown C, 2020, INT J LAW PSYCHIAT, V71, DOI 10.1016/j.ijlp.2020.101572
   Brown E, 2020, SCHIZOPHR RES, V222, P79, DOI 10.1016/j.schres.2020.05.005
   Burton PRS, 2021, PSYCHIAT SERV, V72, P458, DOI 10.1176/appi.ps.202000476
   Canady V. A., 2020, MENTAL HLTH WEEKLY, V30, DOI [10.1002/mhw.32318, DOI 10.1002/MHW.32318]
   Canady V. A., 2020, MENT HLTH WKLY, V30, DOI [10.1002/mhw.32343, DOI 10.1002/MHW.32282, 10.1002/mhw.32282]
   Caputo Fiorella, 2020, Med Leg J, V88, P185, DOI 10.1177/0025817220923693
   Chevance A, 2020, ENCEPHALE, V46, P193, DOI 10.1016/j.encep.2020.04.005
   Choi KR, 2020, J AM PSYCHIAT NURSES, V26, P340, DOI 10.1177/1078390320919803
   Clerici M, 2020, IRISH J PSYCHOL MED, V37, P283, DOI 10.1017/ipm.2020.29
   Correctional Service Canada, 2020, INM COVID 19 TEST FE
   Cranshaw T, 2020, SCHIZOPHRENIA BULL, V46, P751, DOI 10.1093/schbul/sbaa070
   Cuddeback GS, 2020, INT J MENT HEALTH, V49, P106, DOI 10.1080/00207411.2020.1717054
   Cullen W, 2020, QJM-INT J MED, V113, P311, DOI 10.1093/qjmed/hcaa110
   D'Agostino A, 2020, LANCET PSYCHIAT, V7, P385, DOI 10.1016/S2215-0366(20)30133-4
   de Carvalho S. G., 2020, PANDEMIC PRISON INTE, DOI [10.1590/SciELOPreprints.570, DOI 10.1590/SCIELOPREPRINTS.570]
   de Girolamo G, 2020, JAMA PSYCHIAT, V77, P974, DOI 10.1001/jamapsychiatry.2020.1276
   Druss BG, 2020, JAMA PSYCHIAT, V77, P891, DOI 10.1001/jamapsychiatry.2020.0894
   Enos G., 2020, MENTAL HLTH WEEKLY, V30, P1, DOI DOI 10.1002/MHW.32355
   Farrell AM, 2020, INT J LAW PSYCHIAT, V71, DOI 10.1016/j.ijlp.2020.101602
   Flood C. M., 2020, VULNERABLE LAW POLIC
   Fovet T, 2020, ENCEPHALE, V46, pS60, DOI 10.1016/j.encep.2020.05.002
   Garriga M, 2020, ACTA PSYCHIAT SCAND, V141, P479, DOI 10.1111/acps.13173
   Gold A, 2020, LANCET PSYCHIAT, V7, P572, DOI 10.1016/S2215-0366(20)30246-7
   Gouvernement du Quebec, 2020, SIT COR COVID 19 QUE
   Government of Canada, 2020, COR DIS COVID 19
   Heitzman J, 2020, PSYCHIATR POL, V54, P187, DOI 10.12740/PP/120373
   Hewson T, 2020, LANCET PSYCHIAT, V7, P568, DOI 10.1016/S2215-0366(20)30241-8
   Iftene A., 2020, VULNERABLE LAW POLIC
   Ji HF, 2020, EUR J PSYCHIAT, V34, P177, DOI 10.1016/j.ejpsy.2020.04.001
   Kelly BD, 2020, INT J LAW PSYCHIAT, V70, DOI 10.1016/j.ijlp.2020.101564
   Kothari R, 2020, MED SCI LAW, V60, P165, DOI 10.1177/0025802420929799
   Kozloff N, 2020, SCHIZOPHRENIA BULL, V46, P752, DOI 10.1093/schbul/sbaa051
   Kreuzer PM, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00550
   Li C, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.112935
   Li LM, 2020, PSYCHIAT SERV, V71, P624, DOI 10.1176/appi.ps.202000166
   Li S, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100216
   Liebrenz Michael, 2020, Forensic Sci Int Mind Law, V1, P100013, DOI 10.1016/j.fsiml.2020.100013
   Moreno C, 2020, LANCET PSYCHIAT, V7, P813, DOI 10.1016/S2215-0366(20)30307-2
   Muirhead C, 2021, J PSYCHIATR MENT HLT, V28, P302, DOI 10.1111/jpm.12650
   Mulvey EP, 2017, CRIME JUSTICE, V46, P231, DOI 10.1086/688461
   National Alliance on Mental Illness, 2020, COVID 19 RES INF GUI
   National Association of State Mental Health Program Directors, 2020, PEER LED REC SUPP IN
   Nijdam-Jones A, 2017, INT J FORENSIC MENT, V16, P69, DOI 10.1080/14999013.2016.1255281
   Ornell F, 2020, BRAZ J PSYCHIAT, V42, P232, DOI 10.1590/1516-4446-2020-0008
   Percudani M, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112980
   Poremski D, 2020, INFECT CONT HOSP EP, V41, P1238, DOI 10.1017/ice.2020.163
   Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066
   Royal College of Psychiatrists, 2020, COVID 19 SEC HOSP CR
   Shalev D, 2020, GEN HOSP PSYCHIAT, V64, P68, DOI 10.1016/j.genhosppsych.2020.03.009
   Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7647
   Shao Y, 2020, BRAIN BEHAV IMMUN, V88, P947, DOI 10.1016/j.bbi.2020.04.018
   Simpson AIF, 2020, CAN J PSYCHIAT, V65, P695, DOI 10.1177/0706743720935648
   Simpson SA, 2020, PSYCHOSOMATICS, V61, P568, DOI 10.1016/j.psym.2020.04.004
   Starace F, 2020, EPIDEMIOL PSYCH SCI, V29, DOI 10.1017/S2045796020000372
   Statista, 2020, COVID 19 DEATHS WORL
   The Lancet Hiv null, 2020, LANCET HIV, V7, pe75
   Thome J, 2020, PSYCHIAT CLIN NEUROS, V74, P407, DOI 10.1111/pcn.13019
   Tomlin Jack, 2020, Forensic Sci Int Mind Law, V1, P100018, DOI 10.1016/j.fsiml.2020.100018
   Turkozer HB, 2020, MOL PSYCHIATR, V25, P2214, DOI 10.1038/s41380-020-0841-2
   Xiang YT, 2020, INT J BIOL SCI, V16, P1741, DOI 10.7150/ijbs.45072
   Zhu YH, 2020, NEUROSCI BULL, V36, P299, DOI 10.1007/s12264-020-00476-9
   Zuffranieri M, 2020, PSYCHIAT CLIN NEUROS, V74, P507, DOI 10.1111/pcn.13100
   2020, LIVES HOUSES, P1, DOI DOI 10.1017/IPM.2020.58
NR 69
TC 3
Z9 3
U1 1
U2 6
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1556-4886
EI 1556-4991
J9 VICTIMS OFFENDERS
JI Victims Offenders
PD OCT 2
PY 2020
VL 15
IS 7-8
SI SI
BP 1337
EP 1360
DI 10.1080/15564886.2020.1827111
EA OCT 2020
PG 24
WC Criminology & Penology
WE Social Science Citation Index (SSCI)
SC Criminology & Penology
GA PX8TO
UT WOS:000582348100001
OA Bronze
DA 2022-04-20
ER

PT C
AU Asim, H
   Asmat, A
   Ilyas, K
   Hassan, MT
AF Asim, Hira
   Asmat, Ayesha
   Ilyas, Kiran
   Hassan, Malik Tahir
GP IEEE
TI COVID-19: Future Preference of University Students to Promote Online
   Education in Pakistan
SO 2021 INTERNATIONAL CONFERENCE ON DIGITAL FUTURES AND TRANSFORMATIVE
   TECHNOLOGIES (ICODT2)
LA English
DT Proceedings Paper
CT IEEE International Conference on Digital Futures and Transformative
   Technologies (ICoDT2)
CY MAY 20-21, 2021
CL Natl Univ Sci & Technol, Islamabad, PAKISTAN
SP IEEE, IEEE Robot & Automat Soc, Natl Univ Sci & Technol, Sch Elect Engn & Comp Sci
HO Natl Univ Sci & Technol
DE COVID-19; Sentiment Analysis; Digital Future; Distance Learning;
   Transformative Technologies; Knowledge Discovery; Knowledge Acquisition;
   Predictive Data Analytics
AB COVID-19 is a deadly virus that has been transmitted globally in no time. Due to the continuous spread of COVID-19, the Higher Education Commission (HEC) of Pakistan has decided to shift towards online classes. In this study, a survey has been conducted to assess the online learning experience of the students. This paper aims to find the preferences of students regarding e-learning in the upcoming semester(s) for the promotion of digital learning in Pakistan. A well-structured questionnaire is circulated and a total of 519 responses are collected from the prestigious universities of Pakistan after the conclusion of the online semester. It has been observed that only 26% of the students are willing to take online classes in the future. To dig down the reasons behind this low percentage, comparative as well as sentiment analyses of the results have been conducted. The comparative analysis has indicated that the students are not satisfied with their learning outcomes, online examination, and grading in this regard. Similarly, the sentiment analysis of the comments has revealed that 60% of the students have provided negative feedback regarding online classes. Whereas, it has also been observed that many students are in the favor of attending short courses, seminars, and conferences online. Based on the analyses, suitable recommendations have also been provided to promote e-learning in Pakistan.
C1 [Asim, Hira; Hassan, Malik Tahir] Univ Management & Technol, Dept Software Engn, Lahore, Pakistan.
   [Asmat, Ayesha] Univ Management & Technol, Dept Comp Sci, Lahore, Pakistan.
   [Ilyas, Kiran] Univ Management & Technol, Dept Informat & Syst, Lahore, Pakistan.
RP Asim, H (corresponding author), Univ Management & Technol, Dept Software Engn, Lahore, Pakistan.
EM hira.asim@umt.edu.pk; ayesha.asmat@umt.edu.pk; kiran.ilyas@umt.edu.pk;
   tahir.hassan@umt.edu.pk
OI Hassan, Malik Tahir/0000-0002-0651-5297
CR Abbasi S, 2020, PAK J MED SCI, V36, pS57, DOI 10.12669/pjms.36.COVID19-S4.2766
   Adnan M., 2020, PSYCHOL VOL J PEDAGO, V2
   Ayub Hina, 2017, International Journal of Information and Education Technology, V7, P534, DOI 10.18178/ijiet.2017.7.7.925
   Aziz A, 2020, ANN KING EDWARD MED, V26, P181
   Baloch I., 2020, PAKISTAN TOPIC BRIEF, DOI [10.5281/zenodo. 3885606, DOI 10.5281/ZENODO.3885606]
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   Dogar AA, 2020, REV ROMANEASCA PENTR, V12, P12, DOI 10.18662/rrem/12.2Sup1/285
   Farooq Fareeha, 2020, J Coll Physicians Surg Pak, V30, P67, DOI 10.29271/jcpsp.2020.Supp1.S67
   Iqbal T., 2020, PAK J PHYSL, V16, P1
   Massan SUR, 2020, 3C TECNOL, P249, DOI 10.17993/3ctecno.2020.specialissue5.249-263
   Mukhtar K, 2020, PAK J MED SCI, V36, pS27, DOI 10.12669/pjms.36.COVID19-S4.2785
   Salam S, 2017, PROCEEDINGS OF THE 2017 INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE AND ARTIFICIAL INTELLIGENCE (CSAI 2017), P169, DOI 10.1145/3168390.3168422
   Shahzad SK., 2020, ENGLISH LANGUAGE TEA, V13, P1, DOI [10.5539/elt.v13n9p1, DOI 10.5539/ELT.V13N9P1]
NR 13
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-6654-1285-8
PY 2021
DI 10.1109/ICoDT252288.2021.9441486
PG 7
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science
GA BS7GM
UT WOS:000760235700014
DA 2022-04-20
ER

PT J
AU Bugert, CL
   Kwiat, V
   Valera, IC
   Bugert, JJ
   Parvatiyar, MS
AF Bugert, Christina L.
   Kwiat, Victoria
   Valera, Isela C.
   Bugert, Joachim J.
   Parvatiyar, Michelle S.
TI Cardiovascular Injury Due to SARS-CoV-2
SO CURRENT CLINICAL MICROBIOLOGY REPORTS
LA English
DT Article
DE Cardiac injury; COVID-19; Myocarditis; Arrhythmia; Cardiomyopathy
ID ACUTE MYOCARDIAL-INFARCTION; INFLUENZA INFECTION; COVID-19;
   INFLAMMATION; MANAGEMENT; PNEUMONIA; THERAPY; HEART
AB Purpose of Review The world is currently facing the largest global health crisis since the early 1900s due to a novel coronavirus. While SARS-CoV-2 infection causes predictable symptoms in COVID-19 patients, including upper respiratory distress and fever, the heterogeneity of manifestations is surprising. This review focuses on direct and indirect causes of myocardial injury in COVID-19 patients and highlights current knowledge, treatment strategies, and outstanding questions in the field. Recent Findings Data are emerging that highlight the extent of cardiovascular involvement in COVID-19 patients, including evidence that SARS-CoV-2 causes myocarditis and increases cardiac risk. The incidence of cardiac injury is much greater in patients with severe disease presentation and those in intensive care. During the past year, COVID-19 patient mortality rates have improved due to tailored pharmacological treatments and patient management strategies that address the unique presentation of symptoms, which will hopefully also reduce the incidence of cardiac injury.
C1 [Bugert, Christina L.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England.
   [Kwiat, Victoria; Valera, Isela C.; Parvatiyar, Michelle S.] Florida State Univ, Dept Nutr Food & Exercise Sci, Tallahassee, FL 32306 USA.
   [Bugert, Joachim J.] Bundeswehr Inst Microbiol, Munich, Germany.
RP Parvatiyar, MS (corresponding author), Florida State Univ, Dept Nutr Food & Exercise Sci, Tallahassee, FL 32306 USA.
EM mparvatiyar@fsu.edu
RI Bugert, Joachim/AAK-6459-2021; Bugert, Joachim Jakob/D-1705-2012
OI Bugert, Joachim Jakob/0000-0002-0556-3211; Valera,
   Isela/0000-0001-8610-0480; Parvatiyar, Michelle/0000-0002-9416-0069
FU American Heart Association (AHA)American Heart Association
   [16SDG29120002]; FSU Office of Research Development - Collaborative
   Collision: Covid-19 Pandemic [045724]
FX A special thank you to the American Heart Association (AHA Grant
   16SDG29120002) and the FSU Office of Research Development -
   Collaborative Collision: Covid-19 Pandemic #045724 for their support
   during this project.
CR Anderson RM, 2020, LANCET, V396, P1614, DOI 10.1016/S0140-6736(20)32318-7
   Batlle D, 2020, CLIN SCI, V134, P543, DOI 10.1042/CS20200163
   Bavishi C, 2020, PROG CARDIOVASC DIS, V63, P682, DOI 10.1016/j.pcad.2020.05.013
   Bavishi C, 2020, JAMA CARDIOL, V5, P745, DOI 10.1001/jamacardio.2020.1282
   Bhatla A, 2020, HEART RHYTHM, V17, P1439, DOI 10.1016/j.hrthm.2020.06.016
   Bonow RO, 2020, JAMA CARDIOL, V5, P751, DOI 10.1001/jamacardio.2020.1105
   Caforio ALP, 2013, EUR HEART J, V34, P2636, DOI 10.1093/eurheartj/eht210
   Ceriello A, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-01089-2
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941
   Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000
   Corrales-Medina VF, 2015, JAMA-J AM MED ASSOC, V313, P264, DOI 10.1001/jama.2014.18229
   Cox RM, 2021, NAT MICROBIOL, V6, P11, DOI 10.1038/s41564-020-00835-2
   Daviet F, 2020, CIRCULATION, V142, P1875, DOI 10.1161/CIRCULATIONAHA.120.049015
   Dolhnikoff M, 2020, LANCET CHILD ADOLESC, V4, P790, DOI 10.1016/S2352-4642(20)30257-1
   Doolub G, 2021, ESC HEART FAIL, V8, P1691, DOI 10.1002/ehf2.13158
   Esfandiarei M, 2008, ANNU REV PATHOL-MECH, V3, P127, DOI 10.1146/annurev.pathmechdis.3.121806.151534
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Guzik TJ, 2020, CARDIOVASC RES, V116, P1666, DOI 10.1093/cvr/cvaa106
   Hirano T, 2020, IMMUNITY, V52, P731, DOI 10.1016/j.immuni.2020.04.003
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang L, 2020, JACC-CARDIOVASC IMAG, V13, P2330, DOI 10.1016/j.jcmg.2020.05.004
   Huertas A, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01634-2020
   Humeniuk R, 2020, CTS-CLIN TRANSL SCI, V13, P896, DOI 10.1111/cts.12840
   Inciardi RM, 2020, JAMA CARDIOL, V5, P819, DOI 10.1001/jamacardio.2020.1096
   Islam MT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64162-6
   Kang Y, 2020, HEART, V106, P1132, DOI 10.1136/heartjnl-2020-317056
   Kim PS, 2020, JAMA-J AM MED ASSOC, V324, P2149, DOI 10.1001/jama.2020.22813
   Kwong JC, 2018, NEW ENGL J MED, V378, P345, DOI 10.1056/NEJMoa1702090
   Lala A, 2020, J AM COLL CARDIOL, V76, P533, DOI [10.1101/2020.04.20.20072702, 10.1016/j.jacc.2020.06.007]
   Levi M, 2020, LANCET HAEMATOL, V7, pE438, DOI 10.1016/S2352-3026(20)30145-9
   Lindner D, 2020, JAMA CARDIOL, V5, P1281, DOI 10.1001/jamacardio.2020.3551
   Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744
   Mahallawi WH, 2018, CYTOKINE, V104, P8, DOI 10.1016/j.cyto.2018.01.025
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Nishiga M, 2020, NAT REV CARDIOL, V17, P543, DOI 10.1038/s41569-020-0413-9
   Oudit GY, 2009, EUR J CLIN INVEST, V39, P618, DOI 10.1111/j.1365-2362.2009.02153.x
   Panigada M, 2020, J THROMB HAEMOST, V18, P1738, DOI 10.1111/jth.14850
   Paul JF, 2020, EUR HEART J-CARD IMG, V21, P776, DOI 10.1093/ehjci/jeaa107
   Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5
   Perez-Bermejo Juan A, 2020, bioRxiv, DOI 10.1101/2020.08.25.265561
   Pietsch H, 2021, INT J INFECT DIS, V102, P70, DOI 10.1016/j.ijid.2020.10.012
   Prasitlumkum N, 2020, DISEASES-BASEL, V8, DOI 10.3390/diseases8040040
   Puntmann V, 2021, JAMA CARDIOL, V6, P244, DOI 10.1001/jamacardio.2020.5285
   Puntmann VO, 2020, JAMA CARDIOL, V5, P1265, DOI 10.1001/jamacardio.2020.3557
   Radenkovic D, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061909
   Rajpal S, 2021, JAMA CARDIOL, V6, P116, DOI 10.1001/jamacardio.2020.4916
   Rapkiewicz AV, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100434
   Rebello CJ, 2020, INT J OBESITY, V44, P1810, DOI 10.1038/s41366-020-0640-5
   Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/S0140-6736(20)31094-1, 10.1016/50140-6736(20)31094-1]
   Rizzo P, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0791-5
   Rubin R, 2020, JAMA-J AM MED ASSOC, V324, P1381, DOI 10.1001/jama.2020.17709
   Rubino F, 2020, NEW ENGL J MED, V383, P789, DOI [10.1056/NEJMc2021832, 10.1056/NEJMc2018688]
   Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2
   Sala S, 2020, EUR HEART J, V41, P1861, DOI 10.1093/eurheartj/ehaa286
   Sehirli AO, 2020, MOL BIOL REP, V47, P8229, DOI 10.1007/s11033-020-05830-8
   Shah VK, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01949
   Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117
   Shang LH, 2020, LANCET, V395, P683, DOI 10.1016/S0140-6736(20)30361-5
   Sharma A, 2020, CELL REP MED, V1, DOI [10.1016/j.xcrm.2020.100052, 10.1101/2020.04.21.051912]
   Siripanthong B, 2020, HEART RHYTHM, V17, P1463, DOI 10.1016/j.hrthm.2020.05.001
   Ssentongo P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238215
   Tavazzi G, 2020, EUR J HEART FAIL, V22, P911, DOI 10.1002/ejhf.1828
   Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11
   Toots M, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax5866
   Tremblay D, 2020, BLOOD, V136, P144, DOI 10.1182/blood.2020006941
   Unudurthi SD, 2020, LIFE SCI, V260, DOI 10.1016/j.lfs.2020.118482
   Waghmare A, 2020, BIOL BLOOD MARROW TR, V26, P1983, DOI 10.1016/j.bbmt.2020.07.027
   Wagner MJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00639
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Warren-Gash C, 2012, J INFECT DIS, V206, P1652, DOI 10.1093/infdis/jis597
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0
NR 80
TC 2
Z9 2
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 2196-5471
J9 CURR CLIN MICROBIOL
JI Curr. Clin. Microbiol.
PD SEP
PY 2021
VL 8
IS 3
BP 167
EP 177
DI 10.1007/s40588-021-00160-0
EA MAR 2021
PG 11
WC Microbiology
WE Emerging Sources Citation Index (ESCI)
SC Microbiology
GA UM0LS
UT WOS:000625577700001
PM 33717830
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Helsen, K
   Derom, I
   Corthouts, J
   De Bosscher, V
   Willem, A
   Scheerder, J
AF Helsen, Kobe
   Derom, Inge
   Corthouts, Joris
   De Bosscher, Veerle
   Willem, Annick
   Scheerder, Jeroen
TI Participatory sport events in times of COVID-19: analysing the (virtual)
   sport behaviour of event participants
SO EUROPEAN SPORT MANAGEMENT QUARTERLY
LA English
DT Article
DE COVID-19; social ecological theory; population survey; cancellation;
   alternatives
ID PHYSICAL-ACTIVITY; MOTIVATION
AB Research question Due to government restrictions because of COVID-19, all participatory sport events (PSEs) were cancelled. As a result, knowledge is needed as to how and to what extent participants of PSEs modified their sport behaviour to fill the void of event cancellation. Therefore, this study aimed to (1) investigate to what extent event participants have modified their sport behaviour as a result of the COVID-19 measures, and (2) analyse the factors that determine participation in virtual events (real activities using an online recording platform). Research methods A total of 2869 respondents completed an online survey which was widely disseminated in Flanders (Belgium) six weeks after the announcement of the COVID-19 lockdown. The sample included both event and non-event participants. Descriptive and binary logistic regression analyses were used to investigate how event participants adapted their sport behaviour and which factors determined virtual event participation. Results and findings Since the COVID-19 measures, event participants did not decrease the frequency but only the intensity of their sport behaviour. Based on social ecological theory, participation in virtual events could be explained by both individual determinants (e.g. motivation towards developing skills), and interpersonal determinants (e.g. previous participation in a virtual event). Implications This study contributes to research on the impact of COVID-19 measures and consequently the cancellation of PSEs on sport behaviour of event participants. Confronted with an uncertain future, the findings provide insights for event organisers to develop and optimise virtual event experiences in order to reach non-event participants as well.
C1 [Helsen, Kobe; Corthouts, Joris; Scheerder, Jeroen] Katholieke Univ Leuven, Policy Sports & Phys Act Res Grp, Leuven, Belgium.
   [Derom, Inge; De Bosscher, Veerle] Vrije Univ Brussel, Sport & Soc Res Grp, Brussels, Belgium.
   [Willem, Annick] Univ Ghent, Dept Movement & Sport Sci, Ghent, Belgium.
   [Derom, Inge; Corthouts, Joris; De Bosscher, Veerle; Willem, Annick; Scheerder, Jeroen] Flemish Policy Res Ctr Sports, Leuven, Belgium.
RP Scheerder, J (corresponding author), Katholieke Univ Leuven, Policy Sports & Phys Act Res Grp, Leuven, Belgium.
EM Jeroen.scheerder@kuleuven.be
RI Willem, Annick/A-7311-2017; De Bosscher, Veerle/C-6154-2015
OI Willem, Annick/0000-0003-3753-2919; Helsen, Kobe/0000-0002-1114-4451;
   Corthouts, Joris/0000-0002-5198-9387; De Bosscher,
   Veerle/0000-0002-6516-2030
CR Alexandris K, 2009, J HOSP MARKET MANAG, V18, P480, DOI 10.1080/19368620902950048
   Algesheimer R, 2005, J MARKETING, V69, P19, DOI 10.1509/jmkg.69.3.19.66363
   Bielons G., 2019, CONNECTING SPORT PRA, P139
   Borgers J, 2016, EUR SPORT MANAG Q, V16, P635, DOI 10.1080/16184742.2016.1196717
   Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX
   Coleman R, 2010, INT J SPORT MARK SPO, V12, P24
   Coleman SJ, 2017, J PUBLIC HEALTH-UK, V39, pE202, DOI 10.1093/pubmed/fdw090
   Constandt B, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114144
   Crofts C., 2012, International Journal of Sport Management and Marketing, V12, P260, DOI 10.1504/IJSMM.2012.052679
   Crofts C, 2012, ANN LEIS RES, V15, P148, DOI 10.1080/11745398.2012.685297
   Derom I, 2015, ANN LEIS RES, V18, P25, DOI 10.1080/11745398.2014.932699
   Driver, 1983, MASTER LIST IT UNPUB
   Driver, 1977, ITEM POOL SCAL UNPUB
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Funk D, 2011, LEISURE SCI, V33, P250, DOI 10.1080/01490400.2011.564926
   Goethals Luc, 2020, JMIR Aging, V3, pe19007, DOI 10.2196/19007
   Hair J.F.Jr., 2010, MULTIVARIATE DATA AN, V7th ed.
   Helsen K., 2020, SPORTEVENEMENTEN TIJ
   Hoekman R, 2017, LEISURE STUD, V36, P357, DOI 10.1080/02614367.2016.1182201
   Kennelly M, 2017, INT J CONTEMP HOSP M, V29, P883, DOI [10.1108/ijchm-10-2015-0541, 10.1108/IJCHM-10-2015-0541]
   Kyle G, 2004, LEISURE SCI, V26, P123, DOI 10.1080/01490400490432019
   Lane A, 2010, HEALTH EDUC J, V69, P287, DOI 10.1177/0017896910364890
   LAURENT G, 1985, J MARKETING RES, V22, P41, DOI 10.2307/3151549
   Manfredo MJ, 1996, J LEISURE RES, V28, P188, DOI 10.1080/00222216.1996.11949770
   MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401
   MOORE LL, 1991, J PEDIATR-US, V118, P215, DOI 10.1016/S0022-3476(05)80485-8
   Moore SA, 2020, INT J BEHAV NUTR PHY, V17, DOI 10.1186/s12966-020-00987-8
   Mutz M, 2021, INT REV SOCIOL SPORT, V56, P305, DOI 10.1177/1012690220934335
   Nagel S., 2020, FUNCTIONS SPORTS CLU
   Nicholson M, 2011, PARTICIPATION SPORT
   Pietrobelli A, 2020, OBESITY, V28, P1382, DOI 10.1002/oby.22861
   Scheerder, 2020, FUNCTIONS SPORTS CLU, P315, DOI DOI 10.1007/978-3-030-48535-1
   Scheerder J, 2015, RUNNING ACROSS EUROPE: THE RISE AND SIZE OF ONE OF THE LARGEST SPORT MARKETS, P1, DOI 10.1057/9781137446374
   Schnitzer M, 2020, PUBLIC HEALTH, V185, P218, DOI 10.1016/j.puhe.2020.06.042
   Schoemaker J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010098
   Statistics Belgium [StatBel], 2021, POPULATION
   Urbanova LB, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16203914
   van Dyck D, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111315
   Van Tuyckom C., 2011, THESIS GHENT U
   Verschueren, 2019, SPORT POLICY MANAGEM, V49
   Waege H., 2014, PARTICIPATIE VLAANDE
   Wattanapisit A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082745
   Westmattelmann D, 2021, EUR J INFORM SYST, V30, P119, DOI 10.1080/0960085X.2020.1850186
   Willem A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00354
   Wiltshire GR, 2018, SOCIOL HEALTH ILL, V40, P3, DOI 10.1111/1467-9566.12622
   ZAICHKOWSKY JL, 1985, J CONSUM RES, V12, P341, DOI 10.1086/208520
   Zecevic CA, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/468526
NR 47
TC 3
Z9 3
U1 9
U2 16
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1618-4742
EI 1746-031X
J9 EUR SPORT MANAG Q
JI Eur. Sport Manag. Q.
PD JAN 2
PY 2022
VL 22
IS 1
SI SI
BP 35
EP 54
DI 10.1080/16184742.2021.1956560
EA JUL 2021
PG 20
WC Hospitality, Leisure, Sport & Tourism
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics
GA ZS6RS
UT WOS:000678415800001
DA 2022-04-20
ER

PT J
AU Tavares, F
   Santos, E
   Diogo, A
   Ratten, V
AF Tavares, Fernando
   Santos, Eulalia
   Diogo, Ana
   Ratten, Vanessa
TI Teleworking in Portuguese communities during the COVID-19 pandemic
SO JOURNAL OF ENTERPRISING COMMUNITIES-PEOPLE AND PLACES IN THE GLOBAL
   ECONOMY
LA English
DT Article
DE Communities; Teleworking; Work management; Remote work; Flexible forms
   of work; Professional confinement; Crisis; Community; Covid-19; Flexible
   work practices
ID BENEFITS
AB Purpose Human beings spend about a third of their day working, so it is very important that they are integrated into a good community work environment. When the setting is teleworking in a family and housing context, it is important to keep a good environment and also a good physical, psychological and ergonomic aspects to attain job performance. The purpose of this paper is to characterize teleworking carried out in Portuguese communities in the context of the state of emergency caused by the COVID-19 pandemic. Design/methodology/approach A survey questionnaire was used, which analyzed general information about teleworking and the individual's adaptation process and the difficulties they faced during the teleworking period. The sample consists of 359 individuals aged 18 years or over, who were teleworking in their homes and in a family environment. Findings The results show that adapting to teleworking was easy or very easy and that it happened very quickly. The main difficulties encountered by the individuals were the lack of professional interaction/communication with coworkers, the lack of resources related to support infrastructures, such as the internet or a printer, and the reconciliation of teleworking with family life/household chores/dedication to children and time/schedule management. Originality/value This study hopes to contribute to the increase of the scientific knowledge in the teleworking field and to allow companies to rethink the teleworking strategies to optimize resources and costs and to improve the organization's productivity without harming the quality of life and well-being of their workers.
C1 [Tavares, Fernando] Higher Inst Business & Tourism Sci, Porto, Portugal.
   [Santos, Eulalia] Polytech Inst Leiria, Leiria, Portugal.
   [Diogo, Ana] Higher Inst Management & Adm Leiria, Leiria, Portugal.
   [Ratten, Vanessa] La Trobe Univ, Melbourne, Vic, Australia.
RP Ratten, V (corresponding author), La Trobe Univ, Melbourne, Vic, Australia.
EM ftavares@iscet.pt; eulalia.santos@sapo.pt; anabsousa@gmail.com;
   v.ratten@latrobe.edu.au
RI Diogo, Ana Paula Louro/E-2758-2010; santos, Eulália/AAO-4024-2020;
   Tavares, Fernando António de Oliveira/AAC-5055-2022; Tavares, Fernando
   Oliveira/AAE-6873-2021
OI Diogo, Ana Paula Louro/0000-0003-4939-9158; santos,
   Eulália/0000-0001-8069-2657; Tavares, Fernando António de
   Oliveira/0000-0002-9672-8770; 
CR Agarwal S, 2020, J ENTERP COMMUNITIES, V14, P299, DOI 10.1108/JEC-03-2020-0024
   Baruch Y, 2001, INT J MANAG REV, V3, P113, DOI 10.1111/1468-2370.00058
   Baruch Y, 2000, NEW TECH WORK EMPLOY, V15, P34, DOI 10.1111/1468-005X.00063
   Beauregard TA, 2019, CAMB HANDB PSYCHOL, P511
   Belzunegui-Eraso A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093662
   Bucater A., 2016, THESIS
   Dana L.P., 2017, ENTREPRENEURSHIP W E
   Daniels K, 2001, J MANAGE STUD, V38, P1151, DOI 10.1111/1467-6486.00276
   de Vries H, 2019, REV PUBLIC PERS ADM, V39, P570, DOI 10.1177/0734371X18760124
   DirecAo Geral de Saude (DGS), 2020, COV 19
   EEA, 2019, 102015 EEA, DOI [10.2800/822355, DOI 10.2800/822355]
   Fairweather NB, 1999, J BUS ETHICS, V22, P39, DOI 10.1023/A:1006104017646
   Felippe G., 2018, THESIS
   Ferreira J.P., 2018, MULTIFACES REV CIENC, V1, P90
   Franca S.A., 2019, TELETRABALHO TELEWOR, V4, P132, DOI [10.32810/2525-3468.ip.v4iEspecial.2019.42611.132-151, DOI 10.32810/2525-3468.IP.V4IESPECIAL.2019.42611.132-151]
   Galvez A, 2020, BUS ETHICS, V29, P180, DOI 10.1111/beer.12240
   Haddon L., 1994, INT J HUM RESOUR MAN, V5, P193, DOI [10.1080/09585199400000010, DOI 10.1080/09585199400000010]
   Jardon CM, 2020, J ENTERP COMMUNITIES, V14, P161, DOI 10.1108/JEC-05-2019-0040
   Kwon M, 2017, PUBLIC PERS MANAGE, V46, P239, DOI 10.1177/0091026017717240
   Leite A.L., 2019, CONTEXTUS REV CONT E, V17, P187
   Maciel A.G., 2017, REV GESTAO EMPRESARI, V1, P20
   Madsen SR., 2003, HUMAN RESOURCE DEV Q, V14, P35, DOI [10.1002/hrdq.1049, DOI 10.1002/HRDQ.1049]
   Mann S, 2003, NEW TECH WORK EMPLOY, V18, P196, DOI 10.1111/1468-005X.00121
   Maroco J., 2018, ANALISE ESTATISTICA, V7
   Melo PC, 2017, TRANSPORT RES A-POL, V103, P1, DOI 10.1016/j.tra.2017.05.011
   Palacic R., 2017, J ENTERPRISING COMMU, V11
   PRATT JH, 1984, TECHNOL FORECAST SOC, V25, P1, DOI 10.1016/0040-1625(84)90076-3
   QUIVY Raimond, 2013, MANUAL INVESTIGACAO
   Ramadani V., 2020, ORG MINDSET ENTREPRE
   Ramadani V., 2015, J ENTERPRISING COMMU, V9
   Ratten V, 2017, J ENTERP COMMUNITIES, V11, P310, DOI 10.1108/JEC-03-2017-0021
   Ravalet E., 2019, BUILD ENVIRON, V45, P582, DOI DOI 10.2148/BENV.45.4.582
   Rocha Cháris Telles Martins da, 2018, Cad. EBAPE.BR, V16, P152, DOI 10.1590/1679-395154516
   ROSENFIELD C. L., 2011, DICIONARIO TRABALHO, P414
   Salamzadeh A, 2017, J ENTERP COMMUNITIES, V11, P456, DOI 10.1108/JEC-07-2015-0036
   Sullivan C, 2003, NEW TECH WORK EMPLOY, V18, P158, DOI 10.1111/1468-005X.00118
   Tavares A.I., 2017, INT J HEALTHC, V3, P30, DOI DOI 10.5430/IJH.V3N2P30
   Thieriot H., 2020, 11000 AIR POLLUTION
   Thulin E, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11113067
   World Health Organization, 2020, COR DIS COVID 19 PAN
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
NR 41
TC 27
Z9 28
U1 20
U2 85
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1750-6204
EI 1750-6212
J9 J ENTERP COMMUNITIES
JI J. Enterp. Communities
PD JUN 21
PY 2021
VL 15
IS 3
BP 334
EP 349
DI 10.1108/JEC-06-2020-0113
EA SEP 2020
PG 16
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA SW4QH
UT WOS:000574327300001
DA 2022-04-20
ER

PT J
AU Zollkau, J
   Hagenbeck, C
   Hecher, K
   Pecks, U
   Schlembach, D
   Simon, A
   Schlosser, R
   Schleussner, E
AF Zoellkau, Janine
   Hagenbeck, Carsten
   Hecher, Kurt
   Pecks, Ulrich
   Schlembach, Dietmar
   Simon, Arne
   Schloesser, Rolf
   Schleussner, Ekkehard
TI Update on Recommendations for SARS-CoV-2/COVID-19 During Pregnancy,
   Birth and Childbed
SO ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE
LA German
DT Article
DE SARS-CoV-2; COVID-19; pregnancy; birth; childbed; breastfeeding
ID INFECTION
AB With begin of the SARS-CoV-2 pandemic the german obstetric, peri-/neonatological and pediatric professional societies published recommendations for care of pregnant and newborn, as well as for necessary staff protection in March 2020 [1-3]. Because of the rapid emerging increase of knowledge an update is required. This work therefore perceives as prosecution of the existing recommendations [1-3].
   Worldwide national recommendations were recently compared and published in a consensual review [ 4]. In methodological dependence this update of recommendations comments on key questions of pre-, peri- and postnatal care at SARS-CoV- 2 and COVID-19, based on publications up to 30.05.2020. Statements represent a carefully concerned expert consensus and can change contemporary as new knowledge appears.
   The responsibility for concrete management remains at the local medical team, decisions should be supported by these recommendations.
C1 [Zoellkau, Janine; Schleussner, Ekkehard] Univ Klinikum Jena, Klin Geburtsmed, Klinikum 1, D-07740 Jena, Germany.
   [Hagenbeck, Carsten] Univ Dusseldorf, Klin Frauenheilkunde & Geburtshilfe, Dusseldorf, Germany.
   [Hecher, Kurt] Univ Klinikum Hamburg Eppendorf, Klin Geburtshilfe & Pranatalmed, Hamburg, Germany.
   [Pecks, Ulrich] Univ Klinikum Schleswig Holstein, Klin Gynakol & Geburtshilfe, Campus Kiel, Kiel, Germany.
   [Schlembach, Dietmar] Vivantes Klinikum Neukolln, Klin Geburtsmed, Berlin, Germany.
   [Simon, Arne] Univ Klinikum Saarlandes, Klin Padiatr Onkol & Hamatol, Homburg, Germany.
   [Schloesser, Rolf] Univ Klinikum Frankfurt, Schwerpunkt Neonatol, Klin Kinder & Jugendmed, Frankfurt, Germany.
RP Schleussner, E (corresponding author), Univ Klinikum Jena, Klin Geburtsmed, Klinikum 1, D-07740 Jena, Germany.
EM ekkehard.schleussner@med.uni-jena.de
RI Pecks, Ulrich/D-1190-2012; Hagenbeck, Carsten/AAG-4292-2021
OI Pecks, Ulrich/0000-0002-0784-1262; Hagenbeck,
   Carsten/0000-0002-9890-5435
CR ACOG, 2020, NOV COR 2019 COVID 1
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   Barss, 2020, CORONAVIRUS DIS 2019
   Barth RE, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1724
   Baud D, 2020, JAMA-J AM MED ASSOC, V323, P2198, DOI 10.1001/jama.2020.7233
   Boelig RC, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100106
   Bourne T, 2020, ULTRASOUND OBST GYN, V55, P879, DOI 10.1002/uog.22047
   Campbell KH, 2020, JAMA-J AM MED ASSOC, V323, P2520, DOI 10.1001/jama.2020.8904
   CDC, 2020, COR DIS 2019 COVID 1
   CDC, 2020, INT CONS INF PREV CO
   Dashraath P, 2020, AM J OBSTET GYNECOL, V222, P521, DOI 10.1016/j.ajog.2020.03.021
   DGGG, 2020, EMPF PRAV GEB VERS D
   DGPI, 2020, UMG NEUG SARS COV 2
   Dong L, 2020, JAMA-J AM MED ASSOC, V323, P1846, DOI 10.1001/jama.2020.4621
   e.V DGfA-uV, 2020, COVID 19 EMPFEHLUNG
   [e.V PDGfGuG e.V PDGfGuG], 2020, DGGG EMPFIEHLT VATER
   ELHOUSHEIMI A, 2020, AM J OBSTET GYNECOL, DOI DOI 10.1016/J.AJOG.2020.05.005
   Elshafeey F, 2020, INT J GYNECOL OBSTET, V150, P47, DOI 10.1002/ijgo.13182
   Gerste RD, 2020, DTSCH ARZTEBL
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   GroSS Rudiger, 2020, Lancet, V395, P1757, DOI 10.1016/S0140-6736(20)31181-8
   Kagan KO, 2020, ULTRASCHALL MED, V41, P237, DOI 10.1055/a-1152-4550
   Knight M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2107
   Kranke P, 2020, ANASTH INTENSIV NOTF, V55, P266, DOI 10.1055/a-1144-5562
   Liguoro I, 2020, EUR J PEDIATR, V179, P1029, DOI 10.1007/s00431-020-03684-7
   Mario Rudiger UP, 2020, CRONOS NEWSLETTER 08
   Moein ST, 2020, INT FORUM ALLERGY RH, V10, P944, DOI 10.1002/alr.22587
   Morris POB Edward, 2020, RCOG
   Mullins E, 2020, ULTRASOUND OBST GYN, V55, P586, DOI 10.1002/uog.22014
   Ng KF, 2020, PEDIATR INFECT DIS J, V39, pE140, DOI 10.1097/INF.0000000000002738
   Patane L., 2020, AM J OBSTET GYNECOL, DOI [10.1016/j.ajogmf.2020.100145, DOI 10.1016/J.AJOGMF.2020.100145]
   Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097
   RCOG, 2020, COR COVID 19 INF PRE
   RKI, 2020, ERW HYG GES RAHM COV
   RKI, 2020, COVID 19 COR SARS CO
   Schleussner E, 2013, DTSCH ARZTEBL INT, V110, P227, DOI 10.3238/arztebl.2013.0227
   Schwartz DA, 2020, ARCH PATHOL LAB MED, V144, P799, DOI 10.5858/arpa.2020-0901-SA
   Shanes ED, 2020, AM J CLIN PATHOL, V154, P23, DOI 10.1093/ajcp/aqaa089
   Simon AHJ, 2020, MANAGEMENT CARE NEON
   Spinato G, 2020, JAMA-J AM MED ASSOC, V323, P2089, DOI 10.1001/jama.2020.6771
   Stephens AJ, 2020, AM J PERINAT, V37, P829, DOI 10.1055/s-0040-1710308
   Stillkommission N, 2020, STILL COVID 19 STELL
   Stumpfe FM, 2020, GEBURTSH FRAUENHEILK, V80, P380, DOI 10.1055/a-1134-5951
   Sutton D, 2020, NEW ENGL J MED, V382, P2163, DOI 10.1056/NEJMc2009316
   Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Wang C, 2020, ULTRASOUND OBST GYN, V55, P724, DOI 10.1002/uog.22045
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   WHO, 2020, PREGN CHILDB COVID 1
   Wu Y, 2020, BJOG-INT J OBSTET GY, V127, P1109, DOI 10.1111/1471-0528.16276
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yang H, 2020, J INFECTION, V81, pE40, DOI 10.1016/j.jinf.2020.04.003
   Zaigham M, 2020, ACTA OBSTET GYN SCAN, V99, P823, DOI 10.1111/aogs.13867
   Zeng H, 2020, JAMA-J AM MED ASSOC, V323, P1848, DOI 10.1001/jama.2020.4861
   Zollkau JBM, 2020, PERIODENPRAVAL UNPUB
NR 55
TC 3
Z9 3
U1 0
U2 6
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0948-2393
EI 1439-1651
J9 Z GEBURTSH NEONATOL
JI Z. Geburtsh. Neonat.
PD AUG
PY 2020
VL 224
IS 04
BP 217
EP 222
DI 10.1055/a-1199-6404
PG 6
WC Obstetrics & Gynecology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Obstetrics & Gynecology; Pediatrics
GA ND7XA
UT WOS:000562115200015
PM 32838449
OA Green Published
DA 2022-04-20
ER

PT J
AU Hanson, C
   Luedtke, S
   Spicer, N
   Sorensen, JS
   Mayhew, S
   Mounier-Jack, S
AF Hanson, Claudia
   Luedtke, Susanne
   Spicer, Neil
   Sorensen, Jens Stilhoff
   Mayhew, Susannah
   Mounier-Jack, Sandra
TI National health governance, science and the media: drivers of COVID-19
   responses in Germany, Sweden and the UK in 2020
SO BMJ GLOBAL HEALTH
LA English
DT Article
DE COVID-19; health policy; public health
ID RESILIENCE; SYSTEMS; LESSONS
AB The COVID-19 pandemic is an unprecedented global crisis in which governments had to act in a situation of rapid change and substantial uncertainty. The governments of Germany, Sweden and the UK have taken different paths allowing learning for future pandemic preparedness. To help inform discussions on preparedness, inspired by resilience frameworks, this paper reviews governance structures, and the role of science and the media in the COVID-19 response of Germany, Sweden and the UK in 2020. We mapped legitimacy, interdependence, knowledge generation and the capacity to deal with uncertainty. Our analysis revealed stark differences which were linked to pre-existing governing structures, the traditional role of academia, experience of crisis management and the communication of uncertainty-all of which impacted on how much people trusted their government. Germany leveraged diversity and inclusiveness, a 'patchwork quilt', for which it was heavily criticised during the second wave. The Swedish approach avoided plurality and largely excluded academia, while in the UK's academia played an important role in knowledge generation and in forcing the government to review its strategies. However, the vivant debate left the public with confusing and rapidly changing public health messages. Uncertainty and the lack of evidence on how best to manage the COVID-19 pandemic-the main feature during the first wave-was only communicated explicitly in Germany. All country governments lost trust of their populations during the epidemic due to a mix of communication and transparency failures, and increased questioning of government legitimacy and technical capacity by the public.
C1 [Hanson, Claudia] Karolinska Inst, Global Publ Hlth, Stockholm, Sweden.
   [Hanson, Claudia] London Sch Hyg & Trop Med, Dis Control, London, England.
   [Luedtke, Susanne] UCL, Inst Risk & Disaster Reduct, London, England.
   [Luedtke, Susanne] Gesundheitsamt Nuremberg, Nurnberg, Germany.
   [Spicer, Neil; Mayhew, Susannah; Mounier-Jack, Sandra] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England.
   [Sorensen, Jens Stilhoff] Univ Gothenburg, Sch Global Studies, Gothenburg, Vastra Gotaland, Sweden.
RP Hanson, C (corresponding author), Karolinska Inst, Global Publ Hlth, Stockholm, Sweden.; Hanson, C (corresponding author), London Sch Hyg & Trop Med, Dis Control, London, England.
EM claudia.hanson@ki.se
OI Hanson, Claudia/0000-0001-8066-7873
FU Swedish Research CouncilSwedish Research CouncilEuropean Commission
   [2019--01906]
FX Parts of the salary of the first author is covered by a starting grant
   provided by the Swedish Research Council (grant number 2019--01906).
CR 1177 Health Service, 2020, COV 19 COR
   Abbasi K, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4425
   Ahuja, 2021, SPIKE VIRUS VS PEOPL
   Andersson S, 2020, SOC SCI-BASEL, V9, DOI 10.3390/socsci9120232
   [Anonymous], 2020, SCI FORUM COVID 19
   [Anonymous], 2020, WHY LOCKD AR WRONG P, V17
   Ansell C, 2021, PUBLIC MANAG REV, V23, P949, DOI 10.1080/14719037.2020.1820272
   Asbrink E., 2020, CORONAKRISEN VISAR A
   Babawo LS, 2019, LANCET, V393, P2647, DOI 10.1016/S0140-6736(19)31211-5
   Barasa EW, 2017, HEALTH POLICY PLANN, V32, P91, DOI 10.1093/heapol/czx118
   Bekker M, 2020, EUR J PUBLIC HEALTH, V30, P854, DOI 10.1093/eurpub/ckaa181
   Bjurwald L., 2020, THE LOCAL
   Blanchet K, 2017, INT J HEALTH POLICY, V6, P431, DOI 10.15171/ijhpm.2017.36
   Bloomberg, 2021, COV 19 TRACK
   Bohmer MM, 2020, LANCET INFECT DIS, V20, P920, DOI 10.1016/S1473-3099(20)30314-5
   Bundesministerium fuer Gesundheit, 2020, ZUS GEG COR WIRBLEIB
   Bylund PL., 2021, SOUTH ECON J, P1
   Cameron E, 2019, GLOBAL HLTH SECURITY
   Christensen T, 2020, PUBLIC ADMIN REV, V80, P774, DOI 10.1111/puar.13241
   Clarke L., 2020, NEW STATESMAN
   COVID-19 Government Response, 2020, COVID 19 GOV RESP ST
   Daly M, 2020, SOC POLICY ADMIN, V54, P985, DOI 10.1111/spol.12645
   Deutscher Bundestag, GES BUND LAND
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   ECDC (European Centre for Disease Prevention and Control), 2020, TRANSM COVID 19
   Etikrat D., 2020, SOL VER COR KRIS AD
   Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x
   European Centre for Disease Prevention and Control, 2020, COVID 19 CHILDR ROL
   Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387
   Fletcher D, 2013, EUR PSYCHOL, V18, P12, DOI 10.1027/1016-9040/a000124
   Fletcher R., 2020, INFORM INEQUALITY UK
   Frey B.B, 2018, SAGE ENCY ED RES MEA, DOI [DOI 10.4135/9781506326139.N209, 10.4135/9781506326139]
   Ghersetti M., 2021, CORONAPANDEMIN VAREN
   Giesecke J, 2020, LANCET, V395, pE98, DOI 10.1016/S0140-6736(20)31035-7
   Nygren KG, 2021, CURR SOCIOL, V69, P529, DOI 10.1177/0011392121990025
   Goldfinch S, 2021, AUST J PUBL ADMIN, V80, P3, DOI 10.1111/1467-8500.12459
   Gottschalk R., 2020, EMERGING COVID 19 SU
   GOV.UK, 2020, COR COVID 19
   Government of the United Kingdom, 2020, POL PAP COR ACT PLAN
   Haldane V, 2021, NAT MED, V27, P964, DOI 10.1038/s41591-021-01381-y
   Haldane V, 2017, LANCET, V389, P1513, DOI 10.1016/S0140-6736(17)30946-7
   Han E, 2020, LANCET, V396, P1525, DOI 10.1016/S0140-6736(20)32007-9
   Hanefeld J, 2018, HEALTH POLICY PLANN, V33, P355, DOI 10.1093/heapol/czx183
   Harring N, 2021, WORLD DEV, V138, DOI 10.1016/j.worlddev.2020.105236
   Helmholz, 2020, STELL HELMH IN SYST
   House of Commons Public Administration and Constitutional Affairs Committee, 2021, GOV TRANSP ACC COV 1
   House of commons science and technology Committee, 2020, OR EV UK SCI RES TEC
   Institute for Government, 2020, COR DEV
   Ioannidis JPA, 2021, B WORLD HEALTH ORGAN, V99, P19, DOI 10.2471/BLT.20.265892
   Irwin RE, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00588-x
   Islam N, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1137
   Kaiser M, 2021, HEALTH RES POLICY SY, V19, DOI 10.1186/s12961-021-00702-4
   Kavaliunas A, 2020, HEALTH POLICY TECHN, V9, P598, DOI 10.1016/j.hlpt.2020.08.009
   Lazarus JV, 2020, NAT MED, V26, P1005, DOI 10.1038/s41591-020-0950-0
   Leopoldina, 2020, COR NAT LEOP LEGT DR
   Leung G., 2020, NOWCASTING COVID 19
   Lindstrom M, 2021, SSM-POPUL HLTH, V14, DOI 10.1016/j.ssmph.2021.100788
   Lindstrom M, 2020, SSM-POPUL HLTH, V11, DOI 10.1016/j.ssmph.2020.100643
   Ling EJ, 2017, HEALTH POLICY PLANN, V32, P40, DOI 10.1093/heapol/czx109
   Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P2459, DOI 10.1111/apa.15582
   Marten R, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n243
   Meessen B, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002404
   Melin M., 2020, CORONA COMMISSION EL
   Min JW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244273
   Ministry of Health and Social Affairs, 2020, M MEL CHAIR CVID 19
   National Audit Office, 2020, GOV APPR TEST TRAC E
   NDR, GRIMM ONL AW DROST P
   NDR.de-Nachrichten, 2020, COR PODC FOLG UB
   Newton K, 2020, POLIT QUART, V91, P502, DOI 10.1111/1467-923X.12901
   Nielsen R., 2020, 10 FACTSHEET UK COVI
   Norberg J., 2020, YOUTUBE
   O'Driscoll M, 2020, NATURE, DOI 10.1038/s41586-020-2918-0
   OECD, 2020, OECD SURV SCI INN PO
   Parliament, 2020, TEST TRACK TRAC
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Priesemann V, 2021, LANCET, V397, P92, DOI 10.1016/S0140-6736(20)32625-8
   Prime Ministers's Office, 2020, STRAT RESP COVID 19
   Public Health Agency, 2020, CAN COVID 19 BE TRAN
   Public Health Agency, 2020, OUR MISS STRENGTH DE
   Rayzberg, 2021, COMP COVID RESPONSE
   REACT, 2020, REAL TIM ASS COMM TR
   Regeringen, 2005, SVER TSUN GRANSKN FO
   Regeringen, 2019, REG KRISH
   Regeringskansliet, 2021, COV 19 LAG GOR MOJL
   Rhodes T, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002914
   Richards P, 2020, J GLOBAL HIST, V15, P493, DOI 10.1017/S1740022820000303
   Riksdag S., 2021, TILLFALLIG COVID 19
   Riley S., 2020, REAL TIME ASSESSMENT
   Robert Koch Institute, 2000, ROB KOCH I MISS STAT
   Robert Koch Institute, 2020, INF
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Ryan MJ, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001272
   SAGE, 2020, CHILDR TASK FIN GROU
   Sanders, 2020, CHURCH COMMUNICATION, V5, P357, DOI [10.1080/23753234.2020.1824582, DOI 10.1080/23753234.2020.1824582]
   Saulnier DD, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-006779
   Saulnier DD, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-002272
   Scherman J., 2021, SVENSKT REKORD DIREK
   Siegrist M, 2021, RISK ANAL, V41, P787, DOI 10.1111/risa.13675
   Sorensen JS., 2020, TERROR UTOPIA, P961
   Spahn Jens, WIR WERDEN VIEL VERZ
   Streeck H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19509-y
   Thomas S., 2020, EUROPEAN OBSERVATORY
   Topp SM, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002891
   Tr?g?rdh L., 2006, AR SVENSKEN MANNISKA
   UK Parliament, 2020, CRIT JUNCT PUBL SERV
   Vannoni M, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00598-9
   Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7
   Vinke K., 2020, GLOB SUSTAIN, V3, pE25, DOI [10.1017/sus.2020.20, DOI 10.1017/sus.2020.20]
   Vogel G., 2020, ITS BEEN SO SURREAL
   Vogel G., 2020, ITS BEEN SO SURREAL
   Vogel G, 2020, SCIENCE, V370, P159, DOI 10.1126/science.370.6513.159
   Walker AS., 2020, STUDY PROTOCOL INCID
   Woelfert FS, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.572966
   World Health Organization, 2021, WEEKL EP UPD
   World Health Organization, 2020, REPORT WHO CHINA JOI
   YouGov, 2020, COVID 19 GOV HANDL C
NR 116
TC 0
Z9 0
U1 10
U2 10
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2059-7908
J9 BMJ GLOB HEALTH
JI BMJ Glob. Health
PD DEC
PY 2021
VL 6
IS 12
AR e006691
DI 10.1136/bmjgh-2021-006691
PG 15
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA XA2IF
UT WOS:000720476800001
PM 34872972
OA gold, Green Published, Green Accepted
DA 2022-04-20
ER

PT J
AU Ahmed, B
   Rehman, HM
   Javaid, S
   Binyamin, M
AF Ahmed, Bilal
   Rehman, Hafiz Muhammad
   Javaid, Shehla
   Binyamin, Muhammad
TI Knowledge, Attitude, Practice and Risk Assessment of Frontline
   Healthcare Professionals Related To Covid-19 in Lahore
SO BIOSCIENCE RESEARCH
LA English
DT Article
DE Novel Coronavirus; KAP; Lahore; Risk assessment; Doctor; Dentist and
   Nurses
ID CORONAVIRUS
AB Novel Coronavirus is the causative agent of severe acute respiratory syndrome (SARS-CoV) in human. At present, in the outbreak of the novel corona virus (COVID-19), the Health care professionals (HCPs) are frontline workers who directly exposed to covid-19 patients. So, it is of great importance to assess the level of knowledge, attitude, practice and risk assessment of healthcare workers (HCWs) associated with the outbreak. A cross-sectional study involving doctors, dentists and nurses who work in public and private hospitals was conducted. A total 55 matters questionnaire based on WHO (world Health organization) risk assessment was shared with the participants. Total 1073 participants were included in the survey. Out of 1073 participants 53.4% n=573 were male and 46.6% n= 500 were female. HCWs have a good knowledge, attitude, practice and risk assessment 15.82 +/- 3.47, 14.35 +/- 1.71, 11.10 +/- 1.66 and 8.25 +/- 1.09 respectively but 61.7% HCWs not well known about the knowledge of symptom to COVID-19. Kruskal-Wallis independent sample test showed significant p-value (<0.05) in the attitude, practices and risk assessment among HCWs. Spearman's rho correlation shows significant correlation between knowledge and attitude (r=.069, p < 0.05) and significant correlation between attitude and practice (r=.218, p < 0.01). Further investigation and follow-up to the disaster management and risk assessment can help the policy makers to improve the management of future outbreaks.
C1 [Ahmed, Bilal; Rehman, Hafiz Muhammad; Javaid, Shehla; Binyamin, Muhammad] Univ Lahore, Univ Inst Med Lab Technol, Lahore, Pakistan.
RP Javaid, S (corresponding author), Univ Lahore, Univ Inst Med Lab Technol, Lahore, Pakistan.
EM shehlajavaid@mlt.uol.edu.pk
CR Anelli F, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1254
   Basnet S., 2020, CROSS SECTIONAL SURV, V18
   Bassetti M, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13209
   Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4
   Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   de Wilde AH, 2018, CURR TOP MICROBIOL, V419, P1, DOI 10.1007/82_2017_25
   Ejeh FE, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05557
   Erfani A, 2020, B WORLD HEALTH ORGAN, V76, P648, DOI DOI 10.2471/BLT.20.256651
   Haq N., 2012, CROSS SECTIONAL ASSE, V12, P1
   Javaid S., 2021, J DOW U HLTH SCI, V15
   Jemal B., 2020, KNOWLEDGE ATTITUDE P
   Kahn Jeffrey S, 2005, Pediatr Infect Dis J, V24, pS223, DOI 10.1097/01.inf.0000188166.17324.60
   Khan S, 2020, J MED VIROL, V92, P824, DOI 10.1002/jmv.25814
   Lovato A, 2020, AM J OTOLARYNG, V41, DOI 10.1016/j.amjoto.2020.102474
   Malik UR, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176395
   Masters PS, 2019, VIROLOGY, V537, P198, DOI 10.1016/j.virol.2019.08.031
   Moorthy V, 2020, B WORLD HEALTH ORGAN, V98, P150, DOI 10.2471/BLT.20.251561
   Nepal R., 2020, NEPAL, V23, P239
   Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Srichan P., 2020, JBWHO, V16, P344
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196
   Zhan MK, 2020, NEW ENGL J MED, V382, P2267, DOI 10.1056/NEJMc2005696
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 27
TC 0
Z9 0
U1 0
U2 0
PU INNOVATIVE SCIENTIFIC INFORMATION & SERVICES NETWORK
PI FAISALABAD
PA INNOVATIVE SCIENTIFIC INFORMATION & SERVICES NETWORK, FAISALABAD, 00000,
   PAKISTAN
SN 1811-9506
EI 2218-3973
J9 BIOSCI RES
JI Biosci. Res.
PD JAN-MAR
PY 2022
VL 19
IS 1
BP 210
EP 221
PG 12
WC Biology
WE Emerging Sources Citation Index (ESCI)
SC Life Sciences & Biomedicine - Other Topics
GA YZ0UX
UT WOS:000755199800024
DA 2022-04-20
ER

PT J
AU Chen, X
   Rahman, MK
   Rana, MS
   Gazi, MA
   Rahaman, MA
   Nawi, NC
AF Chen, Xia
   Rahman, Muhammad Khalilur
   Rana, Md. Sohel
   Gazi, Md. Abu Issa
   Rahaman, Md. Atikur
   Nawi, Noorshella Che
TI Predicting Consumer Green Product Purchase Attitudes and Behavioral
   Intention During COVID-19 Pandemic
SO FRONTIERS IN PSYCHOLOGY
LA English
DT Article
DE green product; consumers' attitudes; COVID-19 pandemic; green product
   orientation; behavioral intention
ID ENVIRONMENTAL ORIENTATION; FINANCIAL PERFORMANCE; KNOWLEDGE; MANAGEMENT;
   LOYALTY; CHOICE; IMPACT
AB This work has aimed to investigate the consumers' green product purchase attitudes and behavioral intention during COVID-19 pandemic. Data was collected through a survey method of 503 consumers in Malaysia. Data were analyzed using the partial least square method. The findings revealed that fear of COVID-19 pandemic has a significant impact on green product behavioral intention. Green product literacy, green product orientation, and social influence have a significant influence on green product purchase attitudes. The results also indicated that consumers' green product purchase attitudes mediate the effect of green product literacy, green product orientation, and social influence on behavioral intention. The findings of this work will provide strategically relevant references to green marketers and retail managers in the understanding of consumers' green product purchase attitudes and green product behavioral intention during the ongoing uncertainty of the COVID-19 pandemic.
C1 [Chen, Xia; Rahaman, Md. Atikur] Jiujiang Univ, Sch Management, Jiujiang, Peoples R China.
   [Rahman, Muhammad Khalilur; Nawi, Noorshella Che] Univ Malaysia Kelantan, Fac Entrepreneurship & Business, Pengkalan Chepa, Malaysia.
   [Rana, Md. Sohel] Univ Malaya, Fac Business & Accountancy, Kuala Lumpur, Malaysia.
   [Gazi, Md. Abu Issa] Jiujiang Univ, Sch Ecommerce, Jiujiang, Peoples R China.
   [Nawi, Noorshella Che] Univ Malaysia Kelantan, Global Entrepreneurship Res Innovat Ctr GERIC, Pengkalan Chepa, Malaysia.
RP Rahman, MK (corresponding author), Univ Malaysia Kelantan, Fac Entrepreneurship & Business, Pengkalan Chepa, Malaysia.; Gazi, MA (corresponding author), Jiujiang Univ, Sch Ecommerce, Jiujiang, Peoples R China.
EM khalilur.r@umk.edu.my; maigazi@yahoo.com
RI Abu Issa Gazi/AAM-7607-2021; RAHAMAN, ATIKUR/ABB-2609-2020
OI Abu Issa Gazi/0000-0002-1397-8855; RAHAMAN, ATIKUR/0000-0003-3356-7815
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [72064024]
FX Funding This study was supported by the National Natural Science
   Foundation of China (Grant 72064024).
CR Addo PC, 2020, SERV IND J, V40, P471, DOI 10.1080/02642069.2020.1751823
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Amin I, 2021, MANAG RES REV, V44, P825, DOI 10.1108/MRR-05-2020-0280
   An D, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13020740
   Biswas A, 2020, ENVIRON SCI POLLUT R, V27, P5922, DOI 10.1007/s11356-019-07290-5
   Bitan DT, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113100
   Bratu S., 2019, REV CONT PHILOS, V18, P154, DOI [https://doi.org/10.22381/RCP18201910, DOI 10.22381/RCP18201910]
   Byrne B.M, 2013, STRUCTURAL EQUATION
   Chen T.B., 2010, OR MANAG, V4, P27, DOI DOI 10.3968/J.MSE.1913035X20100402.002
   Chin W.W., 2001, PLS GRAPH USERS GUID
   Costa S, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138143
   Costell E, 2010, CHEMOSENS PERCEPT, V3, P42, DOI 10.1007/s12078-009-9057-1
   Dabija DC, 2018, MORAV GEOGR REP, V26, P173, DOI 10.2478/mgr-2018-0014
   Danso A, 2019, BUS STRATEG ENVIRON, V28, P885, DOI 10.1002/bse.2291
   Dhir A, 2021, J RETAIL CONSUM SERV, V59, DOI 10.1016/j.jretconser.2020.102398
   Diamantopoulos A, 2006, BRIT J MANAGE, V17, P263, DOI 10.1111/j.1467-8551.2006.00500.x
   Dijkstra TK, 2015, MIS QUART, V39, P297, DOI 10.25300/MISQ/2015/39.2.02
   Elias T, 2020, HOWARD J COMMUN, V31, P99, DOI 10.1080/10646175.2019.1649761
   Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149
   Ferraz D., 2021, SUSTAINABILITY-BASEL, V13, P1
   Fishbein M., 1980, PREDICTING UNDERSTAN
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Fornell C., 1994, ADV METHODS MARKETIN, P52
   Fraj-Andres E, 2009, J BUS ETHICS, V88, P263, DOI 10.1007/s10551-008-9962-2
   GEISSER S, 1975, J AM STAT ASSOC, V70, P320, DOI 10.2307/2285815
   Gold AH, 2001, J MANAGE INFORM SYST, V18, P185, DOI 10.1080/07421222.2001.11045669
   Graessley S., 2019, J SELF GOV MANAG EC, V7, P25, DOI [10.22381/JSME7120194., DOI 10.22381/JSME7120194]
   Ha JS, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12020509
   Hair J.F., 2021, PRIMER PARTIAL LEAST
   Halder P, 2020, J CLEAN PROD, V265, DOI 10.1016/j.jclepro.2020.121754
   Han H, 2010, INT J HOSP MANAG, V29, P659, DOI 10.1016/j.ijhm.2010.01.001
   Han H, 2010, TOURISM MANAGE, V31, P325, DOI 10.1016/j.tourman.2009.03.013
   Henseler J, 2016, INT MARKET REV, V33, P405, DOI 10.1108/IMR-09-2014-0304
   Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8
   Henseler J, 2013, COMPUTATION STAT, V28, P565, DOI 10.1007/s00180-012-0317-1
   Jian YF, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208688
   Joshi Y., 2015, INT STRATEGIC MANAGE, V3, P128, DOI [DOI 10.1016/J.ISM.2015.04.001, 10.1016/j.ism.2015.04.001]
   Kim MS, 2020, CURR ISSUES TOUR, V23, P1575, DOI 10.1080/13683500.2019.1628188
   Kline RB, 2010, PRINCIPLES PRACTICE
   Koo C, 2014, TECHNOL FORECAST SOC, V88, P140, DOI 10.1016/j.techfore.2014.06.025
   Kumar A, 2021, J RETAIL CONSUM SERV, V58, DOI 10.1016/j.jretconser.2020.102270
   Lee SY, 2008, SUPPLY CHAIN MANAG, V13, P185, DOI 10.1108/13598540810871235
   Lee YK, 2021, ASIA PAC J TOUR RES, V26, P921, DOI 10.1080/10941665.2021.1927122
   Liobikiene G, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11123324
   Nguyen MTT, 2019, YOUNG CONSUM, V20, P246, DOI 10.1108/YC-10-2018-0859
   Mancini M.A., 2021, MODELS CHANGE WELL B, P59
   Mertens G, 2020, J ANXIETY DISORD, V74, DOI 10.1016/j.janxdis.2020.102258
   Mishal A, 2017, INT J CLIM CHANG STR, V9, P682, DOI 10.1108/IJCCSM-11-2016-0168
   Myung E, 2020, J QUAL ASSUR HOSP TO, V21, P667, DOI 10.1080/1528008X.2020.1740132
   Naeem M, 2021, J RETAIL CONSUM SERV, V58, DOI 10.1016/j.jretconser.2020.102226
   Newaz MS, 2020, J ADV MANAG RES, V17, P505, DOI 10.1108/JAMR-01-2020-0008
   Nugraha YD, 2021, J ISLAMIC MARK, DOI 10.1108/JIMA-03-2020-0076
   Ogiemwonyi O, 2020, ENVIRON URBAN ASIA, V11, P297, DOI 10.1177/0975425320938538
   Ojo AO, 2020, SUSTAIN PROD CONSUMP, V24, P298, DOI 10.1016/j.spc.2020.07.017
   Pagiaslis A, 2014, PSYCHOL MARKET, V31, P335, DOI 10.1002/mar.20698
   Panjaitan Togas W S, 2010, 2010 IEEE International Conference on Industrial Engineering & Engineering Management (IE&EM 2010), P2268, DOI 10.1109/IEEM.2010.5674276
   Paswan A, 2017, J CONSUM MARK, V34, P414, DOI 10.1108/JCM-02-2016-1706
   Pavlov G, 2021, EDUC PSYCHOL MEAS, V81, P110, DOI 10.1177/0013164420926231
   PODSAKOFF PM, 1986, J MANAGE, V12, P531, DOI 10.1177/014920638601200408
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Rahman MK, 2021, PATIENT PREFER ADHER, V15, P2633, DOI 10.2147/PPA.S333595
   Ringle CM, 2016, IND MANAGE DATA SYST, V116, P1865, DOI 10.1108/IMDS-10-2015-0449
   Sadiq M, 2021, J RETAIL CONSUM SERV, V59, DOI 10.1016/j.jretconser.2020.102369
   Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6
   Santra I., 2021, MANAGE SCI LETT, V11, P587, DOI [10.5267/j.msl.2020.9.008, DOI 10.5267/J.MSL.2020.9.008]
   Shen YJ, 2021, SCI TOTAL ENVIRON, V755, DOI 10.1016/j.scitotenv.2020.142538
   Shimul A.S., 2021, J GLOB MARK, P1
   Shukor AAA, 2020, INT J EMERG MARK, DOI 10.1108/IJOEM-04-2020-0418
   Sony A, 2017, ASIA-PAC J BUS ADM, V9, P37, DOI 10.1108/APJBA-03-2016-0030
   STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x
   Sun XX, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020543
   Wang L, 2020, J CHINA TOUR RES, V16, P319, DOI 10.1080/19388160.2019.1637318
   Wang ST, 2014, MARK INTELL PLAN, V32, P738, DOI [10.1108/MIP-12-2012-0146, 10.1108/MIP12-2012-0146]
   Wickramasinghe K, 2019, ANATOLIA, V30, P420, DOI 10.1080/13032917.2019.1613667
   Xie XM, 2019, J BUS RES, V101, P697, DOI 10.1016/j.jbusres.2019.01.010
   Yadav R, 2016, J CLEAN PROD, V135, P732, DOI 10.1016/j.jclepro.2016.06.120
   Yimaz Y, 2021, J HOSP TOUR INSIGHTS, DOI 10.1108/JHTI-07-2020-0121
   Yu YB, 2019, J CLEAN PROD, V211, P628, DOI 10.1016/j.jclepro.2018.11.198
   Zeithaml V.A., 1984, PSYCHOL MARKET, V1, P73, DOI [10.1002/mar.4220010308, DOI 10.1002/MAR.4220010308]
   Zheng GW, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13010035
   Zhou C, 2020, SUSTAIN DEV, V28, P685, DOI 10.1002/sd.2019
NR 81
TC 0
Z9 0
U1 16
U2 16
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-1078
J9 FRONT PSYCHOL
JI Front. Psychol.
PD JAN 25
PY 2022
VL 12
AR 760051
DI 10.3389/fpsyg.2021.760051
PG 10
WC Psychology, Multidisciplinary
WE Social Science Citation Index (SSCI)
SC Psychology
GA YV2SD
UT WOS:000752580300001
PM 35145450
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Butt, AS
AF Butt, Atif Saleem
TI Mitigating the effects of COVID-19: an exploratory case study of the
   countermeasures taken by the manufacturing industry
SO JOURNAL OF BUSINESS & INDUSTRIAL MARKETING
LA English
DT Article; Early Access
DE COVID-19; Manufacturing supply chain; Demand; Interviews; Automation;
   Technology; UAE; Supply chain processes
ID LOGISTICS; OPPORTUNITIES; CONFLICTS; GUANXI
AB Purpose The purpose of this study is to understand how manufacturers (both discrete and process) are managing disruptions amid the COVID-19 pandemic outbreak, using UAE as an empirical context. Design/methodology/approach This research uses a multiple case study approach and undertakes 36 semi-structured interviews with senior management of four discrete and four process manufacturing firms that outsource products/components from overseas and domestic suppliers. Findings Results reveal that manufacturing firms are using six distinct actions to mitigate the effects of the COVID-19 pandemic. For instance, they are relying on the automation process, transferring new and updated knowledge to the current and new suppliers, managing workforce diversity, understanding the impact of demand's disruption, managing the ecosystem and finally using digital technologies to mitigate the impact of the COVID-19 pandemic. Research limitations/implications This study has some limitations. Firstly, the results of this study cannot be generalized to a broader population as it attempts to build an initial theory in manufacturing supply chains within the context of a pandemic outbreak. Second, the study uses a cross-sectional approach to explore the actions used by manufacturing firms to mitigate the effects of the COVID-19 pandemic. Practical implications Manufacturing firms can replicate the actions proposed in this study to lessen the effect of the COVID-19 pandemic and emerge stronger in the post-COVID-era. Originality/value This study contributes to the manufacturing supply chain literature within the context of pandemic outbreaks by exploring the steps taken by manufacturing firms to minimize the effects of the COVID-19 pandemic. Particularly, it explores such steps by considering both the discrete and process manufacturing industries within the United Arab Emirates.
C1 [Butt, Atif Saleem] Amer Univ Ras Al Khaimah, Dept Management, Ras Al Khaymah, U Arab Emirates.
RP Butt, AS (corresponding author), Amer Univ Ras Al Khaimah, Dept Management, Ras Al Khaymah, U Arab Emirates.
EM atifbutt10@hotmail.com
RI BUTT, ATIF SALEEM/AAE-1236-2020
OI BUTT, ATIF SALEEM/0000-0003-1139-2831
CR Al Saidi AMO, 2020, LANCET, V396, P295, DOI 10.1016/S0140-6736(20)31493-8
   Altay N, 2014, PROD OPER MANAG, V23, P1015, DOI 10.1111/poms.12102
   [Anonymous], 2020, GULFNEWS
   Butt Atif Saleem, 2019, International Journal of Integrated Supply Management, V12, P193
   Butt A.S, 2021, INT J PHYS DISTRIBUT, DOI [10.1108/IJPDLM-08-2020-0281, DOI 10.1108/IJPDLM-08-2020-0281]
   Butt AS, 2021, KNOWL PROCESS MANAG, V28, P18, DOI 10.1002/kpm.1643
   Butt AS, 2020, KNOWL PROCESS MANAG, V27, P272, DOI 10.1002/kpm.1631
   Butt AS, 2021, TRANSPORT J, V60, P307, DOI 10.5325/transportationj.60.3.0307
   Butt AS, 2021, INT J LOGIST MANAG, DOI 10.1108/IJLM-02-2021-0114
   Butt AS, 2021, INT J LOGIST MANAG, DOI 10.1108/IJLM-11-2020-0455
   Butt AS, 2021, VINE J INF KNOWL MAN, DOI 10.1108/VJIKMS-06-2020-0118
   Butt AS, 2020, J ASIA BUS STUD, V14, P1, DOI 10.1108/JABS-04-2019-0127
   Butt AS, 2020, BENCHMARKING, V27, P2631, DOI 10.1108/BIJ-04-2020-0143
   Butt AS, 2020, INT J KNOWL MANAG, V16, P18, DOI 10.4018/IJKM.2020040102
   Butt AS, 2021, MANAGE DECIS, V59, P1291, DOI 10.1108/MD-01-2020-0038
   Butt AS, 2019, J KNOWL MANAG, V23, P1605, DOI 10.1108/JKM-04-2019-0204
   Butt AS, 2019, BENCHMARKING, V26, P2225, DOI 10.1108/BIJ-02-2019-0067
   Butt AS, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01799
   Butt AS, 2019, MANAG RES REV, V42, P495, DOI 10.1108/MRR-05-2018-0193
   Choi TM, 2020, TRANSPORT RES E-LOG, V140, DOI 10.1016/j.tre.2020.101961
   Choi TM, 2019, TRANSPORT RES E-LOG, V127, P178, DOI 10.1016/j.tre.2019.05.007
   Cooke DL, 2006, SYST DYNAM REV, V22, P213, DOI 10.1002/sdr.338
   CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593
   Correia D, 2021, SUSTAIN CITIES SOC, V75, DOI 10.1016/j.scs.2021.103310
   Dolgui A, 2019, INT J PROD RES, pNIL_1, DOI 10.1080/00207543.2019.1627438
   Eisenhardt KM, 2007, ACAD MANAGE J, V50, P25, DOI 10.5465/AMJ.2007.24160888
   EISENHARDT KM, 1989, ACAD MANAGE J, V32, P543, DOI 10.2307/256434
   FARAHANI N, 2020, COMMUNICATIONS THEOR, V72, P35
   Fusch PI, 2015, QUAL REP, V20, P1408
   Gammelgaard B, 2017, INT J LOGIST MANAG, V28, P910, DOI 10.1108/IJLM-09-2017-0231
   Govindan K, 2020, TRANSPORT RES E-LOG, V138, DOI 10.1016/j.tre.2020.101967
   Ivanov Dmitry, 2020, International Journal of Integrated Supply Management, V13, P90
   Ivanov D, 2020, INT J PROD RES, V58, P2904, DOI 10.1080/00207543.2020.1750727
   Ivanov D, 2020, INT J PROD RES, V58, P3252, DOI 10.1080/00207543.2019.1634850
   Ivanov D, 2017, INT J PROD RES, V55, P6158, DOI 10.1080/00207543.2017.1330572
   Johanis D., 2007, J BUSINESS CONTINUIT, V1, P356
   Keranen J, 2020, IND MARKET MANAG, V88, P389, DOI 10.1016/j.indmarman.2020.05.029
   Lee Eva K, 2009, International Journal of Risk Assessment & Management, V12, P311, DOI 10.1504/IJRAM.2009.025925
   Malik MO, 2021, PROD PLAN CONTROL, V32, P1020, DOI 10.1080/09537287.2020.1784481
   Mamani Hamed, 2012, IIE Transactions on Healthcare Systems Engineering, V2, P78, DOI 10.1080/19488300.2012.666780
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   Queiroz MM, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03685-7
   Sawik Tadeusz, 2013, International Journal of Logistics Systems and Management, V15, P143
   Schatteman O., 2020, SUPPLY CHAIN LESSONS, P1
   Shah SHH, 2021, TOTAL QUAL MANAG BUS, DOI 10.1080/14783363.2021.1890017
   Shah SHH, 2021, INFORM TECHNOL DEV, V27, P718, DOI 10.1080/02681102.2021.1877604
   Sharma RK, 2021, INT J FINANC ECON, V26, P5666, DOI 10.1002/ijfe.2087
   van Hoek R, 2020, INT J OPER PROD MAN, V40, P341, DOI 10.1108/IJOPM-03-2020-0165
   Welch C, 2011, J INT BUS STUD, V42, P740, DOI 10.1057/jibs.2010.55
   Xu S, 2020, INT J PROD RES, V58, P3508, DOI 10.1080/00207543.2020.1717011
   Zhu GY, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12145858
NR 51
TC 3
Z9 3
U1 10
U2 11
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0885-8624
EI 2052-1189
J9 J BUS IND MARK
JI J. Bus. Ind. Mark.
DI 10.1108/JBIM-04-2021-0236
EA SEP 2021
PG 12
WC Business
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA UX4LV
UT WOS:000700816200001
OA Bronze
DA 2022-04-20
ER

PT J
AU Albitar, K
   Gerged, AM
   Kikhia, H
   Hussainey, K
AF Albitar, Khaldoon
   Gerged, Ali Meftah
   Kikhia, Hassan
   Hussainey, Khaled
TI Auditing in times of social distancing: the effect of COVID-19 on
   auditing quality
SO INTERNATIONAL JOURNAL OF ACCOUNTING AND INFORMATION MANAGEMENT
LA English
DT Article
DE Audit quality; Financial reporting; Social distancing; Audit profession;
   COVID-19 crisis
ID GLOBAL FINANCIAL CRISIS; FEES EVIDENCE; AUDITORS; IMPACT; CUTS
AB Purpose This paper aims to discuss the theoretical impact of COVID-19 social distancing outbreak on audit quality. Design/methodology/approach This paper uses a desk study method to explore the possible impact of COVID-19 crisis on five key considerations for audit quality during the pandemic. These include audit fees, going concern assessment, auditor human capital, audit procedures and audit personnel salaries. Findings As many believe that the COVID-19 outbreak is as yet not a financial crisis, the authors, on the contrary, believe that the effects of the COVID-19 pandemic would be the toughest challenge for auditors and their clients since the 2007-2008 global financial crisis. Specifically, the authors believe that the COVID-19 social distancing can largely affect audit fees, going concern assessment, audit human capital, audit procedures, audit personnel salaries and audit effort, which ultimately can pose a severe impact on audit quality. Practical implications Due to the implementations of work-from-home strategy, audit firms are highly recommended to invest more in digital programs, including artificial intelligence, blockchain, network security and data function development. This can help them to be more adaptable to working from home experience, which is ultimately expected to enhance the effectiveness and the flexibility of communication between auditors and their clients. Also, the authors recommend stock markets and other governmental bodies to provide temporary relaxations in compliance requirements to corporations. This procedure is expected to help firms that apply work-from-home strategy to report better earnings figures, which is appeared to be positively associated with audit quality. Originality/value To date, to the best of the authors' knowledge, there is no academic study that explores the potential impact of the COVID-19 outbreak on audit quality. This paper, therefore, fills an important research gap in the auditing literature. In addition, this paper can be used as a base to construct a research instrument (e.g. questionnaire or interviews) to provide empirical evidence on the potential impact of COVID-19 on audit quality.
C1 [Albitar, Khaldoon; Hussainey, Khaled] Univ Portsmouth, Fac Business & Law, Portsmouth, Hants, England.
   [Gerged, Ali Meftah] De Montfort Univ, Leicester Castle Business Sch, Leicester, Leics, England.
   [Gerged, Ali Meftah] Misurata Univ, Fac Econ, Misurata, Libya.
   [Kikhia, Hassan] PwC, Trollhattan, Sweden.
RP Albitar, K (corresponding author), Univ Portsmouth, Fac Business & Law, Portsmouth, Hants, England.
EM khaldoon.albitar@port.ac.uk; ali.gerged@dmu.ac.uk;
   hassan.kikhia@pwc.com; khaled.hussainey@port.ac.uk
CR Albitar K, 2020, INT J ACCOUNT INF MA, V28, P429, DOI 10.1108/IJAIM-09-2019-0108
   Aldhizer G.R, 1995, J ACCOUNTANCY, V1, P61
   Alexeyeva I, 2015, MANAG AUDIT J, V30, P302, DOI 10.1108/MAJ-04-2014-1025
   Arthur N., 2015, J INT ACCOUNT AUDIT, V25, P1
   Bianchi P., 2019, EUROPEAN ACCOUNTING, V29, P1
   Bozec R, 2017, INT J ACCOUNT INF MA, V25, P70, DOI 10.1108/IJAIM-05-2016-0054
   Calderon T. G., 1994, OHIO CPA J, V53, P27
   Chen HM, 2019, ASIAN REV ACCOUNT, V27, P97, DOI 10.1108/ARA-01-2017-0007
   Chen L, 2018, ADV ACCOUNT, V43, P14, DOI 10.1016/j.adiac.2018.07.007
   Chen YS, 2008, INT J HUM RESOUR MAN, V19, P1720, DOI 10.1080/09585190802295363
   Cheng YS, 2009, MANAG AUDIT J, V24, P523, DOI 10.1108/02686900910966512
   DeAngelo, 1981, J ACCOUNT ECON, V3, P113, DOI DOI 10.1016/0165-4101(81)90009-4
   Deloitte, 2020, POT IMPL COVID 19 IN
   Financial Reporting Council, 2020, GUID AUD ISS AR COVI
   Francis JR, 2011, AUDITING-J PRACT TH, V30, P125, DOI 10.2308/ajpt-50006
   Gerged AM, 2020, INT J DISCL GOV, V17, P51, DOI 10.1057/s41310-020-00074-1
   Ghosh A, 2009, AUDITING-J PRACT TH, V28, P171, DOI 10.2308/aud.2009.28.2.171
   Goodell JW, 2020, FINANC RES LETT, V35, DOI 10.1016/j.frl.2020.101512
   Hirt ER, 2004, J EXP SOC PSYCHOL, V40, P374, DOI 10.1016/j.jesp.2003.07.009
   Hoopes JL, 2018, REV ACCOUNT STUD, V23, P1096, DOI 10.1007/s11142-018-9458-y
   Huang J., 2013, CHINA J ACCOUNTING S, V1, P47, DOI DOI 10.1080/21697221.2013.781766
   Kadous K, 2006, ACCOUNT REV, V81, P377, DOI 10.2308/accr.2006.81.2.377
   Karim AKMW, 2013, INT J ACCOUNT INF MA, V21, P241, DOI 10.1108/IJAIM-08-2011-0027
   Kousenidis DV, 2013, INT REV FINANC ANAL, V30, P351, DOI 10.1016/j.irfa.2013.03.004
   KPMG, 2020, COVID 19 POT IMP FIN
   Krishnan GV, 2014, J ACCOUNT PUBLIC POL, V33, P279, DOI 10.1016/j.jaccpubpol.2014.02.004
   Lennox CS, 2018, ACCOUNT HORIZ, V32, P1, DOI 10.2308/acch-51942
   Lenz R, 2015, MANAG AUDIT J, V30, P5, DOI 10.1108/MAJ-08-2014-1072
   Liu C., 1997, THESIS
   Mareque M, 2017, ECON RES-EKON ISTRAZ, V30, P154, DOI 10.1080/1331677X.2017.1305787
   Messier WF, 2013, AUDITING-J PRACT TH, V32, P139, DOI 10.2308/ajpt-50327
   Noh M, 2017, INT J ACCOUNT INF MA, V25, P110, DOI 10.1108/IJAIM-11-2015-0077
   Persellin J., 2018, SSRN ELECT J, DOI [10.2139/ssrn.2534492, DOI 10.2139/SSRN.2534492]
   PWC, 2020, COVID 19 RESP BUS IM
   Rose AM, 2020, BEHAV RES ACCOUNT, V32, P37, DOI 10.2308/bria-52512
   Rose AM, 2017, J INF SYST, V31, P81, DOI 10.2308/isys-51837
   Salehi M, 2019, J ACCOUNT EMERG ECON, V9, P287, DOI 10.1108/JAEE-03-2018-0025
   Samagaio A, 2016, J BUS RES, V69, P5354, DOI 10.1016/j.jbusres.2016.04.137
   Shahzad K, 2018, RES INT BUS FINANC, V45, P94, DOI 10.1016/j.ribaf.2017.07.137
   Tarek M, 2017, INT J ACCOUNT INF MA, V25, P237, DOI 10.1108/IJAIM-03-2016-0022
   Trompeter G, 2010, CONTEMP ACCOUNT RES, V27, P669, DOI 10.1111/j.1911-3846.2010.01021.x
   Xu Y, 2013, ACCOUNT FINANC, V53, P301, DOI 10.1111/j.1467-629X.2011.00459.x
   Yuen DCY, 2013, INT J ACCOUNT INF MA, V21, P209, DOI 10.1108/IJAIM-12-2012-0075
NR 43
TC 12
Z9 12
U1 19
U2 53
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1834-7649
EI 1758-9037
J9 INT J ACCOUNT INF MA
JI Int. J. Account. Inf. Manag.
PD FEB 6
PY 2021
VL 29
IS 1
BP 169
EP 178
DI 10.1108/IJAIM-08-2020-0128
EA SEP 2020
PG 10
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA QK9QN
UT WOS:000572420000001
OA Green Submitted
DA 2022-04-20
ER

PT J
AU Kocak, E
   Dogru, T
   Shehzad, K
   Bulut, U
AF Kocak, Emrah
   Dogru, Tarik
   Shehzad, Khurram
   Bulut, Umit
TI The economic implications of the COVID-19 outbreak on tourism industry:
   Empirical evidence from Turkey
SO TOURISM ECONOMICS
LA English
DT Article; Early Access
DE COVID-19 outbreak; pandemic; tourism industry; government responses;
   global fear; Turkey
ID TIME-SERIES; RETURNS; IMPACT
AB The novel coronavirus (COVID-19) pandemic has caused tremendous fear and uncertainty and affected health, economy, and social life in an unprecedented form worldwide. Yet, the level of knowledge on its economic implications is very limited. Therefore, it is of paramount importance to explain the health, social, and economic impacts of COVID-19. Because the tourism is one of the most affected industries by the pandemic, this study aims to explain the effects of COVID-19 cases and deaths, global fear, and government responses on Turkey's tourism industry. Empirical findings show that the tourism industry reacts negatively to new cases, number of deaths, and global fear measures. Also, government containment and health measures and economic supports positively affect the tourism industry. Furthermore, government stringency policies drive down the tourism industry's performance. The findings of this study provide significant implications for tourism and travel firms, policy makers, and future research.
C1 [Kocak, Emrah] Erciyes Univ, Fac Econ & Adm Sci, Dept Econ, Kayseri, Turkey.
   [Dogru, Tarik] Florida State Univ, Dedman Coll Hospitality, Hospitality Management, Tallahassee, FL 32306 USA.
   [Shehzad, Khurram] Southeast Univ, Sch Econ & Management, Nanjing, Peoples R China.
   [Bulut, Umit] Kirsehir Ahi Evran Univ, Fac Econ & Adm Sci, Kirsehir, Turkey.
RP Dogru, T (corresponding author), Florida State Univ, Coll Hospitality, 288 Champ Way, Tallahassee, FL 32306 USA.
EM emrahkocak@erciyes.edu.tr; tdogru@dedman.fsu.edu; 233189917@seu.edu.cn;
   ubulut@ahievran.edu.tr
RI Shehzad, Khurram/AAX-1290-2020
OI Shehzad, Khurram/0000-0001-7835-5264; Bulut, Umit/0000-0002-8964-0332
CR Aburumman AA, 2020, HUM SOC SCI COMMUN, V7, DOI 10.1057/s41599-020-00630-8
   Al-Awadhi AM, 2020, J BEHAV EXP FINANC, V27, DOI 10.1016/j.jbef.2020.100326
   Alonso AD, 2020, INT J HOSP MANAG, V91, DOI 10.1016/j.ijhm.2020.102654
   Ashraf BN, 2020, J BEHAV EXP FINANC, V27, DOI 10.1016/j.jbef.2020.100371
   Baek S, 2020, FINANC RES LETT, V37, DOI 10.1016/j.frl.2020.101748
   Bakir C, 2020, POLICY SOC, V39, P424, DOI 10.1080/14494035.2020.1783786
   Bayram H, 2020, LANCET, V396, P463, DOI 10.1016/S0140-6736(20)31691-3
   Beland L. P., 2020, IZA DISCUSSION PAPER
   Borsa Istanbul. (BIST), 2021, BORS IST IND
   Bulut U, 2020, TOURISM ECON, V26, P1358, DOI 10.1177/1354816619896957
   Central Bank of the Republic of Turkey (TCCB), 2020, MEAS TAK EC FIN IMP
   Choi JJ, 1999, J BANK FINANC, V23, P1771, DOI 10.1016/S0378-4266(99)00020-5
   DICKEY DA, 1981, ECONOMETRICA, V49, P1057, DOI 10.2307/1912517
   Dogru T, 2019, TOURISM MANAGE, V74, P12, DOI 10.1016/j.tourman.2019.01.014
   Erdem O, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101671
   Espinosa-Mendez C, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101787
   Foo LP, 2021, CURR ISSUES TOUR, V24, P2735, DOI 10.1080/13683500.2020.1777951
   Gallegati M, 2008, COMPUT STAT DATA AN, V52, P3061, DOI 10.1016/j.csda.2007.07.019
   Goodell JW, 2020, FINANC RES LETT, V35, DOI 10.1016/j.frl.2020.101512
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Hale T, 2020, VARIATION GOVT RESPO
   Hatemi-J A, 2008, EMPIR ECON, V35, P497, DOI 10.1007/s00181-007-0175-9
   He PL, 2020, EMERG MARK FINANC TR, V56, P2198, DOI 10.1080/1540496X.2020.1785865
   Investing Database, 2020, WORLD IND
   Jelilov G, 2020, J PUBLIC AFF, V20, DOI 10.1002/pa.2289
   Johns Hopkins Coronavirus Resou Center, 2020, DAT MOT
   Just M, 2020, FINANC RES LETT, V37, DOI 10.1016/j.frl.2020.101775
   Kaushal V, 2021, INT J HOSP MANAG, V92, DOI 10.1016/j.ijhm.2020.102707
   Kocak E, 2022, BUS STRATEG ENVIRON, V31, P32, DOI 10.1002/bse.2872
   Liew KhimSen [Liew K. S. V.], 2020, Journal of Tourism Futures, V8, P109, DOI 10.1108/JTF-03-2020-0045
   Mazur M, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101690
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   OECD Tourism Trends and Policies, 2020, TOUR TRENDS POL, P387, DOI [10.1787/6b47b985-en, DOI 10.1787/6B47B985-EN]
   Ozdemir O, 2021, TOUR MANAG PERSPECT, V39, DOI 10.1016/j.tmp.2021.100864
   Pan L, 2018, ECON MODEL, V68, P661, DOI 10.1016/j.econmod.2017.07.005
   PARK JY, 1992, ECONOMETRICA, V60, P119, DOI 10.2307/2951679
   PHILLIPS PCB, 1990, REV ECON STUD, V57, P99, DOI 10.2307/2297545
   PHILLIPS PCB, 1988, BIOMETRIKA, V75, P335, DOI 10.2307/2336182
   Qiu RTR, 2020, ANN TOURISM RES, V84, DOI 10.1016/j.annals.2020.102994
   Rahman ML, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101832
   Salisu AA, 2020, EMERG MARK FINANC TR, V56, P2310, DOI 10.1080/1540496X.2020.1785424
   Sarwar G, 2019, INT J FINANC ECON, V24, P527, DOI 10.1002/ijfe.1677
   Sharma A, 2020, ANN TOURISM RES, V83, DOI 10.1016/j.annals.2020.102990
   Sharma GD, 2021, TOUR MANAG PERSPECT, V37, DOI 10.1016/j.tmp.2020.100786
   STOCK JH, 1993, ECONOMETRICA, V61, P783, DOI 10.2307/2951763
   Suess C, 2022, TOURISM MANAGE, V88, DOI 10.1016/j.tourman.2021.104405
   Turan NG., 2020, J INT ACAD MANAGEMEN, V3, P1
   Ugur NG, 2020, TOUR MANAG PERSPECT, V36, DOI 10.1016/j.tmp.2020.100744
   Wagner AF, 2020, NAT HUM BEHAV, V4, P440, DOI 10.1038/s41562-020-0869-y
   Williams CC, 2021, INT J TOUR RES, V23, P79, DOI 10.1002/jtr.2395
   World Tourism Organization, 2020, COVID 19 MEAS SUPP T, P87
   Xiong H, 2020, EMERG MARK FINANC TR, V56, P2231, DOI 10.1080/1540496X.2020.1787151
   Zenker S, 2020, TOURISM MANAGE, V81, DOI 10.1016/j.tourman.2020.104164
   Zheng DN, 2021, TOURISM MANAGE, V83, DOI 10.1016/j.tourman.2020.104261
NR 54
TC 0
Z9 0
U1 10
U2 10
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1354-8166
EI 2044-0375
J9 TOURISM ECON
JI Tour. Econ.
AR 13548166211067188
DI 10.1177/13548166211067188
EA FEB 2022
PG 17
WC Economics; Hospitality, Leisure, Sport & Tourism
WE Social Science Citation Index (SSCI)
SC Business & Economics; Social Sciences - Other Topics
GA ZE6SL
UT WOS:000759010000001
DA 2022-04-20
ER

PT J
AU Ismail, II
   Salama, S
AF Ismail, Ismail Ibrahim
   Salama, Sara
TI A systematic review of cases of CNS demyelination following COVID-19
   vaccination
SO JOURNAL OF NEUROIMMUNOLOGY
LA English
DT Review
DE COVID-19; SARS-CoV-2; Vaccine; Demyelinating disease; Multiple
   sclerosis; Transverse myelitis
ID TRANSVERSE MYELITIS; AUTOIMMUNE-DISEASE; MULTIPLE-SCLEROSIS; VACCINES;
   RISK
AB Background: Since the emergency use approval of different types of COVID-19 vaccines, several safety concerns have been raised regarding its early and delayed impact on the nervous system. Objective: This study aims to systematically review the reported cases of CNS demyelination in association with COVID-19 vaccination, which has not been performed, to our knowledge. Methods: A systematic review was performed by screening published articles and preprints of cases of CNS demyelination in association with COVID-19 vaccines in PubMed, SCOPUS, EMBASE, Google Scholar, Ovid and medRxiv databases, until September 30, 2021. This study followed PRISMA guidelines. Descriptive findings of reported cases were reviewed and stratified by demographic and clinical findings, diagnostic work-up, man-agement, and overall outcome. Results: A total of 32 cases were identified, with female predominance (68.8%) and median age of 44 years. Eleven cases were reported after Pfizer vaccine, 8 following AstraZeneca vaccine, 6 following Moderna, 5 following Sinovac/ Sinopharm vaccines, and one following each of Sputnik and Johnson&Johnson vaccines. The majority of cases (71.8%) occurred after the first dose of the vaccine, with neurological symptoms manifesting after a median of 9 days. The most common reported presentations were transverse myelitis (12/32) and MS-like pictures (first diagnosis or a relapse) in another 12/32 cases, followed by ADEM-like (5/32), and NMOSD-like (3/32) presentations. History of a previous immune-mediated disease was reported in 17/32 (53.1%) cases. The mRNA-based vaccines resulted in the greatest number of demyelinating syndromes (17/32), followed by viral vector vaccines (10/32), and inactivated vaccines (5/32). Most MS-like episodes (9/12) were triggered by mRNA-based vaccines, while TM occurred following both viral vector and mRNA-based vaccines. Management included high dose methylprednisolone, PLEX, IVIg, or a combination of those, with a favorable outcome in the majority of case; marked/complete improvement (25/32) or stabilized/ partial recovery in the remaining cases. Conclusion: This systematic review identified few cases of CNS demyelination following all types of approved COVID-19 vaccines so far. Clinical presentation was heterogenous, mainly following the first dose, however, half of the reported cases had a history of immune-mediated disease. Favorable outcome was observed in most cases. We suggest long-term post-marketing surveillance for these cases, to assess for causality, and ensure the safety of COVID-19 vaccines.
C1 [Ismail, Ismail Ibrahim] Ibn Sina Hosp, Dept Neurol, Kuwait, Kuwait.
   [Salama, Sara] Alexandria Univ, Dept Neurol & Psychiat, Alexandria, Egypt.
RP Ismail, II (corresponding author), Ibn Sina Hosp, Gamal Abdel Nasser St,Sabah Med Area, Safat, Kuwait.
EM dr.ismail.ibrahim2012@gmail.com
RI Salama, Sara/AFL-1898-2022
OI Salama, Sara/0000-0003-2380-8152; Ibrahim Ismail,
   Ismail/0000-0002-9788-7044
CR Achiron A, 2021, MULT SCLER J, V27, P864, DOI 10.1177/13524585211003476
   Agmon-Levin N, 2009, LUPUS, V18, P1198, DOI 10.1177/0961203309345730
   Aharon-Maor A, 2000, ISRAEL MED ASSOC J, V2, P225
   Alshararni A, 2021, J RES PHARM SCI, V12, P2083
   Angum F, 2020, CUREUS, V12, DOI 10.7759/cureus.8094
   [Anonymous], SSRN J, V229, DOI [10.1016/j.clim.2021.108786, DOI 10.1016/J.CLIM.2021.108786]
   Beh SC, 2013, NEUROL CLIN, V31, P79, DOI 10.1016/j.ncl.2012.09.008
   Cao LM, 2021, ACTA NEUROL BELG, DOI 10.1007/s13760-021-01608-2
   CDC, 2021, VACCINE ADVERSE EVEN
   Chen S, 2021, NEUROL SCI, V42, P3537, DOI 10.1007/s10072-021-05427-4
   de Martino M, 2013, INT J IMMUNOPATH PH, V26, P283, DOI 10.1177/039463201302600201
   Erdem N.S, IDEGGYOGY SZ, V74, P273
   Etemadifar M, 2021, HUM VACC IMMUNOTHER, V17, P3481, DOI 10.1080/21645515.2021.1928463
   Farez MF, 2011, J NEUROL, V258, P1197, DOI 10.1007/s00415-011-5984-2
   Fitzsimmons W., 2021, SSRN J
   Gao JJ, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9091008
   Garcia-Grimshaw M., 2021, SYSTEMIC NEUROLOGIC
   Goss AL, 2021, ANN NEUROL, V89, P856, DOI 10.1002/ana.26065
   Havla J, 2022, J NEUROL, V269, P55, DOI 10.1007/s00415-021-10648-w
   Helmchen C, 2022, J NEUROL, V269, P49, DOI 10.1007/s00415-021-10647-x
   Hernandez Antonio F, 2021, Toxicol Rep, V8, P871, DOI 10.1016/j.toxrep.2021.04.003
   Hsiao YT, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57101010
   Ismail II, 2022, J NEUROL, V269, P541, DOI 10.1007/s00415-021-10752-x
   Karussis D, 2014, AUTOIMMUN REV, V13, P215, DOI 10.1016/j.autrev.2013.10.003
   Khan E, 2022, J NEUROL, V269, P1121, DOI 10.1007/s00415-021-10785-2
   Khayat-Khoei M., 2021, COVID 19 MRNA VACCIN
   Knoll MD, 2021, LANCET, V397, P72, DOI 10.1016/S0140-6736(20)32623-4
   Ling YZ, 2021, J MED VIROL, V93, P6486, DOI 10.1002/jmv.27203
   Lu L, 2021, ACTA NEUROL SCAND, V144, P111, DOI 10.1111/ane.13444
   Lu L, 2021, ACTA NEUROL SCAND, V144, P3, DOI 10.1111/ane.13417
   Mahase E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2815
   Mailand MT, 2017, J NEUROL, V264, P1035, DOI 10.1007/s00415-016-8263-4
   Malhotra HS, 2021, QJM-INT J MED, V114, P591, DOI 10.1093/qjmed/hcab069
   Maniscalco GT, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.721502
   Mathew T., 2021, NEUROIMMUNOL REPORTS, V1
   McLean P., 2021, NEUROIMMUNOL REPORTS, V1
   Nagy A, 2021, COMPUT STRUCT BIOTEC, V19, P2508, DOI 10.1016/j.csbj.2021.04.061
   Ndwandwe D, 2021, CURR OPIN IMMUNOL, V71, P111, DOI 10.1016/j.coi.2021.07.003
   Notghi AAA, 2021, CLIN MED, V21, pE535, DOI 10.7861/clinmed.2021-0470
   Kenangil GO, 2021, ACTA NEUROL BELG, V121, P1089, DOI 10.1007/s13760-021-01699-x
   Pagenkopf C, 2021, J NEUROIMMUNOL, V358, DOI 10.1016/j.jneuroim.2021.577606
   Raknuzzaman M., 2021, INT J MED SCI CLIN R, V1, P31
   Rinaldi V, 2021, MULT SCLER J, DOI 10.1177/13524585211040222
   Roman GC, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.653786
   Salemi S, 2010, INT REV IMMUNOL, V29, P247, DOI 10.3109/08830181003746304
   Ahadi MS, 2021, ACTA NEUROL BELG, DOI 10.1007/s13760-021-01775-2
   Somers EC, 2009, AM J EPIDEMIOL, V169, P749, DOI 10.1093/aje/kwn408
   Tahir Nayha, 2021, Cureus, V13, pe16624, DOI 10.7759/cureus.16624
   Vegezzi E, 2021, J NEUROIMMUNOL, V359, DOI 10.1016/j.jneuroim.2021.577686
   Velikova T, 2021, RHEUMATOL INT, V41, P509, DOI 10.1007/s00296-021-04792-9
   Vera-Lastra O, 2013, EXPERT REV CLIN IMMU, V9, P361, DOI [10.1586/ECI.13.2, 10.1586/eci.13.2]
   Vogrig A, 2021, CLIN NEUROL NEUROSUR, V208, DOI 10.1016/j.clineuro.2021.106839
   von Csefalvay C., 2021, INF DIS EXCEPT HIVAI, DOI [10.1101/2021.06.13.21258851, DOI 10.1101/2021.06.13.21258851]
   Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1
   Watad A, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050435
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   Wraith DC, 2003, LANCET, V362, P1659, DOI 10.1016/S0140-6736(03)14802-7
NR 57
TC 3
Z9 3
U1 11
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0165-5728
EI 1872-8421
J9 J NEUROIMMUNOL
JI J. Neuroimmunol.
PD JAN 15
PY 2022
VL 362
AR 577765
DI 10.1016/j.jneuroim.2021.577765
EA NOV 2021
PG 16
WC Immunology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Neurosciences & Neurology
GA XG8NQ
UT WOS:000725004900005
PM 34839149
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Javed, T
   Said, F
AF Javed, Tariq
   Said, Fareyha
TI Business Response to Natural Disaster Mitigation (Covid-19). A Case From
   Pakistan
SO SAGE OPEN
LA English
DT Article
DE stakeholder theory; business response; Facebook; Covid-19; stakeholder
   engagement
ID CORPORATE SOCIAL-RESPONSIBILITY; STAKEHOLDER THEORY; MEDIA; CSR;
   SUSTAINABILITY; COMMUNICATION; DISCLOSURE; STRATEGIES; ETHICS;
   DETERMINANTS
AB A company's CSR attitude depends on the ethical values embraced and formally espoused by its Board and/or senior management. The response of corporates to natural disasters has proved to be beneficial for both for-profit organizations as well as society. There are several instances in the developed world where businesses played a leading role in both attempts to curb natural disasters as well as in helping people who suffered due to such disasters. However, in the developing world, the need for corporate participation in natural disaster mitigation is enhanced by the scarce resources of the relevant governmental agencies. Corporates can offer a helping hand in several ways, but perhaps one of the more effective steps is to spread awareness and knowledge about handling the various aspects of the disaster. Drawing from the available literature and underpinning the business ethics theories, this study aimed to explore business responses in Pakistan to constraint the Covid-19 pandemic. The study employs a two-step quantitative content analysis on Facebook as a research method. The findings are that the three selected industries (finance, telecommunication, and petroleum) remain more committed to their marketing efforts than paying due regard to the genuine need of spreading awareness and educating masses on protection against and/or handling Covid-19 pandemic. The public reaction to such less than adequate steps taken by the corporates provides a potent reminder of what people truly expect from corporates and how firms need to be more proactive toward response to a natural disaster.
C1 [Javed, Tariq] Univ Pendidikan Sultan Idris, Tanjung Malim, Perak Darul Rid, Malaysia.
   [Said, Fareyha] Univ Malaya, Kuala Lumpur, Malaysia.
RP Said, F (corresponding author), Univ Malaya, Fac Business & Econ, Jalan Univ, Kuala Lumpur 50603, Wilayah Perseku, Malaysia.
EM fareyhasaid@gmail.com
OI Said, Fareyha/0000-0001-7338-5587
CR Abitbol A, 2017, PUBLIC RELAT REV, V43, P796, DOI 10.1016/j.pubrev.2017.05.002
   Abuin-Penas J, 2022, J HUM SPORT EXERC, V17, P225, DOI 10.14198/jhse.2022.171.20
   Ali W, 2017, CORP SOC RESP ENV MA, V24, P273, DOI 10.1002/csr.1410
   Amjad S.M., 2018, PHILANTHROPY PAKISTA
   Amran A, 2015, BUS STRATEG ENVIRON, V24, P551, DOI 10.1002/bse.1837
   [Anonymous], 2020, TELECOM INDICATORS
   Antonacopoulou EP, 2005, CORP GOV-INT J BUS S, V5, P22, DOI 10.1108/14720700510562631
   Argyris YA, 2015, J ORG COMP ELECT COM, V25, P140, DOI 10.1080/10919392.2015.1033940
   Bellemare MF, 2015, AM J AGR ECON, V97, P1, DOI 10.1093/ajae/aau038
   Bellucci M, 2017, ACCOUNT AUDIT ACCOUN, V30, P874, DOI 10.1108/AAAJ-07-2015-2122
   Berelson B., 1952, CONTENT ANAL COMMUNI
   Bonson E, 2020, INT J PUBLIC ADM DIG, V7, P1, DOI 10.4018/IJPADA.2020070101
   Bonson E, 2013, ONLINE INFORM REV, V37, P787, DOI 10.1108/OIR-03-2012-0054
   Boyd DE, 2016, J BUS RES, V69, P2739, DOI 10.1016/j.jbusres.2015.11.009
   Brewer B, 2021, US SMES AMAZON INITI
   Brown JA, 2013, J BUS ETHICS, V112, P301, DOI 10.1007/s10551-012-1251-4
   Butt S.A., 2016, BUSINESS ETHICS PAKI
   Butt S.A., 2012, CORP GOV-OXFORD
   Carroll A.B., 1999, BUS SOC, V38, P268, DOI 10.1177/000765039903800303
   Cheng Y, 2019, INT J COMMUN-US, V13, P319
   Cho M, 2017, BUS PROF COMMUN Q, V80, P52, DOI 10.1177/2329490616663708
   Colleoni E, 2013, CORP COMMUN, V18, P228, DOI 10.1108/13563281311319508
   Davlasheridze M, 2017, SMALL BUS ECON, V49, P865, DOI 10.1007/s11187-017-9859-5
   DONALDSON T, 1995, ACAD MANAGE REV, V20, P65, DOI 10.5465/AMR.1995.9503271992
   Dutot V, 2016, MANAGE DECIS, V54, P363, DOI 10.1108/MD-01-2015-0015
   El-Bassiouny N, 2018, J ORGAN CHANGE MANAG, V31, P795, DOI 10.1108/JOCM-03-2017-0087
   Ergun O, 2010, INT J PROD ECON, V126, P111, DOI 10.1016/j.ijpe.2009.08.018
   EY Global, 2020, COVID 19 PAND PLANN
   Gao H, 2011, IEEE INTELL SYST, V26, P10, DOI 10.1109/MIS.2011.52
   Garriga E, 2004, J BUS ETHICS, V53, P51, DOI 10.1023/B:BUSI.0000039399.90587.34
   Giannarakis G, 2014, INT J LAW MANAG, V56, P393, DOI 10.1108/IJLMA-05-2013-0021
   Goel M, 2014, PROC ECON FINANC, V11, P49, DOI 10.1016/S2212-5671(14)00175-0
   Goodstein JD, 2007, BUS ETHICS Q, V17, P375, DOI 10.5840/beq200717346
   GRI, SUST REP
   Hall C. M., 2016, BUSINESS POSTDISASTE
   Hall CM, 2010, CURR ISSUES TOUR, V13, P401, DOI 10.1080/13683500.2010.491900
   Herbane B, 2010, INT SMALL BUS J, V28, P43, DOI 10.1177/0266242609350804
   Horisch J, 2014, ORGAN ENVIRON, V27, P328, DOI 10.1177/1086026614535786
   Houston JB, 2015, DISASTERS, V39, P1, DOI 10.1111/disa.12092
   Ittefaq Muhammad, 2019, J CONT E ASIA, V18, P49, DOI DOI 10.17477/jcea.2019.18.1.049.
   Jahangir R., 2020, DAWN 0414
   Kingston J, 2012, NISSAN I ROUTL JPN S, P1
   LEWIS PV, 1985, J BUS ETHICS, V4, P377, DOI 10.1007/BF02388590
   Liu X, 2017, J CLEAN PROD, V142, P1075, DOI 10.1016/j.jclepro.2016.09.102
   Lodhia S., 2020, USE SOCIAL MEDIA LEG
   Lodhia S, 2018, MEDITARI ACCOUNT RES, V26, P2, DOI 10.1108/MEDAR-08-2017-0197
   Lone EJ, 2016, CORP GOV-INT J BUS S, V16, P785, DOI 10.1108/CG-05-2016-0100
   Martin A., 2013, J BUSINESS CONTINUIT, V7, P205
   Masiha S., 2018, J POLITICAL SCI PUBL, V6, P1, DOI [10.4172/2332-0761.1000315, DOI 10.4172/2332-0761.1000315]
   Matar S., 2016, IISTE, V6, P50
   Mathur VN, 2008, CONSTR MANAG ECON, V26, P601, DOI 10.1080/01446190802061233
   McKnight B, 2019, BUS SOC, V58, P813, DOI 10.1177/0007650317698946
   Meikle G., 2016, SOCIAL MEDIA COMMUNI
   Neubaum G, 2014, COMPUT HUM BEHAV, V34, P28, DOI 10.1016/j.chb.2014.01.021
   Norris FH, 2008, AM J COMMUN PSYCHOL, V41, P127, DOI 10.1007/s10464-007-9156-6
   Palen L., 2018, HDB DISASTER RES HDB, P497
   Park Y, 2013, BUS HORIZONS, V56, P75, DOI 10.1016/j.bushor.2012.09.008
   Parmar BL, 2010, ACAD MANAG ANN, V4, P403, DOI 10.1080/19416520.2010.495581
   Perez A, 2015, CORP COMMUN, V20, P11, DOI 10.1108/CCIJ-01-2014-0003
   REED D, 1999, BUSINESS ETHICS Q, V9, P453, DOI DOI 10.2307/3857512
   Reilly AH, 2014, BUS HORIZONS, V57, P747, DOI 10.1016/j.bushor.2014.07.008
   Rosilawati Y, 2021, TECHNIUM SOC SCI J, V18, P170
   Russo A, 2010, J BUS ETHICS, V91, P207, DOI 10.1007/s10551-009-0079-z
   Sajjad A, 2014, CRIT STUD CORP RESPO, V8, P163, DOI 10.1108/S2043-905920140000008010
   Sangle S., 2007, International Journal of Business Governance and Ethics, V3, P56, DOI 10.1504/IJBGE.2007.011934
   Seidler R, 2018, INT J DISAST RISK RE, V31, P92, DOI 10.1016/j.ijdrr.2018.04.023
   Sharon V.C, 2017, J PHARM SCI RES, V9, P139
   Sroka W, 2018, J ENTREP MANAG INNOV, V14, P111, DOI 10.7341/20181435
   Staub Ervin., 2013, POSITIVE SOCIAL BEHA
   Stewart MC, 2016, COMPUT HUM BEHAV, V54, P639, DOI 10.1016/j.chb.2015.07.009
   Swiss Re, 2013, MIND RISK GLOBAL RAN
   Syed MA, 2017, SOC RESPONSIB J, V13, P780, DOI 10.1108/SRJ-08-2016-0146
   Unisdr U., 2009, UNISDR TERM DIS RISK
   Waddock S. A., 2002, LEADING CORPORATE CI
   Wallis AM, 2006, INT J ENVIRON SUSTAI, V5, P287, DOI 10.1504/IJESD.2006.010898
   Wang ZY, 2018, INT J GEOGR INF SCI, V32, P49, DOI 10.1080/13658816.2017.1367003
   Wei H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1388
   Winter P.L., 2006, SOC INFLUENCE, V1, P3, DOI [10.1080/15534510500181459, DOI 10.1080/15534510500181459]
   World Bank, 2019, POP TOT
NR 79
TC 0
Z9 0
U1 2
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2158-2440
J9 SAGE OPEN
JI SAGE Open
PD JAN
PY 2022
VL 12
IS 1
AR 21582440211069388
DI 10.1177/21582440211069388
PG 12
WC Social Sciences, Interdisciplinary
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics
GA YT1NA
UT WOS:000751133100001
OA gold
DA 2022-04-20
ER

PT J
AU Siqueira, ASD
   Teixeira, ER
   da Cunha, DAD
   Santiago, FB
   Kirby, EEF
   Neves, LML
AF de Azeredo Siqueira, Alex Sandro
   Teixeira, Eneas Rangel
   de Oliveira da Cunha, Daianny Arrais
   Santiago, Fernanda Barcellos
   Ferraz Kirby, Endi Evelin
   Lima Neves, Luciene Miguel
TI COVID-19 in oncology palliative care: psychological stress from the
   perspective of psychodynamics at work
SO ANNALS OF PALLIATIVE MEDICINE
LA English
DT Article
DE Psychological stress; nursing team; palliative care; COVID-19; pandemic
ID CANCER-PATIENTS; MANAGEMENT
AB Background: Identify the main stressors of the nursing team in assisting patients in oncology palliative care with suspicions and confirmed for COVID-19.
   Methods: Qualitative, descriptive and exploratory study with theoretical framework in the psychodynamics of work, carried out in the emergency and hospitalization sector of a national reference center for cancer treatment in Rio de Janeiro/Brazil. The semi-structured interview was used to collect the data, from April to May 2020. The data were organized and analyzed using the Collective Subject Discourse (CSD) method with the aid of the Qualiquantisoft (R) software.
   Results: Twenty members of the nursing team participated (10 nurses and 10 nursing technicians). After the analysis, three CSDs with their respective central ideas (CI) emerged. The CSD software, Qualiquantisoft (R), also provided a quantitative analysis of the responses, in which 12 (60%) of the respondents believe that the main stressors are associated with work organization, 6 (30%) of the respondents believe that the main stressors are associated to work relationships and 2 (10%) of respondents believe that the main stressors are associated with working conditions.
   Conclusions: The adaptations that took place in the management of care and in the organization of work, to better serve patients in oncology palliative care with suspicions and confirmed for COVID-19, brought greater impact and psychological stress on the nursing team. Considering all the difficulties and influences that the nursing team members are facing in this pandemic moment by COVID-19 associated with palliative oncology care, it is believed that identifying the source of the psychological stress presented by them may contribute to them have a more effective, humanized and holistic care, in addition to spreading knowledge to nursing and other segments of the health area and bringing subsidies to other scientific productions, as well as highlighting the importance of early detection of psychological stress as a way of preventing impacts physical and psychosocial problems caused by work.
C1 [de Azeredo Siqueira, Alex Sandro; Teixeira, Eneas Rangel; de Oliveira da Cunha, Daianny Arrais; Santiago, Fernanda Barcellos; Ferraz Kirby, Endi Evelin; Lima Neves, Luciene Miguel] Fed Fluminense Univ UFF, Rua Doutor Celestino,74 Ctr, BR-24220045 Niteroi, RJ, Brazil.
RP Siqueira, ASD (corresponding author), Fed Fluminense Univ UFF, Rua Doutor Celestino,74 Ctr, BR-24220045 Niteroi, RJ, Brazil.
EM assiqueira@hotmail.com
CR Arnetz JE, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218126
   Bergbom I, 2017, J HOSP MED MANAGE, V3, P1
   Castôr Karoline Sampaio, 2019, BrJP, V2, P49, DOI 10.5935/2595-0118.20190010
   Correa K, 2020, REV BRASILEIRA CANCE, V66, pE
   Dal'Bosco EB, 2020, REV BRAS ENFERM, V73, DOI 10.1590/0034-7167-2020-0434
   Dejours C., 2009, LOUCURADO TRABALHO E, V5th
   Dejours C, 1994, PSICODINAMICA TRABAL
   Dejours C, 2015, ENTRE DESESPERO ESPE, V1st
   Demo P., 2011, PRATICAR CIENCIA MET, V1st
   do Couto AM, 2018, REV BRAS ENFERM, V71, P959, DOI 10.1590/0034-7167-2017-0105
   Florencio RS, 2020, ACTA PAUL ENFERM, V33, DOI [10.37689/acta-ape/2020A001886, 10.37689/acta-ape/2020ao01886]
   Gallasch CH., 2020, REV ENFERM UERJ, V28, P1, DOI 10.12957/reuerj.2020.49596
   Humerez D, 2020, COGITARE ENFERMAGEM, V25, DOI [10.5380/ce.v25i0.74115, DOI 10.5380/CE.V25I0.74115]
   Justo AM, 2020, PAP SOC REPRESENT, V29
   Ornell F, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311X00063520, 10.1590/0102-311x00063520]
   Ozamiz-Etxebarria N, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311x00054020, 10.1590/0102-311X00054020]
   Pai RR, 2020, INDIAN J PALLIAT CAR, V26, pS121, DOI 10.4103/IJPC.IJPC_182_20
   Pereira C, 2020, REV ADM PUBL-RIO JAN, V54, P952, DOI [10.1590/0034-761220200327, 10.1590/0034-761220200327x]
   Santos L, 2020, REV DOCENCIA ENSINO, V10, P1
   Santos LS, 2020, REV ADM PUBL-RIO JAN, V54, P909, DOI [10.1590/0034-761220200219, 10.1590/0034-761220200219x]
   Silva R, 2019, REVENF, V38
   Soares SSS, 2020, REV ENFERM UERJ, V28
   Ting FI, 2020, EURASIAN J MED ONCOL, V4, P349, DOI 10.14744/ejmo.2020.50870
NR 23
TC 1
Z9 1
U1 8
U2 10
PU AME PUBL CO
PI SHATIN
PA FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG
   00000, PEOPLES R CHINA
SN 2224-5820
EI 2224-5839
J9 ANN PALLIAT MED
JI Ann. Pallliat. Med.
PD MAY
PY 2021
VL 10
IS 5
BP 5260
EP 5269
DI 10.21037/apm-21-56
PG 10
WC Health Care Sciences & Services
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services
GA SL9PG
UT WOS:000657245600024
PM 33894722
OA gold
DA 2022-04-20
ER

PT J
AU Berber, E
   Sumbria, D
   Canakoglu, N
AF Berber, Engin
   Sumbria, Deepak
   Canakoglu, Nurettin
TI Meta-analysis and comprehensive study of coronavirus outbreaks: SARS,
   MERS and COVID-19
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Article
DE Outbreak; SARS; MERS; COVID-19; Meta-analysis
ID ACUTE RESPIRATORY SYNDROME; DISEASE 2019 OUTBREAK; RISK-FACTORS;
   SAUDI-ARABIA; HONG-KONG; SYNDROME EPIDEMIC; ANIMAL MARKET; PALM CIVET;
   INFECTION; PNEUMONIA
AB Background: Zoonotic coronaviruses have caused several endemic and pandemic situations around the world. SARS caused the first epidemic alert at the beginning of this century, followed by MERS. COVID-19 appeared to be highly contagious, with human-to-human transmission by aerosol droplets, and reached nearly all countries around the world. A plethora of studies were performed, with reports being published within a short period of time by scientists and medical physicians. It has been difficult to find the relevant data to create an overview of the situation according to studies from accumulated findings and reports. In the present study we aimed to perform a comprehensive study in the context of the case fatality ratios (CFRs) of three major human Coronavirus outbreaks which occurred during the first twenty years of 21st century. Methods: In this study, we performed meta-analyses on SARS, MERS and COVID-19 outbreak events from publicly available records. Study analyses were performed with the help of highly reputable scientific databases such as PubMed, WOS and Scopus to evaluate and present current knowledge on zoonotic coronavirus outbreaks, starting from 2000 to the end of 2020. Results: A total of 250,194 research studies and records were identified with specific keywords and syn-onyms for the three viruses in order to cover all publications. In the end, 41 records were selected and included after applying several exclusion and inclusion criteria on identified datasets. SARS was found to have a nearly 11% case fatality ratio (CFR), which means the estimated number of deaths as a proportion of confirmed positive cases; Taiwan was the country most affected by the SARS outbreak based on the CFR analysis. MERS had CFRs of 35.8 and 26 in Saudi Arabia during the 2012 and 2015 outbreaks, respectively. COVID-19 resulted in a 2.2 CFR globally, and the USA reported the highest mortality ratio in the world in the end of first year of COVID-19 pandemic. Conclusion: Some members of the Coronaviridae family can cause highly contagious and devastating infections among humans. Within the last two decades, the whole world has witnessed several deadly emerging infectious diseases, which are most commonly zoonotic in nature. We conclude that pre-existing immunity during the early stages of a pandemic might be important, but case control and management strategies should be improved to decrease CFRs. Finally, we have addressed several concerns in relation to outbreak events in this study. (c) 2021 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).
C1 [Berber, Engin; Sumbria, Deepak] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA.
   [Berber, Engin] Erciyes Univ, Coll Vet Med, Dept Virol, Kayseri, Turkey.
   [Sumbria, Deepak] Dr Yashwant Singh Parmar Univ Hort & Forestry, Coll Forestry, Dept Silviculture & Agroforestry, Solan, Himachal Prades, India.
   [Canakoglu, Nurettin] Mugla Sitki Kocman Univ, Milas Fac Vet Sci, Dept Virol, Mugla, Turkey.
RP Berber, E (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA.
EM eberber@utk.edu
RI Berber, Engin/A-3538-2016
OI Berber, Engin/0000-0003-0420-7714; Canakoglu,
   Nurettin/0000-0002-0252-2377; sumbria, deepak/0000-0002-8935-255X
CR Al-Mandhari A, 2020, E MEDITERR HEALTH J, V26, P136, DOI 10.26719/2020.26.2.136
   Al-Romaihi HE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218097
   Al-Tawfiq JA, 2014, INFECT DRUG RESIST, V7, P281, DOI 10.2147/IDR.S51283
   Ali SA, 2020, J INFECT PUBLIC HEAL, V13, P644, DOI [10.1016/j.jiph.2019.02.033, 10.1016/j.jiph.2020.02.033]
   Alraddadi BM, 2016, EMERG INFECT DIS, V22, P49, DOI 10.3201/eid2201.151340
   Alsahafi AJ, 2016, INT J INFECT DIS, V45, P1, DOI 10.1016/j.ijid.2016.02.004
   Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104
   Ayittey FK, 2020, J MED VIROL, V92, P473, DOI 10.1002/jmv.25706
   Ayres JS, 2020, NAT METAB, V2, P572, DOI 10.1038/s42255-020-0237-2
   CDC, CHIN LAT SARS OUTBR
   CDC, 2020, COVID 19 PAND PLANN
   Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P547
   Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P461
   Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chau PH, 2003, J EPIDEMIOL COMMUN H, V57, P766, DOI 10.1136/jech.57.10.766
   Chen KT, 2005, INT J INFECT DIS, V9, P77, DOI 10.1016/j.ijid.2004.04.015
   Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07
   Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757
   Chowell G, 2003, J THEOR BIOL, V224, P1, DOI 10.1016/S0022-5193(03)00228-5
   Chowell G, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0450-0
   Cowling BJ, 2015, EUROSURVEILLANCE, V20, P7, DOI 10.2807/1560-7917.ES2015.20.25.21163
   Dey SK, 2020, J MED VIROL, V92, P632, DOI 10.1002/jmv.25743
   Dhama K, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101830
   Din MAU, 2020, AM J INFECT CONTROL, V48, P713, DOI 10.1016/j.ajic.2020.01.023
   Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1
   Du Toit A, 2020, NAT REV MICROBIOL, V18, P123, DOI 10.1038/s41579-020-0332-0
   European Centre for Disease Prevention and Control (ECDC), COVID 19 SIT UPD WOR
   Forni G, 2021, CELL DEATH DIFFER, V28, P626, DOI 10.1038/s41418-020-00720-9
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Gebhard C, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00304-9
   Globalhealth5050, COVID 19 SEX DIS DAT
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Gossner C, 2016, ZOONOSES PUBLIC HLTH, V63, P1, DOI 10.1111/zph.12171
   Grant MC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234765
   Grasselli G, 2020, JAMA INTERN MED, V180, P1345, DOI 10.1001/jamainternmed.2020.3539
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Gupta S, 2020, JAMA INTERN MED, V180, P1436, DOI 10.1001/jamainternmed.2020.3596
   He YX, 2006, J IMMUNOL, V176, P6085, DOI 10.4049/jimmunol.176.10.6085
   Hsieh YH, 2004, EMERG INFECT DIS, V10, P201, DOI 10.3201/eid1002.030515
   Hsu LY, 2003, EMERG INFECT DIS, V9, P713
   Hui DS, 2018, LANCET INFECT DIS, V18, pE217, DOI 10.1016/S1473-3099(18)30127-0
   Jansen A, 2015, WEST PAC SURVEILL RE, V6, P68, DOI [10.5365/WPSAR.2015.6.3.002, 10.5365/wpsar.2015.6.3.002]
   Jernigan DB, 2020, MMWR-MORBID MORTAL W, V69, P216, DOI 10.15585/mmwr.mm6908e1
   Jiang SB, 2013, FUTURE VIROL, V8, P1, DOI [10.2217/FVL.12.126, 10.2217/fvl.12.126]
   Kan B, 2005, J VIROL, V79, P11892, DOI 10.1128/JVI.79.18.11892-11900.2005
   Khalili M, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001430
   Khan G, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-66
   Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898
   Khudhair A, 2019, EMERG INFECT DIS, V25, P927, DOI 10.3201/eid2505.181728
   Killerby ME, 2020, EMERG INFECT DIS, V26, P191, DOI 10.3201/eid2602.190697
   Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011
   Kim JH, 2021, NAT MED, V27, P205, DOI 10.1038/s41591-021-01230-y
   Koch T, 2020, LANCET INFECT DIS, V20, P827, DOI 10.1016/S1473-3099(20)30248-6
   Korea Centers for Disease Control and Prevention, 2015, Osong Public Health Res Perspect, V6, P269, DOI 10.1016/j.phrp.2015.08.006
   Korytkowski M, 2020, J CLIN ENDOCR METAB, V105, P3076, DOI 10.1210/clinem/dgaa342
   Kronbichler A, 2020, INT J INFECT DIS, V98, P180, DOI 10.1016/j.ijid.2020.06.052
   Lamers MM, 2016, EMERG INFECT DIS, V22, P716, DOI 10.3201/eid2204.152065
   LeDuc JW., 2004, EMERG INFECT DIS, V10, DOI [10.3201/eid1011.040797_02, DOI 10.3201/EID1011.04079702]
   Lee PI, 2020, J MICROBIOL IMMUNOL, V53, P365, DOI 10.1016/j.jmii.2020.02.001
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007]
   Lin JT, 2007, ANTIVIR THER, V12, P1107
   Liu D, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100471
   Lupia T, 2020, J GLOB ANTIMICROB RE, V21, P22, DOI 10.1016/j.jgar.2020.02.021
   Mackay IM, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0439-5
   Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026
   Matsuyama R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3881-4
   Memish ZA, 2014, INT J INFECT DIS, V23, P63, DOI 10.1016/j.ijid.2014.03.1372
   Modjarrad K, 2019, LANCET INFECT DIS, V19, P1013, DOI 10.1016/S1473-3099(19)30266-X
   Mohd HA, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0544-0
   Moore D, 2005, AM J INFECT CONTROL, V33, P88, DOI 10.1016/j.ajic.2004.11.003
   Ng DL, 2016, AM J PATHOL, V186, P652, DOI 10.1016/j.ajpath.2015.10.024
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Nie QH, 2003, WORLD J GASTROENTERO, V9, P1635, DOI 10.3748/wjg.v9.i8.1635
   Oh MD, 2018, KOREAN J INTERN MED, V33, P233, DOI 10.3904/kjim.2018.031
   Olsen SJ, 2003, NEW ENGL J MED, V349, P2416, DOI 10.1056/NEJMoa031349
   Organization WH, 2003, CONS DOC EP SEV AC S
   Parry J, 2003, BRIT MED J, V326, P947, DOI 10.1136/bmj.326.7396.947
   Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   ProMed, SARS WORLDW
   Puthucheary J, 2004, ARCH DIS CHILD, V89, P551, DOI 10.1136/adc.2003.039420
   Qiu WQ, 2018, J ENVIRON PUBLIC HEA, V2018, DOI 10.1155/2018/2710185
   Rafiq D, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2113
   Reluga TC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000793
   Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2098, DOI 10.1001/jama.2020.7681
   Roper RL, 2009, EXPERT REV VACCINES, V8, P887, DOI [10.1586/erv.09.43, 10.1586/ERV.09.43]
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335
   Sehrawat S, 2020, MICROBES INFECT, V22, P400, DOI 10.1016/j.micinf.2020.07.002
   Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005
   Sim SW, 2014, SINGAP MED J, V55, P160
   Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102
   Suess C, 2020, INT J LEGAL MED, V134, P1285, DOI 10.1007/s00414-020-02319-8
   Sumbria D, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.594963
   Sumbria D, 2021, J VIROL, V95, DOI 10.1128/JVI.02056-20
   Takahashi Takehiro, 2020, medRxiv, DOI 10.1101/2020.06.06.20123414
   Tan XD, 2004, HEALTH EDUC RES, V19, P576, DOI 10.1093/her/cyg074
   Thompson RN, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020498
   Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1
   Wells CR, 2020, P NATL ACAD SCI USA, V117, P7504, DOI 10.1073/pnas.2002616117
   WHO, NOV COR INF UPD REV
   WHO, 2019, LAB CONF CAS MERS RE
   WHO, WHO ISS GLOB AL CAS
   Widge AT, 2021, NEW ENGL J MED, V384, P80, DOI 10.1056/NEJMc2032195
   Wong O, 2004, OCCUP ENVIRON MED, V61
   World Health Organization, TIM WHOS COVID 19 RE
   Worldbank, POPULATION
   Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Wu HY, 2010, P NATL ACAD SCI USA, V107, P12257, DOI 10.1073/pnas.1000378107
   Yang CH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61133-9
   Yang Y, 2020, J MED VIROL, V92, P536, DOI 10.1002/jmv.25720
   Yang YS, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102434
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhang XS, 2017, INFLUENZA OTHER RESP, V11, P434, DOI 10.1111/irv.12467
   Zhao S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020388
   Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2
   Zhou YG, 2020, NATL SCI REV, V7, P998, DOI 10.1093/nsr/nwaa041
NR 121
TC 1
Z9 1
U1 2
U2 4
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD AUG
PY 2021
VL 14
IS 8
BP 1051
EP 1064
DI 10.1016/j.jiph.2021.06.007
EA JUN 2021
PG 14
WC Public, Environmental & Occupational Health; Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Infectious Diseases
GA TT0HL
UT WOS:000680032700013
PM 34174535
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Abera, A
   Belay, H
   Zewude, A
   Gidey, B
   Nega, D
   Dufera, B
   Abebe, A
   Endriyas, T
   Getachew, B
   Birhanu, H
   Difabachew, H
   Mekonnen, B
   Legesse, H
   Bekele, F
   Mekete, K
   Seifu, S
   Sime, H
   Yemanebrhan, N
   Tefera, M
   Amare, H
   Beyene, B
   Tsige, E
   Kebede, A
   Tasew, G
   Tollera, G
   Abate, E
   Woyessa, A
   Assefa, A
AF Abera, Adugna
   Belay, Habtamu
   Zewude, Aboma
   Gidey, Bokretsion
   Nega, Desalegn
   Dufera, Boja
   Abebe, Abnet
   Endriyas, Tujuba
   Getachew, Birhanu
   Birhanu, Henok
   Difabachew, Hailemariam
   Mekonnen, Bacha
   Legesse, Helina
   Bekele, Firdawek
   Mekete, Kalkidan
   Seifu, Seble
   Sime, Heven
   Yemanebrhan, Nebiyou
   Tefera, Mesfin
   Amare, Hiwot
   Beyene, Berhane
   Tsige, Estifanos
   Kebede, Adisu
   Tasew, Geremew
   Tollera, Getachew
   Abate, Ebba
   Woyessa, Adugna
   Assefa, Ashenafi
TI Establishment of COVID-19 testing laboratory in resource-limited
   settings: challenges and prospects reported from Ethiopia
SO GLOBAL HEALTH ACTION
LA English
DT Article
DE COVID-19; EPHI; SARS-CoV-2; Ethiopia; pandemic; laboratory; RT-PCR
AB The Coronavirus pandemic is recording unprecedented deaths worldwide. The temporal distribution and burden of the disease varies from setting to setting based on economic status, demography and geographic location. A rapid increase in the number of COVID-19 cases is being reported in Africa as of June 2020. Ethiopia reported the first COVID-19 case on 13 March 2020. Limited molecular laboratory capacity in resource constrained settings is a challenge in the diagnosis of the ever-increasing cases and the overall management of the disease. In this article, the Ethiopian Public Health Institute (EPHI) shares the experience, challenges and prospects in the rapid establishment of one of its COVID-19 testing laboratories from available resources. The first steps in establishing the COVID-19 molecular testing laboratory were i) identifying a suitable space ii) renovating it and iii) mobilizing materials including consumables, mainly from the Malaria and Neglected Tropical Diseases (NTDs) research team at the EPHI. A chain of experimental design was set up with distinct laboratories to standardize the extraction of samples, preparation of the master mix and detection. At the commencement of sample reception and testing, laboratory contamination was among the primary challenges faced. The source of the contamination was identified in the master mix room and resolved. In summary, the established COVID-19 testing lab has tested more than 40,000 samples (August 2020) and is the preferred setting for research and training. The lessons learned may benefit the further establishment of emergency testing laboratories for COVID-19 and/or other epidemic/pandemic diseases in resource-limited settings.
C1 [Abera, Adugna; Belay, Habtamu; Zewude, Aboma; Gidey, Bokretsion; Nega, Desalegn; Dufera, Boja; Endriyas, Tujuba; Getachew, Birhanu; Birhanu, Henok; Difabachew, Hailemariam; Mekonnen, Bacha; Legesse, Helina; Bekele, Firdawek; Mekete, Kalkidan; Seifu, Seble; Sime, Heven; Tasew, Geremew; Woyessa, Adugna; Assefa, Ashenafi] Ethiopian Publ Hlth Inst, Malaria & Neglected Trop Dis Res Team, POB 1242, Addis Ababa, Ethiopia.
   [Abebe, Abnet; Yemanebrhan, Nebiyou; Kebede, Adisu] Ethiopian Publ Hlth Inst, Natl Labs Capac Bldg Directorate, Addis Ababa, Ethiopia.
   [Tefera, Mesfin] Ethiopian Publ Hlth Inst, Natl Polio & Measles Lab, Addis Ababa, Ethiopia.
   [Amare, Hiwot] Ethiopian Publ Hlth Inst, Influenza & Arbovirus Res Lab, Addis Ababa, Ethiopia.
   [Beyene, Berhane] WHO Ethiopia Country Off, Addis Ababa, Ethiopia.
   [Tsige, Estifanos] Ethiopian Publ Hlth Inst, Clin Bacteriol & Mycol Case Team, Addis Ababa, Ethiopia.
   [Tollera, Getachew; Abate, Ebba] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia.
RP Abera, A (corresponding author), Ethiopian Publ Hlth Inst, Malaria & Neglected Trop Dis Res Team, POB 1242, Addis Ababa, Ethiopia.
EM adugnabe@yahoo.com
RI zewude, Aboma/AAE-3970-2021
OI zewude, Aboma/0000-0001-6087-0129; Hirpa, Adugna
   Abera/0000-0001-6572-8113
FU Polio and Virology laboratories at the EPHI; WHO Ethiopia office
FX The EPHI management is acknowledged for their unprecedented support and
   leadership. Bacteriology, Polio and Virology laboratories at the EPHI
   are acknowledged for the support and experience sharing. The WHO
   Ethiopia office and the Gashero project are acknowledged for availing
   expert advice and resources, respectively. Knowledge gained from
   molecular training sponsored by CDC/PMI was instrumental during the
   laboratory establishment. PCL-EPHI teams are highly acknowledged for
   their limitless effort and their families for patience since the work
   does not provide any additional income to the family while continuously
   demanding their commitment. Dr. Lishan Admasu is acknowledged for
   reviewing the laboratory linkage system. Albab Seifu and Ahlam Awad
   Mohammed are acknowledged for proofreading the document.
CR [Anonymous], 2021, COR DIS COVID 19 PAN, DOI DOI 11/44679/INDEX.HTM
   Cable News Network (CNN), 2020, ETH RWAND REC COR TE
   Centers for Disease Control and Prevention, COR DIS 2019 COVID 1
   Congpuong K, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-288
   Ethiopian Public Health Institute (EPHI), COVID19 UPD
   Nalla AK, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00557-20
   Sethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259
   Worldometer, COVID 19 COR PAND LI
   Xinhua, 2020, JACK MA FDN DON MASK
   Zhou W, 2020, CORONAVIRUS PREVENTI, V1st, P145
NR 10
TC 3
Z9 3
U1 2
U2 21
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 1654-9880
J9 GLOBAL HEALTH ACTION
JI Glob. Health Action
PD DEC 31
PY 2020
VL 13
IS 1
AR 1841963
DI 10.1080/16549716.2020.1841963
PG 7
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA OS0FH
UT WOS:000589839300001
PM 33200686
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Liu, BM
   Martins, TB
   Peterson, LK
   Hill, HR
AF Liu, Benjamin M.
   Martins, Thomas B.
   Peterson, Lisa K.
   Hill, Harry R.
TI Clinical significance of measuring serum cytokine levels as inflammatory
   biomarkers in adult and pediatric COVID-19 cases: A review
SO CYTOKINE
LA English
DT Review
DE COVID-19; Cytokine; Inflammatory biomarkers; Multiplex cytokine
   analysis; Kawasaki disease
ID IMMUNOASSAY; ANTIBODY; DISEASE; TRIM56
AB Coronavirus disease 2019 (COVID-19) is a rapidly evolving infectious/inflammatory disorder which has turned into a global pandemic. With severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as its etiologic agent, severe COVID-19 cases usually develop uncontrolled inflammatory responses and cytokine storm-like syndromes. Measuring serum levels of pro-inflammatory cytokines (e.g., IL-6 and others) as inflammatory biomarkers may have several potential applications in the management of COVID-19, including risk assessment, monitoring of disease progression, determination of prognosis, selection of therapy and prediction of response to treatment. This is especially true for pediatric patients with COVID-19 associated Kawasaki-like disease and similar syndromes. In this report, we review the current knowledge of COVID-19 associated cytokines, their roles in host immune and inflammatory responses, the clinical significance and utility of cytokine immunoassays in adult and pediatric COVID-19 patients, as well as the challenges and pitfalls in implementation and interpretation of cytokine immunoassays. Given that cytokines are implicated in different immunological disorders and diseases, it is challenging to interpret the multiplex cytokine data for COVID-19 patients. Also, it should be taken into consideration that biological and technical variables may affect the commutability of cytokine immunoassays and enhance complexity of cytokine immunoassay interpretation. It is recommended that the same method, platform and laboratory should be used when monitoring differences in cytokine levels between groups of individuals or for the same individual over time. It may be important to correlate cytokine profiling data with the SARS-CoV-2 nucleic acid amplification testing and imaging observations to make an accurate interpretation of the inflammatory status and disease progression in COVID-19 patients.
C1 [Liu, Benjamin M.; Martins, Thomas B.; Peterson, Lisa K.; Hill, Harry R.] Univ Utah, Dept Pathol, Sch Med, 500 Chipeta Way, Salt Lake City, UT 84108 USA.
   [Martins, Thomas B.; Peterson, Lisa K.; Hill, Harry R.] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA.
   [Hill, Harry R.] Univ Utah, Sch Med, Dept Med, Suite 5B214,50 N Med Dr, Salt Lake City, UT 84132 USA.
   [Hill, Harry R.] Univ Utah, Sch Med, Dept Pediat, Suite 5B214,50 N Med Dr, Salt Lake City, UT 84132 USA.
RP Liu, BM (corresponding author), Univ Utah, Dept Pathol, Sch Med, 500 Chipeta Way, Salt Lake City, UT 84108 USA.; Hill, HR (corresponding author), Univ Utah, Sch Med, Dept Med, Suite 5B214,50 N Med Dr, Salt Lake City, UT 84132 USA.; Hill, HR (corresponding author), Univ Utah, Sch Med, Dept Pediat, Suite 5B214,50 N Med Dr, Salt Lake City, UT 84132 USA.; Hill, HR (corresponding author), Univ Utah, Sch Med, Dept Pathol, Suite 5B214,50 N Med Dr, Salt Lake City, UT 84132 USA.
EM b.liu@path.utah.edu; harry.hill@hsc.utah.edu
OI Peterson, Lisa/0000-0001-8702-1311
FU ARUP Institute for Clinical and Experimental Pathology; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA
FX This study was supported by the ARUP Institute for Clinical and
   Experimental Pathology and formerly by grants from the National
   Institutes of Health.
CR Albert-Vega C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02367
   [Anonymous], 2020, PNEUMONIA UNKNOWN CA
   Barker T, 2012, CYTOKINE, V60, P23, DOI 10.1016/j.cyto.2012.05.015
   Barker T, 2011, AM J PHYS MED REHAB, V90, P638, DOI 10.1097/PHM.0b013e318214e886
   Barker T, 2009, FREE RADICAL BIO MED, V46, P599, DOI 10.1016/j.freeradbiomed.2008.11.006
   Belhadjer Z, 2020, CIRCULATION, V142, P429, DOI 10.1161/CIRCULATIONAHA.120.048360
   BOSCATO LM, 1988, CLIN CHEM, V34, P27
   Brodin P, 2020, ACTA PAEDIATR, V109, P1082, DOI 10.1111/apa.15271
   Chen XH, 2020, CLIN INFECT DIS, V71, P1937, DOI 10.1093/cid/ciaa449
   Chousterman BG, 2017, SEMIN IMMUNOPATHOL, V39, P517, DOI 10.1007/s00281-017-0639-8
   Del Valle DM, 2020, NAT MED, V26, P1636, DOI 10.1038/s41591-020-1051-9
   Ellington AA, 2009, CLIN CHEM, V55, P1092, DOI 10.1373/clinchem.2008.120717
   Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387
   Fichorova RN, 2008, ANAL CHEM, V80, P4741, DOI 10.1021/ac702628q
   Fung M, 2021, CLIN INFECT DIS, V72, P340, DOI 10.1093/cid/ciaa863
   Gale M, 2018, J INTERF CYTOK RES, V38, P195, DOI 10.1089/jir.2018.29007-mgj
   Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027
   Hall Mark W, 2022, Clin Infect Dis, V74, P144, DOI 10.1093/cid/ciaa904
   Hanson KE, 2020, DIAGN MICR INFEC DIS, V96, DOI 10.1016/j.diagmicrobio.2019.114952
   Henry NL, 2012, MOL ONCOL, V6, P140, DOI 10.1016/j.molonc.2012.01.010
   Hill HR, 2006, METHODS, V38, P312, DOI 10.1016/j.ymeth.2005.11.014
   Hu BY, 2021, J MED VIROL, V93, P250, DOI 10.1002/jmv.26232
   International Child Health Group Royal College of Paediatrics & Child Health Royal College of Paediatrics & Child Heath, 2020, ARCH DIS CHILD, DOI [10.1136/archdischild-2020-320652archdischild-2020-320652., DOI 10.1136/ARCHDISCHILD-2020-320652ARCHDISCHILD-2020-320652]
   Jones Veena G, 2020, Hosp Pediatr, V10, P537, DOI 10.1542/hpeds.2020-0123
   Kalvakolanu DV, 2019, CYTOKINE, V118, P1, DOI 10.1016/j.cyto.2018.12.013
   Kricka LJ, 1999, CLIN CHEM, V45, P942
   Li K, 2012, HEPATOLOGY, V55, P666, DOI 10.1002/hep.24763
   Licciardi F, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-1711
   Liu BM, 2016, J VIROL, V90, P4369, DOI 10.1128/JVI.03172-15
   Liu BM, 2014, J VIROL, V88, P13821, DOI 10.1128/JVI.02505-14
   Liu BM, 2020, J INTERF CYTOK RES, V40, P549, DOI 10.1089/jir.2020.0210
   Mahmudpour M, 2020, CYTOKINE, V133, DOI 10.1016/j.cyto.2020.155151
   Mandel M, 2020, CYTOKINE, V134, DOI 10.1016/j.cyto.2020.155190
   Martins TB, 2004, CLIN DIAGN LAB IMMUN, V11, P325, DOI 10.1128/CDLI.11.2.325-329.2004
   Martins TB, 2002, AM J CLIN PATHOL, V118, P346
   Martins TB, 2006, AM J CLIN PATHOL, V125, P906, DOI 10.1309/Q3E6KF0QD3U3YL6T
   Martins TB, 2011, AM J CLIN PATHOL, V136, P696, DOI 10.1309/AJCP7UBK8IBVMVNR
   McElvaney OJ, 2020, EBIOMEDICINE, V61, DOI 10.1016/j.ebiom.2020.103026
   McKechnie JL, 2020, CELL HOST MICROBE, V27, P863, DOI 10.1016/j.chom.2020.05.009
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Mick E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19587-y
   Minotti C, 2020, J INFECTION, V81, pE61, DOI 10.1016/j.jinf.2020.04.026
   Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925
   Mouton W, 2020, CLIN IMMUNOL, V210, DOI 10.1016/j.clim.2019.108312
   Noroozi R, 2020, CYTOKINE, V133, DOI 10.1016/j.cyto.2020.155143
   Ponti G, 2020, CRIT REV CL LAB SCI, V57, P389, DOI 10.1080/10408363.2020.1770685
   Pouletty M, 2020, ANN RHEUM DIS, V79, P999, DOI 10.1136/annrheumdis-2020-217960
   Ragab D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01446
   Ramsay I, 2016, CLIN INFECT DIS, V63, P57, DOI 10.1093/cid/ciw222
   Remy KE, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140329
   Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/S0140-6736(20)31094-1, 10.1016/50140-6736(20)31094-1]
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Schett G, 2020, NAT REV IMMUNOL, V20, P271, DOI 10.1038/s41577-020-0312-7
   Shen Y, 2012, J BIOL CHEM, V287, P36404, DOI 10.1074/jbc.M112.397075
   Shi YF, 2020, CELL DEATH DIFFER, V27, P1451, DOI 10.1038/s41418-020-0530-3
   Tang YJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01708
   Teijaro JR, 2017, SEMIN IMMUNOPATHOL, V39, P501, DOI 10.1007/s00281-017-0640-2
   Thompson CN, 2020, MMWR-MORBID MORTAL W, V69, P1725, DOI 10.15585/mmwr.mm6946a2
   Tighe P, 2013, METHODS, V61, P23, DOI 10.1016/j.ymeth.2013.01.003
   Titanji BK, 2021, CLIN INFECT DIS, V72, P1247, DOI 10.1093/cid/ciaa879
   Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X
   Wang J, 2011, J VIROL, V85, P3733, DOI 10.1128/JVI.02546-10
   Wilson JG, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140289
   Yang L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00243-2
   Yu XW, 2019, ANALYST, V144, P3250, DOI 10.1039/c9an00297a
   Zaim S, 2020, CURR PROB CARDIOLOGY, V45, DOI 10.1016/j.cpcardiol.2020.100618
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
NR 67
TC 9
Z9 9
U1 2
U2 8
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD JUN
PY 2021
VL 142
AR 155478
DI 10.1016/j.cyto.2021.155478
EA MAR 2021
PG 7
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA RL7NT
UT WOS:000639155700012
PM 33667962
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Aldrighetti, L
   Boggi, U
   Falconi, M
   Giuliante, F
   Cipriani, F
   Ratti, F
   Torzilli, G
AF Aldrighetti, Luca
   Boggi, Ugo
   Falconi, Massimo
   Giuliante, Felice
   Cipriani, Federica
   Ratti, Francesca
   Torzilli, Guido
CA Italian Assoc HepatoBilioPanc
TI Perspectives from Italy during the COVID-19 pandemic: nationwide
   survey-based focus on minimally invasive HPB surgery
SO UPDATES IN SURGERY
LA English
DT Article
DE Liver; Pancreas; Minimally invasive; Pandemic; COVID-19
AB The safety of minimally invasive procedures during COVID pandemic remains hotly debated, especially in a country, like Italy, where minimally invasive techniques have progressively and pervasively entered clinical practice, in both the hepatobiliary and pancreatic community. A nationwide snapshot of the management of HPB minimally invasive surgery activity during COVID-19 pandemic is provided: a survey was developed and conducted within AICEP (Italian Association of HepatoBilioPancreatic Surgeons) with the final aim of conveying the experience, knowledge, and opinions into a unitary report enabling more efficient crisis management. Results from the survey (81 respondents) show that, in Italian hospitals, minimally invasive surgery maintains its role despite the COVID-19 pandemic, with the registered reduction of cases being proportional to the overall reduction of the HPB surgical activity. Respondents agree that the switch from minimally invasive to open technique can be considered as a valid option for cases with a high technical complexity. Several issues merit specific attention: screening for virus positivity should be universally performed; only expert surgical teams should operate on positive patients and specific technical measures to lower the biological risk of contamination during surgery must be followed. Future studies specifically designed to establish the true risks in minimally invasive surgery are suggested. Furthermore, a standard and univocal process of prioritization of patients from Regional Healthcare Systems is advisable.
C1 [Aldrighetti, Luca; Cipriani, Federica; Ratti, Francesca] IRCCS San Raffaele Hosp, Hepatobiliary Surg Div, Olgettina 60, I-20132 Milan, Italy.
   [Boggi, Ugo] Univ Pisa, Dept Transplant & Gen Surg, Pisa, Italy.
   [Falconi, Massimo] IRCCS San Raffaele Hosp, Div Pancreat Surg, Milan, Italy.
   [Giuliante, Felice] Catholic Univ, Fdn Policlin Univ A Gemelli, Hepatobiliary Surg Unit, Rome, Italy.
   [Torzilli, Guido] Humanitas Univ & Res Hosp, IRCCS, Dept Surg, Div Hepatobiliary & Gen Surg, Milan, Italy.
RP Aldrighetti, L (corresponding author), IRCCS San Raffaele Hosp, Hepatobiliary Surg Div, Olgettina 60, I-20132 Milan, Italy.
EM aldrighetti.luca@hsr.it
RI Barberis, Andrea/AAM-5598-2021; Banchini, Filippo/ABC-8737-2021;
   Andrianello, Stefano/H-9655-2019; Ravaioli, Matteo/D-6314-2016;
   Barabino, Matteo/AAC-3593-2022; Cotsoglou, Christian/AAX-2988-2021;
   Ardito, Francesco/AAN-8301-2020; Di Benedetto, Fabrizio/B-8388-2015;
   VISTOLI, FABIO/F-3648-2012; Malleo, Giuseppe/J-4395-2012
OI Barberis, Andrea/0000-0003-0472-0120; Banchini,
   Filippo/0000-0003-3433-1708; Andrianello, Stefano/0000-0003-0556-8271;
   Ravaioli, Matteo/0000-0001-5862-6151; Barabino,
   Matteo/0000-0001-9525-9063; Cotsoglou, Christian/0000-0002-6348-0027;
   Ardito, Francesco/0000-0003-1596-2862; Di Benedetto,
   Fabrizio/0000-0002-6718-8760; VISTOLI, FABIO/0000-0003-2115-4191;
   Patriti, Alberto/0000-0003-2414-268X; Anselmo,
   Alessandro/0000-0003-1041-8120; Romagnoli, Renato/0000-0001-8340-8885;
   zerbi, alessandro/0000-0002-9176-0448; Malleo,
   Giuseppe/0000-0001-5467-2628; Rocca, Aldo/0000-0003-3807-3865; ISABELLA,
   FRIGERIO/0000-0002-7616-4226; Aldrighetti, Luca
   Antonio/0000-0001-7729-2468
CR Aldrighetti L, 2017, UPDATES SURG, V69, P271, DOI 10.1007/s13304-017-0489-x
   Aminian A, 2020, ANN SURG, V272, pE27, DOI 10.1097/SLA.0000000000003925
   do Nascimento IB, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040941
   Capretti G, 2019, UPDATES SURG, V71, P97, DOI 10.1007/s13304-018-0535-3
   Ngoi N, 2020, ANN ONCOL, V31, P840, DOI 10.1016/j.annonc.2020.03.306
   Spinelli A, 2020, BRIT J SURG, V107, P785, DOI 10.1002/bjs.11627
   Tuech JJ, 2020, J VISC SURG, V157, pS7, DOI 10.1016/j.jviscsurg.2020.03.008
   Ueda M, 2020, J NATL COMPR CANC NE, V18, P366, DOI 10.6004/jnccn.2020.7560
   Zangrillo A, 2020, CRIT CARE RESUSC
   Zheng MH, 2020, ANN SURG, V272, pE5, DOI 10.1097/SLA.0000000000003924
NR 10
TC 4
Z9 4
U1 0
U2 1
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 2038-131X
EI 2038-3312
J9 UPDATES SURG
JI Updates Surg.
PD JUN
PY 2020
VL 72
IS 2
BP 241
EP 247
DI 10.1007/s13304-020-00815-5
PG 7
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA MF1YM
UT WOS:000545145400005
PM 32472403
OA Green Published, Bronze, Green Submitted
DA 2022-04-20
ER

PT J
AU Vejacka, M
AF Vejacka, Martin
TI Efficiency of University Course during the Covid-19 Pandemic
SO TEM JOURNAL-TECHNOLOGY EDUCATION MANAGEMENT INFORMATICS
LA English
DT Article
DE Efficiency of education; University course; Covid-19 Pandemic;
   Electronic banking; Learning gain
ID MEASURING LEARNING GAIN; HIGHER-EDUCATION; PHYSICS; SECURITY
AB The education in this field of electronic banking has to adapt to rapid progress in technologies used for provision of banking services. The paper aims to shortly present the course of Electronic Services in Banking and to measure and compare the efficiency of education in the course before and during the Covid-19 pandemic. The efficiency of the educational process in the course was measured as learning gain by comparing pre-course and post-course tests' results using absolute gain, relative gain, and class average normalized gain during a period of five years. The education in the course was evaluated as effective in all observed cases. The additional surveys were conducted before and after the course completion detecting positive shifts in students' knowledge and their adoption of electronic services in banking.
C1 [Vejacka, Martin] Tech Univ Kosice, Fac Econ, Nemcovej 32, Kosice, Slovakia.
RP Vejacka, M (corresponding author), Tech Univ Kosice, Fac Econ, Nemcovej 32, Kosice, Slovakia.
EM martin.vejacka@tuke.sk
FU national project "Decision Support Systems and Business Intelligence
   within Network Economy" - Grant Agency for Science [1/0201/19]; Ministry
   of Education, Science, Research and Sport of the Slovak Republic
FX This research was supported by the national project "Decision Support
   Systems and Business Intelligence within Network Economy" (Contract No.
   1/0201/19) funded by Grant Agency for Science; Ministry of Education,
   Science, Research and Sport of the Slovak Republic.
CR Alsajjan B, 2010, J BUS RES, V63, P957, DOI 10.1016/j.jbusres.2008.12.014
   Anderson R.E., 2019, MULTIVARIATE DATA AN
   Bowman NA, 2010, AM EDUC RES J, V47, P466, DOI 10.3102/0002831209353595
   Bucko J, 2015, CENTRAL EUROPEAN CONFERENCE IN FINANCE AND ECONOMICS (CEFE2015), P91
   Bucko J, 2017, J THEOR APPL EL COMM, V12, P42, DOI 10.4067/S0718-18762017000100004
   BV S.E, 2013, ELECT BANKING ULTIMA
   Colt HG, 2011, SURG ENDOSC, V25, P207, DOI 10.1007/s00464-010-1161-4
   Cunha JM, 2014, ECON EDUC REV, V42, P64, DOI 10.1016/j.econedurev.2014.06.001
   EJBCA, EJBCA COMM OP SOURC
   Epstein J, 2009, JOINT MATH M 115 ANN
   European Commission, 2021, DIG SINGL MARK COUNT
   Evans C, 2018, HIGH EDUC PEDAGOG, V3, P1, DOI 10.1080/23752696.2018.1508360
   Geetha K. T., 2011, J MANAGEMENT SCI, V2, P1
   Hake R, 2002, CONSERV ECOL, V5
   Hake R. R, 2007, SHOULD WE MEASURE CH
   Hake RR, 1998, AM J PHYS, V66, P64, DOI 10.1119/1.18809
   Joshi V.C., 2020, DIGITAL FINANCE BITS
   McGrath C., 2015, LEARNING GAIN HIGHER, P7, DOI [10.7249/RR996, DOI 10.7249/RR996]
   Meltzer DE, 2002, AM J PHYS, V70, P1259, DOI 10.1119/1.1514215
   Moodle.org, 2021, MOODL
   Pal'ova D, 2016, 2016 39TH INTERNATIONAL CONVENTION ON INFORMATION AND COMMUNICATION TECHNOLOGY, ELECTRONICS AND MICROELECTRONICS (MIPRO), P901, DOI 10.1109/MIPRO.2016.7522268
   Polkinghorne M, 2017, J MARK HIGH EDUC, V27, P213, DOI 10.1080/08841241.2017.1380741
   Prather EE, 2009, PHYS TODAY, V62, P41, DOI 10.1063/1.3248478
   Prather EE, 2009, AM J PHYS, V77, P320, DOI 10.1119/1.3065023
   do Valle AGRM, 2014, INT J PRODUCT PERFOR, V63, P4, DOI 10.1108/IJPPM-08-2012-0085
   Scheerens J, 2016, CRITICAL REV KNOWLED, V389
   Schierz PG, 2010, ELECTRON COMMER R A, V9, P209, DOI 10.1016/j.elerap.2009.07.005
   Vejacka M, 2017, E M EKON MANAG, V20, P135, DOI 10.15240/tul/001/2017-4-010
   Vermunt JD, 2018, HIGH EDUC PEDAGOG, V3, P266, DOI 10.1080/23752696.2018.1484672
   Wieman C, 2005, PHYS TODAY, V58, P36, DOI 10.1063/1.2155756
   Willetts D, 2017, U ED, P469, DOI [10.1093/oso/9780198767268.001.0001, DOI 10.1093/OSO/9780198767268.001.0001]
NR 31
TC 0
Z9 0
U1 1
U2 1
PU ASSOC INFORMATION COMMUNICATION TECHNOLOGY EDUCATION & SCIENCE
PI NOVI PAZAR
PA HILMA ROZAJCA 15, NOVI PAZAR, 36300, SERBIA
SN 2217-8309
EI 2217-8333
J9 TEM J
JI TEM J.
PD NOV
PY 2021
VL 10
IS 4
BP 1588
EP 1596
DI 10.18421/TEM104-13
PG 9
WC Computer Science, Information Systems
WE Emerging Sources Citation Index (ESCI)
SC Computer Science
GA XT2HD
UT WOS:000733414200013
OA gold
DA 2022-04-20
ER

PT J
AU Long, B
   Brady, WJ
   Bridwell, RE
   Ramzy, M
   Montrief, T
   Singh, M
   Gottlieb, M
AF Long, Brit
   Brady, William J.
   Bridwell, Rachel E.
   Ramzy, Mark
   Montrief, Tim
   Singh, Manpreet
   Gottlieb, Michael
TI Electrocardiographic manifestations of COVID-19
SO AMERICAN JOURNAL OF EMERGENCY MEDICINE
LA English
DT Article
DE COVFD-19; SARS-CoV-2; Coronavirus; Cardiac; ECG; EKG; Electrocardiogram;
   Emergency medicine; Arrhythmia; Dysrhythmia
ID CLINICAL CHARACTERISTICS; MYOCARDITIS
AB Introduction: Coronavirus disease of 2019 (COVID-19) is a lower respiratory tract infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This disease can impact the cardiovascular system and lead to abnormal electrocardiographic (ECG) findings. Emergency clinicians must be aware of the ECG manifestations of COVID-19.
   Objective: This narrative review outlines the pathophysiology and electrocardiographic findings associated with COVID-19.
   Discussion: COVID-19 is a potentially critical illness associated with a variety of ECG abnormalities, with up to 90% of critically ill patients demonstrating at least one abnormality. The ECG abnormalities in COVID-19 may be due to cytokine storm, hypoxic injury, electrolyte abnormalities, plaque rupture, coronary spasm, microthrombi, or direct endothelial or myocardial injury. While sinus tachycardia is the most common abnormality, others include supraventricular tachycardias such as atrial fibrillation or flutter, ventricular arrhythmias such as ventricular tachycardia or fibrillation, various bradycardias, interval and axis changes, and ST segment and T wave changes. Several ECG presentations are associated with poor outcome, including atrial fibrillation, QT interval prolongation, ST segment and T wave changes, and ventricular tachycardia/fibrillation.
   Conclusions: This review summarizes the relevant ECG findings associated with COVID-19. Knowledge of these findings in COVID-19-related electrocardiographic presentations may assist emergency clinicians in the evaluation and management of potentially infected and infected patients. Published by Elsevier Inc.
C1 [Long, Brit] Brooke Army Med Ctr, Res, SAUSHEC, Emergency Med, Ft Sam Houston, TX 78234 USA.
   [Brady, William J.] Univ Virginia, Sch Med, Dept Emergency Med, Charlottesville, VA 22908 USA.
   [Bridwell, Rachel E.] Brooke Army Med Ctr, SAUSHEC, Emergency Med, Ft Sam Houston, TX 78234 USA.
   [Ramzy, Mark; Montrief, Tim] Univ Pittsburgh, Med Ctr, Dept Crit Care Med, Pittsburgh, PA USA.
   [Singh, Manpreet] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA.
   [Gottlieb, Michael] Rush Univ, Dept Emergency Med, Med Ctr, Chicago, IL 60612 USA.
RP Long, B (corresponding author), 3841 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.
EM Brit.long@yahoo.com; WB4Z@hscmail.mcc.virginia.edu
OI Gottlieb, Michael/0000-0003-3276-8375
CR Abrams MP, 2020, J CARDIOVASC ELECTR, V31, P3086, DOI 10.1111/jce.14772
   Ajibawo T, 2020, J MED CASES N AM
   AMARATUNGA EA, 2020, EUR HEART J, V12, DOI DOI 10.7759/CUREUS.8599
   Ammirati E, 2018, CIRCULATION, V138, P1088, DOI 10.1161/CIRCULATIONAHA.118.035319
   Asif Talal, 2020, Eur J Case Rep Intern Med, V7, P001701, DOI [10.12890/2020_001672, 10.12890/2020_001701]
   Avila J, 2021, AM J EMERG MED, V39, P213, DOI 10.1016/j.ajem.2020.09.065
   AZARKISH M, 2020, RESUSCITATION, V41, P2131
   Baldi E, 2020, EUR HEART J, V41, P3045, DOI 10.1093/eurheartj/ehaa508
   Baldi E, 2020, NEW ENGL J MED, V383, P496, DOI 10.1056/NEJMc2010418
   BANGALORE S, 2020, ANN NONINVAS ELECTRO, V382, P2478
   Bertini M, 2020, EUROPACE, V22, P1848, DOI 10.1093/europace/euaa258
   Bhatla A, 2020, HEART RHYTHM, V17, P1439, DOI 10.1016/j.hrthm.2020.06.016
   BRADLEY A, 2013, NEW ENGL J MED, V346, DOI DOI 10.1136/BMJ.F3719
   BRADY WJ, 2004, BMJ-BRIT MED J, V22, P865, DOI DOI 10.1016/J.EMC.2004.05.010
   Chang David, 2020, HeartRhythm Case Rep, V6, P237, DOI 10.1016/j.hrcr.2020.03.012
   Chen C, 2020, Zhonghua Xin Xue Guan Bing Za Zhi, V48, P567, DOI 10.3760/cma.j.cn112148-20200225-00123
   Chen L, 2020, ESC HEART FAIL, V7, P4408, DOI 10.1002/ehf2.12991
   Chorin E, 2020, NAT MED, V26, P808, DOI 10.1038/s41591-020-0888-2
   Cizgici AY, 2020, AM J EMERG MED, V38, DOI 10.1016/j.ajem.2020.04.080
   Dabbagh Mohammed F, 2020, JACC Case Rep, V2, P1326, DOI 10.1016/j.jaccas.2020.04.009
   Doyen D, 2020, LANCET, V395, P1516, DOI 10.1016/S0140-6736(20)30912-0
   Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031
   DU Y, 2020, NEW ENGL J MED, V201, P1372, DOI DOI 10.1164/RCCM.202003-0543OC
   Elias P, 2020, MAYO CLIN PROC, V95, P2099, DOI 10.1016/j.mayocp.2020.07.028
   Esler M, 2020, J HYPERTENS, V38, P781, DOI 10.1097/HJH.0000000000002450
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   FRIED JA, 2020, J INVEST MED HIGH IM, DOI DOI 10.1161/CIRCULATIONAHA.120.047164
   Giudicessi JR, 2020, MAYO CLIN PROC, V95, P1213, DOI 10.1016/j.mayocp.2020.03.024
   GOTTLIEB M, 2020, JAMA-J AM MED ASSOC, DOI DOI 10.1111/ACEM.14104
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Harbert JL, MEDRXIV2020202004062
   Haseeb S, 2020, J ELECTROCARDIOL, V62, P39, DOI 10.1016/j.jelectrocard.2020.08.007
   He J, 2020, CAN J CARDIOL, V36, DOI 10.1016/j.cjca.2020.03.028
   Hendren NS, 2020, CIRCULATION, V141, P1903, DOI 10.1161/CIRCULATIONAHA.120.047349
   Ho JSY, 2020, HEART LUNG, V49, P681, DOI 10.1016/j.hrtlng.2020.08.013
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Hu HD, 2021, EUR HEART J, V42, P206, DOI 10.1093/eurheartj/ehaa190
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hufnagel G, 2000, HERZ, V25, P279, DOI 10.1007/s000590050021
   Inciardi RM, 2020, JAMA CARDIOL, V5, P819, DOI 10.1001/jamacardio.2020.1096
   Jankelson L, 2020, HEART RHYTHM, V17, P1472, DOI 10.1016/j.hrthm.2020.05.008
   Kang Y, 2020, HEART, V106, P1132, DOI 10.1136/heartjnl-2020-317056
   Kho J, 2020, AM J EMERG MED, V38, P2142, DOI 10.1016/j.ajem.2020.07.054
   Kim IC, 2020, EUR HEART J, V41, P1859, DOI 10.1093/eurheartj/ehaa288
   LAI PH, 2020, EUR HEART J, V5, P1154
   Lei Shaoqing, 2020, EClinicalMedicine, V21, P100331, DOI 10.1016/j.eclinm.2020.100331
   Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A
   Li Y, 2020, ZHONG HUA XIN 55 SHI, P128, DOI DOI 10.3760/CMA.J.CN.113859-20200302-00044
   LI Y, 2020, JAMA CARDIOL, V20
   LIU PP, CIRC-ARRHYTHMIA ELEC, DOI DOI 10.1161/CIRCULATIONAHA.120.047549
   Long B, 2020, AM J EMERG MED, V38, P1504, DOI 10.1016/j.ajem.2020.04.048
   Lugenbiel P, 2020, EUR HEART J-CASE REP, V4, DOI 10.1093/ehjcr/ytaa230
   MEHRA MR, 2020, AM J RESP CRIT CARE, V382, pE102, DOI DOI 10.1056/NEJMOA2007621
   Mercuro Nicholas J, 2020, JAMA Cardiol, V5, P1036, DOI 10.1001/jamacardio.2020.1834
   MIDDELDORP S, 2020, HEART RHYTHM, DOI DOI 10.1111/JTH.14888
   NOUBIAP JJ, 2019, EMERG MED CLIN N AM, V124, P262, DOI DOI 10.1016/J.AMJCARD.2019.04.028
   PRABHU SD, 2004, FRONT MED-PRC, V95, P1140
   Ramireddy A, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.017144
   Ramzy M, 2020, AM J EMERG MED, V38, P2693, DOI 10.1016/j.ajem.2020.08.011
   Roden DM, 2020, CIRCULATION, V141, pE906, DOI 10.1161/CIRCULATIONAHA.120.047521
   Seecheran R, 2020, J INVEST MED HIGH IM, V8, DOI 10.1177/2324709620925571
   Shao F, 2020, RESUSCITATION, V151, P18, DOI 10.1016/j.resuscitation.2020.04.005
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Siripanthong B, 2020, HEART RHYTHM, V17, P1463, DOI 10.1016/j.hrthm.2020.05.001
   Sorgente A, 2020, JACC CASE REP, V2, P1250, DOI DOI 10.1016/J.JACCAS.2020.04.06
   Tian SF, 2020, MODERN PATHOL, V33, P1007, DOI 10.1038/s41379-020-0536-x
   Turagam MK, 2020, CIRC-ARRHYTHMIA ELEC, V13, DOI 10.1161/CIRCEP.120.008920
   ULLMAN E, 2001, J THROMB HAEMOST, V19, P514
   van den Broek MPH, 2020, NETH HEART J, V28, P406, DOI 10.1007/s12471-020-01429-7
   Vidovich Mladen I, 2020, JACC Case Rep, V2, P1245, DOI 10.1016/j.jaccas.2020.04.007
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   WANG EY, 2020, AM J CARDIOL, V13
   Wang L, 2020, Zhonghua Yan Ke Za Zhi, V56, pE009, DOI 10.3760/cma.j.cn112148-20200313-00202
   Wang YN, 2020, ANN NONINVAS ELECTRO, V25, DOI 10.1111/anec.12806
   World Health Organization, CORONAVIRUS DIS COVI
   Yao XH, 2020, ZHONGHUA BING LI XUE, V49, P411, DOI DOI 10.3760/CMA.J.CN112151-20200312-00193
   Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0
NR 80
TC 19
Z9 18
U1 2
U2 5
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0735-6757
EI 1532-8171
J9 AM J EMERG MED
JI Am. J. Emerg. Med.
PD MAR
PY 2021
VL 41
BP 96
EP 103
DI 10.1016/j.ajem.2020.12.060
EA JAN 2021
PG 8
WC Emergency Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Emergency Medicine
GA QM7LM
UT WOS:000621956700020
PM 33412365
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Khateri, S
   Mohammadi, H
   Khateri, R
   Moradi, Y
AF Khateri, Sorour
   Mohammadi, Hedyeh
   Khateri, Rozhin
   Moradi, Yousef
TI The Prevalence of Underlying Diseases and Comorbidities in COVID-19
   Patients; an Updated Systematic Review and Meta-analysis
SO ARCHIVES OF ACADEMIC EMERGENCY MEDICINE
LA English
DT Review
DE Comorbidity; Prognosis; COVID-19; Systematic Review; Meta-analysis
ID SARS
AB Introduction: Gaining knowledge about underlying diseases and associated comorbidities in patients with COVID-19 can be beneficial in developing a proper understanding of the disease prognosis as well as comprehensive management, and treatment of the disease. The aim of this study was to determine the prevalence of underlying diseases and associated comorbidities in COVID-19 patients using a systematic review and meta-analysis. Methods: Major biomedical electronic databases, including Scopus, PubMed, Web of Science, CINAHL and EMBASE were searched for all relevant literature published in English from January to July 2020. Cross-sectional and retrospective studies reporting the prevalence of comorbid conditions such as acute cardiac injury, acute myocardial infarction, acute kidney injury, acute liver injury, shock, acute respiratory disease, and acute respiratory distress syndrome in patients with COVID-19 were included in the study. After selecting eligible studies, two authors extracted data of each study, independently, and any inconsistency was resolved through discussion with the third reviewer until reaching a consensus. The risk of bias was assessed by two independent research experts using the Newcastle-Ottawa Scale (NOS). The variance in the meta-analyses on prevalence was stabilized by double arcsine transformations. Results: The pooled prevalence of acute respiratory injury in patients with COVID-19 was estimated as 34%(95% Cl: 10 - 57%). Also, the prevalence of acute kidney injury, acute liver injury, acute respiratory distress syndrome, and shock were estimated as 10% (95% Cl: 6 - 14%), 19% (95% Cl: 10 - 27%), 23 % (95% Cl: 19 - 27%), and 12 % (95% Cl: 5 - 19 %). Conclusion: According to this meta-analysis, comorbidities such as hypertension, acute liver and kidney injury, acute respiratory distress syndrome, shock, diabetes, and coronary heart disease seem to be a predisposing factor for symptomatic and severe COVID-19 infection.
C1 [Khateri, Sorour; Mohammadi, Hedyeh] Kurdistan Univ, Sch Med, Med Sci, Sanandaj, Iran.
   [Khateri, Rozhin] Kurdistan Univ, Fac Nursing & Midwifery, Med Sci, Sanandaj, Iran.
   [Moradi, Yousef] Kurdistan Univ, Res Inst Hlth Dev, Social Determinants Hlth Res Ctr, Med Sci, Sanandaj, Iran.
RP Khateri, R (corresponding author), Kurdistan Univ, Fac Nursing & Midwifery, Med Sci, Sanandaj, Iran.; Moradi, Y (corresponding author), Kurdistan Univ, Res Inst Hlth Dev, Social Determinants Hlth Res Ctr, Med Sci, Sanandaj, Iran.
EM khateriroj@gmail.com; yousefmoradi211@yahoo.com
RI Moradi, Yousef/AAV-5696-2021
OI Moradi, Yousef/0000-0002-2936-5930
CR Arabi YM, 2020, INTENS CARE MED, V46, P315, DOI 10.1007/s00134-020-05943-5
   Aruru M, 2021, RES SOC ADMIN PHARM, V17, P1967, DOI 10.1016/j.sapharm.2020.04.002
   Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]
   Brown JD, 2020, RES SOCIAL ADM PHARM
   Cai QX, 2020, ALLERGY, V75, P1742, DOI 10.1111/all.14309
   Chan K. S., 2003, Hong Kong Medical Journal, V9, P399
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   Emami A, 2020, ARCH ACAD EMERG MED, V8, DOI 10.22037/aaem.v8i1.600
   Emery SL, 2004, EMERG INFECT DIS, V10, P311, DOI 10.3201/eid1002.030759
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Gupta R, 2020, DIABETES METAB SYND, V14, P211, DOI 10.1016/j.dsx.2020.03.002
   Han H, 2020, J MED VIROL, V92, P819, DOI 10.1002/jmv.25809
   Han SW, 2020, CANCER MED-US, V9, P6667, DOI 10.1002/cam4.3289
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Leung JM, 2020, EUROPEAN RESP J
   Lian JS, 2020, CLIN INFECT DIS, V71, P740, DOI 10.1093/cid/ciaa242
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007]
   Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005
   Seys LJM, 2018, CLIN INFECT DIS, V66, P45, DOI 10.1093/cid/cix741
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Song ZW, 2021, RES SOC ADMIN PHARM, V17, P2027, DOI 10.1016/j.sapharm.2020.03.027
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Tang X, 2020, CHEST, V158, P195, DOI 10.1016/j.chest.2020.03.032
   Ung COL, 2020, RES SOCIAL ADM PHARM
   von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040296, 10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]
   von Elm E, 2007, PREV MED, V45, P247, DOI [10.1016/j.ypmed.2007.08.012, 10.1016/S0140-6736(07)61602-X]
   WANG D, 2020, JAMA-J AM MED ASSOC, DOI [DOI 10.1001/JAMA.2020.1585, 10.1001/jama.2020.1585]
   Wang HP, 2020, LANCET ONCOL, V21, pE181, DOI 10.1016/S1470-2045(20)30149-2
   Wells G, 2017, CLIN EPIDEMIOL, P1
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 37
TC 8
Z9 8
U1 0
U2 1
PU SHAHID BEHESHTI UNIV MEDICAL SCIENCES
PI TEHRAN
PA EMERGENCY MEDICINE DEPT, SHOHADAYE TAJRISH HOSP, SHAHRDARI ST, TAJRISH
   SQ, TEHRAN, 1989934148, IRAN
EI 2645-4904
J9 ARCH ACAD EMERG MED
JI Arch. Acad. Emerg. Med.
PY 2020
VL 8
IS 1
AR e72
PG 17
WC Emergency Medicine
WE Emerging Sources Citation Index (ESCI)
SC Emergency Medicine
GA NP3SX
UT WOS:000570099900001
PM 33134968
DA 2022-04-20
ER

PT J
AU Carrillo-de-la-Pena, MT
   Gonzalez-Villar, A
   Trinanes, Y
AF Carrillo-de-la-Pena, Maria T.
   Gonzalez-Villar, Alberto
   Trinanes, Yolanda
TI Effects of the COVID-19 pandemic on chronic pain in Spain: a scoping
   review
SO PAIN REPORTS
LA English
DT Review
DE COVID-19 pandemic; Chronic pain; Telehealth; Pain clinics
ID SPANISH SOCIETY; MANAGEMENT; HEADACHE; OUTBREAK; IMPACT
AB The COVID-19 outbreak has been a great challenge in the management of chronic pain patients. We have conducted a rapid scoping review to assess the impact of the pandemic (and the associated public health measures) on the health status and management practices of chronic pain patients in Spain. To this end, we performed a bibliographic search in LitCOVID and PubMed, and reviewed official websites and documents, and expert reports. The review showed that (1) the studies consistently indicate that the pandemic has had a very negative impact on the physical and psychological health of chronic pain patients; (2) there are scarce data on how the pandemic affected pain unit consultations and a lack of protocols to organize health care in the face of future waves of contagion, with little implementation of telehealth. We make proposals to improve management of chronic pain patients in pandemic situations, which should pivot around 3 axes: (1) a coordinated response of all the relevant stakeholders to define a future roadmap and research priorities, (2) a biopsychosocial approach in pain management, and (3) development and implementation of novel telemedicine solutions.
C1 [Carrillo-de-la-Pena, Maria T.; Trinanes, Yolanda] Univ Santiago de Compostela, Fac Psychol, Dept Clin Psychol & Psychobiol, Brain & Pain BaP Lab, Santiago De Compostela, Spain.
   [Gonzalez-Villar, Alberto] Univ Minho, Sch Psychol, Psychol Res Ctr, Psychol Neurosci Lab, Braga, Portugal.
   [Trinanes, Yolanda] Galician Hlth Knowledge Agcy ACIS, Santiago De Compostela, Spain.
RP Carrillo-de-la-Pena, MT (corresponding author), Univ Santiago de Compostela, Fac Psychol, Brain & Pain BaP Lab, Santiago 15782, Spain.
EM mteresa.carrillo@usc.es; albertojac.gonzalez@gmail.com
RI Carrillo de la Pena, Maria Teresa/C-4460-2013
OI Carrillo de la Pena, Maria Teresa/0000-0001-6940-2460; Gonzalez-Villar,
   Alberto J./0000-0003-0009-920X; Arendt-Nielsen, Lars/0000-0003-0892-1579
FU Spanish Ministry of Science and InnovationSpanish Government
   [PID2019-107986RB-100]
FX Funding: this study was funded by the Spanish Ministry of Science and
   Innovation (reference PID2019-107986RB-100).
CR Abejon D, 2020, PAIN PRACT, V20, P820, DOI 10.1111/papr.12951
   Montero AA, 2020, MED FAM-SEMERGEN, V46, P365, DOI 10.1016/j.semerg.2020.08.002
   Anderson Stuart, 2008, Health Res Policy Syst, V6, P7, DOI 10.1186/1478-4505-6-7
   Asensio-Samper JM, 2021, REV ESP ANEST REANIM, V68, P495, DOI [10.1016/j.redare.2020.08.013, 10.1016/j.redar.2020.08.005]
   Barrios Vivencio, 2020, Rev Esp Cardiol (Engl Ed), V73, P910, DOI 10.1016/j.rec.2020.06.032
   Brocalero-Camacho A, 2020, BRAIN STIMUL, V13, P1089, DOI 10.1016/j.brs.2020.05.003
   Chaler J, 2020, EUR J PHYS REHAB MED, V56, P369, DOI 10.23736/S1973-9087.20.06304-2
   Cohen SP, 2020, PAIN MED, V21, P1331, DOI 10.1093/pm/pnaa127
   Coma E, 2020, BMC FAM PRACT, V21, DOI 10.1186/s12875-020-01278-8
   Cortiula F, 2020, ANN ONCOL, V31, P553, DOI 10.1016/j.annonc.2020.03.286
   de G., 2020, REV SOC ESP DOLOR, V27, P192
   Deer TR, 2020, ANESTH ANALG, V131, P387, DOI 10.1213/ANE.0000000000005000
   Dejaco C, 2021, ANN RHEUM DIS, V80, P518, DOI 10.1136/annrheumdis-2020-218697
   Eccleston C, 2020, PAIN, V161, P889, DOI 10.1097/j.pain.0000000000001885
   Failde Martuinez I, 2019, REV SOC ESP DOLOR, V26, P259
   Lopez-Bravo A, 2020, NEUROLOGIA, V35, P372, DOI 10.1016/j.nrl.2020.05.006
   Lopez-Medina C, 2021, JOINT BONE SPINE, V88, DOI 10.1016/j.jbspin.2020.105085
   Lopez-Medina C, 2021, ANN RHEUM DIS, V80, DOI 10.1136/annrheumdis-2020-218008
   Micó Segura J A, 2020, Rev. Soc. Esp. Dolor, V27, P72, DOI 10.20986/resed.2020.3808/2020
   Ministerio de Sanidad, 2020, ACT 272 ENF COR COVI, V2020
   Ministerio de Sanidad, 2020, ACT 143 ENF COR COVI, V2020
   Ministerio de Sanidad Instituto de Salud Carlos III, EST NAC SER EP INF S
   Ministerio de Sanidad Instituto de Salud Carlos III, 2020, EST ENE COVID19 CUAR
   Morollon N, 2020, NEUROLOGIA, V35, P628, DOI 10.1016/j.nrl.2020.07.007
   Munn Z, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-017-0468-4
   Nieto R, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113558
   Observatorio 4D, 2020, WOM PAIN DIS DISCR
   Observatorio del dolor, 2020, EF CONF TRAB UN CAD
   Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4
   Serrano-Ibanez ER, 2021, BRIT J HEALTH PSYCH, V26, P544, DOI 10.1111/bjhp.12483
   Shah S, 2020, PAIN PHYSICIAN, V23, pS161
   Sociedad Espauola de Reumatologuia, 2020, DOC POS SOC ESP REUM
   Sociedad Espauola del Dolor, 2020, RES ENC PAC DOL CRON
   Vidal-Alaball J, 2020, ATEN PRIM, V52, P418, DOI 10.1016/j.aprim.2020.04.003
NR 34
TC 5
Z9 5
U1 4
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
EI 2471-2531
J9 PAIN REP
JI Pain Rep.
PY 2021
VL 6
IS 1
AR e899
DI 10.1097/PR9.0000000000000899
PG 6
WC Neurosciences
WE Emerging Sources Citation Index (ESCI)
SC Neurosciences & Neurology
GA WN7WT
UT WOS:000711978800005
PM 33615089
OA gold
DA 2022-04-20
ER

PT J
AU Chebli, JMF
   Queiroz, NSF
   Damiao, AOMC
   Chebli, LA
   Costa, MHD
   Parra, RS
AF Chebli, Julio Maria Fonseca
   Queiroz, Natalia Sousa Freitas
   Damiao, Aderson Omar Mourao Cintra
   Chebli, Liliana Andrade
   Costa, Marcia Henriques de Magalhaes
   Parra, Rogerio Serafim
TI How to manage inflammatory bowel disease during the COVID-19 pandemic: A
   guide for the practicing clinician
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Review
DE Inflammatory bowel disease; SARS-CoV-2; COVID-19; Crohn disease; Colitis
   ulcerative; Biological therapy
ID EVIDENCE-BASED CONSENSUS; DIAGNOSIS; CARE; IBD; VACCINATION; CHILDREN;
   SURGERY; WORLD; NEED
AB Managing inflammatory bowel disease (IBD) during the coronavirus disease 2019 (COVID-19) pandemic has been a challenge faced by clinicians and their patients, especially concerning whether to proceed with biologics and immunosuppressive agents in the background of a global outbreak of a highly contagious new coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2). The knowledge about the impact of this virus on patients with IBD, although it is still scarce, is rapidly evolving. In particular, concerns surrounding medications' impact for IBD on the risk of acquiring SARS-CoV-2 infection or developing COVID-19, and potentially exacerbate viral replication and the COVID-19 course, are a current thinking of both practicing clinicians and providers caring for patients with IBD. Managing patients with IBD infected with SARS-CoV-2 depends on both the clinical activity of the IBD and the occasional development and severity of COVID-19. In this review, we summarize the current data regarding gastrointestinal involvement by SARS-CoV-2 and pharmacologic and surgical management for IBD concerning this infection, and the COVID-19 impact on both the patient's psychological functioning and endoscopy services, and we concisely summarize the telemedicine roles during the COVID-19 pandemic.
C1 [Chebli, Julio Maria Fonseca; Chebli, Liliana Andrade] Univ Fed Juiz de Fora, Div Gastroenterol, Dept Med, Ctr Inflammatory Bowel Dis, BR-36036900 Juiz De Fora, MG, Brazil.
   [Queiroz, Natalia Sousa Freitas; Damiao, Aderson Omar Mourao Cintra] Univ Sao Paulo, Dept Gastroenterol, Sch Med, BR-05403000 Sao Paulo, SP, Brazil.
   [Costa, Marcia Henriques de Magalhaes] Fluminense Fed Univ, Dept Clin Med, BR-24210200 Rio De Janeiro, RJ, Brazil.
   [Parra, Rogerio Serafim] Univ Sao Paulo, Dept Surg & Anat, Ribeirao Preto Med Sch, Ave Bandeirantes 3900, BR-14048900 Ribeirao Preto, SP, Brazil.
RP Parra, RS (corresponding author), Univ Sao Paulo, Dept Surg & Anat, Ribeirao Preto Med Sch, Ave Bandeirantes 3900, BR-14048900 Ribeirao Preto, SP, Brazil.
EM rsparra@hcrp.usp.br
RI Parra, Rogerio Serafim/AAD-4678-2019
OI Parra, Rogerio Serafim/0000-0002-5566-9284; FREITAS QUEIROZ, NATALIA
   SOUSA/0000-0003-2857-0825
CR Aguila EJT, 2020, JGH OPEN, V4, P324, DOI 10.1002/jgh3.12358
   Al-Ani AH, 2020, ALIMENT PHARM THER, V52, P54, DOI 10.1111/apt.15779
   Allez M, 2020, J CROHNS COLITIS, V14, pS774, DOI 10.1093/ecco-jcc/jjaa150
   Allocca M, 2020, CLIN GASTROENTEROL H, V18, P1882, DOI 10.1016/j.cgh.2020.04.028
   Allocca M, 2020, CLIN GASTROENTEROL H, V18, P2134, DOI 10.1016/j.cgh.2020.04.071
   Aziz M, 2020, INFLAMM BOWEL DIS, V26, pE132, DOI 10.1093/ibd/izaa170
   Bellato V, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.020507
   Bernstein CN, 2010, INFLAMM BOWEL DIS, V16, P112, DOI 10.1002/ibd.21048
   Bezzio C, 2021, GUT, V70, P623, DOI 10.1136/gutjnl-2020-321760
   Bhimraj Adarsh, 2020, Clin Infect Dis, DOI 10.1093/cid/ciaa478
   Brazilian SocietyofDigestiveEndoscopy, BRAZILIAN SOC DIGEST
   Brenner EJ, 2020, GASTROENTEROLOGY, V159, P481, DOI 10.1053/j.gastro.2020.05.032
   British ThoracicSociety, BRIT THORACIC SOC
   Caldera F, 2020, INFLAMM BOWEL DIS, V26, P593, DOI 10.1093/ibd/izz164
   Cha MH, 2020, WORLD J GASTROENTERO, V26, P2323, DOI 10.3748/wjg.v26.i19.2323
   Chetan MR, 2020, CLIN RADIOL, V75, P599, DOI 10.1016/j.crad.2020.06.006
   Chiu PWY, 2020, GUT, V69, P991, DOI 10.1136/gutjnl-2020-321185
   Coccolini F, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00307-2
   Cullen G, 2012, GUT, V61, P385, DOI 10.1136/gutjnl-2011-300256
   D'Amico F, 2020, LANCET GASTROENTEROL, V5, P631, DOI 10.1016/S2468-1253(20)30151-5
   Danese S, 2020, NAT REV GASTRO HEPAT, V17, P253, DOI 10.1038/s41575-020-0294-8
   de Leeuw RA, 2020, JMIR PUBLIC HLTH SUR, V6, DOI 10.2196/18928
   De Simone B, 2020, ANN ROY COLL SURG, V102, P323, DOI 10.1308/rcsann.2020.0097
   Din S, 2020, GUT, V69, P1769, DOI 10.1136/gutjnl-2020-321927
   Dolinger MT, 2020, J PEDIATR GASTR NUTR, V71, P153, DOI 10.1097/MPG.0000000000002809
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Doornekamp L, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030455
   Effenberger M, 2020, GUT, V69, P1543, DOI 10.1136/gutjnl-2020-321388
   ElOuali S., 2020, CLEVE CLIN J MED
   European Society of Gastrointestinal Endoscopy and European Society of GastroenterologyandEndoscopyNursesandAssociates, 2020, ESGE ESGENA
   Feitosa MR, 2021, ANN GASTROENTEROL, V34, P39, DOI 10.20524/aog.2020.0558
   Fiorino G, 2020, J CROHNS COLITIS, V14, P1330, DOI 10.1093/ecco-jcc/jjaa058
   Fiorino G, 2020, J CROHNS COLITIS, V14, P1037, DOI 10.1093/ecco-jcc/jjaa023
   Flemming S, 2020, LANGENBECK ARCH SURG, V405, P359, DOI 10.1007/s00423-020-01888-x
   Queiroz NSF, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e1909
   Furfaro F, 2020, NAT REV GASTRO HEPAT, V17, P507, DOI 10.1038/s41575-020-0319-3
   Gao QY, 2020, J DIGEST DIS, V21, P125, DOI 10.1111/1751-2980.12851
   Gomollon F, 2017, J CROHNS COLITIS, V11, P3, DOI 10.1093/ecco-jcc/jjw168
   Grossberg LB, 2021, INFLAMM BOWEL DIS, V27, P940, DOI 10.1093/ibd/izaa174
   Gupta S, 2020, GASTROINTEST ENDOSC, V92, P735, DOI 10.1016/j.gie.2020.04.050
   Gutin LS, 2020, DIGEST DIS SCI, V65, P1571, DOI 10.1007/s10620-020-06299-y
   Harbord M, 2017, J CROHNS COLITIS, V11, P769, DOI 10.1093/ecco-jcc/jjx009
   Hashash JG, 2021, INFLAMM BOWEL DIS, V27, P291, DOI 10.1093/ibd/izaa173
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Iacucci M, 2020, LANCET GASTROENTEROL, V5, P598, DOI 10.1016/S2468-1253(20)30119-9
   International Organization for the Study of Inflammatory Bowel Diseases IOIBD Update on COVID19 for Patients with Crohn's Disease and Ulcerative Colitis, INT ORG STUDY INFLAM
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Kaur M, 2020, CLIN GASTROENTEROL H, V18, P1346, DOI 10.1016/j.cgh.2019.12.040
   Kennedy NA, 2020, GUT, V69, P984, DOI 10.1136/gutjnl-2020-321244
   Kirchgesner J, 2018, GASTROENTEROLOGY, V155, P337, DOI 10.1053/j.gastro.2018.04.012
   Kornbluth A, 2020, INFLAMM BOWEL DIS, V26, P1779, DOI 10.1093/ibd/izaa212
   Lichtenstein GR, 2020, AM J GASTROENTEROL, V115, P1566, DOI 10.14309/ajg.0000000000000817
   Lu Y, 2009, AM J GASTROENTEROL, V104, P444, DOI 10.1038/ajg.2008.120
   Ma C, 2019, ALIMENT PHARM THER, V50, P5, DOI 10.1111/apt.15297
   Magro F, 2020, J CROHNS COLITIS, V14, pS798, DOI 10.1093/ecco-jcc/jjaa160
   Magro F, 2017, J CROHNS COLITIS, V11, P649, DOI 10.1093/ecco-jcc/jjx008
   Manes G, 2020, DIGEST LIVER DIS, V52, P823, DOI 10.1016/j.dld.2020.05.042
   Mao R, 2020, LANCET GASTROENTEROL, V5, P426, DOI 10.1016/S2468-1253(20)30076-5
   Arranz EM, 2020, INFLAMM BOWEL DIS, V26, P1149, DOI 10.1093/ibd/izaa142
   Mellor G, 2013, WORKPLACE HEALTH SAF, V61, P265, DOI 10.3928/21650799-20130516-12
   Melmed GY, 2010, AM J GASTROENTEROL, V105, P148, DOI 10.1038/ajg.2009.523
   Moletta L, 2020, INT J SURG, V79, P180, DOI 10.1016/j.ijsu.2020.05.061
   Neumann H, 2020, DIGEST ENDOSC, V32, P658, DOI 10.1111/den.13712
   Neumann Philipp-Alexander, 2016, World J Gastrointest Pharmacol Ther, V7, P217, DOI 10.4292/wjgpt.v7.i2.217
   Ng SC, 2020, J CROHNS COLITIS, V14, pS791, DOI 10.1093/ecco-jcc/jjaa128
   Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0
   Norsa L, 2020, GASTROENTEROLOGY, V159, P371, DOI [10.1053/j.gastro.2020.03.062, 10.1053/j.gastro.2020.03.06]
   Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227
   Papa A, 2020, THER ADV GASTROENTER, V13, DOI 10.1177/1756284820968747
   Perisetti A, 2020, DIGEST ENDOSC, V32, P715, DOI 10.1111/den.13693
   Rubin DT, 2020, GASTROENTEROLOGY, V159, P350, DOI 10.1053/j.gastro.2020.04.012
   Rubin DT, 2020, GASTROENTEROLOGY, V159, P6, DOI 10.1053/j.gastro.2020.04.002
   Scaldaferri F, 2020, UNITED EUR GASTROENT, V8, P775, DOI 10.1177/2050640620929133
   Sebastian S, 2020, J CROHNS COLITIS, V14, P1632, DOI 10.1093/ecco-jcc/jjaa120
   Seifarth C, 2015, VISZERALMEDIZIN, V31, P273, DOI 10.1159/000438955
   Siegel CA, 2021, GUT, V70, P635, DOI 10.1136/gutjnl-2020-324000
   Siegel CA, 2020, J CROHNS COLITIS, V14, pS769, DOI 10.1093/ecco-jcc/jjaa135
   Sinonquel P, 2020, DIGEST ENDOSC, V32, P723, DOI 10.1111/den.13706
   Soreide K, 2020, BRIT J SURG, V107, P1250, DOI 10.1002/bjs.11670
   Spanish Working Group on Crohn's Disease and Ulcerative Colitis Comunicado de GETECCU-GETEII-ACCU en relacion a la vacunacion frente a SARS-CoV-2 en pacientes con Enfermedad Inflamatoria Intestinal (EII), GRUPO ESPA OL TRABAJ
   Sultan S, 2020, GASTROENTEROLOGY, V159, P739, DOI 10.1053/j.gastro.2020.03.072
   Taxonera C, 2020, ALIMENT PHARM THER, V52, P276, DOI 10.1111/apt.15804
   Taylor S, 2020, J ANXIETY DISORD, V72, DOI 10.1016/j.janxdis.2020.102231
   Teixeira SC, 2020, BRAZ J INFECT DIS, V24, P368, DOI 10.1016/j.bjid.2020.06.003
   Toh JWT, 2016, WORLD J GASTROENTERO, V22, P8892, DOI 10.3748/wjg.v22.i40.8892
   Toscano G, 2020, NEW ENGL J MED, V382, P2574, DOI 10.1056/NEJMc2009191
   Ungaro RC, 2020, CLIN GASTROENTEROL H, V18, P1409, DOI 10.1016/j.cgh.2020.03.020
   Ungaro RC, 2021, GUT, V70, P725, DOI 10.1136/gutjnl-2020-322539
   Vergallo GM, 2019, EUR REV MED PHARMACO, V23, P10178, DOI 10.26355/eurrev_201912_19650
   Vigneswaran Y, 2020, J GASTROINTEST SURG, V24, P1686, DOI 10.1007/s11605-020-04592-9
   Wei SC, 2018, INTEST RES, V16, P546, DOI 10.5217/ir.2018.00052
   Wisniewski A, 2020, UNITED EUR GASTROENT, V8, P303, DOI 10.1177/2050640619889763
   World Health Organization Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages, 2020, WORLD HLTH ORG
   Xiao F, 2020, GASTROENTEROLOGY, V158, P1831, DOI 10.1053/j.gastro.2020.02.055
   Yamamoto T, 2020, EXPERT OPIN BIOL TH, V20, P391, DOI 10.1080/14712598.2020.1718098
   Yang WJ, 2020, J INFECTION, V80, P388, DOI 10.1016/j.jinf.2020.02.016
NR 96
TC 7
Z9 7
U1 1
U2 2
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD MAR 21
PY 2021
VL 27
IS 11
BP 1022
EP 1042
DI 10.3748/wjg.v27.i11.1022
PG 21
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA RG0XG
UT WOS:000635258600003
PM 33776370
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Hajek, A
   De Bock, F
   Huebl, L
   Kretzler, B
   Konig, HH
AF Hajek, Andre
   De Bock, Freia
   Huebl, Lena
   Kretzler, Benedikt
   Koenig, Hans-Helmut
TI Determinants of Postponed Cancer Screening During the COVID-19 Pandemic:
   Evidence from the Nationally Representative COVID-19 Snapshot Monitoring
   in Germany (COSMO)
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE cancer screening; corona-virus; COVID-19; delayed screening; postponed
   screening; SARS-CoV-2; access to health care; availability of medical
   care; health care use; health care utilization; health services
   research; postponed treatment
ID ANXIETY; ADULTS
AB Purpose: The COVID-19 pandemic is accompanied by various challenges for individual health and the health care system. However, preventive examinations such as cancer screenings should not be postponed during a pandemic. Because nationally representative studies describing postponed cancer screenings and identifying its determinants in Germany are lacking, our aim was to close this gap in knowledge. Materials and Methods: We used cross-sectional data from the nationally representative online-survey "COVID-19 Snapshot Monitoring in Germany (COSMO)" (wave 17), which was conducted in July 2020. The analytical sample included 974 individuals (mean age was 45.9 years, SD: 16.5 years; 18 to 74 years). The outcome measure was whether cancer screening had been postponed since March 2020 due to the COVID-19 pandemic (no, attended as planned; yes, postponed). Results: In total, slightly more than 10% of individuals stated to have postponed cancer screenings between March and July 2020 due to the COVID-19 pandemic, particularly women and individuals aged 30 to 49 years. The likelihood of postponed cancer screening was positively associated with higher affect regarding COVID-19 (OR: 1.65, 95% CI: 1.16-2.35), whereas it was negatively associated with younger age (eg, 18 to 29 years, OR: 0.17, 95% CI: 0.05-0.64, compared to individuals 30 to 49 years). Conclusion: Study findings showed that one out of ten individuals postponed cancer screenings during the COVID-19 pandemic. We determined two correlates of them (age and affect regarding COVID-19). Individuals with an increased likelihood of postponed cancer screenings should be specifically addressed.
C1 [Hajek, Andre; Kretzler, Benedikt; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Hlth Econ, Dept Hlth Econ & Hlth Serv Res, Martinistr 52, D-20246 Hamburg, Germany.
   [De Bock, Freia] Fed Ctr Hlth Educ, Cologne, Germany.
   [Huebl, Lena] Univ Med Ctr Hamburg Eppendorf, Bernhard Nocht Inst Trop Med, Dept Trop Med, Hamburg, Germany.
   [Huebl, Lena] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany.
RP Hajek, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Hlth Econ, Dept Hlth Econ & Hlth Serv Res, Martinistr 52, D-20246 Hamburg, Germany.
EM a.hajek@uke.de
OI Hajek, Andre/0000-0002-6886-2745; Huebl, Lena/0000-0002-2822-7202
FU DFGGerman Research Foundation (DFG)European Commission [3970/11-1];
   University of Erfurt; BZgA; RKI; ZPID
FX DFG 3970/11-1; further funding via BZgA, RKI, ZPID, University of Erfurt
   (no funding numbers). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Amit M, 2020, EUR J CANCER, V134, P86, DOI 10.1016/j.ejca.2020.04.016
   Bertz J, 2010, VERBREITUNG KREBSERK
   Betsch C, 2020, LANCET, V395, P1255, DOI 10.1016/S0140-6736(20)30729-7
   Bongaerts THG, 2020, J MED SCREEN, V27, P121, DOI 10.1177/0969141319887996
   Bundesministerium fur Gesundheit, 2019, KREBSFR KREBSFR
   Consedine NS, 2004, CANCER EPIDEM BIOMAR, V13, P501
   Gemeinsamer Bundesausschuss, 2020, RICHTL GEM BUND FRUH
   Gorin SS, 2005, PREV MED, V40, P515, DOI 10.1016/j.ypmed.2004.09.031
   Hajek A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249351
   Hajek A, 2017, CANCER MED-US, V6, P3025, DOI 10.1002/cam4.1226
   Hsia J, 2000, PREV MED, V31, P261, DOI 10.1006/pmed.2000.0697
   Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010
   Kregting LM, BRIT J CANCER, V124, P1, DOI [10.1038/s41416-020-01171-2, DOI 10.1038/S41416-020-01171-2]
   Mahase E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2242
   Munnich R, 2012, STICHPROBENOPTIMIERU, V21
   Osterloh F, 2020, DTSCH ARZTEBL, V117
   Robert-Koch-Institut, 2012, KREBS DEUTSCHLAND 20, V8th
   Spuling SM, 2016, ALTERN WANDEL ZWEI J, P141
   Starker A, 2013, BUNDESGESUNDHEITSBLA, V56, P858, DOI 10.1007/s00103-012-1655-4
   Svihrova V, 2020, BARRIERS CERVICAL CA
   Vanni G, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00938
   Vrdoljak E, 2020, EUR J CANCER, V132, P98, DOI 10.1016/j.ejca.2020.04.001
   WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346
   Wilson J, 1968, PRINCIPLES PRACTICES
NR 24
TC 2
Z9 2
U1 0
U2 0
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 3003
EP 3011
DI 10.2147/RMHP.S297326
PG 9
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA TK8SU
UT WOS:000674423900001
PM 34285614
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Codreanu, TA
   Armstrong, PK
AF Codreanu, Tudor A.
   Armstrong, Paul K.
TI Delusions of Certainty: Commercial Vessel COVID-19 Risk Stratification
SO PREHOSPITAL AND DISASTER MEDICINE
LA English
DT Article
DE COVID-19; disease outbreaks; risk; Severe Acute Respiratory Syndrome
   Coronavirus-2; ships
ID CRUISE SHIPS; INFLUENZA-A; PASSENGER SHIPS; H1N1 2009; NOROVIRUS;
   OUTBREAKS; DISEASES; ABOARD
AB Since the World Health Organization's (WHO's) pandemic declaration on March 11, 2020, coronavirus disease 2019 (COVID-19) outbreaks have occurred on numerous maritime vessels and the containment measures, travel restrictions, and border closures continue to make it increasingly difficult for ship operators world-wide to be granted pratique, conduct trade, and conduct crew changes. Knowledge of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) circulating on-board a ship prior to its arrival has significant implications for the protection of shore-based maritime workers (ie, pilots, stevedores, and surveyors), the broader community, and trade. A useful approach is a graded assessment of the public health risk. The Western Australia (WA) experience and associated observed pitfalls in implementing the prediction equation for the potential presence of SARS-CoV-2 on-board based on five COVID-19 outbreaks on commercial and cruise vessels during 2020 is described. Despite best efforts, the qualitative and quantitative predictors of SARS-CoV-2 circulating on-board commercial vessels are failing to deliver the required certainty, and to date, the only accepted method of ascertaining the presence of SARS-CoV-2 remains the real-time reverse transcription polymerase chain reaction (rRT-PCR) testing reported by an accredited laboratory. Based on legal or regulatory requirements, germane processes, underpinned by robust and auditable processes and procedures, must be put in place to inform the risk assessment of SARS-CoV-2 circulating on-board vessels.
C1 [Codreanu, Tudor A.] Dept Hlth Govt Western Australia, State Hlth Incident Coordinat Ctr, Perth, WA, Australia.
   [Codreanu, Tudor A.] Dept Hlth Govt Western Australia, Disaster Preparedness & Management Unit, Perth, WA, Australia.
   [Armstrong, Paul K.] Dept Hlth Govt Western Australia, Publ Hlth Emergency Operat Ctr, Perth, WA, Australia.
RP Codreanu, TA (corresponding author), State Hlth Incident Coordinat Ctr, 189 Royal St, East Perth, WA 6000, Australia.
EM Tudor.Codreanu@health.wa.gov.au
OI Codreanu, Tudor/0000-0002-4206-2627
CR Adam JK, 2015, TRAVEL MED INFECT DI, V13, P102, DOI 10.1016/j.tmaid.2014.12.002
   Australian Government Department of Agriculture Water and Environment, 2020, MAR ARR REP SYST MAR MAR ARR REP SYST MAR
   Australian Government Department of Agriculture Water and Environment, 2020, 46 2020 CHANG HUM HL 46 2020 CHANG HUM HL
   Australian Government Department of Health, 2020, TRAV ILLN CHECKL AIR TRAV ILLN CHECKL AIR
   Australian Government Department of Health, 2020, WHAT YOU NEED KNOW C
   Bert F, 2014, FOOD ENVIRON VIROL, V6, P67, DOI 10.1007/s12560-014-9145-5
   Birch L., 2020, ABC NEWS
   Brotherton JML, 2003, EPIDEMIOL INFECT, V130, P263, DOI 10.1017/S0950268802008166
   Carling PC, 2009, CLIN INFECT DIS, V49, P1312, DOI 10.1086/606058
   Cartwright D., 2020, CRUISE LINES INSIST
   Chimonas MAR, 2008, J TRAVEL MED, V15, P177, DOI 10.1111/j.1708-8305.2008.00200.x
   Chung WB, 2010, SENSORS-BASEL, V10, P3073, DOI 10.3390/s100403073
   Communicable Diseases Network Australia, 2020, COR DIS 2019 COVID 1
   Deerwester J., 2020, USA TODAY
   Dujarric S., 2020, STATEMENT ATTRIBUTAB
   Escape Writers, 2020, ESCAPE WRITERS ESCAPE WRITERS
   European Commission, 2020, GUIDELINES PROTECTIO
   Gonzaga VE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020822
   Government of Western Australia, 2005, EMERGENCY MANAGEMENT
   Government of Western Australia Department of Health, 2020, PROT MAN RISK HUM LI PROT MAN RISK HUM LI
   *INT LAB ORG, 2019, MAR LAB CONV 2006
   International Maritime Health Association, 2020, TEST SEAF COVID 19 TEST SEAF COVID 19
   International Maritime Organization, 1995, STAND TRAIN CERT WAT STAND TRAIN CERT WAT
   International Maritime Organization, 2020, COR COVID 19 ICS GUI COR COVID 19 ICS GUI
   International Maritime Organization, 1979, INT CONV MAR SEARCH INT CONV MAR SEARCH
   International Maritime Organization, 1974, INT CONV SAF LIF SEA
   International Maritime Organization, 2020, ALL CREW CHANG RES H ALL CREW CHANG RES H
   International Maritime Organization, 2020, 400000 SEAF STUCK SE 400000 SEAF STUCK SE
   Isakbaeva ET, 2005, EMERG INFECT DIS, V11, P154, DOI 10.3201/eid1101.040434
   Kak V, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.IOL5-0007-2015
   Khaokham CB, 2013, INFLUENZA OTHER RESP, V7, P791, DOI 10.1111/irv.12100
   Lanini S., 2014, Eurosurveillance, V19, P20735, DOI 10.2807/1560-7917.ES2014.19.10.20735
   Luen P., 2020, WHY ITS CRITICAL SHI WHY ITS CRITICAL SHI
   Marshall CA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2991-3
   McCarter Y. S., 2009, Clinical Microbiology Newsletter, V31, P161, DOI 10.1016/j.clinmicnews.2009.10.001
   Miller JM, 2000, CLIN INFECT DIS, V31, P433, DOI 10.1086/313974
   Millman AJ, 2015, J TRAVEL MED, V22, P306, DOI 10.1111/jtm.12215
   Minooee E, 1999, CLIN INFECT DIS, V29, P737, DOI 10.1086/520426
   Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180
   Mouchtouri VA, 2015, J TRAVEL MED, V22, P325, DOI 10.1111/jtm.12225
   National Oceanic and Atmospheric Administration, 2020, WHAT IS SEASP WHAT IS SEASP
   Pilbara Port Authority, 2020, PORT PORT HEDL PERTH PORT PORT HEDL PERTH
   Ports Australia, 2020, TRAD STAT TRAD STAT
   PricewaterhouseCoopers, 2020, SHIPP IND RESP COVID SHIPP IND RESP COVID
   Rooney RM, 2004, PUBLIC HEALTH REP, V119, P427, DOI 10.1016/j.phr.2004.05.007
   Schlaich CC, 2009, J TRAVEL MED, V16, P402, DOI 10.1111/j.1708-8305.2009.00343.x
   Sehdev PS, 2002, CLIN INFECT DIS, V35, P1071, DOI 10.1086/344062
   Sweeney K., 2012, SAFETY EVERYONE MUST
   Tarabbo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015933
   United Nations Conference on Trade and Development, 2020, COVID 19 MAR TRANSP COVID 19 MAR TRANSP
   United Nations Conference on Trade and Development, 2020, COVID 19 CUTS GLOB M COVID 19 CUTS GLOB M
   Verhoef L, 2008, EMERG INFECT DIS, V14, P238, DOI 10.3201/eid1402.061567
   Ward KA, 2010, EMERG INFECT DIS, V16, P1731, DOI 10.3201/eid1611.100477
   WHO, 2005, INT HLTH REG
   Widdowson MA, 2004, J INFECT DIS, V190, P27, DOI 10.1086/420888
   Wong K., 2020, FURTHER ENHANCEMENTS
   World Health Organization, 2020, ADVICE USE POINT OF
   World Health Organization, 2020, COR DIS 2019 COVID 1
   World Health Organization, 2020, OP CONS MAN COVID 19
   World Health Organization, 2020, CELL, DOI DOI 10.1016/J.CELL.2020.05.015
   World Health Organization Regional Office for Europe, WHO ANN COVID 19 OUT
   Xi J, 2003, J INFECT DIS, V187, P187
   Zhang N, 2016, SCI REP-UK, V6, DOI 10.1038/srep38790
NR 63
TC 0
Z9 0
U1 1
U2 1
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1049-023X
EI 1945-1938
J9 PREHOSPITAL DISASTER
JI Prehospital Disaster Med.
PD AUG
PY 2021
VL 36
IS 4
BP 481
EP 485
AR PII S1049023X2100056X
DI 10.1017/S1049023X2100056X
PG 5
WC Emergency Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Emergency Medicine
GA TL5TY
UT WOS:000674922300023
PM 34085619
OA Green Published
DA 2022-04-20
ER

PT J
AU Varghese, A
   Dhar, M
   Rao, S
   Raina, R
   Mittal, SK
   Kumar, B
   Bhat, N
AF Varghese, Arun
   Dhar, Minakshi
   Rao, Shalinee
   Raina, Rohit
   Mittal, Sunita K.
   Kumar, Barun
   Bhat, Nowneet
TI Effectiveness of Large-Scale Preparedness Training on Electrocardiogram
   for Medical, Surgical, and Pre-clinical Doctors: A Need-Based Initiative
   for COVID-19 Patient Care
SO CUREUS JOURNAL OF MEDICAL SCIENCE
LA English
DT Article
DE skills; training; electrocardiogram; effectiveness; covid-19
AB Introduction: One of the competencies expected of all doctors posted in coronavirus disease 2019 (COVID-19) wards, is ECG rhythm identification, interpretation, and intervention for immediate management of patients. This study was undertaken to evaluate the effectiveness of the ECG training module as a component of preparedness training to combat COVID-19.
   Methodology: This was a cross-sectional study conducted during training on ECG rhythm identification, interpretation, its management in COVID-19 patients. Study participants included faculty, senior residents, junior residents, and interns of medical, surgical, and paraclinical disciplines. The training session included one hour of didactic lecture and one and half hours of interactive session during which case scenarios were discussed. An objective assessment was conducted through pre-test and post-test. Mean of pre and post-test scores were compared using paired t-test for evaluating statistical significance. Feedback was also taken from participants.
   Results: Out of the 800 participants who gave consent, only 682 who completed both pre and post-test were included in the final analysis. Mean pre-test and post-test scores were 9.29/15 (61.9%) and 11.63/15 (77.5%), respectively, with a mean improvement of +2.34/15 (+15.6%). Of the participants, 38.6% obtained low scores in pre-test and 82% of respondents agreed that knowledge and skills gained from training would be useful in providing patient care.
   Conclusion: Low baseline knowledge on ECG highlights the need for re-training doctors posted in COVID-19 care on cardiac rhythm identification and interpretation. Interactive training is effective in improving ECG interpretative skills among doctors across disciplines and is the appropriate method to retrain/reskill, especially for large-scale capacity building.
C1 [Varghese, Arun] All India Inst Med Sci Rishikesh, Coll Nursing, Rishikesh, India.
   [Dhar, Minakshi; Raina, Rohit] All India Inst Med Sci Rishikesh, Internal Med, Rishikesh, India.
   [Rao, Shalinee] All India Inst Med Sci Rishikesh, Pathol, Rishikesh, India.
   [Mittal, Sunita K.] All India Inst Med Sci Rishikesh, Physiol, Rishikesh, India.
   [Kumar, Barun] All India Inst Med Sci Rishikesh, Cardiol, Rishikesh, India.
   [Bhat, Nowneet] All India Inst Med Sci Rishikesh, Pediat Med, Rishikesh, India.
RP Dhar, M (corresponding author), All India Inst Med Sci Rishikesh, Internal Med, Rishikesh, India.
EM minakshi.dhar@rediffmail.com
RI Varghese, ARUN/AAW-5529-2021
OI Varghese, ARUN/0000-0001-7114-144X
CR Antiperovitch P, 2018, J HOSP MED, V13, P185, DOI 10.12788/jhm.2876
   Becker Daniel E, 2006, Anesth Prog, V53, P53, DOI 10.2344/0003-3006(2006)53[53:FOEI]2.0.CO;2
   Bergamaschi L, 2021, ANN NONINVAS ELECTRO, V26, DOI 10.1111/anec.12815
   Brooks-Harris JE, 1999, WORKSHOPS DESIGNING, DOI [10.4135/9781452204864, DOI 10.4135/9781452204864]
   He J, 2020, CAN J CARDIOL, V36, DOI 10.1016/j.cjca.2020.03.028
   Khan SA, 2020, J BAHRIA U MED DENT, V10, P301, DOI [10.51985/JBUMDC2020064, DOI 10.51985/JBUMDC2020064]
   Kish M, 2008, ADAPTING INFORM COMM, P22, DOI [10.4018/978-1-59904-922-9.ch011, DOI 10.4018/978-1-59904-922-9.CH011]
   Lavranos G, 2013, HIPPOKRATIA, V17, P34
   Mahler SA, 2011, MED EDUC, V45, P347, DOI 10.1111/j.1365-2923.2010.03891.x
   Newman LR, 2019, MED TEACH, V41, P1118, DOI 10.1080/0142159X.2018.1521953
   Piryani RM, 2019, ADV MED EDUC PRACT, V10, P829, DOI 10.2147/AMEP.S218157
   Pugh D, 2019, MED TEACH, V41, P569, DOI 10.1080/0142159X.2018.1505035
   Sam AH, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032550
   Yuan M, 2021, BR J CARDIOL, V28, P55, DOI [10.5837/bjc.2021.024, DOI 10.5837/BJC.2021.024]
NR 14
TC 0
Z9 0
U1 0
U2 0
PU CUREUS INC
PI PALO ALTO
PA PO BOX 61002, PALO ALTO, CA 94306 USA
EI 2168-8184
J9 CUREUS J MED SCIENCE
JI Cureus J Med Sci
PD FEB 8
PY 2022
VL 14
IS 2
AR e22011
DI 10.7759/cureus.22011
PG 6
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA ZE9VI
UT WOS:000759224600015
PM 35340521
OA gold
DA 2022-04-20
ER

PT J
AU Malik, H
   Anees, T
   Mui-zzud-din
AF Malik, Hassaan
   Anees, Tayyaba
   Mui-zzud-din
TI BDCNet: multi-classification convolutional neural network model for
   classification of COVID-19, pneumonia, and lung cancer from chest
   radiographs
SO MULTIMEDIA SYSTEMS
LA English
DT Article; Early Access
DE COVID-19; Deep learning; Chest radiographs; Coronavirus
ID CORONAVIRUS; DIAGNOSIS; FEATURES; SARS
AB Globally, coronavirus disease (COVID-19) has badly affected the medical system and economy. Sometimes, the deadly COVID-19 has the same symptoms as other chest diseases such as pneumonia and lungs cancer and can mislead the doctors in diagnosing coronavirus. Frontline doctors and researchers are working assiduously in finding the rapid and automatic process for the detection of COVID-19 at the initial stage, to save human lives. However, the clinical diagnosis of COVID-19 is highly subjective and variable. The objective of this study is to implement a multi-classification algorithm based on deep learning (DL) model for identifying the COVID-19, pneumonia, and lung cancer diseases from chest radiographs. In the present study, we have proposed a model with the combination of Vgg-19 and convolutional neural networks (CNN) named BDCNet and applied it on different publically available benchmark databases to diagnose the COVID-19 and other chest tract diseases. To the best of our knowledge, this is the first study to diagnose the three chest diseases in a single deep learning model. We also computed and compared the classification accuracy of our proposed model with four well-known pre-trained models such as ResNet-50, Vgg-16, Vgg-19, and inception v3. Our proposed model achieved an AUC of 0.9833 (with an accuracy of 99.10%, a recall of 98.31%, a precision of 99.9%, and an f1-score of 99.09%) in classifying the different chest diseases. Moreover, CNN-based pre-trained models VGG-16, VGG-19, ResNet-50, and Inception-v3 achieved an accuracy of classifying multi-diseases are 97.35%, 97.14%, 97.15%, and 95.10%, respectively. The results revealed that our proposed model produced a remarkable performance as compared to its competitor approaches, thus providing significant assistance to diagnostic radiographers and health experts.
C1 [Malik, Hassaan] Univ Management & Technol, Dept Comp Sci, Lahore 54000, Pakistan.
   [Malik, Hassaan] Natl Coll Business Adm Sr Econ, Dept Comp Sci, Sub Campus Multan, Multan 60000, Pakistan.
   [Anees, Tayyaba] Univ Management & Technol, Dept Software Engn, Lahore 54000, Pakistan.
   [Mui-zzud-din] Khawaja Fareed Univ Engn & Informat Technol, Dept Comp Sci, Rahim Yar Khan 64200, Pakistan.
RP Malik, H (corresponding author), Univ Management & Technol, Dept Comp Sci, Lahore 54000, Pakistan.; Malik, H (corresponding author), Natl Coll Business Adm Sr Econ, Dept Comp Sci, Sub Campus Multan, Multan 60000, Pakistan.
EM f2019288004@umt.edu.pk
OI Malik, Hassaan/0000-0002-4402-5088
CR Alqudah AM, 2020, Augmented COVID-19 X-ray images dataset: 4, DOI 10.17632/2FXZ4PX6D8.4
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   [Anonymous], 2018, FREDERICK NAT LAB CA
   [Anonymous], 2018, NIH CHEST XRAYS
   [Anonymous], 2020, COVID 19 DATABASE
   [Anonymous], 2020, COVID 19 CHEST XRAY
   Apostolopoulos ID, 2020, PHYS ENG SCI MED, V43, P635, DOI 10.1007/s13246-020-00865-4
   Canayaz M, 2021, CHAOS SOLITON FRACT, V151, DOI 10.1016/j.chaos.2021.111310
   Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055
   Chan-Yeung M, 2003, RESPIROLOGY, V8, pS9, DOI 10.1046/j.1440-1843.2003.00518.x
   Chowdhury NK, 2021, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.551
   Ciresan DC, 2013, LECT NOTES COMPUT SC, V8150, P411, DOI 10.1007/978-3-642-40763-5_51
   Cohen JP, 2020, COVID 19 IMAGE DATA
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Frederick Nat Lab, 2018, CANC IM ARCH CANC IM, P1
   Gaillard F., 2014, RADIOPAEDIAORG WIKI
   Hassantabar S, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110170
   He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90
   Horry MJ, 2020, IEEE ACCESS, V8, P149808, DOI 10.1109/ACCESS.2020.3016780
   Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X
   Huang GL, 2017, IEEE ICC
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Hwang EJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.1095
   Islam MM, 2021, IEEE ACCESS, V9, P30551, DOI 10.1109/ACCESS.2021.3058537
   Ismail MM, 2003, AVIAN DIS, V47, P515, DOI 10.1637/5917
   Jain R, 2021, APPL INTELL, V51, P1690, DOI 10.1007/s10489-020-01902-1
   Janizek Joseph D., 2020, CHIL '20: Proceedings of the Conference on Health, Inference, and Learning, P69, DOI 10.1145/3368555.3384458
   Jiang XG, 2020, CMC-COMPUT MATER CON, V63, P537, DOI 10.32604/cmc.2020.010691
   Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Lee J, 2016, J THEOR BIOL, V408, P118, DOI 10.1016/j.jtbi.2016.08.009
   Loey M, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12040651
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]
   Mahmud T, 2020, COMPUT BIOL MED, V122, DOI 10.1016/j.compbiomed.2020.103869
   Malik HA, 2020, Mendeley Data, DOI 10.17632/67dmnmx33v.1
   Malik H, 2020, IEEE ACCESS, V8, P139367, DOI 10.1109/ACCESS.2020.3004766
   Marques G, 2020, APPL SOFT COMPUT, V96, DOI 10.1016/j.asoc.2020.106691
   Mohsen Heba, 2018, Future Computing and Informatics Journal, V3, P68, DOI 10.1016/j.fcij.2017.12.001
   Mooney P, 2018, CHEST XRAY IMAGES PN
   Naeem A, 2020, IEEE ACCESS, V8, P110575, DOI 10.1109/ACCESS.2020.3001507
   Oh Y, 2020, IEEE T MED IMAGING, V39, P2688, DOI 10.1109/TMI.2020.2993291
   Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143
   Quang D, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw226
   Rahimzadeh Mohammad, 2020, Inform Med Unlocked, V19, P100360, DOI 10.1016/j.imu.2020.100360
   Rastgarpour M., 2011, Proceedings of International MultiConference of Engineers and Computer Scientists 2011 (IMECS 2011), P519
   Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y
   Saha Prottoy, 2021, Informatics in Medicine Unlocked, V22, P136, DOI 10.1016/j.imu.2020.100505
   Sethy PK, 2020, INT J MATH ENG MANAG, V5, P643, DOI 10.33889/IJMEMS.2020.5.4.052
   Shiraishi J, 2000, AM J ROENTGENOL, V174, P71, DOI 10.2214/ajr.174.1.1740071
   Simonyan K., 2015, P 3 INT C LEARNING R
   Singh H, 2022, MULTIMEDIA SYST, V28, P113, DOI 10.1007/s00530-021-00798-2
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Szegedy C, 2017, 31 AAAI C ART INT
   Tahamtan A, 2020, EXPERT REV MOL DIAGN, V20, P453, DOI 10.1080/14737159.2020.1757437
   Tsiknakis N, 2020, EXP THER MED, V20, P727, DOI 10.3892/etm.2020.8797
   Wang QL, 2020, IEEE ACCESS, V8, P78530, DOI 10.1109/ACCESS.2020.2990423
   Wang XS, 2017, PROC CVPR IEEE, P3462, DOI 10.1109/CVPR.2017.369
   Worldometer, 2021, CORONAVIRUS UPDATE L
   Xiao B, 2021, IEEE T CYBERNETICS, DOI 10.1109/TCYB.2020.3042837
   Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhang J, 2020, AEXIV200212338
NR 63
TC 0
Z9 0
U1 4
U2 4
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0942-4962
EI 1432-1882
J9 MULTIMEDIA SYST
JI Multimedia Syst.
DI 10.1007/s00530-021-00878-3
EA JAN 2022
PG 15
WC Computer Science, Information Systems; Computer Science, Theory &
   Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science
GA YH8KE
UT WOS:000743409200001
PM 35068705
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU van Hoek, R
   Dobrzykowski, D
AF van Hoek, Remko
   Dobrzykowski, David
TI Towards more balanced sourcing strategies - are supply chain risks
   caused by the COVID-19 pandemic driving reshoring considerations?
SO SUPPLY CHAIN MANAGEMENT-AN INTERNATIONAL JOURNAL
LA English
DT Article
DE Resilience; Risk management; Offshoring; Supply chain vulnerability;
   COVID-19; Reshoring
ID MANAGEMENT; IMPLEMENTATION; RESILIENCE
AB Purpose
   Reshoring is one of the supply chain risk management techniques suggested in literature. However, literature suggests that the decision-making involved in reshoring is complex and not fully understood. In the context of the COVID-19 pandemic, reshoring may represent a way to reduce reliance on global sources and improve resilience of their supply chains. This paper aims to explore if the pandemic is driving reshoring decisions and if the pandemic will actually lead to companies reshoring parts of their supply chain.
   Design/methodology/approach
   This paper critically engages with senior(-most) supply chain managers from three manufacturing companies as they proceed through reshoring decision-making. This enables to develop experiential knowledge about reshoring decision-making processes and their context, as well as insights into the relevance of existing knowledge about reshoring. While not a full multiple case study, the opportunity to engage directly with senior(-most) supply chain managers as they consider reshoring, enables near real-time learning. Not only is reshoring a very timely topic literature has also called for more event-based empirical research. Further to that, it is hoped that this can complement this special issue and support, in a timely manner, the many researchers that are actively studying the impact of the pandemic on supply chains.
   Findings
   Reshoring was being actively considered by all three companies during the research process in Q3 and Q4 of 2020. During this period the pandemic has not yet led to substantial implementation of reshoring, at least by the companies studied in this paper. In response to tariffs on Chinese imports, companies had been diversifying their supply base away from China, but doing so by developing alternative, global sources. Additionally, companies are using alternative risk management techniques, such as supplier collaboration, in the short to medium term. Reshoring decision-making is indeed found to be complex and requires a longer-term time horizon for decision-making and implementation. Logistical challenges and growth in demand do drive a willingness of consumers to pay a premium for locally sourced products. However, when supply normalizes these considerations might lose relevance well before reshoring decision-making and implementation can be completed.
   Originality/value
   This paper studies reshoring in a real-world setting, learning directly from insights from industry as they emerge. This paper develops four extensions to existing knowledge, develop these in frameworks and hope that this will support ongoing consideration in industry and support the many researchers that are active in this domain today. This paper also suggests several directions for further research.
C1 [van Hoek, Remko; Dobrzykowski, David] Sam M Walton Coll Business, SCM Dept, Fayetteville, AR 72701 USA.
RP van Hoek, R (corresponding author), Sam M Walton Coll Business, SCM Dept, Fayetteville, AR 72701 USA.
EM rvanhoek@uark.edu; DDobrzykowski@walton.uark.edu
CR Boffelli A, 2020, J PURCH SUPPLY MANAG, V26, DOI 10.1016/j.pursup.2020.100623
   Chopra S, 2004, MIT SLOAN MANAGE REV, V46, P53
   Ellram LM, 2013, J SUPPLY CHAIN MANAG, V49, P14, DOI 10.1111/jscm.12019
   Ferdows K, 2018, INT J OPER PROD MAN, V38, P390, DOI 10.1108/IJOPM-01-2017-0019
   Foerstl K, 2016, INT J PHYS DISTR LOG, V46, P492, DOI 10.1108/IJPDLM-02-2015-0045
   Ho W, 2015, INT J PROD RES, V53, P5031, DOI 10.1080/00207543.2015.1030467
   Manuj I, 2008, J BUS LOGIST, V29, P133, DOI 10.1002/j.2158-1592.2008.tb00072.x
   OECD, 2016, OECD SCI TECHNOLOGY, V27
   OECD, 2013, INTERCONNECTED EC BE
   Pettit TJ, 2019, J BUS LOGIST, V40, P56, DOI 10.1111/jbl.12202
   Pettit TJ, 2010, J BUS LOGIST, V31, P1, DOI 10.1002/j.2158-1592.2010.tb00125.x
   Rao S, 2009, INT J LOGIST MANAG, V20, P97, DOI 10.1108/09574090910954864
   Scholten K, 2019, INT J OPER PROD MAN, V40, P1, DOI 10.1108/IJOPM-01-2020-789
   Sodhi MS, 2012, PROD OPER MANAG, V21, P1, DOI 10.1111/j.1937-5956.2011.01251.x
   Tang C. S, 2006, INT J LOGIST-RES APP, V9, P33, DOI [10.1080/13675560500405584, DOI 10.1080/13675560500405584]
   Tate WL, 2014, J PURCH SUPPLY MANAG, V20, P66, DOI 10.1016/j.pursup.2014.01.007
   Touboulic A, 2020, J SUPPLY CHAIN MANAG, V56, P36, DOI 10.1111/jscm.12226
   van Hoek R, 2020, LOGISTICS-BASEL, V4, DOI 10.3390/logistics4040023
   van Hoek R, 2020, INT J OPER PROD MAN, V40, P341, DOI 10.1108/IJOPM-03-2020-0165
   van Hoek R, 2020, SUPPLY CHAIN MANAG, V25, P255, DOI 10.1108/SCM-11-2018-0383
   van Hoek R, 2020, SUPPLY CHAIN MANAG, V25, P115, DOI 10.1108/SCM-05-2019-0206
   van Hoek R, 2019, INT J OPER PROD MAN, V39, P829, DOI 10.1108/IJOPM-01-2019-0022
   van Hoek R, 2010, INT J LOGIST MANAG, V21, P230, DOI 10.1108/09574091011071933
   Vanpoucke E, 2019, INT J OPER PROD MAN, V40, P11, DOI 10.1108/IJOPM-09-2017-0562
   Wagner SM, 2008, J BUS LOGIST, V29, P307, DOI 10.1002/j.2158-1592.2008.tb00081.x
   Zanoni A., 2016, FUTURE GLOBAL ORG PR, V10, P365
NR 26
TC 5
Z9 5
U1 21
U2 32
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1359-8546
EI 1758-6852
J9 SUPPLY CHAIN MANAG
JI Supply Chain Manag.
PD SEP 6
PY 2021
VL 26
IS 6
SI SI
BP 689
EP 701
DI 10.1108/SCM-09-2020-0498
EA JUN 2021
PG 13
WC Business; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA UL6FK
UT WOS:000658320300001
OA Bronze
DA 2022-04-20
ER

PT J
AU Dwivedi, A
   Qiu, XM
   Dwivedi, SS
   Tariq, MR
   Jha, SK
   Sigdel, D
AF Dwivedi, Atul
   Qiu, Xiaoming
   Dwivedi, Shweta Shukla
   Tariq, Muhammad Raheel
   Jha, Sarbesh Kumar
   Sigdel, Deepak
TI Impact of Online Lectures on Medical Students During COVID-19 Pandemic
SO JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE
LA English
DT Article
DE COVID-19 pandemic; Online medical lectures; Face to Face Classroom
   System (FFCS)
ID EDUCATION; ENGAGEMENT
AB Introduction: In recent days, trend of taking online lectures is booming in medical education all around the globe. Online lectures show its greatest importance during COVID-19 outbreak and lockdown period, where it is the only possible way to teach the international students from home. However, there are several issues including lack of support from management, ignorance & resistance of other faculty members, changes in syllabus of medical education putting extra pressure on overloaded teaching faculty, low level of satisfaction in students, poor internet connection, poor software qualities, poor language skills in students,lack of communication between teacher and students.
   Material and method: We ran an online survey, under which we send the set of Questions (given in the Table 1) to 54 volunteer Fourth Year Medical students, who were taking online lectures during COVID-19 Pandemic.
   Results: In our online survey we found that 92 % students agree with idea of saving energy and time through online lectures. 46 % students face poor internet problems, 20 % students face problems to understand online lectures because of their poor language skills,22% students reported lack of concentration during online classes, 38% students reported technical issues,42% students are satisfied, 42% partially satisfied, 10 % students not satisfied.
   94% students believe that these online lectures are not enough to make students more confident and independent about medical knowledge. Additionally, 37% students (maximum number of students) reported that they like to take online lectures one zoom app.
   Conclusion: Online teaching in medical colleges is still a new concept; however, with improved technology, it can be a fruitful deal for the coming generations. During COVID -19, these online lectures became a crucial candlelight in the dark era of lockdown worldwide. Last but not the least, online lectures are not the substitute of face-to-face classroom lectures. Contrarily, if we solve the connectivity issues, electronic device issues, software problems, language issues etc., then only online lectures can reach up to the level of face-to-face classroom lectures.
C1 [Dwivedi, Atul] Hubei Polytech Univ HBPU, Med Coll, Dept Clin & Basic Sci, Huangshi, Hubei, Peoples R China.
   [Qiu, Xiaoming] Hubei Polytech Univ HBPU, Edong Hlth Care Grp, Affiliated Hosp, Dept Radiol,Huangshi Cent Hosp, Huangshi, Hubei, Peoples R China.
   [Dwivedi, Shweta Shukla] Dept Dent Surg, Jabalpur, Madhya Pradesh, India.
   [Tariq, Muhammad Raheel] North Sichaun Med Coll, Affiliated Hosp, Dept Internal Med, Nanchong, Sichuan, Peoples R China.
   [Jha, Sarbesh Kumar; Sigdel, Deepak] Koshi Zonal Hosp, Dept Med, Biratnagar, Nepal.
RP Dwivedi, SS (corresponding author), Dept Dent Surg, Jabalpur, Madhya Pradesh, India.
EM shweta0761@gmail.com
CR Albarrak A., 2011, ED TECHNOLOGICAL WOR, V1st
   [Anonymous], 2006, COMP RESULT E LEARNI
   Berge Z.L., 2005, DISTANCE EDUC, V26, P29, DOI [10.1080/01587910500081269, DOI 10.1080/01587910500081269, https://doi.org/10.1080/01587910500081269]
   Deming DJ, 2015, AM ECON REV, V105, P496, DOI 10.1257/aer.p20151024
   Dhir SK, 2017, INDIAN PEDIATR, V54, P871, DOI 10.1007/s13312-017-1152-9
   Dringus L, 2002, J EDUC TECHNOL SYST, V28, P3
   Howlett D., 2009, LEARNING, V6, P372, DOI [10.2304/elea.2009.6.4.372, DOI 10.2304/ELEA.2009.6.4.372]
   Hsiao CC, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0816-9
   Johnson S. D., 2000, Journal of Interactive Learning Research, V11, P29
   Maheshwari S, 2015, ANN PEDIAT CARDIOL, V8, P10, DOI 10.4103/0974-2069.149512
   Mahoney NR, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0828-5
   Masic Izet, 2008, Acta Inform Med, V16, P102, DOI 10.5455/aim.2008.16.102-117
   Mayer RE, 2002, PSYCHOL LEARN MOTIV, V41, P85, DOI 10.1016/S0079-7421(02)80005-6
   Mooney GA, 1997, POSTGRAD MED J, V73, P701, DOI 10.1136/pgmj.73.865.701
   Omar ND, 2012, PROCD SOC BEHV, V67, P464, DOI 10.1016/j.sbspro.2012.11.351
   Ozuah Philip O, 2002, BMC Med Educ, V2, P8, DOI 10.1186/1472-6920-2-8
   Pettersson F, 2015, EDUC INF TECHNOL, V20, P359, DOI 10.1007/s10639-013-9289-1
   Ritchie A, 2011, HEALTH INFO LIBR J, V28, P41, DOI 10.1111/j.1471-1842.2010.00923.x
   Robinson CC, 2008, J EDUC BUS, V84, P101, DOI 10.3200/JOEB.84.2.101-109
   Rosenberg ME., 2001, LEARNING STRATEGIES
   Saiyad S, 2020, INT J APPL BASIC MED, V10, P149, DOI 10.4103/ijabmr.IJABMR_358_20
   Shachar M, 2003, INT REV RES OPEN DIS
   Shrivastava SR, 2019, MAMC J MED SCI, V5, P43, DOI DOI 10.4103/MAMCJMS.MAMCJMS_17_19
   Singh Anudeep, 2017, Korean J Med Educ, V29, P27, DOI 10.3946/kjme.2017.50
   Vaona Alberto, 2018, Cochrane Database Syst Rev, V1, pCD011736, DOI 10.1002/14651858.CD011736.pub2
NR 25
TC 1
Z9 1
U1 2
U2 5
PU AMBER PUBLICATION
PI GUJARAT
PA 402, PARIJAT APT, WALKESHWARI NAGAR, JAMNAGAR, GUJARAT, 361 008, INDIA
SN 2347-2545
EI 2347-2367
J9 J RES MED DENT SCI
JI J. Res. Med. Dent. Sci.
PY 2021
VL 9
IS 4
BP 433
EP 437
PG 5
WC Medicine, Research & Experimental
WE Emerging Sources Citation Index (ESCI)
SC Research & Experimental Medicine
GA SD8SH
UT WOS:000651645900015
DA 2022-04-20
ER

PT J
AU Galanis, P
   Vraka, I
   Fragkou, D
   Bilali, A
   Kaitelidou, D
AF Galanis, Petros
   Vraka, Irene
   Fragkou, Despoina
   Bilali, Angeliki
   Kaitelidou, Daphne
TI Intention of healthcare workers to accept COVID-19 vaccination and
   related factors: A systematic review and meta-analysis
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Review
DE COVID-19; Vaccination; Healthcare workers; Intention; SARS-CoV-2
ID SEASONAL INFLUENZA VACCINATION; HESITANCY; NURSES; RISK; PROFESSIONALS;
   PREVALENCE; PHYSICIANS; KNOWLEDGE; COUNTRIES; VACCINES
AB Considering medical and economic burden of coronavirus disease 2019 (COVID-19), a high COVID-19 vaccination coverage among healthcare workers (HCWs) is an urgent need. The aim of this systematic review and meta-analysis was to evaluate the intention of HCWs to accept COVID-19 vaccination and to identify related factors. We searched PubMed, MEDLINE, Scopus, Web of Science, ProQuest, CINAHL and medRxiv until July 14, 2021. The heterogeneity between results was very high; thus, we applied a random effects model to estimate pooled effects. We performed subgroup and meta-regression analysis to identify possible resources of heterogeneity. Twenty four studies, including 50 940 HCWs, met the inclusion criteria. The overall proportion of HCWs that intend to accept COVID-19 vaccination was 63.5% (95% confidence interval: 56.5%-70.2%) with a wide range among studies from 27.7% to 90.1%. The following factors were associated with increased HCWs' willingness to get vaccinated against COVID-19: male gender, older age, white HCWs, physician profession, higher education level, comorbidity among HCWs, vaccination against flu during previous season, stronger vaccine confidence, positive attitude towards a COVID-19 vaccine, fear about COVID-19, individual perceived risk about COVID-19, and contact with suspected or confirmed COVID-19 patients. The reluctance of HCWs to vaccinate against COVID-19 could diminish the trust of individuals and trigger a ripple effect in the general public. Since vaccination is a complex behavior, understanding the way that HCWs take the decision to accept or refuse COVID-19 vaccination will give us the opportunity to develop the appropriate interventions to increase COVID-19 vaccination uptake.
C1 [Galanis, Petros; Fragkou, Despoina] Natl & Kapodistrian Univ Athens, Sch Hlth Sci, Fac Nursing, Clin Epidemiol Lab, Athens, Greece.
   [Vraka, Irene] PA Kyriakou Childrens Hosp, Dept Radiol, Athens, Greece.
   [Bilali, Angeliki] PA Kyriakou Childrens Hosp, Hosp Waste Management Unit, Athens, Greece.
   [Kaitelidou, Daphne] Natl & Kapodistrian Univ Athens, Sch Hlth Sci, Fac Nursing, Ctr Hlth Serv Management & Evaluat, Athens, Greece.
RP Galanis, P (corresponding author), Natl & Kapodistrian Univ Athens, Sch Hlth Sci, Fac Nursing, Clin Epidemiol Lab, Athens, Greece.
EM pegalan@nurs.uoa.gr
CR Adeniyi OV, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9060666
   Al-Sanafi M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9070701
   Alenazi Bashayer Reda, 2018, Electron Physician, V10, P7217, DOI 10.19082/7217
   Apisarnthanarak A, 2021, INFECT CONT HOSP EP, V42, P1288, DOI 10.1017/ice.2020.1240
   Auta A, 2018, VACCINE, V36, P4851, DOI 10.1016/j.vaccine.2018.06.043
   Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104
   Baron G, 2001, CAN FAM PHYSICIAN, V47, P2261
   Barry M, PLOS ONE, V16
   Blank PR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-272
   Bonanni P, 2018, VACCINE, V36, P5358, DOI 10.1016/j.vaccine.2017.07.100
   Bonanni P, 2008, J PUBLIC HEALTH-HEID, V16, P253, DOI 10.1007/s10389-008-0203-z
   Cacciapaglia G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72611-5
   Centers for Disease Control and Prevention, 2020, INFL VACC COV HLTH C
   Centers for Disease Control and Prevention, 2020, CDC IS MAK COVID 19
   Chawe A, 2021, AFR J LAB MED, V10, DOI 10.4102/ajlm.v10i1.1403
   de Lataillade C, 2009, J PUBLIC HEALTH POL, V30, P83, DOI 10.1057/jphp.2008.40
   Demicheli V, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub4
   Detoc M, 2020, VACCINE, V38, P7002, DOI 10.1016/j.vaccine.2020.09.041
   Di Martino G, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8020248
   Dolan GP, 2013, INFLUENZA OTHER RESP, V7, P93, DOI 10.1111/irv.12087
   dos Santos WM, 2018, REV LAT-AM ENFERM, V26, DOI 10.1590/1518-8345.2885.3074
   Dube E, 2013, HUM VACC IMMUNOTHER, V9, P1763, DOI 10.4161/hv.24657
   Duque J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-41
   Dzieciolowska S, 2021, AM J INFECT CONTROL, V49, P1152, DOI 10.1016/j.ajic.2021.04.079
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Gadoth A, 2021, ANN INTERN MED, V174, P882, DOI 10.7326/M20-7580
   Gagneux-Brunon A, 2021, J HOSP INFECT, V108, P168, DOI [10.1016/j.jhin.2020.11.0200195-6701, 10.1016/j.jhin.2020.11.020]
   Galanis P, 2021, J HOSP INFECT, V108, P120, DOI 10.1016/j.jhin.2020.11.008
   Garcia-Reyna B, 2022, INT J MENT HEALTH AD, V20, P895, DOI 10.1007/s11469-020-00413-x
   Geoghegan S, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00372
   Ghimire Prabina, 2020, J Nepal Health Res Counc, V18, P293, DOI 10.33314/jnhrc.v18i2.2658
   Huynh G, 2021, ASIAN PAC J TROP MED, V14, P159, DOI 10.4103/1995-7645.312513
   Herzog R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-154
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hollmeyer HG, 2009, VACCINE, V27, P3935, DOI 10.1016/j.vaccine.2009.03.056
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Imai Chisato, 2018, PLoS One, V13, pe0198685, DOI 10.1371/journal.pone.0198685
   Jiang L, 2017, EPIDEMIOL INFECT, V145, P3085, DOI 10.1017/S0950268817002035
   Jorgensen P, 2018, VACCINE, V36, P442, DOI 10.1016/j.vaccine.2017.12.019
   Kaplan AK, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.14226
   Keske S, 2020, VACCINE, V38, P8357, DOI 10.1016/j.vaccine.2020.11.003
   Kliner M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012149
   Kose S, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13917
   Kuter BJ, 2021, VACCINE, V39, P1693, DOI 10.1016/j.vaccine.2021.02.029
   La Torre G, 2011, HUM VACCINES, V7, P728, DOI 10.4161/hv.7.7.15413
   Lau LHW, 2020, VACCINE, V38, P6785, DOI 10.1016/j.vaccine.2020.08.038
   Lee, 2021, ARE WE READY COVID 1, DOI [10.1101/2020.07.17.20156026, DOI 10.1101/2020.07.17.20156026]
   Lester RT, 2003, INFECT CONT HOSP EP, V24, P839, DOI 10.1086/502146
   Limbu DK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242126
   Liu P., 2020, ACCEPTANCE PREFERENC, DOI [10.1101/2020.04.09.20060103, DOI 10.1101/2020.04.09.20060103]
   Looi MK, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4113
   Lu PJ, 2016, AM J PREV MED, V51, P1015, DOI 10.1016/j.amepre.2016.08.038
   Lu W, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112936
   MacDonald NE, 2015, EBIOMEDICINE, V2, P792, DOI 10.1016/j.ebiom.2015.06.028
   Malik A.A., 2020, ECLINICALMEDICINE, V26, P100495, DOI [10.1016/j.eclinm.2020.100495, DOI 10.1016/J.ECLINM.2020.100495]
   Mannocci A, 2010, REV HEALTH CARE, V1, P27, DOI 10.7175/rhc.v1i1.15
   McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4
   Mehraeen E, 2020, EUR J INTEGR MED, V40, DOI 10.1016/j.eujim.2020.101226
   Mesas AE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241742
   Miller LE, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000022439
   Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005
   National Advisory Committee on Immunization (NACI), CAN COMM DIS REP 200
   National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention (CDC)., 2009, MMWR RECOMM REP, P1
   Nohl A, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050424
   Fiore Anthony E., 2010, Morbidity and Mortality Weekly Report, V59, P1
   Nzaji MK, 2020, PRAGMAT OBS RES, V11, P103, DOI 10.2147/POR.S271096
   Office of Disease Prevention and Health Promotion, 2020, INCR PERC HLTH CAR P
   Opel DJ, 2013, PEDIATRICS, V132, P1037, DOI 10.1542/peds.2013-2037
   Papagiannis D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144925
   Pless A, 2017, BMC NURS, V16, DOI 10.1186/s12912-017-0215-5
   Poland GA, 2005, VACCINE, V23, P2251, DOI 10.1016/j.vaccine.2005.01.043
   Prematunge C, 2012, VACCINE, V30, P4733, DOI 10.1016/j.vaccine.2012.05.018
   Puri N, 2020, HUM VACC IMMUNOTHER, V16, P2586, DOI 10.1080/21645515.2020.1780846
   Qattan AMN, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.644300
   Rimal RN, 2006, HEALTH COMMUN, V20, P209, DOI 10.1207/s15327027hc2003_1
   Schimmenti A, 2020, CLIN NEUROPSYCHIATR, V17, P41, DOI 10.36131/CN20200202
   Sepandi M, 2020, IRAN J PUBLIC HEALTH, V49, P1211, DOI 10.18502/ijph.v49i7.3574
   Shaw J, 2021, CLIN INFECT DIS, DOI 10.1093/cid/ciab731
   Shekhar R, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020119
   Sheldenkar A, 2019, VACCINE, V37, P4896, DOI 10.1016/j.vaccine.2019.07.011
   Sun YF, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.664905
   Lima CKT, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112915
   Unroe KT, 2021, J AM GERIATR SOC, V69, P593, DOI 10.1111/jgs.17022
   Vasilevska M, 2014, INFECT CONT HOSP EP, V35, P699, DOI 10.1086/676427
   Verger P, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.3.2002047
   Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80
   Wang KL, 2020, VACCINE, V38, P7049, DOI 10.1016/j.vaccine.2020.09.021
   Wang Q, 2018, VACCINE, V36, P7262, DOI 10.1016/j.vaccine.2018.10.045
   WHO, WHO COR DIS COVID 19, P2021
   Wilson R, 2020, VACCINE, V38, P1144, DOI 10.1016/j.vaccine.2019.11.018
   World Health Organization, 2020, WHO SAGE ROADM PRIOR
   World Health Organization, 2019, 10 THREATS GLOB HLTH
   World Health Organization, 2020, WHO SAGE VAL FRAM AL
   Yanez ND, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09826-8
   Yaqub O, 2014, SOC SCI MED, V112, P1, DOI 10.1016/j.socscimed.2014.04.018
   Yu JN, 2021, BIOL RES NURS, V23, P258, DOI 10.1177/1099800420951984
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
NR 97
TC 1
Z9 1
U1 3
U2 3
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD DEC
PY 2021
VL 14
IS 12
BP 543
EP 554
DI 10.4103/1995-7645.332808
PG 12
WC Public, Environmental & Occupational Health; Tropical Medicine
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Tropical Medicine
GA YB8CR
UT WOS:000739233700003
OA gold, Green Submitted
DA 2022-04-20
ER

PT J
AU Halacli, B
   Kaya, A
   Topeli, A
AF Halacli, Burcin
   Kaya, Akin
   Topeli, Arzu
TI Critically ill COVID-19 patient
SO TURKISH JOURNAL OF MEDICAL SCIENCES
LA English
DT Review
DE Coronavirus; SARS-CoV 2; pandemic; respiratory failure; ARDS; intensive
   care
AB Coronavirus disease 2019 (COVID-19) stands out as the major pandemic that we have experienced in the last century. As it affects every social structure, it brought the importance of intensive care support once again to the agenda of healthcare system after causing severe acute respiratory syndrome. The precautions to be taken against this virus, where our knowledge is extremely small, intensive care units take an indispensable place in pandemic planning. In this review, we aimed to emphasize the crucial points regarding intensive care management of COVID-19 patients, which we have written not only for intensivists but also for all healthcare professionals.
C1 [Halacli, Burcin; Topeli, Arzu] Hacettepe Univ, Fac Med, Dept Internal Med, Div Intens Care Med, Ankara, Turkey.
   [Kaya, Akin] Ankara Univ, Fac Med, Pulm & Crit Care, Ankara, Turkey.
RP Topeli, A (corresponding author), Hacettepe Univ, Fac Med, Dept Internal Med, Div Intens Care Med, Ankara, Turkey.
EM atopeli@hacettepe.edu.tr
RI KAYA, AKIN/AAF-8545-2020
OI KAYA, AKIN/0000-0003-1645-7761; Topeli, Arzu/0000-0002-5874-9087;
   Halacli, Burcin/0000-0002-7216-7438
CR [Anonymous], [No title captured]
   [Anonymous], 2020, J INFECT
   Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326
   Brochard L, 2017, AM J RESP CRIT CARE, V195, P438, DOI 10.1164/rccm.201605-1081CP
   Fan E, 2018, JAMA-J AM MED ASSOC, V319, P698, DOI 10.1001/jama.2017.21907
   Gattinoni L, 2020, AM J RESP CRIT CARE, V201, P1299, DOI 10.1164/rccm.202003-0817LE
   Gottlieb M, 2020, AM J EMERG MED, V38, P1007, DOI 10.1016/j.ajem.2019.12.019
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394
   Guan WJ, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Han SW, 2020, CANCER MED-US, V9, P6667, DOI 10.1002/cam4.3289
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6
   Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Liew MF, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2814-x
   MacLaren G, 2020, JAMA-J AM MED ASSOC, V323, P1245, DOI 10.1001/jama.2020.2342
   Matthay MA, 2020, LANCET RESP MED, V8, P433, DOI 10.1016/S2213-2600(20)30127-2
   Phua J, 2020, LANCET RESP MED, V8, P506, DOI 10.1016/S2213-2600(20)30161-2
   Poggiali E, 2020, RADIOLOGY, V295, pE6, DOI 10.1148/radiol.2020200847
   Qiu HB, 2020, INTENS CARE MED, V46, P576, DOI 10.1007/s00134-020-05966-y
   Respiratory care committee of Chinese Thoracic Society, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V17, pE020, DOI 10.3760/cma.j.issn.1001-0939.2020.0020
   Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
   Wax RS, 2020, CAN J ANESTH, V67, P568, DOI 10.1007/s12630-020-01591-x
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 24
TC 21
Z9 22
U1 1
U2 4
PU TUBITAK SCIENTIFIC & TECHNICAL RESEARCH COUNCIL TURKEY
PI ANKARA
PA ATATURK BULVARI NO 221, KAVAKLIDERE, ANKARA, 00000, TURKEY
SN 1300-0144
EI 1303-6165
J9 TURK J MED SCI
JI Turk. J. Med. Sci.
PY 2020
VL 50
SI 1
BP 585
EP 591
DI 10.3906/sag-2004-122
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA LG7EF
UT WOS:000528258800016
PM 32293831
OA Bronze, Green Published, Green Submitted
DA 2022-04-20
ER

PT J
AU Bahat, PY
   Kaya, C
   Selcuki, NFT
   Polat, I
   Usta, T
   Oral, E
AF Bahat, Pinar Yalcin
   Kaya, Cihan
   Selcuki, Nura F. T.
   Polat, Ibrahim
   Usta, Taner
   Oral, Engin
TI The COVID-19 pandemic and patients with endometriosis: A survey-based
   study conducted in Turkey
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE COVID-19; OB; GYN; Pandemic; Physician; Stress; Survey
ID POSTTRAUMATIC STRESS
AB Objective To apply rapid online surveying to determine the knowledge and perceptions of the COVID-19 pandemic on patients with endometriosis in Turkey. Methods An online survey was conducted by the Turkish Endometriosis & Adenomyosis Society and administered to patients with endometriosis who agreed to participate in the study. The survey included 25 questions prepared by an expert committee of four professionals (two gynecologists and two endometriosis specialists). Results Of the 290 questionnaires sent out, 261 (90%) were returned. A total of 213 (83.86%) patients reported that they were afraid of having endometriosis-related problems during the pandemic period. In addition, 133 (53.63%) patients thought the management of their endometriosis was affected because of the pandemic. Conclusion Clinical studies clearly indicate that endometriosis is a condition associated with high levels of chronic stress. The COVID-19 pandemic has led the public to experience psychological problems such as post-traumatic stress disorder, psychological distress, depression, and anxiety. The majority of patients with endometriosis were afraid of having endometriosis-related problems during the pandemic period. The majority of elective endometriosis surgeries have not been postponed. Patients were highly aware of the pandemic and practiced social distancing and hygiene. Only 4 (1.59%) patients with endometriosis required hospitalization.
C1 [Bahat, Pinar Yalcin; Polat, Ibrahim] Hlth Sci Univ, Istanbul Kanuni Sultan Suleyman Training & Res Ho, Dept Obstet & Gynecol, TR-34000 Istanbul, Turkey.
   [Kaya, Cihan] Hlth Sci Univ, Istanbul Bakirkoy Sadi Konuk Training & Res Hosp, Dept Obstet & Gynecol, Istanbul, Turkey.
   [Selcuki, Nura F. T.] Hlth Sci Univ, Istanbul Sisli Hamidiye Etfal Training & Res Hosp, Dept Obstet & Gynecol, Istanbul, Turkey.
   [Usta, Taner] Acibadem Univ Altunizade Hosp, Dept Obstet & Gynecol, Istanbul, Turkey.
   [Oral, Engin] Endometriosis & Adenomyosis Soc, Istanbul, Turkey.
RP Bahat, PY (corresponding author), Hlth Sci Univ, Istanbul Kanuni Sultan Suleyman Training & Res Ho, Dept Obstet & Gynecol, TR-34000 Istanbul, Turkey.
EM dr_pinaryalcin@hotmail.com
RI Oral, Engin/AAB-7442-2021; Polat, Ibrahim/A-7437-2018; Kaya,
   Cihan/F-8883-2013; Bahat, Pinar Yalcin/O-9993-2018
OI Polat, Ibrahim/0000-0002-1418-634X; Kaya, Cihan/0000-0003-4175-7694;
   Bahat, Pinar Yalcin/0000-0003-2558-1924
CR Aerts L, 2019, MINERVA GINECOL, V71, P224, DOI 10.23736/S0026-4784.19.04379-X
   Armour M, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2431-x
   Brasil DL, 2020, MINERVA MED, V111, P90, DOI 10.23736/S0026-4806.19.06350-X
   Brown J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004753.pub4
   Coloma JL, 2019, INT J GYNECOL OBSTET, V146, P157, DOI 10.1002/ijgo.12822
   Cuevas M, 2018, REPROD SCI, V25, P347, DOI 10.1177/1933719117737846
   Graham CJ, 2020, EUR J OBSTET GYN R B, V244, P203, DOI 10.1016/j.ejogrb.2019.10.030
   Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703
   Hudelist G, 2012, HUM REPROD, V27, P3412, DOI 10.1093/humrep/des316
   Ishikura IA, 2020, J CLIN SLEEP MED, V16, P1387, DOI 10.5664/jcsm.8464
   Lagana AS, 2015, EUR J OBSTET GYN R B, V194, P30, DOI 10.1016/j.ejogrb.2015.08.015
   Pope JE, 2020, CURR TREAT OPT RHEUM, V6, P71, DOI 10.1007/s40674-020-00145-y
   Seyhan A, 2015, SEMIN REPROD MED, V33, P422, DOI 10.1055/s-0035-1567820
   Vercellini P, 2018, FERTIL STERIL, V110, P61, DOI 10.1016/j.fertnstert.2018.03.038
   Vijayaraghava A, 2015, J CLIN DIAGN RES, V9, pCC8, DOI 10.7860/JCDR/2015/12851.6021
   World Health Organization, 1997, WHOMSAMNHPSF974
   Wu KK, 2005, EMERG INFECT DIS, V11, P1297, DOI 10.3201/eid1108.041083
   Wu KK, 2005, J TRAUMA STRESS, V18, P39, DOI 10.1002/jts.20004
   Zondervan KT, 2020, NEW ENGL J MED, V382, P1244, DOI 10.1056/NEJMra1810764
NR 19
TC 5
Z9 5
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD NOV
PY 2020
VL 151
IS 2
BP 249
EP 252
DI 10.1002/ijgo.13339
EA SEP 2020
PG 4
WC Obstetrics & Gynecology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Obstetrics & Gynecology
GA NX6DA
UT WOS:000564424800001
PM 32750726
DA 2022-04-20
ER

PT J
AU Trunz, LM
   Lee, P
   Lange, SM
   Pomeranz, CL
   Needleman, L
   Ford, RW
   Karambelkar, A
   Sundaram, B
AF Trunz, Lukas M.
   Lee, Patrick
   Lange, Steven M.
   Pomeranz, Corbin L.
   Needleman, Laurence
   Ford, Robert W.
   Karambelkar, Ajit
   Sundaram, Baskaran
TI Imaging approach to COVID-19 associated pulmonary embolism
SO INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
LA English
DT Review; Early Access
AB The novel coronavirus disease-2019 (COVID-19) illness and deaths, caused by the severe acute respiratory syndrome coronavirus-2, continue to increase. Multiple reports highlight the thromboembolic complications, such as pulmonary embolism (PE), in COVID-19. Imaging plays an essential role in the diagnosis and management of COVID-19 patients with PE. There continues to be a rapid evolution of knowledge related to COVID-19 associated PE. This review summarises the current understanding of prevalence, pathophysiology, role of diagnostic imaging modalities, and management, including catheter-directed therapy for COVID-19 associated PE. It also describes infection control considerations for the radiology department while providing care for patients with COVID-19 associated PE.
C1 [Trunz, Lukas M.; Lee, Patrick; Lange, Steven M.; Pomeranz, Corbin L.; Needleman, Laurence; Ford, Robert W.; Karambelkar, Ajit; Sundaram, Baskaran] Thomas Jefferson Univ, Dept Radiol, Philadelphia, PA 19107 USA.
RP Trunz, LM (corresponding author), Thomas Jefferson Univ, Dept Radiol, Philadelphia, PA 19107 USA.
EM lukas.trunz@jefferson.edu
RI Trunz, Lukas/AAN-4871-2021
OI Trunz, Lukas/0000-0001-8574-3775; Ford, Robert/0000-0002-8160-3537
CR Abbas A, 2014, POSTGRAD MED J, V90, P422, DOI 10.1136/postgradmedj-2013-132000
   Achey B, 2004, HEALTH PHYS, V86, pS85, DOI 10.1097/00004032-200405002-00009
   Adams E, 2021, ANN VASC SURG, V70, P282, DOI 10.1016/j.avsg.2020.08.088
   Al-Samkari H, 2020, BLOOD, V136, P489, DOI 10.1182/blood.2020006520
   American College of Radiology, 2020, ADV EC ACR POS STAT
   Bai HX, 2020, RADIOLOGY, V296, pE46, DOI 10.1148/radiol.2020200823
   Beckman MG, 2010, AM J PREV MED, V38, pS495, DOI 10.1016/j.amepre.2009.12.017
   Beun R, 2020, INT J LAB HEMATOL, V42, P19, DOI 10.1111/ijlh.13230
   Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
   Bompard F, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01365-2020
   Burger IA, 2020, EUR J NUCL MED MOL I, V47, P2062, DOI 10.1007/s00259-020-04837-4
   Carlsson TL, 2020, BRIT J HAEMATOL, V190, pE143, DOI 10.1111/bjh.16920
   Cattaneo M, 2020, THROMB HAEMOSTASIS, V120, P1230, DOI 10.1055/s-0040-1712097
   Centers for Disease Control and Prevention, 2020, INT INF PREV CONTR R, V19
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Ciceri F, 2020, CRIT CARE RESUSC, V22, P95
   Cozzi D, 2020, RADIOL MED, V125, P730, DOI 10.1007/s11547-020-01232-9
   Davenport MS, 2020, J AM COLL RADIOL, V17, P839, DOI 10.1016/j.jacr.2020.05.001
   Dua A, 2021, J VASC SURG-VENOUS L, V9, P299, DOI 10.1016/j.jvsv.2020.08.005
   England A, 2021, RADIOGRAPHY, V27, P193, DOI 10.1016/j.radi.2020.07.015
   Faggiano P, 2020, INT J CARDIOL, V313, P129, DOI 10.1016/j.ijcard.2020.04.028
   Fauvel C, 2020, EUR HEART J, V41, P3058, DOI 10.1093/eurheartj/ehaa500
   Fraisse M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03025-y
   Francone M, 2020, EUR RADIOL, V30, P6808, DOI 10.1007/s00330-020-07033-y
   Gervaise A, 2020, EUR RADIOL, V30, P6170, DOI 10.1007/s00330-020-06977-5
   Gogna A, 2020, AM J ROENTGENOL, V215, P1130, DOI 10.2214/AJR.20.23167
   Goodacre S, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-6
   Grant MC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234765
   Grillet F, 2020, RADIOLOGY, V296, pE186, DOI 10.1148/radiol.2020201544
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Guneyli S, 2020, DIAGN INTERV RADIOL, V26, P323, DOI 10.5152/dir.2020.20260
   Hani C, 2020, DIAGN INTERV IMAG, V101, P263, DOI 10.1016/j.diii.2020.03.014
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Hu X., 2021, AUTOPHAGY, P1, DOI [DOI 10.1080/15548627.2021.1934271, 10.2214/AJR.20.24044]
   Huang C, 2020, Lancet, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jalaber C, 2020, DIAGN INTERV IMAG, V101, P431, DOI 10.1016/j.diii.2020.06.001
   Kabrhel C, 2013, CHEST, V144, P1738, DOI 10.1378/chest.13-1562
   Kaminetzky Mark, 2020, Radiol Cardiothorac Imaging, V2, pe200308, DOI 10.1148/ryct.2020200308
   Karimzadeh S, 2020, J NUCL MED, V61, P1102, DOI 10.2967/jnumed.120.248518
   Kearon C, 2003, CIRCULATION, V107, pI22, DOI 10.1161/01.CIR.0000078464.82671.78
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Lang Min, 2020, Radiol Cardiothorac Imaging, V2, pe200277, DOI 10.1148/ryct.2020200277
   Le Roux PY, 2020, EUR J NUCL MED MOL I, V47, P2499, DOI 10.1007/s00259-020-04964-y
   Lee DSH, 2017, J THORAC IMAG, V32, pW7, DOI 10.1097/RTI.0000000000000253
   Lee Jun Sung, 2016, Vasc Specialist Int, V32, P166, DOI 10.5758/vsi.2016.32.4.166
   Leonard-Lorant I, 2020, RADIOLOGY, V296, pE189, DOI 10.1148/radiol.2020201561
   Llitjos JF, 2020, J THROMB HAEMOST, V18, P1743, DOI 10.1111/jth.14869
   Lu Y, 2020, EUR J NUCL MED MOL I, V47, P2064, DOI 10.1007/s00259-020-04851-6
   Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007
   McFadyen JD, 2020, CIRC RES, V127, P571, DOI 10.1161/CIRCRESAHA.120.317447
   Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134
   Mestre-Gomez B, 2021, J THROMB THROMBOLYS, V51, P40, DOI 10.1007/s11239-020-02190-9
   Middeldorp S, 2020, J THROMB HAEMOST, V18, P1995, DOI 10.1111/jth.14888
   Minet C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1003-9
   Moore AJE, 2018, CARDIOVASC DIAGN THE, V8, P225, DOI 10.21037/cdt.2017.12.01
   Moores LK, 2020, CHEST, V158, P1143, DOI 10.1016/j.chest.2020.05.559
   Mossa-Basha M, 2020, RADIOLOGY, V296, pE106, DOI 10.1148/radiol.2020200988
   Niu Yantao, 2020, Radiat Med Prot, V1, P75, DOI 10.1016/j.radmp.2020.05.005
   Oudkerk M, 2020, RADIOLOGY, V297, pE216, DOI 10.1148/radiol.2020201629
   Petropoulos F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231236
   Poissy J, 2020, CIRCULATION, V142, P184, DOI 10.1161/CIRCULATIONAHA.120.047430
   Poyiadji N, 2020, RADIOLOGY, V297, pE335, DOI 10.1148/radiol.2020201955
   Qiu Y, 2010, SCAND J IMMUNOL, V72, P425, DOI 10.1111/j.1365-3083.2010.02456.x
   Qu JM, 2020, AM J ROENTGENOL, V215, P940, DOI 10.2214/AJR.20.23112
   Reeves RA, 2021, AM J ROENTGENOL, V217, P623, DOI 10.2214/AJR.20.24801
   Ren B, 2020, CIRCULATION, V142, P181, DOI 10.1161/CIRCULATIONAHA.120.047407
   Renu K, 2020, LIFE SCI, V255, DOI 10.1016/j.lfs.2020.117839
   Revel MP, 2020, EUR RADIOL, V30, P4903, DOI 10.1007/s00330-020-06865-y
   Ridge Carole A, 2020, Radiol Cardiothorac Imaging, V2, pe200428, DOI 10.1148/ryct.2020200428
   Roncon L, 2020, J THROMB THROMBOLYS, V50, P221, DOI 10.1007/s11239-020-02131-6
   Rosovsky RP, 2020, CHEST, V158, P2590, DOI 10.1016/j.chest.2020.08.2064
   Safari S, 2020, ARCH ACAD EMERG MED, V8
   Schmiady MO, 2020, EUR HEART J, V41, P3107, DOI 10.1093/eurheartj/ehaa403
   Schoepf UJ, 2002, RADIOLOGY, V222, P483, DOI 10.1148/radiol.2222001802
   Sheth S, 2020, ULTRASOUND Q, V36, P200, DOI 10.1097/RUQ.0000000000000526
   Sista AK, 2017, RADIOLOGY, V284, P5, DOI 10.1148/radiol.2017151978
   Spyropoulos AC, 2020, J THROMB HAEMOST, V18, P1859, DOI 10.1111/jth.14929
   Tan BS., 2020, RADIOLOGY, DOI DOI 10.1148/RADIOL.2020200988
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Toussie D, 2020, RADIOLOGY, V297, pE197, DOI 10.1148/radiol.2020201754
   van Dam LF, 2020, THROMB RES, V193, P86, DOI 10.1016/j.thromres.2020.06.010
   Wallace A, 2017, CARDIOVASC DIAGN THE, V7, pS207, DOI 10.21037/cdt.2017.09.12
   Wang T, 2020, LANCET HAEMATOL, V7, pE362, DOI 10.1016/S2352-3026(20)30109-5
   Weidman EK, 2018, RADIOLOGY, V289, P546, DOI 10.1148/radiol.2018180594
   Whyte MB, 2020, THROMB RES, V195, P95, DOI 10.1016/j.thromres.2020.07.025
   Yao YM, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00466-z
   Zhang L, 2020, CIRCULATION, V142, P114, DOI 10.1161/CIRCULATIONAHA.120.046702
   Zuckier LS, 2020, J NUCL MED, V61, P630, DOI 10.2967/jnumed.120.245571
   Zuin M, 2016, INT J CARDIOL, V225, P14, DOI 10.1016/j.ijcard.2016.09.104
NR 89
TC 0
Z9 0
U1 0
U2 1
PU WILEY-HINDAWI
PI LONDON
PA ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND
SN 1368-5031
EI 1742-1241
J9 INT J CLIN PRACT
JI Int. J. Clin. Pract.
AR e14340
DI 10.1111/ijcp.14340
EA MAY 2021
PG 13
WC Medicine, General & Internal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Pharmacology & Pharmacy
GA SG2AL
UT WOS:000653245400001
PM 33966326
OA Green Published, Green Submitted, Bronze
DA 2022-04-20
ER

PT J
AU Limbu, DK
   Piryani, RM
   Sunny, AK
AF Limbu, Dil K.
   Piryani, Rano M.
   Sunny, Avinash K.
TI Healthcare workers' knowledge, attitude and practices during the
   COVID-19 pandemic response in a tertiary care hospital of Nepal
SO PLOS ONE
LA English
DT Article
AB Background
   COVID-19 is an ongoing pandemic, for which appropriate infection prevention and control measures need to be adopted. Healthcare workers' adherence to prevention and control measures is affected by their knowledge, attitudes, and practices (KAP) towards COVID-19. In this study, we assessed the KAP among healthcare workers towards the COVID-19 during the ongoing pandemic.
   Method
   A self-developed piloted KAP questionnaire was administered to the recruited healthcare workers involved in the COVID-19 response at the Universal College of Medical Sciences Teaching Hospital (UCMSTH), in Bhairahawa, Nepal. The knowledge questionnaire consisted of questions regarding the clinical characteristics, prevention, and management of COVID-19. Assessment on attitudes and practices towards COVID-19 included questions on behaviour and change in practices made towards COVID-19 response. Knowledge scores were calculated and compared by demographic characteristics and their attitude and practices towards COVID-19. Data were analysed using bivariate statistics.
   Results
   A total of 103 healthcare workers participated in the study. The mean age of the participants was 28.24 +/- 6.11 years (range: 20-56); 60.2% were females; 61.2% were unmarried; 60.2% had a medical degree, and 39.8% were the nursing staff. The mean knowledge score was 10.59 +/- 1.12 (range: 7-13), and it did not vary significantly when adjusted for demographic characteristics. The attitude was positive for 53.4% of the participants with a mean knowledge score of 10.35 +/- 1.19 and negative for 46.6% participants with a mean knowledge score of 10.88 +/- 0.98 (p = 0.02). The practice was good (>= 3 score) for 81.5% participants with a mean knowledge score of 10.73 +/- 1.12 and poor for 18.5% participants with a mean knowledge score of 10.46 +/- 1.13 (p = 0.24). The attitude of the participants improved with increasing age (29.55 +/- 7.17, p = 0.02).
   Conclusion
   There is comparably better knowledge regarding COVID-19 among healthcare workers. Appropriate practice correlates with better knowledge and positive attitude towards COVID-19 infection is seen with increasing age. Hence, training on protection and protective measures for having a positive attitude among healthcare workers is necessary against the fight with COVID-19 infection.
C1 [Limbu, Dil K.] Univ Coll Med Sci, Dept Gen Practice & Emergency Med, Bhairahawa, Nepal.
   [Piryani, Rano M.] Univ Coll Med Sci, Dept Internal Med, Bhairahawa, Nepal.
   [Sunny, Avinash K.] Golden Community, Res Div, Lalitpur, Nepal.
RP Sunny, AK (corresponding author), Golden Community, Res Div, Lalitpur, Nepal.
EM avinashkayastha@gmail.com
RI Piryani, Rano Mal/ABF-8765-2020
OI Piryani, Rano Mal/0000-0003-2574-7226; Kayastha,
   Avinash/0000-0002-9965-181X
CR Ghebreyesus TA, 2020, WORLD PSYCHIATRY, V19, P129, DOI 10.1002/wps.20768
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Jiang LL, 2018, J HOSP INFECT, V98, P404, DOI 10.1016/j.jhin.2017.10.020
   McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4
   Ministry of Health and Population Nepal, 2020, 173 MIN JUST, P1
   Murthy S, 2020, JAMA-J AM MED ASSOC, V323, P1499, DOI 10.1001/jama.2020.3633
   Pradhan TR, 2020, KATHMANDU POST
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002
   WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184
   World Health Organization, 152 WHO
   World Health Organization, 2020, CLIN MAN COVID 19 IN
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
NR 14
TC 16
Z9 16
U1 2
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 6
PY 2020
VL 15
IS 11
AR e0242126
DI 10.1371/journal.pone.0242126
PG 8
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA OU2PV
UT WOS:000591376400047
PM 33156873
OA gold, Green Published, Green Submitted
DA 2022-04-20
ER

PT J
AU Almino, RHSC
   de Oliveira, SS
   de Lima, DM
   Prado, NCD
   Merces, BNMO
   da Silva, RAR
AF Silva Costa Almino, Romanniny Hevillyn
   de Oliveira, Sylvia Silva
   de Lima, Dhyanine Morais
   da Costa Prado, Nanete Caroline
   Oliveira Merces, Bn Na Maria
   Rosendo da Silva, Richardson Augusto
TI Occupational stress in the context of COVID-19: analysis based on
   Neuman's theory
SO ACTA PAULISTA DE ENFERMAGEM
LA English
DT Review
DE COVID-19; Coronavirus infections; Disease prevention; Nursing theory;
   Occupational stress; Pandemics
ID PERCEPTIONS; BEHAVIORS
AB Objective: To identify occupational stressors in healthcare professionals and interventions focused on prevention in the context of COVID-19, based on betty Neuman's systems model. Method: A literature review was conducted with the scoping review method, according to Joanna Briggs Institute in the databases The Cochrane Library, Scopus, Web of Science, National Library of Medicine (MEDLINE/PubMed), The Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Latin American and Caribbean Literature on Health Sciences (LILACS). Studies related to stressors and interventions aimed at prevention in the face of occupational stress in healthcare professionals in the context of COVID-19, published in any language and available, in full, free of charge were included. Data were analyzed in the light of Betty Neuman's Theory. Results: The final sample consisted of 27 articles. The stressors identified were categorized into intrapersonal: fear of contagion and restricted knowledge of the disease; interpersonal: change in social relationships and fear of transmission to family members, experiencing the illness of colleagues and family members and loss of loved ones; inadequate health system and work overload. Interventions focused on prevention were indexed according to the level of primary, secondary and tertiary healthcare. Conclusion: Most studies have emphasized primary prevention measures. The use of the theoretical framework will allow nurses and health managers to make decisions and develop future interventions for the management of occupational stress of professionals who deal daily with COVID-19.
C1 [Silva Costa Almino, Romanniny Hevillyn] Univ Fed Rio Grande do Norte, Natal, RN, Brazil.
EM rirosendo@hotmail.com
CR Abdulah Deldar Morad, 2020, Sleep Med X, V2, P100017, DOI 10.1016/j.sleepx.2020.100017
   Babore A, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113366
   Cai WP, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102111
   Castelo Branco de Oliveira Ana Lívia, 2018, av.enferm., V36, P79, DOI 10.15446/av.enferm.v36n1.61488
   Center for Disease Control and Prevention (CDC). The National Institute for Occupational Safety and Health (NIOSH), 2020, STRESS WORK
   Chen HJ, 2020, J CLIN NURS, V29, P4161, DOI 10.1111/jocn.15444
   Chersich MF, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00574-3
   Chew NWS, 2020, BRAIN BEHAV IMMUN, V88, P559, DOI 10.1016/j.bbi.2020.04.049
   Elhadi M, 2020, J PSYCHOSOM RES, V137, DOI 10.1016/j.jpsychores.2020.110221
   Hou TY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233831
   Kackin O, 2021, INT J SOC PSYCHIATR, V67, P158, DOI 10.1177/0020764020942788
   Kang LJ, 2020, BRAIN BEHAV IMMUN, V87, P11, DOI 10.1016/j.bbi.2020.03.028
   Keubo FRN, 2021, ANN MED-PSYCHOL, V179, P141, DOI 10.1016/j.amp.2020.08.012
   Khan MA, 2020, OPHTHALMOL RETINA, V4, P1181, DOI 10.1016/j.oret.2020.05.011
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Li ZY, 2020, BRAIN BEHAV IMMUN, V88, P916, DOI 10.1016/j.bbi.2020.03.007
   Lorente L, 2021, J ADV NURS, V77, P1335, DOI 10.1111/jan.14695
   Lu W, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112936
   Luo TD., 2020, ZHONGHUA LAO DONG WE, V38, P192, DOI [DOI 10.3760/CMA.J.CN121094-20200219-00063, 10.3760/cma.j.cn121094-20200219-00063]
   Mo YY, 2020, J NURS MANAGE, V28, P1002, DOI 10.1111/jonm.13014
   Neuman B., 2011, NEUMAN SYSTEMS MODEL, V5 edn
   Nochaiwong S, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020751
   Peterson M, 2017, INTRODUCTION TO DECISION THEORY, 2ND EDITION, P141
   Que JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100259
   Salopek-Ziha D, 2020, PSYCHIAT DANUB, V32, P287, DOI 10.24869/psyd.2020.287
   Sethi BA, 2020, PAK J MED SCI, V36, pS6, DOI 10.12669/pjms.36.COVID19-S4.2779
   Shechter A, 2020, GEN HOSP PSYCHIAT, V66, P1, DOI 10.1016/j.genhosppsych.2020.06.007
   Song XY, 2020, BRAIN BEHAV IMMUN, V88, P60, DOI 10.1016/j.bbi.2020.06.002
   Vally Z, 2020, PUBLIC HEALTH, V187, P67, DOI 10.1016/j.puhe.2020.08.002
   Xiao H, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923921
   Zhang WR, 2020, PSYCHOTHER PSYCHOSOM, V89, P242, DOI 10.1159/000507639
NR 34
TC 0
Z9 0
U1 1
U2 1
PU UNIV FED SAO PAULO, DEPT ENFERMAGEN
PI SAO PAULO
PA RUA NAPOLEAO DE BARROS, 754 VILA CLEMENTINO, SAO PAULO, CEP04024-002,
   BRAZIL
SN 0103-2100
EI 1982-0194
J9 ACTA PAUL ENFERM
JI Acta Paul. Enferm.
PY 2021
VL 34
AR eAPE002655
DI 10.37689/acta-ape/2021AR02655
PG 11
WC Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing
GA YR1KA
UT WOS:000749756400006
DA 2022-04-20
ER

PT J
AU Crisci, CD
   Ardusso, LRF
   Mossuz, A
   Muller, L
AF Crisci, Carlos D.
   Ardusso, Ledit R. F.
   Mossuz, Antonela
   Mueller, Leila
TI A Precision Medicine Approach to SARS-CoV-2 Pandemic Management
SO CURRENT TREATMENT OPTIONS IN ALLERGY
LA English
DT Article
DE Precision medicine; COVID-19; Biomarkers; Coronavirus management
   algorithm
ID SARS; CORONAVIRUS; COVID-19; RECEPTOR; PNEUMONIA; WUHAN; ACE2
AB Purpose of reviewPrecision medicine (PM) represents a new paradigm in disease diagnosis, prevention, and treatment. To apply PM premises in an emerging coronavirus pandemic acquires potentially greater relevance in order to allow the selection of specific preventive measures as well as biomarkers that will be useful in disease management.Recent findingsThe identification of the new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as the responsible for the coronavirus disease 2019 (COVID-19) pandemic had led to a plethora of strategies to contain viral dissemination, affecting life styles and personal behaviors. Viral genomic sequencing has shown that SARS-CoV-2 spike protein utilizes angiotensin-converting enzyme 2 (ACE2) found on ciliated epithelial cells of the human lungs as its specific receptor. Neutralizing antibodies to the receptor-binding domain of the spike protein were detected in patients recovered from COVID-19; however, both T cells and NK cells were reduced in severe cases. Excessive and uncontrolled releases of pro-inflammatory cytokines such as IL-1B, IL-1RA, IL-7, IL-8, IL-9, IL-10, fibroblast growth factor (FGF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor (TNF alpha) were increased in severe patients. These cytokines might be useful biomarkers of disease worsening and potential targets for new biological therapies currently under investigation.SummaryPresent knowledge and recent developments in PM approach to COVID-19 disease prevention, evaluation, and management are pointed out. Better understanding of pathogenic pathways together with an accurate phenotype classification of patients presented with SARS-CoV-2 infection and symptoms might contribute to a more accurate definition of biomarkers and other diagnostic tools, which may lead to more precise mitigation strategies, personalized pharmacologic options, as well as new biological therapy developments.
C1 [Crisci, Carlos D.] Natl Univ Rosario, Sch Med, Dept Pulmonol Allergy & Immunol, RA-2000 Rosario, Santa Fe, Argentina.
   [Ardusso, Ledit R. F.] Natl Univ Rosario, Sch Med, Allergy & Immunol, Rosario, Argentina.
   [Mossuz, Antonela; Mueller, Leila] Hosp Centenario, Allergy & Immunol Dept, Rosario, Argentina.
RP Crisci, CD (corresponding author), Natl Univ Rosario, Sch Med, Dept Pulmonol Allergy & Immunol, RA-2000 Rosario, Santa Fe, Argentina.
EM carlosdcrisci@gmail.com
CR [Anonymous], 2020, CORONAVIRUS DIS 2019
   Bao L., 2020, REINFECTION COULD NO, V2020
   Caly Leon, 2020, Antiviral Res, V178, P104787, DOI 10.1016/j.antiviral.2020.104787
   Casadevall A, 2020, J CLIN INVEST, V130, P1545, DOI 10.1172/JCI138003
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen Y., 2020, CHARACTERISTICS LYMP, DOI [10.1101/2020.02.10.20021832, DOI 10.1101/2020.02.10.20021832]
   Conti P, 2020, J BIOL REG HOMEOS AG, V34, P327, DOI 10.23812/CONTI-E
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Diaz JH, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa041
   Dulal, 2020, THERAPEUTIC APPL CHL
   Esler M, 2020, J HYPERTENS, V38, P781, DOI 10.1097/HJH.0000000000002450
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   FDA, 2020, QSARS COV 2 IGG IGM
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Gralinski LE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020135
   Guo XZJ, 2017, SEMIN IMMUNOPATHOL, V39, P541, DOI 10.1007/s00281-017-0636-y
   Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304
   Han XY, 2020, CLIN INFECT DIS, V71, P723, DOI 10.1093/cid/ciaa271
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640
   Li XW, 2020, J PHARM ANAL, V10, P102, DOI 10.1016/j.jpha.2020.03.001
   Lippi G, 2020, THROMB HAEMOSTASIS, V120, P876, DOI 10.1055/s-0040-1709650
   Liu WL, 2021, CRIT REV FOOD SCI, V61, P2742, DOI 10.1080/10408398.2020.1784841
   Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021
   Lu S, 2020, EMERG MICROBES INFEC, V9, P542, DOI 10.1080/22221751.2020.1737580
   MAIZTEGUI JI, 1979, LANCET, V2, P1216
   Maxwell KL, 2019, NATURE, V574, P638, DOI 10.1038/d41586-019-02974-x
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Menachery VD, 2016, P NATL ACAD SCI USA, V113, P3048, DOI 10.1073/pnas.1517719113
   Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985
   Miller A., 2020, CORRELATION UNIVERSA, DOI [10.1101/2020.03.24.20042937, 10.1101/2020.03.24.20042937., DOI 10.1101/2020.03.24.20042937]
   Min JY, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/649570
   Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794
   Montreal Heart Institute, 2020, COLCH COR SARS COV2
   Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370
   Pang JX, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030623
   Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248
   Robinson J, 2020, EPIDEMICS PANDEMICS
   Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Russell B, 2020, ECANCERMEDICALSCIENC, V14, DOI 10.3332/ecancer.2020.1023
   Sagner M, 2017, PROG CARDIOVASC DIS, V59, P506, DOI 10.1016/j.pcad.2016.08.002
   Sanchez-Ramon S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02936
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Shi C, 2020, POTENTIAL LOW MOL WE, V28, DOI [10.1101/2020.03.28.20046144, DOI 10.1101/2020.03.28.20046144]
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Shimabukuro-Vornhagen A, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0343-9
   Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012
   Sly PD, 2019, J ALLERGY CLIN IMMUN, V144, P870, DOI 10.1016/j.jaci.2019.05.032
   Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4
   To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1
   Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang W, 2016, HYPERTENSION, V68, P365, DOI 10.1161/HYPERTENSIONAHA.115.06892
   WANG Y, 2019, J INFECT DIS INTERNE, DOI DOI 10.1093/INFDIS/JIZ656/5673088
   Watkins J, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m810
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
   Xiao S, 2018, INDOOR AIR, V28, P51, DOI 10.1111/ina.12430
   Xie XZ, 2020, RADIOLOGY, V296, pE41, DOI 10.1148/radiol.2020200343
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yao XH, 2020, ZHONGHUA BING LI XUE, V49, P411, DOI DOI 10.3760/CMA.J.CN112151-20200312-00193
   Zhang C, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105954
   Zhang JS, 2005, J MED VIROL, V77, P147, DOI 10.1002/jmv.20431
   Zhang W, 2020, CLIN IMMUNOL, V214, DOI 10.1016/j.clim.2020.108393
   Zhao W, 2020, AM J ROENTGENOL, V214, P1072, DOI 10.2214/AJR.20.22976
   Zhou, 2020, EARLY LOW DOSE SHORT, DOI 10.1101/2020.03.06.20032342
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 73
TC 19
Z9 19
U1 1
U2 2
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2196-3053
J9 CURR TREAT OPTION AL
JI Curr. Treat. Options Allerg.
PD SEP
PY 2020
VL 7
IS 3
BP 422
EP 440
DI 10.1007/s40521-020-00258-8
PG 19
WC Allergy
WE Emerging Sources Citation Index (ESCI)
SC Allergy
GA WA7HH
UT WOS:000703055700016
PM 32391242
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Shi, CH
   Zhu, HL
   Liu, J
   Zhou, J
   Tang, WH
AF Shi, Chunhong
   Zhu, Haili
   Liu, Jun
   Zhou, Jian
   Tang, Weihong
TI Barriers to Self-Management of Type 2 Diabetes During COVID-19 Medical
   Isolation: A Qualitative Study
SO DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
LA English
DT Article
DE diabetes mellitus; quarantine; recovery from Coronavirus; treatment
ID GLYCEMIC CONTROL; CARE MANAGEMENT; SOCIAL SUPPORT; PERCEPTIONS;
   ASSOCIATION; POPULATION; ADHERENCE; BEHAVIORS; MELLITUS; OUTCOMES
AB Purpose: Diabetes self-management behaviors are necessary to obtain optimum glycemic control, reduce the risk of complications, and improve health outcomes. The COVID-19 pandemic imposes an additional struggle for self-management by diabetes patients. Although previous studies have reported socio-demographic, behavioral, psychological, and cultural barriers to diabetes self-management, little is known about perceived barriers to diabetes self-management among patients during isolation following their recovery from COVID-19. The purpose of this study was to explore perceived barriers among type 2 diabetes patients during isolation following their recovery from COVID-19.
   Patients and Methods: A qualitative, exploratory, and descriptive research design was utilized. Semi-structured telephonic interviews were conducted with 12 patients with diabetes who had been discharged from one COVID-19 designated hospital and underwent isolation in the designated facilities in Wuhan City, Hubei Province, China. Data were analyzed using Colaizzi's seven steps.
   Results: Barriers to diabetes self-management identified by patients with diabetes during isolation were categorized into five major themes: inadequate knowledge and behavioral beliefs, shortage of resources, suffering from health problems, negative emotions, and lack of support.
   Conclusion: Perceived barriers to diabetes self-management described by diabetes patients indicated a lack of environmental resources and support strategies to meet their needs. Efforts to remove barriers are important in assisting patients with diabetes to improve their quality of life and health outcomes.
C1 [Shi, Chunhong] Xiangnan Univ, Sch Nursing, Chenzhou 423000, Peoples R China.
   [Zhu, Haili; Liu, Jun; Zhou, Jian; Tang, Weihong] Hunan Acad Tradit Chinese Med Affiliated Hosp, 58 Lushan Rd, Changsha 410006, Hunan, Peoples R China.
RP Zhu, HL (corresponding author), Hunan Acad Tradit Chinese Med Affiliated Hosp, 58 Lushan Rd, Changsha 410006, Hunan, Peoples R China.
EM zhuhaili09@126.com
OI Shi, Chunhong/0000-0002-2633-221X
FU First-Class Nursing Discipline Open Fund of Hunan University of
   Traditional Chinese Medicine [2019HLX03]; Research Project of Hunan
   Academy of Traditional Chinese Medicine [201905]
FX This study was supported by the First-Class Nursing Discipline Open Fund
   of Hunan University of Traditional Chinese Medicine [grant number
   2019HLX03], the Research Project of Hunan Academy of Traditional Chinese
   Medicine [grant number 201905].
CR [Anonymous], 2017, Beijing Da Xue Xue Bao Yi Xue Ban, V49, P455
   Armitage R, 2020, LANCET PUBLIC HEALTH, V5, pE256, DOI 10.1016/S2468-2667(20)30061-X
   Asif Mohammad, 2014, J Educ Health Promot, V3, P1, DOI 10.4103/2277-9531.127541
   Bogoch II, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa008
   Brufsky A, 2020, J MED VIROL, V92, P770, DOI 10.1002/jmv.25887
   Bullen Benjamin, 2019, Foot (Edinb), V38, P65, DOI 10.1016/j.foot.2019.01.004
   Byers D, 2016, J HLTH DISPARITIES R, V9, P9
   Christensen NI, 2020, PATIENT PREFER ADHER, V14, P569, DOI 10.2147/PPA.S237631
   Colaizzi P., 1978, PSYCHOL RES PHENOMEN
   FOROUHI NG, 2018, BMJ-BRIT MED J, V361, DOI DOI 10.1136/BMJ.K223442
   Fritz HA, 2017, HEALTH SOC CARE COMM, V25, P26, DOI 10.1111/hsc.12172
   Goderis G, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-41
   Gonzalez JS, 2016, AM PSYCHOL, V71, P539, DOI 10.1037/a0040388
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Gucciardi E, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-33
   Gupta R, 2020, DIABETES METAB SYND, V14, P211, DOI 10.1016/j.dsx.2020.03.002
   Hu J, 2013, DIABETES EDUCATOR, V39, P494, DOI 10.1177/0145721713486200
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hunt CW, 2015, WORLD J DIABETES, V6, P225, DOI 10.4239/wjd.v6.i2.225
   Ilias I, 2020, MED HYPOTHESES, V139, DOI 10.1016/j.mehy.2020.109699
   [嵇加佳 Ji Jiajia], 2014, [中华护理杂志, Chinese Journal of Nursing], V49, P617
   Ji MH, 2020, NURS RES, V69, pE9, DOI 10.1097/NNR.0000000000000401
   Ji MH, 2019, DIABETES EDUCATOR, V45, P105, DOI 10.1177/0145721718811561
   Kato A, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2015-000156
   Kato A, 2016, PATIENT EDUC COUNS, V99, P1233, DOI 10.1016/j.pec.2016.02.002
   Kueh YC, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0303-8
   Kulhawy-Wibe S, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0385-7
   Lee LT, 2017, JNP-J NURSE PRACT, V13, P265, DOI 10.1016/j.nurpra.2016.07.013
   Lin C-Y, 2020, SOCIAL HLTH BEHAV, V3, P1, DOI [10.4103/SHB.SHB_11_20, DOI 10.4103/SHB.SHB_11_20]
   Lin KK, 2017, DIABETES RES CLIN PR, V131, P179, DOI 10.1016/j.diabres.2017.03.013
   Lincoln Y.S., 1985, NATURALISTIC INQUIRY
   Logie CH, 2020, AIDS BEHAV, V24, P2003, DOI 10.1007/s10461-020-02856-8
   Lorig K, 2000, DIABETES SPECTRUM, V13, P234
   Lorig K, 2009, DIABETES EDUCATOR, V35, P641, DOI 10.1177/0145721709335006
   Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01
   Maddaloni E, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3321
   McClintock HFDV, 2015, FAM COMMUNITY HEALTH, V38, P169, DOI 10.1097/FCH.0000000000000069
   Mikhael EM, 2019, DIABETES METAB SYNDR, V12, P1, DOI 10.2147/DMSO.S183776
   Muniyappa R, 2020, AM J PHYSIOL-ENDOC M, V318, pE736, DOI 10.1152/ajpendo.00124.2020
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Pal R, 2021, PRIM CARE DIABETES, V15, P10, DOI 10.1016/j.pcd.2020.07.001
   Pancani L, 2020, FORCED SOCIAL ISOLAT, DOI [10.31234/osf.io/uacfj, DOI 10.31234/0SF.I0/UACFJ56]
   Poth CN., 2016, QUAL INQ
   Rani MA, 2019, J PRIM CARE COMMUNIT, V10, DOI 10.1177/2150132719865820
   Schiotz ML, 2012, DIABETIC MED, V29, P654, DOI 10.1111/j.1464-5491.2011.03485.x
   Shao YC, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/2804178
   Smalls BL, 2015, J DIABETES COMPLICAT, V29, P186, DOI 10.1016/j.jdiacomp.2014.10.008
   State Council response to novel coronavirus infection pneumonia and joint prevention and control mechanism, 2020, STATE COUNCIL RESPON
   Tan CCL, 2018, J NURS RES, V26, P242, DOI 10.1097/jnr.0000000000000226
   Tan CCL, 2015, INT J NURS PRACT, V21, P115, DOI 10.1111/ijn.12388
   Tewahido D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169062
   THOMAS ML, 2018, CHIN J DIABETES MELL, V10, DOI DOI 10.3390/CANCERS10040101
   Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042
   Townsend K, 2013, ANZAM C 2013 HOB TAS
   Wang X, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108200
   Weng JP, 2014, CHIN J DIABETES, V7, P4
   World Health Organization, SURV CAS DEF HUM INF
   Xue ZP, 2020, SLEEP MED, V70, P112, DOI 10.1016/j.sleep.2020.04.014
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017
   Yang K, 2009, DIABETES EDUCATOR, V35, P770, DOI 10.1177/0145721709338528
   Zeh P., 2014, DIVERS EQUAL HLTH CA, V11, P9, DOI [10.21767/2049-5471.100 001, DOI 10.21767/2049-5471.100001]
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
   Zhu L, 2020, CARDIORENAL MED, V10, P470, DOI 10.1159/000510916
NR 63
TC 7
Z9 7
U1 0
U2 7
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-7007
J9 DIABET METAB SYND OB
JI Diabetes Metab. Syndr. Obes.
PY 2020
VL 13
BP 3713
EP 3725
DI 10.2147/DMSO.S268481
PG 13
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Endocrinology & Metabolism
GA OD3XF
UT WOS:000579786100002
PM 33116721
OA Green Published
DA 2022-04-20
ER

PT J
AU Hasler, B
   Bazeyo, W
   Byrne, AW
   Hernandez-Jover, M
   More, SJ
   Ruegg, SR
   Schwarzmann, O
   Wilson, J
   Yawe, A
AF Hasler, Barbara
   Bazeyo, William
   Byrne, Andrew W.
   Hernandez-Jover, Marta
   More, Simon J.
   Ruegg, Simon R.
   Schwarzmann, Ofir
   Wilson, Jeff
   Yawe, Agnes
TI Reflecting on One Health in Action During the COVID-19 Response
SO FRONTIERS IN VETERINARY SCIENCE
LA English
DT Article
DE SARS-CoV-2; One Health; infectious disease epidemiology; collaborative
   networks; community network integration; knowledge integration
ID BIOSECURITY
AB The COVID-19 pandemic, a singular disruptive event in recent human history, has required rapid, innovative, coordinated and collaborative approaches to manage and ameliorate its worst impacts. However, the threat remains, and learning from initial efforts may benefit the response management in the future. One Health approaches to managing health challenges through multi-stakeholder engagement are underscored by an enabling environment. Here we describe three case studies from state (New South Wales, Australia), national (Ireland), and international (sub-Saharan Africa) scales which illustrate different aspects of One Health in action in response to the COVID-19 pandemic. In Ireland, a One Health team was assembled to help parameterise complex mathematical and resource models. In New South Wales, state authorities engaged collaboratively with animal health veterinarians and epidemiologists to leverage disease outbreak knowledge, expertise and technical and support structures for application to the COVID-19 emergency. The African One Health University Network linked members from health institutions and universities from eight countries to provide a virtual platform knowledge exchange on COVID-19 to support the response. Themes common to successful experiences included a shared resource base, interdisciplinary engagement, communication network strategies, and looking global to address local need. The One Health approaches used, particularly shared responsibility and knowledge integration, are benefiting the management of this pandemic and future One Health global challenges.
C1 [Hasler, Barbara] Royal Vet Coll, Vet Epidemiol Econ & Publ Hlth Grp, Dept Pathobiol & Populat Sci, Hatfield, Herts, England.
   [Bazeyo, William; Yawe, Agnes] Makerere Univ, Africa One Hlth Univ Network AFROHUN, Kampala, Uganda.
   [Byrne, Andrew W.] Govt Ireland, Dept Agr Food & Marine, One Hlth Sci Support Unit, Celbridge, Ireland.
   [Hernandez-Jover, Marta] Charles Sturt Univ, Sch Anim & Vet Sci, Fac Sci, Wagga Wagga, NSW, Australia.
   [Hernandez-Jover, Marta] Graham Ctr Agr Innovat, NSW Dept Primary Ind, Wagga Wagga, NSW, Australia.
   [Hernandez-Jover, Marta] Charles Sturt Univ, Wagga Wagga, NSW, Australia.
   [More, Simon J.] Univ Coll Dublin UCD, Sch Vet Med, Ctr Vet Epidemiol & Risk Anal, Dublin, Ireland.
   [Ruegg, Simon R.] Univ Zurich, Vetsuisse Fac, Sect Epidemiol, Zurich, Switzerland.
   [Schwarzmann, Ofir] New South Wales Dept Primary Ind, Biosecur & Food Safety, Orange, NSW, Australia.
   [Wilson, Jeff] Novometrix Res Inc, Moffat, ON, Canada.
RP Hasler, B (corresponding author), Royal Vet Coll, Vet Epidemiol Econ & Publ Hlth Grp, Dept Pathobiol & Populat Sci, Hatfield, Herts, England.
EM bhaesler@rvc.ac.uk
RI Rüegg, Simon/A-3134-2013; Byrne, Andrew/N-3894-2015; Hernandez-Jover,
   Marta/F-8688-2016
OI Rüegg, Simon/0000-0002-6732-3870; Byrne, Andrew/0000-0003-0296-4586;
   More, Simon/0000-0002-4270-0385; Hernandez-Jover,
   Marta/0000-0001-8803-9062
CR Animal Health Committee, 2020, MAN EM AN DIS OUTBR
   [Anonymous], **NON-TRADITIONAL**
   Antoine-Moussiaux N, 2019, SUSTAIN SCI, V14, P1729, DOI 10.1007/s11625-019-00674-z
   ASPPH, 2007, MAST DEGR PUBL HLTH
   Barber A., 2020, BASIC REPROD NUMBER, DOI [10.1101/2020.07.28.20163535, DOI 10.1101/2020.07.28.20163535]
   Byrne, 2020, PRESYMPTOMATIC TRANS, DOI [10.1101/2020.05.08.20094870, DOI 10.1101/2020.05.08.20094870]
   Byrne AW, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039856
   Canyon Deon V, 2013, Hawaii J Med Public Health, V72, P440
   Cook DC, 2010, RISK ANAL, V30, P1303, DOI 10.1111/j.1539-6924.2010.01439.x
   Council of Australian Governments, 2012, INT AGR BIOS
   Craik W, 2017, PRIORITIES AUSTR BIO, P188
   Department of Health, 2020, AUSTR HLTH SECT EM R
   Dept of Health, 2020, NAT PUBL HLTH EM TEA
   Dept . of Health, 2020, IR EP MOD ADV GROUP
   Dept . of Parliamentary Services, 2020, AUSTR COVID 19 RESP
   DeSavigny D, 2009, SYSTEMS THINKING FOR HEALTH SYSTEMS STRENGTHENING, P1
   Enticott G, 2008, ENVIRON PLANN A, V40, P1568, DOI 10.1068/a40304
   Griffin JM., 2020, RAPID REV AVAILABLE, DOI [10.1101/2020.05.08.20095075, DOI 10.1101/2020.05.08.20095075]
   Hanfling DG, 2012, CRISIS STANDARDS CAR
   Higgins V, 2016, ENVIRON PLANN A, V48, P1133, DOI 10.1177/0308518X16633471
   Hitziger M, 2018, B WORLD HEALTH ORGAN, V96, P211, DOI [10.2471/BLT.17.202705, 10.2471/blt.17.202705]
   Lane, 2020, RELATIVE INFECTIOUSN, DOI [10.1101/2020.07.30.20165084, DOI 10.1101/2020.07.30.20165084]
   Lane EA, 2020, COUNTRY DIFFERENCES, DOI [10.1101/2020.05.12.20099473, DOI 10.1101/2020.05.12.20099473]
   McAloon C, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039652
   Mwacalimba KK, 2015, HEALTH POLICY PLANN, V30, P215, DOI 10.1093/heapol/czu001
   NSW Health, 2020, NSW HLTH INFL PAND P
   Ruegg SR, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00020
   Ruegg SR, 2020, ONE HLTH CONTINUES E, DOI [10.24445/conexus.2020.03.003, DOI 10.24445/CONEXUS.2020.03.003]
   Simpson M, 2014, AUSTR BIOSECURITY FU
   Wilson JB, 2020, PREV VET MED, V175, DOI 10.1016/j.prevetmed.2019.104870
   Zinsstag J, 2011, PREV VET MED, V101, P148, DOI 10.1016/j.prevetmed.2010.07.003
NR 31
TC 5
Z9 5
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2297-1769
J9 FRONT VET SCI
JI Front. Vet. Sci.
PD OCT 30
PY 2020
VL 7
AR 578649
DI 10.3389/fvets.2020.578649
PG 6
WC Veterinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Veterinary Sciences
GA OQ3EC
UT WOS:000588669500001
PM 33195585
OA Green Published, Green Accepted, gold
DA 2022-04-20
ER

PT J
AU Wagner, CM
   Swanson, EA
   Moorhead, S
   Mantovani, VM
   Dunn-Lopez, K
   Macieira, TGR
   Abe, N
   Breitenstein, S
AF Wagner, Cheryl Marie
   Swanson, Elizabeth A.
   Moorhead, Sue
   Mantovani, Vanessa Monteiro
   Dunn-Lopez, Karen
   Macieira, Tamara G. R.
   Abe, Noriko
   Breitenstein, Susie
TI NANDA-I, NOC, and NIC linkages to SARS-CoV-2 (COVID-19): Part 3. Family
   response
SO INTERNATIONAL JOURNAL OF NURSING KNOWLEDGE
LA English
DT Article
DE COVID-19 pandemic; family and caregiver needs; NANDA-I; NIC; NOC
   linkages
ID SELF-MANAGEMENT; SOCIAL SUPPORT; STRESS; RESILIENCE; CAREGIVERS; CARE
AB Purpose To provide guidance to nurses caring for families with COVID-19, we developed linkages using interoperable standardized nursing terminologies: NANDA International (NANDA-I) nursing diagnoses, Nursing Interventions Classification (NIC), and Nursing Outcomes Classification (NOC). In addition, we wanted to identify gaps in the terminologies and potential new nursing diagnoses, outcomes, and interventions for future development related to nurse roles in family care during a pandemic.
   Methods Using a consensus process, seven nurse experts created the linkages focused on families during the COVID-19 pandemic using the following steps: (1) creating an initial list of potential nursing diagnoses, (2) selecting and categorizing outcomes that aligned with all components of each nursing diagnosis selected, and (3) identifying relevant nursing interventions.
   Findings We identified a total of seven NANDA-I nursing diagnoses as the basis for the linkage work. These are distributed in three NANDA-I Domains and based in the psychosocial dimension of the Nursing Care in Response to Pandemics model. Eighty-nine different NOC outcomes were identified to guide care based on the nursing diagnoses, and 54 different NIC interventions were suggested as possible interventions. Fifteen new proposed concepts were identified for future development across the three classifications.
   Conclusions The linkages of nursing diagnoses, outcomes, and interventions provide a guide to enhance nursing practice and care documentation that could quantify the impact of nursing care to patient outcomes for families at risk for or infected by COVID-19.
   Implications for Nursing Practice NANDA-I, NOC, and NIC linkages identified in this paper provide resources to support clinical decisions and guide critical thinking for nurses encountering care needs of families with COVID-19. Documentation of these linkages provides data that can create new knowledge to enhance the care of families impacted by COVID-19.
C1 [Wagner, Cheryl Marie; Swanson, Elizabeth A.; Moorhead, Sue; Dunn-Lopez, Karen; Abe, Noriko] Univ Iowa, Coll Nursing, 50 Newton Rd, Iowa City, IA 52242 USA.
   [Mantovani, Vanessa Monteiro] Univ Fed Rio Grande do Sul, Sch Nursing, Porto Alegre, RS, Brazil.
   [Macieira, Tamara G. R.] Univ Florida, Coll Nursing, Gainesville, FL 32611 USA.
   [Breitenstein, Susie] Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA.
RP Wagner, CM (corresponding author), Univ Iowa, Coll Nursing, 50 Newton Rd, Iowa City, IA 52242 USA.
EM c.wagner@mchsi.com
RI Monteiro Mantovani, Vanessa/U-9045-2019; Breitenstein, Susan/A-7890-2019
OI Monteiro Mantovani, Vanessa/0000-0002-2684-2746; Swanson,
   Elizabeth/0000-0002-6681-6294; Goncalves Rezende Macieira,
   Tamara/0000-0003-1100-3760; Breitenstein, Susan/0000-0002-3081-5038;
   Wagner, Cheryl/0000-0003-3767-4239; Dunn Lopez,
   Karen/0000-0002-9700-941X
CR Amorin-Woods D, 2020, AUST NZ J FAM THER, V41, P114, DOI 10.1002/anzf.1416
   Armitage R, 2020, LANCET PUBLIC HEALTH, V5, pE256, DOI 10.1016/S2468-2667(20)30061-X
   Bradley NL, 2020, CAN MED ASSOC J, V192, pE609, DOI 10.1503/cmaj.200634
   Brennan J, 2020, INT PSYCHOGERIATR, V32, P1205, DOI 10.1017/S1041610220000873
   Canevelli M, 2020, J AM GERIATR SOC, V68, P1673, DOI 10.1111/jgs.16644
   Center for Disease Control and Prevention, 2020, COR DIS CAR SOM SICK
   Chappell NL, 2009, INT J AGING HUM DEV, V69, P221, DOI 10.2190/AG.69.3.d
   Cluver L, 2020, LANCET, V395, pE64, DOI 10.1016/S0140-6736(20)30736-4
   Douglas M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1557
   Elman A, 2020, J APPL GERONTOL, V39, P690, DOI 10.1177/0733464820924853
   Folkman S, 2010, PSYCHO-ONCOLOGY, V19, P901, DOI 10.1002/pon.1836
   Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030
   Govindarajan A., 2020, SAFEGUARDING OUR LIV
   Hsu YC, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082857
   Kaakinen, 2005, FAMILY HEALTHCARE NU, P3
   Kamitsuru, 2018, NANDA INT NURSING DI
   Lewis Helen., 2020, ATLANTIC
   Lounsbury DW, 2009, AM J COMMUN PSYCHOL, V44, P213, DOI 10.1007/s10464-009-9266-4
   Luttik MLA, 2020, J FAM NURS, V26, P87, DOI 10.1177/1074840720920883
   Miller EA, 2020, J AGING SOC POLICY, V32, P297, DOI 10.1080/08959420.2020.1780104
   Mion LC, 2019, GERIATR NURS, V40, P640, DOI 10.1016/j.gerinurse.2019.11.003
   Moore SA, 2020, INT J BEHAV NUTR PHY, V17, DOI 10.1186/s12966-020-00987-8
   Moorhead S., 2018, NURSING OUTCOMES CLA, V6
   Moorhead S, 2021, INT J NURS KNOWL, V32, P59, DOI 10.1111/2047-3095.12291
   Patterson J.M., 1988, FAMILY SYST MED, V6, P202, DOI [10.1037/h0089739, DOI 10.1037/H0089739]
   Patterson JM, 2002, J MARRIAGE FAM, V64, P349, DOI 10.1111/j.1741-3737.2002.00349.x
   Phillips Dominique, 2020, HRB Open Res, V3, P24, DOI 10.12688/hrbopenres.13059.1
   Rehm J, 2020, DRUG ALCOHOL REV, V39, P301, DOI 10.1111/dar.13074
   Reinhard S.C., 2008, PATIENT SAFETY QUALI
   Richard AA, 2011, J NURS SCHOLARSHIP, V43, P255, DOI 10.1111/j.1547-5069.2011.01404.x
   Riffin C, 2013, J GERONTOL B-PSYCHOL, V68, P927, DOI 10.1093/geronb/gbs114
   Rosland AM, 2008, J GEN INTERN MED, V23, P1992, DOI 10.1007/s11606-008-0814-7
   Ryan P, 2009, NURS OUTLOOK, V57, P217, DOI 10.1016/j.outlook.2008.10.004
   Saltzman WR, 2013, CLIN CHILD FAM PSYCH, V16, P294, DOI 10.1007/s10567-013-0142-2
   Schulman-Green D, 2012, J NURS SCHOLARSHIP, V44, P136, DOI 10.1111/j.1547-5069.2012.01444.x
   Sultan, 2008, PSYCHOSOCIAL NURSING
   Swanson E, 2020, INT J NURS KNOWL, DOI 10.1111/2047-3095.12307
   Taub A., 2020, NEW YORK TIMES
   Tebb S., 2000, J GERONTOLOGICAL SOC, V34, P51, DOI [10.1300/J083v34n02_06, DOI 10.1300/J083V34N02_06]
   Thompson LA, 2020, JAMA PEDIATR, V174, P628, DOI 10.1001/jamapediatrics.2020.0828
   Tucker MC, 2014, J FAM VIOLENCE, V29, P175, DOI 10.1007/s10896-013-9567-0
   Usher K, 2020, INT J MENT HEALTH NU, V29, P549, DOI 10.1111/inm.12735
   Wagner C.M., 2018, NURSING INTERVENTION
   Wagner CM, 2022, INT J NURS KNOWL, V33, P5, DOI 10.1111/2047-3095.12323
   Williams KL, 2014, AGING MENT HEALTH, V18, P600, DOI 10.1080/13607863.2013.860425
   Wong CC, 2014, J GERONTOL NURS, V40, P30, DOI 10.3928/00989134-20130827-05
   Yingling L.C., 2020, INT ENCY MARRIAGE FA
NR 47
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2047-3087
EI 2047-3095
J9 INT J NURS KNOWL
JI Int. J. Nurs. Knowl.
PD JAN
PY 2022
VL 33
IS 1
BP 5
EP 17
DI 10.1111/2047-3095.12323
EA MAR 2021
PG 13
WC Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing
GA YF4QF
UT WOS:000629611000001
PM 33729703
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Mardawi, Z
   Segui-Mas, E
   Tormo-Carbo, G
AF Mardawi, Zeena
   Segui-Mas, Elies
   Tormo-Carbo, Guillermina
TI Rethinking the accounting ethics education research in the post-
   COVID-19 context
SO COGENT BUSINESS & MANAGEMENT
LA English
DT Review
DE Accounting Ethics; accounting education; systematic literature review;
   multilevel analysis; COVID-19
ID BUSINESS ETHICS; STUDENTS; JUDGMENTS
AB Now more than ever before, studies of accounting ethics should be at the front of every research that is commenced throughout and following COVID-19 to protect students, academics, professionals, and broader communities. Accounting Ethics Education Research is traditionally linked to the global crisis. Therefore, the purpose of this study is to map the knowledge of accounting ethics education literature and to pay closer inception in facing the waves of destressing and the repeated financial scandals in the Covid-19 context. A systematic literature review was performed on 31 empirical research published on the Scopus database for 1993 to 2020. This study also suggests new avenues and insights for future research by analysing the articles into three primary levels according to the scope (environmental, university, and individual), which would help to find the main focus of researchers and draw a clear picture of literature gap. Moreover, this study is the first by far to provide and discuss the key variables (gender, age, accounting ethics course) used by previous studies. The study findings help provide an overarching picture of the accounting ethics education patterns and trends to avoid falling into the same mistakes. In addition, these results draw potential future avenues to bridge the current literature void by presenting fruitful and indispensable directions for future research in the post-pandemic world. It also suggests multidimensional and in-depth insights for reforming the accounting ethics education pedagogy.
C1 [Mardawi, Zeena] Univ Politecn Valencia, Valencia, Spain.
   [Mardawi, Zeena] An Najah Natl Univ, Nablus, Palestine.
   [Segui-Mas, Elies; Tormo-Carbo, Guillermina] Univ Politecn Valencia, Business Management Res Ctr, CEGEA, Valencia, Spain.
RP Mardawi, Z (corresponding author), Univ Politecn Valencia, Valencia, Spain.; Mardawi, Z (corresponding author), An Najah Natl Univ, Nablus, Palestine.
EM zeedwedw@doctor.upv.es
RI Mardawi, Zeena/ABD-1231-2021; Seguí-Mas, Elies/L-2292-2014
OI Mardawi, Zeena/0000-0002-8135-1579; Seguí-Mas, Elies/0000-0001-6985-4758
CR ACCA, 2020, ETH COV 19 WORLD
   ACFE, 2020, COR PAND IS PERF STO
   Ackermann C, 2021, ACCOUNT RES J, V34, P206, DOI 10.1108/ARJ-08-2020-0281
   Adkins N, 2004, J BUS ETHICS, V51, P279, DOI 10.1023/B:BUSI.0000032700.07607.02
   Albitar K, 2021, INT J ACCOUNT INF MA, V29, P169, DOI 10.1108/IJAIM-08-2020-0128
   Alshater MM, 2021, INT J ISLAMIC MIDDLE, V14, P339, DOI 10.1108/IMEFM-08-2020-0419
   Andersen M.L., 2018, J ACCOUNTING ED, V44, P35, DOI [10.1016/j.jaccedu.2018.05.001, DOI 10.1016/J.JACCEDU.2018.05.001]
   Armstrong M.B., 1993, J ACCOUNTING ED, V11, P77
   Auyeung PK, 2006, ACCOUNT RES J, V19, P122, DOI 10.1108/10309610680000683
   Bampton R, 2013, J BUS ETHICS, V114, P549, DOI 10.1007/s10551-012-1341-3
   Bernardi R.A., 2007, RES PROFESSIONAL RES, V11, P47
   Bernardi R.A., 2010, RES PROFESSIONAL RES, P63, DOI [10.1016/s1574-0765(05)10003-x, DOI 10.1016/S1574-0765(05)10003-X]
   Beu D.S., 2003, BUS ETHICS, V12, P88
   Bowyer S, 2021, ACCOUNT RES J, V34, P196, DOI 10.1108/ARJ-08-2020-0243
   Brewerton, 2001, ORG RES METHODS GUID
   Briner R.B., 2012, HDB EVIDENCE BASED M, P112, DOI 10.1093/oxfordhb/9780199763986.013.0007
   Calia C, 2021, ETHICS BEHAV, V31, P60, DOI 10.1080/10508422.2020.1800469
   Caliyurt KT, 2007, SOC RESPONSIB J, V3, P74, DOI 10.1108/17471110710840251
   Cameron RA, 2015, ACCOUNT EDUC, V24, P275, DOI 10.1080/09639284.2015.1036893
   Chan SYS, 2006, MANAG AUDIT J, V21, P436, DOI 10.1108/02686900610661432
   Christensen A, 2018, J BUS ETHICS, V153, P1157, DOI 10.1007/s10551-016-3411-4
   Davis, 1996, J ACCOUNTING ED, V14, DOI [https://doi.org/10.1016/0748-5751(96)00022-X, DOI 10.1016/0748-5751(96)00022-X]
   Deloitte, 2020, COV 19 FRAUD RISK MA
   Duriau VJ, 2007, ORGAN RES METHODS, V10, P5, DOI 10.1177/1094428106289252
   Dwekat A, 2020, ECON RES-EKON ISTRAZ, V33, P3580, DOI 10.1080/1331677X.2020.1776139
   Dyki M, 2021, ACCOUNT RES J, V34, P229, DOI 10.1108/ARJ-09-2020-0285
   Eagly A.H, 1987, SEX DIFFERENCES SOCI
   Elias RZ, 2006, J BUS ETHICS, V68, P83, DOI 10.1007/s10551-006-9041-5
   EY, 2020, MAINT CULT INT COVID
   Ferramosca S, 2020, CORP SOC RESP ENV MA, V27, P178, DOI [10.24215/23143738e041, 10.1002/csr.1792]
   Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814
   Hallinger P, 2020, SIMULAT GAMING, V51, P9, DOI 10.1177/1046878119888246
   Jones MV, 2011, J BUS VENTURING, V26, P632, DOI 10.1016/j.jbusvent.2011.04.001
   Kohlberg, 1984, ESSAYS MORAL DEV
   Kohlberg L., 1969, STAGE SEQUENCE COGNI
   Marzuki M, 2017, ASIAN REV ACCOUNT, V25, P148, DOI 10.1108/ARA-09-2015-0088
   Massey DW, 2009, ISS ACCOUNT EDUC, V24, P481, DOI 10.2308/iace.2009.24.4.481
   Mayring P., 2004, SAGE HDB QUALITATIVE, V1, P159
   McLeod MS, 2016, J BUS ETHICS, V134, P429, DOI 10.1007/s10551-014-2436-9
   Miller W.F., 2020, J ACCOUNTING ED, V51, DOI [10.1016/j.jaccedu.2020.100669, DOI 10.1016/J.JACCEDU.2020.100669]
   Miller WF, 2018, J BUS ETHICS, V153, P1109, DOI 10.1007/s10551-016-3396-z
   Mintz S.M., 2006, J ACCOUNTING ED, V24, P97, DOI [10.1016/j.jaccedu.2006.07.004, DOI 10.1016/J.JACCEDU.2006.07.004]
   Montenegro TM, 2020, J ACAD ETHICS, V18, P301, DOI 10.1007/s10805-020-09376-z
   Nerandzic B, 2012, EKON ISTRAZ, V25, P288, DOI 10.1080/1331677X.2012.11517566
   Norton, 2001, TREATISE HUMAN NATUR
   O'Fallon MJ, 2005, J BUS ETHICS, V59, P375, DOI 10.1007/s10551-005-2929-7
   O'Leary C, 2013, J BUS ETHICS, V113, P225, DOI 10.1007/s10551-012-1291-9
   Othman R, 2021, ACCOUNT RES J, V34, P217, DOI 10.1108/ARJ-09-2020-0283
   Pan Y, 2012, J BUS RES, V65, P84, DOI 10.1016/j.jbusres.2011.02.002
   Podsakoff PM, 2005, STRATEGIC MANAGE J, V26, P473, DOI 10.1002/smj.454
   Pope KR, 2005, J ACAD ETHICS, V3, P89, DOI 10.1007/s10805-005-9000-2
   Rest J.R., 1986, MORAL DEV ADV RES TH
   Sangster A, 2020, ACCOUNT EDUC, V29, P431, DOI 10.1080/09639284.2020.1808487
   Shaub MK., 1994, J ACCOUNTING ED, V12, P1, DOI [10.1016/0748-5751(94)90016-7, DOI 10.1016/0748-5751(94)90016-7]
   Shawver TJ, 2017, J BUS ETHICS, V141, P587, DOI 10.1007/s10551-015-2711-4
   Shawver TJ, 2009, J BUS ETHICS, V88, P663, DOI 10.1007/s10551-008-9973-z
   Shen JF, 2020, INT J ELEC ENG EDUC, DOI 10.1177/0020720920928464
   Sorensen DP, 2017, J BUS ETHICS, V140, P175, DOI 10.1007/s10551-015-2656-7
   Sugahara S., 2010, INT J ACCOUNTING AUD, V6, P54, DOI DOI 10.1504/IJAAPE.2010.030479
   Thorne L., 1999, J ACCOUNTING ED, V17, P157, DOI [10.1016/S0748-5751(99)00019-6, DOI 10.1016/S0748-5751(99)00019-6]
   THORNE L, 2001, J ACCOUNTING ED, V19, P103, DOI DOI 10.1016/S0748-5751(01)00014-8
   Tormo-Carb G, 2019, BUS ETHICS, V28, P506, DOI 10.1111/beer.12236
   Tormo-Carbo G, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10082717
   Tormo-Carbo G, 2016, J BUS ETHICS, V135, P161, DOI 10.1007/s10551-014-2455-6
   Tweedie D, 2013, WORK EMPLOY SOC, V27, P94, DOI 10.1177/0950017012460327
   Uysal OO, 2010, J BUS ETHICS, V93, P137, DOI 10.1007/s10551-009-0187-9
   Waldron M, 2017, MEDITARI ACCOUNT RES, V25, P37, DOI 10.1108/MEDAR-09-2016-0076
   Warinda T, 2013, ASIAN SOCIAL SCI, V9, P191, DOI [10.5539/ass.v9n2p191, DOI 10.5539/ASS.V9N2P191]
   Watts LL, 2017, ACCOUNT RES, V24, P225, DOI 10.1080/08989621.2016.1274975
   Welton RE, 2009, ACCOUNT EDUC, V18, P273, DOI 10.1080/09639280802217990
   West A, 2020, J BUS ETHICS, V164, P61, DOI 10.1007/s10551-018-4064-2
   White A, 2021, ACCOUNT RES J, V34, P304, DOI 10.1108/ARJ-09-2020-0317
   White G.B, 2004, J COLL TEACHING LEAR, V1, DOI [10.19030/tlc.v1i12.2017, DOI 10.19030/TLC.V1I12.2017]
NR 73
TC 0
Z9 0
U1 7
U2 7
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 2331-1975
J9 COGENT BUS MANAG
JI Cogent Bus. Manag.
PD JAN 1
PY 2021
VL 8
IS 1
AR 1984627
DI 10.1080/23311975.2021.1984627
PG 18
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA WD6SA
UT WOS:000705067900001
OA gold
DA 2022-04-20
ER

PT J
AU Alimoradi, Z
   Lin, CY
   Ullah, I
   Griffiths, MD
   Pakpour, AH
AF Alimoradi, Zainab
   Lin, Chung-Ying
   Ullah, Irfan
   Griffiths, Mark
   Pakpour, Amir H.
TI Item Response Theory Analysis of the Fear of COVID-19 Scale (FCV-19S): A
   Systematic Review
SO PSYCHOLOGY RESEARCH AND BEHAVIOR MANAGEMENT
LA English
DT Review
DE COVID-19; fear; item response theory; psychometrics; Rasch; review
ID QUALITY; DEPRESSION
AB Background: The COVID-19 pandemic is still ongoing and is not yet under control. Evidence regarding the impacts of COVID-19 on psychological distress has been widely reported worldwide, and one of the primary concerns regarding psychological distress is fear (ie, fear of COVID-19). Therefore, having a robust instrument for assessing fear of COVID-19 is important. The present systematic review aimed to synthesize the psychometric evidence evaluated using item response theory (IRT) on the Fear of COVID-19 Scale (FCV-19S).
   Methods: Utilizing the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, four academic databases (Scopus, PubMed Central, ProQuest, and ISI Web of Knowledge) were used to search target papers. Keywords used for search were "Fear of COVID-19 Scale" and its abbreviation (ie, "FCV-19S") and IRT-related terms. The COnsensus-based Standards for the selection of health status Measurement INstruments (COSMIN) checklist was then applied to evaluate the methodological quality of the reviewed papers. Moreover, psychometric properties using IRT methods were synthesized using a qualitative method.
   Results: The initial search resulted in 552 papers (73 duplicates) and 479 were screened based on their titles and abstracts. Finally, 16 papers were included for review regarding their methodological quality (via COSMIN) to synthesize the psychometric evidence for FCV-19S. The 16 papers included 21 countries with 16 language versions of FCV-19S.
   Conclusion: All the psychometric evidence indicated that the seven items in the FCV-19S fit with the concept of fear. The FCV-19S is a strong and valid instrument for assessing fear across different languages. The seven items in the FCV-19S appear to be unidimensional in assessing fear, which indicates that all items are necessary in the FCV-19S.
C1 [Alimoradi, Zainab] Qazvin Univ Med Sci, Res Inst Prevent Noncommunicable Dis, Social Determinants Hlth Res Ctr, Qazvin, Iran.
   [Lin, Chung-Ying] Natl Cheng Kung Univ, Inst Allied Hlth Sci, Coll Med, Tainan, Taiwan.
   [Lin, Chung-Ying] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Biostat Consulting Ctr, Tainan, Taiwan.
   [Lin, Chung-Ying] Natl Cheng Kung Univ, Dept Publ Hlth, Coll Med, Tainan, Taiwan.
   [Lin, Chung-Ying] Natl Cheng Kung Univ, Dept Occupat Therapy, Coll Med, Tainan, Taiwan.
   [Ullah, Irfan] Gandhara Univ, Kabir Med Coll, Peshawar, Pakistan.
   [Griffiths, Mark] Nottingham Trent Univ, Dept Psychol, Int Gaming Res Unit, Nottingham, England.
   [Pakpour, Amir H.] Jonkoping Univ, Sch Hlth & Welf, Dept Nursing, Barnarpsgatan 39, S-55111 Jonkoping, Sweden.
RP Ullah, I (corresponding author), Gandhara Univ, Kabir Med Coll, Peshawar, Pakistan.; Pakpour, AH (corresponding author), Jonkoping Univ, Sch Hlth & Welf, Dept Nursing, Barnarpsgatan 39, S-55111 Jonkoping, Sweden.
EM irfanullahecp2@gmail.com; amir.pakpour@ju.se
RI Ullah, Irfan/X-2858-2019; Alimoradi, Zainab/D-4437-2011; Lin,
   Chung-Ying/I-5434-2016; Pakpour, Amir/C-6160-2014
OI Ullah, Irfan/0000-0003-1100-101X; Alimoradi, Zainab/0000-0001-5327-2411;
   Lin, Chung-Ying/0000-0002-2129-4242; Pakpour, Amir/0000-0002-8798-5345;
   Griffiths, Mark/0000-0001-8880-6524
FU Higher Education Sprout Project, Ministry of Education
FX Chung-Ying Lin was supported in part by Higher Education Sprout Project,
   Ministry of Education to the Headquarters of University Advancement at
   National Cheng Kung University (NCKU).
CR Aggen SH, 2005, PSYCHOL MED, V35, P475, DOI 10.1017/S0033291704003563
   Ahorsu DK, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00270-8
   Al-Shannaq Y, 2021, INT J MENT HEALTH AD, DOI 10.1007/s11469-021-00574-3
   Alimoradi Z, 2020, PROSPERO INT PROSPEC
   Basit KA, 2021, DIABETES METAB SYND, V15, P733, DOI 10.1016/j.dsx.2021.03.008
   Bellamkonda N, 2021, INT J MENT HEALTH AD, DOI 10.1007/s11469-021-00521-2
   Bhuiyan AKMI, 2021, INT J MENT HEALTH AD, V19, P2110, DOI 10.1007/s11469-020-00307-y
   Campo-Arias A, 2021, OMEGA-J DEATH DYING, DOI 10.1177/00302228211016216
   Caycho-Rodriguez T, 2022, DEATH STUD, V46, P543, DOI 10.1080/07481187.2020.1836071
   Chang CC, 2018, ASSESSMENT, V25, P777, DOI 10.1177/1073191116658547
   Chang CC, 2015, J CLIN EPIDEMIOL, V68, P674, DOI 10.1016/j.jclinepi.2015.01.018
   Chang KC, 2022, INT J MENT HEALTH AD, V20, P324, DOI 10.1007/s11469-020-00361-6
   Chang KC, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0148-6
   Chen IH, 2022, CURR PSYCHOL, DOI 10.1007/s12144-021-02471-3
   Chen W, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.678979
   Chung GKK, 2022, FRONT MED-LAUSANNE, V9, DOI 10.3389/fmed.2022.800962
   Colizzi Marco, 2020, Brain Behav Immun Health, V5, P100073, DOI 10.1016/j.bbih.2020.100073
   de Medeiros ED, 2021, CURR PSYCHOL, DOI 10.1007/s12144-021-01476-2
   de Vet HC, 2018, COSMIN METHODOLOGY S
   Elemo AS, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00448-0
   Mercado-Lara MF, 2022, INT J MENT HEALTH AD, V20, P1122, DOI 10.1007/s11469-020-00430-w
   Giordani RCF, 2021, PSYCHOL RES BEHAV MA, V14, P345, DOI 10.2147/PRBM.S298948
   Fraley RC, 2000, J PERS SOC PSYCHOL, V78, P350, DOI 10.1037/0022-3514.78.2.350
   Griffiths MD, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00399-6
   Hambleton RK, 1991, FUNDAMENTALS ITEM RE
   Han JW, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18147402
   Hays RD, 2000, MED CARE, V38, P28
   Hill CD, 2007, MED CARE, V45, pS39, DOI 10.1097/01.mlr.0000259879.05499.eb
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Husted JA, 2000, J CLIN EPIDEMIOL, V53, P459, DOI 10.1016/S0895-4356(99)00206-1
   Lin C-Y, 2020, SOCIAL HLTH BEHAV, V3, P1, DOI [10.4103/SHB.SHB_11_20, DOI 10.4103/SHB.SHB_11_20]
   Lin CY, 2021, INT J MENT HEALTH AD, DOI [10.1007/s11469-021-00635-7, 10.1109/TGRS.2021.3062725]
   Lin CY, 2021, NURS OPEN, V8, P1892, DOI 10.1002/nop2.855
   Lin CY, 2021, INT J MENT HEALTH AD, V19, P1854, DOI 10.1007/s11469-020-00278-0
   Lin CY, 2020, EVAL HEALTH PROF, V43, P222, DOI 10.1177/0163278719827997
   Lord F. M., 2012, APPL ITEM RESPONSE T
   Madsen H., 2010, INTRO GEN GEN LINEAR
   McGrory S, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-47
   Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135
   Mokkink LB, 2018, QUAL LIFE RES, V27, P1171, DOI 10.1007/s11136-017-1765-4
   Montemurro N, 2021, BRAIN BEHAV IMMUN, V92, P207, DOI 10.1016/j.bbi.2020.11.034
   Mungas D, 2003, NEUROPSYCHOLOGY, V17, P380, DOI 10.1037/0894-4105.17.3.380
   Nejati B, 2021, EVAL HEALTH PROF, V44, P385, DOI 10.1177/0163278720965688
   Pakpour AH, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.740333
   Pakpour AH, 2021, INT J MENT HEALTH AD, V19, P2407, DOI 10.1007/s11469-020-00334-9
   Pang NTP, 2022, INT J MENT HEALTH AD, V20, P263, DOI 10.1007/s11469-020-00355-4
   Pappas G, 2009, CLIN MICROBIOL INFEC, V15, P743, DOI 10.1111/j.1469-0691.2009.02947.x
   Poon LYJ, 2021, J MED INTERNET RES, V23, DOI 10.2196/26821
   Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213
   Rajabimajd N, 2021, ASIAN J SOCIAL HLTH, V4, P51, DOI [10.4103/shb.shb_24_21, DOI 10.4103/SHB.SHB_24_21]
   Reise SP, 2005, J PERS ASSESS, V84, P228, DOI 10.1207/s15327752jpa8403_02
   Reise SP., PSYCHOMETRIKA, V86, P1, DOI [10.1007/s11336-021-09748-3, DOI 10.1007/S11336-021-09748-3]
   Sakib N, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00289-x
   Santor DA, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-66
   Satici B, 2021, INT J MENT HEALTH AD, V19, P1980, DOI 10.1007/s11469-020-00294-0
   Shanafelt T, 2020, JAMA-J AM MED ASSOC, V323, P2133, DOI 10.1001/jama.2020.5893
   Sijtsma K, 2008, QUAL LIFE RES, V17, P275, DOI 10.1007/s11136-007-9281-6
   Sischka P.E., 2020, J AFFECT DISORD REP, V1, P100020, DOI [10.1016/j.jadr.2020.100020, DOI 10.1016/J.JADR.2020.100020]
   Stanculescu E, 2022, INT J MENT HEALTH AD, V20, P1094, DOI 10.1007/s11469-020-00428-4
   Taylor S, 2020, J ANXIETY DISORD, V72, DOI 10.1016/j.janxdis.2020.102232
   Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   Winter T, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00342-9
   Wouters H, 2008, ALZ DIS ASSOC DIS, V22, P236, DOI 10.1097/WAD.0b013e318174f8b9
NR 64
TC 0
Z9 0
U1 2
U2 2
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1179-1578
J9 PSYCHOL RES BEHAV MA
JI Psychol. Res. Behav. Manag.
PY 2022
VL 15
BP 581
EP 596
DI 10.2147/PRBM.S350660
PG 16
WC Psychology, Clinical; Psychiatry; Psychology, Multidisciplinary
WE Social Science Citation Index (SSCI)
SC Psychology; Psychiatry
GA ZT4EO
UT WOS:000769111500001
PM 35300204
OA Green Accepted, Green Published
DA 2022-04-20
ER

PT J
AU Alhumam, NM
   Almutairi, AA
   Alwesaibi, AA
   Al-Ramadhan, NR
   Alabbad, FA
AF Alhumam, Naif Mohammed
   Almutairi, Adia Abdulaziz
   Alwesaibi, Asma Adel
   Al-Ramadhan, Narjes Radhi
   Alabbad, Fatimah Abdullah
TI Bipolar perception of orthopedics fractures before and during covid-19
   pandemic: a local study
SO MEDICAL SCIENCE
LA English
DT Article
DE COVID-19; quarantine; telemedicine; pandemic
ID IMPACT; DISEASE; VISITS; CARE
AB Background: Patients refrain from seeking medical help in the time of COVID-19 due to the fear of getting infected. Hospitals are overloaded with limited beds, interfering with inpatients stays. Awareness of first aid management of fractures among the general population has been neglected. Thus, the aim of this study is to assess the knowledge of the selected population regarding fractures' first aid, and their readiness to seek medical help before and during the time of quarantine. Methodology: Cross sectional vignette-Based study among Saudi population of Al-Ahasa. Data processed via SPSS using two tailed tests. A total of 1005 respondents were included in this study. Results: Good awareness was detected among 520 (51.7%) participants. Before pandemic, (83.7%) reported that they will Call the ambulance immediately, and only (15.1%) Consult a doctor without visiting the hospital (telemedicine). During the pandemic, (41.5%) told that they can call ambulance while the majority (57.3%; 576) told that they Consult a doctor without visiting the hospital (telemedicine). Men had significantly good awareness level regarding fracture first aids compared to women. Similarly, health care related participants had significantly good awareness level regarding fracture first aids compared to others.
C1 [Alhumam, Naif Mohammed] King Faisal Univ, Surg Dept, Coll Med, Al Hasa, Saudi Arabia.
   [Almutairi, Adia Abdulaziz; Alwesaibi, Asma Adel; Al-Ramadhan, Narjes Radhi; Alabbad, Fatimah Abdullah] King Faisal Univ, Coll Med, Al Hasa, Saudi Arabia.
RP Alhumam, NM (corresponding author), King Faisal Univ, Surg Dept, Coll Med, Al Hasa, Saudi Arabia.
EM Naifhamam@yahoo.com; a.doo.y@hotmail.com; asma.alwesaibi@gmail.com;
   mindcompass@hotmail.com; fatimah.alabbad.97@gmail.com
CR Al-Johani Ala'a A S, 2018, J Family Med Prim Care, V7, P380, DOI 10.4103/jfmpc.jfmpc_64_18
   Al-Robaiaay YK, 2013, AL KINDY COL MED J, V9, P54
   Alhejaili AS, 2016, INT J ADV RES INDORE, V4, P298
   Alsayali R, 2019, MEJFM, P1734
   Alsayali RM, 2019, WORLD FAM MED, V17, P34, DOI 10.5742/MEWFM.2019.93693
   Amro N, 2017, IJIRMS, V24
   Chopra A, 2002, MED CLIN N AM, V86, P75, DOI 10.1016/S0025-7125(03)00073-7
   Eldosoky R. S. H., 2012, Eastern Mediterranean Health Journal, V18, P1021
   Farrell S, 2020, J AM ACAD ORTHOP SUR, V28, pE477, DOI 10.5435/JAAOS-D-20-00391
   Giorgi Pietro Domenico, 2020, Bone Jt Open, V1, P93, DOI 10.1302/2633-1462.15.BJO-2020-0016
   Gong K, 2020, J MED INTERNET RES, V22, DOI 10.2196/18908
   Guo XD, 2020, J BONE JOINT SURG AM, V102, P847, DOI 10.2106/JBJS.20.00417
   Kaur N, 2017, J HLTH INFORM, V8, P4
   Lee SY, 2019, YONSEI MED J, V60, P796, DOI 10.3349/ymj.2019.60.8.796
   Mantica G, 2020, PUBLIC HEALTH, V183, P40, DOI 10.1016/j.puhe.2020.04.046
   Masroor S, 2020, J CARDIAC SURG, V35, P1345, DOI 10.1111/jocs.14638
   Nunez JH, 2020, INJURY, V51, P1414, DOI 10.1016/j.injury.2020.05.016
   Pikoulis E, 2020, PUBLIC HEALTH, V185, P42, DOI [10.1010/j.puhe.2020.05.036, 10.1016/j.puhe.2020.05.036]
   Sadat-Ali M, 2020, OPEN ORTHOP J, V10, P117
   Sadat-Ali M, 2015, SAUDI J MED MED SCI, V3, P54, DOI 10.4103/1658-631X.149682
   Stinner DJ, 2020, J ORTHOP TRAUMA, V34, P333, DOI 10.1097/BOT.0000000000001782
   Wong JS, 2020, JBJS, V102
   Yadav SK, 2020, INJURY, V51, P1683, DOI 10.1016/j.injury.2020.04.034
NR 23
TC 1
Z9 1
U1 0
U2 0
PU DISCOVERY PUBLICATION
PI TAMILNADU
PA KANYAKUMARI DISTRICT, TAMILNADU, 00000, INDIA
SN 2321-7359
EI 2321-7367
J9 MED SCI
JI Med. Sci.
PD NOV-DEC
PY 2020
VL 24
IS 106
BP 4332
EP 4340
PG 9
WC Medicine, Research & Experimental
WE Emerging Sources Citation Index (ESCI)
SC Research & Experimental Medicine
GA PN1XH
UT WOS:000604279100064
DA 2022-04-20
ER

PT J
AU Zewudie, A
   Regasa, T
   Kebede, O
   Abebe, L
   Feyissa, D
   Ejata, F
   Feyisa, D
   Mamo, Y
AF Zewudie, Ameha
   Regasa, Tolcha
   Kebede, Oliyad
   Abebe, Lemi
   Feyissa, Desalegn
   Ejata, Fikadu
   Feyisa, Diriba
   Mamo, Yitagesu
TI Healthcare Professionals' Willingness and Preparedness to Work During
   COVID-19 in Selected Hospitals of Southwest Ethiopia
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE healthcare professionals; preparedness; willingness; COVID-19; Southwest
   Ethiopia
ID DISASTER; INFLUENZA; KNOWLEDGE
AB Background: Many healthcare professionals are dying of COVID-19 while trying to save others. The loss in the healthcare workforce due to sickness and absence will double the risk of a crisis. Identifying barriers of willingness to work during epidemics outbreak and preparedness of healthcare professionals is important to minimize the shortage of human power.
   Methods: Facility-based cross-sectional study was conducted among healthcare professionals working in the selected hospitals of Southwest Ethiopia from June 1-30/2020. The data entry was done by Epi-Data Manager version 4.4.1.0 and exported to SPSS version 23 for analysis. Multivariable logistic regression analysis with a backward stepwise approach was done to identify independent predictors of poor preparedness and willingness of the healthcare professionals to work during COVID-19 and Variables with P-value <0.05 were considered as a statistically significant determinant.
   Results: Of 407 healthcare professionals who participated in the study, 246 (60.4%) were male. The mean age of the respondents was 28.47 +/- 5.60 years. Forty-seven (11.55%) Physicians, 59 (14.50%) pharmacy personnel, 52 (12.78%) Laboratory personnel, 31 (7.62%) Midwives, and 195 (47.91%) Nurses were included in the study. The healthcare professionals who were not prepared for the provision of services during COVID-19 and not willing to work during COVID-19 were 165 (40.5%) and 86 (21.1%) respectively. Having 6 to10 years' experience (AOR=4.046, CI: 1.05-15.58), and divorced marital status (AOR=7.855, CI: 1.781-34.65) were independent predictors of not willing to work during COVID-19. Similarly, lack of personal protective equipment (AOR=28.089, CI: 13.9-56.67) and shortage of infrastructure at the work place (AOR=28.1, CI: 13.9-56.67) were independent predictors of poor preparedness.
   Conclusion and Recommendations: Healthcare professionals' willingness and preparedness to work during COVID-19 was low. Use of Telemedicine, provision of personal protective equipment, increasing hospital's safety with adequate infection control policy, and assigning staff who have experience of more than ten years in the risky wards of the hospitals may decrease staffs absentee and increase in the provision of continuous service.
C1 [Zewudie, Ameha; Regasa, Tolcha; Feyissa, Desalegn; Mamo, Yitagesu] Mizan Tepi Univ, Coll Med & Hlth Sci, Sch Pharm, Dept Clin Pharm & Pharm Practice, Mizan Aman, Ethiopia.
   [Kebede, Oliyad; Ejata, Fikadu; Feyisa, Diriba] Mizan Tepi Univ, Coll Med & Hlth Sci, Sch Pharm, Dept Social Pharm & Pharmaceut, Mizan Aman, Ethiopia.
   [Abebe, Lemi] Mizan Tepi Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Mizan Aman, Ethiopia.
RP Regasa, T (corresponding author), Mizan Tepi Univ, Coll Med & Hlth Sci, Sch Pharm, Dept Clin Pharm & Pharm Practice, Mizan Aman, Ethiopia.
EM negasatolosa@gmail.com
RI Mamo, Yitagesu/AAX-6685-2021; Ejeta, Fikadu/ABA-2461-2021; Feyissa,
   Desalegn/ABD-7619-2020
OI Ejeta, Fikadu/0000-0002-7235-1913; Kebede, Oliyad/0000-0001-6806-4623;
   Regasa, Tolcha/0000-0002-2921-8471; Feyissa,
   Desalegn/0000-0002-5781-0368; Zewudie, Ameha/0000-0002-2657-6089
FU Mizan-Tepi University
FX This study was funded by Mizan-Tepi University. However, the funder had
   no role in study design, analysis and interpretation of the data.
CR AlSaif HI, 2020, INT J GEN MED, V13, P653, DOI 10.2147/IJGM.S272316
   Annan AA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4474-6
   [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9
   Aoyagi Y, 2015, INFLUENZA OTHER RESP, V9, P120, DOI 10.1111/irv.12310
   Arbon P, 2013, AUSTRALAS EMERG NURS, V16, P52, DOI 10.1016/j.aenj.2013.05.003
   Arora S, 2020, J MULTIDISCIP HEALTH, V13, P841, DOI 10.2147/JMDH.S268891
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4
   Blevins Thomas, 2020, Tex Med, V116, P4
   Bonyan R, 2020, J PHARM POLICY PRACT, V13, DOI 10.1186/s40545-020-00247-x
   Brice JH, 2017, SOUTH MED J, V110, P516, DOI 10.14423/SMJ.0000000000000680
   Chaffee Mary, 2009, Disaster Med Public Health Prep, V3, P42, DOI 10.1097/DMP.0b013e31818e8934
   Charney RL, 2015, J EMERG MED, V49, P665, DOI 10.1016/j.jemermed.2015.07.030
   Chemali Z, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7713-1
   Connor SB, 2014, PREHOSP DISASTER MED, V29, P270, DOI 10.1017/S1049023X14000387
   Dickinson James A, 2013, Asia Pac Fam Med, V12, P3, DOI 10.1186/1447-056X-12-3
   Draper H, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-192
   Federal ministry of health National, 2020, COMPR COVID 19 MAN H
   Golden I, 2020, HLTH SCI J, DOI 10.36648/1791-809X.S1.002
   Gowing JR, 2017, PREHOSP DISASTER MED, V32, P321, DOI 10.1017/S1049023X1700019X
   Huynh G, 2020, J TROPICAL MED, V13, P260, DOI DOI 10.4103/1995-7645.280396
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   ICN, 2020, CONF 1500 NURS HAV D
   Imai H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-672
   Kaiser HE, 2009, DISASTER MED PUBLIC, V3, P210, DOI 10.1097/DMP.0b013e3181aa242a
   Lai XQ, 2020, ANTIMICROB RESIST IN, V9, DOI 10.1186/s13756-020-00746-1
   Maharjan K, 2020, J PATAN ACAD HLTH SC, V7, P25, DOI DOI 10.3126/JPAHS.V7I1.2885926
   Martin SD, 2013, AM J NURS, V113, P24, DOI 10.1097/01.NAJ.0000438865.22036.15
   Montemurro N, 2020, BRAIN BEHAV IMMUN, V87, P23, DOI 10.1016/j.bbi.2020.03.032
   Nagesh S, 2020, J GLOB HEALTH, V10, DOI [10.7189/jogh.10.010345, 10.7189/jogh-10-010345]
   Nap RE, 2007, EMERG INFECT DIS, V13, P1714, DOI 10.3201/eid1311.070103
   Pan American Health Organisation (PAHO), 2020, COVID 19 HAS INF SOM COVID 19 HAS INF SOM
   Ricci Cabello I, 2020, IMPACT VIRAL EPIDEMI, DOI [10.1101/2020.04.02.20048892, DOI 10.1101/2020.04.02.20048892]
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Shanafelt T, 2020, JAMA-J AM MED ASSOC, V323, P2133, DOI 10.1001/jama.2020.5893
   Stergachis A, 2011, DISASTER MED PUBLIC, V5, P300, DOI 10.1001/dmp.2011.77
   The United Nations Office for the Coordination of Humanitarian Affairs (OCHA), 2020, ETHIOPIA COVID 19 HU
   Wamai, 2009, JAPANESE MED ASS J, V52, P279
   WHO, 2020, MENT HLTH PSYCH CONS, P1
   WHO, 2020, COVID 19 OP GUID MAI
   WHO, COUNTR TECHN GUID CO
   Wong ELY, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-107
   World Health Organization, 2020, HLTH WORK EXP RISK A
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   2009, EUR HLTH REP 2009, P1
NR 45
TC 5
Z9 6
U1 0
U2 0
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 391
EP 404
DI 10.2147/RMHP.S289343
PG 14
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA QE2WS
UT WOS:000616072300001
PM 33568957
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Mayanquer, CJG
   Enriquez, IRL
   Cano, JM
AF Galarraga Mayanquer, Clara Jaqueline
   Lopez Enriquez, Ivan Raul
   Morillo Cano, Julio
TI COVID-19 IN WORKERS OF MONTUFAR SOCIAL SECURITY HEALTH CENTER DUE TO
   INAPPROPRIATE USE OF PROTECTIVE CLOTHING
SO REVISTA UNIVERSIDAD Y SOCIEDAD
LA English
DT Article
DE Workers; COVID-19; infection; personal protective clothing
AB A recent outbreak of coronavirus infection cataloged as a pandemic in the first quarter of 2020, called SARS-COV-2, demonstrates the importance of proper handling of personal protective clothing in health workers, who work in the first line of care for people possibly infected. However, the lack of knowledge and management of patients with respiratory symptoms favors the contagion of medical personnel, reducing the productivity of health care centers. The objective of this research is to determine the relationship between COVID-19 infection in health personnel at the B San Gabriel health center of the Ecuadorian Institute of Social Security against the misuse of protective clothing due to the high incidence of infections. Through a longitudinal study using a participant observation method in the San Gabriel Health Center, Montufar canton, in the province of Carchi. Only 2 workers were not studied because they were in remote work mode, the other 32 workers were surveyed. It was found that there is a relationship between the inappropriate use of personal protective clothing and COVID-19 infection in health personnel, in addition, bad information and poor training on the subject are also associated.
C1 [Galarraga Mayanquer, Clara Jaqueline; Lopez Enriquez, Ivan Raul; Morillo Cano, Julio] Univ Reg Autonoma Los Andes, Quevedo, Ecuador.
RP Mayanquer, CJG (corresponding author), Univ Reg Autonoma Los Andes, Quevedo, Ecuador.
EM jgalarraga1990@gmail.com; pg.docenteile@uniandes.edu.ec;
   ut.juliomorillo@uniandes.edu.ec
CR Agusti C, 2018, ATEN PRIM, V50, P159, DOI 10.1016/j.aprim.2017.02.008
   Al-Subhi S. H., 2020, REV CUB OBSTET GINEC, V46, P1
   Aleebrahim-Dehkordi E., 2020, J PEDIAT NURSING
   Arias E. B. N., 2021, REV ASOCIACION LATIN, P73
   Barach P, 2021, MAYO CLIN PROC, V96, P20, DOI 10.1016/j.mayocp.2020.10.017
   Boushra MN, 2021, AM J EMERG MED, V40, P193, DOI 10.1016/j.ajem.2020.10.055
   Carralero A. C. Y., 2020, REV ASOCIACION LATIN, V13, P27
   Cordero F. E. T., 2019, NEUTROSOPHIC COMPUTI, V10, P63
   Daniel P, 2021, AM J EMERG MED, V43, P103, DOI 10.1016/j.ajem.2021.01.068
   Garcia A. R., 2021, APLICACION VALOR UMB
   Gomez G. A., 2020, NEUTROSOPHIC SETS SY, V37, P17, DOI [10.5281/zenodo.4121980, DOI 10.5281/ZENODO.4121980]
   Heer M. S., 2021, ITEMS PAGE NUMBER, V5
   Lotfi M, 2020, CLIN CHIM ACTA, V508, P254, DOI 10.1016/j.cca.2020.05.044
   Malagon-Rojas J, 2020, BIOMEDICA, V40, P166, DOI 10.7705/biomedica.5802
   Mar Cornelio O., 2021, REV CUB SALUD PUBLIC, V46, pE2459
   McLaren JTT, 2021, AM J EMERG MED, V49, P367, DOI 10.1016/j.ajem.2021.06.057
   Nguyen J, 2021, AM J EMERG MED, V48, P38, DOI 10.1016/j.ajem.2021.03.088
   Pandey SC, 2020, LIFE SCI, V256, DOI 10.1016/j.lfs.2020.117956
   Penafiel Palacios A. J., 2021, NEUTROSOPHIC SETS SY, V44, P18
   Sedes PR, 2020, MED INTENSIVA, V44, P363, DOI 10.1016/j.medin.2020.03.006
   Smarandache F., 2020, IJNS, V12, P9
   Castan-Abad MT, 2021, ATEN PRIM, V53, DOI 10.1016/j.aprim.2021.102074
   Tufino-Loza C, 2020, REV MEX CIENC PECU, V11, P811, DOI 10.22319/rmcp.v11i3.5242
NR 23
TC 0
Z9 0
U1 0
U2 0
PU UNIV CIENFUEGOS
PI CIENFUEGOS
PA CARRETERA RODAS KM 4, CUATRO CAMINOS, CIENFUEGOS, 00000, CUBA
SN 2218-3620
J9 REV UNIV SOC
JI Rev. Univ. Soc.
PD OCT
PY 2021
VL 13
SU 2
BP 477
EP 483
PG 7
WC Social Sciences, Interdisciplinary
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA XC5BE
UT WOS:000722027400057
DA 2022-04-20
ER

PT J
AU Rohani, P
   Karimi, A
   Tabatabaie, SR
   Khalili, M
   Sayyari, A
AF Rohani, Pejman
   Karimi, Abdollah
   Tabatabaie, Sedigheh Rafiei
   Khalili, Mitra
   Sayyari, Aliakbar
TI Protein losing enteropathy and pneumatosis intestinalis in a child with
   COVID 19 infection
SO JOURNAL OF PEDIATRIC SURGERY CASE REPORTS
LA English
DT Article
DE COVID 19; Children; Pneumatosis intestinalis; Protein losing
   enteropathy; Acute abdomen; "Case report"
ID ACE2
AB Background: Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) is known as COVID 19 seems to be one of the most contagious and dangerous infection in children and adults. According to first adult studies association of gastrointestinal (GI) symptoms with COVID 19 infection was as high as 79% (1).But later study showed lower association around 18% (2).As the pandemic of COVID 19 is going on, different clinical presentation of disease especially in children are well appeared. In addition atypical presentations may confuse and mislead physician to do different diagnostic procedures and interventions. We report a 6 years and half old boy with diarrhea, abdominal pain with first diagnosis acute abdomen due to acute appendicitis. At last diagnosis of pneumatosis intestinalis due to enterocolitis was confirmed.
   Case presentation: A 6 years and half old boy with severe abdominal pain admitted in emergency ward. He had history of fever, nine days of diarrhea and recurrent vomiting. The abdominal pain was severe with moderate tenderness in right lower quadrant. He admitted in pediatric surgery ward after surgical consultation for rolling out acute appendicitis. The results of first lab studies were shown leucopenia, lymphopenia and COVID 19 PCR was positive. During admission the cough has increased and abdominal distention has evolved. Vomiting was intractable and feeding was impossible. Pneumatosis intestinalis in ascending colon and dilatation in colon caliber were detected abdominal. Miliary like pattern in lung has reported in chest CT. Stool exam results revealed loss of protein in high amount in spite of normal pancreatic and enterocyte function. The calprotectin was high and implied high inflammation in large intestine. With all above data necrotizing enterocolitis management was started. After 14 days patients had good appetite and feeding slowly introduced. All symptoms resolved with exception of cough. Albumin and other electrolytes remained stable. The patient discharged without morbidity.
   Conclusion: COVID 19 infection has many different and mysterious presentations. GI manifestations are among important, common presentations. The acute abdomen like presentation with different complications like pneumatosis intestinalis, protein losing enteropathy are not common but knowledge about these presentations assist physician to be aware and make decision accurately.
C1 [Rohani, Pejman; Sayyari, Aliakbar] Shahid Beheshti Univ Med Sci, Res Inst Children Hlth, Pediat Gastroenterol Hepatol & Nutr Res Ctr, Shariati Ave, Tehran, Iran.
   [Karimi, Abdollah; Tabatabaie, Sedigheh Rafiei] Shahid Beheshti Univ Med Sci, Res Inst Children Hlth, Pediat Infect Res Ctr, Tehran, Iran.
   [Khalili, Mitra] Shahid Beheshti Univ Med Sci, Res Inst Children Hlth, Tehran, Iran.
RP Rohani, P (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Children Hlth, Pediat Gastroenterol Hepatol & Nutr Res Ctr, Shariati Ave, Tehran, Iran.
EM rohanipejmanmd@gmail.com
OI Rohani, Pejman/0000-0002-4208-8130
CR Ahmed AOE, 2020, AM J TROP MED HYG, V103, P841, DOI 10.4269/ajtmh.20-0559
   Akobeng AK, 2021, FRONTLINE GASTROENTE, V12, P332, DOI 10.1136/flgastro-2020-101529
   Braamskamp MJAM, 2010, EUR J PEDIATR, V169, P1179, DOI 10.1007/s00431-010-1235-2
   Cai XF, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00258
   Calinescu AM, 2020, ANN SURG, V272, pE244, DOI 10.1097/SLA.0000000000004100
   Effenberger M, 2020, GUT, V69, P1543, DOI 10.1136/gutjnl-2020-321388
   Ekbatani MS, 2021, BRIT J BIOMED SCI, V78, P47, DOI 10.1080/09674845.2020.1785102
   Gahide G, 2020, CLIN MED, V20, pE4, DOI 10.7861/clinmed.2020-0150
   Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Lakshmanan S, 2020, CLIN GASTROENTEROL H, DOI [10.1016/j.cgh.2020.05.048., DOI 10.1016/J.CGH.2020.05.048.]
   Li XM, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02324-w
   Mandal A, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.8750
   Meini S, 2020, BMJ OPEN GASTROENTER, V7, DOI 10.1136/bmjgast-2020-000434
   Moazzam Z, 2020, J PEDIAT SURG CASE R, V59, DOI 10.1016/j.epsc.2020.101533
   Saeed U, 2020, BRIT J SURG, V107, pE186, DOI 10.1002/bjs.11674
   Suwanwongse K, 2020, CUREUS, V12, DOI 10.7759/cureus.9394
   Tian Y, 2020, ALIMENT PHARM THER, V51, P843, DOI 10.1111/apt.15731
   Tullie L, 2020, LANCET CHILD ADOLESC, V4, pE19, DOI 10.1016/S2352-4642(20)30165-6
   Xiong X, 2020, GUT, DOI [10.1136/gutjnl-2020-1, DOI 10.1136/GUTJNL-2020-1]
NR 20
TC 4
Z9 4
U1 0
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2213-5766
J9 J PEDIAT SURG CASE R
JI J. Pediatr. Surg. Case Rep.
PD JAN
PY 2021
VL 64
AR 101667
DI 10.1016/j.epsc.2020.101667
PG 5
WC Pediatrics
WE Emerging Sources Citation Index (ESCI)
SC Pediatrics
GA PI0KU
UT WOS:000600790400006
PM 33173753
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Schweitzer, F
   Kleineberg, NN
   Goreci, Y
   Onur, OA
   Franke, C
   Warnke, C
AF Schweitzer, Finja
   Kleineberg, Nina N.
   Goreci, Yasemin
   Onur, Oezguer A.
   Franke, Christiana
   Warnke, Clemens
TI Neuro-COVID-19 is more than anosmia: clinical presentation,
   neurodiagnostics, therapies, and prognosis
SO CURRENT OPINION IN NEUROLOGY
LA English
DT Review
DE coronavirus disease 2019; diagnosis; long coronavirus disease;
   neurological manifestation; treatment
ID COVID-19; ENCEPHALITIS; SARS
AB Purpose of review
   To provide an overview on current knowledge of neurological symptoms and complications of COVID-19, and to suggest management concepts.
   Recent findings
   Headache, dizziness, excessive tiredness, myalgia, anosmia/hyposmia, and ageusia/dysgeusia are common nonspecific neurological manifestations during early COVID-19 disease found in the majority of patients. Less frequent but more severe and specific neurological manifestations include Guillain--Barre syndrome, encephalopathy, encephalitis/meningitis, epileptic seizures, and cerebrovascular events. Beyond standard neurological examination, these require a more extensive work-up, including cerebrospinal fluid assessment, neurophysiological evaluation, neuroimaging, and cognitive testing. Symptomatic treatment is advisable unless the neurological complication's immune pathogenesis is proven.
   Summary
   Neurological manifestations of COVID-19 occur during the acute, para-infectious, and 'recovery' phase. Therapeutic management depends on the clinical presentation and neurological work-up.
C1 [Schweitzer, Finja; Kleineberg, Nina N.; Goreci, Yasemin; Onur, Oezguer A.; Warnke, Clemens] Univ Cologne, Dept Neurol, Fac Med, Cologne, Germany.
   [Schweitzer, Finja; Kleineberg, Nina N.; Goreci, Yasemin; Onur, Oezguer A.; Warnke, Clemens] Univ Cologne, Univ Hosp Cologne, Cologne, Germany.
   [Kleineberg, Nina N.; Onur, Oezguer A.] Res Ctr Julich, Cognit Neurosci, Inst Neurosci & Med INM 3, Julich, Germany.
   [Franke, Christiana] Charite Univ Med Berlin, Dept Neurol Expt Neurol, Berlin, Germany.
   [Franke, Christiana] Humboldt Univ, Freie Univ Berlin, Berlin, Germany.
   [Franke, Christiana] Berlin Inst Hlth, Berlin, Germany.
RP Warnke, C (corresponding author), Univ Cologne, Dept Neurol, Fac Med, Cologne, Germany.; Warnke, C (corresponding author), Univ Cologne, Univ Hosp Cologne, Cologne, Germany.
EM Clemens.warnke@uk-koeln.de
OI Franke, Christiana/0000-0002-5609-2472
FU German research foundationGerman Research Foundation (DFG) [PR 1274/8-1,
   FR 4479/1-1, WA 4101/2-1]
FX H.P., C.F., and C.W. received funding from the German research
   foundation (PR 1274/8-1; FR 4479/1-1; WA 4101/2-1).
CR Abrams RMC, 2020, J NEUROVIROL, V26, P797, DOI 10.1007/s13365-020-00884-7
   Afshar H, 2020, MULT SCLER RELAT DIS, V43, DOI 10.1016/j.msard.2020.102216
   Aguila-Gordo D, 2020, J CLIN NEUROSCI, V80, P280, DOI 10.1016/j.jocn.2020.07.074
   AlKetbi Reem, 2020, Radiol Case Rep, V15, P1591, DOI 10.1016/j.radcr.2020.06.001
   Andriuta D, 2020, J NEUROL, V267, P2810, DOI 10.1007/s00415-020-09975-1
   Baig AM, 2020, J MED VIROL, V92, P1845, DOI [10.1002/jmv.26105, 10.1002/jmv.26624]
   Baig AM, 2020, ACS CHEM NEUROSCI, V11, P995, DOI 10.1021/acschemneuro.0c00122
   Benameur K, 2020, EMERG INFECT DIS, V26, P2016, DOI 10.3201/eid2609.202122
   Berlit Peter, 2020, Neurol Res Pract, V2, P51, DOI 10.1186/s42466-020-00097-7
   Boika AV, 2020, MOVEMENT DISORD, V35, P1094, DOI 10.1002/mds.28117
   Canas, 2020, ATTRIBUTES PREDICTOR, DOI [10. 1101/2020.10.19.20214494, DOI 10.1101/2020.10.19.20214494, 10.1101/2020.10.19.20214494]
   Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603
   Chen XL, 2021, J NEUROL, V268, P392, DOI 10.1007/s00415-020-10067-3
   Delamarre L, 2020, J NEUROL NEUROSUR PS, V91, P1004, DOI 10.1136/jnnp-2020-323678
   Diez-Porras L, 2020, NEUROMUSCULAR DISORD, V30, P859, DOI 10.1016/j.nmd.2020.08.354
   DosSantos MF, 2020, FRONT NEUROANAT, V14, DOI 10.3389/fnana.2020.00037
   Eberhardt KA, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12091045
   Efe IE, 2020, WORLD NEUROSURG, V140, P46, DOI 10.1016/j.wneu.2020.05.194
   Finsterer J, 2020, J MED VIROL, V92, P1793, DOI 10.1002/jmv.25903
   Franke C, 2021, BRAIN BEHAV IMMUN, V93, P415, DOI 10.1016/j.bbi.2020.12.022
   Gasmi A, 2021, MOL NEUROBIOL, V58, P944, DOI 10.1007/s12035-020-02070-6
   Ghosh R, 2020, AM J CASE REP, V21, DOI 10.12659/AJCR.925641
   Giannis D, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104362
   Goertz YMJ, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00542-2020
   Grant MC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234765
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Gutierrez-Ortiz C, 2020, NEUROLOGY, V95, pE601, DOI 10.1212/WNL.0000000000009619
   Helbok R, 2020, EUR J NEUROL, V27, P1754, DOI 10.1111/ene.14388
   Hoffman LA, 2017, BRAIN, V140, P2246, DOI 10.1093/brain/awx177
   JUNIOR MMS, 2020, POSTGRAD MED J, DOI DOI 10.1136/POSTGRADMEDJ-2020-138791
   Kamal YM, 2020, BMJ CASE REP, V13, DOI 10.1136/bcr-2020-237378
   Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1
   Lyons D, 2020, IRISH J PSYCHOL MED, V37, P295, DOI 10.1017/ipm.2020.40
   Mandal S, 2021, THORAX, V76, P396, DOI 10.1136/thoraxjnl-2020-215818
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Mariager, 2021, CLIN INFECT DIS, DOI DOI 10.1093/CID/CIAB003
   Marshall M, 2020, NATURE, V585, P339, DOI 10.1038/d41586-020-02598-6
   Matschke J, 2020, LANCET NEUROL, V19, P919, DOI 10.1016/S1474-4422(20)30308-2
   Maunder RG, 2009, GEN HOSP PSYCHIAT, V31, P316, DOI 10.1016/j.genhosppsych.2009.04.004
   McCall S, 2008, J NEUROVIROL, V14, P177, DOI 10.1080/13550280801995445
   Merello M, 2021, LANCET NEUROL, V20, P94, DOI 10.1016/S1474-4422(20)30442-7
   Merkler Alexander E, 2020, medRxiv, DOI 10.1101/2020.05.18.20105494
   Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062
   Nabavi N, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3489
   Nath A, 2020, NEUROLOGY, V94, P809, DOI 10.1212/WNL.0000000000009455
   Neumann B, 2020, J NEUROL SCI, V418, DOI 10.1016/j.jns.2020.117090
   Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787
   Panariello A, 2020, BRAIN BEHAV IMMUN, V87, P179, DOI 10.1016/j.bbi.2020.05.054
   Paniz-Mondolfi A, 2020, J MED VIROL, V92, P699, DOI 10.1002/jmv.25915
   Parsons T, 2020, J NEUROL, V267, P2799, DOI 10.1007/s00415-020-09951-9
   Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2013400, 10.1056/NEJMc2011400]
   Rajdev K, 2020, J INVEST MED HIGH IM, V8, DOI 10.1177/2324709620961198
   Reichard RR, 2020, ACTA NEUROPATHOL, V140, P1, DOI 10.1007/s00401-020-02166-2
   Rogers JP, 2020, LANCET PSYCHIAT, V7, P611, DOI 10.1016/S2215-0366(20)30203-0
   Roth C, 2014, NEUROCRIT CARE, V21, P186, DOI 10.1007/s12028-014-0004-x
   Rudroff T, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10121012
   Sasannejad C, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2626-z
   Sattar SB, 2020, CUREUS, V12, DOI 10.7759/cureus.10650
   Spinato G, 2020, JAMA-J AM MED ASSOC, V323, P2089, DOI 10.1001/jama.2020.6771
   Svedung Wettervik Teodor, 2020, Crit Care Explor, V2, pe0197, DOI 10.1097/CCE.0000000000000197
   Taquet M, 2021, LANCET PSYCHIAT, V8, pE1
   Wada S, 2020, INTERNAL MED, V59, P2187, DOI 10.2169/internalmedicine.5447-20
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang MM, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021428
   Wassie GT, 2020, CURR THER RES CLIN E, V93, DOI 10.1016/j.curtheres.2020.100607
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yachou Y, 2020, NEUROL SCI, V41, P2657, DOI 10.1007/s10072-020-04575-3
   Yaghi S, 2020, STROKE, V51, P2002, DOI 10.1161/STROKEAHA.120.030335
   Zhao YM, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100463
NR 70
TC 6
Z9 6
U1 5
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1350-7540
EI 1473-6551
J9 CURR OPIN NEUROL
JI Curr. Opin. Neurol.
PD JUN
PY 2021
VL 34
IS 3
BP 423
EP 431
DI 10.1097/WCO.0000000000000930
PG 9
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA ST1ZT
UT WOS:000662250300023
PM 33709973
DA 2022-04-20
ER

PT J
AU Lauder, AF
   Lauder, MRMT
   Kiftiawati, K
AF Lauder, Allan F.
   Lauder, Multamia R. M. T.
   Kiftiawati, Kiftiawati
TI Preserving and empowering local languages amidst the Covid-19 pandemic
   Lessons from East Kalimantan
SO WACANA-JURNAL ILMU PENGETAHUAN BUDAYA-JOURNAL OF THE HUMANITIES OF
   INDONESIA
LA English
DT Article
DE Covid-19 pandemic; language vitality; local languages; empowering;
   collective memory
AB This article brings together two ostensibly separate subjects: language empowerment and the Covid-19 pandemic. It argues that knowledge of local languages can help disseminate health-related information on a regional level. This addresses two problems simultaneously: the problems raised by the intelligibilty of governmental healthcare protocols and the functions of the use of local languages. The article is a case study presenting a number of interventions in the languages of East Kalimantan and can be seen as an inclusive, grassroots example of health communication. The study was initially a modest attempt to generate on-the-ground examples of health information in the dominant languages of the region of East Kalimantan. These studies demonstrate that the local communities of these languages are very enthusiastic about getting involved in the interventions. They also reveal that communication using IT and social media is thriving.
   One of our observations was that information about this pandemic tends to be understood only by highly educated urban people. This happens because it is conveyed by the government in standard Indonesian, which includes many foreign loanwords. The application of local languages is not just using local language vocabulary, it is instead a trigger to revive the collective memory of disaster management based on local culture. In this case, local languages are recognized and considered useful in helping to break the chain of virus transmission to free Indonesia of the Covid-19 outbreak. There were a number of unexpected developments. We found support for the intervention being rolled out on a national level by Special Task Force for Covid-19 under National Disaster Management Agency (Badan Nasional Penanggulangan Bencana/BNPB). We also welcomed the online publication by the National Agency for Language Development and Cultivation (Badan Bahasa) of the Handbook for managing behavior about health protocols in seventy-seven local languages. The main thrust of this article should therefore be of interest to anyone working to empower local languages and language vitality.
C1 [Lauder, Allan F.] Univ Indonesia, Postgrad Linguist Dept Programme, Humanities Fac, Psycholinguist Corpus Linguist & Res Methods Ling, Kota Depok, Jawa Barat, Indonesia.
   [Lauder, Multamia R. M. T.] Univ Indonesia, Linguist Dept Programme, Humanities Fac, Phonol Methods Res Linguist Dialectol & Socioling, Kota Depok, Jawa Barat, Indonesia.
   [Kiftiawati, Kiftiawati] Univ Mulawarman, Fac Cultural Sci, Indonesian Literature Study Programme, Samarinda, East Kalimantan, Indonesia.
EM allan.lauder@gmail.com; multamia@ui.ac.id; kiftiawati@fib.unmul.ac.id
CR Aziz E. Aminudin, 2020, MEDIAINDONESIA
   Badan Bahasa, 2019, BAH DAN PET BAH IND, VSixth
   Badan Bahasa, 2020, PED PER PER PEN COV
   Badan Pusat Statistik, 2020, POTR PEND IND STAT P
   Budiono Satwiko, 2017, 10 INT C APPL LING C
   Collins James T., 2019, LANGUAGE DEATH INDON
   Collins James T., 2019, PARADIGMA J KAJIAN B, V9, P103
   Crystal David, 2014, LANGUAGE DEATH
   Fishman Joshua, 2001, CAN THREATENED LANGU
   Gadeng A.N, 2018, EARTH ENV SCI, V145, P1
   Harimansyah Ganjar, 2019, KAJIAN VITALITAS BAH
   Harimansyah Ganjar, 2017, PEDOMAN KONSERVASI D
   Hinton L, 2018, ROUTL HANDBK, pXXI
   Jones MC, 2015, ENDANGERED LANGUAGES AND NEW TECHNOLOGIES, pXIII
   Lauder Allan F., 2017, K INT DAN LOK BAH DA
   Lauder Multamia RMT, 2018, PAP K BAH IND 11 BAD
   Lauder Multamia RMT, 2019, VITALITAS BEBERAPA B
   Lauder Multamia RMT, 2020, PAP INT C IND LANG L
   Moseley Christopher J., 2007, ENCY WORLDS ENDANGER
   Nuraini Tantiya Nimas, 2020, KRONOLOGI MUNCULNYA
   Pelupessy Dicky, 2020, STUDI PERILAKU PEMAK
   Supriatnoko, 2015, THESIS U INDONESIA
   Tulius J., 2020, PARADIGMA JURNAL KAJ, V10, P147
   Whaley L.J., 2006, SAVING LANGUAGES INT
NR 24
TC 0
Z9 0
U1 2
U2 2
PU UNIV INDONESIA, FAC HUMANITIES
PI DEPOK
PA GD 2, LT 2, DEPOK, 16424, INDONESIA
SN 1411-2272
EI 2407-6899
J9 WACANA
JI Wacana
PY 2021
VL 22
IS 2
BP 439
EP 466
DI 10.17510/wacana.v22i2.1006
PG 28
WC Humanities, Multidisciplinary
WE Emerging Sources Citation Index (ESCI)
SC Arts & Humanities - Other Topics
GA SG9QH
UT WOS:000653774100008
OA gold
DA 2022-04-20
ER

PT J
AU Issa, MR
   Muslim, NA
   Sharif, ZM
AF Issa, Marwan Rasmi
   Muslim, Noor Awanis
   Sharif, Zainon Mat
TI The Mediating Effect of Model-Based Learning on Attitude and Pain
   Management Awareness Among Nurses During COVID 19 Pandemic in Saudi
   Arabia
SO SAGE OPEN NURSING
LA English
DT Article
DE pain management awareness; nurses attitude about pain management;
   model-based learning
ID KNOWLEDGE; STUDENTS
AB Background: All hospitals are required to provide high-quality pain management; one of the most critical issues in achieving high-quality pain management is that the hospitals have a clear plan to manage the patients' pain and improve the nurses' awareness of pain management during the COVID 19 pandemic. However, there is a significant gap in the literature that this study can cover.
   Aim: This study aimed to investigate the mediating effect of model-based learning on nurses' attitudes toward nurses' pain management awareness during the COVID 19 pandemic in Saudi Arabia government hospitals.
   Method: The Heath Beliefs Model was used, with a quasi-experimental design, with per experimental one group pre-test post-test design, and a quantitative approach using self-administered questionnaires obtained from 330 nurses working with patients suffering from pain. IBM SPSS V23 and Analysis of Moment Structures (AMOS)V23 were applied to analyze the causal relationships between the variables.
   Results: A two-step approach to analyze the study: the first step was to test the measurement models' constructs' reliability and validity. The second step was to test research hypotheses in the structural models. The results show a significant positive relationship between model-based learning and pain management awareness among nurses during COVID 19 pandemic. Furthermore, model-based learning fully mediated the relationship between nurses' attitudes and pain management awareness.
   Conclusions: The study successfully improved nurses' attitudes toward pain management awareness among nurses during COVID 19 pandemic. These findings will help strengthen the debate in the existing literature, and this is a new development window in the pain management area.
C1 [Issa, Marwan Rasmi] King Saud Med City, Riyadh, Saudi Arabia.
   [Issa, Marwan Rasmi; Muslim, Noor Awanis; Sharif, Zainon Mat] Univ Tenaga Nasl UNITEN, Coll Grad Studies COGS, Putrajaya Campus,Jalan IKRAM UNITEN, Kajang 4300, Selangor, Malaysia.
RP Issa, MR (corresponding author), King Saud Med City, Riyadh, Saudi Arabia.; Issa, MR (corresponding author), Univ Tenaga Nasl UNITEN, Coll Grad Studies COGS, Putrajaya Campus,Jalan IKRAM UNITEN, Kajang 4300, Selangor, Malaysia.
EM Marwan.rasmi@yahoo.com
CR [Anonymous], 1974, Health Education Monograph, V2, P324
   Bjorn A, 2017, INTENS CRIT CARE NUR, V42, P68, DOI 10.1016/j.iccn.2017.02.010
   Brunkert T, 2020, J NURS SCHOLARSHIP, V52, P14, DOI 10.1111/jnu.12508
   Campbell E, 2020, PAIN MANAG NURS, V21, P179, DOI 10.1016/j.pmn.2019.07.010
   Chen J, 2020, PAIN MANAG NURS, V21, P365, DOI 10.1016/j.pmn.2019.09.004
   Eaton LH, 2017, APPL NURS RES, V37, P55, DOI 10.1016/j.apnr.2017.07.008
   El-Tallawy SN, 2020, PAIN THER, V9, P453, DOI 10.1007/s40122-020-00190-4
   Fitzgerald K, 2018, CHIROPR MAN THER, V26, DOI 10.1186/s12998-018-0212-0
   Garcia-Martinez E, 2019, BMC FAM PRACT, V20, DOI 10.1186/s12875-019-0919-6
   Ghazali DA, 2019, CONT CLIN TRIAL COMM, V14, DOI 10.1016/j.conctc.2019.100331
   Grewal R, 2018, INT J EVID-BASED HEA, V26, P107, DOI [10.1097/XEB.0000000000000131, DOI 10.1097/XEB.0000000000000131]
   Hay D, 2019, SURGERY, V37, P1, DOI [10.1016/j.mpsur.2019.05.004, DOI 10.1016/J.MPSUR.2019.05.004]
   Hayes K.I.M., 2018, ASS REGISTERED NURSE, V101, P327, DOI [10.1016/j.aorn.2014.11.019, DOI 10.1016/J.AORN.2014.11.019]
   Issa MR, 2019, DIMENS CRIT CARE NUR, V38, P271, DOI 10.1097/DCC.0000000000000375
   Kailainathan P, 2018, BRIT J PAIN, V12, P47, DOI 10.1177/2049463717725015
   KREJCIE RV, 1970, EDUC PSYCHOL MEAS, V30, P607, DOI 10.1177/001316447003000308
   Niemi-Murola L, 2007, EUR J PAIN, V11, P700, DOI 10.1016/j.ejpain.2006.12.001
   Perri GA, 2018, AM J HOSP PALLIAT ME, V35, P92, DOI 10.1177/1049909116684765
   Shindul-Rothschild J, 2017, PAIN MANAG NURS, V18, P401, DOI 10.1016/j.pmn.2017.05.003
   Tsang JLY, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024328
   Ung A, 2016, BRIT J PAIN, V10, P8, DOI 10.1177/2049463715583142
   Wang XQ, 2019, INT J PHYS DISTR LOG, V49, P217, DOI 10.1108/IJPDLM-12-2017-0372
   Zacharoff K.L., 2010, INFLEXXION HLTH SERI, V4th
NR 23
TC 0
Z9 0
U1 1
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2377-9608
J9 SAGE OPEN NURS
JI SAGE Open Nurs.
PD DEC
PY 2021
VL 7
DI 10.1177/23779608211065213
PG 9
WC Nursing
WE Emerging Sources Citation Index (ESCI)
SC Nursing
GA XO5NK
UT WOS:000730231800001
PM 35155775
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Perveen, N
   Bin Muzaffar, S
   Al-Deeb, MA
AF Perveen, Nighat
   Bin Muzaffar, Sabir
   Al-Deeb, Mohammad Ali
TI Exploring human-animal host interactions and emergence of COVID-19:
   Evolutionary and ecological dynamics
SO SAUDI JOURNAL OF BIOLOGICAL SCIENCES
LA English
DT Review
DE Animal reservoir; COVID-19; Interspecies transmission; MERS-CoV;
   SARS-CoV; SARS-CoV-2
ID RESPIRATORY SYNDROME CORONAVIRUS; EMERGING INFECTIOUS-DISEASES; COMPLETE
   GENOME; AVIAN CORONAVIRUSES; BAT; IDENTIFICATION; BETACORONAVIRUS;
   DIVERSITY; DISCOVERY; SEQUENCE
AB The novel coronavirus disease (COVID-19) that emerged in December 2019 had caused substantial morbidity and mortality at the global level within few months. It affected economies, stopped travel, and isolated individuals and populations around the world. Wildlife, especially bats, serve as reservoirs of coronaviruses from which the variant Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) emerged that causes COVID-19. In this review, we describe the current knowledge on COVID-19 and the significance of wildlife hosts in its emergence. Mammalian and avian coronaviruses have diverse host ranges with distinct lineages of coronaviruses. Recombination and reassortments occur more frequently in mixed-animal markets where diverse viral genotypes intermingle. Human coronaviruses have evolved through gene gains and losses primarily in interfaces where wildlife and humans come in frequent contact. There is a gap in our understanding of bats as reservoirs of coronaviruses and there is a misconception that bats periodically transmit coronaviruses to humans. Future research should investigate bat viral diversity and loads at interfaces between humans and bats. Furthermore, there is an urgent need to evaluate viral strains circulating in mixed animal markets, where the coronaviruses circulated before becoming adapted to humans. We propose and discuss a management intervention plan for COVID-19 and raise questions on the suitability of current containment plans. We anticipate that more virulent coronaviruses could emerge unless proper measures are taken to limit interactions between diverse wildlife and humans in wild animal markets. (C) 2020 The Authors. Published by Elsevier B.V. on behalf of King Saud University.
C1 [Perveen, Nighat; Bin Muzaffar, Sabir; Al-Deeb, Mohammad Ali] United Arab Emirates Univ, Dept Biol, POB 15551, Al Ain, U Arab Emirates.
RP Al-Deeb, MA (corresponding author), Biol Dept, POB 15551, Al Ain, U Arab Emirates.
EM 201790740@uaeu.ac.ae; s_muzaffar@uaeu.ac.ae; m_aldeeb@uaeu.ac.ae
RI Al-Deeb, Mohammad Ali/AFK-5849-2022; Perveen, Nighat/AAW-2559-2021
OI Al-Deeb, Mohammad Ali/0000-0003-3138-8709; Perveen,
   Nighat/0000-0002-9292-8679
FU UAE University by UPAR [G00002604]
FX UAE University by UPAR grant # G00002604.
CR Abdul-Rasool Sahar, 2010, Open Virol J, V4, P76, DOI 10.2174/1874357901004010076
   BARDOS V, 1980, INTERVIROLOGY, V13, P275, DOI 10.1159/000149135
   Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011
   Bolles M, 2011, CURR OPIN VIROL, V1, P624, DOI 10.1016/j.coviro.2011.10.012
   Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055
   Chan JFW, 2013, TRENDS MICROBIOL, V21, P544, DOI 10.1016/j.tim.2013.05.005
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07
   Chu DKW, 2006, J GEN VIROL, V87, P2461, DOI 10.1099/vir.0.82203-0
   Chu DKW, 2011, J VIROL, V85, P12815, DOI 10.1128/JVI.05838-11
   Corman VM, 2014, J VIROL, V88, P717, DOI 10.1128/JVI.01600-13
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   Cunningham A., 2020, COVID 19 WILDLIFE FA
   Cunningham AA, 2005, BRIT MED J, V331, P1214, DOI 10.1136/bmj.331.7527.1214
   Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443
   de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13
   Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Esper F, 2005, J INFECT DIS, V191, P492, DOI 10.1086/428138
   Fan Y, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030210
   FEHR AR, 2015, METHOD MOL BIOL, V1282, DOI [10.1007/978-1-4939-2438-7_1, DOI 10.1007/978-1-4939-2438-7_1]
   Forni D, 2017, TRENDS MICROBIOL, V25, P35, DOI 10.1016/j.tim.2016.09.001
   Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P6212, DOI 10.1073/pnas.0400762101
   Ge XY, 2016, VIROL SIN, V31, P31, DOI 10.1007/s12250-016-3713-9
   Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Graham RL, 2013, NAT REV MICROBIOL, V11, P836, DOI 10.1038/nrmicro3143
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Guy JL, 2005, BBA-PROTEINS PROTEOM, V1751, P2, DOI 10.1016/j.bbapap.2004.10.010
   HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190, DOI 10.3181/00379727-121-30734
   HAMRE DOROTHY, 1967, J VIROL, V1, P810
   Hantak MP, 2019, J VIROL, V93, DOI 10.1128/JVI.01429-17
   Hoek L. van der, 2004, Nature Medicine, V10, P368, DOI 10.1038/nm1024
   Hoffmann M, 2020, NOVEL CORONAVIRUS 20, P1, DOI [10.1016/j.cell.2020.02.052, 10.1101/2020.01.31.929042, DOI 10.1101/2020.01.31.929042]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   KAYE HS, 1975, LANCET, V2, P509
   Kocherhans R, 2001, VIRUS GENES, V23, P137, DOI 10.1023/A:1011831902219
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Lam T.T.Y., 2020, IDENTIFICATION 2019, DOI [10.1101/2020.02.13.945485., DOI 10.1101/2020.02.13.945485]
   Lau SKP, 2007, VIROLOGY, V367, P428, DOI 10.1016/j.virol.2007.06.009
   Lau Susanna K P, 2012, J Virol, V86, P11906, DOI 10.1128/JVI.01305-12
   Lau SKP, 2015, J VIROL, V89, P3076, DOI 10.1128/JVI.02420-14
   Lau SKP, 2010, J VIROL, V84, P11385, DOI 10.1128/JVI.01121-10
   Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301
   Li JY, 2020, MICROBES INFECT, V22, P80, DOI 10.1016/j.micinf.2020.02.002
   Lin XD, 2017, VIROLOGY, V507, P1, DOI 10.1016/j.virol.2017.03.019
   Liu P, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11110979
   Martini MC, 2018, AVIAN PATHOL, V47, P286, DOI 10.1080/03079457.2018.1442557
   MCINTOSH K, 1967, P NATL ACAD SCI USA, V57, P933, DOI 10.1073/pnas.57.4.933
   Mihindukulasuriya KA, 2008, J VIROL, V82, P5084, DOI 10.1128/JVI.02722-07
   Milek J, 2018, J VET RES, V62, P249, DOI 10.2478/jvetres-2018-0035
   Morens DM, 2010, MBIO, V1, DOI 10.1128/mBio.00211-10
   Morse SS, 1997, J NUTR, V127, pS951, DOI 10.1093/jn/127.5.951S
   MORSE SS, 1991, PERSPECT BIOL MED, V34, P387
   Munoz M, 1996, EPIDEMIOL INFECT, V117, P203, DOI 10.1017/S0950268800001321
   Ng SKC, 2003, LANCET, V362, P570, DOI 10.1016/S0140-6736(03)14121-9
   Obameso JO, 2017, SCI CHINA LIFE SCI, V60, P1357, DOI 10.1007/s11427-017-9263-6
   Paim FC, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100897
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147
   Plowright RK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2124
   Poon LLM, 2005, J VIROL, V79, P2001, DOI 10.1128/JVI.79.4.2001-2009.2005
   PROVACIA LBV, 2011, EMERG INFECT DIS, V17, P2, DOI DOI 10.1056/NEJMOA
   Pyrc K, 2007, J VIROL, V81, P3051, DOI 10.1128/JVI.01466-06
   REED SE, 1984, J MED VIROL, V13, P179, DOI 10.1002/jmv.1890130208
   Rest JS, 2003, INFECT GENET EVOL, V3, P219, DOI 10.1016/j.meegid.2003.08.001
   Richman DD, 2016, CLIN VIROLOGY, V4th
   Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102
   Swayne DE, 2004, EMERG INFECT DIS, V10, P914, DOI 10.3201/eid1005.030827
   Takekawa JY, 2010, AVIAN BIOL RES, V3, P51, DOI 10.3184/175815510X12737339356701
   Tao Y, 2017, J VIROL, V91, DOI 10.1128/JVI.01953-16
   Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888
   Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666
   TZIPORI S, 1978, AUST VET J, V54, P320, DOI 10.1111/j.1751-0813.1978.tb02478.x
   Vijaykrishna D, 2007, J VIROL, V81, P4012, DOI 10.1128/JVI.02605-06
   Vijgen L, 2005, J VIROL, V79, P1595, DOI 10.1128/JVI.79.3.1595-1604.2005
   Viviani L, 2011, J CYST FIBROS, V10, P370, DOI 10.1016/j.jcf.2011.06.004
   Vlasova AN, 2011, J GEN VIROL, V92, P1369, DOI 10.1099/vir.0.025353-0
   Wahba L, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00160-20
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19
   Wang LF, 2006, EMERG INFECT DIS, V12, P1834
   Wang N, 2018, VIROL SIN, V33, P104, DOI 10.1007/s12250-018-0012-7
   Wang W, 2015, VIROLOGY, V474, P19, DOI 10.1016/j.virol.2014.10.017
   Weingartl HM, 2004, EMERG INFECT DIS, V10, P179, DOI 10.3201/eid1002.030677
   Weiss SR, 2011, ADV VIRUS RES, V81, P85, DOI 10.1016/B978-0-12-385885-6.00009-2
   WHO, 2019, MIDDL E RESP SYNDR C
   WHO, 2020, COR DIS COVID 2019 S
   Woo PCY, 2007, J VIROL, V81, P1574, DOI 10.1128/JVI.02182-06
   Woo PCY, 2006, VIROLOGY, V351, P180, DOI 10.1016/j.virol.2006.02.041
   Woo PCY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.37
   Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11
   Woo PCY, 2010, VIRUSES-BASEL, V2, P1804, DOI 10.3390/v2081803
   Woo PCY, 2009, J VIROL, V83, P908, DOI 10.1128/JVI.01977-08
   Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005
   World Health Organization, 2003, SEV AC RESP SYNDR SA
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Wu T, 2017, AMBIO, V46, P18, DOI 10.1007/s13280-016-0809-2
   Wu ZQ, 2016, ISME J, V10, P609, DOI 10.1038/ismej.2015.138
   Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]
   Xu L, 2016, VIROL SIN, V31, P69, DOI 10.1007/s12250-016-3727-3
   Yan, 2020, SPECIFIC ACE2 EXPRES, DOI 10.1101/2020.02.03.931766
   Ye ZW, 2020, INT J BIOL SCI, V16, P1686, DOI 10.7150/ijbs.45472
   Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196
   Zaki A., 2012, INT SOC INFECT DIS, P2012
   Zhang Q, 2013, ARCH VIROL, V158, P1631, DOI 10.1007/s00705-013-1659-x
   Zhao Q, 2008, J VIROL, V82, P8647, DOI 10.1128/JVI.00298-08
   Zhao Y, 2016, J GEN VIROL, V97, P1566, DOI 10.1099/jgv.0.000464
   Zhao Yu, 2020, American Journal of Respiratory and Critical Care Medicine, V202, P756, DOI 10.1164/rccm.202001-0179LE
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhou P, 2018, NATURE, V556, P255, DOI 10.1038/s41586-018-0010-9
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 112
TC 2
Z9 2
U1 2
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1319-562X
EI 2213-7106
J9 SAUDI J BIOL SCI
JI Saudi J. Biol. Sci.
PD FEB
PY 2021
VL 28
IS 2
BP 1417
EP 1425
DI 10.1016/j.sjbs.2020.11.077
EA FEB 2021
PG 9
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA QF2IM
UT WOS:000616723000020
PM 33281479
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Kamenidou, I
   Stavrianea, A
   Liava, C
AF Kamenidou, Irene (Eirini)
   Stavrianea, Aikaterini
   Liava, Christina
TI Achieving a Covid-19 Free Country: Citizens Preventive Measures and
   Communication Pathways
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; SARS-CoV-2; preventive behavior; research; segmentation;
   marketing communication
ID CORONAVIRUS; TRANSMISSION; KNOWLEDGE; OUTBREAK; RESIDENTS; PNEUMONIA;
   ATTITUDES; WUHAN
AB The Coronavirus Disease 2019 (COVID-19) has spread on a global scale in an extremely short time, causing hundreds of thousands of deaths, and, at the same time, triggering extreme panic. Prevention in medicine is considered the best protection action for individuals in order to avoid infections. This study investigates whether Greek citizens (N= 3359) take the necessary precautions to prevent developing the COVID-19 disease, and it segments them based on homogenous behavior groups. Lastly, it provides communication techniques that should be implemented, targeting each citizen segment for a long-term COVID-19 free country. Data analysis revealed the extent of the applied precaution measures. The ones most applied by citizens were to avoid non-mandatory transportation, contact with individuals with respiratory symptoms, and individuals of high risk for severe illness (vulnerable groups). On the other hand, the least applied measures are daily checks of body temperature, monitoring for fever, cough, or dyspnea, use of a face mask when in public places, or when using public transportation. Additionally, cluster analysis revealed five groups of citizens based on self-reported behavior, namely, the Meticulous Proactive Citizens, the Self-isolated Citizens, the Cautious Citizens, the Occasionally Cautious Citizens, and the Unconcerned Citizens. Communication strategies targeting each segment are also discussed.
C1 [Kamenidou, Irene (Eirini)] Int Hellen Univ, Dept Management Sci & Technol, Kavala Campus, Agios Loukas Kavala 65404, Greece.
   [Stavrianea, Aikaterini] Natl & Kapodistrian Univ Athens, Dept Commun & Media Studies, Athens 10562, Greece.
   [Liava, Christina] Aristotle Univ Thessaloniki, Hippokrat Gen Hosp, Dept Internal Med 4, Konstantinoupoleos Str 49, Thessaloniki 54642, Greece.
RP Kamenidou, I (corresponding author), Int Hellen Univ, Dept Management Sci & Technol, Kavala Campus, Agios Loukas Kavala 65404, Greece.
EM rkam@mst.ihu.gr; aikstavria@media.uoa.gr; christinaliava@aol.com
RI Kamenidou, Irene/AAA-5210-2021
OI KAMENIDOU, IRENE (EIRINI)/0000-0002-8213-5843
CR [Anonymous], 2020, HUFFPOST
   [Anonymous], 2020, CIT MAN WHAT APPL TR
   Ashour HM, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030186
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Boyer R., 1997, HDB STRATEGIC PUBLIC, P481
   CDC, 2020, PUBL HTLH REC TRAV A
   Chan MF, 2008, J CLIN NURS, V17, P1051, DOI 10.1111/j.1365-2702.2007.01998.x
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen Yan, 2020, Zhonghua Yufang Yixue Zazhi, V54, P367, DOI [10.3760/cma.j.cn112150-20200205-00069, 10.3760/cma.j.cn112150.20200205.00069]
   Churchill Jr G.A., 2005, MARKETING RES METHOD
   Civil Aviation Authority, 2020, ANN
   Dolnicar S., 2011, P 21 CAUTHE NAT C AD
   Dolnicar S, 2008, J TRAVEL RES, V47, P63, DOI 10.1177/0047287508318910
   Dolnicar S, 2014, J TRAVEL RES, V53, P296, DOI 10.1177/0047287513496475
   Dolnicar S, 2009, J MARKET MANAG-UK, V25, P357, DOI 10.1362/026725709X429791
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Everitt B.S, 1993, CLUSTER ANAL
   Fang YQ, 2020, J MED VIROL, V92, P645, DOI 10.1002/jmv.25750
   Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387
   Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X
   Gandhi RT, 2020, NEW ENGL J MED, V383, P1757, DOI 10.1056/NEJMcp2009249
   Garfin DR, 2020, HEALTH PSYCHOL, V39, P355, DOI 10.1037/hea0000875
   Glik DC, 2007, ANNU REV PUBL HEALTH, V28, P33, DOI 10.1146/annurev.publhealth.28.021406.144123
   GOV. UK, 2020, COVID 19 INF PREV CO
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   Gu JY, 2020, GASTROENTEROLOGY, V158, P1518, DOI 10.1053/j.gastro.2020.02.054
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Haregu TN, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6056-7
   Hindson J, 2020, NAT REV GASTRO HEPAT, V17, P259, DOI 10.1038/s41575-020-0295-7
   Hou Y, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5340-x
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   IBM, ANOVA
   Johns Hopkins University (JHU), 2020, COVID 19 DASHB CTR S
   JOLLIFFE IT, 1982, J R STAT SOC A STAT, V145, P224, DOI 10.2307/2981536
   Kamenidou I, 2011, J MED PLANTS RES, V5, P3192
   Kamenidou IC, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11030837
   Kent M., 1996, VEGETATION DESCRIPTI
   Kent R., 1993, MARKETING RES ACTION
   Kitunen A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6696-2
   Koo JR, 2020, LANCET INFECT DIS, V20, P678, DOI 10.1016/S1473-3099(20)30162-6
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Lescure FX, 2020, LANCET INFECT DIS, V20, P697, DOI 10.1016/S1473-3099(20)30200-0
   Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2
   Lokuge K., 2020, EXIT STRATEGIES OPTI, DOI [10.1101/2020.04.19.20071217, DOI 10.1101/2020.04.19.20071217]
   m.naftemporiki.gr, 2020, COVID 19 1 POS CAS G
   Machida M, 2020, INT J INFECT DIS, V94, P139, DOI 10.1016/j.ijid.2020.04.014
   Marvanykovi F, 2009, SUBST USE MISUSE, V44, P569, DOI 10.1080/10826080802487283
   MCINTYRE RM, 1980, MULTIVAR BEHAV RES, V15, P225, DOI 10.1207/s15327906mbr1502_7
   Mclntosh K., CORONAVIRUS DIS 2019
   McMichael TM, 2020, NEW ENGL J MED, V382, P2005, DOI 10.1056/NEJMoa2005412
   Muto K, 2020, JAPANESE CITIZENS BE
   National Public Health Organization, 2020, COVID 19 NEWS PUBL S
   NPHO, 2020, PART EP SURV REP INF
   Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227
   PERRY RW, 1980, DISASTERS, V4, P433, DOI 10.1111/j.1467-7717.1980.tb00136.x
   Saunders J, 1994, J MARKETING MANAGEME, V194, P13, DOI DOI 10.1080/0267257X.1994.9964257
   Setti L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082932
   Spector P.E., 1992, SUMMATED RATING SCAL, V82
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   WALSH DC, 1993, HEALTH AFFAIR, V12, P104, DOI 10.1377/hlthaff.12.2.104
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   WHO, 2021, STAT 2 M INT HLTH RE
   WHO, 2020, CLIN 7AN SEV AC RESP
   World Health Organization, 2019, INFECT PREVENTION CO
   World Health Organization, 2020, EB VIR DIS
   Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]
   Yeo C, 2020, LANCET GASTROENTEROL, V5, P335, DOI 10.1016/S2468-1253(20)30048-0
   Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196
   Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhang J, 2020, BRAIN BEHAV IMMUN, V87, P49, DOI 10.1016/j.bbi.2020.04.031
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zickfeld J., 2020, PREDICTORS HEALTHPRO
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
   Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37
NR 76
TC 22
Z9 22
U1 2
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUL
PY 2020
VL 17
IS 13
AR 4633
DI 10.3390/ijerph17134633
PG 18
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA MM7DS
UT WOS:000550314500001
PM 32605097
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Bhutto, SA
   Shaikh, S
   Ashraf, M
   Amar, H
AF Bhutto, Sarfaraz Ahmed
   Shaikh, Saifullah
   Ashraf, Muhammad
   Amar, Hussain
TI THE EPIDEMIC COVID-19 OUTBREAK AND ECONOMIC SLOWDOWN IN DEVELOPING ASIA:
   A REVIEW
SO INTERNATIONAL TRANSACTION JOURNAL OF ENGINEERING MANAGEMENT & APPLIED
   SCIENCES & TECHNOLOGIES
LA English
DT Review
DE Infectious COVID-19 epidemic; MERS; PRC; Coronavirus pandemic; Tourism
   loss; SARS; Economics recession; Developing Asia; Tourism industry
   shrink; Coronavirus consequences for tourism
AB This study has taken a review of COVID-19 outbreak on the economic slowdown in developing Asia. Wuhan, City of PRC where this outbreak raised to the whole world, made several economic challenges for PRC and developing Asian economies. It is observed in this study that economic channels like trade, travel, production and services are affected through demand shock spillover and investment decline. Additionally, this study has reported different economic uncertainties and economic scenarios like best, moderate, and worse for PRC and other developing Asian economies. A brief review has taken for pandemic like SARS (severe acute respiratory syndrome), MERS (Middle-east respiratory syndrome), Ebola, Seasonal flu, and COVID-19. Elliptically, the transition and spread of COVID-19 is higher than other outbreaks, however, death ratio is relatively small compared to Ebola and MERS epidemics. Moreover, this study also briefed the role of Asian Development Bank (ADB) to provide financial and non-financial (knowledge and partnership) assistance to PRC and other developing economies of Asia.
   Disciplinary: Management & Economic Sciences, Public Health. (C) 2020 INT TRANS J ENG MANAG SCI TECH.
C1 [Bhutto, Sarfaraz Ahmed; Shaikh, Saifullah; Ashraf, Muhammad] Shah Abdul Latif Univ Khairpur, Inst Commerce, Sindh, Pakistan.
   [Amar, Hussain] Govt Islamic Arts & Commerce Coll, Sukkur, Sindh, Pakistan.
RP Bhutto, SA (corresponding author), Shah Abdul Latif Univ Khairpur, Inst Commerce, Sindh, Pakistan.
EM Sarfaraz_ahmed0333@yahoo.com
CR Althus C., 2014, ESTIMATING REPROD NU, DOI [10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288, DOI 10.1371/CURRENTS.OUTBREAKS.91AFB5E0F279E7F29E7056095255B288]
   [Anonymous], LANCET, DOI [10.1016/S0140-6736(20)30260-9, DOI 10.1016/S0140-6736(20)30260-9]
   Brahmbhatt M., 2008, SARS TYPE EC EFFECTS, DOI [10.1596/1813-9450-4466, DOI 10.1596/1813-9450-4466]
   CDC, 2019, MERS CLIN FEAT
   CDC, 2017, SARS BAS FACT SHEET
   Centers for Disease and Control (CDC), 2020, 2019 2020 US FLU SEA
   Chang D, 2020, JAMA-J AM MED ASSOC, V323, P1092, DOI 10.1001/jama.2020.1623
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3
   IMF, 2019, DIR TRAD STAT
   Noy I., 2019, ADB EC WORKING PAPER, V591
   UNWTO, 2019, GUID SUCC CHIN OUTB, DOI [10.18111/9789284421138, DOI 10.18111/9789284421138]
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   World Health Organization, 2003, CONS DOC EP SEV AC R
   World Health Organization, 2019, COR DIS COVID 19 SIT
   World Health Organization, 2016, MIDDL E RESP SYNDR C
   World Health Organization, 2020, EB VIR DIS
   Wu J. T. K., 2020, NOWCASTING FORECASTI
   Wu Z., 2020, JAMA-J AM MED ASSOC, V395, P689
NR 19
TC 0
Z9 0
U1 2
U2 21
PU TUENGR GROUP
PI PATHUMTAN
PA 88-244 MOO 3 KLONG NO 2 KLONG-LUANG, PATHUMTAN, 12120, THAILAND
SN 2228-9860
EI 1906-9642
J9 INT TRANS J ENG MANA
JI Int. Trans. J. Eng. Manag. Appl. Sci. Technol.
PY 2020
VL 11
IS 9
AR 11A9P
DI 10.14456/ITJEMAST.2020.178
PG 13
WC Multidisciplinary Sciences
WE Emerging Sources Citation Index (ESCI)
SC Science & Technology - Other Topics
GA LW3KH
UT WOS:000539043200015
DA 2022-04-20
ER

PT J
AU Pfortmueller, CA
   Spinetti, T
   Urman, RD
   Luedi, MM
   Schefold, JC
AF Pfortmueller, Carmen A.
   Spinetti, Thibaud
   Urman, Richard D.
   Luedi, Markus M.
   Schefold, Joerg C.
TI COVID-19-associated acute respiratory distress syndrome (CARDS): Current
   knowledge on pathophysiology and ICU treatment-A narrative review
SO BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY
LA English
DT Review
DE COVID-19; acute lung injury; ventilation; sepsis; immune cells; critical
   care; narrative review
ID CRITICALLY-ILL PATIENTS; EXTRACORPOREAL MEMBRANE-OXYGENATION; ACUTE
   KIDNEY INJURY; CORONAVIRUS DISEASE 2019; UNIT-ACQUIRED WEAKNESS; INHALED
   NITRIC-OXIDE; MANAGEMENT STRATEGIES; ORGAN DYSFUNCTION;
   FLUID-MANAGEMENT; DR EXPRESSION
AB Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces coronavirus-19 disease (COVID-19) and is a major health concern. Following two SARS-CoV-2 pandemic "waves," intensive care unit (ICU) specialists are treating a large number of COVID19associated acute respiratory distress syndrome (ARDS) patients. From a pathophysiological perspective, prominent mechanisms of COVID19-associated ARDS (CARDS) include severe pulmonary infiltration/edema and inflammation leading to impaired alveolar homeostasis, alteration of pulmonary physiology resulting in pulmonary fibrosis, endothelial inflammation (endotheliitis), vascular thrombosis, and immune cell activation. Although the syndrome ARDS serves as an umbrella term, distinct, i.e., CARDS-specific pathomechanisms and comorbidities can be noted (e.g., virus-induced endotheliitis associated with thromboembolism) and some aspects of CARDS can be considered ARDS "atypical." Importantly, specific evidence-based medical interventions for CARDS (with the potential exception of corticosteroid use) are currently unavailable, limiting treatment efforts to mostly supportive ICU care. In this article, we will discuss the underlying pulmonary pathophysiology and the clinical management of CARDS. In addition, we will outline current and potential future treatment approaches. (c) 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Pfortmueller, Carmen A.; Spinetti, Thibaud; Schefold, Joerg C.] Univ Bern, Univ Hosp, Inselspital, Dept Intens Care Med, Freiburgstr, CH-3010 Bern, Switzerland.
   [Urman, Richard D.] Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.
   [Luedi, Markus M.] Univ Bern, Univ Hosp, Inselspital, Dept Anaesthesiol & Pain Med, Freiburgstr, CH-3010 Bern, Switzerland.
RP Schefold, JC (corresponding author), Univ Bern, Univ Hosp, Inselspital, Dept Intens Care Med, Freiburgstr, CH-3010 Bern, Switzerland.
EM carmen.pfortmueller@insel.ch; thibaud.spinetti@insel.ch;
   rurman@bwh.harvard.edu; Markus.Luedi2@insel.ch; joerg.schefold@insel.ch
OI Luedi, Markus/0000-0002-9049-2584; Spinetti, Thibaud/0000-0001-8057-3746
CR Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Adhikari NKJ, 2014, CRIT CARE MED, V42, P404, DOI 10.1097/CCM.0b013e3182a27909
   Agarwal Y, 2020, EUR J PHARMACOL
   Ahmed Mukhtar H, 2020, SN Compr Clin Med, P1, DOI 10.1007/s42399-020-00610-8
   Albert RK, 2014, AM J RESP CRIT CARE, V189, P494, DOI 10.1164/rccm.201311-2056LE
   Ali H, 2020, RENAL FAILURE, V42, P393, DOI 10.1080/0886022X.2020.1756323
   Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639
   Anekwe DE, 2020, PHYSIOTHERAPY, V107, P1, DOI 10.1016/j.physio.2019.12.004
   Angus DC, 2020, JAMA-J AM MED ASSOC, V324, P1317, DOI 10.1001/jama.2020.17022
   [Anonymous], 2020, WHO COR DIS COVID 19
   Aziz M, 2020, J MED VIROL, V92, P2283, DOI 10.1002/jmv.25948
   Barbaro RP, 2020, LANCET, V396, P1071, DOI 10.1016/S0140-6736(20)32008-0
   Barouki R, 2021, ENVIRON INT, V146, DOI 10.1016/j.envint.2020.106272
   Batah SS, 2021, RESP MED, V176, DOI 10.1016/j.rmed.2020.106239
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Bein T, 2018, CURR OPIN CRIT CARE, V24, P35, DOI 10.1097/MCC.0000000000000476
   Bellan M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77698-4
   Benlyamani I, 2020, CYTOM PART A, V97, P1217, DOI 10.1002/cyto.a.24249
   Berger D, 2016, J CACHEXIA SARCOPENI, V7, P403, DOI 10.1002/jcsm.12108
   Bojdani E, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113069
   Bordallo B, 2020, ADV RHEUMATOL, V60, DOI 10.1186/s42358-020-00151-7
   Bourgonje AR, 2020, J PATHOL, V251, P228, DOI 10.1002/path.5471
   Brown SM, 2017, THORAX, V72, P1094, DOI 10.1136/thoraxjnl-2017-210337
   Bulut C, 2020, TURK J MED SCI, V50, P563, DOI 10.3906/sag-2004-172
   Burn W, 2020, INDIAN J PSYCHIAT, V62, P365, DOI 10.4103/psychiatry.IndianJPsychiatry_937_20
   Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5
   Carsetti A, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02956-w
   Chanques G, 2020, INTENS CARE MED, V46, P2342, DOI 10.1007/s00134-020-06307-9
   Chao WC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190952
   Chen WJ, 2020, INT J BIOL SCI, V16, P1954, DOI 10.7150/ijbs.46891
   Coelho CM, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.581314
   Combes A, 2018, NEW ENGL J MED, V378, P1965, DOI 10.1056/NEJMoa1800385
   Combes A, 2020, INTENS CARE MED, V46, P2464, DOI 10.1007/s00134-020-06290-1
   Coppo A, 2020, LANCET RESP MED, V8, P765, DOI 10.1016/S2213-2600(20)30268-X
   Mesquita RD, 2021, WIEN KLIN WOCHENSCHR, V133, P377, DOI 10.1007/s00508-020-01760-4
   Danser AHJ, 2020, HYPERTENSION, V75, P1382, DOI 10.1161/HYPERTENSIONAHA.120.15082
   Dequin PF, 2020, JAMA-J AM MED ASSOC, V324, P1298, DOI 10.1001/jama.2020.16761
   Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985
   Dodek, 2020, CHEST
   Duzgun SA, 2020, INSIGHTS IMAGING, V11, DOI 10.1186/s13244-020-00933-z
   Dziewas R, 2020, EUR J NEUROL, V27, pE46, DOI 10.1111/ene.14367
   Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283
   Fan E, 2018, JAMA-J AM MED ASSOC, V319, P698, DOI 10.1001/jama.2017.21907
   Ferrando C, 2020, REV ESP ANEST REANIM, V67, P425, DOI 10.1016/j.redar.2020.07.003
   Ferrando C, 2020, INTENS CARE MED, V46, P2200, DOI 10.1007/s00134-020-06192-2
   Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326
   Furlow B, 2020, LANCET RHEUMATOL, V2, pE592, DOI 10.1016/S2665-9913(20)30313-1
   Gao YD, 2021, ALLERGY, V76, P428, DOI 10.1111/all.14657
   Gattinoni L, 2016, INTENS CARE MED, V42, P1567, DOI 10.1007/s00134-016-4505-2
   Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2
   Gattinoni L, 2019, SEMIN RESP CRIT CARE, V40, P94, DOI 10.1055/s-0039-1685180
   Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Grieco DL, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03253-2
   Griffiths MJD, 2005, NEW ENGL J MED, V353, P2683, DOI 10.1056/NEJMra051884
   Grimaldi D, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00751-y
   Grissom CK, 2015, CRIT CARE MED, V43, P288, DOI 10.1097/CCM.0000000000000715
   Grzegorowska O, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113746
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   GUERIN C, 2020, INTENSIVE CARE MED
   Gupta S, 2020, JAMA INTERN MED, V180, P1436, DOI 10.1001/jamainternmed.2020.3596
   Hellman U, 2020, J BIOL CHEM, V295, P15418, DOI 10.1074/jbc.AC120.015967
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Hermans G, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0993-7
   Herridge MS, 2016, INTENS CARE MED, V42, P725, DOI 10.1007/s00134-016-4321-8
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552
   Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042
   Hraiech S, 2020, INTENS CARE MED, V46, P2357, DOI 10.1007/s00134-020-06297-8
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ioannou GN, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.22310
   Jacques FH, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.564925
   Jung C, 2021, EUR HEART J-CARD PHA, V7, P76, DOI 10.1093/ehjcvp/pvaa083
   Keyhanian K, 2021, J NEUROIMMUNOL, V350, DOI 10.1016/j.jneuroim.2020.577436
   Kim KK, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022293
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Krittanawong C, 2020, AM J CARDIOVASC DIS, V10, P479
   Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496
   Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728
   Lins RL, 2009, NEPHROL DIAL TRANSPL, V24, P512, DOI 10.1093/ndt/gfn560
   Lippi G, 2020, CLIN CHIM ACTA, V505, P190, DOI 10.1016/j.cca.2020.03.004
   Lombardi AF, 2021, RADIOL MED, V126, P561, DOI 10.1007/s11547-020-01311-x
   Ma AJ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03007-0
   Machado M, 2021, MYCOSES, V64, P132, DOI 10.1111/myc.13213
   Madjid M, 2020, JAMA CARDIOL, V5, P831, DOI 10.1001/jamacardio.2020.1286
   Magadum A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9112508
   Malas MB, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100639
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Marini JJ, 2020, JAMA-J AM MED ASSOC, V323, P2329, DOI 10.1001/jama.2020.6825
   Mascha EJ, 2020, ANESTH ANALG, V131, P24, DOI 10.1213/ANE.0000000000004849
   Matera MG, 2020, RESP MED, V171, DOI 10.1016/j.rmed.2020.106114
   McCoy K, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040700
   MEDURI GU, 1995, CHEST, V107, P1062, DOI 10.1378/chest.107.4.1062
   Mehta N, 2020, JAMA CARDIOL, V5, P1020, DOI 10.1001/jamacardio.2020.1855
   Menard T, 2020, CONT CLIN TRIAL COMM, V20, DOI 10.1016/j.conctc.2020.100662
   Menk M, 2020, INTENS CARE MED, V46, P2157, DOI 10.1007/s00134-020-06299-6
   Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4
   MESSMER AS, 2020, CRIT CARE MED
   Miesbach W, 2020, CLIN APPL THROMB-HEM, V26, DOI 10.1177/1076029620938149
   Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret
   Monneret G, 2021, J MED VIROL, V93, P197, DOI 10.1002/jmv.26317
   Moutchia Jude, 2020, PLoS One, V15, pe0239802, DOI 10.1371/journal.pone.0239802
   Munshi L, 2019, LANCET RESP MED, V7, P163, DOI 10.1016/S2213-2600(18)30452-1
   Noah MA, 2011, JAMA-J AM MED ASSOC, V306, P1659, DOI 10.1001/jama.2011.1471
   Onofrio L, 2020, FUTUR SCI OA, V6, DOI 10.2144/fsoa-2020-0091
   Ostermann M, 2020, J CRIT CARE, V60, P91, DOI 10.1016/j.jcrc.2020.07.023
   Ovsyannikova IG, 2020, IMMUNOL REV, V296, P205, DOI 10.1111/imr.12897
   Pastores SM, 2018, INTENS CARE MED, V44, P474, DOI 10.1007/s00134-017-4951-5
   Payen JF, 2020, ANAESTH CRIT CARE PA, V39, P341, DOI 10.1016/j.accpm.2020.04.010
   Perren A, 2019, DYSPHAGIA, V34, P475, DOI 10.1007/s00455-019-09977-w
   Pfortmueller CA, 2017, INTENS CARE MED EXP, V5, DOI 10.1186/s40635-017-0163-0
   Pham T, 2013, AM J RESP CRIT CARE, V187, P276, DOI 10.1164/rccm.201205-0815OC
   Qi Xiaoming, 2021, Brain Hemorrhages, V2, P76, DOI 10.1016/j.hest.2020.11.001
   Qian SZ, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.552002
   Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248
   Quartuccio L, 2020, JOINT BONE SPINE, V87, P191, DOI 10.1016/j.jbspin.2020.03.011
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Reynolds HR, 2020, NEW ENGL J MED, V382, P2441, DOI 10.1056/NEJMoa2008975
   Ricard JD, 2020, INTENS CARE MED, V46, P2238, DOI 10.1007/s00134-020-06228-7
   Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775
   Rochwerg B, 2020, INTENS CARE MED, V46, P2226, DOI 10.1007/s00134-020-06312-y
   Nogueira SAR, 2020, REV ASSOC MED BRAS, V66, P112, DOI [10.1590/1806-9282.66.s2.112, 10.1590/1806-9282.66.S2.112]
   Rodriguez-Morales Alfonso J, 2020, Travel Med Infect Dis, V34, P101623, DOI 10.1016/j.tmaid.2020.101623
   Rosenberg Andrew L, 2009, J Intensive Care Med, V24, P35, DOI 10.1177/0885066608329850
   Salameh JP, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013639.pub2
   Sasannejad C, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2626-z
   Schefold JC, 2008, CRIT CARE MED, V36, P3118, DOI 10.1097/CCM.0b013e31818bdd8f
   Schefold JC, 2020, J CACHEXIA SARCOPENI, V11, P1399, DOI 10.1002/jcsm.12620
   Schefold JC, 2017, CRIT CARE MED, V45, P2061, DOI 10.1097/CCM.0000000000002765
   Schefold JC, 2014, CRIT CARE, V18, DOI 10.1186/cc13188
   Schefold JC, 2010, J CACHEXIA SARCOPENI, V1, P147, DOI 10.1007/s13539-010-0010-6
   Schefold JC, 2010, INTENS CARE MED, V36, P1810, DOI 10.1007/s00134-010-1965-7
   Schefold JC, 2008, MED HYPOTHESES, V71, P203, DOI 10.1016/j.mehy.2008.03.022
   Schmidt M, 2021, INTENS CARE MED, V47, P60, DOI 10.1007/s00134-020-06294-x
   Schoenfeld, 2020, CLIN INFECT DIS OFFI
   Shaath H, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9112374
   Shang LH, 2020, LANCET, V395, P683, DOI 10.1016/S0140-6736(20)30361-5
   Shao F, 2020, RESUSCITATION, V151, P18, DOI 10.1016/j.resuscitation.2020.04.005
   Sherren PB, 2020, BRIT J ANAESTH, V125, P912, DOI 10.1016/j.bja.2020.08.050
   Shi ZH, 2021, JAMA INTERN MED, V181, P122, DOI 10.1001/jamainternmed.2020.6278
   Spinetti T, 2020, ANESTH ANALG, V131, P993, DOI 10.1213/ANE.0000000000005044
   Strom T, 2010, LANCET, V375, P475, DOI 10.1016/S0140-6736(09)62072-9
   Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003
   Sundermann AJ, 2021, CLIN INFECT DIS, DOI 10.1093/cid/ciab638
   Tang LDY, 2020, SEMIN CARDIOTHORAC V, V24, P127, DOI 10.1177/1089253220921590
   Toft P, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-499
   Tomazini BM, 2020, JAMA-J AM MED ASSOC, V324, P1307, DOI 10.1001/jama.2020.17021
   Totura AL, 2015, MBIO, V6, DOI 10.1128/mBio.00638-15
   Vassiliou AG, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228793
   Vignon P, 2020, INTENS CARE MED, V46, P2252, DOI 10.1007/s00134-020-06310-0
   Vinsonneau C, 2006, LANCET, V368, P379, DOI 10.1016/S0140-6736(06)69111-3
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Wang ZF, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000023327
   WARE LB, 2000, NEW ENGL J MED, V342, P1334, DOI [DOI 10.1056/NEJM200005043421806, 10.1056/NEJM200005043421806]
   WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184
   Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564
   Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85
   Wong CKH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74988-9
   Xiao F, 2020, GASTROENTEROLOGY, V158, P1831, DOI 10.1053/j.gastro.2020.02.055
   Xiao L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223493
   Yang L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00243-2
   Yang XP, 2021, INT IMMUNOPHARMACOL, V90, DOI 10.1016/j.intimp.2020.107159
   Yang ZW, 2020, J INFECTION, V81, pE13, DOI 10.1016/j.jinf.2020.03.062
   Ye Z, 2020, EUR RADIOL, V30, P4381, DOI 10.1007/s00330-020-06801-0
   Zante B, 2020, ANAESTH INTENSIVE TH, V52, P336, DOI 10.5114/ait.2020.100501
   Zhang L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223185
   Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570
   ZHANG X, 2020, AGING-US, P12
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhou YZ, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.588301
   Zhou YQ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59732-7
   Ziehr DR, 2020, AM J RESP CRIT CARE, V201, P1560, DOI 10.1164/rccm.202004-1163LE
   Zuercher P, 2020, CHEST, V158, P1983, DOI 10.1016/j.chest.2020.05.576
   Zuercher P, 2020, INTENS CARE MED, V46, P554, DOI 10.1007/s00134-020-05937-3
   Zuercher P, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2400-2
NR 177
TC 9
Z9 9
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1521-6896
EI 1878-1608
J9 BEST PRAC RES-CL ANA
JI Best Pract. Res.-Clin. Anaesth.
PD OCT
PY 2021
VL 35
IS 3
BP 351
EP 368
DI 10.1016/j.bpa.2020.12.011
EA SEP 2021
PG 18
WC Anesthesiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anesthesiology
GA WW3TJ
UT WOS:000717843000007
PM 34511224
OA Green Published, hybrid
DA 2022-04-20
ER

PT C
AU Sinha, S
   Tushar
   Goel, S
AF Sinha, Shubham
   Tushar
   Goel, Shalini
BE Astya, PN
   Singh, M
   Roy, NR
   Raj, G
TI Research on Data Science Ensembles for Covid-19 Detection and Length of
   Stay Prediction
SO 2021 IEEE INTERNATIONAL CONFERENCE ON COMPUTING, COMMUNICATION, AND
   INTELLIGENT SYSTEMS (ICCCIS)
LA English
DT Proceedings Paper
CT International Conference on Computing, Communication, and Intelligent
   Systems (ICCCIS)
CY FEB 19-20, 2021
CL Noida, INDIA
SP IEEE Ind Applicat Soc, Sharda Univ, Sch Engn & Technol
DE Covid-19; Length of Stay; Catboost; Convolutional Neural Networks;
   Maxpooling; chest X-rays
ID NEURAL-NETWORKS
AB We have demonstrated the use of an iteratively severed model of deep learning which associates for diagnosing Covid-19 pulmonary demonstration of using chest X-rays. In this paper, a customized convolutional neural network model is trained and analyzed on publicly available chest X-rays to grasp modality-strict feature demonstrations. Since the best performing models learn iteratively to make the model memory efficient, this model also learns and tries to improve the results with each step and classify the chest X-rays in their categories accurately. Then another model which predicts the length of stay of a patient at the hospital is created using multi-layered data processing approach. This model will empower hospitals for on time interference to prevent confusions and better management of hospital resources. We propose a method that uses catboost model which generally classifies the data in multiple classes. As a result, this study provides modality strict iterative and knowledge reusable model which influences Covid-19 detection and length of stay prediction.
C1 [Sinha, Shubham; Tushar; Goel, Shalini] GGSIP Univ, HMRITM, Dept CSE, New Delhi, India.
RP Sinha, S (corresponding author), GGSIP Univ, HMRITM, Dept CSE, New Delhi, India.
EM shubhamsinha1320@gmail.com; tushardhiman1999@gmail.com;
   dr.sgoel1803@gmail.com
CR Asari VK, 2001, IEEE T NEURAL NETWOR, V12, P1519, DOI 10.1109/72.963789
   Bachtiar Y., 2019, 2019 INT S EL SMART, DOI [10.1109/isesd.2019.8909510, DOI 10.1109/ISESD.2019.8909510]
   Bharitkar S, 2019, 2019 18 IEEE INT C M, DOI [10.1109/icmla.2019.00065, DOI 10.1109/ICMLA.2019.00065]
   Bot RI, 2014, CENT EUR J MATH, V12, P381, DOI 10.2478/s11533-013-0342-5
   Cai CL, 2020, IEEE T IMAGE PROCESS, V29, P3442, DOI 10.1109/TIP.2019.2960869
   Chollet F., 2017, XCEPTION DEEP LEARNI, V357, P1610
   Dietterich T, 1995, ACM COMPUT SURV, V27, P326, DOI 10.1145/212094.212114
   Gao T, 2020, CHEST XRAY IMAGE ANA, DOI [10.21203/rs.3.rs- 64537/v2, DOI 10.21203/RS.3.RS-64537/V2]
   Gustafson D. H, 2002, HEALTH SERV RES, V37, P631
   He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90
   Hu SP, 2020, IEEE ACCESS, V8, P118869, DOI 10.1109/ACCESS.2020.3005510
   Ibrahim AA, 2020, INT J ADV COMPUT SC, V11, P738
   Khan AH, 2020, IEEE-CAA J AUTOMATIC, V7, P461, DOI 10.1109/JAS.2020.1003048
   Lee J, 2020, COVID 19 PNEUMONIA D, DOI [10.2196/preprints.19407, DOI 10.2196/PREPRINTS.19407]
   Lin ZJ, 2018, IEEE T NEUR NET LEAR, V29, P2472, DOI 10.1109/TNNLS.2017.2691545
   Nouaouri I, 2015, IEEE INT CON AUTO SC, P1415, DOI 10.1109/CoASE.2015.7294296
   Pan Acad Action Comm COVID 19, 2020, EPIDEMIOL HEALTH, V42, DOI 10.4178/epih.e2020020
   Postnikov E. B., 2020, 2020 IEEE 2 GLOB C L, DOI [10.1109/lifetech48969.2020.1570619054, DOI 10.1109/LIFETECH48969.2020.1570619054]
   Punitha S., 2020, GENETICALLY OPTIMIZE, P105, DOI [10.1201/9781003098881-5, DOI 10.1201/9781003098881-5]
   Rohaun S. K., 2020, COVID 19 PANDEMIC UP, V2020, P54, DOI [10.26524/royal.37.4, DOI 10.26524/ROYAL.37.4]
   Srivastava N, 2014, J MACH LEARN RES, V15, P1929
   Ter-Sarkisov A, 2020, COVID CT MASK NET PR, DOI [10.21203/rs.3.rs- 104621/v1, DOI 10.21203/RS.3.RS-104621/V1]
   Wang T, 2020, 2020 5TH INTERNATIONAL CONFERENCE ON COMMUNICATION, IMAGE AND SIGNAL PROCESSING (CCISP 2020), P199, DOI 10.1109/CCISP51026.2020.9273512
   Woods AW, 2000, ANAESTHESIA, V55, P1058, DOI 10.1046/j.1365-2044.2000.01552.x
   Xie YX, 2020, COMPUT SCI ENG, V22, P21, DOI 10.1109/MCSE.2020.3015511
   Zhang F, 2020, IEEE T MED IMAGING, V39, P3331, DOI 10.1109/TMI.2020.2990625
   Zhu T, 2018, IEEE J BIOMED HEALTH, V22, P955, DOI 10.1109/JBHI.2017.2701779
NR 27
TC 0
Z9 0
U1 1
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-7281-8529-3
PY 2021
BP 499
EP 503
DI 10.1109/ICCCIS51004.2021.9397218
PG 5
WC Computer Science, Artificial Intelligence; Computer Science, Theory &
   Methods; Telecommunications
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science; Telecommunications
GA BR9MM
UT WOS:000678296700083
OA Bronze
DA 2022-04-20
ER

PT J
AU Puertas, R
   Carracedo, P
   Marti, L
AF Puertas, Rosa
   Carracedo, Patricia
   Marti, Luisa
TI Environmental policies for the treatment of waste generated by COVID-19:
   Text mining review
SO WASTE MANAGEMENT & RESEARCH
LA English
DT Review; Early Access
DE Covid-19; waste; text mining; environmental policies
ID MEDICAL WASTE; VALIDATION; IMPACT
AB The rapid transmission of COVID-19 has meant that all economic and human efforts have been focused on confronting it, ignoring environmental aspects whose consequences are causing adverse situations all over the planet. The saturation of the sanitary system and confinement measures have multiplied the waste generated, which implies the need to adapt environmental policies to this new situation caused by the pandemic. It is a review article whose objective was to identify the environmental policies that would facilitate an adequate treatment of the waste generated by the pandemic. It was proposed to analyse the current lines of research developed on this paradigm, applying the text mining methodology. A systematic review of 111 studies published in environmental journals indexed in the Web of Science was carried out. The results identified three areas of interest: knowledge of transmission routes, management of the massive generation of plastics and appropriate treatment of solid waste in extreme situations. Leaders are called upon to implement the contingency plans to sustainably alleviate the enormous waste burden caused by society's adaptation to the restrictions imposed by the pandemic. Specifically, innovation aimed at achieving the reuse of medical products, the promotion of the circular economy and educational campaigns to promote clean environments should be encouraged.
C1 [Puertas, Rosa; Marti, Luisa] Univ Politecn Valencia, Camino Vera S-N, Valencia 46002, Spain.
   [Carracedo, Patricia] Univ Int Valencia, Valencia, Spain.
RP Marti, L (corresponding author), Univ Politecn Valencia, Camino Vera S-N, Valencia 46002, Spain.
EM mlmarti@esp.upv.es
CR Abu-Qdais HA, 2020, GLOB J ENVIRON SCI M, V6, P21, DOI 10.22034/GJESM.2019.06.SI.03
   Agamuthu P, 2021, WASTE MANAGE RES, V39, P18, DOI 10.1177/0734242X20959701
   Al Huraimel K, 2020, SCI TOTAL ENVIRON, V744, DOI 10.1016/j.scitotenv.2020.140946
   Aldaco R, 2020, SCI TOTAL ENVIRON, V742, DOI 10.1016/j.scitotenv.2020.140524
   Ammendolia J, 2021, ENVIRON POLLUT, V269, DOI 10.1016/j.envpol.2020.116160
   Ardusso M, 2021, SCI TOTAL ENVIRON, V763, DOI 10.1016/j.scitotenv.2020.144365
   Aydin S, 2021, ENVIRON DEV SUSTAIN, V23, P7573, DOI 10.1007/s10668-020-00933-5
   Bashir MF, 2020, AIR QUAL ATMOS HLTH, V13, P1403, DOI 10.1007/s11869-020-00894-8
   Beig G, 2020, ENVIRON RES, V191, DOI 10.1016/j.envres.2020.110121
   Belhadi A, 2020, ENVIRON MANAGE, V66, P1085, DOI 10.1007/s00267-020-01375-5
   Ben Hassen T, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12176973
   BLASHFIELD RK, 1991, J CLASSIF, V8, P277
   Boroujeni M, 2021, ENVIRON SCI POLLUT R, V28, P14182, DOI 10.1007/s11356-021-12556-y
   Carracedo P, 2021, J BUS RES, V132, P586, DOI 10.1016/j.jbusres.2020.11.043
   Carraturo F, 2020, ENVIRON POLLUT, V265, DOI 10.1016/j.envpol.2020.115010
   Casado-Aranda LA, 2021, ENVIRON RES, V193, DOI 10.1016/j.envres.2020.110416
   Celis JE, 2021, SCI TOTAL ENVIRON, V760, DOI 10.1016/j.scitotenv.2020.144167
   Chauhan A, 2021, J CLEAN PROD, V279, DOI 10.1016/j.jclepro.2020.123854
   Chitra J, 2020, INDIAN J BIOCHEM BIO, V57, P370
   Cloke J, 2020, EURASIAN GEOGR ECON, V61, P374, DOI 10.1080/15387216.2020.1828127
   Conticini E, 2020, ENVIRON POLLUT, V261, DOI 10.1016/j.envpol.2020.114465
   Cosgrove K, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18031104
   Dabrowska J, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020433
   Di Maria F, 2020, SCI TOTAL ENVIRON, V743, DOI 10.1016/j.scitotenv.2020.140803
   Diaz-Elsayed N, 2020, SMART SUSTAIN MANUF, V4, P314, DOI [10.1520/SSMS20200052, 10.1520/ssms20200052]
   Ding ZY, 2021, J HAZARD MATER, V402, DOI 10.1016/j.jhazmat.2020.123472
   Dinov ID., 2018, DATA SCI PREDICTIVE
   Dogan B, 2020, ENVIRON RES, V191, DOI 10.1016/j.envres.2020.110148
   Dombroski K, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12229369
   Dunn J. C., 1974, Journal of Cybernetics, V4, P95
   European Environment Agency (EEA), 2021, PLAST GROW ENV CLIM
   Feinerer I, 2008, J STAT SOFTW, V25, P1
   Fleetwood J, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12125027
   Franch-Pardo I, 2020, SCI TOTAL ENVIRON, V739, DOI 10.1016/j.scitotenv.2020.140033
   Franklin AB, 2020, SCI TOTAL ENVIRON, V733, DOI 10.1016/j.scitotenv.2020.139358
   Gatti RC, 2020, ENVIRON POLLUT, V267, DOI 10.1016/j.envpol.2020.115471
   Penteado CSG, 2021, RESOUR CONSERV RECY, V164, DOI 10.1016/j.resconrec.2020.105152
   Giudice F, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12197939
   Gocmen E, 2020, ENERG SOURCE PART A, DOI 10.1080/15567036.2020.1861133
   Greer F, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/abb42a
   Gupta S, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138860
   Halkidi M, 2002, SIGMOD REC, V31, P19
   Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483
   Han T, 2019, COMPUT NETW, V158, P114, DOI 10.1016/j.comnet.2019.04.021
   Hanney SR, 2020, HEALTH RES POLICY SY, V18, DOI 10.1186/s12961-020-00571-3
   Hartanto BW, 2021, SCI TOTAL ENVIRON, V760, DOI 10.1016/j.scitotenv.2020.144143
   He GJ, 2020, NAT SUSTAIN, V3, DOI 10.1038/s41893-020-0581-y
   Ismail MH, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12218848
   Hendryx M, 2020, ENVIRON POLLUT, V265, DOI 10.1016/j.envpol.2020.115126
   Hochman A, 2021, SCI TOTAL ENVIRON, V750, DOI 10.1016/j.scitotenv.2020.141686
   Hoseinzadeh E, 2020, ECOTOX ENVIRON SAFE, V202, DOI 10.1016/j.ecoenv.2020.111015
   Huang GY, 2020, SCI TOTAL ENVIRON, V745, DOI 10.1016/j.scitotenv.2020.141023
   Ikiz E, 2021, RESOUR CONSERV RECY, V164, DOI 10.1016/j.resconrec.2020.105111
   Ilyas S, 2020, SCI TOTAL ENVIRON, V749, DOI 10.1016/j.scitotenv.2020.141652
   Irfan M, 2021, INT J ENVIRON HEAL R, DOI 10.1080/09603123.2021.1874888
   Didar-Ul Islam SM, 2021, ENVIRON DEV SUSTAIN, V23, P11953, DOI 10.1007/s10668-020-01151-9
   Jin H, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249272
   Jribi S, 2020, ENVIRON DEV SUSTAIN, V22, P3939, DOI 10.1007/s10668-020-00740-y
   Kalina M, 2020, WASTE MANAGE, V108, P202, DOI 10.1016/j.wasman.2020.05.006
   Kalpana P, 2020, INDAN J COMMUNITY HE, V32, P244
   Kapecki T, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12156188
   Kargar S, 2020, SCI TOTAL ENVIRON, V746, DOI 10.1016/j.scitotenv.2020.141183
   Kassambara A, 2017, PRACTICAL GUIDE PRIN
   Khan MS, 2020, SUSTAIN DEV, V28, P1168, DOI 10.1002/sd.2066
   Klemes JJ, 2020, RENEW SUST ENERG REV, V127, DOI 10.1016/j.rser.2020.109883
   Nakada LYK, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.139087
   Kulkarni BN, 2020, SCI TOTAL ENVIRON, V743, DOI 10.1016/j.scitotenv.2020.140693
   Kumar H, 2021, ENVIRON DEV SUSTAIN, V23, P9418, DOI 10.1007/s10668-020-01033-0
   Kumar M, 2020, SCI TOTAL ENVIRON, V746, DOI 10.1016/j.scitotenv.2020.141326
   Kumar M, 2020, SCI TOTAL ENVIRON, V734, DOI 10.1016/j.scitotenv.2020.139278
   Lancia F., 2008, MIND INFINITE DIMENS, P1
   Lassi ZS, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18030988
   Liu JL, 2021, B ENVIRON CONTAM TOX, V106, P237, DOI 10.1007/s00128-021-03121-x
   Liu Q., 2021, AEROSOL AIR QUAL RES, V211, P1
   Liu ZY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165831
   Mahdi H, 2020, TROP MED INFECT DIS, V5, DOI 10.3390/tropicalmed5040160
   Mahdi HA, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020673
   Maher OA, 2021, INT J HYG ENVIR HEAL, V232, DOI 10.1016/j.ijheh.2021.113690
   Malpass D., 2020, FIGHTING TIDE MARINE
   Manupati VK, 2021, J CLEAN PROD, V281, DOI 10.1016/j.jclepro.2020.125175
   Mehran MT, 2021, ENERG SOURCE PART A, DOI 10.1080/15567036.2020.1869869
   Mihai FC, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155439
   Mostafa MK, 2021, J ENVIRON MANAGE, V277, DOI 10.1016/j.jenvman.2020.111496
   Mouchtouri VA, 2020, INT J HYG ENVIR HEAL, V230, DOI 10.1016/j.ijheh.2020.113599
   Neumeyer X, 2020, RESOUR CONSERV RECY, V162, DOI 10.1016/j.resconrec.2020.105058
   Orive G, 2020, SCI TOTAL ENVIRON, V732, DOI 10.1016/j.scitotenv.2020.139298
   Ouhsine O, 2020, GLOB J ENVIRON SCI M, V6, P41, DOI 10.22034/GJESM.2019.06.SI.05
   Pag?s J, 2017, EXPLORATORY MULTIVAR
   Pandey D, 2021, INT J HYG ENVIR HEAL, V231, DOI 10.1016/j.ijheh.2020.113634
   Parashar N, 2021, SCI TOTAL ENVIRON, V759, DOI 10.1016/j.scitotenv.2020.144274
   Silva ALP, 2020, SCI TOTAL ENVIRON, V742, DOI 10.1016/j.scitotenv.2020.140565
   Pei ZP, 2020, SCI TOTAL ENVIRON, V743, DOI 10.1016/j.scitotenv.2020.140879
   Peng J, 2020, AM J INFECT CONTROL, V48, P918, DOI 10.1016/j.ajic.2020.05.035
   Prabha S, 2021, ENVIRON CHEM LETT, V19, P1667, DOI 10.1007/s10311-020-01123-5
   Prata JC, 2020, ENVIRON SCI TECHNOL, V54, P7760, DOI 10.1021/acs.est.0c02178
   Praveena SM, 2021, ENVIRON SCI POLLUT R, V28, P63829, DOI 10.1007/s11356-020-11774-0
   Qian K, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12239942
   Quinete N, 2021, ENVIRON SCI POLLUT R, V28, P1235, DOI 10.1007/s11356-020-11487-4
   R Core Team, 2019, R LANG ENV STAT COMP
   Ragazzi M, 2020, SCI TOTAL ENVIRON, V745, DOI 10.1016/j.scitotenv.2020.141159
   Rahma A, 2019, DRUG DEV IND PHARM, V45, P1029, DOI 10.1080/03639045.2019.1593438
   Rhee SW, 2020, WASTE MANAGE RES, V38, P820, DOI 10.1177/0734242X20933343
   Richter A, 2021, WASTE MANAGE, V122, P49, DOI 10.1016/j.wasman.2021.01.004
   Rodgers RF, 2021, APPETITE, V160, DOI 10.1016/j.appet.2021.105110
   ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7
   Rowan NJ, 2021, SCI TOTAL ENVIRON, V752, DOI 10.1016/j.scitotenv.2020.142259
   Rowan NJ, 2020, SCI TOTAL ENVIRON, V748, DOI 10.1016/j.scitotenv.2020.141362
   Rume T, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04965
   Rupani PF, 2020, INT J ENVIRON SCI TE, V17, P4655, DOI 10.1007/s13762-020-02910-x
   Saadat S, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138870
   Sarkodie SA, 2021, ENVIRON DEV SUSTAIN, V23, P5005, DOI 10.1007/s10668-020-00801-2
   Sen S, 2020, WORLD DEV, V135, DOI 10.1016/j.worlddev.2020.105063
   Setti L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17092986
   Shah SAA, 2021, J CLEAN PROD, V284, DOI 10.1016/j.jclepro.2020.124729
   Shakil MH, 2020, SCI TOTAL ENVIRON, V745, DOI 10.1016/j.scitotenv.2020.141022
   Sharma HB, 2020, RESOUR CONSERV RECY, V162, DOI 10.1016/j.resconrec.2020.105052
   Shehzad K, 2020, ENVIRON POLLUT, V266, DOI 10.1016/j.envpol.2020.115080
   Shurson GC, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12177071
   Singh V, 2020, ENVIRON POLLUT, V266, DOI 10.1016/j.envpol.2020.115368
   Sun SY, 2021, ENVIRON CHEM LETT, V19, P787, DOI 10.1007/s10311-020-01143-1
   Sunkari ED, 2021, SCI TOTAL ENVIRON, V753, DOI 10.1016/j.scitotenv.2020.142298
   Suter F, 2021, ENVIRON URBAN, V33, P99, DOI 10.1177/0956247820987759
   Tabish M, 2021, ENVIRON SCI POLLUT R, V28, P40311, DOI 10.1007/s11356-020-10640-3
   Tauscher K, 2018, EUR MANAG J, V36, P319, DOI 10.1016/j.emj.2017.06.005
   Thakur V, 2021, J CLEAN PROD, V287, DOI 10.1016/j.jclepro.2020.125562
   Tirkolaee EB, 2021, SCI TOTAL ENVIRON, V756, DOI 10.1016/j.scitotenv.2020.143607
   Tleuken A, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13020460
   Torkashvand J, 2021, J ENVIRON HEALTH SCI, V19, P173, DOI 10.1007/s40201-020-00591-9
   Trottier J, 2020, ONE HEALTH-AMSTERDAM, V10, DOI 10.1016/j.onehlt.2020.100157
   Urban RC, 2021, SCI TOTAL ENVIRON, V755, DOI 10.1016/j.scitotenv.2020.142471
   Van Fan Y, 2021, SCI TOTAL ENVIRON, V754, DOI 10.1016/j.scitotenv.2020.142014
   Vanapalli KR, 2021, SCI TOTAL ENVIRON, V750, DOI 10.1016/j.scitotenv.2020.141514
   Varbanov PS, 2021, J CLEAN PROD, V281, DOI 10.1016/j.jclepro.2020.124602
   Wang CY, 2021, FRONT ENV SCI ENG, V15, DOI 10.1007/s11783-021-1398-2
   Wang J, 2020, ENVIRON POLLUT, V262, DOI 10.1016/j.envpol.2020.114665
   Wang YJ, 2020, ENVIRON SCI TECH LET, V7, P802, DOI 10.1021/acs.estlett.0c00605
   William D., 2019, ENG SCI TECHNOLOGY J, V1, P37
   Wu QR, 2021, SCI TOTAL ENVIRON, V750, DOI 10.1016/j.scitotenv.2020.142323
   Wu Y, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.139051
   Wurtzer S, 2020, EUROSURVEILLANCE, V25, P38, DOI 10.2807/1560-7917.ES.2020.25.50.2000776
   Yang L, 2021, RESOUR CONSERV RECY, V164, DOI 10.1016/j.resconrec.2020.105074
   Yao Y, 2021, ECOTOX ENVIRON SAFE, V208, DOI 10.1016/j.ecoenv.2020.111421
   You SM, 2020, COGENT ENVIRON SCI, V6, DOI 10.1080/23311843.2020.1801220
   Younis I., 2020, ENVIRON SCI POLLUT R, V10, P1
   Yu H, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051770
   Yuan D, 2020, ENVIRON INT, V143, DOI 10.1016/j.envint.2020.105964
   Zambrano-Monserrate MA, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138813
   Zand AD, 2021, ENVIRON TECHNOL, V42, P329, DOI 10.1080/09593330.2020.1866082
   Zhao YB, 2020, ENVIRON SCI TECH LET, V7, P402, DOI 10.1021/acs.estlett.0c00304
NR 149
TC 0
Z9 0
U1 1
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0734-242X
EI 1096-3669
J9 WASTE MANAGE RES
JI Waste Manage. Res.
AR 0734242X221084073
DI 10.1177/0734242X221084073
EA MAR 2022
PG 14
WC Engineering, Environmental; Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Environmental Sciences & Ecology
GA ZU0EV
UT WOS:000769520400001
PM 35282720
DA 2022-04-20
ER

PT J
AU Attah, AF
   Fagbemi, AA
   Olubiyi, O
   Dada-Adegbola, H
   Oluwadotun, A
   Elujoba, A
   Babalola, CP
AF Attah, Alfred Francis
   Fagbemi, Adeshola Adebayo
   Olubiyi, Olujide
   Dada-Adegbola, Hannah
   Oluwadotun, Akinseinde
   Elujoba, Anthony
   Babalola, Chinedum Peace
TI Therapeutic Potentials of Antiviral Plants Used in Traditional African
   Medicine With COVID-19 in Focus: A Nigerian Perspective
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Review
DE COVID-19; phytomedicines; Traditional African Medicine; herbal
   immuno-stimulants; herb-drug interaction
ID HUMAN ADULT VOLUNTEERS; POBEGUINII STEM BARK; ANTIMALARIAL EFFICACY;
   QUANTIFIED EXTRACT; PEPTIDE; INHIBITORS; VIRUSES; BERGHEI
AB The coronavirus disease 2019 (COVID-19) pandemic is caused by an infectious novel strain of coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which was earlier referred to as 2019-nCoV. The respiratory disease is the most consequential global public health crisis of the 21st century whose level of negative impact increasingly experienced globally has not been recorded since World War II. Up till now, there has been no specific globally authorized antiviral drug, vaccines, supplement or herbal remedy available for the treatment of this lethal disease except preventive measures, supportive care and non-specific treatment options adopted in different countries via divergent approaches to halt the pandemic. However, many of these interventions have been documented to show some level of success particularly the Traditional Chinese Medicine while there is paucity of well reported studies on the impact of the widely embraced Traditional African Medicines (TAM) adopted so far for the prevention, management and treatment of COVID-19. We carried out a detailed review of publicly available data, information and claims on the potentials of indigenous plants used in Sub-Saharan Africa as antiviral remedies with potentials for the prevention and management of COVID-19. In this review, we have provided a holistic report on evidence-based antiviral and promising anti-SARS-CoV-2 properties of African medicinal plants based on in silico evidence, in vitro assays and in vivo experiments alongside the available data on their mechanistic pharmacology. In addition, we have unveiled knowledge gaps, provided an update on the effort of African Scientific community toward demystifying the dreadful SARS-CoV-2 micro-enemy of man and have documented popular anti-COVID-19 herbal claims emanating from the continent for the management of COVID-19 while the risk potentials of herb-drug interaction of antiviral phytomedicines when used in combination with orthodox drugs have also been highlighted. This review exercise may lend enough credence to the potential value of African medicinal plants as possible leads in anti-COVID-19 drug discovery through research and development.
C1 [Attah, Alfred Francis] Univ Ilorin, Fac Pharmaceut Sci, Dept Pharmacognosy & Drug Dev, Ilorin, Nigeria.
   [Fagbemi, Adeshola Adebayo; Babalola, Chinedum Peace] Univ Ibadan, Fac Pharm, Dept Pharmaceut Chem, Ibadan, Nigeria.
   [Olubiyi, Olujide] Obafemi Awolowo Univ, Dept Pharmaceut Chem, Ife, Nigeria.
   [Olubiyi, Olujide] Forschungszentrum Julich, Inst Biol Informat Proc, Struct Biochem IBI 7, Julich, Germany.
   [Dada-Adegbola, Hannah] Univ Ibadan, Coll Med, Dept Med Microbiol & Parasitol, Ibadan, Nigeria.
   [Oluwadotun, Akinseinde] Nestle Nigeria Plc, Ilupeju Ave, Lagos, Nigeria.
   [Elujoba, Anthony] Obafemi Awolowo Univ, Fac Pharm, Dept Pharmacognosy, Ife, Nigeria.
   [Babalola, Chinedum Peace] Univ Ibadan, Ctr Drug Discovery Dev & Prod, Ibadan, Nigeria.
   [Babalola, Chinedum Peace] Chrisland Univ, Coll Basic Med Sci, Abeokuta, Nigeria.
RP Attah, AF (corresponding author), Univ Ilorin, Fac Pharmaceut Sci, Dept Pharmacognosy & Drug Dev, Ilorin, Nigeria.; Babalola, CP (corresponding author), Univ Ibadan, Fac Pharm, Dept Pharmaceut Chem, Ibadan, Nigeria.; Babalola, CP (corresponding author), Univ Ibadan, Ctr Drug Discovery Dev & Prod, Ibadan, Nigeria.; Babalola, CP (corresponding author), Chrisland Univ, Coll Basic Med Sci, Abeokuta, Nigeria.
EM alfattah2000ng@yahoo.com; peacebab@gmail.com
OI Dada-Adegbola, Hannah/0000-0002-9566-8585
FU Nigerian Government through the Tertiary Education Trust Fund
   [TETFUND/DR & D/CE/SI/CoV-19/UI/VOL.1]
FX While no fund has been received for an open access publication, the data
   gathering for this work has been partly supported by the Nigerian
   Government through the Tertiary Education Trust Fund (TETFUND/DR &
   D/CE/SI/CoV-19/UI/VOL.1) awarded to CB, AE, AFA, OO, and HD-A.
CR Abedini A, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/604536
   ABLORDEPPEY SY, 1990, PLANTA MED, V56, P416, DOI 10.1055/s-2006-960998
   Adebayo JO, 2017, J ETHNOPHARMACOL, V207, P118, DOI 10.1016/j.jep.2017.06.026
   Adepiti AO, 2014, PARASITOL RES, V113, P505, DOI 10.1007/s00436-013-3680-0
   Adzu B, 2013, AVICENNA J PHYTOMEDI, V3, P201
   Afolayan FID, 2020, SCI AFR, V8, DOI 10.1016/j.sciaf.2020.e00428
   Africa CDC, 2020, WHO AFR CDC JOINT PU
   Ahmad S, 2021, J BIOMOL STRUCT DYN, V39, P4225, DOI 10.1080/07391102.2020.1775129
   Akin-Osanaiye BC., 2013, INT J RES BIOCH BIOP, V3, P7
   Akram M, 2014, INT J IMMUNOPATH PH, V27, P313, DOI 10.1177/039463201402700301
   Ali A.M., 1996, PERTANIKA J TROP AGR, V19, P129
   Ali BH, 2003, PHYTOTHER RES, V17, P299, DOI 10.1002/ptr.1309
   [Anonymous], 2020, PUBCH COMP SUMM CID
   Antonio AD, 2020, RSC ADV, V10, P23379, DOI 10.1039/d0ra03774e
   Aracil A, 2019, EUR J INTEGR MED, V28, P76, DOI 10.1016/j.eujim.2019.04.005
   Arunasree KM, 2010, PHYTOMEDICINE, V17, P581, DOI 10.1016/j.phymed.2009.12.008
   Asante DB, 2019, BIOMED PHARMACOTHER, V111, P1187, DOI 10.1016/j.biopha.2018.12.147
   Asres K, 2001, PHYTOTHER RES, V15, P62, DOI 10.1002/1099-1573(200102)15:1&lt;62::AID-PTR956&gt;3.0.CO;2-X
   Attah A. F., 2016, Nigerian Journal of Natural Products and Medicine, V20, P88, DOI 10.4314/njnpm.v20i1.15
   Attah AF, 2016, J ETHNOPHARMACOL, V179, P83, DOI 10.1016/j.jep.2015.12.038
   ATTAURRAHMAN, 1992, J NAT PROD, V55, P676, DOI 10.1021/np50083a020
   ATTAURRAHMAN, 1995, TETRAHEDRON LETT, V36, P1993, DOI 10.1016/0040-4039(95)00210-4
   Awortwe Charles, 2014, Drug Metab Lett, V7, P83
   Azizi Z, 2012, BEHAV PHARMACOL, V23, P241, DOI 10.1097/FBP.0b013e3283534301
   Badam Lalita, 1999, Journal of Communicable Diseases, V31, P79
   Badani H, 2014, BBA-BIOMEMBRANES, V1838, P2180, DOI 10.1016/j.bbamem.2014.04.015
   Badary OA, 2003, DRUG CHEM TOXICOL, V26, P87, DOI 10.1081/DCT-120020404
   Badia-Boungou F, 2019, J MED VIROL, V91, P1210, DOI 10.1002/jmv.25436
   Banzouzi JT, 2004, PHYTOMEDICINE, V11, P338, DOI 10.1078/0944711041495245
   Barku V. Y. A., 2012, International Research Journal of Biochemistry and Bioinformatics, V2, P58
   Barnes J, 2005, J PHARM PHARMACOL, V57, P929, DOI 10.1211/0022357056127
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Bisht Savita, 2007, Journal of Nanobiotechnology, V5, P3, DOI 10.1186/1477-3155-5-3
   Biswas D, 2020, S AFR J BOT, V129, P272, DOI 10.1016/j.sajb.2019.07.049
   Biswas K, 2002, CURR SCI INDIA, V82, P1336
   Bordoloi M, 1996, PHYTOCHEMISTRY, V41, P557, DOI 10.1016/0031-9422(95)00569-2
   Borkotoky S, 2021, J BIOMOL STRUCT DYN, V39, P4111, DOI 10.1080/07391102.2020.1774419
   Borquaye LS, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/5324560
   Bouckaert J, 1996, J BIOL CHEM, V271, P16144, DOI 10.1074/jbc.271.27.16144
   Brahmachari G, 2013, REV BRAS FARMACOGN, V23, P559, DOI [10.1590/S0102-695X2013005000021, 10.1590/S0102-695X2013000300020]
   Bringmann G, 2003, PHYTOCHEMISTRY, V62, P345, DOI 10.1016/S0031-9422(02)00547-2
   Buba C.I., 2016, INT J PHARMACOGN, V3, P67, DOI 10.13040/IJPSR.0975-8232.IJP.3(2).67-81
   Bulugahapitiya V.P., 2012, RUHUNA J SCI, V1, DOI [10.4038/rjs.v1i0.74, DOI 10.4038/RJS.V1I0.74]
   Carlucci MJ, 1997, PLANTA MED, V63, P429, DOI 10.1055/s-2006-957727
   Chainani-Wu N, 2003, J ALTERN COMPLEM MED, V9, P161, DOI 10.1089/107555303321223035
   Challand S, 2009, J ALTERN COMPLEM MED, V15, P1231, DOI 10.1089/acm.2009.0098
   Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chang Y, 2020, POTENTIAL THERAPEUTI, DOI DOI 10.20944/PREPRINTS202002.0242.V1
   Chen B, 2005, J BIOL CHEM, V280, P22395, DOI 10.1074/jbc.M501737200
   Chinedu E., 2014, PHARMATUTOR, V2, P47
   Chodur GM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26059-3
   Choi HJ, 2010, LETT APPL MICROBIOL, V50, P438, DOI 10.1111/j.1472-765X.2010.02805.x
   Chrubasik S, 2005, PHYTOMEDICINE, V12, P684, DOI 10.1016/j.phymed.2004.07.009
   Chukwujekwu JC, 2005, J ETHNOPHARMACOL, V102, P295, DOI 10.1016/j.jep.2005.08.018
   Churiyah, 2015, Hayati Journal of Biosciences, V22, P67
   Cimanga K, 1999, PLANTA MED, V65, P213, DOI 10.1055/s-1999-14059
   Biancatelli RMLC, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01451
   Coriolano MC, 2018, PROTEIN PEPTIDE LETT, V25, P295, DOI 10.2174/0929866525666180130141736
   Coronado M.A, 2020, NOVEL INHIBITORS MAI, V2020, DOI [10.26434/chemrxiv.13200281.v1, DOI 10.26434/CHEMRXIV.13200281.V1]
   Cos P, 2002, J ETHNOPHARMACOL, V79, P155, DOI 10.1016/S0378-8741(01)00362-2
   Cos P, 2002, PHYTOMEDICINE, V9, P62, DOI 10.1078/0944-7113-00083
   Cruz GVB, 2007, J ETHNOPHARMACOL, V111, P148, DOI 10.1016/j.jep.2006.11.006
   Cunningham A.B, 1997, MED PLANTS FOREST CO, V92, P116
   D'Archivio M, 2010, INT J MOL SCI, V11, P1321, DOI 10.3390/ijms11041321
   Daly NL, 2004, FEBS LETT, V574, P69, DOI 10.1016/j.febslet.2004.08.007
   Daly NL, 1999, J MOL BIOL, V285, P333, DOI 10.1006/jmbi.1998.2276
   Danaher RJ, 2011, ORAL SURG ORAL MED O, V112, pE31, DOI 10.1016/j.tripleo.2011.04.007
   Dao TT, 2011, BIOORG MED CHEM LETT, V21, P294, DOI 10.1016/j.bmcl.2010.11.016
   Das AK, 2015, ANN MED HEALTH SCI R, V5, P93, DOI 10.4103/2141-9248.153609
   Das G, 2020, RSC ADV, V10, P28243, DOI 10.1039/d0ra05434h
   De Leo A, 2012, ANTIVIR RES, V96, P196, DOI 10.1016/j.antiviral.2012.09.003
   de Veer SJ, 2019, CHEM REV, V119, P12375, DOI 10.1021/acs.chemrev.9b00402
   Dharmaratne HRW, 2002, PLANTA MED, V68, P86, DOI 10.1055/s-2002-20058
   Divneet Kaur N.K, 2019, J PHARMACOGN PHYTOCH, V8, P2629
   Donma MM, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.109934
   Dzoyem JP, 2013, ELSEV INSIGHT, P859, DOI 10.1016/B978-0-12-405927-6.00024-2
   ELDAKHAKNY M, 1965, ARZNEI-FORSCHUNG, V15, P1227
   Elujoba A. A., 2005, African Journal of Traditional, Complementary and Alternative Medicines, V2, P46
   Esimone C.O, 2020, SILICO SCREENING MOL, DOI [10.1101/2020.05.10.087148, DOI 10.1101/2020.05.10.087148]
   Esimone CO, 2005, J APPL MICROBIOL, V99, P1346, DOI 10.1111/j.1365-2672.2005.02732.x
   Esquenazi D, 2002, RES MICROBIOL, V153, P647, DOI 10.1016/S0923-2508(02)01377-3
   European Medicines Agency, 2020, Eur. Med. Agency, V3, P41
   Fabricant DS, 2001, ENVIRON HEALTH PERSP, V109, P69, DOI 10.2307/3434847
   Faccin-Galhardi LC, 2012, J ETHNOPHARMACOL, V142, P86, DOI 10.1016/j.jep.2012.04.018
   Fahey JW, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071547
   FERREA G, 1993, ANTIVIR RES, V21, P317, DOI 10.1016/0166-3542(93)90010-G
   Fialho LG, 2016, INTERVIROLOGY, V59, P217, DOI 10.1159/000455855
   Fisher CD, 2007, DRUG METAB DISPOS, V35, P995, DOI 10.1124/dmd.106.014340
   Fugh-Berman A, 2000, LANCET, V355, P134, DOI 10.1016/S0140-6736(99)06457-0
   Furst DE, 1996, LUPUS, V5, pS11, DOI 10.1177/096120339600500104
   Gamaniel K., 2009, AFR J TRADIT COMPLEM, V6, P411
   Ghildiyal R., 2020, PLANT DERIVED BIOACT, P279, DOI [DOI 10.1007/978-981-15-1761-7_12, 10.1007/978-981-15-1761-7_12]
   Ghonmode Wasudeo Namdeo, 2013, J Int Oral Health, V5, P61
   Gill JP, 2007, PHARMACOGENOMICS, V8, P187, DOI 10.2217/14622416.8.2.187
   Goel A, 2001, CANCER LETT, V172, P111, DOI 10.1016/S0304-3835(01)00655-3
   Goldman S., 2003, US Pat Appl., Patent No. [10/076 247, 10076247]
   Gostner JM, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-18
   Gran L, 2000, J ETHNOPHARMACOL, V70, P197, DOI 10.1016/S0378-8741(99)00175-0
   Grundemann C, 2012, J NAT PROD, V75, P167, DOI 10.1021/np200722w
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Gyebi GA, 2021, J BIOMOL STRUCT DYN, V39, P3396, DOI 10.1080/07391102.2020.1764868
   Haid S, 2012, GASTROENTEROLOGY, V143, P213, DOI 10.1053/j.gastro.2012.03.036
   Haidara M., 2016, NAT PRODUCT COMMUN, V11, DOI [10.1177/1934578x1601100309, DOI 10.1177/1934578X1601100309]
   Haladyj Ewa, 2018, Reumatologia (Warsaw), V56, P164, DOI 10.5114/reum.2018.76904
   Han SB, 1998, IMMUNOPHARMACOLOGY, V40, P39, DOI 10.1016/S0162-3109(98)00026-5
   Harata K, 2000, J MOL BIOL, V297, P673, DOI 10.1006/jmbi.2000.3594
   Haudecoeur R, 2018, J ETHNOPHARMACOL, V212, P106, DOI 10.1016/j.jep.2017.10.011
   He XR, 2020, CARBOHYD POLYM, V229, DOI 10.1016/j.carbpol.2019.115548
   Henrotin Y, 2010, OSTEOARTHR CARTILAGE, V18, P141, DOI 10.1016/j.joca.2009.10.002
   Hensel A, 2020, PLANTA MED, V86, P659, DOI 10.1055/a-1177-4396
   Heredia A, 2000, J ACQ IMMUN DEF SYND, V25, P246, DOI 10.1097/00126334-200011010-00006
   HOUGHTON PJ, 1995, PLANTA MED, V61, P33, DOI 10.1055/s-2006-957994
   HUDSON JB, 1986, PLANTA MED, P453, DOI 10.1055/s-2007-969252
   Huisman MMH, 2001, BIOPOLYMERS, V58, P279, DOI 10.1002/1097-0282(200103)58:3<279::AID-BIP1005>3.0.CO;2-1
   Iheagwam FN, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/5612486
   Ireland DC, 2008, BIOPOLYMERS, V90, P51, DOI 10.1002/bip.20886
   IROBI ON, 1994, J ETHNOPHARMACOL, V43, P185, DOI 10.1016/0378-8741(94)90041-8
   Trujillo-Correa AI, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2695-1
   Islam SKN, 2004, PHYTOTHER RES, V18, P395, DOI 10.1002/ptr.1449
   Island, 2021, FEATURES EVALUATION
   Iwu M. M., 2014, HDB AFRICAN MED PLAN
   Jacobson JM, 2001, ANTIMICROB AGENTS CH, V45, P517, DOI 10.1128/AAC.45.2.517-524.2001
   Jacques AdoukoS., 2020, J PHARMACOGNOSY PHYT, V12, P1, DOI [10.5897/JPP2019.0555, DOI 10.5897/JPP2019.0555]
   Jain S., 2020, BRAZILIAN J NATURAL, V3, DOI [10.31415/bjns.v3i2.101, DOI 10.31415/BJNS.V3I2.101]
   James E.S., 2007, ISSUES NEW CROPS NEW
   Jassim SAA, 2003, J APPL MICROBIOL, V95, P412, DOI 10.1046/j.1365-2672.2003.02026.x
   Jasso-Miranda C, 2019, INFECT DRUG RESIST, V12, P1833, DOI 10.2147/IDR.S210890
   Jiang ZY, 2013, BIOORG MED CHEM LETT, V23, P2123, DOI 10.1016/j.bmcl.2013.01.118
   Jose RJ, 2020, LANCET RESP MED, V8, pE46, DOI 10.1016/S2213-2600(20)30216-2
   Jung M, 2000, CURR MED CHEM, V7, P649, DOI 10.2174/0929867003374822
   Kacem R, 2006, YAKUGAKU ZASSHI, V126, P301, DOI 10.1248/yakushi.126.301
   Kanwar S.S, 2017, BIOCH PHYSL, V06, DOI [10.4172/2168-9652.1000220, DOI 10.4172/2168-9652.1000220]
   Kaur N, 2006, PROTEIN PEPTIDE LETT, V13, P895
   Khan MA, 2011, AFR J TRADIT COMPLEM, V8, P226, DOI 10.4314/ajtcam.v8i5S.10
   Kim HJ, 2002, PLANTA MED, V68, P1034, DOI 10.1055/s-2002-35665
   Kim KA, 2003, ARCH PHARM RES, V26, P631, DOI 10.1007/BF02976712
   Kini SG, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1014-6
   Komlaga G., 2015, ANTIMALARIAL POTENTI
   Kong LB, 2013, ANTIVIR RES, V98, P44, DOI 10.1016/j.antiviral.2013.02.003
   Kotwal GJ, 2008, VACCINE, V26, P3055, DOI 10.1016/j.vaccine.2007.12.008
   Kraft C, 2003, PHYTOTHER RES, V17, P123, DOI 10.1002/ptr.1066
   Krawitz C, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-16
   Kumar VP, 2015, CARBOHYD POLYM, V117, P115, DOI 10.1016/j.carbpol.2014.09.039
   Kumar VP, 2016, J ETHNOPHARMACOL, V186, P280, DOI 10.1016/j.jep.2016.04.006
   Kurokawa M., 2010, TOANTIMJ, V2, P49, DOI [10.2174/1876518101002020049, DOI 10.2174/1876518101002020049]
   Laforge M, 2020, NAT REV IMMUNOL, V20, P515, DOI 10.1038/s41577-020-0407-1
   Lamorde M, 2010, J ETHNOPHARMACOL, V130, P43, DOI 10.1016/j.jep.2010.04.004
   Landa P, 2009, ARCH PHARM RES, V32, P75, DOI 10.1007/s12272-009-1120-6
   Lazaridi K., 2014, THESIS ACADEMIEJAAR
   Lee CL, 2009, J NAT PROD, V72, P1568, DOI 10.1021/np900158f
   LEEHUANG S, 1995, GENE, V161, P151, DOI 10.1016/0378-1119(95)00186-A
   Leung PC, 2007, AM J CHINESE MED, V35, P575, DOI 10.1142/S0192415X07005077
   Li SY, 2005, ANTIVIR RES, V67, P18, DOI 10.1016/j.antiviral.2005.02.007
   Li ZL, 2016, INFLAMMATION, V39, P1566, DOI 10.1007/s10753-016-0392-5
   Liang LL, 2019, FOOD SCI NUTR, V7, P1754, DOI 10.1002/fsn3.1015
   Lima EBC, 2015, BRAZ J MED BIOL RES, V48, P953, DOI 10.1590/1414-431X20154773
   Lima MD, 2013, EUR J PHARMACOL, V699, P112, DOI 10.1016/j.ejphar.2012.11.040
   Lin FL, 2009, PHYTOTHER RES, V23, P958, DOI 10.1002/ptr.2701
   Lin S, 2007, J NAT PROD, V70, P817, DOI 10.1021/np0700467
   Lin Sheng, 2008, Zhongguo Zhong Yao Za Zhi, V33, P1708
   Lone SA, 2020, EMERG MICROBES INFEC, V9, P1300, DOI 10.1080/22221751.2020.1775132
   Luo H, 2020, CHIN J INTEGR MED, V26, P243, DOI 10.1007/s11655-020-3192-6
   Lutgen P, 2016, MALARIAWORLD
   Madelain V, 2016, CLIN PHARMACOKINET, V55, P907, DOI 10.1007/s40262-015-0364-1
   Madzuki IN, 2019, PHYTOTHER RES, V33, P1784, DOI 10.1002/ptr.6366
   Mahmoud MR, 2002, J ETHNOPHARMACOL, V79, P1, DOI 10.1016/S0378-8741(01)00310-5
   Mahomoodally MF, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/617459
   MARCHETTI M, 1995, RES VIROLOGY, V146, P211, DOI 10.1016/0923-2516(96)80581-4
   Maroyi A, 2014, TROP J PHARM RES, V13, P1527, DOI 10.4314/tjpr.v13i9.21
   Martins FO, 2009, NAT PROD COMMUN, V4, P1693
   Mathy-Hartert M, 2009, INFLAMM RES, V58, P899, DOI 10.1007/s00011-009-0063-1
   Salinas FM, 2019, ANTIVIR RES, V164, P1, DOI 10.1016/j.antiviral.2019.01.018
   MCCHESNEY EW, 1983, AM J MED, V75, P11, DOI 10.1016/0002-9343(83)91265-2
   McFadden Roger, 2011, Nurs Stand, V25, P65
   Meagher JL, 2005, GLYCOBIOLOGY, V15, P1033, DOI 10.1093/glycob/cwi088
   Mehrbod P, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2774-3
   Mehrbod P, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2246-1
   Mehrbod P, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2184-y
   Mehta AA., 2007, PHARMACOGN REV, V1
   Memvanga PB, 2015, J ETHNOPHARMACOL, V169, P76, DOI 10.1016/j.jep.2015.03.075
   Mesia K, 2012, PLANTA MED, V78, P853, DOI 10.1055/s-0031-1298488
   Mesia K, 2012, PLANTA MED, V78, P211, DOI 10.1055/s-0031-1280359
   Mesia K, 2011, PLANTA MED, V77, P111, DOI 10.1055/s-0030-1250134
   Michelini FM, 2018, J PHARM PHARMACOL, V70, P1561, DOI 10.1111/jphp.13002
   Mills E, 2005, AIDS, V19, P95, DOI 10.1097/00002030-200501030-00013
   Mitchell CA, 2017, ANTIVIR RES, V142, P37, DOI 10.1016/j.antiviral.2017.03.007
   MONZINGO AF, 1993, J MOL BIOL, V233, P705, DOI 10.1006/jmbi.1993.1547
   Mouhajir F, 2001, PHARM BIOL, V39, P364, DOI 10.1076/phbi.39.5.364.5892
   Moura MC, 2017, J APPL MICROBIOL, V123, P861, DOI 10.1111/jam.13556
   Mukherjee H, 2013, MICROBIOL RES, V168, P238, DOI 10.1016/j.micres.2012.11.002
   Murata T, 2008, J NAT PROD, V71, P167, DOI 10.1021/np0780093
   Nawrot R, 2014, FOLIA MICROBIOL, V59, P181, DOI 10.1007/s12223-013-0280-4
   Neurath AR, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-41
   Neurath AR, 2005, ANN NY ACAD SCI, V1056, P311, DOI 10.1196/annals.1352.015
   Neuwinger H.D., 2000, AFRICAN TRADITIONAL
   Nguyen KNT, 2016, FEBS J, V283, P2067, DOI 10.1111/febs.13720
   Nie LX, 2020, J ETHNOPHARMACOL, V251, DOI 10.1016/j.jep.2020.112550
   Nwankwo JO, 2000, EUR J CANCER PREV, V9, P351, DOI 10.1097/00008469-200010000-00010
   Nworu CS, 2017, AFR HEALTH SCI, V17, P827, DOI 10.4314/ahs.v17i3.26
   Obodozie OO, 2011, EUR J DRUG METAB PH, V35, P103, DOI 10.1007/s13318-010-0012-y
   Odediran SA, 2014, PARASITOL RES, V113, P1977, DOI 10.1007/s00436-014-3848-2
   Ogbole O. O., 2013, African Journal of Biotechnology, V12, P3878
   Ogbole OO, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1022-7
   Olubiyi OO, 2020, MOLECULES, V25, DOI 10.3390/molecules25143193
   Omoregie ES, 2016, AVICENNA J PHYTOMEDI, V6, P236
   Osadebe P., 2007, PLANTA MED, V73, P108, DOI [10.1055/s-2007-986890, DOI 10.1055/S-2007-986890]
   Osipiuk J., 2020, CRYSTAL STRUCTURE PA
   Sousa AMP, 2020, J PROTEOMICS, V217, DOI 10.1016/j.jprot.2020.103692
   Panraksa P, 2017, ANTIVIR RES, V139, P69, DOI 10.1016/j.antiviral.2016.12.014
   Parvez MK, 2019, PHYTOTHER RES, V33, P2960, DOI 10.1002/ptr.6471
   Pascolutti M, 2014, DRUG DISCOV TODAY, V19, P215, DOI 10.1016/j.drudis.2013.10.013
   Patil L, 2014, INT J PHARM PHARM SC, V6, P9
   PAUL BD, 1974, J PHARM SCI, V63, P958, DOI 10.1002/jps.2600630638
   Boas LCPV, 2019, CELL MOL LIFE SCI, V76, P3525, DOI 10.1007/s00018-019-03138-w
   Peumans WJ, 2000, PLANTA, V211, P546, DOI 10.1007/s004250000307
   Poth AG, 2011, P NATL ACAD SCI USA, V108, P10127, DOI 10.1073/pnas.1103660108
   Pousset J L, 2006, Med Trop (Mars), V66, P606
   Priyadarsini RV, 2009, FREE RADICAL RES, V43, P492, DOI 10.1080/10715760902870637
   Projean D, 2003, XENOBIOTICA, V33, P841, DOI 10.1080/0049825031000121608
   Projean D, 2003, DRUG METAB DISPOS, V31, P748, DOI 10.1124/dmd.31.6.748
   Purvis B, 2019, SUSTAIN SCI, V14, P681, DOI 10.1007/s11625-018-0627-5
   QianCutrone JF, 1996, J NAT PROD, V59, P196, DOI 10.1021/np9600560
   Rahman N, 2020, MOLECULES, V25, DOI 10.3390/molecules25102271
   Rahmasari R., 2017, NAT PRODUCT COMMUN, V12, DOI [10.1177/1934578x1701200432, DOI 10.1177/1934578X1701200432]
   Randhawa Mohammad Akram, 2008, J Ayub Med Coll Abbottabad, V20, P1
   RAO AS, 1990, BOT REV, V56, P1, DOI 10.1007/BF02858531
   Raza A, 2015, WORLD POULTRY SCI J, V71, P523, DOI 10.1017/S0043933915002147
   Rex J.R.S., 2018, MOJ BIORG ORG CHEM, V2, P61, DOI DOI 10.15406/mojboc.2
   Riebensahm C, 2019, EXPERT REV CLIN PHAR, V12, P875, DOI 10.1080/17512433.2019.1638251
   Rivera J.O, 2013, ALTERN INTEG MED
   Rungeler P, 1998, PLANTA MED, V64, P588, DOI 10.1055/s-2006-957527
   SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002
   Salem ML, 2005, INT IMMUNOPHARMACOL, V5, P1749, DOI 10.1016/j.intimp.2005.06.008
   Salim B, 2020, Identification of compounds from nigella sativa as new potential inhibitors of 2019 novel coronavirus ( covid-19 ): molecular docking study, V19, P1
   Sankaranarayanan R, 1996, NAT STRUCT BIOL, V3, P596, DOI 10.1038/nsb0796-596
   Sarkar L, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00116
   Sciences G., 2020, GILEAD SCI STATEMENT
   Segun PA, 2021, NAT PROD RES, V35, P1909, DOI 10.1080/14786419.2019.1644505
   Shakibaei M, 2011, GENES NUTR, V6, P171, DOI 10.1007/s12263-010-0179-5
   Sharon N.O.I., 1986, MICROBIAL LECTINS AG, P55
   Shikalepo R, 2018, J HERB MED, V12, P73, DOI 10.1016/j.hermed.2017.09.007
   Shin HB, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-303
   Shivaprasad HN, 2006, PHARM BIOL, V44, P32, DOI 10.1080/13880200500530542
   Sindambiwe JB, 1999, J ETHNOPHARMACOL, V65, P71, DOI 10.1016/S0378-8741(98)00154-8
   Sithisarn P, 2005, J ETHNOPHARMACOL, V99, P109, DOI 10.1016/j.jep.2005.02.008
   Sodagari HR, 2018, J PHARMACOPUNCT, V21, P294, DOI 10.3831/KPI.2018.21.033
   SPALDIN V, 1994, BRIT J CLIN PHARMACO, V38, P15, DOI 10.1111/j.1365-2125.1994.tb04316.x
   Sreejayan N, 1996, ARZNEIMITTEL-FORSCH, V46, P169
   Sriwilaijaroen N, 2012, ANTIVIR RES, V94, P139, DOI 10.1016/j.antiviral.2012.02.013
   Steinmassl M, 1996, VIRAL IMMUNOL, V9, P27, DOI 10.1089/vim.1996.9.27
   Su XW, 2010, FOODBORNE PATHOG DIS, V7, P1473, DOI 10.1089/fpd.2010.0583
   Sulaiman LK, 2011, AFR J BIOTECHNOL, V10, P4256
   Sumra Naseer, 2018, Clinical Phytoscience, V4, DOI 10.1186/s40816-018-0093-8
   Sundararajan A, 2010, ANTIVIR RES, V88, P1, DOI 10.1016/j.antiviral.2010.06.014
   Surya W, 2018, BBA-BIOMEMBRANES, V1860, P1309, DOI 10.1016/j.bbamem.2018.02.017
   Swanson MD, 2010, J BIOL CHEM, V285, P8646, DOI 10.1074/jbc.M109.034926
   Terstappen GC, 2001, TRENDS PHARMACOL SCI, V22, P23, DOI 10.1016/S0165-6147(00)01584-4
   Thomford NE, 2016, MOLECULES, V21, DOI 10.3390/molecules21020211
   Titanji VPK, 2008, AFR J TRADIT COMPLEM, V5, P302
   Tomlinson ES, 1997, J STEROID BIOCHEM, V62, P345, DOI 10.1016/S0960-0760(97)00038-1
   Troost B, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63397-7
   Udeinya JI, 2008, AM J THER, V15, P108, DOI 10.1097/MJT.0b013e31804c6d1d
   ul Qamar MT, 2020, J PHARM ANAL, V10, P313, DOI 10.1016/j.jpha.2020.03.009
   Umera E.A, 2020, MOL DOCKING ANAL SOM
   UNEP-WCMC UNEP-WCMC, 2016, STAT BIOD AFR MIDT R
   Vimalanathan S, 2005, PHARM BIOL, V43, P740, DOI 10.1080/13880200500406354
   Vlietinck AJ, 1997, CURR ORG CHEM, V1, P307
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Wang CK, 2017, MOLECULES, V22, DOI 10.3390/molecules22112037
   Weber F, 2020, REF MODUL LIFE SCI
   Welch C.R., 2010, THESIS RUTGERS U SCH
   WHO, 2020, NAM COR DIS COVID 19
   WHO International Union for Conservation of Nature and Natural Resources World Wide Fund for Nature, 1993, GUID CONS MED PLANTS
   Wiart C, 2005, PHYTOTHER RES, V19, P1069, DOI 10.1002/ptr.1765
   Wolf R, 2006, INT J DERMATOL, V45, P661, DOI 10.1111/j.1365-4632.2006.02696.x
   Woo ER, 2004, ARCH PHARM RES, V27, P173, DOI 10.1007/BF02980102
   World Health Organization, 2020, WHO SUPP SCI PROV TR
   Worthen DR, 1998, ANTICANCER RES, V18, P1527
   Wu J, 2006, PLANT BREEDING, V125, P390, DOI 10.1111/j.1439-0523.2006.01247.x
   Wu SF, 2012, J VIRAL HEPATITIS, V19, P364, DOI 10.1111/j.1365-2893.2011.01558.x
   Xu J, 2008, ANTIVIR RES, V78, P242, DOI 10.1016/j.antiviral.2007.11.011
   Yang X, 2011, CROP SCI, V51, P2119, DOI 10.2135/cropsci2010.11.0650
   Yang YJ, 2012, PHYTOMEDICINE, V20, P67, DOI 10.1016/j.phymed.2012.08.012
   Yeh RF, 2006, JAIDS-J ACQ IMM DEF, V42, P52
   Yin QH, 2012, CYTOTECHNOLOGY, V64, P43, DOI 10.1007/s10616-011-9389-y
   Younas M, 2018, RSC ADV, V8, P29714, DOI 10.1039/c8ra04879g
   Yu, 2020, TIANJIN J TRADIT CHI, V37, P121
   Zakaryan H, 2017, ARCH VIROL, V162, P2539, DOI 10.1007/s00705-017-3417-y
   Zhang JS, 2002, LIFE SCI, V71, P623, DOI 10.1016/S0024-3205(02)01690-9
   Zhang WX, 2008, DRUG METAB DISPOS, V36, P1283, DOI 10.1124/dmd.107.019737
   Zhang Y, 2013, J NAT PROD, V76, P1058, DOI 10.1021/np4000747
   Zhang Z, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1025-y
   Zhou SF, 2003, DRUG METAB REV, V35, P35, DOI 10.1081/DMR-120018248
   Zibaee E, 2020, CURR PHARM DESIGN, V26, P44, DOI 10.2174/1381612825666191127115601
NR 295
TC 4
Z9 4
U1 2
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD APR 26
PY 2021
VL 12
AR 596855
DI 10.3389/fphar.2021.596855
PG 29
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA RZ4YS
UT WOS:000648604400001
PM 33981214
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Bentley, FS
   Kehoe, RR
   Chung, H
AF Bentley, F. Scott
   Kehoe, Rebecca R.
   Chung, Hyesook
TI Investing for Keeps: Firms' Prepandemic Investments in Human Capital
   Decreased Workforce Reductions Associated With COVID-19 Financial
   Pressures
SO JOURNAL OF APPLIED PSYCHOLOGY
LA English
DT Article
DE COVID-19; layoffs; downsizing; Strategic Human Resource Management;
   resource orchestration
ID HUMAN-RESOURCE PRACTICES; COMPETITIVE ADVANTAGE; VOLUNTARY TURNOVER;
   PERFORMANCE; EMPLOYEES; IMPACT; REORGANIZATION; CAPABILITIES;
   TECHNOLOGY; RETHINKING
AB We examine how firms' prepandemic investments in human capital influence their use of workforce reductions and layoffs (hereafter, workforce reductions) as a response to financial pressures during the coronavirus disease (COVID-19) pandemic. We contend that workforce reductions must be examined in the context of firms' broader financial and resource orchestration environments. First, we suggest that firms' relative exposure to pandemic financial pressures (PFPs) will determine their need to cut costs during the pandemic. Second, we argue that a firm's prior investments in employees' human capital will reduce the attractiveness of workforce reductions as a cost-cutting response to PFPs, as human capital investment (HCI) increases the value of employees' knowledge, skills, and abilities and motivation, thus inducing firms to seek alternative measures to reduce costs. We then argue that the attenuating influence of HCI on the effect of PFPs on workforce reductions will be stronger when HCI is matched with greater investments in physical capital, as employees' human capital will create more value-and will translate to a bigger loss following employee departures-in such circumstances. We demonstrate support for our hypotheses in a sample of 1,364 U.S. banks using data from quarterly Federal Deposit Insurance Corporation (FDIC) reports, news articles, and Worker Adjustment and Retraining Notifications (WARN) Act filings through the fourth quarter of 2020. We discuss implications for our understanding of the impact of the COVID-19 pandemic on organizations and employees and for research on resource orchestration and human capital.
C1 [Bentley, F. Scott] Binghamton Univ, Sch Management, Acad Bldg A, Binghamton, NY 13902 USA.
   [Kehoe, Rebecca R.; Chung, Hyesook] Cornell Univ, ILR Sch, Ithaca, NY USA.
RP Bentley, FS (corresponding author), Binghamton Univ, Sch Management, Acad Bldg A, Binghamton, NY 13902 USA.
EM fbentley@binghamton.edu
FU Center for Advanced Human Resource Studies (CAHRS) at Cornell University
FX This research was supported in part by a grant provided by the Center
   for Advanced Human Resource Studies (CAHRS) at Cornell University.
CR Aalbers HL, 2014, J ECON ISSUES, V48, P451, DOI 10.2753/JEI0021-3624480219
   Baumol W.J., 2003, DOWNSIZING AM REALIT
   Bentley FS, 2020, ACAD MANAGE J, V63, P181, DOI 10.5465/amj.2018.0272
   BLAU PM, 1974, NATURE ORG
   Bordo M., 2000, 7652 NBER
   Broughton K., 2020, WALL STR J
   Budros A, 1997, SOC FORCES, V76, P229, DOI 10.2307/2580324
   Budros A, 2000, SOCIOL FORUM, V15, P273, DOI 10.1023/A:1007521608402
   Budros A, 2004, SOCIOL INQ, V74, P355, DOI 10.1111/j.1475-682X.2004.00096.x
   Budros A, 2002, SOCIOL FORUM, V17, P307, DOI 10.1023/A:1016093330881
   Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644
   Campbell BA, 2012, ACAD MANAGE REV, V37, P376, DOI 10.5465/amr.2010.0276
   Carlson KD, 2012, ORGAN RES METHODS, V15, P413, DOI 10.1177/1094428111428817
   Cassella M., 2020, POLITICO
   Collins CJ, 2006, ACAD MANAGE J, V49, P544, DOI 10.5465/AMJ.2006.21794671
   Crandall R. W., 2006, VIDEO GAMES SERIOUS
   Datta DK, 2010, J MANAGE, V36, P281, DOI 10.1177/0149206309346735
   Davidson, 2020, USA TODAY
   Davies G, 2020, FINANC TIMES
   de la Merced M.J, 2008, NEW YORK TIMES
   de Leon R., 2020, CNBC
   Ethiraj SK, 2012, ORGAN SCI, V23, P725, DOI 10.1287/orsc.1110.0659
   Federal Student Aid, 2020, COVID 19 EM REL FED
   Filatotchev I, 2000, ACAD MANAGE J, V43, P286, DOI 10.2307/1556396
   Flammer C, 2021, STRATEGIC MANAGE J, V42, P1275, DOI 10.1002/smj.3265
   Gardner TM, 2011, PERS PSYCHOL, V64, P315, DOI 10.1111/j.1744-6570.2011.01212.x
   Greene W. H., 2003, ECONOMETRIC ANAL
   Guthrie JP, 2008, ORGAN SCI, V19, P108, DOI 10.1287/orsc.1070.0298
   Hatch NW, 2004, STRATEGIC MANAGE J, V25, P1155, DOI 10.1002/smj.421
   Hess AM, 2011, STRATEGIC MANAGE J, V32, P895, DOI 10.1002/smj.916
   Hitt MA, 2001, ACAD MANAGE J, V44, P13, DOI 10.2307/3069334
   Hunter LW, 2001, IND LABOR RELAT REV, V54, P402, DOI 10.2307/2696101
   Iqbal Z., 1994, J FINANCIAL STRATEGI, V7, P125
   Iverson RD, 2007, IND RELAT, V46, P456, DOI 10.1111/j.1468-232X.2007.00477.x
   Jiang KF, 2012, ACAD MANAGE J, V55, P1264, DOI 10.5465/amj.2011.0088
   Kehoe RR, 2013, J MANAGE, V39, P366, DOI 10.1177/0149206310365901
   Kelly J., 2019, FORBES
   Kennedy P., 2008, GUIDE ECONOMETRICS
   Kim Y, 2014, J APPL PSYCHOL, V99, P361, DOI 10.1037/a0035408
   Klein A, 2020, AM BANKER
   Kurtessis JN, 2017, J MANAGE, V43, P1854, DOI 10.1177/0149206315575554
   Liang N., 2020, BROOKINGS
   Lim DSK, 2013, STRATEGIC MANAGE J, V34, P42, DOI 10.1002/smj.1996
   Loftsgordon A., 2020, FEDERAL STATE FORECL
   Logan L.K., 2021, LIQUIDITY SHOCKS LES
   Mahoney JT, 2015, ACAD MANAGE PERSPECT, V29, P296, DOI 10.5465/amp.2014.0151
   Maritan CA, 2017, J MANAGE, V43, P2609, DOI 10.1177/0149206317727585
   Marous J., 2019, FINANCIAL BRAND 0725
   Marous J., 2021, FINANCIAL BRAND 0125
   Marshall E.D., 2020, REUTERS 0828
   Mishkin F.S., 2004, EC MONEY BANKING FIN
   Molloy JC, 2015, ACAD MANAGE PERSPECT, V29, P309, DOI 10.5465/amp.2014.0152
   Osterman P, 2000, IND LABOR RELAT REV, V53, P179, DOI 10.2307/2696072
   Otani A, 2021, WALL STR J
   Ployhart RE, 2011, ACAD MANAGE J, V54, P353, DOI 10.5465/AMJ.2011.60263097
   Plummer M., 2021, COMMENTARY IT COMES
   Reed KK, 2006, J MANAGE STUD, V43, P867, DOI 10.1111/j.1467-6486.2006.00614.x
   Rothaermel FT, 2007, ORGAN SCI, V18, P898, DOI 10.1287/orsc.1070.0291
   Schwartz J., 2018, FUTURE IS HERE
   Semadeni M, 2014, STRATEGIC MANAGE J, V35, P1070, DOI 10.1002/smj.2136
   Shaw JD, 2013, STRATEGIC MANAGE J, V34, P572, DOI 10.1002/smj.2025
   Shevlin R, 2021, FORBES
   Shi GF, 2019, APPL ECON LETT, V26, P1785, DOI 10.1080/13504851.2019.1602698
   Singh A., 2016, J BANKING FINANCIAL, V2, P23, DOI [10.7172/2353-6845.jbfe.2016.2.2, DOI 10.7172/2353-6845.JBFE.2016.2.2]
   Sirmon DG, 2011, J MANAGE, V37, P1390, DOI 10.1177/0149206310385695
   Sirmon DG, 2009, STRATEGIC MANAGE J, V30, P1375, DOI 10.1002/smj.791
   Soares J., 2020, BANKS CAN DEFUSE NON
   Sturman MC, 2022, J APPL PSYCHOL, V107, P9, DOI 10.1037/apl0000849
   Ton J, 2019, FORBES
   Trevor CO, 2008, ACAD MANAGE J, V51, P259, DOI 10.5465/AMJ.2008.31767250
   Tsui AS, 1997, ACAD MANAGE J, V40, P1089, DOI 10.2307/256928
   Vomberg A, 2015, STRATEGIC MANAGE J, V36, P2122, DOI 10.1002/smj.2328
   Wagar TH, 1997, CAN J ADM SCI, V14, P303
   Wang HL, 2016, J MANAGE, V42, P500, DOI 10.1177/0149206313484519
   Wang HC, 2009, STRATEGIC MANAGE J, V30, P1265, DOI 10.1002/smj.787
   White M.C, 2020, NBC NEWS
   Wood S, 2018, J MANAGE, V44, P3070, DOI 10.1177/0149206316659111
   Yoo HO, 2000, INFORM SOC, V16, P23
NR 78
TC 0
Z9 0
U1 11
U2 11
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0021-9010
EI 1939-1854
J9 J APPL PSYCHOL
JI J. Appl. Psychol.
PD DEC
PY 2021
VL 106
IS 12
BP 1785
EP 1804
DI 10.1037/apl0001002
PG 20
WC Psychology, Applied; Management
WE Social Science Citation Index (SSCI)
SC Psychology; Business & Economics
GA XW3UI
UT WOS:000735548100007
PM 34968090
DA 2022-04-20
ER

PT J
AU Adam, R
   Zsuzsanna, G
   Orsolya, C
   Laszlo, W
   Katalin, F
   Adrienn, M
   Attila, P
   Szilard, T
   Anita, HS
   Marina, V
   Attila, D
   Aniko, S
   Janos, F
   Laszlo, K
AF Adam, Remport
   Zsuzsanna, Gerlei
   Orsolya, Cseprekal
   Laszlo, Wagner
   Katalin, Foldes
   Adrienn, Marton
   Attila, Patonai
   Szilard, Torok
   Anita, Haboub-Sandil
   Marina, Varga
   Attila, Doros
   Aniko, Smudla
   Janos, Fazakas
   Laszlo, Kobori
TI Guidance on the special care of liver or kidney transplant recipients
   diagnosed with COVID-19
SO ORVOSI HETILAP
LA Hungarian
DT Article
DE COVID-19; liver transplantation; renal transplantation;
   immunosuppression
ID HYPERINFLAMMATION; MANAGEMENT; INJURY
AB Due to the COVID-19 pandemic caused by infection with the novel, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant medicine also had to face a new, hitherto unknown challenge. To be prepared for any possibility, we consider it important to summarize the current knowledge regarding COVID-19 of liver and kidney transplant patients. Very early reports from Spanish and French registry recorded fatality rates of 18.6% and 13%, respectively, in renal patients which suggests a moderately worse outcome compared to the general population. In patients with positive PCR test but not showing clinical signs, the reduction of immunosuppression is not advised. In the case of gastrointestinal or respiratory signs with fever, the discontinuation of mycophenolate or mTOR in-hibitors is recommended with decrease of the trough levels of calcineurin inhibitors to the lowest effective limit. Stop (kidney transplanted patients) or decrease (liver transplanted patients) immunosuppression and maintain corticosteroids when pulmonal injury develops and consider anti-IL1 and anti-IL6 monoclonal antibody use when hyperinflammatory syndrome is evolving. No proven effective treatment for SARS-CoV-2 exists currently. The use of lopinavir/ritonavir should be avoided because of the severe drug interaction with calcineurin inhibitors. The efficacy and tolerability of hidroxychloroquin remains to be also questionable; enroll patients into clinical trial with remdesivir or favipiravir if available. COVID-19 is characterized by virus-induced endothelial dysfunction, procoagulant state and renin-angiotensin-aldosteron system imbalance. Early thromboprofilaxis combination with low-molecular-weight heparin and low-dose aspirin is strongly recommended with the maintenance of angiotensin-converting enzyme inhibitor (ACEI) or angiotensin-II-receptor blocker (ARB) therapy when they were prescribed earlier.
C1 [Adam, Remport; Zsuzsanna, Gerlei; Orsolya, Cseprekal; Laszlo, Wagner; Katalin, Foldes; Adrienn, Marton; Attila, Patonai; Szilard, Torok; Anita, Haboub-Sandil; Attila, Doros; Aniko, Smudla; Janos, Fazakas; Laszlo, Kobori] Semmelweis Egyet, Altalanos Orvostud Kar, Transzplantacios Sebeszeti Klin, Budapest, Hungary.
   [Marina, Varga] Semmelweis Egyet, Altalanos Orvostud Kar, Lab Med Int, Budapest, Hungary.
RP Adam, R (corresponding author), Baross U 23-25, H-1083 Budapest, Hungary.
EM remportadam@hotmail.com
CR Akalin E, 2020, NEW ENGL J MED, V382, P2475, DOI 10.1056/NEJMc2011117
   Akos F, 2020, ORVOSI HETILAP, V161, P685, DOI 10.1556/650.2020.31812
   Alberici F, 2020, KIDNEY INT REP, V5, P580, DOI 10.1016/j.ekir.2020.04.001
   American Association for the Study of Liver Diseases, CLIN BEST PRACT ADV
   Andras L, 2020, ORVOSI HETILAP, V161, P672, DOI 10.1556/650.2020.31814
   Anita K, 2020, ORVOSI HETILAP, V161, P667, DOI 10.1556/650.2020.31815
   [Anonymous], 2020, HDB PREV MAN NEW COR
   [Anonymous], 2020, MASSACHUSETTS GEN HO
   Batlle D, 2020, J AM SOC NEPHROL, V31, P1380, DOI 10.1681/ASN.2020040419
   BC Transplant, 2019, CLIN GUID TRANSPL ME
   Bhoori S, 2020, LANCET GASTROENTEROL, V5, P532, DOI 10.1016/S2468-1253(20)30116-3
   British Transplantation Society; The Renal Association, GUID MAN TRANSPL REC
   Cavalli G, 2020, LANCET RHEUMATOL, V2, pE325, DOI 10.1016/S2665-9913(20)30127-2
   Chau TN, 2004, HEPATOLOGY, V39, P302, DOI 10.1002/hep.20111
   Cho HJ, 2020, J INFECT PUBLIC HEAL, V13, P1678, DOI 10.1016/j.jiph.2020.05.001
   D'Antiga L, 2020, LIVER TRANSPLANT, V26, P832, DOI 10.1002/lt.25756
   Du YX, 2020, CLIN PHARMACOL THER, V108, P242, DOI 10.1002/cpt.1844
   Sanchez-Alvarez JE, 2020, NEFROLOGIA, V40, P272, DOI 10.1016/j.nefro.2020.04.002
   Farkash EA, 2020, J AM SOC NEPHROL, V31, P1683, DOI 10.1681/ASN.2020040432
   Gandolfini I, 2020, AM J TRANSPLANT, V20, P1941, DOI 10.1111/ajt.15891
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Henry BM, 2020, CLIN CHIM ACTA, V507, P167, DOI 10.1016/j.cca.2020.04.027
   Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006
   Huang JF, 2020, AM J TRANSPLANT, V20, P1879, DOI 10.1111/ajt.15896
   Ingraham NE, 2020, LANCET RESP MED, V8, P544, DOI 10.1016/S2213-2600(20)30226-5
   Kekes E, 2020, HYPERTON NEPHROL, V24, P5
   Lopez V, 2020, NEFROLOGIA, V40, P265, DOI 10.1016/j.nefro.2020.03.002
   Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4
   Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925
   Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993
   National Institutes of Health, NIH CLIN TRIAL SHOWS
   Pirola CJ, 2020, LIVER INT, V40, P2038, DOI 10.1111/liv.14500
   Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019
   Scavone C, 2020, BRIT J PHARMACOL, V177, P4813, DOI 10.1111/bph.15072
   Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012
   Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003
   Toniati P, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102568
   Trujillo H, 2020, KIDNEY INT REP, V5, P905, DOI 10.1016/j.ekir.2020.04.024
   US Food and Drug Administration (FDA), COR COVID 19 UPD FDA
   Wang JP, 2020, EUR UROL, V77, P769, DOI 10.1016/j.eururo.2020.03.036
   Webb GJ, 2020, LANCET GASTROENTEROL, V5, P643, DOI 10.1016/S2468-1253(20)30125-4
   Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117
   Yang X, 2020, LANCET RESP MED, V8, pE26
   Zatroch I, 2020, ORVOSI HETILAP, V161, P899, DOI 10.1556/650.2020.31870
   Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1
   Zheng SF, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1443
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 48
TC 0
Z9 0
U1 0
U2 0
PU AKADEMIAI KIADO ZRT
PI BUDAPEST
PA BUDAFOKI UT 187-189-A-3, H-1117 BUDAPEST, HUNGARY
SN 0030-6002
EI 1788-6120
J9 ORVOSI HETILAP
JI Orvosi Hetilap
PD AUG
PY 2020
VL 161
IS 32
BP 1310
EP 1321
DI 10.1556/650.2020.31923
PG 12
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA OD3LT
UT WOS:000579753700001
PM 32750019
OA hybrid
DA 2022-04-20
ER

PT J
AU Samaranayake, LP
   Fakhruddin, KS
   Panduwawala, C
AF Samaranayake, Lakshman Perera
   Fakhruddin, Kausar Sadia
   Panduwawala, Chamila
TI Sudden onset, acute loss of taste and smell in coronavirus disease 2019
   (COVID-19): a systematic review
SO ACTA ODONTOLOGICA SCANDINAVICA
LA English
DT Review
DE Loss of taste; loss of smell; dysgeusia; anosmia; chemosensory
   dysfunction; SARS-CoV-2; COVID-19
AB Background Early detection, isolation and management of COVID-19 are crucial to contain the current pandemic. US Centers for Disease Control and Prevention (CDC) recently included 'sudden loss of taste (dysgeusia/ageusia) and smell (anosmia/hyposmia)' as symptoms of COVID-19. If indeed these symptoms are reliable and specific forerunner symptoms of COVID-19, then it may facilitate detection and containment of the disease. Hence, we systematically evaluated the contemporary evidence on dysgeusia and anosmia as trigger prodromal symptoms, and their prevalence in COVID-19 patients. Methods Ovid MEDLINE, EBSCO host and Web of Science databases were searched between 25 December 2019 and 30 May 2020. Results Of the 13 identified records, eight studies, totalling 11,054 COVID-19 patients, were included, as per the selection criteria. Eligible articles reflected research conducted mostly in the European community, as well as China, the US and Iran. In total, anosmia and dysgeusia symptoms were present in 74.9% and 81.3% ambulatory as well as hospitalized, mild-to-severe cases of COVID-19 patients, respectively. The European, US and Iran data indicate olfactory and gustatory symptoms appear prior to general COVID-19 symptoms in 64.5% and 54.0% of the patients, respectively. Conclusions To our knowledge, this is the first systematic review analysing the meager data based on the prevalence of chemosensory dysfunction in COVID-19. Critical analysis of such macro-data, as and when available, is essential to evaluate their utility as harbingers of COVID-19 onset, and to establish clinical practice guidelines both in dentistry and medicine.
C1 [Samaranayake, Lakshman Perera; Fakhruddin, Kausar Sadia; Panduwawala, Chamila] Univ Sharjah, Dept Prevent & Restorat Dent, Sharjah, U Arab Emirates.
   [Samaranayake, Lakshman Perera; Fakhruddin, Kausar Sadia; Panduwawala, Chamila] Univ Sharjah, Dept Oral & Craniofacial Hlth Sci, Sharjah, U Arab Emirates.
   [Samaranayake, Lakshman Perera] Univ Hong Kong, Fac Dent, Hong Kong, Peoples R China.
RP Samaranayake, LP; Fakhruddin, KS (corresponding author), Univ Sharjah, Coll Dent Med, Sharjah 27272, U Arab Emirates.
EM lsamaranayake@sharjah.ac.ae; kfakhruddin@sharjah.ac.ae
CR Bagheri SH, 2020, COINCIDENCE COVID 19, V34, P62, DOI [DOI 10.1101/2020.03.23.20041889, 10.34171/mjiri.34.62]
   Beltran-Corbellini A, 2020, EUR J NEUROL, V27, P1738, DOI 10.1111/ene.14273
   Benezit F, 2020, LANCET INFECT DIS, V20, P1014, DOI 10.1016/S1473-3099(20)30297-8
   Boesveldt S, 2017, CHEM SENSES, V42, P513, DOI 10.1093/chemse/bjx025
   Ciaglia E, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00206
   Desforges M, 2014, ADV EXP MED BIOL, V807, P75, DOI 10.1007/978-81-322-1777-0_6
   Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014
   Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007]
   Mann CJ, 2003, EMERG MED J, V20, P54, DOI 10.1136/emj.20.1.54
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Moein ST, 2020, INT FORUM ALLERGY RH, V10, P944, DOI 10.1002/alr.22587
   Russell B, 2020, ECANCERMEDICALSCIENC, V14, DOI 10.3332/ecancer.2020.1023
   Schardt C, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-16
   Skelly Andrea C, 2012, Evid Based Spine Care J, V3, P9, DOI 10.1055/s-0031-1298595
   Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6
   Syed Q, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.003
   The National Law Review, 2020, NATL LAW REV
   van Riel D, 2015, J PATHOL, V235, P277, DOI 10.1002/path.4461
   Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1038/s41368-020-0074-X, 10.1038/s41368-020-0074-x]
   Xydakis MS, 2020, LANCET INFECT DIS, V20, P1015, DOI 10.1016/S1473-3099(20)30293-0
   Yan CG, 2021, IEEE T PATTERN ANAL, V43, P1445, DOI 10.1109/TPAMI.2020.2975798
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
NR 25
TC 29
Z9 29
U1 1
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0001-6357
EI 1502-3850
J9 ACTA ODONTOL SCAND
JI Acta Odontol. Scand.
PD AUG 17
PY 2020
VL 78
IS 6
BP 467
EP 473
DI 10.1080/00016357.2020.1787505
EA AUG 2020
PG 7
WC Dentistry, Oral Surgery & Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dentistry, Oral Surgery & Medicine
GA NB4BO
UT WOS:000556511300001
PM 32762282
OA Bronze
DA 2022-04-20
ER

PT J
AU Sudario, G
   Wiechmann, W
   Youm, J
   Khanh-Van Le-Bucklin
AF Sudario, Gabriel
   Wiechmann, Warren
   Youm, Julie
   Khanh-Van Le-Bucklin
TI An Effective COVID-19 Medical Student Elective
SO WESTERN JOURNAL OF EMERGENCY MEDICINE
LA English
DT Article
AB Background: The COVID-19 pandemic has revealed the importance of teaching medical students pandemic preparedness and COVID-19 related clinical knowledge. To fill the gap of COVID-19 instruction backed by evaluation data, we present a comprehensive COVID-19 pilot curriculum with multiple levels of evaluation data.
   Methods: In the spring of 2020, the University of California, Irvine (UCI) School of Medicine piloted a two-week, primarily asynchronous COVID-19 elective course for medical students. The goal of the course is to provide a foundation in clinical care for COVID-19 while introducing students to emerging issues of a modem pandemic. Objectives align with institutional objectives, and instruction is delivered in thematic modules. Our curriculum utilizes numerous instructional strategies effective in distance learning including independent learning modules (ILM), reading, video lectures, discussion board debates, simulation and evidence-based argument writing. We designed a three-level, blended evaluation plan grounded in the Kirkpatrick and Kirkpatrick evaluation model that assessed student satisfaction, relevance, confidence, knowledge and behavior.
   Results: Our end of course survey revealed that students had high levels of satisfaction with the curriculum, and felt the course was relevant to their clinical education. Various assessment tools showed excellent levels of knowledge attainment. All respondents rated themselves as highly confident with the use of personal protective equipment, though fewer were confident with ventilator management.
   Conclusion: Overall our pilot showed that we were able to deliver relevant, satisfying COVID-19 instruction while allowing students to demonstrate knowledge and desired behaviors in COVID-19 patient care.
C1 [Sudario, Gabriel; Wiechmann, Warren] Univ Calif Irvine, Dept Emergency Med, Irvine, CA USA.
   [Youm, Julie; Khanh-Van Le-Bucklin] Univ Calif Irvine, Sch Med, Med Educ, Irvine, CA USA.
RP Sudario, G (corresponding author), Univ Calif Irvine, Sch Med, Dept Emergency Med, 1001 Hlth Sci Rd, Irvine, CA 92617 USA.
EM gsudario@uci.edu
CR Anderson L., 2001, TAXONOMY LEARNING TE
   Ashcroft J, 2021, POSTGRAD MED J, V97, P368, DOI 10.1136/postgradmedj-2020-137906
   Dick W, 2015, SYSTEMATIC DESIGN IN, V8th
   Driscoll MP., 2005, PSYCHOL LEARNING INS, V3rd
   Kern DE, 2009, CURRICULUM DEV MEDIC, V2nd
   Kirkpatrick, 2016, KIRKPATRICKS 4 LEVEL
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Theoret C, 2020, MED EDUC, V54, P591, DOI 10.1111/medu.14181
NR 8
TC 0
Z9 0
U1 1
U2 1
PU WESTJEM
PI ORANGE
PA C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01,
   ORANGE, CA 92868 USA
SN 1936-900X
EI 1936-9018
J9 WEST J EMERG MED
JI West. J. Emerg. Med.
PD JAN
PY 2022
VL 23
IS 1
BP 40
EP 46
DI 10.5811/westjem.2021.11.53656
PG 7
WC Emergency Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Emergency Medicine
GA ZZ7IS
UT WOS:000773438600029
PM 35060859
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU de la Poterie, AT
   Clatworthy, Y
   Easton-Calabria, E
   de Perez, EC
   Lux, S
   van Aalst, M
AF Tozier de la Poterie, Arielle
   Clatworthy, Yolanda
   Easton-Calabria, Evan
   Coughlan de Perez, Erin
   Lux, Stefanie
   van Aalst, Maarten
TI Managing multiple hazards: lessons from anticipatory humanitarian action
   for climate disasters during COVID-19
SO CLIMATE AND DEVELOPMENT
LA English
DT Article; Early Access
DE Multi-hazard; forecast-based financing; early action; anticipatory
   humanitarian action; climate risk management; disaster risk reduction;
   disaster risk financing; COVID-19; climate services; localization
ID RISK-ASSESSMENT; VULNERABILITY
AB In the face of climate change, development and humanitarian practitioners increasingly recognize the need to anticipate and manage multiple, concurrent risks. One prominent example of this increasing focus on anticipation is the rapid growth of Forecast-based Financing (FbF), in particular within Red Cross and Red Crescent (RCRC). To evaluate how anticipatory efforts managed multiple compounding risks during the COVID-19 pandemic, we examine how 14 RCRC Societies adapted their Early Action Protocols to COVID-19. Though many National Societies successfully adapted to the onset of the additional hazard of COVID-19, we find that multi-hazard risk management can be improved by: proactively developing guidelines that enable rapid adaptation of existing plans; more flexible funding mechanisms; surge capacity to provide additional human resources; and increasing local capacity and ownership for implementation to ensure supplies, skills, and decision-making authority are available when communication or travel is restricted. These findings align with wider recommendations for improving development, humanitarian, and climate adaptation practice towards local capacity and agency. They also add urgency to broader calls for more flexible disaster financing and more practitioner-oriented investment in climate risk and multi-hazard management.
C1 [Tozier de la Poterie, Arielle] German Red Cross, Anticipat Hub, Berlin, Germany.
   [Clatworthy, Yolanda] Anticipat Hub, Berlin, Germany.
   [Easton-Calabria, Evan] Univ Oxford, Dept Int Dev, Refugee Studies Ctr, Oxford, England.
   [Coughlan de Perez, Erin; van Aalst, Maarten] Red Cross Red Crescent Climate Ctr, The Hague, Netherlands.
   [Coughlan de Perez, Erin; van Aalst, Maarten] Columbia Univ, Int Res Inst Climate & Soc, New York, NY USA.
   [Lux, Stefanie] German Red Cross, Berlin, Germany.
   [van Aalst, Maarten] Univ Twente, Fac Geoinformat Sci & Earth Observat, Enschede, Netherlands.
RP de la Poterie, AT (corresponding author), DRK Generalsekretariat Team Knowledge & Innovat z, Arielle Tozier Poterie Carstennstr 58, D-12205 Berlin, Germany.
EM arielle.tozierdelapoterie@germanredcross.de
RI van Aalst, Maarten/X-2017-2018
OI van Aalst, Maarten/0000-0003-0319-5627; Coughlan de Perez,
   Erin/0000-0001-7645-5720; Easton-Calabria, Evan/0000-0001-9417-181X
FU German Federal Foreign Office
FX We gratefully acknowledge the support of German Federal Foreign Office
   who provided the funding backing to make this research possible.
CR Bahadur A. V., 2016, RESILIENCE SCAN JULY
   Bargain Grand, 2016, SHARED COMMITMENT BE
   Barros V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, pIX
   Belesova K, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3169
   Carpignano A, 2009, J RISK RES, V12, P513, DOI 10.1080/13669870903050269
   CHS Alliance, 2018, FUT HUM SURG LEARN T
   Costella C, 2017, IDS BULL-I DEV STUD, V48, P31, DOI 10.19088/1968-2017.151
   de Renzio P., 2016, ACCOUNTABILITY DILEM
   Feeny E., 2017, OXFAM DISCUSSION PAP
   Frennesson L, 2021, J HUMANIT LOGIST SUP, V11, P81, DOI 10.1108/JHLSCM-06-2020-0048
   Girgin S, 2019, INT J DISAST RISK RE, V35, DOI 10.1016/j.ijdrr.2019.101072
   Harris V, 2019, RES ETH ISS ORG, V22, P33, DOI 10.1108/S1529-209620190000022004
   ICVA/ODI (International Council of Voluntary Agencies/Overseas Development Institute), 2016, LOC HUM PRACT
   IFRC/RCRC Climate Centre, 2020, CLIM REL EXTR WEATH
   International Committee of the Red Cross (ICRC), 2019, ICRCS GUID DOC ACC A
   Ishiwatari M, 2020, PROG DISASTER SCI, V6, DOI 10.1016/j.pdisas.2020.100096
   Kellett J., 2013, GLOBAL FACILITY DISA
   Levine S., 2020, HUMANITARIAN POLICY
   Lung F., 2020, UKAID OPM
   Lux S., 2020, IFRC GERMAN RED CROS
   Maxwell D., 2014, ANOTHER HUMANITARIAN
   Ming XD, 2015, STOCH ENV RES RISK A, V29, P35, DOI 10.1007/s00477-014-0935-y
   National Audit Office (NAO), 2016, RESP CRIS
   Overseas Development Institute (ODI), 2018, FOR HAZ AV DIS IMPL
   Overseas Development Institute (ODI), 2016, TIME LET GO REMAKING
   Oxford Policy Management (OPM), 2016, SHOCK RESP SOC PROT
   Parker B., 2016, WHAT DOES LOCALISATI
   Pei S, 2020, GEOHEALTH, V4, DOI 10.1029/2020GH000319
   Phillips CA, 2020, NAT CLIM CHANGE, V10, P586, DOI 10.1038/s41558-020-0804-2
   Pourghasemi HR, 2020, GEOSCI FRONT, V11, P1203, DOI 10.1016/j.gsf.2019.10.008
   Pourghasemi HR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60191-3
   Raymond C, 2020, NAT CLIM CHANGE, V10, P611, DOI 10.1038/s41558-020-0790-4
   Roepstorff K, 2020, THIRD WORLD Q, V41, P284, DOI 10.1080/01436597.2019.1644160
   Rohwerder B., 2017, FLEXIBILITY FUNDING
   Ruth A., 2017, FORECAST BASED FINAN
   Sahoo B, 2018, J ENVIRON MANAGE, V206, P1166, DOI 10.1016/j.jenvman.2017.10.075
   Shultz JM, 2020, DISASTER MED PUBLIC, V14, P494, DOI 10.1017/dmp.2020.243
   Tozier de la Poterie A., 2017, THESIS
   UN, 2020, UN COORD APP
   United Nations Office for Disaster Risk Reduction (UNISDR), 2020, FACT SHEET HLTH CONT
   van den Homberg MJC, 2020, POLITICS GOV, V8, P456, DOI 10.17645/pag.v8i4.3158
   WHO, 2020, PREP CYCL TROP STORM
   WHS (World Humanitarian Summit), 2016, IN GRAND BARG
   Wilkinson E, 2018, FORECASTING HAZARDS
   Winters MS, 2010, INT STUD REV, V12, P218, DOI 10.1111/j.1468-2486.2010.00929.x
   World Health Organisation W, 2020, COR DIS COVID 19 ADV
   Zscheischler J, 2020, NAT REV EARTH ENV, V1, P333, DOI 10.1038/s43017-020-0060-z
   Zscheischler J, 2018, NAT CLIM CHANGE, V8, P469, DOI 10.1038/s41558-018-0156-3
NR 48
TC 0
Z9 0
U1 3
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1756-5529
EI 1756-5537
J9 CLIM DEV
JI Clim. Dev.
DI 10.1080/17565529.2021.1927659
EA MAY 2021
PG 15
WC Development Studies; Environmental Studies
WE Social Science Citation Index (SSCI)
SC Development Studies; Environmental Sciences & Ecology
GA SC9LU
UT WOS:000650985900001
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Goyal, K
   Kumar, S
   Rao, P
   Colombage, S
   Sharma, A
AF Goyal, Kirti
   Kumar, Satish
   Rao, Purnima
   Colombage, Sisira
   Sharma, Ankit
TI Financial distress and COVID-19: evidence from working individuals in
   India
SO QUALITATIVE RESEARCH IN FINANCIAL MARKETS
LA English
DT Article
DE COVID-19; Financial resilience; Financial vulnerability; Personal
   financial management; Personal financial survey
ID LITERACY; BEHAVIOR; SUPPORT; IMPACT; RISK; KIN
AB Purpose This study aims to explore the impact of the containment measures during COVID-19 on individuals' finances, financial resilience during such distress and identifying the most financially vulnerable among them. Tracing such impact during the pandemic has been challenging due to a lack of representative data. This paper addresses this gap in the present study. Design/methodology/approach A survey has been conducted using a structured questionnaire containing various items that portray the impact on income, spending, saving, investment, borrowing, insurance and retirement. The sample consists of 699 respondents and purposive and snowball sampling has been used for data collection. The results are presented and analyzed using infographics and frequency distributions. This study conducts an analysis of variance and Chi-square tests for significance. Findings This paper finds a fall in income and limited ability to cope with the current economic conditions. The survey highlights inadequate savings and insurance, weak retirement planning, outstanding loans and under-diversified investments inhibiting financial resilience even among the higher-income group. Particularly, lower-income strata, women and not much educated are most financially vulnerable. Further, no substantial financial benefits have been received from the government and people rely on their usual income sources. Originality/value To the best of the authors' knowledge, this is the first study that measures the pandemic's impact on personal finances, especially in connection with a developing economy like India. Policy interventions are critical to the millions for whom financial literacy is required now more than ever.
C1 [Goyal, Kirti; Kumar, Satish] Malaviya Natl Inst Technol, Dept Management Studies, Jaipur, Rajasthan, India.
   [Rao, Purnima] Fortune Inst Int Business, New Delhi, India.
   [Colombage, Sisira] Federat Univ Australia, Federat Business Sch, Dept Accounting & Finance, Ballarat, Vic, Australia.
   [Sharma, Ankit] Chandragupt Inst Management Patna, Dept Finance & Accounting, Patna, Bihar, India.
RP Kumar, S (corresponding author), Malaviya Natl Inst Technol, Dept Management Studies, Jaipur, Rajasthan, India.
EM scholar.satish@gmail.com
RI Rao, Purnima/ACU-6252-2022; KUMAR, SATISH/M-8694-2017; GOYAL,
   KIRTI/ABE-7340-2021
OI KUMAR, SATISH/0000-0001-5200-1476; GOYAL, KIRTI/0000-0002-8270-3134;
   Rao, Purnima/0000-0002-7537-9057
CR Abbott-Chapman J, 2008, J YOUTH STUD, V11, P611, DOI 10.1080/13676260802191938
   Agarwal S, 2015, J HOUS ECON, V27, P4, DOI 10.1016/j.jhe.2015.02.003
   Akhtaruzzaman M, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101604
   Amin A., 2020, BFA GLOBAL
   Anderloni L, 2012, RES ECON, V66, P284, DOI 10.1016/j.rie.2012.03.001
   Angerer XH, 2009, J FINANC, V64, P1037, DOI 10.1111/j.1540-6261.2009.01456.x
   Babiarz P, 2014, J FAM ECON ISS, V35, P40, DOI 10.1007/s10834-013-9369-9
   Baker S. R., 2020, W26949 NAT BUR EC RE
   Boon T. H., 2011, INT J EC MANAGEMENT, V5, P149
   Bucher-Koenen T, 2014, REV FINANC, V18, P2215, DOI 10.1093/rof/rft052
   Caner A, 2004, REV INCOME WEALTH, P493
   Caplan G, 1964, PRINCIPLES PREVENTIV
   Carroll CD, 1997, Q J ECON, V112, P1, DOI 10.1162/003355397555109
   Chandra A, 2017, INT J SOC ECON, V44, P578, DOI 10.1108/IJSE-04-2015-0097
   Christelis D, 2010, EUR ECON REV, V54, P18, DOI 10.1016/j.euroecorev.2009.04.001
   Collins J.M., 2011, COMING CASH PINCH EM, V6, P41
   Copur Z, 2019, J FAM ECON ISS, V40, P305, DOI 10.1007/s10834-018-09606-y
   Corbet S, 2020, FINANC RES LETT, V35, DOI 10.1016/j.frl.2020.101554
   CUDDINGTON JT, 1993, WORLD BANK ECON REV, V7, P173, DOI 10.1093/wber/7.2.173
   Deaton Angus, 1992, UNDERSTANDING CONSUM
   Del Rio A., 2008, APPL FINANCIAL EC, V18, P1209, DOI DOI 10.1080/09603100701604233
   Eberhardt W, 2019, J BEHAV DECIS MAKING, V32, P79, DOI 10.1002/bdm.2097
   Fan VY, 2018, B WORLD HEALTH ORGAN, V96, P129, DOI 10.2471/BLT.17.199588
   Fernando R., 2020, SSRN ELECT J
   Field A., 2013, DISCOVERING STAT USI
   FINRA, 2009, FINANCIAL CAPABILITY
   Folger-Laronde Z, 2022, J SUSTAIN FINANC INV, V12, P490, DOI 10.1080/20430795.2020.1782814
   Garman E. T., 2011, PERSONAL FINANCE, V11th
   Gettleman J., 2020, RESOURCE DOCUMENT
   Gomes F, 2005, J FINANC, V60, P869, DOI 10.1111/j.1540-6261.2005.00749.x
   Gopinath G., 2020, GREAT LOCKDOWN WORST
   Goyal K, 2021, INT J CONSUM STUD, V45, P80, DOI 10.1111/ijcs.12605
   Greasley D, 2001, EXPLOR ECON HIST, V38, P225, DOI 10.1006/exeh.2000.0751
   Harknett K, 2007, J MARRIAGE FAM, V69, P237, DOI 10.1111/j.1741-3737.2006.00356.x
   Hasin, 2020, 5 COVID 19 LOCKDOWNS
   He HW, 2020, J BUS RES, V116, P176, DOI 10.1016/j.jbusres.2020.05.030
   Hoffmann AOI, 2013, J BANK FINANC, V37, P60, DOI 10.1016/j.jbankfin.2012.08.007
   Hopkins S, 2006, HEALTH POLICY, V75, P347, DOI 10.1016/j.healthpol.2005.04.002
   Jappelli T., 2013, J FINANCIAL MANAGEME, V1, P23, DOI 10.12831/73631
   Keynes, 1973, GEN THEORY EMPLOYMEN
   Kidwell B, 2004, J ECON PSYCHOL, V25, P601, DOI 10.1016/S0167-4870(03)00073-4
   Kostova D, 2019, HEALTH ECON, V28, P1248, DOI 10.1002/hec.3938
   Liu Y., 2020, 3559870SSRN
   LUSARDI A, 2011, W17072 NAT BUR EC RE
   Lynch JG, 2011, J MARKETING RES, V48, pSIV, DOI 10.1509/jmkr.48.SPL.Siv
   Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507
   Mensi W, 2020, RESOUR POLICY, V69, DOI 10.1016/j.resourpol.2020.101829
   Modigliani F., 1954, POSTKEYNESIAN EC, P388
   Narayan, 2020, ENERGY RES LETT, V1, P13683, DOI [10. 46557/001c.13683, DOI 10.46557/001C.13683]
   OECD, 2018, OECD INFE TOOLKI MEA
   OECD, 2005, IMPROVING FINANCIAL, DOI [10.1787/9789264012578-en, DOI 10.1787/9789264012578-EN]
   OECD, 2020, COVID 19 PROT PEOPL
   Oni SA, 2002, S AFR J ECON, V70, P1173
   RBI, 2017, REPORT HOUSEHOLD FIN
   Roomp K., 2020, COVID 19 IMPACT SURV
   Roy, 2020, WIRE
   Salignac F, 2019, SOC INDIC RES, V145, P17, DOI 10.1007/s11205-019-02100-4
   Sarkisian N, 2004, AM SOCIOL REV, V69, P812, DOI 10.1177/000312240406900604
   Sengupta R., 2020, 2020013 I GANDH U DE
   Sherraden M.W., 2005, INCLUSION AM DREAM A
   Sidorenko A., 2006, GLOBAL MACROECONOMIC, P79
   Smith J., 2020, SELF COVID19 FINANCI
   Topa G, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02419
   Varcoe K.P., 1990, J CONSUMER STUDIES H, V14, P57, DOI DOI 10.1111/J.1470-6431.1990.TB00036.X
   West T, 2019, STUD ECON FINANC, V36, P334, DOI 10.1108/SEF-11-2017-0318
   Wohlfart J., 2020, CESIFO WORKING PAPER, P49
   Xiao J.J., 2012, J FINANC COUNS PLAN, V23, P15
   Yerokhin O., 2008, NZ ASS EC C, P36
NR 68
TC 0
Z9 0
U1 4
U2 6
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1755-4179
J9 QUAL RES FINANC MARK
JI Qual. Res. Financ. Mark.
PD JUL 27
PY 2021
VL 13
IS 4
BP 503
EP 528
DI 10.1108/QRFM-08-2020-0159
EA JUN 2021
PG 26
WC Business, Finance
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA TR2QS
UT WOS:000666326600001
OA Bronze
DA 2022-04-20
ER

PT J
AU Sahimi, HMS
   Azman, N
   Jaafar, NRN
   Daud, TIM
   Baharudin, A
   Ismail, AK
   Malek, AZA
   Hassan, MR
   Nawi, AM
AF Mohd Salleh Sahimi, Hajar
   Azman, Nazirah
   Nik Jaafar, Nik Ruzyanei
   Mohd Daud, Tuti Iryani
   Baharudin, Azlin
   Ismail, Ahmad Khaldun
   Abdul Malek, Akramul Zikri
   Hassan, Mohd Rohaizat
   Mohammed Nawi, Azmawati
TI Health Anxiety and Its Correlations with Self-Perceived Risk and
   Attitude on COVID-19 among Malaysian Healthcare Workers during the
   Pandemic
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE front liners; COVID 19; health attitude; health risk perception
ID PROTECTIVE BEHAVIORS; IMPACT; DETERMINANTS; PERCEPTION; FEAR
AB Healthcare workers (HCW) are exposed to health-related anxiety in times of pandemic as they are considered to have a high risk of being infected whilst being the vital workforce to manage the outbreak. This study determined the factors that influence health anxiety and its extent in correlations with perceived risk, knowledge, attitude, and practice of HCW. A cross-sectional online survey was conducted on a total of 709 HCW from both public and private healthcare facilities who completed a set of questionnaires on sociodemographic data, knowledge, attitude, and practice of HCW on COVID-19, and health anxiety traits assessed using the short version Health Anxiety Inventory (HAI). Multiple linear regression (adjusted R-2 = 0.06) revealed respondents with higher perceived risk for COVID-19 significantly predicted higher HAI scores (beta 1.281, p < 0.001, 95%, CI: 0.64, 1.92), and those with a higher cautious attitude towards COVID-19 significantly predicted higher HAI scores (beta 0.686, p < 0.001, 95%CI: 0.35, 1.02). Healthcare workers' perceived risk and cautious attitude towards COVID-19 might be potentially influenced by management of the sources and approaches to the dissemination of information of the pandemic. The implementation of certain measures that minimize the infection risk and its related anxiety is important to preserve both their physical and psychological wellbeing.
C1 [Mohd Salleh Sahimi, Hajar; Azman, Nazirah; Nik Jaafar, Nik Ruzyanei; Mohd Daud, Tuti Iryani; Baharudin, Azlin] Hosp Canselor Tuanku Muhriz, Dept Psychiat, Kuala Lumpur 56000, Malaysia.
   [Ismail, Ahmad Khaldun] Univ Kebangsaan Malaysia, Fac Med, Dept Emergency Med, Kuala Lumpur 56000, Malaysia.
   [Abdul Malek, Akramul Zikri] Minist Hlth Malaysia, Dept Psychiat & Mental Hlth, Kuala Lumpur 50586, Malaysia.
   [Hassan, Mohd Rohaizat; Mohammed Nawi, Azmawati] Univ Kebangsaan Malaysia, Fac Med, Dept Community Hlth, Kuala Lumpur 56000, Malaysia.
RP Jaafar, NRN (corresponding author), Hosp Canselor Tuanku Muhriz, Dept Psychiat, Kuala Lumpur 56000, Malaysia.
EM hajarmss@ppukm.ukm.edu.my; drnazirahazman@gmail.com;
   ruzyanei@ppukm.ukm.edu.my; tutimd@ppukm.ukm.edu.my; jelin72@hotmail.com;
   khaldun_ismail@yahoo.com; drakramresearch@gmail.com;
   rohaizat@ppukm.ukm.edu.my; azmawati@ppukm.ukm.edu.my
RI Nawi, Azmawati Mohammed/AAA-6220-2019; Ismail, Ahmad
   Khaldun/AAR-3050-2020; Hassan, Mohd Rohaizat/C-9753-2017; Daud, Tuti I
   Mohd/M-5626-2017
OI Nawi, Azmawati Mohammed/0000-0002-0009-5244; Ismail, Ahmad
   Khaldun/0000-0003-3213-0240; Hassan, Mohd Rohaizat/0000-0002-4658-6532;
   Daud, Tuti I Mohd/0000-0002-9780-1191; Mohd Salleh Sahimi,
   Hajar/0000-0002-5753-3479; Azman, Nazirah/0000-0002-0475-485X; Nik
   Jaafar, Nik Ruzyanei/0000-0002-6262-229X
CR Abramowitz J. S., 2008, PSYCHOL TREATMENT HL
   Ahmad AR, 2020, J MED INTERNET RES, V22, DOI 10.2196/19556
   Alsubaie S, 2019, J INFECT DEV COUNTR, V13, P920, DOI 10.3855/jidc.11753
   [Anonymous], 2020, COVID 19 LIVE UPDATE
   Bailer J, 2016, ANXIETY STRESS COPIN, V29, P219, DOI 10.1080/10615806.2015.1036243
   Banerjee D, 2020, ASIAN J PSYCHIATR, V50, DOI 10.1016/j.ajp.2020.102014
   Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826
   Blakey SM, 2017, J CLIN PSYCHOL MED S, V24, P270, DOI 10.1007/s10880-017-9514-y
   Brown RJ, 2020, CLIN PSYCHOL-SCI PR, V27, DOI 10.1111/cpsp.12299
   Chatterjee SS, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102071
   Chew NWS, 2020, BJPSYCH OPEN, V6, DOI 10.1192/bjo.2020.98
   Chow SK, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9010079
   Colizzi Marco, 2020, Brain Behav Immun Health, V5, P100073, DOI 10.1016/j.bbih.2020.100073
   Department of Statistics Malaysia, 2015, OFF PORT
   Depoux A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa031
   Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193
   Epstein JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003955
   European Broadcasting Union, WORLDS LEAD ALL PUBL
   Ferguson E, 2009, PSYCHOL MED, V39, P277, DOI 10.1017/S0033291708003322
   Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106
   Garfin DR, 2020, HEALTH PSYCHOL, V39, P355, DOI 10.1037/hea0000875
   Gaygisiz Ummugulsum, 2012, J Infect Public Health, V5, P9, DOI 10.1016/j.jiph.2011.09.008
   HARDY L, 1991, BRIT J PSYCHOL, V82, P163, DOI 10.1111/j.2044-8295.1991.tb02391.x
   Harper CA, 2021, INT J MENT HEALTH AD, V19, P1875, DOI 10.1007/s11469-020-00281-5
   Jalloh MF, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000471
   Jungmann SM, 2020, CLIN PSYCHOL SCI, V8, P306, DOI 10.1177/2167702619894904
   Lau JTF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-139
   Liao QY, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-169
   Lippi G, 2020, DIAGNOSIS, V7, P85, DOI 10.1515/dx-2020-0041
   Liu S, 2020, LANCET PSYCHIAT, V7, pE17, DOI 10.1016/S2215-0366(20)30077-8
   Main A, 2011, J COUNS PSYCHOL, V58, P410, DOI 10.1037/a0023632
   Mear, 2012, LINGUISTIC VALIDATIO
   Ministry of Health Malaysia, 2020, SEN DES HOSP BAG MEN
   Ministry of Health Malaysia, 2019, HLTH FACTS 2019
   Nixon J., 2014, LANGUAGE TRANSLATION
   Noor NM, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18030861
   Pallant J., 2020, SPSS SURVIVAL MANUAL
   Prentice-Dunn S., 1986, HEALTH EDUC RES, V1, P153, DOI [10.1093/her/1.3.153, DOI 10.1093/HER/1.3.153]
   RAOSOFT, 2020, SAMPL SIZ CALC
   ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803
   Rudisill C, 2013, J RISK RES, V16, P959, DOI 10.1080/13669877.2012.761271
   Salkovskis PM, 2002, PSYCHOL MED, V32, P843, DOI 10.1017/S0033291702005822
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   van der Weerd W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-575
   Woon LSC, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249155
   World Health Organazation, 2013, PROC TRANSL AD INSTR
   World Health Organisation, 2020, RISK COMM COMM ENG R RISK COMM COMM ENG R
   World Health Organisation, 2020, KEEP HLTH WORK SAF K
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xie XF, 2011, J RISK RES, V14, P1091, DOI 10.1080/13669877.2011.571790
NR 50
TC 3
Z9 3
U1 7
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD MAY
PY 2021
VL 18
IS 9
AR 4879
DI 10.3390/ijerph18094879
PG 13
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA SB9RA
UT WOS:000650321000001
PM 34063714
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Liu, Y
   Gu, ZL
   Xia, S
   Shi, BY
   Zhou, XN
   Shi, Y
   Liu, JM
AF Liu, Yang
   Gu, Zhonglei
   Xia, Shang
   Shi, Benyun
   Zhou, Xiao-Nong
   Shi, Yong
   Liu, Jiming
TI What are the underlying transmission patterns of COVID-19 outbreak? An
   age-specific social contact characterization
SO ECLINICALMEDICINE
LA English
DT Article
DE COVID-19; Underlying transmission patterns; Age-specific social contact
   patterns; Retrospective and prospective analysis
ID WUHAN
AB Background: COVID-19 has spread to 6 continents. Now is opportune to gain a deeper understanding of what may have happened. The findings can help inform mitigation strategies in the disease-affected countries.
   Methods: In this work, we examine an essential factor that characterizes the disease transmission patterns: the interactions among people. We develop a computational model to reveal the interactions in terms of the social contact patterns among the population of different age-groups. We divide a city's population into seven age-groups: 0-6 years old (children); 7-14 (primary and junior high school students); 15-17 (high school students); 18-22 (university students); 23 -44 (young/middle-aged people); 45-64 years old (middle-aged/elderly people); and 65 or above (elderly people). We consider four representative settings of social contacts that may cause the disease spread: (1) individual households; (2) schools, including primary/high schools as well as colleges and universities; (3) various physical workplaces; and (4) public places and communities where people can gather, such as stadiums, markets, squares, and organized tours. A contact matrix is computed to describe the contact intensity between different age-groups in each of the four settings. By integrating the four contact matrices with the next-generation matrix, we quantitatively characterize the underlying transmission patterns of COVID-19 among different populations.
   Findings: We focus our study on 6 representative cities in China: Wuhan, the epicenter of COVID-19 in China, together with Beijing, Tianjin, Hangzhou, Suzhou, and Shenzhen, which are five major cities from three key economic zones. The results show that the social contact-based analysis can readily explain the underlying disease transmission patterns as well as the associated risks (including both confirmed and unconfirmed cases). In Wuhan, the age-groups involving relatively intensive contacts in households and public/communities are dispersedly distributed. This can explain why the transmission of COVID-19 in the early stage mainly took place in public places and families in Wuhan. We estimate that Feb. 11, 2020 was the date with the highest transmission risk in Wuhan, which is consistent with the actual peak period of the reported case number (Feb. 4-14). Moreover, the surge in the number of new cases reported on Feb. 12 and 13 in Wuhan can readily be captured using our model, showing its ability in forecasting the potential/unconfirmed cases. We further estimate the disease transmission risks associated with different work resumption plans in these cities after the outbreak. The estimation results are consistent with the actual situations in the cities with relatively lenient policies, such as Beijing, and those with strict policies, such as Shenzhen.
   Interpretation: With an in-depth characterization of age-specific social contact-based transmission, the retrospective and prospective situations of the disease outbreak, including the past and future transmission risks, the effectiveness of different interventions, and the disease transmission risks of restoring normal social activities, are computationally analyzed and reasonably explained. The conclusions drawn from the study not only provide a comprehensive explanation of the underlying COVID-19 transmission patterns in China, but more importantly, offer the social contact-based risk analysis methods that can readily be applied to guide intervention planning and operational responses in other countries, so that the impact of COVID-19 pandemic can be strategically mitigated. (C) 2020 The Author(s). Published by Elsevier Ltd.
C1 [Liu, Yang; Gu, Zhonglei; Liu, Jiming] Hong Kong Baptist Univ, Dept Comp Sci, Hong Kong, Peoples R China.
   [Liu, Yang; Gu, Zhonglei; Xia, Shang; Shi, Benyun; Zhou, Xiao-Nong; Liu, Jiming] HKBU CSD & NIPD Joint Res Lab Intelligent Dis Sur, Hong Kong, Peoples R China.
   [Xia, Shang; Zhou, Xiao-Nong] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Chinese Ctr Trop Dis Res, Shanghai, Peoples R China.
   [Xia, Shang; Zhou, Xiao-Nong] Natl Hlth & Commiss Peoples Republ China, Key Lab Parasite & Vector Biol, Shanghai, Peoples R China.
   [Xia, Shang; Zhou, Xiao-Nong] WHO Collaborating Ctr Trop Dis, Shanghai, Peoples R China.
   [Shi, Benyun] Nanjing Tech Univ, Sch Comp Sci & Technol, Nanjing, Peoples R China.
   [Shi, Yong] Univ Chinese Acad Sci, Sch Econ & Management, Beijing, Peoples R China.
   [Shi, Yong] Chinese Acad Sci, Key Lab Big Data Min & Knowledge Management, Beijing, Peoples R China.
RP Liu, JM (corresponding author), Hong Kong Baptist Univ, Dept Comp Sci, Hong Kong, Peoples R China.
EM jiming@comp.hkbu.edu.hk
OI shi, yong/0000-0001-7974-1079
FU Hong Kong Research Grant CouncilHong Kong Research Grants Council
   [RGC/HKRU12202415, RGC/HKRU12201318]; National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China (NSFC)
   [71932008, 91546201]
FX The authors would like to specially thank K. Guo from the Key Laboratory
   of Big Data Mining and Knowledge Management, Chinese Academy of
   Sciences, for her helpful discussions in estimating the impact of
   COVID-19 on Chinese GDP. J. Liu acknowledges support from the Hong Kong
   Research Grant Council (under grants: RGC/HKRU12202415 and
   RGC/HKRU12201318). Y. Shi acknowledges support from the National Natural
   Science Foundation of China (under grants 71932008 and 91546201).
CR Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673
   Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE778, DOI 10.1016/S2214-109X(20)30217-5
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Hoang T, 2019, EPIDEMIOLOGY, V30, P723, DOI 10.1097/EDE.0000000000001047
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Iozzi F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001021
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Ma, 2020, TIME VARYING TRANSMI, DOI [10.1101/2020.01.25.919787, DOI 10.1101/2020.01.25.919787]
   Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074
   Sadique MZ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-135
   Strategy and Policy Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P135, DOI 10.3760/cma.j.issn.0254-6450.2020.02.001
   Svensson A, 2007, MATH BIOSCI, V208, P300, DOI 10.1016/j.mbs.2006.10.010
   Tan, 2020, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.20.255695, DOI 10.2471/BLT.20.255695]
   World Health Organization (WHO), 2020, REP WHO CHIN JOINT M
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Xia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065271
NR 18
TC 42
Z9 45
U1 4
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2589-5370
J9 ECLINICALMEDICINE
JI EClinicalMedicine
PD MAY
PY 2020
VL 22
AR 100354
DI 10.1016/j.eclinm.2020.100354
PG 10
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA RV6OQ
UT WOS:000645950000019
PM 32313879
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Gencoglu, O
AF Gencoglu, Oguzhan
TI Large-Scale, Language-Agnostic Discourse Classification of Tweets During
   COVID-19
SO MACHINE LEARNING AND KNOWLEDGE EXTRACTION
LA English
DT Article
DE text classification; sentence embeddings; Twitter; natural language
   processing; deep learning; health informatics; COVID-19
AB Quantifying the characteristics of public attention is an essential prerequisite for appropriate crisis management during severe events such as pandemics. For this purpose, we propose language-agnostic tweet representations to perform large-scale Twitter discourse classification with machine learning. Our analysis on more than 26 million coronavirus disease 2019 (COVID-19) tweets shows that large-scale surveillance of public discourse is feasible with computationally lightweight classifiers by out-of-the-box utilization of these representations.
C1 [Gencoglu, Oguzhan] Tampere Univ, Fac Med & Hlth Technol, Tampere 33720, Finland.
RP Gencoglu, O (corresponding author), Tampere Univ, Fac Med & Hlth Technol, Tampere 33720, Finland.
EM oguzhan.gencoglu@tuni.fi
CR Abd-Alrazaq A, 2020, J MED INTERNET RES, V22, DOI 10.2196/19016
   Aguilar-Gallegos N, 2020, DATA BRIEF, V30, DOI 10.1016/j.dib.2020.105684
   Alshaabi T., 2020, ARXIV200312614
   [Anonymous], COVID 19 TWITTER CHA
   [Anonymous], COVID 19 SOLIDARITY
   Arora Abhinav, 2020, CROSS LINGUAL TRANSF
   Baly R, P 58 ANN M ASS COMP, DOI [10.18653/v1/2020.acl-main.308, DOI 10.18653/V1/2020.ACL-MAIN.308]
   Banda J.M., 2020, Zenodo, DOI 10.5281/zenodo.3738018
   Bella A, 2010, Proceedings 2010 10th IEEE International Conference on Data Mining (ICDM 2010), P737, DOI 10.1109/ICDM.2010.75
   Bento AI, 2020, P NATL ACAD SCI USA, V117, P11220, DOI 10.1073/pnas.2005335117
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   Chan JL, 2020, DISASTER MED PUBLIC, V14, P352, DOI 10.1017/dmp.2019.92
   Chen E., 2020, ARXIV PREPRINT ARXIV
   Chen Emily, 2020, JMIR Public Health Surveill, V6, pe19273, DOI 10.2196/19273
   Chen L, 2020, ARXIV PREPRINT ARXIV, DOI [10.1542/peds.2012-3956, DOI 10.1542/peds.2012-3956]
   Chowdhury J.R., 2020, P AAAI C ART INT NEW, DOI [10.1609/aaai.v34i01.5387, DOI 10.1609/AAAI.V34I01.5387]
   Chowdhury JR, 2019, WEB CONFERENCE 2019: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW 2019), P1555, DOI 10.1145/3308558.3313696
   Cinelli M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73510-5
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   Cullen W, 2020, QJM-INT J MED, V113, P311, DOI 10.1093/qjmed/hcaa110
   Devlin J, 2019, BERT PRETRAINING DEE, DOI DOI 10.18653/V1/N19-1423
   Dewhurst D.R, 2020, ARXIV200403516
   Dhingra B, 2016, PROCEEDINGS OF THE 54TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2016), VOL 2, P269
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Feng F., 2020, ARXIV200701852
   Forman G, 2005, LECT NOTES ARTIF INT, V3720, P564
   Forman G, 2008, DATA MIN KNOWL DISC, V17, P164, DOI 10.1007/s10618-008-0097-y
   Gao Z., 2020, ARXIV200408145
   Gencoglu O, 2018, ARXIV190100439
   Gencoglu O, 2021, IEEE INTERNET COMPUT, V25, P20, DOI 10.1109/MIC.2020.3032461
   Gencoglu O, 2020, COMPUTATION, V8, DOI 10.3390/computation8040085
   Gonzalez P, 2017, PROG ARTIF INTELL, V6, P53, DOI 10.1007/s13748-016-0103-3
   Hamamsy T.C, 2020, TWITTER ACTIVITY TRE, DOI [10.1101/2020.06.18.20134668, DOI 10.1101/2020.06.18.20134668]
   Hosseini Pedram, 2020, ARXIV200508400
   Jang H, 2020, ARXIV200702452
   Jarynowski A., 2020, TRENDS PERCEPTION CO, DOI [10.1101/2020.05.04.20090993, DOI 10.1101/2020.05.04.20090993]
   Ji X, 2015, SOC NETW ANAL MIN, V5, DOI 10.1007/s13278-015-0253-5
   Ji X, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON HEALTHCARE INFORMATICS (ICHI 2013), P335, DOI 10.1109/ICHI.2013.47
   Jordan SE, 2018, DATA, V4, DOI 10.3390/data4010006
   Jurgens M, 2018, J CONTING CRISIS MAN, V26, P79, DOI 10.1111/1468-5973.12212
   Kabir M, 2020, ARXIV200413932
   Kaleel SB, 2015, J COMPUT SCI-NETH, V6, P47, DOI 10.1016/j.jocs.2014.11.004
   Kim HM, 2022, HEALTH COMMUN, V37, P525, DOI 10.1080/10410236.2020.1855744
   Kouzy R, 2020, CUREUS, V12, DOI 10.7759/cureus.7255
   Lacoste A., 2019, ARXIV191009700
   Lamsal R, 2020, IEEE DATAPORT
   Le Q., 2014, P INT C MACHINE LEAR
   Liu J, P 27 INT JOINT C ART, P3456, DOI [10.5555/3304222.3304248, DOI 10.5555/3304222.3304248]
   Lo SL, 2017, EXPERT SYST APPL, V81, P282, DOI 10.1016/j.eswa.2017.03.029
   Lopez C.E., 2020, ARXIV200310359
   Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m641
   Mazoyer B, P 12 LANG RES EV C M, P6220
   McInnes L, 2018, J OPEN SOURCE SOFTW, V3, P861, DOI [DOI 10.21105/JOSS.00861, 10.21105/joss.00861]
   McQuillan L, 2020, ARXIV200703443
   Medford RJ, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa258
   Merchant RM, 2020, JAMA-J AM MED ASSOC, V323, P2011, DOI 10.1001/jama.2020.4469
   Mokus J., 1975, OPTIMIZATION TECHNIQ, P400, DOI DOI 10.1007/3-540-07165-255.PDF
   Mollema L, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3863
   Muller M., 2020, ARXIV200507503
   Nguyen D.Q, 2020, ARXIV200510200
   Odlum M, 2020, STUD HEALTH TECHNOL, V272, P24, DOI 10.3233/SHTI200484
   Omoya Y, 2020, SSRN, DOI [10.2139/ssrn.3599755, DOI 10.2139/SSRN.3599755]
   Ordun C., 2020, ARXIV200503082
   Park HW, 2020, J MED INTERNET RES, V22, DOI 10.2196/18897
   Park S., 2020, JMIR, DOI [10.2196/preprints.23272, DOI 10.2196/PREPRINTS.23272]
   Pennington Jeffrey, 2014, P 2014 C EMP METH NA, P1532, DOI DOI 10.3115/V1/D14-1162
   Peters Matthew, 2018, ARXIV180205365, DOI [DOI 10.18653/V1/N18-1202, 10.18653/v1/N18-1202]
   Rao HR, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102187
   Rasmussen CE, 2004, LECT NOTES ARTIF INT, V3176, P63, DOI 10.1007/978-3-540-28650-9_4
   Reimers N., 2019, P 2019 C EMP METH NA, DOI DOI 10.18653/V1/D19-1410
   Roitero K, P INT WORKSH SEM IND, VVolume 2619
   Rosa K.D., 2011, P ACM SIGIR SWSM, P63
   Rosenberg H, 2020, CAN J EMERG MED, V22, P418, DOI 10.1017/cem.2020.361
   Saad Muhammad, 2020, ARXIV200508379
   Sandman, 1993, RESPONDING COMMUNITY
   Sharma K., 2020, ARXIV PREPRINT ARXIV
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Singh Lisa, 2020, ArXiv
   Thelwall M., 2020, ARXIV200402793
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   Vosoughi S, 2016, SIGIR'16: PROCEEDINGS OF THE 39TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P1041, DOI 10.1145/2911451.2914762
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   Wang Xueting, 2020, medRxiv, DOI 10.1101/2020.07.12.20151936
   Weeg Christopher, 2015, JMIR Public Health Surveill, V1, pe6, DOI 10.2196/publichealth.3953
   Wei J, P 1 WORKSH NLP COVID
   Wicke P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240010
   Wong CML, 2020, J RISK RES, V23, P1021, DOI 10.1080/13669877.2020.1756386
   Xue J, 2020, J MED INTERNET RES, V22, DOI 10.2196/20550
   Yang, 2020, ARXIV200706954
   Yin H, 2020, ARXIV200702304
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhou W., 2020, ARXIV PREPRINT ARXIV
   Zhu J, P 13 INT WORKSH SEM, P788, DOI [10.18653/v1/S19-2138, DOI 10.18653/V1/S19-2138]
NR 93
TC 7
Z9 7
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2504-4990
J9 MACH LEARN KNOW EXTR
JI Mach. Learn. Knowl. Extr.
PD DEC
PY 2020
VL 2
IS 4
BP 603
EP 616
DI 10.3390/make2040032
PG 14
WC Computer Science, Artificial Intelligence; Computer Science,
   Interdisciplinary Applications; Engineering, Electrical & Electronic
WE Emerging Sources Citation Index (ESCI)
SC Computer Science; Engineering
GA TX0LV
UT WOS:000682782200012
OA Green Submitted, gold
DA 2022-04-20
ER

PT J
AU Koratala, A
   Ronco, C
   Kazory, A
AF Koratala, Abhilash
   Ronco, Claudio
   Kazory, Amir
TI Need for Objective Assessment of Volume Status in Critically Ill
   Patients with COVID-19: The Tri-POCUS Approach
SO CARDIORENAL MEDICINE
LA English
DT Editorial Material
DE Point of care ultrasound; POCUS; Fluid volume status; Nephrology;
   COVID-19; Lung ultrasound
ID LUNG ULTRASOUND; FLUID; GUIDE; EDEMA
AB As the coronavirus disease 2019 (COVID-19) continues to spread across the globe, the knowledge of its epidemiology, clinical features, and management is rapidly evolving. Nevertheless, the data on optimal fluid management strategies for those who develop critical illness remain sparse. Adding to the challenge, the fluid volume status of these patients has been found to be dynamic. Some present with several days of malaise, gastrointestinal symptoms, and consequent hypovolemia requiring aggressive fluid resuscitation, while a subset develop acute respiratory distress syndrome with renal dysfunction and lingering congestion necessitating restrictive fluid management. Accurate objective assessment of volume status allows physicians to tailor the fluid management goals throughout this wide spectrum of critical illness. Conventional point-of-care ultrasonography (POCUS) enables the reliable assessment of fluid status and reducing the staff exposure. However, due to specific characteristics of COVID-19 (e.g., rapidly expanding lung lesions), a single imaging method such as lung POCUS will have significant limitations. Herein, we suggest a Tri-POCUS approach that represents concurrent bedside assessment of the lungs, heart, and the venous system. This combinational approach is likely to overcome the limitations of the individual methods and provide a more precise evaluation of the volume status in critically ill patients with COVID-19. (c) 2020 S. Karger AG, Basel
C1 [Koratala, Abhilash] Med Coll Wisconsin, Div Nephrol, Milwaukee, WI 53226 USA.
   [Ronco, Claudio] San Bortolo Hosp, Div Nephrol, Vicenza, Italy.
   [Ronco, Claudio] Int Renal Res Inst Vicenza IRRIV, Vicenza, Italy.
   [Ronco, Claudio] Univ Padua, Dept Med, Padua, Italy.
   [Kazory, Amir] Univ Florida, Div Nephrol Hypertens & Renal Transplantat, Gainesville, FL USA.
RP Koratala, A (corresponding author), Div Nephrol, 8701 W Watertown Plank Rd,Room A 7633, Wauwatosa, WI 53226 USA.
EM akoratala@mcw.edu
RI Koratala, Abhilash/H-8482-2019; Koratala, Abhilash/AAE-9605-2021
OI Koratala, Abhilash/0000-0001-5801-3574; Koratala,
   Abhilash/0000-0001-5801-3574; Ronco, Claudio/0000-0002-6697-4065
CR Beaubien-Souligny W, 2020, ULTRASOUND J, V12, DOI 10.1186/s13089-020-00163-w
   Bouchard J, 2009, KIDNEY INT, V76, P422, DOI 10.1038/ki.2009.159
   Boyd JH, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1407-1
   Chen Y, 2020, HUMAN KIDNEY IS TARG, DOI [10.1101/2020.03.04.20031120, DOI 10.1101/2020.03.04.20031120]
   Copetti R, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-16
   Cox EGM, 2020, CRIT CARE, V24, DOI 10.1186/s13054-019-2719-8
   Feissel M, 2004, INTENS CARE MED, V30, P1834, DOI 10.1007/s00134-004-2233-5
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hall MK, 2015, ACAD EMERG MED, V22, P583, DOI 10.1111/acem.12652
   Inciardi RM, 2020, JAMA CARDIOL, V5, P819, DOI 10.1001/jamacardio.2020.1096
   Jaffee W, 2018, J INTENSIVE CARE MED, V33, P502, DOI 10.1177/0885066617742832
   Kazory Amir, 2020, Proc (Bayl Univ Med Cent), V0, P1, DOI 10.1080/08998280.2020.1754700
   Keddissi Jean I, 2019, Can J Respir Ther, V55, P1, DOI 10.29390/cjrt-2018-016
   Kollias A, 2020, BRIT J HAEMATOL, V189, P846, DOI 10.1111/bjh.16727
   Koratala A, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/1454986
   Marbach JA, 2019, ANN INTERN MED, V171, P264, DOI 10.7326/M19-1337
   Peng QY, 2020, INTENS CARE MED, V46, P849, DOI 10.1007/s00134-020-05996-6
   Phua J, 2020, LANCET RESP MED, V8, P506, DOI 10.1016/S2213-2600(20)30161-2
   Poston JT, 2020, JAMA-J AM MED ASSOC, V323, P1839, DOI 10.1001/jama.2020.4914
   Ronco C, 2020, NAT REV NEPHROL, V16, P308, DOI 10.1038/s41581-020-0284-7
   Saugel B, 2011, J CRIT CARE, V26, P402, DOI 10.1016/j.jcrc.2010.11.001
   Ugalde D, 2018, INTENS CARE MED, V44, P986, DOI 10.1007/s00134-018-5049-4
   Vander Heide R, 2020, PULMONARY CARDIAC PA, V8, P681, DOI [10.1101/2020.04.06.20050575, DOI 10.1101/2020.04.06.20050575]
   Wang XT, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1558-0
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
NR 25
TC 11
Z9 11
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1664-3828
EI 1664-5502
J9 CARDIORENAL MED
JI CardioRenal Med.
PD JUL
PY 2020
VL 10
IS 4
BP 209
EP 216
DI 10.1159/000508544
PG 8
WC Cardiac & Cardiovascular Systems; Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Urology & Nephrology
GA MH0YJ
UT WOS:000546455800001
PM 32460302
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Jaga, A
   Ollier-Malaterre, A
AF Jaga, Ameeta
   Ollier-Malaterre, Ariane
TI 'You Can't Eat Soap': Reimagining COVID-19, Work, Family and Employment
   from the Global South
SO WORK EMPLOYMENT AND SOCIETY
LA English
DT Article; Early Access
DE COVID-19; employment; gender; Global South; inequalities; work and
   family
ID LIFE
AB This article problematises the assumptions regarding work, family and employment that underlie the World Health Organization (WHO)'s COVID-19 guidelines. The scientific evidence grounding sanitary and social distancing recommendations is embedded in conceptualisations of work as skilled jobs in the formal economy and of family as urban and nuclear. These are Global North rather than universal paradigms. We build on theories from the South and an intersectional analysis of gender and class inequalities to highlight contextual complexities currently neglected in responses to COVID-19. We argue that building on both science and local knowledge can help democratise workable solutions for a range of different work, family and employment realities in the Global South. Finally, we propose a research agenda calling for strengthened North-South dialogue to provincialise knowledge, account for differences in histories, locality and resource-availability, and foster greater local participation in policy formulation regarding sanitary measures and vaccination campaigns.
C1 [Jaga, Ameeta] Univ Cape Town, Sch Management Studies, Org Psychol, Cape Town, South Africa.
   [Ollier-Malaterre, Ariane] Univ Quebec Montreal, ESG UQAM, Management, Montreal, PQ, Canada.
RP Jaga, A (corresponding author), Univ Cape Town, Sch Management, Private Bag X3, ZA-7701 Cape Town, South Africa.
EM Ameeta.jaga@uct.ac.za
CR Al-Ali N, 2020, EUR J WOMENS STUD, V27, P333, DOI 10.1177/1350506820943617
   Al-Doghmi N., 2021, RHETORIC SOCIOLINGUI, P235
   Anner Mark, 2020, ABANDONED IMPACT COV
   Azeez EPA, 2021, EURASIAN GEOGR ECON, V62, P93, DOI 10.1080/15387216.2020.1843513
   Bank L, 2020, COVID 19 REVEALS MIG
   Bhan G, 2019, ENVIRON URBAN, V31, P639, DOI 10.1177/0956247818815792
   Broadbent Alex, 2020, CONVERSATION
   Button K, 2018, CURR SOCIOL, V66, P602, DOI 10.1177/0011392118765243
   Chatterjee A., 2020, WIDER WORKING PAPER
   Chaudhuri D., 2021, WHY INEQUALITY IS IN
   Choudhari R, 2020, ASIAN J PSYCHIATR, V54, DOI 10.1016/j.ajp.2020.102254
   Collyer Fran., 2019, KNOWLEDGE GLOBAL POW
   Comaroff J, 2012, ANTHROPOL FORUM, V22, P113, DOI 10.1080/00664677.2012.694169
   Connell R., 2007, SO THEORY
   D'Angelo A, 2020, WORK EMPLOY SOC, V34, P745, DOI 10.1177/0950017020946571
   de Sousa Santos B., 2015, EPISTEMOLOGIES S JUS
   Dzinamarira T, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030250
   Egdell V, 2020, WORK EMPLOY SOC, V34, P937, DOI 10.1177/0950017020909042
   EHRENREICH BARBARA, 2003, GLOBAL WOMAN NANNIES
   Esping-Andersen G., 1990, 3 WORLDS WELFARE CAP
   Fadaee S., 2017, INTERFACE J SOCIAL M, V9, P45
   Federici S., 2004, J ASIAN AFR STUD, V39, P47
   Gallotti M., 2016, MIGRANT DOMESTIC WOR
   Guppy L., 2017, WATER CRISIS REPORT
   Ho H., 2020, IMPACT COVID 19 INFO
   Hodes R, 2018, AJAR-AFR J AIDS RES, V17, P22, DOI 10.2989/16085906.2017.1377267
   ILO, 2020, WORLD EMPL SOC OUTL
   International Labour Organisation (ILO), 2021, GLOB EST INT MIGR WO
   International Labour Organisation (ILO), 2020, GEND IMP COVID 19 GA
   Jaga A., 2014, THESIS U CAPE TOWN S
   Jaga A, 2020, COMMIMITY WORK FAM, V23, P506, DOI 10.1080/13668803.2020.1800591
   Jammulamadaka N, 2020, J BUS ETHICS, V163, P599, DOI 10.1007/s10551-018-4041-9
   Jolly M, 2008, AUST HUMANIT REV, V44, P1
   Kantamneni N, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103439
   Lambert SJ, 2005, LEAS ORG MAN SERIES, P513
   Langlois, 2020, LOGEMENT TRAVAIL VOI
   Lewis S, 2007, INT J HUM RESOUR MAN, V18, P360, DOI 10.1080/09585190601165577
   Lyu HY, 2019, PALGR COMMUN, V5, DOI 10.1057/s41599-019-0302-1
   De Lara AM, 2020, J BIOETHIC INQ, V17, P613, DOI 10.1007/s11673-020-10029-4
   McBride A, 2015, WORK EMPLOY SOC, V29, P331, DOI 10.1177/0950017014538337
   McCarthy L, 2021, HUM RELAT, V74, P2051, DOI 10.1177/0018726720950816
   Milani TM, 2017, J SOCIOLING, V21, P307, DOI 10.1111/josl.12241
   Mitlin D, 2020, DEALING COVID 19 TOW
   Mohanty CT, 2003, SIGNS, V28, P499, DOI 10.1086/342914
   Ndinda, 2018, J INT WOMENS STUDIES, V19, P82
   Ndlovu-Gatsheni SJ, 2020, J DEV SOC, V36, P366, DOI 10.1177/0169796X20963252
   Nyadera IN., 2021, GHJ, V5, P12
   Ollier-Malaterre A, 2017, J MANAGE, V43, P111, DOI 10.1177/0149206316655873
   Perry-Jenkins M, 2017, J FAM THEOR REV, V9, P219, DOI 10.1111/jftr.12188
   Powell GN, 2009, J ORGAN BEHAV, V30, P597, DOI 10.1002/job.568
   Ram M, 2017, INT J SOCIOL SOC POL, V37, P361, DOI 10.1108/IJSSP-06-2016-0075
   Rodriguez V., 2021, ALIGNING PERSPECTIVE, P61
   Roelf W., 2020, REUTERS 0507
   Salamanca JDG, 2020, SPACE CULT, V23, P307, DOI 10.1177/1206331220938626
   Simone A, 2001, INT J URBAN REGIONAL, V25, P102, DOI 10.1111/1468-2427.00300
   Smith C, 2018, WORK EMPLOY SOC, V32, P599, DOI 10.1177/0950017018762276
   van Breda AD, 2020, EMERG ADULTHOOD, V8, P6, DOI 10.1177/2167696819870356
   Waismel-Manor R, 2021, SEX ROLES, V85, P636, DOI 10.1007/s11199-021-01246-1
   Walker M, 2020, CRIT STUD EDUC, DOI 10.1080/17508487.2020.1778052
   Wasdani KP, 2020, LOCAL ENVIRON, V25, P414, DOI 10.1080/13549839.2020.1754375
NR 60
TC 0
Z9 0
U1 1
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0950-0170
EI 1469-8722
J9 WORK EMPLOY SOC
JI Work Employ. Soc.
AR 09500170211069806
DI 10.1177/09500170211069806
EA FEB 2022
PG 12
WC Economics; Industrial Relations & Labor; Sociology
WE Social Science Citation Index (SSCI)
SC Business & Economics; Sociology
GA ZF5NL
UT WOS:000759614400001
OA hybrid
DA 2022-04-20
ER

PT J
AU Hertling, S
   Hertling, D
   Loos, F
   Martin, D
   Graul, I
AF Hertling, Stefan
   Hertling, Doreen
   Loos, Franziska
   Martin, David
   Graul, Isabel
TI Digitization in gynecology and obstetrics in times of COVID-19: Results
   of a national survey
SO INTERNET INTERVENTIONS-THE APPLICATION OF INFORMATION TECHNOLOGY IN
   MENTAL AND BEHAVIOURAL HEALTH
LA English
DT Article
DE Digitization; Telemedicine; Tele-gynecology; Survey; COVID-19
AB Introduction: In the COVID-19 pandemic, many consultations had to be cancelled, postponed, or converted to a virtual format. The use of telemedicine in the management of Women's Health Care could support doctors (telegynecology). This study analyses the use and perception of telemedicine applications among gynecologists in Germany. Materials and methods: This prospective cross-sectional study was based on a survey of gynecologists in Germany during the COVID-19 pandemic. Descriptive statistics were calculated, and regression analyses were performed to show correlations. Results: The gynecologists expect telemedicine to be used in gynecology and obstetrics. 76.4% (365/478) of the respondents rated their knowledge of telemedicine as insufficient. The majority of respondents (437/478, 91.6%) said they did not currently use telemedicine, although 67.3% (321/478) would like to do so. Obstacles to the introduction of telemedicine include the purchase of technical equipment (325/478, 68.1%), administration (305/478, 64.0%) and poor reimbursement (233/478, 48.9%). Gynecologists surveyed would prefer telemedicine to communicate directly with other doctors (388/478, 81.2%) rather than to communicate with patients (228/478, 47.8%). In the treatment phases, 73.2% (349/478) of the respondents would use telemedicine during follow-up. Half of the respondents would choose tele counseling as a specific approach to improving care (246/ 478, 51.5%). Conclusion: Telemedicine in gynecology finds little use but high acceptance. The absence of a structured framework is an obstacle to effective implementation. Training courses should be introduced to improve the limited knowledge in the use of telemedicine. More research in tele-gynecology is needed. These include largescale randomized controlled trials, economic analyses and the exploration of user preferences.
C1 [Hertling, Stefan] Univ Hosp Jena, Dept Obstet & Gynecol, Klinikum 1, D-07747 Jena, Germany.
   [Hertling, Stefan; Graul, Isabel] Univ Hosp Jena, Dept Orthopaed, Campus Eisenberg, Eisenberg, Germany.
   [Hertling, Stefan; Martin, David] Fak Gesundheit, Dept Humanmed, Lehrstuhl Med Theorie Integrat & Anthroposoph Med, Witten, Germany.
   [Hertling, Doreen] Hosp Rummelsberg, Dept Gynecol, Schwarzenbruck, Germany.
   [Graul, Isabel] Univ Hosp Jena, Dept Trauma Hand & Reconstruct Surg, Jena, Germany.
   [Graul, Isabel] Unfall Univ Klinikum Halle, Dept Orthopadie, Halle, Germany.
RP Hertling, S (corresponding author), Univ Hosp Jena, Dept Obstet & Gynecol, Klinikum 1, D-07747 Jena, Germany.
EM stefan.hertling@yahoo.de
OI Hertling, Stefan Ferdinand/0000-0001-5815-7498
CR Campisi G, 2020, MINERVA STOMATOL, V69, P251, DOI 10.23736/S0026-4970.20.04396-4
   Coventry L, 2018, MATURITAS, V113, P48, DOI 10.1016/j.maturitas.2018.04.008
   Crawford A, 2020, J MED INTERNET RES, V22, DOI 10.2196/19361
   Cuffaro L, 2020, NEUROL SCI, V41, P1977, DOI 10.1007/s10072-020-04512-4
   Ebert JF, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.8353
   Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34
   Halatoko WA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242124
   Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x
   Hertling S, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18137110
   Hosseini ES, 2020, VIROLOGY, V551, P1, DOI 10.1016/j.virol.2020.08.011
   Islam T, 2021, SUPPORT CARE CANCER, V29, P2631, DOI 10.1007/s00520-020-05776-4
   Jandoo T, 2020, DIGIT HEALTH, V6, DOI 10.1177/2055207619898984
   Kernder A, 2021, RMD OPEN, V7, DOI 10.1136/rmdopen-2020-001548
   Knitza J, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/17507
   Knitza J, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/14991
   Kritz M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2436
   Krusche M, 2020, Z RHEUMATOL, V79, P554, DOI 10.1007/s00393-020-00822-2
   Kulcsar Z, 2016, SEMIN ARTHRITIS RHEU, V46, P380, DOI 10.1016/j.semarthrit.2016.05.013
   Lowery C, 2020, OBSTET GYN CLIN N AM, V47, P215, DOI 10.1016/j.ogc.2020.02.011
   Mallick R, 2020, FACTS VIEWS VIS OBGY, V12, P7
   Menage J, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4348
   Powley L, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1189-2
   Pullano G, 2020, NATURE, DOI 10.1038/s41586-020-03095-6
   Rommele C, 2020, ANAESTHESIST, V69, P717, DOI 10.1007/s00101-020-00830-6
   Runkle J, 2019, DIGIT HEALTH, V5, DOI 10.1177/2055207619828220
   Samland M, 2020, Z ORTHOP UNFALLCHIR, V158, P577, DOI 10.1055/a-1238-8115
   Seeberger a, 2020, INT J MED EDUC
   Solomon DH, 2020, NAT REV RHEUMATOL, V16, P525, DOI 10.1038/s41584-020-0461-x
   TUROFF M, 1970, TECHNOL FORECAST SOC, V2, P149, DOI 10.1016/0099-3964(70)90004-9
   Uhlig CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108441
   Wooliscroft L, 2020, ANN NEUROL, V88, P658, DOI 10.1002/ana.25840
NR 31
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2214-7829
J9 INTERNET INTERV
JI Internet Interv.
PD DEC
PY 2021
VL 26
AR 100478
DI 10.1016/j.invent.2021.100478
EA NOV 2021
PG 6
WC Psychology, Clinical; Health Care Sciences & Services; Medical
   Informatics; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Psychology; Health Care Sciences & Services; Medical Informatics;
   Psychiatry
GA WZ1ZH
UT WOS:000719771100002
PM 34786351
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ren, TZ
   Cao, LL
   Chin, T
AF Ren, Tianzhou
   Cao, Lele
   Chin, Tachia
TI Crafting Jobs for Occupational Satisfaction and Innovation among
   Manufacturing Workers Facing the COVID-19 Crisis
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; job crafting; occupational satisfaction; innovation; China
ID ENGAGEMENT; CAREER; PERFORMANCE; IMPACT; MEDIATION; PREDICTORS;
   RESOURCES; WORKPLACE; BEHAVIOR; HARMONY
AB China's manufacturing employees are confronted with unprecedent occupational and innovation challenges caused by the ongoing COVID-19 crisis coupled with the pressure of being replaced by digital technologies. To gain a better understanding of the rising occupational uncertainty during this critical time, based on the job demands-resources (JD-R) theory, we examined the associations of employees' job crafting behaviors (JCB) with their occupational satisfaction and innovation workplace behavior (IWB), as well as the mediating effect of work engagement on the above relationships. The final usable data were obtained from the formal survey of 311 employees of six manufacturing companies that have returned to work amid COVID-19. Structural equation modelling was adopted to analyze the data. Results show that employees' JCB strengthens their occupational satisfaction and IWB via work engagement. Theoretically, our research enriches the existing body of knowledge about JCB from a cross-disciplinary angle integrating the perspectives of career and psychology. Practically, we offer valuable first-hand evidence about how manufacturing employees conducted JCB to re-orient their careers and to innovate in the face of the high unemployment situation.
C1 [Ren, Tianzhou; Cao, Lele; Chin, Tachia] Zhejiang Univ Technol, Sch Management, Hangzhou 310023, Peoples R China.
RP Chin, T (corresponding author), Zhejiang Univ Technol, Sch Management, Hangzhou 310023, Peoples R China.
EM rentianzhou@zjut.edu.cn; caolele1028@163.com; tachiachin@zjut.edu.cn
OI Chin, Tachia/0000-0001-5793-7847; cao, lele/0000-0003-2481-1783
FU National Social Science Fund of China [17CSH026]; Social Science
   Research Project of the Ministry of Education of ChinaMinistry of
   Education, China [15YJCZH134]
FX This study was supported by the National Social Science Fund of China
   (No. 17CSH026), and the Social Science Research Project of the Ministry
   of Education of China (15YJCZH134).
CR Abbas M, 2015, CAN J ADM SCI, V32, P128, DOI 10.1002/cjas.1314
   Akkermans J, 2017, APPL PSYCHOL-INT REV, V66, P168, DOI 10.1111/apps.12082
   Bakker AB, 2004, HUM RESOUR MANAGE-US, V43, P83, DOI 10.1002/hrm.20004
   Bakker AB, 2012, HUM RELAT, V65, P1359, DOI 10.1177/0018726712453471
   Bindl UK, 2019, J APPL PSYCHOL, V104, P605, DOI 10.1037/apl0000362
   Brenninkmeijer V, 2015, CAREER DEV INT, V20, P147, DOI 10.1108/CDI-12-2014-0162
   BRISLIN RW, 1986, INT J INTERCULT REL, V10, P215, DOI 10.1016/0147-1767(86)90007-6
   Bruning PF, 2018, ACAD MANAGE J, V61, P499, DOI 10.5465/amj.2015.0604
   Caesens G, 2014, CAREER DEV INT, V19, P813, DOI 10.1108/CDI-09-2013-0114
   Chan AHS, 2004, IND MANAGE DATA SYST, V104, P430, DOI 10.1108/02635570410537516
   Chan AHS, 2010, INT J IND ERGONOM, V40, P689, DOI 10.1016/j.ergon.2010.05.002
   Chin T, 2018, FUTURE OF CHINESE MANUFACTURING: EMPLOYMENT AND LABOUR CHALLENGES, P1
   Chin TC, 2019, CAREER DEV INT, V24, P509, DOI 10.1108/CDI-02-2019-0034
   Chin T, 2019, CAREER DEV INT, V24, P397, DOI 10.1108/CDI-09-2019-331
   Chin T, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11051438
   Chin T, 2015, INT J HUM RESOUR MAN, V26, P1110, DOI 10.1080/09585192.2014.934882
   Chin TC, 2014, CROSS CULT MANAG, V21, P326, DOI 10.1108/CCM-05-2012-0038
   Cullinane SJ, 2017, EUR J WORK ORGAN PSY, V26, P541, DOI 10.1080/1359432X.2017.1320280
   Demerouti E, 2015, J VOCAT BEHAV, V91, P87, DOI 10.1016/j.jvb.2015.09.001
   Esteves T, 2017, J CAREER DEV, V44, P34, DOI 10.1177/0894845316633789
   Garcia-Buades E, 2016, EUR J WORK ORGAN PSY, V25, P597, DOI 10.1080/1359432X.2016.1171752
   GREENHAUS JH, 1990, ACAD MANAGE J, V33, P64, DOI 10.2307/256352
   Hakanen JJ, 2018, J OCCUP HEALTH PSYCH, V23, P289, DOI 10.1037/ocp0000081
   Hammond MM, 2011, PSYCHOL AESTHET CREA, V5, P90, DOI 10.1037/a0018556
   Hayes AF, 2010, MULTIVAR BEHAV RES, V45, P627, DOI 10.1080/00273171.2010.498290
   Joo BK, 2017, EVID-BASED HRM, V5, P206, DOI 10.1108/EBHRM-04-2015-0011
   JUDGE TA, 1995, PERS PSYCHOL, V48, P485, DOI 10.1111/j.1744-6570.1995.tb01767.x
   Karatepe OM, 2017, J AIR TRANSP MANAG, V62, P34, DOI 10.1016/j.jairtraman.2017.02.005
   Lazazzara A., 2020, J VOCAT BEHAV, V116, P1, DOI [10.1016/j.jvb.2019.01.001, DOI 10.1016/J.JVB.2019.01.001, DOI 10.31234/OSF.IO/A9WF7]
   Lee Y, 2016, HUM RESOUR DEV REV, V15, P29, DOI 10.1177/1534484316628356
   Lichtenthaler PW, 2019, EUR J WORK ORGAN PSY, V28, P30, DOI 10.1080/1359432X.2018.1527767
   MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83
   Petrou P, 2017, J OCCUP ORGAN PSYCH, V90, P129, DOI 10.1111/joop.12160
   Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452
   PODSAKOFF PM, 1986, J MANAGE, V12, P531, DOI 10.1177/014920638601200408
   Rudolph CW, 2017, J VOCAT BEHAV, V102, P112, DOI 10.1016/j.jvb.2017.05.008
   Schaufeli WB, 2006, EDUC PSYCHOL MEAS, V66, P701, DOI 10.1177/0013164405282471
   Shin Y, 2020, INT J HUM RESOUR MAN, V31, P1417, DOI 10.1080/09585192.2017.1407352
   Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422
   Sobel M.E., 1982, SOCIOLOGICAL METHODO, V13, P290, DOI DOI 10.2307/270723
   Sulea C, 2012, CAREER DEV INT, V17, P188, DOI 10.1108/13620431211241054
   Suliman A, 2013, J MANAG DEV, V32, P945, DOI 10.1108/JMD-03-2012-0037
   Tims M, 2013, GROUP ORGAN MANAGE, V38, P427, DOI 10.1177/1059601113492421
   Tims M, 2012, J VOCAT BEHAV, V80, P173, DOI 10.1016/j.jvb.2011.05.009
   van den Heuvel M, 2015, J OCCUP ORGAN PSYCH, V88, P511, DOI 10.1111/joop.12128
   Van der Vegt GS, 2003, J MANAGE, V29, P729, DOI 10.1016/S0149-2063(03)00033-3
   Van Wingerden J, 2017, HUM RESOUR MANAGE-US, V56, P51, DOI 10.1002/hrm.21758
   Vincent-Hoper S, 2012, CAREER DEV INT, V17, P663, DOI 10.1108/13620431211283805
   Wang CH, 2020, J KNOWL MANAG, V24, P301, DOI 10.1108/JKM-04-2019-0198
   Wrzesniewski A, 2001, ACAD MANAGE REV, V26, P179, DOI 10.2307/259118
   Xu XH, 2019, J OCCUP ORGAN PSYCH, V92, P848, DOI 10.1111/joop.12277
   XU ZH, 2020, SUSTAINABILITY-BASEL, V12, DOI DOI 10.3390/su12052041
   Zeijen MEL, 2018, HUM RESOUR MANAG J, V28, P357, DOI 10.1111/1748-8583.12187
   Zhang FF, 2019, J ORGAN BEHAV, V40, P126, DOI 10.1002/job.2332
NR 54
TC 15
Z9 15
U1 12
U2 30
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUN
PY 2020
VL 17
IS 11
AR 3953
DI 10.3390/ijerph17113953
PG 12
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA MB5FY
UT WOS:000542629600206
PM 32503169
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ma, LL
   Li, BH
   Jin, YH
   Deng, T
   Ren, XQ
   Zeng, XT
AF Ma, Lin-Lu
   Li, Bui-Hui
   Jin, Ying-Hui
   Deng, Tong
   Ren, Xue-Qun
   Zeng, Xian-Tao
TI Developments, Evolution, and Implications of National Diagnostic
   Criteria for COVID-19 in China
SO FRONTIERS IN MEDICINE
LA English
DT Article
DE COVID-19; SARS-CoV-2; 2019-nCoV; diagnosis; guideline
AB Recently WHO has characterized COVID-19 as a pandemic. Diagnosing the disease accurately and decreasing misdiagnoses and missed diagnoses is very important for management. Therefore, we have analyzed the seven versions of China's national guidelines to examine how the diagnostic criteria roadmap has developed and evolved, in order to share our experience worldwide. In this article, we present the developments from the first to seventh versions, involving changes of case classification, changes to "suspected case," changes in "confirmed case," changes in clinical classifications, changes in "severe case," and unchanged criteria. We have also discussed the reasons and implications for these changes and are looking forward to providing suggestions for worldwide understanding and management of this pandemic. A nucleic acid test is currently accepted as the gold standard method to confirm diagnosis. In addition, imaging examination and epidemiological history should also be considered as auxiliary diagnosis methods.
C1 [Ma, Lin-Lu; Li, Bui-Hui; Jin, Ying-Hui; Zeng, Xian-Tao] Wuhan Univ, Ctr Evidence Based & Translat Med, Zhongnan Hosp, Wuhan, Peoples R China.
   [Li, Bui-Hui; Deng, Tong; Ren, Xue-Qun] Henan Univ, Inst Evidence Based Med & Knowledge Translat, Kaifeng, Peoples R China.
RP Zeng, XT (corresponding author), Wuhan Univ, Ctr Evidence Based & Translat Med, Zhongnan Hosp, Wuhan, Peoples R China.; Ren, XQ (corresponding author), Henan Univ, Inst Evidence Based Med & Knowledge Translat, Kaifeng, Peoples R China.
EM zengxiantao1128@163.com
FU National Key Research and Development Program of China [2020YFC0845500];
   Special Project for Emergency Science and Technology of Hubei Province
   [2020FCA008]
FX This study was supported, in part, by the National Key Research and
   Development Program of China (2020YFC0845500) and the Special Project
   for Emergency Science and Technology of Hubei Province (2020FCA008).
CR Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Chan JFW, 2020, J CLIN MICROBIOL, V58, DOI [10.1128/JCM.00310-20, 10.1128/JCM.00310-20.]
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   Huang J, 2020, NEW MED, V30, P10, DOI DOI 10.12173/j.issn.1004-5511.2020.01.05
   Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6
   Lan L, 2020, JAMA-J AM MED ASSOC, V323, P1502, DOI 10.1001/jama.2020.2783
   Lo RSL, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010061
   Lu Z, 2020, YIXUE XINZHI, V30, P7, DOI DOI 10.12173/j.issn.1004-5511.2020.01.04
   National Health Commission of the People's Republic of China, 2020, FEB 13 DAIL BRIEF NO
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Tsang TK, 2020, LANCET PUBLIC HEALTH, V5, pE289, DOI 10.1016/S2468-2667(20)30089-X
   Phan T, 2020, INFECT GENET EVOL, V81, DOI 10.1016/j.meegid.2020.104260
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   WHO, 2020, WHO CHARACTERIZES CO
   Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
NR 17
TC 6
Z9 8
U1 1
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-858X
J9 FRONT MED-LAUSANNE
JI Front. Med.
PD MAY 15
PY 2020
VL 7
AR 242
DI 10.3389/fmed.2020.00242
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA LV4CX
UT WOS:000538386500001
PM 32574333
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Contini, C
   Caselli, E
   Martini, F
   Maritati, M
   Torreggiani, E
   Seraceni, S
   Vesce, F
   Perri, P
   Rizzo, L
   Tognon, M
AF Contini, Carlo
   Caselli, Elisabetta
   Martini, Fernanda
   Maritati, Martina
   Torreggiani, Elena
   Seraceni, Silva
   Vesce, Fortunato
   Perri, Paolo
   Rizzo, Leonzio
   Tognon, Mauro
TI COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent
   Public Health Interventions
SO MICROORGANISMS
LA English
DT Review
DE SARS-CoV-2; COVID-19; cytokine storm syndrome; COVID-19 planet;
   hyperinflammation; endothelitis; thromboembolism
ID RESPIRATORY SYNDROME CORONAVIRUS; MERS-COV; DROMEDARY CAMELS; SARS;
   PATHOGENESIS; SARS-COV-2; ENTRY; INFECTIONS; MECHANISMS; DIAGNOSIS
AB Until less than two decades ago, all known human coronaviruses (CoV) caused diseases so mild that they did not stimulate further advanced CoV research. In 2002 and following years, the scenario changed dramatically with the advent of the new more pathogenic CoVs, including Severe Acute Respiratory Syndome (SARS-CoV-1), Middle Eastern respiratory syndrome (MERS)-CoV, and the new zoonotic SARS-CoV-2, likely originated from bat species and responsible for the present coronavirus disease (COVID-19), which to date has caused 15,581,007 confirmed cases and 635,173 deaths in 208 countries, including Italy. SARS-CoV-2 transmission is mainly airborne via droplets generated by symptomatic patients, and possibly asymptomatic individuals during incubation of the disease, although for the latter, there are no certain data yet. However, research on asymptomatic viral infection is currently ongoing worldwide to elucidate the real prevalence and mortality of the disease. From a clinical point of view, COVID-19 would be defined as "COVID Planet " because it presents as a multifaceted disease, due to the large number of organs and tissues infected by the virus. Overall, based on the available published data, 80.9% of patients infected by SARS-CoV-2 develop a mild disease/infection, 13.8% severe pneumonia, 4.7% respiratory failure, septic shock, or multi-organ failure, and 3% of these cases are fatal, but mortality parameter is highly variable in different countries. Clinically, SARS-CoV-2 causes severe primary interstitial viral pneumonia and a "cytokine storm syndrome", characterized by a severe and fatal uncontrolled systemic inflammatory response triggered by the activation of interleukin 6 (IL-6) with development of endothelitis and generalized thrombosis that can lead to organ failure and death. Risk factors include advanced age and comorbidities including hypertension, diabetes, and cardiovascular disease. Virus entry occurs via binding the angiotensin-converting enzyme 2 (ACE2) receptor present in almost all tissues and organs through the Spike (S) protein. Currently, SARS-CoV-2 infection is prevented by the use of masks, social distancing, and improved hand hygiene measures. This review summarizes the current knowledge on the main biological and clinical features of the SARS-CoV-2 pandemic, also focusing on the principal measures taken in some Italian regions to face the emergency and on the most important treatments used to manage the COVID-19 pandemic.
C1 [Contini, Carlo; Martini, Fernanda; Torreggiani, Elena; Tognon, Mauro] Univ Ferrara, Dept Med Sci, Pathol Oncol & Expt Biol Sect, Infect Dis & Dermatol Sect, I-44124 Ferrara, Italy.
   [Caselli, Elisabetta] Univ Ferrara, Dept Chem & Pharmaceut Sci, Microbiol Sect, I-44124 Ferrara, Italy.
   [Maritati, Martina] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44124 Ferrara, Italy.
   [Seraceni, Silva] Rete Diagnost Italiana Srl, RDI, Lifebrain Grp, I-35010 Padua, Italy.
   [Vesce, Fortunato] Univ Ferrara, Obstet & Gynecol Sect, Dept Morphol Surg & Expt Med, I-44124 Ferrara, Italy.
   [Perri, Paolo] Univ Ferrara, Dept Biomed Sci & Surg Specialties, I-44124 Ferrara, Italy.
   [Perri, Paolo] Univ Ferrara, Ophthalmol Sect, I-44124 Ferrara, Italy.
   [Rizzo, Leonzio] Univ Ferrara, Dept Econ & Management, I-44124 Ferrara, Italy.
RP Contini, C (corresponding author), Univ Ferrara, Dept Med Sci, Pathol Oncol & Expt Biol Sect, Infect Dis & Dermatol Sect, I-44124 Ferrara, Italy.
EM cnc@unife.it; elisabetta.caselli@unife.it; fernanda.martini@unife.it;
   mrtmtn@unife.it; trrine@unife.it; silva.seraceni@lifebrain.it;
   fortunato.vesce@unife.it; paolo.perri@unife.it; leonzio.rizzo@unife.it;
   tgm@unife.it
RI Contini, Carlo/AAJ-3084-2021; Maritati, Martina/AAI-7273-2021; Caselli,
   Elisabetta/H-1513-2012; Torreggiani, Elena/J-6404-2016
OI Contini, Carlo/0000-0001-8809-6470; Maritati,
   Martina/0000-0002-9938-8492; Caselli, Elisabetta/0000-0001-6048-9141;
   Torreggiani, Elena/0000-0001-7874-2002
CR Mim MA, 2020, PATHOG GLOB HEALTH, V114, P168, DOI 10.1080/20477724.2020.1765651
   Ahmed SF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030254
   Ahn DG, 2020, J MICROBIOL BIOTECHN, V30, P313, DOI 10.4014/jmb.2003.03011
   Alnaeem Abdelmohsen, 2020, Virusdisease, V31, P200, DOI 10.1007/s13337-020-00586-y
   [Anonymous], 2020, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD013600
   [Anonymous], 2020, NAT MED 0618
   Badawi A, 2016, INT J INFECT DIS, V49, P129, DOI 10.1016/j.ijid.2016.06.015
   Benvenuto D, 2020, J MED VIROL, V92, P455, DOI 10.1002/jmv.25688
   Bozkurt B, 2020, TURK OFTALMOL DERG, V50, P59, DOI 10.4274/tjo.galenos.2020.29805
   Brenner SR, 2020, MED HYPOTHESES, V140, DOI 10.1016/j.mehy.2020.109773
   Broughton JP, 2020, NAT BIOTECHNOL, V38, P870, DOI 10.1038/s41587-020-0513-4
   BURKS JS, 1980, SCIENCE, V209, P933, DOI 10.1126/science.7403860
   Calderaro A, 2020, INT J INFECT DIS, V96, P387, DOI 10.1016/j.ijid.2020.05.035
   Cao G.W, 2020, ZHONGHUA LIU XING BI, V41, P1
   Capobianchi MR, 2020, CLIN MICROBIOL INFEC, V26, P954, DOI 10.1016/j.cmi.2020.03.025
   Carod-Artal FJ, 2020, REV NEUROLOGIA, V70, P311, DOI 10.33588/rn.7009.2020179
   Carter LJ, 2020, ACS CENTRAL SCI, V6, P591, DOI 10.1021/acscentsci.0c00501
   Chen JL, 2020, MICROBES INFECT, V22, P69, DOI 10.1016/j.micinf.2020.01.004
   Chen L, 2020, LANCET INFECT DIS, V20, P398, DOI 10.1016/S1473-3099(20)30141-9
   Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941
   Contini C, 2020, COSA SERVONO 1 TAMPO
   Contini C, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.109876
   Contini C, 2020, J INFECT DEV COUNTR, V14, P254, DOI 10.3855/jidc.12671
   Contini Carlo, 2007, Future Microbiol, V2, P373, DOI 10.2217/17460913.2.4.373
   Corman VM, 2015, J VIROL, V89, P11858, DOI 10.1128/JVI.01755-15
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   De Biasi S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17292-4
   Deslandes A, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.106006
   Di Napoli R, 2020, FEATURES EVALUATION
   Ding YQ, 2004, J PATHOL, V203, P622, DOI 10.1002/path.1560
   Eccles R, 2005, LANCET INFECT DIS, V5, P718, DOI 10.1016/S1473-3099(05)70270-X
   Enjuanes L, 2016, ADV VIRUS RES, V96, P245, DOI 10.1016/bs.aivir.2016.08.003
   European Commission Directorate General for Health and Food Safety, DIR GEN HLTH FOOD SA
   Ferner RE, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1610
   Fu JW, 2020, MOL BIOL REP, V47, P4383, DOI 10.1007/s11033-020-05478-4
   Furuta Y, 2017, P JPN ACAD B-PHYS, V93, P449, DOI 10.2183/pjab.93.027
   Goubar A, 2009, EPIDEMIOL INFECT, V137, P1019, DOI 10.1017/S0950268808001635
   Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020
   Guggemos, 2020, NATURE          0401, V581, DOI [10.1038/s41586-020-2196-x, DOI 10.1038/s41586-020-2196-x]
   Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X
   Hoehl S, 2020, NEW ENGL J MED, V382, P1278, DOI 10.1056/NEJMc2001899
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6
   Joung Julia, 2020, medRxiv, DOI 10.1101/2020.05.04.20091231
   Kampf G, 2020, J HOSP INFECT, V105, P587, DOI [10.1016/j.jhin.2020.01.022, 10.1016/j.jhin.2020.06.001]
   Kasraeian M, 2022, J MATERN-FETAL NEO M, V35, P1652, DOI 10.1080/14767058.2020.1763952
   Kucirka L.M, 2020, ANN INT MED, DOI [10.7326/M20-1495, DOI 10.7326/M20-149532422057]
   Lam TTY, 2020, NATURE, V583, P282, DOI 10.1038/s41586-020-2169-0
   Lavezzo E, 2020, NATURE, V584, P425, DOI 10.1038/s41586-020-2488-1
   Lescure FX, 2020, LANCET INFECT DIS, V20, P697, DOI 10.1016/S1473-3099(20)30200-0
   Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728
   Ling Y, 2020, CHINESE MED J-PEKING, V133, P1039, DOI 10.1097/CM9.0000000000000774
   Liu ZX, 2020, J MED VIROL, V92, P595, DOI 10.1002/jmv.25726
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270
   Matthai J, 2020, INDIAN PEDIATR, V57, P533, DOI 10.1007/s13312-020-1851-5
   McINTOSH K., 1974, Current Topics in Microbiology and Immunology, P85
   Mehta P, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01919-2020
   Messacar K, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0018-2016
   Meulen V, 1984, ADV EXP MED BIOL, V173, P227
   Miller R, 2020, CLIN J MED, DOI [10.3949/ccjm.87a.ccc013, DOI 10.3949/CCJM.87A.CCC01332371564]
   Nicholls J, 2003, RESPIROLOGY, V8, pS6, DOI 10.1046/j.1440-1843.2003.00517.x
   Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224
   Qing HL, 2020, ACTA OPHTHALMOL, V98, pE388, DOI 10.1111/aos.14412
   Ramadan N, 2019, GERMS, V9, P35, DOI 10.18683/germs.2019.1155
   Ramesh N, 2020, INDIAN J OCCUP ENVIR, V24, P16, DOI 10.4103/ijoem.IJOEM_49_20
   RESTA S, 1985, SCIENCE, V229, P978, DOI 10.1126/science.2992091
   Riordan JF, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-225
   Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Ruscitti P, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102562
   Scangas GA, 2017, AM J RHINOL ALLERGY, V31, pE3, DOI 10.2500/ajra.2017.31.4403
   Schwartz DA, 2020, ARCH PATHOL LAB MED, V144, P799, DOI 10.5858/arpa.2020-0901-SA
   Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117
   Song ZQ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010059
   Stebbing J, 2020, LANCET INFECT DIS, V20, P400, DOI 10.1016/S1473-3099(20)30132-8
   Stowell SR, 2020, CLIN INFECT DIS, V71, P1935, DOI 10.1093/cid/ciaa510
   Sullivan HC, 2020, TRANSFUS MED REV, V34, P145, DOI 10.1016/j.tmrv.2020.04.001
   Van Bever HP, 2004, PEDIAT ALLERG IMM-UK, V15, P206, DOI 10.1111/j.1399-3038.2004.00137.x
   van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12
   Vivanti AJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17436-6
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20
   Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15
   Wang HH, 2020, EUR J CLIN MICROBIOL, V39, P1629, DOI 10.1007/s10096-020-03899-4
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005
   WENZEL RP, 1974, AM REV RESPIR DIS, V109, P621
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   Wong SH, 2020, J GASTROEN HEPATOL, V35, P744, DOI 10.1111/jgh.15047
   World Health Organization, 2003, CONS DOC EP SEV AC R
   World Health Organization, COR DIS COVID 19 OUT
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xia JH, 2020, J MED VIROL, V92, P589, DOI 10.1002/jmv.25725
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhai SL, 2020, VET REC, V186, DOI 10.1136/vr.m740
   Zhang NR, 2020, J MED VIROL, V92, P408, DOI 10.1002/jmv.25674
   Zhang SY, 2020, CLIN DRUG INVEST, V40, P511, DOI 10.1007/s40261-020-00917-3
   Zhu JF, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00176
NR 105
TC 16
Z9 16
U1 1
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-2607
J9 MICROORGANISMS
JI Microorganisms
PD AUG
PY 2020
VL 8
IS 8
AR 1228
DI 10.3390/microorganisms8081228
PG 21
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA NH6MD
UT WOS:000564781600001
PM 32806657
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Zhang, P
   Zhang, Q
   Guan, HW
   Fan, KS
   Bi, XJ
   Huang, YM
   Liang, LB
   Khoso, AR
   Xu, XX
   Ma, Y
   Hao, YH
   Wu, QH
AF Zhang, Peng
   Zhang, Qiao
   Guan, Hanwen
   Fan, Kaisheng
   Bi, Xuejing
   Huang, Yangmu
   Liang, Libo
   Khoso, Abdul Rahman
   Xu, Xiaoxue
   Ma, Yi
   Hao, Yanhua
   Wu, Qunhong
TI Who is more likely to hesitate to accept COVID-19 vaccine: a
   cross-sectional survey in China
SO EXPERT REVIEW OF VACCINES
LA English
DT Article
DE COVID-19; China; vaccination; vaccine hesitancy; vaccine willingness;
   vaccine acceptance
ID INFLUENZA VACCINATION; HEALTH-CARE; IMMUNIZATION; INTENTION; REFUSAL;
   IMPACT; RISK
AB Background The aim of our study was to identify factors associated with coronavirus disease 2019 (COVID-19)vaccine willingness in China to aid future public health actions to improve vaccination. Research Design and Methods This study was conducted in August 2020 using a mixed-method approach, including a cross-sectional self-administered anonymous questionnaire survey and in-depth interviews with community residents in China. Results Of the participants, 30.9% showedCOVID-19 vaccine hesitancy. Being female(OR = 1.297), having poor health(OR = 1.312), having non-health or medical-related occupations (OR = 1.129), no COVID-19 infection experience(OR = 1.523), living with vulnerable family members(OR = 1.294), less knowledge(OR = 1.371), less attention to COVID-19 information(OR = 1.430), less trust in official media(OR = 1.336), less perceived susceptibility to COVID-19(OR = 1.367), and less protective behavior(OR = 1.195) were more likely to hesitate. Qualitative research has shown that they doubt the importance and necessity, as well as the effectiveness and safety of the vaccination. The economic and service accessibility of the vaccination was an impediment to their vaccine acceptance. Conclusion Nearly one-thirdof people showed hesitancy to accept COVID-19 vaccination in China. Our findings highlight that health communication and publicity should be performed for the targeted population, and immunization programs should be designed to remove underlying barriers to vaccine uptake.
C1 [Zhang, Peng; Zhang, Qiao; Guan, Hanwen; Fan, Kaisheng; Bi, Xuejing; Liang, Libo; Khoso, Abdul Rahman; Xu, Xiaoxue; Ma, Yi; Hao, Yanhua; Wu, Qunhong] Harbin Med Univ, Sch Hlth Management, Harbin, Heilongjiang, Peoples R China.
   [Huang, Yangmu] Peking Univ, Sch Publ Hlth, Beijing, Peoples R China.
RP Hao, YH; Wu, QH (corresponding author), Harbin Med Univ, Sch Hlth Management, Harbin, Heilongjiang, Peoples R China.
EM hyhyjw@126.com; wuqunhong@163.com
FU National Natural Scientific Fund of ChinaNational Natural Science
   Foundation of China (NSFC) [71673072, 72042001]
FX This study was funded by the National Natural Scientific Fund of China
   (71673072, 72042001). Funding body had no influence on the study design,
   data collection, data analysis, data interpretation, or writing of the
   manuscript.
CR Andrew MK, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1180-5
   Bacon SL, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-046127
   Barello S, 2020, EUR J EPIDEMIOL, V35, P781, DOI 10.1007/s10654-020-00670-z
   Batniji R, 2021, LANCET, V397, P791, DOI [10.1016/S0140-6736(21)00190-2, 10.1016/S0140-6736(21)00267-1]
   Betsch C, 2010, J HEALTH PSYCHOL, V15, P446, DOI 10.1177/1359105309353647
   Binagwaho A, 2022, INT J HEALTH POLICY, V11, P100, DOI 10.34172/ijhpm.2021.49
   Casciotti DM, 2014, J ADOLESCENCE, V37, P133, DOI 10.1016/j.adolescence.2013.11.004
   Caserotti M, 2021, SOC SCI MED, V272, DOI 10.1016/j.socscimed.2021.113688
   Catalan-Matamoros D, 2017, REV ESP COMUN SALUD, V8, P114, DOI 10.20318/recs.2017.3995
   Cella Paola, 2020, J Prev Med Hyg, V61, pE340, DOI 10.15167/2421-4248/jpmh2020.61.3.1448
   Cho J, 2006, J BUS RES, V59, P112, DOI 10.1016/j.jbusres.2005.03.006
   Colombo SA., BBC
   Dai Y.J., 2020, CHIN J PUBLIC HLTH, V36, P227
   Di Giuseppe G, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030275
   Dongmei X, 2005, BEIJING U NAT SCI, V41, P628
   Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y
   Dube E, 2018, EXPERT REV VACCINES, V17, P989, DOI 10.1080/14760584.2018.1541406
   Dube E, 2015, EXPERT REV VACCINES, V14, P99, DOI 10.1586/14760584.2015.964212
   Dube E, 2013, HUM VACC IMMUNOTHER, V9, P1763, DOI 10.4161/hv.24657
   ECDC, VACC HES HEALTHC WOR
   Edwards B, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248892
   Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x
   Fabinyi M, 2012, ENVIRON CONSERV, V39, P83, DOI 10.1017/S0376892911000609
   Finucane ML, 2000, J BEHAV DECIS MAKING, V13, P1, DOI 10.1002/(SICI)1099-0771(200001/03)13:1<1::AID-BDM333>3.0.CO;2-S
   Frank K., CANADIANS WILLINGNES
   Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932
   Gualano MR, 2019, HUM VACC IMMUNOTHER, V15, P918, DOI 10.1080/21645515.2018.1564437
   Gualano MR, 2021, VACCINE, V39, P901, DOI 10.1016/j.vaccine.2020.12.061
   Halvorsen K, 2020, PATIENT EDUC COUNS, V103, P1263, DOI 10.1016/j.pec.2020.02.017
   Harrison EA, 2020, EUR J EPIDEMIOL, V35, P325, DOI 10.1007/s10654-020-00634-3
   Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012
   KASPERSON RE, 1992, J SOC ISSUES, V48, P161, DOI 10.1111/j.1540-4560.1992.tb01950.x
   Kim Chanwon, 2017, Crisisonomy, V13, P85, DOI 10.14251/crisisonomy.2017.13.6.85
   Lane S, 2018, VACCINE, V36, P3861, DOI 10.1016/j.vaccine.2018.03.063
   Leask J, 2014, HUM VACC IMMUNOTHER, V10, P2600, DOI 10.4161/hv.29725
   Lindell M.K., 1992, BEHAV FDN COMMUNITY
   Lucia VC, 2021, J PUBLIC HEALTH-UK, V43, P445, DOI 10.1093/pubmed/fdaa230
   MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036
   McClure CC, 2017, CLIN THER, V39, P1550, DOI 10.1016/j.clinthera.2017.07.003
   Moran MB, 2016, PATIENT EDUC COUNS, V99, P147, DOI 10.1016/j.pec.2015.08.016
   Murphy J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20226-9
   Neufeind J, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10563-9
   Neumann-Bohme S, 2020, EUR J HEALTH ECON, V21, P977, DOI 10.1007/s10198-020-01208-6
   Ning LW, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09892-y
   Omoleke S.A., 2020, SAHEL MED J, V23, P126, DOI [10.4103/smj.smj_32_18, DOI 10.4103/SMJ.SMJ_32_18]
   Papagiannis D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144925
   Peretti-Watel P, 2020, LANCET INFECT DIS, V20, P769, DOI 10.1016/S1473-3099(20)30426-6
   Puri N, 2020, HUM VACC IMMUNOTHER, V16, P2586, DOI 10.1080/21645515.2020.1780846
   Ridgeway C.L., 2001, INT ENCY SOCIAL BEHA, P14185, DOI [10.1016/B0-08-043076-7/03999-1, DOI 10.1016/B0-08-043076-7/03999-1]
   Rodriguez SA, 2020, PREV MED, V131, DOI 10.1016/j.ypmed.2019.105968
   Sadaf A, 2013, VACCINE, V31, P4293, DOI 10.1016/j.vaccine.2013.07.013
   Salali Gul Deniz, 2020, Psychol Med, P1, DOI 10.1017/S0033291720004067
   Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020160
   Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010042
   Sherman SM, 2021, HUM VACC IMMUNOTHER, V17, P1612, DOI 10.1080/21645515.2020.1846397
   Ullah I, 2021, Vacunas, V22, P93, DOI 10.1016/j.vacun.2021.01.001
   Usami T, 2009, YAKUGAKU ZASSHI, V129, P1063, DOI 10.1248/yakushi.129.1063
   Wang KL, 2020, VACCINE, V38, P7049, DOI 10.1016/j.vaccine.2020.09.021
   Wang XM, 2018, J HEALTH COMMUN, V23, P413, DOI 10.1080/10810730.2018.1455771
   Weinstein ND, 2007, HEALTH PSYCHOL, V26, P146, DOI 10.1037/0278-6133.26.2.146
   Wilson L, 2018, VACCINE, V36, P1055, DOI 10.1016/j.vaccine.2018.01.025
   Yamey G, 2020, LANCET, V395, P1405, DOI 10.1016/S0140-6736(20)30763-7
   Yoda T, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010048
   Yurttas B, 2021, RHEUMATOL INT, V41, P1105, DOI 10.1007/s00296-021-04841-3
   Zhaobin L., 2020, MED DIET THER HLTH, V20, P12
   Zheng W, 2019, PROG MICROBIOL IMMUN, V47, P74
NR 66
TC 0
Z9 0
U1 15
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-0584
EI 1744-8395
J9 EXPERT REV VACCINES
JI Expert Rev. Vaccines
PD MAR 4
PY 2022
VL 21
IS 3
BP 397
EP 406
DI 10.1080/14760584.2022.2019581
EA JAN 2022
PG 10
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Immunology
GA ZJ3WU
UT WOS:000739690100001
PM 34961405
OA hybrid
DA 2022-04-20
ER

PT J
AU Houlding, E
   Mate, KKV
   Engler, K
   Ortiz-Paredes, D
   Pomey, MP
   Cox, J
   Hijal, T
   Lebouche, B
AF Houlding, Elizabeth
   Mate, Kedar K. V.
   Engler, Kim
   Ortiz-Paredes, David
   Pomey, Marie-Pascale
   Cox, Joseph
   Hijal, Tarek
   Lebouche, Bertrand
TI Barriers to Use of Remote Monitoring Technologies Used to Support
   Patients With COVID-19: Rapid Review
SO JMIR MHEALTH AND UHEALTH
LA English
DT Review
DE remote monitoring; technology; COVID-19; telehealth; asynchronous
   technology; synchronous technology; mHealth; monitoring; review;
   barrier; benefit; equity
ID MANAGEMENT
AB Background: The COVID-19 pandemic has acted as a catalyst for the development and adoption of a broad range of remote monitoring technologies (RMTs) in health care delivery. It is important to demonstrate how these technologies were implemented during the early stages of this pandemic to identify their application and barriers to adoption, particularly among vulnerable populations. Objective: The purpose of this knowledge synthesis was to present the range of RMTs used in delivering care to patients with COVID-19 and to identify perceived benefits of and barriers to their use. The review placed a special emphasis on health equity considerations. Methods: A rapid review of published research was conducted using Embase, MEDLINE, and QxMD for records published from the inception of COVID-19 (December 2019) to July 6, 2020. Synthesis involved content analysis of reported benefits of and barriers to the use of RMTs when delivering health care to patients with COVID-19, in addition to health equity considerations. Results: Of 491 records identified, 48 publications that described 35 distinct RMTs were included in this review. RMTs included use of existing technologies (eg, videoconferencing) and development of new ones that have COVID-19-specific applications. Content analysis of perceived benefits generated 34 distinct codes describing advantages of RMTs, mapped to 10 themes overall. Further, 52 distinct codes describing barriers to use of RMTs were mapped to 18 themes. Prominent themes associated with perceived benefits included a lower burden of care (eg, for hospitals, health care practitioners; 28 records), reduced infection risk (n=33), and support for vulnerable populations (n=14). Prominent themes reflecting barriers to use of RMTs included equity-related barriers (eg, affordability of technology for users, poor internet connectivity, poor health literacy; n=16), the need for quality "best practice" guidelines for use of RMTs in clinical care (n=12), and the need for additional resources to develop and support new technologies (n=11). Overall, 23 of 48 records commented on equity characteristics that stratify health opportunities and outcomes, including general characteristics that vary over time (eg, age, comorbidities; n=17), place of residence (n=11), and socioeconomic status (n=7). Conclusions: Results of this rapid review highlight the breadth of RMTs being used to monitor and inform treatment of COVID-19, the potential benefits of using these technologies, and existing barriers to their use. Results can be used to prioritize further efforts in the implementation of RMTs (eg, developing "best practice" guidelines for use of RMTs and generating strategies to improve equitable access for marginalized populations).
C1 [Houlding, Elizabeth; Cox, Joseph; Lebouche, Bertrand] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Chron Viral Illness Serv, Local D02-4110,Glen Site,1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada.
   [Houlding, Elizabeth] Univ Toronto, Fac Med, Dept Phys Therapy, Toronto, ON, Canada.
   [Houlding, Elizabeth; Mate, Kedar K. V.; Engler, Kim; Ortiz-Paredes, David; Cox, Joseph; Lebouche, Bertrand] McGill Univ, Ctr Hlth, Res Inst, Ctr Outcomes Res & Evaluat, Montreal, PQ, Canada.
   [Pomey, Marie-Pascale] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada.
   [Pomey, Marie-Pascale] Univ Montreal, Ecole Sante Publ, Dept gest Evaluat & Polit Sante, Montreal, PQ, Canada.
   [Cox, Joseph] McGill Univ, Fac Med, Dept Epidemiol & Biostat, Montreal, PQ, Canada.
   [Hijal, Tarek] McGill Univ, Ctr Hlth, Div Radiat Oncol, Montreal, PQ, Canada.
   [Lebouche, Bertrand] McGill Univ, Dept Family Med, Montreal, PQ, Canada.
RP Lebouche, B (corresponding author), McGill Univ, Ctr Hlth, Royal Victoria Hosp, Chron Viral Illness Serv, Local D02-4110,Glen Site,1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada.
EM bertrand.lebouche@gmail.com
RI LEBOUCHE, Bertrand/AAC-6047-2022
OI LEBOUCHE, Bertrand/0000-0002-1273-9393; Hijal,
   Tarek/0000-0002-9341-1735; Mate, Kedar/0000-0003-0027-846X; Houlding,
   Elizabeth/0000-0002-7519-5063; Pomey, Marie-Pascale/0000-0001-5180-8139;
   Engler, Kim/0000-0001-8364-7421; Ortiz-Paredes,
   David/0000-0002-0431-4889; Cox, Joseph/0000-0002-7041-1556
FU Quebec's Ministry of Health [LE 250]; McGill Interdisciplinary
   Initiative in Infection and Immunity (MI4); McGill University Health
   Centre Foundation; CIHRCanadian Institutes of Health Research (CIHR)
   [444186]
FX BL received the Canadian Institutes for Health Research (CIHR), Strategy
   for Patient-Oriented Research Mentorship Chair in Innovative Clinical
   Trials for HIV Care. KM, a postdoctoral fellow, is funded by this
   mentorship chair. BL is also supported by a career award LE 250 from
   Quebec's Ministry of Health for researchers in Family Medicine.r Our
   work is one of the critical research programs being supported by the
   McGill Interdisciplinary Initiative in Infection and Immunity (MI4),
   with seed funding from the McGill University Health Centre Foundation.r
   This work is supported by CIHR funding awarded to MPP and BL ("Real time
   evaluation of the deployment of connected technologies and of the
   partnership of services and care during the COVID-19 sanitary crisis
   -the Techno-COVID-Partnership program," 2020-05-12 Operating Grant:
   COVID-19 May 2020 Rapid Research Funding Opportunity -grant 444186 #).
CR Alwashmi MF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082906
   Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490
   Annis T, 2020, J AM MED INFORM ASSN, V27, P1326, DOI 10.1093/jamia/ocaa097
   Bae YS, 2020, J MED INTERNET RES, V22, DOI 10.2196/19938
   Baranchuk A, MEDICINA
   Barsom EZ, 2020, NAT MED, V26, P632, DOI 10.1038/s41591-020-0845-0
   Cohen JK., REMOTE MONITORING HE
   Crawford A, 2020, J MED INTERNET RES, V22, DOI 10.2196/19361
   Ding XR, 2021, IEEE REV BIOMED ENG, V14, P48, DOI 10.1109/RBME.2020.2992838
   Edelman Linda S, 2020, JMIR Aging, V3, pe20110, DOI 10.2196/20110
   Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x
   Esakandari H, 2020, BIOL PROCED ONLINE, V22, DOI 10.1186/s12575-020-00128-2
   Faezipour M, 2020, TELEMED E-HEALTH, V26, P1202, DOI 10.1089/tmj.2020.0114
   Fagherazzi G, 2020, J MED INTERNET RES, V22, DOI 10.2196/19284
   Ford D, 2020, J AM MED INFORM ASSN, V27, P1871, DOI 10.1093/jamia/ocaa157
   Garritty C, 2021, J CLIN EPIDEMIOL, V130, P13, DOI 10.1016/j.jclinepi.2020.10.007
   Giansanti D, 2020, TELEMED E-HEALTH, V26, P1123, DOI 10.1089/tmj.2020.0159
   GREENHALGH T, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M998
   Greenhalgh T, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1182
   Hartling L, 2015, J CLIN EPIDEMIOL, V68, P1451, DOI 10.1016/j.jclinepi.2015.05.036
   Hau YS, 2020, J MED SYST, V44, DOI 10.1007/s10916-020-01580-z
   Hong Z, 2020, J MED INTERNET RES, V22, DOI 10.2196/19577
   Horowitz RI, 2020, MED HYPOTHESES, V143, DOI 10.1016/j.mehy.2020.109851
   Huang SF, 2020, TELEMED E-HEALTH, V26, P487, DOI 10.1089/tmj.2020.0066
   Hunter A, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00231
   Jain VK, 2020, DIABETES METAB SYND, V14, P1037, DOI 10.1016/j.dsx.2020.06.067
   Jamil B, 2020, J PAK MED ASSOC, V70, pS52, DOI 10.5455/JPMA.12
   Japan ECMOnet COVID-19, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00440-9
   John O, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1583
   Kannampallil T, 2020, TELEMED E-HEALTH, V26, P1120, DOI 10.1089/tmj.2020.0158
   Keshvardoost S, 2020, TELEMED E-HEALTH, V26, P850, DOI 10.1089/tmj.2020.0105
   Krausz Michael, 2020, JMIR Public Health Surveill, V6, pe18995, DOI 10.2196/18995
   Lam Philip W, 2020, CMAJ Open, V8, pE407, DOI 10.9778/cmajo.20200069
   Liu Y, 2020, J MED INTERNET RES, V22, DOI 10.2196/19786
   Lorenc T, 2013, J EPIDEMIOL COMMUN H, V67, P190, DOI 10.1136/jech-2012-201257
   Mann DM, 2020, J AM MED INFORM ASSN, V27, P1132, DOI 10.1093/jamia/ocaa072
   Massaroni C, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00635
   Medina Michelle, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc028
   Ming LC, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/19796
   Moore JT, 2020, MMWR-MORBID MORTAL W, V69, P1122, DOI 10.15585/mmwr.mm6933e1
   Munoz-Price LS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.21892
   Naik BN, 2020, J MED SYST, V44, DOI 10.1007/s10916-020-01599-2
   Nair SC, 2020, TELEMED E-HEALTH, V26, P1325, DOI 10.1089/tmj.2020.0175
   Noah B, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-017-0002-4
   O'Neill J, 2014, J CLIN EPIDEMIOL, V67, P56, DOI 10.1016/j.jclinepi.2013.08.005
   Ohannessian, 2015, EUROPEAN RES TELEMED, V4, P95, DOI [DOI 10.1016/J.EURTEL.2015.08.002, 10.1016/j.eurtel.2015.08.002]
   Pandian PS., 2018, WEARABLE TECHNOLOGIE, P732
   Petrocelli M, 2020, J LARYNGOL OTOL, V134, P571, DOI 10.1017/S0022215120001358
   Pignatiello A, 2011, CHILD ADOL PSYCH CL, V20, P13, DOI 10.1016/j.chc.2010.08.008
   Queiros A, 2018, TECHNOLOGIES, V6, DOI 10.3390/technologies6010022
   Saleem JJ, 2020, J AM MED INFORM ASSN, V27, P1300, DOI 10.1093/jamia/ocaa122
   Schinkothe Timo, 2020, JMIR Public Health Surveill, V6, pe19033, DOI 10.2196/19033
   Sharma M, 2020, COMPUT METH PROG BIO, V196, DOI 10.1016/j.cmpb.2020.105609
   Sharma T, 2020, NAT MED, V26, P1165, DOI 10.1038/s41591-020-0928-y
   Song X, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02884-9
   Sossai P, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13592
   Su DJ, 2019, TELEMED E-HEALTH, V25, P952, DOI 10.1089/tmj.2018.0205
   Thulesius H, 2020, SCAND J PRIM HEALTH, V38, P105, DOI 10.1080/02813432.2020.1770466
   Timmers T, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/19822
   Tom-Aba D, 2018, JMIR PUBLIC HLTH SUR, V4, P217, DOI 10.2196/publichealth.9015
   Trethewey SP, 2020, BRIT J GEN PRACT, V70, P228, DOI 10.3399/bjgp20X709505
   Vaira LA, 2020, HEAD NECK-J SCI SPEC, V42, P1570, DOI 10.1002/hed.26228
   Vegesna A, 2017, TELEMED E-HEALTH, V23, P3, DOI 10.1089/tmj.2016.0051
   Verhoeven Fenne, 2010, J Diabetes Sci Technol, V4, P666
   Walker RC, 2019, INT J MED INFORM, V124, P78, DOI 10.1016/j.ijmedinf.2019.01.013
   Watson AR, 2020, TELEMED E-HEALTH, V26, P1110, DOI 10.1089/tmj.2020.0134
   Wei YQ, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00111-2020
   Xu H, 2020, J MED INTERNET RES, V22, DOI 10.2196/19514
   Ye JC, 2020, JMIR MED INF, V8, DOI 10.2196/19866
NR 69
TC 6
Z9 6
U1 2
U2 8
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 2291-5222
J9 JMIR MHEALTH UHEALTH
JI JMIR mHealth uHealth
PD APR 20
PY 2021
VL 9
IS 4
AR e24743
DI 10.2196/24743
PG 16
WC Health Care Sciences & Services; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Medical Informatics
GA TD0JU
UT WOS:000669023200001
PM 33769943
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Ahmad, B
   Bilal, S
AF Ahmad, Bilal
   Bilal, Saba
TI Does fear of COVID-19 undermine career optimism? A time-lagged
   quantitative inquiry of non-managerial employees
SO KYBERNETES
LA English
DT Article; Early Access
DE COVID-19; Career optimism; Job insecurity; Restaurants; Fear of
   pandemic; Hospitality
ID JOB INSECURITY; YOUNG-ADULTS; RESOURCES; EMPLOYMENT; SUCCESS; IMPACT;
   BIAS
AB Purpose This study intends to examine the impact of a fear of coronavirus disease 2019 (COVID-19) on workers' career optimism via perceived job insecurity among non-managerial working restaurant employees. Design/methodology/approach Time-lagged quantitative data were collected in two waves from 316 non-managerial on-job restaurant employees. Structural equation modeling technique was applied to examine the measurement and structural model. Findings The study showed that workers' fear of COVID-19 positively impacts their job insecurity. Further, the study found that increasing level of job insecurity depletes workers' career optimism-an outlook of their future career prospects. Research limitations/implications The study suggests organizations should work to make employees feel secure in terms of their job continuity and career progression. Eventually, this would support employees in shielding themselves against possible resource loss (e.g. career optimism) due to pandemic crises. Originality/value Extant literature has tested the impact of the COVID-19 pandemic on employees' workplace attitudes and behaviors such as job satisfaction (e.g. Bajrami et al., 2021) and safety performance (e.g. Kim et al., 2021). However, little has been researched on the impact of the COVID-19 pandemic on employees' future career outlook, particularly of non-essential workers in the hospitality industry. To the best of the author's knowledge, an explicit examination of the impact of COVID-19 fear on career optimism has not been conducted previously. Hence, this study will not only be a valuable contribution in the literature of career management, but will also yield important practical implications.
C1 [Ahmad, Bilal] Super Univ, Lahore, Pakistan.
   [Bilal, Saba] Univ Punjab, Lahore, Pakistan.
RP Ahmad, B (corresponding author), Super Univ, Lahore, Pakistan.
EM azrabilalbashir@yahoo.com
OI Ahmad, Bilal/0000-0002-0362-0489; Bilal, Saba/0000-0001-6103-8342
CR Ahmad B, 2021, J ASIAN BUS ECON ST, DOI [10.1108/JABES-07-2021-0110, DOI 10.1108/JABES-07-2021-0110]
   Ahmad B, 2019, ASIA-PAC J BUS ADM, V11, P387, DOI 10.1108/APJBA-01-2019-0018
   Ahmad B, 2019, ASIA-PAC J BUS ADM, V11, P209, DOI 10.1108/APJBA-04-2019-0079
   Ahorsu DK, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00270-8
   Akkermans J, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103434
   All Pakistan Restaurant Association (APRA), 2021, MEMB DIR
   Arslan G., 2021, J POS SCHOOL PSY, DOI DOI 10.47602/JPSP.V5I2.255
   Ashraf BN, 2020, J BEHAV EXP FINANC, V27, DOI 10.1016/j.jbef.2020.100371
   Autin KL, 2020, J CAREER DEV, V47, P487, DOI 10.1177/0894845320944486
   Avkiran NK, 2018, HEALTH CARE MANAG SC, V21, P401, DOI 10.1007/s10729-017-9393-7
   Bajrami DD, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2020.102754
   Bao YP, 2020, LANCET, V395, pE37, DOI 10.1016/S0140-6736(20)30309-3
   Bethlehem J, 2010, INT STAT REV, V78, P161, DOI 10.1111/j.1751-5823.2010.00112.x
   Bewley T. F., 1999, WHY WAGES DONT FALL
   Biber DD, 2020, J AM COLL HEALTH, DOI 10.1080/07448481.2020.1842424
   Brooks D.J., 2020, COVID 19 WORLD WORK
   Brouwer, 2020, J VOCAT BEHAV, V116, P103287, DOI 10.1016/j.jvb.2019.02.011
   Bufquin D, 2021, INT J HOSP MANAG, V93, DOI 10.1016/j.ijhm.2020.102764
   Carver CS, 2010, CLIN PSYCHOL REV, V30, P879, DOI 10.1016/j.cpr.2010.01.006
   Chen CC, 2021, INT J CONTEMP HOSP M, V33, P2500, DOI 10.1108/IJCHM-07-2020-0759
   Chen H, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2020.102850
   Cheng T, 2014, SOC INDIC RES, V118, P1269, DOI 10.1007/s11205-013-0467-8
   Chui H, 2022, J CAREER DEV, V49, P161, DOI 10.1177/0894845320912526
   Delle E, 2022, J CAREER DEV, V49, P269, DOI 10.1177/0894845320930286
   Drosos N, 2021, J EMPLOYMENT COUNS, V58, P36, DOI 10.1002/joec.12156
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Ganson KT, 2021, J ADOLESCENT HEALTH, V68, P53, DOI 10.1016/j.jadohealth.2020.10.008
   GREENHALGH L, 1984, ACAD MANAGE REV, V9, P438, DOI 10.2307/258284
   Griffiths MD, 2010, INT J MENT HEALTH AD, V8, P8, DOI 10.1007/s11469-009-9209-1
   Guan YJ, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103438
   Hair J.F., 2021, PRIMER PARTIAL LEAST
   Haratsis JM, 2015, J CAREER DEV, V42, P431, DOI 10.1177/0894845315572019
   Harman HH., 1967, MODERN FACTOR ANAL
   He J, 2021, INT J CONTEMP HOSP M, V33, P346, DOI 10.1108/IJCHM-04-2020-0300
   Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8
   HOBFOLL SE, 1989, AM PSYCHOL, V44, P513, DOI 10.1037/0003-066X.44.3.513
   Hulme D, 2006, J DEV STUD, V42, P1085, DOI 10.1080/00220380600884050
   ILO, 2020, COVID 19 PROT WORK W
   Jiang LX, 2021, J OCCUP HEALTH PSYCH, V26, P108, DOI 10.1037/ocp0000267
   Jung HS, 2021, INT J HOSP MANAG, V92, DOI 10.1016/j.ijhm.2020.102703
   Kim S, 2021, INT J HOSP MANAG, V93, DOI 10.1016/j.ijhm.2020.102797
   Kuroki M, 2012, ILR REV, V65, P560, DOI 10.1177/001979391206500304
   Lee C, 2018, ANNU REV ORGAN PSYCH, V5, P335, DOI 10.1146/annurev-orgpsych-032117-104651
   Lee K, 2009, GLOB INST, P1
   Lee PC, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2021.102875
   Lewis EF, 2013, RADIOGRAPHY, V19, P240, DOI 10.1016/j.radi.2013.02.003
   Lewis Helen., 2020, ATLANTIC
   Lin WP, 2021, J APPL PSYCHOL, V106, P317, DOI 10.1037/apl0000896
   Lu CQ, 2014, J VOCAT BEHAV, V84, P142, DOI 10.1016/j.jvb.2013.12.004
   Luthans F, 2007, J MANAGE, V33, P321, DOI 10.1177/0149206307300814
   MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371
   Mahmud MS, 2021, INT J SOC PSYCHIATR, V67, P35, DOI 10.1177/0020764020935488
   Mamun MA, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102073
   Manoharan A, 2021, INT J HOSP MANAG, V93, DOI 10.1016/j.ijhm.2020.102796
   Mat Roni S., 2014, INTRO TO SPSS
   McIlveen P, 2016, J CAREER ASSESSMENT, V24, P623, DOI 10.1177/1069072715616059
   Morgeson FP, 2015, ACAD MANAGE REV, V40, P515, DOI 10.5465/amr.2012.0099
   National Restaurant Association, 2020, REST IND IMP SURV
   Noguchi Y, 2020, NATL PUBLIC RADIO
   Park IJ, 2021, TOUR MANAG PERSPECT, V39, DOI 10.1016/j.tmp.2021.100846
   Park IJ, 2020, J CAREER DEV, V47, P96, DOI 10.1177/0894845318781043
   Pizam A, 2009, ANATOLIA, V20, P134, DOI 10.1080/13032917.2009.10518900
   Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553
   Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879
   Hernandez-Sanchez BR, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155293
   Richter AW, 2012, J APPL PSYCHOL, V97, P1282, DOI 10.1037/a0029359
   Rottinghaus PJ, 2005, J CAREER ASSESSMENT, V13, P3, DOI 10.1177/1069072704270271
   Satici B, 2021, INT J MENT HEALTH AD, V19, P1980, DOI 10.1007/s11469-020-00294-0
   Schwarz A, 2017, DATA BASE ADV INF SY, V48, P93, DOI 10.1145/3051473.3051479
   Shafi Mohsin., 2020, RES GLOB, V2, DOI [10.1016/j.resglo.2020.100018, DOI 10.1016/J.RESGLO.2020.100018]
   Shammi M, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04063
   SHIFREN K, 1995, EXP AGING RES, V21, P59, DOI 10.1080/03610739508254268
   Shoss MK, 2017, J MANAGE, V43, P1911, DOI 10.1177/0149206317691574
   Shropshire J., 2012, INT J INFORM COMMUNI, V2, P6
   Siddiqui K, 2020, IMPACT COVID 19 GLOB
   Spur D, 2015, J VOCAT BEHAV, V87, P134, DOI 10.1016/j.jvb.2014.12.007
   Stoeber J., 2016, PSYCHOL PERFECTIONIS, P31
   Stoeber J, 2016, PERS INDIV DIFFER, V97, P256, DOI 10.1016/j.paid.2016.03.065
   Termini CM, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00821-4
   UNCTAD, 2020, UN C TRADE DEV
   UNDP, 2020, COV 19 PAK SOC EC IM, V1
   UNIDO, 2020, HLTH PAND PAND EC
   Vo-Thanh T, 2021, J SUSTAIN TOUR, V29, P907, DOI 10.1080/09669582.2020.1850750
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   Wang HJ, 2014, EUR J WORK ORGAN PSY, V23, P107, DOI 10.1080/1359432X.2012.712751
   World Bank, 2020, S AS EC FOC SPRING 2
   Yildirim M, 2021, CURR PSYCHOL, V40, P5763, DOI 10.1007/s12144-021-01781-w
   Yuan WJ, 2016, PERS INDIV DIFFER, V101, P312, DOI 10.1016/j.paid.2016.06.005
   Zeb S, 2021, COGENT BUS MANAG, V8, DOI 10.1080/23311975.2021.1923359
NR 89
TC 0
Z9 0
U1 4
U2 4
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0368-492X
EI 1758-7883
J9 KYBERNETES
JI Kybernetes
DI 10.1108/K-10-2021-1036
EA MAR 2022
PG 18
WC Computer Science, Cybernetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science
GA ZQ0AY
UT WOS:000766778100001
OA Bronze
DA 2022-04-20
ER

PT J
AU Al Ameer, HH
   AlKadhem, SM
   Busaleh, F
   AlKhwaitm, S
   Llaguno, MBB
AF Al Ameer, Heba H.
   AlKadhem, Sajjad M.
   Busaleh, Fadi
   AlKhwaitm, Sami
   Llaguno, Maria Blesilda B.
TI Multisystem Inflammatory Syndrome in Children Temporally Related to
   COVID-19: A Case Report From Saudi Arabia
SO CUREUS JOURNAL OF MEDICAL SCIENCE
LA English
DT Article
DE multisystem inflammatory syndrome; covid 19; kawasaki disease; kawasaki
   disease shock syndrome
AB The World Health Organization is still revising the epidemiology of multi-system inflammatory syndrome in children (MIS-C) and the preliminary case definition, although there is a dearth of robust evidence regarding the clinical presentations, severity, and outcomes. Researchers, epidemiologists, and clinicians are snuggling to characterize and describe the disease phenomenon while taking care of the diseased persons at the forefronts. This report tackles the first case of a 13-year-old Saudi female with the MIS-C mimicking Kawasaki disease. Her main manifestations were fever, gastrointestinal symptoms, evidence of organ failure with an increase in inflammatory markers, and a history of coronavirus disease (COVID-19) infection. She had glucose-6-phosphate dehydrogenase (G6PD) deficiency and no significant previous history of any disease. She presented with signs of acute illness: high-grade fever (39.6 degrees C) for five days accompanied by sore throat, malaise, reduced oral intake, abdominal pain, diarrhea, skin rash, bilateral non-suppurative conjunctivitis, and erythematous, cracked lips. Eventually, she died despite aggressive management based on the Centers for Disease Control and Prevention and the Saudi Ministry of Health guidelines for COVID-19 management. Based on this case, we suggest that pediatricians need to be aware of such atypical presentations and early referral to tertiary care is imperative for further early diagnosis and management.
   MIS-C is a rare yet severe and highly critical complication of COVID-19 infection in pediatrics, leading to serious and life-threatening illnesses. Knowledge about the wide spectrum of presenting signs and symptoms and disease severity, including early detection and treatment, is pivotal to prevent a tragic outcome.
C1 [Al Ameer, Heba H.] Matern & Children Hosp, Infect Dis, Al Hasa, Saudi Arabia.
   [AlKadhem, Sajjad M.; Busaleh, Fadi] Matern & Children Hosp, Pediat, Al Hasa, Saudi Arabia.
   [AlKhwaitm, Sami] Matern & Children Hosp, Pediat Crit Care Med, Al Hasa, Saudi Arabia.
   [Llaguno, Maria Blesilda B.] King Faisal Univ, Coll Appl Med Sci, Nursing, Al Hasa, Saudi Arabia.
RP AlKadhem, SM (corresponding author), Matern & Children Hosp, Pediat, Al Hasa, Saudi Arabia.
EM sajjad.alkadhem@gmail.com
OI LLAGUNO, MARIA BLESILDA/0000-0002-7436-6318
CR [Anonymous], 2020, GUIDANCE PAEDIAT MUL
   [Anonymous], 2020, SAUDI MOH PROTOCOL P
   [Anonymous], 2020, 2020 HLTH ALERT 13 P
   [Anonymous], 2020, MULTISYSTEM INFLAMMA
   Atal S, 2020, PHARM MED, V34, P223, DOI 10.1007/s40290-020-00342-z
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Licciardi F, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-1711
   Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/S0140-6736(20)31094-1, 10.1016/50140-6736(20)31094-1]
NR 11
TC 9
Z9 9
U1 4
U2 6
PU CUREUS INC
PI PALO ALTO
PA PO BOX 61002, PALO ALTO, CA 94306 USA
EI 2168-8184
J9 CUREUS J MED SCIENCE
JI Cureus J Med Sci
PD SEP 22
PY 2020
VL 12
IS 9
AR e10589
DI 10.7759/cureus.10589
PG 5
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA NR6HD
UT WOS:000571662400009
PM 33110725
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Abualqumboz, M
AF Abualqumboz, Moheeb
TI Project-based work in times of COVID-19: A dynamic framework for
   knowledge exchange
SO KNOWLEDGE AND PROCESS MANAGEMENT
LA English
DT Article; Early Access
ID ORGANIZATIONS; BUSINESS; BARRIERS; TEAMS; COMMUNITIES; ROUTINES
AB Knowledge exchange is the key to help knowledge-intensive firms (KIFs) innovate and communicate with their clients. However, during the COVID-19 pandemic, many assumptions have been challenged, and as a consequence, this study aims to investigate the effect of the pandemic on knowledge exchange processes in KIFs and how firms responded to the pressing challenges that consequently emerged. This study illustrates how KIFs managed to navigate through the pandemic and exchanged knowledge with their clients in a new dynamic landscape despite the challenges that affected their client base and knowledge workers alike. Using multiple data sources, including 27 interviews, observation, informal conversations, and virtual guided tours, the article provides a three-phase framework with the assistance of a simplified process lens. The framework phases (disharmony, normalisation, and harmony) illustrate how KIFs responded to the challenges, developed capabilities, and provided support.
C1 [Abualqumboz, Moheeb] Manchester Metropolitan Univ, Dept Operat Technol Events & Hospitality Manageme, Fac Business & Law, Manchester, Lancs, England.
RP Abualqumboz, M (corresponding author), Manchester Metropolitan Univ, Fac Business & Law, Manchester M15 6BH, Lancs, England.
EM m.abualqumboz@mmu.ac.uk
CR Abualqumboz M, 2021, J KNOWL MANAG, V25, P899, DOI 10.1108/JKM-05-2020-0346
   Ahlstrom D, 2020, J MANAGE STUD, V57, P411, DOI 10.1111/joms.12569
   Ajmal MM, 2008, PROJ MANAG J, V39, P7, DOI 10.1002/pmj.20031
   Akgun AE, 2017, KYBERNETES, V46, P603, DOI 10.1108/K-04-2016-0081
   Argote L, 2011, HANDBOOK OF ORGANIZATIONAL LEARNING AND KNOWLEDGE MANAGEMENT, 2ND EDITION, P659
   Artto K, 2008, INT J MANAG PROJ BUS, V1, P469, DOI 10.1108/17538370810906219
   Bacon E, 2020, J BUS RES, V115, P307, DOI 10.1016/j.jbusres.2019.11.005
   Bartsch V, 2013, INT J PROJ MANAG, V31, P239, DOI 10.1016/j.ijproman.2012.06.009
   Bouncken RB, 2020, BRIT J MANAGE, V31, P769, DOI 10.1111/1467-8551.12408
   Castaneda DI, 2020, KNOWL PROCESS MANAG, V27, P159, DOI 10.1002/kpm.1637
   Chuang CH, 2016, J MANAGE, V42, P524, DOI 10.1177/0149206313478189
   Cropanzano R, 2017, ACAD MANAG ANN, V11, P479, DOI 10.5465/annals.2015.0099
   Dittrich K, 2016, ORGAN SCI, V27, P678, DOI 10.1287/orsc.2015.1024
   Easterby-Smith M, 2008, J MANAGE STUD, V45, P677, DOI 10.1111/j.1467-6486.2008.00773.x
   Eddleston KA, 2017, GROUP ORGAN MANAGE, V42, P346, DOI 10.1177/1059601115619548
   EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557
   Fiedler A, 2021, HUM RELAT, V74, P1033, DOI 10.1177/0018726720905351
   Furlan A, 2019, ORGAN SCI, V30, P280, DOI 10.1287/orsc.2018.1274
   Ghobadi S, 2016, INFORM SYST J, V26, P95, DOI 10.1111/isj.12053
   Harvey JF, 2019, HUM RELAT, V72, P1726, DOI 10.1177/0018726718817812
   Herbst AS, 2017, J KNOWL MANAG, V21, P765, DOI 10.1108/JKM-07-2016-0273
   Hydle KM, 2020, J MANAGE ORGAN, V26, P519, DOI 10.1017/jmo.2017.63
   Kakar AK, 2018, KNOWL PROCESS MANAG, V25, P258, DOI 10.1002/kpm.1584
   Khalid S., 2020, WHO WILL BEAR BRUNT
   Kodama M, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102172
   Kremser W, 2016, ORGAN SCI, V27, P698, DOI 10.1287/orsc.2015.1042
   Krylova KO, 2016, J KNOWL MANAG, V20, P1045, DOI 10.1108/JKM-10-2015-0385
   Kumi R, 2019, KNOWL PROCESS MANAG, V26, P110, DOI 10.1002/kpm.1574
   Langley A, 2013, ACAD MANAGE J, V56, P1, DOI 10.5465/amj.2013.4001
   Lannon J, 2020, J KNOWL MANAG, V24, P8, DOI 10.1108/JKM-09-2018-0605
   Larsson R, 1998, ORGAN SCI, V9, P285, DOI 10.1287/orsc.9.3.285
   Lincoln, 1994, HDB QUALITATIVE RES, P273, DOI DOI 10.1007/BF00988593
   Lipparini A, 2014, STRATEGIC MANAGE J, V35, P578, DOI 10.1002/smj.2110
   Lowendahl B.R, 2005, STRATEG MANAG
   Mejri K, 2018, IND MARKET MANAG, V71, P160, DOI 10.1016/j.indmarman.2017.12.018
   Mueller J, 2015, PROJ MANAG J, V46, P53, DOI 10.1002/pmj.21471
   Nicholson JD, 2018, IND MARKET MANAG, V73, P206, DOI 10.1016/j.indmarman.2018.02.014
   Nurmi N, 2020, ORGAN STUD, V41, P1697, DOI 10.1177/0170840620937885
   Ray A, 2020, KNOWL PROCESS MANAG, V27, P63, DOI 10.1002/kpm.1623
   Sedighi M, 2018, J KNOWL MANAG, V22, P1264, DOI 10.1108/JKM-09-2016-0398
   Sergeeva N, 2021, CONSTR INNOV-ENGL, V21, P934, DOI 10.1108/CI-09-2020-0148
   Siahtiri V, 2020, IND MARKET MANAG, V87, P117, DOI 10.1016/j.indmarman.2020.02.010
   Sun YQ, 2014, INFORM MANAGE-AMSTER, V51, P441, DOI 10.1016/j.im.2014.02.008
   Swart J., 2003, HUMAN RESOURCE MANAG, V13, P60, DOI DOI 10.1111/HRMJ.2003.13.ISSUE-2
   Vargas N, 2017, KNOWL PROCESS MANAG, V24, P114, DOI 10.1002/kpm.1537
   Zieba M, 2021, UNDERSTANDING KNOWLE, P91
   Zieba M, 2020, KYBERNETES, V49, P141, DOI 10.1108/K-04-2019-0297
NR 47
TC 2
Z9 2
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1092-4604
EI 1099-1441
J9 KNOWL PROCESS MANAG
JI Knowl. Process Manag.
DI 10.1002/kpm.1698
EA NOV 2021
PG 9
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA XE0VF
UT WOS:000723114500001
OA Bronze
DA 2022-04-20
ER

PT J
AU Yin, X
   Li, QB
   Hou, SC
   Zhong, Q
   Fan, ZJ
   Huang, QH
   Kukkar, V
   Kang, Z
   Huang, ZJ
   Wang, L
AF Yin, Xi
   Li, Qiubai
   Hou, Shengchao
   Zhong, Qiang
   Fan, Zhongjie
   Huang, Qiuhan
   Kukkar, Vishal
   Kang, Zhen
   Huang, Zhaojun
   Wang, Liang
TI Demographic, signs and symptoms, imaging characteristics of 2126
   patients with COVID-19 pneumonia in the whole quarantine of Wuhan, China
SO CLINICAL IMAGING
LA English
DT Article
DE Computed tomography; COVID-19; Demographic; Sign; Symptom
AB ABSTR A C T Objective: The accurate knowledge of demographic, signs and symptoms, imaging characteristics of coronavirus disease 2019 (COVID-19) is essential for the accurate management of these patients. However, the claims be-tween the previous papers are not always consistent and may even contradict each other, for example, some claims the virus infects more men than women in Wuhan. In this large-scale cohort study, we aimed to update the demographic, signs and symptoms, imaging characteristics of patients with COVID-19 in the whole quarantine of Wuhan, China. Methods: A cohort of 2126 patients with a diagnosis of COVID-19 pneumonia (confirmed by real-time reverse transcriptase-polymerase chain reaction, RT-PCR) who were admitted to one hospital in Wuhan were retro-spectively enrolled. Data were collected between January 13, 2020, and April 8, 2020, the end of Wuhan quarantine. Demographic, signs and symptoms, imaging characteristics were analyzed. CT imaging character-istics associated with respiratory failure or death were identified. Results: Of the 2126 patients with COVID-19, 1051 (49.44%) were men and 1075 (50.56%) were women, 1933 (90.92%) have fever and 1328 (62.46%) have dry cough. The mean age was 57.43 years of age (range 1-95). The CT imaging findings were bilateral pneumonia (1883[88.57%]), unilateral pneumonia (243[11.43%]), ground-glass opacity (GGO) or consolidation (1175[55.27%]), pleural effusion (69[3.25%]). Patients with respiratory failure or death were more likely to have pleural effusion on CT than patients without respiratory failure or death (p < 0.05). Conclusion: Men and women have been infected by SARS-CoV-2 in roughly equal numbers. Fever and cough are the most prevalent symptoms at disease onset in patients. Other prevalent symptoms include fatigue, and sputum production. COVID-19 patients with bilateral pneumonia and pleural effusion are more likely to develop res-piratory failure or death.
C1 [Yin, Xi; Huang, Qiuhan; Kang, Zhen; Huang, Zhaojun; Wang, Liang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Radiol, Jie Fang Da Dao 1095, Wuhan 430030, Peoples R China.
   [Li, Qiubai] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA.
   [Hou, Shengchao] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Med & Hlth Management, Wuhan, Peoples R China.
   [Zhong, Qiang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Clin Med,ICU, Jie Fang Da Dao 1095, Wuhan 430030, Peoples R China.
   [Fan, Zhongjie] Wuhan Red Cross Hosp, Dept Resp Med, Wuhan 430015, Peoples R China.
   [Kukkar, Vishal] UT Southwestern Med Ctr, Dallas, TX USA.
RP Wang, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Radiol, Jie Fang Da Dao 1095, Wuhan 430030, Peoples R China.
EM Qiubai.Li@UTSouthwestern.edu; wang6@tjh.yjmu.edu.cn
CR [Anonymous], WEEKLY EPIDEMIOLOGIC
   Cao YH, 2020, J MED VIROL, V92, P1449, DOI 10.1002/jmv.25822
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Cristiani L, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00749-2020
   Das D, 2020, PHYS ENG SCI MED, V43, P915, DOI 10.1007/s13246-020-00888-x
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037
   Li H, 2020, LANCET, V395, P1517, DOI 10.1016/S0140-6736(20)30920-X
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623
   Santosh KC, 2020, J MED SYST, V44, DOI 10.1007/s10916-020-01562-1
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]
   WHO, PNEUM UNKN CAUS CHIN
   WHO China, 2020, REP WHO CHIN JOINT M, DOI DOI 10.1186/S40249-020-00650-1
   World Health Organisation (WHO), NOV COR CHIN
   Xu X, 2020, EUR J NUCL MED MOL I, V47, P1275, DOI 10.1007/s00259-020-04735-9
   Yang WJ, 2020, J INFECTION, V80, P388, DOI 10.1016/j.jinf.2020.02.016
   Yi Y, 2020, INT J BIOL SCI, V16, P1753, DOI 10.7150/ijbs.45134
   Zhou SC, 2020, AM J ROENTGENOL, V214, P1287, DOI 10.2214/AJR.20.22975
NR 22
TC 0
Z9 1
U1 3
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-7071
EI 1873-4499
J9 CLIN IMAG
JI Clin. Imaging
PD SEP
PY 2021
VL 77
BP 169
EP 174
DI 10.1016/j.clinimag.2021.02.034
EA MAR 2021
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Radiology, Nuclear Medicine & Medical Imaging
GA YI1EN
UT WOS:000743599300009
PM 33691264
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Zhao, XM
   Fan, J
   Basnyat, I
   Hu, BJ
AF Zhao, Xiaoman
   Fan, Ju
   Basnyat, Iccha
   Hu, Baijing
TI Online Health Information Seeking Using "#COVID-19 Patient Seeking Help"
   on Weibo in Wuhan, China: Descriptive Study
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE COVID-19; coronavirus; information seeking; social media; Wuhan
ID UNCERTAINTY MANAGEMENT; EMOTIONAL EXPRESSION; INTERNET; SEARCH;
   BEHAVIOR; ANXIETY; DETERMINANTS; ROLES; AGE
AB Background: First detected in Wuhan, China in December 2019, the COVID-19 pandemic stretched the medical system in Wuhan and posed a challenge to the state's risk communication efforts. Timely access to quality health care information during outbreaks of infectious diseases can be effective to curtail the spread of disease and feelings of anxiety. Although existing studies have extended our knowledge about online health information-seeking behavior, processes, and motivations, rarely have the findings been applied to an outbreak. Moreover, there is relatively little recent research on how people in China are using the internet for seeking health information during a pandemic.
   Objective: The aim of this study is to explore how people in China are using the internet for seeking health information during a pandemic. Drawing on previous research of online health information seeking, this study asks the following research questions: how was the "#COVID-19 Patient Seeking Help" hashtag being used by patients in Wuhan seeking health information on Weibo at the peak of the outbreak? and what kinds of health information were patients in Wuhan seeking on Weibo at the peak of the outbreak?
   Methods: Using entity identification and textual analysis on 10,908 posts on Weibo, we identified 1496 patients with COVID-19 using "#COVID-19 Patient Seeking Help" and explored their online health information-seeking behavior.
   Results: The curve of the hashtag posting provided a dynamic picture of public attention to the COVID-19 pandemic. Many patients faced difficulties accessing offline health care services. In general, our findings confirmed that the internet is used by the Chinese public as an important source of health information. The lockdown policy was found to cut off the patients' social support network, preventing them from seeking help from family members. The ability to seek information and help online, especially for those with young children or older adult members during the pandemic. A high proportion of female users were seeking health information and help for their parents or for older adults at home. The most searched information included accessing medical treatment, managing self-quarantine, and offline to online support.
   Conclusions: Overall, the findings contribute to our understanding of health information-seeking behaviors during an outbreak and highlight the importance of paying attention to the information needs of vulnerable groups and the role social media may play.
C1 [Zhao, Xiaoman] Renmin Univ China, Res Ctr Journalism & Social Dev, Beijing, Peoples R China.
   [Zhao, Xiaoman; Hu, Baijing] Renmin Univ China, Sch Journalism & Commun, 59 Zhongguancun St, Beijing, Peoples R China.
   [Fan, Ju] Renmin Univ China, Data Engn & Knowledge Engn Lab, Beijing, Peoples R China.
   [Fan, Ju] Renmin Univ China, Sch Informat, Beijing, Peoples R China.
   [Basnyat, Iccha] James Madison Univ, Sch Commun Studies, Harrisonburg, VA 22807 USA.
RP Hu, BJ (corresponding author), Renmin Univ China, Sch Journalism & Commun, 59 Zhongguancun St, Beijing, Peoples R China.
EM hubaijing@vip.sina.com
OI , Xiaoman/0000-0002-7667-3813; Basnyat, Iccha/0000-0002-5051-2317
FU MOE Key Project of Key Research Institute of Humanities and Social
   Sciences [16JJD860008]
FX The authors disclosed receipt of the following financial support for the
   research, authorship, or publication of this article: This work was
   supported by the MOE Key Project of Key Research Institute of Humanities
   and Social Sciences (Project No. 16JJD860008).
CR Andreassen HK, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-53
   Anker AE, 2011, PATIENT EDUC COUNS, V82, P346, DOI 10.1016/j.pec.2010.12.008
   [Anonymous], 2020, SUMM HOSP BEDS AV 28
   [Anonymous], 2020, COR DIS SIT SUMM HUB
   [Anonymous], 2020, PEOPLES DAILY
   [Anonymous], 2020, UPD COR DIS 24 MARCH
   [Anonymous], 2019, 44 STAT REP INT DEV
   [Anonymous], 2020, LIST FEV CLIN DES HO
   Bantum EO, 2009, PSYCHOL ASSESSMENT, V21, P79, DOI 10.1037/a0014643
   Barry JM, 2009, NATURE, V459, P324, DOI 10.1038/459324a
   Baumgartner SE, 2011, CYBERPSYCH BEH SOC N, V14, P613, DOI 10.1089/cyber.2010.0425
   Beversdorf W, 2020, LAB INVEST, V100, P3
   Booth A, 2014, J ECON BEHAV ORGAN, V99, P126, DOI 10.1016/j.jebo.2013.12.017
   Bundorf MK, 2006, HEALTH SERV RES, V41, P819, DOI 10.1111/j.1475-6773.2006.00510.x
   Cao WD, 2016, HEALTH COMMUN, V31, P1105, DOI 10.1080/10410236.2015.1045236
   Centers for Disease Control and Prevention, 2020, US COVID 19 CAS DEAT
   Charmaz, 2014, CONSTRUCTING GROUNDE, P1
   Chen SM, 2020, LANCET, V395, P1305, DOI 10.1016/S0140-6736(20)30744-3
   DeLorme DE, 2009, HEALTH COMMUN, V24, P494, DOI 10.1080/10410230903104277
   Fox S., 2006, ONLINE HLTH SEARCH 2
   Gao LL, 2013, MIDWIFERY, V29, P730, DOI 10.1016/j.midw.2012.07.003
   Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634
   Hao HJ, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4365
   Holmes BJ, 2008, HEALTH RISK SOC, V10, P349, DOI 10.1080/13698570802166431
   Jiang SH, 2017, HEALTH COMMUN, V32, P1024, DOI 10.1080/10410236.2016.1196514
   Kahn JH, 2007, AM J PSYCHOL, V120, P263, DOI 10.2307/20445398
   Kammerer Y, 2015, COMPUT HUM BEHAV, V48, P297, DOI 10.1016/j.chb.2015.01.045
   Khan S, 2020, CLIN MICROBIOL INFEC, V26, P399, DOI 10.1016/j.cmi.2020.02.005
   Kitchens B, 2014, DECIS SUPPORT SYST, V57, P454, DOI 10.1016/j.dss.2012.10.050
   Kumar S, 2012, HEALTH EDUC BEHAV, V39, P229, DOI 10.1177/1090198111415105
   Lagoe C, 2015, COMPUT HUM BEHAV, V52, P484, DOI 10.1016/j.chb.2015.06.003
   Lee K, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4345
   Lin CA, 2015, COMPUT HUM BEHAV, V51, P216, DOI 10.1016/j.chb.2015.04.054
   Lin X., 2020, ANAL 25000 LAB CONFI
   Liu L, 2020, INT J HEALTH POLICY, V9, P415, DOI 10.34172/ijhpm.2020.63
   Miller LMS, 2012, J AGING HEALTH, V24, P525, DOI 10.1177/0898264311428167
   National Bureau of Statistics of China, 2020, STAT COMM PEOPL REP
   Niederdeppe J, 2007, HEALTH COMMUN, V22, P153, DOI 10.1080/10410230701454189
   Pan SL, 2020, INT J INFORM MANAGE, V54, DOI 10.1016/j.ijinfomgt.2020.102143
   Peddie KA, 2017, COMPUT HUM BEHAV, V73, P141, DOI 10.1016/j.chb.2017.03.037
   Petrie KJ, 2009, BMJ OPINION     0611
   Pierce M, 2020, LANCET PSYCHIAT, V7, P567, DOI 10.1016/S2215-0366(20)30237-6
   Quinn S, 2017, COMPUT HUM BEHAV, V69, P256, DOI 10.1016/j.chb.2016.12.032
   Rains SA, 2015, HEALTH COMMUN, V30, P339, DOI 10.1080/10410236.2013.858285
   Rains SA, 2014, J HEALTH COMMUN, V19, P1296, DOI 10.1080/10810730.2013.872731
   Strauss, 2014, BASICS QUALITATIVE R, P1
   Tang CX, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6538-2
   Tausczik Y, 2012, HEALTH COMMUN, V27, P179, DOI 10.1080/10410236.2011.571759
   Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105
   van Deursen AJAM, 2011, NEW MEDIA SOC, V13, P893, DOI 10.1177/1461444810386774
   Wang MP, 2014, J MED INTERNET RES, V16, P275, DOI 10.2196/jmir.3386
   Wang MH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072082, 10.1371/journal.pone.0064860, 10.1371/journal.pone.0073741]
   Weeks B, 2010, MASS COMMUN SOC, V13, P341, DOI 10.1080/15205430903470532
   Wong LP, 2010, J COMMUN HEALTH, V35, P676, DOI 10.1007/s10900-010-9271-4
   World Health Organization (WHO), 2020, REP WHO CHIN JOINT M
   Wu D, 2016, LIBR INFORM SCI RES, V38, P272, DOI 10.1016/j.lisr.2016.08.011
   Yan YY, 2010, J MED SYST, V34, P147, DOI 10.1007/s10916-008-9226-9
   Yuli Yang, 2012, Proceedings of the 2012 International Symposium on Information Technology in Medicine and Education (ITME 2012), P608, DOI 10.1109/ITiME.2012.6291380
   Zhao XQ, 2015, J HEALTH COMMUN, V20, P616, DOI 10.1080/10810730.2015.1012244
NR 59
TC 22
Z9 22
U1 28
U2 48
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD OCT 15
PY 2020
VL 22
IS 10
AR e22910
DI 10.2196/22910
PG 13
WC Health Care Sciences & Services; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Medical Informatics
GA PH3GI
UT WOS:000600305300002
PM 33001838
OA Green Published, gold
DA 2022-04-20
ER

PT C
AU Nguyen, HTL
AF Hoang To Loan Nguyen
BE GarciaPerez, A
   Simkin, L
TI Using Online-learning in Audit Education: Impact on Student Satisfaction
   and Knowledge Sharing Processes During the Outbreak of COVID-19
SO PROCEEDINGS OF THE 21ST EUROPEAN CONFERENCE ON KNOWLEDGE MANAGEMENT
   (ECKM 2020)
SE Proceedings of the European Conference on Knowledge Management
LA English
DT Proceedings Paper
CT 21st European Conference on Knowledge Management (ECKM)
CY DEC 02-04, 2020
CL Conventry Univ, ELECTR NETWORK
HO Conventry Univ
DE online learning; knowledge sharing process; student satisfaction; audit
   education
ID MANAGEMENT
AB Teaching and learning processes are assumed to be taken place in a face to face classroom. However, these processes are changed fully or partly due to the use of Internet and network technologies that provide new means of communication. These changes have shifted the education method from tradition classroom settings to online learning program. This shifted paradigm also influenced student's satisfaction in learning and the knowledge sharing processes among teachers and students. This research investigates the student satisfaction and knowledge sharing processes between traditional classroom environment and online learning method, thereby suggesting recommendations for the development of online learning method. We employ a comparative case study to analyze the evaluation of learners about traditional and online learning activities in an auditing course. To collect data, the study conducted a survey on student's feedback about their satisfaction and knowledge sharing process in the course. The collected quantitative data were analyzed using statistical analysis including descriptive statistics, exploratory factor analysis and Cronbach's alpha. Our findings indicate that there are different impacts on students' satisfaction and their knowledge sharing process between two learning environments. Resulted findings suggest that if lecturers are able to apply knowledge sharing activities in online learning environment, it is possible to enhance the knowledge sharing process and student's satisfaction. Future implications and suggestions for programs are provided in light of the findings.
C1 [Hoang To Loan Nguyen] Univ Econ Ho Chi Minh City UEH, Ho Chi Minh City, Vietnam.
RP Nguyen, HTL (corresponding author), Univ Econ Ho Chi Minh City UEH, Ho Chi Minh City, Vietnam.
EM loannht@ueh.edu.vn
FU University of Economics Ho Chi Minh City (UEH); UEH
FX This paper is part of a research project titled ``Knowledge management
   and online learning in auditing"sponsored by University of Economics Ho
   Chi Minh City (UEH). The author would like to thank the UEH for its
   financial support of this research.
CR Arntzen AAB, 2009, J KNOWL MANAG, V13, P127, DOI 10.1108/13673270910942745
   Benson A. D., 2002, Q REV DISTANCE ED, V3, P443
   Biasutti M, 2012, COMPUT EDUC, V59, P861, DOI 10.1016/j.compedu.2012.04.009
   Biasutti M, 2011, COMPUT EDUC, V57, P1865, DOI 10.1016/j.compedu.2011.04.006
   Bliuc AM, 2011, COMPUT EDUC, V56, P856, DOI 10.1016/j.compedu.2010.10.027
   Bolick C. M., 2003, CONT ISSUES TECHNOLO, V3, P300
   Bower M, 2010, COMPUT EDUC, V54, P462, DOI 10.1016/j.compedu.2009.08.030
   Carliner S, 2004, OVERVIEW ONLINE LEAR
   Cheng E.C.K., 2014, KNOWLEDGE MANAGEMENT
   Conrad D., 2002, J DISTANCE ED, V17, P1
   De Smet M, 2010, COMPUT EDUC, V54, P1167, DOI 10.1016/j.compedu.2009.11.002
   KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116
   Kumar S., 2011, P WORLD C E LEARN CO P WORLD C E LEARN CO
   Moore JL, 2011, INTERNET HIGH EDUC, V14, P129, DOI 10.1016/j.iheduc.2010.10.001
   NONAKA I, 1990, CALIF MANAGE REV, V32, P27, DOI 10.2307/41166615
   Nonaka I., 1995, KNOWLEDGE CREATING C
   Senge P. M., 1990, 5 DISCIPLINE ART PRA
   Yeh YC, 2011, COMPUT EDUC, V56, P146, DOI 10.1016/j.compedu.2010.08.011
NR 18
TC 0
Z9 0
U1 1
U2 2
PU ACAD  CONFERENCES LTD
PI NR READING
PA CURTIS FARM, KIDMORE END, NR READING, RG4 9AY, ENGLAND
SN 2048-8963
BN 978-1-912764-82-2
J9 PROC EUR CONF KNOWL
PY 2020
BP 538
EP 546
DI 10.34190/EKM.20.215
PG 9
WC Business; Information Science & Library Science; Management
WE Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Business & Economics; Information Science & Library Science
GA BS0SF
UT WOS:000684204300064
DA 2022-04-20
ER

PT J
AU Bacq, S
   Geoghegan, W
   Josefy, M
   Stevenson, R
   Williams, TA
AF Bacq, Sophie
   Geoghegan, Will
   Josefy, Matthew
   Stevenson, Regan
   Williams, Trenton A.
TI The COVID-19 Virtual Idea Blitz: Marshaling social entrepreneurship to
   rapidly respond to urgent grand challenges
SO BUSINESS HORIZONS
LA English
DT Article
DE COVID-19; Entrepreneurial hustle; Grand challenges; Social
   entrepreneurship; Virtual idea blitz
ID MANAGEMENT
AB In response to societal grand challenges, professors have unique opportunities to effect change, repurposing their expertise to deploy relevant, timely, practical, and research-backed knowledge for the betterment of communities. Drawing on scholarship on postcrisis organizing, entrepreneurial hustle, and social entrepreneurship, we provide a firsthand, real-time case description of a three-day "virtual idea blitz" organized in response to the COVID-19 crisis. The event was organized and executed in less than a week and ultimately involved 200 individuals, including entrepreneurs, coders, medical doctors, venture capitalists, industry professionals, students, and professors from around the world. By the end of the weekend, 21 ideas with corresponding pitches were developed in five thematic areas: health needs, education, small businesses, community, and purchasing. We describe how the community was rapidly rallied, and we discuss the key learning outcomes of this spontaneous entrepreneurial endeavor. We provide evidence from participants and mentors that showcases the value of the time-compressed virtual idea blitz in accelerating social entrepreneurial action. We offer practical guidance to academic, community, and professional institutions that would like to replicate or build upon our approach to stimulate the formation of community and to coordinate efforts to thwart the ongoing threat of COVID-19, as well as other societal challenges that might emerge in the future. (C) 2020 Kelley School of Business, Indiana University. Published by Elsevier Inc. All rights reserved.
C1 [Bacq, Sophie; Geoghegan, Will; Josefy, Matthew; Stevenson, Regan; Williams, Trenton A.] Indiana Univ, Kelley Sch Business, Bloomington, IN 47405 USA.
RP Bacq, S (corresponding author), Indiana Univ, Kelley Sch Business, Bloomington, IN 47405 USA.
EM bacqs@iu.edu; wgeoghe@iu.edu; mjosefy@iu.edu; rstev@indiana.edu;
   trenwill@iu.edu
RI ; Stevenson, Regan/E-7161-2016
OI Josefy, Matthew/0000-0003-1174-1878; Stevenson,
   Regan/0000-0001-7315-6530
FU John and Donna Shoemaker Fellowship; Olsan Family Faculty Fellowship;
   Office of the Vice President of Research, Indiana University
FX The authors would like to thank the Editor, Greg Fisher, for his
   thoughtful guidance, and two anonymous reviewers for their constructive
   and insightful comments. They also would like to thank Don Kuratko and
   the Johnson Center for Entrepreneurship & Innovation. The authors
   gratefully acknowledge the departmental support provided by Tim Baldwin,
   Chair of the Management and Entrepreneurship Department. Regan Stevenson
   acknowledges the financial support of the John and Donna Shoemaker
   Fellowship with which some of this research was supported. Trenton A.
   Williams acknowledges the financial support of the Olsan Family Faculty
   Fellowship with which some of this research was supported. Finally, the
   authors gratefully acknowledge funding provided by the Office of the
   Vice President of Research, Indiana University to support grants to
   accelerate entrepreneurial responses to COVID-19.
CR [Anonymous], 2020, US NEWS WORLD REPORT
   [Anonymous], 2020, KOMO NEWS STAFF 0311
   Bacq S, 2011, ENTREP REGION DEV, V23, P373, DOI 10.1080/08985626.2011.577242
   Bacq S., 2019, RESPONSIBLE GOVERNAN
   Briscoe G, 2014, DIGITAL INNOVATION H
   Corbin J., 2015, BASICS QUALITATIVE R
   Dormehl L., 2020, CULT MAC        0326
   Drabek T. E., 2003, DISASTER PREVENTION, V12, P97, DOI DOI 10.1108/09653560310474214
   Dutton JE, 2006, ADMIN SCI QUART, V51, P59, DOI 10.2189/asqu.51.1.59
   Feld B, 2012, STARTUP COMMUNITIES
   Fisher G, 2020, J MANAGE STUD, V57, P1002, DOI 10.1111/joms.12584
   Flyvbjerg B, 2006, QUAL INQ, V12, P219, DOI 10.1177/1077800405284363
   Gates B, 2020, NEW ENGL J MED, V382, P1677, DOI 10.1056/NEJMp2003762
   George G, 2016, ACAD MANAGE J, V59, P1880, DOI 10.5465/amj.2016.4007
   Graham-Harrison E., 2020, GUARDIAN
   Hannah ST, 2009, LEADERSHIP QUART, V20, P897, DOI 10.1016/j.leaqua.2009.09.006
   Hilbert D., 1902, B AM MATH SOC, V8, P437, DOI [10.1090/S0002-9904-1902-00923-3, DOI 10.1090/S0002-9904-1902-00923-3]
   KANIASTY K, 1993, J PERS SOC PSYCHOL, V64, P395, DOI 10.1037/0022-3514.64.3.395
   Knapp J., 2016, SPRINT SOLVE BIG PRO
   Komssi M, 2015, IEEE SOFTWARE, V32, P60, DOI 10.1109/MS.2014.78
   MCMILLAN DW, 1986, J COMMUNITY PSYCHOL, V14, P6, DOI 10.1002/1520-6629(198601)14:1<6::AID-JCOP2290140103>3.0.CO;2-I
   Merrick A., 2020, GE REPORTS
   Mihalcik C., 2020, CNET
   Nager M., 2011, STARTUP WEEKEND TAKE
   Quarantelli E. L., 1985, WHAT IS DISASTER NEE
   Reid SW, 2018, LEADERSHIP QUART, V29, P150, DOI 10.1016/j.leaqua.2017.11.005
   Saunders C, 2004, ACAD MANAGE EXEC, V18, P19, DOI 10.5465/AME.2004.12691177
   Shah R.J, 2012, BUILDING RESILIENCE
   Siegel Benjamin, 2020, ABC NEWS
   Taleb N.N., 2007, BLACK SWAN IMPACT HI
   Trainer E. H., 2016, 19 ACM C COMP SUPP C
   USAID, 2020, WORK CRIS CONFL
   Weinberger M, 2017, BUSINESS INSIDER
   Williams TA, 2018, J MANAGE STUD, V55, P910, DOI 10.1111/joms.12291
   Williams TA, 2017, ACAD MANAG ANN, V11, P733, DOI 10.5465/annals.2015.0134
   Williams TA, 2016, J BUS VENTURING, V31, P365, DOI 10.1016/j.jbusvent.2016.04.002
   Xu NH, 2018, J SMALL BUS MANAGE, V56, P179, DOI 10.1111/jsbm.12367
NR 37
TC 43
Z9 43
U1 12
U2 56
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0007-6813
EI 1873-6068
J9 BUS HORIZONS
JI Bus. Horiz.
PD NOV-DEC
PY 2020
VL 63
IS 6
BP 705
EP 723
DI 10.1016/j.bushor.2020.05.002
PG 19
WC Business
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA OC7EN
UT WOS:000579318600004
PM 32398883
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Felicetti, AM
   Ammirato, S
   Corvello, V
   Iazzolino, G
   Verteramo, S
AF Felicetti, A. M.
   Ammirato, S.
   Corvello, V
   Iazzolino, G.
   Verteramo, S.
TI Total quality management and corporate social responsibility: a
   systematic review of the literature and implications of the COVID-19
   pandemics
SO TOTAL QUALITY MANAGEMENT & BUSINESS EXCELLENCE
LA English
DT Review; Early Access
DE total quality management; corporate social responsibility; Environmental
   Social Governance; systematic review of the literature; COVID-19
ID ORGANIZATIONAL PERFORMANCE; ENVIRONMENTAL-MANAGEMENT;
   INFORMATION-TECHNOLOGY; TQM IMPLEMENTATION; MEDIATING ROLE; CSR;
   STRATEGY; INDUSTRY; ADOPTION; CULTURE
AB The issue of corporate social responsibility (CSR) has received increasing attention from the literature in recent years. Systematic management of related objectives has become a priority for many companies. This trend has meant that research on CSR intersects with research on quality management. Several studies have analysed the implications of CSR for TQM and vice versa, to form a large and articulated body of knowledge. This body of knowledge, however, is still poorly organised. There are not many studies that systematically analyse it, trace its profile or lines of future development. To fill this gap, in this article, we present the results of a systematic review of the literature at the intersection of the themes of CSR and TQM. To take into account the impact of the COVID pandemic on this research area, a critical review was conducted on the papers published in recent years. The result of the analysis carried out is the identification of the main themes dealt with in the existing literature together with directions for future research.
C1 [Felicetti, A. M.; Ammirato, S.; Corvello, V; Iazzolino, G.; Verteramo, S.] Univ Calabria, Dept Mech Energy & Management Engn, Arcavacata Di Rende, Italy.
RP Corvello, V (corresponding author), Univ Calabria, Dept Mech Energy & Management Engn, Arcavacata Di Rende, Italy.
EM vincenzo.corvello@unical.it
OI Felicetti, Alberto Michele/0000-0002-3692-2643
CR Abbas J, 2020, J CLEAN PROD, V242, DOI 10.1016/j.jclepro.2019.118458
   Abdallah AA, 2021, BUS PROCESS MANAG J, V27, P2123, DOI 10.1108/BPMJ-11-2020-0509
   Adams C.A., 2021, CRIT PERSPECT, DOI [https://doi.org/10.1016/j.cpa.2021.102309, DOI 10.1016/J.CPA.2021.102309]
   Ahidar Ikram, 2019, TQM Journal, V31, P183, DOI 10.1108/TQM-02-2018-0025
   Ahmed PK, 2004, TOTAL QUAL MANAG BUS, V15, P527, DOI 10.1080/1478336042000183604
   Al-Marri K, 2007, INT J QUAL RELIAB MA, V24, P164, DOI 10.1108/02656710710722275
   Ammirato S, 2022, KNOWL MAN RES PRACT, DOI 10.1080/14778238.2022.2041375
   Anil AP, 2019, INT J QUAL RELIAB MA, V36, P1318, DOI 10.1108/IJQRM-10-2018-0266
   Gimenez-Espin JA, 2013, TOTAL QUAL MANAG BUS, V24, P678, DOI 10.1080/14783363.2012.707409
   Baidoun S.D., 2018, TQM J, V30, P98, DOI [https://doi.org/10.1108/TQM-03-2017-0034, DOI 10.1108/TQM-03-2017-0034]
   Barrett J.D, 2009, J QUAL PARTICIP, V31, P24
   Benavides-Velasco CA, 2014, INT J HOSP MANAG, V41, P77, DOI 10.1016/j.ijhm.2014.05.003
   Benitez-Amado J, 2012, EUR J INFORM SYST, V21, P664, DOI 10.1057/ejis.2012.14
   Bhimani H, 2019, TECHNOL FORECAST SOC, V144, P251, DOI 10.1016/j.techfore.2018.10.007
   Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826
   Butler T, 2012, INFORM SYST FRONT, V14, P221, DOI 10.1007/s10796-009-9197-5
   Campbell JL, 2007, ACAD MANAGE REV, V32, P946
   Casteleiro C, 2022, TOTAL QUAL MANAG BUS, V33, P243, DOI 10.1080/14783363.2020.1832460
   Castka P, 2008, IND MANAGE DATA SYST, V108, P297, DOI 10.1108/02635570810858732
   Cavallone M., 2021, TQM J ADV ONLINE PUB, DOI [https://doi.org/10.1108/TQM-05-2021-0148, DOI 10.1108/TQM-05-2021-0148]
   Chalmeta R, 2012, INT J COMPUT INTEG M, V25, P716, DOI 10.1080/0951192X.2012.665178
   Chams N, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13137026
   Chang J., 2009, ADV NEURAL INFORM PR, P288, DOI [10.5555/2984093.2984126, DOI 10.5555/2984093.2984126]
   Chaudhri V, 2016, INT J BUS COMMUN, V53, P419, DOI 10.1177/2329488414525469
   Chen T, 2020, J FINANC ECON, V135, P483, DOI 10.1016/j.jfineco.2019.06.007
   Chen ZY, 2014, PR MACH LEARN RES, V32, P703
   Chiarini Andrea, 2016, TQM Journal, V28, P360, DOI 10.1108/TQM-03-2014-0035
   Chih HL, 2010, J BUS ETHICS, V93, P115, DOI 10.1007/s10551-009-0186-x
   Christofi M, 2021, INT BUS REV, V30, DOI 10.1016/j.ibusrev.2019.101625
   Ciasullo MV, 2017, J GLOB FASH MARK, V8, P143, DOI 10.1080/20932685.2017.1279066
   Ciasullo MV, 2020, BUS STRATEG ENVIRON, V29, P2110, DOI 10.1002/bse.2490
   Ciasullo MV, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9091617
   Danyen Shameer, 2015, International Journal of Productivity and Quality Management, V16, P249
   Daraio C, 2022, MANAGE DECIS, V60, P995, DOI 10.1108/MD-01-2021-0069
   Darnall N, 2006, STRATEGIC MANAGE J, V27, P301, DOI 10.1002/smj.518
   Denyer D., 2009, SAGE HDB ORG RES MET
   Devin B, 2018, J BUS ETHICS, V150, P199, DOI 10.1007/s10551-016-3181-z
   Edinger-Schons LM, 2019, J BUS ETHICS, V157, P359, DOI 10.1007/s10551-018-3790-9
   Elliot S, 2011, MIS QUART, V35, P197
   Engle R., 2019, CORP SOC RESP ENV MA, V26, P1627, DOI [https://doi.org/10.1002/csr.1871, DOI 10.1002/CSR.1871]
   Eurosif, 2018, EUR SRI STUD 2018
   Fisscher O., 2005, THE TQM MAGAZINE, V17, P150, DOI [https://doi.org/10.1108/09544780510583227, DOI 10.1108/09544780510583227]
   Flynn B. B., 1994, Journal of Operations Management, V11, P339, DOI 10.1016/S0272-6963(97)90004-8
   Franco S, 2020, INT J HOSP MANAG, V88, DOI 10.1016/j.ijhm.2019.102395
   Galbreath J, 2010, BRIT J MANAGE, V21, P511, DOI 10.1111/j.1467-8551.2009.00633.x
   Gangi F, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11071899
   GarcYa-Bernal J., 2015, QUAL MANAG J, V22, P23, DOI DOI 10.1080/10686967.2015.11918439
   Georgiev S, 2020, BENCHMARKING, V27, P473, DOI 10.1108/BIJ-01-2019-0037
   Ghobadian A, 2007, INT J QUAL RELIAB MA, V24, P704, DOI 10.1108/02656710710774683
   Goncalves Helen Silva, 2009, TQM Journal, V21, P462, DOI 10.1108/17542730910983380
   Gorenak Stefka, 2010, International Journal of Sustainable Society, V2, P248, DOI 10.1504/IJSSOC.2010.034763
   Greening D.W., 2000, BUSINESS SOC, V39, P254, DOI DOI 10.1177/000765030003900302
   Gun Jea Yu, 2020, International Journal of Productivity and Quality Management, V31, P434, DOI 10.1504/IJPQM.2020.110940
   Guterres A., 2020, OPENING REMARKS VIRT
   Haffar M, 2013, TOTAL QUAL MANAG BUS, V24, P693, DOI 10.1080/14783363.2013.791112
   Hall CM, 2020, TOURISM GEOGR, V22, P577, DOI 10.1080/14616688.2020.1759131
   Hamdan Y., 2021, INT J ENTREPRENEURSH, V25, P1
   He HW, 2020, J BUS RES, V116, P176, DOI 10.1016/j.jbusres.2020.05.030
   Henderson R. M, 2020, HARVARD BUSINESS REV, P2
   Holjevac IA, 2008, TOTAL QUAL MANAG BUS, V19, P1029, DOI 10.1080/14783360802264103
   Ikram M, 2019, J CLEAN PROD, V226, P628, DOI 10.1016/j.jclepro.2019.03.265
   Ikram M, 2021, J ASIA BUS STUD, DOI 10.1108/JABS-07-2021-0316
   Isaksson R, 2006, BUS PROCESS MANAG J, V12, P632, DOI 10.1108/14637150610691046
   Jahdi KS, 2009, J BUS ETHICS, V88, P103, DOI 10.1007/s10551-009-0113-1
   Jensen MC, 2002, BUS ETHICS Q, V12, P235, DOI 10.2307/3857812
   Jones P, 2020, INT J CONTEMP HOSP M, V32, P3037, DOI 10.1108/IJCHM-04-2020-0357
   Tari JJ, 2011, J BUS ETHICS, V102, P623, DOI 10.1007/s10551-011-0833-x
   Kaynak H, 2003, J OPER MANAG, V21, P405, DOI 10.1016/S0272-6963(03)00004-4
   Khurshid MA, 2018, BENCHMARKING, V25, P2566, DOI 10.1108/BIJ-04-2017-0084
   Kok P, 2001, J BUS ETHICS, V31, P285
   Kraus S, 2020, INT ENTREP MANAG J, V16, P1023, DOI 10.1007/s11365-020-00635-4
   Kumar V, 2018, BENCHMARKING, V25, P3081, DOI 10.1108/BIJ-06-2017-0150
   Laise D, 2015, BENCHMARKING, V22, P338, DOI 10.1108/BIJ-01-2013-0005
   Lansiluoto Aapo, 2012, TQM Journal, V24, P388, DOI 10.1108/17542731211261557
   Jorge ML, 2016, COGENT BUS MANAG, V3, DOI 10.1080/23311975.2016.1228569
   Li ZH, 2020, BUS STRATEG ENVIRON, V29, P1045, DOI 10.1002/bse.2416
   Odeh RBSM, 2021, INT J PRODUCT PERFOR, DOI 10.1108/IJPPM-02-2021-0093
   Do MH, 2021, BENCHMARKING, V28, P1296, DOI 10.1108/BIJ-09-2020-0469
   Masa'deh R., 2018, MODERN APPL SCI, V12, P1, DOI [https://doi.org/10.25255/jbm.2019.7.2.162.191, DOI 10.25255/JBM.2019.7.2.162.191]
   McAdam R., 2003, CORP GOVERNANCE, V3, P36, DOI [10.1108/14720700310497104, DOI 10.1108/14720700310497104]
   McWilliams A, 2011, J MANAGE, V37, P1480, DOI 10.1177/0149206310385696
   Mehralian G, 2016, J CLEAN PROD, V135, P689, DOI 10.1016/j.jclepro.2016.06.116
   Mellat-Parast M, 2013, INT J PROD RES, V51, P2805, DOI 10.1080/00207543.2012.656333
   Molina-Azorin JF, 2015, TOURISM MANAGE, V50, P41, DOI 10.1016/j.tourman.2015.01.008
   Moratis L, 2017, TOTAL QUAL MANAG BUS, V28, P147, DOI 10.1080/14783363.2015.1050179
   Murmura F, 2017, J CLEAN PROD, V164, P1406, DOI 10.1016/j.jclepro.2017.07.073
   Nayebpour MR, 2003, J BUS ETHICS, V44, P37, DOI 10.1023/A:1023282307686
   Nunhes TV, 2016, J CLEAN PROD, V139, P1234, DOI 10.1016/j.jclepro.2016.08.159
   Palumbo R, 2021, TQM J, V33, P915, DOI 10.1108/TQM-05-2020-0120
   Paranitharan KP, 2017, INT J ADV MANUF TECH, V92, P2569, DOI 10.1007/s00170-017-0271-8
   Parast MM, 2012, INT J PROD ECON, V139, P447, DOI 10.1016/j.ijpe.2011.11.033
   Pedersen ER, 2008, MEAS BUS EXCELL, V12, P4, DOI 10.1108/13683040810864341
   Perles GSM, 2002, J BUS ETHICS, V39, P59, DOI 10.1023/A:1016327916711
   Petcu MA, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13137303
   Porter ME, 2006, HARVARD BUS REV, V84, P78
   Prajogo DI, 2011, INT J OPER PROD MAN, V31, P712, DOI 10.1108/01443571111144823
   Qiu S, 2021, INT J HOSP MANAG, V93, DOI 10.1016/j.ijhm.2020.102759
   Raju, 2020, INT J SUPPLY CHAIN M, V9, P294
   Ramanathan R, 2017, J CLEAN PROD, V155, P79, DOI 10.1016/j.jclepro.2016.08.116
   Ravina-Ripoll R, 2021, INT J BUS ENVIRON, V12, P287
   Rebelo Manuel Ferreira, 2014, TQM Journal, V26, P143, DOI 10.1108/TQM-08-2012-0055
   Reverte C, 2016, J CLEAN PROD, V112, P2870, DOI 10.1016/j.jclepro.2015.09.128
   Rivera DE, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13042153
   Robson A, 2007, INT J QUAL RELIAB MA, V24, P722, DOI 10.1108/02656710710774692
   Rousseau R., 2014, MEASURING SCHOLARLY, P285, DOI [10.1007/978-3-319-10377-8_13, DOI 10.1007/978-3-319-10377-8_13, 10.1007/978-3-319-10377-8_13(InEng.)]
   Salah Souraj, 2020, International Journal of Business Excellence, V20, P471
   Salomone R, 2008, J CLEAN PROD, V16, P1786, DOI 10.1016/j.jclepro.2007.12.003
   Sila I, 2003, INT J PROD RES, V41, P235, DOI 10.1080/0020754021000022212
   Sila I, 2020, TOTAL QUAL MANAG BUS, V31, P210, DOI 10.1080/14783363.2018.1458609
   Sivarajah U, 2017, J BUS RES, V70, P263, DOI 10.1016/j.jbusres.2016.08.001
   Skare M, 2021, TECHNOL FORECAST SOC, V163, DOI 10.1016/j.techfore.2020.120469
   Snyder H, 2019, J BUS RES, V104, P333, DOI 10.1016/j.jbusres.2019.07.039
   Sweis Rateb J., 2016, International Journal of Productivity and Quality Management, V19, P258
   Tang Xiaofen, 2013, TQM Journal, V25, P417, DOI 10.1108/17542731311314890
   Turker D, 2014, EUR MANAG J, V32, P837, DOI 10.1016/j.emj.2014.02.001
   van Eck NJ, 2017, SCIENTOMETRICS, V111, P1053, DOI 10.1007/s11192-017-2300-7
   Verma P, 2022, TQM J, V34, P29, DOI 10.1108/TQM-02-2021-0037
   Vinten G., 1998, THE TQM MAGAZINE, V10, P89, DOI [https://doi.org/10.1108/09544789810211380, DOI 10.1108/09544789810211380]
   Visse M, 2012, EVAL PROGRAM PLANN, V35, P97, DOI 10.1016/j.evalprogplan.2011.08.003
   Voegtlin C, 2016, HUM RESOUR MANAGE R, V26, P181, DOI 10.1016/j.hrmr.2015.12.003
   Wang Y, 2015, INT J INFORM MANAGE, V35, P160, DOI 10.1016/j.ijinfomgt.2014.11.005
   Wilson JP, 2020, TOTAL QUAL MANAG BUS, V31, P761, DOI 10.1080/14783363.2018.1445965
   Yoshino N, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101695
   Young S, 2009, ASIA PAC J HUM RESOU, V47, P167, DOI 10.1177/1038411109105440
   Zairi M., 2002, MANAG AUDIT J, V17, P174, DOI [https://doi.org/10.1108/02686900210424312, DOI 10.1108/02686900210424312]
   Zhao ZY, 2012, J CLEAN PROD, V29-30, P277, DOI 10.1016/j.jclepro.2011.12.036
NR 126
TC 0
Z9 0
U1 4
U2 4
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1478-3363
EI 1478-3371
J9 TOTAL QUAL MANAG BUS
JI Total Qual. Manag. Bus. Excell.
DI 10.1080/14783363.2022.2049443
EA MAR 2022
PG 20
WC Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA ZU5EE
UT WOS:000769864400001
DA 2022-04-20
ER

PT J
AU Bravo, LG
   Nistor, N
   Ramirez, BC
   Soto, IG
   Contreras, MV
   Vives, MN
   Robles, PM
AF Gonzalez Bravo, Luis
   Nistor, Nicolae
   Castro Ramirez, Bernardo
   Gutierrez Soto, Ilse
   Varas Contreras, Marcela
   Nunez Vives, Monica
   Maldonado Robles, Pia
TI Higher education managers' perspectives on quality management and
   technology acceptance: A tale of elders, mediators, and working bees in
   times of Covid-19
SO COMPUTERS IN HUMAN BEHAVIOR
LA English
DT Article
DE Educational management information systems; Quality management; Higher
   education; Quality management and accreditation; perceptions scale;
   Information and media literacy
ID USER ACCEPTANCE; SYSTEMS; MODEL
AB The Covid-19 pandemic has emphasized the role of educational management information systems (EMIS) for quality management (QM) in higher education, and set new directions for post-pandemic studies. Successful implementation of QM processes depends largely on managers' perceptions about quality and educational technology. However, higher education managers' profiles regarding these quality perceptions and their EMIS acceptance have been insufficiently investigated so far. In response to this research gap, we identified such profiles based on a quantitative survey of N = 70 managers from Chilean higher education institutions during the Covid-19 pandemic. A cluster analysis revealed three distinct manager types: "Elders" (oldest participants, almost equally distributed across positions, with least frequent EMIS access, moderate EMIS acceptance, and highest QM perceptions), "Mediators" (in operational and middle-management positions, with moderately frequent access to EMIS, and lowest EMIS acceptance and QM perceptions), and "Working Bees" (younger fe -males in operational positions, with most frequent EMIS access, highest EMIS acceptance, and moderate QM perceptions). Knowledge of these profiles may enable customized training in the recovery after the Covid-19 pandemic.
C1 [Gonzalez Bravo, Luis; Castro Ramirez, Bernardo; Gutierrez Soto, Ilse; Varas Contreras, Marcela; Nunez Vives, Monica; Maldonado Robles, Pia] Univ Concepcion, Barrio Univ S-N, Concepcion, Chile.
   [Gonzalez Bravo, Luis; Nistor, Nicolae] Ludwig Maximilian Univ Munchen, Fac Psychol & Educ Sci, Leopoldstr 13, D-80802 Munich, Germany.
   [Nistor, Nicolae] Walden Univ, Richard W Riley Coll Educ & Leadership, 100 Washington Ave South,Suite 900, Minneapolis, MN 55401 USA.
RP Nistor, N (corresponding author), Ludwig Maximilian Univ Munchen, Fac Psychol & Educ Sci, Leopoldstr 13, D-80802 Munich, Germany.
EM lgonzalez@udec.cl; nic.nistor@uni-muenchen.de; becastro@udec.cl;
   ilsegutierrez@udec.cl; mvaras@udec.cl; mnunez@udec.cl;
   piamaldonado@udec.cl
OI Gonzalez-Bravo, Luis/0000-0001-7310-3762; varas,
   marcela/0000-0003-2721-9865; Nunez Vives, Monica Claudia
   Elena/0000-0003-1128-3328
CR Alexander B., 2019, HORIZON REPORT 2019
   Aljbour H. R. A, 2021, J ARTS LIT HUMANITIE, V65, P415, DOI [10.33193/JALHSS.65.2021.449, DOI 10.33193/JALHSS.65.2021.449]
   Alzahrani B, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13095169
   Ammenwerth Elske, 2019, Stud Health Technol Inform, V263, P64, DOI 10.3233/SHTI190111
   Aveiga Macay V., 2019, RECUS REV ELECT COOP, V4, P26, DOI [10.33936/recus.v4i1.1750, DOI 10.33936/RECUS.V4I1.1750]
   Bagozzi RP, 2007, J ASSOC INF SYST, V8, P243
   Baird A. F., 2019, SOCIOL FOCUS, V52, P343, DOI [10.1080/00380237.2019.1668321, DOI 10.1080/00380237.2019.1668321]
   Bendermacher GWG, 2017, HIGH EDUC, V73, P39, DOI 10.1007/s10734-015-9979-2
   Cardoso S, 2013, QUAL ASSUR EDUC, V21, P96, DOI 10.1108/09684881311293089
   Chaurasia SS, 2018, INT J EDUC MANAG, V32, P1099, DOI 10.1108/IJEM-08-2017-0199
   Crawford J., 2020, J APPL TEACHING LEAR, V3, P1, DOI [10.37074/jalt.2020.3.1.7, DOI 10.37074/JALT.2020.3.1.7]
   da Silva A. P, 2017, REV ELETRNICA SISTEM, V16, P1, DOI [10.21529/resi.2017.1603003, DOI 10.21529/RESI.2017.1603003]
   Danaiata D, 2018, LECT NOTES BUS INF P, V273, P55, DOI 10.1007/978-3-319-73459-0_4
   Devolder P, 2012, INFORM MANAGE-AMSTER, V49, P233, DOI 10.1016/j.im.2012.05.003
   Duque JF, 2021, HIGH EDUC, V82, P669, DOI 10.1007/s10734-020-00633-z
   Dwivedi YK, 2019, INFORM SYST FRONT, V21, P719, DOI 10.1007/s10796-017-9774-y
   Dziminska M, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10082599
   Elizondo J. F, 2019, REV PUCE, V2019, P63, DOI [10.26807/revpuce.v0i109.246, DOI 10.26807/REVPUCE.V0I109.246]
   ESG, 2015, STAND GUID QUAL ASS
   Fardella C, 2020, DIGIT EDUC REV, P64
   Garg A, 2017, 2017 INTERNATIONAL CONFERENCE OF ELECTRONICS, COMMUNICATION AND AEROSPACE TECHNOLOGY (ICECA), VOL 2, P604, DOI 10.1109/ICECA.2017.8212737
   Garone A, 2019, BRIT J EDUC TECHNOL, V50, P2466, DOI 10.1111/bjet.12867
   Bravo LG, 2020, EUR J DENT EDUC, V24, P706, DOI 10.1111/eje.12559
   Bravo LG, 2021, INFORM DEV, V37, P58, DOI 10.1177/0266666919894725
   González-Bravo Luis, 2020, Calidad en la educación, P321, DOI 10.31619/caledu.n53.860
   González-Bravo Luis, 2015, Educare, V19, P181
   Hashim MAM, 2022, EDUC INF TECHNOL, V27, P3171, DOI 10.1007/s10639-021-10739-1
   Heavin C, 2018, J DECIS SYST, V27, P38, DOI 10.1080/12460125.2018.1468697
   Iglesias-Pradas S, 2021, COMPUT HUM BEHAV, V119, DOI 10.1016/j.chb.2021.106713
   Iivari N, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102183
   Kayanda A., 2020, INT J ED DEV USING I, V16, P72
   Kudyba S, 2020, INFORM SYST MANAGE, V37, P284, DOI 10.1080/10580530.2020.1818903
   Kumar P., 2020, INVESTIGACION OPERAC, V41, P151
   Lave J., 1991, SITUATED LEARNING LE
   Lee YH, 2013, BEHAV INFORM TECHNOL, V32, P173, DOI 10.1080/0144929X.2011.577190
   Magsamen-Conrad K, 2020, HEALTH COMMUN, V35, P308, DOI 10.1080/10410236.2018.1563027
   Mercader C, 2020, INT J EDUC TECHNOL H, V17, DOI 10.1186/s41239-020-0182-x
   Michel -Madera M., 2012, APERTURA, V4, P96
   Mora A., 2009, DESAFIOS PERSPECTIVA, P403
   Mukred M, 2019, IEEE ACCESS, V7, P35963, DOI 10.1109/ACCESS.2019.2904617
   Nistor N, 2020, COMPUT HUM BEHAV, V105, DOI 10.1016/j.chb.2019.106202
   Nistor N, 2010, STUD CONTIN EDUC, V32, P251, DOI 10.1080/0158037X.2010.517996
   Noecker, 2019, QUALITY 4 0 TAKES MO
   Nurhas I, 2021, BEHAV INFORM TECHNOL, DOI 10.1080/0144929X.2021.1962977
   Oksanen A, 2021, COMPUT HUM BEHAV, V122, DOI 10.1016/j.chb.2021.106853
   Opazo P., 2019, ANALISIS INSTITUCION
   Papagiannidis S, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102166
   Phahlane M. M., 2014, P SO ASS INF SYST C, V2, P1
   Pulido-Rocatagliata S., 2018, REV VENEZ GERENC, V23, P238
   Pynoo B, 2011, COMPUT HUM BEHAV, V27, P568, DOI 10.1016/j.chb.2010.10.005
   Rezvani Z., 2017, INT J FAMILY BUS MAN, V1, P1
   Sanchez-Ruiz L, 2019, J IND ENG MANAG-JIEM, V12, P51, DOI 10.3926/jiem.2743
   Schaffhauser D, 2020, CDC ISSUES COVID 19
   Scherer R, 2019, COMPUT EDUC, V128, P13, DOI 10.1016/j.compedu.2018.09.009
   Seyfried M, 2018, HIGH EDUC, V75, P1061, DOI 10.1007/s10734-017-0185-2
   Shawyun T., 2021, HDB RES MODERN ED TE, P139, DOI [10.4018/978-1-7998-3476-2.ch009, DOI 10.4018/978-1-7998-3476-2.CH009]
   Staub D, 2019, QUAL HIGH EDUC, V25, P171, DOI 10.1080/13538322.2019.1634342
   Stensaker B, 2011, ASSESS EVAL HIGH EDU, V36, P465, DOI 10.1080/02602930903432074
   Thompson RC, 2018, AFR J INF SYST, V10, P21
   Tillman A, 2020, SAP ADDRESSES SUPPLY
   Tsiligiris V, 2021, STUD HIGH EDUC, V46, P228, DOI 10.1080/03075079.2019.1628203
   UNESCO, 2021, REIM FUT ED MAN INF
   Berrocoso JV, 2010, REV EDUC, P99
   van Wyk C., 2020, GUIDELINES DATA MANA
   Vega Angarita O. M, 2020, AV ENFERM, V38, P7, DOI [10.15446/av.enferm.v38n1.83875, DOI 10.15446/AV.ENFERM.V38N1.83875]
   Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540
   Venkatesh V, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102197
   Wang B, 2020, ACAD MANAG ANN, V14, P695, DOI 10.5465/annals.2018.0127
   Wenger E., 1999, COMMUNITIES PRACTICE
   Woo SE, 2018, ORGAN RES METHODS, V21, P814, DOI 10.1177/1094428117752467
   Yim O, 2015, QUANT METH PSYCHOL, V11, P8, DOI 10.20982/tqmp.11.1.p008
   Zhao FQ, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.584857
NR 72
TC 0
Z9 0
U1 10
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0747-5632
EI 1873-7692
J9 COMPUT HUM BEHAV
JI Comput. Hum. Behav.
PD JUN
PY 2022
VL 131
AR 107236
DI 10.1016/j.chb.2022.107236
PG 11
WC Psychology, Multidisciplinary; Psychology, Experimental
WE Social Science Citation Index (SSCI)
SC Psychology
GA ZF7BM
UT WOS:000759720500002
PM 35185275
OA Green Published
DA 2022-04-20
ER

PT J
AU Zaim, S
   Chong, JH
   Sankaranarayanan, V
   Harky, A
AF Zaim, Sevim
   Chong, Jun Heng
   Sankaranarayanan, Vissagan
   Harky, Amer
TI COVID-19 and Multiorgan Response
SO CURRENT PROBLEMS IN CARDIOLOGY
LA English
DT Review
ID CRITICALLY-ILL PATIENTS; CLINICAL-COURSE; CORONAVIRUS; TRANSMISSION;
   WUHAN; SARS; MANAGEMENT; MORTALITY; OUTBREAK; OUTCOMES
AB Since the outbreak and rapid spread of COVID-19 starting late December 2019, it has been apparent that disease prognosis has largely been influenced by multiorgan involvement. Comorbidities such as cardiovascular diseases have been the most common risk factors for severity and mortality. The hyperinflammatory response of the body, coupled with the plausible direct effects of severe acute respiratory syndrome on body-wide organs via angiotensin-converting enzyme 2, has been associated with complications of the disease. Acute respiratory distress syndrome, heart failure, renal failure, liver damage, shock, and multiorgan failure have precipitated death. Acknowledging the comorbidities and potential organ injuries throughout the course of COVID-19 is therefore crucial in the clinical management of patients. This paper aims to add onto the ever-merging landscape of medical knowledge on COVID19, encapsulating its multiorgan impact.
RI Harky, Amer/AAO-2125-2020
OI Harky, Amer/0000-0001-5507-5841
CR Aggarwal G, 2020, CURR PROB CARDIOLOGY, V45, DOI 10.1016/j.cpcardiol.2020.100617
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   Arabi YM, 2014, ANN INTERN MED, V160, P389, DOI 10.7326/M13-2486
   Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326
   Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Beeching NJ, 2020, BMJ BEST PRACTICE
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen J, 2020, J INFECTION, V80, pE1, DOI 10.1016/j.jinf.2020.03.004
   Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]
   Chen Y, 2020, HUMAN KIDNEY IS TARG, DOI [10.1101/2020.03.04.20031120, DOI 10.1101/2020.03.04.20031120]
   Chen Y, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00104
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Chu KH, 2005, KIDNEY INT, V67, P698, DOI 10.1111/j.1523-1755.2005.67130.x
   Ding YQ, 2004, J PATHOL, V203, P622, DOI 10.1002/path.1560
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Fardet L, 2014, ARTHRITIS RHEUMATOL, V66, P2613, DOI 10.1002/art.38690
   Faubel S, 2016, NAT REV NEPHROL, V12, P48, DOI 10.1038/nrneph.2015.158
   Fried JA, 2020, CIRCULATION, V141, P1930, DOI 10.1161/CIRCULATIONAHA.120.047164
   Gaudry S, 2016, NEW ENGL J MED, V375, P122, DOI 10.1056/NEJMoa1603017
   Ghani RA, 2006, NEPHROLOGY, V11, P386, DOI 10.1111/j.1440-1797.2006.00600.x
   Guan W-J, 2020, NEW ENGL J MED
   Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Hu HD, 2021, EUR HEART J, V42, P206, DOI 10.1093/eurheartj/ehaa190
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jin M, 2020, EMERG INFECT DIS, V26, P1618, DOI 10.3201/eid2607.200445
   Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6
   Khan IH, 2020, J CARDIAC SURG, V35, P1287, DOI 10.1111/jocs.14596
   Khashkhusha TR, 2020, J CARDIAC SURG, V35, P1172, DOI 10.1111/jocs.14582
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728
   [李仲平 Li Zhongping], 2020, [中国软科学, China Soft Science], P1
   Liang KV, 2016, CLIN J AM SOC NEPHRO, V11, P30, DOI 10.2215/CJN.01290215
   Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Mao L, 2020, MEDRXIV 202002222002, DOI [10.1101/2020.02.22.20026500, DOI 10.1101/2020.02.22.20026500]
   McIntosh, CORONAVIRUS DIS 2019
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Meng J, 2020, EMERG MICROBES INFEC, V9, P757, DOI 10.1080/22221751.2020.1746200
   Naicker S, 2020, KIDNEY INT, V97, P824, DOI 10.1016/j.kint.2020.03.001
   Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639
   Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370
   Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248
   Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Schwartz DA, 2020, ARCH PATHOL LAB MED, V144, P799, DOI 10.5858/arpa.2020-0901-SA
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Shi HS, 2020, RADIOLOGY, V295, P20, DOI 10.1148/radiol.2020200269
   Tang N, 2020, J THROMB HAEMOST, V18, P1094, DOI 10.1111/jth.14817
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]
   Weiss P, 2020, LANCET, V395, P1014, DOI 10.1016/S0140-6736(20)30633-4
   WHO, CLIN MAN SEV AC RESP
   Wong SH, 2020, J GASTROEN HEPATOL, V35, P744, DOI 10.1111/jgh.15047
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Wu D, 2020, INT J INFECT DIS, V94, P44, DOI 10.1016/j.ijid.2020.03.004
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]
   Xu XT, 2020, SCI CHINA LIFE SCI, V63, P457, DOI 10.1007/s11427-020-1637-5
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017
   Yeo C, 2020, LANCET GASTROENTEROL, V5, P335, DOI 10.1016/S2468-1253(20)30048-0
   Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196
   Zeng JH, 2020, INFECTION, V48, P773, DOI 10.1007/s15010-020-01424-5
   Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1
   Zhang H, 2020, DIGESTIVE SYSTEM IS, P1, DOI [10.1101/2020.01.30.927806v1, DOI 10.1101/2020.01.30.927806, 10.1101/2020.01.30.927806]
   Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zuo, 2020, SINGLE CELL RNA EXPR, DOI 10.1101/2020.01.26.919985
NR 77
TC 344
Z9 352
U1 13
U2 75
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0146-2806
EI 1535-6280
J9 CURR PROB CARDIOLOGY
JI Curr. Probl. Cardiol.
PD AUG
PY 2020
VL 45
IS 8
AR 100618
DI 10.1016/j.cpcardiol.2020.100618
PG 21
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA LW7PE
UT WOS:000539334600003
PM 32439197
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Fang, XH
   Wu, L
   Lu, LS
   Kan, XH
   Wang, H
   Xiong, YJ
   Ma, DC
   Wu, GC
AF Fang, Xue-Hui
   Wu, Li
   Lu, Lun-Shan
   Kan, Xiao-Hong
   Wang, Hua
   Xiong, Yan-Jun
   Ma, Dong-Chun
   Wu, Guo-Cui
TI Mental health problems and social supports in the COVID-19 healthcare
   workers: a Chinese explanatory study
SO BMC PSYCHIATRY
LA English
DT Article
DE COVID-19; Tuberculosis; Social support; Lonely; Depression
AB Background: Coronavirus disease 2019 (COVID-19) has spread rapidly in China and other overseas areas, which has aroused widespread concern. The sharp increase in the number of patients has led to great psychological pressure on health care workers. The purpose of this study was to understand their mental health status and needs, so as to provide a scientific basis for alleviating the psychological pressure of health care workers.
   Methods: Using a cross-sectional study design, 540 health care workers were randomly selected from two designated tuberculosis medical institutions in Anhui Province. The basic situation, perceived social support, depression level, loneliness and COVID-19 related knowledge were collected and analyzed by questionnaire.
   Results: A total of 511 valid questionnaires were finally retrieved. There were 139 people in epidemic prevention and control positions (27.20%). Depression level: People in isolation ward, fever clinic and pre-check triage were at the level of mild to moderate depression. Female was higher than male; nurse was higher than doctor; middle and junior job titles were higher than senior titles; junior college degree or below were higher than bachelor's degree, master's degree and above; isolation ward, fever clinic and pre-check triage were significantly higher than those of non-prevention and control positions (p < 0.05). Loneliness scores: Doctors were higher than that of medical technicians, and isolation ward, fever clinic and pre-check triage were higher than those of other medical departments (p < 0.05). Social support: Doctors were lower than that of medical technicians, and isolation ward, fever clinic and pre-check triage were significantly lower than those of other departments (p < 0.05). The score of social support was negatively correlated with depression and loneliness (p < 0.001), while depression was positively correlated with loneliness (p < 0.001). Health care workers most want to receive one-to-one psychological counseling (29.75%), and provide crisis management (24.07%). The awareness rate of health care workers on COVID-19's knowledge was relatively high.
   Conclusions: The psychological problems of health care workers, especially women, nurses with low educational background, low professional title, and staff in the epidemic prevention and control positions are relatively serious.
C1 [Fang, Xue-Hui] Anhui Inst TB Control, Anhui Prov Chest Hosp, Personnel Off, Hefei 230022, Anhui, Peoples R China.
   [Fang, Xue-Hui; Kan, Xiao-Hong; Wang, Hua; Xiong, Yan-Jun; Ma, Dong-Chun] Anhui Med Univ, Anhui Prov Chest Hosp, Hefei, Peoples R China.
   [Wu, Li; Wu, Guo-Cui] Anhui Med Univ, Sch Nursing, Hefei 230032, Anhui, Peoples R China.
   [Lu, Lun-Shan] Anhui Prov Hosp, Infect Hosp, Hefei 230001, Anhui, Peoples R China.
   [Kan, Xiao-Hong] Anhui Prov Chest Hosp, Sci & Educ Div, Anhui Inst TB Control, Hefei 230022, Anhui, Peoples R China.
   [Wang, Hua; Xiong, Yan-Jun] Anhui Prov Chest Hosp, TB Dept, Anhui Inst TB Control, Hefei 230022, Anhui, Peoples R China.
   [Ma, Dong-Chun] Anhui Prov Chest Hosp, Hosp Off, Anhui Inst TB Control, Hefei 230022, Peoples R China.
RP Ma, DC (corresponding author), Anhui Med Univ, Anhui Prov Chest Hosp, Hefei, Peoples R China.; Wu, GC (corresponding author), Anhui Med Univ, Sch Nursing, Hefei 230032, Anhui, Peoples R China.; Ma, DC (corresponding author), Anhui Prov Chest Hosp, Hosp Off, Anhui Inst TB Control, Hefei 230022, Peoples R China.
EM madongchun126@126.com; gcwu82@126.com
FU Scientific Research Project of Anhui Provincial Health Commission
   [2020XK001]
FX This study was supported by Scientific Research Project of Anhui
   Provincial Health Commission (2020XK001). The funding body had no role
   in study design, collection, analysis, interpretation of data or in
   writing the manuscript.
CR [Anonymous], 2020, 113 WHO
   Bhuiyan AKMI, 2021, INT J MENT HEALTH AD, V19, P2110, DOI 10.1007/s11469-020-00307-y
   BLUMENTHAL JA, 1987, PSYCHOSOM MED, V49, P331, DOI 10.1097/00006842-198707000-00002
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chu WJ., 2017, J TRADIT CHIN MED, V25, P20
   Commission NH, 2020, CIRC NAT HLTH COMM I
   Didar-Ul Islam SM, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04399
   Dsouza DD, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113145
   Dunstan DA, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1489-6
   Griffiths MD, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113105
   Hai H, 2004, STUDY CURRENT SITUAT
   Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954
   Inoue N, 2016, IJC METAB ENDOCR, V12, P3, DOI 10.1016/j.ijcme.2016.05.002
   Jiao LN., 2017, CHINESE DISASTER RES, V5, P30
   Kannan S, 2020, EUR REV MED PHARMACO, V24, P2006, DOI 10.26355/eurrev_202002_20378
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Liang ZQ., 2004, CHINA PUBLIC HLTH, V01, P50
   Luo TD., 2020, ZHONGHUA LAO DONG WE, V38, P192, DOI [DOI 10.3760/CMA.J.CN121094-20200219-00063, 10.3760/cma.j.cn121094-20200219-00063]
   Mamun MA, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00362-5
   Mamun MA, 2020, ASIAN J PSYCHIATR, V54, DOI 10.1016/j.ajp.2020.102295
   Mamun MA, 2020, BRAIN BEHAV IMMUN, V87, P163, DOI 10.1016/j.bbi.2020.05.028
   Mamun MA, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102073
   Ng QX, 2020, ASIAN J PSYCHIATR, V54, DOI 10.1016/j.ajp.2020.102258
   Ng QX, 2020, INT J SOC PSYCHIATR, V66, P519, DOI 10.1177/0020764020926562
   Qi JJ., 2020, GEN PRACT NURS, V18, P703
   Qian M, 2020, PSYCHOL RESPONSES BE, DOI [DOI 10.1101/2020.02.18.20024448, 10.1101/2020.02.18.20024448.]
   RUSSELL D, 1978, J PERS ASSESS, V42, P290, DOI 10.1207/s15327752jpa4203_11
   Shao L., 2004, N CHINA NATL DEFENSE, V03, P209
   Ullah, 2020, SOCIAL HLTH BEHAV, V3, P75, DOI [10.4103/SHB.SHB_26_20, DOI 10.4103/SHB.SHB_26_20]
   Wang XD., 1999, BEIJING CHINA MENTAL, V12, P82
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xiao H, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923549
   Xueqin H., 2018, STUDY RELATIONSHIP H
   Yang XY., 2020, CHINESE CRITICAL CAR, V32, P01
   Yuan J., 2017, OCCUP HEALTH, V33, P2918
   Zhang, 2019, NURS PRACT RES, V16, P12
   Zhang RM., 2012, CHINA HLTH NUTR LATE, V22, P11
   Zhou T, 2016, ASIAN J SOC PSYCHOL, V19, P311, DOI 10.1111/ajsp.12149
   Zhu X, 2020, ANN TRANSPL, V25, DOI 10.12659/AOT.920984
   Zuo DM., 2007, ARMED POLICE MED, V18, P108
NR 40
TC 19
Z9 19
U1 11
U2 33
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-244X
J9 BMC PSYCHIATRY
JI BMC Psychiatry
PD JAN 12
PY 2021
VL 21
IS 1
AR 34
DI 10.1186/s12888-020-02998-y
PG 8
WC Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Psychiatry
GA PU7SB
UT WOS:000609499900004
PM 33435867
OA Green Published, Green Submitted, gold
DA 2022-04-20
ER

PT J
AU Rao, A
   Ma, HT
   Moloney, G
   Kwong, JC
   Juni, P
   Sander, B
   Kustra, R
   Baral, SD
   Mishra, S
AF Rao, Amrita
   Ma, Huiting
   Moloney, Gary
   Kwong, Jeffrey C.
   Juni, Peter
   Sander, Beate
   Kustra, Rafal
   Baral, Stefan D.
   Mishra, Sharmistha
TI A disproportionate epidemic: COVID-19 cases and deaths among essential
   workers in Toronto, Canada
SO ANNALS OF EPIDEMIOLOGY
LA English
DT Article
DE COVID-19; Essential workers; Disease transmission; Health inequity;
   Infectious disease
AB Shelter-in-place mandates and closure of nonessential businesses have been central to COVID19 response strategies including in Toronto, Canada. Approximately half of the working population in Canada are employed in occupations that do not allow for remote work suggesting potentially limited impact of some of the strategies proposed to mitigate COVID-19 acquisition and onward transmission risks and associated morbidity and mortality. We compared per-capita rates of COVID-19 cases and deaths from January 23, 2020 to January 24, 2021, across neighborhoods in Toronto by proportion of the population working in essential services. We used person-level data on laboratory-confirmed COVID-19 community cases and deaths, and census data for neighborhood-level attributes. Cumulative per-capita rates of COVID-19 cases and deaths were 3.3-fold and 2.5-fold higher, respectively, in neighborhoods with the highest versus lowest concentration of essential workers. Findings suggest that the population who continued to serve the essential needs of society throughout COVID-19 shouldered a disproportionate burden of transmission and deaths. Taken together, results signal the need for active intervention strategies to complement restrictive measures to optimize both the equity and effectiveness of COVID-19 responses. (c) 2021 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
C1 [Rao, Amrita; Baral, Stefan D.] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Ma, Huiting; Moloney, Gary; Juni, Peter; Mishra, Sharmistha] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada.
   [Kwong, Jeffrey C.; Sander, Beate] ICES, Toronto, ON, Canada.
   [Kwong, Jeffrey C.] Univ Toronto, Fac Med, Dept Family & Community Med, Toronto, ON, Canada.
   [Kwong, Jeffrey C.; Sander, Beate] Publ Hlth Ontario, Toronto, ON, Canada.
   [Kwong, Jeffrey C.; Kustra, Rafal] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Kwong, Jeffrey C.] Univ Hlth Network, Toronto, ON, Canada.
   [Sander, Beate] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
   [Mishra, Sharmistha] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada.
RP Mishra, S (corresponding author), Li Ka Shing Knowledge Inst, MAP Ctr Urban Hlth Solut, Room 315,209 Victoria St, Toronto, ON M5B 1T8, Canada.
EM sharmistha.mishra@utoronto.ca
RI Baral, Stefan/AAG-4818-2020
OI Baral, Stefan/0000-0002-5482-2419
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [VR5-172683]
FX This work was supported by the Canadian Institutes of Health Research
   (grant no. VR5-172683) .
CR [Anonymous], COVID-19: Active Outbreaks 2021
   [Anonymous], 2021, LIKELY SOURCE INFECT
   Canadian Institute for Health Information, 2021, COVID 19 INT TIM CAN
   Chen YH, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252454
   City of Toronto, COVID 19 STAT CAS TO
   City of Toronto, 2021, COVID 19 CHANG CIT S
   Deng Z, 2020, RUNNING EC REMOTELY
   Jones RP., FEDERAL SICKNESS BEN
   Kisling LA, 2020, PREVENTION STRATEGIE
   Ministry of Health Ontario., ONT IS RESP COVID 19
   ODonnell J, 2020, ESSENTIAL WORKERS CO
   Office of the Premier Ontario., 2020, ONT ANN PROV SHUTD S
   Public Safety Canada, GUID ESS SERV FUNCT
   Statistics Canada, 2016, VIS MIN POP GROUP RE
   Statistics Canada, GEN SOC SURV CAN WOR
   Statistics Canada, NAT OCC CLASS NOC 20
   The University of British Columbia, 2020, RES BRIEF AB WORK HO
   Thompson A, 2021, SCI BRIEFS ONTARIO C, V2, P1
   Watsa V, HOPKINS CLIN BRING V
   Weill JA, 2020, P NATL ACAD SCI USA, V117, P19658, DOI 10.1073/pnas.2009412117
NR 20
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1047-2797
EI 1873-2585
J9 ANN EPIDEMIOL
JI Ann. Epidemiol.
PD NOV
PY 2021
VL 63
BP 63
EP 67
DI 10.1016/j.annepidem.2021.07.010
EA AUG 2021
PG 5
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA WC6MC
UT WOS:000704369300010
OA Green Published, hybrid, Green Submitted
DA 2022-04-20
ER

PT J
AU Acosta, A
   McCorriston, S
   Nicolli, F
   Venturelli, E
   Wickramasinghe, U
   ArceDiaz, E
   Scudiero, L
   Sammartino, A
   Schneider, F
   Steinfeld, H
AF Acosta, Alejandro
   McCorriston, Steve
   Nicolli, Francesco
   Venturelli, Ester
   Wickramasinghe, Upali
   ArceDiaz, Eduardo
   Scudiero, Lavinia
   Sammartino, Alejandro
   Schneider, Fritz
   Steinfeld, Henning
TI Immediate effects of COVID-19 on the global dairy sector
SO AGRICULTURAL SYSTEMS
LA English
DT Article
DE COVID-19; Dairy sector; Longitudinal qualitative approach; Supply chain;
   Sectorial policy reforms
ID IMPACT
AB CONTEXT: The emergence and rapid spread of the coronavirus disease (COVID-19) has posed an unprecedented threat to both societies and economies. The dairy sector is an example of the challenges that food supply chains have faced due to the pandemic. OBJECTIVE: This study aims to provide primary evidence of the immediate effects of COVID-19 on the global dairy sector, particularly focusing on the outcome of the implemented response mechanisms, and the potential medium and long-term implications of the pandemic on the sector. METHODS: We employed a longitudinal qualitative analysis framework that combines the use of questionnaires, media-search, focus-group discussions, semi-structured interviews, and secondary evidence reviews. Information was gathered at two points in time: three months after the beginning of the outbreak and one year later. We applied this framework in five different geographical regions: Africa, Asia, Europe, Latin America, and North America. RESULTS AND CONCLUSIONS: Our study indicates that the pandemic has been perceived as a series of episodes affecting the sector from both demand and supply sides. These waves have impacted the sector differently depending on regions and countries' trade profiles, relative resource scarcity, per capita income, and market structure. Although in one year the sector has mostly recovered from the shock, the analysis concludes that the pandemic has accelerated on-going structural changes taking place in the dairy sector. SIGNIFICANCE: The study expands existing knowledge about the effects of the pandemic on the dairy sector and adds to the newly evolving literature about the medium and long-term effects of the COVID-19 on food systems across the globe. Despite the preliminary nature of the results, they provide important insights to inform sectorial policy discussions.
C1 [Acosta, Alejandro; ArceDiaz, Eduardo; Steinfeld, Henning] Food & Agr Org United Nations FAO, Anim Prod & Hlth Div, Viale Terme Caracalla, I-00153 Rome, Italy.
   [McCorriston, Steve] Univ Exeter, Dept Econ, Exeter EX4 4PU, Devon, England.
   [Nicolli, Francesco] Univ Ferrara, Dept Econ & Management, Via Voltapaletto 11, I-44121 Ferrara, Italy.
   [Nicolli, Francesco] European Univ Inst, Florence Sch Regulat Climate, Via Giovanni Boccaccio 121, I-50133 Florence, Italy.
   [Venturelli, Ester] Wageningen Univ & Res, Hollandseweg 1, NL-6706 KN Wageningen, Netherlands.
   [Wickramasinghe, Upali] Food & Agr Org United Nations FAO, Markets & Trade Div, Viale Terme di Caracalla, I-00153 Rome, Italy.
   [Scudiero, Lavinia] Royal Vet Coll, Dept Prod & Populat Hlth, Vet Epidemiol Econ & Publ Hlth Grp, Hawkshead Lane, Hatfield, Herts, England.
   [Sammartino, Alejandro] Pan Amer Dairy Fed, Herrera & Reissig 967, Montevideo, Uruguay.
   [Schneider, Fritz] Bern Univ Appl Sci, Sch Agr, Forest & Food Sci, Langgasse 85, Zollikofen, Switzerland.
RP Acosta, A (corresponding author), Food & Agr Org United Nations FAO, Anim Prod & Hlth Div, Viale Terme Caracalla, I-00153 Rome, Italy.
EM alejandro.acosta@fao.org
OI Acosta, Alejandro/0000-0002-0546-0546
CR Acosta A, 2020, AUST J AGR RESOUR EC, V64, P960, DOI 10.1111/1467-8489.12387
   Australian Trade and Investment Commission, 2020, INT FREIGHT ASS MECH
   Blazy JM, 2021, AGR SYST, V190, DOI 10.1016/j.agsy.2021.103106
   Brinkmann S., 2014, OXFORD HDB QUALITATI, P277, DOI DOI 10.1093/OXFORDHB/9780199811755.013.030
   Burfisher M.E, 2021, INTRO COMPUTABLE GEN
   Dairy UK, 2020, NEW 1M DAIRY CAMPAIG
   De la Fuente L., 2019, WORLD BANK GROUP POV
   European Milk Board, 2020, MARK RESP PROGR
   Fan E.X, 2003, EC RES DEP POLICY BR, P15
   Fang PX, 2021, AGR SYST, V190, DOI 10.1016/j.agsy.2021.103094
   FAO, 2016, IMP EB VIR DIS OUTBR
   FAO, 2021, DAIR MARK REV OV GLO
   Gov.UK, 2020, SUPP BUS SELF EMPL P
   Government of Canada, 2020, CAN COVID 19 EC RESP
   Keogh-Brown MR, 2010, EUR J HEALTH ECON, V11, P543, DOI 10.1007/s10198-009-0210-1
   Kumar P, 2021, AGR SYST, V187, DOI 10.1016/j.agsy.2020.103027
   Lambert SD, 2008, J ADV NURS, V62, P228, DOI 10.1111/j.1365-2648.2007.04559.x
   Liamputtong P., 2015, FOCUS GROUP METHODOL, P31
   Livanis G., 2014, WORKING PAPERS, DOI [10.22004/ag.econ.19485, DOI 10.22004/AG.ECON.19485]
   Lloyd T., 2001, AM AGR EC ASS ANN M, V44, P347, DOI [10.1016/S0169-5150(01)00091-3, DOI 10.1016/S0169-5150(01)00091-3]
   McKibbin, 2004, ASIAN ECON PAP, V3, P113, DOI [DOI 10.1162/1535351041747932, 10.1162/1535351041747932]
   McKibbin W.J., 2006, MISCELLANEOUS PUBLIC
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   Middendorf BJ, 2021, AGR SYST, V190, DOI 10.1016/j.agsy.2021.103108
   Ministry of Finance, 2020, INT NOT COVID 19 AAT
   Murray SA, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3702
   Nchanji EB, 2021, AGR SYST, V188, DOI 10.1016/j.agsy.2020.103034
   Obese FY, 2021, ANIM FRONT, V11, P43, DOI 10.1093/af/vfaa056
   Okrent A.M., 2018, MEASURING VALUE US F, P1
   Park M, 2008, AGR ECON-BLACKWELL, V39, P183, DOI 10.1111/j.1574-0862.2008.00325.x
   Perrin A, 2021, AGR SYST, V190, DOI 10.1016/j.agsy.2021.103082
   Read BL, 2018, INT J QUAL METH, V17, DOI 10.1177/1609406918783452
   Rowley J, 2012, MANAG RES REV, V35, P260, DOI 10.1108/01409171211210154
   Sanjuan AI, 2003, EUR REV AGRIC ECON, V30, P155, DOI 10.1093/erae/30.2.155
   Schmidhuber J., 2020, COVID 19 CHANNELS TR
   Siu A., 2004, ASIAN ECON PAP, V3, P62, DOI [DOI 10.1162/1535351041747996, 10.1162/1535351041747996]
   Snow V., AGR SYST, V187, P2021
   Tittonell P, 2021, AGR SYST, V190, DOI 10.1016/j.agsy.2021.103098
   Trade Data Monitor, 2020, TDM INS
   Weersink A, 2021, AGR SYST, V188, DOI 10.1016/j.agsy.2020.103039
   WTO, 2020, ANN REPORT DIRECTOR
NR 41
TC 2
Z9 2
U1 3
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-521X
EI 1873-2267
J9 AGR SYST
JI Agric. Syst.
PD AUG
PY 2021
VL 192
AR 103177
DI 10.1016/j.agsy.2021.103177
EA JUN 2021
PG 10
WC Agriculture, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Agriculture
GA UJ8UB
UT WOS:000691553600002
OA hybrid
DA 2022-04-20
ER

PT J
AU Chen, DD
   Song, F
   Cui, NQ
   Tang, LW
   Zhang, H
   Shao, J
   Qiu, RL
   Wang, D
   Wang, XY
   Ye, ZH
AF Chen, Dandan
   Song, Feng
   Cui, Nianqi
   Tang, Leiwen
   Zhang, Hui
   Shao, Jing
   Qiu, Ruolin
   Wang, Dan
   Wang, Xiyi
   Ye, Zhihong
TI The Perceptions and Views of Rural Residents Towards COVID-19 Recovered
   Patients in China: A Descriptive Qualitative Study
SO INTERNATIONAL JOURNAL OF GENERAL MEDICINE
LA English
DT Article
DE rural residents; perceptions; views; COVID-19 recovered patients; China
ID ACUTE RESPIRATORY SYNDROME; PSYCHOLOGICAL DISTRESS; SURVIVORS; SARS;
   ASSOCIATION; KNOWLEDGE; ATTITUDES; OUTCOMES; PEOPLE
AB Introduction: With the effective treatments of novel coronavirus disease 2019 (COVID-19), thousands of patients have recovered from COVID-19 globally. The public perceptions and views are vital to facilitate recovered COVID-19 patients reintegrate into society. In China, the rural population accounts for nearly 70% of the total population. Therefore, we chose to evaluate perceptions and views of rural residents towards COVID-19 recovered patients in China.
   Methods: Fifteen participants were sampled from a village with the severe COVID-19 epidemic in Zibo city, Shandong Province. The fifteen participants who lived in the village with COVID-19 recovered patients were included. They were over 18 years of age and were voluntary to participant in the study. A descriptive qualitative design using semi-structured telephone interviews was undertaken. Thematic analysis was undertaken.
   Results: Five main themes emerged from the data: (1) Perceived personal characteristics of COVID-19 recovered patients; (2) Perceived difficulties faced by COVID-19 recovered patients; (3) Perceptions on the social relationship with COVID-19 recovered patients; (4) Views on COVID-19 recovered patients going to public venues; (5) Views on helping COVID-19 recovered patients. Each theme was supported by several subthemes.
   Conclusion: Our study showed that discrimination and reduced social intimacy exist among rural residents. To improve their views or the situation, relevant departments could lead health educational programs and encourage supportive social connections. Through these strategic messaging, rural residents are expected to recognize that COVID-19 recovered patients need more social support, rather than discrimination and resistance, which helps recovered patients better return to society.
C1 [Chen, Dandan; Tang, Leiwen; Shao, Jing; Qiu, Ruolin; Wang, Dan; Wang, Xiyi; Ye, Zhihong] Zhejiang Univ, Affiliated Sir Run Run Shaw Hosp, Sch Med, 3 East Qingchun Rd, Hangzhou 310016, Zhejiang, Peoples R China.
   [Song, Feng] Yunnan Coll Business Management, Med Fac, Kunming, Yunnan, Peoples R China.
   [Cui, Nianqi] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Hangzhou, Zhejiang, Peoples R China.
   [Zhang, Hui] Guizhou Prov Peoples Hosp, Dept Cardiol, Guiyang, Guizhou, Peoples R China.
RP Ye, ZH (corresponding author), Zhejiang Univ, Affiliated Sir Run Run Shaw Hosp, Sch Med, 3 East Qingchun Rd, Hangzhou 310016, Zhejiang, Peoples R China.
EM yezh@zju.edu.cn
OI Qiu, Ruolin/0000-0001-9908-2760; Ye, Zhihong/0000-0001-6947-3330
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Abel T, 2020, INT J PUBLIC HEALTH, V65, P231, DOI 10.1007/s00038-020-01366-7
   Ahayalimudin N., 2012, BIOMED CENTRAL LTD B, V12, pA3, DOI [10.1186/1471-2458-12-S2-A3, DOI 10.1186/1471-2458-12-S2-A3]
   Alemi Q, 2019, INT HEALTH, V11, P440, DOI 10.1093/inthealth/ihz013
   Aquino-Jarquin G, 2019, NANOMED-NANOTECHNOL, V18, P428, DOI 10.1016/j.nano.2019.03.006
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Caelli K., 2003, INT J QUAL METH, V2, P1, DOI DOI 10.1177/160940690300200201
   Campbell DE, 2014, CAMB STUD SOC THEOR, P3
   Cheng SKW, 2004, J NERV MENT DIS, V192, P868, DOI 10.1097/01.nmd.0000147169.03998.dc
   Cheng SKW, 2004, PSYCHOL MED, V34, P1187, DOI 10.1017/S0033291704002272
   China N.H.C.O, 2020, LAT SIT COVID 19 EP
   Fereday J., 2006, INT J QUAL METH, V5, P1, DOI [10.1177/160940690600500107, DOI 10.1177/160940690600500107]
   Guba E., 2018, SAGE HDB QUALITATIVE, V5th
   Hezima A, 2020, E MEDITERR HEALTH J, V26, P646, DOI 10.26719/emhj.20.076
   HUANG D, 2020, J CHENGDU MED COLL, DOI DOI 10.1080/10543406.2020.1814797
   Huang YE, 2021, PSYCHOL HEALTH MED, V26, P23, DOI 10.1080/13548506.2020.1754438
   Kamate Shivlingesh Krishnappa, 2009, J Infect Dev Ctries, V4, P7
   Lau JTF, 2006, HEALTH EDUC RES, V21, P662, DOI 10.1093/her/cyl064
   Lee AM, 2007, CAN J PSYCHIAT, V52, P233, DOI 10.1177/070674370705200405
   Letshwenyo-Maruatona SB, 2019, AJAR-AFR J AIDS RES, V18, P58, DOI 10.2989/16085906.2018.1552879
   Li YJ, 2020, J MED VIROL, V92, P1938, DOI 10.1002/jmv.25905
   Mak WWS, 2006, SOC SCI MED, V63, P1912, DOI 10.1016/j.socscimed.2006.04.016
   Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52
   Nicolson P, 2001, J HEALTH PSYCHOL, V6, P551, DOI 10.1177/135910530100600508
   O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388
   Patton MQ, 2002, QUALITATIVE RES EVAL, P46
   Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362
   Sher L, 2019, ACTA PSYCHIAT SCAND, V140, P169, DOI 10.1111/acps.13059
   Sher L, 2020, ACTA NEUROPSYCHIATR, V32, P270, DOI 10.1017/neu.2020.21
   Tansey CM, 2007, ARCH INTERN MED, V167, P1312, DOI 10.1001/archinte.167.12.1312
   Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048
   Whitley R, 2005, CAN J PSYCHIAT, V50, P108, DOI 10.1177/070674370505000206
   World Health Organization, 2020, WHO COR DIS COVID 19
   Wu CM, 2020, CLIN TRANSL MED, V10, DOI 10.1002/ctm2.52
   Xu JH, 2019, SOC PSYCH PSYCH EPID, V54, P1101, DOI 10.1007/s00127-018-1636-5
   Yuan J, 2020, CLIN INFECT DIS, V71, P2230, DOI 10.1093/cid/ciaa398
   Zhang JF, 2020, INT J INFECT DIS, V97, P212, DOI 10.1016/j.ijid.2020.03.007
   Zhou Y., 2017, QUALITATIVE RES NURS, P98
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 40
TC 2
Z9 2
U1 9
U2 12
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1178-7074
J9 INT J GEN MED
JI Int. J. Gen. Med.
PY 2021
VL 14
BP 709
EP 720
DI 10.2147/IJGM.S293368
PG 12
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC General & Internal Medicine
GA QY4OY
UT WOS:000630022000001
PM 33688242
OA Green Published, gold
DA 2022-04-20
ER

PT C
AU Zhang, H
AF Zhang, Han
BE GarciaPerez, A
   Simkin, L
TI Blockchain Facilitates a Resilient Supply Chain in Steel Manufacturing
   under COVID-19
SO PROCEEDINGS OF THE 22ND EUROPEAN CONFERENCE ON KNOWLEDGE MANAGEMENT
   (ECKM 2021)
SE Proceedings of the European Conference on Knowledge Management
LA English
DT Proceedings Paper
CT 22nd European Conference on Knowledge Management (ECKM)
CY SEP 02-03, 2021
CL Coventry Univ, ELECTR NETWORK
HO Coventry Univ
DE Blockchain; Supply chain; COVID-19; Steel; Sustainability
AB The impact of COVID-19 caused a crash in the supply chain across almost all manufacturers, retailers, and wholesalers and now dramatically impacts many of the processes in the manufacturing sectors. In particular, the steel industry, as an energy-intensive industry, is being urged to adopt digitalisation technology to achieve optimization and sustainable production. Industries are fortunate to showcase an opportunity to advance the supply chain towards sustainability to deal with such a crisis. It is acknowledged that digital technology like blockchain can provide intercession by discovering real-time problems to perform certain Sustainable Development Goals related to procurement, production and processing, logistics and transportation and the environment. However, the data structure which requires implementation by blockchain technology in the steel supply chain is restricted. Blockchain technology has the outstanding position to transform the supply chain. The main challenge is that tracing border activities in the steel supply chain has not well been monitored. The digital system is drastically required to develop advanced technology to handle the disruptions and build a resilient supply chain. Using blockchain technology can capture the goods movement across the entire supply chain to verify the quality and product provenance. Furthermore, the rapid technology innovation in the steel sector involves the continuous update of skills and personnel. This study aims to explore the role of blockchain technology in the steel supply chain industry, such as inter-organizational trust, data transparency and immutability, interoperability and product type, and social influence and behavioural intention. A qualitative research approach was adopted on exploring multiple-case studies. The study reveals that blockchain technology contributes to a resilient steel supply chain in reducing risks and uncertainties with its transparency and immutability function. In the future, an integrated technology implementation framework should be developed to deploy Artificial Intelligence and Blockchain technology in manufacturing industries to accelerate the digital transformation.
C1 [Zhang, Han] Coventry Univ, Coventry, W Midlands, England.
RP Zhang, H (corresponding author), Coventry Univ, Coventry, W Midlands, England.
EM Zhangh65@uni.coventry.ac.uk
CR Babich V, 2020, M&SOM-MANUF SERV OP, V22, P223, DOI 10.1287/msom.2018.0752
   Casino F., 2020, TELEMAT INFORM
   Chang YL, 2020, INT J PROD RES, V58, P2082, DOI 10.1080/00207543.2019.1651946
   Conejo AN, 2020, J ENVIRON MANAGE, V259, DOI 10.1016/j.jenvman.2019.109782
   Deloitte, 2021, BLOCKCH COMPL CAN TE
   Eudero M.I, 2019, APPL SCI
   Gammelgaard B., 2019, BLOCKCHAIN TECHNOLOG
   Garrod JZ, 2019, ECON SOC, V48, P602, DOI 10.1080/03085147.2019.1678316
   Ghode D, 2020, J ENTERP INF MANAG, V33, P437, DOI 10.1108/JEIM-07-2019-0186
   Government of Canada, 2018, TRAC STEEL IND SUPPL
   Huang MC, 2018, J PURCH SUPPLY MANAG, V24, P260, DOI 10.1016/j.pursup.2017.12.002
   IBM, 2020, WHAT IS SUPPL CHAIN
   Kamble S, 2019, INT J PROD RES, V57, P2009, DOI 10.1080/00207543.2018.1518610
   Kim S.K., 2020, SUSTAINABILITY-BASEL
   Kushnir D., 2019, J CLEAN PROD, V242, P118
   Ledger Insights, 2020, GOV CAN CONTR PEER L
   Lv Y., 2020, SUSTAINABILITY-BASEL
   Macrinici D, 2018, TELEMAT INFORM, V35, P2337, DOI 10.1016/j.tele.2018.10.004
   Olson DL, 2018, INT J PROD RES, V56, P733, DOI 10.1080/00207543.2017.1398427
   Pinto J.T.D.M, 2019, EC FINANCE
   Pinto JTM, 2020, RESOUR CONSERV RECY, V153, DOI 10.1016/j.resconrec.2019.104517
   Queiroz MM, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03685-7
   Ramirez-Pena M, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12166373
   RCS Global, 2017, BLOCKCH TRAC MIN MET
   Saberi S, 2019, INT J PROD RES, V57, P2117, DOI 10.1080/00207543.2018.1533261
   Sarkis J, 2020, RESOUR CONSERV RECY, V159, DOI 10.1016/j.resconrec.2020.104894
   Schniederjans DG, 2020, INT J PROD ECON, V220, DOI 10.1016/j.ijpe.2019.07.012
   Tang Y., 2019, ETHICS BLOCKCHAIN
   Treiblmaier H, 2019, LOGISTICS-BASEL, V3, DOI 10.3390/logistics3010010
   Vendrell-Herrero F, 2017, IND MARKET MANAG, V60, P69, DOI 10.1016/j.indmarman.2016.06.013
   Wamba S.F., 2020, INT J PROD ECON
   Wan P.K., 2020, BLOCKCHAIN ENABLED I
   World Trade Organisation, 2020, TRAD SET PLUNG COVID
   WSA, 2019, SUST STEEL IND 2019 SUST STEEL IND 2019
NR 34
TC 0
Z9 0
U1 2
U2 2
PU ACAD  CONFERENCES LTD
PI NR READING
PA CURTIS FARM, KIDMORE END, NR READING, RG4 9AY, ENGLAND
SN 2048-8963
BN 978-1-914587-07-8
J9 PROC EUR CONF KNOWL
PY 2021
BP 964
EP 972
DI 10.34190/EKM.21.058
PG 9
WC Business; Management
WE Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Business & Economics
GA BS7BB
UT WOS:000758201900111
DA 2022-04-20
ER

PT J
AU Augustine, R
   Abhilash
   Nayeem, A
   Salam, SA
   Augustine, P
   Dan, P
   Maureira, P
   Mraiche, F
   Gentile, C
   Hansbro, PM
   McClements, L
   Hasan, A
AF Augustine, Robin
   Abhilash
   Nayeem, Ajisha
   Salam, Shaheen Abdul
   Augustine, Priya
   Dan, Pan
   Maureira, Pablo
   Mraiche, Fatima
   Gentile, Carmine
   Hansbro, Philip M.
   McClements, Lana
   Hasan, Anwarul
TI Increased complications of COVID-19 in people with cardiovascular
   disease: Role of the renin-angiotensin-aldosterone system (RAAS)
   dysregulation
SO CHEMICO-BIOLOGICAL INTERACTIONS
LA English
DT Article
DE Cardiovascular diseases; COVID-19; Coronavirus; SARS-CoV-2; RAAS; ACE2
ID ACUTE RESPIRATORY SYNDROME; MULTISYSTEM INFLAMMATORY SYNDROME; SYNDROME
   CORONAVIRUS INFECTION; RECEPTOR-BINDING DOMAIN; CRITICALLY-ILL PATIENTS;
   CONVERTING ENZYME-2; SARS-CORONAVIRUS; MERS-COV; ACE2 EXPRESSION;
   CLINICAL CHARACTERISTICS
AB The rapid spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19), has had a dramatic negative impact on public health and economies worldwide. Recent studies on COVID-19 complications and mortality rates suggest that there is a higher prevalence in cardiovascular diseases (CVD) patients. Past investigations on the associations between pre-existing CVDs and susceptibility to coronavirus infections including SARS-CoV and the Middle East Respiratory Syndrome coronavirus (MERS-CoV), have demonstrated similar results. However, the underlying mechanisms are poorly understood. This has impeded adequate risk stratification and treatment strategies for CVD patients with SARSCoV-2 infections. Generally, dysregulation of the expression of angiotensin-converting enzyme (ACE) and the counter regulator, angiotensin-converting enzyme 2 (ACE2) is a hallmark of cardiovascular risk and CVD. ACE2 is the main host receptor for SARS-CoV-2. Although further studies are required, dysfunction of ACE2 after virus binding and dysregulation of the renin-angiotensin-aldosterone system (RAAS) signaling may worsen the outcomes of people affected by COVID-19 and with preexisting CVD. Here, we review the current knowledge and outline the gaps related to the relationship between CVD and COVID-19 with a focus on the RAAS. Improved understanding of the mechanisms regulating viral entry and the role of RAAS may direct future research with the potential to improve the prevention and management of COVID-19.
C1 [Augustine, Robin; Hasan, Anwarul] Qatar Univ, Coll Engn, Dept Mech & Ind Engn, Doha 2713, Qatar.
   [Augustine, Robin; Hasan, Anwarul] Qatar Univ, Biomed Res Ctr BRC, POB 2713, Doha, Qatar.
   [Abhilash] Majlis Arts & Sci Coll, Dept Microbiol, Malappuram 676552, Kerala, India.
   [Nayeem, Ajisha] St Marys Coll, Dept Biotechnol, Trichur 680020, Kerala, India.
   [Salam, Shaheen Abdul] MES Coll Marampally, Dept Biosci, Ernakulam 683107, Kerala, India.
   [Augustine, Priya] Kongunadu Arts & Sci Coll, Dept Zool, Coimbatore 641029, Tamil Nadu, India.
   [Dan, Pan; Maureira, Pablo] Lorraine Univ, Reg Cent Hosp Nancy, Dept Cardiovasc & Transplantat Surg, Nancy, France.
   [Dan, Pan] Wuhan Univ, Dept Thorac & Cardiovasc Surg, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Mraiche, Fatima] Qatar Univ, Coll Pharm, QU Hlth, POB 2713, Doha, Qatar.
   [Gentile, Carmine] Univ Technol Sydney, Fac Engn & IT, Sch Biomed Engn, Sydney, NSW, Australia.
   [Gentile, Carmine] Univ Sydney, Fac Med & Hlth, Sch Med, Sydney, NSW, Australia.
   [Gentile, Carmine] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.
   [Hansbro, Philip M.] Centenary Inst, Ctr Inflammat, Camperdown, NSW, Australia.
   [Hansbro, Philip M.; McClements, Lana] Univ Technol Sydney, Fac Sci, Sch Life Sci, Sydney, NSW, Australia.
RP Augustine, R; Hasan, A (corresponding author), Qatar Univ, Coll Engn, Dept Mech & Ind Engn, Doha 2713, Qatar.
EM robin.augustine@qu.edu.qa; ahasan@qu.edu.qa
RI Gentile, Carmine/G-6446-2017; Hansbro, Phil/G-7486-2013
OI Gentile, Carmine/0000-0002-3689-4275; Hansbro, Phil/0000-0002-4741-3035;
   Augustine, Robin/0000-0001-9724-8392; McClements,
   Lana/0000-0002-4911-1014
FU Qatar University [QUERG-CMED-2020-2]; Qatar National Research Fund
   (Qatar Foundation) [NPRP12S-0310-190276]; National Health and Medical
   Research Council (NHMRC) of AustraliaNational Health and Medical
   Research Council (NHMRC) of Australia [1175134]; NSFCNational Natural
   Science Foundation of China (NSFC) [82000392]; Qatar National Library
FX This publication was made possible by Qatar University Emergency
   Response Grant (QUERG-CMED-2020-2) from the Qatar University and
   NPRP12S-0310-190276 grant funded by Qatar National Research Fund (a part
   of Qatar Foundation). All statements made here are the sole
   responsibility of the authors. P.M.H. is funded by an Investigator Grant
   from the National Health and Medical Research Council (NHMRC) of
   Australia (1175134). P.D was supported by the grant NSFC No. 82000392.
   Open Access funding provided by the Qatar National Library.
CR Abate SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235653
   Ahmed M, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100527
   Al Ghamdi M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1492-4
   Al-Dorzi HM, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1234-4
   Al-Tawfiq JA, 2014, CLIN INFECT DIS, V59, P160, DOI 10.1093/cid/ciu226
   Alhogbani T, 2016, ANN SAUDI MED, V36, P78, DOI 10.5144/0256-4947.2016.78
   Alifano M, 2020, BIOCHIMIE, V174, P30, DOI 10.1016/j.biochi.2020.04.008
   Almekhlafi GA, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1303-8
   ANGUIANO L, 2017, CURR MED CHEM
   Annweiler Cedric, 2020, Infectious Disorders - Drug Targets, V20, P407, DOI 10.2174/1871526520666200518073329
   Arabi YM, 2014, ANN INTERN MED, V160, P389, DOI 10.7326/M13-2486
   Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4
   Augustine R, 2020, J CLIN MED, V9, DOI 10.3390/jcm9103372
   Augustine R, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9080182
   Badawi A, 2016, INT J INFECT DIS, V49, P129, DOI 10.1016/j.ijid.2016.06.015
   Bandyopadhyay D, 2020, AM J CARDIOVASC DRUG, V20, P311, DOI 10.1007/s40256-020-00420-2
   Banik GR, 2016, VIROL SIN, V31, P81, DOI 10.1007/s12250-015-3679-z
   Banik S., 2020, CLIN MED, V2, P1077, DOI [10.1007/s42399-020-00376-z, DOI 10.1007/S42399-020-00376-Z]
   Bansal M, 2020, DIABETES METAB SYND, V14, P247, DOI 10.1016/j.dsx.2020.03.013
   Bauer AZ, 2021, J CLIN HYPERTENS, V23, P21, DOI 10.1111/jch.14101
   Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011
   Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885
   Bornstein SR, 2020, NAT REV ENDOCRINOL, V16, P297, DOI 10.1038/s41574-020-0353-9
   Bozkurt B, 2020, J CARD FAIL, V26, P370, DOI 10.1016/j.cardfail.2020.04.013
   Burchill L, 2008, EXP PHYSIOL, V93, P622, DOI 10.1113/expphysiol.2007.040386
   Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114
   Carter MJ, 2020, NAT MED, V26, P1701, DOI 10.1038/s41591-020-1054-6
   Cattaneo M, 2020, THROMB HAEMOSTASIS, V120, P1230, DOI 10.1055/s-0040-1712097
   Chan JWM, 2003, THORAX, V58, P686, DOI 10.1136/thorax.58.8.686
   Chan KS, 2003, RESPIROLOGY, V8, pS36, DOI 10.1046/j.1440-1843.2003.00522.x
   Chen Cheng-Yu, 2005, J Chin Med Assoc, V68, P4, DOI 10.1016/S1726-4901(09)70124-8
   Chen FF, 2020, J CRIT CARE, V60, P32, DOI 10.1016/j.jcrc.2020.07.003
   Chen KT, 2005, INT J INFECT DIS, V9, P77, DOI 10.1016/j.ijid.2004.04.015
   Chen L, 2020, CARDIOVASC RES, V116, P1097, DOI 10.1093/cvr/cvaa078
   Chen SY, 2004, ANN EMERG MED, V43, P1, DOI 10.1016/S0196-0644(03)00817-5
   Choi KW, 2003, ANN INTERN MED, V139, P715, DOI 10.7326/0003-4819-139-9-200311040-00005
   Choksi TT, 2021, AM J NEPHROL, V52, P250, DOI 10.1159/000515232
   Chong PY, 2004, ARCH PATHOL LAB MED, V128, P195
   Chrzanowski W, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00554
   Chung MK, 2020, EBIOMEDICINE, V58, DOI 10.1016/j.ebiom.2020.102907
   Cinatl J, 2004, CELL MOL LIFE SCI, V61, P2100, DOI 10.1007/s00018-004-4222-9
   Clay CC, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-4
   Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941
   Consiglio CR, 2020, CELL, V183, P968, DOI 10.1016/j.cell.2020.09.016
   Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786
   Devaux CA, 2020, J MICROBIOL IMMUNOL, V53, P425, DOI 10.1016/j.jmii.2020.04.015
   Deye N, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-015-0104-6
   Dhakal BP, 2020, HEART LUNG CIRC, V29, P973, DOI 10.1016/j.hlc.2020.05.101
   Ding YQ, 2004, J PATHOL, V203, P622, DOI 10.1002/path.1560
   Ding YQ, 2003, J PATHOL, V200, P282, DOI 10.1002/path.1440
   Dolinger MT, 2020, J PEDIATR GASTR NUTR, V71, P153, DOI 10.1097/MPG.0000000000002809
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1
   Dorjee K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243191
   Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031
   Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756
   Dugail I, 2020, BIOCHIMIE, V179, P257, DOI 10.1016/j.biochi.2020.07.001
   ElAbd R, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.600385
   Emami A, 2020, ARCH ACAD EMERG MED, V8, DOI 10.22037/aaem.v8i1.600
   Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088
   Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8
   European society of cardiology, 2020, EUR HEART J, P1
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387
   Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Ferreira-Gonzalez I., 2021, CLIN KIDNEY J
   Fraga-Silva RA, 2010, MOL MED, V16, P210, DOI 10.2119/molmed.2009.00160
   Fried JA, 2020, CIRCULATION, V141, P1930, DOI 10.1161/CIRCULATIONAHA.120.047164
   Gallagher PE, 2008, AM J PHYSIOL-HEART C, V295, pH2373, DOI 10.1152/ajpheart.00426.2008
   Ganatra S, 2019, J AM COLL CARDIOL, V74, P3153, DOI 10.1016/j.jacc.2019.10.049
   Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3
   Garout MA, 2018, CENT EUR J PUBL HEAL, V26, P87, DOI 10.21101/cejph.a4764
   Giannis D, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104362
   Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   Greene AG, 2020, AM J EMERG MED, V38, DOI 10.1016/j.ajem.2020.05.117
   Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guo JY, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016219
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Guy JL, 2008, EXP PHYSIOL, V93, P579, DOI 10.1113/expphysiol.2007.040139
   Guzik TJ, 2020, CARDIOVASC RES, V116, P1666, DOI 10.1093/cvr/cvaa106
   Hakeam HA, 2021, J CARDIOVASC PHARM T, V26, P244, DOI 10.1177/1074248420976279
   Halim AA, 2016, EGYPT J CHEST DIS TU, V65, P81, DOI 10.1016/j.ejcdt.2015.11.011
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Han H, 2020, J MED VIROL, V92, P819, DOI 10.1002/jmv.25809
   Harmer D, 2002, FEBS LETT, V532, P107, DOI 10.1016/S0014-5793(02)03640-2
   Hasan A, 2021, J BIOMOL STRUCT DYN, V39, P3025, DOI 10.1080/07391102.2020.1754293
   Henry BM, 2021, J MED VIROL, V93, P678, DOI 10.1002/jmv.26479
   Henry BM, 2020, PROG CARDIOVASC DIS, V63, P702, DOI 10.1016/j.pcad.2020.07.006
   Hikmet F, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209610
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Hu HD, 2021, EUR HEART J, V42, P206, DOI 10.1093/eurheartj/ehaa190
   Huang H, 2009, EUR J HISTOCHEM, V53, P217, DOI 10.4081/ejh.2009.e26
   Immovilli P, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02957-9
   Ishiyama Y, 2004, HYPERTENSION, V43, P970, DOI 10.1161/01.HYP.0000124667.34652.1a
   Iwanami J, 2014, HYPERTENS RES, V37, P616, DOI 10.1038/hr.2014.49
   Jafarzadeh A, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118102
   Kang Y, 2020, HEART, V106, P1132, DOI 10.1136/heartjnl-2020-317056
   Kar S, 2010, J APPL PHYSIOL, V108, P923, DOI 10.1152/japplphysiol.00840.2009
   Karram T, 2005, AM J PHYSIOL-HEART C, V289, pH1351, DOI 10.1152/ajpheart.01186.2004
   Kaushik S, 2020, J PEDIATR-US, V224, P24, DOI 10.1016/j.jpeds.2020.06.045
   Kim, 2020, MERS TRANSMISSION RI, DOI [10.1186/s12889-018-5484-8, DOI 10.1186/S12889-018-5484-8]
   Kirchdoerfer RN, 2016, NATURE, V531, P118, DOI 10.1038/nature17200
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Kumari V, 2020, LANCET GLOB HEALTH, V8, pE1116, DOI 10.1016/S2214-109X(20)30319-3
   Kuster GM, 2020, EUR HEART J, V41, P1801, DOI 10.1093/eurheartj/ehaa235
   Lang ZW, 2003, PATHOLOGY, V35, P526, DOI 10.1080/00313020310001619118
   Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685
   Leong HN, 2006, ANN ACAD MED SINGAP, V35, P326
   Lew TWK, 2003, JAMA-J AM MED ASSOC, V290, P374, DOI 10.1001/jama.290.3.374
   Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9
   Li H, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105951
   Li JY, 2020, JAMA CARDIOL, V5, P825, DOI 10.1001/jamacardio.2020.1624
   Li SSL, 2003, CIRCULATION, V108, P1798, DOI 10.1161/01.CIR.0000094737.21775.32
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Li ZQ, 2020, FRONT MED-PRC, V14, P533, DOI 10.1007/s11684-020-0786-5
   Liu S., 2020, SSRN ELECT J, DOI [10.2139/ssrn.3548753, DOI 10.2139/SSRN.3548753]
   LIU Y, 2021, P NATL ACAD SCI USA, V118
   Liu Y, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016812
   Liu YX, 2020, SCI CHINA LIFE SCI, V63, P364, DOI 10.1007/s11427-020-1643-8
   Liu Z., 2020, CLIN CHAR COR PNEUM
   Lopez-Sainz A, 2019, AMYLOID, V26, P156, DOI 10.1080/13506129.2019.1625322
   Lovren F, 2008, AM J PHYSIOL-HEART C, V295, pH1377, DOI 10.1152/ajpheart.00331.2008
   Lu L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4067
   Ma SJ, 2021, BIOCHIMIE, V187, P1, DOI 10.1016/j.biochi.2021.05.001
   Madjid M, 2020, JAMA CARDIOL, V5, P831, DOI 10.1001/jamacardio.2020.1286
   Mahajan Kunal, 2020, Med J Armed Forces India, V76, P253, DOI 10.1016/j.mjafi.2020.05.004
   Mahmoud IS, 2020, BIOCHIMIE, V175, P93, DOI 10.1016/j.biochi.2020.05.012
   Matsuyama R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3881-4
   McClements L., 2020, TRANSL METAB SYNDR R, V3, P1, DOI [10.1016/j, DOI 10.1016/J]
   Mehra MR, 2020, JACC-HEART FAIL, V8, P512, DOI 10.1016/j.jchf.2020.03.004
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Memish ZA, 2020, LANCET, V395, P1063, DOI 10.1016/S0140-6736(19)33221-0
   Meng J, 2020, EMERG MICROBES INFEC, V9, P757, DOI 10.1080/22221751.2020.1746200
   Mubarak A, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/6491738
   Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929
   Nakra NA, 2020, CHILDREN-BASEL, V7, DOI 10.3390/children7070069
   Nassar MS, 2018, EUR REV MED PHARMACO, V22, P4956, DOI 10.26355/eurrev_201808_15635
   Ng KHL, 2005, POSTGRAD MED J, V81, DOI 10.1136/pgmj.2004.030049
   Nicin L, 2020, EUR HEART J, V41, P1804, DOI 10.1093/eurheartj/ehaa311
   Nishiga M, 2020, NAT REV CARDIOL, V17, P543, DOI 10.1038/s41569-020-0413-9
   Noris M, 2020, KIDNEY INT, V98, P314, DOI 10.1016/j.kint.2020.05.013
   Ob A., HYPERTENS CORON ARTE, V37, P547, DOI [10.19193/0393-6384_2021_1_85, DOI 10.19193/0393-6384_2021_1_85]
   Oddy C, 2021, CLIN THER, V43, pE97, DOI 10.1016/j.clinthera.2021.02.004
   Oudit GY, 2009, EUR J CLIN INVEST, V39, P618, DOI 10.1111/j.1365-2362.2009.02153.x
   Oudit GY, 2003, TRENDS CARDIOVAS MED, V13, P93, DOI 10.1016/S1050-1738(02)00233-5
   Parit R, 2021, EUR J PHARMACOL, V896, DOI 10.1016/j.ejphar.2021.173899
   Patel VB, 2016, CIRC RES, V118, P1313, DOI 10.1161/CIRCRESAHA.116.307708
   Pathangey G, 2021, AM J PHYSIOL-LUNG C, V320, pL301, DOI 10.1152/ajplung.00259.2020
   Peeri NC, 2020, INT J EPIDEMIOL, V49, P717, DOI 10.1093/ije/dyaa033
   Peng C, 2021, CHINESE MED J-PEKING, V134, P1602, DOI 10.1097/CM9.0000000000001479
   Peng L., SERV HEAL SCI
   Perico L, 2021, NAT REV NEPHROL, V17, P46, DOI 10.1038/s41581-020-00357-4
   Poissy J, 2020, CIRCULATION, V142, P184, DOI 10.1161/CIRCULATIONAHA.120.047430
   Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634
   Qian ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076469
   Reynolds HR, 2020, NEW ENGL J MED, V382, P2441, DOI 10.1056/NEJMoa2008975
   Rico-Mesa JS, 2020, CURR CARDIOL REP, V22, DOI 10.1007/s11886-020-01291-4
   Samavati L, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00317
   Sanchis-Gomar F, 2020, MAYO CLIN PROC, V95, P1222, DOI 10.1016/j.mayocp.2020.03.026
   Senchenkova EY, 2014, MICROCIRCULATION, V21, P401, DOI 10.1111/micc.12120
   Shan C, 2020, CELL RES, V30, P670, DOI 10.1038/s41422-020-0364-z
   Sharifi M, 2021, TALANTA, V223, DOI 10.1016/j.talanta.2020.121704
   Shi LJ, 2010, DRUG DISCOV TODAY, V15, P332, DOI 10.1016/j.drudis.2010.02.003
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Shirato K, 2013, J VIROL, V87, P12552, DOI 10.1128/JVI.01890-13
   Sims AC, 2005, J VIROL, V79, P15511, DOI 10.1128/JVI.79.24.15511-15524.2005
   Singh AK, 2020, DIABETES METAB SYND, V14, P283, DOI 10.1016/j.dsx.2020.03.016
   Sinha S, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209628
   Sukumaran V, 2012, FREE RADICAL RES, V46, P850, DOI 10.3109/10715762.2012.684878
   Surjit M, 2004, BIOCHEM BIOPH RES CO, V317, P1030, DOI 10.1016/j.bbrc.2004.03.154
   Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666
   Turner AJ, 2004, TRENDS PHARMACOL SCI, V25, P291, DOI 10.1016/j.tips.2004.04.001
   Umapathi T, 2004, J NEUROL, V251, P1227, DOI 10.1007/s00415-004-0519-8
   Updated recommendations, 2015, WHO GUID GLOB SURV S
   Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760
   van der Hoek L, 2007, ANTIVIR THER, V12, P651
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Villalba-Orero M, 2020, EUR HEART J, V41, P852
   Vura NVRK, 2021, EXCLI J, V20, P1145, DOI 10.17179/excli2021-3821
   Wang JT, 2004, EMERG INFECT DIS, V10, P818, DOI 10.3201/eid1005.030640
   Wang NS, 2013, CELL RES, V23, P986, DOI 10.1038/cr.2013.92
   Wang W, 2014, J MOL MED, V92, P847, DOI 10.1007/s00109-014-1149-y
   Wang XX, 2016, J MOL CELL CARDIOL, V97, P180, DOI 10.1016/j.yjmcc.2016.05.012
   Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369
   Willyard C, 2020, NATURE, V581, P250, DOI 10.1038/d41586-020-01403-8
   Wong RSM, 2003, BRIT MED J, V326, P1358, DOI 10.1136/bmj.326.7403.1358
   Worldometer, WORLDOMETER WORLDOME, V2021, P1
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Wu YP, 2003, NEW ENGL J MED, V349, P708, DOI 10.1056/NEJMc031468
   XI CR, 2020, PREPRINTS
   Xiong TY, 2020, EUR HEART J, V41, P1798, DOI 10.1093/eurheartj/ehaa231
   Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yahyavi A, 2021, INTERN EMERG MED, V16, P883, DOI 10.1007/s11739-020-02523-9
   Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762
   Yan TT, 2020, FASEB J, V34, P6017, DOI 10.1096/fj.202000782
   Yang G, 2020, HYPERTENSION, V76, P51, DOI 10.1161/HYPERTENSIONAHA.120.15143
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017
   Yang M, 2008, THROMB RES, V122, P473, DOI 10.1016/j.thromres.2007.12.021
   Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196
   Yoshikawa T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008729
   Yu CM, 2006, POSTGRAD MED J, V82, P140, DOI 10.1136/pgmj.2005.037515
   Zhang H, 2020, INT J INFECT DIS, V96, P19, DOI 10.1016/j.ijid.2020.04.027
   Zhang LT, 2020, J THROMB HAEMOST, V18, P1324, DOI 10.1111/jth.14859
   Zhang P, 2020, CIRC RES, V126, P1671, DOI 10.1161/CIRCRESAHA.120.317134
   Zhang W, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI151053
   Zhao MM, 2020, BIOMED PHARMACOTHER, V127, DOI 10.1016/j.biopha.2020.110230
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu H, 2020, CURR CARDIOL REP, V22, DOI [10.1007/s11886-020-01292-3, 10.1007/s11886-020-01302-4]
   Zores F, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00071
   Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0
   Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37
NR 217
TC 1
Z9 1
U1 3
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0009-2797
EI 1872-7786
J9 CHEM-BIOL INTERACT
JI Chem.-Biol. Interact.
PD JAN 5
PY 2022
VL 351
AR 109738
DI 10.1016/j.cbi.2021.109738
EA NOV 2021
PG 13
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
GA XB1ML
UT WOS:000721098600001
PM 34740598
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Galassi, G
   Marchioni, A
AF Galassi, Giuliana
   Marchioni, Alessandro
TI Myasthenia gravis at the crossroad of COVID-19: focus on immunological
   and respiratory interplay
SO ACTA NEUROLOGICA BELGICA
LA English
DT Review
DE COVID-19; Acute respiratory distress (ARDS); Myasthenic crisis;
   Myasthenia gravis; Non invasive ventilation; Mechanical ventilation
ID T-CELLS; MECHANICAL VENTILATION; CRISIS; MANAGEMENT; PATHOGENESIS;
   CORONAVIRUS; SARS-COV-2; IL-17
AB Coronavirus disease 2019 (COVID-19), a disease caused by the novel betacoronavirus (SARS-CoV-2) has become a global pandemic threat. COVID-19 caused by SARS-CoV-2 is reported to originate in December 2019 in Wuhan, China and spreading rapidly around world. SARS-CoV-2 is structurally similar to the other coronaviruses, causing the severe respiratory syndrome (SARS-CoV) and the middle east respiratory syndrome (MERS-CoV), both binding to the angiotensin-converting enzyme 2 (ACE2) receptor to enter human cells. ACE 2 is widely expressed in several cells including, neural tissue. COVID-19 presents with fever and respiratory symptoms, possibly leading to acute respiratory distress (ARDS) but there are several published reports of acute cerebrovascular diseases, seizures, olfactory and gustatory dysfunctions, isolated involvement of cranial nerves, myositis/rabdhomyolisis as well myasthenic crisis (MC) and Guillain-Barre syndrome (GBS). The ARDS described during COVID-19 pandemic, coupled with respiratory muscle failure occurring in myasthenia gravis (MG), may result in a life-threatening condition, challenging for intensivists, pulmonologists and neurologists. Infections are recognized trigger of exacerbations and crisis in MG and patients with MG probably exhibit a mortality higher than the general population during this COVID-19 pandemic. We review the current state of knowledge on MG during the COVID-19 pandemic to focus the immunological and respiratory interplay between these two conditions.
C1 [Galassi, Giuliana] Dept Biomed Metab & Neural Sci, Via P Giardini 1350, I-41010 Modena, Italy.
   [Marchioni, Alessandro] Univ Hosp Modena, Dept Med & Surg Sci, Resp Dis Unit, Modena, Italy.
RP Galassi, G (corresponding author), Dept Biomed Metab & Neural Sci, Via P Giardini 1350, I-41010 Modena, Italy.
EM giulianagalassi@alice.it
CR Aad G, 2012, PHYS LETT B, V716, P1, DOI 10.1016/j.physletb.2012.08.020
   Aguilo-Seara G, 2017, CYTOKINE, V96, P279, DOI 10.1016/j.cyto.2017.05.008
   Godoy DA, 2013, ARQ NEURO-PSIQUIAT, V71, P627, DOI 10.1590/0004-282X20130108
   Aksoy E, 2020, CASE REP INFECT DIS, V2020, DOI 10.1155/2020/8845844
   Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518
   Alhazzani W, 2020, CRIT CARE MED, V48, pE440, DOI [10.1097/CCM.0000000000004363, 10.1007/s00134-020-06022-5]
   Anand P, 2020, MUSCLE NERVE, V62, P254, DOI 10.1002/mus.26918
   Asadi-Pooya AA, 2020, J NEUROL SCI, V413, DOI 10.1016/j.jns.2020.116832
   BELLEMARE F, 1982, J APPL PHYSIOL, V53, P1190, DOI 10.1152/jappl.1982.53.5.1190
   Berlin DA, 2020, NEW ENGL J MED, V383, P2451, DOI 10.1056/NEJMcp2009575
   Camelo AE, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.01053
   Cao YH, 2016, J IMMUNOL, V196, P2075, DOI 10.4049/jimmunol.1501339
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Delly F, 2020, J NEUROL SCI, V414, DOI 10.1016/j.jns.2020.116888
   Dhont S, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01462-5
   Diaz JH, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa041
   Esnault P, 2020, AM J RESP CRIT CARE, V202, P1173, DOI 10.1164/rccm.202005-1582LE
   Franco C, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02130-2020
   Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2
   Gladstone DE, 2020, ANN INTERN MED, V173, P852, DOI 10.7326/L20-0681
   Grasselli G, 2020, LANCET RESP MED, V8, P1201, DOI 10.1016/S2213-2600(20)30370-2
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Gummi RR, 2019, MUSCLE NERVE, V60, P693, DOI 10.1002/mus.26689
   Gunes H, 2021, EUR J PEDIATR, V180, P983, DOI 10.1007/s00431-020-03841-y
   Heliopoulos I, 2003, MUSCLE NERVE, V27, P715, DOI 10.1002/mus.10378
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Huber M, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.576153
   Hubers A, 2020, J NEUROL NEUROSUR PS, V91, P1124, DOI 10.1136/jnnp-2020-323565
   Jacob S, 2020, J NEUROL SCI, V412, DOI 10.1016/j.jns.2020.116803
   Jaretzki A, 2000, NEUROLOGY, V55, P16, DOI 10.1212/WNL.55.1.16
   Kushlaf H, 2020, MUSCLE NERVE, V62, pE65, DOI 10.1002/mus.27020
   Laghi F, 2014, RESP PHYSIOL NEUROBI, V198, P32, DOI 10.1016/j.resp.2014.03.004
   Leis AA, 2014, MUSCLE NERVE, V49, P26, DOI 10.1002/mus.23869
   Liu RL, 2010, EUR J IMMUNOL, V40, P1577, DOI 10.1002/eji.200939792
   Lizarraga AA, 2016, SEMIN NEUROL, V36, P615, DOI 10.1055/s-0036-1592106
   Lucchese G, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102556
   Mantegazza R, 2018, CURR OPIN NEUROL, V31, P517, DOI 10.1097/WCO.0000000000000596
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Matthay MA, 2020, LANCET RESP MED, V8, P433, DOI 10.1016/S2213-2600(20)30127-2
   Melzer N, 2016, J NEUROL, V263, P1473, DOI 10.1007/s00415-016-8045-z
   Moschella Phillip, 2020, Clin Pract Cases Emerg Med, V4, P524, DOI 10.5811/cpcem.2020.9.49049
   Muir R, 2016, AM J RESP CRIT CARE, V193, P407, DOI 10.1164/rccm.201410-1782OC
   Muppidi S, 2020, LANCET NEUROL, V19, P970, DOI 10.1016/S1474-4422(20)30413-0
   Neumann B, 2020, NEUROLOGY, V94, pE299, DOI 10.1212/WNL.0000000000008688
   Pacha O, 2020, NAT REV IMMUNOL, V20, P345, DOI 10.1038/s41577-020-0328-z
   Hoang P, 2020, NEUROLOGY, V95, P840, DOI 10.1212/WNL.0000000000010651
   Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248
   Rabinstein A, 2002, NEUROLOGY, V59, P1647, DOI 10.1212/01.WNL.0000033797.79530.16
   Rabinstein AA, 2005, NEUROCRIT CARE, V3, P213, DOI 10.1385/NCC:3:3:213
   Ramaswamy SB, 2020, J NEUROMUSCULAR DIS, V7, P361, DOI 10.3233/JND-200520
   Rao HCY, 2020, J MED VIROL, V92, P786, DOI 10.1002/jmv.25918
   Rein N, 2020, J NEUROL SCI, V417, DOI 10.1016/j.jns.2020.117053
   Restivo DA, 2020, ANN INTERN MED, V173, P1027, DOI 10.7326/L20-0845
   RIEDER P, 1995, INTENS CARE MED, V21, P663, DOI 10.1007/BF01711545
   RIO FG, 1994, THORAX, V49, P703
   Rochwerg B, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02426-2016
   Roe K, 2020, TRANSBOUND EMERG DIS, V67, P1414, DOI 10.1111/tbed.13594
   Roper J, 2017, J EMERG MED, V53, P843, DOI 10.1016/j.jemermed.2017.06.009
   Sakaguchi H, 2012, MUSCLE NERVE, V46, P440, DOI 10.1002/mus.23445
   Salik I, 2020, J CLIN ANESTH, V67, DOI 10.1016/j.jclinane.2020.110001
   Scopelliti G, 2020, NEUROL SCI, V41, P3419, DOI 10.1007/s10072-020-04826-3
   Seneviratne J, 2008, ARCH NEUROL-CHICAGO, V65, P54, DOI 10.1001/archneurol.2007.1
   Singh S, 2020, CLIN NEUROL NEUROSUR, V196, DOI 10.1016/j.clineuro.2020.106045
   Spinelli E, 2020, INTENS CARE MED, V46, P606, DOI 10.1007/s00134-020-05942-6
   Sriwastava S, 2021, J NEUROL, V268, P2690, DOI 10.1007/s00415-020-10263-1
   Thiruppathi M, 2012, CLIN IMMUNOL, V145, P209, DOI 10.1016/j.clim.2012.09.012
   Tobin MJ, 2020, AM J RESP CRIT CARE, V202, P356, DOI 10.1164/rccm.202006-2157CP
   Varelas PN, 2002, CRIT CARE MED, V30, P2663, DOI 10.1097/00003246-200212000-00009
   Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]
   Wang WJ, 2020, CELL MOL IMMUNOL, V17, P650, DOI 10.1038/s41423-020-0447-2
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Xie YC, 2016, CYTOKINE, V78, P44, DOI 10.1016/j.cyto.2015.06.011
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zhang J, 2020, CLIN MICROBIOL INFEC, V26, P767, DOI 10.1016/j.cmi.2020.04.012
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 75
TC 1
Z9 1
U1 0
U2 5
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0300-9009
EI 2240-2993
J9 ACTA NEUROL BELG
JI Acta Neurol. Belg.
PD JUN
PY 2021
VL 121
IS 3
BP 633
EP 642
DI 10.1007/s13760-021-01612-6
EA APR 2021
PG 10
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA SJ9WG
UT WOS:000636142000001
PM 33811309
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Karanasios, S
AF Karanasios, Stan
TI The pursuit of relevance and impact: A review of the immediate response
   of the information systems field to COVID-19
SO INFORMATION SYSTEMS JOURNAL
LA English
DT Review; Early Access
DE COVID-19; information systems research; pandemic; review
ID METHODOLOGICAL EXAMINATION; USER ACCEPTANCE; KNOWLEDGE; CRISIS;
   CLASSIFICATION; TECHNOLOGY; MANAGEMENT; FUTURE; WORLD
AB The COVID-19 pandemic demanded an immediate response from the research community, including adjustment to how researchers undertake research. As in many fields, information systems scholars attempted 'rapid response' research that addresses the immediate crisis. This paper reviews the state of the immediate research and scholarly discussion in the information systems field. Seventy-one journal papers are reviewed. The review categorises nine thematic areas and one broad area of discussion. The methods by which information systems scholars address immediate research questions are identified. The contributions are discussed, future research directions are outlined and a model is proposed that traces the pathway from initiation of research/generation of new knowledge to practice impact. A further model is proposed to help information systems scholars clearly establish the link between the study of information systems phenomena and COVID-19.
C1 [Karanasios, Stan] Univ Queensland, Business Sch, Business Informat Syst, Brisbane, Qld 4072, Australia.
RP Karanasios, S (corresponding author), Univ Queensland, Business Sch, Business Informat Syst, Brisbane, Qld 4072, Australia.
EM s.karanasios@uq.edu.au
RI Karanasios, Stan/I-6377-2016
OI Karanasios, Stan/0000-0003-0937-6058
CR Adam M, 2020, EUR J INFORM SYST, V29, P595, DOI 10.1080/0960085X.2020.1814681
   Agarwal R, 2005, MIS QUART, V29, P381
   Agerfalk PJ, 2020, EUR J INFORM SYST, V29, P203, DOI 10.1080/0960085X.2020.1771968
   Ahuja, 2020, INT C INF SYST
   Ahuja, 2020, DIGITAL TECHNOLOGIES
   Allen DK, 2014, EUR J INFORM SYST, V23, P418, DOI 10.1057/ejis.2013.8
   Ammirato S, 2021, KNOWL MAN RES PRACT, V19, P415, DOI 10.1080/14778238.2020.1801364
   Andrade AD, 2019, INFORM SYST J, V29, P838, DOI 10.1111/isj.12252
   Jnr BA, 2021, ENTERP INF SYST-UK, V15, P617, DOI 10.1080/17517575.2020.1829075
   Antons D, 2021, ORGAN RES METHODS, DOI 10.1177/1094428121991230
   Bacon C. J., 2001, Data Base for Advances in Information Systems, V32, P46
   BARKI H, 1993, MIS QUART, V17, P209, DOI 10.2307/249802
   Barnes SJ, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102175
   Beaunoyer E, 2020, COMPUT HUM BEHAV, V111, DOI 10.1016/j.chb.2020.106424
   Boell SK, 2015, J INF TECHNOL, V30, P161, DOI 10.1057/jit.2014.26
   Bolisani E, 2021, KNOWL MAN RES PRACT, V19, P454, DOI 10.1080/14778238.2020.1851615
   Budd J, 2020, NAT MED, V26, P1183, DOI 10.1038/s41591-020-1011-4
   Bunker D, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102201
   Carillo K, 2021, EUR J INFORM SYST, V30, P69, DOI 10.1080/0960085X.2020.1829512
   Carroll N, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102186
   Carugati A, 2020, EUR J INFORM SYST, V29, P762, DOI 10.1080/0960085X.2020.1832868
   Casalegno C, 2021, KNOWL MAN RES PRACT, V19, P459, DOI 10.1080/14778238.2020.1860664
   Cerf VG, 2020, COMMUN ACM, V63, P7, DOI 10.1145/3397262
   Chakraborty T, 2021, INTERNET RES, V31, P419, DOI 10.1108/INTR-05-2020-0281
   Chatterjee S, 2021, INFORM SYST J, V31, P550, DOI 10.1111/isj.12320
   Chen Q, 2020, COMPUT HUM BEHAV, V110, DOI 10.1016/j.chb.2020.106380
   Chen WS, 2004, INFORM SYST J, V14, P197, DOI 10.1111/j.1365-2575.2004.00173.x
   Choo CW, 2014, J ASSOC INF SCI TECH, V65, P84, DOI 10.1002/asi.22952
   Collins C, 2021, INT J INFORM MANAGE, V60, DOI 10.1016/j.ijinfomgt.2021.102383
   Coombs C, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102182
   Cranor LF, 2020, COMMUN ACM, V63, P22, DOI 10.1145/3423993
   DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008
   Davis GB, 2002, COMMUN ACM, V45, P67
   Davison, 2005, INFORM SYSTEMS DEV C
   Davison RM, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102149
   De R, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102171
   Denholm J., 2020, THIS ISNT 1 GLOBAL P
   Doyle R, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102184
   Dwivedi YK, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102211
   Eachempati P, 2021, ENTERP INF SYST-UK, V15, P794, DOI 10.1080/17517575.2020.1856418
   Edghiem F, 2021, KNOWL MAN RES PRACT, V19, P439, DOI 10.1080/14778238.2020.1848364
   Ein-Dor P, 1993, INFORM SYST RES, V4, P166, DOI 10.1287/isre.4.2.166
   Elbanna A, 2019, INT J INFORM MANAGE, V47, P112, DOI 10.1016/j.ijinfomgt.2019.01.011
   Fahey RA, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102181
   Faraj S, 2011, ORGAN SCI, V22, P1224, DOI 10.1287/orsc.1100.0614
   Fletcher G, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102185
   Grover V, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102234
   Guitton MJ, 2020, COMPUT HUM BEHAV, V111, DOI 10.1016/j.chb.2020.106357
   Guo ZN, 2008, DECIS SUPPORT SYST, V44, P673, DOI 10.1016/j.dss.2007.09.006
   Hacker J, 2020, EUR J INFORM SYST, V29, P563, DOI 10.1080/0960085X.2020.1814680
   Hafermalz E, 2021, EUR J INFORM SYST, V30, P89, DOI 10.1080/0960085X.2020.1841572
   Hu HY, 2021, ENERGY TECHNOL-GER, V9, DOI 10.1002/ente.202000730
   Iacuzzi S, 2021, KNOWL MAN RES PRACT, V19, P433, DOI 10.1080/14778238.2020.1838963
   Iivari N, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102183
   Janssen M, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102180
   Jawahar D., 2009, COMTEMPORARY ISSUES, P131
   Kelly J., 2021, FORBES
   Kodama M, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102172
   Laato S, 2020, EUR J INFORM SYST, V29, P288, DOI 10.1080/0960085X.2020.1770632
   Lagna A, 2022, INFORM SYST J, V32, P61, DOI 10.1111/isj.12333
   Leclercq-Vandelannoitte A, 2020, EUR J INFORM SYST, V29, P746, DOI 10.1080/0960085X.2020.1820912
   Li L, 2014, J INF TECHNOL-UK, V29, P208, DOI 10.1057/jit.2014.15
   Luciano EM, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102194
   Mahmoud HAH, 2021, PERS UBIQUIT COMPUT, V25, P129, DOI 10.1007/s00779-020-01419-x
   Malaurent J, 2020, INFORM SYST J, V30, P639, DOI 10.1111/isj.12272
   Marks P, 2020, COMMUN ACM, V63, P21, DOI 10.1145/3409803
   Markus ML, 2018, MIS QUART, V42, P1255, DOI 10.25300/MISQ/2018/12903
   McKinsey, 2020, COVID 19 HAS PUSH CO
   MENTZAS G, 1994, INT J INFORM MANAGE, V14, P397, DOI 10.1016/0268-4012(94)90015-9
   Milano G, 2020, COMMUN ACM, V63, P53, DOI 10.1145/3422826
   Mirbabaie M, 2020, J INF TECHNOL-UK, V35, P195, DOI 10.1177/0268396220929258
   Nabity-Grover T, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102188
   Naidoo R, 2020, EUR J INFORM SYST, V29, P306, DOI 10.1080/0960085X.2020.1771222
   Nunamaker JF, 2017, MIS QUART, V41, P335, DOI 10.25300/MISQ/2017/41.2.01
   O'Leary DE, 2020, J ORG COMP ELECT COM, V30, P1, DOI 10.1080/10919392.2020.1755790
   O'Leary K, 2020, COMMUN ASSOC INF SYS, V47, P476, DOI 10.17705/1CAIS.04722
   Okoli C, 2010, SPROTUS WORKING PAPE, DOI 10.2139/ssrn.1954824
   OSCH WV, 2020, J ASSOC INF SYST, V21, P1370
   Pan SL, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102196
   Pan SL, 2020, INT J INFORM MANAGE, V54, DOI 10.1016/j.ijinfomgt.2020.102143
   Pan SL, 2020, INFORM SYST J, V30, P403, DOI 10.1111/isj.12274
   Pan SL, 2012, J ASSOC INF SYST, V13, P31
   Papadopoulos T, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102192
   Papagiannidis S, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102166
   Pare G, 2015, INFORM MANAGE-AMSTER, V52, P183, DOI 10.1016/j.im.2014.08.008
   Parra CM, 2021, INT J INFORM MANAGE, V57, DOI 10.1016/j.ijinfomgt.2020.102271
   Pee LG, 2021, EUR J INFORM SYST, V30, P157, DOI 10.1080/0960085X.2020.1863751
   Piccoli, 2020, MIS Q EXEC, V19, pv
   Pietz J, 2020, EUR J INFORM SYST, V29, P388, DOI 10.1080/0960085X.2020.1793698
   Powell P, 2015, INFORM SYST J, V25, P1, DOI 10.1111/isj.12050
   Prommegger B, 2021, EUR J INFORM SYST, V30, P100, DOI 10.1080/0960085X.2020.1841573
   Queiroz MM, 2021, ANN OPER RES, DOI 10.1007/s10479-021-04107-y
   Rahi S, 2021, ENTERP INF SYST-UK, V15, P769, DOI 10.1080/17517575.2020.1850872
   Rai, 2020, MANAGEMENT INFORM SY, V44, piii
   Rao HR, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102187
   Recker J, 2019, J ASSOC INF SYST, V20, P735, DOI 10.17705/1jais.00550
   Reynolds P, 2015, J INF TECHNOL-UK, V30, P101, DOI 10.1057/jit.2015.1
   Richter A, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102157
   Riemer K, 2020, EUR J INFORM SYST, V29, P731, DOI 10.1080/0960085X.2020.1819898
   Rousseau DM, 2001, J ORGAN BEHAV, V22, P1, DOI 10.1002/job.78
   Rowe F, 2020, EUR J INFORM SYST, V29, P545, DOI 10.1080/0960085X.2020.1803155
   Rowe F, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102178
   Sakurai M, 2020, EUR J INFORM SYST, V29, P585, DOI 10.1080/0960085X.2020.1814171
   Savage N, 2020, COMMUN ACM, V63, P9, DOI 10.1145/3427933
   Schunk SJ, 2021, EUR HEART J, V42, P1742, DOI 10.1093/eurheartj/ehab107
   Seetharaman P, 2020, INT J INFORM MANAGE, V54, DOI 10.1016/j.ijinfomgt.2020.102173
   Sein MK, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102164
   Sen A., 2019, 2 BIG REASONS DIGITA
   Shankar K, 2021, J ASSOC INF SCI TECH, V72, P280, DOI 10.1002/asi.24406
   Sipior JC, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102170
   Spinuzzi C, 2012, J BUS TECH COMMUN, V26, P399, DOI 10.1177/1050651912444070
   Stern L.N., 2021, I MUST BE BOLD IMPAC
   Tarafdar M, 2018, J ASSOC INF SYST, V19, P523, DOI 10.17705/1jais.00500
   Thomas O, 2020, BUS INFORM SYST ENG+, V62, P385, DOI 10.1007/s12599-020-00657-w
   Tim Y, 2017, INFORM SYST J, V27, P197, DOI 10.1111/isj.12114
   Trang S, 2020, EUR J INFORM SYST, V29, P415, DOI 10.1080/0960085X.2020.1784046
   Tweardy, 2020, COVID 19 SHAP FUT DI
   Urbaczewski A, 2020, EUR J INFORM SYST, V29, P405, DOI 10.1080/0960085X.2020.1802358
   Vaast E, 2017, MIS QUART, V41, P1179
   van der Aalst W, 2020, BUS INFORM SYST ENG+, V62, P463, DOI 10.1007/s12599-020-00666-9
   Vardi MY, 2020, COMMUN ACM, V63, P9, DOI 10.1145/3388890
   Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540
   Venkatesh V, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102197
   Vial G, 2019, J STRATEGIC INF SYST, V28, P118, DOI 10.1016/j.jsis.2019.01.003
   Wade M, 2020, MIS Q EXEC, V19, P213, DOI 10.17705/2msqe.00034
   Waizenegger L, 2020, EUR J INFORM SYST, V29, P429, DOI 10.1080/0960085X.2020.1800417
   Wang B, 2020, J ASSOC INF SYST, V21, P1379, DOI 10.17705/1jais.00641
   Wang WS, 2021, KAOHSIUNG J MED SCI, V37, P215, DOI 10.1002/kjm2.12322
   Wareham J., 2014, ICT SOC CHALLENGES M, P1
   Webster J, 2002, MIS QUART, V26, pXIII
   Westerman G., 2017, DIGITAL ADVANTAGE DI
   Westmattelmann D, 2021, EUR J INFORM SYST, V30, P119, DOI 10.1080/0960085X.2020.1850186
   Whitelaw S, 2020, LANCET DIGIT HEALTH, V2, pE435, DOI 10.1016/S2589-7500(20)30142-4
   Wiener M, 2018, COMMUN ASSOC INF SYS, V43, P466, DOI 10.17705/1CAIS.04326
   Willcocks L, 2021, J INF TECHNOL-UK, V36, P188, DOI 10.1177/0268396220978660
   Xie B, 2020, J ASSOC INF SCI TECH, V71, P1419, DOI 10.1002/asi.24357
   Xu LW, 2020, J ASSOC INF SYST, V21, P545, DOI 10.17705/1jais.00612
   Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X
   Zorina A, 2021, J ASSOC INF SYST, V22, P1146, DOI 10.17705/1jais.00691
NR 139
TC 0
Z9 0
U1 12
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1350-1917
EI 1365-2575
J9 INFORM SYST J
JI Inf. Syst. J.
DI 10.1111/isj.12372
EA DEC 2021
PG 32
WC Information Science & Library Science
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science
GA XP6GH
UT WOS:000730961100001
OA Bronze
DA 2022-04-20
ER

PT J
AU Ye, YS
   Wang, RX
   Feng, D
   Wu, RJ
   Li, ZF
   Long, CX
   Feng, ZC
   Tang, SF
AF Ye, Yisheng
   Wang, Ruoxi
   Feng, Da
   Wu, Ruijun
   Li, Zhifei
   Long, Chengxu
   Feng, Zhanchun
   Tang, Shangfeng
TI The Recommended and Excessive Preventive Behaviors during the COVID-19
   Pandemic: A Community-Based Online Survey in China
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; health belief model; preventive behaviors; mental health
ID HEALTH LITERACY; RISK; INFECTION; FACEMASKS; KNOWLEDGE; SEEKING; TRUST
AB COVID-19 presents unprecedented challenges to the global public health response. Preventive behaviors and keeping social distance are regarded as compelling ways to prevent COVID-19. This study focused on the sociological and psychological factors associated with proper and excessive preventive behaviors of the COVID-19 outbreak in China. For the sample, we collected the data of 4788 participants who were surveyed between 4 April and 15 April 2020 from eight provinces in China. This study designed a self-filled questionnaire that included demographic information, six components of the Health Belief Model, and target preventive behaviors. Descriptive analysis, Chi-square test, logistic regression analysis, Mantel-Haenszel hierarchical analysis, and propensity score matching were employed in this study. The results showed that 54.7% of the participants had adequate basic prevention, 63.6% of the participants had adequate advanced prevention, and 5.8% of the participants practiced excessive prevention. The elder participants were less likely to engage in proper preventive behaviors. Perceived susceptibility, perceived benefits, perceived barriers, cues to action, and knowledge levels were associated with preventive behaviors. Excessive preventive behaviors in high-risk groups with suspected symptoms were associated with their extreme psychological condition, while the support from the community and family plays an important role in avoiding these behaviors.
C1 [Ye, Yisheng; Wang, Ruoxi; Long, Chengxu; Feng, Zhanchun; Tang, Shangfeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Med & Hlth Management, Wuhan 430030, Hubei, Peoples R China.
   [Ye, Yisheng; Wang, Ruoxi; Long, Chengxu; Feng, Zhanchun; Tang, Shangfeng] Res Ctr Rural Hlth Serv, Key Res Inst Humanities & Social Sci Hubei Prov D, Wuhan 430030, Hubei, Peoples R China.
   [Feng, Da] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Wuhan 430030, Hubei, Peoples R China.
   [Wu, Ruijun; Li, Zhifei] China Natl Ctr Biotechnol Dev, Beijing 100039, Peoples R China.
RP Feng, ZC; Tang, SF (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Med & Hlth Management, Wuhan 430030, Hubei, Peoples R China.; Feng, ZC; Tang, SF (corresponding author), Res Ctr Rural Hlth Serv, Key Res Inst Humanities & Social Sci Hubei Prov D, Wuhan 430030, Hubei, Peoples R China.
EM yishengye@hust.edu.cn; ruoxiwang@hust.edu.cn; fengda@hust.edu.cn;
   wurj@cncbd.org.cn; lizf@cncbd.org.cn; longchengxu@hust.edu.cn;
   zcfeng@hust.edu.cn; sftang2018@hust.edu.cn
RI ; Wang, Ruoxi/U-8016-2017
OI Ye, Yisheng/0000-0001-6468-9677; Wang, Ruoxi/0000-0002-9695-0582
FU Fundamental Research Funds for the Central UniversitiesFundamental
   Research Funds for the Central Universities [:2020kfyXGYJ071,
   2020kfyXGYJ013]
FX This research was funded by the Fundamental Research Funds for the
   Central Universities, Grant NO:2020kfyXGYJ071&2020kfyXGYJ013. The funder
   had no role in the design of the study; the collection, analysis, and
   interpretation of data; or the writing of the manuscript.
CR Al-Mohammed HI, 2010, ASIAN PAC J TROP MED, V3, P906, DOI 10.1016/S1995-7645(10)60218-0
   Butler MJ, 2020, BRAIN BEHAV IMMUN, V87, P53, DOI 10.1016/j.bbi.2020.04.040
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen XW, 2018, J HEALTH COMMUN, V23, P724, DOI 10.1080/10810730.2018.1511658
   Clements John M, 2020, JMIR Public Health Surveill, V6, pe19161, DOI 10.2196/19161
   Coe Antoinette B, 2012, Innov Pharm, V3, P1
   Cunningham SA, 2017, PREV MED, V105, P52, DOI 10.1016/j.ypmed.2017.08.020
   Delbaere K, 2010, J AM GERIATR SOC, V58, P1679, DOI 10.1111/j.1532-5415.2010.03017.x
   Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Fernandez Varela J.M., 1997, GERIATR MADR, V13, P33
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Hua W, 2020, CONTACT DERMATITIS, V83, P115, DOI 10.1111/cod.13601
   HUANG L, 2020, PSYCHOL HEALTH MED, DOI DOI 10.1080/13548506.2020.1746817
   Jang WM, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16122161
   Jing QL, 2020, LANCET INFECT DIS, V20, P1141, DOI 10.1016/S1473-3099(20)30471-0
   Kim Y, 2015, DISASTER MED PUBLIC, V9, P145, DOI 10.1017/dmp.2014.87
   Kreuter MW, 2003, HEALTH EDUC BEHAV, V30, P133, DOI 10.1177/1090198102251021
   Laestadius Linnea, 2020, JMIR Public Health Surveill, V6, pe19501, DOI 10.2196/19501
   Lau JTF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-18
   Li SY, 2020, J MED INTERNET RES, V22, DOI 10.2196/19782
   Lubetkin EI, 2015, AM J HEALTH BEHAV, V39, P441, DOI 10.5993/AJHB.39.3.16
   Malosh R, 2014, VACCINE, V32, P1841, DOI 10.1016/j.vaccine.2014.01.075
   Narang S, 2016, J ADV ORAL RES, V7, P27, DOI 10.1177/2229411220160205
   Ogoina D, 2020, AM J TROP MED HYG, V103, P33, DOI 10.4269/ajtmh.20-0433
   Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130
   Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058
   Saghazadeh A, 2020, EXPERT REV CLIN IMMU, V16, P465, DOI 10.1080/1744666X.2020.1750954
   Saiman L, 2014, INFECT CONT HOSP EP, V35, pS1, DOI 10.1086/676882
   Shatri H, 2020, ACTA MED INDONES, V52, P179
   Sim SW, 2014, SINGAP MED J, V55, P160
   Singh M, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3703-2
   Tabata S, 2020, LANCET INFECT DIS, V20, P1043, DOI 10.1016/S1473-3099(20)30482-5
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Tang SF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003233
   Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748
   WHO, 2020, COR DIS COVID 2019 S
   Wilder-Smith A, 2020, LANCET INFECT DIS, V20, pE102, DOI 10.1016/S1473-3099(20)30129-8
   Wise T., 2020, CHANGES RISK PERCEPT, DOI [10.31234/osf.io/dz428., DOI 10.31234/OSF.IO/DZ428, 10.1098/rsos.200742]
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Zhang CQ, 2019, ASIA-PAC J PUBLIC HE, V31, P246, DOI 10.1177/1010539519844082
   Zhang N, 2020, GLOB HEALTH RES POL, V5, DOI 10.1186/s41256-020-00168-x
   Zhang Y, 2020, INT J COMP METH-SING, V17, DOI 10.1142/S0219876219500312
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 51
TC 14
Z9 14
U1 21
U2 53
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD OCT
PY 2020
VL 17
IS 19
AR 6953
DI 10.3390/ijerph17196953
PG 16
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA ON2CY
UT WOS:000586517100001
PM 32977538
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Zieba, K
AF Zieba, Krzysztof
TI How can systems thinking help us in the COVID-19 crisis?
SO KNOWLEDGE AND PROCESS MANAGEMENT
LA English
DT Article; Early Access
ID KNOWLEDGE MANAGEMENT; DYNAMICS; SARS-COV-2; COMPLEXITY; BUSINESS
AB The COVID-19 pandemic outbreak remains one of the most influential events in the global economy over the recent years. While being primarily public health related, it has a tremendous impact on many other aspects, including business management. Many businesses were forced to introduce rapid changes to their business models in order to survive. The aim of this paper is to show the complexity and interrelations of changes triggered by COVID-19 outbreak. Understanding of this complexity is crucial for developing business resilience to similar events in the future. The paper uses systems thinking approach to analyze influence of COVID-19 pandemic on business operations and to show the importance of the proper government response to the COVID-19 crisis. A causal loop diagram is used to show the complicated mechanisms behind the impact of pandemic on several aspects of business operation and management. Perceptions of some variables play more important roles than actual variables, and it often requires more than one actor to solve a particular problem. Adaptive business management may prove to be a particular challenge for small business owners. The paper provides useful insights into the complex nature of contemporary business operation and management in the wake of a major epidemiological crisis. It may contribute to a better understanding of important factors that often tend to be disregarded and not paid enough attention to. It offers food for thought not only for academics, but also to business owners/managers, aware of the complexity of contemporary world and to government-level decision-makers.
C1 [Zieba, Krzysztof] Gdansk Univ Technol, Fac Management & Econ, Narutowicza 11-12 Str, PL-80233 Gdansk, Poland.
RP Zieba, K (corresponding author), Gdansk Univ Technol, Fac Management & Econ, Narutowicza 11-12 Str, PL-80233 Gdansk, Poland.
EM kzieba@zie.pg.gda.pl
OI Zieba, Krzysztof/0000-0003-4307-9022
CR Araz OM, 2020, HEALTH SYST, V9, P119, DOI 10.1080/20476965.2020.1758000
   Atkeson A., 2020, NBER WORKING PAPER S
   Baker Scott R., 2020, NBER WORKING PAPER S
   Bamakan SMH, 2021, PUBLIC HEALTH, V190, pE18, DOI 10.1016/j.puhe.2020.11.007
   Bartik AW, 2020, P NATL ACAD SCI USA, V117, P17656, DOI 10.1073/pnas.2006991117
   Bendavid E, 2021, EUR J CLIN INVEST, V51, DOI 10.1111/eci.13484
   Bradley DT, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100325
   Bratianu C., 2015, J DYNAMICS KNOWLEDGE, V3, P409
   Bratianu C, 2021, KNOWL PROCESS MANAG, V28, P11, DOI 10.1002/kpm.1656
   Bratianu C, 2020, MANAG MARK, V15, P410, DOI 10.2478/mmcks-2020-0024
   Cegarra-Navarro JG, 2005, J WORKPLACE LEARN, V17, P276, DOI 10.1108/13665620510606715
   Cegarra-Navarro JG, 2021, KNOWL PROCESS MANAG, V28, P134, DOI 10.1002/kpm.1662
   Conti P, 2021, J BIOL REG HOMEOS AG, V35, P1
   Donthu N, 2020, J BUS RES, V117, P284, DOI 10.1016/j.jbusres.2020.06.008
   Fei Gao, 2002, Journal of Knowledge Management, V6, P7
   Fernandes N., 2020, EC EFFECTS CORONAVIR, DOI [10.2139/ssrn.3557504, 10.2139/SSRN.3557504]
   FORRESTER JW, 1994, SYST DYNAM REV, V10, P245, DOI 10.1002/sdr.4260100211
   Cegarra-Navarro JG, 2019, J ORGAN CHANGE MANAG, V32, P67, DOI 10.1108/JOCM-04-2018-0107
   Gombos K, 2021, POPUL HEALTH MANAG, V24, P35, DOI 10.1089/pop.2020.0159
   Gonella F, 2020, FRONT COMMUN, V5, DOI 10.3389/fcomm.2020.00063
   Haley D, 2021, SYSTEMS-BASEL, V9, DOI 10.3390/systems9010013
   Hassan I, 2020, E MEDITERR HEALTH J, V26, P872, DOI 10.26719/emhj.20.090
   Ioannidis JPA, 2020, EUR J CLIN INVEST, V50, DOI [10.1111/eci.13222, 10.1111/eci.13223]
   Jackson MC, 2020, SYSTEMS-BASEL, V8, DOI 10.3390/systems8040052
   Kaakinen M, 2020, MEDIA PSYCHOL, V23, P25, DOI 10.1080/15213269.2018.1544910
   Kawalek JP, 2004, SYST RES BEHAV SCI, V21, P17, DOI 10.1002/sres.556
   Kirby T, 2021, LANCET RESP MED, V9, pE20, DOI 10.1016/S2213-2600(21)00005-9
   Klement R, 2020, SYSTEMS THINKING SAR
   Klement RJ, 2020, PUBLIC HEALTH, V185, P70, DOI 10.1016/j.puhe.2020.06.019
   Kontoangelos K, 2020, PSYCHIAT INVEST, V17, P491, DOI 10.30773/pi.2020.0161
   Lee E, 2020, SYSTEMS-BASEL, V8, DOI 10.3390/systems8020018
   Leischow SJ, 2008, AM J PREV MED, V35, pS196, DOI 10.1016/j.amepre.2008.05.014
   Loker A, 2020, AGROECOL SUST FOOD, V44, P1118, DOI 10.1080/21683565.2020.1775752
   Luna-Reyes LF, 2003, SYST DYNAM REV, V19, P271, DOI 10.1002/sdr.280
   Mackolil J, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102156
   Martelo-Landroguez S, 2019, KNOWL MAN RES PRACT, V17, P203, DOI 10.1080/14778238.2019.1599497
   Martinez-Moyano IJ, 2013, SYST DYNAM REV, V29, P102, DOI 10.1002/sdr.1495
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   Millar V, 2011, HARVARD BUS REV, V36, P152
   Monat J.P., 2015, AM J SYSTEMS SCI, V4, P11, DOI [10.5923/j.ajss.20150401.02, DOI 10.5923/J.AJSS.20150401.02]
   Moon MJ, 2020, PUBLIC ADMIN REV, V80, P651, DOI 10.1111/puar.13214
   Cegarra JLM, 2014, INT J INFORM MANAGE, V34, P437, DOI 10.1016/j.ijinfomgt.2014.02.006
   Naughton CC, 2020, RESOUR CONSERV RECY, V162, DOI 10.1016/j.resconrec.2020.105050
   Pennycook G, 2020, PSYCHOL SCI, V31, P770, DOI 10.1177/0956797620939054
   Pentina I, 2014, COMPUT HUM BEHAV, V35, P211, DOI 10.1016/j.chb.2014.02.045
   Ramnath VR, 2020, RESPIROLOGY, V25, P800, DOI 10.1111/resp.13894
   Rovetta A, 2020, JMIR PUBLIC HLTH SUR, V6, DOI 10.2196/19374
   Rubenstein-Montano B, 2001, DECIS SUPPORT SYST, V31, P5, DOI 10.1016/S0167-9236(00)00116-0
   Sahin O, 2020, SYSTEMS-BASEL, V8, DOI 10.3390/systems8020020
   Scala A, 2020, COVID 19 SOCIAL MED
   Seetharaman P, 2020, INT J INFORM MANAGE, V54, DOI 10.1016/j.ijinfomgt.2020.102173
   Sibley CG, 2020, AM PSYCHOL, V75, P618, DOI 10.1037/amp0000662
   Solomon DH, 2020, ARTHRITIS RHEUMATOL, V72, P1806, DOI 10.1002/art.41468
   Spohr Dominic., 2017, BUSINESS INFORM REV, V34, P150, DOI [10.1177/0266382117722446, DOI 10.1177/0266382117722446]
   Swanson RC, 2012, HEALTH POLICY PLANN, V27, P54, DOI 10.1093/heapol/czs090
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   van Hoek R, 2020, LOGISTICS-BASEL, V4, DOI 10.3390/logistics4040023
   Willmsen C, 2020, HUNDRED BUSINESSES M
   Wouters OJ, 2021, LANCET, V397, P1023, DOI 10.1016/S0140-6736(21)00306-8
NR 59
TC 4
Z9 4
U1 5
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1092-4604
EI 1099-1441
J9 KNOWL PROCESS MANAG
JI Knowl. Process Manag.
DI 10.1002/kpm.1680
EA JUN 2021
PG 10
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA SV9IZ
UT WOS:000664132900001
DA 2022-04-20
ER

PT J
AU Alhassan, SM
   Iqbal, P
   Fikrey, L
   Ibrahim, MIM
   Qamar, MS
   Chaponda, M
   Munir, W
AF Alhassan, Shahda Mohamed
   Iqbal, Phool
   Fikrey, Lubna
   Ibrahim, Mohanad Ibrahim Mohamed
   Qamar, Muhammad Sohaib
   Chaponda, Masautso
   Munir, Waqar
TI Post COVID 19 acute acalculous cholecystitis raising the possibility of
   underlying dysregulated immune response, a case report
SO ANNALS OF MEDICINE AND SURGERY
LA English
DT Article
DE Acalculous cholecystitis; COVID 19; Novel coronavirus disease 2019;
   SARS-CoV-2; Dysregulated immune response
ID PATIENT
AB Introduction: Novel Coronavirus disease 2019 or COVID-19 has rapidly spread throughout the world and has become an unprecedented pandemic. It has a vast spectrum of clinical presentations and can affect various organs. Rarely, it has been reported to cause acalculous cholecystitis in a non ICU setting patient.
   Case presentation: Here we report a rare association of COVID 19 with acalculous cholecystitis in a 40 years old healthy woman. She developed fever, malaise, generalized body weakness, and right hypochondrial pain after fourteen days of COVID 19 infection, raising the possibility of Post COVID dysregulated immune response resulting in acalculous cholecystitis. She was managed conservatively with broad spectrum antibiotics.
   Discussion: Acalculous cholecystitis primarily occurs due to the gall bladder's hypomotility and most commonly seen in critically ill patients such as severe burns, mechanically ventilated patients, and prolonged parenteral nutrition. The management depends upon treating the underlying pathology and, in some severe cases, may need surgical intervention as well. Up to our knowledge, COVID 19, causing acalculous cholecystitis, is a rare association described only in a few critically ill patients but not in young, healthy patients. It can be attributed to the body's dysregulated immunological response against the virus resulting in systemic inflammation.
   Conclusion: Currently, there is are no clear guidelines for managing acute cholecystitis in COVID-19 patients. It depends on the patient's clinical state and disease severity. We aim to highlight the importance of early diagnosis and management in such clinical scenarios to avoid fatal complications.
C1 [Alhassan, Shahda Mohamed; Iqbal, Phool; Fikrey, Lubna; Ibrahim, Mohanad Ibrahim Mohamed; Chaponda, Masautso; Munir, Waqar] Hamad Med Corp, Doha, Qatar.
   [Qamar, Muhammad Sohaib] Ozarks Med Ctr, West Plains, MO 65775 USA.
   [Chaponda, Masautso; Munir, Waqar] Communicable Dis Ctr, Doha, Qatar.
RP Iqbal, P (corresponding author), Hamad Med Corp, Doha, Qatar.
EM shuhdaa.bakri@gmail.com; Dr.phooliqba89@gmail.com;
   Fikreylubna@hotmail.com; Mohanad.im18@gmail.com;
   Mu.sohaibqamar@gmail.com; Mchaponda@hamad.qa; wmunir@hamad.qa
RI iqbal, phool/AAO-3200-2020; Ahmed, Shahda/AAD-4382-2021
OI iqbal, phool/0000-0003-3472-9281; Munir, Waqar/0000-0001-7165-6291
FU Qatar National Library
FX This work was financially supported by Qatar National Library.
CR Agha RA, 2018, INT J SURG, V60, P132, DOI 10.1016/j.ijsu.2018.10.028
   Asti E, 2020, UPDATES SURG, V72, P917, DOI 10.1007/s13304-020-00814-6
   Bruni A, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00320-5
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   Fu LW, 2020, J INFECTION, V80, P656, DOI 10.1016/j.jinf.2020.03.041
   Jones M.W., 2020, STATPEARLS
   Lai CC, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106024
   Mattone E, 2020, ANN MED SURG, V58, P73, DOI 10.1016/j.amsu.2020.08.027
   Roy J, 2020, J CARD FAIL, V26, P639, DOI 10.1016/j.cardfail.2020.06.002
   Soy M, 2020, CLIN RHEUMATOL, V39, P2085, DOI 10.1007/s10067-020-05190-5
   Waltuch T, 2020, AM J EMERG MED, V38, DOI 10.1016/j.ajem.2020.05.058
NR 11
TC 10
Z9 10
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2049-0801
J9 ANN MED SURG
JI Ann. Med. Surg.
PD DEC
PY 2020
VL 60
BP 434
EP 437
DI 10.1016/j.amsu.2020.11.031
PG 4
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA PN9CX
UT WOS:000604771600012
PM 33224493
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Perillat, L
   Baigrie, BS
AF Perillat, Lucie
   Baigrie, Brian S.
TI COVID-19 and the generation of novel scientific knowledge:
   Evidence-based decisions and data sharing
SO JOURNAL OF EVALUATION IN CLINICAL PRACTICE
LA English
DT Article
DE epistemology; evidence&#8208; based medicine; medical research;
   philosophy of medicine
AB Rationale, aims and objectives The COVID-19 pandemic has impacted every facet of society, including medical research. This paper is the second part of a series of articles that explore the intricate relationship between the different challenges that have hindered biomedical research and the generation of novel scientific knowledge during the COVID-19 pandemic. In the first part of this series, we demonstrated that, in the context of COVID-19, the scientific community has been faced with numerous challenges with respect to (1) finding and prioritizing relevant research questions and (2) choosing study designs that are appropriate for a time of emergency.
   Methods During the early stages of the pandemic, research conducted on hydroxychloroquine (HCQ) sparked several heated debates with respect to the scientific methods used and the quality of knowledge generated. Research on HCQ is used as a case study in both papers. The authors explored biomedical databases, peer-reviewed journals, pre-print servers and media articles to identify relevant literature on HCQ and COVID-19, and examined philosophical perspectives on medical research in the context of this pandemic and previous global health challenges.
   Results This second paper demonstrates that a lack of research prioritization and methodological rigour resulted in the generation of fleeting and inconsistent evidence that complicated the development of public health guidelines. The reporting of scientific findings to the scientific community and general public highlighted the difficulty of finding a balance between accuracy and speed.
   Conclusions The COVID-19 pandemic presented challenges in terms of (3) evaluating evidence for the purpose of making evidence-based decisions and (4) sharing scientific findings with the rest of the scientific community. This second paper demonstrates that the four challenges outlined in the first and second papers have often compounded each other and have contributed to slowing down the creation of novel scientific knowledge during the COVID-19 pandemic.
C1 [Perillat, Lucie] Univ Toronto, Fac Arts & Sci, 100 St George St, Toronto, ON M5S 3G3, Canada.
   [Baigrie, Brian S.] Univ Toronto, Inst Hist & Philosophy Sci & Technol, Toronto, ON, Canada.
   [Baigrie, Brian S.] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
RP Perillat, L (corresponding author), Univ Toronto, Fac Arts & Sci, 100 St George St, Toronto, ON M5S 3G3, Canada.
EM lucie.perillat@mail.utoronto.ca
OI Perillat, Lucie/0000-0002-5124-8570
CR Abramowitz S., 2018, DATA SHARING PUBLIC, P124
   [Anonymous], 2020, SHAR RES DAT FIND RE
   Arshad S, 2020, INT J INFECT DIS, V97, P396, DOI 10.1016/j.ijid.2020.06.099
   Baigrie, 2021, J EVAL CLIN PRACT, P1
   Baigrie B, 2020, J EVAL CLIN PRACT, V26, P1341, DOI 10.1111/jep.13474
   Black N, 1996, BRIT MED J, V312, P1215
   Borgerson K, 2009, PERSPECT BIOL MED, V52, P218, DOI 10.1353/pbm.0.0086
   Caplan AL, 2020, J CLIN INVEST, V130, P2752, DOI 10.1172/JCI139562
   Chen Jun, 2020, Zhejiang Da Xue Xue Bao Yi Xue Ban, V49, P215, DOI 10.3785/j.issn.1008-9292.2020.03.03
   Djulbegovic B, 2009, CANCER CONTROL, V16, P158, DOI 10.1177/107327480901600208
   FDA, 2020, HYDR FACH SHEET HLTH
   FDA, 2018, FAST TRACK BREAKTHR
   (FDA) FaDA, 2020, COR COVID 19 UPD FDA
   Feuer W., 2020, WHO RESUMES CORONAVI
   Fidler DP, 2011, JAMA-J AM MED ASSOC, V306, P200, DOI 10.1001/jama.2011.960
   Food and Drug Administration, 2019, AD DES CLIN TRIAL DR
   Gallo P, 2006, DRUG INF J, V40, P445, DOI 10.1177/216847900604000410
   Ganann R, 2010, IMPLEMENT SCI, V5, P10, DOI 10.1186/1748-5908-5-56
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410
   GLOPID-R, 2020, GLOPID R ROADM DAT S
   Hickok, 2020, HUSBAND WIFE POISON
   Ibrahim S., 2020, POTENTIAL SHORTAGES
   IOANNIDIS J. P., 2020, STAT-US
   Ioannidis JPA, 2020, EUR J CLIN INVEST, V50, DOI [10.1111/eci.13222, 10.1111/eci.13223]
   Irving M, 2017, EVAL HEALTH PROF, V40, P244, DOI 10.1177/0163278716645161
   Kelly SE, 2016, PEERJ, V4, DOI 10.7717/peerj.2522
   Khangura S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-10
   Leeming, 2020, PREVIOUS OUTBREAKS P
   Mercuri M, 2018, J EVAL CLIN PRACT, V24, P1223, DOI 10.1111/jep.13016
   Mercuri M, 2018, J EVAL CLIN PRACT, V24, P1211, DOI 10.1111/jep.12997
   Mercuri M, 2018, J EVAL CLIN PRACT, V24, P1203, DOI 10.1111/jep.12998
   Mercuri M, 2018, J EVAL CLIN PRACT, V24, P1240, DOI 10.1111/jep.12993
   Molina JM, 2020, MED MALADIES INFECT, V50, P384, DOI 10.1016/j.medmal.2020.03.006
   Nouri SN, 2021, J EVAL CLIN PRACT, V27, P16, DOI 10.1111/jep.13498
   Parkhurst JO, 2016, SOC EPISTEMOL, V30, P665, DOI 10.1080/02691728.2016.1172365
   RECOVERY, 2020, STAT CHIEF INV RECOV
   Retraction Watch, 2020, RETR COR COVID 19 PA
   Roberts, 2003, EVIDENCE HIERARCHIES, V57, P527, DOI [10.1136/jech.57.7.527, DOI 10.1136/JECH.57.7.527]
   Rome BN, 2020, NEW ENGL J MED, V382, P2282, DOI 10.1056/NEJMp2009457
   Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630
   Ruano J, 2020, J CLIN EPIDEMIOL, V124, P183, DOI 10.1016/j.jclinepi.2020.04.015
   Russell J, 2008, J HEALTH SERV RES PO, V13, P40, DOI 10.1258/jhsrp.2007.006029
   Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012
   Smith MJ, 2020, AM J PUBLIC HEALTH, V110, P947, DOI 10.2105/AJPH.2020.305686
   Tang W, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1849
   Thibert C., 2020, FIGARO          0614, P10
   Turnbull BW, 2017, CLIN TRIALS, V14, P462, DOI 10.1177/1740774516689261
   United Nations Environment Programme (UNEP), 1992, RIO DECLARATION ENV
   Upshur Ross E G, 2012, N S W Public Health Bull, V23, P108, DOI 10.1071/NB11044
   Watt A, 2008, ANZ J SURG, V78, P1037, DOI 10.1111/j.1445-2197.2008.04730.x
   Watt A, 2008, INT J TECHNOL ASSESS, V24, P133, DOI 10.1017/S0266462308080185
   WHO, 2016, ZIK OP
   WHO, 2014, WHO HDB GUID DEV
   WHO, 2020, PHARM TREATM COV 19
   WHO, 2020, OMS MET TERM ET HYDR
   World Health Organization, 2020, COVID 19 INF CONS PO
   World Health Organization, 2020, WHO DISC HYDR LOP TR
   Worrall J, 2007, BRIT J PHILOS SCI, V58, P451, DOI 10.1093/bjps/axm024
NR 59
TC 3
Z9 3
U1 1
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1356-1294
EI 1365-2753
J9 J EVAL CLIN PRACT
JI J. Eval. Clin. Pract.
PD JUN
PY 2021
VL 27
IS 3
BP 708
EP 715
DI 10.1111/jep.13548
EA FEB 2021
PG 8
WC Health Care Sciences & Services; Medical Informatics; Medicine, General
   & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services; Medical Informatics; General & Internal
   Medicine
GA SH9GG
UT WOS:000617485600001
PM 33580747
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Ahmadi, A
   Poopak, A
   Nazemi, S
   Mohammadi, N
   Eslami, B
   Seyyedsalehi, MS
   Doshmangir, L
   Allameh, SF
   Zendehdel, K
AF Ahmadi, Ayat
   Poopak, Amirhossein
   Nazemi, Sina
   Mohammadi, Negin
   Eslami, Bita
   Seyyedsalehi, Monireh Sadat
   Doshmangir, Leila
   Allameh, Seyyed Farshad
   Zendehdel, Kazem
TI Incidence of symptomatic COVID-19 in close contacts of patients after
   discharge from hospital
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE COVID-19; Patients discharge; Close-contact transmission; Comorbidity
AB Background There is a little evidence about the infectiousness of recovered COVID-19 patients. Considering that the circumstance of the isolation of the COVID-19 patients after-discharge is not always optimal, it is not very unlikely that viral transmission still occurs after hospital discharge. This study aims to investigate the incidence of symptomatic COVID-19 in close contacts of recovered patients after discharge from hospital. Methods Four hundred fifty discharged COVID-19 patients discharged from the largest public treatment center in Tehran, capital city of Iran, were followed up. Demographic and clinical data of participants were collected from medical records. Follow-up data were acquired via telephone call interviews with patients or their main caregivers at home. Results The study's response rate was 93.77% (422 participated in the study). 60.90% patients were male and 39.10% were female (sex ratio = 1.55 male). The most prevalent comorbidities in these patients were hypertension (29.68%) and diabetes (24.80%). The mean of home isolation after discharge was 25.85. Forty-one (9.71%) patients had at least one new case in their close contacts, up to 3 weeks after they were discharged. There was a significant association between having at least a comorbidity with the odds of getting infected in close contacts [OR (CI) 2.22 (1.05-4.68)]. Density of inhabitant per room in a house' and the quality of isolation had significant associations with observing new cases in the patients' close contacts [high to moderate; OR (CI) 2.44 (1.06-5.61], [bad to good; OR (CI) 2.31 (1.17-4.59)], respectively. Conclusion After hospital discharge, COVID-19 transmission can still occur, when a large number of people lives together in a single house. Another explanation can be that the less precaution measures are taken by recovered patients' cohabitants. Such conditions are also likely to happen when the recovered patient has other chronic diseases and requires additional care.
C1 [Ahmadi, Ayat] Univ Tehran Med Sci, Knowledge Utilizat Res Ctr, Tehran, Iran.
   [Poopak, Amirhossein; Nazemi, Sina; Seyyedsalehi, Monireh Sadat; Zendehdel, Kazem] Univ Tehran Med Sci, Canc Res Ctr, Canc Inst, Tehran, Iran.
   [Mohammadi, Negin] Univ Tehran Med Sci, Radiat Oncol Res Ctr, Canc Inst, Tehran, Iran.
   [Eslami, Bita] Univ Tehran Med Sci, Breast Dis Res Ctr, Canc Inst, Tehran, Iran.
   [Doshmangir, Leila] Tabriz Univ Med Sci, Social Determinants Hlth Res Ctr, Tabriz, Iran.
   [Doshmangir, Leila] Tabriz Univ Med Sci, Tabriz Hlth Serv Management Res Ctr, Dept Hlth Policy & Management, Tabriz, Iran.
   [Allameh, Seyyed Farshad] Univ Tehran Med Sci, Dept Gastroenterol, Tehran, Iran.
RP Zendehdel, K (corresponding author), Univ Tehran Med Sci, Canc Res Ctr, Canc Inst, Tehran, Iran.
EM kzendeh@tums.ac.ir
FU Tehran University of Medical SciencesTehran University of Medical
   Sciences
FX This study was funded by Tehran University of Medical Sciences.
CR CDC, 2020, COR COVID 19 SYMPT C
   Cento V, 2020, J INFECTION, V81, pE90, DOI 10.1016/j.jinf.2020.06.024
   Cerami Carla, 2021, medRxiv, DOI 10.1101/2021.03.10.21253173
   Cheng HY, 2020, JAMA INTERN MED, V180, P1156, DOI 10.1001/jamainternmed.2020.2020
   Foppiani A, 2020, PHARMACOL RES, V160, DOI 10.1016/j.phrs.2020.105063
   Gesesew HA, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-044618
   Greysen SR, 2021, J GEN INTERN MED, V36, P1715, DOI 10.1007/s11606-021-06711-x
   Hu SX, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21710-6
   Krupp K, 2020, J INFECTION, V81, P459, DOI 10.1016/j.jinf.2020.06.030
   Li W, 2020, CLIN INFECT DIS, V71, P1943, DOI 10.1093/cid/ciaa450
   Luo L, 2020, MODES CONTACT RISK T, DOI [10.2139/ssrn.3566149, DOI 10.2139/SSRN.3566149]
   Luo L, MODES CONTACT RISK T
   Ng OT, 2021, LANCET INFECT DIS, V21, P333, DOI 10.1016/S1473-3099(20)30833-1
   Rees EM, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01726-3
   Rhee C, 2021, CLIN INFECT DIS, V72, P1467, DOI 10.1093/cid/ciaa1249
   Sanyaolu Adekunle, 2020, SN Compr Clin Med, V2, P1069, DOI 10.1007/s42399-020-00363-4
   Steyerberg EW, 2008, CLIN PREDICTION MODE
   Sze S, 2021, AGE AGEING, V50, P16, DOI 10.1093/ageing/afaa206
   Wang X, 2020, FOLLOW UP STUDY 131, DOI [10.2139/ssrn.3551342, DOI 10.2139/SSRN.3551342]
   Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   World Health Organization, CRIT REL COVID 19 PA
   Yazdizadeh B, 2020, HEALTH RES POLICY SY, V18, DOI 10.1186/s12961-020-00667-w
   Zheng Z, 2020, J MED VIROL, V92, P2412, DOI 10.1002/jmv.25994
NR 24
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAR 26
PY 2022
VL 22
IS 1
AR 293
DI 10.1186/s12879-022-07300-x
PG 7
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA 0A5CY
UT WOS:000773973600004
PM 35346079
OA gold, Green Published
DA 2022-04-20
ER

PT C
AU Castaneda, DI
   Cuellar, S
AF Castaneda, Delio Ignacio
   Cuellar, Sergio
BE GarciaPerez, A
   Simkin, L
TI Knowledge Sharing in Business Education: Systematic Review
SO PROCEEDINGS OF THE 22ND EUROPEAN CONFERENCE ON KNOWLEDGE MANAGEMENT
   (ECKM 2021)
SE Proceedings of the European Conference on Knowledge Management
LA English
DT Proceedings Paper
CT 22nd European Conference on Knowledge Management (ECKM)
CY SEP 02-03, 2021
CL Coventry Univ, ELECTR NETWORK
HO Coventry Univ
DE Knowledge sharing; knowledge management; business education
ID MANAGEMENT; STRATEGIES; CREATION; FUTURE
AB The paper aims to investigate the evolution of the theme knowledge sharing in business education in the academic literature. Based on an extensive search, it can be stated that this is the first systematic review of this topic. The method employed in this study was a systematic review that covered publications from 1997, when the first paper relating the topic was published in the selected databases, to 2020. The analysis was based on 306 articles. From them, 251 articles came from Scopus and 108 from ISI Web of Science. Some articles are in both databases. Four periods were identified: embryonic, emergent, growth young, and growth highest. One of the findings is that knowledge sharing in business education is growing in virtual environments, especially in the last year, where the COVID 19 pandemic restricted the option of face-to-face education in classrooms. It is recommended that business schools decrease the percentage of time they spend in lectures and increase the time and strategies in which students share knowledge, discuss problems and make decisions based on collective reflection.
C1 [Castaneda, Delio Ignacio; Cuellar, Sergio] Pontificia Univ Javeriana, Bogota, Colombia.
RP Castaneda, DI (corresponding author), Pontificia Univ Javeriana, Bogota, Colombia.
EM delio.castaneda@javeriana.edu.co; scuellar@javeriana.edu.co
CR Al-Kurdi O, 2018, J ENTERP INF MANAG, V31, P226, DOI 10.1108/JEIM-09-2017-0129
   Bayona JA, 2017, INT J MANAG EDUC-OXF, V15, P409, DOI 10.1016/j.ijme.2017.07.002
   Anson R, 2014, J EDUC BUS, V89, P27, DOI 10.1080/08832323.2012.754735
   Argote L, 2000, ORGAN BEHAV HUM DEC, V82, P150, DOI 10.1006/obhd.2000.2893
   Ashton W., 1997, KEEPING ABREAST SCI
   Bacon DR, 2005, J MANAG EDUC, V29, P248, DOI 10.1177/1052562904263729
   Benito Amat C., 2014, REV HISPANA ANALISIS, V25, P201
   Birkinshaw J., 2001, BUS STRAT REV, V12, P11, DOI 10.1111/1467-8616.00161
   Bock GW, 2005, MIS QUART, V29, P87, DOI 10.2307/25148669
   Boud, 2001, PEER LEARNING HIGHER, P1
   Castaneda D. I, 2020, GESTION CONOCIMIENTO
   Castaneda DI, 2020, KNOWL PROCESS MANAG, V27, P159, DOI 10.1002/kpm.1637
   Castañeda Z Delio Ignacio, 2015, Suma Psicol., V22, P63
   Chanchetti LF, 2016, INT J HYDROGEN ENERG, V41, P18301, DOI 10.1016/j.ijhydene.2016.08.137
   Charband Y, 2018, KYBERNETES, V47, P1456, DOI 10.1108/K-06-2017-0227
   Chen IYL, 2009, EDUC TECHNOL SOC, V12, P134
   Cheng EWL, 2000, INT J HUM RESOUR MAN, V11, P837, DOI 10.1080/09585190050075150
   Cocieru OC, 2020, J EDUC BUS, V95, P541, DOI 10.1080/08832323.2020.1729684
   COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553
   Crowther D., 2002, INT J ED MANAGEMENT, V16, P268
   DeWitt D, 2020, J EDUC BUS, V95, P255, DOI 10.1080/08832323.2019.1635977
   Ekahitanond, 2013, ALBERTA J EDUC RES, V59, P247
   Ghoshal S, 2005, ACAD MANAG LEARN EDU, V4, P75, DOI 10.5465/AMLE.2005.16132558
   GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469
   Grzimek V, 2020, J EDUC BUS, V95, P439, DOI 10.1080/08832323.2019.1699770
   Harmon J., 2018, ORGAN MANAG J, V15, P17
   Harmon OR, 2014, INT ADV ECON RES, V20, P33, DOI 10.1007/s11294-013-9453-9
   Harrington Denis, 2011, Journal of European Industrial Training, V35, P116, DOI 10.1108/03090591111109334
   Hernaus T, 2019, J KNOWL MANAG, V23, P597, DOI 10.1108/JKM-11-2017-0531
   Kanawattanachai P, 2007, MIS QUART, V31, P783
   Keong F., 2001, EDUC TRAIN, V43, P268
   Kong XD, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12010075
   Lin CY, 2020, AUSTRALAS J EDUC TEC, V36, P126, DOI 10.14742/ajet.4446
   March JG, 1991, ORGAN SCI, V2, P71, DOI 10.1287/orsc.2.1.71
   Marin A, 2016, J KNOWL MANAG, V20, P959, DOI 10.1108/JKM-11-2015-0438
   Molchanova O., 2018, P EUR C KNOWL MAN PA
   Munoz-Pascual L, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12010161
   Tho ND, 2017, J KNOWL MANAG, V21, P1240, DOI 10.1108/JKM-08-2016-0349
   NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14
   Nonaka I, 2000, LONG RANGE PLANN, V33, P5, DOI 10.1016/S0024-6301(99)00115-6
   Nonaka I, 2009, ORGAN SCI, V20, P635, DOI 10.1287/orsc.1080.0412
   Ojeaga I., 2012, INT ED STUDIES, V5, P218
   Pearlstein J, 2020, J EDUC BUS, V95, P375, DOI 10.1080/08832323.2019.1665488
   Piaget J, 1979, SCI ED PSYCHOL CHILD
   Prince M, 2004, J ENG EDUC, V93, P223, DOI 10.1002/j.2168-9830.2004.tb00809.x
   Robb CC, 2020, J EDUC BUS, V95, P321, DOI 10.1080/08832323.2019.1644275
   Rynes SL, 2001, ACAD MANAGE J, V44, P340, DOI 10.2307/3069460
   Schneckenberg D, 2014, EDUC RES-UK, V56, P412, DOI 10.1080/00131881.2014.965569
   Sebastianelli R, 2011, J EDUC BUS, V86, P317, DOI 10.1080/08832323.2010.525545
   Stanley D, 2020, J EDUC BUS, V95, P506, DOI 10.1080/08832323.2019.1703097
   Staples DS, 2008, INFORM SYST J, V18, P617, DOI 10.1111/j.1365-2575.2007.00244.x
   STARBUCK WH, 1992, J MANAGE STUD, V29, P713, DOI 10.1111/j.1467-6486.1992.tb00686.x
   Starkey K, 2001, BRIT J MANAGE, V12, pS3, DOI 10.1111/1467-8551.12.s1.2
   Szulanski G, 1996, STRATEGIC MANAGE J, V17, P27, DOI 10.1002/smj.4250171105
   Teng JTC, 2011, J KNOWL MANAG, V15, P104, DOI 10.1108/13673271111108729
   Tranfield D, 2003, BRIT J MANAGE, V14, P207, DOI 10.1111/1467-8551.00375
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
   Vygotsky L.S, 1978, READ, DOI DOI 10.2307/J.CTVJF9VZ4.11
   Wang S, 2010, HUM RESOUR MANAGE R, V20, P115, DOI 10.1016/j.hrmr.2009.10.001
   Wasko MM, 2005, MIS QUART, V29, P35, DOI 10.2307/25148667
   Zhou SH, 2010, J KNOWL MANAG, V14, P449, DOI 10.1108/13673271011050157
NR 61
TC 0
Z9 0
U1 0
U2 0
PU ACAD  CONFERENCES LTD
PI NR READING
PA CURTIS FARM, KIDMORE END, NR READING, RG4 9AY, ENGLAND
SN 2048-8963
BN 978-1-914587-07-8
J9 PROC EUR CONF KNOWL
PY 2021
BP 138
EP 144
DI 10.34190/EKM.21.009
PG 7
WC Business; Management
WE Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Business & Economics
GA BS7BB
UT WOS:000758201900017
DA 2022-04-20
ER

PT J
AU Dolighan, T
   Owen, M
AF Dolighan, Tim
   Owen, Michael
TI Teacher Efficacy for Online Teaching During the COVID-19 Pandemic
SO BROCK EDUCATION-A JOURNAL OF EDUCATIONAL RESEARCH AND PRACTICE
LA English
DT Article
DE online teaching; self-efficacy; COVID-19 pandemic; professional
   development
ID PEDAGOGICAL CONTENT KNOWLEDGE; PERCEIVED SELF-EFFICACY;
   PROFESSIONAL-DEVELOPMENT; TECHNOLOGY INTEGRATION; EDUCATION; BELIEFS;
   ICT; PERCEPTIONS; STRATEGIES; IMPACT
AB This study examines secondary teachers' efficacy for teaching in a fully online teaching environment during the sudden transition to online teaching due to the COVID-19 pandemic. The study sought to identify how specific variables, teaching experience, professional development (PD) experience, and teaching supports correlate with the self-efficacy perceptions of teachers transitioning to online teaching during a pandemic. More specifically, we examined self-efficacy perceptions of teachers in the domains of student engagement, instructional strategies, classroom management, and computer skills. The instrument used to measure teacher efficacy for online teaching was a 32-item, web-based survey that was given to Ontario secondary teachers in a southern Ontario Catholic district school board. We argue that prior experience with online learning such as additional qualification (AQ) courses or online PD would build greater self-efficacy amongst teachers as they transition to online learning. The results indicate that higher online teaching efficacy scores correlated with having taken online AQ courses and online PD sessions. The highest online teaching efficacy scores correlated with having previously used a board-provided learning management system (LMS) and using virtual technology supports. These indicators are correlated with higher scores of online teaching efficacy but require further investigation as to how they can better provide support for teachers in online learning environments.
C1 [Dolighan, Tim; Owen, Michael] Brock Univ, St Catharines, ON, Canada.
RP Dolighan, T (corresponding author), Brock Univ, St Catharines, ON, Canada.
EM tim.dolighan@brocku.ca
CR Akyol Z., 2010, WEB BASED ED CONCEPT, P474
   Anderson T., 2017, CONTACT N        SEP
   Angeli C, 2009, COMPUT EDUC, V52, P154, DOI 10.1016/j.compedu.2008.07.006
   Armor D., 1976, ANAL SCH PREFERRED R
   Ashton P., 1986, MAKING DIFFERENCE TE
   Ashton P. T., 1982, AM ED RES ASS ANN M
   BANDURA A, 1993, EDUC PSYCHOL, V28, P117, DOI 10.1207/s15326985ep2802_3
   Bandura A., 2006, SELF EFFICACY BELIEF, P307, DOI DOI 10.1017/CBO9781107415324.004
   Bandura A., 1986, SOCIAL FDN THOUGHT A
   Barbour MK, 2014, PERSPECT INSTR TECHN, P21
   Beltman S, 2011, EDUC RES REV-NETH, V6, P185, DOI 10.1016/j.edurev.2011.09.001
   Berge Z, 1998, ONLINE J DISTANCE LE, V1
   Berman P., 1977, FEDERAL PROGRAMS SUP, VVII
   Blayone TJB, 2017, INT J EDUC TECHNOL H, V14, DOI 10.1186/s41239-017-0051-4
   Cantoni L., 2013, INT J ED DEV USING I, V9, P100
   Cho MH, 2013, DISTANCE EDUC, V34, P290, DOI 10.1080/01587919.2013.835770
   Corry M, 2018, RES LEARN TECHNOL, V26, DOI 10.25304/rlt.v26.2047
   Creswell J., 2011, BEST PRACTICES MIXED
   Eaton S., 2017, SIGNATURE PEDAGOGIES
   Eickelmann B, 2017, EUR EDUC RES J, V16, P733, DOI 10.1177/1474904117725899
   Ertmer P.A., 2014, INT HDB RES TEACHER, P403
   Ertmer PA, 2010, J RES TECHNOL EDUC, V42, P255, DOI 10.1080/15391523.2010.10782551
   Garrison DR, 2013, HANDBOOK OF DISTANCE EDUCATION, 3RD EDITION, P104
   Gibson, 1986, ANN M CAL ED RES ASS
   Good T., 2003, LOOKING CLASSROOMS
   Gosselin K. P., 2009, THESIS
   Hall A.B., 2019, J DIGITAL LEARNING T, V35, DOI [10.1080/21532974.2019.1647579, DOI 10.1080/21532974.2019.1647579]
   Hammond M, 2011, TECHNOL PEDAGOG EDUC, V20, P289, DOI 10.1080/1475939X.2011.610930
   Hatlevik IKR, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00935
   Hatlevik OE, 2017, SCAND J EDUC RES, V61, P555, DOI 10.1080/00313831.2016.1172501
   Horvitz BS, 2015, INNOV HIGH EDUC, V40, P305, DOI 10.1007/s10755-014-9316-1
   Hung ML, 2016, COMPUT EDUC, V94, P120, DOI 10.1016/j.compedu.2015.11.012
   Jackson BL, 2019, J RES TECHNOL EDUC, V51, P7, DOI 10.1080/15391523.2018.1530622
   Kennedy, 2014, HDB RES K 12 ONLINE, P225
   Kennedy K., 2012, J APPL INSTRUCTIONAL, V2, P35
   Klassen RM, 2010, J EDUC PSYCHOL, V102, P741, DOI 10.1037/a0019237
   Koellner K, 2015, J TEACH EDUC, V66, P51, DOI 10.1177/0022487114549599
   Kopcha TJ, 2012, COMPUT EDUC, V59, P1109, DOI 10.1016/j.compedu.2012.05.014
   Kopcha TJ, 2011, J EDUC COMPUT RES, V45, P49, DOI [10.2190/EC.45.1.C, 10.2190/EC.45.1.c]
   Lee MH, 2010, INSTR SCI, V38, P1, DOI 10.1007/s11251-008-9075-4
   Lightsey R, 1999, J COGN PSYCHOTHER, DOI [10.1891/0889-8391.13.2.158, DOI 10.1891/0889-8391.13.2.158]
   Liu X., 2007, Q REV DISTANCE ED, V8, P9
   Lowes S., 2007, WHAT WORKS K 12 LEAR, P161
   Martin NK, 2012, TEACH TEACH EDUC, V28, P546, DOI 10.1016/j.tate.2011.12.003
   Mishra P, 2006, TEACH COLL REC, V108, P1017, DOI 10.1111/j.1467-9620.2006.00684.x
   Moore-Hayes C, 2011, CANADIAN J LEARNING, V37, P1
   Niederhauser DS, 2010, COMPUT HUM BEHAV, V26, P436, DOI 10.1016/j.chb.2009.12.002
   Northcote M, 2015, ISS EDUC RES, V25, P319
   Ontario College of Teachers, 2021, ADD QUAL
   Panisoara IO, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218002
   Perkmen S., 2008, THESIS
   Pringle J., 2020, CTV NEWS
   Rice KL, 2006, J RES TECHNOL EDUC, V38, P425, DOI 10.1080/15391523.2006.10782468
   Robinia KA, 2010, J PROF NURS, V26, P168, DOI 10.1016/j.profnurs.2010.02.006
   Rose, 2007, RES COMMITTEE ISSUES
   Sang GY, 2012, ASIA PAC EDUC REV, V13, P417, DOI 10.1007/s12564-012-9206-0
   Schnackenberg H., 2014, INT J ED PRACTICE, V2, P147, DOI [10.18488/journal.61/2014.2.7/61.7.147.158, DOI 10.18488/JOURNAL.61/2014.2.7/61.7.147.158]
   Semiz K, 2012, AUSTRALAS J EDUC TEC, V28, P1248
   Shea P., 2007, ONLINE LEARNING, V11
   STEIN MK, 1988, TEACH TEACH EDUC, V4, P171, DOI 10.1016/0742-051X(88)90016-9
   Teo T, 2014, COMPUT EDUC, V75, P127, DOI 10.1016/j.compedu.2014.01.014
   Tondeur J, 2017, ETR&D-EDUC TECH RES, V65, P555, DOI 10.1007/s11423-016-9481-2
   Tondeur J, 2012, COMPUT EDUC, V59, P134, DOI 10.1016/j.compedu.2011.10.009
   Tschannen-Moran M, 1998, REV EDUC RES, V68, P202, DOI 10.2307/1170754
   Tschannen-Moran M, 2001, TEACH TEACH EDUC, V17, P783, DOI 10.1016/S0742-051X(01)00036-1
   vanOostveen R, 2019, EDUC INF TECHNOL, V24, P1863, DOI 10.1007/s10639-018-9686-6
   Zheng B., 2015, J ONLINE LEARNING RE, V1, P275
NR 67
TC 2
Z9 2
U1 7
U2 16
PU BROCK UNIV, FAC EDUCATION
PI CATHARINES
PA 500 GLENRIDGE AVE, ST, CATHARINES, ON L2S 3A1, CANADA
SN 1183-1189
J9 BROCK EDUC
JI Brock Educ.
PY 2021
VL 30
IS 1
BP 95
EP 116
PG 22
WC Education & Educational Research
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research
GA QW6OX
UT WOS:000628767600006
DA 2022-04-20
ER

PT J
AU Huynh, G
   Nguyen, HTN
   Nguyen, VT
   Pham, A
AF Giao Huynh
   Han Thi Ngoc Nguyen
   Vien Truong Nguyen
   An Le Pham
TI Development and Psychometric Properties of the Health Belief Scales
   Toward COVID-19 Vaccine in Ho Chi Minh City, Vietnam
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19; COVID-19 vaccine; health belief model; psychometric; Vietnam
ID HEPATITIS-B VACCINATION; VALIDITY; RELIABILITY; KNOWLEDGE; ATTITUDES
AB Background: Beliefs of an individual about health conditions can play an important role in contributing to their behavior concerning good and bad health practices. The aim of this study was to develop and assess a set of vaccination belief scales in relation to COVID-19 vaccines.
   Methods: A cross-sectional study was conducted between July 2020 and January 2021 using a systematic random sampling of 425 adult outpatients at two hospitals in Ho Chi Minh City, Vietnam. An instrument was designed based on the dimensional structure and wording of the health belief model (HBM), which was followed by the assessment of the instrument's internal consistency and the construct validity.
   Results: The 15-item instrument showed the content validity index (CVI) of scales reached a value of 1.0. Exploratory factor analysis was performed on the first sample (n = 170) and extracted 12 out of 15 draft items in a four-factor model (threat of disease, perceived benefits, perceived barriers, and cues to action) that accounted for 68.3% of the total variance. Cronbach's alpha coefficient of 0.765 showed as satisfactory. Following this, the confirmatory factor analysis in the remaining sample (n = 255) found a good fit between a four-factor model and a theoretical model of HBM with acceptable values of fit indices.
   Conclusion: Beliefs scales for COVID-19 vaccination have been determined to be valid and reliable. They can be a helpful instrument for health educators to use for assessing immunization beliefs of individuals and the public where there is the need to implement new vaccines, such as the COVID-19 vaccine, before they are used more widely across the community.
C1 [Giao Huynh; Vien Truong Nguyen] Univ Med & Pharm Ho Chi Minh City, Fac Publ Hlth, Ho Chi Minh City, Vietnam.
   [Han Thi Ngoc Nguyen] Univ Med Ctr Ho Chi Minh City, Infect Control Dept, Ho Chi Minh City, Vietnam.
   [An Le Pham] Univ Med & Pharm Ho Chi Minh City, Family Med Training Ctr, 217 Hong Bang St,Dist 5, Ho Chi Minh City, Vietnam.
RP Huynh, G (corresponding author), Univ Med & Pharm Ho Chi Minh City, Fac Publ Hlth, Ho Chi Minh City, Vietnam.; Pham, A (corresponding author), Univ Med & Pharm Ho Chi Minh City, Family Med Training Ctr, 217 Hong Bang St,Dist 5, Ho Chi Minh City, Vietnam.
EM hgiaoytcc@ump.edu.vn; p.lean@uq.edu.au
OI Truong Vien, Nguyen/0000-0003-3802-5927; HUYNH,
   GIAO/0000-0002-6882-1097; , Han Thi Ngoc Nguyen/0000-0002-1986-0647
FU University of Medicine and Pharmacy at Ho Chi Minh City
FX This research received a grant from the University of Medicine and
   Pharmacy at Ho Chi Minh City.
CR Bassareo PP, 2020, POSTGRAD MED J, V96, P633, DOI 10.1136/postgradmedj-2020-138370
   Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136
   Brown TA., 2006, CONFIRMATORY FACTOR, DOI [10.1007/978-3-319-65361-7_8, DOI 10.1007/978-3-319-65361-7_8]
   Carpenter S, 2018, COMMUN METHODS MEAS, V12, P25, DOI 10.1080/19312458.2017.1396583
   CDC, 2020, SYMPT COR 2020
   CDC, INT IMP EMERG SARS C
   Chen RT, 1996, EPIDEMIOL REV, V18, P99, DOI 10.1093/oxfordjournals.epirev.a017931
   de Souza AC, 2017, EPIDEMIOL SERV SAUDE, V26, P649, DOI 10.5123/S1679-49742017000300022
   Huynh G, 2020, RISK MANAG HEALTHC P, V13, P2149, DOI 10.2147/RMHP.S276715
   Huynh G, 2020, RISK MANAG HEALTHC P, V13, P1571, DOI 10.2147/RMHP.S268876
   Haleem Abid, 2020, Curr Med Res Pract, V10, P78, DOI 10.1016/j.cmrp.2020.03.011
   Huynh G, 2021, ASIAN PAC J TROP MED, V14, P122, DOI 10.4103/1995-7645.307534
   Giao H, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/9323814
   JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101
   JosephHair JF, 2014, MULTIVARIATE DATA AN, V7th
   Kim HW, 2012, VACCINE, V30, P5327, DOI 10.1016/j.vaccine.2012.06.040
   Lance CE, 2006, ORGAN RES METHODS, V9, P202, DOI 10.1177/1094428105284919
   LYNN MR, 1986, NURS RES, V35, P382
   MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130
   Mahase E, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4944
   Mahase E, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4826
   Mahase E, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4564
   Ministry of Health Vietnam, COVID 19 2020
   Ministry of Health Vietnam, 3 TINH NGU VIEN DAU
   Pielak KL, 2003, CAN J PUBLIC HEALTH, V94, P193, DOI 10.1007/BF03405065
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147
   Rhodes SD, 2008, J HOMOSEXUAL, V55, P124, DOI 10.1080/00918360802129386
   Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282
   Shahrabani S, 2009, EUR J HEALTH ECON, V10, P227, DOI 10.1007/s10198-008-0124-3
   Shi Jingcheng, 2012, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V37, P152, DOI 10.3969/j.issn.1672-7347.2012.02.007
   Sun JD, 2011, J PSYCHOEDUC ASSESS, V29, P534, DOI 10.1177/0734282910394976
   Thompson B, 2004, EXPLORATORY FACTOR A
   WHO, SARS COV 2 VAR UN KI
   WHO, 2020, COR DIS COVID PAND 2
   WHO, 2019, VACC IMM VACC
   WHO, 2020, REP WHO CHIN JO MISS
   WHO, 2020, DRAFT LANDSC COVID 1
NR 38
TC 7
Z9 7
U1 2
U2 2
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 2517
EP 2526
DI 10.2147/RMHP.S301645
PG 10
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA SZ4YO
UT WOS:000666572600001
PM 34163271
OA gold, Green Published
DA 2022-04-20
ER

PT C
AU Ye, YF
   Fan, YJ
   Hou, SF
   Zhang, YM
   Qian, YY
   Sun, SY
   Peng, Q
   Ju, MX
   Song, W
   Loparo, K
AF Ye, Yanfang
   Fan, Yujie
   Hou, Shifu
   Zhang, Yiming
   Qian, Yiyue
   Sun, Shiyu
   Peng, Qian
   Ju, Mingxuan
   Song, Wei
   Loparo, Kenneth
GP ASSOC COMP MACHINERY
TI Community Mitigation: A Data-driven System for COVID-19 Risk Assessment
   in a Hierarchical Manner
SO CIKM '20: PROCEEDINGS OF THE 29TH ACM INTERNATIONAL CONFERENCE ON
   INFORMATION & KNOWLEDGE MANAGEMENT
LA English
DT Proceedings Paper
CT 29th ACM International Conference on Information and Knowledge
   Management (CIKM)
CY OCT 19-23, 2020
CL ELECTR NETWORK
SP Assoc Comp Machinery, ACM SIGIR, ACM SIGWEB
DE Data-driven System; Heterogeneous Data; Community-level COVID-19 Risk
   Assessment; Community Mitigation
AB The fast evolving and deadly outbreak of coronavirus disease (COVID-19) has posed grand challenges to human society. To slow the spread of virus infections and better respond with actionable strategies for community mitigation, leveraging the large-scale and real-time pandemic related data generated from heterogeneous sources (e.g., disease related data, demographic data, mobility data, and social media data), in this work, we propose and develop a data-driven system (named alpha-Satellite), as an initial offering, to provide real-time COVID-19 risk assessment in a hierarchical manner in the United States. More specifically, given a location (either user input or automatic positioning), the system will automatically provide risk indices associated with the specific location, the county that location is in and the state as a whole to enable people to select appropriate actions for protection while minimizing disruptions to daily life to the extent possible. In alpha-Satellite, we first construct an attributed heterogeneous information network (AHIN) to model the collected multi-source data in a comprehensive way; and then we utilize meta-path based schemes to model both vertical and horizontal information associated with a given location (i.e., point of interest, POI); finally we devise a novel heterogeneous graph neural network to aggregate its neighborhood information to estimate the risk of the given POI in a hierarchical manner. To comprehensively evaluate the performance of alpha-Satellite in real-time COVID-19 risk assessment, a set of studies are first performed to validate its utility; based on a real-world dataset consisting of 6,538 annotated POIs, the experimental results show that alpha-Satellite achieves the area of under curve (AUC) of 0.9378, which outperforms the state-of-the-art baselines. After we launched the system for public tests, it had attracted 51,190 users as of May 30. Based on the analysis of its large-scale users, we have a key finding that people from more severe regions (i.e., with larger numbers of COVID-19 cases) have stronger interests using the system for actionable information. Our system and generated benchmark datasets have been made publicly accessible through our website(1).
C1 [Ye, Yanfang; Fan, Yujie; Hou, Shifu; Zhang, Yiming; Qian, Yiyue; Sun, Shiyu; Peng, Qian; Ju, Mingxuan; Song, Wei] Case Western Reserve Univ, Dept Comp & Data Sci, Cleveland, OH 44106 USA.
   [Loparo, Kenneth] Case Western Reserve Univ, Dept Elect Comp & Syst Engn, Cleveland, OH 44106 USA.
RP Ye, YF (corresponding author), Case Western Reserve Univ, Dept Comp & Data Sci, Cleveland, OH 44106 USA.
EM yanfang.ye@case.edu; yxf370@case.edu; sxh1055@case.edu;
   yxz2092@case.edu; yxq250@case.edu; sxs2293@case.edu; qxp36@case.edu;
   mxj255@case.edu; wxs338@case.edu; kal4@case.edu
FU NSFNational Science Foundation (NSF) [IIS-2027127, IIS-2040144,
   IIS-1951504, CNS-2034470, CNS-1940859, CNS-1946327, CNS-1814825,
   OAC-1940855]; DoJ/NIJ [NIJ 2018-75-CX-0032]
FX This work is partially supported by the NSF under grants IIS-2027127,
   IIS-2040144, IIS-1951504, CNS-2034470, CNS-1940859, CNS-1946327,
   CNS-1814825 and OAC-1940855, and by the DoJ/NIJ under grant NIJ
   2018-75-CX-0032. The authors would also like to thank the strong support
   from Google for the use of Google Maps Platform.
CR 1point3acres, 2020, COVID 19 US CAN
   Bird S, 2009, NATURAL LANGUAGE PRO
   CDC, 2020, 1918 PAND H1N1 VIR
   CDC, 2020, AR YOU HIGH RISK SEV
   CDC, 2020, IMPL MIT STRAT COMM
   Centers for Disease Control and Prevention (CDC), 2020, How COVID-19 Spreads
   CHEN J, 2020, DEEP LEARNING BASED, DOI DOI 10.1101/2020.02.25.20021568
   Couture Victor, 2020, EXPOSURE INDICES DER
   Dong YX, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P135, DOI 10.1145/3097983.3098036
   Fan SH, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P2478, DOI 10.1145/3292500.3330673
   Fan YJ, 2018, KDD'18: PROCEEDINGS OF THE 24TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P253, DOI 10.1145/3219819.3219862
   Finkel J.R., 2005, P 43 ANN M ASS COMP, P363
   Hermanowicz Slav W, 2020, FORECASTING WUHAN CO
   Hou SF, 2019, PROCEEDINGS OF THE 28TH ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM '19), P609, DOI 10.1145/3357384.3357875
   Hou SF, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1507, DOI 10.1145/3097983.3098026
   Jahanbin Kia, 2020, USING TWITTER WEB NE
   Kipf T.N., 2016, ARXIV PREPRINT ARXIV
   Li X, 2017, PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'17), P1621, DOI 10.1145/3038912.3052576
   Maas A.L., 2013, P 30 INT C MACH LEAR, V30, P3
   Perozzi B, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P701, DOI 10.1145/2623330.2623732
   Randhawa GS, 2020, BIORXIV
   Shi W., 2020, DEEP LEARNING BASED, DOI [10.2139/ssrn.3546089, DOI 10.2139/SSRN.3546089]
   Srinivasa Rao ASR, 2020, INFECT CONT HOSP EP, V41, P826, DOI [10.1017/ice.2070.61, DOI 10.1017/ICE.2020.61]
   StatsIndiana, 2020, CIT TO COUNT FIND
   Sunt YZ, 2011, PROC VLDB ENDOW, V4, P992
   Velikovic P., 2017, ARXIV PREPRINT ARXIV
   Wang S, 2021, EUR RADIOL, V31, P6096, DOI [10.1079/9781789246070.0001, 10.1007/s00330-021-07715-1]
   Welling, 2018, ABS170306103 ARXIV, DOI DOI 10.1007/978-3-319-93417-4_38
   WHO, 2021, STAT 2 M INT HLTH RE
   Yan L, 2020, PREDICTION SURVIVAL, DOI [10.1101/2020.02.27.20028027, DOI 10.1101/2020.02.27.20028027]
   Ye Y, 2017, KNOWLEDGE INFORM SYS, P1
   Ye YF, 2019, PROCEEDINGS OF THE TWENTY-EIGHTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P4150
   Ye YF, 2018, 34TH ANNUAL COMPUTER SECURITY APPLICATIONS CONFERENCE (ACSAC 2018), P542, DOI 10.1145/3274694.3274742
   Ye Yanfang, 2017, COMPUT SURVEYS
NR 34
TC 1
Z9 1
U1 1
U2 2
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1601 Broadway, 10th Floor, NEW YORK, NY, UNITED STATES
BN 978-1-4503-6859-9
PY 2020
BP 2909
EP 2916
DI 10.1145/3340531.3412753
PG 8
WC Computer Science, Information Systems; Computer Science, Theory &
   Methods
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science
GA BS6LW
UT WOS:000749561302156
DA 2022-04-20
ER

PT J
AU Cossu, A
   Lo Barco, T
   Darra, F
   Fontana, E
   Fiorini, E
   Marangone, M
   Biban, P
   Dalla Bernardina, B
   Cantalupo, G
AF Cossu, Alberto
   Lo Barco, Tommaso
   Darra, Francesca
   Fontana, Elena
   Fiorini, Elena
   Marangone, Martina
   Biban, Paolo
   Dalla Bernardina, Bernardo
   Cantalupo, Gaetano
TI Remote Teamwork Management of NORSE During the COVID-19 Lockdown
SO NEUROLOGY-CLINICAL PRACTICE
LA English
DT Editorial Material
AB New-onset refractory status epilepticus (NORSE) is rare condition, and sharing knowledge is vital in its management, based on strict collaboration between multiple specialists, continuous EEG (c-EEG) monitoring, and prompt therapy modification. The coronavirus disease 2019 (COVID-19) pandemic challenged many of these established practices because of "social distancing" measures, making it necessary to work around physical restrictions. We report a case of a 10-year-old with NORSE admitted in a pediatric intensive-care unit and monitored with c-EEG and amplitude-integrated EEG. The monitoring interface was livestreamed using videoconference web-based platforms allowing remote viewing. Multiple daily web meetings took place between team members, where real-time therapy response was evaluated and confronted with medium-term trends in the epileptic activity, dictating further treatment and diagnostic steps. In addition to the known use of telemedicine in chronic conditions, we report how its use can be exploited to treat urgent conditions such as NORSE. By taking advantage of new tools and virtual environments, we were able to share treatment and diagnostic decisions and guarantee real-time therapy adjustments and a coherent course in treatment despite restrictions necessary for the COVID-19 pandemic. The constant specialist monitoring and the coherent and on-time communication of the patient's condition relieved the family stress, usually complained in these situations.
C1 [Lo Barco, Tommaso; Darra, Francesca; Cantalupo, Gaetano] Univ Verona, Dept Surg Sci Dent Gynecol & Pediat, Child Neuropsychiat, Verona, Italy.
   [Lo Barco, Tommaso] Univ Modena & Reggio Emilia, Clin & Expt Med PhD Program, Modena, Italy.
   [Darra, Francesca; Fontana, Elena; Marangone, Martina; Cantalupo, Gaetano] Univ Hosp Verona, Child Neuropsychiat Unit, Verona, Italy.
   [Biban, Paolo] Univ Hosp Verona, Pediat Intens Care Unit, Verona, Italy.
   [Dalla Bernardina, Bernardo] Ctr Res Epilepsies Pediat Age CREP, Verona, Italy.
RP Cantalupo, G (corresponding author), Univ Verona, Dept Surg Sci Dent Gynecol & Pediat, Child Neuropsychiat, Verona, Italy.; Cantalupo, G (corresponding author), Univ Hosp Verona, Child Neuropsychiat Unit, Verona, Italy.
EM albcossu@gmail.com; tommaso.lobarco@univr.it; francesca.darra@univr.it;
   elena.fontana@aovr.veneto.it; elena.fiorini2@aovr.veneto.it;
   martina.marangone@aovr.veneto.it; paolo.biban@aovr.veneto.it;
   bernardo.dallabernardina@univr.it; gaetano.cantalupo@univr.it
CR [Anonymous], 2020, VENETO RIORGANIZZA A
   Gaspard N, 2018, EPILEPSIA, V59, P745, DOI 10.1111/epi.14022
   Gofton TE, 2019, MAYO CLIN PROC, V94, P857, DOI 10.1016/j.mayocp.2018.12.004
   Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P96, DOI 10.1097/WNP.0000000000000165
   Nouri S, 2020, NEJM CATAL INNOV CAR, P1, DOI [10.1056/CAT.20.0123, DOI 10.1056/CAT.20.0123]
   O'Byrne William T 3rd, 2008, Anesthesiol Clin, V26, P729, DOI 10.1016/j.anclin.2008.07.010
   Ohannessian R, 2020, JMIR PUBLIC HLTH SUR, V6, P121, DOI 10.2196/18810
   Payne ET, 2014, BRAIN, V137, P1429, DOI 10.1093/brain/awu042
   Sculier C, 2019, SEIZURE-EUR J EPILEP, V68, P72, DOI 10.1016/j.seizure.2018.09.018
   Williams JA, 2019, SEIZURE-EUR J EPILEP, V71, P93, DOI 10.1016/j.seizure.2019.05.025
NR 10
TC 0
Z9 0
U1 3
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2163-0402
EI 2163-0933
J9 NEUROL-CLIN PRACT
JI Neurol.-Clin. Pract.
PD APR
PY 2021
VL 11
IS 2
BP E170
EP E173
DI 10.1212/CPJ.0000000000001027
PG 4
WC Clinical Neurology
WE Emerging Sources Citation Index (ESCI)
SC Neurosciences & Neurology
GA SO2UQ
UT WOS:000658832600029
PM 33842087
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Terblanche, E
   Hills, J
   Russell, E
   Lewis, R
   Rose, L
AF Terblanche, Ella
   Hills, Jessica
   Russell, Edie
   Lewis, Rhiannon
   Rose, Louise
TI Dietetic-Led Nutrition Interventions in Patients with COVID-19 during
   Intensive Care and Ward-Based Rehabilitation: A Single-Center
   Observational Study
SO NUTRIENTS
LA English
DT Article
DE COVID-19; intensive care; dietitian; dietician; nutrition; malnutrition;
   weight loss
ID MALNUTRITION; MANAGEMENT
AB Background: In this study, a report of dietitian-led nutrition interventions for patients with COVID-19 during ICU and ward-based rehabilitation is provided. As knowledge of COVID-19 and its medical treatments evolved through the course of the pandemic, dietetic-led interventions were compared between surge 1 (S1) and surge 2 (S2). Methods: A prospective observational study was conducted of patients admitted to the ICU service in a large academic hospital (London, UK). Clinical and nutrition data were collected during the first surge (March-June 2020; n = 200) and the second surge (November 2020-March 2021; n = 253) of COVID-19. Results: A total of 453 patients were recruited. All required individualized dietetic-led interventions during ICU admission as the ICU nutrition protocol did not meet nutritional needs. Feed adjustments for deranged renal function (p = 0.001) and propofol calories (p = 0.001) were more common in S1, whereas adjustment for gastrointestinal dysfunction was more common in S2 (p = 0.001). One-third of all patients were malnourished on ICU admission, and all lost weight in ICU, with a mean (SD) total percentage loss of 8.8% (6.9%). Further weight loss was prevented over the remaining hospital stay with continued dietetic-led interventions. Conclusions: COVID-19 patients have complex nutritional needs due to malnutrition on admission and ongoing weight loss. Disease complexity and evolving nature of medical management required multifaceted dietetic-led nutritional strategies, which differed between surges.
C1 [Terblanche, Ella; Hills, Jessica; Russell, Edie; Lewis, Rhiannon] St Georges Univ Hosp NHS Fdn Trust, Dietet Dept, London SE1 8WA, England.
   [Terblanche, Ella; Rose, Louise] Kings Coll London, Florence Nightingale Fac Nursing Midwifery & Pall, London WC2R 2LS, England.
   [Rose, Louise] Guys & St Thomas NHS Fdn Trust, Adult Crit Care, London SE1 7EH, England.
RP Terblanche, E (corresponding author), St Georges Univ Hosp NHS Fdn Trust, Dietet Dept, London SE1 8WA, England.; Terblanche, E (corresponding author), Kings Coll London, Florence Nightingale Fac Nursing Midwifery & Pall, London WC2R 2LS, England.
EM ella.terblanche@kcl.ac.uk; jessica.hills@uon.edu.au;
   edie.russell@stgeorges.nhs.uk; r.lewis3@rbht.nhs.uk;
   louise.rose@kcl.ac.uk
OI Terblanche MBE, Ella/0000-0002-1761-8996; Rose,
   Louise/0000-0003-1700-3972
CR BAPEN British Association of Parenteral and Enteral Nutrition, MALN UN SCREEN TOOL
   Barazzoni R, 2020, CLIN NUTR, V39, P1631, DOI 10.1016/j.clnu.2020.03.022
   BDA British Dietetic Association,, CRIT CAR SPEC GROUP
   Bedock D, 2020, CLIN NUTR ESPEN, V40, P214, DOI 10.1016/j.clnesp.2020.09.018
   Behrens S, 2021, NUTR CLIN PRACT, V36, P105, DOI 10.1002/ncp.10592
   Cederholm T, 2019, J CACHEXIA SARCOPENI, V10, P207, DOI 10.1002/jcsm.12383
   Chappell D, 2008, CRIT CARE, V12, DOI 10.1186/cc6930
   Chapple LAS, 2020, NUTR DIET, V77, P426, DOI 10.1111/1747-0080.12636
   de Watteville Aude, 2021, Clin Nutr, DOI 10.1016/j.clnu.2021.05.024
   Eden Timothy, 2021, BMJ Nutr Prev Health, V4, P342, DOI [10.1136/bmjnph-2021-000270, 10.1136/bmjnph-2021-000271]
   Ghorbanzadeh K, 2021, ACUTE CRIT CARE, V36, P133, DOI 10.4266/acc.2020.00626
   Jha AK, 2021, ACUTE CRIT CARE, V36, P1, DOI 10.4266/acc.2020.00864
   Martindale R, 2020, JPEN-PARENTER ENTER, V44, P1174, DOI 10.1002/jpen.1930
   Minnelli N, 2020, JPEN-PARENTER ENTER, V44, P1439, DOI 10.1002/jpen.1996
   Niederer LE, 2021, CLIN NUTR ESPEN, V45, P341, DOI 10.1016/j.clnesp.2021.07.021
   Rothpletz-Puglia P., 2021, INTERNET J ALLIED HL, V19, P12, DOI [10.46743/1540-580X/2021.2031, DOI 10.46743/1540-580X/2021.2031]
   Singer P, 2019, CLIN NUTR, V38, P48, DOI 10.1016/j.clnu.2018.08.037
   Whittle J, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03286-7
NR 18
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD MAR
PY 2022
VL 14
IS 5
AR 1062
DI 10.3390/nu14051062
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA ZR9JE
UT WOS:000768091000001
PM 35268037
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Metwally, ABM
   Diab, A
   Mohamed, MK
AF Metwally, Abdelmoneim Bahyeldin Mohamed
   Diab, Ahmed
   Mohamed, Mostafa Kayed
TI Telework operationalization through internal CSR, governmentality and
   accountability during the Covid-19: evidence from a developing country
SO INTERNATIONAL JOURNAL OF ORGANIZATIONAL ANALYSIS
LA English
DT Article; Early Access
DE Egypt; CSR; Governmentality; Telecommunication; Telework; Covid-19
ID CORPORATE SOCIAL-RESPONSIBILITY; OFFICE SCIENTIFIC MANAGEMENT;
   CONSTRUCTION; IMPACT
AB Purpose
   This study aims to examine the impact of Covid-19 on transforming accountability, corporate social responsibility (CSR) and office operation and control. This paper explains how unleashing the rationality of health and safety along with internal CSR made the transformation to telework successfully operable in a periphery of a western multinational corporation.
   Design/methodology/approach
   The study draws upon the theories of governmentality and social accountability. It adopts an interpretative qualitative research approach and uses the case study method. Data were collected from one of the biggest private sector telecommunication companies in Egypt.
   Findings
   This study finds that Covid-19 and its related health and safety discourse represented a good rationale for the western home office to accelerate the initiation of its office transformation plan to reach full working from home policy in a less developed country peripheral subsidiary. Under the guise of CSR, the company spent a large budget to make this transformation quickly operable, while its Egyptian subsidiary is financially distressed. Moreover, the company achieved its objectives from this new rationality as employees currently prefer the telework mode which reduces the company costs in the long run.
   Practical implications
   The study provides practitioners with evidence and practicable knowledge regarding the impact of Covid-19 on office reconfiguration and the ways used to achieve this in the Egyptian telecommunication sector.
   Originality/value
   The current study extends the governmentality literature by illustrating that transformation to telework in emerging markets is an operational manifestation of cost reduction and efficiency rationality under the guise of CSR. Moreover, it extends the office transformation literature by bringing early evidence regarding office transition plans during COVID-19 in an emerging market.
C1 [Metwally, Abdelmoneim Bahyeldin Mohamed] Bangor Univ, Bangor Business Sch, BIBF Campus, Manama, Bahrain.
   [Metwally, Abdelmoneim Bahyeldin Mohamed; Mohamed, Mostafa Kayed] Assiut Univ, Fac Commerce, Dept Accounting, Assiut, Egypt.
   [Diab, Ahmed] Prince Sultan Univ, Dept Accounting, Riyadh, Saudi Arabia.
   [Diab, Ahmed] Beni Suef Univ, Fac Commerce, Bani Suwayf, Egypt.
RP Metwally, ABM (corresponding author), Bangor Univ, Bangor Business Sch, BIBF Campus, Manama, Bahrain.; Metwally, ABM (corresponding author), Assiut Univ, Fac Commerce, Dept Accounting, Assiut, Egypt.
EM a.metwally@aun.edu.eg; adiab@psu.edu.sa; m_kayed@aun.edu.eg
RI Mohamed, Mostafa/AAW-1484-2021
OI Metwally, Abdelmoneim Bahyeldin Mohamed/0000-0003-1660-766X
CR Abdelmotaleb M, 2018, MANAGE DECIS, V56, P2325, DOI 10.1108/MD-06-2017-0552
   Aguinis H, 2020, MANAG RES, V18, P421, DOI 10.1108/MRJIAM-06-2020-1053
   Alawattage C., 2009, CRIT PERSPECT, V20, P701
   Awio G, 2011, ACCOUNT AUDIT ACCOUN, V24, P63, DOI 10.1108/09513571111098063
   Baker CR, 2014, CRIT PERSPECT ACCOUN, V25, P620, DOI 10.1016/j.cpa.2014.02.005
   Baldry C, 1997, INT LABOUR REV, V136, P365
   Bell M., 1995, GEOGRAPHY IMPERIALIS
   Burchell G., 1991, DISCIPLINE PUNISH BI
   COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943
   Dean Mitchell., 2009, GOVT POWER RULE MODE
   Diab A, 2020, J ACCOUNT EMERG ECON, V10, P655, DOI 10.1108/JAEE-11-2019-0214
   Diab AAA, 2020, QUAL RES ACCOUNT MAN, V17, P675, DOI 10.1108/QRAM-12-2019-0134
   Diab AAA, 2019, QUAL RES ACCOUNT MAN, V16, P373, DOI 10.1108/QRAM-08-2017-0081
   Donzelot J, 1979, POLICING FAMILIES
   Edwards M, 1995, NONGOVERNMENTAL ORG, P3
   Elam, 2003, DESIGNING SELECTING
   Filimonau V, 2020, INT J HOSP MANAG, V91, DOI 10.1016/j.ijhm.2020.102659
   FOUCAULT M, 1982, CRIT INQUIRY, V8, P777, DOI 10.1086/448181
   Foucault M., 1988, TECHNOLOGIES SELF SE
   Foucault M., 1984, M FOUCAULT FOUCAULT, P188
   Foucault Michel, 1980, POWERKNOWLEDGE
   Graham C, 2004, J CURRICULUM STUD, V36, P295, DOI 10.1080/0022027032000167080
   Gray R., 2006, ACCOUNT AUDIT ACCOUN, V19, P793
   Guan YJ, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103438
   He HW, 2020, J BUS RES, V116, P176, DOI 10.1016/j.jbusres.2020.05.030
   Hickey S, 2016, J DEV STUD, V52, P1225, DOI 10.1080/00220388.2015.1134778
   Hopper T., 2003, CRIT PERSPECT, V14, P739, DOI [10.1016/S1045-2354(02)00188-0, DOI 10.1016/S1045-2354(02)00188-0]
   Hopper T., 1993, MANAGEMENT ACCOUNTIN, V4, P181, DOI DOI 10.1006/MARE.1993.1011
   Hopper T., 2009, ACCOUNT AUDIT ACCOUN, V22, P469
   Hopper T., 2005, CRIT PERSPECT, V16, P473, DOI [10.1016/j.cpa.2003.07.001, DOI 10.1016/J.CPA.2003.07.001]
   HUNTINGTON S., 2002, CLASH CIVILIZATIONS
   Jayasinghe K., 2020, J PUBLIC BUDGETING A, V32, P439, DOI DOI 10.1108/JPBAFM-09-2019-0143
   Jeacle I, 2013, BUS HIST, V55, P1074, DOI 10.1080/00076791.2013.838034
   Kohli D.S., 2012, MANUAL SOCIAL ACCOUN
   Kornberger M, 2004, ORGAN STUD, V25, P1095, DOI 10.1177/0170840604046312
   Lai A, 2014, CRIT PERSPECT ACCOUN, V25, P579, DOI 10.1016/j.cpa.2014.04.002
   Latour B., 1987, SCI ACTION FOLLOW SC
   Mason J., 2002, QUALITATIVE RES
   Metwally A.M., 2016, NSBM J MANAGEMENT, V2, P1
   MILLER P, 1987, ACCOUNT ORG SOC, V12, P235, DOI 10.1016/0361-3682(87)90039-0
   MILLER P, 1990, ECON SOC, V19, P1, DOI 10.1080/03085149000000001
   Moon TW, 2014, CAREER DEV INT, V19, P49, DOI 10.1108/CDI-05-2013-0060
   Naseeb H., 2021, J RISK MANAGEMENT FI, V14, P59
   O'Dwyer B., 2007, ACCOUNT AUDIT ACCOUN, V20, P446
   Oakes L. S, 2008, ACCOUNTING AUDITING, V21, P765, DOI DOI 10.1108/09513570810893245
   Paldam M., 2000, EUR J POLIT ECON, V16, P339, DOI [10.1016/S0176-2680(99)00064-6, DOI 10.1016/S0176-2680(99)00064-6]
   Parker LD, 2020, ACCOUNT AUDIT ACCOUN, V33, P1943, DOI 10.1108/AAAJ-06-2020-4609
   Parker LD, 2019, CONTEMP ACCOUNT RES, V36, P1883, DOI 10.1111/1911-3846.12478
   Parker LD, 2016, J ACCOUNT ORGAN CHAN, V12, P177, DOI 10.1108/JAOC-01-2015-0007
   Parker LD, 2014, ACCOUNT ORG SOC, V39, P632, DOI 10.1016/j.aos.2014.10.001
   Putnam R., 1993, MAKING DEMOCRACY WOR
   Rahaman A, 2010, CONTEMP ACCOUNT RES, V27, P1093, DOI 10.1111/j.1911-3846.2010.01040.x
   ROBERTS J, 1991, ACCOUNT ORG SOC, V16, P355, DOI 10.1016/0361-3682(91)90027-C
   Rolfo L, 2018, ERGONOMICS, V61, P644, DOI 10.1080/00140139.2017.1398844
   ROSE N, 1991, ACCOUNT ORG SOC, V16, P673, DOI 10.1016/0361-3682(91)90019-B
   ROSE N, 1992, BRIT J SOCIOL, V43, P173, DOI 10.2307/591464
   Rose N., 1992, VALUES ENTERPRISE CU
   Rose N, 2006, ANNU REV LAW SOC SCI, V2, P83, DOI 10.1146/annurev.lawsocsci.2.081805.105900
   Ryan B., 2002, RES METHOD METHODOLO
   Said Edward W., 1979, ORIENTALISM
   Sargiacomo M, 2014, CRIT PERSPECT ACCOUN, V25, P652, DOI 10.1016/j.cpa.2014.03.011
   Sciulli N, 2018, FINANC ACCOUNT MANAG, V34, P30, DOI 10.1111/faam.12134
   Shehata S., 2009, SHOP FLOOR CULTURE P
   Siggelkow N, 2007, ACAD MANAGE J, V50, P20, DOI 10.5465/amj.2007.24160882
   Siwale J., 2006, ACCOUNTING AUDITING, V19, P405, DOI DOI 10.1108/09513570610670352
   Soobaroyen T, 2013, ACCOUNT FORUM, V37, P92, DOI 10.1016/j.accfor.2013.04.002
   Sorensen E., 2012, INNOVATION J, V17, P2
   Spence LJ, 2014, ACCOUNT ORG SOC, V39, P433, DOI 10.1016/j.aos.2012.03.003
   Taylor FW, 1911, PRINCIPLES SCI MANAG
   Turker D, 2009, J BUS ETHICS, V89, P189, DOI 10.1007/s10551-008-9993-8
   Vives A., 2006, J CORPORATE CITIZENS, V2006, P39, DOI DOI 10.9774/GLEAF.4700.2006.SP.00006
   Yin K, 2018, CASE STUDY RES APPL
   Yu A, 2021, ACCOUNT ORG SOC, V90, DOI 10.1016/j.aos.2020.101198
NR 73
TC 3
Z9 3
U1 4
U2 23
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1934-8835
EI 1758-8561
J9 INT J ORGAN ANAL
JI Int. J. Organ. Anal.
DI 10.1108/IJOA-11-2020-2500
EA MAY 2021
PG 24
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA RY2JM
UT WOS:000647743600001
OA Bronze
DA 2022-04-20
ER

PT J
AU Delshad, M
   Tavakolinia, N
   Pourbagheri-Sigaroodi, A
   Safaroghli-Azar, A
   Bagheri, N
   Bashash, D
AF Delshad, Mahda
   Tavakolinia, Naeimeh
   Pourbagheri-Sigaroodi, Atieh
   Safaroghli-Azar, Ava
   Bagheri, Nader
   Bashash, Davood
TI The contributory role of lymphocyte subsets, pathophysiology of
   lymphopenia and its implication as prognostic and therapeutic
   opportunity in COVID-19
SO INTERNATIONAL IMMUNOPHARMACOLOGY
LA English
DT Review
DE COVID-19; SARS-CoV-2; Lymphocytes; Lymphopenia; Prognosis;
   Pathophysiology
ID CLINICAL CHARACTERISTICS; INHIBITION; PNEUMONIA; INFECTION; PATHOLOGY;
   CYTOKINE; CELLS
AB The incidence of the novel coronavirus disease (COVID-19) outbreak caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has brought daunting complications for people as well as physicians around the world. An ever-increasing number of studies investigating the characteristics of the disease, day by day, is shedding light on a new feature of the virus with the hope that eventually these efforts lead to the proper treatment. SARS-CoV-2 activates antiviral immune responses, but in addition may overproduce proinflammatory cytokines, causing uncontrolled inflammatory responses in patients with severe COVID-19. This condition may lead to lymphopenia and lymphocyte dysfunction, which in turn, predispose patients to further infections, septic shock, and severe multiple organ dysfunction. Therefore, accurate knowledge in this issue is important to guide clinical management of the disease and the development of new therapeutic strategies in patients with COVID-19. In this review, we provide a piece of valuable information about the alteration of each subtype of lymphocytes and important prognostic factors associated with these cells. Moreover, through discussing the lymphopenia pathophysiology and debating some of the most recent lymphocyte- or lymphopeniarelated treatment strategies in COVID-19 patients, we tried to brightening the foreseeable future for COVID19 patients, especially those with severe disease.
C1 [Delshad, Mahda] Zanjan Univ Med Sci, Sch Allied Med Sci, Dept Lab Sci, Zanjan, Iran.
   [Tavakolinia, Naeimeh] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran.
   [Pourbagheri-Sigaroodi, Atieh; Safaroghli-Azar, Ava; Bashash, Davood] Shahid Beheshti Univ Med Sci, Sch Allied Med Sci, Dept Hematol & Blood Banking, Tehran, Iran.
   [Bagheri, Nader] Shahrekord Univ Med Sci, Basic Hlth Sci Inst, Cellular & Mol Res Ctr, Shahrekord, Iran.
RP Bashash, D (corresponding author), Shahid Beheshti Univ Med Sci, Sch Allied Med Sci, Dept Hematol & Blood Banking, Tehran, Iran.
EM D.bashash@sbmu.ac.ir
RI Bagheri, Nader/V-1546-2017; Bashash, Davood/S-3774-2018
OI Bagheri, Nader/0000-0001-5196-5513; Bashash, Davood/0000-0002-8029-4920
FU Shahid Beheshti University of Medical Sciences (Tehran, Iran)
FX Acknowledgment The authors would like to express their gratitude to
   Shahid Beheshti University of Medical Sciences (Tehran, Iran) for
   supporting this study.
CR Alijotas-Reig J, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102569
   Altuntas F, 2021, TRANSFUS APHER SCI, V60, DOI 10.1016/j.transci.2020.102955
   Asghar MS, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.9575
   Azkur AK, 2020, ALLERGY, V75, P1564, DOI 10.1111/all.14364
   Benincasa G., 2020, BRIT J ANAESTH
   Bermejo-Martin JF, 2020, J INFECTION, V80, pE23, DOI 10.1016/j.jinf.2020.02.029
   Bonam SR, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100016
   Bourgey M., 2021, MED
   Cao Min, 2020, medRxiv, DOI 10.1101/2020.03.04.20030395
   CHEN G, 2020, J CLIN INVEST, DOI DOI 10.1172/JCI137244
   Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005
   Chhetri S, 2020, IDCASES, V21, DOI 10.1016/j.idcr.2020.e00829
   Chi YW, 2020, J MICROENCAPSUL, V37, P134, DOI 10.1080/02652048.2019.1705409
   CHIAPPELLI F, 2020, EUR RESPIR J, V16, P219
   Chodankar NR, 2020, NANO-MICRO LETT, V12, DOI 10.1007/s40820-019-0337-2
   CHOUDHERY MS, 2020, FRONT IMMUNOL, V44, P2182
   Chu H, 2016, J INFECT DIS, V213, P904, DOI 10.1093/infdis/jiv380
   Ciccullo A, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106017
   Clarice CSH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215061
   Conti P, 2020, J BIOL REG HOMEOS AG, V34, P327, DOI 10.23812/CONTI-E
   Corley M.J., 2020, DNA METHYLATION ANAL, DOI [10.20944/preprints202003.0295.v1, DOI 10.20944/PREPRINTS202003.0295.V1]
   Corley MJ, 2021, J LEUKOCYTE BIOL, V110, P21, DOI 10.1002/JLB.5HI0720-466R
   Cure E, 2020, DIABETES METAB SYND, V14, P405, DOI 10.1016/j.dsx.2020.04.024
   Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827
   Ding YQ, 2003, J PATHOL, V200, P282, DOI 10.1002/path.1440
   Eid M.M., 2020, ADV J EMERG MED
   El Jamal SM, 2020, PATHOL RES PRACT, V216, DOI 10.1016/j.prp.2020.153063
   Elsoukkary SS, 2021, PATHOBIOLOGY, V88, P56, DOI 10.1159/000511325
   Falasca L, 2020, J INFECT DIS, V222, P1807, DOI 10.1093/infdis/jiaa578
   FATHI N, 2020, FRONT IMMUNOL, V44, P1792
   FENG X, 2020, ANTIVIR RES, V7, P301
   Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972
   Fojta M., 2020, BRIEFINGS BIOINF
   Foldes D, 2020, AM J HEMATOL, V95, P861, DOI 10.1002/ajh.25834
   French MA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00780
   GE X, 2013, BIOINFORMATION, V77, P389
   Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009
   Golchin A, 2020, STEM CELL REV REP, V16, P427, DOI 10.1007/s12015-020-09973-w
   Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310
   Han SW, 2020, CANCER MED-US, V9, P6667, DOI 10.1002/cam4.3289
   Henry BM, 2020, AM J EMERG MED, V38, P1722, DOI 10.1016/j.ajem.2020.05.073
   Hotchkiss RS, 2019, INTENS CARE MED, V45, P1360, DOI 10.1007/s00134-019-05704-z
   HOU H, 2020, P NATL ACAD SCI USA, V201, P76
   Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jiang YJ, 2020, CLIN IMMUNOL, V218, DOI 10.1016/j.clim.2020.108516
   Kaneko Naoki, 2020, Cell, V183, P143, DOI [10.2139/ssrn.3652322, 10.1016/j.cell.2020.08.025]
   KOGELMANN K, 2017, DIABETES METAB SYND, V21, P74
   Kouidou S, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9121006
   Kulkarni R, 2020, DYNAMICS OF IMMUNE ACTIVATION IN VIRAL DISEASES, P9, DOI 10.1007/978-981-15-1045-8_2
   Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114
   La Rosee F, 2020, LEUKEMIA, V34, P1805, DOI 10.1038/s41375-020-0891-0
   Laing A.G., 2020, CONSENSUS COVID 19 I, DOI [10.1101/2020.06.08.20125112, DOI 10.1101/2020.06.08.20125112]
   Lang ZW, 2003, PATHOLOGY, V35, P526, DOI 10.1080/00313020310001619118
   LEE N, 2006, NATURE, V35, P179
   LI MY, 2020, J INFECT DIS, V9, P1
   Li S, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.145027
   Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9
   Liao YT, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109271
   Liu J, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102763
   LIU Q, 2020, FASEB J, V7, P1868
   LIU WJ, 2017, J INFECTION, V137, P82
   Liu Y, 2020, INFECT DIS-NOR, V52, P858, DOI 10.1080/23744235.2020.1794027
   Liu YW, 2020, J INFECTION, V81, pE6, DOI 10.1016/j.jinf.2020.04.002
   Long L, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00990-2020
   LU G, 2020, INT IMMUNOPHARMACOL, V508, P98
   LU Y, 2020, CELL BIOL INT, V7, P432
   Ma AJ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03007-0
   MARKET M, 2020, STEM CELL REV REP, V11, P1512
   Mastaglio S, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108450
   Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511
   Mehta P, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01919-2020
   MENG X, 2016, SIGNAL TRANSDUCT TAR, V45, P72
   MILLER JD, 2008, CELL DISCOV, V28, P710
   Miss D.B. Atieh Pourbagheri-Sigaroodi, 2020, IJBC, V12, P75
   Mizutani T, 2010, MOLECULAR BIOLOGY OF THE SARS-CORONAVIRUS, P305, DOI 10.1007/978-3-642-03683-5_19
   Moll G, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01091
   Mousavi SA, 2020, HEMATOLOGY, V25, P383, DOI 10.1080/16078454.2020.1833435
   Neidleman J., 2020, SARS COV 2 SPECIFIC
   Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7
   Odabasi Zekaver, 2020, Crit Care Explor, V2, pe0141, DOI 10.1097/CCE.0000000000000141
   Ouyang YB, 2020, CLIN INFECT DIS, V71, P2052, DOI 10.1093/cid/ciaa462
   Park SY, 2018, ALLERGY ASTHMA IMMUN, V10, P387, DOI 10.4168/aair.2018.10.4.387
   Peng Y D, 2020, Zhonghua Xin Xue Guan Bing Za Zhi, V48, P450, DOI 10.3760/cma.j.cn112148-20200220-00105
   Pirsalehi A, 2020, IRAN J MICROBIOL, V12, P466, DOI 10.18502/ijm.v12i5.4609
   Prieto-Perez L, 2020, MODERN PATHOL, V33, P2139, DOI 10.1038/s41379-020-0613-1
   Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248
   Qu JX, 2020, CLIN INFECT DIS, V71, P2255, DOI 10.1093/cid/ciaa489
   Qu K, 2015, CELL SYST, V1, P51, DOI 10.1016/j.cels.2015.06.003
   Qu R, 2020, J MED VIROL, V92, P1533, DOI 10.1002/jmv.25767
   Rajarshi Keshav, 2020, Biotechnology Reports, V26, pe00467, DOI 10.1016/j.btre.2020.e00467
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   SARKAR C, 2020, LEUKEMIA, V11, P1428
   SARRIS AH, 1993, J EXP MED, V178, P1127, DOI 10.1084/jem.178.3.1127
   Satarker S, 2021, POSTGRAD MED, V133, P489, DOI 10.1080/00325481.2020.1855921
   SHETTY R, 2020, FRONT PHARMACOL, V68, P693
   Stahel PF, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01661
   STEBBING J, 2020, EUR RESPIR J, V20, P400
   Stephen-Victor E, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02182-2020
   Tabary M, 2020, PATHOL RES PRACT, V216, DOI 10.1016/j.prp.2020.153097
   Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4
   Tan MK, 2020, IMMUNOLOGY, V160, P261, DOI 10.1111/imm.13223
   Tang YJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01708
   Tavakolpour S, 2020, IMMUNOL LETT, V225, P31, DOI 10.1016/j.imlet.2020.06.013
   Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2
   Tse GMK, 2004, J CLIN PATHOL, V57, P260, DOI 10.1136/jcp.2003.013276
   van Eeden C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176351
   Vassallo M, 2020, INT J INFECT DIS, V101, P174, DOI 10.1016/j.ijid.2020.09.1438
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   WANG J, 2016, LANCET RESP MED, V113, pE2029
   [王科雯 Wang Kewen], 2020, [测绘通报, Bulletin of Surveying and Mapping], P1
   Wang WJ, 2020, CELL MOL IMMUNOL, V17, P650, DOI 10.1038/s41423-020-0447-2
   WEI J, 2021, MOL BIOL SARS CORONA, V184, P76
   Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071
   Wen W, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-00187-5
   Wen W, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0168-9
   Wolf RC, 2020, NEUROPSYCHOBIOLOGY, V79, P335, DOI [10.1038/s41586-020-2196-x, 10.1159/000505601, 10.1038/s41586-020-2984-3]
   Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x
   Wu DD, 2020, J MICROBIOL IMMUNOL, V53, P368, DOI 10.1016/j.jmii.2020.03.005
   WU MY, 2020, BLOOD, V21, P171
   Wu Y, 2020, NOVEL SEVERE ACUTE R, DOI [10.1101/2020.03.27.20045427, DOI 10.1101/2020.03.27.20045427]
   XI Y, 2020, CELL MOL IMMUNOL, V5, P203
   Xiong, 2020, NOVEL GENE SPECIFIC
   Xiong Y, 2020, EMERG MICROBES INFEC, V9, P761, DOI 10.1080/22221751.2020.1747363
   XU B, 2020, J INFECTION, V81, pE51, DOI 10.1016/j.jinf.2020.04.012
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yanchun P., 2020, BROAD STRONG MEMORY
   Yang AP, 2020, INT IMMUNOPHARMACOL, V84, DOI 10.1016/j.intimp.2020.106504
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Ye GL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47143-2
   YE LL, 2018, AUTOIMMUN REV, V9, P583
   YIP CYC, 2020, CLIN CHIM ACTA, V190, P33
   Yu K., 2020, THYMOSIN ALPHA 1 PRO
   ZHAN J, 2006, LANCET, V20, P2321
   Zhang YG, 2020, CELL MOL IMMUNOL, V17, P878, DOI 10.1038/s41423-020-0484-x
   Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344
   Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 140
TC 8
Z9 9
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-5769
EI 1878-1705
J9 INT IMMUNOPHARMACOL
JI Int. Immunopharmacol.
PD JUN
PY 2021
VL 95
AR 107586
DI 10.1016/j.intimp.2021.107586
EA MAR 2021
PG 17
WC Immunology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Pharmacology & Pharmacy
GA SJ5ZZ
UT WOS:000655614200002
PM 33765611
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Liang, GQ
   Zhao, JX
   Lau, HYP
   Leung, CWK
AF Liang, Guanqing
   Zhao, Jingxin
   Lau, Helena Yan Ping
   Leung, Cane Wing-Ki
TI Using Social Media to Analyze Public Concerns and Policy Responses to
   COVID-19 in Hong Kong
SO ACM TRANSACTIONS ON MANAGEMENT INFORMATION SYSTEMS
LA English
DT Article
DE COVID-19; social media; sentiment analysis; public opinion; natural
   language processing
AB The outbreak of COVID-19 has caused huge economic and societal disruptions. To fight against the coronavirus, it is critical for policymakers to take swift and effective actions. In this article, we take Hong Kong as a case study, aiming to leverage social media data to support policymakers' policy-making activities in different phases. First, in the agenda setting phase, we facilitate policymakers to identify key issues to be addressed during COVID-19. In particular, we design a novel epidemic awareness index to continuously monitor public discussion hotness of COVID-19 based on large-scale data collected from social media platforms. Then we identify the key issues by analyzing the posts and comments of the extensively discussed topics. Second, in the policy evaluation phase, we enable policymakers to conduct real-time evaluation of anti-epidemic policies. Specifically, we develop an accurate Cantonese sentiment classification model to measure the public satisfaction with anti-epidemic policies and propose a keyphrase extraction technique to further extract public opinions. To the best of our knowledge, this is the first work which conducts a large-scale social media analysis of COVID-19 in Hong Kong. The analytical results reveal some interesting findings: (1) there is a very low correlation between the number of confirmed cases and the public discussion hotness of COVID-19. Themajor public concern in the early stage is the shortage of anti-epidemic items. (2) The top-3 anti-epidemic measures with the greatest public satisfaction are daily press conference on COVID-19 updates, border closure, and social distancing rules.
C1 [Liang, Guanqing; Zhao, Jingxin; Lau, Helena Yan Ping; Leung, Cane Wing-Ki] Wisers Informat Ltd, Wisers AI Lab, 109-111 Gloucester Rd, Hong Kong, Peoples R China.
RP Liang, GQ (corresponding author), Wisers Informat Ltd, Wisers AI Lab, 109-111 Gloucester Rd, Hong Kong, Peoples R China.
EM quincyliang@wisers.com; jessicazhao@wisers.com; helenalau@wisers.com;
   caneleung@wisers.com
CR Alshaabi T., 2020, ARXIV200312614
   Banda Juan M, 2020, ArXiv
   Bojanowski P., 2017, T ASS COMPUT LINGUIS, V5, P135, DOI DOI 10.1162/TACL_A_00051
   BREWER GD, 1974, POLICY SCI, V5, P239, DOI 10.1007/BF00144283
   Chen Emily, 2020, JMIR Public Health Surveill, V6, pe19273, DOI 10.2196/19273
   Cinelli Matteo, 2020, Sci Rep, V10, P16598, DOI 10.1038/s41598-020-73510-5
   Das S, 2021, J HUM BEHAV SOC ENVI, V31, P154, DOI 10.1080/10911359.2020.1781015
   Deriu J, 2016, P 10 INT WORKSH SEM, P1124, DOI [10.18653/v1/S16-1173, DOI 10.18653/V1/S16-1173]
   Devlin J, 2019, BERT PRETRAINING DEE, DOI DOI 10.18653/V1/N19-1423
   Go A., 2009, TWITTER SENTIMENT CL, DOI DOI 10.1016/J.SEDGEO.2006.07.004
   Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020
   Han XH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082788
   Kleinberg B., 2020, MEASURING EMOTIONS C
   Lee K, 2009, GLOB INST, P1
   Li CL, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.10.2000199
   Li X, 2020, ARXIV200514464
   Pennycook G, 2020, PSYCHOL SCI, V31, P770, DOI 10.1177/0956797620939054
   Qin L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072365
   Read J., 2005, P ACL STUD RES WORKS, DOI DOI 10.3115/1628960.1628969
   Singh Lisa, 2020, ArXiv
   Statista, 2019, PEN RAT LEAD SOC NET
   van Dijck J, 2013, MEDIA COMMUN, V1, P2, DOI 10.17645/mac.v1i1.70
   Yin H, 2020, LECT NOTES ARTIF INT, V12447, P610, DOI 10.1007/978-3-030-65390-3_46
   Zhao YX, 2020, J MED INTERNET RES, V22, DOI 10.2196/18825
   Zhu BR, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110123
NR 25
TC 0
Z9 0
U1 3
U2 3
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1601 Broadway, 10th Floor, NEW YORK, NY USA
SN 2158-656X
EI 2158-6578
J9 ACM TRANS MANAG INF
JI ACM Trans. Manag. Inf. Syst.
PD DEC
PY 2021
VL 12
IS 4
AR 30
DI 10.1145/3460124
PG 20
WC Computer Science, Information Systems
WE Emerging Sources Citation Index (ESCI)
SC Computer Science
GA YY3KP
UT WOS:000754690100004
DA 2022-04-20
ER

PT J
AU Chayomchai, A
AF Chayomchai, Ampol
TI The Online Technology Acceptance Model of Generation-Z People in
   Thailand during COVID-19 Crisis
SO MANAGEMENT & MARKETING-CHALLENGES FOR THE KNOWLEDGE SOCIETY
LA English
DT Article
DE Online Technology; Technology Acceptance Model; Generation-Z; Thailand;
   COVID-19
ID PERCEIVED RISK; SERVICES; UTAUT
AB This research aims to study the acceptance of the online technology of Thai people in Generation-Z during the incidence of COVID-19 disease. During this period, Thai people must quarantine themselves at home or work from home to prevent the outbreak of this disease and must comply with the laws of the Thai government. The researchers are interested in the Generation Z population because they are highly interested in technology. Previous literature and research used multiple models of acceptance and use of technology such as the Technology Acceptance Model, Unified Theory of Acceptance and Use of Technology model. This study adapted various variables from many models in the past, including personal innovativeness, performance expectancy, effort expectancy, social influence, trust, and behavioral intention to use technology. The research uses questionnaires as a research tool. 457 usable questionnaires from online data collection were used for data analysis. Descriptive and inferential statistical analysis was performed. The researcher tested the hypothesis by assessment of the Partial Least Square-Structural Equation Model. Research findings found that the behavioral intention to use online technology during COVID-19 disease is predicted by three key factors including performance expectancy, effort expectancy, and trust. Effort expectancy positively influences performance expectancy. In addition, personal innovativeness and the trust of users directly significantly affect performance expectancy and effort expectancy. The researcher suggests that the management level can use the findings in the planning of the organization's management or marketers can utilize the results for the marketing strategy of the organization.
C1 [Chayomchai, Ampol] Phetchabun Rajabhat Univ, Phetchabun, Thailand.
RP Chayomchai, A (corresponding author), Phetchabun Rajabhat Univ, Phetchabun, Thailand.
EM ampol.cha@pcru.ac.th
CR Abrahao R.S., 2016, RAI REV ADM INOVACAO, V13, P221, DOI [10.1016/j.rai.2016.06.003, DOI 10.1016/J.RAI.2016.06.003]
   Abu-Shanab Emad, 2012, International Journal of Technology Diffusion, V3, P36, DOI 10.4018/jtd.2012040104
   Acharya V., 2019, INT J RECENT TECHNOL, V8, P397
   Alraja M.N., 2016, INT REV MANAG MARKET, V6, P930
   Alwahaishi Saleh, 2013, Journal of Technology Management & Innovation, V8, P61, DOI 10.4067/S0718-27242013000200005
   An LP, 2016, AER ADV ENG RES, V24, P303
   Aujla A, 2019, BIOMARK RES, V7, DOI 10.1186/s40364-019-0160-4
   BENCSIK A, 2016, J COMPETITIVENESS, V0008, P00090, DOI DOI 10.7441/J0C.2016.03.06
   Bervell B, 2017, EURASIA J MATH SCI T, V13, P6471, DOI 10.12973/ejmste/78076
   Betz CL, 2019, J PEDIATR NURS, V44, pA7, DOI 10.1016/j.pedn.2018.12.013
   Bratianu C, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12041348
   Catherine N., 2017, GLOBAL J COMPUTER SC, V17, P4
   .Centers for Disease Control Prevention, 2020, INT GUID MAN COR DIS
   Chao CM, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01652
   Cochran W.G., 1977, SAMPLING TECHNIQUES, V3rd ed.
   Dajani D, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02536
   Dolot A, 2018, E-MENTOR, P44, DOI 10.15219/em74.1351
   Duzenli T, 2019, APPL ECOL ENV RES, V17, P3737, DOI 10.15666/aeer/1702_37373751
   Emergency Operation Center Department of Disease Control Ministry of Public Health of Thailand, 2020, COR DIS 2019 SIT
   Farrell W., 2020, GENERATION Z THAILAN
   Fonseca LM, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12083359
   Gaidhani S., 2019, INT J MANAGEMENT TEC, V9, P2804
   GALKA A, 2013, MARKETING B, V23
   Gao S, 2014, MOB INF SYST, V10, P147, DOI 10.1155/2014/146435
   Hair J.F., 2021, PRIMER PARTIAL LEAST
   Hair J. F., 2014, MULTIVALIATE DATA AN
   Halasi D., 2016, GENERATION Z LABOUR
   Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8
   Im I, 2008, INFORM MANAGE-AMSTER, V45, P1, DOI 10.1016/j.im.2007.03.005
   Jaradat Mohammed-Issa Riad Mousa, 2014, International Journal of Business Information Systems, V16, P271, DOI 10.1504/IJBIS.2014.063768
   Khechine Hager, 2014, Interdisciplinary Journal of e-Learning and Learning Objects, V10, P33
   Lai PC, 2017, JISTEM J.Inf.Syst. Technol. Manag., V14, P21, DOI 10.4301/s1807-17752017000100002
   Lee JH, 2013, SOC BEHAV PERSONAL, V41, P587, DOI 10.2224/sbp.2013.41.4.587
   Liebana-Cabanillas F, 2014, COMPUT HUM BEHAV, V35, P464, DOI 10.1016/j.chb.2014.03.022
   Lumpur U.K., 2017, INT J REAL ESTATES S, V11, P59
   Lwoga ET, 2017, ELECTR J INF SYS DEV, V81, DOI 10.1002/j.1681-4835.2017.tb00595.x
   Maduku D. K., 2014, INVESTMENT MANAGEMEN, V11, P37
   Marchewka J.T., 2007, COMMUNICATIONS IIMA, V7, P93
   Mazhar F., 2014, INT J ACCOUNTING FIN, V4, P478
   Mazuri A.G., 2017, WORLD APPL SCI J, V35, P1918
   Onaolapo Sodiq, 2018, Interdisciplinary Journal of e-Learning and Learning Objects, V14, P92, DOI 10.28945/4085
   Rahi S, 2018, WORLD J SCI TECHNOL, V15, P338, DOI 10.1108/WJSTSD-05-2018-0040
   Ringle C.M., 2015, SMART PLS 3
   Rouibah Kamel, 2010, International Journal of Handheld Computing Research, V1, P41, DOI 10.4018/jhcr.2010100103
   Sair S.A., 2018, J COMMER SOC SCI, V12, P501
   Salim B., 2012, INT J INF SCI, V2, P92, DOI [10.5923/j.ijis.20120206.05, DOI 10.5923/J.IJIS.20120206.05]
   Samsudeen S.N., 2018, J INFORM SYSTEMS INF, V2, P1
   Shafinah K, 2013, PROC TECH, V11, P127, DOI 10.1016/j.protcy.2013.12.171
   Singh Anjali, 2014, IOSR J BUSINESS MANA, V16, P59, DOI DOI 10.9790/487X-16715963
   Siraye Zeleke, 2014, International Journal of Electronic Finance, V8, P21, DOI 10.1504/IJEF.2014.063993
   Tan PJB, 2013, SAGE OPEN, V3, DOI 10.1177/2158244013503837
   Thomas T., 2013, J ED, V9, P71
   Torocsik M., 2014, ACTA U SAPIENTIAE CO, V1, P23
   Venkatesh V, 2016, J ASSOC INF SYST, V17, P328, DOI 10.17705/1jais.00428
   World Health Organization, 2020, 97 WHO
   Zuiderwijk A, 2015, GOV INFORM Q, V32, P429, DOI 10.1016/j.giq.2015.09.005
NR 56
TC 4
Z9 5
U1 4
U2 12
PU SCIENDO
PI WARSAW
PA BOGUMILA ZUGA 32A, WARSAW, MAZOVIA, POLAND
SN 1842-0206
EI 2069-8887
J9 MANAG MARK
JI Manag. Mark.
PD OCT
PY 2020
VL 15
SU 1
BP 496
EP 513
DI 10.2478/mmcks-2020-0029
PG 18
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA OH5NR
UT WOS:000582631600006
OA gold
DA 2022-04-20
ER

PT J
AU Holge-Hazelton, B
   Kjerholt, M
   Rosted, E
   Hansen, ST
   Borre, LZ
   McCormack, B
AF Holge-Hazelton, Bibi
   Kjerholt, Mette
   Rosted, Elizabeth
   Hansen, Stine Thestrup
   Borre, Line Zacho
   McCormack, Brendan
TI Health Professional Frontline Leaders' Experiences During the COVID-19
   Pandemic: A Cross-Sectional Study
SO JOURNAL OF HEALTHCARE LEADERSHIP
LA English
DT Article
DE assessment; clinical leadership; management; communication
ID COMMUNICATION; MANAGEMENT; SARS
AB Purpose: The aim was to identify the differences in experiences of Danish healthcare leaders in the beginnning of the coronavirus (COVID-19) pandemic and to generate knowledge for future leadership during and post crises.
   Background: The global spread of COVID-19 has affected healthcare systems worldwide and has forced healthcare leaders to face challenges few were prepared for. It is expected that the pandemic may hit in several waves within the next year and therefore healthcare leaders must be prepared for these waves.
   Methods: An online survey was developed, and comparative analyses were performed.
   Results: One hundred and sixty hospital leaders were invited, and 72% completed the questionnaire. Significant differences were found within three selected characteristics: 1) Management level: significantly more heads of departments experienced taking complex decisions (P=0.05), being able to work in a way consistent with their beliefs and values (P=0.05), and they were less likely to experience that collaboration with other leaders was adversely affected by the COVID-19 situation compared to ward managers (P=0.04). On the other hand, ward managers were significantly more often worried about both their own health (P=0.01) and their family's health (P=0.04). 2) Management education: those with a formal management education more often experienced having the managerial competences to effectively manage the COVID-19 situation (P=0.00), and performing meaningful tasks during the situation (P=0.04). 3) Years of experience: significantly more leaders with more than five years of experience identified having the managerial competences to effectively manage the situation (P=0.01).
   Conclusion: Leadership support during a healthcare crisis like the COVID-19 pandemic should strategically focus on ward managers, leaders with no formal management education and leaders with less than two years of experience. Hospital leaders may use this knowledge to re-contextualize what is already known about targeted leadership support during healthcare crises and to act accordingly.
C1 [Holge-Hazelton, Bibi; Borre, Line Zacho] Zealand Univ Hosp, Res Support Unit, Munkesovej 14, DK-4000 Roskilde, Denmark.
   [Holge-Hazelton, Bibi; Rosted, Elizabeth] Univ Southern Denmark, Dept Reg Hlth Res, DK-5000 Odense C, Denmark.
   [Kjerholt, Mette] Zealand Univ Hosp, Dept Hematol, DK-4000 Roskilde, Denmark.
   [Rosted, Elizabeth] Zealand Univ Hosp, Dept Oncol & Palliat Care, DK-4000 Roskilde, Denmark.
   [Hansen, Stine Thestrup] Zealand Univ Hosp, Dept Plast Surg & Breast Surg, DK-4000 Roskilde, Denmark.
   [McCormack, Brendan] Queen Margaret Univ Edinburgh, Ctr Person Centred Practice Res, Musselburgh EH21 6UU, East Lothian, Scotland.
RP Holge-Hazelton, B (corresponding author), Zealand Univ Hosp, Res Support Unit, Munkesovej 14, DK-4000 Roskilde, Denmark.
EM bibh@regionsjaelland.dk
RI Hansen, Stine Thestrup/AAV-6839-2020; Rosted, Elizabeth/L-6081-2017
OI Hansen, Stine Thestrup/0000-0002-3692-2723; mccormack, brendan
   George/0000-0001-8525-8905; Holge-Hazelton, Bibi/0000-0002-3456-6569;
   Zacho Borre, Line/0000-0003-0357-3317; Rosted,
   Elizabeth/0000-0002-1186-650X
CR [Anonymous], 2020, SIT UPD WORLDW
   [Anonymous], 2020, WMA DECL HELS ETH PR, P4
   Bensimon CM., 2006, BMC MED ETHICS, V7, DOI [10.1186/1472, DOI 10.1186/1472]
   Cardiff S, 2018, J CLIN NURS, V27, P3056, DOI 10.1111/jocn.14492
   Chen YRR, 2020, PUBLIC RELAT REV, V46, DOI 10.1016/j.pubrev.2018.12.006
   Daly J, 2020, J CLIN NURS, V29, P2751, DOI 10.1111/jocn.15305
   Dinibutun SR, 2020, J HEALTHC LEADERSH, V12, P85, DOI 10.2147/JHL.S270440
   Evans S, 2017, INT J HUM RESOUR MAN, V28, P3128, DOI 10.1080/09585192.2016.1146786
   Finset A, 2020, PATIENT EDUC COUNS, V103, P873, DOI 10.1016/j.pec.2020.03.027
   Greenberg N, 2020, BMJ LEAD, DOI 10.1136/lea-der-2020-00027340.
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hartge T, 2019, INT J BUS COMMUN, V56, P100, DOI 10.1177/2329488415605061
   Hills A., 2000, J CONTING CRISIS MAN, V8, P109, DOI [10.1111/1468-5973.00130, DOI 10.1111/1468-5973.00130]
   Johansson B, 2010, J NURS MANAGE, V18, P70, DOI 10.1111/j.1365-2834.2009.01060.x
   Kester Kelly, 2018, Nurs Manage, V49, P42, DOI 10.1097/01.NUMA.0000533768.28005.36
   Lloyd-Smith M, 2020, BMJ LEAD, V4, P109, DOI 10.1136/leader-2020-000245
   Lynch BM, 2017, J CLIN NURS
   McConnell, 2007, J CONTING CRISIS MAN, V15, P50, DOI DOI 10.1111/J.1468-5973.2007.00504.X
   Orvik A, 2015, J NURS MANAGE, V23, P65, DOI 10.1111/jonm.12084
   Pegram AM, 2014, J NURS MANAGE, V22, P685, DOI 10.1111/jonm.12047
   Pfeffermann G, 2014, LANCET GLOB HEALTH, V2, pE504, DOI 10.1016/S2214-109X(14)70272-4
   Polit D.E., 2017, NURSING RES GENERATI, V10
   Porter ME, 2011, HARVARD BUS REV, V89, P62
   Rakowsky S, 2020, ACAD MED, V95, P1152, DOI 10.1097/ACM.0000000000003419
   Saltman Deborah Claire, 2020, Aust J Gen Pract, V49, DOI 10.31128/AJGP-COVID-12
   Shih FJ, 2009, J CLIN NURS, V18, P3391, DOI 10.1111/j.1365-2702.2008.02521.x
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Sonnino RE, 2016, J HEALTHC LEADERSH, V8, P19, DOI 10.2147/JHL.S68068
   Sundhedsstyrelsen, 2020, COVID 19 RISK ASS ST
   Thorne S, 2011, QUAL HEALTH RES, V21, P443, DOI 10.1177/1049732310392595
   Tierney K.J., 2019, DISASTERS SOCIOLOGIC
   Torani S, 2019, J EDUC HEALTH PROMOT, V8, DOI 10.4103/jehp.jehp_262_18
   Tsang S, 2017, SAUDI J ANAESTH, V11, pS80, DOI 10.4103/sja.SJA_203_17
   Tseng Hsin-Chao, 2005, J Nurs Res, V13, P58
   Van Dyk J, 2016, J NURS MANAGE, V24, P533, DOI 10.1111/jonm.12355
   Verma JP, 2019, TESTING STAT ASSUMPT
   Vermeir P, 2015, INT J CLIN PRACT, V69, P1257, DOI 10.1111/ijcp.12686
   Vogus TJ, 2020, BMJ LEAD, V4, P48, DOI 10.1136/leader-2020-000235
   von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040296, 10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]
   Walton M, 2020, EUR HEART J-ACUTE CA, V9, P241, DOI 10.1177/2048872620922795
   Wu DL, 2004, J SAFETY RES, V35, P345, DOI 10.1016/j.jsr.2003.11.010
NR 41
TC 6
Z9 6
U1 3
U2 5
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1179-3201
J9 J HEALTHC LEADERSH
JI J. Healthc. Leadersh.
PY 2021
VL 13
BP 7
EP 18
DI 10.2147/JHL.S287243
PG 12
WC Health Policy & Services
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services
GA PX7XW
UT WOS:000611568800001
PM 33505179
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Gudina, EK
   Siebeck, M
   Eshete, MT
AF Gudina, Esayas Kebede
   Siebeck, Matthias
   Eshete, Million Tesfaye
TI Evidence Gaps and Challenges in the Fight Against COVID-19 in Africa:
   Scoping Review of the Ethiopian Experience
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Review
DE COVID-19; Ethiopia; pandemic; preparedness; research; scoping review
ID HEALTH-PROFESSIONALS; ADDIS-ABABA; KNOWLEDGE; ZONE; PREVENTION;
   HOSPITALS; 1ST
AB Background: Ethiopia, like many African countries, took immediate actions to contain the coronavirus disease (COVID-19) outbreak and its impacts. However, the pandemic control measures were not guided by robust local evidence and not tailored to national contexts. In this review, we aimed to evaluate the evidence gaps and challenges of COVID-19 control measures in Ethiopia during the early months of the pandemic. Design: Scoping Review. Data Source: Searches were conducted in PubMed, LitCovid, Web of Sciences, Embase, MedRx, ChemRxiv, BioRx, and Google Scholar. Eligibility Criteria: Peer-reviewed or pre-print original research articles on COVID-19 from Ethiopia during a period of January 1, 2020 and October 10, 2020 were included in this review. Results: Of 573 articles found, 64 were eligible for inclusion. However, only 25 of them were peer-reviewed; 78% (50/64) were based on cross-sectional descriptive studies. Most of the studies focused on human behavior and healthcare system; only 13 articles addressed epidemiology and clinical spectrum of COVID-19. The studies have revealed a good level of awareness and a favorable attitude by community and healthcare workers (HCWs) towards COVID-19 and its control. However, the practices of infection prevention were found to be low among HCWs and the community. The outbreak unfolded at a slower rate than initially feared but the impact of the counter measures against COVID-19 on the delivery of essential healthcare services was felt more than the direct impact of the pandemic. Moreover, the actions taken by the country did not appear to be tailored to the pattern of the outbreak and existing local evidence. The overall number of published COVID-19-related scientific articles from Ethiopia during the review period was found to be limited. Conclusion: COVID-19 control in Ethiopia was challenged by lack of robust local scientific evidence, and the pandemic control measures were not adapted to local context and the outbreak patterns. Thus, Ethiopia and other African countries should design culturally sensitive and locally acceptable public health interventions for COVID-19 and potential future outbreaks based on locally generated scientific evidence.
C1 [Gudina, Esayas Kebede] Jimma Univ, Inst Hlth, Dept Internal Med, Jimma, Ethiopia.
   [Gudina, Esayas Kebede; Siebeck, Matthias; Eshete, Million Tesfaye] LMU, Univ Hosp, Ctr Int Hlth LMU, Munich, Germany.
   [Siebeck, Matthias] LMU, Univ Hosp, Inst Med Educ, Munich, Germany.
   [Eshete, Million Tesfaye] Jimma Univ, Inst Hlth, Dept Anesthesiol, Jimma, Ethiopia.
RP Gudina, EK (corresponding author), Jimma Univ, Inst Hlth, Dept Internal Med, Jimma, Ethiopia.; Gudina, EK (corresponding author), LMU, Univ Hosp, Ctr Int Hlth LMU, Munich, Germany.
EM esakgd@gmail.com
RI Gudina, Esayas Kebede/AAX-2374-2020
OI Gudina, Esayas Kebede/0000-0002-6264-9695
FU CIHLMU Center for International Health at Ludwig-Maximilians-University
   - DAAD; Federal Ministry for Economic Cooperation and Development (BMZ),
   Germany
FX This work was funded by the CIHLMU Center for International Health at
   Ludwig-Maximilians-University, supported by the DAAD with funds from the
   Federal Ministry for Economic Cooperation and Development (BMZ) ,
   Germany [Award/grant number - not applicable] .
CR Abate L., 2020, ACAD J RES SCI PUBL, V2, P156
   Abdela SG, 2020, AM J TROP MED HYG, V103, P1198, DOI 10.4269/ajtmh.20-0464
   Abebe A, 2020, INFECT DRUG RESIST, V13, P2979, DOI 10.2147/IDR.S268033
   Addis Y, 2020, RES SQ, DOI [10.21203/rs.3.rs-51668/v1, DOI 10.21203/RS.3.RS-51668/V1]
   Akalu Y, 2020, INFECT DRUG RESIST, V13, P1949, DOI 10.2147/IDR.S258736
   Alemu BN, 2020, SERO PREVALENCE ANTI, DOI [10.1101/2020.10.13.337287, DOI 10.1101/2020.10.13.337287]
   Ambelu A., 2020, RES SQ, DOI [10.21203/rs.3.rs-33408/v1, DOI 10.21203/RS.3.RS-33408/V1]
   Ambie MB, 2020, RES SQ, DOI [10.21203/rs.3.rs-57926/v1, DOI 10.21203/RS.3.RS-57926/V1]
   [Anonymous], 2016, NATURE, V530, P129, DOI 10.1038/530129a
   Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]
   Asemahagn MA, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00254-3
   Aweke Z, 2020, CURR MED RES OPIN, V36, P1955, DOI 10.1080/03007995.2020.1835854
   Ayele AD, 2020, RES SQ, DOI [10.21203/rs.3.rs-50212/v1, DOI 10.21203/RS.3.RS-50212/V1]
   Belay L., 2020, EJRH, V12, P51
   Burki T, 2020, LANCET INFECT DIS, V20, P1240, DOI 10.1016/S1473-3099(20)30800-8
   Chekole YA, 2020, ADV PUBLIC HLTH, V2020, DOI 10.1155/2020/5036861
   Chowdhury Anis Z, 2020, Development (Rome), P1, DOI 10.1057/s41301-020-00256-y
   Dagne H, 2020, RES SQ, DOI [10.21203/rs.3.rs-34504/v1, DOI 10.21203/RS.3.RS-34504/V1]
   Defar A, 2020, KNOWLEDGE PRACTICE A, DOI [10.1101/2020.08.14.20172429, DOI 10.1101/2020.08.14.20172429]
   Deressa W, 2020, RISK PERCEPTIONS PRE, DOI [10.1101/2020.10.30.20223180, DOI 10.1101/2020.10.30.20223180]
   Deressa W, 2020, AVAILABILITY PERSONA, DOI [10.1101/2020.10.30.20223149, DOI 10.1101/2020.10.30.20223149]
   Dires A, 2020, RES SQ, DOI [10.21203/rs.3.rs-73649/v1, DOI 10.21203/RS.3.RS-73649/V1]
   Dzinamarira T, 2020, J MED VIROL, V92, P2465, DOI 10.1002/jmv.26159
   Earnshaw VA, 2020, TRANSL BEHAV MED, V10, P850, DOI 10.1093/tbm/ibaa090
   Edae CK, 2020, ASSESSMENT PREPAREDN, DOI DOI 10.1101/2020080657/V1
   Emiru TD, 2020, SSRN ELECT J, DOI [10.2139/ssrn.3667842, DOI 10.2139/SSRN.3667842]
   Fauci AS, 2001, CLIN INFECT DIS, V32, P675, DOI 10.1086/319235
   Feleke DG., 2020, RES SQ, DOI [10.21203/ rs.3.rs-68848/v2, DOI 10.21203/RS.3.RS-68848/V2]
   Gebremariam BM, 2020, PAN AFR MED J, V37, DOI 10.11604/pamj.supp.2020.37.7.24436
   Gebrewahd GT, 2020, REPROD HEALTH, V17, DOI 10.1186/s12978-020-01002-w
   Gelaw AB., 2020, RES SQ, DOI [10.21203/rs.3.rs-30820/v2, DOI 10.21203/RS.3.RS-30820/V2]
   Girma A, 2020, COVID 19 RELATED STR, DOI [10.1101/2020.08.14.20174318, DOI 10.1101/2020.08.14.20174318]
   Girma S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241101
   Girma S, 2020, RISK MANAG HEALTHC P, V13, P1327, DOI 10.2147/RMHP.S267261
   Gudina EK, 2020, ETHIOP J HEALTH DEV, V34, P301
   Hailu W, 2020, RES SQ, DOI [10.21203/rs.3.rs-68688/v1, DOI 10.21203/RS.3.RS-68688/V1]
   Ismail AS., 2020, J ADV MED MED RES, V32, P23, DOI [10.9734/jammr/2020/v32i1330549, DOI 10.9734/JAMMR/2020/V32I1330549]
   Jamie AH., 2020, J ANTIVIR ANTIRETROV, V12, P5
   Jamie AH., 2020, EC NURS HEALTHCARE, V2, P64
   John Hopkins University, COVID 19 DASHB CTR S
   Kasahun GG, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05763-9
   Kassaw C., 2021, J PSYCHOSOC REHABIL, V8, P1
   Kassaw C., 2020, PSYCHOL IMPACT COVID, DOI [10.20944/preprints202006.0356.v1, DOI 10.20944/PREPRINTS202006.0356.V1]
   Kassaw C, 2020, PSYCHOL RES BEHAV MA, V13, P631, DOI 10.2147/PRBM.S256551
   Kassie BA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238415
   Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233744
   Kempen JH, 2020, AM J TROP MED HYG, V103, P2022, DOI 10.4269/ajtmh.20-0816
   Ketema B, 2020, RES SQ, DOI [10.21203/rs.3.rs-56009/v1, DOI 10.21203/RS.3.RS-56009/V1]
   Leulseged T, 2020, CHARACTERISTICS OUTC, DOI [10.1101/2020.10.27.20220640, DOI 10.1101/2020.10.27.20220640]
   Leulseged TW, 2020, DURATION SUPPLEMENTA, DOI [10.1101/ 2020.10.08.20209122, DOI 10.1101/2020.10.08.20209122]
   Leulseged TW, 2020, COVID 19 DIS SEVERIT, DOI [10.1101/ 2020.10.09.20209999, DOI 10.1101/2020.10.09.20209999]
   Leulseged TW, 2020, DETERMINANTS TIME CO, DOI [10.1101/:2020.10.07.20208413, DOI 10.1101/:2020.10.07.20208413]
   Leulseged TW, 2020, DETERMINANTS DEV SYM, DOI [10.1101/2020.10.09.20209734, DOI 10.1101/2020.10.09.20209734]
   Lucas-Dominguez R, 2021, SCIENTOMETRICS, V126, P4975, DOI 10.1007/s11192-021-03971-6
   Maru EH, 2020, PREDICTORS DEATH SEV, DOI [10.1101/ 2020.10.07.20205575, DOI 10.1101/2020.10.07.20205575]
   McNamara J, 2020, ENVIRON RESOUR ECON, V76, P1045, DOI 10.1007/s10640-020-00474-5
   Mechessa DF, 2020, INT J GEN MED, V13, P507, DOI 10.2147/IJGM.S263665
   Mengesha CH, 2020, SSRN ELECT J, DOI [10.2139/ssrn.3605275, DOI 10.2139/SSRN.3605275]
   Mersha A, 2020, HLTH PROFESSIONALS P, DOI [10.1101/2020.09.05.20188805, DOI 10.1101/2020.09.05.20188805]
   Mola S, 2020, RES SQ, DOI [10.21203/rs.3.rs-36120/v1, DOI 10.21203/RS.3.RS-36120/V1]
   Moradian N, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02364-2
   Mukemil A, 2020, NEUROPSYCH DIS TREAT, V17, P1363, DOI DOI 10.21203/RS.3.RS-62244/V1
   Mulu A, 2021, PAN AFR MED J, V38, DOI 10.11604/pamj.2021.38.6.26902
   Mulu GB, 2020, INFECT DRUG RESIST, V13, P3171, DOI 10.2147/IDR.S265829
   National Public Health Emergency Operation Center (PHEOC) of Ethiopia, COVID 19 PAND PREP R
   Negera E, 2020, INADEQUATE LEVEL KNO, DOI [10.1101/2020.07.22.215590, DOI 10.1101/2020.07.22.215590]
   Nigussie TF, 2020, GLOB SCI J, V8, P1283
   Ogundele OA, 2020, PAN AFR MED J, V35, DOI [10.11604/pamj.supp.2020.35.111.24921, 10.11604/pamj.supp.2020.35.2.24921]
   Palaparthy V, 2020, PARIS21 COVID 19 RES, P1
   Raposo VL, 2020, J MED ETHICS, V46, P451, DOI 10.1136/medethics-2020-106210
   Salyer SJ, 2021, LANCET, V397, P1265, DOI 10.1016/S0140-6736(21)00632-2
   Shiferaw, 2020, RES SQUARE, DOI [10.21203/rs.3.rs-28556/v1, DOI 10.21203/RS.3.RS-28556/V1, 10.21203/rs.3.rs- 28556/v1]
   Sidamo NB, 2021, RISK MANAG HEALTHC P, V14, P1219, DOI 10.2147/RMHP.S297114
   Tadesse AW, 2020, RES SQ, DOI [10.21203/rs.3.rs-38099/v1, DOI 10.21203/RS.3.RS-38099/V1]
   Tadesse DB, 2020, RES SQ, DOI [10.21203/rs.3.rs-26236/v1, DOI 10.21203/RS.3.RS-26236/V1]
   Tadesse W, 2020, RES SQUARE, V10, DOI [10.21203/rs.3.rs-38100/v1, DOI 10.21203/RS.3.RS-38100/V1]
   Teklu S, 2020, ETHIOP J HEALTH SCI, V30, P645, DOI 10.4314/ejhs.v30i5.2
   Temesgen K, 2020, IMPACT COVID 19 INFE, DOI [10.1105/2020.09.20.20198259, DOI 10.1105/2020.09.20.20198259]
   Temesgen K., 2020, MATERNAL HLTH CARE S, DOI [10.1101/2020.10.09.20210054, DOI 10.1101/2020.10.09.20210054]
   Tesfaye L, 2020, INDIRECT IMPACT COVI, DOI [10.2139/ssrn.3694748, DOI 10.2139/SSRN.3694748]
   Tolu LB, 2020, RISK MANAG HEALTHC P, V13, P771, DOI 10.2147/RMHP.S258273
   Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850
   Tsegaye D, 2020, RES SQ, DOI [10.21203/rs.3.rs-49537/v2, DOI 10.21203/RS.3.RS-49537/V2]
   Van Damme Wim, 2020, BMJ Glob Health, V5, DOI 10.1136/bmjgh-2020-003098
   Wadvalla BA, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2830
   Wolde GD, 2020, RES SQ, DOI [10.21203/rs.3.rs-29437/v1, DOI 10.21203/RS.3.RS-29437/V1]
   Wondimu W, 2020, RES SQ, DOI [10.21203/rs.3.rs-84406/v1, DOI 10.21203/RS.3.RS-84406/V1]
   World Health Organization, WHO COR DIS COVID 19
   Worldometer, WORLD POPULATION
   Xu TL, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00716-0
   Zar HJ, 2020, PAEDIATR RESPIR REV, V35, P70, DOI 10.1016/j.prrv.2020.06.016
   Zikargae MH, 2020, RISK MANAG HEALTHC P, V13, P2803, DOI 10.2147/RMHP.S278234
NR 92
TC 0
Z9 0
U1 2
U2 2
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 4511
EP 4521
DI 10.2147/RMHP.S333545
PG 11
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA WV9JL
UT WOS:000717545300002
PM 34764709
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Li, JP
   Sun, LM
   Feng, X
   He, PY
   Zhang, Y
AF Li, Jiapei
   Sun, Liming
   Feng, Xin
   He, Peiyi
   Zhang, Yue
TI Social media communication of the scientific and technological
   literature in emergency under COVID-19
SO LIBRARY HI TECH
LA English
DT Article
DE Science communication; Social media; Emergency; Factor analysis;
   Visualization; COVID-19
ID INFORMATION; ALTMETRICS; WEB
AB Purpose This paper takes the current COVID-19 pandemic raging around the world as a realistic background and uses the informal scientific communication mode in social media as the theoretical basis. It aims to explore the characteristics and rules of scientific communication in social media under emergency events, grasp the potential and risks of scientific communication in social media in special times and provide a perspective of academic communication for the scientific response. Design/methodology/approach The authors select the enumeration data of the early COVID-19 theme papers spread on social media networks as the research object, apply descriptive statistical analysis to the basic statistical distribution of variables and use factor analysis and visualization methods to explore the law and characteristics of the spread of scientific papers on social media platforms. Findings It was found that users of the COVID-19 paper are mainly in North America, Europe and South America, followed by those in East Asia, Southeast Asia and Oceania. The users are mainly public figures, doctors and other practitioners, science communicators and scientists. The process of social media communication reflects three ways of knowledge construction, social interaction and academic communication, and there are three ways of communication law and changing trend of cross transition and integration. Originality/value This study observes the function and role of science communication in social media in a special period from a unique perspective of academic communication, so as to promote academic means to fight against the epidemic.
C1 [Li, Jiapei] Hebei GEO Univ, Sch Management, Shijiazhuang, Hebei, Peoples R China.
   [Sun, Liming] Hebei GEO Univ, Sch Language & Culture, Shijiazhuang, Hebei, Peoples R China.
   [Feng, Xin] Yanshan Univ, Sch Econ & Management, Qinhuangdao, Hebei, Peoples R China.
   [He, Peiyi] Hebei GEO Univ, Sch Informat Engn, Shijiazhuang, Hebei, Peoples R China.
   [Zhang, Yue] Hebei GEO Univ, Sch Urban Geol & Engn, Shijiazhuang, Hebei, Peoples R China.
RP Feng, X (corresponding author), Yanshan Univ, Sch Econ & Management, Qinhuangdao, Hebei, Peoples R China.
EM lijiapei126@126.com; sunlm1976@163.com; 149987543@qq.com;
   2425808906@qq.com; 1547677269@qq.com
OI Sun, Liming/0000-0001-6211-3594; Feng, Xin/0000-0002-0140-8003
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [11905042]; Youth Fund for Humanities and
   Social Sciences Research for the Ministry of Education [20YJC870005,
   16YJC630022]; 333Funded Project of "333 Talent Project" in Hebei
   Province [A202001015]; Humanities and Social Science Research Project of
   Hebei Education Department [SD2021017]
FX The authors acknowledge the financial support from the National Natural
   Science Foundation of China (No. 11905042), the Youth Fund for
   Humanities and Social Sciences Research for the Ministry of Education
   (No. 20YJC870005, No. 16YJC630022), 333Funded Project of "333 Talent
   Project" in Hebei Province (No. A202001015), Humanities and Social
   Science Research Project of Hebei Education Department (No. SD2021017).
CR Ai FL, 2016, SAFETY SCI, V90, P62, DOI 10.1016/j.ssci.2015.09.022
   Bai Y., 2017, SCI DISCOVERY, V5, P426
   Bharosa N, 2010, INFORM SYST FRONT, V12, P49, DOI 10.1007/s10796-009-9174-z
   Broniatowski DA, 2018, AM J PUBLIC HEALTH, V108, P1378, DOI 10.2105/AJPH.2018.304567
   Cao Y.Q., 2008, WATER CONSERVANCY EC, V36, P33
   Carminati B, 2013, IEEE T DEPEND SECURE, V10, P129, DOI 10.1109/TDSC.2013.11
   Chung IJ, 2011, RISK ANAL, V31, P1883, DOI 10.1111/j.1539-6924.2011.01623.x
   Collins K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162680
   Dietsch D, 2018, INT J INNOV MANAG, V22, DOI 10.1142/S1363919618500457
   Flanagin AJ, 2014, INFORM COMMUN SOC, V17, P683, DOI 10.1080/1369118X.2013.808361
   Guo, 2017, INFORM SCIENTIST, V35, P14
   Hassona Y, 2019, ORAL DIS, V25, P1502, DOI 10.1111/odi.13111
   He, 2019, SCI SOC, V9, P46
   Kuttschreuter M, 2014, FOOD QUAL PREFER, V37, P10, DOI 10.1016/j.foodqual.2014.04.006
   Melero Remedios, 2015, Biochem Med (Zagreb), V25, P152, DOI 10.11613/BM.2015.016
   Mikhalov A.N., 1980, SCI COMMUNICATION IN
   Neylon C., 2010, ALTMETRICS AMANIFEST
   Piwowar H, 2013, NATURE, V493, P159, DOI 10.1038/493159a
   Shehata A, 2017, J DOC, V73, P825, DOI 10.1108/JD-06-2016-0083
   Shema H, 2014, J ASSOC INF SCI TECH, V65, P1018, DOI 10.1002/asi.23037
   Swigon M, 2017, MALAYS J LIBR INF SC, V22, P101, DOI 10.22452/mjlis.vol22no2.7
   Tassone VC, 2018, HIGH EDUC, V76, P337, DOI 10.1007/s10734-017-0211-4
   [万洪秀 Wan Hongxiu], 2019, [长江科学院院报, Journal of Yangtze River Scientific Research Institute], V36, P153
   Wooldridge J, 2019, J ASSOC INF SCI TECH, V70, P271, DOI 10.1002/asi.24122
   Yang S.Y., 2011, INFORM DOCUMENTATION, V36, P61
   Yu, 2019, MODERN INTELLIGENCE, V39, P153
   Zach Lisl, 2011, Science & Technology Libraries, V30, P404, DOI 10.1080/0194262X.2011.626341
   [张立伟 Zhang Liwei], 2018, [科学学研究, Studies in Science of Science], V36, P1008
   Zhang X, 2019, SCIENTOMETRICS, V119, P1311, DOI 10.1007/s11192-019-03088-x
   Zhang Z, 2014, INT J GEOGR INF SCI, V28, P1922, DOI 10.1080/13658816.2014.908472
NR 30
TC 0
Z9 0
U1 19
U2 42
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0737-8831
J9 LIBR HI TECH
JI Libr. Hi Tech
PD SEP 13
PY 2021
VL 39
IS 3
SI SI
BP 796
EP 813
DI 10.1108/LHT-10-2020-0268
EA JUN 2021
PG 18
WC Information Science & Library Science
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science
GA UQ5FY
UT WOS:000659388100001
OA Bronze
DA 2022-04-20
ER

PT J
AU Al Khathlan, N
   Padhi, BK
AF Al Khathlan, Noor
   Padhi, Bijaya Kumar
TI Adherence to COVID-19 Appropriate Behavior Among Respiratory Therapists:
   A Cross-Sectional Study in the Kingdom of Saudi Arabia
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE respiratory care; respiratory therapist; COVID-19 protective behavior;
   transmission-reducing behaviors; Saudi Arabia; COVID-19 appropriate
   behavior
ID HEALTH-CARE WORKERS; KNOWLEDGE; PROFESSION
AB Background: Adherence to novel coronavirus disease 2019 (COVID-19) appropriate behavior plays a crucial element in the management of the infections of COVID-19. Despite the importance of transmission-reducing behaviors among healthcare professionals, there is a lack of literature in this area of research explicitly relating to respiratory therapists (RTs). Therefore, it is essential to assess the adherence level to COVID-19 transmission-reducing behaviors among the RTs in Saudi Arabia.
   Methods: A web-based online survey was conducted using questions based on the risk assessment guidelines of WHO. A random representative sample of RTs (N = 215) residing in Saudi Arabia was recruited for the study. Descriptive and inferential statistics were computed using STATA software. Logistic regression analysis was used to identify key factors that are associated with adherence to COVID-19 appropriate behavior among the study participants.
   Results: Of the 215 participants, 59.5% were aged between 26 and 35 years, and 40.9% were women. Most (85.5%) participants had a bachelor's degree while 12.0% had a master's degree. About 56.2% of RTs provided direct care to a confirmed patient of COVID-19 during the study periods. The study showed 80.9% of RTs in Saudi Arabia adhered to personal protective equipment (PPE) at the workplace and 65.0% at home. Moreover, the findings of the study indicated that senior RTs (with > 5 years of experience) demonstrated a higher adherence level to the guidelines than RTs with < 5 years of experience. High-risk perception [aOR:2.32; 95% CI: 1.09-3.27], and work history of < 5 years [aOR:2.00; 95% CI: 1.14-3.15], were found to be the strongest predictors in explaining the adherence to appropriate behavior among the RTs at the workplace. Whereas the high-risk perception [aOR:2.32; 95% CI: 1.09-3.27] and being married [aOR:1.85; 95% CI: 1.08-3.82] were found to be the strongest predictors at home.
   Conclusion: Adherence ("Always" or "Most times") to COVID-19 appropriate behavior was found to be high at hospital settings among the study participants. However, the same practice was found to be inconsistence in non-healthcare settings among the RTs. Considering the paramount role of COVID-19 appropriate behavior in reducing the transmissions the policy focus, therefore, needs to be on creating a well-spread behavior change communication that is curtailing the adoption of appropriate behavior in the non-healthcare settings.
C1 [Al Khathlan, Noor] Imam Abdulrahman Bin Faisal Univ, Coll Appl Med Sci, Dept Resp Care, Dammam, Saudi Arabia.
   [Padhi, Bijaya Kumar] Post Grad Inst Med Educ & Res, Dept Community Med, Chandigarh, India.
   [Padhi, Bijaya Kumar] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India.
RP Al Khathlan, N (corresponding author), Imam Abdulrahman Bin Faisal Univ, Coll Appl Med Sci, Dept Resp Care, Dammam, Saudi Arabia.
EM Naalkhathlan@iau.edu.sa
RI Al Khathlan, Noor/ABD-4133-2021
OI Al Khathlan, Noor/0000-0002-2635-2528
FU Deanship of Scientific Research at Imam Abdulrahman Bin Faisal
   University [Covid19-2020-031-CAMS]
FX This research is funded by The Deanship of Scientific Research at Imam
   Abdulrahman Bin Faisal University (grant number Covid19-2020-031-CAMS).
CR Al-Otaibi HM, 2016, ANN THORAC MED, V11, P237, DOI 10.4103/1817-1737.191872
   AL-Shammary AA, 2021, HEALTH PROMOT PERSPE, V11, P69, DOI 10.34172/hpp.2021.10
   Alghamdi AN, 2021, ASIA-PAC J PUBLIC HE, V33, P623, DOI 10.1177/10105395211014637
   Alotaibi G, 2015, ANN THORAC MED, V10, P55, DOI 10.4103/1817-1737.146878
   Alyami H., 2021, SAUDI J HLTH SCI, V10, P21, DOI [10.4103/sjhs.sjhs22220, DOI 10.4103/SJHS.SJHS_222_20]
   Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020
   Conner M, 2005, PREDICTING HLTH BEHA
   Diefenbach MA, 1996, J SOC DISTRESS HOMEL, V5, P11, DOI 10.1007/BF02090456
   Giannis D, 2021, POSTGRAD MED J, V97, P326, DOI 10.1136/postgradmedj-2020-137988
   Girma S, 2020, RISK MANAG HEALTHC P, V13, P1327, DOI 10.2147/RMHP.S267261
   Hester Thomas B, 2020, ATS Sch, V1, P145, DOI 10.34197/ats-scholar.2020-0049PS
   Kamel G., 2021, BMC HEALTH SERV RES, P1, DOI [10.21203/rs.3.rs-151581/v1, DOI 10.21203/RS.3.RS-151581/V1]
   Li YF, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246454
   Milne S, 2000, J APPL SOC PSYCHOL, V30, P106, DOI 10.1111/j.1559-1816.2000.tb02308.x
   Mirtskhulava V, 2015, INFECT CONT HOSP EP, V36, P522, DOI 10.1017/ice.2015.5
   Nguyen Long H, 2020, medRxiv, DOI [10.1016/S2468-2667(20)30164-X, 10.1101/2020.04.29.20084111]
   Roberts KJ, 2021, RESP CARE, V66, P199, DOI 10.4187/respcare.08459
   Saunders-Hastings P, 2017, EPIDEMICS-NETH, V20, P1, DOI 10.1016/j.epidem.2017.04.003
   Tabah A, 2020, J CRIT CARE, V59, P70, DOI 10.1016/j.jcrc.2020.06.005
   Tenna A, 2013, INFECT CONT HOSP EP, V34, P1289, DOI 10.1086/673979
   Wong ELY, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18073420
   World Health Organization, 2020, HLTH WORKERS EXPOSUR
   [吴安华 Wu Anhua], 2020, [中国感染控制杂志, Chinese Journal of Infection Control], V19, P99
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
NR 24
TC 1
Z9 1
U1 2
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD AUG 18
PY 2021
VL 9
AR 715982
DI 10.3389/fpubh.2021.715982
PG 7
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA UL3UY
UT WOS:000692581400001
PM 34490196
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Garcia-Milon, A
   Olarte-Pascual, C
   Juaneda-Ayensa, E
AF Garcia-Milon, Alba
   Olarte-Pascual, Cristina
   Juaneda-Ayensa, Emma
TI Assessing the moderating effect of COVID-19 on intention to use
   smartphones on the tourist shopping journey
SO TOURISM MANAGEMENT
LA English
DT Article
DE COVID-19; Tourist shopping journey; Technology acceptance models;
   Smartphone; Moderating effect; Performance expectancy; Effort
   expectancy; Social influence
ID TECHNOLOGY ACCEPTANCE MODEL; INFORMATION-TECHNOLOGY; UNIFIED THEORY;
   CONSUMER ACCEPTANCE; MOBILE BANKING; EMOTIONS; METAANALYSIS; UTAUT;
   SATISFACTION; EXPERIENCES
AB This work proposes the first model to examine the moderating effect of the COVID-19 syndemic on the accep-tance and use of smartphones during the tourist shopping journey. The model was tested with 1800 tourists, 900 non-COVID-19 (i.e. prior to COVID-19) and 900 during the COVID-19 period. The results showed that: 1) the model has better fit for the COVID-19 period as its explanatory capacity for that stage is greater (R-2 = 0.773) than for the non-COVID-19 period (R-2 = 0.691); 2) tourists have increased their intention to use smartphones, especially to make payments for purchases; and 3) there are statistically significant differences in the impact of four of the six model variables (performance expectancy, effort expectancy, social influence, and arousal). This research advances knowledge of the impact of COVID-19 on the technological behaviour of tourists, has important practical implications, and raises new research questions about the future of tourism.
C1 [Garcia-Milon, Alba; Olarte-Pascual, Cristina; Juaneda-Ayensa, Emma] Univ La Rioja, Business Fac, Ciguena St 60, Logrono 26006, La Rioja, Spain.
RP Olarte-Pascual, C (corresponding author), Univ La Rioja, Business Fac, Ciguena St 60, Logrono 26006, La Rioja, Spain.
EM algarcm@unirioja.es; cristina.olarte@unirioja.es;
   emma.juaneda@unirioja.es
RI Olarte-Pascual, Cristina/AAT-4680-2021
OI Olarte-Pascual, Cristina/0000-0002-9853-0266; Garcia-Milon,
   Alba/0000-0003-0367-8012
FU Extraordinary Chair of Commerce of the University of La Rioja; Logrono
   City Council; FPI-UR 2019; COBEMADE research group at the University of
   La Rioja [REGI 2020/40]; autonomous community of La Rioja through the
   program RIS3 [CAR-PID 2019-105764RB-I00]
FX This research has been made possible thanks to the support of the
   Extraordinary Chair of Commerce of the University of La Rioja and the
   Logrono City Council and funded by a predoctoral contract FPI-UR 2019.
   The authors would also like to acknowledge the COBEMADE research group
   at the University of La Rioja (reference REGI 2020/40) and the
   autonomous community of La Rioja through the program RIS3 Ref: CAR-PID
   2019-105764RB-I00.
CR AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Alalwan AA, 2017, INT J INFORM MANAGE, V37, P99, DOI 10.1016/j.ijinfomgt.2017.01.002
   ARMSTRONG JS, 1977, J MARKETING RES, V14, P396, DOI 10.2307/3150783
   Bakar N. A., 2020, INT J INNOVATIVE TEC, V9, P3118, DOI [10.35940/ijitee.b7661.019320, DOI 10.35940/IJITEE.B7661.019320]
   Baptista G, 2015, COMPUT HUM BEHAV, V50, P418, DOI 10.1016/j.chb.2015.04.024
   Beaudry A, 2010, MIS QUART, V34, P689
   Bigne JE, 2005, TOURISM MANAGE, V26, P833, DOI 10.1016/j.tourman.2004.05.006
   Bigne JE, 2004, ANN TOURISM RES, V31, P682, DOI 10.1016/j.annals.2003.12.018
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   Bruner GC, 2005, J BUS RES, V58, P553, DOI 10.1016/j.jbusres.2003.08.002
   Chang J, 2006, TOURISM MANAGE, V27, P934, DOI 10.1016/j.tourman.2005.06.001
   Chebli A., 2020, Journal of Tourism Management Research, V7, P196, DOI 10.18488/journal.31.2020.72.196.207
   Chen RJC, 2013, SUSTAINABILITY-BASEL, V5, P617, DOI 10.3390/su5020617
   Chin WW, 1998, QUANT METH SER, P295
   Choi MJ, 2016, J TRAVEL TOUR MARK, V33, P1, DOI 10.1080/10548408.2014.969393
   Coromina L, 2016, TOURISM MANAGE, V56, P75, DOI 10.1016/j.tourman.2016.03.025
   DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982
   DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008
   de Pinedo N., 2020, CONFIDENCIAL
   Dijkstra TK, 2015, MIS QUART, V39, P297, DOI 10.25300/MISQ/2015/39.2.02
   Ditrendia, 2018, INF DITR MOB ESP MUN, P1
   DONOVAN RJ, 1982, J RETAILING, V58, P34
   Escobar-Rodriguez T, 2014, TOURISM MANAGE, V43, P70, DOI 10.1016/j.tourman.2014.01.017
   Fall L. T., 2005, Journal of Travel & Tourism Marketing, V19, P77, DOI 10.1300/J073v19n02_07
   Foley C., 2007, Leisure Studies, V26, P179, DOI 10.1080/02614360500418555
   Fong MW, 2020, EMERG INFECT DIS, V26, P976, DOI 10.3201/eid2605.190995
   Fuentes C, 2017, J RETAIL CONSUM SERV, V38, P137, DOI 10.1016/j.jretconser.2017.06.002
   Garcia-Milon A., 2019, MULTILEVEL APPROACH, P87, DOI [10.4018/978-1-7998-0365-2, DOI 10.4018/978-1-7998]
   Garcia-Milon A, 2020, TOUR MANAG PERSPECT, V36, DOI 10.1016/j.tmp.2020.100730
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Gupta A, 2018, J HOSP TOUR TECHNOL, V9, P48, DOI [10.1108/JHTT-02-2017-0013, 10.1108/jhtt-02-2017-0013]
   Hair JF, 2013, LONG RANGE PLANN, V46, P1, DOI 10.1016/j.lrp.2013.01.001
   Hassan S, 2015, J ELECTRON COMMER OR, V13, P74, DOI [10.4018/JECO.2015100104, 10.4018/jeco.2015100104]
   Henseler J, 2016, INT MARKET REV, V33, P405, DOI 10.1108/IMR-09-2014-0304
   Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8
   Hernandez-Orallo E, 2020, IEEE ACCESS, V8, P99083, DOI 10.1109/ACCESS.2020.2998042
   Herrero A, 2017, COMPUT HUM BEHAV, V71, P209, DOI 10.1016/j.chb.2017.02.007
   Heung V. C. S., 2000, Journal of Travel Research, V38, P396, DOI 10.1177/004728750003800408
   Hew JJ, 2016, INT J MOB COMMUN, V14, P170, DOI 10.1504/IJMC.2016.075023
   Higgins-Desbiolles F, 2020, TOURISM GEOGR, V22, P610, DOI 10.1080/14616688.2020.1757748
   Hoque A., 2020, ASIAN J MULTIDISCIPL, V3
   Horton R, 2020, LANCET, V396, P874, DOI 10.1016/S0140-6736(20)32000-6
   Hsieh AT, 2006, TOURISM MANAGE, V27, P138, DOI 10.1016/j.tourman.2004.06.017
   Huang JH, 2002, TOURISM MANAGE, V23, P145, DOI 10.1016/S0261-5177(01)00051-6
   Hubert M, 2017, PSYCHOL MARKET, V34, P175, DOI 10.1002/mar.20982
   Hystad PW, 2008, TOURISM MANAGE, V29, P151, DOI 10.1016/j.tourman.2007.02.017
   Ibukun E., 2016, ASIAN J INFORM TECHN, V15, P3422
   INE, 2020, ENC GAST TUR
   Ivanov SH, 2022, TOURISM ECON, V28, P3, DOI 10.1177/1354816620946541
   Jin HP, 2017, TOURISM MANAGE, V62, P120, DOI 10.1016/j.tourman.2017.03.027
   Johns Hopkins University,, 2020, COVID 19 DASHB CTR S
   Juaneda-Ayensa E, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01117
   Khalilzadeh J, 2017, TOURISM MANAGE, V62, P89, DOI 10.1016/j.tourman.2017.03.026
   Kim HH, 2015, J TRAVEL TOUR MARK, V32, P692, DOI 10.1080/10548408.2014.943458
   Kock N, 2012, J ASSOC INF SYST, V13, P546, DOI 10.17705/1jais.00302
   Kourouthanassis P, 2015, PERVASIVE MOB COMPUT, V18, P71, DOI 10.1016/j.pmcj.2014.08.009
   Kulviwat S, 2007, PSYCHOL MARKET, V24, P1059, DOI 10.1002/mar.20196
   Law R, 2000, TOURISM MANAGE, V21, P241, DOI 10.1016/S0261-5177(99)00056-4
   Law R, 2018, J HOSP MARKET MANAG, V27, P626, DOI 10.1080/19368623.2018.1423251
   Lee M. B., 2003, ELECTRON COMMER R A, V2, P254, DOI [10.1016/S1567-4223(03)00028-0, DOI 10.1016/S1567-4223(03)00028-0]
   Leong LY, 2019, J COMPUT INFORM SYST, V59, P146, DOI 10.1080/08874417.2017.1320953
   Li SS, 2015, CURR ISSUES TOUR, V18, P805, DOI 10.1080/13683500.2014.975679
   Little TD, 2007, MODELING CONTEXTUAL
   Lloyd AE, 2011, TOURISM MANAGE, V32, P520, DOI 10.1016/j.tourman.2010.04.004
   Lu Y, 2019, COMPUT HUM BEHAV, V90, P153, DOI 10.1016/j.chb.2018.08.056
   Luo X, 2010, DECIS SUPPORT SYST, V49, P222, DOI 10.1016/j.dss.2010.02.008
   Macedo IM, 2017, COMPUT HUM BEHAV, V75, P935, DOI 10.1016/j.chb.2017.06.013
   Manfreda KL, 2008, INT J MARKET RES, V50, P79, DOI 10.1177/147078530805000107
   Manuell ME, 2011, DISASTERS, V35, P417, DOI 10.1111/j.1467-7717.2010.01219.x
   Moore GC, 1991, INFORM SYST RES, V2, P192, DOI 10.1287/isre.2.3.192
   Muniz J, 2013, PSICOTHEMA, V25, P151, DOI 10.7334/psicothema2013.24
   Nanni A, 2021, ANN TOURISM RES, V86, DOI 10.1016/j.annals.2020.102942
   Neuburger L, 2021, CURR ISSUES TOUR, V24, P1003, DOI 10.1080/13683500.2020.1803807
   Partala T, 2015, COMPUT HUM BEHAV, V53, P381, DOI 10.1016/j.chb.2015.07.012
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Rabbiosi C, 2011, J TOUR CULT CHANGE, V9, P70, DOI 10.1080/14766825.2010.549233
   Ram J, 2014, J ENG TECHNOL MANAGE, V33, P113, DOI 10.1016/j.jengtecman.2014.04.001
   Raman A., 2013, INT ED STUDIES, V6, P157, DOI 10.5539/ies.v6n7p157
   Rippe CB, 2017, PSYCHOL MARKET, V34, P733, DOI 10.1002/mar.21019
   Rodriguez-Torrico P, 2020, CURR ISSUES TOUR, V23, P1659, DOI 10.1080/13683500.2019.1637828
   Roldan J.L., 2012, RES METHODOLOGIES, DOI DOI 10.4018/978-1-4666-0179-6.CH010
   Russell, 1974, APPROACH ENV PSYCHOL
   Martin HS, 2012, TOURISM MANAGE, V33, P341, DOI 10.1016/j.tourman.2011.04.003
   Sarstedt M, 2011, ADV INT MARKETING, V22, P195, DOI 10.1108/S1474-7979(2011)0000022012
   Shaw R, 2020, PROG DISASTER SCI, V6, DOI 10.1016/j.pdisas.2020.100090
   Siang T. G., 2016, INFORMATION A, V19, P3167
   Sim JJ, 2014, TELEMAT INFORM, V31, P569, DOI 10.1016/j.tele.2013.11.005
   Sirakaya E, 2005, TOURISM MANAGE, V26, P815, DOI 10.1016/j.tourman.2004.05.004
   Smartme Analytics, 2020, EST IMP COR US MOV
   Statista, 2020, WORLDS LEAD TOUR SOU
   Tamilmani K, 2019, INT J INFORM MANAGE, V46, P222, DOI 10.1016/j.ijinfomgt.2019.01.008
   Tan GWH, 2018, TELEMAT INFORM, V35, P1617, DOI 10.1016/j.tele.2018.04.009
   Tehseen S., 2017, J MANAG SCI, V4, P142, DOI DOI 10.20547/JMS.2014.1704202
   THOMPSON RL, 1991, MIS QUART, V15, P125, DOI 10.2307/249443
   Thorbjornsen H, 2007, PSYCHOL MARKET, V24, P763, DOI 10.1002/mar.20183
   Timothy D.J, 2005, SHOPPING TOURISM RET
   Unwto, TOUR COV 19
   Unwto, 2020, GLOB GUID REST TOUR
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926
   Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540
   Venkatesh V, 2012, MIS QUART, V36, P157
   Wang D, 2016, J TRAVEL RES, V55, P52, DOI 10.1177/0047287514535847
   Wang D, 2014, ANN TOURISM RES, V48, P11, DOI 10.1016/j.annals.2014.04.008
   Way KA, 2013, J HOSP MARKET MANAG, V22, P116, DOI 10.1080/19368623.2012.627261
   Wen J, 2021, TOUR REV, V76, P74, DOI 10.1108/TR-03-2020-0110
   Worldometer, 2020, WORLD
   Wu KW, 2011, INT J INFORM MANAGE, V31, P572, DOI 10.1016/j.ijinfomgt.2011.03.004
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yuksel A, 2007, TOURISM MANAGE, V28, P703, DOI 10.1016/j.tourman.2006.04.025
   Yuksel A, 2007, TOURISM MANAGE, V28, P58, DOI 10.1016/j.tourman.2005.07.017
   Yuksel A, 2017, TOURISM MANAGE, V59, P376, DOI 10.1016/j.tourman.2016.08.003
   Zeng ZJ, 2020, TOURISM GEOGR, V22, P724, DOI 10.1080/14616688.2020.1762118
   Zenker S, 2020, TOURISM MANAGE, V81, DOI 10.1016/j.tourman.2020.104164
   Zhang Wen, 2005, Current Issues in Tourism, V8, P22, DOI 10.1080/13683500508668203
NR 115
TC 2
Z9 2
U1 19
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0261-5177
EI 1879-3193
J9 TOURISM MANAGE
JI Tourism Manage.
PD DEC
PY 2021
VL 87
AR 104361
DI 10.1016/j.tourman.2021.104361
EA JUN 2021
PG 12
WC Environmental Studies; Hospitality, Leisure, Sport & Tourism; Management
WE Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Social Sciences - Other Topics;
   Business & Economics
GA WQ3JE
UT WOS:000713714900007
OA hybrid
DA 2022-04-20
ER

PT J
AU Petre, B
   Kirkove, D
   de Andrade, V
   Crozet, C
   Toro-Arrocet, D
   Margat, A
   Gagnayre, R
AF Petre, Benoit
   Kirkove, Delphine
   de Andrade, Vincent
   Crozet, Cyril
   Toro-Arrocet, Daniela
   Margat, Aurore
   Gagnayre, Remi
TI Learnings from Health Behavioural Survey Practices in France and Belgium
   During the First COVID-19 Stay-at-Home Order
SO PATIENT PREFERENCE AND ADHERENCE
LA English
DT Article
DE pandemic; covid 19; community monitoring; preventive health behavior
AB The COVID-19 pandemic has compelled public authorities to establish preventive measures involving individual behaviour modification strategies (mask-wearing, social distancing, etc.) with a view to community protection. In this context, documenting people's behaviour changes, the impact of public health measures, and individuals' knowledge, motivations, and beliefs - even their perception of how the crisis is being managed - is essential for understanding the experience of the population and adapting the management approach accordingly. This article presents findings and lessons on how to monitor a population's behaviour during a crisis, obtained by reviewing forty-five surveys conducted in Belgium and France during the first Covid-19 stay-at-home order, from April to May 2020. The central message is to argue that the citizens' role in this type of survey - and in managing the crisis, more generally - should be reconsidered by thinking of them as true health partners and members of a community that could be mobilised to help.
C1 [Petre, Benoit; Kirkove, Delphine] Univ Liege, Dept Publ Hlth, Liege, Belgium.
   [de Andrade, Vincent; Crozet, Cyril; Toro-Arrocet, Daniela; Margat, Aurore; Gagnayre, Remi] Sorbonne Paris Nord Univ, Educ & Hlth Practices Lab, UR 3412, UFR Sante Med Biol Humaine, Bobigny, France.
RP Petre, B (corresponding author), Univ Liege, Dept Publ Hlth, Quartier Hop, Ave Hippocrate 13,B23, B-4000 Liege, Belgium.
EM benoit.petre@uliege.be
OI CROZET, Cyril/0000-0001-6267-835X; Gagnayre, Remi/0000-0002-8942-9713
CR Amlot R, 2020, BMJ Opin
   Glasziou PP, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1847
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Sante Publique France, 2020, STUDIES SURVEYS
   Van den Broucke S, 2020, HEALTH PROMOT INT, V35, P181, DOI 10.1093/heapro/daaa042
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   WHO Regional Office Europe, 2020, PAND FAT REINV PUBL
NR 7
TC 1
Z9 1
U1 1
U2 1
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1177-889X
J9 PATIENT PREFER ADHER
JI Patient Prefer. Adherence
PY 2021
VL 15
BP 807
EP 809
DI 10.2147/PPA.S298401
PG 3
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA RO9VU
UT WOS:000641387500001
PM 33897257
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Al Zoubi, S
   Gharaibeh, L
   Jaber, HM
   Al-Zoubi, Z
AF Al Zoubi, Sura
   Gharaibeh, Lobna
   Jaber, Hatim M.
   Al-Zoubi, Zaha
TI Household Drug Stockpiling and Panic Buying of Drugs During the COVID-19
   Pandemic: A Study From Jordan
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE COVID-19; drug shortages; panic buying; drug stockpiling; lockdown; drug
   management; Jordan
ID PATTERNS; AMMAN
AB The coronavirus disease that emerged in 2019 (COVID-19) has affected health, societies and economies. Policies that have been imposed by different countries to slow the spread of the disease, including national lockdowns, curfews, border closures and enforcement of social distancing measures have disturbed the drug supply chain and resulted in drug shortages. Uncertainty concerning the pandemic has also led to the panic buying of drugs and the stockpiling of drugs in households, which has amplified the problem. In this cross-sectional study, a self-developed questionnaire was distributed online in order to a) assess the practice of household drug stockpiling prior to the national lockdown in Jordan, b) investigate the factors affecting it and c) measure peoples' knowledge about the consequences of this behaviour. Results from this study show that drug purchasing was reported by 44.3% of the participants and was most common among participants from non-medical backgrounds (336, 75.7%) or those who have chronic diseases (261, 58.8%) and taking chronic supplements (282, 63.5%) regardless of their age, gender, living area or the possession of health insurance. Analgesics and antipyretics were the most frequently purchased drugs (225, 70.5%) and anticipation of their need was the most common reason for purchasing drugs (231, 52.0%). Buyers were also less aware, when compared to non-buyers, that panic buying and drug stockpiling may lead to drug shortages (204, 45.9% vs 325, 58.1%) and that this behaviour can pose a health hazard, especially to children (221, 47.5% vs 342, 61.2%). Our study shows that panic buying of drugs and household drug stockpiling were common in Jordan during the COVID-19 pandemic and this was related to participants' medical knowledge and educational backgrounds. Therefore, educating the general population regarding rational drug use is urgently needed. This is also a compelling case for the development of national guidelines for drug management that target the general population and healthcare personnel, especially pharmacists, to avoid drug shortages during crises.
C1 [Al Zoubi, Sura] Al Balqa Appl Univ, Sch Med, Dept Basic Med Sci, As Salt, Jordan.
   [Gharaibeh, Lobna] Al Ahliyya Amman Univ, Fac Pharm, Pharmacol & Diagnost Res Ctr, Amman, Jordan.
   [Jaber, Hatim M.] Al Balqa Appl Univ, Sch Med, Dept Community Med, As Salt, Jordan.
RP Al Zoubi, S (corresponding author), Al Balqa Appl Univ, Sch Med, Dept Basic Med Sci, As Salt, Jordan.
EM sura.zoubi@bau.edu.jo
CR Al-Husseini A, 2018, SAUDI PHARM J, V26, P306, DOI 10.1016/j.jsps.2018.01.012
   Alomari M.W., 2015, EUR J SOC SCI, V49
   American Pharmacists Association AS of H-SP Foundation and NA of CDS, 2007, PHARM GUID PAND PREP
   Arafat S M Yasir, 2020, Neurol Psychiatry Brain Res, V37, P100, DOI 10.1016/j.npbr.2020.07.002
   Arafat SMY, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113061
   Aslani P, 2020, HEALTH EXPECT, V23, P257, DOI 10.1111/hex.13052
   Badreldin HA, 2021, RES SOC ADMIN PHARM, V17, P1946, DOI 10.1016/j.sapharm.2020.05.017
   Bell J Simon, 2020, Aust J Gen Pract, V49, DOI 10.31128/AJGP-COVID-06
   Bookwalter CM, 2021, US PHARM, V46, P25
   Chatterjee P, 2020, LANCET, V395, P675, DOI 10.1016/S0140-6736(20)30459-1
   Chen YY, 2021, AGEING RES REV, V65, DOI 10.1016/j.arr.2020.101205
   Chua G, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18063247
   Department of Statistics, 2021, EST POP 2020 SOM SEL
   Elek P, 2021, HEALTH ECON, V30, P2312, DOI 10.1002/hec.4378
   FDA, 2021, FDA APPR 1 TREATM CO
   Ghosal S, 2020, DIABETES METAB SYND, V14, P707, DOI 10.1016/j.dsx.2020.05.026
   Ji T, 2020, CLIN INFECT DIS, V71, P1454, DOI 10.1093/cid/ciaa390
   Kostev K, 2020, J PSYCHIATR RES, V130, P19, DOI 10.1016/j.jpsychires.2020.07.005
   Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037
   Lins S, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04746
   Liu S, 2020, INT J CLIN PHARM-NET, V42, P299, DOI 10.1007/s11096-020-01017-0
   Naser AY, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13822
   Raosoft, 2021, SAMPLE SIZE CALCULAT
   Taghrir MH, 2020, ARCH IRAN MED, V23, P265, DOI 10.34172/aim.2020.08
   The World Health Organization, 2021, COVID 19 VACC
   Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839
   Wijaya, 2020, SOC SCI HUMANIT OPEN, DOI [10.2139/ssrn.3603750, DOI 10.2139/SSRN.3603750]
   Worldometer, 2021, JORD POP
   Yousef AMM, 2008, PHARM WORLD SCI, V30, P24, DOI 10.1007/s11096-007-9135-x
   Yuen KF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103513
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
NR 31
TC 0
Z9 0
U1 5
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD DEC 22
PY 2021
VL 12
AR 813405
DI 10.3389/fphar.2021.813405
PG 8
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA YI2ZU
UT WOS:000743722800001
PM 35002744
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Keykhaei, M
   Koolaji, S
   Mohammadi, E
   Kalantar, R
   Moghaddam, SS
   Aminorroaya, A
   Zokaei, S
   Azadnajafabad, S
   Rezaei, N
   Ghasemi, E
   Rezaei, N
   Haghshenas, R
   Farzi, Y
   Rashedi, S
   Larijani, B
   Farzadfar, F
AF Keykhaei, Mohammad
   Koolaji, Sogol
   Mohammadi, Esmaeil
   Kalantar, Reyhaneh
   Saeedi Moghaddam, Sahar
   Aminorroaya, Arya
   Zokaei, Shaghayegh
   Azadnajafabad, Sina
   Rezaei, Negar
   Ghasemi, Erfan
   Rezaei, Nazila
   Haghshenas, Rosa
   Farzi, Yosef
   Rashedi, Sina
   Larijani, Bagher
   Farzadfar, Farshad
TI Dissection of non-pharmaceutical interventions implemented by Iran,
   South Korea, and Turkey in the fight against COVID-19 pandemic
SO JOURNAL OF DIABETES AND METABOLIC DISORDERS
LA English
DT Review
DE COVID-19; Iran; Non-pharmaceutical interventions; South Korea; Turkey
ID CORONAVIRUS DISEASE 2019; HEALTH; OUTBREAK; SYSTEM
AB Purpose The novel coronavirus disease 2019 (COVID-19) has imposed a great global burden on public health. As one of the most affected countries, Iran has tackled emerging challenges in the path to overcoming the epidemic, with three peaks of the disease propagation as of February 19, 2020. To flatten the curve of the COVID-19 pandemic, most countries have implemented bundles of intrusive, sometimes extremely stringent non-pharmaceutical interventions (NPIs). In this communication, we have dissected the effectiveness of NPIs and compared the strategies implemented by Iran, Turkey, and South Korea to mitigate the disease's spread. Methods We searched online databases via PubMed, Web of Knowledge, and Scopus. Titles/abstracts and full-texts were screened by two reviewers and discrepancies were resolved upon discussion. Results Our results provide insights into five domains: prevention, screening, in-patient and out-patient facilities, governance, and management of diabetes mellitus. Analysis of previous efforts put in place illustrates that by fostering efficient social distancing measures, increasing the capability to perform prompt polymerase chain reaction tests, applying smart contact tracing, and supplying adequate personal protective equipment, Turkey and South Korea have brought the epidemic sub-optimally under control. Conclusion From the perspective of policymakers, these achievements are of utmost importance given that attaining the aspirational goals in the management of the COVID-19 necessities a suitable adjustment of previous successful strategies. Hence, policymakers should be noticed that a suitable combination of NPIs is necessary to stem the disease's propagation.
C1 [Keykhaei, Mohammad; Koolaji, Sogol; Mohammadi, Esmaeil; Kalantar, Reyhaneh; Saeedi Moghaddam, Sahar; Aminorroaya, Arya; Azadnajafabad, Sina; Rezaei, Negar; Ghasemi, Erfan; Rezaei, Nazila; Haghshenas, Rosa; Farzi, Yosef; Rashedi, Sina; Farzadfar, Farshad] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, 10 Al E Ahmad & Chamran Highway Intersect, Tehran 1411713137, Iran.
   [Aminorroaya, Arya] Univ Tehran Med Sci, Tehran Heart Ctr, Tehran, Iran.
   [Zokaei, Shaghayegh] Islamic Azad Univ, Sch Adv Med Sci, Tehran Med Branch, Tehran, Iran.
   [Rezaei, Negar; Farzi, Yosef; Larijani, Bagher; Farzadfar, Farshad] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Endocrinol & Metab Res Ctr, Tehran, Iran.
RP Farzadfar, F (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, 10 Al E Ahmad & Chamran Highway Intersect, Tehran 1411713137, Iran.; Farzadfar, F (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Endocrinol & Metab Res Ctr, Tehran, Iran.
EM f-farzadfar@tums.ac.ir
RI Azadnajafabad, Sina/ABC-5770-2020; Rezaei, Negar/AAS-8147-2020; Saeedi
   Moghaddam, Sahar/AGX-5835-2022; Aminorroaya, Arya/G-8026-2019; Rashedi,
   Sina/ABE-4931-2021; Zokaei, Shaghayegh/AAT-8326-2021
OI Azadnajafabad, Sina/0000-0003-0105-3801; Rezaei,
   Negar/0000-0001-7047-7638; Saeedi Moghaddam, Sahar/0000-0002-3112-9179;
   Aminorroaya, Arya/0000-0003-3197-2657; Rashedi,
   Sina/0000-0003-0146-5611; 
CR Agley J, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-020-10103-x
   Ahmadi A., 2020, MED J ISLAMIC REPUBL, V34, P183
   Alimohamadi Y, 2020, RISK MANAG HEALTHC P, V13, P1695, DOI 10.2147/RMHP.S265079
   [Anonymous], 2020, UPD COVID 19 TOK
   [Anonymous], 2020, COR INF DIS 19 REG D
   Arab-Zozani M, 2021, DISASTER MED PUBLIC, V15, pE43, DOI 10.1017/dmp.2020.261
   Asgary A, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-020-10153-1
   Aydin S, 2021, ENVIRON DEV SUSTAIN, V23, P7573, DOI 10.1007/s10668-020-00933-5
   Azadnajafabad S, 2021, INT J HEALTH POLICY, DOI 10.34172/ijhpm.2020.252
   Bairwa M, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003416
   Barasheed O, 2016, INT J INFECT DIS, V47, P105, DOI 10.1016/j.ijid.2016.03.023
   Barten Dennis G, 2020, Disaster Med Public Health Prep, P1, DOI 10.1017/dmp.2020.303
   Brown NM, 2020, LANCET REG HEALTH-EU
   Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757
   Choi DH, 2021, J KOREAN MED SCI, V36, DOI 10.3346/jkms.2021.36.e44
   Choi JY, 2020, POSTGRAD MED J, V96, P399, DOI 10.1136/postgradmedj-2020-137738
   Choi S, 2020, EPIDEMIOL HEALTH, V42, DOI 10.4178/epih.e2020064
   Chun SY, 2020, DIABETES METAB J, V44, P897, DOI 10.4093/dmj.2020.0199
   Chung H, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e431
   Cinelli Matteo, 2020, Sci Rep, V10, P16598, DOI 10.1038/s41598-020-73510-5
   Deiana G, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-020-10093-w
   Dighe A, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01791-8
   Dodangeh M, 2020, GERMS, V10, P112, DOI 10.18683/germs.2020.1192
   Faridi S, 2020, AEROSOL AIR QUAL RES, V20, P1805, DOI 10.4209/aaqr.2020.05.0225
   Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7
   Gul S, 2020, J INFECT DEV COUNTR, V14, P713, DOI 10.3855/jidc.12844
   Guner R, 2020, TURK J MED SCI, V50, P571, DOI 10.3906/sag-2004-146
   Habibzadeh P, 2020, INT J OCCUP ENV MED, V11, P65, DOI 10.15171/ijoem.2020.1921
   Haug N, 2020, NAT HUM BEHAV, V4, DOI 10.1038/s41562-020-01009-0
   Heo K, 2020, ANN GLOB HEALTH, V86, DOI 10.5334/aogh.2993
   Hussain A, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108142
   Jeong HE, 2021, EPIDEMIOL HEALTH, V43, DOI 10.4178/epih.e2021007
   Ju MJ, 2021, SCI TOTAL ENVIRON, V750, DOI 10.1016/j.scitotenv.2020.141521
   Kang SK, 2020, SAF HEALTH WORK-KR, V11, P125, DOI 10.1016/j.shaw.2020.04.007
   Kwon O, 2020, EPIDEMIOL HEALTH, V42, DOI 10.4178/epih.e2020045
   Lee David, 2020, Transp Res Interdiscip Perspect, V5, P100111, DOI 10.1016/j.trip.2020.100111
   Lin XL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71908-9
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Malek M, 2020, ARCH IRAN MED, V23, P564, DOI 10.34172/aim.2020.61
   Mardani A, 2020, APPL SOFT COMPUT, V96, DOI 10.1016/j.asoc.2020.106613
   Mirjalili H, 2021, J DIABETES METAB DIS, V20, P905, DOI 10.1007/s40200-021-00768-5
   Molayaghobi NS, 2019, J NURS MANAGE, V27, P1091, DOI 10.1111/jonm.12777
   Moon SJ, 2020, DIABETES METAB J, V44, P737, DOI 10.4093/dmj.2020.0141
   Moradi G, 2019, ARCH IRAN MED, V22, P361
   Muniz-Rodriguez K, 2020, EMERG INFECT DIS, V26, P1915, DOI 10.3201/eid2608.200536
   Murray CJL, 2020, LANCET PUBLIC HEALTH, V5, pE469, DOI 10.1016/S2468-2667(20)30187-0
   Nakamoto I, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/22098
   Nikpouraghdam M, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104378
   Noh J, 2020, DIABETES METAB J, V44, P372, DOI 10.4093/dmj.2020.0138
   Onmez A, 2020, DIABETES METAB SYND, V14, P1963, DOI 10.1016/j.dsx.2020.10.007
   Pazoki M, 2021, J DIABETES METAB DIS, V20, P59, DOI 10.1007/s40200-020-00701-2
   Peck KR, 2020, CLIN MICROBIOL INFEC, V26, P805, DOI 10.1016/j.cmi.2020.04.025
   Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6
   Raeisi A, 2020, ARCH IRAN MED, V23, P216, DOI 10.34172/aim.2020.01
   Raoofi A, 2020, ARCH IRAN MED, V23, P220, DOI 10.34172/aim.2020.02
   Rezapour A, 2021, INT J SURG, V85, P10, DOI 10.1016/j.ijsu.2020.11.015
   Rovetta A, 2020, J MED INTERNET RES, V22, DOI 10.2196/20673
   SAEEDI P, 2019, DIABETES RES CLIN PR, V157, DOI DOI 10.1016/J.DIABRES.2019.107843
   Sahafizadeh E, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa077
   Sala A, 2020, J BIOPHOTONICS, V13, DOI 10.1002/jbio.202000118
   Shakibaei S, 2021, SUSTAIN CITIES SOC, V65, DOI 10.1016/j.scs.2020.102619
   Sonmez A, 2021, J DIABETES, V13, P585, DOI 10.1111/1753-0407.13171
   Soodejani MT, 2020, ARCH IRAN MED, V23, P776, DOI 10.34172/aim.2020.103
   Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105
   Vizheh M, 2020, J DIABETES METAB DIS, V19, P1967, DOI 10.1007/s40200-020-00643-9
   Won KC, 2020, DIABETES METAB J, V44, P211, DOI 10.4093/dmj.2020.0092
   Worby CJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17922-x
   Yang Y, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e429
   Yavarian J, 2020, IRAN J PUBLIC HEALTH, V49, P1564, DOI 10.18502/ijph.v49i8.3903
NR 69
TC 0
Z9 0
U1 5
U2 6
PU SPRINGER INT PUBL AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
EI 2251-6581
J9 J DIABETES METAB DIS
JI J. Diabetes Metab. Disord.
PD DEC
PY 2021
VL 20
IS 2
BP 1919
EP 1931
DI 10.1007/s40200-021-00877-1
EA SEP 2021
PG 13
WC Endocrinology & Metabolism
WE Emerging Sources Citation Index (ESCI)
SC Endocrinology & Metabolism
GA XE9GG
UT WOS:000696640400001
PM 34540760
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Yilmaz, Y
   Sarikaya, O
   Senol, Y
   Baykan, Z
   Karaca, O
   Yilmaz, ND
   Altintas, L
   Onan, A
   Sayek, I
AF Yilmaz, Yusuf
   Sarikaya, Ozlem
   Senol, Yesim
   Baykan, Zeynep
   Karaca, Ozan
   Demiral Yilmaz, Nilufer
   Altintas, Levent
   Onan, Arif
   Sayek, Iskender
TI RE-AIMing COVID-19 online learning for medical students: a massive open
   online course evaluation
SO BMC MEDICAL EDUCATION
LA English
DT Article
DE COVID-19; Massive open online course; Low; and middle-income countries;
   Online learning; Medical student
ID HEALTH PROGRAMS; FRAMEWORK; KNOWLEDGE; IMPACT
AB Background Clinical training during the COVID-19 pandemic is high risk for medical students. Medical schools in low- and middle-income countries (LMIC) have limited capacity to develop resources in the face of rapidly developing health emergencies. Here, a free Massive Open Online Course (MOOC) was developed as a COVID-19 resource for medical students working in these settings, and its effectiveness was evaluated. Methods The RE-AIM (reach, effectiveness, adoption, implementation, and maintenance) framework was utilized to evaluate the effectiveness of MOOC in teaching medical students about COVID-19. The data sources included the student registration forms, metrics quantifying their interactions within the modules, students' course feedback, and free-text responses. The data were collected from the Moodle learning management system and Google analytics from May 9 to September 15, 2020. The research team analyzed the quantitative data descriptively and the qualitative data thematically. Results Among the 16,237 unique visitors who accessed the course, only 6031 medical students from 71 medical schools registered, and about 4993 (83% of registrants) completed the course, indicating high levels of satisfaction (M = 8.17, SD = 1.49) on a 10-point scale. The mean scores of each assessment modules were > 90%. The free-text responses from 987 unique students revealed a total of 17 themes (e.g., knowing the general information on COVID-19, process management of the pandemic in public health, online platform use, and instructional design) across the elements of the RE-AIM framework. Mainly, the students characterized the MOOC as well-organized and effective. Conclusions Medical students learned about COVID-19 using a self-paced and unmonitored MOOC. MOOCs could play a vital role in the dissemination of accurate information to medical students in LMIC in future public health emergencies. The students were interested in using similar MOOCs in the future.
C1 [Yilmaz, Yusuf] McMaster Univ, Dept Med, Fac Hlth Sci, McMaster Educ Res Innovat & Theory MERIT, 100 Main St West,5th Floor,Room 5003, Hamilton, ON L8N 3Z5, Canada.
   [Yilmaz, Yusuf] McMaster Univ, Dept Med, Fac Hlth Sci, Off Continuing Profess Dev, 100 Main St West,5th Floor,Room 5003, Hamilton, ON L8N 3Z5, Canada.
   [Yilmaz, Yusuf; Karaca, Ozan; Demiral Yilmaz, Nilufer] Ege Univ, Dept Med Educ, Fac Med, Izmir, Turkey.
   [Sarikaya, Ozlem] Marmara Univ, Sch Med, Dept Med Educ, Istanbul, Turkey.
   [Senol, Yesim; Onan, Arif] Akdeniz Univ, Dept Med Educ, Fac Med, Antalya, Turkey.
   [Baykan, Zeynep] Erciyes Univ, Dept Med Educ, Fac Med, Kayseri, Turkey.
   [Altintas, Levent] Acibadem Univ, Dept Med Educ, Fac Med, Istanbul, Turkey.
   [Sayek, Iskender] Assoc Evaluat & Accreditat Med Educ Programs, Izmir, Turkey.
RP Yilmaz, Y (corresponding author), McMaster Univ, Dept Med, Fac Hlth Sci, McMaster Educ Res Innovat & Theory MERIT, 100 Main St West,5th Floor,Room 5003, Hamilton, ON L8N 3Z5, Canada.; Yilmaz, Y (corresponding author), McMaster Univ, Dept Med, Fac Hlth Sci, Off Continuing Profess Dev, 100 Main St West,5th Floor,Room 5003, Hamilton, ON L8N 3Z5, Canada.; Yilmaz, Y (corresponding author), Ege Univ, Dept Med Educ, Fac Med, Izmir, Turkey.
EM yusufyyilmaz@gmail.com
RI Yilmaz, Yusuf/ABB-8410-2020; SARIKAYA, OZLEM/B-2354-2008; Karaca,
   Ozan/ABE-6079-2020; Altintas, Levent/X-1562-2018
OI Yilmaz, Yusuf/0000-0003-4378-4418; SARIKAYA, OZLEM/0000-0002-6962-1185;
   Karaca, Ozan/0000-0001-5431-0942; Senol, Yesim/0000-0002-7842-3041;
   Altintas, Levent/0000-0002-4950-6956; Onan, Arif/0000-0003-1666-9078
CR Ahmed H, 2020, LANCET INFECT DIS, V20, P777, DOI 10.1016/S1473-3099(20)30226-7
   Alzoubi H, 2020, J PURE APPL MICROBIO, V14, P17, DOI 10.22207/JPAM.14.1.04
   American Association of Medical Colleges (AAMC), 2020, IMP GUID MED STUD CL
   Bandari DK, 2020, NOVEL CORONAVIRUS CO, V6, DOI DOI 10.1101/2020.03.09.20033381
   Caliskan F, 2020, POSTGRAD MED, V132, P764, DOI 10.1080/00325481.2020.1795486
   Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934
   Chen BY, 2019, ACAD MED, V94, P678, DOI 10.1097/ACM.0000000000002580
   Cubukcu E., 2020, SAGLIK VE TOPLUM, V30, P46
   DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982
   DeWitt DE, 2020, ANN INTERN MED, V173, P143, DOI 10.7326/M20-1262
   Farber ON, 2020, MED STUDENTS CAN HEL
   Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322
   Glasgow RE, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00064
   Glasgow RE, 2018, PREV CHRONIC DIS, V15, DOI 10.5888/pcd15.170271
   Goodnough A, 2020, NEW YORK TIMES
   Gutl C., 2014, CCIS, V446, P37, DOI [DOI 10.1007/978-3-319-10671-7_4, 10.1007/978-3-319-10671, DOI 10.1007/978-3-319-10671]
   Hilburg R, 2020, ADV CHRONIC KIDNEY D
   Jauregui E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1474-2
   Khasawneh AI, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00253
   Kiesewetter J, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-1987-y
   Lasheras I, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186603
   Liang ZC, 2020, ACAD MED, V95, P1359, DOI 10.1097/ACM.0000000000003441
   Miller DG, 2020, ANN INTERN MED, V173, P145, DOI 10.7326/M20-1281
   Modi PD, 2020, CUREUS, V12, DOI 10.7759/cureus.7514
   Molenda M., 2003, PERFORMANCE IMPROVEM, V42, P34, DOI [10.1002/pfi.4930420508, DOI 10.1002/PFI.4930420508]
   Nagji A, 2020, AEM EDUC TRAIN, V4, P330, DOI 10.1002/aet2.10498
   Nakhostin-Ansari Amin, 2020, Iran J Psychiatry, V15, P228, DOI 10.18502/ijps.v15i3.3815
   Nawrot I, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P1077, DOI 10.1145/2567948.2580054
   Oktay C, 2020, TIP EGITIMI DUNYA, P139
   OSYM, 2013, 2013 OSYS YUKS PROGR
   Pather N, 2020, ANAT SCI EDUC, V13, P284, DOI 10.1002/ase.1968
   Rose CC, 2021, ACAD MED, DOI [10.1097/ACM.0000000000004122, DOI 10.1097/ACM.0000000000004122]
   Salman M, 2020, DRUGS THER PERSPECT, V36, P319, DOI 10.1007/s40267-020-00737-7
   Sarikaya O, 2006, INT J CLIN PRACT, V60, P1414, DOI 10.1111/j.1742-1241.2006.00869.x
   Schwingel A, 2017, J AGING HEALTH, V29, P551, DOI 10.1177/0898264316641075
   Shoup JA, 2015, TRANSL BEHAV MED, V5, P216, DOI 10.1007/s13142-014-0300-1
   Soltanimehr E, 2019, BMC MED EDUC, V19, DOI 10.1186/s12909-019-1649-0
   Stephens KK, 2020, MANAGE COMMUN Q, V34, P426, DOI 10.1177/0893318920934890
   Strickland CD, 2015, AM J ROENTGENOL, V204, pW289, DOI 10.2214/AJR.14.13180
   Subbarao I, 2008, DISASTER MED PUBLIC, V2, P57, DOI 10.1097/DMP.0b013e31816564af
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Teeman T, 2020, DLY BEAST       0403
   Teo AR, 2011, ACAD MED, V86, P860, DOI 10.1097/ACM.0b013e31821d6ae2
   Thomas PA, 2016, CURRICULUM DEV MED E
   Utunen H, 2020, J MED INTERNET RES, V22, DOI 10.2196/19076
   Varghese V., 2014, THESIS
   Villatoro T, 2019, ACAD PATHOL, V6, DOI 10.1177/2374289519884715
   Wadood MA., 2020, KNOWLEDGE ATTITUDE P, V2020
   Wang MY, 2021, EUR J CLIN NUTR, V75, P335, DOI 10.1038/s41430-020-0643-2
   Whelan A., 2020, AAMC GUIDANCE MED ST
NR 50
TC 4
Z9 4
U1 15
U2 29
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6920
J9 BMC MED EDUC
JI BMC Med. Educ.
PD MAY 27
PY 2021
VL 21
IS 1
AR 303
DI 10.1186/s12909-021-02751-3
PG 14
WC Education & Educational Research; Education, Scientific Disciplines
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Education & Educational Research
GA SI8PX
UT WOS:000655094000001
PM 34039344
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ogoanah, FN
   Ojo, FO
AF Ogoanah, Felix Nwabeze
   Ojo, Fredrick Osaro
TI "This Coronavirus Didn't Ask Questions before Entering Nigeria": A
   Socio-cognitive Account of Covid-19 Humour in Nigeria
SO ENGLISH ACADEMY REVIEW-SOUTHERN AFRICAN JOURNAL OF ENGLISH STUDIES
LA English
DT Article
DE Covid-19; humour; comedy; socio-cognition; culture
AB The purpose of this study is to critically examine humorous responses to the Covid-19 pandemic, in various contexts, with a focus on discursive structures of presupposition and dissociation which are ideologically laden based on people's prior knowledge about Covid-19 situation management in Nigeria, and their attitudes towards the published guidelines. The study is based on Teun van Dijk's socio-cognitive approach to discourse, which attempts to show how the relation between discourse and society is cognitively mediated by way of the mental representations created by language users as members of society. The data for this study are Nigerian comedies about the novel coronavirus, purposively selected from YouTube. The study finds that Nigerians consider the guidelines published by the Nigeria Centre for Disease Control (NCDC) as ridiculous, hence the humorous responses found in comedies. The study also finds that this attitude may be based on people's views of the intrigues surrounding the pandemic, and that the laughter generated signifies audience involvement in the humour created when the comedies reference the NCDC guidelines.
C1 [Ogoanah, Felix Nwabeze; Ojo, Fredrick Osaro] Univ Benin, Benin, Nigeria.
RP Ogoanah, FN (corresponding author), Univ Benin, Benin, Nigeria.
EM felix.ogoanah@uniben.edu
OI OJO, Fredrick Osaro/0000-0002-0492-2964
CR Adegoju A, 2015, DISCOURSE STUD, V17, P643, DOI 10.1177/1461445615602378
   Akinpelu Y., 2020, PREMIUM TIMES 0518
   [Anonymous], 2020, VANGUARD NEWS
   Burmeister JM, 2014, PSYCHOL POP MEDIA CU, V3, P223, DOI 10.1037/ppm0000029
   Chimuanya L, 2016, ADV LINGUIST COMMUN, P252, DOI 10.4018/978-1-5225-0338-5.ch014
   Degano C., 2007, ARGUMENTATION, V21, P361, DOI [https://doi.org/10.1007/s10503-007-9058-7, DOI 10.1007/S10503-007-9058-7]
   Edopikin MC., 2020, YOUTUBE 0311
   Fatboiz Comedy, 2020, YOUTUBE 0316
   Filani I, 2020, DISCOURSE STUD, V22, P319, DOI 10.1177/1461445620906035
   Filani Ibukun., 2016, COMEDY STUDIES, V7, P89
   Filani Ibukun, 2015, EUROPEAN J HUMOUR RE, V3, P41
   Hassan I., 2020, AFRICAN ARGUMEN 0326
   Katayama H., 2009, JOLIE, V2, P125
   Odimakin Y., 2020, VANGUARD NEWS 0331
   Ogoanah Felix N., 2018, EUROPEAN J HUMOUR RE, V6, DOI [10.7592/EJHR2018.6.4.ogoanah, DOI 10.7592/EJHR2018.6.4.OGOANAH]
   Shem Mama., 2020, YOUTUBE 0321
   Stylus UK., 2020, YOUTUBE 0329
   Tao Iya., 2020, YOUTUBE 0323
   Van Dijk T.A., 2009, SOC DISCOURSE
   van Dijk TeunA., 2009, METHODS CRITICAL DIS, V2, P62
   van Rees MA, 2005, CONTROVERSIES, V2, P53
NR 21
TC 0
Z9 0
U1 0
U2 0
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1013-1752
EI 1753-5360
J9 ENGL ACAD REV
JI Engl. Acad. Rev.
PD JUL 3
PY 2021
VL 38
IS 2
SI SI
BP 76
EP 92
DI 10.1080/10131752.2021.1986985
PG 17
WC Language & Linguistics
WE Emerging Sources Citation Index (ESCI)
SC Linguistics
GA XF2EG
UT WOS:000723888400007
DA 2022-04-20
ER

PT J
AU Marques, L
   Giolo, G
AF Marques, Lenia
   Giolo, Guilherme
TI Cultural leisure in the time of COVID-19: impressions from the
   Netherlands
SO WORLD LEISURE JOURNAL
LA English
DT Article
DE Cultural leisure; COVID-19; students; Higher Education; digital culture
AB Amongst leisure practices, culture plays a fundamental role in the leisure landscape. Leisure provides opportunities for escaping daily routines of work and care, and contributes to expanding knowledge, skills and sense of belonging and self-realization. But what happens to leisure, and cultural leisure in the face of extreme scenarios? This article takes a closer looks at the city of Rotterdam in the Netherlands, asking in general 1) what we can observe in cultural leisure in times of COVID-19, and, more specifically, 2) how cultural leisure practices have changed amongst students, in particular during times of pandemic. Students feel they are spending much more time studying, which has seemingly resulted in a subjective experience of increased uneasiness and even meaninglessness that pervades their daily lives. The shift in leisure practices and timings, as well as perception of time and actual time management, are seemingly disrupting normal student life. Students also benefited from digital cultural initiatives by artists, museums, festivals, and other cultural agents. The constraints of the lockdown also propelled forms of creativity in their leisure practices.
C1 [Marques, Lenia; Giolo, Guilherme] Erasmus Univ, Erasmus Sch Hist Culture & Commun, POB 1738, NL-3000 DR Rotterdam, Netherlands.
RP Marques, L (corresponding author), Erasmus Univ, Erasmus Sch Hist Culture & Commun, POB 1738, NL-3000 DR Rotterdam, Netherlands.
EM marques@eshcc.eur.nl
RI ; Marques, Lenia/L-5322-2015
OI Giolo, Guilherme/0000-0003-4240-2799; Marques, Lenia/0000-0002-6360-9919
CR Agyar E, 2013, PROCD SOC BEHV, V93, P2186, DOI 10.1016/j.sbspro.2013.10.185
   Boekman Foundation, 2020, WILL CULT SECT EM CO
   Government of the Netherlands, 2020, DUTCH MEAS COR
   Hunt J, 2010, J ADOLESCENT HEALTH, V46, P3, DOI 10.1016/j.jadohealth.2009.08.008
   Kit-Powell J., 2020, FORBES
   Lehto XY, 2014, ANN LEIS RES, V17, P200, DOI 10.1080/11745398.2014.902293
   Misenzahl M., 2020, BUSINESS INSIDER
   NPO Radio 2, 2002, NPO RADIO 2
   Parr MG, 2004, LEISURE SCI, V26, P1, DOI 10.1080/01490400490272512
   Roberts K, 2018, WORLD LEISURE J, V60, P3, DOI 10.1080/16078055.2016.1261645
   Sullivan R., 2020, CNN
   Swain S., 2017, PALGRAVE HDB LEISURE, P229, DOI DOI 10.1057/978-1-137-56479-5_13
   United Nations, 1948, UNIVERSAL DECLARATIO
   Vice Redactie, 2020, VICE
   Wise J. B., 2014, Journal of Unconventional Parks, Tourism & Recreation Research, V5, P17
   World Leisure Organization, 2020, CHART LEIS
NR 16
TC 1
Z9 1
U1 1
U2 10
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1607-8055
EI 2333-4509
J9 WORLD LEISURE J
JI World Leisure J.
PD OCT 1
PY 2020
VL 62
IS 4
BP 344
EP 348
DI 10.1080/16078055.2020.1825256
EA OCT 2020
PG 5
WC Hospitality, Leisure, Sport & Tourism
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA OU6YM
UT WOS:000582173300001
OA hybrid
DA 2022-04-20
ER

PT J
AU Ezema, CI
   Onyeso, OK
   Okafor, UA
   Mabry, LM
   Adje, ME
   Shiraku, J
   Brismee, JM
   Froment, F
   Stewart, A
   Awosoga, OA
AF Ezema, Charles, I
   Onyeso, Ogochukwu K.
   Okafor, Udoka A.
   Mabry, Lance M.
   Adje, Mishael E.
   Shiraku, Jessica
   Brismee, Jean-Michel
   Froment, Frederic
   Stewart, Aimee
   Awosoga, Olu A.
TI Knowledge, attitude and adherence to standard precautions among
   frontline clinical physiotherapists during the COVID-19 pandemic: a
   cross-sectional survey
SO EUROPEAN JOURNAL OF PHYSIOTHERAPY
LA English
DT Article; Early Access
DE Infectious disease transmission; personal protective equipment;
   physiotherapy; telehealth; standard precautions
ID PROGRAMS
AB Purpose: To investigate the knowledge of pathology and prevention of the novel coronavirus (COVID-19), attitude towards clinical practice, and adherence to standard precautions among clinical physiotherapists during the pandemic.
   Material and methods: A snowballing method was used to recruit physiotherapists (across 53 countries) who responded to a newly designed and validated survey on the participants' demographics, knowledge of COVID-19, attitude, practices, and standard precaution adherence during the pandemic. Data were analysed using descriptive statistics, Cronbach's Alpha, Pearson's correlation, and ANOVA.
   Results: All participants (n=2550, 100%) were knowledgeable on COVID-19 symptomatology. However, only (n = 312, 12.2%) were actively involved in the management of confirmed cases. The percentage score of participants' knowledge regarding COVID-19 pathology, and prevention, their attitude, and adherence to standard precautions averaged 77.73 +/- 10.11, 89.70 +/- 9.26, 77.44 +/- 7.04, and 61.59 +/- 16.63, respectively. Knowledge about COVID-19 pathology differed significantly across demographic variables (p < 0.001, eta(2) <= 0.07). Most participants (n = 1936, 75.9%) reported an inadequate supply of personal protective equipment (PPE).
   Conclusion: Participants had good knowledge of COVID-19 pathology and a positive attitude towards safe clinical practice. However, adherence to standard precautions was suboptimal due to inadequate infectious disease training and PPE supply.
C1 [Ezema, Charles, I] Gregory Univ, Fac Hlth Sci, Dept Physiotherapy, Uturu, Nigeria.
   [Ezema, Charles, I; Onyeso, Ogochukwu K.] Univ Nigeria, Coll Med, Fac Hlth Sci & Technol, Dept Med Rehabil, Nsukka, Nigeria.
   [Onyeso, Ogochukwu K.; Awosoga, Olu A.] Univ Lethbridge, Fac Hlth Sci, Lethbridge, AB, Canada.
   [Okafor, Udoka A.] Univ Lagos, Coll Med, Fac Clin Sci, Dept Physiotherapy, Lagos, Nigeria.
   [Mabry, Lance M.] High Point Univ, Dept Phys Therapy, High Point, NC USA.
   [Adje, Mishael E.] Trier Univ Appl Sci, Dept Therapeut Sci, Trier, Germany.
   [Shiraku, Jessica] Nairobi Hosp, Dept Phys Med & Rehabil, Nairobi, Kenya.
   [Brismee, Jean-Michel; Froment, Frederic] Texas Tech Univ, Hlth Sci Ctr, Dept Rehabil Sci, Ctr Rehabil Res, Lubbock, TX 79430 USA.
   [Stewart, Aimee] Univ Witwatersrand, Sch Therapeut Sci, Dept Physiotherapy, Fac Hlth Sci, Johannesburg, South Africa.
RP Onyeso, OK (corresponding author), Univ Nigeria, Coll Med, Dept Med Rehabil, Nsukka 410101, Nigeria.
EM kzetfrank@yahoo.com
RI Mabry, Lance M./AAH-7068-2019; Onyeso, Ogochukwu Kelechi/AFL-0401-2022;
   Onyeso, Ogochukwu Kelechi/AAH-1837-2022
OI Mabry, Lance M./0000-0001-5942-5108; Onyeso,
   Ogochukwu/0000-0002-8821-4075; Adje, Mishael/0000-0002-7631-0588;
   Brismee, Jean-Michel/0000-0002-1037-7704; Awosoga,
   Olu/0000-0003-3523-5435
CR Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x
   Aweto HA., 2020, REV ROMANA KINETOTER, V26, P11
   Barratt R, 2020, INFECT DIS HEALTH, V25, P253, DOI 10.1016/j.idh.2020.05.005
   Belingheri M, 2020, OCCUP MED-OXFORD, V70, P82, DOI 10.1093/occmed/kqaa048
   Berlin DA, 2020, NEW ENGL J MED, V383, P2451, DOI 10.1056/NEJMcp2009575
   Bujang MA, 2018, MALAYS J MED SCI, V25, P85, DOI 10.21315/mjms2018.25.6.9
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Ellul MA, 2020, LANCET NEUROL, V19, P767, DOI 10.1016/S1474-4422(20)30221-0
   Fox-Wasylyshyn SM, 2005, RES NURS HEALTH, V28, P488, DOI 10.1002/nur.20100
   Gammon J, 2008, J CLIN NURS, V17, P157, DOI 10.1111/j.1365-2702.2006.01852.x
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Leochico CFD, 2020, ANN PHYS REHABIL MED, V63, P563, DOI 10.1016/j.rehab.2020.06.001
   Li LQ, 2020, J MED VIROL, V92, P577, DOI 10.1002/jmv.25757
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Mabry LM, 2020, PHYSIOTHER RES INT, V25, DOI 10.1002/pri.1822
   Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227
   Onyeso OKK, 2019, SOUTH AFR J PHYSIOTH, V75, DOI 10.4102/sajp.v75i1.1338
   Onyeso OK, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02183-5
   Pinto TF, 2020, BRAZ J PHYS THER, V24, P185, DOI 10.1016/j.bjpt.2020.04.004
   Rajgor DD, 2020, LANCET INFECT DIS, V20, P776, DOI 10.1016/S1473-3099(20)30244-9
   Rausch Anne-Kathrin, 2021, Arch Physiother, V11, P18, DOI 10.1186/s40945-021-00112-3
   Refeai SA, 2020, INT J PREVENTIVE MED, V11, DOI 10.4103/ijpvm.IJPVM_320_18
   Schober P, 2018, ANESTH ANALG, V126, P1763, DOI 10.1213/ANE.0000000000002864
   Thomas P, 2020, J PHYSIOTHER, V66, P73, DOI 10.1016/j.jphys.2020.03.011
   Vetter TR, 2017, ANESTH ANALG, V125, P1375, DOI 10.1213/ANE.0000000000002370
   Warmbrod RJ., 2014, J AGR ED, V55, P30, DOI [10.5032/jae.2014.05030, DOI 10.5032/JAE.2014.05030, DOI 10.5032/jae.2014.05030]
   WHO, 2020, SHORT PERS PROT EQ E
   WHO, 2020, NAM COR DIS COVID 19
   World Health Organization, 2020, TRANSM SARS COV 2 IM
   World Health Organization, 2021, WEEKLY EPIDEMIOLOGIC
   Yang S, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.66
   Ye G., 2020, J INFECTION, V81, pe1, DOI [10.1016/j.jinf.2020.04.034, DOI 10.1016/j.jinf.2020.04.034]
NR 32
TC 0
Z9 0
U1 3
U2 3
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 2167-9169
EI 2167-9177
J9 EUR J PHYSIOTHER
JI Eur. J. Physiother.
DI 10.1080/21679169.2021.2020898
EA DEC 2021
PG 9
WC Rehabilitation
WE Emerging Sources Citation Index (ESCI)
SC Rehabilitation
GA XY2OO
UT WOS:000736818600001
DA 2022-04-20
ER

PT J
AU Boutsikari, EC
   Christakou, A
   Elpidoforou, M
   Kopsidas, I
   Nikolovienis, N
   Kardara, D
   Boutsikari, CC
   Triantafyllou, C
AF Boutsikari, Eleni C.
   Christakou, Anna
   Elpidoforou, Michail
   Kopsidas, Ioannis
   Nikolovienis, Nicholas
   Kardara, Despina
   Boutsikari, Chrissoula C.
   Triantafyllou, Christos
TI Greek population's perceptions of non-pharmacological interventions
   towards the first wave of COVID-19 pandemic mitigation: A
   regression-based association analysis
SO PNEUMON
LA English
DT Article
DE COVID-19; infectious diseases; non-harmacological intervention; public
   perception; Greece; knowledge gap ypothesis
ID VACCINATION; INFECTIONS; ATTITUDES; KNOWLEDGE; PERIOD
AB INTRODUCTION In the ongoing coronavirus disease 2019 (COVID-19) pandemic, even though vaccines have been rolled out and the vaccination campaigns in some countries have already been followed by a decline in number and severity of cases, non-pharmaceutical interventions (NPI) are still playing an important role on COVID-19 management (e.g. social distancing) that are imposed by the authorities and require the public's adherence and behavioral adjustment. This study aims to identify factors that affect the general public's attitudes towards the importance of NPI in Greece.
   METHODS This prevalence study, enrolled 657 adults from the general Greek population in order to assess their beliefs and identify possible factors that influence their perceptions of NPI. All associations were assessed through multivariate logistic regression.
   RESULTS Overall, Greeks considered NPI important for health protection. The participants who were less likely to consider NPI important were men compared to women (OR=1.64; 95% CI: 1.15-2.36, p=0.007), people aged <40 years compared to those >= 40 years (OR=0.48; 95% CI: 0.34-0.68, p<0.001), and people who did not choose the Hellenic National Public Health Organization (NPHO) to get informed about COVID-19 compared to other sources (OR=0.65; 95% CI: 0.46-0.92, p=0.014).
   CONCLUSIONS This study profiled Greek people who do and do not consider NPI important, primarily on their demographic characteristics. Focused communicational strategies in certain population subgroups are recommended.
C1 [Boutsikari, Eleni C.] Natl & Kapodistrian Univ Athens, Dept Hyg Epidemiol & Med Stat, 75 Mikras Asias Str, Athens 11527, Greece.
   [Christakou, Anna] Gen Hosp Athens Evangelismos, Athens, Greece.
   [Christakou, Anna; Nikolovienis, Nicholas] Univ West Attica, Dept Physiotherapy, Athens, Greece.
   [Elpidoforou, Michail] Univ West Attica, Dept Phys Therapy, Lab Neuromuscular & Cardiovasc Study Mot, Athens, Greece.
   [Kopsidas, Ioannis; Kardara, Despina] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece.
   [Nikolovienis, Nicholas] Morgan Stanley Childrens Hosp, New York Presbyterian, New York, NY USA.
   [Boutsikari, Chrissoula C.; Triantafyllou, Christos] Natl & Kapodistrian Univ Athens, Dept Nursing, Athens, Greece.
RP Boutsikari, EC (corresponding author), Natl & Kapodistrian Univ Athens, Dept Hyg Epidemiol & Med Stat, 75 Mikras Asias Str, Athens 11527, Greece.
EM E.Boutsikari@med.uoa.gr
RI Christakou, Anna/ABH-2177-2021
OI Kopsidas, Ioannis/0000-0001-6499-4807; Triantafyllou,
   Christos/0000-0002-3198-3965
CR [Anonymous], 2021, STAT VERS 17
   Antoniou K, 2020, PNEUMON, V33, P28
   Bouros D, 2020, PNEUMON, V33, P7
   Choi Bernard C K, 2005, Prev Chronic Dis, V2, pA13
   Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Gerwin LE, 2012, J LAW MED ETHICS, V40, P630, DOI 10.1111/j.1748-720X.2012.00695.x
   Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8
   Johnson NL, 2006, ENCY STAT SCI, DOI [10.1002/0471667196, DOI 10.1002/0471667196.ESS5050.PUB2]
   Kanellopoulou A, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11193-x
   Ke RA, 2021, J THEOR BIOL, V517, DOI 10.1016/j.jtbi.2021.110621
   Kiviniemi MT, 2018, BRIT J HEALTH PSYCH, V23, P420, DOI 10.1111/bjhp.12297
   Kotrlik JW., 2001, INF TECHNOL LEARN PE, V19, P43, DOI DOI 10.1109/LPT.2009.2020494
   Kourlaba G, 2020, PNEUMON, V33, P175
   Latiff Latiffah Abdul, 2012, Glob J Health Sci, V4, P95, DOI 10.5539/gjhs.v4n2p95
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19
   Mishra P, 2019, ANN CARD ANAESTH, V22, P67, DOI 10.4103/aca.ACA_157_18
   Norquist JM, 2012, QUAL LIFE RES, V21, P1013, DOI 10.1007/s11136-011-0003-8
   Nwagbara UI, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249853
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Qualtrics XM, 2021, QUALTR
   Rodriguez-Morales Alfonso J, 2020, Travel Med Infect Dis, V34, P101623, DOI 10.1016/j.tmaid.2020.101623
   Russell D, 2018, AM J INFECT CONTROL, V46, P1211, DOI 10.1016/j.ajic.2018.05.005
   Taylor S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246317
   Torner N, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1890-3
   Vandenbroucke JP, 2007, LANCET, V4, P297
   Weaver K.F., 2017, INTRO STAT ANAL RES, DOI [10.1002/9781119454205, DOI 10.1002/9781119454205]
   World Health Organization, 2012, World Health Organ Tech Rep Ser, P1
   World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zimmermann P, 2020, PEDIATR INFECT DIS J, V39, P355, DOI 10.1097/INF.0000000000002660
NR 32
TC 0
Z9 0
U1 0
U2 0
PU HELLENIC BRONCHOLOGIC SOC
PI ATHENS
PA SOTIRIA HOSPITAL, 152 MESOGION AVE, ATHENS, 11527, GREECE
SN 1105-848X
EI 1791-4914
J9 PNEUMON
JI Pneumon
PD JUN-SEP
PY 2021
VL 34
IS 3
DI 10.18332/pne/141592
EA SEP 2021
PG 11
WC Respiratory System
WE Emerging Sources Citation Index (ESCI)
SC Respiratory System
GA YV3BW
UT WOS:000719923100001
OA gold
DA 2022-04-20
ER

PT J
AU Idwan, S
   Fayyoumi, E
   Hijazi, H
   Matar, I
AF Idwan, Sahar
   Fayyoumi, Ebaa
   Hijazi, Haneen
   Matar, Izzeddin
TI COVID-19 Pandemic Endorses New Era of E-learning Case Study: Hashemite
   University
SO JOURNAL OF E-LEARNING AND KNOWLEDGE SOCIETY
LA English
DT Article
DE E-Learning; COVID-19; E-Content; Virtual Classroom (VC); Learning
   Management System (LMS); HU
ID CHALLENGES
AB Technology has affected the development of the education process over time. COVID-19 pandemic has forced educational facilities to close. Consequently, transformation from face-to-face educational approach to the E-learning approach has pushed the world to enter a new state of learning. This situation has elicited doubts about the implementation and the difficulties related with this immediate action. In this paper, statistical analysis was used on the filled survey by the instructors and students at the Hashemite University (HU) to investigate the quality of the E-learning process. Various factors such as e-content, Virtual Classroom (VC) and Learning Management System (LMS), and Technology Infrastructure affect E-learning process. A contradiction between instructors' and students' opinions regarding the usage of the E-learning at HU exists. Therefore, a set of recommendations was made to overcome the shortage in the E-learning process and to reach a full satisfaction about the quality of its implementation in future.
C1 [Idwan, Sahar; Fayyoumi, Ebaa] Hashemite Univ, Dept Comp Sci & Applicat, Fac Prince Al Hussein Bin Ahdallah II Informat Te, Zarqa, Jordan.
   [Hijazi, Haneen] Hashemite Univ, Dept Software Engn, Fac Prince Al Hussein Bin Ahdallah II Informat Te, Zarqa, Jordan.
   [Matar, Izzeddin] Univ Petra, Fac Informat Technol, Dept Software Engn, Amman, Jordan.
RP Idwan, S (corresponding author), Hashemite Univ, Dept Comp Sci & Applicat, Fac Prince Al Hussein Bin Ahdallah II Informat Te, Zarqa, Jordan.
EM sahar@hu.edu.jo
OI Hijazi, Haneen/0000-0001-7364-0218
CR Agarwal S, 2020, INDIAN J PEDIATR, V87, P554, DOI 10.1007/s12098-020-03327-7
   Al-Shboul M., 2013, WORLD APPL SCI J, V21, P902, DOI DOI 10.5829/idosi.wasj.2013.21.6.227
   Alkhawaja MI., 2019, INT J ACAD RES BUSIN, V9, P487, DOI [10.6007/ijarbss/v9-i9/6317, DOI 10.6007/IJARBSS/V9-I9/6317]
   Almarabeh T., 2013, J AM SCI, V9, P281
   Buttar S. S., 2016, PEOPLE INT J SOCIAL, V2, P1686
   Daniel S. J, 2020, ED COVID 19 PANDEMIC
   Fayyoumi E, 2015, INT J INNOV LEARN, V17, P470, DOI 10.1504/IJIL.2015.069632
   Ferri F, 2020, SOCIETIES, V10, DOI 10.3390/soc10040086
   Hassan M. M., 2020, INT J ED MANAG ENG, V10, P17, DOI [10.5815/ijeme.2020.05.03, DOI 10.5815/IJEME.2020.05.03]
   Int@j, 2018, JORDAN ICT ITES SECT
   Khan MA., 2020, INT J CREATIVE RES T, V3, P3135
   Lemay D, 2021, COMPUTERS HUMAN BEHA, V4
   Levine A., 2002, BARRIERS DISTANCE ED
   Mahalakshmi K., 2020, J XIDIAN U, V14, P2405
   Mahyoob M, 2020, ARAB WORLD ENGL J, V11, P351, DOI 10.24093/awej/vol11no4.23
   Marinoni G., 2020, IMPACT COVID 19 HIGH
   MINISTRY OF HIGHER EDUCATION AND SCIENTIFIC, 2009, NAT ELEARNING STRAT
   Nenko Y, 2020, REV BRAS EDUC CAMPO, V5, DOI 10.20873/uft.rbec.e8925
   Peter R., 2021, J LINGUISTICS ENGLIS, V1
   Powell L., 2021, ACCOUNT RES J, V34
   Prokopenko I, 2020, REV ROMANEASCA PENTR, V12, P130, DOI 10.18662/rrem/12.1sup2/256
   Pujari V., 2020, INT J ADV INNOVATIVE, V7, P117
   Sahu P, 2020, CUREUS, V12, DOI 10.7759/cureus.7541
   Saravanakumar AR., 2020, INT J CONTROL AUTOM, V13, P1088
   Sugino C, 2021, EDUC SCI, V11, DOI 10.3390/educsci11050231
   Sum ALW, 2021, FRONT EDUC, V6, DOI 10.3389/feduc.2021.624370
   Turnbull D., 2019, ENCY ED INFORM TECHN, DOI [10.1007/978-3-030-10576-1_248, DOI 10.1007/978-3-319-60013-0_248-1]
   UNDP U., 2020, COVID 19 IMPACT HOUS
   Wargo E., 2020, J STUDY POSTSECONDAR, V5
   Wilp T., 2020, INT J 1 AID ED, V3
NR 30
TC 0
Z9 0
U1 0
U2 0
PU SOC ITALIANA E-LEARNING
PI ROME
PA VIA ORAZIO RAIMONDO 18, ROME, 00173, ITALY
SN 1826-6223
EI 1971-8829
J9 J E-LEARN KNOWL SOC
JI J. E-Learn. Knowl. Soc.
PD DEC
PY 2021
VL 17
IS 2
BP 56
EP 65
DI 10.20368/1971-8829/1135416
PG 10
WC Education & Educational Research
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research
GA YY2TD
UT WOS:000754644700006
DA 2022-04-20
ER

PT J
AU Hirschhorn, F
AF Hirschhorn, Fabio
TI A multi-level governance response to the Covid-19 crisis in public
   transport
SO TRANSPORT POLICY
LA English
DT Article
DE COVID-19; Multi-level governance; Informal governance; Decision-making;
   State-aid; Financial crisis
AB This paper examines the Dutch policy reaction to the financial crisis in the public transport sector caused by Covid-19. Using the multi-level governance theory complemented with the notion of informal governance, the analysis explains the decision-making that defined a State-aid scheme to public transport operators following a process of consultation and concertation between state and non-state actors across governance tiers. To agree on a financial rescue package, these actors engage in front-stage and back-stage political interactions, constrained and enabled by formal and informal governance structures and practices. By analyzing how the interplay between the political mobilization of actors, policy-making arrangements, and existing polity structures shapes political alignment around the financial support scheme, the paper concludes that the crisis did not change customary governance and policy-making practices. Stakeholders sought their usual partners and followed existing routines in path-dependent ways to address the policy challenge brought by Covid-19. Despite being triggered by a major exogenous shock, the policy response to the crisis was driven mainly by endogenous forces; the decision-making mechanism remained the same and the network of actors did not shrink or expand.
C1 [Hirschhorn, Fabio] Delft Univ Technol, Fac Technol Policy & Management, Jaffalaan 5, NL-2628 BX Delft, Netherlands.
RP Hirschhorn, F (corresponding author), Delft Univ Technol, Fac Technol Policy & Management, Jaffalaan 5, NL-2628 BX Delft, Netherlands.
EM f.hirschhorn@tudelft.nl
OI Hirschhorn, Fabio/0000-0002-2017-3991
FU K2 Swedish Knowledge Centre for Public Transport, Sweden
FX This work was partially supported by K2 Swedish Knowledge Centre for
   Public Transport, Sweden. The sponsors were not involved in study
   design; in the collection, analysis and interpretation of data; in the
   writing of the report; and in the decision to submit the article for
   publication.
CR Alcantara C, 2016, TERRIT POLIT GOV, V4, P33, DOI 10.1080/21622671.2015.1047897
   Bache I., 2004, PUBLIC POLICY ADMIN, V19, P31, DOI [DOI 10.1177/095207670401900103, https://doi.org/10.1177/095207670401900103, 10.1177/095207670401900103]
   Bache I., 2008, EUROPEANIZATION MULT
   Bache I., 2016, HDB THEORIES GOVERNA, P486
   Battilana J, 2006, ORGANIZATION, V13, P653, DOI 10.1177/1350508406067008
   Beebe J., 2001, RAPID QUALITATIVE IN
   Bennett A., 2005, CASE STUDIES THEORY
   Blom-Hansen J, 2005, J EUR PUBLIC POLICY, V12, P624, DOI 10.1080/13501760500160136
   Christiansen T, 2003, INFORMAL GOVERNANCE IN THE EUROPEAN UNION, P1
   European Commission, 2020, **NON-TRADITIONAL**
   Flyvbjerg B, 2006, QUAL INQ, V12, P219, DOI 10.1177/1077800405284363
   Hirschhorn F, 2020, RES TRANSP ECON, V83, DOI 10.1016/j.retrec.2020.100829
   Hirschhorn F, 2019, TRANSPORT RES A-POL, V124, P419, DOI 10.1016/j.tra.2019.04.008
   Hooghe L, 2003, AM POLIT SCI REV, V97, P233
   Hooghe Liesbet., 2001, MULTILEVEL GOVERNANC
   Marks G., 1993, STATE EUROPEAN COMMU, V2, P391
   Marsden G., 2020, INT E C PAND TRANSP
   Nederlandse Spoorwegen, 2020, NS ANN REP 2020
   Peters BG, 2001, POLICY POLIT, V29, P131, DOI 10.1332/0305573012501251
   Piattoni S., 2010, THEORY MULTILEVEL GO
   PIATTONI S., 2009, J EUROPEAN INTEGRATI, V31, P163, DOI [DOI 10.1080/07036330802642755, 10.1080/07036330802642755]
   Reardon L, 2018, POLICY SCI, V51, P457, DOI 10.1007/s11077-018-9330-8
   Sager F, 2012, AM J EVAL, V33, P60, DOI 10.1177/1098214011411574
   Stephenson P, 2013, J EUR PUBLIC POLICY, V20, P817, DOI 10.1080/13501763.2013.781818
   Thomann, 2019, EUROPEAN POLICY ANAL, V5, P37, DOI [10.1002/epa2.1062, DOI 10.1002/EPA2.1062]
   Treib O, 2007, J EUR PUBLIC POLICY, V14, P1, DOI 10.1080/135017606061071406
   Van Tatenhove J, 2006, PERSPECT EUR POLITIC, V7, P8, DOI DOI 10.1080/15705850600839470
   Vickerman R, 2021, TRANSPORT POLICY, V103, P95, DOI 10.1016/j.tranpol.2021.01.005
   Zhang JY, 2021, TRANSPORT POLICY, V103, P68, DOI 10.1016/j.tranpol.2021.01.011
   Zonneveld W, 2014, SPATIAL PLANNING SYSTEMS AND PRACTICES IN EUROPE: A COMPARATIVE PERSPECTIVE ON CONTINUITY AND CHANGES, P61
NR 30
TC 0
Z9 0
U1 2
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0967-070X
EI 1879-310X
J9 TRANSPORT POLICY
JI Transp. Policy
PD OCT
PY 2021
VL 112
BP 13
EP 21
DI 10.1016/j.tranpol.2021.08.007
EA AUG 2021
PG 9
WC Economics; Transportation
WE Social Science Citation Index (SSCI)
SC Business & Economics; Transportation
GA UU0ON
UT WOS:000698504900002
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Kong, Y
   Jiang, H
   Liu, ZS
   Guo, Y
   Hu, DH
AF Kong, Yi
   Jiang, Hao
   Liu, Zhisheng
   Guo, Yi
   Hu, Dehua
TI The Uptake and Vaccination Willingness of COVID-19 Vaccine among Chinese
   Residents: Web-Based Online Cross-Sectional Study
SO VACCINES
LA English
DT Article
DE COVID-19 vaccine; vaccination willingness; vaccine hesitancy;
   influential factor
ID BEIJING MUNICIPALITY; ACCEPTANCE; POPULATION; KNOWLEDGE; HESITANCY;
   RECEIVE
AB Objective: To investigate the uptake and vaccination willingness of the COVID-19 vaccine among Chinese residents and analyze the difference and factors that impact vaccination. Methods: The snowball sampling method was used to distribute online questionnaires. Relevant sociodemographic data along with the circumstances of COVID-19 vaccination were collected from the respondents. The chi(2) test, independent samples t test and binary logistic regression analysis were used to analyze the data. Results: Among 786 respondents, 84.22% had been vaccinated. Over 80% of the vaccinated population have completed all the injections because of supporting the national vaccination policies of China, while the unvaccinated population (23.91%) is mainly due to personal health status. Meanwhile, statistical analysis revealed that the main predictors of not being vaccinated were younger age (3 to 18 years old), personal health status, and lower vaccinated proportion of family members and close friends (p < 0.05). Conclusions: There was a high level of uptake of the COVID-19 vaccine in China, and people who have not been vaccinated generally had a low willingness to vaccinate in the future. Based on our results, it suggested the next work to expand the coverage of the COVID-19 vaccination should be concentrated on targeted publicity and education for people who have not been vaccinated.
C1 [Kong, Yi; Jiang, Hao; Liu, Zhisheng; Guo, Yi; Hu, Dehua] Cent South Univ, Sch Life Sci, Dept Biomed Informat, Changsha 410013, Peoples R China.
   [Liu, Zhisheng] Cent South Univ, Xiangya Sch Med, Changsha 410013, Peoples R China.
RP Guo, Y; Hu, DH (corresponding author), Cent South Univ, Sch Life Sci, Dept Biomed Informat, Changsha 410013, Peoples R China.
EM kongyi@csu.edu.cn; jianghao1209@csu.edu.cn; 220126@csu.edu.cn;
   yiguo@csu.edu.cn; hudehua@csu.edu.cn
OI Guo, Yi/0000-0003-2727-9809
FU National Social Science Fund of China [20BTQ081]; Key International
   Cooperation Projects of Hunan Province of China [2021WK2003]; Project of
   Theory, Practice and Popularization of Scientific and Technological
   Novelty Search by Shenzhen Health Development Research and Data
   Management Center [H202111120250001]
FX FundingThis research work is supported by National Social Science Fund
   of China (Grant No.20BTQ081), Key International Cooperation Projects of
   Hunan Province of China (Grant No.2021WK2003) and the Project of Theory,
   Practice and Popularization of Scientific and Technological Novelty
   Search by Shenzhen Health Development Research and Data Management
   Center (Grant No.H202111120250001).
CR Abebe H, 2021, INFECT DRUG RESIST, V14, P2015, DOI 10.2147/IDR.S312116
   Al-Hanawi MK, 2021, J INFECT PUBLIC HEAL, V14, P1489, DOI 10.1016/j.jiph.2021.08.002
   Al-Marshoudi S, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9060602
   Alabdulla M, 2021, INFLUENZA OTHER RESP, V15, P361, DOI 10.1111/irv.12847
   An ZJ, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj-2021-066125
   Baines A, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050421
   Bell S, 2020, VACCINE, V38, P7789, DOI 10.1016/j.vaccine.2020.10.027
   Carcelen AC, 2022, HUM VACC IMMUNOTHER, V18, DOI 10.1080/21645515.2021.1948784
   Central People's Government of the People's Republic of China, VACC 12 17 YEAR OLDS
   Chen H, 2021, J MED INTERNET RES, V23, DOI 10.2196/29329
   Diament Sean M, 2022, Soc Sci Med, V292, P114562, DOI 10.1016/j.socscimed.2021.114562
   Dong C, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182111192
   Elhadi M, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10987-3
   Ella KM, 2020, INDIAN PEDIATR, V57, P407, DOI 10.1007/s13312-020-1812-z
   Fisher KA, 2020, ANN INTERN MED, V173, P964, DOI 10.7326/M20-3569
   Francis DB, 2021, J RACIAL ETHN HEALTH, DOI 10.1007/s40615-021-01094-5
   Garett R, 2021, TRANSL BEHAV MED, V11, P2194, DOI 10.1093/tbm/ibab128
   Goldman RD, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph181910224
   Ayhan SG, 2021, INT J GYNECOL OBSTET, V154, P291, DOI 10.1002/ijgo.13713
   Heaton PM, 2021, J INFECT DIS, V224, P931, DOI 10.1093/infdis/jiab234
   Hernandez RG, 2021, HUM VACC IMMUNOTHER, V17, P2962, DOI 10.1080/21645515.2021.1912551
   Hou ZY, 2021, J MED INTERNET RES, V23, DOI 10.2196/27632
   Jiang N, 2021, NURSE EDUC PRACT, V55, DOI 10.1016/j.nepr.2021.103148
   Kadkhoda K, 2021, AM J CLIN PATHOL, V155, P471, DOI 10.1093/ajcp/aqaa272
   Kant R, 2021, PAC JOURNAL REV, V27, P47
   Lazarus JV, 2021, NAT MED, V27, P354, DOI 10.1038/s41591-020-01226-0
   Liu D, 2021, HUM VACC IMMUNOTHER, V17, P2405, DOI 10.1080/21645515.2021.1899732
   Liu RG, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030292
   Ma R, 2021, CHINA CDC WEEKLY, V3, P531, DOI 10.46234/ccdcw2021.118
   Mose A, 2021, INT J GEN MED, V14, P2385, DOI 10.2147/IJGM.S314346
   National Health Commission of the People's Republic of China, GUID VACC COVID 19 V, VFirst
   National Health Commission of the People's Republic of China, NAT SIT COVID 19 VAC
   Peng LH, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9090995
   Pereira B, 2022, PSYCHOL MARKET, V39, P921, DOI 10.1002/mar.21629
   Ricotta Emily E, 2021, medRxiv, DOI 10.1101/2021.03.17.21253760
   Salali Gul Deniz, 2021, Psychol Med, P1, DOI 10.1017/S0033291721004013
   Shih SF, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.558270
   Stahl JP, 2016, MED MALADIES INFECT, V46, P117, DOI 10.1016/j.medmal.2016.02.002
   Stuckelberger S, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13071199
   Suo LD, 2021, CHINA CDC WEEKLY, V3, P569, DOI 10.46234/ccdcw2021.130
   Tahir MJ, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11814-5
   Wang C, 2021, VACCINE, V39, P2833, DOI 10.1016/j.vaccine.2021.04.020
   Wang JH, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030482
   Wang JL, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9111291
   Worasathit R, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0137-6
   World Health Organization, WHO COR DIS COVID 19
   Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344
   Zhao YM, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9101172
NR 48
TC 0
Z9 0
U1 7
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD JAN
PY 2022
VL 10
IS 1
AR 90
DI 10.3390/vaccines10010090
PG 12
WC Immunology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Research & Experimental Medicine
GA ZD3UD
UT WOS:000758125700001
PM 35062751
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Zhu, CL
   Wu, JP
   Liu, MY
   Wang, LY
   Li, DW
   Kouvelas, A
AF Zhu, Chunli
   Wu, Jianping
   Liu, Mingyu
   Wang, Linyang
   Li, Duowei
   Kouvelas, Anastasios
TI Recovery preparedness of global air transport influenced by COVID-19
   pandemic: Policy intervention analysis
SO TRANSPORT POLICY
LA English
DT Article
DE Air transport; Post-recovery; Policy intervention; COVID-19; Causal
   Bayesian network (CBN)
ID BAYESIAN NETWORK MODEL; RESILIENCE; CAUSAL; INFRASTRUCTURE; MECHANISMS;
   COMPLEX; EVENT
AB The outbreak of COVID-19 constitutes an unprecedented disruption globally, in which risk management framework is on top priority in many countries. Travel restriction and home/office quarantine are some frequently utilized non-pharmaceutical interventions, which bring the worst crisis of airline industry compared with other transport modes. Therefore, the post-recovery of global air transport is extremely important, which is full of uncertainty but rare to be studied. The explicit/implicit interacted factors generate difficulties in drawing insights into the complicated relationship and policy intervention assessment. In this paper, a Causal Bayesian Network (CBN) is utilized for the modelling of the post-recovery behaviour, in which parameters are synthesized from expert knowledge, open-source information and interviews from travellers. The tendency of public policy in reaction to COVID-19 is analyzed, whilst sensitivity analysis and forward/backward belief propagation analysis are conducted. Results show the feasibility and scalability of this model. On condition that no effective health intervention method (vaccine, medicine) will be available soon, it is predicted that nearly 120 days from May 22, 2020, would be spent for the number of commercial flights to recover back to 58.52%?60.39% on different interventions. This intervention analysis framework is of high potential in the decision making of recovery preparedness and risk management for building the new normal of global air transport.
C1 [Zhu, Chunli; Wu, Jianping; Liu, Mingyu; Wang, Linyang; Li, Duowei] Tsinghua Univ, Dept Civil Engn, Beijing 100084, Peoples R China.
   [Zhu, Chunli; Kouvelas, Anastasios] Swiss Fed Inst Technol, Inst Transport Planning & Syst, CH-8093 Zurich, Switzerland.
RP Zhu, CL (corresponding author), Tsinghua Univ, Dept Civil Engn, Beijing 100084, Peoples R China.
EM zcl17@mails.tsinghua.edu.cn
OI Zhu, Chunli/0000-0002-6109-9484
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [U1709212, U1509205]; China Scholarship
   CouncilChina Scholarship Council [201906210384]
FX This work was supported by the National Natural Science Foundation of
   China (grant number:U1709212,U1509205) ; and China Scholarship Council
   (grant number: 201906210384) .
CR Agarwal S, 2017, J POLIT ECON, V125, P654, DOI 10.1086/691701
   Al-Lamee R, 2018, LANCET, V391, P31, DOI 10.1016/S0140-6736(17)32714-9
   Anderson GL, 2012, QUAL INQ, V18, P674, DOI 10.1177/1077800412452857
   [Anonymous], 2014, INT J RES ENG TECHNO
   Barabadi A, 2018, RELIAB ENG SYST SAFE, V169, P209, DOI 10.1016/j.ress.2017.08.018
   Becker B., 2020, VOXEU ORG
   Cardillo A, 2013, EUR PHYS J-SPEC TOP, V215, P23, DOI 10.1140/epjst/e2013-01712-8
   Chen XZ, 2017, INT J TECHNOL ASSESS, V33, P206, DOI 10.1017/S0266462317000344
   Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757
   Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982
   Dunn S, 2016, TRANSPORT RES E-LOG, V90, P39, DOI 10.1016/j.tre.2015.09.011
   Fenton N., 2019, IEEE T KNOWL DATA EN, P1
   Fenton N, 2018, RISK ASSESSMENT DECI, V2nd
   Fenton NE, 2020, J RISK RES, V23, P862, DOI 10.1080/13669877.2020.1756381
   Grisham T, 2009, INT J MANAG PROJ BUS, V2, P112, DOI 10.1108/17538370910930545
   Hakim MM, 2016, J TRANSP GEOGR, V56, P120, DOI 10.1016/j.jtrangeo.2016.09.006
   Harder VS, 2010, PSYCHOL METHODS, V15, P234, DOI 10.1037/a0019623
   Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7
   Holling CS., 1996, ENG RESILIENCE VERSU, V31, P32, DOI DOI 10.17226/4919
   Hossain NUI, 2019, RELIAB ENG SYST SAFE, V189, P378, DOI 10.1016/j.ress.2019.04.037
   Hosseini S, 2016, INT J PROD ECON, V180, P68, DOI 10.1016/j.ijpe.2016.07.007
   Hosseini S, 2016, COMPUT IND ENG, V93, P252, DOI 10.1016/j.cie.2016.01.007
   Iacus SM, 2020, SAFETY SCI, V129, DOI 10.1016/j.ssci.2020.104791
   Jacobsson S, 2013, ENERG POLICY, V63, P1182, DOI 10.1016/j.enpol.2013.08.077
   Janic M, 2015, TRANSPORT RES A-POL, V81, P77, DOI 10.1016/j.tra.2015.07.012
   Jensen F.V., 2001, BAYESIAN NETWORKS DE, P3
   Ji Q, 2018, Q REV ECON FINANC, V70, P203, DOI 10.1016/j.qref.2018.05.016
   Kiani Behdad, 2009, International Journal of Electronic Business Management, V7, P159
   Koch D, 2017, J THEOR BIOL, V433, P94, DOI 10.1016/j.jtbi.2017.08.023
   Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218
   Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4
   Li HJ, 2012, ACCIDENT ANAL PREV, V49, P366, DOI 10.1016/j.aap.2012.02.013
   Li S, 2017, ECONOMET STAT, V2, P81, DOI 10.1016/j.ecosta.2016.11.002
   Maparu TS, 2017, TRANSPORT RES A-POL, V100, P319, DOI 10.1016/j.tra.2017.04.033
   Mattsson LG, 2015, TRANSPORT RES A-POL, V81, P16, DOI 10.1016/j.tra.2015.06.002
   Opdyke A, 2017, CONSTR MANAG ECON, V35, P514, DOI 10.1080/01446193.2016.1247973
   Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530
   Pearl J., 2009, CAUSALITY
   Perez-Minana E, 2016, ENVIRON MODELL SOFTW, V85, P184, DOI 10.1016/j.envsoft.2016.07.007
   Rathfon D, 2013, DISASTERS, V37, P333, DOI 10.1111/j.1467-7717.2012.01305.x
   Reutlinger A, 2016, PHILOS SCI, V83, P733, DOI 10.1086/687859
   Rodrigues PP, 2018, ARTIF INTELL MED, V91, P12, DOI 10.1016/j.artmed.2018.07.005
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Wesseling M, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0097-1
   Zanin M, 2013, EUR PHYS J-SPEC TOP, V215, P5, DOI 10.1140/epjst/e2013-01711-9
   Zhao SD, 2016, NEUROCOMPUTING, V173, P1943, DOI 10.1016/j.neucom.2015.09.066
   Zhu CL, 2020, RELIAB ENG SYST SAFE, V204, DOI 10.1016/j.ress.2020.107095
   Zimmerman C, 2011, SOC SCI MED, V73, P327, DOI 10.1016/j.socscimed.2011.05.028
NR 48
TC 4
Z9 4
U1 12
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0967-070X
EI 1879-310X
J9 TRANSPORT POLICY
JI Transp. Policy
PD JUN
PY 2021
VL 106
BP 54
EP 63
DI 10.1016/j.tranpol.2021.03.009
EA APR 2021
PG 10
WC Economics; Transportation
WE Social Science Citation Index (SSCI)
SC Business & Economics; Transportation
GA RW8FF
UT WOS:000646754500005
PM 33785994
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Gathiram, P
   Moodley, J
   Khaliq, OP
AF Gathiram, Premjith
   Moodley, Jagidesa
   Khaliq, Olive P.
TI Covid-19 pandemic: Perspectives on management
SO JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Review
ID ANGIOTENSIN-CONVERTING ENZYME; CYTOKINE STORM; CORONAVIRUS; ACE2;
   EFFICACY; RECEPTOR
AB The pandemic COVID-19 presents a major challenge to identify effective drugs for treatment. Clinicians need evidence based on randomized trials regarding effective medical treatments for this infection. Currently no effective therapies exist for the progression of the mild forms to severe disease. Knowledge however is rapidly expanding. Remdesivir, an anti- retroviral agent has in vitro activity against this virus and has shown to decrease the duration of ICU care in patients with severe disease, while low dose dexamethasone also showed a decrease in the duration of stay in cases of severe disease requiring assisted ventilation. At the time of writing this article, two mRNA-based vaccines have shown an approximate 95 % efficacy in preventing infection in large clinical trials. At least one of these drugs has regulatory permission for vaccination in high-income countries. Low and middle-income countries may have difficulties in initiating vaccine programs on large scales because of availability, costs, refrigeration and dissemination. Adequately powered randomized trials are required for drugs with in vitro activity against the virus. Supportive care should be provided for stable, hypoxia and pneumonia free patients on imaging. Vaccines are of obvious benefit and given the preliminary evidence of the efficacy of over 95 %, Low and middle-income countries must develop links with the WHO COVAX program to ensure global distribution of vaccines.
C1 [Gathiram, Premjith] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Dept Family Med, Durban, Kwazulu Natal, South Africa.
   [Moodley, Jagidesa; Khaliq, Olive P.] Univ KwaZulu Natal, Womens Hlth & HIV Res Grp, Dept Obstet & Gynaecol, Durban, Kwazulu Natal, South Africa.
RP Gathiram, P (corresponding author), Univ KwaZulu Natal, Coll Hlth Sci, Durban, Kwazulu Natal, South Africa.
EM Gathiramp@ukzn.ac.za
CR Abassi Z, 2020, AM J PHYSIOL-HEART C, V318, pH1080, DOI 10.1152/ajpheart.00215.2020
   Agrawal S, 2020, MONALDI ARCH CHEST D, V90, DOI 10.4081/monaldi.2020.1289
   Al-Mandhari A, 2020, E MEDITERR HEALTH J, V26, P136, DOI 10.26719/2020.26.2.136
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   [Anonymous], NEW YORK TIMES
   Aronson JK, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1313
   Berg M.K., 2020, MEDRXIV2020040520054
   Bizzarri M, 2020, EUR REV MED PHARMACO, V24, P3426, DOI 10.26355/eurrev_202003_20715
   Borba MGS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8857
   Busse LW, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02862-1
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Cao YC, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101647
   Castells MC, 2021, NEW ENGL J MED, V384, P643, DOI 10.1056/NEJMra2035343
   CDC,, 2021, DIFF COVID 19 VACC
   Challen R, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n579
   Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x
   Cossarizza A, 2020, CYTOM PART A, V97, P340, DOI 10.1002/cyto.a.24002
   Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786
   Deng LS, 2020, J INFECTION, V81, pE1, DOI 10.1016/j.jinf.2020.03.002
   Dhama K, 2020, HUM VACC IMMUNOTHER, V16, P1232, DOI 10.1080/21645515.2020.1735227
   Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1
   Dyer O, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n883
   Esler M, 2020, J HYPERTENS, V38, P781, DOI 10.1097/HJH.0000000000002450
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Ferner RE, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1432
   Fihn SD, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9035
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Georgiev T, 2020, RHEUMATOL INT, V40, P825, DOI 10.1007/s00296-020-04570-z
   Gordon CJ, 2020, J BIOL CHEM, V295, P6785, DOI 10.1074/jbc.RA120.013679
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Guo JY, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016219
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hamming I, 2007, J PATHOL, V212, P1, DOI 10.1002/path.2162
   Hillaker E, 2020, PHARMACOTHERAPY, V40, P592, DOI 10.1002/phar.2403
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X
   Huang C, 2020, Lancet, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   JIANG JB, 1982, LANCET, V2, P285
   Kaur SP, 2020, VIRUS RES, V288, DOI 10.1016/j.virusres.2020.198114
   Kim JH, 2021, NAT MED, V27, P205, DOI 10.1038/s41591-021-01230-y
   KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571
   Ko WC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105933
   Koka V, 2008, AM J PATHOL, V172, P1174, DOI 10.2353/ajpath.2008.070762
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Lawton G, 2020, NEW SCI, V245, P9, DOI 10.1016/S0262-4079(20)30836-8
   Li YD, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00695-2
   Li ZY, 2020, DRUG DISCOV THER, V14, P73, DOI 10.5582/ddt.2020.01015
   Lim J, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e79
   Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n774
   Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n597
   Max-Planck-Gesellschaft, 2020, ART ANN TEST AG COR
   Mehra MR, 2020, LANCET, V395, P1820, DOI [10.1016/S0140-6736(20)31180-6, 10.1016/S0140-6736(20)31324-6]
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Miller A., 2020, CORRELATION UNIVERSA, DOI [10.1101/2020.03.24.20042937, 10.1101/2020.03.24.20042937., DOI 10.1101/2020.03.24.20042937]
   Mohammadi S, 2020, PHYTOTHER RES, V34, P1556, DOI 10.1002/ptr.6628
   Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623
   Schlagenhauf P, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101658
   Stebbings S, 2016, CLIN RHEUMATOL, V35, P1829, DOI 10.1007/s10067-015-3110-z
   Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9
   The World Health Organization, 2021, COVID 19 VACC
   Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200
   Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang N, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00298
   World Health Organization, 2020, ROLL UPD COR DIS COV
   World Health Organization, 2020, WHO REC AG US REMD C
   World Health Organization=, 2020, CORONAVIRUS
   World Health Organization, 2020, SARS COV 2 VAR 2020
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762
   Yang G, 2020, HYPERTENSION, V76, P51, DOI 10.1161/HYPERTENSIONAHA.120.15143
   Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237
   Ye XT, 2020, EUR REV MED PHARMACO, V24, P3390, DOI 10.26355/eurrev_202003_20706
   Zhang CX, 2020, J PROTEOME RES, V19, P1351, DOI 10.1021/acs.jproteome.0c00129
   Zhu Z, 2020, J INFECTION, V81, pE21, DOI 10.1016/j.jinf.2020.03.060
NR 75
TC 0
Z9 1
U1 2
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-0378
EI 1872-7603
J9 J REPROD IMMUNOL
JI J. Reprod. Immunol.
PD AUG
PY 2021
VL 146
AR 103344
DI 10.1016/j.jri.2021.103344
EA JUN 2021
PG 7
WC Immunology; Reproductive Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Reproductive Biology
GA TK5UR
UT WOS:000674223800004
PM 34146892
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Klos-Adamkiewicz, Z
   Gutowski, P
AF Klos-Adamkiewicz, Zuzanna
   Gutowski, Piotr
TI The Outbreak of COVID-19 Pandemic in Relation to Sense of Safety and
   Mobility Changes in Public Transport Using the Example of Warsaw
SO SUSTAINABILITY
LA English
DT Article
DE mobility; COVID-19; travel patterns; public transport; travel behaviour
ID TRAVEL BEHAVIOR; 1ST WAVE; IMPACT; PERCEPTIONS; MANAGEMENT; PATTERNS;
   LOCKDOWN; NORMS
AB Worldwide, many different actions have been taken by local and national governments to control the spread of COVID-19. The impact of these measures can be seen in different areas, especially in passenger transport and travel behaviour. This study examines the changes that have occurred in travel behaviour, using the example of the capital city of Warsaw, Poland, in relation to measures undertaken to control the spread of COVID-19 and the sense of safety among passengers that was supposed to be provided by public transport organisers. Data were collected through an online survey questionnaire that included questions about past (before COVID-19) and present (during COVID-19) travel behaviour, mode choice and the frequency of trips by public transport users in Warsaw. The results showed significant changes in mobility and travel behaviour along with most common threats seen by public transport users. There was a major shift from public to individual modes of transport in the city area. The outcomes of this study could play a significant role in transport planning in the case of any other situation that affects public transport on such a level as the COVID-19 pandemic has. In particular, local and national authorities could use this knowledge for better planning for any type of lockdowns.
C1 [Klos-Adamkiewicz, Zuzanna; Gutowski, Piotr] Univ Szczecin, Inst Management, 8 Cukrowa St, PL-71004 Szczecin, Poland.
RP Gutowski, P (corresponding author), Univ Szczecin, Inst Management, 8 Cukrowa St, PL-71004 Szczecin, Poland.
EM zuzanna.klos-adamkiewicz@usz.edu.pl; piotr.gutowski@usz.edu.pl
FU  [RID/IZ/2021/1/44]
FX The project was financed within the framework of the program of the
   Minister of Science and Higher Education under the name `Regional
   Excellence Initiative' in the years 2019-2022; project number
   RID/IZ/2021/1/44.
CR Ababio-Donkor A, 2020, RES TRANSP ECON, V83, DOI 10.1016/j.retrec.2020.100966
   Abdullah M., 2021, TRANSPORT ENG, V5, DOI [10.1016/j.treng.2021.100078, DOI 10.1016/J.TRENG.2021.100078]
   Abdullah M, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11083630
   Abdullah Muhammad, 2020, Transp Res Interdiscip Perspect, V8, P100255, DOI 10.1016/j.trip.2020.100255
   Abou-Zeid M, 2012, TRANSPORT POLICY, V24, P48, DOI 10.1016/j.tranpol.2012.07.013
   Abu-Rayash A, 2020, ENERGY RES SOC SCI, V68, DOI 10.1016/j.erss.2020.101693
   Aditjandra PT, 2013, RES TRANSP BUS MANAG, V7, P69, DOI 10.1016/j.rtbm.2013.03.008
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Allahviranloo M, 2019, TRANSPORT RES A-POL, V129, P271, DOI 10.1016/j.tra.2019.08.007
   Anke J, 2021, EUR TRANSP RES REV, V13, DOI 10.1186/s12544-021-00469-3
   Anthony DL, 2014, J HEALTH SOC BEHAV, V55, P107, DOI 10.1177/0022146514521371
   Anwari N, 2021, TRANSPORTATION RES I, V9, DOI [10.1016/j.trip.2021.100334, DOI 10.1016/J.TRIP.2021.100334]
   Arthi V, 2021, EXPLOR ECON HIST, V79, DOI 10.1016/j.eeh.2020.101381
   Askitas N., 2021, SSRN ELECT J, DOI [10.2139/ssrn.3619687, DOI 10.2139/SSRN.3619687]
   Awad-Nunez S, 2021, TRANSPORT POLICY, V106, P205, DOI 10.1016/j.tranpol.2021.04.010
   Awad-Nunez S, 2021, EUR TRANSP RES REV, V13, DOI 10.1186/s12544-021-00476-4
   Badr HS, 2020, LANCET INFECT DIS, V20, P1247, DOI 10.1016/S1473-3099(20)30553-3
   Bamberg S, 2007, J ENVIRON PSYCHOL, V27, P190, DOI 10.1016/j.jenvp.2007.04.001
   Bates J, 2001, TRANSPORT RES E-LOG, V37, P191, DOI 10.1016/S1366-5545(00)00011-9
   Beck MJ, 2020, TRANSPORT POLICY, V99, P95, DOI 10.1016/j.tranpol.2020.08.004
   Beutels P, 2009, TROP MED INT HEALTH, V14, P85, DOI 10.1111/j.1365-3156.2008.02210.x
   Bhaduri E., 2020, TRANSPORTATION RES I, V8, P100273, DOI [10.1016/j.trip.2020.100273, DOI 10.1016/J.TRIP.2020.100273]
   Bohmer MM, 2020, LANCET INFECT DIS, V20, P920, DOI 10.1016/S1473-3099(20)30314-5
   Bohman H, 2021, TRANSPORT POLICY, V106, P109, DOI 10.1016/j.tranpol.2021.03.013
   Bottom J, 1999, TRANSPORTATION AND TRAFFIC THEORY, P577
   Brashers DE, 2000, COMMUN MONOGR, V67, P63, DOI 10.1080/03637750009376495
   Briand AS, 2017, TRANSPORT RES C-EMER, V79, P274, DOI 10.1016/j.trc.2017.03.021
   Bucsky Peter, 2020, Transp Res Interdiscip Perspect, V8, P100141, DOI 10.1016/j.trip.2020.100141
   Budd Lucy, 2020, Transp Res Interdiscip Perspect, V6, P100151, DOI 10.1016/j.trip.2020.100151
   Carteni A, 2020, SCI TOTAL ENVIRON, V741, DOI 10.1016/j.scitotenv.2020.140489
   Chlond B, 2018, TRANSP RES PROC, V32, P563, DOI 10.1016/j.trpro.2018.10.022
   Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811
   Dai JC, 2021, TRANSPORT POLICY, V103, P21, DOI 10.1016/j.tranpol.2021.01.007
   Daly P., 2007, MED J, V49, P240, DOI [10.1079/9781845936259.0000, DOI 10.1079/9781845936259.0000]
   de Haas Mathijs, 2020, Transp Res Interdiscip Perspect, V6, P100150, DOI 10.1016/j.trip.2020.100150
   De Vos Jonas, 2020, Transp Res Interdiscip Perspect, V5, P100121, DOI 10.1016/j.trip.2020.100121
   Delbosc A, 2012, TRANSPORT POLICY, V24, P302, DOI 10.1016/j.tranpol.2012.09.009
   Dingil AE, 2021, TRANSP LETT, V13, P434, DOI 10.1080/19427867.2021.1901011
   Dobson R, 2020, OCCUP ENVIRON MED, V77, P798, DOI 10.1136/oemed-2020-106659
   Domanski C., 2001, METODY STATYSTYCZNE
   Dong HM, 2021, TRANSPORT POLICY, V101, P81, DOI 10.1016/j.tranpol.2020.12.004
   Donzelli G, 2020, ATMOSPHERE-BASEL, V11, DOI 10.3390/atmos11101118
   Eisenmann C, 2021, TRANSPORT POLICY, V103, P60, DOI 10.1016/j.tranpol.2021.01.012
   Fatmi MR, 2020, J URBAN MANAG, V9, P270, DOI 10.1016/j.jum.2020.08.002
   Goodwin R, 2011, INT J BEHAV MED, V18, P88, DOI 10.1007/s12529-010-9083-z
   Hadjidemetriou Georgios M, 2020, Transp Res Interdiscip Perspect, V6, P100167, DOI 10.1016/j.trip.2020.100167
   Herrera M, 2021, FUTURE INTERNET, V13, DOI 10.3390/fi13050112
   Hiselius LW, 2016, J CLEAN PROD, V123, P34, DOI 10.1016/j.jclepro.2015.08.055
   Jenelius Erik, 2020, Transp Res Interdiscip Perspect, V8, P100242, DOI 10.1016/j.trip.2020.100242
   Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032
   Klos-Adamkiewicz Z., 2017, MIEJSKI TRANSPORT ZB
   Kopsidas A, 2021, TRANSP LETT, V13, P344, DOI 10.1080/19427867.2021.1901029
   Kostelecka A., 2016, WRAZ OPRACOWANIEM MO
   Le Quere C, 2020, NAT CLIM CHANGE, V10, P647, DOI 10.1038/s41558-020-0797-x
   Liao QY, 2015, INT J BEHAV MED, V22, P672, DOI 10.1007/s12529-015-9465-3
   Liu CW, 2017, CALIF MANAGE REV, V59, P135, DOI 10.1177/0008125617707973
   Metcalfe R, 2012, J TRANSP GEOGR, V24, P503, DOI 10.1016/j.jtrangeo.2012.01.019
   Molloy J ., 2020, MOBIS COVID19 MOBILI
   Molloy J, 2021, TRANSPORT POLICY, V104, P43, DOI 10.1016/j.tranpol.2021.01.009
   MOSER MR, 1979, AM J EPIDEMIOL, V110, P1
   Politis I., 2021, TRANSP RES INTERDISC, V10, P100345, DOI [10.1016/j.trip.2021.100345, DOI 10.1016/J.TRIP.2021.100345]
   Przybylowski A, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13010364
   Riggs W., 2016, J TRANSP HEALTH, V3, pS30
   Shibayama T, 2021, EUR J TRANSP INFRAST, V21, P70, DOI 10.18757/ejtir.2021.21.1.5135
   Stradling S, 2007, TRANSPORT POLICY, V14, P283, DOI 10.1016/j.tranpol.2007.02.003
   Takami K., 2020, TRANSPORTATION RES I, P7
   Tarkowski M., 2020, PRACE KOMISJI GEOGRA, V23, P46, DOI [10.4467/2543859XPKG.20.007.12105, DOI 10.4467/2543859XPKG.20.007.12105]
   Tirachini A, 2020, J PUBLIC TRANSPORT, V22, P1, DOI 10.5038/2375-091.22.1.1
   Troko J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-16
   van der Drift S., 2021, J LOCAT BASED SERV, P1, DOI [10.1080/17489725.2021.1876259, DOI 10.1080/17489725.2021.1876259]
   WHO, EUR COR DIS COVID 19
   Wielechowski M, 2020, ECONOMIES, V8, DOI 10.3390/economies8040078
   ZTM w Warszawie, 2021, ZARZ TRANSP MIEJSK W
NR 73
TC 1
Z9 1
U1 6
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD FEB
PY 2022
VL 14
IS 3
AR 1780
DI 10.3390/su14031780
PG 22
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA ZC0JR
UT WOS:000757217700001
OA gold
DA 2022-04-20
ER

PT J
AU Solazzo, G
   Maruccia, Y
   Ndou, V
   Del Vecchio, P
AF Solazzo, Gianluca
   Maruccia, Ylenia
   Ndou, Valentina
   Del Vecchio, Pasquale
TI How to exploit Big Social Data in the Covid-19 pandemic: the case of the
   Italian tourism industry
SO SERVICE BUSINESS
LA English
DT Article; Early Access
DE Covid-19; Big Social Data; Smart Tourism Destination; Topic extraction;
   Sentiment analysis
ID CRISIS MANAGEMENT; SMART; ANALYTICS; MEDIA; KNOWLEDGE; RESILIENCE;
   FRAMEWORK; CREATION; NETWORK
AB From March 2020, restrictive measures have been taken to limit the Covid-19 pandemic, thus impacting and hugely affecting the tourism industry. In this new scenario, tourism destination managers and stakeholders need to look ahead to the future, trying to wisely react to overcome this crisis. This paper aims at demonstrating how a Smart Tourism Destination can tackle the consequences of the Covid-19 pandemic using smart and digital technologies such as Big Data and Analytics. In particular, the monitoring of Italian public debates on social media allowed discovering knowledge from unstructured data that provide valuable insights for destination stakeholders and decision-makers.
C1 [Solazzo, Gianluca; Maruccia, Ylenia; Ndou, Valentina; Del Vecchio, Pasquale] Univ Salento Bldg Aldo Romano, Dept Engn Innovat, Campus Ecotekne, Lecce, Italy.
RP Maruccia, Y (corresponding author), Univ Salento Bldg Aldo Romano, Dept Engn Innovat, Campus Ecotekne, Lecce, Italy.
EM gianluca.solazzo@unisalento.it; ylenia.maruccia@unisalento.it;
   valentina.ndou@unisalento.it; pasquale.delvecchio@unisalento.it
OI Maruccia, Ylenia/0000-0003-1975-6310
CR Abdar M, 2017, EXPERT SYST APPL, V67, P239, DOI 10.1016/j.eswa.2016.08.065
   Aldao C, 2021, TOUR REV, V76, P929, DOI 10.1108/TR-07-2020-0297
   Aldunce P, 2015, GLOBAL ENVIRON CHANG, V30, P1, DOI 10.1016/j.gloenvcha.2014.10.010
   Amore A., 2017, TOURISM RESILIENCE I
   [Anonymous], 2020, FORBES
   Antony J. K., 2019, ATNA - Journal of Tourism Studies, V14, P83, DOI 10.12727/ajts.21.5
   Ardito L, 2019, CURR ISSUES TOUR, V22, P1805, DOI 10.1080/13683500.2019.1612860
   Avis M, 2003, QUAL HEALTH RES, V13, P995, DOI 10.1177/1049732303253298
   Baccianella S, 2010, LREC 2010 - SEVENTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION
   Basile V, 2013, P 4 WORKSH COMP APPR, P100
   Bethune E., 2022, J DEST MARK MANAGE, V23
   Bosco C, 2014, 5 INT WORKSH EM SOC, P56
   Brandt T, 2017, INFORM MANAGE-AMSTER, V54, P703, DOI 10.1016/j.im.2017.01.004
   Buhalis D., 2015, INFORM COMMUNICATION, V2015, P377, DOI DOI 10.1007/978-3-319-14343-9_28
   Buhalis D., 2014, INFORM COMMUNICATION, P553
   Buhalis D, 2020, TOUR REV, V75, P267, DOI 10.1108/TR-06-2019-0258
   Buhalis D, 2015, J DESTIN MARK MANAGE, V4, P151, DOI 10.1016/j.jdmm.2015.04.001
   Bulchand-Gidumal J, 2022, J DESTIN MARK MANAGE, V23, DOI 10.1016/j.jdmm.2022.100689
   Caragliu A, 2013, SMART CITIES EUROPE
   Caragliu A, 2011, J URBAN TECHNOL, V18, P65, DOI 10.1080/10630732.2011.601117
   Carter SM, 2007, QUAL HEALTH RES, V17, P1316, DOI 10.1177/1049732307306927
   Cavlek N, 2002, ANN TOURISM RES, V29, P478, DOI 10.1016/S0160-7383(01)00067-6
   Chuang J, 2012, PROCEEDINGS OF THE INTERNATIONAL WORKING CONFERENCE ON ADVANCED VISUAL INTERFACES, P74, DOI 10.1145/2254556.2254572
   Chun J, 2020, TOURISM MANAGE, V81, DOI 10.1016/j.tourman.2020.104136
   Davenport TH, 2013, TURNING SMARTER TRAV, P17
   Del Chiappa G, 2015, J DESTIN MARK MANAGE, V4, P145, DOI 10.1016/j.jdmm.2015.02.001
   Del Vecchio P, 2018, INFORM PROCESS MANAG, V54, P847, DOI 10.1016/j.ipm.2017.10.006
   Desdemoustier J, 2019, CITIES, V92, P175, DOI 10.1016/j.cities.2019.03.021
   Duran G., 2022, HDB RES DIGITAL COMM, P203
   Faulkner B, 2001, TOURISM MANAGE, V22, P135, DOI 10.1016/S0261-5177(00)00048-0
   Femenia-Serra F, 2021, ASIA PAC J TOUR RES, V26, P365, DOI 10.1080/10941665.2018.1561478
   Femenia-Serra F, 2019, SERV IND J, V39, P109, DOI 10.1080/02642069.2018.1508458
   Filieri R, 2016, ANN TOURISM RES, V58, P46, DOI 10.1016/j.annals.2015.12.019
   Fuchs M, 2011, FOOD, AGRI-CULTURE AND TOURISM: LINKING LOCAL GASTRONOMY AND RURAL TOURISM: INTERDISCIPLINARY PERSPECTIVES, P140, DOI 10.1007/978-3-642-11361-1_10
   Garcia-Milon A, 2020, TOUR MANAG PERSPECT, V36, DOI 10.1016/j.tmp.2020.100730
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Gretzel U., 2000, Journal of Travel Research, V39, P146, DOI 10.1177/004728750003900204
   Gretzel U, 2018, MANAGING ASIAN DESTI
   Gretzel U, 2018, TOUR REV INT, V22, P263, DOI 10.3727/154427218X15369305779065
   Gretzel U, 2016, INT J TOUR CITIES, V2, P105, DOI 10.1108/IJTC-04-2016-0007
   Gretzel U, 2015, ELECTRON MARK, V25, P179, DOI 10.1007/s12525-015-0196-8
   Hajibaba H, 2017, J TRAVEL RES, V56, P1065, DOI 10.1177/0047287516677167
   Hesse-Biber SN, 2011, FOCUS GROUP INTERVIE, P163
   Hopken W., 2019, ADV METHODOLOGIES TE, P28
   Hu YH, 2017, INFORM PROCESS MANAG, V53, P436, DOI 10.1016/j.ipm.2016.12.002
   Iacus SM, 2020, SAFETY SCI, V129, DOI 10.1016/j.ssci.2020.104791
   Iorio C., 2020, QUAL QUANT, V54, P1655
   Jia ZY, 2012, PROCEDIA ENGINEER, V29, P138, DOI 10.1016/j.proeng.2011.12.683
   Jovicic DZ, 2019, CURR ISSUES TOUR, V22, P276, DOI 10.1080/13683500.2017.1313203
   Ketter E, 2021, J TRAVEL TOUR MARK, V38, P819, DOI 10.1080/10548408.2021.1921670
   Kim H, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11174660
   Kirk CP, 2020, J BUS RES, V117, P124, DOI 10.1016/j.jbusres.2020.05.028
   Kushwaha AK, 2021, INT J INF MANAGE DAT, V1, P1000
   Lalicic L, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10061852
   Li JJ, 2018, TOURISM MANAGE, V68, P301, DOI 10.1016/j.tourman.2018.03.009
   Liamputtong P, 2005, QUALITATIVE RES METH
   MacEachren AM, 2006, ENVIRON PLANN B, V33, P435, DOI 10.1068/b3188
   MacKay K, 2017, INT J CONTEMP HOSP M, V29, P669, DOI [10.1108/ijchm-10-2015-0618, 10.1108/IJCHM-10-2015-0618]
   Mair J, 2016, CURR ISSUES TOUR, V19, P1, DOI 10.1080/13683500.2014.932758
   Malizia A, 2011, J VISUAL LANG COMPUT, V22, P150, DOI 10.1016/j.jvlc.2010.12.003
   Marine-Roig E, 2015, J DESTIN MARK MANAGE, V4, P162, DOI 10.1016/j.jdmm.2015.06.004
   Maruccia Y, 2019, IFKAD 2019 INT FOR K, P92
   McKercher B, 2004, ANN TOURISM RES, V31, P716, DOI 10.1016/j.annals.2003.11.002
   Menk A, 2017, PROC INT C TOOLS ART, P788, DOI 10.1109/ICTAI.2017.00124
   Miah SJ, 2017, INFORM MANAGE-AMSTER, V54, P771, DOI 10.1016/j.im.2016.11.011
   Micera R, 2013, IFKAD 2013: 8TH INTERNATIONAL FORUM ON KNOWLEDGE ASSET DYNAMICS, P1405
   Moe TunLin, 2006, Disaster Prevention & Management, V15, P396, DOI 10.1108/09653560610669882
   Montero AA., 2021, FRONT PSYCHOL, V12
   Navigli R, 2012, ARTIF INTELL, V193, P217, DOI 10.1016/j.artint.2012.07.001
   Olshannikova Ekaterina, 2017, Journal of Big Data, V4, DOI 10.1186/s40537-017-0063-x
   de Pablos PO, 2015, ADV BUS STRATEGY COM, pXVI
   Organisation for Economic Co-operation and Development (OECD), 2020, POL RESP COR COVID 1
   Park JH, 2016, INT J INFORM MANAGE, V36, P1320, DOI 10.1016/j.ijinfomgt.2016.05.027
   Pasquinelli C, 2021, J PLACE MANAG DEV, DOI 10.1108/JPMD-07-2020-0073
   Pasquinelli C, 2020, J SUSTAIN TOUR, V28, P1805, DOI 10.1080/09669582.2020.1760871
   Pianta E., 2002, P GLOB WORDNET C
   Prayag G, 2018, TOUR MANAG PERSPECT, V25, P133, DOI 10.1016/j.tmp.2017.11.012
   Raguseo E, 2017, INFORM MANAGE-AMSTER, V54, P745, DOI 10.1016/j.im.2016.12.002
   Schroeder A, 2013, J TRAVEL TOUR MARK, V30, P126, DOI 10.1080/10548408.2013.751271
   Sievert C., 2014, P WORKSH INT LANG LE, P63, DOI [10.3115/v1/W14-3110, DOI 10.3115/V1/W14-3110]
   Sigala M, 2012, NEW DIRECT TOUR ANAL, P1
   Sigala Marianna, 2012, International Journal of Business Information Systems, V9, P415, DOI 10.1504/IJBIS.2012.046293
   Sigala M, 2020, J BUS RES, V117, P312, DOI 10.1016/j.jbusres.2020.06.015
   Sigalat-Signes E, 2020, J INNOV KNOWL, V5, P96, DOI 10.1016/j.jik.2019.06.002
   Solazzo G, 2020, IFKAD 2020 KNOWLEDGE
   Solazzo G, 2022, MEAS BUS EXCELL, V26, P122, DOI 10.1108/MBE-11-2020-0156
   Solazzo G, 2021, J KNOWL MANAG, V25, P1853, DOI 10.1108/JKM-10-2020-0801
   Steiner C, 2012, EC CRISIS INT TOURIS
   Sukowski ukasz, 2020, J INTERCULTURAL MANA, V12, P1, DOI [10.2478/joim-2020-0029, DOI 10.2478/JOIM-2020-0029]
   Sutton JN, 2008, P C INF SYST CRIS RE
   Taleb N.N., 2007, BLACK SWAN IMPACT HI, V2
   Trunfio M, 2021, EUR J TOUR RES, V29, DOI 10.54055/ejtr.v29i.2437
   Nguyen TT, 2017, PERS UBIQUIT COMPUT, V21, P267, DOI 10.1007/s00779-016-0992-y
   United Nations World Tourism Organization (UNWTO), 2020, IMP ASS COV 19 OUTBR
   UNWTO, 2020, SUPP JOBS EC TRAV TO, DOI [10.18111/9789284421633, DOI 10.18111/9789284421633]
   UNWTO, 2020, TRAV RESTR 4 WORLD T
   Vieweg S, 2008, P 5 INT ISCRAM C, P44
   Wang D, 2013, J DESTIN MARK MANAGE, V2, P59, DOI 10.1016/j.jdmm.2013.05.004
   World Economic Forum, 2020, THES NEW GADG WER DE
   Xiang Z, 2015, J TRAVEL RES, V54, P511, DOI 10.1177/0047287514522883
   Xiang Z, 2015, INT J HOSP MANAG, V44, P120, DOI 10.1016/j.ijhm.2014.10.013
   Xie G, 2021, TOURISM MANAGE, V82, DOI 10.1016/j.tourman.2020.104208
   Yu M, 2021, CURR ISSUES TOUR, V24, P2699, DOI 10.1080/13683500.2020.1752632
   Zenker S, 2020, TOURISM MANAGE, V81, DOI 10.1016/j.tourman.2020.104164
NR 104
TC 0
Z9 0
U1 5
U2 5
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1862-8516
EI 1862-8508
J9 SERV BUS
JI Serv. Bus.
DI 10.1007/s11628-022-00487-8
EA MAR 2022
PG 27
WC Business; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA ZR6US
UT WOS:000767916100001
OA Bronze
DA 2022-04-20
ER

PT J
AU Yang, L
   Lou, JM
   Zhou, JN
   Zhao, XB
   Jiang, Z
AF Yang, Lin
   Lou, Jiaming
   Zhou, Junuo
   Zhao, Xianbo
   Jiang, Zhou
TI Complex network-based research on organization collaboration and
   cooperation governance responding to COVID-19
SO ENGINEERING CONSTRUCTION AND ARCHITECTURAL MANAGEMENT
LA English
DT Article; Early Access
DE Organization collaboration; Cooperation governance; Complex network;
   COVID-19 pandemic
ID NEWS COVERAGE; HEALTH; OUTBREAK; LESSONS; SECTOR
AB Purpose - With multiple-related organizations, worldwide infections, deep economic recession and public disorder, and large consumption amount of anti-epidemic resources, the coronavirus disease 2019 (COVID-19) has been defined as a public health emergency of international concern (PHEIC). Nowadays, Wuhan has recovered from the pandemic disaster and reentered normalization. The purposes of this study are to (1) summarize organization collaboration patterns, successful experience and latent defects under across-stage evolution of Wuhan's cooperation governance mode against the pandemic, and on the basis, (2) reveal how the COVID-19 development trends and organizations' collaborative behaviors affected each other.
   Design/methodology/approach - Detailed content analysis of online news reports covering COVID-19 prevention and control measures on the website of Wuhan Municipal Government was adopted to identify organizations and their mutual collaborative interrelationships. Four complex network (CN) models of organization collaboration representing the outbreak, preliminary control, recession and normalization stages, respectively, were established then. Time-span-based dynamic parameter analyses of the proposed networks, comprising network cohesiveness analysis and node centrality analysis, were undertaken to indicate changes of global and local characteristics in networks.
   Findings - First, the definite collaborative status of Wuhan Headquarters for Pandemic Prevention and Control (WHPPC) has persisted throughout the period. Medical institutions and some other administrations were the most crucial participants collaborating with the WHPPC. Construction-industry organizations altered pandemic development trends twice to make the situation controllable. Media, large-scale enterprises, etc. set about underscoring themselves contributions since the third stage. Grassroots cadres and healthcare force, small and medium-sized enterprises (SMEs), financial institutions, etc. were essential collaborated objects. Second, four evolution mechanisms of organization collaboration responding to the COVID-19 in Wuhan has been proposed.
   Research limitations/implications - First, universality of Wuhan-style governance experience may be affected. Second, the stage-dividing process may not be the most appropriate. Then, data source was single and link characteristics were not considered when modeling.
   Practical implications - This study may offer beneficial action guidelines to governmental agencies, the society force, media, construction-industry organizations and the market in other countries or regions suffering from COVID-19. Other organizations involved could also learn from the concluded organizations' contributions and four evolution mechanisms to find improvement directions.
   Originality/value - This study adds to the current theoretical knowledge body by verifying the feasibility and effectiveness of investigating cooperation governance in public emergencies from the perspectives of analyzing the across-stage organization collaboration CNs.
C1 [Yang, Lin; Lou, Jiaming; Zhou, Junuo] Wuhan Univ, Sch Civil Engn, Wuhan, Peoples R China.
   [Zhao, Xianbo] Cent Queensland Univ, Sch Engn & Technol, Sydney, NSW, Australia.
   [Jiang, Zhou] RMIT Univ, Grad Sch Business & Law, Melbourne, Vic, Australia.
RP Zhao, XB (corresponding author), Cent Queensland Univ, Sch Engn & Technol, Sydney, NSW, Australia.
EM yang.lin@whu.edu.cn; jiaminglou@whu.edu.cn; junuozhou@whu.edu.cn;
   b.zhao@cqu.edu.au; dr.zhou.jiang@gmail.com
RI Zhao, Xianbo/H-1540-2017
OI Zhao, Xianbo/0000-0003-0153-5173; Jiang, Zhou/0000-0002-6249-2659
FU National Science Foundation of ChinaNational Natural Science Foundation
   of China (NSFC) [71702136, 71972018]
FX This research was supported by the National Science Foundation of China
   (Grant no. 71702136 and 71972018). Besides the funding, the newsmen
   reporting the pandemic situation, experts attending the focus group
   discussion, and operation and maintenance engineers on the staff of news
   websites and the CN software used in this research are greatly
   appreciated by the authors.
CR Agyekum K, 2022, J ENG DES TECHNOL, V20, P222, DOI 10.1108/JEDT-11-2020-0476
   Ahmad AR, 2020, J MED INTERNET RES, V22, DOI 10.2196/19556
   AlKhaldi M, 2020, GLOB PUBLIC HEALTH, V15, P1244, DOI 10.1080/17441692.2020.1781914
   Alsharef A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041559
   Andrew SA, 2015, LOCAL GOV STUD, V41, P673, DOI 10.1080/03003930.2015.1007131
   Ansell C, 2021, PUBLIC MANAG REV, V23, P949, DOI 10.1080/14719037.2020.1820272
   Arslan A, 2021, MULTINATL BUS REV, V29, P21, DOI 10.1108/MBR-07-2020-0153
   Assaad R, 2021, J MANAGE ENG, V37, DOI 10.1061/(ASCE)ME.1943-5479.0000906
   Bailey K, 2021, INT J MANAG REV, V23, P3, DOI 10.1111/ijmr.12237
   Bangura MS, 2020, GLOB HEALTH RES POL, V5, DOI 10.1186/s41256-020-00174-z
   Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009
   Borgatti SP, 2003, J MANAGE, V29, P991, DOI 10.1016/S0149-2063(03)00087-4
   Caballero-Anthony M, 2021, FUDAN J HUM SOC SCI, V14, P153, DOI 10.1007/s40647-020-00312-4
   Cenat JM, 2020, J LOSS TRAUMA, V25, P643, DOI 10.1080/15325024.2020.1774704
   Chakraborty C, 2020, ARCH MED RES, V51, P728, DOI 10.1016/j.arcmed.2020.05.021
   Chen LK, 2021, AUTOMAT CONSTR, V124, DOI 10.1016/j.autcon.2021.103555
   Chen SQ, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.664214
   Choi YJ, 2020, WORLD MED HEALTH POL, V12, P430, DOI 10.1002/wmh3.376
   Christensen T, 2020, PUBLIC ADMIN REV, V80, P774, DOI 10.1111/puar.13241
   Cofais C, 2020, J AM GERIATR SOC, V68, P2191, DOI 10.1111/jgs.16687
   Collins A, 2020, J RISK RES, V23, P1073, DOI 10.1080/13669877.2020.1760332
   Curtis CA, 2018, J CONTING CRISIS MAN, V26, P202, DOI 10.1111/1468-5973.12138
   Fan HM, 2018, WIRELESS PERS COMMUN, V102, P951, DOI 10.1007/s11277-017-5118-y
   Farias DBL, 2015, CANADIAN FOREIGN POL, V21, P1, DOI 10.1080/11926422.2013.845583
   Fiorillo A, 2020, EUR PSYCHIAT, V63, DOI 10.1192/j.eurpsy.2020.89
   Gong FH, 2020, FRONT MED-PRC, V14, P220, DOI 10.1007/s11684-020-0755-z
   Gu EW, 2020, J CHIN GOV, V5, P160, DOI 10.1080/23812346.2020.1740468
   Hansen MT, 2005, ACAD MANAGE J, V48, P776
   Haryanto, 2021, CONTEMP SE ASIA, V43, P45
   He AJ, 2020, POLICY DES PRACT, V3, P242, DOI 10.1080/25741292.2020.1799911
   Hu HZ, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/181038
   Hu X, 2019, INT J STRATEG PROP M, V23, P108, DOI 10.3846/ijspm.2019.7436
   Huang K, 2021, INVEST ECON-MEX, V80, P32, DOI 10.22201/fe.01851667p.2021.316.78667
   Huang L, 2013, DISCRETE DYN NAT SOC, V2013, DOI 10.1155/2013/303187
   Le HT, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.589437
   Nguyen HV, 2020, INT J HEALTH PLAN M, V35, P988, DOI 10.1002/hpm.3004
   Criado JI, 2021, TRANSFORM GOV-PEOPLE, V15, P612, DOI 10.1108/TG-08-2020-0242
   Imran M, 2015, ACM COMPUT SURV, V47, DOI 10.1145/2771588
   Ingirige B, 2016, CONSTR MANAG ECON, V34, P592, DOI 10.1080/01446193.2016.1200735
   Janssen M, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102180
   Javed S, 2020, HEALTH PROMOT PERSPE, V10, P300, DOI 10.34172/hpp.2020.48
   Jennings W, 2021, J EUR PUBLIC POLICY, V28, P1174, DOI 10.1080/13501763.2021.1942151
   Joyce P, 2021, INT REV ADM SCI, V87, P536, DOI 10.1177/0020852320983406
   Kaim A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18189555
   Kim K, 2018, ASIA-PAC J PUBLIC HE, V30, P207, DOI 10.1177/1010539518762847
   Koutoupis A, 2021, CORP GOV-INT J BUS S, V21, P969, DOI 10.1108/CG-10-2020-0447
   Kuhlmann S, 2021, INT REV ADM SCI, V87, P556, DOI 10.1177/0020852320979359
   Legler T, 2021, FORO INT, V61, P333, DOI 10.24201/fi.v61i2.2833
   Lele G, 2021, REG FED STUD, DOI 10.1080/13597566.2021.1960513
   Li Z, 2021, ENG CONSTR ARCHIT MA, V28, P2884, DOI 10.1108/ECAM-03-2020-0195
   Lian JKM, 2018, ENG CONSTR ARCHIT MA, V25, P77, DOI 10.1108/ECAM-09-2015-0133
   Lin XY, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.566499
   Liu C, 2022, J MANAGE ENG, V38, DOI 10.1061/(ASCE)ME.1943-5479.0001006
   Liu J, 2020, NAT HAZARDS, V104, P2687, DOI 10.1007/s11069-020-04379-w
   Malik MW, 2021, ACTA TROP, V219, DOI 10.1016/j.actatropica.2021.105910
   Mao YX, 2020, CHIN PUB ADM REV-US, V11, P132
   Miyawaki R, 2017, HEALTH COMMUN, V32, P420, DOI 10.1080/10410236.2016.1138391
   Moon MJ, 2020, PUBLIC ADMIN REV, V80, P651, DOI 10.1111/puar.13214
   Nam K, 2019, DECIS SUPPORT SYST, V117, P100, DOI 10.1016/j.dss.2018.11.004
   Nawaz A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.573431
   Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480
   Ning Y, 2020, GLOB HEALTH RES POL, V5, DOI 10.1186/s41256-020-00161-4
   Oyenuga A, 2021, WMU J MARIT AFF, V20, P215, DOI 10.1007/s13437-021-00233-3
   Ozdemir V, 2020, OMICS, V24, P645, DOI 10.1089/omi.2020.0169
   Park J, 2021, WORLD DEV, V137, DOI 10.1016/j.worlddev.2020.105198
   Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6
   Raj-Reichert G, 2013, GEOFORUM, V44, P23, DOI 10.1016/j.geoforum.2012.05.007
   Rehman MSU, 2021, J ENG DES TECHNOL, DOI 10.1108/JEDT-12-2020-0481
   Robins G, 2011, PUBLIC ADMIN, V89, P1293, DOI 10.1111/j.1467-9299.2010.01884.x
   Sadiq AA, 2020, AM REV PUBLIC ADM, V50, P635, DOI 10.1177/0275074020942060
   Sahoo BP, 2021, INT J SOCIOL SOC POL, V41, P1170, DOI 10.1108/IJSSP-01-2021-0012
   Sharma A, 2021, J BUS RES, V122, P597, DOI 10.1016/j.jbusres.2020.09.011
   Solis F, 2013, J CONSTR ENG M, V139, P379, DOI 10.1061/(ASCE)CO.1943-7862.0000589
   Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725
   Su JL, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.648276
   Sun YL, 2021, INT J DISAST RISK SC, V12, P593, DOI 10.1007/s13753-021-00364-4
   Tang P, 2017, J CLEAN PROD, V162, P1551, DOI 10.1016/j.jclepro.2017.06.144
   Tuech JJ, 2020, BRIT J SURG, V107, pE189, DOI 10.1002/bjs.11639
   Verbeke A, 2020, BRIT J MANAGE, V31, P444, DOI 10.1111/1467-8551.12422
   Vervoort D., 2021, INT J QUAL HEALTH C, V33
   Wang K, 2021, ENG CONSTR ARCHIT MA, DOI 10.1108/ECAM-10-2020-0835
   Wang WS, 2021, J MANAGE ENG, V37, DOI 10.1061/(ASCE)ME.1943-5479.0000922
   White S, 2005, J MANAGE STUD, V42, P1383, DOI 10.1111/j.1467-6486.2005.00548.x
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   Wolf-Fordham S, 2020, AM REV PUBLIC ADM, V50, P560, DOI 10.1177/0275074020943706
   Xin X, 2021, CURR MED SCI, V41, P77, DOI 10.1007/s11596-021-2321-6
   Yan JJ, 2020, RISK MANAG HEALTHC P, V13, P723, DOI 10.2147/RMHP.S251389
   Yang B, 2021, CHINA NONPROFIT REV, V12, P233, DOI 10.1163/18765149-12341378
   Yang KF, 2020, PUBLIC ADMIN REV, V80, P657, DOI 10.1111/puar.13248
   Yates D, 2011, INT J INFORM MANAGE, V31, P6, DOI 10.1016/j.ijinfomgt.2010.10.001
   Yin J, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P4234
   Zafri NM, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06544
   Zhao T, 2020, AM REV PUBLIC ADM, V50, P777, DOI 10.1177/0275074020942455
   Zheng LZ, 2021, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.599769
   Zhou SH, 2020, J MANAGE ENG, V36, DOI 10.1061/(ASCE)ME.1943-5479.0000821
   Zhu TK, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13137089
NR 96
TC 0
Z9 0
U1 14
U2 14
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0969-9988
EI 1365-232X
J9 ENG CONSTR ARCHIT MA
JI Eng. Constr. Archit. Manag.
DI 10.1108/ECAM-08-2021-0731
EA FEB 2022
PG 31
WC Engineering, Industrial; Engineering, Civil; Management
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Engineering; Business & Economics
GA YW1IS
UT WOS:000753174600001
DA 2022-04-20
ER

PT J
AU Bolisani, E
   Scarso, E
   Ipsen, C
   Kirchner, K
   Hansen, JP
AF Bolisani, Ettore
   Scarso, Enrico
   Ipsen, Christine
   Kirchner, Kathrin
   Hansen, John Paulin
TI Working from home during COVID-19 pandemic: lessons learned and issues
SO MANAGEMENT & MARKETING-CHALLENGES FOR THE KNOWLEDGE SOCIETY
LA English
DT Article
DE COVID-19; working from home; communication tools; smart working;
   knowledge workers
ID TELEWORK
AB During the COVID pandemic, many companies, schools, and public organizations all around the world asked their employees to work from home i.e. to adopt what are called "smart working" modalities. This has and will presumably have a serious impact on both employees and employers, which still needs to be clarified and investigated: indeed, if smart working becomes a common working modality, this may have a significant impact on both organizations and employees. This paper reports the results of an online survey of "smart workers" in Italy during the COVID pandemic, when a great number of employees suddenly moved to working from home with no or little preparation. The study offers interesting indications about the involvement and usefulness perception of smart working by the sampled people and makes it possible to single out different categories of employees based on their attitude towards this modality. Also, it points out the potential impact on socialization among colleagues, and the consequent implications for knowledge sharing and knowledge management. From the collected responses, a fully positive or negative conclusion about working from home was not possible, nor a clear indication about the efficiency and effectiveness of this working modality. The analysis, instead, highlighted the presence of different but numerically similar groups of people, i.e. those who were not satisfied at all with the experience, those who were very satisfied, and those who were "undecided". Furthermore, respondents underlined the importance and the difficulty to maintain working contacts and the intense use of communication systems made for this purpose. Lastly, collected opinions on positive and negative aspects of working from home provided some practical suggestions about how to successfully implement this solution.
C1 [Bolisani, Ettore; Scarso, Enrico] Univ Padua, Vicenza, Italy.
   [Ipsen, Christine; Kirchner, Kathrin; Hansen, John Paulin] Tech Univ Denmark, Lyngby, Denmark.
RP Bolisani, E (corresponding author), Univ Padua, Vicenza, Italy.
EM ettore.bolisani@unipd.it
RI Kirchner, Kathrin/C-4984-2016; Ipsen, Christine/A-8583-2017
OI Kirchner, Kathrin/0000-0002-4638-0403; Ipsen,
   Christine/0000-0002-2394-5571; Hansen, John Paulin/0000-0001-5594-3645
CR Alizadeh T, 2013, AUST PLAN, V50, P304, DOI 10.1080/07293682.2013.764906
   Belanger F, 2008, INFORM SYST J, V18, P101, DOI 10.1111/j.1365-2575.2007.00252.x
   Bratianu C, 2020, KYBERNETES, V49, P6, DOI 10.1108/K-02-2019-0122
   Bratianu C, 2019, SYSTEMS-BASEL, V7, DOI 10.3390/systems7020020
   Brynjolfsson E., 2020, W27344 NAT BUR EC RE
   Dalkir K., 2008, BUILDING KNOWLEDGE S, P89
   Dockery A.M., 2014, AUSTR J LABOUR EC, V17, P163
   Everitt B. S., 2011, CLUSTER ANAL
   Fogarty H, 2011, NEW TECH WORK EMPLOY, V26, P183, DOI 10.1111/j.1468-005X.2011.00268.x
   Fragouli E., 2019, INT J INFORM BUSINES, V11, P74
   Gottlieb C., 2020, COVID EC, V8, P71
   Govindaraju M, 2005, INT FED INFO PROC, V185, P349
   Hassan G.A.S., 2016, RES REPORT
   Ipsen C., 2020, RES REPORT
   Kang Yong-Sik, 2016, Journal of Information Technology Applications & Management, V23, P61, DOI 10.21219/jitam.2016.23.1.061
   Kaufman L., 2009, FINDING GROUPS DATA, V344
   Kim Y. Y., 2017, INT INFORM I TOKYO I, V20, P699
   Kim YY, 2015, P ANN HICSS, P1038, DOI 10.1109/HICSS.2015.128
   Lange V., 2020, J MEDITERR KNOWL JMK, V5, P163
   Malik A, 2016, INT J MANPOWER, V37, P1042, DOI 10.1108/IJM-12-2015-0225
   Mallia K. L., 2000, ELECT J COMMUNICATIO, V10
   NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14
   Park Ki-Ho, 2018, Journal of Information Technology Applications & Management, V25, P23, DOI 10.21219/jitam.2018.25.4.023
   Park Ki-Ho, 2013, [Journal of Digital Convergence, 디지털융복합연구], V11, P197
   Richardson H., 2006, INFORM TECHNOLOGY PE
   Senatori, 2017, WELL BEING WORK, P231
   Sing K., 2007, QUANTITATIVE SOCIAL
   Troup C, 2012, COMMIMITY WORK FAM, V15, P471, DOI 10.1080/13668803.2012.724220
   van der Lippe T, 2020, NEW TECH WORK EMPLOY, V35, P60, DOI 10.1111/ntwe.12153
NR 29
TC 23
Z9 23
U1 37
U2 76
PU SCIENDO
PI WARSAW
PA BOGUMILA ZUGA 32A, WARSAW, MAZOVIA, POLAND
SN 1842-0206
EI 2069-8887
J9 MANAG MARK
JI Manag. Mark.
PD OCT
PY 2020
VL 15
SU 1
BP 458
EP 476
DI 10.2478/mmcks-2020-0027
PG 19
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA OH5NR
UT WOS:000582631600004
OA gold, Green Submitted
DA 2022-04-20
ER

PT J
AU Chan, EYY
   Dubois, C
   Fong, AHY
   Shaw, R
   Chatterjee, R
   Dabral, A
   Loyzaga, A
   Kim, YK
   Hung, KKC
   Wong, CS
AF Chan, Emily Ying Yang
   Dubois, Caroline
   Fong, Ada Ho Yin
   Shaw, Rajib
   Chatterjee, Ranit
   Dabral, Ambika
   Loyzaga, Antonia
   Kim, Yong-kyun
   Hung, Kevin Kei Ching
   Wong, Chi Shing
TI Reflection of Challenges and Opportunities within the COVID-19 Pandemic
   to Include Biological Hazards into DRR Planning
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Editorial Material
DE health-EDRM; disaster risk reduction; biological hazards; Sendai
   Framework; COVID-19 pandemic
AB COVID-19 has reinforced the need to revisit the integration of health within disaster risk reduction (DRR) strategies for biological hazards in a system-wide approach. In November 2020, DRR experts attended the Asia-Pacific Partnership for Disaster Risk Reduction (APP-DRR) Forum to share progress and learnings in the areas of health system resilience, data management, residual risk management, risk communication, digital literacy, and knowledge product marketing. Advancements for health in DRR included the importance of multi-sectoral, multi-hazard action plans; adaptation to technological advancements in data collection, dissemination and protection; promoting the health and wellbeing of essential and nonprofessional workers; and improving inclusivity in digital literacy. COVID-19 has affected progress towards the Sustainable Development Goals (SDG) and created a unique opportunity within DRR to re-evaluate the adequacy of response mechanisms against concurrent, cascading or interacting risks of future biological hazards. Health emergency disaster risk management (Health-EDRM) is a new World Health Organization paradigm that includes DRR at intra-, inter- and multidisciplinary levels. Scientific advancement under Health-EDRM is necessary for health and non-health actors in DRR education and research. Continuous education on the multifaceted risk governance is a key to building awareness, capacity and accelerating towards achieving the international DRR and the SDG targets.
C1 [Chan, Emily Ying Yang; Hung, Kevin Kei Ching; Wong, Chi Shing] Univ Oxford, Collaborating Ctr, Hong Kong, Peoples R China.
   [Chan, Emily Ying Yang; Hung, Kevin Kei Ching; Wong, Chi Shing] Chinese Univ Hong Kong, CUHK Disaster & Med Humanitarian Response CCOUC, Hong Kong, Peoples R China.
   [Chan, Emily Ying Yang] Univ Oxford, Nuffield Dept Med, Oxford OX3 7BN, England.
   [Chan, Emily Ying Yang; Dubois, Caroline; Hung, Kevin Kei Ching; Wong, Chi Shing] Chinese Univ Hong Kong, Fac Med, JC Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China.
   [Chan, Emily Ying Yang; Dubois, Caroline; Fong, Ada Ho Yin] GX Fdn, Hong Kong, Peoples R China.
   [Chan, Emily Ying Yang; Hung, Kevin Kei Ching] Chinese Univ Hong Kong, Prince Wales Hosp, Accid & Emergency Med Acad Unit, Hong Kong, Peoples R China.
   [Shaw, Rajib] Keio Univ, Grad Sch Media & Governance, Fujisawa, Kanagawa 2520882, Japan.
   [Shaw, Rajib; Chatterjee, Ranit; Dabral, Ambika] Resilience Innovat Knowledge Acad RIKA, New Delhi 110059, India.
   [Chatterjee, Ranit] Kyoto Univ, Grad Sch Informat, Kyoto 6068501, Japan.
   [Loyzaga, Antonia] Natl Resilience Council, Pasay City 1300, Philippines.
   [Kim, Yong-kyun] Minist Interior & Safety, Sejong 30128, South Korea.
RP Chan, EYY (corresponding author), Univ Oxford, Collaborating Ctr, Hong Kong, Peoples R China.; Chan, EYY (corresponding author), Chinese Univ Hong Kong, CUHK Disaster & Med Humanitarian Response CCOUC, Hong Kong, Peoples R China.; Chan, EYY (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford OX3 7BN, England.; Chan, EYY (corresponding author), Chinese Univ Hong Kong, Fac Med, JC Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China.; Chan, EYY (corresponding author), GX Fdn, Hong Kong, Peoples R China.; Chan, EYY (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Accid & Emergency Med Acad Unit, Hong Kong, Peoples R China.
EM emily.chan@cuhk.edu.hk; caroline.dubois@gxfoundation.hk;
   fong.adahy@gmail.com; shaw@sfc.keio.ac.jp; ranit@rikaindia.com;
   ambika@rikaindia.com; aloyzaga@observatory.ph; unkim68@gmail.com;
   kevin.hung@cuhk.edu.hk; cswong@cuhk.edu.hk
RI Hung, Kevin KC/H-8327-2016; Kim, Yong Kyun/E-6084-2017; Dabral,
   Ambika/AAU-4156-2021
OI Hung, Kevin KC/0000-0001-8706-7758; Kim, Yong Kyun/0000-0002-3633-7065;
   Dabral, Ambika/0000-0003-4228-6038; Shaw, Rajib/0000-0003-3153-1800;
   chatterjee, Ranit/0000-0003-2947-9417; Chan, Emily Ying
   Yang/0000-0002-8854-5093; Dubois, Caroline/0000-0002-8810-4159
CR [Anonymous], 2020, LANCET, V395, P1587, DOI 10.1016/S0140-6736(20)31200-9
   Centers for Disease Control and Prevention, OP SCH COVID 19 CDCS
   Chan E.Y.Y, 2020, HLTH DISASTERS HLTH
   Chan EYY, 2020, LANCET, V395, P1957, DOI 10.1016/S0140-6736(20)31254-X
   Dabral A., 2020, INTEGRATING BI UNPUB
   Davido B, 2020, CLIN MICROBIOL INFEC, V26, P1448, DOI 10.1016/j.cmi.2020.07.028
   Ebrahim SH, 2020, LANCET PLANET HEALTH, V4, pE379, DOI 10.1016/S2542-5196(20)30175-3
   Findlay M.J, 2020, SSRN ELECT J, P1, DOI [10.2139/ssrn.3607706, DOI 10.2139/SSRN.3607706]
   Gallagher MW, 2020, COGNITIVE THER RES, V44, P1043, DOI 10.1007/s10608-020-10143-y
   Government of Hong Kong, NEW REQ RED GATH
   Government of Hong Kong, POINTS NOT QUAR INB
   Government of Japan, NAT ACT PLAN PAND IN
   Ika LA, 2020, INT J PROJ MANAG, V38, P548, DOI 10.1016/j.ijproman.2020.10.005
   International Labour Organization, 2020, POL FRAM TACKL EC SO
   Jurzyk E, 2020, COVID 19 INEQUALITY
   Karlsson U, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3944
   Lucero-Prisno DE, 2020, LANCET REG HEALTH-W, V1, DOI 10.1016/j.lanwpc.2020.100003
   McCaffery KJ, 2020, PUBLIC HEALTH RES PR, V30, DOI 10.17061/phrp30342012
   McNicholas C, WHO ARE ESSENTIAL WO
   Munene MB, 2018, INT J DISAST RISK RE, V28, P653, DOI 10.1016/j.ijdrr.2018.01.021
   Okan O, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155503
   Public Health England, COR COVID 19 SAF TRA
   Public Health England, GUID SHIELD PROT PEO
   Singapore Ministry of Health, PAND READ RESP PLAN
   Singapore Ministry of Health, UPD BORD MEAS COMM S
   Singer M, 2017, LANCET, V389, P941, DOI 10.1016/S0140-6736(17)30003-X
   Sorensen K, 2015, EUR J PUBLIC HEALTH, V25, P1053, DOI 10.1093/eurpub/ckv043
   United Nations, 2020, UN RES ROADM COVID 1
   United Nations, 2016, GEN ASS REP OP END I
   United Nations International Strategy for Disaster Reduction, 2015, SEND FRAM DIS RISK R
   United Nations International Strategy for Disaster Reduction, 2005, HYOGO FRAMEWORK ACTI
   United Nations International Strategy for Disaster Reduction, 2017, CROSS SECT MULT RISK
   United Nations Office for Disaster Risk Reduction, AS PAC PARTN DIS RIS
   Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   WHO, 2019, HLTH EM DIS RISK MAN
   Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239
   World Health Organisation, 2015, ETH EP EM DIS RES SU
   World Health Organization, DIGITAL TECHNOLOGY C
   World Health Organization, 2020, MASK US CONT COVID 1
   Yonally E, 2020, RCCE STRATEGIES OVER
NR 41
TC 1
Z9 1
U1 13
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD FEB
PY 2021
VL 18
IS 4
AR 1614
DI 10.3390/ijerph18041614
PG 11
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA QP1KQ
UT WOS:000623595800001
PM 33567697
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Jones, BA
   Slater, BJ
AF Jones, Brian A.
   Slater, Bethany J.
TI Non-operative management of acute appendicitis in a pediatric patient
   with concomitant COVID-19 infection
SO JOURNAL OF PEDIATRIC SURGERY CASE REPORTS
LA English
DT Article
DE Appendicitis; COVID19; Nonoperative; Pediatric
AB Introduction: In late December 2019, reports emerged from Wuhan, China of a novel corovonavirus SARS-CoV-2, which caused severe acute respiratory distress syndrome referred to as COVID-19. As the virus spread, reports of severe perioperative complications, including fatalities, began to emerge in the literature. We present a case of a previously healthy patient who developed classic symptoms of appendicitis. The patient was also found to be positive for COVID-19. Given the risks to both the patient and surgical team, we elected to pursue a non-operative management strategy for this patient with appendicitis.
   Materials and methods: A 13 year old female with COVID-19 presented with a day of right lower quadrant abdominal pain. A computerized tomography (CT) scan diagnosed uncomplicated appendicitis. The patient was successfully treated non-operatively with antibiotics and discharged home.
   Conclusion: To our knowledge, this case illustrates the first report of a pediatric patient with concomitant appendicitis and COVID-19 infection. We have been able to utilize a non-operative management strategy to effectively treat the patient's acute appendicitis, while protecting her from the risks of undergoing a general anesthetic as well as the operative team. We hope this report can provide others with a potential management strategy for similar patients.
C1 [Jones, Brian A.; Slater, Bethany J.] Univ Chicago Med, Chicago, IL USA.
RP Slater, BJ (corresponding author), 5841 S Maryland Ave, Chicago, IL USA.
EM bjslater1@gmail.com
CR Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Minneci PC, 2016, JAMA SURG, V151, P408, DOI 10.1001/jamasurg.2015.4534
   Sperlich B, 2020, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01520
   Svensson JF, 2015, ANN SURG, V261, P67, DOI 10.1097/SLA.0000000000000835
   Tanaka Y, 2015, J PEDIATR SURG, V50, P1893, DOI 10.1016/j.jpedsurg.2015.07.008
   Varadhan KK, 2010, WORLD J SURG, V34, P199, DOI 10.1007/s00268-009-0343-5
   Wilms IMHA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008359.pub2
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
NR 8
TC 10
Z9 10
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2213-5766
J9 J PEDIAT SURG CASE R
JI J. Pediatr. Surg. Case Rep.
PD AUG
PY 2020
VL 59
AR 101512
DI 10.1016/j.epsc.2020.101512
PG 2
WC Pediatrics
WE Emerging Sources Citation Index (ESCI)
SC Pediatrics
GA MJ1TO
UT WOS:000547876700004
PM 32542177
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Agbontaen, KO
   Somasundram, K
   Baker, M
AF Agbontaen, Kaladerhan Osemwengie
   Somasundram, Khevan
   Baker, Matthew
TI Critical COVID-19 in a 24-week pregnant woman with 32 days of invasive
   mechanical ventilation before delivery of fetus: a case of successful
   collaborative multidisciplinary care
SO BMJ CASE REPORTS
LA English
DT Article
DE COVID-19; pregnancy; adult intensive care; mechanical ventilation;
   infectious diseases
ID INFECTIONS
AB We describe the successful treatment of a 24-week pregnant, 44-year-old woman with COVID-19. Management of this complex case required multidisciplinary collaboration and included prolonged invasive mechanical ventilation and prone positioning. Caesarean section delivery was delayed for 32 days, with no monitored fetal compromise, while stabilising the mother. To our knowledge, this is the longest reported duration of invasive ventilation while pregnant in a patient with COVID-19. COVID-19 has been shown to cause increased disease severity in pregnant women, and certain pregnancy-related physiological adaptations that occur could help explain this association. While COVID-19 has been shown to cause no increased adverse neonatal outcomes, clinicians should be aware that data show increased preterm birth in symptomatic pregnant women, thereby increasing the chance of prematurity-related complications. Further research on COVID-19 in pregnancy is crucial to facilitate better management, and full inclusion of pregnant women in therapeutic clinical trials will help achieve this.
C1 [Agbontaen, Kaladerhan Osemwengie; Somasundram, Khevan; Baker, Matthew] Chelsea & Westminster Hosp NHS Fdn Trust, Intens Care Med, London, England.
RP Agbontaen, KO (corresponding author), Chelsea & Westminster Hosp NHS Fdn Trust, Intens Care Med, London, England.
EM kaladerhan.agbontaen@nhs.net
OI Agbontaen, Kaladerhan/0000-0002-5571-230X
CR Allen EK, 2013, INT FORUM ALLERGY RH, V3, P731, DOI 10.1002/alr.21191
   Allotey J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3320
   Amarsy R, 2020, MED MALADIES INFECT, V50, P750, DOI 10.1016/j.medmal.2020.05.004
   Badr DA, 2020, AM J OBSTET GYNECOL, V223, P764, DOI 10.1016/j.ajog.2020.07.045
   Chen MM, 2020, EUR J OBSTET GYN R B, V255, P124, DOI 10.1016/j.ejogrb.2020.10.035
   Coronavirus (COVID-19) Infection in Pregnancy, 2021, ROYAL COLL OBST GYN
   Guidance For: Prone Positioning in Adult Critical Care, 2019, INTENSIVE CARE SOC F
   Hall OJ, 2017, MUCOSAL IMMUNOL, V10, P1097, DOI 10.1038/mi.2017.35
   Jacobson Jennifer, 2021, Case Rep Womens Health, V29, pe00273, DOI 10.1016/j.crwh.2020.e00273
   Mahlen SD, 2011, CLIN MICROBIOL REV, V24, P755, DOI 10.1128/CMR.00017-11
   Martinez-Portilla RJ, 2021, ULTRASOUND OBST GYN, V57, P224, DOI 10.1002/uog.23575
   Masi AC, 2019, EARLY HUM DEV, V138, DOI 10.1016/j.earlhumdev.2019.104854
   Silverman MA, 2017, GASTROENTEROL CLIN N, V46, P61, DOI 10.1016/j.gtc.2016.09.010
   Tolcher MC, 2020, OBSTET GYNECOL, V136, P259, DOI 10.1097/AOG.0000000000004012
   Trikha A., 2018, J OBSTET ANAESTH CRI, V8, P7
   Vousden N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251123
   Wastnedge EAN, 2021, PHYSIOL REV, V101, P303, DOI 10.1152/physrev.00024.2020
   Whitehead CL, 2020, LANCET, V395, pE92, DOI 10.1016/S0140-6736(20)31029-1
   Zambrano LD, 2020, MMWR-MORBID MORTAL W, V69, P1641, DOI 10.15585/mmwr.mm6944e3
NR 19
TC 0
Z9 0
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
EI 1757-790X
J9 BMJ CASE REP
JI BMJ Case Rep.
PD SEP
PY 2021
VL 14
IS 9
AR e243516
DI 10.1136/bcr-2021-243516
PG 6
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA UU3TF
UT WOS:000698721500022
PM 34497055
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Alcocer-Diaz-Barreiro, L
   Cossio-Aranda, J
   Verdejo-Paris, J
   Odin-de-los-Rios, M
   Galvan-Oseguera, H
   Alvarez-Lopez, H
   Alcocer-Gamba, MA
AF Alcocer-Diaz-Barreiro, Luis
   Cossio-Aranda, Jorge
   Verdejo-Paris, Juan
   Odin-de-los-Rios, Manuel
   Galvan-Oseguera, Hector
   Alvarez-Lopez, Humberto
   Alcocer-Gamba, Marco A.
TI COVID-19 and the renin, angiotensin, aldosterone system. A complex
   relationship
SO ARCHIVOS DE CARDIOLOGIA DE MEXICO
LA Spanish
DT Article
DE COVID-19; Renin-angiotensin-aldosterone system; Angiotensin conversion
   enzyme type 2; Coronavirus SARS- CoV-2 2019
AB The COVID-19 pandemic has had major negative health, psychological, social and economic repercussions for individuals, families, communities, countries and for humanity in general. The interrelation with age and the presence of chronic non-communicable diseases (hypertension, diabetes, obesity, smoking) seems to go further than what would be explained by the prevalence and distribution of both. The drugs that act on the renin-angiotensin-aldosterone system are in many cases the backbone for the management of these diseases, it has been known for a long time that these drugs significantly increase the expression of receptors for angiotensin conversion enzyme type 2 in the lung tissue. This fact, together with the knowledge that the route of entry of the virus into the cell is precisely the ACE-2 receptor, initiated a hypothesis, based on very low-quality evidence, which quickly became generalized in the media, that the use of these drugs could be negative and that they should be interrupted immediately. The response of practically all Scientific Societies was almost immediate, with the precise indication that treatment with these drugs should not be discontinued, since the evidence of their usefulness is based on very solid and high-quality evidence. Simultaneously, a different hypothesis also appeared, also based on very preliminary evidence, that these drugs are not only harmful but also beneficial, however these medicaments are not yet accepted as agents for the prevention or treatment of this disease or its complications. This review reports current knowledge on the relationship between COVID-19 and SRAA.
C1 [Alcocer-Diaz-Barreiro, Luis; Alcocer-Gamba, Marco A.] Interamer Soc Hypertens, Inst Mexicano Salud Cardiovasc, Ciudad De Mexico, Mexico.
   [Alcocer-Diaz-Barreiro, Luis; Cossio-Aranda, Jorge; Verdejo-Paris, Juan; Odin-de-los-Rios, Manuel] Soc Mexicana Cardiol, Ciudad De Mexico, Mexico.
   [Cossio-Aranda, Jorge; Verdejo-Paris, Juan] Inst Nacl Carciol Ignacio Chavez, Ciudad De Mexico, Mexico.
   [Alcocer-Diaz-Barreiro, Luis; Galvan-Oseguera, Hector] GREHTA Mexico, Grp Expertos Hipertens Arterial, Ciudad De Mexico, Mexico.
   [Galvan-Oseguera, Hector] Inst Mexican Seguro Social, Ctr Med Nacl Siglo XXI, Hosp Cardiol, Ciudad De Mexico, Mexico.
   [Alvarez-Lopez, Humberto] Ctr Med Puerta de Hierro Andares Zapopan, Guadalajara, Jalisco, Mexico.
RP Alcocer-Diaz-Barreiro, L (corresponding author), Interamer Soc Hypertens, Inst Mexicano Salud Cardiovasc, Ciudad De Mexico, Mexico.; Alcocer-Diaz-Barreiro, L (corresponding author), Soc Mexicana Cardiol, Ciudad De Mexico, Mexico.; Alcocer-Diaz-Barreiro, L (corresponding author), GREHTA Mexico, Grp Expertos Hipertens Arterial, Ciudad De Mexico, Mexico.
EM alcocerdb@gmail.com
CR Battistoni A, 2020, EUR HEART J-CARD PHA, V6, P248, DOI 10.1093/ehjcvp/pvaa030
   Chappell MC, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2013.00201
   Esler M, 2020, J HYPERTENS, V38, P781, DOI 10.1097/HJH.0000000000002450
   Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461
   Gutierrez F, 2006, J INFECTION, V53, P166, DOI 10.1016/j.jinf.2005.11.006
   Karram T, 2005, AM J PHYSIOL-HEART C, V289, pH1351, DOI 10.1152/ajpheart.01186.2004
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Meng J, 2020, EMERG MICROBES INFEC, V9, P757, DOI 10.1080/22221751.2020.1746200
   Sparks M.A., CORONAVIRUS CONUNDRU
   Sun M L, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE014, DOI [10.3760/cma.j.issn.1001-0939.2020.03.016, 10.3760/cma.j.issn.1001-0939.2020.0014]
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 13
TC 2
Z9 2
U1 0
U2 0
PU INST NACIONAL CARDIOLOGIA IGNACIO CHAVEZ
PI MEXICO CITY
PA DEPT PUBLICACIONES, JUAN BADIANO NO 1, COL. SECCION XVI, DELEGACION
   TLALPAN, MEXICO CITY, D F 00000, MEXICO
SN 1405-9940
J9 ARCH CARDIOL MEX
JI Arch. Cardiol. Mex.
PD MAY
PY 2020
VL 90
SU 1
BP 19
EP 25
DI 10.24875/ACM.M20000063
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
WE Emerging Sources Citation Index (ESCI)
SC Cardiovascular System & Cardiology
GA UQ5CO
UT WOS:000696081600004
PM 32523145
OA gold
DA 2022-04-20
ER

PT J
AU Ahmady, S
   Kallestrup, P
   Sadoughi, MM
   Katibeh, M
   Kalantarion, M
   Amini, M
   Khajeali, N
AF Ahmady, Soleiman
   Kallestrup, Per
   Sadoughi, Mohammad Mehdi
   Katibeh, Marzieh
   Kalantarion, Masomeh
   Amini, Mitra
   Khajeali, Nasrin
TI Distance learning strategies in medical education during COVID-19: A
   systematic review
SO JOURNAL OF EDUCATION AND HEALTH PROMOTION
LA English
DT Review
DE COVID-19; distance education; educational technology; handheld
   computers; medical students; simulation training
ID TRAINING-PROGRAM; ONLINE; GUIDE; SIMULATION; MULTIMEDIA; CURRICULUM;
   STUDENTS; OUTCOMES; IMPACT; SKILLS
AB The current outbreak of coronavirus disease 2019 (COVID-19) across the world forced universities to suspend learning to limit the spread of the virus. Many medical schools have shifted to online education as an information delivery mechanism where the educator and learner are separated in space and potentially also in time. This systematic review aims to explore and understand the variety of distance learning strategies in medical students in the contexts of COVID-19. A systematic review was conducted in Web of Sciences, PubMed, Educational Resources and Information Center, and Scopus from December 2019 to July 2020. Eight sets of terminology were used, combining "Distance learning" AND "Medical education" AND "Pandemic." Studies were reviewed independently by two reviewers. Data were extracted and quality appraised using QualSyst tools, and synthesized by performing thematic analysis. A total of 473 articles were identified after removing duplicates and 314 records were screened, of which 125 were included in this study. The primary articles were 52 primarily qualitative articles. Five learning strategies consisted of technology-enhanced learning (TEL), simulation-based learning, technology-based clinical education, mobile learning, and blended learning. Tools, methods, and learning resources associated with these five learning strategies were extracted from the articles. Our review highlights that TEL and simulation-based learning were more commonly used than others in distance learning in medical education during the COVID-19 pandemic. These strategies have the potential to improve learners' level of knowledge and performance through making online learning resources such as Massive Open Online Courses, virtual clinical cases, and blended sources accessible.
C1 [Ahmady, Soleiman; Kalantarion, Masomeh] Shahid Beheshti Univ Med Sci, Dept Med Educ, Virtual Sch Med Educ & Management, Tehran, Iran.
   [Kallestrup, Per; Katibeh, Marzieh] Aarhus Univ, Ctr Global Hlth, Dept Publ Hlth, Aarhus, Denmark.
   [Sadoughi, Mohammad Mehdi] Shahid Beheshti Univ Med Sci, Ophthalm Res Ctr, Res Inst Ophthalmol & Vis Sci, Tehran, Iran.
   [Amini, Mitra] Shiraz Univ Med Sci, Clin Educ Res Ctr, Shiraz, Iran.
   [Khajeali, Nasrin] Ahvaz Jundishapur Univ Med Sci, Dept Med Educ, Ahvaz, Iran.
RP Kalantarion, M (corresponding author), Shahid Beheshti Univ Med Sci, Dept Med Educ, Virtual Sch Med Educ & Management, Tehran, Iran.
EM kalantarion65@gmail.com
RI Kallestrup, Per/AAA-8313-2022
OI Kallestrup, Per/0000-0001-6041-4510
CR Agarwal S, 2020, NEUROLOGY, V94, pE2608, DOI 10.1212/WNL.0000000000009675
   Almarzooq ZI, 2020, J AM COLL CARDIOL, V75, P2635, DOI 10.1016/j.jacc.2020.04.015
   Anwar A, 2020, J CLIN ANESTH, V66, DOI 10.1016/j.jclinane.2020.109949
   Ashokka B, 2020, MED TEACH, V42, P762, DOI 10.1080/0142159X.2020.1757634
   Barberio B, 2020, NAT REV GASTRO HEPAT, V17, P447, DOI 10.1038/s41575-020-0323-7
   Billings DM, 2007, CIN-COMPUT INFORM NU, V25, P121, DOI 10.1097/01.NCN.0000270044.67905.4a
   Bloom DA, 2020, PEDIATR RADIOL, V50, P1055, DOI 10.1007/s00247-020-04728-8
   Carvalho VO, 2020, J CARDIAC SURG, V35, P1170, DOI 10.1111/jocs.14646
   Chatziralli I, 2021, EYE, V35, P1459, DOI 10.1038/s41433-020-1080-0
   Chen Cathy Hsi, 2020, JMIR Med Educ, V6, pe19725, DOI 10.2196/19725
   Chick RC, 2020, J SURG EDUC, V77, P729, DOI 10.1016/j.jsurg.2020.03.018
   Chong A, 2020, ACAD RADIOL, V27, P856, DOI 10.1016/j.acra.2020.04.001
   Codispoti CD, 2020, J ALLERGY CLIN IMMUN, V145, P1357, DOI 10.1016/j.jaci.2020.03.018
   Comer BT, 2020, OTOLARYNG HEAD NECK, V163, P70, DOI 10.1177/0194599820923621
   Cook DA, 2004, J GEN INTERN MED, V19, P698, DOI 10.1111/j.1525-1497.2004.30029.x
   Dolan B., 2011, MOBIHEALTHNEWS
   El-Hussein MOM, 2010, EDUC TECHNOL SOC, V13, P12
   Ellaway R, 2008, MED TEACH, V30, P455, DOI [10.1080/01421590802108349, 10.1080/01421590802108331]
   Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5
   Gaba DM, 2004, QUAL SAF HEALTH CARE, V13, pI2, DOI 10.1136/qshc.2004.009878
   George P, 2013, MED TEACH, V35, P226, DOI 10.3109/0142159X.2012.735384
   Gewin V, 2020, NATURE, V580, P295, DOI 10.1038/d41586-020-00896-7
   Guragai M, 2020, J NEPAL MED ASSOC, V58, P352, DOI 10.31729/jnma.4924
   Henderson JV, 1998, INT J PSYCHIAT MED, V28, P41, DOI 10.2190/NQEN-KRT8-19GA-R0BV
   Hughes BA, 2020, J PLAST RECONSTR AES, V73, pE1, DOI 10.1016/j.bjps.2020.05.034
   Jha AK, 2001, MAKING HLTH CARE SAF, P511
   Katibeh M, 2020, OPHTHAL EPIDEMIOL, V27, P417, DOI 10.1080/09286586.2020.1768552
   Kaup S, 2020, INDIAN J OPHTHALMOL, V68, P1220, DOI 10.4103/ijo.IJO_1241_20
   Kaveevivitchai C, 2009, NURS EDUC TODAY, V29, P65, DOI 10.1016/j.nedt.2008.06.010
   Kekkonen-Moneta S, 2002, BRIT J EDUC TECHNOL, V33, P423, DOI 10.1111/1467-8535.00279
   Kesselman A, 2020, CLIN IMAG, V67, P72, DOI 10.1016/j.clinimag.2020.05.026
   Kirkwood A, 2014, LEARN MEDIA TECHNOL, V39, P6, DOI 10.1080/17439884.2013.770404
   Kmet L.M., 2004, STANDARD QUALITY ASS
   Kononowicz AA, 2019, J MED INTERNET RES, V21, DOI 10.2196/14676
   Lateef Fatimah, 2010, J Emerg Trauma Shock, V3, P348, DOI 10.4103/0974-2700.70743
   Lee L, 2008, AUSTRALAS J AGEING, V27, P170, DOI 10.1111/j.1741-6612.2008.00298.x
   Leung GM, 2003, BMJ-BRIT MED J, V327, P1090, DOI 10.1136/bmj.327.7423.1090
   Lewis CT, 2020, WORLD NEUROSURG, V138, P545, DOI 10.1016/j.wneu.2020.04.179
   Longhurst GJ, 2020, ANAT SCI EDUC, V13, P298, DOI 10.1002/ase.1967
   Maharaj S, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0079-6
   Masters K, 2016, MED TEACH, V38, P537, DOI 10.3109/0142159X.2016.1141190
   McCutcheon K, 2015, J ADV NURS, V71, P255, DOI 10.1111/jan.12509
   Mishra D, 2020, INDIAN J OPHTHALMOL, V68, P999, DOI 10.4103/ijo.IJO_1067_20
   Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005
   Moran J, 2018, ACAD PSYCHIATR, V42, P796, DOI 10.1007/s40596-018-0946-y
   Mosa AM, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-67
   Mosalanejad L, 2019, J EDUC HEALTH PROMOT, V8, DOI 10.4103/jehp.jehp_402_19
   Mousa Albeir Y, 2020, J Vasc Surg, V72, P380, DOI 10.1016/j.jvs.2020.04.469
   Mukhopadhyay S, 2020, ARCH PATHOL LAB MED, V144, P1027, DOI 10.5858/arpa.2020-0201-ED
   Oh, 2008, PERFORMANCE IMPROVEM, V47, P5, DOI [10.1002/pfi, DOI 10.1002/PFI, 10.1002/pfi.20018, DOI 10.1002/PFI.20018]
   Oliver R., 1999, DISTANCE EDUC, V20, P240, DOI [10.1080/0158791990200205, DOI 10.1080/0158791990200205]
   Pather N, 2020, ANAT SCI EDUC, V13, P284, DOI 10.1002/ase.1968
   Plancher Kevin D, 2020, Arthrosc Sports Med Rehabil, V2, pe295, DOI 10.1016/j.asmr.2020.04.007
   Popay J., 2009, EVALUATION, V15, P49, DOI [DOI 10.1177/1356389008097871, 10.1177/1356389008097871]
   Regier DS, 2020, AM J MED GENET A, V182, P1302, DOI 10.1002/ajmg.a.61595
   Roberts C, 2020, CLIN TEACH, V17, P241, DOI 10.1111/tct.13183
   Roberts V, 2020, MED EDUC ONLINE, V25, DOI 10.1080/10872981.2020.1772014
   Roy SF, 2020, J CLIN PATHOL, V73, P444, DOI 10.1136/jclinpath-2020-206682
   Sandhu P, 2020, MED EDUC ONLINE, V25, DOI 10.1080/10872981.2020.1764740
   Schneider SL, 2021, ARCH DERMATOL RES, V313, P389, DOI 10.1007/s00403-020-02088-9
   Siddiqui UD, 2020, DIGEST DIS SCI, V65, P1888, DOI 10.1007/s10620-020-06386-0
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Spinelli A, 2020, BRIT J SURG, V107, P785, DOI 10.1002/bjs.11627
   Vazquez AG, 2020, J LAPAROENDOSC ADV S, V30, P993, DOI 10.1089/lap.2020.0535
   Wang CY, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13020036
   Wang FL, 2010, HDB RES HYBRID LEARN
   Webb C, 2007, REVIEWING RESEARCH EVIDENCE FOR NURSING PRACTICE: SYSTEMATIC REVIEWS, P1, DOI 10.1002/9780470692127
   Wilder S, 2015, EDUC REV, V67, P414, DOI 10.1080/00131911.2014.974511
   Yuen JC, 2020, PLAST RECONSTR SURG, V146, p109E, DOI 10.1097/PRS.0000000000007074
   Yusoff MSB, 2020, MALAYS J MED SCI, V27, P137, DOI 10.21315/mjms2020.27.3.14
   Zardosht R, 2020, J EDUC HEALTH PROMOT, V9, DOI 10.4103/jehp.jehp_348_19
   Zayapragassarazan Z, 2020, F10000RESEARCH, DOI [10.7490/f1000research.1117835.1, DOI 10.7490/F1000RESEARCH.1117835.1]
   Zayapragassarazan Z, 2020, ONLINE SUBMISSION, V9, P1
   Zuo LL, 2020, MED EDUC, V54, P664, DOI 10.1111/medu.14194
NR 74
TC 0
Z9 0
U1 1
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 2277-9531
EI 2319-6440
J9 J EDUC HEALTH PROMOT
JI J. Educ. Health Promot.
PD JAN-DEC
PY 2021
VL 10
IS 1
DI 10.4103/jehp.jehp_318_21
PG 9
WC Education, Scientific Disciplines; Public, Environmental & Occupational
   Health
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research; Public, Environmental & Occupational
   Health
GA YY8SL
UT WOS:000755055700018
PM 35071627
DA 2022-04-20
ER

PT J
AU Schernhammer, E
   Weitzer, J
   Laubichler, MD
   Birmann, BM
   Bertau, M
   Zenk, L
   Caniglia, G
   Jager, CC
   Steiner, G
AF Schernhammer, Eva
   Weitzer, Jakob
   Laubichler, Manfred D.
   Birmann, Brenda M.
   Bertau, Martin
   Zenk, Lukas
   Caniglia, Guido
   Jaeger, Carlo C.
   Steiner, Gerald
TI Correlates of COVID-19 vaccine hesitancy in Austria: trust and the
   government
SO JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE behaviour; communicable diseases; vaccine hesitancy; COVID-19
ID SCALE; NEED
AB Background With the coronavirus disease 2019 (COVID-19) pandemic surging and new mutations evolving, trust in vaccines is essential. Methods We explored correlates of vaccine hesitancy, considering political believes and psychosocial concepts, conducting a non-probability quota-sampled online survey with 1007 Austrians. Results We identified several important correlates of vaccine hesitancy, ranging from demographics to complex factors such as voting behavior or trust in the government. Among those with hesitancy towards a COVID-19 vaccine, having voted for opposition parties (opp) or not voted (novote) were (95% Confidence Intervall (CI)opp, 1.44-2.95) to 2.25-times (95%CInovote, 1.53-3.30) that of having voted for governing parties. Only 46.2% trusted the Austrian government to provide safe vaccines, and 80.7% requested independent scientific evaluations regarding vaccine safety to increase willingness to vaccine. Conclusions Contrary to expected, psychosocial dimensions were only weakly correlated with vaccine hesitancy. However, the strong correlation between distrust in the vaccine and distrust in authorities suggests a common cause of disengagement from public discourse.
C1 [Schernhammer, Eva; Weitzer, Jakob] Med Univ Vienna, Ctr Publ Hlth, Dept Epidemiol, A-1090 Vienna, Austria.
   [Schernhammer, Eva; Laubichler, Manfred D.; Steiner, Gerald] Complex Sci Hub, A-1080 Vienna, Austria.
   [Schernhammer, Eva; Birmann, Brenda M.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA.
   [Schernhammer, Eva; Birmann, Brenda M.] Harvard Med Sch, Boston, MA 02115 USA.
   [Laubichler, Manfred D.] Arizona State Univ, Sch Complex Adapt Syst, Tempe, AZ 85287 USA.
   [Laubichler, Manfred D.] Santa Fe Inst, Santa Fe, NM 87501 USA.
   [Bertau, Martin; Steiner, Gerald] TU Bergakad Freiberg, Inst Tech Chem, D-09599 Freiberg, Germany.
   [Zenk, Lukas] Danube Univ Krems, Dept Knowledge & Commun Management, A-3500 Krems Der Donau, Austria.
   [Caniglia, Guido] Konrado Lorenz Inst Evolut & Cognit Res, A-3400 Klosterneuburg, Austria.
   [Jaeger, Carlo C.] Global Climate Forum, D-10178 Berlin, Germany.
RP Steiner, G (corresponding author), Complex Sci Hub, A-1080 Vienna, Austria.; Steiner, G (corresponding author), TU Bergakad Freiberg, Inst Tech Chem, D-09599 Freiberg, Germany.
EM gerald.steiner@donau-uni.ac.at
OI Bertau, Martin/0000-0003-1236-1164
CR Bauchner H, 2020, JAMA-J AM MED ASSOC, V324, P1296, DOI 10.1001/jama.2020.18860
   Bauer A, 2021, WIEN KLIN WOCHENSCHR, V133, P703, DOI 10.1007/s00508-020-01777-9
   Brentler A., JACOBIN MAGAZINE
   Burgess RA, 2021, LANCET, V397, P8, DOI 10.1016/S0140-6736(20)32642-8
   Caserotti M, 2021, SOC SCI MED, V272, DOI 10.1016/j.socscimed.2021.113688
   Chou WYS, 2020, HEALTH COMMUN, V35, P1718, DOI 10.1080/10410236.2020.1838096
   Cordero DA, 2021, J PUBLIC HEALTH-UK, V43, pE303, DOI 10.1093/pubmed/fdab020
   Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y
   Freeman Daniel, 2020, Psychol Med, P1, DOI [10.1017/S0033291721002609, 10.1017/S0033291720005188]
   Hinz A, 2017, INT J CLIN HLTH PSYC, V17, P161, DOI 10.1016/j.ijchp.2017.02.003
   Kreidl P, 2020, WIEN KLIN WOCHENSCHR, V132, P645, DOI 10.1007/s00508-020-01723-9
   Kreps S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25594
   Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9
   Moshammer H, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093270
   Murphy J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20226-9
   Palamenghi L, 2020, EUR J EPIDEMIOL, V35, P785, DOI 10.1007/s10654-020-00675-8
   Puri N, 2020, HUM VACC IMMUNOTHER, V16, P2586, DOI 10.1080/21645515.2020.1780846
   Republik ?sterreich Parlament, WIE VIEL GEH WAHL EN
   Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010042
   Sandhofer MJ, 2017, WIEN KLIN WOCHENSCHR, V129, P59, DOI 10.1007/s00508-016-1062-1
   Schlink S, 2007, Z SOZIALPSYCHOL, V38, P153, DOI 10.1024/0044-3514.38.3.153
   Schumacher J, 2005, Z KLIN PSYCH PSYCHIA, V53, P16
   Vergara RJD, 2021, J PUBLIC HEALTH-UK, V43, pE291, DOI 10.1093/pubmed/fdaa282
   Vienna U.O., AUSTRIAN CORONA PANE
   Volpp KG, 2021, JAMA-J AM MED ASSOC, V325, P125, DOI 10.1001/jama.2020.24036
   Wagnild G M, 1993, J Nurs Meas, V1, P165
   Wang KL, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010062
   WEBSTER DM, 1994, J PERS SOC PSYCHOL, V67, P1049, DOI 10.1037/0022-3514.67.6.1049
NR 28
TC 16
Z9 16
U1 3
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1741-3842
EI 1741-3850
J9 J PUBLIC HEALTH-UK
JI J. Public Health
PD MAR 7
PY 2022
VL 44
IS 1
BP E106
EP E116
DI 10.1093/pubmed/fdab122
EA MAY 2021
PG 11
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA 0E4ZZ
UT WOS:000764415100001
PM 33948665
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Lee, JK
   Bullen, C
   Ben Amor, Y
   Bush, SR
   Colombo, F
   Gaviria, A
   Karim, SSA
   Kim, B
   Lavis, JN
   Lazarus, JV
   Lo, YC
   Michie, SF
   Norheim, OF
   Oh, J
   Reddy, KS
   Rostila, M
   Saenz, R
   Smith, LDG
   Thwaites, JW
   Were, MK
   Xue, L
AF Lee, Jong-Koo
   Bullen, Chris
   Ben Amor, Yanis
   Bush, Simon R.
   Colombo, Francesca
   Gaviria, Alejandro
   Karim, Salim S. Abdool
   Kim, Booyuel
   Lavis, John N.
   Lazarus, Jeffrey, V
   Lo, Yi-Chun
   Michie, Susan F.
   Norheim, Ole F.
   Oh, Juhwan
   Reddy, Kolli Srinath
   Rostila, Mikael
   Saenz, Rocio
   Smith, Liam D. G.
   Thwaites, John W.
   Were, Miriam K.
   Xue, Lan
CA Lancet COVID-19 Commission Task Fo
TI Institutional and behaviour-change interventions to support COVID-19
   public health measures: a review by the Lancet Commission Task Force on
   public health measures to suppress the pandemic
SO INTERNATIONAL HEALTH
LA English
DT Review
DE behaviour change; COVID-19; pandemic; public health
ID DISEASES; IMPACT
AB The Lancet COVID-19 Commission Task Force for Public Health Measures to Suppress the Pandemic was launched to identify critical points for consideration by governments on public health interventions to control coronavirus disease 2019 (COVID-19). Drawing on our review of published studies of data analytics and modelling, evidence synthesis and contextualisation, and behavioural science evidence and theory on public health interventions from a range of sources, we outline evidence for a range of institutional measures and behaviour-change measures. We cite examples of measures adopted by a range of countries, but especially jurisdictions that have, thus far, achieved low numbers of COVID-19 deaths and limited community transmission of severe acute respiratory syndrome coronavirus 2. Finally, we highlight gaps in knowledge where research should be undertaken. As countries consider long-term measures, there is an opportunity to learn, improve the response and prepare for future pandemics.
C1 [Lee, Jong-Koo; Oh, Juhwan] Seoul Natl Univ, Coll Med, Seoul 03080, South Korea.
   [Lee, Jong-Koo] Seoul Natl Univ Hosp, Dept Family Med, Seoul 03080, South Korea.
   [Bullen, Chris] Univ Auckland, Sch Populat Hlth, Auckland 1142, New Zealand.
   [Ben Amor, Yanis] Columbia Univ, Ctr Sustainable Dev, Earth Inst, New York, NY 10115 USA.
   [Bush, Simon R.] Sightsavers, POB KIA 18190, Accra, Ghana.
   [Colombo, Francesca] OECD Hlth Div, F-75016 Paris, France.
   [Gaviria, Alejandro] Univ los Andes, Sch Econ, Bogota 111711, Colombia.
   [Karim, Salim S. Abdool] Ctr AIDS Programme Res South Africa CAPRISA, Private Bag X7, ZA-4013 Durban, South Africa.
   [Karim, Salim S. Abdool] Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA.
   [Kim, Booyuel] Seoul Natl Univ, Grad Sch Environm Studies, Dept Environm Planning, Seoul 08826, South Korea.
   [Kim, Booyuel] Seoul Natl Univ, Environm Planning Inst, Seoul 08826, South Korea.
   [Lavis, John N.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON L8S 4K1, Canada.
   [Lazarus, Jeffrey, V] Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona 08036, Spain.
   [Lo, Yi-Chun] Taiwan Ctr Dis Control, Taipei 100, Taiwan.
   [Michie, Susan F.] UCL, UCL Ctr Behav Change, Dept Clin Educ & Hlth Psychol, London WC1E 7HB, England.
   [Norheim, Ole F.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Postboks 7804, NO-5020 Bergen, Norway.
   [Reddy, Kolli Srinath] Publ Hlth Fdn India, Gurgaon 122002, Haryana, India.
   [Rostila, Mikael] Stockholm Univ, Dept Publ Hlth Sci, S-10691 Stockholm, Sweden.
   [Saenz, Rocio] Univ Costa Rica, Sch Publ Hlth, San Jose 11501, Costa Rica.
   [Smith, Liam D. G.] Monash Univ, BehaviourWorks Australia, Melbourne, Vic 3800, Australia.
   [Thwaites, John W.] Monash Univ, Monash Sustainable Dev Inst, Melbourne, Vic 3800, Australia.
   [Were, Miriam K.] Champ AIDS Free Generat Africa, POB 63056-00200, Nairobi, Kenya.
   [Xue, Lan] Tsinghua Univ, Sch Publ Policy & Management, Beijing 100084, Peoples R China.
RP Bullen, C (corresponding author), Univ Auckland, Sch Populat Hlth, Auckland 1142, New Zealand.
EM c.bullen@auckland.ac.nz
RI Norheim, Ole Frithjof/AAC-8771-2020; Lazarus, Jeffrey V./R-6248-2018;
   Abdool Karim, Salim/N-5947-2013; Bullen, Christopher/E-4594-2017;
   Michie, Susan/A-1745-2010
OI Norheim, Ole Frithjof/0000-0002-5748-5956; Lazarus, Jeffrey
   V./0000-0001-9618-2299; Abdool Karim, Salim/0000-0002-4986-2133; Bullen,
   Christopher/0000-0001-6807-2930; Michie, Susan/0000-0003-0063-6378
FU Health Research Council of New Zealand (NZ)Health Research Council of
   New Zealand; Heart Foundation of NZ; NZ Ministry of Health; Ministry of
   Education of the Republic of Korea; National Research Foundation of
   KoreaNational Research Foundation of Korea [NRF-2018S1A3A2075117]; NIHR
   (UK) NETSCC; MRC (UK)UK Research & Innovation (UKRI)Medical Research
   Council UK (MRC); NIHRNational Institute for Health Research (NIHR); PHA
   of Canada; CIHR (Canada)Canadian Institutes of Health Research (CIHR);
   Fidelity Charitable; Centre for Effective Altruism, US
FX CB reports research grants from the Health Research Council of New
   Zealand (NZ), the Heart Foundation of NZ and the NZ Ministry of Health.
   BK reports research grants from the Ministry of Education of the
   Republic of Korea and the National Research Foundation of Korea
   [NRF2018S1A3A2075117]. J Lazarus reports research funding from the
   European Commission and Gilead Sciences, outside the submitted work. SM
   reports a research grant from NIHR (UK) NETSCC, and grants from MRC
   (UK). J Lavis reports grants from NIHR, CIHR (Canada), PHA of Canada,
   Fidelity Charitable and Centre for Effective Altruism, US.
CR Ahern S, 2021, BMJ LEAD, V5, P266, DOI 10.1136/leader-2020-000271
   AN B, 2020, AM REV ADM, V50, P6
   Anglemyer A, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013699
   Anoko JN, 2020, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2020-003121
   [Anonymous], 2020, NATURE, V580, P563, DOI 10.1038/d41586-020-01264-1
   [Anonymous], DEUTCHE WELLE DW NEW
   Ansell C, 2021, PUBLIC MANAG REV, V23, P949, DOI 10.1080/14719037.2020.1820272
   Assefa Y, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0470-1
   Ataguba OA, 2020, GLOBAL HEALTH ACTION, V13, DOI 10.1080/16549716.2020.1788263
   Bambra C, 2020, J EPIDEMIOL COMMUN H, V74, P964, DOI 10.1136/jech-2020-214401
   Barrelet C, 2013, INFLUENZA OTHER RESP, V7, P114, DOI 10.1111/irv.12090
   Becher M., 2020, COMP EXPT EVIDENCE C
   Bedrosian N, 2021, ENVIRON SCI TECHNOL, V55, P4162, DOI 10.1021/acs.est.0c05651
   Betsch C, 2020, LANCET, V395, P1255, DOI 10.1016/S0140-6736(20)30729-7
   Blanchet K, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003675
   Branden M, 2020, LANCET HEALTH LONGEV, V1, pE80, DOI 10.1016/S2666-7568(20)30016-7
   Burns J, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013717
   Chou R, 2021, ANN INTERN MED, V174, pW24, DOI 10.7326/L20-1429
   Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9
   Chu IYH, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa192
   Devine D, 2021, POLIT STUD REV, V19, P274, DOI 10.1177/1478929920948684
   Elgar FJ, 2020, SOC SCI MED, V263, DOI 10.1016/j.socscimed.2020.113365
   Galbadage T, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00163
   Gesser-Edelsburg A, 2014, DISASTER MED PUBLIC, V8, P158, DOI 10.1017/dmp.2014.27
   Giustiniano L, 2020, MANAGE ORGAN REV, V16, P971, DOI 10.1017/mor.2020.57
   Han Qing., 2020, TRUST GOVT ITS ASS H, DOI [10.31234/osf.io/p5gns, 10.31234/osf.io, DOI 10.31234/OSF.IO/P5GNS]
   Haug N, 2020, NAT HUM BEHAV, V4, DOI 10.1038/s41562-020-01009-0
   Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7
   Homeida M., 2002, Annals of Tropical Medicine and Parasitology, V96, pS93, DOI 10.1179/000349802125000673
   Howlett M., DESIGNING GOVT INSTR, P31
   Kim DKD, 2020, WORLD MED HEALTH POL, V12, P398, DOI 10.1002/wmh3.363
   Kneebone S, 2017, ENVIRON SCI POLICY, V70, P9, DOI 10.1016/j.envsci.2016.11.013
   Koehn, 2020, HARVARD BUS REV
   Kretzschmar ME, 2020, LANCET PUBLIC HEALTH, V5, pE452, DOI 10.1016/S2468-2667(20)30157-2
   Lalot F, 2022, GROUP PROCESS INTERG, V25, P106, DOI 10.1177/1368430220967986
   Lancet COVID-19 Commission, TASK FORC PUBL HLTH
   Lazarus JV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240011
   LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958
   MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401
   Michie S, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2982
   Michie S, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19990
   Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42
   Molyneux D, 2021, INFECT DIS POVERTY, V10, DOI 10.1186/s40249-020-00791-3
   Molyneux DH, 2020, INT HEALTH, V12, P367, DOI 10.1093/inthealth/ihaa040
   National Collaborating Centre for Methods and Tools, 2020, RAP REV WHAT IS KNOW
   National Collaborating Centre for Methods and Tools, 2020, WHAT AR BEST PRACT R
   Nussbaumer-Streit Barbara, 2020, Cochrane Database Syst Rev, V9, pCD013574, DOI 10.1002/14651858.CD013574.pub2
   OECD, DEUTCHE WELLE DW NEW
   OECD, 2019, TOOLS ETH APPL BEH I, DOI [10.1787/9ea76a8f-en, DOI 10.1787/9EA76A8F-EN]
   OECD, 2020, REAL POT PRIM HLTH C
   OECD, TERR IMP COV 19 MAN
   OECD, 2020, TRANSP COMM TRUST RO
   Paakkari L, 2020, LANCET PUBLIC HEALTH, V5, pE249, DOI 10.1016/S2468-2667(20)30086-4
   Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529
   Park YJ, 2020, EMERG INFECT DIS, V26, P2465, DOI 10.3201/eid2610.201315
   Parker C, 2017, REGULATORY THEORY: FOUNDATIONS AND APPLICATIONS, P217
   Pawson R, 2021, EVALUATION-US, V27, P149, DOI 10.1177/1356389020968579
   Petherick, 2020, RELATIONSHIP NUMBER
   Petticrew M., 2020, SOCIAL DISTANCING BA, DOI [10.1101/2020.09.1620195966, DOI 10.1101/2020.09.1620195966]
   Presseau J, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-019-0951-x
   Reicher S, 2020, BRIT J SOC PSYCHOL, V59, P694, DOI 10.1111/bjso.12398
   Shingler-Nace Autum, 2020, Nurse Lead, V18, P202, DOI 10.1016/j.mnl.2020.03.017
   Siegrist M, 2014, EUR PSYCHOL, V19, P23, DOI 10.1027/1016-9040/a000169
   Skegg D, 2021, LANCET, V397, P777, DOI 10.1016/S0140-6736(21)00424-4
   Thomas A, 2011, EMERGING HLTH THREAT, V4, P1, DOI DOI 10.3402/EHTJ.V4I0.7160
   Tripodi E., 2020, 27378 NBER, DOI 10.3386/w27378
   Truelove HB, 2014, GLOBAL ENVIRON CHANG, V29, P127, DOI 10.1016/j.gloenvcha.2014.09.004
   UK Government, 2020, SPI B POS STRAT SUST
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   Van Rooij, 2020, COMPLIANCE COVID 19
   Viswanathan M, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013718
   Vrolix K., 2006, BEHAV ADAPTATION RIS, P1
   Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151
   West R, 2020, NAT HUM BEHAV, V4, P451, DOI 10.1038/s41562-020-0887-9
   WHO, 2020, WHO PULS SURV CONT E
   WHO, 2021, STAT 2 M INT HLTH RE
   WHO, 2020, STAT BEH INS AR VAL
   Winter P.L., 2006, SOC INFLUENCE, V1, P3, DOI [10.1080/15534510500181459, DOI 10.1080/15534510500181459]
   Wolf LJ, 2020, BRIT J SOC PSYCHOL, V59, P618, DOI 10.1111/bjso.12401
   World Health Organization (WHO), 2016, WORK HLTH GROWTH INV
   Yang F, 2021, MEDIA INT AUST, V178, P182, DOI 10.1177/1329878X20968277
NR 81
TC 2
Z9 2
U1 3
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1876-3413
EI 1876-3405
J9 INT HEALTH
JI Int. Health
PD SEP
PY 2021
VL 13
IS 5
BP 399
EP 409
DI 10.1093/inthealth/ihab022
EA MAY 2021
PG 11
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA UR2IY
UT WOS:000696579000002
PM 33974687
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Lavezzolo, S
   Ramiro, L
   Fernandez-Vazquez, P
AF Lavezzolo, Sebastian
   Ramiro, Luis
   Fernandez-Vazquez, Pablo
TI Technocratic attitudes in COVID-19 times: Change and preference over
   types of experts
SO EUROPEAN JOURNAL OF POLITICAL RESEARCH
LA English
DT Article; Early Access
DE conjoint analysis; COVID-19; experts; Spain; technocratic attitudes
AB Western publics show a sizable support for experts' involvement in political decision making, that is, technocratic attitudes. This article analyzes two key aspects of these attitudes: technocratic attitudes' stability and the heterogeneity in the demand for experts depending on the context. We first analyze how technocratic attitudes have been affected by an external event, the COVID-19 pandemic, that has placed experts' role at the forefront of the public debate; this allows us to analyze the stability or change in these attitudes. Second, given that the pandemic quickly evolved from being a public health issue to becoming a political issue combining economic and public health dimensions, we examine whether framing the COVID-19 pandemic exclusively as a public health problem or as including a prominent economic dimension as well affects the type of public officials who are preferred to lead the political management of the crisis (independent experts with diverse professional skills or party politicians belonging to different parties and with a specialization in different policy fields). We pursue these two research goals through a panel survey conducted in Spain at two different time points, one before and another during the pandemic, in which we measure technocratic attitudes using an exhaustive battery; and through a survey experiment combining a conjoint design and a framing experiment. Results show that, first, technocratic attitudes have significantly increased as a consequence of the coronavirus outbreak; second, people's preference for experts prevails against any other experimental treatment such as party affiliation; and, finally, preferences for the type of experts vary depending on the problem to be solved. In this way, this paper significantly increases our knowledge of the factors that affect variation in public attitudes towards experts' involvement in political decision-making.
C1 [Lavezzolo, Sebastian; Fernandez-Vazquez, Pablo] Carlos III Univ Madrid, Social Sci Dept, Madrid, Spain.
   [Ramiro, Luis] Univ Nacl Educac & Distancia UNED, Dept Polit Sci, Madrid, Spain.
RP Lavezzolo, S (corresponding author), Carlos III Univ Madrid, Social Sci Dept, Madrid, Spain.
EM selavezz@inst.uc3m.es
RI Ramiro, Luis/AAB-4470-2020
OI Ramiro, Luis/0000-0002-1523-2475; FERNANDEZ-VAZQUEZ,
   PABLO/0000-0003-1296-1936; Lavezzolo, Sebastian/0000-0002-4570-1738
CR Aassve A, 2021, HEALTH ECON, V30, P840, DOI 10.1002/hec.4218
   ABC, 2020, SAN QUED BAJ MAND UN
   Alexiadou D., 2020, TECHNOCRATIC CHALLEN, P131
   Alexiadou D, 2019, EUR J POLIT RES, V58, P845, DOI 10.1111/1475-6765.12338
   Amat C., 2020, PANDEMICS MEET UNPUB
   angel Centeno Miguel, 1998, POLITICS EXPERTISE L
   [Anonymous], 2020, EL PAIS 0312
   Ashworth S, 2018, AM J POLIT SCI, V62, P37, DOI 10.1111/ajps.12334
   Bertsou E., 2020, TECHNOCRATIC CHALLEN
   Bertsou E, 2022, EUR J POLIT RES, V61, P255, DOI 10.1111/1475-6765.12448
   Bertsou E, 2022, AM J POLIT SCI, V66, P5, DOI 10.1111/ajps.12554
   Bertsou E, 2017, WEST EUR POLIT, V40, P430, DOI 10.1080/01402382.2016.1242046
   Bickerton C.h., 2020, TECHNOCRATIC CHALLEN, P29
   Bickerton C, 2017, CRIT REV INT SOC POL, V20, P186, DOI 10.1080/13698230.2014.995504
   Caramani D., 2020, TECHNOCRATIC CHALLEN, P1
   Caramani D, 2017, AM POLIT SCI REV, V111, P54, DOI 10.1017/S0003055416000538
   CARMINES EG, 1980, AM POLIT SCI REV, V74, P78, DOI 10.2307/1955648
   CENTENO MA, 1993, THEOR SOC, V22, P307, DOI 10.1007/BF00993531
   Chen CWS, 2021, INT J INFECT DIS, V102, P327, DOI 10.1016/j.ijid.2020.10.050
   Chong D, 2007, ANNU REV POLIT SCI, V10, P103, DOI 10.1146/annurev.polisci.10.072805.103054
   Coffe H, 2014, ELECT STUD, V35, P1, DOI 10.1016/j.electstud.2014.03.006
   Colantone I, 2018, AM J POLIT SCI, V62, P936, DOI 10.1111/ajps.12358
   Covert B., 2020, NEW YORK TIMES
   Dargent E, 2015, TECHNOCRACY AND DEMOCRACY IN LATIN AMERICA: THE EXPERTS RUNNING GOVERNMENT, P1, DOI 10.1017/CBO9781107446663
   Dommett K, 2020, POLIT STUD-LONDON, V68, P332, DOI 10.1177/0032321719844122
   European Parliament, 2020, PUBL OP EU TIM COVID
   Fietzer T., 2020, 27082 NBER
   Fischer Frank, 1990, TECHNOCRACY POLITICS
   Font J, 2015, POLIT STUD-LONDON, V63, P153, DOI 10.1111/1467-9248.12191
   Foster C, 2017, EUR UNION POLIT, V18, P511, DOI 10.1177/1465116517723499
   Ganuza E, 2020, POLITICS GOV, V8, P520, DOI 10.17645/pag.v8i4.3206
   Hainmueller J, 2014, POLIT ANAL, V22, P1, DOI 10.1093/pan/mpt024
   Heyne L, 2021, ELECT STUD, V70, DOI 10.1016/j.electstud.2021.102288
   Lavezzolo S, 2021, WEST EUR POLIT, V44, P1506, DOI 10.1080/01402382.2020.1778917
   Lavezzolo S, 2018, EUR POLIT SCI REV, V10, P267, DOI 10.1017/S1755773917000108
   Lazarus JV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240011
   Louwerse T, 2021, WEST EUR POLIT, V44, P1025, DOI 10.1080/01402382.2021.1886519
   Mair P, 2009, MPIFG WORKING PAPER, V09, P1
   Mair P, 2006, NEW LEFT REV, P25
   Mansbridge J, 2012, PS-POLIT SCI POLIT, V45, P1, DOI 10.1017/S104909651100165X
   McDonnell D, 2014, EUR J POLIT RES, V53, P654, DOI 10.1111/1475-6765.12054
   Meynaud J., 1969, TECHNOCRACY
   Pastorella G, 2016, POLIT STUD-LONDON, V64, P948, DOI 10.1111/1467-9248.12217
   Radaelli CM, 1999, J EUR PUBLIC POLICY, V6, P757, DOI 10.1080/135017699343360
   Rieger M.O., 2020, TRUST GOVT ACT UNPUB
   Sanchez-Cuenca I., 2020, TECHNOCRATIC CHALLEN, P44
   Scharpf F.W., 1999, GOVERNING EUROPE
   Theiss-Morse, 2002, STEALTH DEMOCRACY AM
   Tucker P, 2018, UNELECTED POWER: THE QUEST FOR LEGITIMACY IN CENTRAL BANKING AND THE REGULATORY STATE, P1
   TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683
   Vibert F, 2007, RISE OF THE UNELECTED: DEMOCRACY AND THE NEW SEPARATION OF POWERS, P1, DOI 10.1017/CBO9780511491160
   Webb P, 2013, EUR J POLIT RES, V52, P747, DOI 10.1111/1475-6765.12021
   World Medical Association, 2020, LET SCI LEAD COV 19
NR 53
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0304-4130
EI 1475-6765
J9 EUR J POLIT RES
JI Eur. J. Polit. Res.
DI 10.1111/1475-6765.12491
EA NOV 2021
PG 20
WC Political Science
WE Social Science Citation Index (SSCI)
SC Government & Law
GA WQ6ZN
UT WOS:000713962600001
PM 34898810
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Hoda, Q
   Fatma, A
   Pahwa, S
   Gupta, C
AF Hoda, Quaisul
   Fatma, Askary
   Pahwa, Shilpa
   Gupta, Chitra
TI TARGET BASED PHARMACOLOGICAL APPROACHES FOR DRUG DEVELOPMENT AGAINST
   NOVEL CORONA VIRUS (COVID-19)
SO INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH
LA English
DT Review
DE COVID-19; Hydroxychloroquine; Methylcobalamine; Valproic acid; BCG
   vaccine; Plasma therapy; ACE2 receptor; Vitamin D; Zinc
ID REGULATORY T-CELLS; VITAMIN-D; 1,25-DIHYDROXYVITAMIN D-3; CONVALESCENT
   PLASMA; WUHAN; SUPPLEMENTATION; TRANSMISSION; CALCITRIOL; INDUCTION;
   INFLUENZA
AB The novel coronavirus (COVID-19) outbreak has covered almost 185 countries worldwide, causing infection to 32, 50,000 people and the death of approximately 2, 30,000 people to date. World Health Organisation (WHO) has declared it a pandemic that seems to be unstoppable as no vaccine or drug is available as of now to kill the virus. Several research labs are trying to develop a vaccine against the virus as soon as possible. Several drugs, like a combination of hydroxychloroquine and azithromycin, have been shown to be beneficial in COVID-19 infected patients. In-silico experiments suggest that methylcobalamin and valproic acid can reduce virus titer and thereby reducing the severity of the infection. BCG vaccine may provide immunity against the infection of coronavirus. As there is a strong correlation between the immune system of the infected person and the virulence of coronavirus, any therapy which could help in boosting the immune system shall be of prime importance. Hence, the efficacy of convalescent plasma therapy has been tried in COVID-19 infection, thinking that the antibodies from convalescent plasma might suppress viremia. Angiotensin-converting enzyme 2 (ACE2) receptors have been shown to be the entry point in human cells for COVID-19. RNA dependent RNA polymerase (RdRp) of the virus could be a potent target for inhibitor drug design and discovery against COVID-19. Recently, non-classical actions of vitamin D have been recognized. It affects upon cell proliferation and differentiation as well as immunologic functions resulting in an ability to maintain tolerance and to promote protective immunity. Zinc has been shown to affect multiple aspects of the immune system. Zinc has a significant role in the normal development and function of cells mediating innate immunity, neutrophils, and natural killer (NK) cells. The deficiency of zinc affects macrophages, phagocytosis, cytokine production, and intracellular killing. As there is a strong correlation between the immune system of the infected person and the virulence of coronavirus, any therapy which could help in boosting the immune system shall be of prime importance.
C1 [Hoda, Quaisul; Pahwa, Shilpa; Gupta, Chitra] Lloyd Inst Management & Technol, Knowledge Pk 2, Greater Noida 201310, Uttar Pradesh, India.
   [Fatma, Askary] Govt Delhi, Directorate Hlth Serv, F-17 Arjun Gali, New Delhi 110032, India.
RP Hoda, Q (corresponding author), Lloyd Inst Management & Technol, Dept Pharm, Knowledge Pk 2, Greater Noida 201310, Uttar Pradesh, India.
EM quaisul.hoda@lloydcollege.in
RI GUPTA, CHITRA/AGG-4574-2022
CR Almerighi C, 2009, CYTOKINE, V45, P190, DOI 10.1016/j.cyto.2008.12.009
   Arts RJW, 2018, CELL HOST MICROBE, V23, P89, DOI 10.1016/j.chom.2017.12.010
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629
   BHALLA AK, 1984, J IMMUNOL, V133, P1748
   Bhavesh NS, 2020, PREPRINTS, V01, P93
   Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974
   Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175
   Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634
   Cheng Y, 2005, EUR J CLIN MICROBIOL, V24, P44, DOI 10.1007/s10096-004-1271-9
   Cui CM, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101295
   Daniel C, 2008, J PHARMACOL EXP THER, V324, P23, DOI 10.1124/jpet.107.127209
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560
   Gorman S, 2007, J IMMUNOL, V179, P6273, DOI 10.4049/jimmunol.179.9.6273
   Graham RL, 2008, VIRUS RES, V133, P88, DOI 10.1016/j.virusres.2007.02.017
   Gregori S, 2001, J IMMUNOL, V167, P1945, DOI 10.4049/jimmunol.167.4.1945
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Kasmi Y, 2019, CORONAVIRIDAE 100000, V1, P135
   KUMEL G, 1990, J GEN VIROL, V71, P2989, DOI 10.1099/0022-1317-71-12-2989
   Lai ST, 2005, EUR J CLIN MICROBIOL, V24, P583, DOI 10.1007/s10096-005-0004-z
   LEMIRE JM, 1984, J CLIN INVEST, V74, P657, DOI 10.1172/JCI111465
   Letko Michael, 2020, bioRxiv, DOI 10.1101/2020.01.22.915660
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Mattner F, 2000, EUR J IMMUNOL, V30, P498, DOI 10.1002/1521-4141(200002)30:2<498::AID-IMMU498>3.3.CO;2-H
   Modrow S, 2013, MOL VIROLOGY, P185, DOI DOI 10.1007/978-3-642-20718-1_14
   Narayanan N, 2020, PREPRINTS, V72, P2057
   Patel VB, 2016, CIRC RES, V118, P1313, DOI 10.1161/CIRCRESAHA.116.307708
   Penna G, 2005, BLOOD, V106, P3490, DOI 10.1182/blood-2005-05-2044
   Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058
   Rodriguez M, 2009, AIDS RES HUM RETROV, V25, P9, DOI 10.1089/aid.2008.0183
   Saikatendu KS, 2005, STRUCTURE, V13, P1665, DOI 10.1016/j.str.2005.07.022
   Shang WL, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-020-0170-0
   Soo YOY, 2004, CLIN MICROBIOL INFEC, V10, P676, DOI 10.1111/j.1469-0691.2004.00956.x
   Suara RO, 2004, ANTIMICROB AGENTS CH, V48, P783, DOI 10.1128/AAC.48.3.783-790.2004
   Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543
   Ujike M, 2015, VIRUSES-BASEL, V7, P1700, DOI 10.3390/v7041700
   Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094
   Villamor E, 2006, NUTR REV, V64, P226, DOI [10.1111/j.1753-4887.2006.tb00205.x, 10.1301/nr.2006.may.226-233]
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wessels I, 2020, THORAX, V75, P253, DOI 10.1136/thoraxjnl-2019-213357
   Williams C.J.B, 1849, LOND J MED, V1, P1, DOI [10.1136/bmj.s2-1.1.1, DOI 10.1136/BMJ.S2-1.1.1]
   Woodworth BA, 2010, AMJ RHINOL ALLERGY, V24, P6, DOI 10.2500/ajra.2010.24.3379
   World Health Organization, 2003, Midwifery, V19, P72
   World Health Organization, 2020, PNEUM UNKN CAUS CHIN
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
NR 49
TC 0
Z9 0
U1 0
U2 3
PU INT JOURNAL PHARMACEUTICAL SCIENCES & RESEARCH
PI HARYANA
PA 1117, SECTOR 12 A, PANCHKULA, HARYANA, 00000, INDIA
SN 0975-8232
J9 INT J PHARM SCI RES
JI Int. J. Pharm.l Sci. Res.
PD NOV
PY 2020
VL 11
IS 11
BP 5284
EP 5289
DI 10.13040/IJPSR.0975-8232.11(11).5284-89
PG 6
WC Pharmacology & Pharmacy
WE Emerging Sources Citation Index (ESCI)
SC Pharmacology & Pharmacy
GA OM1EQ
UT WOS:000585772600001
OA gold
DA 2022-04-20
ER

PT J
AU Xiong, J
   Wang, K
   Yan, J
   Xu, L
   Huang, H
AF Xiong, Jie
   Wang, Ke
   Yan, Jie
   Xu, Lu
   Huang, Han
TI The window of opportunity brought by the COVID-19 pandemic: an ill wind
   blows for digitalisation leapfrogging
SO TECHNOLOGY ANALYSIS & STRATEGIC MANAGEMENT
LA English
DT Article; Early Access
DE COVID-19; window of opportunity; leapfrogging; digital transformation
ID CATCH-UP; INDUSTRIAL LEADERSHIP; STRATEGY; CRISIS
AB We analyse how the COVID-19 pandemic crisis created the window of opportunity (WOP) in the digital industry and digital applications. These led to the leapfrogging of digital transformation in China. This was considered a major contribution to the pandemic recovery in early to mid-2020. By exploring this phenomenon, we examine alternatives for sustainable development during such turbulent circumstances mediating the destruction arisen from the crisis. We unveil the mechanisms that reveal the large-scale digitalisation that emerged as part of the response to managing the crisis. We find that during this crisis in China, the WOPs from policy, technology and demand perspectives facilitated the leapfrogging of the digital transformation in numerous social and economic areas. More importantly, we also discover that the WOPs are unevenly distributed among firms, time, and locations. Based on these results, we put forth that the COVID-19 pandemic brings a relative window of opportunity (RWOP) to society, impacting industries and firms. However, these impacts are disproportionately distributed. To the best of our knowledge, this is one of the first studies to illustrate how a social crisis leads to WOPs enhancing digital transformation. Furthermore, this also ultimately provided a coping mechanism to deal with the pandemic.
C1 [Xiong, Jie] ESSCA Sch Management, Dept Strategy Entrepreneurship & Int Business, Angers 01, France.
   [Wang, Ke; Huang, Han] Huazhong Univ Sci & Technol, Sch Management, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China.
   [Yan, Jie] Grenoble Ecole Management, Dept Management & Technol, Grenoble, France.
   [Xu, Lu] CleRMa UCA, Dept Innovat & Dev, ESC Clermont Business Sch, Clermont Ferrand, France.
   [Huang, Han] Wuhan Technol & Business Univ, Sch Management, 3 Huangjiahu West Rd, Wuhan 430065, Hubei, Peoples R China.
RP Huang, H (corresponding author), Huazhong Univ Sci & Technol, Sch Management, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China.; Huang, H (corresponding author), Wuhan Technol & Business Univ, Sch Management, 3 Huangjiahu West Rd, Wuhan 430065, Hubei, Peoples R China.
EM hwang.han@outlook.com
RI Wang, Ke/AAC-8144-2022
OI Yan, Jie/0000-0002-1521-5341; Huang, Han/0000-0001-7279-9745; Xu,
   Lu/0000-0001-9293-0536; Wang, Ke/0000-0002-1077-1082
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [71772142]
FX This research was funded by the National Natural Science Foundation of
   China (#71772142). The first two authors contributed equally.
CR Chakrabarti A, 2015, STRATEGIC MANAGE J, V36, P1717, DOI 10.1002/smj.2309
   Coccia M, 2017, TECHNOL ANAL STRATEG, V29, P1048, DOI 10.1080/09537325.2016.1268682
   CRESWELL JW, 2007, QUALITATIVE INQUIRY
   de Figueiredo RJP, 2019, STRATEGIC MANAGE J, V40, P1268, DOI 10.1002/smj.3026
   DUNCAN RB, 1972, ADMIN SCI QUART, V17, P313, DOI 10.2307/2392145
   Guennif S, 2012, RES POLICY, V41, P430, DOI 10.1016/j.respol.2011.09.005
   Hain DS, 2020, IND CORP CHANGE, V29, P1233, DOI 10.1093/icc/dtaa021
   HANNAN MT, 1984, AM SOCIOL REV, V49, P149, DOI 10.2307/2095567
   Huang H, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13042144
   Kang H, 2017, RES POLICY, V46, P376, DOI 10.1016/j.respol.2016.09.004
   KEATS BW, 1988, ACAD MANAGE J, V31, P570, DOI 10.2307/256460
   Landini F, 2017, RES POLICY, V46, P431, DOI 10.1016/j.respol.2016.09.005
   Lee K, 2001, RES POLICY, V30, P459, DOI 10.1016/S0048-7333(00)00088-3
   Lee K, 2017, RES POLICY, V46, P338, DOI 10.1016/j.respol.2016.09.006
   Lim ENK, 2009, STRATEGIC MANAGE J, V30, P577, DOI 10.1002/smj.752
   Mathews JA, 2005, CALIF MANAGE REV, V47, P6, DOI 10.2307/41166293
   Morrison A, 2017, RES POLICY, V46, P417, DOI 10.1016/j.respol.2016.09.007
   Mowery D., 1999, SOURCES IND LEADERSH
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Oetzel J, 2021, STRATEGIC MANAGE J, V42, P1545, DOI 10.1002/smj.3272
   Ramani SV, 2018, RES POLICY, V47, P1538, DOI 10.1016/j.respol.2018.05.008
   Reymen IMMJ, 2015, STRATEG ENTREP J, V9, P351, DOI 10.1002/sej.1201
   Teece D.J., 2020, STRATEGIC MANAGEMENT, V1, P103
   van Hoek R, 2020, INT J OPER PROD MAN, V40, P341, DOI 10.1108/IJOPM-03-2020-0165
   VANDEVEN AH, 1992, STRATEGIC MANAGE J, V13, P169, DOI 10.1002/smj.4250131013
   Verbeke A, 2020, BRIT J MANAGE, V31, P444, DOI 10.1111/1467-8551.12422
   Wan WP, 2009, STRATEGIC MANAGE J, V30, P791, DOI 10.1002/smj.744
   Wang YG, 2020, J BUS RES, V116, P214, DOI 10.1016/j.jbusres.2020.05.029
   Wenzel M, 2021, STRATEGIC MANAGE J, V42, pV7, DOI 10.1002/smj.3161
   Xiong J., 2021, J BUS STRAT, DOI [10.1108/JBS-10-2020-0223, DOI 10.1108/JBS-10-2020-0223]
   Yin R.K., 2003, CASE STUDY RES DESIG, V179
   Yu J., 2020, BRIT J HEALTHCARE MA, V26, P1
   Zahra SA, 2021, J WORLD BUS, V56, DOI 10.1016/j.jwb.2020.101143
NR 33
TC 1
Z9 1
U1 21
U2 27
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0953-7325
EI 1465-3990
J9 TECHNOL ANAL STRATEG
JI Technol. Anal. Strateg. Manage.
DI 10.1080/09537325.2021.1979212
EA SEP 2021
PG 13
WC Management; Multidisciplinary Sciences
WE Social Science Citation Index (SSCI)
SC Business & Economics; Science & Technology - Other Topics
GA UQ8DN
UT WOS:000696289400001
DA 2022-04-20
ER

PT J
AU Jumbe, V
   Mhango, V
   Muula, A
   Kaima, R
   Chimbwete, LR
   Mangwana, A
   Msutu, B
   Tembo, L
   Bigland, C
   Kewley, S
   Van Hout, MC
AF Jumbe, Vincent
   Mhango, Victor
   Muula, Adamson
   Kaima, Ruth
   Chimbwete, Luntha Rosemary
   Mangwana, Apatsa
   Msutu, Benjamin
   Tembo, Lisa
   Bigland, Charlotte
   Kewley, Stephanie
   Van Hout, Marie Claire
TI A multi-stakeholder situation assessment of COVID-19 disease
   preparedness and mitigation measures in a large prison complex in Malawi
SO INTERNATIONAL JOURNAL OF PRISONER HEALTH
LA English
DT Article; Early Access
DE Prisoners; Malawi; Human rights; Infectious disease; COVID-19; Mandela
   rules
ID TUBERCULOSIS; HEALTH; ACCESS; HIV
AB Purpose Prisons in the sub-Saharan African region face unprecedented challenges during the COVID-19 pandemic. In Malawi, the first prison system case of COVID-19 was notified in July 2020. While prison settings were included in the second domestic COVID-19 response plan within the Law Enforcement cluster (National COVID-19 preparedness and response plan, July-December 2020), they were initially not included in the K157bn (US$210m) COVID-19 fund. The purpose of the study was to assess prison preparedness, prevention and control of COVID-19 in Malawi.. Design/methodology/approach A multi-method situation assessment of the COVID-19 response and human rights assurance of prisoners and staff was conducted in a large prison complex in Malawi. Qualitative research underpinned by the Empirical Phenomenological Psychological (EPP) framework consisted of interviews with key informants such as prison health personnel, senior prison staff, penal and judicial policymakers, government and civil society organisations (n = 14) and focus group discussions with consenting male (n = 48) and female prisoners (n = 48) and prison wardens (n = 24). Prison site visits were supported by detailed observations based on the World Health Organisation Checklist for COVID-19 in prisons (n = 9). Data were collected and analysed thematically using the EPP stepwise approach and triangulated based on Bronfenbrenner's model conceptualising COVID-19 as a multi-level event disrupting the prison eco-system. Findings The results are presented as MICRO-MESO level individual and community experiences of incarceration during COVID-19 spanning several themes: awareness raising and knowledge of COVID-19 in prisons; prison congestion and the impossibility of social distancing; lack of adequate ventilation, hygiene and sanitation and provisions and correct use of personal protective equipment; MESO-MACRO level interplay between the prison community of prisoners and staff and judicial policy impacts; medical system COVID-19 response, infrastructure and access to health care; COVID-19 detection and quarantine measures and prisoner access to the outside world. Originality/value This unique situation assessment of the Malawian prison system response to mitigate COVID-19 illustrates the dynamics at the micro-level whereby prisoners rely on the state and have restricted agency in protecting themselves from disease. This is due to severe structural inadequacies based on low resource allocation to prisons leading to a compromised ability to prevent and treat disease; an infirm and congested infrastructure and bottlenecks in the judicial system fuelling a continued influx of remand detainees leading to high overcapacity. Multi-pronged interventions involving key stakeholders, with prison management and line Ministry as coordinators are warranted to optimise COVID-19 interventions and future disease outbreaks in the Malawian prison system.
C1 [Jumbe, Vincent] Kamuzu Univ Hlth Sci, Dept Hlth Syst & Policy, Blantyre, Malawi.
   [Mhango, Victor; Kaima, Ruth; Chimbwete, Luntha Rosemary; Mangwana, Apatsa; Msutu, Benjamin; Tembo, Lisa] Ctr Human Rights Educ Advice Assistance CHREAA, Blantyre, Malawi.
   [Muula, Adamson] Kamuzu Univ Hlth Sci, Dept Publ Hlth, Blantyre, Malawi.
   [Bigland, Charlotte; Van Hout, Marie Claire] Liverpool John Moores Univ, Publ Hlth Inst, Liverpool, Merseyside, England.
   [Kewley, Stephanie] Liverpool John Moores Univ, Sch Psychol, Liverpool, Merseyside, England.
RP Van Hout, MC (corresponding author), Liverpool John Moores Univ, Publ Hlth Inst, Liverpool, Merseyside, England.
EM m.c.vanhout@ljmu.ac.uk
OI Kewley, stephanie/0000-0001-6841-5577
FU Global Challenges Research Fund (GCRF) Small Grants Scheme 2021;
   Liverpool John Liverpool John Moore's University, 2021
FX The Global Challenges Research Fund (GCRF) Small Grants Scheme 2021,
   Liverpool John Liverpool John Moore's University, 2021. Grant holder:
   Professor Marie Claire Van Hout.
CR Amnesty International, 2020, SUBS AFR PROT DET RI
   Amnesty International, 2020, SO AFR OP LETT SADC
   Amon JJ, 2020, HEALTH HUM RIGHTS, V22, P367
   [Anonymous], 2020, NEWS 24
   Bachelet Michelle, 2020, URG ACT NEED PREV CO
   Banda HT, 2009, INT J TUBERC LUNG D, V13, P1557
   Beaudry G, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003201
   Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX
   Chikoti M, 2020, MALAWI 24
   Chilora S, 2020, TIMES
   Chilundu S., 2020, NATION
   Chimphambano C, 2007, Malawi Med J, V19, P107
   Chireh B, 2020, PAN AFR MED J, V36, DOI 10.11604/pamj.2020.36.121.24133
   Chirwa Z, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00069
   DIGNITY, 2020, SYNTH GUID REC PREV
   Gadama L, 2020, INT J PRISON HEALTH, V16, P303, DOI 10.1108/IJPH-12-2019-0069
   Gondwe A, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10870-1
   Guta W., 2021, MAULA PRISON COVID 1
   Harries AD, 2004, INT J TUBERC LUNG D, V8, P614
   Hout M. C. van, 2020, Journal of Sustainable Development in Africa, V22, P166
   Husserl E.G.A., 1970, LOGICAL INVESTIGATIO
   Jefferson AM, 2019, CRIMINOL CRIM JUSTIC, V19, P572, DOI 10.1177/1748895818787016
   Kachisi Grey S, 2002, Malawi Med J, V14, P17
   Kanyerere HS, 2012, PUBLIC HEALTH ACTION, V2, P10, DOI 10.5588/pha.11.0022
   Kapalamula A., 2020, TIMES
   Karlsson G, 1993, PSYCHOL QUALITATIVE
   Kateta M.W., 2021, MALAWI AUDIT CONFIRM
   Katey D, 2021, INT J PRISON HEALTH, V17, P373, DOI 10.1108/IJPH-12-2020-0101
   Lee K, 2009, GLOB INST, P1
   Lines R., 2020, HLTH HUMAN RIGHTS J
   Lucero-Prisno DE, 2020, GLOB HEALTH RES POL, V5, DOI 10.1186/s41256-020-00148-1
   Makombe SD, 2007, J INFECT DEV COUNTR, V1, P303, DOI 10.3855/jidc.368
   Malawi Inspectorate of Prisons, 2019, REP INSP PRIS POL SE
   Masina L., 2020, VOA NEWS
   Mekonnen B, 2021, INT J GEN MED, V14, P337, DOI 10.2147/IJGM.S287066
   Mhlanga-Gunda R., 2021, COVID 19 PREPAREDNES
   Ministry of Health, 2007, NAT TUB PROGR MAL PO
   Ministry of Health, 2020, NAT COVID 19 PREP RE
   Ministry of Health, 2014, TUBERCULOSIS CONTROL
   Mpawa H, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21623
   Muheya G., 2020, NYASA TIMES
   Mukwenha Solomon, 2021, Public Health Pract (Oxf), V2, P100089, DOI 10.1016/j.puhip.2021.100089
   Muntingh LM, 2020, J HUM RIGHTS PRACT, V12, P284, DOI 10.1093/jhuman/huaa031
   Mzumara GW, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-006035
   Nkengasong JN, 2020, LANCET, V395, P841, DOI 10.1016/S0140-6736(20)30464-5
   Nweze Victor Nnanna, 2021, Public Health Pract (Oxf), V2, P100083, DOI 10.1016/j.puhip.2021.100083
   O'Grady J, 2011, TUBERCULOSIS, V91, P173, DOI 10.1016/j.tube.2010.12.002
   Patel P, 2020, PAN AFR MED J, V35, DOI 10.11604/pamj.supp.2020.35.2.23960
   Penal Reform International (PRI), 2020, COR HEALTHC HUM RIGH
   Pensulo C, 2020, GUARDIAN
   Pensulo C., 2020, CORONAVIRUS BANISHES
   Phiri M.M., 2020, COVID 19 MALAWI FREE
   Prison Insider, 2020, AFR COR PRIS FEV CON
   Reliefweb, 2021, MAL REC 1 SHIPM COVI
   Saalim K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252890
   Simpson PL, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1551
   Singano V, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08841-z
   Sonenthal PD, 2020, LANCET GLOB HEALTH, V8, pE890, DOI 10.1016/S2214-109X(20)30250-3
   Southern African Development Community (SADC), 2020, SADC REG RESP COVID
   Southern African Litigation Centre, 2020, CIV SOC CALLS URG DE
   United Nations Malawi, 2020, MAL COVID 19 SIT UPD
   United Nations Office on Drugs and Crime (UNODC), 2020, POS PAP COVID 19 PRE
   United Nations Office on Drugs and Crime (UNODC) World Health Organization (WHO) UNAIDS and Office of the High Commissioner for Human Rights (OHCHR), 2020, UNODC WHO UNAIDS OHC
   US Department of State, 2020, 2020 COUNTR REP HUM
   Van Hout MC, 2021, PUBLIC HEALTH, V190, pE5, DOI 10.1016/j.puhe.2020.10.016
   Van Hout MC, 2020, PUBLIC HEALTH, V185, P128, DOI 10.1016/j.puhe.2020.06.037
   Van Hout M.C., 2020, HLTH HUMAN RIGHTS J
   Van Hout MC, 2021, INT J PRISON HEALTH, DOI 10.1108/IJPH-05-2021-0045
   Water Supply and Sanitation Collaborative Council, 2020, WASH ASS COVID 19 PR
   World Health Organization (WHO), 2020, PREP PREV CONTR COVI
   World Health Organization (WHO), 2020, CHECKL EV PREP PREV
   World Prison Brief, 2020, AFR WORLD PRIS BRIEF
   Zachariah R, 2002, T ROY SOC TROP MED H, V96, P617, DOI 10.1016/S0035-9203(02)90330-5
NR 73
TC 1
Z9 1
U1 0
U2 0
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1744-9200
EI 1744-9219
J9 INT J PRISON HEALTH
JI Int. J. Pris. Health
DI 10.1108/IJPH-10-2021-0105
EA FEB 2022
PG 21
WC Public, Environmental & Occupational Health
WE Emerging Sources Citation Index (ESCI)
SC Public, Environmental & Occupational Health
GA ZE2ZQ
UT WOS:000758757300001
PM 35148041
OA Green Accepted
DA 2022-04-20
ER

PT J
AU Rosman, L
   Armbruster, T
   Kyazimzade, S
   Tugaoen, Z
   Mazzella, AJ
   Deyo, Z
   Walker, J
   Machineni, S
   Gehi, A
AF Rosman, Lindsey
   Armbruster, Tiffany
   Kyazimzade, Sayyad
   Tugaoen, Zachary
   Mazzella, Anthony J.
   Deyo, Zack
   Walker, Jennifer
   Machineni, Sriram
   Gehi, Anil
TI Effect of a virtual self-management intervention for atrial fibrillation
   during the outbreak of COVID-19
SO PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
LA English
DT Article
DE atrial fibrillation; digital health; intervention; patient education;
   telehealth
ID DEPRESSION
AB Background As the pandemic continues to unfold, effective, technology-based solutions are needed to help patients with atrial fibrillation (AF) maintain their health and well-being during the outbreak of COVID-19.
   Methods This single-center, pilot study investigated the effects of a 4-week (eight sessions) virtual AF self-management program. Questionnaires were completed at baseline and 1 week after the intervention, and assessed AF knowledge, adherence to self-management behaviors, mental health, physical function, and disease-specific quality of life in patients with AF. Secondary outcomes included knowledge of COVID-19, intervention, acceptability, and satisfaction.
   Results Of 68 patients who completed baseline questionnaires, 57 participated in the intervention and were included in the analysis (mean age of 73.4 +/- 10.0 years, 60% male). Adherence to AF self-monitoring behaviors, including monitoring their heart rate (p < .001), heart rhythm (p = .003), and blood pressure (p = .013) were significantly improved at the end of the intervention compared with baseline. Symptom identification (p = .007) and management (p < .001) also improved. Reductions in sleep disturbance (p < .001), anxiety (p = .014), and depression (p = .046) were also observed. Misinformation and inaccurate beliefs about COVID-19 were significantly reduced at the end of the intervention compared with baseline.
   Conclusions This pilot study suggests that a virtual patient education program could have beneficial effects on adherence to guideline-recommend self-care of AF, emotional wellbeing, physical function, and knowledge of COVID-19 in patients with AF. Future randomized studies in larger samples are needed to determine the clinical benefits of the intervention.
C1 [Rosman, Lindsey; Armbruster, Tiffany; Mazzella, Anthony J.; Walker, Jennifer; Gehi, Anil] Univ N Carolina, Dept Med, Div Cardiol, 160 Dent Circle,CB 7075,Burnett Womack Bldg, Chapel Hill, NC 27599 USA.
   [Kyazimzade, Sayyad; Tugaoen, Zachary] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA.
   [Deyo, Zack] Univ North Carolina Hosp, Dept Pharm, Chapel Hill, NC USA.
   [Deyo, Zack] Univ N Carolina, Eshelman Sch Pharm, Div Practice Adv & Clin Educ, Chapel Hill, NC 27515 USA.
   [Machineni, Sriram] Univ N Carolina, Dept Med, Div Endocrinol & Metab, Chapel Hill, NC 27515 USA.
RP Rosman, L (corresponding author), Univ N Carolina, Dept Med, Div Cardiol, 160 Dent Circle,CB 7075,Burnett Womack Bldg, Chapel Hill, NC 27599 USA.
EM Lindsey_Rosman@med.unc.edu
CR Ades PA, 2017, MAYO CLIN PROC, V92, P234, DOI 10.1016/j.mayocp.2016.10.014
   Taylor Rod S, 2015, Cochrane Database Syst Rev, pCD007130, DOI [10.1002/14651858.CD007130.pub4, 10.1002/14651858.CD007130.pub3]
   Banerjee A, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.117.004297
   Barnason S, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/HCQ.0000000000000025
   Beyth RJ, 2000, ANN INTERN MED, V133, P687, DOI 10.7326/0003-4819-133-9-200011070-00010
   Calkins H, 2017, J ARRYTHM, V33, P369, DOI 10.1016/j.joa.2017.08.001
   Clarkesmith DE, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008600.pub3
   Desteghe L, 2018, INT J CARDIOL, V272, P123, DOI 10.1016/j.ijcard.2018.07.065
   DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101
   Dougherty CM, 2019, HEART RHYTHM, V16, P453, DOI 10.1016/j.hrthm.2018.10.011
   Eapen ZJ, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003119
   Frasure-Smith N, 2009, CIRCULATION, V120, P134, DOI 10.1161/CIRCULATIONAHA.109.851675
   Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338
   Hays RD, 2018, QUAL LIFE RES, V27, P1885, DOI 10.1007/s11136-018-1842-3
   Hendriks JML, 2012, EUR HEART J, V33, P2692, DOI 10.1093/eurheartj/ehs071
   Hill JA, 2019, HEART RHYTHM, V16, P332, DOI 10.1016/j.hrthm.2018.12.030
   Hindricks G, 2021, EUR HEART J, V42, P373, DOI [10.1093/eurheartj/ehaa612, 10.1093/eurheartj/ehab648, 10.15829/1560-4071-2021-4701]
   Holmes DN, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.118.005358
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040
   Kannan V, 2019, J AM MED INFORM ASSN, V26, P703, DOI 10.1093/jamia/ocz038
   Kaufman BG, 2018, HEART, V104, P494, DOI 10.1136/heartjnl-2017-311800
   Kiss P, 2021, EUR HEART J-QUAL CAR, V7, P18, DOI 10.1093/ehjqcco/qcaa084
   Lampert R, 2014, J AM COLL CARDIOL, V64, P1533, DOI 10.1016/j.jacc.2014.07.959
   Lane DA, 2006, INT J CARDIOL, V110, P354, DOI 10.1016/j.ijcard.2005.07.031
   Mutsaerts MAQ, 2013, HUM REPROD, V28, P979, DOI 10.1093/humrep/det026
   Obeid Jihad S, 2017, J Clin Transl Sci, V1, P246, DOI 10.1017/cts.2017.301
   Reza N, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.120.007219
   Richards EA, 2018, INT J HEALTH PROMOT, V56, P51, DOI 10.1080/14635240.2017.1415160
   Rosman L., 2021, PACING CLIN ELECTROP
   Shiffman D, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.22119
   Spertus J, 2011, CIRC-ARRHYTHMIA ELEC, V4, P15, DOI 10.1161/CIRCEP.110.958033
   Thrall G, 2006, AM J MED, V119, DOI 10.1016/jamjmed.2005.10.057
   Valtorta NK, 2016, HEART, V102, P1009, DOI 10.1136/heartjnl-2015-308790
   Wessler BS, 2020, JAMA CARDIOL, V5, P981, DOI 10.1001/jamacardio.2020.2890
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021
NR 37
TC 4
Z9 4
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0147-8389
EI 1540-8159
J9 PACE
JI PACE-Pacing Clin. Electrophysiol.
PD MAR
PY 2021
VL 44
IS 3
BP 451
EP 461
AR 1-11
DI 10.1111/pace.14188
EA FEB 2021
PG 11
WC Cardiac & Cardiovascular Systems; Engineering, Biomedical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Engineering
GA QQ6MG
UT WOS:000618935200001
PM 33565642
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Fanos, V
   Pintus, R
   Pintus, MC
   Mussap, M
   Marcialis, MA
AF Fanos, Vassilios
   Pintus, Roberta
   Pintus, Maria Cristina
   Mussap, Michele
   Marcialis, Maria Antonietta
TI Seven secrets of COVID-19: fever, ACE2 receptors, gut-lung axis,
   metabolomics, microbiomics, probiotics, diet
SO JOURNAL OF PEDIATRIC AND NEONATAL INDIVIDUALIZED MEDICINE
LA English
DT Review
DE COVID-19; Coronavirus; fever; ACE2 receptors; gut-lung axis;
   metabolomics; microbiomics; probiotics; diet
AB The aim of this work is to investigate 7 secrets of COVID-19 (fever, ACE2 receptors, gut-lung axis, metabolomics, microbiomics, probiotics, diet), hoping to reveal a small part of some of these and to increase anyhow the knowledge on SARS-CoV-2 and its weaknesses to be able to defeat it.
   In particular, in the opinion of the authors, significant improvements in contrasting the Coronavirus, and the pandemics that will follow, could derive from the use of "omics" disciplines, namely metabolomics (the stethoscope of the future) and microbiomics (an unrecognized player).
   The discovery of new biomarkers using metabolomics could be used in clinical practice as predictive diagnostic tools or to evaluate the effectiveness and toxicity of a drug, in order to be able to provide the patient with a personalized, tailor-made medicine: precision medicine.
   Our understanding of the role of the gut microbiome in COVID-19 infection remains in its infancy, but future research may potentially aid our understanding of viral infection, and create new ways in which we might treat and prevent it.
   We strongly believe that the 3 M's (Metabolomics, Microbiomics and Machine learning [Artificial Intelligence]) will be the right route to the future for risk assessment, early diagnosis, patient management and decision-making.
   By now, probiotics could help, fighting face to face against the virus. Moreover, the diet may be a key driver in determining the severity of COVID-19 and further studies are needed to explore the secret language between diet, bacteria, viruses and metabolites in determining individualized susceptibility or resilience to COVID-19.
C1 [Fanos, Vassilios; Pintus, Roberta; Mussap, Michele] Univ Cagliari, Dept Surg, Cagliari, Italy.
   [Fanos, Vassilios; Pintus, Maria Cristina; Marcialis, Maria Antonietta] AOU Cagliari, Neonatal Intens Care Unit, Cagliari, Italy.
RP Pintus, R (corresponding author), Univ Cagliari, Dept Surg, Cagliari, Italy.
EM gomberta@icloud.com
RI Mussap, Michele/O-6984-2019
OI Mussap, Michele/0000-0002-3417-1284
CR Acevedo MAW, 2021, CURR OPIN VIROL, V46, P15, DOI 10.1016/j.coviro.2020.08.005
   Agus A, 2018, CELL HOST MICROBE, V23, P716, DOI 10.1016/j.chom.2018.05.003
   Ahmed M, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100527
   Angurana SK, 2021, BRIT J NUTR, V126, P1564, DOI 10.1017/S000711452000361X
   Antunes AEC, 2020, FOOD RES INT, V136, DOI 10.1016/j.foodres.2020.109577
   Arjmand Babak, 2020, Gastroenterol Hepatol Bed Bench, V13, P321
   Ashrafian H, 2021, MED PRIN PRACT, V30, P301, DOI 10.1159/000513545
   Baghbani T, 2020, MICROB CELL FACT, V19, DOI 10.1186/s12934-020-01483-1
   Bakadia BM, 2021, LIFE SCI, V264, DOI 10.1016/j.lfs.2020.118653
   Barberis E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228623
   Barik S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228776
   Bartley JM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01164
   Bassareo PP, 2020, J PEDIATR-US, V224, P184, DOI 10.1016/j.jpeds.2020.06.033
   Bassareo PP, 2020, MINERVA PEDIATR, DOI DOI 10.23736/S0026-4946.20.06140-X
   Baud D, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00186
   Blasco H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73966-5
   Bosi A, 2020, INT J TRYPTOPHAN RES, V13, DOI 10.1177/1178646920928984
   Bottari B, 2021, INT J FOOD SCI NUTR, V72, P293, DOI 10.1080/09637486.2020.1807475
   Bousquet J, 2021, WORLD ALLERGY ORGAN, V14, DOI 10.1016/j.waojou.2020.100498
   Bousquet J, 2021, INT ARCH ALLERGY IMM, V182, P489, DOI 10.1159/000513538
   Bousquet J, 2020, CLIN TRANSL ALLERGY, V10, DOI 10.1186/s13601-020-00362-7
   Bruzzone C, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101645
   Budden KF, 2017, NAT REV MICROBIOL, V15, P55, DOI 10.1038/nrmicro.2016.142
   Butler MJ, 2020, BRAIN BEHAV IMMUN, V87, P53, DOI 10.1016/j.bbi.2020.04.040
   Cavezzi A, 2020, CLINICS PRACT, V10, P24, DOI 10.4081/cp.2020.1271
   Chen WS, 2017, INT IMMUNOPHARMACOL, V42, P44, DOI 10.1016/j.intimp.2016.11.001
   Comitini Federica, 2020, Minerva Pediatr, DOI 10.23736/S0026-4946.20.05938-1
   D'Adamo GL, 2021, IMMUNOL CELL BIOL, V99, P168, DOI 10.1111/imcb.12404
   Dhar D, 2020, VIRUS RES, V285, DOI 10.1016/j.virusres.2020.198018
   Dietrich CG, 2020, EUR J GASTROEN HEPAT, V32, P1475, DOI 10.1097/MEG.0000000000001922
   Dog an, 2020, J MED VIROL
   Dong YW, 2019, BIOCHEM BIOPH RES CO, V516, P365, DOI 10.1016/j.bbrc.2019.06.039
   dos Santos GC, 2020, ANAL CHEM, V92, P15688, DOI 10.1021/acs.analchem.0c04679
   Edeas M, 2020, INT J INFECT DIS, V97, P303, DOI 10.1016/j.ijid.2020.05.110
   Fajgenbaum DC, 2020, NEW ENGL J MED, V383, P2255, DOI 10.1056/NEJMra2026131
   Fan J, 2020, J INFECTION, V81, pE64, DOI 10.1016/j.jinf.2020.06.047
   Fan Y, 2021, NAT REV MICROBIOL, V19, P55, DOI 10.1038/s41579-020-0433-9
   Fanos V, 2016, METABOLOMICS AND MICROBIOMICS: PERSONALIZED MEDICINE FROM THE FETUS TO THE ADULT, P1
   Fanos V, 2020, IN PRESS
   Fanos V, 2020, J PEDIATR NEONATAL I, V9, DOI 10.7363/090139
   Ferreira C, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8101514
   Fraser Douglas D, 2020, Crit Care Explor, V2, pe0272, DOI 10.1097/CCE.0000000000000272
   Furue M, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7070090
   Galeotti C, 2020, NAT REV RHEUMATOL, V16, P413, DOI 10.1038/s41584-020-0448-7
   Gohil K, 2021, 3 BIOTECH, V11, DOI 10.1007/s13205-020-02554-1
   Grassin-Delyle S, 2021, EBIOMEDICINE, V63, DOI 10.1016/j.ebiom.2020.103154
   Gu SL, 2020, CLIN INFECT DIS, V71, P2669, DOI 10.1093/cid/ciaa709
   Guimaraes Marilia Z. P., 2007, P151
   Gul MH, 2021, EXPERT REV RESP MED, V15, P171, DOI 10.1080/17476348.2020.1816172
   Gupta VK, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18476-8
   Haiminen N, 2020, FUNCTIONAL PROFILING
   Han MZ, 2020, COMPUT STRUCT BIOTEC, V18, P3615, DOI 10.1016/j.csbj.2020.11.027
   He LH, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01388
   Hoang A, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100433
   Hod M, NEW TECHNOLOGIES PER
   Hon KLE, 2020, WORLD J PEDIATR, V16, P323, DOI 10.1007/s12519-020-00375-z
   Invernizzi R, 2020, IMMUNOLOGY, V160, P171, DOI 10.1111/imm.13195
   Janda L, 2021, BIOLOGIA, V76, P819, DOI 10.2478/s11756-020-00614-8
   Joung EJ, 2007, ANTIOXID REDOX SIGN, V9, P2087, DOI 10.1089/ars.2007.1827
   Kim M, 2016, CELL HOST MICROBE, V20, P202, DOI 10.1016/j.chom.2016.07.001
   Korenori Y, 2013, MOL NUTR FOOD RES, V57, P854, DOI 10.1002/mnfr.201200689
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Li S, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.145027
   Liu Q, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021427
   Lyon J, 2017, JAMA-J AM MED ASSOC, V317, P1713, DOI 10.1001/jama.2017.3023
   Malavolta M, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/4159013
   Marcialis MA, 2020, J MATERN-FETAL NEO M, DOI 10.1080/14767058.2020.1815701
   Marcialis MA, 2021, CLIN INFECT DIS, V72, P2245, DOI 10.1093/cid/ciaa965
   Marotz Clarisse, 2020, medRxiv, DOI 10.1101/2020.11.19.20234229
   Marsland BJ, 2015, ANN AM THORAC SOC, V12, pS150, DOI 10.1513/AnnalsATS.201503-133AW
   Martinez OM, 2020, NAT MED, V26, P1819, DOI 10.1038/s41591-020-1140-9
   Mehta Puja, 2020, Lancet, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Meoni G, 2020, METABOLOMIC LIPIDOMI
   Migaud M, 2020, AM J RESP CELL MOL, V63, P396, DOI 10.1165/rcmb.2020-0206LE
   Miniello VL, 2015, CLIN CHIM ACTA, V451, P88, DOI 10.1016/j.cca.2015.01.022
   Mitra B, 2020, EMERG MED AUSTRALAS, V32, P867, DOI 10.1111/1742-6723.13578
   Morais AHA, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061737
   Moran MM, 2018, BRIT J PHARMACOL, V175, P2185, DOI 10.1111/bph.14044
   Mussap M, 2020, EXPERT REV CLIN PHAR, V13, P115, DOI 10.1080/17512433.2020.1713750
   Nalli M, 2017, FITOTERAPIA, V122, P126, DOI 10.1016/j.fitote.2017.09.007
   O'Shea TJ, 2014, EMERG INFECT DIS, V20, P741, DOI 10.3201/eid2005.130539
   Ogawa N, 2016, CELL CALCIUM, V60, P115, DOI 10.1016/j.ceca.2016.02.009
   Okumura Y, 2010, BIOSCI BIOTECH BIOCH, V74, P1068, DOI 10.1271/bbb.90964
   Olaimat AN, 2020, NPJ SCI FOOD, V4, DOI 10.1038/s41538-020-00078-9
   Paez-Franco JC, 2020, RES SQUARE
   Pang XC, 2020, ACTA PHARMACOL SIN, V41, P1255, DOI 10.1038/s41401-020-0430-6
   Paraluppi V, 2020, J PEDIATR NEONATAL I, V9, DOI 10.7363/090138
   Patel SS, 2020, CRIT REV FOOD SCI, V60, P887, DOI 10.1080/10408398.2018.1552244
   Peng Y, 2020, GASTROENTEROLOGY
   Perikleous E, 2020, PEDIATR PULM, V55, P3252, DOI 10.1002/ppul.25087
   Peroni DG, 2020, ACTA PAEDIATR, V109, P2139, DOI 10.1111/apa.15417
   Pinna G, 2020, CURR PEDIATR REV
   Polonikov A, 2020, ACS INFECT DIS, V6, P1558, DOI 10.1021/acsinfecdis.0c00288
   Rajeev R, 2020, VIRUS RES, V290, DOI 10.1016/j.virusres.2020.198175
   Rajula HSR, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56090455
   Ren L, DYNAMICS UPPER RESP
   Rishi P, 2020, INDIAN J MICROBIOL, V60, P420, DOI 10.1007/s12088-020-00908-0
   Saleh J, 2020, MITOCHONDRION, V54, P1, DOI 10.1016/j.mito.2020.06.008
   Sapkota D, 2021, J CLIN PATHOL, V74, P344, DOI 10.1136/jclinpath-2020-206834
   Scaldaferri F, 2020, INFLAMM BOWEL DIS, V26, P1306, DOI 10.1093/ibd/izaa181
   Segal JP, 2020, THER ADV GASTROENTER, V13, DOI 10.1177/1756284820974914
   Sen R, 2020, FUTURE DRUG DISCOV, V2020
   Sestili P, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.579944
   Shahbazi R, 2020, MOLECULES, V25, DOI 10.3390/molecules25214891
   Sharma L, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8111744
   Shekerdemian LS, 2020, JAMA PEDIATR, V174, P868, DOI 10.1001/jamapediatrics.2020.1948
   Shelly A, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12101150
   Shen B., 2020, CELL, V182, P59, DOI [10.1016/j.cell.2020.05.032, DOI 10.1016/j.cell.2020.05.032]
   Sinaei R, 2021, WORLD J PEDIATR, V17, P10, DOI 10.1007/s12519-020-00392-y
   Song JW, 2020, CELL METAB, V32, P188, DOI 10.1016/j.cmet.2020.06.016
   Song XY, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.20495
   Soni VK, 2020, EUR J PHARMACOL, V886, DOI 10.1016/j.ejphar.2020.173551
   Srinivasan K, 2016, CRIT REV FOOD SCI, V56, P1488, DOI 10.1080/10408398.2013.772090
   Suhail S, 2020, PROTEIN J, V39, P644, DOI 10.1007/s10930-020-09935-8
   Sundararaman A, 2020, APPL MICROBIOL BIOT, V104, P8089, DOI 10.1007/s00253-020-10832-4
   Terada Y, 2015, J NAT PROD, V78, P1937, DOI 10.1021/acs.jnatprod.5b00272
   Thomas T, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140327
   Tiwari SK, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01877
   de Lima RMT, 2018, PHYTOTHER RES, V32, P1885, DOI 10.1002/ptr.6134
   Trottein F, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107915
   van der Lelie D, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00453-20
   Varvarousis D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16857-6
   Viana SD, 2020, AGEING RES REV, V62, DOI 10.1016/j.arr.2020.101123
   Walton GE, 2021, BRIT J NUTR, V126, P219, DOI 10.1017/S0007114520003980
   Wang J, 2020, ACE2 EXPRESSION COLO, DOI 10.1101/2020.02.05.20020545
   Watanabe T, 2015, J NUTR SCI VITAMINOL, V61, pS86, DOI 10.3177/jnsv.61.S86
   Wesley Perroud M, 2020, COVID 19 AUTOMATED D
   World Health Organization, FOOD NUTR TIPS SELF
   Wu D, 2020, NATL SCI REV, V7, P1157, DOI 10.1093/nsr/nwaa086
   Wypych TP, 2019, NAT IMMUNOL, V20, P1279, DOI 10.1038/s41590-019-0451-9
   Xiang ZT, 2021, J ORAL MICROBIOL, V13, DOI 10.1080/20002297.2020.1853451
   Xiao F, 2020, GASTROENTEROLOGY, V158, P1831, DOI 10.1053/j.gastro.2020.02.055
   Xu, 2020, PROGR WORSENING RESP, DOI [10.1101/2020.07.13.20152181, DOI 10.1101/2020.07.13.20152181]
   Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1038/s41368-020-0074-X, 10.1038/s41368-020-0074-x]
   Yang MQ, 2016, CHIN J NAT MEDICINES, V14, P434, DOI 10.1016/S1875-5364(16)30040-1
   Yildiz S, 2018, MICROBIOME, V6, DOI 10.1186/s40168-017-0386-z
   Yin Y, 2019, BRIT J PHARMACOL, V176, P3364, DOI 10.1111/bph.14766
   Zeberg H, 2020, NATURE, V587, P610, DOI 10.1038/s41586-020-2818-3
   Zeppa SD, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.576551
   Zhao Y, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00362-w
   Zhou J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao4966
   Zhou YD, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000970
   Zhu RY, 2017, PHARMACOL RES, V122, P78, DOI 10.1016/j.phrs.2017.05.019
   Zhu YJ., 2020, GUT MICROBIOTA MAY U, DOI [10.1101/2020.04.22.20076091, DOI 10.1101/2020.04.22.20076091]
   Zmora N, 2019, NAT REV GASTRO HEPAT, V16, P35, DOI 10.1038/s41575-018-0061-2
   Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0
   Zuo T, 2020, GASTROENTEROLOGY, V159, P1302, DOI 10.1053/j.gastro.2020.06.048
NR 147
TC 3
Z9 3
U1 2
U2 2
PU HYGEIA PRESS CORRIDORI MARINELLA
PI QUARTU SANT ELENA
PA VIA MONTECATINI 53, QUARTU SANT ELENA, CA09045, ITALY
SN 2281-0692
J9 J PEDIATR NEONATAL I
JI J. Pediatr. Neonatal Individ. Med.
PD APR
PY 2021
VL 10
IS 1
AR e100145
DI 10.7363/100145
PG 18
WC Pediatrics
WE Emerging Sources Citation Index (ESCI)
SC Pediatrics
GA SJ6QI
UT WOS:000655656800015
DA 2022-04-20
ER

PT J
AU Butt, GF
   Hodson, J
   Wallace, GR
   Rauz, S
   Murray, PI
AF Butt, Gibran F.
   Hodson, James
   Wallace, Graham R.
   Rauz, Saaeha
   Murray, Philip, I
TI Public perceptions of eye symptoms and hospital services during the
   first UK lockdown of the COVID-19 pandemic: a web survey study
SO BMJ OPEN OPHTHALMOLOGY
LA English
DT Article
DE COVID-19; infection; public health
ID PATIENT-CARE; ENGLAND GO; KNOWLEDGE; INFORMATION; ADULTS
AB Objective This study aimed to explore the British public's healthcare-seeking beliefs concerning eye symptoms, and assess how the first COVID-19 lockdown influenced these.
   Methods and analysis An anonymous web-based survey was disseminated through mailing lists and social media between June and August 2020. The survey sought participants' views on the severity and urgency of the need for medical review for four ophthalmic and two general medical scenarios on a five-point scale. Participants were asked to answer questions twice: once ignoring the COVID-19 pandemic, and once taking this into account, with additional questions asked to identify factors influencing the decision to seek medical attention and ward admission.
   Results A total of 402 participants completed the survey (mean age 61.6 years, 63.1% female and 87.7% of white ethnicity). Scores for symptom severity and urgency of medical review increased significantly with the severity of the clinical scenario (both p<0.001). However, participants gave significantly lower scores for the urgency of medical attention when accounting for the COVID-19 pandemic (compared with no pandemic) for all scenarios (all p<0.001). Younger age, greater deprivation and non-white ethnicity were correlated with a lower perception of seriousness and urgency of medical attention.
   Conclusions During the first UK lockdown of the COVID-19 pandemic, reduced urgency of medical review for ocular and systemic pathologies was reported in response to the pandemic, which represents a barrier to healthcare-seeking behaviour. This has the potential to critically delay medical review and timely management, negatively impacting patient outcomes.
C1 [Butt, Gibran F.; Wallace, Graham R.; Rauz, Saaeha; Murray, Philip, I] Univ Birmingham, Acad Unit Ophthalmol, Inst Inflammat & Ageing, Birmingham, W Midlands, England.
   [Hodson, James] Univ Hosp Birmingham NHS Fdn Trust, Med Stat, Birmingham, W Midlands, England.
   [Rauz, Saaeha] Sandwell & West Birmingham Hosp NHS Trust, Ophthalmol, Birmingham, W Midlands, England.
RP Rauz, S (corresponding author), Univ Birmingham, Acad Unit Ophthalmol, Inst Inflammat & Ageing, Birmingham, W Midlands, England.; Rauz, S (corresponding author), Sandwell & West Birmingham Hosp NHS Trust, Ophthalmol, Birmingham, W Midlands, England.
EM s.rauzs.rauz@bham.ac.uk
RI Rauz, Saaeha/ABF-2202-2021
OI Rauz, Saaeha/0000-0003-4627-3496; Murray, Philip/0000-0001-8491-3795
FU Medical Research Council (MRC) Developmental Pathway Funding SchemeUK
   Research & Innovation (UKRI)Medical Research Council UK (MRC)
   [MR/N019016/1]; MRCUK Research & Innovation (UKRI)Medical Research
   Council UK (MRC) [MR/N019016/1]
FX This study was supported by a Medical Research Council (MRC)
   Developmental Pathway Funding Scheme (MR/N019016/1). GFB is funded by
   the MRC (MR/N019016/1).
CR Academy of Medical Royal Colleges, 2020, PAT PUBL MUST CONT S
   Aghababaeian H, 2020, ALCOHOL, V88, P29, DOI 10.1016/j.alcohol.2020.07.006
   Al-Khersan H, 2021, AM J OPHTHALMOL, V222, P368, DOI 10.1016/j.ajo.2020.08.044
   Ali SH, 2020, JMIR PUBLIC HLTH SUR, V6, P154, DOI 10.2196/21071
   [Anonymous], 2020, LANCET INFECT DIS, V20, P875, DOI 10.1016/S1473-3099(20)30565-X
   [Anonymous], 2020, Nature, DOI 10.1038/d41586-020-01409-2
   Anwar A, 2020, CUREUS, V12, DOI 10.7759/cureus.10453
   Babu N, 2020, INDIAN J OPHTHALMOL, V68, P1540, DOI 10.4103/ijo.IJO_1673_20
   Benigeri M, 2003, HEALTH PROMOT INT, V18, P381, DOI 10.1093/heapro/dag409
   Bergman YS, 2020, INT PSYCHOGERIATR, V32, P1371, DOI 10.1017/S1041610220001258
   Bin Naeem S, 2021, HEALTH INFO LIBR J, V38, P143, DOI 10.1111/hir.12320
   Care Quality Comission, 2021, NEW STRAT CHANG WORL
   Desai SM, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.104988
   Enoch J, 2019, JAMA OPHTHALMOL, V137, P1317, DOI 10.1001/jamaophthalmol.2019.3537
   Hardesty DM, 2004, J BUS RES, V57, P98, DOI 10.1016/S0148-2963(01)00295-8
   Hardey M, 1999, SOCIOL HEALTH ILL, V21, P820, DOI 10.1111/1467-9566.00185
   Hattenbach LO, 2021, OPHTHALMOLOGE, V118, P166, DOI 10.1007/s00347-021-01411-7
   Hung KKC, 2022, INT J HEALTH POLICY, V11, P508, DOI 10.34172/ijhpm.2020.183
   Ibrahim YW, 2009, BRIT J OPHTHALMOL, V93, P1319, DOI 10.1136/bjo.2008.151167
   Irving EL, 2018, OPHTHAL PHYSL OPT, V38, P422, DOI 10.1111/opo.12566
   Kordovski VM, 2020, PERCEPT MOTOR SKILL, V127, P960, DOI 10.1177/0031512520938178
   Lassale C, 2020, BRAIN BEHAV IMMUN, V88, P44, DOI 10.1016/j.bbi.2020.05.074
   Leigh JP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241259
   Lewis K, 2020, J PSYCHIATR PRACT, V26, P400, DOI 10.1097/PRA.0000000000000488
   Li J, 2021, J MED VIROL, V93, P1449, DOI 10.1002/jmv.26424
   Mckinsey Company, 2020, COVID 19 UK ASS JOBS
   Miedziak AI, 1999, OPHTHALMOLOGY, V106, P1166, DOI 10.1016/S0161-6420(99)90250-6
   Ministry of Housing Communities and Local Government MHCLG, 2019, ENGLISH INDICES DEPR
   Moorthy A, 2020, J PUBLIC HEALTH-UK, V42, P486, DOI 10.1093/pubmed/fdaa096
   Moussa G, 2020, BRIT J HOSP MED, V81, DOI 10.12968/hmed.2020.0408
   Moussa G, 2021, EYE, V35, P2146, DOI 10.1038/s41433-020-01333-9
   Nair AG, 2020, INDIAN J OPHTHALMOL, V68, P725, DOI 10.4103/ijo.IJO_797_20
   Nguyen-Huynh MN, 2020, STROKE, V51, P2918, DOI 10.1161/STROKEAHA.120.031099
   NHS England Statistics, 2020, A E ATT EM ADM
   Pennycook G, 2020, J PERS, V88, P185, DOI 10.1111/jopy.12476
   Posarelli C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239796
   Poyser A, 2021, EUR J OPHTHALMOL, V31, P2894, DOI 10.1177/1120672120974944
   Poyser A, 2021, EYE, V35, P2322, DOI 10.1038/s41433-020-01137-x
   Pritchard R, 2020, BMC PUBLIC HLTH, DOI [10.21203/rs.3.rs-76617/v1, DOI 10.21203/RS.3.RS-76617/V1]
   Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768
   Robles-Holmes Hailey, 2022, Am J Emerg Med, V53, P276, DOI 10.1016/j.ajem.2021.05.011
   ROSENSTOCK IM, 1966, MILBANK FUND Q, V44, P94, DOI 10.2307/3348967
   Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651
   Salvetat ML, 2021, EUR J OPHTHALMOL, DOI 10.1177/11206721211028046
   Scott AW, 2016, JAMA OPHTHALMOL, V134, P1111, DOI 10.1001/jamaophthalmol.2016.2627
   Sharma M, 2020, STROKE VASC NEUROL, V5, P403, DOI 10.1136/svn-2020-000441
   Shickle D, 2014, OPHTHAL PHYSL OPT, V34, P30, DOI 10.1111/opo.12099
   Shickle D, 2014, OPHTHAL PHYSL OPT, V34, P38, DOI 10.1111/opo.12100
   Simons G, 2017, ARTHRIT CARE RES, V69, P633, DOI 10.1002/acr.22979
   Sindermann C, 2020, CURR OPIN PSYCHOL, V36, P44, DOI 10.1016/j.copsyc.2020.03.014
   Smith K, 2020, EVID-BASED MENT HEAL, V23, P89, DOI 10.1136/ebmental-2020-300174
   Smith LE, 2020, PUBLIC HEALTH, V187, P41, DOI 10.1016/j.puhe.2020.07.024
   StatsWales, 2019, WELSH INDEX MULTIPLE
   The Royal College of Ophthalmologists, 2017, WAY FORW EM EYE CAR
   Uhr JH, 2016, JAMA OPHTHALMOL, V134, P424, DOI 10.1001/jamaophthalmol.2015.6212
   Williams Simon N, 2020, BMJ Open, V10, pe039334, DOI 10.1136/bmjopen-2020-039334
   Zimmerman MS, 2020, HEALTH INFO LIBR J, V37, P173, DOI 10.1111/hir.12287
NR 57
TC 0
Z9 0
U1 1
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2397-3269
J9 BMJ OPEN OPHTHALMOL
JI BMJ Open Ophthalmol.
PD OCT
PY 2021
VL 6
IS 1
AR e000854
DI 10.1136/bmjophth-2021-000854
PG 10
WC Ophthalmology
WE Emerging Sources Citation Index (ESCI)
SC Ophthalmology
GA WI1CH
UT WOS:000708103400001
PM 34693022
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Adams, K
   McClure, ML
   Fuller, HJA
AF Adams, Kathleen
   McClure, Marsha L.
   Fuller, Helen J. A.
TI A description of rapid design and implementation of new features in an
   electronic health record in the United States Department of Veterans
   Affairs, Veterans Health Administration response to the Covid-19
   pandemic
SO KNOWLEDGE MANAGEMENT & E-LEARNING-AN INTERNATIONAL JOURNAL
LA English
DT Article
DE Covid-19; Patient safety; Decision support; Electronic health records;
   Health informatics
ID CORONAVIRUS; USABILITY; CARE
AB The onset of the COVID-19 global pandemic called for the implementation of new functionality to the Electronic Health Record (EHR) system for the United States Department of Veterans Affairs (VA), and VA responded rapidly. VA's EHR-related COVID-19 response can be grouped into two categories: 1) a new banner to provide a rapid way to view a patient's COVID-19 status and 2) EHR templates for addressing COVID-19 screening and patient care during the COVID-19 pandemic. COVID-19 clinical reminder dialog templates were rapidly implemented to meet provider and patient needs for scenarios involving the care of patients suspected of COVID-19 infection and for treating and monitoring patients who tested positive. Semi-structured interviews were conducted with solution developers and users to elicit feedback on the design process as well as overall usability and utility. The new functionality in the EHR was developed, evaluated, and delivered at record speed in real time as the pandemic unfolded. This paper presents the process used for the rapid delivery of the new functionality and describes how VA was able to maintain a high standard of usability while creating this enhanced functionality in the face of an unprecedented challenge.
C1 [Adams, Kathleen; McClure, Marsha L.; Fuller, Helen J. A.] US Dept Vet Affairs, Off Hlth Informat, Vet Hlth Adm, Washington, DC 20421 USA.
RP Adams, K (corresponding author), US Dept Vet Affairs, Off Hlth Informat, Vet Hlth Adm, Washington, DC 20421 USA.
EM Kathleen.Adams@va.gov; Marsha.McClure@va.gov; Helen.Fuller@va.gov
FU VA Contract [36C77619D0018]; VHA's Clinical Informatics and Data
   Management Office; VA Office of Information Technology
FX This work was supported in part by a VA Contract (#36C77619D0018,
   awarded on 9/30/20). The authors would like to thank Anthony Masalonis,
   Ellen Bass, Claire Hayes Watson, Nakina Eugene, and Michael J. Fritz for
   their contributions. This work was also supported by VHA's Clinical
   Informatics and Data Management Office, and the VA Office of Information
   Technology. Finally, we would like to acknowledge the COVID-19
   Initiative Workgroup, VA front-line workers, and our Veterans who have
   sacrificed and worked tirelessly to serve our nation.
CR Campbell JL, 2020, KNOWL MANAG E-LEARN, V12, P505, DOI 10.34105/j.kmel.2020.12.028
   Department of Veterans Affairs, 2021, VA
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Grange ES, 2020, APPL CLIN INFORM, V11, P265, DOI 10.1055/s-0040-1709715
   He F, 2020, J MED VIROL, V92, P719, DOI 10.1002/jmv.25766
   Hollnagel E., 2013, RESILIENT HLTH CARE
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Johns Hopkins University Center for Systems and Science Engineering, 2021, COVID 19 MAP J HOPK
   Joseph AL, 2020, KNOWL MANAG E-LEARN, V12, P387, DOI 10.34105/j.kmel.2020.12.021
   Kannampallil TG, 2020, J AM MED INFORM ASSN, V27, P1142, DOI 10.1093/jamia/ocaa073
   Luo J, 2021, ANN EPIDEMIOL, V55, P10, DOI 10.1016/j.annepidem.2020.12.003
   Medlock M. C., 2002, US PROF ASS ORL FLOR
   Reeves JJ, 2020, J AM MED INFORM ASSN, V27, P853, DOI 10.1093/jamia/ocaa037
   Russ AL, 2018, J BIOMED INFORM, V78, P123, DOI 10.1016/j.jbi.2018.01.001
   Russ Alissa L, 2010, AMIA Annu Symp Proc, V2010, P702
   The White House Archive, 2020, PROCL DECL NAT EM NO
   Turer RW, 2020, J AM MED INFORM ASSN, V27, P967, DOI 10.1093/jamia/ocaa048
   Veterans Health Administration, 2021, VET HLTH ADM VA 4 MI
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 21
TC 0
Z9 0
U1 0
U2 0
PU LABORATORY KNOWLEDGE MANAGEMENT & E-LEARNING UNIV
PI HONG KONG
PA RM 212, RUNME SHAW BLDG, FAC EDUCATION, UNIV HONG KONG, HONG KONG,
   00000, HONG KONG
SN 2073-7904
J9 KNOWL MANAG E-LEARN
JI Knowl. Manag. E-Learn.
PD DEC
PY 2021
VL 13
IS 4
BP 438
EP 451
DI 10.34105/j.kmel.2021.13.024
PG 15
WC Education & Educational Research
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research
GA ZV1JT
UT WOS:000770291900006
OA gold
DA 2022-04-20
ER

PT J
AU Kuleshov, MV
   Stein, DJ
   Clarke, DJB
   Kropiwnicki, E
   Jagodnik, KM
   Bartal, A
   Evangelista, JE
   Hom, J
   Cheng, MX
   Bailey, A
   Zhou, A
   Ferguson, LB
   Lachmann, A
   Ma'ayan, A
AF Kuleshov, Maxim, V
   Stein, Daniel J.
   Clarke, Daniel J. B.
   Kropiwnicki, Eryk
   Jagodnik, Kathleen M.
   Bartal, Alon
   Evangelista, John E.
   Hom, Jason
   Cheng, Minxuan
   Bailey, Allison
   Zhou, Abigail
   Ferguson, Laura B.
   Lachmann, Alexander
   Ma'ayan, Avi
TI The COVID-19 Drug and Gene Set Library
SO PATTERNS
LA English
DT Article
ID SCREEN; ENTRY
AB In a short period, many research publications that report sets of experimentally validated drugs as potential COVID-19 therapies have emerged. To organize this accumulating knowledge, we developed the COVID-19 Drug and Gene Set Library (https://amp.pharm.mssm.edu/covid19/), a collection of drug and gene sets related to COVID-19 research from multiple sources. The platform enables users to view, download, analyze, visualize, and contribute drug and gene sets related to COVID-19 research. To evaluate the content of the library, we compared the results from six in vitro drug screens for COVID-19 repurposing candidates. Surprisingly, we observe low overlap across screens while highlighting overlapping candidates that should receive more attention as potential therapeutics for COVID-19. Overall, the COVID-19 Drug and Gene Set Library can be used to identify community consensus, make researchers and clinicians aware of new potential therapies, enable machine-learning applications, and facilitate the research community to work together toward a cure.
C1 [Kuleshov, Maxim, V; Stein, Daniel J.; Clarke, Daniel J. B.; Kropiwnicki, Eryk; Jagodnik, Kathleen M.; Bartal, Alon; Evangelista, John E.; Hom, Jason; Cheng, Minxuan; Bailey, Allison; Zhou, Abigail; Lachmann, Alexander; Ma'ayan, Avi] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci,Mt Sinai Ctr Bioinformat, Knowledge Management Ctr Illuminating Druggable G, Big Data Knowledge Lib Integrated Network Based C, One Gustave L Levy Pl,Box 1603, New York, NY 10029 USA.
   [Ferguson, Laura B.] Univ Texas Austin, Dept Neurol, Dell Med Sch, 1601 Trinity St,Bldg B, Austin, TX 78712 USA.
RP Ma'ayan, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol Sci,Mt Sinai Ctr Bioinformat, Knowledge Management Ctr Illuminating Druggable G, Big Data Knowledge Lib Integrated Network Based C, One Gustave L Levy Pl,Box 1603, New York, NY 10029 USA.
EM avi.maayan@mssm.edu
OI Kuleshov, Maxim/0000-0002-7812-7752; Evangelista, John
   E/0000-0003-4836-0518; Clarke, Daniel/0000-0003-3471-7416; ,
   Daniel/0000-0002-9442-2604
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U54HL127624, U24CA224260, U24AA025479,
   F32AA028148]
FX We would like to thank Akira Mitsui, Russ Altman, Anne Carpenter, Pedro
   Bellester, and Tudor Oprea for contributing information about missing
   publications and contributing drug and gene sets to the library. This
   project is partially funded by NIH U54HL127624 and U24CA224260 awarded
   to A.M. and NIH grants U24AA025479 and F32AA028148 supporting the work
   of L.B.F.
CR Alakwaa FM, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00297-20
   Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026
   Bouhaddou M, 2020, CELL, V182, P685, DOI 10.1016/j.cell.2020.06.034
   Cava C, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040404
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Ellinger B., 2020, IDENTIFICATION INHIB, DOI [DOI 10.21203/RS.3.RS-23951/V1, 10.21203/rs.3.rs-23951/v1]
   Gaulton A, 2017, NUCLEIC ACIDS RES, V45, pD945, DOI 10.1093/nar/gkw1074
   Ge Y., 2020, BIORXIV, DOI [10.1101/2020.03.11.986836%, 10.1101/2020.03.11.986836, DOI 10.1101/2020.03.11.986836]
   Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1
   Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9
   Guenther LC, 2017, J CUTAN MED SURG, V21, p2S, DOI 10.1177/1203475417733414
   Gundersen GW, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1321-1
   Gundersen GW, 2015, BIOINFORMATICS, V31, P3060, DOI 10.1093/bioinformatics/btv297
   Heiser K, 2020, IDENTIFICATION POTEN
   Hijikata A, 2020, FEBS LETT, V594, P1960, DOI 10.1002/1873-3468.13806
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   HORBY P, 2020, NEW ENGL J MED, DOI 10.1101/2020.07.15.20151852
   Jensen L. J., 2017, BIORXIV, DOI [10.1101/115022, DOI 10.1101/115022]
   Jeon S, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.00819-20
   Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y
   Ko M., 2020, bioRxiv
   Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88
   Lachmann A, 2019, NUCLEIC ACIDS RES, V47, pW571, DOI 10.1093/nar/gkz393
   Lachmann A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03751-6
   Lopez-Lopez JR, 1998, MOL PHARMACOL, V53, P330, DOI 10.1124/mol.53.2.330
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   MELOT C, 1983, CHEST, V83, P528, DOI 10.1378/chest.83.3.528
   Mirabelli Carmen, 2021, Proc Natl Acad Sci U S A, V118, DOI [10.1101/2020.05.27.117184, 10.1073/pnas.2105815118]
   Osborne JD, 2007, GENERIF IS MORE COMP
   PALMER KJ, 1993, DRUGS, V45, P430, DOI 10.2165/00003495-199345030-00009
   Pedregosa F, 2011, J MACH LEARN RES, V12, P2825
   Rensi S., 2020, HOMOLOGY MODELING TM, DOI [10.26434/chemrxiv.12009582, DOI 10.26434/CHEMRXIV.12009582]
   Ritchie AI, 2020, LANCET, V395, P1111, DOI 10.1016/S0140-6736(20)30691-7
   Riva Laura, 2020, bioRxiv, DOI 10.1101/2020.04.16.044016
   Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100
   Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049
   Torre D, 2018, CELL SYST, V7, P556, DOI 10.1016/j.cels.2018.10.007
   Touret F, 2020, IN VITRO SCREENING F, DOI [10.1101/2020.04.03.023846, DOI 10.1101/2020.04.03.023846]
   Wang ZC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12846
   Wang ZC, 2016, BIOINFORMATICS, V32, P2338, DOI 10.1093/bioinformatics/btw168
   Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037
   Xing Jing, 2020, bioRxiv, DOI 10.1101/2020.04.07.030734
   YAWALKAR SJ, 1979, LEPROSY REV, V50, P135
NR 45
TC 27
Z9 26
U1 2
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2666-3899
J9 PATTERNS
JI Patterns
PD SEP 11
PY 2020
VL 1
IS 6
AR 100090
DI 10.1016/j.patter.2020.100090
PG 10
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Computer Science, Interdisciplinary Applications
WE Emerging Sources Citation Index (ESCI)
SC Computer Science
GA SH0LO
UT WOS:000653829700008
PM 32838343
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Dalky, HF
   Ghader, N
   Al Kuwari, M
   Alnajar, M
   Ismaile, S
   Almalik, M
   Shudifat, R
   Sanad, S
   Al-Nsair, N
   Al Matrooshi, F
AF Dalky, Heyam F.
   Ghader, Nariman
   Al Kuwari, Muna
   Alnajar, Malek
   Ismaile, Samantha
   Almalik, Mona
   Shudifat, Raed
   Sanad, Sarah
   Al-Nsair, Nezam
   Al Matrooshi, Fatima
TI Assessment of the Awareness, Perception, Attitudes, and Preparedness of
   Health-care Professionals Potentially Exposed to COVID-19 in the United
   Arab Emirates
SO JOURNAL OF MULTIDISCIPLINARY HEALTHCARE
LA English
DT Article
DE vigilance; pandemic; attitude; COVID-19; infection control; health-care
   professionals
ID KNOWLEDGE
AB Background: Since COVID-19 surfaced in December 2019, health-care organizations across the globe have struggled to maintain the safety and well-being of health-care professionals (HCPs).
   Purpose: This study investigates the HCPs' general understanding of the health risks of COVID-19 and to what extent they are equipped with the knowledge to protect themselves and others against this contagion.
   Methods: This cross-sectional study used a web-based structured questionnaire posted on the UAE government electronic survey portal. A collection of 941 HCPs from diverse general and specialty hospitals in the UAE responded to an electronic participation invite.
   Results: Our analysis showed that the majority of HCPs (97.6%) had updated information about COVID-19 modes of transmission, risks of contamination, high-risk groups, and the potential consequences of testing positive. Furthermore, the results of the chi-squared testing revealed that the HCPs' confidence and vigilance of the COVID-19 threats were significantly increased (p< 0.01) by being experienced, having had infection control training, or/and having undergone COVID-19 education.
   Conclusion: We conclude that HCPs have an evidence-based understanding of the ways their own health is at risk while they are performing their duties in hospital setups. Further, the study found that HCPs who undergo special infection control training and who are kept posted on the official updates on COVID-19 are more likely to remain vigilant at all times to minimize the risks to themselves and their patients. Although the generalizability of the study findings should be considered with caution, the results could be generalizable to health-care professionals who received similar COVID-19 related training in the UAE or other regional countries.
C1 [Dalky, Heyam F.] Higher Coll Technol, Fac Hlth Sci, Nursing Dept, Psychiat Mental Hlth, POB 9747, Sharjah, U Arab Emirates.
   [Dalky, Heyam F.] Jordan Univ Sci & Technol, Fac Nursing, Psychiat Mental Hlth, Irbid 22110, Jordan.
   [Ghader, Nariman] Minist Hlth & Prevent HQ, Specialized Care Dept, Strateg Planning & Inst Performance, Dubai, U Arab Emirates.
   [Al Kuwari, Muna] Minist Hlth & Prevent HQ, Specialized Care Dept, Specialized Care Management, Hosp Sect, Dubai, U Arab Emirates.
   [Alnajar, Malek; Ismaile, Samantha; Almalik, Mona; Shudifat, Raed; Sanad, Sarah] Higher Coll Technol, Fac Hlth Sci, Nursing Dept, Sharjah, U Arab Emirates.
   [Almalik, Mona] Univ Mutah, Fac Nursing, Maternal & Child Hlth Nursing Dept, Mutah, Jordan.
   [Al-Nsair, Nezam] Higher Coll Technol, Fac Hlth Sci, Sharjah, U Arab Emirates.
   [Al Matrooshi, Fatima] Minist Hlth & Prevent HQ, Specialized Care Dept, Hosp Sect, Dubai, U Arab Emirates.
RP Dalky, HF (corresponding author), Higher Coll Technol, Fac Hlth Sci, Nursing Dept, Psychiat Mental Hlth, POB 9747, Sharjah, U Arab Emirates.
EM hdalky@hct.ac.ae
RI Dalky, Heyam Fawaz/AAZ-5743-2021
OI Alnajar, Malek/0000-0003-0666-4396; Dalky, Heyam/0000-0002-5744-4038
CR Abu Dhabi Public Health Center, 2020, CORONAVIRUS DIS COVI
   Albarrak AI, 2021, J INFECT PUBLIC HEAL, V14, P89, DOI 10.1016/j.jiph.2019.06.029
   American Dental Association, 2020, CORONAVIRUS FREQUENT
   Asaad AM, 2020, E MEDITERR HEALTH J, V1, P25
   Bandari DK, 2020, NOVEL CORONAVIRUS CO, V6, DOI DOI 10.1101/2020.03.09.20033381
   Centers for Disease Control and Prevention, 2020, UPDATE INTERIM GUIDE
   Dubai Health Authority, 2020, NOVEL CORONAVIRUS CO
   Gaffar BO, 2019, SAUDI MED J, V40, P714, DOI 10.15537/smj.2019.7.24304
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   Kim KH, 2020, INT NEUROUROL J, V24, P1, DOI 10.5213/inj.2020edi.001
   Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246
   Ministry of Health and Prevention, 2020, ALL YOU NEED KNOW CO
   Modi PD, 2020, CUREUS, V12, DOI 10.7759/cureus.7514
   Nemati M, 2020, ARCH CLIN INFECT DIS, V15, DOI 10.5812/archcid.102848
   Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212
   Wang X, 2021, JAMA-J AM MED ASSOC, V325, P50, DOI 10.1001/jama.2020.23370
   World Health Organization, 2020, WHO COR DIS COVID 19
   World Health Organization, 2020, INFECT PREVENTION CO
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 20
TC 3
Z9 3
U1 0
U2 0
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2390
J9 J MULTIDISCIP HEALTH
JI J. Multidiscip. Healthc.
PY 2021
VL 14
BP 91
EP 102
DI 10.2147/JMDH.S278479
PG 12
WC Health Care Sciences & Services
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services
GA QB3XN
UT WOS:000614075300001
PM 33488085
OA Green Published
DA 2022-04-20
ER

PT J
AU Choukou, MA
   Sanchez-Ramirez, DC
   Pol, M
   Uddin, M
   Monnin, C
   Syed-Abdul, S
AF Choukou, Mohamed-Amine
   Sanchez-Ramirez, Diana C.
   Pol, Margriet
   Uddin, Mohy
   Monnin, Caroline
   Syed-Abdul, Shabbir
TI COVID-19 infodemic and digital health literacy in vulnerable
   populations: A scoping review
SO DIGITAL HEALTH
LA English
DT Review
DE Digital health; literacy; vulnerable; COVID-19; misinformation; digital
   divide
ID OLDER-ADULTS; EDUCATION
AB Background People from lower and middle socioeconomic classes and vulnerable populations are among the worst affected by the COVID-19 pandemic, thus exacerbating disparities and the digital divide. Objective To draw a portrait of e-services as a digital approach to support digital health literacy in vulnerable populations amid the COVID-19 infodemic, and identify the barriers and facilitators for their implementation. Methods A scoping review was performed to gather published literature with a broad range of study designs and grey literature without exclusions based on country of publication. A search was created in Medline (Ovid) in March 2021 and translated to Medline, PsycINFO, Scopus and CINAHL with Full Text (EBSCOhost). The combined literature search generated 819 manuscripts. To be included, manuscripts had to be written in English, and present information on digital intervention(s) (e.g. social media) used to enable or increase digital health literacy among vulnerable populations during the COVID-19 pandemic (e.g. older adults, Indigenous people living on reserve). Results Five articles were included in the study. Various digital health literacy-enabling e-services have been implemented in different vulnerable populations. Identified e-services aimed to increase disease knowledge, digital health literacy and social media usage, help in coping with changes in routines and practices, decrease fear and anxiety, increase digital knowledge and skills, decrease health literacy barriers and increase technology acceptance in specific groups. Many facilitators of digital health literacy-enabling e-services implementation were identified in expectant mothers and their families, older adults and people with low-income. Barriers such as low literacy limited to no knowledge about the viruses, medium of contamination, treatment options played an important role in distracting and believing in misinformation and disinformation. Poor health literacy was the only barrier found, which may hinder the understanding of individual health needs, illness processes and treatments for people with HIV/AIDS. Conclusions The literature on the topic is scarce, sparse and immature. We did not find any literature on digital health literacy in Indigenous people, though we targeted this vulnerable population. Although only a few papers were included, two types of health conditions were covered by the literature on digital health literacy-enabling e-services, namely chronic conditions and conditions that are new to the patients. Digital health literacy can help improve prevention and adherence to a healthy lifestyle, improve capacity building and enable users to take the best advantage of the options available, thus strengthening the patient's involvement in health decisions and empowerment, and finally improving health outcomes. Therefore, there is an urgent need to pursue research on digital health literacy and develop digital platforms to help solve current and future COVID-19-related health needs.
C1 [Choukou, Mohamed-Amine] Univ Manitoba, Coll Rehabil Sci, Rady Fac Hlth Sci, Dept Occupat Therapy, R111-771 McDermot Ave, Winnipeg, MB R3E 0T6, Canada.
   [Choukou, Mohamed-Amine] Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada.
   [Choukou, Mohamed-Amine] Riverview Hlth Ctr, Winnipeg, MB, Canada.
   [Sanchez-Ramirez, Diana C.] Univ Manitoba, Coll Rehabil Sci, Rady Fac Hlth Sci, Dept Resp Therapy, Winnipeg, MB, Canada.
   [Pol, Margriet] Amsterdam Univ Appl Sci, Fac Hlth, Ctr Expertise Urban Vital, Dept Occupat Therapy, Amsterdam, Netherlands.
   [Pol, Margriet] Vrije Univ, Amsterdam Univ Med Ctr, Publ Hlth Res Inst, Dept Med Older People, Amsterdam, Netherlands.
   [Uddin, Mohy] King Saud bin Abdul Aziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Res Qual Management Sect, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia.
   [Monnin, Caroline] Univ Manitoba, Neil John Maclean Hlth Sci Lib, Winnipeg, MB, Canada.
   [Syed-Abdul, Shabbir] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, 15F,172-1,Sec 2,Keelung Rd, Taipei, Taiwan.
   [Syed-Abdul, Shabbir] Taipei Med Univ, Coll Med Sci & Technol, Int Ctr Hlth Informat Technol ICHIT, Taipei, Taiwan.
RP Choukou, MA (corresponding author), Univ Manitoba, Coll Rehabil Sci, Rady Fac Hlth Sci, Dept Occupat Therapy, R111-771 McDermot Ave, Winnipeg, MB R3E 0T6, Canada.; Syed-Abdul, S (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, 15F,172-1,Sec 2,Keelung Rd, Taipei, Taiwan.
EM Amine.choukou@umanitoba.ca; drshabbir@tmu.edu.tw
OI Choukou, Mohamed-Amine/0000-0001-9477-2412; Syed-Abdul,
   Shabbir/0000-0002-0412-767X; Monnin, Caroline/0000-0001-7445-0969
FU Gerry McDole Professorship in Improved Healthcare Delivery to Rural,
   Remote and Underserved Populations of Manitoba 2020-2023 Grant
FX The authors disclosed receipt of the following financial support for the
   research, authorship and/or publication of this article: This work was
   supported by the Gerry McDole Professorship in Improved Healthcare
   Delivery to Rural, Remote and Underserved Populations of Manitoba
   2020-2023 Grant.
CR Abdul SS, 2021, JMIR PUBLIC HLTH SUR, V7, DOI 10.2196/31645
   ADAY LA, 1994, ANNU REV PUBL HEALTH, V15, P487, DOI 10.1146/annurev.pu.15.050194.002415
   [Anonymous], 2006, AM J MANAG CARE, V12, pS348
   [Anonymous], 2017, 1 M WHO GCM NCD WORK
   Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]
   Berkman ND, 2010, J HEALTH COMMUN, V15, P9, DOI 10.1080/10810730.2010.499985
   Bhattacharya C, 2021, SOC NETW ANAL MIN, V11, DOI 10.1007/s13278-021-00750-2
   Bracken-Roche D, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-016-0164-6
   Bramer WM, 2016, J MED LIBR ASSOC, V104, P240, DOI 10.3163/1536-5050.104.3.014
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   CADTH, COVID 19 SEARCH STRI
   Chang BL, 2004, J AM MED INFORM ASSN, V11, P448, DOI 10.1197/jamia.M1535
   Choukou MA, 2021, INT J MED INFORM, V148, DOI 10.1016/j.ijmedinf.2021.104408
   Cinelli M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73510-5
   Claeson M, 2008, INT ENCY PUBLIC HLTH, P197
   Clark B, 2018, CAN MED ASSOC J, V190, pE308, DOI 10.1503/cmaj.180242
   Dadaczynski K, 2021, J MED INTERNET RES, V23, DOI 10.2196/24097
   de Groot N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212633
   Giuliani M, 2020, INT J RADIAT ONCOL, V108, P404, DOI 10.1016/j.ijrobp.2020.05.036
   Greenall M, 2017, B WORLD HEALTH ORGAN, V95, P159, DOI [10.2471/BLT.16.179192, 10.2471/blt.16.179192]
   Guven DC, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01553
   Harris Kathy, 2019, Health Lit Res Pract, V3, pS33, DOI 10.3928/24748307-20190325-02
   Islam MS, 2020, AM J TROP MED HYG, V103, P1621, DOI 10.4269/ajtmh.20-0812
   Jafree SR, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045163
   Jennings B., 2016, EMERGENCY ETHICS, DOI [10.1093/med/9780190270742.001.0001, DOI 10.1093/MED/9780190270742.001.0001]
   Kor PPK, 2021, J NURS SCHOLARSHIP, V53, P75, DOI 10.1111/jnu.12616
   Leung AYM, 2022, AGING MENT HEALTH, V26, P544, DOI 10.1080/13607863.2020.1870206
   Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69
   Li XJ, 2020, J MED INTERNET RES, V22, DOI 10.2196/19684
   Van Jaarsveld GM, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.577427
   Moher D, 2010, INT J SURG, V8, P658, DOI 10.1016/j.ijsu.2010.07.299
   Nguyen Linh Hoang Thuy, 2021, Front Digit Health, V3, P739476, DOI 10.3389/fdgth.2021.739476
   Norgaard O, 2015, KNOW MAN E LEARN, V7, P522, DOI DOI 10.34105/J.KMEL.2015.07.035
   Norman CD, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.2.e9
   Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847
   Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4
   Pasadino F, 2020, MCN-AM J MATERN-CHIL, V45, P364, DOI 10.1097/NMC.0000000000000665
   Patil U, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18063301
   Quinn LM, 2021, DIABETIC MED, V38, DOI 10.1111/dme.14469
   Saibene A, 2020, ADDRESSING DIGITAL D, V2804
   Sixsmith A, 2020, QUAL AGEING OLDER AD, V21, P247, DOI 10.1108/QAOA-07-2020-0029
   Soomro KA, 2020, INT J EDUC TECHNOL H, V17, DOI 10.1186/s41239-020-00191-5
   Syed-Abdul S, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2237
   Symon, 2004, ESSENTIAL GUIDE QUAL
   Tangcharoensathien V, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0342-3
   van der Vaart Rosalie, 2017, J Med Internet Res, V19, pe27, DOI 10.2196/jmir.6709
   van Tilburg TG, 2021, J GERONTOL B-PSYCHOL, V76, pE249, DOI 10.1093/geronb/gbaa111
   Voigt-Barbarowicz M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072372
   Vrdelja M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18168507
   Wildenbos GA, 2018, INT J MED INFORM, V114, P66, DOI 10.1016/j.ijmedinf.2018.03.012
   World Health Organization, 2020, INF
   World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053
NR 52
TC 0
Z9 0
U1 11
U2 11
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 2055-2076
J9 DIGIT HEALTH
JI Digit. Health
PD FEB
PY 2022
VL 8
AR 20552076221076927
DI 10.1177/20552076221076927
PG 13
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health; Medical Informatics
GA ZD5FS
UT WOS:000758225000001
PM 35223076
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Dovey, Z
   Mohamed, N
   Gharib, Y
   Ratnani, P
   Hammouda, N
   Nair, SS
   Chakravarty, D
   Sobotka, S
   Lantz, A
   Wiklund, P
   Kyprianou, N
   Tewari, A
AF Dovey, Zachary
   Mohamed, Nihal
   Gharib, Yasmine
   Ratnani, Parita
   Hammouda, Nada
   Nair, Sujit S.
   Chakravarty, Dimple
   Sobotka, Stanislaw
   Lantz, Anna
   Wiklund, Peter
   Kyprianou, Natasha
   Tewari, Ash
TI Impact of COVID-19 on Prostate Cancer Management: Guidelines for
   Urologists
SO EUROPEAN UROLOGY OPEN SCIENCE
LA English
DT Review
DE COVID-19 pandemic; Infection risks; Prostate cancer; Treatment delays;
   Triage
ID RESPIRATORY SYNDROME CORONAVIRUS; INFLUENZA VACCINATION; IMMEDIATE
AB Context: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has resulted in a global health emergency, the like of which has never been seen before. Prostate cancer (PCa) services across the globe have been on hold due to changing medical and surgical priorities. There is also epidemiological evidence that PCa patients have increased incidence and mortality from SARS-CoV2 infection due to gender differences, age, and higher propensity for risk factors (eg, respiratory disease, obesity, hypertension, and smoking status).
   Objective: To contribute to the emerging body of knowledge on the risks of SARS-CoV2 infection to PCa patients and, in the face of PCa treatment delays, provide evidence-based recommendations for ongoing management of specific PCa patient groups.
   Evidence acquisition: A literature search was performed using all sources (MEDLINE, EMBASE, ScienceDirect, Cochrane Libraries, and Web of Science) as well as the media to harness emerging data on the SARS-CoV-2 pandemic and its influence on PCa. Eligibility criteria were originality of data and relevance to PCa management. The authors note that during these unprecedented times, retrospective data are constantly being updated from multiple sources globally.
   Evidence synthesis: A total of 72 articles and data sources were found initially. Owing to repetition, lack of originality, or nonrelevance, six articles were rejected, leaving 23 retrospective studies, seven basic science research articles, 15 societal and journal guidelines, and 21 epidemiological data sources, from countries at different stages of SARS-CoV-2 pandemic. These were analyzed qualitatively to produce evidence-based guidelines for the management of PCa patients at different stages of the patient journey, with strategies to reduce the risk of viral spread.
   Conclusions: PCa patients may have an increased risk of SARS-CoV-2 infection as well as morbidity and mortality if infected. Once appropriately triaged, and to reduce viral spread, PCa patients can have surveillance by telemedicine, and institute lifestyle changes and social quarantining measures. If risk stratification suggests that treatment should be planned, androgen deprivation therapy can be started, or potentially surgery or radiation therapy is possible on a case-by-case basis.
   Patient summary: Prostate cancer patients can be followed up remotely until the severe acute respiratory syndrome coronavirus 2 pandemic resolves, but higherrisk cases may have treatment expedited to limit any negative impact on prostate cancer outcomes. (c) 2020 Published by Elsevier B.V. on behalf of European Association of Urology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Dovey, Zachary; Mohamed, Nihal; Gharib, Yasmine; Ratnani, Parita; Hammouda, Nada; Nair, Sujit S.; Chakravarty, Dimple; Sobotka, Stanislaw; Wiklund, Peter; Tewari, Ash] Icahn Sch Med Mt Sinai, Dept Urol, 1425 Madison Ave,Suite L6-70, New York, NY 10029 USA.
   [Lantz, Anna; Wiklund, Peter] Karolinska Inst, Dept Med Epidemiol & Biostat, Solna, Sweden.
   [Lantz, Anna; Wiklund, Peter] Karolinska Univ Hosp, Dept Urol, Solna, Sweden.
   [Kyprianou, Natasha] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA.
RP Tewari, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Urol, 1425 Madison Ave,Suite L6-70, New York, NY 10029 USA.
EM ash.tewari@mountsinai.org
RI Lantz, Anna/AAE-6648-2019; Hammouda, Nada/B-8454-2017; ratnani,
   parita/AGX-5042-2022
OI Lantz, Anna/0000-0002-5335-8028; Hammouda, Nada/0000-0002-0198-7287;
   ratnani, parita/0000-0002-4153-1014; Wiklund, Peter/0000-0001-6497-4697
CR Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Begley S, 2020, LOOK CORONAVIRUS RIS
   Bendix A., MEN REPRESENT MAJORI
   Benyon B., ARE PATIENTS CANC HI
   Boehmer LM, 2010, ONCOLOGY-NY, V24, P1167
   Cai H, 2020, LANCET RESP MED, V8, pE20, DOI 10.1016/S2213-2600(20)30117-X
   CDC, 2020, COVID 19 RESP TEAM S
   Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Danastas K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21145150
   Dovey ZS, 2020, BUILDING IMPLEMENTIN
   Elflien J., 2020, CORONAVIRUS COVID 19
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Farooqi AA, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-34
   Foerster B, 2018, JAMA ONCOL, V4, P953, DOI 10.1001/jamaoncol.2018.1071
   Fossati N, 2017, UROL ONCOL-SEMIN ORI, V35, DOI 10.1016/j.urolonc.2016.11.010
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Gupta N, 2019, BJU INT, V124, P268, DOI 10.1111/bju.14659
   He F, 2020, J MED VIROL, V92, P719, DOI 10.1002/jmv.25766
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Hollander JE, 2020, NEW ENGL J MED, V382, P1679, DOI 10.1056/NEJMp2003539
   Howard J., 2020, CARDIAC INJURY COVID
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Kimmig R, 2020, J GYNECOL ONCOL, V31, DOI 10.3802/jgo.2020.31.e59
   Koo JR, 2020, LANCET INFECT DIS, V20, P678, DOI 10.1016/S1473-3099(20)30162-6
   Kumar DS, 2020, CAN MED ASSOC J, V192, pE546, DOI 10.1503/cmaj.200641
   Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480
   Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   Ling Y, 2020, CHINESE MED J-PEKING, V133, P1039, DOI 10.1097/CM9.0000000000000774
   Livingston Edward, 2020, JAMA, V323, P1335, DOI 10.1001/jama.2020.4344
   Loeb S, 2016, SCAND J UROL, V50, P246, DOI 10.3109/21681805.2016.1166153
   Lurie N, 2018, JAMA INTERN MED, V178, P745, DOI 10.1001/jamainternmed.2018.1314
   MA XT, 2020, JAMA ONCOL, DOI DOI 10.1001/JAMAONCOL.2020
   Markowski MC, 2019, CLIN GENITOURIN CANC, V17, P470, DOI 10.1016/j.clgc.2019.08.002
   McCarthy N., 2020, CORONAVIRUS IS IMPAC
   Mohile SG, 2009, CRIT REV ONCOL HEMAT, V70, P235, DOI 10.1016/j.critrevonc.2008.09.004
   Naicker S, 2020, KIDNEY INT, V97, P824, DOI 10.1016/j.kint.2020.03.001
   Naspro R, 2020, NAT REV UROL, V17, P251, DOI 10.1038/s41585-020-0312-1
   Novara Giacomo, 2020, Eur Urol, V78, pe12, DOI 10.1016/j.eururo.2020.04.015
   Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, ZHONGHUA LIU XING BI, V41, P145, DOI DOI 10.3760/CMA.J.ISSN.0254-6450.2020.02.003
   Onder G., 2020, COVID 19 CASE FATALI
   Park B, 2014, J KOREAN MED SCI, V29, P1688, DOI 10.3346/jkms.2014.29.12.1688
   Pass W., 2020, MDEDGE NEWS     3103
   Ring A, 2002, SUPPORT CARE CANCER, V10, P462, DOI 10.1007/s00520-001-0337-9
   Roser M., 2020, CORONAVIRUS DIS COVI
   Sanguineti G, 2019, RADIAT ONCOL, V14, DOI 10.1186/s13014-019-1223-2
   Schepisi G, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122627
   So W., 2020, S KOREA CORONAVIRUS
   Statista Research Department, 2020, IT COR CAS DISTR GEN
   Stensland KD, 2020, EUR UROL, V77, P663, DOI 10.1016/j.eururo.2020.03.027
   Sutcliffe S, 2016, INT J CANCER, V138, P2221, DOI 10.1002/ijc.29966
   Thomala LL, 2020, CHINA GENDER DISTRIB
   THOMASRUDDEL D, 2020, ANAESTHESIST 0324, DOI DOI 10.1007/S00101-020-00760-3
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Vardavas CI, 2020, TOB INDUC DIS, V18, DOI 10.18332/tid/119324
   Wax RS, 2020, CAN J ANESTH, V67, P568, DOI 10.1007/s12630-020-01591-x
   Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2
   Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]
   Xiao F, 2020, GASTROENTEROLOGY, V158, P1831, DOI 10.1053/j.gastro.2020.02.055
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zaorsky NG, 2020, ADV RADIAT ONCOL, V5, P659, DOI 10.1016/j.adro.2020.03.010
   Zhang L, 2020, ANN ONCOL, V31, P894, DOI 10.1016/j.annonc.2020.03.296
   Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071
   Zhao SL, 2020, QUANT BIOL, V8, P11, DOI 10.1007/s40484-020-0199-0
   Zheng MH, 2020, ANN SURG, V272, pE5, DOI 10.1097/SLA.0000000000003924
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0
NR 71
TC 5
Z9 5
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2666-1691
EI 2666-1683
J9 EUR UROL OPEN SCI
JI Eur. Urol. Open Sci.
PD JUL
PY 2020
VL 20
BP 1
EP 11
DI 10.1016/j.euros.2020.05.005
PG 11
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA NT6YN
UT WOS:000573083800001
PM 34173542
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Zhong, R
   Paluch, RM
   Shum, V
   Zatzick, CD
   Robinson, SL
AF Zhong, Rui
   Paluch, Rebecca M.
   Shum, Vanessa
   Zatzick, Christopher D.
   Robinson, Sandra L.
TI Hot, Cold, or Both? A Person-Centered Perspective on Death Awareness
   During the COVID-19 Pandemic
SO JOURNAL OF APPLIED PSYCHOLOGY
LA English
DT Article
DE death awareness; well-being; prosocial behavior; COVID-19; latent
   profile analysis
ID TERROR-MANAGEMENT THEORY; MORTALITY SALIENCE; EMOTIONAL EXHAUSTION;
   JOB-PERFORMANCE; WORK; MODELS; GROWTH; DEPRESSION; ATTITUDES; VARIABLES
AB The COVID-19 pandemic-as an omnipresent mortality cue-heightens employees' awareness of their mortality and vulnerability. Extant research has identified two distinct forms of death awareness: death anxiety and death reflection. Because researchers have exclusively examined death anxiety and death reflection as independent and unique variables across individuals while overlooking their interplay and coexistence within individuals, we know little about whether and why employees can have different combined experiences of two forms of death awareness over a certain period of time (e.g., during the pandemic), and how these different employee experiences relate to theoretically and practically important work-relevant consequences. To address this gap in our knowledge, we adopted a person-centered approach using latent profile analysis to consider death anxiety and death reflection conjointly within employees during the COVID-19 pandemic. Across two studies, we identified three distinct death awareness profiles-the disengaged, calm reflectors, and anxious reflectors-and found membership in these profiles systematically varied according to health- (e.g., risk of severe illness from COVID-19), work- (e.g., job-required human contact), and community-related (e.g., the number of regional infections) factors influencing the self-relevance of COVID-19 as a mortality cue. In addition, we found that these death awareness profiles differentially predicted important employee outcomes, including well-being (i.e., depression and emotional exhaustion) and prosocial behaviors at work (i.e., organizational citizenship behaviors and pro-diversity behavior).
C1 [Zhong, Rui; Paluch, Rebecca M.; Robinson, Sandra L.] Univ British Columbia, Sauder Sch Business, Org Behav & Human Resources Div, 2053 Main Mall, Vancouver, BC V6T 1Z2, Canada.
   [Shum, Vanessa; Zatzick, Christopher D.] Simon Fraser Univ, Beedie Sch Business, Management & Org Studies, Burnaby, BC, Canada.
RP Zhong, R (corresponding author), Univ British Columbia, Sauder Sch Business, Org Behav & Human Resources Div, 2053 Main Mall, Vancouver, BC V6T 1Z2, Canada.
EM rui.zhong@sauder.ubc.cu
OI ZHONG, RUI/0000-0002-3767-3212
FU Social Sciences and Humanities Research Council of CanadaSocial Sciences
   and Humanities Research Council of Canada (SSHRC) [GR003053]
FX This research was supported by a research grant from Social Sciences and
   Humanities Research Council of Canada awarded to Sandra L. Robinson
   (GR003053).
CR [Anonymous], 2021, NEW YORK TIMES
   [Anonymous], NEW YORK TIMES
   Asparouhov T, 2020, MPLUS WEB NOTES, V21
   Asparouhov T, 2014, STRUCT EQU MODELING, V21, P329, DOI 10.1080/10705511.2014.915181
   Bauer DJ, 2003, PSYCHOL METHODS, V8, P338, DOI 10.1037/1082-989X.8.3.338
   Belmi P, 2016, J APPL PSYCHOL, V101, P702, DOI 10.1037/apl0000076
   Blackie LER, 2011, PSYCHOL SCI, V22, P998, DOI 10.1177/0956797611415542
   Bolino MC, 2016, ACAD MANAG ANN, V10, P599, DOI 10.1080/19416520.2016.1153260
   Brown KT, 2013, J APPL SOC PSYCHOL, V43, P2211, DOI 10.1111/jasp.12172
   Burke BL, 2010, PERS SOC PSYCHOL REV, V14, P155, DOI 10.1177/1088868309352321
   Cable D., 2020, SCI AM
   Caldas MP, 2021, J APPL PSYCHOL, V106, P29, DOI 10.1037/apl0000850
   Carpenter NC, 2014, J ORGAN BEHAV, V35, P547, DOI 10.1002/job.1909
   Chawla N, 2021, PERS PSYCHOL, V74, P657, DOI 10.1111/peps.12437
   Chawla N, 2020, J APPL PSYCHOL, V105, P19, DOI 10.1037/apl0000423
   Chen FN, 2001, SOCIOL METHOD RES, V29, P468, DOI 10.1177/0049124101029004003
   Cozzolino PJ, 2006, PSYCHOL INQ, V17, P278, DOI 10.1080/10478400701366944
   Cozzolino PJ, 2004, PERS SOC PSYCHOL B, V30, P278, DOI 10.1177/0146167203260716
   Cropanzano R, 2003, J APPL PSYCHOL, V88, P160, DOI 10.1037/0021-9010.88.1.160
   Dahling JJ, 2017, J VOCAT BEHAV, V101, P133, DOI 10.1016/j.jvb.2017.05.007
   Early A., 2020, GOOD HOUSEKEEPING
   Edmondson D, 2008, PSYCHOL SCI, V19, P754, DOI 10.1111/j.1467-9280.2008.02152.x
   Einhorn C., 2020, OUT RETIREMENT CORON
   Enders CK, 2007, PSYCHOL METHODS, V12, P121, DOI 10.1037/1082-989X.12.2.121
   Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7
   FESTINGER L, 1962, SCI AM, V207, P93, DOI 10.1038/scientificamerican1062-93
   Frias A, 2011, J POSIT PSYCHOL, V6, P154, DOI 10.1080/17439760.2011.558848
   Gabriel AS, 2020, J APPL PSYCHOL, V105, P907, DOI 10.1037/apl0000473
   Gabriel AS, 2015, J APPL PSYCHOL, V100, P863, DOI 10.1037/a0037408
   Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530
   Grant AM, 2009, ACAD MANAGE REV, V34, P600, DOI 10.5465/AMR.2009.44882929
   Greenberg J, 1997, ADV EXP SOC PSYCHOL, V29, P61, DOI 10.1016/S0065-2601(08)60016-7
   GREENBERG J, 1990, J PERS SOC PSYCHOL, V58, P308, DOI 10.1037/0022-3514.58.2.308
   Greenberg J., 1984, PUBLIC SELF PRIVATE, V13, P189
   Halbesleben JRB, 2007, J APPL PSYCHOL, V92, P93, DOI 10.1037/0021-9010.92.1.93
   Hayes J, 2010, PSYCHOL BULL, V136, P699, DOI 10.1037/a0020524
   Hirschberger G, 2008, PERS SOC PSYCHOL B, V34, P666, DOI 10.1177/0146167207313933
   Hofmann DA, 1998, J MANAGE, V24, P623, DOI 10.1177/014920639702300602
   Homan AC, 2007, J APPL PSYCHOL, V92, P1189, DOI 10.1037/0021-9010.92.5.1189
   Howard J, 2016, J VOCAT BEHAV, V95-96, P74, DOI 10.1016/j.jvb.2016.07.004
   Hu J, 2020, J APPL PSYCHOL, V105, P1218, DOI 10.1037/apl0000620
   Jonas E, 2002, PERS SOC PSYCHOL B, V28, P1342, DOI 10.1177/014616702236834
   Jonas E, 2008, J PERS SOC PSYCHOL, V95, P1239, DOI 10.1037/a0013593
   Jones J.A., 2014, PSYCHOL SEX ORIENTAT, V1, P181, DOI [DOI 10.1037/SGD0000033, 10.1037/sgd0000033]
   Juhl J, 2016, CURR DIR PSYCHOL SCI, V25, P99, DOI 10.1177/0963721415625218
   Kashdan TB, 2014, PERS INDIV DIFFER, V71, P171, DOI 10.1016/j.paid.2014.07.035
   Koopman J, 2016, ACAD MANAGE J, V59, P414, DOI 10.5465/amj.2014.0262
   Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C
   Lee K, 2002, J APPL PSYCHOL, V87, P131, DOI 10.1037/0021-9010.87.1.131
   Lennard AC, 2019, J APPL PSYCHOL, V104, P1164, DOI 10.1037/apl0000400
   Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767
   Lykins ELB, 2007, PERS SOC PSYCHOL B, V33, P1088, DOI 10.1177/0146167207303015
   MCADAMS DP, 1992, J PERS SOC PSYCHOL, V62, P1003, DOI 10.1037/0022-3514.62.6.1003
   McGregor HA, 1998, J PERS SOC PSYCHOL, V74, P590, DOI 10.1037/0022-3514.74.3.590
   Morin AJS, 2016, ORGAN RES METHODS, V19, P231, DOI 10.1177/1094428115621148
   Morin AJS, 2011, ORGAN RES METHODS, V14, P58, DOI 10.1177/1094428109356476
   Muthen L. K., 2012, MPLUS USERS GUIDE, V7th
   Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396
   Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452
   Pugh SD, 2011, J APPL PSYCHOL, V96, P377, DOI 10.1037/a0021395
   Pyszczynski T, 1999, PSYCHOL REV, V106, P835, DOI 10.1037/0033-295X.106.4.835
   Pyszczynski T, 2021, J HUMANIST PSYCHOL, V61, P173, DOI 10.1177/0022167820959488
   Pyszczynski T, 2015, ADV EXP SOC PSYCHOL, V52, P1, DOI 10.1016/bs.aesp.2015.03.001
   Rubinstein JS, 2001, J EXP PSYCHOL HUMAN, V27, P763, DOI 10.1037//0096-1523.27.4.763
   Simon L, 1997, J PERS SOC PSYCHOL, V72, P1132, DOI 10.1037/0022-3514.72.5.1132
   Sliter MT, 2014, J APPL PSYCHOL, V99, P759, DOI 10.1037/a0035729
   Spurk D, 2020, J VOCAT BEHAV, V120, DOI 10.1016/j.jvb.2020.103445
   Stein JH, 2011, J ORGAN BEHAV, V32, P1189, DOI 10.1002/job.715
   Thompson D, 2021, RETIRED DOCTORS NURS
   TOOTHMAKER LE, 1994, J OPER RES SOC, V45, P119
   Trougakos JP, 2020, J APPL PSYCHOL, V105, P1234, DOI 10.1037/apl0000739
   Vail KE, 2012, PERS SOC PSYCHOL REV, V16, P303, DOI 10.1177/1088868312440046
   Vaziri H, 2020, J APPL PSYCHOL, V105, P1073, DOI 10.1037/apl0000819
   Wanberg CR, 2020, J APPL PSYCHOL, V105, P1382, DOI 10.1037/apl0000831
   Welsh DT, 2020, J APPL PSYCHOL, V105, P166, DOI 10.1037/apl0000429
   World Economic Forum, 2020, THESE ARE OCCUPATION
   World Health Organization, 2020, COVID 19 VULNERABLE
   Yuan ZY, 2019, J ORGAN BEHAV, V40, P417, DOI 10.1002/job.2339
   Zyphur MJ, 2009, ACAD MANAGE REV, V34, P677, DOI 10.5465/AMR.2009.44885862
NR 79
TC 2
Z9 2
U1 29
U2 36
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0021-9010
EI 1939-1854
J9 J APPL PSYCHOL
JI J. Appl. Psychol.
PD JUN
PY 2021
VL 106
IS 6
BP 839
EP 855
DI 10.1037/apl0000931
PG 17
WC Psychology, Applied; Management
WE Social Science Citation Index (SSCI)
SC Psychology; Business & Economics
GA SV6LR
UT WOS:000663932700004
PM 34138590
DA 2022-04-20
ER

PT J
AU Pit, S
   Fisk, M
   Freihaut, W
   Akintunde, F
   Aloko, B
   Berge, B
   Burmeister, A
   Ciacaru, A
   Deller, J
   Dulmage, R
   Han, TH
   Hao, Q
   Honeyman, P
   Huber, PC
   Linner, T
   Lundberg, S
   Nwamara, M
   Punpuing, K
   Schramm, J
   Yamada, H
   Yap, JCH
AF Pit, Sabrina
   Fisk, Malcolm
   Freihaut, Winona
   Akintunde, Fashola
   Aloko, Bamidele
   Berge, Britta
   Burmeister, Anne
   Ciacaru, Adriana
   Deller, Jurgen
   Dulmage, Rae
   Han, Tae Hwa
   Hao, Qiang
   Honeyman, Peter
   Huber, Peter C.
   Linner, Thomas
   Lundberg, Stefan
   Nwamara, Mofoluwaso
   Punpuing, Kamolpun
   Schramm, Jennifer
   Yamada, Hajime
   Yap, Jason C. H.
TI COVID-19 and the ageing workforce: global perspectives on needs and
   solutions across 15 countries
SO INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH
LA English
DT Article
DE Ageing; COVID-19; health equity; employment; planning; workforce;
   international; solution
AB Background COVID-19 has a direct impact on the employment of older people. This adds to the challenge of ageism. The World Health Organization has started a worldwide campaign to combat ageism and has called for more research and evidence-based strategies that have the potential to be scaled up. This study specifically aims to identify solutions to combat the adverse effects of COVID-19 on the global ageing workforce. Methods We present 15 case studies from different countries and report on what those countries are doing or not doing to address the impact of COVID-19 on ageing workers. Results We provide examples of how COVID-19 influences older people's ability to work and stay healthy, and offer case studies of what governments, organizations or individuals can do to help ensure older people can obtain, maintain and, potentially, expand their current work. Case studies come from Australia, Austria, Canada, China, Germany, Israel, Japan, Nigeria, Romania, Singapore, Sweden, South Korea, Thailand, United Kingdom (UK), and the United States (US). Across the countries, the impact of COVID-19 on older workers is shown as widening inequalities. A particular challenge has arisen because of a large proportion of older people, often with limited education and working in the informal sector within rural areas, e.g. in Nigeria, Thailand and China. Remedies to the particular disadvantage experienced by older workers in the context of COVID are presented. These range from funding support to encouraging business continuity, innovative product and service developments, community action, new business models and localized, national and international actions. The case studies can be seen as frequently fitting within strategies that have been proven to work in reducing ageism within the workplace. They include policy and laws that have increased benefits to workers during lockdowns (most countries); educational activities such as coaching seniorpreneurship (e,g, Australia); intergenerational contact interventions such as younger Thai people who moved back to rural areas and sharing their digital knowledge with older people and where older people reciprocate by teaching the younger people farming knowledge. Conclusion Global sharing of this knowledge among international, national and local governments and organizations, businesses, policy makers and health and human resources experts will further understanding of the issues that are faced by older workers. This will facilitate the replication or scalability of solutions as called for in the WHO call to combat ageism in 2021. We suggest that policy makers, business owners, researchers and international organisations build on the case studies by investing in evidence-based strategies to create inclusive workplaces. Such action will thus help to challenge ageism, reduce inequity, improve business continuity and add to the quality of life of older workers.
C1 [Pit, Sabrina] Western Sydney Univ, Univ Ctr Rural Hlth, Sch Med, Lismore, NSW 2480, Australia.
   [Pit, Sabrina] Univ Sydney, Fac Med & Hlth, Lismore, NSW 2480, Australia.
   [Pit, Sabrina] NSW Rural Doctors Network, Newcastle, NSW 2303, Australia.
   [Fisk, Malcolm] De Montfort Univ, Gateway House, Leicester LE1 9BH, Leics, England.
   [Freihaut, Winona] Univ Melbourne, Melbourne, Vic, Australia.
   [Akintunde, Fashola; Aloko, Bamidele] Chartered Inst Personnel Management Nigeria, Soc Human Resources SHRM, Lagos, Nigeria.
   [Berge, Britta] AARP Publ Policy Inst, 601 E St NW, Washington, DC 20049 USA.
   [Burmeister, Anne] Erasmus Univ, Rotterdam Sch Management RSM, Dept Org & Personnel Management, Mandeville Bldg T10-50,Burgemeester Oudlaan 50, NL-3062 PA Rotterdam, Netherlands.
   [Ciacaru, Adriana] Federat COLUMNA, Trade Union Field Social Assistance & Child Prote, Vespasian St 39, Bucharest, Romania.
   [Deller, Jurgen] Leuphana Univ, Inst Management & Org, Luneburg, Germany.
   [Han, Tae Hwa] Yonsei Univ, Yonsei Univ Hlth Syst, Coll Med, Hlth IT Ctr, 50-1 Yonsei Ro, Seoul 120752, South Korea.
   [Hao, Qiang] Beijing Century Myway Educ Technol Inc, 209 Tower A,Heqiao Bldg,Guanghua Rd, Beijing, Peoples R China.
   [Honeyman, Peter] Hebrew Univ Jerusalem, Sch Publ Hlth, Jerusalem, Israel.
   [Huber, Peter C.] Austrian Assoc Supporting Blind & Visually Impair, Staff Unit Org, Standardizat, Res Commun, Schlosshofer Str 2-6, A-1210 Vienna, Austria.
   [Linner, Thomas] Tech Univ Munich TUM, Arcisstr 21, D-80333 Munich, Germany.
   [Lundberg, Stefan] ANEC European Consumer Voice Standardisat, Swedish Consumers Assoc, Vantorsvagen 209, S-12555 Alvsjo, Sweden.
   [Nwamara, Mofoluwaso] Soc Human Resources SHRM Nigeria, Lagos, Nigeria.
   [Punpuing, Kamolpun] Natl Sci & Technol Dev Agcy, Res Strateg Planning & Management Div, 11 Thailand Sci Pk,Phahonyothin Rd, Khlong Luang 12120, Pathum Thani, Thailand.
   [Schramm, Jennifer] AARP Publ Policy Inst, Financial Secur, 601 E St NW, Washington, DC 20049 USA.
   [Yamada, Hajime] Univ Tokyo, Bunkyo Ku, 5-28-20 Hakusan, Tokyo 1120001, Japan.
   [Yap, Jason C. H.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, 12 Sci Dr 2,10-00 Tahir Fdn Bldg, Singapore 117549, Singapore.
RP Pit, S (corresponding author), Western Sydney Univ, Univ Ctr Rural Hlth, Sch Med, Lismore, NSW 2480, Australia.
EM sabrina.pit@sydney.edu.au
RI Deller, Jürgen/A-7638-2008; Burmeister, Anne/O-5034-2019
OI Burmeister, Anne/0000-0003-3980-7947
CR AARP, 2020, WHY MOD EMPL SHOULD
   AARP Public Policy Institute, 2020, EMPL DAT DIG
   ABF, 2020, EX ED ED EAS ENT LAB
   Adva Center, 2020, 1 ADV CTR
   Allington D, 2020, LIFE LOCKDOWN CORONA
   [Anonymous], 2020, THAIPUBLICATHAI LABO
   Australian Bureau of Statistics, 2021, LAB FORC
   Australian HR Institute, 2021, EMPL RET OLD WORK
   Blackham A, 2017, AGEING SOC, V37, P1362, DOI 10.1017/S0144686X16000313
   Brake T, 2018, READ BODY LANGUAGE E
   Bui Truc Thi Mai, 2020, Public Policy Aging Rep, V30, P154, DOI 10.1093/ppar/praa029
   Bundesagentur fur Arbeit, 2020, AUSW COR KRIS ARB
   Centre for Ageing Better, 2020, PER FUT AG
   Centre for Infectious Disease Epidemiology & Research, 2020, 282 CTR INF DIS EP R
   Chantarat S., 2020, ABRIDGED, V11, P1
   Chen JIP, 2020, ANN ACAD MED SINGAP, V49, P561
   Deloitte, 2020, DEL SEN HIR SURV 202
   Fisk M, 2020, J MED INTERNET RES, V22, DOI 10.2196/19264
   Fleming S, 2020, THESE 5 CHARTS SHOW
   Folkhalsomyndigheten, 2020, PROT YOURS OTH SPREA
   Foster K, 2020, SWEDES SWITCH HOME D
   Foundation of Thai Gerontology Research and Development Institute, 2018, SIT THAI ELD 2018
   Ghilarducci T., 2020, 1 NEARLY 50 YEARS OL
   Gibson J, 2020, DIPLOMAT
   Gimhae-si Kim S, 2020, NEWSIS
   Guha P, 2021, J PUBLIC AFF, V21, DOI 10.1002/pa.2470
   International Organization for Standardization, 2020, 23617 ISOCD
   Keynes M, 2019, OPEN U BUSINESS BARO
   Kim Y, 2020, FINANCIAL NEWS
   Koenig G., 2015, LONG ROAD BACK STRUG
   Kuoppamaki S, 2020, DIGITIZING LIFE
   Lebowitz R., 2020, KEREN HISHTALMUT
   Linner T., 2016, AGING SOC AMBIENT AS, P71, DOI DOI 10.1007/978-3-319-26345-8_7
   Mahanakorn Partners Group, 2020, MEAS ALL EFF COVID 1
   MAIA, 2020, MOD METH ACT AG WORK
   Mansour G., 2020, AGEING WELL CHANGING
   Maritz A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12114612
   Milasi S., 2020, SCI POLICY BRIEF
   Ministry of Manpower Singapore, 2020, FAQS COVID 19
   Morrow-Howell N, 2020, J AGING SOC POLICY, V32, P526, DOI 10.1080/08959420.2020.1759758
   National Statistical Office Thailand, 2019, ELD PEOPL EMPL SURV
   OECD, 2020, EC SURV ISR
   Perenyi A, 2018, INT J ENTREP BEHAV R, V24, P81, DOI 10.1108/IJEBR-12-2016-0424
   PWC Nigeria, 2020, ANALYSES
   Romero AM, 2020, INDEPENDENT
   Singapore Government, 2020, COVID 19 UPD 8
   Singapore Government, 2020, TAK CAR OUR SEN AM C
   Statistik Austria, 2020, VOR BEV OST 2019 210
   Statistik Austria Statistik Austria, 2020, BEV NACH ALT GESCHL
   Szytniewski BB, 2017, TOURISM GEOGR, V19, P63, DOI 10.1080/14616688.2016.1233289
   VeHadarta, 2020, VEHADARTA 3 STRENGTH
   Wallace CA, 2020, CRISIS ACCESS COVID
   Westermeier C., 2020, TRIFFT CORONA KRISE
   World Health Organisation, 2021, GLOB REP AG
   You Gov, 2020, PERS MEAS TAK AV COV
   Zhiyan Consulting Group, R542164 ZHIYAN CONS
NR 56
TC 0
Z9 0
U1 16
U2 16
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-9276
J9 INT J EQUITY HEALTH
JI Int. J. Equity Health
PD OCT 7
PY 2021
VL 20
IS 1
AR 221
DI 10.1186/s12939-021-01552-w
PG 22
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA WE8ES
UT WOS:000705852800003
PM 34620164
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Appiah-Otoo, I
   Kursah, MB
AF Appiah-Otoo, Isaac
   Kursah, Matthew Biniyam
TI Modelling spatial variations of novel coronavirus disease (COVID-19):
   evidence from a global perspective
SO GEOJOURNAL
LA English
DT Article; Early Access
DE Coronavirus; Novel coronavirus (SARS-COV-2); COVID-19; Spatial
   variation; Global pandemics
AB In late December 2019, strange pneumonia was detected in a seafood market in Wuhan, China which was later termed COVID-19 by the World Health Organization. At present, the virus has spread across 232 countries worldwide killing 2,409,011 as of 17 February 2021 (9:37 CET). Motivated by a recent dataset, knowledge gaps, surge in global cases, and the need to combat the virus spread, this study examined the relationship between COVID-19 confirmed cases and attributable deaths at the global and regional levels. We used a panel of 232 countries (further disaggregated into Africa-49, Americas-54, Eastern Mediterranean-23, Europe-61, Southeast Asia-10, and Western Pacific-35) from 03 January 2020 to 28 November 2020, and the instrumental variable generalized method of moment's model (IV-GMM) for analysing the datasets. The results showed that COVID-19 confirmed cases at both the global and regional levels have a strong positive effect on deaths. Thus, the confirmed cases significantly increase attributable deaths at the global and regional levels. At the global level, a 1% increase in confirmed cases increases attributable deaths by 0.78%. Regionally, a 1% increase in confirmed cases increases attributable deaths by 0.65% in Africa, 0.90% in the Americas, 0.67% in the Eastern Mediterranean, 0.72% in Europe, 0.88% in Southeast Asia, and 0.52% in the Western Pacific. This study expands the understanding of the relationship between COVID-19 cases and deaths by using a global dataset and the instrumental variable generalized method of moment's model (IV-GMM) for the analysis that addresses endogeneity and omitted variable issues.
C1 [Appiah-Otoo, Isaac] Univ Elect Sci & Technol China, Ctr West African Studies, Sch Management & Econ, Chengdu, Peoples R China.
   [Kursah, Matthew Biniyam] Univ Educ, Dept Geog Educ, Box 25, Winneba, Ghana.
RP Appiah-Otoo, I (corresponding author), Univ Elect Sci & Technol China, Ctr West African Studies, Sch Management & Econ, Chengdu, Peoples R China.
EM appiahotooi@yahoo.com; mkursah@uew.edu.gh
OI Appiah-Otoo, Isaac/0000-0002-3683-0634
CR Acheampong AO, 2019, SCI TOTAL ENVIRON, V677, P436, DOI 10.1016/j.scitotenv.2019.04.353
   Adekunle IA, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138998
   Ahmadi M, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138705
   Appiah-Otoo I, 2021, TELECOMMUN POLICY, V45, DOI 10.1016/j.telpol.2020.102082
   Appiah-Otoo I, 2021, ENVIRON SCI POLLUT R, V28, P29432, DOI 10.1007/s11356-021-12760-w
   Aronu CO, 2021, SCI AFR, V11, DOI 10.1016/j.sciaf.2020.e00689
   Aslam M, 2021, MATH METHOD APPL SCI, V44, P6389, DOI 10.1002/mma.7191
   Bashir MF, 2020, ENVIRON RES, V187, DOI 10.1016/j.envres.2020.109652
   Bashir MF, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138835
   Coccia M, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138474
   Cunningham GB, 2021, J SPORT HEALTH SCI, V10, P570, DOI 10.1016/j.jshs.2021.03.008
   Desjardins MR, 2020, APPL GEOGR, V118, DOI 10.1016/j.apgeog.2020.102202
   Gaskin DJ, 2021, TRANSPORT POLICY, V102, P35, DOI 10.1016/j.tranpol.2020.12.001
   Huang B, 2021, APPL INTELL, V51, P3074, DOI 10.1007/s10489-021-02239-z
   Jablonska K, 2021, PUBLIC HEALTH, V194, P135, DOI 10.1016/j.puhe.2021.02.037
   Jain M, 2021, ENVIRON SCI POLLUT R, V28, P28518, DOI 10.1007/s11356-021-12613-6
   Kodge BG, 2021, SPAT INF RES, V29, P223, DOI 10.1007/s41324-020-00349-3
   Ma YL, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138226
   Magazzino C, 2021, J ENVIRON MANAGE, V286, DOI 10.1016/j.jenvman.2021.112241
   Roy I, 2021, INT J ENVIRON SCI TE, V18, P2903, DOI 10.1007/s13762-020-02991-8
   Sarkodie SA, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03747
   Sharma P, 2020, J PUBLIC AFF, V20, DOI 10.1002/pa.2222
   Yahya BM, 2021, APPL GEOMAT, V13, P481, DOI 10.1007/s12518-021-00365-4
NR 23
TC 3
Z9 3
U1 2
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0343-2521
EI 1572-9893
J9 GEOJOURNAL
JI GeoJournal
DI 10.1007/s10708-021-10427-0
EA APR 2021
PG 15
WC Geography
WE Emerging Sources Citation Index (ESCI)
SC Geography
GA RR5YZ
UT WOS:000643174500001
PM 33935350
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Campos, L
   Soares, LES
   Berlingieri, G
   Ramires, MCCH
   Guirado, MMG
   Lyra, LADP
   Teixeira, IS
   Oliveira, PC
   Alvares, CMA
   Palma, LF
AF Campos, Luana
   Soares, Luis Eduardo Silva
   Berlingieri, Giuseppina
   Ramires, Marcia Christina Camargo Hernandes
   Guirado, Milena Miranda Goulart
   Lyra, Luciana Aparecida de Oliveira P.
   Teixeira, Inessa Solek
   Oliveira, Patricia Costa
   Alvares, Cristina Maria Arvate
   Palma, Luiz Felipe
TI A Brazilian multicenter pilot case series on the efficacy of
   photobiomodulation therapy for COVID-19-related taste dysfunction
SO PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY
LA English
DT Article
DE COVID-19; SARS-CoV-2; taste perception; lasers; low-level light therapy
AB Background and aim: Among the most common symptoms of COVID-19 is taste dysfunction, which has a ranging clinical presentation. As well as its pathophysiology remains to be unclear, there is not enough information about the efficacy and safety of the available treatments. This study aims to report a series of cases using PBMT for the management of COVID-19-related taste impairment. Case series: 8 female and 2 male patients sought medical help for taste impairment (either partially or completely) after COVID-19 infection. Photobiomodulation therapy (PBMT) on the tongue mucosa was then proposed but with 3 different protocols. Taste perception at baseline and before every laser session was evaluated using a visual analog scale. Irrespective of the PBMT protocol, taste recovery was noted in all cases but with varying degrees of improvement. Conclusion: given the high prevalence rates of taste dysfunction in COVID-19 patients and the lack of information about the available treatments, PBMT seems to be a promising therapeutic modality but not dependent on the total number of laser sessions and the interval between them. The choice of the most suitable laser protocol as well as the knowledge of the exact photonic mechanisms, however, need to be better studied.
C1 [Campos, Luana; Alvares, Cristina Maria Arvate] Univ Santo Amaro, Grad Program Implantol, Sch Dent, Sao Paulo, SP, Brazil.
   [Campos, Luana; Soares, Luis Eduardo Silva; Berlingieri, Giuseppina; Ramires, Marcia Christina Camargo Hernandes; Guirado, Milena Miranda Goulart; Lyra, Luciana Aparecida de Oliveira P.; Teixeira, Inessa Solek; Oliveira, Patricia Costa] Study Grp Laser & Hlth Inst, Sao Paulo, SP, Brazil.
   [Soares, Luis Eduardo Silva] Univ Vale Paraiba, Grad Program Biomed Engn, Res & Dev Inst, Sao Jose Dos Campos, SP, Brazil.
   [Ramires, Marcia Christina Camargo Hernandes; Guirado, Milena Miranda Goulart] Doutor Jose de Carvalho Florence Hospital, Sao Jose Dos Campos, SP, Brazil.
   [Lyra, Luciana Aparecida de Oliveira P.] Univ Posit, Scholl Hlth Sci, Curitiba, PR, Brazil.
   [Teixeira, Inessa Solek] Imperial Charity Hosp, Florianopolis, SC, Brazil.
   [Oliveira, Patricia Costa] Inst Fed Parana, Campus Londrina, Londrina, PR, Brazil.
   [Palma, Luiz Felipe] Univ Ibirapuera, Grad Dent Program, Sao Paulo, SP, Brazil.
RP Palma, LF (corresponding author), Univ Ibirapuera, Av Interlagos 1329, BR-04661100 Sao Paulo, SP, Brazil.
EM luizfelipep@hotmail.com
RI Campos, Luana/J-9150-2012
OI Campos, Luana/0000-0002-2747-2812; Silva Soares, Luis
   Eduardo/0000-0001-9360-7407
CR Ramires MCCH, 2021, PHOTODIAGN PHOTODYN, V33, DOI 10.1016/j.pdpdt.2021.102196
   Ercoli T, 2021, NEUROL SCI, V42, P4921, DOI 10.1007/s10072-021-05611-6
   Juvekar M, 2021, INDIAN J OTOLARYNGOL, DOI 10.1007/s12070-021-02871-8
   Li JH, 2021, MILITARY MED RES, V8, DOI 10.1186/s40779-021-00339-y
   Mastrangelo A, 2021, NEUROSCI LETT, V748, DOI 10.1016/j.neulet.2021.135694
   Soares LES, 2021, PHOTODIAGN PHOTODYN, V36, DOI 10.1016/j.pdpdt.2021.102574
   Teixeira IS, 2021, PHOTODIAGN PHOTODYN, V34, DOI 10.1016/j.pdpdt.2021.102281
   Watson DLB, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256998
NR 8
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1572-1000
EI 1873-1597
J9 PHOTODIAGN PHOTODYN
JI Photodiagnosis Photodyn. Ther.
PD MAR
PY 2022
VL 37
AR 102643
DI 10.1016/j.pdpdt.2021.102643
PG 4
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA YD9UI
UT WOS:000740778100007
PM 34826638
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Singh, YP
AF Singh, Yash Pal
TI Effect of COVID-19 on Psychological, Socioeconomic Status and
   Performance of Clinical Practices of Dental Professional in Riyadh,
   Saudi Arabia
SO ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH
LA English
DT Article
DE COVID-19; Psychological; Socioeconomic Impact; Dental Practices
ID DENTISTS; OUTBREAK; PRACTITIONERS; MANAGEMENT; KNOWLEDGE
AB Background: Prevailing conditions of COVID-19 has hit all sectors of society including dentistry. Both personal and professional lives of dentists have been influenced. Several studies have been undertaken regarding aspects likes influence of clinical practices, awareness regarding the pandemic among patients and dentists. Only a few studies have been conducted in Saudi Arabia. The present study evaluates the impact of COVID-19 on Fear, anxiety, socioeconomic status and performance of clinical practices of dental professionals in Riyadh. Methods: A Questionnaire was designed as Google form and sent to 400 dental professionals and responses were statistically evaluated. Results: 244 males and 156 females' dental professionals participated in study. Most of the clinical practices were found to be open but with lower patient volumes. There was decline in both monthly volumes of patients and volumes of collections. Majority of dental professionals were in fear of getting COVID-19 and transmitting to their families. They were afraid of getting quarantined also. In general, all agreed that it will take more than a year for their practices to come back to normal but most of them did not want to shift their profession. There was found to be significant association between designation and effects of COVID-19. Conclusion: There was definite negative impact of COVID-19 on socioeconomic status and performance of clinical practices along with increase in Fear and anxiety among dental professionals.
C1 [Singh, Yash Pal] Dar Al Uloom Univ, Dept Restorat & Prosthet Dent Sci, Riyadh, Saudi Arabia.
RP Singh, YP (corresponding author), Dar Al Uloom Univ, Dept Restorat & Prosthet Dent Sci, Riyadh, Saudi Arabia.
EM dryashpal.singh@gmail.com
FU Deanship of Graduate Studies and Scientific Research at Dar Al Uloom
   University
FX This Project is supported by Deanship of Graduate Studies and Scientific
   Research at Dar Al Uloom University.
CR Ahmed MA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082821
   Al-Khalifa KS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237630
   AlBaker AA, 2017, SAUDI PHARM J, V25, P1208, DOI 10.1016/j.jsps.2017.09.005
   Alsalleeh F, 2018, SAUDI DENT J, V30, P70, DOI 10.1016/j.sdentj.2017.10.008
   [Anonymous], Survey results of economic impact of COVID-19 on dental practices.
   Arora S, 2020, J MULTIDISCIP HEALTH, V13, P841, DOI 10.2147/JMDH.S268891
   Barabari P, 2020, DENT J-BASEL, V8, DOI 10.3390/dj8020053
   Cagetti MG, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113835
   Consolo U, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103459
   Gambarini Elisa, 2020, J Contemp Dent Pract, V21, P718
   Goswami Mridula, 2020, Int J Clin Pediatr Dent, V13, P269, DOI 10.5005/jp-journals-10005-1757
   Kumar D, 2020, AIMS MICROBIOL, V6, P183, DOI 10.3934/microbiol.2020013
   Luo M, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113190
   Maciaszek J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082527
   Putrino A, 2020, BMC ORAL HEALTH, V20, DOI 10.1186/s12903-020-01187-3
   Ren YF, 2020, J DENT, V101, DOI 10.1016/j.jdent.2020.103434
   Seneviratne CJ, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00566
   Shacham M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082900
   Stangvaltaite-Mouhat L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165843
   Tysiac-Mista M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134703
NR 20
TC 1
Z9 1
U1 0
U2 1
PU NIGERIAN MEDICAL ASSOC, ENUGU STATE
PI ABUJA
PA 8 BENGHAZI ST, OFF ADDIS ABABA CRES, ABUJA, NIGERIA
SN 2141-9248
EI 2277-9205
J9 ANN MED HEALTH SCI R
JI Ann. Med. Health Sci. Res.
PD MAR-APR
PY 2021
VL 11
IS 3
BP 1331
EP +
PG 8
WC Health Care Sciences & Services
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services
GA SN5XA
UT WOS:000658361000004
DA 2022-04-20
ER

PT J
AU Valeeva, R
   Kalimullin, A
AF Valeeva, Roza
   Kalimullin, Aydar
TI Adapting or Changing: The COVID-19 Pandemic and Teacher Education in
   Russia
SO EDUCATION SCIENCES
LA English
DT Article
DE COVID-19; teacher education; Russia; distance learning
AB Adaptation of the Russian education system to the changes forced by the COVID-19 pandemic was complicated by the sheer size of the country, which entails the differentiation of the regions in terms of the quality of education, access to knowledge networks, communication resources, and top universities. Amid the pandemic, the country's education system experienced an initial shock after the introduction of distance learning in March 2020, attempted to return to classroom learning in September 2020, and introduced blended learning in October 2020. Each stage brought about changes in organization and management of teaching and learning processes, development of online learning platforms and courses, and technological improvements. A diversified teacher education system impeded these changes. In effect, only the largest among 300 education institutions that offer teacher education programs had the necessary resources to provide high-quality distance and blended learning. Their experience could form the basis for creating a standardized model of teacher training for the purposes of blended learning. This is most probable in the context of the tight control and the top-down approach typical of the Russian education system. The article, therefore, analyzes some examples regarding teacher training during the pandemic implemented at Russian universities. These cases have the potential to become major trends that would ensure consistency of the country's education system in extreme situations that might recur in the future.
C1 [Valeeva, Roza; Kalimullin, Aydar] Kazan Fed Univ, Inst Psychol & Educ, Pedag Dept, Kazan 420008, Russia.
RP Valeeva, R (corresponding author), Kazan Fed Univ, Inst Psychol & Educ, Pedag Dept, Kazan 420008, Russia.
EM valeykin@yandex.ru; kalimullin@yandex.ru
RI Kalimullin, Aydar/N-1528-2013
OI Kalimullin, Aydar/0000-0001-7788-7728
FU Kazan Federal University Strategic Academic Leadership Program
FX This paper has been supported by the Kazan Federal University Strategic
   Academic Leadership Program.
CR Accounts Chamber of the Russian Federation, 2020, COR EP IMP ED
   Aleshkovskii I.A., 2020, VYSSHEE OBRAZOVANIE, V29, P86, DOI [10.31992/0869-3617-2020-29-10-86-100, 10 .31992/0869-3617-2020-29-10- 86-100, DOI 10.31992/0869-3617-2020-29-10-86-100]
   Flores MA, 2020, J EDUC TEACHING, V46, P507, DOI 10.1080/02607476.2020.1799709
   Bilenko P.N., 2020, DIDACTIC CONCEPT DIG
   British Council, SURV TEACH TEACH ED
   Carrillo C, 2020, EUR J TEACH EDUC, V43, P466, DOI 10.1080/02619768.2020.1821184
   Cherdakly U.S, 2020, WORLD SCI CULT ED, V3, P278, DOI [10.24411/1991-5497-2020-00542, DOI 10.24411/1991-5497-2020-00542]
   Danilyuk A.Y., 2019, DIGITAL GEN ED
   Dyakova Sechkareva, 2019, VESTNIK ARMAVIRSKOGO, V2, P24
   Ellis V, 2020, EUR J TEACH EDUC, V43, P559, DOI 10.1080/02619768.2020.1821186
   Ferdig R.E., 2021, WHAT TEACHER ED SHOU
   Gafurov I.R, 2020, HIGH ED RUSS, V29, P101
   Gruzdev I.A., DISTANTSIONNYY SMOTR
   Hodges Charles., 2020, EDUCAUSE REV, V502
   Ibragimov G.I., 2015, ALMA MAT, V5, P38
   Ilyushenko N.S., 2019, P 2 INT C DES FUT DI, P215
   Isaeva N. V., 2020, ANALITICHESKIJ BYULL, V6, P92
   Kidd W, 2020, EUR J TEACH EDUC, V43, P542, DOI 10.1080/02619768.2020.1820480
   Klimov A.A, 2019, SOVREM INF TEKHNOLOG, V15, P468, DOI [10.25559/SITITO.15.201902.468-476, DOI 10.25559/SITITO.15.201902.468-476]
   Kolesnikova I.A, 2019, VYSS OBRAZ 5 ROSS HI, V8, P67, DOI [10.31992/0869-3617-2019-28-8-9-67-82, DOI 10.31992/0869-3617-2019-28-8-9-67-82]
   Kruglova N. R., 2020, PROF OBRAZ 5 SOVREM, V10, P3499, DOI DOI 10.15372/PEMW20200113
   la Velle L, 2020, J EDUC TEACHING, V46, P596, DOI 10.1080/02607476.2020.1803051
   Laboratory of Media Communications in Education National Research University Higher School of Economics, 2020, PROBLEMS TRANSITION
   MacPhail A, 2020, RES TEACHER ED, V10, P53, DOI DOI 10.15123/UEL.88Z97
   Milkevich O.A, 2020, NAR OBRAZ PUBLIC ED, V3, P29
   Mutton T, 2020, J EDUC TEACHING, V46, P439, DOI 10.1080/02607476.2020.1805189
   Orekin P.V., 2020, RUSSIA NEW ERA CHOOS
   Ruiz LMS, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13063532
   Saprykina D.I., 2020, PROBLEMS TRANSITION, VVolume 4
   Schleicher A, IMPACT COVID 19 ED I
   School Barometer (Experience Opinions Needs and Requirements), COVID 19 CURR ISS SC
   Shafranov-Kutsev G.F, 2017, VESTN TYUMENSKOGO GO, V3, P8, DOI [10.21684/2411-7897-2017-3-4-8-18, DOI 10.21684/2411-7897-2017-3-4-8-18]
   Shurukhina T.N., 2020, SOVREM PROBL NAUK OB, P6, DOI [10.17513/spno.30265, DOI 10.17513/SPNO.30265]
   Strekalova N.B., 2019, VESTNIK SAMARSKOGO U, V25, P84, DOI 10.18287/2542-0445-2019-25-2-84-88
   [Тульчинский Григорий Львович Tulchinsky Grigory], 2017, [Философские науки, Filosofskie nauki], P121
   Vayndorf-Sysoeva M.E., 2018, VESTN MOSK GOS OBL U, V3, P26, DOI [10.18384/2310-7219-2018-3-25-36, DOI 10.18384/2310-7219-2018-3-25-36]
   Verbitsky A.A., 2019, ELECT SCI J HOMO CYB, V1
   Zair-Bek S.I., 2020, READINESS RUSSIAN SC
   Zernov V.A., 2020, OBS ROSS SCI WORK FR, V223, P304, DOI [10.38197/2072-2060-2020-223-3-304-322, DOI 10.38197/2072-2060-2020-223-3-304-322]
NR 39
TC 4
Z9 4
U1 9
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-7102
J9 EDUC SCI
JI Educ. Sci.
PD AUG
PY 2021
VL 11
IS 8
AR 408
DI 10.3390/educsci11080408
PG 12
WC Education & Educational Research
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research
GA UG0BP
UT WOS:000688929500001
OA gold
DA 2022-04-20
ER

PT J
AU Marginean, CO
   Melit, LE
   Simu, I
   Puiac, C
   Szederjesi, J
   Sasaran, MO
AF Marginean, Cristina Oana
   Melit, Lorena Elena
   Simu, Iunius
   Puiac, Claudiu
   Szederjesi, Janos
   Sasaran, Maria Oana
TI Pediatric COVID-19: Low Incidence, but Possible Fatality-A Case Report
   and a Review of the Literature
SO CHILDREN-BASEL
LA English
DT Review
DE SARS-CoV-2; COVID-19; coagulopathy; pneumonia; children
AB Background: Pediatric COVID-19 is a current health burden mostly due to the lack of knowledge in terms of symptoms, clinical course and management. COVID-19-associated coagulopathy is one of the most recently described complications among adults, along with acquired thrombophilia resulting in an increased risk for venous, arterial and microvascular thrombosis. Case presentation: We report the case of a 4-year-old male child, admitted to our clinic for generalized seizures being intubated and mechanically ventilated before admission, with a personal history of ureterovesical junction obstruction, mild hydronephrosis, and an episode of generalized seizures. The laboratory tests revealed anemia, an increased number of monocytes, and a mildly increased C-reactive protein. A real-time polymerase chain reaction (RT-PCR) of the oropharyngeal swab was performed and it tested positive for SARS-CoV-2 in the child and both of his parents. The thoracic CT showed consolidation in the lower lobe of the left lung associated with an opacity in the right apex, suggesting possible atelectasis. We initiated antibiotic, antiviral, corticosteroids, as well as anticoagulants and antipyretics, continuing the chronic anticonvulsant therapy. The patient's condition deteriorated progressively, and, after 72 h of hospitalization, he developed desaturation and bradycardia. The laboratory parameters on the third day showed leucopenia, neutropenia, increased creatine kinase, a high ferritin level, hypoalbuminemia, a prolonged prothrombin time and an increased international normalized ration. The patient died on the fourth day of admission. Conclusion: In spite of its low incidence and frequent benign clinical course, COVID-19 complications such as coagulopathy might represent a leading cause of death, even in pediatric patients.
C1 [Marginean, Cristina Oana; Melit, Lorena Elena] George Emil Palade Univ Med Pharm Sci & Technol T, Dept Pediat 1, Gheorghe Marinescu St 38, Targu Mures 540136, Romania.
   [Simu, Iunius] George Emil Palade Univ Med Pharm Sci & Technol T, Dept Radiol, Gheorghe Marinescu St 38, Targu Mures 540136, Romania.
   [Puiac, Claudiu] George Emil Palade Univ Med Pharm Sci & Technol T, Dept Emergency Med, Gheorghe Marinescu St 38, Targu Mures 540136, Romania.
   [Szederjesi, Janos] George Emil Palade Univ Med Pharm Sci & Technol T, Dept Anestesiol, Gheorghe Marinescu St 38, Targu Mures 540136, Romania.
   [Sasaran, Maria Oana] George Emil Palade Univ Med Pharm Sci & Technol T, Dept Pediat 3, Gheorghe Marinescu St 38, Targu Mures 540136, Romania.
RP Melit, LE (corresponding author), George Emil Palade Univ Med Pharm Sci & Technol T, Dept Pediat 1, Gheorghe Marinescu St 38, Targu Mures 540136, Romania.
EM marginean.oana@gmail.com; lory_chimista89@yahoo.com;
   iuniuspaul.simu@gmail.com; claudiupuiac@gmail.com; yangzi37@gmail.com;
   oanam93@yahoo.com
RI Melit, Lorena Elena/AAE-6650-2022; Marginean, Cristina
   Oana/AAR-5227-2021
CR Balasubramanian S, 2020, INDIAN PEDIATR, V57, P435, DOI 10.1007/s13312-020-1819-5
   Baron DM, 2020, ANAESTHESIA, V75, P1105, DOI 10.1111/anae.15095
   Becker RC, 2020, J THROMB THROMBOLYS, V50, P54, DOI 10.1007/s11239-020-02134-3
   CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI 10.15585/mmwr.mm6915e4
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Fox SE, 2020, LANCET RESP MED, V8, P681, DOI 10.1016/S2213-2600(20)30243-5
   Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020
   Helms Eric, 2006, Am J Obstet Gynecol, V194, pe32, DOI 10.1016/j.ajog.2006.01.025
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Lee PI, 2020, J MICROBIOL IMMUNOL, V53, P371, DOI 10.1016/j.jmii.2020.02.011
   Livingston Edward, 2020, JAMA, V323, P1335, DOI 10.1001/jama.2020.4344
   Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073
   Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270
   Murray MA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/692546
   Nickbakhsh S, 2019, P NATL ACAD SCI USA, V116, P27142, DOI 10.1073/pnas.1911083116
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Tian Y, 2020, ALIMENT PHARM THER, V51, P843, DOI 10.1111/apt.15731
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 19
TC 0
Z9 0
U1 4
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9067
J9 CHILDREN-BASEL
JI Children-Basel
PD DEC
PY 2021
VL 8
IS 12
AR 1128
DI 10.3390/children8121128
PG 7
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA XX2PW
UT WOS:000736145500001
PM 34943324
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Khesht, AMS
   Karpisheh, V
   Saeed, BQ
   Zekiy, AO
   Yapanto, LM
   Afjadi, MN
   Aksoun, M
   Esfahani, MN
   Aghakhani, F
   Movahed, M
   Joshi, N
   Abbaszadeh-Goudarzi, K
   Hallaj, S
   Ahmadi, M
   Dolati, S
   Mahmoodpoor, A
   Hashemi, V
   Jadidi-Niaragh, F
AF Khesht, Armin Mahmoud Salehi
   Karpisheh, Vahid
   Saeed, Balsam Qubais
   Zekiy, Angelina Olegovna
   Yapanto, Lis M.
   Afjadi, Mohsen Nabi
   Aksoun, Mohsen
   Esfahani, Maryam Nasr
   Aghakhani, Fatemeh
   Movahed, Mahsa
   Joshi, Navneet
   Abbaszadeh-Goudarzi, Kazem
   Hallaj, Shahin
   Ahmadi, Majid
   Dolati, Sanam
   Mahmoodpoor, Ata
   Hashemi, Vida
   Jadidi-Niaragh, Farhad
TI Different T cell related immunological profiles in COVID-19 patients
   compared to healthy controls
SO INTERNATIONAL IMMUNOPHARMACOLOGY
LA English
DT Article
DE COVID-19; T cells; Cell mediated immunity; Inflammation
ID IMMUNITY; TH17; FOXP3
AB In various pathological conditions, cellular immunity plays an important role in immune responses. Among immune cells, T lymphocytes pdomote cellular and humoral responses as well as innate immunity. Therefore, careful investigation of these cells has a significant impact on accurate knowledge in COVID-19 disease pathogenesis. In current research, the frequency and function of various T lymphocytes involved in immune responses examined in SARS-CoV-2 patients with various disease severity compared to normal subjects. In order to make an accurate comparison among patients with various disease severity, this study was performed on asymptomatic recovered cases (n = 20), ICU hospitalized patients (n = 30), non-ICU hospitalized patients (n = 30), and normal subjects (n = 20). To precisely evaluate T cells activity following purification, their cytokine secretion activity was examined. Similarly, immediately after purification of Treg cells, their inhibitory activity on T cells was investigated. The results showed that COVID-19 patients with severe disease (ICU hospitalized patients) not only had a remarkable increase in Th1 and Th17 but also a considerable decrease in Th2 and Treg cells. More importantly, as the IL-17 and IFN-gamma secretion was sharply increased in severe disease, the secretion of IL-10 and IL-4 was decreased. Furthermore, the inhibitory activity of Treg cells was reduced in severe disease patients in comparison to other groups. In severe COVID-19 disease, current findings indicate when the inflammatory arm of cellular immunity is significantly increased, a considerable reduction in anti-inflammatory and regulatory arm occurred.
C1 [Khesht, Armin Mahmoud Salehi; Aksoun, Mohsen; Esfahani, Maryam Nasr; Hallaj, Shahin; Jadidi-Niaragh, Farhad] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran.
   [Khesht, Armin Mahmoud Salehi] Islamic Azad Univ, Najafabad Branch, Fac Mat Engn, Dept Biochem, Najafabad, Iran.
   [Karpisheh, Vahid] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran.
   [Saeed, Balsam Qubais] Univ Sharjah, Coll Med, Dept Clin Sci, Sharjah, U Arab Emirates.
   [Zekiy, Angelina Olegovna] Sechenov First Moscow State Med Univ, Dept Prosthet Dent, Moscow, Russia.
   [Yapanto, Lis M.] Univ Negeri Gorontalo, Fac Fisheries & Marine Sci, Dept Aquat Management, Gorontalo, Indonesia.
   [Afjadi, Mohsen Nabi] Univ Tarbiat Modares, Fac Biol Sci, Dept Biochem, Tehran, Iran.
   [Aghakhani, Fatemeh] Islamic Azad Univ, Tehran Med Branch, Dept Microbiol, Tehran, Iran.
   [Movahed, Mahsa] Yazd Univ, Fac Sci, Dept Biol, Yazd, Iran.
   [Joshi, Navneet] Mody Univ Sci & Technol, Dept Biosci, Lakshmangarh, Rajasthan, India.
   [Abbaszadeh-Goudarzi, Kazem] Sabzevar Univ Med Sci, Dept Med Biotechnol, Fac Med, Sabzevar, Iran.
   [Ahmadi, Majid] Tabriz Univ Med Sci, Stem Cell Res Ctr, Tabriz, Iran.
   [Dolati, Sanam] Tabriz Univ Med Sci, Phys Med & Rehabil Res Ctr, Aging Res Inst, Tabriz, Iran.
   [Mahmoodpoor, Ata] Tabriz Univ Med Sci, Imam Reza Med Res & Training Hosp, Dept Anesthesiol, Fac Med, Tabriz, Iran.
   [Hashemi, Vida] Maragheh Univ Med Sci, Dept Basic Sci, Fac Med, Maragheh, Iran.
   [Jadidi-Niaragh, Farhad] Tabriz Univ Med Sci, Fac Med, Dept Immunol, Tabriz, Iran.
RP Hashemi, V (corresponding author), Maragheh Univ Med Sci, Dept Basic Sci, Fac Med, Maragheh, Iran.; Jadidi-Niaragh, F (corresponding author), Tabriz Univ Med Sci, Tabriz, Iran.
EM hashemivi@mrgums.ac.ir; jadidif@tbzmed.ac.ir
RI Joshi, Navneet/AAP-4924-2021; Hallaj, Shahin/AAH-3779-2020; Yapanto, Lis
   M/T-4160-2018
OI Joshi, Navneet/0000-0003-0155-3785; Hallaj, Shahin/0000-0002-9541-1915;
   Yapanto, Lis M/0000-0002-5602-8219
FU Maragheh University of Medical Sciences; Tabriz University of Medical
   Sciences [65883]
FX We would like to thank Maragheh University of Medical Sciences for
   financial support of this study. Also, we appreciate Tabriz University
   of Medical Sciences for supporting this study (grant number: 65883) . We
   would like to give special thanks to Mrs. Elham Rezaei for her excellent
   contribution in this study.
CR Ahmadi M, 2017, SYST BIOL REPROD MED, V63, P350, DOI 10.1080/19396368.2017.1390007
   Ak A.A.J., 2020, INT J SURG, V76, P71
   Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Barnes BJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20200652
   Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208
   Carli G, 2021, ALLERGY, V76, P866, DOI 10.1111/all.14426
   Casanova JL, 2020, CELL, V181, P1194, DOI 10.1016/j.cell.2020.05.016
   Chen Y., 2020, CHARACTERISTICS LYMP, DOI [10.1101/2020.02.10.20021832, DOI 10.1101/2020.02.10.20021832]
   De Biasi S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17292-4
   Decaro N, 2010, EMERG INFECT DIS, V16, P41, DOI 10.3201/eid1601.090726
   Feng XD, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00301
   Gao YY, 2015, P NATL ACAD SCI USA, V112, pE3246, DOI 10.1073/pnas.1421463112
   Groeneveld ABJ, 2002, VASC PHARMACOL, V39, P247, DOI 10.1016/S1537-1891(03)00013-2
   Hajizadeh, 2020, INT J BIOL MACROMOL
   Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254
   Hassannia H, 2020, IMMUNOLOGY, V159, P75, DOI 10.1111/imm.13126
   Hoe E, 2017, MICROBIOL IMMUNOL, V61, P49, DOI 10.1111/1348-0421.12471
   Jadidi-Niaragh F, 2013, CANCER INVEST, V31, P121, DOI 10.3109/07357907.2012.756110
   Jadidi-Niaragh F, 2012, IMMUNOPHARM IMMUNOT, V34, P727, DOI 10.3109/08923973.2011.619987
   Jahanshahlu L, 2020, ARCH MED RES, V51, P721, DOI 10.1016/j.arcmed.2020.05.016
   Jose RJ, 2020, LANCET RESP MED, V8, pE46, DOI 10.1016/S2213-2600(20)30216-2
   Karpisheh V, 2021, LIFE SCI, V284, DOI 10.1016/j.lfs.2021.119132
   Karpisheh V, 2020, PATHOL RES PRACT, V216, DOI 10.1016/j.prp.2020.153247
   L opez-Ruz M. A, 2020, FRONT IMMUNOL, V11
   Lalueza A., FRONT CELL INFECT MI, V11, P79
   Li XW, 2020, J PHARM ANAL, V10, P102, DOI 10.1016/j.jpha.2020.03.001
   Liu YX, 2020, NATL SCI REV, V7, P1003, DOI 10.1093/nsr/nwaa037
   Livingston Edward, 2020, JAMA, V323, P1122, DOI 10.1001/jama.2020.2633
   Masjedi A, 2020, INT J BIOL MACROMOL, V149, P487, DOI 10.1016/j.ijbiomac.2020.01.273
   Masjedi A, 2019, INT J BIOL MACROMOL, V133, P436, DOI 10.1016/j.ijbiomac.2019.03.223
   Mazzoni A, 2020, EUR J IMMUNOL, V50, P2013, DOI 10.1002/eji.202048915
   Mazzoni A, 2020, J CLIN INVEST, V130, P4694, DOI [10.1172/JCI138554, 10.1172/JCI138554.]
   Meckiff BJ, 2020, CELL, V183, P1340, DOI 10.1016/j.cell.2020.10.001
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085
   Oja AE, 2020, EUR J IMMUNOL, V50, P1998, DOI 10.1002/eji.202048908
   Orlov M, 2020, J IMMUNOL, V205, P892, DOI 10.4049/jimmunol.2000554
   PETTE M, 1990, NEUROLOGY, V40, P1770, DOI 10.1212/WNL.40.11.1770
   Qin C., DYSREGULATION IMMUNE
   Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248
   Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71
   Ratajewski M., 2020, VACCINES-BASEL, V8, P673
   Recalcati S, 2020, J EUR ACAD DERMATOL, V34, pE346, DOI 10.1111/jdv.16533
   Rokni M, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2107
   Romagnani S, 2000, ANN ALLERG ASTHMA IM, V85, P9, DOI 10.1016/S1081-1206(10)62426-X
   Sadeghi A, 2021, J CELL PHYSIOL, V236, P2829, DOI 10.1002/jcp.30047
   Stebbing J, 2020, LANCET INFECT DIS, V20, P400, DOI 10.1016/S1473-3099(20)30132-8
   Stone M., 2020, SARS COV2 INFECT IND
   Taghizadieh A, 2020, RESPIR MED CASE REP, V30, DOI 10.1016/j.rmcr.2020.101090
   Tahmasebi S, 2020, J CELL PHYSIOL, V235, P9211, DOI 10.1002/jcp.29804
   Tan MK, 2020, IMMUNOLOGY, V160, P261, DOI 10.1111/imm.13223
   Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8
   Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045
   Woodland DL, 2001, IMMUNOL RES, V24, P53, DOI 10.1385/IR:24:1:53
   Wu DD, 2020, J MICROBIOL IMMUNOL, V53, P368, DOI 10.1016/j.jmii.2020.03.005
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Wu YC, 2020, J CHIN MED ASSOC, V83, P217, DOI 10.1097/JCMA.0000000000000270
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
   Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1038/s41368-020-0074-X, 10.1038/s41368-020-0074-x]
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Zhang BC, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00157
   Zhang D, 2021, J LEUKOCYTE BIOL, V109, P13, DOI 10.1002/JLB.4HI0720-470R
   Zheng HY, 2020, CELL MOL IMMUNOL, V17, P541, DOI 10.1038/s41423-020-0401-3
   Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2
   Zhou X, 2020, MPAIRED T CELL FUNCT
   Zhu Z, 2020, INT J INFECT DIS, V95, P332, DOI 10.1016/j.ijid.2020.04.041
NR 69
TC 3
Z9 3
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-5769
EI 1878-1705
J9 INT IMMUNOPHARMACOL
JI Int. Immunopharmacol.
PD AUG
PY 2021
VL 97
AR 107828
DI 10.1016/j.intimp.2021.107828
EA JUN 2021
PG 12
WC Immunology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Pharmacology & Pharmacy
GA TR7PD
UT WOS:000679152100003
PM 34091116
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Ofori-Boateng, K
   Ohemeng, W
   Agyapong, EK
   Bribinti, BJ
AF Ofori-Boateng, Kenneth
   Ohemeng, Williams
   Agyapong, Elvis Kwame
   Bribinti, Ben Justice
TI The impact of COVID-19 on stock returns of listed firms on the stock
   market: Ghana's experience
SO AFRICAN JOURNAL OF ECONOMIC AND MANAGEMENT STUDIES
LA English
DT Article
DE COVID-19; Stock returns; GSECI; EGARCH; Ghana; A1; C4; G1; M21
ID VOLATILITY
AB Purpose In Ghana, even though scholars and experts in the field of economics and finance have expressed their opinions and perceptions on the effect of the pandemic on the Ghana Stock Exchange, there has been no study conducted to that effect. This study, therefore, aimed at examining the impact of COVID-19 on the stock returns on the Ghana stock exchange. This would help policy makers and investors in making efficient decisions. Design/methodology/approach The outbreak of the novel COVID-19 has been a thorn in the flesh of the world in its entirety, affecting many aspects of life including the stock market. This study, therefore, examined the impact of the outbreak on the stock returns of the Ghana Stock Exchange. The study utilized data from the All Share Prices of the Ghana stock exchange, commonly known as the Ghana stoke exchange composite index (GSECI) for analysis. The data covered the period before the outbreak of COVID-19 and during the outbreak. It was revealed that the Ghana stock exchange experienced better returns on the market before the outbreak of the virus. The outbreak of COVID-19 has led to wide variations in the market increasing the risk of investments. The exponential General Autoregressive Conditional Heteroscedasticity (EGARCH) (1, 1) model also reveals that the outbreak of COVID-19 has a significant negative effect on the returns in the market. The market in these periods of COVID-19 is highly volatile. It is recommended that investors should carefully consider risk mitigation strategies to enable them diversify their investments effectively and efficiently against the high risk associated with the market in this COVID-19 era. Findings It was revealed that the Ghana stock exchange experienced better returns on the market before the outbreak of the virus. The outbreak of COVID-19 has led to wide variations in the market increasing the risk of investments. The EGARCH (1, 1) model also revealed that the outbreak of COVID-19 had a significant negative effect on stock returns in the market. The market during these periods of COVID-19 was viewed as highly volatile. Research limitations/implications The outbreak of COVID-19 is hence deduced to have a negative impact on the Ghana stock exchange. However, the knowledge of how the market has been affected by the disease, it is important that financial risk mitigation studies be undertaken. This goes beyond what this study has done. The study can further be expanded to include other important economic variables such as GDP, inflation, exchange rates and the likes in to the model. Practical implications Investors should carefully consider risk mitigation strategies to enable them diversify their investments effectively and efficiently against the high risk associated with the market in this COVID-19 era. Social implications It is also important that investors consider diversification of their investments in order to reduce the risk in their investments. It will be more appropriate for most investors to invest with companies such as banks and the telecommunications companies listed on the on the market. This is because most of the telecommunication companies in these times have taken advantage and are making good profit on their businesses. Likewise, some of the financial institutions are considered essential institution in these times. Investing in industries such as manufacturing and the oil and gas sector may be more risky.
   Originality/value The decline in economic and financial market indicators could be credited to the failure of most business entities, organizations and firms which are struggling to sustain their operations in these times of COVID-19. These also include firms listed on the Ghana stock exchange with whom investors transact their daily businesses. However, about 70% of the Ghanaian economy heavily depends on these business and firms found in the private and informal sector. According to the Ghana Statistics Service COVID-19 Business Tracker Survey, about 131,000 businesses expressed their uncertainties with the business environment and also faced the challenge of financial accessibility. The study is appropriate to unearth the true effect and offer policy interventions.
C1 [Ofori-Boateng, Kenneth; Agyapong, Elvis Kwame; Bribinti, Ben Justice] Ghana Inst Management & Publ Adm, Accounting & Finance, Accra, Ghana.
   [Ohemeng, Williams] Ghana Inst Management & Publ Adm, Econ, Accra, Ghana.
RP Ofori-Boateng, K (corresponding author), Ghana Inst Management & Publ Adm, Accounting & Finance, Accra, Ghana.
EM koboateng@gimpa.edu.gh
OI , Elvis/0000-0003-1544-9057; Ofori-Boateng, Kenneth/0000-0002-8657-013X
CR Ahmadi S, 2020, APPL WATER SCI, V10, DOI 10.1007/s13201-020-01271-7
   Ajami R., 2020, J ASIA PAC BUS, V21, P1, DOI DOI 10.1080/10599231.2020.1745046
   Aluko OA, 2018, FUTUR BUS J, V4, P189, DOI 10.1016/j.fbj.2018.06.001
   Alzubi B., 2018, J ECONOM ADM SCI, V23, P17
   Bhowmik, 2013, STOCK MARKET VOLATIL, V3, P107
   BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1
   Chen Ming-Hsiang, 2007, Int J Hosp Manag, V26, P200, DOI 10.1016/j.ijhm.2005.11.004
   Del Giudice A, 2017, RES INT BUS FINANC, V41, P600, DOI 10.1016/j.ribaf.2017.05.004
   deLisle Jacques, 2003, Orbis, V47, P587, DOI 10.1016/S0030-4387(03)00076-0
   DeSantis G, 1997, J INT MONEY FINANC, V16, P561, DOI 10.1016/S0261-5606(97)00020-X
   Eskandar T, 2010, MODELING FORECASTING
   Feinstein Z., 2020, J FINANCE EC, V3, P45
   Ghana Statistical Service, 2020, COVID 19 UPD
   Hollstein F, 2018, REV ASSET PRICING ST, V8, P253, DOI 10.1093/rapstu/rax019
   Igwe, 2020, AFRICAN DEV I RES ME, V1, P1
   Iqbal N, 2021, J RISK FINANC MANAG, V14, DOI 10.3390/jrfm14070314
   Kenu Ernest, 2020, Ghana Med J, V54, P72, DOI 10.4314/gmj.v54i2.1
   Kodong J., 2016, STUDIES EC ECONOMETR, V33, P69
   Li K, 2018, J BEHAV EXP FINANC, V19, P36, DOI 10.1016/j.jbef.2018.03.004
   Liu HY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082800
   Liu YN, 2020, BORSA ISTANB REV, V20, P37, DOI 10.1016/j.bir.2019.08.002
   Macciocchi D, 2016, NEW MICROBIOL, V39, P287
   Marinc R.I, 2018, P 2016 UBT INT C DUR, P28
   Ministry of Health, 2020, INF GHAN COVID 19 CA
   Nippani S., 2004, APPL FINANCIAL EC, V14, P1105, DOI [10.1080/0960310042000310579, DOI 10.1080/0960310042000310579]
   Olufadewa I.I., 2020, INT J TRAVEL MED GLO, V8, P51, DOI [10.34172/ijtmgh.2020.09, DOI 10.34172/IJTMGH.2020.09]
   Ozili PK, 2021, J ECONOM ADM SCI, V37, P401, DOI 10.1108/JEAS-05-2020-0074
   Sakib N, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00289-x
   Shu HC, 2010, J ECON BEHAV ORGAN, V76, P267, DOI 10.1016/j.jebo.2010.06.004
   Siu A., 2004, ASIAN ECON PAP, V3, P62, DOI [DOI 10.1162/1535351041747996, 10.1162/1535351041747996]
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   Spiewanowski, 2017, IESEG SCH MANAGEMENT, V2017-ACF-02
   You SM, 2020, SCIENCE, V368, P1438, DOI 10.1126/science.abc7778
NR 33
TC 1
Z9 1
U1 4
U2 4
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2040-0705
EI 2040-0713
J9 AFR J ECON MANAG STU
JI Afr. J. Econ. Manag. Stud.
PD FEB 15
PY 2022
VL 13
IS 1
BP 136
EP 146
DI 10.1108/AJEMS-02-2021-0074
EA DEC 2021
PG 11
WC Economics
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA ZD4XK
UT WOS:000730364700001
OA Bronze
DA 2022-04-20
ER

PT J
AU Mendez, PF
AF Mendez, Pablo F.
TI Blue uncertainty: Warding off systemic risks in the Anthropocene-Lessons
   from COVID-19
SO EARTH SYSTEM GOVERNANCE
LA English
DT Article
DE COVID-19; Anthropocene risk; Radical uncertainty; Adaptive inference;
   Modulating contingency; Blue uncertainty
ID ACUTE RESPIRATORY SYNDROME; CORONAVIRUS
AB COVID-19 has made evident the complex interdependence of social and ecological systems and that to reduce the risk of future zoonotic pandemics we must safeguard nature. Approaches based on complexity science taking into account that interdependence and its associated systemic risks must be mainstreamed in current policy making, in general. However, at present, that could result in failure for three main reasons: (1) those approaches might be too sophisticated for current policy making pursuing sustainable development; (2) the reductionist views from conventional economics still deeply influence economic and environmental policy making; (3) it is unlikely that far-reaching policies aimed at stimulating post-pandemic economic development can be steered through radically innovative approaches that remain untested. Here, using COVID-19 as an example, I suggest that the use of innovative complexity-based approaches could be enabled through intermediary approaches equipped to resonate with the mindset pervading current policy making. (C) 2021 The Author(s). Published by Elsevier B.V.
C1 [Mendez, Pablo F.] Univ Politecn Valencia, Inst Innovat & Knowledge Management, INGENIO CSIC UPV, Edificio 8E,Camino Vera S-N, Valencia 46022, Spain.
RP Mendez, PF (corresponding author), Univ Politecn Valencia, Inst Innovat & Knowledge Management, INGENIO CSIC UPV, Edificio 8E,Camino Vera S-N, Valencia 46022, Spain.
EM pfmendez@ingenio.upv.es
RI Fernandez Mendez, Pablo/K-3002-2014
OI Fernandez Mendez, Pablo/0000-0003-1825-6496
CR Angelstam P, 2013, AMBIO, V42, P129, DOI 10.1007/s13280-012-0368-0
   Arrow K, 1996, ECOL APPL, V6, P13, DOI 10.2307/2269539
   Avishai, 2020, NEW YORKER
   Ball J., 2020, SPECTATOR
   Bar-Yam, 2020, TRANSITION EXTINCTIO
   Bar -Yam Y., 2020, IMPACT NONPHARMACEUT
   Bardosh KL, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0172
   Baxter R, 2021, SCAND J PUBLIC HEALT, V49, P29, DOI 10.1177/1403494820969544
   Bontempi E, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109814
   Brandt P, 2013, ECOL ECON, V92, P1, DOI 10.1016/j.ecolecon.2013.04.008
   Cairney P., 2020, UNDERSTANDING PUBLIC, V2
   Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07
   Cirillo P, 2020, NAT PHYS, V16, P606, DOI 10.1038/s41567-020-0921-x
   Collins SL, 2011, FRONT ECOL ENVIRON, V9, P351, DOI 10.1890/100068
   Daszak P., 2020, WORKSH REP BIOD PAND
   Desvars-Larrive A, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00609-9
   Diaz S., 2020, IPBES GUEST ARTICLE
   Eagle A, 2005, BRIT J PHILOS SCI, V56, P749, DOI 10.1093/bjps/axi138
   Eker S, 2020, HUM SOC SCI COMMUN, V7, DOI 10.1057/s41599-020-00553-4
   Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x
   Foxon TJ, 2013, ENVIRON INNOV SOC TR, V6, P126, DOI 10.1016/j.eist.2012.12.002
   Frankel J., 2020, VIEWS EC WORLD
   Frutos R, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00223
   FUNTOWICZ SO, 1993, FUTURES, V25, P739, DOI 10.1016/0016-3287(93)90022-L
   Galaz V, 2018, FUTURE EARTH STOCKHO, V7, DOI 10.17045/sthlmuni.7105748
   Gandhi TK, 2020, J HOSP MED, V15, P363, DOI 10.12788/jhm.3461
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Giachi S, 2020, TIPCWP202001 TIPC
   GNDE, 2020, GREEN NEW DEAL EUR
   Gordon LJ, 2020, AGR HUM VALUES, V37, P645, DOI 10.1007/s10460-020-10105-w
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Hall N, 2017, INT ENVIRON AGREEM-P, V17, P37, DOI 10.1007/s10784-016-9345-6
   Halpern SD, 2020, JAMA-J AM MED ASSOC, V324, P337, DOI 10.1001/jama.2020.11623
   Hamann M, 2018, ANNU REV ENV RESOUR, V43, P61, DOI 10.1146/annurev-environ-102017-025949
   He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5
   Holling CS, 2002, ECOSYSTEMS, V5, P319, DOI 10.1007/s10021-001-0076-2
   Huang N. E., 2020, HERD IMMUNITY SUPPRE, DOI 10.1101/2020.03.28.20046177
   ILO (International Labour Organization), 2020, COUNTR POL RESP COVI
   Ioannidis JPA, 2022, INT J FORECASTING, V38, P423, DOI 10.1016/j.ijforecast.2020.08.004
   Keynes J. M., 1921, TREATISE PROBABILITY
   Keys PW, 2019, NAT SUSTAIN, V2, P667, DOI 10.1038/s41893-019-0327-x
   Kim, 2020, ARCHITECTURES EARTH
   King, 2020, RADICAL UNCERTAINTY
   Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793
   Knight F.H., 1921, RISK UNCERTAINTY PRO
   Kumar M, 2020, SCI TOTAL ENVIRON, V734, DOI 10.1016/j.scitotenv.2020.139278
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007]
   Maechler S, 2020, REV INT POLIT ECON, DOI 10.1080/09692290.2020.1831573
   Mahoney J, 2000, THEOR SOC, V29, P507, DOI 10.1023/A:1007113830879
   Mallee H, 2020, CURR OPIN ENV SUST, V46, P16, DOI 10.1016/j.cosust.2020.09.011
   McGillivray, 2020, CONVERSATION
   Menachery VD, 2016, P NATL ACAD SCI USA, V113, P3048, DOI 10.1073/pnas.1517719113
   Mendez PF, 2019, ECOL SOC, V24, DOI 10.5751/ES-10898-240230
   Moore C, 2020, TRANSMISSION T 024 C
   Morse S. S., 1996, EMERGING VIRUSES
   N AS, 2020, J RISK RES, P1, DOI DOI 10.1080/13669877.2020.1772346
   Naidoo R, 2020, NATURE, V583, P198, DOI 10.1038/d41586-020-01999-x
   Norman J., 2020, SYSTEMIC RISK PANDEM
   Norstrom AV, 2020, NAT SUSTAIN, V3, P182, DOI 10.1038/s41893-019-0448-2
   North DC, 2005, PRINC ECON HIST W WO, P1
   OECD, 2019, GOV SDG ACC, DOI [10.1787/0666b085-en, DOI 10.1787/0666B085-EN]
   OECD (Organisation for Economic Co-operation and Development), 2020, OECD SCI TECHNOLOGY, V88, DOI [DOI 10.1787/0CA0CA45-EN, 10.1787/0ca0ca45-en]
   Osterblom H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127533
   Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104
   Panovska-Grif fiths, 2020, CONVERSATION
   Passamonti F, 2020, LANCET HAEMATOL, V7, pE737, DOI 10.1016/S2352-3026(20)30251-9
   Phillips CA, 2020, NAT CLIM CHANGE, V10, P586, DOI 10.1038/s41558-020-0804-2
   Richard AN, 2020, SWISS MED WKLY, V150, DOI 10.4414/smw.2020.20224
   Ritchie H., 2020, POLICY RESPONSES COR
   RITTEL HWJ, 1973, POLICY SCI, V4, P155, DOI 10.1007/BF01405730
   Rockstr_om, 2020, COVID 19 IS SYMPTOM
   Sachs JD, 2019, NAT SUSTAIN, V2, P805, DOI 10.1038/s41893-019-0352-9
   Scagliarini A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00302
   Seel N.M., 2012, ENCY SCI LEARNING, P2194, DOI [10.1007/978-1-4419-1428-6_1557, DOI 10.1007/978-1-4419-1428-6_1557]
   Stanger A, 2019, P SANT FE INSTR 2019
   Taleb N.N., 2007, BLACK SWAN IMPACT HI
   Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888
   Thornton T.B, 2018, EC POLITICAL EC PROB
   UNEP , 2021, MAK PEAC NAT SCI BLU
   UNEP (United Nations Environment Program), 2020, REC GLOB CARB DIOX C
   van Dorp L, 2020, INFECT GENET EVOL, V83, DOI 10.1016/j.meegid.2020.104351
   Vincent K, 2020, NAT CLIM CHANGE, V10, P877, DOI 10.1038/s41558-020-00910-w
   Waltner-Toews D, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0171
   Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9
   Wilke CO, 2020, P NATL ACAD SCI USA, V117, P28549, DOI 10.1073/pnas.2020200117
   Woloshin S, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2015897
   World Economic Forum, 2020, BIOD LOSS HURT OUR A
   World Health Organization (WHO), 2020, PAND FAT REINV PUBL
NR 88
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2589-8116
J9 EARTH SYST GOV-NETH
JI Earth Syst. Gov.
PD MAR
PY 2021
VL 7
SI SI
AR 100101
DI 10.1016/j.esg.2021.100101
EA MAR 2021
PG 9
WC Environmental Studies; International Relations; Political Science;
   Public Administration
WE Emerging Sources Citation Index (ESCI)
SC Environmental Sciences & Ecology; International Relations; Government &
   Law; Public Administration
GA UO2PZ
UT WOS:000694543100009
OA Green Submitted, gold, Green Published
DA 2022-04-20
ER

PT J
AU Moreno-Torres, V
   de la Fuente, S
   Mills, P
   Munoz, A
   Munez, E
   Ramos, A
   Fernandez-Cruz, A
   Arias, A
   Pintos, I
   Vargas, JA
   Cuervas-Mons, V
   de Mendoza, C
AF Moreno-Torres, Victor
   de la Fuente, Sara
   Mills, Patricia
   Munoz, Alejandro
   Munez, Elena
   Ramos, Antonio
   Fernandez-Cruz, Ana
   Arias, Ana
   Pintos, Ilduara
   Antonio Vargas, Juan
   Cuervas-Mons, Valentin
   de Mendoza, Carmen
TI Major determinants of death in patients hospitalized with COVID-19
   during the first epidemic wave in Madrid, Spain
SO MEDICINE
LA English
DT Article
DE coronavirus; COVID-19; mortality; pneumonia; SARS-CoV-2; Spain
ID NEW-YORK-CITY
AB Spain is one of the European countries most largely affected by COVID-19, being Madrid the epicenter. A good knowledge of the main features of hospitalized patients during the complete lockdown should improve the management of new COVID-19 surges. All patients hospitalized at one large tertiary hospital in Madrid for suspected COVID-19 pneumonia from March 1 to May 31 were retrospectively identified. A total of 1752 patients were admitted with suspected pneumonia due to SARS-CoV-2 infection during the 3-month study period. The peak of daily admissions (n = 84) was reached on March 24, whereas the maximal cumulative number of hospitalized patients (n = 626) occurred on March 30. Overall, 85.3% had a positive PCR test for SARS-CoV-2 at least once during admission. Their median age was 65 (54-77) and 59.9% were male. The median length of hospitalization was of 7 (4-13) days. Roughly 6.5% were admitted at the intensive care unit. Death occurred in 242 (13.8%). Overall, 75% of deaths occurred in patients older than 75 years-old. It was 38.2% in patients hospitalized older than 80 years-old versus 2.2% in patients younger than 60 years-old (p < 0.001). Up to 94 (38.8%) of deceased patients had been transferred from nursing homes. The median Charlson co-morbidity score was 6 in deceased patients. The in-hospital mortality rate during the first wave of COVID-19 in Madrid was 14%. It was largely driven by older age, the presence of underlying chronic conditions (>= 2) and living at nursing homes.
C1 [Moreno-Torres, Victor; de la Fuente, Sara; Mills, Patricia; Munoz, Alejandro; Munez, Elena; Ramos, Antonio; Fernandez-Cruz, Ana; Arias, Ana; Pintos, Ilduara; Antonio Vargas, Juan; Cuervas-Mons, Valentin; de Mendoza, Carmen] Hosp Puerta de Hierro Majadahonda, Dept Internal Med, Madrid, Spain.
   [Moreno-Torres, Victor; de Mendoza, Carmen] Res Inst Segovia de Arana Puerta de Hierro Majada, Internal Med Lab, Majadahonda, Spain.
   [Ramos, Antonio; Antonio Vargas, Juan; Cuervas-Mons, Valentin] Univ Autonoma Madrid, Sch Med, Med Dept, Madrid, Spain.
RP de Mendoza, C (corresponding author), Puerta de Hierro Univ Hosp & Res Inst, Internal Med Dept, Madrid, Spain.
EM cmendoza.cdm@gmail.com
RI Cruz, Ana Fernández/L-2429-2019; MUÑEZ, ELENA/AAU-9049-2021;
   Ramos-Martinez, Antonio/G-5535-2016; Cuervas-Mons, Valentin/C-8504-2017
OI Cruz, Ana Fernández/0000-0003-1189-1120; Ramos-Martinez,
   Antonio/0000-0002-4840-9425; Munez Rubio, Elena/0000-0002-5256-097X;
   Moreno-Torres, Victor/0000-0002-9798-4514; Cuervas-Mons,
   Valentin/0000-0003-3086-9463
FU ISCIII-Fondos Feder [CM19/00223, CES12/003]
FX This work was funded in part by grants from ISCIII-Fondos Feder
   (CM19/00223; and CES12/003).
CR Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457
   Bushman D, 2020, MMWR-MORBID MORTAL W, V69, P918, DOI 10.15585/mmwr.mm6928a5
   Casas-Rojo JM, 2020, REV CLIN ESP, V220, P480, DOI 10.1016/j.rce.2020.07.003
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2
   Cummings Matthew J, 2020, medRxiv, DOI 10.1101/2020.04.15.20067157
   Direccion general de salud publica Servicio madrileno de salud, 2020, DAT COVID 19 COM MAD
   European Centre for Disease Prevention and Control, CAS DEF COR DIS 2019
   Fernandez-Cruz A, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01168-20
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394
   Guallar MP, 2020, INT J INFECT DIS, V97, P290, DOI 10.1016/j.ijid.2020.06.035
   Mallapaty S, 2020, NATURE, V585, P16, DOI 10.1038/d41586-020-02483-2
   Nakeshbandi M, 2020, INT J OBESITY, V44, P1832, DOI 10.1038/s41366-020-0648-x
   Nunez-Gill IJ, 2020, EMERGENCIAS, V32, P293
   Pan Y, 2020, CLIN CHEM, V66, P794, DOI 10.1093/clinchem/hvaa091
   Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5
   Sanchez GV, 2020, MMWR-MORBID MORTAL W, V69, P882, DOI 10.15585/mmwr.mm6927e1
   Singh AK, 2020, DIABETES OBES METAB, V22, P1915, DOI 10.1111/dom.14124
   Somers EC., 2020, CLIN INFECT DIS, V73, P445, DOI [10.1093/cid/ciaa954, DOI 10.1093/CID/CIAA954]
   Soriano V, 2021, CLIN INFECT DIS, V72, P1101, DOI 10.1093/cid/ciaa769
   Soriano V, 2020, THER ADV INFECT DIS, V7, DOI 10.1177/2049936120932755
   To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1
   Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yehia BR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.18039
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 27
TC 6
Z9 6
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD APR 23
PY 2021
VL 100
IS 16
AR e25634
DI 10.1097/MD.0000000000025634
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA SO6OH
UT WOS:000659089900088
PM 33879741
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ehrlich, JA
   Ghimire, S
   Khraiche, M
   Raza, MF
AF Ehrlich, Justin Andrew
   Ghimire, Shankar
   Khraiche, Maroula
   Raza, Mian Farrukh
TI COVID-19 countermeasures, sporting events, and the financial impacts to
   the North American leagues
SO MANAGERIAL FINANCE
LA English
DT Article
DE Sports finance; North American league; League revenue; Financial impacts
   of pandemics; COVID-19 and sports
ID ECONOMIC-IMPACT; STADIUMS; TEAMS
AB Purpose The purpose of this paper is to analyze how the coronavirus disease 2019 (COVID-19) countermeasures will affect the financing of the North American leagues. In particular, we focus on the missed revenue from gate receipts for the Big Four leagues. Design/methodology/approach The authors forecast the 2020 revenue for each of the four major leagues under two scenarios: (1) expected revenue under the normal conditions of fans in attendance and (2) expected revenues in the absence of fans due to the countermeasures in place. Then, the authors calculate the loss in gate receipts as a difference in the revenue under fans and no-fans scenarios. Findings Based on the current estimates, the combined financial loss of the clubs from NFL, MLB, NBA and NHL is expected to be above 6.8bn dollars in gate receipts alone. Practical implications The findings are useful to the league management to prepare for the suboptimal financial situation. Originality/value To the best of our knowledge, this is the first study that explores the effect of the COVID-19 pandemic across the major league sports leagues in North America.
C1 [Ehrlich, Justin Andrew] Syracuse Univ, Dept Sports Management, Syracuse, NY USA.
   [Ghimire, Shankar] Western Illinois Univ, Sch Accounting Finance Econ & Decis Sci, Macomb, IL 61455 USA.
   [Khraiche, Maroula] Univ Texas Rio Grande Valley, Dept Econ & Finance, Edinburg, TX USA.
   [Raza, Mian Farrukh] Univ Wisconsin, Dept Econ, Whitewater, WI 53190 USA.
RP Ghimire, S (corresponding author), Western Illinois Univ, Sch Accounting Finance Econ & Decis Sci, Macomb, IL 61455 USA.
EM sp-ghimire@wiu.edu
RI Raza, Mian Farrukh/AAU-5573-2021
OI Ghimire, Shankar/0000-0001-7664-9330; Ehrlich,
   Justin/0000-0001-5729-6461
CR Agha N, 2013, J SPORT ECON, V14, P227, DOI 10.1177/1527002511422939
   Allen K., 2005, US TODAY
   [Anonymous], 2020, ESPN
   [Anonymous], 2020, FORBES
   Baade R., 2006, 0604 COLL HOL CROSS
   Baumann A., 2012, J NATL ASS ADM LAW J, V32, P251
   Berri D. J., 2004, Journal of Sports Economics, V5, P33, DOI 10.1177/1527002503254051
   Birren G, 2014, DEPAUL J SPORTS L CO, V10, P1
   Blair J., 2019, MLBPA WON BATTLE 199
   Carpenter K., 2013, SPORTS LAWYERS J, V20, P1
   CROMPTON JL, 1995, J SPORT MANAGE, V9, P14, DOI 10.1123/jsm.9.1.14
   Diamond J., 2020, WALL STREET J
   Fuhr J.P., 1999, ATLANTIC ECON J, V27, P221
   Futterman M, 2020, NY TIMES
   Ge Q, 2016, J SPORT ECON, V17, P427, DOI 10.1177/1527002516641166
   Golianopolous T., 2019, UNMITIGATED DISASTER
   Helin K., 2020, NBA SEASON IS CANCEL
   Horowitz D., 2011, THESIS
   Iqbal M., 2019, LABOR LOCKOUTS NBA T
   Lavoie M., 2005, Journal of Sports Economics, V6, P314, DOI 10.1177/1527002504268614
   Lewis J., 2013, LABOR STUDIES J, V38, P300, DOI DOI 10.1177/0160449X14522324
   Miller J.J., 2017, LEGAL ASPECTS SPORTS
   Mirtle J., 2010, GLOBE MAIL
   MLB Revenue by Team/Franchise 2019, 2020, STAT
   NBA Teams Revenue Ranking 2018/19, 2020, STAT
   NFL Revenue by Team, 2019, STAT
   NHL Teams Revenue 2018/19, 2020, STAT
   Parlow M.J., 2010, DEPAUL J SPORTS CONT, V6, P10
   Rosentraub M.S., 2009, MAJOR LEAGUE WINNERS
   ROSENTRAUB MS, 1994, J URBAN AFF, V16, P221, DOI 10.1111/j.1467-9906.1994.tb00327.x
   Schmidt MB, 2004, AM ECON REV, V94, P344, DOI 10.1257/000282804322970841
   Snyder B., 2007, WELL PAID SLAVE CURT
   Staudohar P.D., 2012, OXFORD HDB SPORTS EC, V11, P97
   Staudohar P.D., 2013, MON LABOR REV, V136, P1
   Staudohar P.D., 2006, LABOR LAW J, V57, P246
   Strang K., 2013, ESPN
   Swindell D, 1998, PUBLIC ADMIN REV, V58, P11, DOI 10.2307/976884
   Treber J, 2018, J SPORT ECON, V19, P677, DOI 10.1177/1527002516672058
   Winfree JA, 2008, J SPORT ECON, V9, P425, DOI 10.1177/1527002508316266
NR 39
TC 4
Z9 4
U1 1
U2 20
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0307-4358
EI 1758-7743
J9 MANAG FINANC
JI Manag. Financ.
PD JUN 3
PY 2021
VL 47
IS 6
SI SI
BP 887
EP 895
DI 10.1108/MF-05-2020-0275
EA JUL 2020
PG 9
WC Business, Finance
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA SR2NF
UT WOS:000547619500001
OA Bronze
DA 2022-04-20
ER

PT J
AU Yang, Y
   Koh, Y
AF Yang, Yun (Yvonne)
   Koh, Yoon
TI Is restaurant crowdfunding immune to the COVID-19 pandemic?
SO INTERNATIONAL JOURNAL OF CONTEMPORARY HOSPITALITY MANAGEMENT
LA English
DT Article
DE Crowdfunding; Restaurant; Crowdfunding success; COVID-19; Pandemic; Red
   zone
ID UNCERTAINTY; COMMITMENT; IMPACT; TRUST
AB Purpose In 2020, the COVID-19 pandemic had a devastating impact on global health care and the economy. The restaurant industry has been especially hit hard by the statewide "stay-at-home" orders. To get back on track, many of these businesses need capital. A new and effective form of fundraising for business startups is crowdfunding (CF). However, there has been little research on the pandemic impact on CF. This study aims to fill this gap by investigating the pandemic-related impact on restaurant CF. Design/methodology/approach This study extracted all 2,686 restaurant CF projects in the USA from the Kickstarter platform from April 2010 to January 2021. By conducting descriptive analyses and multiple logistic regression models, this study examined the pandemic impact on CF success. Findings This study finds that, while controlling the effects of other determinants, businesses in the midst of the pandemic are more likely to be successfully funded than businesses unaffected by the pandemic. Findings also reveal that restaurant startups lowered their funding goals and posted more updates/comments/pledge levels during the pandemic, which made projects more likely to be selected as a "Project We Love" and increased the odds of funding success. However, mentioning COVID-19-related information or locating projects in "red zones" are not found to have any significant direct or moderating impact on the funding success. Research limitations/implications This study pioneers the research topic restaurant CF and attempts to raise the research attention of small- and medium-sized enterprises and entrepreneurial financing. Using quantitative methods, it provides a new perspective on pandemic-impact research. Social exchange theory is extended to the context of reward-based CF under crisis. Finally, to the best of the authors' knowledge, this is the first investigation of the possible moderating effect of project location on the relationship between restaurant CF characteristics and success. Practical implications The findings of this study suggest restaurateurs to be confident about the fundraising of their startup business through reward-based CF, even when located within so-called pandemic red zones, and perform appropriate communication strategies while using the reward-based CF. Originality/value This study is one of the earliest to examine the main and moderating effects of the pandemic-related factors on business CF in the hospitality realm. The findings are reference for researchers and restaurateurs on fundraising in a crisis context.
C1 [Yang, Yun (Yvonne); Koh, Yoon] Univ Houston, Conrad N Hilton Coll Hotel & Restaurant Managemen, Houston, TX 77004 USA.
RP Yang, Y (corresponding author), Univ Houston, Conrad N Hilton Coll Hotel & Restaurant Managemen, Houston, TX 77004 USA.
EM yyang60@uh.edu
OI Koh, Yoon/0000-0002-0213-0082
FU Hospitality Financial and Technology Professionals (HFTP)
FX This study is partially funded by the Hospitality Financial and
   Technology Professionals (HFTP).
CR Agrawal A., 2014, INNOVATION POLICY EC, V14, P63, DOI [DOI 10.1086/674021, 10.1086/674021]
   Ahlers GKC, 2015, ENTREP THEORY PRACT, V39, P955, DOI 10.1111/etap.12157
   Altin M., 2018, Journal of Foodservice Business Research, V21, P462, DOI 10.1080/15378020.2018.1448134
   [Anonymous], 2020, TIM WHOS RESP COVID
   Armantier O., 2020, HAVE HOUSEHOLDS USED
   Barrero JM, 2020, BROOKINGS PAP ECO AC, P329, DOI 10.1353/eca.2020.0012
   Bartik AW, 2020, P NATL ACAD SCI USA, V117, P17656, DOI 10.1073/pnas.2006991117
   Battaglia F., 2020, EQUITY CROWDFUNDING
   Belleflamme P, 2014, J BUS VENTURING, V29, P585, DOI 10.1016/j.jbusvent.2013.07.003
   Bi S, 2017, J BUS RES, V71, P10, DOI 10.1016/j.jbusres.2016.10.001
   BIERSTEDT R, 1965, AM SOCIOL REV, V30, P789, DOI 10.2307/2091154
   Breier M, 2021, INT J HOSP MANAG, V92, DOI 10.1016/j.ijhm.2020.102723
   Brown R., 2020, J BUS VENTUR INSIGHT, V14, pe00174, DOI [10.1016/j.jbvi.2020.e00174, DOI 10.1016/J.JBVI.2020.E00174]
   Brown R, 2020, INT SMALL BUS J, V38, P380, DOI 10.1177/0266242620937464
   Burt R.S., 1995, STRUCTURAL HOLES SOC
   Chan CSR, 2018, VENTUR CAP, V20, P285, DOI 10.1080/13691066.2018.1480267
   Chen HC, 2021, FINANC RES LETT, V42, DOI 10.1016/j.frl.2021.101940
   Clark J, 2021, RES INT BUS FINANC, V58, DOI 10.1016/j.ribaf.2021.101452
   de Larrea GL, 2019, INT J HOSP MANAG, V78, P150, DOI 10.1016/j.ijhm.2018.10.003
   De Luca VV, 2019, INT J ENTREP BEHAV R, V25, P1321, DOI 10.1108/IJEBR-11-2018-0755
   del Rio-Chanona RM, 2020, OXFORD REV ECON POL, V36, pS94, DOI 10.1093/oxrep/graa033
   Delamater, 2003, HDB SOCIAL PSYCHOL, DOI DOI 10.1007/0-387-36921-X_3
   Farhoud M., 2021, J BUS VENTURING INSI, V15
   Frydrych D, 2014, VENTUR CAP, V16, P247, DOI 10.1080/13691066.2014.916512
   Giudici G, 2018, SMALL BUS ECON, V50, P307, DOI 10.1007/s11187-016-9830-x
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469
   Guillet BD, 2021, INT J CONTEMP HOSP M, V33, P604, DOI 10.1108/IJCHM-06-2020-0623
   Heath A, 1976, RATIONAL CHOICE SOCI
   Homans G.C., 1961, AM BEHAV SCI, V4, P3, DOI [10.1177/2F000276426100400802, DOI 10.1177/000276426100400802]
   Honisch E, 2019, INT J HOSP TOUR ADM, V20, P182, DOI 10.1080/15256480.2017.1359733
   Hwang P., 2000, J CONTING CRISIS MAN, V8, P129, DOI DOI 10.1111/1468-5973.00132
   IATA Economics, 2020, COVID 19 UPD IMP ASS
   Jiang YY, 2020, INT J CONTEMP HOSP M, V32, P2563, DOI 10.1108/IJCHM-03-2020-0237
   Josefy M, 2017, ENTREP THEORY PRACT, V41, P161, DOI 10.1111/etap.12263
   Kickstarter, 2021, WHAT SHOULD CONS SET
   Kim MJ, 2021, J TRAVEL RES, V60, P947, DOI 10.1177/0047287520919515
   Kim MJ, 2020, J TRAVEL TOUR MARK, V37, P141, DOI 10.1080/10548408.2020.1722784
   Koh Y, 2020, INT J CONTEMP HOSP M, V32, P3051, DOI 10.1108/IJCHM-02-2020-0159
   KOLLOCK P, 1994, AM J SOCIOL, V100, P313, DOI 10.1086/230539
   Leland, 2020, ARE PEOPLE STILL SUP
   Lin MF, 2016, MANAGE SCI, V62, P1393, DOI 10.1287/mnsc.2015.2206
   Liu MT, 2021, INT J CONTEMP HOSP M, V33, P1249, DOI 10.1108/IJCHM-07-2020-0678
   Martins C, 2021, INT J CONTEMP HOSP M, V33, P3134, DOI 10.1108/IJCHM-02-2020-0149
   Mayo Clinic, 2021, US COR MAP WHAT DO T
   Mills K., 2014, HARVARD BUSINESS SCH
   Mollick E, 2014, J BUS VENTURING, V29, P1, DOI 10.1016/j.jbusvent.2013.06.005
   OECD, 2020, COR COVID 19 SME POL
   One Point Three Acres, 2021, GLOB COVID 19 TRACK
   Payne AF, 2008, J ACAD MARKET SCI, V36, P83, DOI 10.1007/s11747-007-0070-0
   Poretti C, 2021, TOURISM ECON, DOI 10.1177/13548166211005198
   Qiu S, 2021, INT J HOSP MANAG, V93, DOI 10.1016/j.ijhm.2020.102759
   Quinn U., 1992, International Journal of Contemporary Hospitality Management, V4, P11, DOI 10.1108/09596119210007929
   R?diger, 2014, ENTREPRENEURSHIP INN, P31, DOI DOI 10.1007/978-3-319-02384-7_4
   Raeymaeckers P, 2021, NONPROF VOLUNT SEC Q, V50, P1304, DOI 10.1177/0899764021991675
   Rajwa P, 2020, J GEN INTERN MED, V35, P2482, DOI 10.1007/s11606-020-05896-x
   Rice E.R.W., 2002, EFFECT SOCIAL UNCERT
   Saleh SN, 2021, J MED INTERNET RES, V23, DOI 10.2196/25429
   Sedlacek P., 2020, STARTUPS EMPLOYMENT
   Simon M, 2019, J BUS RES, V104, P206, DOI 10.1016/j.jbusres.2019.07.010
   STR, 2020, US HOT REVPAR FOR DR
   Sun YP, 2021, PAC-BASIN FINANC J, V65, DOI 10.1016/j.pacfin.2020.101463
   The National Restaurant Association, 2021, REST IND FACTS GLANC
   Theokary C., 2020, J SMALL BUS MANAGE, P1, DOI [10.1080/00472778.2020.1796466, DOI 10.1080/00472778.2020.1796466]
   Thibaut J. W., 1959, SOCIAL PSYCHOL GROUP
   Troise C, 2020, J ENTERP COMMUNITIES, V14, P277, DOI 10.1108/JEC-03-2020-0018
   UNWTO, 2020, INT TOUR ARR COULD F
   Yacoub L, 2021, INT J CONTEMP HOSP M, V33, P929, DOI 10.1108/IJCHM-08-2020-0814
   Yamagishi T, 1998, AM J SOCIOL, V104, P165, DOI 10.1086/210005
   Zhao Q, 2017, TELEMAT INFORM, V34, P370, DOI 10.1016/j.tele.2016.06.006
NR 70
TC 0
Z9 0
U1 5
U2 5
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0959-6119
EI 1757-1049
J9 INT J CONTEMP HOSP M
JI Int. J. Contemp. Hosp. Manag.
PD MAR 11
PY 2022
VL 34
IS 4
BP 1353
EP 1373
DI 10.1108/IJCHM-06-2021-0817
EA JAN 2022
PG 21
WC Hospitality, Leisure, Sport & Tourism; Management
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics; Business & Economics
GA ZS1YR
UT WOS:000747247200001
OA Bronze
DA 2022-04-20
ER

PT J
AU Hezer, S
   Gelmez, E
   Ozceylan, E
AF Hezer, Seda
   Gelmez, Emel
   Ozceylan, Eren
TI Comparative analysis of TOPSIS, VIKOR and COPRAS methods for the
   COVID-19 Regional Safety Assessment
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; Regional safety; Multi-criteria decision making; TOPSIS;
   VIKOR; COPRAS
ID COMPLEX PROPORTIONAL ASSESSMENT; DECISION-MAKING; MULTICRITERIA
   EVALUATION; FUZZY; SELECTION; RANKING
AB COVID-19, which emerged in December 2019, has affected the entire world. Therefore, COVID-19 has been a subject of research in various disciplines, especially in the field of health. One of these studies was the report made by the Deep Knowledge Group (DKG) consortium in which safe regions for COVID19 were determined. In the report, the main criteria of quarantine efficiency, government efficiency of risk management, monitoring and detection, health readiness, regional resilience, and emergency preparedness are used in the evaluation of countries and regions (alternatives). As the data and research structure used in this report are based on multi-criteria, the purpose of this study is to evaluate and analyse the safety levels of 100 regions in the world in terms of COVID-19 using Technique for Order Performance by Similarity to Ideal Solution (TOPSIS), Vise Kriterijumsa Optimizacija I Kompromisno Resenje (VIKOR) and Complex Proportional Assessment (COPRAS) methods. The data and information required in the methods were obtained from a report prepared by the DKG. The results of the methods were compared with the ranking results presented in a report of the DKG. Accordingly, it has been observed that the method that provides the closest results to the results of the report is the COPRAS method, and the method that gives the most distant results is the VIKOR method.
   (c) 2021 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).
C1 [Hezer, Seda] Konya Tech Univ, Dept Ind Engn, TR-42075 Konya, Turkey.
   [Gelmez, Emel] Selcuk Univ, Dept Business Adm, TR-42075 Konya, Turkey.
   [Ozceylan, Eren] Gaziantep Univ, Dept Ind Engn, TR-27100 Gaziantep, Turkey.
RP Ozceylan, E (corresponding author), Gaziantep Univ, Dept Ind Engn, TR-27100 Gaziantep, Turkey.
EM erenozceylan@gmail.com
OI Ozceylan, Eren/0000-0002-5213-6335
CR Albahri OS, 2020, J INFECT PUBLIC HEAL, V13, P1381, DOI 10.1016/j.jiph.2020.06.028
   Alqahtani AY, 2020, EDUC SCI, V10, DOI 10.3390/educsci10090216
   ATANASSOV KT, 1986, FUZZY SET SYST, V20, P87, DOI 10.1016/S0165-0114(86)80034-3
   Bagheri M, 2018, DECISION SCI LETT, V7, P87, DOI DOI 10.5267/J.DSL.2017.4.001
   Bathrinath S, MAT TODAY PROC 2020
   Chakraborty S, 2019, J MODEL MANAG, V14, P430, DOI 10.1108/JM2-08-2018-0110
   Chatterjee P, 2011, MATER DESIGN, V32, P851, DOI 10.1016/j.matdes.2010.07.010
   Chen CT, 2000, FUZZY SET SYST, V114, P1, DOI 10.1016/S0165-0114(97)00377-1
   Chen SM, 2010, EXPERT SYST APPL, V37, P2790, DOI 10.1016/j.eswa.2009.09.012
   Cheng S, 2002, J ENVIRON SCI HEAL A, V37, P975, DOI 10.1081/ESE-120004517
   Chmielarz W, 2018, PROCEDIA COMPUT SCI, V126, P1964, DOI 10.1016/j.procs.2018.07.256
   Gnanavelbabu A, 2018, MATER TODAY-PROC, V5, P13406, DOI 10.1016/j.matpr.2018.02.334
   Hashemabadi AG, 2014, ADVMANAG APPL EC, V4, P85
   Hassanpour M., 2019, J APPL RESIND ENG, V6, P33
   Huang Ganyu, 2020, J Shanghai Jiaotong Univ Sci, V25, P140, DOI 10.1007/s12204-020-2167-2
   Jati H., 2012, WORLD ACAD SCI ENG T, V71, P1663
   Kaklauskas A, 2010, AUTOMAT CONSTR, V19, P326, DOI 10.1016/j.autcon.2009.12.006
   Keshavarz Ghorabaee M, 2016, J CLEAN PROD, V137, P213, DOI 10.1016/j.jclepro.2016.07.031
   Kildiene S, 2011, J BUS ECON MANAG, V12, P417, DOI 10.3846/16111699.2011.575190
   Kiritsis D, 2003, IEEE INT SYMP ELECTR, P48
   Korzeb Z, 2020, EQUILIBRIUM, V15, P205, DOI 10.24136/eq.2020.010
   LAI YJ, 1994, EUR J OPER RES, V76, P486, DOI 10.1016/0377-2217(94)90282-8
   Linkov I, 2012, ENV ASSESS MGMT, P1, DOI 10.1201/b11471
   Liu PD, 2009, TECHNOL ECON DEV ECO, V15, P453, DOI 10.3846/1392-8619.2009.15.453-463
   Liu Y, 2020, EXPERT SYST APPL, V161, DOI 10.1016/j.eswa.2020.113738
   Luthra S, 2017, J CLEAN PROD, V140, P1686, DOI 10.1016/j.jclepro.2016.09.078
   Madic M, 2014, 5 INT C TRANSP LOG T, P47
   Majumder P, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/7904
   Makhesana MA, 2015, RAPID PROTOTYPING J, V21, P671, DOI 10.1108/RPJ-03-2014-0027
   Mancev M., 2013, J INFO THECA, V14, P15
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Mendel JM, 2006, IEEE T FUZZY SYST, V14, P808, DOI 10.1109/TFUZZ.2006.879986
   Mousavi-Nasab SH, 2017, MATER DESIGN, V121, P237, DOI 10.1016/j.matdes.2017.02.041
   Opricovic S, 2004, EUR J OPER RES, V156, P445, DOI [10.1016/S0377-2217(03)00020-1, 10.1016/s0377-2217(03)00020-1]
   Opricovic S, 2007, EUR J OPER RES, V178, P514, DOI 10.1016/j.ejor.2006.01.020
   Barrios MAO, 2016, INT J INF TECH DECIS, V15, P861, DOI 10.1142/S021962201640006X
   Ozceylan E, 2013, INT J PROD RES, V51, P2443, DOI 10.1080/00207543.2012.740579
   Ozili P, 2022, INT J SOCIOL SOC POL, V42, P177, DOI 10.1108/IJSSP-05-2020-0171
   Ozkan B, 2019, KYBERNETES, V48, P2266, DOI 10.1108/K-09-2018-0456
   Podvezko V, 2011, INZ EKON, V22, P134
   Popovic G, 2012, SERB J MANAG, V7, P257, DOI 10.5937/sjm7-2268
   Sadeghzadeh K, 2011, INT J HYDROGEN ENERG, V36, P13272, DOI 10.1016/j.ijhydene.2010.07.064
   Sayadi MK, 2009, APPL MATH MODEL, V33, P2257, DOI 10.1016/j.apm.2008.06.002
   Sayan M, 2020, COMPUT MATH METHOD M, V2020, DOI 10.1155/2020/1560250
   Shirazi H, 2020, INT J HEALTHCARE MAN, V13, P312, DOI 10.1080/20479700.2020.1803622
   Gomes CFS, 2017, J MODEL MANAG, V12, P475, DOI 10.1108/JM2-01-2016-0005
   Toloie-Eshlaghy A, 2012, AM J SCI RES, V59, P42
   Dang V, 2019, INT J ETHICS SYST, V36, P119, DOI 10.1108/IJOES-06-2019-0101
   Vinodhini GAF, 2020, J CRIT REV, V7, P1333
   Wang L, 2020, INT J INTELL SYST, V35, P150, DOI 10.1002/int.22204
   Wen J, 2021, TOUR REV, V76, P74, DOI 10.1108/TR-03-2020-0110
   World Health Organization, CORONAVIRUS DIS COVI
   Wu J, 2011, J SYST ENG ELECTRON, V22, P604, DOI 10.3969/j.issn.1004-4132.2011.04.008
   Yang WJ, 2020, J INFECTION, V80, P388, DOI 10.1016/j.jinf.2020.02.016
   ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X
   Zavadskas EK, 2009, INT J STRATEG PROP M, V13, P319, DOI 10.3846/1648-715X.2009.13.319-338
   Zavadskas EK, 1996, DEUTSCH LITAUISCH PO, P3
   Zeng QL, 2013, J MED SYST, V37, DOI 10.1007/s10916-012-9908-1
NR 58
TC 8
Z9 8
U1 4
U2 8
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD JUN
PY 2021
VL 14
IS 6
BP 775
EP 786
DI 10.1016/j.jiph.2021.03.003
EA MAY 2021
PG 12
WC Public, Environmental & Occupational Health; Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Infectious Diseases
GA SO2IS
UT WOS:000658801600017
PM 34022737
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Gonzalez-Timoneda, A
   Hernandez, VH
   Moya, SP
   Blazquez, RA
AF Gonzalez-Timoneda, Alba
   Hernandez, Veronica Hernandez
   Moya, Sonia Pardo
   Blazquez, Ruben Alfaro
TI Experiences and attitudes of midwives during the birth of a pregnant
   woman with COVID-19 infection: A qualitative study
SO WOMEN AND BIRTH
LA English
DT Article
DE COVID-19; Attitude; Health workers; Midwifery; Pandemic; Qualitative
ID CARE; BURNOUT; WOMEN
AB Background: The COVID-19 pandemic has become one of the most important threats to global health. Midwives are at the core of the response to the pandemic. Women still need midwifery support and care. The work of midwives is acknowledged as emotionally demanding, and their welfare may be compromised by a range of workplace and personal stress factors. Aim: To investigate the experiences and attitudes of midwives who have provided pregnancy and childbirth care to women with a confirmed or suspected COVID-19 infection. Methods: A qualitative phenomenological study was carried out in two Spanish tertiary hospitals. Fourteen midwives were recruited by purposive sampling technique. Data were collected through individual in-depth interviews and analysed using Giorgi's descriptive method. Findings: Three themes emerged: "challenges and differences when working in a pandemic", "emotional and mental health and wellbeing" and "women's emotional impact perceived by midwives". Midwives pointed to several factors tied to a safe, supportive and empowering work place: support from staff and managers, access to adequate personal protective equipment, and reliable guidelines. They also dealt with professional and personal challenges during the pandemic, showing feelings of fear, anxiety, uncertainty, discomfort, lack of support, and knowledge. Finally, midwives expressed their concerns about the feelings of pregnant women with COVID-19, such as fear, anxiety, and loneliness. Conclusion: The results of this study show some of the challenges for midwives during the course of the COVID-19 pandemic, emphasizing the value of a good communication, emotional support, and stress management, to provide woman-centred care. (c) 2020 Australian College of Midwives. Published by Elsevier Ltd. All rights reserved.
C1 [Gonzalez-Timoneda, Alba; Moya, Sonia Pardo; Blazquez, Ruben Alfaro] Univ & Polytech Hosp La Fe, Midwife Dept Obstet & Gynaecol, Valencia, Spain.
   [Gonzalez-Timoneda, Alba; Blazquez, Ruben Alfaro] Univ Valencia, Sch Nursing & Podiatry, Valencia, Spain.
   [Hernandez, Veronica Hernandez] Gregorio Maranon Univ Hosp, Midwife Dept Obstet & Gynaecol, Madrid, Spain.
RP Blazquez, RA (corresponding author), Univ & Polytech Hosp La Fe, Midwife Dept Obstet & Gynaecol, Valencia, Spain.; Blazquez, RA (corresponding author), Univ Valencia, Sch Nursing & Podiatry, Valencia, Spain.
EM ruben.ab87@hotmail.com
RI Gonzalez Timoneda, Alba/C-8205-2019
OI Gonzalez Timoneda, Alba/0000-0003-1871-7758; Alfaro Blazquez,
   Ruben/0000-0002-6024-1995
CR American College of Obstetricians and Gynecologists, 2020, GEN INF REG PREGN IN
   Bick D., 2020, MIDWIFERY, P85
   Caparros-Gonzalez R.A., 2020, SPAN J PUBLIC HLTH, V94, P1
   Cipriano PF, 2018, INT NURS REV, V65, P305, DOI 10.1111/inr.12483
   Comunidad de Madrid Hospital General Universitario Gregorio Maranon, 2020, OBSTET GINECOLOGIA
   Creedy DK, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-016-1212-5
   Cresswell J.W., 2011, DESIGNING CONDUCTING, V2nd
   Cronie D, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4454-x
   dra E. Ke., 2015, POL NURS, V3, P293
   European Centre for Disease Prevention and Control (ECDC), 2020, INF PREV CONTR COVID
   Fenwick J, 2015, MIDWIFERY, V31, P239, DOI 10.1016/j.midw.2014.09.003
   Generalitat Valenciana, 2020, DEP SAL FE
   Giorgi A., DESCRIPTIVE PHENOMEN
   Hall LH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159015
   Hildingsson I, 2013, SEX REPROD HEALTHC, V4, P87, DOI 10.1016/j.srhc.2013.07.001
   Houghton C., 2020, COCHRANE DB SYST REV, V4, pCD013582, DOI DOI 10.1002/14651858.CD013582
   Hunter B, 2014, MIDWIFERY, V30, P926, DOI 10.1016/j.midw.2014.03.010
   Husserl E., 1962, IDEAS GEN INTRO PURE
   Ives J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-56
   Jaracz M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176698
   Johnstone MJ, 2014, NURS HEALTH SCI, V16, P67, DOI 10.1111/nhs.12130
   Kisely S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1642
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Lawler Denise, 2010, Pract Midwife, V13, P20
   Levine MS, 2015, J NURS MEAS, V23, P287, DOI 10.1891/1061-3749.23.2.287
   Lewis L, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-015-0759-x
   Lincoln Y.S., 1985, NATURALISTIC INQUIRY
   Matsuishi K, 2012, PSYCHIAT CLIN NEUROS, V66, P353, DOI 10.1111/j.1440-1819.2012.02336.x
   Ministerio de Sanidad,, 2020, MAN MUJ EMB REC NAC
   Mollart L, 2013, WOMEN BIRTH, V26, P26, DOI 10.1016/j.wombi.2011.08.002
   Muhr T., 2016, ATLAS TI QUALITATIVE
   Mullins E, 2020, ULTRASOUND OBST GYN, V55, P586, DOI 10.1002/uog.22014
   Nemcek MA, 2007, J ADV NURS, V59, P240, DOI 10.1111/j.1365-2648.2007.04309.x
   Pezaro S, 2016, WOMEN BIRTH, V29, pE59, DOI 10.1016/j.wombi.2015.10.006
   Rasmussen SA, 2020, AM J OBSTET GYNECOL, V222, P415, DOI 10.1016/j.ajog.2020.02.017
   Royal College of Obstetricians and Gynaecologists, 2020, COR COVID 19 INF PRE
   Rozo JA, 2017, WORKPLACE HEALTH SAF, V65, P262, DOI 10.1177/2165079917705669
   Sauls DJ, 2007, NURS RES, V56, P117, DOI 10.1097/01.NNR.0000263972.54619.4a
   Sawyer A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-108
   Sun DD, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001090
   Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042
   Trifiletti E, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01362
   Uchmanowicz I, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024296
   WHO China, 2020, REP WHO CHIN JOINT M, DOI DOI 10.1186/S40249-020-00650-1
   World Health Organization, 2020, ROLL UPD COR DIS COV
   World Health Organization, 2020, 117 WHO
   Yoshida Y, 2013, MIDWIFERY, V29, P921, DOI 10.1016/j.midw.2012.11.002
NR 47
TC 4
Z9 4
U1 5
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1871-5192
EI 1878-1799
J9 WOMEN BIRTH
JI Women Birth
PD SEP
PY 2021
VL 34
IS 5
BP 465
EP 472
DI 10.1016/j.wombi.2020.12.001
EA AUG 2021
PG 8
WC Nursing; Obstetrics & Gynecology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing; Obstetrics & Gynecology
GA UC8GI
UT WOS:000686760000012
PM 33358355
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Liang, C
   Liu, B
   Chan, HK
AF Liang, Chao
   Liu, Bai
   Chan, Hing Kai
TI Policy-oriented restart of supply and demand after COVID-19: firm-level
   evidence for China
SO INTERNATIONAL JOURNAL OF EMERGING MARKETS
LA English
DT Article; Early Access
DE Work resumption; Consumption vouchers; Policy effect; Supply; Demand;
   COVID-19
ID RISK
AB Purpose China is the only major economy in the world that has achieved positive gross domestic product (GDP) growth in 2020. The paper aims to explore the effect of China's public policy restarting supply and consumption after coronavirus disease-2019 (COVID-19). Design/methodology/approach Affected by the epidemic, global economic growth slowed down. Using the stock price data of Chinese A-share listed company, combining natural experiment and event study method, the paper examines the policy effects of work resumption and consumer vouchers. Findings Compared with demand capacity, the work resumption has a more significant role in promoting the supply industry. Issuing consumer vouchers can effectively promote local demand recovery, and the effect is mainly concentrated in the industries involved in consumption vouchers. At the same time, public management capacity and the income level of residents play an important role in restarting supply and demand. Practical implications Understanding China's public policies and effects are of positive significance to the restoration of economic development in other countries. Originality/value The study contributes to knowledge by empirically examining the effect of China's public policies against the COVID-19 pandemic. The paper also expands the scope of policy-oriented research based on the perspective of supply and demand capacity building.
C1 [Liang, Chao] Changchun Univ Sci & Technol, Changchun, Peoples R China.
   [Liu, Bai] Jilin Univ, Changchun, Peoples R China.
   [Chan, Hing Kai] Univ Nottingham Ningbo China, Ningbo, Zhejiang, Peoples R China.
RP Liu, B (corresponding author), Jilin Univ, Changchun, Peoples R China.
EM Liubai@jlu.edu.cn
OI Liu, Bai/0000-0001-6556-020X
FU National Social Science Fund of China [18BJY232]
FX This work was supported by the National Social Science Fund of China
   (No: 18BJY232).
CR Alfano V, 2020, APPL HEALTH ECON HEA, V18, P509, DOI 10.1007/s40258-020-00596-3
   Bakke TE, 2016, J FINANC ECON, V120, P623, DOI 10.1016/j.jfineco.2016.02.007
   Beatty TKM, 2015, AM J AGR ECON, V97, P390, DOI 10.1093/ajae/aau097
   Buonsenso D, 2020, INT J INFECT DIS, V97, P23, DOI 10.1016/j.ijid.2020.05.104
   CAMPBELL CJ, 1993, J FINANC ECON, V33, P73, DOI 10.1016/0304-405X(93)90025-7
   Chang CP, 2021, EMERG MARK FINANC TR, V57, P2389, DOI 10.1080/1540496X.2021.1873129
   del Rio-Chanona RM, 2020, OXFORD REV ECON POL, V36, pS94, DOI 10.1093/oxrep/graa033
   Dhanorkar S, 2020, PROD OPER MANAG, V29, P1738, DOI 10.1111/poms.13182
   Dinardo J., 2010, NATURAL EXPT QUASINA
   Ding WZ, 2021, J FINANC ECON, V141, P802, DOI 10.1016/j.jfineco.2021.03.005
   Doidge C, 2015, J FINANC, V70, P45, DOI 10.1111/jofi.12101
   Financial Times, 2020, FINANC TIMES
   Garvey J, 2008, RISK ANAL, V28, P151, DOI 10.1111/j.1539-6924.2008.001011.x
   Goenka A, 2021, ECON MODEL, V104, DOI 10.1016/j.econmod.2021.105639
   Gourio F, 2012, AM ECON REV, V102, P2734, DOI 10.1257/aer.102.6.2734
   Guerrieri V., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts)
   Guidolin M, 2007, AM ECON REV, V97, P1978, DOI 10.1257/aer.97.5.1978
   Hassan M.K., 2021, GLOB FINANC J, P100643, DOI [10.1016/J.GFJ.2021.100643, DOI 10.1016/J.GFJ.2021.100643, 10.1016/j.gfj.2021.100643]
   Hoynes HW, 2009, AM ECON J-APPL ECON, V1, P109, DOI 10.1257/app.1.4.109
   Hsieh CT, 2010, J PUBLIC ECON, V94, P523, DOI 10.1016/j.jpubeco.2010.03.001
   International Monetary Fund, 2020, POL RESP COV 19
   Ioannidou V, 2015, REV FINANC, V19, P95, DOI 10.1093/rof/rfu035
   Kan K, 2017, AM ECON J-ECON POLIC, V9, P137, DOI 10.1257/pol.20130426
   Ke X, 2022, J APPL ECONOMET, V37, P187, DOI 10.1002/jae.2871
   Kinateder H, 2021, FINANC RES LETT, V43, DOI 10.1016/j.frl.2021.101951
   Lai SJ, 2020, NATURE, V585, P410, DOI 10.1038/s41586-020-2293-x
   LANCHIMBA CINTYA, 2020, Brazil. J. Polit. Econ., V40, P622, DOI 10.1590/0101-31572020-3199
   Lehmann P, 2021, SUSTAIN SCI, V16, P2137, DOI 10.1007/s11625-021-01003-z
   Liu Q, 2021, MANAGE SCI, V67, P7291, DOI 10.1287/mnsc.2021.4119
   McDonald IM, 2020, AUST ECON REV, V53, P415, DOI 10.1111/1467-8462.12387
   Narayanan BG, 2021, METHODSX, V8, DOI 10.1016/j.mex.2021.101293
   Pollitt H, 2021, CLIM POLICY, V21, P1257, DOI 10.1080/14693062.2021.1965525
   Qi JL, 2022, NAT HUM BEHAV, V6, P55, DOI 10.1038/s41562-021-01189-3
   Seven U, 2021, RES INT BUS FINANC, V56, DOI 10.1016/j.ribaf.2020.101349
   Siddik MNA, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05634
   Signoli M, 2012, CLIN MICROBIOL INFEC, V18, P218, DOI 10.1111/j.1469-0691.2012.03787.x
   Singh S, 2021, INT J PROD RES, V59, P1993, DOI 10.1080/00207543.2020.1792000
   WHO China, 2020, REP WHO CHIN JOINT M, DOI DOI 10.1186/S40249-020-00650-1
   Wilde PE, 2009, AM J AGR ECON, V91, P416, DOI 10.1111/j.1467-8276.2008.01235.x
   World Health Organization, 2020, PRESS C WHO CHIN JOI
   Xu XL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236387
   Yao XY, 2020, INT REV ECON FINANC, V68, P217, DOI 10.1016/j.iref.2020.04.004
NR 42
TC 0
Z9 0
U1 11
U2 11
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1746-8809
EI 1746-8817
J9 INT J EMERG MARK
JI Int. J. Emerg. Mark.
DI 10.1108/IJOEM-08-2021-1284
EA FEB 2022
PG 15
WC Business; Economics; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA YT7KR
UT WOS:000751534500001
DA 2022-04-20
ER

PT J
AU Priya, R
   Sujatha, V
AF Priya, Ritu
   Sujatha, V.
TI AYUSH for COVID-19: Science or Superstition?
SO INDIAN JOURNAL OF PUBLIC HEALTH
LA English
DT Editorial Material
DE Epistemology; evidence generation; traditional health knowledge systems
AB There is a lot of discussion on COVID-19 control strategies from the mainstream approaches, but it is also necessary to examine the contributions of the Ayurveda, Yoga and Naturopathy, Unani, Siddha, Sowa Riga and Homeopathy (AYUSH) sector, which is now being brought into public health interventions nationally. Although the AYUSH sector had previously joined the management of dengue and chikungunya outbreaks in some Indian states, its participation has remained contentious and there is reluctance in mainstream public health discourses to seriously examine their interventions. This is a commentary on the efforts made by the Ministry of AYUSH, state AYUSH directorates, AYUSH research institutions, and public hospitals, based on official documents as well as official statements reported in the media, with the aim of bringing out concerns in the process of adapting traditional textual knowledge and practices to public health requirements of the current age.
C1 [Priya, Ritu] Jawaharlal Nehru Univ, Ctr Social Med & Community Hlth, New Delhi 110067, India.
   [Sujatha, V.] Jawaharlal Nehru Univ, Ctr Study Social Syst, New Delhi, India.
RP Priya, R (corresponding author), Jawaharlal Nehru Univ, Ctr Social Med & Community Hlth, New Delhi 110067, India.
EM ritupriyajnu@gmail.com
CR Central Council for Research in Ayurveda and Siddha, 2009, DEP AYUSH MAN CHIK A
   Government of Kerala, 2020, AYUSH DEP COVID 19 A
   Jain Jaspreet, 2018, VirusDisease, V29, P32, DOI 10.1007/s13337-018-0421-0
   Ministry of AYUSH, 2020, NOT PUBL EXTR GAZ IN
   Panikkar K. N., 1992, STUDIES HIST, V8, P283
   Press Information Bureau, 2020, ADV REC SYMPT RESP T
   Press Information Bureau, AYUSH MIN URG DIL CO
   Priya R, 2020, WIRE
   Shaikh S, CORONA VIRUS SPREAD
NR 9
TC 11
Z9 12
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 0019-557X
EI 2229-7693
J9 INDIAN J PUBLIC HLTH
JI Indian J. Public Health
PD JUN
PY 2020
VL 64
SU 2
BP 105
EP 107
DI 10.4103/ijph.IJPH_500_20
PG 3
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA QG7ME
UT WOS:000617766700010
PM 32496237
OA gold
DA 2022-04-20
ER

PT J
AU Lombardi, S
   Cunha, MPE
   Giustiniano, L
AF Lombardi, Sara
   Pina e Cunha, Miguel
   Giustiniano, Luca
TI Improvising resilience: The unfolding of resilient leadership in
   COVID-19 times
SO INTERNATIONAL JOURNAL OF HOSPITALITY MANAGEMENT
LA English
DT Article
DE Resilience; Leadership; Improvisation; Hospitality; COVID-19 pandemic;
   Paradox
ID ORGANIZATIONAL IMPROVISATION; CRISIS MANAGEMENT; DARK SIDE; QUALITY;
   KNOWLEDGE; STRENGTH; FAILURES; POWER; RISK
AB The spread of the COVID-19 pandemic in Italy has had disastrous effects on the national economy. The hospitality sector has experienced a significant impact from the crisis: starting from March 2020 it has literally collapsed. Experts believe it will take three years for the sector to recover. Confronted with a dramatic uncertainty, which imposed rapid action, hospitality leaders need to nurture resilience. To enrich current understanding of the way resilient leadership unfolds to respond to jolts, we draw on an exploratory qualitative research involving Italian hotel managers. Following in-depth interviews, we show that resilient leadership and improvisation are deeply interconnected. Their interdependence entails two practices, namely gardening and learning. This suggests a paradoxical tension: to exercise resilience, leaders need to be at the same time in the system, by actively learning from events, and outside the system, by zooming out as they focus on ongoing planning for the next move.
C1 [Lombardi, Sara] Univ Florence, Via Pandette 32, I-50127 Florence, Italy.
   [Pina e Cunha, Miguel] Univ Nova Lisboa, Nova Sch Business & Econ, R Holanda 1, P-2775405 Carcavelos, Portugal.
   [Giustiniano, Luca] Luiss Univ, Viale Romania 32, I-00197 Rome, Italy.
RP Lombardi, S (corresponding author), Univ Florence, Via Pandette 32, I-50127 Florence, Italy.
EM sara.lombardi@unifi.it; mpc@novasbe.pt; lgiusti@luiss.it
OI Giustiniano, Luca/0000-0002-3044-6535; Lombardi,
   Sara/0000-0002-0462-7658
FU Fundacao para a Ciencia e a TecnologiaPortuguese Foundation for Science
   and TechnologyEuropean Commission [UID/ECO/00124/2019, UIDB/00124/2020,
   PINFRA/22209/2016]; POR Lisboa; POR Norte [PINFRA/22209/2016]
FX Miguel Cunha acknowledges funding by Fundacao para a Ciencia e a
   Tecnologia (UID/ECO/00124/2019, UIDB/00124/2020 and Social Sciences
   DataLab, PINFRA/22209/2016), POR Lisboa and POR Norte (Social Sciences
   DataLab, PINFRA/22209/2016).
CR Adler A. B., 2013, BUILDING PSYCHOL RES, P223, DOI DOI 10.1037/14190-010
   Agenzia Nazionale del Turismo, 2020, STATISTA
   Andersen E, 2016, HARVARD BUS REV, V94, P98
   Avey JB, 2011, LEADERSHIP QUART, V22, P282, DOI 10.1016/j.leaqua.2011.02.004
   Barrett F., 2012, YES MESS SURPRISING
   Batista MD, 2016, BRIT J MANAGE, V27, P406, DOI 10.1111/1467-8551.12143
   Baumard P, 2005, LONG RANGE PLANN, V38, P281, DOI 10.1016/j.lrp.2005.03.004
   Bigley GA, 2001, ACAD MANAGE J, V44, P1281, DOI 10.2307/3069401
   Bolino MC, 2015, J APPL PSYCHOL, V100, P56, DOI 10.1037/a0037583
   Britt TW, 2016, IND ORGAN PSYCHOL-US, V9, P378, DOI 10.1017/iop.2015.107
   Carmeli A, 2009, J ORGAN BEHAV, V30, P709, DOI 10.1002/job.565
   Ciuchta MP, 2021, J MANAGE, V47, P288, DOI 10.1177/0149206320966987
   Cohen O, 2017, TECHNOL FORECAST SOC, V121, P119, DOI 10.1016/j.techfore.2016.11.008
   Cooke FL, 2021, HUM RESOUR MANAGE R, V31, DOI 10.1016/j.hrmr.2020.100747
   Corbin J.M., 2008, BASICS QUALITATIVE R, V3rd ed., P127, DOI DOI 10.4135/9781452230153
   Coutu DL, 2002, HARVARD BUS REV, V80, P46
   Crane MF, 2016, J OCCUP HEALTH PSYCH, V21, P468, DOI 10.1037/a0040064
   Cunha M.P., 1999, INT J MANAG REV, V1, P299, DOI [10.1111/1468-2370.00017, DOI 10.1111/1468-2370.00017]
   Dansereau F, 2013, LEADERSHIP QUART, V24, P798, DOI 10.1016/j.leaqua.2013.10.008
   Demoskopika, 2020, STATISTA
   Eidelson R, 2011, AM PSYCHOL, V66, P643, DOI 10.1037/a0025272
   Eisenhardt KM, 2007, ACAD MANAGE J, V50, P25, DOI 10.5465/AMJ.2007.24160888
   EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557
   Federalberghi, 2020, BAROMETRO CRISI
   Federazione delle Associazioni Italiane Alberghi e Turismo, 2020, STATISTA
   Fisher DM, 2019, APPL PSYCHOL-INT REV, V68, P583, DOI 10.1111/apps.12162
   Forster C, 2017, GER J HUM RESOUR MAN, V31, P281, DOI 10.1177/2397002217709400
   Foss NJ, 2021, J MANAGE STUD, V58, P268, DOI 10.1111/joms.12643
   Garud R, 2006, ORGAN SCI, V17, P277, DOI 10.1287/orsc.1050.0179
   Gioia DA, 2013, ORGAN RES METHODS, V16, P15, DOI 10.1177/1094428112452151
   Giustiniano L., 2018, ELGAR INTRO THEORIES
   Giustiniano L, 2020, MANAGE ORGAN REV, V16, P971, DOI 10.1017/mor.2020.57
   Giustiniano L, 2016, BUS HORIZONS, V59, P223, DOI 10.1016/j.bushor.2015.11.007
   Hadida AL, 2015, INT J MANAG REV, V17, P437, DOI 10.1111/ijmr.12047
   Harland L., 2004, J LEADERSH ORG STUD, V11, P2, DOI [10.1177/107179190501100202, DOI 10.1177/107179190501100202]
   Harms PD, 2017, APPL PSYCHOL-INT REV, V66, P78, DOI 10.1111/apps.12077
   Hartmann S, 2020, APPL PSYCHOL-INT REV, V69, P913, DOI 10.1111/apps.12191
   Haver A, 2014, SCAND J HOSP TOUR, V14, P152, DOI 10.1080/15022250.2014.899141
   Heifetz RA, 2002, HARVARD BUS REV, V80, P65
   Holling CS., 1996, ENG RESILIENCE VERSU, V31, P32, DOI DOI 10.17226/4919
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   James EH., 2010, LEADING PRESSURE SUR
   James EH, 2011, ACAD MANAG ANN, V5, P455, DOI 10.1080/19416520.2011.589594
   Kao CY, 2016, INT J HOSP MANAG, V56, P98, DOI 10.1016/j.ijhm.2016.05.001
   Kim M, 2015, ASIAN NURS RES, V9, P21, DOI 10.1016/j.anr.2014.09.003
   King GA, 2010, NEW HORIZ INNO MANAG, P361
   Kossek EE, 2016, ACAD MANAG ANN, V10, P729, DOI 10.1080/19416520.2016.1159878
   Krueger JI, 2011, AM PSYCHOL, V66, P642, DOI 10.1037/a0025080
   La Repubblica, 2020, OCSE PIL ITALIANO CR
   Langley A, 1999, ACAD MANAGE REV, V24, P691, DOI 10.2307/259349
   Linnenluecke MK, 2017, INT J MANAG REV, V19, P4, DOI 10.1111/ijmr.12076
   Mak AHN, 2010, INT J TOUR RES, V12, P205, DOI 10.1002/jtr.746
   Marshall MN, 1996, FAM PRACT, V13, P522, DOI 10.1093/fampra/13.6.522
   Masten AS, 2012, ANNU REV PSYCHOL, V63, P227, DOI 10.1146/annurev-psych-120710-100356
   Maxwell J.A., 2012, QUALITATIVE RES DESI, VVolume 41
   McChrystal G.S., 2015, TEAM TEAMS NEW RULES
   Abrantes ACM, 2018, J BUS RES, V84, P59, DOI 10.1016/j.jbusres.2017.11.005
   Miner AS, 2001, ADMIN SCI QUART, V46, P304, DOI 10.2307/2667089
   Mjelde FV, 2016, WORK, V54, P283, DOI 10.3233/WOR-162298
   Moorman C, 1998, J MARKETING, V62, P1, DOI 10.2307/1251740
   Mordor Intelligence, 2019, HOSPITALITY IND ITAL
   Nag R, 2007, ACAD MANAGE J, V50, P821
   O'Donohoe S, 2010, INT J ADVERT, V29, P328, DOI 10.2501/S026504871020118X
   Packer MJ, 2017, SCI QUALITATIVE RES
   Penny WYK, 2013, INT J HOSP MANAG, V34, P348, DOI 10.1016/j.ijhm.2012.11.010
   Cunha MPE, 2019, LEARN ORGAN, V26, P238, DOI 10.1108/TLO-07-2018-0126
   Cunha MPE, 2014, CREAT INNOV MANAG, V23, P359, DOI 10.1111/caim.12076
   Pinar M, 2011, INT J HOSP MANAG, V30, P73, DOI 10.1016/j.ijhm.2010.06.007
   Polivy J, 2000, CURR DIR PSYCHOL SCI, V9, P128, DOI 10.1111/1467-8721.00076
   Rak CF, 1996, J COUNS DEV, V74, P368, DOI 10.1002/j.1556-6676.1996.tb01881.x
   Rego A, 2021, J MANAGE, V47, P1155, DOI 10.1177/0149206320904765
   Renjen P., 2020, ESSENCE RESILIENT LE
   Ribaudo R, 2019, ITALY HOTELS CHAINS
   Roux-Dufort C., 2003, INT STUD MANAG ORG, V33, P86, DOI DOI 10.1111/PADM.12183
   Schreier M., 2012, QUALITATIVE CONTENT
   Smith WK, 2016, HARVARD BUS REV, V94, P63
   Sommer SA, 2016, GROUP ORGAN MANAGE, V41, P172, DOI 10.1177/1059601115578027
   Strauss A., 1990, BASICS QUALITATIVE R
   Tracey P, 2016, ACAD MANAGE J, V59, P740, DOI 10.5465/amj.2013.0483
   Tsoukas H, 2017, J MANAGE STUD, V54, P132, DOI 10.1111/joms.12219
   Uhl-Bien M, 2007, LEADERSHIP QUART, V18, P298, DOI 10.1016/j.leaqua.2007.04.002
   UNWTO, 2020, IMPACT ASSESSMENT CO
   van Woerkom M, 2016, J APPL PSYCHOL, V101, P141, DOI 10.1037/apl0000033
   Vogus TJ, 2012, ACAD MANAG LEARN EDU, V11, P722, DOI 10.5465/amle.2011.0002c
   Wanberg CR, 2000, J APPL PSYCHOL, V85, P132, DOI 10.1037/0021-9010.85.1.132
   WEICK KE, 1993, ADMIN SCI QUART, V38, P628, DOI 10.2307/2393339
   Williams TA, 2017, ACAD MANAG ANN, V11, P733, DOI 10.5465/annals.2015.0134
   World Travel & Tourism Council (WTTC), 2020, STATISTA
   Zahra SA, 2002, ACAD MANAGE REV, V27, P185, DOI 10.2307/4134351
NR 89
TC 10
Z9 10
U1 19
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0278-4319
EI 1873-4693
J9 INT J HOSP MANAG
JI Int. J. Hosp. Manag.
PD MAY
PY 2021
VL 95
AR 102904
DI 10.1016/j.ijhm.2021.102904
EA MAR 2021
PG 13
WC Hospitality, Leisure, Sport & Tourism
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics
GA UO7IQ
UT WOS:000694867200018
DA 2022-04-20
ER

PT J
AU Meng, L
   Hua, F
   Bian, Z
AF Meng, L.
   Hua, F.
   Bian, Z.
TI Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for
   Dental and Oral Medicine
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE virology; infection control; dental public health; dental education;
   transmission; dental practice management
ID ACUTE-RESPIRATORY-SYNDROME; INTERNATIONAL ASSOCIATION; TRAUMATOLOGY
   GUIDELINES; MANAGEMENT; INJURIES; SARS; EFFICACY
AB The epidemic of coronavirus disease 2019 (COVID-19), originating in Wuhan, China, has become a major public health challenge for not only China but also countries around the world. The World Health Organization announced that the outbreaks of the novel coronavirus have constituted a public health emergency of international concern. As of February 26, 2020, COVID-19 has been recognized in 34 countries, with a total of 80,239 laboratory-confirmed cases and 2,700 deaths. Infection control measures are necessary to prevent the virus from further spreading and to help control the epidemic situation. Due to the characteristics of dental settings, the risk of cross infection can be high between patients and dental practitioners. For dental practices and hospitals in areas that are (potentially) affected with COVID-19, strict and effective infection control protocols are urgently needed. This article, based on our experience and relevant guidelines and research, introduces essential knowledge about COVID-19 and nosocomial infection in dental settings and provides recommended management protocols for dental practitioners and students in (potentially) affected areas.
C1 [Meng, L.; Bian, Z.] Wuhan Univ, Minist Educ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Luoyu Rd 237, Wuhan 430079, Hubei, Peoples R China.
   [Meng, L.; Bian, Z.] Wuhan Univ, Minist Educ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Luoyu Rd 237, Wuhan 430079, Hubei, Peoples R China.
   [Hua, F.] Wuhan Univ, Sch & Hosp Stomatol, Ctr Evidence Based Stomatol, Wuhan, Peoples R China.
RP Bian, Z (corresponding author), Wuhan Univ, Minist Educ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Luoyu Rd 237, Wuhan 430079, Hubei, Peoples R China.; Bian, Z (corresponding author), Wuhan Univ, Minist Educ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Luoyu Rd 237, Wuhan 430079, Hubei, Peoples R China.
EM bianzhuan@whu.edu.cn
RI Hua, Fang/G-6344-2013; Meng, liuyan/W-4927-2018; , Patricia
   Casas-Agustench/M-7762-2014
OI Hua, Fang/0000-0002-2438-5924; Meng, liuyan/0000-0001-7161-6492; ,
   Patricia Casas-Agustench/0000-0003-4424-1087
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [81870761, 81970923, 81901044]; National Key
   Research and Development Program of China [2016YFC1000505]; Key Research
   Program of the Provincial Department of Science and Technology
   [2017ACA181]
FX The article was supported by grants from the National Natural Science
   Foundation of China (Nos. 81870761, 81970923, 81901044), The National
   Key Research and Development Program of China (2016YFC1000505), and the
   Key Research Program of the Provincial Department of Science and
   Technology (No. 2017ACA181). The authors acknowledge technical
   assistance from Chujian Jiang and clinical advice from Prof. Yong Cheng
   and Tianjuan Xia and all the other staff and students from the School
   and Hospital of Stomatology, Wuhan University, China, who contributed
   directly or indirectly to the article. Fortunately, 5 staff confirmed to
   have COVID-19 have been convalescing and discharged from hospital. The
   authors declare no potential conflicts of interest with respect to the
   authorship and/or publication of this article.
CR Andersson L, 2012, DENT TRAUMATOL, V28, P88, DOI 10.1111/j.1600-9657.2012.01125.x
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   [Anonymous], 2020, QUEST ANSW COR
   Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Centers for Disease Control and Prevention, 2020, DIS BURD INFL
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Day PF, 2020, DENT TRAUMATOL, V36, P343, DOI 10.1111/edt.12576
   del Rio C, 2020, JAMA-J AM MED ASSOC, V323, P1039, DOI 10.1001/jama.2020.1490
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   DiAngelis AJ, 2012, DENT TRAUMATOL, V28, P2, DOI 10.1111/j.1600-9657.2011.01103.x
   Guan W-J, 2020, CLIN CHARACTERISTICS, DOI [10.1101/2020.1102.1106.20020974., DOI 10.1101/2020.1102.1106.20020974]
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Cono Joanne, 2003, MMWR Recomm Rep, V52, P1
   Larson EL, 2000, BEHAV MED, V26, P14, DOI 10.1080/08964280009595749
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Li RWK, 2004, BRIT DENT J, V197, P130, DOI 10.1038/sj.bdj.4811522
   Li ZY, 2020, ZHONGHUA KOU QIANG Y, V55, pE001, DOI DOI 10.3760/cma.j.issn.1002-0098.2020.0001
   Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m408
   Malik YS, 2020, VET QUART, V40, P68, DOI 10.1080/01652176.2020.1727993
   Marui VC, 2019, J AM DENT ASSOC, V150, P1015, DOI 10.1016/j.adaj.2019.06.024
   National Health Commission of China, 2020, UPD NOV COR PNEUM OU
   National Health Commission of China, 2020, DIAGN TREATM PROT NO
   Park Seung Won, 2016, Korean J Med Educ, V28, P209, DOI 10.3946/kjme.2016.30
   Patil NG, 2003, MED EDUC, V37, P1127, DOI 10.1046/j.1365-2923.2003.01723.x
   Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Samaranayake LP, 2004, J AM DENT ASSOC, V135, P1292, DOI 10.14219/jada.archive.2004.0405
   SAMARANAYAKE LP, 1989, J DENT CHILD, V56, P442
   Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P139, DOI 10.3760/cma.j.issn.0254-6450.2020.02.002
   Vandenberghe B, 2010, EUR RADIOL, V20, P2637, DOI 10.1007/s00330-010-1836-1
   WANG D, 2020, JAMA-J AM MED ASSOC, DOI [DOI 10.1001/JAMA.2020.1585, 10.1001/jama.2020.1585]
   Wong JGWS, 2004, MED TEACH, V26, P657, DOI 10.1080/01421590400006572
   Xu Z, 2020, EXUBERANT ELEVATION, DOI 10.1101/2020.02.11.20021493
   Zhu HP, 2020, TRANSL PEDIATR, V9, P51, DOI 10.21037/tp.2020.02.06
NR 39
TC 680
Z9 743
U1 24
U2 125
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD MAY
PY 2020
VL 99
IS 5
BP 481
EP 487
AR 0022034520914246
DI 10.1177/0022034520914246
EA MAR 2020
PG 7
WC Dentistry, Oral Surgery & Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dentistry, Oral Surgery & Medicine
GA LG0AY
UT WOS:000523821200001
PM 32162995
OA Green Published
DA 2022-04-20
ER

PT J
AU Schneider, J
   Mijocevic, H
   Ulm, K
   Ulm, B
   Weidlich, S
   Wurstle, S
   Rothe, K
   Treiber, M
   Iakoubov, R
   Mayr, U
   Lahmer, T
   Rasch, S
   Herner, A
   Burian, E
   Lohofer, F
   Braren, R
   Makowski, MR
   Schmid, RM
   Protzer, U
   Spinner, C
   Geisler, F
AF Schneider, Jochen
   Mijocevic, Hrvoje
   Ulm, Kurt
   Ulm, Bernhard
   Weidlich, Simon
   Wuerstle, Silvia
   Rothe, Kathrin
   Treiber, Matthias
   Iakoubov, Roman
   Mayr, Ulrich
   Lahmer, Tobias
   Rasch, Sebastian
   Herner, Alexander
   Burian, Egon
   Lohoefer, Fabian
   Braren, Rickmer
   Makowski, Marcus R.
   Schmid, Roland M.
   Protzer, Ulrike
   Spinner, Christoph
   Geisler, Fabian
TI SARS-CoV-2 serology increases diagnostic accuracy in CT-suspected,
   PCR-negative COVID-19 patients during pandemic
SO RESPIRATORY RESEARCH
LA English
DT Article
DE COVID-19; SARS-CoV-2; Serology; Computed tomography; Efficacy; Accuracy
AB Background: In the absence of PCR detection of SARS-CoV-2 RNA, accurate diagnosis of COVID-19 is challenging. Low-dose computed tomography (CT) detects pulmonary infiltrates with high sensitivity, but findings may be non-specific. This study assesses the diagnostic value of SARS-CoV-2 serology for patients with distinct CT features but negative PCR.
   Methods: IgM/IgG chemiluminescent immunoassay was performed for 107 patients with confirmed (group A: PCR + ; CT +/-) and 46 patients with suspected (group B: repetitive PCR-; CT +) COVID-19, admitted to a German university hospital during the pandemic's first wave. A standardized, in-house CT classification of radiological signs of a viral pneumonia was used to assess the probability of COVID-19.
   Results: Seroconversion rates (SR) determined on day 5, 10, 15, 20 and 25 after symptom onset (SO) were 8%, 25%, 65%, 76% and 91% for group A, and 0%, 10%, 19%, 37% and 46% for group B, respectively; (p < 0.01). Compared to hospitalized patients with a non-complicated course (non-ICU patients), seroconversion tended to occur at lower frequency and delayed in patients on intensive care units. SR of patients with CT findings classified as high certainty for COVID-19 were 8%, 22%, 68%, 79% and 93% in group A, compared with 0%, 15%, 28%, 50% and 50% in group B (p < 0.01). SARS-CoV-2 serology established a definite diagnosis in 12/46 group B patients. In 88% (8/9) of patients with negative serology > 14 days after symptom onset (group B), clinico-radiological consensus reassessment revealed probable diagnoses other than COVID-19. Sensitivity of SARS-CoV-2 serology was superior to PCR > 17d after symptom onset.
   Conclusions: Approximately one-third of patients with distinct COVID-19 CT findings are tested negative for SARS-CoV-2 RNA by PCR rendering correct diagnosis difficult. Implementation of SARS-CoV-2 serology testing alongside current CT/PCR-based diagnostic algorithms improves discrimination between COVID-19-related and non-related pulmonary infiltrates in PCR negative patients. However, sensitivity of SARS-CoV-2 serology strongly depends on the time of testing and becomes superior to PCR after the 2(nd) week following symptom onset.
C1 [Schneider, Jochen; Weidlich, Simon; Wuerstle, Silvia; Treiber, Matthias; Iakoubov, Roman; Mayr, Ulrich; Lahmer, Tobias; Rasch, Sebastian; Herner, Alexander; Schmid, Roland M.; Spinner, Christoph; Geisler, Fabian] Tech Univ Munich, Sch Med, Dept Internal Med 2, Munich, Germany.
   [Schneider, Jochen; Mijocevic, Hrvoje; Weidlich, Simon; Rothe, Kathrin; Protzer, Ulrike; Spinner, Christoph] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany.
   [Mijocevic, Hrvoje; Protzer, Ulrike] Tech Univ Munich, Sch Med, Inst Virol, Munich, Germany.
   [Ulm, Kurt] Tech Univ Munich, Sch Med, Inst Med Stat & Epidemiol, Munich, Germany.
   [Ulm, Bernhard] Tech Univ Munich, Sch Med, Dept Anaesthesiol & Intens Care Med, Munich, Germany.
   [Rothe, Kathrin] Tech Univ Munich, Sch Med, Inst Med Microbiol Immunol & Hyg, Munich, Germany.
   [Burian, Egon; Lohoefer, Fabian; Braren, Rickmer; Makowski, Marcus R.] Tech Univ Munich, Sch Med, Inst Diagnost & Intervent Radiol, Munich, Germany.
RP Schneider, J; Geisler, F (corresponding author), Tech Univ Munich, Sch Med, Dept Internal Med 2, Munich, Germany.
EM Jochen.Schneider@tum.de; Fabian.geisler@mri.tum.de
RI Makowski, Marcus R/Q-7957-2018
OI Spinner, Christoph/0000-0002-3875-5367; Wurstle,
   Silvia/0000-0003-0787-3894
FU University Hospital Klinikum rechts der Isar
FX This study is dedicated to Professor Wolfgang Huber, who substantially
   contributed to this work and lost his fight for life during the COVID-19
   pandemic. Prof. Wolfgang Huber was a world-class expert in the field of
   hemodynamic monitoring on intensive care units. He was a major
   contributor to the clinical implementation of Pulse Contour Cardiac
   Output (PiCCO) technology, which has become indispensable in modern
   intensive care. During his time at the University Hospital Klinikum
   rechts der Isar, he trained physicians in intensive medical care with
   pleasant dedication and contributed widely to the publication of his
   research. As well as his outstanding knowledge in intensive care
   medicine, Prof. Wolfgang Huber had also substantial experience in the
   management of infectious diseases and gastroenterological conditions
   such as chronic inflammatory bowel disease, acute pancreatitis, and
   liver cirrhosis. With all due respect to you, Wolfgang: we will keep
   your legacy alive.
CR Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Chen J, 2020, J INFECTION, V80, pE1, DOI 10.1016/j.jinf.2020.03.004
   Crobach MJT, 2009, CLIN MICROBIOL INFEC, V15, P1053, DOI 10.1111/j.1469-0691.2009.03098.x
   Feng H, 2020, JPN J RADIOL, V38, P409, DOI 10.1007/s11604-020-00967-9
   Fourati S, 2020, INTENS CARE MED, V46, P1781, DOI 10.1007/s00134-020-06157-5
   Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Lippi G, 2020, CLIN CHEM LAB MED, V58, P1070, DOI 10.1515/cclm-2020-0285
   Qu JX, 2020, CLIN INFECT DIS, V71, P2255, DOI 10.1093/cid/ciaa489
   Shiley KT, 2010, J THORAC IMAG, V25, P68, DOI 10.1097/RTI.0b013e3181b0ba8b
   Sun BQ, 2020, EMERG MICROBES INFEC, V9, P940, DOI 10.1080/22221751.2020.1762515
   Tahamtan A, 2020, EXPERT REV MOL DIAGN, V20, P453, DOI 10.1080/14737159.2020.1757437
   Tobias A, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138539
   Wee LE, 2020, J HOSP INFECT, V105, P113, DOI 10.1016/j.jhin.2020.04.016
   Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3
   Zhang JN, 2020, LANCET RESP MED, V8, pE11, DOI 10.1016/S2213-2600(20)30071-0
NR 17
TC 1
Z9 1
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1465-993X
J9 RESP RES
JI Respir. Res.
PD APR 23
PY 2021
VL 22
IS 1
AR 119
DI 10.1186/s12931-021-01717-9
PG 10
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA RR1YI
UT WOS:000642902100003
PM 33892720
OA gold, Green Published, Green Submitted
DA 2022-04-20
ER

PT J
AU Lake, EA
   Demissie, BW
   Gebeyehu, NA
   Wassie, AY
   Gelaw, KA
   Azeze, GA
AF Lake, Eyasu Alem
   Demissie, Birhanu Wondimeneh
   Gebeyehu, Natneal Atnafu
   Wassie, Addisu Yeshambel
   Gelaw, Kelemu Abebe
   Azeze, Gedion Asnake
TI Knowledge, attitude and practice towards COVID-19 among health
   professionals in Ethiopia: A systematic review and meta-analysis
SO PLOS ONE
LA English
DT Review
AB Background
   The World Health Organization (WHO) declared coronavirus disease 2019 (COVID-19) a global pandemic on 11th March, 2020. In Ethiopia, more than 90,490 and 1,300 confirmed cases and deaths were reported by the Federal Ministry of Health at the time of writing up this project. As health care providers are frontline workers managing the COVID-19 pandemic, this systematic review and meta-analysis aimed to assess the pooled level of knowledge, attitude, and practice towards COVID-19 among health professionals in Ethiopia.
   Methods
   PubMed, Google Scholar, Excerpta Medica database (EMBASE), Cochrane Library, Web of Science, and African Journal of Online (AJOL) were searched. The data were extracted using Microsoft Excel and analyzed using STATA version 14. Publication bias was checked by funnel plot and more objectively through Egger's regression test, with P < 0.05 considered to indicate potential publication bias. The heterogeneity of studies was checked using I-2 statistics. Pooled analysis was conducted using a weighted inverse variance random-effects model. Subgroup analysis was done related to geographic region and time. A leave-one-out sensitivity analysis was also employed.
   Result
   A total of 11 studies with 3,843 study participants for knowledge, eight studies with 2,842 study participants for attitude and 10 studies with 3, 435 study participants for practice were used to estimate the pooled level of good knowledge, positive attitude and poor practice among health professionals. The overall estimated good level of knowledge, positive attitude and poor practice towards COVID-19 was found to be 79.4% (95% CI: 73.5%-85.2%; I2 = 96%), 73.7% (95%CI: 63.09%-84.4%; I2 = 98.3%) and 40.3% (95%CI: 31.1%-49.6%; I2 = 97.1%) respectively.
   Conclusion
   Study findings showed that there were significant gaps in COVID-19 related knowledge, attitude and practice with respect to World Health Organization recommendations on COVID-19 management and personal protection practices. This study therefore recommends that institutions provide with immediate effect accurate and up-to-date information on COVID-19 and training that encourages improved knowledge, attitude and practice to mitigate this pandemic.
C1 [Lake, Eyasu Alem; Demissie, Birhanu Wondimeneh] Wolaita Sodo Univ, Coll Hlth Sci & Med, Dept Nursing, Wolaita Sodo, Ethiopia.
   [Gebeyehu, Natneal Atnafu; Wassie, Addisu Yeshambel; Gelaw, Kelemu Abebe; Azeze, Gedion Asnake] Wolaita Sodo Univ, Coll Hlth Sci & Med, Dept Midwifery, Wolaita Sodo, Ethiopia.
RP Lake, EA (corresponding author), Wolaita Sodo Univ, Coll Hlth Sci & Med, Dept Nursing, Wolaita Sodo, Ethiopia.
EM eyasmsc208@gmail.com
CR Asemahagn MA, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00254-3
   Bandari DK, 2020, NOVEL CORONAVIRUS CO, V6, DOI DOI 10.1101/2020.03.09.20033381
   Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12
   Chen YX, 2020, J INFECTION, V81, P420, DOI 10.1016/j.jinf.2020.05.067
   Demoz GT., 2020, KNOWLEDGE ATTITUDE P
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Egger M, 2001, SYSTEMATIC REV HLTH
   Feleke DG., ASSESSMENT KNOWLEDGE
   FMOH, 2020, NAT COMPR COVID 19 M
   Gan WH, 2020, SAF HEALTH WORK-KR, V11, P241, DOI 10.1016/j.shaw.2020.03.001
   Girma S, 2020, RISK MANAG HEALTHC P, V13, P1327, DOI 10.2147/RMHP.S267261
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jamie AH., 2020, PUBLIC HLTH INDONESI, V6, P72
   Jemal B., KNOWLEDGE ATTITUDE P
   Joanna Briggs Institute, 2018, CRIT APPR TOOLS AUST
   Kassie BA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238415
   Khubchandani, 2020, KNOWLEDGE ATTITUDE P
   Masters PS, 2019, VIROLOGY, V537, P198, DOI 10.1016/j.virol.2019.08.031
   McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4
   Mersha A., 2020, HLTH PROFESSIONAL PR
   PRISMA, 2011, PRISMA TRANSP REP SY
   Tamire AH., 2020, ETHIOP MED J, V58
   Teferi SC., 2020, J BIOMEDICAL RES ENV, V6, P040
   Tesfaye ZT, 2020, INTEGR PHARM RES PRA, V9, P105, DOI 10.2147/IPRP.S261275
   Tsegaye D., KNOWLEDGE PREVENTIVE
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   World Health Organization, COR DIS COVID 19 ACT
   Worldometer.info, COR CAS
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
NR 29
TC 6
Z9 7
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 19
PY 2021
VL 16
IS 2
AR e0247204
DI 10.1371/journal.pone.0247204
PG 16
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA QK8KQ
UT WOS:000620629200050
PM 33606744
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Basheti, IA
   Nassar, R
   El-hajji, F
   Othman, B
   Alkoudsi, KT
   Al-Ani, Z
AF Basheti, Iman A.
   Nassar, Razan
   El-hajji, Feras
   Othman, Bayan
   Alkoudsi, Kinda T.
   Al-Ani, Zaid
TI COVID-19 and role of pharmacists: Knowledge and perceptions of
   pharmacists from Iraq and Syria
SO PHARMACY PRACTICE-GRANADA
LA English
DT Article
DE Coronavirus; Pandemics; Pharmacists; Pharmaceutical associations; Syria;
   Iraq
AB Objectives: To assess pharmacists from Syria and Iraq on their knowledge, readiness, and perspectives on their roles during the COVID-19 pandemic. In addition to investigate pharmacists' perceived barriers towards delivering their emergency roles during the COVID-19 pandemic and perceived policymakers' responsibilities. Methods: This cross-sectional study design was conducted in Iraq and Syria during COVID-19 outbreak over one month (April 2020). The study objectives were addressed through a validated online questionnaire. Data was analyzed using statistical package for social science (SPSS). Results: A total of 916 individuals participated in this study (447 from Iraq and 439 from Syria). Most of Iraqi participants were students while most of Syrian participants were graduates and technicians. The mean age for the Iraqi participants was 22.5 (SD= 4.1) while the mean age for the Syrian participants was 28.7 (SD= 9.1). A significant difference (p< 0.001) was found in following the latest coronavirus updates on management among pharmacy graduates and technicians and undergraduate students. Media was reported as the most used source for knowledge about epidemics/pandemics among the Iraqi and the Syrian participants. Around 72% strongly agreed/agreed that the faculties of pharmacy have a role in preparing them to deal with epidemics/pandemics. In addition, 64.3% strongly agreed/agreed that pharmacist associations and societies have a role in preparing them to deal with epidemics/pandemics such as the coronavirus. Moreover, 82.9% believed that pharmacists should receive training programs on how to provide mental health support for people during epidemic and pandemic outbreaks. Conclusion: Tertiary pharmacy education providers and pharmacy professional bodies have a strong role in preparing pharmacists to deal with pandemics. Therefore, the importance of providing beforehand training programs on epidemics/pandemics management, workshops, lectures, and online information resources for such circumstances is crucial for pharmacists.
C1 [Basheti, Iman A.; El-hajji, Feras] Appl Sci Private Univ, Fac Pharm, Dept Clin Pharm & Therapeut, Clin Pharm, Amman, Jordan.
   [Nassar, Razan; Othman, Bayan] Appl Sci Private Univ, Fac Pharm, Dept Clin Pharm & Therapeut, Amman, Jordan.
   [Alkoudsi, Kinda T.] FlowCell, Biotechnol, Swampscott, MA USA.
   [Al-Ani, Zaid] Appl Sci Private Univ, Fac Pharm, Amman, Jordan.
RP Basheti, IA (corresponding author), Appl Sci Private Univ, Fac Pharm, Dept Clin Pharm & Therapeut, Clin Pharm, Amman, Jordan.
EM dr_iman@asu.edu.jo; r_nassar@asu.edu.jo; f_elhajji@asu.edu.jo;
   b_othman@asu.edu.jo; kinda.alkoudsi@gmail.com; zaidalani94@gmail.com
CR Al-Quteimat OM, 2021, RES SOC ADMIN PHARM, V17, P480, DOI 10.1016/j.sapharm.2020.03.018
   Aruru M, 2021, RES SOC ADMIN PHARM, V17, P1967, DOI 10.1016/j.sapharm.2020.04.002
   Association AP, PHARM GUID COR
   Association CP, 2020, CORONAVIRUS SARS COV, V2nd
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Basheti IA, 2020, J PHARM POLICY PRACT, V13, DOI 10.1186/s40545-020-00254-y
   Basheti IA, 2021, RES SOC ADMIN PHARM, V17, P514, DOI 10.1016/j.sapharm.2020.04.020
   Cadogan CA, 2021, RES SOC ADMIN PHARM, V17, P2032, DOI 10.1016/j.sapharm.2020.03.015
   Carico R, 2021, RES SOC ADMIN PHARM, V17, P1984, DOI 10.1016/j.sapharm.2020.03.017
   CDC, 2020, US CTR DIS CONTR PRE
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Federation IP, 2020, COR COVID 19 PREP
   Gharibah M, 2020, COVID 19 PANDEMIC SY
   Government KR, 2020, COVID 19 SIT UPD IR
   Government KR, KRG TAK ACT PREV COR
   Greenhalgh T, 2020, VIDEO CONSULTATIONS
   Hedima EW, 2020, PHARM COMMUNITY PHAR, DOI [10.1016/j.sapharm.2020.04.017, DOI 10.1016/J.SAPHARM.2020.04.017]
   Hollander JE, 2020, NEW ENGL J MED, V382, P1679, DOI 10.1056/NEJMp2003539
   Jalabneh R, 2020, USE MOBILE PHONE APP
   Servick K, 2020, SCIENCE, DOI 10.1126/science.abc9379
   Lima CKT, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112915
   Walton M, 2020, EUR HEART J-ACUTE CA, V9, P241, DOI 10.1177/2048872620922795
   WHO, WHO IR HLTH PROF
   WHO. World Health Organization, NOV COV COVID 19 SIT
   World Health Organization (WHO), 2020, COR
   Yang Y, 2020, LANCET PSYCHIAT, V7, pE19, DOI 10.1016/S2215-0366(20)30079-1
   Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196
   Zheng SQ, 2021, RES SOC ADMIN PHARM, V17, P1819, DOI 10.1016/j.sapharm.2020.03.012
NR 29
TC 0
Z9 0
U1 0
U2 0
PU CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICAS
PI REDONDELA
PA RUA REGATEIRAS, 55, REDONDELA, 36800, SPAIN
SN 1885-642X
EI 1886-3655
J9 PHARM PRACT-GRANADA
JI Pharm. Pract.-Granada
PD JAN-MAR
PY 2022
VL 20
IS 1
AR 2585
DI 10.18549/PharmPract.2022.1.2585
PG 11
WC Pharmacology & Pharmacy
WE Emerging Sources Citation Index (ESCI)
SC Pharmacology & Pharmacy
GA 0I1SP
UT WOS:000779206300001
OA gold
DA 2022-04-20
ER

PT J
AU Turner, S
   Nino, N
   Segura, C
   Botero-Tovar, N
AF Turner, Simon
   Nino, Natalia
   Segura, Carolina
   Botero-Tovar, Natalia
TI Organisational responses to mitigate the effects of COVID-19 on
   healthcare workers: a qualitative case study from Bogota, Colombia
SO BMC HEALTH SERVICES RESEARCH
LA English
DT Article
DE COVID-19; Coronavirus; Colombia; Qualitative; Workforce; Human
   resources; Wellbeing; Coordination; Health system
ID EXPERIENCES; SYSTEM
AB Background Healthcare organisations have undergone organisational change to respond to COVID-19. This pandemic has presented challenges for employee adjustment, with impacts on the availability and coordination of human resources in healthcare. This study aimed to characterise the organisational actions regarding the coordination of human resources in healthcare within Bogota, Colombia, to respond to the COVID-19 pandemic. Methods We followed a case study approach to understand the response to the emergency taking into account the narratives of managerial actors who have been directly involved in the planning of guidelines oriented to face the pandemic or in the implementation of health services for COVID-19. Twenty-two interviews with multiple health system organisations within Bogota were conducted between May and September 2020 and analysed thematically. Results Three themes emerged from the analysis of the interview data: to retain human resources, to implement actions to improve the mental and physical health of the healthcare workers, and to enhance healthcare workers knowledge, skills and availability to respond to COVID-19. Conclusions Organisational actions led by hospital managers to retain, protect, and train human health resources in the dynamic context of the COVID-19 pandemic were identified. Other system-wide organisations like scientific associations contributed to the coordination of human resources across hospitals to respond to COVID-19 in Bogota, Colombia. The actions of hospital managers, and roles of system-wide intermediary organisations, in coordinating human resources need to be explored in other health system contexts facing COVID-19.
C1 [Turner, Simon; Nino, Natalia; Segura, Carolina; Botero-Tovar, Natalia] Univ los Andes, Sch Management, Bogota, Colombia.
RP Turner, S (corresponding author), Univ los Andes, Sch Management, Bogota, Colombia.
EM s.turner@uniandes.edu.co
OI Turner, Simon/0000-0002-1801-8351; Nino Machado,
   Natalia/0000-0001-7887-9439; Botero, Natalia/0000-0001-7664-5452
FU Mincienciaton National Program of Colombia of the Ministry of Science,
   Technology and Innovation [1204101577001]; "Fondo de Apoyo a Profesores
   Asistentes" (FAPA) de la Universidad de los Andes
FX This research was funded by the Mincienciaton National Program of
   Colombia of the Ministry of Science, Technology and Innovation (Project
   code 1204101577001). ST also acknowledges support from "Fondo de Apoyo a
   Profesores Asistentes" (FAPA) de la Universidad de los Andes. The
   funders of the study had no role in study design, data collection, data
   analysis, data interpretation, or writing of the paper.
CR Al-Dabbagh ZS, 2020, J PUBLIC AFF, V20, DOI 10.1002/pa.2186
   Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x
   Brickman D, 2020, AM J CRIT CARE, V29, pE104, DOI 10.4037/ajcc2020142
   Carnevale JB, 2020, J BUS RES, V116, P183, DOI 10.1016/j.jbusres.2020.05.037
   Chiu M, 2020, CAN J ANESTH, V67, P1667, DOI 10.1007/s12630-020-01744-y
   Delgado D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082798
   Ferlie E, 2005, ACAD MANAGE J, V48, P117, DOI 10.5465/amj.2005.15993150
   Gao XY, 2020, J CLIN NURS, V29, P4270, DOI 10.1111/jocn.15464
   Guerrero R, 2011, SALUD PUBLICA MEXICO, V53, pS144
   Halcomb E, 2020, J NURS SCHOLARSHIP, V52, P553, DOI 10.1111/jnu.12589
   Halcomb E, 2020, J NURS MANAGE, V28, P1553, DOI 10.1111/jonm.13108
   Huang LS, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2841-7
   Kabene Stefane M, 2006, Hum Resour Health, V4, P20, DOI 10.1186/1478-4491-4-20
   Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7
   Martin-Delgado J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242185
   Ministerio de Educacion Nacional, 2017, SIST NAC INFORM ED S SIST NAC INFORM ED S, V1
   Murphy B, 2020, RESIDENCY PANDEMIC C
   O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388
   Ornell F, 2020, CADERNOS SAUDE PUBL, V36, P1
   Patton MQ., 1990, QUALITATIVE EVALUATI, V2nd ed
   Pope C, 2002, QUAL SAF HEALTH CARE, V11, P148, DOI 10.1136/qhc.11.2.148
   Rangachari P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124267
   Raurell-Torreda M, 2020, ENFERM INTENSIV, V31, P49, DOI 10.1016/j.enfi.2020.04.001
   Secretaria Distrital de Salud, OBS SAL BOG SALUDATA OBS SAL BOG SALUDATA
   Seymour-Walsh AE, 2020, RURAL REMOTE HEALTH, V20, DOI 10.22605/RRH6000
   Shand J, 2019, J INTEGR CARE, V27, P83, DOI 10.1108/JICA-06-2018-0042
   Smith C, 2020, SOC SCI MED, V258, DOI 10.1016/j.socscimed.2020.113119
   Spinelli A, 2020, BRIT J SURG, V107, P785, DOI 10.1002/bjs.11627
   Sun NN, 2020, AM J INFECT CONTROL, V48, P592, DOI 10.1016/j.ajic.2020.03.018
   Swaithes L, 2020, RHEUMATOLOGY, V59, P1804, DOI 10.1093/rheumatology/keaa387
   Tomlin J, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01960
   Turner S, 2021, IMPLEMENT SCI, V16, DOI 10.1186/s13012-021-01114-2
   Turner Simon, 2020, Implement Sci Commun, V1, P75, DOI 10.1186/s43058-020-00063-z
   Turner S, 2018, SOCIOL HEALTH ILL, V40, P654, DOI 10.1111/1467-9566.12670
   Yin RK, 2013, EVALUATION-US, V19, P321, DOI 10.1177/1356389013497081
NR 35
TC 2
Z9 2
U1 5
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6963
J9 BMC HEALTH SERV RES
JI BMC Health Serv. Res.
PD AUG 11
PY 2021
VL 21
IS 1
AR 792
DI 10.1186/s12913-021-06825-2
PG 10
WC Health Care Sciences & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA TZ1AF
UT WOS:000684207000005
PM 34380486
OA Green Published, Green Submitted, gold
DA 2022-04-20
ER

PT J
AU Steiner, G
   Zenk, L
   Schernhammer, E
AF Steiner, Gerald
   Zenk, Lukas
   Schernhammer, Eva
TI Preparing for the Next Wave of COVID-19: Resilience in the Face of a
   Spreading Pandemic
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE pandemic spread; healthcare workers; COVID-19; network scenarios
ID NUMBER
AB COVID-19 painfully demonstrates how little resilience our societies have to novel viruses. Societies, decision makers, and scientists lack (1) a comprehensive understanding of the complexity of viral outbreaks and their impact on society; (2) intervention portfolios; and (3) a global crisis and resilience policy, all of which are required to develop appropriate measures and to improve societal resilience. We highlight COVID-19 immunity as one key benchmark in preparation for the next wave of the pandemic. Specifically, using network scenarios, we demonstrate the substantial advantage of reintegrating health care workers with acquired COVID-19 immunity in epidemic hotspots, which would not only enable their safe contribution to the health care system but also drastically contain further spread.
C1 [Steiner, Gerald; Zenk, Lukas] Danube Univ Krems, Fac Business & Globalizat, Dept Knowledge & Commun Management, A-3500 Krems An Der Donau, Austria.
   [Steiner, Gerald; Schernhammer, Eva] Complex Sci Hub Vienna, A-1090 Vienna, Austria.
   [Schernhammer, Eva] Med Univ Vienna, Ctr Publ Hlth, Dept Epidemiol, A-1090 Vienna, Austria.
   [Schernhammer, Eva] Harvard Med Sch, Channing Div Network Med, Boston, MA 02115 USA.
RP Schernhammer, E (corresponding author), Complex Sci Hub Vienna, A-1090 Vienna, Austria.; Schernhammer, E (corresponding author), Med Univ Vienna, Ctr Publ Hlth, Dept Epidemiol, A-1090 Vienna, Austria.; Schernhammer, E (corresponding author), Harvard Med Sch, Channing Div Network Med, Boston, MA 02115 USA.
EM gerald.steiner@donau-uni.ac.at; lukas.zenk@donau-uni.ac.at;
   eva.schernhammer@channing.harvard.edu
RI Zenk, Lukas/AAJ-8733-2021
OI Steiner, Gerald/0000-0003-3340-3941; Zenk, Lukas/0000-0002-8354-1747
CR Adam D., 2020, RES SQ
   [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9
   Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821
   Brandes U, 2004, MATH VIS, P321
   Bucuvalas J., 2014, J HEALTHC INF MANAG, V28, P58
   Guerra FM, 2017, LANCET INFECT DIS, V17, pE420, DOI 10.1016/S1473-3099(17)30307-9
   James A, 2007, P ROY SOC B-BIOL SCI, V274, P741, DOI 10.1098/rspb.2006.0219
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Lessells R.J., 2020, REPORT NOSOCOMIAL OU
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Li YK, 2020, CURR MED SCI, V40, P295, DOI 10.1007/s11596-020-2176-2
   Li YG, 2004, AM J EPIDEMIOL, V160, P719, DOI 10.1093/aje/kwh273
   Linkov I, 2014, NAT CLIM CHANGE, V4, P407, DOI 10.1038/nclimate2227
   Nikbakht R, 2018, J RES HEALTH SCI, V18
   Stein RA, 2011, INT J INFECT DIS, V15, pE510, DOI 10.1016/j.ijid.2010.06.020
   Steiner Gerald, 2018, Environment Systems & Decisions, V38, P92, DOI 10.1007/s10669-018-9674-9
   Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xia ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13857
   Zhang S, 2020, INT J INFECT DIS, V93, P201, DOI 10.1016/j.ijid.2020.02.033
NR 20
TC 3
Z9 3
U1 2
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUN
PY 2020
VL 17
IS 11
AR 4098
DI 10.3390/ijerph17114098
PG 6
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA MB5FY
UT WOS:000542629600351
PM 32521811
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU De Cos, O
   Castillo, V
   Cantarero, D
AF De Cos, Olga
   Castillo, Valentin
   Cantarero, David
TI Facing a Second Wave from a Regional View: Spatial Patterns of COVID-19
   as a Key Determinant for Public Health and Geoprevention Plans
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE spatial patterns; COVID-19; microdata; geographic information
   technologies; ArcGIS; public health; geoprevention
AB Several studies on spatial patterns of COVID-19 show huge differences depending on the country or region under study, although there is some agreement that socioeconomic factors affect these phenomena. The aim of this paper is to increase the knowledge of the socio-spatial behavior of coronavirus and implementing a geospatial methodology and digital system called SITAR (Fast Action Territorial Information System, by its Spanish acronym). We analyze as a study case a region of Spain called Cantabria, geocoding a daily series of microdata coronavirus records provided by the health authorities (Government of Cantabria-Spain) with the permission of Medicines Ethics Committee from Cantabria (CEIm, June 2020). Geocoding allows us to provide a new point layer based on the microdata table that includes cases with a positive result in a COVID-19 test. Regarding general methodology, our research is based on Geographical Information Technologies using Environmental Systems Research Institute (ESRI) Technologies. This tool is a global reference for spatial COVID-19 research, probably due to the world-renowned COVID-19 dashboard implemented by the Johns Hopkins University team. In our analysis, we found that the spatial distribution of COVID-19 in urban locations presents a not random distribution with clustered patterns and density matters in the spread of the COVID-19 pandemic. As a result, large metropolitan areas or districts with a higher number of persons tightly linked together through economic, social, and commuting relationships are the most vulnerable to pandemic outbreaks, particularly in our case study. Furthermore, public health and geoprevention plans should avoid the idea of economic or territorial stigmatizations. We hold the idea that SITAR in particular and Geographic Information Technologies in general contribute to strategic spatial information and relevant results with a necessary multi-scalar perspective to control the pandemic.
C1 [De Cos, Olga; Castillo, Valentin] Univ Cantabria, Dept Geog Urbanism & Land Planning, Santander 39005, Spain.
   [De Cos, Olga; Castillo, Valentin; Cantarero, David] Res Inst Marques Valdecilla IDIVAL, Res Grp Hlth Econ & Hlth Serv Management, Santander 39011, Spain.
   [Cantarero, David] Univ Cantabria, Dept Econ, Santander 39005, Spain.
RP De Cos, O (corresponding author), Univ Cantabria, Dept Geog Urbanism & Land Planning, Santander 39005, Spain.; De Cos, O (corresponding author), Res Inst Marques Valdecilla IDIVAL, Res Grp Hlth Econ & Hlth Serv Management, Santander 39011, Spain.
EM olga.decos@unican.es; valentin.castillo@unican.es;
   david.cantarero@unican.es
OI Castillo, Valentin/0000-0001-8025-4892; De Cos, Olga/0000-0002-2245-5378
FU Government of Cantabria (Spain) [UC: 10.3834.64001]; IDIVAL support
   program
FX This research was funded by Government of Cantabria (Spain) grant number
   UC: 10.3834.64001 called "Asistencia en la adecuacion de Cantabria al
   plan para la transicion haca una nueva normalidad en tiempos del
   Covid-19: aportaciones socioeconomicas" University of Cantabria-IDIVAL
   Valdecilla-Government of Cantabria (Spain). And the APC was funded by
   IDIVAL support program.
CR Agbehadji IE, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155330
   Arakpogun EO, 2020, WORLD DEV, V136, DOI 10.1016/j.worlddev.2020.105105
   Bamweyana I, 2020, J GIS, V12, P302
   Batista F, 2016, JRC TECHNICAL REPORT
   Berkowitz RL, 2020, CITIES HLTH, P1, DOI [10.1080/23748834.2020 -.1792069, DOI 10.1080/23748834.2020.1792069]
   Bherwani H, 2021, ENVIRON DEV SUSTAIN, V23, P5846, DOI 10.1007/s10668-020-00849-0
   Borjas GJ, 2020, RWP20008 HK, DOI [10.2139/ssrn.3572329, DOI 10.2139/SSRN.3572329]
   Boulos MKN, 2020, INT J HEALTH GEOGR, V19, DOI 10.1186/s12942-020-00202-8
   Buzai G.D., 2020, POSICION, V3, P2683
   Carozzi F., 2020, SSRN J, DOI [10.2139/ssrn.3643204, DOI 10.2139/SSRN.3643204]
   Cassaro FAM, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138834
   Cori L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093114
   De Cos O., 2018, SCRIPTA NOVA, VXXIII, P606, DOI [10.1344/sn2019.23.21614, DOI 10.1344/SN2019.23.21614]
   Dhaval DD, 2020, ORF OCCASIONAL PAPER, V244, P1
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Franch-Pardo I, 2020, SCI TOTAL ENVIRON, V739, DOI 10.1016/j.scitotenv.2020.140033
   Hamidi S, 2020, J AM PLANN ASSOC, V86, P495, DOI 10.1080/01944363.2020.1777891
   Jindal C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113986
   Kim SJ, 2020, HEALTH EDUC BEHAV, V47, P509, DOI 10.1177/1090198120929677
   Mbuh M., 2020, EAI ENDORSED T SMART, V4, P3, DOI [10.4108/eai.26-6-2018.162219, DOI 10.4108/EAI.26-6-2018.162219]
   Baena-Diez JM, 2020, J PUBLIC HEALTH-UK, V42, P698, DOI 10.1093/pubmed/fdaa136
   Ministerio de Fomento, 2018, AR URB ESP CONST CUA
   Mollalo A, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138884
   Paez A, 2021, GEOGR ANAL, V53, P397, DOI 10.1111/gean.12241
   Perez N., 2020, REV CUBANA HIGIENE E, V57, pe371
   Perles M.J., 2020, PROPUESTA METODOLOGI
   Rae A., 2018, THINK YOUR COUNTRY I
   Rezaei Mehdi, 2020, Iran J Public Health, V49, P114, DOI 10.18502/ijph.v49iS1.3679
   Rosenkrantz L, 2021, HEALTH PLACE, V67, DOI 10.1016/j.healthplace.2020.102389
   Setti L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082932
   Whittle RS, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01731-6
   Zhou CH, 2020, GEOGR SUSTAIN, V1, P77, DOI 10.1016/j.geosus.2020.03.005
NR 32
TC 10
Z9 10
U1 5
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD NOV
PY 2020
VL 17
IS 22
AR 8468
DI 10.3390/ijerph17228468
PG 18
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA OY4DV
UT WOS:000594199400001
PM 33207598
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Khadhraoui, M
   Bellaaj, H
   Ben Ammar, M
   Hamam, H
   Jmaiel, M
AF Khadhraoui, Mayara
   Bellaaj, Hatem
   Ben Ammar, Mehdi
   Hamam, Habib
   Jmaiel, Mohamed
TI Survey of BERT-Base Models for Scientific Text Classification: COVID-19
   Case Study
SO APPLIED SCIENCES-BASEL
LA English
DT Article
DE BERT; COVID-19; scientific text classification; transfer learning;
   scientific publications; deep learning
ID NETWORK
AB On 30 January 2020, the World Health Organization announced a new coronavirus, which later turned out to be very dangerous. Since that date, COVID-19 has spread to become a pandemic that has now affected practically all regions in the world. Since then, many researchers in medicine have contributed to fighting COVID-19. In this context and given the great growth of scientific publications related to this global pandemic, manual text and data retrieval has become a challenging task. To remedy this challenge, we are proposing CovBERT, a pre-trained language model based on the BERT model to automate the literature review process. CovBERT relies on prior training on a large corpus of scientific publications in the biomedical domain and related to COVID-19 to increase its performance on the literature review task. We evaluate CovBERT on the classification of short text based on our scientific dataset of biomedical articles on COVID-19 entitled COV-Dat-20. We demonstrate statistically significant improvements by using BERT.
C1 [Khadhraoui, Mayara] Univ Sfax, Natl Engn Sch Sfax ENIS, Sfax 3038, Tunisia.
   [Khadhraoui, Mayara; Bellaaj, Hatem; Jmaiel, Mohamed] Univ Sfax, Dept Comp Engn & Appl Math, ReDCAD Lab, Sfax 3029, Tunisia.
   [Ben Ammar, Mehdi] Solut Galore Inc, Moncton, NB E1C 5Y1, Canada.
   [Ben Ammar, Mehdi; Hamam, Habib] Univ Moncton, Fac Engn, Moncton, NB E1A 3E9, Canada.
   [Hamam, Habib] Int Inst Technol & Management, BP 1989, Commune Dakanda, Libreville, Gabon.
   [Hamam, Habib] Spectrum Knowledge Prod & Skills Dev, Sfax 3027, Tunisia.
   [Hamam, Habib] Univ Johannesburg, Sch Elect Engn, Dept Elect & Elect Engn Sci, ZA-2006 Johannesburg, South Africa.
RP Khadhraoui, M (corresponding author), Univ Sfax, Natl Engn Sch Sfax ENIS, Sfax 3038, Tunisia.; Khadhraoui, M (corresponding author), Univ Sfax, Dept Comp Engn & Appl Math, ReDCAD Lab, Sfax 3029, Tunisia.
EM khadhraouimayara@gmail.com; hatem.bellaaj@redcad.org;
   mehdi.benammar@gmail.com; habib.hamam@umoncton.ca;
   mohamed.jmaiel@redcad.org
RI Hamam, Habib/C-1761-2019
OI Hamam, Habib/0000-0002-5320-1012
FU Natural Sciences and Engineering Research Council of Canada
   (NSERC)Natural Sciences and Engineering Research Council of Canada
   (NSERC); New Brunswick Innovation Foundation (NBIF)
FX The authors would like to thank Jihene Maatoug and Sihem Ben Fradj,
   members of the Epidemiology Department of CHU Farhat Hached, in Sousse,
   for their valuable cooperation and revision of our dataset. The authors
   also thank the Natural Sciences and Engineering Research Council of
   Canada (NSERC) and YNew Brunswick Innovation Foundation (NBIF) for their
   financial support of the global project. These granting agencies did not
   contribute to the design of the study or the collection, analysis and
   interpretation of the data.
CR Alt C, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P1388
   Amato F, 2013, J APPL BIOMED, V11, P47, DOI 10.2478/v10136-012-0031-x
   Asgari-Chenaghlu M., 2017, THESIS U TABRIZ TABR, DOI [10.13140/RG.2.2.27845.65766, DOI 10.13140/RG.2.2.27845.65766]
   Beltagy I., 2019, P 2019 C EMP METH NA, P3615, DOI DOI 10.18653/V1/D19-1371
   Bird Steven, 2002, P ACL 02 WORKSH EFF
   Chung J., 2014, ARXIV PREPRINT ARXIV
   Devlin J, 2019, BERT PRETRAINING DEE, DOI DOI 10.18653/V1/N19-1423
   Figueroa RL, 2012, J AM MED INFORM ASSN, V19, P809, DOI 10.1136/amiajnl-2011-000648
   Garla VN, 2013, J AM MED INFORM ASSN, V20, P882, DOI 10.1136/amiajnl-2012-001350
   Holzinger A, 2018, LECT NOTES COMPUT SC, V11015, P1, DOI 10.1007/978-3-319-99740-7_1
   Howard J, 2018, PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL), VOL 1, P328
   Huang K., 2019, CLINICALBERT MODELIN
   Jincheng Xu, 2019, 2019 IEEE 21st International Conference on High Performance Computing and Communications; IEEE 17th International Conference on Smart City; IEEE 5th International Conference on Data Science and Systems (HPCC/SmartCity/DSS). Proceedings, P1714, DOI 10.1109/HPCC/SmartCity/DSS.2019.00234
   Khadhraoui M., 2020, P ICOST 2020 HAMM TU, P24, DOI [10.1007/978-3-030-51517-131, DOI 10.1007/978-3-030-51517-131]
   Lee JB, 2020, AM J SPEECH-LANG PAT, V29, P393, DOI [10.1044/2019_AJSLP-CAC48-18-0220, 10.1093/bioinformatics/btz682]
   Liang Yao, 2018, 2018 IEEE International Conference on Healthcare Informatics Workshop (ICHI-W). Proceedings, P70, DOI 10.1109/ICHI-W.2018.00024
   Maas A., 2011, HUMAN LANGUAGE TECHN, P142
   Matthew E.P., 2019, P 2019 C EMP METH NA, P43, DOI [DOI 10.18653/V1/D19-1005, 10.18653/v1/D19-1005]
   Mikolov T, 2017, P 15 C EUR CHAPT ASS, P427, DOI [10.18653/v1/e17, DOI 10.18653/V1/E17-2068]
   Minyong Shi, 2019, 2019 IEEE/ACIS 18th International Conference on Computer and Information Science (ICIS). Proceedings, P253
   Mironczuk MM, 2018, EXPERT SYST APPL, V106, P36, DOI 10.1016/j.eswa.2018.03.058
   Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191
   Pennington Jeffrey, 2014, P 2014 C EMP METH NA, P1532, DOI DOI 10.3115/V1/D14-1162
   Peters Matthew, 2018, ARXIV180205365, DOI [DOI 10.18653/V1/N18-1202, 10.18653/v1/N18-1202]
   SALTON G, 1988, INFORM PROCESS MANAG, V24, P513, DOI 10.1016/0306-4573(88)90021-0
   Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002
   Vaswani A., 2017, 31 C NEURAL INFORM P, P5998
   Wang BX, 2018, PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL), VOL 1, P2311
   Wang S., 2012, P 50 ANN M ASS COMP
   Wang X., 2022, SECUR COMMUN NETW, V2022, DOI [10.1155/2022/4260804, DOI 10.1155/2022/4260804]
   Wang X, 2020, IEEE ACCESS, V8, P119527, DOI 10.1109/ACCESS.2020.3004995
   Xiao Yijun, 2016, ARXIV PREPRINT ARXIV
   Yao L, 2016, IEEE INT C BIOINFORM, P1926, DOI 10.1109/BIBM.2016.7822817
   Yousaf A, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su132212693
   Yu Y, 2019, NEURAL COMPUT, V31, P1235, DOI 10.1162/neco_a_01199
   Zhang D., P 26 ANN INT ACM SIG, P26, DOI [DOI 10.1145/860435.860443, 10.1145/860435.860443]
   Zheng SM, 2019, LECT NOTES COMPUT SC, V11936, P442, DOI 10.1007/978-3-030-36204-1_37
   Zu ZY, 2020, RADIOLOGY, V296, pE15, DOI 10.1148/radiol.2020200490
NR 38
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3417
J9 APPL SCI-BASEL
JI Appl. Sci.-Basel
PD MAR
PY 2022
VL 12
IS 6
AR 2891
DI 10.3390/app12062891
PG 19
WC Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials
   Science, Multidisciplinary; Physics, Applied
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Chemistry; Engineering; Materials Science; Physics
GA 0D5MK
UT WOS:000776039200001
OA gold
DA 2022-04-20
ER

PT J
AU Cartas, US
   Paca, MJG
   Herrera, KL
   Cajo, IMH
AF Solis Cartas, Urbano
   Guallo Paca, Mariana Jesus
   Lemus Herrera, Ketty
   Hidalgo Cajo, Ivan Mesias
TI Educational transformations in Higher Education secondary to COVID-19;
   teacher's role
SO REVISTA CUBANA DE REUMATOLOGIA
LA Spanish
DT Article
DE COVID-19; Teacher; Higher education; Virtual environments
AB Introduction: The COVID-19 pandemic generated transformations in the educational sphere; especially in higher education. The virtual class system was established for which university teachers had to go through an intensive process that allowed them to face the challenge of virtual education and continue with the teaching-learning process in Ecuador.
   Objective: to determine the opinion of university students and teachers in relation to the importance of teacher preparation as a basis for educational transformations in Higher Education.
   Methodology: a basic, descriptive research was carried out, which included 108 university professors and 487 university students belonging to the medicine and nutrition careers of the Faculty of Public Health of the Polytechnic School of Chimborazo.
   Results: The main results include that 80.56% of the teachers had not received previous training and 73.15% had no previous experience in the use of virtual environments. 84.27% of students believe that teacher preparation influences the quality of virtual teaching activities and 57.02% considered that there is a need to improve mastery of virtual environments.
   Conclusions: The preparation of teachers in the management of virtual environments constitutes a fundamental element to achieve the success of virtual education; it's considered necessary to maintain a training program that allows consolidating knowledge and acquiring new skills and abilities in pursuit of quality online education.
C1 [Solis Cartas, Urbano] Univ Nacl Chimborazo, Escuela Super Politecn Chimborazo, Chimborazo, Ecuador.
   [Guallo Paca, Mariana Jesus; Hidalgo Cajo, Ivan Mesias] Escuela Super Politecn Chimborazo, Riobamba, Chimborazo, Ecuador.
   [Lemus Herrera, Ketty] Univ Ciencias Med La Habana, Med Gen Integral & Psiquiatria, Fac Ciencias Med Dr Enrique Cabrera, Hosp Gen Docente Enrique Cabrera, Havana, Cuba.
RP Cartas, US (corresponding author), Univ Nacl Chimborazo, Escuela Super Politecn Chimborazo, Chimborazo, Ecuador.
EM umsmwork74@gmail.com
CR Castellano Gil JM, 2020, CONRADO, V16, P325
   Chia Proenza D, 2020, REV CUBANA REUMATOLO, V22, pE830
   De la Rosa E. V., 2020, EDUC MED SUPER, V34, P1
   Diaz Quinones JA, MEDISUR, V18, P496
   Fontana-Hernandez A, 2020, REV ELECT EDUCARE, V24, P44, DOI [10.15359/ree.24-s.12, DOI 10.15359/REE.24-S.12]
   Gomez Conde SY, 2020, REV CUBANA REUMATOLO, V22, pE831
   Herrera-Añazco Percy, 2020, Acta méd. Peru, V37, P169, DOI 10.35663/amp.2020.372.999
   Leon MI, 2020, MEDISUR-REV CIENC ME, V18, P404
   Lagos Reinoso GG, 2020, INNOVA RES J, V5, P19, DOI [10.33890/innova.v5.n3.2.2020.1600, DOI 10.33890/INNOVA.V5.N3.2.2020.1600]
   Lanchares JPT, 2020, ODOVTOS INT J DENT S, V22, P16, DOI 10.15517/IJDS.2020.42166
   Lizaraso Caparo F, 2020, HORIZONTE MED LIMA, V20, P1205, DOI [10.24265/horizmed.2020.v20n2.01, DOI 10.24265/HORIZMED.2020.V20N2.01]
   Ordorika Imanol, 2020, Rev. educ. sup, V49, P1, DOI 10.36857/resu.2020.194.1120
   Ramos Robledo A, 2020, REV CUB INVESTIG BIO, V39, P849
   Renzo Aquino-Canchari C, 2020, REV CUBANA INVESTIGA, V39, pE758
   San Juan Bosch MA, 2020, MEDISUR, V18, P410
   Solis Cartas U, 2020, REV INVESTIGACION TA, V7, P74, DOI [10.33789/talentos.7.2.137, DOI 10.33789/TALENTOS.7.2.137]
   Solis Cartas U, REV CUB MED MILITAR, V49, pE783
   Solis Cartas U., 2020, REV CUBA REUMATOL, V22, P791
NR 18
TC 0
Z9 0
U1 2
U2 2
PU SOC CUBANA REUMATOLOGIA
PI HABANA
PA CALLE 216 ENTRE 13 & 15, SIBONEY PLAYA, HABANA, 00000, CUBA
SN 1606-5581
EI 1817-5996
J9 REV CUBA REUMATOL
JI Rev. Cuba. Reumatol.
PD JAN-APR
PY 2021
VL 23
IS 1
SU 1
AR e213
PG 12
WC Rheumatology
WE Emerging Sources Citation Index (ESCI)
SC Rheumatology
GA WU4NN
UT WOS:000716523600003
DA 2022-04-20
ER

PT J
AU Shi, W
   Yuan, GF
   Hall, BJ
   Liu, XL
   Su, Y
   Zhao, L
   Jia, P
AF Shi, Wei
   Yuan, Guangzhe Frank
   Hall, Brian J.
   Liu, Xiaoli
   Su, Ya
   Zhao, Li
   Jia, Peng
TI Mental Disorders and Emotional Competence Among Chinese Adolescents
   Before and During COVID-19 Pandemic: A Longitudinal Mediation Model
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE anxiety; depression; emotional competence; longitudinal mediation model;
   COVID-19 exposure
ID YOUTH DEVELOPMENT SCALE; POSTTRAUMATIC STRESS; ANXIETY SENSITIVITY;
   LIFETIME PREVALENCE; HEALTH; SYMPTOMS; DYSREGULATION; INTELLIGENCE;
   RESILIENCE; DEPRESSION
AB Background: The outbreak of the COVID-19 pandemic has had a profound influence on the mental health and well-being of individuals across the globe. Emotional competence, defined as one's ability to recognize, understand, and manage their emotions, has been found linked with mental health problems (e.g., depression and anxiety) in previous studies. However, there is limited knowledge about the direction of the association between these factors among populations exposed to COVID-19. This study examined the possible mediation relationships between depression, anxiety, emotional competence, and COVID-19 exposure among Chinese adolescents.Methods: Responses from 7,958 Chinese adolescents who had previously taken part in a two-wave study before (December 23, 2019-January 13, 2020) and during COVID-19 (June 16, 2020-July 8, 2020) were analyzed (51.67% males, mean age = 11.74, SD = 2.15). Structural equation modeling with three covariates (i.e., age, gender, and ethnicity) was used to test the longitudinal mediation relationships between COVID-19 exposure and depression, anxiety via emotional competence.Results: Results indicated that the prevalence of depression (38.67 to 36.74%) and anxiety (13.02 to 12.77%) decreased from Time 1 to Time 2. The T2 emotional competence significantly mediated the relationship between T2 COVID-19 exposure and T2 anxiety (indirect effect [95% CI] = 0.011 [0.004-0.019], p < 0.05). T2 emotional competence also significantly mediated the relationship between T2 COVID-19 exposure and T2 depression (indirect effect [95% CI] = 0.013 [0.005-0.022], p < 0.05). The results indicated that T2 emotional competence had a significant and negative influence on T2 anxiety (beta = -0.266, SE = 0.005, p < 0.001), and T2 depression (beta = -0.326, SE = 0.029, p < 0.001).Conclusions: This longitudinal research study demonstrated the crucial role of emotional competence in influencing the severity of long-term mental health problems, and suggested that emotional competence interventions can be conducted to improve mental well-being among Chinese adolescents exposed to COVID-19.
C1 [Shi, Wei; Jia, Peng] Sichuan Univ, Inst Disaster Management & Reconstruct IDMR, Chengdu, Peoples R China.
   [Yuan, Guangzhe Frank] Univ Macau, Fac Social Sci, Dept Psychol, Macau, Peoples R China.
   [Hall, Brian J.] New York Univ, Global & Community Mental Hlth Res Grp, Shanghai, Peoples R China.
   [Hall, Brian J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA.
   [Liu, Xiaoli] Sichuan Univ, Off Humanities & Social Sci Adm, Chengdu, Peoples R China.
   [Su, Ya] Dickinson Coll, Dept Sociol, Carlisle, PA 17013 USA.
   [Zhao, Li] Sichuan Univ, West China Sch Publ Hlth, Dept Hlth Policy & Management, Chengdu, Peoples R China.
   [Zhao, Li] Sichuan Univ, West China Hosp 4, Chengdu, Peoples R China.
   [Zhao, Li] Sichuan Univ, China PUMC CC Chen Inst Hlth, Hlth Emergency Management Res Ctr, Chengdu, Peoples R China.
   [Jia, Peng] Wuhan Univ, Sch Resources & Environm Sci, Wuhan, Peoples R China.
   [Jia, Peng] Wuhan Univ, Int Inst Spatial Lifecourse Epidemiol ISLE, Wuhan, Peoples R China.
RP Jia, P (corresponding author), Sichuan Univ, Inst Disaster Management & Reconstruct IDMR, Chengdu, Peoples R China.; Zhao, L (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Hlth Policy & Management, Chengdu, Peoples R China.; Zhao, L (corresponding author), Sichuan Univ, West China Hosp 4, Chengdu, Peoples R China.; Zhao, L (corresponding author), Sichuan Univ, China PUMC CC Chen Inst Hlth, Hlth Emergency Management Res Ctr, Chengdu, Peoples R China.; Jia, P (corresponding author), Wuhan Univ, Sch Resources & Environm Sci, Wuhan, Peoples R China.; Jia, P (corresponding author), Wuhan Univ, Int Inst Spatial Lifecourse Epidemiol ISLE, Wuhan, Peoples R China.
EM zhaoli@scu.edu.cn; jiapengff@hotmail.com
CR Abdi R, 2019, PERS INDIV DIFFER, V142, P282, DOI 10.1016/j.paid.2018.09.026
   Arbuckle JL., 2014, AMOS VERSION 230 CO
   Barlow DH, 2000, AM PSYCHOL, V55, P1247, DOI 10.1037/0003-066X.55.11.1247
   Barrett P, 2001, BRIT J CLIN PSYCHOL, V40, P399, DOI 10.1348/014466501163887
   Beaupre MG, 2005, J CROSS CULT PSYCHOL, V36, P355, DOI 10.1177/0022022104273656
   Boyd CP, 2000, J GENET PSYCHOL, V161, P479, DOI 10.1080/00221320009596726
   Chen GM, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.622762
   Cheng P, 2020, COMMUNITY MENT HLT J, V56, P786, DOI 10.1007/s10597-020-00624-5
   Ciarrochi J, 2006, BRIT J GUID COUNS, V34, P231, DOI 10.1080/03069880600583287
   Ciarrochi J, 2003, PERS INDIV DIFFER, V35, P1947, DOI 10.1016/S0191-8869(03)00043-6
   Ciarrochi JV, 2001, BRIT J GUID COUNS, V29, P233, DOI 10.1080/03069880020047157
   Cindrich SL, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.619129
   Corp. I. IBM SPSS, 2017, STAT WIND
   Davidson RJ., 2009, HDB DEPRESSION, V2, P218
   Ellis A., 1991, J RATION-EMOT COGN-B, V9, P139, DOI [10.1007/BF01061227, DOI 10.1007/BF01061227]
   Elmer T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236337
   Frias CE, 2020, J PSYCHOSOC NURS MEN, V58, P5, DOI 10.3928/02793695-20200506-02
   Hall BJ, 2019, EUR J PSYCHOTRAUMATO, V10, DOI 10.1080/20008198.2018.1558709
   Hofmann SG, 2012, DEPRESS ANXIETY, V29, P409, DOI 10.1002/da.21888
   Hou KT, 2002, STRUCTURAL EQUATION
   Howell A., 2020, ETHNICITY INEQUALITY, V1
   Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424
   Jia P, 2021, OBES REV, V22, DOI 10.1111/obr.13162
   Jiang LJ, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00315
   Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168
   Kumschick IR, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01448
   Lazaratou H, 2010, COMMUNITY MENT HLT J, V46, P289, DOI 10.1007/s10597-010-9296-2
   Li HCW, 2010, J ADV NURS, V66, P2582, DOI 10.1111/j.1365-2648.2010.05440.x
   Li JY, 2020, CHILD ADOL PSYCH MEN, V14, DOI 10.1186/s13034-020-00318-6
   Li WW, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.600739
   Luo MY, 2021, INT J HEALTH POLICY, DOI 10.34172/ijhpm.2021.17
   Luo W, 2021, EPIDEMIOL PSYCH SCI, V30, DOI 10.1017/S2045796021000202
   Martins A, 2010, PERS INDIV DIFFER, V49, P554, DOI 10.1016/j.paid.2010.05.029
   Mathews BL, 2016, CLIN CHILD FAM PSYCH, V19, P162, DOI 10.1007/s10567-016-0204-3
   Meda N, 2021, J PSYCHIATR RES, V134, P69, DOI 10.1016/j.jpsychires.2020.12.045
   Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017
   Mikolajczak M, 2015, EMOTION, V15, P653, DOI 10.1037/emo0000034
   Nelis D, 2011, EMOTION, V11, P354, DOI 10.1037/a0021554
   Newman JC, 2002, AM J PUBLIC HEALTH, V92, P294, DOI 10.2105/AJPH.92.2.294
   Nielsen L, 2015, HEALTH EDUC, V115, P339, DOI 10.1108/HE-03-2014-0039
   Nolen-Hoeksema S, 2011, PERSPECT PSYCHOL SCI, V6, P589, DOI 10.1177/1745691611419672
   Paulus DJ, 2018, COMPR PSYCHIAT, V84, P54, DOI 10.1016/j.comppsych.2018.03.012
   Penner F, 2021, J AM ACAD CHILD PSY, V60, P513, DOI 10.1016/j.jaac.2020.12.027
   Pierce M, 2020, LANCET PSYCHIAT, V7, P883, DOI 10.1016/S2215-0366(20)30308-4
   Qi M, 2020, J ADOLESCENT HEALTH, V67, P514, DOI 10.1016/j.jadohealth.2020.07.001
   Schutte NS, 2007, PERS INDIV DIFFER, V42, P921, DOI 10.1016/j.paid.2006.09.003
   Schutte NS, 2002, COGNITION EMOTION, V16, P769, DOI 10.1080/02699930143000482
   Bitton MS, 2021, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.568016
   Shek DTL, 2007, RES SOCIAL WORK PRAC, V17, P380, DOI 10.1177/1049731506296196
   Shek DTL, 2010, SOC INDIC RES, V98, P41, DOI 10.1007/s11205-009-9515-9
   Shi W, 2020, EUR J PSYCHOTRAUMATO, V11, DOI 10.1080/20008198.2020.1761621
   Shi W, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00442
   Shi W, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102065
   Su LY, 2008, J ANXIETY DISORD, V22, P612, DOI 10.1016/j.janxdis.2007.05.011
   Teo T, 2020, PATIENT EDUC COUNS, V103, P1615, DOI 10.1016/j.pec.2020.02.035
   Torous J, 2020, JMIR MENT HEALTH, V7, DOI 10.2196/18848
   Tull MT, 2006, COGNITIVE THER RES, V30, P177, DOI 10.1007/s10608-006-9036-7
   van Zyl LE, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.633533
   [王凯 Wang Kai], 2002, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V10, P270
   Wang SM, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030340
   Watson H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210587
   Weston R, 2006, COUNS PSYCHOL, V34, P719, DOI 10.1177/0011000006286345
   World Health Organization, 2020, ADOLESCENT MENTAL HL
   Xu J, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.723648
   Yildirim M, 2022, DEATH STUD, V46, P979, DOI 10.1080/07481187.2020.1793434
   Yin TX, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-05915-0
   Yu B, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.697068
   Yu H, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02826-3
   Yu L, 2021, APPL RES QUAL LIFE, V16, P2419, DOI 10.1007/s11482-021-09912-y
   Yuan GZ, 2021, J HEALTH PSYCHOL, V26, P1872, DOI 10.1177/1359105319890395
   Yuan GZ, 2018, J NERV MENT DIS, V206, P130, DOI 10.1097/NMD.0000000000000778
   Zhang Ning, 2022, Annu Rev Psychol, V73, P575, DOI 10.1146/annurev-psych-030221-031857
   Zhang YY, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.697642
   Zhao Li, 2021, Int J Epidemiol, DOI 10.1093/ije/dyab237
NR 74
TC 0
Z9 0
U1 8
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD DEC 10
PY 2021
VL 9
AR 767004
DI 10.3389/fpubh.2021.767004
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA YH3AU
UT WOS:000743043400001
PM 34957019
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Muhammad, K
   Ullah, H
   Khan, ZA
   Saudagar, AKJ
   AlTameem, A
   AlKhathami, M
   Khan, MB
   Abul Hasanat, MH
   Malik, KM
   Hijji, M
   Sajjad, M
AF Muhammad, Khan
   Ullah, Hayat
   Khan, Zulfiqar Ahmad
   Saudagar, Abdul Khader Jilani
   AlTameem, Abdullah
   AlKhathami, Mohammed
   Khan, Muhammad Badruddin
   Abul Hasanat, Mozaherul Hoque
   Mahmood Malik, Khalid
   Hijji, Mohammad
   Sajjad, Muhammad
TI WEENet: An Intelligent System for Diagnosing COVID-19 and Lung Cancer in
   IoMT Environments
SO FRONTIERS IN ONCOLOGY
LA English
DT Article
DE medical imaging; COVID-19 diagnosis; machine learning; Internet of
   Medical Things; deep learning; x-ray imaging; cancer categorization
ID CLASSIFICATION; FRAMEWORK
AB The coronavirus disease 2019 (COVID-19) pandemic has caused a major outbreak around the world with severe impact on health, human lives, and economy globally. One of the crucial steps in fighting COVID-19 is the ability to detect infected patients at early stages and put them under special care. Detecting COVID-19 from radiography images using computational medical imaging method is one of the fastest ways to diagnose the patients. However, early detection with significant results is a major challenge, given the limited available medical imaging data and conflicting performance metrics. Therefore, this work aims to develop a novel deep learning-based computationally efficient medical imaging framework for effective modeling and early diagnosis of COVID-19 from chest x-ray and computed tomography images. The proposed work presents "WEENet" by exploiting efficient convolutional neural network to extract high-level features, followed by classification mechanisms for COVID-19 diagnosis in medical image data. The performance of our method is evaluated on three benchmark medical chest x-ray and computed tomography image datasets using eight evaluation metrics including a novel strategy of cross-corpse evaluation as well as robustness evaluation, and the results are surpassing state-of-the-art methods. The outcome of this work can assist the epidemiologists and healthcare authorities in analyzing the infected medical chest x-ray and computed tomography images, management of the COVID-19 pandemic, bridging the early diagnosis, and treatment gap for Internet of Medical Things environments.
C1 [Muhammad, Khan] Sungkyunkwan Univ, Visual Analyt Knowledge Lab VIS2KNOW Lab, Sch Convergence, Coll Comp & Informat, Seoul, South Korea.
   [Ullah, Hayat; Khan, Zulfiqar Ahmad] Sejong Univ, Dept Software, Seoul, South Korea.
   [Saudagar, Abdul Khader Jilani; AlTameem, Abdullah; AlKhathami, Mohammed; Khan, Muhammad Badruddin; Abul Hasanat, Mozaherul Hoque] Imam Mohammad Ibn Saud Islamic Univ IMSIU, Dept Informat Syst, Coll Comp & Informat Sci, Riyadh, Saudi Arabia.
   [Mahmood Malik, Khalid] Oakland Univ, Dept Comp Sci & Engn, Rochester, MI 48309 USA.
   [Hijji, Mohammad] Univ Tabuk, Fac Comp & Informat Technol, Dept Comp Sci, Tabuk, Saudi Arabia.
   [Sajjad, Muhammad] Islamia Coll Peshawar, Digital Image Proc Lab, Peshawar, Pakistan.
   [Sajjad, Muhammad] Norwegian Univ Sci & Technol NTNU, Color & Visual Comp Lab, Dept Comp Sci, Gjovik, Norway.
RP Muhammad, K (corresponding author), Sungkyunkwan Univ, Visual Analyt Knowledge Lab VIS2KNOW Lab, Sch Convergence, Coll Comp & Informat, Seoul, South Korea.; Saudagar, AKJ (corresponding author), Imam Mohammad Ibn Saud Islamic Univ IMSIU, Dept Informat Syst, Coll Comp & Informat Sci, Riyadh, Saudi Arabia.
EM khan.muhammad@ieee.org; aksaudagar@imamu.edu.sa
RI Muhammad, Khan/L-9059-2016
OI Muhammad, Khan/0000-0003-4055-7412
FU Deputyship for Research & Innovation, Ministry of Education in Saudi
   Arabia [959]
FX & nbsp;This work was supported by the Deputyship for Research &
   Innovation, Ministry of Education in Saudi Arabia for funding this
   research work through the project number 959.
CR Bellavista P, 2021, FRONT SUSTAIN CITIES, V3, DOI 10.3389/frsc.2021.638743
   Bogoch II, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa008
   Castiglione A, 2021, IEEE T IND INFORM, V17, P6480, DOI 10.1109/TII.2021.3057524
   D. A. R. I. i. D. S. a. C. Intelligence, COVIDGR
   Dourado CMJM, 2021, IEEE J SEL AREA COMM, V39, P541, DOI 10.1109/JSAC.2020.3020598
   Du M, 2018, IEEE COMMUN MAG, V56, P62, DOI 10.1109/MCOM.2018.1701148
   Feki I, 2021, APPL SOFT COMPUT, V106, DOI 10.1016/j.asoc.2021.107330
   He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90
   Heidarian S, 2021, FRONT ARTIF INTELL, V4, DOI 10.3389/frai.2021.598932
   Howard A. G., 2017, MOBILENETS EFFICIENT
   Hu SP, 2020, IEEE ACCESS, V8, P118869, DOI 10.1109/ACCESS.2020.3005510
   Huang C, 2020, Lancet, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Iandola F. N., 2016, P 5 INT C LEARN REPR, DOI DOI 10.1007/978-3-319-24553-9
   Ibrahim DM, 2021, COMPUT BIOL MED, V132, DOI 10.1016/j.compbiomed.2021.104348
   Ismael AM, 2021, EXPERT SYST APPL, V164, DOI 10.1016/j.eswa.2020.114054
   Jain R, 2021, APPL INTELL, V51, P1690, DOI 10.1007/s10489-020-01902-1
   KRAMER MA, 1991, AICHE J, V37, P233, DOI 10.1002/aic.690370209
   Liang XL, 2021, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.612962
   Lu HD, 2020, IEEE INTERNET THINGS, V7, P9255, DOI 10.1109/JIOT.2020.2981557
   Minaee S, 2020, MED IMAGE ANAL, V65, DOI 10.1016/j.media.2020.101794
   Mohammad-Rahimi H, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.638011
   Narin A, 2021, PATTERN ANAL APPL, V24, P1207, DOI 10.1007/s10044-021-00984-y
   Oh Y, 2020, IEEE T MED IMAGING, V39, P2688, DOI 10.1109/TMI.2020.2993291
   Parah SA, 2021, IEEE INTERNET THINGS, V8, P15652, DOI 10.1109/JIOT.2020.3038009
   Qinghao Ye, 2021, 2021 IEEE 34th International Symposium on Computer-Based Medical Systems (CBMS), P521, DOI 10.1109/CBMS52027.2021.00103
   Quarato CMI, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.707602
   Rachakonda L, 2021, IEEE T CONSUM ELECTR, V67, P20, DOI 10.1109/TCE.2020.3043683
   Rahman T, 2021, COMPUT BIOL MED, V132, DOI 10.1016/j.compbiomed.2021.104319
   Salem O, 2022, IEEE T IND INFORM, V18, P2053, DOI 10.1109/TII.2021.3089462
   Shamsi A, 2021, IEEE T NEUR NET LEAR, V32, P1408, DOI 10.1109/TNNLS.2021.3054306
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Shrey SB, 2020, COMM COM INF SC, V1212, P262, DOI 10.1007/978-981-15-4818-5_20
   Simonyan K., 2014, ARXIV14091556
   Song FX, 2020, RADIOLOGY, V295, P210, DOI [10.1148/radiol.2020200274, 10.1148/radiol.2020209021]
   Sun Y, 2022, IEEE T IND INFORM, V18, P1981, DOI 10.1109/TII.2021.3070544
   Tan MX, 2019, PROC CVPR IEEE, P2815, DOI 10.1109/CVPR.2019.00293
   Tan MX, 2019, PR MACH LEARN RES, V97
   Tang SJ, 2021, IEEE T IND INFORM, V17, P6539, DOI 10.1109/TII.2021.3057683
   Wang HY, 2018, SPE J, V23, P1648, DOI 10.2118/189844-PA
   Wang L, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.704256
   WHO, 2020, NOV COR 2019 NCOV SI
   Wu YH, 2021, IEEE T IMAGE PROCESS, V30, P3113, DOI 10.1109/TIP.2021.3058783
   Xie XZ, 2020, RADIOLOGY, V296, pE41, DOI 10.1148/radiol.2020200343
   Xu CH, 2020, IEEE T NETW SCI ENG, V7, P104, DOI 10.1109/TNSE.2018.2843326
   Yoo SH, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00427
   Zhang WS, 2021, IEEE INTERNET THINGS, V8, P5926, DOI 10.1109/JIOT.2020.3032544
   Zhang WS, 2021, IEEE INTERNET THINGS, V8, P15884, DOI 10.1109/JIOT.2021.3056185
   Zoph B, 2018, PROC CVPR IEEE, P8697, DOI 10.1109/CVPR.2018.00907
NR 48
TC 0
Z9 0
U1 5
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2234-943X
J9 FRONT ONCOL
JI Front. Oncol.
PD FEB 2
PY 2022
VL 11
AR 811355
DI 10.3389/fonc.2021.811355
PG 13
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA ZF4SZ
UT WOS:000759560900001
PM 35186717
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Yusefi, AR
   Daneshi, S
   Davarani, ER
   Nikmanesh, P
   Mehralian, G
   Bastani, P
AF Yusefi, Ali Reza
   Daneshi, Salman
   Davarani, Esmat Rezabeigi
   Nikmanesh, Parnian
   Mehralian, Gholamhossein
   Bastani, Peivand
TI Resilience level and its relationship with hypochondriasis in nurses
   working in COVID-19 reference hospitals
SO BMC NURSING
LA English
DT Article
DE Resilience; Hypochondriasis; Nurses; Crisis; Coronavirus; COVID-19; Iran
AB Introduction A new coronavirus, called COVID-19, is an acute respiratory disease, which may arouse many psychological disorders since there is no specialized knowledge about it. The present study aimed to investigate the level of resilience and its relationship with hypochondriasis in nurses working in a COVID-19 reference hospital in south of Iran. Methods This cross-sectional study was conducted in 2020, in which 312 nurses participated using the census method. Data collection tools were the Conker-Davidson standard resilience scale (CD-RISC) and the Evans Hypoglycaemia Awareness Questionnaire. Data were analyzed using t-test, ANOVA, Pearson correlation coefficient, and multiple linear regression using SPSS software version 23. Results The mean scores of resilience and hypochondriasis were 72.38 +/- 7.11 and 49.75 +/- 8.13, respectively, indicating the moderate level of these two variables among nurses. Hypochondriasis in 18.91, 61.22, and 1.28% of the nurses was mild, moderate, and severe, respectively. There was a significant negative correlation between resilience and hypochondriasis (r = - 0.214 and P < 0.001). In this regard, control (P < 0.001), positive acceptance of change (P < 0.001), spiritual effects (P = 0.001), trust in individual instincts (P = 0.001), and perception of competence (P = 0.002) were detected as the predictors of nurses' hypochondriasis. Conclusion The nurses had moderate levels of resilience and hypochondriasis. Promoting knowledge about COVID-19and increasing information on how to protect oneself and others against the disease along with supportive packages from their managers are thus recommended.
C1 [Yusefi, Ali Reza] Jiroft Univ Med Sci, Sch Hlth, Dept Publ Hlth, Healthcare Serv Management, Jiroft, Iran.
   [Daneshi, Salman] Jiroft Univ Med Sci, Dept Publ Hlth, Jiroft, Iran.
   [Davarani, Esmat Rezabeigi] Kerman Univ Med Sci, Inst Future Studies Hlth, Hlth Disasters & Emergencies Res Ctr, Kerman, Iran.
   [Nikmanesh, Parnian] Iran Univ Med Sci, Sch Management & Informat Sci, Healthcare Serv Management, Tehran, Iran.
   [Mehralian, Gholamhossein] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmacoecon & Pharm Adm, Tehran, Iran.
   [Bastani, Peivand] Shiraz Univ Med Sci, Sch Hlth Management & Informat Sci, Hlth Human Resources Res Ctr, Shiraz, Iran.
RP Mehralian, G (corresponding author), Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmacoecon & Pharm Adm, Tehran, Iran.
EM gmehralian@gmail.com
RI yusefi, alireza/AAG-4415-2021; Bastani, Peivand/AAE-1769-2022
OI Bastani, Peivand/0000-0002-0412-0267
FU Shiraz University of Medical Sciences [20180]
FX This research project was approved by the Shiraz University of Medical
   Sciences (No. 20180). The researchers would like to thank the study
   participants for their sincere cooperation with the researchers in
   completing the questionnaires.
CR Abolhassani M., 2016, BEYHAGH, V21, P42
   Afshari D, 2021, WORK, V68, P297, DOI 10.3233/WOR-203376
   Akhavan M., 2019, SHENAKHT J PSYCHOL P, V6, P83, DOI [10.29252/shenakht.6.3.83, DOI 10.29252/SHENAKHT.6.3.83]
   Ang SY, 2018, INT NURS REV, V65, P459, DOI 10.1111/inr.12441
   Ansari Shahidi M., 2018, YAFTEH, V20, P48
   Arasteh M., 2008, Scientific Journal of Kurdistan University of Medical Sciences, V13, pPe35
   Aten J.D., 2020, J PSYCHOL CHRISTIANI, V39, P288
   BARSKY AJ, 1990, SOC PSYCH PSYCH EPID, V25, P89
   Bazazan A, 2019, ACCIDENT ANAL PREV, V126, P31, DOI 10.1016/j.aap.2018.01.042
   Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20
   Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113
   Cooper AL, 2021, J ADV NURS, V77, P2623, DOI 10.1111/jan.14763
   Crowe S, 2021, INTENS CRIT CARE NUR, V63, DOI 10.1016/j.iccn.2020.102999
   Di Giuseppe M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18105258
   Fathi Ashtiani A., 2020, J MARINE MED, V2, P1
   Geraminejad N., 2018, J HEALTHC MANAG, V9, P65
   Ghasemnejad SM., 2011, MED SCI J ISLAMIC AZ, V21, P222
   Jose S, 2020, INDIAN J CRIT CARE M, V24, P1081, DOI 10.5005/jp-journals-10071-23667
   Keyhani M, 2015, IRAN J MED ED, V14, P857
   Khani H., 2016, IRAN J MIL CARING SC, V3, P34, DOI [10.18869/acadpub.mcs.3.1.34, DOI 10.18869/ACADPUB.MCS.3.1.34]
   Khoshnazary S., 2016, IRANIAN J PSYCHIAT N, V3, P28
   Kim SC, 2021, NURS OPEN, V8, P900, DOI 10.1002/nop2.697
   Lee KJ, 2015, AM J CRIT CARE, V24, P422, DOI 10.4037/ajcc2015720
   Lei L, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924609
   Liberati E, 2021, BMC PSYCHIATRY, V21, DOI 10.1186/s12888-021-03261-8
   Looper KJ, 2001, PSYCHOL MED, V31, P577, DOI 10.1017/S0033291701003737
   Luceno-Moreno L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155514
   McAllister M, 2009, NURS EDUC TODAY, V29, P371, DOI 10.1016/j.nedt.2008.10.011
   Mousavi S., 2019, Q J NURS MANAGE, V8, P52
   Mousavi SM., 2020, J OCCUP HYG ENG, V7, P31
   Mozaffari MS, 2011, JPMM, V2, P165
   Nasri S., 2004, J IRAN PSYCHIAT CLIN, V4, P25
   Ou XL, 2021, PSYCHOL HEALTH MED, V26, P98, DOI 10.1080/13548506.2020.1861312
   Pasah G., 2005, KNOWLEDGE RES APPL P, V25, P1
   Pearman A, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.02065
   Rezabeigi-Davarani E., 2021, J ADV MED BIOMED RES, V29, P302, DOI [10.30699/jambs.29.136.302, DOI 10.30699/JAMBS.29.136.302]
   Roberts NJ, 2021, RESP MED, V176, DOI 10.1016/j.rmed.2020.106219
   Shojafard J., 2014, J RESCUE RELIEF, V2, P1
   Stutz WE, 2018, METHODS ECOL EVOL, V9, P1109, DOI 10.1111/2041-210X.12938
   Sull A, 2015, J OCCUP MED TOXICOL, V10, DOI 10.1186/s12995-015-0061-x
   Talaei A., 2009, J ILAM U MED SCI, V17, P8
   Waller MA, 2001, AM J ORTHOPSYCHIAT, V71, P290, DOI 10.1037/0002-9432.71.3.290
   Warelow P, 2007, INT J MENT HEALTH NU, V16, P132, DOI 10.1111/j.1447-0349.2007.00456.x
   Yazdanirad S, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06808
   Yoruk S, 2021, PERSPECT PSYCHIATR C, V57, P390, DOI 10.1111/ppc.12659
   Zakeri H, 2010, PROCD SOC BEHV, V5, P1067, DOI 10.1016/j.sbspro.2010.07.236
   Zangrillo A, 2020, CRIT CARE RESUSC, V22, P91
   Zhu HB, 2020, GLOB HEALTH RES POL, V5, DOI 10.1186/s41256-020-00135-6
   Ziaaddini Z., 2019, Qom University of Medical Sciences Journal, V12, pPe80, DOI 10.29252/qums.12.12.79
NR 49
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1472-6955
J9 BMC NURS
JI BMC Nurs.
PD NOV 2
PY 2021
VL 20
IS 1
AR 219
DI 10.1186/s12912-021-00730-z
PG 9
WC Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing
GA WQ7ZB
UT WOS:000714029600001
PM 34727947
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Varghese, PM
   Tsolaki, AG
   Yasmin, H
   Shastri, A
   Ferluga, J
   Vatish, M
   Madan, T
   Kishore, U
AF Varghese, Praveen Mathews
   Tsolaki, Anthony G.
   Yasmin, Hadida
   Shastri, Abhishek
   Ferluga, Janez
   Vatish, Manu
   Madan, Taruna
   Kishore, Uday
TI Host-pathogen interaction in COVID-19: Pathogenesis, potential
   therapeutics and vaccination strategies
SO IMMUNOBIOLOGY
LA English
DT Review
DE COVID-19; SARS-CoV-2; Life-cycle; Pathophysiology; Co-morbidities;
   Pregnancy; Vaccine; Anti-virals
ID RESPIRATORY SYNDROME CORONAVIRUS; MOUSE HEPATITIS-VIRUS; SPIKE PROTEIN;
   MURINE CORONAVIRUS; DISEASE 2019; S PROTEIN; SARS-COV; COMPLEMENT
   ACTIVATION; CONVERTING ENZYME; CRYSTAL-STRUCTURE
AB The current coronavirus pandemic, COVID-19, is the third outbreak of disease caused by the coronavirus family, after Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome. It is an acute infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This severe disease is characterised by acute respiratory distress syndrome, septic shock, metabolic acidosis, coagulation dysfunction, and multiple organ dysfunction syndromes. Currently, no drugs or vaccines exist against the disease and the only course of treatment is symptom management involving mechanical ventilation, immune suppressants, and repurposed drugs. The severe form of the disease has a relatively high mortality rate. The last six months have seen an explosion of information related to the host receptors, virus transmission, virus structure-function relationships, pathophysiology, co-morbidities, immune response, treatment and the most promising vaccines. This review takes a critically comprehensive look at various aspects of the host-pathogen interaction in COVID-19. We examine the genomic aspects of SARS-CoV-2, modulation of innate and adaptive immunity, complement-triggered microangiopathy, and host transmission modalities. We also examine its pathophysiological impact during pregnancy, in addition to emphasizing various gaps in our knowledge. The lessons learnt from various clinical trials involving repurposed drugs have been summarised. We also highlight the rationale and likely success of the most promising vaccine candidates.
C1 [Varghese, Praveen Mathews; Tsolaki, Anthony G.; Ferluga, Janez; Kishore, Uday] Brunel Univ London, Coll Hlth & Life Sci, Biosci, London UB8 3PH, England.
   [Varghese, Praveen Mathews] Vellore Inst Technol, Sch Biosci & Technol, Vellore, Tamil Nadu, India.
   [Yasmin, Hadida] Cooch Behar Panchanan Barma Univ, Dept Zool, Immunol & Cell Biol Lab, Cooch Behar, W Bengal, India.
   [Shastri, Abhishek] Cent & North West London NHS Fdn Trust, London, England.
   [Vatish, Manu] John Radcliffe Oxford Univ Hosp, Womens Ctr, Dept Obstet & Gynaecol, Oxford OX3 9DU, England.
   [Madan, Taruna] ICMR Natl Inst Res Reprod Hlth, Dept Innate Immun, JM St, Mumbai, Maharashtra, India.
RP Kishore, U (corresponding author), Brunel Univ London, Coll Hlth & Life Sci, Biosci, London UB8 3PH, England.
EM Uday.Kishore@brunel.ac.uk
RI Varghese, Praveen Mathews/AAA-4916-2021; Yasmin, Hadida/AAQ-8649-2021
OI Varghese, Praveen Mathews/0000-0001-9502-378X; Yasmin,
   Hadida/0000-0001-7292-3937; Shastri, Abhishek/0000-0002-9220-5083;
   vatish, manu/0000-0002-6012-2574
CR Ahn JY, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e149
   Akbar AN, 2020, SCIENCE, V369, P256, DOI 10.1126/science.abb0762
   Al-Bari MAA, 2017, PHARMACOL RES PERSPE, V5, DOI 10.1002/prp2.293
   Alenina N, 2002, J HISTOCHEM CYTOCHEM, V50, P691, DOI 10.1177/002215540205000510
   [Anonymous], 2020, LANCET HAEMATOL, V7, pE353, DOI 10.1016/S2352-3026(20)30117-4
   [Anonymous], 2020, MIL MED RES, DOI DOI 10.1186/S40779-020-0233-9
   [Anonymous], 2019, VIRUSES BASEL, DOI DOI 10.3390/v11030280
   Arabi YM, 2016, EMERG INFECT DIS, V22, P1554, DOI 10.3201/eid2209.151164
   Assistance publique Hopitaux de Paris, 2020, TOC AM SIGN PRON PAT
   Aziz M, 2020, GASTROENTEROLOGY, V159, P1132, DOI 10.1053/j.gastro.2020.05.003
   Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Baergen RN, 2020, PEDIATR DEVEL PATHOL, V23, P177, DOI 10.1177/1093526620925569
   Balfour H., 2020, EUR PHARM REV
   Bandiera L, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.201663
   Bangash MN, 2020, LANCET GASTROENTEROL, V5, P529, DOI 10.1016/S2468-1253(20)30084-4
   Barnes BJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20200652
   Belhadjer Z, 2020, CIRCULATION, V142, P429, DOI 10.1161/CIRCULATIONAHA.120.048360
   Belot A, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.22.2001010
   Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106
   Berg M.K., 2020, MANDATED BACILLUS CA, DOI 10.1101/2020.04.05.20054163
   Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11
   Bian H., 2020, MEPLAZUMAB TREATS CO, DOI [10.1101/2020.03.21.20040691, DOI 10.1101/2020.03.21.20040691]
   Bittner Z., 2019, 864702 BIORXIV, DOI [10.1101/864702, DOI 10.1101/864702]
   Blitz MJ, 2020, AM J OBSTET GYNECOL, V223, P595, DOI 10.1016/j.ajog.2020.06.020
   Bottcher-Friebertshauser E, 2013, PATHOG DIS, V69, P87, DOI 10.1111/2049-632X.12053
   Bonam SR, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100016
   Bonomi L, 2020, J THORAC ONCOL, V15, pE83, DOI 10.1016/j.jtho.2020.03.021
   BOOM BW, 1989, J INVEST DERMATOL, V93, pS68, DOI 10.1111/1523-1747.ep12581073
   Borba MG, 2020, CHLOROQUINE DIPHOSPH, DOI [10.1101/2020.04.07.20056424, DOI 10.1101/2020.04.07.20056424]
   Boriskin YS, 2008, CURR MED CHEM, V15, P997, DOI 10.2174/092986708784049658
   Bos ECW, 1996, VIROLOGY, V218, P52, DOI 10.1006/viro.1996.0165
   Boscarino JA, 2008, J VIROL, V82, P2989, DOI 10.1128/JVI.01906-07
   Brainard J. S., 2020, FACEMASKS SIMILAR BA, DOI [10.1101/2020.04.01.20049528, DOI 10.1101/2020.04.01.20049528]
   Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9
   Breslin N, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100118
   Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006
   Byrne JC, 2013, J IMMUNOL, V190, P5207, DOI 10.4049/jimmunol.1300057
   Caly L, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104787
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Cao W, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa102
   Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3
   Cao YN, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0147-1
   Capes A, 2020, ANN HEMATOL, V99, P1679, DOI 10.1007/s00277-020-04137-9
   Carvelli J, 2020, NATURE, V588, P146, DOI 10.1038/s41586-020-2600-6
   Catanzaro M, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0191-1
   Cavalli G, 2020, LANCET RHEUMATOL, V2, pE325, DOI 10.1016/S2665-9913(20)30127-2
   CDC, 2020, YOU AR PREGN BREASTF
   Chaiworapongsa T, 2002, J Matern Fetal Neonatal Med, V11, P368, DOI 10.1080/713605566
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776
   Chang CK, 2006, J BIOMED SCI, V13, P59, DOI 10.1007/s11373-005-9035-9
   Chang JC, 2019, CLIN APPL THROMB-HEM, V25, DOI 10.1177/1076029619887437
   Chang JC, 2019, THROMB J, V17, DOI 10.1186/s12959-019-0198-4
   Chang JC, 2018, BLOOD COAGUL FIBRIN, V29, P573, DOI 10.1097/MBC.0000000000000765
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen Jun, 2020, Zhejiang Da Xue Xue Bao Yi Xue Ban, V49, P215, DOI 10.3785/j.issn.1008-9292.2020.03.03
   Chen L, 2020, BRIT J OPHTHALMOL, V104, P748, DOI 10.1136/bjophthalmol-2020-316304
   Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]
   Chen Y, 2020, HUMAN KIDNEY IS TARG, DOI [10.1101/2020.03.04.20031120, DOI 10.1101/2020.03.04.20031120]
   Chen Y, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00104
   Chinese Clinical Trial Registry, 2020, RAND DOUBL BLIND PLA
   Chong EA, 2020, CLIN CANCER RES, V26, P3514, DOI 10.1158/1078-0432.CCR-20-1427
   Choy KT, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104786
   Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9
   Chu H, 2020, CLIN INFECT DIS, V71, P1400, DOI 10.1093/cid/ciaa410
   Colavita F, 2020, ANN INTERN MED, V173, P242, DOI 10.7326/M20-1176
   Columbus Cristie, 2020, Proc (Bayl Univ Med Cent), V33, P209, DOI 10.1080/08998280.2020.1731272
   Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000
   Corbett Kizzmekia S, 2020, bioRxiv, DOI [10.1038/s41586-020-2622-0, 10.1101/2020.06.11.145920]
   Corse E, 2000, J VIROL, V74, P4319, DOI 10.1128/JVI.74.9.4319-4326.2000
   Cortegiani A, 2020, J CRIT CARE, V57, P279, DOI 10.1016/j.jcrc.2020.03.005
   Coutard B, 2020, ANTIVIR RES, V176, DOI 10.1016/j.antiviral.2020.104742
   Cugno M, 2020, J ALLERGY CLIN IMMUN, V146, P215, DOI 10.1016/j.jaci.2020.05.006
   D'Amico F, 2020, CLIN GASTROENTEROL H, V18, P1663, DOI 10.1016/j.cgh.2020.04.001
   da Silva JC, 2013, CLINICS, V68, P766, DOI 10.6061/clinics/2013(06)07
   Darlenski R., 2020, CLIN DERMATOL, DOI [10.1016/j.23579, DOI 10.1016/J.23579]
   Daruich A, 2020, J FR OPHTALMOL, V43, pE167, DOI 10.1016/j.jfo.2020.04.001
   Davidson J, 2001, PFLUG ARCH EUR J PHY, V442, P526
   de Bont CM, 2019, CELL MOL IMMUNOL, V16, P19, DOI 10.1038/s41423-018-0024-0
   de Haan CAM, 2005, ADV VIRUS RES, V64, P165, DOI 10.1016/S0065-3527(05)64006-7
   De Maeyer RPH, 2020, NAT IMMUNOL, V21, P615, DOI 10.1038/s41590-020-0646-0
   Decroly E, 2008, J VIROL, V82, P8071, DOI 10.1128/JVI.00407-08
   Deng W, 2020, SCIENCE, V369, P818, DOI 10.1126/science.abc5343
   Devaux CA, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105938
   Dias F., 2002, CRIT CARE, V6, pP2, DOI [10.1186/cc1662., DOI 10.1186/CC1662]
   Didangelos A, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00367-20
   Diurno F, 2020, EUR REV MED PHARMACO, V24, P4040, DOI 10.26355/eurrev_202004_20875
   Dockery DM, 2020, J EMERG MED, V59, P137, DOI 10.1016/j.jemermed.2020.04.060
   Dong LY, 2020, DRUG DISCOV THER, V14, P58, DOI 10.5582/ddt.2020.01012
   DRAPER D, 1995, AM J OBSTET GYNECOL, V173, P1506, DOI 10.1016/0002-9378(95)90640-1
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Drosten C, 2014, NEW ENGL J MED, V371, P828, DOI 10.1056/NEJMoa1405858
   Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090
   Du Z, 2020, J MED VIROL, V92, P1735, DOI 10.1002/jmv.25820
   Duan K, 2020, P NATL ACAD SCI USA, V117, P9490, DOI 10.1073/pnas.2004168117
   Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756
   Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777
   Epand RM, 2003, BBA-BIOMEMBRANES, V1614, P116, DOI 10.1016/S0005-2736(03)00169-X
   Escher R, 2020, THROMB RES, V190, P62, DOI 10.1016/j.thromres.2020.04.014
   Esper F, 2005, J INFECT DIS, V191, P499, DOI 10.1086/428291
   Fagone P, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102571
   Fahmy DH, 2020, J EUR ACAD DERMATOL, V34, P1388, DOI 10.1111/jdv.16545
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680
   Feng MY, 2015, P NATL ACAD SCI USA, V112, P2145, DOI 10.1073/pnas.1424907112
   Fischer F, 1998, J VIROL, V72, P7885, DOI 10.1128/JVI.72.10.7885-7894.1998
   Flint EJ, 2019, ACTA OBSTET GYN SCAN, V98, P700, DOI 10.1111/aogs.13540
   Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4
   Fox SE, 2020, LANCET RESP MED, V8, P681, DOI 10.1016/S2213-2600(20)30243-5
   Franceschi C, 2017, TRENDS ENDOCRIN MET, V28, P199, DOI 10.1016/j.tem.2016.09.005
   Fredericksen BL, 2002, J VIROL, V76, P11440, DOI 10.1128/JVI.76.22.11440-11446.2002
   Galeotti C, 2020, NAT REV RHEUMATOL, V16, P413, DOI 10.1038/s41584-020-0448-7
   Galeotti C, 2017, INT IMMUNOL, V29, P491, DOI 10.1093/intimm/dxx039
   Casas CG, 2020, BRIT J DERMATOL, V183, P71, DOI 10.1111/bjd.19163
   Gando S, 2020, THROMB RES, V191, P15, DOI 10.1016/j.thromres.2020.03.023
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Gao J, 2013, J VIROL, V87, P13134, DOI 10.1128/JVI.02433-13
   Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932
   Gardinassi LG, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01636
   Gattinoni L, 2020, AM J RESP CRIT CARE, V201, P1299, DOI 10.1164/rccm.202003-0817LE
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gautret P, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101663
   Gavriilaki E, 2020, BRIT J HAEMATOL, V189, pE227, DOI 10.1111/bjh.16783
   Ghinai I, 2020, LANCET, V395, P1137, DOI 10.1016/S0140-6736(20)30607-3
   Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10
   Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Gralinski LE, 2018, MBIO, V9, DOI 10.1128/mBio.01753-18
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Grove J, 2011, J CELL BIOL, V195, P1071, DOI 10.1083/jcb.201108131
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020
   Guaraldi G, 2020, LANCET RHEUMATOL, V2, pE474, DOI 10.1016/S2665-9913(20)30173-9
   Haga S, 2008, P NATL ACAD SCI USA, V105, P7809, DOI 10.1073/pnas.0711241105
   HAMMERSCHMIDT DE, 1980, LANCET, V1, P947
   He Y, 2020, J INFECTION, V80, pE18, DOI 10.1016/j.jinf.2020.02.031
   Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597
   Heurich A, 2014, J VIROL, V88, P1293, DOI 10.1128/JVI.02202-13
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Hopkins C, 2020, J OTOLARYNGOL-HEAD N, V49, DOI 10.1186/s40463-020-00423-8
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Hosier H, 2020, J CLIN INVEST, V130, P4947, DOI 10.1172/JCI139569
   Hou P, 2020, INCIDENCE CLIN CHARA, DOI [10.1101/2020.03.17.20037572, DOI 10.1101/2020.03.17.20037572, 10.1101/2020.03.17.20037572v 1]
   Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698
   Huang C., 2020, FAVIPIRAVIR VERSUS A, DOI [10.1101/2020.03.17.20037432, DOI 10.1101/2020.03.17.20037432]
   Huang C, 2020, Lancet, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4
   Hurst KR, 2009, J VIROL, V83, P7221, DOI 10.1128/JVI.00440-09
   Ip WKE, 2005, J INFECT DIS, V191, P1697, DOI 10.1086/429631
   Ito M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8360
   Java A, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140711
   Jefferson T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006207.pub4
   Jiang Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.162
   Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152
   Johnson Johnson, 2020, LACK EVIDENCE SUPPOR
   Joyner M.J., 2020, J CLIN INVEST, DOI [10.1172/jci140200, DOI 10.1172/JCI140200]
   Kam YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007870
   Kerr H, 2012, IMMUNOBIOLOGY, V217, P195, DOI 10.1016/j.imbio.2011.07.028
   Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Kremer S, 2020, RADIOLOGY, V297, pE242, DOI [10.1148/radiol.202020222, 10.1148/radiol.2020202222]
   Krempl C, 1997, J VIROL, V71, P3285, DOI 10.1128/JVI.71.4.3285-3287.1997
   KRIJNSELOCKER J, 1994, J CELL BIOL, V124, P55, DOI 10.1083/jcb.124.1.55
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Kuhn JH, 2004, CELL MOL LIFE SCI, V61, P2738, DOI 10.1007/s00018-004-4242-5
   Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114
   LAI MMC, 1985, J VIROL, V56, P449, DOI 10.1128/JVI.56.2.449-456.1985
   Lam Lk Metthew, 2020, medRxiv, DOI 10.1101/2020.05.20.20104398
   LANGLOIS PF, 1988, AM REV RESPIR DIS, V138, P368, DOI 10.1164/ajrccm/138.2.368
   Lao Wilson P, 2020, World J Otorhinolaryngol Head Neck Surg, V6, pS22, DOI 10.1016/j.wjorl.2020.04.001
   Lazarian G, 2020, BRIT J HAEMATOL, V190, P29, DOI 10.1111/bjh.16794
   Le Berre A, 2020, DIAGN INTERV IMAG, V101, P321, DOI 10.1016/j.diii.2020.04.003
   Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z
   Lee YL, 2020, J INFECTION, V81, pE55, DOI 10.1016/j.jinf.2020.04.019
   Lei JQ, 2020, RADIOLOGY, V295, P18, DOI 10.1148/radiol.2020200236
   Li DZ, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0163-5
   Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480
   Li F, 2012, J VIROL, V86, P2856, DOI 10.1128/JVI.06882-11
   Li N, 2020, CLIN INFECT DIS, V71, P2035, DOI 10.1093/cid/ciaa352
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006
   Li YP, 2020, MED-CAMBRIDGE, V1, P105, DOI 10.1016/j.medj.2020.04.001
   Lian N, 2020, CLIN MICROBIOL INFEC, V26, P917, DOI 10.1016/j.cmi.2020.04.026
   Liang L, 2020, ACTA OPHTHALMOL, V98, P223, DOI [10.1111/aos.14413, 10.1001/jamaophthalmol.2020.1291]
   Ling ZK, 2020, EUR J RADIOL, V126, DOI 10.1016/j.ejrad.2020.108956
   Liu JY, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02374-0
   Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158
   Liu PP, 2020, CIRCULATION, V142, P68, DOI 10.1161/CIRCULATIONAHA.120.047549
   Liu X, 2017, J ALLERGY CLIN IMMUN, V140, P1054, DOI 10.1016/j.jaci.2017.01.017
   Lo MW, 2020, J IMMUNOL, V205, P1488, DOI 10.4049/jimmunol.2000644
   Loganathan SK, 2020, SCIENCE, V367, P1264, DOI 10.1126/science.aax0902
   Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1
   Lowe D., 2020, SCI TRANSL MED, DOI [10.1101/2020.04.13.036293V1., DOI 10.1101/2020.04.13.036293V1]
   Lu DW, 2020, J MED VIROL, V92, P1660, DOI 10.1002/jmv.25927
   Lu GW, 2015, TRENDS MICROBIOL, V23, P468, DOI 10.1016/j.tim.2015.06.003
   Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073
   Ma J, 2020, J INFECTION, V81, P327, DOI 10.1016/j.jinf.2020.04.006
   Maffei D, 2020, GILEAD ANNOUNCES RES
   Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007
   Mannick JB, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq1564
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Mason RJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00607-2020
   Mastaglio S, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108450
   Matsumoto M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01897
   Matsuyama S, 2005, P NATL ACAD SCI USA, V102, P12543, DOI 10.1073/pnas.0503203102
   Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10
   Mazumder Archisman, 2020, F1000Res, V9, P315, DOI [10.12688/f1000research.23496.1, 10.12688/f1000research.23496.2]
   McGee MC, 2021, J LEUKOCYTE BIOL, V109, P49, DOI 10.1002/JLB.5COVR0620-306R
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134
   Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262
   Mermelstein S, 2020, PRACT NEUROL, V20, P345, DOI 10.1136/practneurol-2020-002583
   Millet JK, 2014, P NATL ACAD SCI USA, V111, P15214, DOI 10.1073/pnas.1407087111
   Mohtadi N, 2020, VIROLOGY, V548, P1, DOI 10.1016/j.virol.2020.05.006
   Molina JM, 2020, MED MALADIES INFECT, V50, P384, DOI 10.1016/j.medmal.2020.03.006
   Moon Chang, 2020, Nat Rev Immunol, V20, P277, DOI 10.1038/s41577-020-0304-7
   Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925
   Mueller AL, 2020, AGING-US, V12, P9959, DOI 10.18632/aging.103344
   Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993
   Nakamura Y, 2018, INT J RHEUM DIS, V21, P16, DOI 10.1111/1756-185X.13211
   Nakamura Y, 2012, J EPIDEMIOL, V22, P216, DOI 10.2188/jea.JE20110126
   Nal B, 2005, J GEN VIROL, V86, P1423, DOI 10.1099/vir.0.80671-0
   National Institute for Health Research, 2020, 1 DRUG RED MORT HOSP
   National Institute of Allergy and Infectious Diseases (NIAID), 2020, PHAS 1 OP LAB DOS RA
   Navarro-Millan I, 2020, ARTHRITIS RHEUMATOL, V72, P1990, DOI 10.1002/art.41422
   Neuman BW, 2011, J STRUCT BIOL, V174, P11, DOI 10.1016/j.jsb.2010.11.021
   Nikolich-Zugich J, 2020, GEROSCIENCE, V42, P505, DOI 10.1007/s11357-020-00186-0
   Nunan D, 2020, LOSS SMELL TASTE SYM
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   ODay MP, 1997, SEMIN PERINATOL, V21, P268, DOI 10.1016/S0146-0005(97)80069-9
   OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327
   Oliver Charles Matthew, 2020, F1000Res, V9, P310, DOI 10.12688/f1000research.23204.2
   Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227
   Ottestad William, 2020, Tidsskr Nor Laegeforen, V140, DOI 10.4045/tidsskr.20.0299
   Page TH, 2018, BIOCHEM BIOPH RES CO, V499, P260, DOI 10.1016/j.bbrc.2018.03.140
   Pan XF, 2020, LANCET INFECT DIS, V20, P410, DOI 10.1016/S1473-3099(20)30114-6
   Panigada M, 2020, J THROMB HAEMOST, V18, P1738, DOI 10.1111/jth.14850
   Parmigiani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079816
   Paterson RW, 2020, BRAIN, V143, P3104, DOI 10.1093/brain/awaa240
   Paul S, 2021, ACTA HAEMATOL-BASEL, V144, P132, DOI 10.1159/000508199
   Pecheur EI, 2016, J VIROL, V90, P3086, DOI 10.1128/JVI.02077-15
   Peisajovich SG, 2003, BBA-BIOMEMBRANES, V1614, P122, DOI 10.1016/S0005-2736(03)00170-6
   Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]
   Perlman S, 2005, NAT REV IMMUNOL, V5, P917, DOI 10.1038/nri1732
   Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147
   Pharmaceuticals I, 2020, SAF TOL IMM INO 4800
   Pia L, 2020, NAT REV IMMUNOL, DOI 10.1038/s41577-020-0333-2
   Pouletty M, 2020, ANN RHEUM DIS, V79, P999, DOI 10.1136/annrheumdis-2020-217960
   Pujadas E., 2020, MOUNT SINAI COVID 19, DOI 10.1101/2020.05.18.20099960v1
   Qi FR, 2020, BIOCHEM BIOPH RES CO, V526, P135, DOI 10.1016/j.bbrc.2020.03.044
   Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248
   Raamsman MJB, 2000, J VIROL, V74, P2333, DOI 10.1128/JVI.74.5.2333-2342.2000
   Rabano-Suarez P, 2020, NEUROLOGY, V95, pE767, DOI 10.1212/WNL.0000000000009829
   Radzikowska U, 2020, ALLERGY, V75, P2829, DOI 10.1111/all.14429
   Rajendran K, 2020, J MED VIROL, V92, P1475, DOI 10.1002/jmv.25961
   Ramlall V, 2020, NAT MED, V26, P1609, DOI 10.1038/s41591-020-1021-2
   Recalcati S, 2020, J EUR ACAD DERMATOL, V34, pE212, DOI 10.1111/jdv.16387
   Reguera J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002859
   Reichard RR, 2020, ACTA NEUROPATHOL, V140, P1, DOI 10.1007/s00401-020-02166-2
   Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9
   Rockx B, 2020, SCIENCE, V368, P1012, DOI 10.1126/science.abb7314
   Rogers JP, 2020, LANCET PSYCHIAT, V7, P611, DOI 10.1016/S2215-0366(20)30203-0
   Roschewski M, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd0110
   Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Royal College of Obstetricians and Gynaecologists, 2020, ROYAL COLL MIDW ROYA
   Salvi R, 2020, BIOMED PHARMACOTHER, V128, DOI 10.1016/j.biopha.2020.110267
   Sarkar M, 2017, LUNG INDIA, V34, P47, DOI 10.4103/0970-2113.197116
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Sawicki SG, 2007, J VIROL, V81, P20, DOI 10.1128/JVI.01358-06
   Schwegmann-Wessels C, 2006, GLYCOCONJUGATE J, V23, P51, DOI 10.1007/s10719-006-5437-9
   SETHNA PB, 1991, J VIROL, V65, P320, DOI 10.1128/JVI.65.1.320-325.1991
   Shanes ED, 2020, AM J CLIN PATHOL, V154, P23, DOI 10.1093/ajcp/aqaa089
   Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117
   Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y
   Shao Z., 2020, CLIN EFFICACY INTRAV, DOI [10.1101/2020.04.11.20061739, DOI 10.1101/2020.04.11.20061739]
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783
   Shi H, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105974
   Shilts J., 2020, BIORXIV, DOI [10. 1101/2020.07.25.221036, DOI 10.1101/2020.07.25.221036]
   Shin D, 2020, NATURE, V587, P657, DOI 10.1038/s41586-020-2601-5
   Shirato K, 2014, J MED VIROL, V86, P2146, DOI 10.1002/jmv.23950
   Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10
   Shulman ST, 2015, NAT REV RHEUMATOL, V11, P475, DOI 10.1038/nrrheum.2015.54
   Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102
   Sinha N, 2020, POSTGRAD MED J, V96, P550, DOI 10.1136/postgradmedj-2020-137785
   Sinkey RG, 2020, AM J PATHOL, V190, P388, DOI 10.1016/j.ajpath.2019.10.020
   Snijder EJ, 2006, J VIROL, V80, P5927, DOI 10.1128/JVI.02501-05
   Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6
   Taneja V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01931
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Tang T, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104792
   Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8
   Thibaud S, 2020, BRIT J HAEMATOL, V190, pE73, DOI 10.1111/bjh.16863
   Thoms M, 2020, SCIENCE, V369, P1249, DOI 10.1126/science.abc8665
   To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1
   TOOZE J, 1984, EUR J CELL BIOL, V33, P281
   Toscano G, 2020, NEW ENGL J MED, V382, P2574, DOI 10.1056/NEJMc2009191
   Toubiana J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2094
   Trad A.T.A., 2020, SSRN ELECT J, P1, DOI [10.2139/ssrn.3576828, DOI 10.2139/SSRN.3576828]
   Treon SP, 2020, BLOOD, V135, P1912, DOI 10.1182/blood.2020006288
   U.S. Food & Drug Administration, 2020, FDA DRUG SAF COMM CA
   Uchida H, 2010, J NEUROSCI, V30, P4806, DOI 10.1523/JNEUROSCI.5541-09.2010
   University Hospital Southampton, 2020, SOUTH RES TRIAL INH
   University Hospital Southampton, 2020, INT BET COR DRUGS TR
   University of Oxford, 2020, STUD CAND COVID 19 V
   University of Southampton 2020, 2020, ENC RES TRIAL INH DR
   Vaira LA, 2020, LARYNGOSCOPE, V130, P1787, DOI 10.1002/lary.28692
   van Doremalen Neeltje, 2020, bioRxiv, DOI 10.1101/2020.05.13.093195
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Varatharaj A, 2020, LANCET PSYCHIAT, V7, P875, DOI 10.1016/S2215-0366(20)30287-X
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X
   Villalain J, 2010, J PHYS CHEM B, V114, P8544, DOI 10.1021/jp102619w
   von Weyhern CH, 2020, LANCET, V395, pE109, DOI 10.1016/S0140-6736(20)31282-4
   Vukmanovic-Stejic M, 2018, J ALLERGY CLIN IMMUN, V142, P844, DOI 10.1016/j.jaci.2017.10.032
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094124
   Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
   Watanabe R, 2008, J VIROL, V82, P11985, DOI 10.1128/JVI.01412-08
   Weiss SR, 2011, ADV VIRUS RES, V81, P85, DOI 10.1016/B978-0-12-385885-6.00009-2
   Wen W, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0168-9
   Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369
   WHO, 2004, SUMM PROB SARS CAS O
   WHO, 2020, DRAFT LANDSC COVID 1
   Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4
   Wong HYF, 2020, RADIOLOGY, V296, pE72, DOI 10.1148/radiol.2020201160
   World Health Organization, 2020, FREQ ASK QUEST BREAS
   World Health Organization, 2020, MIDDL E RESP SYNDR M
   Wu AP, 2020, CELL HOST MICROBE, V27, P325, DOI 10.1016/j.chom.2020.02.001
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Wu KL, 2009, P NATL ACAD SCI USA, V106, P19970, DOI 10.1073/pnas.0908837106
   Xiao JY, 2020, EMERG INFECT DIS, V26, P967, DOI 10.3201/eid2605.190994
   Xiao K., 2020, ISOLATION CHARACTERI, DOI [10.1101/2020.02.17.951335, DOI 10.1101/2020.02.17.951335]
   Xie Y, 2020, J INFECTION, V81, P340, DOI 10.1016/j.jinf.2020.03.044
   Xiong TY, 2020, EUR HEART J, V41, P1798, DOI 10.1093/eurheartj/ehaa231
   Xiong Y, 2020, EMERG MICROBES INFEC, V9, P761, DOI 10.1080/22221751.2020.1747363
   Xu JB, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020244
   Xu RH, 2004, EMERG INFECT DIS, V10, P1030, DOI 10.3201/eid1006.030852
   Xu YH, 2004, J BIOL CHEM, V279, P49414, DOI 10.1074/jbc.M408782200
   Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yan D., 2020, EFFICACY HYDROXYCHLO, DOI 10.1101/2020.03.22.20040758
   Yang D, 2015, VIRUS RES, V206, P120, DOI 10.1016/j.virusres.2015.02.025
   Yarmarkovich M, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100036
   Ye MX, 2020, J MED VIROL, V92, P1890, DOI 10.1002/jmv.25882
   Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204
   Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284
   Zagorski E, 2020, BRIT J HAEMATOL, V190, pE183, DOI 10.1111/bjh.16892
   Zaigham M, 2020, ACTA OBSTET GYN SCAN, V99, P823, DOI 10.1111/aogs.13867
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zang RC, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc3582
   Zanin L, 2020, ACTA NEUROCHIR, V162, P1491, DOI 10.1007/s00701-020-04374-x
   Zhang BC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235458
   Zhang D, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-73
   Zhang L, 2020, ANN ONCOL, V31, P894, DOI 10.1016/j.annonc.2020.03.296
   Zhang LT, 2020, J THROMB HAEMOST, V18, P1324, DOI 10.1111/jth.14859
   Zhang Qi, 2020, J Med Virol, V92, P540, DOI 10.1002/jmv.25733
   Zhang X, 2020, OCUL SURF, V18, P360, DOI 10.1016/j.jtos.2020.03.010
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou L, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, P281, DOI 10.3760/cma.j.cn112147-20200229-00219
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
   Zhou Y., 2020, COLD SPRING HARBOR L, DOI [10.1101/2020.02.11.20021956, DOI 10.1101/2020.02.11.20021956]
   Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017
   Zhu FC, 2020, LANCET, V395, P1845, DOI 10.1016/S0140-6736(20)31208-3
   Zhu HP, 2020, TRANSL PEDIATR, V9, P51, DOI 10.21037/tp.2020.02.06
   Zhu JQ, 2004, BIOCHEM BIOPH RES CO, V319, P283, DOI 10.1016/j.bbrc.2004.04.141
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035
   Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979
   Zulfiqar AA, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2010472
   Zuo Y, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138999
NR 379
TC 23
Z9 23
U1 1
U2 8
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0171-2985
EI 1878-3279
J9 IMMUNOBIOLOGY
JI Immunobiology
PD NOV
PY 2020
VL 225
IS 6
AR 152008
DI 10.1016/j.imbio.2020.152008
PG 27
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA PA4LB
UT WOS:000595608300004
PM 33130519
OA Green Submitted, Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Yu, ZG
   Xu, W
   Yu, LH
AF Yu, Zhonggen
   Xu, Wei
   Yu, Liheng
TI Constructing an Online Sustainable Educational Model in COVID-19
   Pandemic Environments
SO SUSTAINABILITY
LA English
DT Article
DE online sustainable educational model; online education; COVID-19;
   pandemic; environment
ID LEARNING-ENVIRONMENT; SOCIAL MEDIA; KNOWLEDGE; STUDENTS
AB The outbreak of COVID-19 forced billions of learners to stay at home in order to receive online education. The aim of the study is to construct an online sustainable educational model to facilitate this learning approach. This study included 53 peer-reviewed articles for the review study following the selection process of the Preferred Reporting Items for Systematic Review and Meta-analysis Protocol (PRISMA-P) and the clustering techniques of VOSviewer. It is concluded that the model consists of online educational platforms, online assessment systems, social media, and digital literacy. With these features, online education could be sustained. However, challenges should also be addressed to sustain online education during the pandemic. Designers, scientists, and teachers should make every effort to increase learning engagement, enhance learning supervision, formulate adequate emergency programs, minimize educational inequalities, solve technical issues, and formulate systematic learning management and organization. The sustainable online educational model may be updated and perfected by including more practical features in the future.
C1 [Yu, Zhonggen] Beijing Language & Culture Univ, Fac Foreign Studies, Dept English Studies, Beijing 100083, Peoples R China.
   [Xu, Wei] City Univ Macau, Fac Humanities & Social Sci, Macau 999078, Peoples R China.
   [Yu, Liheng] Jiangsu Ocean Univ, Sch Elect Engn, Lianyungang 222005, Peoples R China.
RP Yu, ZG (corresponding author), Beijing Language & Culture Univ, Fac Foreign Studies, Dept English Studies, Beijing 100083, Peoples R China.; Xu, W (corresponding author), City Univ Macau, Fac Humanities & Social Sci, Macau 999078, Peoples R China.; Yu, LH (corresponding author), Jiangsu Ocean Univ, Sch Elect Engn, Lianyungang 222005, Peoples R China.
EM yuzhonggen@blcu.edu.cn; weixu@cityu.mo; dz4177588@163.com
OI Yu, Zhonggen/0000-0002-3873-980X
FU process of higher education marketization in Macao [HSS-CITYU-2021-02];
   2019 MOOC of Beijing Language and Culture University [MOOC201902];
   Beijing Co-construction Project-Research and reform of the
   "Undergraduate Teaching Reform and Innovation Project" of Beijing higher
   education in 2020-innovative "multilingual +" excellent talent training
   system [202010032003]; Graduate Students of Beijing Language and Culture
   University "Xi Jinping: The Governance of China" [SJTS202108]
FX A study on the quality assurance system in the process of higher
   education marketization in Macao, Grant No.: HSS-CITYU-2021-02; 2019
   MOOC of Beijing Language and Culture University (MOOC201902) (Important)
   "Introduction to Linguistics"; "Introduction to Linguistics" of online
   and offline mixed courses in Beijing Language and Culture University in
   2020; special fund of Beijing Co-construction Project-Research and
   reform of the "Undergraduate Teaching Reform and Innovation Project" of
   Beijing higher education in 2020-innovative "multilingual +" excellent
   talent training system (202010032003); the research project of Graduate
   Students of Beijing Language and Culture University "Xi Jinping: The
   Governance of China" (SJTS202108).
CR Agarwal A, 2021, ANDROLOGIA, V53, DOI 10.1111/and.13961
   Alismaiel OA, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su132413565
   Azevedo J.P., 2020, SIMULATING POTENTIAL
   Azman A, 2021, QUAL SOC WORK, V20, P553, DOI 10.1177/1473325020973308
   Beaunoyer E, 2020, COMPUT HUM BEHAV, V111, DOI 10.1016/j.chb.2020.106424
   Beena KKT, 2022, COGENT ENG, V9, DOI 10.1080/23311916.2021.2010509
   Besalti M, 2022, TECHTRENDS, DOI 10.1007/s11528-022-00697-x
   Bhagat S, 2020, INFORM SYST MANAGE, V37, P366, DOI 10.1080/10580530.2020.1824040
   Bilandzic M, 2013, LIBR HI TECH, V31, P254, DOI 10.1108/07378831311329040
   Charters M, 2021, INT J ART DES EDUC, V40, P723, DOI 10.1111/jade.12384
   Chih-Hsiung Tu, 2002, American Journal of Distance Education, V16, P131, DOI 10.1207/S15389286AJDE1603_2
   Chu AMY, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13095038
   Consorti F, 2021, MED TEACH, V43, P546, DOI 10.1080/0142159X.2021.1877266
   Czekierda L, 2021, B POL ACAD SCI-TECH, V69, DOI 10.24425/bpasts.2021.137934
   Daniel Sir John, 2020, Prospects (Paris), P1, DOI 10.1007/s11125-020-09464-3
   Davis CHF, 2015, COMMUNITY COLL J RES, V39, P409, DOI 10.1080/10668926.2013.828665
   de-Marcos L, 2016, COMPUT EDUC, V95, P99, DOI 10.1016/j.compedu.2015.12.008
   DeFilippis EM, 2020, J AM COLL CARDIOL, V75, P2630, DOI 10.1016/j.jacc.2020.04.013
   Dew M, 2021, PHYS TEACH, V59, P162, DOI 10.1119/5.0027816
   Drane CF, 2021, AUST EDUC RES, V48, P585, DOI 10.1007/s13384-020-00409-5
   Fardoun H, 2020, EDUC KNOWL SOC, V21, DOI 10.14201/eks.23437
   Fernandes E, 2016, PROC FRONT EDUC CONF
   Fonseca D, 2021, UNIVERSAL ACCESS INF, V20, P421, DOI [10.1007/s10209-020-00765-0, 10.1007/s10209-020-00776-x]
   Gaworski M, 2021, PROCESSES, V9, DOI 10.3390/pr9081357
   Gorfinkel L, 2021, MEDIA INT AUST, V178, P87, DOI 10.1177/1329878X20968291
   Hodges CB, 2021, ETR&D-EDUC TECH RES, V69, P397, DOI 10.1007/s11423-020-09838-6
   Hu SG, 2017, INFORM TECHNOL PEOPL, V30, P265, DOI 10.1108/ITP-04-2016-0099
   Huang R., 2020, HDB FACILITATING FLE
   Garcia-Penalvo FJ, 2020, EDUC KNOWL SOC, V21, DOI 10.14201/eks.23013
   Kapoor K, 2022, ANAT HISTOL EMBRYOL, V51, P163, DOI 10.1111/ahe.12783
   Khalil R, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02208-z
   Khan MN, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.648253
   Kimmerle J, 2015, EDUC PSYCHOL-US, V50, P120, DOI 10.1080/00461520.2015.1036273
   Kolyvas S, 2021, CURR PSYCHOL, DOI 10.1007/s12144-021-02349-4
   Liu YF, 2022, INTERACT LEARN ENVIR, DOI 10.1080/10494820.2022.2028853
   Mahdy MAA, 2022, ANAT SCI EDUC, V15, P67, DOI 10.1002/ase.2149
   Maqbool M, 2021, IT PROF, V23, P63, DOI 10.1109/MITP.2021.3049155
   Mogaji E., 2020, IMPACT PANDEMIC HIGH
   Mohan G, 2021, IRISH EDUC STUD, V40, P265, DOI 10.1080/03323315.2021.1915841
   Moher D, 2015, SYST REV, V4, DOI [10.1186/2046-4053-4-1, 10.1186/s13643-015-0087-2]
   Morales-Rodriguez FM, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13115824
   Nip JYM, 2016, INFORM COMMUN SOC, V19, P1127, DOI 10.1080/1369118X.2015.1104372
   Opsahl AG, 2021, J CONTIN EDUC NURS, V52, P11, DOI 10.3928/00220124-20201215-05
   Palau R, 2021, TECHNOL PEDAGOG EDUC, V30, P183, DOI 10.1080/1475939X.2020.1863855
   Panakaje N, 2022, ENVIRON SCI POLLUT R, V29, P27788, DOI 10.1007/s11356-021-15306-2
   Pangrazio L, 2016, DISCOURSE-ABINGDON, V37, P163, DOI 10.1080/01596306.2014.942836
   Pham HH, 2020, HIGH EDUC RES DEV, V39, P1327, DOI 10.1080/07294360.2020.1823945
   Quendler E, 2016, INT J CONTIN ENG EDU, V26, P273, DOI 10.1504/IJCEELL.2016.078447
   Ranieri M, 2016, INT ADV EDU-GLOB, P249
   Riandi M.H., 2021, INT J RES ENG SCI MA, V4, P60, DOI [10.47607/ijresm.2021.466, DOI 10.47607/IJRESM.2021.466]
   Roman DX, 2021, J ENVIRON EDUC, V52, P325, DOI 10.1080/00958964.2021.1981204
   Romero-Hall E, 2017, ONLINE LEARN, V21, P141
   Serafin JM, 2020, J CHEM EDUC, V97, P3007, DOI 10.1021/acs.jchemed.0c00780
   Shamir-Inbal T, 2021, J EDUC COMPUT RES, V59, P1243, DOI 10.1177/0735633121992781
   Shim TE, 2020, CHILD YOUTH SERV REV, V119, DOI 10.1016/j.childyouth.2020.105578
   Sorour SE, 2021, CMC-COMPUT MATER CON, V66, P2671, DOI 10.32604/cmc.2021.014395
   Straight M, 2008, CIN-COMPUT INFORM NU, V26, P23, DOI 10.1097/01.NCN.0000304761.56671.ad
   Tang K.Y, 2022, INT REV RES OPEN DIS, V23, P104, DOI 10.19173/irrodl.v23i1.6319
   Tranfield D, 2003, BRIT J MANAGE, V14, P207, DOI 10.1111/1467-8551.00375
   Triemstra JD, 2021, ACAD MED, V96, P1276, DOI 10.1097/ACM.0000000000004013
   Tyler CJ, 2021, ADV PHYSIOL EDUC, V45, P538, DOI 10.1152/advan.00070.2021
   UNESCO, 2022, COVID 19 ED DISR RES
   Van Lancker W, 2020, LANCET PUBLIC HEALTH, V5, pE243, DOI 10.1016/S2468-2667(20)30084-0
   Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X
   Vollbrecht PJ, 2020, ADV PHYSIOL EDUC, V44, P722, DOI 10.1152/advan.00140.2020
   Wu S., 2019, MOD ED TECHNOL, V29, P101
   Xu JZ, 2022, COMPUT EDUC, V177, DOI 10.1016/j.compedu.2021.104367
   Yu ZG, 2021, INTERACT LEARN ENVIR, DOI 10.1080/10494820.2021.1989466
   Yu ZG, 2021, J EDUC COMPUT RES, V59, P522, DOI 10.1177/0735633120969214
   Zhang H., 2017, J OPEN LEARN, V22, P35
NR 70
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD MAR
PY 2022
VL 14
IS 6
AR 3598
DI 10.3390/su14063598
PG 16
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA 0B3WX
UT WOS:000774570300001
OA gold
DA 2022-04-20
ER

PT J
AU Cao, JJ
   Yang, T
   Lai, IKW
   Wu, J
AF Cao, Jijuan
   Yang, Ting
   Lai, Ivan Ka Wai
   Wu, Jun
TI Is online education more welcomed during COVID-19? An empirical study of
   social impact theory on online tutoring platforms
SO INTERNATIONAL JOURNAL OF ELECTRICAL ENGINEERING EDUCATION
LA English
DT Article; Early Access
DE Online Tutoring Platform; Social Impact Theory; COVID-19; UTAUT
AB During the COVID-19 pandemic, Online Tutoring Platforms (OTPs) have been applied extensively in education in China. The aim of this study is to investigate the determinants that influence college students' behavioural intention of using OTPs to acquire knowledge. This study also explores how students' attitude change in using OTPs five months after the outbreak of the COVID-19 pandemic based on a hierarchical component model which is combined by the Social Impact Theory (SIT) and Unified Theory of Acceptance and Use of Technology (UTAUT). Partial least squares (PLS) analysis is employed to analyse the data collected from 1133 students in Mainland China. The results of the analysis indicate that social impact consists of three dimensions (compliance, identification, internalization) significantly influences college students' attitude toward OTPs and further affects college students' behavioural intention toward OTPs usage. Furthermore, performance expectancy and effort expectancy also positively affect students' behavioural intention toward using OTPs to acquire knowledge. This study makes several suggestions for universities to encourage students using OTPs to cope with the situation of Covid-19 pandemic and for educators to promote online tutoring for reforming universities in the future.
C1 [Cao, Jijuan; Wu, Jun] Guangzhou Panyu Polytech, Sch Innovat & Entrepreneurship, Guangzhou, Peoples R China.
   [Cao, Jijuan; Lai, Ivan Ka Wai] City Univ Macau, Fac Int Tourism & Management, Taipa, Macau, Peoples R China.
   [Yang, Ting] Jinan Univ, Int Business Sch, Guangzhou, Peoples R China.
RP Wu, J (corresponding author), Guangzhou Panyu Polytech, Guangzhou 511483, Peoples R China.
EM 87442733@qq.com
FU Youth Program of The Education Science Planning Department in Guangzhou
   [202012523]; Major Projects of Guangdong Provincial Department of
   Education [2017GWTSCX028]; Innovation and Entrepreneurship Project of
   Guangzhou Education Bureau [2020KC018, 2019PT102]; Major Scientific
   Research Platform Cultivation Project of Guangzhou Panyu Polytechnic
   [2017Y01PY]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported in part by the Youth Program of The Education Science
   Planning Department in Guangzhou under Grant 202012523, Major Projects
   of Guangdong Provincial Department of Education under Grant
   2017GWTSCX028, Innovation and Entrepreneurship Project of Guangzhou
   Education Bureau under Grant 2020KC018, Innovation and Entrepreneurship
   Project of Guangzhou Education Bureau under Grant 2019PT102, Major
   Scientific Research Platform Cultivation Project of Guangzhou Panyu
   Polytechnic under Grant 2017Y01PY.
CR Aini Q, 2019, PROCEDIA COMPUT SCI, V161, P242, DOI 10.1016/j.procs.2019.11.120
   Ajzen I., 1980, UNDERSTANDING ATTITU
   Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI DOI 10.1007/BF02723327
   Bass BM, 2003, J APPL PSYCHOL, V88, P207, DOI 10.1037/0021-9010.88.2.207
   DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Hair JF, 2013, LONG RANGE PLANN, V46, P1, DOI 10.1016/j.lrp.2013.01.001
   Kelman H.C., 1958, J CONFLICT RESOLUT, V2, P51, DOI [DOI 10.1177/002200275800200106, 10.1177/002200275800200106]
   Kristl, 2017, TURKISH ONLINE J ED, V16, P11
   Lai IKW, 2013, INT C HYBR LEARN CON, P334
   Lakhal S, 2017, J COMPUT EDUC, V4, P251, DOI 10.1007/s40692-017-0086-5
   Lu D, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11030928
   Mok Q, 2019, TECHNOLOGY ED PEDAGO, P179
   Ringle C.M., 2015, SMART PLS 3
   Sarstedt M., 2016, PRIMER PARTIAL LEAST
   SUTTON CD, 1993, EDUC PSYCHOL MEAS, V53, P217, DOI 10.1177/0013164493053001024
   Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540
   Wong K.K.K., 2013, MARKETING B, V24, P1, DOI DOI 10.1108/EBR-10-2013-0128
   Yang T., 2018, P INT C TECHN ED, P101
NR 19
TC 1
Z9 1
U1 7
U2 24
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0020-7209
EI 2050-4578
J9 INT J ELEC ENG EDUC
JI Int. J. Elec. Eng. Educ.
AR 0020720920984001
DI 10.1177/0020720920984001
EA JAN 2021
PG 12
WC Education, Scientific Disciplines; Engineering, Electrical & Electronic
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Education & Educational Research; Engineering
GA RB5ME
UT WOS:000632154400001
OA hybrid
DA 2022-04-20
ER

PT J
AU Dohale, V
   Ambilkar, P
   Gunasekaran, A
   Verma, P
AF Dohale, Vishwas
   Ambilkar, Priya
   Gunasekaran, Angappa
   Verma, Priyanka
TI Supply chain risk mitigation strategies during COVID-19: exploratory
   cases of "make-to-order" handloom saree apparel industries
SO INTERNATIONAL JOURNAL OF PHYSICAL DISTRIBUTION & LOGISTICS MANAGEMENT
LA English
DT Article
DE COVID-19; Supply chain risk management; Supply chain disruption; Risk
   mitigation strategy; Multiple case study; Handloom industry
AB Purpose This study attempts to identify the supply chain risks (SCRs) induced during the COVID-19 disruption in an Indian handloom saree industry and determine suitable risk mitigation strategies (RMSs) to overcome the impact of the epidemic disruption. Design/methodology/approach This work determined 11 SCRs through an extensive literature review in the context of the handloom apparel industry and validated through the experts. Further, a multiple case-based approach is used in this research. Within case and cross-case analyses of four relevant Indian handloom "make-to-order" saree manufacturing firms are conducted to determine the severity of the SCRs considering the pandemic situations to identify appropriate strategies to mitigate the shock of SCRs. Findings This study identified the critical SCRs in the context of the Indian handloom "make-to-order" saree industries that emerged during the COVID-19 and proposed a risk mitigation strategy matrix (RMSM) to address the SCRs based on their criticality and predictability dimensions. Research limitations/implications The study provides a novel contribution to the body of knowledge on supply chain risk management (SCRM) in the form of the RMSM tool. Supply chain managers from the different sectors can extend the proposed RMSM to overcome the SCRs. Multiple case analyses facilitate supply chain professionals working in handloom apparel industries to benchmark and adopt the proposed RMSs in their firm. Originality/value This research is one of its kind that carried exploratory investigation of the handloom apparel industry cases to assess and determine the strategies for mitigating the SCRs caused during a pandemic outbreak.
C1 [Dohale, Vishwas; Ambilkar, Priya; Verma, Priyanka] Natl Inst Ind Engn, Dept Operat & Supply Chain Management, Mumbai, Maharashtra, India.
   [Gunasekaran, Angappa] Calif State Univ, Sch Business & Publ Adm, Bakersfield, CA 93311 USA.
RP Gunasekaran, A (corresponding author), Calif State Univ, Sch Business & Publ Adm, Bakersfield, CA 93311 USA.
EM vishwas.dohale.2017@nitie.ac.in; Priya.Ambilkar.2017@nitie.ac.in;
   agunasekaran@csub.edu; priyankaverma@nitie.ac.in
RI Dohale, Vishwas/E-7957-2019
OI Dohale, Vishwas/0000-0002-7895-3309; Verma,
   Priyanka/0000-0002-1266-8281; Ambilkar, Priya/0000-0002-9195-1746
CR Abeysekara N, 2019, BUS PROCESS MANAG J, V25, P1673, DOI 10.1108/BPMJ-09-2018-0241
   AEPC, 2020, OUR COUNC IS ENT MED
   Alora A, 2022, INT J PRODUCT PERFOR, V71, P477, DOI 10.1108/IJPPM-11-2018-0422
   Andersson R., 2020, TQM J, V32, P1021
   [Anonymous], 2020, BUSINESS WIRE
   [Anonymous], 2020, TEXTILE VALUE CHAIN
   [Anonymous], 2020, OV TEXT IND IND IMP
   [Anonymous], 2020, FORTUNE
   Bier T, 2020, INT J PROD RES, V58, P1835, DOI 10.1080/00207543.2019.1687954
   Bonanni L., 2019, HARVARD BUS REV, P2
   Carbonara N, 2018, INT J PROD RES, V56, P5249, DOI 10.1080/00207543.2017.1403663
   Chowdhury NA, 2019, J RETAIL CONSUM SERV, V51, P102, DOI 10.1016/j.jretconser.2019.05.024
   Christopher M., 2004, International Journal of Physical Distribution & Logistics Management, V34, P388, DOI 10.1108/09600030410545436
   Das, 2020, TEXTILE VALUE CHAIN, V8, P40
   Deloitte, 2020, COVID 19 MAN SUPPL C
   Dixit V, 2020, INT J PROD ECON, V227, DOI 10.1016/j.ijpe.2020.107655
   Donaldson T, 2020, SOURCING J
   Dubey R, 2021, INT J PROD RES, V59, P110, DOI 10.1080/00207543.2019.1582820
   EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557
   Fan YY, 2018, INT J PHYS DISTR LOG, V48, P205, DOI 10.1108/IJPDLM-01-2017-0043
   Gunasekaran A, 2015, INT J PROD RES, V53, P6809, DOI 10.1080/00207543.2015.1093667
   Gunessee S, 2020, INT J OPER PROD MAN, V40, P1201, DOI 10.1108/IJOPM-07-2019-0530
   Handfield R, 2020, SUPPLY CHAIN MANAG, V25, P803, DOI 10.1108/SCM-11-2019-0423
   Heckmann I, 2015, OMEGA-INT J MANAGE S, V52, P119, DOI 10.1016/j.omega.2014.10.004
   Ho W, 2015, INT J PROD RES, V53, P5031, DOI 10.1080/00207543.2015.1030467
   Hult GTM, 2010, DECISION SCI, V41, P435, DOI 10.1111/j.1540-5915.2010.00276.x
   ILO, 2020, UN NEWS
   Ivanov D, 2020, INT J PROD RES, V58, P2904, DOI 10.1080/00207543.2020.1750727
   Ivanov D, 2020, TRANSPORT RES E-LOG, V136, DOI 10.1016/j.tre.2020.101922
   Jafari H, 2016, IND MANAGE DATA SYST, V116, P445, DOI 10.1108/IMDS-06-2015-0257
   Joshi, 2020, TIMES INDIA
   Kamble SS, 2018, COMPUT IND, V101, P107, DOI 10.1016/j.compind.2018.06.004
   Kauppi K, 2016, INT J PROD ECON, V182, P484, DOI 10.1016/j.ijpe.2016.10.006
   Kilubi I, 2016, INT J LOGIST-RES APP, V19, P604, DOI 10.1080/13675567.2016.1150440
   Kochan CG, 2018, INT J PHYS DISTR LOG, V48, P842, DOI 10.1108/IJPDLM-02-2017-0099
   Majumdar A, 2021, INT J PROD RES, V59, P752, DOI 10.1080/00207543.2019.1708988
   Manuj I, 2008, INT J PHYS DISTR LOG, V38, P192, DOI 10.1108/09600030810866986
   Mehrjoo M., 2016, INT J PROD RES, V7543, P1
   Meredith J, 1998, J OPER MANAG, V16, P441, DOI 10.1016/S0272-6963(98)00023-0
   Naeem M, 2021, J RETAIL CONSUM SERV, V58, DOI 10.1016/j.jretconser.2020.102226
   Nakano M, 2020, INT J LOGIST-RES APP, V23, P443, DOI 10.1080/13675567.2019.1704707
   NITI Aayog, 2020, WEAV WAY IND TEXT IN
   Norrman A, 2020, INT J PHYS DISTR LOG, V50, P641, DOI 10.1108/IJPDLM-07-2019-0219
   Paul SK, 2021, INT J PHYS DISTR LOG, V51, P104, DOI 10.1108/IJPDLM-04-2020-0127
   Prentice C, 2020, J RETAIL CONSUM SERV, V57, DOI 10.1016/j.jretconser.2020.102203
   PwC, 2020, MAT IS YOUR RISK MAN
   Queiroz MM, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03685-7
   Rajagopal V, 2017, COMPUT IND ENG, V113, P646, DOI 10.1016/j.cie.2017.09.043
   Riege AM., 2003, QUAL MARKET RES, V6, P75, DOI [10.1108/13522750310470055, DOI 10.1108/13522750310470055]
   Rizou M, 2020, TRENDS FOOD SCI TECH, V102, P293, DOI 10.1016/j.tifs.2020.06.008
   Rowley J, 2002, MANAGEMENT RES NEWS, V25, P1, DOI DOI 10.1108/01409170210782990
   Sannith J., 2020, KANCHIPURAM COVID 19
   Sarkar J., 2020, TIMES INDIA
   Sarkis J, 2021, INT J OPER PROD MAN, V41, P63, DOI 10.1108/IJOPM-08-2020-0568
   Sharma RK, 2021, INT J FINANC ECON, V26, P5666, DOI 10.1002/ijfe.2087
   Srinivasan R, 2018, PROD OPER MANAG, V27, P1849, DOI 10.1111/poms.12746
   Tang C, 2008, INT J PROD ECON, V116, P12, DOI 10.1016/j.ijpe.2008.07.008
   Tarei PK, 2020, BENCHMARKING, V27, P1683, DOI 10.1108/BIJ-12-2019-0523
   Trent R.J., 2014, SUPPLY CHAIN RISK MA
   UPTON DM, 1994, CALIF MANAGE REV, V36, P72, DOI 10.2307/41165745
   Venkatesh VG, 2015, J RETAIL CONSUM SERV, V26, P153, DOI 10.1016/j.jretconser.2015.06.001
   Vishnu C. R., 2019, International Journal of Logistics Systems and Management, V32, P548
   Weskamp C, 2019, OMEGA-INT J MANAGE S, V83, P123, DOI 10.1016/j.omega.2018.02.008
   Wieland A, 2012, INT J PHYS DISTR LOG, V42, P887, DOI 10.1108/09600031211281411
   World Bank, 2020, GLOB EC PROSP, DOI [https://doi.org/10.1596/978-1-4648-1553-9, DOI 10.1596/978-1-4648-1553-9, 10.1596/978-1-4648-1553-9]
   Yang B, 2004, INT J OPER PROD MAN, V24, P468, DOI 10.1108/01443570410532542
   Yang B, 2010, INT J PROD RES, V48, P1901, DOI 10.1080/00207540902791850
   Yin R.K., 1984, APPL CASE STUDY RES
   Yin R.K., 2014, CASE STUDY RES APPL, V5th ed.
NR 69
TC 16
Z9 16
U1 6
U2 21
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0960-0035
EI 1758-664X
J9 INT J PHYS DISTR LOG
JI Int. J. Phys. Distrib. Logist. Manag.
PD MAR 2
PY 2022
VL 52
IS 2
BP 109
EP 129
DI 10.1108/IJPDLM-12-2020-0450
EA APR 2021
PG 21
WC Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA ZO5NJ
UT WOS:000639939600001
OA Bronze
DA 2022-04-20
ER

PT J
AU Chakir, M
   El Jamili, M
   Boudhar, Z
   El Hattaoui, M
AF Chakir, Mariame
   El Jamili, Mohammed
   Boudhar, Zainab
   El Hattaoui, Mustapha
TI Simultaneous acute myocardial infarction, bilateral pulmonary embolism,
   and acute ischaemic cerebral stroke, a delayed complication in a patient
   with COVID-19 infection: case report
SO EUROPEAN HEART JOURNAL-CASE REPORTS
LA English
DT Article
DE COVID-19; Venous thromboembolism; Arterial thrombosis; Case report
ID GUIDELINES; MANAGEMENT
AB Background The simultaneous occurrence of acute myocardial infarction, pulmonary embolism, and acute cerebral stroke is a rare concomitant finding that requires thorough aetiological investigation. Multiple reports note delayed COVID-19 arterial and venous thromboembolic complications. However, to the best of our knowledge, this is the first report of such a simultaneous finding after COVID-19.
   Case summary A 60-year-old male patient, with a history of Type II diabetes and no risk factors for thromboembolism, experienced simultaneous acute myocardial infarction, bilateral pulmonary embolism, and acute ischaemic stroke. The occurrence of these multi-systemic thromboembolic events made us rule out differential diagnoses of thrombophilia, systemic lupus erythematosus, antiphospholipid syndrome, vasculitis, cancer, disseminated intravascular coagulation, and paradoxical embolism through a patent foramen ovate. On laboratory analysis, the patient was positive for IgG SARS-COV2 antibodies, but negative for IgM antibodies and had two negative nasal polymerase chain reaction swab tests. After thorough aetiological investigation, the most probable diagnosis was thought to be delayed complications of COVID-19 infection.
   Discussion Multiple mechanisms, such as endothelial dysfunction, complement activation, and virus-induced antiphospholipid syndrome, may explain the hypercoagulable state related to COVID-19. To the best of our knowledge, this is the first case of concomitant multi-systemic thrombosis development, recognized as a delayed complication of COVID-19 infection. This highlights a need among cardiologists for an increased awareness of such late-onset complications. It also emphasizes the importance of identifying the optimal duration and dose of prophylactic anticoagulation as well as the characteristics of the population that would benefit from it after COVID-19.
C1 [Chakir, Mariame; El Jamili, Mohammed; Boudhar, Zainab; El Hattaoui, Mustapha] Univ Hosp Mohammed VIth, Dept Cardiol, Marrakech, Morocco.
RP Chakir, M (corresponding author), Univ Hosp Mohammed VIth, Dept Cardiol, Marrakech, Morocco.
EM mariamechakir@hotmail.com
RI CHAKIR, Mariame/ABD-3724-2021
OI CHAKIR, Mariame/0000-0002-3175-0395
CR [Anonymous], 2021, STROK GUID INT
   Barros-Gomes S, 2018, ECHO RES PRACT, V5, pI9, DOI 10.1530/ERP-18-0044
   Conway EM, 2020, J THROMB HAEMOST, V18, P2812, DOI 10.1111/jth.15050
   Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041
   Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a
   Kashi M, 2020, THROMB RES, V192, P75, DOI 10.1016/j.thromres.2020.05.025
   Libby P, 2020, EUR HEART J, V41, P3038, DOI 10.1093/eurheartj/ehaa623
   Roberts LN, 2020, BLOOD, V136, P1347, DOI 10.1182/blood.2020008086
   Schweblin C, 2020, EUR HEART J-CASE REP, V4, DOI 10.1093/ehjcr/ytaa371
   Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575
NR 10
TC 1
Z9 1
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2514-2119
J9 EUR HEART J-CASE REP
JI Eur. Heart J.-Case Rep.
PD JUN
PY 2021
VL 5
IS 6
AR ytab218
DI 10.1093/ehjcr/ytab218
EA JUN 2021
PG 6
WC Cardiac & Cardiovascular Systems
WE Emerging Sources Citation Index (ESCI)
SC Cardiovascular System & Cardiology
GA UB0CR
UT WOS:000685521200031
PM 34189400
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Iniguez, M
   Perez-Matute, P
   Villoslada-Blanco, P
   Recio-Fernandez, E
   Ezquerro-Perez, D
   Alba, J
   Ferreira-Laso, ML
   Oteo, JA
AF Iniguez, Maria
   Perez-Matute, Patricia
   Villoslada-Blanco, Pablo
   Recio-Fernandez, Emma
   Ezquerro-Perez, Diana
   Alba, Jorge
   Lourdes Ferreira-Laso, M.
   Oteo, Jose A.
TI ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With
   Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study
SO FRONTIERS IN ENDOCRINOLOGY
LA English
DT Article
DE COVID-19; angiotensin converting enzyme; polymorphisms; hypertension;
   dyslipidemia; diabetes
ID ANGIOTENSIN; POLYMORPHISM; ASSOCIATION; DISEASE
AB Coronavirus disease 19 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection continues to scale and threaten human health and public safety. It is essential to identify those risk factors that lead to a poor prognosis of the disease. A predisposing host genetic background could be one of these factors that explain the interindividual variability to COVID-19 severity. Thus, we have studied whether the rs4341 and rs4343 polymorphisms of the angiotensin converting enzyme (ACE) gene, key regulator of the renin-aldosterone-angiotensin system (RAAS), could explain the different outcomes of 128 COVID-19 patients with diverse degree of severity (33 asymptomatic or mildly symptomatic, 66 hospitalized in the general ward, and 29 admitted to the ICU). We found that G allele of rs4341 and rs4343 was associated with severe COVID-19 in hypertensive patients, independently of gender (p<0.05). G-carrier genotypes of both polymorphisms were also associated with higher mortality (p< 0.05) and higher severity of COVID-19 in dyslipidemic (p<0.05) and type 2 diabetic patients (p< 0.01). The association of G alleles with disease severity was adjusted for age, sex, BMI and number of comorbidities, suggesting that both the metabolic comorbidities and the G allele act synergistically on COVID-19 outcome. Although we did not find a direct association between serum ACE levels and COVID-19 severity, we found higher levels of ACE in the serum of patients with the GG genotype of rs4341 and rs4343 (p<0.05), what could explain the higher susceptibility to develop severe forms of the disease in patients with the GG genotype, in addition to hypertension and dyslipidemia. In conclusion, our preliminary study suggests that the G-containing genotypes of rs4341 and rs4343 confer an additional risk of adverse COVID-19 prognosis. Thus, rs4341 and rs4343 polymorphisms of ACE could be predictive markers of severity of COVID-19 in those patients with hypertension, dyslipidemia or diabetes. The knowledge of these genetic data could contribute to precision management of SARS-CoV-2 infected patients when admitted to hospital.
C1 [Iniguez, Maria; Perez-Matute, Patricia; Villoslada-Blanco, Pablo; Recio-Fernandez, Emma; Oteo, Jose A.] Ctr Biomed Res La Rioja CIBIR, Infect Dis Microbiota & Metab Unit, Infect Dis Dept, Logrono, Spain.
   [Ezquerro-Perez, Diana; Alba, Jorge; Oteo, Jose A.] Hosp Univ San Pedro, Infect Dis Dept, Logrono, Spain.
   [Lourdes Ferreira-Laso, M.] Hosp Univ San Pedro, Dept Anesthesiol & Postoperat Care, Logrono, Spain.
RP Oteo, JA (corresponding author), Ctr Biomed Res La Rioja CIBIR, Infect Dis Microbiota & Metab Unit, Infect Dis Dept, Logrono, Spain.; Oteo, JA (corresponding author), Hosp Univ San Pedro, Infect Dis Dept, Logrono, Spain.
EM jaoteo@riojasalud.es
RI Oteo, Jose A./AAB-3134-2020
OI Oteo, Jose A./0000-0001-7080-6542; Villoslada-Blanco,
   Pablo/0000-0002-1220-5228; Perez-Matute, Patricia/0000-0003-2232-7971
CR Abate SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235653
   Abdollahi MR, 2008, DIS MARKERS, V24, P11, DOI 10.1155/2008/813679
   Ahluwalia TS, 2009, DNA CELL BIOL, V28, P141, DOI 10.1089/dna.2008.0810
   Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014
   [Anonymous], 2021, SPANISH COALITION UN
   [Anonymous], 2021, COVID 19 DASHBOARD C
   [Anonymous], 2018, SOC ESPANOLA NEUROLO
   [Anonymous], EUROPEAN SOC CARDIOL
   [Anonymous], 2021, ENF NUEV COR COVID 1
   Benetti E, 2020, EUR J HUM GENET, V28, P1602, DOI 10.1038/s41431-020-0691-z
   Cadegiani FA, 2020, BMC ENDOCR DISORD, V20, DOI 10.1186/s12902-020-00626-0
   Cadegiani FA, 2020, AM J PHYSIOL-ENDOC M, V318, pE587, DOI 10.1152/ajpendo.00136.2020
   Cevik M, 2020, CLIN MICROBIOL INFEC, V26, P842, DOI 10.1016/j.cmi.2020.04.023
   Chung MK, 2020, EBIOMEDICINE, V58, DOI 10.1016/j.ebiom.2020.102907
   D'Ardes D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21083003
   Eisenmann JC, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-14
   Firouzabadi N, 2012, PSYCHIAT RES, V200, P336, DOI 10.1016/j.psychres.2012.05.002
   Freitas AI, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-15
   Glenn KL, 2009, MOL BIOL REP, V36, P1305, DOI 10.1007/s11033-008-9313-5
   Gomez J, 2020, GENE, V762, DOI 10.1016/j.gene.2020.145102
   Gunal O, 2021, ANN SAUDI MED, V41, P141, DOI 10.5144/0256-4947.2021.141
   Jiang MH, 2013, CLINICS, V68, P1428, DOI 10.6061/clinics/2013(11)08
   Lecube A, 2017, ENDOCRINOL DIAB NUTR, V64, P15, DOI [10.1016/j.endonu.2016.07.002, 10.1016/j.endien.2017.03.007]
   Li MC, 2021, HUM GENOMICS, V15, DOI 10.1186/s40246-020-00299-9
   Mach F, 2019, ATHEROSCLEROSIS, V290, P140, DOI [10.1093/eurheartj/ehz455, 10.1016/j.atherosclerosis.2019.08.014]
   McKenzie CA, 2001, HUM MOL GENET, V10, P1077, DOI 10.1093/hmg/10.10.1077
   Miravitlles M, 2017, ARCH BRONCONEUMOL, V53, P324, DOI 10.1016/j.arbres.2017.03.018
   Neumann FJ., 2019, J HYPERTENS, V40, P87, DOI DOI 10.1097/HJH.0000000000001961
   Peckham H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19741-6
   Richardson S., 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.7681, 10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775]
   Sanyaolu Adekunle, 2020, SN Compr Clin Med, V2, P1069, DOI 10.1007/s42399-020-00363-4
   Sarangarajan R, 2021, J RACIAL ETHN HEALTH, V8, P973, DOI 10.1007/s40615-020-00853-0
   Schuler R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08300-7
   Schuler R, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004465
   Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268
   Su SL, 2014, SCI WORLD J, DOI 10.1155/2014/169798
   Yamamoto N, 2020, GENE, V758, DOI 10.1016/j.gene.2020.144944
   Yang YL, 2015, J RENIN-ANGIO-ALDO S, V16, P975, DOI 10.1177/1470320315598697
   Zhou J, 2015, INT J CLIN EXP PATHO, V8, P15079
NR 39
TC 2
Z9 2
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2392
J9 FRONT ENDOCRINOL
JI Front. Endocrinol.
PD AUG 19
PY 2021
VL 12
DI 10.3389/fendo.2021.688071
PG 11
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA UM8NU
UT WOS:000693583400001
PM 34489863
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Amankwah-Amoah, J
   Khan, Z
   Wood, G
AF Amankwah-Amoah, Joseph
   Khan, Zaheer
   Wood, Geoffrey
TI COVID-19 and business failures: The paradoxes of experience, scale, and
   scope for theory and practice
SO EUROPEAN MANAGEMENT JOURNAL
LA English
DT Article
DE Business failure; Paradox organizational failure; Closure; Exit;
   COVID-19; Novel global crisis
ID INSTITUTIONAL FIT; BANKRUPTCY; AGE; EXPLORATION; PERFORMANCE;
   LEGITIMACY; ALIGNMENT; INSIGHTS; TRENDS; DEATH
AB In light of growing scholarly works on business failure, across the social science domains, it is surprising that past studies have largely overlooked how extreme environmental shocks and 'black swan' events such as those caused by the coronavirus (COVID-19) pandemic and other global crises, can precipitate business failures. Drawing insights from the current literature on business failure and the unfolding event of COVID-19, we highlight the paradoxes posed by novel exogenous shocks (that is, shocks that transcend past experiences) and the implications for SMEs. The pandemic has accelerated the reconfi-guration of the relationship between states and markets, increasing the divide between those with political connections and those without, and it may pose new legitimacy challenges for some players even as others seem less concerned by such matters, whilst experiential knowledge resources may be both an advantage and a burden.
   (c) 2020 Elsevier Ltd. All rights reserved.
C1 [Amankwah-Amoah, Joseph] Univ Kent, Kent Business Sch, Canterbury ME4 4TE, Kent, England.
   [Khan, Zaheer] Univ Aberdeen, Business Sch, Kings Coll, Aberdeen AB24 3FX, Scotland.
   [Wood, Geoffrey] Western Univ, DAN Management, London, ON, Canada.
RP Amankwah-Amoah, J (corresponding author), Univ Kent, Kent Business Sch, Canterbury ME4 4TE, Kent, England.
EM J.Amankwah-Amoah@kent.ac.uk; zaheer.khan@abdn.ac.uk; gwood23@uwo.ca
RI Amankwah-Amoah, Joseph/AAO-7423-2021
OI Amankwah-Amoah, Joseph/0000-0003-0383-5831; Khan,
   Zaheer/0000-0001-5538-3123
CR Aldrich HE, 2001, ENTREP THEORY PRACT, V25, P41, DOI DOI 10.1177/104225870102500404
   Amankwah-Amoah J, 2020, J CLEAN PROD, V271, DOI 10.1016/j.jclepro.2020.123000
   Amankwah-Amoah J, 2020, BUS STRATEG ENVIRON, V29, P240, DOI 10.1002/bse.2361
   Amankwah-Amoah J, 2019, J BUS RES, V98, P367, DOI 10.1016/j.jbusres.2019.02.064
   Amankwah-Amoah J, 2019, J BUS RES, V97, P208, DOI 10.1016/j.jbusres.2019.01.036
   Amankwah-Amoah J, 2018, EUR MANAG REV, V15, P97, DOI 10.1111/emre.12131
   Amankwah-Amoah J, 2018, GROUP ORGAN MANAGE, V43, P648, DOI 10.1177/1059601116643447
   Amankwah-Amoah J, 2016, J BUS RES, V69, P3388, DOI 10.1016/j.jbusres.2016.02.005
   Andrews R, 2006, PUBLIC MANAG REV, V8, P273, DOI 10.1080/14719030600587612
   Bau M, 2017, ENTREP THEORY PRACT, V41, P909, DOI 10.1111/etap.12233
   Baum JAC, 1996, HDB ORG STUDIES, P77
   Boso N, 2019, J BUS RES, V98, P370, DOI 10.1016/j.jbusres.2018.01.063
   Bradley SW, 2011, STRATEGIC MANAGE J, V32, P486, DOI 10.1002/smj.887
   Cook L., 2020, COVID 19 IS ESCALATI
   Dahlin KB, 2018, ACAD MANAG ANN, V12, P252, DOI 10.5465/annals.2016.0049
   DAVENI RA, 1989, ACAD MANAGE J, V32, P577, DOI 10.2307/256435
   DAVENI RA, 1989, MANAGE SCI, V35, P1120, DOI 10.1287/mnsc.35.9.1120
   Desai VM, 2011, ACAD MANAGE J, V54, P263, DOI 10.5465/AMJ.2011.60263082
   DRAZIN R, 1986, ADMIN SCI QUART, V30, P514
   Dunn, 2020, STORY CORONAVIRUS IM
   Eisenhardt KM, 2000, STRATEGIC MANAGE J, V21, P1105, DOI 10.1002/1097-0266(200010/11)21:10/11<1105::AID-SMJ133>3.0.CO;2-E
   European Investment Bank, 2020, DOES THIS CHANG EV S
   Fleisher CS, 2010, J STRATEG MARK, V18, P553, DOI 10.1080/0965254X.2010.529152
   FREEMAN J, 1983, AM SOCIOL REV, V48, P692, DOI 10.2307/2094928
   Gammeltoft P, 2012, EUR MANAG J, V30, P175, DOI 10.1016/j.emj.2012.03.007
   Habersang S, 2019, J MANAGE STUD, V56, P19, DOI 10.1111/joms.12341
   Hamilton EA, 2006, GROUP ORGAN MANAGE, V31, P327, DOI 10.1177/1059601106286885
   Headd B, 2003, SMALL BUS ECON, V21, P51, DOI 10.1023/A:1024433630958
   Heracleous L, 2016, LONG RANGE PLANN, V49, P491, DOI 10.1016/j.lrp.2015.08.006
   International Civil Aviation Organization, 2020, TAKE OFF GUID AIR TR
   JENSEN MC, 1986, AM ECON REV, V76, P323
   Kucher A, 2020, REV MANAG SCI, V14, P633, DOI 10.1007/s11846-018-0303-2
   Lazonick W., 2019, PREDATORY VALUE EXTR
   Lejano RP, 2013, POLICY SCI, V46, P83, DOI 10.1007/s11077-012-9163-9
   McDermott J., 2019, CORPORATE SOC CLASS
   Mellahi K, 2004, INT J MANAG REV, V5-6, P21, DOI 10.1111/j.1460-8545.2004.00095.x
   Micelotta E, 2017, J MANAGE, V43, P1885, DOI 10.1177/0149206317699522
   Miller D, 1996, STRATEGIC MANAGE J, V17, P505, DOI 10.1002/(SICI)1097-0266(199607)17:7<505::AID-SMJ852>3.3.CO;2-9
   Nelson R, 1982, EVOLUTIONARY THEORY
   Opinium Research, 2020, IMP COR UK SMES
   Pereira V, 2020, ACAD MANAGE PERSPECT, V34, P480, DOI 10.5465/amp.2019.0023
   Rider CI, 2015, ORGAN SCI, V26, P633, DOI 10.1287/orsc.2014.0953
   Sabherwal R, 2001, ORGAN SCI, V12, P179, DOI 10.1287/orsc.12.2.179.10113
   Salaudeen A., 2020, AFRICAN AIRLINES LOS
   Shaver J.M., 2002, ASIA PACIFIC J MANAG, V19, P489, DOI DOI 10.1023/A:1020561407735
   Shepherd DA, 2003, ACAD MANAGE REV, V28, P318, DOI 10.2307/30040715
   SHEPPARD JP, 1994, J MANAGE, V20, P795, DOI 10.1016/0149-2063(94)90031-0
   Silverman BS, 1997, STRATEGIC MANAGE J, V18, P31, DOI 10.1002/(SICI)1097-0266(199707)18:1+<31::AID-SMJ920>3.3.CO;2-J
   SIRUNYAN AM, 2020, TIDAL WAVE BANKRUPTC, V80, DOI DOI 10.1140/epjc/s10052-019-7499-4
   Thompson JD., 1967, ORG ACTION
   Thornhill S, 2003, ORGAN SCI, V14, P497, DOI 10.1287/orsc.14.5.497.16761
   Volberda HW, 2012, ORGAN SCI, V23, P1040, DOI 10.1287/orsc.1110.0687
   Wenzel M, 2021, STRATEGIC MANAGE J, V42, pV7, DOI 10.1002/smj.3161
   Wolfsteller P., 2020, TRANSSTATES AIRLINES
   Wood G, 2015, ACAD MANAGE PERSPECT, V29, P271, DOI 10.5465/amp.2013.0006
   Wood G, 2014, INT J MANAG REV, V16, P384, DOI 10.1111/ijmr.12025
   World Health Organization (WHO), 2020, 137 WHO, P46
   Worldometer, 2020, COR CAS 2020
   Zhang HX, 2019, J BUS RES, V98, P415, DOI 10.1016/j.jbusres.2018.06.020
NR 59
TC 57
Z9 57
U1 24
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0263-2373
EI 1873-5681
J9 EUR MANAG J
JI Eur. Manag. J.
PD APR
PY 2021
VL 39
IS 2
BP 179
EP 184
DI 10.1016/j.emj.2020.09.002
EA MAR 2021
PG 6
WC Business; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA RF6PV
UT WOS:000634965100004
OA Green Accepted, Bronze
DA 2022-04-20
ER

PT J
AU Ul Haq, I
   Maneengam, A
   Chupradit, S
   Huo, CH
AF Ul Haq, Inzamam
   Maneengam, Apichit
   Chupradit, Supat
   Huo, Chunhui
TI Modeling the turnover intentions of Thai health-care personnel in
   pandemic times: moderating role of Covid-19 burnout
SO LEADERSHIP IN HEALTH SERVICES
LA English
DT Article; Early Access
DE Transformational leadership; Job satisfaction; Knowledge hiding;
   Covid-19 Burnout; Job turnover intentions; Pandemic; Health leadership
   initiatives; Health services
ID TRANSFORMATIONAL LEADERSHIP; JOB-SATISFACTION; MEDIATING ROLE;
   ORGANIZATIONAL COMMITMENT; BEHAVIORS; PERFORMANCE; SUCCESS; QUALITY;
   PEOPLE; IMPACT
AB Purpose Covid-19 cases are rising at a high rate in Thailand. Thailand's administration has formulated many initiatives to combat the spread of coronavirus. However, during a pandemic, health-care workers have a diverse range of tasks that make it more challenging to continue working in hospitals. Consequently, the authors modeled the turnover intentions of health-care personnel to capture relevant psychological aspects of employees during the pandemic. Specifically, this study aims to focused on the moderating role of Covid-19 burnout (CBO) in the relationship between transformational leadership (TL) and job turnover intentions (JTI) with job satisfaction (JS) and knowledge hiding (KH) as mediators. Design/methodology/approach This research collected data using self-administered questionnaire. A two-stage partial least square-structural equation modeling (PLS-SEM) is carried out as an analysis technique to measure the linear relationship among constructs. The study tests hypotheses (direct and indirect effects) using 310 sample size of health-care personnel. Findings The findings indicated that CBO intensified the JTI of health-care personnel and strengthened the association of JS and KH with JTI during the Covid-19 pandemic. TL had a negative indirect effect on JTI. In addition, JS had a negative impact on JTI. Originality/value The study highlights the importance of TL and JS as ways to reduce or alleviate JTI in health-care personnel during the Covid-19 pandemic in Thailand. Furthermore, CBO and KH can enhance JTI in health-care personnel.
C1 [Ul Haq, Inzamam] Comsats Univ Islamabad, Dept Management Sci, Islamabad, Pakistan.
   [Maneengam, Apichit] King Mongkuts Inst Technol North Bangkok, Dept Mech Engn Technol, Bangkok, Thailand.
   [Chupradit, Supat] Chiang Mai Univ, Fac Associated Med Sci, Dept Occupat Therapy, Chiang Mai, Thailand.
   [Huo, Chunhui] Liaoning Univ, Asia Australia Business Coll, Shenyang, Peoples R China.
RP Huo, CH (corresponding author), Liaoning Univ, Asia Australia Business Coll, Shenyang, Peoples R China.
EM huoch@lnu.edu.cn
CR Aga DA, 2016, INT J PROJ MANAG, V34, P806, DOI 10.1016/j.ijproman.2016.02.012
   Akhlaghimofrad A., 2021, MANAGEMENT SCI LETT, V11, P2081
   Almen N, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18073446
   Ariyabuddhiphongs V., 2017, Journal of Human Resources in Hospitality & Tourism, V16, P215, DOI 10.1080/15332845.2016.1202730
   Balogun AO, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17061925
   BASS BM, 1990, ORGAN DYN, V18, P19, DOI 10.1016/0090-2616(90)90061-S
   Berger V.W., 2005, ENCY STAT BEHAV SCI, V4, P1840
   Burns JM, 2005, LEADERSHIP-LONDON, V1, P11, DOI 10.1177/1742715005049347
   Cheng C, 2016, PERS REV, V45, P1200, DOI 10.1108/PR-05-2015-0118
   Choi SL, 2016, HUM RESOUR HEALTH, V14, DOI 10.1186/s12960-016-0171-2
   Coudounaris DN, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12177117
   Curado C, 2021, LEADERSH HEALTH SERV, DOI 10.1108/LHS-06-2021-0051
   De Boeck E, 2017, TRENDS FOOD SCI TECH, V62, P202, DOI 10.1016/j.tifs.2017.01.004
   Depret E, 1999, J EXP SOC PSYCHOL, V35, P461, DOI 10.1006/jesp.1999.1380
   Dolbier CL, 2005, AM J HEALTH PROMOT, V19, P194, DOI 10.4278/0890-1171-19.3.194
   Dwivedi S, 2015, INDIAN J IND RELAT, V50, P452
   Eberly MB, 2017, J VOCAT BEHAV, V102, P72, DOI 10.1016/j.jvb.2017.07.004
   Escartin J, 2017, WORK STRESS, V31, P42, DOI 10.1080/02678373.2017.1295113
   Gammoh BS, 2014, J PROD BRAND MANAG, V23, P543, DOI 10.1108/JPBM-10-2013-0434
   Gharakhani D., 2019, J HEALTH, V10, P109
   Hair J.F., 2017, INT J MULTIVAR DATA, V1, P107, DOI DOI 10.1504/IJMDA.2017.10008574
   Haq I.U., 2020, VILAKSHAN XIMB J MAN, V17, P39
   HERZBERG F, 1968, HARVARD BUS REV, V46, P53
   Isaac O, 2019, COMPUT EDUC, V136, P113, DOI 10.1016/j.compedu.2019.02.012
   Ishaque A., 2020, J BUSINESS EC, V12, P107
   Jabeen F, 2018, J ORGAN CHANGE MANAG, V31, P352, DOI 10.1108/JOCM-01-2017-0016
   Jankelova N, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9030346
   Jena LK, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.723938
   Kelloway E K, 1999, J Occup Health Psychol, V4, P337, DOI 10.1037/1076-8998.4.4.337
   Kim SW, 1996, HUM RELAT, V49, P947, DOI 10.1177/001872679604900704
   Kulari G, 2022, LEADERSH HEALTH SERV, DOI 10.1108/LHS-06-2021-0060
   Kuo HT, 2014, J NURS MANAGE, V22, P225, DOI 10.1111/jonm.12044
   Labrague LJ, 2020, J NURS MANAGE, V28, P1104, DOI 10.1111/jonm.13053
   Ladan S., 2017, J BUSINESS RETAIL MA, V11, P60
   Ladan S., 2017, INT J BUSINESMANAG, V7, P261
   Lambert EG, 2018, J POLICE CRIM PSYCHO, V33, P85, DOI 10.1007/s11896-017-9236-y
   Leach L, 2021, LEADERSH HEALTH SERV, V34, P353, DOI 10.1108/LHS-03-2021-0011
   Lepold A, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071362
   Leunissen JM, 2018, J OCCUP HEALTH PSYCH, V23, P44, DOI 10.1037/ocp0000059
   Li JF, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020714
   Lin R.S.-J., 2014, INT J INNOVATION MAN, V5, P171
   Liu F, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18126418
   LONGSHORE JM, 1987, ACAD MANAGE REV, V12, P756, DOI 10.2307/258081
   Misiolek-Marin A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249267
   Mittal S, 2016, INT J MANPOWER, V37, P1322, DOI 10.1108/IJM-10-2014-0202
   Muterera J, 2018, INT PUBLIC MANAG J, V21, P131, DOI 10.1080/10967494.2015.1106993
   Nimer A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041557
   Nonnis M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18073726
   OREILLY CA, 1991, ACAD MANAGE J, V34, P487, DOI 10.2307/256404
   Park T, 2020, CHILD YOUTH SERV REV, V108, DOI 10.1016/j.childyouth.2019.104624
   Peachey JW, 2014, LEADERSHIP ORG DEV J, V35, P740, DOI 10.1108/LODJ-10-2012-0128
   Peng H, 2013, J KNOWL MANAG, V17, P398, DOI 10.1108/JKM-12-2012-0380
   Peng H, 2012, INT J SELECT ASSESS, V20, P119, DOI 10.1111/j.1468-2389.2012.00586.x
   Piccolo RF, 2006, ACAD MANAGE J, V49, P327
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Promchart K, 2020, J BEHAV SCI, V15, P16
   Puni A, 2018, LEADERSHIP ORG DEV J, V39, P522, DOI 10.1108/LODJ-11-2017-0358
   Riza SD, 2018, J MANAGE, V44, P2558, DOI 10.1177/0149206315624962
   Sammut R, 2020, LEADERSH HEALTH SERV, V33, P385, DOI 10.1108/LHS-01-2020-0002
   Sarstedt M., 2017, HDB MARKET RES, V26, P1, DOI DOI 10.1007/978-3-319-05542-8_15-1
   Scuotto V, 2022, J BUS RES, V140, P76, DOI 10.1016/j.jbusres.2021.11.045
   SHAMIR B, 1993, ORGAN SCI, V4, P577, DOI 10.1287/orsc.4.4.577
   Shkoler O, 2017, J WORK ORGAN PSYCHOL, V33, P157, DOI 10.1016/j.rpto.2017.05.002
   Specchia ML, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041552
   SPENCER DG, 1983, J OCCUP PSYCHOL, V56, P137, DOI 10.1111/j.2044-8325.1983.tb00121.x
   Sygit-Kowalkowska E, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18084282
   Tengilimoglu D, 2021, LEGAL MED-TOKYO, V48, DOI 10.1016/j.legalmed.2020.101811
   Thant ZM, 2021, PUBLIC ORGAN REV, V21, P157, DOI 10.1007/s11115-020-00481-6
   Tse HHM, 2013, LEADERSHIP QUART, V24, P763, DOI 10.1016/j.leaqua.2013.07.005
   Ul Haq I, 2020, INT J FINANC ENG, V7, DOI 10.1142/S2424786320500267
   Viotti S, 2021, MED LAV, V112, P209, DOI 10.23749/mdl.v112i3.10732
   Wells JE, 2011, TEAM PERFORM MANAG, V17, P23, DOI 10.1108/13527591111114693
   Wong M.M.L., 2021, J WORK-APPL MANAG, V13, P284
   Yang XY, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18084223
   Yang YF, 2016, PSYCHOL REP, V119, P154, DOI 10.1177/0033294116657586
   Yildirim M, 2022, DEATH STUD, V46, P524, DOI 10.1080/07481187.2020.1818885
   Yucel I, 2021, ADM SCI, V11, DOI 10.3390/admsci11030081
   Zhang Y., 2016, J HUMAN RESOURCE SUS, V4, P85
   Zhang Z, 2021, J KNOWL MANAG, DOI 10.1108/JKM-02-2021-0155
NR 79
TC 0
Z9 0
U1 0
U2 0
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1751-1879
EI 1751-1887
J9 LEADERSH HEALTH SERV
JI Leadersh. Health Serv.
DI 10.1108/LHS-11-2021-0090
EA APR 2022
PG 19
WC Health Policy & Services
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services
GA 0K7DO
UT WOS:000780950500001
PM 35363454
OA Bronze
DA 2022-04-20
ER

PT J
AU Sit, SMM
   Lam, TH
   Lai, AYK
   Wong, BYM
   Wang, MP
   Ho, SY
AF Sit, Shirley Man-Man
   Tai-Hing Lam
   Lai, Agnes Yuen-Kwan
   Wong, Bonny Yee-Man
   Wang, Man-Ping
   Ho, Sai-Yin
TI Fear of COVID-19 and its associations with perceived personal and family
   benefits and harms in Hong Kong
SO TRANSLATIONAL BEHAVIORAL MEDICINE
LA English
DT Article
DE COVID-19; Fear; Mental health; Perceived benefits and harms; Family;
   Well-being
AB Fear of COVID-19 is associated with public health compliance but also with negative well-being; however, no articles have reported associations of such fear with perceived benefits and harms. We assessed the level of fear of COVID-19 in Hong Kong adults and its associations with sociodemographic factors and perceived benefits and harms of COVID-19. In a 6-day population-based cross-sectional online survey in May 2020, 4,890 adults provided data on fear and perceived benefits and harms, personal happiness and family well-being, and sociodemographic characteristics. Linear regression was used to analyze associations. The level of fear was moderate (mean score 6.3/10). Fewer respondents reported perceived benefits (10.6%-21.7%) than harms (13.4%-43.5%). Females, younger age groups, and respondents with lower education or more cohabitants had greater fear. Fear was associated with perceived personal (increased knowledge of personal epidemic prevention) and family benefits (improved family hygiene), both with a very small effect size (Cohen's d = 0.03). Fear was also associated with lower personal happiness and perceived personal (increased negative emotions, feeling depressed and anxious, decreased income, and decreased work efficiency) and family harms (increased conflicts and negative emotions among family members), with small effect sizes (0.08-0.37). We have first shown sociodemographic differences in the fear of COVID-19 and such fear was associated with both perceived personal and family benefits and harms of COVID-19. Our findings may guide the management of fear to reduce sociodemographic differences, and maximize benefits and minimize harms.
C1 [Sit, Shirley Man-Man; Tai-Hing Lam; Wong, Bonny Yee-Man; Ho, Sai-Yin] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Peoples R China.
   [Lai, Agnes Yuen-Kwan; Wang, Man-Ping] Univ Hong Kong, Sch Nursing, Hong Kong, Peoples R China.
RP Lai, AYK (corresponding author), Univ Hong Kong, Sch Nursing, Hong Kong, Peoples R China.
EM agneslai@hku.hk
OI Sit, Shirley/0000-0002-8429-707X; LAI, Agnes Yuen
   Kwan/0000-0002-7321-2632; Wong, Bonny Yee-Man/0000-0002-7642-1528
FU Hong Kong Jockey Club Charities Trust
FX This study was funded by the Hong Kong Jockey Club Charities Trust.
CR Ahorsu DK, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00270-8
   Bakioglu F, 2021, INT J MENT HEALTH AD, V19, P2369, DOI 10.1007/s11469-020-00331-y
   Campbell A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0078
   Centre for Health Protection, LAT SIT CAS COVID 19
   Cheng Kar Keung, 2020, Lancet, DOI 10.1016/S0140-6736(20)30918-1
   Choi EPH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103740
   Cowling BJ, 2020, LANCET PUBLIC HEALTH, V5, pE279, DOI 10.1016/S2468-2667(20)30090-6
   Else-Quest NM, 2006, PSYCHOL BULL, V132, P33, DOI 10.1037/0033-2909.132.1.33
   Fitzpatrick KM, 2020, DEPRESS ANXIETY, V37, P957, DOI 10.1002/da.23080
   Fitzpatrick KM, 2020, PSYCHOL TRAUMA-US, V12, pS17, DOI 10.1037/tra0000924
   Gasparro R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155338
   Harper CA, 2021, INT J MENT HEALTH AD, V19, P1875, DOI 10.1007/s11469-020-00281-5
   Ho HCY, 2016, J FAM PSYCHOL, V30, P752, DOI 10.1037/fam0000233
   Ho HCY, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00638
   Hong Kong Census and Statistics Department, 2019, CENS
   Hong Kong Census and Statistics Department, 2019, TABL 002 POP AG GROU
   Hong Kong Population Bycensus, 2016, SUMM RES 2016 POP BY
   Hong Kong Public Opinion Research Institute, HKPOP PANEL
   Kok G, 2014, INT J PSYCHOL, V49, P98, DOI 10.1002/ijop.12001
   Lai AYK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00434
   Lee, 2020, S CHINA MORNING POST
   Lu W, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112936
   Nella D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/673623
   Ornell F, 2020, BRAZ J PSYCHIAT, V42, P232, DOI 10.1590/1516-4446-2020-0008
   Person B, 2004, EMERG INFECT DIS, V10, P358, DOI 10.3201/eid1002.030750
   Reznik A, 2021, INT J MENT HEALTH AD, V19, P1903, DOI 10.1007/s11469-020-00283-3
   Sasaki N, 2020, J OCCUP HEALTH, V62, DOI 10.1002/1348-9585.12134
   Satici B, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00305-0
   Shen C, 2019, QUAL LIFE RES, V28, P535, DOI 10.1007/s11136-018-2019-9
   Shigemura J, 2020, PSYCHIAT CLIN NEUROS, V74, P281, DOI 10.1111/pcn.12988
   Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83
   Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1
   Yadav Sankalp, 2015, J Clin Diagn Res, V9, pLA01, DOI 10.7860/JCDR/2015/15127.6559
   Yildirim M, 2021, PERS INDIV DIFFER, V168, DOI 10.1016/j.paid.2020.110347
   Yildirim M, 2021, PSYCHOL HEALTH MED, V26, P35, DOI 10.1080/13548506.2020.1776891
NR 35
TC 10
Z9 10
U1 5
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1869-6716
EI 1613-9860
J9 TRANSL BEHAV MED
JI Transl. Behav. Med.
PD MAR
PY 2021
VL 11
IS 3
BP 793
EP 801
DI 10.1093/tbm/ibab018
EA MAR 2021
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA SA6FG
UT WOS:000649397400013
PM 33755146
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Satu, MS
   Khan, MI
   Mahmud, M
   Uddin, S
   Summers, MA
   Quinn, JMW
   Moni, MA
AF Satu, Md Shahriare
   Khan, Md Imran
   Mahmud, Mufti
   Uddin, Shahadat
   Summers, Matthew A.
   Quinn, Julian M. W.
   Moni, Mohammad Ali
TI TClustVID: A novel machine learning classification model to investigate
   topics and sentiment in COVID-19 tweets
SO KNOWLEDGE-BASED SYSTEMS
LA English
DT Article
DE COVID-19; Twitter data; Machine learning; TClustVID; Classification;
   Topics modeling
ID SOCIAL MEDIA
AB COVID-19, caused by SARS-CoV2 infection, varies greatly in its severity but presents with serious respiratory symptoms with vascular and other complications, particularly in older adults. The disease can be spread by both symptomatic and asymptomatic infected individuals. Uncertainty remains over key aspects of the virus infectiousness (particularly the newly emerging variants) and the disease has had severe economic impacts globally. For these reasons, COVID-19 is the subject of intense and widespread discussion on social media platforms including Facebook and Twitter. These public forums substantially influence public opinions and in some cases can exacerbate the widespread panic and misinformation spread during the crisis. Thus, this work aimed to design an intelligent clustering-based classification and topic extracting model named TClustVID that analyzes COVID-19-related public tweets to extract significant sentiments with high accuracy. We gathered COVID-19 Twitter datasets from the IEEE Dataport repository and employed a range of data preprocessing methods to clean the raw data, then applied tokenization and produced a word-to-index dictionary. Thereafter, different classifications were employed on these datasets which enabled the exploration of the performance of traditional classification and TClustVID. Our analysis found that TClustVID showed higher performance compared to traditional methodologies that are determined by clustering criteria. Finally, we extracted significant topics from the clusters, split them into positive, neutral and negative sentiments, and identified the most frequent topics using the proposed model. This approach is able to rapidly identify commonly prevailing aspects of public opinions and attitudes related to COVID-19 and infection prevention strategies spreading among different populations. (C) 2021 Published by Elsevier B.V.
C1 [Satu, Md Shahriare] Noakhali Sci & Technol Univ, Dept Management Informat Syst, Noakhali 3814, Bangladesh.
   [Khan, Md Imran] Gono Bishwabidyalay, Dept Comp Scienc & Engn, Dhaka 1344, Bangladesh.
   [Mahmud, Mufti] Nottingham Trent Univ, Dept Comp Sci, Clifton Campus, Nottingham NG11 8NS, England.
   [Mahmud, Mufti] Nottingham Trent Univ, Med Technol Innovat Facil, Clifton Campus, Nottingham NG11 8NS, England.
   [Uddin, Shahadat] Univ Sydney, Fac Engn, Complex Syst Res Grp, Darlington, NSW 2008, Australia.
   [Summers, Matthew A.; Quinn, Julian M. W.; Moni, Mohammad Ali] Garvan Inst Med Res, Hlth Ageing Theme, Darlinghurst, NSW 2010, Australia.
   [Moni, Mohammad Ali] Univ New South Wales, UNSW Digital Hlth, WHO Collaborating Ctr eHlth, Fac Med,Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia.
RP Moni, MA (corresponding author), Garvan Inst Med Res, Hlth Ageing Theme, Darlinghurst, NSW 2010, Australia.
EM m.moni@unsw.edu.au
RI Mahmud/C-7752-2012
OI Mahmud/0000-0002-2037-8348; Khan, Md. Imran/0000-0002-7398-5280; Moni,
   Mohammad Ali/0000-0003-0756-1006; Satu, Md.
   Shahriare/0000-0003-1007-572X
CR Ahmed S, 2020, 2020 2 INT SUST RES, P1, DOI 10.1109/R10-HTC49770.2020.9357016
   Ahuja S., 2017, 2017 2 INT C TEL NET
   Akay A, 2015, IEEE J BIOMED HEALTH, V19, P210, DOI 10.1109/JBHI.2014.2336251
   Al-Rakhami MS, 2020, IEEE ACCESS, V8, P155961, DOI 10.1109/ACCESS.2020.3019600
   Aljameel SS, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18010218
   Alnajran N, 2017, ICAART: PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON AGENTS AND ARTIFICIAL INTELLIGENCE, VOL 2, P239, DOI 10.5220/0006202802390249
   Alomari E, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18010282
   Baird A., IEEE INTELL SYST, V36
   Behera RK, 2021, INFORM PROCESS MANAG, V58, DOI 10.1016/j.ipm.2020.102435
   Boon-Itt S, 2020, JMIR PUBLIC HLTH SUR, V6, P245, DOI 10.2196/21978
   Cambria E, 2020, CIKM '20: PROCEEDINGS OF THE 29TH ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT, P105, DOI 10.1145/3340531.3412003
   Cambria E, 2016, IEEE INTELL SYST, V31, P102, DOI 10.1109/MIS.2016.31
   Cambria E, 2010, LECT NOTES COMPUT SC, V5967, P148
   Chaturvedi I, 2019, PATTERN RECOGN LETT, V125, P264, DOI 10.1016/j.patrec.2019.04.024
   Dragoni M, 2018, IEEE INTELL SYST, V33, P77, DOI 10.1109/MIS.2018.033001419
   Fiander DJ, 2012, CHAND PUBL SOC MEDIA, P193
   Gencoglu O, 2020, MACH LEARN KNOW EXTR, V2, P603, DOI 10.3390/make2040032
   Godfrey D., 2014, ARXIV PREPRINT ARXIV
   Hung M, 2020, J MED INTERNET RES, V22, DOI 10.2196/22590
   Imran AS, 2020, IEEE ACCESS, V8, P181074, DOI 10.1109/ACCESS.2020.3027350
   Jiang Q., IEEE INTELL SYST, V36, P75
   Kaur S., 2020, PROCEDIA COMPUTER SC, V177, P423
   Khatua A, 2019, INFORM PROCESS MANAG, V56, P247, DOI 10.1016/j.ipm.2018.10.010
   Kouzy R, 2020, CUREUS, V12, DOI 10.7759/cureus.7255
   Lamsal R, 2020, Corona virus (covid-19) tweets dataset, DOI 10.21227/781w-ef42
   Lee KH, 2011, ACTA HORTIC, V900, P251, DOI 10.1109/ICDMW.2011.171
   Li TR, 2019, FRONT PHYS-LAUSANNE, V7, DOI 10.3389/fphy.2019.00098
   Lippi G., 2020, CLIN CHIM ACTA INT J
   Long ZJ, 2020, IEEE ACCESS, V8, P136046, DOI 10.1109/ACCESS.2020.3011123
   Mackey Tim, 2020, JMIR Public Health Surveill, V6, pe19509, DOI 10.2196/19509
   Mamgain Nehal, 2016, 2016 International Conference on Computational Techniques in Information and Communication Technologies (ICCTICT). Proceedings, P525, DOI 10.1109/ICCTICT.2016.7514636
   McCord M., 2011, Autonomic and Trusted Computing. Proceedings 8th International Conference (ATC 2011), P175, DOI 10.1007/978-3-642-23496-5_13
   Medford R. J., 2020, INFODEMIC LEVERAGING
   Nemes L, 2021, J INFORM TELECOMMUN, V5, P1, DOI 10.1080/24751839.2020.1790793
   Nguyen D.T., 2016, ARXIV PREPRINT ARXIV
   Ong V, 2017, FED CONF COMPUT SCI, P367, DOI 10.15439/2017F359
   Pedregosa F, 2011, J MACH LEARN RES, V12, P2825
   Pennington J., 2014, P 2014 C EMPIRICAL M, P1532
   Poria S, 2018, IEEE INTELL SYST, V33, P17, DOI 10.1109/MIS.2018.2882362
   Pratama BY, 2015, 2015 INTERNATIONAL CONFERENCE ON DATA AND SOFTWARE ENGINEERING (ICODSE), P170, DOI 10.1109/ICODSE.2015.7436992
   Samuel J, 2020, INFORMATION, V11, DOI 10.3390/info11060314
   Sang K, 2021, J RECEPT SIG TRANSD, V41, P442, DOI 10.1080/10799893.2020.1819319
   Satu M.S., APPL SCI
   Sethi Manoj, 2020, 2020 International Conference on Electronics and Sustainable Communication Systems (ICESC). Proceedings, P509, DOI 10.1109/ICESC48915.2020.9155674
   Xiang XL, 2021, J GERONTOL B-PSYCHOL, V76, pE190, DOI 10.1093/geronb/gbaa128
   Xu RH, 2004, EMERG INFECT DIS, V10, P1030, DOI 10.3201/eid1006.030852
   Xue J, 2020, J MED INTERNET RES, V22, DOI 10.2196/20550
   Xue J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239441
   Yin H, 2020, LECT NOTES ARTIF INT, V12447, P610, DOI 10.1007/978-3-030-65390-3_46
   Zhang HS, 2020, J AM MED INFORM ASSN, V27, P225, DOI 10.1093/jamia/ocz191
   Zhang X, 2020, PREDICTING CORONAVIR
NR 51
TC 12
Z9 12
U1 4
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0950-7051
EI 1872-7409
J9 KNOWL-BASED SYST
JI Knowledge-Based Syst.
PD AUG 17
PY 2021
VL 226
AR 107126
DI 10.1016/j.knosys.2021.107126
EA MAY 2021
PG 16
WC Computer Science, Artificial Intelligence
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Computer Science
GA SV1ZS
UT WOS:000663624500009
PM 33972817
OA Green Published, Bronze, Green Submitted
DA 2022-04-20
ER

PT J
AU Zhang, F
   Shih, SF
   Harapan, H
   Rajamoorthy, Y
   Chang, HY
   Singh, A
   Lu, YH
   Wagner, AL
AF Zhang, Felicia
   Shih, Shu-Fang
   Harapan, Harapan
   Rajamoorthy, Yogambigai
   Chang, Hao-Yuan
   Singh, Awnish
   Lu, Yihan
   Wagner, Abram L.
TI Changes in COVID-19 risk perceptions: methods of an internet survey
   conducted in six countries
SO BMC RESEARCH NOTES
LA English
DT Article
DE COVID-19; Vaccine hesitancy; Risk perceptions; Behavioral; attitudinal
   changes
AB Objectives This study assessed changes in behaviors/attitudes related to the COVID-19. With the understanding that behaviors and vaccine decision-making could contribute to global spread of infectious diseases, this study collected several waves of internet-based surveys from individuals in the United States, mainland China, Taiwan, Malaysia, Indonesia, and India. The aims of this study were to (1) characterize the relationship between the epidemiology of disease and changes over time in risk perceptions, knowledge, and attitudes towards hygienic behaviors; (2) examine if risk perceptions affect acceptance of less-than-ideal vaccines; and (3) contrast adherence to public health recommendations across countries which have had different governmental responses to the outbreak. Data description We conducted cross-sectional online surveys in six countries from March 2020 to April 2021. By the end of June 2021, there will be six waves of surveys for the United States and China, and four waves for the rest of countries. There are common sets of questions for all countries, however, some questions were adapted to reflect local situations and some questions were designed intentionally for specific countries to capture different COVID-19 mitigation actions. Participants were asked about their adherence towards countermeasures, risk perceptions, and acceptance of a hypothetical vaccine for COVID-19.
C1 [Zhang, Felicia; Wagner, Abram L.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Shih, Shu-Fang] Virginia Commonwealth Univ, Dept Hlth Adm, Coll Hlth Profess, Richmond, VA 23298 USA.
   [Harapan, Harapan] Univ Syiah Kuala, Sch Med, Med Res Unit, Banda Aceh 23111, Indonesia.
   [Harapan, Harapan] Univ Syiah Kuala, Sch Med, Trop Dis Ctr, Banda Aceh 23111, Indonesia.
   [Harapan, Harapan] Univ Syiah Kuala, Sch Med, Dept Micro Biol, Banda Aceh 23111, Indonesia.
   [Rajamoorthy, Yogambigai] Univ Tunku Abdul Rahman, Fac Accountancy & Management, Dept Econ, Sungai Long Campus, Kajang 43000, Selangor, Malaysia.
   [Chang, Hao-Yuan] Natl Taiwan Univ, Sch Nursing, Coll Med, Taipei 10051, Taiwan.
   [Chang, Hao-Yuan] Natl Taiwan Univ Hosp, Dept Nursing, Taipei 10051, Taiwan.
   [Singh, Awnish] Natl Inst Hlth & Family Welfare, Natl Tech Advisory Grp Immunisat Secretariat, New Delhi 110067, India.
   [Lu, Yihan] Fudan Univ Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ, Shanghai 200032, Peoples R China.
RP Wagner, AL (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.
EM awag@umich.edu
RI Harapan, Harapan/I-8741-2016
OI Harapan, Harapan/0000-0001-7630-8413; CHANG,
   HAO-YUAN/0000-0001-5810-7562; Wagner, Abram/0000-0003-4691-7802
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [K01AI137123]; National Science
   Foundation, Division of Social and Economic SciencesNational Science
   Foundation (NSF) [2027836]
FX Waves 1 in the United States and in China were supported by the National
   Institute of Allergy and Infectious Diseases of the National Institutes
   of Health (Award Number K01AI137123). The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health. The other waves
   were supported by an award from the National Science Foundation,
   Division of Social and Economic Sciences (Award Number: #2027836).
CR Akel KB, 2021, HUM VACC IMMUNOTHER, V17, P2639, DOI 10.1080/21645515.2021.1884476
   Center for Systems Science and Engineering, 2020, COR COVID 19 GLOB CA
   Centers for Disease Control and Prevention, 2019, SEASONAL INFLUENZA V
   Dynata, 2021, DAT INS PLATF
   Gidengil CA, 2012, AM J PUBLIC HEALTH, V102, P672, DOI 10.2105/AJPH.2011.300407
   Hale T, 2021, NAT HUM BEHAV, V5, P529, DOI 10.1038/s41562-021-01079-8
   Izrael D, 2000, P 25 ANN SAS US GROU, P1350
   Larson HJ, 2015, VACCINE, V33, P4165, DOI 10.1016/j.vaccine.2015.04.037
   Lu J, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050472
   Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8
   The special committee for ensuring access to covid-19 vaccine supply (JKJAV), 2021, NAT COV 19 IMM PROGR
   US Census, 2021, INT DAT BAS
   Uzicanin A, 2011, J INFECT DIS, V204, pS133, DOI 10.1093/infdis/jir102
   Wagner AL, 2021, HUM VACC IMMUNOTHER, V17, P2940, DOI 10.1080/21645515.2021.1917233
   Wagner AL, 2021, COVID 19 VACCINE HES, DOI [10.3886/E130422V2, DOI 10.3886/E130422V2]
NR 15
TC 1
Z9 1
U1 3
U2 3
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 1756-0500
J9 BMC RES NOTES
JI BMC Res. Notes
PD NOV 25
PY 2021
VL 14
IS 1
AR 428
DI 10.1186/s13104-021-05846-8
PG 3
WC Biology; Multidisciplinary Sciences
WE Emerging Sources Citation Index (ESCI)
SC Life Sciences & Biomedicine - Other Topics; Science & Technology - Other
   Topics
GA XD3JK
UT WOS:000722606800005
PM 34823587
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Hogberg, K
AF Hogberg, Karin
TI Between hope and despair sensegiving and sensemaking in hotel
   organizations during the COVID-19 crisis
SO JOURNAL OF HOSPITALITY AND TOURISM MANAGEMENT
LA English
DT Article
DE Sensemaking; Sensegiving; Hotel employees; Leadership; Followership;
   COVID-19
ID NARRATIVE INQUIRY; LEADERSHIP; PERFORMANCE; HOSPITALITY; MANAGEMENT;
   STYLES
AB The COVID-19 crisis has had a severe impact on the hospitality industry and its actors. In a very short period of time, hotels were shut down or lost most of their bookings, faced huge financial losses and went into crisis mode. During the pandemic, the hotel industry has struggled with ever-changing restrictions which have had large effects on the industry as a whole as well as on organizations and individual employees. There are obviously challenges for both leaders and followers in the hospitality industry related to this worldwide crisis. The aim of this paper is to study how leaders practice sensegiving and how employees make sense of the changed conditions during the COVID-19 crisis in hotel organizations. The following research question is asked: How do leaders practice sensegiving and how does the process of sensemaking among employees evolve over time? Data were collected in five hotels in Sweden, Norway and Denmark from March 2020 to April 2021 by conducting in-depth interviews with hotel managers and employees. A sensegiving and sensemaking approach was used as an analytical lens. The findings illustrate a reciprocal process of making sense of the crisis between leaders and followers. Furthermore, the results show that the pandemic blurred boundaries between private and professional life that had effects on both the sensegiving and sensemaking processes. To the author's knowledge, few studies have focused on the interplay between leaders' sensegiving practices and followers' sensemaking process during crisis. Furthermore, few studies have investigated sensemaking at all in the hospitality industry.
C1 [Hogberg, Karin] Univ West, Gustava Melins Gata 2, S-43162 Trollhattan, Sweden.
RP Hogberg, K (corresponding author), Univ West, Gustava Melins Gata 2, S-43162 Trollhattan, Sweden.
EM karin.hogberg@hv.se
CR Agho A., 2009, J LEADERSH ORG STUD, V16, P159, DOI DOI 10.1177/1548051809335360
   Alegbeleye ID, 2020, J LEADERSH STUD, V13, P6, DOI 10.1002/jls.21673
   Alkandari A., 2017, J SOCIAL SCI COES RJ, V6, P833, DOI DOI 10.25255/JSS.2017.6.4.833.850
   Alvesson M, 2003, LEADERSHIP QUART, V14, P359, DOI 10.1016/S1048-9843(03)00031-6
   Alvesson M, 2016, J MANAGE INQUIRY, V25, P139, DOI 10.1177/1056492615589974
   AVOLIO BJ, 1995, LEADERSHIP QUART, V6, P199, DOI 10.1016/1048-9843(95)90035-7
   Backhaus L, 2021, PUBLIC MANAG REV, DOI 10.1080/14719037.2021.1906935
   Baker S.D., 2007, J LEADERSHIP ORG STU, V14, P50, DOI [10.1177/0002831207304343, DOI 10.1177/0002831207304343]
   Baker SD, 2014, FOLLOWERSHIP: WHAT IS IT AND WHY DO PEOPLE FOLLOW?, P73
   Bass BM, 2003, J APPL PSYCHOL, V88, P207, DOI 10.1037/0021-9010.88.2.207
   Blanchard AL, 2009, PSYCHOL-MANAG J, V12, P111, DOI 10.1080/10887150902888718
   BOJE DM, 1991, ADMIN SCI QUART, V36, P106, DOI 10.2307/2393432
   Bresnen MJ, 1995, LEADERSHIP QUART, V6, P495, DOI 10.1016/1048-9843(95)90024-1
   Bundy J, 2017, J MANAGE, V43, P1661, DOI 10.1177/0149206316680030
   Burhan M, 2021, INT J HOSP MANAG, V98, DOI 10.1016/j.ijhm.2021.103037
   Campo S, 2014, INT J CONTEMP HOSP M, V26, P1292, DOI 10.1108/IJCHM-08-2013-0373
   Carsten MK, 2010, LEADERSHIP QUART, V21, P543, DOI 10.1016/j.leaqua.2010.03.015
   Chen HL, 2022, CURR ISSUES TOUR, V25, P198, DOI 10.1080/13683500.2020.1763269
   Chen MH, 2011, INT J HOSP MANAG, V30, P200, DOI 10.1016/j.ijhm.2010.06.005
   Christianson MK, 2021, J MANAGE STUD, V58, P572, DOI 10.1111/joms.12658
   Christianson MK, 2019, ADMIN SCI QUART, V64, P45, DOI 10.1177/0001839217750856
   Clandinin DJ, 2006, RES STUD MUSIC EDUC, V27, P44, DOI 10.1177/1321103X060270010301
   Clifton J, 2014, LEADERSHIP-LONDON, V10, P99, DOI 10.1177/1742715013504428
   Cunliffe AL, 2011, HUM RELAT, V64, P1425, DOI 10.1177/0018726711418388
   Deale CS, 2016, J TEACH TRAVEL TOUR, V16, P235, DOI 10.1080/15313220.2016.1180964
   DUTTON JE, 1986, J MANAGE STUD, V23, P501, DOI 10.1111/j.1467-6486.1986.tb00434.x
   Dvir T, 2003, LEADERSHIP QUART, V14, P327, DOI 10.1016/S1048-9843(03)00018-3
   Estefan A, 2016, NARRAT WORKS, V6, P15
   Fairhurst GT, 2012, LEADERSHIP QUART, V23, P1043, DOI 10.1016/j.leaqua.2012.10.005
   Filstad C, 2014, J WORKPLACE LEARN, V26, P3, DOI 10.1108/JWL-03-2012-0016
   Ghaderi Z, 2021, J HOSP TOUR INSIGHTS, DOI 10.1108/JHTI-10-2020-0199
   GIOIA DA, 1991, STRATEGIC MANAGE J, V12, P433, DOI 10.1002/smj.4250120604
   Gossling S, 2021, J SUSTAIN TOUR, V29, P733, DOI 10.1080/09669582.2021.1873353
   Hotho, 2006, MANAGE DECIS, V44
   House R. J., 1993, LEADERSHIP THEORY RE, P81
   Huertas-Valdivia I, 2019, TOURISM MANAGE, V71, P402, DOI 10.1016/j.tourman.2018.10.027
   Humphries, 1999, ADV QUALITATIVE ORG, V2, P37
   KELLEY RE, 1988, HARVARD BUS REV, V66, P142
   Le D, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2020.102808
   Lofland J., 2006, ANAL SOCIAL SETTINGS, V4th
   Maitlis S, 2007, ACAD MANAGE J, V50, P57
   Maitlis S, 2010, J MANAGE STUD, V47, P551, DOI 10.1111/j.1467-6486.2010.00908.x
   Mumford MD, 2007, LEADERSHIP QUART, V18, P515, DOI 10.1016/j.leaqua.2007.09.002
   Novikov V., 2016, EMERGING LEADERSHIP, V9, P9
   Pforr C., 2007, Journal of Travel & Tourism Marketing, V23, P249
   Ritchie BW, 2019, ANN TOURISM RES, V79, DOI 10.1016/j.annals.2019.102812
   Sahin S, 2015, WORLD CONFERENCE ON TECHNOLOGY, INNOVATION AND ENTREPRENEURSHIP, P2298, DOI 10.1016/j.sbspro.2015.06.181
   Sakurai M, 2020, EUR J INFORM SYST, V29, P585, DOI 10.1080/0960085X.2020.1814171
   Santana G., 2003, Journal of Travel & Tourism Marketing, V15, P299, DOI 10.1300/J073v15n04_05
   Sashkin M., 2004, NATURE LEADERSHIP, P179
   Schildt H, 2020, ORGAN STUD, V41, P241, DOI 10.1177/0170840619847718
   Schindler J. H, 2012, THESIS WALDEN U
   Seto I., 2018, P ISCRAM AS PAC
   Shamir B., 2007, FOLLOWER CTR PERSPEC, P9
   Sonenshein S, 2010, ACAD MANAGE J, V53, P477, DOI 10.5465/AMJ.2010.51467638
   Sparr JL, 2018, J CHANG MANAG, V18, P162, DOI 10.1080/14697017.2018.1446696
   Speakman M, 2012, J DESTIN MARK MANAGE, V1, P67, DOI 10.1016/j.jdmm.2012.05.003
   Spillane J.P., 2012, DISTRIBUTED LEADERSH, V4
   Stafford G., 2002, Cornell Hotel and Restaurant Administration Quarterly, V43, P27, DOI 10.1016/S0010-8804(02)80054-4
   Tallberg J, 2010, INT STUD QUART, V54, P241, DOI 10.1111/j.1468-2478.2009.00585.x
   Taylor J. R., 2000, LEAS COMMUNICATION S
   Tengblad S, 2006, J MANAGE STUD, V43, P1437, DOI 10.1111/j.1467-6486.2006.00651.x
   Tew P. J., 2008, International Journal of Contemporary Hospitality Management, V20, P332, DOI 10.1108/09596110810866145
   Thiel CE, 2012, J BUS ETHICS, V107, P49, DOI 10.1007/s10551-012-1299-1
   Vasickova V., 2019, ACTA OECONOMICA PRAG, V27, P61
   Viitala R, 2014, J HEALTH ORGAN MANAG, V28, P602, DOI 10.1108/JHOM-02-2014-0032
   Visentin M, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2020.102820
   Weick K.E., 1979, SOCIAL PSYCHOL ORG, V2nd
   Weick K.E., 1995, SENSEMAKING ORG
   Weick KE, 2010, J MANAGE STUD, V47, P537, DOI 10.1111/j.1467-6486.2010.00900.x
   Weick KE, 2005, ORGAN SCI, V16, P409, DOI 10.1287/orsc.1050.0133
   Wut TM, 2021, TOURISM MANAGE, V85, DOI 10.1016/j.tourman.2021.104307
   Youngs H., 2021, DISTRIBUTED LEADERSH, P203
   Yukl G, 1999, LEADERSHIP QUART, V10, P285, DOI 10.1016/S1048-9843(99)00013-2
   Zenker S, 2020, TOURISM MANAGE, V81, DOI 10.1016/j.tourman.2020.104164
NR 75
TC 2
Z9 2
U1 3
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1447-6770
EI 1839-5260
J9 J HOSP TOUR MANAG
JI J. Hosp. Tour. Manag.
PD DEC
PY 2021
VL 49
BP 460
EP 468
DI 10.1016/j.jhtm.2021.10.002
EA OCT 2021
PG 9
WC Hospitality, Leisure, Sport & Tourism; Management
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics; Business & Economics
GA XN7PK
UT WOS:000729692000005
OA Bronze
DA 2022-04-20
ER

PT J
AU Chisita, CT
   Chizoma, US
AF Chisita, Collence Takaingenhamo
   Chizoma, Ukwoma Scholastica
TI Rethinking academic library space amidst the COVID-19 pandemic in South
   Africa: preparing for the future
SO INFORMATION DISCOVERY AND DELIVERY
LA English
DT Article
DE Digital libraries; Higher education; Academic libraries; Library
   services; Access to information; COVID-19
AB Purpose
   Academic libraries' response to the Coronavirus disease (COVID-19) pandemic might be an opportunity to reassert and reemphasise their roles in the national disaster management matrix. The purpose of this study is to review the responses of academic libraries in South Africa during the COVID-19 pandemic. The global outbreak of COVID-19 has precipitated a challenge amongst all institutions, communities and libraries as evidenced by the growing lockdowns, deaths and shocking statistics of infections. This has triggered a fundamental need to rethink how libraries can establish innovative ways to continue providing services to users.
   Design/methodology/approach
   This study adopted the interpretive research paradigm to review the situation in South Africa in response to the COVID-19 pandemic. The study used an analysis of secondary sources, the activities that took place and personal experience to answer the research questions.
   Findings
   The analysis showed that academic libraries and publishers have risen to the occasion, offering more free content and curating personalised collections so that citizens can have uninterrupted access to content and learning. The digital libraries in South Africa are considered vital alleyways to high-quality e-books, journals and educational content, including open educational resources. Digital library services have enabled academic libraries in South Africa to excel in providing online services, therefore ensuring that learning, research and teaching continued.
   Originality/value
   This study, using Habermas's idea of the public sphere as a fundamental theoretical framework, notes that when the physical space is closed, it is necessary for academic libraries in South Africa to make use of the digital space. This study will contribute to the corpus of knowledge relating to South African digital libraries' response to the COVID-19 pandemic.
C1 [Chisita, Collence Takaingenhamo] Univ South Africa, Dept Informat Sci, Pretoria, South Africa.
   [Chizoma, Ukwoma Scholastica] Univ Nigeria, Dept Lib, Nsukka, Nigeria.
   [Chizoma, Ukwoma Scholastica] Univ South Africa, Sch Interdisciplinary Res & Grad Studies SIRGS, Muckleneuk Campus, Pretoria, South Africa.
RP Chisita, CT (corresponding author), Univ South Africa, Dept Informat Sci, Pretoria, South Africa.
EM chisitacollence@gmail.com; scholar.ukwoma@unn.edu.ng
RI chisita, collence/ABD-4222-2020
FU Department of Information Sciences at the University of South Africa
   (UNISA)
FX The authors would like to acknowledge the Department of Information
   Sciences at the University of South Africa (UNISA) for the support and
   the reviewers for their wise counsel.
CR Alba D., 2020, NEW YORK TIMES, P3
   Ali MY, 2020, HEALTH INFO LIBR J, V37, P158, DOI 10.1111/hir.12307
   American Library Association, 2020, LIB RESP COMB XEN FA
   [Anonymous], 2008, EC REPORT
   Ballard T., 2020, GOING VIRTUAL LIB SE
   Bangani S, 2020, GLOB KNOWL MEM COMMU, V69, P289, DOI 10.1108/GKMC-07-2019-0075
   Beagle D, 1999, J ACAD LIBR, V25, P82, DOI 10.1016/S0099-1333(99)80003-2
   Breeding, 2020, COMPUT LIBR
   Chisita Collence Takaingenhamo, 2020, Library Hi Tech News, V37, P11, DOI 10.1108/LHTN-03-2020-0022
   Chisita C.T., 2015, M LIB 5 DEVICES PEOP, P159, DOI [10.29085/9781783300730.019, DOI 10.29085/9781783300730.019]
   Chothia A., 2020, CORONAVIRUS OUTBREAK
   Clark VE, 2020, J NEUROSURG, V133, P12, DOI 10.3171/2020.4.JNS201034
   Committee of Higher Education Libraries of South Africa, 2020, REP COVID 19 S UNPUB
   Crawford J., 2020, J APPL LEARN TEACH, V3, P1, DOI DOI 10.37074/JALT.2020.3.1.7
   Daniel B, 2015, BRIT J EDUC TECHNOL, V46, P904, DOI 10.1111/bjet.12230
   Daniels K, 2014, LITERACY, V48, P103, DOI 10.1111/lit.12031
   Das P., 2020, COVID 19 PUT BRAKE A
   de Jager K, 2015, PERFORM MEAS METR, V16, P289, DOI 10.1108/PMM-08-2015-0021
   Dutton B., 2020, ZOOM BOMBING FUTURE
   Elmborg JK, 2011, REF USER SERV Q, V50, P338, DOI 10.5860/rusq.50n4.338
   Flynn S., 2020, COALITION LETT WIPO
   Gazula, 2013, NAT CONV KNOWL LIB, P361
   Gill JR, 2020, JAMA-J AM MED ASSOC, V324, P27, DOI 10.1001/jama.2020.9536
   Gorman M., 2000, OUR ENDURING VALUES, P1
   Habermas Jurgen, 1991, STRUCTURAL TRANSFORM
   Holl B., 2015, 21 CENTURY LIB LEARN
   IFLA, 2020, COVID 19 GLOBAL LIB
   IFLA, 2015, STATE LIB S AFRICA I
   Johnson EDM, 2017, ADV LIBR ADM ORGAN, V36, P1, DOI 10.1108/S0732-067120160000036001
   Kahn M, 2018, EDUC INFORM, V34, P163, DOI 10.3233/EFI-180177
   KEISER BE, 2010, SEARCHER, V18, P18
   Kellner Douglas, 2000, PERSPECTIVES HABERMA
   Kosciejew M, 2021, GLOB KNOWL MEM COMMU, V70, P304, DOI 10.1108/GKMC-04-2020-0041
   Lawson K., 2004, New Library World, V105, P125, DOI 10.1108/03074800410526758
   Leitner G., 2020, GETTING READY LIFT R
   LIASA, 2020, LIASA STATEMENT COVI
   MAACK MN, 1993, LIBR QUART, V63, P257
   Mhlanga D, 2020, EDUC SCI, V10, DOI 10.3390/educsci10070180
   Montgomery SE, 2014, J ACAD LIBR, V40, P70, DOI 10.1016/j.acalib.2013.11.003
   Morriello R., 2020, RES INFORM
   Mozur P, 2020, NEW YORK TIMES
   Nabo-Bazana, 2020, U WORLD NEWS AFRICAN
   National Library of South Africa, 2014, LIB INF SERV LIS TRA
   Ng'ambi D, 2016, BRIT J EDUC TECHNOL, V47, P843, DOI 10.1111/bjet.12485
   Ngulube P, 2019, INT J KNOWL MANAG, V15, P85, DOI 10.4018/IJKM.2019010106
   OCLC, 2020, WEB JUNCTION
   OpenDOAR, 2020, WELCOME OPENDOAR
   Poole N., 2020, CILIP CORONAVIRUS IN
   Pyati AK, 2019, J AUST LIB INF ASSOC, V68, P356, DOI 10.1080/24750158.2019.1670773
   Sabinet, 2020, STATEMENT SABINET CO
   Soudien, 2012, ANN HIGH ED LEARN TE
   Spencer ME, 2017, PORTAL-LIBR ACAD, V17, P389, DOI 10.1353/pla.2017.0024
   Tammaro AM., 2020, INT INF LIBR REV, V52, P216, DOI DOI 10.1080/10572317.2020.1785172
   Thrill J., 2020, PHASED REOPENING PLA
   Vermuelen J., 2020, FREE DATA U STUDENTS
   Wang T, 2020, PUBLIC LIBR Q, V39, P283, DOI 10.1080/01616846.2020.1764325
   Zimba ZF, 2021, SOC WORK EDUC, V40, P263, DOI 10.1080/02615479.2020.1746261
NR 57
TC 2
Z9 2
U1 11
U2 31
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2398-6247
J9 INF DISCOV DELIV
JI Inf. Discov. Deliv.
PD MAY 20
PY 2021
VL 49
IS 2
BP 105
EP 113
DI 10.1108/IDD-07-2020-0087
EA MAR 2021
PG 9
WC Information Science & Library Science
WE Emerging Sources Citation Index (ESCI)
SC Information Science & Library Science
GA SI7LK
UT WOS:000632725000001
OA Bronze
DA 2022-04-20
ER

PT J
AU El Idrissi, M
   El Manzani, Y
   Maatalah, WA
   Lissaneddine, Z
AF El Idrissi, Mostapha
   El Manzani, Younes
   Maatalah, Widad Ahl
   Lissaneddine, Zakaria
TI Organizational crisis preparedness during the COVID-19 pandemic: an
   investigation of dynamic capabilities and organizational agility roles
SO INTERNATIONAL JOURNAL OF ORGANIZATIONAL ANALYSIS
LA English
DT Article; Early Access
DE Dynamic capabilities; Organizational agility; Pandemic; COVID-19;
   Organizational crisis preparedness; Morocco
ID SUPPLY CHAIN AGILITY; INFORMATION-TECHNOLOGY; KNOWLEDGE MANAGEMENT;
   ABSORPTIVE-CAPACITY; PERFORMANCE; ENTERPRISE; STRATEGY; IMPACT; MODEL;
   INDICATORS
AB Purpose While there is a consensus that dynamic capabilities (DC) and organizational agility are two key mechanisms that help firms to survive and cope with the environment's dynamic change and uncertainties, little is known about their roles in leveraging firms' preparedness to overcome organizational crises during turbulent contexts such as the COVID-19. The purpose of this study is twofold. This paper first analyzes the direct relationship between DC and organizational agility dimensions (i.e. customer, operational and partnering agilities). Second, this paper investigates the direct link between organizational agility dimensions and a firm's organizational crisis preparedness. Design/methodology/approach Based on a survey of Moroccan firms administrated during the early stage of the COVID-19 pandemic, a theoretically derived model was tested using partial least squares structural equation modeling. Findings The results show that DC are significantly related to the three types of agility and that only customer and operational agility affect organizational crisis preparedness. Originality/value This research provides new insights into crisis management literature by introducing and empirically examining the impact of DC and organizational agility in addressing global crises such as the COVID-19 pandemic.
C1 [El Idrissi, Mostapha] Univ Cadi Ayyad, Marrakech, Morocco.
   [El Manzani, Younes] Univ Paris Saclay, UVSQ, Versailles, France.
   [Maatalah, Widad Ahl] Inst Super Int Tourisme Tanger, Tanger, Morocco.
   [Lissaneddine, Zakaria] Univ Moulay Ismail, ENCG, Meknes, Morocco.
RP El Idrissi, M (corresponding author), Univ Cadi Ayyad, Marrakech, Morocco.
EM m.elidrissi@uca.ma
CR Akhtar P, 2018, TECHNOL FORECAST SOC, V136, P307, DOI 10.1016/j.techfore.2017.04.023
   Al-Omoush KS, 2020, J INNOV KNOWL, V5, P279, DOI 10.1016/j.jik.2020.10.002
   Aslam H, 2018, INT J OPER PROD MAN, V38, P2266, DOI 10.1108/IJOPM-09-2017-0555
   Atapattu M, 2014, AUSTRALAS J INF SYST, V18, P111
   Avery EJ, 2019, PUBLIC RELAT REV, V45, P119, DOI 10.1016/j.pubrev.2018.08.001
   Baltar F, 2012, INTERNET RES, V22, P57, DOI 10.1108/10662241211199960
   Barreto I, 2010, J MANAGE, V36, P256, DOI 10.1177/0149206309350776
   Baskarada S, 2018, INT J ORGAN ANAL, V26, P331, DOI 10.1108/IJOA-05-2017-1163
   Becker JM, 2012, LONG RANGE PLANN, V45, P359, DOI 10.1016/j.lrp.2012.10.001
   Blome C, 2013, INT J PROD RES, V51, P1295, DOI 10.1080/00207543.2012.728011
   Boin A, 2016, PUBLIC ADMIN, V94, P289, DOI 10.1111/padm.12264
   Bowers MR, 2017, BUS HORIZONS, V60, P551, DOI 10.1016/j.bushor.2017.04.001
   Braun B, 2015, BRIT J POLIT INT REL, V17, P419, DOI 10.1111/1467-856X.12026
   Brown S, 2003, INT J OPER PROD MAN, V23, P707, DOI 10.1108/01443570310481522
   Caiazza R, 2021, INT ENTREP MANAG J, V17, P1419, DOI 10.1007/s11365-021-00753-7
   Carmeli A, 2008, LONG RANGE PLANN, V41, P177, DOI 10.1016/j.lrp.2008.01.001
   Chen Y, 2014, EUR J INFORM SYST, V23, P326, DOI 10.1057/ejis.2013.4
   Chin WW, 1998, QUANT METH SER, P295
   Clampit JA, 2022, INT SMALL BUS J, V40, P403, DOI 10.1177/02662426211033270
   Cohen J., 1988, STAT POWER ANAL BEHA, V2, DOI [DOI 10.4324/9780203771587, 10.4324/9780203771587]
   COLLIS DJ, 1994, STRATEGIC MANAGE J, V15, P143, DOI 10.1002/smj.4250150910
   Crandall W.R., 2014, CRISIS MANAGEMENT LE, V2d ed.
   Diamantopoulos A, 2006, BRIT J MANAGE, V17, P263, DOI 10.1111/j.1467-8551.2006.00500.x
   Dominic E., 2005, J SERV MARK, V19, P336
   Dyduch W, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252423
   Eisenhardt KM, 2000, STRATEGIC MANAGE J, V21, P1105, DOI 10.1002/1097-0266(200010/11)21:10/11<1105::AID-SMJ133>3.0.CO;2-E
   Elsubbaugh S., 2004, J CONTING CRISIS MAN, V12, P112
   Enander A, 2015, J CONTING CRISIS MAN, V23, P1, DOI 10.1111/1468-5973.12067
   Evans JR, 2018, INTERNET RES, V28, P854, DOI 10.1108/IntR-03-2018-0089
   Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149
   Felipe CM, 2020, DECISION SCI, V51, P575, DOI 10.1111/deci.12379
   Felipe CM, 2016, J BUS RES, V69, P4624, DOI 10.1016/j.jbusres.2016.04.014
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Gunasekaran A., 2016, INT J IND SYSTEMS EN, V23, P290, DOI DOI 10.1504/IJISE.2016.076870
   Gyemang M.D., 2020, MANAGEMENT SCI LETT, P1533
   Haapio H, 2021, J FINANC SERV MARK, V26, P205, DOI 10.1057/s41264-021-00099-9
   Hair J.F., 2021, PRIMER PARTIAL LEAST
   Hair JF, 2019, EUR BUS REV, V31, P2, DOI 10.1108/EBR-11-2018-0203
   Hazaa Y.M.H., 2021, FACTORS INFLUENCING, V8
   HCP, 2020, REPR ACT ENTR SUIT L
   HCP, 2021, EFF COV ACT ENTR 3EM
   Hede S, 2017, SAFETY SCI, V95, P83, DOI 10.1016/j.ssci.2017.02.010
   Helfat CE, 2011, STRATEGIC MANAGE J, V32, P1243, DOI 10.1002/smj.955
   Helfat CE, 2009, STRATEG ORGAN, V7, P91, DOI 10.1177/1476127008100133
   Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8
   Henseler J, 2014, ORGAN RES METHODS, V17, P182, DOI 10.1177/1094428114526928
   Henseler J, 2009, ADV INT MARKETING, V20, P277, DOI 10.1108/S1474-7979(2009)0000020014
   Hernantes J, 2017, TECHNOL FORECAST SOC, V121, P1, DOI 10.1016/j.techfore.2017.05.011
   Huang PY, 2014, EUR J INFORM SYST, V23, P462, DOI 10.1057/ejis.2014.4
   Irfan M, 2019, OPER MANAGE RES, V12, P113, DOI 10.1007/s12063-019-00142-y
   Ivanov D, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03640-6
   Jankelova N, 2021, ENTREP SUSTAIN ISS, V8, P757, DOI 10.9770/jesi.2021.8.4(47)
   Jaques T, 2012, J PUBLIC AFF, V12, P366, DOI 10.1002/pa.1422
   Kale E, 2019, INT J HOSP MANAG, V78, P276, DOI 10.1016/j.ijhm.2018.09.010
   Kang J, 2021, MARK INTELL PLAN, V39, P454, DOI 10.1108/MIP-05-2020-0217
   Karimi-Alaghehband F, 2019, J INF TECHNOL, V34, P129, DOI 10.1177/0268396218816271
   Klein G, 2017, RISK MANAG-UK, V19, P225, DOI 10.1057/s41283-017-0019-7
   Klein VB, 2021, KNOWL PROCESS MANAG, V28, P117, DOI 10.1002/kpm.1660
   KOVOORMISRA S, 1995, TECHNOL FORECAST SOC, V48, P143, DOI 10.1016/0040-1625(94)00041-T
   KovoorMisra S, 1996, TECHNOL FORECAST SOC, V53, P169, DOI 10.1016/S0040-1625(96)00061-3
   Kraus S, 2020, INT J ENTREP BEHAV R, DOI 10.1108/IJEBR-04-2020-0214
   Kuckertz A., 2020, J BUS VENTURING INSI, DOI 10.1016/j.jbvi.2020.e00169
   Lee OK, 2015, INFORM SYST RES, V26, P398, DOI 10.1287/isre.2015.0577
   Lu Y, 2011, MIS QUART, V35, P931
   Mandal S, 2018, MANAG RES REV, V41, P1201, DOI 10.1108/MRR-11-2017-0400
   Mao HY, 2021, INFORM TECHNOL PEOPL, V34, P421, DOI 10.1108/ITP-12-2018-0560
   Mao HY, 2015, INFORM DEV, V31, P358, DOI 10.1177/0266666913518059
   Marco-Lajara B, 2021, ANATOLIA, DOI 10.1080/13032917.2021.1969960
   Memon M. A., 2020, J APPL STRUCTURAL EQ, V4, P1, DOI 10.47263/ jasem.4(2)01
   Mikalef P, 2017, J BUS RES, V70, P1, DOI 10.1016/j.jbusres.2016.09.004
   Mitroff I., 1987, ACAD MANAGE EXEC, V1, P283
   Mooi E, 2011, CONCISE GUIDE TO MARKET RESEARCH: THE PROCESS, DATA, AND METHODS USING IBM SPSS STATISTICS, P237, DOI 10.1007/978-3-642-12541-6_9
   Oliva FL, 2019, MANAGE DECIS, V57, P1960, DOI 10.1108/MD-06-2018-0670
   Ouedraogo A, 2007, J CONTING CRISIS MAN, V15, P220
   Overby E, 2006, EUR J INFORM SYST, V15, P120, DOI 10.1057/palgrave.ejis.3000600
   Papadopoulos T, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102192
   Pavlou PA, 2011, DECISION SCI, V42, P239, DOI 10.1111/j.1540-5915.2010.00287.x
   Pearson C.M., 1993, ACAD MANAGE PERSPECT, V7
   Pearson CM, 1998, ACAD MANAGE REV, V23, P59, DOI 10.2307/259099
   Peteraf M., 2007, DYNAMIC CAPABILITIES, P30
   PETERAF MA, 1993, STRATEGIC MANAGE J, V14, P179, DOI 10.1002/smj.4250140303
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Ponis ST, 2012, KNOWL PROCESS MANAG, V19, P148, DOI 10.1002/kpm.1390
   Puliga G, 2022, R&D MANAGE, V52, P331, DOI 10.1111/radm.12502
   Queiroz M, 2018, J STRATEGIC INF SYST, V27, P4, DOI 10.1016/j.jsis.2017.10.002
   Reinartz W, 2009, INT J RES MARK, V26, P332, DOI 10.1016/j.ijresmar.2009.08.001
   Roberts N, 2012, J BUS RES, V65, P579, DOI 10.1016/j.jbusres.2011.02.009
   Sambamurthy V, 2003, MIS QUART, V27, P237
   SANCHEZ R, 1995, STRATEGIC MANAGE J, V16, P135, DOI 10.1002/smj.4250160921
   Sarstedt M, 2019, AUSTRALAS MARK J, V27, P197, DOI 10.1016/j.ausmj.2019.05.003
   Saxton L, 2013, PRACT NURSE, V43, P31
   Schilke O, 2018, ACAD MANAG ANN, V12, P390, DOI 10.5465/annals.2016.0014
   Sharifi H, 2001, INT J OPER PROD MAN, V21, P772, DOI 10.1108/01443570110390462
   Sheaffer Z, 2003, J MANAGE STUD, V40, P573, DOI 10.1111/1467-6486.00351
   Sheaffer Z., 2016, ACAD MANAGEMENT P, V2016, P12161
   Srivastava RK, 1999, J MARKETING, V63, P168, DOI 10.2307/1252110
   Staupe-Delgado R, 2018, J CONTING CRISIS MAN, V26, P212, DOI 10.1111/1468-5973.12175
   Tallon PP, 2008, INFORM TECHNOL MANAG, V9, P21, DOI 10.1007/s10799-007-0024-8
   Teece D, 2016, CALIF MANAGE REV, V58, P13, DOI 10.1525/cmr.2016.58.4.13
   Teece DJ, 2007, STRATEGIC MANAGE J, V28, P1319, DOI 10.1002/smj.640
   Teece DJ, 2018, J MANAGE ORGAN, V24, P359, DOI 10.1017/jmo.2017.75
   Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z
   Thielsch MT, 2021, APPL PSYCHOL-INT REV, V70, P150, DOI 10.1111/apps.12303
   Tolk Andreas, 2020, International Journal of System of Systems Engineering, V10, P91
   Vagnoni E, 2016, FORESIGHT, V18, P625, DOI 10.1108/FS-03-2016-0012
   Walter A. T, 2021, MANAGEMENT REV Q, V71, P343, DOI [10.1007/s11301-020-00186-6, DOI 10.1007/S11301-020-00186-6]
   Wilden R, 2015, J ACAD MARKET SCI, V43, P181, DOI 10.1007/s11747-014-0380-y
   Wilden R, 2013, LONG RANGE PLANN, V46, P72, DOI 10.1016/j.lrp.2012.12.001
   Winter SG, 2003, STRATEGIC MANAGE J, V24, P991, DOI 10.1002/smj.318
   World Bank, 2021, MOR EC MON BUILD MOM
   World Health Organization, 2020, WHO COR DIS 2019 COV
   Yusuf YY, 1999, INT J PROD ECON, V62, P33, DOI 10.1016/S0925-5273(98)00219-9
   Zahra SA, 2002, ACAD MANAGE REV, V27, P185, DOI 10.2307/4134351
   Zahra SA, 2006, J MANAGE STUD, V43, P917, DOI 10.1111/j.1467-6486.2006.00616.x
   Zhu M, 2021, OPER MANAGE RES, V14, P166, DOI 10.1007/s12063-020-00174-9
   Zollo M, 2002, ORGAN SCI, V13, P339, DOI 10.1287/orsc.13.3.339.2780
NR 116
TC 0
Z9 0
U1 2
U2 2
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1934-8835
EI 1758-8561
J9 INT J ORGAN ANAL
JI Int. J. Organ. Anal.
DI 10.1108/IJOA-09-2021-2973
EA MAR 2022
PG 23
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA ZX1FX
UT WOS:000771646900001
OA Bronze
DA 2022-04-20
ER

PT J
AU Ganapati, A
   Padiyar, S
   Nair, A
   Gowri, M
   Kachroo, U
   Nair, AM
   Priya, S
   Mathew, J
AF Ganapati, Arvind
   Padiyar, Shivraj
   Nair, Aiswarya
   Gowri, Mahasampath
   Kachroo, Upasana
   Nair, Aswin M.
   Priya, Sangeetha
   Mathew, John
TI Impact of COVID-19 Pandemic and Resultant Lockdown in India on Patients
   with Chronic Rheumatic Diseases: An Online Survey
SO INDIAN JOURNAL OF RHEUMATOLOGY
LA English
DT Article
DE COVID-19; chronic rheumatic diseases; health; pandemic; rheumatology;
   tele-health
ID HEALTH
AB Background: Impact of COVID-19 pandemic and consequential lockdown in India, on patients with chronic rheumatic diseases (CRD) pertaining these components of interest: (a) physical health, (b) mental health, (c) facets of social well-being, (d) health-care accessibility, and (e) COVID-19 related knowledge, attitude, and practices (KAP) was assessed.
   Methods: An online/onsite self-reported questionnaire-based cross-sectional survey was utilized to capture responses during May 20, 2020, to June 6, 2020, from CRD (both inflammatory and non-inflammatory) patients satisfying eligibility criteria, at a tertiary hospital in India. Adverse impact was defined as strong agreement/agreement on Likert scale to an impact on the individual components of interest.
   Results: From 1533 completed responses analyzed, adverse impact was noted on physical health (32.3%), mental health (42.9%), social health (54.8%), occupational life (55.9%), and financial condition (54.4%). Self-reported COVID-19 diagnosis (1.4%), flare/possible flare of CRD (41.3%), and symptoms of mental distress (64%) were also reported. Awareness and utilization of tele-video consultation (TVC) were 27.3% and 11.2%, respectively, with 89.9% expressing difficulty in procuring medication. COVID-19 KAP assessment revealed awareness of COVID-19 suspect symptoms and safety practices to be >60% and >70% respectively, with safety adherence being >75%.
   Conclusion: Majority of respondents reported adverse impact on social health, occupational life, financial condition, and interruption of CRD management, possibly complicated by the lack of awareness and low utilization of TVC. Although mental distress was greatly reported in the participants, a general preponderance toward self-education of current scenario and safety adherence was noted, indicating a favorable reception of future health-care directives.
C1 [Ganapati, Arvind; Padiyar, Shivraj; Nair, Aswin M.; Priya, Sangeetha; Mathew, John] Christian Med Coll & Hosp, Dept Clin Immunol & Rheumatol, Ida Scudder Rd, Vellore 632004, Tamil Nadu, India.
   [Nair, Aiswarya] Christian Med Coll & Hosp, Dept Psychiat, Vellore, Tamil Nadu, India.
   [Gowri, Mahasampath] Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India.
   [Kachroo, Upasana] Christian Med Coll & Hosp, Dept Physiol, Vellore, Tamil Nadu, India.
RP Mathew, J (corresponding author), Christian Med Coll & Hosp, Dept Clin Immunol & Rheumatol, Ida Scudder Rd, Vellore 632004, Tamil Nadu, India.
EM johnmathew@cmcvellore.ac.in
RI Nair, Aswin M/L-7766-2019; Padiyar, Shivraj/ABB-8468-2021; ,
   Shivraj/ABA-3016-2021
OI Nair, Aswin M/0000-0001-9529-917X; , Shivraj/0000-0002-5369-7062
CR [Anonymous], 2020, INDIAN EXPRESS
   [Anonymous], 2020, UN NEWS
   [Anonymous], 2020, HINDUSTAN TIMES
   [Anonymous], 2020, WHO DIRECTOR GEN OPE
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   Chellaiyan VG, 2019, J FAM MED PRIM CARE, V8, P1872, DOI 10.4103/jfmpc.jfmpc_264_19
   COVID-19 Global Rheumatology Alliance, GLOB RHEUM COMM RESP
   Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34
   Figueroa-Parra G, 2020, ANN RHEUM DIS, V79, P839, DOI 10.1136/annrheumdis-2020-217322
   Ganapathy K., 2020, HINDU
   Ghosal S, 2020, DIABETES METAB SYND, V14, P319, DOI 10.1016/j.dsx.2020.03.014
   Gianfrancesco M, 2020, ANN RHEUM DIS, V79, P859, DOI 10.1136/annrheumdis-2020-217871
   Kretchy IA, 2021, RES SOC ADMIN PHARM, V17, P2023, DOI 10.1016/j.sapharm.2020.04.007
   Lee YC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3306
   McCloud T, 2019, J EPIDEMIOL COMMUN H, V73, P977, DOI 10.1136/jech-2019-212154
   Monaghesh E, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09301-4
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Ohannessian R, 2020, JMIR PUBLIC HLTH SUR, V6, P121, DOI 10.2196/18810
   Pfefferbaum B, 2012, DISASTER MED PUBLIC, V6, P67, DOI 10.1001/dmp.2012.2
   Renahy E, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-69
   Richardson T, 2017, COMMUNITY MENT HLT J, V53, P344, DOI 10.1007/s10597-016-0052-0
   Sreevatsan A., 2020, COVID 19 LOCKDOWN IM
   Szucs TD, 2006, VACCINE, V24, P6776, DOI 10.1016/j.vaccine.2006.06.072
   Vanjak A, 2020, LANCET RHEUMATOL, V2, pE317, DOI 10.1016/S2665-9913(20)30124-7
   Wani RT, 2019, J FAM MED PRIM CARE, V8, P1846, DOI 10.4103/jfmpc.jfmpc_288_19
NR 25
TC 1
Z9 1
U1 2
U2 2
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 0973-3698
EI 0973-3701
J9 INDIAN J RHEUMATOL
JI Indian J. Rheumatol.
PD MAR
PY 2021
VL 16
IS 1
BP 30
EP 42
DI 10.4103/injr.injr_231_20
PG 13
WC Rheumatology
WE Emerging Sources Citation Index (ESCI)
SC Rheumatology
GA SE1YU
UT WOS:000651871400007
OA gold
DA 2022-04-20
ER

PT J
AU Alonso, AD
   Bressan, A
   Vu, OTK
   Ha Do, LT
   Garibaldi, R
   Pozzi, A
AF Abel Duarte Alonso
   Bressan, Alessandro
   Oanh Thi Kim Vu
   Lan Thi Ha Do
   Garibaldi, Roberta
   Pozzi, Andrea
TI How consumers relate to wine during COVID-19-a comparative, two nation
   study
SO INTERNATIONAL JOURNAL OF WINE BUSINESS RESEARCH
LA English
DT Article; Early Access
DE Wine consumers; Wine involvement; COVID-19; Changes; Comparative
   analysis
ID PRODUCT INVOLVEMENT; PERSONAL INVOLVEMENT; FAMILY BUSINESSES; TOURISTS;
   CONSUMPTION; INTENTION; ONLINE; STRATEGIES; REGION
AB Purpose The purpose of this study is to examine consumers' relationship with wine during the COVID-19 crisis and associated implications for hospitality and tourism operations. Despite the severe impacts of COVID-19's aftermath, including recent reports of a global decrease in wine consumption, academic research has neglected this domain. Consequently, there is an empirical and conceptual vacuum that the present research will address. Design/methodology/approach The study proposes a comparative investigation, with data gathered from 241 Italian and Spanish wine consumers through an online questionnaire. Findings Overall, the analysis reveals marginal changes in wine consumption during the crisis. At the same time, however, an increased interest for more wine events and an organised wine route, for learning more about wines and new wine harvests, and the influence of comments from others in enhancing one's wine knowledge during the crisis is also identified. Originality/value The study is one of the few studies conducted to date that seek to ascertain the extent to which wine consumers' involvement with wine has changed during a major crisis. The findings and subsequent analysis contribute to the development of five distinctive dimensions associated with consumers: the more involved/interested, the inquisitive/explorer, the non-traditional/avid, the frugal/less involved and the conservative/avid. The first two dimensions, which are supported by mean scores close to the level of agreement (mean = 4.0) have a number of practical and conceptual implications. In addition, a conceptual framework illustrating various conceptual/empirical relationships is proposed.
C1 [Abel Duarte Alonso; Oanh Thi Kim Vu; Lan Thi Ha Do] RMIT Univ Vietnam, Sch Business & Management, Ho Chi Minh City, Vietnam.
   [Bressan, Alessandro] Univ Notre Dame, Sch Business, Chippendale, Australia.
   [Garibaldi, Roberta] Univ Bergamo, Dept Management, Bergamo, Italy.
   [Pozzi, Andrea] Univ Bergamo, Dept Foreign Languages, Bergamo, Italy.
RP Alonso, AD (corresponding author), RMIT Univ Vietnam, Sch Business & Management, Ho Chi Minh City, Vietnam.
EM abel.alonso@rmit.edu.vn
CR ACEVIN, 2020, NEW ACEVIN REP FEAT
   Afonso C, 2018, J BUS RES, V89, P313, DOI 10.1016/j.jbusres.2017.11.042
   Alsharef A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041559
   Bade R, 2021, ADDICTION, V116, P1600, DOI 10.1111/add.15256
   Barber N, 2008, J FOOD PROD MARK, V14, P69, DOI 10.1300/J038v14n01_05
   Bonn MA, 2016, INT J CONTEMP HOSP M, V28, P2399, DOI 10.1108/IJCHM-01-2015-0010
   Bonn MA, 2016, J HOSP MARKET MANAG, V25, P841, DOI 10.1080/19368623.2016.1115382
   Brown G. P., 2006, Journal of Travel & Tourism Marketing, V21, P31, DOI 10.1300/J073v21n01_03
   Bruwer J, 2019, INT J WINE BUS RES, V31, P12, DOI 10.1108/IJWBR-06-2018-0027
   Bruwer J, 2009, INT J WINE BUS RES, V21, P235, DOI 10.1108/17511060910985962
   Bruwer J, 2012, J TRAVEL TOUR MARK, V29, P611, DOI 10.1080/10548408.2012.719819
   Calvo-Porral C, 2018, EUR RES MANAG BUS EC, V24, P130, DOI 10.1016/j.iedeen.2018.06.001
   Charters S, 2006, QUAL MARK RES, V9, P181, DOI 10.1108/13522750610658810
   Chetty RF, 2020, EC IMPACTS COVID 19
   Cox David, 2009, Journal of Wine Research, V20, P209, DOI 10.1080/09571260903450963
   David C., 2007, THESIS U OTAGO NZ
   De Toni D, 2021, INT J WINE BUS RES, DOI 10.1108/IJWBR-01-2021-0006
   Famularo B, 2010, INT J WINE BUS RES, V22, P362, DOI 10.1108/17511061011092410
   Getz D., 2006, INT J WINE MARK, V18, P78, DOI [10.1108/09547540610681077, DOI 10.1108/09547540610681077]
   Gu QS, 2018, J TRAVEL TOUR MARK, V35, P633, DOI 10.1080/10548408.2017.1401031
   Gursoy D, 2003, ANN TOURISM RES, V30, P906, DOI 10.1016/S0160-7383(03)00059-8
   Gursoy D, 2020, J HOSP MARKET MANAG, V29, P527, DOI 10.1080/19368623.2020.1788231
   Havitz ME, 1999, J LEISURE RES, V31, P122, DOI 10.1080/00222216.1999.11949854
   Hollebeek LD, 2007, FOOD QUAL PREFER, V18, P1033, DOI 10.1016/j.foodqual.2007.04.007
   Humphries J.E., 2020, 2230 COWL FDN NYU ST
   Iaia L, 2019, BRIT FOOD J, V121, P1442, DOI 10.1108/BFJ-07-2018-0445
   Iaia L, 2017, BRIT FOOD J, V119, P2294, DOI 10.1108/BFJ-02-2017-0110
   Iazzi A, 2020, BRIT FOOD J, V122, P2443, DOI 10.1108/BFJ-07-2019-0478
   Karagiannis D, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12125223
   Lockshin L., 2020, GRAPEGROWER WINEMAKE, V680, DOI [10.3316/informit.390248968658193, DOI 10.3316/INFORMIT.390248968658193]
   Luo Y, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2020.102849
   Maizza Amedeo, 2017, World Review of Entrepreneurship, Management and Sustainable Development, V13, P521
   Nella A, 2014, J TRAVEL TOUR MARK, V31, P783, DOI 10.1080/10548408.2014.889639
   Nunnally J. C., 1978, PSYCHOMETRIC THEORY, V2nd
   Ogbeide Osadebamwen Anthony, 2013, Journal of Wine Research, V24, P210, DOI 10.1080/09571264.2013.795483
   OIV, 2021, STAT WORLD VIT SECT
   PETTY RE, 1981, J PERS SOC PSYCHOL, V41, P847, DOI 10.1037/0022-3514.41.5.847
   Pucci T, 2019, BRIT FOOD J, V121, P275, DOI 10.1108/BFJ-06-2018-0400
   Quester P.G., 1996, INT J WINE MARK, V8, P37
   Rahman I, 2015, INT J HOSP MANAG, V44, P1, DOI 10.1016/j.ijhm.2014.09.004
   Rebelo J, 2021, SPAN J AGRIC RES, V19, DOI [10.5424/sjar/2021192-17697, 10.5424/sjar/2021192R-17697]
   Ritchie C, 2007, INT J CONSUM STUD, V31, P534, DOI 10.1111/j.1470-6431.2007.00610.x
   Roe D, 2017, BRIT FOOD J, V119, P1362, DOI 10.1108/BFJ-10-2016-0476
   Rokonuzzaman M, 2020, J RETAIL CONSUM SERV, V52, DOI 10.1016/j.jretconser.2019.101933
   ROTHSCHILD ML, 1974, COMMUN RES, V1, P264, DOI 10.1177/009365027400100302
   Santos V, 2022, J ORGAN CHANGE MANAG, V35, P348, DOI 10.1108/JOCM-11-2020-0362
   Scorrano P, 2019, INT J WINE BUS RES, V31, P130, DOI 10.1108/IJWBR-06-2017-0043
   Sharma R, 2021, INT J HOSP MANAG, V96, DOI 10.1016/j.ijhm.2021.102977
   Statista, 2021, WIN CONS WORLDW 2020
   Statista, 2020, KEY FIG WIN TOUR IT
   Taylor JJ, 2018, INT J CONTEMP HOSP M, V30, P702, DOI 10.1108/IJCHM-06-2016-0335
   White CJ, 2009, ANN TOURISM RES, V36, P561, DOI 10.1016/j.annals.2009.04.001
   Wittwer G., 2020, 202003 U AD WIN EC R
   WRIGHT PL, 1974, PUBLIC OPIN QUART, V38, P192, DOI 10.1086/268151
   Wu G, 2021, CURR ISSUES TOUR, V24, P2278, DOI 10.1080/13683500.2020.1828310
   ZAICHKOWSKY JL, 1986, J ADVERTISING, V15, P4, DOI 10.1080/00913367.1986.10672999
NR 56
TC 0
Z9 0
U1 0
U2 0
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1751-1062
EI 1751-1070
J9 INT J WINE BUS RES
JI Int. J. Wine Bus. Res.
DI 10.1108/IJWBR-09-2021-0051
EA MAR 2022
PG 18
WC Agronomy
WE Emerging Sources Citation Index (ESCI)
SC Agriculture
GA 0E5FL
UT WOS:000776707200001
OA Bronze
DA 2022-04-20
ER

PT J
AU Agyekum, K
   Kukah, AS
   Amudjie, J
AF Agyekum, Kofi
   Kukah, Augustine Senanu
   Amudjie, Judith
TI The impact of COVID-19 on the construction industry in Ghana: the case
   of some selected firms
SO JOURNAL OF ENGINEERING DESIGN AND TECHNOLOGY
LA English
DT Article
DE Ghana; Construction industry; Impact; Case study; Construction firms;
   COVID-19
AB Purpose
   With its impact already felt, the construction industry worldwide is gradually reviving following the lifting up of lockdowns amid the COVID-19 pandemic. Though some articles have been written regarding its impact on the construction industry in other countries, much is yet to be known concerning the current impact in Ghana. This study aims to examine the impact of COVID-19 on Ghana's construction industry and assess how construction companies are contributing to the fight against COVID-19.
   Design/methodology/approach
   Semi-structured interviews with nine key professionals working with D1K1 firms currently working on projects of almost similar sizes within the confines of a reputable tertiary institution in Ghana were conducted over a span of three weeks. Thematic analysis was conducted with Nvivo 12 Pro Application software.
   Findings
   From the findings, the major impact includes: a decrease in work rate, delays in payments and an increase in the cost of materials arising from border closure. On the measures by construction companies in contributing to the fight against the pandemic, findings indicated: educating the workforce on the virus, the provision of PPEs, regular and effective checks on entry and exit from the site.
   Practical implications
   The study is significant, as knowledge of the impact posed by the pandemic will provide some idea of the measures to put in place to ensure the gradual to full recovery of the industry.
   Originality/value
   The originality of this study lies in the fact that it is a pioneering study on the impact of COVID-19 on the Ghanaian construction industry.
C1 [Agyekum, Kofi; Kukah, Augustine Senanu; Amudjie, Judith] Kwame Nkrumah Univ Sci & Technol, Dept Construct Technol & Management, Kumasi, Ghana.
RP Kukah, AS (corresponding author), Kwame Nkrumah Univ Sci & Technol, Dept Construct Technol & Management, Kumasi, Ghana.
EM augustinekukah@gmail.com
RI Kukah, Augustine Senanu Komla/ABF-6068-2021; Agyekum, Kofi/R-1479-2018
OI Agyekum, Kofi/0000-0002-7903-5390
CR Addi RA, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/7857
   Agyekum K, 2018, ACTA STRUCTILIA, V25, P39, DOI 10.18820/24150487/as25i2.2
   Alenezi T., 2020, INT J ENG RES GEN SC, V8, P6
   Amoah C, 2021, J FACIL MANAG, V19, P111, DOI 10.1108/JFM-08-2020-0061
   Amponsah R., 2020, OPEN J BUSINESS MANA, V8, P1404, DOI [https://doi.org/10.4236/ojbm.2020.84089, DOI 10.4236/OJBM.2020.84089]
   Annan JS, 2015, SAF HEALTH WORK, V6, P146, DOI 10.1016/j.shaw.2014.12.002
   Anyango A., 2020, TOP CONSTRUCTION CO
   Araya F, 2021, SAFETY SCI, V133, DOI 10.1016/j.ssci.2020.105022
   Asante LA, 2020, AFR SPECTR, V55, P170, DOI 10.1177/0002039720943612
   Ayarkwa J., 2016, J CONSTRUCTION DEV C, V21, P131, DOI [10.21315/jcdc2016.21.2.7, DOI 10.21315/JCDC2016.21.2.7]
   Ayittey FK, 2020, J MED VIROL, V92, P473, DOI 10.1002/jmv.25706
   Ayodele OA, 2020, J CONSTR ENG M, V146, DOI 10.1061/(ASCE)CO.1943-7862.0001725
   Ayrakwa K., 2020, INFRASTRUCTURE DEV G
   Babar K., 2020, COVID 19 IMPACT CONS
   Bagnetto, 2020, AFRICAN STREET VENDO
   Bawa M.A., 2017, INT J EC COMMER MANA, VV, P662
   Beck C.T., 2017, NURSING RES GENERATI
   Belzunegui-Eraso A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093662
   Braimah, 2014, INT REFEREED J ENG S, V3, P24
   Brown P., 2020, COVID 19 SECTOR IMPA
   Centres for Disease Control and Prevention (CDC), 2019, 2019 NOV COR 2019 NC
   Chmutina K, 2014, ENERG POLICY, V66, P62, DOI 10.1016/j.enpol.2013.10.080
   Christophe G., 2020, COVID 19 ENG CONSTRU
   CIRT, 2020, SENT IND 2 QUART REP
   Construction Covid-19 Response Task Team, 2020, CONSTR SECT SHORT TE
   Construction Manager, 2020, CONSTR EXP SHED 10 W
   Damon C., 2014, YOU CANT BEAT THEM J, P1
   Doddy J., 2020, CONSTRUCTION IND CAN
   EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557
   ENR, 2020, AGC SURV 28 MEMB REP
   Fernandes N., 2020, SSRN ELECT J
   Fini AAF, 2018, J CONSTR ENG M, V144, DOI 10.1061/(ASCE)CO.1943-7862.0001434
   Gamil Y., 2020, MEDITERRANEAN J SOCI, V11, P122, DOI 10.36941/mjss-2020-0047
   Ghana Health Service, 2021, COVID 19 UPD GHAN
   Ghana Statistical Service (GSS), 2019, SUMM REP FIN RES HOU
   Gilbane, 2020, COVID 19 IMP CONSTR
   Gumble C., 2020, MAKING BEST BAD SITU
   Harari YN, 2020, FINANC TIMES
   Helm D, 2020, ENVIRON RESOUR ECON, V76, P21, DOI 10.1007/s10640-020-00426-z
   Hook J., 2020, ENG CONSTRUCTION POS
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   International Labour Organization, 2017, GLOB EST MOD SLAV FO
   Ivanov D, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03640-6
   Jallow H, 2021, SMART SUSTAIN BUILT, V10, P581, DOI 10.1108/SASBE-05-2020-0068
   Jones K., 2020, CONSTRUCTION TECHNOL
   Kale A.R., 2020, PURAKALA, V31, P98
   Kazeem, 2020, AFRICA RELIANCE INFO
   Madalena I., 2020, COVID 19 CURRENT IMP
   Marsh, 2020, 5 WAYS COVID 19 HAS
   Mason J., 2002, QUALITATIVE RES
   Master Builders Association, 2020, SOC DIST IS MUST BUI
   National Electrical Contractors Association, 2020, COVID 19 GUID CONSTR
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Occupational Safety and Health Administration, 2020, GUID PREP WORKPL COV
   Ofori, 2015, J CONSTR DEV COUNTR, V20, P115
   Ogunnusi M, 2020, INT J REAL ESTATE ST, V14
   Organisation WH, 2020, NAMING CORONAVIRUS D
   Parse R., 1990, NURSING SCI Q, V3, P9, DOI [10.1177/089431849000300106, DOI 10.1177/089431849000300106]
   Prasad R., 2020, COVID 19 CONSTRUCTIO
   Qiu W., 2017, HLTH CULT SOC, V10, P3, DOI [10.5195/HCS.2017.221, DOI 10.5195/HCS.2017.221]
   Reja U., 2003, ADV METHODOL STAT, V19, P159
   Sertyesilisik B., 2017, HDB RES UNEMPLOYMENT, P1
   Simpeh F, 2021, INT J CONSTR MANAG, DOI 10.1080/15623599.2021.1874678
   Trigunarsyah, 2020, P INT STRUCT ENG CON, P1
   Venkitachalam, 2020, STUDIES INDIAN PLACE
   WHO, 2020, Q A COR COVID 19
   World Health Organisation (WHO), 2020, COVID 19 PREV MEAS C
   World Health Organization (WHO), 2019, ADV PUBL
   Yelin D, 2020, LANCET INFECT DIS, V20, P1115, DOI 10.1016/S1473-3099(20)30701-5
   Yin R.K., 2014, CASE STUDY RES APPL, V5th ed.
   YIN RK, 1994, AM J EVALUATION
NR 71
TC 15
Z9 15
U1 11
U2 25
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1726-0531
J9 J ENG DES TECHNOL
JI J. Eng. Des. Technol.
PD JAN 3
PY 2022
VL 20
IS 1
SI SI
BP 222
EP 244
DI 10.1108/JEDT-11-2020-0476
EA MAY 2021
PG 23
WC Engineering, Multidisciplinary
WE Emerging Sources Citation Index (ESCI)
SC Engineering
GA XZ8UW
UT WOS:000647710900001
OA Bronze
DA 2022-04-20
ER

PT J
AU Reveiz, L
   Toledo, J
   Torres, M
   Izcovich, A
   Balbin, GJ
   Sa, MB
   Lisboa, TC
   Cuellar, GG
   Jaimes, F
   Delso, LAG
   Meza, JC
   Restrepo, S
   Rodriguez, A
   Salazar, L
   Sosa, O
   Ubiergo, SU
   Li, HY
   Mendez, J
   de la Fuente, L
   Castro, JL
   Lemgrubei, A
   Caccavo, F
   Beltran, M
   Peiris, S
   Pardo, R
AF Reveiz, Ludovic
   Toledo, Joao
   Torres, Marcela
   Izcovich, Ariel
   Josefina Balbin, Graciela
   Sa, Marcio Borges
   Lisboa, Thiago Costa
   Cuellar, Gustavo Gabriel
   Jaimes, Fabian
   Gorordo Delso, Luis Antonio
   Meza, Juan Carlos
   Restrepo, Sonia
   Rodriguez, Angel
   Salazar, Leonardo
   Sosa, Ojino
   Ugarte Ubiergo, Sebastian
   Li, Ho Yeh
   Mendez, Jairo
   de la Fuente, Luis
   Castro, Jose Luis
   Lemgrubei, Alexandre
   Caccavo, Francisco
   Beltran, Mauricio
   Peiris, Sasha
   Pardo, Rodrigo
CA Org Panamer Salud
TI Summary of Evidence and Recommendations: Guidelines for Care of
   Critically Ill Adult Patients with COVID-19 in the Americas
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE COVID-19; coronavirus; evidence-based medicine; respiratory tract
   infections; intensive care units; therapeu-tics; Americas
AB Introduction. In 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has spread around the world. Approximately 5% of infected patients are critical cases that require admission to the intensive care unit (ICU). In these patients, COVID-19 can be complicated by acute respiratory distress syndrome, septic shock, and multi-organ failure, including kidney and heart failure. Objective. Summarize the recommendations included in the Guidelines for Care of Critically Ill Adult Patients with COVID-19 in the Americas, version 3, published by the Pan American Health Organization in 2021 to guide the management of critically ill adult patients with COVID-19 treated in the ICU, and address key aspects of implementation of the recommendations. Methodology. The guidelines and their recommendations were summarized. In addition, a systematic search was carried out in Pubmed, Lilacs, Health Systems Evidence, Epistemonikos, and gray literature on studies carried out in the Region of the Americas, in order to identify barriers, facilitators, and implementation strategies. Results. Forty-three recommendations are presented that address the identification of markers and risk factors for mortality, infection prevention and control, specimen collection, supportive care (ventilatory and hemodynamic), pharmacological treatment, early rehabilitation, use of imaging studies, prevention of complications, and discharge criteria for critical patients with COVID-19. Conclusions. The recommendations seek to provide knowledge on the management of critical patients with COVID-19 and offer considerations for implementation of the recommendations in the Region.
C1 [Reveiz, Ludovic; Torres, Marcela; Izcovich, Ariel] OPS, Dept Evidencia & Inteligencia Acc Salud & Equipo, Washington, DC USA.
   [Toledo, Joao; Mendez, Jairo; de la Fuente, Luis; Peiris, Sasha] OPS, Dept Emergencias Salud & Equipo Sistema Gest Inci, Washington, DC USA.
   [Josefina Balbin, Graciela] Minist Salud Peru, Lima, Peru.
   [Sa, Marcio Borges] Hosp Son Llatzer, Grp Sepsis IDISBA & Federac Panamer & Iber Med Cr, Nacl Codigo Sepsis Espana, Palma De Mallorca, Spain.
   [Lisboa, Thiago Costa] Univ Fed Rio Grande do Sul, Univ La Salle, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
   [Lisboa, Thiago Costa] Hosp Coracao Brasil, Inst Pesquisa, Brasilia, DF, Brazil.
   [Cuellar, Gustavo Gabriel] Univ Nacl Asuncion, Fac Ciencias Med, San Lorenzo, Paraguay.
   [Jaimes, Fabian] Univ Antioquia, Dept Med Interna, Fac Med, Medellin, Colombia.
   [Gorordo Delso, Luis Antonio] Hosp Juarez Mexico, Unidad Cuidados Intens Adultos, Mexico City, DF, Mexico.
   [Gorordo Delso, Luis Antonio] Fdn Sepsis Mexico, Mexico City, DF, Mexico.
   [Meza, Juan Carlos] SCCM SOPEMI, Programa Segunda Especializac Med Humana, Mexico City, DF, Mexico.
   [Meza, Juan Carlos] SCCM SOPEMI, FMH USMP Fac ACLS, PHTLS, Mexico City, DF, Mexico.
   [Meza, Juan Carlos] SCCM SOPEMI, PALS, AMLS Amer Heart Assoc PLST, Mexico City, DF, Mexico.
   [Meza, Juan Carlos] SCCM SOPEMI, FCCS FDM & MCCRC, Mexico City, DF, Mexico.
   [Restrepo, Sonia] Univ Nacl Colombia, Hosp Fdn Misericordia, Fac Med, Bogota, Colombia.
   [Restrepo, Sonia] Hosp Univ San Ignacio Colombia, Bogota, Colombia.
   [Rodriguez, Angel] Adscrito Al Hosp Med Sur Mexico, OPS, Mexico City, DF, Mexico.
   [Salazar, Leonardo] Adscrito Al Hosp Med Sur Mexico, Com Educ ELSO Latinoamer, Mexico City, DF, Mexico.
   [Salazar, Leonardo] Adscrito Al Hosp Med Sur Mexico, Programa ECMO & VAD, Fdn Cardiovasc Colombia, Mexico City, DF, Mexico.
   [Sosa, Ojino] Adscrito Al Hosp Med Sur Mexico, Med Interna & Med Crit, Mexico City, DF, Mexico.
   [Sosa, Ojino] Adscrito Al Hosp Med Sur Mexico, Div Educ Continua, Coordinat Educ Salud, Inst Mexican Seguro Social IMSS, Mexico City, DF, Mexico.
   [Ugarte Ubiergo, Sebastian] Univ Andres Bello, Jefe Ctr Pacientes Crit, Clin Indisa, Santiago, Chile.
   [Ugarte Ubiergo, Sebastian] Council World Federat Soc Intens & Crit Care Med, FEPIMCTI, Santiago, Chile.
   [Li, Ho Yeh] Hosp Clin FMUSP Brasil, UTI DMIP, Sao Paulo, Brazil.
   [Castro, Jose Luis; Lemgrubei, Alexandre; Caccavo, Francisco; Beltran, Mauricio] OPS, Dept Sistemas & Serv Salud, Washington, DC USA.
RP Reveiz, L (corresponding author), Org Panamer Salud, Washington, DC 20037 USA.
EM reveizl@paho.org
RI Lisboa, Thiago/W-2973-2019
OI Lisboa, Thiago/0000-0003-4306-2212
CR Banco Mundial, OX ALL COVID 19 COR
   DECIDE Grade, 2011, DECIDE GRADE 2011 20
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Houghton C, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013582
   Lewis CC, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0342-x
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Organizaci6n Mundial de la Salud, 2020, CLIN MAN SEV AC RESP
   Organizacion Mundial de la Salud, 2020, CLIN CAR SEV AC RESP
   Organizacion Mundial de la Salud, 2020, COR DIS COVID 19 OUT
   Organizacion Mundial de la Salud, 2014, HDB GUID DEV, V2
   Organizacion Panamericana de la Salud, 2021, GUIA CUID CRIT PAC A
   Organizacion Panamericana de la Salud, 2020, ASP TECN REG US OX P
   Organizacion Panamericana de la Salud, 2020, RAPID REV
   Organizacion Panamericana de la Salud, 2010, VENT NAT CONTR INF E
   Organizacion Panamericana de la Salud, 2020, ALG MAN PAC CON SOSP
   Parohan M, 2020, AGING MALE, V23, P1416, DOI 10.1080/13685538.2020.1774748
   Stein F, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002786
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 19
TC 0
Z9 0
U1 3
U2 3
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2021
VL 45
AR e128
DI 10.26633/RPSP.2021.128
PG 16
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA XM3CH
UT WOS:000728709300001
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Guo, QF
   Lee, DC
AF Guo, Qinfeng
   Lee, Danny C.
TI The ecology of COVID-19 and related environmental and sustainability
   issues
SO AMBIO
LA English
DT Article
DE Assessment; Disease ecology; Epidemics; Environment; Knowledge gaps;
   Retrospective approach
ID GLOBALIZATION; OUTBREAK; REVEALS
AB Around the globe, human behavior and ecosystem health have been extensively and sometimes severely affected by the unprecedented COVID-19 pandemic. Most efforts to study these complex and heterogenous effects to date have focused on public health and economics. Some studies have evaluated the pandemic's influences on the environment, but often on a single aspect such as air or water pollution. The related research opportunities are relatively rare, and the approaches are unique in multiple aspects and mostly retrospective. Here, we focus on the diverse research opportunities in disease ecology and ecosystem sustainability related to the (intermittent) lockdowns that drastically reduced human activities. We discuss several key knowledge gaps and questions to address amid the ongoing pandemic. In principle, the common knowledge accumulated from invasion biology could also be effectively applied to COVID-19, and the findings could offer much-needed information for future pandemic prevention and management.
C1 [Guo, Qinfeng] US Forest Serv, USDA, Southern Res Stn, 3041 Cornwallis Rd, Res Triangle Pk, NC 27709 USA.
   [Lee, Danny C.] US Forest Serv, USDA, Southern Res Stn, 200 WT Weaver Blvd, Asheville, NC 28804 USA.
RP Guo, QF (corresponding author), US Forest Serv, USDA, Southern Res Stn, 3041 Cornwallis Rd, Res Triangle Pk, NC 27709 USA.
EM qinfeng.guo@usda.gov
RI Liu, Hai-Ying/P-5557-2014
OI Liu, Hai-Ying/0000-0001-8667-3465; Guo, Qinfeng/0000-0002-4375-4916
CR Adyel TM, 2020, SCIENCE, V369, P1314, DOI 10.1126/science.abd9925
   Al-Kindi KM, 2020, EARTH SYST ENVIRON, V4, P797, DOI 10.1007/s41748-020-00194-2
   Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401
   Bai XM, 2020, NATURE, V584, P517, DOI 10.1038/d41586-020-02459-2
   Bakar N.A., 2020, INT J ADV ENG RES SC, V7, P189, DOI [10.22161/ijaers.74.23, DOI 10.22161/IJAERS.74.23]
   Bivins A, 2020, ENVIRON SCI TECHNOL, V54, P7754, DOI 10.1021/acs.est.0c02388
   Britton T, 2020, SCIENCE, V369, P846, DOI 10.1126/science.abc6810
   Buckley R, 2020, BIOL CONSERV, V247, DOI 10.1016/j.biocon.2020.108640
   Buxton RT, 2020, CONSERV BIOL, V34, P1331, DOI 10.1111/cobi.13652
   Cawthorn DM, 2021, AMBIO, V50, P812, DOI 10.1007/s13280-020-01430-9
   Cinquin O, 2002, J THEOR BIOL, V216, P229, DOI 10.1006/jtbi.2002.2544
   Cooke SJ, 2021, CONSERV PHYSIOL, V9, DOI 10.1093/conphys/coaa139
   Corlett RT, 2020, BIOL CONSERV, V246, DOI 10.1016/j.biocon.2020.108571
   Derryberry EP, 2020, SCIENCE, V370, P575, DOI 10.1126/science.abd5777
   Di Marco M, 2020, P NATL ACAD SCI USA, V117, P3888, DOI 10.1073/pnas.2001655117
   Diffenbaugh NS, 2020, NAT REV EARTH ENV, V1, P470, DOI 10.1038/s43017-020-0079-1
   Dobson AP, 2020, SCIENCE, V369, P379, DOI 10.1126/science.abc3189
   Edeling Wouter, 2020, MODEL UNCERTAINTY DE
   Edwards CE, 2020, P NATL ACAD SCI USA, V117, P26915, DOI [10.1073/pnas.2001046117, 10.1073/pnas.2001046117/-/DCSupplemental]
   Farzanegan MR, 2021, J RISK FINANC MANAG, V14, DOI 10.3390/jrfm14030105
   Gibb R, 2020, NATURE, V584, P398, DOI 10.1038/s41586-020-2562-8
   Gupta A, 2020, EARTH SYST ENVIRON, V4, P523, DOI 10.1007/s41748-020-00179-1
   Hallema DW, 2020, ECOL PROCESS, V9, DOI 10.1186/s13717-020-00231-y
   Huang X, 2021, NATL SCI REV, V8, DOI 10.1093/nsr/nwaa137
   Hulme PE, 2020, NEOBIOTA, P161, DOI 10.3897/neobiota.62.52463
   Jechow A, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12203412
   Jeschke JM, 2013, AMBIO, V42, P541, DOI 10.1007/s13280-013-0387-5
   Karabulut G, 2020, ANN TOURISM RES, V84, DOI 10.1016/j.annals.2020.102991
   Le Quere C, 2020, NAT CLIM CHANGE, V10, P647, DOI 10.1038/s41558-020-0797-x
   Le TH, 2020, SCIENCE, V369, P702, DOI 10.1126/science.abb7431
   Li WZ, 2020, EARTH SYST ENVIRON, V4, P513, DOI 10.1007/s41748-020-00176-4
   Lindsey P, 2020, NAT ECOL EVOL, V4, P1300, DOI 10.1038/s41559-020-1275-6
   Liu Z., 2020, ARXIV200607690 ARXIV200607690, V2006
   McNeely JA, 2021, AMBIO, V50, P767, DOI 10.1007/s13280-020-01447-0
   Mello MM, 2020, SCIENCE, V368, P951, DOI 10.1126/science.abb9045
   Merow C, 2020, P NATL ACAD SCI USA, V117, P27456, DOI 10.1073/pnas.2008590117
   Munnink BBO, 2021, SCIENCE, V371, P172, DOI 10.1126/science.abe5901
   National Interagency Coordination Center, 2021, WILDL FIR SUMM STAT WILDL FIR SUMM STAT
   Phillips CA, 2020, NAT CLIM CHANGE, V10, P586, DOI 10.1038/s41558-020-0804-2
   Poirier C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74089-7
   Rohrer M, 2020, EARTH SYST ENVIRON, V4, P789, DOI 10.1007/s41748-020-00184-4
   Rowe BR, 2021, ENVIRON RES, V198, DOI 10.1016/j.envres.2021.111189
   Rume T, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04965
   Rutz C, 2020, NAT ECOL EVOL, V4, P1156, DOI 10.1038/s41559-020-1237-z
   Selcuk M, 2021, EARTH SYST ENVIRON, V5, P87, DOI 10.1007/s41748-020-00197-z
   Shea K, 2020, SCIENCE, V368, P577, DOI 10.1126/science.abb9934
   Sicard P, 2020, SCI TOTAL ENVIRON, V735, DOI 10.1016/j.scitotenv.2020.139542
   Smith KF, 2007, ECOLOGY, V88, P1903, DOI 10.1890/06-1052.1
   Stroebel, 2020, GEOGRAPHIC SPREAD CO
   Tan MK, 2021, ECOLOGY, V102, DOI 10.1002/ecy.3323
   Tobias A, 2020, SCI TOTAL ENVIRON, V726, DOI 10.1016/j.scitotenv.2020.138540
   Venter ZS, 2020, P NATL ACAD SCI USA, V117, P18984, DOI 10.1073/pnas.2006853117
   Watsa M, 2020, SCIENCE, V369, P145, DOI 10.1126/science.abc0017
   Wu T, 2021, AMBIO, V50, P822, DOI 10.1007/s13280-020-01497-4
   Zambrano-Monserrate MA, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138813
NR 55
TC 0
Z9 0
U1 4
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0044-7447
EI 1654-7209
J9 AMBIO
JI Ambio
PD APR
PY 2022
VL 51
IS 4
BP 1014
EP 1021
DI 10.1007/s13280-021-01603-0
EA JUL 2021
PG 8
WC Engineering, Environmental; Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Environmental Sciences & Ecology
GA ZA1HU
UT WOS:000674518400001
PM 34279809
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Basu, S
   Anwar, MR
   Ghosal, I
   Ghosh, R
AF Basu, Sudip
   Anwar, Md Razi
   Ghosal, Indrajit
   Ghosh, Rituparna
TI A Review on Effect of Social Marketing during COVID-19 in India
SO PACIFIC BUSINESS REVIEW INTERNATIONAL
LA English
DT Review
DE Social Marketing; Positive Effects; Negative Effects; COVID-19 pandemic;
   Marketing; Society
AB In the view of Philip Kotler, Nancy Lee, and Michael Rothschild (2006) "Social Marketing is a process that applies marketing principles and techniques to create, communicate, and deliver value in order to influence target audience behaviours that benefit society as well as the intended audience. Social Marketing does not work to exploit turnover or sales; rather the aim of Social Marketing campaigns is to change the activities in the society that will support the overall public of a country to use only competent lighting to preserve the energy or persuading more individuals to use seat belts. Our study is based on only India and this chapter explored how Social Marketing can bear a significant impact during COVID -19 pandemic and with the help of various reviews we will catch out the positive and negative effects of Social Marketing in COVID - 19 in India.
   Methods: A systematic review conducted on the recent COVID situation for the last one-year (i.e. published papers along the last one year) in Scopus, Web of Science, Science Direct and Sage. For this, we have searched digital marketing, restricted to the title, "Interest" and "Market", COVID lockdown.
   Results: Since the COVID has broken down for the past one year only and there are very few papers are published based on the very contemporary title considered for the article hence this study identified45 articles in the scientific literature, but only 17 articles were classified as eligible according to the previously established criteria.
   Discussion: This methodical review highlight the positively association between COVID on Social Marketing in digital era.
C1 [Basu, Sudip; Anwar, Md Razi] Sch Business & Management Studies, NSHM Knowledge Campus Durgapur, Paschim Bardhaman, W Bengal, India.
   [Ghosal, Indrajit] Poornima Univ, Sch Comp Sci & Engn, Jaipur, Rajasthan, India.
   [Ghosh, Rituparna] Inst Management Study, Kolkata, India.
RP Basu, S (corresponding author), Sch Business & Management Studies, NSHM Knowledge Campus Durgapur, Paschim Bardhaman, W Bengal, India.
CR Bach C, 2016, EUROPEAN J ENG TECHN, V1, P17
   Bennett R., 1998, INT J ADVERT, V17, P483, DOI DOI 10.1080/02650487.1998.11104734
   Buzby J. C., 1996, FoodReview, V19, P46
   Dann S, 2010, J BUS RES, V63, P147, DOI 10.1016/j.jbusres.2009.02.013
   Dutta P.K., 2020, INDIA TODAY
   Glanz K., 2008, HLTH BEHAV HLTH ED T, V4
   Glouberman S, 2016, 1 COMPLICATED COMPLE, P21
   Grier S, 2005, ANNU REV PUBL HEALTH, V26, P319, DOI 10.1146/annurev.publhealth.26.021304.144610
   Hastings G., 2002, SOC MARK Q, V8, P2
   Keller K. L, 1998, BRANDING PERSPECTIVE
   Kotler P, 2006, SOCIAL MARKETING IMP, V2nd
   Laasch O., 2014, PRINCIPLES RESPONSIB
   Pilloton E., 2009, DESIGN REV 100 PRODU
   Rose C., 2007, USING VALUES MODES
   Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651
   Russell-Bennett R, 2013, J SOC MARKET, V3, P223, DOI 10.1108/JSOCM-02-2013-0017
   Schultz W, 2010, COMMUNITY BASED SOCI
   Shah K, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7405
   Sood S., 2020, RES HUMANIT MED ED, V7, P23, DOI DOI 10.4103/IJA.IJA_697_20
   Stead M, 2007, HEALTH EDUC, V107, P126, DOI 10.1108/09654280710731548
   W.H. Organization, 2020, MENT HLTH CONS COVID
   Wansink B, 2007, MINDLESS EATING WHY
   World Health Organization, 2020, NOV COR CHIN 2020
   World Health Organization, 2020, COR DIS 2019 COVID 1
   World Health Organization, 2020, PNEUM UNKN CAUS CHIN
   Zeng S, 2017, IFAC PAPERSONLINE, V50, P13581, DOI 10.1016/j.ifacol.2017.08.2375
NR 26
TC 0
Z9 0
U1 0
U2 0
PU PACIFIC INST MANAGEMENT
PI RAJASTHAN
PA PACIFIC HILLS, PRATAP NAGAR EXTENSION, AIR PORT RD, UDAIPUR, RAJASTHAN,
   313 001, INDIA
SN 0974-438X
J9 PAC BUS REV INT
JI Pac. Bus. Rev. Int.
PD NOV
PY 2021
VL 14
IS 5
BP 96
EP 102
PG 7
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA ZH4XT
UT WOS:000760944600010
DA 2022-04-20
ER

PT J
AU Lotan, T
   Shinar, D
AF Lotan, Tsippy
   Shinar, David
TI Sustainable Public Safety and the Case of Two Epidemics: COVID-19 and
   Traffic Crashes. Can We Extrapolate from One to the Other?
SO SUSTAINABILITY
LA English
DT Article
DE COVID-19; motor vehicle crashes; sustainable safety; policy; epidemic
   eradication; best practices
ID ROAD SAFETY
AB COVID-19 and motor vehicle crashes (MVC) are both considered epidemics by the U.S. Centers for Disease Control (CDC) and the World Health Organization (WHO), yet their progression, treatment and success in treatment have been very different. In this paper, we propose that the well-established sustainable safety approach to road safety can be applied to the management of COVID-19. We compare COVID-19 and MVC in terms of several defining characteristics, including evolvement and history, definitions and measures of evaluation, main attributes and characteristics, countermeasures, management and coping strategies, and key success factors. Despite stark differences, there are also some similarities between the two epidemics, and these enable insights into how the principles of sustainable road safety can be utilized to cope with and guide the treatment of COVID-19. Major guidelines that can be adopted include an aggressive policy set at the highest national level. The policy should be data- and science-based and would be most effective when relying on a systems approach (such as Sweden's Vision Zero, the Netherlands' Sustainable Safety, and the recommended EU Safe System). The policy should be enforceable and supplemented with positive public information and education campaigns (rather than scare tactics). Progression of mortality and morbidity should be tracked continuously to enable adjustments. Ethical issues (such as invasion of privacy) should be addressed to maximize public acceptance. Interestingly, the well-established domain of MVC can also benefit from the knowledge, experience, and strategies used in addressing COVID-19 by raising the urgency of detection and recognition of new risk factors (e.g., cell phone distractions), developing and implementing appropriate policy and countermeasures, and emphasizing the saliency of the impact of MVC on our daily lives.
C1 [Lotan, Tsippy] OR YAROK, IL-4703749 Ramat Hasharon, Israel.
   [Shinar, David] Ben Gurion Univ Negev, Dept Ind Engn & Management, IL-8443944 Beer Sheva, Israel.
RP Lotan, T (corresponding author), OR YAROK, IL-4703749 Ramat Hasharon, Israel.
EM tsippy.l@gmail.com; shinar@bgu.ac.il
CR Bush G.W., 2005, WE WAIT PANDEMIC APP
   CAMERON M, 2004, WORLD REP ROAD TRAFF, V10, P255
   Davies S. E., 2013, UN CHRONICLE, V50, P20, DOI [10.18356/0dfec716-en, DOI 10.18356/0DFEC716-EN]
   Dellinger AM, 2012, J SAFETY RES, V43, P279, DOI 10.1016/j.jsr.2012.08.004
   ELLISON PA, 1995, J SOC BEHAV PERS, V10, P265
   Elvik R, 2009, HANDBOOK OF ROAD SAFETY MEASURES, 2ND EDITION, P1
   Farmer CM, 2015, TRAFFIC INJ PREV, V16, P684, DOI 10.1080/15389588.2015.1012584
   GORDON JE, 1949, AM J PUBLIC HEALTH, V39, P504, DOI 10.2105/AJPH.39.4.504
   Guttman, 2014, COMMUNICATION PUBLIC
   Haddon W.J., 1967, TXB PREVENTIVE MED, VVolume 33, P591
   HAKKERT AS, 1981, ACCIDENT ANAL PREV, V13, P65, DOI 10.1016/0001-4575(81)90021-X
   Hauer E, 2019, ACCIDENT ANAL PREV, V129, P180, DOI 10.1016/j.aap.2019.04.022
   Hauer E, 2016, ACCIDENT ANAL PREV, V94, P168, DOI 10.1016/j.aap.2016.05.024
   Hays JN., 2005, EPIDEMICS PANDEMICS
   Hilton J, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008031
   Kahane C.J., 2015, 812 DOT HS, V812, P69
   Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793
   Lamont M, 2010, ANTHROPOL TODAY, V26, P3, DOI 10.1111/j.1467-8322.2010.00755.x
   Manchon JB, 2021, THEOR ISS ERGON SCI, V22, P528, DOI 10.1080/1463922X.2020.1830450
   Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139
   NHTSA, 2020, TRAFF SAF FACTS, V812, P947
   Noy IY, 2018, SAFETY SCI, V102, P68, DOI 10.1016/j.ssci.2017.07.018
   NSW, 2012, NEW ROAD SAF STRAT 2
   Obama B., NIH TALK
   Organisation for Economic Co-operation and Development (OECD), 2020, REG QUAL COV 19 US R
   Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768
   Shinar D, 2017, TRAFFIC SAFETY AND HUMAN BEHAVIOR, 2ND EDITION, P1
   Shinar D, 2019, ACCIDENT ANAL PREV, V125, P224, DOI 10.1016/j.aap.2019.02.015
   Stolow JA, 2020, HEALTH EDUC BEHAV, V47, P531, DOI 10.1177/1090198120935073
   SWOV, 2018, PRINC DES ORG CAS FR
   Taiwan Ministry of Health and Welfare, 2020, CRUC POL COMB COVID
   Tingvall C, 1997, TRANSPORTATION, TRAFFIC SAFETY AND HEALTH, P37
   Unger JP, 2021, INT J HEALTH SERV, V51, P37, DOI 10.1177/0020731420946590
   Vergara RJD, 2021, J PUBLIC HEALTH-UK, V43, pE291, DOI 10.1093/pubmed/fdaa282
   WHO, 2009, GLOB PLAN DEC ACT RO
   WHO HIV/AIDS, 2020, KEY FACTS
   (WHO) WHO, 2011, GLOB PLAN DEC ACT RO
   Wikipedia, 2020, LIST EP
   World Health Organization, 2007, EV BUS STRENGTH HLTH
   World Health Organization, 2019, GLOBAL STATUS REPORT
NR 40
TC 0
Z9 0
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD MAR
PY 2021
VL 13
IS 6
AR 3136
DI 10.3390/su13063136
PG 19
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA RV3QO
UT WOS:000645751900001
OA gold
DA 2022-04-20
ER

PT J
AU Smarz-Widelska, I
   Grywalska, E
   Morawska, I
   Forma, A
   Michalski, A
   Mertowski, S
   Hrynkiewicz, R
   Niedzwiedzka-Rystwej, P
   Korona-Glowniak, I
   Parczewski, M
   Zaluska, W
AF Smarz-Widelska, Iwona
   Grywalska, Ewelina
   Morawska, Izabela
   Forma, Alicja
   Michalski, Adam
   Mertowski, Sebastian
   Hrynkiewicz, Rafal
   Niedzwiedzka-Rystwej, Paulina
   Korona-Glowniak, Izabela
   Parczewski, Milosz
   Zaluska, Wojciech
TI Pathophysiology and Clinical Manifestations of COVID-19-Related Acute
   Kidney Injury-The Current State of Knowledge and Future Perspectives
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE COVID-19; SARS-CoV-2; acute kidney injury; AKI; survival rate;
   glomerulopathy; SARS-CoV-2 tropism; coronavirus
ID CORONAVIRUS DISEASE; SARS-COV-2; PATHOLOGY; HYPERINFLAMMATION;
   EPIDEMIOLOGY; POLYMORPHISM; MORTALITY; INFECTION; FAILURE; FOCUS
AB The continually evolving severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has resulted in a vast number of either acute or chronic medical impairments of a pathophysiology that is not yet fully understood. SARS-CoV-2 tropism for the organs is associated with bilateral organ cross-talks as well as targeted dysfunctions, among which acute kidney injury (AKI) seems to be highly prevalent in infected patients. The need for efficient management of COVID-related AKI patients is an aspect that is still being investigated by nephrologists; however, another reason for concern is a disturbingly high proportion of various types of kidney dysfunctions in patients who have recovered from COVID-19. Even though the clinical picture of AKI and COVID-related AKI seems to be quite similar, it must be considered that regarding the latter, little is known about both the optimal management and long-term consequences. These discrepancies raise an urgent need for further research aimed at evaluating the molecular mechanisms associated with SARS-CoV-2-induced kidney damage as well as standardized management of COVID-related AKI patients. The following review presents a comprehensive and most-recent insight into the pathophysiology, clinical manifestations, recommended patient management, treatment strategies, and post-mortem findings in patients with COVID-related AKI.
C1 [Smarz-Widelska, Iwona] Cardinal Stefan Wyszynski Prov Hosp Lublin, Dept Nephrol, PL-20718 Lublin, Poland.
   [Grywalska, Ewelina; Morawska, Izabela; Michalski, Adam; Mertowski, Sebastian] Med Univ Lublin, Dept Clin Immunol & Immunotherapy, PL-20093 Lublin, Poland.
   [Forma, Alicja] Med Univ Lublin, Dept Forens Med, PL-20090 Lublin, Poland.
   [Hrynkiewicz, Rafal; Niedzwiedzka-Rystwej, Paulina] Univ Szczecin, Inst Biol, PL-71412 Szczecin, Poland.
   [Korona-Glowniak, Izabela] Med Univ Lublin, Dept Pharmaceut Microbiol, Chodzki 1, PL-20093 Lublin, Poland.
   [Parczewski, Milosz] Pomeranian Med Univ, Dept Infect Trop Dis & Immune Deficiency, PL-71455 Szczecin, Poland.
   [Zaluska, Wojciech] Med Univ Lublin, Dept Nephrol, PL-20954 Lublin, Poland.
RP Grywalska, E (corresponding author), Med Univ Lublin, Dept Clin Immunol & Immunotherapy, PL-20093 Lublin, Poland.; Niedzwiedzka-Rystwej, P (corresponding author), Univ Szczecin, Inst Biol, PL-71412 Szczecin, Poland.
EM i.widelska@interia.pl; ewelina.grywalska@gmail.com;
   izabelamorawska19@gmail.com; aforma@onet.pl;
   adam.96.michalski@gmail.com; mertowskisebastian@gmail.com;
   rafal.hrynkiewicz@usz.edu.pl; paulina.niedzwiedzka-rystwej@usz.edu.pl;
   iza.glowniak@umlub.pl; mparczewski@yahoo.co.uk;
   wojciech.zaluska@umlub.pl
RI Morawska, Izabela/V-1791-2017; Parczewski, Milosz/I-1869-2014;
   Hrynkiewicz, Rafał/AAG-2054-2021; Michalski, Adam/AAD-2802-2022
OI Parczewski, Milosz/0000-0003-1869-1084; Hrynkiewicz,
   Rafał/0000-0002-0688-6928; Michalski, Adam/0000-0001-9598-373X;
   Grywalska, Ewelina/0000-0002-0451-4741; Mertowski,
   Sebastian/0000-0002-7121-1396; Niedzwiedzka-Rystwej,
   Paulina/0000-0003-4065-3842; Morawska, Izabela/0000-0001-9462-8779;
   Forma, Alicja/0000-0001-8714-7627; Zaluska,
   Wojciech/0000-0001-6043-3236; Korona-Glowniak,
   Izabela/0000-0003-1634-0387
FU Polish National Science Centre (NCN) [UMO-2016/23/B/NZ6/02844]; Medical
   University of Lublin [DS460]
FX This work was supported by Research Grant No. UMO-2016/23/B/NZ6/02844 of
   the Polish National Science Centre (NCN) and Research Grant No. DS460 of
   the Medical University of Lublin.
CR Abassi Z, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.574753
   Adamsick ML, 2020, J AM SOC NEPHROL, V31, P1384, DOI 10.1681/ASN.2020050589
   Afrin LB, 2020, INT J INFECT DIS, V100, P327, DOI 10.1016/j.ijid.2020.09.016
   Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231
   Akilesh S, 2021, AM J KIDNEY DIS, V77, P82, DOI 10.1053/j.ajkd.2020.10.001
   Al-Khafaji A, 2015, CHEST, V148, P550, DOI 10.1378/chest.14-1925
   Alfano G, 2021, BLOOD PURIFICAT, V50, P263, DOI 10.1159/000507914
   Anand IS, 2013, CLIN J AM SOC NEPHRO, V8, P1800, DOI 10.2215/CJN.04090413
   Martinez-Rojas MA, 2020, AM J PHYSIOL-RENAL, V318, pF1454, DOI 10.1152/ajprenal.00160.2020
   Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326
   Baj J, 2021, FORENSIC SCI MED PAT, V17, P101, DOI 10.1007/s12024-020-00341-1
   Baj J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061753
   Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041
   Batlle D, 2020, J AM SOC NEPHROL, V31, P1380, DOI 10.1681/ASN.2020040419
   Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161
   Borges L, 2020, MEDIAT INFLAMM, V2020, DOI 10.1155/2020/8829674
   Brodin P, 2021, NAT MED, V27, P28, DOI 10.1038/s41591-020-01202-8
   Cai AX, 2021, NEPHRON, V145, P297, DOI 10.1159/000514314
   Calomeni E, 2020, KIDNEY INT, V98, P233, DOI 10.1016/j.kint.2020.05.003
   Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3
   Chan Lili, 2020, medRxiv, DOI 10.1101/2020.05.04.20090944
   Chang JH, 2019, AM J KIDNEY DIS, V73, P134, DOI 10.1053/j.ajkd.2018.05.008
   Chaudhri I, 2020, KIDNEY BLOOD PRESS R, V45, P1018, DOI 10.1159/000511946
   Chawla LS, 2017, NAT REV NEPHROL, V13, P241, DOI 10.1038/nrneph.2017.2
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen RC, 2020, CHEST, V158, P97, DOI 10.1016/j.chest.2020.04.010
   Chen Y, 2020, HUMAN KIDNEY IS TARG, DOI [10.1101/2020.03.04.20031120, DOI 10.1101/2020.03.04.20031120]
   Chen YT, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03134-8
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740
   Cheruiyot Isaac, 2020, Acta Biomed, V91, pe2020029, DOI 10.23750/abm.v91i3.10222
   Chong WH, 2021, AM J MED SCI, V361, P287, DOI 10.1016/j.amjms.2020.10.025
   Chueh TI, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113547
   Coelho A.V.C., 2020, J CLIN PATHOL, DOI [10.1136/jclinpath-2020-207023, DOI 10.1136/JCLINPATH-2020-207023]
   Cui SP, 2020, J THROMB HAEMOST, V18, P1421, DOI 10.1111/jth.14830
   Delanghe JR, 2020, CLIN CHIM ACTA, V505, P192, DOI 10.1016/j.cca.2020.03.031
   Devaux CA, 2020, J MICROBIOL IMMUNOL, V53, P425, DOI 10.1016/j.jmii.2020.04.015
   Doher MP, 2021, BLOOD PURIFICAT, V50, P520, DOI 10.1159/000513425
   Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8
   Fabrizi F, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9121052
   Fanelli V, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02872-z
   Farkash EA, 2020, J AM SOC NEPHROL, V31, P1683, DOI 10.1681/ASN.2020040432
   Ferrari D, 2020, CLIN CHEM LAB MED, V58, P1095, DOI 10.1515/cclm-2020-0398
   Fontana F, 2020, KIDNEY INT REP, V5, P1815, DOI 10.1016/j.ekir.2020.07.008
   Gabarre P, 2020, INTENS CARE MED, V46, P1339, DOI 10.1007/s00134-020-06153-9
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gomez H, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000052
   Gong J, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05681-5
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Gupta S, 2020, AM J KIDNEY DIS, V76, P63, DOI 10.1053/j.ajkd.2019.10.011
   Gustine JN, 2021, AM J PATHOL, V191, P4, DOI 10.1016/j.ajpath.2020.08.009
   Hansrivijit P, 2020, J INVEST MED, V68, P1261, DOI 10.1136/jim-2020-001407
   Haroun MW, 2021, CUREUS J MED SCIENCE, V13, DOI 10.7759/cureus.12552
   Hassanein M, 2020, CLEV CLIN J MED, V87, P619, DOI 10.3949/ccjm.87a.20072
   He L, 2021, KIDNEY DIS-BASEL, V7, P120, DOI 10.1159/000511403
   Heyman SN, 2021, J CLIN MED, V10, DOI 10.3390/jcm10061200
   Heyman SN, 1996, J AM SOC NEPHROL, V7, P1066
   Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006
   Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7
   Huang C., 2020, FAVIPIRAVIR VERSUS A, DOI [10.1101/2020.03.17.20037432, DOI 10.1101/2020.03.17.20037432]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Husain-Syed F, 2016, AM J RESP CRIT CARE, V194, P402, DOI 10.1164/rccm.201602-0420CP
   Jobe A, 2021, COMPUT STRUCT BIOTEC, V19, P1889, DOI 10.1016/j.csbj.2021.03.025
   Johns Hopkins Coronavirus Resource Center, COVID 19 MAP
   Jordan Rachel E, 2020, BMJ, V368, pm1198, DOI 10.1136/bmj.m1198
   Kane-Gill SL, 2015, CRIT CARE CLIN, V31, P675, DOI 10.1016/j.ccc.2015.06.005
   Kellum JA, 2020, NEPHROL DIAL TRANSPL, V35, P1652, DOI 10.1093/ndt/gfaa231
   Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789
   Kolhe NV, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003406
   Kudose S, 2020, J AM SOC NEPHROL, V31, P1959, DOI 10.1681/ASN.2020060802
   Kuiper JW, 2011, CRIT CARE, V15, DOI 10.1186/cc10282
   Kyrou I, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-020-00460-9
   Larsen CP, 2020, KIDNEY INT REP, V5, P935, DOI 10.1016/j.ekir.2020.04.002
   Li H, 2020, J INFECTION, V80, P646, DOI 10.1016/j.jinf.2020.03.035
   Li Q, 2020, CLIN INTERV AGING, V15, P2095, DOI 10.2147/CIA.S273720
   [李仲平 Li Zhongping], 2020, [中国软科学, China Soft Science], P1
   Lin LR, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-042573
   Liu F, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104370
   Liu YL, 2020, PLATELETS, V31, P490, DOI 10.1080/09537104.2020.1754383
   Long DA, 2004, HYPERTENSION, V43, P722, DOI 10.1161/01.HYP.0000120964.22281.3e
   Luther T, 2021, ACTA ANAESTH SCAND, V65, P364, DOI 10.1111/aas.13746
   Mayi BS, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009153
   Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713
   Miller SE, 2020, KIDNEY INT, V98, P231, DOI 10.1016/j.kint.2020.05.004
   Mishra KP, 2021, NEUROIMMUNOMODULAT, V27, P80, DOI 10.1159/000513198
   Mizuiri Sonoo, 2015, World J Nephrol, V4, P74, DOI 10.5527/wjn.v4.i1.74
   Mohamed Muner M B, 2020, Kidney360, V1, P614, DOI 10.34067/KID.0002652020
   Moitinho MS, 2020, REV BRAS ENFERM, V73, DOI 10.1590/0034-7167-2020-0354
   Mokhtari AK, 2021, J SURG RES, V266, P35, DOI 10.1016/j.jss.2021.03.049
   Nadim MK, 2020, NAT REV NEPHROL, V16, P747, DOI 10.1038/s41581-020-00356-5
   Nadim MK, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008834
   Nasr SH, 2020, KIDNEY INT REP, V5, P759, DOI 10.1016/j.ekir.2020.04.030
   Ng JH, 2020, ADV CHRONIC KIDNEY D, V27, P365, DOI 10.1053/j.ackd.2020.09.003
   Ng JH, 2021, AM J KIDNEY DIS, V77, P204, DOI 10.1053/j.ajkd.2020.09.002
   Nimkar Abhishek, 2020, Mayo Clin Proc Innov Qual Outcomes, V4, P687, DOI 10.1016/j.mayocpiqo.2020.07.003
   Ostermann M, 2020, J CRIT CARE, V60, P91, DOI 10.1016/j.jcrc.2020.07.023
   Othman H, 2020, BIOCHEM BIOPH RES CO, V527, P702, DOI 10.1016/j.bbrc.2020.05.028
   Oussalah A, 2020, CLIN INFECT DIS, V71, P2447, DOI 10.1093/cid/ciaa677
   Palevsky PM, 2021, J AM SOC NEPHROL, V32, P1029, DOI 10.1681/ASN.2020121768
   Pan XW, 2020, INTENS CARE MED, V46, P1114, DOI 10.1007/s00134-020-06026-1
   Parmar MS, 2021, KIDNEY MED, V3, P128, DOI 10.1016/j.xkme.2020.09.006
   Pei GC, 2020, J AM SOC NEPHROL, V31, P1157, DOI 10.1681/ASN.2020030276
   Pelayo J, 2020, CARDIORENAL MED, V10, P223, DOI 10.1159/000509182
   Peleg Y, 2020, KIDNEY INT REP, V5, P940, DOI 10.1016/j.ekir.2020.04.017
   Perez-Miller S, 2021, ACS CHEM NEUROSCI, V12, P1299, DOI 10.1021/acschemneuro.0c00619
   Perico L, 2020, NEPHRON, V144, P213, DOI 10.1159/000507305
   Post A, 2020, AM J KIDNEY DIS, V76, P431, DOI 10.1053/j.ajkd.2020.05.004
   Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2013400, 10.1056/NEJMc2011400]
   Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248
   Rabb H, 2020, J CLIN INVEST, V130, P2749, DOI 10.1172/JCI138871
   Reddy YNV, 2020, AM J KIDNEY DIS, V76, P696, DOI 10.1053/j.ajkd.2020.07.005
   Ronco C, 2020, NAT REV NEPHROL, V16, P308, DOI 10.1038/s41581-020-0284-7
   Ronco C, 2017, NEPHROL DIAL TRANSPL, V32, P408, DOI 10.1093/ndt/gfx016
   Rosenberg AZ, 2015, NAT REV NEPHROL, V11, P150, DOI 10.1038/nrneph.2015.9
   Rossi GM, 2020, KIDNEY INT REP, V5, P1100, DOI 10.1016/j.ekir.2020.05.005
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Santoriello D, 2020, J AM SOC NEPHROL, V31, P2158, DOI 10.1681/ASN.2020050744
   Selby NM, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1963
   Shao MJ, 2020, PHARMACOL RES, V161, DOI 10.1016/j.phrs.2020.105107
   Sharma P, 2020, J AM SOC NEPHROL, V31, P1948, DOI 10.1681/ASN.2020050699
   Shetty AA, 2021, J AM SOC NEPHROL, V32, P33, DOI 10.1681/ASN.2020060804
   Silver SA, 2021, KIDNEY MED, V3, P83, DOI 10.1016/j.xkme.2020.11.008
   Sodhi CP, 2018, AM J PHYSIOL-LUNG C, V314, pL17, DOI 10.1152/ajplung.00498.2016
   Soleimani M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093275
   Sourial MY, 2020, AM J KIDNEY DIS, V76, P401, DOI 10.1053/j.ajkd.2020.06.001
   Santos RAS, 2018, PHYSIOL REV, V98, P505, DOI 10.1152/physrev.00023.2016
   Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003
   Sundaram S, 2021, DIABETES METAB SYND, V15, P187, DOI 10.1016/j.dsx.2020.12.021
   Tan CC, 2020, J MED VIROL, V92, P856, DOI 10.1002/jmv.25871
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Tufan A, 2020, TURK J MED SCI, V50, P620, DOI 10.3906/sag-2004-168
   Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760
   Vandenberghe W, 2016, CARDIORENAL MED, V6, P116, DOI 10.1159/000442300
   Velez JCQ, 2020, NAT REV NEPHROL, V16, P565, DOI 10.1038/s41581-020-0332-3
   Vincent, 2013, ANN UPDATE INTENSIVE, P679, DOI [10.1007/978-3-642-35109-9_54, DOI 10.1007/978-3-642-35109-9_54]
   Wang B, 2021, KIDNEY BLOOD PRESS R, V46, P17, DOI 10.1159/000512211
   Wang LW, 2020, AM J NEPHROL, V51, P343, DOI 10.1159/000507471
   Wysocki J, 2020, J AM SOC NEPHROL, V31, P1941, DOI 10.1681/ASN.2020050667
   Xia P, 2020, J AM SOC NEPHROL, V31, P2205, DOI 10.1681/ASN.2020040426
   Xiao Y., 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa270, DOI 10.1093/CID/CIAA270]
   Xu JY, 2021, J INTENSIVE CARE MED, V36, P319, DOI 10.1177/0885066620970858
   Xu S., 2020, ACUTE KIDNEY INJURY, DOI [10.1101/2020.03.24.20042408, DOI 10.1101/2020.03.24.20042408]
   Xu Z, 2017, SCI REP-UK, V7, DOI 10.1038/srep44911
   Yang XB, 2020, J THROMB HAEMOST, V18, P1469, DOI 10.1111/jth.14848
   Yang XP, 2021, INT IMMUNOPHARMACOL, V90, DOI 10.1016/j.intimp.2020.107159
   Zheng XZ, 2020, SEMIN NEPHROL, V40, P430, DOI 10.1016/j.semnephrol.2020.09.001
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   zhou H, 2020, URINALYSIS NOT BLOOD
NR 148
TC 2
Z9 2
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUL
PY 2021
VL 22
IS 13
AR 7082
DI 10.3390/ijms22137082
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA TG3RX
UT WOS:000671326200001
PM 34209289
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Tanno, LK
   Demoly, P
   Martin, B
   Berstein, J
   Morais-Almeida, M
   Levin, M
   Fiocchi, A
   Sanchez-Borges, M
   Caraballo, LR
   Wong, G
   Ortega-Martell, JA
   Rouadi, P
   Yanez, A
   Wang, LL
   Peden, DB
   Chikhladze, M
   Gonzalez-Diaz, SN
   Fontainet, JF
   Sublett, J
   Chang, YS
   Passalacqua, G
   Ansotegui, IJ
   Ebisawa, M
   Senna, G
   Caminati, M
AF Tanno, Luciana Kase
   Demoly, Pascal
   Martin, Bryan
   Berstein, Jonathan
   Morais-Almeida, Mario
   Levin, Michael
   Fiocchi, Alessandro
   Sanchez-Borges, Mario
   Caraballo, Luis R.
   Wong, Gary
   Ortega-Martell, Jose Antonio
   Rouadi, Philip
   Yanez, Anahi
   Wang, Liang Lu
   Peden, David B.
   Chikhladze, Manana
   Gonzalez-Diaz, Sandra N.
   Fontainet, Jean-Francois
   Sublett, James
   Chang, Yoon-Seok
   Passalacqua, Giovanni
   Ansotegui, Ignacio J.
   Ebisawa, Motohiro
   Senna, Gianenrico
   Caminati, Marco
TI Allergy and coronavirus disease (COVID-19) international survey:
   Real-life data from the allergy community during the pandemic
SO WORLD ALLERGY ORGANIZATION JOURNAL
LA English
DT Article
DE Allergy; Allergen immunotherapy; Asthma; Biological agents; Coronavirus;
   COVID-19; Inhaled steroids; Treatment; Prevention
ID ASTHMA; CORTICOSTEROIDS; BENRALIZUMAB; OMALIZUMAB; BIOLOGICS; APPROVAL;
   RHINITIS
AB Background: The COVID-19 outbreak brought an unprecedented challenge to the world. Knowledge in the field has been increasing exponentially and the main allergy societies have produced guidance documents for better management of allergic patients during this period. However, few publications so far have provided real-life data from the allergy community concerning allergy practice during the COVID-19 outbreak. Therefore, we proposed an international survey on the management of allergic patients during the current pandemic.
   Methods: We performed an online survey undertaken to reach out the worldwide allergy community by e-mail and social media. The web-based questionnaire contained 24 questions covering demographic data from the participants, clinical practice during this period, and questions related to the new international classification and coding tools addressed for COVID-19. It was circulated for 8 weeks and had anonymous and volunteer context.
   Results: Data are presented for 635 participants from 78 countries of all continents. Allergists with long-term professional experience were the main audience. As expected, we received many responses as "I have no data" or "I don't know" to the questions of the survey. However, most with more experience on managing allergic patients during the pandemic agreed that patients suffering from allergic or hypersensitivity conditions have no increased risk of contracting COVID-19 or developing SARS CoV-2. Also, participants mentioned that none of the allergy treatments (inhaled corticosteroids, allergen immunotherapy, biological agents increased the risk of contracting COVID-19 infection including severe presentations.
   Conclusion: The data presented are a starting point in the process of getting feedback on all the recommendations provided by the allergy societies; it could also be the basis of new strategies to support health professionals while new COVID-19 specific treatments and vaccines are being explored. The information here presented intends to be helpful to the community but represents a course of action in a highly specific situation due to the state of emergency, and it should be helpful to health systems.
C1 [Tanno, Luciana Kase] Hosp Sirio Libanes, Sao Paulo, Brazil.
   [Tanno, Luciana Kase; Demoly, Pascal] Univ Hosp Montpellier, Montpellier, France.
   [Tanno, Luciana Kase; Demoly, Pascal] Sorbonne Univ, INSERM, IPLESP, Equipe EPAR,UMRS 1136, F-75013 Paris, France.
   [Tanno, Luciana Kase; Demoly, Pascal] WHO Collaborating Ctr Sci Classificat Support, Montpellier, France.
   [Martin, Bryan] Ohio State Univ, Med & Pediat, Columbus, OH USA.
   [Berstein, Jonathan] Univ Cincinnati, Med Ctr, Dept Internal Med, Div Immunol,Allergy Sect, Cincinnati, OH 45221 USA.
   [Morais-Almeida, Mario] CUF Descobertas Hosp, Allergy Ctr, Lisbon, Portugal.
   [Levin, Michael] Univ Cape Town, Div Paediat Allergol, Cape Town, South Africa.
   [Fiocchi, Alessandro] Bambino Gesu Childrens Hosp IRCCS, Multifactorial & Syst Dis Res Area, Predict & Prevent Med Res Unit, Rome, Italy.
   [Sanchez-Borges, Mario] Ctr Med Docente Trinidad & Clin El Avila, Allergy & Clin Immunol Dept, Caracas, Venezuela.
   [Caraballo, Luis R.] Univ Cartagena, Inst Immunol Res, Cartagena De Indias, Colombia.
   [Wong, Gary] Chinese Univ Hong Kong, Dept Paediat, Hong Kong, Peoples R China.
   [Ortega-Martell, Jose Antonio] Autonomous Univ Hidalgo State, Sch Med, Pachuca, Hidalgo, Mexico.
   [Rouadi, Philip] Eye & Ear Univ Hosp, Dept Otolaryngol Head & Neck Surg, Beirut, Lebanon.
   [Yanez, Anahi] INAER Invest Alergia & Enfermedades Resp, Buenos Aires, DF, Argentina.
   [Wang, Liang Lu] Peking Union Med Coll Hosp, Dept Allergy, Beijing, Peoples R China.
   [Peden, David B.] Univ N Carolina, Dept Pediat, Div Allergy Immunol & Rheumatol, Chapel Hill, NC 27515 USA.
   [Chikhladze, Manana] Akaki Tsereteli State Univ, Med Fac, Tskaltubo, Kutaisi, Georgia.
   [Gonzalez-Diaz, Sandra N.] Univ Autonoma Nuevo Leon, Monterrey, NL, Mexico.
   [Fontainet, Jean-Francois] Univ Hosp Reims, Dept Malad Allerg & Resp, Reims, France.
   [Sublett, James] Univ Louisville, Sch Med, Pediat Allergy & Immunol, Louisville, KY 40292 USA.
   [Chang, Yoon-Seok] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Allergy & Clin Immunol, Seoul, South Korea.
   [Passalacqua, Giovanni] Univ Genoa, IRCCS Policlin San Martino, Allergy & Resp Dis, Genoa, Italy.
   [Ansotegui, Ignacio J.] Hosp Quironsalud Bizkaia, Bilbao, Spain.
   [Ebisawa, Motohiro] Sagamihara Natl Hosp, Natl Hosp Org, Sagamihara, Kanagawa, Japan.
   [Senna, Gianenrico; Caminati, Marco] Univ Hosp Verona, Allergy Asthma & Clin Immunol Sect, Dept Med, Verona, Italy.
   [Caminati, Marco] Univ Verona, Dept Med, Verona, Italy.
RP Tanno, LK (corresponding author), Univ Hosp Montpellier, Hop Arnaud Villeneuve, Dept Pulmonol, Div Allergy, 371 Av Doyen Gaston Giraud, F-34295 Montpellier, France.
EM luciana.tanno@gmail.com
RI Caminati, Marco/AAC-6302-2022; Wong, Gary WK/AAY-9207-2020
OI Caminati, Marco/0000-0001-7383-1487; Wong, Gary WK/0000-0001-5939-812X;
   Rouadi, philip/0000-0002-5365-9568; Ebisawa,
   Motohiro/0000-0003-4117-558X; Peden, David/0000-0003-4526-4627
FU MEDA/Mylan Pharma grant through CHUM administration; AllerGOS grant;
   Novartis grant through CHUM administration
FX Pascal Demoly and Luciana Kase Tanno received an unrestricted Novartis
   and MEDA/Mylan Pharma grants through CHUM administration. LKT received a
   research AllerGOS grant.
CR [Anonymous], 2003, FDA Consum, V37, P5
   [Anonymous], 2020, NOVARTIS RECEIVES EU
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Baker J, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0814-6
   Bleecker ER, 2016, LANCET, V388, P2115, DOI 10.1016/S0140-6736(16)31324-1
   Bousquet J, 2020, ALLERGY, V75, P2440, DOI 10.1111/all.14302
   Calonge N, 2020, JAMA-J AM MED ASSOC, V324, P629, DOI 10.1001/jama.2020.12901
   Caminati M, 2020, J ALLERGY CLIN IMMUN, V146, P541, DOI 10.1016/j.jaci.2020.05.049
   Casale TB, 2017, J ALLERGY CLIN IMMUN, V139, P1411, DOI 10.1016/j.jaci.2017.03.006
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Compalati E, 2020, J INVEST ALLERG CLIN, V30, P459, DOI 10.18176/jiaci.0568
   Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034
   Denman S, 2016, BRIT J DERMATOL, V175, P1405, DOI 10.1111/bjd.15074
   Desai M, 2019, CLIN CHEST MED, V40, P179, DOI 10.1016/j.ccm.2018.10.011
   Fala Loretta, 2016, Am Health Drug Benefits, V9, P106
   Gelincik A, 2020, ALLERGY, V75, P2775, DOI 10.1111/all.14439
   GUAN W, 2020, CLINICAL CHARACTERIS
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X
   Huang KW, 2019, LANCET, V394, P407, DOI 10.1016/S0140-6736(19)31147-X
   Jackson DJ, 2020, J ALLERGY CLIN IMMUN, V146, P203, DOI 10.1016/j.jaci.2020.04.009
   Johnston SL, 2020, ALLERGY, V75, P1543, DOI 10.1111/all.14348
   Kartush AG, 2019, AM J RHINOL ALLERGY, V33, P203, DOI 10.1177/1945892418814768
   Kaufman Michele B, 2016, P T, V41, P355
   Keswani A, 2020, ANN ALLERG ASTHMA IM, V125, P479, DOI 10.1016/j.anai.2020.07.012
   Klimek Ludger, 2020, Allergol Select, V4, P44, DOI 10.5414/ALX02147E
   Lee JH, 2020, ALLERGY ASTHMA IMMUN, V12, P783, DOI 10.4168/aair.2020.12.5.783
   Levin M, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2020.100125
   Lombardi C, 2020, ANN ALLERG ASTHMA IM, V125, P707, DOI 10.1016/j.anai.2020.07.029
   Markham A, 2018, DRUGS, V78, P505, DOI 10.1007/s40265-018-0876-8
   Morais-Almeida M, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2020.100126
   Mullard A, 2017, NAT REV DRUG DISCOV, V16, P305, DOI 10.1038/nrd.2017.88
   Papadopoulos NG, 2020, J ALLER CL IMM-PRACT, V8, P2592, DOI 10.1016/j.jaip.2020.06.001
   PFAAR O, 2020, IN PRESS, DOI DOI 10.1111/ALL.14453
   Reinke Thomas, 2018, Manag Care, V27, P14
   Scadding GK, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2020.100124
   Shaker MS, 2020, IN PRESS
   Shih J, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0807-5
   Sokolowska M, 2020, ALLERGY, V75, P2445, DOI 10.1111/all.14462
   Straumann A, 2010, GUT, V59, P21, DOI 10.1136/gut.2009.178558
   Tanno LK, 2020, J ALLER CL IMM-PRACT, V8, P2144, DOI 10.1016/j.jaip.2020.05.002
   Tanno LK, 2020, ALLERGY, V75, P2206, DOI 10.1111/all.14468
   Velavan TP, 2020, TROP MED INT HEALTH, V25, P278, DOI 10.1111/tmi.13383
   Wallace DV, 2017, ANN INTERN MED, V167, P876, DOI 10.7326/M17-2203
   World Health Organization, 2020, INT CLASSIFICATION D
   World Health Organization, 2020, INT CLASS DIS
   World Health Organization website, 2020, CORONAVIRUS DIS COVI
   World Health Organization website, 2020, TESTING STRATEGY REC
   Wu KCP, 2015, J INVEST DERMATOL, V135, P13, DOI 10.1038/jid.2014.362
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
   Zheng XY, 2018, ARCH VIROL, V163, P845, DOI 10.1007/s00705-017-3700-y
NR 52
TC 2
Z9 2
U1 1
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1939-4551
J9 WORLD ALLERGY ORGAN
JI World Allergy Organ. J.
PD FEB
PY 2021
VL 14
IS 2
AR 100515
DI 10.1016/j.waojou.2021.100515
EA MAR 2021
PG 17
WC Allergy; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Allergy; Immunology
GA RB6GV
UT WOS:000632209300001
PM 33552380
OA Green Published, gold, Green Accepted
DA 2022-04-20
ER

PT J
AU Matute, J
   Palau-Saumell, R
   Meyer, J
   Derqui, B
   Jimenez-Asenjo, N
AF Matute, Jorge
   Palau-Saumell, Ramon
   Meyer, Jan
   Derqui, Belen
   Jimenez-Asenjo, Noelia
TI Are you getting it? Integrating theories to explain intentions to get
   vaccinated against COVID-19 in Spain
SO JOURNAL OF RISK RESEARCH
LA English
DT Article; Early Access
DE Covid-19; vaccine; coronavirus; behavioral intentions; health risk
ID HEALTH BELIEF MODEL; PLS-SEM; INFLUENZA VACCINATION; PLANNED BEHAVIOR;
   ATTITUDES; TRUST; WILLINGNESS; GOVERNMENT; DECISION; PARENTS
AB Based on the Health-Belief Model, the Theory of Reasoned Action and elements from social exchange, political ideology and fairness theories, this study explores the factors explaining individuals' intentions to be vaccinated against COVID-19. Data were collected from a representative sample of the Spanish population composed of 507 citizens. The proposed model is tested with Partial Least Squares. Empirical testing suggests that attitudes toward the vaccine and moral norms directly determine citizens' behavioral intentions to get vaccinated. These attitudes are mainly explained by perceptions about the benefits and risks associated with the vaccine and, to a lesser extent, by the perceived susceptibility, severity and knowledge of the disease, and each individual's personal health orientation. Contrary to our expectations, perceived social pressures and cues to action do not explain behavioral intentions and attitudes, respectively. The findings from this study also suggest that political ideology indirectly, rather than directly, determines attitudes and behavioral intentions to get vaccinated via increased perceptions of trust and fairness involving the government's decisions regarding the vaccination campaign. Overall, results suggest that reasons for accepting, or rejecting, the vaccine are heterogeneous and more complex than expected. Findings provide relevant insights for policymakers when it comes to designing effective interventions to increase the acceptance of the vaccine and reduce infection rates in the short term.
C1 [Matute, Jorge; Palau-Saumell, Ramon; Meyer, Jan; Derqui, Belen; Jimenez-Asenjo, Noelia] Univ Ramon Llull, IQS Sch Management, Via Augusta,390, Barcelona 08017, Spain.
RP Matute, J (corresponding author), Univ Ramon Llull, IQS Sch Management, Via Augusta,390, Barcelona 08017, Spain.
EM jorge.matute@iqs.url.edu
RI Palau-Saumell, Ramon/S-7380-2018; Matute, Jorge/O-9603-2019
OI Matute, Jorge/0000-0002-2402-327X; Palau-Saumell,
   Ramon/0000-0003-4756-624X; Meyer, Jan-Hinrich/0000-0001-6818-0683;
   Jimenez-Asenjo, Noelia/0000-0002-7682-4271; Derqui,
   Belen/0000-0003-4882-129X
FU Ministry of Business and Knowledge, Catalonia; Universitat Ramon Llull
FX This work was supported by the Secretary of Universities and Research
   (Ministry of Business and Knowledge, Catalonia), and the Universitat
   Ramon Llull.
CR Alvarez F, 2019, FUTURE MICROBIOL, V14, P1429, DOI 10.2217/fmb-2019-0203
   Baumgaertner B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191728
   Blue Carolyn L, 2002, AAOHN J, V50, P227
   Breakwell GM, 2021, J RISK RES, V24, P335, DOI 10.1080/13669877.2020.1864011
   Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136
   Castro-Sanchez E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022132
   Cepeda-Carrion G, 2019, J KNOWL MANAG, V23, P67, DOI 10.1108/JKM-05-2018-0322
   Champion V.L., 2008, HLTH BEHAV HLTH ED T, V4th ed., P45
   Chen SF, 2010, J CLIN NURS, V19, P2713, DOI 10.1111/j.1365-2702.2010.03320.x
   Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193
   Fall E, 2018, PSYCHOL HEALTH, V33, P746, DOI 10.1080/08870446.2017.1401623
   Fishbein M, 2003, COMMUN THEOR, V13, P164, DOI 10.1111/j.1468-2885.2003.tb00287.x
   Gadarian SK, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249596
   Gao L, 2017, RESOUR CONSERV RECY, V127, P107, DOI 10.1016/j.resconrec.2017.08.030
   Goodwin GP, 2012, J EXP SOC PSYCHOL, V48, P250, DOI 10.1016/j.jesp.2011.08.006
   Hair J, 2017, IND MANAGE DATA SYST, V117, P442, DOI 10.1108/IMDS-04-2016-0130
   Hair JF, 2014, EUR BUS REV, V26, P106, DOI 10.1108/EBR-10-2013-0128
   Hair JF, 2019, EUR BUS REV, V31, P2, DOI 10.1108/EBR-11-2018-0203
   Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8
   Hochbaum GM., 1958, PUBLIC PARTICIPATION
   Huang XY, 2020, TOUR MANAG PERSPECT, V33, DOI 10.1016/j.tmp.2019.100589
   JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101
   Jaspal R, 2022, CURR PSYCHOL, V41, P492, DOI 10.1007/s12144-021-01681-z
   Juraskova I, 2012, INT J BEHAV MED, V19, P518, DOI 10.1007/s12529-011-9182-5
   Kim M, 2018, J ENVIRON PLANN MAN, V61, P1511, DOI 10.1080/09640568.2017.1354815
   Krouwel A, 2017, J SOC POLIT PSYCHOL, V5, P435, DOI 10.5964/jspp.v5i2.745
   Lewandowsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075637
   Mehrabian A, 1996, BASIC APPL SOC PSYCH, V18, P469, DOI 10.1207/s15324834basp1804_7
   Mesch GS, 2015, HEALTH PROMOT INT, V30, P213, DOI 10.1093/heapro/dau094
   Navarro-Illana P, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-490
   Nunkoo R, 2013, TOURISM MANAGE, V36, P120, DOI 10.1016/j.tourman.2012.11.018
   Nunkoo R, 2012, ANN TOURISM RES, V39, P997, DOI 10.1016/j.annals.2011.11.017
   OECD, 2020, OECD POL RES COR COV OECD POL RES COR COV
   Painter M, 2020, POLITICAL BELIEFS AF, DOI DOI 10.2139/SSRN.3569098
   Quintal VA, 2010, TOURISM MANAGE, V31, P797, DOI 10.1016/j.tourman.2009.08.006
   Ringle CM, 2016, IND MANAGE DATA SYST, V116, P1865, DOI 10.1108/IMDS-10-2015-0449
   Roberto AJ, 2011, HEALTH COMMUN, V26, P303, DOI 10.1080/10410236.2010.550021
   Rodriguez-Perez A, 2020, INT J SOC PSYCHOL, V35, P625, DOI 10.1080/02134748.2020.1783856
   Salmon DA, 2005, ARCH PEDIAT ADOL MED, V159, P470, DOI 10.1001/archpedi.159.5.470
   Sarstedt M, 2019, AUSTRALAS MARK J, V27, P197, DOI 10.1016/j.ausmj.2019.05.003
   Schomerus G, 2009, PSYCHOL MED, V39, P1855, DOI 10.1017/S0033291709005832
   Schwartz S.H., 1977, ADV EXP SOC PSYCHOL, V10, P221, DOI [10.1016/S0065-2601(08)60358-5, DOI 10.1016/S0065-2601(08)60358-5, 10.1016/s0065-2601(08)60358-5]
   Shahrabani S, 2010, INT J ENV RES PUB HE, V7, P853, DOI 10.3390/ijerph7030853
   Shahrabani S, 2009, EUR J HEALTH ECON, V10, P227, DOI 10.1007/s10198-008-0124-3
   Shattuck D., 2020, GLOBAL SURVEY COVID
   Sherman SM, 2021, HUM VACC IMMUNOTHER, V17, P1612, DOI 10.1080/21645515.2020.1846397
   Shmueli G, 2019, EUR J MARKETING, V53, P2322, DOI 10.1108/EJM-02-2019-0189
   Streukens S, 2016, EUR MANAG J, V34, P618, DOI 10.1016/j.emj.2016.06.003
   Tsutsui Y, 2010, HEALTH POLICY, V97, P238, DOI 10.1016/j.healthpol.2010.05.008
   Verelst F, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0820
   Vila-Candel R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3823-1
   Vinck P, 2019, LANCET INFECT DIS, V19, P529, DOI 10.1016/S1473-3099(19)30063-5
   Virseda S, 2010, VACCINE, V28, P4751, DOI 10.1016/j.vaccine.2010.04.101
   Warren GW, 2021, J RISK RES, V24, P369, DOI 10.1080/13669877.2020.1870533
   Wong CML, 2020, J RISK RES, V23, P1021, DOI 10.1080/13669877.2020.1756386
   Wong JCS, 2021, J RISK RES, V24, P352, DOI 10.1080/13669877.2020.1864012
   Wong LP, 2020, HUM VACC IMMUNOTHER, V16, P2204, DOI 10.1080/21645515.2020.1790279
   Yang ZJ, 2015, J HEALTH COMMUN, V20, P69, DOI 10.1080/10810730.2014.904023
   YouGov.com, 2021, EL 52 ESP CONS SEG V EL 52 ESP CONS SEG V
NR 59
TC 1
Z9 1
U1 6
U2 10
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1366-9877
EI 1466-4461
J9 J RISK RES
JI J. Risk Res.
DI 10.1080/13669877.2021.1958044
EA JUL 2021
PG 20
WC Social Sciences, Interdisciplinary
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics
GA TU6DU
UT WOS:000681125600001
DA 2022-04-20
ER

PT J
AU Kishaba, T
   Suzuki, T
   Yamazato, S
   Miyagi, T
   Nagano, H
AF Kishaba, Tomoo
   Suzuki, Tomoharu
   Yamazato, Shoshin
   Miyagi, Tadayoshi
   Nagano, Hiroaki
TI Lung Rest with Femoro-Femoral Veno-Venous Extracorporeal Membrane
   Oxygenation for COVID-19 Severe Pneumonia with Pneumomediastinum
SO TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE COVID-19; extracorporeal membrane oxygenation; lung rest;
   pneumomediastinum; prone position ventilation
AB Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sometimes causes severe coronavirus disease 2019 (COVID-19) pneumonia. Here, we report the case of a 35-year-old man with obesity who showed severe respiratory failure from SARS-CoV-2 infection. Immediate high-resolution computed tomography (HRCT) of the chest after endotracheal intubation revealed a significant pneumomediastinum with diffuse ground-glass opacity and consolidation. Ventilator management was difficult with low tidal volume and low positive end expiratory pressure. Therefore, we administered extracorporeal membrane oxygenation (ECMO) to allow lung rest and prevent further progression of the pneumomediastinum and maintain oxygenation. Since implementing ECMO, the patient's oxygenation has stabilized and follow-up HRCT of the chest revealed dramatic improvement of the pneumomediastinum. We gradually tapered off ECMO and employed a pressure-control mode. He was extubated on day 11. To our knowledge, this is the first reported patient who showed complete pneumomediastinum recovery from COVID-19 pneumonia with ECMO.
C1 [Kishaba, Tomoo; Yamazato, Shoshin; Nagano, Hiroaki] Okinawa Chubu Hosp, Dept Resp Med, 281 Miyazato, Uruma, Okinawa 9042293, Japan.
   [Suzuki, Tomoharu] Okinawa Chubu Hosp, Dept Intens Care Unit, Uruma, Okinawa, Japan.
   [Miyagi, Tadayoshi] Okinawa Chubu Hosp, Dept Cardiovasc Med, Uruma, Okinawa, Japan.
RP Kishaba, T (corresponding author), Okinawa Chubu Hosp, Dept Resp Med, 281 Miyazato, Uruma, Okinawa 9042293, Japan.
EM kishabatomoo@gmail.com
CR Chowdhary A, 2021, ACAD RADIOL, V28, P1586, DOI 10.1016/j.acra.2021.07.013
   Giani M, 2021, MEMBRANES-BASEL, V11, DOI 10.3390/membranes11030172
   Guven BB, 2021, EPIDEMIOL INFECT, V149, DOI 10.1017/S0950268821001291
   Maeda A., 2020, RESPIROL CASE REP, V9
   Ren PP, 2021, ANN TRANSL MED, V9, DOI 10.21037/atm-21-812
   Sah A, 2021, J COMMUNITY HOSP INT, V11, P304, DOI 10.1080/20009666.2021.1896831
   Xiang CL, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020208
NR 7
TC 0
Z9 0
U1 0
U2 0
PU TOHOKU UNIV MEDICAL PRESS
PI SENDAI
PA 2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN
SN 0040-8727
EI 1349-3329
J9 TOHOKU J EXP MED
JI Tohoku J. Exp. Med.
PD FEB
PY 2022
VL 256
IS 2
BP 127
EP 130
DI 10.1620/tjem.256.127
PG 4
WC Medicine, General & Internal; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Research & Experimental Medicine
GA ZE4KB
UT WOS:000758852500003
PM 35173091
OA gold
DA 2022-04-20
ER

PT J
AU Cahapay, MB
AF Cahapay, Michael B.
TI The Phenomenon of Leading without Guidebook: Educational Leadership
   Practices of Philippine School Principals in Virulent COVID-19 Times
SO INTERNATIONAL JOURNAL OF EDUCATIONAL LEADERSHIP AND MANAGEMENT
LA English
DT Article
DE educational leadership practices; lived experience; school principal;
   COVID-19; Philippines
AB The school principals play a pivotal role in leading educational institutions. Their lived experience as educational leaders in the context of a virulent crisis, however, is largely unexplored. This paper sought to discover the essence of educational leadership practices of school principals in the context of the current COVID-19 crisis. Following phenomenology as a research design, the researcher explored the world of six Filipino school principals through interview procedures. The analysis method developed by Colaizzi (1978) was used. The results revealed six emerging themes of educational leadership practices during a crisis as follows: 1.) navigating the crisis with adaptive leadership; 2.) cultivating practices in crisis management; 3.) managing through the machine; 4.) freezing the standards and patterns; 5.) promoting inclusivity in the new normal; and 6.) caring first for what is essential. These themes form the basis of the description and structure of the phenomenon offered at the end of the paper. Considering the present scarcity of knowledge on how school principals respond in times of crisis, this paper provides insights into educational leadership practices within the context of the COVID-19 situation.
C1 [Cahapay, Michael B.] Mindanao State Univ, Gen Santos City, Philippines.
RP Cahapay, MB (corresponding author), Mindanao State Univ, Gen Santos City, Philippines.
EM mbcahapay@up.edu.ph
RI Cahapay, Michael B./AAW-2455-2020
OI Cahapay, Michael B./0000-0002-0588-0022
CR [Anonymous], 2020, LANCET, V396, P583, DOI [10.1038/d41586-020-02265-w, 10.1016/S0140-6736(20)31818-3]
   ASHWORTH PD, 1993, J ADV NURS, V18, P1415, DOI 10.1046/j.1365-2648.1993.18091415.x
   Cahapay MB, 2021, INT J SOCIOL EDUC, V10, P171, DOI 10.17583/rise.2021.7317
   Cahapay MB, 2020, J LOSS TRAUMA, V25, P598, DOI 10.1080/15325024.2020.1770955
   Colaizzi P., 1978, PSYCHOL RES PHENOMEN
   Department of Education, 2020, DEPED BAS ED LEARN C
   Euber J., 2020, NEW YORK TIMES
   Fink S., 2002, CRISIS MANAGEMENT PL
   Harris A, 2020, LEADING SCH LOCKDOWN
   Harris A, 2020, SCH LEADERSH MANAG, V40, P243, DOI 10.1080/13632434.2020.1811479
   Henaku EugeneAdu., 2020, INT J MULTIDISCIPLIN, V1, P54
   Joshi A, 2021, INTERACT TECHNOL SMA, V18, P205, DOI 10.1108/ITSE-06-2020-0087
   Karakaya F., 2020, J EDUC SCI ENVIRON H, V6, P246, DOI [10.21891/jeseh.792984, DOI 10.21891/JESEH.792984]
   Kaul M., 2020, CALM CRISIS SCH PRIN
   Kruse SD, 2020, FRONT EDUC, V5, DOI 10.3389/feduc.2020.614641
   Lin CS, 2013, QUAL QUANT METHODS L, P469
   Marshall J., 2020, ISEA CCEAM, V48, P30
   Morrow R., 2015, PSYCHOLOGIST, V28, P643
   Morse JM, 1994, HDB QUALITATIVE RES, P220, DOI DOI 10.1109/HICSS.2013.531
   Moser A, 2017, EUR J GEN PRACT, V24, DOI [10.1080/13814788.2017.1375091, 10.1080/13814788.2017.1375092]
   Patton MQ., 2001, QUALITATIVE RES EVAL, V3rd ed.
   Poth CN., 2016, QUAL INQ
   Rahiem Maila DH, 2020, INT J LEARNING TEACH, V19, P1, DOI [DOI 10.26803/IJLTER.19.6.1, 10.26803/ijlter.19.6.1]
   Said F, 2021, IJERI-INT J EDUC RES, P260, DOI 10.46661/ijeri.5256
   Salmons J., 2015, QUALITATIVE ONLINE I
   Sanders Carolyn, 2003, Contemp Nurse, V14, P292
   UNESCO, 2020, SUPP TEACH BACK TO S
   Wirihana L, 2018, NURSE RES, V25, P30, DOI 10.7748/nr.2018.e1516
NR 28
TC 0
Z9 0
U1 1
U2 1
PU HIPATIA PRESS
PI BARCELONA
PA C-CLARAMUNT 4, BARCELONA, 08030, SPAIN
SN 2014-9018
J9 INT J EDUC LEADERSH
JI INT. J. EDUC. LEADERSH. MANAG.
PD JAN
PY 2022
VL 10
IS 1
DI 10.17583/ijelm.2022.7666
PG 23
WC Education & Educational Research
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research
GA YL1EE
UT WOS:000745641700001
DA 2022-04-20
ER

PT J
AU Crafa, A
   Cannarella, R
   Condorelli, RA
   Mongioi, LM
   Barbagallo, F
   Aversa, A
   La Vignera, S
   Calogero, AE
AF Crafa, Andrea
   Cannarella, Rossella
   Condorelli, Rosita A.
   Mongioi, Laura M.
   Barbagallo, Federica
   Aversa, Antonio
   La Vignera, Sandro
   Calogero, Aldo E.
TI Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection
   and COVID-19 severity: A systematic review and meta-analysis
SO ECLINICALMEDICINE
LA English
DT Review
DE SARS-CoV-2; COVID-19; Vitamin D; Vitamin D deficiency; COVID-19
   severity; 25-hydroxy-cholecalciferol
ID VITAMIN-D DEFICIENCY; ACUTE-PHASE RESPONSE; CORONAVIRUS DISEASE; D
   SUPPLEMENTATION
AB Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of coronavirus disease 19 (COVID-19), a respiratory infection that, starting from December 2019, has spread around the world in a few months, becoming a pandemic. The lack of initial knowledge on its management has led to a great effort in developing vaccines and in finding therapeutic weapons capable of improving the clinical outcome of the affected patients. In particular, the possible role of vitamin D status in the management of COVID-19 has been widely analysed, resulting in a great amount of data. This systematic review and meta-analysis aimed to assess whether hypovitaminosis D is a risk factor for developing SARS-CoV-2 infection and whether it affects the worsening of the clinical course of COVID-19. Methods: Data were extracted through extensive searches in the Pubmed, MEDLINE, Cochrane, Academic One Files, Google Scholar, and Scopus databases from December 2019 to January 2021, using the keywords: "Vitamin D", "25 hydroxy Vitamin D", "25 hydroxycholecalciferol", "cholecalciferol", "COVID 1900, "SARS-CoV-200. We included observational cohort, cross-sectional, and case-control studies that evaluated differences in serum levels of 25-hydroxy-cholecalciferol [25(OH)D] in patients who were positive or negative for SARS-CoV-2, in patients with mild or severe forms of COVID-19, and in patients who died or were discharged from the hospital. Finally, studies that evaluated the risk of developing severe illness or death in patients with vitamin D deficiency (VDD), defined as levels of 25(OH)D <20 ng/ml, were also included. We calculated the mean difference (MD) and the 95% confidence intervals (CI) for quantitative variables such as 25(OH)D levels in patients with or without SARSCoV-2 infection, in those with mild vs. severe COVID-19, or those who have died vs. those who have been discharged. Instead, we calculated odds ratios and 95% CI for qualitative ones, such as the number of patients with severe illness/death in the presence of VDD vs. those with normal serum 25(OH)D levels. A p-value lower than 0.05 was considered statistically significant. The study was registered on PROSPERO (CRD42021241473). Findings: Out of 662 records, 30 articles met inclusion criteria and, therefore, were included in the meta-analysis. We found that the serum levels of 25(OH)D were significantly lower in patients with SARS-CoV-2 infection than in negative ones [MD -3.99 (-5.34, -2.64); p <0.00001; I2= 95%]. Furthermore, its levels were significantly lower in patients with severe disease [MD -6.88 (-9.74, -4.03); p <0.00001; I2=98%] and in those who died of COVID-19 [MD -8.01 (-12.50, -3.51); p = 0.0005; I2=86%]. Finally, patients with VDD had an increased risk of developing severe disease [OR 4.58 (2.24, 9.35); p <0.0001; I2=84%] but not a fatal outcome [OR 4.92 (0.83, 29.31); p = 0.08; I2=94%]. Interpretation: This meta-analysis revealed a large heterogeneity of the studies included due to the different enrolment criteria of patient samples (age, body mass index, ethnicity, comorbidities), the country where they live, all factors influencing serum 25(OH)D levels, and the different criteria used to define the severity of COVID-19. Furthermore, the observational nature of these studies does not allow to establish a cause-effect relationship, even taking into account that 25(OH)D represents a marker of acute inflammation.
   Treatment with vitamin D might be considered for the primary prevention of SARS-CoV-2 infection and the management of patients with COVID-19. However, further intervention studies are needed to prove this hypothesis.
C1 [Crafa, Andrea; Cannarella, Rossella; Condorelli, Rosita A.; Mongioi, Laura M.; Barbagallo, Federica; La Vignera, Sandro; Calogero, Aldo E.] Univ Catania, Dept Clin & Expt Med, Via S Sofia 78, I-95123 Catania, Italy.
   [Aversa, Antonio] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy.
RP Calogero, AE (corresponding author), Univ Catania, Dept Clin & Expt Med, Via S Sofia 78, I-95123 Catania, Italy.
EM aldo.calogero@unict.it
RI Crafa, Andrea/AAV-9892-2021
CR Abdollahi A, 2021, J MED VIROL, V93, P2359, DOI 10.1002/jmv.26726
   Abrishami A, 2021, EUR J NUTR, V60, P2249, DOI 10.1007/s00394-020-02411-0
   Alipio M, 2020, VITAMIN D SUPPLEMENT
   Annweiler G, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113377
   Arvinte Cristian, 2020, Med Drug Discov, V8, P100064, DOI 10.1016/j.medidd.2020.100064
   Autier P, 2017, LANCET DIABETES ENDO, V5, P986, DOI [10.1016/S2213-8587(17)30357-1, 10.1016/s2213-8587(17)30357-1]
   Baktash V, 2021, POSTGRAD MED J, V97, P442, DOI 10.1136/postgradmedj-2020-138712
   Bassatne A, 2021, METABOLISM, V119, DOI 10.1016/j.metabol.2021.154753
   Bertoldo F, 2010, J BONE MINER RES, V25, P447, DOI 10.1359/jbmr.090819
   Bikle DD, 2020, J ENDOCR SOC, V4, DOI 10.1210/jendso/bvz038
   Calvo A, 2020, RES SQUARE, DOI [10.21203/rs.3.rs-30390/v1, DOI 10.21203/RS.3.RS-30390/V1]
   Carpagnano GE, 2021, J ENDOCRINOL INVEST, V44, P765, DOI 10.1007/s40618-020-01370-x
   Cereda E, 2021, NUTRITION, V82, DOI 10.1016/j.nut.2020.111055
   Cereda E, 2021, CLIN NUTR, V40, P2469, DOI 10.1016/j.clnu.2020.10.055
   Chodick G, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa069
   D'Avolio A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051359
   Daneshkhah A, 2020, POSSIBLE ROLE VITAMI, DOI [10.1101/2020.04.08.20058578, DOI 10.1101/2020.04.08.20058578]
   De Smet D, 2021, AM J CLIN PATHOL, V155, P381, DOI [10.1093/ajcp/aqaa252, 10.1093/AJCP/AQAA252]
   Faniyi AA, 2020, EUR RESPIR J, V10
   Fasano A, 2020, MOVEMENT DISORD, V35, P1089, DOI 10.1002/mds.28176
   Faul J L, 2020, Ir Med J, V113, P84
   Pham H, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16173020
   Hastie CE, 2021, EUR J NUTR, V60, P545, DOI 10.1007/s00394-020-02372-4
   Hastie CE, 2020, DIABETES METAB SYND, V14, P561, DOI 10.1016/j.dsx.2020.04.050
   Haugen J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010052
   Hernandez JL, 2021, J CLIN ENDOCR METAB, V106, pE1343, DOI 10.1210/clinem/dgaa733
   Holick MF, 2017, REV ENDOCR METAB DIS, V18, P153, DOI 10.1007/s11154-017-9424-1
   Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385
   Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1
   Ilie PC, 2020, AGING CLIN EXP RES, V32, P1195, DOI 10.1007/s40520-020-01570-8
   Im JH, 2020, INT J INFECT DIS, V100, P390, DOI 10.1016/j.ijid.2020.08.018
   Jain A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77093-z
   Jordan Rachel E, 2020, BMJ, V368, pm1198, DOI 10.1136/bmj.m1198
   [Каронова Т.Л. Karonova T.L.], 2020, [Журнал инфектологии, Jurnal infektologii], V12, P21, DOI 10.22625/2072-6732-2020-12-3-21-27
   Kaufman HW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239252
   Kerget B, 2020, TUBERK TORAK, V68, P227, DOI 10.5578/tt.70027
   La Vignera S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082948
   Lau FH., 2020, VITAMIN INSUFFICIENC, DOI [10.1101/2020.04.24.20075838, DOI 10.1101/2020.04.24.20075838]
   Ling SF, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123799
   Lips P, 2019, EUR J ENDOCRINOL, V180, pP23, DOI 10.1530/EJE-18-0736
   Luchsinger LL, 2021, SCIENCE, V371, P1116, DOI 10.1126/science.abg9461
   Luo X, 2021, J NUTR, V151, P98, DOI 10.1093/jn/nxaa332
   Macaya F, 2020, NUTR HOSP, V37, P1039, DOI 10.20960/nh.03193
   Maghbooli Z, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239799
   Mardani R, 2020, VIRUS RES, V289, DOI 10.1016/j.virusres.2020.198148
   Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583
   Goncalves TJM, 2020, CLIN NUTR ESPEN, V40, P110, DOI 10.1016/j.clnesp.2020.10.008
   Mehta Puja, 2020, Lancet, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Meltzer DO, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19722
   Mendy Angelico, 2020, medRxiv, DOI 10.1101/2020.06.25.20137323
   Merzon E, 2020, FEBS J, V287, P3693, DOI 10.1111/febs.15495
   Murai IH, 2021, JAMA-J AM MED ASSOC, V325, P1053, DOI 10.1001/jama.2020.26848
   National Institute for Health and Care Excellence, 2020, VIT D COVID 19 EV RE
   National Institutes of Health (NIH), QUALITY ASSESSMENT T
   NIH NIH, QUAL ASS CAS CONTR S
   Ohaegbulam KC, 2020, AM J THER, V27, pE485, DOI 10.1097/MJT.0000000000001222
   Padhi S, 2020, INT IMMUNOPHARMACOL, V88, DOI 10.1016/j.intimp.2020.107001
   Panagiotou G, 2020, CLIN ENDOCRINOL, V93, P508, DOI 10.1111/cen.14276
   Pizzini A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092775
   Radujkovic A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092757
   Raharusuna P., PATTERNS COVID 19 MO
   Raisi-Estabragh Z, 2020, J PUBLIC HEALTH-UK, V42, P451, DOI 10.1093/pubmed/fdaa095
   Reijven PLM, 2020, CLIN NUTR, V39, P2663, DOI 10.1016/j.clnu.2019.12.028
   Roth DE, 2018, ANN NY ACAD SCI, V1430, P44, DOI 10.1111/nyas.13968
   [Anonymous], 2016, BMJ, V354, pi4086, DOI [10.1136/bmj.g7647, 10.1136/bmj.i4086]
   Silva MC, 2015, NUTR RES, V35, P91, DOI 10.1016/j.nutres.2014.12.008
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Sun JK, 2020, AGING-US, V12, P11287, DOI 10.18632/aging.103526
   Szeto B, 2020, J BONE MINER RES, V35, P47
   Tan CW, 2020, NUTRITION, V79-80, DOI 10.1016/j.nut.2020.111017
   Tang LW, 2021, SCI TOTAL ENVIRON, V751, DOI 10.1016/j.scitotenv.2020.141816
   van Schoor N, 2017, ENDOCRIN METAB CLIN, V46, P845, DOI 10.1016/j.ecl.2017.07.002
   Vassiliou AG, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123773
   Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135
   Whittemore PB, 2020, AM J INFECT CONTROL, V48, P1042, DOI 10.1016/j.ajic.2020.06.193
   Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839
   Ye K, 2021, J AM COLL NUTR, V40, P724, DOI 10.1080/07315724.2020.1826005
NR 77
TC 9
Z9 9
U1 3
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2589-5370
J9 ECLINICALMEDICINE
JI EClinicalMedicine
PD JUL
PY 2021
VL 37
AR 100967
DI 10.1016/j.eclinm.2021.100967
EA JUN 2021
PG 14
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA UL6XY
UT WOS:000692793000030
PM 34179737
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ferreira, P
   Gomes, S
AF Ferreira, Pedro
   Gomes, Sofia
TI The Role of Resilience in Reducing Burnout: A Study with Healthcare
   Workers during the COVID-19 Pandemic
SO SOCIAL SCIENCES-BASEL
LA English
DT Article
DE burnout; resilience; personal resources; healthcare; COVID-19
ID JOB BURNOUT; RESOURCES; DEMANDS
AB Although burnout is a widely studied topic, there is still much to learn about this symptom during a pandemic crisis like the one caused by COVID-19. Moreover, and according to the Job Demands-Resources (JD-R) theory, the relation between personal resources and burnout is still an understudied topic. The main goal of this research is to understand the influence of mental resilience on the three dimensions of burnout-emotional exhaustion, depersonalization and personal achievement-among healthcare workers when exposed to a pandemic situation. A cross-sectional study was conducted based on the administration of an online survey to a sample of 196 healthcare workers (nurses and doctors) during the second wave of COVID-19 in Portugal. Hypotheses were tested using Partial Least Squares. The results show that during a pandemic situation, higher levels of resilience associated both with lower levels of emotional exhaustion (Emotional Exhaustion: -0.17; 95% Confidence Interval-CI: -0.38, 0.04) and depersonalization (Depersonalization: -0.17; 95% CI: -0.31, -0.03), and higher levels of personal achievement (Personal Achievement: 0.50; 95% CI: 0.40, 0.61). Resilience should be considered an important asset for reducing levels of burnout when facing highly stressing situations. The main contribution of this research is related to the role of personal resources as an inhibitor of negative consequences of job strain, such as burnout. The findings add new knowledge to the topic of fighting (not just understanding) burnout in deeply stressful situations, like the COVID-19 pandemic, reinforcing the importance of developing personal resources. Resilience skills may be developed, thus reducing the risk of burnout.
C1 [Ferreira, Pedro; Gomes, Sofia] Univ Portucalense, REMIT Res Econ Management & Informat Technol, R Dr Antonio Bernardino Almeida 541, P-4200072 Porto, Portugal.
RP Ferreira, P (corresponding author), Univ Portucalense, REMIT Res Econ Management & Informat Technol, R Dr Antonio Bernardino Almeida 541, P-4200072 Porto, Portugal.
EM pferreira@upt.pt; sofiag@upt.pt
RI Gomes, Sofia/AAX-9149-2021; Ferreira, Pedro/G-5855-2015
OI Gomes, Sofia/0000-0002-0326-0655; Ferreira, Pedro/0000-0002-6506-7869
CR Andries JPM, 2017, ANAL CHIM ACTA, V982, P37, DOI 10.1016/j.aca.2017.06.001
   Arrogante O, 2017, INTENS CRIT CARE NUR, V42, P110, DOI 10.1016/j.iccn.2017.04.010
   Bakker A. B., 2007, J MANAGERIAL PSYCHOL, V22, P309, DOI DOI 10.1108/02683940710733115
   Bakker AB, 2021, ANXIETY STRESS COPIN, V34, P1, DOI 10.1080/10615806.2020.1797695
   Bakker AB, 2017, J OCCUP HEALTH PSYCH, V22, P273, DOI 10.1037/ocp0000056
   Bakker AB, 2005, J OCCUP HEALTH PSYCH, V10, P170, DOI 10.1037/1076-8998.10.2.170
   Batra K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17239096
   Britt TW, 2021, APPL PSYCHOL-INT REV, V70, P120, DOI 10.1111/apps.12304
   Buck K, 2019, FAM MED, V51, P657, DOI 10.22454/FamMed.2019.424025
   Busch IM, 2021, PSYCHOTHER PSYCHOSOM, V90, P178, DOI 10.1159/000513733
   Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271
   Contreras F, 2020, SAGE OPEN, V10, DOI 10.1177/2158244019900563
   De Brier N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244052
   Di Monte C, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.567201
   Duarte I, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09980-z
   Earvolino-Ramirez M, 2007, NURS FORUM, V42, P73, DOI 10.1111/j.1744-6198.2007.00070.x
   General Health Directorate, 2021, EST EP COVID19 PORT
   Grover SL, 2018, PERS REV, V47, P968, DOI 10.1108/PR-08-2016-0213
   Hair JF, 2019, EUR BUS REV, V31, P2, DOI 10.1108/EBR-11-2018-0203
   Hobfoll SE, 2002, REV GEN PSYCHOL, V6, P307, DOI 10.1037//1089-2680.6.4.307
   Huang J, 2016, CURR PSYCHOL, V35, P562, DOI 10.1007/s12144-015-9321-2
   Janssen E, 2020, J ADV NURS, V76, P3495, DOI 10.1111/jan.14563
   Jose S, 2020, INDIAN J CRIT CARE M, V24, P1081, DOI 10.5005/jp-journals-10071-23667
   Kalisch R, 2015, BEHAV BRAIN SCI, V38, DOI 10.1017/S0140525X1400082X
   Kim SC, 2021, NURS OPEN, V8, P900, DOI 10.1002/nop2.697
   MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205
   McBride O, 2021, INT J METH PSYCH RES, V30, DOI 10.1002/mpr.1861
   Orru G, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18010337
   Pereira SD, 2021, REV LAT-AM ENFERM, V29, DOI 10.1590/1518-8345.3320.3386
   Purvis TE, 2019, NEUROCRIT CARE, V31, P406, DOI 10.1007/s12028-019-00822-4
   Ringle CM, 2020, INT J HUM RESOUR MAN, V31, P1617, DOI 10.1080/09585192.2017.1416655
   Ritchey F. J., 2008, STAT IMAGINATION ELE, V2
   Schaufeli W.B., 2014, BRIDGING OCCUPATIONA, P43, DOI DOI 10.1007/978-94-007-5640-3_4
   Schaufeli WB, 2009, CAREER DEV INT, V14, P204, DOI 10.1108/13620430910966406
   Seo YE, 2020, PSYCHIAT INVEST, V17, P674, DOI 10.30773/pi.2020.0056
   Shepherd CD, 2011, J PERS SELL SALES M, V31, P397, DOI 10.2753/PSS0885-3134310403
   Suresh Pal., 2019, QUANTITATIVE METHODS
   Wang C, 2020, BMC PALLIAT CARE, V19, DOI 10.1186/s12904-020-00677-z
   World Health Organization, 2020, WHO DIR GEN STAT IHR
   Xanthopoulou D., 2007, INT J STRESS MANAGE, V14, P121, DOI [10.1037/1072-5245.14.2.121, DOI 10.1037/1072-5245.14.2.121]
   Yildirim M, 2022, DEATH STUD, V46, P524, DOI 10.1080/07481187.2020.1818885
   Zito M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192126
NR 42
TC 0
Z9 0
U1 6
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-0760
J9 SOC SCI-BASEL
JI Soc. Sci.-Basel
PD SEP
PY 2021
VL 10
IS 9
AR 317
DI 10.3390/socsci10090317
PG 13
WC Social Sciences, Interdisciplinary
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA UZ2CS
UT WOS:000702018700001
OA gold
DA 2022-04-20
ER

PT J
AU Griffith, J
   Marani, H
   Monkman, H
AF Griffith, Janessa
   Marani, Husayn
   Monkman, Helen
TI COVID-19 Vaccine Hesitancy in Canada: Content Analysis of Tweets Using
   the Theoretical Domains Framework
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE vaccine hesitancy; vaccine; COVID-19; immunization; Twitter;
   infodemiology; infoveillance; social media; behavioral science;
   behavior; Canada; content analysis; framework; hesitancy
ID BEHAVIORAL-SCIENCE THEORY; TWITTER; IMPLEMENTATION
AB Background: With the approval of two COVID-19 vaccines in Canada, many people feel a sense of relief, as hope is on the horizon. However, only about 75% of people in Canada plan to receive one of the vaccines.
   Objective: The purpose of this study is to determine the reasons why people in Canada feel hesitant toward receiving a COVID-19 vaccine.
   Methods: We screened 3915 tweets from public Twitter profiles in Canada by using the search words "vaccine" and "COVID." The tweets that met the inclusion criteria (ie, those about COVID-19 vaccine hesitancy) were coded via content analysis. Codes were then organized into themes and interpreted by using the Theoretical Domains Framework.
   Results: Overall, 605 tweets were identified as those about COVID-19 vaccine hesitancy. Vaccine hesitancy stemmed from the following themes: concerns over safety, suspicion about political or economic forces driving the COVID-19 pandemic or vaccine development, a lack of knowledge about the vaccine, antivaccine or confusing messages from authority figures, and a lack of legal liability from vaccine companies. This study also examined mistrust toward the medical industry not due to hesitancy, but due to the legacy of communities marginalized by health care institutions. These themes were categorized into the following five Theoretical Domains Framework constructs: knowledge, beliefs about consequences, environmental context and resources, social influence, and emotion.
   Conclusions: With the World Health Organization stating that one of the worst threats to global health is vaccine hesitancy, it is important to have a comprehensive understanding of the reasons behind this reluctance. By using a behavioral science framework, this study adds to the emerging knowledge about vaccine hesitancy in relation to COVID-19 vaccines by analyzing public discourse in tweets in real time. Health care leaders and clinicians may use this knowledge to develop public health interventions that are responsive to the concerns of people who are hesitant to receive vaccines.
C1 [Griffith, Janessa] Womens Coll Hosp, Inst Hlth Syst Solut & Virtual Care, 76 Grenville St, Toronto, ON M5S 1B2, Canada.
   [Griffith, Janessa] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada.
   [Griffith, Janessa] Douglas Coll, Fac Hlth Sci, Hlth Informat Management, Vancouver, BC, Canada.
   [Marani, Husayn] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
   [Monkman, Helen] Univ Victoria, Fac Human & Social Dev, Sch Hlth Informat Sci, Victoria, BC, Canada.
RP Griffith, J (corresponding author), Womens Coll Hosp, Inst Hlth Syst Solut & Virtual Care, 76 Grenville St, Toronto, ON M5S 1B2, Canada.
EM janessa.griffith@wchospital.ca
OI Monkman, Helen/0000-0003-0772-9075
CR Al-Rawi A, 2020, J MED INTERNET RES, V22, DOI 10.2196/21646
   Angus RI., 2020, MORE CANADIANS WILLI
   [Anonymous], 2020, COR DIS COVID 19 HER
   [Anonymous], Long-term effects of coronavirus (long COVID)
   [Anonymous], Leading countries based on number of Twitter users as of October 2020
   [Anonymous], Distribution of Twitter users worldwide as of January 2021, by age group
   [Anonymous], 10 THREATS GLOBAL HL
   [Anonymous], 2020, MAJ CAN INT GET COVI
   Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0605-9
   Bandura A., 1977, SOCIAL LEARNING THEO, V1
   Benda NC, 2020, AM J PUBLIC HEALTH, V110, P1123, DOI 10.2105/AJPH.2020.305784
   Boyd R, 2021, NEW YORK TIMES
   covid vaccine, GOOGLE TRENDS
   Denecke K, 2013, METHOD INFORM MED, V52, P326, DOI [10.3414/ME12.02-0010, 10.3414/ME12-02-0010]
   Detoc M, 2020, VACCINE, V38, P7002, DOI 10.1016/j.vaccine.2020.09.041
   Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y
   Dube E, 2013, HUM VACC IMMUNOTHER, V9, P1763, DOI 10.4161/hv.24657
   Garbutt JM, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0729-6
   Glanz K, 2010, ANNU REV PUBL HEALTH, V31, P399, DOI 10.1146/annurev.publhealth.012809.103604
   Gostin LO, 2021, JAMA-J AM MED ASSOC, V325, P532, DOI 10.1001/jama.2020.26553
   Harrison EA, 2020, EUR J EPIDEMIOL, V35, P325, DOI 10.1007/s10654-020-00634-3
   Jackson C, 1997, HEALTH EDUC RES, V12, P143, DOI 10.1093/her/12.1.143
   Kenny E, 2020, BRIT J HEALTH PSYCH, V25, P519, DOI 10.1111/bjhp.12419
   Lunden I, 2020, TWITTER PRIORITIZES
   Mosby I, 2021, CAN MED ASSOC J, V193, pE381, DOI 10.1503/cmaj.210112
   New user FAQ, TWITTER
   Nowak SA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239826
   Parker Jon, 2013, 2013 IEEE/ACM International Conference on Advances in Social Networks Analysis and Mining (ASONAM), P556
   Roth Yoel, 2020, TWITTER
   Scanfeld D, 2010, AM J INFECT CONTROL, V38, P182, DOI 10.1016/j.ajic.2009.11.004
   Shi W, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228701
   Sinnenberg L, 2017, AM J PUBLIC HEALTH, V107, pE1, DOI 10.2105/AJPH.2016.303512
   Sutton J, 2018, J AM COLL RADIOL, V15, P210, DOI 10.1016/j.jacr.2017.09.043
   Tavoschi L, 2020, HUM VACC IMMUNOTHER, V16, P1062, DOI 10.1080/21645515.2020.1714311
   Taylor S, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.575950
   Tilburt JC, 2008, VACCINE, V26, pD27, DOI 10.1016/j.vaccine.2008.07.068
NR 36
TC 29
Z9 29
U1 18
U2 25
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD APR 13
PY 2021
VL 23
IS 4
AR e26874
DI 10.2196/26874
PG 10
WC Health Care Sciences & Services; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services; Medical Informatics
GA RQ2PG
UT WOS:000642261400005
PM 33769946
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Abdulla, F
   Nain, Z
   Karimuzzaman, M
   Hossain, MM
   Rahman, A
AF Abdulla, Faruq
   Nain, Zulkar
   Karimuzzaman, Md.
   Hossain, Md. Moyazzem
   Rahman, Azizur
TI A Non-Linear Biostatistical Graphical Modeling of Preventive Actions and
   Healthcare Factors in Controlling COVID-19 Pandemic
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19 pandemic; social distance; lockdown; quarantine; case fatality
   rate; life expectancy
AB Background: With the insurgence of the COVID-19 pandemic, many people died in the past several months, and the situation is ongoing with increasing health, social, and economic panic and vulnerability. As most of the countries relying on different preventive actions to control the outcomes of COVID-19, it is necessary to boost the knowledge about the effectiveness of such actions so that the policymakers take their country-based appropriate actions. This study generates evidence of taking the most impactful actions to combat COVID-19. Objective: In order to generate community-based scientific evidence, this study analyzed the outcome of COVID-19 in response to different control measures, healthcare facilities, life expectancy, and prevalent diseases. Methods: It used more than a hundred countries' data collected from different databases. We performed a comparative graphical analysis with non-linear correlation estimation using R. Results: The reduction of COVID-19 cases is strongly correlated with the earliness of preventive initiation. The apathy of taking nationwide immediate precaution measures has been identified as one of the critical reasons to make the circumstances worse. There is significant non-linear relationship between COVID-19 case fatality and number of physicians (NCC = 0.22; p-value <= 0.001), nurses and midwives (NCC = 0.17; p-value <= 0.001), hospital beds (NCC = 0.20; p-value <= 0.001), life expectancy of both sexes (NCC = 0.22; p-value <= 0.001), life expectancy of female (NCC = 0.27; p-value <= 0.001), and life expectancy of male (NCC = 0.19; p-value <= 0.001). COVID-19 deaths were found to be reduced with increased medical personnel and hospital beds. Interestingly, no association between the comorbidities and severity of COVID-19 was found excluding asthma, cancer, Alzheimer's, and smoking. Conclusions: Enhancing healthcare facilities and early imposing the control measures could be valuable to prevent the COVID-19 pandemic. No association between COVID-19 and other comorbidities warranted further investigation at the pathobiological level.
C1 [Abdulla, Faruq] Islamic Univ, Dept Stat, Fac Sci, Kushtia 7003, Bangladesh.
   [Abdulla, Faruq] Res Training & Management RTM Int, Dhaka 1216, Bangladesh.
   [Nain, Zulkar] Islamic Univ, Fac Biol Sci, Dept Biotechnol & Genet Engn, Kushtia 7003, Bangladesh.
   [Karimuzzaman, Md.; Hossain, Md. Moyazzem] Jahangirnagar Univ, Fac Math & Phys Sci, Dept Stat, Dhaka 1342, Bangladesh.
   [Hossain, Md. Moyazzem] Newcastle Univ, Sch Math Stat & Phys, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Rahman, Azizur] Charles Sturt Univ, Sch Comp & Math, Wagga Wagga, NSW 2650, Australia.
RP Rahman, A (corresponding author), Charles Sturt Univ, Sch Comp & Math, Wagga Wagga, NSW 2650, Australia.
EM faruqiustat09mnil@gmail.com; znain.bd@gmail.com;
   karimuzzaman.statju@gmail.com; M.M.Hossain2@newcastle.ac.uk;
   azrahman@csu.edu.au
RI Abdulla, Faruq/AAV-6666-2020; Hossain, Moyazzem/I-6547-2018
OI Abdulla, Faruq/0000-0003-3952-5843; Hossain,
   Moyazzem/0000-0003-3593-6936; Rahman, Associate Professor
   Azizur/0000-0002-7670-5192; Nain, Zulkar/0000-0003-0819-3137; ,
   Karimuzzaman/0000-0002-2278-2379
CR Abood Rafid A, 2019, Sultan Qaboos Univ Med J, V19, pe236, DOI 10.18295/squmj.2019.19.03.010
   Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x
   Akha AAS, 2018, J IMMUNOL METHODS, V463, P21, DOI 10.1016/j.jim.2018.08.005
   Ali H, 2021, AIR QUAL ATMOS HLTH, V14, P381, DOI 10.1007/s11869-020-00943-2
   Alwashmi MF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082906
   Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007
   Anderson A., 2020, COVID 19 OUTBREAK HI
   [Anonymous], 2020, SOCIAL SCI HUMANITAR
   [Anonymous], 2019, INT J INNOV RES ADV
   Anwar A, 2020, CUREUS, V12, DOI 10.7759/cureus.10453
   Armitage R, 2020, LANCET PUBLIC HEALTH, V5, pE256, DOI 10.1016/S2468-2667(20)30061-X
   Bawazir A, 2018, J INFECT PUBLIC HEAL, V11, P89, DOI 10.1016/j.jiph.2017.05.003
   Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5
   Bohn MK, 2020, PHYSIOLOGY, V35, P288, DOI 10.1152/physiol.00019.2020
   Cao YB, 2020, ACAD EMERG MED, V27, P309, DOI 10.1111/acem.13951
   CDC, 2020, CDC ACT PREP 1 RESP
   Center for Disease Control, 2020, INT GUID BUS EMPL PL
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Dai WH, 2020, SCIENCE, V368, P1331, DOI 10.1126/science.abb4489
   Di Gennaro F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082690
   Dutta A, 2021, WORLD DEV, V138, DOI 10.1016/j.worlddev.2020.105234
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Farahani M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160206
   Franceschi C, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00061
   Gerst-Emerson K, 2015, AM J PUBLIC HEALTH, V105, P1013, DOI 10.2105/AJPH.2014.302427
   Glynn JR, 2020, LANCET INFECT DIS, V20, P1123, DOI 10.1016/S1473-3099(20)30311-X
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Goronzy JJ, 2012, CELL MOL LIFE SCI, V69, P1615, DOI 10.1007/s00018-012-0970-0
   Hale MW, 2015, NEUROSCI BIOBEHAV R, V58, P46, DOI 10.1016/j.neubiorev.2014.12.009
   Hassan SA, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7355
   Heydari ST, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-020-10125-5
   Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3
   Horton R, 2020, LANCET, V395, P935, DOI 10.1016/S0140-6736(20)30669-3
   Huang C, 2020, Lancet, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Irfan M, 2021, INT J ENVIRON HEAL R, DOI 10.1080/09603123.2021.1874888
   Ji YP, 2020, LANCET GLOB HEALTH, V8, pE480, DOI 10.1016/S2214-109X(20)30068-1
   Kalache A, 2019, EUR J NUTR, V58, P1, DOI 10.1007/s00394-019-02027-z
   Kandel N, 2020, LANCET, V395, P1047, DOI 10.1016/S0140-6736(20)30553-5
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   Kmietowicz Z, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1170
   Kruk ME, 2018, LANCET, V392, P2170, DOI 10.1016/S0140-6736(18)31668-4
   Kurotani K, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1209
   Kwok KO, 2020, J INFECTION, V80, pE32, DOI 10.1016/j.jinf.2020.03.027
   Lau LS, 2020, NAT MED, V26, P647, DOI 10.1038/s41591-020-0851-2
   Li GD, 2020, NAT REV DRUG DISCOV, V19, P149, DOI 10.1038/d41573-020-00016-0
   Li HO, 2020, ANTIMICROB AGENTS CH, V64, DOI [10.1128/AAC.00483-20, 10.1128/AAC.00483-20.]
   Liu LQ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17217990
   Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7
   MacNee W, 2014, EUR RESPIR J, V44, P1332, DOI 10.1183/09031936.00134014
   Malik YS, 2020, VET QUART, V40, P68, DOI 10.1080/01652176.2020.1727993
   Mersha A, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10256-3
   Meydani SN, 2004, JAMA-J AM MED ASSOC, V292, P828, DOI 10.1001/jama.292.7.828
   Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024
   Plumper T, 2022, J EUR PUBLIC POLICY, V29, P321, DOI 10.1080/13501763.2020.1847170
   Qualls N, 2017, MMWR RECOMM REP, V66, P1, DOI 10.15585/mmwr.rr6601a1
   Ranjan C., 2020, NLCOR COMPUTE NONLIN
   Raoult D, 2020, CELL STRESS, V4, P66, DOI 10.15698/cst2020.04.216
   Santini ZI, 2020, LANCET PUBLIC HEALTH, V5, pE62, DOI 10.1016/S2468-2667(19)30230-0
   Shen KL, 2020, WORLD J PEDIATR, V16, P223, DOI 10.1007/s12519-020-00343-7
   Siam M. H. B., 2020, Journal of Advanced Biotechnology and Experimental Therapeutics, V3, P68
   Syal K, 2020, J MED VIROL, V92, P1380, DOI 10.1002/jmv.25870
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036
   UNICEF WHO IFRC, 2020, INT GUID COVID 19 PR
   van Gelder N, 2020, EClinicalMedicine, V21, P100348, DOI 10.1016/j.eclinm.2020.100348
   Vinceti M, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100457
   Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]
   Wang HP, 2020, LANCET ONCOL, V21, pE181, DOI 10.1016/S1470-2045(20)30149-2
   Wang Q, 2005, PHYSICA D, V200, P287, DOI 10.1016/j.physd.2004.11.001
   WHO Bangladesh, 2020, COVID 19 MORB MORT W, V18
   Xiao YH, 2020, LANCET INFECT DIS, V20, P523, DOI 10.1016/S1473-3099(20)30152-3
   Xu X, 2020, EUR J NUCL MED MOL I, V47, P1275, DOI 10.1007/s00259-020-04735-9
   Yasir A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082954
   Yu HY, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.573421
NR 74
TC 3
Z9 3
U1 2
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD MAY
PY 2021
VL 18
IS 9
AR 4491
DI 10.3390/ijerph18094491
PG 14
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA SB8SF
UT WOS:000650256100001
PM 33922634
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Alamrouni, A
   Aslanova, F
   Mati, S
   Maccido, HS
   Jibril, AA
   Usman, AG
   Abba, SI
AF Alamrouni, Abdelgader
   Aslanova, Fidan
   Mati, Sagiru
   Maccido, Hamza Sabo
   Jibril, Afaf A.
   Usman, A. G.
   Abba, S., I
TI Multi-Regional Modeling of Cumulative COVID-19 Cases Integrated with
   Environmental Forest Knowledge Estimation: A Deep Learning Ensemble
   Approach
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE artificial intelligence; ARIMA; ensemble ARIMA; forest knowledge;
   prediction
ID PERFORMANCE; DEMAND; HYBRID; SEGMENTATION
AB Reliable modeling of novel commutative cases of COVID-19 (CCC) is essential for determining hospitalization needs and providing the benchmark for health-related policies. The current study proposes multi-regional modeling of CCC cases for the first scenario using autoregressive integrated moving average (ARIMA) based on automatic routines (AUTOARIMA), ARIMA with maximum likelihood (ARIMAML), and ARIMA with generalized least squares method (ARIMAGLS) and ensembled (ARIMAML-ARIMAGLS). Subsequently, different deep learning (DL) models viz: long short-term memory (LSTM), random forest (RF), and ensemble learning (EML) were applied to the second scenario to predict the effect of forest knowledge (FK) during the COVID-19 pandemic. For this purpose, augmented Dickey-Fuller (ADF) and Phillips-Perron (PP) unit root tests, autocorrelation function (ACF), partial autocorrelation function (PACF), Schwarz information criterion (SIC), and residual diagnostics were considered in determining the best ARIMA model for cumulative COVID-19 cases (CCC) across multi-region countries. Seven different performance criteria were used to evaluate the accuracy of the models. The obtained results justified both types of ARIMA model, with ARIMAGLS and ensemble ARIMA demonstrating superiority to the other models. Among the DL models analyzed, LSTM-M1 emerged as the best and most reliable estimation model, with both RF and LSTM attaining more than 80% prediction accuracy. While the EML of the DL proved merit with 96% accuracy. The outcomes of the two scenarios indicate the superiority of ARIMA time series and DL models in further decision making for FK.
C1 [Alamrouni, Abdelgader] Near East Univ, Fac Educ, Dept Environm Educ & Management, CY-700006 Nicosia, Cyprus.
   [Aslanova, Fidan] Near East Univ, Fac Civil & Environm Engn, Dept Environm Engn, CY-700006 Nicosia, Cyprus.
   [Mati, Sagiru] Yusuf Maitama Sule Univ, Dept Econ, Kano 700282, Nigeria.
   [Maccido, Hamza Sabo] Baze Univ, Fac Engn, Dept Elect & Comp Engn, Abuja 900288, Nigeria.
   [Jibril, Afaf A.] Bayero Univ, Fac Clin Sci, Kano 700006, Nigeria.
   [Usman, A. G.] Near East Univ, Fac Pharm, Dept Analyt Chem, TRNC, TR-99138 Mersin, Turkey.
   [Abba, S., I] King Fand Univ Petr & Minerals, Interdisciplinary Res Ctr Membrane & Water Secur, Dhahran 31261, Saudi Arabia.
   [Abba, S., I] Baze Univ, Fac Engn, Dept Civil Engn, Abuja 900288, Nigeria.
RP Abba, SI (corresponding author), King Fand Univ Petr & Minerals, Interdisciplinary Res Ctr Membrane & Water Secur, Dhahran 31261, Saudi Arabia.; Abba, SI (corresponding author), Baze Univ, Fac Engn, Dept Civil Engn, Abuja 900288, Nigeria.
EM 20167251@std.neu.edu.tr; fidan.aslanova@neu.edu.tr; smati@smati.com.ng;
   hamza.maccido@bazeuniversity.edu.ng; afafabubakar@gmail.com;
   abdullahigusman@gmail.com; sani.abba@kfupm.edu.sa
RI Mati, Sagiru/P-3408-2017; Abba, Sani Isah/C-8573-2017
OI Mati, Sagiru/0000-0003-1413-3974; Abba, Sani Isah/0000-0001-9356-2798
CR Abba SI, 2022, APPL SOFT COMPUT, V114, DOI 10.1016/j.asoc.2021.108036
   Abba SI, 2021, HYDROLOG SCI J, V66, P1584, DOI 10.1080/02626667.2021.1937179
   Abba SI, 2020, J HYDROL, V587, DOI 10.1016/j.jhydrol.2020.124974
   Abba S.I., 2019, P INT C THEOR APPL S
   Abba SI, 2020, IEEE ACCESS, V8, P157218, DOI 10.1109/ACCESS.2020.3017743
   Abdullahi HU, 2020, DUTSE J PURE APPL SC, V6, P362
   Al-Mukhtar M, 2019, ENVIRON MONIT ASSESS, V191, DOI 10.1007/s10661-019-7821-5
   Alabdulrazzaq H, 2021, RESULTS PHYS, V27, DOI 10.1016/j.rinp.2021.104509
   Areepong Y., 2020, SCI ENG HLTH STUD, V15
   ArunKumar KE, 2021, APPL SOFT COMPUT, V103, DOI 10.1016/j.asoc.2021.107161
   Baba Nura Muhammad, 2015, Journal of Theoretical and Applied Information Technology, V81, P266
   Box G.E., 2015, TIME SERIES ANAL FOR
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Burki TK, 2020, LANCET RESP MED, V8, P238, DOI 10.1016/S2213-2600(20)30056-4
   DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348
   Gong Y, 2013, WATER RESOUR MANAG, V37, P2267
   Guleryuz D, 2021, PROCESS SAF ENVIRON, V149, P927, DOI 10.1016/j.psep.2021.03.032
   Handa A, 2018, LUNG INDIA, V35, P41, DOI 10.4103/lungindia.lungindia_225_17
   Ismail A.A., 2018, IMPROVING LONG HORIZ
   Kazienko P, 2013, J UNIVERS COMPUT SCI, V19, P457
   Liu P, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11072058
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]
   Mati S, 2021, SOC SCI MED, V270, DOI 10.1016/j.socscimed.2020.113645
   Mohammed H., 2017, P 2017 IEEE INT C BE, P1, DOI 10.1109/BESC.2017.8256398
   Mubarak AS, 2021, DESALIN WATER TREAT, V221, P31, DOI 10.5004/dwt.2021.27049
   Musa B, 2021, PROCESSES, V9, DOI 10.3390/pr9071166
   Nourani V, 2018, WATER SCI TECHNOL, V78, P2064, DOI 10.2166/wst.2018.477
   Pang NTP, 2021, INFECT DIS MODEL, V6, P898, DOI 10.1016/j.idm.2021.07.004
   Pham QB, 2021, ENVIRON SCI POLLUT R, V28, P32564, DOI 10.1007/s11356-021-12792-2
   Qin H., ARXIV191108414, V2019
   Pham QB, 2020, DESALIN WATER TREAT, V203, P80, DOI 10.5004/dwt.2020.26160
   Pham QB, 2019, WATER RESOUR MANAG, V33, P5067, DOI 10.1007/s11269-019-02408-3
   Rostami-Tabar B, 2021, APPL SOFT COMPUT, V100, DOI 10.1016/j.asoc.2020.106932
   Sammen SS, 2021, STOCH ENV RES RISK A, V35, P2479, DOI 10.1007/s00477-021-02012-1
   Shamshirband S, 2020, ENG APPL COMP FLUID, V14, P939, DOI 10.1080/19942060.2020.1788644
   Shi F, 2021, IEEE REV BIOMED ENG, V14, P4, DOI 10.1109/RBME.2020.2987975
   Shi XJ, 2015, ADV NEUR IN, V28
   Sohail A, 2021, RESULTS PHYS, V21, DOI 10.1016/j.rinp.2021.103819
   Tang YJ, 2020, EMERG MICROBES INFEC, V9, P827, DOI 10.1080/22221751.2020.1760146
   Taylor KE, 2001, J GEOPHYS RES-ATMOS, V106, P7183, DOI 10.1029/2000JD900719
   Tiwari MK, 2013, WATER RESOUR RES, V49, P6486, DOI 10.1002/wrcr.20517
   Toga G, 2021, J INFECT PUBLIC HEAL, V14, P811, DOI 10.1016/j.jiph.2021.04.015
   Usman AG, 2021, J SEP SCI, V44, DOI 10.1002/jssc.202000890
   Vandamme JP, 2007, EDUC ECON, V15, P405, DOI 10.1080/09645290701409939
   Wang GT, 2020, IEEE T MED IMAGING, V39, P2653, DOI 10.1109/TMI.2020.3000314
   Wunsch A., 2020, HYDROL EARTH SYST SC, V552, P1
   Yu P, 2020, J INFECT DIS, V221, P1757, DOI 10.1093/infdis/jiaa077
   Zhang D, 2018, J HYDROL, V567, P792, DOI 10.1016/j.jhydrol.2017.11.029
   Zhang JF, 2018, J HYDROL, V561, P918, DOI 10.1016/j.jhydrol.2018.04.065
   Zhou LX, 2020, IEEE T MED IMAGING, V39, P2638, DOI 10.1109/TMI.2020.3001810
NR 50
TC 2
Z9 2
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JAN
PY 2022
VL 19
IS 2
AR 738
DI 10.3390/ijerph19020738
PG 22
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA YM4FE
UT WOS:000746531400001
PM 35055559
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Jimenez-Barreto, J
   Loureiro, S
   Braun, E
   Sthapit, E
   Zenker, S
AF Jimenez-Barreto, Jano
   Loureiro, Sandra
   Braun, Erik
   Sthapit, Erose
   Zenker, Sebastian
TI Use numbers not words! Communicating hotels' cleaning programs for
   COVID-19 from the brand perspective
SO INTERNATIONAL JOURNAL OF HOSPITALITY MANAGEMENT
LA English
DT Article
DE COVID-19; Hotel brand personality; Cleaning program; Numerical
   quantifiers; Verbal quantifiers; Dual-process theory
ID INFORMATION; PERSONALITY; STYLE
AB After hotels in many countries were forced to close in government-imposed lockdowns during the COVID-19 pandemic, there is an inherent need to communicate how they deal with the coronavirus to motivate guests to visit. However, lack of knowledge about how to persuasively communicate about hotels' cleaning programs for COVID-19 can challenge the industry's survival. We investigated how hotels that position their brand as a particular personality (sincere vs. exciting) could benefit from different communication styles (inclusion of numerical vs. verbal quantifiers) when presenting their COVID-19 cleaning procedures. Study 1 explored tourists' central attitudinal responses toward hotels' cleaning programs. Study 2 demonstrated that sincere hotel brands would benefit from using numerical and verbal quantifiers to communicate their cleaning policies, whereas exciting hotel brands would benefit only from numerical quantifiers. Our results invite hotel managers to use their brand personality positioning to influence tourists' attitudes and intentions in a pandemic context.
C1 [Jimenez-Barreto, Jano] Univ Autonoma Madrid, Coll Econ & Business Adm, Dept Finance & Mkt Res, Business Studies, Ctra Colmenar,C Francisco Tomas & Valiente 5, ES-28049 Madrid, Spain.
   [Loureiro, Sandra] Inst Univ Lisboa ISCTE IUL, Lisbon, Portugal.
   [Loureiro, Sandra] Business Res Unit BRUIUL, Lisbon, Portugal.
   [Braun, Erik; Zenker, Sebastian] Copenhagen Business Sch, Dept Mkt, Solbjerg Plads 3C, DK-2000 Frederiksberg, Denmark.
   [Sthapit, Erose] Haaga Helia Univ Appl Sci, Pasila Campus,Ratapihantie 13, FI-00520 Helsinki, Finland.
RP Jimenez-Barreto, J (corresponding author), Univ Autonoma Madrid, Coll Econ & Business Adm, Dept Finance & Mkt Res, Business Studies, Ctra Colmenar,C Francisco Tomas & Valiente 5, ES-28049 Madrid, Spain.
EM jano.jimenez@uam.es; sandramloureiro@netcabo.pt; cbr.marktg@cbs.dk;
   erose.sthapit@haaga-helia.fi; sze.marktg@cbs.dk
RI Jiménez-Barreto, Jano/ABG-1024-2020; Sthapit, Erose/J-6290-2019;
   Loureiro, Sandra Maria Correia/B-5180-2010
OI Sthapit, Erose/0000-0002-1650-3900; Loureiro, Sandra Maria
   Correia/0000-0001-8362-4430; Jimenez Barreto, Jano/0000-0002-1953-6863
FU Spanish Ministry of Economy, Industry, and CompetitivenessSpanish
   Government [BES-2016-078666]
FX This work was supported by the Spanish Ministry of Economy, Industry,
   and Competitiveness, Individual Grant Number: BES-2016-078666.
CR Aaker J, 2004, J CONSUM RES, V31, P1, DOI 10.1086/383419
   Aaker JL, 1997, J MARKETING RES, V34, P347, DOI 10.2307/3151897
   [Anonymous], 2020, LOS ANGELES TIMES
   [Anonymous], 2020, NEW YORK TIMES
   Bartosiak M, 2021, CURR ISSUES TOUR, V24, P1109, DOI 10.1080/13683500.2020.1765749
   Baum T, 2020, INT J CONTEMP HOSP M, V32, P2397, DOI 10.1108/IJCHM-03-2020-0242
   Berezan O, 2016, J HOSP TOUR TECHNOL, V7, P100, DOI 10.1108/JHTT-08-2015-0031
   Bufquin D, 2020, INT J HOSP MANAG, V87, DOI 10.1016/j.ijhm.2019.102378
   CHAIKEN S, 1980, J PERS SOC PSYCHOL, V39, P752, DOI 10.1037/0022-3514.39.5.752
   Childers TL, 2000, J BUS RES, V47, P109, DOI 10.1016/S0148-2963(98)00055-1
   Coulter RobinHiggie., 2000, WHY CONSUMPTION CONT, P259
   De Neys W., 2017, DUAL PROCESS THEORY
   Ettinger A, 2018, INT J HOSP MANAG, V68, P94, DOI 10.1016/j.ijhm.2017.09.002
   Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629
   Evans JST, 2013, PERSPECT PSYCHOL SCI, V8, P223, DOI 10.1177/1745691612460685
   Foroudi P, 2020, INT J HOSP MANAG, V88, DOI 10.1016/j.ijhm.2020.102519
   Foroudi P, 2019, INT J HOSP MANAG, V76, P271, DOI 10.1016/j.ijhm.2018.05.016
   GARFIELD E, 1982, CURR CONTENTS, P5
   Gretry A, 2017, J BUS RES, V74, P77, DOI 10.1016/j.jbusres.2017.01.012
   Hao F, 2020, INT J HOSP MANAG, V90, DOI 10.1016/j.ijhm.2020.102636
   Hard Rock Hotels Casino,, 2020, HARD ROCK OFFICIAL W
   Hardeman G, 2017, TOURISM MANAGE, V59, P484, DOI 10.1016/j.tourman.2016.09.011
   Hu XW, 2021, INT J HOSP MANAG, V92, DOI 10.1016/j.ijhm.2020.102662
   Im J, 2021, INT J HOSP MANAG, V92, DOI 10.1016/j.ijhm.2020.102701
   Jani D, 2014, INT J HOSP MANAG, V37, P11, DOI 10.1016/j.ijhm.2013.10.007
   Jun SH, 2013, ANN TOURISM RES, V40, P191, DOI 10.1016/j.annals.2012.09.001
   Kahneman D, 2015, FORTUNE, V172, P20
   Kim H.R., 2005, AP ASIA PACIFIC ADV, V6, P111
   Kim H, 2017, J DESTIN MARK MANAGE, V6, P416, DOI 10.1016/j.jdmm.2016.06.010
   Lee JS, 2010, J TRAVEL TOUR MARK, V27, P132, DOI 10.1080/10548400903579688
   Liu D, 2020, Q J EXP PSYCHOL, V73, P481, DOI 10.1177/1747021820903439
   Liu D, 2021, THINK REASONING, V27, P69, DOI 10.1080/13546783.2020.1720813
   Liu D, 2019, FOOD QUAL PREFER, V78, DOI 10.1016/j.foodqual.2019.103739
   Luffarelli J, 2019, J MARKETING RES, V56, P89, DOI 10.1177/0022243718820548
   Maille V, 2011, RECH APPL MARKET-ENG, V26, P77
   Merriam AH, 1990, SO COMMUN J, V55, P337
   Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291
   Pennebaker J.W., 2015, DEV PSYCHOMETRIC PRO
   Pennebaker JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115844
   Peters E, 2007, HEALTH AFFAIR, V26, P741, DOI 10.1377/hlthaff.26.3.741
   PETTY RE, 1981, J PERS SOC PSYCHOL, V41, P847, DOI 10.1037/0022-3514.41.5.847
   Roeh I., 1984, TEXT TALK, V4, P347
   Saldana J, 2013, CODING MANUAL QUALIT
   Santana S, 2020, J RETAILING, V96, P138, DOI 10.1016/j.jretai.2019.09.005
   Shin H, 2020, INT J HOSP MANAG, V91, DOI 10.1016/j.ijhm.2020.102664
   Strauss A., 1990, BASICS QUALITATIVE R
   Su N, 2017, INT J HOSP MANAG, V66, P1, DOI 10.1016/j.ijhm.2017.06.006
   Sundar A, 2016, J CONSUM RES, V43, P44, DOI 10.1093/jcr/ucw003
   Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676
   The Washington Post The Washington Post, 2020, WASHINGTON POST
   Tran X., 2013, Journal of Vacation Marketing, V19, P329, DOI 10.1177/1356766713481218
   Viswanathan M, 1997, ADV CONSUM RES, V24, P412
   Wang IM, 2019, PERS SOC PSYCHOL B, V45, P120, DOI 10.1177/0146167218780735
   Windschitl PD, 1996, J EXP PSYCHOL-APPL, V2, P343, DOI 10.1037/1076-898X.2.4.343
   WITT W, 1976, J COMMUN, V26, P67, DOI 10.1111/j.1460-2466.1976.tb01359.x
   WTTC, 2020, LAT RES WTTC
   YALCH RF, 1984, J CONSUM RES, V11, P522, DOI 10.1086/208988
   Zenker S, 2020, TOURISM MANAGE, V81, DOI 10.1016/j.tourman.2020.104164
NR 58
TC 3
Z9 3
U1 7
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0278-4319
EI 1873-4693
J9 INT J HOSP MANAG
JI Int. J. Hosp. Manag.
PD APR
PY 2021
VL 94
AR 102872
DI 10.1016/j.ijhm.2021.102872
EA FEB 2021
PG 11
WC Hospitality, Leisure, Sport & Tourism
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics
GA RA2OQ
UT WOS:000631257900066
PM 33897084
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Zhu, Y
   Chen, TT
   Wang, J
   Wang, M
   Johnson, RE
   Jin, YH
AF Zhu, Yue
   Chen, Tingting
   Wang, Jie
   Wang, Mo
   Johnson, Russell E.
   Jin, Yanghua
TI How Critical Activities Within COVID-19 Intensive Care Units Increase
   Nurses' Daily Occupational Calling
SO JOURNAL OF APPLIED PSYCHOLOGY
LA English
DT Article
DE occupational calling; COVID-19 pandemic; health care; prosocial
   motivation
ID CARDIAC-ARREST; WORK; PERFORMANCE; DYNAMICS; BEHAVIOR; OUTCOMES; JOB;
   VARIABILITY; PERSONALITY; COMMITMENT
AB During normal and predictable circumstances, employees' occupational calling (i.e., a transcendent passion to use their talent and competencies toward positive societal impact and a sense of meaningfulness derived from working in a chosen occupational domain) is observed to be relatively stable. However, with the onset of the COVID-19 pandemic, circumstances have become anything but normal and predictable, thus putting employees' sense of occupational calling to the test. In this study, we investigate the possibility that occupational calling fluctuates across days during situations of crisis, and we identify antecedents and consequence of such fluctuations. To test our model, we conducted a daily diary study of 66 nurses working in intensive care units over 5 consecutive work days in a specialized Wuhan hospital that only admitted confirmed COVID-19 patients during the peak of the pandemic in China. We found that the daily number of code blue events (i.e., cardiopulmonary resuscitation efforts with the primary goal of patient revival) was positively related to daily occupational calling for nurses. Moreover, individual differences in prosocial motivation predicted the average level and variability of occupational calling over the 5 days, which subsequently related to the nurses' job performance. Our study sheds light on how occupational calling enables people with the needed occupational knowledge and skills to function effectively in crisis situations.
C1 [Zhu, Yue; Jin, Yanghua] Zhejiang Gongshang Univ, Sch Business Adm, 18 Xuezheng St, Hangzhou, Peoples R China.
   [Chen, Tingting] Lingnan Univ, Dept Management, Hong Kong, Peoples R China.
   [Wang, Jie] Univ Nottingham Ningbo China, Nottingham Univ Business Sch China, Ningbo, Peoples R China.
   [Wang, Mo] Univ Florida, Warrington Coll Business, Dept Management, Gainesville, FL USA.
   [Johnson, Russell E.] Michigan State Univ, Broad Coll Business, Dept Management, E Lansing, MI 48824 USA.
RP Jin, YH (corresponding author), Zhejiang Gongshang Univ, Sch Business Adm, 18 Xuezheng St, Hangzhou, Peoples R China.
EM jinyanghua@163.com
RI Wang, Mo/AAT-1501-2021; Wang, Jie/AAO-6595-2020
OI Wang, Jie/0000-0002-3201-0129; Chen, Tingting/0000-0003-4467-0244; Zhu,
   Yue/0000-0002-4617-7042
FU National Science Foundation of ChinaNational Natural Science Foundation
   of China (NSFC) [71902092]; Outstanding Researcher Support System at
   Nottingham University Business School China
FX This research was supported in part by a research grant from the
   National Science Foundation of China (Grant 71902092) and the
   Outstanding Researcher Support System at Nottingham University Business
   School China awarded to Jie Wang. We have no known conflict of interest
   to disclose.
CR Alhazzani W, 2020, CRIT CARE MED, V48, pE440, DOI [10.1097/CCM.0000000000004363, 10.1007/s00134-020-06022-5]
   Barnes B, 2020, NURSE           0319
   Beal DJ, 2013, J APPL PSYCHOL, V98, P593, DOI 10.1037/a0032559
   Bolino MC, 2016, ACAD MANAG ANN, V10, P599, DOI 10.1080/19416520.2016.1153260
   Brilli RJ, 2001, CRIT CARE MED, V29, P2007, DOI 10.1097/00003246-200110000-00026
   Brislin RW., 1986, FIELD METHODS CROSS, VVol. 8, P137, DOI DOI 10.1037/0022-3514.90.4.644
   Bunderson JS, 2009, ADMIN SCI QUART, V54, P32, DOI 10.2189/asqu.2009.54.1.32
   Carenzo L, 2020, ANAESTHESIA, V75, P928, DOI 10.1111/anae.15072
   Chen JT, 2018, J CAREER DEV, V45, P103, DOI 10.1177/0894845316671214
   Craig S, 2020, MED J AUSTRALIA, V213, P126, DOI 10.5694/mja2.50699
   Curlin FA, 2007, ANN FAM MED, V5, P353, DOI 10.1370/afm.677
   de Leeuw J., 1998, INTRO MULTILEVEL MOD, DOI [10.4135/9781849209366, DOI 10.4135/9781849209366]
   Dickerson Suzanne Steffan, 2002, J N Y State Nurses Assoc, V33, P26
   Dik BJ, 2019, J CAREER ASSESSMENT, V27, P323, DOI 10.1177/1069072717748676
   Dik BJ, 2012, J CAREER ASSESSMENT, V20, P242, DOI 10.1177/1069072711434410
   Dobrow SR, 2013, J ORGAN BEHAV, V34, P431, DOI 10.1002/job.1808
   Dobrow SR, 2011, PERS PSYCHOL, V64, P1001, DOI 10.1111/j.1744-6570.2011.01234.x
   Duffy RD, 2007, J VOCAT BEHAV, V70, P590, DOI 10.1016/j.jvb.2007.03.007
   Duffy RD, 2014, J VOCAT BEHAV, V85, P309, DOI 10.1016/j.jvb.2014.08.009
   Duffy RD, 2014, J COUNS PSYCHOL, V61, P605, DOI 10.1037/cou0000042
   Duffy RD, 2011, J VOCAT BEHAV, V78, P210, DOI 10.1016/j.jvb.2010.09.013
   Fleeson W, 2002, J PERS SOC PSYCHOL, V83, P1409, DOI 10.1037//0022-3514.83.6.1409
   GANZACH Y, 1995, J APPL PSYCHOL, V80, P491, DOI 10.1037/0021-9010.80.4.491
   Gatto M., 2002, J NEW YORK STATE NUR, V33, P5
   Gazica MW, 2015, J VOCAT BEHAV, V91, P1, DOI 10.1016/j.jvb.2015.08.008
   Gielnik MM, 2020, J APPL PSYCHOL, V105, P487, DOI 10.1037/apl0000451
   Grant AM, 2008, J APPL PSYCHOL, V93, P48, DOI 10.1037/0021-9010.93.1.48
   Grant AM, 2011, ACAD MANAGE J, V54, P73, DOI 10.5465/AMJ.2011.59215085
   Grote G, 2020, WORK AGING RETIRE, V6, P246, DOI 10.1093/workar/waaa020
   Hassager C, 2020, EUR HEART J-ACUTE CA, V9, P239, DOI 10.1177/2048872620922789
   Hofmann DA, 1998, J MANAGE, V24, P623, DOI 10.1177/014920639702300602
   Jager AJ, 2017, MAYO CLIN PROC, V92, P415, DOI 10.1016/j.mayocp.2016.11.012
   Johnson RE, 2012, J APPL PSYCHOL, V97, P1262, DOI 10.1037/a0029043
   Keltner D, 2014, ANNU REV PSYCHOL, V65, P425, DOI 10.1146/annurev-psych-010213-115054
   Kent D, 2019, ORGAN STUD, V40, P975, DOI 10.1177/0170840618765582
   Kim SS, 2018, HUM RELAT, V71, P1319, DOI 10.1177/0018726717743310
   Knafo A, 2011, DEV PSYCHOPATHOL, V23, P53, DOI 10.1017/S0954579410000647
   Lakanmaa RL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/536724
   Lanaj K, 2016, J APPL PSYCHOL, V101, P1097, DOI 10.1037/apl0000118
   Lanaj K, 2014, ORGAN BEHAV HUM DEC, V124, P11, DOI 10.1016/j.obhdp.2014.01.001
   Lee AYP, 2018, J MANAGE ORGAN, V24, P129, DOI 10.1017/jmo.2016.16
   Matta FK, 2017, ACAD MANAGE J, V60, P743, DOI 10.5465/amj.2014.0455
   Mischel W, 1998, ANNU REV PSYCHOL, V49, P229, DOI 10.1146/annurev.psych.49.1.229
   MISCHEL W, 1995, PSYCHOL REV, V102, P246, DOI 10.1037/0033-295X.102.2.246
   Murthy S, 2020, JAMA-J AM MED ASSOC, V323, P1499, DOI 10.1001/jama.2020.3633
   Muthen LK., 2017, MPLUS USERS GUIDE, V8
   Qiu HB, 2020, INTENS CARE MED, V46, P576, DOI 10.1007/s00134-020-05966-y
   Riza SD, 2015, J APPL PSYCHOL, V100, P695, DOI 10.1037/a0038011
   Roberson QM, 2007, ORGAN RES METHODS, V10, P564, DOI 10.1177/1094428106294746
   Rousek JB, 2011, IIE T HEALTHC SYST E, V1, P197, DOI DOI 10.1080/19488300.2011.628556
   Rudolph CW, 2020, WORK AGING RETIRE, V6, P139, DOI 10.1093/workar/waaa009
   RYAN RM, 1989, J PERS SOC PSYCHOL, V57, P749, DOI 10.1037/0022-3514.57.5.749
   Scott BA, 2012, ACAD MANAGE J, V55, P905, DOI 10.5465/amj.2010.1050
   Shao F, 2020, RESUSCITATION, V151, P18, DOI 10.1016/j.resuscitation.2020.04.005
   Singh P., 2008, INT TERRORISM THREAT, P219, DOI [10.4337/9781848443815.00019, DOI 10.4337/9781848443815.00019]
   Steger MF, 2009, APPL PSYCHOL-HLTH WE, V1, P303, DOI 10.1111/j.1758-0854.2009.01018.x
   Thompson JA, 2019, ANNU REV ORGAN PSYCH, V6, P421, DOI 10.1146/annurev-orgpsych-012218-015140
   Truxillo DM, 2020, WORK AGING RETIRE, V6, P242, DOI 10.1093/workar/waaa016
   Vindigni SM, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-017-0253-9
   WHO China, 2020, REP WHO CHIN JOINT M, DOI DOI 10.1186/S40249-020-00650-1
   Wrzesniewski A, 2002, J MANAGE INQUIRY, V11, P230, DOI 10.1177/1056492602113003
   Wrzesniewski A, 1997, J RES PERS, V31, P21, DOI 10.1006/jrpe.1997.2162
   Xie BG, 2017, J VOCAT BEHAV, V100, P78, DOI 10.1016/j.jvb.2017.03.001
   Xie JF, 2020, INTENS CARE MED, V46, P837, DOI 10.1007/s00134-020-05979-7
NR 64
TC 9
Z9 10
U1 27
U2 64
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0021-9010
EI 1939-1854
J9 J APPL PSYCHOL
JI J. Appl. Psychol.
PD JAN
PY 2021
VL 106
IS 1
BP 4
EP 14
DI 10.1037/apl0000853
PG 11
WC Psychology, Applied; Management
WE Social Science Citation Index (SSCI)
SC Psychology; Business & Economics
GA PW8IK
UT WOS:000610911600002
PM 33151706
DA 2022-04-20
ER

PT J
AU Zhao, WJ
   Zhang, L
   Wang, JL
   Wang, LL
AF Zhao, Wenjing
   Zhang, Lin
   Wang, Junling
   Wang, Lili
TI How has academia responded to the urgent needs created by COVID-19? A
   multi-level global, regional and national analysis
SO JOURNAL OF INFORMATION SCIENCE
LA English
DT Article; Early Access
DE academic research; COVID-19; reported cases; response patterns
ID BIBLIOMETRIC ANALYSIS; GASTROINTESTINAL ENDOSCOPY; SCIENCE;
   COLLABORATION; WEB
AB In the context of the COVID-19 pandemic, gaining insights into how academia has responded to this urgent challenge is of great significance. This article presents academic response patterns at a global, regional and national level from an analysis of publication volume versus reported cases of COVID-19, scientific collaboration and research focus. We also compare academic activity associated with this newly emerging infection to that related to long-standing infections. Our results show that the research community has responded quickly to COVID-19. The highly developed countries, which have the highest number of confirmed cases, are also the major academic contributors. National-level analysis reveals diverse response patterns from different countries. Specifically, academic research in the United Kingdom remained at a relatively constant level throughout the whole year (2020), while the global share of China's research output was prone to shift as its domestic pandemic status changed. Strong alliances have formed among countries with academic capabilities in response to the COVID-19 pandemic. The distribution of disciplines is relatively decentralised, indicating that a diverse and broad knowledge base contributes to the COVID-19 literature. Most of the analysed countries show dynamic patterns of research focus that vary over time as the pandemic evolves, except India. As one of the world's biggest suppliers of vaccines, India makes consistent efforts on vaccine research, especially those related to pharmaceutical preparations. Our findings may serve as resources for fostering strategies to respond to future threats of pandemics.
C1 [Zhao, Wenjing; Zhang, Lin] Wuhan Univ, Ctr Studies Informat Resources, Sch Informat Management, Wuhan 430072, Hubei, Peoples R China.
   [Zhao, Wenjing; Zhang, Lin] Wuhan Univ, Ctr Sci Technol & Educ Assessment CSTEA, Wuhan, Peoples R China.
   [Zhang, Lin] Katholieke Univ Leuven, Ctr R&D Monitoring ECOOM, Leuven, Belgium.
   [Zhang, Lin] Katholieke Univ Leuven, Dept MSI, Leuven, Belgium.
   [Wang, Junling] Swiss Fed Inst Technol, Dept Comp Sci, Zurich, Switzerland.
   [Wang, Lili] Maastricht Univ, UNU MERIT, Maastricht, Netherlands.
RP Zhang, L (corresponding author), Wuhan Univ, Ctr Studies Informat Resources, Sch Informat Management, Wuhan 430072, Hubei, Peoples R China.
EM linzhang1117@whu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [71573085, 71974150]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship and/or publication of this article: This
   article was financially supported by National Natural Science Foundation
   of China (Grant Nos. 71573085, 71974150).
CR Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9
   Al-Ajlouni YA, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-041995
   Arantes PR, 2020, ACS CENTRAL SCI, V6, P1654, DOI 10.1021/acscentsci.0c01236
   Aviv-Reuven S, 2021, SCIENTOMETRICS, V126, P6761, DOI 10.1007/s11192-021-04059-x
   Tran BX, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114095
   Bedford J, 2019, NATURE, V575, P130, DOI 10.1038/s41586-019-1717-y
   Belli S, 2020, SCIENTOMETRICS, V124, P2661, DOI 10.1007/s11192-020-03590-7
   Bhattacharjee B, 2020, PSYCHIAT QUART, V91, P1135, DOI 10.1007/s11126-020-09836-0
   Bjork BC, 2013, J INFORMETR, V7, P914, DOI 10.1016/j.joi.2013.09.001
   Bloom DE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00549
   Blumenthal D, 2020, NEW ENGL J MED, V383, P1483, DOI 10.1056/NEJMsb2021088
   Brasil A., 2020, LEIDEN MADTRICS 0430
   Brenner MH, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.592467
   Cai X, 2021, SCIENTOMETRICS, V126, P3683, DOI 10.1007/s11192-021-03873-7
   Carley S, 2017, J DATA INFO SCI, V2, P68, DOI 10.1515/jdis-2017-0015
   Chen YC., 2017, BIOTECHNOLOGIES APPL, P97
   Cheng X, 2020, J INF SCI, DOI 10.1177/0165551520954674
   Chiu WT, 2004, SCIENTOMETRICS, V61, P69, DOI 10.1023/B:SCIE.0000037363.49623.28
   Colavizza G, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244839
   Conceicao P., 2020, COVID 19 HUMAN DEV C
   COVID-19 Clinical Res Coalition, 2020, LANCET, V395, P1322, DOI 10.1016/S0140-6736(20)30798-4
   de Oliveira JF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229790
   Else H, 2020, NATURE, V588, P553, DOI 10.1038/d41586-020-03564-y
   Fang Z., 2020, ARXIV200210616
   Farooq R, 2021, J FAM COMMUNITY MED, V28, P1, DOI 10.4103/jfcm.JFCM_332_20
   Fry CV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236307
   Ghosh D, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.020348
   Gronvall GK, 2020, SURVIVAL, V62, P77, DOI 10.1080/00396338.2020.1763613
   Guler G, 2021, PROG BIOPHYS MOL BIO, V164, P3, DOI 10.1016/j.pbiomolbio.2021.05.007
   Gunjan D, 2020, J DIG ENDOSC, V11, P33, DOI 10.1055/s-0040-1712269
   Haghani M, 2020, SCIENTOMETRICS, V125, P2695, DOI 10.1007/s11192-020-03706-z
   Haghani M, 2020, SAFETY SCI, V129, DOI 10.1016/j.ssci.2020.104806
   He S, 2020, MATH BIOSCI ENG, V17, P2792, DOI 10.3934/mbe.2020153
   Hospital Adam, 2015, Adv Appl Bioinform Chem, V8, P37, DOI 10.2147/AABC.S70333
   Hossain MM, 2020, CURRENT STATUS GLOBA, V9, P374, DOI DOI 10.2139/SSRN.3547824
   Kagan D, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa085
   Khazaei Z, 2020, ARCH CLIN INFECT DIS, V15, DOI 10.5812/archcid.103093
   Kovacevic M., 2020, COVID 19 HUMAN DEV E
   Lakhtakia S, 2020, J DIG ENDOSC, V11, P41, DOI 10.1055/s-0040-1712270
   Lariviere V., 2020, LSE IMPACT BLOG 0305
   Lawal Y, 2021, INT J INFECT DIS, V102, P118, DOI 10.1016/j.ijid.2020.10.038
   Lederer EM., 2020, CHIEF SAYS COVID 19
   Lee JJ, 2021, J HIGH EDUC-UK, V92, P303, DOI 10.1080/00221546.2020.1827924
   McGill MJ., 1987, INTRO MODERN INFORM
   Mork J, 2017, J BIOMED SEMANT, V8, DOI 10.1186/s13326-017-0113-5
   Nasir S, 2018, ADV LIFE SCI-PAK, V5, P88
   NIH-Fogarty International Center, 2020, NIH FOG COLL COVID 1
   Nii-Trebi NI, 2017, BIOMED RES INT, V2017, P1, DOI 10.1155/2017/5245021
   NLM, 2021, MEDLINE PUBMED DAT E
   NLM, MESH TREE VIEW
   Ogbolosingha A. J., 2020, AM J PREV MED PUBLIC, V6, P68
   Padma TV, 2021, NATURE, V592, P500, DOI 10.1038/d41586-021-00996-y
   Pathak M, 2020, INDIAN J BIOCHEM BIO, V57, P439
   Persson O, 1997, SCIENTOMETRICS, V39, P209, DOI 10.1007/BF02457449
   Quaresima V, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012488
   Rafols I, 2010, J AM SOC INF SCI TEC, V61, P1871, DOI 10.1002/asi.21368
   Ren XW, 2021, CELL, V184, P1895, DOI 10.1016/j.cell.2021.01.053
   Rutayisire E, 2020, INT J INFECT DIS, V97, P267, DOI 10.1016/j.ijid.2020.06.024
   The National Institute for Occupational Safety and Health (NIOSH), 2018, EMERG INFECT DIS
   The World Bank, 2021, WORLD BANK POP ALL C
   Tian JJ, 2020, MATH BIOSCI ENG, V17, P2842, DOI 10.3934/mbe.2020158
   Turki H, 2021, J INF SCI, DOI 10.1177/01655515211006605
   UNDP, 2020, HUM DEV IND HDI
   UNDP, 2020, 2020 HUM DEV REP NEX
   VOA News, 2021, VOA NEWS 0101
   Wagner CS., 2005, INT J TECHNOLOGY GLO, V1, P185, DOI DOI 10.1504/IJTG.2005.007050
   Waltman L, 2010, J INFORMETR, V4, P629, DOI 10.1016/j.joi.2010.07.002
   Wamai RG, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18168638
   Wang LL, 2019, ASIAN J TECHNOL INNO, V27, P152, DOI 10.1080/19761597.2019.1641417
   Wang Panpan, 2021, J Biosaf Biosecur, V3, P4, DOI 10.1016/j.jobb.2020.12.002
   Wu LY, 2021, J INF SCI, DOI 10.1177/01655515211030866
   Yang LM, 2005, ISSI 2005: PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE OF THE INTERNATIONAL SOCIETY FOR SCIENTOMETRICS AND INFORMETRICS, VOLS 1 AND 2, P654
   Yin Y, 2021, SCIENCE, V371, P128, DOI 10.1126/science.abe3084
   Yong, 2020, ATLANTIC
   Zacharias P, 2020, J DIG ENDOSC, V11, P55, DOI 10.1055/s-0040-1712236
   Zhang L, 2020, SCIENTOMETRICS, V125, P1733, DOI 10.1007/s11192-020-03572-9
   Zhang L, 2020, SCIENTOMETRICS, V124, P747, DOI 10.1007/s11192-020-03531-4
   Zhao SL, 2020, QUANT BIOL, V8, P11, DOI 10.1007/s40484-020-0199-0
   Zhao W., DOES ACAD RESPOND BU, V2021, P1
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
   Zyoud SH, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05293-z
NR 81
TC 0
Z9 0
U1 2
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0165-5515
EI 1741-6485
J9 J INF SCI
JI J. Inf. Sci.
AR 01655515221084646
DI 10.1177/01655515221084646
EA MAR 2022
PG 27
WC Computer Science, Information Systems; Information Science & Library
   Science
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Computer Science; Information Science & Library Science
GA ZY1PC
UT WOS:000772360700001
OA Green Submitted
DA 2022-04-20
ER

PT J
AU Dombradi, V
   Joo, T
   Palla, G
   Pollner, P
   Belicza, E
AF Dombradi, Viktor
   Joo, Tamas
   Palla, Gergely
   Pollner, Peter
   Belicza, Eva
TI Comparison of hesitancy between COVID-19 and seasonal influenza
   vaccinations within the general Hungarian population: a cross-sectional
   study
SO BMC PUBLIC HEALTH
LA English
DT Article
DE COVID-19; SARS-CoV-2; Influenza; Vaccination; Hesitancy; Population
ID VACCINE HESITANCY; INTENTION; TRIAL; TRUST; RISK
AB Background The willingness to get COVID-19 or seasonal influenza vaccines has not yet been thoroughly investigated together, thus, this study aims to explore this notion within the general adult population. Methods The responses of 840 Hungarian participants were analysed who took part in a nationwide computer-assisted telephone interviewing. During the survey questions concerning various demographic characteristics, perceived financial status, and willingness to get the two types of vaccines were asked. Descriptive statistics, comparative statistics and word co-occurrence network analysis were conducted. Results 48.2% of participants were willing to get a COVID-19 vaccine, while this ratio for the seasonal influenza was only 25.7%. The difference was significant. Regardless of how the participants were grouped, based on demographic data or perceived financial status, the significant difference always persisted. Being older than 59 years significantly increased the willingness to get both vaccines when compared to the middle-aged groups, but not when compared to the younger ones. Having higher education significantly elevated the acceptance of COVID-19 vaccination in comparison to secondary education. The willingness of getting any type of COVID-19 vaccine correlated with the willingness to get both influenza and COVID-19. Finally, those who were willing to get either vaccine coupled similar words together to describe their thoughts about a COVID-19 vaccination. Conclusion The overall results show a clear preference for a COVID-19 vaccine and there are several similarities between the nature of willingness to get either type of vaccine.
C1 [Dombradi, Viktor; Palla, Gergely; Pollner, Peter; Belicza, Eva] Semmelweis Univ, Fac Hlth & Publ Adm, Hlth Serv Management Training Ctr, Budapest, Hungary.
   [Joo, Tamas] Semmelweis Univ, Fac Hlth & Publ Adm, Hlth Secur & Cyber Def Knowledge Ctr, Hlth Serv Management Training Ctr, Budapest, Hungary.
   [Joo, Tamas] Hungarian Healthcare Management Assoc, Budapest, Hungary.
   [Palla, Gergely; Pollner, Peter] Eotvos Lorand Univ, Dept Biol Phys, MTA ELTE Stat & Biol Phys Res Grp, Eotvos Lorand Res Network ELKH, Budapest, Hungary.
RP Belicza, E (corresponding author), Semmelweis Univ, Fac Hlth & Publ Adm, Hlth Serv Management Training Ctr, Budapest, Hungary.
EM belicza.eva@emk.semmelweis.hu
RI Dombrádi, Viktor/U-5687-2019
OI Dombrádi, Viktor/0000-0002-3171-671X
FU Ministry for Innovation and Technology in Hungary [2020-4.1.1.-TKP2020]
FX The research was financed by the Thematic Excellence Programme
   (Temateruleti Kivalosagi Program, 2020-4.1.1.-TKP2020) of the Ministry
   for Innovation and Technology in Hungary, within the framework of the
   DigitalBiomarker thematic programme of the Semmelweis University. The
   funder was not involved in the design of the study and collection,
   analysis and interpretation of data or writing the manuscript.
CR About Hungary, COR HER LAT REG UPD
   Al Halabi CK, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10902-w
   Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47
   Alwi SARS, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11071-6
   Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389
   Bambra C, 2020, J EPIDEMIOL COMMUN H, V74, P964, DOI 10.1136/jech-2020-214401
   Bandyopadhyay S, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003097
   Caserotti M, 2021, SOC SCI MED, V272, DOI 10.1016/j.socscimed.2021.113688
   CDC, FLU VACCINATION COVE
   Chen MS, 2021, HUM VACC IMMUNOTHER, V17, P2279, DOI 10.1080/21645515.2020.1853449
   Commonwealth of Australia. Department of Health, GETT VACC COVID 19
   Detoc M, 2020, VACCINE, V38, P7002, DOI 10.1016/j.vaccine.2020.09.041
   Dodd RH, 2021, LANCET INFECT DIS, V21, P318, DOI 10.1016/S1473-3099(20)30559-4
   Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y
   Ebrahimi OV, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.700213
   European Commission, PUBL OP COV 19 VACC
   Faasse K, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.551004
   Federal Public Service (FPS) Health Food Chain Safety and Environment, COR COVID 19
   Fisher KA, 2020, ANN INTERN MED, V173, P964, DOI 10.7326/M20-3569
   Graffigna G, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040576
   Jarrett C, 2015, VACCINE, V33, P4180, DOI 10.1016/j.vaccine.2015.04.040
   Jin HJ, 2021, B WORLD HEALTH ORGAN, V99, P112, DOI 10.2471/BLT.20.267112
   Jorgensen P, 2018, VACCINE, V36, P442, DOI 10.1016/j.vaccine.2017.12.019
   Karabela SN, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11262-1
   Karlsson LC, 2021, PERS INDIV DIFFER, V172, DOI 10.1016/j.paid.2020.110590
   Kourlaba G, 2021, GLOB HEALTH RES POL, V6, DOI 10.1186/s41256-021-00188-1
   Kreps S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25594
   Larson HJ, 2018, HUM VACC IMMUNOTHER, V14, P1599, DOI 10.1080/21645515.2018.1459252
   Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9
   Logunov DY, 2021, LANCET, V397, P671, DOI 10.1016/S0140-6736(21)00234-8
   Magadmi RM, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11501-5
   Meier BP, 2021, J SOC PSYCHOL, V161, P403, DOI [10.1080/00224545.2021.1935830, 10.1093/pubmed/fdab013]
   Mercadante AR, 2021, RES SOC ADMIN PHARM, V17, P1596, DOI 10.1016/j.sapharm.2020.12.012
   Baena-Diez JM, 2020, J PUBLIC HEALTH-UK, V42, P698, DOI 10.1093/pubmed/fdaa136
   Mohamad O, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11361-z
   National Health Service (NHS), WHO CAN GET COVID 19
   Newman M. E., 2006, STRUCTURE DYNAMICS N
   Nezopont Intezet Ltd, US
   Nossier SA, 2021, J EGYPT PUBLIC HEAL, V96, DOI 10.1186/s42506-021-00081-2
   Ogilvie GS, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11098-9
   Omar DI, 2021, J INFECT PUBLIC HEAL, V14, P1481, DOI 10.1016/j.jiph.2021.06.019
   Organisation for Economic Co-operation and Development (OECD), INFL VACC RAT
   Pennings S, 2021, J MED ETHICS, V47, P709, DOI 10.1136/medethics-2020-107076
   Pogue K, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040582
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Rigby E, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.35955
   Ruiz JB, 2021, VACCINE, V39, P1080, DOI 10.1016/j.vaccine.2021.01.010
   Salali Gul Deniz, 2020, Psychol Med, P1, DOI 10.1017/S0033291720004067
   Savulescu J, 2021, J MED ETHICS, V47, P78, DOI 10.1136/medethics-2020-106821
   Schmelz K, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016385118
   Schmid P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170550
   Schwarzinger M, 2021, LANCET PUBLIC HEALTH, V6, pE210, DOI 10.1016/S2468-2667(21)00012-8
   Smetana J, 2018, HUM VACC IMMUNOTHER, V14, P540, DOI 10.1080/21645515.2017.1343226
   Statista Research Department, IMP COR PAND GLOB EC
   Trent Mallory, 2022, Vaccine, V40, P2498, DOI 10.1016/j.vaccine.2021.06.048
   Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1
   Wake AD, 2021, RISK MANAG HEALTHC P, V14, P2609, DOI 10.2147/RMHP.S311074
   Wang Q, 2018, VACCINE, V36, P7262, DOI 10.1016/j.vaccine.2018.10.045
   Ward JK, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113414
   World Health Organization, COR DIS COVID 19 PAN
   World Health Organization, FRAM DEC MAK IMPL MA
   Yoda T, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010048
NR 62
TC 0
Z9 0
U1 2
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD DEC 23
PY 2021
VL 21
IS 1
AR 2317
DI 10.1186/s12889-021-12386-0
PG 13
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA XU3HK
UT WOS:000734160300006
PM 34949176
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Bahramian, H
   Gharib, B
   Baghalian, A
AF Bahramian, H.
   Gharib, B.
   Baghalian, A.
TI COVID-19 Considerations in Pediatric Dentistry
SO JDR CLINICAL & TRANSLATIONAL RESEARCH
LA English
DT Article
DE coronavirus; virology; dental care for children; infection control;
   transmission; dental practice management
AB One of the most important current medical concerns across the globe is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, which has been designated by the World Health Organization as a novel viral pneumonia named coronavirus disease 2019 (COVID-19). COVID-19 has substantially affected all aspects of human lives and forced most people to self-quarantine themselves and stay home in order to remain safe. As pediatric dentists as a part of the health care system deferring elective procedures, we are obliged to manage emergency situations such as cellulitis, severe tooth pain, and dental trauma. Therefore, we need to beware of the symptoms and risks of the emerging disease and, accordingly, change the policies in our offices to minimize the risk of transmission while checking up and treating our patients in the safest possible way.
   Knowledge Transfer Statement: This article aims to acquaint clinicians treating pediatric patients with COVID-19 hazards and delineate the steps required for minimizing cross-infection in case of providing emergency treatment to children in dental offices.
C1 [Bahramian, H.] Univ Tehran Med Sci, Sch Dent, Community Oral Hlth Dept, Tehran, Iran.
   [Gharib, B.] Univ Tehran Med Sci, Dept Pediat, Tehran, Iran.
   [Baghalian, A.] Univ Tehran Med Sci, Sch Dent, Pediat Dent Dept, North Kargar St, Tehran 1439955991, Iran.
RP Baghalian, A (corresponding author), Univ Tehran Med Sci, Sch Dent, Pediat Dent Dept, North Kargar St, Tehran 1439955991, Iran.
EM abaghalian@sina.tums.ac.ir
RI Gharib, Behdad/AAT-1261-2021
CR [Anonymous], 2020, GUIDELINE PROVIDING
   Centers for Disease Control and Prevention, 2020, COVID 19 SPREADS
   Centers for Disease Control and Prevention, 2020, FREQ ASK QUEST PERS
   Elvis A M, 2011, J Nat Sci Biol Med, V2, P66, DOI 10.4103/0976-9668.82319
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hagbom M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11431
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huizinga JD, 2021, DIGEST DIS SCI, V66, P668, DOI 10.1007/s10620-020-06373-5
   Kam KQ, 2020, CLIN INFECT DIS, V71, P847, DOI 10.1093/cid/ciaa201
   Kowalski W., 2020, 2020 COVID 19 CORONA
   Liu WY, 2020, NEW ENGL J MED, V382, P1370, DOI 10.1056/NEJMc2003717
   Lu CW, 2020, LANCET, V395, pE39, DOI 10.1016/S0140-6736(20)30313-5
   National Center for Immunization and Respiratory Diseases Division of Viral Diseases, 2020, COV 19 SPREADS
   National Committee of COVID-19 Epidemiology and Iranian CDC-Ministry of Health and Medical Education, 2020, 16 NAT COMM COVID 19
   National Committee on COVID-19 Epidemiology, 2020, DAIL SIT REP COR DIS
   Ogimi C, 2019, J PEDIAT INF DIS SOC, V8, P21, DOI 10.1093/jpids/pix093
   Panahi L, 2020, ARCH ACAD EMERG MED, V8, DOI 10.22037/aaem.v8i1.634
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   Qiu HY, 2020, LANCET INFECT DIS, V20, P689, DOI 10.1016/S1473-3099(20)30198-5
   RILEY RL, 1989, AM REV RESPIR DIS, V139, P1286, DOI 10.1164/ajrccm/139.5.1286
   SAMARANAYAKE LP, 1989, J DENT CHILD, V56, P442
   Shen KL, 2020, WORLD J PEDIATR, V16, P219, DOI 10.1007/s12519-020-00344-6
   Society of Pediatrics Chinese Medical Association, 2020, Zhonghua Er Ke Za Zhi, V58, P169, DOI [10.3760/cma.j.issn.0578-1310.2020.0004, 10.3760/cma.j.issn.0578-1310.2020.03.001]
   Sun D, 2020, WORLD J PEDIATR, V16, P251, DOI 10.1007/s12519-020-00354-4
   US Environmental Protection Agency, 2020, LIST N DIS US AG SAR
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Wax RS, 2020, CAN J ANESTH, V67, P568, DOI 10.1007/s12630-020-01591-x
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 32
TC 10
Z9 10
U1 3
U2 9
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2380-0844
EI 2380-0852
J9 JDR CLIN TRANSL RES
JI JDR Clin. Transl. Res.
PD OCT
PY 2020
VL 5
IS 4
BP 307
EP 311
AR 2380084420941503
DI 10.1177/2380084420941503
EA JUL 2020
PG 5
WC Dentistry, Oral Surgery & Medicine
WE Emerging Sources Citation Index (ESCI)
SC Dentistry, Oral Surgery & Medicine
GA NU8KY
UT WOS:000552063000001
PM 32663415
DA 2022-04-20
ER

PT J
AU Wu, YY
   Li, HY
   Zhang, ZH
   Liang, WH
   Zhang, TS
   Tong, ZH
   Guo, XZ
   Qi, XS
AF Wu, Yanyan
   Li, Hongyu
   Zhang, Zhongheng
   Liang, Wenhua
   Zhang, Tiansong
   Tong, Zhenhua
   Guo, Xiaozhong
   Qi, Xingshun
TI Risk factors for mortality of coronavirus disease 2019 (COVID-19)
   patients during the early outbreak of COVID-19: a systematic review and
   meta-analysis
SO ANNALS OF PALLIATIVE MEDICINE
LA English
DT Review
DE Coronavirus disease 2019 (COVID-19); severe acute respiratory syndrome
   coronavirus 2 (SARS-CoV-2); meta-analysis; mortality; risk factors
ID ACE2; OBESITY; WUHAN
AB Background: Identification of risk factors for poor prognosis of patients with coronavirus disease 2019 (COVID-19) is necessary to enable the risk stratification and modify the patient's management. Thus, we performed a systematic review and meta-analysis to evaluate the in-hospital mortality and risk factors of death in COVID-19 patients.
   Methods: All studies were searched via the PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), VIP, and Wanfang databases. The in-hospital mortality of COVID-19 patients was pooled. Odds ratios (ORs) or mean difference (MD) with 95% confidence intervals (CIs) were calculated for evaluation of risk factors.
   Results: A total of 80 studies were included with a pooled in-hospital mortality of 14% (95% CI: 12.2-15.9%). Older age (MD = 13.32, 95% CI: 10.87-15.77; P<0.00001), male (OR = 1.66, 95% CI: 1.37-2.01; P<0.00001), hypertension (OR = 2.67, 95% CI: 2.08-3.43; P<0.00001), diabetes (OR = 2.14, 95% CI: 1.76-2.6; P<0.00001), chronic respiratory disease (OR = 3.55, 95% CI: 2.65-4.76; P<0.00001), chronic heart disease/cardiovascular disease (OR = 3.15, 95% CI: 2.43-4.09; P<0.00001), elevated levels of high-sensitive cardiac troponin I (MD = 66.65, 95% CI: 16.94-116.36; P=0.009), D-dimer (MD = 4.33, 95% CI: 2.97-5.68; P<0.00001), C-reactive protein (MD = 48.03, 95% CI: 27.79-68.27; P<0.00001), and a decreased level of albumin at admission (MD = -3.98, 95% CI: -5.75 to -2.22; P<0.0001) are associated with higher risk of death. Patients who developed acute respiratory distress syndrome (OR = 62.85, 95% CI: 29.45-134.15; P<0.00001), acute cardiac injury (OR = 25.16, 95% CI: 6.56-96.44; P<0.00001), acute kidney injury (OR = 22.86, 95% CI: 4.60-113.66; P=0.0001), and septic shock (OR = 24.09, 95% CI: 4.26-136.35; P=0.0003) might have a higher in-hospital mortality.
   Conclusions: Advanced age, male, comorbidities, increased levels of acute inflammation or organ damage indicators, and complications are associated with the risk of mortality in COVID-19 patients, and should be integrated into the risk stratification system.
C1 [Wu, Yanyan; Li, Hongyu; Guo, Xiaozhong; Qi, Xingshun] Gen Hosp Northern Theater Command, Gen Hosp Shenyang Mil Area, Dept Gastroenterol, Liver Cirrhosis Study Grp, Shenyang, Peoples R China.
   [Wu, Yanyan; Li, Hongyu; Guo, Xiaozhong; Qi, Xingshun] Jinzhou Med Univ, Postgrad Coll, Jinzhou, Peoples R China.
   [Zhang, Zhongheng] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Emergency Med, Sch Med, Hangzhou, Peoples R China.
   [Liang, Wenhua] Guangzhou Med Univ, Affiliated Hosp 1, Dept Thorac Oncol & Surg, China State Key Lab Resp Dis, Guangzhou, Peoples R China.
   [Liang, Wenhua] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, Guangzhou, Peoples R China.
   [Zhang, Tiansong] Jingan Dist Cent Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China.
   [Tong, Zhenhua] Gen Hosp Northern Command, Sect Med Serv, Gen Hosp Shenyang Mil Area, Shenyang, Peoples R China.
RP Qi, XS (corresponding author), Gen Hosp Northern Theater Command, Dept Gastroenterol, Gen Hosp Shenyang Mil Area, 83 Wenhua Rd, Shenyang 110840, Peoples R China.
EM xingshunqi@126.com
RI Zhang, Zhongheng/E-1282-2011
OI Zhang, Zhongheng/0000-0002-2336-5323
CR Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
   Bonanad C, 2020, J AM MED DIR ASSOC, V21, P915, DOI 10.1016/j.jamda.2020.05.045
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen Y, 2020, BIOCHEM BIOPH RES CO, V525, P135, DOI 10.1016/j.bbrc.2020.02.071
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hasan SS, 2020, EXPERT REV RESP MED, V14, P1149, DOI 10.1080/17476348.2020.1804365
   Hradsky O, 2021, EUR J PUBLIC HEALTH, V31, P12, DOI 10.1093/eurpub/ckaa226
   Hu Y, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104371
   Jaillon S, 2019, CLIN REV ALLERG IMMU, V56, P308, DOI 10.1007/s12016-017-8648-x
   Levi M, 2017, THROMB RES, V149, P38, DOI 10.1016/j.thromres.2016.11.007
   Li R, 2020, J INFECTION, V80, P469, DOI 10.1016/j.jinf.2020.02.013
   Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705
   Lin L, 2020, EMERG MICROBES INFEC, V9, P727, DOI 10.1080/22221751.2020.1746199
   Lippi G, 2020, POL ARCH INTERN MED, V130, P304, DOI 10.20452/pamw.15272
   Lippi G, 2020, PROG CARDIOVASC DIS, V63, P390, DOI 10.1016/j.pcad.2020.03.001
   Liu, 2020, PREPRINTS, DOI 10.13140/RG.2.2.22934.29762
   Liu YX, 2020, SCI CHINA LIFE SCI, V63, P364, DOI 10.1007/s11427-020-1643-8
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   [罗蒙 Luo Meng], 2020, [中草药, Chinese Traditional and Herbal Drugs], V51, P1450
   Martins PR, 2020, EUR J INTERN MED, V76, P97, DOI 10.1016/j.ejim.2020.04.043
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Parohan M, 2020, AGING MALE, V23, P1416, DOI 10.1080/13685538.2020.1774748
   Patel SK, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00227
   Pranata R, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.104949
   Sanchis-Gomar F, 2020, MAYO CLIN PROC, V95, P1445, DOI 10.1016/j.mayocp.2020.05.006
   Sharma A, 2020, MAYO CLIN PROC, V95, P2040, DOI 10.1016/j.mayocp.2020.06.046
   Soro-Paavonen A, 2012, J HYPERTENS, V30, P375, DOI 10.1097/HJH.0b013e32834f04b6
   Sun DW, 2020, CLIN CHIM ACTA, V508, P122, DOI 10.1016/j.cca.2020.05.027
   Tian WJ, 2020, J MED VIROL, V92, P1875, DOI 10.1002/jmv.26050
   Turner AJ, 2004, TRENDS PHARMACOL SCI, V25, P291, DOI 10.1016/j.tips.2004.04.001
   Ulhaq ZS, 2020, MED MALADIES INFECT, V50, P382, DOI 10.1016/j.medmal.2020.04.002
   Vahidy FS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245556
   Vrsalovic M, 2020, J INFECTION, V81, pE99, DOI 10.1016/j.jinf.2020.05.022
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang XH, 2020, RESEARCH-CHINA, V2020, DOI 10.34133/2020/2402961
   WHO, 2020, REP WHO CHIN JOINT M
   WHO, 2020, NOV COR 2019 NCOV SI
   WHO, COR DIS 2019 COVID 1
   Wu Y Y, 2020, Zhonghua Gan Zang Bing Za Zhi, V28, P240, DOI 10.3760/cma.j.cn501113-20200224-00067
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yang JK, 2006, DIABETIC MED, V23, P623, DOI 10.1111/j.1464-5491.2006.01861.x
   Yang JK, 2010, ACTA DIABETOL, V47, P193, DOI 10.1007/s00592-009-0109-4
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 46
TC 10
Z9 10
U1 1
U2 3
PU AME PUBL CO
PI SHATIN
PA FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG
   00000, PEOPLES R CHINA
SN 2224-5820
EI 2224-5839
J9 ANN PALLIAT MED
JI Ann. Pallliat. Med.
PD MAY
PY 2021
VL 10
IS 5
BP 5069
EP +
DI 10.21037/apm-20-2557
PG 23
WC Health Care Sciences & Services
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services
GA SL9PG
UT WOS:000657245600006
PM 33894729
OA gold
DA 2022-04-20
ER

PT J
AU Lam, HY
   Ho, GTS
   Mo, DY
   Tang, V
AF Lam, H. Y.
   Ho, G. T. S.
   Mo, Daniel Y.
   Tang, Valerie
TI Enhancing data-driven elderly appointment services in domestic care
   communities under COVID-19
SO INDUSTRIAL MANAGEMENT & DATA SYSTEMS
LA English
DT Article
DE Domestic care service; Artificial intelligence of things; Fuzzy
   association rule mining; COVID-19
ID RESIDENTIAL CARE; HOME-CARE; HEALTH; QUALITY; SATISFACTION; IMPROVEMENT;
   CUSTOMER; DISEASE; SYSTEM; CHINA
AB Purpose Under the impact of Coronavirus disease 2019 (COVID-19), this paper contributes in the deployment of the Artificial Intelligence of Things (AIoT)-based system, namely AIoT-based Domestic Care Service Matching System (AIDCS), to the existing electronic health (eHealth) system so as to enhance the delivery of elderly-oriented domestic care services. Design/methodology/approach The proposed AIDCS integrates IoT and Artificial Intelligence (AI) technologies to (1) capture real-time health data of the elderly at home and (2) provide the knowledge support for decision making in the domestic care appointment service in the community. Findings A case study was conducted in a local domestic care centre which provided elderly oriented healthcare services to the elderly. By integrating IoT and AI into the service matching process of the mobile apps platform provided by the local domestic care centre, the results proved that customer satisfaction and the quality of the service delivery were improved by observing the key performance indicators of the transactions after the implementation of the AIDCS. Originality/value Following the outbreak of COVID-19, this is a new attempt to overcome the limited research done on the integration of IoT and AI techniques in the domestic care service. This study not only inherits the ability of the existing eHealth system to automatically capture and monitor the health status of the elderly in real-time but also improves the overall quality of domestic care services in term of responsiveness, effectiveness and efficiency.
C1 [Lam, H. Y.; Ho, G. T. S.; Mo, Daniel Y.; Tang, Valerie] Hang Seng Univ Hong Kong, Dept Supply Chain & Informat Management, Shatin, Hong Kong, Peoples R China.
RP Ho, GTS (corresponding author), Hang Seng Univ Hong Kong, Dept Supply Chain & Informat Management, Shatin, Hong Kong, Peoples R China.
EM georgeho@hsu.edu.hk
OI Mo, Daniel/0000-0001-8307-9065; Tang, Valerie/0000-0002-4528-1091; Lam,
   H.Y./0000-0002-5858-1894; Ho, G.T.S./0000-0002-8550-4974
CR Aburayya A., 2020, MANAG SCI LETT, V10, P1265
   Altaf W, 2017, ARTIF INTELL REV, V47, P313, DOI 10.1007/s10462-016-9483-9
   Atnafu A., 2015, ADV PUBLIC HEAL, V2015, P1, DOI [10.1155/2015/892464, DOI 10.1155/2015/892464]
   Azimi I, 2017, J AMB INTEL HUM COMP, V8, P273, DOI 10.1007/s12652-016-0387-y
   Bai, 2016, 12 SWED NAT COMP NET
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Beam AL, 2016, JAMA-J AM MED ASSOC, V316, P2368, DOI 10.1001/jama.2016.17217
   Bhargava M., 2013, INT J ADV RES COMPUT, V4, P1
   Bisio I, 2017, IEEE INTERNET THINGS, V4, P135, DOI 10.1109/JIOT.2016.2628938
   Chau PH, 2013, CLIN INTERV AGING, V8, P1167, DOI 10.2147/CIA.S49190
   Cheng Y, 2012, AGEING SOC, V32, P1277, DOI 10.1017/S0144686X11000870
   Cheng Y, 2011, SOC SCI MED, V72, P365, DOI 10.1016/j.socscimed.2010.10.008
   Chiang KF, 2016, J CLIN NURS, V25, P2008, DOI 10.1111/jocn.13231
   Chong A M, 2001, J Interprof Care, V15, P223
   Choy JC, 2016, GERONTOLOGIST, V56, P577
   Espin V, 2016, EXPERT SYST, V33, P201, DOI 10.1111/exsy.12143
   Fan YM, 2019, IEEE ACCESS, V7, P54819, DOI 10.1109/ACCESS.2019.2913189
   Giunti G, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.8996
   Hasin MAA, 2011, INT J QUAL RES, V5, P237
   Hjelmar U, 2018, SOC SCI MED, V216, P41, DOI 10.1016/j.socscimed.2018.09.029
   HKSAR, 2017, PROJ HONG KONGS HEAL
   Husain W., 2015, J ENG APPL SCI, V10, P18138
   Jiang HY, 2012, M&SOM-MANUF SERV OP, V14, P654, DOI 10.1287/msom.1120.0402
   Kamsu-Foguem B, 2013, EXPERT SYST APPL, V40, P1034, DOI 10.1016/j.eswa.2012.08.039
   Kiser Kim, 2011, Minn Med, V94, P22
   Kranenburg, 2008, INTERNET THINGS CRIT
   Kuo MH, 2016, HEALTH POLICY TECHN, V5, P131, DOI 10.1016/j.hlpt.2016.02.004
   Kvist E, 2012, EUR J AGEING, V9, P111, DOI 10.1007/s10433-012-0225-9
   Lai Y.H., 2019, INTERACT LEARN ENVIR, V1, P1
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Lian J, 2010, IEEE ENG MED BIOL, V29, P127, DOI 10.1109/MEMB.2009.935718
   Lindberg B, 2013, INT J TELEMED APPL, V2013, DOI 10.1155/2013/461829
   Maquee A, 2012, INT J SYST ASSUR ENG, V3, P175, DOI 10.1007/s13198-012-0121-x
   Mishra D, 2016, IND MANAGE DATA SYST, V116, P1331, DOI 10.1108/IMDS-11-2015-0478
   Mittal M., 2019, MENT HYG, V50, pS2
   Moeuf A, 2018, INT J PROD RES, V56, P1118, DOI 10.1080/00207543.2017.1372647
   Pangaribowo E.H., 2020, J AGING RES, V2020, P1
   Prakash P, 2010, INVEST RADIOL, V45, P202, DOI 10.1097/RLI.ob013e3181dzfeec
   Raymond L, 2005, J MANUF TECHNOL MANA, V16, P936, DOI 10.1108/17410380510627898
   Reps JM, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON DATA MINING WORKSHOP (ICDMW), P763, DOI 10.1109/ICDMW.2014.53
   Sarno R, 2020, J BIG DATA-GER, V7, DOI 10.1186/s40537-019-0277-1
   Satpathy S, 2020, J SUPERCOMPUT, V76, pS849, DOI 10.1007/s11227-019-03013-2
   Shih WF, 2018, J STAT MANAG SYST, V21, P1299, DOI 10.1080/09720510.2018.1498189
   Stojkoska BR, 2017, WIREL COMMUN MOB COM, P1, DOI 10.1155/2017/8323646
   Sumathi G, 2020, COMPUT INTELL-US, V36, P773, DOI 10.1111/coin.12269
   Tang V, 2019, IND MANAGE DATA SYST, V119, P1819, DOI 10.1108/IMDS-01-2019-0024
   Tao H., 2015, CHINESE NURSING RES, V2, P31
   Taranu I., 2016, DATABASE SYSTEMS J B, V6, P33
   Tin K Y K, 2015, Hong Kong Med J, V21, P1
   Tu MR, 2018, IND MANAGE DATA SYST, V118, P65, DOI 10.1108/IMDS-11-2016-0503
   Varghese J., 2020, J COMPOSITION THEORY, V13, P888
   Ventola C Lee, 2014, P T, V39, P356
   Vogus TJ, 2016, HUM RESOUR MANAGE R, V26, P37, DOI 10.1016/j.hrmr.2015.09.005
   Weinberg DB, 2013, HEALTH SERV RES, V48, P319, DOI 10.1111/j.1475-6773.2012.01438.x
   Wong BN, 2017, IND MANAGE DATA SYST, V117, P1426, DOI 10.1108/IMDS-08-2016-0342
   Wong CW, 2011, J POLICY PRACT INTEL, V8, P231, DOI 10.1111/j.1741-1130.2011.00318.x
   Woo J, 2011, J CLIN NURS, V20, P3463, DOI 10.1111/j.1365-2702.2011.03702.x
   Zheng H, 2019, INT J MACH LEARN CYB, V10, P2187, DOI 10.1007/s13042-018-0806-9
   Zhou HY, 2020, IEEE J BIOMED HEALTH, V24, P1541, DOI 10.1109/JBHI.2019.2953885
NR 59
TC 0
Z9 0
U1 9
U2 22
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0263-5577
EI 1758-5783
J9 IND MANAGE DATA SYST
JI Ind. Manage. Data Syst.
PD JUL 5
PY 2021
VL 121
IS 7
BP 1552
EP 1576
DI 10.1108/IMDS-07-2020-0392
EA APR 2021
PG 25
WC Computer Science, Interdisciplinary Applications; Engineering,
   Industrial
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science; Engineering
GA TF1KU
UT WOS:000646272900001
OA Bronze
DA 2022-04-20
ER

PT J
AU Huang, YE
   Zhao, N
AF Huang, Yeen
   Zhao, Ning
TI Generalized anxiety disorder, depressive symptoms and sleep quality
   during COVID-19 outbreak in China: a web-based cross-sectional survey
SO PSYCHIATRY RESEARCH
LA English
DT Article
DE COVID-19; Mental health; Anxiety; Depressive symptoms; Sleep
ID PSYCHOLOGICAL IMPACT; HOSPITAL WORKERS; SARS; IMMEDIATE; DISEASE; HEALTH
AB China has been severely affected by Coronavirus Disease 2019(COVID-19) since December, 2019. We aimed to assess the mental health burden of Chinese public during the outbreak, and to explore the potential influence factors. Using a web-based cross-sectional survey, we collected data from 7,236 self-selected volunteers assessed with demographic information, COVID-19 related knowledge, generalized anxiety disorder (GAD), depressive symptoms, and sleep quality. The overall prevalence of GAD, depressive symptoms, and sleep quality of the public were 35.1%, 20.1%, and 18.2%, respectively. Younger people reported a significantly higher prevalence of GAD and depressive symptoms than older people. Compared with other occupational group, healthcare workers were more likely to have poor sleep quality. Multivariate logistic regression showed that age (< 35 years) and time spent focusing on the COVID-19 (>= 3 hours per day) were associated with GAD, and healthcare workers were at high risk for poor sleep quality. Our study identified a major mental health burden of the public during the COVID-19 outbreak. Younger people, people spending too much time thinking about the outbreak, and healthcare workers were at high risk of mental illness. Continuous surveillance of the psychological consequences for outbreaks should become routine as part of preparedness efforts worldwide.
C1 [Huang, Yeen; Zhao, Ning] Shenzhen Univ, Nanshan Hosp, Affiliated Hosp 6, Hlth Sci Ctr, Shenzhen 518052, Peoples R China.
   [Huang, Yeen; Zhao, Ning] Huazhong Univ Sci & Technol, Union Shenzhen Hosp, Dept Rehabil Med, Shenzhen 518052, Peoples R China.
RP Zhao, N (corresponding author), Shenzhen Univ, Nanshan Hosp, Affiliated Hosp 6, Hlth Sci Ctr, Shenzhen 518052, Peoples R China.
EM zhaoning2018@email.szu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC)
FX This work was supported by the National Natural Science Foundation of
   China. The funder had no role in the design and conduct of the study;
   management, collection, analysis, and interpretation of the data;
   preparation, review, or approval of the manuscript; and decision to
   submit the manuscript for publication.
CR [Anonymous], 2020, JAPAN TIMES
   [Anonymous], 2020, PEOPLES DAILY CHINA
   Buysse D J, 1989, Psychiatry Res, V28, P193
   Furer P, 1997, Depress Anxiety, V6, P78, DOI 10.1002/(SICI)1520-6394(1997)6:2<78::AID-DA4>3.0.CO;2-1
   Gao WJ, 2020, J AFFECT DISORDERS, V263, P292, DOI 10.1016/j.jad.2019.11.121
   Grein TW, 2000, EMERG INFECT DIS, V6, P97, DOI 10.3201/eid0602.000201
   GUO XJ, 2016, SCI REP, V6, DOI DOI 10.1038/SREP28033.
   Kobayashi I, 2007, PSYCHOPHYSIOLOGY, V44, P660, DOI 10.1111/j.1469-8986.2007.537.x
   Lee AM, 2007, CAN J PSYCHIAT, V52, P233, DOI 10.1177/070674370705200405
   Lee SM, 2018, COMPR PSYCHIAT, V87, P123, DOI 10.1016/j.comppsych.2018.10.003
   Liu XC, 1996, CHINESE J PSYCHIAT, P103, DOI DOI 10.1007/BF02951625
   Lu YC, 2006, PSYCHOTHER PSYCHOSOM, V75, P370, DOI 10.1159/000095443
   Mak IWC, 2009, GEN HOSP PSYCHIAT, V31, P318, DOI 10.1016/j.genhosppsych.2009.03.001
   Maunder R, 2003, CAN MED ASSOC J, V168, P1245
   McAlonan GM, 2007, CAN J PSYCHIAT, V52, P241, DOI 10.1177/070674370705200406
   National Health Commission of the People's Republic of China, 2020, NEWS 21 569 MED STAF
   Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Su TP, 2007, J PSYCHIATR RES, V41, P119, DOI 10.1016/j.jpsychires.2005.12.006
   Tong X, 2016, EPILEPSY RES, V120, P31, DOI 10.1016/j.eplepsyres.2015.11.019
   Wang X, 2021, JAMA-J AM MED ASSOC, V325, P50, DOI 10.1001/jama.2020.23370
   Wang Y, 2018, J CLIN PSYCHIAT, V28, P168, DOI DOI 10.3969/J.ISSN.1005-3220.2018.03.007
   WHO, 2020, NOV COR 2019 NCOV SI
   World Health Organization, 2020, CURR NOV COR 2019 NC
   Wuhan Municipal Health Commission, 2020, REP NOV COR INF PNEU
   XINHUANET, 2020, LAT CHIN CONF HUM TO
   [张宝山 ZHANG BaoShan], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P506
   [章婕 ZHANG Jie], 2010, [中国心理卫生杂志, Chinese Mental Health Journal], V24, P139
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 30
TC 1302
Z9 1346
U1 83
U2 374
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-1781
EI 1872-7123
J9 PSYCHIAT RES
JI Psychiatry Res.
PD JUN
PY 2020
VL 288
AR 112954
DI 10.1016/j.psychres.2020.112954
PG 6
WC Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Psychiatry
GA LN0WN
UT WOS:000532666200017
PM 32325383
OA Green Published, Green Submitted, Bronze
DA 2022-04-20
ER

PT J
AU Imtiaz, A
   Khan, NM
   Hossain, MA
AF Imtiaz, Asif
   Khan, Noor Muhammad
   Hossain, Md. Akram
TI COVID-19 in Bangladesh: measuring differences in individual
   precautionary behaviors among young adults
SO JOURNAL OF PUBLIC HEALTH-HEIDELBERG
LA English
DT Article; Early Access
DE COVID-19; Precautionary behavior; Young adults; Self-control; Mental
   health; Health policy
ID SELF-CONTROL; RISK-TAKING; HEALTH; ATTITUDES; KNOWLEDGE; SPREAD
AB Aim The novel coronavirus disease 2019 (COVID-19) is present in Bangladesh, and various control measures have been taken to flatten the epidemic curve. Due to the current demographic distribution in Bangladesh, young adults comprise almost one-third of the total population of the country. Therefore, their precautionary behavior is very important to ensure the success of preventive policies. This exploratory study examined the differences in the adoption of precautionary behaviors among young adults, and estimated and compared the predictors of precautionary behavior adoption among young adults living in the capital city Dhaka and a nearby district, Tangail.
   Subject and methods A total of 350 respondents from each district participated in the study. ANOVA and two-sample t-tests were utilized to detect differences in precautionary behavior across demographic groups of young adults, and quantile regression modeling was used to find the predictors of adopting precautionary behaviors and to compare these predictors between the two districts.
   Results Individuals who had a postgraduate education and had good mental health tended to show better precautionary behaviors in Dhaka. Female respondents from Tangail who had no psychological distress took precautionary behaviors more often than their male counterparts. However, no significant differences in the adoption of precautionary behaviors to prevent COVID-19 among young adults were found between the two districts. Better self-control ability, higher education and good mental health emerged as factors that significantly shaped the precautionary behaviors of young adults in this study.
   Conclusion Having better knowledge did not ensure better adoption of precautionary behaviors among the participants. In effect, the government's strong intervention to keep people maintaining social distance and a strict lockdown in severely affected areas are probable immediate solutions.
C1 [Imtiaz, Asif; Hossain, Md. Akram] Univ Dhaka, Dept Management Informat Syst, Dhaka 1000, Bangladesh.
   [Khan, Noor Muhammad] Mawlana Bhashani Sci & Technol Univ, Dept Stat, Santosh 1902, Tangail, Bangladesh.
RP Imtiaz, A (corresponding author), Univ Dhaka, Dept Management Informat Syst, Dhaka 1000, Bangladesh.
EM asifimtiaz.mis@du.ac.bd
RI Khan, Noor Muhammad/AAJ-7997-2021
OI Khan, Noor Muhammad/0000-0003-4713-7277; Imtiaz,
   Asif/0000-0002-6282-5863; HOSSAIN, MD AKRAM/0000-0003-0784-6351
CR Ajilore K, 2017, HEALTH EDUC J, V76, P648, DOI 10.1177/0017896917710969
   Almutairi KM, 2015, FAM COMMUNITY HEALTH, V38, P332, DOI 10.1097/FCH.0000000000000082
   [Anonymous], 2020, 2019 NCOV OUTBR EM I
   [Anonymous], 2020, REUTERS
   [Anonymous], 2020, ABC NEWS
   BBS, 2019, BANGL SAMPL VIT STAT
   Bell DM, 2004, EMERG INFECT DIS, V10, P1900, DOI 10.3201/eid1011.040729
   Chappell B, 2020, WHO SETS 6 COND END
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117
   Duckworth AL, 2005, PSYCHOL SCI, V16, P939, DOI 10.1111/j.1467-9280.2005.01641.x
   Duell N, 2018, J YOUTH ADOLESCENCE, V47, P1052, DOI 10.1007/s10964-017-0752-y
   Gates B, 2020, NEW ENGL J MED, V382, P1677, DOI 10.1056/NEJMp2003762
   Goldberg D. P., 1972, MAUDSLEY MONOGRAPH, V21
   Goldberg DP, 1998, PSYCHOL MED, V28, P915, DOI 10.1017/S0033291798006874
   Haushofer J., 2020, COMBINING BEHAV EC I
   Hofmann W., 2008, HLTH PSYCHOL REV, V2, P111, DOI DOI 10.1080/17437190802617668
   Honda Keiko, 2005, Cancer Detect Prev, V29, P25, DOI 10.1016/j.cdp.2004.08.004
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Kharlamov A., 2020, IMPACT CROSS CULTURA, DOI [10.13140/RG.2.2.23764.96649, DOI 10.13140/RG.2.2.23764.96649]
   Kwok KO, 2020, EMERG INFECT DIS, V26, P1575, DOI 10.3201/eid2607.200500
   Lee-Baggley D, 2004, ASIAN J SOC PSYCHOL, V7, P9, DOI 10.1111/j.1467-839X.2004.00131.x
   Li JB, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134820
   Li JB, 2016, PERS INDIV DIFFER, V97, P130, DOI 10.1016/j.paid.2016.03.042
   Li JP, 2021, COMBUST SCI TECHNOL, V193, P1639, DOI 10.1080/00102202.2019.1706501
   Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]
   Lindencrona F, 2008, SOC PSYCH PSYCH EPID, V43, P121, DOI 10.1007/s00127-007-0280-2
   Liu Y, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1186
   Liu Z, 2004, PREV MED TRIB, V10, P659
   Machado JAF, 2005, J APPL ECONOMET, V20, P445, DOI 10.1002/jae.788
   McMurray, 2014, SPSS EXPLAINED, DOI [10.4324/9781315797564, DOI 10.4324/9781315797564]
   Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108
   NIPORT Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV
   Nooh HZ, 2021, J PUBLIC HEALTH-HEID, V29, P1107, DOI 10.1007/s10389-020-01209-y
   Paul, 2020, REUTERS
   Pawlowski B, 2008, EVOL PSYCHOL-US, V6, P29, DOI 10.1177/147470490800600104
   Tachfouti N, 2012, PAN AFR MED J, V12
   Tamornpark R, 2020, SSRN, DOI 10.2139/ssrn.3546046
   Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x
   Tao N., 2003, J ANHUI I ED, V21, P78
   The Daily Star, 2020, DAILY STAR
   Tromp DM, 2005, HEALTH EDUC RES, V20, P665, DOI 10.1093/her/cyh031
   Vartti AM, 2009, INT J BEHAV MED, V16, P41, DOI 10.1007/s12529-008-9004-6
   Wei Y, 2006, STAT MED, V25, P1369, DOI 10.1002/sim.2271
   Wills TA, 2008, PSYCHOL ADDICT BEHAV, V22, P459, DOI 10.1037/a0012965
   World Health Organization (WHO), 2020, COR
   Yildirim M, 2022, INT J MENT HEALTH AD, V20, P1035, DOI 10.1007/s11469-020-00424-8
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhou X, 2004, PREV MED TRIB, V10, P407
NR 50
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2198-1833
EI 1613-2238
J9 J PUBLIC HEALTH-HEID
JI J. Public Health-Heidelberg
DI 10.1007/s10389-020-01453-2
EA JAN 2021
PG 12
WC Public, Environmental & Occupational Health
WE Emerging Sources Citation Index (ESCI)
SC Public, Environmental & Occupational Health
GA PP0CG
UT WOS:000605537100003
PM 33432285
OA Green Published, Bronze, Green Submitted
DA 2022-04-20
ER

PT J
AU Triggle, CR
   Bansal, D
   Ding, H
   Islam, MM
   Abd Farag, EA
   Hadi, HA
   Sultan, AA
AF Triggle, Chris R.
   Bansal, Devendra
   Ding, Hong
   Islam, Md Mazharul
   Farag, Elmoubashar Abu Baker Abd
   Hadi, Hamad Abdel
   Sultan, Ali A.
TI A Comprehensive Review of Viral Characteristics, Transmission,
   Pathophysiology, Immune Response, and Management of SARS-CoV-2 and
   COVID-19 as a Basis for Controlling the Pandemic
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE SARS-CoV-2; COVID-19; immune response; pathophysiology; drugs; COVID
   vaccines; transmission
ID RESPIRATORY SYNDROME CORONAVIRUS; MULTISYSTEM INFLAMMATORY SYNDROME;
   SARS-CORONAVIRUS; PROTEIN; INTERFERON; VACCINE; COV; INFECTION; DISEASE;
   INNATE
AB COVID-19 emerged from China in December 2019 and during 2020 spread to every continent including Antarctica. The coronavirus, SARS-CoV-2, has been identified as the causative pathogen, and its spread has stretched the capacities of healthcare systems and negatively affected the global economy. This review provides an update on the virus, including the genome, the risks associated with the emergence of variants, mode of transmission, immune response, COVID-19 in children and the elderly, and advances made to contain, prevent and manage the disease. Although our knowledge of the mechanics of virus transmission and the immune response has been substantially demystified, concerns over reinfection, susceptibility of the elderly and whether asymptomatic children promote transmission remain unanswered. There are also uncertainties about the pathophysiology of COVID-19 and why there are variations in clinical presentations and why some patients suffer from long lasting symptoms-"the long haulers." To date, there are no significantly effective curative drugs for COVID-19, especially after failure of hydroxychloroquine trials to produce positive results. The RNA polymerase inhibitor, remdesivir, facilitates recovery of severely infected cases but, unlike the anti-inflammatory drug, dexamethasone, does not reduce mortality. However, vaccine development witnessed substantial progress with several being approved in countries around the globe.
C1 [Triggle, Chris R.; Ding, Hong] Weill Cornell Med Qatar, Qatar Fdn, Dept Pharmacol, Doha, Qatar.
   [Bansal, Devendra; Hadi, Hamad Abdel] Minist Publ Hlth, Dept Hlth Protect & Communicable Dis Control, Doha, Qatar.
   [Islam, Md Mazharul] Minist Municipal & Environm, Dept Anim Resources, Doha, Qatar.
   [Hadi, Hamad Abdel] Hamad Med Corp, Communicable Dis Ctr, Doha, Qatar.
   [Sultan, Ali A.] Cornell Univ, Weill Cornell Med, Dept Microbiol & Immunol, Doha, Qatar.
RP Sultan, AA (corresponding author), Cornell Univ, Weill Cornell Med, Dept Microbiol & Immunol, Doha, Qatar.
EM als2026@qatar-med.cornell.edu
RI islam, Mazharul/V-5971-2018; Hadi, Hamad Abdel/AAR-6325-2021
OI islam, Mazharul/0000-0002-7357-9645; Hadi, Hamad
   Abdel/0000-0001-8647-1695
FU Weill Cornell Medicine-Qatar Distributed eLibrary
FX The publication of this article was funded by the Weill Cornell
   Medicine-Qatar Distributed eLibrary.
CR A.a.P.H.I. Service, 2020, USDA STAT CONF COVID
   Abbasi J, 2020, JAMA-J AM MED ASSOC, V324, P1125, DOI 10.1001/jama.2020.16866
   Abbott A, 2020, NATURE, V585, P493, DOI 10.1038/d41586-020-02619-4
   Adams Emily R, 2020, Wellcome Open Res, V5, P139, DOI 10.12688/wellcomeopenres.15927.1
   Alfuwaires M, 2017, BIOL PHARM BULL, V40, P345, DOI 10.1248/bpb.b16-00870
   American Academy of Pediatrics, 2020, CHILDR COVID 19 STAT
   Anderson EJ, 2020, NEW ENGL J MED, V383, P2427, DOI 10.1056/NEJMoa2028436
   Angeletti S, 2020, J MED VIROL, V92, P584, DOI 10.1002/jmv.25719
   [Anonymous], 2020, CLIN SCI, DOI DOI 10.1042/CS20200623
   [Anonymous], 2021, MUTATIONS ARISING SA
   [Anonymous], 2020, FRONT PSYCHIATRY, DOI DOI 10.3389/FPSYT.2020.578628
   Arshad S, 2020, INT J INFECT DIS, V97, P396, DOI 10.1016/j.ijid.2020.06.099
   Balfour H., 2020, ASTRAZENECA TEST COM
   Barcena M, 2009, P NATL ACAD SCI USA, V106, P582, DOI 10.1073/pnas.0805270106
   Barnes GD, 2020, J THROMB THROMBOLYS, V50, P72, DOI 10.1007/s11239-020-02138-z
   Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585
   Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Belhadjer Z, 2020, CIRCULATION, V142, P429, DOI 10.1161/CIRCULATIONAHA.120.048360
   Bestle D, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000786
   Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4
   Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026
   Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4
   Bonow RO, 2020, JAMA-J AM MED ASSOC, V324, P1131, DOI 10.1001/jama.2020.15088
   Bos LDJ, 2021, JAMA INTERN MED, V181, P9, DOI 10.1001/jamainternmed.2020.6047
   Bosco-Lauth AM, 2020, P NATL ACAD SCI USA, V117, P26382, DOI 10.1073/pnas.2013102117
   Boulware DR, 2020, NEW ENGL J MED, V383, P517, DOI 10.1056/NEJMoa2016638
   Bradley BT, 2020, LANCET, V396, P320, DOI 10.1016/S0140-6736(20)31305-2
   Burbelo Peter D, 2020, medRxiv, DOI 10.1101/2020.04.20.20071423
   Burkard C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004502
   Butler D, 2017, NATURE, V541, P444, DOI 10.1038/nature.2017.21329
   Cairns E., 2020, EVALUATE ADVANTAGE
   Callaway E, 2020, NATURE, V585, P174, DOI 10.1038/d41586-020-02544-6
   CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019
   Cameron MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045842
   Cavalcanti AB, 2020, NEW ENGL J MED, V383, P2041, DOI 10.1056/NEJMoa2019014
   Centers for Disease Control Prevention, 2020, INT IMPL EM SARS COV
   Chamie J., 2020, CAUSALITY IVERMECTIN
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849
   Chen XY, 2020, CELL MOL IMMUNOL, V17, P647, DOI 10.1038/s41423-020-0426-7
   Chen YY, 2021, AGEING RES REV, V65, DOI 10.1016/j.arr.2020.101205
   Cheng HY, 2020, JAMA INTERN MED, V180, P1156, DOI 10.1001/jamainternmed.2020.2020
   Cheng YW, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108254
   Cohen J, 2020, SCIENCE, V370, P1151, DOI 10.1126/science.370.6521.1151
   Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000
   Corum Jonathan, 2020, NEW YORK TIMES
   Coutard B, 2020, ANTIVIR RES, V176, DOI 10.1016/j.antiviral.2020.104742
   Couzin-Frankel J, 2020, SCIENCE, DOI [10.1126/science.abf7779, DOI 10.1126/SCIENCE.ABF7779]
   Crooke SN, 2019, EXP GERONTOL, V124, DOI 10.1016/j.exger.2019.110632
   Cyranoski D, 2020, NATURE, V588, P548, DOI 10.1038/d41586-020-03563-z
   Cyranoski David, 2020, Nature, DOI 10.1038/d41586-020-01541-z
   Dai WH, 2020, SCIENCE, V368, P1331, DOI 10.1126/science.abb4489
   Davies NG., 2021, ESTIMATED TRANSMISSI, DOI [10.1126/science.abg3055, 10.1101/2021.02.01.21250959, DOI 10.1101/2020.12.24.20248822]
   De Maio F, 2020, MICROBES INFECT, V22, P592, DOI 10.1016/j.micinf.2020.08.006
   de Vries RD, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00338-w
   de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117
   Dixit E, 2013, ADV IMMUNOL, V117, P99, DOI 10.1016/B978-0-12-410524-9.00004-9
   Doherty M, 2016, VACCINE, V34, P6707, DOI 10.1016/j.vaccine.2016.10.025
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   doubtGOV . UK, 2020, OXFORD UNIVERSITYAST
   Drago J., 2020, THERAPEUTIC POTENTIA, DOI [10.1101/2020.11.30.20236570, DOI 10.1101/2020.11.30.20236570]
   Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018
   Fausther-Bovendo H, 2014, HUM VACC IMMUNOTHER, V10, P2875, DOI 10.4161/hv.29594
   Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680
   Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X
   Feng ZG, 2020, PEDIATR INVEST, V4, P257, DOI 10.1002/ped4.12225
   Folegatti PM, 2020, LANCET INFECT DIS, V20, P816, DOI 10.1016/S1473-3099(20)30160-2
   Freedberg DE, 2020, GASTROENTEROLOGY, V159, P1129, DOI 10.1053/j.gastro.2020.05.053
   Frieman M, 2008, VIRUS RES, V133, P101, DOI 10.1016/j.virusres.2007.03.015
   Fulop T, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01960
   Gallais F, 2021, EMERG INFECT DIS, V27, P113, DOI 10.3201/eid2701.203611
   Gandhi M, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2026913
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gibb R, 2020, NATURE, V584, P398, DOI 10.1038/s41586-020-2562-8
   Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10
   Godfred-Cato S, 2020, MMWR-MORBID MORTAL W, V69, P1074, DOI 10.15585/mmwr.mm6932e2
   Gotzinger F, 2020, LANCET CHILD ADOLESC, V4, P653, DOI 10.1016/S2352-4642(20)30177-2
   Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301
   Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Gupta A, 2020, NAT MED, V26, P1017, DOI 10.1038/s41591-020-0968-3
   Gussow Ayal B, 2020, bioRxiv, DOI 10.1101/2020.04.05.026450
   Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Han E, 2020, LANCET, V396, P1525, DOI 10.1016/S0140-6736(20)32007-9
   Haseltine W., 2020, SCI AM
   Haug N, 2020, NAT HUM BEHAV, V4, DOI 10.1038/s41562-020-01009-0
   Heald-Sargent T, 2020, JAMA PEDIATR, V174, P902, DOI 10.1001/jamapediatrics.2020.3651
   Hempel T, 2021, CHEM SCI, V12, P983, DOI 10.1039/d0sc05064d
   Henderson LA, 2020, ARTHRITIS RHEUMATOL, V72, P1059, DOI 10.1002/art.41285
   Hermine O, 2021, JAMA INTERN MED, V181, P32, DOI 10.1001/jamainternmed.2020.6820
   Hill MA, 2021, METABOLISM, V114, DOI 10.1016/j.metabol.2020.154408
   Hinton RDM., 2020, LETT AUTHORIZATION
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   HORBY P, 2020, NEW ENGL J MED, DOI 10.1101/2020.07.15.20151852
   Horby P, 2020, NEW ENGL J MED, V383, P2030, DOI 10.1056/NEJMoa2022926
   Hosseini A, 2020, BIOMED PHARMACOTHER, V132, DOI 10.1016/j.biopha.2020.110859
   Hsueh PR, 2004, CLIN MICROBIOL INFEC, V10, P1062, DOI 10.1111/j.1469-0691.2004.01009.x
   Hu WC, 2012, VIRAL IMMUNOL, V25, P277, DOI 10.1089/vim.2011.0099
   Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258
   Huertas A, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01634-2020
   Hughes S., 2020, MEDSCAPE
   Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179
   IHME Foundations, 2020, DESP VACC COVID DEAT
   Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483
   Jahun A., 2020, NEUTRALISING ANTIBOD, DOI [DOI 10.1101/2020.12.05.20241927, 2012.2005.20241927]
   Jans DA, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9092100
   Jiang L, 2020, LANCET INFECT DIS, V20, pE276, DOI 10.1016/S1473-3099(20)30651-4
   Johns Hopkins University & Medicine, 2020, COR RES CTR
   Jones Bryan E, 2020, bioRxiv, DOI 10.1101/2020.09.30.318972
   Kaddoura M, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01196
   Kindler E, 2016, CELL HOST MICROBE, V19, P139, DOI 10.1016/j.chom.2016.01.012
   King CR, 2020, J VIROL, V94, DOI 10.1128/JVI.00710-20
   Knoll MD, 2021, LANCET, V397, P72, DOI 10.1016/S0140-6736(20)32623-4
   Koopmans M, 2021, LANCET INFECT DIS, V21, P18, DOI [10.1016/1473-3099(20)30912-9, 10.1016/S1473-3099(20)30912-9]
   Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043
   Koyama T, 2020, B WORLD HEALTH ORGAN, V98, P495, DOI 10.2471/BLT.20.253591
   Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3
   Kupeferschmidt K., 2020, SCIENCE
   Lan SH, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106103
   Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z
   Leclerc Quentin J, 2020, Wellcome Open Res, V5, P83, DOI [10.12688/wellcomeopenres.15889.2, 10.12688/wellcomeopenres.15889.1]
   Libster R, 2021, NEW ENGL J MED, V384, P610, DOI 10.1056/NEJMoa2033700
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Liu M, 2020, JAMA INTERN MED, V180, P1116, DOI 10.1001/jamainternmed.2020.1764
   Logunov DY, 2020, LANCET, V396, P887, DOI 10.1016/S0140-6736(20)31866-3
   Lokugamage KG, 2020, J VIROL, V94, DOI [10.1128/JVI.01410-20, 10.1101/2020.03.07.982264]
   Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6
   Lopes LR, 2020, BRAZ J MICROBIOL, V51, P1593, DOI 10.1007/s42770-020-00321-1
   Lu W, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20052
   Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073
   Lucchese G, 2020, CELL MOL IMMUNOL, V17, P539, DOI 10.1038/s41423-020-0377-z
   Lumley SF, 2021, NEW ENGL J MED, V384, P533, DOI 10.1056/NEJMoa2034545
   Mackenzie JS, 2020, MICROBIOL AUST, V41, P45, DOI 10.1071/MA20013
   Madu IG, 2009, J VIROL, V83, P7411, DOI 10.1128/JVI.00079-09
   Maisonnasse P, 2020, NATURE, V585, P584, DOI 10.1038/s41586-020-2558-4
   Mantlo Emily, 2020, bioRxiv, DOI 10.1101/2020.04.02.022764
   Marshall M, 2020, NATURE, V585, P339, DOI 10.1038/d41586-020-02598-6
   Martinez-Fleta P, 2020, J IMMUNOL, V205, P3130, DOI 10.4049/jimmunol.2000842
   Maruggi G, 2019, MOL THER, V27, P757, DOI 10.1016/j.ymthe.2019.01.020
   McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991
   McGregor G, 2020, FORTUNE
   Menachery VD, 2017, CURR OPIN VIROL, V23, P1, DOI 10.1016/j.coviro.2017.01.002
   Merler S., 2020, PROBABILITY SYMPTOMS
   Millet JK, 2015, VIRUS RES, V202, P120, DOI 10.1016/j.virusres.2014.11.021
   Minakshi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008342
   Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038
   Morawska L, 2020, CLIN INFECT DIS, V71, P2311, DOI 10.1093/cid/ciaa939
   Morens DM, 2020, CELL, V182, P1077, DOI 10.1016/j.cell.2020.08.021
   Mueller AL, 2020, AGING-US, V12, P9959, DOI 10.18632/aging.103344
   Mulligan MJ, 2020, NATURE, V586, P589, DOI 10.1038/s41586-020-2639-4
   Munnink Bas B. Oude, 2021, Science (Washington D C), V371, P172, DOI 10.1126/science.abe5901
   Munoz-Fontela C, 2020, NATURE, V586, P509, DOI 10.1038/s41586-020-2787-6
   Nakra NA, 2020, CHILDREN-BASEL, V7, DOI 10.3390/children7070069
   National Institutes of Health, 2020, ANT THER PAT COVID 1
   National Institutes of Health, 2020, PHAS 3 TRIAL NOV INV
   Nebehay S., 2020, ONE 7 REPORTED COVID
   Neuman BW, 2006, J VIROL, V80, P7918, DOI 10.1128/JVI.00645-06
   Nicholson TW, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2446
   Norman DC, 2000, CLIN INFECT DIS, V31, P148, DOI 10.1086/313896
   O'Hare R., 2020, IMPERIALS COVID 19 V
   OIE, 2021, COVID 19 PORTAL
   Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841
   Ortega JT, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10060954
   Pachetti M, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02344-6
   Pandey S, 2020, DIABETES METAB SYND, V14, P1921, DOI 10.1016/j.dsx.2020.09.027
   Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243
   Parr JB, 2021, JAMA INTERN MED, V181, P12, DOI 10.1001/jamainternmed.2020.6557
   Parri N, 2020, NEW ENGL J MED, V383, P187, DOI 10.1056/NEJMc2007617
   Peck KM, 2015, ANNU REV VIROL, V2, P95, DOI 10.1146/annurev-virology-100114-055029
   Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]
   Pfaender Stephanie, 2020, bioRxiv, DOI 10.1101/2020.03.05.979260
   Piazza G, 2020, JAMA-J AM MED ASSOC, V324, P2548, DOI 10.1001/jama.2020.23422
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Poland GA, 2020, LANCET, V396, P1595, DOI 10.1016/S0140-6736(20)32137-1
   Pooja RM., 2020, ARXIV201200653V1
   Posfay-Barbe KM, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-1576
   Potter C, 2020, ZERO COVID 19 DEATHS
   ProMed-mail, 2020, PROAHEDR COVID 19 UP
   Pruijssers Andrea J, 2020, bioRxiv, DOI 10.1101/2020.04.27.064279
   Ramasamy MN, 2020, LANCET, V396, P1979, DOI 10.1016/S0140-6736(20)32466-1
   Rambaut A., 2020, ARTIC NETW
   Ratmann, 2021, TRANSMISSION SARS CO
   Rauch S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01963
   Riphagen S, 2020, LANCET, V6736, P2019, DOI [DOI 10.1016/S0140-6736(20)31094-1, 10.1016/S0140-6736(20)31094-1]
   Risch, 2020, RANDOMIZED CONTROLLE, DOI [10.1101/2020.09.30.20204693, DOI 10.1101/2020.09.30.20204693]
   Roback JD, 2020, JAMA-J AM MED ASSOC, V323, P1561, DOI 10.1001/jama.2020.4940
   Roltgen Katharina, 2020, medRxiv, DOI 10.1101/2020.08.15.20175794
   Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630
   Sattler A, 2020, J CLIN INVEST, V130, DOI 10.1172/JCI140965
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Schafer SK, 2020, PSYCHOTHER PSYCHOSOM, V89, P386, DOI 10.1159/000510752
   Schlottau K, 2020, LANCET MICROBE, V1, pE218, DOI 10.1016/S2666-5247(20)30089-6
   Schuez-Havupalo L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014635
   Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017
   Shaman J., 2020, COVID 19 TRANSMISSON, DOI [10.1101/2020.09.08.20190710, DOI 10.1101/2020.09.08.20190710]
   Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117
   Sharma O, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.585354
   Shekerdemian LS, 2020, JAMA PEDIATR, V174, P868, DOI 10.1001/jamapediatrics.2020.1948
   Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783
   Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005
   Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015
   Shi Y, 2020, J ZHEJIANG UNIV-SC B, V21, P343, DOI 10.1631/jzus.B2000083
   Shin D, 2020, NATURE, V587, P657, DOI 10.1038/s41586-020-2601-5
   Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5
   Siemieniuk RAC, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2980
   Sikkema RS, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S095026881800345X, 10.1017/s0950268819000669]
   Simon AK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3085
   Singh AK, 2020, DIABETES METAB SYND, V14, P303, DOI 10.1016/j.dsx.2020.04.004
   Sinha P, 2020, JAMA INTERN MED, V180, P1152, DOI 10.1001/jamainternmed.2020.3313
   Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227
   Smorenberg A, 2021, EUR J INTERN MED, V83, P1, DOI 10.1016/j.ejim.2020.11.024
   Spinner CD, 2020, JAMA-J AM MED ASSOC, V324, P1048, DOI 10.1001/jama.2020.16349
   Sriram K, 2020, P NATL ACAD SCI USA, V117, P29274, DOI 10.1073/pnas.2009875117
   Stanifer ML, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107863
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   Sudharsanan N, 2020, ANN INTERN MED, V173, P714, DOI 10.7326/M20-2973
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Tegally H., 2020, EMERGENCE RAPID SPRE, DOI [10.1101/2020.12.21.20248640, DOI 10.1101/2020.12.21.20248640]
   Thiel V, 2008, CYTOKINE GROWTH F R, V19, P121, DOI 10.1016/j.cytogfr.2008.01.001
   Tikkinen KAO, 2020, NAT MED, V26, P1671, DOI 10.1038/s41591-020-1077-z
   Tortorici MA, 2019, ADV VIRUS RES, V105, P93, DOI 10.1016/bs.aivir.2019.08.002
   Toubiana J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2094
   Trial Site, 2020, TRIAL SITE NEWS
   Trial Site, 2021, ELI LILLYS MONOCLONA
   US Department of Health and Human Services, 2020, FACT SHEET EXPL OP W
   van der Made CI, 2020, JAMA-J AM MED ASSOC, V324, P663, DOI 10.1001/jama.2020.13719
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Varadhan R, 2014, J GERONTOL A-BIOL, V69, P165, DOI 10.1093/gerona/glt023
   Venturini E, 2020, ITAL J PEDIATR, V46, DOI 10.1186/s13052-020-00900-w
   Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X
   Vestergaard LS, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.26.2001214
   Vidal, 2020, THE GUARDIAN
   Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1
   Vrieze DJ, 2020, SCIENCE, DOI [10.1126/science.abg2359, DOI 10.1126/SCIENCE.ABG2359]
   Vuong W, 2020, NAT COMMUN, V11, DOI [10.1038/s41467-020-18096-2, 10.13018/BMR50262]
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wang F, 2020, J INFECT DIS, V221, P1762, DOI 10.1093/infdis/jiaa150
   Wang LF, 2007, CURR TOP MICROBIOL, V315, P325
   Wang N, 2020, PHYTOMEDICINE, V79, DOI 10.1016/j.phymed.2020.153333
   Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9
   Wathelet MG, 2007, J VIROL, V81, P11620, DOI 10.1128/JVI.00702-07
   Weinreich DM, 2021, NEW ENGL J MED, V384, P238, DOI 10.1056/NEJMoa2035002
   Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369
   WHO, 2021, OR SARS COV 2 VIR
   WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184
   Wise J, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4857
   Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3
   World Health Organization, 2020, SARS COV 2 VARI
   World Health Organization, 2020, COVID 19 VIRT PRESS
   Wu LP, 2007, EMERG INFECT DIS, V13, P1562, DOI 10.3201/eid1310.070576
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xia SL, 2020, JAMA-J AM MED ASSOC, V324, P951, DOI 10.1001/jama.2020.15543
   Yonker LM, 2020, J PEDIATR-US, V227, P45, DOI 10.1016/j.jpeds.2020.08.037
   Zeng H, 2020, JAMA-J AM MED ASSOC, V323, P1848, DOI 10.1001/jama.2020.4861
   Zhang P, 2020, CIRC RES, V126, P1671, DOI 10.1161/CIRCRESAHA.120.317134
   Zhang Q., 2020, SARS COV 2 NEUTRALIZ, DOI [10.1101/2020.04.01.021196, DOI 10.1101/2020.04.01.021196]
   Zhang RY, 2020, P NATL ACAD SCI USA, V117, P14857, DOI 10.1073/pnas.2009637117
   Zhao S, 2020, J CARDIOTHOR VASC AN, V34, P1125, DOI 10.1053/j.jvca.2020.02.039
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu FC, 2020, LANCET, V396, P479, DOI 10.1016/S0140-6736(20)31605-6
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 266
TC 26
Z9 29
U1 11
U2 19
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD FEB 26
PY 2021
VL 12
AR 631139
DI 10.3389/fimmu.2021.631139
PG 23
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA QV1TI
UT WOS:000627760200001
PM 33717166
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Chan, NN
   Ong, KW
   Siau, CS
   Lee, KW
   Peh, SC
   Yacob, S
   Chia, YC
   Seow, VK
   Ooi, PB
AF Chan, Nee Nee
   Ong, Khang Wei
   Siau, Ching Sin
   Lee, Kai Wei
   Peh, Suat Cheng
   Yacob, Shakila
   Chia, Yook Chin
   Seow, Vei Ken
   Ooi, Pei Boon
TI The lived experiences of a COVID-19 immunization programme: vaccine
   hesitancy and vaccine refusal
SO BMC PUBLIC HEALTH
LA English
DT Article
DE COVID-19 Immunization Programme; Lived Experiences; Vaccine Hesitancy;
   Vaccine Refusal; Malaysia
AB Background The COVID-19 pandemic has resulted in a global health emergency and lock-down measures to curb the uncontrolled transmission chain. Vaccination is an effective measure against COVID-19 infections. In Malaysia amidst the national immunisation programme (NIP) which started in February 2021, there were rising concerns regarding the prevalence of vaccine hesitancy and refusal, and therefore, vaccine uptake among Malaysians. Although there are many quantitative studies on COVID-19 vaccination, the subjective experience of individuals was understudied. This study aims to explore the lived experiences of Malaysians regarding vaccine hesitancy and refusal, and facilitating factors that could enhance vaccine acceptance and uptake. Methods This qualitative study employed the hermeneutic phenomenological study design. Purposive sampling strategies were used to recruit Malaysians that had direct experiences with friends, family members and their community who were hesitating or refusing to accept the COVID-19 vaccines. A semi-structured interview guide was developed based on the expert knowledge of the investigators and existing literature on the topic. A series of focus group interviews (FGIs) was conducted online facilitated by a multidisciplinary team of experts. The group interviews were transcribed verbatim and analysed. Results Fifty-nine participants took part in seven FGIs. We found that "incongruence" was the overall thematic meaning that connected all the 3 main themes. These themes comprise firstly, the incongruence between the aims and implementation of the National Immunization Program which highlighted the gap between realities and needs on the ground. Secondly, the incongruence between Trust and Mistrust revealed a trust deficit in the government, COVID-19 news, and younger people's preference to follow the examples of local vaccination "heroes". Thirdly, the incongruence in communication showed the populace's mixed views regarding official media and local social media. Conclusions This study provided rich details on the complex picture of the COVID-19 immunization program in Malaysia and its impact on vaccine hesitancy and refusal. The inter-related and incongruent factors explained the operational difficulty and complexity of the NIP and the design of an effective health communication campaign. Identified gaps such as logistical implementation and communication strategies should be noted by policymakers in implementing mitigation plans.
C1 [Chan, Nee Nee] Quest Int Univ, Fac Social Sci, Dept English & Educ, Ipoh 30250, Perak, Malaysia.
   [Chan, Nee Nee] UCSI Univ, Fac Social Sci & Liberal Arts, Kuala Lumpur 56000, Malaysia.
   [Ong, Khang Wei] Quest Int Univ, Dept Pharmacol, Fac Med, Ipoh 30250, Perak, Malaysia.
   [Siau, Ching Sin] Univ Kebangsaan Malaysia, Fac Hlth Sci, Ctr Community Hlth Studies ReaCH, Kuala Lumpur 50300, Malaysia.
   [Lee, Kai Wei] Univ Tunku Abdul Rahman, Fac Med & Hlth Sci, Dept Preclin Sci, Kajang 43000, Malaysia.
   [Lee, Kai Wei] Univ Tunku Abdul Rahman, Ctr Res Communicable Dis, Kajang 43000, Malaysia.
   [Peh, Suat Cheng] Sunway Univ, Jeffrey Sachs Ctr Sustainable Dev, Bandar Sunway, Malaysia.
   [Peh, Suat Cheng; Chia, Yook Chin; Ooi, Pei Boon] Sunway Univ, Sch Med & Life Sci, Dept Med Sci, Bandar Sunway 47500, Selangor, Malaysia.
   [Yacob, Shakila] Univ Malaya, Fac Arts & Social Sci, Dept Hist, Kuala Lumpur 50603, Malaysia.
   [Yacob, Shakila] Univ Malaya, Int Inst Publ Policy & Management INPUMA, Kuala Lumpur 50603, Malaysia.
   [Chia, Yook Chin] Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur 50603, Malaysia.
   [Seow, Vei Ken] Sunway Med Ctr, Emergency Med Dept, Bandar Sunway 47500, Selangor, Malaysia.
RP Ooi, PB (corresponding author), Sunway Univ, Sch Med & Life Sci, Dept Med Sci, Bandar Sunway 47500, Selangor, Malaysia.; Seow, VK (corresponding author), Sunway Med Ctr, Emergency Med Dept, Bandar Sunway 47500, Selangor, Malaysia.
EM seowvk@sunway.com.my; peiboono@sunway.edu.my
RI Yacob, Shakila/B-9733-2010
OI Yacob, Shakila/0000-0002-2998-0255
FU Sunway Medical Centre, Malaysia; Sunway University, Malaysia
   [SRB/IIR/SMC/F/21/001]
FX This research was funded by Sunway Medical Centre, Malaysia and Sunway
   University, Malaysia. Grant ID: SRB/IIR/SMC/F/21/001.
CR Adil MT, 2021, POSTGRAD MED J, V97, P110, DOI 10.1136/postgradmedj-2020-138386
   Agarwal R, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2107873118
   Alwi SARS, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11071-6
   Aschwanden C, 2021, NATURE, V591, P520, DOI 10.1038/d41586-021-00728-2
   Bedford H, 2018, VACCINE, V36, P6556, DOI 10.1016/j.vaccine.2017.08.004
   Betsch C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208601
   Bradbury-Jones C, 2009, J ADV NURS, V65, P663, DOI 10.1111/j.1365-2648.2008.04922.x
   Brown K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019381
   Clancy Marie, 2013, Nurse Res, V20, P12
   Dabla-Norris E, 2021, IMF WORKING PAPERS, V2021
   DiGiovanni C., 2003, BIOSECUR BIOTERROR, V2004, P2
   Dubowitz T, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08507-w
   Fadda M, 2017, J PUBLIC HEALTH RES, V6, P100, DOI 10.4081/jphr.2017.955
   Gadamer HG., 2014, TRUTH METHOD
   Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87
   Gonzalez-Melado F., 2020, ENFERM INFEC MICR CL, DOI [10.1016/j.eimc.2020.08.001, DOI 10.1016/J.EIMC.2020.08.001]
   Government of Malaysia, 2021, MYSEJAHTERA
   Heidegger M., 1998, BEING TIME
   Islam MS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251605
   Jacobson Sheldon H., WHY COVID 19 HERD IM, P2021
   Jemima M., FORBES, P2021
   Joschka M., 2021, STATISTA
   June LFW LCTHWY, 2020, FACTORS INFLUENCING
   Kementerian Kesihatan Malaysia, 2020, HAS TINJ VAKS COVID
   Kupferschmidt K, 2020, SCIENCE, V367, P1412, DOI 10.1126/science.367.6485.1412
   Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081
   Lee HG, 2021, THE STAR
   Lee K, 2009, GLOB INST, P1
   Lincoln Y.S., 2006, NATURALISTIC INQUIRY
   Luo MY, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-019-7841-7
   Luz PM, 2017, VACCINE, V35, P5890, DOI 10.1016/j.vaccine.2017.08.078
   MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036
   Machingaidze S, 2021, NAT MED, V27, P1338, DOI 10.1038/s41591-021-01459-7
   Marco-Franco JE, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020744
   Ministry of Health Malaysia, COVIDNOW MAL
   Neubauer BE, 2019, PERSPECT MED EDUC, V8, P90, DOI 10.1007/s40037-019-0509-2
   Ogilvie GS, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11098-9
   Palamenghi L, 2020, EUR J EPIDEMIOL, V35, P785, DOI 10.1007/s10654-020-00675-8
   Quite impossible, 2021, CHANNELNEWSASIA
   Roberts RJ, 2016, HUM VACC IMMUNOTHER, V12, P2704, DOI 10.1080/21645515.2016.1217141
   ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203
   Rowe R, 2006, EUR J PUBLIC HEALTH, V16, P4, DOI 10.1093/eurpub/ckl004
   Safeek AR, 2021, NEW STRAITS TIMES
   Shimabukuro T, 2021, MMWR-MORBID MORTAL W, V70, P46, DOI 10.15585/mmwr.mm7002e1
   STEPHANIE L, 2021, THE STAR
   The Special Committee For Ensuring Access To COVID-19 Vaccine Supply (JKJAV), NAT COVID 19 IMM PRO, P2021
   Thomson A, 2016, VACCINE, V34, P1018, DOI 10.1016/j.vaccine.2015.11.065
   Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042
   TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124
   van der Weerd W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-575
   Wagner CE, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.614113
   Ward PR, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00022
   Welsh KJ, 2021, VACCINE, V39, P3329, DOI 10.1016/j.vaccine.2021.04.054
   WHO, 2021, STAT 2 M INT HLTH RE
   Wong LP, 2020, HUM VACC IMMUNOTHER, V16, P1511, DOI 10.1080/21645515.2019.1706935
   World Health Organization, 2021, STAT COVID 19 VACC W
   Wui KLT, 2020, J KOMUN, V36, P194, DOI 10.17576/JKMJC-2020-3604-12
   Wyller TB, 2021, TIDSSKRIFT NORSKE LE, V141, P1
   YOURSAY, 2021, MALAYSIAKINI
   Zakaria Z, 2021, ACTA NEUROCHIR, V163, P2359, DOI 10.1007/s00701-021-04860-w
NR 60
TC 0
Z9 0
U1 5
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD FEB 14
PY 2022
VL 22
IS 1
AR 296
DI 10.1186/s12889-022-12632-z
PG 13
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA YY9WF
UT WOS:000755134900015
PM 35164734
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Chen, YN
   Dai, YQ
   Liu, AY
   Liu, W
   Jia, L
AF Chen, Yining
   Dai, Yaqin
   Liu, Anyu
   Liu, Wei
   Jia, Lei
TI Can the COVID-19 risk perception affect tourists' responsible behavior
   intention: an application of the structural equation model
SO JOURNAL OF SUSTAINABLE TOURISM
LA English
DT Article; Early Access
DE COVID-19; KAP model; theory of planned behavior; responsible tourism
   behavior; propensity score weighting; PLS-SEM
ID PROTECTION MOTIVATION THEORY; REASONED ACTION APPROACH; PREVENTION
   MEASURES; PLANNED BEHAVIOR; PERCEIVED RISK; KNOWLEDGE; ATTITUDES;
   VISITORS; METAANALYSIS; MANAGEMENT
AB Responsible tourism has received great attention as a recovery strategy post COVID-19 in the tourism industry. The originality of this study is the integration of knowledge-attitude-practice theory and theory of planned behavior to disclose how knowledge influences responsible tourism behavior intention and the development of a new scale of responsible tourism behavior in the post COVID-19 era. By using a mixed-methods approach with quota sampling, a propensity score weighting structure equation model is adopted to examine the behavior developed scales and proposed framework. From a methodological perspective, the propensity score weighting structural equation model was adopted to address the sampling bias in the non-probability sampling, which is a supplement and deepening of the research methods in tourism economics. This study finds that the responsible behavioral intention is partially mediated by the knowledge in travel risk. Behavioral attitude and subjective norm are the mediators and their indirect effects are causally moderated by tourists' past travel experience. Finally, the theoretical and practical implications of the findings are discussed.
C1 [Chen, Yining; Dai, Yaqin; Jia, Lei] Beijing Jiaotong Univ, Sch Econ & Management, Siyuan East Bldg, Beijing 100044, Peoples R China.
   [Liu, Anyu] Univ Surrey, Sch Hospitality & Tourism Management, Fac Arts & Social Sci, Guildford, Surrey, England.
   [Liu, Wei] Univ Essex, Essex Business Sch, Colchester, Essex, England.
RP Dai, YQ (corresponding author), Beijing Jiaotong Univ, Sch Econ & Management, Siyuan East Bldg, Beijing 100044, Peoples R China.
EM 19120729@bjtu.edu.cn
FU Beijing-Shanghai high speed railway tourism product development and
   industrialization innovation market model research project
FX This work was supported by Beijing-Shanghai high speed railway tourism
   product development and industrialization innovation market model
   research project.
CR AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Ajzen I., 1980, UNDERSTANDING ATTITU
   Ajzen I., 2006, CONSTRUCTING THEORY
   Ajzen I., 2010, PREDICTING CHANGING
   Aro AR, 2009, INT J BEHAV MED, V16, P68, DOI 10.1007/s12529-008-9003-7
   Bamberg S, 2007, J ENVIRON PSYCHOL, V27, P14, DOI 10.1016/j.jenvp.2006.12.002
   Caruana R, 2014, ANN TOURISM RES, V46, P115, DOI 10.1016/j.annals.2014.03.006
   Chang W, 2020, INT J CONTEMP HOSP M, V32, P2117, DOI 10.1108/IJCHM-06-2019-0551
   Cherry CC, 2016, TRAVEL MED INFECT DI, V14, P475, DOI 10.1016/j.tmaid.2016.08.011
   CHURCHILL GA, 1979, J MARKETING RES, V16, P64, DOI 10.2307/3150876
   Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI 10.4324/9780203771587
   Dai Y.J., 2020, CHIN J PUBLIC HLTH, V36, P227
   Denton G, 2020, INT J HOSP MANAG, V90, DOI 10.1016/j.ijhm.2020.102608
   Field A., 2017, DISCOVERING STAT USI, V5th ed.
   Fishbein M, 2008, MED DECIS MAKING, V28, P834, DOI 10.1177/0272989X08326092
   Foroudi P, 2021, INT J HOSP MANAG, V92, DOI 10.1016/j.ijhm.2020.102717
   Frey N, 2010, TOURISM MANAGE, V31, P621, DOI 10.1016/j.tourman.2009.06.017
   Goodwin H., 2014, ETHICS TOURISM CRITI
   Goodwin H., 2016, RESPONSIBLE TOURISM
   Goodwin H., 2001, RESPONSIBLE TOURISM
   Grimwood BSR, 2015, ANN TOURISM RES, V50, P22, DOI 10.1016/j.annals.2014.10.006
   Hair J.F., 2014, PRIMER PARTIAL LEAST
   Hair JF, 2020, J BUS RES, V109, P101, DOI 10.1016/j.jbusres.2019.11.069
   Han H, 2017, J SUSTAIN TOUR, V25, P1240, DOI 10.1080/09669582.2016.1259318
   Han H, 2015, INT J HOSP MANAG, V45, P22, DOI 10.1016/j.ijhm.2014.11.004
   Han H, 2010, TOURISM MANAGE, V31, P325, DOI 10.1016/j.tourman.2009.03.013
   Han JH, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8070644
   Hu H, 2018, WASTE MANAGE, V79, P273, DOI 10.1016/j.wasman.2018.07.047
   Im J, 2021, J DESTIN MARK MANAGE, V20, DOI 10.1016/j.jdmm.2021.100566
   Jenkins I., 2013, SUSTAINABILITY TOURI, DOI [https://doi.org/10.1007/978-3-8349-7043-5, DOI 10.1007/978-3-8349-7043-5]
   Kock F, 2020, ANN TOURISM RES, V85, DOI 10.1016/j.annals.2020.103053
   Kowalczuk P, 2021, J BUS RES, V124, P357, DOI 10.1016/j.jbusres.2020.10.050
   Krippendorf J., 1987, HOLIDAY MAKERS UNDER
   Lee CK, 2012, TOURISM MANAGE, V33, P89, DOI 10.1016/j.tourman.2011.02.006
   Lee HY, 2017, TOURISM MANAGE, V60, P298, DOI 10.1016/j.tourman.2016.12.003
   Lee TH, 2015, J SUSTAIN TOUR, V23, P1063, DOI 10.1080/09669582.2015.1032298
   Lepp A, 2003, ANN TOURISM RES, V30, P606, DOI 10.1016/S0160-7383(03)00024-0
   Li X, 2021, J HOSP TOUR MANAG, V46, P172, DOI 10.1016/j.jhtm.2020.12.006
   Lin YH, 2020, J SUSTAIN TOUR, V28, P705, DOI 10.1080/09669582.2019.1701679
   Liu AY, 2021, ANN TOURISM RES, V88, DOI 10.1016/j.annals.2021.103182
   Liu JY, 2019, TOUR MANAG PERSPECT, V31, P236, DOI 10.1016/j.tmp.2019.05.007
   MADDEN TJ, 1992, PERS SOC PSYCHOL B, V18, P3, DOI 10.1177/0146167292181001
   McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4
   Miao L, 2021, ANN TOURISM RES, V88, DOI 10.1016/j.annals.2021.103159
   Mihalic T, 2016, J CLEAN PROD, V111, P461, DOI 10.1016/j.jclepro.2014.12.062
   Mody M, 2014, TOUR MANAG PERSPECT, V12, P113, DOI 10.1016/j.tmp.2014.09.008
   MOUTINHO L, 1987, EUR J MARKETING, V21, P1, DOI 10.1108/EUM0000000004718
   Park T, 2021, RES SOC ADMIN PHARM, V17, P1859, DOI 10.1016/j.sapharm.2020.06.004
   Piyaphanee W, 2009, J TRAVEL MED, V16, P101, DOI 10.1111/j.1708-8305.2008.00282.x
   Qiu HongLiang, 2017, Tourism Tribune, V32, P75
   Qiu RTR, 2021, ANN TOURISM RES, V88, DOI 10.1016/j.annals.2021.103155
   Roehl W. S., 1992, Journal of Travel Research, V30, P17, DOI 10.1177/004728759203000403
   ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803
   ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41
   Seabra C, 2013, TOURISM MANAGE, V36, P502, DOI 10.1016/j.tourman.2012.09.008
   Seyitoglu F, 2021, CURR ISSUES TOUR, V24, P1631, DOI 10.1080/13683500.2020.1774518
   Shin H, 2020, INT J HOSP MANAG, V91, DOI 10.1016/j.ijhm.2020.102664
   Si HY, 2021, SUSTAIN CITIES SOC, V65, DOI 10.1016/j.scs.2020.102626
   Sonmez S. F., 1998, Journal of Travel Research, V37, P171, DOI 10.1177/004728759803700209
   Sridhar S, 2016, TRAVEL MED INFECT DI, V14, P360, DOI 10.1016/j.tmaid.2016.05.012
   Stanford D, 2008, J SUSTAIN TOUR, V16, P258, DOI [10.2167/jost788.0, 10.1080/09669580802154082]
   Stieger JR, 2021, CEREB CORTEX, V31, P426, DOI 10.1093/cercor/bhaa234
   Su LJ, 2018, J BUS RES, V86, P179, DOI 10.1016/j.jbusres.2018.02.011
   Prasetyo YT, 2020, INT J INFECT DIS, V99, P312, DOI 10.1016/j.ijid.2020.07.074
   United Nations World Tourism Organization, 2020, GLOB COD ETH TOUR
   United Nations World Tourism Organization, 2020, COVID 1 19 TRANSF TO
   Wang SY, 2020, WASTE MANAGE, V113, P41, DOI 10.1016/j.wasman.2020.05.031
   Wilcox S, 1999, HEALTH PSYCHOL, V18, P346, DOI 10.1037/0278-6133.18.4.346
   Zheng DN, 2022, J TRAVEL RES, V61, P581, DOI 10.1177/0047287521995562
   Zhou L.Q., 2014, J ZHEJIANG U HUMANIT, V44, P88, DOI DOI 10.3785/J.ISSN.1008-942X.2013.09.251
NR 70
TC 0
Z9 0
U1 26
U2 31
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0966-9582
EI 1747-7646
J9 J SUSTAIN TOUR
JI J. Sustain. Tour.
DI 10.1080/09669582.2021.1977938
EA SEP 2021
PG 20
WC Green & Sustainable Science & Technology; Hospitality, Leisure, Sport &
   Tourism
WE Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Social Sciences - Other Topics
GA UQ3UV
UT WOS:000695993200001
DA 2022-04-20
ER

PT J
AU Ramirez-Montoya, MS
AF Ramirez-Montoya, Maria-Soledad
TI Digital transformation and educational innovation in Latin America
   within the framework of COVID-19
SO CAMPUS VIRTUALES
LA Spanish
DT Article
DE Educational innovation; Digital transformation; Open education;
   COVID-19; Educational research
AB The health contingency showed responses of digital transformation and pending subjects of educational innovation in the university environments of Latin America. This article aims to present the responses that were held in Latin American universities as a result of COVID-19, as well as the challenges for a future that is already part of the present. We worked with the methodology of multiple case studies with an instrumental approach, with descriptive and categorical analyses in Argentina, Chile, Colombia, Costa Rica, Ecuador, Mexico, Peru, Dominican Republic, Uruguay and Venezuela. The findings address the challenges of digital transformation (virtualization, training, infrastructure, connectivity, culture, management, open education) and educational innovation (new processes, products, services, knowledge and research). This article is intended to be of value to decision makers, the academic community and society in general, with an invitation for solidarity commitment.
C1 [Ramirez-Montoya, Maria-Soledad] Tecnol Monterrey, Monterrey, Mexico.
RP Ramirez-Montoya, MS (corresponding author), Tecnol Monterrey, Monterrey, Mexico.
EM solramirez@tec.mx
CR Abad-Segura E, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12052107
   Akhmetshin E.M., 2019, INT J ENG ADV TECHNO, V9, P7387
   Bozhko YV, 2016, COMM COM INF SC, V674, P386, DOI 10.1007/978-3-319-49700-6_37
   Branch J.W., 2020, RADICAL SOLUTIONS EL, P41
   Cano L. d., 2019, INT WORKSH HIGH ED L, P179
   Benavides LMC, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20113291
   Datta Pratim, 2020, Journal of Information Technology Teaching Cases, V10, P54, DOI 10.1177/2043886920910437
   Kuhn S, 2018, RADIOLOGE, V58, P236, DOI 10.1007/s00117-017-0351-7
   Kuzminska o., 2019, INT C INF COMM TECHN, P210, DOI [10.1007/978-3-030-39459-2_10., DOI 10.1007/978-3-030-39459-2_10]
   Kuzu O. h., 2020, DIGITAL TRANSFORMATI, V29, P9, DOI [10.31992/0869-3617-2019-29-3-9-23., DOI 10.31992/0869-3617-2019-29-3-9-23]
   Maxwell J., 2005, QUALITATIVE RES DESI, V2nd
   Minina A, 2019, PROCEEDINGS OF THE 2019 IEEE COMMUNICATION STRATEGIES IN DIGITAL SOCIETY SEMINAR (2019 COMSDS), P117, DOI 10.1109/COMSDS.2019.8709652
   Perez Gama J. A., 2018, P LACCEI INT MULTICO, DOI [10.18687/LACCEI2018.1.1.274, DOI 10.18687/LACCEI2018.1.1.274]
   Prensky M., 2009, INNOV J ONLINE ED, V5, P3
   Ramirez-Montoya M. S., 2019, INNOVACION ED TENDEN
   Ramirez-Montoya M. S., 2017, INNOVACION ED INVEST
   Ramirez-Montoya MS, 2020, COMUNICAR, V28, P9, DOI 10.3916/C65-2020-01
   Sirotkina N, 2019, EDUCATION EXCELLENCE AND INNOVATION MANAGEMENT THROUGH VISION 2020, P8970
   Stake R., 2007, INVESTIGACION CON ES
   Traxler J., 2012, LINKING RES PRACTICE, P68
   UNESCO, 2015, UNESCO OBJETIVOS DES
   Yin R.K., 2013, CASE STUDY RES DESIG
NR 22
TC 8
Z9 8
U1 2
U2 14
PU RED UNIV CAMPUS VIRTUALES
PI HUELVA
PA AVENIDA DE MARZO, HUELVA, 21071, SPAIN
SN 2255-1514
J9 CAMPUS VIRTUALES
JI Campus Virtuales
PD OCT
PY 2020
VL 9
IS 2
BP 123
EP 139
PG 17
WC Education & Educational Research
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research
GA OL5PH
UT WOS:000585391200010
DA 2022-04-20
ER

PT J
AU Lee-Baggley, D
   Thakrar, S
AF Lee-Baggley, Dayna
   Thakrar, Sulaye
TI Helping Patients and Health Care Providers Through the COVID-19
   Pandemic: Empirically Based Tips and Strategies to Manage Mental and
   Physical Health
SO NEPHROLOGY NURSING JOURNAL
LA English
DT Article
DE COVID-19; coping; psychological health; chronic illness; health care
   provider skills; pandemic
ID PET OWNERSHIP; SELF-COMPASSION; STRESS RELIEF; SUPPORT; SLEEP;
   METAANALYSIS; LONELINESS; MEDITATION; REDUCTION; RESPONSES
AB The COVID-19 pandemic is enacting a heavy mental health toll on people around the world. This article provides evidence-based information and techniques to promote and foster mental and physical health for our patients and health care providers. The article 1) reviews common emotional reactions faced by patients during the COVID-19 pandemic, 2) reviews how health care providers can help patients make sense of their experiences, and 3) teaches evidence-based skills that health care providers can use to support patients during the COVID-19 pandemic and care for themselves. The article provides tips and strategies that can be helpful in interacting with patients and supporting the well-being of health care providers. These strategies are based on empirically supported knowledge and skills drawn from literature on stress, coping, emotional management, chronic disease management, and behavior changes, and provides ways to discuss these tips with patients in applicable, understandable ways.
C1 [Lee-Baggley, Dayna] Canc Care Nova Scotia, Halifax, NS, Canada.
   [Lee-Baggley, Dayna; Thakrar, Sulaye] Nova Scotia Hlth, Behav Change Res Inst, Halifax, NS, Canada.
   [Lee-Baggley, Dayna] Dalhousie Univ, Fac Med, Halifax, NS, Canada.
   [Lee-Baggley, Dayna] St Marys Univ, Ind Org Psychol, Halifax, NS, Canada.
   [Thakrar, Sulaye] Nova Scotia Hlth, Halifax, NS, Canada.
RP Lee-Baggley, D (corresponding author), Canc Care Nova Scotia, Halifax, NS, Canada.; Lee-Baggley, D (corresponding author), Nova Scotia Hlth, Behav Change Res Inst, Halifax, NS, Canada.; Lee-Baggley, D (corresponding author), Dalhousie Univ, Fac Med, Halifax, NS, Canada.; Lee-Baggley, D (corresponding author), St Marys Univ, Ind Org Psychol, Halifax, NS, Canada.
FU Allied
FX Allied Research Grant.
CR Allen K, 2001, HYPERTENSION, V38, P815, DOI 10.1161/hyp.38.4.815
   American Psychological Association, 2020, STRESS AM 2020 SURV
   Arhant-Sudhir K, 2011, CLIN EXP PHARMACOL P, V38, P734, DOI 10.1111/j.1440-1681.2011.05583.x
   Astin JA, 2003, J AM BOARD FAM PRACT, V16, P131, DOI 10.3122/jabfm.16.2.131
   Berscheid E., 2003, PSYCHOL HUMAN STRENG, P37, DOI 10.1037/10566-003
   Carrera P, 2007, COGNITION EMOTION, V21, P422, DOI 10.1080/02699930600557904
   Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x
   Coppola F, 2009, SOC BEHAV PERSONAL, V37, P307, DOI 10.2224/sbp.2009.37.3.307
   Czeisler ME, 2020, MENTAL HLTH SUBSTANC
   Davidson J.R., 2012, SINK SLEEP STEP STEP
   Dean W, 2020, ANN EMERG MED, V76, P385, DOI 10.1016/j.annemergmed.2020.05.023
   Dillon A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00832
   Drake CL, 2014, SLEEP, V37, P1295, DOI 10.5665/sleep.3916
   Esler M, 2012, STRESS AND CARDIOVASCULAR DISEASE, P273, DOI 10.1007/978-1-84882-419-5_15
   Fitzpatrick KM, 2020, J ANXIETY DISORD, V75, DOI 10.1016/j.janxdis.2020.102291
   Friedmann E, 2003, AM J CARDIOL, V91, P718, DOI 10.1016/S0002-9149(02)03412-4
   Germer C., 2020, MEDITATIONS
   Germer CK, 2013, J CLIN PSYCHOL, V69, P856, DOI 10.1002/jclp.22021
   Gilbert P, 2014, BRIT J CLIN PSYCHOL, V53, P6, DOI 10.1111/bjc.12043
   Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018
   Grant N, 2009, ANN BEHAV MED, V37, P29, DOI 10.1007/s12160-009-9081-z
   Gross James J., 1998, REV GEN PSYCHOL, V2, P271, DOI DOI 10.1037/1089-2680.2.3.271
   Grossman E, 2001, J HUM HYPERTENS, V15, P263, DOI 10.1038/sj.jhh.1001147
   Han JE, 2018, PHYSIOL BEHAV, V192, P98, DOI 10.1016/j.physbeh.2018.02.037
   Harris R., 2007, HAPPINESS TRAP STOP
   Harris R., 2019, ACT MADE SIMPLE EASY
   Hayes S. C., 2005, GET OUT YOUR MIND YO
   Holingue C, 2020, AM J PUBLIC HEALTH, V110, P1628, DOI 10.2105/AJPH.2020.305857
   Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352
   Hope N, 2014, SELF IDENTITY, V13, P579, DOI 10.1080/15298868.2014.889032
   Hosseini Z, 2021, J HYPERTENS, V39, P651, DOI 10.1097/HJH.0000000000002688
   Hur MH, 2014, MATURITAS, V79, P362, DOI 10.1016/j.maturitas.2014.08.006
   Ingulli K., 2013, ECOPSYCHOLOGY, V5, P52, DOI [10.1089/eco.2012.0042, DOI 10.1089/ECO.2012.0042]
   Santini ZI, 2016, J AFFECT DISORDERS, V204, P59, DOI 10.1016/j.jad.2016.06.032
   Jackson EM, 2013, ACSMS HEALTH FIT J, V17, P14, DOI 10.1249/FIT.0b013e31828cb1c9
   Jakubiak BK, 2016, J EXP SOC PSYCHOL, V65, P59, DOI 10.1016/j.jesp.2016.04.001
   Johnson SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079314
   Kavin K., 2020, WASHINGTON POST
   Kesner RP, 2011, NEUROBIOL LEARN MEM, V96, P417, DOI 10.1016/j.nlm.2011.07.002
   Kroska EB, 2020, J CONTEXT BEHAV SCI, V18, P28, DOI 10.1016/j.jcbs.2020.07.011
   Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009
   Lee-Baggley D., 2019, HLTH HABITS SUCK GET
   Li Y, 2019, ARCH PSYCHIAT NURS, V33, P164, DOI 10.1016/j.apnu.2018.11.008
   Linehan M.M., 2014, DBT SKILLS TRAINING
   Lowe CJ, 2019, TRENDS COGN SCI, V23, P349, DOI 10.1016/j.tics.2019.01.005
   Marin MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047189
   McCallie MS, 2006, J HUM BEHAV SOC ENVI, V13, P51, DOI 10.1300/J137v13n03_04
   McGonigal K, 2015, UPSIDE STRESS WHY ST
   McNicholas J, 2005, BMJ-BRIT MED J, V331, P1252, DOI 10.1136/bmj.331.7527.1252
   Mikulincer M, 2007, PSYCHOL INQ, V18, P139, DOI 10.1080/10478400701512646
   Neely ME, 2009, MOTIV EMOTION, V33, P88, DOI 10.1007/s11031-008-9119-8
   Neff K, 2003, SELF IDENTITY, V2, P85, DOI 10.1080/15298860390129863
   Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035
   Pascoe MC, 2015, J PSYCHIATR RES, V68, P270, DOI 10.1016/j.jpsychires.2015.07.013
   Pierce M, 2020, LANCET PSYCHIAT, V7, P883, DOI 10.1016/S2215-0366(20)30308-4
   Plana V., 2020, DAILY HIVE NEWS
   Porcelli AJ, 2009, PSYCHOL SCI, V20, P278, DOI 10.1111/j.1467-9280.2009.02288.x
   Proctor T. M., 2010, CIVILIANS WORLD WAR
   Raudenska J, 2020, BEST PRAC RES-CL ANA, V34, P553, DOI 10.1016/j.bpa.2020.07.008
   Ray J., 2019, AM STRESS WORRY ANGE
   Sadeh A, 2004, HEALTH PSYCHOL, V23, P542, DOI 10.1037/0278-6133.23.5.542
   Sandi C, 2013, WIRES COGN SCI, V4, P245, DOI 10.1002/wcs.1222
   Schnall S, 2008, J EXP SOC PSYCHOL, V44, P1246, DOI 10.1016/j.jesp.2008.04.011
   Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0
   Seppala E, 2013, SOC RES, V80, P411
   Sonnentag S, 2007, J OCCUP HEALTH PSYCH, V12, P204, DOI 10.1037/1076-8998.12.3.204
   Srivastava S, 2009, J PERS SOC PSYCHOL, V96, P883, DOI 10.1037/a0014755
   Stepanski EJ, 2003, SLEEP MED REV, V7, P215, DOI 10.1053/smrv.2001.0246
   Stetter F, 2002, APPL PSYCHOPHYS BIOF, V27, P45, DOI 10.1023/A:1014576505223
   Tirch D., 2014, ACT PRACTITIONERS GU
   Tirch D., 2019, EXPERIENCING ACT INS
   Uvnas-Moberg K, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01529
   Vallis M, 2018, PUBLIC HEALTH, V154, P70, DOI 10.1016/j.puhe.2017.10.022
   Van Rheenen TE, 2020, J AFFECT DISORDERS, V275, P69, DOI 10.1016/j.jad.2020.06.037
   Veale D., 2008, ADV PSYCHIAT TREATME, V14, P29, DOI [10.1192/apt.bp.107.004051, DOI 10.1192/APT.BP.107.004051]
   Zajacova A., 2020, MENTAL HLTH EC CONCE, DOI [10.31235/osf.io/76me2, DOI 10.31235/OSF.IO/76ME2]
NR 76
TC 1
Z9 1
U1 1
U2 8
PU JANNETTI PUBLICATIONS, INC
PI PITMAN
PA EAST HOLLY AVENUE, BOX 56, PITMAN, NJ 08071-0056 USA
SN 1526-744X
EI 2163-5390
J9 NEPHROL NURS J
JI Nephrol. Nurs. J.
PD NOV-DEC
PY 2020
VL 47
IS 6
BP 511
EP +
DI 10.37526/1526-744X.2020.47.6.511
PG 12
WC Nursing; Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing; Urology & Nephrology
GA QM1TY
UT WOS:000621562400003
PM 33377751
DA 2022-04-20
ER

PT J
AU Ahmed, S
   Ghani, F
AF Ahmed, Sibtain
   Ghani, Farooq
TI Trend analysis of lab tests requisitions of COVID-19 prognostic
   biomarkers at a clinical chemistry reference laboratory-an observational
   study
SO ANNALS OF MEDICINE AND SURGERY
LA English
DT Article
DE COVID-19; C-reactive protein; Procalcitonin; Lactate dehydrogenase;
   Ferritin; Prognosis
ID PROCALCITONIN; IMPACT
AB Background: Biochemical parameters, such as C-reactive protein (C-RP), Procalcitonin (PCT), Lactate dehydrogenase (LDH) and Ferritin are associated with COVID-19 severity and prognosis. This trend analysis of COVID-19 prognostic biomarker requisitions is aimed at providing a reflection of the clinical practices adopted amidst the peak of the pandemic. This knowledge of the prognostic biomarkers utilized, will further aid to classify patients based on their risk, for optimal resource allocation and improve outcomes.
   Material & methods: This cross-sectional study was conducted at the clinical chemistry laboratory at the Aga Khan University Hospital (AKUH), Karachi Pakistan. A team consisting of two clinical chemistry consultants reviewed the COVID-19 prognostic biomarkers tests performance data from March to July 2020 using the integrated laboratory information management system (ILMS). The test statistics of March to July 2020 when COVID-19 cases were on the rise in the country were compared with those of the same months from 2019. The changes in the test groups were expressed in percentages. Microsoft Excel for windows 2019 was used for data analysis.
   Results: The total specimens received for testing in 2020 (n = 574,092) showed a percent decline of approximately (-) 33% compared to 2019 (n = 858,756). Contrary to the overall decline in volumes an upward surge was noted for the prognostic biomarkers. From March to July, the highest percent change was noted for LDH (+155.1%), followed by PCT (+66.7.1%), C-RP (+26.5%) and Ferritin (+22.1%) in 2020 compared to the same time frame in 2019. The highest percent change was noted in June.
   Conclusion: During the COVID 19 pandemic, a significant increase in utilization of laboratory services was seen for COVID-19 prognostic markers.
C1 [Ahmed, Sibtain; Ghani, Farooq] Aga Khan Univ, Pathol & Lab Med, Stadium Rd, Karachi 74800, Pakistan.
RP Ghani, F (corresponding author), Aga Khan Univ, Pathol & Lab Med, Stadium Rd, Karachi 74800, Pakistan.
EM sibtain.ahmed@aku.edu; farooq.ghani@aku.edu
CR Ahmed R., 2020, REAL TIME FORECAST F, DOI [10.2139/ssrn.3594111, DOI 10.2139/SSRN.3594111]
   Ahmed S, 2020, ANN MED SURG, V55, P300, DOI 10.1016/j.amsu.2020.06.004
   Ahmed S, 2018, ANN MED SURG, V35, P180, DOI 10.1016/j.amsu.2018.10.004
   [Anonymous], 2020, CHINESE MED J-PEKING, V133, P1087, DOI 10.1097/CM9.0000000000000819
   Chandir S, 2020, LANCET GLOB HEALTH, V8, pE1118, DOI 10.1016/S2214-109X(20)30290-4
   Figliozzi S, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13362
   Jafri L, 2020, ANN MED SURG, V57, P70, DOI 10.1016/j.amsu.2020.07.022
   Lippi G, 2020, CLIN CHEM LAB MED, V58, P1063, DOI 10.1515/cclm-2020-0240
   Lippi G, 2020, CLIN CHIM ACTA, V505, P190, DOI 10.1016/j.cca.2020.03.004
   Ponti G, 2020, CRIT REV CL LAB SCI, V57, P389, DOI 10.1080/10408363.2020.1770685
   Qazi SH, 2021, J PEDIATR SURG, V56, P201, DOI 10.1016/j.jpedsurg.2020.08.012
   Rana RES, 2020, ANN MED SURG, V54, P79, DOI 10.1016/j.amsu.2020.04.035
   Shi JC, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01633-7
   Xi XM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-256
   Yan Z, 2020, MEDIA CULT SOC CHANG, P1
NR 15
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2049-0801
J9 ANN MED SURG
JI Ann. Med. Surg.
PD DEC
PY 2020
VL 60
BP 522
EP 525
DI 10.1016/j.amsu.2020.10.067
PG 4
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA PN8TE
UT WOS:000604744200011
PM 33173580
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Mejjad, N
   Cherif, E
   Rodero, A
   Krawczyk, DA
   El Kharraz, J
   Moumen, A
   Laqbaqbi, M
   Fekri, A
AF Mejjad, Nezha
   Cherif, El Khalil
   Rodero, Antonio
   Krawczyk, Dorota Anna
   El Kharraz, Jauad
   Moumen, Aniss
   Laqbaqbi, Mourad
   Fekri, Ahmed
TI Disposal Behavior of Used Masks during the COVID-19 Pandemic in the
   Moroccan Community: Potential Environmental Impact
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; behavior; facemasks; Morocco; environmental impact; plastic
   pollution; public health
ID SURGICAL FACE MASKS; N95 RESPIRATORS; MANAGEMENT; POLLUTION; TANGIER;
   DESIGN; DEBRIS; VIRUS; SARS; PPE
AB The spread of coronavirus disease-2019 (COVID-19) levied on the Moroccan authorities to increase their mask production capacity, which reached up to 12 million facemask units produced per day. This increase in personal protective equipment (PPE) production and consumption is an efficient tool to address the spread of COVID-19. However, this results in more plastic and microplastic debris being added into the land and marine environments, which will harm the ecosystem, wildlife, and public health. Such a situation needs deep individual behavior observation and tracking, as well as an assessment of the potential environmental impact of this new type of waste. For this reason, we assessed the Moroccan population's behavior regarding the use and disposal of facemasks and gloves. An exploratory survey was prepared and shared via social media and email with the population of Rabat-Sale-Kenitra and Casablanca-Settat regions. Additionally, we calculated the estimated number and weight of daily and weekly PPE used and generated by the studied regions. The survey showed that 70% of the respondents threw their discarded masks and gloves in house trash or trash bins after their first use, whereas nearly 30% of respondents admitted that they did not wear masks because they did not leave their homes during the lockdown, while from the 70% of facemask users, more than five million (equivalent to 40,000 kg) of facemasks would be generated and disposed of daily by the community of these regions, which presents 35% of the total engendered facemask waste in Morocco. Accordingly, the environment impact of facemasks showed that the greenhouse gas footprint is about 640 kT CO2 eq./year for the whole of Morocco, while the energy footprint is around 60,000 GWh/year. Furthermore, an urgent multidisciplinary environmental assessment of the potential impact of PPE must be conducted among the 12 Moroccan regions. This study demonstrated the real impact of the COVID-19 PPE on human behavior and the environment and suggests a need for providing new didactic management of facemasks and gloves.
C1 [Mejjad, Nezha; Fekri, Ahmed] Ben Msik Fac Sci, Lab Appl Geol Geomat & Environm, Casablanca 20670, Morocco.
   [Mejjad, Nezha] Univ Chouaib Doukkali, Fac Sci, Dept Geol Lab GMSSURAC 45, El Jadida 24000, Morocco.
   [Cherif, El Khalil] Univ Porto, Fac Sci, Lab Chem Res Unit CIQUP, P-4099002 Porto, Portugal.
   [Cherif, El Khalil] Univ Lisbon, Inst Super Tecn, Inst Syst & Robot, P-1649004 Lisbon, Portugal.
   [Rodero, Antonio] Univ Cordoba, Sch Engn Sci Belmez, Cordoba 14071, Spain.
   [Krawczyk, Dorota Anna] Bialystok Tech Univ, Fac Civil Engn & Environm Sci, PL-15351 Bialystok, Poland.
   [El Kharraz, Jauad] Univ Valencia, Global Change Unit, Valencia 46010, Spain.
   [Moumen, Aniss] Univ Ibn Tofail, Natl Sch Appl Sci Kenitra, Kenitra 14000, Morocco.
   [Laqbaqbi, Mourad] Ibn Tofail Univ, Multidisciplinary Fac Sidi Kacem, Lab Adv Mat & Proc Engn, Kenitra 14000, Morocco.
RP Cherif, E (corresponding author), Univ Porto, Fac Sci, Lab Chem Res Unit CIQUP, P-4099002 Porto, Portugal.; Cherif, E (corresponding author), Univ Lisbon, Inst Super Tecn, Inst Syst & Robot, P-1649004 Lisbon, Portugal.; Rodero, A (corresponding author), Univ Cordoba, Sch Engn Sci Belmez, Cordoba 14071, Spain.
EM mejjadnezha@gmail.com; elkhalil.cherif@fc.up.pt; fa1rosea@uco.es;
   d.krawczyk@pb.edu.pl; jauad@uv.es; aniss.oumoumen@uit.ac.ma;
   mouradlaqbaqbi@gmail.com; ahmedfekri13@gmail.com
RI MEJJAD, Nezha/I-6702-2015; Moumen, Aniss/I-6858-2015; Rodero,
   Antonio/M-1020-2014
OI MEJJAD, Nezha/0000-0002-6750-6781; Moumen, Aniss/0000-0001-5330-0136;
   Rodero, Antonio/0000-0003-0152-620X; El KHARRAZ,
   Jauad/0000-0001-6880-1259
FU BUT Inter Academic Partnerships NAWA projectPolish National Agency for
   Academic Exchange (NAWA) [PPI/APM/2018/1/00033/DEC/1]; scientific
   research at Bialystok University of Technology [WZ/WBiIS/9/2019]
FX The authors would like to thank all the researchers who have worked hard
   to advance the knowledge and improve the outcomes of this work. The
   authors would like to thank all the studied population in
   Rabat-Sale-Kenitra and Casablanca-Settat regions, Morocco, for their
   collaboration in the framework of the COVID-19 survey questionnaire.
   Dorota Anna Krawczyk and Antonio Rodero would like to acknowledge the
   financial support from funds of BUT Inter Academic Partnerships
   (PPI/APM/2018/1/00033/DEC/1) NAWA project and WZ/WBiIS/9/2019 scientific
   research at Bialystok University of Technology. We would also like to
   thank the editor and the reviewers for their comments which helped us to
   improve the paper.
CR Akkouri N., 2020, P 3 GEOMEAST INT C E, P131
   Allison A. L., 2020, UCL OPEN, DOI [10.14324/111.444/000031.v2, DOI 10.14324/111.444/000031.V2]
   Ammendolia J, 2021, ENVIRON POLLUT, V269, DOI 10.1016/j.envpol.2020.116160
   [Anonymous], 2020, TRADE MEDICAL GOODS
   [Anonymous], WKRG NEWS
   Aragaw Tadele Assefa, 2021, Environ Syst Res (Heidelb), V10, P8, DOI 10.1186/s40068-020-00217-x
   Ardusso M, 2021, SCI TOTAL ENVIRON, V763, DOI 10.1016/j.scitotenv.2020.144365
   Bachiri A., 2016, INT J RECENT ADV MUL, V3, P1841
   Bao R, 2020, SCI TOTAL ENVIRON, V731, DOI 10.1016/j.scitotenv.2020.139052
   Barycka K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242901
   Behera Bikash Chandra, 2021, Environ Nanotechnol Monit Manag, V15, P100432, DOI 10.1016/j.enmm.2021.100432
   Benson NU, 2021, J ENVIRON CHEM ENG, V9, DOI 10.1016/j.jece.2021.105222
   Cherif E, 2020, WATER-SUI, V12, DOI 10.3390/w12092638
   Cherif E, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11080972
   Chin AWH, 2020, LANCET MICROBE, V1, pE10, DOI 10.1016/S2666-5247(20)30003-3
   Chughtai AA, 2015, AM J INFECT CONTROL, V43, P72, DOI 10.1016/j.ajic.2014.10.009
   Cowing M.J., HLTH SAFETY GUIDELIN, V1
   Dahchour A., 2019, WASTE MANAGEMENT MEN, P13
   De-la-Torre GE, 2021, SCI TOTAL ENVIRON, V774, DOI 10.1016/j.scitotenv.2021.145774
   Derraji A., 2020, DISPONIBILIT MASQUES
   Dharmadhikari AS, 2012, AM J RESP CRIT CARE, V185, P1104, DOI 10.1164/rccm.201107-1190OC
   El-Ogri F, 2016, DESALIN WATER TREAT, V57, P17061, DOI 10.1080/19443994.2016.1138328
   Fadare OO, 2020, SCI TOTAL ENVIRON, V737, DOI 10.1016/j.scitotenv.2020.140279
   Ferronato N, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16061060
   Fiorillo L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093132
   IMANOR (Institut Marocaine de Normalisation), 2020, MASQ PROT TISS NONT
   Jack L, 2006, P I CIVIL ENG-MUNIC, V159, P43, DOI 10.1680/muen.2006.159.1.43
   Jain S, 2020, BIOFUELS-UK, DOI 10.1080/17597269.2020.1797350
   Klemes JJ, 2020, ENERGY, V211, DOI 10.1016/j.energy.2020.118701
   Li Y, 2006, AM J IND MED, V49, P1056, DOI 10.1002/ajim.20395
   MacIntyre CR, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006577
   MacIntyre CR, 2011, INFLUENZA OTHER RESP, V5, P170, DOI 10.1111/j.1750-2659.2011.00198.x
   Mbarki A., 2013, Journal of Environmental Protection, V4, P914, DOI 10.4236/jep.2013.49105
   MCINET, LUTTE COVID 19
   McKinney KR, 2006, J ENVIRON HEALTH, V68, P26
   Mejjad N, 2018, ENVIRON SCI POLLUT R, V25, P22872, DOI 10.1007/s11356-018-2370-y
   Mol MPG, 2020, WASTE MANAGE RES, V38, P485, DOI 10.1177/0734242X20918312
   Msaad S., 2020, J MAT ENV SCI, V11, P452
   Cruvinel VRN, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6879-x
   Nzediegwu C, 2020, RESOUR CONSERV RECY, V161, DOI 10.1016/j.resconrec.2020.104947
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Okoro OV, 2020, CHEMENGINEERING, V4, DOI 10.3390/chemengineering4030054
   Osterholm MT, 2015, MBIO, V6, DOI 10.1128/mBio.00137-15
   Ouhsine O, 2020, GLOB J ENVIRON SCI M, V6, P41, DOI 10.22034/GJESM.2019.06.SI.05
   Ouigmane A., 2019, HDB ENV MAT MANAGEME, DOI [10.1007/978-3-319-58538-3_82-11, DOI 10.1007/978-3-319-58538-3_82-11]
   Saadat S, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138870
   Sbai SE, 2021, AIR QUAL ATMOS HLTH, V14, P617, DOI 10.1007/s11869-020-00965-w
   Schuyler QA, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-14
   Short, 2020, CASE STUD CHEM ENV E, V1, DOI DOI 10.1016/J.CSCEE.2020.100006
   Singh S, 2021, J COLLOID INTERF SCI, V592, P342, DOI 10.1016/j.jcis.2021.02.049
   Sweep Net, REPORT GIZ
   Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd
   The Lancet, 2020, Lancet, V395, P537, DOI 10.1016/S0140-6736(20)30379-2
   Tomas ME, 2015, JAMA INTERN MED, V175, P1904, DOI 10.1001/jamainternmed.2015.4535
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Vanapalli KR, 2021, SCI TOTAL ENVIRON, V750, DOI 10.1016/j.scitotenv.2020.141514
   Verlicchi P, 2015, SCI TOTAL ENVIRON, V514, P467, DOI 10.1016/j.scitotenv.2015.02.020
   Wang CY, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13020036
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   Wang Q, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138915
   World Bank, 2013, MOROCCO MUNICIPAL SO
   World Bank, WASTE WORKERS ARE PR
   World Health Organization, COR
   Xiang Y, 2020, AM J INFECT CONTROL, V48, P880, DOI 10.1016/j.ajic.2020.05.026
   Yan J, 2018, P NATL ACAD SCI USA, V115, P1081, DOI 10.1073/pnas.1716561115
NR 65
TC 6
Z9 6
U1 18
U2 29
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD APR
PY 2021
VL 18
IS 8
AR 4382
DI 10.3390/ijerph18084382
PG 19
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA RT1AU
UT WOS:000644199900001
PM 33924217
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Scalise, A
   Falcone, M
   Avruscio, G
   Brocco, E
   Ciacco, E
   Parodi, A
   Tasinato, R
   Ricci, E
AF Scalise, Alessandro
   Falcone, Marco
   Avruscio, Giampiero
   Brocco, Enrico
   Ciacco, Eugenio
   Parodi, Aurora
   Tasinato, Rolando
   Ricci, Elia
TI What COVID-19 taught us: New opportunities and pathways from
   telemedicine and novel antiseptics in wound healing
SO INTERNATIONAL WOUND JOURNAL
LA English
DT Article; Early Access
DE antiseptics; COVID-19; fast track; telemedicine; wound healing
ID CARE; MANAGEMENT; FOOT; SKIN; METALLOPROTEINASES; MICROENVIRONMENT;
   STEWARDSHIP; CHALLENGES; THERAPY; DISEASE
AB The COVID-19 pandemic deeply impacted the capacity of the health systems to maintain preventive and curative services, especially for the most vulnerable populations. During the pandemic, the wound healing centres in Italy assisted a significant reduction of the frequency of their hospital admission, since only urgencies, such as severe infections or wound haemorrhagic complications, were allowed to the hospital. The aim of this multidisciplinary work is to highlight the importance of a new pathway of wound care with patient-based therapeutic approach, tailored treatments based on the characteristics of the wound and fast tracks focused on the outpatient management, reserving hospital assessment only for patients with complicated or complex wounds. This analysis highlights the point that patients with chronic wounds need to be critically evaluated in order to find the best and most appropriate care pathway, which should vary according to the patient and, especially, to the characteristics of the wound. Moreover, the most adequate topic antiseptic should be started as soon as possible. An appropriate and correct management of the wound care will allow to link the knowledge based on years of clinical practice with the new challenges and the need to visit patients remotely, when possible.
C1 [Scalise, Alessandro] Polytech Univ, Sch Med, Dept Plast & Reconstruct Surg, Ancona, Italy.
   [Falcone, Marco] Univ Pisa, Azienda Osped Univ Pisana, Dept Clin & Expt Med, Pisa, Italy.
   [Avruscio, Giampiero] Hosp Univ Padua, Dept Cardiac Thorac & Vasc Sci, Angiol Unit, Padua, Italy.
   [Brocco, Enrico] Policlin Abano Terme, Med Diabet Foot Unit, Padua, Italy.
   [Ciacco, Eugenio] ASL 1 Abruzzo, Pharm Unit, San Salvatore Hosp, Laquila, Italy.
   [Parodi, Aurora] Univ Genoa, DiSSal Dermatol Clin, Dermatol Clin Hosp Policlin San Martino IRCCS, Genoa, Italy.
   [Tasinato, Rolando] Asl 3 Veneto, Gen Surg Dept, Mirano Hosp, Venice, Italy.
   [Ricci, Elia] Casa Cura San Luca, Difficult Wounds Serv, Pecetto Torinese, TO, Italy.
RP Scalise, A (corresponding author), Polytech Univ, Sch Med, Dept Plast & Reconstruct Surg, Ancona, Italy.
EM alessandro.scalise@ospedaliriuniti.marche.it
FU Angelini S.p.A.
FX The authors acknowledge Claudia Laterza, MD of Sanitanova s.r.l. and
   Enrica Piras for medical writing and editorial assistance. This work has
   been supported by an unrestricted grant by Angelini S.p.A.
CR Ashcroft GS, 2004, ADV MOL CEL, V34, P321, DOI 10.1016/S1569-2558(03)34022-6
   Avruscio Giampiero, 2020, Disaster Med Public Health Prep, P1, DOI 10.1017/dmp.2020.448
   Bednarek RS., 2021, STATPEARLS
   Bowers S, 2020, AM FAM PHYSICIAN, V101, P159
   Budri AMV, 2020, J CLIN NURS, V29, P2927, DOI 10.1111/jocn.15316
   Caley MP, 2015, ADV WOUND CARE, V4, P225, DOI 10.1089/wound.2014.0581
   Cannavale T, 2021, ADV SKIN WOUND CARE, V34, P120, DOI 10.1097/01.ASW.0000733208.81005.dd
   Sanchez MC, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7080098
   Chen LH, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/15574
   Dissemond J, 2011, SKIN PHARMACOL PHYS, V24, P245, DOI 10.1159/000327210
   Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]
   Drago F, 2019, EUR J DERMATOL, V29, P6, DOI 10.1684/ejd.2018.3486
   Dunnill C, 2017, INT WOUND J, V14, P89, DOI 10.1111/iwj.12557
   Edsberg LE, 2016, J WOUND OSTOMY CONT, V43, P585, DOI 10.1097/WON.0000000000000281
   Falcone M, 2019, CLIN MICROBIOL INFEC, V25, P562, DOI 10.1016/j.cmi.2018.07.028
   Falcone M, 2021, J GLOB ANTIMICROB RE, V26, P140, DOI 10.1016/j.jgar.2021.05.010
   Falcone M, 2021, DIABETES RES CLIN PR, V174, DOI 10.1016/j.diabres.2021.108732
   Falcone M, 2020, J GLOB ANTIMICROB RE, V22, P325, DOI 10.1016/j.jgar.2020.02.022
   Falcone M, 2016, INTERN EMERG MED, V11, P637, DOI 10.1007/s11739-016-1450-6
   Frykberg RG, 2015, ADV WOUND CARE, V4, P560, DOI 10.1089/wound.2015.0635
   Gohel MS, 2018, NEW ENGL J MED, V378, P2105, DOI 10.1056/NEJMoa1801214
   Golan Y, 2019, CLIN INFECT DIS, V68, pS206, DOI 10.1093/cid/ciz004
   Halim AS, 2012, INDIAN J PLAST SURG, V45, P193, DOI 10.4103/0970-0358.101277
   Hinchliffe RJ, 2016, DIABETES-METAB RES, V32, P136, DOI 10.1002/dmrr.2705
   Iyer Sandhya P, 2019, Niger J Surg, V25, P36, DOI 10.4103/njs.NJS_34_17
   Junker JPE, 2013, ADV WOUND CARE, V2, P348, DOI 10.1089/wound.2012.0412
   Kramer A, 2018, SKIN PHARMACOL PHYS, V31, P28, DOI 10.1159/000481545
   Krejner A, 2016, CHRONIC WOUND CARE M, V3, P29, DOI 10.2147/CWCMR.S73819
   Leaper DJ, 2012, INT WOUND J, V9, P1, DOI 10.1111/j.1742-481X.2012.01097.x
   Li SX, 2020, EXP DERMATOL, V29, P107, DOI 10.1111/exd.14046
   Lipsky BA, 2016, J ANTIMICROB CHEMOTH, V71, P3026, DOI 10.1093/jac/dkw287
   Manna B., 2021, STATPEARLS
   Musuuza J, 2020, J VASC SURG, V71, P1433, DOI 10.1016/j.jvs.2019.08.244
   Nguyen T. T., 2016, WOUND HLTH NEW INSIG, P37, DOI [DOI 10.5772/64611, 10.5772/64611]
   Packer CF., 2021, STATPEARLS
   Prompers L, 2008, DIABETOLOGIA, V51, P747, DOI 10.1007/s00125-008-0940-0
   Punjataewakupt A, 2019, EUR J CLIN MICROBIOL, V38, P39, DOI 10.1007/s10096-018-3393-5
   Quain AM, 2015, WOUNDS, V27, P327
   Queen D, 2019, INT WOUND J, V16, P311, DOI 10.1111/iwj.13108
   Rahim K, 2017, MICROB ECOL, V73, P710, DOI 10.1007/s00248-016-0867-9
   Raizman R, 2019, J WOUND CARE, V28, pS28, DOI 10.12968/jowc.2019.28.Sup9.S28
   Rajpaul Kumal, 2015, Br J Community Nurs, VSuppl Wound Care, pS10, DOI 10.12968/bjcn.2015.20.Sup3.S6
   Rennie MY, 2017, J WOUND CARE, V26, P452, DOI 10.12968/jowc.2017.26.8.452
   Rogers Lee C, 2020, J Am Podiatr Med Assoc, DOI 10.7547/20-051
   Roth B, 2017, J WOUND CARE, V26, P79, DOI 10.12968/jowc.2017.26.3.79
   Sabino F., 2015, METALLOPROTEINASES M, V2, P1, DOI [10.2147/MNM.S68420, DOI 10.2147/MNM.S68420]
   Scalise A, 2015, SEMIN VASC SURG, V28, P151, DOI 10.1053/j.semvascsurg.2016.01.003
   Scalise A., 2021, AO, V8, P14
   Scalise A, 2020, INT WOUND J, V17, P1538, DOI 10.1111/iwj.13430
   Schneider LA, 2007, ARCH DERMATOL RES, V298, P413, DOI 10.1007/s00403-006-0713-x
   Schultz G, 2005, WOUND REPAIR REGEN, V13, pS1, DOI 10.1111/j.1067-1927.2005.1304S1.x
   Serena TE, 2019, J WOUND CARE, V28, P346, DOI 10.12968/jowc.2019.28.6.346
   Shanmugam VK, 2017, J VASC SURG-VENOUS L, V5, P280, DOI 10.1016/j.jvsv.2016.09.006
   Shukla V K, 2007, J Wound Care, V16, P291
   Slaviero L, 2018, Ann Burns Fire Disasters, V31, P198
   Tinelli G, 2020, ANN VASC SURG, V68, P93, DOI 10.1016/j.avsg.2020.06.044
   Tiseo G, 2021, EXPERT REV ANTI-INFE, V19, P1373, DOI 10.1080/14787210.2021.1926986
   Tollow P, 2016, PHLEBOLOGY, V31, P82, DOI 10.1177/0268355515581278
   Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531
   Vowden P, 2011, WOUNDS INT, V2
   Werdin Frank, 2009, Eplasty, V9, pe19
   Woo KY, 2009, OSTOMY WOUND MANAG, V55, P40
   Zeng Q., 2011, SKIN TISSUE ENG COMP, V2017, P467
   Zoppo G, 2020, J WOUND CARE, V29, P692, DOI 10.12968/jowc.2020.29.12.692
NR 64
TC 2
Z9 2
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-4801
EI 1742-481X
J9 INT WOUND J
JI Int. Wound J.
DI 10.1111/iwj.13695
EA OCT 2021
PG 9
WC Dermatology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dermatology; Surgery
GA WA2XM
UT WOS:000702754200001
PM 34599861
OA gold
DA 2022-04-20
ER

PT J
AU Gangakhedkar, GR
   Solanki, SL
AF Gangakhedkar, Gauri Raman
   Solanki, Sohan Lal
TI Impact of the COVID-19 pandemic on anesthesiologists in India: A
   cross-sectional online survey of the practices, preparedness, and
   mind-set
SO JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY
LA English
DT Article
DE Airway; anaesthesiologists; coronavirus; COVID-19; crisis management;
   critical care; infection control; operating room; personal protective
   equipment; preparedness; pandemic; resource allocation
ID HEALTH-CARE WORKERS; SOCIETY
AB Background and Aims: India is one of the five worst hit countries in the world due to COVID-19, by the fourth week of June 2020. The impact of COVID-19 on the health practices is well-documented but there are no studies assessing its impact on anesthesiologists in India. This study aims at assessment of the impact of COVID-19 on the practices followed, the preparedness, and mindset of anesthesiologists in India.
   Material and Methods: Using Google forms, a cross-sectional, questionnaire-based survey was conducted between the 5th and 22nd of May, 2020, among trainees and practicing anesthesiologists, in India. The anesthesiologists were invited to participate, using their e-mail addresses and through the social media platforms such as Facebook and WhatsApp. The responses that were generated, were analyzed using SPSS version 23 (IBM, Armonk, NY).
   Results: Of the 707 anesthesiologists who participated, 68.3% had already worked in a COVID-19 specialty unit. Only 41.7% of the anesthesiologists felt confident that they had sufficient knowledge to deal with COVID-19 infected patients. Fear of catching the infection and infecting loved ones were important causes of anxiety, which was seen in 95% of the participants. Majority of the participants, (64.5%) did not think that elective surgical procedures could be restarted at this point.
   Conclusion: COVID-19 has had grave impact on anesthesiologists, on the professional and personal front, and will possibly cause near-permanent changes in the work culture. Restarting elective surgical procedures, will require meticulous planning. In spite of their self-perceived under-preparedness to combat COVID-19, an overwhelming majority of participating anesthesiologists were prepared to contribute to the management of COVID-19.
C1 [Gangakhedkar, Gauri Raman; Solanki, Sohan Lal] Homi Bhabha Natl Inst, Tata Mem Hosp, Dept Anesthesiol Crit Care & Pain, Mumbai, Maharashtra, India.
RP Solanki, SL (corresponding author), Tata Mem Hosp, Dept Anesthesiol Crit Care & Pain, Mumbai 400012, Maharashtra, India.
EM me_sohans@yahoo.co.in
CR Al Harbi MK, 2020, SAUDI J ANAESTH, V14, P387, DOI 10.4103/sja.SJA_265_20
   Al-Jabir A, 2020, INT J SURG, V79, P168, DOI [10.1016/j.ijsu.2020.05.022, 10.1016/j.ijsu.2020.05.002]
   [Anonymous], 2020, IND COR 457621 CAS 1
   [Anonymous], 2020, GUID MEAS BE TAK MIN
   [Anonymous], 2020, ADV HOSP MED ED I
   Chatterjee P, 2020, INDIAN J MED RES, V151, P459, DOI 10.4103/ijmr.IJMR_2234_20
   Eldawlatly A, 2020, SAUDI J ANAESTH, V14, P295, DOI 10.4103/sja.SJA_253_20
   Hunter E, 2020, LANCET, V395, pE77, DOI 10.1016/S0140-6736(20)30970-3
   Leung K, 2020, LANCET, V395, P1382, DOI 10.1016/S0140-6736(20)30746-7
   Ling L, 2020, ANAESTH CRIT CARE PA, V39, P163, DOI 10.1016/j.accpm.2020.02.002
   Loupy A, 2020, LANCET, V395, pE95, DOI 10.1016/S0140-6736(20)31040-0
   Malhotra N, 2020, INDIAN J ANAESTH, V64, P259, DOI 10.4103/ija.IJA_288_20
   Miller TR, 2020, ANESTH ANALG, V131, P112, DOI 10.1213/ANE.0000000000004882
   Nepogodiev D, 2020, BRIT J SURG, V107, P1440, DOI 10.1002/bjs.11746
   Quintao VC, 2020, REV BRAS ANESTESIOL, V70, P77, DOI [10.1016/j.bjane.2020.03.002, 10.1016/j.bjan.202.0.03.002]
   Shanafelt T, 2020, JAMA-J AM MED ASSOC, V323, P2133, DOI 10.1001/jama.2020.5893
   Solanki S, 2020, INDIAN J ANAESTH SS2, V64, P97
   Tsamakis K, 2020, EXP THER MED, V19, P3451, DOI 10.3892/etm.2020.8646
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yang MP, 2020, BRIT J ANAESTH, V124, P666, DOI 10.1016/j.bja.2020.03.022
   Yong PSA, 2020, BRIT J ANAESTH, V125, pE176, DOI 10.1016/j.bja.2020.04.007
   Zhang HF, 2020, ANESTHESIOLOGY, V132, P1333, DOI 10.1097/ALN.0000000000003300
NR 22
TC 1
Z9 1
U1 1
U2 2
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0970-9185
EI 2231-2730
J9 J ANAESTH CLIN PHARM
JI J. Anaesth. Clin. Pharm.
PD JUL-SEP
PY 2020
VL 36
IS 3
BP 331
EP 336
DI 10.4103/joacp.JOACP_375_20
PG 6
WC Pharmacology & Pharmacy
WE Emerging Sources Citation Index (ESCI)
SC Pharmacology & Pharmacy
GA OP5EA
UT WOS:000588105400007
PM 33487899
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Jornayvaz, FR
   Assouline, B
   Pugin, JM
   Gariani, K
AF Jornayvaz, Francois R.
   Assouline, Benjamin
   Pugin, Jerome
   Gariani, Karim
TI Extremely high-dose insulin requirement in a diabetic patient with
   COVID-19: a case report
SO BMC ENDOCRINE DISORDERS
LA English
DT Article
DE COVID-19; Insulin resistance; Type 2 diabetes; Case report
ID SARS
AB Background Detailed description of hyperglycemia management in diabetic patients infected with SARS-CoV-2 remain limited, although patients with diabetes show higher complication and mortality rate than patients without diabetes. Transient non-severe increased insulin requirement in patients hospitalized for medical conditions such as sepsis or myocardial infarction is a well-known phenomenon. However, extremely high-dose insulin requirement remains a very rarely reported entity. Here, we report the case of an extreme and transitory insulin requirement episode in a type 2 diabetic patient presenting an acute respiratory distress syndrome caused by SARS-CoV-2. Case presentation A 57-year-old man resident in Geneva, Switzerland, previously known for type 2 diabetes for 3 years was admitted for an aggravation of his dyspnea. His type 2 diabetes was treated only with metformin and his latest Hb1Ac was 6.1%. Chest CT SCAN showed a bilateral multilobar ground-glass opacification. Twenty-four hours after his admission he presented a worsening of dyspnea and severe hypoxemia requiring a transfer to the intensive care unit rapidly followed by oro-tracheal intubation for mechanical ventilation support. A bronchoalveolar lavage was performed and test of SARS-CoV-2 by RT-qPCR assay was positive. At day 3, he presented a rapidly progressive insulin requirement at a rate of up to 50 units/hour intravenous insulin aspart. Despite the high insulin doses, he maintained an elevated plasma glucose level at 270 mg/dL on average. His extremely high-dose insulin requirement "resolved" at day 9, and the insulin infusion rate was rapidly reduced. Conclusions This case may reflect a specific and profound impact of SARS-CoV-2 on metabolic homeostasis, in particular in diabetic patients that appear more prone to complications of COVID-19 infection. Yet, the mechanisms behind this remain to be elucidated. The optimal management of hyperglycemia of diabetic patients infected with SARS-CoV-2 has yet not be defined, however insulin remain the mainstay of treatment approach. Report of extreme dysregulation of chronic conditions such as diabetes in patients with COVID-19 may help clinicians to better take care of patients during the pandemic of SARS-CoV-2. To the best of our knowledge this is the first description of extremely high-dose insulin requirement in patient with COVID-19.
C1 [Jornayvaz, Francois R.; Gariani, Karim] Geneva Univ Hosp, Div Endocrinol Diabet Nutr & Therapeut Patient Ed, Geneva, Switzerland.
   [Assouline, Benjamin; Pugin, Jerome] Geneva Univ Hosp, Div Intens Care, Geneva, Switzerland.
RP Gariani, K (corresponding author), Geneva Univ Hosp, Div Endocrinol Diabet Nutr & Therapeut Patient Ed, Geneva, Switzerland.
EM karim.gariani@hcuge.ch
RI Jornayvaz, François/AAL-2134-2020
OI Jornayvaz, Francois/0000-0001-9425-3137
CR Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500
   Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   De Block C, 2006, DIABETES CARE, V29, P1750, DOI 10.2337/dc05-2353
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Kolyva AS, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.34
   Liu FR, 2020, CLIN GASTROENTEROL H, V18, P2128, DOI 10.1016/j.cgh.2020.04.040
   Mantovani A, 2020, NUTR METAB CARDIOVAS, V30, P1236, DOI 10.1016/j.numecd.2020.05.014
   Marik PE, 2004, INTENS CARE MED, V30, P748, DOI 10.1007/s00134-004-2167-y
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Wang SF, 2020, DIABETOLOGIA, V63, P2102, DOI 10.1007/s00125-020-05209-1
   Yang JK, 2006, DIABETIC MED, V23, P623, DOI 10.1111/j.1464-5491.2006.01861.x
   Yang JK, 2010, ACTA DIABETOL, V47, P193, DOI 10.1007/s00592-009-0109-4
NR 13
TC 1
Z9 1
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6823
J9 BMC ENDOCR DISORD
JI BMC Endocr. Disord.
PD OCT 16
PY 2020
VL 20
IS 1
AR 155
DI 10.1186/s12902-020-00632-2
PG 4
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA OA8TA
UT WOS:000578052700001
PM 33066762
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Raimo, N
   Rella, A
   Vitolla, F
   Sanchez-Vicente, MI
   Garcia-Sanchez, IM
AF Raimo, Nicola
   Rella, Angela
   Vitolla, Filippo
   Sanchez-Vicente, Maria-Ines
   Garcia-Sanchez, Isabel-Maria
TI Corporate Social Responsibility in the COVID-19 Pandemic Period: A
   Traditional Way to Address New Social Issues
SO SUSTAINABILITY
LA English
DT Article
DE corporate social responsibility; COVID-19 pandemic; health crisis;
   spanish setting
ID CSR; SUSTAINABILITY; DISCLOSURE; SPAIN
AB The COVID-19 pandemic has had serious health, social and economic consequences. In this difficult context, companies are called upon to implement corporate social responsibility (CSR) activities to support society and the weakest individuals. This study examines how Spanish companies have supported society and vulnerable individuals through partnerships with non-governmental organizations (NGOs). In this regard, a multiple case study analysis based on 14 companies listed on the Madrid Stock Exchange that have created collaborations with different NGOs was conducted. The results show that these partnerships are mainly aimed at providing food, health, social and technological support to society and vulnerable individuals. To the best of our knowledge, this is the first study that examines the support provided by companies to society during the COVID-19 pandemic in the European context.
C1 [Raimo, Nicola; Rella, Angela; Vitolla, Filippo] LUM Univ, Dept Management Finance & Technol, I-70010 Bari, Italy.
   [Sanchez-Vicente, Maria-Ines] Univ Salamanca, Fac Econ & Empresa, Salamanca 37007, Spain.
   [Garcia-Sanchez, Isabel-Maria] Univ Salamanca, IME Inst Multidisciplinar Empresa, Salamanca 37007, Spain.
RP Raimo, N (corresponding author), LUM Univ, Dept Management Finance & Technol, I-70010 Bari, Italy.
EM raimo@lum.it; rella.phdstudent@lum.it; vitolla@lum.it; inesachz@usal.es;
   lajefa@usal.es
RI ISABEL-MARIA, GARCIA-SANCHEZ/F-4271-2016
OI ISABEL-MARIA, GARCIA-SANCHEZ/0000-0003-4711-8631; Raimo,
   Nicola/0000-0003-1512-4906
FU Junta de Castilla y LeonJunta de Castilla y Leon; Fondo Europeo de
   Desarrollo Regional (Unidad de Excelencia "Gestion Economica para la
   Sostenibilidad" (GECOS)) [CLU-2019-03]
FX Junta de Castilla y Leon y Fondo Europeo de Desarrollo Regional
   (Grant/Award No. CLU-2019-03 Unidad de Excelencia "Gestion Economica
   para la Sostenibilidad" (GECOS)).
CR Bapuji H, 2020, BUS SOC, V59, P1067, DOI 10.1177/0007650320921172
   Begum A., 2016, J FINANC CRIME, V23, P748, DOI DOI 10.1108/JFC-03-2015-0013
   Bermejo N, 2021, FEDEA POLICY PAPERS, V5, P1
   Carroll A.B., 1999, BUS SOC, V38, P268, DOI 10.1177/000765039903800303
   Ceylan Z, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138817
   Chappell T, 1993, SOUL BUSINESS MANAGI
   Chong M, 2009, CORP REPUT REV, V12, P106, DOI 10.1057/crr.2009.8
   Corral-Lage J, 2019, REV CONTAB, V22, P145, DOI 10.6018/rcsar.376151
   CRESWELL JW, 2007, QUALITATIVE INQUIRY
   Denzin N., 1984, RES ACT
   Droppert H, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0100-5
   Ducharme J., TIME
   Fernando M, 2010, EUR MANAG J, V28, P68, DOI 10.1016/j.emj.2009.08.002
   Frankental, 2001, CORPORATE COMMUNICAT, V6, P18, DOI [DOI 10.1108/13563280110381170, 10.1108/13563280110381170]
   Gao YQ, 2011, BALT J MANAG, V6, P263, DOI 10.1108/17465261111131848
   Garcia-Sanchez I.-M., 2020, J OPEN INNOV-TECHNOL, V6, P126, DOI [10.3390/joitmc6040126, DOI 10.3390/JOITMC6040126]
   Garcia-Sanchez IM, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13073841
   Garcia-Sanchez IM, 2021, ADM SCI, V11, DOI 10.3390/admsci11010029
   Garcia-Sanchez IM, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12187605
   Garcia-Sanchez IM, 2021, MEDITARI ACCOUNT RES, V29, P908, DOI 10.1108/MEDAR-11-2019-0604
   Gardberg NA, 2019, BUS SOC, V58, P1177, DOI 10.1177/0007650317694856
   Gelashvili V, 2020, REV CONTAB, V23, P139, DOI 10.6018/rcsar.361531
   Guan DB, 2020, NAT HUM BEHAV, V4, P577, DOI 10.1038/s41562-020-0896-8
   Guerriero C, 2020, NAT SUSTAIN, V3, P494, DOI 10.1038/s41893-020-0563-0
   Guthrie J., 2004, J INTELLECT CAP, V5, P282, DOI [DOI 10.1108/14691930410533704, 10.1108/14691930410533704]
   Hasan M.M., 2017, J FINANCE ACCOUNT, V5, P193, DOI [10.11648/j.jfa.20170505.13, DOI 10.11648/J.JFA.20170505.13]
   HOLMES L, 2000, CORPORATE SOCIAL RES
   Idowu S.O., 2004, MANAGEMENT ENV QUALI, V15, P420, DOI DOI 10.1108/14777830410540153
   Jamali D, 2008, J BUS ETHICS, V82, P213, DOI 10.1007/s10551-007-9572-4
   Johnson BR, 2011, CORP SOC RESP ENV MA, V18, P352, DOI 10.1002/csr.253
   Johnson H.L., 1971, BUSINESS CONT SOC FR
   Johnstone B, 2008, CORPORATE CITIZENSHI
   JONES TM, 1980, CALIF MANAGE REV, V22, P59, DOI 10.2307/41164877
   Krippendorff K., 1980, CONTENT ANAL INTRO I
   Kucharska W, 2019, CORP SOC RESP ENV MA, V26, P453, DOI 10.1002/csr.1696
   Laurisz N, 2019, ADM SCI, V9, DOI 10.3390/admsci9040074
   Lichtenstein DR, 2004, J MARKETING, V68, P16, DOI 10.1509/jmkg.68.4.16.42726
   Lopez-Arceiz FJ, 2020, REV CONTAB, V23, P148, DOI 10.6018/rcsar.369331
   Madsen PM, 2015, STRATEGIC MANAGE J, V36, P776, DOI 10.1002/smj.2246
   Mahmud A, 2021, SAGE OPEN, V11, DOI 10.1177/2158244020988710
   Mahmud Ashek, 2021, Int J Community Wellbeing, V4, P315, DOI 10.1007/s42413-020-00071-w
   Manuel T, 2020, SOC BUS REV, V15, P235, DOI 10.1108/SBR-06-2020-0086
   Martinez-Cordoba PJ, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13031222
   Maykrantz SA, 2021, ADM SCI, V11, DOI 10.3390/admsci11020041
   McAdam R., 2003, CORP GOVERNANCE, V3, P36, DOI [10.1108/14720700310497104, DOI 10.1108/14720700310497104]
   McWilliams A, 2001, ACAD MANAGE REV, V26, P117, DOI 10.5465/AMR.2001.4011987
   Michael B., 2003, CORP SOC RESP ENV MA, V10, P115, DOI [10.1002/csr.41, DOI 10.1002/CSR.41]
   Morrone D, 2021, INT J DIG CULT ELECT, DOI [10.1504/IJDCET.2021.10035987, DOI 10.1504/IJDCET.2021.10035987]
   Muller E, 2015, NEW ENGL J MED, V372, P613, DOI 10.1056/NEJMoa1408896
   Nicolo G, 2022, MANAGE DECIS, V60, P976, DOI 10.1108/MD-01-2021-0034
   Pedersen ER, 2010, J BUS ETHICS, V91, P155, DOI 10.1007/s10551-009-0078-0
   Raimo N, 2021, MEAS BUS EXCELL, V25, P493, DOI 10.1108/MBE-11-2020-0149
   Raimo N, 2021, CORP SOC RESP ENV MA, V28, P1412, DOI 10.1002/csr.2134
   Raimo N, 2021, INT J ENTREP BEHAV R, DOI 10.1108/IJEBR-01-2021-0082
   Raimo N, 2020, MEAS BUS EXCELL, V24, P575, DOI 10.1108/MBE-05-2020-0082
   Raimo N, 2021, BRIT FOOD J, V123, P49, DOI 10.1108/BFJ-03-2020-0278
   Raimo N, 2020, BUS STRATEG ENVIRON, V29, P2238, DOI 10.1002/bse.2498
   Ricciardelli A, 2020, CORP SOC RESP ENV MA, V27, P1989, DOI 10.1002/csr.1940
   Sen S, 2006, J ACAD MARKET SCI, V34, P158, DOI 10.1177/0092070305284978
   Sidor M, 2021, ADM SCI, V11, DOI 10.3390/admsci11010024
   Smith NC, 2003, CALIF MANAGE REV, V45, P52, DOI 10.2307/41166188
   Stake RobertE., 2000, HDB QUALITATIVE RES, DOI DOI 10.1258/096214400320575624
   Venugopalan M, 2021, ADM SCI, V11, DOI 10.3390/admsci11010031
   Vitolla F, 2020, OWN CONTR, V18, P281, DOI [10.22495/cocv18i1siart4, DOI 10.22495/COCV18I1SIART4]
   Vitolla F, 2022, MEDITARI ACCOUNT RES, V30, P142, DOI 10.1108/MEDAR-08-2020-0973
   Vitolla F, 2020, CORP SOC RESP ENV MA, V27, P1152, DOI 10.1002/csr.1879
   Vitolla F, 2019, BUS STRATEG ENVIRON, V28, P1558, DOI 10.1002/bse.2332
   Vitolla F, 2019, CORP SOC RESP ENV MA, V26, P1591, DOI 10.1002/csr.1850
   Vitolla F, 2019, CORP SOC RESP ENV MA, V26, P518, DOI 10.1002/csr.1734
   Vitolla Filippo., 2018, INT J BUSINESS MANAG, V13, P244, DOI [10.5539/ijbm.v13n12p244, DOI 10.5539/IJBM.V13N12P244]
   Vuontisjarvi T, 2006, J BUS ETHICS, V69, P331, DOI 10.1007/s10551-006-9094-5
   Wei J., 2015, GLOBAL BUSINESS ORG, V34, P50, DOI DOI 10.1002/JOE.21614
   Zhao XP, 2022, J MANAGE, V48, P114, DOI 10.1177/0149206320946108
NR 73
TC 6
Z9 6
U1 6
U2 15
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD JUN
PY 2021
VL 13
IS 12
AR 6561
DI 10.3390/su13126561
PG 16
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA SZ4LS
UT WOS:000666539200001
OA gold
DA 2022-04-20
ER

PT J
AU Islam, A
   Abul Kalam, M
   Abu Sayeed, M
   Shano, S
   Rahman, MK
   Islam, S
   Ferdous, J
   Choudhury, SD
   Hassan, MM
AF Islam, Ariful
   Abul Kalam, Md
   Abu Sayeed, Md
   Shano, Shahanaj
   Rahman, Md Kaisar
   Islam, Shariful
   Ferdous, Jinnat
   Choudhury, Shusmita Dutta
   Hassan, Mohammad Mahmudul
TI Escalating SARS-CoV-2 circulation in environment and tracking waste
   management in South Asia
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Review
DE COVID-19; Environment; Waste management; Sanitation; Public health;
   South Asia
ID WATER MANAGEMENT; DEVELOPING-COUNTRIES; VIRAL-RNA; CORONAVIRUS;
   COVID-19; SURVIVAL; BANGLADESH; CHALLENGES; STABILITY; SPECIMENS
AB The novel coronavirus disease of 2019 (COVID-19) pandemic has caused an exceptional drift of production, utilization, and disposal of personal protective equipment (PPE) and different microplastic objects for safety against the virus. Hence, we reviewed related literature on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA detected from household, biomedical waste, and sewage to identify possible health risks and status of existing laws, regulations, and policies regarding waste disposal in South Asian (SA) countries. The SARS-CoV-2 RNA was detected in sewage and wastewater samples of Nepal, India, Pakistan, and Bangladesh. Besides, this review reiterates the enormous amounts of PPE and other single-use plastic wastes generated from healthcare facilities and households in the SA region with inappropriate disposal, landfilling, and/or incineration techniques wind-up polluting the environment. Consequently, the Delta variant (B.1.617.2) of SARS-CoV-2 has been detected in sewer treatment plant in India. Moreover, the overuse of non-biodegradable plastics during the pandemic is deteriorating plastic pollution condition and causes a substantial health risk to the terrestrial and aquatic ecosystems. We recommend making necessary adjustments, adopting measures and strategies, and enforcement of the existing biomedical waste management and sanitation-related policy in SA countries. We propose to adopt the knowledge gaps to improve COVID-19-associated waste management and legislation to prevent further environmental pollution. Besides, the citizens should follow proper disposal procedures of COVID-19 waste to control the environmental pollution.
C1 [Islam, Ariful; Abu Sayeed, Md; Shano, Shahanaj; Rahman, Md Kaisar; Islam, Shariful; Ferdous, Jinnat; Choudhury, Shusmita Dutta] EcoHlth Alliance, New York, NY 10001 USA.
   [Islam, Ariful] Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Burwood, Vic 3216, Australia.
   [Abul Kalam, Md] Helen Keller Int, Dhaka 1212, Bangladesh.
   [Abu Sayeed, Md; Shano, Shahanaj; Rahman, Md Kaisar; Islam, Shariful; Ferdous, Jinnat; Choudhury, Shusmita Dutta] Inst Epidemiol Dis Control & Res IEDCR, Dhaka 1212, Bangladesh.
   [Hassan, Mohammad Mahmudul] Chattogram Vet & Anim Sci Univ, Fac Vet Med, Chattogram 4225, Bangladesh.
RP Islam, A (corresponding author), EcoHlth Alliance, New York, NY 10001 USA.; Islam, A (corresponding author), Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Burwood, Vic 3216, Australia.
EM arif@ecohealthalliance.org
RI Hassan, Mohammad Mahmudul/U-6929-2019
OI Hassan, Mohammad Mahmudul/0000-0001-6495-4637; Kalam, Md.
   Abul/0000-0003-4236-8519
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U01AI153420-01]
FX The authors did not receive any external funds to conduct this research.
   However, the research team's time partially was supported by NIH
   U01AI153420-01 (PI Epstein) through EcoHealth Alliance.
CR Abd El-Salam MM, 2010, J ENVIRON MANAGE, V91, P618, DOI 10.1016/j.jenvman.2009.08.012
   Abdel-Shafy H.I., 2018, EGYPT J PETROL, V27, P1275, DOI [10.1016/j.ejpe.2018.07.003, DOI 10.1016/J.EJPE.2018.07.003]
   Abdulla F, 2008, WASTE MANAGE, V28, P450, DOI 10.1016/j.wasman.2007.02.035
   Abedin J, 2021, MICROORGANISMS, V9, P1696
   ADB, 2020, ADB DAT ROOM MAN INF
   Adu RO, 2020, J ENVIRON PUBLIC HEA, V2020, DOI 10.1155/2020/2934296
   Ahmed F, 2021, SCI TOTAL ENVIRON, V776, DOI 10.1016/j.scitotenv.2021.145724
   Ahmed W, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138764
   Alam MU, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197201
   Albastaki A, 2021, SCI TOTAL ENVIRON, V760, DOI 10.1016/j.scitotenv.2020.143350
   Ali M, 2017, WASTE MANAGE RES, V35, P581, DOI 10.1177/0734242X17691344
   Ali M, 2016, WASTE MANAGE RES, V34, P87, DOI 10.1177/0734242X15616474
   Amin MA., 2020, DHAKA TRIBUNE COVID
   Amin N, 2021, HOSP DHAKA DISCHARGE
   Amin N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221193
   Ananth AP, 2010, WASTE MANAGE, V30, P154, DOI 10.1016/j.wasman.2009.07.018
   [Anonymous], 2011, TECHNICAL GUIDELINES
   [Anonymous], 2020, THE CNN
   Aragaw TA, 2020, MAR POLLUT BULL, V159, DOI 10.1016/j.marpolbul.2020.111517
   Arora S., 2020, BMJ-BRIT MED J, P1, DOI [10.1101/2020.09.18.20197178, DOI 10.1101/2020.09.18.20197178]
   Babu B. R., 2009, Journal of International Environmental Application & Science, V4, P65
   Bahauddin K., 2012, J ENV SCI NATURAL RE, V5, P99, DOI 10.3329/jesnr.v5i1.11601
   Banik Rajon, 2020, Public Health Pract (Oxf), V1, P100024, DOI 10.1016/j.puhip.2020.100024
   Behnam B, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12219077
   Brackney DE, 2020, SARS COV 2 RNA CONCE, DOI [10.1101/2020.05.19.20105999, DOI 10.1101/2020.05.19.20105999]
   Brito ACC., 2017, SOLID WASTE MANAG RU, V81
   Casanova L, 2009, WATER RES, V43, P1893, DOI 10.1016/j.watres.2009.02.002
   Chakraborty P, 2021, SCI TOTAL ENVIRON, V778, DOI 10.1016/j.scitotenv.2021.146252
   Chartier Y, 2014, SAFE MANAGEMENT WAST
   Cheval S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114140
   Chin AWH, 2020, LANCET MICROBE, V1, pE10, DOI 10.1016/S2666-5247(20)30003-3
   Dana, 2011, OIDA INT J SUSTAIN D, V2, P29
   Datta P, 2018, J LAB PHYS, V10, P6, DOI 10.4103/JLP.JLP_89_17
   Dhokhikah Y., 2012, J APPL ENVIRON BIOL, V2, P329
   Dorji U, 2019, PROCESS SAF ENVIRON, V132, P82, DOI 10.1016/j.psep.2019.09.023
   Duan SM, 2003, BIOMED ENVIRON SCI, V16, P246
   Edita, 2020, STRENGTHENING WASTE
   ESDO, 2020, ESDOS ONL PRESS BRIE
   Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X
   Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254
   Ferronato N, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16061060
   Foladori P, 2020, SCI TOTAL ENVIRON, V743, DOI 10.1016/j.scitotenv.2020.140444
   Gerba CP, 2017, WATER RES, V108, P25, DOI 10.1016/j.watres.2016.11.020
   Ghinai I, 2020, LANCET, V395, P1137, DOI 10.1016/S0140-6736(20)30607-3
   Penteado CSG, 2021, RESOUR CONSERV RECY, V164, DOI 10.1016/j.resconrec.2020.105152
   Goh GKM, 2020, MICROB PATHOGENESIS, V144, DOI 10.1016/j.micpath.2020.104177
   Gundy PM, 2009, FOOD ENVIRON VIROL, V1, P10, DOI 10.1007/s12560-008-9001-6
   Gupta, 2020, SEWAGE SURVEILLANCE, DOI [10.1101/2020.06.18.20135277, DOI 10.1101/2020.06.18.20135277]
   Gwenzi W, 2021, SCI TOTAL ENVIRON, V753, DOI 10.1016/j.scitotenv.2020.141751
   Haq KA, 2006, INT J WATER RESOUR D, V22, P291, DOI 10.1080/07900620600677810
   Haque MS, 2021, WASTE MANAGE RES, V39, P3, DOI 10.1177/0734242X20980828
   Haque MS, 2021, J ENVIRON CHEM ENG, V9, DOI 10.1016/j.jece.2020.104660
   Haramoto E, 2020, SCI TOTAL ENVIRON, V737, DOI 10.1016/j.scitotenv.2020.140405
   Harhay MO, 2009, TROP MED INT HEALTH, V14, P1414, DOI 10.1111/j.1365-3156.2009.02386.x
   Hasan MK, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02145
   Hassan MM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-36
   Hassan Mohammad M., 2020, Infection Ecology & Epidemiology, V10, P1792620, DOI 10.1080/20008686.2020.1792620
   Hemalatha M, 2021, SCI TOTAL ENVIRON, V768, DOI 10.1016/j.scitotenv.2020.144704
   Idris A., 2004, J MATER CYCLES WASTE, V6, P104, DOI DOI 10.1007/S10163-004-0117-Y
   IGES, 2020, WAST MAN COVID 19 PA
   Ilyas S, 2020, SCI TOTAL ENVIRON, V749, DOI 10.1016/j.scitotenv.2020.141652
   Iqbal SS, 2016, J ENV TREAT TECHNOL, V4, P78
   Islam A, 2021, TRANSBOUND EMERG DIS, V68, P3643, DOI 10.1111/tbed.13973
   Islam Ariful, 2021, Biosaf Health, V3, P39, DOI 10.1016/j.bsheal.2020.09.006
   Didar-Ul Islam SM, 2021, ENVIRON DEV SUSTAIN, V23, P11953, DOI 10.1007/s10668-020-01151-9
   Islam T., 2021, J ADV BIOTECHNOL EXP, V4
   Islam T, 2020, J PUBLIC HEALTH-UK, V42, P637, DOI 10.1093/pubmed/fdaa088
   Johnston D, 2021, CUGH 2021 VIRT C CUG
   Jui UM, 2020, WORRYING SPIKE HAZAR
   Kam KQ, 2020, CLIN INFECT DIS, V71, P847, DOI 10.1093/cid/ciaa201
   Kamal ASM, 2008, URBAN WATER J, V5, P345, DOI 10.1080/15730620802030056
   Kataki S, 2021, RESOUR CONSERV RECY, V164, DOI 10.1016/j.resconrec.2020.105156
   Kitajima M, 2020, SCI TOTAL ENVIRON, V739, DOI 10.1016/j.scitotenv.2020.139076
   Kumar M, 2020, SCI TOTAL ENVIRON, V746, DOI 10.1016/j.scitotenv.2020.141326
   Kumar S, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160764
   Laohalidanond, 2015, HDB CLEAN ENERGY SYS, P1
   LeChevallier MW, 2020, WATER ENVIRON RES, V92, P524, DOI 10.1002/wer.1249
   Lesimple A, 2020, J WATER PROCESS ENG, V38, DOI 10.1016/j.jwpe.2020.101544
   Lo IL, 2020, INT J BIOL SCI, V16, P1698, DOI 10.7150/ijbs.45357
   Mahmood S, 2011, ANN KING EDWARD MED, V17, P113
   Manaf LA, 2009, WASTE MANAGE, V29, P2902, DOI 10.1016/j.wasman.2008.07.015
   Mandal P, 2020, J ENVIRON CHEM ENG, V8, DOI 10.1016/j.jece.2020.104317
   Mansour G, 2017, SITUATION ANAL URBAN
   Medema G, 2020, ENVIRON SCI TECH LET, V7, P511, DOI 10.1021/acs.estlett.0c00357
   Mohankumar S., 2011, International Journal of Pharmaceutical and Biological Archives, V2, P1621
   Mohee R, 2005, WASTE MANAGE, V25, P575, DOI 10.1016/j.wasman.2004.10.003
   MOHFW, 2008, MED WAST MAN RUL 200
   Napit R., 2021, RAPID GENOMIC SURVEI, DOI [10.1101/2021.03.29.21254053, DOI 10.1101/2021.03.29.21254053]
   Nasrin F., 2016, INT RES J SOC SCI, V5, P36
   Nzediegwu C, 2020, RESOUR CONSERV RECY, V161, DOI 10.1016/j.resconrec.2020.104947
   Ouhsine O, 2020, GLOB J ENVIRON SCI M, V6, P41, DOI 10.22034/GJESM.2019.06.SI.05
   Pandey D, 2021, INT J HYG ENVIR HEAL, V231, DOI 10.1016/j.ijheh.2020.113634
   Qu GB, 2020, ENVIRON SCI TECHNOL, V54, P3730, DOI 10.1021/acs.est.0c01102
   Quilliam RS, 2020, ENVIRON INT, V140, DOI 10.1016/j.envint.2020.105790
   Rabenau HF, 2005, MED MICROBIOL IMMUN, V194, P1, DOI 10.1007/s00430-004-0219-0
   Ragaert P, 2004, FOOD QUAL PREFER, V15, P259, DOI 10.1016/S0950-3293(03)00066-1
   RAHMAN M, 2020, GLOBAL HLTH LANCET
   Rahman M.I., 2017, INT J ENV PROTECTION, V5, P19, DOI DOI 10.11648/J.IJEPP.20170502.11
   Rahman MH, 2020, CURR PHARM DESIGN, V26, P5224, DOI 10.2174/1381612826666200713174140
   Rajendran, 2019, RECENT ADV COMPUTATI, V823, P173, DOI [DOI 10.1007/978-3-030-12500-4_11, 10.1007/978-3-030-12500-4_11]
   Randazzo W, 2020, WATER RES, V181, DOI 10.1016/j.watres.2020.115942
   Ray A., 2008, J ENVIRON DEV, V17, P3, DOI [10.1177/1070496507310742, DOI 10.1177/1070496507310742]
   Raza S., 2020, LONGITUDINAL SURVEY, DOI [10.1101/2020.07.31.20165126, DOI 10.1101/2020.07.31.20165126]
   Rimoldi SG, 2020, SCI TOTAL ENVIRON, V744, DOI 10.1016/j.scitotenv.2020.140911
   Rume T, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04965
   Saadat S, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138870
   Sangkham S., 2020, CASE STUD CHEM ENV E, V2, DOI DOI 10.1016/J.CSCEE.2020.100052
   Seilmaier, 2020, NATURE, DOI [10.1038/s41586-020-2196-x, DOI 10.1038/S41586-020-2196-X]
   Sembiring E, 2010, RESOUR CONSERV RECY, V54, P802, DOI 10.1016/j.resconrec.2009.12.010
   Shah KS., 2008, PUBLIC HLTH COMMU ME, P261
   Shammi M, 2021, GLOB SOC WELFARE, V8, P133, DOI 10.1007/s40609-020-00195-z
   Sharif, 2020, DETECTION SARS CORON, DOI [10.1101/2020.06.03.20121426, DOI 10.1101/2020.06.03.20121426]
   Sharma HB, 2020, RESOUR CONSERV RECY, V162, DOI 10.1016/j.resconrec.2020.105052
   Sharma S, 2022, CNS NEUROL DISORD-DR, V21, P228, DOI 10.2174/1871527320666210308113457
   Sharmin A., 2016, WATER WASTEWATER BAN
   Sheheli, 2007, PROGR AGR, V18, P241, DOI DOI 10.3329/PA.V18I2.18278
   Shekdar AV, 2009, WASTE MANAGE, V29, P1438, DOI 10.1016/j.wasman.2008.08.025
   Short, 2020, CASE STUD CHEM ENV E, V1, DOI DOI 10.1016/J.CSCEE.2020.100006
   Siddiqui, 2012, J ENV OCCUPATIONAL S, V1, P129
   Sinclair RG, 2008, ADV APPL MICROBIOL, V65, P249, DOI 10.1016/S0065-2164(08)00609-6
   Singh N, 2020, RESOUR CONSERV RECY, V163, DOI 10.1016/j.resconrec.2020.105071
   Singh N, 2020, ENVIRON SCI TECHNOL, V54, P8500, DOI 10.1021/acs.est.0c03022
   Sizun J, 2000, J HOSP INFECT, V46, P55, DOI 10.1053/jhin.2000.0795
   Somani Mohit, 2020, Bioresour Technol Rep, V11, P100491, DOI 10.1016/j.biteb.2020.100491
   Sunkari ED, 2021, SCI TOTAL ENVIRON, V753, DOI 10.1016/j.scitotenv.2020.142298
   Syed EH, 2012, HOME HLTH CARE MAN P, V24, P140, DOI 10.1177/1084822311425235
   Tajmim T., 2020, DENGUE THREAT RISES
   Tareq SM., 2020, ENVIRON SCI TECHNOL, V55, P4087
   Thakur V, 2015, WASTE MANAGE RES, V33, P855, DOI 10.1177/0734242X15594248
   Thompson RC, 2009, PHILOS T R SOC B, V364, P2153, DOI 10.1098/rstb.2009.0053
   Tiwari, 2020, WASTE MANAGEMENT PAR, P337, DOI [10.1007/978-981-13-6358-0_14, DOI 10.1007/978-981-13-6358-0_14]
   Tudor TL, 2005, WASTE MANAGE, V25, P606, DOI 10.1016/j.wasman.2004.10.004
   United Nations Children's Fund (UNICEF), 2020, WATER SANITATION HYG
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Wang XW, 2005, J VIROL METHODS, V126, P171, DOI 10.1016/j.jviromet.2005.02.005
   Warnes SL, 2015, MBIO, V6, DOI 10.1128/mBio.01697-15
   WaterAid, 2019, FAECAL SLUDGE MANAGE
   WHO, 2018, HLTH CAR WAST
   WHO UNICEF, 2020, JOINT MON PROGR JMP
   Wong G, 2020, ZOOL RES, V41, P213, DOI 10.24272/j.issn.2095-8137.2020.031
   World Health Organization, 2005, MAN SOL HLTH CAR WAS
   Worldometers, 2021, COR
   Wu Fuqing, 2020, medRxiv, DOI 10.1101/2020.06.15.20117747
   Wu YJ, 2020, LANCET GASTROENTEROL, V5, P434, DOI 10.1016/S2468-1253(20)30083-2
   Wurtzer S, 2020, EUROSURVEILLANCE, V25, P38, DOI 10.2807/1560-7917.ES.2020.25.50.2000776
   Xiao F, 2020, GASTROENTEROLOGY, V158, P1831, DOI 10.1053/j.gastro.2020.02.055
   Xu B, 2020, LANCET INFECT DIS, V20, P534, DOI 10.1016/S1473-3099(20)30119-5
   Xu SQ, 2020, LANCET, V395, P1321, DOI 10.1016/S0140-6736(20)30845-X
   Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4
   Yu H, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051770
   Zamparas M, 2019, SUSTAIN CHEM PHARM, V13, DOI 10.1016/j.scp.2019.100163
   Zhang DY, 2020, SCI TOTAL ENVIRON, V741, DOI 10.1016/j.scitotenv.2020.140445
NR 152
TC 0
Z9 0
U1 13
U2 14
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD NOV
PY 2021
VL 28
IS 44
BP 61951
EP 61968
DI 10.1007/s11356-021-16396-8
EA SEP 2021
PG 18
WC Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology
GA WW6JV
UT WOS:000698576900007
PM 34558044
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Davis, B
   Rothrock, AN
   Swetland, S
   Andris, H
   Davis, P
   Rothrock, SG
AF Davis, Bennett
   Rothrock, Ava N.
   Swetland, Sarah
   Andris, Halle
   Davis, Phil
   Rothrock, Steven G.
TI Viral and atypical respiratory co-infections in COVID-19: a systematic
   review and meta-analysis
SO JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN
LA English
DT Review
DE COVID-19; influenza; human; mycoplasma; pneumonia; viral; respiratory
   tract infections
ID COMMUNITY-ACQUIRED PNEUMONIA; RECOMMENDATIONS; INFECTION
AB Objectives: Respiratory co-infections have the potential to affect the diagnosis and treatment of COVID-19 patients. This meta-analysis was performed to analyze the prevalence of respiratory pathogens (viruses and atypical bacteria) in COVID-19 patients.
   Methods: This review was consistent with Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA). Searched databases included: PubMed, EMBASE, Web of Science, Google Scholar, and grey literature. Studies with a series of SARS-CoV-2-positive patients with additional respiratory pathogen testing were included. Independently, 2 authors extracted data and assessed quality of evidence across all studies using Cochrane's Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology and within each study using the Newcastle Ottawa scale. Data extraction and quality assessment disagreements were settled by a third author. Pooled prevalence of co-infections was calculated using a random-effects model with univariate meta-regression performed to assess the effect of study subsets on heterogeneity. Publication bias was evaluated using funnel plot inspection, Begg's correlation, and Egger's test.
   Results: Eighteen retrospective cohorts and 1 prospective study were included. Pooling of data (1880 subjects) showed an 11.6% (95% confidence interval [CI] = 6.9-17.4, I-2 = 0.92) pooled prevalence of respiratory co-pathogens. Studies with 100% co-pathogen testing (1210 subjects) found a pooled prevalence of 16.8% (95% CI = 8.1-27.9, I-2 = 0.95) and studies using serum antibody tests (488 subjects) found a pooled prevalence of 26.8% (95%, CI = 7.9-51.9, I-2 = 0.97). Meta-regression found no moderators affecting heterogeneity.
   Conclusion: Co-infection with respiratory pathogens is a common and potentially important occurrence in patients with COVID-19. Knowledge of the prevalence and type of co-infections may have diagnostic and management implications.
C1 [Davis, Bennett] Univ Queensland, Ochsner Clin Sch, Brisbane, Qld, Australia.
   [Rothrock, Ava N.; Swetland, Sarah; Andris, Halle; Davis, Phil; Rothrock, Steven G.] Dr P Phillips Hosp, Orlando Hlth, Orlando, FL 32819 USA.
   [Rothrock, Steven G.] Florida State Univ, Coll Med, Tallahassee, FL 32306 USA.
RP Rothrock, SG (corresponding author), Dr P Phillips Hosp, Orlando Hlth, Orlando, FL 32819 USA.
FU JACEP Open policy
FX By JACEP Open policy, all authors are required to disclose any and all
   commercial, financial, and other relationships in anyway related to the
   subject of this article as per ICMJEconflict of interest guidelines (see
   www.icmje.org).The authors have stated that no such relationships exist.
CR Ai JW, 2020, OPTIMIZING DIAGNOSTI, DOI [10.1101/2020.02.13.20022673, DOI 10.1101/2020.02.13.20022673]
   Alaska public health alert, UPD CRIT COR DIS 201
   Alexander PE, 2016, J CLIN EPIDEMIOL, V70, P111, DOI 10.1016/j.jclinepi.2015.09.006
   Alexander PE, 2016, J CLIN EPIDEMIOL, V72, P98, DOI 10.1016/j.jclinepi.2014.10.011
   Alexander PE, 2014, J CLIN EPIDEMIOL, V67, P629, DOI 10.1016/j.jclinepi.2013.09.020
   [Anonymous], 2020, JAMA, DOI DOI 10.1001/JAMA.2020.6775
   Asner SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099392
   Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
   Basile K, 2018, EXPERT REV MOL DIAGN, V18, P75, DOI 10.1080/14737159.2018.1419065
   Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500
   Bordi L, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.8.2000170
   Burk M, 2016, EUR RESPIR REV, V25, P178, DOI 10.1183/16000617.0076-2015
   Byington CL, 2015, CLIN INFECT DIS, V61, P1217, DOI 10.1093/cid/civ486
   Centers for Disease Control and Prevention, 2020, UPD GUID EV TEST PER
   Centers for Disease Control and Prevention, INFL FLU IS FLU SEAS
   Chang Z, 2020, SEX DIFFERENCES CLIN
   COOK DJ, 1993, JAMA-J AM MED ASSOC, V269, P2749, DOI 10.1001/jama.269.21.2749
   Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Familiari F, 2018, AM J SPORT MED, V46, P3541, DOI 10.1177/0363546517732531
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Fleming PS, 2016, J CLIN EPIDEMIOL, V78, P34, DOI 10.1016/j.jclinepi.2016.03.012
   Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204
   Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X
   Huang C, 2020, Lancet, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Kaminski A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008013.pub2
   Kansas Department of Health and Environment, DEF PERS INV
   Klein EY, 2016, INFLUENZA OTHER RESP, V10, P394, DOI 10.1111/irv.12398
   Lee SS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230497
   Li Q., 2020, SIMPLE LAB PARAMETER, DOI [10.1101/2020.02.13.20022830, DOI 10.1101/2020.02.13.20022830]
   Liu HH, 2020, J INFECTION, V80, pE7, DOI 10.1016/j.jinf.2020.03.007
   Liu L, 2020, LANCET INFECT DIS
   Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3
   Nha Kyung Wook, 2019, Knee Surg Relat Res, V31, P81, DOI 10.5792/ksrr.17.090
   Ni W., 2020, LANCET, DOI [10.1101/2020.02.29.20027698, DOI 10.2139/SSRN.3550013]
   Nielsen SM, 2018, AUTOIMMUN REV, V17, P1090, DOI 10.1016/j.autrev.2018.05.008
   Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248
   Qiu Y, 2010, SCAND J IMMUNOL, V72, P425, DOI 10.1111/j.1365-3083.2010.02456.x
   Schmucker CM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176210
   Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE
   Schunemann H, GRADE HDB GRADING QU
   Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002
   Suurmond R, 2017, RES SYNTH METHODS, V8, P537, DOI 10.1002/jrsm.1260
   Takah NF, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5171-9
   Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461
   Touzard-Romo Francine, 2020, R I Med J (2013), V103, P75
   Turner RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059202
   Wang M, 2015, RESPIROLOGY, V20, P405, DOI 10.1111/resp.12472
   Wang ZL, 2020, CLIN INFECT DIS, V71, P769, DOI 10.1093/cid/ciaa272
   WHO, 2020, EP UPD NOV COR 2019
   Wiffen PJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012637.pub2
   World Health Organization, 2020, LAB TEST HUM SUSP CA
   World Health Organization, 104 WHO
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Wu J, 2020, CLIN INFECT DIS, V71, P706, DOI 10.1093/cid/ciaa199
   Wu XJ, 2020, EMERG INFECT DIS, V26, P1324, DOI 10.3201/eid2606.200299
   Xiao Y., 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa270, DOI 10.1093/CID/CIAA270]
   Zahariadis George, 2006, Can Respir J, V13, P17
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
   Zhang YG, 2017, J CLIN MICROBIOL, V55, P79, DOI [10.1128/JCM.01701-16, 10.1128/JCM.01224-16]
   Zhou, 2020, CLIN DIAGNOSIS 8274, DOI [10.1101/2020.02.12.20022327v2, DOI 10.1101/2020.02.12.20022327]
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 62
TC 12
Z9 12
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2688-1152
J9 JACEP OPEN
JI J. Am. Coll. Emerg. Phys. Open
PD AUG
PY 2020
VL 1
IS 4
BP 533
EP 548
DI 10.1002/emp2.12128
PG 16
WC Emergency Medicine
WE Emerging Sources Citation Index (ESCI)
SC Emergency Medicine
GA RZ6GN
UT WOS:000648695100030
PM 32838380
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Tiernan, JP
   Davies, MM
AF Tiernan, Jim P.
   Davies, Michael M.
CA Assoc Cotoproctology Great nd
TI Effect of COVID-19 on the detection and management of colorectal cancer
   in England
SO LANCET GASTROENTEROLOGY & HEPATOLOGY
LA English
DT Letter
AB We read with interest the Article by Eva Morris and colleagues,1 published in The Lancet Gastroenterology & Hepatology, and welcome the valid concerns raised. Analysis of populationbased data has provided a rapid insight into the effect of COVID-19 on referral and management of patients with colorectal cancer in England during the first wave of the pandemic and the subsequent recovery period. This study documents changes made to investigative and treatment pathways in response to national guidance in the UK2 and the subsequently reduced capacity to investigate patients presenting with bowel symptoms. Armed with our knowledge of treating patients alongside the threat of COVID-19, it is all too easy to forget the extent of our ignorance and fear when the pandemic began, particularly regarding the unknown
C1 [Tiernan, Jim P.] St James Univ Hosp, John Goligher Colorectal Unit, Leeds, W Yorkshire, England.
   [Tiernan, Jim P.; Davies, Michael M.] Assoc Coloproctol Great Britain & Ireland, London, England.
   [Davies, Michael M.] Univ Wales Hosp, Dept Colorectal Surg, Cardiff, Wales.
RP Tiernan, JP (corresponding author), St James Univ Hosp, John Goligher Colorectal Unit, Leeds, W Yorkshire, England.; Tiernan, JP (corresponding author), Assoc Coloproctol Great Britain & Ireland, London, England.
EM j.tiernan@nhs.net
CR Chapman C, 2019, BJS OPEN, V3, P395, DOI 10.1002/bjs5.50131
   Morris EJA, 2021, LANCET GASTROENTEROL, V6, P199, DOI 10.1016/S2468-1253(21)00005-4
   Richards M., 2020, DIAGNOSTICS RECOVERY
   Thompson MR, 2020, BMJ-BRIT MED J, V371, P1
   Walsh C, 2020, CONSIDERATIONS MULTI
NR 5
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
EI 2468-1253
J9 LANCET GASTROENTEROL
JI Lancet Gastroenterol. Hepatol.
PD MAY
PY 2021
VL 6
IS 5
BP 342
EP 342
PG 1
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA RN3XF
UT WOS:000640285700006
PM 33857442
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Belso-Martinez, JA
   Mas-Tur, A
   Sanchez, M
   Lopez-Sanchez, MJ
AF Belso-Martinez, Jose Antonio
   Mas-Tur, Alicia
   Sanchez, Mariola
   Lopez-Sanchez, Maria Jose
TI The COVID-19 response system and collective social service provision.
   Strategic network dimensions and proximity considerations
SO SERVICE BUSINESS
LA English
DT Article
DE Social services; Response networks; Systems; COVID-19; SNA
ID MANAGEMENT; INNOVATION; COLLABORATION; RESILIENCE; DYNAMICS; CONTEXT;
   PREPAREDNESS; PERFORMANCE; ROLES
AB This paper aims to study and question the emerging social response network to the COVID-19 health crisis in the Valencian region (Spain). Our approach is twofold: a network approach using social network analysis techniques and a social services approach. We seek to analyze the different roles, strategic positions, ego-density and brokerage of the participating organizations. Furthermore, we examine the critical factors for explaining why the different organizations in the ecosystem cooperate. We find that associations and knowledge agents play the most relevant roles. Conversely, local and non-local governments rarely played brokerage roles to coordinate or inter-connect isolated operations of individual organizations. Finally, our results suggest important guidelines for practitioners that may facilitate the collaboration, coordination, and performance of a response network in the future.
C1 [Belso-Martinez, Jose Antonio; Sanchez, Mariola; Lopez-Sanchez, Maria Jose] Miguel Hernandez Univ, Econ & Financial Studies Dept, Alicante, Spain.
   [Mas-Tur, Alicia] Univ Valencia, Business Management Dept, Valencia, Spain.
RP Mas-Tur, A (corresponding author), Univ Valencia, Business Management Dept, Valencia, Spain.
EM jbelso@umh.es; alicia.mas@uv.es; m.sanchezr@umh.es; maria.lopez@umh.es
RI Sánchez-Romero, Mariola/ABC-9012-2020
OI Sánchez-Romero, Mariola/0000-0003-0211-3212
FU Chair GVA-UMH for the Transformation of the Economic Model
FX Financial support from the Chair GVA-UMH for the Transformation of the
   Economic Model is gratefully acknowledge.
CR Abbasi A, 2016, COMPUT MATH ORGAN TH, V22, P47, DOI 10.1007/s10588-015-9196-7
   Abbasi A, 2014, NAT HAZARDS, V71, P1957, DOI 10.1007/s11069-013-0988-0
   Abedi V, 2020, RACIAL EC HLTH COVID
   Akehurst G, 2008, SERV BUS, V2, P1, DOI 10.1007/s11628-006-0015-6
   [Anonymous], 2020, IMF WORLD EC OUTLOOK
   [Anonymous], 2020, NY TIMES, P1
   Balland PA, 2016, ECON GEOGR, V92, P35, DOI 10.1080/00130095.2015.1094370
   Bell GG, 2007, ORGAN SCI, V18, P955, DOI 10.1287/orsc.1070.0308
   Bendle LJ, 2010, SERV IND J, V30, P1607, DOI 10.1080/02642060903580656
   Borgatti S, 2018, ANAL SOCIAL NETWORKS, P231
   Boschma RA, 2005, REG STUD, V39, P61, DOI 10.1080/0034340052000320887
   Boschma R, 2010, HANDBOOK OF EVOLUTIONARY ECONOMIC GEOGRAPHY, P120
   Bourdin S., 2020, DOES LOCKDOWN WORK S
   Broekel T, 2012, J ECON GEOGR, V12, P409, DOI 10.1093/jeg/lbr010
   Butts CT, 2007, SOCIOL METHODOL, V37, P257, DOI 10.1111/j.1467-9531.2007.00183.x
   Butts CT, 2012, SOC NETWORKS, V34, P82, DOI 10.1016/j.socnet.2011.08.003
   Cheshire L, 2015, ENVIRON PLANN A, V47, P1081, DOI 10.1177/0308518X15592310
   Comfort LK, 2006, PUBLIC WORKS MANAG P, V10, P328, DOI 10.1177/1087724X06289052
   Comfort Louise K., 2010, DESIGNING RESILIENCE
   Cowan R, 2007, MANAGE SCI, V53, P1051, DOI 10.1287/mnsc.1060.0618
   Echeverri P, 2018, SERV IND J, V38, P282, DOI 10.1080/02642069.2017.1374373
   Farmaki A, 2019, SERV IND J, V39, P668, DOI 10.1080/02642069.2018.1435643
   Finsterwalder J, 2017, SERV IND J, V37, P766, DOI 10.1080/02642069.2017.1351550
   Fisk RP, 2016, J SERV MANAGE, V27, P43, DOI 10.1108/JOSM-04-2015-0125
   Gao PC, 2020, ENVIRON PLANN A, V52, P698, DOI 10.1177/0308518X20910162
   Georgalakis J, 2020, SOC SCI MED, V250, DOI 10.1016/j.socscimed.2020.112851
   Gluckler J, 2012, SERV IND J, V32, P515, DOI 10.1080/02642069.2011.596534
   Gluckler J, 2011, SERV IND J, V31, P941, DOI 10.1080/02642060903078743
   GOULD R. V., 1989, SOCIOL METHODOL, V19, P89, DOI DOI 10.2307/270949
   Grabher G., 1993, EMBEDDED FIRM SOCIOE
   Gulati R, 1999, AM J SOCIOL, V104, P1439, DOI 10.1086/210179
   Guo XS, 2015, DISASTER PREV MANAG, V24, P201, DOI 10.1108/DPM-10-2014-0209
   Hansen T, 2015, REG STUD, V49, P1672, DOI 10.1080/00343404.2013.873120
   Hossain L, 2010, DISASTERS, V34, P755, DOI 10.1111/j.1467-7717.2010.01168.x
   Hossain L, 2008, PROJ MANAG J, V39, P68, DOI 10.1002/pmj.20086
   IOM (Institute of Medicine), 2015, PSYCH TEST SERV DIS
   Jiang YW, 2017, J HOSP TOUR MANAG, V31, P70, DOI 10.1016/j.jhtm.2016.09.004
   Sanzo MJ, 2015, SERV BUS, V9, P611, DOI 10.1007/s11628-014-0242-1
   Kapucu N, 2005, CONNECTIONS, V26, P33
   Kapucu N, 2021, DISASTERS, V45, P717, DOI 10.1111/disa.12439
   Kapucu N, 2016, ADMIN SOC, V48, P931, DOI 10.1177/0095399714541270
   Kapucu N, 2013, RISK HAZARDS CRISIS, V4, P215, DOI 10.1002/rhc3.12043
   Kapucu N, 2013, AM REV PUBLIC ADM, V43, P312, DOI 10.1177/0275074012444719
   Kapucu Naim., 2011, EUROPEAN J EC POLITI, V4, P83
   Kim Y, 2021, SOC SCI COMPUT REV, V39, P371, DOI 10.1177/0894439319858679
   KRACKHARDT D, 1988, SOC NETWORKS, V10, P359, DOI 10.1016/0378-8733(88)90004-4
   Lai CH, 2019, J CONTING CRISIS MAN, V27, P14, DOI 10.1111/1468-5973.12224
   Lazzeretti L, 2016, J BUS RES, V69, P5855, DOI 10.1016/j.jbusres.2016.04.068
   Lind BE, 2008, INT J EMERG MANAG, V5, P75, DOI 10.1504/IJEM.2008.019908
   Mattes J, 2012, REG STUD, V46, P1085, DOI 10.1080/00343404.2011.552493
   McGuire M, 2006, PUBLIC ADMIN REV, V66, P33, DOI 10.1111/j.1540-6210.2006.00664.x
   Mingxuan D, 2020, CITIES, V99, P102620
   Mukherji N., 2020, SOCIAL EC FACTORS UN
   Nigam, 2020, COVID 19 LOCKDOWN VI
   Nolte IM, 2011, PUBLIC ADMIN, V89, P1385, DOI 10.1111/j.1467-9299.2011.01950.x
   Nooteboom B., 2000, J MANAGEMENT GOVERNA, V4, P69, DOI [10.1080/09629350020025755, DOI 10.1023/A:1009941416749]
   NORTH DC, 1991, J ECON PERSPECT, V5, P97, DOI 10.1257/jep.5.1.97
   Oh N, 2014, J COMP POLICY ANAL, V16, P94, DOI 10.1080/13876988.2013.863639
   Pan PL, 2016, J CONTING CRISIS MAN, V24, P95, DOI 10.1111/1468-5973.12105
   Proenca T, 2018, SERV IND J, V38, P321, DOI 10.1080/02642069.2017.1377189
   PROVAN KG, 1991, J PUBLIC ADM RES THE, V0001, P00391
   Sadri AM, 2018, NAT HAZARDS, V90, P1377, DOI 10.1007/s11069-017-3103-0
   Sadri AM, 2017, NAT HAZARDS REV, V18, DOI 10.1061/(ASCE)NH.1527-6996.0000244
   Salehi R, 2006, CAN PUBLIC POL, V32, P373
   Scott N, 2010, SERV IND J, V30, P1581, DOI 10.1080/02642060903580623
   Shearmur R, 2016, ENTREP REGION DEV, V28, P337, DOI 10.1080/08985626.2016.1154984
   Shearmur R, 2015, REG STUD, V49, P1654, DOI 10.1080/00343404.2013.870988
   Sivaramakrishnan K, 2011, AM J PUBLIC HEALTH, V101, P1032, DOI 10.2105/AJPH.2010.300026
   STALLINGS RA, 1985, PUBLIC ADMIN REV, V45, P93, DOI 10.2307/3135003
   The World Bank, 2020, POV OV
   Trias APL, 2019, INT J DISAST RISK RE, V33, P217, DOI 10.1016/j.ijdrr.2018.10.007
   Wachtendorf T, 2006, HDB DISASTER RES, P387
   Waugh William L., 2003, PUBLIC ORG REV, V3, P373, DOI DOI 10.1023/B:PORJ.0000004815.29497.E5
   White J, 2014, IOM COMMITTEE POST D
   World Health Organization, 2020, 133 WHO
   WORLD HEALTH ORGANIZATION, 2020, 102 WHO
   Wuyts S, 2005, J ECON BEHAV ORGAN, V58, P277, DOI 10.1016/j.jebo.2004.03.019
   Zyck S, 2014, CDA ONE ALEWIFE CTR, V400, P2140
NR 78
TC 14
Z9 14
U1 3
U2 12
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1862-8516
EI 1862-8508
J9 SERV BUS
JI Serv. Bus.
PD SEP
PY 2020
VL 14
IS 3
BP 387
EP 411
DI 10.1007/s11628-020-00421-w
EA JUL 2020
PG 25
WC Business; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA NH8PW
UT WOS:000551009600001
OA Bronze
DA 2022-04-20
ER

PT J
AU Lorenzo, A
   Olivas, JA
AF Lorenzo, Antonio
   Olivas, Jose A.
TI Intelligent Data Analysis of the Influence of COVID-19 on the Stock
   Market using Case Based Reasoning
SO JOURNAL OF COMPUTER SCIENCE & TECHNOLOGY
LA English
DT Article
DE Forecast; Prediction; Covid-19; Stock Markets; Case-Based Reasonig
   (CBR); Analogy Learning
AB Starting with the differences between forecasting and prediction and going deeper into prediction, a knowledge-based model is presented. The evolution of the stocks markets are analyzed, as well as how the epidemics and pandemics prior to the stock markets have affected them and how it is currently being affected by covid-19. The defined model is applied to a use case using Case-Based Reasoning (CBR): it makes an analogy between the 2008 crisis with the covid-19 crisis in 2020 to predict whether the stock markets will take more or less time to recover.
C1 [Lorenzo, Antonio] Castilla La Mancha Govt, Dept Business Intelligence, Toledo, Spain.
   [Lorenzo, Antonio; Olivas, Jose A.] Univ Castilla La Mancha, Informat Technol & Syst Inst Univ, SMILe Soft Management Internet & Learning, Ciudad Real, Spain.
RP Lorenzo, A (corresponding author), Castilla La Mancha Govt, Dept Business Intelligence, Toledo, Spain.; Lorenzo, A (corresponding author), Univ Castilla La Mancha, Informat Technol & Syst Inst Univ, SMILe Soft Management Internet & Learning, Ciudad Real, Spain.
EM alorenzo@jccm.es; JoseAngel.Olivas@uclm.es
FU FEDER of the Spanish Ministry of Economy and Competition [MERINET:
   TIN2016-76843-C4-2-R]; State Research Agency (AEI) of the Spanish
   Ministry of Economy and Competition [MERINET: TIN2016-76843-C4-2-R]
FX This work has been partially supported by FEDER and the State Research
   Agency (AEI) of the Spanish Ministry of Economy and Competition under
   grant MERINET: TIN2016-76843-C4-2-R (AEI/FEDER, UE).
CR Albulescu C., 2020, ARXIV200306184
   Ding S, 2018, ENERGY, V149, P314, DOI 10.1016/j.energy.2018.01.169
   Fan V. Y., 2016, W22137 NAT BUR EC RE
   Gormsen N. J., 2020, 202022 U CHIC BEEK F
   Minh DL, 2018, IEEE ACCESS, V6, P55392, DOI 10.1109/ACCESS.2018.2868970
   Noy I., 2019, 2003 SEVERE ACUTE RE
   Selvin S, 2017, 2017 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P1643, DOI 10.1109/ICACCI.2017.8126078
   Sezer OB, 2020, APPL SOFT COMPUT, V90, DOI 10.1016/j.asoc.2020.106181
   Stuparu D., 2017, EGU GEN ASS C, V19, P17173
   University of Valencia Spain, PRED MOD INF COV 19
   Win the Brexit, UNK DEC LEAV EUR UN
NR 11
TC 1
Z9 1
U1 1
U2 6
PU UNIV NAC LA PLATA, FAC INFORMATICA
PI LA PLATA
PA 50 Y 115, 1ER PISO, LA PLATA, 1900, ARGENTINA
SN 1666-6046
EI 1666-6038
J9 J COMPUT SCI TECHNOL
JI J. Comput. Sci. Technol.
PD OCT
PY 2020
VL 20
IS 2
BP 90
EP 98
DI 10.24215/16666038.20.e10
PG 9
WC Computer Science, Artificial Intelligence
WE Emerging Sources Citation Index (ESCI)
SC Computer Science
GA OU9MU
UT WOS:000591848200004
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Salunke, AA
   Warikoo, V
   Pathak, SK
   Nandy, K
   Mujawar, J
   Mendhe, H
   Shah, A
   Kottakota, V
   Menon, V
   Pandya, S
AF Salunke, Abhijeet Ashok
   Warikoo, Vikas
   Pathak, Subodh Kumar
   Nandy, Kunal
   Mujawar, Jalil
   Mendhe, Harshal
   Shah, Anand
   Kottakota, Vishwanth
   Menon, Vivek
   Pandya, Shashank
TI A proposed ABCD scoring system for better triage of patients with
   COVID-19: Use of clinical features and radiopathological findings
SO DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS
LA English
DT Article
DE ABCD Score; COVID-19 scoring system; Triage score; Corona disease score
ID DISEASE; IMPACT
AB Background and aims: Currently there are limited tools available for triage of patients with COVID -19. We propose a new ABCD scoring system for patients who have been tested positive for COVID-19.
   Methods: The ABCD score is for patients who have been tested positive for COVID-19 and admitted in a hospital. This score includes age of the patient, blood tests included leukopenia, lymphocytopenia, CRP level, LDH level,D-Dimer, Chest radiograph and CT Scan, Comorbidities and Dyspnea.
   Results: The triage score had letters from alphabets which included A, B, C, D. The score was developed using these variables which outputs a value from 0 to 1. We had used the code according to traffic signal system; green(mild), yellow moderate) and red(severe). The suggestions for mild (green)category: symptomatic treatment in ward, in moderate (yellow) category: active treatment, semi critical care and oxygen supplementation, in severe (red) category: critical care and intensive care.
   Conclusions: This study is, to our knowledge, is the first scoring tool that has been prepared by Indian health care processional's and used alphabets A, B,C,D as variables for evaluation of admitted patients with COVID-19. This triage tool will be helpful in better management of patients with COVID-19. This score component includes clinical and radiopathological findings.A multi-centre study is required to validate all available scoring systems. (C) 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.
C1 [Salunke, Abhijeet Ashok] NUH Singapore, Orthoped Oncol, Singapore, Singapore.
   [Salunke, Abhijeet Ashok; Warikoo, Vikas] Gujarat Canc Res Inst, Surg Oncol, Ahmadabad, Gujarat, India.
   [Pathak, Subodh Kumar] MM Deemed Univ, MMIMSR, Mullana, Ambala, India.
   [Nandy, Kunal; Kottakota, Vishwanth; Menon, Vivek; Pandya, Shashank] Gujarat Canc Res Inst, Ahmadabad, Gujarat, India.
   [Mujawar, Jalil] Sahyadri Hosp, Pune, Maharashtra, India.
   [Mendhe, Harshal] GMC, Dept Prevent & Social Med, Rajandgaon, Chattisgarh, India.
   [Shah, Anand] Gujarat Canc Res Inst, Dept Prevent & Social Med, Ahmadabad, Gujarat, India.
RP Salunke, AA (corresponding author), NUH Singapore, Orthoped Oncol, Singapore, Singapore.; Salunke, AA (corresponding author), Gujarat Canc Res Inst, Surg Oncol, Ahmadabad, Gujarat, India.
EM drabhijeetsalunke@gmail.com
RI Kunal, Nandy/AAJ-3478-2021
CR Bazyar Jafar, 2019, Open Access Maced J Med Sci, V7, P482, DOI 10.3889/oamjms.2019.119
   Duca Andrea, 2020, Emerg Med Pract, V22, pCD1
   Hu H, 2020, ACAD EMERG MED
   Ji D, 2020, CLIN INFECT DIS, V71, P1393, DOI 10.1093/cid/ciaa414
   Nandy K, 2020, DIABETES METAB SYND, V14, P1017, DOI 10.1016/j.dsx.2020.06.064
   Salunke AA, 2020, DIABETES METAB SYND, V14, P1495, DOI 10.1016/j.dsx.2020.07.053
   Salunke AA, 2020, DIABETES METAB SYND, V14, P1431, DOI 10.1016/j.dsx.2020.07.037
   Skandalakis PN, 2006, WORLD J SURG, V30, P1392, DOI 10.1007/s00268-005-0436-8
   Wallis LA, 2020, AFRICAN FEDERATION E
   Yu X, 2020, CRIT CARE, V24, P2, DOI DOI 10.1186/S13054-019-2710-4
NR 10
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1871-4021
EI 1878-0334
J9 DIABETES METAB SYND
JI Diabetes Metab. Syndr.-Clin. Res. Rev.
PD NOV-DEC
PY 2020
VL 14
IS 6
BP 1637
EP 1640
DI 10.1016/j.dsx.2020.08.019
PG 4
WC Endocrinology & Metabolism
WE Emerging Sources Citation Index (ESCI)
SC Endocrinology & Metabolism
GA PO7TE
UT WOS:000605370300018
PM 32892061
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Zhang, YP
   Zhou, RG
AF Zhang, Yaping
   Zhou, Ronggang
TI Promoting social distancing and preventing panic buying during the
   epidemic of COVID-19: the contributions of people's psychological and
   behavioural factors
SO JOURNAL OF PUBLIC HEALTH-HEIDELBERG
LA English
DT Article; Early Access
DE Risk perception; Psychological stress; Safeguard; Concerns about
   COVID-19; Social distancing; Panic buying
ID MENTAL-HEALTH-CARE; POPULATION; KNOWLEDGE; RESPONSES; OUTBREAK; IMPACT;
   NEED
AB Objectives COVID-19 disease has progressed to the level of a global pandemic. This study aimed to investigate people's psychological and behavioural responses to the COVID-19 epidemic and explore the predictors for social distancing and panic buying. Methods A 17-item questionnaire was developed and distributed randomly to people using social media. Descriptive statistics and one-way ANOVA were used to assess people's psychological and behavioural responses. Hierarchical regression was conducted to investigate the predictive effects of psychological and behavioural variables on reports of social distancing and panic buying respectively. Results Respondents reported a low degree of risk perception and risk beliefs with regard to being outside, and had moderate psychological stress and positive safeguarding behaviours for being outside. Respondents reported high concern regarding COVID-19 and tended to keep social distancing during the epidemic. They would panic-purchase food and supplies. In addition, psychological stress emerged as a very strong predictor for reporting COVID-19 concerns and panic buying. Furthermore, reported concerns about COVID-19 information sharing had a significant predictive influence on panic buying of food. Safeguarding behaviours for being outside had a significant predictive effect on respondents reported social distancing of cancelling outings. Reported concerns about COVID-19 were stronger predictors for reported social distancing. Conclusion It is important to relieve people's psychological stress and manage information sharing to control panic buying. In addition, we should promote adoption of safeguarding behaviours for being outside and emphasise the concerns with regard to COVID-19 to encourage people keep social distancing. Measures should be implemented according to the characteristics of the population.
C1 [Zhang, Yaping; Zhou, Ronggang] Beihang Univ, Sch Econ & Management, Beijing, Peoples R China.
   [Zhou, Ronggang] Beihang Univ, Beijing Key Lab Emergence Support Simulat Technol, Beijing, Peoples R China.
RP Zhou, RG (corresponding author), Beihang Univ, Sch Econ & Management, Beijing, Peoples R China.; Zhou, RG (corresponding author), Beihang Univ, Beijing Key Lab Emergence Support Simulat Technol, Beijing, Peoples R China.
EM zhangyaping@buaa.edu.cn; zhrg@buaa.edu.cn
FU Green oriented social and economic complex system management and
   decision making [72021001]; Fundamental Research Funds for the Central
   UniversitiesFundamental Research Funds for the Central Universities
   [YWF-20-BJJ-314]; National Natural Science Foundation of China
   (NSFC)National Natural Science Foundation of China (NSFC) [71640034]
FX This study was supported by Green oriented social and economic complex
   system management and decision making (72021001), the Fundamental
   Research Funds for the Central Universities (YWF-20-BJJ-314) and the
   National Natural Science Foundation of China (NSFC, 71640034).
CR [Anonymous], 2021, COR DIS COVID 19 PAN, DOI DOI 11/44679/INDEX.HTM
   Bandari DK, 2020, NOVEL CORONAVIRUS CO, V6, DOI DOI 10.1101/2020.03.09.20033381
   Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826
   CDC, 2020, SOC DIST
   Chen SM, 2020, LANCET, V395, P764, DOI 10.1016/S0140-6736(20)30421-9
   Fong MW, 2020, EMERG INFECT DIS, V26, P976, DOI 10.3201/eid2605.190995
   FORNELL C, 1981, J MARKETING RES, V18, P382, DOI 10.2307/3150980
   Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P1095, DOI 10.1001/jama.2014.11176
   Ho CSH, 2020, ANN ACAD MED SINGAP, V49, P155
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Lee D, 2019, J AFFECT DISORDERS, V259, P136, DOI 10.1016/j.jad.2019.06.036
   Leung CC, 2020, LANCET, V395, P945, DOI 10.1016/S0140-6736(20)30520-1
   Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857
   Liao QY, 2019, PSYCHOL HEALTH, V34, P162, DOI 10.1080/08870446.2018.1515436
   Oosterhoff B, 2020, J ADOLESCENT HEALTH, V67, P179, DOI 10.1016/j.jadohealth.2020.05.004
   Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6
   Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213
   Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   Wise T, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200742
   World Health Organization, 2020, WHO DIR GEN OP REM M, DOI WHO
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8
   Xu JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144868
   Zhou RG, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00350
NR 27
TC 5
Z9 5
U1 9
U2 15
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2198-1833
EI 1613-2238
J9 J PUBLIC HEALTH-HEID
JI J. Public Health-Heidelberg
DI 10.1007/s10389-021-01497-y
EA MAR 2021
PG 15
WC Public, Environmental & Occupational Health
WE Emerging Sources Citation Index (ESCI)
SC Public, Environmental & Occupational Health
GA QZ6PT
UT WOS:000630846200001
PM 33777652
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Rodriguez-Gonzalez, M
   Castellano-Martinez, A
   Cascales-Poyatos, HM
   Perez-Reviriego, AA
AF Rodriguez-Gonzalez, Moises
   Castellano-Martinez, Ana
   Cascales-Poyatos, Helena Maria
   Perez-Reviriego, Alvaro Antonio
TI Cardiovascular impact of COVID-19 with a focus on children: A systematic
   review
SO WORLD JOURNAL OF CLINICAL CASES
LA English
DT Review
DE COVID-19; SARS-CoV-2; Congenital heart diseases; Myocardial dysfunction;
   Pediatric Multisystem Inflammatory Syndrome; Cardiac Biomarkers
ID MULTISYSTEM INFLAMMATORY SYNDROME; KAWASAKI-LIKE DISEASE; CONGENITAL
   HEART-DISEASE; SARS-COV-2 INFECTION; CORONAVIRUS DISEASE;
   CLINICAL-FEATURES; MIS-C; HOSPITALIZED-PATIENTS; MANAGEMENT; STATEMENT
AB BACKGROUND
   Since the beginning of the pandemic, coronavirus disease-2019 (COVID-19) in children has shown milder cases and a better prognosis than adults. Although the respiratory tract is the primary target for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), cardiovascular involvement is emerging as one of the most significant and life-threatening complications of SARS-CoV-2 infection in adults.
   AIM
   To summarize the current knowledge about the potential cardiovascular involvement in pediatric COVID-19 in order to give a perspective on how to take care of them during the current pandemic emergency.
   METHODS
   Multiple searches in MEDLINE, PubMed were performed using the search terms "COVID-19" or "SARS-CoV-2" were used in combination with "myocardial injury" or "arrhythmia" or "cardiovascular involvement" or "heart disease" or "congenital heart disease" or "pulmonary hypertension" or "long QT" or "cardiomyopathies" or "channelopathies" or "Multisystem inflammatory system" or "PMIS" or "MIS-C" or "Pediatric multisystem inflammatory syndrome" or "myocarditis" or "thromboembolism to identify articles published in English language from January 1st, 2020 until July 31st, 2020. The websites of World Health Organization, Centers for Disease control and Prevention, and the Johns Hopkins Coronavirus Resource Center were reviewed to provide up to date numbers and infection control recommendations. Reference lists from the articles were reviewed to identify additional pertinent articles. Retrieved manuscripts concerning the subject were reviewed by the authors, and the data were extracted using a standardized collection tool. Data were subsequently analyzed with descriptive statistics. For Pediatric multisystemic inflammatory syndrome temporally associated with COVID-19 (PMIS), multiple meta-analyses were conducted to summarize the pooled mean proportion of different cardiovascular variables in this population in pseudo-cohorts of observed patients.
   RESULTS
   A total of 193 articles were included. Most publications used in this review were single case reports, small case series, and observational small-sized studies or literature reviews. The meta-analysis of 16 studies with size > 10 patients and with complete data about cardiovascular involvement in children with PMIS showed that PMIS affects mostly previously healthy school-aged children and adolescents presenting with Kawasaki disease-like features and multiple organ failure with a focus on the heart, accounting for most cases of pediatric COVID-19 mortality. They frequently presented cardiogenic shock (53%), ECG alterations (27%), myocardial dysfunction (52%), and coronary artery dilation (15%). Most cases required PICU admission (75%) and inotropic support (57%), with the rare need for extracorporeal membrane oxygenation (4%). Almost all of these children wholly recovered in a few days, although rare deaths have been reported (2%). Out of PMIS cases we identified 10 articles reporting sporadic cases of myocarditis, pulmonary hypertension and cardiac arrythmias in previously healthy children. We also found another 10 studies reporting patients with pre-existing heart diseases. Most cases consisted in children with severe COVID-19 infection with full recovery after intensive care support, but cases of death were also identified.
   The management of different cardiac conditions are provided based on current guidelines and expert panel recommendations.
   CONCLUSION
   There is still scarce data about the role of cardiovascular involvement in COVID-19 in children. Based on our review, children (previously healthy or with pre-existing heart disease) with acute COVID-19 requiring hospital admission should undergo a cardiac workup and close cardiovascular monitoring to identify and treat timely life-threatening cardiac complications.
C1 [Rodriguez-Gonzalez, Moises] Puerta Mar Univ Hosp, Div Pediat Cardiol, 21 Ana Viya Ave, Cadiz 11009, Spain.
   [Rodriguez-Gonzalez, Moises; Castellano-Martinez, Ana] Puerta Mar Univ Hosp, Biomed Res & Innovat Inst Cadiz, Cadiz 11009, Spain.
   [Castellano-Martinez, Ana] Puerta Mar Univ Hosp, Pediat Nephrol Div, Cadiz 11009, Spain.
   [Cascales-Poyatos, Helena Maria] Motril San Antonio Primary Care Ctr, Div Pediat, Motril 18600, Spain.
   [Perez-Reviriego, Alvaro Antonio] Santa Ana Hosp, Div Pediat, UGC Pediatria AG Granada, Motril 18600, Spain.
RP Rodriguez-Gonzalez, M (corresponding author), Puerta Mar Univ Hosp, Div Pediat Cardiol, 21 Ana Viya Ave, Cadiz 11009, Spain.
EM doctormoisesrodriguez@gmail.com
RI Rodriguez-Gonzalez, Moises/J-9699-2019
OI Rodriguez-Gonzalez, Moises/0000-0002-5587-435X; Castellano-Martinez,
   Ana/0000-0001-7563-1235
CR Abdelnabi M, 2020, EUR CARDIOL REV, V15, P41, DOI 10.15420/ecr.2019.1.3
   Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1093/europace/eur245, 10.1016/j.hrthm.2011.05.020]
   Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Ashraf O, 2020, CRIT CARE NURS Q, V43, P390, DOI 10.1097/CNQ.0000000000000324
   Atal S, 2020, PHARM MED, V34, P223, DOI 10.1007/s40290-020-00342-z
   Azevedo RB, 2021, J HUM HYPERTENS, V35, P4, DOI 10.1038/s41371-020-0387-4
   Balasubramanian S, 2020, Indian Pediatr, V57, P681, DOI 10.1007/s13312-020-1901-z
   Balasubramanian S, 2020, INDIAN PEDIATR, V57, P435, DOI 10.1007/s13312-020-1819-5
   Bapst T, 2020, BMJ CASE REP, V13, DOI 10.1136/bcr-2020-236986
   Barker PCA, 2020, J AM SOC ECHOCARDIOG, V33, P658, DOI 10.1016/j.echo.2020.04.005
   Bautista-Hernandez V, 2011, CURR VASC PHARMACOL, V9, P619, DOI 10.2174/157016111796642733
   Belhadjer Z, 2020, CIRCULATION, V142, P429, DOI 10.1161/CIRCULATIONAHA.120.048360
   Belot A, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.22.2001010
   Berthelot JM, 2020, EMERG MICROBES INFEC, V9, P1514, DOI 10.1080/22221751.2020.1785336
   Bhaskar S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01648
   Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026
   Blondiaux E, 2020, RADIOLOGY, V297, pE283, DOI 10.1148/radiol.2020202288
   Blumfield E, 2020, AJR AM J ROENTGENOL
   Bohn MK, 2020, PHYSIOLOGY, V35, P288, DOI 10.1152/physiol.00019.2020
   Brodin P, 2020, ACTA PAEDIATR, V109, P1082, DOI 10.1111/apa.15271
   Capone CA, 2020, J PEDIATR-US, V224, P141, DOI [10.1018/j.jpeds.2020.08.044, 10.1016/j.jpeds.2020.06.044]
   Carter MJ, 2020, NAT MED, V26, P1701, DOI 10.1038/s41591-020-1054-6
   Castagnoli R, 2020, JAMA PEDIATR, V174, P882, DOI 10.1001/jamapediatrics.2020.1467
   Centers for Disease Control and Prevention, 2020, EM PREP RESP HLTH AL
   Chang David, 2020, HeartRhythm Case Rep, V6, P237, DOI 10.1016/j.hrcr.2020.03.012
   Chao JY, 2020, J PEDIATR-US, V223, P14, DOI 10.1016/j.jpeds.2020.05.006
   Checchia PA, 2017, INFECT DIS THER, V6, P37, DOI 10.1007/s40121-016-0142-x
   Chen C, 2020, Zhonghua Xin Xue Guan Bing Za Zhi, V48, P567, DOI 10.3760/cma.j.cn112148-20200225-00123
   Cheung EW, 2020, JAMA-J AM MED ASSOC, V324, P294, DOI 10.1001/jama.2020.10374
   Chiotos K, 2020, J PEDIAT INF DIS SOC, V9, P393, DOI 10.1093/jpids/piaa069
   Chiotos K, 2020, J PEDIAT INF DIS SOC, V9, P701, DOI 10.1093/jpids/piaa045
   Chorin E, 2020, HEART RHYTHM, V17, P1425, DOI 10.1016/j.hrthm.2020.05.014
   Craver R, 2020, FETAL PEDIATR PATHOL, V39, P263, DOI 10.1080/15513815.2020.1761491
   Cui XJ, 2021, J MED VIROL, V93, P1057, DOI 10.1002/jmv.26398
   Cui YX, 2020, J INFECT DIS, V221, P1775, DOI 10.1093/infdis/jiaa113
   Davies P, 2020, LANCET CHILD ADOLESC, V4, P669, DOI 10.1016/S2352-4642(20)30215-7
   de Farias ECF, 2020, PEDIATR INFECT DIS J, V39, pE374, DOI 10.1097/INF.0000000000002865
   Dearani JA, 2020, WORLD J PEDIATR CONG, V11, P548, DOI 10.1177/2150135120934741
   DeBiasi RL, 2020, J PEDIATR-US, V223, P199, DOI 10.1016/j.jpeds.2020.05.007
   Del Barba P, 2020, PEDIATR PULM, V55, P1879, DOI 10.1002/ppul.24895
   Ding YD, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00431
   Dolbec K, 2011, EMERG MED CLIN N AM, V29, P811, DOI 10.1016/j.emc.2011.08.005
   Dolhnikoff M, 2020, LANCET CHILD ADOLESC, V4, P790, DOI 10.1016/S2352-4642(20)30257-1
   Dolinger MT, 2020, J PEDIATR GASTR NUTR, V71, P153, DOI 10.1097/MPG.0000000000002809
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   Drozdzal S, 2020, DRUG RESIST UPDATE, V53, DOI 10.1016/j.drup.2020.100719
   Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756
   Ebina-Shibuya R, 2020, INT J INFECT DIS, V97, P371, DOI 10.1016/j.ijid.2020.06.014
   Escosa-Garcia L, 2020, PEDIATR PULM, V55, P2576, DOI 10.1002/ppul.25025
   Faggiano P, 2020, INT J CARDIOL, V313, P129, DOI 10.1016/j.ijcard.2020.04.028
   Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680
   Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3
   Garot Jerome, 2020, JACC Case Rep, V2, P1342, DOI 10.1016/j.jaccas.2020.05.060
   Giacomet V, 2020, PEDIATR INFECT DIS J, V39, pE149, DOI 10.1097/INF.0000000000002750
   Giudicessi JR, 2020, MAYO CLIN PROC, V95, P1213, DOI 10.1016/j.mayocp.2020.03.024
   Gnecchi M, 2020, LANCET, V395, pE116, DOI 10.1016/S0140-6736(20)31307-6
   Godfred-Cato S, 2020, MMWR-MORBID MORTAL W, V69, P1074, DOI 10.15585/mmwr.mm6932e2
   Gotzinger F, 2020, LANCET CHILD ADOLESC, V4, P653, DOI 10.1016/S2352-4642(20)30177-2
   Cortes RG, 2020, INTENS CARE MED, V46, P1774, DOI 10.1007/s00134-020-06146-8
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Gray B, 2020, HEART LUNG CIRC, V29, pE85, DOI 10.1016/j.hlc.2020.04.006
   Greene AG, 2020, AM J EMERG MED, V38, DOI 10.1016/j.ajem.2020.05.117
   Grimaud M, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00690-8
   Guo CX, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01719-2
   Guzik TJ, 2020, CARDIOVASC RES, V116, P1666, DOI 10.1093/cvr/cvaa106
   Hameed S, 2021, RADIOLOGY, V298, pE1, DOI 10.1148/radiol.2020202543
   Han H, 2020, EMERG MICROBES INFEC, V9, P1123, DOI 10.1080/22221751.2020.1770129
   Hanff TC, 2020, CLIN INFECT DIS, V71, P870, DOI 10.1093/cid/ciaa329
   Harada M, 2015, CIRC J, V79, P495, DOI 10.1253/circj.CJ-15-0138
   Heidemann SM, 2020, AM J CASE REP, V21, DOI 10.12659/AJCR.925779
   Hoang A, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100433
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Imazio M, 2020, HEART, V106, P1127, DOI [10.1136/heartjnl-2020-317186, 10.1136/heartjnl-2020-317108]
   Jia R, 2020, VIROL SIN, V35, P734, DOI 10.1007/s12250-020-00265-8
   Johns Hopkins University & Medicine, CORONAVIRUS RESOURCE
   Jones Veena G, 2020, Hosp Pediatr, V10, P537, DOI 10.1542/hpeds.2020-0123
   Climent FJ, 2020, REV ESP CARDIOL, V73, P667, DOI 10.1016/j.recesp.2020.04.015
   Katneni UK, 2020, THROMB HAEMOSTASIS, V120, P1668, DOI 10.1055/s-0040-1715841
   Kaushik S, 2020, J PEDIATR-US, V224, P24, DOI 10.1016/j.jpeds.2020.06.045
   Kesici S, 2020, EUR HEART J, V41, P3021, DOI 10.1093/eurheartj/ehaa515
   Kest H, 2020, CASE REP PEDIAT, V2020, DOI 10.1155/2020/8875987
   Kim L, 2020, MMWR-MORBID MORTAL W, V69, P1081, DOI 10.15585/mmwr.mm6932e3
   Kimura D, 2019, CARDIOL YOUNG, V29, P615, DOI 10.1017/S1047951119000313
   Krishnan US, 2020, J PEDIATR-US, V225, P246, DOI 10.1016/j.jpeds.2020.06.076
   Kumar S, 2020, HEART LUNG CIRC, V29, pE57, DOI 10.1016/j.hlc.2020.04.001
   Kuo Ho-Chang, 2020, J Pediatr, V224, P179, DOI 10.1016/j.jpeds.2020.07.022
   Lara D, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-1509
   Lazzerini PE, 2020, CIRC-ARRHYTHMIA ELEC, V13, DOI 10.1161/CIRCEP.120.008627
   Lazzerini PE, 2017, HEART, V103, P1821, DOI 10.1136/heartjnl-2016-311079
   Leusveld EM, 2020, EXPERT REV CARDIOVAS, V18, P503, DOI 10.1080/14779072.2020.1797488
   Li XY, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03183-z
   Licciardi F, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-1711
   Lingappan K, 2020, AM J PHYSIOL-LUNG C, V319, pL39, DOI 10.1152/ajplung.00183.2020
   Linnane N, 2020, CARDIOL YOUNG, V30, P1350, DOI 10.1017/S1047951120001882
   Liu Y, 2020, J THROMB THROMBOLYS, V50, P825, DOI 10.1007/s11239-020-02174-9
   Livingston Edward, 2020, JAMA, V323, P1335, DOI 10.1001/jama.2020.4344
   Loi M, 2020, PEDIATR BLOOD CANCER, V67, DOI 10.1002/pbc.28485
   Lu XX, 2020, PEDIAT ALLERG IMM-UK, V31, P449, DOI 10.1111/pai.13267
   Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270
   Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007
   Mangalmurti N, 2020, IMMUNITY, V53, P19, DOI 10.1016/j.immuni.2020.06.017
   Marraro Giuseppe A, 2020, Zhongguo Dang Dai Er Ke Za Zhi, V22, P183
   McCrindle BW, 2020, JAMA-J AM MED ASSOC, V324, P246, DOI 10.1001/jama.2020.10370
   McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484
   Meena J, 2020, INDIAN PEDIATR, V57, P820, DOI 10.1007/s13312-020-1961-0
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Mercuro Nicholas J, 2020, JAMA Cardiol, V5, P1036, DOI 10.1001/jamacardio.2020.1834
   Miao HJ, 2020, EUR J CLIN MICROBIOL, V39, P2211, DOI 10.1007/s10096-020-03973-x
   Miller J, 2020, GASTROENTEROLOGY, V159, P1571, DOI 10.1053/j.gastro.2020.05.079
   Moghadam SO, 2020, INT J GEN MED, V13, P443, DOI 10.2147/IJGM.S263666
   Molloy EJ, 2020, PEDIATR RES, V88, P340, DOI 10.1038/s41390-020-0881-y
   Moraleda C, 2020, CLIN INFECT DIS
   Most ZM., 2020, CIRCULATION
   Ng KF, 2020, J MED VIROL, V92, P2880, DOI 10.1002/jmv.26206
   Nishiga M, 2020, NAT REV CARDIOL, V17, P543, DOI 10.1038/s41569-020-0413-9
   Offerhaus JA, 2020, HEART RHYTHM, V17, P1480, DOI 10.1016/j.hrthm.2020.07.001
   Olfe J, 2020, CARDIOL YOUNG, V30, P1358, DOI 10.1017/S1047951120002127
   Ortmans S, 2019, EXPERT OPIN PHARMACO, V20, P2101, DOI 10.1080/14656566.2019.1669561
   Ouldali N, 2020, LANCET CHILD ADOLESC, V4, P662, DOI 10.1016/S2352-4642(20)30175-9
   Pagnesi M, 2020, HEART, V106, P1324, DOI 10.1136/heartjnl-2020-317355
   Park A, 2020, CELL HOST MICROBE, V27, P870, DOI 10.1016/j.chom.2020.05.008
   Parri N, 2020, EUR J PEDIATR, V179, P1315, DOI 10.1007/s00431-020-03683-8
   Pinsky MR, 2018, ANN AM THORAC SOC, V15, pS45, DOI 10.1513/AnnalsATS.201704-339FR
   Poissy J, 2020, CIRCULATION, V142, P184, DOI 10.1161/CIRCULATIONAHA.120.047430
   Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5
   Pouletty M, 2020, ANN RHEUM DIS, V79, P999, DOI 10.1136/annrheumdis-2020-217960
   Ramcharan T, 2020, PEDIATR CARDIOL, V41, P1391, DOI 10.1007/s00246-020-02391-2
   Ramireddy A, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.017144
   Rauf A, 2020, INDIAN J PEDIATR, V87, P745, DOI 10.1007/s12098-020-03357-1
   Ribeiro AT, 2020, ANN FOREST SCI, V77, DOI 10.1007/s13595-019-0909-9
   Riollano-Cruz M, 2021, J MED VIROL, V93, P424, DOI 10.1002/jmv.26224
   Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/S0140-6736(20)31094-1, 10.1016/50140-6736(20)31094-1]
   Rivera-Figueroa EI, 2020, INDIAN PEDIATR, V57, P680, DOI 10.1007/s13312-020-1900-0
   Rodriguez-Gonzalez M, 2020, CARDIOL YOUNG, V30, P1346, DOI 10.1017/S1047951120001857
   Rodriguez-Gonzalez M, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9030085
   Rodriguez-Gonzalez M, 2019, BIOMARK MED, V13, P605, DOI 10.2217/bmm-2018-0348
   Rodriguez-Gonzalez M, 2019, EMERGENCIAS, V31, P111
   Rodriguez-Gonzalez M, 2019, BIOMARK MED, V13, P307, DOI 10.2217/bmm-2018-0324
   Rodriguez-Gonzalez M, 2019, WORLD J CLIN CASES, V7, P548, DOI 10.12998/wjcc.v7.i5.548
   Rodriguez-Gonzalez M, 2018, AN PEDIATR, V89, P286, DOI 10.1016/j.anpedi.2018.01.007
   Rodriguez-Gonzalez M, 2018, J EMERG MED, V55, P118, DOI 10.1016/j.jemermed.2018.04.013
   Rodriguez-Gonzalez M, 2014, ANN PEDIAT CARDIOL, V7, P74, DOI 10.4103/0974-2069.126578
   Romand J A, 1994, New Horiz, V2, P457
   Ronconi G, 2020, J Biol Regul Homeost Agents, V34, P767, DOI 10.23812/EDITORIAL-RONCONI-E-59
   Rowley AH, 2020, J PEDIATR-US, V224, P129, DOI 10.1016/j.jpeds.2020.06.057
   Royal College of Paediatrics and Child Health, GUID PAED MULT INFL
   Ruggiero A, 2020, ACTA PAEDIATR, V109, P1690, DOI 10.1111/apa.15328
   Russell MR, 2020, J HEART LUNG TRANSPL, V39, P732, DOI 10.1016/j.healun.2020.04.021
   Sabatino J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061774
   Salik I, 2020, J CLIN ANESTH, V66, DOI 10.1016/j.jclinane.2020.109914
   Salvi R, 2020, BIOMED PHARMACOTHER, V128, DOI 10.1016/j.biopha.2020.110267
   Samuel S, 2020, HEART RHYTHM
   Sanna G, 2020, EUR J PEDIATR, V179, P1079, DOI 10.1007/s00431-020-03699-0
   Schupper AJ, 2020, CHILD NERV SYST, V36, P1579, DOI 10.1007/s00381-020-04755-8
   Schwier NC, 2015, PHARMACOTHERAPY, V35, P99, DOI 10.1002/phar.1527
   Serwer Gerald, 2008, Curr Treat Options Cardiovasc Med, V10, P442, DOI 10.1007/s11936-008-0036-7
   Shekerdemian LS, 2020, JAMA PEDIATR, V174, P868, DOI 10.1001/jamapediatrics.2020.1948
   Simpson M, 2020, J PEDIATR-US, V227, P302, DOI 10.1016/j.jpeds.2020.07.069
   Singh AP, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061867
   Siripanthong B, 2020, HEART RHYTHM, V17, P1463, DOI 10.1016/j.hrthm.2020.05.001
   Song JC, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00247-7
   Stephens EH, 2020, J THORAC CARDIOV SUR, V160, P522, DOI 10.1016/j.jtcvs.2020.04.006
   Stephens EH, 2020, WORLD J PEDIATR CONG, V11, P395, DOI 10.1177/2150135120931398
   Stout KK, 2019, J AM COLL CARDIOL, V73, P1494, DOI 10.1016/j.jacc.2018.08.1028
   Su L, 2020, EMERG MICROBES INFEC, V9, P707, DOI 10.1080/22221751.2020.1744483
   SUN BQ, 2020, EMERG MICROBES INFEC, V9, P940, DOI [DOI 10.1080/22221751.2020.1762515, 10.1080/22221751.2020.1762515]
   Sun D, 2020, WORLD J PEDIATR, V16, P251, DOI 10.1007/s12519-020-00354-4
   Swierad M, 2020, POL ARCH INTERN MED, V130, P700, DOI 10.20452/pamw.15370
   Tagarro A, 2020, JAMA PEDIAT
   Tissieres P, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00717-0
   Toubiana J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2094
   Tuncer T, 2020, CARDIOL YOUNG, V30, P1482, DOI 10.1017/S1047951120002425
   Veer M, 2020, CRIT CARE NURS Q, V43, P381, DOI 10.1097/CNQ.0000000000000323
   Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X
   Viner RM, 2020, LANCET, V395, P1741, DOI 10.1016/S0140-6736(20)31129-6
   von der Beck D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180920
   Waltuch T, 2020, AM J EMERG MED, V38, DOI 10.1016/j.ajem.2020.05.058
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wasson JH, 2020, J AMBUL CARE MANAG, V43, P323, DOI 10.1097/JAC.0000000000000355
   Wei X, 2020, EUR HEART J, V41, P1855, DOI 10.1093/eurheartj/ehaa333
   Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   Winant Abbey J, 2020, Radiol Cardiothorac Imaging, V2, pe200346, DOI 10.1148/ryct.2020200346
   World Health Organization, 2020, MULT INFL SYNDR CHIL
   World Health Organization, 2020, WHO DIR OP REM MED B
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xia W, 2020, PEDIATR PULM, V55, P1169, DOI 10.1002/ppul.24718
   Yasuhara J, 2020, PEDIATR PULM, V55, P2565, DOI 10.1002/ppul.24991
   Yozgat CY, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13770
   Zachariah P, 2020, JAMA PEDIATR, V174, DOI 10.1001/jamapediatrics.2020.2430
   Zheng F, 2020, CURR MED SCI, V40, P275, DOI 10.1007/s11596-020-2172-6
   Zhou HM, 2020, PULM CIRC, V10, DOI 10.1177/2045894020924566
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zimmermann P, 2020, PEDIATR INFECT DIS J, V39, P355, DOI 10.1097/INF.0000000000002660
NR 194
TC 19
Z9 22
U1 2
U2 6
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 2307-8960
J9 WORLD J CLIN CASES
JI World J. Clin. Cases
PD NOV 6
PY 2020
VL 8
IS 21
BP 5250
EP 5283
DI 10.12998/wjcc.v8.i21.5250
PG 34
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA PA5RI
UT WOS:000595692200017
PM 33269260
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Atif, M
   Ahmad, M
   Malik, I
   Mushtaq, I
   Ahmad, N
   Mehjabin
   Babar, ZUD
AF Atif, Muhammad
   Ahmad, Muhammad
   Malik, Iram
   Mushtaq, Irem
   Ahmad, Nafees
   Mehjabin
   Babar, Zaheer-Ud-Din
TI How medicines sales staff is responding to presumptive COVID-19 patients
   attending drug retail outlets: An exploratory qualitative study
SO INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT
LA English
DT Article
DE community pharmacies; COVID-19; drug retail outlets; Drug Regulatory
   Authority of Pakistan; medicines sales staff; pharmacy services
ID CARE
AB The objective of this qualitative study was to explore how the medicine sales staff responded to presumptive COVID-19 patients in Pakistan. The data were obtained from the medicine sales staff working at drug retail outlets of Bahawalpur, Punjab, Pakistan, through in-depth face-to-face interviews using a semi-structured interview guide. A two-step sampling strategy was used, including purposive and convenient sampling techniques. Sample size was determined by applying the saturation point criteria. A total of 17 interviews were audio-recorded, transcribed verbatim and analysed using the thematic analysis. Analysis of data yielded six themes and seven sub-themes. The themes included (1) knowledge about various aspects of COVID-19, (2) practices of sales staff in response to COVID-19 pandemic, (3) attitude of sales staff towards COVID-19 pandemic, (4) services offered to presumptive COVID-19 patients, (5) challenges encountered during pandemic and (6) suggestions to improve delivery of pharmacy services by sales staff. In Pakistan, non-pharmacist sales staff had superficial knowledge about COVID-19. Presumptive COVID-19 patients were provided with only basic pharmacy services. Professional training is advised among pharmacy sales staff as a short-term solution to improve their knowledge. As a long-term goal, the availability of pharmacists at drug retail outlets is warranted.
C1 [Atif, Muhammad; Ahmad, Muhammad; Malik, Iram; Mehjabin] Islamia Univ Bahawalpur, Fac Pharm, Dept Pharm Practice, Bahawalpur, Pakistan.
   [Mushtaq, Irem] Islamia Univ Bahawalpur, Dept Educ, Bahawalpur, Pakistan.
   [Ahmad, Nafees] Univ Balochistan, Fac Pharm & Hlth Sci, Dept Pharm Practice, Quetta, Pakistan.
   [Babar, Zaheer-Ud-Din] Univ Huddersfield, Dept Pharm, Huddersfield, W Yorkshire, England.
RP Atif, M (corresponding author), Islamia Univ Bahawalpur, Fac Pharm, Dept Pharm Practice, Bahawalpur, Pakistan.
EM pharmacist_atif@yahoo.com
CR Alice, 2020, REGULATORY FLEXIBILI
   Amariles P, 2021, RES SOC ADMIN PHARM, V17, P1988, DOI 10.1016/j.sapharm.2020.03.007
   Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5
   Anney V.N., 2014, J EMERGING TRENDS ED, V5, P272, DOI DOI 10.3109/08941939.2012.723954
   [Anonymous], 2020, NEWS ALERTS
   Asghar S, 2020, RES SOC ADMIN PHARM, V16, P805, DOI 10.1016/j.sapharm.2019.09.003
   Atif M., 2017, PHARM POLICY COUNTRI, P25, DOI DOI 10.1007/978-3-319-51673-8_3
   Atif M, 2020, DRUG SAFETY DEV COUN, P287
   Atif M, 2019, ENCY PHARM PRACTICE, P239
   Atif M, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06812-7
   Atif M, 2020, J PHARM POLICY PRACT, V13, DOI 10.1186/s40545-020-00240-4
   Atif M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072379
   Atif M, 2020, J INFECT PUBLIC HEAL, V13, P118, DOI 10.1016/j.jiph.2019.07.003
   Atif M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027028
   Atif M, 2019, INFECT DRUG RESIST, V12, P687, DOI 10.2147/IDR.S189114
   Atif M, 2018, J CHIN MED ASSOC, V81, P444, DOI 10.1016/j.jcma.2017.12.002
   Austin Z, 2021, RES SOC ADMIN PHARM, V17, P1867, DOI 10.1016/j.sapharm.2020.05.027
   Auta A, 2012, N AM J MED SCI, V4, P24, DOI 10.4103/1947-2714.92899
   Barker AK, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013190
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Caelli K., 2003, INT J QUAL METH, V2, P1, DOI DOI 10.1177/160940690300200201
   Denzin N.K, 2008, INTRO DISCIPLINE PRA
   Gebretekle G., 2020, PHARM PREPAREDNESS R
   Gentles SJ, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917725678
   Gregory PAM, 2020, CAN PHARM J, V153, P243, DOI 10.1177/1715163520945741
   Hamid H, 2020, DRUGS THER PERSPECT, V36, P355, DOI 10.1007/s40267-020-00745-7
   Hangoma J.M, 2020, COMMUNITY PHARM KNOW
   Hashmi FK, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2442-6
   Journal TP, 2020, PHARM RECEIVE PACKS
   Kwena Z, 2008, SEX TRANSM DIS, V35, P480, DOI 10.1097/OLQ.0b013e3181644b84
   Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7
   Liu Q, 2020, J MED INTERNET RES, V22, DOI 10.2196/19118
   Loveland T., 2020, PHARM DEV RELATED CO
   Malik I, 2020, GLOBAL PHARM POLICY, P139, DOI DOI 10.1007/978-981-15-2724-1_6
   Malik I, 2020, THER INNOV REGUL SCI, V54, P492, DOI 10.1007/s43441-019-00081-7
   Malik I, 2020, RES SOC ADMIN PHARM, V16, P848, DOI 10.1016/j.sapharm.2020.02.018
   Malik I, 2019, RES SOC ADMIN PHARM, V15, P1495, DOI 10.1016/j.sapharm.2019.09.060
   Ministry of National Health Services Regulations Coordination, KNOW COVID 19 SEE RE
   Nadeem MF, 2021, RES SOC ADMIN PHARM, V17, P2046, DOI 10.1016/j.sapharm.2020.05.021
   National Pharmacy Association, 2020, COVID 19 TRAIN YO YO
   Saha S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2072-z
   Sakeena MHF, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0351-z
   Saqib A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197482
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042
   Zheng SQ, 2021, RES SOC ADMIN PHARM, V17, P1819, DOI 10.1016/j.sapharm.2020.03.012
NR 46
TC 0
Z9 0
U1 2
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0749-6753
EI 1099-1751
J9 INT J HEALTH PLAN M
JI Int. J. Health Plan. Manag.
PD NOV
PY 2021
VL 36
IS 6
BP 2297
EP 2312
DI 10.1002/hpm.3293
EA AUG 2021
PG 16
WC Health Policy & Services; Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA WX4ZV
UT WOS:000684729300001
PM 34390010
OA Green Published
DA 2022-04-20
ER

PT J
AU Gharibo, C
   Sharma, A
   Soin, A
   Shah, S
   Diwan, S
   Buenaventura, R
   Nampiaparampil, DE
   Aydin, S
   Bakshi, S
   Abdi, S
   Jha, SS
   Cordner, H
   Kaye, AD
   Abd-Elsayed, A
   Candido, KD
   Knezevic, NN
   Atluri, S
   Wargo, BW
   Sanapati, MR
   Datta, S
   Hirsch, JA
   Manchikanti, L
   Rajput, K
AF Gharibo, Christopher
   Sharma, Amit
   Soin, Amol
   Shah, Shalini
   Diwan, Sudhir
   Buenaventura, Ricardo
   Nampiaparampil, Devi E.
   Aydin, Steve
   Bakshi, Sanjay
   Abdi, Salahadin
   Jha, Sachin Sunny
   Cordner, Harold
   Kaye, Alan D.
   Abd-Elsayed, Alaa
   Candido, Kenneth D.
   Knezevic, Nebojsa Nick
   Atluri, Sairam
   Wargo, Bradley W.
   Sanapati, Mahendra R.
   Datta, Sukdeb
   Hirsch, Joshua A.
   Manchikanti, Laxmaiah
   Rajput, Kartic
TI Triaging Interventional Pain Procedures During COVID-19 or Related
   Elective Surgery Restrictions: Evidence-Informed Guidance from the
   American Society of Interventional Pain Physicians (ASIPP)
SO PAIN PHYSICIAN
LA English
DT Article
DE Coronavirus; COVID-19; interventional pain management; COVID risk
   factors; elective surgeries; interventional techniques; chronic pain;
   immunosuppression
ID LUMBOSACRAL DISC HERNIATION; UNITED-STATES; PRESCRIBING OPIOIDS;
   EPIDURAL INJECTION; CLINICAL-EFFICACY; CDC GUIDELINE; MANAGEMENT;
   PREVALENCE; IMPACT; RISK
AB Background: The COVID-19 pandemic has worsened the pain and suffering of chronic pain patients due to stoppage of "elective" interventional pain management and office visits across the United States. The reopening of America and restarting of interventional techniques and elective surgical procedures has started. Unfortunately, with resurgence in some states, restrictions are once again being imposed. In addition, even during the Phase II and III of reopening, chronic pain patients and interventional pain physicians have faced difficulties because of the priority selection of elective surgical procedures.
   Chronic pain patients require high intensity care, specifically during a pandemic such as COVID-19. Consequently, it has become necessary to provide guidance for triaging interventional pain procedures, or related elective surgery restrictions during a pandemic.
   Objectives: The aim of these guidelines is to provide education and guidance for physicians, healthcare administrators, the public and patients during the COVID-19 pandemic. Our goal is to restore the opportunity to receive appropriate care for our patients who may benefit from interventional techniques.
   Methods: The American Society of Interventional Pain Physicians (ASIPP) has created the COVID-19 Task Force in order to provide guidance for triaging interventional pain procedures or related elective surgery restrictions to provide appropriate access to interventional pain management (IPM) procedures in par with other elective surgical procedures.
   In developing the guidance, trustworthy standards and appropriate disclosures of conflicts of interest were applied with a section of a panel of experts from various regions, specialties, types of practices (private practice, community hospital and academic institutes) and groups. The literature pertaining to all aspects of COVID-19, specifically related to epidemiology, risk factors, complications, morbidity and mortality, and literature related to risk mitigation and stratification was reviewed. The evidence - informed with the incorporation of the best available research and practice knowledge was utilized, instead of a simplified evidence-based approach. Consequently, these guidelines are considered evidence-informed with the incorporation of the best available research and practice knowledge.
   Results: The Task Force defined the medical urgency of a case and developed an IPM acuity scale for elective IPM procedures with 3 tiers. These included urgent, emergency, and elective procedures. Examples of urgent and emergency procedures included new onset or exacerbation of complex regional pain syndrome (CRPS), acute trauma or acute exacerbation of degenerative or neurological disease resulting in impaired mobility and inability to perform activities of daily living. Examples include painful rib fractures affecting oxygenation and post-dural puncture headaches limiting the ability to sit upright, stand and walk. In addition, emergency procedures include procedures to treat any severe or debilitating disease that prevents the patient from carrying out activities of daily living. Elective procedures were considered as any condition that is stable and can be safely managed with alternatives.
   Limitations: COVID-19 continues to be an ongoing pandemic. When these recommendations were developed, different stages of reopening based on geographical regulations were in process. The pandemic continues to be dynamic creating every changing evidence-based guidance. Consequently, we provided evidence-informed guidance.
   Conclusion: The COVID-19 pandemic has created unprecedented challenges in IPM creating needless suffering for pain patients. Many IPM procedures cannot be indefinitely postponed without adverse consequences. Chronic pain exacerbations are associated with marked functional declines and risks with alternative treatment modalities. They must be treated with the concern that they deserve. Clinicians must assess patients, local healthcare resources, and weigh the risks and benefits of a procedure against the risks of suffering from disabling pain and exposure to the COVID-19 virus.
C1 [Gharibo, Christopher; Sharma, Amit; Soin, Amol; Shah, Shalini; Diwan, Sudhir; Buenaventura, Ricardo; Nampiaparampil, Devi E.; Aydin, Steve; Bakshi, Sanjay; Abdi, Salahadin; Jha, Sachin Sunny; Cordner, Harold; Kaye, Alan D.; Abd-Elsayed, Alaa; Candido, Kenneth D.; Knezevic, Nebojsa Nick; Atluri, Sairam; Wargo, Bradley W.; Sanapati, Mahendra R.; Datta, Sukdeb; Hirsch, Joshua A.; Manchikanti, Laxmaiah; Rajput, Kartic] Amer Soc Intervent Pain Phys, Paducah, KY USA.
RP Gharibo, C (corresponding author), NYU Langone Hlth, 333 East 38th St, New York, NY 10026 USA.; Gharibo, C (corresponding author), Pain Med, 333 East 38th St, New York, NY 10026 USA.
EM christopher.gharibo@nyulangone.org; amit1881@me.com; drsoin@gmail.com;
   shahshalini@gmail.com; sudhir.diwan63@gmail.com; rbuena@sbcglobal.net;
   devichechi@gmail.com; steve.aydin@gmail.com; drbakshi58@gmail.com;
   SAbdi@mdanderson.org; sunnyjha@gmail.com; gassdoc@aol.com;
   akaye@lsuhsc.edu; alaawny@hotmail.com; kdcandido1@gmail.com;
   nick.knezevic@gmail.com; saiatluri@gmail.com; drbwargo@gmail.com;
   msanapati@gmail.com; sukdeb@hotmail.com; jahirsch@mgh.harvard.edu;
   drlm@thepainmd.com
OI Abdi, Salahadin/0000-0002-3892-9208; Knezevic, Nebojsa
   Nick/0000-0001-8028-1495; Nampiaparampil, Devi/0000-0001-7577-3890
CR Abdul AJ, 2017, PAIN PHYSICIAN, V20, pE991
   American Medical Association, ISS BRIEF REP INCR O
   American Medical Association, ISS BRIEF RED BARR V
   American-College-of-Surgeons, 2020, COVID 19 GUID TRIAG
   Anson P., 2020, PAIN NEWS NETWO 0715
   Barnes M, 2020, N ENGL J MED
   Becker WC, 2020, ANN INTERN MED, V173, P59, DOI 10.7326/M20-1210
   Blyth FM, 2019, AM J PUBLIC HEALTH, V109, P35, DOI 10.2105/AJPH.2018.304747
   Brico Elizabeth, 2020, THE APPEAL
   Canadian Institutes of Health Research (CIHR), INTR EV INF DEC MAK
   Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112
   Center for Disease Control and Prevention, FRAM HEALTHC SYST PR
   Centers for Disease Control and Prevention, COR DIS 2019 COVID 1
   Centers for Disease Control and Prevention, GUID OP AM
   Centers for Medicare and Medicaid Services, NON EL MED SERV TRET
   Chakravarthy K, 2018, PAIN PHYSICIAN, V21, P507
   Chang HY, 2014, AM J EMERG MED, V32, P421, DOI 10.1016/j.ajem.2014.01.015
   Choiniere M, 2010, CAN J ANAESTH, V57, P539, DOI 10.1007/s12630-010-9305-5
   Cortiula F, 2020, ANN ONCOL, V31, P553, DOI 10.1016/j.annonc.2020.03.286
   Da Silva JAP, 2018, ANN RHEUM DIS, V77, P790, DOI 10.1136/annrheumdis-2017-211893
   Dasgupta N, 2018, AM J PUBLIC HEALTH, V108, P182, DOI 10.2105/AJPH.2017.304187
   Dieleman JL, 2020, JAMA-J AM MED ASSOC, V323, P863, DOI 10.1001/jama.2020.0734
   Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464
   Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6501e1
   Dubey MJ, 2020, DIABETES METAB SYND, V14, P817, DOI 10.1016/j.dsx.2020.06.008
   Dubey S, 2020, DIABETES METAB SYND, V14, P779, DOI 10.1016/j.dsx.2020.05.035
   Eccleston C, 2020, PAIN, V161, P889, DOI 10.1097/j.pain.0000000000001885
   Elbinoune I, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.89.8831
   Estabrooks C A, 1998, Can J Nurs Res, V30, P15
   Farmer AD, 2019, UNITED EUR GASTROENT, V7, P7, DOI 10.1177/2050640618818305
   Fischer B, 2018, PAIN PHYSICIAN, V21, P219
   Fong RY, 2018, INT EMERG NURS, V41, P13, DOI 10.1016/j.ienj.2018.05.001
   Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543
   Fuggle N, 2019, DRUG AGING, V36, P129, DOI 10.1007/s40266-019-00666-9
   Graham R., 2011, COMMITTEE STANDARDS
   Grinspoon, 2020, TALE 2 EPIDEMICS COV
   Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6
   Heath C, 2020, ANAESTHESIA, V75, P1364, DOI 10.1111/anae.15180
   Hussaini SMQ, 2020, J GEN INTERN MED, V35, P3699, DOI 10.1007/s11606-020-06275-2
   Ingersoll A., 2020, INVESTIGATEPOST 0521
   Institute of Medicine (IOM), 2011, REL PAIN AM BLUEPR T
   IQVIA Institute for Human Data Science, MED US SPEND US REV
   IsHak WW, 2018, HARVARD REV PSYCHIAT, V26, P352, DOI 10.1097/HRP.0000000000000198
   Jha S, 2020, PAIN PHYSICIAN, V23, pS271
   Kaye AD, 2019, PAIN PHYSICIAN, V22, pS75
   Kaye K, 2020, AESTHET PLAST SURG, V14, P1
   Knezevic NN, 2020, PAIN PHYSICIAN, V23, pS239
   Lee JH, 2018, PAIN PHYSICIAN, V21, P449
   Lee JH, 2018, PAIN PHYSICIAN, V21, P433
   Lozada C., 2020, WASHINGTON POST
   Malfliet A, 2017, EUR J PAIN, V21, P769, DOI 10.1002/ejp.1003
   Manchikanti L, 2020, PAIN PHYSICIAN, V23, pS319
   Manchikanti L, 2020, PAIN PHYSICIAN, V23, pS1
   Manchikanti L, 2020, CURR PAIN HEADACHE R, V24, DOI 10.1007/s11916-020-00859-7
   Manchikanti L, 2019, PAIN PHYSICIAN, V22, P521
   Manchikanti L, 2018, PAIN PHYSICIAN, V21, P415
   Manchikanti L, 2018, PAIN PHYSICIAN, V21, P309
   Manchikanti L, 2014, PAIN PHYSICIAN, V17, pE319
   McDermott D., 2020, HAVE HEALTHCARE UTIL
   Mercadante S, 2019, CURR PHARM DESIGN, V25, P3197, DOI 10.2174/1381612825666190717152226
   Miles A, 2011, J EVAL CLIN PRACT, V17, P531, DOI 10.1111/j.1365-2753.2011.01713.x
   Mitsi V, 2016, NEUROSCIENCE, V338, P81, DOI 10.1016/j.neuroscience.2016.05.017
   Mokdad AH, 2018, JAMA-J AM MED ASSOC, V319, P1444, DOI 10.1001/jama.2018.0158
   Moride Y, 2019, PAIN PHYSICIAN, V22, P229
   Mouton C, 2020, J EXP ORTHOP, V7, DOI 10.1186/s40634-020-00248-4
   National Institute of Drug Abuse [NIDA], 2019, OV DEATH RAT
   National Institute on Drug Abuse, 2018, OV DEATH RAT
   Navani A, 2019, PAIN PHYSICIAN, V22, pS1
   Nijs J, 2018, PHYS THER, V98, P325, DOI 10.1093/ptj/pzy020
   Orhan C, 2018, PAIN PHYSICIAN, V21, P541
   Page GG, 2003, ADV EXP MED BIOL, V521, P117
   Plein LM, 2018, BRIT J PHARMACOL, V175, P2717, DOI 10.1111/bph.13750
   Pollard EM, 2019, J PAIN RES, V12, P1311, DOI 10.2147/JPR.S186662
   Racine M, 2018, PROG NEURO-PSYCHOPH, V87, P269, DOI 10.1016/j.pnpbp.2017.08.020
   Ramos VL, 2019, PRIMARY CARE, V46, P319, DOI 10.1016/j.pop.2019.05.001
   Sanchez M, 2020, PROPUBLICA ILLI 0530
   Seth P, 2018, AM J PUBLIC HEALTH, V108, P500, DOI 10.2105/AJPH.2017.304265
   Shah S, 2020, PAIN PHYSICIAN, V23, pS161
   Shanthanna H, 2020, ANAESTHESIA, V75, P935, DOI 10.1111/anae.15076
   Sheng JY, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/9724371
   Siddiqui S., ELECT SURG ACUITY SC
   Smith TJ, 2002, J CLIN ONCOL, V20, P4040, DOI 10.1200/JCO.2002.02.118
   Uppal V, 2020, ANAESTHESIA, V75, P1350, DOI 10.1111/anae.15105
   van der Leeuw G, 2018, J AM GERIATR SOC, V66, P1318, DOI 10.1111/jgs.15413
   Volkow, 2020, COVID 19 POTENTIAL I
   Wahezi SE, 2020, PAIN PHYSICIAN, V23, pS205
   Wan W, 2020, WASH POST
   Webster LR, 2017, ANESTH ANALG, V125, P1741, DOI 10.1213/ANE.0000000000002496
   Whitlock EL, 2017, JAMA INTERN MED, V177, P1146, DOI 10.1001/jamainternmed.2017.1622
   Woodbury MG, 2014, WOUND CARE CANADA, V12, P26
   World Health Organization, EVIPNET ACT 10 YEARS
   Yeoh CB, 2020, ANESTH ANALG, V131, P16, DOI 10.1213/ANE.0000000000004884
NR 92
TC 20
Z9 20
U1 0
U2 0
PU AM SOC INTERVENTIONAL PAIN PHYSICIANS
PI PADUCAH
PA 81 LAKEVIEW DR, PADUCAH, KY 42001 USA
SN 1533-3159
J9 PAIN PHYSICIAN
JI Pain Physician
PD AUG
PY 2020
VL 23
IS 4
SU S
SI SI
BP S183
EP S203
PG 21
WC Anesthesiology; Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Anesthesiology; Neurosciences & Neurology
GA OS6HP
UT WOS:000590262800003
PM 32942785
DA 2022-04-20
ER

PT J
AU Ali, MAM
   Spinler, SA
AF Ali, Mohammad A. M.
   Spinler, Sarah A.
TI COVID-19 and thrombosis: From bench to bedside
SO TRENDS IN CARDIOVASCULAR MEDICINE
LA English
DT Article
ID RENIN-ANGIOTENSIN SYSTEM; ENDOTHELIAL-CELLS; FACTOR-VIII; ACE2;
   EXPRESSION; COMPLICATIONS
AB Coronavirus disease of 2019 (COVID-19) is the respiratory viral infection caused by the coronavirus SARS-CoV2 (Severe Acute Respiratory Syndrome Coronavirus 2). Despite being a respiratory illness, COVID-19 is found to increase the risk of venous and arterial thromboembolic events. Indeed, the link between COVID-19 and thrombosis is attracting attention from the broad scientific community. In this review we will analyze the current available knowledge of the association between COVID-19 and thrombosis. We will highlight mechanisms at both molecular and cellular levels that may explain this association. In addition, the article will review the antithrombotic properties of agents currently utilized or being studied in COVID-19 management. Finally, we will discuss current professional association guidance on prevention and treatment of thromboembolism associated with COVID-19. Published by Elsevier Inc.
C1 [Ali, Mohammad A. M.] SUNY Binghamton, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Binghamton, NY USA.
   [Spinler, Sarah A.] SUNY Binghamton, Sch Pharm & Pharmaceut Sci, Dept Pharm Practice, Binghamton, NY USA.
RP Ali, MAM (corresponding author), SUNY Binghamton, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, PB-420, Johnson City, NY 13790 USA.
EM mali@binghamton.edu
RI Pharmacy Practice, Binghamton University/AAD-2844-2022
OI Ali, Mohammad/0000-0002-6404-4198; Spinler, Sarah/0000-0003-4552-0053
CR Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Albani F, 2020, ECLINICALMEDICINE, V27, DOI 10.1016/j.eclinm.2020.100562
   Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495
   Ayerbe L, 2020, J THROMB THROMBOLYS, V50, P298, DOI 10.1007/s11239-020-02162-z
   Aziz M, 2020, J MED VIROL, V92, P2283, DOI 10.1002/jmv.25948
   Barnes GD, 2020, J THROMB THROMBOLYS, V50, P72, DOI 10.1007/s11239-020-02138-z
   Bianconi V, 2020, DRUGS, V80, P1383, DOI 10.1007/s40265-020-01365-1
   Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
   Bohgaki M, 2004, INT IMMUNOL, V16, P1633, DOI 10.1093/intimm/dxh166
   Bowles L, 2020, NEW ENGL J MED, V383, P288, DOI 10.1056/NEJMc2013656
   Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385
   Brinkmann V, 2018, J INNATE IMMUN, V10, P414, DOI 10.1159/000489829
   Cai YY, 2007, J VIROL, V81, P446, DOI 10.1128/JVI.01705-06
   Campbell CM, 2020, EUR HEART J-CASE REP, V4, DOI 10.1093/ehjcr/ytaa050
   Catanzaro M, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0191-1
   Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]
   Choudry FA, 2020, J AM COLL CARDIOL, V76, P1168, DOI 10.1016/j.jacc.2020.07.022
   Cui SP, 2020, J THROMB HAEMOST, V18, P1421, DOI 10.1111/jth.14830
   Danilczyk U, 2006, CIRC RES, V98, P463, DOI 10.1161/01.RES.0000205761.22353.5f
   DELIZARRONDO SM, 2017, CIRCULATION, V136, P646, DOI DOI 10.1161/CIRCULATIONAHA.117.027290
   Desai A, 2021, INT J CARDIOL, V324, P249, DOI 10.1016/j.ijcard.2020.09.062
   Do H, 1999, J BIOL CHEM, V274, P19587, DOI 10.1074/jbc.274.28.19587
   Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1
   Everett LA, 2014, BLOOD, V123, P3697, DOI 10.1182/blood-2014-02-554501
   Fahs SA, 2014, BLOOD, V123, P3706, DOI 10.1182/blood-2014-02-555151
   Fried JA, 2020, CIRCULATION, V141, P1930, DOI 10.1161/CIRCULATIONAHA.120.047164
   Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107
   Gallagher PE, 2008, AM J PHYSIOL-HEART C, V295, pH2373, DOI 10.1152/ajpheart.00426.2008
   Goshua George, 2020, Lancet Haematol, V7, pe575, DOI 10.1016/S2352-3026(20)30216-7
   Gralinski LE, 2018, MBIO, V9, DOI 10.1128/mBio.01753-18
   Hanff TC, 2020, AM J HEMATOL, V95, P1578, DOI 10.1002/ajh.25982
   Helms J, 2020, INTENS CARE MED, V46, P1502, DOI 10.1007/s00134-020-06082-7
   Hemila H, 2020, INFECT CHEMOTHER, V52, P222, DOI 10.3947/ic.2020.52.2.222
   Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042
   Hsu A, 2020, THROMB RES, V196, P375, DOI 10.1016/j.thromres.2020.09.030
   Hu M, 2020, HIGHLY PATHOGENIC CO, DOI 10.1101/2020.03.29.20041962
   Inciardi RM, 2020, JAMA CARDIOL, V5, P819, DOI 10.1001/jamacardio.2020.1096
   Ionescu F, 2021, EUR J HAEMATOL, V106, P165, DOI 10.1111/ejh.13533
   Ionescu Filip, 2020, TH Open, V4, pe263, DOI 10.1055/s-0040-1716721
   Jakob A, 2020, EUR J PEDIATR, V179, P377, DOI 10.1007/s00431-019-03513-6
   Jia XM, 2020, CURR ATHEROSCLER REP, V22, DOI 10.1007/s11883-020-00895-z
   Jiang YT, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0063-8
   Jimenez-Guiu X, 2021, J VASC SURG-VENOUS L, V9, P592, DOI 10.1016/j.jvsv.2020.08.028
   Juthani P, 2020, CASE REP INFECT DIS, V2020, DOI 10.1155/2020/8864985
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Koka V, 2008, AM J PATHOL, V172, P1174, DOI 10.2353/ajpath.2008.070762
   Kwon PS, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-00192-8
   Lax SF, 2020, ANN INTERN MED, V173, P350, DOI 10.7326/M20-2566
   Leebeek FWG, 2016, NEW ENGL J MED, V375, P2067, DOI 10.1056/NEJMra1601561
   Levi M, 2020, BLOOD ADV, V4, P2850, DOI 10.1182/bloodadvances.2020002197
   Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21
   Li MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00662-x
   LI X, 2017, DRUGS, V179, P389
   Li X, 2020, J INFLAMM-LOND, V17, DOI 10.1186/s12950-020-0238-7
   Liu SQ, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200688
   Llitjos JF, 2020, J THROMB HAEMOST, V18, P1743, DOI 10.1111/jth.14869
   Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024
   Lopes RD, 2020, AM HEART J, V226, P49, DOI 10.1016/j.ahj.2020.05.002
   Magro G, 2020, VIRUS RES, V286, DOI 10.1016/j.virusres.2020.198070
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Martin J, 2007, CURR PHARM DESIGN, V13, P1751, DOI 10.2174/138161207780831248
   McFadyen JD, 2020, CIRC RES, V127, P571, DOI 10.1161/CIRCRESAHA.120.317447
   Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006
   Mestre-Gomez B, 2021, J THROMB THROMBOLYS, V51, P40, DOI 10.1007/s11239-020-02190-9
   Mizutani T, 2007, ANN NY ACAD SCI, V1102, P86, DOI 10.1196/annals.1408.006
   Moores LK, 2020, CHEST, V158, P1143, DOI 10.1016/j.chest.2020.05.559
   MOTLEKAR NA, 2006, BRIT J HAEMATOL, V113, P91
   Nadkarni GN, 2020, J AM COLL CARDIOL, V76, P1815, DOI 10.1016/j.jacc.2020.08.041
   Nannoni S, 2021, INT J STROKE, V16, P137, DOI 10.1177/1747493020972922
   NOPP S, 2020, J VASC SURG-VENOUS L, V4, P1178
   Obi AT, 2019, J VASC SURG-VENOUS L, V7, P317, DOI 10.1016/j.jvsv.2018.08.010
   Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9
   Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787
   Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001
   PIAZZA G, 2020, RES PRACT THROMB HAE, V76, P2060
   Poissy J, 2020, CIRCULATION, V142, P184, DOI 10.1161/CIRCULATIONAHA.120.047430
   Rand JH, 1997, THROMB HAEMOSTASIS, V78, P445
   Ren B, 2020, CIRCULATION, V142, P181, DOI 10.1161/CIRCULATIONAHA.120.047407
   Ritis K, 2006, J IMMUNOL, V177, P4794, DOI 10.4049/jimmunol.177.7.4794
   Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061
   Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Singh B, 2020, ANN VASC SURG
   Skendros P, 2020, J CLIN INVEST, V130, P6151, DOI 10.1172/JCI141374
   Santos RAS, 2018, PHYSIOL REV, V98, P505, DOI 10.1152/physrev.00023.2016
   Spyropoulos AC, 2020, J THROMB HAEMOST, V18, P1859, DOI 10.1111/jth.14929
   Subramaniam S, 2017, BLOOD, V129, P2291, DOI 10.1182/blood-2016-11-749879
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Tomar B, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061383
   Tree JA, 2021, BRIT J PHARMACOL, V178, P626, DOI 10.1111/bph.15304
   Turner AJ, 2004, TRENDS PHARMACOL SCI, V25, P291, DOI 10.1016/j.tips.2004.04.001
   Vanhoutte PM, 2017, ACTA PHYSIOL, V219, P22, DOI 10.1111/apha.12646
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   VAUGHAN DE, 1995, J CLIN INVEST, V95, P995, DOI 10.1172/JCI117809
   Verdecchia P, 2020, EUR J INTERN MED, V76, P14, DOI 10.1016/j.ejim.2020.04.037
   Vuille-Dit-Bille RN, 2015, AMINO ACIDS, V47, P693, DOI 10.1007/s00726-014-1889-6
   Watanabe T, 2005, HYPERTENSION, V45, P163, DOI 10.1161/01.HYP.0000153321.13792.b9
   Wehbe Z, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00836
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   Wojta J, 2003, PATHOPHYSIOL HAEMO T, V33, P438, DOI 10.1159/000083842
   Xu X, 2020, Zhonghua Bing Li Xue Za Zhi, V49, P576, DOI 10.3760/cma.j.cn112151-20200401-00278
   Yau JW, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0124-z
   Zuo Y, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138999
NR 103
TC 20
Z9 21
U1 1
U2 4
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1050-1738
EI 1873-2615
J9 TRENDS CARDIOVAS MED
JI Trends Cardiovasc. Med.
PD APR
PY 2021
VL 31
IS 3
BP 143
EP 160
DI 10.1016/j.tcm.2020.12.004
EA MAR 2021
PG 18
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA RB0GU
UT WOS:000631796700003
PM 33338635
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Wickramasinghe, ND
   Jayarathne, SW
   Pilapitiya, SD
AF Wickramasinghe, Nuwan Darshana
   Jayarathne, Shamalee Wasana
   Pilapitiya, Senaka Devendra
TI Value-Added Roles of Medical Students During the COVID-19 Pandemic:
   Assessment of Medical Students' Perceptions and Willingness in Sri Lanka
SO INTERNATIONAL JOURNAL OF GENERAL MEDICINE
LA English
DT Article
DE COVID-19; health sector response; medical students; Sri Lanka;
   value-added roles
ID CREATIVITY; EDUCATION
AB Purpose: Since the coronavirus disease 2019 (COVID-19) pandemic is an opportune time to introduce the value-added roles of medical students, this study assessed medical students' perceptions and willingness to assist in COVID-19 health sector preparedness and response via value-added roles in Sri Lanka. Methods: A cross-sectional online survey was conducted among all medical students studying in six batches of the Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, in June 2020. A Google form in English with 10 statements about individual perceptions of medical students' roles and their willingness to assist in the COVID-19 health sector response via value-added roles was used to collect data. The responses were recorded on a five-point Likert scale. The chi-squared test for independence was used to explore the associations between the academic year and the responses to each statement. Results: Out of 856 (response rate 79.6%) study participants, the majority were females (n=601, 70.2%). The majority (n=804, 93.9%) reported that they have a responsibility to contribute to the country's COVID-19 health sector response. There was a statistically significant association between medical students' perceived level of clinical knowledge, having the clinical skills to assist in the COVID-19 health sector response and academic year (p<0.001). The commonly identified value-added roles were developing (n=770, 89.9%) and disseminating (n=744, 86.9%) health education messages, and field contact tracing activities (n=653, 76.3%). Other value-added roles were assisting the curative health sector in COVID-19 patient management (n=380, 44.4%) and other non-COVID-19 patient management (n=463, 54.1%). Conclusion: Medical students are mostly willing to engage in preventive health sector value-added roles and, to a lesser extent, in curative health sector value-added roles during the COVID-19 outbreak. However, medical educators need to clearly define the value-added roles and provide adequate training and supervision for medical students across academic years to enable them to combine learning with making meaningful contributions to the health-care system during the COVID-19 pandemic.
C1 [Wickramasinghe, Nuwan Darshana] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Community Med, Saliyapura 50008, Sri Lanka.
   [Jayarathne, Shamalee Wasana] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Med Educ Unit, Saliyapura 50008, Sri Lanka.
   [Pilapitiya, Senaka Devendra] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Med, Saliyapura 50008, Sri Lanka.
RP Wickramasinghe, ND (corresponding author), Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Community Med, Saliyapura 50008, Sri Lanka.
EM nuwick74@yahoo.com
RI Wickramasinghe, Nuwan Darshana/I-3578-2019
OI Wickramasinghe, Nuwan Darshana/0000-0001-6025-6022; Jayarathne, Y G S
   Wasana/0000-0002-6315-8329
CR Armstrong A, 2020, J PLAST RECONSTR AES, V73, P1174, DOI 10.1016/j.bjps.2020.03.027
   Bank I, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02261-8
   Ediriweera DS, 2020, EPIDE MIOLOGICAL MOD
   Gonzalo JD, 2017, ACAD MED, V92, P1294, DOI 10.1097/ACM.0000000000001662
   Gonzalo JD, 2017, AM J MED QUAL, V32, P261, DOI 10.1177/1062860616645401
   Gonzalo JD, 2017, ACAD MED, V92, P123, DOI 10.1097/ACM.0000000000001177
   Green MJ, 2016, J MED HUMANIT, V37, P475, DOI 10.1007/s10912-016-9397-1
   Harvey A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1268
   Hasan MT, 2020, CONSIDERING VOLUNTAR
   Hewage S, 2020, JCCPSL, V26, P65, DOI 10.4038/jccpsl.v26i1.8314/
   Kim Yura, 2020, Yeungnam Univ J Med, V37, P79, DOI 10.12701/yujm.2019.00458
   Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m986
   Miller DG, 2020, ANN INTERN MED, V173, P145, DOI 10.7326/M20-1281
   Morris CS, 2018, ACAD MED, V93, P1752, DOI 10.1097/ACM.0000000000002462
   Patrinely JR, 2020, MED SCI EDUC, V30, P1641, DOI 10.1007/s40670-020-01052-6
   Representatives STARSurg, 2020, LANCET, V395, P1254, DOI 10.1016/S0140-6736(20)30795-9
   Roll R, 2020, ACAD MED, V95, pE6, DOI 10.1097/ACM.0000000000003588
   Rose S, 2020, JAMA-J AM MED ASSOC, V323, P2131, DOI 10.1001/jama.2020.5227
   Shaywitz DA, 2004, PLOS MED, V1, P176, DOI 10.1371/journal.pmed.0010034
   Stokes DC, 2020, ACAD EMERG MED, V27, P343, DOI 10.1111/acem.13972
   Tempski P, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248627
   Thomson E, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13516
   Walker PGT, 2020, SCIENCE, V369, P413, DOI 10.1126/science.abc0035
   World Health Organization, 2020, RESP COMM SPREAD COV
   Yu Nan-Ze, 2020, World J Virol, V9, P38, DOI 10.5501/wjv.v9.i3.38
NR 25
TC 1
Z9 1
U1 0
U2 1
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1178-7074
J9 INT J GEN MED
JI Int. J. Gen. Med.
PY 2021
VL 14
BP 3187
EP 3196
DI 10.2147/IJGM.S309021
PG 10
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA TD7KW
UT WOS:000669502000001
PM 34262332
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Abdulmuhsin, AA
   Degirmenci, B
   Efendioglu, IH
   Durmaz, Y
AF Abdulmuhsin, Amir A.
   Degirmenci, Bekir
   Efendioglu, Ibrahim Halil
   Durmaz, Yakup
TI The perception of COVID-19 and avoidance behavior in Turkey: the role of
   income level, gender and education
SO INTERNATIONAL JOURNAL OF EMERGING MARKETS
LA English
DT Article; Early Access
DE COVID-19; Lay theory; Avoidance behavior; Consumer behavior; Turkey;
   Emerging markets
ID PANDEMIC INFLUENZA; CONSPIRACY THEORIES; RISK PERCEPTION; KNOWLEDGE;
   OUTBREAK; ATTITUDES; ANXIETY; MODELS; CHINA; SARS
AB Purpose This study aims to reveal both the effect of the perception of COVID-19 on avoidance behaviors and the mediating role of the perception of personal control in this relationship. COVID-19 emerged in December 2019 and since then, it has spread globally in a short period and has affected people socially, economically and culturally. Design/methodology/approach The data for the research was collected from 418 participants during COVID-19, through online questionnaires. The obtained data were analyzed through AMOS and SPSS software using structural equation modeling. Findings The research results show that some perceptions of COVID-19 affect avoidance behavior and that personal control has a mediating role. It has also been found that gender plays a moderating role in the relationship between COVID-19 and avoidance behavior. It has been found that women are especially more sensitive compared to men in perceiving COVID-19. This study also found that perception of COVID-19 changes depending on income. Practical implications After the pandemic is over, people will get in contact with each other less than before, and trade will change accordingly. People will avoid shopping in crowded places, and consumer behaviors will undergo different changes. All of these results considered, it is expected that avoidance behavior will cause some permanent behavioral changes in consumers. Originality/value The study answers the critical question about the effect of the perception of COVID-19 on avoidance behavior. Furthermore, the role of income level, gender and education in this relationship will be highlighted.
C1 [Abdulmuhsin, Amir A.] Univ Mosul, Dept Management Informat Syst, Coll Adm & Econ, Mosul, Iraq.
   [Degirmenci, Bekir] Adiyaman Univ, Adiyaman, Turkey.
   [Efendioglu, Ibrahim Halil] Gaziantep Univ, Gaziantep, Turkey.
   [Durmaz, Yakup] Hasan Kalyoncu Univ, Gaziantep, Turkey.
RP Abdulmuhsin, AA (corresponding author), Univ Mosul, Dept Management Informat Syst, Coll Adm & Econ, Mosul, Iraq.
EM dr.amir_alnasser@uomosul.edu.iq
RI DURMAZ, Yakup/AAK-2365-2021; Abdulmuhsin, Amir A./AAW-4559-2020;
   EFENDIOGLU, Ibrahim Halil/AAJ-9982-2021
OI DURMAZ, Yakup/0000-0003-0332-4185; Abdulmuhsin, Amir
   A./0000-0002-1383-8342; EFENDIOGLU, Ibrahim Halil/0000-0002-4968-375X;
   DEGIRMENCI, BEKIR/0000-0001-5236-5245
CR Abdulmuhsin AA, 2021, INT J KNOWL MAN STUD, V12, P1
   Abdulmuhsin AA, 2021, INT J ORGAN ANAL, V29, P529, DOI 10.1108/IJOA-09-2020-2424
   Afacan E., 2020, AVRASYA SOSYAL VE EK, V7, P1
   Afsar B, 2020, CORP SOC RESP ENV MA, V27, P109, DOI 10.1002/csr.1777
   Ahmed W, 2020, J MED INTERNET RES, V22, DOI 10.2196/19458
   Akan H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-413
   Alpago H., 2020, IBAD SOSYAL BILIMLER, P99, DOI [10.21733/ibad.716444, DOI 10.21733/IBAD.716444]
   Altunsik R., 2012, SOSYAL BILIMLERDE AR
   ARIK FS, 1991, TARIH ARASTIRMALARI, V15, P27
   Baker S. R., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts)
   Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160
   Bohlen B., 2010, MCKINSEY Q, V1, P17
   Bostan S, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/7944
   Bullers S, 2001, SOCIOL INQ, V71, P145, DOI 10.1111/j.1475-682X.2001.tb01106.x
   Ceyhan S., 2020, TURK STUD, V15, P259, DOI DOI 10.7827/TURKISHSTUDIES.45988
   Cinnirella, 2007, SOCIAL PSYCHOL REV, V9, P18
   Cirakoglu OC, 2011, TURK PSIKOL DERG, V26, P49
   Cook TM, 2020, ANAESTHESIA, V75, P920, DOI 10.1111/anae.15071
   Depoux A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa031
   Donmez, 2020, MANAS SOSYAL ARA T R, V9, P2159, DOI [10.33206/mjss.763029, DOI 10.33206/MJSS.763029]
   Douglas KM, 2017, CURR DIR PSYCHOL SCI, V26, P538, DOI 10.1177/0963721417718261
   DWECK CS, 1995, PSYCHOL INQ, V6, P267, DOI 10.1207/s15327965pli0604_1
   Eastwood K, 2009, B WORLD HEALTH ORGAN, V87, P588, DOI 10.2471/BLT.08.060772
   Eaton Jw, 2020, PERCEPTIONS BEHAV RE, P1
   Eaton LA, 2020, J BEHAV MED, V43, P341, DOI 10.1007/s10865-020-00157-y
   El Sayed M, 2011, PREHOSP EMERG CARE, V15, P506, DOI 10.3109/10903127.2011.598608
   Ergun I., 2020, PARAMEDIK VE ACIL SA, V1, P16
   Fang YQ, 2020, J MED VIROL, V92, P645, DOI 10.1002/jmv.25750
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Forster J, 2006, J EXP SOC PSYCHOL, V42, P133, DOI 10.1016/j.jesp.2005.02.004
   Furnham A., 1988, LAY THEORIES EVERYDA
   Garfin DR, 2020, HEALTH PSYCHOL, V39, P355, DOI 10.1037/hea0000875
   Genu║ S., 2020, COVID 19 TUKETICILER
   Goodwin R, 2011, INT J BEHAV MED, V18, P88, DOI 10.1007/s12529-010-9083-z
   GREENBERG MR, 1995, RISK ANAL, V15, P503, DOI 10.1111/j.1539-6924.1995.tb00343.x
   Gualeryuaz I., 2019, J AKDENIZ U COMMUNIC, V26, DOI [10.31123/akil.441385, DOI 10.31123/AKIL.441385]
   Guanche Garcell H, 2020, REV HABAN CIENC MED, V19
   Gustafson PE, 1998, RISK ANAL, V18, P805, DOI 10.1023/B:RIAN.0000005926.03250.c0
   Hair J.F., 2010, MULTIVARIATE DATA AN, V7th
   Hale T, 2020, VARIATION GOVT RESPO
   Hayes AF., 2017, INTRO MEDIATION MODE
   HELLEWELL J, 2020, LANCET GLOB HEALTH, DOI [DOI 10.1016/S2214-109X(20)30074-7, 10.1016/S2214-109X(20)30074-7]
   Ipsos, 2020, COR BEH CHANG WHAT D
   Jarvis CI, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01597-8
   Jolley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089177
   Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032
   Karagu┬z Y., 2019, SPSS VE AMOS UYGULA
   Kilic S, 2016, J MOOD DISORD, V6, P47, DOI 10.5455/jmood.20160307122823
   Koh D, 2020, OCCUP MED-OXFORD, V70, P3, DOI 10.1093/occmed/kqaa036
   Kramer A, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103442
   Kristiansen IS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-48
   Kwok KO, 2020, EMERG INFECT DIS, V26, P1575, DOI 10.3201/eid2607.200500
   Lau JTF, 2004, J EPIDEMIOL COMMUN H, V58, P988, DOI 10.1136/jech.2003.017483
   Leppin A, 2009, INT J BEHAV MED, V16, P7, DOI 10.1007/s12529-008-9002-8
   Leung GM, 2005, CLIN INFECT DIS, V40, P1713, DOI 10.1086/429923
   Li CL, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.10.2000199
   Lin QY, 2020, INT J INFECT DIS, V93, P211, DOI 10.1016/j.ijid.2020.02.058
   Llewellyn S, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1160
   MCCAULEY C, 1979, J PERS SOC PSYCHOL, V37, P637, DOI 10.1037/0022-3514.37.5.637
   McKinsey, 2020, COR LEAD CRIS INS OR
   Moral & Partners, 2020, COVID 19 SALG KARS A
   Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658
   Raude J, 2009, EUR J EPIDEMIOL, V24, P339, DOI 10.1007/s10654-009-9351-x
   Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1
   Rosengren S, 2020, SSE WORKING PAPER SE
   Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083
   Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651
   Sachan R, 2012, INT J SCI RES PUBLIC, V2, P1
   Sadique MZ, 2007, EMERG INFECT DIS, V13, P1307, DOI 10.3201/eid1309.070372
   SECER I, 2017, SPSS VE LISREL ILE P
   Shahsavari S, 2020, J COMPUT SOC SCI, V3, P279, DOI 10.1007/s42001-020-00086-5
   SMITH RE, 1989, J PERS SOC PSYCHOL, V56, P228, DOI 10.1037/0022-3514.56.2.228
   Sogut S, 2021, PERSPECT PSYCHIATR C, V57, P246, DOI 10.1111/ppc.12555
   Son Kim Og, 2016, [Journal of the Korea Convergence Society, 한국융합학회논문지], V7, P59, DOI 10.15207/JKCS.2016.7.3.059
   Srichan Peeradone, 2020, SSRN ELECT J, DOI [10.2139/ssrn.3546046, DOI 10.2139/SSRN.3546046]
   Statista, 2020, MONTHL UN RAT US MAY
   Tabachnick BG, 2012, USING MULTIVARIATE S
   Taylor MR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-347
   Tutku E.K.I.Z., 2020, ULUSLARARASI SAGLIK, V6, P139
   TYRRELL DA, 1966, LANCET, V1, P76
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   van Prooijen JW, 2017, MEM STUD, V10, P323, DOI 10.1177/1750698017701615
   Varnali, 2020, COVID 19 SALGININDA
   Vijai C., 2020, SHANL INT J MANAGE, V8, P69, DOI [10.34293/management.v8i1.322, DOI 10.34293/MANAGEMENT.V8I1.322]
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   World Health Organization, 2020, RAT US PERS PROT EQ
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Yildiz S., 2017, KESIT AKAD DERGISI, V3, P421, DOI [10.18020/kesit.1279, DOI 10.18020/KESIT.1279]
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 90
TC 6
Z9 6
U1 8
U2 20
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1746-8809
EI 1746-8817
J9 INT J EMERG MARK
JI Int. J. Emerg. Mark.
DI 10.1108/IJOEM-11-2020-1308
EA MAR 2021
PG 26
WC Business; Economics; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA RA6YY
UT WOS:000631564000001
OA Bronze, Green Submitted
DA 2022-04-20
ER

PT J
AU Perin, M
   De Panfilis, L
AF Perin, Marta
   De Panfilis, Ludovica
TI Among equity and dignity: an argument-based review of European ethical
   guidelines under COVID-19
SO BMC MEDICAL ETHICS
LA English
DT Review
DE COVID-19 pandemic; Allocation of Health Care Resources; Human Dignity;
   Ethics
ID INTENSIVE-CARE; DECISION-MAKING; LIFE
AB Background Under COVID-19 pandemic, many organizations developed guidelines to deal with the ethical aspects of resources allocation. This study describes the results of an argument-based review of ethical guidelines developed at the European level. It aims to increase knowledge and awareness about the moral relevance of the outbreak, especially as regards the balance of equity and dignity in clinical practice and patient's care. Method According to the argument-based review framework, we started our research from the following two questions: what are the ethical principles adopted by the ethical guidelines produced at the beginning of the COVID-19 outbreak related to resource allocation? And what are the practical consequences in terms of 'priority' of access, access criteria, management of the decision-making process and patient care? Results Twenty-two ethical guidelines met our inclusion criteria and the results of our analysis are organized into 4 ethical concepts and related arguments: the equity principle and emerging ethical theories; triage criteria; respecting patient's dignity, and decision making and quality of care. Conclusion Further studies can investigate the practical consequences of the application of the guidelines described, in terms of quality of care and health care professionals' moral distress.
C1 [Perin, Marta; De Panfilis, Ludovica] Azienda USL IRCCS Reggio Emilia, Bioeth Unit, Reggio Emilia, Italy.
   [Perin, Marta] Univ Modena & Reggio Emilia, PhD Program Clin & Expt Med, Modena, Italy.
RP Perin, M (corresponding author), Azienda USL IRCCS Reggio Emilia, Bioeth Unit, Reggio Emilia, Italy.
EM marta.perin@ausl.re.it
RI Perin, Marta/AGQ-5379-2022; De Panfilis, Ludovica/T-4891-2019
OI Perin, Marta/0000-0003-4631-7380; De Panfilis,
   Ludovica/0000-0002-5509-7626
CR Ammer V, 2020, RECOMMENDATIONS CLIN, P10
   Angelos P, 2020, J AM COLL SURGEONS, V230, P1119, DOI 10.1016/j.jamcollsurg.2020.03.028
   Auriemma CL, 2020, AM J BIOETHICS, V20, P28, DOI 10.1080/15265161.2020.1764141
   Belgium Society of Intensive Care, 2020, ETH PRINC PROP CRIT, P1
   Berlinger N, 2020, HAST CENT
   Biddison ELD, 2019, CHEST, V155, P848, DOI 10.1016/j.chest.2018.09.025
   Bioethics Commission, 2020, MAN SCARC RES HEALTH, P15
   British Medical Association, 2020, COVID 19 ETH ISS GUI, P1
   Cesari M, 2020, J AM MED DIR ASSOC, V21, P576, DOI 10.1016/j.jamda.2020.03.025
   Committee on Bioethics (DH-BIO), 2020, DH BIO STAT HUM RIGH
   Conselho Nacional de Etica para as Ciencias da Vida, 2020, PUBLIC HLTH EMERGENC, P1
   Curtis JR, 2010, LANCET, V376, P1347, DOI 10.1016/S0140-6736(10)60143-2
   de Casterle BD, 2012, INT J NURS STUD, V49, P360, DOI 10.1016/j.ijnurstu.2011.09.012
   De Panfilis L, 2020, BIOLAW J, P447
   De Panfilis L, 2019, BMC PALLIAT CARE, V18, DOI 10.1186/s12904-019-0453-2
   Delmas-goyon P, 2020, COVID 19 CONTRIBUTIO, P1
   Deutscher Ethikrat, 2020, SOL RESP COR CRIS, P1
   Dzieciatkowski T, 2020, CARDIOL J
   Edwards SD, 2009, NURS PHILOS, V10, P231, DOI 10.1111/j.1466-769X.2009.00415.x
   Ehni HJ, 2021, BIOETHICS, V35, P125, DOI 10.1111/bioe.12836
   Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114
   Escher M, 2019, HEALTH SERV RES
   European Group on Ethics in Science and New Technologies (EGE), 2020, STAT EUR SOL PROT FU, P1
   Farrell TW, 2020, J AM GERIATR SOC
   General Medical Council, 2020, COR YOUR FREQ ASK QU
   Gomez-Virseda C, 2019, BMC MED ETHICS, V20, DOI 10.1186/s12910-019-0417-3
   Gostin LO, 2020, HASTINGS CENT REP, V50, P8, DOI 10.1002/hast.1090
   Gurbilek N., 2013, J CHEM INF MODEL
   Ireland Department of Health, 2020, ETH FRAM DEC MAK PAN, P1
   Jeffrey DI., 2020, J MED ETHICS
   Jobges S, 2020, BIOETHICS, V34, P948, DOI 10.1111/bioe.12805
   La PL, 2020, BIOLAWJOURNAL RIV BI, V1, P359, DOI [10.15168/2284-4503-596, DOI 10.15168/2284-4503-596]
   Mannelli C, 2020, J MED ETHICS, V46, P364, DOI 10.1136/medethics-2020-106227
   Matheny Antommaria AH., 2020, ANN INTERN MED
   McCullough LB, 2007, J MED PHILOS, V32, P65, DOI 10.1080/03605310601152206
   McDougall R, 2014, J MED PHILOS, V39, P89, DOI 10.1093/jmp/jht059
   Ministerio de Sanidad Gobierno de Espana, 2020, MINISTRY HLTH REPORT
   Mounk Y., 2020, ATLANTIC
   National Bioethics Commission of Mexico, 2020, REC REG COVID 19 PAN
   National Center for Hydrology and Meteorology, 2020, ANN REP 2019 2020, P1
   Nuffield Council on Bioethics, 2020, RAP POL BRIEF ETH CO, P1
   Orfali K, 2021, HASTINGS CENT REP, V51, P16, DOI 10.1002/hast.1206
   Pontifical Academy for Life, 2020, GLOB PAND UN BROTH N, P1
   Rosenbaum L, 2020, NEW ENGL J MED, V382, P1873, DOI 10.1056/NEJMp2005492
   Royal College of Physicians, 2020, ETH DIM COVID 19 FRO, P1
   Scottish Government, 2020, COVID 19 GUID ETH AD, P1
   Singer PA, 1998, HOSP Q
   Solomon MZ, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2008300
   Sprung CL, 2013, INTENS CARE MED, V39, P1916, DOI 10.1007/s00134-013-3033-6
   Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790
   Sulmasy DP., 2008, HUMAN DIGNITY BIOETH, P325
   Swiss Academy of Medical Sciences, 2020, COVID 19 PAND TRIAG, P1
   Tanzi S, 2020, PALLIATIVE MED, V34, P1220, DOI 10.1177/0269216320947289
   Truog RD, 2020, NEW ENGL J MED
   UK Department of health and Social Care, 2020, GUID RESP COVID 19 E
   UNESCO International Bioethics Committee (IBC) UNESCO World Commission on the Ethics of Scientific Knowledge and Technology (COMEST), 2020, STAT COVD 19 ETH CON
   University of the Philippines Manila Covid-19 Ethics Study Group, 2020, COVID 19
   Vergano M., 2020, RACCOMANDAZIONI ETIC
   Westview press, 1995, JUSTICE CARE ESSENTI
   White DB, 2020, JAMA-J AM MED ASSOC, V323, P1773, DOI 10.1001/jama.2020.5046
   Zareifopoulos N, 2020, MONALDI ARCH CHEST D, V90, DOI 10.4081/monaldi.2020.1296
NR 61
TC 0
Z9 0
U1 1
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1472-6939
J9 BMC MED ETHICS
JI BMC Med. Ethics
PD MAR 31
PY 2021
VL 22
IS 1
AR 36
DI 10.1186/s12910-021-00603-9
PG 29
WC Ethics; Medical Ethics; Social Sciences, Biomedical
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics; Medical Ethics; Biomedical Social
   Sciences
GA RH8HS
UT WOS:000636453100002
PM 33789633
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Chen, YM
   Cheng, LY
   Lian, RN
   Song, ZW
   Tian, JH
AF Chen, Yamin
   Cheng, Luying
   Lian, Rongna
   Song, Ziwei
   Tian, Jinhui
TI COVID-19 vaccine research focusses on safety, efficacy,
   immunoinformatics, and vaccine production and delivery: a bibliometric
   analysis based on VOSviewer
SO BIOSCIENCE TRENDS
LA English
DT Review
DE COVID-19; vaccine; bibliometric analysis; VOSviewer
ID RESEARCH TRENDS; BREAKTHROUGH; ETHICS
AB Coronavirus Disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has affected tens of millions of people globally since it was declared a pandemic by the World Health Organization (WHO) on March 11, 2020. There is an urgent need for safe and effective preventive vaccines to curb this pandemic. A growing amount of related research has been published. This study aimed to provide the current status of COVID-19 vaccine using bibliometric analysis. We searched Embase.com and MEDLINE comprehensively and included articles, articles in press, reviews, short surveys, conference abstracts and conference papers about COVID-19 vaccine. VOSviewer1.6.11 (Leiden University, Leiden, Netherlands) was applied to perform the bibliometric analysis of these papers. A total of 1,312 papers were finally included. The BMJ has been the most popular journal in this field. The United States maintained a top position worldwide and has provided a pivotal influence, followed by China, India and United Kingdom. Among all the institutions, Harvard University was regarded as a leader for research collaboration. We analyzed the keywords and identified seven COVID-19 vaccine research hotspot clusters. COVID-19 vaccine research hotspots focus on clinical trials on vaccine safety and efficacy, research on vaccine immunology and immunoinformatics, and vaccine hesitancy. Our analysis results demonstrated that cooperation between countries, institutions, and authors were insufficient. The results suggested that clinical trials on vaccine safety, efficacy, immunology, immunoinformatics, production and delivery are research hotspots. Furthermore, we can predict that there will be a lot of research focusing on vaccine adverse reactions.
C1 [Chen, Yamin; Tian, Jinhui] Lanzhou Univ, Key Lab Evidence Based Med & Knowledge Translat G, Lanzhou, Peoples R China.
   [Chen, Yamin; Cheng, Luying; Song, Ziwei] Lanzhou Univ, Evidence Based Nursing Ctr, Sch Nursing, Lanzhou, Peoples R China.
   [Lian, Rongna] Lanzhou Univ, Clin Med Coll 1, Lanzhou, Peoples R China.
   [Tian, Jinhui] Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, 199 Donggang West Rd, Lanzhou 730000, Gansu, Peoples R China.
RP Tian, JH (corresponding author), Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, 199 Donggang West Rd, Lanzhou 730000, Gansu, Peoples R China.
EM tianjh@lzu.edu.cn
FU Gansu Province Science and Technology Plan Funded Project [20CX4ZA027]
FX This work is supported by Gansu Province Science and Technology Plan
   Funded Project (Grant No. 20CX4ZA027). The funders had no role in the
   design and conduct of the study; collection, management, analysis, and
   interpretation of the data; preparation, review, or approval of the
   manuscript; and decision to submit the manuscript for publication.
CR Bornmann L, 2014, EMBO REP, V15, P1228, DOI 10.15252/embr.201439608
   Bos R, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-020-00243-x
   Buschmann MD, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010065
   Calina D, 2020, DARU, V28, P807, DOI 10.1007/s40199-020-00371-8
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952
   Clarke L, 2020, J EVID-BASED MED, V13, P161, DOI 10.1111/jebm.12395
   Campos DMD, 2020, J EVID-BASED MED, V13, P255, DOI 10.1111/jebm.12414
   de Vrieze J, 2021, SCIENCE, V371, P10, DOI 10.1126/science.371.6524.10
   Dong R, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01784
   Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y
   Ellegaard O, 2015, SCIENTOMETRICS, V105, P1809, DOI 10.1007/s11192-015-1645-z
   Fan JC, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00477
   Farzanegan R, 2017, ARCH IRAN MED, V20, P598, DOI 0172009/AIM.008
   Fisher KA, 2020, ANN INTERN MED, V173, P964, DOI 10.7326/M20-3569
   Frederiksen LSF, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01817
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Gao Y, 2019, ENVIRON SCI POLLUT R, V26, P17809, DOI 10.1007/s11356-019-05071-8
   Glanville J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1028
   Gong Wenping, 2021, Indian J Tuberc, V68, P401, DOI 10.1016/j.ijtb.2020.10.012
   Heaton PM, 2020, NEW ENGL J MED, V383, P1986, DOI 10.1056/NEJMe2025111
   Hotez PJ, 2020, NAT REV IMMUNOL, V20, P347, DOI 10.1038/s41577-020-0323-4
   I MLF, 2020, CLIN CHIM ACTA, V508, P254
   Jamrozik E, 2020, LANCET INFECT DIS, V20, pE198, DOI 10.1016/S1473-3099(20)30438-2
   Lee L, 2020, PHARMACY-BASEL, V8, DOI 10.3390/pharmacy8040199
   Leng ZK, 2020, AGING DIS, V11, P216, DOI 10.14336/AD.2020.0228
   Li G, 2020, J INT MED RES, V48
   Liang YD, 2017, J PAIN RES, V10, P951, DOI 10.2147/JPR.S132808
   Ma XT, 2020, J EVID-BASED MED, V13, P173, DOI 10.1111/jebm.12388
   Mao XJ, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020137
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Qiu YY, 2018, ARCH OSTEOPOROS, V13, DOI 10.1007/s11657-018-0534-5
   Romero L, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00564
   Shi SZ, 2021, CLIN EXP MED, V21, P181, DOI 10.1007/s10238-020-00624-5
   Shi Y, 2020, J ZHEJIANG UNIV-SC B, V21, P343, DOI 10.1631/jzus.B2000083
   Tao ZB, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.04.26
   Le TT, 2020, NAT REV DRUG DISCOV, V19, P305, DOI 10.1038/d41573-020-00073-5
   Twomey JD, 2020, DRUG RESIST UPDATE, V53, DOI 10.1016/j.drup.2020.100733
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wendler D, 2020, SCIENCE, V370, P1277, DOI 10.1126/science.abf5084
   Whitehead CL, 2020, LANCET, V395, pE92, DOI 10.1016/S0140-6736(20)31029-1
   WHO, STAT COVID 19 VACC W
   Wibawa T, 2021, TROP MED INT HEALTH, V26, P14, DOI 10.1111/tmi.13503
   World Health Organization, COR DIS COVID 19 PAN
   World Health Organization, COVAX STAT WHO EM US
   World Health Organization (WHO), COVID 19 VACC
   Xing YY, 2020, EUROSURVEILLANCE, V25, P12, DOI 10.2807/1560-7917.ES.2020.25.10.2000191
   Yang Limin, 2020, Sheng Wu Gong Cheng Xue Bao, V36, P593, DOI 10.13345/j.cjb.200094
   Yu YT, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-4235
   Zyoud SH, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-1076-z
NR 51
TC 10
Z9 10
U1 26
U2 38
PU IRCA-BSSA
PI TOKYO
PA PEARL CITY KOISHIKAWA 603, 2-4-5 KASUGA, BUNKYO-KU, TOKYO, 112-0003,
   JAPAN
SN 1881-7815
EI 1881-7823
J9 BIOSCI TRENDS
JI BioSci. Trends
PD APR
PY 2021
VL 15
IS 2
BP 64
EP 73
DI 10.5582/bst.2021.01061
PG 10
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA RX0SP
UT WOS:000646930700001
PM 33746182
OA gold
DA 2022-04-20
ER

PT J
AU Milone, M
   Carrano, FM
   Letic, E
   Shamiyeh, A
   Forgione, A
   Eom, BW
   Muller-Stich, BP
   Ponz, CB
   Kontovounisios, C
   Preda, D
   Ignjatovic, D
   Cassinotti, E
   Yiannakopoulou, E
   Theodoropoulos, G
   Faria, G
   Morelli, L
   Gorter-Stam, M
   Markar, S
   Arulampalam, T
   Velthoven, T
   Antoniou, SA
   Francis, NK
AF Milone, Marco
   Carrano, Francesco Maria
   Letic, Emina
   Shamiyeh, Andreas
   Forgione, Antonello
   Eom, Bang Wool
   Muller-Stich, Beat P.
   Balague Ponz, Carmen
   Kontovounisios, Christos
   Preda, Daniel
   Ignjatovic, Dejan
   Cassinotti, Elisa
   Yiannakopoulou, Eugenia
   Theodoropoulos, George
   Faria, Gil
   Morelli, Luca
   Gorter-Stam, Marguerite
   Markar, Sheraz
   Arulampalam, Thanjakumar
   Velthoven, Therese
   Antoniou, Stavros A.
   Francis, Nader K.
TI Surgical challenges and research priorities in the era of the COVID-19
   pandemic: EAES membership survey
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Article
DE COVID-19; Pandemic; Laparoscopy; Surgical challenges
AB Background Healthcare systems and general surgeons are being challenged by the current pandemic. The European Association for Endoscopic Surgery (EAES) aimed to evaluate surgeons' experiences and perspectives, to identify gaps in knowledge, to record shortcomings in resources and to register research priorities. Methods An ad hoc web-based survey of EAES members and affiliates was developed by the EAES Research Committee. The questionnaire consisted of 69 items divided into the following sections: (Iota) demographics, (II) institutional burdens and management strategies, and (III) analysis of resource, knowledge, and evidence gaps. Descriptive statistics were summarized as frequencies, medians, ranges,, and interquartile ranges, as appropriate. Results The survey took place between March 25th and April 16th with a total of 550 surgeons from 79 countries. Eighty-one percent had to postpone elective cases or suspend their practice and 35% assumed roles not related to their primary expertise. One-fourth of respondents reported having encountered abdominal pathologies in COVID-19-positive patients, most frequently acute appendicitis (47% of respondents). The effect of protective measures in surgical or endoscopic procedures on infected patients, the effect of endoscopic surgery on infected patients, and the infectivity of positive patients undergoing laparoscopic surgery were prioritized as knowledge gaps and research priorities. Conclusions Perspectives and priorities of EAES members in the era of the pandemic are hereto summarized. Research evidence is urgently needed to effectively respond to challenges arisen from the pandemic.
C1 [Milone, Marco] Univ Naples Federico II, Dept Clin Med & Surg, Via Pansini 5, Naples, Italy.
   [Carrano, Francesco Maria] Univ Roma Tor Vergata, Dept Appl Med Surg Sci, Rome, Italy.
   [Carrano, Francesco Maria] Humanitas Clin & Res Ctr IRCCS, Via Manzoni 56, Milan, Italy.
   [Letic, Emina] Univ Sarajevo, Fac Med, Dept Gen Surg, Cekalusa 90, Sarajevo 71000, Bosnia & Herceg.
   [Shamiyeh, Andreas] Acad Teaching Hosp Linz, Ludwig Boltzmann Inst Operat Laparoscopy, Krankenhausstr 9, A-4020 Linz, Austria.
   [Shamiyeh, Andreas] Acad Teaching Hosp Linz, Surg Dept 2, Krankenhausstr 9, A-4020 Linz, Austria.
   [Forgione, Antonello] Osped Niguarda Ca Granda, AIMS Acad, Dept Surg Oncol & Minimally Invas Surg, Milan, Italy.
   [Eom, Bang Wool] Natl Canc Ctr, Ctr Gastr Canc, Res Inst & Hosp, 323 Ilsan Ro, Goyang, Gyeonggi Do, South Korea.
   [Muller-Stich, Beat P.] Heidelberg Univ Hosp, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany.
   [Balague Ponz, Carmen] Hosp Santa Creu & Sant Pau, Serv Gen & Digest Surg, Barcelona, Spain.
   [Kontovounisios, Christos] Imperial Coll London, Dept Surg & Canc, Chelsea & Westminster Campus,369 Fulham Rd, London SW10 9NH, England.
   [Preda, Daniel] Craiova Emergency Clin Cty Hosp, Clin Surg 1, Craiova, Romania.
   [Ignjatovic, Dejan] Akershus Univ Hosp, Dept Digest Surg, Oslo, Norway.
   [Cassinotti, Elisa] Fdn IRCCS Ca Granda, Maggiore Policlin Hosp, Milan, Italy.
   [Yiannakopoulou, Eugenia] Univ West Attica, Fac Hlth Sci, Dept Biomed Sci, Athens, Greece.
   [Theodoropoulos, George] Athens Univ, Hippocrat Hosp, Dept Propaedeut Surg 1, Med Sch, Athens 11527, Greece.
   [Faria, Gil] CINTESIS Ctr Res Hlth Technol & Informat Syst, P-4200450 Porto, Portugal.
   [Faria, Gil] Hosp Pedro Hispano, Gen Surg, Unidade Local Saude Matosinhos, P-4464513 Senhora Da Hora, Portugal.
   [Morelli, Luca] Univ Pisa, Dept Traslat Res & New Surg & Med Technol, Azienda Osped Univ Pisana, Pisa, Italy.
   [Gorter-Stam, Marguerite] Vrije Univ Amsterdam Med Ctr, Dept Surg, Amsterdam, Netherlands.
   [Markar, Sheraz] Imperial Coll Healthcare NHS Trust, Dept Surg & Canc, Div Surg, St Marys Hosp, London, England.
   [Arulampalam, Thanjakumar] Colchester Gen Hosp, Dept Gen Surg, Colchester, Essex, England.
   [Velthoven, Therese] European Assoc Endoscop Surg, Rome, Italy.
   [Antoniou, Stavros A.] European Univ Cyprus, Dept Surg, Nicosia, Cyprus.
   [Francis, Nader K.] Northwick Pk Hosp & Clin Res Ctr, Griffin Inst, Northwick Pk Inst Med Res, Harrow HA1 3UJ, Middx, England.
   [Francis, Nader K.] Yeovil Dist Hosp, Yeovil BA21 4AT, Somerset, England.
RP Francis, NK (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Griffin Inst, Northwick Pk Inst Med Res, Harrow HA1 3UJ, Middx, England.; Francis, NK (corresponding author), Yeovil Dist Hosp, Yeovil BA21 4AT, Somerset, England.
EM nader.francis@ydh.nhs.uk
RI Kontovounisios, Christos/ABC-9225-2020; Daniel, Preda
   Silviu/ABE-8063-2020; Müller-Stich, Beat/ABF-5069-2020; Carrano,
   Francesco Maria/AAB-6807-2021
OI Daniel, Preda Silviu/0000-0002-0232-0070; Carrano, Francesco
   Maria/0000-0003-1189-9907; Ignjatovic, Dejan/0000-0002-8565-0568;
   Muller-Stich, Beat Peter/0000-0002-8552-8538; KONTOVOUNISIOS,
   CHRISTOS/0000-0002-1828-1395
CR [Anonymous], 2020, RECOMMENDATIONS SPAN
   [Anonymous], 2020, WHO DIRECTOR GENERAL
   Di Saverio S, 2020, COLORECTAL DIS, V22, P625, DOI 10.1111/codi.15056
   Gorter RR, 2016, SURG ENDOSC, V30, P4668, DOI 10.1007/s00464-016-5245-7
   Keller DS, 2016, SURG ENDOSC, V30, P2192, DOI 10.1007/s00464-015-4459-4
   Mowbray NG, 2020, BRIT J SURG, V107, P1406, DOI 10.1002/bjs.11679
   Qureshi MS, 2012, COLORECTAL DIS, V14, pE477, DOI 10.1111/j.1463-1318.2012.02992.x
   The Royal College of Surgeons of Edinburgh, INT GEN SURG GUID CO
   Zheng M, 2020, ANN SURG, DOI [10.1097/SLA.000000000000392, DOI 10.1097/SLA.000000000000392]
NR 9
TC 4
Z9 4
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0930-2794
EI 1432-2218
J9 SURG ENDOSC
JI Surg. Endosc.
PD OCT
PY 2020
VL 34
IS 10
BP 4225
EP 4232
DI 10.1007/s00464-020-07835-7
EA AUG 2020
PG 8
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA NW0NT
UT WOS:000555743700009
PM 32749615
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Kariuki, P
   Goyayi, ML
   Ofusori, LO
AF Kariuki, Paul
   Goyayi, Maria Lauda
   Ofusori, Lizzy Oluwatoyin
TI COVID-19, migration and inclusive cities through e-governance:
   strategies to manage asylum seekers in Durban, South Africa
SO DIGITAL POLICY REGULATION AND GOVERNANCE
LA English
DT Article
DE Migrants; E-governance; South Africa; Asylum seekers; COVID-19
ID IMMIGRATION; CHALLENGES; GOVERNMENT; MOBILITY; REFUGEES; HEALTH
AB Purpose This paper aims to examine the role of electronic governance (e-governance) in enabling asylum seekers' access to public services in the city of Durban, South Africa. Because of COVID-19, the government scaled down its operations, limiting access to public services, including among migrants. Design/methodology/approach Because of COVID-19-related restrictions, a systematic review was conducted of the relevant academic literature as well as the information portals of relevant government departments, municipalities and research reports on migration and refugees in South Africa. A total of 320 peer-reviewed research articles were identified. These were filtered and 68 relevant articles were selected. Findings The study found that asylum seekers have limited access to public services via information communication technology-enabled mechanisms. Whilst the city government has embraced e-governance, it is still in its nascent stages. Research limitations/implications This study was limited to a desktop one because of COVID-19 restrictions and it focused exclusively on asylum seekers. Therefore, its findings can only be generalised to this category of people. Practical implications Future studies on this subject should gather data from all categories of migrants to gain in-depth perspectives. Social implications All spheres of governance in South Africa should recognise asylum seekers as a constituency that deserves access to public services. E-governance can facilitate easier access to these services, and policies need to be aligned with this reality. Originality/value This study examined the efficacy of e-governance in enabling access to government services by asylum seekers during COVID-19. To the best of the authors' knowledge, no other study on this subject was conducted during this period.
C1 [Kariuki, Paul] Univ Kwazulu Natal, Dept Publ Governance, Coll Law & Management Studies, Durban, South Africa.
   [Goyayi, Maria Lauda; Ofusori, Lizzy Oluwatoyin] Univ Kwazulu Natal, Coll Law & Management Studies, Dept Informat Syst & Technol, Durban, South Africa.
RP Goyayi, ML (corresponding author), Univ Kwazulu Natal, Coll Law & Management Studies, Dept Informat Syst & Technol, Durban, South Africa.
EM kariukip@ukzn.ac.za; marygoyayi@yahoo.com; ofusoril@ukzn.ac.za
OI Ofusori, Lizzy Oluwatoyin/0000-0002-6036-619X
CR Abubakar I, 2018, LANCET, V392, P2606, DOI 10.1016/S0140-6736(18)32114-7
   Achkasov VA, 2016, VOPR GOS MUNITSIPALN, P77
   Adamson FB, 2020, INT MIGR REV, V54, P853, DOI 10.1177/0197918319879057
   Ahmad, 2020, EMPLOYING RECENT TEC, P128, DOI [10.4018/978-1-7998-1851-9.ch007, DOI 10.4018/978-1-7998-1851-9.CH007]
   Albu LL, 2020, ROM J ECON FORECAST, V23, P5
   Alexey GB, 2016, VOPR GOS MUNITSIPALN, P163
   Ali El Dahshan, 2020, SOHAG U INT J ED RES, V2, P8
   Amnesty International, 2019, LIV LIMB RIGHTS AS S
   Ataguba JE, 2020, APPL HEALTH ECON HEA, V18, P325, DOI 10.1007/s40258-020-00580-x
   Bakewell O, 2013, J INTERCULT STUD, V34, P477, DOI 10.1080/07256868.2013.827830
   Bollaert E, 2018, AFR GEOGR REV, V37, P146, DOI 10.1080/19376812.2017.1354227
   Boucher AK, 2020, J ETHN MIGR STUD, V46, P2533, DOI 10.1080/1369183X.2018.1561063
   Briskman L, 2020, J SOCIOL, V56, P100, DOI 10.1177/1440783319882540
   Bukuluki Paul, 2020, Soc Sci Humanit Open, V2, P100045, DOI 10.1016/j.ssaho.2020.100045
   Cin, 2018, YOUTH GENDER CAPABIL, P92
   Clibborn S, 2020, J AUST POLIT ECON, P62
   Cravero C.E., 2015, P 7 INT C INF COMM T, P1
   Delius P., 2017, HIST MIGRANT LABOR S
   Department of Home Affairs, 2019, DEP HOM AFF VOT 05
   Dhal S., 2020, INDIAN J PUBLIC ADM, V66, P110
   Easterlin, 1980, POPULATION EC CHANGE, P361
   Edwards B., 2016, BECOMING URBAN HUMAN
   Eichler GM, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11020522
   European Employment Policy Observatory, 2016, CHALL LAB MARK INT A
   Gusciute E., 2020, IRISH J SOCIOLOGY, V28, P237, DOI DOI 10.1177/0791603520940145
   Hamel, 2009, HUMAN DEV RES PAPER, V39, P1
   Holler J, 2014, FROM MACHINE-TO-MACHINE TO THE INTERNET OF THINGS: INTRODUCTION TO A NEW AGE OF INTELLIGENCE, P1
   Hossain A., 2020, CENTRAL E EUROPEAN E, V338, P203
   Igoye A, 2020, PUBLIC INTEGR, V22, P406, DOI 10.1080/10999922.2020.1753383
   Kellerman A, 2011, J TRANSP GEOGR, V19, P729, DOI 10.1016/j.jtrangeo.2010.08.015
   Kenny PD, 2020, J ETHN MIGR STUD, DOI 10.1080/1369183X.2020.1776596
   Kluzer S., 2011, ICT SOCIAL EC INTEGR
   Laine, 2020, MIGRATION CONUNDRUMS, P227, DOI [10.1007/978-981-15-2478-3_10, DOI 10.1007/978-981-15-2478-3_10]
   Lampoltshammer, 2017, IMPACT INFORM COMMUN
   Loh, 2016, THESIS GEORGETOWN U
   Lorgelly PK, 2020, APPL HEALTH ECON HEA, V18, P339, DOI 10.1007/s40258-020-00590-9
   Majchrzak A., 2016, MIS QUART, V40, P267
   Mallett R, 2012, J DEV EFFECT, V4, P445, DOI 10.1080/19439342.2012.711342
   Marceca M, 2017, PEOPLE'S MOVEMENTS IN THE 21ST CENTURY - RISKS, CHALLENGES AND BENEFITS, P103, DOI 10.5772/67013
   MASSEY DS, 1993, POPUL DEV REV, V19, P431, DOI 10.2307/2938462
   Masuku, 2018, THESIS U KWAZULU NAT
   Matsinhe DM, 2011, THIRD WORLD Q, V32, P295, DOI 10.1080/01436597.2011.560470
   Mbiyozo A.-N., 2018, ALIGNING S AFRICAS M
   Meda L, 2012, AFR EDUC RE, V9, pS152, DOI 10.1080/18146627.2012.755287
   Mesmar S, 2016, J PUBLIC HEALTH POL, V37, pS167, DOI 10.1057/s41271-016-0040-1
   Middleton, 2009, THESIS U WITWATERSRA
   Molobe ID, 2020, PAN AFR MED J, V35, DOI [10.11604/pamj.supp.2020.35.2.22863, 10.11604/pamj.2020.35.2.22863]
   Mosca DT, 2020, GLOB SOC POLICY, V20, P247, DOI 10.1177/1468018120922228
   Motomura, 2006, AM WAITING LOST STOR
   Mukumbang FC, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-004085
   Mukumbang FC, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01259-4
   Mustafee N, 2020, CONCURR COMP-PRACT E, V32, DOI 10.1002/cpe.5620
   Mutula SM, 2010, ELECTRON LIBR, V28, P38, DOI 10.1108/02640471011023360
   Nawyn SJ, 2016, INT J SOCIOL, V46, P81, DOI 10.1080/00207659.2016.1163991
   Ngoepe M, 2015, J SCI TECHNOL POLICY, V6, P190, DOI 10.1108/JSTPM-05-2014-0021
   Paquet M, 2020, INT MIGR, V58, P166, DOI 10.1111/imig.12555
   Peberdy S, 2001, AFR TODAY, V48, P15, DOI 10.1353/at.2001.0060
   Pernegger L, 2014, URBAN EARTH, V13, P61
   Phillips L, 2014, AFR STUD-UK, V73, P410, DOI 10.1080/00020184.2014.962875
   Piore MJ., 1979, BIRDS PASSAGE MIGRAN
   Ponzanesi S, 2019, TELEV NEW MEDIA, V20, P547, DOI 10.1177/1527476419857687
   Prei&beta;, 2020, INFORM COMMUNICATION
   Qina, 2015, THESIS STELLENBOSCH
   Rama S., 2020, ORIENTAL ANTHR BI AN, V20, P82
   Robeyns I, 2017, WELLBEING FREEDOM SO
   Rodr?guez C.M., 2007, MICH LAW REV, V106, P1111
   Schewel K, 2020, INT MIGR REV, V54, P328, DOI 10.1177/0197918319831952
   Schultz D., 2014, VESTNIK ROSSIYSKOGO, P90
   Segatti A, 2011, AFR DEV FORUM, P31
   Sherefedin A.J., 2018, J MANAGEMENT ADM, P150
   Sikanyiso, 2020, S AFRICA IS DENYING
   Sirkeci I, 2020, MIGR LETT, V17, P379, DOI 10.33182/ml.v17i2.935
   SJAASTAD LA, 1962, J POLIT ECON, V70, P80, DOI 10.1086/258726
   STARK O, 1982, ECON DEV CULT CHANGE, V31, P191, DOI 10.1086/451312
   STARK O, 1984, J DEV ECON, V14, P251, DOI 10.1016/0304-3878(84)90053-1
   Stark O., 1991, MIGRATION LABOR
   Stupart, 2016, IS S AFRICA HOME MOR
   Talhouk R, 2020, J MED INTERNET RES, V22, DOI 10.2196/14283
   Taylor J.E., 1986, MIGRATION HUMAN CAPI, V4, P147
   Taylor W., 2005, INT J ED DEV USING I, V1, P5
   Todaro, 1977, EC DEV 3 WORLD INTRO
   TODARO MP, 1987, POPUL DEV REV, V13, P101, DOI 10.2307/1972122
   Topcu M.K., 2020, COMPETENCY FRAMEWORK, P18
   Trujillo CM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.1701130
   UNDP, 2017, JOURN EXTR AFR DRIV, P79
   UNHCR, 2016, CONN REF INT MOB CON
   UNHCR, 2018, GLOB TRENDS FORC DIS
   Uprety D, 2019, INT J HEALTH ECON MA, V19, P1, DOI 10.1007/s10754-018-9242-3
   Van der Waldt G., 2016, AFRICAN J PUBLIC AFF, V9, P115
   Van Lennep, 2019, MIGRATION 4 STATE S
   Vearey, 2017, URBAN FORUM, V28, P75, DOI DOI 10.1007/S12132-017-9304-5
   Vearey J, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4143
   Vearey J, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25137
   Vigneswaran D, 2020, INT MIGR REV, V54, P262, DOI 10.1177/0197918318823191
   Whitaker BE, 2020, AFR STUD REV, V63, P18, DOI 10.1017/asr.2019.52
   Wickramage K, 2018, LANCET, V392, P2528, DOI 10.1016/S0140-6736(18)32855-1
   Wickramage K, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5932-5
   Wilson, 2012, P EDMEDIA 2012 WORLD, P1492
   Wilson-Strydom M., 2018, J GLOBAL ETHICS, V14, P71, DOI DOI 10.1080/17449626.2018.1496349
   Zanker FL, 2020, AFR SPECTR, V55, P100, DOI 10.1177/0002039720925826
NR 100
TC 0
Z9 0
U1 4
U2 4
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2398-5038
EI 2398-5046
J9 DIGIT POLICY REGUL G
JI Digit. Policy Regul. Gov.
PD APR 6
PY 2022
VL 24
IS 2
BP 141
EP 161
DI 10.1108/DPRG-08-2020-0114
EA AUG 2021
PG 21
WC Information Science & Library Science
WE Emerging Sources Citation Index (ESCI)
SC Information Science & Library Science
GA 0G6WQ
UT WOS:000688206400001
OA Bronze
DA 2022-04-20
ER

PT J
AU Han, B
   Zang, F
   Liu, J
   Li, SQ
   Zhang, WH
   Zhang, YX
   Li, ZJ
AF Han, Bin
   Zang, Feng
   Liu, Juan
   Li, Songqin
   Zhang, Weihong
   Zhang, Yongxiang
   Li, Zhanjie
TI Effect Analysis of "Four-Step" Training and Assessment Tool in the
   Prevention and Control of COVID-19
SO INFECTION AND DRUG RESISTANCE
LA English
DT Article
DE training and assessment tool; infection prevention and control;
   COVID-19; four-step; questionnaire
ID INFECTION-CONTROL; EDUCATION
AB Purpose: To improve the ability of infection prevention and control (IPC) of medical staff during the COVID-19 epidemic period, the "four-step" mode of whole staff training and assessment was used. Methods: During the period from March 9 to March 18, 2020, 5425 medical staff from The First Affiliated Hospital of Nanjing Medical University were selected as the objects of this study. There are four stages in the training assessment mode. The first stage is the basic assessment stage; the second stage releases the electronic version of the knowledge point manual; the third stage conducts online exercises; the fourth stage conducts the final assessment. Results: In the first stage, the participation rate of medical staff was 95.04%. In the fourth stage, the participation rate of medical staff was 98.01%. The average score of female medical staff in the first stage and the fourth stage was higher than that of males (P< 0.001). The average score of medical staff under 30 years old in the first stage and the fourth stage was higher than that of other age groups (P< 0.05). In the fourth stage, the correct rate of each part of exercises in the knowledge points of IPC was higher than that in the first stage (P< 0.001). In the two stages, the two parts of "COVID-19 prevention and control" and "multi-drug resistant bacteria prevention and control" had the highest accuracy, while the "disinfection and sterilization" and "infectious disease management" had the lowest accuracy (P< 0.001). Conclusion: The "four-step" infection control training assessment mode has realized "full participation" and "effective training", and the level of medical staff's IPC has been significantly improved.
C1 [Han, Bin] Nanjing Med Univ, Dept Gynecol, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China.
   [Zang, Feng; Liu, Juan; Li, Songqin; Zhang, Weihong; Zhang, Yongxiang; Li, Zhanjie] Nanjing Med Univ, Dept Infect Control, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China.
RP Zhang, YX; Li, ZJ (corresponding author), Nanjing Med Univ, Dept Infect Control, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China.
EM zyx3019@sina.cn; LZJ070591@163.com
FU National Key R D Program Fund [2020YFC0848100]; Research Foundation for
   Infection Prevention and Control of Chinese Geriatrics Association
   [GRYJ-LRK2018016]; Jiangsu Provincial Hospital Management Innovation
   Research Fund [JSYGY-3-2019-484]
FX This project was supported by the National Key R & D Program Fund
   (2020YFC0848100) , the Research Foundation for Infection Prevention and
   Control of Chinese Geriatrics Association (GRYJ-LRK2018016) , and the
   Jiangsu Provincial Hospital Management Innovation Research Fund
   (JSYGY-3-2019-484) . The funders had an important role in the design of
   the study; in the collection, analyses, or interpretation of data; in
   the writing of the manuscript, or in the decision to publish the
   results.
CR Aga QAA, 2021, J MED VIROL, V93, P6588, DOI 10.1002/jmv.27214
   Alp E, 2015, J INFECT DEV COUNTR, V9, P1040, DOI 10.3855/jidc.6832
   Arslan A, 2018, PROG NEURO-PSYCHOPH, V80, P155, DOI 10.1016/j.pnpbp.2017.06.018
   Chen WL, 2018, ELECTRON J PRACT CLI, V3
   Cheng GL, 2020, W CHINA MED, V35, P348
   Dadras O, 2021, EUR J MED RES, V26, DOI 10.1186/s40001-021-00539-1
   Guo LiPing, 2020, Chinese Journal of Nosocomiology, V30, P1125
   Hartling L, 2010, MED TEACH, V32, P28, DOI 10.3109/01421590903200789
   Huang YC, 2013, J INFECT DEV COUNTR, V7, P144, DOI 10.3855/jidc.3099
   Kaur J, 2017, AM J INFECT CONTROL, V45, P1035, DOI 10.1016/j.ajic.2017.04.285
   Mehraeen E, 2021, HUM VACC IMMUNOTHER, V17, P3500, DOI 10.1080/21645515.2021.1933689
   Mehraeen Esmaeil, 2021, Infectious Disorders - Drug Targets, V21, pe170721187995, DOI 10.2174/1871526520666201116095934
   Qin X., 2018, DISCUSSION CURRENT S
   Schreiber PW, 2018, INFECT CONT HOSP EP, V39, P1277, DOI 10.1017/ice.2018.183
   SeyedAlinaghi S, 2021, EUR J MED RES, V26, DOI 10.1186/s40001-021-00524-8
   SeyedAlinaghi S, 2021, EUR J MED RES, V26, DOI 10.1186/s40001-021-00516-8
   SeyedAlinaghi S, 2021, ARCH ACAD EMERG MED, V9, DOI 10.22037/aaem.v9i1.1058
   Ward DJ, 2011, NURS EDUC TODAY, V31, P9, DOI 10.1016/j.nedt.2010.03.007
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Yin WJ, 2015, CHIN J INFECT CONTRO, V14, P622
   Yingbin L, 2017, CHINESE MED RECORD
   Zare Hamed, 2021, Int Immunopharmacol, V101, P108351, DOI 10.1016/j.intimp.2021.108351
   [邹晓妮 Zou Xiaoni], 2015, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V25, P2600
NR 23
TC 0
Z9 0
U1 0
U2 0
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-6973
J9 INFECT DRUG RESIST
JI Infect. Drug Resistance
PY 2022
VL 15
BP 1247
EP 1257
DI 10.2147/IDR.S346559
PG 11
WC Infectious Diseases; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases; Pharmacology & Pharmacy
GA 0F7KT
UT WOS:000777535000003
PM 35360372
OA Green Published
DA 2022-04-20
ER

PT J
AU Rowland, B
   Kunadian, V
AF Rowland, Ben
   Kunadian, Vijay
TI Challenges in the management of older patients with acute coronary
   syndromes in the COVID-19 pandemic
SO HEART
LA English
DT Review
ID ACUTE MYOCARDIAL-INFARCTION
AB Ischaemic heart disease (IHD), in particular acute coronary syndrome (ACS), comprising ST-elevation myocardial infarction, non-ST-elevation myocardial infarction and unstable angina, is the leading cause of death worldwide. Age is a major predictor of adverse outcome following ACS. COVID-19 infection seems to escalate the risk in older patients with heart disease. Increasing odds of in-hospital death is associated with older age following COVID-19 infection. Importantly, it seems older patients with comorbidities such as cardiovascular disease (CVD), in particular IHD, diabetes and hypertension, are at the highest risk of mortality following COVID-19 infection. The evidence is sparse on the optimal care of older patients with ACS with lack of robust randomised controlled trials. In this setting, with the serious threat imposed by the COVID-19 pandemic in the context of rapidly evolving knowledge with much unknown, it is important to weigh the risks and benefits of treatment strategies offered to older patients. In cases where risks outweigh the benefits, it might not be an unreasonable option to treat such patients with a conservative or a palliative approach. Further evidence to elucidate whether invasive management is beneficial in older patients with ACS is required out-with the COVID-19 pandemic. Though it is hoped that the actual acute phase of COVID-19 infection will be short lived, it is vital that important clinical research is continued, given the long-term benefits of ongoing clinical research for patients with long-term conditions, including CVD. This review aimed to evaluate the challenges and the management strategies in the care of older patients presenting with ACS in the context of the COVID-19 pandemic.
C1 [Rowland, Ben; Kunadian, Vijay] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England.
   [Rowland, Ben; Kunadian, Vijay] Freeman Rd Hosp, Cardiothorac Ctr, Newcastle Upon Tyne, Tyne & Wear, England.
RP Kunadian, V (corresponding author), Newcastle Univ, Fac Med Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM vijay.kunadian@newcastle.ac.uk
OI Kunadian, Vijay/0000-0003-2975-6971
FU British Heart Foundation Clinical Study Grant [CS/15/7/316]; Newcastle
   NIHR Biomedical Research Centre; Astra ZenecaAstraZeneca [ISSBRIL0303]
FX VK is supported by the British Heart Foundation Clinical Study Grant
   (CS/15/7/316), Newcastle NIHR Biomedical Research Centre and
   Institutional Research Grant from Astra Zeneca (ISSBRIL0303).
CR Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326
   Armitage R, LANCET PUBLIC HLTH
   Batty J, 2019, INT J CARDIOL, V274, P45, DOI 10.1016/j.ijcard.2018.09.086
   Betriu A, 1997, NEW ENGL J MED, V336, P1621
   Cheung K-S, CIRCULATION CARDIOVA
   Clerkin KJ, CIRCULATION, P58
   Curtis JR, 2020, JAMA-J AM MED ASSOC, V323, P1771, DOI 10.1001/jama.2020.4894
   Dai XM, 2016, J GERIATR CARDIOL, V13, P101, DOI 10.11909/j.issn.1671-5411.2016.02.012
   Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031
   Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114
   Erne P, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006218
   Garcia S, 2020, J AM COLL CARDIOL, V75, P2871, DOI 10.1016/j.jacc.2020.04.011
   Gu SZ, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011218
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Hendren NS, CIRCULATION
   Hu Y, 2020, NEW ENGLAND J MED
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041
   Ishihara M, 2015, CIRC J, V79, P1255, DOI 10.1253/circj.CJ-15-0217
   Kunadian V., BRIT HEART FDN SENIO
   Kuster GM, 2020, EUR HEART J, P426
   Kwong JC, 2018, NEW ENGL J MED, V378, P345, DOI 10.1056/NEJMoa1702090
   Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9
   Thang ND, 2016, CLIN INTERV AGING, V11, P1309, DOI 10.2147/CIA.S110034
   Office for National Statistics (ONS), 2020, DEATHS INV COVID 19
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Roffi M, 2015, REV ESP CARDIOL, V68, P1125, DOI 10.1016/j.rec.2015.10.009
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Sanchis J., INVASIVE VERSUS CONS
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Simms AD, 2012, J GERIATR CARDIOL, V9, P192, DOI 10.3724/SP.J.1263.2012.01312
   Sinclair H, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2016-000436
   Skulstad H, 2020, EUR HEART J-CARD IMG, V21, P592, DOI 10.1093/ehjci/jeaa072
   Tse G, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.09.002
   Van de Werf F., STRATEGIC REPERFUSIO
   Veerasamy M, 2015, CARDIOL REV, V23, P26, DOI 10.1097/CRD.0000000000000016
   Wallentin L, 2016, LANCET, V388, P1903, DOI 10.1016/S0140-6736(16)31276-4
   Wan H, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON BIG KNOWLEDGE (IEEE ICBK 2017), P220, DOI 10.1109/ICBK.2017.1
   WHO China, 2020, REP WHO CHIN JOINT M, DOI DOI 10.1186/S40249-020-00650-1
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Xiong TY, 2020, EUR HEART J, V41, P1798, DOI 10.1093/eurheartj/ehaa231
   Yamauchi-Takihara K, 2011, CARDIOVASC RES, V89, P483, DOI 10.1093/cvr/cvq407
   Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9
   Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhou, INT J INFECT DIS
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 47
TC 10
Z9 9
U1 0
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1355-6037
EI 1468-201X
J9 HEART
JI Heart
PD SEP
PY 2020
VL 106
IS 17
BP 1296
EP +
DI 10.1136/heartjnl-2020-317011
PG 6
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA NK9CX
UT WOS:000567027800006
PM 32444504
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Oliaei, S
   Alinaghi, SAS
   Mehrtak, M
   Karimi, A
   Noori, T
   Mirzapour, P
   Shojaei, A
   MohsseniPour, M
   Mirghaderi, SP
   Alilou, S
   Shobeiri, P
   Cheshmekabodi, HA
   Mehraeen, E
   Dadras, O
AF Oliaei, Shahram
   Alinaghi, Seyed Ahmad Seyed
   Mehrtak, Mohammad
   Karimi, Amirali
   Noori, Tayebeh
   Mirzapour, Pegah
   Shojaei, Alireza
   MohsseniPour, Mehrzad
   Mirghaderi, Seyed Peyman
   Alilou, Sanam
   Shobeiri, Parnian
   Cheshmekabodi, Hadiseh Azadi
   Mehraeen, Esmaeil
   Dadras, Omid
TI The effects of hyperbaric oxygen therapy (HBOT) on coronavirus
   disease-2019 (COVID-19): a systematic review
SO EUROPEAN JOURNAL OF MEDICAL RESEARCH
LA English
DT Review
DE COVID-19; Hyperbaric oxygenation; Hyperbaric oxygen therapy; SARS-CoV-2
AB Background Oxygenation serves as a cornerstone in the treatment of COVID-19, and several methods have been extensively studied so far. Herein, we aimed to systematically review the studies discussing hyperbaric oxygen therapy (HBOT) to examine its reported efficacy and adverse events in patients with COVID-19. Methods We systematically searched and retrieved the relevant articles using keywords on the online databases, including PubMed, Scopus, Embase, Web of Science, and Cochrane databases up to April 11th, 2021. The retrieved records underwent a two-step title/abstract and full-text screening process, and the eligible papers were identified. National Institutes of health (NIH) quality assessment tool was used for this study. This study was registered in the International Prospective Register of Systematic Reviews (PROSPERO) with ID CRD42021269821. Results Eight articles from three countries were included. All the included studies had good and fair quality scores, with no poor studies included in this systematic review (Good: n = 5, Fair: n = 3). Studies were divided into clinical trials and case reports/series. Most of the studies used HBOT less than 1.5-2 absolute atmospheres (ATA) for 90 min sessions and thereafter sessions were decreased to 60 min. Trials demonstrated most of the patients recovered after receiving HBOT, and blood oxygen saturation increased after several sessions of HBOT. Conclusion Overall, HBOT seems to be a safe and effective oxygenation method in patients with COVID-19. However, there is limited knowledge and evidence regarding the effects and mechanism of HBOT in COVID-19 treatment, and further evaluations require extensive well-designed studies.
C1 [Oliaei, Shahram] Navy & AJA Med Univ, Golestan Hosp, HBOT Res Ctr, Tehran, Iran.
   [Alinaghi, Seyed Ahmad Seyed; Mirzapour, Pegah; Shojaei, Alireza; MohsseniPour, Mehrzad] Tehran Uni Med Sci, Iranian Inst Reduct High Risk Behav, Iranian Res Ctr HIV AIDS, Tehran, Iran.
   [Mehrtak, Mohammad] Ardabil Univ Med Sci, Sch Med & Allied Med Sci, Healthcare Serv Management, Ardebil, Iran.
   [Karimi, Amirali; Mirghaderi, Seyed Peyman; Alilou, Sanam; Shobeiri, Parnian] Univ Tehran Med Sci, Sch Med, Tehran, Iran.
   [Noori, Tayebeh] Zabol Univ Med Sci, Dept Hlth Informat Technol, Zabol, Iran.
   [Cheshmekabodi, Hadiseh Azadi] Iran Univ Med Sci, Sch Hlth Informat Management & Informat Sci, Hlth Informat Technol, Tehran, Iran.
   [Mehraeen, Esmaeil] Supreme Natl Def Univ, AMAD Res Inst, Tehran, Iran.
   [Mehraeen, Esmaeil] Khalkha Univ Med Sci, Dept Hlth Informat Technol, Khalkha 1419733141, Iran.
   [Dadras, Omid] Kyoto Univ, Grad Sch Med, Dept Global Hlth & Socioepidemiol, Kyoto, Japan.
RP Mehraeen, E (corresponding author), Supreme Natl Def Univ, AMAD Res Inst, Tehran, Iran.; Mehraeen, E (corresponding author), Khalkha Univ Med Sci, Dept Hlth Informat Technol, Khalkha 1419733141, Iran.
EM es.mehraeen@gmail.com
RI Shobeiri, Parnian/AAN-6093-2021; Dadras, Omid/X-2514-2019;
   SeyedAlinaghi, SeyedAhmad/M-2938-2017
OI Shobeiri, Parnian/0000-0002-5282-3282; Dadras, Omid/0000-0001-9385-2170;
   SeyedAlinaghi, SeyedAhmad/0000-0003-3210-7905; Mohsseni Pour,
   Mehrzad/0000-0003-0297-0791; Karimi, Amirali/0000-0003-1241-7754;
   Mirghaderi, Seyed Peyman/0000-0002-3522-8772
CR Baj J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061753
   Barbaro RP, 2020, LANCET, V396, P1071, DOI 10.1016/S0140-6736(20)32008-0
   Barrot L, 2020, NEW ENGL J MED, V382, P999, DOI 10.1056/NEJMoa1916431
   Boet S., 2020, PROTOCOL MULTICENTRE, DOI [10.1101/2020.07.15.20154609, DOI 10.1101/2020.07.15.20154609]
   Chen R, OUTCOMES HYPERBARIC
   Chu DK, 2018, LANCET, V391, P1693, DOI 10.1016/S0140-6736(18)30479-3
   Dadras O, 2021, EUR J MED RES, V26, DOI 10.1186/s40001-021-00539-1
   De Maio A, 2020, CELL STRESS CHAPERON, V25, P717, DOI 10.1007/s12192-020-01121-0
   Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326
   Geier MR, 2020, MED HYPOTHESES, V140, DOI 10.1016/j.mehy.2020.109760
   Ghiasvand Fereshteh, 2021, Infectious Disorders - Drug Targets, V21, pe170721187994, DOI 10.2174/1871526520666201116095440
   Ghiasvand Fereshteh, 2020, Infectious Disorders - Drug Targets, V20, P559, DOI 10.2174/1871526520666200429115535
   Gorenstein SA, 2020, UNDERSEA HYPERBAR M, V47, P405, DOI 10.22462/01.03.2020.1
   Guo DZ, 2020, UNDERSEA HYPERBAR M, V47, P181, DOI 10.22462/04.06.2020.2
   Hachmo Y, 2020, AGING-US, V12, P22445, DOI 10.18632/aging.202188
   Hadanny A, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-0893-8
   Hajhosseini B, 2020, PRS-GLOB OPEN, V8, DOI 10.1097/GOX.0000000000003136
   Harch PG, 2020, MED GAS RES, V10, P61, DOI 10.4103/2045-9912.282177
   Hawa AAA, 2021, J WOUND CARE, V30, pS8, DOI 10.12968/jowc.2021.30.Sup2.S8
   Heyboer M, 2017, ADV WOUND CARE, V6, P210, DOI 10.1089/wound.2016.0718
   Jiang B, 2020, EUR REV MED PHARMACO, V24, P10239, DOI 10.26355/eurrev_202010_23248
   Kjellberg A, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.110224
   Krishnan A, 2021, INTERN EMERG MED, V16, P815, DOI 10.1007/s11739-020-02616-5
   Levina OA., 2020, RUSSIAN SKLIFOSOVSKY, V9, P314, DOI [10.23934/2223-9022-2020-9-3-314-320, DOI 10.23934/2223-9022-2020-9-3-314-320]
   Li G, 2014, CLIN RADIOL, V69, P294, DOI 10.1016/j.crad.2013.10.016
   Liang Y, 2020, IRAN J RADIOL, V17, DOI 10.5812/iranjradiol.104475
   McFee RB, 2020, DM-DIS MON, V66, DOI 10.1016/j.disamonth.2020.101058
   Mehraeen Esmaeil, 2021, Infect Disord Drug Targets, DOI 10.2174/1871526521666210726150435
   Mehraeen E, 2020, INDIAN HEART J, V72, P500, DOI 10.1016/j.ihj.2020.11.007
   Mehraeen E, 2020, EUR J INTEGR MED, V40, DOI 10.1016/j.eujim.2020.101226
   Mehraeen E, 2021, EUR ARCH OTO-RHINO-L, V278, P307, DOI 10.1007/s00405-020-06120-6
   Okumus N, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06104-9
   Oliaei S, 2020, P 12 IADIS INT C E H
   [Петриков С. С. Petrikov S. S.], 2020, [Общая реаниматология, General Reanimatology, Obshchaya reanimatologiya], V16, P4, DOI 10.15360/1813-9779-2020-6-4-18
   Schmidt M, 2020, LANCET RESP MED, V8, P1121, DOI 10.1016/S2213-2600(20)30328-3
   SeyedAlinaghi S, 2021, IMMUN INFLAMM DIS, V9, P1160, DOI 10.1002/iid3.497
   SeyedAlinaghi S, 2021, EUR J MED RES, V26, DOI 10.1186/s40001-021-00516-8
   SeyedAlinaghi S, 2021, ARCH ACAD EMERG MED, V9, DOI 10.22037/aaem.v9i1.1058
   Thibodeaux K, 2020, J WOUND CARE, V29, pS4, DOI 10.12968/jowc.2020.29.Sup5a.S4
   Zhong XiaoLing, 2020, Academic Journal of Second Military Medical University, V41, P621, DOI 10.16781/j.0258-879x.2020.06.0621
NR 40
TC 6
Z9 6
U1 2
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0949-2321
EI 2047-783X
J9 EUR J MED RES
JI Eur. J. Med. Res.
PD AUG 19
PY 2021
VL 26
IS 1
AR 96
DI 10.1186/s40001-021-00570-2
PG 12
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA UC8JM
UT WOS:000686768300001
PM 34412709
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Teixeira, TOA
   de Moura, VT
   dos Santos, GP
   Carneiro, IA
   De Domenico, EBL
AF Augustinho Teixeira, Tamara Otsuru
   de Moura, Veronica Torel
   dos Santos, Gislene Padilha
   Carneiro, Ieda Aparecida
   Lopes De Domenico, Edvane Birelo
TI The COVID-19 pandemic and specialized oncology care: An experience
   report
SO REVISTA CUIDARTE
LA Portuguese
DT Article
DE Safety Management; Medical Oncology; Coronavirus Infections; Ambulatory
   Care; Pandemics
ID IMPACT
AB Introduction:The COVID-19 pandemic has brought many challenges to oncology care, leading to the implementation of new operational models in health management and care. Objective: To describe the experiences related to the implementation of health management and care models in cancer treatment centers during the COVID-19 outbreak. Materials and Methods: A qualitative descriptive case report was conducted including experiences from March 5 to January 31, 2021. Reports were provided by different cancer treatment centers in Sao Paulo, Brazil. Results: Actions such as identification of patients eligible for telemedicine and telenursing strategies, preparation of COVID-19-free environments for healthcare professionals and patients, and support for educational actions to increase knowledge and adoption of safety behavior for healthcare professionals and patients were observed in the three reports. Discussion: A common element described in the reports is the implementation of actions to improve the safety of healthcare professionals, patients and the environment, as well as the continuity of cancer care. Scientific literature and recommendations of advisory boards, associations and organizations were supplementary to the measures applied. Conclusions: Social distancing due to the risk of COVID-19 spread proved to a successful field for the introduction of new health management and care in cancer treatment. Although there will certainly be loss and damage to cancer treatment processes during this pandemic, mapping the drop in cancer diagnosis, as well as treatment interruptions, is essential to mitigate any consequences.
C1 [Augustinho Teixeira, Tamara Otsuru] Hosp Alemao Oswaldo Cruz, Melhoria Continua & Nav Pacientes, Sao Paulo, Brazil.
   [de Moura, Veronica Torel; dos Santos, Gislene Padilha] Hosp BP Mirante, Sao Paulo, SP, Brazil.
   [Carneiro, Ieda Aparecida] Univ Fed Sao Paulo, Hosp Sao Paulo, Campus Sao Paulo, Sao Paulo, Brazil.
   [Lopes De Domenico, Edvane Birelo] Univ Fed Sao Paulo, Dept Enfermagem Clin & Cirurg, Escola Paulista Enfermagem, Sao Paulo, Brazil.
   [Lopes De Domenico, Edvane Birelo] Grp Pesquisa GEPEBE, Sao Paulo, Brazil.
   [Lopes De Domenico, Edvane Birelo] Programa Extensao Univ Acolhe Onco, Sao Paulo, Brazil.
RP Teixeira, TOA (corresponding author), Hosp Alemao Oswaldo Cruz, Melhoria Continua & Nav Pacientes, Sao Paulo, Brazil.
EM ta_augustinho@yahoo.com.br; vero.paula@gmail.com;
   gislenepadilha_2@hotmail.com; ieda.carneiro@unifesp.br;
   domenico.edvane@unifesp.br
FU Financiamento: O presente estudo nAo teve fontes de financiamento
FX Financiamento: O presente estudo nAo teve fontes de financiamento.
CR A Beneficencia Portuguesa de Sao Paulo, 2021, UM HIST VAL VID 160
   American Society of Clinical Oncology, SPEC REP GUID CANC C
   Bakouny Z, 2020, CANCER CELL, V38, P629, DOI 10.1016/j.ccell.2020.09.018
   Bergerot CD, 2020, J GERIATR ONCOL, V11, P280, DOI 10.1016/j.jgo.2019.07.006
   Cidade de Sao Paulo, 2021, PREF IN MONT HOSP CA
   Conselho Federal de Enfermagem, RES AUT TEL ENF DUR
   Edmondson AC, 2014, ANNU REV ORGAN PSYCH, V1, P23, DOI 10.1146/annurev-orgpsych-031413-091305
   Elkaddoum R, 2020, FUTURE ONCOL, V16, P1225, DOI 10.2217/fon-2020-0324
   European Oncology Nursing Society, COLL IS KEY, V31, P2021
   European Society for Medical Oncology, CANC PAT MAN COVID 1
   Faria MRT, 2020, J NURS, V19, P1
   Governo do Estado de Sao Paulo, GOV SP DET QUAR TOD
   Governo do Estado de Sao Paulo, RED HEB CAM COMB AO
   Hospital Alemao Oswaldo Cruz, HOSPITAL
   Hospital Sao Paulo-Associacao Paulista para o desenvolvimento da Medicina, NOSS HIST
   Instituto Nacional de Cancer, PORT N 467 20 MARC 2
   Kuderer NM, 2020, LANCET, V395, P1907, DOI 10.1016/S0140-6736(20)31187-9
   Mayor S, 2020, LANCET ONCOL, V21, P633, DOI 10.1016/S1470-2045(20)30240-0
   Oncology Nursing Society, ONS INT GUID COVID 1, P2021
   Shortell, 2020, NEJM CATALYST INNOVA, V1, P1, DOI DOI 10.1056/CAT.20.0111
   Smrke A, 2020, JCO GLOB ONCOL, V6, P1046, DOI 10.1200/GO.20.00220
   Sociedade Brasileira de Oncologia Clinica, ESP SBOC COR COVID 1
   Trehan A, 2020, PEDIATR BLOOD CANCER, V67, DOI 10.1002/pbc.28438
   Union for International Cancer Control, MEMB ORG
   World Health Organization, WHO DIR GEN OP REM M
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
NR 26
TC 0
Z9 0
U1 2
U2 2
PU UNIV SANTANDER
PI BUCARAMANGA
PA CALLE 70 NO 55-210, CAMPUS LAGOS CACIQUE, BUCARAMANGA, 680001, COLOMBIA
SN 2216-0973
EI 2346-3414
J9 REV CUID
JI Rev. Cuid.
PD MAY-AUG
PY 2021
VL 12
IS 2
AR e1377
DI 10.15649/cuidarte.1377
PG 17
WC Nursing
WE Emerging Sources Citation Index (ESCI)
SC Nursing
GA YY8ZI
UT WOS:000755074700007
OA gold
DA 2022-04-20
ER

PT J
AU Sokolowski, MM
AF Sokolowski, Maciej M.
TI Regulation in the COVID-19 pandemic and post-pandemic times:
   day-watchman tackling the novel coronavirus
SO TRANSFORMING GOVERNMENT- PEOPLE PROCESS AND POLICY
LA English
DT Article
DE Regulation; Pandemic; COVID-19; Regulators; Day-watchman
AB Purpose
   While fighting with the novel coronavirus will not be the main goal of sectoral regulators, different regulatory authorities join the struggle by providing a regulatory response. The purpose of this paper is to address this regulatory response in pandemic gathered around eight thematic areas.
   Design/methodology/approach
   This paper discusses the regulatory response in pandemic gathered around eight thematic areas, namely, the objectives, rules and standards, authorization and permits, procedure, monitoring and surveillance, enforcement, accountability and an institution presenting regulatory actions to tackle coronavirus (COVID-19) in reference to day-watchman type regulation.
   Findings
   Tackling the COVID-19 pandemic should be a knowledge-based approach (taking as much as possible from best available practices with respect to the novel coronavirus) with a framework of rules, standards, authorization, permits and guidance, monitored and enforced in a way adjusted to conditions of the pandemic, being as safe (as non-physical, as online) as possible, with suspended or extended deadlines, free of unnecessary administrative burdens. In this way, regulation should be pragmatic and flexible, as under the day-watchman model.
   Research limitations/implications
   In a post-pandemic regime, in the short run, the regulators should try to minimize the social and economic challenges faced by consumers and entrepreneurs. Among them, one may find scaling back, at least temporarily, the rules developed in non-disaster contexts. However, in the end, the post-disaster reforms tended to strengthen regulators' hands, also under the deregulated government. The day-watchman type regulation balances both, as a middle ground approach, being a bridge between "a total subordination" and "a complete release."
   Practical implications
   The disaster management (including public law regulation) provided by public authorities when tackling the effects of hurricanes, earthquakes or tsunamis can be a benchmark for regulatory responses to the COVID-19 pandemic. This concerns the support offered to entities and individuals affected by the negative consequences of reducing or stopping their businesses and staying in isolation.
   Social implications
   The day-watchman approach, visible in certain examples of public response to COVID-19 may serve as a framework for establishing a regulatory regime that would automatically take effect in case of another pandemic, limiting delays in regulatory actions, reducing non-compliance and accelerating recovery.
   Originality/value
   This study provides an analysis of different theories on public regulation addressing the notion of regulation using the day-watchman theory, which could be applied in regulatory actions during a pandemic. The paper discusses concrete steps taken by regulatory authorities worldwide, bringing examples from the USA, Canada, the UK, France, China, Japan, Australia and New Zealand. It juxtaposes the regulatory experiences derived from different catastrophes such as hurricanes, earthquakes or tsunamis with the regulatory response in a pandemic.
C1 [Sokolowski, Maciej M.] Univ Warsaw, Fac Law & Adm, Warsaw, Poland.
   [Sokolowski, Maciej M.] Univ Tokyo, Grad Sch Publ Policy, Tokyo, Japan.
RP Sokolowski, MM (corresponding author), Univ Warsaw, Fac Law & Adm, Warsaw, Poland.; Sokolowski, MM (corresponding author), Univ Tokyo, Grad Sch Publ Policy, Tokyo, Japan.
EM mm.sokolowski@wpia.uw.edu.pl
RI Sokołowski, Maciej M./AAH-7151-2019
OI Sokołowski, Maciej M./0000-0002-0630-465X
FU Ministry of Science and Higher Education of PolandMinistry of Science
   and Higher Education, Poland
FX This paper was completed during a research stay in Japan under the
   Mobility Plus funding received from the Ministry of Science and Higher
   Education of Poland.
CR Abbott M, 2016, ECONOMICS OF THE GAS SUPPLY INDUSTRY, P183
   Almond P., 2019, HLTH SAFETY CONT BRI
   Barton B., 2006, REGULATING ENERGY NA, P11
   Black J, 2002, CRITICAL REFLECTIONS
   Chamlee-Wright E., 2008, MERCATUS CTR POLICY, V6, P1
   Claessens S, 2010, J ASIAN ECON, V21, P247, DOI 10.1016/j.asieco.2010.02.002
   Djalante R, 2017, DISAST RISK REDUCT, P21, DOI 10.1007/978-3-319-54466-3_2
   GAO A, 2015, CARBON CLIM LAW REV, V0009, P00005
   Gilardi F, 2011, HANDBOOK ON THE POLITICS OF REGULATION, P201
   Gotham KevinFox., 2014, CRISIS CITIES DISAST
   Gruenberg M.J., 2007, PREPARED STATEMENT M, P66
   Harris Richard A., 1989, POLITICS REGULATORY
   Hazard Jr G.C., 2001, ENV CONTRACTS COMP A, P71
   Herrero Alicia Garcia, 2020, Inter Econ, V55, P66, DOI 10.1007/s10272-020-0871-7
   Kingston J., 2016, REBUILDING ASIA FOLL, P367
   Ladeur K.H., 1999, EUI WORKING PAPER LA, V99, P1
   Lane J., 2000, NEW PUBLIC MANAGEMEN
   Macrory R., 2008, REGULATION ENFORCEME
   Malawani AD, 2020, TRANSFORM GOV-PEOPLE, V14, P237, DOI 10.1108/TG-09-2019-0088
   Marshall, 2012, PLANNING MAJOR INFRA
   OECD, 2020, REG QUAL COVID 19 MA
   Ogus, 1994, REGULATION LEGAL FOR
   Priest GL, 1996, J RISK UNCERTAINTY, V12, P219, DOI 10.1007/BF00055795
   Prosser T, 2010, REGULATORY ENTERPRIS
   SCHNEIDER SK, 1992, PUBLIC ADMIN REV, V52, P135, DOI 10.2307/976467
   Sikor T., 2008, PUBLIC PRIVATE NATUR, P1
   Skarbek D, 2010, NEW THINK POLIT ECON, P72
   Sokolowski M.M, 2018, PRAWO ADMINISTRACYJN, P591
   Sokolowski M.M, 2020, EC FREEDOM MARKET RE, P167
   Sokoowski M.M., 2013, REGULACJA INNOWACJA, P309
   Sokoowski M.M., 2020, EUROPEAN LAW COMBINE
   Sokoowski M.M., 2016, REGULATION EUROPEAN
   Thatcher M, 2002, J EUR PUBLIC POLICY, V9, P859, DOI 10.1080/1350176022000046391
   Tolan P., 2016, MISS LAW J, V85, P553
   Visvizi A, 2020, TRANSFORM GOV-PEOPLE, V14, P333, DOI 10.1108/TG-06-2020-0137
   Wnukowski D., 2020, PISM B, V45, P1
   World Health Organization, 2020, RESP COMM SPREAD COV
NR 37
TC 6
Z9 6
U1 0
U2 2
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1750-6166
EI 1750-6174
J9 TRANSFORM GOV-PEOPLE
JI Transform. Gov.-People Process Policy
PD JUN 23
PY 2021
VL 15
IS 2
SI SI
BP 206
EP 218
DI 10.1108/TG-07-2020-0142
EA NOV 2020
PG 13
WC Information Science & Library Science
WE Emerging Sources Citation Index (ESCI)
SC Information Science & Library Science
GA SW6XB
UT WOS:000595846100001
DA 2022-04-20
ER

PT J
AU Zhou, CH
   Lou, BH
   Li, H
   Wang, X
   Ao, HS
   Duan, FJ
AF Zhou, Chenghui
   Lou, Baohui
   Li, Hui
   Wang, Xin
   Ao, Hushan
   Duan, Fujian
TI Incidence, risk factors and prognostic effect of imaging right
   ventricular involvement in patients with COVID-19: a dose-response
   analysis protocol for systematic review
SO BMJ OPEN
LA English
DT Review
DE COVID-19; echocardiography; risk management; protocols & guidelines
ID RIGHT HEART-FAILURE; METAANALYSIS
AB Introduction Emerging evidence has shown that COVID-19 infection may result in right ventricular (RV) disturbance and be associated with adverse clinical outcomes. The aim of this meta-analysis is to summarise the incidence, risk factors and the prognostic effect of imaging RV involvement in adult patients with COVID-19.
   Methods A systematical search will be performed in PubMed, EMBase, ISI Knowledge via Web of Science and preprint databases (MedRxiv and BioRxiv) (until October 2021) to identify all cohort studies in adult patients with COVID-19. The primary outcome will be the incidence of RV involvement (dysfunction and/or dilation) assessed by echocardiography, CT or MRI. Secondary outcomes will include the risk factors for RV involvement and their association with all-cause mortality during hospitalisation. Additional outcomes will include the RV global or free wall longitudinal strain (RV-GLS or RV-FWLS), tricuspid annular plane systolic excursion (TAPSE), fractional area change (FAC) and RV diameter. Univariable or multivariable meta-regression and subgroup analyses will be performed for the study design and patient characteristics (especially acute or chronic pulmonary embolism and pulmonary hypertension). Sensitivity analyses will be used to assess the robustness of our results by removing each included study at one time to obtain and evaluate the remaining overall estimates of RV involvement incidence and related risk factors, association with all-cause mortality, and other RV parameters (RV-GLS or RV-FWLS, TAPSE, S', FAC and RV diameter). Both linear and cubic spline regression models will be used to explore the dose-response relationship between different categories (>2) of RV involvement and the risk of mortality (OR or HR).
   Ethics and dissemination There was no need for ethics approval for the systematic review protocol according to the Institutional Review Board/Independent Ethics Committee of Fuwai Hospital. This meta-analysis will be disseminated through a peer-reviewed journal for publication.
   PROSPERO registration number CRD42021231689.
C1 [Zhou, Chenghui; Ao, Hushan] Chinese Acad Med Sci & Peking Union Med Coll, Dept Anesthesiol, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing, Peoples R China.
   [Lou, Baohui] Chinese Acad Med Sci, Dept Radiol, Beijing Hosp, Natl Ctr Gerontol, Beijing, Peoples R China.
   [Lou, Baohui] Chinese Acad Med Sci, Inst Geriatr Med, Beijing, Peoples R China.
   [Li, Hui] Chinese Acad Med Sci & Peking Union Med Coll, Dept Echocardiog, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing, Peoples R China.
   [Wang, Xin; Duan, Fujian] Chinese Acad Med Sci & Peking Union Med Coll, Dept Cardiac Surg, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing, Peoples R China.
RP Duan, FJ (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Dept Cardiac Surg, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing, Peoples R China.
EM duanfujian@aliyun.com
FU Beijing Municipal Science & Technology CommissionBeijing Municipal
   Science & Technology Commission [Z201100005520004]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   (NSFC) [81771826, 81970290]
FX This work was supported by the Beijing Municipal Science & Technology
   Commission (No. Z201100005520004), and National Natural Science
   Foundation of China (81771826 and 81970290).
CR Agricola E, 2020, JACC-CARDIOVASC IMAG, V13, P1792, DOI 10.1016/j.jcmg.2020.05.017
   Armstrong RA, 2020, ANAESTHESIA, V75, P1340, DOI 10.1111/anae.15201
   Ashraf H, 2020, CARDIOL CLIN, V38, P175, DOI 10.1016/j.ccl.2020.01.008
   BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005
   Bhavana V, 2020, LIFE SCI, V261, DOI 10.1016/j.lfs.2020.118336
   Bursi F, 2020, ECHOCARDIOGR-J CARD, V37, P2029, DOI 10.1111/echo.14869
   Cameli M, 2020, ECHOCARDIOGR-J CARD, V37, P1278, DOI 10.1111/echo.14779
   Dweck MR, 2020, EUR HEART J-CARD IMG, V21, P949, DOI 10.1093/ehjci/jeaa178
   Fried JA, 2020, CIRCULATION, V141, P1930, DOI 10.1161/CIRCULATIONAHA.120.047164
   Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015
   Grasselli G, 2020, JAMA INTERN MED, V180, P1345, DOI 10.1001/jamainternmed.2020.3539
   Kholdani CA, 2015, CLIN CHEST MED, V36, P511, DOI 10.1016/j.ccm.2015.05.015
   Kim J, 2020, J AM COLL CARDIOL, V76, P1965, DOI 10.1016/j.jacc.2020.08.066
   Li YH, 2020, EUROINTERVENTION, V15, P1444, DOI 10.4244/EIJ-D-19-00737
   Li YM, 2020, JACC-CARDIOVASC IMAG, V13, P2287, DOI 10.1016/j.jcmg.2020.04.014
   Mahmoud-Elsayed HM, 2020, CAN J CARDIOL, V36, P1203, DOI 10.1016/j.cjca.2020.05.030
   Murad MH, 2018, BMJ EVID-BASED MED, V23, P60, DOI 10.1136/bmjebm-2017-110853
   Pearce L, 2020, EXPERT OPIN THER TAR, V24, P723, DOI 10.1080/14728222.2020.1783243
   Schott JP, 2020, ECHOCARDIOGR-J CARD, V37, P1551, DOI 10.1111/echo.14835
   [Anonymous], 2016, BMJ, V354, pi4086, DOI [10.1136/bmj.g7647, 10.1136/bmj.i4086]
   Skulstad H, 2020, EUR HEART J-CARD IMG, V21, P592, DOI 10.1093/ehjci/jeaa072
   Song Y, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106080
   Surkova E, 2016, INT J CARDIOL, V214, P54, DOI 10.1016/j.ijcard.2016.03.074
   Szekely Y, 2020, CIRCULATION, V142, P342, DOI 10.1161/CIRCULATIONAHA.120.047971
   Tan TC, 2015, EUR J CLIN INVEST, V45, P755, DOI 10.1111/eci.12462
   Worldometers.info, COVID 19 CORONAVIRUS
   Zhao ZR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236618
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 28
TC 0
Z9 0
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD MAY
PY 2021
VL 11
IS 5
AR e049866
DI 10.1136/bmjopen-2021-049866
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA ZL4WD
UT WOS:000763677900016
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Portella, CFS
   Ghelman, R
   Abdala, CVM
   Schveitzer, MC
AF Portella, Caio Fabio Schlechta
   Ghelman, Ricardo
   Abdala, Carmen Veronica Mendes
   Schveitzer, Mariana Cabral
TI Evidence map on the contributions of traditional, complementary and
   integrative medicines for health care in times of COVID-19
SO INTEGRATIVE MEDICINE RESEARCH
LA English
DT Review
DE COVID-19; Evidence map; Systematic review; Complementary therapies;
   Integrative medicine
ID POSTTRAUMATIC-STRESS-DISORDER; CHINESE MEDICINE; MEDITATION; PREVENTION;
   INFLUENZA; VETERANS; REVIEWS; THERAPY; YOGA
AB Background: Due to the pandemic, there is a significant interest in the therapeutic resources linked to TCIM to support potentially therapeutic research and intervention in the management of Coronavirus 19 (COVID-19). At the date of this evidence maps ' publication, there is no evidence of specific treatments for COVID-19. This map organizes information about symptoms management (especially on dimensions related to mental health and mild viral respiratory infections, as well as immune system strengthening and antiviral activity). Method: This evidence map applies methodology developed by Latin American and Caribbean Center on Health Sciences Information based on the 3iE evidence gap map. A search was performed in the Traditional, Complementary and Integrative Medicine Virtual Health Library and PubMed, using the MeSH and DeCS terms for respiratory viral diseases associated with epidemics, COVID-19 symptoms, relevant mental health topics, pharmacological and non-pharmacological interventions related to TCIM. Results: For the map, 126 systematic reviews and controlled clinical studies were characterized, distributed in a matrix with 62 interventions (18 phytotherapy, 9 mind-body therapies, 11 traditional Chinese medicine, 7 homeopathic and anthroposophic dynamized medicines and 17 supplements), and 67 outcomes (14 immunological response, 23 mental health, 25 complementary clinical management of the infection and 5 other). Conclusion: The map presents an overview of possible TCIM contributions to various dimensions of the COVID-19 pandemic, especially in the field of mental health, and it is directed to researchers and health professionals specialized in TCIM. Most of the antiviral activity outcomes described in this map refers to respiratory viruses in general, and not specifically to SARS-CoV-2 (Severe Acute Respiratory Syndrome CoronaVirus 2). This information may be useful to guide new research, but not necessarily to support a therapeutic recommendation. Finally, any suspicion of COVID-19 infection should follow the protocols recommended by the health authorities of each country/region. (c) 2020 Korea Institute of Oriental Medicine. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Portella, Caio Fabio Schlechta; Ghelman, Ricardo] Brazilian Acad Consortium Integrat Hlth CABSIn Sa, Sao Paulo, SP, Brazil.
   [Abdala, Carmen Veronica Mendes] WHO, BIREME Latin Amer & Caribbean Ctr Hlth Sci Inform, PAHO, Sao Paulo, SP, Brazil.
   [Schveitzer, Mariana Cabral] Univ Fed Sao Paulo, UNIFESP, Sao Paulo, SP, Brazil.
RP Schveitzer, MC (corresponding author), Univ Fed Sao Paulo, UNIFESP, Sao Paulo, SP, Brazil.
EM mariana.cabral@unifesp.br
RI Ghelman, Ricardo/ABA-1854-2021; Schlechta Portella, Caio
   Fabio/D-6400-2017; Schveitzer, Mariana/G-9203-2012
OI Ghelman, Ricardo/0000-0002-6700-6488; Schlechta Portella, Caio
   Fabio/0000-0003-1317-1493; mendes abdala, carmen
   veronica/0000-0002-9236-2978; Schveitzer, Mariana/0000-0001-9833-2932
FU BIREME/PAHO/WHO
FX The authors would like to express their gratitude to TCIM Americas
   Network volunteers and BIREME/PAHO/WHO for support forthis research and
   the technical expert panel advising of the project. Any errors of fact
   or interpretation in this manuscript remain theresponsibility of the
   authors. We would like do a special knowledge to Natalia Sofia Aldana,
   Alan Kornin, Lissandra ZanoveloFogac a, Alan da Silva Menezes de Assis,
   Daniel Alan Costa, MikaellyPereira Coser, Fabian, Laszlo Flegner, Erika
   Cardozo Pereira, DaniloAlberti dos Santos, Gleyce Moreno Barbosa,
   Priscilla Araujo Dupratde Britto Pereira, Rosely Cordon, Cassio Guedes
   Pelegrini Junior, Raquel da Silva Terezam, Leila Brito Bergold, Raquel
   de Luna Antonio, Andres Felipe Rodriguez Molina.
CR Akatsu H, 2013, JPEN-PARENTER ENTER, V37, P631, DOI 10.1177/0148607112467819
   Carpenter JK, 2019, CLIN PSYCHOL REV, V74, DOI 10.1016/j.cpr.2019.101785
   Chen W, 2011, PLOS ONE, V6, DOI [10.1371/journaLpone,0028091, DOI 10.1371/JOURNALPONE.0028091]
   Chernyshov V P, 2000, Am J Ther, V7, P195, DOI 10.1097/00045391-200007030-00007
   Cushing RE, 2018, J ALTERN COMPLEM MED, V24, P106, DOI 10.1089/acm.2017.0176
   Duan-Porter W, 2016, J PHYS ACT HEALTH, V13, P281, DOI 10.1123/jpah.2015-0027
   Dusek JA, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1025-0
   Gallegos AM, 2017, CLIN PSYCHOL REV, V58, P115, DOI 10.1016/j.cpr.2017.10.004
   Gierisch JM, 2011, EFFIC COMPLEMENT A S
   Grant MJ, 2009, HEALTH INFO LIBR J, V26, P91, DOI 10.1111/j.1471-1842.2009.00848.x
   Grant S, 2018, J TRAUMA DISSOCIATIO, V19, P39, DOI 10.1080/15299732.2017.1289493
   Hamre HJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/243801
   Hamre HJ, 2005, WIEN KLIN WOCHENSCHR, V117, P500, DOI 10.1007/s00508-005-0389-9
   Heffner KL, 2016, PSYCHOL TRAUMA-US, V8, P365, DOI 10.1037/tra0000106
   Hilton L, 2017, PSYCHOL TRAUMA-US, V9, P453, DOI 10.1037/tra0000180
   Huang JP, 2018, J PSYCHIATR RES, V107, P1, DOI 10.1016/j.jpsychires.2018.09.018
   Joyce S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017858
   Karan NB, 2019, PHYSIOL BEHAV, V211, DOI 10.1016/j.physbeh.2019.112676
   LEE MD, 2018, NUTRIENTS, V10, DOI DOI 10.1190/NU10040409
   Lei WT, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111175
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007]
   Liu JP, 2004, J ALTERN COMPLEM MED, V10, P1041, DOI 10.1089/acm.2004.10.1041
   Liu XM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004882.pub3
   Love MF, 2019, STROKE, V50, P434, DOI 10.1161/STROKEAHA.118.021150
   Mannucci C, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/3624094
   Mathie RT, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001957.pub6
   Mousa HAL, 2017, J EVID-BASED INTEGR, V22, P166, DOI 10.1177/2156587216641831
   OrganizaciOn Mundial de la Salud, 2011, ESTR OMS MED TRAD 20, P12
   Pascoe MC, 2017, J PSYCHIATR RES, V95, P156, DOI 10.1016/j.jpsychires.2017.08.004
   Patwardhan B, 2005, EVID-BASED COMPL ALT, V2, P465, DOI 10.1093/ecam/neh140
   Petrof EO, 2012, CRIT CARE MED, V40, P3290, DOI 10.1097/CCM.0b013e318260cc33
   Poon PMK, 2006, AM J CHINESE MED, V34, P13, DOI 10.1142/S0192415X0600359X
   Snilstveit B, 2016, J CLIN EPIDEMIOL, V79, P120, DOI 10.1016/j.jclinepi.2016.05.015
   Sperber SJ, 2004, CLIN INFECT DIS, V38, P1367, DOI 10.1086/386324
   Strauss C, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01154
   Vidal K, 2012, REJUV RES, V15, P89, DOI 10.1089/rej.2011.1241
   World Health Organization, 2020, WHO COR DIS COVID 19
   World Health Organization, 2019, WHO GLOB REP TRAD CO
   Zakay-Rones Z, 2004, J INT MED RES, V32, P132, DOI 10.1177/147323000403200205
   Zhang L, 2020, J MED VIROL, V92, P479, DOI 10.1002/jmv.25707
   Zhang MM, 2004, WORLD J GASTROENTERO, V10, P3500
   Zhao P, 2014, ALTERN THER HEALTH M, V20, P25
NR 42
TC 7
Z9 9
U1 4
U2 14
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2213-4220
EI 2213-4239
J9 INTEGR MED RES
JI Integr. Med. Res.
PD SEP
PY 2020
VL 9
IS 3
SI SI
AR 100473
DI 10.1016/j.imr.2020.100473
PG 7
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA NR5DK
UT WOS:000571582500018
PM 32766112
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Xing, YF
   He, W
   Cao, GH
   Li, YH
AF Xing, Yunfei
   He, Wu
   Cao, Gaohui
   Li, Yuhai
TI Using data mining to track the information spreading on social media
   about the COVID-19 outbreak
SO ELECTRONIC LIBRARY
LA English
DT Article
DE Data mining; Information spreading; COVID-19 outbreak; Social media;
   Twitter
ID SENTIMENT ANALYSIS; NETWORK ANALYSIS; TWEETS; FEATURES; TWITTER; MODEL;
   BEHAVIORS; KNOWLEDGE; FRAMEWORK; SYSTEM
AB Purpose COVID-19, a causative agent of the potentially fatal disease, has raised great global public health concern. Information spreading on the COVID-19 outbreak can strongly influence people behaviour in social media. This paper aims to question of information spreading on COVID-19 outbreak are addressed with a massive data analysis on Twitter from a multidimensional perspective. Design/methodology/approach The evolutionary trend of user interaction and the network structure is analysed by social network analysis. A differential assessment on the topics evolving is provided by the method of text clustering. Visualization is further used to show different characteristics of user interaction networks and public opinion in different periods. Findings Information spreading in social media emerges from different characteristics during various periods. User interaction demonstrates multidimensional cross relations. The results interpret how people express their thoughts and detect topics people are most discussing in social media. Research limitations/implications This study is mainly limited by the size of the data sets and the unicity of the social media. It is challenging to expand the data sets and choose multiple social media to cross-validate the findings of this study. Originality/value This paper aims to find the evolutionary trend of information spreading on the COVID-19 outbreak in social media, including user interaction and topical issues. The findings are of great importance to help government and related regulatory units to manage the dissemination of information on emergencies, in terms of early detection and prevention.
C1 [Xing, Yunfei; Cao, Gaohui; Li, Yuhai] Cent China Normal Univ, Sch Informat Management, Wuhan, Peoples R China.
   [He, Wu] Old Dominion Univ, Dept Informat Technol & Decis Sci, Norfolk, VA USA.
RP Xing, YF (corresponding author), Cent China Normal Univ, Sch Informat Management, Wuhan, Peoples R China.
EM xingyf@mail.ccnu.edu.cn; WHe@odu.edu; ghcao@mail.ccnu.edu.cn;
   yhli@mail.ccnu.edu.cn
FU China Postdoctoral Science FoundationChina Postdoctoral Science
   Foundation [2020M672393]; National Social Science Foundation of China
   [19BTQ075]
FX This research is funded by China Postdoctoral Science Foundation
   (2020M672393) and National Social Science Foundation of China
   (19BTQ075).
CR Ahmed W, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218235
   Ahmed W, 2019, ONLINE INFORM REV, V43, P149, DOI 10.1108/OIR-03-2018-0093
   Al-Rakhami MS, 2020, IEEE ACCESS, V8, P155961, DOI 10.1109/ACCESS.2020.3019600
   Al-Shargabi AA, 2021, IEEE ACCESS, V9, P90616, DOI 10.1109/ACCESS.2021.3091537
   Albahli AS, 2021, CMC-COMPUT MATER CON, V67, P1613, DOI 10.32604/cmc.2021.014265
   Alharbi A, 2021, CMC-COMPUT MATER CON, V68, P303, DOI 10.32604/cmc.2021.016230
   Ali K, 2019, SCI COMMUN, V41, P314, DOI 10.1177/1075547019846124
   Amin S, 2021, CMC-COMPUT MATER CON, V68, P2231, DOI 10.32604/cmc.2021.016896
   Bahja M, 2020, IEEE ACCESS, V8, P209127, DOI 10.1109/ACCESS.2020.3039168
   Bari OA, 2020, J INTELL SYST, V29, P753, DOI 10.1515/jisys-2017-0567
   Carracedo P, 2021, J BUS RES, V132, P586, DOI 10.1016/j.jbusres.2020.11.043
   Castillo C, 2013, INTERNET RES, V23, P560, DOI 10.1108/IntR-05-2012-0095
   Chadwick A, 2021, SOC MEDIA SOC, V7, DOI 10.1177/20563051211008817
   Chatfield AT, 2013, GOV INFORM Q, V30, P377, DOI 10.1016/j.giq.2013.05.021
   Chen JY, 2019, INFORM SCIENCES, V504, P32, DOI 10.1016/j.ins.2019.07.048
   Chen SJ, 2020, TELEMAT INFORM, V47, DOI 10.1016/j.tele.2019.101326
   Chua CEH, 2019, DECIS SUPPORT SYST, V127, DOI 10.1016/j.dss.2019.113142
   Chung YY, 2019, ACM TRANS MANAG INF, V10, DOI 10.1145/3365537
   de Albuquerque JP, 2015, INT J GEOGR INF SCI, V29, P667, DOI 10.1080/13658816.2014.996567
   de Bruijn JA, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0326-9
   De Santis E, 2020, IEEE ACCESS, V8, P132527, DOI 10.1109/ACCESS.2020.3010033
   Du ZJ, 2020, INFORM SCIENCES, V531, P119, DOI 10.1016/j.ins.2020.03.100
   Fan C, 2019, COMPUT-AIDED CIV INF, V34, P1055, DOI 10.1111/mice.12457
   Garcia MB, 2020, CYBERN INF TECHNOL, V20, P141, DOI 10.2478/cait-2020-0052
   Greco F, 2020, INT J INFORM MANAGE, V51, DOI 10.1016/j.ijinfomgt.2019.04.007
   Gruzd A, 2020, BIG DATA SOC, V7, DOI 10.1177/2053951720938405
   Hagen L, 2018, SOC SCI COMPUT REV, V36, P523, DOI 10.1177/0894439317721985
   He W, 2019, J ENTERP INF MANAG, V32, P152, DOI 10.1108/JEIM-02-2018-0031
   He W, 2017, INFORM TECHNOL MANAG, V18, P149, DOI 10.1007/s10799-015-0243-3
   Imran AS, 2020, IEEE ACCESS, V8, P181074, DOI 10.1109/ACCESS.2020.3027350
   Jiang XG, 2020, CMC-COMPUT MATER CON, V63, P537, DOI 10.32604/cmc.2020.010691
   Jo Y, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18105084
   Kang AL, 2021, SCI TOTAL ENVIRON, V769, DOI 10.1016/j.scitotenv.2021.145158
   Kavota JK, 2020, INT J INFORM MANAGE, V52, DOI 10.1016/j.ijinfomgt.2020.102068
   Khadangi E, 2018, QUAL QUANT, V52, P249, DOI 10.1007/s11135-016-0465-4
   Khatua A, 2019, INFORM PROCESS MANAG, V56, P247, DOI 10.1016/j.ipm.2018.10.010
   Kim J, 2020, INT J INFORM MANAGE, V51, DOI 10.1016/j.ijinfomgt.2019.102051
   Kim J, 2018, INT J INFORM MANAGE, V40, P153, DOI 10.1016/j.ijinfomgt.2018.02.003
   Krawczyk K, 2021, J MED INTERNET RES, V23, DOI [10.2196/31544, 10.2196/28253]
   Kurten S, 2021, CYBERPSYCH BEH SOC N, V24, P117, DOI 10.1089/cyber.2020.0341
   Leon RD, 2020, INFORM PROCESS MANAG, V57, DOI 10.1016/j.ipm.2020.102237
   Li SY, 2020, INFORM PROCESS MANAG, V57, DOI 10.1016/j.ipm.2019.102177
   Lu ZY, 2019, INFORM SCIENCES, V473, P166, DOI 10.1016/j.ins.2018.09.027
   Lv LS, 2019, IEEE ACCESS, V7, P115725, DOI 10.1109/ACCESS.2019.2936217
   Mamidi R, 2019, JMIR PUBLIC HLTH SUR, V5, P78, DOI 10.2196/11036
   Massaro M, 2021, J MED SYST, V45, DOI 10.1007/s10916-021-01726-7
   Montes-Orozco E, 2020, IEEE ACCESS, V8, P122874, DOI 10.1109/ACCESS.2020.3007726
   Nanath K, 2021, BEHAV INFORM TECHNOL, DOI 10.1080/0144929X.2021.1941259
   Noor S, 2021, KYBERNETES, V50, P1633, DOI 10.1108/K-05-2020-0258
   Obadimu A, 2021, INFORM PROCESS MANAG, V58, DOI 10.1016/j.ipm.2021.102660
   Pan D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241167
   Pouyanfar S, 2019, WORLD WIDE WEB, V22, P1893, DOI 10.1007/s11280-018-0636-4
   Qiu JT, 2019, INFORM SCIENCES, V489, P274, DOI 10.1016/j.ins.2019.03.041
   Rosa RL, 2020, IEEE ACCESS, V8, P158806, DOI 10.1109/ACCESS.2020.3020391
   Shahraki ZK, 2019, INFORM PROCESS MANAG, V56, DOI 10.1016/j.ipm.2019.05.006
   Sharma PK, 2019, FUTURE GENER COMP SY, V93, P952, DOI 10.1016/j.future.2017.08.031
   Son J, 2019, INT J INFORM MANAGE, V45, P56, DOI 10.1016/j.ijinfomgt.2018.10.012
   Stamatelatos G, 2020, INFORM PROCESS MANAG, V57, DOI 10.1016/j.ipm.2019.102172
   Tang XB, 2019, ELECTRON LIBR, V37, P607, DOI 10.1108/EL-02-2019-0044
   Taskin Z, 2019, ONLINE INFORM REV, V43, P676, DOI 10.1108/OIR-07-2018-0217
   Tunger D, 2018, SCIENTOMETRICS, V117, P2041, DOI 10.1007/s11192-018-2919-z
   Ugur NG, 2020, TOUR MANAG PERSPECT, V36, DOI 10.1016/j.tmp.2020.100744
   Van Eck NJ, 2007, STUD CLASS DATA ANAL, P299
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
   Wang HC, 2018, ELECTRON LIBR, V36, P220, DOI 10.1108/EL-10-2016-0230
   Wang TY, 2020, IEEE ACCESS, V8, P138162, DOI 10.1109/ACCESS.2020.3012595
   Wang XW, 2020, INF DISCOV DELIV, V48, P213, DOI 10.1108/IDD-10-2019-0075
   Wang XG, 2015, NEUROCOMPUTING, V168, P1037, DOI 10.1016/j.neucom.2015.05.021
   Wang Y, 2021, COMPUT HUM BEHAV, V114, DOI 10.1016/j.chb.2020.106568
   WHO, 2020, NOV COR 2019 NCOV SI
   Wrycza S, 2020, INFORM SYST MANAGE, V37, P288, DOI 10.1080/10580530.2020.1820631
   Xing YF, 2021, ASLIB J INFORM MANAG, V73, P517, DOI 10.1108/AJIM-07-2020-0216
   Xing YF, 2021, J GLOB INF MANAG, V29, P93, DOI 10.4018/JGIM.20210701.oa5
   Yie KY, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052461
   Yue K, 2017, NEUROCOMPUTING, V219, P364, DOI 10.1016/j.neucom.2016.09.042
   Zhang J, 2020, J ASSOC INF SCI TECH, V71, P282, DOI 10.1002/asi.24245
   Zhang L, 2018, ELECTRON LIBR, V36, P782, DOI 10.1108/EL-05-2017-0120
   Zhu LH, 2020, INFORM SCIENCES, V526, P1, DOI 10.1016/j.ins.2020.03.076
NR 78
TC 0
Z9 0
U1 23
U2 23
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0264-0473
EI 1758-616X
J9 ELECTRON LIBR
JI Electron. Libr.
PD FEB 1
PY 2022
VL 40
IS 1-2
BP 63
EP 82
DI 10.1108/EL-04-2021-0086
EA NOV 2021
PG 20
WC Information Science & Library Science
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science
GA YT5OD
UT WOS:000722645600001
DA 2022-04-20
ER

PT J
AU Aravind, A
   Nair, S
   Aparna, TK
   Thomas, AJ
   Oommen, S
   Vijayan, A
AF Aravind, A.
   Nair, Samyukta
   Aparna, T. K.
   Thomas, Arun Jacob
   Oommen, Sajna
   Vijayan, Aravind
TI Attention to COVID-19 Pandemic among Dental Experts of Kerala State,
   India: A Knowledge, Attitude, and Practice Study
SO JOURNAL OF PHARMACY AND BIOALLIED SCIENCES
LA English
DT Article
DE Dental practitioners; fear; safety
AB Background: Dentists are the common preys for the transmission of pandemic disease because of the airborne spread via routine dental checkups. This study which is a cross-sectional one gives the idea about awareness and alertness of dentists about COVID-19 in Kerala, India. Materials and Methods: The survey comprised 25 closed-ended questions. The survey was separated into two sections. The initial segment of the poll was identified with the socio-segment qualities that were researched, while the subsequent part was worried about dental practitioners' perspectives toward the management of COVID-19 and the apparent danger of defilement in dental facilities. Results: Coronavirus management in dental clinics differs regarding adherence to the rules. An aggregate of 750 respondents finished the form, out of which 686 (91.46%) complete reactions were incorporated. The majority of the respondents concurred on inquiries regarding the knowledge, practice, and mentality of dental specialists toward the COVID-19 pandemic. Conclusion: The feedback of most dental specialists with respect to the readiness and view of disease control measures against the COVID-19 pandemic was positive. Dental facilities need to adhere more to the central and state government suggestions in alertness of their facilities or by tutoring their dental specialists and staff.
C1 [Aravind, A.] Kannur Dent Coll, Dept Publ Hlth Dent, Anjarakandy, Kerala, India.
   [Nair, Samyukta] Sunshine Dent Specialists, Trivandrum, Kerala, India.
   [Aparna, T. K.] KMCT Dent Coll, Dept Periodont, Kozhikode, India.
   [Thomas, Arun Jacob] Noorul Islam Coll Dent Sci, Dept Oral Pathol & Microbiol, Thiruvananthapuram, Kerala, India.
   [Oommen, Sajna] Noorul Islam Coll Dent Sci, Dept Prosthodont, Thiruvananthapuram, Kerala, India.
   [Vijayan, Aravind] Mt Zion Med Coll, Dept Dent, Pathanamthitta, Kerala, India.
RP Aravind, A (corresponding author), Kannur Dent Coll, Dept Publ Hlth Dent, Anjarakandy, Kerala, India.
EM draravindashok@gmail.com
CR Ali S., 2020, J ISLAMABAD MED DENT, V9, P65, DOI [10.35787/jimdc.v9i1.517, DOI 10.35787/JIMDC.V9I1.517]
   American Dental Association, 2020, WHAT CONST DENT EM
   Ather A, 2020, J ENDODONT, V46, P584, DOI 10.1016/j.joen.2020.03.008
   Azimi Maryam, 2016, Iran J Nurs Midwifery Res, V21, P458
   Centers for Disease Control and Prevention, INT INF PREV CONTR R
   Centers for Disease Control and Prevention, DENT SETT INT INF PR
   Centers for Disease Control and Prevention, INF CONTR SEV AC RES
   Izzetti R, 2020, J DENT RES, V99, P1030, DOI 10.1177/0022034520920580
   Marui VC, 2019, J AM DENT ASSOC, V150, P1015, DOI 10.1016/j.adaj.2019.06.024
   Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   Raza M, 2020, INDIAN J DENT SCI, V12, P209
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Scottish Dental Clinical Effectiveness Programme, 2020, MAN AC DENT PROBL
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Spagnuolo G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062094
   Turkish Dental Association, 2020, EM PRACT DENT TR MIN
   Verbeek JH, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD011621.pub5, 10.1002/14651858.CD011621.pub4]
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   World Health Organization, 2020, 11 WHO
   World Health Organization, PEDIATR MED RODZ
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 22
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0975-7406
J9 J PHARM BIOALLIED SC
JI J. Pharm. Bioallied Sci.
PD JUN
PY 2021
VL 13
IS 5
SI SI
BP 836
EP 840
DI 10.4103/jpbs.JPBS_831_20
PG 5
WC Pharmacology & Pharmacy
WE Emerging Sources Citation Index (ESCI)
SC Pharmacology & Pharmacy
GA SU1FH
UT WOS:000662885700181
PM 34447211
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Islam, MN
   Islam, AMT
   Hossain, MS
   Prodhan, MTR
   Chowdhury, MH
   Al Mamun, MH
AF Islam, Md. Nazrul
   Islam, Abu Reza Md. Towfiqul
   Hossain, Md. Sajjat
   Prodhan, Md. Tabiur Rahman
   Chowdhury, Mohammad Hasan
   Al Mamun, Md. Hasan
TI Mass Media Influence on Changing Healthy Lifestyle of Community People
   During COVID-19 Pandemic in Bangladesh: A Cross-Sectional Survey
SO ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE healthy lifestyle behavior; COVID-19; social media
AB We aimed to assess mass media influence on changing the healthy lifestyle behavior of people during the early phase of the COVID-19 (coronavirus disease 2019) pandemic. Principal component analysis and stepwise multiple regression model showed that knowledge level, media credibility, and media check-in had the most considerable contribution to influencing community people's healthy lifestyle.
C1 [Islam, Md. Nazrul; Islam, Abu Reza Md. Towfiqul; Hossain, Md. Sajjat; Prodhan, Md. Tabiur Rahman] Begum Rokeya Univ, Rangpur, Bangladesh.
   [Chowdhury, Mohammad Hasan] Noakhali Sci & Technol Univ, Noakhali, Bangladesh.
   [Al Mamun, Md. Hasan] Univ Rajshahi, Rajshahi, Bangladesh.
RP Islam, AMT (corresponding author), Begum Rokeya Univ, Dept Disaster Management, Acad Bldg 2,Cadet Coll Rd, Rangpur 5400, Bangladesh.
EM towfiq_dm@brur.ac.bd
RI Towfiqul Islam, Abu Reza Md./N-4022-2014
OI Towfiqul Islam, Abu Reza Md./0000-0001-5779-1382
FU media personnel fighting this infectious disease period
FX We are grateful to all the frontline doctors, nurse, and media personnel
   fighting this infectious disease period and all the researchers cited in
   the reference lists. Also, the authors acknowledge to all the
   respondents in this survey. Preprint version of this article can be
   found in Research Square (doi:10.21203/rs.3.rs-106338/v1).
CR [Anonymous], DAILY STAR
   Institute of Epidemiology Disease Control and Research, BANGLADESH CORONAVIR
   Islam AMT, 2021, ENVIRON DEV SUSTAIN, V23, P9139, DOI 10.1007/s10668-020-01016-1
   Maryon-Davis A., 2012, INNOVAIT, V5, P767
   Paul A, 2021, ASIA-PAC J PUBLIC HE, V33, P100, DOI 10.1177/1010539520977304
   World Health Organization, WEEKLY OPERATIONAL U
   Zheng Y, 2020, ANATOLIA, V31, P337, DOI 10.1080/13032917.2020.1747208
NR 7
TC 1
Z9 1
U1 6
U2 11
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1010-5395
EI 1941-2479
J9 ASIA-PAC J PUBLIC HE
JI Asia-Pac. J. Public Health
PD JUL
PY 2021
VL 33
IS 5
BP 617
EP 619
AR 10105395211011030
DI 10.1177/10105395211011030
EA APR 2021
PG 3
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA UL5YS
UT WOS:000644042500001
PM 33870719
OA Bronze
DA 2022-04-20
ER

PT J
AU Thanh, PT
   Nguyen, HTH
   Ngan, LB
   Nguyen, DMD
   Phan, GH
   Nguyen, TMN
AF Pham Tien Thanh
   Hanh Thi Hong Nguyen
   Le Thi Bao Ngan
   Doan My Duyen Nguyen
   Gia Han Phan
   Thi My Nhung Nguyen
TI No one left behind: risk communication to the street vendors during
   COVID-19 social distancing
SO LIBRARY HI TECH
LA English
DT Article; Early Access
DE COVID-19; Risk communication; Preventive behavior; Vulnerable group;
   Street vendor; Developing countries
ID GOVERNMENT ACTIONS; PUBLIC SUPPORT; FAKE NEWS; HEALTH; MEDIA;
   INFORMATION; MANAGEMENT; KNOWLEDGE; INFLUENZA; LESSONS
AB Purpose COVID-19 presents a serious and unprecedented challenge around the globe. Street vendors are the most vulnerable group during this pandemic regarding livelihood loss and contagion risk. This research aims to examine the roles of risk communication work in enhancing COVID-19 risk perceptions and adoption of COVID-19 preventive behaviors among street vendors. Design/methodology/approach The data were collected from the street vendors in urban Vietnam. A binary probit model was used for analyzing the relationships among exposure to risk communication, risk perception and adoption of preventive behaviors. Findings The analysis reveals the outreach of risk communication work to the street vendors. A rather large proportion of the respondents perceive high risks associated with COVID-19. All respondents adopt COVID-19 preventive behaviors; however, the proportion of regular adoption is moderate and even very low for most behaviors. Their frequent exposure to risk communication significantly raises their risk perceptions and encourages their regular adoption of preventive behaviors, particularly regarding the measures that are affordable and less detrimental to their livelihood. Originality/value This research is among the first attempts to examine exposure to risk communication to the vulnerable group, how they perceive risks and the extent to which they adopt preventive behaviors during a public health crisis. This research draws some implications for risk communication and social welfare policies to obtain sustainable development goals.
C1 [Pham Tien Thanh; Hanh Thi Hong Nguyen; Le Thi Bao Ngan; Doan My Duyen Nguyen; Gia Han Phan; Thi My Nhung Nguyen] Ton Duc Thang Univ, Fac Business Adm, Ho Chi Minh City, Vietnam.
RP Nguyen, HTH (corresponding author), Ton Duc Thang Univ, Fac Business Adm, Ho Chi Minh City, Vietnam.
EM nguyenthihonghanh@tdtu.edu.vn
RI Thanh, Pham Tien/J-7668-2019
OI Thanh, Pham Tien/0000-0003-1198-2487
CR Abbas J, 2021, RISK MANAG HEALTHC P, V14, P1917, DOI 10.2147/RMHP.S284313
   Akalu Y, 2020, INFECT DRUG RESIST, V13, P1949, DOI 10.2147/IDR.S258736
   Al-Jundi SA, 2020, SUSTAIN CITIES SOC, V62, DOI 10.1016/j.scs.2020.102316
   Anwar A, 2020, CUREUS, V12, DOI 10.7759/cureus.10453
   Balbuena P., 2020, WORLDS STREET VENDOR
   Bicchieri C, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252892
   Biswas RK, 2020, J EVAL CLIN PRACT, V26, P1599, DOI 10.1111/jep.13467
   Bondielli A, 2019, INFORM SCIENCES, V497, P38, DOI 10.1016/j.ins.2019.05.035
   Briand S., 2020, J COMMUNICATION HEAL, V13, P6
   Brosius, 2020, HARVARD KENNEDY SCH, V1, DOI [10.37016/mr-2020-023, DOI 10.37016/MR-2020-023]
   Ha BTT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093125
   Burnett ML, 2020, DISASTER MED PUBLIC, V14, pE47, DOI 10.1017/dmp.2020.320
   Cerda AA, 2022, HEALTH EXPECT, V25, P506, DOI 10.1111/hex.13274
   Chan DKC, 2021, INFECT CONT HOSP EP, V42, P375, DOI 10.1017/ice.2020.245
   Chatterjee R, 2020, PROG DISASTER SCI, V7, DOI 10.1016/j.pdisas.2020.100109
   Chavarria E, 2021, J DEV STUD, V57, P1245, DOI 10.1080/00220388.2021.1898594
   Choi S, 2021, INT J HEALTHCARE MAN, V14, P271, DOI 10.1080/20479700.2020.1862997
   Clark Cory, 2020, Glob Transit, V2, P76, DOI 10.1016/j.glt.2020.06.003
   Coulthard P, 2020, BRIT DENT J, V228, P503, DOI 10.1038/s41415-020-1482-1
   Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193
   Duong DM, 2020, ASIA-PAC J PUBLIC HE, V32, P161, DOI 10.1177/1010539520927290
   Fakhruddin B, 2020, PROG DISASTER SCI, V8, DOI 10.1016/j.pdisas.2020.100139
   Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802
   Flint SW, 2020, LANCET DIABETES ENDO, V8, P474, DOI 10.1016/S2213-8587(20)30156-X
   Folger-Laronde Z, 2022, J SUSTAIN FINANC INV, V12, P490, DOI 10.1080/20430795.2020.1782814
   Glik DC, 2007, ANNU REV PUBL HEALTH, V28, P33, DOI 10.1146/annurev.publhealth.28.021406.144123
   Gujarati D.N., 2009, BASIC ECONOMETRICS
   Hamiduzzaman M., 2020, LOCAL DEV SOC, V1, P177, DOI [10.1080/26883597.2020.1801334, DOI 10.1080/26883597.2020.1801334]
   Hao Rongzhang, 2021, J Biosaf Biosecur, V3, P76, DOI 10.1016/j.jobb.2021.06.003
   Hilyard KM, 2010, HEALTH AFFAIR, V29, P2294, DOI 10.1377/hlthaff.2010.0474
   Janssen M, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102180
   Jose R, 2021, CLIN EPIDEMIOL GLOB, V9, P41, DOI 10.1016/j.cegh.2020.06.009
   Karasneh R, 2021, RES SOC ADMIN PHARM, V17, P1897, DOI 10.1016/j.sapharm.2020.04.027
   Tung LT, 2020, DATA BRIEF, V33, DOI 10.1016/j.dib.2020.106348
   Lee Hye-Young, 2013, Osong Public Health Res Perspect, V4, P278, DOI 10.1016/j.phrp.2013.09.008
   Lee JJ, 2020, J MED INTERNET RES, V22, DOI 10.2196/22205
   Li HOY, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002604
   Lin LS, 2014, PUBLIC HEALTH REP, V129, P49, DOI 10.1177/00333549141296S408
   Liu ZR, 2014, FOOD CONTROL, V41, P212, DOI 10.1016/j.foodcont.2014.01.027
   Majithia A.S., 2020, IMPACT COVID 19 STRE
   Mboowa G, 2021, AM J TROP MED HYG, V104, P502, DOI 10.4269/ajtmh.20-1174
   Ministry of Health of Vietnam, 2020, MESS FEAT 5K VIETN K
   Moll R, 2016, BRIT MED BULL, V117, P15, DOI 10.1093/bmb/ldw007
   Moroz H., 2020, POTENTIAL RESPONSES, DOI [10.1596/33625, DOI 10.1596/33625]
   Muhamad J.W., 2021, COMMUNICATING SCI TI, V1st ed., P110
   Muyanja C, 2011, FOOD CONTROL, V22, P1551, DOI 10.1016/j.foodcont.2011.01.016
   Nguyen TV, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-004100
   Nguyen TH, 2021, LIBR HI TECH, V39, P776, DOI 10.1108/LHT-09-2020-0241
   Oh SH, 2021, HEALTH COMMUN, V36, P972, DOI 10.1080/10410236.2020.1724639
   Olapegba PO, 2020, DATA BRIEF, V30, DOI 10.1016/j.dib.2020.105685
   Ortiz-Martinez Y, 2017, AM J INFECT CONTROL, V45, P816, DOI 10.1016/j.ajic.2017.02.027
   Ozdemir S, 2022, INT J HEALTH POLICY, V11, P579, DOI 10.34172/ijhpm.2020.199
   Paek HJ, 2008, HEALTH PROMOT PRACT, V9, p60S, DOI 10.1177/1524839908322114
   Pickles K, 2021, J MED INTERNET RES, V23, DOI 10.2196/23805
   Pollack T., 2020, EMERGING COVID 19 SU
   Ren W, 2021, J HEALTH PSYCHOL, DOI 10.1177/13591053211003125
   Requia WJ, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.139144
   Scartoni FR, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.593903
   Seale H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235112
   Seshaiyer P, 2020, WORLD MED HEALTH POL, V12, P443, DOI 10.1002/wmh3.380
   Skinner C, 2021, TOWN PLAN REV, V92, P301, DOI 10.3828/tpr.2020.38
   Sommariva S, 2018, AM J HEALTH EDUC, V49, P246, DOI 10.1080/19325037.2018.1473178
   Song S, 2020, RES GLOB, V2, P1
   Strekalova YA, 2017, HEALTH EDUC BEHAV, V44, P332, DOI 10.1177/1090198116660310
   Sutton J, 2021, HEALTH SECUR, V19, P370, DOI 10.1089/hs.2020.0161
   Tam L.T., 2021, GLOBAL J FLEXIBLE SY, V22, P45
   Tang CSK, 2004, PREV MED, V39, P1187, DOI 10.1016/j.ypmed.2004.04.032
   Tanvatanakul V, 2007, HEALTH EDUC J, V66, P173, DOI 10.1177/0017896907076755
   Trivedi PravinK., 2005, MICROECONOMETRICS ME
   United Nations, 2020, UN RAD SPREADS COVID
   Van den Broucke S, 2020, HEALTH PROMOT INT, V35, P181, DOI 10.1093/heapro/daaa042
   La VP, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12072931
   Vo HL, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.589900
   WHO, 2021, STAT 2 M INT HLTH RE
   Wickramage Kolitha, 2013, F1000Res, V2, P163, DOI 10.12688/f1000research.2-163.v1
   Wieland ML, 2021, J CLIN TRANSL SCI, V5, DOI 10.1017/cts.2020.47
   Wooldridge J.M., 2015, INTRO ECONOMETRICS M
   World Health Organization (WHO), 2020, RISK COMM COMM ENG R
   Yildirim M, 2021, PSYCHOL HEALTH MED, V26, P35, DOI 10.1080/13548506.2020.1776891
NR 79
TC 0
Z9 0
U1 8
U2 9
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0737-8831
J9 LIBR HI TECH
JI Libr. Hi Tech
DI 10.1108/LHT-03-2021-0100
EA SEP 2021
PG 19
WC Information Science & Library Science
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science
GA US9GY
UT WOS:000697734700001
OA Bronze
DA 2022-04-20
ER

PT J
AU Fissi, S
   Gori, E
   Romolini, A
   Contri, M
AF Fissi, Silvia
   Gori, Elena
   Romolini, Alberto
   Contri, Marco
TI Facing covid-19: the digitalization path of Opera di Santa Maria del
   Fiore in Florence
SO EUROPEAN PLANNING STUDIES
LA English
DT Article
DE Digital transformation; digitalization; Italy; museums; Covid-19
ID AUGMENTED REALITY; VIRTUAL-REALITY; CULTURAL-HERITAGE; MUSEUMS;
   EXPERIENCE; INNOVATION; ART; AGE
AB Over the past few decades, digital technologies have become essential for the competitive success of museums and the achievement of their institutional mission. To the best of our knowledge, few studies have analyzed the effect of the Covid-19 pandemic on digitalization in the museum sector. In light of this, the present study aims to investigate whether the pandemic has accelerated the digital transformation of museums. It examines the case of Opera di Santa Maria del Fiore in Florence through semi-structured interviews and secondary sources. The results show that the museum started its digitalization some time ago, but the pandemic has accelerated it. The institution has been developing several new digital projects using various online and onsite tools.
C1 [Fissi, Silvia; Gori, Elena] Univ Florence, Dept Business & Econ, Via Pandette 9, I-50127 Florence, Italy.
   [Romolini, Alberto] Int Telemat Univ Uninettuno, Fac Econ, Rome, Italy.
   [Contri, Marco] Univ Pisa, Dept Econ & Management, Pisa, Italy.
RP Fissi, S (corresponding author), Univ Florence, Dept Business & Econ, Via Pandette 9, I-50127 Florence, Italy.
EM silvia.fissi@unifi.it
OI Contri, Marco/0000-0001-5644-2105
CR Agostino D, 2021, ACCOUNT HIST, V26, P102, DOI 10.1177/1032373220934893
   Agostino D, 2020, MUS MANAGE CURATOR, V35, P362, DOI 10.1080/09647775.2020.1790029
   Agostino D, 2021, PUBLIC MONEY MANAGE, V41, P69, DOI 10.1080/09540962.2020.1764206
   Alshawaaf N, 2021, J BUS RES, V125, P597, DOI 10.1016/j.jbusres.2020.02.045
   Anton C, 2018, CURR ISSUES TOUR, V21, P1406, DOI 10.1080/13683500.2017.1373753
   Ateca-Amestoy, 2018, EC CULTURA, V28, P419
   Badell JI, 2015, MUS MANAGE CURATOR, V30, P244, DOI 10.1080/09647775.2015.1042512
   Barton J, 2005, LIBR REV, V54, P149, DOI 10.1108/00242530510588908
   Bertacchini E, 2013, INT J ARTS MANAG, V15, P60
   Borowiecki KJ, 2017, ECON INNOV NEW TECH, V26, P227, DOI 10.1080/10438599.2016.1164488
   Bryman A, 2015, SOCIAL RES METHODS
   Camarero C, 2018, INT J HUM-COMPUT INT, V34, P1119, DOI 10.1080/10447318.2017.1418475
   Camarero C, 2012, J SERV RES-US, V15, P39, DOI 10.1177/1094670511419648
   Capriotti P, 2018, PROF INFORM, V27, P642, DOI 10.3145/epi.2018.may.17
   Capuano N, 2016, BEHAV INFORM TECHNOL, V35, P968, DOI 10.1080/0144929X.2016.1208774
   Castiglione C., 2014, 18 INT C CULT EC U Q
   Cinti T., 2011, CITY CULTURE SOC, V2, P159, DOI [10.1016/j.ccs.2011.09.001, DOI 10.1016/J.CCS.2011.09.001]
   Cori E, 2021, CULTURAL INITIATIVES, P23
   Crooke E., 2020, MUSEUM SOC, V18, P305, DOI [10.29311/mas.v18i3.3533, DOI 10.29311/MAS.V18I3.3533]
   De Bernardi P, 2019, TOUR ANAL, V24, P315, DOI 10.3727/108354219X15511864843876
   Deng XY, 2019, J BUS RES, V100, P561, DOI 10.1016/j.jbusres.2018.11.008
   Dieck MCT, 2018, CURR ISSUES TOUR, V21, P2014, DOI 10.1080/13683500.2016.1224818
   Errichiello L, 2019, INT J TOUR RES, V21, P590, DOI 10.1002/jtr.2283
   Evrard Y, 2018, J CULT ECON, V42, P353, DOI 10.1007/s10824-017-9309-x
   Fenu C, 2018, INT J HUM-COMPUT ST, V114, P20, DOI 10.1016/j.ijhcs.2018.01.009
   Fernandez-Hernandez R, 2021, MUS MANAGE CURATOR, V36, P553, DOI 10.1080/09647775.2020.1803114
   Fletcher A, 2012, MUS MANAG CURATORSHI, V27, P505, DOI 10.1080/09647775.2012.738136
   Folstad A, 2018, J SERV THEOR PRACT, V28, P196, DOI 10.1108/JSTP-11-2014-0261
   Frey B, 2019, EC ART CULTURE
   Frey BS, 2021, EUR PLAN STUD, V29, P601, DOI 10.1080/09654313.2021.1903841
   Gobble MM, 2018, RES TECHNOL MANAGE, V61, P56, DOI 10.1080/08956308.2018.1471280
   Gori, 2020, INT J DIGIT CULT ELE, V3, DOI [https://doi.org/10.1504/IJDCET.2020.105906, DOI 10.1504/IJDCET.2020.105906]
   Greenhill E, 2013, MUSEUM MEDIA MESSAGE
   Guarino M., 2020, QUAL QUANT, V54, P1445
   Guccio C, 2020, EUR PLAN STUD, DOI 10.1080/09654313.2020.1865277
   Guidi G., 2018, IOP C SERIES MAT SCI, V364, P1
   Guttentag DA, 2010, TOURISM MANAGE, V31, P637, DOI 10.1016/j.tourman.2009.07.003
   Han D.-I.D., 2019, AUGMENTED REALITY VI
   He ZY, 2018, TOURISM MANAGE, V68, P127, DOI 10.1016/j.tourman.2018.03.003
   Heidenreich M, 2015, EUR PLAN STUD, V23, P1441, DOI 10.1080/09654313.2013.817544
   ICOM, 2020, MUS MUS PROF COVID 1
   Iorio M, 2011, J HERIT TOUR, V6, P1, DOI 10.1080/1743873X.2010.515311
   Irpet, 2021, ANN PAND IMP STRAT R
   Istat, 2019, IT MUS
   Jung T, 2015, TOURISM MANAGE, V49, P75, DOI 10.1016/j.tourman.2015.02.013
   Jung TH, 2017, J PLACE MANAG DEV, V10, P140, DOI 10.1108/JPMD-07-2016-0045
   Kabassi K, 2017, J CULT HERIT, V24, P184, DOI 10.1016/j.culher.2016.10.016
   Kaplan A, 2019, BUS HORIZONS, V62, P15, DOI 10.1016/j.bushor.2018.08.004
   Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003
   Kotler P., 2008, MUSEUM STRATEGY MARK
   Kruklidis A, 2017, STUDIES DIGITAL HERI, V1, P282, DOI [10.14434/sdh.v1i2.23192, DOI 10.14434/SDH.V1I2.23192]
   Lazzeretti L., 2015, INT REV PUBL NONPROF, V12, P267, DOI [10.1007/s12208-015-0136-5, DOI 10.1007/S12208-015-0136-5]
   Lazzeretti L, 2016, CAPITAL CULT, P945, DOI 10.13138/2039-2362/1436
   Lazzeretti L, 2015, EUR PLAN STUD, V23, P1548, DOI 10.1080/09654313.2013.819073
   Lee H, 2020, INFORM MANAGE-AMSTER, V57, DOI 10.1016/j.im.2019.103229
   Li C, 2019, MUS MANAGE CURATOR, V34, P273, DOI 10.1080/09647775.2018.1520142
   Lune H., 2017, QUALITATIVE RES METH
   MacDonald S., 2006, COMPANION MUSEUM STU, P170
   Marin-Morales J, 2019, INTERACT COMPUT, V31, P208, DOI 10.1093/iwc/iwz018
   Matzler Kurt, 2013, Journal of Business Strategy, V34, P30, DOI 10.1108/02756661311310431
   Navarrete T., 2013, HDB EC CULTURAL HERI
   NeMo, 2021, FOLL SURV IMP COVID
   Network of European Museum Organisations (NEMO), 2020, SURV IMP COVID 19 SI
   Padilla-Melendez A, 2013, INT J INFORM MANAGE, V33, P892, DOI 10.1016/j.ijinfomgt.2013.07.004
   Pinna G., 2021, MUSEI SCI ITALIANI 2, P123
   Raimo N, 2021, INT J ENTREP BEHAV R, DOI 10.1108/IJEBR-01-2021-0082
   Rubin J, 2019, TEA AECOM 2019 THEM
   Samaroudi M, 2020, MUS MANAGE CURATOR, V35, P337, DOI 10.1080/09647775.2020.1810483
   Schiuma G., 2021, CULTURAL INITIATIVES, P45
   Trunfio M, 2020, CURR ISSUES TOUR, V23, P1053, DOI 10.1080/13683500.2019.1586847
   UNESCO, 2020, MUS WORLD FAC COVID
   Waller DS, 2019, MUS MANAGE CURATOR, V34, P323, DOI 10.1080/09647775.2018.1550622
   Yin R.K., 2014, CASE STUDY RES APPL, V5th ed.
NR 73
TC 0
Z9 0
U1 9
U2 9
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0965-4313
EI 1469-5944
J9 EUR PLAN STUD
JI Eur. Plan. Stud.
PD APR 3
PY 2022
VL 30
IS 4
BP 573
EP 589
DI 10.1080/09654313.2021.1974352
EA SEP 2021
PG 17
WC Environmental Studies; Geography; Regional & Urban Planning; Urban
   Studies
WE Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Geography; Public Administration;
   Urban Studies
GA ZP4FI
UT WOS:000692342000001
DA 2022-04-20
ER

PT J
AU Harms, R
   Alfert, C
   Cheng, CF
   Kraus, S
AF Harms, Rainer
   Alfert, Carina
   Cheng, Cheng-Feng
   Kraus, Sascha
TI Effectuation and causation configurations for business model innovation:
   Addressing COVID-19 in the gastronomy industry
SO INTERNATIONAL JOURNAL OF HOSPITALITY MANAGEMENT
LA English
DT Article
DE COVID-19; Gastronomy entrepreneurs; Effectuation; Business model
   innovation; Configurations; fsQCA
ID DECISION-MAKING; ENTREPRENEURSHIP; ORGANIZATION; ORIENTATION; CREATION;
   HOSPITALITY; UNCERTAINTY; INTERPLAY; IMPACT
AB The gastronomy sector is among those that are hit particularly hard by a loss of customers and regulatory uncertainty of the COVID-19 crisis. When established ways of doing business become almost impossible, business model innovation (BMI) is a possible reaction to this high uncertainty level. Effectuation and causation are decision-making logics that may lead to BMI and help a firm navigate uncertainty. We investigate configurations of causation and effectuation components associated with a high BMI level during the first wave of COVID-19. We perform fuzzy-set-qualitative comparative analysis (fsQCA) on a sample of 143 gastronomy entrepreneurs in Munster county, Germany. We identify two paths that lead to a high BMI level: "the planning soloist" and "the hedging networker." We conclude that innovators among the gastronomy entrepreneurs use effectuation and causation components in complex configurations.
C1 [Harms, Rainer; Alfert, Carina] Univ Twente, Fac Behav Management & Social Sci, NIKOS ESIM, POB 217, NL-7522 NB Enschede, Netherlands.
   [Harms, Rainer] Natl Res Univ Higher Sch Econ, Res Lab Sci & Technol Studies, Myasnitskaya Ulitsa 20, Moscow 101000, Russia.
   [Harms, Rainer] Natl Res Univ Higher Sch Econ, Inst Stat Studies & Econ Knowledge, Myasnitskaya Ulitsa 20, Moscow 101000, Russia.
   [Cheng, Cheng-Feng] Natl Taichung Univ Sci & Technol, 129,Sec 3,Sanmin Rd, Taichung 404, Taiwan.
   [Kraus, Sascha] Free Univ Bozen Bolzano, Piazza Univ 11, I-39100 Bolzano, Italy.
RP Harms, R (corresponding author), Univ Twente, Fac Behav Management & Social Sci, NIKOS ESIM, POB 217, NL-7522 NB Enschede, Netherlands.
EM r.harms@utwente.nl; c.alfert@utwente.nl; chengcf@nutc.edu.tw;
   Sascha.kraus@zfke.de
OI Kraus, Sascha/0000-0003-4886-7482; Harms, Rainer/0000-0002-3835-5582
FU Basic Research Program of the National Research University Higher School
   of Economics (HSE); Russian Academic Excellence Project '5-100'Ministry
   of Education and Science, Russian FederationProject 5-100, Ministry of
   Education and Science, Russian Federation
FX Rainer Harms' part of this work is based on the study funded by the
   Basic Research Program of the National Research University Higher School
   of Economics (HSE) and by the Russian Academic Excellence Project
   '5-100'. We acknowledge the help of the FH Munster team in data
   collection and discussions.
CR Aksoy L, 2019, J SERV MANAGE, V30, P449, DOI 10.1108/JOSM-07-2019-413
   Alonso AD, 2020, INT J HOSP MANAG, V91, DOI 10.1016/j.ijhm.2020.102654
   Amit R, 2001, STRATEGIC MANAGE J, V22, P493, DOI 10.1002/smj.187
   An WW, 2020, SMALL BUS ECON, V54, P843, DOI 10.1007/s11187-019-00155-8
   Anderson B.S., 2014, HDB RES ENTREPRENEUR, P215
   Andries P, 2013, STRATEG ENTREP J, V7, P288, DOI 10.1002/sej.1170
   Anthes E., 2020, WASH POST
   De Vasconcelos RBB, 2020, INT J INNOV MANAG, V24, DOI 10.1142/S136391962050005X
   Bertels HM, 2015, RES TECHNOL MANAGE, V58, P20, DOI 10.5437/08956308X5802294
   Blair E, 2006, J ACAD MARKET SCI, V34, P4, DOI 10.1177/0092070305283778
   Bogers M, 2017, BRIT FOOD J, V119, P2325, DOI 10.1108/BFJ-07-2017-0394
   Breier Matthias, 2020, INT J HOSP MANAG
   Brenk S., 2019, J BUSINESS EC, V89, P1097
   Brettel M, 2012, J BUS VENTURING, V27, P167, DOI 10.1016/j.jbusvent.2011.01.001
   Chandler GN, 2011, J BUS VENTURING, V26, P375, DOI 10.1016/j.jbusvent.2009.10.006
   Crawford GC, 2015, J BUS VENTURING, V30, P696, DOI 10.1016/j.jbusvent.2015.01.001
   DEHOGA, 2020, COR 2020 ZWISCH GAST
   Evald MR, 2013, J ENTERP CULT, V21, P275, DOI 10.1142/S021849581350012X
   Filser M, 2021, BUS STRATEG ENVIRON, V30, P891, DOI 10.1002/bse.2660
   Fiss PC, 2011, ACAD MANAGE J, V54, P393, DOI 10.5465/AMJ.2011.60263120
   Foss NJ, 2017, J MANAGE, V43, P200, DOI 10.1177/0149206316675927
   Frazier ML, 2016, J ORGAN BEHAV, V37, P1023, DOI 10.1002/job.2091
   Futterer F, 2018, LONG RANGE PLANN, V51, P64, DOI 10.1016/j.lrp.2017.06.008
   Galkina T, 2017, IND MARKET MANAG, V67, P158, DOI 10.1016/j.indmarman.2017.09.004
   Gresov C, 1997, ACAD MANAGE REV, V22, P403, DOI 10.2307/259328
   Gursoy D, 2020, J HOSP MARKET MANAG, V29, P527, DOI 10.1080/19368623.2020.1788231
   Harms R, 2020, J SMALL BUS MANAGE, V58, P200, DOI 10.1080/00472778.2019.1659677
   Harms R, 2012, J INT ENTREP, V10, P95, DOI 10.1007/s10843-012-0089-2
   Harms R, 2009, ENTREP REGION DEV, V21, P25, DOI 10.1080/08985620701876416
   Johnson MW, 2008, HARVARD BUS REV, V86, P50
   Kallmuenzer A, 2019, TOURISM MANAGE, V74, P319, DOI 10.1016/j.tourman.2019.04.002
   Kalus M., 2020, MUNSTER EROFFNET DIG
   Kaushal V, 2021, INT J HOSP MANAG, V92, DOI 10.1016/j.ijhm.2020.102707
   Kindstrom D, 2010, EUR MANAG J, V28, P479, DOI 10.1016/j.emj.2010.07.002
   KPMG, 2016, APP CHANG KEY TRENDS
   Kraus S, 2020, INT J ENTREP BEHAV R, DOI 10.1108/IJEBR-04-2020-0214
   Kraus S, 2018, INT ENTREP MANAG J, V14, P15, DOI 10.1007/s11365-017-0461-8
   Kraus Sascha, INT J INNOV TECHNOL
   Kuckertz Andreas Brandle L., 2020, J BUS VENTUR INSIGHT
   Laskovaia A, 2019, ENTREP REGION DEV, V31, P456, DOI 10.1080/08985626.2018.1541593
   LIN IF, 1995, PUBLIC OPIN QUART, V59, P236, DOI 10.1086/269471
   Mansoori Y, 2020, SMALL BUS ECON, V54, P791, DOI 10.1007/s11187-019-00153-w
   McKelvie A, 2020, SMALL BUS ECON, V54, P689, DOI 10.1007/s11187-019-00149-6
   MINTZBERG H, 1985, STRATEGIC MANAGE J, V6, P257, DOI 10.1002/smj.4250060306
   Misangyi VF, 2017, J MANAGE, V43, P255, DOI 10.1177/0149206316679252
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Ragin C.C., 2008, REDESIGNING SOCIAL I
   Ragin C. C, 2017, USERS GUIDE FUZZY SE
   Reymen I, 2017, R&D MANAGE, V47, P595, DOI 10.1111/radm.12249
   Ries E., 2011, THE LEAN STARTUP
   Romme AGL, 2003, ORGAN SCI, V14, P558, DOI 10.1287/orsc.14.5.558.16769
   Sarasvathy SD, 2001, ACAD MANAGE REV, V26, P243, DOI 10.2307/259121
   Schlenker debate, PERS SOC PSYCHOL B, V2, P404
   Sitoh MK, 2014, IEEE T ENG MANAGE, V61, P213, DOI 10.1109/TEM.2013.2293731
   Smolka KM, 2018, ENTREP THEORY PRACT, V42, P571, DOI [10.1177/1042258718783429, 10.1111/etap.12266]
   Song HJ, 2021, INT J HOSP MANAG, V92, DOI 10.1016/j.ijhm.2020.102702
   Spieth P., 2016, J BUSINESS EC, V86, P671, DOI [DOI 10.1007/S11573-015-0794-0, 10.1007/s11573-015-0794-0]
   Statista, 2020, STAT BRANCH GASTR 20
   Szambelan SM, 2020, SMALL BUS ECON, V54, P865, DOI 10.1007/s11187-019-00156-7
   Teece DJ, 2010, LONG RANGE PLANN, V43, P172, DOI 10.1016/j.lrp.2009.07.003
   Thiem Alrik, 2013, QUALITATIVE COMP ANA
   THORNGATE W, 1976, PERS SOC PSYCHOL B, V2, P404, DOI 10.1177/014616727600200413
   Townsend DM, 2018, ACAD MANAG ANN, V12, P659, DOI 10.5465/annals.2016.0109
   Werhahn D, 2015, EUR MANAG J, V33, P305, DOI 10.1016/j.emj.2015.03.002
   Wiltbank R, 2006, STRATEGIC MANAGE J, V27, P981, DOI 10.1002/smj.555
   Yu XY, 2018, TECHNOL FORECAST SOC, V135, P121, DOI 10.1016/j.techfore.2017.11.017
   Yunus M, 2010, LONG RANGE PLANN, V43, P308, DOI 10.1016/j.lrp.2009.12.005
   Zaheer A, 2010, ACAD MANAGE PERSPECT, V24, P62, DOI 10.5465/AMP.2010.50304417
NR 68
TC 10
Z9 10
U1 17
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0278-4319
EI 1873-4693
J9 INT J HOSP MANAG
JI Int. J. Hosp. Manag.
PD MAY
PY 2021
VL 95
AR 102896
DI 10.1016/j.ijhm.2021.102896
EA MAR 2021
PG 8
WC Hospitality, Leisure, Sport & Tourism
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics
GA UO7IQ
UT WOS:000694867200016
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Lv, WZ
   Wu, S
   Jiang, CX
   Cui, YH
   Qiu, XS
   Zhang, Y
AF Lv, Wenzhe
   Wu, Sheng
   Jiang, Chunxiao
   Cui, Yuanhao
   Qiu, Xuesong
   Zhang, Yan
TI Towards Large-Scale and Privacy-Preserving Contact Tracing in COVID-19
   Pandemic: A Blockchain Perspective
SO IEEE TRANSACTIONS ON NETWORK SCIENCE AND ENGINEERING
LA English
DT Article
DE Blockchain; Protocols; COVID-19; Privacy; Security; Monitoring; Resource
   management; Blockchain; potential field; contact tracking; COVID-19
ID LOCATION; PROOF
AB Activity-tracking applications and location-based services using short-range communication (SRC) techniques have been abruptly demanded in the COVID-19 pandemic, especially for automated contact tracing. The attention from both public and policy keeps raising on related practical problems, including 1) how to protect data security and location privacy? 2) how to efficiently and dynamically deploy SRC Internet of Thing (IoT) witnesses to monitor large areas? To answer these questions, in this paper, we propose a decentralized and permissionless blockchain protocol, named Bychain. Specifically, 1) a privacy-preserving SRC protocol for activity-tracking and corresponding generalized block structure is developed, by connecting an interactive zero-knowledge proof protocol and the key escrow mechanism. As a result, connections between personal identity and the ownership of on-chain location information are decoupled. Meanwhile, the owner of the on-chain location data can still claim its ownership without revealing the private key to anyone else. 2) An artificial potential field-based incentive allocation mechanism is proposed to incentivize IoT witnesses to pursue the maximum monitoring coverage deployment. We implemented and evaluated the proposed blockchain protocol in the real-world using the Bluetooth 5.0. The storage, CPU utilization, power consumption, time delay, and security of each procedure and performance of activities are analyzed. The experiment and security analysis is shown to provide a real-world performance evaluation.
C1 [Lv, Wenzhe; Wu, Sheng; Cui, Yuanhao; Qiu, Xuesong] Beijing Univ Posts & Telecommun, Beijing 100876, Peoples R China.
   [Jiang, Chunxiao] Tsinghua Univ, Tsinghua Space Ctr, Beijing 100084, Peoples R China.
   [Jiang, Chunxiao] Beijing Natl Res Ctr Informat Sci & Technol, Beijing 100084, Peoples R China.
   [Zhang, Yan] Univ Oslo, Dept Informat, Oslo, Norway.
RP Wu, S (corresponding author), Beijing Univ Posts & Telecommun, Beijing 100876, Peoples R China.
EM lvwz@bupt.edu.cn; thuraya@bupt.edu.cn; jchx@tsinghua.edu.cn;
   cuiyuanhao@bupt.edu.cn; xsqiu@bupt.edu.cn; yanzhang@ieee.org
OI QIU, XUESONG/0000-0002-7899-539X
FU National Nature Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [61922050, 62022019]; National Key Research
   and Development Program of China [2020YFB1804800]
FX This work was supported by the National Nature Science Foundation of
   China (61922050, 62022019) and the National Key Research and Development
   Program of China (2020YFB1804800).
CR Pham A, 2016, IEEE T MOBILE COMPUT, V15, P2109, DOI 10.1109/TMC.2015.2483498
   Apple Inc, 2019, PRIV PRES CONT TRAC
   Aruba, 2019, LOC SERV AR BLUET BE
   Aujla GS, 2020, IEEE T VEH TECHNOL, V69, P5850, DOI 10.1109/TVT.2020.2972278
   Aujla GS, 2020, IEEE NETWORK, V34, P83, DOI 10.1109/MNET.001.1900151
   Bertoni S ., 2014, FORBES
   Buterin V., 2014, ETHERUM JAN, V3, P1
   Buttyan L, 2007, LECT NOTES COMPUT SC, V4572, P129, DOI 10.1007/978-3-540-73275-4_10
   Cachin C, 2016, WORKSH DISTR CRYPT C
   Caldwell Sydnee, 2017, 23891 NBER
   Carbunar B, 2012, IEEE INT CONF MOB, P182, DOI 10.1109/MASS.2012.6502516
   Decker C, 2013, IEEE INT CONF PEER, DOI 10.1109/p2p.2013.6688704
   Doolittle D, 2013, UT STUDENTS USE FAKE
   Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936
   Fortino G, 2018, FUTURE GENER COMP SY, V89, P804, DOI 10.1016/j.future.2018.07.021
   Fortino G, 2020, IEEE T ENG MANAGE, V67, P1231, DOI 10.1109/TEM.2019.2918162
   Nguyen GT, 2018, J INF PROCESS SYST, V14, P101, DOI 10.3745/JIPS.01.0024
   Hyunghoon C ., 2020, ARXIV200311511
   Jiang CX, 2020, IEEE T WIREL COMMUN, V19, P4685, DOI 10.1109/TWC.2020.2986114
   Jiang CX, 2017, IEEE WIREL COMMUN, V24, P98, DOI 10.1109/MWC.2016.1500356WC
   Kiayias A, 2017, LECT NOTES COMPUT SC, V10401, P357, DOI 10.1007/978-3-319-63688-7_12
   Lenders V., 2008, P 9 WORKSH MOB COMP, P60, DOI DOI 10.1145/1411759.1411775
   Li J., 2020, ARXIV200503599
   Moos M ., 2018, ANAL BITCOIN COSTS 1
   Nakamoto S., BITCOIN PEER TO PEER
   Qiu JF, 2020, IEEE INTERNET THINGS, V7, P451, DOI 10.1109/JIOT.2019.2944213
   Saleh F, 2021, REV FINANC STUD, V34, P1156, DOI 10.1093/rfs/hhaa075
   Scheider F. E., 2000, DISTRIBUTED AUTONOMO
   Sharma V, 2019, IEEE T IND INFORM, V15, P5723, DOI 10.1109/TII.2019.2922039
   Talasila M., 2010, P INT C MOB UB SYST, P210
   Wang JJ, 2020, IEEE COMMUN SURV TUT, V22, P1472, DOI 10.1109/COMST.2020.2965856
   Wang XL, 2016, IEEE ACM T NETWORK, V24, P3276, DOI 10.1109/TNET.2016.2515119
   Xiao Y, 2020, IEEE COMMUN SURV TUT, V22, P1432, DOI 10.1109/COMST.2020.2969706
   Yang Z, 2019, IEEE INTERNET THINGS, V6, P1495, DOI 10.1109/JIOT.2018.2836144
   Zhou LJ, 2018, IEEE ACCESS, V6, P43472, DOI 10.1109/ACCESS.2018.2847632
   Zhu ZC, 2013, IEEE T MOBILE COMPUT, V12, P51, DOI 10.1109/TMC.2011.237
NR 36
TC 3
Z9 3
U1 2
U2 2
PU IEEE COMPUTER SOC
PI LOS ALAMITOS
PA 10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA
SN 2327-4697
J9 IEEE T NETW SCI ENG
JI IEEE Trans. Netw. Sci. Eng.
PD JAN 1
PY 2022
VL 9
IS 1
BP 282
EP 298
DI 10.1109/TNSE.2020.3030925
PG 17
WC Engineering, Multidisciplinary; Mathematics, Interdisciplinary
   Applications
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Mathematics
GA YG0HR
UT WOS:000742179800026
OA Bronze
DA 2022-04-20
ER

PT J
AU Challinor, A
   Naylor, K
   Verstreken, P
AF Challinor, Alexander
   Naylor, Kathryn
   Verstreken, Patrick
TI The effects of COVID-19 on self-harm in a high-secure psychiatry
   hospital
SO JOURNAL OF FORENSIC PRACTICE
LA English
DT Article
DE Self-harm; Prison; Suicide; Forensic psychiatry; Secure hospitals;
   Pandemic; COVID-19
ID SUICIDE; BEHAVIORS
AB Purpose Self-harm, including death from suicide, remains a significant public health challenge. The prison population is known to be a high-risk group for self-harm and suicide. The purpose of this study is to explore the trends in the frequency of self-harm over the course of the COVID-19 pandemic within a high-secure hospital. The authors hypothesised that the pandemic could adversely affect the mental health of patients, which could increase the rates of self-harm. Reasons for changes in the frequency of self-harm and the strategies used in response to the pandemic were also investigated. Design/methodology/approach This paper encompasses findings from a quality improvement project that investigated self-harming behaviours from February 2020 to February 2021 in a high-secure psychiatric hospital. Incidents of self-harm were recorded based on the hospital's ward structure. Data was collected on the incidence of self-harm rates over the COVID-19 pandemic, with a focus on how the pandemic may have had an effect on self-harm. Findings This paper found an increase in the incidents of self-harm during the initial stages of the pandemic. The first national lockdown period yielded a rise in self-harm incidents from pre-COVID levels. The frequency of self-harm reduced following the first lockdown and returned to pre-COVID levels. The authors explored the psychological effects of COVID, isolation, interpersonal dynamics and changes in the delivery of care as reasons for these trends. Practical implications This study demonstrates the substantial challenges of the COVID-19 pandemic to secure psychiatric services. Having an awareness of how the pandemic can impact on self-harm is important, as it allows the correct balance of restriction of our patients' liberty to a degree deemed necessary to control the pandemic and the delivery of effective patient care. The key clinical implications include the importance of direct face-to-face patient contact, effective communication, therapeutic interventions and activities, the psychological impact of quarantine and the influence the pandemic can have on an individual's function of self-harm. Originality/value This paper is the first, to the authors' knowledge, to explore the impact of COVID-19 in a high-security psychiatric hospital. The authors also explore possible explanations for the changes in the trends of self-harm and include the consideration of strategies for improving the prevention and management of self-harm in high-secure settings during a pandemic.
C1 [Challinor, Alexander] Mersey Care NHS Fdn Trust, Res & Dev Team, Liverpool, Merseyside, England.
   [Challinor, Alexander] Univ Liverpool, Fac Hlth & Life Sci, Liverpool, Merseyside, England.
   [Naylor, Kathryn] Mersey Care NHS Fdn Trust, Ashworth Hosp, Forens Psychiat, Liverpool, Merseyside, England.
   [Verstreken, Patrick] Mersey Care NHS Fdn Trust, Ashworth Hosp, Forens Psychiatrist Psychiat, Liverpool, Merseyside, England.
RP Challinor, A (corresponding author), Mersey Care NHS Fdn Trust, Res & Dev Team, Liverpool, Merseyside, England.; Challinor, A (corresponding author), Univ Liverpool, Fac Hlth & Life Sci, Liverpool, Merseyside, England.
EM alex.challinor1@nhs.net
OI Challinor, Alexander/0000-0001-7305-0007
CR Andover MS, 2014, CAN J PSYCHIAT, V59, P569, DOI 10.1177/070674371405901102
   Batejan, 2014, OXFORD HDB SUICIDE S, DOI DOI 10.1093/OXFORDHB/9780195388565.013.0017
   Bowlby J., 1988, SECURE BASE CLIN APP
   Brooker C, 2010, J AGGRESS CONFL PEAC, V2, P34, DOI 10.5042/jacpr.2010.0535
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   Brown J., 2021, CORONAVIRUS HIST ENG
   Cipriano A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01946
   Comtois KA, 2006, J CLIN PSYCHOL, V62, P161, DOI 10.1002/jclp.20220
   Dunster-Page C, 2017, J AFFECT DISORDERS, V223, P165, DOI 10.1016/j.jad.2017.07.040
   Edmondson AJ, 2016, J AFFECT DISORDERS, V191, P109, DOI 10.1016/j.jad.2015.11.043
   Favril L, 2020, LANCET PSYCHIAT, V7, P682, DOI 10.1016/S2215-0366(20)30190-5
   Fazel S, 2008, J CLIN PSYCHIAT, V69, P1721, DOI 10.4088/JCP.v69n1107
   Fliege H, 2009, J PSYCHOSOM RES, V66, P477, DOI 10.1016/j.jpsychores.2008.10.013
   Hewson T, 2021, BJPSYCH BULL, V45, P131, DOI 10.1192/bjb.2020.83
   Howard League of Penal Reforms, 2003, SUICIDE SELF HARM PR
   Hurst JE, 2017, EVOL HUM BEHAV, V38, P1, DOI 10.1016/j.evolhumbehav.2016.06.001
   Klonsky ED, 2007, CLIN PSYCHOL REV, V27, P226, DOI 10.1016/j.cpr.2006.08.002
   Ministry of Justice, 2019, SAF CUST STAT ENGL W
   Motto JA, 2001, PSYCHIATR SERV, V52, P828, DOI 10.1176/appi.ps.52.6.828
   Muehlenkamp J, 2013, SUICIDE LIFE-THREAT, V43, P67, DOI 10.1111/j.1943-278X.2012.00128.x
   Nock MK, 2004, J CONSULT CLIN PSYCH, V72, P885, DOI 10.1037/0022-006X.72.5.885
   Rona RJ, 2007, BRIT MED J, V335, P603, DOI 10.1136/bmj.39274.585752.BE
   Sarkar, 2011, ADV PSYCHIAT TREATME, V17, P435, DOI [10.1192/apt.bp.110.008045, DOI 10.1192/APT.BP.110.008045]
   Sarkar J, 2011, J FORENSIC PSYCHI PS, V22, P845, DOI 10.1080/14789949.2011.622407
   Scientific Advisory Group for Emergencies, 2020, INN LAT FLOW SARS CO
   Sheldon K., 2010, BRIT J FORENSIC PRAC, V12, P22, DOI [10.5042/bjfp.2010.0035, DOI 10.5042/BJFP.2010.0035]
   Snow L., 2002, BRIT J FORENSIC PRAC, V4, P18, DOI [10.1108/14636646200200023, DOI 10.1108/14636646200200023]
   Uppal G, 2009, CRIM BEHAV MENT HEAL, V19, P265, DOI 10.1002/cbm.741
   Wang H, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249454
   Wilson S, 2017, PSYCHOL BULL, V143, P677, DOI 10.1037/bul0000101
NR 30
TC 0
Z9 0
U1 3
U2 4
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2050-8794
EI 2050-8808
J9 J FORENSIC PRACT
JI J. Forensic Pract.
PD SEP 22
PY 2021
VL 23
IS 3
BP 230
EP 239
DI 10.1108/JFP-04-2021-0019
EA AUG 2021
PG 10
WC Criminology & Penology
WE Emerging Sources Citation Index (ESCI)
SC Criminology & Penology
GA US4YI
UT WOS:000683387400001
OA Bronze
DA 2022-04-20
ER

PT J
AU Tayyebi, H
   Hasanikhah, M
   Heidarikhoo, M
   Fakoor, S
   Aminian, A
AF Tayyebi, Hamed
   Hasanikhah, Masoud
   Heidarikhoo, Mohamadreza
   Fakoor, Sajad
   Aminian, Amir
TI Length of hospital stay and mortality of hip fracture surgery in
   patients with Coronavirus disease 2019 (COVID-19) infection: A
   systematic review and meta-analysis
SO CURRENT ORTHOPAEDIC PRACTICE
LA English
DT Review
DE COVID-19; hip fracture; surgery; mortality
ID EMERGENCY-SURGERY; 30-DAY MORTALITY; SURGICAL DELAY; OUTCOMES;
   MANAGEMENT; RISK; CARE; COMPLICATIONS
AB Background:
   Coronavirus disease 2019 (COVID-19) patients who undergo hip fracture surgery are expected to have worse outcomes because they are vulnerable to developing COVID-19-associated complications. The present review attempted to assess the in-hospital and 30-day mortality rates as well as the length of hospital stay in patients with COVID-19 infection who had hip fracture surgery.
   Methods:
   Two authors independently searched Google Scholar, PubMed, Web of Knowledge, SCOPUS, and Embase, based on the MeSH-matched scientific keywords. The nine-star Newcastle-Ottawa Scale (NOS) scoring system was employed to assess the methodological quality of all eligible studies.
   Results:
   Eleven cohort studies that included 336 patients comprised the study. Three studies reported in-hospital mortality. Eight studies reported 30-day postoperative mortality. The pooled in-hospital mortality rate was 29.8% (95% CI: 26.6%-35.6%). The pooled 30-day postoperative mortality rate was 35.0% (95% CI: 29.9%-40.5%). The mean hospital stay was 11.29 days (95% CI: 10.65 days-11.94 days).
   Conclusions:
   The rates of in-hospital and 30-day mortality in COVID-19 patients who undergo hip fracture surgery is high. These data suggest delaying hip fracture surgery until COVID-19 infection of the patients is controlled.
C1 [Tayyebi, Hamed; Hasanikhah, Masoud; Heidarikhoo, Mohamadreza; Fakoor, Sajad; Aminian, Amir] Iran Univ Med Sci, Sch Med, Shafa Orthoped Hosp, Bone & Joint Reconstruct Res Ctr, Tehran, Iran.
RP Aminian, A (corresponding author), Shafa Orthoped Hosp, Baharestan Sq, Tehran, Iran.
EM amir_aminian@yahoo.com
CR Belmont PJ, 2014, ARCH ORTHOP TRAUM SU, V134, P597, DOI 10.1007/s00402-014-1959-y
   Carretta E, 2011, INT ORTHOP, V35, P419, DOI 10.1007/s00264-010-1004-x
   Cheung ZB, 2020, J ORTHOP, V21, P291, DOI 10.1016/j.jor.2020.06.003
   Choi HJ, 2014, INDIAN J ORTHOP, V48, P599, DOI 10.4103/0019-5413.144232
   Coimbra R, 2020, EUR J TRAUMA EMERG S, V46, P505, DOI 10.1007/s00068-020-01364-7
   Daugaard CL, 2012, ACTA ORTHOP, V83, P609, DOI 10.3109/17453674.2012.747926
   De C, 2020, INDIAN J ORTHOP, V54, P386, DOI 10.1007/s43465-020-00272-7
   De Simone B, 2020, ANN ROY COLL SURG, V102, P323, DOI 10.1308/rcsann.2020.0097
   Egol KA, 2020, J ORTHOP TRAUMA, V34, P395, DOI 10.1097/BOT.0000000000001845
   Endo A, 2018, J ORTHOP TRAUMA, V32, P34, DOI 10.1097/BOT.0000000000001026
   Erickson BJ, 2015, ORTHOPEDICS, V38, pE593, DOI 10.3928/01477447-20150701-57
   Groff H, 2020, HIP INT, V30, P204, DOI 10.1177/1120700019835160
   Haddad FS, 2020, BONE JOINT J, V102B, P545, DOI 10.1302/0301-620X.102B5.BJJ-2020-0552
   Hall AJ, 2020, BONE JOINT J, V102B, P1219, DOI 10.1302/0301-620X.102B9.BJJ-2020-1100.R1
   Hormati A, 2020, ARCH IRAN MED, V23, P864, DOI 10.34172/aim.2020.115
   Hughson Jason, 2011, Hosp Pract (1995), V39, P52, DOI 10.3810/hp.2011.02.374
   Hung WW, 2012, JAMA-J AM MED ASSOC, V307, P2185, DOI 10.1001/jama.2012.4842
   Ireland AW, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0697-3
   Kayani B, 2020, BONE JOINT J, V102B, P1136, DOI 10.1302/0301-620X.102B9.BJJ-2020-1127.R1
   Konda SR, 2020, J ORTHOP TRAUMA, V34, pE317, DOI 10.1097/BOT.0000000000001895
   Lavikainen P, 2020, J GERONTOL A-BIOL, V75, P2184, DOI 10.1093/gerona/glaa199
   LeBrun DG, 2020, J ORTHOP TRAUMA, V34, P403, DOI 10.1097/BOT.0000000000001849
   Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006
   Lim Michael Anthonius, 2021, J Clin Orthop Trauma, V12, P187, DOI 10.1016/j.jcot.2020.09.015
   Lim Michael Anthonius, 2020, Can J Kidney Health Dis, V7, p2054358120938573, DOI 10.1177/2054358120938573
   Menendez ME, 2020, J SHOULDER ELB SURG, V29, P1083, DOI 10.1016/j.jse.2020.03.024
   Vives JMM, 2020, J BONE JOINT SURG AM, V102, DOI 10.2106/JBJS.20.00686
   Muse IO, 2020, J CLIN ANESTH, V67, DOI 10.1016/j.jclinane.2020.110017
   Narang A, 2021, INT ORTHOP, V45, P23, DOI 10.1007/s00264-020-04739-y
   Puche-Sanz I, 2020, ARCH ESP UROL, V73, P353
   Randau TM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238759
   Sadighi M, 2020, ARCH BONE JT SURG-AB, V8, P378, DOI 10.22038/abjs.2020.47899.2372
   Sanz-Reig J, 2018, CHIN J TRAUMATOL, V21, P163, DOI 10.1016/j.cjtee.2017.10.006
   Sarac NJ, 2020, J BONE JOINT SURG AM, V102, P942, DOI 10.2106/JBJS.20.00510
   Simunovic N, 2011, INDIAN J ORTHOP, V45, P27, DOI 10.4103/0019-5413.73660
   Tan STS, 2017, SINGAP MED J, V58, P253, DOI 10.11622/smedj.2016045
   Thakrar A, 2020, J ORTHOP TRAUMA, V34, pE325, DOI 10.1097/BOT.0000000000001889
   Tsang C, 2017, BONE JOINT RES, V6, P550, DOI 10.1302/2046-3758.69.BJR-2017-0020.R1
   Vaccaro AR, 2020, J AM ACAD ORTHOP SUR, V28, P464, DOI 10.5435/JAAOS-D-20-00379
   Van Waesberghe J, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0380-9
   Wells GA., 2000, NEWCASTLE OTTAWA SCA
   World Health Organization, 2020, EST MORT COVID 19 SC
   Yoo J, 2019, OSTEOPOROSIS INT, V30, P145, DOI 10.1007/s00198-018-4747-7
NR 43
TC 0
Z9 0
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1940-7041
EI 1941-7551
J9 CURR ORTHOP PRACT
JI Curr. Orthop. Pract.
PD MAR-APR
PY 2022
VL 33
IS 2
BP 172
EP 177
DI 10.1097/BCO.0000000000001087
PG 6
WC Orthopedics
WE Emerging Sources Citation Index (ESCI)
SC Orthopedics
GA ZH4WX
UT WOS:000760942400010
PM 35222789
OA Green Published
DA 2022-04-20
ER

PT J
AU Izna
   Kuntamukkula, VKS
   Khanna, SS
   Salokhe, O
   Tiwari, RVC
   Tiwari, H
AF Izna
   Kuntamukkula, Venkata Krishna Sasank
   Khanna, Shilpa Sunil
   Salokhe, Onkar
   Tiwari, Rahul Vinay Chandra
   Tiwari, Heena
TI Knowledge and Apprehension of Dental Health Professionals Pertaining to
   COVID in Southern India: A Questionnaire Study
SO JOURNAL OF PHARMACY AND BIOALLIED SCIENCES
LA English
DT Article
DE COVID-19; dentists; oral manifestations
ID MAXILLOFACIAL SURGERY; CONTAMINATION; AEROSOLS; SPLATTER; SARS
AB Aim: This study was intended to evaluate the knowledge and apprehension of dental health professionals pertaining to COVID-19. Materials and Methods: In this cross-sectional survey, a self-administered questionnaire survey was used to validate the dental health professional's knowledge and apprehension pertaining to COVID-19. In this regard, a preliminary study with a convenience sample of 124 dentists working in various clinics in southern India was conducted so as to evaluate the knowledge and apprehension of dentists related to COVID-19 in India. This study, while limited in sample size, benefits the general practitioners as target readers to assess the awareness pertaining to COVID-19. Results: The results of this study reveal that there exists a good knowledge among dental health professionals pertaining to the COVID-19 virus and its oral manifestations in addition to the precautions to be taken for the prevention of COVID-19 in a clinical setup. However, there exists an apprehension as well as lack of awareness pertaining to the laboratory test to be carried out in a patient suspected with COVID-19 infections as well as the role of a mouthwash and the management of contaminated air in the dental clinic. Conclusion: The results elicited that there is a dearth of knowledge and relatively a fair apprehension among dental health professionals pertaining to COVID-19.
C1 [Izna] Govt Med Coll & Associated Hosp, Dept Microbiol, Rajauri, Jammu & Kashmir, India.
   [Kuntamukkula, Venkata Krishna Sasank] Sri Sai Coll Dent Surg, Dept Oral & Maxillofacial Surg, Vikarabad, Telangana, India.
   [Khanna, Shilpa Sunil] Sri Ramakrishna Dent Coll & Hosp, Dept Oral & Maxillofacial Surg, Coimbatore, Tamil Nadu, India.
   [Salokhe, Onkar] Vasantdada Patil Dent Coll, Dept Orthodont & Dentofacial Orthopead, Sangli, Maharashtra, India.
   [Tiwari, Rahul Vinay Chandra] Sankalchand Patel Univ, Narsinbhai Patel Dent Coll & Hosp, Dept OMFS, Visnagar, Gujarat, India.
RP Izna (corresponding author), Govt Med Coll & Associated Hosp, Dept Microbiol, Rajauri, Jammu & Kashmir, India.
EM driznamb@gmail.com
RI Tiwari, Dr. Heena/ABA-1697-2021; TIWARI, RAHUL/ABA-1556-2021
OI Tiwari, Dr. Heena/0000-0001-8801-384X; TIWARI, RAHUL/0000-0003-4156-776X
CR Allevi F, 2020, BRIT J ORAL MAX SURG, V58, P692, DOI 10.1016/j.bjoms.2020.04.035
   Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4
   Barnes JB, 1998, J PERIODONTOL, V69, P434, DOI 10.1902/jop.1998.69.4.434
   Day M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1375
   Dutil S, 2009, J OCCUP ENVIRON HYG, V6, P121, DOI 10.1080/15459620802633957
   Givi B, 2020, JAMA OTOLARYNGOL, V146, P579, DOI 10.1001/jamaoto.2020.0780
   Harrel SK, 2004, J AM DENT ASSOC, V135, P429, DOI 10.14219/jada.archive.2004.0207
   Harrel SK, 1998, J AM DENT ASSOC, V129, P1241, DOI 10.14219/jada.archive.1998.0421
   Hu T, 2007, INFECT CONT HOSP EP, V28, P80, DOI 10.1086/510808
   Kirk-Bayley J, 2020, USE POVIDONE IODINE, DOI [10.2139/ssrn.3563092, DOI 10.2139/SSRN.3563092]
   Li RWK, 2004, BRIT DENT J, V197, P130, DOI 10.1038/sj.bdj.4811522
   Liu JY, 2020, EMERG INFECT DIS, V26, P1320, DOI 10.3201/eid2606.200239
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   Robb N D, 1996, Dent Update, V23, P182
   SAMARANAYAKE LP, 1989, J DENT CHILD, V56, P442
   Scully C, 2016, ORAL DIS, V22, P171, DOI 10.1111/odi.12356
   Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6
   Tanner R.S., 2007, MANUAL ENV MICROBIOL
   Wenzel RP, 2003, NEW ENGL J MED, V348, P1947, DOI 10.1056/NEJMp030072
   Whaites E., 1996, ESSENTIALS DENT RADI, V2nd, P107
   Zimmermann M, 2020, J CRANIO MAXILL SURG, V48, P521, DOI 10.1016/j.jcms.2020.03.011
NR 21
TC 0
Z9 0
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0975-7406
J9 J PHARM BIOALLIED SC
JI J. Pharm. Bioallied Sci.
PD JUN
PY 2021
VL 13
IS 5
SI SI
BP 448
EP 451
DI 10.4103/jpbs.JPBS_551_20
PG 4
WC Pharmacology & Pharmacy
WE Emerging Sources Citation Index (ESCI)
SC Pharmacology & Pharmacy
GA SU1FH
UT WOS:000662885700101
PM 34447131
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Soni, R
   Riyal, S
   Tomar, M
AF Soni, Radhika
   Riyal, Shubham
   Tomar, Manish
TI Concern, perceived risk and attitudes of the general public towards
   COVID-19: Special reference to Delhi-NCR
SO JOURNAL OF STATISTICS AND MANAGEMENT SYSTEMS
LA English
DT Article
DE Own practices; Personal risk; Insecurity; Fear; Knowledge; Attitude;
   Coronavirus; COVID-19
AB As the rising cases of the Coronavirus India has taken third place in the world. The pandemic is becoming difficult to cope with, it has become a regular problem in the world for any person. In fact, there is insufficient research into the effect of Coronavirus, on individuals and their own ways of coping up. Therefore, pandemic-related behavioural issues need a swift diagnosis. The paper's aim is to understand the concerns of the general public, perceived risks and attitudes towards the spread of COVID 19 and to understand the perception of the people in Delhi-NCR during the initial spread of the novel Coronavirus and to identify various factors which may be of concern. The study employed an Analysis of Covariance Structures to test the proposed framework by modelling the structure equation using AMOS and factor analysis using SPSS. The outcome of the study indicates that people are very much aware and have ample knowledge to combat the pandemic crisis. People are very much conscious and practice safety measures to keep them safe. This research is one of its kind, which was carried in the month of April when the pandemic just entered the country; it helped us to understand and measure various factors that are being adopted by the general public.
C1 [Soni, Radhika; Riyal, Shubham; Tomar, Manish] Guru Gobind Singh Indraprastha Univ, Rukmini Devi Inst Adv Studies, New Delhi 110078, India.
RP Soni, R (corresponding author), Guru Gobind Singh Indraprastha Univ, Rukmini Devi Inst Adv Studies, New Delhi 110078, India.
EM radhika.thapar@rdias.ac.in
CR Artiga S., 2020, COMMUNITIES COLOR HI
   Benson NM, 2020, LANCET PSYCHIAT, V7, P476, DOI 10.1016/S2215-0366(20)30198-X
   Bhatnagar V, 2021, J INTERDISCIP MATH, V24, P489, DOI 10.1080/09720502.2020.1761635
   Cabrini L, 2020, LANCET, V395, P685, DOI 10.1016/S0140-6736(20)30359-7
   Cousins S, 2020, LANCET, V395, P1474, DOI 10.1016/S0140-6736(20)31097-7
   Ferguson NM, 2020, REPORT 9 IMPACT NON
   Fore HH, 2020, LANCET GLOB HEALTH, V8, pE861, DOI 10.1016/S2214-109X(20)30238-2
   Gralinski LE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020135
   HELLEWELL J, 2020, LANCET GLOB HEALTH, DOI [DOI 10.1016/S2214-109X(20)30074-7, 10.1016/S2214-109X(20)30074-7]
   Kirby T, 2020, LANCET RESP MED, V8, P547, DOI 10.1016/S2213-2600(20)30228-9
   Kirissci M, 2020, J ANAL-INDIA, P1
   Kluge HHP, 2020, LANCET, V395, P1678, DOI 10.1016/S0140-6736(20)31067-9
   Menendez Clara, 2020, LANCET GLOBAL HLTH
   Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213
   Singh Vijendra, 2020, J DISCRETE MATH SCI
   Ustun G, 2021, INT J SOC PSYCHIATR, V67, P54, DOI 10.1177/0020764020938807
   WebMD LLC, 2020, LONG DOES COR LIV SU
   Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3
NR 18
TC 1
Z9 1
U1 1
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0972-0510
EI 2169-0014
J9 J STAT MANAG SYST
JI J. Stat. Manag. Syst.
PD FEB 17
PY 2021
VL 24
IS 2
SI SI
BP 229
EP 249
DI 10.1080/09720510.2020.1838063
EA DEC 2020
PG 21
WC Statistics & Probability
WE Emerging Sources Citation Index (ESCI)
SC Mathematics
GA RB6NU
UT WOS:000597047900001
OA Bronze
DA 2022-04-20
ER

PT J
AU Filep, S
   King, B
   McKercher, B
AF Filep, Sebastian
   King, Brian
   McKercher, Bob
TI Reflecting on tourism and COVID-19 research
SO TOURISM RECREATION RESEARCH
LA English
DT Article; Early Access
DE Tourism; COVID-19; pandemic; reflection; research knowledge
AB Reflection is a form of deep thinking that is evident in everyday lives - private and professional - and this article offers insights for key parties about reflecting on research outcomes to ensure enhanced tourism impacts post-pandemic. Using a hermeneutic perspective on reflection, the authors reflect on research outcomes since the pandemic began. Three types of reflection are deployed: anticipatory, active and recollective. While the ultimate effects of the pandemic remain uncertain, a scholarly rush to collect new data has been observed. Earlier research predictions seem unlikely to materialise. Taken collectively, the reflections suggest that researchers should slow down and allow for collection of more research data over extended time periods to generate stronger theoretical contributions. Scholars may apply anticipatory, active and recollective reflection to applicable research contexts. Documentation of the reflective process alerts practitioners to economic and social trends which may impact on global tourism post-pandemic.
C1 [Filep, Sebastian] Hong Kong Polytech Univ, Sch Hotel & Tourism Management, Hong Kong, Peoples R China.
   [King, Brian] Texas A&M Univ, Recreat Pk & Tourism Sci, College Stn, TX 77843 USA.
   [McKercher, Bob] Univ Queensland, Business Sch, Brisbane, Qld, Australia.
RP Filep, S (corresponding author), Hong Kong Polytech Univ, Sch Hotel & Tourism Management, Hong Kong, Peoples R China.
EM sebastian.filep@polyu.edu.hk
RI King, Brian Edward Melville/E-7201-2014
OI King, Brian Edward Melville/0000-0002-5300-5564; McKercher,
   Robert/0000-0001-7451-1266
CR Brodeur A, 2021, J PUBLIC ECON, V193, DOI 10.1016/j.jpubeco.2020.104346
   Brouder P, 2020, TOURISM GEOGR, V22, P484, DOI 10.1080/14616688.2020.1760928
   Davis J, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-511
   Deery Chris, 2020, Evid Based Dent, V21, P46, DOI 10.1038/s41432-020-0089-3
   Dewey John, 1916, DEMOCRACY ED
   Donthu N, 2021, J BUS RES, V133, P285, DOI 10.1016/j.jbusres.2021.04.070
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Hall CM, 2020, TOURISM GEOGR, V22, P577, DOI 10.1080/14616688.2020.1759131
   Haux T, 2020, RUSH RES COVID 19 RI
   Hemmerdinger J, 2021, FLIGHT GLOBAL STRATE
   Josephs L., 2021, CNBC
   Lew AA, 2020, TOURISM GEOGR, V22, P455, DOI 10.1080/14616688.2020.1770326
   Lim WM, 2022, CURR ISSUES TOUR, V25, P1258, DOI 10.1080/13683500.2021.1910218
   Lim WM, 2021, TOUR RECREAT RES, V46, P314, DOI 10.1080/02508281.2021.1881708
   Lim WM, 2021, J STRATEG MARK, DOI 10.1080/0965254X.2021.1890190
   McColl-Kennedy JR, 2017, J SERV MANAGE, V28, P2, DOI 10.1108/JOSM-01-2016-0018
   McKercher B., 2005, Journal of Travel & Tourism Marketing, V19, P107, DOI 10.1300/J073v19n02_09
   Moran Dermot, 2000, INTRO PHENOMENOLOGY
   Mortari L, 2015, INT J QUAL METH, V14, DOI 10.1177/1609406915618045
   Paul J, 2021, INT J CONSUM STUD, DOI 10.1111/ijcs.12695
   Pearson J, 1985, DISCOURSE TRUTH PROB
   Salinas M.S, 2021, INT MONETARY FUND DE
   Schon D.A., 1983, REFLECTIVE PRACTITIO
   Snyder H, 2019, J BUS RES, V104, P333, DOI 10.1016/j.jbusres.2019.07.039
   Stankov U, 2020, TOURISM GEOGR, V22, P703, DOI 10.1080/14616688.2020.1768432
   Taylor I., 2020, TRAVEL WEEKLY
   Torraco R.J., 2005, HUMAN RESOURCE DEV R, V4, P356, DOI [https://doi.org/10.1177/1534484305278283, DOI 10.1177/1534484305278283, 10.1177/1534484305278283]
   UNWTO (United Nations World Tourism Organization), 2021, UNWTO WORLD TOUR BAR, V19, DOI 10.18111/wtobarometereng.2021.19.1.2
   Van Mannen M., 1991, TACT TEACHING
   Xinhua, 2021, CHIN SEE INCR DOM TO
NR 30
TC 0
Z9 0
U1 5
U2 5
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0250-8281
EI 2320-0308
J9 TOUR RECREAT RES
JI Tour. Recreat. Res.
DI 10.1080/02508281.2021.2023839
EA JAN 2022
PG 5
WC Hospitality, Leisure, Sport & Tourism
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA YJ1LI
UT WOS:000744298700001
OA hybrid
DA 2022-04-20
ER

PT J
AU Nemat, A
   Raufi, N
   Sediqi, MF
   Rasib, AR
   Asady, A
AF Nemat, Arash
   Raufi, Nahid
   Sediqi, Mohammad Faiq
   Rasib, Aziz Rahman
   Asady, Abdullah
TI Knowledge, Attitudes, and Practices of Medical Students Regarding
   COVID-19 in Afghanistan: A Cross-Sectional Study
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE SARS-COV2; pandemic; surveys and questionnaires; public health
AB Background: The coronavirus pandemic has had devastating effects on many nations, including Afghanistan. Public awareness and following recommendations play an important part in managing such a large-scale crisis, which are affected largely by knowledge, attitudes, and practices (KAP). Medical students can act as reliable sources of information for the public in such a scenario. This study aimed to investigate KAP of medical students regarding COVID-19.
   Methods: A cross-sectional online survey was conducted in October 2020 among medical students in Afghanistan, Kabul University of Medical Sciences. Information on sociodemographics and KAP, was collected using a web-based questionnaire.
   Results: A total of 1,169 medical students completed the survey. More than half were female (54.6%), a majority (95%) aged >= 20 years, and more than half (56.2%) lived in the city of Kabul. Overall, students had acceptable KAP regarding COVID-19, except for a few undesirable responses with regard to the risks of close contact with COVID-19 patients, incubation periods, and groups vulnerable to COVID-19.
   Conclusion: Overall, the students had acceptable KAP regarding COVID-19, except for the few undesired aforementioned responses, which need more focus during awareness campaigns in future.
C1 [Nemat, Arash; Asady, Abdullah] Kabul Univ Med Sci, Dept Microbiol, Jamaal Mina 1001, Kabul, Afghanistan.
   [Nemat, Arash] Southern Med Univ, Nanfang Hosp, Dept Cardiol, Guangzhou, Peoples R China.
   [Raufi, Nahid] Kabul Univ Med Sci, Dept Dermatol, Kabul, Afghanistan.
   [Raufi, Nahid] Southern Med Univ, Guangdong Prov Dermatol Hosp, Dept Dermatol, Guangzhou, Peoples R China.
   [Sediqi, Mohammad Faiq] Kabul Univ Med Sci, Dept Histol, Kabul, Afghanistan.
   [Rasib, Aziz Rahman] Kabul Univ Med Sci, Dept Neuropsychiat, Kabul, Afghanistan.
RP Nemat, A (corresponding author), Kabul Univ Med Sci, Dept Microbiol, Jamaal Mina 1001, Kabul, Afghanistan.
EM dr.arashnemat@yahoo.com
RI Nemat, Arash/ABC-7219-2021; Asady, Abdullah/AAX-5132-2021
OI Nemat, Arash/0000-0002-7044-5473; Asady, Abdullah/0000-0001-9775-739X
CR Abou-Abbas L, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09585-6
   Acerra JR, 2009, INT J EMERG MED, V2, P77, DOI 10.1007/s12245-009-0106-y
   Alhazmi A, 2020, J PUBLIC HEALTH RES, V9, P345, DOI 10.4081/jphr.2020.1867
   Chakraborty I, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138882
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   GARDA World, 2020, AFGH AUTH EXT COVID
   Gohel KH, 2021, CLIN EPIDEMIOL GLOB, V9, P104, DOI 10.1016/j.cegh.2020.07.008
   Gostin LO, 2020, JAMA-J AM MED ASSOC, V323, P2137, DOI 10.1001/jama.2020.5460
   Hasan H, 2020, AM J TROP MED HYG
   Husseini AA, 2020, ERCIYES MED J, V42, P468, DOI 10.14744/etd.2020.80270
   Mayer J, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01020
   Ministry of Public Health, 2020, COVID 19 PANDEMIC GU
   Mousavi SH, 2020, LANCET INFECT DIS, V20, P657, DOI 10.1016/S1473-3099(20)30231-0
   Mustafa Ruba M, 2020, Eur J Dent, V14, pS50, DOI 10.1055/s-0040-1719212
   Nemat A, 2021, AM J TROP MED HYG, V104, P537, DOI 10.4269/ajtmh.20-1367
   Noreen K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243696
   Olaimat AN, 2020, AM J TROP MED HYG, V103, P1177, DOI 10.4269/ajtmh.20-0418
   Olaimat AN, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00254
   Orcutt BN, 2020, DEEP CARBON: PAST TO PRESENT, P1
   Rubin EJ, 2020, SARS COV 2 VACCINATI
   Salman M, 2020, DRUGS THER PERSPECT, V36, P319, DOI 10.1007/s40267-020-00737-7
   Shah J, 2020, LANCET GLOB HEALTH, V8, pE771, DOI 10.1016/S2214-109X(20)30124-8
   Shanmugaraj B, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9070842
   Sohrabi C, 2020, INT J SURG
   WHO, 2021, **NON-TRADITIONAL**
   World Health Organisation W, 2020, COR DIS COVID 19 ADV
   World Health Organization, 2020, LAB TEST COR DIS 201
   World Health Organization, 2021, AFGH CURR COVID 19 S
   Yuan T, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.925877
NR 29
TC 4
Z9 4
U1 5
U2 6
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 1491
EP 1497
DI 10.2147/RMHP.S308039
PG 7
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA RN4KD
UT WOS:000640319500001
PM 33883955
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Le, TT
   Nguyen, VK
AF Thanh Tiep Le
   Van Kha Nguyen
TI Effects of quick response to COVID-19 with change in corporate
   governance principles on SMEs' business continuity: evidence in Vietnam
SO CORPORATE GOVERNANCE-THE INTERNATIONAL JOURNAL OF BUSINESS IN SOCIETY
LA English
DT Article; Early Access
DE Business continuity; Emerging markets; Corporate governance principles;
   COVID-19
ID MODELS; CRISIS; IMPACT; RESILIENCE; MANAGEMENT; DISCLOSURE
AB Purpose The purpose of this paper is to evaluate the negative impacts of the Coronavirus Disease-2019 (COVID-19) emergency on small- and medium-sized enterprises' (SMEs) business continuity (BC) by examining the moderating role of corporate governance principles (CGP) on SMEs' BC in the context of an emerging market. Design/methodology/approach Based on an extended literature review on the negative impacts of the COVID-19 emergency, CGP and BC studies, the authors evaluate the impact of these constructs on SMEs' BC in an emerging market. This paper follows a quantitative approach. The study sample was composed of 334 responses covering directors, managers and owners of enterprises. The Smart PLS SEM version 3.3.2 was used to analyse the data from SMEs of Vietnam in the year 2021. Findings The findings of this study clarify the areas of the COVID-19 consequences that negatively affect the BC. In addition, this study reveals that CGP moderates the links between COVID-19 outcomes and BC, whereby good CGP can facilitate a business to reduce the adverse effects of COVID-19 on BC. In addition to this, good CGP can help a firm to enhance its capability to respond to fluctuations in the external environment of the business. Originality/value To the best of the authors' knowledge, this is the first research that examines the moderating role of CGP. The originality of this study is that it gives an insight into how SMEs in an emerging economy overcome the adverse effects of the COVID-19 emergency on BC to keep their business going, and moreover, have the ability to move towards sustainability in today's challenging context. This study provides the theoretical and managerial implications that may be of great interest to the academics, business practitioners and policymakers.
C1 [Thanh Tiep Le] Ho Chi Minh City Univ Econ & Finance, Ho Chi Minh City, Vietnam.
   [Van Kha Nguyen] HCMC Univ Food Ind, Ho Chi Minh City, Vietnam.
RP Le, TT (corresponding author), Ho Chi Minh City Univ Econ & Finance, Ho Chi Minh City, Vietnam.
EM tieplt@uef.edu.vn
CR Abdullah RG, 2021, INT J BUS SOC, V22, P1, DOI 10.33736/ijbs.3159.2021
   Achim MV, 2021, INT J BUS SOC, V22, P546, DOI 10.33736/ijbs.3734.2021
   Adedeji BS, 2020, CORP GOV-INT J BUS S, V20, P401, DOI 10.1108/CG-09-2019-0291
   Adian I., 2020, POLICY RES WORKING P
   Ahsan T, 2021, CORP GOV-INT J BUS S, V21, P78, DOI 10.1108/CG-04-2020-0121
   Al Maqatari FA, 2020, COGENT BUS MANAG, V7, DOI 10.1080/23311975.2020.1797261
   Al-Fadly A, 2020, ENTREP SUSTAIN ISS, V8, P629, DOI 10.9770/jesi.2020.8.2(38)
   ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411
   Aslam E, 2021, CORP GOV-INT J BUS S, V21, P111, DOI 10.1108/CG-08-2020-0312
   Badea, 2021, LAND FORCES ACAD REV, V26, P62
   Baicu CG, 2020, MANAG MARK, V15, P534, DOI 10.2478/mmcks-2020-0031
   Barclay D., 1995, TECHNOLOGY STUDIES, V2, P285, DOI DOI 10.1017/CBO9781107415324.004
   Brandas C, 2013, PROCD SOC BEHV, V73, P744, DOI 10.1016/j.sbspro.2013.02.113
   Chakraborty I, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138882
   Cheval S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114140
   Chin W.W., 2010, HDB PARTIAL LEAST SQ, P655, DOI DOI 10.1007/978-3-540-32827-8_29
   Chin WW, 1998, QUANT METH SER, P295
   Coombs W.T., 2015, ONGOING CRISIS COMMU, V4th
   Coombs WT, 2018, J INT MANAG, V24, P199, DOI 10.1016/j.intman.2017.12.003
   Diamantopoulos A, 2006, BRIT J MANAGE, V17, P263, DOI 10.1111/j.1467-8551.2006.00500.x
   Duttagupta S, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18062832
   Fabeil N.F., 2020, J ECON BUS, V3, P837, DOI [10.31014/aior.1992.03.02.241, DOI 10.31014/AIOR.1992.03.02.241]
   Farooq M.S., 2017, 6 INT C EMPL ED ENTR
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Gregurec I, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13031098
   Hair J.F., 2010, MULTIVARIATE DATA AN, V7th
   Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202
   Heath J, 2004, J BUS ETHICS, V53, P247, DOI 10.1023/B:BUSI.0000039418.75103.ed
   Heikkila M, 2018, J SMALL BUS ENTERP D, V25, P107, DOI 10.1108/JSBED-03-2017-0097
   Henseler J, 2016, IND MANAGE DATA SYST, V116, P2, DOI 10.1108/IMDS-09-2015-0382
   Henseler J, 2009, ADV INT MARKETING, V20, P277, DOI 10.1108/S1474-7979(2009)0000020014
   Hoekstra JC., 2020, ITALIAN J MARKETING, V4, P249, DOI [10.1007/s43039-020-00016-3, DOI 10.1007/S43039-020-00016-3]
   International Finance Corporation, 2009, SME BANK KNOWL GUID
   Janang JS, 2020, INT J BUS SOC, V21, P660
   Jo H, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13010136
   Kabwe M, 2021, CORP GOV-INT J BUS S, V21, P1, DOI 10.1108/CG-03-2020-0103
   Khan N., 2021, PURE APPL BIOL, V10, P62, DOI [10.19045/bsoab.2021.100008, DOI 10.19045/BSOAB.2021.100008]
   Kock N, 2015, INT J E-COLLAB, V11, P1, DOI 10.4018/ijec.2015100101
   Koutoupis A, 2021, CORP GOV-INT J BUS S, V21, P969, DOI 10.1108/CG-10-2020-0447
   Laufer D, 2015, BUS HORIZONS, V58, P137, DOI 10.1016/j.bushor.2014.10.002
   Lee KYM, 2020, INT J BUS SOC, V21, P607
   Margherita A, 2021, BUS HORIZONS, V64, P683, DOI 10.1016/j.bushor.2021.02.020
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Niemimaa M, 2019, INT J INFORM MANAGE, V49, P208, DOI 10.1016/j.ijinfomgt.2019.04.010
   Nueangnong V, 2020, COGENT SOC SCI, V6, DOI 10.1080/23311886.2020.1818936
   OECD, 2021, SME ENTR POL VIET NA, DOI [10.1787/30c79519-en, DOI 10.1787/30C79519-EN]
   Parker H, 2018, J BUS RES, V88, P535, DOI 10.1016/j.jbusres.2017.12.022
   Power K., 2020, Sustainability: Science, Practice & Policy, V17, P67, DOI 10.1080/15487733.2020.1776561
   Qin XL, 2021, OPER MANAGE RES, DOI 10.1007/s12063-020-00177-6
   Rehman A, 2021, CORP GOV-INT J BUS S, V21, P212, DOI 10.1108/CG-06-2020-0269
   Rehman A, 2020, CORP GOV-INT J BUS S, V20, P601, DOI 10.1108/CG-07-2019-0220
   Sadiq R, 2020, INT J BUS SOC, V21, P1
   Sarstedt M., 2016, PRIMER PARTIAL LEAST
   Schatter F, 2019, DECIS SUPPORT SYST, V118, P10, DOI 10.1016/j.dss.2018.12.006
   Shahar NA, 2020, J ISLAMIC ACCOUNT BU, V11, P845, DOI 10.1108/JIABR-05-2016-0057
   Smith HJ, 2003, MIT SLOAN MANAGE REV, V44, P85
   Solikhah B, 2021, COGENT BUS MANAG, V8, DOI 10.1080/23311975.2021.1876543
   Souchon AL, 2012, INT MARKET REV, V29, P175, DOI 10.1108/02651331211216970
   Susi V, 2020, CORP GOV-INT J BUS S, V20, P703, DOI 10.1108/CG-11-2019-0348
   Tuan V. K., 2020, J BUSINESS MANAGEMEN, V4, P169
   Usman B, 2020, INT J BUS SOC, V21, P521
   Wang Y, 2019, CORP GOV-INT J BUS S, V20, P158, DOI 10.1108/CG-07-2018-0244
   Wetzels M, 2009, MIS QUART, V33, P177, DOI 10.2307/20650284
   Wong Wei Ning Zechariah, 2009, J Bus Contin Emer Plan, V4, P62
   Yang ZL, 2015, BUS HORIZONS, V58, P193, DOI 10.1016/j.bushor.2014.11.003
   Zhou XY, 2017, SAFETY SCI, V91, P93, DOI 10.1016/j.ssci.2016.06.014
NR 66
TC 0
Z9 0
U1 2
U2 2
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1472-0701
EI 1758-6054
J9 CORP GOV-INT J BUS S
JI Corp. Gov.-Int. J. Bus. Soc.
DI 10.1108/CG-09-2021-0334
EA FEB 2022
PG 21
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA YT6KO
UT WOS:000751466500001
DA 2022-04-20
ER

PT J
AU Abate, HK
   Mekonnen, CK
   Ferede, YM
AF Abate, Hailemichael Kindie
   Mekonnen, Chilot Kassa
   Ferede, Yohannes Mulu
TI Depression Among HIV-Positive Pregnant Women at Northwest Amhara
   Referral Hospitals During COVID-19 Pandemic
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19; depression; prevalence; HIV positive mothers; pregnancy;
   referral hospitals; Ethiopia
ID ANXIETY SYMPTOMS; RISK-FACTORS; STRATEGIES; INFECTION; AFRICAN
AB Background: Depression is the most common mental health disorder among HIV-positive pregnant mothers, which increases mortality, poor quality of life; it also increases the burden of disease. Depression hurts birth outcomes and maternal health. Objective: To assess depression and its associated factors among HIV-positive pregnant women attending antenatal care at Northwest Amhara referral hospitals, 2021. Methods: An institution-based cross-sectional study was conducted among 291 HIVpositive pregnant mothers from March 15, 2021 to April 30, 2021 at Northwest Amhara referral hospitals. Census was applied to reach the study participants. An intervieweradministered questionnaire was used for data collection. A binary logistic regression was conducted to see the relationship between dependent variables and independent. Those variables having a p-value of <= 0.05 were found to be statistically associated with the response. Results: Depression among HIV-positive pregnant women was found to be 28.7% [95% CI (24.8-33.40)] with a response rate of 96.04. Age >= 30 years [AOR = 1.32, 95% CI (1.24- 3.35)], urban residency [AOR = 1.76, 95% CI (1.57-4.61)], having first pregnancy <18 years [AOR = 3.82, 95% CI (1.54-17.34)], known HIV serostatus during pregnancy [AOR = 1.29, 95% CI (1.08-2.47)], and COVID-19-related knowledge [AOR = 0.32, 95% CI (0.12-1.12) were significantly associated with depression. Conclusions and Recommendations: Nearly one-third of the pregnant women attending antenatal care were depressed. The age of the mother, residence, known HIV serostatus during pregnancy, age in the first pregnancy, and COVID-19-related knowledge were significantly associated with depression, and strengthening the existing care provided was the recalled interventions to combat antenatal depression during the COVID-19 pandemic.
C1 [Abate, Hailemichael Kindie; Mekonnen, Chilot Kassa; Ferede, Yohannes Mulu] Univ Gondar, Dept Med Nursing, Gondar, Ethiopia.
RP Abate, HK (corresponding author), Univ Gondar, Dept Med Nursing, Gondar, Ethiopia.
EM haile206k@gmail.com
OI mekonnen, chilot/0000-0002-8452-7445
FU University of Gondar College of Medicine and Health Sciences
FX The study was funded by the University of Gondar College of Medicine and
   Health Sciences. However, the funders have no significant role to play
   in the study design, data collection, analysis, and manuscript
   preparation.
CR Ahmed T, 2012, ANN NUTR METAB, V61, P8, DOI 10.1159/000345165
   Allotey J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3320
   Bitew T, 2014, ETHIOP J HEALTH SCI, V24, P162, DOI 10.4314/ejhs.v24i2.9
   Blaney NT, 2004, AIDS PATIENT CARE ST, V18, P405, DOI 10.1089/1087291041518201
   Bonacquisti A, 2014, AIDS CARE, V26, P100, DOI 10.1080/09540121.2013.802277
   Brooks SK, 2020, PUBLIC HEALTH, V189, P26, DOI 10.1016/j.puhe.2020.09.006
   Ceulemans M, 2021, ACTA OBSTET GYN SCAN, V100, P1219, DOI 10.1111/aogs.14092
   Dow A, 2014, JAIDS-J ACQ IMM DEF, V65, P359, DOI 10.1097/QAI.0000000000000050
   Ettman CK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19686
   Favre G, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100160
   Gelaye B, 2013, PSYCHIAT RES, V210, P653, DOI 10.1016/j.psychres.2013.07.015
   Getinet Wondale, 2018, Depress Res Treat, V2018, P3649269, DOI 10.1155/2018/3649269
   Glover V, 2014, BEST PRACT RES CL OB, V28, P25, DOI 10.1016/j.bpobgyn.2013.08.017
   Gol, 2020, HEALTH-LONDON, V3, P4
   Grigoriadis S, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.17r12011
   Hamzehgardeshi Z, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-021-03694-9
   Ho CSH, 2020, ANN ACAD MED SINGAP, V49, P155
   Islam MS, 2020, INFECT CONT HOSP EP, V41, P1196, DOI 10.1017/ice.2020.237
   Jelly P, 2021, CUREUS J MED SCIENCE, V13, DOI 10.7759/cureus.12875
   Kassa AM, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-044202
   Kim MH, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18965
   Lebel C, 2020, J AFFECT DISORDERS, V277, P5, DOI 10.1016/j.jad.2020.07.126
   Logie C, 2013, AIDS PATIENT CARE ST, V27, P114, DOI 10.1089/apc.2012.0296
   Martini J, 2015, J AFFECT DISORDERS, V175, P385, DOI 10.1016/j.jad.2015.01.012
   Nakamura Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74088-8
   Nath S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023766
   Nigussie TF, 2020, GLOB SCI J, V8, P1283
   Nwafor JI, 2021, MALAWI MED J, V33, P54, DOI [10.4314/mmj.v33i1.8, 10.4314/mmj.v33/1.8]
   Poudel K, 2020, INT J SOC PSYCHIATR, V66, P748, DOI 10.1177/0020764020942247
   Racine N, 2021, LANCET PSYCHIAT, V8, P405, DOI 10.1016/S2215-0366(21)00074-2
   Rochat TJ, 2013, ARCH WOMEN MENT HLTH, V16, P401, DOI 10.1007/s00737-013-0353-z
   Rochat TJ, 2006, JAMA-J AM MED ASSOC, V295, P1376, DOI 10.1001/jama.295.12.1376
   Sasaki TK, 2013, SE ASIAN J TROP MED, V44, P388
   Sharma R, 2020, INT J COMMUNITY MED, V7, P4648
   Simunic, 2020, FRONT PSYCHOL, V11, P817, DOI [10.3389/ fpsyg.2020.00011, DOI 10.3389/FPSYG.2020.00011]
   Sinesi A, 2019, BJPSYCH OPEN, V5, DOI 10.1192/bjo.2018.75
   Soto-Balbuena C, 2018, PSICOTHEMA, V30, P257, DOI 10.7334/psicothema2017.379
   Tomfohr-Madsen LM, 2021, PSYCHIAT RES, V300, DOI 10.1016/j.psychres.2021.113912
   van den Beld AW, 2018, LANCET DIABETES ENDO, V6, P647, DOI 10.1016/S2213-8587(18)30026-3
   Wang C., 2020, APPL PSYCHOL-HLTH WE, V17, P1729, DOI [10.3390/ijerph17051729, DOI 10.3390/IJERPH17051729]
   Westgren M, 2020, ACTA OBSTET GYN SCAN, V99, P815, DOI 10.1111/aogs.13900
   Wong SSH, 2021, PSYCHOL MUSIC, V49, P1027, DOI 10.1177/0305735620922595
NR 42
TC 0
Z9 0
U1 1
U2 1
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 4897
EP 4905
DI 10.2147/RMHP.S320311
PG 9
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA XO5LN
UT WOS:000730226900003
PM 34908887
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Campus, G
   Diaz-Betancourt, M
   Cagetti, MG
   Carvalho, JC
   Carvalho, TS
   Cortes-Martinicorena, JF
   Deschner, J
   Douglas, GVA
   Giacaman, RA
   Machiulskiene, V
   Manton, DJ
   Raggio, DP
   Ramos-Gomez, F
   Sava-Rosianu, R
   Morozova, NS
   Spagnuolo, G
   Vukovic, A
   Wolf, TG
AF Campus, Guglielmo
   Diaz-Betancourt, Marcela
   Cagetti, Maria Grazia
   Carvalho, Joana C.
   Carvalho, Thiago S.
   Cortes-Martinicorena, Javier F.
   Deschner, James
   Douglas, Gail V. A.
   Giacaman, Rodrigo A.
   Machiulskiene, Vita
   Manton, David J.
   Raggio, Daniela P.
   Ramos-Gomez, Francisco
   Sava-Rosianu, Ruxandra
   Morozova, Natalia S.
   Spagnuolo, Gianrico
   Vukovic, Ana
   Wolf, Thomas G.
CA COVIDent Collaboration Grp
TI Study Protocol for an Online Questionnaire Survey on Symptoms/Signs,
   Protective Measures, Level of Awareness and Perception Regarding
   COVID-19 Outbreak among Dentists. A Global Survey
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; infection; dentist; protective measures; awareness; infection
   control
AB The Centres for Disease Control and Prevention and the World Health Organization have developed preparedness and prevention checklists for healthcare professionals regarding the containment of COVID-19. The aim of the present protocol is to evaluate the impact of the COVID-19 outbreak among dentists in different countries where various prevalence of the epidemic has been reported. Several research groups around the world were contacted by the central management team. The online anonymous survey will be conducted on a convenience sample of dentists working both in national health systems and in private or public clinics. In each country/area, a high (similar to 5-20%) proportion of dentists working there will be invited to participate. The questionnaire, developed and standardized previously in Italy, has four domains: (1) personal data; (2) symptoms/signs relative to COVID-19; (3) working conditions and PPE (personal protective equipment) adopted after the infection's outbreak; (4) knowledge and self-perceived risk of infection. The methodology of this international survey will include translation, pilot testing, and semantic adjustment of the questionnaire. The data will be entered on an Excel spreadsheet and quality checked. Completely anonymous data analyses will be performed by the central management team. This survey will give an insight into the dental profession during COVID-19 pandemic globally.
C1 [Campus, Guglielmo; Diaz-Betancourt, Marcela; Carvalho, Thiago S.; Wolf, Thomas G.] Univ Bern, Dept Restorat Prevent & Paediat Dent, Freiburgstr 7, CH-3012 Bern, Switzerland.
   [Campus, Guglielmo] Univ Sassari, Sch Dent, Dept Surg Microsurg & Med Sci, Viale San Pietro, I-07100 Sassari, Italy.
   [Cagetti, Maria Grazia] Univ Milan, Dept Biomed Surg & Dent Sci, Via Beldiletto 1, I-20142 Milan, Italy.
   [Carvalho, Joana C.] UCLouvain, Fac Med & Dent, B-1200 Brussels, Belgium.
   [Deschner, James; Wolf, Thomas G.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Periodontol & Operat Dent, D-55116 Mainz, Germany.
   [Douglas, Gail V. A.] Univ Leeds, Sch Dent, Dept Dent Publ Hlth, Leeds LS2 9JT, W Yorkshire, England.
   [Giacaman, Rodrigo A.] Univ Talca, Fac Hlth Sci, Dept Oral Rehabil, Cariol Unit, Talca 3460000, Chile.
   [Giacaman, Rodrigo A.] Univ Talca, Fac Hlth Sci, Dept Oral Rehabil, Gerodontol Unit, Talca 3460000, Chile.
   [Machiulskiene, Vita] Lithuanian Univ Hlth Sci, Fac Odontol, Clin Dent & Oral Pathol, LT-44131 Kaunas, Lithuania.
   [Manton, David J.] Univ Groningen, UMCG, Ctr Tandheelkunde Mondzorgkunde, Paediat Dent, NL-97009747 Groningen, Netherlands.
   [Raggio, Daniela P.] Univ Sao Paulo, Sch Dent, Dept Orthodont & Pediat Dent, BR-05508060 Sao Paulo, Brazil.
   [Ramos-Gomez, Francisco] Univ Calif Los Angeles, Sch Dent, UCLA Ctr Childrens Oral Hlth, Los Angeles, CA 90095 USA.
   [Sava-Rosianu, Ruxandra] Univ Med & Pharm Victor Babes Timisoara, Fac Dent, Dept Prevent Community Dent & Oral Hlth, Timisoara 300363, Romania.
   [Morozova, Natalia S.; Spagnuolo, Gianrico] Sechenov Univ, Inst Dent, Moscow 3200900, Russia.
   [Spagnuolo, Gianrico] Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Via Pansini 5, I-80131 Naples, Italy.
   [Vukovic, Ana] Univ Belgrade, Sch Dent Med, Dept Pediat & Prevent Dent, Belgrade 11000, Serbia.
   [Cortes-Martinicorena, Javier F.] Univ Barcelona, Prevent & Community Dent Unit, Barcelona 08193, Spain.
RP Campus, G (corresponding author), Univ Bern, Dept Restorat Prevent & Paediat Dent, Freiburgstr 7, CH-3012 Bern, Switzerland.; Campus, G (corresponding author), Univ Sassari, Sch Dent, Dept Surg Microsurg & Med Sci, Viale San Pietro, I-07100 Sassari, Italy.
EM guglielmo.campus@zmk.unibe.ch; marcela.betancourt@zmk.unibe.ch;
   maria.cagetti@unimi.it; joana.carvalho@uclouvain.be;
   thiago.saads@zmk.unibe.ch; javiercortes@dentalcortes.es;
   James.deschner@uni-mainz.de; g.v.a.douglas@leeds.ac.uk;
   giacaman@utalca.cl; Vita.Maciulskiene@lsmuni.lt; d.j.manton@umcg.nl;
   danielar@usp.br; frg@dentistry.ucla.edu; savarosianu@yahoo.com;
   kns74@bk.ru; gianrico.spagnuolo@gmail.com; ana.vukovic@stomf.bg.ac.rs;
   thomas.wolf@zmk.unibe.ch
RI Cagetti, Maria Grazia/AAD-1507-2021; Carvalho, Thiago Saads/B-8945-2012;
   Morozova, Natalia/ABA-4006-2021; Spagnuolo, Gianrico/N-5110-2015;
   Manton, David John/H-9141-2019; Serban, Stefan/T-9174-2019; John,
   Jacob/ABD-7448-2020; John, Jacob/B-8683-2010; Ramos-Gomez,
   Francisco/ABF-4255-2021; Raggio, Daniela/B-9411-2012; DESCHNER,
   JAMES/AAW-3998-2021; Mani, Shani Ann/B-5113-2011; Giacaman, Rodrigo
   A./A-9811-2010
OI Carvalho, Thiago Saads/0000-0002-2435-1169; Morozova,
   Natalia/0000-0002-6453-1615; Spagnuolo, Gianrico/0000-0003-3769-9786;
   Manton, David John/0000-0002-4570-0620; Serban,
   Stefan/0000-0001-7911-688X; John, Jacob/0000-0001-8452-0676;
   Ramos-Gomez, Francisco/0000-0002-4961-2150; Raggio,
   Daniela/0000-0002-0048-2068; Mani, Shani Ann/0000-0001-5766-1887; Abou
   El Fadl, Reham/0000-0001-6222-3021; Giacaman, Rodrigo
   A./0000-0003-3362-5173; Diaz-Betancourt, Marcela/0000-0001-5796-5039;
   Elwishahy, Abdelrahman/0000-0002-1757-5447; Wolf, Thomas
   Gerhard/0000-0002-4044-1893; bustillos, Lorena/0000-0002-6886-5129
CR Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283
   Cagetti MG, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113835
   Centers for Disease Control and Prevention, GUID DENT SETT INT I
   Centers for Disease Control and Prevention (CDC), HEALTHC PERS PREP CH
   Chen Xuyu, 2020, Int J Environ Res Public Health, V17, DOI 10.3390/ijerph17082893
   Hodge J.G. Jr, EMERGENCY LEGAL PREP
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   Spagnuolo G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062094
   Stehr-Green P.A., 2003, FOCUS FIELD EPIDEMIO, V2, P1
   Szymanska J, 2007, ANN AGR ENV MED, V14, P203
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Volgenant C M C, 2018, Curr Oral Health Rep, V5, P221, DOI 10.1007/s40496-018-0201-3
   World Health Organization (WHO), COR DIS COVID 2019 A
   Zemouri C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178007
NR 15
TC 18
Z9 19
U1 1
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD AUG
PY 2020
VL 17
IS 15
AR 5598
DI 10.3390/ijerph17155598
PG 8
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA NL9FT
UT WOS:000567713600001
PM 32756475
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Mowbray, NG
   Ansell, J
   Horwood, J
   Cornish, J
   Rizkallah, P
   Parker, A
   Wall, P
   Spinelli, A
   Torkington, J
AF Mowbray, N. G.
   Ansell, J.
   Horwood, J.
   Cornish, J.
   Rizkallah, P.
   Parker, A.
   Wall, P.
   Spinelli, A.
   Torkington, J.
TI Safe management of surgical smoke in the age of COVID-19
SO BRITISH JOURNAL OF SURGERY
LA English
DT Review
ID LARYNGEAL PAPILLOMATOSIS; HUMAN-PAPILLOMAVIRUS; LASER; VIRUS; THEATER;
   PLUME; DNA
AB Background The COVID-19 global pandemic has resulted in a plethora of guidance and opinion from surgical societies. A controversial area concerns the safety of surgically created smoke and the perceived potential higher risk in laparoscopic surgery.
   Methods The limited published evidence was analysed in combination with expert opinion. A review was undertaken of the novel coronavirus with regards to its hazards within surgical smoke and the procedures that could mitigate the potential risks to healthcare staff.
   Results Using existing knowledge of surgical smoke, a theoretical risk of virus transmission exists. Best practice should consider the operating room set-up, patient movement and operating theatre equipment when producing a COVID-19 operating protocol. The choice of energy device can affect the smoke produced, and surgeons should manage the pneumoperitoneum meticulously during laparoscopic surgery. Devices to remove surgical smoke, including extractors, filters and non-filter devices, are discussed in detail.
   Conclusion There is not enough evidence to quantify the risks of COVID-19 transmission in surgical smoke. However, steps can be undertaken to manage the potential hazards. The advantages of minimally invasive surgery may not need to be sacrificed in the current crisis.
C1 [Mowbray, N. G.; Ansell, J.; Horwood, J.; Cornish, J.; Torkington, J.] Univ Hosp Wales, Dept Gen Surg, Cardiff, Wales.
   [Rizkallah, P.; Parker, A.] Cardiff Univ, Sch Med, Cardiff, Wales.
   [Wall, P.] Isca Healthcare Res, Caerleon, Wales.
   [Spinelli, A.] Ist Clin Humanitas, Dept Gen & Minimally Invas Surg, Rozzano, Italy.
RP Mowbray, NG (corresponding author), Univ Hosp Wales, Dept Gen Surg, Duthie Ward, Heath Park Way, Cardiff CF14 4XW, Wales.
EM ngmowbray@doctors.org.uk
RI Parker, Alan L/B-8187-2009; Spinelli, Antonino/ABI-1441-2020; Mowbray,
   Nicholas/A-1683-2018
OI Parker, Alan L/0000-0002-9302-1761; Spinelli,
   Antonino/0000-0002-1493-1768; Mowbray, Nicholas/0000-0001-9931-0145
CR Ansell J, 2014, SURG ENDOSC, V28, P2057, DOI 10.1007/s00464-014-3427-8
   AORN, 2017, AORN J, V105, P498, DOI 10.1016/j.aorn.2017.02.008
   BAGGISH MS, 1991, LASER SURG MED, V11, P197, DOI 10.1002/lsm.1900110302
   Berubi K, 2009, STUDY ABILITY INNERV
   Brandt C, 2008, ANN SURG, V248, P695, DOI 10.1097/SLA.0b013e31818b757d
   Calero L, 2003, LARYNGO RHINO OTOL, V82, P790
   Capizzi PJ, 1998, LASER SURG MED, V23, P172, DOI 10.1002/(SICI)1096-9101(1998)23:3<172::AID-LSM7>3.0.CO;2-M
   Chen X, 2020, ANESTHESIOLOGY, DOI 10.1097/ALN.0000000000003301
   Choi SH, 2018, SURG ENDOSC, V32, P4290, DOI 10.1007/s00464-018-6222-0
   Chow TT, 2006, J HOSP INFECT, V64, P371, DOI 10.1016/j.jhin.2006.07.020
   Edwards Ben E, 2012, AORN J, V95, P337, DOI 10.1016/j.aorn.2011.07.019
   Fallis I, 2009, INTERNAL REPORT
   Fencl JL, 2017, ASSOC OPER ROOM NURS, V105, P489, DOI 10.1016/j.aorn.2017.03.006
   Georgesen C, 2018, J AM ACAD DERMATOL, V79, P746, DOI 10.1016/j.jaad.2018.06.003
   GLOSTER HM, 1995, J AM ACAD DERMATOL, V32, P436, DOI 10.1016/0190-9622(95)90065-9
   Goon PKC, 2017, DERMATOLOGY THER, V7, P249, DOI 10.1007/s13555-017-0182-5
   HALLMO P, 1991, EUR ARCH OTO-RHINO-L, V248, P425, DOI 10.1007/BF01463570
   Hensman C, 1998, SURG ENDOSC-ULTRAS, V12, P1017, DOI 10.1007/s004649900771
   Ilmarinen T, 2012, EUR ARCH OTO-RHINO-L, V269, P2367, DOI 10.1007/s00405-012-2049-9
   JOHNSON GK, 1991, J MED VIROL, V33, P47, DOI 10.1002/jmv.1890330110
   Kakchekeeva T, 2016, ANN SURG ONCOL, V23, pS592, DOI 10.1245/s10434-016-5108-4
   Katoch Saloni, 2019, J Cutan Aesthet Surg, V12, P1, DOI 10.4103/JCAS.JCAS_177_18
   Kisch T, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001104
   Kwak HD, 2016, OCCUP ENVIRON MED, V73, P857, DOI 10.1136/oemed-2016-103724
   Lee KW, 2011, AEROSOL MEASUREMENT, P197
   Liu Y, 2019, J CANCER, V10, P2788, DOI 10.7150/jca.31464
   Mowbray N, 2013, SURG ENDOSC, V27, P3100, DOI 10.1007/s00464-013-2940-5
   Neuman BW, 2006, J VIROL, V80, P7918, DOI 10.1128/JVI.00645-06
   Nichol K, 2013, AM J INFECT CONTROL, V41, P8, DOI 10.1016/j.ajic.2011.12.018
   Ning Z, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-15
   Rebmann T, 2013, AM J INFECT CONTROL, V41, P1218, DOI 10.1016/j.ajic.2013.02.017
   Rioux M, 2013, J OTOLARYNGOL-HEAD N, V42, DOI 10.1186/1916-0216-42-54
   Seipp HM, 2018, J OCCUP ENVIRON HYG, V15, P773, DOI 10.1080/15459624.2018.1513134
   Society of American Gastrointestinal and Endoscopic Surgeons, SAGES EAES REC REG S
   Society of American Gastrointestinal and Endoscopic Surgeons, RES SMOK GAS EV OP L
   Solass W, 2013, ANN SURG ONCOL, V20, P3504, DOI 10.1245/s10434-013-3039-x
   Spagnolo A M, 2013, J Prev Med Hyg, V54, P131
   Spinelli A., 2020, ADVICES MINIMIZE POT
   The Royal College of Surgeons of Edinburgh, INT GEN SURG GUID CO
   Vankadari N, 2020, EMERG MICROBES INFEC, V9, P601, DOI 10.1080/22221751.2020.1739565
   [王科雯 Wang Kewen], 2020, [测绘通报, Bulletin of Surveying and Mapping], P1
   Weld KJ, 2007, J ENDOUROL, V21, P347, DOI 10.1089/end.2006.9994
   Wolf RC, 2020, NEUROPSYCHOBIOLOGY, V79, P335, DOI [10.1038/s41586-020-2196-x, 10.1159/000505601, 10.1038/s41586-020-2984-3]
   World Health Organization, 2016, GLOB GUID PREV SURG
   World Health Organization (WHO), MOD TRANSM VIR CAUS
   Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762
   Zheng MH, 2020, ANN SURG, V272, pE5, DOI 10.1097/SLA.0000000000003924
NR 47
TC 120
Z9 124
U1 2
U2 16
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0007-1323
EI 1365-2168
J9 BRIT J SURG
JI Br. J. Surg.
PD OCT
PY 2020
VL 107
IS 11
BP 1406
EP 1412
DI 10.1002/bjs.11679
EA MAY 2020
PG 7
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA NO3PX
UT WOS:000529874100001
PM 32363596
OA Green Accepted, Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Zheng, QY
   Wang, XW
   Pan, QW
   Wang, L
AF Zheng, Qinyue
   Wang, Xinwei
   Pan, Qiuwei
   Wang, Lei
TI Optimal strategy for a dose-escalation vaccination against COVID-19 in
   refugee camps
SO AIMS MATHEMATICS
LA English
DT Article
DE COVID-19; refugee camps; vaccine administration; optimal control;
   epidemic control; limited medical resources
ID TRANSMISSION; EPIDEMIC; DYNAMICS
AB An immunogenic and safe vaccine against COVID-19 for use in the healthy population will become available in the near future. In this paper, we aim to determine the optimal vaccine administration strategy in refugee camps considering maximum daily administration and limited total vaccine supply. For this purpose, extended SEAIRD compartmental models are established to describe the epidemic dynamics with both single-dose and double-dose vaccine administration. Taking the vaccination rates in different susceptible compartments as control variables, the optimal vaccine administration problems are then solved under the framework of nonlinear constrained optimal control problems. To the best of our knowledge, this is the first paper that addresses an optimal vaccine administration strategy considering practical constraints on limited medical care resources. Numerical simulations show that both the single-dose and double-dose strategies can successfully control COVID-19. By comparison, the double-dose vaccination strategy can achieve a better reduction in infection and death, while the single-dose vaccination strategy can postpone the infection peak more efficiently. Further studies of the influence of parameters indicate that increasing the number of medical care personnel and total vaccine supply can greatly contribute to the fight against COVID-19. The results of this study are instructive for potential forthcoming vaccine administration. Moreover, the work in this paper provides a general framework for developing epidemic control strategies in the presence of limited medical resources.
C1 [Zheng, Qinyue] Shandong Univ, Sch Management, Shandong Key Lab Social Supernetwork Computat & D, Jinan 250100, Shandong, Peoples R China.
   [Wang, Xinwei] Dalian Univ Technol, Dept Engn Mech, Dalian 116024, Liaoning, Peoples R China.
   [Wang, Xinwei] Dalian Univ Technol, State Key Lab Struct Anal Ind Equipment, Dalian 116024, Liaoning, Peoples R China.
   [Pan, Qiuwei] Erasmus MC Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.
   [Pan, Qiuwei] Northwest Minzu Univ, Biomed Res Ctr, Lanzhou 730030, Gansu, Peoples R China.
   [Wang, Lei] Dalian Univ Technol, Sch Math Sci, Dalian 116024, Liaoning, Peoples R China.
RP Wang, XW (corresponding author), Dalian Univ Technol, Dept Engn Mech, Dalian 116024, Liaoning, Peoples R China.; Wang, XW (corresponding author), Dalian Univ Technol, State Key Lab Struct Anal Ind Equipment, Dalian 116024, Liaoning, Peoples R China.
EM wangxinwei@dlut.edu.cn
FU National Key Research and Development Plan [2019YFB1706502]; Natural
   Science Foundation of Shandong ProvinceNatural Science Foundation of
   Shandong Province [ZR2020QG055]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China (NSFC) [12102077];
   Fundamental Research Funds for the Central UniversitiesFundamental
   Research Funds for the Central Universities [DUT20YG125]
FX The authors are grateful for the National Key Research and Development
   Plan (2019YFB1706502); the Natural Science Foundation of Shandong
   Province (ZR2020QG055); the National Natural Science Foundation of China
   (12102077); the Fundamental Research Funds for the Central Universities
   (DUT20YG125).
CR Aldila D, 2018, INT J AP MAT COM-POL, V28, P169, DOI 10.2478/amcs-2018-0013
   Alizon S., 2020, OPTIMAL COVID 19 EPI
   Altan A, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110071
   Bayes C., 2020, MODELLING DEATH RATE, DOI [10.48550/arXiv.2004.02386, DOI 10.48550/ARXIV.2004.02386]
   Cesari L., 1983, OPTIMIZATION THEORY, DOI [10.1007/978-1-4613-8165-5, DOI 10.1007/978-1-4613-8165-5]
   Chen YC, 2020, IEEE T NETW SCI ENG, V7, P3279, DOI 10.1109/TNSE.2020.3024723
   Chenthamarakshan V., 2020, COGMOL TARGET SPECIF, DOI [10.48550/arXiv.2004.01215, DOI 10.48550/ARXIV.2004.01215]
   Chowdhury R, 2020, EUR J EPIDEMIOL, V35, P389, DOI 10.1007/s10654-020-00649-w
   Crokidakis N, 2020, INT J MOD PHYS C, V31, DOI 10.1142/S0129183120501351
   Curtis FE, 2010, SIAM J SCI COMPUT, V32, P3447, DOI 10.1137/090747634
   Dandekar R., 2020, NEURAL NETWORK AIDED, DOI [10.48550/arXiv.2004.02752, DOI 10.48550/ARXIV.2004.02752]
   Dandekar R, 2020, NEURAL NETWORK AIDED, DOI [10.48550/arXiv.2003.09403, DOI 10.48550/ARXIV.2003.09403]
   Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4
   Gaeta G, 2021, MATH ENG-US, V3, DOI 10.3934/mine.2021013
   Gatto M, 2020, P NATL ACAD SCI USA, V117, P10484, DOI 10.1073/pnas.2004978117
   Ge YY, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00568-6
   Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7
   Higazy M, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.110007
   Hou Z, 2020, RISK PERCEPTION EMOT, DOI [10.2139/ssrn.3551338, DOI 10.2139/SSRN.3551338]
   Hu F., 2020, ALPHA SATELLITE AI D, DOI [10.48550/arXiv.2003.00728, DOI 10.48550/ARXIV.2003.00728]
   Iboi EA, 2020, INFECT DIS MODEL, V5, P510, DOI 10.1016/j.idm.2020.07.006
   Imran Ali, 2020, Inform Med Unlocked, V20, P100378, DOI 10.1016/j.imu.2020.100378
   Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   Kohler J, 2021, ANNU REV CONTROL, V51, P525, DOI 10.1016/j.arcontrol.2020.11.002
   Kupferschmidt K, 2020, SCIENCE, V369, P238, DOI 10.1126/science.369.6501.238
   Lenhart S, 2007, OPTIMAL CONTROL APPL, P97, DOI [10.1201/9781420011418, DOI 10.1201/9781420011418, /10.1201 /9781420011418]
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Libotte GB, 2020, COMPUT METH PROG BIO, V196, DOI 10.1016/j.cmpb.2020.105664
   Mandal M, 2020, CHAOS SOLITON FRACT, V136, DOI 10.1016/j.chaos.2020.109889
   Moore S. E., 2020, CONTROLLING TRANSMIS, DOI [10.48550/arXiv.2004.00443, DOI 10.48550/ARXIV.2004.00443]
   Mulligan MJ, 2020, NATURE, V586, P589, DOI 10.1038/s41586-020-2639-4
   Ndiaye B. M., 2020, ANAL COVID 19 PANDEM, DOI [10.48550/arXiv.2004.01574, DOI 10.48550/ARXIV.2004.01574]
   Nie YB, 2018, 2018 UKACC 12TH INTERNATIONAL CONFERENCE ON CONTROL (CONTROL), P336, DOI 10.1109/CONTROL.2018.8516795
   Okuonghae D, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110032
   Patterson MA, 2014, ACM T MATH SOFTWARE, V41, DOI 10.1145/2558904
   Perone, 2020, ARIMA MODEL FORECAST
   Salje H, 2020, SCIENCE, V369, P208, DOI 10.1126/science.abc3517
   Schuller Bjorn W, 2021, Front Digit Health, V3, P564906, DOI 10.3389/fdgth.2021.564906
   Shen ZH, 2021, RESULTS PHYS, V31, DOI 10.1016/j.rinp.2021.105028
   Tang B, 2020, INFECT DIS MODEL, V5, P248, DOI 10.1016/j.idm.2020.02.001
   Tang YJ, 2020, EMERG MICROBES INFEC, V9, P827, DOI 10.1080/22221751.2020.1760146
   Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105
   Truelove S, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003144
   Tsay C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67459-8
   Ullah Mohammad Sharif, 2022, Chaos Solitons Fractals, V155, P111636, DOI 10.1016/j.chaos.2021.111636
   Wang LD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76550-z
   Wang XW, 2021, OPTIMIZATION, V70, P2527, DOI 10.1080/02331934.2020.1786568
   Wang XW, 2019, COMMUN NONLINEAR SCI, V67, P37, DOI 10.1016/j.cnsns.2018.07.003
   Wang XW, 2017, ISA T, V68, P335, DOI 10.1016/j.isatra.2017.02.018
   WHO, 2020, COR DIS COVID 2019 S
   WHO, 2020, CRIT COVID 19 VACC P
   World Health Organization, 2020, PUSH COVID 19 VACC
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Yan X, 2008, MATH COMPUT MODEL, V47, P235, DOI 10.1016/j.mcm.2007.04.003
   Ye Y. F., 2020, ALPHA SATELLITE AI D, DOI [10.48550/arXiv.2003.12232, DOI 10.48550/ARXIV.2003.12232]
   Yousefpour A, 2020, CHAOS SOLITON FRACT, V136, DOI 10.1016/j.chaos.2020.109883
   Zhang K, 2020, MATH BIOSCI ENG, V17, P5449, DOI 10.3934/mbe.2020294
   Zhu FC, 2020, LANCET, V396, P479, DOI 10.1016/S0140-6736(20)31605-6
   Zhu FC, 2020, LANCET, V395, P1845, DOI 10.1016/S0140-6736(20)31208-3
NR 60
TC 0
Z9 0
U1 3
U2 3
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
EI 2473-6988
J9 AIMS MATH
JI AIMS Math.
PY 2022
VL 7
IS 5
BP 9288
EP 9310
DI 10.3934/math.2022515
PG 23
WC Mathematics, Applied; Mathematics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Mathematics
GA ZS8FL
UT WOS:000768695700002
OA gold
DA 2022-04-20
ER

PT J
AU Shu, W
   Pang, SQ
   Chen, M
AF Shu, Wesley
   Pang, Songquan
   Chen, Minder
TI Achieving structured knowledge management with a novel online group
   decision support system
SO INFORMATION DEVELOPMENT
LA English
DT Article
DE knowledge management; Ba; socialization; externalization; combination;
   internalization (SECI) model; group decision support system; TeamSpirit;
   knowledge adoption
AB Knowledge management (KM) is a complicated process that involves socialization, externalization, combination, and internalization and requires close collaboration among the people involved. Although Nonaka proposed the SECI (Socialization, Externalization, Combination, Internalization) model and the concept of Ba, which provides a process-oriented view of knowledge creation and transfer, practicing it is rather ad hoc. COVID-19 has provided a chance for practitioners to find a new method for KM. In this study, we adapted a group problem-solving system called TeamSpirit and structured it as a Ba for the SECI model. We then compared TeamSpirit with two other implementations of Ba, email and face-to-face communication, to evaluate their effects on knowledge externalization, knowledge combination, and knowledge internalization. Then, we evaluated whether these knowledge-conversion processes could improve knowledge acquisition and intention to share knowledge. A 3 x 2 mixed factorial design experiment was conducted. The results show that (a) TeamSpirit was better than the others, and face-to-face was better than email for each of the three knowledge conversion processes (externalization, combination, and internalization) and (b) the better the team's knowledge conversion process lead, the stronger its knowledge acquisition and knowledge-sharing intention.
C1 [Shu, Wesley] Xian Jiaotong Liverpool Univ, Xian, Peoples R China.
   [Pang, Songquan] Natl Chengchi Univ, Grad Inst Technol Innovat & Intellectual Property, 64 ZhiNan Rd, Taipei, Taiwan.
   [Chen, Minder] Calif State Univ Channel Isl, Management Informat Syst, Camarillo, AA USA.
RP Pang, SQ (corresponding author), Natl Chengchi Univ, Grad Inst Technol Innovat & Intellectual Property, 64 ZhiNan Rd, Taipei, Taiwan.
EM shuwesley@gmail.com; pangsongquan@gmail.com; minder.chen@csuci.edu
CR AlShamsi O, 2018, J KNOWL MANAG, V22, P384, DOI 10.1108/JKM-05-2017-0181
   Andreeva T, 2011, KNOWL PROCESS MANAG, V18, P56, DOI 10.1002/kpm.351
   Andrews KM, 2000, J MANAGE STUD, V37, P797, DOI 10.1111/1467-6486.00204
   [Anonymous], 2020, HOFSTEDE INSIGHTS
   Balde M, 2018, J KNOWL MANAG, V22, P1688, DOI 10.1108/JKM-06-2017-0241
   Barkhi R, 2011, INFORM MANAGE-AMSTER, V48, P125, DOI 10.1016/j.im.2011.02.003
   BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588
   Caputo F, 2019, J KNOWL MANAG, V23, P1314, DOI 10.1108/JKM-10-2018-0645
   Carneiro J, 2019, NEUROCOMPUTING, V338, P399, DOI 10.1016/j.neucom.2018.05.126
   Charband Y, 2016, INFORM SYST FRONT, V18, P1131, DOI 10.1007/s10796-016-9628-z
   Chen ANK, 2005, MIS QUART, V29, P279
   Chen M, 2007, DECIS SUPPORT SYST, V43, P1186, DOI 10.1016/j.dss.2005.07.008
   Chen M, 2007, DECIS SUPPORT SYST, V43, P530, DOI 10.1016/j.dss.2005.05.014
   Cho HC, 2010, J AM SOC INF SCI TEC, V61, P1198, DOI 10.1002/asi.21316
   Dayan R, 2017, J KNOWL MANAG, V21, P308, DOI 10.1108/JKM-02-2016-0068
   Dickson GW., 2000, AMCIS 2000 P, V217
   DIEHL M, 1987, J PERS SOC PSYCHOL, V53, P497, DOI 10.1037/0022-3514.53.3.497
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   French S, 2007, DECIS SUPPORT SYST, V43, P1476, DOI 10.1016/j.dss.2006.06.003
   Gail, 1995, J MANAGEMENT DEV, V14, P4, DOI DOI 10.1108/02621719510086147
   GALLUPE RB, 1992, ACAD MANAGE J, V35, P350, DOI 10.2307/256377
   Ganguly A, 2019, J KNOWL MANAG, V23, P1105, DOI 10.1108/JKM-03-2018-0190
   Heidrich B., 2013, EC FORUM, V16, P82
   Henttonen K, 2016, J KNOWL MANAG, V20, P749, DOI 10.1108/JKM-10-2015-0414
   HOFSTEDE G, 1984, J CROSS CULT PSYCHOL, V15, P417, DOI 10.1177/0022002184015004003
   Isaksen SG, 2016, J CREATIVE BEHAV, V50, P268, DOI 10.1002/jocb.75
   Jarrahi MH, 2019, J ASSOC INF SCI TECH, V70, P313, DOI 10.1002/asi.24134
   Jeong S, 2018, HUM RESOUR DEV Q, V29, P243, DOI 10.1002/hrdq.21323
   KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575
   Kalogeropoulos DA, 2003, COMPUT METH PROG BIO, V72, P65, DOI 10.1016/S0169-2607(02)00118-9
   Kirkman BL, 2006, J INT BUS STUD, V37, P285, DOI 10.1057/palgrave.jibs.8400202
   Kuan Yew Wong, 2005, Journal of Knowledge Management, V9, P64, DOI 10.1108/13673270510602773
   Kwok RCW, 2002, EUR J INFORM SYST, V11, P98, DOI 10.1057/palgrave/ejis/3000421
   Lee H, 2003, J MANAGE INFORM SYST, V20, P179
   Lee J, 2013, J KNOWL MANAG, V17, P16, DOI 10.1108/13673271311300714
   Li M, 2018, J KNOWL MANAG, V22, P887, DOI 10.1108/JKM-10-2016-0458
   Li YH, 2009, IND MARKET MANAG, V38, P440, DOI 10.1016/j.indmarman.2008.02.004
   Liao SH, 2000, EUR J OPER RES, V123, P558, DOI 10.1016/S0377-2217(99)00109-5
   Liao SH, 2003, EXPERT SYST APPL, V25, P155, DOI 10.1016/S0957-4174(03)00043-5
   Lievre P, 2015, J KNOWL MANAG, V19, P1069, DOI 10.1108/JKM-02-2015-0054
   Limayem M, 2006, DECIS SUPPORT SYST, V42, P945, DOI 10.1016/j.dss.2005.08.004
   Lin CH, 2013, INFORM SYST FRONT, V15, P497, DOI 10.1007/s10796-011-9341-x
   Lin CH, 2010, IND MANAGE DATA SYST, V110, P230, DOI 10.1108/02635571011020322
   Lin HF, 2007, J INF SCI, V33, P135, DOI 10.1177/0165551506068174
   Lindlof L, 2013, INT J COMPUT INTEG M, V26, P1128, DOI 10.1080/0951192X.2011.651160
   Loon M, 2019, J BUS RES, V94, P432, DOI 10.1016/j.jbusres.2017.11.022
   Magnier-Watanabe R, 2011, KNOWL MAN RES PRACT, V9, P17, DOI 10.1057/kmrp.2011.1
   Main LF, 2019, J CREATIVE BEHAV, V53, P274, DOI 10.1002/jocb.176
   Martin R, 2018, IND INNOV, V25, P966, DOI 10.1080/13662716.2017.1343132
   McSweeney B, 2002, HUM RELAT, V55, P89, DOI 10.1177/0018726702551004
   Naseem A, 2017, ANNU REV CONTROL, V43, P169, DOI 10.1016/j.arcontrol.2017.03.003
   Nogueira SI, 2016, J CREATIVE BEHAV, V50, P333, DOI 10.1002/jocb.81
   Nonaka I, 1998, CALIF MANAGE REV, V40, P40, DOI 10.2307/41165942
   Nonaka I, 2000, LONG RANGE PLANN, V33, P5, DOI 10.1016/S0024-6301(99)00115-6
   NONAKA I, 1991, HARVARD BUS REV, V69, P96
   Nonaka I, 1995, KNOWLEDGE CREATING C
   Nonaka I, 2009, ORGAN SCI, V20, P635, DOI 10.1287/orsc.1080.0412
   Nunnally J.C, 1994, PSYCHOMETRIC THEORY
   Olaisen J, 2017, INT J INFORM MANAGE, V37, P1441, DOI 10.1016/j.ijinfomgt.2016.10.002
   Osborn A.F., 1963, APPL IMAGINATION PRI
   OWENS HD, 1995, DECIS SUPPORT SYST, V13, P167, DOI 10.1016/0167-9236(93)E0039-G
   Ozbayrak M, 2003, DECIS SUPPORT SYST, V35, P487, DOI 10.1016/S0167-9236(02)00128-8
   Pomerol JC, 1997, EUR J OPER RES, V99, P3, DOI 10.1016/S0377-2217(96)00378-5
   Rouhani S, 2016, J ENTERP INF MANAG, V29, P19, DOI 10.1108/JEIM-12-2014-0126
   Schulze A, 2006, J MANAGE, V32, P210, DOI 10.1177/0149206305280102
   Senoo D, 2007, EUR J INNOV MANAG, V10, P296, DOI 10.1108/14601060710776725
   Siddiqui AW, 2018, DECIS SUPPORT SYST, V114, P1, DOI 10.1016/j.dss.2018.08.005
   Stojanovic-Aleksic V, 2019, J KNOWL MANAG, V23, P1543, DOI 10.1108/JKM-05-2018-0286
   Sussman SW, 2003, INFORM SYST RES, V14, P47, DOI 10.1287/isre.14.1.47.14767
   Titus, 2000, J MARKETING ED, V22, P225, DOI [10.1177/0273475300223006, DOI 10.1177/0273475300223006]
   Toraldo ML, 2018, ORGAN RES METHODS, V21, P438, DOI 10.1177/1094428116657394
   TREFFINGER DJ, 1995, EDUC PSYCHOL REV, V7, P301, DOI 10.1007/BF02213375
   Treffinger DJ, 2005, GIFTED CHILD QUART, V49, P342, DOI 10.1177/001698620504900407
   Treffinger DJ., 2007, GIFTED TALENTED INT, V22, P8
   Tyagi S, 2015, INT J INFORM MANAGE, V35, P204, DOI 10.1016/j.ijinfomgt.2014.12.007
   WATSON RT, 1988, MIS QUART, V12, P463, DOI 10.2307/249214
   Wu Y, 2010, J KNOWL MANAG, V14, P791, DOI 10.1108/13673271011084862
   Yazdani M, 2017, EXPERT SYST APPL, V88, P376, DOI 10.1016/j.eswa.2017.07.014
   Yeh YC, 2012, THINK SKILLS CREAT, V7, P245, DOI 10.1016/j.tsc.2012.05.004
   Zhang W, 2018, J KNOWL MANAG, V22, P1037, DOI 10.1108/JKM-02-2017-0061
   Zigurs I, 1998, MIS QUART, V22, P313, DOI 10.2307/249668
NR 81
TC 3
Z9 3
U1 4
U2 18
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0266-6669
EI 1741-6469
J9 INFORM DEV
JI Inf. Dev.
PD MAR
PY 2022
VL 38
IS 1
BP 23
EP 39
AR 0266666920969842
DI 10.1177/0266666920969842
EA NOV 2020
PG 17
WC Information Science & Library Science
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science
GA ZP2DT
UT WOS:000600911600001
DA 2022-04-20
ER

PT J
AU Liu, ZL
   Geva-May, I
AF Liu, Zhilin
   Geva-May, Iris
TI Comparative Public Policy Analysis of COVID-19 as a Naturally Occurring
   Experiment
SO JOURNAL OF COMPARATIVE POLICY ANALYSIS
LA English
DT Article
DE comparative public policy; policy analysis; COVID-19; public health
   crisis; natural experiment; comparative studies
ID DESIGNING DISASTER RESILIENCE; COMPARATIVE PERSPECTIVES; STATES; FIELD
AB This collection presents an effort to draw on the COVID-19 global pandemic, as a rare "naturally occurring experiment", to advance the comparative public policy scholarship and disseminate knowledge on international policy approaches to this extreme crisis situation. From a comparative lens, these articles reveal how factors such as partisan politics, intergovernmental relationships, culture, and state capacity shape crisis policy responses in contrast to normal policymaking. This collection also provides important lesson drawing: national-local coordination, social safety nets, and a well-organized sector of community workers are all part of a society's capacity and resilience in a time of crisis.
C1 [Liu, Zhilin] Tsinghua Univ, Sch Publ Policy & Management, Room 418, Beijing, Peoples R China.
   [Geva-May, Iris] Simon Fraser Univ, Sch Publ Policy & Adm, Vancouver, BC, Canada.
   [Geva-May, Iris] Carleton Univ, Ottawa, ON, Canada.
RP Liu, ZL (corresponding author), Tsinghua Univ, Sch Publ Policy & Management, Room 418, Beijing, Peoples R China.
EM zhilinliu@tsinghua.edu.cn; jcpaeditorial@gmail.com
CR Ansell C., 2010, J CONTING CRISIS MAN, V18, P195, DOI [10.1111/j.1468-5973.2010.00620, DOI 10.1111/J.1468-5973.2010.00620.X]
   Baekkeskov E, 2016, PUBLIC ADMIN, V94, P299, DOI 10.1111/padm.12244
   Beland D., 2021, J COMP POLICY ANAL, V23, P143, DOI [10.1080/13876988.2020, DOI 10.1080/13876988.2020]
   Benton JE, 2020, AM REV PUBLIC ADM, V50, DOI 10.1177/0275074020941698
   Boulos G, 2012, J COMP POLICY ANAL, V14, P160, DOI 10.1080/13876988.2012.664690
   Capano G, 2020, POLICY SOC, V39, P326, DOI 10.1080/14494035.2020.1783790
   Capano G, 2020, POLICY SOC, V39, P285, DOI 10.1080/14494035.2020.1787628
   Capano G, 2017, POLICY SCI, V50, P269, DOI 10.1007/s11077-016-9267-8
   Chen C, 2021, J COMP POLICY ANAL, V23, P262, DOI 10.1080/13876988.2021.1878885
   Comfort LK, 2020, PUBLIC ADMIN REV, V80, P616, DOI 10.1111/puar.13252
   Comfort LK, 2012, J COMP POLICY ANAL, V14, P199, DOI 10.1080/13876988.2012.696440
   Comfort LK, 2012, J COMP POLICY ANAL, V14, P109, DOI 10.1080/13876988.2012.664709
   Curley C, 2021, J COMP POLICY ANAL, V23, P191, DOI 10.1080/13876988.2021.1880871
   Dai YX, 2021, J COMP POLICY ANAL, V23, P157, DOI 10.1080/13876988.2021.1878887
   Downey DC, 2020, AM REV PUBLIC ADM, V50, P526, DOI 10.1177/0275074020941696
   Dunlop CA, 2020, PUBLIC POLICY ADMIN, V35, P365, DOI 10.1177/0952076720939631
   Geva-May I, 2018, J COMP POLICY ANAL, V20, P18, DOI 10.1080/13876988.2017.1405618
   GevaMay I, 2005, THINKING LIKE A POLICY ANALYST: POLICY ANALYSIS AS A CLINICAL PROFESSION, P1, DOI 10.1057/9781403980939
   Gofen A, 2021, J COMP POLICY ANAL, V23, P3, DOI 10.1080/13876988.2020.1861421
   Goyal N, 2021, J COMP POLICY ANAL, V23, P250, DOI 10.1080/13876988.2021.1880872
   Hale T., 2020, DATA USE POLICY CREA
   Henstra D, 2012, J COMP POLICY ANAL, V14, P175, DOI 10.1080/13876988.2012.665215
   IMF, 2020, POLICY RESPONSES COV
   Kettl DF, 2020, PUBLIC ADMIN REV, V80, P595, DOI 10.1111/puar.13243
   Kingdon JW., 1984, AGENDAS ALTERNATIVES
   Lai AYH, 2012, J COMP POLICY ANAL, V14, P217, DOI 10.1080/13876988.2012.687622
   Lee C, 2020, J COMP POLICY ANAL, V22, P281, DOI 10.1080/13876988.2019.1668657
   Liu Z., 2021, J COMP POLICY ANAL, V23, P204, DOI [10.1080/13876988.2021, DOI 10.1080/13876988.2021]
   Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644
   Mattei P, 2021, J COMP POLICY ANAL, V23, P274, DOI 10.1080/13876988.2021.1878886
   Mei CQ, 2020, POLICY SOC, V39, P309, DOI 10.1080/14494035.2020.1787627
   Migone AR, 2020, POLICY SOC, V39, P382, DOI 10.1080/14494035.2020.1783788
   Moynihan DP, 2008, PUBLIC ADMIN REV, V68, P350, DOI 10.1111/j.1540-6210.2007.00867.x
   Nair S, 2020, J COMP POLICY ANAL, V22, P344, DOI 10.1080/13876988.2019.1695973
   Nemec J, 2021, J COMP POLICY ANAL, V23, P282, DOI 10.1080/13876988.2021.1878884
   OECD, 2020, COUNTRY POLICY TRACK
   Rocco P, 2020, POLICY SOC, V39, P458, DOI 10.1080/14494035.2020.1783793
   Sudhipongpracha T, 2021, J COMP POLICY ANAL, V23, P234, DOI 10.1080/13876988.2021.1879599
   Warner ME, 2021, J COMP POLICY ANAL, V23, P176, DOI 10.1080/13876988.2021.1874243
   Weible CM, 2020, POLICY SCI, V53, P225, DOI 10.1007/s11077-020-09381-4
   Weimer D., 2017, POLICY ANAL CONCEPTS
   White JD, 2012, J COMP POLICY ANAL, V14, P126, DOI 10.1080/13876988.2012.664688
   Yan B, 2021, J COMP POLICY ANAL, V23, P219, DOI 10.1080/13876988.2021.1878458
   Yan B, 2020, AM REV PUBLIC ADM, V50, P762, DOI 10.1177/0275074020942445
   Zhang X, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249520
   Zhu XF, 2020, J COMP POLICY ANAL, V22, P275, DOI 10.1080/13876988.2019.1711059
NR 46
TC 4
Z9 4
U1 11
U2 23
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1387-6988
EI 1572-5448
J9 J COMP POLICY ANAL
JI J. Comp. Policy Anal.
PD MAR 4
PY 2021
VL 23
IS 2
SI SI
BP 131
EP 142
DI 10.1080/13876988.2021.1894074
PG 12
WC Public Administration
WE Social Science Citation Index (SSCI)
SC Public Administration
GA RP5FE
UT WOS:000641753100001
OA hybrid
DA 2022-04-20
ER

PT J
AU Regmi, K
   Lwin, CM
AF Regmi, Krishna
   Lwin, Cho Mar
TI Factors Associated with the Implementation of Non-Pharmaceutical
   Interventions for Reducing Coronavirus Disease 2019 (COVID-19): A
   Systematic Review
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Review
DE non-pharmaceutical interventions; social distancing; quarantine;
   isolation; COVID-19; COVID-19 pandemic; SARS-CoV-2; prevention; control;
   systematic review
ID MENTAL-HEALTH; QUALITATIVE RESEARCH; OUTBREAK; QUARANTINE; RISK;
   MANAGEMENT; BEHAVIORS; ADHERENCE; KNOWLEDGE; ANXIETY
AB There has been much discussion recently about the importance of implementing non-pharmaceutical interventions (NPIs) to protect the public from coronavirus disease 2019 (COVID-19) infection. Different governments across the world have adopted NPIs (e.g., social distancing, quarantine, isolation, lockdowns, curfews, travel restrictions, closures of schools and colleges). Two fundamental strategies, namely a strict containment strategy-also called suppression strategy-and a mitigation strategy have been adopted in different countries, mainly to reduce the reproduction number (R-0) to below one and hence to reduce case numbers to low levels or eliminate human-to-human transmission, as well as to use NPIs to interrupt transmission completely and to reduce the health impact of epidemics, respectively. However, the adoption of these NPI strategies is varied and the factors impacting NPI are inconsistent and unclear. This study, therefore, aimed to review the factors associated with the implementation of NPIs (social distancing, social isolation and quarantine) for reducing COVID-19. Following PRISMA guidelines, we searched for published and unpublished studies, undertaking a systematic search of: MEDLINE, EMBASE, Allied and Complementary Medicine, COVID-19 Research, WHO database on COVID-19, and Google Scholar. Thirty-three studies were included in the study. Seven descriptive themes emerged on enablers and barriers to NPIs: the positive impact of NPIs, effective public health interventions, positive change in people's behaviour and concerns about COVID-19, the role of mass media, physical and psychological impacts, and ethnicity/age associated with COVID-19. This study has highlighted that the effectiveness of NPIs in isolation is likely to be limited, therefore, a combination of multiple measures e.g., SD, isolation and quarantine, and workplace distancing appeared more effective in reducing COVID-19. Studies suggest that targeted approaches alongside social distancing might be the way forward, and more acceptable. Further research to promote country- and context-specific adoption of NPIs to deliver public health measures is needed. Studies comparing the effectiveness of interventions and strategies will help provide more evidence for future pandemics.
C1 [Regmi, Krishna] Univ Bedfordshire, Inst Hlth Res, Luton LU1 3JU, Beds, England.
   [Regmi, Krishna] Univ Dundee, Sch Med, Ctr Med Educ, Dundee DD2 4BF, Scotland.
   [Lwin, Cho Mar] Univ Med Mandalay, Dept Rheumatol, Mandalay 05024, Myanmar.
RP Regmi, K (corresponding author), Univ Bedfordshire, Inst Hlth Res, Luton LU1 3JU, Beds, England.; Regmi, K (corresponding author), Univ Dundee, Sch Med, Ctr Med Educ, Dundee DD2 4BF, Scotland.
EM krishna.r.regmi@gmail.com; chomarlwindr@gmail.com
CR Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217
   Alanezi F, 2020, J HEALTHC LEADERSH, V12, P117, DOI 10.2147/JHL.S266491
   Alobuia WM, 2020, J PUBLIC HEALTH-UK, V42, P470, DOI 10.1093/pubmed/fdaa069
   Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5
   [Anonymous], 2020, LANCET CHILD ADOLESC, V4, P341, DOI 10.1016/S2352-4642(20)30105-X
   Atchison C, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-043577
   Bauerle A, 2020, J PUBLIC HEALTH-UK, V42, P672, DOI 10.1093/pubmed/fdaa106
   Baker N., 2020, HOUSING PANDEMIC 4 G
   Bayham J, 2020, LANCET PUBLIC HEALTH, V5, pE271, DOI 10.1016/S2468-2667(20)30082-7
   Borenstein M., 2009, INTRO META ANAL
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   Butler P., 2020, POOR HOUSING LINKED
   Byanaku A., 2020, KNOWLEDGE ATTITUDES, DOI 10.1101/2020.04.26.20080820v2
   Centers for Disease Control and Prevention, 2020, NONPH INT NPIS
   Challen R, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n579
   Chatwin J, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-040649
   Chen HQ, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-021-00672-w
   Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9
   Cowling BJ, 2020, LANCET PUBLIC HEALTH, V5, pE279, DOI 10.1016/S2468-2667(20)30090-6
   European Centre for Disease Prevention and Control, CONS REL SOC DIST ME
   European Centre for Disease Prevention and Control, COR DIS 2019 COVID 1
   Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X
   Feng Y, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00587-y
   Ferguson N., 9 IMP NONPH INT NPIS
   Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795
   Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7
   Fong MW, 2020, EMERG INFECT DIS, V26, P976, DOI 10.3201/eid2605.190995
   Galle F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103481
   Geldsetzer P, 2020, ANN INTERN MED, V173, P157, DOI 10.7326/M20-0912
   Gerber AS, 2014, J HEALTH POLIT POLIC, V39, P171, DOI 10.1215/03616878-2395208
   Glasziou PP, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1847
   Gough D., 2017, INTRO SYSTEMATIC REV
   Grannell A, 2020, CLIN OBES, V10, DOI 10.1111/cob.12406
   Guyatt G., 2007, USERS GUIDES MED LIT
   Haque Z., 2020, OVER EXPOSED UNDER P
   Harapan H, 2020, J INFECT PUBLIC HEAL, V13, P667, DOI 10.1016/j.jiph.2020.03.019
   Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703
   Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7
   Hlremath P, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102088
   Holmes R, 2020, IS COVID 19 SOCIAL M
   Islam MS, 2021, J PUBLIC HEALTH-UK, V43, P13, DOI 10.1093/pubmed/fdaa182
   Jing QL, 2020, LANCET INFECT DIS, V20, P1141, DOI 10.1016/S1473-3099(20)30471-0
   Johnson C.Y., 2020, VALUABLE TIME CORONA
   Kahler CJ, 2020, J AEROSOL SCI, V148, DOI 10.1016/j.jaerosci.2020.105617
   Katz R, 2019, PUBLIC HEALTH REP, V134, P150, DOI 10.1177/0033354918819755
   Khunti K, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1548
   Lai SJ, 2020, NATURE, V585, P410, DOI 10.1038/s41586-020-2293-x
   Lee K, 2009, GLOB INST, P1
   Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0
   Li ZJ, 2020, LANCET, V396, P63, DOI 10.1016/S0140-6736(20)31278-2
   Liu M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2195
   Liu ZY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17238766
   Lockwood C, 2015, INT J EVID-BASED HEA, V13, P179, DOI 10.1097/XEB.0000000000000062
   Mahtani K.R., WHAT IS EVIDENCE SOC
   Makhashvili N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00641-9
   Mal PR, 2020, J PAK MED ASSOC, V70, pS21, DOI 10.5455/JPMA.05
   Malecki KMC, 2021, CLIN INFECT DIS, V72, P697, DOI 10.1093/cid/ciaa758
   Marmot M, 2020, BUILD BACK FAIRER CO
   Martin A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212993
   Meier K., 2020, PUBLIC PERSPECTIVES, DOI DOI 10.1101/2020.04.02.20049676
   Baena-Diez JM, 2020, J PUBLIC HEALTH-UK, V42, P698, DOI 10.1093/pubmed/fdaa136
   Ministry of Housing C & LG, 2020, OV HOUS
   Mohamed AAO, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10319-5
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   Moorthy A, 2020, J PUBLIC HEALTH-UK, V42, P486, DOI 10.1093/pubmed/fdaa096
   Munn, 2020, JBI MANUAL EVIDENCE, DOI [10.46658/JBIRM-17-06, DOI 10.46658/JBIMES-20-08]
   Nabity-Grover T, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102188
   Nicol GE, 2020, J AM GERIATR SOC, V68, P922, DOI 10.1111/jgs.16443
   Oh SH, 2021, HEALTH COMMUN, V36, P972, DOI 10.1080/10410236.2020.1724639
   Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130
   Park M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040967
   Peplow M., 2020, DEVELOPING COUNTRIES
   Pollock AM, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1284
   Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6
   Public Health England, DISP RISK OUTC COVID
   Rahman, 2020, LOCKDOWN LIVING HOUS
   Randhawa G., COVID 19 MUST BE TIP
   Rashid H, 2015, PAEDIATR RESPIR REV, V16, P119, DOI 10.1016/j.prrv.2014.01.003
   Razaq A., BAME COVID 19 DEATHS
   Regmi K, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-041383
   Regmi Krishna, 2015, Infection Ecology & Epidemiology, V5, P28877, DOI 10.3402/iee.v5.28877
   Rios-González Carlos Miguel, 2020, Rev. salud publica Parag., V10, P17, DOI 10.18004/rspp.2020.diciembre.17
   Rocklov J, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa030
   Rose TC, 2020, INEQUALITIES COVID 1, DOI [10.1101/2020.04.25.20079491, DOI 10.1101/2020.04.25.20079491, 10.1101/2020.04.25 .20079491]
   Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083
   Shokraneh F, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1601
   Shorey S, 2020, J PUBLIC HEALTH-UK, V42, P665, DOI 10.1093/pubmed/fdaa105
   Sikkema RS, 2020, LANCET INFECT DIS, V20, P1273, DOI 10.1016/S1473-3099(20)30527-2
   Singh DR, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06176-y
   Sjodin H, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.13.2000280
   Skoda EM, 2020, J PUBLIC HEALTH-UK, V42, P688, DOI 10.1093/pubmed/fdaa124
   Smith LE, 2020, PUBLIC HEALTH, V187, P41, DOI 10.1016/j.puhe.2020.07.024
   Solerte SB, 2020, DIABETES CARE, V43, P2999, DOI 10.2337/dc20-1521
   Solnick RE, 2021, ACAD EMERG MED, V28, P172, DOI 10.1111/acem.14188
   Tang B, 2020, INT J INFECT DIS, V95, P288, DOI 10.1016/j.ijid.2020.03.018
   Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45
   University of Michigan, MICH MED PROJ SHOW A
   Vally Z, 2020, PUBLIC HEALTH, V187, P67, DOI 10.1016/j.puhe.2020.08.002
   van Elsland S.L., CORONAVIRUS PANDEMIC
   Vandenberg O, 2021, NAT REV MICROBIOL, V19, P171, DOI 10.1038/s41579-020-00461-z
   Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X
   Wang LX, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-021-00674-8
   Webster RK, 2020, PUBLIC HEALTH, V182, P163, DOI 10.1016/j.puhe.2020.03.007
   WHO, COVID 19
   WHO, OV PUBL HLTH SOC MEA
   Williams SN, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039334
   Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239
   Wolkewitz M, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-00972-6
   World Health Organisation, BAS PROT MEAS NEW CO
   World Health Organization, 2020, SOC MED COVID 19 GLO
   Wu Y, 2020, PUBLIC HEALTH, V185, P57, DOI 10.1016/j.puhe.2020.05.016
   Xie S., 2020, EFFECTIVENESS SOCIAL, DOI [10.1101/2020.03.20.20040055, DOI 10.1101/2020.03.20.20040055]
   Zeb A, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/3452402
   Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 115
TC 12
Z9 12
U1 8
U2 25
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD APR
PY 2021
VL 18
IS 8
AR 4274
DI 10.3390/ijerph18084274
PG 27
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA RS9TJ
UT WOS:000644112800001
PM 33920613
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ahuja, N
   Bhinder, J
   Nguyen, J
   Langan, T
   O'Brien-Irr, M
   Montross, B
   Khan, S
   Sharma, AM
   Harris, LM
AF Ahuja, Natasha
   Bhinder, Jasmine
   Nguyen, Jessica
   Langan, Tom, Jr.
   O'Brien-Irr, Monica
   Montross, Brittany
   Khan, Sikandar
   Sharma, Aditya M.
   Harris, Linda M.
TI Venous thromboembolism in patients with COVID-19 infection: risk
   factors, prevention, and management
SO SEMINARS IN VASCULAR SURGERY
LA English
DT Review
ID PLASMINOGEN-ACTIVATOR INHIBITOR-1; CORONAVIRUS DISEASE 2019;
   VEIN-THROMBOSIS; INFLAMMATION; COAGULATION; COAGULOPATHY; EXPRESSION;
   BIOMARKERS
AB Venous thromboembolic complications have emerged as serious sequelae in COVID-19 infections. This article summarizes the most current information regarding pathophysiology, risk factors and hematologic markers, incidence and timing of events, atypical venous thromboembolic complications, prophylaxis recommendations, and therapeutic recommendations. Data will likely to continue to rapidly evolve as more knowledge is gained regarding venous events in COVID-19 patients. (C) 2021 Elsevier Inc. All rights reserved.
C1 [Ahuja, Natasha; Bhinder, Jasmine; Nguyen, Jessica; Langan, Tom, Jr.; O'Brien-Irr, Monica; Montross, Brittany; Khan, Sikandar; Harris, Linda M.] Univ Buffalo, Buffalo Gen Med Ctr, Jacobs Sch Med & Biomed Sci, Kaleida Hlth, 100 High St B7, Buffalo, NY 14203 USA.
   [Sharma, Aditya M.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA.
RP Harris, LM (corresponding author), Univ Buffalo, Buffalo Gen Med Ctr, Jacobs Sch Med & Biomed Sci, Kaleida Hlth, 100 High St B7, Buffalo, NY 14203 USA.
EM lharris@kaleidahealth.org
OI Sharma, Aditya/0000-0003-1756-2504
CR Abou-Ismail MY, 2020, THROMB RES, V194, P101, DOI 10.1016/j.thromres.2020.06.029
   Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Al-Samkari H, 2020, BLOOD, V136, P489, DOI 10.1182/blood.2020006520
   Aleman Washington, 2021, Radiol Case Rep, V16, P899, DOI 10.1016/j.radcr.2021.01.039
   ALICIA ACW, 2020, THROMB HAEMOSTASIS, V120, P1654
   Arganaraz GA, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00687-7
   Argiro R, 2020, J NEUROL SCI, V416, DOI 10.1016/j.jns.2020.117023
   ATTAC ACTIV-4a & REMAP-CAP Multiform RCT, RES INT AN
   Barnes BJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20200652
   Barnes GD, 2020, J THROMB THROMBOLYS, V50, P72, DOI 10.1007/s11239-020-02138-z
   Lemos ACB, 2020, THROMB RES, V196, P359, DOI 10.1016/j.thromres.2020.09.026
   Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
   Bilaloglu S, 2020, JAMA-J AM MED ASSOC, V324, P799, DOI 10.1001/jama.2020.13372
   Campbell CM, 2020, CIRCULATION, V141, P1739, DOI 10.1161/CIRCULATIONAHA.120.047419
   Carmo A, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0412-2020
   Cavagna Enrico, 2020, Radiol Cardiothorac Imaging, V2, pe200289, DOI 10.1148/ryct.2020200289
   Chaudhary R, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100647
   Chauhan AJ, 2020, J THROMB HAEMOST, V18, P2110, DOI 10.1111/jth.14981
   Choi JJ, 2020, THROMB RES, V196, P318, DOI 10.1016/j.thromres.2020.09.022
   Ciceri F, 2020, CRIT CARE RESUSC, V22, P95
   COVID-19 Treatment Guidelines Panel, 2020, CORONAVIRUS DIS 2019
   Cui SP, 2020, J THROMB HAEMOST, V18, P1421, DOI 10.1111/jth.14830
   Cuker A, 2021, BLOOD ADV, V5, P872, DOI 10.1182/bloodadvances.2020003763
   Dakay K, 2021, J STROKE CEREBROVASC, V30, DOI 10.1016/j.jstrokecerebrovasdis.2020.105434
   Daughety MM, 2020, THROMB RES, V196, P483, DOI 10.1016/j.thromres.2020.10.004
   Dobesh PP, 2020, PHARMACOTHERAPY, V40, P1130, DOI 10.1002/phar.2465
   Dujardin RWG, 2020, THROMB RES, V196, P308, DOI 10.1016/j.thromres.2020.09.017
   Escher R, 2020, THROMB RES, V190, P62, DOI 10.1016/j.thromres.2020.04.014
   Esmon CT, 2003, J THROMB HAEMOST, V1, P1343, DOI 10.1046/j.1538-7836.2003.00261.x
   Fogarty H, 2020, BRIT J HAEMATOL, V189, P1044, DOI 10.1111/bjh.16749
   Foley JH, 2016, CIRC RES, V118, P1392, DOI 10.1161/CIRCRESAHA.116.306853
   Fraisse M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03025-y
   Frydman GH, 2020, CLIN APPL THROMB-HEM, V26, DOI 10.1177/1076029620943671
   Gan R, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.110024
   Goodfellow M, 2021, OBES SURG, V31, P2308, DOI 10.1007/s11695-020-05214-8
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hashemi A, 2020, SEMIN THROMB HEMOST, V46, P789, DOI 10.1055/s-0040-1714273
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hurdman J, 2020, GUIDANCE VENOUS THRO
   Ierardi AM, 2021, RADIOL MED, V126, P722, DOI 10.1007/s11547-020-01312-w
   Itoyama S, 2004, BIOCHEM BIOPH RES CO, V323, P1124, DOI 10.1016/j.bbrc.2004.08.208
   Jackson SP, 2019, BLOOD, V133, P906, DOI 10.1182/blood-2018-11-882993
   Jimenez D, 2021, CHEST, V159, P1182, DOI 10.1016/j.chest.2020.11.005
   Kirshblum SC, 2021, AM J PHYS MED REHAB, V100, P419, DOI 10.1097/PHM.0000000000001729
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Koleilat I, 2021, J VASC SURG-VENOUS L, V9, P36, DOI 10.1016/j.jvsv.2020.06.012
   Kreuziger L B, COVID 19 VTE ANTICOA
   Kwok B, 2021, J THROMB THROMBOLYS, V51, P330, DOI 10.1007/s11239-020-02264-8
   Leonard-Lorant I, 2020, RADIOLOGY, V296, pE189, DOI 10.1148/radiol.2020201561
   Li JY, 2021, J THROMB HAEMOST, V19, P1038, DOI 10.1111/jth.15261
   Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9
   Lippi G, 2021, MAYO CLIN PROC, V96, P203, DOI 10.1016/j.mayocp.2020.10.031
   Liu YX, 2020, SCI CHINA LIFE SCI, V63, P364, DOI 10.1007/s11427-020-1643-8
   Luo, THROMB RES, V201, P23
   Malas MB, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100639
   Marongiu F, 2020, J THROMB HAEMOST, V18, P1511, DOI 10.1111/jth.14818
   Merad M, 2020, NAT REV IMMUNOL, V20, P448, DOI 10.1038/s41577-020-0353-y
   Middeldorp S, 2020, J THROMB HAEMOST, V18, P1995, DOI 10.1111/jth.14888
   Mohammadi S, 2020, J THROMB THROMBOLYS, V50, P604, DOI 10.1007/s11239-020-02177-6
   Monteil V, 2020, CELL, V181, P905, DOI 10.1016/j.cell.2020.04.004
   Moores LK, 2020, CHEST, V158, P1143, DOI 10.1016/j.chest.2020.05.559
   Motaganahalli RL, 2021, J VASC SURG-VENOUS L, V9, P605, DOI 10.1016/j.jvsv.2020.10.006
   Mui LW, 2021, EMERG RADIOL, V28, P423, DOI 10.1007/s10140-020-01868-0
   Nakamura S, 2000, KIDNEY INT, V58, P251, DOI 10.1046/j.1523-1755.2000.00160.x
   Ofosu A, 2020, AM J GASTROENTEROL, V115, P1545, DOI 10.14309/ajg.0000000000000781
   Panigada M, 2020, J THROMB HAEMOST, V18, P1738, DOI 10.1111/jth.14850
   Poterucha TJ, 2017, THROMB HAEMOSTASIS, V117, P437, DOI 10.1160/TH16-08-0620
   Ramlall Vijendra, 2020, medRxiv, DOI 10.1101/2020.05.05.20092452
   Ren B, 2020, CIRCULATION, V142, P181, DOI 10.1161/CIRCULATIONAHA.120.047407
   Rivera-Lebron B, 2019, CLIN APPL THROMB-HEM, V25, DOI 10.1177/1076029619853037
   Rosovsky RP, 2020, CHEST, V158, P2590, DOI 10.1016/j.chest.2020.08.2064
   Sadeghipour P, 2021, JAMA-J AM MED ASSOC, V325, P1620, DOI 10.1001/jama.2021.4152
   Santoliquido A, 2020, J THROMB HAEMOST, V18, P2358, DOI 10.1111/jth.14992
   Singh B, 2020, DIGEST LIVER DIS, V52, P1407, DOI 10.1016/j.dld.2020.09.025
   Spyropoulos AC, 2020, J THROMB HAEMOST, V18, P1859, DOI 10.1111/jth.14929
   Susen S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03000-7
   Talasaz AH, 2021, J AM COLL CARDIOL, V77, P1903, DOI 10.1016/j.jacc.2021.02.035
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Testa S, 2020, J THROMB HAEMOST, V18, P1320, DOI 10.1111/jth.14871
   Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841
   Thondapu V, 2021, J VASC SURG-VENOUS L, V9, P835, DOI 10.1016/j.jvsv.2020.11.006
   Tian SF, 2020, MODERN PATHOL, V33, P1007, DOI 10.1038/s41379-020-0536-x
   Tran HN, 2019, PREV MED REP, V13, P268, DOI 10.1016/j.pmedr.2019.01.006
   Trigonis RA, 2020, CRIT CARE MED, V48, pE805, DOI 10.1097/CCM.0000000000004472
   Tu TM, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.105379
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   VAUGHAN DE, 1995, J CLIN INVEST, V95, P995, DOI 10.1172/JCI117809
   Veyseh M, 2020, BMJ CASE REP, V13, DOI 10.1136/bcr-2020-236786
   Xiong XM, 2021, THROMB J, V19, DOI 10.1186/s12959-021-00284-9
   Yu Y, 2020, CLIN APPL THROMB-HEM, V26, DOI 10.1177/1076029620953217
   Zarychanski R., 2021, THERAPEUTIC ANTICOAG, DOI [DOI 10.1101/2021.03.10.21252749, 10.1101/2021.03.10.21252749]
   Zhang R, 2021, J VASC SURG-VENOUS L, V9, P289, DOI 10.1016/j.jvsv.2020.11.023
   Zhang XH, 2007, BLOOD, V110, P228, DOI 10.1182/blood-2006-12-063636
   Zhou Y, 2020, INT J INFECT DIS, V99, P47, DOI 10.1016/j.ijid.2020.07.029
   Zores F, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00071
   Zuo Y, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138999
NR 97
TC 0
Z9 0
U1 1
U2 1
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0895-7967
EI 1558-4518
J9 SEMIN VASC SURG
JI Semin. Vasc. Surg.
PD SEP
PY 2021
VL 34
IS 3
BP 101
EP 116
DI 10.1053/j.semvascsurg.2021.06.002
EA OCT 2021
PG 16
WC Surgery; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery; Cardiovascular System & Cardiology
GA WG4WM
UT WOS:000706996800007
PM 34642030
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Aziz, AAHHA
   Abdul-Mumin, KH
   Rahman, HA
AF Aziz, Amal Atiqah Hamizah Hj Abdul
   Abdul-Mumin, Khadizah H.
   Rahman, Hanif Abdul
TI Willingness of university nursing students to volunteer during the
   COVID-19 pandemic in Brunei Darussalam
SO BELITUNG NURSING JOURNAL
LA English
DT Article
DE COVID-19; willingness; nursing; students; volunteerism; online survey;
   nursing; Brunei Darussalam
ID HEALTH-CARE WORKFORCE; MEDICAL-STUDENTS; NURSES; DUTY
AB Background: Volunteering among nursing students has become a valuable resource during an outbreak to help alleviate the strain in nursing staff shortages. However, evidence of willingness to volunteer is scarce, particularly in Asian countries.
   Objective: To study Bruneian university nursing students' willingness to volunteer during a pandemic in Brunei.
   Methods: An online cross-sectional study was conducted at Universiti Brunei Darussalam from January to February 2021. A self-administered questionnaire was used to measure willingness factors, including motivational factors, barriers, enablers, and level of agreement to volunteer during the COVID-19 pandemic. Sub-group inferential analysis was applied.
   Results: 72 participants were included in this study. 75.0% of whom were willing to volunteer during the COVID-19 pandemic. Factors that influenced the willingness of nursing students to volunteer were marital status (p<0.001), year of study (p<0.001), altruism (p<0.001), personal safety (p<0.001), and knowledge level (p<0.001).
   Conclusion: Nursing students are an invaluable resource, and they are highly willing to be part of disaster management. Training and planning should prepare the nursing students for disaster or pandemic readiness and integrated them into the undergraduate nursing curriculum. Align with this, safety aspects of nursing students during volunteering should also be considered, including the provision of childcare assistance, sufficient personal protective equipment, vaccination, and prophylaxis to the volunteers.
C1 [Aziz, Amal Atiqah Hamizah Hj Abdul; Abdul-Mumin, Khadizah H.; Rahman, Hanif Abdul] Univ Brunei Darussalam, PAPRSB Inst Hlth Sci, Tungku Link Rd, BE-1410 Gadong, Brunei.
RP Rahman, HA (corresponding author), Univ Brunei Darussalam, PAPRSB Inst Hlth Sci, Tungku Link Rd, BE-1410 Gadong, Brunei.
EM hanif.rahman@ubd.edu.bn
OI Abdul Rahman, Hanif/0000-0003-3022-8690; Abdul-Mumin, khadizah
   H./0000-0003-3474-5089
CR AlSaif HI, 2020, INT J GEN MED, V13, P653, DOI 10.2147/IJGM.S272316
   [Anonymous], 2015, MEDWAVE, V15, DOI 10.5867/medwave.2015.04.6136
   Astorp MS, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039082
   Ben Natan M, 2015, RES THEOR NURS PRACT, V29, P266, DOI 10.1891/1541-6577.29.4.266
   Blackwood K., 2017, THESIS U W FLORIDA P
   Cervera-Gasch A, 2020, NURS EDUC TODAY, V92, DOI 10.1016/j.nedt.2020.104473
   Dyson SE, 2017, NURSE EDUC PRACT, V23, P15, DOI 10.1016/j.nepr.2017.01.004
   Gomez-Ibanez R, 2020, NURSE EDUC PRACT, V49, DOI 10.1016/j.nepr.2020.102920
   Gouda P, 2020, DISASTER MED PUBLIC, V14, P308, DOI 10.1017/dmp.2019.81
   Hayter M, 2020, J CLIN NURS, V29, P3115, DOI 10.1111/jocn.15317
   Iserson KV, 2020, WEST J EMERG MED, V21, P490, DOI 10.5811/westjem.2020.4.47553
   Lazarus Gilbert, 2020, Korean J Med Educ, V32, P237, DOI 10.3946/kjme.2020.165
   Martin-Delgado L, 2021, J PROF NURS, V37, P588, DOI 10.1016/j.profnurs.2021.02.008
   McNeill C, 2020, NURS ETHICS, V27, P348, DOI 10.1177/0969733019846645
   Mortelmans LJM, 2015, INT J EMERG MED, V8, DOI 10.1186/s12245-015-0077-0
   O'Byrne L, 2020, J MED ETHICS, V46, P623, DOI 10.1136/medethics-2020-106353
   Patel J, 2020, CLIN MED, V20, pE244, DOI 10.7861/clinmed.2020-0219
   Pogoy JM, 2021, BELITUNG NURS J, V7, P186, DOI 10.33546/bnj.1427
   Quisao EZS, 2021, BELITUNG NURS J, V7, P203, DOI 10.33546/bnj.1405
   Rasmussen S, 2020, LANCET, V395, pE79, DOI 10.1016/S0140-6736(20)30923-5
   Swift A, 2020, J CLIN NURS, V29, P3111, DOI 10.1111/jocn.15298
   World Health Organization, 2020, CUM NUMB CONF HUM CA
   World Health Organization, 2021, WHO COR COVID 19 DAS
   Yonge O, 2010, PUBLIC HEALTH NURS, V27, P174, DOI 10.1111/j.1525-1446.2010.00839.x
   Yu Nan-Ze, 2020, World J Virol, V9, P38, DOI 10.5501/wjv.v9.i3.38
NR 25
TC 0
Z9 0
U1 4
U2 4
PU BELITUNG RAYA FOUNDATION
PI BELITUNG
PA RT 06 RW 02, URISAN JAYA, PADANG, BELITUNG TIMUR, MANGGAR, BANGKA,
   BELITUNG, INDONESIA
SN 2528-181X
EI 2477-4073
J9 BELITUNG NURS J
JI Belitung Nurs. J.
PD JUL-AUG
PY 2021
VL 7
IS 4
BP 285
EP 293
DI 10.33546/bnj.1518
PG 9
WC Nursing
WE Emerging Sources Citation Index (ESCI)
SC Nursing
GA UK5XI
UT WOS:000692042100004
OA gold
DA 2022-04-20
ER

PT J
AU Balasubramanian, S
   Fernandes, C
AF Balasubramanian, Sreejith
   Fernandes, Cedwyn
TI Confirmation of a crisis leadership model and its effectiveness: Lessons
   from the COVID-19 pandemic
SO COGENT BUSINESS & MANAGEMENT
LA English
DT Article
DE Crisis leadership; conceptual model; COVID-19; theoretical framework;
   structural equation modeling; confirmatory factor analysis; empirical
   study; survey research
ID SUPPLY CHAIN MANAGEMENT; KNOWLEDGE MANAGEMENT; EMPOWERMENT; BUSINESS;
   SECTOR
AB Despite the significance of crisis leadership for organizations, especially in the wake of COVID-19, empirical research in this area is still nascent. Therefore, "What attributes make an effective leader during a crisis?" is unclear. Using lessons learned from the COVID-19 pandemic, this study seeks to address this gap in the literature by i) developing and validating a robust multi-dimensional crisis leadership model and ii) measure its effectiveness in handling the crisis. A higher-order measurement model of crisis leadership comprising of seven constructs (compassion and care, openness and communication, resilience and courage, decisiveness, consultation and collaboration, and empowerment) and two structural models to measure its predictive validity (effectiveness in handling the crisis) were proposed based on the review of crisis leadership literature. Next, using data collected through a global survey, the validity of the proposed models, including the relevance/appropriateness of each construct and the predictive power of the crisis leadership model in explaining the organizations' effectiveness in handling the crisis, were assessed. The second-order confirmatory factor analysis established the existence of a higher-order measurement model for crisis leadership, with each of the seven constructs contributing uniquely and strongly. The structural equation modeling results confirmed the strong predictive power of the crisis leadership model in explaining the organizations' effectiveness in handling the crisis across its different (beginning, current, and future) phases. The findings show that crisis leadership is multifaceted and requires an all-encompassing effort and provides a road map for organizations looking to develop crisis leadership capabilities for senior managers and leaders.
C1 [Balasubramanian, Sreejith] Middlesex Univ Dubai, Business Sch, Knowledge Pk, Dubai, U Arab Emirates.
   [Fernandes, Cedwyn] Middlesex Univ Dubai, Knowledge Pk, Dubai, U Arab Emirates.
RP Balasubramanian, S (corresponding author), Middlesex Univ Dubai, Business Sch, Knowledge Pk, Dubai, U Arab Emirates.
EM s.balasubramanian@mdx.ac.ae
OI BALASUBRAMANIAN, SREEJITH/0000-0002-0475-7305
CR Aarons GA, 2017, ADM POLICY MENT HLTH, V44, P480, DOI 10.1007/s10488-015-0672-7
   Ahern S, 2021, BMJ LEAD, V5, P266, DOI 10.1136/leader-2020-000271
   Al Ahbabi SA, 2019, J KNOWL MANAG, V23, P351, DOI 10.1108/JKM-08-2017-0348
   Al Saidi AMO, 2020, LANCET, V396, P295, DOI 10.1016/S0140-6736(20)31493-8
   Al Yami M, 2021, VINE J INF KNOWL MAN, DOI 10.1108/VJIKMS-07-2020-0123
   Allen L.A., 1991, MANAG REV, V80, P46
   ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411
   [Anonymous], 2017, FORBES
   [Anonymous], 2020, FORBES
   [Anonymous], 2020, TIM WHOS RESP COVID
   Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI DOI 10.1007/BF02723327
   Balasubramanian S, 2021, TECHNOL FORECAST SOC, V165, DOI 10.1016/j.techfore.2020.120536
   Balasubramanian S, 2020, MANAG ENVIRON QUAL, V31, P1375, DOI 10.1108/MEQ-01-2020-0004
   Balasubramanian S, 2019, INT J PUBLIC SECT MA, V33, P1, DOI 10.1108/IJPSM-05-2019-0131
   Balasubramanian S, 2017, SUPPLY CHAIN MANAG, V22, P58, DOI 10.1108/SCM-07-2016-0227
   Bundy J, 2017, J MANAGE, V43, P1661, DOI 10.1177/0149206316680030
   Caringal-Go JF, 2021, LEADERSHIP ORG DEV J, V42, P630, DOI 10.1108/LODJ-07-2020-0284
   Chen IJ, 2004, J OPER MANAG, V22, P119, DOI 10.1016/j.jom.2003.12.007
   Chiou TY, 2011, TRANSPORT RES E-LOG, V47, P822, DOI 10.1016/j.tre.2011.05.016
   Coleman HJ., 1996, LEADERSHIP ORG DEV J, V17, P29, DOI [10.1108/01437739610120574, DOI 10.1108/01437739610120574]
   Coombs W.T., 2008, INT ENCY COMMUNICATI, V1, P1
   Crayne MP, 2021, AM PSYCHOL, V76, P462, DOI 10.1037/amp0000715
   Deloitte, 2020, LEAD TIM COVID 19
   Deloitte, 2020, HEART RES LEAD RESP
   Deloitte, 2020, LEAD STYL FUT COVID
   Dirani KM, 2020, HUM RESOUR DEV INT, V23, P380, DOI 10.1080/13678868.2020.1780078
   Donthu N, 2020, J BUS RES, V117, P284, DOI 10.1016/j.jbusres.2020.06.008
   Eichenauer CJ, 2022, J LEADERSH ORG STUD, V29, P190, DOI 10.1177/15480518211010761
   Ferry K., 2020, LEADERSHIP OUTBREAK
   FINK SL, 1971, J APPL BEHAV SCI, V7, P15, DOI 10.1177/002188637100700103
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Forster BB, 2020, CAN ASSOC RADIOL J, V71, P421, DOI 10.1177/0846537120926752
   Francisco C.D.C., 2020, INT J ACAD MULTIDISC, V4, P15, DOI DOI 10.17613/ETSV-NN43
   Garver M., 1999, J BUSINESS LOGISTICS, V20, P33
   Gold AH, 2001, J MANAGE INFORM SYST, V18, P185, DOI 10.1080/07421222.2001.11045669
   Haslam SA, 2021, SOC ISS POLICY REV, V15, P35, DOI 10.1111/sipr.12075
   Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8
   Hersey P., 1979, GROUP ORGAN STUD, V4, P418, DOI [10.1177/105960117900400404, DOI 10.1177/105960117900400404]
   Hersey P., 2000, COACHING LEADERSHIP, P247
   Hershey P., 1977, MANAGEMENT ORG BEHAV, V3rd
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   James EH, 2005, ORGAN DYN, V34, P141, DOI 10.1016/j.orgdyn.2005.03.005
   Joniakova Z, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9030313
   Kaul V, 2020, GASTROENTEROLOGY, V159, P809, DOI 10.1053/j.gastro.2020.04.076
   KELLER T, 1995, HUM RELAT, V48, P127, DOI 10.1177/001872679504800202
   ?kerblom S., 2006, SCAND J MANAG, V22, P307, DOI DOI 10.1016/J.SCAMAN.2006.10.002
   Kline RB, 2010, PRINCIPLES PRACTICE
   Lagowska Urszula, 2020, BAR, Braz. Adm. Rev., V17, pe200062, DOI 10.1590/1807-7692bar2020200062
   Lee SM, 2012, IND MANAGE DATA SYST, V112, P1148, DOI 10.1108/02635571211264609
   Lei P.-W., 2007, ED MEASURE ISSUES PR, V26, P33, DOI [10.1111/j.1745-3992.2007.00099.x, DOI 10.1111/J.1745-3992.2007.00099.X]
   Loosemore M., 1998, J CONTING CRISIS MAN, V6, P23, DOI [10.1111/1468-5973.00065, DOI 10.1111/1468-5973.00065]
   McCleskey J.A., 2014, J BUSINESS STUDIES Q, V5, P117
   McKinsey & Company, 2020, LEAD CRIS RESP COR O
   Mckinsey Company, 2021, WILL COVID 19 PAND E
   Meng J, 2013, J PUBLIC RELAT RES, V25, P141, DOI 10.1080/1062726X.2013.758583
   Mujtaba B.G., 2009, J DIVERSITY MANAGEME, V4, P1
   NEDARC, 2019, RAND SEL
   Nunnally J.C, 1994, PSYCHOMETRIC THEORY
   Overby J., 2012, J APPL BUSINESS RES, V28, P1073, DOI [https://doi.org/10.19030/jabr.v28i5.7247, DOI 10.19030/JABR.V28I5.7247]
   Pearson CM, 1998, ACAD MANAGE REV, V23, P59, DOI 10.2307/259099
   Quinn RE, 1997, ORGAN DYN, V26, P37, DOI 10.1016/S0090-2616(97)90004-8
   Ramalingam B., 2020, HARVARD BUS REV
   Rao P, 2021, COGENT BUS MANAG, V8, DOI 10.1080/23311975.2021.1938377
   Sadiq AA, 2021, INT J PUBLIV LEADERS, V17, P65, DOI 10.1108/IJPL-08-2020-0071
   Schyns B., 2016, IMPLICIT LEADERSHIP, P1, DOI [10.1007/978-3-319-31816-5_2186-1, DOI 10.1007/978-3-319-31816-5_2186-1]
   Sehgal R, 2021, J GEN MANAGE, V47, P18, DOI 10.1177/03063070211013337
   Shaluf I., 2003, DISASTER PREVENTION, V12, P24, DOI DOI 10.1108/09653560310463829
   Shen W, 2019, J LEADERSH ORG STUD, V26, P204, DOI 10.1177/1548051818784001
   Sims HP, 2009, BUS HORIZONS, V52, P149, DOI 10.1016/j.bushor.2008.10.002
   Soete L., 2021, LEARNING COVID 19 PA
   Stokes Y, 2019, WESTERN J NURS RES, V41, P96, DOI 10.1177/0193945917740706
   Stoller JK, 2020, BMJ LEAD, V4, P77, DOI 10.1136/leader-2020-000244
   UN Global Compact, 2020, COVID 19 WHAT MAK GO
   VENKATRAMAN N, 1989, MANAGE SCI, V35, P942, DOI 10.1287/mnsc.35.8.942
   Vera D, 2004, ACAD MANAGE REV, V29, P222
   Wisittigars B, 2019, FACILITIES, V37, P881, DOI 10.1108/F-10-2017-0100
NR 76
TC 0
Z9 0
U1 26
U2 26
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 2331-1975
J9 COGENT BUS MANAG
JI Cogent Bus. Manag.
PD DEC 31
PY 2022
VL 9
IS 1
AR 2022824
DI 10.1080/23311975.2021.2022824
PG 31
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA YE5CZ
UT WOS:000741144800001
OA Green Accepted, gold
DA 2022-04-20
ER

PT J
AU Zhang, SX
   Miller, SO
   Xu, W
   Yin, A
   Chen, BZ
   Delios, A
   Dong, RK
   Chen, RZ
   McIntyre, RS
   Wan, X
   Wang, SH
   Chen, JY
AF Zhang, Stephen X.
   Miller, Saylor O.
   Xu, Wen
   Yin, Allen
   Chen, Bryan Z.
   Delios, Andrew
   Dong, Rebecca Kechen
   Chen, Richard Z.
   McIntyre, Roger S.
   Wan, Xue
   Wang, Senhu
   Chen, Jiyao
TI Meta-analytic evidence of depression and anxiety in Eastern Europe
   during the COVID-19 pandemic
SO EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY
LA English
DT Review
DE COVID-19; epidemic; general population; healthcare workers; frontline
   healthcare workers; psychiatry
ID GENERAL-POPULATION; MENTAL-HEALTH; OUTBREAK
AB Objective To perform a systematic and meta-analysis on the prevalence rates of mental health symptoms including anxiety and depression during the COVID-19 pandemic in the general population in Eastern Europe, as well as three select sub-populations: students, general healthcare workers, and frontline healthcare workers. Data sources Studies in PubMed, Embase, Web of Science, PsycINFO, and medRxiv up to 6 February 2021. Eligibility criteria and data analysis Prevalence rates of mental health symptoms in the general population and key sub-populations during the COVID-19 pandemic in Eastern Europe. Data were pooled using a random-effects meta-analysis to estimate the prevalence rates of anxiety and depression. Results The meta-analysis identifies and includes 21 studies and 26 independent samples in Eastern Europe. Poland (n = 4), Serbia (n = 4), Russia (n = 3), and Croatia (n = 3) had the greatest number of studies. To our knowledge, no studies have been conducted in eleven Eastern European countries including Hungary, Slovakia, and Slovenia. The pooled prevalence of anxiety in 18 studies with 22 samples was 30% (95% CI: 24-37%) pooled prevalence of depression in 18 studies with 23 samples was 27% (95% CI: 21-34%). Implications The cumulative evidence from the meta-analysis reveals high prevalence rates of clinically significant symptoms during the COVID-19 pandemic in Eastern Europe. The findings suggest evidence of a potential mental health crisis in Eastern Europe during the ongoing COVID-19 pandemic. Our synthesis also reveals a relative lack of studies in certain Eastern European countries as well as high heterogeneities among the existing studies, calling for more effort to achieve evidence-based mental healthcare in Eastern Europe.
C1 [Zhang, Stephen X.] Univ Adelaide, Fac Profess, Adelaide, SA, Australia.
   [Miller, Saylor O.; Chen, Jiyao] Oregon State Univ, Coll Business, 416 Austin Hall, Corvallis, OR 97331 USA.
   [Xu, Wen] Univ Nottingham Ningbo China, Business Sch China, Ningbo, Peoples R China.
   [Yin, Allen] Southeast Univ, Sch Humanities, Nanjing, Peoples R China.
   [Chen, Bryan Z.; Chen, Richard Z.] Crescent Valley High Sch, Corvallis, OR USA.
   [Delios, Andrew] Univ Adelaide, Coll Business, Adelaide, SA, Australia.
   [Dong, Rebecca Kechen] Univ South Australia, Business Sch, Adelaide, SA, Australia.
   [McIntyre, Roger S.] Univ Toronto, Dept Psychiat & Pharmacol, Toronto, ON, Canada.
   [Wan, Xue] Tongji Univ, Sch Econ & Management, Shanghai, Peoples R China.
   [Wang, Senhu] Natl Univ Singapore, Dept Sociol, Singapore, Singapore.
RP Chen, JY (corresponding author), Oregon State Univ, Coll Business, 416 Austin Hall, Corvallis, OR 97331 USA.
EM jiyao.chen@oregonstate.edu
RI Zhang, Stephen/J-3755-2013
OI Zhang, Stephen/0000-0001-6123-1193; Dong, Rebecca
   Kechen/0000-0002-2486-4511; WAN, Xue(Skylar)/0000-0002-4171-8292
FU College of Business of Oregon State University
FX JC has received research support from College of Business of Oregon
   State University.
CR Babicki M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18116101
   Bachilo E.V., 2020, MENTAL HLTH MED WORK
   Batra K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17239096
   Behghadami Mehrdad Amir, 2019, Bull Emerg Trauma, V7, P201, DOI 10.29252/beat-070301
   Borenstein M, 2017, RES SYNTH METHODS, V8, P5, DOI 10.1002/jrsm.1230
   Chen J., INT J MENT HEALTH AD
   Chen J., 2021, MENTAL HLTH COVID 19, DOI [10.1101/2021.04.19.21255755, DOI 10.1101/2021.04.19.21255755]
   Chen X., 2021, SYSTEMATIC REV METAA, DOI [10.1101/2021.04.11.21255274, DOI 10.1101/2021.04.11.21255274]
   Chen X., 2021, ONE YEAR EVIDENCE ME, DOI [10.1101/2021.02.01.21250929, DOI 10.1101/2021.02.01.21250929]
   Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142
   Cypryanska M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241464
   de Pablo GS, 2020, J AFFECT DISORDERS, V275, P48, DOI 10.1016/j.jad.2020.06.022
   Ding KL, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052686
   Dzhambov AM, 2021, ENVIRON RES, V196, DOI 10.1016/j.envres.2020.110420
   Elezi F, 2020, INDIAN J PSYCHIAT, V62, P470, DOI 10.4103/psychiatry.IndianJPsychiatry_842_20
   Franic T, 2020, IRISH J PSYCHOL MED, V37, P214, DOI 10.1017/ipm.2020.55
   Furuya-Kanamori L, 2018, INT J EVID-BASED HEA, V16, P195, DOI 10.1097/XEB.0000000000000141
   Gallic M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.567368
   Gallopen F, 2020, J PSYCHOSOM RES, V137, DOI 10.1016/j.jpsychores.2020.110212
   Grabowski J, 2021, EUROSURVEILLANCE, V26, P18, DOI 10.2807/1560-7917.ES.2021.26.7.2100117
   Hale T, 2021, NAT HUM BEHAV, V5, P529, DOI 10.1038/s41562-021-01079-8
   Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1
   Hong QN, 2018, EDUC INFORM, V34, P285, DOI 10.3233/EFI-180221
   Hossain MM, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06677
   Karpenko OA, 2020, CONSORTIUM PSYCHIAT, V1, DOI DOI 10.17650/2712-7672-2020-1-1-8-20
   Kolodziejczyk A, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.625355
   Kowalski J, 2020, PSYCHIAT RES, V294, DOI 10.1016/j.psychres.2020.113540
   Krupchanka Dzmitry, 2016, BJPsych Int, V13, P96
   Lateef T, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-021-00685-5
   Lin KG, 2020, AM J PSYCHIAT, V177, P635, DOI 10.1176/appi.ajp.2020.20040374
   Luo M, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113190
   Maciaszek J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082527
   Margetic B, 2021, PERS INDIV DIFFER, V175, DOI 10.1016/j.paid.2021.110691
   Markovic I, 2020, VOJNOSANIT PREGL, V77, P1201, DOI 10.2298/VSP200713108M
   Mechili EA, 2021, J PSYCHIATR MENT HLT, V28, P317, DOI 10.1111/jpm.12672
   Moron M, 2021, PERS INDIV DIFFER, V168, DOI 10.1016/j.paid.2020.110348
   Mosolova E, 2020, PSYCHIAT DANUB, V32, P549, DOI 10.24869/psyd.2020.549
   Nekliudov NA, 2020, J MED INTERNET RES, V22, DOI 10.2196/20955
   Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39
   Pappa S, 2022, PSYCHIAT CLIN NEUROS, V76, P41, DOI 10.1111/pcn.13306
   Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]
   Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017
   Ren X, 2020, PSYCHIAT QUART, V91, P1033, DOI 10.1007/s11126-020-09796-5
   Rogowska AM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113494
   Rogowska AM, 2020, PSYCHOL RES BEHAV MA, V13, P797, DOI 10.2147/PRBM.S266511
   Sahebi A, 2021, PROG NEURO-PSYCHOPH, V107, DOI 10.1016/j.pnpbp.2021.110247
   Salari N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00589-w
   Salopek-Ziha D, 2020, PSYCHIAT DANUB, V32, P287, DOI 10.24869/psyd.2020.287
   Secosan I, 2020, BEHAV SCI-BASEL, V10, DOI 10.3390/bs10110164
   [Anonymous], 2016, BMJ, V354, pi4086, DOI [10.1136/bmj.g7647, 10.1136/bmj.i4086]
   Sigorski D, 2020, ESMO OPEN, V5, DOI 10.1136/esmoopen-2020-000970
   Sljivo A, 2020, PSYCHIAT DANUB, V32, P266, DOI 10.24869/psyd.2020.266
   Stephen X., RISK MANAGEMENT HEAL
   Stojanov J, 2021, INT J SOC PSYCHIATR, V67, P175, DOI 10.1177/0020764020942800
   Usher K, 2020, INT J MENT HEALTH NU, V29, P1018, DOI 10.1111/inm.12790
   Villani L, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-006422
   Vujcic I, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041957
   Wankowicz P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165849
   Winkler P, 2020, EPIDEMIOL PSYCH SCI, V29, DOI 10.1017/S2045796020000888
   Wu TC, 2021, J AFFECT DISORDERS, V281, P91, DOI 10.1016/j.jad.2020.11.117
   Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001
NR 61
TC 4
Z9 4
U1 12
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2000-8198
EI 2000-8066
J9 EUR J PSYCHOTRAUMATO
JI Eur. J. Psychotraumatol.
PD DEC 31
PY 2022
VL 13
IS 1
AR 2000132
DI 10.1080/20008198.2021.2000132
PG 14
WC Psychology, Clinical; Psychiatry
WE Social Science Citation Index (SSCI)
SC Psychology; Psychiatry
GA YZ2OU
UT WOS:000755321400001
PM 35186214
DA 2022-04-20
ER

PT C
AU Karthikeyan, D
   Varde, AS
   Wang, WT
AF Karthikeyan, Divydharshini
   Varde, Aparna S.
   Wang, Weitian
BE Wu, XT
   Jermaine, C
   Xiong, L
   Hu, XH
   Kotevska, O
   Lu, SY
   Xu, WJ
   Aluru, S
   Zhai, CX
   Al-Masri, E
   Chen, ZY
   Saltz, J
TI Transfer learning for decision support in Covid-19 detection from a few
   images in big data
SO 2020 IEEE INTERNATIONAL CONFERENCE ON BIG DATA (BIG DATA)
SE IEEE International Conference on Big Data
LA English
DT Proceedings Paper
CT 8th IEEE International Conference on Big Data (Big Data)
CY DEC 10-13, 2020
CL ELECTR NETWORK
SP IEEE, IEEE Comp Soc, IBM, Ankura
DE AI; big data mining; Covid-19; decision support; E-health; image
   recognition; transfer learning
AB The novel coronavirus (Covid-19) has spread rapidly amongst countries all around the globe. Compared to the rise in cases, there are few Covid-19 testing kits available. Due to the lack of testing kits for the public, it is useful to implement an automated AI-based E-health decision support system as a potential alternative method for Covid-19 detection. As per medical examinations, the symptoms of Covid-19 could be somewhat analogous to those of pneumonia, though certainly not identical. Considering the enormous number of cases of Covid-19 and pneumonia, and the complexity of the related images stored, the data pertaining to this problem of automated detection constitutes big data. With rapid advancements in medical imaging, the development of intelligent predictive and diagnostic tools have also increased at a rapid rate. Data mining and machine learning techniques are widely accepted to aid medical diagnosis. In this paper, a huge data set of X-ray images from patients with common bacterial pneumonia, confirmed Covid-19 disease, and normal healthy cases are utilized for AI-based decision support in detecting the Coronavirus disease. The transfer learning approach, which enables us to learn from a smaller set of samples in a problem and transfer the discovered knowledge to a larger data set, is employed in this study. We consider transfer learning using three different models that are pre-trained on several images from the ImageNet source. The models deployed here are VGG16, VGG19, and ResNet101. The dataset is generated by gathering different classes of images. We present our approach and preliminary evaluation results in this paper. We also discuss applications and open issues.
C1 [Karthikeyan, Divydharshini; Varde, Aparna S.; Wang, Weitian] Montclair State Univ, Dept Comp Sci, Montclair, NJ 07043 USA.
   [Varde, Aparna S.] Montclair State Univ, Environm Sci & Management PhD Program, Montclair, NJ 07043 USA.
RP Karthikeyan, D (corresponding author), Montclair State Univ, Dept Comp Sci, Montclair, NJ 07043 USA.
EM karthikeyand1@montclair.edu; vardea@montclair.edu; wangw@montclair.edu
FU Montclair State University; Department of Computer Science; doctoral
   faculty program from the Graduate School; College of Science and
   Mathematics; faculty scholarship program from Computer Science
FX This work incurs financial support from internal sources at Montclair
   State University. Divyadharshini Karthikeyan is funded by a graduate
   assistantship from the Department of Computer Science. Aparna Varde is
   supported by a doctoral faculty program from the Graduate School and a
   faculty scholarship program from Computer Science. Weitian Wang has
   startup funds from the College of Science and Mathematics. We thank all
   our sources for the procurement of funding that supports and encourages
   such research.
CR Ahmed N, 2020, IEEE ACCESS, V8, P134577, DOI 10.1109/ACCESS.2020.3010226
   Apostolopoulos ID, 2020, PHYS ENG SCI MED, V43, P635, DOI 10.1007/s13246-020-00865-4
   Boulos MKN, 2020, INT J HEALTH GEOGR, V19, DOI 10.1186/s12942-020-00202-8
   Conti C.J., 2020, IEEE INT IOT EL MECH
   Du XX, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON VEHICULAR ELECTRONICS AND SAFETY (ICVES), P54
   El-Din Hemdan E., ARXIV200311055
   Garcia-Gasulla D, 2018, J ARTIF INTELL RES, V61, P563, DOI 10.1613/jair.5756
   Ghoshal B., 2020, ARXIV PREPRINT
   Hawkins DM, 2004, J CHEM INF COMP SCI, V44, P1, DOI 10.1021/ci0342472
   Hopkins Johns, 2020, COVID CONTROL
   Hussain M, 2019, ADV INTELL SYST, V840, P191, DOI 10.1007/978-3-319-97982-3_16
   Jhunjhunwala A., 2020, T INDIAN NATL ACAD E, V5, P157, DOI [10.1007/s41403-020-00109-7, DOI 10.1007/S41403-020-00109-7]
   Jinia AJ, 2020, IEEE ACCESS, V8, P111347, DOI 10.1109/ACCESS.2020.3002886
   Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90
   Kaur Taranjit, 2019, 2019 International Conference on Information Technology (ICIT), P94, DOI 10.1109/ICIT48102.2019.00023
   Khan NUZ, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0188-9
   Kingma D.P., 2014, ARXIV PREPRINT ARXIV, P1
   Li W., 2020, 200312338 ARXIV
   NY Department of Health, 2020, COVID AL NY
   Ozturk T, 2020, COMPUT BIOL MED, V121, DOI 10.1016/j.compbiomed.2020.103792
   Pamuk Z, 2020, AUTOMATIC DETECTION
   Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191
   Pathak D., 2018, IEEE UEMC UB COMP EL, P227
   Sethy P., 2020, ARXIV2020030300
   Shorfuzzaman M, 2020, CMC-COMPUT MATER CON, V64, P1359, DOI 10.32604/cmc.2020.011326
   Simonyan K., 2014, ARXIV14091556
   Sinha R., 2018, ARXIV180403928
   Sun JM, 2020, TRENDS MOL MED, V26, P483, DOI 10.1016/j.molmed.2020.02.008
   Tancer J., 2011, 2011 IEEE International Conference on Data Mining Workshops, P188, DOI 10.1109/ICDMW.2011.166
   Varghese Christina, 2020, Responsible Design, Implementation and Use of Information and Communication Technology. 19th IFIP WG 6.11 Conference on e-Business, e-Services, and e-Society, I3E 2020. Proceedings. Lecture Notes in Computer Science (LNCS 12067), P389, DOI 10.1007/978-3-030-45002-1_34
   Weiss Karl, 2016, Journal of Big Data, V3, DOI 10.1186/s40537-016-0043-6
   Yang GZ, 2020, SCI ROBOT, V5, DOI 10.1126/scirobotics.abb5589
NR 32
TC 3
Z9 3
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2639-1589
BN 978-1-7281-6251-5
J9 IEEE INT CONF BIG DA
PY 2020
BP 4873
EP 4881
DI 10.1109/BigData50022.2020.9377886
PG 9
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Computer Science, Theory & Methods
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science
GA BR6NZ
UT WOS:000662554704117
OA Bronze
DA 2022-04-20
ER

PT J
AU Birhanu, A
   Balis, B
   Yadeta, TA
   Bayu, M
AF Birhanu, Abdi
   Balis, Bikila
   Assebe Yadeta, Tesfaye
   Bayu, Miesso
TI Personal protective equipment utilization practice and psychological
   preparedness of health care workers against COVID-19 pandemic in Eastern
   Ethiopia
SO SAGE OPEN MEDICINE
LA English
DT Article
DE Associated factors; health care worker; COVID-19; personal protective
   equipment; psychological preparedness; SARS-CoV-2
ID ASSOCIATION; PREVENTION; KNOWLEDGE; PERIOD; IMPACT
AB Objectives: Effective implementation of prevention and control actions by health professionals is substantial to contain the deadly COVID-19 pandemic. Thus, this study aimed to assess health care worker's practice of using personal protective equipment and psychological preparedness against the COVID-19 pandemic in Eastern Ethiopia.
   Methods: A facility-based cross-sectional study design was used. The health care workers (HCW) who were working in the selected health facilities were randomly selected. Variables that had p-value of < 0.15 were transformed to multivariable logistic regression model. Finally, the significance level was declared at the p-value < 0.05 with a 95% confidence interval (CI).
   Results: A total of 418 HCWs were randomly selected and included in this study. The study participants mean age was 27.96 years with a +/- 5.6SD. HCWs who were male (adjusted odds ratio(AOR) = 2.21, 95% CI: 1.29-3.79), regularly using sanitizer, accessing COVID-19 management guideline (AOR = 2.83, 95% CI: 1.46-5.47), trained on COVID-19 prevention methods (AOR = 2.6, 95% CI: 1.4-4.7), hopeless of eventually getting COVID-19 at workplace (AOR = 1.9, 95% CI: 1.13-3.28), and feeling unsafe at work when using standard precautions (AOR = 0.46, 95% CI: 0.27-0.79) were associated with good PPE using compared to their counterparts. Moreover, nursing/midwifery professionals practiced good personal protective equipment compared to physicians (AOR = 3.7, 95% CI: 1.8-7.7).
   Conclusion: The study demonstrated that being a male, being a nurse/midwifery, regularly sanitizing hands/medical equipment, having COVID-19 management guidelines, trained on COVID-19, and feeling of eventually getting COVID-19 at workplace had a positive association with PPE utilization. Besides, the study revealed that not feeling safe at work when using standard precautions was negatively associated with PPE utilization of HCWs. Therefore, the prevention priorities should be given to frontline HCWs by providing all possible support and strictly implementing the prevention and control guidelines of COVID-19 to prevent the health system from collapse.
C1 [Birhanu, Abdi; Bayu, Miesso] Haramaya Univ, Sch Med, Coll Hlth & Med Sci, POB 235, Harar, Ethiopia.
   [Balis, Bikila; Assebe Yadeta, Tesfaye] Haramaya Univ, Sch Nursing & Midwifery, Coll Hlth & Med Sci, Harar, Ethiopia.
RP Birhanu, A (corresponding author), Haramaya Univ, Sch Med, Coll Hlth & Med Sci, POB 235, Harar, Ethiopia.; Balis, B (corresponding author), Haramaya Univ, Sch Nursing & Midwifery, Coll Hlth & Med Sci, Harar, Ethiopia.
EM abdiibiree@gmail.com; bik.balis2008@gmail.com
RI Birhanu, Abdi/AAZ-2214-2021
OI Birhanu, Abdi/0000-0003-1312-0637
FU Haramaya University
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This
   project was funded by Haramaya University.
CR Afulani PA., 2020, PERCEIVED PREPAREDNE
   Alao MA, 2020, ADV PUBLIC HLTH, V2020, DOI 10.1155/2020/4619214
   Alshekaili M, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-042030
   Apisarnthanarak A, 2021, INFECT CONT HOSP EP, V42, P1288, DOI 10.1017/ice.2020.1240
   Asemahagn MA, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00254-3
   Barrett ES, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05587-2
   Belfroid E, 2018, J HOSP INFECT, V98, P212, DOI 10.1016/j.jhin.2017.07.001
   Bender WR, 2020, AM J PERINAT, V37, P1271, DOI 10.1055/s-0040-1715505
   Boyce MR, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00062
   Cai HZ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924171
   CDC, 2020, PROT HEALTHC PERS
   Chekole YA., 2020, PREVALENCE RISK FACT
   Chen J, 2021, SOC PSYCH PSYCH EPID, V56, P47, DOI 10.1007/s00127-020-01954-1
   Dai Y.H. G., 2020, PSYCHOL IMPACT CORON, DOI [10.1101/2020.03.03.20030874, DOI 10.1101/2020.03.03.20030874]
   Daria S, 2021, ASIA-PAC J PUBLIC HE, V33, P665, DOI 10.1177/10105395211021686
   Daria S, 2021, INT J HEALTH PLAN M, V36, P1947, DOI 10.1002/hpm.3245
   Das R, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045727
   Delgado D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082798
   Deressa W., 2020, RISK PERCEPTIONS PRE
   Desta M, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3277-5
   Dinibutun SR, 2020, J HEALTHC LEADERSH, V12, P85, DOI 10.2147/JHL.S270440
   Dunlop Catherine, 2020, BJGP Open, V4, DOI 10.3399/bjgpopen20X101041
   Adane DE, 2021, SAGE OPEN MED, V9, DOI 10.1177/20503121211001151
   Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x
   FMOH, 2020, NAT GUID FAM PLANN S
   FMOH, 2020, NAT COMPR COV 19 MAN
   Galbraith N, 2021, BJPSYCH BULL, V45, P93, DOI 10.1192/bjb.2020.44
   Gill S, 2020, CURR ONCOL, V27, P71, DOI 10.3747/co.27.6643
   Greenberg N, 2020, BMJ LEAD, V4, P101, DOI 10.1136/leader-2020-000273
   Haile TG, 2017, J ENVIRON PUBLIC HEA, V2017, DOI 10.1155/2017/2050635
   Hakim M, 2021, HEALTH SECUR, V19, P140, DOI 10.1089/hs.2020.0142
   Hossain MA, 2021, J MULTIDISCIP HEALTH, V14, P229, DOI 10.2147/JMDH.S293717
   Karlberg J, 2004, AM J EPIDEMIOL, V159, P229, DOI 10.1093/aje/kwh056
   Khanal P, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00621-z
   Lakshmi G, 2016, INT J COMMUNITY MED, V5
   Mersha A, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10256-3
   Mulu GB, 2020, INFECT DRUG RESIST, V13, P3171, DOI 10.2147/IDR.S265829
   Norton EJ, 2021, J PUBLIC HEALTH-UK, V43, P67, DOI 10.1093/pubmed/fdaa187
   Pan American Health Organization/ World Health Organization, 2020, COVID 19 HAS INF SOM
   Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]
   Rajamani A, 2021, AUST CRIT CARE, V34, P135, DOI 10.1016/j.aucc.2020.09.006
   Repon MAU, 2021, SCI PROGRESS-UK, V104, DOI 10.1177/00368504211026409
   Romero CS, 2022, PSYCHOL MED, V52, P188, DOI 10.1017/S0033291720001671
   Sandesh R, 2020, CUREUS, V12, DOI 10.7759/cureus.8974
   Semo BW, 2020, PSYCHOL RES BEHAV MA, V13, P713, DOI 10.2147/PRBM.S264286
   Si MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00724-0
   Thiam AB, 2015, PAN AFR MED J, V20, DOI [10.11604/pamj.2015.20.379.6070, 10.11694/pamj.supp.2015.22.1.6626]
   Wang W, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00733
   Wankowicz P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165849
   WHO, 2020, 10000 HLTH WORK AFR
   WHO, 2020, COR DIS COVID 19 PAN
   WHO, 2020, TECHN GUID INF PREV
   World Health Organization, 2018, PREF PROD CHAR PERS
   World Health Organization, 2020, COR DIS COV 19 OUTBR
   World Health Organization of the United Nations (WHO), 2021, WHO COR VIR DIS COVI
   Zhang LW, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8010064
   Zhang XR, 2020, J AFFECT DISORDERS, V277, P495, DOI 10.1016/j.jad.2020.08.041
   Zhao Y, 2020, AM J RESP CRIT CARE, V202, P756, DOI 10.1164/rccm.202001-0179LE
NR 58
TC 0
Z9 0
U1 1
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2050-3121
J9 SAGE OPEN MED
JI SAGE Open Med.
PD OCT
PY 2021
VL 9
AR 20503121211051925
DI 10.1177/20503121211051925
PG 10
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA WG0VB
UT WOS:000706716200001
PM 34659769
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Frohlich, MR
   Rettke, H
   Conca, A
   Boden, K
AF Frohlich, Martin R.
   Rettke, Horst
   Conca, Antoinette
   Boden, Karsten
TI Inter- und intraprofessionelle Zusammenarbeit in Krisensituationen auf
   der Intensivstation am Beispiel von COVID-19 Eine qualitative,
   retrospektive Analyse
SO PFLEGE
LA English
DT Article
DE Collaboration; crisis situation; intensive care unit; COVID-19;
   qualitative content analysis
ID COLLABORATION; TEAMWORK; PERCEPTIONS; PHYSICIANS; NURSES
AB Interprofessional and intraprofessional collaboration in crises situations in the intensive care unit regarding COVID-19 - a qualitative, retrospective analysis Abstract. Background: Interprofessional collaboration is elementary in the intensive care unit, a success factor in difficult patient situations and complex therapies. The COVID-19-pandemic challenged newly composed treatment teams, however, experience does not exist. Aim: We analyzed personal experiences and views on inter- and intraprofessional collaboration in intensive care units during the COVID-19-pandemic and identified influencing factors. Methods: We used a qualitative, retrospective study design, collected data from physicians, nurses in intensive care, anesthesia and surgery and physiotherapists during group discussions using the story / dialogue method. We analyzed the data according to Mayring's Qualitative content analysis. Results: We identified two main categories, each with three sub-categories: 1. Mastering a exceptional situation actively (Recognizing a common goal; Acting in solidarity; Getting to know each other in inter- / intraprofessional collaboration), 2. Having overcome the exceptional situation in retrospect (Maintaining personal contacts; Gaining new knowledge and perspectives; Taking what has been learned into the future). The participants rated the interprofessional and intraprofessional collaboration as good to very good. Conclusions: Factors promoting collaboration and positive experiences are to be incorporated into everyday work. The intraprofessional management team thereby defines common goals and values for the best possible patient care.
C1 [Frohlich, Martin R.; Conca, Antoinette] Kantonsspital Aarau, Fachabt Pflegeentwicklung, Aarau, Switzerland.
   [Frohlich, Martin R.] Kantonsspital Aarau, Bereich Perioperat Med, Aarau, Switzerland.
   [Boden, Karsten] Kantonsspital Aarau, Direkt Pflege & MTTD, Aarau, Switzerland.
RP Frohlich, MR (corresponding author), Kantonsspital Aarau, Fachabt Pflegeentwicklung, Bereich Perioperat Med, Tellstr 25, CH-5001 Aarau, Switzerland.
EM martin.froehlich@ksa.ch
CR Alexanian JA, 2015, CRIT CARE MED, V43, P1880, DOI 10.1097/CCM.0000000000001136
   Atzeni G., 2017, SWISS ACAD REPORTS, V12, P1
   Avvenire, 2020, COR SON OLTR 35000 C
   Chamberlain-Salaun J, 2013, J MULTIDISCIP HEALTH, V6, P65, DOI 10.2147/JMDH.S40676
   Chen SY, 2015, J NURS MANAGE, V23, P297, DOI 10.1111/jonm.12126
   D'Amour Danielle, 2005, J Interprof Care, V19 Suppl 1, P116, DOI 10.1080/13561820500082529
   Donovan AL, 2018, CRIT CARE MED, V46, P980, DOI 10.1097/CCM.0000000000003067
   Ervin JN, 2018, AM PSYCHOL, V73, P468, DOI 10.1037/amp0000247
   European Medicines Agency, 2015, GUID GOOD CLIN PRACT
   Fishman A., 2020, BEITRAG ZUM ANN M SS
   Fumeaux T., 2017, SWISS MED WKLY, V147, pW14549
   George KL, 2018, DIMENS CRIT CARE NUR, V37, P144, DOI 10.1097/DCC.0000000000000301
   Guris RJD, 2019, BRIT J ANAESTH, V122, P767, DOI 10.1016/j.bja.2019.01.017
   Halberg N, 2020, J CLIN NURS, V29, P932, DOI 10.1111/jocn.15157
   Hales P, 2020, J INTERPROF CARE, V34, P614, DOI 10.1080/13561820.2020.1813093
   Hanifa ALB, 2018, INTENS CRIT CARE NUR, V48, P85, DOI 10.1016/j.iccn.2018.06.004
   Hirsbrunner T., 2020, INT PRACTICE DEV J, V10, P1
   Ho WH, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-8
   House S, 2017, J NURS ADMIN, V47, P165, DOI 10.1097/NNA.0000000000000460
   Hunziker S, 2011, J AM COLL CARDIOL, V57, P2381, DOI 10.1016/j.jacc.2011.03.017
   Labonte R, 1999, HEALTH EDUC RES, V14, P39, DOI 10.1093/her/14.1.39
   Lin YP, 2020, J ADV NURS, V76, P373, DOI 10.1111/jan.14244
   Mahler C., 2014, GMS Z MED AUSBILDUNG, V31, P1
   Mayring P., 2010, QUALITATIVE INHALTSA, V11
   Piquette D, 2009, J INTERPROF CARE, V23, P273, DOI 10.1080/13561820802697818
   Porter-O'Grady T, 2001, J NURS ADMIN, V31, P468, DOI 10.1097/00005110-200110000-00010
   Reeves S, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000072.pub3
   Rettke H, 2020, PFLEGE, V33, P85, DOI 10.1024/1012-5302/a000718
   Rose L, 2011, NURS CRIT CARE, V16, P5, DOI 10.1111/j.1478-5153.2010.00398.x
   Schweizerische Akademie der Medizinischen Wissenschaften (SAMW), 2014, CHART ZUS FACHL GES
   Schweizerische Eidgenossenschaft der Bundesrat, 2020, AUSS LAG
   Schweizerische Gesellschaft fur Intensivmedizin, 2020, STELL COR KRANKH 201
   SHAPIRO BS, 1995, PAIN, V61, P139, DOI 10.1016/0304-3959(94)00164-A
   Sottas B., 2015, UBERSICHTSSTUDIE NUT
   Spiegel, 2020, NUTZT Z IHR NOCH HAB
   Tang CJ, 2013, INT NURS REV, V60, P291, DOI 10.1111/inr.12034
   Wendel Garcia PD, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02919-1
   World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053
NR 38
TC 0
Z9 0
U1 0
U2 0
PU HOGREFE AG-HOGREFE AG SUISSE
PI BERN
PA LANGGASSSTRASSE 76, BERN, SWITZERLAND
SN 1012-5302
EI 1664-283X
J9 PFLEGE
JI Pflege
PD SEP
PY 2021
VL 34
IS 5
BP 251
EP 262
DI 10.1024/1012-5302/a000821
PG 12
WC Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing
GA UW7AU
UT WOS:000700306400004
PM 34109801
DA 2022-04-20
ER

PT J
AU Ferrando, C
   Suarez-Sipmann, F
   Mellado-Artigas, R
   Hernandez, M
   Gea, A
   Arruti, E
   Aldecoa, C
   Martinez-Palli, G
   Martinez-Gonzalez, MA
   Slutsky, AS
   Villar, J
AF Ferrando, Carlos
   Suarez-Sipmann, Fernando
   Mellado-Artigas, Ricard
   Hernandez, Maria
   Gea, Alfredo
   Arruti, Egoitz
   Aldecoa, Cesar
   Martinez-Palli, Graciela
   Martinez-Gonzalez, Miguel A.
   Slutsky, Arthur S.
   Villar, Jesus
CA COVID-19 Spanish ICU Network
TI Clinical features, ventilatory management, and outcome of ARDS caused by
   COVID-19 are similar to other causes of ARDS
SO INTENSIVE CARE MEDICINE
LA English
DT Article
DE Acute respiratory distress syndrome; Coronavirus; Mechanical
   ventilation; Outcome
ID RESPIRATORY-DISTRESS-SYNDROME; EPIDEMIOLOGY
AB Purpose The main characteristics of mechanically ventilated ARDS patients affected with COVID-19, and the adherence to lung-protective ventilation strategies are not well known. We describe characteristics and outcomes of confirmed ARDS in COVID-19 patients managed with invasive mechanical ventilation (MV). Methods This is a multicenter, prospective, observational study in consecutive, mechanically ventilated patients with ARDS (as defined by the Berlin criteria) affected with with COVID-19 (confirmed SARS-CoV-2 infection in nasal or pharyngeal swab specimens), admitted to a network of 36 Spanish and Andorran intensive care units (ICUs) between March 12 and June 1, 2020. We examined the clinical features, ventilatory management, and clinical outcomes of COVID-19 ARDS patients, and compared some results with other relevant studies in non-COVID-19 ARDS patients. Results A total of 742 patients were analysed with complete 28-day outcome data: 128 (17.1%) with mild, 331 (44.6%) with moderate, and 283 (38.1%) with severe ARDS. At baseline, defined as the first day on invasive MV, median (IQR) values were: tidal volume 6.9 (6.3-7.8) ml/kg predicted body weight, positive end-expiratory pressure 12 (11-14) cmH(2)O. Values of respiratory system compliance 35 (27-45) ml/cmH(2)O, plateau pressure 25 (22-29) cmH(2)O, and driving pressure 12 (10-16) cmH(2)O were similar cto values from non-COVID-19 ARDS observed in other studies. Recruitment maneuvers, prone position and neuromuscular blocking agents were used in 79%, 76% and 72% of patients, respectively. The risk of 28-day mortality was lower in mild ARDS [hazard ratio (RR) 0.56 (95% CI 0.33-0.93),p = 0.026] and moderate ARDS [hazard ratio (RR) 0.69 (95% CI 0.47-0.97),p = 0.035] when compared to severe ARDS. The 28-day mortality was similar to other observational studies in non-COVID-19 ARDS patients. Conclusions In this large series, COVID-19 ARDS patients have features similar to other causes of ARDS, compliance with lung-protective ventilation was high, and the risk of 28-day mortality increased with the degree of ARDS severity.
C1 [Ferrando, Carlos; Mellado-Artigas, Ricard; Martinez-Palli, Graciela] Hosp Clin Barcelona, Inst Invest August Pi & Sunyer, Dept Anesthesiol & Crit Care, Villarroel 170, Barcelona 08025, Spain.
   [Ferrando, Carlos; Suarez-Sipmann, Fernando; Villar, Jesus] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain.
   [Suarez-Sipmann, Fernando] Uppsala Univ Hosp, Dept Surg Sci, Hedenstierna Lab, Uppsala, Sweden.
   [Suarez-Sipmann, Fernando] Hosp Univ La Princesa, Intens Care Unit, Madrid, Spain.
   [Hernandez, Maria] Hosp Cruces, Dept Anesthesiol & Crit Care, Baracaldo, Vizcaya, Spain.
   [Gea, Alfredo] Univ Navarra, Med Sch, Dept Prevent Med & Publ Hlth, Pamplona, Spain.
   [Arruti, Egoitz] Ubikare Technol, Vizcaya, Spain.
   [Aldecoa, Cesar] Hosp Univ Rio Hortega, Dept Anesthesiol & Crit Care, Valladolid, Spain.
   [Martinez-Gonzalez, Miguel A.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA.
   [Martinez-Gonzalez, Miguel A.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid, Spain.
   [Slutsky, Arthur S.; Villar, Jesus] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Slutsky, Arthur S.] Univ Toronto, Dept Med, Toronto, ON, Canada.
   [Villar, Jesus] Hosp Univ Dr Negrin, Res Unit, Multidisciplinary Organ Dysfunct Evaluat Res Netw, Las Palmas Gran Canaria, Spain.
RP Ferrando, C (corresponding author), Hosp Clin Barcelona, Inst Invest August Pi & Sunyer, Dept Anesthesiol & Crit Care, Villarroel 170, Barcelona 08025, Spain.; Ferrando, C (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain.
EM cafeoranestesia@gmail.com
RI Martinez-Gonzalez, Miguel A./AAE-7669-2019; Slutsky, Arthur/M-3325-2019;
   Monedero, Pablo/A-1696-2008; Balaguer-Castro, Mariano/Y-3415-2018;
   Almuedo Riera, Alex/AAD-4957-2022; López-Baamonde, Manuel/AAF-9721-2021;
   Rivas, Eva/AFU-7933-2022; Andrea, Rut/L-2806-2019; Villar,
   Jesús/R-4526-2019; Garutti, Ignacio/H-9035-2017; Arruti,
   Egoitz/M-1905-2014; Ripolles-Melchor, Javier/O-3330-2018
OI Monedero, Pablo/0000-0002-1596-5644; Balaguer-Castro,
   Mariano/0000-0003-3625-6887; Almuedo Riera, Alex/0000-0003-4643-4456;
   López-Baamonde, Manuel/0000-0001-5537-1755; Rivas,
   Eva/0000-0002-5816-998X; Andrea, Rut/0000-0002-8409-5013; Villar,
   Jesús/0000-0001-5687-3562; Mellado Artigas, Ricard/0000-0003-2815-6819;
   Garutti, Ignacio/0000-0001-8284-2903; Martinez-Palli,
   Graciela/0000-0002-7163-8090; Ibanez-Esteve,
   Cristina/0000-0002-9774-4836; Toapanta Gaibor, Nestor
   David/0000-0001-5369-6759; Ferrer, Miguel/0000-0001-8171-6673; Gracia,
   Isabel/0000-0001-8442-8247; Perez Ferrer, Antonio/0000-0003-0913-4446;
   Cunat, Tomas/0000-0002-6475-9230; Margarit, Andrei/0000-0001-9194-7352;
   Castella, Manuel/0000-0001-9274-2121; Suarez de la Rica,
   Alejandro/0000-0003-1139-8547; Gea, Alfredo/0000-0002-2229-4690;
   Reverter, Enric/0000-0002-4967-6947; Arruti, Egoitz/0000-0003-0674-3609;
   Castro Rebollo, Pedro/0000-0002-6118-8970; Ripolles-Melchor,
   Javier/0000-0002-1958-9316; Balibrea, Jose M./0000-0002-0764-7179; de
   Diego, Oriol/0000-0002-8476-7094; Abad-Motos, Ane/0000-0002-9644-2887;
   Leon, Irene/0000-0003-2172-8933; Ferrando, Carlos/0000-0002-1907-5323;
   Perdomo Linares, Juan Manuel/0000-0001-7458-297X; Carreras-Castaner,
   Anna/0000-0002-7231-2236; borrat, xavier/0000-0002-9348-9284; MARCOS
   CONTRERAS, SERGIO/0000-0001-5788-7536; Casas Reza,
   Pablo/0000-0002-2799-8523; Ojeda, Antonio/0000-0003-4950-1044
FU Instituto de Salud Carlos III, Madrid, SpainInstituto de Salud Carlos
   III [CB06/06/1088, PI16/00049, PI18/01611, PI19/00141]; Canadian
   Institutes of Health Research (CIHR)Canadian Institutes of Health
   Research (CIHR) [FDN143285, OV3-170344]
FX Instituto de Salud Carlos III, Madrid, Spain (#CB06/06/1088;
   #PI16/00049; #PI18/01611; #PI19/00141); and Canadian Institutes of
   Health Research (CIHR) FDN143285, and OV3-170344.
CR [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326
   Bellani G, 2020, INTENS CARE MED, V46, P1180, DOI 10.1007/s00134-020-06035-0
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Beloncle FM, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00675-7
   Brock GN, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-144
   Cavalcanti AB, 2017, JAMA-J AM MED ASSOC, V318, P1335, DOI 10.1001/jama.2017.14171
   Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2
   Gattinoni L, 2020, AM J RESP CRIT CARE, V201, P1299, DOI 10.1164/rccm.202003-0817LE
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Guerin C, 2018, INTENS CARE MED, V44, P22, DOI 10.1007/s00134-017-4996-5
   Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Kacmarek RM, 2016, CRIT CARE MED, V44, P32, DOI 10.1097/CCM.0000000000001383
   Madotto F, 2018, INTENS CARE MED, V44, P564, DOI 10.1007/s00134-018-5152-6
   Marini JJ, 2020, JAMA-J AM MED ASSOC, V323, P2329, DOI 10.1001/jama.2020.6825
   Moss M, 2019, NEW ENGL J MED, V380, P1997, DOI 10.1056/NEJMoa1901686
   Pensier J, 2019, INTENS CARE MED, V45, P1691, DOI 10.1007/s00134-019-05821-9
   Pistillo N, 2018, INTENS CARE MED, V44, P674, DOI 10.1007/s00134-018-5092-1
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Schenck EJ, 2020, ANN AM THORAC SOC, V17, P1158, DOI 10.1513/AnnalsATS.202005-427RL
   Slutsky AS, 2019, NEW ENGL J MED, V380, P2061, DOI 10.1056/NEJMe1905627
   Spinelli E, 2020, INTENS CARE MED, V46, P606, DOI 10.1007/s00134-020-05942-6
   Villar J, 2015, CRIT CARE MED, V43, P346, DOI 10.1097/CCM.0000000000000703
   Villar J, 2011, INTENS CARE MED, V37, P1932, DOI 10.1007/s00134-011-2380-4
   von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040296, 10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]
   Wenjie T, 2020, NOVEL CORONAVIRUS GE
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Ziehr DR, 2020, AM J RESP CRIT CARE, V201, P1560, DOI 10.1164/rccm.202004-1163LE
NR 32
TC 144
Z9 145
U1 6
U2 17
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0342-4642
EI 1432-1238
J9 INTENS CARE MED
JI Intensive Care Med.
PD DEC
PY 2020
VL 46
IS 12
SI SI
BP 2200
EP 2211
DI 10.1007/s00134-020-06192-2
EA JUL 2020
PG 12
WC Critical Care Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA OZ3WD
UT WOS:000553720400001
PM 32728965
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Lukito-Budi, AS
   Manik, HFGG
   Indarti, N
AF Lukito-Budi, Andy Susilo
   Manik, Hardo Firmana Given Grace
   Indarti, Nurul
TI Reorienting the organisational strategy of SMEs during the COVID-19
   crisis: can entrepreneurial orientation help?
SO JOURNAL OF STRATEGY AND MANAGEMENT
LA English
DT Article; Early Access
DE Adaptive process; Entrepreneurial orientation; Environmental shock;
   COVID-19; SMEs; Innovation
ID DYNAMIC CAPABILITIES; MILES; LEADERSHIP; KNOWLEDGE; BUSINESS;
   PERFORMANCE; CHOICE; IMPACT
AB Purpose This paper offers innovative strategies on how small- and medium-sized enterprises (SMEs) can respond to the COVID-19 crisis by incorporating an entrepreneurial orientation concept corresponding to the nature of the environmental shock. Design/methodology/approach This paper conceptualises a solution by elaborating three critical items, namely entrepreneurial orientation, adaptive process and strategy types as key factors to develop the framework solution. This paper outlines a strategy proposal for SMEs to respond to the crisis. Findings The environmental factor represents the crisis, which leads to a degree of innovation, i.e., radical and incremental, and can be approached using an adjusted adaptive consolidation process from Child. This paper identifies four strategy options from Miles and Snow to respond to the crisis; i.e. (1) defender-exploitative innovation; (2) analyser-organisational ambidexterity; (3) prospector-exploratory innovation and (4) reactor-abandon or shut down the business. Originality/value While most of the suggestions from previous COVID-19-related works are acknowledged, this paper brings more insight from an academic perspective, specifically organisational theory, to cope with the pandemic crisis. The steps and strategy to be chosen can guide policymakers to decide what is their best move to respond to this crisis. In addition, the proposed strategies call for future research to provide empirical evidence by exploring and examining various scenarios in different kinds of businesses.
C1 [Lukito-Budi, Andy Susilo] Atma Jaya Catholic Univ Indonesia, Fac Econ & Business, Jakarta, Indonesia.
   [Manik, Hardo Firmana Given Grace] Duta Wacana Christian Univ, Fac Business, Dept Management, Yogyakarta, Indonesia.
   [Indarti, Nurul] Univ Gadjah Mada, Fac Econ & Business, Dept Management, Yogyakarta, Indonesia.
RP Indarti, N (corresponding author), Univ Gadjah Mada, Fac Econ & Business, Dept Management, Yogyakarta, Indonesia.
EM nurulindarti@ugm.ac.id
OI Indarti, Nurul/0000-0002-2448-6450; Manik, Hardo Firmana Given
   Grace/0000-0003-0769-3236
CR Achanga P, 2006, J MANUF TECHNOL MANA, V17, P460, DOI 10.1108/17410380610662889
   Al-Omoush KS, 2021, J BUS RES, V132, P765, DOI 10.1016/j.jbusres.2020.10.056
   Amankwah-Amoah J, 2021, EUR MANAG J, V39, P179, DOI 10.1016/j.emj.2020.09.002
   Badstreet Dun, 2020, ASEAN SME TRANSF STU
   Beaver G., 2003, STRATEG CHANG, V12, P115, DOI [10.1002/jsc.624, DOI 10.1002/JSC.624]
   Blackmore K, 2013, AUST J MANAGE, V38, P171, DOI 10.1177/0312896212444692
   Brown R., 2020, EC COMMENTARY, V44, P1
   Chandler GN, 2011, J BUS VENTURING, V26, P375, DOI 10.1016/j.jbusvent.2009.10.006
   Child J, 1997, ORGAN STUD, V18, P43, DOI 10.1177/017084069701800104
   Covin JG, 2011, ENTREP THEORY PRACT, V35, P855, DOI 10.1111/j.1540-6520.2011.00482.x
   Csath M., 2020, DEV LEARN ORG INT J, DOI [10.1108/DLO-04-2020-0086, DOI 10.1108/DLO-04-2020-0086]
   Desarbo WS, 2005, STRATEGIC MANAGE J, V26, P47, DOI 10.1002/smj.431
   Digital Innovation Hubs Working Group, 2018, REPORT WORKING GROUP
   Donthu N, 2020, J BUS RES, V117, P284, DOI 10.1016/j.jbusres.2020.06.008
   Duriin, 2020, EC ANAL, V53, P14, DOI DOI 10.28934/EA.20.53.1.PP14-27
   Eggers F, 2020, J BUS RES, V116, P199, DOI 10.1016/j.jbusres.2020.05.025
   Eisenhardt KM, 2000, STRATEGIC MANAGE J, V21, P1105, DOI 10.1002/1097-0266(200010/11)21:10/11<1105::AID-SMJ133>3.0.CO;2-E
   Garba A, 2020, GRAS MULTIDISCIPLINA, V4, P1
   GEM, 2020, DIAGN COVID 19 IMP E
   GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469
   Helgeson J.F., 2020, ELICITING LESSONS SM
   Hemmington N, 2022, TOUR HOSP RES, V22, P102, DOI 10.1177/1467358421993875
   HREBINIAK LG, 1985, ADMIN SCI QUART, V30, P336, DOI 10.2307/2392666
   Ihsanuddin, 2020, AD 7 BANT PEM SEL PA
   Indonesian Statistics Bureau, 2020, AN HAS SURV DAMP COV
   KataData, 2020, DIG UMKM TENG PAND C
   Khalifa AS, 2021, J STRATEGY MANAG, V14, P35, DOI 10.1108/JSMA-04-2020-0092
   Kirk CP, 2020, J BUS RES, V117, P124, DOI 10.1016/j.jbusres.2020.05.028
   Koryak O, 2015, INT SMALL BUS J, V33, P89, DOI 10.1177/0266242614558315
   Laskovaia A, 2019, ENTREP REGION DEV, V31, P456, DOI 10.1080/08985626.2018.1541593
   Lin CH, 2014, J BUS RES, V67, P1979, DOI 10.1016/j.jbusres.2013.10.013
   Lozano R, 2021, J ORGAN CHANGE MANAG, V34, P613, DOI 10.1108/JOCM-09-2020-0276
   Lukito-Budi A.S., 2021, MEMILIH MENJADI BESA, V1st ed.
   Lumpkin GT, 1996, ACAD MANAGE REV, V21, P135, DOI 10.2307/258632
   Manik HFGG, 2021, J ENTERP COMMUNITIES, DOI 10.1108/JEC-03-2020-0021
   Miles R.E., 2003, ORG STRATEGY STUCTUR
   Muijs D, 2011, INT J EDUC MANAG, V25, P45, DOI 10.1108/09513541111100116
   Naushad M, 2021, J ASIAN FINANC ECON, V8, P225, DOI 10.13106/jafeb.2021.vol8.no4.0225
   Nofiani D, 2021, J ENTREP EMERG ECON, V13, P1262, DOI 10.1108/JEEE-09-2020-0331
   O'Regan N, 2006, J MANUF TECHNOL MANA, V17, P603, DOI 10.1108/17410380610668540
   OECD, 2021, OECD SME ENTR OUTL 2
   OECD, 2017, M OECD COUNC MIN LEV
   OECD, 2020, OECD EC OUTL 2020 SI
   Papadopoulos T, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102192
   Parnell J.A., 1993, BRIT J MANAGE, V4, P29, DOI DOI 10.1111/J.1467-8551.1993.TB00159.X
   PEARCE JA, 1994, STRATEGIC MANAGE J, V15, P407, DOI 10.1002/smj.4250150507
   Perry SC, 2001, J SMALL BUS MANAGE, V39, P201, DOI 10.1111/1540-627X.00019
   Riom C., 2020, 9 CTR EC PERF COV 19
   Sanfelici M., 2020, INT J COMMUNITY SOCI, V2, P191, DOI [https://doi.org/10.1177/2516602620936037, DOI 10.1177/2516602620936037]
   Seetharaman P, 2020, INT J INFORM MANAGE, V54, DOI 10.1016/j.ijinfomgt.2020.102173
   Shahri MH, 2020, J STRATEGY MANAG, V13, P241, DOI 10.1108/JSMA-08-2019-0154
   Sheth J, 2020, J BUS RES, V117, P280, DOI 10.1016/j.jbusres.2020.05.059
   Sine WD, 2006, ACAD MANAGE J, V49, P121
   Soininen JS, 2013, INT J ENTREP BEHAV R, V19, P611, DOI [10.1108/JEBR-10-2012-0106, 10.1108/IJEBR-10-2012-0106]
   Suarez FF, 2005, ACAD MANAGE J, V48, P710
   Teece D, 2016, CALIF MANAGE REV, V58, P13, DOI 10.1525/cmr.2016.58.4.13
   Teece DJ, 2012, J MANAGE STUD, V49, P1395, DOI 10.1111/j.1467-6486.2012.01080.x
   Thorgren S., 2020, J BUS VENTURING INSI, V14, DOI [10.1016/j.jbvi.2020.e00187, DOI 10.1016/J.JBVI.2020.E00187]
   ULRICH D, 1984, ACAD MANAGE REV, V9, P471, DOI 10.2307/258287
   Un CA, 2015, J PROD INNOVAT MANAG, V32, P138, DOI 10.1111/jpim.12229
   Valdiserri G.A., 2010, ENTREPRENEURIAL EXEC, V15, P47
   Vasudeva G, 2011, ACAD MANAGE J, V54, P611, DOI 10.5465/AMJ.2011.61968108
   Voss ZG, 2005, EUR J MARKETING, V39, P1132, DOI 10.1108/03090560510610761
   Wales WJ, 2013, INT SMALL BUS J, V31, P357, DOI 10.1177/0266242611418261
   Walter A, 2006, J BUS VENTURING, V21, P541, DOI 10.1016/j.jbusvent.2005.02.005
   Wenzel M, 2021, STRATEGIC MANAGE J, V42, pV7, DOI 10.1002/smj.3161
   Yip WF, 2021, LANCET REG HEALTH-W, V7, DOI 10.1016/j.lanwpc.2020.100091
   Zdnet, 2020, BRAZ SMBS ACC TECH A
NR 68
TC 0
Z9 0
U1 1
U2 1
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1755-425X
J9 J STRATEGY MANAG
JI J. Strategy Manag.
DI 10.1108/JSMA-07-2021-0156
EA MAR 2022
PG 13
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA ZY2ZO
UT WOS:000772457500001
OA Bronze
DA 2022-04-20
ER

PT J
AU Hossain, MB
   Wicaksono, T
   Nor, KM
   Dunay, A
   Illes, CB
AF Hossain, Md Billal
   Wicaksono, Tutur
   Nor, Khalil Md
   Dunay, Anna
   Illes, Csaba Balint
TI E-commerce Adoption of Small and Medium-Sized Enterprises During
   COVID-19 Pandemic: Evidence from South Asian Countries
SO JOURNAL OF ASIAN FINANCE ECONOMICS AND BUSINESS
LA English
DT Article
DE E-commerce Adoption; SMEs; South Asia; Open Innovation; COVID-19
   Pandemic
AB COVID-19 has spread across the world in the last two years, confining people to their homes and shutting down businesses and markets. The world is currently experiencing a catastrophic economic and social crisis. To benefit people and to protect them, industries invented new . products. These products were made by small and medium-sized businesses across the globe. In South Asia, there was also a rigorous lockdown, people were laid off, and SMEs adopted E-commerce to assist clients and customers. Therefore, the study aims to analyze the impact of the COVID-19 pandemic on B-commerce adoption through open innovation strategies in South Asian countries. 500 respondents were selected through an online questionnaire to collect data from different countries of South Asia. The prominent countries are; India, Pakistan, and Bangladesh. The results of the study show that perceived compatibility and complexity have a positive influence on E-commerce adoption. In normal circumstances, however, the open innovation model is feasible. Knowledge and experience sharing and management attitude have a moderate impact on E-commerce adoption. These results are beneficial for researchers and SME managers in South Asia to overcome the challenges of the COVID-19 pandemic and increase the number of skilled people employed. This study suggests that SMEs should hire skilled workers to upgrade their systems.
C1 [Hossain, Md Billal; Wicaksono, Tutur] Hungarian Univ Agr & Life Sci, Doctoral Sch Econ & Reg Sci, Pater Karoly U 1, H-2100 Godollo, Hungary.
   [Wicaksono, Tutur] Univ Al Azhar Indonesia UAI, Fac Econ & Business, Jakarta, Indonesia.
   [Nor, Khalil Md] Univ Technol Malaysia, Azman Hashim Int Business Sch, Johor Baharu, Malaysia.
   [Dunay, Anna; Illes, Csaba Balint] Hungarian Univ Agr & Life Sci, Inst Econ Sci, Godollo, Hungary.
RP Hossain, MB; Wicaksono, T (corresponding author), Hungarian Univ Agr & Life Sci, Doctoral Sch Econ & Reg Sci, Pater Karoly U 1, H-2100 Godollo, Hungary.; Wicaksono, T (corresponding author), Univ Al Azhar Indonesia UAI, Fac Econ & Business, Jakarta, Indonesia.
EM Hossain.Md.Billal@phd.uni-mate.hu; wicaksono.tutur@phd.uni-mate.hu;
   kmdnor@management.utm.my; dunay.anna@uni-mate.hu;
   Illes.Balint.Csaba@uni-mate.hu
RI Illés, Csaba B/A-1543-2017; Dunay, Anna/A-3386-2017
OI Illés, Csaba B/0000-0001-9546-2897; Dunay, Anna/0000-0003-0254-9243;
   Hossain, Md Billal/0000-0003-0118-7076
CR Ahmad SZ, 2015, INFORM TECHNOL DEV, V21, P555, DOI 10.1080/02681102.2014.899961
   Alfonso V., 2021, BIS B, V36
   Alhaimer R, 2022, J INTERNET COMMER, V21, P26, DOI 10.1080/15332861.2021.1882758
   Bhatti A., 2020, INT J FUTUR GENER CO, V13, P1449
   Bozer G, 2018, EUR J WORK ORGAN PSY, V27, P342, DOI 10.1080/1359432X.2018.1446946
   Chaffey D., 2019, DIGITAL BUSINESS E C
   Chin W.W., 2001, PLS GRAPH USERS GUID
   Daugherty T, 2005, ADVERT CONS, P457
   Deventer M., 2018, INT J E BUSINESS E G, V10, P18, DOI [10.21511/bbs.12(1-1).2017.05, DOI 10.21511/BBS.12(1-1).2017.05]
   Faraoni M, 2019, BRIT FOOD J, V121, P574, DOI 10.1108/BFJ-04-2018-0216
   Ghobakhloo M, 2011, IND MANAGE DATA SYST, V111, P1238, DOI 10.1108/02635571111170785
   Gkika E. C., 2020, J OPEN INNOV-TECHNOL, V6, P41, DOI [10.3390/joitmc6020041, DOI 10.3390/JOITMC6020041]
   Guzman S. A., 2018, J INFORM SYSTEMS ENG, V3, P26, DOI [10.20897/jisem/3937, DOI 10.20897/JISEM/3937]
   Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202
   Hutajulu RS, 2021, J ASIAN FINANC ECON, V8, P57, DOI 10.13106/jafeb.2021.vol8.no10.0057
   Kussusanti S, 2019, J ASIAN FINANC ECON, V6, P129, DOI 10.13106/jafeb.2019.vol6.no1.129
   McPhillips M, 2020, J OPEN INNOV-TECHNOL, V6, P84
   Mohamad Abdul Hadi, 2020, IOP Conference Series: Materials Science and Engineering, V864, DOI 10.1088/1757-899X/864/1/012049
   Mohd Zain Z., 2020, J INT BUSINESS EC EN, V5, P50
   Priambodo IT, 2021, J ASIAN FINANC ECON, V8, P865, DOI 10.13106/jafeb.2021.vol8.no3.0865
   Rebeka E., 2015, MEDITERRANEAN J SOCI, V6, P72, DOI [10.5901/mjss.2015.v6n1p72, DOI 10.5901/MJSS.2015.V6N1P72]
   Rogers EM, 2002, ADDICT BEHAV, V27, P989, DOI 10.1016/S0306-4603(02)00300-3
   Schneider Friedrich, 2010, International Economic Journal, V24, P443
   Schniederjans M. J., 2013, E COMMERCE OPERATION
   Singer DRJ, 2020, HEALTH POLICY TECHN, V9, P1, DOI 10.1016/j.hlpt.2020.02.001
   Tan KS, 2009, IND MANAGE DATA SYST, V109, P224, DOI 10.1108/02635570910930118
   Tapeh AG, 2008, KNOWL-BASED SYST, V21, P946, DOI 10.1016/j.knosys.2008.04.005
   Teo T. L., 2004, ACIS, V54, P16, DOI 10.112331/acis.54.16
   Tran LTT, 2021, J RETAIL CONSUM SERV, V58, DOI 10.1016/j.jretconser.2020.102287
   Wicaksono T., 2021, J OPEN INNOV TECHNOL, V7, P91, DOI [10.3390/joitmc7010091, DOI 10.3390/JOITMC7010091]
NR 30
TC 1
Z9 1
U1 4
U2 4
PU KOREA DISTRIBUTION SCIENCE ASSOC
PI GYEONGGI
PA HANSHIN OFFICETEL STE 1030, 2463-4, SHINHEUNG-DONG SUJEONG-GU, SEONGNAM,
   GYEONGGI, 461-713, SOUTH KOREA
SN 2288-4637
EI 2288-4645
J9 J ASIAN FINANC ECON
JI J. Asian Financ. Econ. Bus.
PD JAN
PY 2022
VL 9
IS 1
BP 291
EP 298
DI 10.13106/jafeb.2022.vol9.no1.0291
PG 8
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA YE4NQ
UT WOS:000741104900026
DA 2022-04-20
ER

PT J
AU Upshaw, TL
   Brown, C
   Smith, R
   Perri, M
   Ziegler, C
   Pinto, AD
AF Upshaw, Tara L.
   Brown, Chloe
   Smith, Robert
   Perri, Melissa
   Ziegler, Carolyn
   Pinto, Andrew D.
TI Social determinants of COVID-19 incidence and outcomes: A rapid review
SO PLOS ONE
LA English
DT Review
ID FULL SYSTEMATIC REVIEWS; DETENTION FACILITIES; CORONAVIRUS DISEASE;
   HEALTH; MORTALITY; PEOPLE; HOSPITALIZATION; INFECTION; OUTBREAK; IMPACT
AB Early reports indicate that the social determinants of health are implicated in COVID-19 incidence and outcomes. To inform the ongoing response to the pandemic, we conducted a rapid review of peer-reviewed studies to examine the social determinants of COVID-19. We searched Ovid MEDLINE, Embase, PsycINFO, CINAHL and Cochrane Central Register of Controlled Trials from December 1, 2019 to April 27, 2020. We also searched the bibliographies of included studies, COVID-19 evidence repositories and living evidence maps, and consulted with expert colleagues internationally. We included studies identified through these supplementary sources up to June 25, 2020. We included English-language peer-reviewed quantitative studies that used primary data to describe the social determinants of COVID-19 incidence, clinical presentation, health service use and outcomes in adults with a confirmed or presumptive diagnosis of COVID-19. Two reviewers extracted data and conducted quality assessment, confirmed by a third reviewer. Forty-two studies met inclusion criteria. The strongest evidence was from three large observational studies that found associations between race or ethnicity and socioeconomic deprivation and increased likelihood of COVID-19 incidence and subsequent hospitalization. Limited evidence was available on other key determinants, including occupation, educational attainment, housing status and food security. Assessing associations between sociodemographic factors and COVID-19 was limited by small samples, descriptive study designs, and the timeframe of our search. Systematic reviews of literature published subsequently are required to fully understand the magnitude of any effects and predictive utility of sociodemographic factors related to COVID-19 incidence and outcomes. PROSPERO: CRD4202017813.
C1 [Upshaw, Tara L.; Brown, Chloe; Smith, Robert; Perri, Melissa; Pinto, Andrew D.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Upstream Lab, MAP Ctr Urban Hlth Solut, Toronto, ON, Canada.
   [Upshaw, Tara L.] Univ Toronto, Translat Res Program, Fac Med, Toronto, ON, Canada.
   [Brown, Chloe] Univ Toronto, Undergrad Med Educ, Fac Med, Toronto, ON, Canada.
   [Smith, Robert; Pinto, Andrew D.] Inst Hlth Policy Management & Evaluat, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Smith, Robert; Pinto, Andrew D.] Univ Toronto, Dept Family & Community Med, Fac Med, Toronto, ON, Canada.
   [Perri, Melissa; Pinto, Andrew D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Ziegler, Carolyn] Unity Hlth Toronto, Hlth Sci Lib, Toronto, ON, Canada.
   [Pinto, Andrew D.] St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada.
RP Pinto, AD (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Upstream Lab, MAP Ctr Urban Hlth Solut, Toronto, ON, Canada.; Pinto, AD (corresponding author), Inst Hlth Policy Management & Evaluat, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Pinto, AD (corresponding author), Univ Toronto, Dept Family & Community Med, Fac Med, Toronto, ON, Canada.; Pinto, AD (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Pinto, AD (corresponding author), St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada.
EM andrew.pinto@mail.utoronto.ca
RI ; Ziegler, Carolyn/G-3937-2011
OI Pinto, Andrew/0000-0003-1841-9347; Brown, Chloe/0000-0001-9636-2177;
   Upshaw, Tara/0000-0002-9769-8673; Ziegler, Carolyn/0000-0002-5545-0610;
   Smith, Robert/0000-0002-3499-2816
FU Government of Ontario; University of Toronto COVID-19 Student Engagement
   Award; Canadian Institutes for Health ResearchCanadian Institutes of
   Health Research (CIHR); Department of Family and Community Medicine,
   Faculty of Medicine, University of Toronto; Department of Family and
   Community Medicine, St. Michael's Hospital; Li Ka Shing Knowledge
   Institute, St. Michael's Hospital; Physicians' Services Incorporated
   Foundation
FX Tara Upshaw Tara Upshaw This project was supported in part by an Early
   Researcher Award from the Government of Ontario, held by Andrew Pinto,
   and a University of Toronto COVID-19 Student Engagement Award, which
   supported Tara Upshaw and Chloe Brown. Tara Upshaw is supported by a
   Canada Graduate Scholarship from the Canadian Institutes for Health
   Research. Andrew Pinto is supported as a Clinician-Scientist by the
   Department of Family and Community Medicine, Faculty of Medicine,
   University of Toronto, the Department of Family and Community Medicine,
   St. Michael's Hospital, and the Li Ka Shing Knowledge Institute, St.
   Michael's Hospital, by a fellowship from the Physicians' Services
   Incorporated Foundation and as the Associate Director for Clinical
   Research at the University of Toronto Practice-Based Research Network
   (UTOPIAN). The opinions, results and conclusions reported in this
   article are those of the authors and are independent from any funding
   sources.
CR Akiyama MJ, 2020, NEW ENGL J MED, V382, P2075, DOI 10.1056/NEJMp2005687
   Azar KMJ, 2020, HEALTH AFFAIR, V39, P1253, DOI 10.1377/hlthaff.2020.00598
   Baggett TP, 2020, JAMA-J AM MED ASSOC, V323, P2191, DOI 10.1001/jama.2020.6887
   Bangalore S, 2020, NEW ENGL J MED, V382, P2478, DOI 10.1056/NEJMc2009020
   Batty GD, 2020, BRAIN BEHAV IMMUN, V89, P569, DOI 10.1016/j.bbi.2020.06.021
   Blanco JL, 2020, LANCET HIV, V7, pE314, DOI 10.1016/S2352-3018(20)30111-9
   Britten N., 2006, ESRC METHODS PROGRAM, V93, DOI [10.13140/2.1.1018.4643, DOI 10.13140/2.1.1018.4643]
   Caul S., 2020, NATL STAT
   CDC COVID-19 Response Team, 2020, MMWR Morb Mortal Wkly Rep, V69, P477, DOI 10.15585/mmwr.mm6915e6
   Chen JT, 2021, J PUBLIC HEALTH MAN, V27, pS43, DOI 10.1097/PHH.0000000000001263
   Chu JJ, 2020, J MED VIROL, V92, P807, DOI 10.1002/jmv.25793
   Chung H., 2020, COVID 19 LAB TESTING
   Clift AK, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3731
   COVID Tracking Project,, 2020, ANT RES POL CTR COVI
   COVID-19 National Incident Room Surveillance Team, 2020, Commun Dis Intell (2018), V44, DOI 10.33321/cdi.2020.44.34
   COVID-19 National Incident Room Surveillance Team, 2020, Commun Dis Intell (2018), V44, DOI 10.33321/cdi.2020.44.29
   Dai H, 2020, INT J INFECT DIS, V95, P106, DOI 10.1016/j.ijid.2020.04.003
   de Gier B, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.50.2001884
   de Lusignan S, 2020, LANCET INFECT DIS, V20, P1034, DOI 10.1016/S1473-3099(20)30371-6
   Dean HD, 2010, PUBLIC HEALTH REP, V125, P1, DOI 10.1177/00333549101250S401
   Department of Public Health, 2020, CHIC COVID 19 UPD
   Dhunna S., 2020, COVID 19 ITS TIME PR
   Drefahl S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18926-3
   Dyal JW, 2020, MMWR-MORBID MORTAL W, V69, P557, DOI 10.15585/mmwr.mm6918e3
   Egede LE, 2020, HEALTH AFFAIR, V39, P1926, DOI 10.1377/hlthaff.2020.01081
   EPPI-Centre at the University of College London, COVID 19 LIV SYST MA
   Fan JC, 2020, EMERG INFECT DIS, V26, P1257, DOI 10.3201/eid2606.200251
   Gamio L., 2020, NEW YORK TIMES 0315
   Ganann R, 2010, IMPLEMENT SCI, V5, P10, DOI 10.1186/1748-5908-5-56
   Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3
   Garritty C, 2021, J CLIN EPIDEMIOL, V130, P13, DOI 10.1016/j.jclinepi.2020.10.007
   Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P545, DOI 10.15585/mmwr.mm6918e1
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   Hasan Z, 2020, CHEST, V157, P1420, DOI 10.1016/j.chest.2020.03.027
   Hastie CE, 2020, DIABETES METAB SYND, V14, P561, DOI 10.1016/j.dsx.2020.04.050
   Hong QN, 2018, EDUC INFORM, V34, P285, DOI 10.3233/EFI-180221
   Hsu HE, 2020, MMWR-MORBID MORTAL W, V69, P864, DOI 10.15585/mmwr.mm6927a3
   Huang YE, 2021, PSYCHOL HEALTH MED, V26, P23, DOI 10.1080/13548506.2020.1754438
   Jia J, 2020, DISASTER MED PUBLIC, V14, P643, DOI 10.1017/dmp.2020.59
   Jing QL, 2020, LANCET INFECT DIS, V20, P1141, DOI 10.1016/S1473-3099(20)30471-0
   Jones, 2020, WASH POST
   Joy M, 2020, BRIT J GEN PRACT, V70, pE890, DOI 10.3399/bjgp20X713393
   Kumar S, 2012, AM J PUBLIC HEALTH, V102, P134, DOI 10.2105/AJPH.2011.300307
   Laurencin CT, 2020, J RACIAL ETHN HEALTH, V7, P398, DOI 10.1007/s40615-020-00756-0
   Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1
   Lee K, 2009, GLOB INST, P1
   Lewer D, 2020, LANCET RESP MED, V8, P1181, DOI 10.1016/S2213-2600(20)30396-9
   Li T, 2020, EUR J CLIN NUTR, V74, P871, DOI 10.1038/s41430-020-0642-3
   Lowcock Elizabeth C, 2012, Am J Public Health, V102, pe51, DOI 10.2105/AJPH.2012.300814
   Lundon DJ, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.571364
   Maness SB, 2021, PUBLIC HEALTH REP, V136, P18, DOI 10.1177/0033354920969169
   Mehta N, 2020, JAMA CARDIOL, V5, P1020, DOI 10.1001/jamacardio.2020.1855
   Morrison A., 2020, OUTCRY RACIAL DATA G
   Mosites E, 2020, MMWR-MORBID MORTAL W, V69, P521, DOI 10.15585/mmwr.mm6917e1
   New York State Department of Health, 2020, COVID 19 TRACK
   Nobel YR, 2020, GASTROENTEROLOGY, V159, P373, DOI 10.1053/j.gastro.2020.04.017
   Norwegian Institute of Public Health, 2020, LIVE MAP COVID 19 EV
   Office for National Statistics, 2020, COR COVID 19 REL DEA
   Oschinski M., 2020, COVID 19 ONTARIOS SA
   Ouyang YB, 2020, CLIN INFECT DIS, V71, P2052, DOI 10.1093/cid/ciaa462
   Pace R, 2012, INT J NURS STUD, V49, P47, DOI 10.1016/j.ijnurstu.2011.07.002
   Paradies Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138511
   Placzek H, 2014, AM J PUBLIC HEALTH, V104, pE31, DOI 10.2105/AJPH.2013.301626
   Popay J., 2009, EVALUATION, V15, P49, DOI [DOI 10.1177/1356389008097871, 10.1177/1356389008097871]
   Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686
   Pung R, 2020, LANCET, V395, P1039, DOI 10.1016/S0140-6736(20)30528-6
   Richard Lucie, 2021, CMAJ Open, V9, pE1, DOI 10.9778/cmajo.20200287
   RICHARDSON S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775]
   Roberts KC, 2015, HEALTH PROMOT CHRON, V35, DOI 10.24095/hpcdp.35.6.01
   Royle P, 2003, HLTH TECHNOL ASSESS, V7, P1, DOI DOI 10.3310/HTA7340
   Rozenfeld Y, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01242-z
   Seligman B, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003490
   Semenza JC, 2010, EUROSURVEILLANCE, V15, P2
   Shaw KM, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160088
   Shi Y, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2833-7
   Shingler B., 2020, CBC NEWS
   Social Interventions Research and Evaluation Network, 2020, COVID 19 RES PAG
   Sun H, 2020, J AM GERIATR SOC, V68, P1162, DOI 10.1111/jgs.16507
   Sun YXH, 2020, CLIN INFECT DIS, V71, P786, DOI 10.1093/cid/ciaa322
   Sze S, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100630
   Thebault R, 2020, WASH POST
   Tobolowsky FA, 2020, MMWR-MORBID MORTAL W, V69, P523, DOI 10.15585/mmwr.mm6917e2
   Tolia VM, 2020, WEST J EMERG MED, V21, P503, DOI 10.5811/westjem.2020.3.47348
   Toussie D, 2020, RADIOLOGY, V297, pE197, DOI 10.1148/radiol.2020201754
   Tsai J, 2020, LANCET PUBLIC HEALTH, V5, pE186, DOI 10.1016/S2468-2667(20)30053-0
   Wallace M, 2020, MMWR-MORBID MORTAL W, V69, P587, DOI 10.15585/mmwr.mm6919e1
   Wallace M, 2020, MMWR-MORBID MORTAL W, V69, P594, DOI 10.15585/mmwr.mm6919e3
   Wang LZ, 2020, CLIN EPIDEMIOL, V12, P387, DOI 10.2147/CLEP.S249903
   Wang RR, 2020, INT J INFECT DIS, V95, P421, DOI 10.1016/j.ijid.2020.03.070
   Wang X, 2020, J HOSP INFECT, V105, P399, DOI 10.1016/j.jhin.2020.04.019
   Watt A, 2008, ANZ J SURG, V78, P1037, DOI 10.1111/j.1445-2197.2008.04730.x
   Watt A, 2008, INT J TECHNOL ASSESS, V24, P133, DOI 10.1017/S0266462308080185
   Williams DR, 2019, ANNU REV PUBL HEALTH, V40, P105, DOI 10.1146/annurev-publhealth-040218-043750
   Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4
   World Health Organization Commission on the Social Determinants of Health (CSDH), 2008, CLOSING GAP GENERATI
   Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328
   Xiao H, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923921
   Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]
   Yan CRH, 2020, INT FORUM ALLERGY RH, V10, P821, DOI 10.1002/alr.22592
   Yehia BR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.18039
   Yu X, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02893-8
   Zhang J, 2020, BRAIN BEHAV IMMUN, V87, P49, DOI 10.1016/j.bbi.2020.04.031
NR 102
TC 22
Z9 22
U1 2
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 31
PY 2021
VL 16
IS 3
AR e0248336
DI 10.1371/journal.pone.0248336
PG 22
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics
GA RH6VV
UT WOS:000636354600034
PM 33788848
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Kobayashi, H
   Morishita, T
   Yoshinaga, S
   Enomoto, T
   Fukumoto, H
   Abe, H
   Inoue, T
AF Kobayashi, Hiromasa
   Morishita, Takashi
   Yoshinaga, Shintarou
   Enomoto, Toshiyuki
   Fukumoto, Hironori
   Abe, Hiroshi
   Inoue, Tooru
TI Enlargement of preexisting superficial temporal artery pseudo-aneurysm
   co-incidental to mask wearing during the Covid-19 pandemic
SO INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT
LA English
DT Article
DE Superficial temporal artery; Pseudo-aneurysm; Mask wearing; The Covid-19
   pandemic
ID PSEUDOANEURYSM
AB The superficial temporal artery (STA) pseudo-aneurysm is usually associated with trauma. We report a unique case of an STA pseudo-aneurysm that developed due to mask wearing during the Covid-19 pandemic. A 70-yearold female presented with a 3-month history of a rapidly growing pseudo-aneurysm of the right STA. Over the past 3 months the patient had been wearing a mask for the prevention of Covid-19. The STA aneurysm was located exactly at a pressure point created by the rubber mask. Therefore, we assumed that an enlargement of the preexisting aneurysm had taken pace due to irritation from the elastic band of the mask. Surgical excision of the aneurysm and reconstruction of the STA using STA-STA bypass were performed. To our knowledge, we here report the first case of an STA pseudo-aneurysm that was potentially affected indirectly by the Covid-19 pandemic. Clinicians should be cautious about the preexisting medical condition that is potentially worsened by mask band compression.
C1 [Kobayashi, Hiromasa; Morishita, Takashi; Yoshinaga, Shintarou; Enomoto, Toshiyuki; Fukumoto, Hironori; Abe, Hiroshi; Inoue, Tooru] Fukuoka Univ, Fac Med, Dept Neurosurg, Nanakuma 7-45-1, Fukuoka, Japan.
RP Morishita, T (corresponding author), Fukuoka Univ, Fac Med, Dept Neurosurg, Nanakuma 7-45-1, Fukuoka, Japan.
EM tmorishita@fukuoka-u.ac.jp
FU Iofukushikai Social Welfare Corporation
FX This research was partially supported by Iofukushikai Social Welfare
   Corporation.
CR Bobinski L, 2004, ACTA NEUROCHIR, V146, P1039, DOI 10.1007/s00701-004-0310-8
   Hakan T, 2011, TURK NEUROSURG, V21, P430, DOI 10.5137/1019-5149.JTN.2944-10.1
   Hong JT, 2006, SURG NEUROL, V66, P86, DOI 10.1016/j.surneu.2005.10.022
   LEE KS, 1988, NEUROSURGERY, V23, P499, DOI 10.1227/00006123-198810000-00017
   Nishizawa S, 2000, NEUROL MED-CHIR, V40, P408, DOI 10.2176/nmc.40.408
   Prado A, 2007, PLAST RECONSTR SURG, V119, P2334, DOI 10.1097/01.prs.0000261095.07321.09
   Walker MT, 2003, AM J NEURORADIOL, V24, P147
NR 7
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2214-7519
J9 INTERDISCIP NEUROSUR
JI Interdiscip. Neurosurg.
PD MAR
PY 2022
VL 27
AR 101396
DI 10.1016/j.inat.2021.101396
EA OCT 2021
PG 3
WC Clinical Neurology
WE Emerging Sources Citation Index (ESCI)
SC Neurosciences & Neurology
GA WM4QL
UT WOS:000711071400012
PM 34660208
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Shah, V
   Tyagi, N
   Trivedi, D
AF Shah, Vitrag
   Tyagi, Niraj
   Trivedi, Darshan
TI Extra Precautions While Caring Suspected COVID-19 Patient in ICU Beyond
   PPE and Hand Hygiene
SO INDIAN JOURNAL OF CRITICAL CARE MEDICINE
LA English
DT Review
DE Corona; COVID; COVID-19; High-flow nasal cannula (HFNC) oxygen therapy;
   ICU; Infection; Infection control; Mask; Nosocomial infection
ID BREATHING SYSTEM FILTERS; MOISTURE EXCHANGERS; ANESTHESIA; MANAGEMENT;
   HEAT
AB Since the diagnosis of the first case of COVID-19 in December 2019, there have been reports of several healthcare workers infected with COVID19. It has changed the infection control practices of most ICUs all over the world. Prevention is better than cure is definitely proven true as there is no definite cure for COVID-19 yet. Personal protective equipment and hand hygiene are must while handling any suspected COVID-19 patient. Apart from that, there are several other things, which should be followed in ICU and specifically while caring for patient on ventilator. There are a large number of interventions done while treating any critically ill patient in ICU, which can generate aerosols and exaggerate spread of COVID-19, which include high-flow nasal cannula, NIV, nebulization, suctioning, bag and mask ventilation, endotracheal intubation, and bronchoscopy. We will be reviewing those things beyond PPE and hand hygiene along with the rationale of each of them, which can help to minimize the risk of exposure to healthcare workers and other patients in the surrounding. It will help not only to prevent COVID-19 transmission but also to reduce overall nosocomial infection rate. As per our knowledge, this will be the first paper reviewing innovative ideas to minimize the risk of infection in a comprehensive manner.
C1 [Shah, Vitrag; Trivedi, Darshan] Kiran Multi Superspecial Hosp & Res Ctr, Dept Crit Care Med, Surat, Gujarat, India.
   [Tyagi, Niraj] Sir Ganga Ram Hosp, Dept Crit Care Med, Delhi, India.
RP Shah, V (corresponding author), Kiran Multi Superspecial Hosp & Res Ctr, Dept Crit Care Med, Surat, Gujarat, India.
EM dr.vitrag@gmail.com
RI Shah, Vitrag/ABG-1392-2021
OI Shah, Vitrag/0000-0001-8337-7708
CR Alhazzani W, 2020, CRIT CARE MED, V48, pE440, DOI [10.1097/CCM.0000000000004363, 10.1007/s00134-020-06022-5]
   Chan MTV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18614-1
   Cook TM, 2020, ANAESTHESIA, V75, P785, DOI 10.1111/anae.15054
   Dragor, 2020, SARS COV 2 HANDLING
   Dragor, FILTER HMES SUPPORTI
   Dragor, 2020, GUIDELINE BREATHING
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Frank S, 2020, JAMA OTOLARYNGOL, V146, P1054, DOI 10.1001/jamaoto.2020.3053
   Lazzeri M, 2020, MONALDI ARCH CHEST D, V90, DOI 10.4081/monaldi.2020.1285
   Liew MF, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2828-4
   Matava CT, 2020, CAN J ANESTH, V67, P902, DOI 10.1007/s12630-020-01649-w
   Maves RC, MANAGEMENT PATIENTS
   Patwa A, 2020, INDIAN J ANAESTH, V64, pS107, DOI 10.4103/ija.IJA_498_20
   Peng F, 2020, J INT MED RES, V48, DOI 10.1177/0300060520901872
   Respiratory care committee of Chinese Thoracic Society, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V17, pE020, DOI 10.3760/cma.j.issn.1001-0939.2020.0020
   Rungta N, 2020, INDIAN J CRIT CARE M, V24, pS43, DOI 10.5005/jp-journals-10071-G23185
   Saran S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02907-5
   Thomas P, 2020, J PHYSIOTHER, V66, P73, DOI 10.1016/j.jphys.2020.03.011
   WHO, 2020, INFECT PREVENTION CO
   Wilkes AR, 2011, ANAESTHESIA, V66, P31, DOI 10.1111/j.1365-2044.2010.06563.x
   Wilkes AR, 2011, ANAESTHESIA, V66, P40, DOI 10.1111/j.1365-2044.2010.06564.x
NR 21
TC 0
Z9 0
U1 2
U2 3
PU JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD
PI NEW DEHLI
PA 4838-24, ANSARI RD, DARYAGANJ, NEW DEHLI, 110 002, INDIA
SN 0972-5229
EI 1998-359X
J9 INDIAN J CRIT CARE M
JI Indian J. Crit. Care Med.
PD MAR
PY 2021
VL 25
IS 3
BP 331
EP 335
DI 10.5005/jp-journals-10071-23767
PG 5
WC Critical Care Medicine
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA QQ3OI
UT WOS:000624433200021
PM 33790517
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Baber, H
   Fanea-Ivanovici, M
   Lee, YT
   Tinmaz, H
AF Baber, Hasnan
   Fanea-Ivanovici, Mina
   Lee, Yoo-Taek
   Tinmaz, Hasan
TI A bibliometric analysis of digital literacy research and emerging themes
   pre-during COVID-19 pandemic
SO INFORMATION AND LEARNING SCIENCES
LA English
DT Article
DE Digital literacy; information literacy; Bibliometric analysis;
   VOSviewer; digital competence; COVID-19
ID INFORMATION LITERACY
AB Purpose - Digital literacy is not the mere ability to use a digital device or know to use various software. It is a domain of exploration for sociology, psychology, education and, of course, technology. This study aims to present a quantitative analysis of the literature on digital literacy using a bibliometric approach.
   Design/methodology/approach - Using data from the Web of Science database, the importance of the research is evaluated by reviewing 2307 publications and examining the yearly publication, field category productivity, citation structure, most cited resources, documents, most-cited authors, most productive authors, and country in the field of digital literacy. Further, a cluster analysis is conducted to see the most recurrent keywords and emerging trends in this field. At last, the authors analyzed the thematic progression of keywords over these five years based on the normalized citations. Additionally, a graphical representation of the bibliometric data using VOSviewer is presented in the paper.
   Findings - The results suggest a steady rate of publication in this field, with most of the research published in education and library fields and the USA leading the country in this realm. The emerging themes in this field are 'Fake News', 'Competence', 'Educational Technology', 'Health Literacy', 'Self-Efficacy' and, interestingly, 'COVID-19'. The results also revealed that COVID-19 has been examined and associated with fake news, higher education, social media and information literacy.
   Originality/value - This paper provides an overall summary of the most recent research work published from 2017 to 2021 on digital literacy in the backdrop of COVID-19. The study presents the thematic progression over the years and particularly the new keywords that emerged in the limelight of the pandemic. It contributes by updating the existing body of knowledge in the field of digital literacy and presents preliminary results related to COVID-19.
C1 [Baber, Hasnan] Abu Dhabi Sch Management, Abu Dhabi, U Arab Emirates.
   [Fanea-Ivanovici, Mina] Bucharest Univ Econ Studies, Dept Econ & Econ Policies, Bucharest, Romania.
   [Lee, Yoo-Taek] Woosong Univ, Endicott Coll Int Studies, Daejeon, South Korea.
   [Tinmaz, Hasan] Woosong Univ, Endicott Coll Int Studies, Technol Studies, Daejeon, South Korea.
RP Tinmaz, H (corresponding author), Woosong Univ, Endicott Coll Int Studies, Technol Studies, Daejeon, South Korea.
EM htinmaz@endicott.ac.kr
OI Baber, Hasnan/0000-0002-8951-3501
FU Woosong University
FX This research is funded by Woosong University Academic Research in 2021.
CR Abdulai AF, 2021, INT J MED INFORM, V145, DOI 10.1016/j.ijmedinf.2020.104322
   Al Mamun MA, 2022, EDUC INF TECHNOL, V27, P1261, DOI 10.1007/s10639-021-10630-z
   Bhardwaj RK, 2017, INFORM LEARN SCI, V118, P67, DOI 10.1108/ILS-09-2016-0068
   Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6
   Carter RA, 2020, INFORM LEARN SCI, V121, P321, DOI 10.1108/ILS-04-2020-0114
   Donthu N, 2021, J BUS RES, V133, P285, DOI 10.1016/j.jbusres.2021.04.070
   DQ, 2019, DQ GLOBAL STANDARDS
   Ellegaard O, 2015, SCIENTOMETRICS, V105, P1809, DOI 10.1007/s11192-015-1645-z
   European Commission, 2021, GLOSSARY DIGITAL LIT
   European Parliament, 2021, DIGITAL AGENDA EUROP
   G20, 2020, BRIDGING DIGITAL DIV
   Guo YM, 2021, FUTURE GENER COMP SY, V116, P316, DOI 10.1016/j.future.2020.10.023
   Hood WW, 2001, SCIENTOMETRICS, V52, P291, DOI 10.1023/A:1017919924342
   Kolle SR, 2017, ELECTRON LIBR, V35, P283, DOI 10.1108/EL-08-2015-0160
   Suelves DM, 2021, RIED-REV IBEROAM EDU, V24, P329, DOI 10.5944/ried.24.2.30006
   Martinez-Bravo MC, 2020, PROF INFORM, V29, DOI 10.3145/epi.2020.jul.28
   Mas-Tur A, 2020, REV MANAG SCI, V14, P933, DOI 10.1007/s11846-020-00406-z
   Pinto M, 2020, SCIENTOMETRICS, V124, P1479, DOI 10.1007/s11192-020-03523-4
   Pinto M, 2015, SCIENTOMETRICS, V102, P1555, DOI 10.1007/s11192-014-1498-x
   Poszytek P, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13169338
   Sanchez-Cruzado C, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13041858
   Sousa MJ, 2019, J BUS RES, V94, P257, DOI 10.1016/j.jbusres.2017.12.051
   UNESCO, 2016, GLOBAL ED MONITORING
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
   van Laar E, 2017, COMPUT HUM BEHAV, V72, P577, DOI 10.1016/j.chb.2017.03.010
   Xie B, 2020, J AGING SOC POLICY, V32, P460, DOI 10.1080/08959420.2020.1771237
   Yang Kilseok, 2020, [Journal of Digital Convergence, 디지털융복합연구], V18, P1, DOI 10.14400/JDC.2020.18.7.001
   Zainuddin Z, 2020, INFORM LEARN SCI, V121, P645, DOI 10.1108/ILS-04-2020-0069
   Zurita G, 2020, J NETW COMPUT APPL, V165, DOI 10.1016/j.jnca.2020.102695
NR 29
TC 0
Z9 0
U1 8
U2 8
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2398-5348
EI 1758-6909
J9 INFORM LEARN SCI
JI Inf. Learn. Sci.
PD MAR 10
PY 2022
VL 123
IS 3/4
BP 214
EP 232
DI 10.1108/ILS-10-2021-0090
EA MAR 2022
PG 19
WC Information Science & Library Science
WE Emerging Sources Citation Index (ESCI)
SC Information Science & Library Science
GA ZS1RW
UT WOS:000763504700001
OA Bronze
DA 2022-04-20
ER

PT J
AU Jethi, N
   Pandav, G
   Nagri, D
   Pandav, S
   Kumari, D
   Kaur, M
AF Jethi, Navdeep
   Pandav, Gaurav
   Nagri, Divya
   Pandav, Sakshi
   Kumari, Dibya
   Kaur, Manpreet
TI Asymptomatic COVID-19 patients and possible screening before an
   emergency aerosol related endodontic protocols in dental clinic-A Review
SO JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE
LA English
DT Review
DE Aerosols; antibody test; COVID-19 asymptomatic carriers; screening in
   dentistry
AB Dentistry is related to the cure of oral and dental infections, so exposure and proximity of dental practitioners to oral and nasal fluids of a patient is very obvious. Before you proceed for an aerosol-generating procedure like RCT, and crown preparations, diagnosis, and screening of COVID-19 is very important, as failure may end up infecting yourself and would become a source of infection to your patient community. Due to limitations of data, medicines, and PPE shortage all around the world, screening of asymptomatic carriers of COVID-19 is very troublesome but necessary. To avoid any silent positive patient, the possible way is to ensure mandatory testing of every patient before you treat it. As the door to door surveillance of COVID-19 patients seems near to impossible in the Pandemic era for densely populated developing countries like India. The possible screening regimes include personal surveillance and contact tracing in the very first appointments. So, on the basis of the knowledge and sources we have so far, we have tried to classify the asymptomatic patients seen in the clinics and their possible screening management there. As it is said classification of a disease, is the first step toward a deep understanding of it. After screening, suspects can be sent to more resourceful places for their managements, and incidences of community spread of the disease through dental clinics can be avoided.
C1 [Jethi, Navdeep; Kumari, Dibya] Daswani Dent Coll & Res Ctr, Kota, Rajasthan, India.
   [Pandav, Gaurav; Pandav, Sakshi; Kaur, Manpreet] Guru Nanak Dev Dent Coll & Res Inst, Patiala, Punjab, India.
   [Nagri, Divya] ITS Dent Coll, Greater Noida, Uttar Pradesh, India.
RP Jethi, N (corresponding author), NAVDEEP Med, Near Civil Hosp, Rampura Phul 151103, Punjab, India.
EM navdeepk43@gmail.com
CR [Anonymous], 2020, CORONAVIRUS DIS 2019
   Chu CY, 2010, EMERG INFECT DIS, V16, P1300, DOI 10.3201/eid1608.091787
   Coronavirus disease, 2019, CORONAVIRUS DIS 2019
   Day M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1165
   Huang C, 2020, Lancet, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Li ZT, 2020, J MED VIROL, V92, P1518, DOI 10.1002/jmv.25727
   Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180
   Ng EYK, 2005, MED PHYS, V32, P93, DOI 10.1118/1.1819532
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Qian G, 2020, CLIN INFECT DIS, V316, P1
   Schmidt M.S., 2020, NEW YORK TIMES
   U B., 2020, POTENT HUMAN NEUTRAL
   Udugama B, 2020, ACS NANO, V14, P3822, DOI 10.1021/acsnano.0c02624
   Yi Y, 2020, INT J BIOL SCI, V16, P1753, DOI 10.7150/ijbs.45134
NR 14
TC 2
Z9 2
U1 0
U2 2
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 2249-4863
EI 2278-7135
J9 J FAM MED PRIM CARE
JI J. Fam. Med. Prim. Care
PD SEP
PY 2020
VL 9
IS 9
BP 4552
EP 4556
DI 10.4103/jfmpc.jfmpc_796_20
PG 5
WC Primary Health Care
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA RZ2PH
UT WOS:000648440600011
PM 33209762
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Atlasi, R
   Chakoli, AN
   Ramezani, A
   Tabatabaei-Malazy, O
   Larijani, B
AF Atlasi, Rasha
   Noroozi Chakoli, Abdolreza
   Ramezani, Aboozar
   Tabatabaei-Malazy, Ozra
   Larijani, Bagher
TI Scientometric analyzing the output of researchers and organizations on
   COVID-19 for better conducting the scientific efforts: with a glance to
   endocrinology
SO JOURNAL OF DIABETES AND METABOLIC DISORDERS
LA English
DT Article
DE Scientometrics; Coronavirus; COVID-19; Scientific production
AB Purpose As COVID-19 spreads rapidly and could affect the people and also lead to their death, especially individuals with underlying diseases, such as diabetes, the research community is also active in publishing novel research about it. Analyzing scientific outputs in this topic can represent an overview of publications. For this purpose, this study was conducted to determine status of publishing research works related to COVID-19 and analyzing the all documents published and indexed in Web of Science database and illustrate the co-occurrence and co-authority of hot papers in this documents.
   Methodology Our search strategy was based on using the related key terms including COVID-19, coronavirus, SARS2, etc., to find out all the published scientific works related to coronavirus disease indexed in web of science (WoS) in 2020. We then extracted the all hot papers and especially hot papers in endocrinology category and analyzed them. The data saved and imported in VOSviewer and ScientoPy programs for analysis and illustration of our data. We have shown our analysis in the tables, figures and maps.
   Results Totally, 56,402 records and 309 hot papers were retrieved. 3 of these hot papers were in endocrinology category. The most common type of publication was original papers followed by editorial papers in the second rank. The country with the most published documents was the USA followed by China. The journals of "British Medical Journal" and "Journal of Medical Virology" were ranked as the first and second sources, respectively. The "Harvard University" was the top organization with high proportion of scientific publications and "the Lancet" was the top-ranked journal that published highly-cited papers.
   Conclusion The literature on COVID-19 is increasing with a high and fast growth. In this regard, there is a need to evaluate these publications once in a while and their results should be published to use this information for more effective management of future research works with emphasizes on the gaps of researches and more citable documents and allocation of budgets on more needed research and don't carry out the duplicates research. This would be helpful for prevention, control, and treatment of COVID-19 that is now among the most common topics in the world.
C1 [Atlasi, Rasha] Univ Tehran Med Sci, Sch Allied Med Sci, Dept Med Lib & Informat Sci, Tehran, Iran.
   [Atlasi, Rasha] Univ Tehran Med Sci, Evidence Based Practice Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran.
   [Noroozi Chakoli, Abdolreza] Shahed Univ, Fac Humanities Sci, Dept Informat Sci & Knowledge Studies & Scientome, Persian Gulf Highway, Tehran 3319118651, Iran.
   [Ramezani, Aboozar] Univ Tehran Med Sci, Tehran, Iran.
   [Tabatabaei-Malazy, Ozra] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, Tehran, Iran.
   [Tabatabaei-Malazy, Ozra; Larijani, Bagher] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Endocrinol & Metab Res Ctr, Tehran, Iran.
RP Chakoli, AN (corresponding author), Shahed Univ, Fac Humanities Sci, Dept Informat Sci & Knowledge Studies & Scientome, Persian Gulf Highway, Tehran 3319118651, Iran.
EM Rashaatlasi@gmail.com; Noroozi@shahed.ac.ir;
   Ramezani-a@alummus.tums.ac.ir; Tabatabaeiml@sina.tums.ac.ir;
   Emrc@tums.ac.ir
RI Noroozi Chakoli, Abdolreza/Y-6474-2019
OI Noroozi Chakoli, Abdolreza/0000-0002-0088-9159
CR Tran BX, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114095
   Belkacemi Y, 2020, EUR J CANCER, V135, P130, DOI 10.1016/j.ejca.2020.05.015
   Chahrour M, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7357
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   Cortegiani A, 2020, J CRIT CARE, V57, P279, DOI 10.1016/j.jcrc.2020.03.005
   De Felice F, 2020, IN VIVO, V34, P1613, DOI 10.21873/invivo.11951
   de Haan CAM, 2005, ADV VIRUS RES, V64, P165, DOI 10.1016/S0065-3527(05)64006-7
   Dehghanbanadaki Hojat, 2020, Med J Islam Repub Iran, V34, P51, DOI 10.34171/mjiri.34.51
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Hadi AG, 2020, BIOINTERFACE RES APP, V10, P7234, DOI 10.33263/BRIAC106.7234.7242
   IDF, COVID 19 DIABETES IN
   Liu N, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-01059-y
   Lou J, 2020, EUR REV MED PHARMACO, V24, P3411, DOI 10.26355/eurrev_202003_20712
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Motlagh A, 2020, ARCH IRAN MED, V23, P255, DOI 10.34172/aim.2020.07
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Park M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040967
   Purcell LN, 2020, INT J SURG, V76, P111, DOI 10.1016/j.ijsu.2020.03.002
   Rahim F., 2020, BIBLIOMETRIC ANAL GL, DOI [10.1101/2020.03.19.20038752, DOI 10.1101/2020.03.19.20038752]
   Rodriguez-Morales Alfonso J, 2020, Travel Med Infect Dis, V34, P101623, DOI 10.1016/j.tmaid.2020.101623
   Shamsi A, 2020, J DIABETES METAB DIS, V19, P1845, DOI 10.1007/s40200-020-00606-0
   WHO, 2020, WHO HLTH EMERGENCY D
   WHO, DIABETES WHO
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
NR 27
TC 4
Z9 4
U1 2
U2 10
PU SPRINGER INT PUBL AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
EI 2251-6581
J9 J DIABETES METAB DIS
JI J. Diabetes Metab. Disord.
PD JUN
PY 2021
VL 20
IS 1
BP 107
EP 118
DI 10.1007/s40200-020-00718-7
EA JAN 2021
PG 12
WC Endocrinology & Metabolism
WE Emerging Sources Citation Index (ESCI)
SC Endocrinology & Metabolism
GA SW4XZ
UT WOS:000614478700001
PM 33532371
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Sanchez-Garcia, JC
   Cortes-Martin, J
   Rodriguez-Blanque, R
   Marin-Jimenez, AE
   Montiel-Troya, M
   Diaz-Rodriguez, L
AF Carlos Sanchez-Garcia, Juan
   Cortes-Martin, Jonathan
   Rodriguez-Blanque, Raquel
   Eugenia Marin-Jimenez, Ana
   Montiel-Troya, Maria
   Diaz-Rodriguez, Lourdes
TI Depression and Anxiety in Patients with Rare Diseases during the
   COVID-19 Pandemic
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE rare disease; depression; anxiety; COVID-19; SARS CoV-2; pandemic
AB Scientific knowledge on depression and anxiety in patients with rare diseases during the COVID-19 pandemic is scarce; however, it is essential to perform comprehensive management of these patients. The aim of this study was to research how the situation caused by the SARS-CoV-2 pandemic has influenced the lives of patients with rare diseases regarding depression and anxiety. This Spanish study considered a heterogeneous population sample of 86 patients with confirmed diagnosis of different rare diseases. Participants took part in a cross-sectional online study by completing specific questionnaires on the study topic. Depression was measured using the Patient Health Questionnaire (PHQ-9), and the General Anxiety Disorder Scale (GAD-7) was used for evaluating anxiety. Data collection through an online questionnaire allowed for a greater population scope and therefore the inclusion patients of other nationalities in the study sample. Finally, as a general result, this study found that, in the face of the pandemic, anxiety and depression remained at a higher level in this group than in the general population, making these patients a vulnerable population group.
C1 [Carlos Sanchez-Garcia, Juan] Univ Granada, Fac Hlth Sci, Sch Nursing, Andalusia Res Plan,Junta Andalucia,JMADOC,Res Grp, Granada 18071, Spain.
   [Cortes-Martin, Jonathan] Hosp Univ Virgen de las Nieves, Res Grp CTS 1068, Junta Andalucia, Andalusia Res Plan, Granada 18014, Spain.
   [Rodriguez-Blanque, Raquel] Dist Sanitario Granada Metropolitano, Andalusia Res Plan, Res Grp CTS1068, Junta Andalucia, Granada 18013, Spain.
   [Eugenia Marin-Jimenez, Ana] Univ Granada, Fac Econ & Business Sci, Quantitat Methods Econ & Enterprise, Res Grp CTS1068,Andalusia Res Plan,Junta Andaluci, Granada 18071, Spain.
   [Montiel-Troya, Maria] Univ Granada, Fac Hlth Sci, Res Grp CTS1068, Andalusia Res Plan,Junta Andalucia,Sch Nursing, Ceuta Campus, Ceuta 51001, Spain.
   [Diaz-Rodriguez, Lourdes] Univ Granada, Fac Hlth Sci, Sch Nursing, Res Grp CTS1068,Andalusia Res Plan,Junta Andaluci, Granada 18071, Spain.
RP Rodriguez-Blanque, R (corresponding author), Dist Sanitario Granada Metropolitano, Andalusia Res Plan, Res Grp CTS1068, Junta Andalucia, Granada 18013, Spain.
EM jsangar@ugr.es; jonathan.cortes.martin@gmail.com;
   raquel.rodriguez.blanque.sspa@juntadeandalucia.es; anamarin@ugr.es;
   mariamontiel@ugr.es; ddiaz@ugr.es
RI Blanque, Raquel Rodríguez/AAC-8984-2019; GARCIA, JUAN CARLOS
   SANCHEZ/B-2145-2018; Marin Jimenez, Ana Eugenia/Z-3057-2019; Diaz
   Rodriguez, Lourdes/L-8433-2014
OI Blanque, Raquel Rodríguez/0000-0003-2086-1222; GARCIA, JUAN CARLOS
   SANCHEZ/0000-0002-4650-2159; Marin Jimenez, Ana
   Eugenia/0000-0003-4170-4381; Cortes-Martin,
   Jonathan/0000-0002-4019-8555; Diaz Rodriguez,
   Lourdes/0000-0001-7906-5656
CR Arrieta J, 2017, J CLIN PSYCHOL, V73, P1076, DOI 10.1002/jclp.22390
   Brotto L, 2016, J SEX MED, V13, P538, DOI 10.1016/j.jsxm.2016.01.019
   Choi EPH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103740
   Chung CCY, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2020.104062
   EURORDIRS, QUE ENF RAR
   EURORDIS, 2005, ENF RAR CON EST PRIO
   Evans WRH, 2018, BRIT J GEN PRACT, V68, P224, DOI 10.3399/bjgp18X695957
   Fiumara A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9092716
   Gobierno de Espana, 2020, B OF EST REAL DECR 4, P25390
   Goncalves Estrella F., 2008, GUIA BUENA PRACTICA, V2nd
   Katavic SS, 2019, HEALTH INFO LIBR J, V36, P341, DOI 10.1111/hir.12261
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Levis B, 2020, JAMA-J AM MED ASSOC, V323, P2290, DOI 10.1001/jama.2020.6504
   Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093
   Lowe B, 2004, PSYCHOTHER PSYCHOSOM, V73, P386, DOI 10.1159/000080393
   ORPHANET, ENF RAR
   Ozamiz-Etxebarria N, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311x00054020, 10.1590/0102-311X00054020]
   Rare Disease Hong Kong, COVID 19 WORS HLTH C
   Shire, 2013, J RARE DISORDERS
   Silibello G, 2016, ITAL J PEDIATR, V42, DOI 10.1186/s13052-016-0285-0
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Szymus K, 2020, NEUROL NEUROCHIR POL, V54, P305, DOI [10.5603/JNNS.a2020.0025, 10.5603/PJNNS.a2020.0025]
   Uhlenbusch N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211343
   Velvin G, 2015, CLIN GENET, V87, P109, DOI 10.1111/cge.12422
   Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028
   Watkins LL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000068
   World Health Organization, WHO DIR GEN OP REM M
   Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001
NR 28
TC 2
Z9 2
U1 2
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD MAR
PY 2021
VL 18
IS 6
AR 3234
DI 10.3390/ijerph18063234
PG 10
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA RL7WC
UT WOS:000639177400001
PM 33800980
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU SoleimanvandiAzar, N
   Irandoost, SF
   Ahmadi, S
   Xosravi, T
   Ranjbar, H
   Mansourian, M
   Lebni, JY
AF SoleimanvandiAzar, Neda
   Irandoost, Seyed Fahim
   Ahmadi, Sina
   Xosravi, Tareq
   Ranjbar, Hadi
   Mansourian, Morteza
   Lebni, Javad Yoosefi
TI Explaining the reasons for not maintaining the health guidelines to
   prevent COVID-19 in high-risk jobs: a qualitative study in Iran
SO BMC PUBLIC HEALTH
LA English
DT Article
DE COVID-19; Coronavirus; High-risk jobs; Prevention; Qualitative study;
   Iran
ID CORONAVIRUS; INFECTION; ADHERENCE; KNOWLEDGE; HIV/AIDS; EFFICACY; SYSTEM
AB Background Although the workers in many occupations are at the greatest risk of catching and spreading COVID-19 due to assembling and contacting people, the owners of these occupations do not follow COVID-19 health instructions. The purpose of this study is to explain the reasons for not maintaining health guidelines to prevent COVID-19 in high-risk jobs in Iran. Methods The present study was conducted with a qualitative approach among people with high-risk jobs in Tehran during March and April of 2020. Data were collected through semi-structured interviews with 31 people with high-risk occupations selected by purposeful sampling and snowballing. The data were analyzed using the conventional qualitative content analysis method and MAXQDA-18 software. Guba and Lincoln's criteria were also used to evaluate the quality of the research results. Results 4 main categories and 13 sub-categories were obtained, including individual factors (personality traits, lack of self-efficacy, little knowledge of the disease and how to observe health norms related to it, misconceptions about health), structural factors (difficulty of access to health supplies, lack of supportive environment, weak laws and supervision, the poor performance of officials and national media), economic factors (economic costs of living, lack of government economic support), Socio-cultural factors (learning, cultural beliefs, social customs, and rituals). Conclusion COVID-19 prevention requires intervention at different levels. At the individual level: increasing people's awareness and understanding about how to prevent COVID-19 and strengthening self-efficacy in observing health norms, at the social level: highlighting positive patterns of observing health issues and training people about the consequences of social interactions during the outbreak of the virus, and at the macro level: strengthening regulatory rules and increasing people's access to hygienic products and support for the vulnerable must be taken into account.
C1 [SoleimanvandiAzar, Neda] Iran Univ Med Sci, Prevent Med & Publ Hlth Res Ctr, Psychosocial Hlth Res Inst, Tehran, Iran.
   [Irandoost, Seyed Fahim] Urmia Univ Med Sci, Sch Hlth, Dept Publ Hlth, Orumiyeh, Iran.
   [Ahmadi, Sina] Univ Social Welf & Rehabil Sci, Social Welf Management Res Ctr, Dept Social Welf Management, Tehran, Iran.
   [Xosravi, Tareq] Islamic Azad Univ, Sanandaj Branch, Sanandaj, Iran.
   [Ranjbar, Hadi] Iran Univ Med Sci, Mental Hlth Res Ctr, Psychosocial Hlth Res Inst, Tehran, Iran.
   [Mansourian, Morteza] Iran Univ Med Sci, Hlth Management & Econ Res Ctr, Tehran, Iran.
   [Lebni, Javad Yoosefi] Iran Univ Med Sci, Hlth Promot Res Ctr, Tehran, Iran.
RP Lebni, JY (corresponding author), Iran Univ Med Sci, Hlth Promot Res Ctr, Tehran, Iran.
EM j.yousefi28@yahoo.com
RI Irandoost, Seyed Fahim/AAC-8010-2022
OI Ahmadi, Sina/0000-0002-7553-8206
FU Iran University of Medical Sciences [99-1-90-17877]
FX This research was supported by Iran University of Medical Sciences under
   Grant: (Grant No. 99-1-90-17877). The funders, however, played no role
   in designing the study, collecting and analyzing data, manuscript
   preparation, and the decision to publish the manuscript.
CR Abramowitz S, 2017, J HEALTH COMMUN, V22, P59, DOI 10.1080/10810730.2016.1209599
   Adab Z., 2016, RAHAVARD SALAMAT J, V2, P10
   [Anonymous], 2021, CORONAVIRUS JOHN HOP
   Bellato Alessio, 2020, Soc Sci Humanit Open, V2, P100062, DOI 10.1016/j.ssaho.2020.100062
   Brown V, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0853-y
   Carlucci L, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.559288
   Casero-Ripolles A, 2020, PROF INFORM, V29, DOI 10.3145/epi.2020.mar.23
   Centers for Disease Control and Prevention, 2020, CENT DIS CONTROL PRE
   Chen MY., 2007, DISCOURSE, V29, P367
   Chen Q, 2020, COMPUT HUM BEHAV, V110, DOI 10.1016/j.chb.2020.106380
   Chirico F, 2021, J HEALTH RES, V35, P359, DOI 10.1108/JHR-10-2020-0514
   Chirico F, 2021, J OCCUP ENVIRON MED, V63, pE255, DOI 10.1097/JOM.0000000000002170
   Chirico F, 2021, WORKPLACE HEALTH SAF, V69, P5, DOI 10.1177/2165079920950161
   Chirico F, 2020, SAMJ S AFR MED J, V110, P436, DOI 10.7196/SAMJ.2020.v110i6.14855
   d'Alessandro E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034054
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114
   Fernandes N., 2020, EC EFFECTS CORONAVIR, DOI [10.2139/ssrn.3557504, 10.2139/SSRN.3557504]
   Flick U., 2018, INTRO QUALITATIVE RE
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Gharehghani MAM, 2020, INT J WOMENS HEALTH, V12, P681, DOI 10.2147/IJWH.S260481
   Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001
   Guidance CI, 2020, INTERIM GUIDANCE BUS
   Habibzadeh P, 2020, INT J OCCUP ENV MED, V11, P65, DOI 10.15171/ijoem.2020.1921
   Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7
   Irandoost SF, 2019, J EDUC HEALTH PROMOT, V8, DOI 10.4103/jehp.jehp_13_19
   Kasozi KI, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00416
   Lake MA, 2020, CLIN MED, V20, P124, DOI 10.7861/clinmed.2019-coron
   lebni JY, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05649
   Lebni JY, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08752-z
   Li SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062032
   Liem A, 2020, LANCET PSYCHIAT, V7, pE20, DOI 10.1016/S2215-0366(20)30076-6
   Lincoln YS., 2011, SAGE HDB QUALITATIVE, V4, P97
   Liu X, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P994, DOI 10.3760/cma.j.cn112338-20200216-00108
   Lotfi R, 2013, ARCH SEX BEHAV, V42, P873, DOI 10.1007/s10508-012-0040-6
   Magnavita N., 2020, Zdrowie Publiczne i Zarzaadzanie. Zeszyty Naukowe Ochrony Zdrowia, V18, P32, DOI 10.4467/20842627OZ.20.002.12656
   Magnavita N, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10248906
   Mann CL, 2020, REAL FINANCIAL LENSE, P81
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   Mekonnen HS, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00279-8
   Mishra S, 2019, J TRANSP GEOGR, V78, P135, DOI 10.1016/j.jtrangeo.2019.05.017
   Nzaji MK, 2020, J MULTIDISCIP HEALTH, V13, P1215, DOI 10.2147/JMDH.S274944
   Ozatay F, 2020, POLICY NOTE, V202006, P1
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   Rafeemanesh E, 2020, ARCH BONE JT SURG-AB, V8, P242, DOI 10.22038/abjs.2020.47410.2323
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Sastry S, 2011, HEALTH COMMUN, V26, P437, DOI 10.1080/10410236.2011.554166
   Smith LE, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n608
   Taghrir MH, 2020, ARCH IRAN MED, V23, P265, DOI 10.34172/aim.2020.08
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Vazquez-Nava F, 2021, J ASTHMA, V58, P1630, DOI 10.1080/02770903.2020.1818774
   Wald PC., 2010, CULTURES CARRIERS OU
   World Health Organization, 2020, WHO COR DIS 2019 COV
   World Health Organization, 2020, GETT YOUR WORKPL REA
   worldometers.info, 2021, WORLDOMETERS INFO
   Yang XY, 2020, CHILDREN-BASEL, V7, DOI 10.3390/children7120311
   Yang Y, 2020, J MED VIROL, V92, P536, DOI 10.1002/jmv.25720
   Yoosefi Lebni Javad, 2020, Disaster Med Public Health Prep, P1, DOI 10.1017/dmp.2020.498
   Lebni JY, 2021, INT J SOC PSYCHIATR, V67, P298, DOI 10.1177/0020764020939984
   Zangrillo A, 2020, CRIT CARE RESUSC, V22, P91
NR 61
TC 12
Z9 12
U1 2
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD MAY 3
PY 2021
VL 21
IS 1
AR 848
DI 10.1186/s12889-021-10889-4
PG 15
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA SK3UY
UT WOS:000656145400003
PM 33941149
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Douthit, BJ
AF Douthit, Brian J.
TI The influence of the learning health system to address the COVID-19
   pandemic: An examination of early literature
SO INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT
LA English
DT Article
DE COVID-19; learning health systems; literature review; response readiness
AB Introduction The COVID-19 pandemic has demanded immediate response from healthcare systems around the world. The learning health system (LHS) was created with rapid uptake of the newest evidence in mind, making it essential in the face of a pandemic. The goal of this review is to gain knowledge on the initial impact of the LHS on addressing the COVID-19 pandemic.
   Methods PubMed, Scopus and the Duke University library search tool were used to identify current literature regarding the intersection of the LHS and the COIVD-19 pandemic. Articles were reviewed for their purpose, findings and relation to each component of the LHS.
   Results Twelve articles were included in the review. All stages of the LHS were addressed from this sample. Most articles addressed some component of interoperability. Articles that interpreted data unique to COVID-19 and demonstrated specific tools and interventions were least common.
   Conclusions Gaps in interoperability are well known and unlikely to be solved in the coming months. Collaboration between health systems, researchers, governments and professional societies is needed to support a robust LHS which grants the ability to rapidly adapt to global emergencies.
C1 [Douthit, Brian J.] Duke Univ, Sch Nursing, 307 Trent Dr, Durham, NC 27705 USA.
RP Douthit, BJ (corresponding author), Duke Univ, Sch Nursing, 307 Trent Dr, Durham, NC 27705 USA.
EM brian.douthit@duke.edu
OI Douthit, Brian/0000-0001-6634-8171
FU Robert Wood Johnson Foundation (RWJF) as a Future of Nursing
   ScholarsRobert Wood Johnson Foundation (RWJF)
FX Brian Douthit is supported by the Robert Wood Johnson Foundation (RWJF)
   as a Future of Nursing Scholars. The views presented here are solely the
   responsibility of the author and do not necessarily represent the
   official views of the RWJF. The author received no external funding for
   the development of this manuscript.
CR Banerjee A, 2020, LANCET, V395, P1715, DOI 10.1016/S0140-6736(20)30854-0
   Bobrow BJ, 2020, JACEP OPEN, V1, P242, DOI 10.1002/emp2.12088
   Centers for Disease Control and Prevention (CDC), 2020, VACC TEST APPR PROC
   Foraker RE, 2021, LEARN HEALTH SYST, V5, DOI 10.1002/lrh2.10235
   Fox J, 2021, LEARN HEALTH SYST, V5, DOI 10.1002/lrh2.10236
   Greene SM, 2012, ANN INTERN MED, V157, P207, DOI 10.7326/0003-4819-157-3-201208070-00012
   HL7 International, 2017, HL7 STAND HLTH
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Iroju Olaronke, 2013, International Journal of Innovation and Applied Studies, V3, P262
   Johns Hopkins University & Medicine, 2020, COR RES CTR
   Li X, 2020, LANCET, V395, P1802, DOI 10.1016/S0140-6736(20)30122-7
   Moher D., 2009, PLOS MED, V6
   Pulk RA, 2020, AM J HEALTH-SYST PH, V77, P1874, DOI 10.1093/ajhp/zxaa219
   SLOAN C, 2020, COVID 19 HOSPITALIZA
   Stufi M, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10051705
   Sugarman J, 2021, LEARN HEALTH SYST, V5, DOI 10.1002/lrh2.10238
   Tanniru MR, 2021, LEARN HEALTH SYST, V5, DOI 10.1002/lrh2.10234
   The Learning Healthcare Project, 2015, BACKGR LEARN HEATHC
   Touson JC, 2021, LEARN HEALTH SYST, V5, DOI 10.1002/lrh2.10239
   Wensing M, 2020, IMPLEMENT SCI, V15, DOI 10.1186/s13012-020-01006-x
   Whelan P, 2020, JMIR MENT HEALTH, V7, DOI 10.2196/19547
   World Health Organization (WHO), 2020, ROLLING UPDATES CORO
NR 22
TC 2
Z9 2
U1 3
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0749-6753
EI 1099-1751
J9 INT J HEALTH PLAN M
JI Int. J. Health Plan. Manag.
PD MAR
PY 2021
VL 36
IS 2
BP 244
EP 251
DI 10.1002/hpm.3088
EA OCT 2020
PG 8
WC Health Policy & Services; Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA QZ8VX
UT WOS:000583748300001
PM 33103264
DA 2022-04-20
ER

PT J
AU Salomaa, M
   Caputo, A
AF Salomaa, Maria
   Caputo, Andrea
TI Business as usual? Assessing the impact of the COVID-19 pandemic to
   research, development and innovation (RDI) activities of universities of
   applied sciences
SO TERTIARY EDUCATION AND MANAGEMENT
LA English
DT Article
DE Innovation; RDI services; Case studies; Remote working; Knowledge
   transfer; COVID-19
ID 3RD MISSION; ENTREPRENEURSHIP; STRATEGIES
AB Universities of applied sciences (UAS) have a strong mandate to carry out research, development and innovation (RDI) activities in collaboration with local stakeholders. Geographical proximity is one of the key factors for the creation and success of RDI activities because of the positive balance between costs and benefits of local knowledge transfer, but they also depend on the networks of individual staff members. This paper aims to explore how maintaining and developing purpose-built and individual RDI partnerships during the COVID-19 pandemic has been managed. An enhanced conceptual framework for assessing contextual dimensions of the RDI activities beyond academic entrepreneurship as business ventures has been developed. The paper focuses on a single case study drawing on semi-structured research interviews investigating how the swap to remote working have affected RDI activities at Tampere University of Applied Sciences, one of the biggest UAS in Finland with intense regional linkages. The contribution of the study is twofold; firstly, the paper introduces an expanded theoretical approach for assessing the external and internal factors having an impact on the RDI activities beyond academic entrepreneurship. Secondly, by testing the proposed framework, it shares insights and good practices derived from empirical evidence, namely binary data and semi-structured interviews revealing experiences of RDI personnel and project managers involved with different phases of RDI process, for optimising high-quality innovation support, knowledge transfer activities and co-creation of new knowledge in exceptional circumstances.
C1 [Salomaa, Maria] Tampere Univ Appl Sci, External Funding, Kuntokatu 3, Tampere 33520, Finland.
   [Salomaa, Maria] Univ Lincoln, Lincoln Int Business Sch, Lincoln, England.
   [Caputo, Andrea] Univ Trento, Dept Econ & Management, Trento, Italy.
   [Caputo, Andrea] Univ Lincoln, Dept Management, Lincoln, England.
RP Salomaa, M (corresponding author), Tampere Univ Appl Sci, External Funding, Kuntokatu 3, Tampere 33520, Finland.; Salomaa, M (corresponding author), Univ Lincoln, Lincoln Int Business Sch, Lincoln, England.
EM maria.salomaa@tuni.fi; acaputo@lincoln.ac.uk
CR Aarrevaara T, 2011, CHANG ACAD, V2, P243, DOI 10.1007/978-94-007-1140-2_12
   Breznitz SM, 2012, J TECHNOL TRANSFER, V37, P139, DOI 10.1007/s10961-010-9183-6
   Charalampous M, 2019, EUR J WORK ORGAN PSY, V28, P51, DOI 10.1080/1359432X.2018.1541886
   Charles D, 2014, CAMB J REG ECON SOC, V7, P327, DOI 10.1093/cjres/rst029
   Davey T., 2011, STUDY COOPERATION HI
   Di Gregorio D, 2003, RES POLICY, V32, P209, DOI 10.1016/S0048-7333(02)00097-5
   Etzkowitz H., 2008, SCI PUBL POLICY, V35, P681, DOI DOI 10.3152/030234208X389701
   Fitjar R.D., 2020, PANDEMIC REGIONAL RO
   Fitjar RD, 2018, REG STUD, V52, P1525, DOI 10.1080/00343404.2017.1413237
   Fitjar RD, 2017, GROWTH CHANGE, V48, P22, DOI 10.1111/grow.12161
   Flyvbjerg B, 2006, QUAL INQ, V12, P219, DOI 10.1177/1077800405284363
   Galan-Muros V, 2016, R&D MANAGE, V46, P369, DOI 10.1111/radm.12180
   Geertz C, 1973, INTERPRETATION CULTU
   Gibb A, 2006, INT REV ENTREP, V4, P73
   Gibson, 2015, ENTREPRENEURIAL U CO
   Goransson B, 2009, SCI PUBL POLICY, V36, P157, DOI 10.3152/030234209X406863
   Grimaldi R, 2011, RES POLICY, V40, P1045, DOI 10.1016/j.respol.2011.04.005
   Heino P., 2017, THEORIES EXPERIENCES, P98
   Hellstrom T, 2017, SCI PUBL POLICY, V44, P599, DOI 10.1093/scipol/scw087
   Jaeger A, 2014, REV REG RES, V34, P95, DOI 10.1007/s10037-014-0091-3
   Kajaste M, 2018, QUAL HIGH EDUC, V24, P271, DOI 10.1080/13538322.2018.1558505
   Kettunen J., 2011, CREATIVE ED, V2, P56, DOI [10.4236/ce.2011.21008, DOI 10.4236/CE.2011.21008]
   Kitagawa F, 2016, SCI PUBL POLICY, V43, P736, DOI 10.1093/scipol/scw015
   Merino, 2017, STRATEGIC DESIGN RES, V10, P204, DOI [10.4013/sdrj.2017.103.02, DOI 10.4013/SDRJ.2017.103.02]
   Miller K, 2014, R&D MANAGE, V44, P265, DOI 10.1111/radm.12064
   Morrison K., 2017, RES METHODS ED, DOI [10.4324/9781315456539, DOI 10.4324/9781315456539]
   Patton MQ, 2002, QUALITATIVE EVALUATI, V3
   Piirainen T., 2010, EXPLORING QUADRUPLE
   Plewa C, 2013, R&D MANAGE, V43, P365, DOI 10.1111/radm.12021
   Polverani L., 2016, HDB COHESION POLICY, P325
   Saldana J., 2011, FUNDAMENTALS QUALITA
   Salomaa M, 2019, REG STUD REG SCI, V6, P233, DOI 10.1080/21681376.2019.1586574
   Sansone G, 2021, INT ENTREP MANAG J, V17, P369, DOI 10.1007/s11365-019-00601-9
   Saunders M., 2016, RES METHODS BUSINESS
   Seikkula-Leino J, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12187323
   Sonesson, 2016, FORMATION DOCTORAL E
   Taylor, 2008, HIGHER ED EUROPE, V33, P1, DOI [10.1080/03797720802228191, DOI 10.1080/03797720802228191]
   Teichler U, 2008, HIGH EDUC, V56, P349, DOI 10.1007/s10734-008-9122-8
   The Finnish Higher Education Evaluation Council, 2011, PRELIMINARY REPORT, V16
   Urbano D, 2017, TECHNOL FORECAST SOC, V123, P271, DOI 10.1016/j.techfore.2016.06.021
   Uyarra E, 2010, EUR PLAN STUD, V18, P1227, DOI 10.1080/09654311003791275
   Vallance P., 2013, U CITY, DOI [10.4324/9780203068366, DOI 10.4324/9780203068366]
   Welter F, 2019, SMALL BUS ECON, V52, P319, DOI 10.1007/s11187-018-0094-5
   Welter F, 2011, J SMALL BUS MANAGE, V49, P107, DOI 10.1111/j.1540-627X.2010.00317.x
   Wildavsky B, 2010, GREAT BRAIN RACE: HOW GLOBAL UNIVERSITIES ARE RESHAPING THE WORLD, P1
   Wright M, 2014, J TECHNOL TRANSFER, V39, P322, DOI 10.1007/s10961-012-9286-3
   Zahra SA, 2011, ACAD MANAGE PERSPECT, V25, P67, DOI 10.5465/amp.2010.0149
   Zegel S., 2015, PUBLICATIONS MINISTR, V2015, P11
NR 48
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1358-3883
EI 1573-1936
J9 TERT EDUC MANAG
JI Tert. Educ. Manag.
PD DEC
PY 2021
VL 27
IS 4
BP 351
EP 366
DI 10.1007/s11233-021-09079-z
EA NOV 2021
PG 16
WC Education & Educational Research
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research
GA WW5VP
UT WOS:000714292900001
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Rodriguez-Herrera, R
   Rivera-Diaz, M
   Huante-Anaya, A
AF Rodriguez-Herrera, Raymundo
   Rivera-Diaz, Mauricio
   Huante-Anaya, Alfonso
TI Diagnostic and therapeutic aspects in the infection by SARS-CoV-2,
   (COVID-19) in Pediatrics
SO ACTA PEDIATRICA DE MEXICO
LA Spanish
DT Article
DE Pathogenicity; Human coronavirus; Respiratory tract; SARS-CoV-2;
   COVID-19; Pandemic; Paediatric population
ID CORONAVIRUS; MANAGEMENT; CHILDREN; WUHAN
AB The high pathogenicity human coronavirus predominantly infects the lower respiratory tract causing fatal pneumonia, as it is the case of the current pandemic due to the SARS-CoV-2 virus denominated COVID-19 illness, to which human beings do not have pre-existing immunity. Since the outbreak, an increasing number of studies had investigated COVID-19 on adults, but epidemiologic and clinic characteristics data on offspring are few, who they seem to develop moderate to mild or silent forms of the illness. Even though the mortality is really low, it does exist the risk that pediatric cases could be underdiagnosed. As mentioned, we had revised and selected the most useful and recent information inside our medical branch about the diagnosis and treatment criteria in order to contribute with the knowledge and tendency of the morbidity and mortality of this pandemic on the pediatric population.
C1 [Rodriguez-Herrera, Raymundo] Inst Nacl Pediat, Dept Med Interna, Ciudad De Mexico, Mexico.
   [Rivera-Diaz, Mauricio] Secretaria Salud CD MX, Serv Urgencias, Ciudad De Mexico, Mexico.
   [Huante-Anaya, Alfonso] Inst Nacl Pediat, Ciudad De Mexico, Mexico.
RP Rodriguez-Herrera, R (corresponding author), Inst Nacl Pediat, Dept Med Interna, Ciudad De Mexico, Mexico.
EM raymundo.rdzh@gmail.com
CR Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18
   Al-Tawfiq JA, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101615
   Asociacion Espanola de Pediatria, INF FAM RESP COM INT
   Bacharier LB, 2015, JAMA-J AM MED ASSOC, V314, P2034, DOI 10.1001/jama.2015.13896
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Belhadjer Z, 2020, CIRCULATION, V142, P429, DOI 10.1161/CIRCULATIONAHA.120.048360
   Cai JH, 2020, CLIN INFECT DIS, V71, P1547, DOI 10.1093/cid/ciaa198
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Cao YC, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101647
   Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5
   Centers for Disease Control and Prevention, EM PREP RESP HLTH AL
   Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x
   Chen ZM, 2020, WORLD J PEDIATR, V16, P240, DOI 10.1007/s12519-020-00345-5
   DeBolt C, 2020, NEW ENGL J MED, V382, P929, DOI DOI 10.1056/NEJM0A2001191
   Devaux CA, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105938
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   FDA, REC INV COVID 19 CON
   Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4
   Fu BQ, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02339-3
   Fu LW, 2020, J INFECTION, V80, P656, DOI 10.1016/j.jinf.2020.03.041
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330
   Giannis D, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104362
   Hennon TR, 2020, PROG PEDIATR CARDIOL, V57, DOI 10.1016/j.ppedcard.2020.101232
   Hospital Universitario de Getafe, 2020, MAN PAC CON COVID 19
   Kashiouris MG, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020292
   Lasheras I, 2020, MED CLIN-BARCELONA, V155, P23, DOI 10.1016/j.medcli.2020.04.004
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]
   Li TH, 2020, EMERG MICROBES INFEC, V9, P687, DOI 10.1080/22221751.2020.1741327
   Li TS, 2020, EMERG MICROBES INFEC, V9, P582, DOI 10.1080/22221751.2020.1735265
   Lu HZ, 2020, BIOSCI TRENDS, V14, P69, DOI 10.5582/bst.2020.01020
   Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073
   Luo P, 2020, J MED VIROL, V92, P814, DOI 10.1002/jmv.25801
   Marik, CRITICAL CARE COVID
   Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993
   National Center for Immunization and Respiratory Diseases (NCIRD), 2020, DIV VIR DIS INT CLIN
   Nhan, 2018, J ANTIVIR ANTIRETROV, V10, P6, DOI DOI 10.4172/1948-5964.1000173
   NYC Health, 2020, HLTH AL 13 PED MULT
   Pan T, 2020, SCAND J GASTROENTERO, V55, P123, DOI 10.1080/00365521.2019.1707275
   Paraluppi V, 2020, J PEDIATR NEONATAL I, V9, DOI 10.7363/090138
   Peking Union Medical College Hospital, EFF INTR IMM THER SE
   Qing Y, 2020, J INFECTION, V0, P607, DOI DOI 10.1016/J.JINF.2020.03.037
   Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/S0140-6736(20)31094-1, 10.1016/50140-6736(20)31094-1]
   Royal College of Paediatrics and Child Health, 2020, GUID PAED MULT INFL
   Sahraei Z, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105945
   Sankar J, 2020, INDIAN J PEDIATR, V87, P433, DOI 10.1007/s12098-020-03292-1
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Shen KL, 2020, WORLD J PEDIATR, V16, P223, DOI 10.1007/s12519-020-00343-7
   Tang A, 2020, EMERG INFECT DIS, V26, P1337, DOI 10.3201/eid2606.200301
   Tin ku J, INT PULMONOLOGISTS C
   Ulloa GR, 2020, REV CHIL INFECTOL, V37, P199
   Uyeki TM, 2018, CLIN INFECT DIS, V66, P1501, DOI 10.1093/cid/cix1150
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang LS, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.20
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369
   WHO, 2020, NAM COR DIS COVID 19
   World Health Organization, SOL CLIN TRIAL COVID
   World Health Organization, MULT INFL SINDR CHIL
   World Health Organization, 2020, CLIN MAN COVID 19 IN
   Wu Renyi, 2020, Curr Pharmacol Rep, V6, P56, DOI 10.1007/s40495-020-00216-7
   Zhang C, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105954
   Zhang W, 2020, CLIN IMMUNOL, V214, DOI 10.1016/j.clim.2020.108393
   Zhang YY, 2020, DRUG DISCOV THER, V14, P100, DOI 10.5582/ddt.2020.03006
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 68
TC 0
Z9 0
U1 0
U2 3
PU INST NAC PEDIATRIA
PI MEXICO D F
PA AVE INSURGENTES SUR NO 3700-C, COL INSURGENTES CUICUILCO, MEXICO D F,
   04530, MEXICO
SN 0186-2391
EI 2395-8235
J9 ACTA PEDIATR MEX
JI Acta Pediatr. Mex.
PY 2020
VL 41
IS 6
BP 271
EP 285
PG 15
WC Pediatrics
WE Emerging Sources Citation Index (ESCI)
SC Pediatrics
GA OW8IU
UT WOS:000593124200005
DA 2022-04-20
ER

PT J
AU Rao, RR
   Sathish, M
   Rao, JR
AF Rao, Ramesh Renganath
   Sathish, Murali
   Rao, Jonnalagadda Raghava
TI Research advances in the fabrication of biosafety and functional
   leather: A way-forward for effective management of COVID-19 outbreak
SO JOURNAL OF CLEANER PRODUCTION
LA English
DT Review
DE COVID-19; Bio-safety; Leather; Functional materials; Antimicrobial
   leather
ID LAYERED DOUBLE HYDROXIDE; FLAME-RETARDANT; SILVER NANOPARTICLES;
   ESSENTIAL OILS; ANTIMICROBIAL ACTIVITY; THERMAL-STABILITY; AG
   NANOPARTICLES; NATURAL LEATHER; COLLAGEN-FIBERS; COTTON FABRICS
AB With the recent events following the pandemic COVID-19, global awareness about the use of biosafety materials has been in raise. Leather industry being a major commodity-driven sector, its role in addressing the issues concerning the safe use of leather products has become inevitable for the sustainability of the industry. A sig-nificant number of researches have been conducted to fabricate bio-safe leather by incorporating different types of antimicrobial agents during leather manufacturing. Besides, the increasing diversity in the development of synthetic materials and the impact of COVID-19 outbreak on automotive industry may create more demand from customers for incorporating different functionalities in leather without losing its inherent properties. Some of the key functionalities discussed include resistance to microbial growth, self-cleaning through superhydrophobicity and photocatalysis, thermal regulation, flame retardance and scented leather. This review focusses on the fabrication of such advanced functional leather materials over the past decade with special emphasis on anti-microbial leather. Some of the key factors elaborated in the review include the state of art approaches for the preparation of functional materials, mode of incorporation of the same into the leather matrix, the mechanism behind with a perspective on the challenges involved in fabrication for real-world applications. A major outcome of this review is that even though several kinds of cutting edge researches are happening in the field of leather manufacturing, most of them were not validated for its practical applicability and sustainability of the proposed solution. This could be majorly attributed to the cost involved in fabrication of such materials, which forms a crucial factor when it comes to a mass production industry such as leather. Also, the researchers should concentrate on the toxicity of the fabricated materials which can impede the process of adopting such emerging and need of the hour technologies in the near future. Knowledge obtained from this review on fabrication of bio -safety leather against bacteria, mold and fungi would help further to integrate the antiviral property into the same which is a global need. Also, fabrication of functionalized leather would open new avenues for leather manufactures to venture into the development of advanced leather products such as flexible electronics, radi-ation shielding and fire fighting garments etc.
C1 [Rao, Ramesh Renganath] Cent Leather Res Inst, CSIR, Leather Proc Technol Dept, Chennai 600020, Tamil Nadu, India.
   [Rao, Ramesh Renganath] Anna Univ, Alagappa Coll Technol, Dept Leather Technol, Chennai 600020, Tamil Nadu, India.
   [Sathish, Murali] Cent Leather Res Inst, CSIR, Reg Ctr Extens & Dev, Kolkata 700046, W Bengal, India.
   [Rao, Jonnalagadda Raghava] Cent Leather Res Inst, CSIR, Inorgan & Phys Chem Lab, Chennai 600020, Tamil Nadu, India.
RP Rao, JR (corresponding author), Cent Leather Res Inst, CSIR, Inorgan & Phys Chem Lab, Chennai 600020, Tamil Nadu, India.
EM jrrao@clri.res.in
RI Ramesh, Renganath Rao/ABE-3442-2021; Rao, Jonnalagadda
   Raghava/V-6803-2018
OI Rao, Jonnalagadda Raghava/0000-0001-5191-3182; Ramesh, Renganath
   Rao/0000-0002-2103-9057
FU Council of Scientific and Industrial Research (CSIR)Council of
   Scientific & Industrial Research (CSIR) - India
   [R/2020/INO/CLRI-SRF/1403]
FX The first author thanks Council of Scientific and Industrial Research
   (CSIR) for providing Senior Research Fellowship (SRF) to carry out this
   work. CSIR-CLRI communication no. R/2020/INO/CLRI-SRF/1403.
CR Akpan UG, 2009, J HAZARD MATER, V170, P520, DOI 10.1016/j.jhazmat.2009.05.039
   Aksoy A, 2013, FIBER POLYM, V14, P316, DOI 10.1007/s12221-013-0316-z
   Ara K, 2006, CAN J MICROBIOL, V52, P357, DOI 10.1139/W05-130
   Ayyappan VG, 2020, J APPL POLYM SCI, V137, DOI 10.1002/app.48627
   Babu HV, 2017, WOODH PUB S COMPOS S, V73, P201, DOI 10.1016/B978-0-08-100136-3.00008-X
   Bacardit A, 2010, J AM LEATHER CHEM AS, V105, P51
   Ballottin D, 2017, MAT SCI ENG C-MATER, V75, P582, DOI 10.1016/j.msec.2017.02.110
   Bao Y, 2017, COLLOID SURFACE A, V518, P232, DOI 10.1016/j.colsurfa.2017.01.033
   BARGHOORN E. S., 1950, Journal of the American Leather Chemists' Association, V45, P688
   Bayramoglu EE, 2006, J AM LEATHER CHEM AS, V101, P96
   Bayramoglu EE, 2007, J AM LEATHER CHEM AS, V102, P347
   Bielak E., 2016, POL J COMMODITY SCI, V4, P153, DOI [10.19202/j.cs.2016.04.16, DOI 10.19202/J.CS.2016.04.16]
   Bielak E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60285-y
   Bielak E, 2017, J AM LEATHER CHEM AS, V112, P377
   Bryskier A, 1993, Int J Antimicrob Agents, V2, P151, DOI 10.1016/0924-8579(93)90052-7
   Chang CC, 2008, DYES PIGMENTS, V79, P170, DOI 10.1016/j.dyepig.2008.02.003
   Chang JM, 2017, J AM LEATHER CHEM AS, V112, P15
   Chang JM, 2015, POLYM CHEM-UK, V6, P8150, DOI 10.1039/c5py01091h
   Chen Y, 2010, FIBER POLYM, V11, P689, DOI 10.1007/s12221-010-0689-1
   Covington A.D., 2020, TANNING CHEM SCI LEA, Vsecond
   da Silva MG, 2018, J CLEAN PROD, V199, P807, DOI 10.1016/j.jclepro.2018.07.221
   Duan BR, 2019, RESULTS PHYS, V15, DOI 10.1016/j.rinp.2019.102717
   Emam HE, 2013, J CLEAN PROD, V39, P17, DOI 10.1016/j.jclepro.2012.08.038
   Fama L, 2012, CARBOHYD POLYM, V87, P1989, DOI 10.1016/j.carbpol.2011.10.007
   Fan QQ, 2018, PROG ORG COAT, V125, P215, DOI 10.1016/j.porgcoat.2018.09.015
   Fernandes IP, 2013, CARBOHYD POLYM, V98, P1229, DOI 10.1016/j.carbpol.2013.07.030
   Fernandez ICS, 2007, BIOMATERIALS, V28, P4105, DOI 10.1016/j.biomaterials.2007.05.023
   Ferrero F, 2015, J CLEAN PROD, V96, P244, DOI 10.1016/j.jclepro.2013.12.044
   Gaidau C, 2017, ARAB J CHEM, V10, P985, DOI 10.1016/j.arabjc.2016.09.002
   Gao YS, 2014, ACS APPL MATER INTER, V6, P5094, DOI 10.1021/am500265a
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Ghayempour S, 2015, CELLULOSE, V22, P4065, DOI 10.1007/s10570-015-0765-1
   Gilman JW, 2000, CHEM MATER, V12, P1866, DOI 10.1021/cm0001760
   Gilman JW, 1999, APPL CLAY SCI, V15, P31, DOI 10.1016/S0169-1317(99)00019-8
   Gimenez-Arnau A, 2009, CONTACT DERMATITIS, V61, P249, DOI 10.1111/j.1600-0536.2009.01628.x
   Goswami P, 2012, MATER RES BULL, V47, P2077, DOI 10.1016/j.materresbull.2012.03.037
   Hebeish A, 2011, CARBOHYD POLYM, V86, P936, DOI 10.1016/j.carbpol.2011.05.048
   Heidemann E., 2000, ULLMANNS ENCY IND CH
   Heidemann E., 1993, FUNDAMENTALS LEATHER
   Hong KH, 2008, CARBOHYD POLYM, V71, P598, DOI 10.1016/j.carbpol.2007.07.004
   Hong KH, 2007, POLYM ENG SCI, V47, P1750, DOI 10.1002/pen.20866
   Hong KH, 2007, J APPL POLYM SCI, V106, P2661, DOI 10.1002/app.26900
   Hong KH, 2010, J APPL POLYM SCI, V115, P1138, DOI 10.1002/app.31221
   HOPFENBERG HB, 1976, ACS SYM SER, P26
   Howard G.T, 2011, TRANSW RES NETW, P215
   Hu R, 2020, ADV ENERGY MATER, V10, DOI 10.1002/aenm.201903921
   Huang HY, 2020, ACS NANO, V14, P3747, DOI 10.1021/acsnano.0c02618
   Ihara T, 2003, APPL CATAL B-ENVIRON, V42, P403, DOI 10.1016/S0926-3373(02)00269-2
   Jennings M.B., 1999, FOOT, V9, P68, DOI [10.1054/foot.1999.0521, DOI 10.1054/FOOT.1999.0521]
   Jiang YP, 2015, POLYM DEGRAD STABIL, V115, P110, DOI 10.1016/j.polymdegradstab.2015.02.018
   Kang HL, 2014, CARBOHYD POLYM, V100, P158, DOI 10.1016/j.carbpol.2013.07.051
   Kayaoglu BK, 2013, FIBER POLYM, V14, P1706, DOI 10.1007/s12221-013-1706-y
   Killig F, 2004, J MEMBRANE BIOL, V200, P133, DOI 10.1007/s00232-004-0700-0
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Koizhaiganova M, 2015, INT BIODETER BIODEGR, V105, P262, DOI 10.1016/j.ibiod.2015.09.017
   Kral I., 2014, FUTURE LEATHER
   Krishnamurthy M, 2017, GREEN MATER, V5, DOI 10.1680/jgrma.17.00001
   Kumar VS, 2004, J MOL CATAL A-CHEM, V223, P313, DOI 10.1016/j.molcata.2003.09.047
   Lan TX, 2018, J COLLOID INTERF SCI, V532, P331, DOI 10.1016/j.jcis.2018.07.133
   Law KY, 2014, J PHYS CHEM LETT, V5, P686, DOI 10.1021/jz402762h
   Leather International, 2007, FIR RES PROT LEATH
   Leather Mahi., 2020, LEATHER JACKET CARE
   Lee JS, 2013, J MATER CHEM A, V1, P7312, DOI 10.1039/c3ta11434a
   Lee KC, 2008, SURF COAT TECH, V202, P5339, DOI 10.1016/j.surfcoat.2008.06.080
   Li C, 2016, ACS SUSTAIN CHEM ENG, V4, P3113, DOI 10.1021/acssuschemeng.6b00134
   Liang M, 2014, ACS APPL MATER INTER, V6, P4638, DOI 10.1021/am500665p
   Lin YSE, 1998, WATER RES, V32, P1997, DOI 10.1016/S0043-1354(97)00460-0
   Lippitz A, 2005, SURF COAT TECH, V200, P250, DOI 10.1016/j.surfcoat.2005.02.091
   Liu C, 2016, J MATER CHEM C, V4, P914, DOI 10.1039/c5tc02591e
   Liu GY, 2018, J COLLOID INTERF SCI, V514, P338, DOI 10.1016/j.jcis.2017.09.049
   Liu GY, 2017, J COLLOID INTERF SCI, V490, P642, DOI 10.1016/j.jcis.2016.11.103
   Liu JL, 2014, INT J POLYM MATER PO, V63, P809, DOI 10.1080/00914037.2014.886217
   Liu XF, 2015, J MATER CHEM C, V3, P345, DOI 10.1039/c4tc01873g
   Liu Y, 2011, BIOMATERIALS, V32, P1291, DOI 10.1016/j.biomaterials.2010.10.018
   Lok CN, 2006, J PROTEOME RES, V5, P916, DOI 10.1021/pr0504079
   Luo QQ, 2016, J APPL POLYM SCI, V133, DOI 10.1002/app.43465
   Lyu B, 2020, APPL CLAY SCI, V190, DOI 10.1016/j.clay.2020.105559
   Lyu B, 2019, J ENVIRON MANAGE, V238, P235, DOI 10.1016/j.jenvman.2019.03.001
   Ma JZ, 2015, COLLOID SURFACE A, V472, P21, DOI 10.1016/j.colsurfa.2015.02.019
   Memedovic O., 2008, INT J TECHNOLOGICAL, V1, P482, DOI 10.1504/IJTLID.2008.021965
   Mijakovic I, 2005, J MOL MICROB BIOTECH, V9, P189, DOI 10.1159/000089647
   Mohamed OA, 2006, J APPL POLYM SCI, V99, P2039, DOI 10.1002/app.22409
   Kalali EN, 2016, J MATER CHEM A, V4, P2147, DOI 10.1039/c5ta09482h
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Ocak B, 2015, J SOC LEATH TECH CH, V99, P238
   Orlita A, 2004, INT BIODETER BIODEGR, V53, P157, DOI 10.1016/S0964-8305(03)00089-1
   Petica A, 2015, J COAT TECHNOL RES, V12, P1153, DOI 10.1007/s11998-015-9711-2
   Prakash AJ, 2014, J AM LEATHER CHEM AS, V109, P411
   Renzi AI, 2010, APPL THERM ENG, V30, P1369, DOI 10.1016/j.applthermaleng.2010.02.026
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Robertson JMC, 2005, J PHOTOCH PHOTOBIO A, V175, P51, DOI 10.1016/j.jphotochem.2005.04.033
   Sanchez-Olivares G, 2014, APPL CLAY SCI, V102, P254, DOI 10.1016/j.clay.2014.10.007
   Sathishkumar M, 2009, COLLOID SURFACE B, V73, P332, DOI 10.1016/j.colsurfb.2009.06.005
   Shahid-ul-Islam, 2013, J CLEAN PROD, V57, P2, DOI 10.1016/j.jclepro.2013.06.004
   Shahidi F., 2002, Food lipids: chemistry, nutrition, and biotechnology, P465
   Sirirerkratana K, 2019, J CLEAN PROD, V215, P123, DOI 10.1016/j.jclepro.2019.01.037
   Sirvaityte J, 2011, REV CHIM-BUCHAREST, V62, P884
   Sirvaityte J, 2012, P EST ACAD SCI, V61, P220, DOI 10.3176/proc.2012.3.12
   Sivakumar PM, 2010, CARBOHYD POLYM, V79, P717, DOI 10.1016/j.carbpol.2009.09.027
   Sportelli MC, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7080203
   Stanic V, 2011, APPL SURF SCI, V257, P4510, DOI 10.1016/j.apsusc.2010.12.113
   Thanikaivelan P, 2005, CRIT REV ENV SCI TEC, V35, P37, DOI 10.1080/10643380590521436
   Torres-Giner S, 2008, ENG LIFE SCI, V8, P303, DOI 10.1002/elsc.200700066
   Tzhayik O, 2017, ULTRASON SONOCHEM, V38, P614, DOI 10.1016/j.ultsonch.2016.08.020
   UNIDO, 2010, FUT TRENDS WORLD LEA
   Velmurugan P, 2014, CARBOHYD POLYM, V106, P319, DOI 10.1016/j.carbpol.2014.02.021
   Velmurugan P, 2017, SURF INTERFACES, V9, P124, DOI 10.1016/j.surfin.2017.08.009
   Velmurugan P, 2015, RSC ADV, V5, P59903, DOI 10.1039/c5ra05508c
   Wang XL, 2019, CHEM ENG SCI, V196, P64, DOI 10.1016/j.ces.2018.12.005
   Wang XL, 2015, J MATER CHEM C, V3, P10146, DOI 10.1039/c5tc02689j
   Wang YP, 2020, ACS APPL MATER INTER, V12, P19916, DOI 10.1021/acsami.0c01663
   Wang Z.L., 1998, FUNCTIONAL SMART MAT, DOI [10.1007/978-1-4615-5367-0, DOI 10.1007/978-1-4615-5367-0]
   Wei T, 2017, ACS APPL MATER INTER, V9, P37511, DOI 10.1021/acsami.7b13565
   Wu K, 2019, ACS APPL MATER INTER, V11, P40685, DOI 10.1021/acsami.9b15612
   Xia QF, 2019, ACS APPL MATER INTER, V11, P2352, DOI 10.1021/acsami.8b17061
   Xiang J, 2018, APPL SURF SCI, V458, P978, DOI 10.1016/j.apsusc.2018.07.165
   Xu H, 2013, PROG ORG COAT, V76, P924, DOI 10.1016/j.porgcoat.2013.02.013
   Xu WL, 2017, J THERM ANAL CALORIM, V128, P1107, DOI 10.1007/s10973-016-5974-9
   Xue Y, 2012, J BIOMAT SCI-POLYM E, V23, P1115, DOI 10.1163/092050611X576639
   Yang LT, 2016, FIBER POLYM, V17, P1018, DOI 10.1007/s12221-016-5808-1
   Yang ZJ, 2014, FLAVOUR FRAG J, V29, P114, DOI 10.1002/ffj.3186
   Yi GS, 2019, ENVIRON SCI-NANO, V6, P68, DOI 10.1039/c8en01095a
   Yin ZC, 2020, J CLEAN PROD, V253, DOI 10.1016/j.jclepro.2020.120058
   Yu YJ, 2020, MATER CHEM FRONT, V4, P1930, DOI 10.1039/d0qm00255k
   Zhang P, 2011, NANOSCALE, V3, P3357, DOI 10.1039/c1nr10405e
   Zhang X, 2017, CHEM ENG J, V313, P1152, DOI 10.1016/j.cej.2016.11.014
   Zhang Y, 2010, J MATER SCI-MATER M, V21, P2453, DOI 10.1007/s10856-010-4101-x
NR 127
TC 0
Z9 0
U1 13
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0959-6526
EI 1879-1786
J9 J CLEAN PROD
JI J. Clean Prod.
PD AUG 10
PY 2021
VL 310
AR 127464
DI 10.1016/j.jclepro.2021.127464
EA MAY 2021
PG 20
WC Green & Sustainable Science & Technology; Engineering, Environmental;
   Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics; Engineering; Environmental Sciences
   & Ecology
GA SV4BI
UT WOS:000663765300006
OA Bronze
DA 2022-04-20
ER

PT J
AU Rimsha, S
   Moosa, FA
   Zaheer, F
   Kamal, MT
   Majid, A
AF Rimsha, Shehzadi
   Moosa, Foad Ali
   Zaheer, Farhan
   Kamal, Mohammed Taha
   Majid, Aamina
TI What Does the Future Hold for a Surgical Trainee? This Lockdown Is Not a
   Letdown Yet: A Survey on Moodle Learning Management System as a Part of
   Blended Learning During COVID-19 Pandemic
SO CUREUS
LA English
DT Article
DE blended learning; moodle; general surgery; pakistan; covid-19;
   e-learning; learning management system; education
ID PAKISTAN; LMS
AB Background
   The COVID-19 pandemic brought about a major shift in the educational training of surgical trainees. As the Lockdown was implemented and the daily workforce reduced, an alternate method was employed to provide uninterrupted learning. Blended learning that includes virtual learning with face-to-face learning/teaching was utilized for the surgical trainees. MOODLE (Modular object-oriented dynamic learning environment), an open-source learning management system, was integrated as an Online Component of our Blended Learning Program. We aimed to evaluate the perception of postgraduate trainees of General Surgery regarding the benefits and limitations of Blended Learning, particularly its online component, i.e., Moodie LMS, for the betterment of surgical -education during the COVID-19 pandemic.
   Material and Methods
   Thirty-three postgraduate general surgery trainees were enrolled in a blended learning program, in which its online component, Moodle LMS, comprised four major topics on General Surgery. A questionnaire was provided to the trainees to obtain feedback on blended learning in general, and Moodie LMS was mainly themed on the Likert scale.
   Results
   The approach of blended learning was positively received by the participants, the majority of whom were females (75%) and comprising of Year 1 residents (33.3%). Nearly half of the participants found Moodie LMS user-friendly, practical and a good platform for learning. However, nearly two thirds (60.6%) were uncertain if it ever helped in applying knowledge to interpret laboratory and radiological results for patient management. Even then, most of them found that the face-to-face component of blended learning helped them develop specific clinical and surgical skills (42.4%). Emphatically, 78.7% would recommend it for surgical training.
   Conclusion
   Blended learning was found to be beneficial in the training process of surgical postgraduates in the current COV1D-19 pandemic situation. We recommend it for the training of doctors for optimized learning.
C1 [Rimsha, Shehzadi; Moosa, Foad Ali; Zaheer, Farhan; Kamal, Mohammed Taha; Majid, Aamina] Dow Univ Hlth Sci, Gen Surg, Civil Hosp Karachi, Karachi, Pakistan.
RP Majid, A (corresponding author), Dow Univ Hlth Sci, Gen Surg, Civil Hosp Karachi, Karachi, Pakistan.
EM aamina.majid@gmail.com
CR Al-Busaidi KA., 2010, COMMUNICATIONS IBIMA, V2010, P1
   Amir LR, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02312-0
   Binks AP, 2021, TEACH LEARN MED, V33, P334, DOI 10.1080/10401334.2021.1891543
   Bridges SM, 2010, MED EDUC, V44, P1131, DOI 10.1111/j.1365-2923.2010.03830.x
   Deepak KC, 2017, PROCEDIA COMPUT SCI, V116, P121, DOI 10.1016/j.procs.2017.10.021
   DeSantis AJ, 2021, AM J SURG, V222, P471, DOI 10.1016/j.amjsurg.2021.03.018
   Farooq Fareeha, 2020, J Coll Physicians Surg Pak, V30, P67, DOI 10.29271/jcpsp.2020.Supp1.S67
   Ferrara M, 2020, EYE, V34, P2089, DOI 10.1038/s41433-020-1061-3
   Huynh R, 2017, ACAD MED, V92, P430, DOI 10.1097/ACM.0000000000001596
   Jeganathan S, 2020, BRIT DENT J, V228, P371, DOI 10.1038/s41415-020-1332-1
   Kamal AA, 2020, INT J ADV COMPUT SC, V11, P217
   Kasim NNM, 2016, INT J EMERG TECHNOL, V11, P55, DOI 10.3991/ijet.v11i06.5644
   Khalid S., 2019, SOTL S, V3, P57, DOI [10.36615/sotls.v3i1.73, DOI 10.36615/SOTLS.V3I1.73]
   MacDonald DR., 2021, B ROY COLL SURG ENGL, V103, P44, DOI DOI 10.1308/RCSBULL.2021.12
   Martin-Blas T, 2009, COMPUT EDUC, V52, P35, DOI 10.1016/j.compedu.2008.06.005
   Moletta Lucia, 2020, Int J Surg, V79, P180, DOI 10.1016/j.ijsu.2020.05.061
   Mumtaz N, 2021, PAK J MED SCI, V37, P283, DOI 10.12669/pjms.37.1.2894
   Noermanzah S, 2020, ENGLISH REV J ENGLIS, V9, P1, DOI [10.25134/ erjee.v9i1.3781, DOI 10.25134/ERJEE.V9I1.3781]
   Osama M, 2020, INT J SURG, V79, P252, DOI 10.1016/j.ijsu.2020.06.004
   Qamar K, PAK ARMED FORCES MED, V71, P3
   Raza SA, 2021, J EDUC COMPUT RES, V59, P183, DOI 10.1177/0735633120960421
   Salim H, 2018, BMC MED EDUC, V18, DOI 10.1186/s12909-018-1315-y
   Shchedrina E, 2021, INT J EMERG TECHNOL, V16, P95, DOI 10.3991/ijet.v16i02.18813
   Srivastava V, 2020, INDIAN J SURG, V82, P762, DOI 10.1007/s12262-020-02592-2
   Turnbull D, 2019, LEARNING MANAGEMENT
   Westerlaken M, 2019, BMC MED EDUC, V19, DOI 10.1186/s12909-019-1717-5
NR 26
TC 0
Z9 0
U1 5
U2 5
PU CUREUS INC
PI PALO ALTO
PA PO BOX 61002, PALO ALTO, CA 94306 USA
EI 2168-8184
J9 CUREUS
JI Cureus
PD JUL 28
PY 2021
VL 13
IS 7
AR e16690
DI 10.7759/cureus.16690
PG 11
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA UE2HC
UT WOS:000687714100005
PM 34513349
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Tong, Y
   Wang, ZZ
   Zheng, JZ
   Ying, YB
   Liu, J
   Zhang, JJ
   Liu, GT
AF Tong Yan
   Wang Zhizhong
   Zheng Jianzhong
   Ying Yubo
   Liu Jie
   Zhang Junjun
   Liu Guangtian
TI Depressive and Anxiety Symptoms Among People Under Quarantine During the
   COVID-19 Epidemic in China: A Cross-Sectional Study
SO FRONTIERS IN PSYCHIATRY
LA English
DT Article
DE COVID-19; quarantine; depression; anxiety; cross-sectional study
ID MENTAL-HEALTH; TRANSMISSION DYNAMICS; GENERAL-POPULATION; RISK-FACTORS;
   PREVALENCE; PHQ-9; VALIDATION; VALIDITY; IMPACT; GAD-7
AB Background: During the coronavirus disease 2019 (COVID-19) pandemic, quarantine as an effective public health measure has been widely used in China and elsewhere to slow down the spread, while high-risk psychological response populations remain under-reported.
   Objective: The aim of the study is to investigate the depressive and anxiety symptoms among the high-risk individuals quarantined during the COVID-19 pandemic in China.
   Methods: An online survey was conducted from February 29 to April 10, 2020, among individuals quarantined for at least 2 weeks due to the high-risk exposure. Chinese versions of the nine-item Patient Health Questionnaire (PHQ-9) with a seven-item Generalized Anxiety Disorder (GAD-7) were applied to assess depressive and anxiety symptoms, respectively. Compliance with quarantine and knowledge of COVID-19 was also assessed. An unconditional logistic regression model was performed to identify the correlators.
   Results: Of the 1,260 participants completing the full survey, 14.0% (95% CI: 12.2-16.1%), 7.1% (95% CI: 5.9-8.7%), and 6.3% (95% CI: 5.1-7.8%) had at least moderate symptoms of depression, anxiety, and a combination of depression and anxiety (CDA), respectively; 14.8% (95% CI: 13.0-16.9%) had at least one condition. Multivariate analysis showed that participants with an undergraduate or above degree were more likely to report depressive (OR = 2.98, 95% CI: 1.56-5.72) and anxiety symptoms (OR = 2.95, 95% CI: 1.14-7.63) than those with middle school education. Those who were unemployed (OR = 0.37, 95% CI: 0.21-0.65 for depression; OR = 0.31, 95% CI: 0.14-0.73 for anxiety), students (OR = 0.14, 95% CI: 0.04-0.48 for depression; OR = 0.11, 95% CI: 0.01-0.85 for anxiety), and more knowledgeable of COVID-19 (OR = 0.84, 95% CI: 0.73-0.96 for depression, OR = 0.82, 95% CI: 0.68-0.98 for anxiety) were less likely to report depressive and anxiety symptoms. Higher quarantine compliance correlated with lower risks of depressive (OR = 0.94, 95% CI: 0.91-0.96) and anxiety symptoms (OR = 0.95, 95% CI: 0.91-0.98).
   Conclusion: Individuals under quarantine during the COVID-19 pandemic suffered prevalent depressive and anxiety symptoms. Consequently, comprehensive interventional measures, including knowledge dissemination, timely virus tests, and strengthened communication, may minimize quarantine's adverse effects.
C1 [Tong Yan; Zheng Jianzhong; Ying Yubo; Liu Jie; Zhang Junjun] Shanxi Med Univ, Sch Publ Hlth, Dept Sociai Med, Taiyuan, Peoples R China.
   [Wang Zhizhong] Guangdong Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Dongguan, Peoples R China.
   [Wang Zhizhong] Ningxia Med Univ, Sch Publ Hlth & Management, Dept Epidemiol & Hlth Stat, Yinchuan, Ningxia, Peoples R China.
   [Zheng Jianzhong] Chang Zhi Med Coll, Dept Prevent Med, Changzhi, Peoples R China.
   [Liu Guangtian] Fourth People Hosp Ningxia, Dept Infect Dis, Yinchuan, Ningxia, Peoples R China.
RP Zheng, JZ (corresponding author), Shanxi Med Univ, Sch Publ Hlth, Dept Sociai Med, Taiyuan, Peoples R China.; Wang, ZZ (corresponding author), Guangdong Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Dongguan, Peoples R China.; Wang, ZZ (corresponding author), Ningxia Med Univ, Sch Publ Hlth & Management, Dept Epidemiol & Hlth Stat, Yinchuan, Ningxia, Peoples R China.; Zheng, JZ (corresponding author), Chang Zhi Med Coll, Dept Prevent Med, Changzhi, Peoples R China.
EM wzhzh_lion@126.com; zjzhong4183@163.com
FU key research and development program in the Ningxia Hui Autonomous
   Region [2020BEG01003]
FX This study was funded by the key research and development program in the
   Ningxia Hui Autonomous Region (2020BEG01003). The funding body played no
   role in designing the study, collecting, analyzing, interpreting the
   data, writing the manuscript, or submitting the paper for publication.
CR Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   Bussone S, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.589444
   Caleo G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5158-6
   Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934
   Cetron Martin, 2005, Yale J Biol Med, V78, P329
   Das-Munshi J, 2008, BRIT J PSYCHIAT, V192, P171, DOI 10.1192/bjp.bp.107.036707
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Merino MD, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17239087
   Du N, 2017, ASIA-PAC PSYCHIAT, V9, DOI 10.1111/appy.12266
   Gonzalez-Sanguino C, 2020, BRAIN BEHAV IMMUN, V87, P172, DOI 10.1016/j.bbi.2020.05.040
   Guan CS, 2020, ACAD RADIOL, V27, P609, DOI 10.1016/j.acra.2020.03.002
   Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703
   Jeong H, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016048
   Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Kwong A., 2020, WELLCOME OPEN RES, V5, P1, DOI [10.12688/wellcomeopenres.16206.1, DOI 10.12688/WELLCOMEOPENRES.16206.1]
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Li ZY, 2020, BRAIN BEHAV IMMUN, V88, P916, DOI 10.1016/j.bbi.2020.03.007
   Liu XH, 2012, COMPR PSYCHIAT, V53, P15, DOI 10.1016/j.comppsych.2011.02.003
   Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093
   Marjanovic Z, 2007, INT J NURS STUD, V44, P991, DOI 10.1016/j.ijnurstu.2006.02.012
   Moriarty AS, 2015, GEN HOSP PSYCHIAT, V37, P567, DOI 10.1016/j.genhosppsych.2015.06.012
   Nguyen HC, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040965
   Peng M, 2020, J AFFECT DISORDERS, V275, P119, DOI 10.1016/j.jad.2020.06.035
   Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213
   Ren YL, 2020, J AFFECT DISORDERS, V277, P893, DOI 10.1016/j.jad.2020.08.045
   Roberts T, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1837-1
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Rubin GJ, 2016, EUR J PSYCHOTRAUMATO, V7, DOI 10.3402/ejpt.v7.30933
   Salari N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00589-w
   Sawaya H, 2016, PSYCHIAT RES, V239, P245, DOI 10.1016/j.psychres.2016.03.030
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Torales J, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.558691
   Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048
   Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028
   Wang YG, 2011, GEN HOSP PSYCHIAT, V33, P75, DOI 10.1016/j.genhosppsych.2010.11.001
   WATSON D, 1995, J ABNORM PSYCHOL, V104, P3, DOI 10.1037/0021-843X.104.1.3
   Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020
   Wilder-Smith A, 2020, LANCET INFECT DIS, V20, pE102, DOI 10.1016/S1473-3099(20)30129-8
   World Health Organization, 2020, ADV PUBL
   World Health Organization, WHO DIR GEN OP REM M
   Wu WY., 2010, SHANGHAI ARCH PSYCHI, V22, P200, DOI DOI 10.3969/J.ISSN.1002-0829.2010.04.002
   Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001
   Zhang WR, 2020, PSYCHOTHER PSYCHOSOM, V89, P242, DOI 10.1159/000507639
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhou YJ, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-01006-x
   Zhou YJ, 2020, J AFFECT DISORDERS, V277, P510, DOI 10.1016/j.jad.2020.08.059
NR 49
TC 5
Z9 5
U1 3
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-0640
J9 FRONT PSYCHIATRY
JI Front. Psychiatry
PD FEB 15
PY 2021
VL 12
AR 566241
DI 10.3389/fpsyt.2021.566241
PG 10
WC Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Psychiatry
GA QO5QW
UT WOS:000623197800001
PM 33658949
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Hirai, N
   Nishioka, Y
   Sekine, T
   Nishihara, Y
   Okuda, N
   Nishimura, T
   Fujikura, H
   Imakita, N
   Fukumori, T
   Ogawa, T
   Hishiya, N
   Suzuki, Y
   Nakano, R
   Yano, H
   Sato, M
   Maeda, K
   Imamura, T
   Kasahara, K
AF Hirai, Nobuyasu
   Nishioka, Yuichi
   Sekine, Takahiro
   Nishihara, Yuji
   Okuda, Nao
   Nishimura, Tomoko
   Fujikura, Hiroyuki
   Imakita, Natsuko
   Fukumori, Tatsuya
   Ogawa, Taku
   Hishiya, Naokuni
   Suzuki, Yuki
   Nakano, Ryuichi
   Yano, Hisakazu
   Sato, Masatoshi
   Maeda, Koichi
   Imamura, Tomoaki
   Kasahara, Kei
TI Factors associated with viral clearance periods from patients with
   COVID-19: A retrospective observational cohort study
SO JOURNAL OF INFECTION AND CHEMOTHERAPY
LA English
DT Article
DE Viral clearance periods; COVID-19; Comorbid conditions; Age
AB Introduction: Knowledge is limited on the virologic course of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, particularly the time taken for viral clearance and the optimal time to discontinue isolation. This study aims to identify the clinical and demographic factors influencing the time taken for viral clearance in patients with COVID-19 to determine the optimal isolation period.
   Methods: This two-center retrospective observational cohort study was conducted between March 1 and June 31, 2020. Patients with COVID-19, which was confirmed by real-time reverse transcription polymerase chain reaction, were included. Data were extracted from medical records. The positive duration, which was defined as the period from the day of symptom onset to the negative conversion day, was assessed using a generalized linear model. Results: We included 63 patients. The mean positive duration was 20 days. The positive duration was significantly shorter for patients younger than 30 years of age and those between 30 and 60 years of age than for patients older than 60 years of age. We observed a more scattered distribution of the positive duration in older patients than in younger patients.
   Conclusions: Younger patients who recovered from COVID-19 took less time to clear SARS-CoV-2 than older patients; thus, a classification of the isolation periods based on age could be considered. A uniform viral clearance period for older patients may be difficult to determine because of biases such as underlying medical conditions. Further surveillance measures are recommended to determine the viral clearance time and the optimal isolation period.
   (c) 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Hirai, Nobuyasu; Sekine, Takahiro; Nishihara, Yuji; Okuda, Nao; Nishimura, Tomoko; Fujikura, Hiroyuki; Imakita, Natsuko; Fukumori, Tatsuya; Ogawa, Taku; Kasahara, Kei] Nara Med Univ, Ctr Infect Dis, Shijo Cho, Kashihara, Nara, Japan.
   [Nishioka, Yuichi; Imamura, Tomoaki] Nara Med Univ, Dept Publ Hlth Hlth Management & Policy, Shijo Cho, Kashihara, Nara, Japan.
   [Hishiya, Naokuni; Suzuki, Yuki; Nakano, Ryuichi; Yano, Hisakazu] Nara Med Univ, Dept Microbiol & Infect Dis, Shijo Cho, Kashihara, Nara, Japan.
   [Sato, Masatoshi; Maeda, Koichi] Nara Prefecture Gen Med Ctr, Dept Infect Dis, Shichijo Nishimachi, Nara, Nara, Japan.
RP Hirai, N (corresponding author), Nara Med Univ, Ctr Infect Dis, Shijo Cho, Kashihara, Nara, Japan.
EM nobuyasuhirai1986@naramed-u.ac.jp
RI Nishioka, Yuichi/ABD-9296-2020
OI Nishioka, Yuichi/0000-0002-1956-3925
CR Cheng HY, 2020, JAMA INTERN MED, V180, P1156, DOI 10.1001/jamainternmed.2020.2020
   Guggemos, 2020, NATURE          0401, V581, DOI [10.1038/s41586-020-2196-x, DOI 10.1038/s41586-020-2196-x]
   Hattori T, 2021, J INFECTION, V82, P177, DOI 10.1016/j.jinf.2020.06.046
   Hu XW, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138812
   Ip DKM, 2017, CLIN INFECT DIS, V64, P736, DOI 10.1093/cid/ciw841
   Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383
   Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005
   Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6
   Trump S, 2021, NAT BIOTECHNOL, V39, P705, DOI 10.1038/s41587-020-00796-1
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017
   Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 13
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1341-321X
EI 1437-7780
J9 J INFECT CHEMOTHER
JI J. Infect. Chemother.
PD JUN
PY 2021
VL 27
IS 6
BP 864
EP 868
DI 10.1016/j.jiac.2021.02.015
EA APR 2021
PG 5
WC Infectious Diseases; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases; Pharmacology & Pharmacy
GA RK2QD
UT WOS:000638145300013
PM 33642249
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Amiri, P
   Karahanna, E
AF Amiri, Parham
   Karahanna, Elena
TI Chatbot use cases in the Covid-19 public health response
SO JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
LA English
DT Review; Early Access
DE chatbot; conversational agents; Covid-19; pandemic; public health
   response
AB Objective To identify chatbot use cases deployed for public health response activities during the Covid-19 pandemic. Material and Methods We searched PubMed/MEDLINE, Web of Knowledge, and Google Scholar in October 2020 and performed a follow-up search in July 2021. We screened articles based on their abstracts and keywords in their text, reviewed potentially relevant articles, and screened their references to (a) assess whether the article met inclusion criteria and (b) identify additional articles. Chatbots, their use cases, and chatbot design characteristics were extracted from the articles and information from other sources and by accessing those chatbots that were publicly accessible. Results Our search returned 3334 articles, 61 articles met our inclusion criteria, and 61 chatbots deployed in 30 countries were identified. We categorized chatbots based on their public health response use case(s) and design. Six categories of public health response use cases emerged comprising 15 distinct use cases: risk assessment, information dissemination, surveillance, post-Covid eligibility screening, distributed coordination, and vaccine scheduler. Design-wise, chatbots were relatively simple, implemented using decision-tree structures and predetermined response options, and focused on a narrow set of simple tasks, presumably due to need for quick deployment. Conclusion Chatbots' scalability, wide accessibility, ease of use, and fast information dissemination provide complementary functionality that augments public health workers in public health response activities, addressing capacity constraints, social distancing requirements, and misinformation. Additional use cases, more sophisticated chatbot designs, and opportunities for synergies in chatbot development should be explored.
C1 [Amiri, Parham; Karahanna, Elena] Univ Georgia, Dept Management Informat Syst, Athens, GA USA.
RP Amiri, P (corresponding author), Univ Georgia, 620 S Lumpkin St,B423 Amos Hall, Athens, GA 30602 USA.
EM amiri@uga.edu
CR Almalki Manal, 2020, Acta Inform Med, V28, P241, DOI 10.5455/aim.2020.28.241-247
   Anderson M., 2018, QUARTER RURAL AM SAY
   Anderson M., 2017, DIGITAL DIVIDE PERSI
   [Anonymous], HEALTHCONNECT COVID
   [Anonymous], 2020, U REPORT COVID 19 OU
   [Anonymous], 2020, P 11 ACM INT C BIOIN
   Bitran H., 2020, DELIVERING INFORM EL
   Car LT, 2020, J MED INTERNET RES, V22, DOI 10.2196/17158
   Desai V., 2021, CHATBOT COVIDVACCINE, DOI [10.2139/ssrn.3874429, DOI 10.2139/SSRN.3874429]
   Di Donato V., 2020, CNN 0406
   Diederich S, 2022, J ASSOC INF SYST, V23, P96, DOI 10.17705/1jais.00724
   Dourado I, 2020, AIDS BEHAV, V24, P1994, DOI 10.1007/s10461-020-02927-w
   Eaton M., 2020, NEW YORK TIMES
   Espinoza Juan, 2020, JMIR Public Health Surveill, V6, pe18808, DOI 10.2196/18808
   Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47
   Gray M., 2020, NEW YORK POST 0606
   Harzheim E, 2020, CIENC SAUDE COLETIVA, V25, P2493, DOI 10.1590/1413-81232020256.1.11492020
   Hassounah M, 2020, J MED INTERNET RES, V22, DOI 10.2196/19338
   Judson TJ, 2020, J AM MED INFORM ASSN, V27, P1450, DOI 10.1093/jamia/ocaa130
   Kadirvelu B., 2021, COVID 19 DOES NOT LO
   Kalter L, 2020, MED HELPLINE CALLS S
   Kawashima T, 2021, PUBLIC HEALTH, V192, P12, DOI 10.1016/j.puhe.2020.05.018
   Kellam A., 2020, AMICUS CURIAE, V1, P361
   Kim J, 2020, DIGIT GOV RES PRACT, V2, P1
   Landman A.B., 2020, HARVARD BUSINESS REV
   Lee S., ARXIV PREPRINT ARXIV
   MEDIA H, 2020, ROUNDUP TECHS ROLE T
   Mehl A, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/21364
   Miles MB., 1994, QUALITATIVE DATA ANA, V2nd ed
   Miner AS, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0280-0
   Munsch N, 2020, J MED INTERNET RES, V22, DOI 10.2196/21299
   Perrin A., 2019, DIGITAL GAP RURAL NO
   Poliak A, 2020, P 1 WORKSH NLP COVID
   Rodsawang C., 2020, OSIR J, V13, P71
   Scale Customer Service with Watson Assistant and the Expertise of IBM, SEC SCAL CUST SERV W
   Sermet Y, ARXIV PREPRINT ARXIV
   Tanoue Y, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113067
   Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850
   Vota W, 2020, 3 EARLY DIGITAL HLTH
   Yoneoka D, 2020, J EPIDEMIOL, V30, P362, DOI 10.2188/jea.JE20200150
   Montenegro JLZ, 2019, EXPERT SYST APPL, V129, P56, DOI 10.1016/j.eswa.2019.03.054
NR 41
TC 0
Z9 0
U1 9
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1067-5027
EI 1527-974X
J9 J AM MED INFORM ASSN
JI J. Am. Med. Inf. Assoc.
DI 10.1093/jamia/ocac014
EA FEB 2022
PG 11
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Health Care Sciences & Services;
   Information Science & Library Science; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Computer Science; Health Care Sciences & Services; Information Science &
   Library Science; Medical Informatics
GA ZM2YE
UT WOS:000764228500001
PM 35137107
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Al-Omoush, KS
   Palacios-Marques, D
   Ulrich, K
AF Al-Omoush, Khaled Saleh
   Palacios-Marques, Daniel
   Ulrich, Klaus
TI The impact of intellectual capital on supply chain agility and
   collaborative knowledge creation in responding to unprecedented pandemic
SO TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE
LA English
DT Article
DE Intellectual capital; Supply chain agility; Collaborative knowledge
   creation; Corporate sustainability; COVID-19
ID COMPETITIVE ADVANTAGE; PERFORMANCE; CAPABILITIES; FRAMEWORK; ENABLERS
AB This study explores the relationships between intellectual capital, supply chain agility, collaborative knowledge creation, and corporate sustainability during unprecedented crises such as the COVID-19 epidemic. Data were collected from food and beverages firms and analyzed using Smart-Partial Least Squares (Smart-PLS) structural equation modeling software. The sample consisted of 289 managers, directors, and heads of department. The results reveal that intellectual capital significantly impacts supply chain agility, collaborative knowledge creation, and corporate sustainability. Furthermore, the findings confirm that collaborative knowledge creation and supply chain agility significantly impact corporate sustainability during the COVID-19 crises. This study contributes to the literature on intellectual capital, dynamic capabilities, supply chain management, and knowledge management, and the role of these capabilities in preserving corporate sustainability during unprecedented crises.
C1 [Al-Omoush, Khaled Saleh] Al Zaytoonah Univ Jordan, Amman, Jordan.
   [Palacios-Marques, Daniel] Univ Politecn Valencia, Valencia, Spain.
   [Ulrich, Klaus] ESIC Business & Mkt Sch, Barcelona, Spain.
RP Al-Omoush, KS (corresponding author), Al Zaytoonah Univ Jordan, Amman, Jordan.
EM k.alomoush@zuj.edu.jo
CR Al Humdan E, 2020, INT J PHYS DISTR LOG, V50, P287, DOI 10.1108/IJPDLM-06-2019-0192
   Al-Jitan M.W, 2021, JORDANS FOOD IND SEC
   Al-Omoush KS, 2020, J INNOV KNOWL, V5, P279, DOI 10.1016/j.jik.2020.10.002
   Al-Shboul MA, 2017, SUPPLY CHAIN MANAG, V22, P172, DOI 10.1108/SCM-09-2016-0335
   Alvino F, 2021, J INTELLECT CAP, V22, P76, DOI 10.1108/JIC-11-2019-0259
   Alzoubi H., 2020, UNCERTAIN SUPPLY CHA, V8, P273
   Arianpoor A, 2021, MANAG ENVIRON QUAL, V32, P175, DOI 10.1108/MEQ-03-2020-0040
   Baah C, 2022, BENCHMARKING, V29, P172, DOI 10.1108/BIJ-10-2020-0519
   Barchiesi MA, 2021, TECHNOL FORECAST SOC, V170, DOI 10.1016/j.techfore.2021.120907
   Blome C, 2013, INT J PROD RES, V51, P1295, DOI 10.1080/00207543.2012.728011
   Bontis N., 1999, EUR MANAG J, V17, P391, DOI DOI 10.1016/S0263-2373(99)00019-5
   Bontis N., 2001, J INTELLECT CAP, V2, P183
   Braunscheidel MJ, 2009, J OPER MANAG, V27, P119, DOI 10.1016/j.jom.2008.09.006
   Cegarra-Navarro JG, 2020, J INTELLECT CAP, V21, P459, DOI 10.1108/JIC-03-2019-0048
   Chen W., 2016, PACIS, P37
   Dabic M, 2021, J BUS RES, V123, P683, DOI 10.1016/j.jbusres.2020.10.013
   Do QN, 2021, SUPPLY CHAIN MANAG, V26, P737, DOI 10.1108/SCM-09-2020-0470
   Faccin K, 2018, J ENG TECHNOL MANAGE, V48, P28, DOI 10.1016/j.jengtecman.2018.04.001
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Fritz M., 2021, TECHNOL FORECAST SOC, V173
   Gligor DM, 2015, J OPER MANAG, V33-34, P71, DOI 10.1016/j.jom.2014.10.008
   Gligor DM, 2014, INT J LOGIST MANAG, V25, P160, DOI 10.1108/IJLM-07-2012-0062
   Gligor DM, 2013, J BUS LOGIST, V34, P94, DOI 10.1111/jbl.12012
   Golgeci I, 2020, IND MARKET MANAG, V84, P63, DOI 10.1016/j.indmarman.2019.05.006
   Guan DB, 2020, NAT HUM BEHAV, V4, P577, DOI 10.1038/s41562-020-0896-8
   Gunasekaran A, 1999, INT J PROD ECON, V62, P87, DOI 10.1016/S0925-5273(98)00222-9
   Hair JF, 2014, EUR BUS REV, V26, P106, DOI 10.1108/EBR-10-2013-0128
   Han YQ, 2015, MANAGE DECIS, V53, P40, DOI 10.1108/MD-08-2013-0411
   Haq M.A., 2020, S ASIAN J BUS MANAG, V14, P104
   Hsu IC, 2012, DECISION SCI, V43, P489, DOI 10.1111/j.1540-5915.2012.00357.x
   Inkinen H, 2015, J INTELLECT CAP, V16, P518, DOI 10.1108/JIC-01-2015-0002
   Irfan M, 2019, OPER MANAGE RES, V12, P113, DOI 10.1007/s12063-019-00142-y
   Ivanov D, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03640-6
   Forcadell FJ, 2021, TECHNOL FORECAST SOC, V162, DOI 10.1016/j.techfore.2020.120355
   Khan M., 2014, INT J ACAD RES BUS S, V4, P159
   Kraus S, 2020, TECHNOL FORECAST SOC, V160, DOI 10.1016/j.techfore.2020.120262
   Lo FY, 2021, INT J EMERG MARK, V16, P909, DOI 10.1108/IJOEM-02-2020-0205
   Lo FY, 2021, TECHNOL FORECAST SOC, V162, DOI 10.1016/j.techfore.2020.120346
   Tuan LT, 2016, INT J LOGIST-RES APP, V19, P583, DOI 10.1080/13675567.2015.1137278
   Mandal S, 2018, J BUS IND MARK, V33, P1012, DOI 10.1108/JBIM-06-2017-0141
   Mubarik MS, 2022, J INTELLECT CAP, V23, P713, DOI 10.1108/JIC-06-2020-0206
   Nafei W., 2016, INT BUS RES, V9, P153
   Namvar Morteza, 2013, International Journal of Commerce and Management, V23, P97, DOI 10.1108/10569211311324902
   Nandi S, 2021, SUSTAIN PROD CONSUMP, V27, P10, DOI 10.1016/j.spc.2020.10.019
   Naughton S, 2020, PROD PLAN CONTROL, V31, P1164, DOI 10.1080/09537287.2019.1701130
   Ngai EWT, 2011, J STRATEGIC INF SYST, V20, P232, DOI 10.1016/j.jsis.2010.11.002
   Nickerson JA, 2004, ORGAN SCI, V15, P617, DOI 10.1287/orsc.1040.0093
   Nissen V., 2017, P 13 INT TAG WIRTSCH
   NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14
   Nonaka I., 1995, KNOWLEDGE CREATING C
   Raymond L, 2015, P ANN HICSS, P3740, DOI 10.1109/HICSS.2015.450
   Rusland SL, 2020, COGENT BUS MANAG, V7, DOI 10.1080/23311975.2020.1785106
   Sambamurthy V, 2003, MIS QUART, V27, P237
   Hernandez JPSI, 2020, TECHNOL FORECAST SOC, V151, DOI 10.1016/j.techfore.2019.119774
   Sangari MS, 2015, INT J LOGIST MANAG, V26, P356, DOI 10.1108/IJLM-01-2013-0012
   Sarkis J, 2021, INT J OPER PROD MAN, V41, P63, DOI 10.1108/IJOPM-08-2020-0568
   Pinto CAS, 2020, BRAZ J OPER PROD MAN, V17, DOI 10.14488/BJOPM.2020.033
   Shakina E, 2014, ECON RES-EKON ISTRAZ, V27, P861, DOI 10.1080/1331677X.2014.974918
   Shi YY, 2017, SUPPLY CHAIN MANAG, V22, P40, DOI 10.1108/SCM-06-2016-0189
   Shiranifar Alireza, 2019, International Journal of Logistics Systems and Management, V34, P123
   Shou YY, 2020, IEEE T ENG MANAGE, V67, P92, DOI 10.1109/TEM.2018.2870490
   Siltori PFS, 2021, TECHNOL FORECAST SOC, V167, DOI 10.1016/j.techfore.2021.120741
   Srikalimah S, 2020, J ASIAN FINANC ECON, V7, P397, DOI 10.13106/jafeb.2020.vol7.no12.397
   STARIK M, 1995, ACAD MANAGE REV, V20, P908, DOI 10.2307/258960
   Subramaniam M, 2005, ACAD MANAGE J, V48, P450, DOI 10.5465/AMJ.2005.17407911
   Tooranloo HS, 2018, COMPET REV, V28, P541, DOI 10.1108/CR-01-2017-0009
   Tseng ML, 2019, TECHNOL FORECAST SOC, V144, P524, DOI 10.1016/j.techfore.2017.10.014
   Um J, 2017, INT J LOGIST MANAG, V28, P464, DOI 10.1108/IJLM-07-2015-0113
   Wasiluk KL, 2013, J INTELLECT CAP, V14, P102, DOI 10.1108/14691931311289048
   Weber Y, 2014, CALIF MANAGE REV, V56, P5, DOI 10.1525/cmr.2014.56.3.5
   Wu KJ, 2017, INT J PROD ECON, V190, P96, DOI 10.1016/j.ijpe.2016.08.027
   Yang J, 2014, INT J PROD ECON, V150, P104, DOI 10.1016/j.ijpe.2013.12.018
   Yaseen SG, 2016, COMPUT HUM BEHAV, V62, P168, DOI 10.1016/j.chb.2016.03.075
   Yusoff YM, 2019, J CLEAN PROD, V234, P626, DOI 10.1016/j.jclepro.2019.06.153
   Zhao LM, 2019, SCIENTOMETRICS, V119, P657, DOI 10.1007/s11192-019-03049-4
NR 75
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0040-1625
EI 1873-5509
J9 TECHNOL FORECAST SOC
JI Technol. Forecast. Soc. Chang.
PD MAY
PY 2022
VL 178
AR 121603
DI 10.1016/j.techfore.2022.121603
PG 10
WC Business; Regional & Urban Planning
WE Social Science Citation Index (SSCI)
SC Business & Economics; Public Administration
GA 0H0DQ
UT WOS:000778411300035
DA 2022-04-20
ER

PT J
AU Meini, S
   Zini, C
   Passaleva, MT
   Frullini, A
   Fusco, F
   Carpi, R
   Piani, F
AF Meini, Simone
   Zini, Chiara
   Passaleva, Maria Teresa
   Frullini, Anna
   Fusco, Francesca
   Carpi, Roberto
   Piani, Fiorella
TI Pneumatosis intestinalis in COVID-19
SO BMJ OPEN GASTROENTEROLOGY
LA English
DT Article
DE bacterial overgrowth; clinical decision making; colonic diseases;
   colonic microflora; infectious disease
ID PNEUMOPERITONEUM
AB Introduction COVID-19 is a respiratory illness due to novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), described in December 2019 in Wuhan (China) and rapidly evolved into a pandemic. Gastrointestinal (GI) tract can also be involved. Case presentation A 44-year-old man was hospitalised for COVID-19-associated pneumonia. A rapid recovery of respiratory and general symptoms was observed after 1 week of treatment with lopinavir/ritonavir plus hydroxychloroquine and broad-spectrum antibiotics (piperacillin-tazobactam plus teicoplanin). No GI symptoms were reported during hospitalisation, but a lung contrast-enhancement CT (CE-CT) excluding thromboembolism showed, as collateral finding, intraperitoneal free bubbles not present on a previous CT examination; the subsequent abdominal CE-CT described pneumatosis intestinalis (PI) involving the caecum and the right colon. Ciprofloxacin plus metronidazole was started, and the 2-week follow-up CT showed the complete resolution of PI. Discussion The pathogenesis of PI is poorly understood. PI involving the caecum and right colon has been described for HIV and Cytomegalovirus infections, but, to our best knowledge, never before in COVID-19. We hypothesise a multifactorial aetiopathogenesis for PI, with a possible role of the bowel wall damage and microbiota impairment due to SARS-CoV-2 infection, and we suggest a conservative management in the absence of symptoms.
C1 [Meini, Simone; Passaleva, Maria Teresa; Frullini, Anna; Piani, Fiorella] Osped Santa Maria Annunziata, Azienda USL Toscana Ctr, Med Interna, Florence, Italy.
   [Zini, Chiara; Fusco, Francesca; Carpi, Roberto] Osped Santa Maria Annunziata, Azienda USL Toscana Ctr, Radiol, Florence, Italy.
RP Meini, S (corresponding author), Osped Santa Maria Annunziata, Azienda USL Toscana Ctr, Med Interna, Florence, Italy.
EM simonemeini2@gmail.com
OI Meini, Simone/0000-0002-8711-8305
FU OSMA ONLUS
FX OSMA ONLUS funded the article processing charges, but had no role in the
   preparation of the article, in the collection, analysis and
   interpretation of data, in the writing of the report, and in the
   decision to submit the article for publication.
CR Baron SA, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105944
   Blair Holly Alison, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-207234
   Cascella M, 2020, FEATURES EVALUATION, V8
   HENG Y, 1995, AM J GASTROENTEROL, V90, P1747
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Jin X, 2020, GUT, V69, P1002, DOI 10.1136/gutjnl-2020-320926
   JOHN A, 1992, DIGEST DIS SCI, V37, P813, DOI 10.1007/BF01300377
   Ng SC, 2020, GUT, V69, P973, DOI 10.1136/gutjnl-2020-321195
   Olson DE, 2009, RADIOLOGY, V253, P513, DOI 10.1148/radiol.2532090168
   Park Ju Yee, 2007, Korean J Gastroenterol, V50, P188
   PRUITT RE, 1988, J RHEUMATOL, V15, P1575
   Rashid MU, 2011, INT J ANTIMICROB AG, V38, P474, DOI 10.1016/j.ijantimicag.2011.08.012
   Ribolla M, 2020, INT J SURG CASE REP, V69, P92, DOI 10.1016/j.ijscr.2020.03.042
   Varelas LJ, 2020, J GASTROEN HEPATOL, V35, P1065, DOI 10.1111/jgh.14920
   WOOD BJ, 1995, AM J ROENTGENOL, V165, P1387, DOI 10.2214/ajr.165.6.7484571
   Wright NJ, 2011, BMJ CASE REPORTS
   WYATT SH, 1994, RADIOL CLIN N AM, V32, P1023
   Zhang H, 2020, GUT, V69, P1010, DOI 10.1136/gutjnl-2020-320953
NR 18
TC 21
Z9 22
U1 0
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2054-4774
J9 BMJ OPEN GASTROENTER
JI BMJ Open Gastroenterol.
PY 2020
VL 7
IS 1
AR e000434
DI 10.1136/bmjgast-2020-000434
PG 5
WC Gastroenterology & Hepatology
WE Emerging Sources Citation Index (ESCI)
SC Gastroenterology & Hepatology
GA MA3DQ
UT WOS:000541798400001
PM 32522754
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Guo, SY
   Kaminga, AC
   Xiong, J
AF Guo, Shengyu
   Kaminga, Atipatsa Chiwanda
   Xiong, Jie
TI Depression and Coping Styles of College Students in China During
   COVID-19 Pandemic: A Systemic Review and Meta-Analysis
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Review
DE COVID-19; depression; college students; meta-analysis; mental health
   apps
ID HEALTH MOBILE APPS; MENTAL-HEALTH; DIAGNOSIS
AB Background: The rapid spread and uncertain outcome of the 2019 novel coronavirus disease (COVID-19) around the world have caused worry, fear, and stress among the general population. Nevertheless, the prevalence of depression among college students in China during lockdown, following the COVID-19 pandemic, and their coping strategies have not been quantitatively assessed. Objective: We aimed to evaluate the prevalence of depression among college students in China during the lockdown due to the COVID-19 pandemic and assess their coping strategies. Methods: Systematic review and meta-analysis were conducted to assess the prevalence of depression among college students in China and their coping strategies. Results: The results indicated that, during lockdown in the COVID-19 pandemic, the prevalence rates of college students in China suffering from mild, moderate, and severe depression were 25% (95% CI = 17-33%), 7% (95% CI = 2-14%), and 2% (95% CI = 1-5%), respectively. Besides, the proportion of college students who use WeChat and Weibo to acquire COVID-19 knowledge was 39% (95% CI = 13-68%), whereas the proportion of college students using mental health application services (APPs) to deal with depression was 59% (95% CI = 41-73%). Conclusions: The prevalence of depression among college students in China was high during the lockdown in the COVID-19 pandemic. Thus, considering the adverse outcomes of depression, it is imperative to screen college students in China for depression during the CIVID-19 pandemic and provide them with necessary psychological interventions to control and prevent depression. Social media platforms, such as WeChat and Weibo, and mental health APPs could provide an opportunity for psychological health information dissemination for college students. However, their effectiveness in reducing depression will have to be assessed.
C1 [Guo, Shengyu] Changsha Univ, Dept Econ & Management, Changsha, Peoples R China.
   [Kaminga, Atipatsa Chiwanda] Mzuzu Univ, Dept Math & Stat, Mzuzu, Malawi.
   [Xiong, Jie] Changsha Univ, Dept Math & Comp Sci, Changsha, Peoples R China.
RP Xiong, J (corresponding author), Changsha Univ, Dept Math & Comp Sci, Changsha, Peoples R China.
EM zndxxhl@126.com
FU Education fund of Hunan Province [18B409]
FX This work was supported by the Education fund of Hunan Province (number:
   18B409;
   http://jyt.hunan.gov.cn/sjyt/xxgk/tzgg/201903/t20190318_5297301.html).
CR Abdelsattar M, 2015, DRYAD, V11, DOI [10.5061/dryad.4c2bj, DOI 10.5061/DRYAD.4C2BJ]
   Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934
   Chang Jinghui, 2020, Nan Fang Yi Ke Da Xue Xue Bao, V40, P171, DOI 10.12122/j.issn.1673-4254.2020.02.06
   Chia WN, 2020, EMERG MICROBES INFEC, V9, P1497, DOI 10.1080/22221751.2020.1780951
   Daming M., 2020, SICHUAN MENTAL HLTH, V33, P202
   Nascimento MD, 2020, EDUC GERONTOL, V46, P499, DOI 10.1080/03601277.2020.1795371
   de Miranda DM, 2020, INT J DISAST RISK RE, V51, DOI 10.1016/j.ijdrr.2020.101845
   East ML, 2015, JMIR MENT HEALTH, V2, DOI 10.2196/mental.3954
   GOTLIB IH, 1995, J CONSULT CLIN PSYCH, V63, P90, DOI 10.1037/0022-006X.63.1.90
   Guo SY, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019148
   Hallensleben N, 2019, EUR PSYCHIAT, V56, P43, DOI 10.1016/j.eurpsy.2018.11.003
   Han Xu, 2013, Disease Surveillance, V28, P288
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Huang SH, 2014, J AM MED INFORM ASSN, V21, P1069, DOI 10.1136/amiajnl-2014-002733
   Jing L, 2006, Chin Mental Health J., V1032, P560
   Kenny R, 2016, HEALTH INFORM J, V22, P265, DOI 10.1177/1460458214555041
   Kim HHS, 2020, J PUBLIC HEALTH-UK, V42, P704, DOI 10.1093/pubmed/fdaa148
   Klomek AB, 2020, LANCET PSYCHIAT, V7, P390, DOI 10.1016/S2215-0366(20)30142-5
   Kola L, 2020, LANCET PSYCHIAT, V7, P655, DOI 10.1016/S2215-0366(20)30235-2
   Lee J, 2020, LANCET CHILD ADOLESC, V4, P421, DOI 10.1016/S2352-4642(20)30109-7
   Liu Dan., 2020, PSYCHOL MONTHLY, V15, P51, DOI [10.19738/j.cnki.psy.2020.17.016, DOI 10.19738/J.CNKI.PSY.2020.17.016]
   Liu S.F., 2004, HLTH PSYCHOL J, V12, P117
   Luo TD., 2020, ZHONGHUA LAO DONG WE, V38, P192, DOI [DOI 10.3760/CMA.J.CN121094-20200219-00063, 10.3760/cma.j.cn121094-20200219-00063]
   Ma L, 2020, HLTH RES, V40, P258
   Minjiang D., 2020, J HUAIHAI I TECHNOL, V18, P129
   Restauri N, 2020, J AM COLL RADIOL, V17, P921, DOI 10.1016/j.jacr.2020.05.021
   Rios-Barnes M, 2021, ARCH BRONCONEUMOL, V57, P84, DOI 10.1016/j.arbres.2020.08.016
   Seidel EJ, 2020, J COMMUN HEALTH, V45, P1259, DOI 10.1007/s10900-020-00905-w
   Shi L, 2021, EUR PSYCHIAT, V64, DOI 10.1192/j.eurpsy.2021.5
   Son C, 2020, J MED INTERNET RES, V22, DOI 10.2196/21279
   Tagupa H., 2020, HEARING J, V73, P46, DOI [10.1097/01.HJ.0000666456.65020.b9, DOI 10.1097/01.HJ.0000666456.65020.B9]
   Tanne JH, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3110
   Usher K, 2020, AUSTRALAS PSYCHIATRY, V28, P599, DOI 10.1177/1039856220943018
   Wang DX., 2020, PSYCHOL MONTHLY, V15, P37, DOI [10.19738/j.cnki.psy.2020.17.011, DOI 10.19738/J.CNKI.PSY.2020.17.011]
   Wei JL, 2020, J MULTIMEDIA NETW TE, V7, P217
   Wu CM, 2020, CLIN TRANSL MED, V10, DOI 10.1002/ctm2.52
   Yehudai M, 2022, INT J MENT HEALTH AD, V20, P316, DOI 10.1007/s11469-020-00360-7
   Yujie Z, 2020, MODERN COMMERCE TRAD, V41, P52
   Zhang ZH., 2020, DOES COVID 19 IMPACT DOES COVID 19 IMPACT
NR 39
TC 3
Z9 3
U1 32
U2 41
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD JUL 7
PY 2021
VL 9
AR 613321
DI 10.3389/fpubh.2021.613321
PG 10
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA TL3DH
UT WOS:000674735400001
PM 34307268
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Niewiadomski, P
AF Niewiadomski, Przemyslaw
TI CORPORATE MATURITY DESIDERATA IN THE FACE OF THE COVID-19 PANDEMIC - THE
   DIGITAL PLANE OF LOGISTICS MICROFOUNDATIONS
SO LOGFORUM
LA English
DT Article
DE COVID-19; maturity; logistics subsystems; agricultural machinery sector
ID DYNAMIC-CAPABILITIES; MODEL
AB Background: In the light of the economic slowdown and significant strategic uncertainty resulting from the currently prevailing SARS-Cov-2 epidemic crisis, it is reasonable to undertake research to identify key competences that are relevant to the continuity of the supply chain functioning. The logistics processes in their current shape will undergo a significant change. Therefore, based on a widespread discussion that has been recently taking place in the environment of scientists, politicians, local government officials and management practitioners, the question once again arises about the level of preparation of enterprises for functioning in this specific environment Aiming to fill the existing gap in knowledge, a series of studies was conducted, the main purpose of which was to recognize key competences from the point of view of existence in the conditions triggered by the COVID-19 crisis. Considering the empirical evidence confirming the existence of a strong relationship between company stability and an effective supply chain, the following research direction aggregates logistic microfoundations to the attribute of a "mature" enterprise.
   Methods: Referring to the outlined objective, using the method of reconstruction and interpretation of the literature on the subject, it was recommended to nominate questions assessing the level of maturity of logistics subsystems (theoretical layer) as a necessary action. At the conceptual (design) level, it was crucial to compile the research tool being the resultant of the related literature exploration (theoretical model) and discussion among deliberately selected experts ("virtual" brainstorming). At the empirical level, this enabled the recognition of competences that determine the survival of enterprises in crisis conditions, and thus allowed the development of recommendations for managers of manufacturing enterprises.
   Results: The paper proposes a procedure and a tool to identify key capabilities that determine the survival of enterprises in COVID-19 crisis conditions. The brainstorming research model reflects the areas of digital technology that the manufacturers, in the context of the current pandemic, should absorb (coincidence). Moreover, it was established that the process of economic recovery will take place in cooperation with enterprises absorbing the logistic management model based on digital technologies. To sum up, it should be noted that the maturity of such an enterprise is manifested in the use of descriptions defined in the research, not only in terms of production, but also in the entire supply chain. All these activities need to be harmonized, creating a crisis-proof enterprise. The organization of such an enterprise is characterized by delegating as many tasks as possible to competent employees who, using the knowledge and available digital technologies, add value throughout the entire chain.
   Conclusions: The results of the research confirmed the author's belief that on the one hand digital technologies imply the possibility of surviving in the face of the crisis caused by COVID-19 (continuity of the supply chain, remote work without participation, or with limited human participation, etc.), on the other, implemented by enterprises, can be a kind of "protective shield" against the negative effects of a pandemic; from the perspective of the issue taken in the research work, they determine the maturity of the company's logistics subsystems. It seems that relatively small scientific recognition and complexity of problems occurring in business practice justify treating the COVID-19 issue as the subject of research, which is reflected in this publication.
C1 [Niewiadomski, Przemyslaw] Uniwersytet Zielona Gora, Zielona Gora, Poland.
RP Niewiadomski, P (corresponding author), Uniwersytet Zielona Gora, Zielona Gora, Poland.
EM p.niewiadomski@wez.uz.zgora.pl
FU University of Zielona Gora
FX Statutory fund of University of Zielona Gora.
CR Asdecker B, 2018, J MODEL MANAG, V13, P840, DOI 10.1108/JM2-03-2018-0042
   Cheshmberah M, 2020, LOGFORUM, V16, P103, DOI 10.17270/J.LOG.2020.377
   Ciesielski M., 2011, ZARZADZANIE LANCUCHA
   Cronemyr P., 2013, TOTAL QUAL MANAGE, V24, P7
   Quintana CDD, 2014, INT J MANPOWER, V35, P514, DOI 10.1108/IJM-05-2013-0107
   Du ZW, 2020, EMERG INFECT DIS, V26, P1049, DOI 10.3201/eid2605.200146
   Fawcett SE, 2011, J SUPPLY CHAIN MANAG, V47, P38, DOI 10.1111/j.1745-493X.2010.03213.x
   Gibson D, 2015, EDUC INF TECHNOL, V20, P403, DOI 10.1007/s10639-013-9291-7
   Hammervoll T, 2012, INT J PHYS DISTR LOG, V42, P316
   Jantti M, 2012, LIBR MANAGE, V33, P421, DOI 10.1108/01435121211266249
   Jozinovic P., 2015, INT C BUS INF SYST, P16, DOI DOI 10.1007/978-3-319-19027-3_2
   Lasi H, 2014, BUS INFORM SYST ENG+, V6, P239, DOI 10.1007/s12599-014-0334-4
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   Rohloff M., 2009, INT C BPM, DOI [10.1007/978-3-642-03848-8_10, DOI 10.1007/978-3-642-03848-8_10]
   Urbaniak M., 2010, KIERUNKI DOSKONALENI
   Wang CY, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13020036
   Wendler R, 2012, INFORM SOFTWARE TECH, V54, P1317, DOI 10.1016/j.infsof.2012.07.007
   Wilden R, 2015, J ACAD MARKET SCI, V43, P181, DOI 10.1007/s11747-014-0380-y
   Yue XG, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13020022
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 20
TC 2
Z9 2
U1 5
U2 20
PU POZNAN SCH LOGISTICS
PI POZNAN
PA UL E ESTKOWSKIEGO 6, POZNAN, 61-755, POLAND
SN 1895-2038
EI 1734-459X
J9 LOGFORUM
JI LogForum
PY 2020
VL 16
IS 4
BP 503
EP 519
DI 10.17270/J.LOG.2020.495
PG 17
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA NV6UZ
UT WOS:000574455200003
DA 2022-04-20
ER

PT J
AU Diz-Otero, M
   Portela-Pino, I
   Dominguez-Lloria, S
   Pino-Juste, M
AF Diz-Otero, Mario
   Portela-Pino, Iago
   Dominguez-Lloria, Sara
   Pino-Juste, Margarita
TI Digital competence in secondary education teachers during the
   COVID-19-derived pandemic: comparative analysis
SO EDUCATION AND TRAINING
LA English
DT Article; Early Access
DE Digital competence; Secondary school teachers; New technologies; Teacher
   training; COVID-19
ID STUDENTS; GENDER
AB Purpose Continuous training in professional teaching competencies has become one of the challenges of the school of the 21st century, especially if we refer to the mastery of digital competence. The aim of this study is to analyze the degree of digital competence of secondary school teachers of different areas of knowledge during the global pandemic of COVID-19 in the Galician autonomous community and obtain data that allow us to infer whether there is an association between individual variables such as age, gender, degree, work experience and their mastery of digital competence. Design/methodology/approach A cross-sectional descriptive quasi-experimental study is performed using an accidental sample of secondary school teachers from different fields of knowledge. Findings The different results obtained determine that the level of knowledge and use of digital media and tools is low. There are no significant differences depending on the variables analyzed, but it is necessary to establish specific continuing education plans for the improvement of digital competence in secondary school teachers to enable the effective use and management of information and communication technologies in future professionals. Originality/value Therefore, the findings of this study allow the development of educational interventions focused on increasing the digital competence of teachers, taking into account their individual characteristics.
C1 [Diz-Otero, Mario] Univ Santiago de Compostela, Fac Educ Sci, Dept Appl Didact, Area Didact Mus Express, Santiago De Compostela, Spain.
   [Portela-Pino, Iago] Univ Isabel 1, Hlth Sci Dept, Burgos, Spain.
   [Dominguez-Lloria, Sara] Univ Vigo, Fac Ciencias Educ & Deporte, Dept Special Didact, Area Didact Mus Express, Pontevedra, Spain.
   [Pino-Juste, Margarita] Univ Vigo, Sch Org & Res Methods, Dept Didact, Vigo, Spain.
RP Dominguez-Lloria, S (corresponding author), Univ Vigo, Fac Ciencias Educ & Deporte, Dept Special Didact, Area Didact Mus Express, Pontevedra, Spain.
EM saradominguez.lloria@uvigo.es
RI ; Pino Juste, Margarita/K-9242-2014
OI Dominguez-Lloria, Sara/0000-0002-4318-3017; Pino Juste,
   Margarita/0000-0002-2551-5903
CR Berzosa I., 2016, CONTEXTOS ED, V19, P147
   Cabero J., 2008, REV PORT PEDAG, V42, P7, DOI [DOI 10.14195/1647-861442-21, 10.14195/1647-861442-21]
   Gonzalez MC, 2018, CROAT J EDUC, V20, P11, DOI 10.15516/cje.v20i1.2632
   Cabezas M., 2014, EDUTEC REV ELECT TEC, V48, pA275
   Cabezas-Gonzalez M., 2017, FONSECA J COMMUNICAT, V15, P109, DOI 10.14201/fjc201715109125
   Caena F, 2019, EUR J EDUC, V54, P356, DOI 10.1111/ejed.12345
   Camacho M, 2018, REV EDUC, V379, P170, DOI [10.4438/1988-592X-RE-2017-379-366, DOI 10.4438/1988-592X-RE-2017-379-366]
   Castaneda L, 2018, RED-REV EDUC DISTANC, DOI 10.6018/red/56/6
   Cattaneo AAP, 2022, COMPUT EDUC, V176, DOI 10.1016/j.compedu.2021.104358
   Cid T.E., 2013, TIC NO ENSINO POLITI, P25
   Durndell A, 2002, COMPUT HUM BEHAV, V18, P521, DOI 10.1016/S0747-5632(02)00006-7
   Falcó Boudet José María, 2017, REDIE, V19, P73, DOI 10.24320/redie.2017.19.4.1359
   Lueg CF, 2017, IJERI-INT J EDUC RES, P79
   Flores-Lueg Carolina, 2016, Estud. pedagóg., V42, P129
   Mendez VG, 2017, EDUC SIGLO XXI, V35, P253, DOI 10.6018/j/298601
   Munoz-Repiso AGV, 2017, EDUC XX1, V20, P137, DOI 10.5944/educXX1.13447
   Gisbert-Cervera M., 2016, REV INTERUNIVERSITAR, P74, DOI [10.6018/riite2016/257631, DOI 10.6018/RIITE2016/257631]
   Gomez-Gomez M., 2017, 3 ESTUDIO USO TECNOL
   Gomez-Jimenez O., 2020, REV COMUN SALUD, V10, P483, DOI [10.35669/rcys.2020.10(2).483-502, DOI 10.35669/RCYS.2020.10(2).483-502]
   Gottschalk, 2019, IMPACTS TECHNOLOGY U
   Gruzina Y.M., 2020, MANAGE SCI, V9, P75, DOI [10.26794/2404-022X-2019-9-4-75-84, DOI 10.26794/2404-022X-2019-9-4-75-84]
   Guillen-Gamez FD, 2021, TECHNOL KNOWL LEARN, V26, P481, DOI 10.1007/s10758-019-09432-7
   Hernandez RM, 2017, PROPOS REPRESENT, V5, P337, DOI 10.20511/pyr2017.v5n1.149
   Hernandez-Sampieri Roberto, 1997, METODOLOGIA INVESTIG
   Hinojo-Lucena Francisco Javier, 2019, Educare, V23, P283, DOI 10.15359/ree.23-3.14
   INTEF, 2017, MARC COMP DIG DOC
   Jimenez-Hernandez D, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12229473
   Krumsvik RJ, 2016, NORD J DIGIT LIT, V11, P143, DOI 10.18261/issn.1891-943x-2016-03-02
   Larson L, 2018, SPRINGER INT HBK ED, P37, DOI 10.1007/978-3-319-71054-9_2
   Belmonte JL, 2020, REV FUENTES, V22, P75, DOI 10.12795/revistafuentes.2020.v22.i1.07
   Belmonte JL, 2019, REMIE-MULTIDISCIP J, V9, P194, DOI 10.4471/remie.2019.4149
   Margaryan A, 2011, COMPUT EDUC, V56, P429, DOI 10.1016/j.compedu.2010.09.004
   Marin D., 2019, INNOEDUCA, V5, P4, DOI [10.24310/innoeduca.2019.v5i1.4890, DOI 10.24310/INNOEDUCA.2019.V5I1.4890]
   OECD (Organization for Economic Cooperation and Development), 2018, FUT ED SKILLS ED 203
   Onetto A., 2016, REV LATINOAM TECNOL, V15, P55, DOI 10.17398/1695- 288X.15.3.55
   Palau R, 2019, REV ELECTRON LEEME, P24, DOI 10.7203/LEEME.44.15709
   Chacon JP, 2018, REDU, V16, P175, DOI 10.4995/redu.2018.8935
   Pereira-Perez Z., 2011, REV ELECTRON EDUCARE, V15, P15, DOI [10.15359/ree.15-1.2, DOI 10.15359/REE.15-1.2]
   Escoda AP, 2016, RIE-REV INVESTIG EDU, V34, P399, DOI 10.6018/rie.34.2.215121
   Redecker C., 2017, TECH REP JRC107466, DOI [10.2760/159770, DOI 10.2760/159770]
   Rokenes FM, 2014, NORD J DIGIT LIT, V9, P250
   Romero S.J., 2015, TECNOLOGIA CIENCIA E, V4, P33
   Ruiz-Olabuenaga J. L., 2007, METODOLOGIA INVESTIG
   Sa M.J., 2020, U J ED RES, V8, P4520, DOI 10.13189/ujer.2020.081020
   Gil JMS, 2018, EDUC SIGLO XXI, V36, P209, DOI 10.6018/j/333051
   Schleicher A., 2019, HELPING OUR YOUNGEST
   Touron J, 2018, REV ESP PEDAGOG, V76, P25, DOI 10.22550/REP76-1-2018-02
   Guerrero TSV, 2016, PIXEL-BIT, P57, DOI 10.12795/pixelbit.2016.i49.04
   Vazquez-Cano E, 2017, PRISM SOC, P347
   Vtolina I., 2015, DISCOURSE COMMUN SUS, V6, P86, DOI [10.1515/dcse-2015-0006, DOI 10.1515/DCSE-2015-0006]
   Zakharov K., 2021, LECT NOTES NETWORKS, V247, P857
NR 51
TC 0
Z9 0
U1 7
U2 7
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0040-0912
EI 1758-6127
J9 EDUC TRAIN
JI Educ. Train.
DI 10.1108/ET-01-2022-0001
EA JAN 2022
PG 12
WC Education & Educational Research
WE Social Science Citation Index (SSCI)
SC Education & Educational Research
GA YT6XG
UT WOS:000751499500001
DA 2022-04-20
ER

PT J
AU Thai, TT
   Le, PTV
   Huynh, QHN
   Pham, PTTTT
   Bui, HTH
AF Truc Thanh Thai
   Phuc Truong Vinh Le
   Quynh Ho Ngoc Huynh
   Phuong Thi Thu Thi Thu Pham
   Han Thi Hy Bui
TI Perceived Stress and Coping Strategies During the COVID-19 Pandemic
   Among Public Health and Preventive Medicine Students in Vietnam
SO PSYCHOLOGY RESEARCH AND BEHAVIOR MANAGEMENT
LA English
DT Article
DE COVID-19; perceived stress; coping strategy; public health; preventive
   medicine; students
ID PSYCHOMETRIC PROPERTIES; BRIEF-COPE
AB Purpose: Little is known about the effect of COVID-19 pandemic on public health and preventive medicine students, particularly in resource-limited countries. This study evaluated stress level in this population in Vietnam and their coping strategies during the COVID-19 pandemic.
   Patients and Methods: A cross-sectional study was conducted in April 2020 among 563 public health and preventive medicine students. A structured questionnaire included background information, the level of stress measured by the Perceived Stress Scale (PSS) and coping strategies evaluated by the Brief COPE. To compare the PSS score and Brief COPE score among participants with different characteristics, two-sided t tests or ANOVA tests were used when appropriate.
   Results: Most participants were females (71.4%), and the mean age was 21.6 years old (SD = 2.1). Almost all had moderate to high levels of knowledge, attitude and skill toward COVID-19 prevention and protection. The mean PSS score was 17.02 (SD 4.06), and more than 80% had a certain level of stress. The mean score of approach coping strategies was higher than avoidant coping strategies (2.74 and 1.84). Students with a high level of stress had a higher preference for avoidance coping strategies.
   Conclusion: Although students reported relatively good knowledge, attitude and skill as well as the preference for adaptive coping strategies, they experienced a high level of stress during the COVID-19 pandemic.
C1 [Truc Thanh Thai; Phuc Truong Vinh Le; Quynh Ho Ngoc Huynh] Univ Med & Pharm Ho Chi Minh City, Fac Publ Hlth, Ho Chi Minh City, Vietnam.
   [Phuong Thi Thu Thi Thu Pham] Hosp Rehabil Occupat Dis, Ho Chi Minh City, Vietnam.
   [Han Thi Hy Bui] Woolcock Inst Med Res, Hanoi, Vietnam.
RP Huynh, QHN (corresponding author), Univ Med & Pharm, Fac Publ Hlth, Ho Chi Minh City, Vietnam.
EM hhnquynhytcc@ump.edu.vn
RI Le, PhuongThao/AAT-4123-2020
OI Le, PhuongThao/0000-0002-3393-8199; Phuc, Le Truong
   Vinh/0000-0002-6121-186X; Thai, Truc Thanh/0000-0003-2512-8281; Pham,
   Phuong/0000-0002-2401-8833
CR Ahorsu DK, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00270-8
   Al-Rabiaah A, 2020, J INFECT PUBLIC HEAL, V13, P687, DOI 10.1016/j.jiph.2020.01.005
   Algorani EB, COPING MECH, V2021, P2
   Arenliu A, 2020, RAPID ASSESSMENT PSY
   Asmundson GJG, 2020, J ANXIETY DISORD, V70, DOI 10.1016/j.janxdis.2020.102196
   Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934
   Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6
   Chang KC, 2020, J FORMOS MED ASSOC, V119, P1772, DOI 10.1016/j.jfma.2020.07.032
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   Flesia, 2020, STABLE PSYCHOL TRAIT, DOI [10.31234/osf.io/yb2h8, DOI 10.31234/OSF.IO/YB2H8]
   Garcia FE, 2018, PSICOL-REFLEX CRIT, V31, DOI 10.1186/s41155-018-0102-3
   Gunnell D, 2020, LANCET PSYCHIAT, V7, P468, DOI 10.1016/S2215-0366(20)30171-1
   Huang L., 2020, EMOTIONAL RESPONSES, V15, DOI [10.1371/journal.pone.0237303, DOI 10.1101/2020.03.05.20031898, 10.1101/2020.03.05.20031898]
   Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954
   Kelvin DJ, 2020, J INFECT DEV COUNTR, V14, P1, DOI 10.3855/jidc.12496
   Khalid I, 2016, CLIN MED RES, V14, P7, DOI 10.3121/cmr.2016.1303
   Kim JS, 2016, J CLIN NURS, V25, P2542, DOI 10.1111/jocn.13295
   Lee EH, 2012, ASIAN NURS RES, V6, P121, DOI 10.1016/j.anr.2012.08.004
   Limcaoco R.S.G., 2020, MEDRXIV, DOI [10.1101/2020.04.03.20043992, DOI 10.1101/2020.04.03.20043992]
   Mahmoud Jihan Saber Raja, 2012, Issues Ment Health Nurs, V33, P149, DOI 10.3109/01612840.2011.632708
   Mamun MA, 2021, J AFFECT DISORDERS, V279, P462, DOI 10.1016/j.jad.2020.10.036
   Mohanraj R, 2015, AIDS BEHAV, V19, P341, DOI 10.1007/s10461-014-0872-2
   Peters RM, 2020, WESTERN J NURS RES, V42, P927, DOI 10.1177/0193945920907686
   Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272
   Pramukti I, 2020, J MED INTERNET RES, V22, DOI 10.2196/24487
   Quek TTC, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16152735
   Al-Dubai SAR, 2011, MALAYS J MED SCI, V18, P57
   Roll R, 2020, ACAD MED, V95, pE6, DOI 10.1097/ACM.0000000000003588
   Rossi R, 2020, MEDRXIV, DOI [10.1101/2020.04.09.20057802, DOI 10.1101/2020.04.09.20057802]
   Shigemura J, 2020, PSYCHIAT CLIN NEUROS, V74, P281, DOI 10.1111/pcn.12988
   Singh Shantanu, 2016, Ind Psychiatry J, V25, P179, DOI 10.4103/ipj.ipj_68_16
   Taylor S, 2020, J ANXIETY DISORD, V72, DOI 10.1016/j.janxdis.2020.102232
   Thakur V, 2020, BRAIN BEHAV IMMUN, V88, P952, DOI 10.1016/j.bbi.2020.04.062
   Dao-Tran TH, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1221-6
   Thai TT, 2020, SCH MENT HEALTH, V12, P378, DOI 10.1007/s12310-019-09358-6
   Pham T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221432
   Vahedian Azimi A, 2020, COMP SEVERITY PSYCHO
   Vietnam Ministry of Health, INF PAG COVID 19
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   Wang PW, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9040380
   Wong JGWS, 2004, MED TEACH, V26, P657, DOI 10.1080/01421590400006572
   World Health Organization, 2020, 112 WHO
   World Health Organization, WHO DIR GEN OP REM M
   Wu WZ, 2020, J MED VIROL, V92, P1962, DOI 10.1002/jmv.25914
   Yang H, 2020, J CHIN GOV, V5, P234, DOI 10.1080/23812346.2020.1745411
   Yang X., 2020, Lancet Respir. Med, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
NR 46
TC 3
Z9 3
U1 5
U2 6
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1179-1578
J9 PSYCHOL RES BEHAV MA
JI Psychol. Res. Behav. Manag.
PY 2021
VL 14
BP 795
EP 804
DI 10.2147/PRBM.S317059
PG 10
WC Psychology, Clinical; Psychiatry; Psychology, Multidisciplinary
WE Social Science Citation Index (SSCI)
SC Psychology; Psychiatry
GA SW3ZZ
UT WOS:000664457000001
PM 34177277
OA Green Published
DA 2022-04-20
ER

PT J
AU Tonetto, LM
   Saurin, TA
   Fogliatto, FS
   Tortorella, GL
   Narayanamurthy, G
   da Rosa, VM
   Tengkawan, J
AF Tonetto, Leandro Miletto
   Saurin, Tarcisio Abreu
   Fogliatto, Flavio Sanson
   Tortorella, Guilherme Luz
   Narayanamurthy, Gopalakrishnan
   da Rosa, Valentina Marques
   Tengkawan, Jeslyn
TI Information and communication technologies in emergency care services
   for patients with COVID-19: a multi-national study
SO INTERNATIONAL JOURNAL OF PRODUCTION RESEARCH
LA English
DT Article; Early Access
DE COVID-19; emergency care; complexity; healthcare 4; 0; information and
   communication technologies
ID HEALTH-CARE; COMPLEXITY; PATTERNS; RESILIENCE; FRAMEWORK; IMPACTS;
   WORKERS; CLOUD
AB Information and communication technologies (ICTs) are known for supporting healthcare services in dealing with adverse situations. However, little is known on the contribution of ICTs in a prolonged crisis involving a new disease, such as the COVID-19 pandemic. In this study, we carry out an exploratory investigation of which ICTs contribute the most to the emergency care of patients diagnosed with COVID-19 according to healthcare technology experts and how physicians perceive these contributions. Initially, we applied an online survey to 109 healthcare technology experts. Then, we conducted 16 in-depth follow-up interviews with emergency medicine professionals from 10 countries to identify the ICTs contributing the most to treat COVID-19 patients. Results from the survey indicated four ICTs as the most useful to support the treatment of COVID-19 patients; they are remote consultations, digital platforms for data sharing, digital non-invasive care, and interconnected medical decision support. The interviews provided insight into the applicability of those ICTs for the studied context. The four main ICTs were also found to be logically compatible with the complexity of the pandemic, reducing undesirable complexity attributes (e.g. physical proximity between caregivers and infected patients) and amplifying desirable ones (e.g. interactions that support collaborative work and knowledge sharing).
C1 [Tonetto, Leandro Miletto] Univ Vale Rio dos Sinos, Grad Program Design, Porto Alegre, RS, Brazil.
   [Saurin, Tarcisio Abreu; Fogliatto, Flavio Sanson; da Rosa, Valentina Marques] Univ Fed Rio Grande do Sul, Grad Program Ind Engn PPGEP UFRGS, Porto Alegre, RS, Brazil.
   [Tortorella, Guilherme Luz] Univ Melbourne, Melbourne, Vic, Australia.
   [Narayanamurthy, Gopalakrishnan] Univ Liverpool, Dept Operat Management, Liverpool, Merseyside, England.
   [Tengkawan, Jeslyn] Mataram Univ Acad Hosp, West Nusa Tenggara, Indonesia.
RP Tonetto, LM (corresponding author), Univ Vale Rio dos Sinos, Av Nilo Pecanha 1600, BR-91330002 Porto Alegre, RS, Brazil.
EM ltonetto@unisinos.br
RI ; Saurin, Tarcisio/O-7551-2014
OI Fogliatto, Flavio/0000-0002-0323-8060; Tengkawan,
   Jeslyn/0000-0002-8644-1872; Tortorella, Guilherme/0000-0003-2396-4665;
   Tonetto, Leandro Miletto/0000-0002-4403-2085; Saurin,
   Tarcisio/0000-0003-2929-5888
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoConselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)
   [303509/20155, 310740/2020-7]
FX This work is supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico [grant numbers 303509/20155, 310740/2020-7].
CR Alhamid MF, 2019, MULTIMED TOOLS APPL, V78, P8997, DOI 10.1007/s11042-017-5239-z
   Alwashmi MF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082906
   Angelini A, 2019, INT ORTHOP, V43, P123, DOI 10.1007/s00264-018-4232-0
   ARMSTRONG JS, 1977, J MARKETING RES, V14, P396, DOI 10.2307/3150783
   Ashby W.R., 1991, CYBERNETICA, P405, DOI DOI 10.1007/978-1-4899-0718-9_28
   Azzawi Mustafa Abdullah, 2016, INT J APPL ENG RES, V11, P10216
   Bai CG, 2020, INT J PROD ECON, V229, DOI 10.1016/j.ijpe.2020.107776
   Bielicki Julia A, 2020, Lancet Infect Dis, V20, pe261, DOI 10.1016/S1473-3099(20)30458-8
   Braithwaite J, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2014
   Braithwaite J, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1057-z
   Bueno WP, 2019, SAFETY SCI, V118, P814, DOI 10.1016/j.ssci.2019.06.023
   Catarinucci L, 2015, IEEE INTERNET THINGS, V2, P515, DOI 10.1109/JIOT.2015.2417684
   Chen M, 2018, FUTURE GENER COMP SY, V86, P403, DOI 10.1016/j.future.2018.03.054
   Churruca K, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027308
   Cilliers P, 2005, THEOR CULT SOC, V22, P255, DOI 10.1177/0263276405058052
   Colpani A, 2018, AIP CONF PROC, V1960, DOI 10.1063/1.5034998
   Das S, 2011, IEEE T ENG MANAGE, V58, P124, DOI 10.1109/TEM.2010.2048906
   Dekker S, 2011, DRIFT INTO FAILURE: FROM HUNTING BROKEN COMPONENTS TO UNDERSTANDING COMPLEX SYSTEMS, P1
   Dekker S, 2013, COGN TECHNOL WORK, V15, P189, DOI 10.1007/s10111-011-0211-6
   Demirkan H, 2013, IT PROF, V15, P38, DOI 10.1109/MITP.2013.35
   Ellis LA, 2019, SAFETY SCI, V118, P241, DOI 10.1016/j.ssci.2019.04.044
   Farshid M., 2018, GO BOLDLY BUSINESS H, DOI [10.1016/j.bushor.2018.05.009, DOI 10.1016/J.BUSHOR.2018.05.009]
   Favaro FM, 2013, RELIAB ENG SYST SAFE, V113, P131, DOI 10.1016/j.ress.2012.12.018
   Ferrara P, 2020, PUBLIC HEALTH, V185, P1, DOI 10.1016/j.puhe.2020.05.014
   Frank AG, 2019, INT J PROD ECON, V210, P15, DOI 10.1016/j.ijpe.2019.01.004
   Goncalves A, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-00977-1
   Grelot L, 2016, J INFECT DIS, V213, P1462, DOI 10.1093/infdis/jiv585
   Hamm JM, 2020, JACEP OPEN, V1, P1630, DOI 10.1002/emp2.12204
   Hollnagel E., 2017, SAFETY 2 PRACTICE DE
   Ivanov Dmitry, 2021, Int J Prod Econ, V232, P107921, DOI 10.1016/j.ijpe.2020.107921
   Jayaraman PP, 2020, WIRES DATA MIN KNOWL, V10, DOI 10.1002/widm.1350
   Landman AB, 2011, PREHOSP EMERG CARE, V15, P149, DOI 10.3109/10903127.2010.534235
   Lasi H, 2014, BUS INFORM SYST ENG+, V6, P239, DOI 10.1007/s12599-014-0334-4
   LEVESON NG, 1993, COMPUTER, V26, P18, DOI 10.1109/MC.1993.274940
   Mathew R, 2020, J EMERG TRAUMA SHOCK, V13, P169, DOI 10.4103/JETS.JETS_33_20
   McCarthy JF, 2004, ANN NY ACAD SCI, V1020, P239, DOI 10.1196/annals.1310.020
   Munzer BW, 2019, J MED INTERNET RES, V21, DOI 10.2196/12368
   Neuendorf K. A., 2017, CONTENT ANAL GUIDEBO, V2nd
   Onasanya A, 2021, WIREL NETW, V27, P4297, DOI 10.1007/s11276-018-01932-1
   Otto C., 2006, J MOB MULTIMED, V1, P307
   Page SE., 2010, DIVERSITY COMPLEXITY
   Paxton Chris, 2017, 2017 IEEE International Conference on Robotics and Automation (ICRA), P564, DOI 10.1109/ICRA.2017.7989070
   Perrow C, 1984, NORMAL ACCIDENTS LIV
   Rajan JP, 2018, TECHNOL HEALTH CARE, V26, P379, DOI 10.3233/THC-171173
   Ramasesh RV, 2014, J OPER MANAG, V32, P190, DOI 10.1016/j.jom.2014.03.003
   Reddy MC, 2009, INT J MED INFORM, V78, P259, DOI 10.1016/j.ijmedinf.2008.08.003
   Ren H, 2005, 2005 IEEE INT C INF, P6, DOI [10.1109/ICIA.2005.1635137, DOI 10.1109/ICIA.2005.1635137]
   Rizwan A, 2018, IEEE ACCESS, V6, P41903, DOI 10.1109/ACCESS.2018.2859340
   Rodrigues MJ, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20082186
   Sakr S, 2016, BIG DATA RES, V4, P44, DOI 10.1016/j.bdr.2016.05.002
   Saurin TA, 2021, SAFETY SCI, V134, DOI 10.1016/j.ssci.2020.105087
   Soliman M, 2018, INT J PROD ECON, V197, P342, DOI 10.1016/j.ijpe.2018.01.024
   Sultan N, 2014, INT J INFORM MANAGE, V34, P177, DOI 10.1016/j.ijinfomgt.2013.12.011
   Sultan N, 2010, INT J INFORM MANAGE, V30, P109, DOI 10.1016/j.ijinfomgt.2009.09.004
   Thompson DS, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1343-4
   Thuemmler C, 2017, HEALTH 4.0: HOW VIRTUALIZATION AND BIG DATA ARE REVOLUTIONIZING HEALTHCARE, P23, DOI 10.1007/978-3-319-47617-9_2
   Tortorella GL, 2021, INT J PROD ECON, V235, DOI 10.1016/j.ijpe.2021.108106
   Tortorella GL, 2021, TECHNOL FORECAST SOC, V166, DOI 10.1016/j.techfore.2021.120666
   Tortorella GL, 2020, PROD PLAN CONTROL, V31, P1245, DOI 10.1080/09537287.2019.1702226
   Wang YC, 2018, TECHNOL FORECAST SOC, V126, P3, DOI 10.1016/j.techfore.2015.12.019
   Whitelaw S, 2020, LANCET DIGIT HEALTH, V2, pE435, DOI 10.1016/S2589-7500(20)30142-4
   Wilson JR, 2014, APPL ERGON, V45, P5, DOI 10.1016/j.apergo.2013.03.021
   Xiaoling Xia, 2019, Journal of Physics: Conference Series, V1314, DOI 10.1088/1742-6596/1314/1/012067
   Xu LD, 2018, INT J PROD RES, V56, P2941, DOI 10.1080/00207543.2018.1444806
   Yang JJ, 2015, COMPUT IND, V69, P3, DOI 10.1016/j.compind.2015.01.012
   Yang Z, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0644-9
   Yee Jane, 2020, J Am Coll Emerg Physicians Open, DOI 10.1002/emp2.12034
NR 67
TC 0
Z9 0
U1 7
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0020-7543
EI 1366-588X
J9 INT J PROD RES
JI Int. J. Prod. Res.
DI 10.1080/00207543.2021.1967501
EA AUG 2021
PG 17
WC Engineering, Industrial; Engineering, Manufacturing; Operations Research
   & Management Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Operations Research & Management Science
GA UJ4JF
UT WOS:000691252800001
DA 2022-04-20
ER

PT J
AU Stipic, D
   Bradac, M
   Lipic, T
   Podobnik, B
AF Stipic, Dorian
   Bradac, Mislav
   Lipic, Tomislav
   Podobnik, Boris
TI Effects of quarantine disob e dience and mobility restrictions on
   COVID-19 pandemic waves in dynamical networks
SO CHAOS SOLITONS & FRACTALS
LA English
DT Article
DE Network theory; COVID-19; Pandemics; Modeling; Bayesian optimisation;
   Data science
AB For the global COVID-19 pandemic it is still not adequately understood how quarantine disobedience and change in mobility restrictions influence the pandemic spreading and waves. Here, we propose a new metapopulation epidemiological model as a network composed of equal clusters to predict the course of the epidemic based on the contiguous spreading between the neighbours, the probability of quarantine misbehaviour, and the probability of mobility, which control contacts outside the cluster. We exemplify the model by comparing simulation results with real data on COVID-19 pandemic in Croatia. Fitting the data over the first and second pandemic waves, when the probability of mobility is set by the stringency index, the probability of quarantine misbehaviour is found by a Bayesian optimization yielding a fascinating agreement between the daily COVID-19 deaths and model output and efficiently predicting the timing of pandemic bursts. A sudden increase in the probability of quarantine misbehaviour alongside the sudden increase in the probability of mobility generate the model third wave in good agreement with daily COVID-19 deaths. (c) 2021 Published by Elsevier Ltd.
C1 [Stipic, Dorian; Bradac, Mislav] Univ Zagreb, Fac Elect Engn & Comp, Zagreb, Croatia.
   [Stipic, Dorian; Podobnik, Boris] Zagreb Sch Econ & Management, Zagreb, Croatia.
   [Lipic, Tomislav] Rudjer Boskovic Inst, Lab Machine Learning & Knowledge Representat, Zagreb, Croatia.
   [Podobnik, Boris] Luxembourg Sch Business, Luxembourg, Luxembourg.
   [Podobnik, Boris] Univ Rijeka, Fac Civil Engn, Rijeka 51000, Croatia.
   [Podobnik, Boris] Fac Informat Studies Novo Mesto, Novo Mesto 8000, Slovenia.
RP Podobnik, B (corresponding author), Zagreb Sch Econ & Management, Zagreb, Croatia.; Podobnik, B (corresponding author), Luxembourg Sch Business, Luxembourg, Luxembourg.; Podobnik, B (corresponding author), Univ Rijeka, Fac Civil Engn, Rijeka 51000, Croatia.; Podobnik, B (corresponding author), Fac Informat Studies Novo Mesto, Novo Mesto 8000, Slovenia.
EM Boris.podobnik.zg@gmail.com
RI Lipic, Tomislav/J-3641-2017
OI Lipic, Tomislav/0000-0002-8037-8198
FU Croatian Research Agency [KK.01.1.1.01.0009]
FX B.P. and T.L. acknowledge the gracious support of this work by the
   Croatian Research Agency KK.01.1.1.01.0009 (DATACROSS) and ZSEM. We are
   grateful to Marko Jusup, Antonio Majdandzic, Ana Mestrovic, Igor Rudan
   and Dijana Tolic for helpful suggestions.
CR Abate SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235653
   Alban A, 2020, INTENS CARE MED, V46, P1624, DOI 10.1007/s00134-020-06066-7
   Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9
   Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500
   Bjornstad ON, 2020, NAT METHODS, V17, P557, DOI 10.1038/s41592-020-0856-2
   Bjornstad ON, 2020, NAT METHODS, V17, P455, DOI 10.1038/s41592-020-0822-z
   Callaway E, 2020, NATURE, V581, P363, DOI 10.1038/d41586-020-01092-3
   Chande A, 2020, NAT HUM BEHAV, V4, DOI 10.1038/s41562-020-01000-9
   Chang S, 2021, NATURE, V589, P82, DOI 10.1038/s41586-020-2923-3
   Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757
   Chu DK, 2020, LANCET, V6736, P1, DOI [10.1016/S0140-6736(20)31142-9, DOI 10.1016/S0140-6736(20)31142-9]
   Cinelli M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73510-5
   Cirillo P, 2020, NAT PHYS, V16, P606, DOI 10.1038/s41567-020-0921-x
   De Domenico M, 2016, NAT PHYS, V12, P901, DOI 10.1038/nphys3865
   Del Valle SY, 2007, SOC NETWORKS, V29, P539, DOI 10.1016/j.socnet.2007.04.005
   Esteban A, 2013, AM J RESP CRIT CARE, V188, P220, DOI 10.1164/rccm.201212-2169OC
   Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541
   European centre for disease prevention and control (ECDC), 2020, COR AVIR DIS 2019 CO
   Eurostat, AVER PERS HOUS HOUS
   FARARO TJ, 1983, SOC NETWORKS, V5, P1, DOI 10.1016/0378-8733(83)90013-8
   Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7
   Garlaschelli D, 2003, NATURE, V423, P165, DOI 10.1038/nature01604
   Huberman BA, 1999, NATURE, V401, P131, DOI 10.1038/43604
   IHME COVID-19 forecasting team, 2020, MOD COVID 19 SECN US
   Jusup M, 2015, PHYS LIFE REV, V15, P43, DOI 10.1016/j.plrev.2015.09.006
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   Kretzschmar M, 1996, MATH BIOSCI, V133, P165, DOI 10.1016/0025-5564(95)00093-3
   Legido-Quigley H, 2020, LANCET, V395, P848, DOI 10.1016/S0140-6736(20)30551-1
   Liu YW, 2020, J AM STAT ASSOC, DOI 10.1080/01621459.2020.1831926
   Maier BF, 2020, SCIENCE, V368, P742, DOI 10.1126/science.abb4557
   Majdandzic A, 2014, NAT PHYS, V10, P34, DOI [10.1038/NPHYS2819, 10.1038/nphys2819]
   Mckee M, 2020, NAT MED, V26, P640, DOI 10.1038/s41591-020-0863-y
   Miller IF, 2020, NAT MED, V26, P1212, DOI 10.1038/s41591-020-0952-y
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200
   Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925
   Paterlini Marta, 2020, Nature, V580, P574, DOI 10.1038/d41586-020-01098-x
   Rapoport A, 1989, SOME ASPECTS EPIDEMI, P327
   Sha D, 2020, TRANSPORT RES REC, V2674, P215, DOI 10.1177/0361198120936252
   Vargas-Hernandez RA, 2020, J PHYS CHEM A, V124, P4053, DOI 10.1021/acs.jpca.0c01375
   WHO, 2020, REP WHO CHIN JO MISS
   Zaric Gregory S, 2002, Health Care Manag Sci, V5, P147, DOI 10.1023/A:1014489218178
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zlatic V., BISTABILITY SUDR K M
NR 44
TC 1
Z9 1
U1 2
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-0779
EI 1873-2887
J9 CHAOS SOLITON FRACT
JI Chaos Solitons Fractals
PD SEP
PY 2021
VL 150
AR 111200
DI 10.1016/j.chaos.2021.111200
EA JUL 2021
PG 16
WC Mathematics, Interdisciplinary Applications; Physics, Multidisciplinary;
   Physics, Mathematical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Mathematics; Physics
GA UD5OW
UT WOS:000687256800014
PM 34177135
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Rathi, H
   Burman, V
   Datta, SK
   Rana, SV
   Mirza, AA
   Saha, S
   Kumar, R
   Naithani, M
AF Rathi, Himani
   Burman, Vishakha
   Datta, Sudip Kumar
   Rana, Satya Vati
   Mirza, Anissa Atif
   Saha, Sarama
   Kumar, Raman
   Naithani, Manisha
TI Review on COVID-19 Etiopathogenesis, Clinical Presentation and Treatment
   Available with Emphasis on ACE2
SO INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY
LA English
DT Review
DE Severe acute respiratory syndrome coronavirus-2 (SARS-COV-2); Novel
   coronavirus disease-2019 (COVID-19); Etiopathogenesis; Clinical trials
ID ANGIOTENSIN-CONVERTING-ENZYME; HOSPITALIZED-PATIENTS; CORONAVIRUS
   OUTBREAK; GLOBAL HEALTH; SYSTEM; VIRUS; WUHAN; DRUG; MERS; SARS
AB In December 2019, Wuhan city in the Hubei province of China reported for the first time a cluster of patients infected with a novel coronavirus, since then there has been an outburst of this disease across the globe affecting millions of human inhabitants. Severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2), is a member of beta coronavirus family which upon exposure caused a highly infectious disease called novel coronavirus disease-2019 (COVID-19). COVID-19, a probably bat originated disease was declared by World Health Organization (WHO) as a global pandemic in March 2020. Since then, despite rigorous global containment and quarantine efforts, the disease has affected nearly 56,261,952 laboratory confirmed human population and caused deaths of over 1,349,506 lives worldwide. Virus passes in majority through respiratory droplets and then enters lung epithelial cells by binding to angiotensin converting enzyme 2 (ACE2) receptor and there it undergoes replication and targeting host cells causing severe pathogenesis. Majority of human population exposed to SARS-CoV-2 having fully functional immune system undergo asymptomatic infection while 5-10% are symptomatic and only 1-2% are critically affected and requires ventilation support. Older people or people with co-morbidities are severely affected by COVID-19. These categories of patients also display cytokine storm due to dysfunctional immune response which brutally destroys the affected organs and may lead to death in some. Real time PCR is still considered as standard method of diagnosis along with other serology, radiological and biochemical investigations. Till date, no specific validated medication is available for the treatment of COVID-19 patients. Thus, this review provides detailed knowledge about the different landscapes of disease incidence, etiopathogenesis, involvement of various organs, diagnostic criteria's and treatment guidelines followed for management of COVID-19 infection since its inception. In conclusion, extensive research to recognize novel pathways and their cross talk to combat this virus in precarious settings is our future positive hope.
C1 [Rathi, Himani; Rana, Satya Vati; Mirza, Anissa Atif; Saha, Sarama; Kumar, Raman; Naithani, Manisha] All India Inst Med Sci, Dept Biochem, Rishikesh, Uttarakhand, India.
   [Burman, Vishakha] SVBP Univ Agr & Technol, Dept Biotechnol, Meerut, Uttar Pradesh, India.
   [Datta, Sudip Kumar] All India Inst Med Sci, Dept Lab Med, New Delhi, India.
RP Kumar, R (corresponding author), All India Inst Med Sci, Dept Biochem, Rishikesh, Uttarakhand, India.
EM raman_baliyan1987@yahoo.co.in
RI naithani, manisha/AAS-1909-2021; Saha, Sarama/AAS-2070-2021
OI naithani, manisha/0000-0002-0984-4176; KUMAR, RAMAN/0000-0001-7817-3364
CR Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18
   Krishnan RA, 2020, INDIAN J CLIN BIOCHE, V35, P285, DOI 10.1007/s12291-020-00906-5
   Azhar M, 2020, BIORXIV, DOI [10.1101/2020.04.07.028167, DOI 10.1101/2020.04.07.028167]
   Balayan T, 2017, AIDS RES TREAT, V2017, DOI 10.1155/2017/2345617
   Banales JM, 2019, NAT REV GASTRO HEPAT, V16, P269, DOI 10.1038/s41575-019-0125-y
   Begum Feroza, 2020, F1000Res, V9, P371, DOI 10.12688/f1000research.23805.1
   Bindom SM, 2010, DIABETES, V59, P2540, DOI 10.2337/db09-0782
   Bloch EM, 2020, J CLIN INVEST, V130, P2757, DOI 10.1172/JCI138745
   Caly Leon, 2020, Antiviral Res, V178, P104787, DOI 10.1016/j.antiviral.2020.104787
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Centers for Disease Control and Prevention, 2020, COR DIS 2019 COVID 1
   Chandwani Ashish, 2008, Ther Clin Risk Manag, V4, P1023
   Chavez S, 2021, AM J EMERG MED, V44, P220, DOI 10.1016/j.ajem.2020.03.036
   chen d, 2020, HYPOKALEMIA CLIN IMP, DOI [10.1101/2020.02.27.20028530, DOI 10.1101/2020.02.27.20028530]
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chitranshi N, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02448-z
   Chowell G, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0450-0
   Chu DKW, 2020, CLIN CHEM, V66, P549, DOI 10.1093/clinchem/hvaa029
   Biancatelli RMLC, 2020, EXPERT REV ANTI-INFE, V18, P99, DOI 10.1080/14787210.2020.1706483
   Coutard B, 2020, ANTIVIR RES, V176, DOI 10.1016/j.antiviral.2020.104742
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   Cunningham AC, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2818-6
   Das SK, 2020, INDIAN J CLIN BIOCHE, V35, P385, DOI 10.1007/s12291-020-00919-0
   de Wilde AH, 2018, CURR TOP MICROBIOL, V419, P1, DOI 10.1007/82_2017_25
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1
   Du YX, 2020, CLIN PHARMACOL THER, V108, P242, DOI 10.1002/cpt.1844
   El-Sahly HM, 2000, CLIN INFECT DIS, V31, P96, DOI 10.1086/313937
   Fan ZY, 2020, CLIN GASTROENTEROL H, V18, P1561, DOI 10.1016/j.cgh.2020.04.002
   Fang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071433
   Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461
   Forni D, 2017, TRENDS MICROBIOL, V25, P35, DOI 10.1016/j.tim.2016.09.001
   Furuta Y, 2017, P JPN ACAD B-PHYS, V93, P449, DOI 10.2183/pjab.93.027
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015
   Golchin A, 2019, CURR STEM CELL RES T, V14, P22, DOI 10.2174/1574888X13666180913123424
   Gombart AF, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010236
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Grant WB, 2020, NUTRIENTS, V12, DOI 10.3390/nu12040988
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Harmer D, 2002, FEBS LETT, V532, P107, DOI 10.1016/S0014-5793(02)03640-2
   Harrison C, 2020, NAT BIOTECHNOL, V38, P379, DOI 10.1038/d41587-020-00003-1
   Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228
   Hassan SS, 2020, GENOMICS, V112, P3890, DOI 10.1016/j.ygeno.2020.07.001
   Himani, 2020, INDIAN J BIOCHEM BIO, V57, P236
   Himani, 2020, INDIAN J CLIN BIOCHE, V35, P80, DOI 10.1007/s12291-018-0797-z
   Hindson J, 2020, NAT REV GASTRO HEPAT, V17, P259, DOI 10.1038/s41575-020-0295-7
   Hoffmann M, 2020, NOVEL CORONAVIRUS 20, P1, DOI [10.1016/j.cell.2020.02.052, 10.1101/2020.01.31.929042, DOI 10.1101/2020.01.31.929042]
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Huang C., 2020, FAVIPIRAVIR VERSUS A, DOI [10.1101/2020.03.17.20037432, DOI 10.1101/2020.03.17.20037432]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Ibrahim H, 2020, CLIN IMMUNOL, V219, DOI 10.1016/j.clim.2020.108544
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   Jarvis L. M., 2020, C EN, V98, P5
   Ji HL, 2020, PHYSIOL REV, V100, P1065, DOI 10.1152/physrev.00013.2020
   Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682
   Jia HP, 2016, SHOCK, V46, P239, DOI 10.1097/SHK.0000000000000633
   Jiang F, 2020, J GEN INTERN MED, V35, P1545, DOI 10.1007/s11606-020-05762-w
   Soler MJ, 2013, NEPHROL DIAL TRANSPL, V28, P2687, DOI 10.1093/ndt/gft320
   Kadam RU, 2017, P NATL ACAD SCI USA, V114, P206, DOI 10.1073/pnas.1617020114
   Kang CK, 2017, J KOREAN MED SCI, V32, P744, DOI 10.3346/jkms.2017.32.5.744
   Kellner MJ, 2019, NAT PROTOC, V14, P2986, DOI 10.1038/s41596-019-0210-2
   Khan A, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1823-x
   Kiely DG, 1997, CARDIOVASC RES, V33, P201, DOI 10.1016/S0008-6363(96)00180-0
   Koka V, 2008, AM J PATHOL, V172, P1174, DOI 10.2353/ajpath.2008.070762
   Kuba K, 2010, PHARMACOL THERAPEUT, V128, P119, DOI 10.1016/j.pharmthera.2010.06.003
   Kumar R, 2021, VIRUS RES, V292, DOI [10.1016/j.viruses.2020.198235, 10.1016/j.virusres.2020.198235]
   Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1
   Lei GS, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01226-17
   Leng ZK, 2020, AGING DIS, V11, P216, DOI 10.14336/AD.2020.0228
   Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9
   Li YC, 2011, J INVEST MED, V59, P868, DOI 10.2310/JIM.0b013e31820ee448
   Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728
   Lin L, 2020, GUT, V69, P997, DOI 10.1136/gutjnl-2020-321013
   Lin M, 2016, MOL BIOL REP, V43, P397, DOI 10.1007/s11033-016-3971-5
   Lingeswaran M, 2020, INDIAN J CLIN BIOCHE, V35, P260, DOI 10.1007/s12291-020-00897-3
   Lippi G, 2020, CLIN CHEM LAB MED, V58, P1131, DOI [10.1515/cclm-2020-1761, 10.1515/cclm-2020-0198]
   Liu J, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0156-0
   Liu T, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012421
   Liu YX, 2020, SCI CHINA LIFE SCI, V63, P364, DOI 10.1007/s11427-020-1643-8
   Lu CL, 2014, INT J MOL MED, V34, P1293, DOI 10.3892/ijmm.2014.1917
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Mitra P, 2020, ANN NATL ACAD MED SC, V56, P102, DOI DOI 10.1055/s-0040-1714159
   Mitra P, 2020, INDIAN J CLIN BIOCHE, V35, P257, DOI 10.1007/s12291-020-00886-6
   Monteagudo LA, 2020, ACR OPEN RHEUMATOL, V2, P276, DOI 10.1002/acr2.11135
   Morales-Ortega A, 2020, CLIN IMMUNOL, V218, DOI 10.1016/j.clim.2020.108518
   Mousavi S, 2019, EUR J MICROBIOL IMMU, V9, P73, DOI 10.1556/1886.2019.00016
   Mousavizadeh L, 2021, J MICROBIOL IMMUNOL, V54, P159, DOI 10.1016/j.jmii.2020.03.022
   Narayanan K, 2015, VIRUS RES, V202, P89, DOI 10.1016/j.virusres.2014.11.019
   Nazinitsky A, 2010, INFECT DIS CLIN PRAC, V18, P188, DOI DOI 10.1097/IPC.0B013E3181D2EE41
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Ohtsuki M, 2010, INT J CARDIOL, V145, P333, DOI 10.1016/j.ijcard.2009.11.057
   Oudit GY, 2010, J CARD FAIL, V16, pS16, DOI 10.1016/j.cardfail.2010.06.054
   Patel VB, 2016, CIRC RES, V118, P1313, DOI 10.1161/CIRCRESAHA.116.307708
   Paz Ocaranza Maria, 2020, Nat Rev Cardiol, V17, P116, DOI 10.1038/s41569-019-0244-8
   Ralph R, 2020, J INFECT DEV COUNTR, V14, P3, DOI 10.3855/jidc.12425
   Ramamoorthy S, 2016, RHEUM DIS CLIN N AM, V42, P15, DOI 10.1016/j.rdc.2015.08.002
   Reina J, 2020, REV ESP QUIM, V33, P176, DOI 10.37201/req/028.2020
   Rokni M, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2107
   Rondanelli M, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/5813095
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Satyam A, 2020, CLIN IMMUNOL, V221, DOI 10.1016/j.clim.2020.108603
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6
   Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6
   Song ZQ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010059
   South AM, 2020, NAT REV NEPHROL, V16, P305, DOI 10.1038/s41581-020-0279-4
   South AM, 2020, AM J PHYSIOL-HEART C, V318, pH1084, DOI 10.1152/ajpheart.00217.2020
   Srinivas Pavithra, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc030
   Stolz D, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00407-2019
   Tahamtan A, 2020, EXPERT REV MOL DIAGN, V20, P453, DOI 10.1080/14737159.2020.1757437
   Tang A, 2020, EMERG INFECT DIS, V26, P1337, DOI 10.3201/eid2606.200301
   Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036
   Thabet Lamia, 2020, Tunis Med, V98, P304
   Tikellis Chris, 2012, Int J Pept, V2012, P256294, DOI 10.1155/2012/256294
   Tikellis C, 2011, CURR OPIN NEPHROL HY, V20, P62, DOI 10.1097/MNH.0b013e328341164a
   Tiwari M, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104441
   Turner AJ, 2004, TRENDS PHARMACOL SCI, V25, P291, DOI 10.1016/j.tips.2004.04.001
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang N, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00298
   Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748
   Wei R, 2015, NUTRIENTS, V7, P8251, DOI 10.3390/nu7105392
   Wong SH, 2020, J GASTROEN HEPATOL, V35, P744, DOI 10.1111/jgh.15047
   World Health Organization, 2020, COR DIS COVID 19 SIT, V114
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Xia JH, 2020, J MED VIROL, V92, P589, DOI 10.1002/jmv.25725
   Xia S, 2020, CELL MOL IMMUNOL, V17, P765, DOI 10.1038/s41423-020-0374-2
   Xiao F, 2020, GASTROENTEROLOGY, V158, P1831, DOI 10.1053/j.gastro.2020.02.055
   Xiong Y, 2020, EMERG MICROBES INFEC, V9, P761, DOI 10.1080/22221751.2020.1747363
   Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yan, 2020, SPECIFIC ACE2 EXPRES, DOI 10.1101/2020.02.03.931766
   Yang SNY, 2020, ANTIVIR RES, V177, DOI 10.1016/j.antiviral.2020.104760
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196
   Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204
   Yu F, 2020, MICROBES INFECT, V22, P74, DOI 10.1016/j.micinf.2020.01.003
   Yuan YM, 2015, J RENIN-ANGIO-ALDO S, V16, P249, DOI 10.1177/1470320315576256
   Zhang B, 2020, J CHEM RES, V44, P571, DOI 10.1177/1747519820912675
   Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1
   Zhang NR, 2014, EXPERT REV VACCINES, V13, P761, DOI 10.1586/14760584.2014.912134
   Zhang RF, 2009, AM J PHYSIOL-LUNG C, V297, pL631, DOI 10.1152/ajplung.90415.2008
   Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071
   Zhao DH, 2020, CLIN INFECT DIS, V71, P756, DOI 10.1093/cid/ciaa247
   Zhao Yu, 2020, American Journal of Respiratory and Critical Care Medicine, V202, P756, DOI 10.1164/rccm.202001-0179LE
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhou D, 2020, J ANTIMICROB CHEMOTH, V75, P1667, DOI 10.1093/jac/dkaa114
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 156
TC 4
Z9 4
U1 0
U2 1
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0970-1915
EI 0974-0422
J9 INDIAN J CLIN BIOCHE
JI Indian J. Clin. Biochem.
PD JAN
PY 2021
VL 36
IS 1
BP 3
EP 22
DI 10.1007/s12291-020-00953-y
EA JAN 2021
PG 20
WC Biochemistry & Molecular Biology
WE Emerging Sources Citation Index (ESCI)
SC Biochemistry & Molecular Biology
GA PU3AP
UT WOS:000604220300001
PM 33424145
OA Bronze, Green Published
DA 2022-04-20
ER

EF
